FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Abd El-Hakeem, EE
   Kaki, AM
   Almazlom, SA
   Alsayyad, AJ
AF Abd El-Hakeem, E. E.
   Kaki, A. M.
   Almazlom, S. A.
   Alsayyad, A. J.
TI Laparoscopic partial nephrectomy in a patient on simvastatin Delayed
   recovery from neuromuscular blockade
SO ANAESTHESIST
LA English
DT Article
DE Delayed recovery; General anesthesia; Hypercholesterolemia;
   Neuromuscular blockade; Simvastatin
ID RESIDUAL PARALYSIS; MUSCLE-RELAXANTS; BLOCKING-AGENTS; SUGAMMADEX;
   REVERSAL; ROCURONIUM; RHABDOMYOLYSIS; NEOSTIGMINE; DURATION; DRUGS
AB Delayed recovery from anesthesia remains a very challenging subject for anesthesiologists. This case report describes the clinical course of delayed recovery from neuromuscular blockade after laparoscopic partial nephrectomy in a patient on simvastatin. The patient was hypertensive on regular treatment with oral captopril 25 mg twice daily and amlodipine 5 mg once daily and hypercholesterolemic on regular simvastatin 40 mg once daily with a normal electrocardiogram (ECG). All preoperative laboratory findings were within normal ranges. The patient was premedicated with midazolam 1 mg and general anesthesia was induced with fentanyl 2 A mu g/kg body weight, propofol 2 mg/kg and rocuronium bromide 0.6 mg/kg to facilitate tracheal intubation. Anesthesia was maintained with inhalation of isoflurane 1.0-1.5 % in 40 % oxygen-enriched air and 25 A mu g boluses of fentanyl. The patient did not require any additional rocuronium throughout surgery which was finished after 4 h. The patient most probably had preoperative simvastatin-induced myotoxicity. This potentiated the muscle relaxant effect of rocuronium bromide and was the reason for patient unresponsiveness and delayed postoperative recovery. We can conclude that anesthesiologists should preoperatively identify statin myotoxicity and to avoid neuromuscular blocking drugs for statin-treated patients. Also, preoperative adjustment of statin dosage may be recommended.
C1 [Abd El-Hakeem, E. E.] Assiut Univ, Fac Med, Dept Anaesthesiol, Assiut, Egypt.
   [Kaki, A. M.; Almazlom, S. A.] King Abdulaziz Univ, Fac Med, Dept Anaesthesiol, Jeddah, Saudi Arabia.
   [Alsayyad, A. J.] King Abdulaziz Univ, Fac Med, Dept Urol, Jeddah, Saudi Arabia.
RP Abd El-Hakeem, EE (reprint author), Assiut Univ, Fac Med, Dept Anaesthesiol, Assiut, Egypt.
EM esezzat@hotmail.com
CR ARGOV Z, 1979, NEW ENGL J MED, V301, P409
   Bays H, 2006, AM J CARDIOL, V97, p6C, DOI 10.1016/j.amjcard.2005.12.006
   CALDWELL JE, 1995, ANESTH ANALG, V80, P1168, DOI 10.1097/00000539-199506000-00018
   Debaene B, 2003, ANESTHESIOLOGY, V98, P1042, DOI 10.1097/00000542-200305000-00004
   FELDMAN SA, 1963, BRIT J ANAESTH, V35, P546, DOI 10.1093/bja/35.9.546
   Femando PUE, 1987, ACTA ANAESTH SCAND, V31, P593
   Floyd JS, 2012, JAMA-J AM MED ASSOC, V307, P1580, DOI 10.1001/jama.2012.489
   Fuchs-Buder T, 2012, CURR OPIN ANESTHESIO, V25, P217, DOI 10.1097/ACO.0b013e32834f012d
   Gotto AM, 2006, AM J CARDIOL, V97, p3C, DOI 10.1016/j.amjcard.2005.12.005
   Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585
   GROB D, 1976, ANN NY ACAD SCI, V274, P143, DOI 10.1111/j.1749-6632.1976.tb47683.x
   Grosse-Sundrup M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6329
   Groudine SB, 2007, ANESTH ANALG, V104, P555, DOI 10.1213/01.ane.00002601358.46070.c3
   Husband A, 2009, CLIN PHARM, V1, P319
   Jahr JS, 2015, AM J THER, V22, P288, DOI 10.1097/MJT.0000000000000092
   Jones RK, 2008, ANESTHESIOLOGY, V109, P816, DOI 10.1097/ALN.0b013e31818a3fee
   KirkegaardNielsen H, 1996, CAN J ANAESTH, V43, P932
   Kumar V Vijay, 2011, Indian J Anaesth, V55, P433, DOI 10.4103/0019-5049.84836
   Link E, 2008, NEW ENGL J MED, V359, P789
   MARTYN JAJ, 1980, ANESTHESIOLOGY, V52, P352
   Maybauer DM, 2007, ANAESTHESIA, V62, P12, DOI 10.1111/j.1365-2044.2006.04862.x
   MITCHELL MM, 1978, ANESTHESIOLOGY, V49, P44, DOI 10.1097/00000542-197807000-00014
   Osmer C, 1996, EUR J ANAESTH, V13, P389, DOI 10.1046/j.1365-2346.1996.00993.x
   Plummer-Roberts Anna L, 2016, AANA J, V84, P57
   Saranagi S, 2009, INTERNET J ANESTHESI, DOI [10.5580/914, DOI 10.5580/914]
   Schaller Stefan Josef, 2013, Core Evid, V8, P57, DOI 10.2147/CE.S35675
   Shaikh SI, 2014, INT J BIOMED ADV RES, V5, P252
   Silverman D G, 1992, J Clin Anesth, V4, P28, DOI 10.1016/0952-8180(92)90116-I
   Thompson PD, 2006, AM J CARDIOL, V97, p69C, DOI 10.1016/j.amjcard.2005.12.013
NR 29
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0003-2417
EI 1432-055X
J9 ANAESTHESIST
JI Anaesthesist
PD JUN
PY 2017
VL 66
IS 6
BP 422
EP 425
DI 10.1007/s00101-017-0284-6
PG 4
WC Anesthesiology
SC Anesthesiology
GA EX6PO
UT WOS:000403364400005
PM 28265685
OA No
DA 2017-08-17
ER

PT J
AU Moawad, AR
   Tan, SL
   Taketo, T
AF Moawad, Adel R.
   Tan, Seang Lin
   Taketo, Teruko
TI Beneficial effects of glutathione supplementation during vitrification
   of mouse oocytes at the germinal vesicle stage on their preimplantation
   development following maturation and fertilization in vitro
SO CRYOBIOLOGY
LA English
DT Article
DE GV-oocyte vitrification; In vitro maturation; Glutathione
   supplementation; Blastocyst development
ID L-CARNITINE SUPPLEMENTATION; MATURING HAMSTER OOCYTES; BOVINE OOCYTES;
   HUMAN EMBRYOS; CRYOPRESERVATION; CULTURE; NUCLEAR; BLASTOCYSTS; BANKING;
   MEDIA
AB Oocyte cryopreservation is imperative for assisted reproductive technologies (ART). Although cryopreservation of oocytes at the Metaphase II has been widely used, immature oocytes at the germinal vesicle stage (GV-oocytes) need to be cryopreserved in certain situations such as cancer patients; however, the success rate of embryonic development from the GV-oocytes remains low largely due to the requirement for in vitro maturation (IVM). Our aim was to investigate the effects of glutathione (GSH) supplementation during vitrification and warming of mouse GV-oocytes on the preservation of developmental competence. GV-oocytes within cumulus oocyte complexes (COCs) were collected from C57BL/6J (B6) and (B6.DBA)F1 mouse strains and subjected to vitrification and warming, followed by IVM. The vitrification, warming or IVM medium was supplemented with GSH at 0-4.0 mM. In vitro matured oocytes were then fertilized in vitro and cultured in KSOMaa up to 4 days. The first cleavage and blastocyst development were evaluated morphologically, and their rates were statistically analysed by one-way ANOVA followed by Tukey's multiple comparisons test. The difference was considered significant at P < 0.05. The results showed that GSH supplementation in the IVM medium exhibited no or rather inhibitory effects on the first cleavage or blastocyst development in both mouse strains except that 1.0 mM GSH increased the blastocyst development rate in B6. By contrast, 1 mM GSH supplementation during vitrification and warming increased the blastocyst development rate in both mouse strains, more efficiently in B6 than (B6.DBA)F1. In conclusion, GSH supplementation during vitrification and warming of GV-oocytes protects the oocytes from freezing-inflicted loss of developmental competence. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Moawad, Adel R.; Taketo, Teruko] McGill Univ, Dept Surg, Montreal, PQ, Canada.
   [Tan, Seang Lin; Taketo, Teruko] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ, Canada.
   [Taketo, Teruko] McGill Univ, Dept Biol, Montreal, PQ, Canada.
   [Tan, Seang Lin] McGill Univ, Div Reprod Endocrinol & Infertil, MUHC Reprod Ctr, Montreal, PQ, Canada.
   [Tan, Seang Lin] OriginElle Fertil Clin, Montreal, PQ, Canada.
   [Tan, Seang Lin] Womens Hlth Ctr, Montreal, PQ, Canada.
   [Moawad, Adel R.] Cairo Univ, Fac Vet Med, Dept Theriogenol, Giza, Egypt.
RP Taketo, T (reprint author), McGill Univ, Ctr Hlth, Res Inst, Room EM03220,1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.
EM teruko.taketo@mcgill.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Mitacs Elevate Postdoctoral Fellowship [IT00308]
FX This work was partially supported by the Natural Sciences and
   Engineering Research Council of Canada (NSERC) Discovery Grant and
   Mitacs Elevate Postdoctoral Fellowship (IT00308) to ARM.
CR Aono N, 2005, FERTIL STERIL, V84, P1078, DOI 10.1016/j.fertnstert.2005.03.077
   Aono N, 2003, J REPROD DEVELOP, V49, P501, DOI 10.1262/jrd.49.501
   Balaban B, 2005, REPROD BIOMED ONLINE, V10, P485
   Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004
   Baughman JM, 2006, NAT GENET, V38, P1232, DOI 10.1038/ng1106-1232
   Biggers JD, 1998, INT J DEV BIOL, V42, P879
   Boquest AC, 1999, THERIOGENOLOGY, V51, P1311, DOI 10.1016/S0093-691X(99)00075-8
   Chian RC, 2009, FERTIL STERIL, V91, P372, DOI 10.1016/j.fertnstert.2007.11.088
   Cobo A, 2011, REPROD BIOMED ONLINE, V23, P341, DOI 10.1016/j.rbmo.2011.05.014
   Eppig JJ, 1996, REPROD FERT DEVELOP, V8, P485, DOI 10.1071/RD9960485
   Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175
   Gupta MK, 2010, FERTIL STERIL, V93, P2602, DOI 10.1016/j.fertnstert.2010.01.043
   Huang JYJ, 2010, AM J SURG, V200, P177, DOI 10.1016/j.amjsurg.2009.04.004
   Isachenko V, 2006, FERTIL STERIL, V85, P741, DOI 10.1016/j.fertnstert.2005.08.047
   Ishizuka Y, 2013, THERIOGENOLOGY, V80, P421, DOI 10.1016/j.theriogenology.2013.07.002
   Kim DH, 2007, J REPROD DEVELOP, V53, P843, DOI 10.1262/jrd.18155
   Kim SS, 2011, FERTIL STERIL, V95, P1535, DOI 10.1016/j.fertnstert.2011.01.003
   Kopeika J, 2015, HUM REPROD UPDATE, V21, P209, DOI 10.1093/humupd/dmu063
   Le Du A, 2005, HUM REPROD, V20, P420, DOI 10.1093/humrep/deh603
   Lee HH, 2015, HUM REPROD, V30, P2110, DOI 10.1093/humrep/dev170
   LEGGE M, 1991, HUM REPROD, V6, P867
   LIEBERMAN MW, 1995, AM J PATHOL, V147, P1175
   Loutradi KE, 2008, FERTIL STERIL, V90, P186, DOI 10.1016/j.fertnstert.2007.06.010
   Luvoni GC, 1996, MOL REPROD DEV, V43, P437, DOI 10.1002/(SICI)1098-2795(199604)43:4<437::AID-MRD5>3.0.CO;2-Q
   Mikkelsen AL, 2005, REPROD BIOMED ONLINE, V10, P593
   Moawad AR, 2014, HUM REPROD, V29, P2256, DOI 10.1093/humrep/deu201
   Moawad AR, 2013, CRYOLETTERS, V34, P634
   Moawad AR, 2013, REPROD FERT DEVELOP, V25, P1204, DOI 10.1071/RD12215
   Moawad AR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107433
   Moawad AR, 2012, CRYOBIOLOGY, V65, P139, DOI 10.1016/j.cryobiol.2012.04.008
   Moawad AR, 2011, CELL REPROGRAM, V13, P289, DOI 10.1089/cell.2010.0089
   Nagy ZP, 2009, FERTIL STERIL, V92, P520, DOI 10.1016/j.fertnstert.2008.06.005
   Noyes N, 2010, J ASSIST REPROD GEN, V27, P69, DOI 10.1007/s10815-009-9382-y
   Ozawa M, 2006, MOL REPROD DEV, V73, P998, DOI 10.1002/mrd.20533
   PERREAULT SD, 1988, DEV BIOL, V125, P181, DOI 10.1016/0012-1606(88)90070-X
   Rao GD, 2004, LANCET, V363, P1829, DOI 10.1016/S0140-6736(04)16320-4
   Rosen Allison, 2009, Semin Oncol Nurs, V25, P268, DOI 10.1016/j.soncn.2009.08.004
   Ruppert-Lingham CJ, 2003, HUM REPROD, V18, P392, DOI 10.1093/humrep/deg071
   Shahedi A, 2013, EUR J OBSTET GYN R B, V167, P69, DOI 10.1016/j.ejogrb.2012.11.006
   Somfai T, 2010, THERIOGENOLOGY, V73, P147, DOI 10.1016/j.theriogenology.2009.08.008
   Son WY, 2008, REPROD BIOMED ONLINE, V17, P59
   Son WY, 2009, EXPERT REV MED DEVIC, V6, P1, DOI 10.1586/17434440.6.1.1
   Takahashi M, 1999, MOL REPROD DEV, V54, P1, DOI 10.1002/(SICI)1098-2795(199909)54:1<1::AID-MRD1>3.0.CO;2-0
   Tamas S, 2007, CRYOBIOLOGY, V55, P115, DOI 10.1016/j.cryobiol.2007.06.008
   Tharasanit T, 2009, REPRODUCTION, V137, P391, DOI 10.1530/REP-08-0333
   TOTH TL, 1994, FERTIL STERIL, V61, P1077
   Tucker MJ, 1998, FERTIL STERIL, V70, P578, DOI 10.1016/S0015-0282(98)00205-2
   Vieira AD, 2002, CRYOBIOLOGY, V45, P91, DOI 10.1016/S0011-2240(02)00109-8
   Wu J, 2001, REPRODUCTION, V121, P389
   Zhao XM, 2011, MOL REPROD DEV, V78, P942, DOI 10.1002/mrd.21389
   Zuelke KA, 2003, MOL REPROD DEV, V64, P106, DOI 10.1002/mrd.10214
NR 51
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
EI 1090-2392
J9 CRYOBIOLOGY
JI Cryobiology
PD JUN
PY 2017
VL 76
BP 98
EP 103
DI 10.1016/j.cryobiol.2017.04.002
PG 6
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA EX4GV
UT WOS:000403193400012
PM 28412286
OA No
DA 2017-08-17
ER

PT J
AU Fahmy, NM
   Al-Sayed, E
   Abdel-Daim, MM
   Singab, AN
AF Fahmy, Nouran M.
   Al-Sayed, Eman
   Abdel-Daim, Mohamed M.
   Singab, Abdel Nasser
TI Anti-Inflammatory and Analgesic Activities of Terminalia Muelleri Benth.
   (Combretaceae)
SO DRUG DEVELOPMENT RESEARCH
LA English
DT Article
DE carrageenan; chebulinic acid; cytokines; hot-plate test; isoorientin
ID EXPERIMENTAL-MODELS; IN-VIVO; ANTIOXIDANT; RATS; FLAVONOIDS; EXTRACTS;
   CHEBULA; FRUITS
AB The anti-inflammatory and analgesic activities of a polyphenol-rich fraction (TMEF) obtained from Terminalia muelleri Benth. were measured. The analgesic activity of TMEF was tested using acetic acid-induced writhing and hot plate models in mice. The anti-inflammatory activity was assessed using carrageenan-induced paw edema model by measuring PGE(2), TNF-, IL-1, and IL-6 plasma levels as well as the paw thickness. TMEF was tested at doses of 100, 200, and 400 mg/kg p.o. and diclofenac sodium was used as a standard (100 mg/kg) in all experiments. The group treated with 400 mg/kg of TMEF showed a greater inhibition in the number of writhes (by 63%) than the standard-treated group (61%). Pretreatment with TMEF increased the analgesic effect in hot plate test in a dose-dependent manner with a maximum effect after 120 min. TMEF pretreatment alos reduced the edema thickness by 48, 53, and 62% at the tested doses, respectively. TMEF administration inhibited the carrageenan-induced elevations in PGE(2) (by 34, 43, and 47%), TNF- (18, 28, and 41%), IL-1 (14, 22, and 29%), and IL-6 (26, 31, and 46%). Four phenolic compounds were isolated from Terminalia muelleri for the first time. Drug Dev Res 78 : 146-154, 2017. (c) 2017 Wiley Periodicals, Inc.
C1 [Fahmy, Nouran M.; Al-Sayed, Eman; Singab, Abdel Nasser] Ain Shams Univ, Dept Pharmacognosy, Fac Pharm, Cairo 11566, Egypt.
   [Abdel-Daim, Mohamed M.] Suez Canal Univ, Dept Pharmacol, Fac Vet Med, Ismailia 41522, Egypt.
RP Abdel-Daim, MM (reprint author), Suez Canal Univ, Dept Pharmacol, Fac Vet Med, Ismailia 41522, Egypt.
EM abdeldaim.m@vet.suez.edu.eg
OI Abdel-Daim, Mohamed/0000-0002-4341-2713; Singab, Abdel
   nasser/0000-0001-7445-963X
FU Egyptian Science and Technology Development Funds (STDF) [5251]
FX The authors acknowledge the Egyptian Science and Technology Development
   Funds (STDF) for its financial support through the grant (No. 5251)
   entitled "Center for Drug Discovery and Development Research". The
   authors are also grateful to Dr. Maarit Karonen, Department of
   Chemistry, University of Turku Finland, for measuring the HRESIMS.
CR Abdel-Salam OME, 2005, THESCIENTIFICWORLDJO, V5, P586, DOI 10.1100/tsw.2005.78
   Al-Sayed E, 2015, PHYTOMEDICINE, V22, P5, DOI 10.1016/j.phymed.2014.10.002
   Al-Sayed E, 2015, MED CHEM RES, V24, P1438, DOI 10.1007/s00044-014-1218-3
   Al-Sayed E, 2012, FOOD CHEM, V133, P1017, DOI 10.1016/j.foodchem.2011.09.036
   Atta AH, 2004, J ETHNOPHARMACOL, V95, P235, DOI 10.1016/j.jep.2004.07.006
   Bink A, 2012, J INFECT DIS, V206, P1790, DOI 10.1093/infdis/jis594
   BRUCE RD, 1985, FUND APPL TOXICOL, V5, P151, DOI 10.1016/0272-0590(85)90059-4
   DERAEDT R, 1980, EUR J PHARMACOL, V61, P17, DOI 10.1016/0014-2999(80)90377-5
   Eesha BR, 2011, ASIAN PAC J TROP MED, V4, P466, DOI 10.1016/S1995-7645(11)60127-2
   Eldahshan OA, 2015, CYTOTECHNOLOGY, V67, P831, DOI 10.1007/s10616-014-9723-2
   Esmat A, 2012, J MED FOOD, V15, P278, DOI 10.1089/jmf.2011.0099
   Fahmy N, 2015, MED AROMAT PLANTS, V4, DOI [10.4172/2167-0412.1000218, DOI 10.4172/2167-0412.1000218]
   Fahmy NM, 2016, PHARM BIOL, V54, P303, DOI 10.3109/13880209.2015.1035794
   Ghosh S, 2013, MED CHEM RES, V22, P4347, DOI 10.1007/s00044-012-0449-4
   Gilman EF, 2013, TERMINALIA MUELLERI
   Latha RCR, 2011, CHEM-BIOL INTERACT, V189, P112, DOI 10.1016/j.cbi.2010.11.005
   Laughlin TM, 2002, J PHARMACOL EXP THER, V302, P1168, DOI 10.1124/jpet.302.3.1168
   Lee CJ, 2010, FOOD CHEM, V118, P315, DOI 10.1016/j.foodchem.2009.04.123
   Libby P, 2006, AM J CLIN NUTR, V83, p456S
   Mabry T. J., 1970, SYSTEMATIC IDENTIFIC
   Nair V, 2010, J PHARM PHARMACOL, V62, P1801, DOI 10.1111/j.2042-7158.2010.01193.x
   Pfundstein B, 2010, PHYTOCHEMISTRY, V71, P1132, DOI 10.1016/j.phytochem.2010.03.018
   Ponou BK, 2010, PHYTOCHEMISTRY, V71, P2108, DOI 10.1016/j.phytochem.2010.08.020
   Rayyan S, 2010, J AGR FOOD CHEM, V58, P7211, DOI 10.1021/jf100848c
   Rogerio AP, 2006, J PHARM PHARMACOL, V58, P1265, DOI 10.1211/jpp.58.9.0014
   Stace CA., 2007, COMBRETACEAE
   Talwar S, 2011, J ETHNOPHARMACOL, V134, P323, DOI 10.1016/j.jep.2010.12.015
   Tunalier Z, 2007, J ETHNOPHARMACOL, V110, P539, DOI 10.1016/j.jep.2006.10.024
   Wang Y, 2014, J ETHNOPHARMACOL, V151, P944, DOI 10.1016/j.jep.2013.12.003
   Wen P., 2007, ASIAN J TRAD MED, V2, P149
   YAKSH TL, 1976, SCIENCE, V192, P1357, DOI 10.1126/science.1273597
   Yang BR, 2012, J AGR FOOD CHEM, V60, P8672, DOI 10.1021/jf302925v
   Zucolotto SM, 2009, PLANTA MED, V75, P1221, DOI 10.1055/s-0029-1185536
NR 33
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4391
EI 1098-2299
J9 DRUG DEVELOP RES
JI Drug Dev. Res.
PD JUN
PY 2017
VL 78
IS 3-4
BP 146
EP 154
DI 10.1002/ddr.21385
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EX5KT
UT WOS:000403281700003
PM 28524398
OA No
DA 2017-08-17
ER

PT J
AU Mohamed, HT
   Untereiner, V
   Sockalingum, GD
   Brezillon, S
AF Mohamed, Hossam Taha
   Untereiner, Valerie
   Sockalingum, Ganesh D.
   Brezillon, Stephane
TI Implementation of infrared and Raman modalities for glycosaminoglycan
   characterization in complex systems
SO GLYCOCONJUGATE JOURNAL
LA English
DT Review
DE Glycosaminoglycans; Infrared spectroscopy; Raman spectroscopy; CHO-WT;
   CHO-745; Chondrocytes; Conditioned media; Data analysis
ID EXTENDED THERMODYNAMIC APPROACH; ION-INTERACTION CHROMATOGRAPHY; TANDEM
   MASS-SPECTROMETRY; WET-SPUN FILMS; CHONDROITIN SULFATE;
   CAPILLARY-ELECTROPHORESIS; DERMATAN SULFATE; IR SPECTROMETRY;
   HYALURONIC-ACID; STRUCTURAL-CHARACTERIZATION
AB Glycosaminoglycans (GAGs) are natural, linear and negatively charged heteropolysaccharides which are incident in every mammalian tissue. They consist of repeating disaccharide units, which are composed of either sulfated or non-sulfated monosaccharides. Depending on tissue types, GAGs exhibit structural heterogeneity such as the position and degree of sulfation or within their disaccharide units composition being heparin, heparan sulfate, chondroitine sulfate, dermatan sulfate, keratan sulfate, and hyaluronic acid. They are covalently linked to a core protein (proteoglycans) or as free chains (hyaluronan). GAGs affect cell properties and functions either by direct interaction with cell receptors or by sequestration of growth factors. These evidences of divert biological roles of GAGs make their characterization at cell and tissue levels of importance. Thus, non-invasive techniques are interesting to investigate, to qualitatively and quantitatively characterize GAGs in vitro in order to use them as diagnostic biomarkers and/or as therapeutic targets in several human diseases including cancer. Infrared and Raman microspectroscopies and imaging are sensitive enough to differentiate and classify GAG types and subtypes in spite of their close molecular structures. Spectroscopic markers characteristic of reference GAG molecules were identified. Beyond these investigations of the standard GAG spectral signature, infrared and Raman spectral signatures of GAG were searched in complex biological systems like cells. The aim of the present review is to describe the implementation of these complementary vibrational spectroscopy techniques, and to discuss their potentials, advantages and disadvantages for GAG analysis. In addition, this review presents new data as we show for the first time GAG infrared and Raman spectral signatures from conditioned media and live cells, respectively.
C1 [Mohamed, Hossam Taha] Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt.
   [Mohamed, Hossam Taha; Untereiner, Valerie; Sockalingum, Ganesh D.; Brezillon, Stephane] CNRS, UMR7369, Matrice Extracellulaire & Dynam Cellulaire MEDyC, Reims, France.
   [Mohamed, Hossam Taha; Untereiner, Valerie; Sockalingum, Ganesh D.] UFR Pharm, MeDIAN Biophoton & Technol Sante, Reims, France.
   [Untereiner, Valerie] Univ Reims, PICT, Reims, France.
   [Brezillon, Stephane] Univ Reims, UFR Med, Lab Biochim Med & Biol Mol, Reims, France.
RP Brezillon, S (reprint author), CNRS, UMR7369, Matrice Extracellulaire & Dynam Cellulaire MEDyC, Reims, France.; Brezillon, S (reprint author), Univ Reims, UFR Med, Lab Biochim Med & Biol Mol, Reims, France.
EM stephane.brezillon@univ-reims.fr
OI Mohamed, Hossam/0000-0003-1989-5783
FU European commission; funding scheme Marie Sklodovska-Curie; Research of
   Innovation Staff Exchange (RISE); GLYCANC [645756]; Ligue Nationale
   contre le Cancer (Comite de la Marne et Comite de Haute-Marne,
   Conference de Coordination InterRegionale du Grand Est (CCIR-GE));
   FEDER; Region Champagne-Ardenne CPER);  [H2020-MSCA-RISE-2014]
FX Financial support from the European commission, H2020-MSCA-RISE-2014,
   funding scheme Marie Sklodovska-Curie, Research of Innovation Staff
   Exchange (RISE), GLYCANC ID 645756, the Ligue Nationale contre le Cancer
   (Comite de la Marne et Comite de Haute-Marne, Conference de Coordination
   InterRegionale du Grand Est (CCIR-GE)), the FEDER and the Region
   Champagne-Ardenne (CPER 2015-2019), is gratefully acknowledged. The
   authors thank the Reims PICT-IBiSA Platform.
CR Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x
   Atha DH, 1996, J PHARM SCI-US, V85, P52, DOI 10.1021/js950216c
   Baker MJ, 2016, CHEM SOC REV, V45, P1803, DOI 10.1039/c5cs00585j
   BANSIL R, 1978, BIOCHIM BIOPHYS ACTA, V541, P535, DOI 10.1016/0304-4165(78)90163-0
   Behnke B, 1996, ANAL CHEM, V68, P1110, DOI 10.1021/ac950925a
   Bergholt MS, 2016, J BIOPHOTONICS, V9, P333, DOI 10.1002/jbio.201400141
   Brauchle E, 2014, CLIN EXP DERMATOL, V39, P636, DOI 10.1111/ced.12357
   Brezillon S, 2014, ANAL BIOANAL CHEM, V406, P5795, DOI 10.1007/s00216-014-7994-2
   Brezillon S, 2013, FEBS J, V280, P2369, DOI 10.1111/febs.12210
   Butler HJ, 2016, NAT PROTOC, V11, P664, DOI 10.1038/nprot.2016.036
   BYCHKOV S M, 1981, Byulleten' Eksperimental'noi Biologii i Meditsiny, V91, P442
   CABASSI F, 1978, CARBOHYD RES, V63, P1, DOI 10.1016/S0008-6215(00)80924-6
   Cecchi T, 2009, J CHROMATOGR A, V1216, P5164, DOI 10.1016/j.chroma.2009.04.088
   Cecchi T, 2001, ANAL CHEM, V73, P2632, DOI 10.1021/ac001341y
   Cecchi T, 2001, CHROMATOGRAPHIA, V54, P589, DOI 10.1007/BF02492183
   Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277
   Chang YQ, 2012, ANAL BIOCHEM, V427, P91, DOI 10.1016/j.ab.2012.05.004
   Chen SG, 2011, CARBOHYD POLYM, V83, P688, DOI 10.1016/j.carbpol.2010.08.040
   Craig D, 2014, ANAL CHEM, V86, P4775, DOI 10.1021/ac4038762
   Draux F, 2011, ANALYST, V136, P2718, DOI 10.1039/c0an00998a
   Draux F, 2010, ANAL BIOANAL CHEM, V397, P2727, DOI 10.1007/s00216-010-3759-8
   Draux F, 2009, ANALYST, V134, P542, DOI 10.1039/b812610k
   Duchez S, 2011, EUR J IMMUNOL, V41, P3632, DOI 10.1002/eji.201140865
   Ellis R, 2009, CONNECT TISSUE RES, V50, P29, DOI 10.1080/03008200802398422
   Esko J. D., 2009, ESSENTIALS GLYCOBIOL
   Foot M, 2005, J PHARMACEUT BIOMED, V38, P397, DOI 10.1016/j.jpba.2005.01.026
   FURA A, 1993, ANAL CHEM, V65, P2805, DOI 10.1021/ac00068a017
   Garnjanagoonchorn W, 2007, CHEM ENG PROCESS, V46, P465, DOI 10.1016/j.cep.2006.05.019
   GILLI R, 1994, CARBOHYD RES, V263, P315, DOI 10.1016/0008-6215(94)00147-2
   GRANT D, 1991, BIOCHEM J, V275, P193
   GRANT D, 1990, BIOCHEM SOC T, V18, P1277
   GRANT D, 1990, BIOCHEM SOC T, V18, P1279
   GRANT D, 1990, BIOCHEM SOC T, V18, P1281
   Haxaire K, 2003, BIOPOLYMERS, V72, P149, DOI 10.1002/bip.10342
   Haxaire K, 2003, BIOPOLYMERS, V72, P10, DOI 10.1002/bip.10245
   Hileman RE, 1997, GLYCOBIOLOGY, V7, P231
   Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200
   Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609
   Itano N, 1999, CANCER RES, V59, P2499
   Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393
   Jones CJ, 2011, ANNU REV ANAL CHEM, V4, P439, DOI 10.1146/annurev-anchem-061010-113911
   JUHASZ P, 1994, P NATL ACAD SCI USA, V91, P4333, DOI 10.1073/pnas.91.10.4333
   Kamilari E., 2013, 9 PANH SCI CHEM ENG
   Karousou E, 2015, METHODS MOL BIOL, V1229, P143, DOI 10.1007/978-1-4939-1714-3_14
   Karousou E, 2014, MOLECULES, V19, P7959, DOI 10.3390/molecules19067959
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Lamari FN, 2002, BIOMED CHROMATOGR, V16, P95, DOI 10.1002/bmc.144
   LEE SA, 1993, J BIOMOL STRUCT DYN, V11, P191
   Li BYZ, 2011, METHODS MOL BIOL, V690, P285, DOI 10.1007/978-1-60761-962-8_19
   Liu CY, 2012, METHODS MOL BIOL, V836, P285, DOI 10.1007/978-1-61779-498-8_18
   Liu ZL, 2010, BIOCHEMISTRY-US, V49, P9839, DOI 10.1021/bi101305b
   LONGAS MO, 1991, ANAL BIOCHEM, V192, P193, DOI 10.1016/0003-2697(91)90205-8
   LONGAS MO, 1986, BIOCHIM BIOPHYS ACTA, V884, P265, DOI 10.1016/0304-4165(86)90172-8
   LONGAS MO, 1987, CARBOHYD RES, V159, P127, DOI 10.1016/S0008-6215(00)90010-7
   Maccari F, 2016, GLYCOCONJUGATE J, V33, P181, DOI 10.1007/s10719-016-9655-5
   MacNair JE, 1997, ANAL CHEM, V69, P983, DOI 10.1021/ac961094r
   Mainreck N, 2012, METHODS MOL BIOL, V836, P117, DOI 10.1007/978-1-61779-498-8_8
   Mainreck N, 2011, J PHARM SCI-US, V100, P441, DOI 10.1002/jps.22288
   Mao WJ, 2002, BIOMED CHROMATOGR, V16, P77, DOI 10.1002/bmc.153
   Marechal Y, 2003, BIOPOLYMERS, V72, P162, DOI 10.1002/bip.10343
   Miller GJ, 2014, CARBOHYD RES, V400, P44, DOI 10.1016/j.carres.2014.06.026
   Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499
   Netelenbos T, 2003, LEUKEMIA, V17, P175, DOI 10.1038/sj.leu.2402738
   ORR SFD, 1954, BIOCHIM BIOPHYS ACTA, V14, P173, DOI 10.1016/0006-3002(54)90156-0
   Pacella Elena, 2015, Ophthalmol Eye Dis, V7, P1, DOI 10.4137/OED.S17204
   Parker F. S, 1983, APPL INFRARED RAMAN
   PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83
   Plaas AH., 2001, METHODS MOL BIOL, V171
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Reineck I, 2003, J BIOMOL STRUCT DYN, V21, P153
   REINHOLD VN, 1995, ANAL CHEM, V67, P1772, DOI 10.1021/ac00107a005
   Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005
   Ruiz-Calero V, 2001, J CHROMATOGR A, V914, P277, DOI 10.1016/S0021-9673(00)01181-X
   Schwertfeger KL, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00236
   Servaty R, 2001, INT J BIOL MACROMOL, V28, P121, DOI 10.1016/S0141-8130(00)00161-6
   Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10359, DOI 10.1073/pnas.97.19.10359
   Siddiqui MF., 2016, AM J OBSTET GYNECOL, VS0002-9378
   Souza-Fernandes AB, 2006, CRIT CARE, V10, DOI 10.1186/cc5069
   Takagaki K, 1998, GLYCOBIOLOGY, V8, P719, DOI 10.1093/glycob/8.7.719
   Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001
   TERHO T, 1966, NATURE, V211, P198, DOI 10.1038/211198a0
   Tfayli A, 2007, BIOPOLYMERS, V87, P261, DOI 10.1002/bip.20832
   Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622
   Volpi N, 2009, ANAL BIOCHEM, V388, P140, DOI 10.1016/j.ab.2009.02.012
   Wang WB, 2015, J BIOPHOTONICS, V8, P527, DOI 10.1002/jbio.201400026
   Yang HO, 2000, GLYCOBIOLOGY, V10, P1033, DOI 10.1093/glycob/10.10.1033
   Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174
   Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082
   Zamfir A, 2002, RAPID COMMUN MASS SP, V16, P2015, DOI 10.1002/rcm.820
NR 91
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0282-0080
EI 1573-4986
J9 GLYCOCONJUGATE J
JI Glycoconjugate J.
PD JUN
PY 2017
VL 34
IS 3
SI SI
BP 309
EP 323
DI 10.1007/s10719-016-9743-6
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EX5ZX
UT WOS:000403322800005
PM 27928742
OA No
DA 2017-08-17
ER

PT J
AU Tawfik, DM
   Ahmad, TA
   Sheweita, SA
   Haroun, M
   El-Sayed, LH
AF Tawfik, Dina M.
   Ahmad, Tarek A.
   Sheweita, Salah A.
   Haroun, Medhat
   El-Sayed, Laila H.
TI The detection of antigenic determinants of Acinetobacter baumannii
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE Acinetobacter baumannii; Vaccines; Epitope mapping; Lipopolysaccharide;
   Outer membrane protein
ID PASSIVE-IMMUNIZATION; INFECTION-CONTROL; 1ST STEP; T-CELLS; VACCINES;
   POLYSACCHARIDE; EPIDEMIOLOGY; MEMBRANE; PROTEINS; LIPIDS
AB Background: Acinetobacter baumannii continues to pose a threat to burdened patients in ICUs all around the world. Lately, infection control techniques are not sufficient to curb A. baumannii's progression and chemotherapeutics are losing their potency against it. Thus, immunization became a key player in providing an ideal solution to the dilemma. None of the vaccines under investigation have reached the market and the search for a tailored vaccine remains a challenge. The notion of unravelling the bacterial antigens to design a novel epitope-based vaccine proved its merits.
   Methods: In this work, the propitious polysaccharide and protein antigenic determinants of A. baumannii were mapped by mimicking the infection. The immune response was evaluated by western blot, ELISA, and cellular proliferation assay techniques.
   Results: The screening showed that OMPs induced the most eminent sustained IgG response. In addition, OMP gave the highest cellular proliferation and a fold increase in ELISA that reached up to 10-fold by week 6. Whilst, the LPS gave a rapid IgM response, that reached 5-fold and the response was visible from week 1 in the western blot. The OMPs had a more pronounced effect in eliciting a cellular immune response.
   Conclusion: The results elaborated the valuable role of using pure OMPs and detoxified LPS together; as a major cornerstone in designing an ideal vaccine against A. baumannii.
C1 [Tawfik, Dina M.; Sheweita, Salah A.; Haroun, Medhat] Alexandria Univ, Biotechnol Dept, Inst Grad Studies & Res, Alexandria, Egypt.
   [Tawfik, Dina M.; Ahmad, Tarek A.; El-Sayed, Laila H.] Alexandria Univ, SeptivaK Res Grp, Dept Immunol, Med Res Inst, Alexandria, Egypt.
   [Ahmad, Tarek A.] Bibliotheca Alexandrina, Special Projects Dept, Alexandria, Egypt.
   [El-Sayed, Laila H.] Alexandria Univ, Med Res Inst, Immunol & Allergy Dept, Alexandria, Egypt.
RP Ahmad, TA (reprint author), Alexandria Univ, SeptivaK Res Grp, Dept Immunol, Med Res Inst, Alexandria, Egypt.; Ahmad, TA (reprint author), Bibliotheca Alexandrina, Special Projects Dept, Alexandria, Egypt.
EM Tarek.adnan.ahmad@gmail.com
CR Ahmad T. A., 2016, Trials in Vaccinology, V5, P53, DOI 10.1016/j.trivac.2016.03.001
   Ahmad T. A., 2016, TRIALS VACCINOLOGY, V5, P71, DOI DOI 10.1016/J.TRIVAC.2016.04.003
   Ahmad TA, 2016, VACCINE REPORTS, V6, P13
   Alzubaidi A.N.A., 2015, AM J BIOMED, V3, P59
   Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125
   Araujo A., 2015, J EXPERIM APP ANIM S, V1, P336
   Bieback K, 2003, J GEN VIROL, V84, P1179, DOI 10.1099/vir.0.19027-0
   Bonin RF, 2014, PROTEOM CLIN APPL, V8, P916, DOI 10.1002/prca.201300133
   Castro -Concha L., 2006, PLANT CELL CULTURE P, P71
   Chiang MH, 2015, HUM VACC IMMUNOTHER, V11, P1065, DOI 10.1080/21645515.2015.1010910
   Childs LM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0245
   Cross AS, 2014, VIRULENCE, V5, P219, DOI 10.4161/viru.25965
   El-Kholy A, 2012, AM J INFECT CONTROL, V40, pE216, DOI 10.1016/j.ajic.2011.12.010
   Faddin J. F. Mac, 2016, BIOCH TESTS IDENTIFI, P1976
   Fagon JY, 2000, ANN INTERN MED, V132, P621
   FILIP C, 1973, J BACTERIOL, V115, P717
   Garcia-Quintanilla M, 2013, CURR PHARM BIOTECHNO, V14, P897
   Gershoni JM, 2007, BIODRUGS, V21, P145, DOI 10.2165/00063030-200721030-00002
   Gunzer M, 2001, J IMMUNOL METHODS, V258, P55, DOI 10.1016/S0022-1759(01)00466-5
   Hawley JS, 2007, ANTIMICROB AGENTS CH, V51, P376, DOI 10.1128/AAC.00858-06
   HITCHCOCK PJ, 1983, EUR J BIOCH, V133
   Huang W., 2014, PLOS ONE, V9
   Karlyshev AV, 2001, INFECT IMMUN, V69, P5921, DOI 10.1128/IAI.69.9.5921-5924.2001
   Kubler-Kielb J, 2011, METHODS MOL BIOL, V751, P317, DOI 10.1007/978-1-61779-151-2_20
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lin L, 2012, MBIO, V3, DOI 10.1128/mBio.00312-12
   McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10
   McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052
   McConnell M. J., FEMS MICROBIOL REV, V37
   McFarland J, 1907, J AMER MED ASSOC, V49, P1176
   MEYER TS, 1965, BIOCHIM BIOPHYS ACTA, V107, P144, DOI 10.1016/0304-4165(65)90403-4
   Morgan DJ, 2010, INFECT CONT HOSP EP, V31, P716, DOI 10.1086/653201
   NNIS National nosocomial infections surveillance (NNIS), 1996, AM J INFECT CONTROL, V24
   Oncul O, 2002, J HOSP INFECT, V51, P47, DOI 10.1053/jhin.2002.1205
   Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06
   Porsch-ozciirtimez M., 2004, CLIN DIAG LAB IMMUN, V11
   Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Rosenthal VD, 2014, AM J INFECT CONTROL, V42, P942, DOI 10.1016/j.ajic.2014.05.029
   Russo TA, 2013, INFECT IMMUN, V81, P915, DOI 10.1128/IAI.01184-12
   SCHMID P, 1973, PHYSIOL CHEM PHYS M, V5, P141
   Solomon S, 2003, AM J INFECT CONTROL, V31, P481
   Strassle P, 2012, AM J INFECT CONTROL, V40, P1005, DOI 10.1016/j.ajic.2012.05.027
   Sydnor ERM, 2011, CLIN MICROBIOL REV, V24, P141, DOI 10.1128/CMR.00027-10
   TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2
   VANDERMEER NM, 1994, INFECT IMMUN, V62, P1052
   Watts J. L., 2008, PERFORMANCE STANDARD
   WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6
   WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83
NR 49
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
EI 1879-0542
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUN
PY 2017
VL 186
BP 59
EP 67
DI 10.1016/j.imlet.2017.04.004
PG 9
WC Immunology
SC Immunology
GA EX3JY
UT WOS:000403129600010
PM 28427887
OA No
DA 2017-08-17
ER

PT J
AU Tammam, RH
   Saleh, MM
AF Tammam, Reham H.
   Saleh, Mahmoud M.
TI On the electrocatalytic urea oxidation on nickel oxide nanoparticles
   modified glassy carbon electrode
SO JOURNAL OF ELECTROANALYTICAL CHEMISTRY
LA English
DT Article
DE Urea; Oxidation; Nanoparticles E; lectrocatalysis; Nickel
ID ALKALINE-MEDIUM; HYDROGEN-PRODUCTION; ELECTROCHEMICAL IMPEDANCE; GLUCOSE
   ELECTROOXIDATION; BINARY CATALYST; FORMIC-ACID; MECHANISM; AMMONIA;
   ARRAYS; WATER
AB Electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) are used here to investigate the electrochemical characteristics of the urea oxidation on nickel oxide (NiOx) nanoparticles modified glassy carbon (GC) electrode from alkaline 0.5 M NaOH solution. The effects of NiOx loading and urea concentration on urea electrocatalytic oxidation are discussed in the light of the EIS data and corresponding equivalent circuits. The Nyquist plots show semicircles with fitting parameters that are dependent on the applied conditions. Charge transfer resistance is found to be lower in presence of urea due to higher rates of urea electrooxidation. Cyclic voltammetry (CV) helps to investigate the catalytic properties of urea oxidation on the GC/NiOx. The relation between the peak current of urea oxidation and the potential scan rate are measured and fitted with that calculated by Randles-Sevcik equation. The results indicate a diffusion-controlled irreversible process. Optimization of the loading extent of NiOx and interpretation of the effect of urea concentration is enabled from the CVs, EIS and equivalent circuit parameters.
C1 [Tammam, Reham H.; Saleh, Mahmoud M.] Cairo Univ, Fac Sci, Dept Chem, Cairo, Egypt.
   [Saleh, Mahmoud M.] King Faisal Univ, Coll Sci, Chem Dept, Al Hasa, Saudi Arabia.
RP Tammam, RH; Saleh, MM (reprint author), Cairo Univ, Fac Sci, Dept Chem, Cairo, Egypt.; Saleh, MM (reprint author), King Faisal Univ, Coll Sci, Chem Dept, Al Hasa, Saudi Arabia.
EM reham_tammam@cu.edu.eg; mmsaleh@kfu.edu.sa
CR Adekunle AS, 2008, ELECTROCHIM ACTA, V53, P5774, DOI 10.1016/j.electacta.2008.03.044
   Barakat NAM, 2016, J MOL CATAL A-CHEM, V421, P83, DOI 10.1016/j.molcata.2016.05.011
   Barakat NAM, 2016, APPL CATAL A-GEN, V510, P180, DOI 10.1016/j.apcata.2015.11.015
   Bard A. J., 1980, ELECTROCHEMICAL METH
   Bode H., 1966, ELECTROCHIM ACTA, V11, P1079, DOI 10.1016/0013-4686(66)80045-2
   Boggs BK, 2009, CHEM COMMUN, P4859, DOI 10.1039/b905974a
   Bradley H.J., 2005, WATER RES, V39, P2245
   Cataldo M.H., 2014, DIAM RELAT MATER, V44, P109
   Cibrev D, 2013, INT J HYDROGEN ENERG, V38, P2746, DOI 10.1016/j.ijhydene.2012.12.027
   Czerwinski A, 1999, J POWER SOURCES, V77, P28, DOI 10.1016/S0378-7753(98)00162-1
   Danaee I, 2008, ELECTROCHIM ACTA, V53, P6602, DOI 10.1016/j.electacta.2008.04.042
   Danaee I, 2010, ELECTROCHIM ACTA, V55, P2093, DOI 10.1016/j.electacta.2009.11.039
   Danaee I, 2009, INT J HYDROGEN ENERG, V34, P859, DOI 10.1016/j.ijhydene.2008.10.067
   Daramola DA, 2010, J PHYS CHEM A, V114, P11513, DOI 10.1021/jp105159t
   Das D, 2001, INT J HYDROGEN ENERG, V26, P13, DOI 10.1016/S0360-3199(00)00058-6
   Ding R, 2014, NANOSCALE, V6, P1369, DOI 10.1039/c3nr05359h
   El-Refaei SM, 2013, J POWER SOURCES, V223, P125, DOI 10.1016/j.jpowsour.2012.08.098
   El-Refaei SM, 2013, ELECTROCHIM ACTA, V92, P460, DOI 10.1016/j.electacta.2013.01.024
   Guo F, 2016, ELECTROCHIM ACTA, V210, P474, DOI 10.1016/j.electacta.2016.05.149
   Guo F, 2015, J POWER SOURCES, V278, P562, DOI 10.1016/j.jpowsour.2014.12.125
   Jara CC, 2008, J APPL ELECTROCHEM, V38, P915, DOI 10.1007/s10800-008-9496-4
   Ji RY, 2013, ELECTROCHEM COMMUN, V29, P21, DOI 10.1016/j.elecom.2013.01.006
   Jiang JY, 2008, ENVIRON SCI TECHNOL, V42, P3059, DOI 10.1021/es702466k
   King RL, 2011, J POWER SOURCES, V196, P2773, DOI 10.1016/j.jpowsour.2010.11.006
   Lan R, 2011, J POWER SOURCES, V196, P5021, DOI 10.1016/j.jpowsour.2011.02.015
   Liang YH, 2015, ELECTROCHIM ACTA, V153, P456, DOI 10.1016/j.electacta.2014.11.193
   McCubbin DR, 2002, ENVIRON SCI TECHNOL, V36, P1141, DOI 10.1021/es010705g
   Nguyen NS, 2016, BIOSENS BIOELECTRON, V77, P372, DOI 10.1016/j.bios.2015.09.046
   Prakash S, 2013, BIOSENS BIOELECTRON, V41, P43, DOI 10.1016/j.bios.2012.09.031
   Rice C, 2002, J POWER SOURCES, V111, P83, DOI 10.1016/S0378-7753(02)00271-9
   Rong L., 2010, ENERG ENVIRON SCI, V3, P438
   Salimi A, 2007, ANAL CHEM, V79, P7431, DOI 10.1021/ac0702948
   Simka W, 2009, J APPL ELECTROCHEM, V39, P1137, DOI 10.1007/s10800-008-9771-4
   Sorensen B., 2005, HYDROGEN FUEL CELLS, V217
   Tammam RH, 2014, J POWER SOURCES, V246, P178, DOI 10.1016/j.jpowsour.2013.07.068
   TERBLANCHE APS, 1991, WATER SA, V17, P77
   Toghill KE, 2010, SENSOR ACTUAT B-CHEM, V147, P642, DOI 10.1016/j.snb.2010.03.091
   Vedharathinam V, 2013, ELECTROCHIM ACTA, V108, P660, DOI 10.1016/j.electacta.2013.06.137
   Vedharathinam V, 2012, ELECTROCHIM ACTA, V81, P292, DOI 10.1016/j.electacta.2012.07.007
   Vidotti M, 2008, ELECTROCHIM ACTA, V53, P4030, DOI 10.1016/j.electacta.2007.11.029
   Vilana J, 2016, APPL SURF SCI, V360, P816, DOI 10.1016/j.apsusc.2015.11.072
   Vitse F, 2005, J POWER SOURCES, V142, P18, DOI 10.1016/j.jpowsour.2004.09.043
   Wang D, 2013, ELECTROCHIM ACTA, V89, P732, DOI 10.1016/j.electacta.2012.11.046
   Wang D, 2012, J POWER SOURCES, V217, P498, DOI 10.1016/j.jpowsour.2012.06.029
   Wang L, 2015, J POWER SOURCES, V280, P550, DOI 10.1016/j.jpowsour.2015.01.141
   Wu MS, 2014, J POWER SOURCES, V272, P711, DOI 10.1016/j.jpowsour.2014.09.009
   Wu MS, 2014, ELECTROCHIM ACTA, V144, P194, DOI 10.1016/j.electacta.2014.08.098
   Yan W, 2014, ELECTROCHIM ACTA, V134, P266, DOI 10.1016/j.electacta.2014.03.134
   Yan W, 2012, APPL CATAL B-ENVIRON, V127, P221, DOI 10.1016/j.apcatb.2012.08.022
   Yu HQ, 2002, INT J HYDROGEN ENERG, V27, P1359, DOI 10.1016/S0360-3199(02)00073-3
   Zhang WB, 2016, ELECTROCHEM COMMUN, V63, P1, DOI 10.1016/j.elecom.2015.12.004
   Zhou L, 2008, INT J HYDROGEN ENERG, V33, P5897, DOI 10.1016/j.ijhydene.2008.08.009
NR 52
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1572-6657
EI 1873-2569
J9 J ELECTROANAL CHEM
JI J. Electroanal. Chem.
PD JUN 1
PY 2017
VL 794
BP 189
EP 196
DI 10.1016/j.jelechem.2017.04.023
PG 8
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA EX3JK
UT WOS:000403128200026
OA No
DA 2017-08-17
ER

PT J
AU Zahra, WK
AF Zahra, W. K.
TI Trigonometric B-Spline Collocation Method for Solving PHI-Four and
   Allen-Cahn Equations
SO MEDITERRANEAN JOURNAL OF MATHEMATICS
LA English
DT Article
DE Time-dependent problems; PHI-Four equation; Allen-Cahn equation;
   trigonometric B-spline; collocation method; convergence analysis; von
   Neumann stability
ID FISHERS EQUATION; NUMERICAL-SOLUTION
AB In this paper, we develop a numerical solution based on non-polynomial B-spline (trigonometric B-spline) collocation method for solving time-dependent equations involving PHI-Four and Allen-Cahn equations. A three-time-level implicit algorithm has been derived. This algorithm combines the trigonometric B-spline interpolant and the theta-weighted scheme for space and time discretization, respectively. Convergence analysis is discussed and the accuracy of the presented method is O(tau(2) + h(2)). Applying von Neumann stability analysis, the proposed technique is shown to be unconditionally stable. Three test problems are demonstrated to reveal that our method is reliable, efficient and very encouraging.
C1 [Zahra, W. K.] Tanta Univ, Fac Engn, Dept Phys & Engn Math, Tanta 31521, Egypt.
   [Zahra, W. K.] Egypt Japan Univ Sci & Technol, Dept Math, Basic & Appl Sci Sch, Alexandria 21934, Egypt.
RP Zahra, WK (reprint author), Tanta Univ, Fac Engn, Dept Phys & Engn Math, Tanta 31521, Egypt.; Zahra, WK (reprint author), Egypt Japan Univ Sci & Technol, Dept Math, Basic & Appl Sci Sch, Alexandria 21934, Egypt.
EM wzahra@f-eng.tanta.edu.eg
CR Abd Hamid N., 2010, WORLD ACAD SCI ENG T, V4, P276
   ALOFI AS, 2013, WORLD APPL SCI J, V21, P62, DOI DOI 10.5829/idosi.wasj.2013.21.mae.99920
   Benes M, 2004, APPL NUMER MATH, V51, P187, DOI 10.1016/j.apnum.2004.05.001
   Bhrawy A.H., 2013, BOUND VALUE PROBL, V87, P1
   Dag I, 2010, NUMER METH PART D E, V26, P1483, DOI 10.1002/num.20507
   Ehsani F., 2013, TECH J ENG APPL SCI, V14, P1378
   Gupta Y., 2011, INT J COMPUTER APPL, V30, P21
   Hariharan G, 2014, J MEMBRANE BIOL, V247, P371, DOI 10.1007/s00232-014-9638-z
   Hariharan G., 2009, APPL MATH SCI, V3, P2523
   Ishtiaq A., 2011, INT J NONLINEAR SCI, V11, P380
   LYCHE T, 1979, J APPROX THEORY, V25, P266, DOI 10.1016/0021-9045(79)90017-0
   Mittal RC, 2010, INT J COMPUT MATH, V87, P3039, DOI 10.1080/00207160902878555
   Mohammadi R., 2013, APPL MATH, V4, P933
   Mohammadi R, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/5/050206
   Najafi M., 2012, INT J APPL MATH RES, V4, P659
   Nikolis A., 2004, APPL MATH E NOTES, V4, P142
   Nikolis A., 2005, APPL MATH E NOTES, V5, P116
   Prenter P. M., 1975, SPLINE VARIATIONAL M
   Sahin A, 2008, KYBERNETES, V37, P326, DOI 10.1108/03684920810851212
   Sassaman R, 2009, COMMUN NONLINEAR SCI, V14, P3239, DOI 10.1016/j.cnsns.2008.12.020
   Soliman A.A., 2009, INT J NONLINEAR SCI, V3, P274
   Triki H., 2005, PHYS LETT A, V373, P2162
   Triki H, 2013, APPL MATH MODEL, V37, P3821, DOI 10.1016/j.apm.2012.07.031
   Walz G, 1997, BIT, V37, P189, DOI 10.1007/BF02510180
   Wazwaz A., 2012, J KING SAUD U, V25, P129
   Zahra WK, 2013, AIP CONF PROC, V1558, P568, DOI 10.1063/1.4825554
   Zahra W.K., 2016, ACTA U APUL, V46, P35
   Zahra W.K., 2016, COMMUN ADV COMPUT SC, V2, P1
NR 28
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1660-5446
EI 1660-5454
J9 MEDITERR J MATH
JI Mediterr. J. Math.
PD JUN
PY 2017
VL 14
IS 3
AR UNSP 122
DI 10.1007/s00009-017-0916-8
PG 19
WC Mathematics, Applied; Mathematics
SC Mathematics
GA EX6FM
UT WOS:000403338100023
OA No
DA 2017-08-17
ER

PT J
AU Kashif, I
   Ratep, A
AF Kashif, I.
   Ratep, A.
TI Effect of copper addition on BO4, H2O groups and optical properties of
   lithium lead borate glass
SO OPTICAL AND QUANTUM ELECTRONICS
LA English
DT Article
DE Lead lithium borate glass; FTIR; Optical band gap; Type of transition
ID NUCLEAR-MAGNETIC-RESONANCE; STRUCTURAL-PROPERTIES; TETRABORATE GLASSES;
   PHYSICAL-PROPERTIES; NEODYMIUM OXIDE; SYSTEM; CONDUCTIVITY; ABSORPTION;
   PBO-SIO2; IONS
AB Lead lithium borate glass samples composition 50Li(2)B(4)O(7)-(50-x)Pb3O4-x CuO, where x = 0-35 mol% were prepared by melt quenching method. The density of the prepared samples was measured and molar volume was calculated. IR spectra were measured for the prepared samples at room temperature to investigate the glass structure. The IR spectra were deconvoluted using curves of Gaussian shape at approximately the same frequencies. The deconvoluted data were used to study the effect of CuO content on all the structural borate and water groups. The optical band gap obtained directly from absorption coefficient, refractive index and extinction coefficient, also by using the Tauc model. The type of transition is determined by the simple and accurate method.
C1 [Kashif, I.] Al Azhar Univ, Fac Sci, Phys Dept, Cairo 11884, Egypt.
   [Ratep, A.] Ain Shams Univ, Fac Girls, Phys Dept, Cairo, Egypt.
RP Kashif, I (reprint author), Al Azhar Univ, Fac Sci, Phys Dept, Cairo 11884, Egypt.
EM ismailkashif52@yahoo.com
CR Abdel-Khalek EK, 2016, J NON-CRYST SOLIDS, V441, P58, DOI 10.1016/j.jnoncrysol.2016.03.015
   ALANI SKJ, 1985, J MATER SCI, V20, P661, DOI 10.1007/BF01026540
   Bhogi A, 2015, J NON-CRYST SOLIDS, V426, P47, DOI 10.1016/j.jnoncrysol.2015.06.012
   Coelho J, 2012, SPECTROCHIM ACTA A, V86, P392, DOI 10.1016/j.saa.2011.10.054
   Cormack A. N., 1996, MOL ENG, V6, P183
   CORMIER G, 1994, J NON-CRYST SOLIDS, V168, P115, DOI 10.1016/0022-3093(94)90126-0
   DAVIS EA, 1970, PHILOS MAG, V22, P903, DOI 10.1080/14786437008221061
   DUPREE R, 1987, PHYS CHEM GLASSES, V28, P78
   Farouk M, 2015, SPECTROCHIM ACTA A, V149, P338, DOI 10.1016/j.saa.2015.04.070
   Gautam Chandkiram, 2012, ISRN Ceramics, DOI 10.5402/2012/428497
   GNUTZMAN.U, 1974, APPL PHYS, V3, P9, DOI 10.1007/BF00892328
   Kamitsos E.I., 1987, GLASS PHYS CHEM+, V28, P203
   Kashif I, 2017, MATER RES BULL, V89, P273, DOI 10.1016/j.materresbull.2017.02.006
   Kashif I, 2015, J MOL STRUCT, V1102, P1, DOI 10.1016/j.molstruc.2015.07.070
   Kashif I, 2015, APPL PHYS A-MATER, V120, P1427, DOI 10.1007/s00339-015-9329-3
   Kashif I, 2015, OPT QUANT ELECTRON, V47, P673, DOI 10.1007/s11082-014-9943-x
   Kashif I, 2014, RESULTS PHYS, V4, P1, DOI 10.1016/j.rinp.2013.11.002
   Kashif I, 2012, J ALLOY COMPD, V539, P124, DOI 10.1016/j.jallcom.2012.04.099
   Kaur S, 2016, J LUMIN, V180, P190, DOI 10.1016/j.jlumin.2016.08.027
   Kumar MP, 2008, MATER SCI-POLAND, V26, P647
   LEVENTHA.M, 1965, PHYS CHEM GLASSES, V6, P113
   Lim SG, 2002, J APPL PHYS, V91, P4500, DOI 10.1063/1.1456246
   Madhuri V., 2015, CHEM SOLIDS, V78, P70
   MASSOT M, 1995, J NON-CRYST SOLIDS, V182, P49, DOI 10.1016/0022-3093(94)00575-3
   MUSIC S, 1994, J MATER SCI, V29, P1227, DOI 10.1007/BF00975069
   MYDLAR MF, 1970, PHYS CHEM GLASSES, V11, P196
   Nadeem M. Y., 2000, TURK J PHYS, V24, P651
   Obayes HK, 2016, MATER DESIGN, V94, P121, DOI 10.1016/j.matdes.2016.01.018
   Othman HA, 2016, J MOL STRUCT, V1106, P286, DOI 10.1016/j.molstruc.2015.10.076
   Pisarski WA, 2005, MAT SCI ENG B-SOLID, V122, P94, DOI 10.1016/j.mseb.2005.05.002
   Raghavaiah BV, 2004, OPT COMMUN, V235, P341, DOI 10.1016/j.optcom.2004.02.082
   RAO BG, 1984, J CHEM SOC FARAD T 1, V80, P3491, DOI 10.1039/f19848003491
   RAO KJ, 1985, J MATER SCI, V20, P1678, DOI 10.1007/BF00555271
   Rosmawati S, 2008, Journal of Applied Sciences, V8, P1956, DOI 10.3923/jas.2008.1956.1961
   Sasi Kumar M.V., 2016, J TAIBAH U IN PRESS
   Singh KJ, 2008, NUCL INSTRUM METH B, V266, P944, DOI 10.1016/j.nimb.2008.02.004
   Soliman AA, 2009, MATER SCI ENG B-ADV, V158, P30, DOI 10.1016/j.mseb.2008.12.034
   TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224
   URBACH F, 1953, PHYS REV, V92, P1324, DOI 10.1103/PhysRev.92.1324
   WANG B, 1991, J NON-CRYST SOLIDS, V134, P249, DOI 10.1016/0022-3093(91)90383-H
   Wen HL, 2016, MATER RES BULL, V83, P400, DOI 10.1016/j.materresbull.2016.06.032
   Zaid MHM, 2016, J NON-CRYST SOLIDS, V449, P107, DOI 10.1016/j.jnoncrysol.2016.07.020
NR 42
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0306-8919
EI 1572-817X
J9 OPT QUANT ELECTRON
JI Opt. Quantum Electron.
PD JUN
PY 2017
VL 49
IS 6
AR 231
DI 10.1007/s11082-017-1067-7
PG 14
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA EX6CC
UT WOS:000403328900031
OA No
DA 2017-08-17
ER

PT J
AU Chini, A
   Ben-Romdhane, W
   Hassairi, A
   Aboul-Soud, MAM
AF Chini, Andrea
   Ben-Romdhane, Walid
   Hassairi, Afif
   Aboul-Soud, Mourad A. M.
TI Identification of TIFY/JAZ family genes in Solanum lycopersicum and
   their regulation in response to abiotic stresses
SO PLOS ONE
LA English
DT Article
ID ARABIDOPSIS JAZ PROTEINS; TRANSCRIPTION FACTORS; ABSCISIC-ACID; LEAF
   GROWTH; JASMONATE; REPRESSION; COMPLEX; MOTIF; EXPRESSION; ZIM
AB Plant phenotypic plasticity determines plant adaptation to changing environments and agricultural productivity. Phytohormones are essential plant signalling molecules regulating this plasticity through complex signalling networks. Jasmonates (JAs) are key phytohormones regulating many aspects of growth, development and defence responses. An important role of JAs in tolerance to abiotic stresses is also emerging. The expression of JAZ (JASMONATE-ZIM-DOMAIN PROTEIN) genes, encoding for the key repressors in the JA-pathway, is regulated by multiple abiotic stresses, suggesting a role for the JAZ proteins in response to these stresses. The JAZ proteins belong to the TIFY family, well described in many plant species. However, only the role of few tomato JAZ proteins in response to microbial infection has been analysed so far. Here, we identify the members of the tomato TIFY family, and characterize them phylogenetically. In addition, we analyse the transcriptional regulation of several SlJAZ in response to abiotic stresses and hormone treatments both in root and leaves to assess their specific expression in response to stresses. Most SlJAZ are JA-induced and responsive to one or more abiotic stresses, providing clues for functional analysis of JAZ genes in abiotic responses in tomato.
C1 [Chini, Andrea] CNB CSIC, Plant Mol Genet Dept, Madrid, Spain.
   [Ben-Romdhane, Walid; Hassairi, Afif] King Saud Univ, Dept Plant Prod, Coll Food & Agr Sci, Riyadh, Saudi Arabia.
   [Ben-Romdhane, Walid; Hassairi, Afif] Univ Sfax, LPAP, CBS, Sfax, Tunisia.
   [Aboul-Soud, Mourad A. M.] King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia.
   [Aboul-Soud, Mourad A. M.] Cairo Univ, Cairo Univ Res Pk, Biochem & Mol Biol Dept, Giza, Egypt.
RP Chini, A (reprint author), CNB CSIC, Plant Mol Genet Dept, Madrid, Spain.; Aboul-Soud, MAM (reprint author), King Saud Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia.; Aboul-Soud, MAM (reprint author), Cairo Univ, Cairo Univ Res Pk, Biochem & Mol Biol Dept, Giza, Egypt.
EM achini@cnb.csic.es; maboulsoud@KSU.EDU.SA
FU National Plan for Science, Technology and Innovation (MAARIFAH); King
   Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia
   [11-BI02119-02]
FX This Project was funded by the National Plan for Science, Technology and
   Innovation (MAARIFAH), King Abdulaziz City for Science and Technology,
   Kingdom of Saudi Arabia, Award Number (11-BIO2119-02).; We would like to
   thank Roberto Solano and Sandra Fonseca for her critical reading of the
   manuscript. This Project was funded by the National Plan for Science,
   Technology and Innovation (MAARIFAH), King Abdulaziz City for Science
   and Technology, Kingdom of Saudi Arabia, Award Number (11-BIO2119-02).
CR Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002
   Chen Xiaodong, 2016, Plant Diversity, V38, P118, DOI 10.1016/j.pld.2016.06.001
   Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006
   Chini A, 2016, CURR OPIN PLANT BIOL, V33, P147, DOI 10.1016/j.pbi.2016.07.005
   Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x
   Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x
   Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x
   Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097
   Clauw P, 2016, PLANT CELL, V28, P2417, DOI 10.1105/tpc.16.00483
   Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161
   Ge LF, 2016, P NATL ACAD SCI USA, V113, P12414, DOI 10.1073/pnas.1611763113
   Gimenez-Ibanez Selena, 2016, Plants-Basel, V5, P9, DOI 10.3390/plants5010009
   Gimenez-Ibanez S, 2015, ESSAYS BIOCHEM, V58, P83, DOI [10.1042/bse0580083, 10.1042/BSE0580083]
   Gonzalez N, 2015, PLANT CELL, V27, P2273, DOI 10.1105/tpc.15.00006
   Gonzalez-Guzman M, 2014, J EXP BOT, V65, P4451, DOI 10.1093/jxb/eru219
   Goossens J, 2015, NEW PHYTOL, V206, P1229, DOI 10.1111/nph.13398
   Hruz Tomas, 2008, Advances in Bioinformatics, P420747, DOI 10.1155/2008/420747
   Ishiga Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075728
   Kagale S, 2010, PLANT PHYSIOL, V152, P1109, DOI 10.1104/pp.109.151704
   Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001
   Ke J, 2015, SCI ADV, V1, DOI [DOI 10.1126/SCIADV.1500107, 10.1126/SCIADV.1500107]
   Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325
   Maza Elie, 2013, Commun Integr Biol, V6, pe25849, DOI 10.4161/cib.25849
   Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x
   Pauwels L, 2015, PLANT PHYSIOL, V169, P1405, DOI 10.1104/pp.15.00479
   Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854
   Pazos F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00363
   Perez AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084891
   Pietrosemoli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055524
   Riemann M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01077
   Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119
   Schachtman DP, 2008, TRENDS PLANT SCI, V13, P281, DOI 10.1016/j.tplants.2008.04.003
   Shaikhali J, 2012, PLANT CELL, V24, P3009, DOI 10.1105/tpc.112.100099
   Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430
   Shyu C, 2012, PLANT CELL, V24, P536, DOI 10.1105/tpc.111.093005
   Sun JQ, 2011, MOL PLANT, V4, P607, DOI 10.1093/mp/ssr008
   Sun W, 2010, PLANT CELL PHYSIOL, V51, P997, DOI 10.1093/pcp/pcq056
   Thatcher LF, 2016, J EXP BOT, V67, P2367, DOI 10.1093/jxb/erw040
   Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960
   Thireault C, 2015, PLANT J, V82, P669, DOI 10.1111/tpj.12841
   Toda Y, 2013, PLANT CELL, V25, P1709, DOI 10.1105/tpc.113.112052
   Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004
   Velez-Bermudez IC, 2015, PLANT CELL, V27, P3245, DOI 10.1105/tpc.15.00545
   Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-841
   Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067
   Wu H, 2015, PLANT SCI, V232, P1, DOI 10.1016/j.plantsci.2014.12.010
   Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091
   Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109
   Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444
   Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8
   Zhang F, 2017, P NATL ACAD SCI USA, V114, P1720, DOI 10.1073/pnas.1616938114
   Zhang F, 2015, NATURE, V525, P269, DOI 10.1038/nature14661
   Zhang LH, 2015, J PLANT RES, V128, P995, DOI 10.1007/s10265-015-0755-2
   Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044465
   Zhang ZB, 2015, MOL GENET GENOMICS, V290, P1849, DOI 10.1007/s00438-015-1042-6
NR 55
TC 0
Z9 0
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 1
PY 2017
VL 12
IS 6
AR e0177381
DI 10.1371/journal.pone.0177381
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW6HZ
UT WOS:000402611800008
PM 28570564
OA gold
DA 2017-08-17
ER

PT J
AU Moussa, TAA
   Al-Qaysi, SAS
   Thabit, ZA
   Kadhem, SB
AF Moussa, Tarek A. A.
   Al-Qaysi, Safaa A. S.
   Thabit, Zaid A.
   Kadhem, Sanaa B.
TI Microbial levan from Brachybacterium phenoliresistens: Characterization
   and enhancement of production
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Levan; Brachybacterium phenoliresistens; Rhizosphere soil; Nutritional
   factors; Physical factors
ID FRUCTO-OLIGOSACCHARIDES; ZYMOMONAS-MOBILIS; BACILLUS; OPTIMIZATION;
   LEVANSUCRASE
AB Levan producing bacteria was isolated from rhizosphere soil. The molecular identification"of this isolate was conducted using 16S rRNA, which resulted in a sequenced region of 1298 base pairs. The sequence alignment in the gene bank indicated that this isolate has a high percentage of similarity (99%) to the retrieved consensus sequence of Brachybacterium phenoliresistens strain phenol-A. The produced levan was characterized using TLC, FTIR, 1H NMR and 13C NMR spectroscopy techniques. The effects of nutritional and physical factors on this isolate's levan production were investigated. The results demonstrated that the optimal sources for carbon and casein during levan production were sucrose and casein, yielding 7.88 g/l and 8.12 g/l of levan, respectively. The highest levan yield (7.97 g/l) was obtained at a sucrose concentration of 300 g/l. At an initial pH of 7.8, this bacterium yielded their highest levan production of 7.88 g/l. The optimal incubation period was 72 h with a yield of 8.58 g/l, the optimal temperature was 30 degrees C and resulted in 7.87 g/l, and the highest levan production yield was obtained at 150 rpm and yielded 8.12 g/l. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Moussa, Tarek A. A.] Cairo Univ, Fac Sci, Dept Bot & Microbiol, Giza 12613, Egypt.
   [Al-Qaysi, Safaa A. S.; Kadhem, Sanaa B.] Baghdad Univ, Fac Sci Women, Dept Biol, Baghdad, Iraq.
   [Thabit, Zaid A.] Al Nahrain Univ, Biotechnol Res Ctr, Environm Biotechnol Dept, Baghdad, Iraq.
RP Moussa, TAA (reprint author), Cairo Univ, Fac Sci, Dept Bot & Microbiol, Giza 12613, Egypt.; Al-Qaysi, SAS (reprint author), Baghdad Univ, Fac Sci Women, Dept Biol, Baghdad, Iraq.
EM tarekmoussa@yahoo.com; safaa.ahmed.bio@gmail.com
FU Biotechnology Research Center, Environmental Biotechnology Department,
   Industrial Microbiology Lab; Al Nahrain University (Iraq)
FX This work was supported by Biotechnology Research Center, Environmental
   Biotechnology Department, Industrial Microbiology Lab, and Al Nahrain
   University (Iraq).
CR Abdel-Fattah AF, 2005, CURR MICROBIOL, V51, P402, DOI 10.1007/s00284-005-0111-1
   Abou-Taleb K. A., 2015, British Microbiology Research Journal, V5, P22, DOI 10.9734/BMRJ/2015/12448
   Abou-Taleb K. A., 2014, J AGR TECHNOL, V10, P899
   Ananthalakshmy VK, 1999, BRAZ ARCH BIOL TECHN, V42, P291
   Arvidson SA, 2006, CARBOHYD POLYM, V65, P144, DOI 10.1016/j.carbpol.2005.12.039
   Barone JR, 2007, CARBOHYD POLYM, V69, P554, DOI 10.1016/j.carbpol.2007.01.017
   Bekers M, 2005, PROCESS BIOCHEM, V40, P1535, DOI 10.1016/j.procbio.2004.01.052
   Chou JH, 2007, INT J SYST EVOL MICR, V57, P2674, DOI 10.1099/ijs.0.65019-0
   Dahech I, 2012, INT J BIOL MACROMOL, V51, P329, DOI 10.1016/j.ijbiomac.2012.04.030
   Euzenat O, 1997, PROCESS BIOCHEM, V32, P237, DOI 10.1016/S0032-9592(96)00058-1
   Feng J, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv079
   Ghaly A. E., 2007, American Journal of Biochemistry and Biotechnology, V3, P47
   HAN YW, 1990, J AGR FOOD CHEM, V38, P393, DOI 10.1021/jf00092a011
   Higgins D G, 1994, Methods Mol Biol, V25, P307
   Holt JG, 1994, BERGEYS MANUAL DETER, V9, P175
   Jathore NR, 2012, FOOD SCI BIOTECHNOL, V21, P1045, DOI 10.1007/s10068-012-0136-8
   Kucukasik F, 2011, APPL MICROBIOL BIOT, V89, P1729, DOI 10.1007/s00253-010-3055-8
   Poli A, 2009, CARBOHYD POLYM, V78, P651, DOI 10.1016/j.carbpol.2009.05.031
   Rhee S. -K., 2005, BIOPOLYM ONLINE, V5
   Santos L. E, 2013, ROM BIOTECH LETT, V18, P8413
   Sarilmiser HK, 2015, J BIOSCI BIOENG, V119, P455, DOI 10.1016/j.jbiosc.2014.09.019
   Senthilkumar V., 2005, Indian Journal of Biotechnology, V4, P491
   Shih IL, 2005, J AGR FOOD CHEM, V53, P8211, DOI 10.1021/jf058084o
   Shih IL, 2010, CARBOHYD POLYM, V82, P111, DOI 10.1016/j.carbpol.2010.04.030
   Silbir S, 2014, CARBOHYD POLYM, V99, P454, DOI 10.1016/j.carbpol.2013.08.031
   Srikanth R, 2015, CARBOHYD POLYM, V123, P8, DOI 10.1016/j.carbpol.2014.12.079
   Srikanth R, 2015, CARBOHYD POLYM, V120, P102, DOI 10.1016/j.carbpol.2014.12.003
   Tauro P., 1986, INTRO MICROBIOLOGY, P18
   Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35
   van Hijum SAFT, 2006, MICROBIOL MOL BIOL R, V70, P157, DOI 10.1128/MMBR.70.1.157-176.2006
   Vaningelgem F, 2004, J APPL MICROBIOL, V97, P1257, DOI 10.1111/j.1365-2672.2004.02418.x
NR 31
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD JUN
PY 2017
VL 57
BP 9
EP 15
DI 10.1016/j.procbio.2017.03.008
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA EX3GW
UT WOS:000403121600002
OA No
DA 2017-08-17
ER

PT J
AU Mansour, HA
   Mahfouz, H
   Maher, N
AF Mansour, Hoda Anwer
   Mahfouz, Hala
   Maher, Nesma
TI ANTI-MUTAGENIC POTENTIAL OF ALGAL EXTRACTS ON CHROMOSOMAL ABERRATIONS IN
   ALLIUM CEPA L.
SO ACTA BIOLOGICA HUNGARICA
LA English
DT Article
DE Algal extracts; antioxidant compounds and activity; anti-mutagenic
   effects; sodium azide; genotoxicity; Allium cepa L.
ID FUNCTIONAL-PROPERTIES; BROWN SEAWEEDS; VICIA-FABA; RED ALGAE; IN-VITRO;
   ANTIOXIDANT; ROOT; MUTAGENICITY; GENOTOXICITY; INDUCTION
AB In the present study, sodium azide (SA) toxicity and the anti-mutagenic effects of different algal extracts at 0.1% and 0.2% concentrations were studied on the mitotic index (MI), chromosomal and nuclear aberrations using Allium cepa L. root assay. Moreover, phytochemical screening of photosynthetic pigments, antioxidants compounds, total antioxidant, DPPH scavenging activity, polysaccharides, and phenolic contents were done for two red seaweeds (Laurencia obtusa (Hudson) Lamouroux and Polysiphonia morrowii Harvey) and for one brown seaweed (Dictyopteris delicatula Lamouroux). Treatment with 300 mu g/ml sodium azide (SA) induced the highest number of aberrations in A. cepa root. A highly significant decrease in the MI appeared after treatment with SA, whereas its value increased following different algal extracts treatments. The highest anti-mutagenic inhibition activity of Dictyopteris delicatula added at 0.2% concentration was 72.96%, 69.84%, 56.89% and 43.59% with the algal polyphenol, polysaccharide, aqueous and methanol extract treatments, respectively. The different algal extracts minimized the genotoxicity and exhibited anti-mutagenic potential against SA in a dose-dependent manner. Phytochemical studies showed that Dictyopteris delicatula contained the highest total phenol, chlorophyll-a and carotenoid quantity. Moreover it exhibited the highest total antioxidant and DPPH scavenging activities. Total polysaccharides and the weight percentage of sulphated polysaccharides were relatively higher in Polysiphonia morrowii followed by Laurencia obtusa. Hydroquinone and bromophenol were detected only in the studied brown and red seaweeds, respectively. Polysiphonia morrowii and Laurencia obtusa contained the highest quantity of galactose, rhmnose and xylose, while Dictyopteris delicatula contained fucose and mannitol as main monosaccharide units. In conclusion, the studied seaweeds may be considered as rich sources of natural antioxidants. Meanwhile the investigated different algal extracts can minimize the genotoxicity in a dose-dependent manner and exhibit anti-mutagenic potential against the mutagenic substance sodium azide.
C1 [Mansour, Hoda Anwer; Mahfouz, Hala; Maher, Nesma] Ain Shams Univ, Fac Sci, Bot Dept, Cairo, Egypt.
RP Mansour, HA (reprint author), Ain Shams Univ, Fac Sci, Bot Dept, Cairo, Egypt.
EM rodynarwan@yahoo.com
CR Abdul QA, 2016, J SCI FOOD AGR, V96, P1856, DOI 10.1002/jsfa.7489
   Aguilera J, 2002, POLAR BIOL, V25, P432, DOI 10.1007/s00300-002-0362-2
   Aleem A. A., 1993, MARINE ALGAE ALEXAND
   AMER SM, 1986, CYTOLOGIA, V51, P21
   AOAC, 1995, OFF METH AN ASS OFF
   AZUINE MA, 1992, NUTR CANCER, V17, P77
   Barcelos GRM, 2007, J ETHNOPHARMACOL, V114, P268, DOI 10.1016/j.jep.2007.08.006
   BLAKENEY AB, 1980, J SCI FOOD AGR, V31, P889, DOI 10.1002/jsfa.2740310905
   Burritt DJ, 2002, PLANTA, V215, P829, DOI 10.1007/s00425-002-0805-6
   Chojnacka K., 2012, OPEN C P J, V3, P20
   Christaki E, 2013, J SCI FOOD AGR, V93, P5, DOI 10.1002/jsfa.5902
   Costa LS, 2010, BIOMED PHARMACOTHER, V64, P21, DOI 10.1016/j.biopha.2009.03.005
   Dai-Hung Ngo, 2013, International Journal of Biological Macromolecules, V62, P70
   Darlington C. D., 1976, HANDLING CHROMOSOMES
   El Din NGS, 2012, J APPL PHYCOL, V24, P613, DOI 10.1007/s10811-012-9831-3
   Elghamery A. A., 2003, NIGELLA SATIVA L TRI, V537, P2941
   Fernandes TCC, 2007, PESTIC BIOCHEM PHYS, V88, P252, DOI 10.1016/j.pestbp.2006.12.003
   FISKESJO G, 1988, MUTAT RES, V197, P243, DOI 10.1016/0027-5107(88)90096-6
   Gadano A, 2002, J ETHNOPHARMACOL, V81, P11, DOI 10.1016/S0378-8741(01)00418-4
   Gupta S, 2011, TRENDS FOOD SCI TECH, V22, P315, DOI 10.1016/j.tifs.2011.03.011
   Hayat S, 2002, CHEM PHARM BULL, V50, P1297
   Hsu CY, 2008, FITOTERAPIA, V79, P64, DOI 10.1016/j.fitote.2007.07.007
   Hwang PA, 2010, J MAR SCI TECH-TAIW, V18, P41
   Kayalvizhi K., 2014, J BIOTECHNOL SCI, V2, P29
   Kim Su Il, 2007, Journal of Chitin and Chitosan, V12, P65
   Kumar N. J. I., 2009, OUR NATURE, V7, P48
   Lamsal K, 2010, AFR J BIOTECHNOL, V9, P4204
   de Oliveira ALL, 2012, QUIM NOVA, V35, P2186, DOI 10.1590/S0100-40422012001100016
   Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671
   Li K, 2008, J NAT PROD, V71, P28, DOI 10.1021/np070281p
   Liman R, 2010, CHEMOSPHERE, V80, P1056, DOI 10.1016/j.chemosphere.2010.05.011
   Lu Xi Z, 2011, J MAR SCI TECHNOL, V19, P377
   Luo HY, 2010, J MED PLANTS RES, V4, P2557
   Machu L, 2015, MOLECULES, V20, P1118, DOI [10.3390/molecules20011118, 10.33]
   Magalhaes KD, 2011, INT J MOL SCI, V12, P3352, DOI 10.3390/ijms12053352
   Malik C. P., 1980, PLANT ENZYMOLOGY HIS
   Maruhen A., 2016, CYTOTECHNOLOGY, V68, P1215
   METZNER H, 1965, PLANTA, V65, P186, DOI 10.1007/BF00384998
   MUKHERJEE SP, 1983, PHYSIOL PLANTARUM, V58, P166, DOI 10.1111/j.1399-3054.1983.tb04162.x
   Nagai T, 2003, FOOD CHEM, V81, P327, DOI 10.1016/S0308-8146(02)00426-0
   Naguib M. I., 1963, ZUCKER, V16, P15
   Namvar F, 2012, FOOD CHEM, V130, P376, DOI 10.1016/j.foodchem.2011.07.054
   Nwosu F, 2011, FOOD CHEM, V126, P1006, DOI 10.1016/j.foodchem.2010.11.111
   Onofrejova L, 2010, J PHARMACEUT BIOMED, V51, P464, DOI 10.1016/j.jpba.2009.03.027
   Osama A. H., 2013, LIFE SCI J, V10, P1543
   Osuna-Ruiz I, 2016, PHARM BIOL, V9, P1
   de Souza MCR, 2007, J APPL PHYCOL, V19, P153, DOI 10.1007/s10811-006-9121-z
   Sachindra NM, 2007, J AGR FOOD CHEM, V55, P8516, DOI 10.1021/jf071848a
   Schoenwaelder Monica E. A., 2008, Algae, V23, P163
   SHAHIN SA, 1991, MUTAT RES, V261, P169, DOI 10.1016/0165-1218(91)90064-S
   Sobral O, 2013, ECOTOXICOLOGY, V22, P838, DOI 10.1007/s10646-013-1079-4
   Synytsya A, 2010, CARBOHYD POLYM, V81, P41, DOI 10.1016/j.carbpol.2010.01.052
   Usov AI, 2011, ADV CARBOHYD CHEM BI, V65, P115, DOI 10.1016/B978-0-12-385520-6.00004-2
   Yvonne V. Y., 2006, FOOD CHEM TOXICOL, V44, P1144
   Zakaria N. A., 2011, J CHEM PHARM RES
NR 55
TC 0
Z9 0
U1 0
U2 0
PU AKADEMIAI KIADO RT
PI BUDAPEST
PA PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY
SN 0236-5383
EI 1588-256X
J9 ACTA BIOL HUNG
JI Acta Biol. Hung.
PD JUN
PY 2017
VL 68
IS 2
BP 137
EP 149
DI 10.1556/018.68.2017.2.2
PG 13
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EX5XO
UT WOS:000403316600002
PM 28605976
OA No
DA 2017-08-17
ER

PT J
AU EL-Shamy, EF
AF EL-Shamy, E. F.
TI Nonlinear Propagation of Positron-Acoustic Periodic Travelling Waves in
   a Magnetoplasma with Superthermal Electrons and Positrons
SO CHINESE PHYSICS LETTERS
LA English
DT Article
ID ION PLASMAS; SOLITARY WAVES; NONTHERMAL ELECTRONS; GARDNER SOLITONS;
   SMALL AMPLITUDE; DOUBLE-LAYERS
AB The nonlinear propagation of positron acoustic periodic (PAP) travelling waves in a magnetoplasma composed of dynamic cold positrons, superthermal kappa distributed hot positrons and electrons, and stationary positive ions is examined. The reductive perturbation technique is employed to derive a nonlinear Zakharov-Kuznetsov equation that governs the essential features of nonlinear PAP travelling waves. Moreover, the bifurcation theory is used to investigate the propagation of nonlinear PAP periodic travelling wave solutions. It is found that kappa distributed hot positrons and electrons provide only the possibility of existence of nonlinear compressive PAP travelling waves. It is observed that the superthermality of hot positrons, the concentrations of superthermal electrons and positrons, the positron cyclotron frequency, the direction cosines of wave vector.. along the z-axis, and the concentration of ions play pivotal roles in the nonlinear propagation of PAP travelling waves. The present investigation may be used to understand the formation of PAP structures in the space and laboratory plasmas with superthermal hot positrons and electrons.
C1 [EL-Shamy, E. F.] King Khalid Univ, Coll Sci, Dept Phys, Abha 9004, Saudi Arabia.
   [EL-Shamy, E. F.] Damietta Univ, Dept Phys, Fac Sci, New Damietta 34517, Egypt.
RP EL-Shamy, EF (reprint author), King Khalid Univ, Coll Sci, Dept Phys, Abha 9004, Saudi Arabia.; EL-Shamy, EF (reprint author), Damietta Univ, Dept Phys, Fac Sci, New Damietta 34517, Egypt.
EM emadel_shamy@hotmail.com
CR Abdelwahed HG, 2017, PHYS PLASMAS, V24, DOI 10.1063/1.4975664
   BEREZHIANI VI, 1994, PHYS REV E, V50, P448, DOI 10.1103/PhysRevE.50.448
   Chow S N, 1981, METHOD BIFURCATION T
   El-Labany SK, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4774067
   El-Labany SK, 2010, PHYS LETT A, V374, P960, DOI 10.1016/j.physleta.2009.12.027
   El-Shamy EF, 2016, PHYS PLASMAS, V23, DOI 10.1063/1.4972817
   El-Shamy EF, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.033105
   El-Shamy EF, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4892570
   El-Shamy EF, 2012, ASTROPHYS SPACE SCI, V338, P279, DOI 10.1007/s10509-011-0930-4
   El-Shamy EF, 2010, PHYS LETT A, V374, P4425, DOI 10.1016/j.physleta.2010.09.002
   El-Shamy EF, 2010, IEEE T PLASMA SCI, V38, P909, DOI 10.1109/TPS.2010.2042465
   El-Shamy EF, 2009, PHYS LETT A, V374, P290, DOI 10.1016/j.physleta.2009.10.060
   Guernica A V, 1988, PHYS SCR, V38, P855
   Kakati H, 2000, PHYS PLASMAS, V7, P808, DOI 10.1063/1.873875
   Mahmood S, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/328
   Masood W, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2949702
   MICHEL FC, 1982, REV MOD PHYS, V54, P1, DOI 10.1103/RevModPhys.54.1
   Miller H.R., 1987, ACTIVE GALACTIC NUCL
   Nejoh YN, 1996, AUST J PHYS, V49, P967
   POPEL SI, 1995, PHYS PLASMAS, V2, P716, DOI 10.1063/1.871422
   Rahman MM, 2015, BRAZ J PHYS, V45, P314, DOI 10.1007/s13538-015-0324-0
   Rahman MM, 2014, ASTROPHYS SPACE SCI, V352, P193, DOI 10.1007/s10509-014-1899-6
   Rahman MM, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14084-4
   Rhee T, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011682
   Roy K, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2896231
   Ryu CM, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2779282
   Sahu B, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/06/065504
   Samanta UK, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4804347
   Selim MM, 2015, ASTROPHYS SPACE SCI, V360, DOI 10.1007/s10509-015-2574-2
   Shah MG, 2015, J PLASMA PHYS, V81, DOI 10.1017/S0022377815001014
   Shah MG, 2015, CHINESE PHYS LETT, V32, DOI 10.1088/0256-307X/32/8/085203
   Shah MG, 2015, BRAZ J PHYS, V45, P219, DOI 10.1007/s13538-015-0304-4
   Shukla PK, 2004, PHYS SCRIPTA, VT113, P133
   Tiwari RS, 2007, PHYS LETT A, V365, P335, DOI 10.1016/j.physleta.2007.01.020
   Tribeche M, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3372841
   Tribeche M, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3160619
   Uddin MJ, 2015, PHYS PLASMAS, V22, DOI 10.1063/1.4907226
   Uddin MJ, 2015, IEEE T PLASMA SCI, V43, P985, DOI 10.1109/TPS.2015.2409736
   WASHIMI H, 1966, PHYS REV LETT, V17, P996, DOI 10.1103/PhysRevLett.17.996
   Yoon PH, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2006JA011681
   Yoon PH, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.215003
NR 41
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0256-307X
EI 1741-3540
J9 CHINESE PHYS LETT
JI Chin. Phys. Lett.
PD JUN
PY 2017
VL 34
IS 6
AR 065201
DI 10.1088/0256-307X/34/6/065201
PG 5
WC Physics, Multidisciplinary
SC Physics
GA EX5HV
UT WOS:000403271700018
OA No
DA 2017-08-17
ER

PT J
AU Abd Eldaim, MA
   Matsuoka, S
   Okamatsu-Ogura, Y
   Kamikawa, A
   Ahmed, MM
   Terao, A
   Nakajima, K
   Kimura, K
AF Abd Eldaim, Mabrouk Attia
   Matsuoka, Shinya
   Okamatsu-Ogura, Yuko
   Kamikawa, Akihiro
   Ahmed, Mohamed Mohamed
   Terao, Akira
   Nakajima, Kei-ichi
   Kimura, Kazuhiro
TI Retinoic acid modulates lipid accumulation glucose concentration
   dependently through inverse regulation of SREBP-1 expression in 3T3L1
   adipocytes
SO GENES TO CELLS
LA English
DT Article
ID ELEMENT-BINDING PROTEIN-1; ACTIVATED RECEPTOR-GAMMA; WHITE
   ADIPOSE-TISSUE; LIVER-X RECEPTOR; VITAMIN-A; MEDIATED TRANSCRIPTION;
   3T3-L1 CELLS; DIFFERENTIATION; ADIPOGENESIS; PROMOTER
AB It is well known that retinoic acid (RA) suppresses adipogenesis, although there are some contradicting reports. In this study, we examined the effect of extracellular glucose on RA-induced suppression of adipogenesis in 3T3L1 cell culture. When the cells were cultured in normal glucose medium (NG), the addition of RA suppressed lipid accumulation. However, when cultured in high glucose medium (HG), addition of RA to the cells enhanced lipid accumulation. These changes were accompanied by parallel alterations in fatty acid synthase (FAS) and sterol regulatory element-binding protein (SREBP)-1 gene expression. Transfection of SREBP-1 siRNA suppressed RA-induced enhancement of lipid accumulation and FAS expression in the cells cultured with HG. Transfection of the nuclear form of SREBP-1a cDNA into the cells cultured with NG inhibited RA-induced suppression of lipid accumulation and FAS expression. Moreover, RA- and HG-induced SREBP-1a expression occurred at the early phase of adipogenesis and was dependent on glucocorticoid to induce liver X receptor (LXR) , peroxisomal proliferator-activated receptor (PPAR) and retinoid X receptor (RXR), the key nuclear factors influencing the SREBP-1a gene expression. These results suggest that RA suppresses and enhances lipid accumulation through extracellular glucose concentration-dependent modulation of SREBP-1 expression.
C1 [Abd Eldaim, Mabrouk Attia; Matsuoka, Shinya; Okamatsu-Ogura, Yuko; Kamikawa, Akihiro; Ahmed, Mohamed Mohamed; Terao, Akira; Kimura, Kazuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Labs Biochem, Sapporo, Hokkaido 0600818, Japan.
   [Abd Eldaim, Mabrouk Attia] Menoufia Univ, Dept Biochem & Chem Nutr, Fac Vet Med, Menoufia 32721, Egypt.
   [Nakajima, Kei-ichi] Natl Agr Res Ctr Hokkaido Reg, Sapporo, Hokkaido 0628555, Japan.
RP Kimura, K (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Labs Biochem, Sapporo, Hokkaido 0600818, Japan.
EM k-kimura@vetmed.hokudai.ac.jp
FU Japan Society for the Promotion of Science (JSPS)
FX This work was supported by grant from the Japan Society for the
   Promotion of Science (JSPS) to K.K.
CR Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685
   Arnett AM, 2007, J ANIM SCI, V85, P3062, DOI 10.2527/jas.2007-0176
   Bennett MK, 2008, J BIOL CHEM, V283, P15628, DOI 10.1074/jbc.M800391200
   Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242
   Brandebourg TD, 2005, J ANIM SCI, V83, P98
   Cagen LM, 2005, BIOCHEM J, V385, P207
   Cheng YH, 2008, J CLIN ENDOCR METAB, V93, P1915, DOI 10.1210/jc.2007-1536
   Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Fajas L, 1999, MOL CELL BIOL, V19, P5495
   Fernandez-Alvarez A, 2008, FEBS LETT, V582, P177, DOI 10.1016/j.febslet.2007.11.083
   Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539
   Garcia-Rojas P, 2010, J ANIM SCI, V88, P1801, DOI 10.2527/jas.2009-2579
   Gorocica-Buenfil MA, 2007, J ANIM SCI, V85, P3355, DOI 10.2527/jas.2007-0172
   Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x
   Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200
   Im SS, 2009, MOL CELL BIOL, V29, P4864, DOI 10.1128/MCB.00553-09
   Inoue J, 2001, BIOCHEM BIOPH RES CO, V283, P1157, DOI 10.1006/bbrc.2001.4915
   Jones BH, 1998, BIOCHEM J, V335, P405
   KAWADA T, 1990, COMP BIOCHEM PHYS A, V96, P323, DOI 10.1016/0300-9629(90)90699-S
   Marchildon F, 2010, J BIOL CHEM, V285, P13274, DOI 10.1074/jbc.M109.054536
   Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760
   Mills JP, 2008, EXP BIOL MED, V233, P1255, DOI 10.3181/0803-RM-94
   Payne VA, 2010, BIOCHEM J, V425, P215, DOI 10.1042/BJ20091112
   Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009
   Redonnet A, 2008, BRIT J NUTR, V100, P722, DOI 10.1017/S0007114508967568
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Roder K, 2007, BIOCHEM SOC T, V35, P1211, DOI 10.1042/BST0351211
   Roder K, 2007, FEBS LETT, V581, P2715, DOI 10.1016/j.febslet.2007.05.022
   SAFONOVA I, 1994, MOL CELL ENDOCRINOL, V104, P201, DOI 10.1016/0303-7207(94)90123-6
   Sagara C, 2013, BIOCHEM BIOPH RES CO, V433, P102, DOI 10.1016/j.bbrc.2013.02.057
   Saladin R, 1999, CELL GROWTH DIFFER, V10, P43
   Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497
   Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552
   Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832
   Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8
   Shimano H, 2009, FEBS J, V276, P616, DOI 10.1111/j.1742-4658.2008.06806.x
   Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247
   Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590
   Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001
   Zhang CK, 2005, BIOCHEM J, V386, P161, DOI 10.1042/BJ20041514
   Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081
   Zulet MA, 2008, J NUTR SCI VITAMINOL, V54, P347, DOI 10.3177/jnsv.54.347
NR 42
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1356-9597
EI 1365-2443
J9 GENES CELLS
JI Genes Cells
PD JUN
PY 2017
VL 22
IS 6
BP 568
EP 582
DI 10.1111/gtc.12498
PG 15
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA EX5QF
UT WOS:000403296400005
PM 28488421
OA No
DA 2017-08-17
ER

PT J
AU Sutanto, KD
   El Salamouny, S
   Tufail, M
   Rasool, KG
   Sukirno, S
   Shepard, M
   Shapiro, M
   Aldawood, AS
AF Sutanto, Koko Dwi
   El Salamouny, Said
   Tufail, Muhammad
   Rasool, Khawaja Ghulam
   Sukirno, Sukirno
   Shepard, Merle
   Shapiro, Martin
   Aldawood, Abdulrahman Saad
TI Evaluation of Natural Additives to Enhance the Persistence of Spodoptera
   littoralis (Lepidoptera: Noctuidae) Nucleopolyhedrovirus (SpliMNPV)
   Under Field Conditions in Saudi Arabia
SO JOURNAL OF ECONOMIC ENTOMOLOGY
LA English
DT Article
DE biological control; plant extract; Noctuidae; SpliMNPV; Spodoptera
   littoralis
ID NUCLEAR POLYHEDROSIS-VIRUS; ULTRAVIOLET-RADIATION PROTECTANTS; SUNLIGHT;
   BACULOVIRUSES; FORMULATIONS; STABILITY; EXTRACTS; TEA
AB Nucleopolyhedrovirus is an effective biocontrol agent but for its biggest disadvantage of short persistence under sunlight conditions. In this study, 10 plant extracts were evaluated as ultraviolet (UV) protectants to improve the persistence of Spodoptera littoralis multiple-embedded nucleopolyhedrovirus (SpliMNPV) against cotton leafworm (Spodoptera littoralis Boisduval). In the primary lab screening test, 5 out of 10 additives (cloves, henna, green tea, pomegranate, and grape extracts) presented a high rate of virus protection with original activity remaining (OAR) percentage of 100%, 97%, 91%, 90.6%, and 77%, respectively, when used at a concentration of 1% and exposed to UVB for a period of 1 h. A secondary screening was then performed with these best five extracts at a concentration of 0.5% and for an exposure timing of 5 h to UVB. Among these, clove and henna that showed highest protection with OAR values of 96.6% and 76.5%, respectively, were selected for the field trials. When applied on cabbage in the field during sunny summer conditions, clove and henna extracts enhanced the persistence of SpliMNPV by twofold. These findings are encouraging to be applied in the field studies.
C1 [Sutanto, Koko Dwi; El Salamouny, Said; Tufail, Muhammad; Rasool, Khawaja Ghulam; Sukirno, Sukirno; Aldawood, Abdulrahman Saad] King Saud Univ, EERU, Dept Plant Protect, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia.
   [El Salamouny, Said] Cairo Univ, Dept Econ Entomol & Pesticides, Fac Agr, Giza, Egypt.
   [Tufail, Muhammad] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo, Japan.
   [Sukirno, Sukirno] Gadjah Mada Univ, Entomol Lab, Fac Biol, Yogyakarta 55281, Indonesia.
   [Shepard, Merle; Shapiro, Martin] Clemson Univ, Coastal Res & Educ Ctr, 2700 Savannah Highway, Charleston, SC USA.
RP Tufail, M (reprint author), King Saud Univ, EERU, Dept Plant Protect, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia.; Tufail, M (reprint author), Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo, Japan.
EM kokodwisutanto@yahoo.com; said_elsalamouny@yahoo.com;
   mtufail@ksu.edu.sa; krasool@ksu.edu.sa; sukirnobiougm@ugm.ac.id;
   gcarner@clemson.edu; mshapir@clemson.edu; aldawood@ksu.edu.sa
FU National Plan for Science, Technology and Innovation (MAARIFAH); King
   Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia
   [10-AGR1196-02]
FX This Project was funded by the National Plan for Science, Technology and
   Innovation (MAARIFAH), King Abdulaziz City for Science and Technology,
   Kingdom of Saudi Arabia, Award Number (10-AGR1196-02). We also would
   like to thank Dr. Yaser Abobakr, and our EERU members Shehzad Salman,
   Alan Soffan, Muhammad Shakeel, Khalid Mehmood, and Mureed Husain for
   their technical assistance.
CR ABUL-NASR SALAH, 1956, BULL SOC ENT EGYPTE, V40, P321
   Albarrak Ali Saleh, 2009, Pakistan Entomologist, V31, P148
   Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658
   Behle RW, 1997, J ECON ENTOMOL, V90, P1560
   Behle RW, 2003, J ECON ENTOMOL, V96, P1066, DOI 10.1603/0022-0493-96.4.1066
   BURGES HD, 1980, ENTOMOPHAGA, V25, P329, DOI 10.1007/BF02374693
   Dougherty EM, 1996, BIOL CONTROL, V7, P71, DOI 10.1006/bcon.1996.0067
   El Salamouny S, 2009, J ENTOMOL SCI, V44, P50
   El-Salamouny S, 2009, J ECON ENTOMOL, V102, P1767
   El-Sheikh EA, 2015, EGYPT J BIOL PEST CO, V25, P587
   Ellis S. E., 2004, NEW PEST RESPONSE GU
   Elnagar S., 2003, B ENT SOC EGYPT, V29, P165
   El Salamouny S., 2004, J AGR SCI MANSOURA U, V28, P105
   El Salamouny S., 2000, 3 ANN M SOC INV PATH
   FINNEY DJ, 1977, ANN I STAT MATH, V29, P467, DOI 10.1007/BF02532806
   Friedberg EC, 1995, DNA REPAIR MUTAGENES
   Gil MI, 2000, J AGR FOOD CHEM, V48, P4581, DOI 10.1021/jf000404a
   IGNOFFO CM, 1991, J INVERTEBR PATHOL, V57, P134, DOI 10.1016/0022-2011(91)90053-S
   IGNOFFO CM, 1971, J ECON ENTOMOL, V64, P850
   IGNOFFO CM, 1989, ENVIRON ENTOMOL, V18, P177
   JAQUES R P, 1977, Miscellaneous Publications of the Entomological Society of America, V10, P99
   JONES KA, 1993, BIOCONTROL SCI TECHN, V3, P189, DOI 10.1080/09583159309355275
   Murillo R, 2003, INT J PEST MANAGE, V49, P147, DOI 10.1080/0967087021000043102
   Musa A.E., 2012, J FOR PROD IND, V1, P35
   Pudjianto, 2016, Journal of Agricultural and Urban Entomology, V32, P13, DOI 10.3954/JAUE14-04.2
   Seufi AM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-13
   Shan B, 2005, J AGR FOOD CHEM, V53, P7749, DOI 10.1021/jf051513y
   SHAPIRO M, 1990, J ECON ENTOMOL, V83, P168
   Shapiro M., 2012, JES, V47, P1
   Shapiro M., 2008, BIOCONTROL SCI TECHN, V18, P605
   Shapiro M, 2009, J AGR URBAN ENTOMOL, V26, P1, DOI 10.3954/1523-5475-26.1.1
   Shapiro M, 2009, J AGR URBAN ENTOMOL, V26, P47, DOI 10.3954/1523-5475-26.2.47
   SHOREY HH, 1965, J ECON ENTOMOL, V58, P522
   SPSS Inc, 2005, SPSS WIND US GUID VE
   Svobodova Alena, 2003, Biomedical Papers (Olomouc), V147, P137
   Tamez-Guerra P, 2000, J ECON ENTOMOL, V93, P210
   Verghese J., 2010, INVENT RAPID COSM, V1, P1
   Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016
   Zhang WJ, 2009, FITOTERAPIA, V80, P207, DOI 10.1016/j.fitote.2009.02.006
NR 39
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-0493
EI 1938-291X
J9 J ECON ENTOMOL
JI J. Econ. Entomol.
PD JUN
PY 2017
VL 110
IS 3
BP 924
EP 930
DI 10.1093/jee/tox085
PG 7
WC Entomology
SC Entomology
GA EX3RO
UT WOS:000403150200014
OA No
DA 2017-08-17
ER

PT J
AU Zoromba, MS
   Abdel-Aziz, MH
   Bassyouni, M
   Gutub, S
   Demko, D
   Abdelkader, A
AF Zoromba, Mohamed Shafick
   Abdel-Aziz, Mohamed Helmy
   Bassyouni, Mohamed
   Gutub, Saud
   Demko, Denisa
   Abdelkader, Amr
TI Electrochemical Activation of Graphene at Low Temperature: The Synthesis
   of Three-Dimensional Nanoarchitectures for High Performance
   Supercapacitors and Capacitive Deionization
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Molten salts; Desalination; Porous electrodes; Sponge-templated;
   Electrosorption; Ultracapacitor
ID CALCIOTHERMIC REDUCTION; WATER DESALINATION; CHARGE EFFICIENCY; CARBON
   COMPOSITES; ENERGY-STORAGE; KOH ACTIVATION; ELECTRODES; OXIDE; SHEETS;
   NANOTUBES
AB An electrochemical technique is developed to activate graphene oxide (GO) at relatively low temperature and assemble it into porous electrodes. The activation process is carried out in molten KOH by switching the polarity between 2 symmetrical GO electrodes. The electrochemically activated graphene (ECAG) showed a specific surface area as high as 2170 m(2) g(-1) and nanometer-sized pore created at a temperature as low as 450 degrees C. The ECAG electrode shows a significant enhancement in the electrochemical activity and thus improved electrochemical performance when being used as electrodes in supercapacitors and capacitive deionization (CDI) cells. A specific capacitance of 275 F g(-1) is obtained in 6 M KOH electrolyte, and 189 F g(-1) in 1 M NaCl electrolyte, which maintains 95% after 5000 cycles. The desalination capacity of the electrodes was evaluated by a batch mode electrosorption experiment. The ECAG electrode was able to remove 14.25 mg of salts per gram of the active materials and satisfy a high adsorption rate of 2.01 mg CI min(-1). The low energy consumption of the CDI system is demonstrated by its high charge efficiency, which is estimated to be 0.83.
C1 [Zoromba, Mohamed Shafick; Abdel-Aziz, Mohamed Helmy; Bassyouni, Mohamed] King Abdulaziz Univ, Chem & Mat Engn Dept, Rabigh 21911, Saudi Arabia.
   [Gutub, Saud] King Abdulaziz Univ, Civil Engn Dept, Rabigh 21911, Saudi Arabia.
   [Zoromba, Mohamed Shafick] Port Said Univ, Fac Sci, Dept Chem, Port Said, Egypt.
   [Bassyouni, Mohamed] Univ Alexandria, Fac Engn, Dept Chem Engn, Alexandria, Egypt.
   [Bassyouni, Mohamed] Higher Technol Inst, Dept Chem Engn, Tenth Of Ramadan City, Egypt.
   [Demko, Denisa; Abdelkader, Amr] Univ Cambridge, Dept Engn, Cambridge CB3 0FA, England.
   [Abdelkader, Amr] Univ Manchester, NGI, Booth St East, Manchester M13 9QS, Lancs, England.
RP Abdelkader, A (reprint author), Univ Cambridge, Dept Engn, Cambridge CB3 0FA, England.; Abdelkader, A (reprint author), Univ Manchester, NGI, Booth St East, Manchester M13 9QS, Lancs, England.
EM aa494@cam.ac.uk
OI Helmy Abdel-Aziz, Mohamed/0000-0002-3075-4968; Abdelkader,
   Amr/0000-0002-8103-2420
FU Deanship of Scientific Research (DSR) at King Abdulaziz University,
   Jeddah [G-422-829-37]; DSR
FX The Deanship of Scientific Research (DSR), at King Abdulaziz University,
   Jeddah, funded this project under grant no. G-422-829-37. The authors,
   therefore, acknowledge with thanks DSR technical and financial support.
   The authors would also like to thank Tyler Lieberthal for helping with
   the graphics.
CR Abdelkader AM, 2016, ACS SUSTAIN CHEM ENG, V4, P4465, DOI 10.1021/acssuschemeng.6b01195
   Abdelkader AM, 2014, CHEM COMMUN, V50, P8402, DOI 10.1039/c4cc03260h
   Abdelkader AM, 2010, J MATER CHEM, V20, P6039, DOI 10.1039/c0jm00096e
   Abdelkader AM, 2009, J ALLOY COMPD, V469, P571, DOI 10.1016/j.jallcom.2008.02.039
   Abdelkader AM, 2015, NANOSCALE, V7, P11386, DOI 10.1039/c5nr02840j
   Abdelkader AM, 2015, J MATER CHEM A, V3, P8519, DOI 10.1039/c5ta00545k
   Abdelkader AM, 2014, ACS NANO, V8, P11225, DOI 10.1021/nn505700x
   Abdelkader AM, 2007, ISIJ INT, V47, P25, DOI 10.2355/isijinternational.47.25
   Anderson MA, 2010, ELECTROCHIM ACTA, V55, P3845, DOI 10.1016/j.electacta.2010.02.012
   Avraham E, 2011, J ELECTROCHEM SOC, V158, pP168, DOI 10.1149/2.078112jes
   Cao XH, 2014, ENERG ENVIRON SCI, V7, P1850, DOI 10.1039/c4ee00050a
   Chen WF, 2010, CARBON, V48, P1146, DOI 10.1016/j.carbon.2009.11.037
   Cohen I, 2011, J PHYS CHEM C, V115, P19856, DOI 10.1021/jp206956a
   Frackowiak E, 2002, CHEM PHYS LETT, V361, P35, DOI 10.1016/S0009-2614(02)00684-X
   Futaba DN, 2006, NAT MATER, V5, P987, DOI 10.1038/nmat1782
   Gao X, 2015, ENVIRON SCI TECHNOL, V49, P10920, DOI 10.1021/acs.est.5b02320
   Hu CG, 2015, ENERG ENVIRON SCI, V8, P31, DOI 10.1039/c4ee02594f
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Humplik T, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/292001
   Lei H, 2015, J MATER CHEM A, V3, P5934, DOI 10.1039/c4ta05713a
   Li HB, 2012, J MATER CHEM, V22, P15556, DOI 10.1039/c2jm32207b
   Li HB, 2010, ENVIRON SCI TECHNOL, V44, P8692, DOI 10.1021/es101888j
   Lim E, 2016, ADV FUNCT MATER, V26, P3711, DOI 10.1002/adfm.201505548
   Liu PY, 2016, J MATER CHEM A, V4, P5303, DOI 10.1039/c5ta10680j
   Ma YF, 2015, ADV MATER, V27, P5296, DOI 10.1002/adma.201501622
   Mauter MS, 2008, ENVIRON SCI TECHNOL, V42, P5843, DOI 10.1021/es8006904
   Mendoza-Sanchez B, 2016, ADV MATER, V28, P6104, DOI 10.1002/adma.201506133
   Oren Y, 2008, DESALINATION, V228, P10, DOI 10.1016/j.desal.2007.08.005
   Park S, 2008, CHEM MATER, V20, P6592, DOI 10.1021/cm801932u
   Pekala RW, 1998, J NON-CRYST SOLIDS, V225, P74, DOI 10.1016/S0022-3093(98)00011-8
   Porada S, 2013, PROG MATER SCI, V58, P1388, DOI 10.1016/j.pmatsci.2013.03.005
   Porada S, 2012, ACS APPL MATER INTER, V4, P1194, DOI 10.1021/am201683j
   Rasines G, 2015, CARBON, V83, P262, DOI 10.1016/j.carbon.2014.11.015
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y
   Sui ZY, 2012, J MATER CHEM, V22, P8767, DOI 10.1039/c2jm00055e
   Suss ME, 2015, ENERG ENVIRON SCI, V8, P2296, DOI [10.1039/c5ee00519a, 10.1039/C5EE00519A]
   Wang H, 2014, J MATER CHEM A, V2, P4739, DOI 10.1039/c3ta15152b
   Wang H, 2013, J MATER CHEM A, V1, P11778, DOI 10.1039/c3ta11926b
   Wang JC, 2012, J MATER CHEM, V22, P23710, DOI 10.1039/c2jm34066f
   Wen XR, 2013, J MATER CHEM A, V1, P12334, DOI 10.1039/c3ta12683h
   Wu SL, 2016, SMALL, V12, P2376, DOI 10.1002/smll.201503855
   Xia XH, 2014, NANO TODAY, V9, P785, DOI 10.1016/j.nantod.2014.12.001
   Xu J, 2016, ADV MATER, V28, P5222, DOI 10.1002/adma.201600586
   Yan J, 2012, CARBON, V50, P2179, DOI 10.1016/j.carbon.2012.01.028
   Yan ZQ, 2015, NANOSCALE, V7, P5563, DOI 10.1039/c5nr00030k
   Yang XW, 2011, ADV MATER, V23, P2833, DOI 10.1002/adma.201100261
   Yu GH, 2013, NANO ENERGY, V2, P213, DOI 10.1016/j.nanoen.2012.10.006
   Zhao R, 2010, J PHYS CHEM LETT, V1, P205, DOI 10.1021/jz900154h
   Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770
NR 50
TC 1
Z9 1
U1 20
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD JUN
PY 2017
VL 5
IS 6
BP 4573
EP 4581
DI 10.1021/acssuschemeng.6b02869
PG 9
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA EX0ZT
UT WOS:000402950000012
OA No
DA 2017-08-17
ER

PT J
AU Al-Sabagh, AM
   Yehia, FZ
   Eshaq, G
   ElMetwally, AE
AF Al-Sabagh, A. M.
   Yehia, F. Z.
   Eshaq, Gh.
   ElMetwally, A. E.
TI Eclectic Hydroxylation of Benzene to Phenol Using Ferrites of Fe and Zn
   as Durable and Magnetically Retrievable Catalysts
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Ferrites; Catalysis; Hydroxylation; Benzene; Phenol
ID HIGHLY SELECTIVE SYNTHESIS; ONE-POT SYNTHESIS; HYDROGEN-PEROXIDE;
   AROMATIC-HYDROCARBONS; MESOPOROUS SILICA; OXIDE CATALYSTS; GRAPHENE
   OXIDE; CARBON NITRIDE; NITROUS-OXIDE; IONIC LIQUID
AB Ferrites of iron and zinc were prepared and examined as catalysts for the eclectic hydroxylation of benzene in the presence of hydrogen peroxide as an oxidant under mild conditions. The obtained results revealed that iron ferrite is more efficient than zinc ferrite or other catalysts used in benzene hydroxylation. The efficacy of iron ferrite is attributed to the random occupation of the octahedral sites by divalent and trivalent iron cations, which eventually boosts the redox reaction within the octahedral site without altering the spinel structure. The catalyst durability testing revealed that the catalysts sustain the employed experimental conditions for five successive runs. The mechanism of benzene hydroxylation in the presence of iron ferrite and zinc ferrite was also suggested.
C1 [Al-Sabagh, A. M.; Yehia, F. Z.; Eshaq, Gh.; ElMetwally, A. E.] Egyptian Petr Res Inst, Cairo 11727, Egypt.
   [Eshaq, Gh.; ElMetwally, A. E.] Egyptian Petr Res Inst, Petrochem Technol Lab, Petrochem Dept, 1 Ahmed El Zomor St El Zohour Reg, Cairo 11727, Egypt.
RP Eshaq, G; ElMetwally, AE (reprint author), Egyptian Petr Res Inst, Cairo 11727, Egypt.; Eshaq, G; ElMetwally, AE (reprint author), Egyptian Petr Res Inst, Petrochem Technol Lab, Petrochem Dept, 1 Ahmed El Zomor St El Zohour Reg, Cairo 11727, Egypt.
EM ghadaamer2002@yahoo.com; ahmed_ezzatt@msn.com
CR Al-Sabagh AM, 2016, GREEN CHEM, V18, P3997, DOI 10.1039/c6gc00534a
   Bianchi D, 2003, J MOL CATAL A-CHEM, V200, P111, DOI 10.1016/S1381-1169(03)00041-4
   Borah P, 2016, GREEN CHEM, V18, P397, DOI 10.1039/c5gc01194a
   Bresser D, 2013, ADV ENERGY MATER, V3, P513, DOI 10.1002/aenm.201200735
   Burghart FJ, 2000, PHYSICA B, V289, P286, DOI 10.1016/S0921-4526(00)00394-X
   BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513
   Chen XF, 2009, J AM CHEM SOC, V131, P11658, DOI 10.1021/ja903923s
   Costa RCC, 2006, J HAZARD MATER, V129, P171, DOI 10.1016/j.jhazmat.2005.08.028
   Ding GD, 2013, CHEMCATCHEM, V5, P192, DOI 10.1002/cctc.201200502
   Ehrich H, 2002, APPL CATAL A-GEN, V230, P271, DOI 10.1016/S0926-860X(02)00040-6
   ElShafei GMS, 2017, SEP PURIF TECHNOL, V178, P122, DOI 10.1016/j.seppur.2017.01.028
   Gade VB, 2017, ACS SUSTAIN CHEM ENG, V5, P3314, DOI 10.1021/acssuschemeng.6b03167
   Gawande MB, 2015, COORDIN CHEM REV, V288, P118, DOI 10.1016/j.ccr.2015.01.001
   Gawande MB, 2014, CHEMCATCHEM, V6, P3312, DOI 10.1002/cctc.201402663
   Gawande MB, 2013, CHEM SOC REV, V42, P3371, DOI 10.1039/c3cs35480f
   Goldman A., 2006, MODERN FERRITE TECHN
   Hock H, 1944, BER DTSCH CHEM GES, V77, P257, DOI 10.1002/cber.19440770321
   Hu LY, 2014, CATAL COMMUN, V43, P179, DOI 10.1016/j.catcom.2013.10.005
   Hudson R, 2014, GREEN CHEM, V16, P4493, DOI 10.1039/c4gc00418c
   Jiang T, 2013, NEW J CHEM, V37, P1654, DOI 10.1039/c3nj41163j
   Jiang W, 2014, J MOL CATAL A-CHEM, V382, P8, DOI 10.1016/j.molcata.2013.10.017
   Jiang YQ, 2012, APPL CATAL A-GEN, V445, P172, DOI 10.1016/j.apcata.2012.08.016
   Jourshabani M, 2016, IND ENG CHEM RES, V55, P3900, DOI 10.1021/acs.iecr.5b04976
   Khatri PK, 2011, CHEM COMMUN, V47, P1610, DOI 10.1039/c0cc01941k
   Kusakari T, 2004, CHEM COMMUN, P992, DOI 10.1039/b401373e
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   Lemke K, 2003, APPL CATAL A-GEN, V243, P41, DOI 10.1016/S0926-860X(02)00535-5
   Maaz K, 2007, J MAGN MAGN MATER, V308, P289, DOI 10.1016/j.jmmm.2006.06.003
   Mathew DS, 2007, CHEM ENG J, V129, P51, DOI 10.1016/j.cej.2006.11.001
   Mehrdad A, 2010, ULTRASON SONOCHEM, V17, P168, DOI 10.1016/j.ultsonch.2009.07.003
   Monfared HH, 2004, J MOL CATAL A-CHEM, V217, P161, DOI 10.1016/j.molcata.2004.03.020
   Naidek KP, 2011, J COLLOID INTERF SCI, V358, P39, DOI 10.1016/j.jcis.2011.03.001
   Navarro R, 2014, APPL CATAL A-GEN, V474, P272, DOI 10.1016/j.apcata.2013.08.043
   Niwa S, 2002, SCIENCE, V295, P105, DOI 10.1126/science.1066527
   Nomiya K, 1997, J MOL CATAL A-CHEM, V126, P43, DOI 10.1016/S1381-1169(97)00096-4
   Peng JJ, 2003, GREEN CHEM, V5, P224, DOI 10.1039/b211239f
   Pillai V, 1996, J MAGN MAGN MATER, V163, P243, DOI 10.1016/S0304-8853(96)00280-6
   Renuka NK, 2010, J MOL CATAL A-CHEM, V316, P126, DOI 10.1016/j.molcata.2009.10.010
   Sahunin Chantanapha, 2006, ScienceAsia, V32, P181, DOI 10.2306/scienceasia1513-1874.2006.32.181
   Senn MS, 2012, NATURE, V481, P173, DOI 10.1038/nature10704
   Shang SS, 2015, RSC ADV, V5, P31965, DOI 10.1039/c5ra04836b
   Shebanova ON, 2003, J SOLID STATE CHEM, V174, P424, DOI 10.1016/S0022-4596(03)00294-9
   Shi HX, 2011, CATAL COMMUN, V12, P1022, DOI 10.1016/j.catcom.2011.03.012
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Stockmann M, 2001, APPL CATAL A-GEN, V208, P343, DOI 10.1016/S0926-860X(00)00733-X
   Sun K, 2008, J CATAL, V254, P383, DOI 10.1016/j.jcat.2008.01.017
   Tanarungsun G, 2008, CATAL COMMUN, V9, P1886, DOI 10.1016/j.catcom.2008.03.008
   Tian K, 2016, GREEN CHEM, V18, P5643, DOI [10.1039/c6gc01231k, 10.1039/C6GC01231K]
   Varshney D, 2011, MATER CHEM PHYS, V131, P413, DOI 10.1016/j.matchemphys.2011.09.066
   VERBLE JL, 1974, PHYS REV B, V9, P5236, DOI 10.1103/PhysRevB.9.5236
   Vestal CR, 2004, INT J NANOTECHNOL, V1, P240
   Wang C, 2015, CATAL COMMUN, V68, P1, DOI 10.1016/j.catcom.2015.04.014
   Wang WT, 2013, GREEN CHEM, V15, P1150, DOI 10.1039/c3gc00084b
   Wang YB, 2014, APPL CATAL B-ENVIRON, V147, P534, DOI 10.1016/j.apcatb.2013.09.017
   Xin HC, 2009, CHEM COMMUN, P7590, DOI 10.1039/b917038c
   Xu J, 2015, CATAL SCI TECHNOL, V5, P1504, DOI 10.1039/c4cy01373e
   Yamada M, 2016, CHEM SCI, V7, P2856, DOI 10.1039/c5sc04312c
   Yao LM, 2014, J POWER SOURCES, V258, P305, DOI 10.1016/j.jpowsour.2014.02.055
   Yehia F. Z., 2016, Egyptian Journal of Petroleum, V25, P239, DOI 10.1016/j.ejpe.2015.05.015
   Yehia FZ, 2015, DESALIN WATER TREAT, V56, P2160, DOI 10.1080/19443994.2014.958541
   Zhang X, 2017, RSC ADV, V7, P2934, DOI 10.1039/c6ra27831k
NR 61
TC 0
Z9 0
U1 6
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD JUN
PY 2017
VL 5
IS 6
BP 4811
EP 4819
DI 10.1021/acssuschemeng.7b00214
PG 9
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA EX0ZT
UT WOS:000402950000038
OA No
DA 2017-08-17
ER

PT J
AU Mwafy, A
   Elkholy, S
AF Mwafy, Aman
   Elkholy, Said
TI Performance assessment and prioritization of mitigation approaches for
   pre-seismic code structures
SO ADVANCES IN STRUCTURAL ENGINEERING
LA English
DT Article
DE dynamic response simulations; mitigation measures; pre-code reinforced
   concrete buildings; seismic performance; vulnerability assessment
ID HIGHRISE BUILDINGS; RC FRAME; STRENGTH; OVERSTRENGTH; DESIGN
AB The selection of an efficient mitigation technique from a number of alternatives to reduce the seismic risk of pre-seismic code school buildings is the main focus of this study. An on-ground survey of the school building stock in a large study area that extends for 6000 km(2) enabled the selection of four different benchmark structures. Detailed simulation models are developed for the selected benchmark buildings and 14 retrofit alternatives to define their performance criteria and assess their seismic vulnerability. The earthquake hazard of the study region is accounted for using a wide range of ground motions, representing two seismic scenarios pertinent to several medium seismicity regions. The relative seismic performance of pre-code buildings and different mitigation alternatives from a large number of dynamic response simulations up to collapse is described in terms of fragility curves as well as a proposed measure of response termed the overall performance factor. This measure of response along with the systematic seismic assessment approach adopted in this study enable prioritizing different retrofit alternatives based on their performance-to-cost ratios, which help to arrive at an efficient and cost-effective mitigation strategy for the implementation at the regional scale.
C1 [Mwafy, Aman; Elkholy, Said] United Arab Emirates Univ, Dept Civil & Environm Engn, POB 15551, Al Ain, U Arab Emirates.
   [Mwafy, Aman] Univ British Columbia, Sch Engn, Vancouver, BC, Canada.
   [Mwafy, Aman] Zagazig Univ, Fac Engn, Zagazig, Egypt.
   [Elkholy, Said] Fayoum Univ, Fac Engn, Al Fayyum, Egypt.
RP Mwafy, A (reprint author), United Arab Emirates Univ, Dept Civil & Environm Engn, POB 15551, Al Ain, U Arab Emirates.
EM amanmwafy@uaeu.ac.ae
FU United Arab Emirates University [31N227, 31N132]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the United Arab Emirates University under research
   grants No. 31N227 and 31N132.
CR ACI 318, 2011, 318 ACI
   ALCOCER SM, 1993, ACI STRUCT J, V90, P249
   ALCOCER SM, 1993, J STRUCT ENG-ASCE, V119, P1413, DOI 10.1061/(ASCE)0733-9445(1993)119:5(1413)
   [Anonymous], 2010, ASCESEI7
   [Anonymous], 2007, ASCESEI41
   [Anonymous], 2014, SCESEI41
   Billah AHMM, 2014, ENG STRUCT, V62-63, P105, DOI 10.1016/j.engstruct.2014.01.005
   European Committee for Standardization (CEN), 2004, 199812004 CEN EN
   Cundall PA, 1971, P INT S ROCK MECH IS
   El-Kholy SA, 2012, ARAB J SCI ENG, V37, P921, DOI 10.1007/s13369-012-0237-y
   Elkholy S, 2010, P 9 INT S NEW TECHN
   Elkholy S., 2005, JSCE J EARTHQ ENG, V28, P1
   Elnashai AS, 2002, STRUCT DES TALL BUIL, V11, P329, DOI 10.1002/tal.204
   Elnashai AS, 2012, ZEUS NL SYSTEM INELA
   Federal Emergency Management Agency (FEMA), 2006, TECHN SEISM REH EX B
   [Anonymous], 2001, FIB B, V14
   Ghobarah A, 1999, EARTHQUAKE ENG STRUC, V28, P79, DOI 10.1002/(SICI)1096-9845(199901)28:1<79::AID-EQE805>3.0.CO;2-J
   Housing and Building National Research Center (HBRC), 2012, EG COD CALC LOADS FO
   Jalayer F, 2009, EARTHQ ENG STRUCT D, V38, P951, DOI 10.1002/eqe.876
   Jeong SH, 2012, ENG STRUCT, V34, P527, DOI 10.1016/j.engstruct.2011.10.019
   Jeong SH, 2005, J EARTHQ ENG, V9, P95, DOI 10.1142/S1363246905001906
   Ji J, 2007, ENG STRUCT, V29, P3197, DOI 10.1016/j.engstruct.2007.08.026
   Kim SJ, 2011, J STRUCT ENG, V137, P252, DOI 10.1061/(ASCE)ST.1943-541X.0000306
   Kim SJ, 2009, ENG STRUCT, V31, P2998, DOI 10.1016/j.engstruct.2009.08.001
   Kwon OS, 2006, ENG STRUCT, V28, P289, DOI 10.1016/j.engstruct.2005.07.010
   Meguro K, 2001, J STRUCT ENG-ASCE, V127, P1295, DOI 10.1061/(ASCE)0733-9445(2001)127:11(1295)
   Meguro K, 1989, STRUCTURAL ENG EARTH, V6, P283
   Mwafy A, 2008, ENG STRUCT, V30, P1590, DOI 10.1016/j.engstruct.2007.10.015
   Mwafy A, 2015, STRUCT DES TALL SPEC, V24, P257, DOI 10.1002/tal.1165
   Mwafy A, 2013, P I CIVIL ENG-STR B, V166, P282, DOI 10.1680/stbu.11.00022
   Mwafy A, 2010, ENG STRUCT, V32, P2192, DOI 10.1016/j.engstruct.2010.03.022
   Mwafy AM, 2012, J EARTHQ TSUNAMI, V6, DOI 10.1142/S1793431112500194
   Pacific Earthquake Engineering Research Center (PEER), 2014, PEER NGA DAT
   PRIESTLEY MJN, 1994, J STRUCT ENG-ASCE, V120, P2310, DOI 10.1061/(ASCE)0733-9445(1994)120:8(2310)
   Sykora D, 1993, DTIC DOCUMENT
   Thermou GE, 2006, PROG STRUCT ENG MAT, V8, P1, DOI 10.1002/pse.208
   Wen Y. K., 2003, UNCERTAINTY MODELING
NR 37
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1369-4332
EI 2048-4011
J9 ADV STRUCT ENG
JI Adv. Struct. Eng.
PD JUN
PY 2017
VL 20
IS 6
BP 917
EP 939
DI 10.1177/1369433216667188
PG 23
WC Construction & Building Technology; Engineering, Civil
SC Construction & Building Technology; Engineering
GA EW4FT
UT WOS:000402458100006
OA No
DA 2017-08-17
ER

PT J
AU Moghadam, MHB
   Shehab, A
   Cherian, G
AF Moghadam, M. H. Beheshti
   Shehab, A.
   Cherian, G.
TI Methionine supplementation augments tissue n-3 fatty acid and tocopherol
   content in broiler birds fed flaxseed
SO ANIMAL FEED SCIENCE AND TECHNOLOGY
LA English
DT Article
DE n-3 fatty acid; Broiler; Flax; Methionine; Tocopherol
ID HOMOCYSTEINE METABOLISM; NUTRIENT UTILIZATION; DIETARY METHIONINE;
   ADIPOSE-TISSUE; DL-METHIONINE; CHICKENS; GLUTATHIONE; LINSEED;
   PERFORMANCE; CARCASS
AB Methionine (Met) is the first limiting amino acid in meat-type broiler chicken diets and serves as a lipotropic agent with antioxidant properties. The objectives of the current study is based on the hypothesis that Met supplementation will enhance n-3 fatty acid (FA) status, antioxidant content, lipid stability, and production indices in broilers fed flax. The effect of Met supplementation (50 and 100% above Cobb 500 requirement level) on tissue FA composition, tocopherol (Toc) content, lipid oxidation products, and growth performance of broilers fed flax is investigated. One hundred and twenty (n = 120) day-old Cobb chicks were fed corn-soybean meal-based diet containing 0% flax, (Control), 15% flax (Diet 1), Diet 1 + 50% more Met (Diet 2), and Diet 1 + 100% more Met (Diet 3) for 42 days. Total lipids in liver and adipose tissue was lowest in Diet 3 (P < 0.05) Feeding flax led to a reduction total lipids in breast muscle (P < 0.05) and was not affected by Met level (P > 0.05). alpha-Linolenic acid (18:3n-3) was highest in thigh muscle and liver of Diet 3 and adipose tissue of chickens fed Diet 2 and Diet 3 (P < 0.05). Total long chain ( > 20 C) n-3 FA was highest in the breast muscle of chickens fed Diet 2 and Diet 3 (P < 0.05). Total saturated FA were lowest in the breast and thigh muscle of Diet 3 fed birds (P < 0.05). Addition of Met led to an increase in alpha-Toc in breast muscle in birds fed Diet 2 and Diet 3 (P < 0.05). Lipid oxidation products were lower in the thigh muscle and adipose tissue of birds fed Diet 2 and Diet 3 than Diet 1 and Control (P < 0.05). Body weight gain was lowest in birds fed flax (P < 0.05). Met supplementation had no effect on weight gain or feed conversion in birds fed flax (P > 0.05). No effect of diet on feed consumption was observed (P > 0.05). Overall, results from the current study demonstrate that Met supplementation is a novel way to enrich tissues with n-3 FA and Toc in chickens fed flax.
C1 [Moghadam, M. H. Beheshti; Shehab, A.; Cherian, G.] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA.
   [Moghadam, M. H. Beheshti] Sari Agr Sci & Nat Resources Univ, Mazandaran, Iran.
   [Shehab, A.] Benha Univ, Banha, Egypt.
RP Cherian, G (reprint author), Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA.
EM Gita.Cherian@oregonstate.edu
FU Oregon State University Agriculture Research Foundation
FX We acknowledge support from an Oregon State University Agriculture
   Research Foundation grant awarded to G. Cherian.
CR AJUYAH AO, 1991, POULTRY SCI, V70, P2304
   Alzueta C, 2003, BRIT POULTRY SCI, V44, P67, DOI 10.1080/0007166031000085337
   Apperson K.D., 2016, POULT SCI
   Arab-Tehrany E, 2012, TRENDS FOOD SCI TECH, V25, P24, DOI 10.1016/j.tifs.2011.12.002
   BEATTY PW, 1980, ARCH BIOCHEM BIOPHYS, V204, P80, DOI 10.1016/0003-9861(80)90009-0
   Betel M., 2009, POULTRY SCI, V88, P1740
   Blaszczyk I, 2010, BIOL TRACE ELEM RES, V133, P60, DOI 10.1007/s12011-009-8412-z
   Calder P.C., 2013, J NUTR S, p592S
   Cherian G., 2002, POULT SCI, V1420
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501
   Head B.A., 2016, THESIS
   Huang T, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-6
   Ji B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-441
   Lands B, 2014, PROG LIPID RES, V55, P17, DOI 10.1016/j.plipres.2014.04.002
   LEE KH, 1991, CAN J ANIM SCI, V71, P897
   LEE KH, 1995, POULTRY SCI, V74, P1341
   Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617
   MADHUSUDHAN KT, 1986, POULTRY SCI, V65, P164
   Maroufyan E, 2012, POULTRY SCI, V91, P2173, DOI 10.3382/ps.2012-02317
   Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w
   Nemeth K, 2004, ACTA VET HUNG, V52, P369, DOI 10.1556/AVet.52.2004.3.12
   Ortiz LT, 2001, BRIT POULTRY SCI, V42, P57, DOI 10.1080/713655010
   Panda A.K., 2016, EUR J LIPID SCI TECH
   Pillai PB, 2006, POULTRY SCI, V85, P90
   Podda M, 1996, J LIPID RES, V37, P893
   Rocha-e-Silva RC, 2010, COMP BIOCHEM PHYS C, V151, P294, DOI 10.1016/j.cbpc.2009.12.001
   Rodriguez ML, 2001, BRIT POULTRY SCI, V42, P368, DOI 10.1080/00071660120055359
   Shen YR, 2005, J SCI FOOD AGR, V85, P2005, DOI 10.1002/jsfa.2155
   Steel R. G. D., 1980, PRINCIPLES PROCEDURE
   Swennen Q, 2011, BRIT J NUTR, V106, P1845, DOI 10.1017/S0007114511002558
   Vazquez-Anon M, 2006, POULTRY SCI, V85, P1409
   Waladkhani AR, 1996, ALCOHOL ALCOHOLISM, V31, P463
   Wu GY, 2004, J NUTR, V134, P489
   Zhai W, 2016, J APPL POULTRY RES, V25, P223, DOI 10.3382/japr/pfw004
NR 35
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0377-8401
EI 1873-2216
J9 ANIM FEED SCI TECH
JI Anim. Feed Sci. Technol.
PD JUN
PY 2017
VL 228
BP 149
EP 158
DI 10.1016/j.anifeedsci.2017.04.014
PG 10
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA EX3JO
UT WOS:000403128600017
OA No
DA 2017-08-17
ER

PT J
AU Elrefai, M
   Hasenberg, T
   Diouf, S
   Weiss, C
   Kienle, P
   Otto, M
AF Elrefai, Mohamad
   Hasenberg, Till
   Diouf, Stefanie
   Weiss, Christel
   Kienle, Peter
   Otto, Mirko
TI Quality of Life After Bariatric Surgery: Comparison of Four Different
   Surgical Procedures
SO BARIATRIC SURGICAL PRACTICE AND PATIENT CARE
LA English
DT Article
DE bariatric surgery; quality of life
ID Y GASTRIC BYPASS; EXCESS WEIGHT-LOSS; BODY-MASS INDEX;
   SLEEVE-GASTRECTOMY; OBESITY SURGERY; DUODENAL SWITCH; RISK-FACTORS;
   FOLLOW-UP; OUTCOMES; INTERVENTION
AB Objective: To identify predictors that may affect postoperative quality of life (QOL) after bariatric surgery.
   Methods: German speaking patients who underwent bariatric surgery between 2003 and 2010 were included. Out of the total of 132 patients fulfilling the inclusion criteria, 113 could be reached via phone interview (85.6%). Sixty-five patients underwent laparoscopic Roux-en-Y gastric bypass (LRYGB), 26 laparoscopic sleeve gastrectomy (LSG), 15 patients biliopancreatic diversion with duodenal switch (BPD/DS), and 7 patients laparoscopic gastric banding (LAGB). The German version of the bariatric QOL index questionnaire was used.
   Results: The study participants achieved a mean score of 51.2 +/- 10.2 points, which is in normal range of healthy individuals. Patients operated at younger age had a better QOL than elderly patients. Men and women showed comparable postoperative QOL. Patients who had been already working before surgery or started to work postoperatively achieved more QOL score points than those who did not. LRYGB, LSG, LAGB, and BPD/DS all equally resulted in a good QOL after surgery (51 +/- 11.3, 51.9 +/- 7.1, 45.3 +/- 9.6, 54 +/- 9.7, p = 0.2).
   Conclusion: LRYGB, LSG, LAGB, and BPD/DS do not differ in terms of QOL 3.3 years after surgery. Young age and pre-and postoperative integration into work are positive predictors for good QOL after surgery. Postoperative QOL is significantly correlated to magnitude of weight loss after surgery (both percentage of total weight loss and percentage of excess weight loss).
C1 [Elrefai, Mohamad; Diouf, Stefanie; Kienle, Peter; Otto, Mirko] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, Mannheim, Germany.
   [Elrefai, Mohamad] Mansoura Univ, Dept Surg, Gastroenterol Surg Ctr, Mansoura, Egypt.
   [Hasenberg, Till] Alfried Krupp Hosp, Dept Surg, Essen, Germany.
   [Weiss, Christel] Heidelberg Univ, Dept Med Stat Biomath & Informat Proc, Mannheim, Germany.
RP Otto, M (reprint author), UMM, Dept Surg, Theodor Kutzer Ufer 1-3, D-68135 Mannheim, Germany.
EM mirko.otto@umm.de
CR Bond DS, 2004, AM SURGEON, V70, P811
   Brunault P, 2015, QUAL LIFE RES, V24, P493, DOI 10.1007/s11136-014-0775-8
   Brunault P, 2011, OBES SURG, V21, P1225, DOI 10.1007/s11695-011-0411-4
   Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724
   Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0
   Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041
   Charalampakis V, 2015, SURG OBES RELAT DIS, V11, P70, DOI 10.1016/j.soard.2014.04.024
   DeMaria EJ, 2010, ANN SURG, V252, P559, DOI 10.1097/SLA.0b013e3181f2aed0
   DeMaria EJ, 2010, ANN SURG, V251, P406, DOI 10.1097/SLA.0b013e3181d03db5
   Fezzi M, 2011, OBES SURG, V21, P1161, DOI 10.1007/s11695-011-0361-x
   Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541
   Hachem A, 2016, OBES SURG, V26, P395, DOI 10.1007/s11695-015-1940-z
   Hamoui N, 2007, J AM COLL SURGEONS, V204, P603, DOI 10.1016/j.jamcollsurg.2007.01.011
   Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026
   Josbeno DA, 2010, SURG OBES RELAT DIS, V6, P361, DOI 10.1016/j.soard.2008.08.003
   Karlsson J, 1998, INT J OBESITY, V22, P113, DOI 10.1038/sj.ijo.0800553
   Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573
   Karlsson J, 2003, INT J OBESITY, V27, P617, DOI 10.1038/sj.ijo.0802272
   Kinzl JF, 2001, OBES SURG, V11, P455, DOI 10.1381/096089201321209323
   Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13
   Le Pen C, 1998, J EPIDEMIOL COMMUN H, V52, P445
   Lee WJ, 2004, OBES SURG, V14, P626, DOI 10.1381/096089204323093390
   Limbach KE, 2014, OBES SURG, V24, P1379, DOI 10.1007/s11695-014-1213-2
   Maggard MA, 2005, ANN INTERN MED, V142, P547
   Merhi ZO, 2007, FERTIL STERIL, V87, P711, DOI 10.1016/j.fertnstert.2006.07.1511
   Mitchell JE, 2013, OBESITY, V21, P665, DOI 10.1002/oby.20066
   Muller MK, 2008, OBES SURG, V18, P1551, DOI 10.1007/s11695-008-9522-y
   Otto M, 2016, OBES SURG, V26, P479, DOI 10.1007/s11695-015-1792-6
   Peterli R, 2013, ANN SURG, V258, P690, DOI 10.1097/SLA.0b013e3182a67426
   Scozzari G, 2012, ANN SURG, V256, P724, DOI 10.1097/SLA.0b013e3182734113
   Sczepaniak JP, 2015, OBES SURG, V25, P788, DOI 10.1007/s11695-014-1496-3
   Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622
   Strain GW, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.29
   Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5
   van de Laar A, 2011, OBES SURG, V21, P763, DOI 10.1007/s11695-010-0347-0
   Velcu Laura M, 2005, Surg Obes Relat Dis, V1, P413, DOI 10.1016/j.soard.2005.04.007
   Weiner S, 2005, OBES SURG, V15, P538, DOI 10.1381/0960892053723439
   Xavier de Toledo Duarte Maria Ignez, 2014, Arquivos de Gastroenterologia, V51, P320, DOI 10.1590/S0004-28032014000400010
   Zhang Y, 2014, OBES SURG, V24, P1617, DOI 10.1007/s11695-014-1258-2
NR 39
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2168-023X
EI 2168-0248
J9 BARIATR SURG PRACT P
JI Bariatr. Surg. Pract. Patient Care
PD JUN
PY 2017
VL 12
IS 2
BP 61
EP 66
DI 10.1089/bari.2016.0050
PG 6
WC Nursing
SC Nursing
GA EX2SO
UT WOS:000403077000005
OA No
DA 2017-08-17
ER

PT J
AU Ibrahim, AA
   El-Lebedy, D
   Ashmawy, I
   Hady, MA
AF Ibrahim, Alshaymaa Ahmed
   El-Lebedy, Dalia
   Ashmawy, Ingy
   Hady, Maha Abdel
TI Association between paraoxonase-1 gene Q192R and L55M polymorphisms in
   systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS)
   in a population from Cairo of Egypt
SO CLINICAL RHEUMATOLOGY
LA English
DT Article
DE Anti-phospholipid syndrome; Paraoxonase-1; Polymorphism; Systemic lupus
   erythematosus
ID PON1 55 POLYMORPHISM; OXIDATIVE STRESS; CLASSIFICATION CRITERIA;
   MYOCARDIAL-INFARCTION; DISEASE; RISK; LIPOPROTEIN; DERIVATION; VARIANTS
AB Paraoxonase-1 (PON1) is involved in the oxidative stress process that cause tissue damage observed in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS). The aim of the present study was to investigate the association of PON1 Q192R and L55M polymorphisms with risk of SLE and associated APS among Egyptian sample. The study included 120 SLE patients (45 without APS and 75 with APS) and 120 healthy subjects. PON1 Q192R and L55M polymorphisms were genotyped by real-time PCR. No significant differences in Q192R genotypes or allele frequencies were found between patients and controls (p = 0.5 and 0.1, respectively). The frequency of the 55M allele was significantly higher in SLE patients than in controls (66.6 vs. 43.3%), while the 55L allele was more frequent in controls (56.6%) than in patients (33.3%) (p = 0.03). The LL genotype was more frequent in controls (21.6%) than in patients (10%) while M allele carrier genotypes (LM + MM) were more frequent among patients (90%) than controls (78.3%), p = 0.04. Also, the 55M allele was more frequent in APS patients (73.3%) than in patients without APS (55.6%), p = 0.004. M allele carrier genotypes (LM + MM) was significantly higher among APS patients (95.4%) than in non-APS patients (80%), p = 0.008. Our results indicated that the PON1 L55M polymorphism associated with SLE and associated APS in a population from Cairo of Egypt, while the Q192R polymorphism plays no role in disease susceptibility. A large scale study to assess PON1 polymorphisms, PON1 activity, and markers of oxidative stress interaction is needed to clarify the role of PON-1 polymorphisms in the pathogenesis of SLE and associated APS.
C1 [Ibrahim, Alshaymaa Ahmed; El-Lebedy, Dalia; Ashmawy, Ingy] Natl Res Ctr, Clin & Chem Pathol Dept, El Buhouth St, Cairo 12311, Egypt.
   [Hady, Maha Abdel] Natl Res Ctr, Internal Med Dept, Cairo, Egypt.
RP Ibrahim, AA (reprint author), Natl Res Ctr, Clin & Chem Pathol Dept, El Buhouth St, Cairo 12311, Egypt.
EM shaymaa_t@hotmail.com
CR Ali O. M., 2014, Journal of Molecular Biomarkers and Diagnosis, V5, P180
   Asefi M, 2012, BRIT J DERMATOL, V167, P1279, DOI 10.1111/j.1365-2133.2012.11170.x
   Bahrehmand F, 2014, LUPUS, V23, P263, DOI 10.1177/0961203313518622
   Bahrehmand F, 2013, IRAN J ALLERGY ASTHM, V12, P211
   BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606
   Chen YJ, 2012, KNOWL-BASED SYST, V33, P1, DOI 10.1016/j.knosys.2012.02.016
   Dasgupta S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-7
   El-Lebedy Dalia, 2014, J Diabetes Metab Disord, V13, P124, DOI 10.1186/s40200-014-0125-y
   Elfasakhany F, 2014, CLIN MED DIAGNOSTICS, V4, P15
   Fekih O, 2017, ENDOKRYNOL POL, V68, P35, DOI 10.5603/EP.a2016.0027
   Franco JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110242
   Gorshunskaia M Iu, 2011, Tsitol Genet, V45, P48
   Gurbuz S, 2015, WORLD J EMERG MED, V6, P201, DOI 10.5847/wjem.j.1920-8642.2015.03.007
   Hashemi M, 2010, GENETMOLRES, P333
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Hussein YM, 2011, MOL CELL BIOCHEM, V351, P117, DOI 10.1007/s11010-011-0718-4
   Kaman D, 2009, CELL BIOCHEM FUNCT, V27, P88, DOI 10.1002/cbf.1539
   Kocakap DBS, 2016, ANATOL J CARDIOL, V16, P175, DOI 10.5152/akd.2015.6010
   Kucukali CI, 2015, IN VIVO, V29, P103
   Lai ZW, 2015, CLIN IMMUNOL, V158, P148, DOI 10.1016/j.clim.2015.03.024
   Lakshmy R, 2010, INDIAN J MED RES, V131, P522
   Liu YL, 2012, GENE, V501, P188, DOI 10.1016/j.gene.2012.03.067
   Lopez-Pedrera C, 2016, RHEUMATOLOGY
   Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x
   Ortak H, 2013, MOL VIS, V19, P486
   Passam FH, 2011, J THROMB HAEMOST, V9, P275, DOI 10.1111/j.1538-7836.2011.04301.x
   Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473
   Rahman MFA, 2015, ARCH MED SCI, V11, P513, DOI 10.5114/aoms.2015.52353
   Shahmohamadnejad S, 2015, CLIN BIOCHEM, V48, P63, DOI 10.1016/j.clinbiochem.2014.08.016
   Tripi LM, 2006, ARTHRITIS RHEUM, V54, P1928, DOI 10.1002/art.21889
   Vaisi-Raygani A, 2011, MOL BIOL REP, V38, P5421, DOI 10.1007/s11033-011-0696-3
   Yang J., 2016, OXID MED CELL LONGEV, V2016
   Yilmaz A, 2009, J NEPHROL, V22, P726
   Zakrzewska-Pniewska B, 2013, NEUROL NEUROCHIR POL, V47, P49, DOI 10.5114/ninp.2013.32935
NR 34
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD JUN
PY 2017
VL 36
IS 6
BP 1305
EP 1310
DI 10.1007/s10067-017-3567-z
PG 6
WC Rheumatology
SC Rheumatology
GA EX2TJ
UT WOS:000403079400013
PM 28185016
OA No
DA 2017-08-17
ER

PT J
AU Basavarajappa, HD
   Sulaiman, RS
   Qi, XP
   Shetty, T
   Babu, SSP
   Sishtla, KL
   Lee, B
   Quigley, J
   Alkhairy, S
   Briggs, CM
   Gupta, K
   Tang, B
   Shadmand, M
   Grant, MB
   Boulton, ME
   Seo, SY
   Corson, TW
AF Basavarajappa, Halesha D.
   Sulaiman, Rania S.
   Qi, Xiaoping
   Shetty, Trupti
   Babu, Sardar Sheik Pran
   Sishtla, Kamakshi L.
   Lee, Bit
   Quigley, Judith
   Alkhairy, Sameerah
   Briggs, Christian M.
   Gupta, Kamna
   Tang, Buyun
   Shadmand, Mehdi
   Grant, Maria B.
   Boulton, Michael E.
   Seo, Seung-Yong
   Corson, Timothy W.
TI Ferrochelatase is a therapeutic target for ocular neovascularization
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE age-related macular degeneration; angiogenesis; ferrochelatase;
   griseofulvin; heme synthesis
ID ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; CHOROIDAL
   NEOVASCULARIZATION; NITRIC-OXIDE; ERYTHROPOIETIC PROTOPORPHYRIA;
   GENE-EXPRESSION; RETINAL NEOVASCULARIZATION; BIOLOGICAL EVALUATION;
   BINDING-PROTEINS; HOUSE MOUSE
AB Ocular neovascularization underlies major blinding eye diseases such as "wet" age-related macular degeneration (AMD). Despite the successes of treatments targeting the vascular endothelial growth factor (VEGF) pathway, resistant and refractory patient populations necessitate discovery of new therapeutic targets. Using a forward chemical genetic approach, we identified the heme synthesis enzyme ferrochelatase (FECH) as necessary for angiogenesis in vitro and in vivo. FECH is overexpressed in wet AMD eyes and murine choroidal neovascularization; siRNA knockdown of Fech or partial loss of enzymatic function in the Fech(m1Pas) mouse model reduces choroidal neovascularization. FECH depletion modulates endothelial nitric oxide synthase function and VEGF receptor 2 levels. FECH is inhibited by the oral antifungal drug griseofulvin, and this compound ameliorates choroidal neovascularization in mice when delivered intravitreally or orally. Thus, FECH inhibition could be used therapeutically to block ocular neovascularization.
C1 [Basavarajappa, Halesha D.; Sulaiman, Rania S.; Qi, Xiaoping; Shetty, Trupti; Babu, Sardar Sheik Pran; Sishtla, Kamakshi L.; Quigley, Judith; Alkhairy, Sameerah; Briggs, Christian M.; Gupta, Kamna; Shadmand, Mehdi; Grant, Maria B.; Boulton, Michael E.; Corson, Timothy W.] Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA.
   [Basavarajappa, Halesha D.; Sulaiman, Rania S.; Qi, Xiaoping; Shetty, Trupti; Babu, Sardar Sheik Pran; Sishtla, Kamakshi L.; Quigley, Judith; Alkhairy, Sameerah; Briggs, Christian M.; Gupta, Kamna; Shadmand, Mehdi; Grant, Maria B.; Boulton, Michael E.; Corson, Timothy W.] Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA.
   [Basavarajappa, Halesha D.; Tang, Buyun; Corson, Timothy W.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.
   [Sulaiman, Rania S.; Shetty, Trupti; Grant, Maria B.; Corson, Timothy W.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.
   [Sulaiman, Rania S.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.
   [Lee, Bit; Seo, Seung-Yong] Gachon Univ, Coll Pharm, Incheon, South Korea.
RP Corson, TW (reprint author), Indiana Univ Sch Med, Eugene & Marilyn Glick Eye Inst, Indianapolis, IN 46202 USA.; Corson, TW (reprint author), Indiana Univ Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA.; Corson, TW (reprint author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Corson, TW (reprint author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.
EM tcorson@iu.edu
FU International Retinal Research Foundation; Retina Research Foundation;
   Carl Marshall & Mildred Almen Reeves Foundation, Inc.; Ralph W. and
   Grace M. Showalter Research Trust Fund; NIH/NCATS [KL2TR001106,
   UL1TR001108]; NIH/NEI [R01EY025641]; Ausich Graduate Scholarship from
   Kemin Health; Basic Science Research Program through National Research
   Foundation of Korea (NRF) - Ministry of Education
   [NRF-2013R1A1A2007151]; Pioneer Research Center Program through NRF -
   Ministry of Science, ICT & Future Planning [2014M3C1A3001556]; Research
   to Prevent Blindness, Inc.;  [R01EY012601];  [R01EY007739]; 
   [R01HL110170];  [R01DK090730];  [R01EY025383];  [R01EY018358];  [JDRF
   2-SRA-2014-146-Q-R]
FX We thank Michael Sturek for the porcine brain and Harry Dailey for the
   FECH expression plasmid and protein production advice. This work was
   supported by grants from the International Retinal Research Foundation,
   the Retina Research Foundation, the Carl Marshall & Mildred Almen Reeves
   Foundation, Inc., the Ralph W. and Grace M. Showalter Research Trust
   Fund, NIH/NCATS KL2TR001106 and UL1TR001108, and NIH/NEI R01EY025641
   (T.W.C.); the Ausich Graduate Scholarship from Kemin Health (H.D.B.);
   R01EY012601, R01EY007739, R01HL110170, R01DK090730, and R01EY025383
   (M.B.G.); R01EY025383, R01EY018358, and JDRF 2-SRA-2014-146-Q-R
   (M.E.B.); the Basic Science Research Program through the National
   Research Foundation of Korea (NRF) funded by the Ministry of Education
   (NRF-2013R1A1A2007151) and the Pioneer Research Center Program through
   the NRF funded by the Ministry of Science, ICT & Future Planning
   (2014M3C1A3001556) (S.-Y.S.); and an unrestricted grant from Research to
   Prevent Blindness, Inc. (T.W.C., M.B.G., and M.E.B.).
CR Abouammoh M, 2011, CURR OPIN OPHTHALMOL, V22, P152, DOI 10.1097/ICU.0b013e32834595d0
   Basavarajappa HD, 2015, J MED CHEM, V58, P5015, DOI 10.1021/acs.jmedchem.5b00449
   Basavarajappa HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095694
   BORGERS M, 1980, REV INFECT DIS, V2, P520
   BOULECHFAR S, 1993, GENOMICS, V16, P645, DOI 10.1006/geno.1993.1242
   BRADY AM, 1992, ARCH TOXICOL, V66, P175, DOI 10.1007/BF01974011
   COLE SPC, 1984, MOL CELL BIOCHEM, V64, P127
   Corson TW, 2011, CHEMBIOCHEM, V12, P1767, DOI 10.1002/cbic.201100007
   DAILEY HA, 1994, J BIOL CHEM, V269, P390
   Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672
   Das A, 2003, PROG RETIN EYE RES, V22, P721, DOI 10.1016/j.perteyeres.2003.08.001
   Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316
   Elewski Boni, 2005, Ther Clin Risk Manag, V1, P299
   EPSTEIN WL, 1972, ARCH DERMATOL, V106, P344, DOI 10.1001/archderm.106.3.344
   Folk JC, 2010, NEW ENGL J MED, V363, P1648, DOI 10.1056/NEJMct1000495
   Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532
   Grover C, 2012, INT J DERMATOL, V51, P455, DOI 10.1111/j.1365-4632.2011.05341.x
   Gupta V, 2013, MOL PHARMACOL, V84, P824, DOI 10.1124/mol.113.087940
   Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009
   Hanout M, 2013, BIOMED RES INT, DOI 10.1155/2013/830837
   HOLLEY A, 1990, J BIOCHEM TOXICOL, V5, P175, DOI 10.1002/jbt.2570050307
   Kaiser PK, 2013, OPHTHALMOLOGY, V120, pS11, DOI 10.1016/j.ophtha.2013.01.061
   Kim JH, 2008, MOL VIS, V14, P556
   Kim JH, 2007, BIOCHEM BIOPH RES CO, V362, P848, DOI 10.1016/j.bbrc.2007.08.100
   Lally DR, 2012, CURR OPIN OPHTHALMOL, V23, P182, DOI 10.1097/ICU.0b013e328352411c
   Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135
   Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19
   Lee B, 2016, BIOORG MED CHEM LETT, V26, P4277, DOI 10.1016/j.bmcl.2016.07.043
   Lee B, 2014, ORG BIOMOL CHEM, V12, P7673, DOI 10.1039/c4ob01604a
   Liu K, 2015, BIOCHEM PHARMACOL, V98, P493, DOI 10.1016/j.bcp.2015.09.002
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOCHHEAD AC, 1967, BRIT J DERMATOL, V79, P96, DOI 10.1111/j.1365-2133.1967.tb11463.x
   Lux A, 2007, BRIT J OPHTHALMOL, V91, P1318, DOI 10.1136/bjo.2006.113902
   Martinez MDC, 2009, CELL MOL BIOL, V55, P127, DOI 10.1170/T862
   Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086
   Montezuma SR, 2009, SEMIN OPHTHALMOL, V24, P52, DOI 10.1080/08820530902800017
   Niphakis MJ, 2015, CELL, V161, P1668, DOI 10.1016/j.cell.2015.05.045
   Park J, 2016, ACS CHEM BIOL, V11, P44, DOI 10.1021/acschembio.5b00671
   Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001
   Petersen AB, 2014, CHEM REV, V114, P12088, DOI 10.1021/cr400368e
   Poor SH, 2014, INVEST OPHTH VIS SCI, V55, P6525, DOI 10.1167/iovs.14-15067
   Prasad PS, 2010, MATURITAS, V66, P46, DOI 10.1016/j.maturitas.2010.02.006
   Rathel T. R., 2003, BIOL PROCED ONLINE, V5, P136, DOI 10.1251/bpo55
   Rezzola S, 2013, EXP EYE RES, V112, P51, DOI 10.1016/j.exer.2013.04.014
   Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009
   Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784
   Shim JS, 2004, PLANTA MED, V70, P171, DOI 10.1055/s-2004-815496
   Smith AG, 2014, EXPERT OPIN EMERG DR, V19, P157, DOI 10.1517/14728214.2014.884559
   Sulaiman RS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25509
   Sulaiman RS, 2015, J OCUL PHARMACOL TH, V31, P447, DOI 10.1089/jop.2015.0049
   Sulaiman RS, 2014, EXP EYE RES, V129, P161, DOI 10.1016/j.exer.2014.10.002
   Takagi H, 1996, INVEST OPHTH VIS SCI, V37, P1311
   Tsuboi H, 2007, J DERMATOL, V34, P790, DOI 10.1111/j.1346-8138.2007.00386.x
   TUDER RM, 1995, J CLIN INVEST, V95, P1798, DOI 10.1172/JCI117858
   TUTOIS S, 1991, J CLIN INVEST, V88, P1730, DOI 10.1172/JCI115491
   Wenzel Andrea A, 2015, Mol Vis, V21, P515
   Ziche M, 2000, J NEURO-ONCOL, V50, P139, DOI 10.1023/A:1006431309841
NR 57
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD JUN
PY 2017
VL 9
IS 6
BP 786
EP 801
DI 10.15252/emmm.201606561
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EW5EC
UT WOS:000402527000006
PM 28377496
OA gold
DA 2017-08-17
ER

PT J
AU Al-Wabel, MI
   Sallam, AS
   Usman, ARA
   Ahmad, M
   El-Naggar, AH
   El-Saeid, MH
   Al-Faraj, A
   El-Enazi, K
   Al-Romian, FA
AF Al-Wabel, Mohammad I.
   Sallam, Abd El-Azeem S.
   Usman, Adel R. A.
   Ahmad, Mahtab
   El-Naggar, Ahmed Hamdy
   El-Saeid, Mohammed Hamza
   Al-Faraj, Abdulelah
   El-Enazi, Khaled
   Al-Romian, Fahad A.
TI Trace metal levels, sources, and ecological risk assessment in a densely
   agricultural area from Saudi Arabia
SO ENVIRONMENTAL MONITORING AND ASSESSMENT
LA English
DT Article
DE Pollution; Agrochemicals; Anthropogenic source; Soil quality; Principal
   component analysis
ID LONG-TERM IRRIGATION; HEAVY-METALS; PHOSPHORUS FERTILIZERS; WASTE-WATER;
   CROP UPTAKE; SOILS; POLLUTION; CADMIUM; CHINA; ACCUMULATION
AB The present study was conducted in one of the most densely cultivated area of Al-Qassim region in Kingdom of Saudi Arabia to (i) monitor trace metal (Cd, Co, Cr, Cu, Fe, Mn, Ni, Pb, and Zn) contents in surface and subsurface soils, (ii) assess the pollution and potential ecological risk levels of trace metals, and (iii) identify trace metal sources using enrichment factor (EF), correlation matrix, and principal component analysis (PCA). The pollution levels of the analyzed trace metals calculated by the geoaccumulation index (I-geo) and contamination factor (C-f) suggested that the soils were highly contaminated with Cd and moderately contaminated with Pb. Based on the average values of EF, soil samples were found to present extremely high enrichment for Cd, significant enrichment for Pb, moderate enrichment for Zn, and deficient to minimal enrichment for other trace metals. Among the analyzed trace metals, a very high ecological risk was observed only in the case of Cd at some sampling sites. Meanwhile, other investigated trace metals had a low ecological risk. The results of PCA combined with correlation matrix suggested that Fe, Mn, Zn, Cu, Cr Ni, Cu, and Co represent natural abundance in soil, but Cd, Pb, and Cu are of anthropogenic inputs, mainly due to agrochemical and fertilizer applications. It could be generally concluded that the obtained results can be useful for assessing and conducting a future program for trace metal monitoring in agricultural areas of Saudi Arabia.
C1 [Al-Wabel, Mohammad I.; Sallam, Abd El-Azeem S.; Usman, Adel R. A.; Ahmad, Mahtab; El-Naggar, Ahmed Hamdy; El-Saeid, Mohammed Hamza; El-Enazi, Khaled] King Saud Univ, Soil Sci Dept, Coll Food & Agr Sci, POB 2460, Riyadh 11451, Saudi Arabia.
   [Usman, Adel R. A.] Assiut Univ, Soils & Water Dept, Fac Agr, Assiut 71526, Egypt.
   [El-Naggar, Ahmed Hamdy] Ain Shams Univ, Soil Sci Dept, Fac Agr, Cairo 11241, Egypt.
   [Al-Faraj, Abdulelah] King Saud Univ, Agr Engn Dept, Coll Food & Agr Sci, POB 2460, Riyadh 11451, Saudi Arabia.
   [Al-Romian, Fahad A.] Promising Res Ctr Biol Control & Agr Informat, Al Qassim, Saudi Arabia.
RP Al-Wabel, MI (reprint author), King Saud Univ, Soil Sci Dept, Coll Food & Agr Sci, POB 2460, Riyadh 11451, Saudi Arabia.
EM malwabel@ksu.edu.sa
FU Promising Research Center in Biological Control and Agricultural
   Information, Al-Qassim University, Buraydah, KSA [ALC012]
FX The investigators of research project no. ALC012 thank the Promising
   Research Center in Biological Control and Agricultural Information,
   Al-Qassim University, Buraydah, KSA, for providing funding and unlimited
   support and help. The authors are also grateful to the Department of
   Soil Science, College of Food, and Agricultural Sciences, King Saud
   University, for providing research facilities.
CR Abbaslou H, 2014, ARCH AGRON SOIL SCI, V60, P1125, DOI 10.1080/03650340.2013.864387
   Al-Salamah I S, 2009, Journal of Applied Sciences, V9, P3555, DOI 10.3923/jas.2009.3555.3561
   Al-Wabel M. I., 2011, Research Journal of Environmental Sciences, V5, P269, DOI 10.3923/rjes.2011.269.278
   Al-Wabel M, 2016, ARAB J GEOSCI, V9, DOI 10.1007/s12517-015-2122-y
   Almasoud FI, 2015, ARAB J GEOSCI, V8, P1691, DOI 10.1007/s12517-014-1298-x
   Atafar Z, 2010, ENVIRON MONIT ASSESS, V160, P83, DOI 10.1007/s10661-008-0659-x
   Azeez JO, 2014, ARCH AGRON SOIL SCI, V60, P275, DOI 10.1080/03650340.2013.792406
   Bai JH, 2015, J HYDROL, V520, P186, DOI 10.1016/j.jhydrol.2014.11.007
   Bai JH, 2011, PHYS CHEM EARTH, V36, P447, DOI 10.1016/j.pce.2010.03.025
   Bai JH, 2011, ENVIRON POLLUT, V159, P817, DOI 10.1016/j.envpol.2010.11.004
   Bai JH, 2010, SOIL TILL RES, V106, P344, DOI 10.1016/j.still.2009.11.003
   Balkhair KS, 2016, SAUDI J BIOL SCI, V23, pS32, DOI 10.1016/j.sjbs.2015.09.023
   Bao Z, 2014, POL J ENVIRON STUD, V23, P309
   Bortey-Sam N, 2015, INT J ENV RES PUB HE, V12, P11448, DOI 10.3390/ijerph120911448
   Effendi H, 2016, PROCEDIA ENVIRON SCI, V33, P574, DOI 10.1016/j.proenv.2016.03.110
   El-Mergawi RA, 2010, J FOOD AGRIC ENVIRON, V8, P253
   Gan Ju-li, 2000, Journal of Fisheries of China, V24, P533
   Gee G.W., 1994, METHODS SOIL ANAL 1
   Gupta N, 2008, B ENVIRON CONTAM TOX, V80, P115, DOI 10.1007/s00128-007-9327-z
   HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8
   HE QB, 1994, WATER AIR SOIL POLL, V74, P251
   HE QB, 1994, WATER AIR SOIL POLL, V74, P267
   Hernandez L, 2003, SCI TOTAL ENVIRON, V312, P195, DOI 10.1016/S0048-9697(03)00223-7
   Hu YN, 2013, ENVIRON SCI POLLUT R, V20, P6150, DOI 10.1007/s11356-013-1668-z
   Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017
   Kabata-Pendias A., 2011, TRACE ELEMENTS SOILS
   Kelepertzis E, 2014, GEODERMA, V221, P82, DOI 10.1016/j.geoderma.2014.01.007
   Khan K, 2013, FOOD CHEM TOXICOL, V58, P449, DOI 10.1016/j.fct.2013.05.014
   Lindsay W. L., 1979, CHEM EQUILIBRIUM SOI
   Lu QQ, 2016, WETLANDS, V36, pS125, DOI 10.1007/s13157-014-0598-y
   Mapanda F, 2005, AGR ECOSYST ENVIRON, V107, P151, DOI 10.1016/j.agee.2004.11.005
   Mar SS, 2012, SOIL SCI PLANT NUTR, V58, P492, DOI 10.1080/00380768.2012.704394
   Mico C, 2006, CHEMOSPHERE, V65, P863, DOI 10.1016/j.chemosphere.2006.03.016
   Mico C, 2006, SPAN J AGRIC RES, V4, P363
   MULLER G, 1979, UMSCHAU, V79, P778
   Naveedullah, 2013, BIOMED RES INT, V2013
   Nazzal Y., 2015, ITALIAN J GEOSCIENCE, V135, P210
   Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSABOOKSER5.3.C34
   Zoffoli HJO, 2013, ENVIRON MONIT ASSESS, V185, P2423, DOI 10.1007/s10661-012-2721-y
   Oyedele DJ, 2006, ELECT J ENV AGR FOOD, V5, P1446
   Reeve JR, 2012, SOIL SCI SOC AM J, V76, P278, DOI 10.2136/sssaj2011.0123
   Roberts TL, 2014, PROCEDIA ENGINEER, V83, P52, DOI 10.1016/j.proeng.2014.09.012
   Sparks D. L., 1996, AM SOC AGRONOMY
   StatSoft Inc, 1992, STATISTICA WIND
   Sutherland RA, 2000, ENVIRON GEOL, V39, P611
   Tabatabai M. A., 1996, METHODS SOIL ANAL 3
   Toth G, 2016, ENVIRON INT, V88, P299, DOI 10.1016/j.envint.2015.12.017
   TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2
   USEPA, 1994, TEST METH EV SOL WAS
   VROM, 2001, NEW DUTCH LIST
   Wentz D., 2001, SALT TOLERANCE PLANT
   Wu JS, 2016, ENVIRON SCI POLLUT R, V23, P1428, DOI 10.1007/s11356-015-5303-z
   Xiao R, 2015, SCI TOTAL ENVIRON, V517, P66, DOI 10.1016/j.scitotenv.2015.02.052
   Xu YG, 2015, PLANT SOIL ENVIRON, V61, P352, DOI 10.17221/100/2015-PSE
   Ye C, 2011, J HAZARD MATER, V191, P366, DOI 10.1016/j.jhazmat.2011.04.090
NR 55
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-6369
EI 1573-2959
J9 ENVIRON MONIT ASSESS
JI Environ. Monit. Assess.
PD JUN
PY 2017
VL 189
IS 6
AR 252
DI 10.1007/s10661-017-5919-1
PG 21
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EX2UN
UT WOS:000403083300009
PM 28474201
OA No
DA 2017-08-17
ER

PT J
AU Kabir, MH
   Abd El-Aty, AM
   Rahman, MM
   Chung, HS
   Lee, HS
   Park, SH
   Hacimuftuoglu, F
   Chang, BJ
   Shin, HC
   Shim, JH
AF Kabir, Md. Humayun
   Abd El-Aty, A. M.
   Rahman, Md. Musfiqur
   Chung, Hyung Suk
   Lee, Han Sol
   Park, Sun-Hyang
   Hacimuftuoglu, Fazil
   Chang, Byung-Joon
   Shin, Ho-Chul
   Shim, Jae-Han
TI Dissipation pattern and risk quotients assessment of amisulbrom in
   Korean melon cultivated in plastic house conditions
SO ENVIRONMENTAL MONITORING AND ASSESSMENT
LA English
DT Article
DE Amisulbrom; Oriental melon; Dissipation pattern; Residue analysis; Risk
   quotients
ID MASS-SPECTROMETRY; CHROMATOGRAPHY; FRUITS
AB Amisulbrom formulated as suspension concentrate was applied at the rate recommended for Korean melon to determine the dissipation pattern (at two different sites), the pre-harvest residue limit (PHRL), and risk assessments. Samples collected over 10 days were extracted using liquid-liquid extraction (LLE) and cleaned up with solid-phase extraction (SPE) Florisil cartridge. Residual concentrations were determined using liquid chromatography-ultraviolet detector (LC-UVD) and confirmed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The standard showed good instrument response linearity with a correlation coefficient (R-2) = 0.9999, and the recovery ranged from 87.5 to 93.7%. The dissipation half-life calculated from two different sites were found to be 7.0 and 8.8 days for sites 1 and 2, respectively. A PHRL graph constructed from the data indicated that if the residue levels were less than 0.55-0.59 mg/kg 3 days before harvest or less than 0.61-0.74 mg/kg 7 days before harvest, then they would be lower than the maximum residue limits (MRLs) at harvest. Risk assessments showed that the risk quotient (RQ) was 4.39-3.47% at 0 day, declined to 1.53-1.63% at 10 days. Therefore, the current data indicate that the amisulbrom can be applied safely to Korean melon; hence, it is unlikely to induce adverse health effects in consumers.
C1 [Kabir, Md. Humayun; Rahman, Md. Musfiqur; Chung, Hyung Suk; Lee, Han Sol; Shim, Jae-Han] Chonnam Natl Univ, Coll Agr & Life Sci, Nat Prod Chem Lab, 300 Yongbong Dong, Gwangju 500757, South Korea.
   [Abd El-Aty, A. M.; Shin, Ho-Chul] Konkuk Univ, Dept Vet Pharmacol & Toxicol, Coll Vet Med, Seoul 143701, South Korea.
   [Abd El-Aty, A. M.] Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza 12211, Egypt.
   [Park, Sun-Hyang] Wonkwang Univ, Sch Med, Dept Anat, Iksan 570749, Jeonbuk, South Korea.
   [Hacimuftuoglu, Fazil] Ataturk Univ, Dept Soil Sci & Plant Nutr, Fac Agr, TR-25240 Erzurum, Turkey.
   [Chang, Byung-Joon] Konkuk Univ, Dept Vet Anat, Coll Vet Med, Seoul 143701, South Korea.
RP Shim, JH (reprint author), Chonnam Natl Univ, Coll Agr & Life Sci, Nat Prod Chem Lab, 300 Yongbong Dong, Gwangju 500757, South Korea.; Abd El-Aty, AM (reprint author), Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza 12211, Egypt.
EM abdelaty44@hotmail.com; jhshim@jnu.ac.kr
OI Abd El-Aty, A. M./0000-0001-6596-7907
FU Ministry of Food and Drug Safety, Republic of Korea [00-16-8-0021-00]
FX This study was supported by a grant (00-16-8-0021-00) from the Ministry
   of Food and Drug Safety, Republic of Korea in 2016.
CR Ahn K. G., 2014, KOREAN J PESTICIDE S, V18, P321
   Burger Y, 2003, J AM SOC HORTIC SCI, V128, P537
   Chang H. S., 2011, AGRIBUSINESS INFORM, V3, P11
   Chun OK, 2003, FOOD CHEM TOXICOL, V41, P1063, DOI 10.1026/S0278-6915(03)00044-9
   Chung H. S., 2017, BIOMEDICAL CHROMATOG, DOI [10.1002/bmc.3965, DOI 10.1002/BMC.3965]
   Farha W, 2016, BIOMED CHROMATOGR, V30, P990, DOI 10.1002/bmc.3638
   Francotte E, 1996, J CHROMATOGR B, V686, P77, DOI 10.1016/S0378-4347(96)00242-3
   Hem L, 2011, FOOD CHEM, V126, P1533, DOI 10.1016/j.foodchem.2010.11.147
   Hwang KW, 2012, KOREAN J PESTIC SCI, V16, P288, DOI [10.7585/kjps.2012.16.4.288, DOI 10.7585/KJPS.2012.16.4.288]
   Kabir MH, 2016, BIOMED CHROMATOGR, V30, P1721, DOI 10.1002/bmc.3745
   Kabir MH, 2016, APPL BIOL CHEM, V59, P43, DOI 10.1007/s13765-015-0126-7
   Lee E. Y., 2009, KOREAN J PESTIC SCI, V13, P13
   MFDS, 2015, PEST SAF INF
   Montemurro N, 2002, J AGR FOOD CHEM, V50, P5975, DOI 10.1021/jf0256687
   [Anonymous], 2007, EOUROBLIGHT WORKSH
   Nunez-Palenius HG, 2008, CRIT REV BIOTECHNOL, V28, P13, DOI 10.1080/07388550801891111 
   Ortelli D, 2004, ANAL CHIM ACTA, V520, P33, DOI 10.1016/j.aca.2004.03.037
   Fernandez-Trujillo JP, 2011, BREEDING FOR FRUIT QUALITY, P261
   PAPADOPOULOUMOURKIDOU E, 1995, PESTIC SCI, V45, P111, DOI 10.1002/ps.2780450204
   Rahman MM, 2013, BIOMED CHROMATOGR, V27, P924, DOI 10.1002/bmc.2883
   SANTE guideline, 2015, 119452015 SANTE
   Shin AY, 2017, PEERJ, V5, DOI 10.7717/peerj.2834
   SPSS, 2010, DAT SOL VERS 18
   Sur N, 2000, PEST MANAG SCI, V56, P289, DOI 10.1002/(SICI)1526-4998(200003)56:3<289::AID-PS119>3.0.CO;2-F
   Tasho RP, 2016, SCI TOTAL ENVIRON, V563, P366, DOI 10.1016/j.scitotenv.2016.04.140
   Zhang JF, 2013, SCI TOTAL ENVIRON, V445, P281, DOI 10.1016/j.scitotenv.2012.12.061
NR 26
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-6369
EI 1573-2959
J9 ENVIRON MONIT ASSESS
JI Environ. Monit. Assess.
PD JUN
PY 2017
VL 189
IS 6
AR 302
DI 10.1007/s10661-017-6017-0
PG 9
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EX2UN
UT WOS:000403083300059
PM 28560618
OA No
DA 2017-08-17
ER

PT J
AU Darwish, AM
   Ali, MK
   Omar, AHE
AF Darwish, Atef M.
   Ali, Mohammed K.
   Omar, Abdel-Hady E.
TI A rare fundal papillary adenofibromatous uterine cyst in a
   postmenopausal woman: A first case report
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Letter
ID UTERUS
C1 [Ali, Mohammed K.] Assiut Univ, Womans Hlth Hosp, Obstet & Gynecol Dept, Assiut, Egypt.
   Assiut Univ, Pathol Dept, Assiut, Egypt.
RP Ali, MK (reprint author), Assiut Univ, Womans Hlth Hosp, Obstet & Gynecol Dept, Assiut, Egypt.
EM mohammedelksoy@yahoo.com
CR Atef M Darwish, 2010, GYNECOL SURG, V8, P19
   Darwish A, 2015, AM RES J NURS, V1, P7
   Kataoka ML, 1998, J COMPUT ASSIST TOMO, V22, P555, DOI 10.1097/00004728-199807000-00010
   Kim JY, 2002, AM J ROENTGENOL, V179
   Navada M, 2012, CASE REP ONCOL MED, V2012, P3
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD JUN
PY 2017
VL 213
BP 148
EP 149
DI 10.1016/j.ejogrb.2017.04.026
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA EX3LV
UT WOS:000403134500027
PM 28455157
OA No
DA 2017-08-17
ER

PT J
AU Alrashidi, Y
   Galhoum, AE
   Wiewiorski, M
   Herrera-Perez, M
   Hsu, RY
   Barg, A
   Valderrabano, V
AF Alrashidi, Yousef
   Galhoum, Ahmed E.
   Wiewiorski, Martin
   Herrera-Perez, Mario
   Hsu, Raymond Y.
   Barg, Alexej
   Valderrabano, Victor
TI How To Diagnose and Treat Infection in Total Ankle Arthroplasty
SO FOOT AND ANKLE CLINICS
LA English
DT Article
DE Total ankle arthroplasty; Infected total ankle arthroplasty;
   Periprosthetic ankle infection; Diagnosis of total ankle arthroplasty
   infection; Treatment of total ankle arthroplasty infection
ID PERIPROSTHETIC JOINT INFECTION; TOTAL KNEE ARTHROPLASTY; C-REACTIVE
   PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; INTRAOPERATIVE GRAM STAIN;
   TOTAL HIP-ARTHROPLASTY; BLOOD-CELL COUNT; RISK-FACTORS; REVISION
   ARTHROPLASTY; SALVAGE ARTHRODESIS
AB Periprosthetic infection after total ankle arthroplasty (TAA) is a serious complication, often requiring revision surgery, including revision arthroplasty, conversion to ankle arthrodesis, or even amputation. Risk factors for periprosthetic ankle infection include prior surgery at the site of infection, low functional preoperative score, diabetes, and wound healing problems. The clinical presentation of patients with periprosthetic ankle joint infection can be variable and dependent on infection manifestation: acute versus chronic. The initial evaluation in patients with suspected periprosthetic joint infections should include blood tests: C-reactive protein and erythrocyte sedimentation rate. Joint aspiration and synovial fluid analysis can help confirm suspected periprosthetic ankle infection.
C1 [Alrashidi, Yousef] Taibah Univ, Coll Med, Orthopaed Dept, POB 30001, Almadinah Almunawwarah 41411, Saudi Arabia.
   [Galhoum, Ahmed E.] Nasser Inst Res & Treatment, Cairo, Egypt.
   [Galhoum, Ahmed E.] Schmerzklin Basel, Swiss Ortho Ctr, Dept Orthopaed & Traumatol, Hirschgasslein 15, CH-4010 Basel, Switzerland.
   [Wiewiorski, Martin] Kantonsspital Winterthur, Orthopaed & Trauma Dept, Brauerstr 15, CH-8401 Winterthur, Switzerland.
   [Herrera-Perez, Mario] Univ Hosp Canary Islands, Dept Orthopaed, Calle El Pilar 50 4 piso, Tenerife 38002, Spain.
   [Hsu, Raymond Y.; Barg, Alexej] Univ Utah, Dept Orthopaed, 590 Wakara Way, Salt Lake City, UT 84108 USA.
   [Valderrabano, Victor] Schmerzklin Basel, Swiss Ortho Ctr, Orthopaed Dept, Swiss Med Network, Hirschgasslein 15, CH-4010 Basel, Switzerland.
RP Valderrabano, V (reprint author), Schmerzklin Basel, Swiss Ortho Ctr, Orthopaed Dept, Swiss Med Network, Hirschgasslein 15, CH-4010 Basel, Switzerland.
EM vvalderrabano@gsmn.ch
CR Austin MS, 2008, J ARTHROPLASTY, V23, P65, DOI 10.1016/j.arth.2007.09.005
   Barg A, 2014, ANKLE REPLACEMENT MA, P1078
   Barg A, 2015, DTSCH ARZTEBL INT, V112, P177, DOI 10.3238/arztebl.2015.0177
   Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149
   Bedair H, 2011, CLIN ORTHOP RELAT R, V469, P34, DOI 10.1007/s11999-010-1433-2
   Berbari E, 2010, J BONE JOINT SURG AM, V92A, P2102, DOI 10.2106/JBJS.I.01199
   Cadden AR, 2012, SEMIN MUSCULOSKEL R, V16, P205, DOI 10.1055/s-0032-1320125
   Cho EH, 2014, CLIN ORTHOP RELAT R, V472, P1921, DOI 10.1007/s11999-014-3536-7
   Culpan P, 2007, J BONE JOINT SURG BR, V89B, P1178, DOI 10.1302/0301-620X.89B9.19108
   Deirmengian C, 2015, CLIN ORTHOP RELAT R, V473, P198, DOI 10.1007/s11999-014-3722-7
   Deirmengian CA, 2016, J ARTHROPLASTY, V31, pS152, DOI 10.1016/j.arth.2016.01.060
   Della Valle CJ, 1999, J ARTHROPLASTY, V14, P500, DOI 10.1016/S0883-5403(99)90108-0
   Della Valle C, 2010, J AM ACAD ORTHOP SUR, V18, P760
   Della Valle CJ, 2007, J ARTHROPLASTY, V22, P90, DOI 10.1016/j.arth.2007.04.013
   Di Cesare PE, 2005, J BONE JOINT SURG AM, V87A, P1921, DOI 10.2106/JBJS.D.01803
   Diaz-Ledezma C, 2015, J ARTHROPLASTY, V30, P1044, DOI 10.1016/j.arth.2015.01.008
   Dinneen A, 2013, BONE JOINT J, V95B, P554, DOI 10.1302/0301-620X.95B4.30388
   Doets HC, 2010, ACTA ORTHOP, V81, P142, DOI 10.3109/17453671003628764
   Elgeidi A, 2014, INT ORTHOP, V38, P2591, DOI 10.1007/s00264-014-2475-y
   Espinosa N, 2011, ORTHOPADE, V40, P1008, DOI 10.1007/s00132-011-1830-6
   Espinosa N, 2013, CLIN PODIATR MED SUR, V30, P171, DOI 10.1016/j.cpm.2012.10.004
   Ferrao P, 2012, FOOT ANKLE INT, V33, P173, DOI 10.3113/FAI.2012.0173
   Fukui A, 2008, FOOT ANKLE INT, V29, P624, DOI 10.3113/FAI.2008.0624
   Ghanem E, 2008, J BONE JOINT SURG AM, V90A, P1637, DOI 10.2106/JBJS.G.00470
   Gougoulias N, 2010, CLIN ORTHOP RELAT R, V468, P199, DOI 10.1007/s11999-009-0987-3
   Greidanus NV, 2007, J BONE JOINT SURG AM, V89A, P1409, DOI 10.2106/JBJS.D.02602
   Gross Christopher, 2015, Foot Ankle Spec, V8, P143, DOI 10.1177/1938640014565046
   Gross CE, 2016, FOOT ANKLE INT, V37, P709, DOI 10.1177/1071100716641729
   Gross CE, 2016, FOOT ANKLE INT, V37, P522, DOI 10.1177/1071100715624206
   Hallock GG, 2015, MICROSURG, V37, P34
   Hintermann B, 2011, ORTHOPADE, V40, P1000, DOI 10.1007/s00132-011-1829-z
   Hintermann B, 2013, J BONE JOINT SURG AM, V3, pe12
   Hintermann B, 2013, J BONE JOINT SURG AM, V95A, P1166, DOI 10.2106/JBJS.L.00538
   Hoell S, 2015, BONE JOINT J, V97B, P71, DOI 10.1302/0301-620X.97B1.33802
   Hopgood P, 2006, J BONE JOINT SURG BR, V88B, P1032, DOI 10.1302/0301-620X.88B8
   Horisberger M, 2015, ACTA ORTHOP, V86, P412, DOI 10.3109/17453674.2015.1009673
   Hsu AR, 2014, FOOT ANKLE INT, V35, P719, DOI 10.1177/1071100714534217
   Janz V, 2013, J ORTHOP RES, V31, P2021, DOI 10.1002/jor.22451
   Joseph Thomas N, 2003, J Am Acad Orthop Surg, V11, P38
   Kamrad I, 2016, FOOT ANKLE INT, V37, P255, DOI 10.1177/1071100715617508
   Kapadia BH, 2016, LANCET, V387, P386, DOI 10.1016/S0140-6736(14)61798-0
   Kessler B, 2014, BONE JOINT J, V96B, P772, DOI 10.1302/0301-620X.96B6.33298
   Kessler B, 2012, J BONE JOINT SURG AM, V94A, P1871, DOI 10.2106/JBJS.K.00593
   Kim DR, 2016, KOREAN J RADIOL, V17, P413, DOI 10.3348/kjr.2016.17.3.413
   Kim TW, 2016, J ARTHROPLASTY, V31, P1990, DOI 10.1016/j.arth.2016.02.037
   Kohonen I, 2013, FOOT ANKLE INT, V34, P180, DOI 10.1177/1071100712460224
   LARSSON S, 1992, CLIN ORTHOP RELAT R, P237
   Lee HS, 2014, J BONE JOINT SURG AM, V96A, P1468, DOI 10.2106/JBJS.M.01280
   Lima AL, 2013, INTERDISCIP PERSPECT, V2013
   Lindsjo U, 1985, Clin Orthop Relat Res, P68
   Madhu R, 2006, J BONE JOINT SURG BR, V88B, P1197, DOI 10.1302/0301-620X.88B9.17588
   Mason JB, 2003, J ARTHROPLASTY, V18, P1038, DOI 10.1016/S0883-5403(03)00448-0
   Mason LW, 2015, FOOT ANKLE INT, V36, P635, DOI 10.1177/1071100715573050
   Matsumoto T, 2015, FOOT ANKLE INT, V36, P787, DOI 10.1177/1071100715574934
   McArthur BA, 2015, BONE JOINT J, V97B, P939, DOI 10.1302/0301-620X.97B7.35500
   Morgan PM, 2009, J BONE JOINT SURG AM, V91A, P2124, DOI 10.2106/JBJS.H.00853
   Myerson MS, 2014, FOOT ANKLE INT, V35, P855, DOI 10.1177/1071100714543643
   Nilsdotter-Augustinsson A, 2007, ACTA ORTHOP, V78, P629, DOI 10.1080/17453670710014329
   Parvizi J, 2006, J BONE JOINT SURG AM, V88A, P138, DOI 10.2106/JBJS.F.00609
   Parvizi J, 2014, J ARTHROPLASTY, V29, P1331, DOI 10.1016/j.arth.2014.03.009
   Parvizi J, 2010, J AM ACAD ORTHOP SUR, V18, P771
   Patton D, 2015, FOOT ANKLE INT, V36, P626, DOI 10.1177/1071100714568869
   Paul J, 2015, FOOT ANKLE INT, V36, P1438, DOI 10.1177/1071100715596745
   Rahm S, 2015, FOOT ANKLE INT, V36, P349, DOI 10.1177/1071100714559272
   Raikin SM, 2010, J BONE JOINT SURG AM, V92A, P2150, DOI 10.2106/JBJS.I.00870
   Renz N, 2016, CHIRURG, V158, P45
   Sagherian BH, 2015, FOOT ANKLE INT, V36, P318, DOI 10.1177/1071100714556760
   SALTZMAN CL, 1995, FOOT ANKLE INT, V16, P572
   Schinsky MF, 2008, J BONE JOINT SURG AM, V90A, P1869, DOI 10.2106/JBJS.G.01255
   Schipper ON, 2015, FOOT ANKLE INT, V36, P1448, DOI 10.1177/1071100715597437
   Segawa H, 1999, J BONE JOINT SURG AM, V81A, P1434
   Shukla SK, 2010, J ARTHROPLASTY, V25, P87, DOI 10.1016/j.arth.2010.05.006
   Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672
   Springer BD, 2015, J ARTHROPLASTY, V30, P908, DOI 10.1016/j.arth.2015.03.042
   Toossi N, 2012, J ARTHROPLASTY, V27, P51, DOI 10.1016/j.arth.2012.03.021
   Trampuz A, 2004, AM J MED, V117, P556, DOI 10.1016/j.amjmed.2004.06.022
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Trebse R, 2005, J BONE JOINT SURG BR, V87B, P249, DOI 10.1302/0301-620X.87B2.15618
   Triantafyllopoulos GK, 2015, INT ORTHOP, V39, P1203, DOI 10.1007/s00264-015-2753-3
   Triantafyllopoulos GK, 2015, J ARTHROPLASTY, V30, P649, DOI 10.1016/j.arth.2014.10.026
   Whalen JL, 2010, FOOT ANKLE INT, V31, P301, DOI 10.3113/FAI.2010.0301
   White J, 1998, J BONE JOINT SURG BR, V80B, P909, DOI 10.1302/0301-620X.80B5.8708
   Wiewiorski M, 2015, FOOT ANKLE INT, V36, P479, DOI 10.1177/1071100714565792
   Yamamoto T, 2016, J PLAST RECONSTR AES, V69, P1260, DOI 10.1016/j.bjps.2016.06.010
   Young JL, 2009, FOOT ANKLE INT, V30, P252, DOI 10.3113/FAI.2009.0252
   Yue B, 2015, NUCL MED COMMUN, V36, P305, DOI 10.1097/MNM.0000000000000266
   Zaidi R, 2013, BONE JOINT J, V95B, P1500, DOI 10.1302/0301-620X.95B11.31633
   Zgonis Thomas, 2004, J Foot Ankle Surg, V43, P97, DOI 10.1053/j.jfas.2004.01.003
   Zmistowski B, 2012, J ARTHROPLASTY, V27, P1589, DOI 10.1016/j.arth.2012.03.059
   Zwipp Hans, 2005, Oper Orthop Traumatol, V17, P518, DOI 10.1007/s00064-005-1143-9
   [Anonymous], 2012, J ARTHROPLASTY S, V27, P46
NR 91
TC 1
Z9 1
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1083-7515
EI 1558-1934
J9 FOOT ANKLE CLIN
JI Foot Ankle Clin.
PD JUN
PY 2017
VL 22
IS 2
BP 405
EP +
DI 10.1016/j.fcl.2017.01.009
PG 20
WC Orthopedics
SC Orthopedics
GA EX2CY
UT WOS:000403034300011
PM 28502355
OA No
DA 2017-08-17
ER

PT J
AU Garavelli, L
   Ivanovski, I
   Caraffi, SG
   Santodirocco, D
   Pollazzon, M
   Cordelli, DM
   Abdalla, E
   Accorsi, P
   Adam, MP
   Baldo, C
   Bayat, A
   Belligni, E
   Bonvicini, F
   Breckpot, J
   Callewaert, B
   Cocchi, G
   Cuturilo, G
   Devriendt, K
   Dinulos, MB
   Djuric, O
   Epifanio, R
   Faravelli, F
   Formisano, D
   Giordano, L
   Grasso, M
   Gronborg, S
   Iodice, A
   Iughetti, L
   Lacombe, D
   Maggi, M
   Malbora, B
   Mammi, I
   Moutton, S
   Moller, R
   Muschke, P
   Napoli, M
   Pantaleoni, C
   Pascarella, R
   Pellicciari, A
   Poch-Olive, ML
   Raviglione, F
   Rivieri, F
   Russo, C
   Savasta, S
   Scarano, G
   Selicorni, A
   Silengo, M
   Sorge, G
   Tarani, L
   Tone, LG
   Toutain, A
   Trimouille, A
   Valera, ET
   Vergano, SS
   Zanotta, N
   Zollino, M
   Dobyns, WB
   Paciorkowski, AR
AF Garavelli, Livia
   Ivanovski, Ivan
   Caraffi, Stefano Giuseppe
   Santodirocco, Daniela
   Pollazzon, Marzia
   Cordelli, Duccio Maria
   Abdalla, Ebtesam
   Accorsi, Patrizia
   Adam, Margaret P.
   Baldo, Chiara
   Bayat, Allan
   Belligni, Elga
   Bonvicini, Federico
   Breckpot, Jeroen
   Callewaert, Bert
   Cocchi, Guido
   Cuturilo, Goran
   Devriendt, Koenraad
   Dinulos, Mary Beth
   Djuric, Olivera
   Epifanio, Roberta
   Faravelli, Francesca
   Formisano, Debora
   Giordano, Lucio
   Grasso, Marina
   Gronborg, Sabine
   Iodice, Alessandro
   Iughetti, Lorenzo
   Lacombe, Didier
   Maggi, Massimo
   Malbora, Baris
   Mammi, Isabella
   Moutton, Sebastien
   Moller, Rikke
   Muschke, Petra
   Napoli, Manuela
   Pantaleoni, Chiara
   Pascarella, Rosario
   Pellicciari, Alessandro
   Luisa Poch-Olive, Maria
   Raviglione, Federico
   Rivieri, Francesca
   Russo, Carmela
   Savasta, Salvatore
   Scarano, Gioacchino
   Selicorni, Angelo
   Silengo, Margherita
   Sorge, Giovanni
   Tarani, Luigi
   Tone, Luis Gonzaga
   Toutain, Annick
   Trimouille, Aurelien
   Valera, Elvis Terci
   Vergano, Samantha Schrier
   Zanotta, Nicoletta
   Zollino, Marcella
   Dobyns, William B.
   Paciorkowski, Alex R.
TI Neuroimaging findings in Mowat-Wilson syndrome: a study of 54 patients
SO GENETICS IN MEDICINE
LA English
DT Article
DE agenesis of corpus callosum; brain MRI; genotype-phenotype correlation;
   Mowat-Wilson syndrome; ZEB2
ID SMAD-INTERACTING PROTEIN-1; CHARACTERISTIC FACIAL FEATURES;
   CENTRAL-NERVOUS-SYSTEM; BOX 1B GENE; HIRSCHSPRUNG-DISEASE;
   MENTAL-RETARDATION; ZFHX1B SIP1; MUTATIONS; EXPRESSION; PHENOTYPE
AB Purpose: Mowat-Wilson syndrome (MWS) is a genetic disease characterized by distinctive facial features, moderate to severe intellectual disability, and congenital malformations, including Hirschsprung disease, genital and eye anomalies, and congenital heart defects, caused by haploinsufficiency of the ZEB2 gene. To date, no characteristic pattern of brain dysmorphology in MWS has been defined.
   Methods: Through brain magnetic resonance imaging (MRI) analysis, we delineated a neuroimaging phenotype in 54 MWS patients with a proven ZEB2 defect, compared it with the features identified in a thorough review of published cases, and evaluated genotypephenotype correlations.
   Results: Ninety-six percent of patients had abnormal MRI results. The most common features were anomalies of corpus callosum (79.6% of cases), hippocampal abnormalities (77.8%), enlargement of cerebral ventricles (68.5%), and white matter abnormalities (reduction of thickness 40.7%, localized signal alterations 22.2%). Other consistent findings were large basal ganglia, cortical, and cerebellar malformations. Most features were underrepresented in the literature. We also found ZEB2 variations leading to synthesis of a defective protein to be favorable for psychomotor development and some epilepsy features but also associated with corpus callosum agenesis.
   Conclusion: This study delineated the spectrum of brain anomalies in MWS and provided new insights into the role of ZEB2 in neuro-development.
C1 [Garavelli, Livia; Ivanovski, Ivan; Santodirocco, Daniela; Pollazzon, Marzia; Bonvicini, Federico; Djuric, Olivera] Arcispedale Santa Maria Nuova IRCCS, Dept Obstet & Pediat, Clin Genet Unit, Reggio Emilia, Italy.
   [Ivanovski, Ivan] Univ Modena, Dept Surg Med Dent & Morphol Sci, Transplant Oncol & Regenerat Med, Modena, Italy.
   [Caraffi, Stefano Giuseppe] Arcispedale Santa Maria Nuova IRCCS, Lab Translat Res, Reggio Emilia, Italy.
   [Cordelli, Duccio Maria; Pellicciari, Alessandro] Univ Bologna, S Orsola Malpighi Hosp, Child Neurol & Psychiat Unit, Bologna, Italy.
   [Abdalla, Ebtesam] King Abdulaziz Univ, Fac Med, Dept Med Genet, Jeddah, Saudi Arabia.
   [Abdalla, Ebtesam] Univ Alexandria, Med Res Inst, Dept Human Genet, Alexandria, Egypt.
   [Giordano, Lucio] Spedali Civili Brescia, Neurophychiatr Dept, Brescia, Italy.
   [Adam, Margaret P.] Univ Washington, Sch Med, Div Med Genet, Seattle, WA 98195 USA.
   [Baldo, Chiara; Grasso, Marina] Galliera Hosp, Lab Human Genet, Genoa, Italy.
   [Bayat, Allan] Univ Hosp Copenhagen, Dept Pediat, Copenhagen, Denmark.
   [Bayat, Allan] Univ Hosp Copenhagen, Dept Clin Genet, Rigshosp, Copenhagen, Denmark.
   [Belligni, Elga; Silengo, Margherita] Univ Turin, Dept Paediat, Turin, Italy.
   [Bonvicini, Federico; Iughetti, Lorenzo] Univ Modena, Pediat Unit, Dept Med & Surg Sci Mothers, Children & Adults, Modena, Italy.
   [Bonvicini, Federico; Iughetti, Lorenzo] Univ Modena, Pediat Unit, Dept Med & Surg Sci Mothers, Children & Adults, Reggio Emilia, Italy.
   [Breckpot, Jeroen; Devriendt, Koenraad] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium.
   [Callewaert, Bert] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium.
   [Cocchi, Guido] Univ Bologna, S Orsola Malpighi Hosp, Neonatol Unit, Bologna, Italy.
   [Cuturilo, Goran] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Cuturilo, Goran] Univ Childrens Hosp, Dept Med Genet, Belgrade, Serbia.
   [Dinulos, Mary Beth] Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03766 USA.
   [Epifanio, Roberta; Zanotta, Nicoletta] IRCCS, E Medea Sci Inst, Clin Neurophysiol Unit, Lecce, Italy.
   [Faravelli, Francesca] Children NHS Fdn Trust, Great Ormond St Hosp, NE Thames Reg Genet Serv, Clin Genet, London, England.
   [Formisano, Debora] Arcispedale Santa Maria Nuova IRCCS, Sci Directorate, Reggio Emilia, Italy.
   [Gronborg, Sabine] Univ Hosp Copenhagen, Dept Clin Genet, Ctr Rare Dis, Copenhagen, Denmark.
   [Iodice, Alessandro] Arcispedale Santa Maria Nuova IRCCS, Neuropsychiatr Dept, Reggio Emilia, Italy.
   [Lacombe, Didier; Moutton, Sebastien; Trimouille, Aurelien] CHU, Genet Med, Bordeaux, France.
   [Lacombe, Didier] Univ Bordeaux, INSERM U1211, Bordeaux, France.
   [Maggi, Massimo; Napoli, Manuela; Pascarella, Rosario; Russo, Carmela] Arcispedale Santa Maria Nuova IRCCS, Neuroradiol Unit, Reggio Emilia, Italy.
   [Malbora, Baris] Tepecik Training & Res Hosp, Dept Pediat Hematol & Oncol, Izmir, Turkey.
   [Mammi, Isabella] Dolo Hosp, Med Genet Unit, Venice, Italy.
   [Moutton, Sebastien] CHU Bordeaux, Ctr Reference Anomalies Dev Embryonnaire, Serv Genet Med, Bordeaux, France.
   [Moller, Rikke] Danish Epilepsy Ctr, Dianalund, Denmark.
   [Moller, Rikke] Univ Southern Denmark, Inst Reg Hlth Serv, Odense, Denmark.
   [Muschke, Petra] Univ Hosp Magdeburg, Inst Human Genet, Magdeburg, Germany.
   [Pantaleoni, Chiara] IRCCS Fdn Ist Neurol C Besta, Dev Neurol Dept, Milan, Italy.
   [Luisa Poch-Olive, Maria] H San Pedro, Dept Pediat, Logrono, Spain.
   [Raviglione, Federico] IRCCS, Carlo Besta Neurol Inst, Clin Neurophysiol & Epilepsy Ctr, Milan, Italy.
   [Rivieri, Francesca] St Chiara Hosp, Genet Unit, Trento, Italy.
   [Savasta, Salvatore] IRCCS San Matteo, Dept Pediat, Pavia, Italy.
   [Scarano, Gioacchino] Gaetano Rummo Hosp, Dept Med Genet, Benevento, Italy.
   [Selicorni, Angelo] Univ Milan, Hosp S Gerardo, Dept Pediat, Monza, Italy.
   [Selicorni, Angelo] ASST Lariana, Dept Pediat, Como, Italy.
   [Sorge, Giovanni] Univ Catania, Vittorio Emanuele Hosp, Dept Pediat & Med Sci, Catania, Italy.
   [Tarani, Luigi] Univ Roma La Sapienza, Dept Pediat, Rome, Italy.
   [Tone, Luis Gonzaga; Valera, Elvis Terci] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Sao Paulo, Brazil.
   [Toutain, Annick] Tours Univ Hosp, Dept Genet, Tours, France.
   [Vergano, Samantha Schrier] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA USA.
   [Vergano, Samantha Schrier] Childrens Hosp Kings Daughters, Div Med Genet & Metab, Norfolk, VA USA.
   [Zollino, Marcella] Catholic Univ, Inst Genom Med, Gemelli Hosp Fdn, Rome, Italy.
   [Dobyns, William B.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Dobyns, William B.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA.
   [Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.
   [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA.
RP Garavelli, L (reprint author), Arcispedale Santa Maria Nuova IRCCS, Dept Obstet & Pediat, Clin Genet Unit, Reggio Emilia, Italy.
EM garavelli.livia@asmn.re.it
FU Telethon Italy [GEP 14131, GTB12001]; National Institute of Neurological
   Disorders and Stroke [K08NS078054]; Associazione Italiana Mowat Wilson
   ONLUS (AIMW)
FX The financial support of Telethon Italy (grant GEP 14131) is gratefully
   acknowledged. A.R.P. is supported by the National Institute of
   Neurological Disorders and Stroke under award K08NS078054. The authors
   thank the Galliera Genetic Bank, member of the Telethon Genetic Biobank
   Network (project GTB12001), funded by Telethon Italy, and the
   Associazione Italiana Mowat Wilson ONLUS (AIMW), for assistance in
   managing patients' samples. We also thank all cooperating family members
   for contributing the medical and neuroimaging data necessary for this
   study. In addition, we are grateful to Luca Valcavi for helping with the
   design and adaptation of the figures and tables.
CR Adam MP, 2006, AM J MED GENET A, V140A, P2730, DOI 10.1002/ajmg.a.31530
   Amiel J, 2001, AM J HUM GENET, V69, P1370, DOI 10.1086/324342
   Balasubramaniam S, 2010, SINGAP MED J, V51, pE54
   Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503
   Cordelli DM, 2013, EPILEPSIA, V54, P1331, DOI 10.1111/epi.12204
   Cordelli DM, 2013, AM J MED GENET A, V161A, P273, DOI 10.1002/ajmg.a.35717
   Das S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-94
   Dastot-Le Moal Florence, 2007, Hum Mutat, V28, P313, DOI 10.1002/humu.20452
   Edwards TJ, 2014, BRAIN, V137, P1579, DOI 10.1093/brain/awt358
   Espinosa-Parrilla Y, 2002, MECH DEVELOP, V114, P187, DOI 10.1016/S0925-4773(02)00062-X
   Evans E, 2012, AM J MED GENET A, V158A, P358, DOI 10.1002/ajmg.a.34405
   Garavelli L, 2005, HORM RES, V63, P187, DOI 10.1159/000085894
   Garavelli L, 2003, AM J MED GENET A, V116A, P385, DOI 10.1002/ajmg.a.10855
   Garavelli L, 2009, AM J MED GENET A, V149A, P417, DOI 10.1002/ajmg.a.32693
   Garavelli L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-42
   Ghoumid J, 2013, HUM MOL GENET, V22, P2652, DOI 10.1093/hmg/ddt114
   McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035
   Miquelajauregui A, 2007, P NATL ACAD SCI USA, V104, P12919, DOI 10.1073/pnas.0609863104
   Mowat DR, 2003, J MED GENET, V40, P305, DOI 10.1136/jmg.40.5.305
   Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617
   Murray SB, 2015, AM J MED GENET A, V167, P2402, DOI 10.1002/ajmg.a.37171
   Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0
   Nishizaki Y, 2014, GENESIS, V52, P56, DOI 10.1002/dvg.22726
   Postigo AA, 2000, P NATL ACAD SCI USA, V97, P6391, DOI 10.1073/pnas.97.12.6391
   Seuntjens E, 2009, MECH DEVELOP, V126, pS202, DOI 10.1016/j.mod.2009.06.497
   Silengo M, 2004, AM J MED GENET A, V127A, P109, DOI 10.1002/ajmg.a.20607
   Srivatsa S, 2015, NEURON, V85, P998, DOI 10.1016/j.neuron.2015.01.018
   Valera ET, 2013, CHILD NERV SYST, V29, P2151, DOI 10.1007/s00381-013-2283-5
   Van de Putte T, 2007, HUM MOL GENET, V16, P1423, DOI 10.1093/hmg/ddm093
   van den Berghe V, 2013, NEURON, V77, P70, DOI 10.1016/j.neuron.2012.11.009
   Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8
   Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860
   Weng QJ, 2012, NEURON, V73, P713, DOI 10.1016/j.neuron.2011.12.021
   Wenger TL, 2014, AM J MED GENET A, V164, P2557, DOI 10.1002/ajmg.a.36696
   Wilson M, 2003, AM J MED GENET A, V119A, P257, DOI 10.1002/ajmg.a.20053
   Yamada Y, 2014, AM J MED GENET A, V164, P1899, DOI 10.1002/ajmg.a.36551
   Zollino M, 2011, EUR J HUM GENET, V19
   Zweier C, 2006, AM J MED GENET A, V140A, P869, DOI 10.1002/ajmg.a.31196
   Zweier C, 2005, EUR J MED GENET, V48, P97, DOI 10.1016/j.ejmg.2005.01.003
   Zweier C, 2002, AM J MED GENET, V108, P177, DOI 10.1002/ajmg.10226
NR 40
TC 1
Z9 1
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1098-3600
EI 1530-0366
J9 GENET MED
JI Genet. Med.
PD JUN
PY 2017
VL 19
IS 6
BP 691
EP 700
DI 10.1038/gim.2016.176
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA EW5AK
UT WOS:000402517400012
PM 27831545
OA No
DA 2017-08-17
ER

PT J
AU Elsayed, WT
   Hegazy, YG
   El-bages, MS
   Bendary, FM
AF Elsayed, Wael Taha
   Hegazy, Yasser G.
   El-bages, Mohamed S.
   Bendary, Fahmy M.
TI Improved Random Drift Particle Swarm Optimization With Self-Adaptive
   Mechanism for Solving the Power Economic Dispatch Problem
SO IEEE TRANSACTIONS ON INDUSTRIAL INFORMATICS
LA English
DT Article
DE Economic dispatch (ED) problem; metaheuristic technique; random drift
   particle swarm optimization (RDPSO); valve point effects
ID LOAD DISPATCH; DIFFERENTIAL EVOLUTION; GENERATOR CONSTRAINTS; GENETIC
   ALGORITHM; SEARCH ALGORITHM; SQP METHOD; NONCONVEX
AB This paper proposes an improved version of the random drift particle swarm optimization algorithm for solving the economic dispatch problem. The improvement is achieved through adding a crossover operation followed by a greedy selection process while replacing the mean best position of the particles with the personal best position of each particle in the velocity updating equation. The improved algorithm is also augmented with a self-adaption mechanism that eliminates the need for tuning the algorithm parameters based on characteristics of the considered optimization problem. Practical features such as valve point effects, prohibited operating zones, multiple fuel options, and ramp rate limits are considered in the mathematical formulation of the economic dispatch problem. In order to demonstrate the efficacy of the proposed algorithm, five benchmark test systems are utilized. The obtained results showed that the improved random drift particle swarm optimization algorithm is capable of providing superior results compared to the original algorithm and the state of the art techniques proposed in previous literature.
C1 [Elsayed, Wael Taha] Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada.
   [Hegazy, Yasser G.] German Univ Cairo, Fac Informat & Engn Technol, Cairo 11432, Egypt.
   [El-bages, Mohamed S.; Bendary, Fahmy M.] Benha Univ, Shoubra Fac Engn, Elect Engn Dept, Cairo 11629, Egypt.
RP Elsayed, WT (reprint author), Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada.
EM wtahagha@uwaterloo.ca; yasser.higazi@guc.edu.eg;
   mohamed.albags@feng.bu.edu.eg; fahmybendary10@gmail.com
OI Elsayed, Wael/0000-0001-6637-5276
CR Adarsh BR, 2016, ENERGY, V96, P666, DOI 10.1016/j.energy.2015.12.096
   Al-Betar MA, 2016, APPL SOFT COMPUT, V47, P449, DOI 10.1016/j.asoc.2016.05.034
   Amjady N, 2010, EXPERT SYST APPL, V37, P5239, DOI 10.1016/j.eswa.2009.12.084
   Aragon VS, 2015, INFORM SCIENCES, V295, P609, DOI 10.1016/j.ins.2014.10.026
   Bakirtzis EA, 2014, IEEE T POWER SYST, V29, P149, DOI 10.1109/TPWRS.2013.2278215
   Banerjee S, 2015, INT J ELEC POWER, V73, P456, DOI 10.1016/j.ijepes.2015.05.036
   Basu M, 2016, INT J ELEC POWER, V80, P325, DOI 10.1016/j.ijepes.2016.02.005
   Basu M, 2015, INT J ELEC POWER, V69, P304, DOI 10.1016/j.ijepes.2015.01.015
   Basu M, 2014, INT J ELEC POWER, V63, P855, DOI 10.1016/j.ijepes.2014.07.003
   Cai JJ, 2012, ENERGY, V38, P346, DOI 10.1016/j.energy.2011.11.052
   Cai JJ, 2012, ENERG CONVERS MANAGE, V53, P175, DOI 10.1016/j.enconman.2011.08.023
   Chiang CL, 2005, IEEE T POWER SYST, V20, P1690, DOI 10.1109/TPWRS.2005.857924
   Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692
   Coelho LD, 2014, INT J ELEC POWER, V57, P178, DOI 10.1016/j.ijepes.2013.11.024
   Eberhart R., 1995, MICRO MACH HUM SCI, V6, P39, DOI DOI 10.1109/MHS.1995.494215
   Elsayed WT, 2016, ELECTR POW SYST RES, V141, P325, DOI 10.1016/j.epsr.2016.08.002
   Elsayed WT, 2015, IEEE T POWER SYST, V30, P2179, DOI 10.1109/TPWRS.2014.2360369
   Gaing ZL, 2003, IEEE T POWER SYST, V18, P1187, DOI 10.1109/TPWRS.2003.814889
   He XZ, 2016, NEUROCOMPUTING, V171, P1454, DOI 10.1016/j.neucom.2015.07.107
   Hosseini SSS, 2015, ADAPT LEARN OPTIM, V18, P129, DOI 10.1007/978-3-319-14400-9_6
   Khamsawang S, 2010, ENERG CONVERS MANAGE, V51, P365, DOI 10.1016/j.enconman.2009.09.034
   Labbi Y, 2016, INT J ELEC POWER, V79, P298, DOI 10.1016/j.ijepes.2016.01.028
   Le LD, 2015, PROCEEDINGS OF THE 18TH ASIA PACIFIC SYMPOSIUM ON INTELLIGENT AND EVOLUTIONARY SYSTEMS, VOL 2, P89, DOI 10.1007/978-3-319-13356-0_8
   Lu YL, 2011, ENG APPL ARTIF INTEL, V24, P378, DOI 10.1016/j.engappai.2010.10.014
   Moradi-Dalvand M, 2012, ELECTR POW SYST RES, V93, P93, DOI 10.1016/j.epsr.2012.07.009
   Neto J. X. V., 2017, ELECT POWER ENERGY S, V84, P13
   Niknam T, 2011, APPL SOFT COMPUT, V11, P2805, DOI 10.1016/j.asoc.2010.11.010
   Noman N, 2008, ELECTR POW SYST RES, V78, P1322, DOI 10.1016/j.epsr.2007.11.007
   Omar M A, 1993, ELEMENTARY SOLID STA
   Park JB, 2010, IEEE T POWER SYST, V25, P156, DOI 10.1109/TPWRS.2009.2030293
   Pothiya S, 2008, ENERG CONVERS MANAGE, V49, P506, DOI 10.1016/j.enconman.2007.08.012
   Pradhan M, 2016, INT J ELEC POWER, V83, P325, DOI 10.1016/j.ijepes.2016.04.034
   Sen T, 2016, INT J ELEC POWER, V78, P735, DOI 10.1016/j.ijepes.2015.11.121
   Singh H, 2016, IET GENER TRANSM DIS, V10, P192, DOI 10.1049/iet-gtd.2015.0648
   Singh NJ, 2016, APPL SOFT COMPUT, V43, P298, DOI 10.1016/j.asoc.2016.02.042
   Sinha N, 2003, IEEE T EVOLUT COMPUT, V7, P83, DOI 10.1109/TEVC.2002.806788
   Sun J, 2014, IEEE T IND INFORM, V10, P222, DOI 10.1109/TII.2013.2267392
   Victoire TAA, 2004, ELECTR POW SYST RES, V71, P51, DOI 10.1016/j.epsr.2003.12.017
   Vo DN, 2013, IET GENER TRANSM DIS, V7, P645, DOI 10.1049/iet-gtd.2012.0142
   Wang SK, 2007, IET GENER TRANSM DIS, V1, P793, DOI 10.1049/iet-gtd:20070183
   Xie L, 2014, IEEE T SMART GRID, V5, P511, DOI 10.1109/TSG.2013.2282300
   Zaman MF, 2016, IEEE T POWER SYST, V31, P1486, DOI 10.1109/TPWRS.2015.2428714
NR 42
TC 0
Z9 0
U1 6
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1551-3203
EI 1941-0050
J9 IEEE T IND INFORM
JI IEEE Trans. Ind. Inform.
PD JUN
PY 2017
VL 13
IS 3
BP 1017
EP 1026
DI 10.1109/TII.2017.2695122
PG 10
WC Automation & Control Systems; Computer Science, Interdisciplinary
   Applications; Engineering, Industrial
SC Automation & Control Systems; Computer Science; Engineering
GA EX0RY
UT WOS:000402929700009
OA No
DA 2017-08-17
ER

PT J
AU Singer, MS
   Halawa, AM
   Adawy, A
AF Singer, Mohamed S.
   Halawa, Abdelsamie M.
   Adawy, Adel
TI Outcome of low profile mesh plate in management of comminuted displaced
   fracture patella
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Mesh plate; Patella; Comminuted patella; Patellar fractures; Low profile
   plate; Patellectomy; Difficult patellar fracture; Patellar plate; Knee
   cap; Anterior knee pain
ID TENSION-BAND FIXATION; TITANIUM MESH; PATELLECTOMY; SCREWS
AB Purpose: To assess the clinical results of using mesh plate in management of displaced comminuted fracture patella.
   Patients and methods: Between January 2014 and October 2015, nine patients with closed displaced comminuted fracture patella were fixed using mesh plate and 2 mm mini screws.
   Results: All fractures united after an average of 10 weeks. At final follow-up of an average 19.6 months, average postoperative Lysholm score was 89.1 +/- 4.9, and average Postoperative Bostman scale was 27.2 +/- 3.1. No hardware related complications were recorded.
   Conclusion: Low profile mesh plate is a good option in management of comminuted fracture patella with good clinical outcome. This new surgical technique may be particularly useful in comminuted fractures when patellectomy would otherwise be considered. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Singer, Mohamed S.; Halawa, Abdelsamie M.; Adawy, Adel] Benha Univ, Orthoped Dept, El Shaheed Farid Nada St, Banha 13511, Qalyubia, Egypt.
RP Singer, MS (reprint author), Benha Univ, Orthoped Dept, El Shaheed Farid Nada St, Banha 13511, Qalyubia, Egypt.
EM mhmedsharaf@yahoo.com
CR Berg EE, 1997, J ORTHOP TRAUMA, V11, P573, DOI 10.1097/00005131-199711000-00005
   BOSTMAN O, 1981, INJURY, V13, P196, DOI 10.1016/0020-1383(81)90238-2
   Dickens AJ, 2015, INJURY, V46, P1001, DOI 10.1016/j.injury.2015.02.017
   Fox AJS, 2012, J KNEE SURG, V25, P127, DOI 10.1055/s-0032-1313741
   Gear AJL, 2002, ANN PLAS SURG, V48, P1, DOI 10.1097/00000637-200201000-00001
   Gosal HS, 2001, INJURY, V32, P129, DOI 10.1016/S0020-1383(00)00170-4
   Hambright DS, 2017, J ORTHOP TRAUMA, V31, pE66, DOI 10.1097/BOT.0000000000000686
   Hoshino CM, 2013, J BONE JOINT SURG AM, V95A, P653, DOI 10.2106/JBJS.K.01549
   KAUFER H, 1971, J BONE JOINT SURG AM, VA 53, P1551
   LeBrun CT, 2012, J ORTHOP TRAUMA, V26, P422, DOI 10.1097/BOT.0b013e318228c1a1
   Lorich DG, 2015, J ORTHOP TRAUMA, V29, pE504, DOI 10.1097/BOT.0000000000000415
   Matejcic A, 2015, INJURY, V46, pS87, DOI 10.1016/j.injury.2015.10.068
   Melvin JS, 2011, J AM ACAD ORTHOP SUR, V19, P198
   SALTZMAN CL, 1990, J BONE JOINT SURG AM, V72A, P1279
   SUTTON FS, 1976, J BONE JOINT SURG AM, V58, P537
   Thelen S, 2013, ORTHOPEDICS, V36, pE1437, DOI 10.3928/01477447-20131021-29
   WEBER MJ, 1980, J BONE JOINT SURG AM, V62, P215
   Wild M, 2016, INJURY, V47, P1737, DOI 10.1016/j.injury.2016.06.018
   Yang L, 2010, KNEE, V17, P283, DOI 10.1016/j.knee.2010.02.005
   Zhang Sheng-zhi, 2012, Zhongguo Gu Shang, V25, P335
NR 20
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUN
PY 2017
VL 48
IS 6
BP 1229
EP 1235
DI 10.1016/j.injury.2017.03.026
PG 7
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA EW4QO
UT WOS:000402486200022
PM 28413065
OA No
DA 2017-08-17
ER

PT J
AU Salama, TMS
   Hassan, MI
AF Salama, Tamer M. Said
   Hassan, Mohamed Ibrahim
TI Incidence of Biliary Reflux Esophagitis After Laparoscopic Omega Loop
   Gastric Bypass in Morbidly Obese Patients
SO JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES
LA English
DT Article
DE bariatric surgery; gastric bypass; mini-gastric bypass; biliary reflux;
   reflux esophagitis
ID ROUX-EN-Y; SURGERY; CONTROVERSY; EXPERIENCE
AB Background: Omega loop gastric bypass is a successful bariatric surgery with numerous favorable circumstances as being basic, effective on weight reduction and treatment of obesity associated metabolic disorder, the short expectation to learn and adapt, and the simplicity of correction and inversion. However, there are arguments about the possibility of biliary reflux and/or the potential danger of gastroesophageal malignancy after the procedure. Methods: Fifty patients experiencing morbid obesity with body mass index >40 or >35kg/m(2) with two related comorbidities, for example, diabetes type II, hypertension, or dyslipidemia, underwent omega loop gastric bypass with a follow-up period up to 18 months, investigating for any symptom of reflux infection by upper gastrointestinal tract endoscopy and pH metry. Results: Reflux esophagitis (a gastroesophageal reflux disease) was detected in 3 patients (6%); 2 cases (4%) showed (Grade A) acidic reflux esophagitis at 6 and 12 months postoperatively. Just 1 case (2%) had experienced gastroesophageal biliary reflux esophagitis (Grade A) at 12 months. No metaplasia or dysplasia was detected in the endoscopic biopsies. Conclusion: Omega loop gastric bypass is a safe and effective bariatric procedure with low incidence of postoperative biliary reflux, metaplasia, or dysplasia at the esophagogastric junction, confirmed 18 months after the operation.
C1 [Salama, Tamer M. Said; Hassan, Mohamed Ibrahim] Ain Shams Univ, Dept Gen Surg, Fac Med, 16 Foud Badwany St Nasr City, Cairo 316465, Egypt.
RP Salama, TMS (reprint author), Ain Shams Univ, Dept Gen Surg, Fac Med, 16 Foud Badwany St Nasr City, Cairo 316465, Egypt.
EM drtamer1981@hotmail.com
CR Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0
   Chakhtoura G, 2008, OBES SURG, V18, P1130, DOI 10.1007/s11695-008-9594-8
   Collins BJ, 2007, ARCH SURG-CHICAGO, V142, P1000, DOI 10.1001/archsurg.142.10.1000
   Dhahri Abdennaceur, 2009, Rev Prat, V59, P1198
   Fisher BL, 2001, OBES SURG, V11, P773
   Fried M, 2008, OBESITY FACTS, V1, P52, DOI 10.1159/000113937
   Johnson WH, 2007, SURG OBES RELAT DIS, V3, P37, DOI 10.1016/j.soard.2006.09.012
   Kular KS, 2014, OBES SURG, V24, P1430, DOI 10.1007/s11695-014-1220-3
   Lee WJ, 2015, J BIOMED RES, V29, P98, DOI 10.7555/JBR.28.20140120
   Mahawar KK, 2014, OBES SURG, V24, P324, DOI 10.1007/s11695-013-1090-0
   Mahawar KK, 2013, OBES SURG, V23, P1890, DOI 10.1007/s11695-013-1026-8
   MASON RC, 1988, GUT, V29, P830, DOI 10.1136/gut.29.6.830
   Musella M, 2014, SURG ENDOSC, V28, P156, DOI 10.1007/s00464-013-3141-y
   Noun R, 2012, OBES SURG, V22, P697, DOI 10.1007/s11695-012-0618-z
   Parmar CD, 2016, CLIN OBES, V6, P61, DOI 10.1111/cob.12124
   Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202
   Quan Y, 2015, GASTROENT RES PRACT, V15, P150
   Tolone S, 2016, SURG OBES RELAT DIS, V12, P62, DOI 10.1016/j.soard.2015.03.011
   Victorzon M, 2015, SCAND J SURG, V104, P48, DOI 10.1177/1457496914564106
NR 19
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1092-6429
EI 1557-9034
J9 J LAPAROENDOSC ADV S
JI J. Laparoendosc. Adv. Surg. Tech.
PD JUN
PY 2017
VL 27
IS 6
BP 618
EP 622
DI 10.1089/lap.2016.0401
PG 5
WC Surgery
SC Surgery
GA EX2LQ
UT WOS:000403058200010
PM 28157428
OA No
DA 2017-08-17
ER

PT J
AU Hamza, TA
   Sherif, RM
AF Hamza, Tamer A.
   Sherif, Rana M.
TI In vitro evaluation of marginal discrepancy of monolithic zirconia
   restorations fabricated with different CAD-CAM systems
SO JOURNAL OF PROSTHETIC DENTISTRY
LA English
DT Article
ID BIAXIAL FLEXURAL STRENGTH; ALL-CERAMIC CROWNS; CAD/CAM SYSTEM; DENTAL
   CAD/CAM; FINISH LINES; ADAPTATION; THICKNESS; PORCELAIN; ACCURACY;
   COPINGS
AB Statement of problem. Dental laboratories use different computer-aided design and computer aided manufacturing (CAD-CAM) systems to fabricate fixed prostheses; however, limited evidence is available concerning which system provides the best marginal discrepancy.
   Purpose. The purpose of this in vitro study was to evaluate the marginal fit of 5 different monolithic zirconia restorations milled with different CAD-CAM systems.
   Material and methods. Thirty monolithic zirconia crowns were fabricated on a custom-designed stainless steel die and were divided into 5 groups according to the type of monolithic zirconia crown and the CAD-CAM system used: group TZ, milled with an MCXL milling machine; group CZ, translucent zirconia milled with a motion milling machine; group ZZ, zirconia milled with a dental milling unit; group PZ, translucent zirconia milled with a zirconia milling unit; and group BZ, solid zirconia milled using an S1 VHF milling machine. The marginal fit was measured with a binocular microscope at an original magnification of x100. The results were tabulated and statistically analyzed with 1-way ANOVA and post hoc surface range test, and pairwise multiple comparisons were made using Bonferroni correction (alpha=.05).
   Results. The type of CAD-CAM used affected the marginal fit of the monolithic restoration. The mean (+/- SD) highest marginal discrepancy was recorded in group TZI at 39.3 +/- 2.3 mu m, while the least mean marginal discrepancy was recorded in group IZ (22.8 +/- 8.9 mu m). The Bonferroni post hoc test showed that group TZI was significantly different from all other groups tested (P<.05).
   Conclusions. Within the limitation of this in vitro study, all tested CAD-CAM systems produced monolithic zirconia restorations with clinically acceptable marginal discrepancies; however, the CAD-CAM system with the 5-axis milling unit produced the best marginal fit.
C1 [Hamza, Tamer A.] Misr Int Univ, Fac Oral & Dent Med, Cairo, Egypt.
   [Sherif, Rana M.] Cairo Univ, Fac Oral & Dent Med, Cairo, Egypt.
RP Hamza, TA (reprint author), Misr Int Univ, Fac Oral & Dent Med, Fixed Prosthodont, Cairo, Egypt.
EM drtamerhamza@hotmail.com
CR Allen Kenneth L, 2004, Gen Dent, V52, P234
   Souza ROA, 2012, J PROSTHODONT, V21, P94, DOI 10.1111/j.1532-849X.2011.00793.x
   Baladhandayutham B, 2015, J PROSTHET DENT, V114, P266, DOI 10.1016/j.prosdent.2015.03.006
   Calamia JR, 1994, URR OPIN COSMET DENT, P67
   CHO HD, 1993, INT J PROD RES, V31, P2559, DOI 10.1080/00207549308956883
   Contrepois M, 2013, J PROSTHET DENT, V110, P447, DOI 10.1016/j.prosdent.2013.08.003
   Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1
   Euan R, 2012, J PROSTHODONT, V21, P291, DOI 10.1111/j.1532-849X.2011.00831.x
   Fonseca RG, 2014, J ADHES DENT, V16, P451, DOI 10.3290/j.jad.a32663
   Goldberg A J, 1990, Adv Dent Res, V4, P14
   Hamza TA, 2013, J PROSTHET DENT, V109, P83, DOI 10.1016/S0022-3913(13)60020-7
   Ilie N, 2015, J PROSTHET DENT, V113, P114, DOI 10.1016/j.prosdent.2014.08.013
   Larson Thomas D, 2012, Northwest Dent, V91, P22
   Layton DM, 2013, INT J PROSTHODONT, V26, P111, DOI 10.11607/ijp.3202
   Lin WS, 2012, J PROSTHODONT, V21, P353, DOI 10.1111/j.1532-849X.2012.00845.x
   Martinez-Rus F, 2011, J PROSTHET DENT, V105, P108, DOI 10.1016/S0022-3913(11)60009-7
   Matsuzaki F, 2015, DENT MATER J, V34, P910, DOI 10.4012/dmj.2015-107
   MCLEAN JW, 1971, BRIT DENT J, V131, P107, DOI 10.1038/sj.bdj.4802708
   Miyazaki T, 2013, J PROSTHODONT RES, V57, P236, DOI 10.1016/j.jpor.2013.09.001
   Miyazaki T, 2009, DENT MATER J, V28, P44
   Nakamura T, 2003, INT J PROSTHODONT, V16, P244
   Pereira GKR, 2016, MAT SCI ENG C-MATER, V63, P70, DOI 10.1016/j.msec.2016.02.049
   Pfeiffer J, 1998, Int J Comput Dent, V1, P29
   Quintas AF, 2004, J PROSTHET DENT, V92, P250, DOI 10.1016/j.prosdent.2004.06.023
   Re Dino, 2014, Int J Esthet Dent, V9, P426
   Selz CF, 2015, J DENT, V43, P1428, DOI 10.1016/j.jdent.2015.10.017
   Shim JS, 2015, J APPL ORAL SCI, V23, P515, DOI 10.1590/1678-775720150081
   Silva NRFA, 2012, J PROSTHODONT, V21, P433, DOI 10.1111/j.1532-849X.2012.00861.x
   Sorrentino R, 2016, J MECH BEHAV BIOMED, V61, P328, DOI 10.1016/j.jmbbm.2016.04.014
   Subasi Gulce, 2012, Eur J Dent, V6, P163
   Sulaiman TA, 2015, DENT MATER, V31, P1180, DOI 10.1016/j.dental.2015.06.016
   Tapie L, 2015, INT J COMPUT DENT, V18, P343
   Vigolo Paolo, 2008, J Prosthodont, V17, P621, DOI 10.1111/j.1532-849X.2008.00366.x
   Wiedhahn K, 2016, INT J COMPUT DENT, V19, P9
   Willer J, 1998, J PROSTHET DENT, V80, P346, DOI 10.1016/S0022-3913(98)70136-2
   Yucel MT, 2013, J DENT SCI, V8, P225, DOI 10.1016/j.jds.2012.05.009
NR 36
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3913
EI 1097-6841
J9 J PROSTHET DENT
JI J. Prosthet. Dent.
PD JUN
PY 2017
VL 117
IS 6
BP 762
EP 766
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EX4IE
UT WOS:000403197400013
PM 27836145
OA No
DA 2017-08-17
ER

PT J
AU Soltani, M
   Abd Malek, R
   Ware, I
   Ramli, S
   Elsayed, EA
   Aziz, R
   El-Enshasy, HA
AF Soltani, M.
   Abd Malek, R.
   Ware, I.
   Ramli, S.
   Elsayed, E. A.
   Aziz, R.
   El-Enshasy, H. A.
TI Optimization of Cordycepin Extraction from Cordyceps militaris
   Fermentation Broth
SO JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH
LA English
DT Article
DE Cordyceps Militaris; Cordycepin; Response Surface Methodology;
   Optimization of Extraction
ID SCIENTIFIC REDISCOVERY; SINENSIS
AB Cordyceps is one of the components of traditional Chinese medicine. This mushroom becomes worldwide famous due to its significant therapeutic effects on various diseases. Nucleoside like cordycepin, a major bioactive compound from Cordyceps militaris, is commonly known as promising anticancer and antitumor compound. The aim of study is to determine an optimal mixture ratio of solvent-solvent-based extraction method, which is used for extraction of cordycepin, from cultivated Cordyceps militaris DSMZ 23612 fermentation broth. Hence, the optimization process was performed using statistical (RSM) design leaded an optimal cordycepin extraction using solvent mixture including hot water (23%), ethanol (30%), methanol (25%) and ethyl acetate (22%). In addition, the final extracted cordycepin (786:94 mgL(-1) of 81% purity) was achieved through extraction parameters as sample: solvent ratio (v/v), extraction temperature, extraction time and frequency at (1:10), 35 degrees C, 90 min and 1 cycle, respectively. The experimental values obtained were fit with those predidted, thus indicate the suitability of RSM and method for optimization of cordycepin extraction.
C1 [Soltani, M.; Abd Malek, R.; Ware, I.; Ramli, S.; Aziz, R.; El-Enshasy, H. A.] Univ Teknol Malaysia, IBD, Skudai, Johor, Malaysia.
   [Elsayed, E. A.] King Saud Univ, Dept Zool, Fac Sci, Riyadh, Saudi Arabia.
   [Elsayed, E. A.] Natl Res Ctr, Nat & Microbial Prod Dept, Cairo, Egypt.
   [El-Enshasy, H. A.] Univ Teknol Malaysia, Fac Chem Engn & Energy, Skudai, Johor, Malaysia.
   [El-Enshasy, H. A.] City Sci Res & Technol Applicat CSAT, Alexandria, Egypt.
RP El-Enshasy, HA (reprint author), Univ Teknol Malaysia, IBD, Skudai, Johor, Malaysia.; El-Enshasy, HA (reprint author), Univ Teknol Malaysia, Fac Chem Engn & Energy, Skudai, Johor, Malaysia.; El-Enshasy, HA (reprint author), City Sci Res & Technol Applicat CSAT, Alexandria, Egypt.
EM henshasy@ibd.utm.my
FU MOHE [Q.J130000.2509.06H98]; Universiti Teknologi Malaysia (UTM)
   [Q.J130000.2509.06H98]
FX The authors would like to thanks the MOHE and Universiti Teknologi
   Malaysia (UTM) for GUP grant no Q.J130000.2509.06H98 for supporting this
   research.
CR Ahmadipourroudposht M, 2015, MAT SCI ENG C-MATER, V50, P234, DOI 10.1016/j.msec.2015.02.008
   Chang S. T., 1992, MYCOLOGIST, V6, P64, DOI DOI 10.1016/S0269-915X(09)80449-7
   Das SK, 2010, PROCESS BIOCHEM, V45, P129, DOI 10.1016/j.procbio.2009.08.008
   Das S K, 2010, WORLD C ENG COMP SCI
   El Enshasy HA, 2013, TRENDS BIOTECHNOL, V31, P668, DOI 10.1016/j.tibtech.2013.09.003
   Elsayed EA, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/805841
   Fan DD, 2012, BIOCHEM ENG J, V60, P30, DOI 10.1016/j.bej.2011.09.014
   Hawksworth D L, 1998, ASPECTS TROPICAL MYC, P265
   Holliday J, 2008, INT J MED MUSHROOMS, V10, P219, DOI 10.1615/IntJMedMushr.v10.i3.30
   Jiapeng T, 2013, PREP BIOCHEM BIOTECH, V44, P90
   Kang C, 2014, SCI WORLD J, DOI 10.1155/2014/510627
   Kaul T N, 2001, BIOL CONSERVATION MU, P45
   Ling JY, 2009, SEP PURIF TECHNOL, V66, P625, DOI 10.1016/j.seppur.2008.12.022
   Maftoun P., 2015, INT J BIOTECHNOLOGY, V4, P67
   Mao XB, 2004, BIOTECHNOL PROGR, V20, P1408, DOI 10.1021/bp049765r
   MARKS DB, 1971, J GEN MICROBIOL, V69, P253
   Masuda M, 2007, ENZYME MICROB TECH, V40, P1199, DOI 10.1016/j.enzmictec.2006.09.008
   Masuda M, 2014, PROCESS BIOCHEM, V49, P181, DOI 10.1016/j.procbio.2013.10.017
   Miles P G, 1997, WORLD SCI PRESS, V1, P161
   Soltani M, 2015, IOSR J PHARM BIOL SC, V10, P79
   Soltani M, 2013, J PURE APPL MICROBIO, V7, P1601
   Tuli S H, 2014, WORLD J PAHRM PHARM, V3, P1525
   Wang HJ, 2014, MOLECULES, V19, P20808, DOI 10.3390/molecules191220808
   Wang Y, 2004, ACTA BOT BOREALI-OCC, V25, P1863
   Wasser S. P., 1999, International Journal of Medicinal Mushrooms, V1, P31
   Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65
   Xiao JianHui, 2014, African Journal of Microbiology Research, V8, P75
   Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289
   Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P429, DOI 10.1089/acm.1998.4.429
NR 29
TC 0
Z9 0
U1 0
U2 0
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0022-4456
EI 0975-1084
J9 J SCI IND RES INDIA
JI J. Sci. Ind. Res.
PD JUN
PY 2017
VL 76
IS 6
BP 355
EP 361
PG 7
WC Engineering, Multidisciplinary
SC Engineering
GA EX3KK
UT WOS:000403130800006
OA No
DA 2017-08-17
ER

PT J
AU Nakano, A
   Masuda, K
   Hiromoto, T
   Takahashi, K
   Matsumoto, Y
   Habib, AGK
   Darwish, AGG
   Yukawa, M
   Tsuchiya, E
   Ueno, M
AF Nakano, Akemi
   Masuda, Kenta
   Hiromoto, Taisuke
   Takahashi, Katsunori
   Matsumoto, Yoshitake
   Habib, Ahmed G. K.
   Darwish, Ahmed G. G.
   Yukawa, Masashi
   Tsuchiya, Eiko
   Ueno, Masaru
TI Rad51-Dependent Aberrant Chromosome Structures at Telomeres and
   Ribosomal DNA Activate the Spindle Assembly Checkpoint (vol 34, 1389,
   2014)
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Correction
C1 [Nakano, Akemi; Masuda, Kenta; Hiromoto, Taisuke; Takahashi, Katsunori; Matsumoto, Yoshitake; Habib, Ahmed G. K.; Darwish, Ahmed G. G.; Yukawa, Masashi; Tsuchiya, Eiko; Ueno, Masaru] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima, Japan.
   [Darwish, Ahmed G. G.] Menia Univ, Fac Agr, Dept Biochem, Al Minya, Egypt.
RP Nakano, A (reprint author), Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima, Japan.
CR Nakano A, 2014, MOL CELL BIOL, V34, P1389, DOI 10.1128/MCB.01704-13
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JUN
PY 2017
VL 37
IS 12
AR UNSP e00175
DI 10.1128/MCB.00175-17
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EW3JN
UT WOS:000402391700006
OA No
DA 2017-08-17
ER

PT J
AU Soliman, SE
   VandenHoven, C
   MacKeen, LD
   Heon, E
   Gallie, BL
AF Soliman, Sameh E.
   VandenHoven, Cynthia
   MacKeen, Leslie D.
   Heon, Elise
   Gallie, Brenda L.
TI Optical Coherence Tomography-Guided Decisions in Retinoblastoma
   Management
SO OPHTHALMOLOGY
LA English
DT Article
ID CHILDREN; CLASSIFICATION; INFANTS; DISEASE; RETINA; OCT
AB Purpose: Assess the role of handheld optical coherence tomography (OCT) in guiding management decisions during diagnosis, treatment, and follow-up of eyes affected by retinoblastoma.
   Design: Retrospective, noncomparative, single-institution case series.
   Participants: All children newly diagnosed with retinoblastoma from January 2011 to December 2015 who had an OCT session during their active treatment at The Hospital for Sick Children (SickKids) in Toronto, Canada. The OCT sessions for fellow eyes of unilateral retinoblastoma without any suspicious lesion and those performed more than 6 months after the last treatment were excluded.
   Methods: Data collected included age at presentation, sex, family history, RB1 mutation status, 8th edition TNMH cancer staging and International Intraocular Retinoblastoma Classification (IIRC), and number of OCT sessions per eye. Details of each session were scored for indication-related details (informative or not) and assessed for guidance (directive or not), diagnosis (staging changed, new tumors found or excluded), treatment (modified, stopped, or modality shifted), or follow-up modified.
   Main Outcome Measures: Frequency of OCT-guided management decisions, stratified by indication and type of guidance (confirmatory vs. influential).
   Results: Sixty-three eyes of 44 children had 339 OCT sessions over the course of clinical management (median number of OCT scans per eye, 5; range, 1-15). The age at presentation and presence of a heritable RB1 mutation significantly correlated with an increased number of OCT sessions. Indications included evaluation of post-treatment scar (55%) or fovea (16%), and posterior pole scanning for new tumors (11%). Of all sessions, 92% (312/339) were informative; 19 of 27 noninformative sessions had large, elevated lesions; of these, 14 of 19 were T2a or T2b (IIRC group C or D) eyes. In 94% (293/312) of the informative sessions, OCT directed treatment decisions (58%), diagnosis (16%), and follow-up (26%). Optical coherence tomography influenced and changed management from pre-OCT clinical plans in 15% of all OCT sessions and 17% of directive sessions.
   Conclusions: Optical coherence tomography improves the accuracy of clinical evaluation in retinoblastoma management. (C) 2017 by the American Academy of Ophthalmology
C1 [Soliman, Sameh E.; VandenHoven, Cynthia; MacKeen, Leslie D.; Heon, Elise; Gallie, Brenda L.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.
   [Soliman, Sameh E.] Univ Alexandria, Dept Ophthalmol, Fac Med, Alexandria, Egypt.
   [Heon, Elise; Gallie, Brenda L.] Univ Toronto, Dept Ophthalmol Vis Sci, Fac Med, Toronto, ON, Canada.
   [Gallie, Brenda L.] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada.
   [Gallie, Brenda L.] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON, Canada.
   [Gallie, Brenda L.] Toronto Western Res Inst, Div Visual Sci, Toronto, ON, Canada.
RP Soliman, SE (reprint author), 555 Univ Ave,Room 7265, Toronto, ON M5G 1X8, Canada.
EM samehelsayedsoliman@yahoo.com
CR Astudillo PPP, 2014, J AAPOS, V18, P500, DOI 10.1016/j.jaapos.2014.06.012
   Berry JL, 2016, OCUL ONCOL PATHOL, V2, P148, DOI 10.1159/000442167
   Bremner R, 2009, CELL, V137, P992, DOI 10.1016/j.cell.2009.05.034
   Canadian RS, 2009, CAN J OPHTHALMOL, V44, pS1
   Choudhry N, 2016, OPHTHALMOLOGY, V123, P1368, DOI 10.1016/j.ophtha.2016.01.045
   Dimaras H, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.21
   Gallie BL, 2017, TAYLOR HOYTS PAEDIAT, P424
   Hasanreisoglu M, 2015, RETINA-J RET VIT DIS, V35, P1486, DOI 10.1097/IAE.0000000000000477
   Introini U, 2012, EYE, V26, P976, DOI 10.1038/eye.2012.75
   Lee H, 2016, INVEST OPHTH VIS SCI, V57
   Lengyel O, 2004, KLIN MONATSBL AUGENH, V221, P386, DOI 10.1055/s-2004-812883
   Maldonado RS, 2010, INVEST OPHTH VIS SCI, V51, P2678, DOI 10.1167/iovs.09-4403
   Malhotra PP, 2015, EUR J OPHTHALMOL, V25, pE123, DOI 10.5301/ejo.5000634
   Mallipatna A, 2017, AJCC CANC STAGING MA, P819
   Mallipatna A, 2015, INDIAN J OPHTHALMOL, V63, P586, DOI 10.4103/0301-4738.167108
   Medina CA, 2014, BRIT J OPHTHALMOL, V98, P40, DOI 10.1136/bjophthalmol-2013-304299
   Munier FL, 2014, OPHTHALMIC GENET, V35, P193, DOI 10.3109/13816810.2014.973045
   Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1078, DOI 10.1136/bjophthalmol-2011-301450
   Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1084, DOI 10.1136/bjophthalmol-2011-301016
   Linn Murphree A, 2005, OPHTHALMOL CLIN N AM, V18, P41
   Panozzo G, 2004, Semin Ophthalmol, V19, P13
   Pierro L, 2014, J PEDIAT OPHTH STRAB, V51, P320, DOI 10.3928/01913913-20140819-04
   Quellec G, 2010, IEEE T MED IMAGING, V29, P1321, DOI 10.1109/TMI.2010.2047023
   Rootman DB, 2013, BRIT J OPHTHALMOL, V97, P59, DOI 10.1136/bjophthalmol-2012-302133
   Rubowitz A, 2007, OPHTHALMOLOGY, V114, P1956, DOI 10.1016/j.ophtha.2007.04.005
   Saktanasate J, 2015, JAMA OPHTHALMOL, V133, DOI 10.1001/jamaophthalmol.2015.1123
   Samara WA, 2015, J AAPOS, V19, P368, DOI 10.1016/j.jaapos.2015.02.019
   Scott AW, 2009, AM J OPHTHALMOL, V147, P364, DOI 10.1016/j.ajo.2008.08.010
   Shields CL, 2015, INDIAN J OPHTHALMOL, V63, P128, DOI 10.4103/0301-4738.154384
   Soliman SE, 2016, OPHTHALMOLOGY, V123, P2610, DOI 10.1016/j.ophtha.2016.08.027
   Villani A, 2016, LANCET ONCOL, V17, P1295, DOI 10.1016/S1470-2045(16)30249-2
   Watts P, 2002, EYE, V16, P75, DOI 10.1038/sj/EYE/6700070
   Yousef YA, 2012, J AAPOS, V16, P481, DOI 10.1016/j.jaapos.2012.05.010
NR 33
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD JUN
PY 2017
VL 124
IS 6
BP 859
EP 872
DI 10.1016/j.ophtha.2017.01.052
PG 14
WC Ophthalmology
SC Ophthalmology
GA EW3MW
UT WOS:000402402800023
PM 28318638
OA No
DA 2017-08-17
ER

PT J
AU Fina, J
   Casadevall, R
   AbdElgawad, H
   Prinsen, E
   Markakis, MN
   Beemster, GTS
   Casati, P
AF Fina, Julieta
   Casadevall, Romina
   AbdElgawad, Hamada
   Prinsen, Els
   Markakis, Marios N.
   Beemster, Gerrit T. S.
   Casati, Paula
TI UV-B Inhibits Leaf Growth through Changes in Growth Regulating Factors
   and Gibberellin Levels
SO PLANT PHYSIOLOGY
LA English
DT Article
ID CELL-DIVISION RATE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; MAIZE LEAF;
   DESCHAMPSIA-ANTARCTICA; ULTRAVIOLET-RADIATION; KINEMATIC ANALYSIS; OZONE
   DEPLETION; ROOT-GROWTH; LEAVES
AB Ultraviolet-B (UV-B) radiation affects leaf growth in a wide range of species. In this work, we demonstrate that UV-B levels present in solar radiation inhibit maize (Zea mays) leaf growth without causing any other visible stress symptoms, including the accumulation of DNA damage. We conducted kinematic analyses of cell division and expansion to understand the impact of UV-B radiation on these cellular processes. Our results demonstrate that the decrease in leaf growth in UV-B-irradiated leaves is a consequence of a reduction in cell production and a shortened growth zone (GZ). To determine the molecular pathways involved in UV-B inhibition of leaf growth, we performed RNA sequencing on isolated GZ tissues of control and UV-B-exposed plants. Our results show a link between the observed leaf growth inhibition and the expression of specific cell cycle and developmental genes, including growth-regulating factors (GRFs) and transcripts for proteins participating in different hormone pathways. Interestingly, the decrease in the GZ size correlates with a decrease in the concentration of GA19, the immediate precursor of the active gibberellin, GA1, by UV-B in this zone, which is regulated, at least in part, by the expression of GRF1 and possibly other transcription factors of the GRF family.
C1 [Fina, Julieta; Casadevall, Romina; Casati, Paula] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, S2002LRK, Rosario, Argentina.
   [AbdElgawad, Hamada; Prinsen, Els; Markakis, Marios N.; Beemster, Gerrit T. S.] Univ Antwerp, Dept Biol, Integrated Mol Plant Physiol Res, B-2000 Antwerp, Belgium.
   [AbdElgawad, Hamada] Univ Beni Suef, Dept Bot & Microbiol, Fac Sci, Bani Suwayf 62511, Egypt.
RP Casati, P (reprint author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, S2002LRK, Rosario, Argentina.
EM casati@cefobi-conicet.gov.ar
FU FONCyT [PICT 2013-268, PICT 2015-157]; Interuniversity Attraction Poles
   from the Belgian Federal Science Policy Office; FWO [G0D0514N,
   G0B6716N]; European Molecular Biology Organization; Erasmus Mundus
   EADICII program; GOA (University of Antwerp)
FX This work was supported by FONCyT (grant nos. PICT 2013-268 and PICT
   2015-157 to P.C.), the Interuniversity Attraction Poles from the Belgian
   Federal Science Policy Office, the FWO (grant nos. G0D0514N and G0B6716N
   to G.T.S.B.), the European Molecular Biology Organization (short-term
   fellowship to J.F.), the Erasmus Mundus EADICII program (to R.C.), and
   the GOA (research grant from the University of Antwerp to M.N.C.).
CR Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011
   Avramova V, 2015, TRENDS PLANT SCI, V20, P787, DOI 10.1016/j.tplants.2015.09.002
   Avramova V, 2015, PLANT PHYSIOL, V169, P1382, DOI 10.1104/pp.15.00276
   Baek GH, 2011, P NATL ACAD SCI USA, V108, P13558, DOI 10.1073/pnas.1104051108
   Ballare CL, 2001, J PHOTOCH PHOTOBIO B, V62, P67, DOI 10.1016/S1011-1344(01)00152-X
   Barroco RM, 2003, CELL MOL LIFE SCI, V60, P401, DOI 10.1007/s000180300033
   Baskin TI, 2000, PLANT MOL BIOL, V43, P545, DOI 10.1023/A:1006383921517
   Baute J, 2016, PLANT PHYSIOL, V170, P1848, DOI 10.1104/pp.15.01883
   Beemster GTS, 2005, PLANT PHYSIOL, V138, P734, DOI 10.1104/pp.104.053884
   Beemster GTS, 1996, J EXP BOT, V47, P1663, DOI 10.1093/jxb/47.11.1663
   Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Biever JJ, 2014, J EXP BOT, V65, P2949, DOI 10.1093/jxb/eru035
   Bornman Janet F., 1993, P427
   Casadevall R, 2013, PLANT CELL, V25, P3570, DOI 10.1105/tpc.113.117473
   Casati P, 2003, PLANT PHYSIOL, V132, P1739, DOI 10.1104/pp.103.022871
   Curtis MJ, 2007, DNA REPAIR, V6, P1341, DOI 10.1016/j.dnarep.2007.03.004
   Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Falcone F. M., 2012, FRONT PLANT SCI, V3, P222, DOI [10.3389/fpls.2012.00222, DOI 10.3389/FPLS.2012.00222]
   Faure JD, 1998, DEVELOPMENT, V125, P909
   Fiorani F, 2000, PLANT PHYSIOL, V124, P845, DOI 10.1104/pp.124.2.845
   Flint SD, 2004, PHOTOCHEM PHOTOBIOL, V79, P399, DOI 10.1562/0031-8655(2004)79<399:SFTOBS>2.0.CO;2
   FUJIOKA S, 1988, PLANT PHYSIOL, V88, P1367, DOI 10.1104/pp.88.4.1367
   Furukawa T, 2010, DNA REPAIR, V9, P940, DOI 10.1016/j.dnarep.2010.06.006
   Gardner G, 2009, PLANT CELL ENVIRON, V32, P1573, DOI 10.1111/j.1365-3040.2009.02021.x
   Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698
   Gonzalez R, 1998, PLANT CELL ENVIRON, V21, P23, DOI 10.1046/j.1365-3040.1998.00243.x
   Granier C, 2000, PLANT PHYSIOL, V124, P1393, DOI 10.1104/pp.124.3.1393
   Granier C, 2009, PLANT CELL ENVIRON, V32, P1175, DOI 10.1111/j.1365-3040.2009.01955.x
   Li W. H., 2000, FUNDAMENTALS MOL EVO
   Gutierrez C, 2002, CURR OPIN PLANT BIOL, V5, P480, DOI 10.1016/S1369-5266(02)00301-1
   Hectors K, 2007, NEW PHYTOL, V175, P255, DOI 10.1111/j.1469-8137.2007.02092.x
   Hectors K, 2010, J EXP BOT, V61, P4339, DOI 10.1093/jxb/erq235
   Hefner E, 2003, J EXP BOT, V54, P669, DOI 10.1093/jxb/erg069
   Hewezi T, 2012, PLANT PHYSIOL, V159, P321, DOI 10.1104/pp.112.193649
   Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106
   Hofmann RW, 2003, PLANT CELL ENVIRON, V26, P603, DOI 10.1046/j.1365-3040.2003.00996.x
   Hopkins L, 2002, PLANT CELL ENVIRON, V25, P617, DOI 10.1046/j.1365-3040.2002.00834.x
   Kakani VG, 2003, ANN BOT-LONDON, V91, P817, DOI 10.1093/aob/mcg086
   Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041
   Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598
   Kuhn BM, 2011, PLANT PHYSIOL, V156, P585, DOI 10.1104/pp.111.175976
   Laakso K, 2000, PLANT CELL ENVIRON, V23, P461, DOI 10.1046/j.1365-3040.2000.00566.x
   Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703
   Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x
   Luo L, 2012, J PLANT RES, V125, P661, DOI 10.1007/s10265-012-0479-5
   Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Nelissen H, 2015, PLANT CELL, V27, P1605, DOI 10.1105/tpc.15.00269
   Nelissen H, 2012, CURR BIOL, V22, P1183, DOI 10.1016/j.cub.2012.04.065
   Nemchenko A, 2006, J EXP BOT, V57, P3767, DOI 10.1093/jxb/erl137
   Nogues S, 1998, PLANT PHYSIOL, V117, P173, DOI 10.1104/pp.117.1.173
   Piazza P, 2005, NEW PHYTOL, V167, P693, DOI 10.1111/j.1469-8137.2005.01466.x
   Robson TM, 2012, PHYSIOL PLANTARUM, V144, P146, DOI 10.1111/j.1399-3054.2011.01546.x
   Ruhland CT, 2000, PHYSIOL PLANTARUM, V109, P244, DOI 10.1034/j.1399-3054.2000.100304.x
   Ruhland CT, 2005, PHOTOCHEM PHOTOBIOL, V81, P1086, DOI 10.1562/2004-09-18-RA-321
   Rymen B, 2007, PLANT PHYSIOL, V143, P1429, DOI 10.1104/pp.106.093948
   Rymen B, 2010, METHODS MOL BIOL, V655, P203, DOI 10.1007/978-1-60761-765-5_14
   SCHLENK H, 1960, ANAL CHEM, V32, P1412, DOI 10.1021/ac60167a011
   Searles PS, 2001, OECOLOGIA, V127, P1, DOI 10.1007/s004420000592
   Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276
   Sprangers K, 2016, JOVE-J VIS EXP, V118
   Stapleton A. E., 1993, Plant Molecular Biology Reporter, V11, P230, DOI 10.1007/BF02669850
   STAXEN I, 1994, PHYSIOL PLANTARUM, V91, P735, DOI 10.1034/j.1399-3054.1994.910427.x
   Tardieu F, 2000, PLANT MOL BIOL, V43, P555, DOI 10.1023/A:1006438321386
   Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320
   Vercruyssen L, 2015, PLANT PHYSIOL, V167, P817, DOI 10.1104/pp.114.256180
   Wargent JJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P279, DOI 10.1111/j.1751-1097.2008.00433.x
   West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/99.104.040022
NR 70
TC 1
Z9 1
U1 11
U2 11
PU AMER SOC PLANT BIOLOGISTS
PI ROCKVILLE
PA 15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
SN 0032-0889
EI 1532-2548
J9 PLANT PHYSIOL
JI Plant Physiol.
PD JUN
PY 2017
VL 174
IS 2
BP 1110
EP 1126
DI 10.1104/pp.17.00365
PG 17
WC Plant Sciences
SC Plant Sciences
GA EX3SH
UT WOS:000403152200052
PM 28400494
OA No
DA 2017-08-17
ER

PT J
AU Siddhanamatha, HR
   Heung, E
   Lopez-Olivo, MD
   Abdel-Wahab, N
   Ojeda-Prias, A
   Willcockson, I
   Leong, A
   Suarez-Almazor, ME
AF Siddhanamatha, Harish Rajashekarappa
   Heung, Eric
   Lopez-Olivo, Maria de los Angeles
   Abdel-Wahab, Noha
   Ojeda-Prias, Ana
   Willcockson, Irmgard
   Leong, Amye
   Suarez-Almazor, Maria Eugenia
TI Quality assessment of websites providing educational content for
   patients with rheumatoid arthritis
SO SEMINARS IN ARTHRITIS AND RHEUMATISM
LA English
DT Review
DE Education; Patient; Quality reporting; Rheumatoid arthritis; Websites
ID WORLD-WIDE-WEB; HEALTH INFORMATION; MEDICAL INFORMATION; INTERNET; CARE;
   OPPORTUNITIES; IMPACT
AB Objective: We performed an environmental scan of currently available websites providing educational information about rheumatoid arthritis (RA) and evaluated the quality of these websites.
   Methods: We searched three separate search engines, Google, Bing, and Ask.com, on August 27, 2015, using two search terms, "arthritis" and "rheumatoid." Only patient education websites were included. Two independent investigators evaluated the accuracy, completeness, technical elements, design and esthetics, readability, usability, and accessibility of the websites. The navigation experience was also evaluated by an adult training expert.
   Results: We identified 46 websites. Nearly all websites (98%) provided accurate information. However, no website covered all essential RA topics. Common essential topics not covered included epidemiology, pathogenesis, treatment and disease monitoring, complications, self-management, risks and benefits of treatment, prognosis, treatment adherence, questions for patients to ask their doctors, and costs. For the technical elements, all websites disclosed their ownership, but the date that the content was last updated was mentioned in only 10 websites, ranging from 2007 to 2015. The mean reading level was grade 12.1 (standard deviation +/- 2.3). Most websites (78%) were easy to navigate but only 33% were friendly for people with visual and/or hearing impairments. The navigation experience was rated fair or poor in 41% of the websites.
   Conclusion: Current patient information on the Internet does not comprehensively address all educational needs of patients with RA, and is often outdated. The findings from our study highlight potential areas for improvement in online education materials for patients with RA. (C) 2017 Published by Elsevier Inc.
C1 [Siddhanamatha, Harish Rajashekarappa; Lopez-Olivo, Maria de los Angeles; Abdel-Wahab, Noha; Suarez-Almazor, Maria Eugenia] Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.
   [Heung, Eric] Massachusetts Coll Pharm & Hlth Sci MCPHS Univ, Worcester, MA USA.
   [Abdel-Wahab, Noha] Assiut Univ Hosp, Rheumatol & Rehabil Dept, Assiut, Egypt.
   [Ojeda-Prias, Ana] Univ Houston, Houston, TX USA.
   [Willcockson, Irmgard] Lonestar Coll, Montgomery, TX USA.
   [Leong, Amye] Hlth Motivat, Santa Barbara, CA USA.
RP Suarez-Almazor, ME (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Gen Internal Med, Unit 437, 1515 Holcombe Blvd, Houston, TX 77030 USA.
EM msalmazor@mdanderson.org
FU Rheumatology Research Foundation; Rheumatology Research Foundation
   Innovative Research Grant [14038089]
FX Dr. Lopez-Olivo is the recipient of an investigator career award from
   the Rheumatology Research Foundation; no other author relationships or
   conflicts of interest have influenced the submitted work.; Funding for
   this project was provided by a Rheumatology Research Foundation
   Innovative Research Grant. (Grant no. 14038089)
CR Abbott S A, 1998, Gastroenterol Nurs, V21, P207, DOI 10.1097/00001610-199809000-00003
   Barlow JH, 1999, PATIENT EDUC COUNS, V38, P195, DOI 10.1016/S0738-3991(98)00144-X
   Brooke J., 1986, SYSTEM USABILITY SCA
   Yvonne Chan YF, 2014, HLTH PROMOT PERSPECT, V4, P1
   Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105
   Chitika Inc, 2013, VAL GOOGL RES POS
   Coiera E, 1996, BRIT MED J, V312, P3
   Culver M, 2005, MUSCULOSKELET CARE, V3, P33, DOI 10.1002/msc.24
   Castillo-Ortiz JD, 2016, RHEUMATOL INT, V36, P1281, DOI 10.1007/s00296-016-3507-2
   Doak CC, 1996, AM J NURS, V96, P16
   DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6
   eEurope, 2002, J MED INTERNET RES, V4, pE15
   Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691
   Fahy Eamonn, 2014, Australas Med J, V7, P24, DOI 10.4066/AMJ.2014.1900
   Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618
   Houts PS, 2006, PATIENT EDUC COUNS, V64, P393, DOI 10.1016/j.pec.2006.06.023
   Joplin S, 2015, BIOMED RES INT, DOI 10.1155/2015/150658
   LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403
   Morison JL, 1992, PRIMER NEW I RES, P86
   Murray E, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.3.e17
   Pew Internet, 2012, PEW RES INT PROJ SEA
   Plain Language Action and Information Network (PLAIN), 2011, FED PLAIN LANG GUID
   Reid P, 2011, STUD HEALTH TECHNOL, V164, P353, DOI 10.3233/978-1-60750-709-3-353
   Rhee RL, 2013, ARTHRIT CARE RES, V65, P1702, DOI 10.1002/acr.22046
   Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721
   Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244
   Sonnenberg FA, 1997, ARCH INTERN MED, V157, P151, DOI 10.1001/archinte.157.2.151
   Suarez-Almazor ME, 2001, J RHEUMATOL, V28, P185
   U. S. Department of Health & Human Services, 2016, HHS WEB STAND US GUI
   van Deursen AJAM, 2009, INTERACT COMPUT, V21, P393, DOI 10.1016/j.intcom.2009.06.005
   Wang LP, 2012, J MED INTERNET RES, V14, P370, DOI 10.2196/jmir.1943
   Winker MA, 2000, JAMA-J AM MED ASSOC, V283, P1600, DOI 10.1001/jama.283.12.1600
NR 32
TC 0
Z9 0
U1 6
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0049-0172
EI 1532-866X
J9 SEMIN ARTHRITIS RHEU
JI Semin. Arthritis Rheum.
PD JUN
PY 2017
VL 46
IS 6
BP 715
EP 723
DI 10.1016/j.semarthrit.2017.01.006
PG 9
WC Rheumatology
SC Rheumatology
GA EX4IJ
UT WOS:000403197900005
PM 28258768
OA No
DA 2017-08-17
ER

PT J
AU Abou Shousha, M
   Yoo, SH
   Sayed, MS
   Edelstein, S
   Council, M
   Shah, RS
   Abernathy, J
   Schmitz, Z
   Stuart, P
   Bentivegna, R
   Fernandez, MP
   Smith, C
   Yin, XT
   Harocopos, GJ
   Dubovy, SR
   Feuer, WJ
   Wang, JH
   Perez, VL
AF Abou Shousha, Mohamed
   Yoo, Sonia H.
   Sayed, Mohamed S.
   Edelstein, Sean
   Council, Matthew
   Shah, Ravi S.
   Abernathy, Joshua
   Schmitz, Zachary
   Stuart, Patrick
   Bentivegna, Rocio
   Fernandez, Maria P.
   Smith, Christopher
   Yin, Xiaotang
   Harocopos, George J.
   Dubovy, Sander R.
   Feuer, William J.
   Wang, Jianhua
   Perez, Victor L.
TI In Vivo Characteristics of Corneal Endothelium/Descemet Membrane Complex
   for the Diagnosis of Corneal Graft Rejection
SO AMERICAN JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID ENDOTHELIAL-CELL DENSITY; CAPILLARY BASEMENT-MEMBRANE; PENETRATING
   KERATOPLASTY; ALLOGRAFT-REJECTION; FAILURE; TRANSPLANTATION; MARKER
AB PURPOSE: To evaluate the utility of endothelial/Descemet membrane complex (En/DM) characteristics in diagnosing corneal graft rejection.
   DESIGN: Diagnostic reliability study.
   METHODS: One hundred thirty-nine eyes (96 corneal grafts post penetrating keratoplasty or Descemet stripping automated endothelial keratoplasty: 40 clear, 23 actively rejecting, 24 rejected, and 9 nonimmunologic failed grafts; along with 43 age-matched control eyes) were imaged using high-definition optical coherence tomography. Images were used to describe En/DM and measure central corneal thickness (CCT) and central En/DM thickness (DMT). En/DM rejection index (DRI) was computed to detect the relative En/DM thickening to the entire cornea.
   RESULTS: In actively rejecting grafts, DMT and DRI were significantly greater than controls and clear grafts (28, 17, and 17 mu m and 1.5, 1 and 1, respectively; P < .001). Rejected grafts had the highest DMT and DRI compared to all groups (59 mu m and 2.1; P < .001). DMT and DRI showed excellent accuracy, significantly better than that of CCT, in differentiating actively rejecting from clear grafts (100% and 96% sensitivity; 92.5% and 92.5% specificity), actively rejecting from rejected grafts (88% and 83% sensitivity; 91% and 83% specificity), and nonimmunologic failed from rejected grafts (100% and 100% sensitivity; 88% and 100% specificity). DMT correlated significantly with rejection severity (P < .001).
   CONCLUSIONS: In corneal grafts, in vivo relative thickening of the En/DM is diagnostic of graft rejection as measured by DMT and DRI. These indices have excellent accuracy, sensitivity, and specificity in detecting graft immunologic status, superior to CCT. DMT is a quantitative index that correlates accurately with the severity of rejection. 2017 Elsevier Inc. All rights reserved.
C1 [Abou Shousha, Mohamed; Yoo, Sonia H.; Sayed, Mohamed S.; Fernandez, Maria P.; Dubovy, Sander R.; Feuer, William J.; Wang, Jianhua; Perez, Victor L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, 900 NW 17th St,Room 340H, Miami, FL 33136 USA.
   [Abou Shousha, Mohamed; Edelstein, Sean; Council, Matthew; Shah, Ravi S.; Abernathy, Joshua; Schmitz, Zachary; Stuart, Patrick; Bentivegna, Rocio; Smith, Christopher; Yin, Xiaotang] St Louis Univ, Eye Inst, St Louis, MO 63103 USA.
   [Abou Shousha, Mohamed] Univ Alexandria, Dept Ophthalmol, Fac Med, Alexandria, Egypt.
   [Harocopos, George J.] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA.
   [Harocopos, George J.] Washington Univ, Dept Pathol, St Louis, MO 63130 USA.
   [Harocopos, George J.] Washington Univ, Dept Immunol, St Louis, MO USA.
RP Abou Shousha, M (reprint author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, 900 NW 17th St,Room 340H, Miami, FL 33136 USA.
EM m.aboushousha@med.miami.edu
OI Abou Shousha, Mohamed/0000-0002-4508-0492
FU NATIONAL EYE INSTITUTE (NEI), BETHESDA, MARYLAND K23 AWARD
   [K23EY026118]; NEI core center grant [P30 EY014801]; Research to Prevent
   Blindness (RPB), New York, New York; American Society of Cataract and
   Refractive Surgery (ASCRS) Foundation, Fairfax, Virginia
FX THIS STUDY WAS SUPPORTED BY A NATIONAL EYE INSTITUTE (NEI), BETHESDA,
   MARYLAND K23 AWARD (K23EY026118), NEI core center grant to the
   University of Miami (P30 EY014801), Research to Prevent Blindness (RPB),
   New York, New York, and the American Society of Cataract and Refractive
   Surgery (ASCRS) Foundation, Fairfax, Virginia. The funding organizations
   had no role in the design or conduct of this research.
CR Aita K, 2007, AM J TRANSPLANT, V7, P923, DOI 10.1111/j.1600-6143.2006.01708.x
   Aldave AJ, 2013, CORNEA, V32, P149, DOI 10.1097/ICO.0b013e31825e83bf
   ALLDREDGE OC, 1981, ARCH OPHTHALMOL-CHIC, V99, P599
   Anne WK, AUSTR CORNEAL GRAFT
   Benetz BA, 2013, JAMA OPHTHALMOL, V131, P601, DOI 10.1001/jamaophthalmol.2013.1693
   Claerhout I, 2003, INVEST OPHTH VIS SCI, V44, P4747, DOI 10.1167/iovs.03-0536
   Guilbert E, 2013, AM J OPHTHALMOL, V155, P560, DOI 10.1016/j.ajo.2012.09.027
   HILL JC, 1991, OPHTHALMOLOGY, V98, P329
   Huang D, 2008, ANTERIOR SEGMENT OPT, P165
   Hutchings N, 2010, INVEST OPHTH VIS SCI, V51, P4579, DOI 10.1167/iovs.09-4676
   Ing JJ, 1998, OPHTHALMOLOGY, V105, P1855, DOI 10.1016/S0161-6420(98)91030-2
   INOMATA H, 1970, INVEST OPHTH VISUAL, V9, P263
   JAKUS MARIE A., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P243, DOI 10.1083/jcb.2.4.243
   KURZ GH, 1968, AM J OPHTHALMOL, V66, P184
   Lass JH, 2010, ARCH OPHTHALMOL-CHIC, V128, P63, DOI 10.1001/archophthalmol.2010.128.63
   Lee HS, 2009, EUR J OPHTHALMOL, V19, P930
   Lin RC, 2004, OPT LETT, V29, P83, DOI 10.1364/OL.29.000083
   Monnereau C, 2014, AM J OPHTHALMOL, V158, P485, DOI 10.1016/j.ajo.2014.05.030
   MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P1402
   MUSCH DC, 1991, AM J OPHTHALMOL, V111, P739
   Roufosse CA, 2012, TRANSPLANTATION, V94, P269, DOI 10.1097/TP.0b013e31825774ab
   Shimizu T, 2009, CLIN TRANSPLANT, V23, P39, DOI 10.1111/j.1399-0012.2009.01008.x
   Shousha Mohamed Abou, 2013, Ophthalmology, V120, P883, DOI 10.1016/j.ophtha.2012.10.025
   Shousha Mohamed Abou, 2010, Ophthalmology, V117, P1220, DOI 10.1016/j.ophtha.2009.10.027
   Siddiqui MT, 1996, MODERN PATHOL, V9, P320
   TADDESSEHEATH L, 1994, J NATL MED ASSOC, V86, P779
   Tao AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080986
   Verdier DD, 2013, CORNEA, V32, P729, DOI 10.1097/ICO.0b013e31827b14c7
   WILLIAMS KA, 1995, EYE, V9, P219
   WILSON SE, 1990, SURV OPHTHALMOL, V34, P325, DOI 10.1016/0039-6257(90)90110-H
   Yamazoe K, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-5
NR 31
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9394
EI 1879-1891
J9 AM J OPHTHALMOL
JI Am. J. Ophthalmol.
PD JUN
PY 2017
VL 178
BP 27
EP 37
DI 10.1016/j.ajo.2017.02.026
PG 11
WC Ophthalmology
SC Ophthalmology
GA EW6CB
UT WOS:000402591700004
PM 28259779
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, SA
AF Ahmed, S. A.
TI Room-temperature ferromagnetism in Co-, Cr-, and V-doped ZnO diluted
   magnetic semiconductor
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID SOL-GEL METHOD; THIN-FILMS; ANNEALING TEMPERATURE; DOPING CONCENTRATION;
   DOPANT CONCENTRATION; ELECTRIC PROPERTIES; OPTICAL-PROPERTIES;
   NANOPARTICLES; PHOTOLUMINESCENCE; DEPENDENCE
AB In this study, diluted magnetic semiconductors Zn0.998TM0.002O (TM = Co, Cr, or V) samples were synthesized using the solid-state reaction method. X-ray diffraction measurements indicated that all the samples had a single crystalline wurtzite structure; moreover, no metallic transition metal or other secondary phases were found. The magnetization measurements showed that all the samples exhibited room-temperature ferromagnetism (RTFM) with a saturation magnetization and a coercive field of 2.310 mu(B)/Co and similar to 350 Oe, 2.479 mu(B)/Cr and similar to 325 Oe, and 2.198 mu(B)/V and similar to 170 Oe for Co-, Cr-, and V-doped ZnO, respectively. The structural and magnetic investigations demonstrate that RTFM is an intrinsic property of the samples. Thus, ferromagnetism does not originate from clusters or secondary phases; it is due to the Co/Cr/V: ZnO matrices. This study has shown that very light doping of Co, Cr, orVin ZnO results in appreciable RT ferromagnetic ordering that is useful for spintronic applications.
C1 [Ahmed, S. A.] Sohag Univ, Fac Sci, Phys Dept, Sohag 82524, Egypt.
   [Ahmed, S. A.] Qassim Univ, Coll Arts & Sci, Phys Dept, PO 3137, Unayzah 51911, Saudi Arabia.
RP Ahmed, SA (reprint author), Sohag Univ, Fac Sci, Phys Dept, Sohag 82524, Egypt.; Ahmed, SA (reprint author), Qassim Univ, Coll Arts & Sci, Phys Dept, PO 3137, Unayzah 51911, Saudi Arabia.
EM saadzf2003@gmail.com
CR Ahmed SA, 2017, J MATER SCI-MATER EL, V28, P3733, DOI 10.1007/s10854-016-5981-4
   Ahmed SA, 2017, J MATER SCI, V52, P4977, DOI 10.1007/s10853-016-0736-4
   Ahmed SA, 2016, J MATER SCI-MATER EL, V27, P7589, DOI 10.1007/s10854-016-4741-9
   Ahmed S. A., 2017, RESULTS PHYS, V7, P604
   Aravind A, 2014, APPL PHYS A-MATER, V115, P843, DOI 10.1007/s00339-013-7875-0
   Beltran JJ, 2013, J APPL PHYS, V113, DOI 10.1063/1.4799778
   Bhargava R, 2011, MATER CHEM PHYS, V125, P664, DOI 10.1016/j.matchemphys.2010.09.075
   Chen YP, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2919077
   Choudhury B, 2013, J APPL PHYS, V114, DOI 10.1063/1.4833562
   Coey JMD, 2005, NAT MATER, V4, P173, DOI 10.1038/nmat1310
   Coey JMD, 2004, APPL PHYS LETT, V84, P1332, DOI 10.1063/1.1650041
   Dutta S, 2005, J APPL PHYS, V98, DOI 10.1063/1.2035308
   Dutta S, 2006, J APPL PHYS, V100, DOI 10.1063/1.2401311
   El Ghoul J, 2016, J MATER SCI-MATER EL, V27, P2159, DOI 10.1007/s10854-015-4006-z
   Fu CF, 2013, PHYS STATUS SOLIDI A, V210, P1358, DOI 10.1002/pssa.201329014
   Ghosh M, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445704
   Hofmann DM, 2007, APPL PHYS A-MATER, V88, P147, DOI 10.1007/S00339-007-3956-2
   Hong NH, 2005, J APPL PHYS, V97, DOI 10.1063/1.1854072
   Jacob S, 2012, MAT SCI SEMICON PROC, V15, P326, DOI 10.1016/j.mssp.2011.09.004
   Kim YJ, 2004, APPL PHYS LETT, V84, P3531, DOI 10.1063/1.1703845
   Kittilstved KR, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.147209
   Krithiga R, 2009, J CRYST GROWTH, V311, P4610, DOI 10.1016/j.jcrysgro.2009.08.033
   Lakshmi YK, 2009, MATER CHEM PHYS, V113, P749, DOI 10.1016/j.matchemphys.2008.08.021
   Li J, 2010, APPL PHYS A-MATER, V98, P537, DOI 10.1007/s00339-009-5489-3
   Liao ZM, 2008, PHYS LETT A, V372, P4505, DOI 10.1016/j.physleta.2008.04.013
   Liu SH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2745642
   Liu Y, 2011, J SOLID STATE CHEM, V184, P1273, DOI 10.1016/j.jssc.2011.03.049
   Liu Y, 2009, J ALLOY COMPD, V486, P835, DOI 10.1016/j.jallcom.2009.07.076
   Meher SK, 2011, J PHYS CHEM C, V115, P25543, DOI 10.1021/jp209165v
   Pan QT, 2007, J PHYS D APPL PHYS, V40, P6829, DOI 10.1088/0022-3727/40/21/051
   Pearton SJ, 2004, SEMICOND SCI TECH, V19, pR59, DOI 10.1088/0268-1242/19/10/R01
   Reddy DA, 2011, APPL PHYS A-MATER, V105, P119, DOI 10.1007/s00339-011-6563-1
   Reddy KM, 2007, SOL ENERG MAT SOL C, V91, P1496, DOI 10.1016/j.solmat.2007.03.012
   Roberts BK, 2005, J APPL PHYS, V97, DOI 10.1063/1.1847914
   Saeki H, 2001, SOLID STATE COMMUN, V120, P439, DOI 10.1016/S0038-1098(01)00400-8
   Santara B, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/23/235304
   Sanyal D, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/04/045217
   SHIN S, 1990, PHYS REV B, V41, P4993, DOI 10.1103/PhysRevB.41.4993
   Snure M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3067998
   Sun HQ, 1999, PHYS STATUS SOLIDI B, V215, P1127, DOI 10.1002/(SICI)1521-3951(199910)215:2<1127::AID-PSSB1127>3.0.CO;2-M
   Tong LN, 2012, J MAGN MAGN MATER, V324, P1795, DOI 10.1016/j.jmmm.2011.12.042
   Tsakonas C, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/9/095305
   Tseng LT, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-673
   Ueda K, 2001, APPL PHYS LETT, V79, P988, DOI 10.1063/1.1384478
   Venkatesan M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.177206
   Wang F, 2013, J MAGN MAGN MATER, V340, P5, DOI 10.1016/j.jmmm.2013.03.026
   Wang S, 2010, J ALLOY COMPD, V505, P362, DOI 10.1016/j.jallcom.2010.05.183
   Wu R, 2005, CHEM PHYS LETT, V406, P457, DOI 10.1016/j.cplett.2005.03.030
   Xiong Z, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3624589
   Ye JD, 2005, APPL PHYS A-MATER, V81, P759, DOI 10.1007/s00339-004-2996-0
   Yilmaz S, 2017, J MATER SCI-MATER EL, V28, P3191, DOI 10.1007/s10854-016-5908-0
   Yilmaz S, 2014, APPL PHYS A-MATER, V115, P313, DOI 10.1007/s00339-013-7817-x
   Yu MP, 2011, MATER CHEM PHYS, V126, P797, DOI 10.1016/j.matchemphys.2010.12.041
   Zou CW, 2012, APPL PHYS A-MATER, V109, P163, DOI 10.1007/s00339-012-7027-y
NR 54
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JUN
PY 2017
VL 123
IS 6
AR 440
DI 10.1007/s00339-017-1058-3
PG 9
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EX1KO
UT WOS:000402981700031
OA No
DA 2017-08-17
ER

PT J
AU Khalil, R
AF Khalil, Reda
TI Impedance and modulus spectroscopy of poly(vinyl alcohol)-Mg[ClO4](2)
   salt hybrid films
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID RECHARGEABLE MAGNESIUM BATTERIES; SOLID ELECTROLYTES;
   ELECTRIC-CONDUCTIVITY; POLYMER ELECTROLYTES; RELAXATION; PERFORMANCE;
   GLASSES; CELLS; NANOPARTICLES; SYSTEMS
AB The electrical and dielectric properties of PVA/Mg[ClO4](2) hybrid films were investigated in the temperature range of 90-150 degrees C and the frequency range of 20 Hz-10 MHz using impedance and modulus spectroscopy. Impedance and modulus analyses had indicated the temperature independent distribution of relaxation times and the non-Debye behavior in these composites. The co-operative motion due to strong coupling between the mobile Mg2+ ions is assumed to give rise to non-Debye type of relaxation. Complex impedance Nyquist plots are used to interpret the relaxation mechanism. The nature of Nyquist plot confirms the presence of bulk effects, grain boundaries and electrolyte/electrode polarization, and non-Debye type of relaxation processes occurs in the composites. A thermally activated relaxation was observed, which was ascribed to be a non-Debye-type relaxation caused by the mobility of magnesium ion in polymer matrix. A comparison between Z '', imaginary part of complex impedance, and M '', imaginary part of complex electric modulus, indicates that the short-and long-range charge motion dominates at low and high temperatures, respectively. The activation energies, which were obtained from the electric modulus and bulk conductivity, are matched well. The non-coincidence of peaks corresponding to the modulus and impedance indicates deviation from Debye-type relaxation.
C1 [Khalil, Reda] Benha Univ, Phys Dept, Fac Sci, Banha, Egypt.
RP Khalil, R (reprint author), Benha Univ, Phys Dept, Fac Sci, Banha, Egypt.
EM r.khalil@fsc.bu.edu.eg
CR ALMOND DP, 1983, SOLID STATE IONICS, V9-10, P277, DOI 10.1016/0167-2738(83)90247-3
   ALMOND DP, 1987, SOLID STATE IONICS, V23, P27, DOI 10.1016/0167-2738(87)90078-6
   Aurbach D, 2001, J POWER SOURCES, V97-8, P28, DOI 10.1016/S0378-7753(01)00585-7
   Aurbach D, 2000, NATURE, V407, P724, DOI 10.1038/35037553
   Bajpai M., 2016, ADV MAT LETT, V7, P414
   CAO WQ, 1990, SOLID STATE IONICS, V42, P213, DOI 10.1016/0167-2738(90)90010-O
   Coe-Sullivan S, 2003, ORG ELECTRON, V4, P123, DOI 10.1016/j.orgel.2003.08.016
   Das BC, 2008, ACS NANO, V2, P1930, DOI 10.1021/nn800335f
   GERHARDT R, 1994, J PHYS CHEM SOLIDS, V55, P1491, DOI 10.1016/0022-3697(94)90575-4
   Gray F. M., 1997, RSC MAT MONOGRAPHS
   GREGORY TD, 1990, J ELECTROCHEM SOC, V137, P775, DOI 10.1149/1.2086553
   Guchhait A, 2009, CHEM MATER, V21, P5292, DOI 10.1021/cm902404s
   Guo ZS, 2010, MACROMOLECULES, V43, P1860, DOI 10.1021/ma902573d
   Hatta FF, 2005, IONICS, V11, P418, DOI 10.1007/BF02430259
   Hemalatha KS, 2015, J APPL PHYS, V118, DOI 10.1063/1.4933286
   HODGE IM, 1976, J ELECTROANAL CHEM, V74, P125, DOI 10.1016/0368-1874(76)85001-0
   HOWELL FS, 1974, J PHYS CHEM-US, V78, P639, DOI 10.1021/j100599a016
   Khalil R, 2017, J ADV PHYS, V6, P102, DOI 10.1166/jap.2017.1288
   Khalil R, 2014, MATER EXPRESS, V4, P483, DOI 10.1166/mex.2014.1197
   Lanfredi S, 2002, SOLID STATE IONICS, V146, P329, DOI 10.1016/S0167-2738(01)01030-X
   Liu JJ, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.144106
   MacCallum JR, 1987, POLYM ELECTROLYTE RE
   MacDonald J, 1987, IMPEDANCE SPECTROSCO
   Meyer WH, 1998, ADV MATER, V10, P439, DOI 10.1002/(SICI)1521-4095(199804)10:6<439::AID-ADMA439>3.0.CO;2-I
   Moynihan CT, 1998, SOLID STATE IONICS, V105, P175, DOI 10.1016/S0167-2738(97)00462-1
   Muldoon J, 2012, ENERG ENVIRON SCI, V5, P5941, DOI 10.1039/c2ee03029b
   NAGAOKA K, 1984, J POLYM SCI POL LETT, V22, P659, DOI 10.1002/pol.1984.130221205
   Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b
   Noor IS, 2013, ELECTROCHIM ACTA, V102, P149, DOI 10.1016/j.electacta.2013.04.010
   Ortega N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014111
   Pandey GP, 2011, J SOLID STATE ELECTR, V15, P2253, DOI 10.1007/s10008-010-1240-4
   Sathiyamoorthi R, 2007, J POWER SOURCES, V171, P922, DOI 10.1016/j.jpowsour.2007.06.023
   Shao YY, 2015, NANO ENERGY, V12, P750, DOI 10.1016/j.nanoen.2014.12.028
   SINCLAIR DC, 1989, J APPL PHYS, V66, P3850, DOI 10.1063/1.344049
   Smirnova TN, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/24/245707
   Sural M, 2000, SOLID STATE IONICS, V130, P259, DOI 10.1016/S0167-2738(00)00641-X
   Vittadello M, 2002, SOLID STATE IONICS, V147, P341, DOI 10.1016/S0167-2738(02)00030-9
   Wang CC, 2014, SOLID STATE COMMUN, V179, P29, DOI 10.1016/j.ssc.2013.11.008
   WIECZOREK W, 1995, ELECTROCHIM ACTA, V40, P2251, DOI 10.1016/0013-4686(95)00172-B
   YAMAMOTO K, 1988, JPN J APPL PHYS 1, V27, P1845, DOI 10.1143/JJAP.27.1845
NR 40
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JUN
PY 2017
VL 123
IS 6
AR 422
DI 10.1007/s00339-017-1026-y
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EX1KO
UT WOS:000402981700013
OA No
DA 2017-08-17
ER

PT J
AU Raaif, M
   Mohamed, SH
AF Raaif, M.
   Mohamed, S. H.
TI The effect of Cu on the properties of CdO/Cu/CdO multilayer films for
   transparent conductive electrode applications
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID ZNO THIN-FILMS; LIGHT-EMITTING-DIODES; CDO FILMS; PHOTOCATALYTIC
   PROPERTIES; PHYSICAL-PROPERTIES; ROOM-TEMPERATURE; SPRAY-PYROLYSIS;
   DEPOSITION; SUBSTRATE; MICROSTRUCTURE
AB Transparent conductive CdO/Cu/CdO multilayer films were prepared using rf plasma magnetron sputtering and electron beam evaporation techniques. The CdO layers were prepared using rf plasma magnetron sputtering, while the Cu interlayer was prepared by electron beam evaporation technique. The Cu layer thickness was varied between 1 and 10 nm. The structural and optical properties as well as the sheet resistance of the multilayer films were studied. X-ray diffraction measurements revealed the presence of cubic CdO structure and the Cu peak was only observed for the multilayers prepared with 10 nm of Cu. It has been observed that the Cu interlayer thickness has a great influence on the optical and electrical properties of the multilayers. The transmittance of the multilayer films decreased while the reflectance increased with increasing Cu interlayer thickness. The refractive index and the extinction coefficient of the multilayer films were calculated. The estimated optical band gap values were found to be decreased from 2.75 +/- 0.02 to 2.40 +/- 0.02 eV as the Cu interlayer thickness increased from 1 to 10 nm. The sheet resistance was sensitive to the Cu interlayer thickness and it decreased with increasing Cu interlayer thickness. A sheet resistSSance of 21.7 X/sq, an average transmittance (between 700 and 1000 nm) of 77%, and an optical band gap of 2.5 +/- 0.02 eV were estimated for the multilayer film with 2 nm Cu layer. The multilayer film with 2 nm Cu layer has the highest figure of merit value of 3.2 9 10(-3) Omega(-1). This indicates that the properties of this multilayer film are suitable for transparent conductive electrode applications.
C1 [Raaif, M.; Mohamed, S. H.] Sohag Univ, Fac Sci, Phys Dept, Sohag 82524, Egypt.
RP Mohamed, SH (reprint author), Sohag Univ, Fac Sci, Phys Dept, Sohag 82524, Egypt.
EM abo_95@yahoo.com
CR Al-Kuhaili MF, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/21/215302
   Bou A, 2016, THIN SOLID FILMS, V617, P86, DOI 10.1016/j.tsf.2015.12.041
   Cho EN, 2012, EXPERT SYST APPL, V39, P8885, DOI 10.1016/j.eswa.2012.02.019
   Colak H, 2013, MAT SCI SEMICON PROC, V16, P712, DOI 10.1016/j.mssp.2012.12.013
   Dakhel AA, 2013, J SOLID STATE CHEM, V208, P14, DOI 10.1016/j.jssc.2013.09.037
   Dhar A, 2014, ECS SOLID STATE LETT, V3, pN33, DOI 10.1149/2.0061411ssl
   Ding XW, 2012, APPL SURF SCI, V258, P3082, DOI 10.1016/j.apsusc.2011.11.041
   El-Kabnay N, 2008, PHYSICA B, V403, P31, DOI 10.1016/j.physb.2007.08.016
   ELKADRY N, 1995, THIN SOLID FILMS, V259, P194, DOI 10.1016/0040-6090(94)06416-4
   Guillen C, 2011, THIN SOLID FILMS, V520, P1, DOI 10.1016/j.tsf.2011.06.091
   Gupta RK, 2011, PHYSICA E, V43, P1666, DOI 10.1016/j.physe.2011.05.019
   GURUMURUGAN K, 1994, SEMICOND SCI TECH, V9, P1827, DOI 10.1088/0268-1242/9/10/013
   HAACKE G, 1976, J APPL PHYS, V47, P4086, DOI 10.1063/1.323240
   Han H, 2008, J APPL PHYS, V103, DOI 10.1063/1.2829788
   Heavens O. S., 1970, THIN FILM PHYS
   Indluru A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3153977
   Jenkins F. A., 1957, FUNDAMENTALS OPTICS
   Liu SW, 2016, ORG ELECTRON, V31, P240, DOI 10.1016/j.orgel.2016.01.035
   Manickathai K, 2008, INDIAN J PURE AP PHY, V46, P561
   Mohamed SH, 2008, J PHYS CHEM SOLIDS, V69, P2378, DOI 10.1016/j.jpcs.2008.03.019
   Mouchaal Y, 2015, VACUUM, V111, P32, DOI 10.1016/j.vacuum.2014.09.013
   Nichelatti E, 2009, J NON-CRYST SOLIDS, V355, P1115, DOI 10.1016/j.jnoncrysol.2008.11.040
   Riaz U, 2015, MATER RES BULL, V71, P75, DOI 10.1016/j.materresbull.2015.06.035
   Sahu DR, 2006, APPL SURF SCI, V253, P827, DOI 10.1016/j.apsusc.2006.01.023
   Sankarasubramanian K, 2015, MAT SCI SEMICON PROC, V40, P879, DOI 10.1016/j.mssp.2015.07.090
   Seo I, 2015, J KOREAN PHYS SOC, V66, P790, DOI 10.3938/jkps.66.790
   Sharma V, 2016, NUCL INSTRUM METH B, V379, P141, DOI 10.1016/j.nimb.2016.04.059
   Srikant V, 1997, J APPL PHYS, V81, P6357, DOI 10.1063/1.364393
   Tauc J., 1974, AMORPHOUS LIQUID SEM
   Tauc J., 1972, OPTICAL PROPERTIES S
   Terasako T, 2014, THIN SOLID FILMS, V572, P20, DOI 10.1016/j.tsf.2014.07.061
   Thambidurai M, 2015, SUPERLATTICE MICROST, V86, P559, DOI 10.1016/j.spmi.2015.08.020
   Tsai MY, 2016, THIN SOLID FILMS, V605, P186, DOI 10.1016/j.tsf.2015.09.022
   Wang FH, 2016, APPL SURF SCI, V370, P83, DOI 10.1016/j.apsusc.2016.02.161
   Yoshino Y, 2000, VACUUM, V59, P403, DOI 10.1016/S0042-207X(00)00294-3
   Yu SH, 2014, THIN SOLID FILMS, V562, P501, DOI 10.1016/j.tsf.2014.04.064
   Zaien M, 2013, MATER LETT, V105, P84, DOI 10.1016/j.matlet.2013.04.070
   Zhao ZM, 2015, J ALLOY COMPD, V652, P307, DOI 10.1016/j.jallcom.2015.08.117
   Zhu YK, 2013, APPL SURF SCI, V265, P738, DOI 10.1016/j.apsusc.2012.11.096
NR 39
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JUN
PY 2017
VL 123
IS 6
AR 441
DI 10.1007/s00339-017-1050-y
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EX1KO
UT WOS:000402981700032
OA No
DA 2017-08-17
ER

PT J
AU Shaaban, KS
   Abo-naf, SM
   Elnaeim, AMA
   Hassouna, MEM
AF Shaaban, Kh. S.
   Abo-naf, S. M.
   Abd Elnaeim, A. M.
   Hassouna, M. E. M.
TI Studying effect of MoO3 on elastic and crystallization behavior of
   lithium diborate glasses
SO APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING
LA English
DT Article
ID SODIUM-BORATE GLASSES; NA2O-B2O3-BI2O3-MOO3 GLASSES; SPECTROSCOPIC
   PROPERTIES; OPTICAL-PROPERTIES; SPECTRA; SYSTEM; TEMPERATURE; ENERGIES;
   OXIDE; RAMAN
AB The effect of MoO3 addition on the crystallization characteristics of 2Al(2)O(3)-23Li(2)O-(75 - x) B2O3 glass (where x MoO3 = 0, 10, 20, and 40 mol %) has been investigated. The compositional dependence of the glass transition (T-g), and crystallization (T-c) temperatures was determined by the differential thermal analysis (DTA). It was found that both the T-g and T-c decrease with increasing MoO3 content. The amorphous nature of the as-quenched glass and crystallinity of the produced glass-ceramics were confirmed by X-ray powder diffraction (XRD) analysis. Glass-ceramics embedded with diomignite (lithium diborate, Li2B4O7) were produced from all investigated glasses by heat-treating the as-quenched glasses at the appropriate temperatures obtained from the DTA traces. Addition of MoO3 to the glass composition at 10% MoO3, causes the formation of lithium molybdenum oxide (Li4MoO5) crystalline phase in addition to the diomignite phase. Increasing MoO3 content to 20% causes a phase transformation of lithium molybdenum oxide from the (Li4MoO5) to the (Li2MoO4) phase and the formation of another lithium borate (Li4B2O5) phase in addition to the diomignite. Further increase of MoO3 content to 40% results in another phase transformation to the lithium aluminum molybdenum oxide [LiAl(MoO4)(2)], and, in this case, the molybdenum content was excess enough to crystallize the molybdate (MoO3) itself. Scanning electron microscopy (SEM) was used to characterize the morphology and microstructure of the formed solid solution phases. The values of the T-g decrease with increasing the MoO3 content. The ultrasonic wave velocities and elastic moduli were determined using the pulse-echo method. Both velocities (v(L) and v(T)) were increased as the MoO3 content, this increase can be attributed to the higher bond strength of Mo-O (607 kJ mol(-1)) than that of B-O (392 kJ mol(-1)).
C1 [Shaaban, Kh. S.; Abd Elnaeim, A. M.] El Azhar Univ, Fac Sci, Phys Dept, Assiut 71524, Egypt.
   [Abo-naf, S. M.] Natl Res Ctr, Glass Res Dept, El Behoos Str, Cairo 12622, Egypt.
   [Hassouna, M. E. M.] Beni Suef Univ, Chem Dept, Fac Sci, Bani Suwayf, Egypt.
RP Shaaban, KS (reprint author), El Azhar Univ, Fac Sci, Phys Dept, Assiut 71524, Egypt.
EM khamies1078@yahoo.com
CR Baccaro S, 2007, NUCL INSTRUM METH B, V260, P613, DOI 10.1016/j.nimb.2007.04.214
   BENSON SW, 1965, J CHEM EDUC, V42, P502
   Doweidar H, 2013, VIB SPECTROSC, V68, P91, DOI 10.1016/j.vibspec.2013.05.015
   DOWEIDAR H, 1990, J MATER SCI, V25, P253, DOI 10.1007/BF00544216
   Gaafar MS, 2009, PHYSICA B, V404, P1668, DOI 10.1016/j.physb.2009.01.045
   Halimah MK, 2014, SAINS MALAYS, V43, P899
   Hwa LG, 1998, J NON-CRYST SOLIDS, V238, P193, DOI 10.1016/S0022-3093(98)00688-7
   IORDANOVA R, 1994, J NON-CRYST SOLIDS, V180, P58, DOI 10.1016/0022-3093(94)90397-2
   KAMITSOS EI, 1987, J PHYS CHEM-US, V91, P1073, DOI 10.1021/j100289a014
   KAMITSOS EI, 1990, J NON-CRYST SOLIDS, V126, P52, DOI 10.1016/0022-3093(90)91023-K
   Kashif I, 2008, J ALLOY COMPD, V450, P352, DOI 10.1016/j.jallcom.2006.10.149
   KERR JA, 1966, CHEM REV, V66, P465, DOI 10.1021/cr60243a001
   KODAMA M, 1991, J MATER SCI, V26, P4048
   Lara C, 2004, J NON-CRYST SOLIDS, V348, P149, DOI 10.1016/j.jnoncrysol.2004.08.140
   Moustafa YM, 1996, J NON-CRYST SOLIDS, V194, P34, DOI 10.1016/0022-3093(95)00465-3
   Pal M., 2011, J MODERN PHYS, V2, P1062
   Rada S, 2009, J MOL STRUCT, V924, P89, DOI 10.1016/j.molstruc.2008.12.032
   Rao LS, 2009, SOLID STATE SCI, V11, P578, DOI 10.1016/j.solidstatesciences.2008.06.022
   Reddy MS, 2007, J ALLOY COMPD, V438, P41, DOI 10.1016/j.jallcom.2006.08.054
   Saad M., 1987, J MAT SCI FORUM, V19, P8
   Saddeek YB, 2007, J PHYS D APPL PHYS, V40, P4674, DOI 10.1088/0022-3727/40/15/048
   Saddeek YB, 2010, PHYSICA B, V405, P2407, DOI 10.1016/j.physb.2010.02.055
   Saddeek YB, 2010, J ALLOY COMPD, V494, P210, DOI 10.1016/j.jallcom.2009.11.123
   Gowda VCV, 2007, J NON-CRYST SOLIDS, V353, P1150, DOI 10.1016/j.jnoncrysol.2006.12.117
   Wang J. S., 1994, Optical Materials, V3, P187, DOI 10.1016/0925-3467(94)90004-3
   Wen G, 2007, ACTA MATER, V55, P3583, DOI 10.1016/j.actamat.2007.02.009
   WHATMORE RW, 1981, ELECTRON LETT, V17, P11, DOI 10.1049/el:19810009
NR 27
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-8396
EI 1432-0630
J9 APPL PHYS A-MATER
JI Appl. Phys. A-Mater. Sci. Process.
PD JUN
PY 2017
VL 123
IS 6
AR 457
DI 10.1007/s00339-017-1052-9
PG 9
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EX1KO
UT WOS:000402981700048
OA No
DA 2017-08-17
ER

PT J
AU Lotfy, K
AF Lotfy, Kh.
TI A novel solution of fractional order heat equation for photothermal
   waves in a semiconductor medium with a spherical cavity
SO CHAOS SOLITONS & FRACTALS
LA English
DT Article
DE Photothermal; Fractional order; Thermoelasticity; Spherical cavity;
   Elastic waves
ID THERMOELASTICITY; FREQUENCY; MECHANISM; MEMORY; MODEL
AB In this paper, we consider a one dimensional problem of waves in a thermoelastic infinite medium with a spherical cavity. We are concerned with the study a new model of fractional order heat conduction law for a spherical cavity of a semiconductor medium. The governing equations are solved under the effect of the theory of coupled plasma, elastic, thermal waves through a photothermal process. The inner surface of the cavity is taken traction free with thermal shock. Time-dependence is removed by Laplace transform technique to governing equations. This method has been used to get the exact expression of some physical quantities, thermal activation coupling parameters and illustrated graphically. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Lotfy, Kh.] Zagazig Univ, Fac Sci, Dept Math, POB 44519, Zagazig, Egypt.
RP Lotfy, K (reprint author), Zagazig Univ, Fac Sci, Dept Math, POB 44519, Zagazig, Egypt.
EM Khlotfy_1@yahoo.com
CR Abd-Alla Abdelmooty M., 2017, Archives of Civil and Mechanical Engineering, V17, P564, DOI 10.1016/j.acme.2016.10.012
   Abo-Dahab S, 2016, WAVES RANDOM COMPLEX
   BIOT MA, 1956, J APPL PHYS, V27, P240, DOI 10.1063/1.1722351
   CAPUTO M, 1971, PURE APPL GEOPHYS, V91, P134, DOI 10.1007/BF00879562
   Caputo M., 1971, Rivista del Nuovo Cimento, V1, P161, DOI 10.1007/BF02820620
   CAPUTO M, 1974, J ACOUST SOC AM, V56, P897, DOI 10.1121/1.1903344
   Chandrasekharaiah D. S., 1986, APPL MECH REV, V39, P355, DOI DOI 10.1115/1.3143705
   Chandrasekharaiah D. S., 1998, APPL MECH REV, V51, P705, DOI DOI 10.1115/1.3098984
   Christofides C, 2002, J APPL PHYS, V92, P1280, DOI 10.1063/1.1484232
   Ezzat MA, 2011, APPL MATH MODEL, V35, P4965, DOI 10.1016/j.apm.2011.04.004
   Ezzat MA, 2011, CAN J PHYS, V89, P311, DOI 10.1139/P11-022
   Ezzat MA, 2011, EUR J MECH A-SOLID, V30, P491, DOI 10.1016/j.euromechsol.2011.02.004
   GORDON JP, 1964, B AM PHYS SOC, V9, P501, DOI DOI 10.1063/1.1713919
   Green AE, 1972, THERMOELASTICITY J E, V2
   Hamza F, 2016, MECH ADV MATER STRUC, V23, P689, DOI 10.1080/15376494.2015.1029158
   Hobiny AD, 2017, MECH TIME-DEPEND MAT, V21, P61, DOI 10.1007/s11043-016-9318-8
   HONIG G, 1984, J COMPUT APPL MATH, V10, P113, DOI 10.1016/0377-0427(84)90075-X
   KREUZER LB, 1971, J APPL PHYS, V42, P2934, DOI 10.1063/1.1660651
   Lord H, 1967, J MECH PHYS SOLIDS, V15
   Lotfy Kh, 2017, MECH TIME-DEPEND MAT, DOI [10.1007/s11043-017-9340-5, DOI 10.1007/S11043-017-9340-5.]
   Lotfy K, 2016, CAN J PHYS, V94, P400, DOI 10.1139/cjp-2015-0782
   Lotfy Kh, 2015, J COMPUT THEOR NANOS, V12, P1869
   Mainardi F., 1998, TRANSFORM METHODS SP, P309
   Mandelis A, 1997, OPT ENG, V36, P459, DOI 10.1117/1.601217
   Othman MIA, 2010, INT COMMUN HEAT MASS, V37, P192, DOI 10.1016/j.icheatmasstransfer.2009.09.017
   Povstenko YZ, 2005, J THERM STRESSES, V28, P83, DOI 10.1080/014957390523741
   Rabotnov Yu. N., 1966, CREEP STRUCTURAL ELE
   Sharma JN, 2003, J THERM STRESS, V26
   Song YQ, 2012, ACTA MECH, V223, P1545, DOI 10.1007/s00707-012-0677-1
   Song YQ, 2010, INT J SOLIDS STRUCT, V47, P1871, DOI 10.1016/j.ijsolstr.2010.03.020
   TAM AC, 1986, REV MOD PHYS, V58, P381, DOI 10.1103/RevModPhys.58.381
   Tam A. C., 1983, ULTRASENSITIVE SPECT, P1
   Tam A. C., 1989, PHOTOTHERMAL INVESTI, P1
   Todorovic DM, 2003, REV SCI INSTRUM, V74, P582, DOI 10.1063/1.1523133
   Todorovic DM, 1999, J APPL PHYS, V85, P7716, DOI 10.1063/1.370576
   VASILEV AN, 1984, SOV PHYS SEMICOND+, V18, P1095
NR 36
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0779
EI 1873-2887
J9 CHAOS SOLITON FRACT
JI Chaos Solitons Fractals
PD JUN
PY 2017
VL 99
BP 233
EP 242
DI 10.1016/j.chaos.2017.04.017
PG 10
WC Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary;
   Physics, Mathematical
SC Mathematics; Physics
GA EX0XY
UT WOS:000402945300031
OA No
DA 2017-08-17
ER

PT J
AU Basta, AH
   El-Saied, H
   Baraka, AM
   Lotfy, VF
AF Basta, Altaf H.
   El-Saied, Houssni
   Baraka, Amin M.
   Lotfy, Vivian F.
TI Performance of Carbon Xerogels in the Production of Environmentally
   Friendly Urea Formaldehyde-Bagasse Composites
SO CLEAN-SOIL AIR WATER
LA English
DT Article
DE Aliphatic aldehyde-carbon xerogels; Formaldehyde scavengers; High
   performance agro-composites; Kinetics; UF adhesive systems
ID WOOD COMPOSITES; LIGNOCELLULOSIC COMPOSITES; GRAFT-COPOLYMERIZATION;
   RICE STRAW; MOLE RATIO; PART II; POLYMERS; BEHAVIOR; FIBERS;
   PARTICLEBOARD
AB This work deals with evaluating the ability of new synthesized xerogel-based activated carbons (XACs) to provide a low toxic urea-formaldehyde adhesive system, as well as good quality bagasse-composites. The xerogels were synthesized from resorcinol and different chain length aliphatic aldehydes. A preliminarily study was carried out to evaluate the adsorption capacity of formaldehyde by these investigated XACs. Differential scanning calorimetry, non-isothermal thermogravimetric analysis, infrared spectra, gel time, and bond strength tests were carried out to evaluate the performance of XAC-UF adhesive systems, in comparison with commercial UF. The modulus of rupture, modulus of elasticity, internal bond strength, thickness swelling, and free-HCHO of board were also examined to evaluate the quality of final bagasse-composites. The results show that, the investigated XACs had a positive effect on the adsorption of formaldehyde. The HCHO-adsorption capacities of XACs ranged from 111 to 200 mg/g XAC. However, butyraldehyde-based XAC had higher formaldehyde adsorption capacity. Moreover, XACs led to an increase in thermal stability of the UF adhesive system and improved properties of the resulted bagasse composite. Greater improvement was noticed by applying butyraldehyde-based XAC-UF adhesive system. Its MOR (26.6 MPa) and MOE (4082 MPa) that exceeded the ANSI standard requirements for wood particleboard of class H-3; while, its IB value (0.44 MPa) exceeded the M-2 grade. Applying the butyraldehyde-based XAC adhesive system also led to reduction of the free-HCHO of the produced bagasse composite by approximately 38%.
C1 [Basta, Altaf H.; El-Saied, Houssni; Lotfy, Vivian F.] Natl Res Ctr, Cellulose & Paper Dept, El Buhous St, Cairo 12622, Egypt.
   [Baraka, Amin M.] Cairo Univ, Chem Dept, Fac Sci, Cairo, Egypt.
RP Basta, AH (reprint author), Natl Res Ctr, Cellulose & Paper Dept, El Buhous St, Cairo 12622, Egypt.
EM altaf_basta2004@yahoo.com
CR [Anonymous], 1999, A2081 ANSI COMP PAN
   [Anonymous], 1999, D247199 ASTM
   [Anonymous], 2011, D90698 ASTM
   [Anonymous], 2006, ASTMD103706A
   Basta AH, 2016, SOFT MATER, V14, P297, DOI 10.1080/1539445X.2016.1212065
   Basta AH, 2011, BIOMASS BIOENERG, V35, P1954, DOI 10.1016/j.biombioe.2011.01.043
   Basta AH, 2005, PIGM RESIN TECHNOL, V34, P12, DOI 10.1108/03699420510572557
   Basta AH, 2008, CARBOHYD POLYM, V74, P301, DOI 10.1016/j.carbpol.2008.02.021
   Basta AH, 2006, DES MONOMERS POLYM, V9, P325, DOI 10.1163/156855506777952138
   Basta AH, 2014, RSC ADV, V4, P21794, DOI 10.1039/c4ra00858h
   Basta AH, 2013, PIGM RESIN TECHNOL, V42, P24, DOI 10.1108/03699421311288733
   Basta AH, 2011, J POLYM ENVIRON, V19, P405, DOI 10.1007/s10924-011-0286-4
   Bueso J. G., 2000, HOLZ ALS ROH UND WER, V58, P9
   Bulota M., 2012, THESIS
   Cai ZY, 2004, FOREST PROD J, V54, P226
   Chow P, 1996, FOREST PROD J, V46, P62
   Christjanson P, 2006, P EST ACAD SCI, V55, P212
   COATS AW, 1964, NATURE, V201, P68, DOI 10.1038/201068a0
   Darmawan S., 2010, J FOR RES, V7, P100
   Dziurka D., 2014, FOR WOOD TECHNOL, V85, P53
   El-Saied H, 2007, POLYM-PLAST TECHNOL, V46, P327, DOI 10.1080/03602550601155906
   El-Saied H, 2012, J POLYM ENVIRON, V20, P838, DOI 10.1007/s10924-012-0439-0
   Formaldehyde, 2011, REP CARC, P195
   HE ZK, 2013, J HEAT MASS TRANSFER, V49, P879, DOI DOI 10.1007/S00231-013-1135-X
   Ho Y. S., 1998, J CHEM ENG, V70, P115, DOI DOI 10.1016/S0923-0467(98)00076-1
   Khan TA, 2013, BIORESOURCES, V8, P4171
   Kumar A, 2015, HOLZFORSCHUNG, V69, P199, DOI 10.1515/hf-2014-0038
   Kumar A, 2013, BIORESOURCES, V8, P6231
   Kumar A, 2013, INT J ADHES ADHES, V46, P34, DOI 10.1016/j.ijadhadh.2013.05.017
   Lagergren S., 1898, KUNGLIGA SVENSKA VET, V4, P1
   Levdik I., 1967, VSES NAUCH ISSLED IR, V52, P109
   Li XJ, 2011, IND CROP PROD, V33, P665, DOI 10.1016/j.indcrop.2011.01.004
   Liu Y, 2014, CONSTR BUILD MATER, V66, P132, DOI 10.1016/j.conbuildmat.2014.05.088
   Ma CJ, 2011, CARBON, V49, P2873, DOI 10.1016/j.carbon.2011.02.058
   MANSOUR OY, 1991, J APPL POLYM SCI, V43, P1147, DOI 10.1002/app.1991.070430615
   Mao A, 2013, BIORESOURCES, V8, P2453
   MYERS GE, 1984, FOREST PROD J, V34, P35
   Nabil FL, 2016, SAINS MALAYS, V45, P255
   Nelson M. L., 1964, J APPL POLYM SCI, V8, P1325, DOI DOI 10.1002/APP.1964.070080323
   Pisal A., 2009, DETERMINATION FORMAL
   ROFFAEL E, 1980, HOLZ ROH WERKST, V38, P85, DOI 10.1007/BF02607519
   Rong H., 2003, COLLOIDAL INTERFACE, V216, P207
   Rong HQ, 2002, CARBON, V40, P2291, DOI 10.1016/S0008-6223(02)00109-4
   Shiratori N., 2007, P INT C CARB CARB 20
   Taghiyari HR, 2015, J FORESTRY RES, V26, P495, DOI 10.1007/s11676-015-0033-0
   Thakur VK, 2012, INT J POLYM ANAL CH, V17, P133, DOI 10.1080/1023666X.2012.640455
   Thakur VK, 2012, INT J POLYM ANAL CH, V17, P48, DOI 10.1080/1023666X.2012.638470
   Thakur VK, 2012, J POLYM ENVIRON, V20, P164, DOI 10.1007/s10924-011-0372-7
   Thakur VK, 2014, CARBOHYD POLYM, V104, P87, DOI 10.1016/j.carbpol.2014.01.016
   US EPA, 2002, WOOD PROD IND PART S, VI
   Walker J. F., 1964, FORMALDEHYDE, P96
   [International Agency for Research on Cancer World Health Organization], 2004, IARC CLASS FORM CARC
   Zhang H, 2013, J ADHES SCI TECHNOL, V27, P1023, DOI 10.1080/01694243.2012.727173
   Zhang JZ, 2013, BIORESOURCES, V8, P5500
   Zhang YH, 2011, BIORESOURCES, V6, P464
NR 55
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1863-0650
EI 1863-0669
J9 CLEAN-SOIL AIR WATER
JI Clean-Soil Air Water
PD JUN
PY 2017
VL 45
IS 6
AR 1600524
DI 10.1002/clen.201600524
PG 9
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Environmental Sciences; Marine
   & Freshwater Biology; Water Resources
SC Science & Technology - Other Topics; Environmental Sciences & Ecology;
   Marine & Freshwater Biology; Water Resources
GA EX1TC
UT WOS:000403008100003
OA No
DA 2017-08-17
ER

PT J
AU Osman, W
   Shonouda, M
AF Osman, Wafaa
   Shonouda, Mourad
TI X-ray metal assessment and ovarian ultrastructure alterations of the
   beetle, Blaps polycresta (Coleoptera, Tenebrionidae), inhabiting
   polluted soil
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Biomonitor; Beetle ovary; Heavy metals; Cadmium; Soil pollution;
   Ultrastructure alterations; X-ray analysis
ID HEAVY-METALS; OXIDATIVE STRESS; CADMIUM; TISSUE; CELLS; BIOACCUMULATION;
   INVERTEBRATES; CONTAMINATION; LOCALIZATION; BIOMONITORS
AB X-ray analysis was applied to estimate the percentages of heavy metals in ovarian tissues of the tenebrionid beetle, Blaps polycresta. Calcium, phosphorus, sulfur, cadmium, copper, and zinc were the most common detected metals in ovaries of insects collected from reference and polluted sites. Only cadmium showed significantly higher percentages in the polluted ovaries compared with the reference ones. Ultrastructure investigation revealed severe alterations in polluted ovaries both in the tropharium and in the vitellarium. Contraction of nuclear membrane of trophocytes was observed; therefore, cavities and spaces appeared in the cytoplasm followed by nuclear pyknosis. In the vitellarium, fragmentation of chromatin materials in nuclei of the follicular cells was detected. The cytoplasm was poor in the rough endoplasmic reticulum and mitochondria. Damage of yolk bodies occurred in addition to break off in the layer of microvilli. Accumulation of electron-dense vesicles and multivesicular bodies were observed in both reference and polluted ovaries. These alterations in ovarian ultrastructure of B. polycresta show the severe impact of cadmium pollution on cell organelles of insects and could be used as an interesting tool for monitoring heavy metals inside the body organs due to soil pollution.
C1 [Osman, Wafaa; Shonouda, Mourad] Alexandria Univ, Dept Zool, Fac Sci, Alexandria, Egypt.
RP Osman, W (reprint author), Alexandria Univ, Dept Zool, Fac Sci, Alexandria, Egypt.
EM wa.osman@gmail.com
CR Akpoveta O. V., 2010, Journal of Applied Sciences and Environmental Management, V14, P57
   Al-Dhafar Z. M., 2012, Journal of Agricultural Science and Technology A, V2, P888
   ANDERSON LM, 1971, J CELL SCI, V8, P735
   Avgin S.S., 2000, MUN ENTOMOL ZOOL, V5, P209
   Ballan-Dufrancais CN, 2002, MICROSC RES TECHNIQ, V56, P403, DOI 10.1002/jemt.10041
   Bednarska AJ, 2013, ECOTOXICOLOGY, V22, P118, DOI 10.1007/s10646-012-1008-y
   Bischof C, 1995, COMP BIOCH PHYSL C, V77C, P279
   Braeckman B, 1999, TISSUE CELL, V31, P45, DOI 10.1054/tice.1998.0019
   Braeckman B, 1999, TISSUE CELL, V31, P223
   Buening Juergen, 2006, Arthropod Systematics & Phylogeny, V64, P115
   BUNING J, 1979, ZOOMORPHOLOGIE, V93, P33, DOI 10.1007/BF02568673
   Buning J, 1994, INSECT OVARY ULTRAST, P31
   Butovsky RO, 2011, ZOOKEYS, P215, DOI 10.3897/zookeys.100.1529
   Cervera A, 2004, J INSECT PHYSIOL, V50, P737, DOI 10.1016/j.jinsphys.2004.06.001
   Czarniewska E, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-4
   Ehrampoush MH, 2015, J ENVIRON HEALTH SCI, V13, DOI 10.1186/s40201-015-0237-4
   El-Samad L. M., 2015, J ADV BIOL, V7, P1153
   Emerald DM, 2012, INT J RECENT SCI RES, V3, P791
   Fontanetti CS, 2010, MICROSCOPY SCI TECHN, P1001
   Ghannem S, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5373-3
   Heikens A, 2001, ENVIRON POLLUT, V113, P385, DOI 10.1016/S0269-7491(00)00179-2
   Hopkin SP, 2002, ENCY SOIL SCI, P207
   Hopkin SP, 1989, ECOPHYSIOLOGY METALS
   Introna F, 2001, FORENSIC SCI INT, V120, P42, DOI 10.1016/S0379-0738(01)00418-2
   Jelaska LS, 2007, ECOTOX ENVIRON SAFE, V66, P74, DOI 10.1016/j.ecoenv.2005.10.017
   Kamel Kamal E., 2005, Journal of the Egyptian German Society of Zoology, V47, P87
   Khan FR, 2012, J EXP BIOL, V215, P822, DOI 10.1242/jeb.062505
   King R.C., 1985, P37
   LASKOWSKI R, 1991, OIKOS, V60, P387, DOI 10.2307/3545083
   Lauverjat S., 1989, Biology of Metals, V2, P97, DOI 10.1007/BF01129208
   Lim PE, 2003, WATER SCI TECHNOL, V48, P307
   Lin CC, 2005, J HAZARD MATER, V122, P7, DOI 10.1016/j.jhazmat.2005.02.017
   Lynch J. M., 1997, P79
   Malik A, 2004, ENVIRON INT, V30, P261, DOI 10.1016/j.envint.2003.08.001
   Markov G, 2016, B ENVIRON CONTAM TOX, V96, P458, DOI 10.1007/s00128-016-1754-2
   McMurray CT, 2003, NAT GENET, V34, P239, DOI 10.1038/ng0703-239
   Mhatre G. N., 1997, P349
   Mircic D, 2010, ARCH BIOL SCI, V62, P1013, DOI 10.2298/ABS1004013M
   Mohapatra AK, 2007, ASIAN J EXP SCI, V21, P79
   MORGAN JE, 1993, ENVIRON POLLUT, V82, P1, DOI 10.1016/0269-7491(93)90155-H
   Niu C, 2002, INSECT SCI, V9, P27
   Oriel J, 1995, B ENVIRON CONTAM TOX, V55, P216
   Osman W, 2015, ENVIRON SCI POLLUT R, V22, P14104, DOI 10.1007/s11356-015-4606-4
   Patricio Karina, 2007, Brazilian Journal of Morphological Sciences, V24, P25
   RAY A, 1979, INT J INSECT MORPHOL, V8, P113, DOI 10.1016/0020-7322(79)90010-2
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Royle UN, 1998, WATER AIR SOIL POLL, V106, P171
   Scheifler R, 2002, CHEMOSPHERE, V48, P571, DOI 10.1016/S0045-6535(02)00116-9
   Shonouda Mourad L., 2016, Journal of Entomology, V13, P122, DOI 10.3923/je.2016.122.131
   Skalski Tomasz, 2011, Baltic Journal of Coleopterology, V11, P1
   Sorour J, 2001, ECOTOX ENVIRON SAFE, V48, P268, DOI 10.1006/eesa.2000.2003
   SPOSITO G, 1984, MET IONS BIOL SYST, V18, P287
   Sreelatha K.B., 2010, Journal of Biopesticides, V3, P253
   Stewart AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027578
   Sun Hong-Xia, 2007, Acta Entomologica Sinica, V50, P178
   Szklarzewicz T, 2000, ACTA ZOOL-STOCKHOLM, V81, P307, DOI 10.1046/j.1463-6395.2000.00061.x
   Tchounwon P.B., 2012, MOL CLIN ENV TOXICOL, P133, DOI DOI 10.1007/978-3-7643-8340-4
   Telfer W.H., 1982, P118
   van Straalen NM, 2001, PEDOBIOLOGIA, V45, P451, DOI 10.1078/0031-4056-00099
   Wan TL, 2014, ENVIRON ENTOMOL, V43, P654, DOI 10.1603/EN13026
   White PA, 2004, MUTAT RES-REV MUTAT, V567, P227, DOI 10.1016/j.mrrev.2004.09.03
   Wittig R., 1993, Plants as biomonitors: indicators for heavy metals in the terrestrial environment., P3
   Xie GQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087639
   ZAMAN K, 1995, ARCH INSECT BIOCHEM, V29, P199, DOI 10.1002/arch.940290209
   Zhang YM, 2001, ITAL J ZOOL, V68, P137
NR 65
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD JUN
PY 2017
VL 24
IS 17
BP 14867
EP 14876
DI 10.1007/s11356-017-9095-1
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EX1PS
UT WOS:000402997700028
PM 28477258
OA No
DA 2017-08-17
ER

PT J
AU El-Bahrawy, H
   Hegazy, S
   Farrag, W
   Werida, R
AF El-Bahrawy, Hoda
   Hegazy, Sahar
   Farrag, Wael
   Werida, Rehab
TI Targeting inflammation using celecoxib with glimepiride in the treatment
   of obese type 2 diabetic Egyptian patients
SO INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES
LA English
DT Article
DE Visfatin; Celecoxib; Adiponectin; Leptin; T2DM; Obesity
ID MUSCULAR INSULIN-RESISTANCE; OXIDATIVE STRESS; CELL-FUNCTION; FED RATS;
   ASSOCIATION; MECHANISMS; INHIBITORS; PLASMA; FAT
AB Obesity, insulin resistance (IR), inflammation, and progressive decline in pancreatic beta cell function are major features of type 2 diabetes mellitus (T2DM). We aimed to investigate the effect of co-administration of celecoxib (CE) with glimepiride (GL) in the treatment of obese T2DM patients. Body Mass Index (BMI), serum glucose, C-peptide, lipid profile, adiponectin, tumor necrosis factor-alpha (TNF-alpha), visfatin, and leptin levels were determined in 40 obese T2DM patients before and after treatment with GL alone or in combination with a selective cyclooxygenase-2 (COX-2) inhibitor CE for 3 months. Homeostasis model assessment of insulin resistance (HOMA2-IR) and atherogenic index (AI) was calculated. Increased levels of serum glucose, C-peptide, total cholesterol (TCH), low-density lipoprotein (LDL-C), triglycerides (TGs), visfatin, TNF-alpha, leptin, AI, and HOMA2-IR shown in obese diabetic patients were significantly decreased after co-treatment with GL plus CE compared to patients who received GL alone. On the other hand, adiponectin levels showed a significant increase after treatment. The obtained results demonstrate that targeting inflammation using celecoxib with glimepiride improves insulin resistance, glycemia, and inflammatory process in obese type 2 diabetics.
C1 [El-Bahrawy, Hoda] Tanta Univ, Biochem Dept, Fac Pharm, El Gharbia, Egypt.
   [Hegazy, Sahar] Tanta Univ, Clin Pharm Dept, Fac Pharm, El Gharbia, Egypt.
   [Farrag, Wael] Tanta Univ, Internal Med Dept, Fac Med, El Gharbia, Egypt.
   [Werida, Rehab] Tanta Univ, Drug Informat Ctr, Fac Pharm, El Gharbia 31527, Egypt.
RP Werida, R (reprint author), Tanta Univ, Drug Informat Ctr, Fac Pharm, El Gharbia 31527, Egypt.
EM Rehab_werida@hotmail.com
CR ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Alpert E, 2007, BIOCHEM PHARMACOL, V73, P368, DOI 10.1016/j.bcp.2006.10.008
   Aroor A, 2013, CARDIORENAL MED, V3, P48, DOI 10.1159/000348756
   AUBREELECAT A, 1989, ANAL BIOCHEM, V178, P427, DOI 10.1016/0003-2697(89)90665-9
   BROUCKAERT P, 1993, IMMUNOBIOLOGY, V187, P317
   BUCOLO G, 1973, CLIN CHEM, V19, P476
   Cernea S, 2013, BIOCHEM MEDICA, V23, P266
   Coll T, 2010, ENDOCRINOLOGY, V151, P537, DOI 10.1210/en.2009-0874
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Gokalp D, 2008, DIAB METAB SYNDR CLI, V2, P253, DOI DOI 10.1016/J.DSX.2008.07.001
   GONEN B, 1978, DIABETOLOGIA, V15, P1, DOI 10.1007/BF01219319
   Helmersson J, 2004, CIRCULATION, V109, P1729, DOI 10.1161/01.CIR.0000124718.99562.91
   Hermans MP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-132
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hsieh PS, 2008, EUR J CLIN INVEST, V38, P812, DOI 10.1111/j.1365-2362.2008.02026.x
   Hsieh PS, 2009, OBESITY, V17, P1150, DOI 10.1038/oby.2008.674
   Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113
   Jeusette IC, 2005, AM J VET RES, V66, P81, DOI 10.2460/ajvr.2005.66.81
   Kim MK, 2006, J MOL BIOL, V362, P66, DOI 10.1016/j.jmb.2006.06.082
   Konheim YL, 2003, HUM GENET, V113, P377, DOI 10.1007/s00439-003-1000-y
   Liu TT, 2009, CHINESE J PHYSIOL, V52, P65, DOI 10.4077/CJP.2009.AMH034
   Matsuda M, 2014, REV ENDOCR METAB DIS, V15, P1, DOI 10.1007/s11154-013-9271-7
   Perucca E, 1993, Drugs, V46 Suppl 1, P79
   Raucci R, 2013, CYTOKINE, V61, P1, DOI 10.1016/j.cyto.2012.08.036
   Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069
   Sone H, 2001, ANN INTERN MED, V134, P344
   Tian YF, 2011, LIFE SCI, V89, P107, DOI 10.1016/j.lfs.2011.05.006
   Tsao TS, 2002, EUR J PHARMACOL, V440, P213, DOI 10.1016/S0014-2999(02)01430-9
   TURKINGTON RW, 1982, ARCH INTERN MED, V142, P1102
   Uslu S, 2012, EXP THER MED, V4, P113, DOI 10.3892/etm.2012.557
   Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wiesner G, 1999, J CLIN ENDOCR METAB, V84, P2270, DOI 10.1210/jc.84.7.2270
   Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6
NR 34
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0973-3930
EI 1998-3832
J9 INT J DIABETES DEV C
JI Int. Diabetes Dev. Ctries.
PD JUN
PY 2017
VL 37
IS 2
BP 97
EP 102
DI 10.1007/s13410-015-0355-7
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EX1NX
UT WOS:000402992200002
OA No
DA 2017-08-17
ER

PT J
AU Mansour, ZSI
AF Mansour, Zeinab S. I.
TI On fractional q-Sturm-Liouville problems
SO JOURNAL OF FIXED POINT THEORY AND APPLICATIONS
LA English
DT Article
DE Left- and right-sided Riemann-Liouville and Caputo q-derivatives;
   eigenvalues and eigenfunctions; existence and uniqueness theorem; q,
   alpha Wronskian
ID SAMPLING THEORY; INTEGRALS
AB In this paper, we formulate a regular q-fractional Sturm-Liouville problem (qFSLP) which includes the left-sided Riemann-Liouville and the right-sided Caputo q-fractional derivatives of the same order , . The properties of the eigenvalues and the eigenfunctions are investigated. A q-fractional version of the Wronskian is defined and its relation to the simplicity of the eigenfunctions is verified. We use a fixed point theorem to introduce a sufficient condition on eigenvalues for the existence and uniqueness of the associated eigenfunctions when . These results are a generalization of the integer regular q-Sturm-Liouville problem introduced by Annaby and Mansour (J Phys A Math Gen 39:8747, 2005). An example for a qFSLP whose eigenfunctions are little q-Jacobi polynomials is introduced.
C1 [Mansour, Zeinab S. I.] King Saud Univ, Fac Sci, Dept Math, Riyadh, Saudi Arabia.
   [Mansour, Zeinab S. I.] Cairo Univ, Fac Sci, Dept Math, Giza, Egypt.
RP Mansour, ZSI (reprint author), King Saud Univ, Fac Sci, Dept Math, Riyadh, Saudi Arabia.; Mansour, ZSI (reprint author), Cairo Univ, Fac Sci, Dept Math, Giza, Egypt.
EM zsmansour@ksu.edu.sa
FU DSFP program of the King Saud University in Riyadh [DSFP/MATH 01]
FX The author thanks the anonymous referee for his(her) careful reading and
   insightful comments and suggestions. The author also thanks Dr. Maryam
   Al-Towailb for her fruitful comments and suggestions after reading the
   manuscript. This research is supported by the DSFP program of the King
   Saud University in Riyadh through grant DSFP/MATH 01.
CR Abreu LD, 2005, J PHYS A-MATH GEN, V38, P10311, DOI 10.1088/0305-4470/38/48/005
   Abreu LD, 2007, J MATH ANAL APPL, V334, P223, DOI 10.1016/j.jmaa.2006.12.050
   AGARWAL RP, 1969, PROC CAMB PHILOS S-M, V66, P365
   Amrein W., 2005, STURM LIOUVILLE THEO
   Annaby M., 2006, J PHYS A, V39, P8747
   Annaby MH, 2007, J COMPUT APPL MATH, V206, P73, DOI 10.1016/j.cam.2006.05.024
   Annaby MH, 2012, NAGOYA MATH J, V205, P67
   Annaby MH, 2012, LECT NOTES MATH, V2056, P1, DOI 10.1007/978-3-642-30898-7
   Ansari A, 2015, INTEGR TRANSF SPEC F, V26, P51, DOI 10.1080/10652469.2014.966102
   Gasper G., 2004, BASIC HYPERGEOMETRIC
   Hajji MA, 2014, J COMPUT PHYS, V272, P550, DOI 10.1016/j.jcp.2014.04.048
   Klimek M, 2013, COMPUT MATH APPL, V66, P795, DOI 10.1016/j.camwa.2012.12.011
   Klimek M, 2014, J MATH ANAL APPL, V416, P402, DOI 10.1016/j.jmaa.2014.02.009
   KOELINK HT, 1994, J MATH ANAL APPL, V186, P690, DOI 10.1006/jmaa.1994.1327
   Lavagno A, 2009, REP MATH PHYS, V64, P79, DOI 10.1016/S0034-4877(09)90021-0
   Mansour ZSI, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-016-0659-7
   Nemri A., 2010, MATEMATICHE, V65, P73
   Rajkovic PM, 2009, ACTA MATH SIN, V25, P1635, DOI 10.1007/s10114-009-8253-x
   Sturm C., 2009, J MATH PURE APPL, V2, P220
   Zayernouri M, 2015, SIAM J SCI COMPUT, V37, pA1777, DOI 10.1137/140985536
   Zayernouri M, 2013, J COMPUT PHYS, V252, P495, DOI 10.1016/j.jcp.2013.06.031
NR 21
TC 2
Z9 2
U1 1
U2 1
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1661-7738
EI 1661-7746
J9 J FIX POINT THEORY A
JI J. Fixed Point Theory Appl.
PD JUN
PY 2017
VL 19
IS 2
BP 1591
EP 1612
DI 10.1007/s11784-016-0331-y
PG 22
WC Mathematics, Applied; Mathematics
SC Mathematics
GA EW9WG
UT WOS:000402869500028
OA No
DA 2017-08-17
ER

PT J
AU Sherif, RS
   Attalla, EM
   Elshemey, WM
   Madian, NG
AF Sherif, Reham S.
   Attalla, Ehab M.
   Elshemey, Wael M.
   Madian, Noha G.
TI The risk of secondary cancer in nasopharyngeal carcinoma paediatric
   patients due to intensity modulated radiotherapy and mega-voltage cone
   beam computed tomography
SO JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY
LA English
DT Article
DE IMRT; MV-CBCT; NPC; secondary cancers
ID RADIATION-INDUCED CANCERS; CHILDHOOD-CANCER; THYROID-CANCER; 2ND
   CANCERS; THERAPY; IMRT; CT; MALIGNANCIES; HEAD; CARCINOGENESIS
AB IntroductionThere is a growing interest in the study of radiation-induced secondary cancer. The aim of this work is (i) to estimate the peripheral doses attributable to intensity modulated radiotherapy (IMRT) and mega-voltage cone beam computed tomography (MV-CBCT) for some organs at risk (OARs) which surround the target being treated (Nasopharynx) in paediatric patients. (ii) To estimate the risk of radiation-induced secondary cancers attributable to patient setup verification imaging dose using MV-CBCT for Nasopharyngeal Carcinoma (NPC) in paediatric patients and comparing it with that attributable to the therapeutic dose using IMRT.
   MethodsIntensity modulated radiotherapy treatment planning of 10 NPC paediatric patients was carried out on KonRad release 2.2.23. The additional radiation doses to the patients attributable to MV-CBCT were calculated also using Xio Version 4.4. A paediatric phantom and thermoluminescent dosimeters (TLDs) were used to measure the patient doses attributable to IMRT. These doses were then compared with the calculated doses. The risk of induced secondary cancers attributable to IMRT and MV-CBCT was calculated and compared to each other.
   ResultsThe absorbed doses (mean dose) for the OARs (Brain, Brain stem, spinal cord, thyroid, oesophagus, mandible, heart, optic nerve, lung and eye) were higher for the therapeutic dose than for the imaging dose used in the verification of patient position before and during the treatment. The risk of induced secondary cancers in thyroid, oesophagus and lung (the only organs from the OARs which have tabulated values for risk calculations) was higher for therapeutic dose (7.290.73%, 2.62 +/- 0.17% and 6.76 +/- 0.87%, respectively) than for verification imaging dose (0.14 +/- 0.00%, 0.06 +/- 0.00%, 0.10 +/- 0.03% respectively).
   ConclusionThe risk of secondary cancers attributable to verification imaging dose using MV-CBCT is very small compared to therapeutic dose using IMRT. Therefore, it is important to focus on the risk of secondary cancers attributable to therapeutic dose especially when using IMRT, where the produced leakage radiation is considerably high compared to some other techniques (such as conformal radiotherapy).
C1 [Sherif, Reham S.; Elshemey, Wael M.; Madian, Noha G.] Cairo Univ, Fac Sci, Dept Biophys, Cairo Univ Rd,POB 12613, Giza, Egypt.
   [Attalla, Ehab M.] Cairo Univ, Natl Canc Inst, Radiotherapy & Nucl Med Dept, Cairo, Egypt.
   [Attalla, Ehab M.] Children Canc Hosp, Cairo, Egypt.
RP Sherif, RS (reprint author), Cairo Univ, Fac Sci, Dept Biophys, Cairo Univ Rd,POB 12613, Giza, Egypt.
EM rsalah@sci.cu.edu.eg
CR Abou-Elenein Hassan S, 2011, J Med Phys, V36, P205, DOI 10.4103/0971-6203.89969
   Cheung Ky, 2006, Biomed Imaging Interv J, V2, pe19, DOI 10.2349/biij.2.1.e19
   D'Arienzo M, 2012, INT J ENV RES PUB HE, V9, P4223, DOI 10.3390/ijerph9114223
   Dasu A, 2005, ACTA ONCOL, V44, P829, DOI 10.1080/02841860500401159
   DesBruin ML, 2009, J CLIN ONCOL, V27, P4239
   DesVathaire F, 1999, ARCH INTERN MED, V159, P2713
   Furetta C., 1998, OPERATIONAL THERMOLU
   Gillis A, 2005, AM SOC THER RAD ONC
   Hall EJ, 2006, INT J RADIAT ONCOL, V65, P1, DOI 10.1016/j.ijrobp.2006.01.027
   Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7
   Hansen EK, 2006, INT J RADIAT ONCOL, V64, P355, DOI 10.1016/j.ijrobp.2005.07.957
   ICRP, 2007, INT COMM RAD PROT IC, V103
   Inskip PD, 2001, MED PEDIATR ONCOL, V36, P568, DOI 10.1002/mpo.1132
   Kim DW, 2013, HEALTH PHYS, V104, P499, DOI 10.1097/HP.0b013e318285c685
   Kim GY, 2008, MED DOSIM, V33, P93, DOI 10.1016/j.meddos.2007.05.004
   Kim S, 2010, AM J ROENTGENOL, V194, P186, DOI 10.2214/AJR.08.2168
   Linsay KA, 2001, BRIT J RADIOL, V74, P529
   Mazonakis M, 2003, INT J ONCOL, V22, P221
   Morin O, 2007, MED PHYS, V34, P1819, DOI 10.1118/1.2722470
   Mutic S, 2001, INT J RADIAT ONCOL, V50, P239, DOI 10.1016/S0360-3016(01)01463-8
   Ng J, 2015, CANCER MANAG RES, V7, P1, DOI 10.2147/CMAR.S47220
   Nguyen J, 2015, MED PHYS, V42, P81, DOI 10.1118/1.4903272
   Podgorsak EB, 2005, RAD ONCOLOGY PHYS HD
   Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1
   Salz H, 2012, Z MED PHYS, V22, P6, DOI 10.1016/j.zemedi.2011.03.004
   Schneider U, 2011, GENES-BASEL, V2, P1033, DOI 10.3390/genes2041033
   Sklar C, 2000, J CLIN ENDOCR METAB, V85, P3227, DOI 10.1210/jc.85.9.3227
   Suit H, 2007, RADIAT RES, V167, P12, DOI 10.1667/RR0527.1
   Teo PML, 2004, RADIOTHER ONCOL, V73, P163, DOI 10.1016/j.radonc.2004.06.005
   Trott KR, 2009, RADIOTHER ONCOL, V91, P1, DOI 10.1016/j.radonc.2009.01.007
   Verellen D, 1999, RADIOTHER ONCOL, V53, P199, DOI 10.1016/S0167-8140(99)00079-1
   Wheldon EG, 2000, INT J RADIAT BIOL, V76, P699
   Wu WCV, 2011, MED DOSIM, V36, P109, DOI 10.1016/j.meddos.2010.01.005
   Yoon M, 2010, INT J RADIAT ONCOL, V77, P1477, DOI 10.1016/j.ijrobp.2009.07.011
   Yu CC, 2011, RADIAT MEAS, V46, P1948, DOI 10.1016/j.radmeas.2011.09.012
   Zaghloul MS, 2010, CLIN ONCOL-UK, V22, P850, DOI 10.1016/j.clon.2010.08.006
NR 36
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1754-9477
EI 1754-9485
J9 J MED IMAG RADIAT ON
JI J. Med. Imag. Radiat. Oncol.
PD JUN
PY 2017
VL 61
IS 3
BP 402
EP 409
DI 10.1111/1754-9485.12562
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EX1QU
UT WOS:000403001400018
PM 28019086
OA No
DA 2017-08-17
ER

PT J
AU Indolfi, G
   Thorne, C
   El Sayed, MH
   Giaquinto, C
   Gonzalez-Peralta, RP
AF Indolfi, Giuseppe
   Thorne, Claire
   El Sayed, Manal H.
   Giaquinto, Carlo
   Gonzalez-Peralta, Regino P.
TI The Challenge of Treating Children With Hepatitis C Virus Infection
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Article
DE chronic viral hepatitis; direct-acting antiviral therapy; hepatitis C
   virus; pediatric hepatology; pediatric liver disease
ID SIMEPREVIR PLUS SOFOSBUVIR; PEGYLATED INTERFERON ALPHA-2A; GENOTYPE 1
   INFECTION; RIBAVIRIN; VELPATASVIR; CIRRHOSIS; EFFICACY; PHASE-3; SAFETY
AB The development of oral hepatitis C virus (HCV) direct-acting antivirals (DAAs) has revolutionized the therapeutic field. Nowadays, multiple safe and highly effective antiviral regimens are commercially available to treat adults with hepatitis C infection. These new regimens for the first time genuinely raise the prospects of eradicating HCV. Many challenges, however, remain from identifying infected individuals to optimizing treatment and ensuring global access to antiviral therapy to all population groups, including children. Recently, in April 2017, the association of sofosbuvir with ribavirin and the fixed-dose combination sofosbuvir/ledipasvir have been approved by the Food and Drug Administration for treatment of children with chronic HCV infection 12 years of age and older. The only drugs currently approved for children younger than 12 years are pegylated interferon and ribavirin. There are 6 registered ongoing pediatric trials assessing safety and efficacy of DAAs, but their current completion time-lines are years away. Herein, we summarize the state of the art of DAAs' development for adult and children and highlight the crucial importance of overcoming barriers to treating children with HCV.
C1 [Indolfi, Giuseppe] Meyer Childrens Univ Hosp Florence, Pediat & Liver Unit, Viale Gaetano Pieraccini 34, I-50139 Florence, Italy.
   [Thorne, Claire] UCL, UCL Inst Child Hlth, London, England.
   [El Sayed, Manal H.] Ain Shams Univ, Dept Pediat, Fac Med, Cairo, Egypt.
   [Giaquinto, Carlo] Univ Padua, Dept Women & Child Hlth, Padua, Italy.
   [Giaquinto, Carlo] PENTA Fdn, Padua, Italy.
   [Gonzalez-Peralta, Regino P.] Univ Florida, Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA.
RP Indolfi, G (reprint author), Meyer Childrens Univ Hosp Florence, Pediat & Liver Unit, Viale Gaetano Pieraccini 34, I-50139 Florence, Italy.
EM g.indolfi@meyer.it
FU Gilead; Abbvie; Target NASH; Braintree; Sucampo
FX R.P.G.-P. receives research grants from Gilead, Abbvie, Target NASH,
   Braintree and Sucampo and he serves on Safety Monitoring Boards of Shire
   and Genetech-Roche and Scientific Advisory Board of Retrophin, Albireo
   and Horizon. C.T. has received funding from Abbvie. G.I. has served on
   Scientific Advisory Board of Alexion.
CR American Association for Ne Study of Liver Disease, HCV GUID REC TEST MA
   Backus LI, 2015, ALIMENT PHARM THER, V42, P559, DOI 10.1111/apt.13300
   Balistreri WF, 2016, HEPATOLOGY
   Bortolotti F, 2008, GASTROENTEROLOGY, V134, P1900, DOI 10.1053/j.gastro.2008.02.082
   CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562
   Chung RT, 2014, NEW ENGL J MED, V370, P1576, DOI 10.1056/NEJMp1400986
   Druyts E, 2013, CLIN INFECT DIS, V56, P961, DOI 10.1093/cid/cis1031
   El-Shabrawi MH, 2013, WORLD J GASTROENTERO, V19, P7880, DOI 10.3748/wjg.v19.i44.7880
   Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610
   Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612
   Gower F, 2014, J HEPATOL, P545
   Kwo P, 2016, HEPATOLOGY, V64, P370, DOI 10.1002/hep.28467
   Lawitz E, 2016, HEPATOLOGY, V64, P360, DOI 10.1002/hep.28422
   Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9
   Lewib E, 2013, NEW ENGL J MED, V368, P1878
   Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259
   Pho MT, 2014, HEPATOLOGY, V60, P12, DOI 10.1002/hep.27220
   Pol S, 2015, J HEPATOL, V62, pS258
   Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006
   Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015
   Schwarz KB, 2016, HEPATOLOGY, V64, p349A
   Schwarz KB, 2016, J PEDIATR GASTR NUTR, V62, P93, DOI 10.1097/MPG.0000000000000929
   Schwarz KB, 2011, GASTROENTEROLOGY, V140, P450, DOI 10.1053/j.gastro.2010.10.047
   Sulkowski MS, 2016, GASTROENTEROLOGY, V150, P419, DOI 10.1053/j.gastro.2015.10.013
   Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218
   Vargas HE, 2016, HEPATOLOGY, V64, P330, DOI 10.1002/hep.28559
   Wirth S, 2010, J HEPATOL, V52, P501, DOI 10.1016/j.jhep.2010.01.016
   Zoulim F, 2015, GUT, V64, P1824, DOI 10.1136/gutjnl-2015-310421
NR 28
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-2116
EI 1536-4801
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD JUN
PY 2017
VL 64
IS 6
BP 851
EP 854
DI 10.1097/MPG.0000000000001589
PG 4
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA EX0GI
UT WOS:000402897700012
PM 28362694
OA No
DA 2017-08-17
ER

PT J
AU Aly, H
   Said, RN
   Wali, IE
   Elwakkad, A
   Soliman, Y
   Awad, AR
   Shawky, MA
   Abu Alam, MS
   Mohamed, MA
AF Aly, Hany
   Said, Reem N.
   Wali, Iman E.
   Elwakkad, Amany
   Soliman, Yssra
   Awad, Alaa R.
   Shawky, Mahmoud A.
   Abu Alam, Mohamed S.
   Mohamed, Mohamed A.
TI Medically Graded Honey Supplementation Formula to Preterm Infants as a
   Prebiotic: A Randomized Controlled Trial
SO JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
LA English
DT Article
DE Bifidobacterium bifidum; lactobacilli; microbiota; neonates; premature
ID INTESTINAL MICROBIOTA; OLIGOSACCHARIDES; MIXTURE
AB Objectives: The aim of the study was to assess the effect of medically graded enteral honey supplementation on the intestinal microbiota, immune response, and somatic growth of preterm infants.
   Methods: Aprospective randomized controlled trial was conducted on preterm infants with gestational age <= 34 weeks and postnatal age >3 days. After reaching 1/2 goal enteral feeds, medically graded bee honey was added to milk at a dose of 5, 10, 15, and 0 g/day for 2 weeks in groups A, B, C, and D, respectively. Anthropometric measurements, CD4 and CD8 cytokines, stool cultures, and stool polymerase chain reaction assays for molecular detection of microbiomes were performed at 0, 7, and 14 days of intervention. Analysis of variance test was used to detect differences among the 4 groups.
   Results: A total of 40 subjects were enrolled; 10 in each arm of the study. Compared with group D, all 3 intervention groups demonstrated significant increase in weight (P<0.0001). Head circumference increased in groups B and C (P = 0.0056). There were no changes in CD4 or CD8 cytokines (P = 0.24 and P = 0.11, respectively). Enterobacter stool colonization decreased in groups A and B (P = 0.002), whereas Bifidobacterium bifidum colony counts increased in groups A, B, and C (P = 0.002) and lactobacilli colony counts increased in group B (P<0.0001). Applying real-time polymerase chain reaction, B bifidum and lactobacilli increased in group C (P<0.0001).
   Conclusions: Supplementation of milk formula with medically graded honey was associated with changes in physical growth and colonic microbiota of preterm infants. Further studies are needed to examine the sustainability of these effects and associated long-term outcomes.
C1 [Aly, Hany; Mohamed, Mohamed A.] George Washington Univ, Newborn Serv, Washington, DC 20052 USA.
   [Aly, Hany; Mohamed, Mohamed A.] Childrens Natl Med Ctr, 900 23rd St,NW,Suite G2092, Washington, DC 20037 USA.
   [Said, Reem N.; Shawky, Mahmoud A.; Abu Alam, Mohamed S.] Cairo Univ, Div Neonatol, Fac Med, Cairo, Egypt.
   [Wali, Iman E.] Cairo Univ, Dept Med Microbiol & Immunol, Fac Med, Cairo, Egypt.
   [Elwakkad, Amany] Natl Res Ctr, Dept Clin Pathol, Cairo, Egypt.
   [Soliman, Yssra] Albert Einstein Coll Med, New York, NY USA.
RP Aly, H (reprint author), Childrens Natl Med Ctr, 900 23rd St,NW,Suite G2092, Washington, DC 20037 USA.; Aly, H (reprint author), George Washington Univ, Div Newborn Serv, 900 23rd St,NW,Suite G2092, Washington, DC 20037 USA.
EM haly@mfa.gwu.edu
CR Abdel-Rahman M A, 2005, J AM APITHER SOC, V12, P11
   BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   Boehm G, 2002, ARCH DIS CHILD, V86, P178, DOI 10.1136/fn.86.3.F178
   Dine M, 1992, NELSON TXB PEDIAT, P67
   Fanaro S, 2005, J PEDIATR GASTR NUTR, V41, P186, DOI 10.1097/01.mpg.0000172747.64103.d7
   Formon S, 1993, NUTR NORMAL INFANTS, P529
   Hanson LA, 2003, ANN ALLERG ASTHMA IM, V90, P59
   Hussein S Z, 2014, Clin Ter, V165, pe125, DOI 10.7471/CT.2014.1695
   Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463
   Mohan R, 2006, J CLIN MICROBIOL, V44, P4025, DOI 10.1128/JCM.00767-06
   Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251
   Moro G, 2002, J PEDIATR GASTR NUTR, V34, P291, DOI 10.1097/00005176-200203000-00014
   Moro GE, 2003, ACTA PAEDIATR, V92, P77
   Mugambi MN, 2012, NUTR J, V11, P1
   POSTMES T, 1995, EXPERIENTIA, V51, P986, DOI 10.1007/BF01921753
   Pursely S, 1998, MANUAL NEONATAL CARE, V4, P37
   Mijanur Rahman M, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/958721
   Rao S, 2009, ARCH PEDIAT ADOL MED, V163, P755, DOI 10.1001/archpediatrics.2009.94
   Tanzi MG, 2002, PHARMACOTHERAPY, V22, P1479, DOI 10.1592/phco.22.16.1479.33696
   Underwood MA, 2009, J PEDIATR GASTR NUTR, V48, P216, DOI 10.1097/MPG.0b013e31818de195
   Ustunol Z., 2000, REP NATL HONEY BOARD, P1
NR 21
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-2116
EI 1536-4801
J9 J PEDIATR GASTR NUTR
JI J. Pediatr. Gastroenterol. Nutr.
PD JUN
PY 2017
VL 64
IS 6
BP 966
EP 970
DI 10.1097/MPG.0000000000001597
PG 5
WC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
SC Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics
GA EX0GI
UT WOS:000402897700033
PM 28379925
OA No
DA 2017-08-17
ER

PT J
AU O'Mary, HL
   Aldayel, AM
   Valdes, SA
   Naguib, YW
   Li, X
   Sahrady, K
   Cui, ZR
AF O'Mary, Hannah L.
   Aldayel, Abdulaziz M.
   Valdes, Solange A.
   Naguib, Youssef W.
   Li, Xu
   Sahrady, Karun
   Cui, Zhengrong
TI Acid-Sensitive Sheddable PEGylated, Mannose-Modified Nanoparticles
   Increase the Delivery of Betamethasone to Chronic Inflammation Sites in
   a Mouse Model
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE lipopolysaccharides; in vitro release; cell uptake; TNF-alpha release;
   tissue pharmacokinetics
ID RHEUMATOID-ARTHRITIS; DRUG-DELIVERY; MECHANISMS; MACROPHAGES;
   GLUCOCORTICOIDS; EFFICACY; DISEASES; PRODRUG
AB Inflammation is implicated in a host of chronic illnesses. Within these inflamed tissues, the pH of the microenvironment is decreased and immune cells, particularly macrophages, infiltrate the area. Additionally, the vascular integrity of these sites is altered with increased fenestrations between endothelial cells. These distinctive properties may be exploited to enhance targeted delivery of anti-inflammatory therapies. Using a mouse model of chronic inflammation, we previously showed that acid-sensitive sheddable PEGylation increases the distribution and retention of nanoparticles in chronic inflammation sites. Here we demonstrated that surface modification of the acid-sensitive sheddable PEGylated nanoparticles with mannose, a ligand to mannose receptors present in chronic inflammation site, significantly increases the targeted delivery of the nanoparticles to these areas. Furthermore, we showed that the acid-sensitive sheddable PEGylated, mannose-modified nanoparticles are able to significantly increase the delivery of betamethasone-21-acetate (BA), a model anti-inflammatory compound; to chronic inflammation sites as compared to free BA. These results highlight the ability to engineer formulations to target chronic inflammation sites by exploiting the microenvironment of these regions.
C1 [O'Mary, Hannah L.; Aldayel, Abdulaziz M.; Valdes, Solange A.; Naguib, Youssef W.; Li, Xu; Sahrady, Karun; Cui, Zhengrong] Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA.
   [Cui, Zhengrong] Inner Mongolia Med Univ, Inner Mongolia Key Lab Mol Biol, Hohhot, Inner Mongolia, Peoples R China.
   [Naguib, Youssef W.] Menia Univ, Fac Pharm, Dept Pharmaceut, Al Minya 61111, Egypt.
RP Cui, ZR (reprint author), Univ Texas Austin, Coll Pharm, Div Mol Pharmaceut & Drug Delivery, Austin, TX 78712 USA.; Cui, ZR (reprint author), Inner Mongolia Med Univ, Inner Mongolia Key Lab Mol Biol, Hohhot, Inner Mongolia, Peoples R China.
EM Zhengrong.cui@austin.utexas.edu
FU U.S. National Institutes of Health [CA135274]; Alfred and Dorothy
   Mannino Fellowship in Pharmacy at UT Austin; National Natural Science
   Foundation of China [81460454]; Inner Mongolia Natural Science Fund
   [2014ZD05]; KAIMRC Scholarship Program; Becas-Chile Scholarship from the
   Government of Chile
FX This work is supported in part by the U.S. National Institutes of Health
   (CA135274) and the Alfred and Dorothy Mannino Fellowship in Pharmacy at
   UT Austin (to Z.C.). Z.C. is also supported by the National Natural
   Science Foundation of China (81460454) and the Inner Mongolia Natural
   Science Fund (2014ZD05). A.M.A. is a King Abdullah International Medical
   Research Center (KAIMRC) scholar and is supported by the KAIMRC
   Scholarship Program. S.A.V. is supported by the Becas-Chile Scholarship
   from the Government of Chile. Mouse image used in the graphical abstract
   is by Gwilz and is distributed under CC BY-SA 4.0 license.
CR Afsar U.AHMED, 2011, [Frontiers in Biology, 生物学前沿], V6, P274
   Aldayel AM, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.39
   Barnes PJ, 1998, CLIN SCI, V94, P557
   FALCHUK KH, 1970, AM J MED, V49, P223, DOI 10.1016/S0002-9343(70)80078-X
   FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99
   Jacobson JA, 2008, RADIOLOGY, V248, P378, DOI 10.1148/radiol.2482062110
   Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333
   Kou L, 2013, AJPS, V8, P1, DOI DOI 10.1016/J.AJPS.2013.07.001
   Laria A, 2016, J INFLAMM RES, V9, P1, DOI 10.2147/JIR.S82320
   Laveti Durgaprasad, 2013, Inflammation & Allergy Drug Targets, V12, P349
   Libby P, 2007, NUTR REV, V65, pS140, DOI 10.1301/nr.2007.dec.S140-S146
   Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275
   Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850
   O'Mary H, 2016, CURR MED CHEM, V23, P2490
   Owen J. A., 2013, J KUBY IMMUNOLOGY, p[xxvii, 692]
   Put S, 2013, J NUCL MED, V54, P807, DOI 10.2967/jnumed.112.111781
   Quan LD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3130
   Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004
   SORG C, 1991, CHEST, V100, pS173, DOI 10.1378/chest.100.3_Supplement.173S
   Thomas TP, 2011, ARTHRITIS RHEUM-US, V63, P2671, DOI 10.1002/art.30459
   Tseng JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50690
   Uchida M, 2011, ACS NANO, V5, P2493, DOI 10.1021/nn102863y
   van der Velden VHJ, 1998, MEDIAT INFLAMM, V7, P229
   Wijagkanalan W, 2008, MOL PHARMACOL, V74, P1183, DOI 10.1124/mol.108.050153
   Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007
   Zhu SJ, 2013, MOL PHARMACEUT, V10, P3525, DOI 10.1021/mp400216r
   Zhu SJ, 2012, BIOCONJUGATE CHEM, V23, P966, DOI 10.1021/bc2005945
NR 27
TC 0
Z9 0
U1 4
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD JUN
PY 2017
VL 14
IS 6
BP 1929
EP 1937
DI 10.1021/acs.molpharmaceut.7b00024
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EX0ZY
UT WOS:000402950500009
PM 28463518
OA No
DA 2017-08-17
ER

PT J
AU Elmallah, MIY
   Micheau, O
   Eid, MAG
   Hebishy, AMS
   Abdelfattah, MS
AF Elmallah, Mohammed I. Y.
   Micheau, Olivier
   Eid, Mennat Allah G.
   Hebishy, Ali M. S.
   Abdelfattah, Mohamed S.
TI Marine actinomycete crude extracts with potent TRAIL-resistance
   overcoming activity against breast cancer cells
SO ONCOLOGY REPORTS
LA English
DT Article
DE marine actinomycetes; MDA-MB-231 breast cancer cells; apoptosis;
   TRAIL-resistance
ID SP IFM 11307; DEATH RECEPTORS; INDUCED APOPTOSIS; NATURAL-PRODUCTS;
   PLANT-EXTRACTS; MECHANISMS; TARGETS; APO2L/TRAIL; CARCINOMA; THERAPY
AB Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent, as it can kill tumor cells selectively. In our search of bioactive natural products to overcome TRAIL-resistance, we isolated 47 actinomycete strains from different sediments and seawater samples collected from the Red Sea coast in Egypt and found four crude extracts (EGY1, EGY3, EGY24 and EGY34) displaying TRAIL sensitizing activity in the resistant breast cancer cell line MDA-MB-231. None of these crude extracts exhibited cytotoxic effect on normal mouse embryonic fibroblasts (MEF), with the exception of EGY34. Analysis of the signaling pathways underlying the sensitization of MDA-MB-231 cells to TRAIL-induced apoptosis, by western blotting, revealed that all crude extracts facilitated initiator caspase-8/-10 activation upon TRAIL stimulation, but that in addition, EGY3 and EGY34, alone, induced strong ER-stress activation, with the appearance of BiP in the cytosolic extracts. Our results pave the way to the discovery and the development of marine-derived drugs for cancer therapy.
C1 [Elmallah, Mohammed I. Y.; Eid, Mennat Allah G.; Hebishy, Ali M. S.; Abdelfattah, Mohamed S.] Helwan Univ, Fac Sci, Marine Nat Prod Unit MNPRU, Cairo 11795, Egypt.
   [Elmallah, Mohammed I. Y.; Hebishy, Ali M. S.; Abdelfattah, Mohamed S.] Helwan Univ, Fac Sci, Dept Chem, Cairo 11795, Egypt.
   [Micheau, Olivier] Univ Bourgogne Franche Comte, LNC, INSERM, UMR1231, F-21079 Dijon, France.
   [Micheau, Olivier] Univ Bourgogne Franche Comte, UFR Sci Sante, F-21079 Dijon, France.
RP Abdelfattah, MS (reprint author), Helwan Univ, Fac Sci, Marine Nat Prod Unit MNPRU, Cairo 11795, Egypt.
EM mabdelfattah@science.helwan.edu.eg
RI Micheau, Olivier/C-3574-2011
OI Micheau, Olivier/0000-0001-8499-7984
FU Science and Technology Development Fund (STDF), Egypt [4930]
FX This work was supported by the Science and Technology Development Fund
   (STDF), Egypt (grant no. 4930).
CR Abdelfattah MS, 2016, J ANTIBIOT, V69, P446, DOI 10.1038/ja.2015.129
   Abdelfattah MS, 2016, J NAT MED-TOKYO, V70, P266, DOI 10.1007/s11418-015-0951-3
   Abdelfattah MS, 2013, NAT PROD RES, V27, P2126, DOI 10.1080/14786419.2013.793686
   Abdelfattah MS, 2012, J ANTIBIOT, V65, P245, DOI 10.1038/ja.2012.11
   Abdelfattah MS, 2011, J ANTIBIOT, V64, P729, DOI 10.1038/ja.2011.85
   Abdelfattah MS, 2010, J NAT PROD, V73, P1999, DOI 10.1021/np100400t
   Abdelfattah Mohamed Saleh, 2016, Asian Pacific Journal of Tropical Biomedicine, V6, P651, DOI 10.1016/j.apjtb.2016.06.004
   Abdelhamed S, 2013, ONCOL REP, V29, P1991, DOI 10.3892/or.2013.2293
   Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7
   Blunt JW, 2007, NAT PROD REP, V24, P31, DOI 10.1039/b603047p
   Blunt JW, 2009, NAT PROD REP, V26, P170, DOI 10.1039/b805113p
   Blunt JW, 2006, NAT PROD REP, V23, P26, DOI 10.1039/b502792f
   Elmallah MIY, 2015, MAR DRUGS, V13, P6884, DOI 10.3390/md13116884
   Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007
   Lloyd G. K., 2002, PHARM NEWS, V9, P489
   Ferretti C, 2007, INT J ONCOL, V30, P161
   Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011
   Griffith TS, 1998, CURR OPIN IMMUNOL, V10, P559, DOI 10.1016/S0952-7915(98)80224-0
   HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7
   Henson ES, 2008, LEUKEMIA LYMPHOMA, V49, P27, DOI 10.1080/10428190701713655
   Humphreys RC, 2008, ADV EXP MED BIOL, V615, P127, DOI 10.1007/978-1-4020-6554-5_7
   Jacquemin G, 2012, HAEMATOL-HEMATOL J, V97, P38, DOI 10.3324/haematol.2011.046466
   Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121
   Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006
   Kieser T, 2000, PRACTICAL STREPTOMYC
   KUSTER E, 1964, NATURE, V202, P928, DOI 10.1038/202928a0
   LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187
   Lee YS, 2013, INT J ONCOL, V43, P591, DOI 10.3892/ijo.2013.1964
   Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006
   Mayer AMS, 2007, COMP BIOCHEM PHYS C, V145, P553, DOI 10.1016/j.cbpc.2007.01.015
   Micheau O, 2013, BRIT J PHARMACOL, V169, P1723, DOI 10.1111/bph.12238
   Morizot A, 2011, CELL DEATH DIFFER, V18, P700, DOI 10.1038/cdd.2010.144
   Morle A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.12
   Ndozangue-Touriguine O, 2008, ONCOGENE, V27, P6012, DOI 10.1038/onc.2008.197
   Oliveras-Ferraros C, 2011, INT J ONCOL, V38, P1533, DOI 10.3892/ijo.2011.993
   Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186
   Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203
   Szliszka E, 2011, INT J ONCOL, V38, P941, DOI 10.3892/ijo.2011.930
   Takahashi Y, 2003, J GEN APPL MICROBIOL, V49, P141, DOI 10.2323/jgam.49.141
   Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007
   Thorburn A, 2008, DRUG RESIST UPDATE, V11, P17, DOI 10.1016/j.drup.2008.02.001
   Van Slambrouck S, 2007, ONCOL REP, V17, P1487
   Williams PG, 2009, TRENDS BIOTECHNOL, V27, P45, DOI 10.1016/j.tibtech.2008.10.005
   Zhu HB, 2004, MOL THER, V9, P666, DOI 10.1016/j.ymthe.2004.02.007
NR 46
TC 0
Z9 0
U1 2
U2 2
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1021-335X
EI 1791-2431
J9 ONCOL REP
JI Oncol. Rep.
PD JUN
PY 2017
VL 37
IS 6
BP 3635
EP 3642
DI 10.3892/or.2017.5595
PG 8
WC Oncology
SC Oncology
GA EW7LT
UT WOS:000402692300055
PM 28440502
OA No
DA 2017-08-17
ER

PT J
AU El-Khamy, S
   Moussa, K
   El-Sherif, A
AF El-Khamy, Said
   Moussa, Karim
   El-Sherif, Amr
TI A smart multi-user massive MIMO system for next G Wireless
   communications using evolutionary optimized antenna selection
SO TELECOMMUNICATION SYSTEMS
LA English
DT Article
DE Multi-user; Massive; MIMO; Antenna selection; Binary optimization
AB Massive multi-user multiple input multiple output is a very promising technique for next generation communication. It can provide further improvement to the wireless communication link performance due to relatively large number of transmitting antennas equipped at the base station. This large number has the potential to improve the performance but these systems suffer from high cost, complexity and large size. The transmit antenna selection (TAS) can be employed to solve these problems and with the objective of maximizing the achievable ergodic capacity. In this paper, The TAS problem is solved using a modified evolutionary algorithm, in particular, the chaotic binary particle swarm optimization algorithm is utilized for maximization of the total achievable capacities with reduced system complexity and minimized hardware cost. The multi-user is supported using the zero-forcing baseband beamforming. The convergence of the proposed evolutionary algorithm is proved and its performance is evaluated using numerical analysis. The presented results proved that the proposed evolutionary algorithm can achieve competitive ergodic capacities while utilizing small number of radio frequency chains. In addition, the proposed technique is better than random and maximum norm TAS. It can achieve near optimal performance that can be achieved by exhaustive search TAS but with reduced computational complexity.
C1 [El-Khamy, Said; El-Sherif, Amr] Alexandria Univ, Dept Elect Engn, Alexandria 21544, Egypt.
   [Moussa, Karim] Alexandria Inst Engn & Technol, Alexandria 21311, Egypt.
RP Moussa, K (reprint author), Alexandria Inst Engn & Technol, Alexandria 21311, Egypt.
EM elkhamy@ieee.org; karim.moussa@aiet.edu.eg; aasherif@alexu.edu.eg
CR Annapureddy VS, 2009, IEEE T INFORM THEORY, V55, P3032, DOI 10.1109/TIT.2009.2021380
   Bansal J. C., 2011, P 3 WORLD C NAT BIOL, P633, DOI [10.1109/NaBIC.2011.6089659, DOI 10.1109/NABIC.2011.6089659]
   Bjornson E., 2013, ARXIV13072584, P1
   Bjornson E, 2015, IEEE T WIREL COMMUN, V14, P3059, DOI 10.1109/TWC.2015.2400437
   Dong K., 2011, EURASIP J WIREL COMM, V2011, P1
   Dongsik Jo, 2014, 2014 International Workshop on Collaborative Virtual Environments (3DCVE). Proceedings, P1, DOI 10.1109/3DCVE.2014.7160932
   Gao X., 2013, 2013 IEEE GLOB WORKS
   Gopalakrishnan B, 2011, SPAWC 2011: 2011 IEEE 12TH INTERNATIONAL WORKSHOP ON SIGNAL PROCESSING ADVANCES IN WIRELESS COMMUNICATIONS, P381, DOI 10.1109/SPAWC.2011.5990435
   Ngo HQ, 2013, IEEE T COMMUN, V61, P2350, DOI 10.1109/TCOMM.2013.032713.120408
   Karamalis PD, 2004, IEEE T WIREL COMMUN, V3, P1994, DOI 10.1109/TWC.2004.837447
   Kennedy J., 1995, IEEE INT C NEUR NETW
   Kennedy J., 1997, 1997 IEEE INT C SYST, V5
   Larsson E. G., 2013, IEEE COMMUNICATIONS, V52, P1
   Lu L., 2014, IEEE J-STSP, V4553, P1
   Marzetta TL, 2015, BELL LABS TECH J, V20, P11
   Marzetta TL, 2010, IEEE T WIREL COMMUN, V9, P3590, DOI 10.1109/TWC.2010.092810.091092
   Mirjalili S. Z., 2011, INT C GEN EV METH, V1, P2
   Paulraj A., 2003, INTRO SPACE TIME WIR
   Rusek F, 2013, IEEE SIGNAL PROC MAG, V30, P40, DOI 10.1109/MSP.2011.2178495
   Sanayei S, 2004, IEEE COMMUN MAG, V42, P68, DOI 10.1109/MCOM.2004.1341263
   Shepard C, 2012, MOBICOM 12: PROCEEDINGS OF THE 18TH ANNUAL INTERNATIONAL CONFERENCE ON MOBILE COMPUTING AND NETWORKING, P53
   Vieira J, 2014, IEEE GLOBE WORK, P287, DOI 10.1109/GLOCOMW.2014.7063446
   Yeh W.-C., 2012, 2012 IEEE INT C AC S
   Yoo T, 2006, IEEE J SEL AREA COMM, V24, P528, DOI 10.1109/JSAC.2005.862421
NR 24
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1018-4864
EI 1572-9451
J9 TELECOMMUN SYST
JI Telecommun. Syst.
PD JUN
PY 2017
VL 65
IS 2
BP 309
EP 317
DI 10.1007/s11235-016-0232-9
PG 9
WC Telecommunications
SC Telecommunications
GA EX1TS
UT WOS:000403009900008
OA No
DA 2017-08-17
ER

PT J
AU Wada, H
   Dohi, T
   Miyauchi, K
   Doi, S
   Naito, R
   Konishi, H
   Tsuboi, S
   Ogita, M
   Kasai, T
   Hassan, A
   Okazaki, S
   Isoda, K
   Suwa, S
   Daida, H
AF Wada, Hideki
   Dohi, Tomotaka
   Miyauchi, Katsumi
   Doi, Shinichiro
   Naito, Ryo
   Konishi, Hirokazu
   Tsuboi, Shuta
   Ogita, Manabu
   Kasai, Takatoshi
   Hassan, Ahmed
   Okazaki, Shinya
   Isoda, Kikuo
   Suwa, Satoru
   Daida, Hiroyuki
TI Prognostic Impact of the Geriatric Nutritional. Risk Index on Long-Term
   Outcomes in Patients Who Underwent Percutaneous Coronary Intervention
SO AMERICAN JOURNAL OF CARDIOLOGY
LA English
DT Article
ID PRESERVED EJECTION FRACTION; CONGESTIVE-HEART-FAILURE; BODY-MASS INDEX;
   SERUM-ALBUMIN; MORTALITY; INFLAMMATION; ATHEROSCLEROSIS;
   SUPPLEMENTATION; MALNUTRITION; METABOLISM
AB Malnutrition has been identified as an important predictor of poor clinical outcomes in patients with heart failure. The aim of this study is to examine the prognostic impact of nutritional status in patients with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). The impact of nutrition, assessed using the geriatric nutritional risk index (GNRI) calculated by serum albumin and body mass index, was evaluated in 2,853 patients with CAD who underwent their first PCI between 2000 and 2011. Patients were assigned to tertiles based on their GNRI levels. The incidences of all cause death and cardiac death were assessed. The median GNRI values were 101 (inter quartile range 95 to 106). Lower GNRI levels were associated with older age and higher prevalence of acute coronary syndrome and chronic kidney disease. During the median follow-up period of 7.4 years, Kaplan-Meier curves showed ongoing divergence in rates of mortality among tertiles (GNRI <98: 35.1%; 98 to 104: 20.6%; 104: 12.1%; log -rank p <0.0001). Stratification analysis by age also showed that the lowest GNRI tertile was associated with mortality in both patients <65 years and those >= 65 years. After adjusting for established cardiovascular risk factors, lower GNRI was an independent predictor of all cause death (hazard ratio 1.55 per 10 decrease, 95% confidence interval 1.30 to 1.84, p <0.0001) and cardiac death (hazard ratio 1.44, 95% confidence interval 1.08 to 1.90, p = 0.01). In conclusion, nutritional status was associated with long-term clinical outcomes in CAD patients after PCI. Evaluation of GNRI carries important prognostic information and may guide the therapeutic approach to such patients. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Wada, Hideki; Dohi, Tomotaka; Miyauchi, Katsumi; Doi, Shinichiro; Kasai, Takatoshi; Hassan, Ahmed; Okazaki, Shinya; Isoda, Kikuo; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.
   [Naito, Ryo] Juntendo Univ, Urayasu Hosp, Dept Cardiovasc Med, Chiba, Japan.
   [Konishi, Hirokazu; Tsuboi, Shuta; Ogita, Manabu; Suwa, Satoru] Juntendo Univ, Dept Cardiol, Shizuoka Hosp, Shizuoka, Japan.
   [Hassan, Ahmed] Suez Canal Univ, Dept Cardiol, Ismailia, Egypt.
RP Dohi, T (reprint author), Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.
EM tdohi@juntendo.ac.jp
CR Andrews R, 1998, EUR HEART J, V19, P617, DOI 10.1053/euhj.1997.0767
   Basta G, 2016, INT J CARDIOL, V221, P987, DOI 10.1016/j.ijcard.2016.07.039
   Berger MM, 2003, CURR OPIN CLIN NUTR, V6, P195, DOI 10.1097/01.mco.0000058590.27240.07
   Bouillanne O, 2005, AM J CLIN NUTR, V82, P777
   Bourdel-Marchasson I, 2001, Am J Cardiovasc Drugs, V1, P363, DOI 10.2165/00129784-200101050-00006
   BROQVIST M, 1994, EUR HEART J, V15, P1641
   CORTI MC, 1994, JAMA-J AM MED ASSOC, V272, P1036, DOI 10.1001/jama.272.13.1036
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   Silva FRD, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0113-1
   Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x
   Honda Y, 2016, AM J CARDIOL, V118, P550, DOI 10.1016/j.amjcard.2016.05.045
   Kalantar-Zadeh K, 2008, AM J CARDIOL, V101, p89E, DOI 10.1016/j.amjcard.2008.03.007
   Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091
   Kobayashi I, 2010, NEPHROL DIAL TRANSPL, V25, P3361, DOI 10.1093/ndt/gfq211
   Liu M, 2012, EUR J HEART FAIL, V14, P39, DOI 10.1093/eurjhf/hfr154
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   Shah Bhumika, 2006, Nutr Clin Pract, V21, P312, DOI 10.1177/0115426506021003312
   Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x
   Teramoto T, 2013, J ATHEROSCLER THROMB, V20, P655
   Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501
   Veronese N, 2015, OBES REV, V16, P1001, DOI 10.1111/obr.12309
NR 21
TC 0
Z9 0
U1 0
U2 0
PU EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
PI BRIDGEWATER
PA 685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA
SN 0002-9149
EI 1879-1913
J9 AM J CARDIOL
JI Am. J. Cardiol.
PD JUN 1
PY 2017
VL 119
IS 11
BP 1740
EP 1745
DI 10.1016/j.amjcard.2017.02.051
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EX0ZP
UT WOS:000402949600006
PM 28388993
OA No
DA 2017-08-17
ER

PT J
AU Mahmoud, HK
   Al-Sagheer, AA
   Reda, FM
   Mahgoub, SA
   Ayyat, MS
AF Mahmoud, Hemat K.
   Al-Sagheer, Adham A.
   Reda, Fayez M.
   Mahgoub, Samir A.
   Ayyat, Mohamed S.
TI Dietary curcumin supplement influence on growth, immunity, antioxidant
   status, and resistance to Aeromonas hydrophila in Oreochromis niloticus
SO AQUACULTURE
LA English
DT Article
DE Curcumin; Growth; Immune response; Oxidative stress; Niletilapia;
   Disease resistance
ID CARP CYPRINUS-CARPIO; INTESTINAL ENZYME-ACTIVITIES; OXIDATIVE STRESS;
   ANTIBACTERIAL PROPERTIES; INFLAMMATORY RESPONSES; SIGNALING PATHWAY;
   ESSENTIAL OILS; JUVENILE JIAN; VAR. JIAN; FISH
AB An 84-day feeding trial was performed to investigate the effects of dietary curcumin (CUR) supplementation on growth performance, feed utilization, immunity, antioxidant response, and resistance to Aeromonas hydrophila in Oreochromis niloticus. Three hundred tilapia fish (average initial weight; 2.55 +/- 0.003 g) were fed five diets supplemented with 0 (basal diet), 50, 100, 150 or 200 mg CUR kg(-1) diet. Herein, a concentration-dependent inhibition of both A. hydrophila and A. sobria following in vitro CUR treatment was evident. The in vivo results revealed that CUR supplementation at different levels, especially at 50 mg kg(-1) diet, evoked significantly higher final weight, daily weight gain, and specific growth rate in tilapia. Also, CUR100 and CUR150 fish groups had the best feed conversion and protein efficiency ratios. Also, a significant increase in both crude lipid and protein content of the whole body was recorded in fish fed 50 or 100 mg CUR kg(-1) diet. A significant increase of both catalase activity and reduced glutathione content with a significant incline in the MDA level were recorded with dietary CUR supplementation. Lysozyme activity, total IgG and IgM levels significantly increased, especially in fish fed the 50 mg CUR kg(-1) diet. A concentration-dependent decline in the total bacteria, Coliforms, Escherichia coli and Aeromonas spp. counts was recorded in water samples and intestinal content of tilapia with CUR addition. High survival rate was obvious in all CUR supplemented groups after challenge with A. hydrophila. It is concluded that CUR could be a candidate dietary supplement in fish improving growth performance, feed utilization, oxidative status, immune responses, and disease resistance.
C1 [Mahmoud, Hemat K.; Al-Sagheer, Adham A.; Ayyat, Mohamed S.] Zagazig Univ, Fac Agr, Dept Anim Prod, Zagazig 44511, Egypt.
   [Reda, Fayez M.] Zagazig Univ, Fac Agr, Dept Poultry, Zagazig 44511, Egypt.
   [Mahgoub, Samir A.] Zagazig Univ, Fac Agr, Dept Microbiol, Zagazig 44511, Egypt.
RP Al-Sagheer, AA (reprint author), Zagazig Univ, Fac Agr, Dept Anim Prod, Zagazig 44511, Egypt.
EM adham_alsaht@zu.edu.eg
CR Abdelwahab A. M., 2012, World Journal of Fish and Marine Sciences, V4, P496
   Acar U, 2015, AQUACULTURE, V437, P282, DOI 10.1016/j.aquaculture.2014.12.015
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Amend D. F., 1981, FISH BIOL SERODIAGNO, P447
   AOAC, 2000, OFFICIAL METHODS ANA
   Austin B., 2007, BACTERIAL FISH PATHO
   Baba E, 2016, AQUACULTURE, V465, P13, DOI 10.1016/j.aquaculture.2016.08.023
   Baba E, 2016, ITAL J ANIM SCI, V15, P325, DOI 10.1080/1828051X.2016.1185977
   Bellio P, 2014, PHYTOMEDICINE, V21, P430, DOI 10.1016/j.phymed.2013.10.011
   Betts JW, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-172
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012
   Biswas SK, 2005, ANTIOXID REDOX SIGN, V7, P32, DOI 10.1089/ars.2005.7.32
   Boonla O, 2014, NITRIC OXIDE-BIOL CH, V42, P44, DOI 10.1016/j.niox.2014.09.001
   Brum A, 2017, AQUACULTURE, V468, P235, DOI 10.1016/j.aquaculture.2016.10.020
   Cao LP, 2015, FISH SHELLFISH IMMUN, V43, P150, DOI 10.1016/j.fsi.2014.12.025
   DEANS SG, 1987, INT J FOOD MICROBIOL, V5, P165, DOI 10.1016/0168-1605(87)90034-1
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   Ellis AE, 1999, FISH SHELLFISH IMMUN, V9, P291, DOI 10.1006/fsim.1998.0192
   Esiobu N, 2002, INT J ENVIRON HEAL R, V12, P133, DOI 10.1080/09603120220129292
   FAO, 2014, STAT WORLD FISH AQ 2
   Farhangi B, 2015, EUR J PHARMACOL, V758, P188, DOI 10.1016/j.ejphar.2015.03.076
   Fu YH, 2014, INT IMMUNOPHARMACOL, V20, P54, DOI 10.1016/j.intimp.2014.01.024
   Giannenas I, 2012, AQUACULTURE, V350, P26, DOI 10.1016/j.aquaculture.2012.04.027
   Gobi N, 2016, FISH SHELLFISH IMMUN, V58, P572, DOI 10.1016/j.fsi.2016.09.062
   Gullu K, 2016, AQUAC RES, V47, P2697, DOI 10.1111/are.12717
   Hu Z.Z., 2003, CEREAL FEED IND, V11, P29
   Jiang J, 2016, AQUACULTURE, V463, P174, DOI 10.1016/j.aquaculture.2016.05.040
   Jiang TT, 2014, AQUACULT NUTR, V20, P632, DOI 10.1111/anu.12125
   Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041
   Liang G, 2008, CHEM PHARM BULL, V56, P162, DOI 10.1248/cpb.56.162
   Ling J, 2010, AQUACULT NUTR, V16, P616, DOI 10.1111/j.1365-2095.2009.00699.x
   Magnadottir B, 2006, FISH SHELLFISH IMMUN, V20, P137, DOI 10.1016/j.fsi.2004.09.006
   Mahfouz ME, 2015, MOL BIOL+, V49, P275, DOI 10.1134/S0026893315020089
   Malar H. V., 2013, INT J RES ZOOL, V3, P21
   Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006
   Manju M, 2012, FISH PHYSIOL BIOCHEM, V38, P309, DOI 10.1007/s10695-011-9508-x
   Martin RCG, 2012, FOOD CHEM TOXICOL, V50, P227, DOI 10.1016/j.fct.2011.10.070
   Martinez-Alvarez RM, 2005, REV FISH BIOL FISHER, V15, P75, DOI 10.1007/s11160-005-7846-4
   Mirzaei H, 2017, BIOMED PHARMACOTHER, V85, P102, DOI 10.1016/j.biopha.2016.11.098
   Mun SH, 2013, PHYTOMEDICINE, V20, P714, DOI 10.1016/j.phymed.2013.02.006
   Noga E. J., 2011, FISH DIS DIAGNOSIS T
   NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP
   Prasad S, 2014, BIOTECHNOL ADV, V32, P1053, DOI 10.1016/j.biotechadv.2014.04.004
   Qin Ying, 2014, Acta Pharm Sin B, V4, P284, DOI 10.1016/j.apsb.2014.06.006
   Rebecca A. A., 2014, INT J PURE APPL ZOOL, V2
   Rechtman MM, 2010, FEBS LETT, V584, P2485, DOI 10.1016/j.febslet.2010.04.067
   Roitt I., 1998, IMMUNOLOGY, V28, P367
   Saluja B, 2013, PULM PHARMACOL THER, V26, P296, DOI 10.1016/j.pupt.2012.12.009
   Saurabh S, 2008, AQUAC RES, V39, P223, DOI 10.1111/j.1365-2109.2007.01883.x
   Seehofer D, 2010, J SURG RES, V159, P497, DOI 10.1016/j.jss.2008.12.006
   Shi XL, 2015, NEUROSCI LETT, V594, P105, DOI 10.1016/j.neulet.2015.03.045
   Srikanth K, 2013, ENVIRON SCI POLLUT R, V20, P2133, DOI 10.1007/s11356-012-1459-y
   Sun YZ, 2010, FISH SHELLFISH IMMUN, V29, P803, DOI 10.1016/j.fsi.2010.07.018
   Tang HG, 2008, J ZHEJIANG UNIV-SC B, V9, P684, DOI 10.1631/jzus.B0820088
   TODA S, 1985, CHEM PHARM BULL, V33, P1725
   Tyagi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121313
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Verma VK, 2012, FISH SHELLFISH IMMUN, V33, P590, DOI 10.1016/j.fsi.2012.06.031
   Wang JB, 2007, RESERVOIR FISHERIES, V6, P105
NR 60
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0044-8486
EI 1873-5622
J9 AQUACULTURE
JI Aquaculture
PD JUN 1
PY 2017
VL 475
BP 16
EP 23
DI 10.1016/j.aquaculture.2017.03.043
PG 8
WC Fisheries; Marine & Freshwater Biology
SC Fisheries; Marine & Freshwater Biology
GA EW4IF
UT WOS:000402464500003
OA No
DA 2017-08-17
ER

PT J
AU Owayez, AS
   Abd El-Ghany, GM
   Abu Hashim, II
AF Owayez, Ali Saeed
   Abd El-Ghany, Galal Mahmoud
   Abu Hashim, Irhan Ibrahim
TI Potential Use of Polyvinyl Acetate-Polyvinylpyrrolidone Mixture for the
   Development of Atenolol Sustained Release Matrix Tablets: Optimization
   of Formulation through in Vitro-in Vivo Assessment Study
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE polyvinyl acetate-polyvinylpyrrolidone mixture; atenolol; sustained;
   tablet; stability; bioavailability
ID DRUG-RELEASE; TRANSDERMAL DELIVERY; DIRECT COMPRESSION; SR; CELLULOSE;
   POLYMERS
AB The objective of this study was to develop sustained release matrix tablets of atenolol (AT) using different concentrations of polyvinyl acetate polyvinylpyrrolidone mixture (KSR) (20, 30, or 40%) with various types of fillers such as spray dried lactose (SP.D.L), avicel pH 101 (AV), and emcompress (EMS). The physical characteristics of the prepared tablets were evaluated. Characterization of the optimized formulation was performed using Fourier transform (FT)-IR spectroscopy and differential scanning calorimetry (DSC). Moreover, the in vitro release profiles of AT formulations were investigated in different pH dissolution media. Drug release kinetics and mechanisms were also determined. The results revealed that there was no potential incompatibility of the drug with the polymer. The release profiles of AT were affected by the concentration of KSR, fillers used, and pH of the dissolution media. The drug release kinetic from most of the formulations obeyed Higuchi diffusion model. The selected formulae were investigated for their stability by storage at 30 and 40 degrees C with atmospheric humidity and 75% relative humidity (RH), respectively. The results demonstrated that no change in the physicochemical properties of the tablets stored at 30 degrees C/atmospheric RH in comparison with some changes at 40 degrees C/75% RH. Finally, the in vivo study provided an evidence that the optimized AT tablet containing 40% KSR and SP.D.L exhibited prominent higher oral bioavailability and more efficient sustained-release effect than the drug alone or the commercial tablet product. It is noteworthy that KSR could be considered as a promising useful release retardant for the production of AT sustained release matrix tablets.
C1 [Owayez, Ali Saeed; Abd El-Ghany, Galal Mahmoud; Abu Hashim, Irhan Ibrahim] Mansoura Univ, Dept Pharmaceut, Fac Pharm, Mansoura 35516, Egypt.
RP Abu Hashim, II (reprint author), Mansoura Univ, Dept Pharmaceut, Fac Pharm, Mansoura 35516, Egypt.
EM irhanabuhashim@hotmail.com
CR AlKhatib HS, 2010, AAPS PHARMSCITECH, V11, P253, DOI 10.1208/s12249-010-9378-z
   Srinivasa Babu P., 2014, BJPR, V4, P1861
   Barhate S. D., 2011, PHARM LETT, V3, P34
   Bhowmik A., 2013, J APPL PHARM SCI, V3, P103
   Bolhuis G. K., 1996, PHARM POWDER COMPACT, P419
   Buhler V, 2008, KOLL POL EXC PHARM I, P259
   Cho CW, 2004, INT J PHARM, V287, P67, DOI 10.1016/j.ijpharm.2004.08.013
   Das U., 2012, INT CURR PHARM J, V1, P186
   Dash S, 2010, ACTA POL PHARM, V67, P217
   Dey S., 2012, J PHARM PHARM SCI, V4, P433
   Dey S, 2014, INT J BIOL MACROMOL, V65, P346, DOI 10.1016/j.ijbiomac.2014.01.049
   Draganoiu E. S., 2003, THESIS U CINCINNATI, P88
   Ferrari F, 1996, INT J PHARM, V136, P71, DOI 10.1016/0378-5173(96)04489-4
   Fouad EA, 2015, TROP J PHARM RES, V14, P371, DOI 10.4314/tjpr.v14i3.3
   Gibaldi M., 1991, BIOPHARMACEUTICS CLI, p[7, 8, 28, 37, 54, 61, 71, 146, 377]
   Grund J., 2013, THESIS FREIENUNIVERS
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hossain A, 2013, J APPL PHARM SCI, V3, P85
   Ibn Razzak MSM, 2009, PAK J PHARM SCI, V22, P303
   Kim J, 2004, INT J PHARM, V273, P23, DOI 10.1016/j.ijpharm.2003.12.004
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9
   Kumar S., 2013, PHARM LETT, V5, P436
   Lee YS, 2000, AAPS PHARMSCITECH, V1, P44, DOI 10.1208/pt010321
   Lotfipour F., 2004, Farmaco (Lausanne), V59, P819, DOI 10.1016/j.farmac.2004.06.006
   Martindale, 2014, COMPLETE DRUG REFERE, P1308
   Mohsen A, 2012, J PHARM RES, V2, P12
   Mohylyuk V., 2015, INT J PHARM TECH RES, V8, P147
   Mulani H. T., 2011, J PHARM SCI RES, V3, P1233
   Mundargi RC, 2007, DRUG DEV IND PHARM, V33, P79, DOI 10.1080/03639040600975030
   Narla S. K., 2010, INT J CHEM TECH RES, V2, P1153
   Pezzini B. R., 2014, African Journal of Pharmacy and Pharmacology, V8, P1058
   Pragathi N. A., 2015, IJRPNS, V4, P50
   Pundir S, 2013, INT J DRUG RES TECH, V3, P12
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Reza Md Selim, 2002, Pak J Pharm Sci, V15, P63
   Rowe R. C., 2009, HDB PHARM EXCIPIENTS, p[95, 131]
   Sadek H. M., 1981, PHARM TECHNOL, V5, P42
   Sahoo J, 2008, AAPS PHARMSCITECH, V9, P577, DOI 10.1208/s12249-008-9092-2
   Sakr W, 2011, SAUDI PHARM J, V19, P19, DOI 10.1016/j.jsps.2010.11.002
   Sarwar MS, 2012, BRAZ J PHARM SCI, V48, P621, DOI 10.1590/S1984-82502012000400005
   Saxena A., 2013, IPP, V1, P185
   Shao ZJ, 2001, PHARM DEV TECHNOL, V6, P247, DOI 10.1081/PDT-100002201
   Sharma Pushkar R, 2013, J Young Pharm, V5, P167, DOI 10.1016/j.jyp.2013.11.003
   Siepmann F, 2010, J CONTROL RELEASE, V141, P216, DOI 10.1016/j.jconrel.2009.08.027
   Singh I, 2012, ACTA POL PHARM, V69, P87
   Strubing S, 2008, J CONTROL RELEASE, V126, P149, DOI 10.1016/j.jconrel.2007.11.013
   Sumathi S, 2002, J PHARM PHARM SCI, V5, P12
   Tsai TM, 1998, J PHARM SCI, V87, P117, DOI 10.1021/js960486a
   Usman S., 2014, NAT PROD CHEM RES, V2, P1
   Vijayanand P., 2015, PHARM SINICA, V6, P103
   Vueba ML, 2004, EUR J PHARM BIOPHARM, V58, P51, DOI 10.1016/j.ejpb.2004.03.006
   Wadher KJ, 2013, PHARM LETT, V5, P264
   Whalen K., 2015, LIPPINCOTT ILLUSTRAT, P230
   Wiranidchapong C, 2015, DRUG DEV IND PHARM, V41, P1037, DOI 10.3109/03639045.2014.925917
   Yasmin D, 2013, INT J CURR PHARM RES, V2, P112
   Yilmaz B, 2011, ASIAN J CHEM, V23, P49
NR 56
TC 0
Z9 0
U1 1
U2 1
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD JUN
PY 2017
VL 65
IS 6
BP 545
EP 557
PG 13
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA EW4TI
UT WOS:000402493400005
PM 28566647
OA No
DA 2017-08-17
ER

PT J
AU Abdelwahab, NS
   Mohamed, MA
AF Abdelwahab, Nada Sayed
   Mohamed, Mona Ali
TI Three New Methods for Resolving Ternary Mixture with Overlapping
   Spectra: Comparative Study
SO CHEMICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE area under the curve; modified absorption factor; modified amplitude
   center; metronidazole; diloxanide; mebeverine
ID MANIPULATING RATIO SPECTRA; SPECTROPHOTOMETRIC METHODS; ANTIPROTOZOAL
   DRUGS; BINARY-MIXTURE; DOSAGE FORMS; CURVE; AREA
AB In this study three new spectrophotometric methods have been developed and validated for simultaneous determination of ternary mixture of metronidazole (MET), diloxanide (DLX) and mebeverine HCl (MEB) without prior separation steps. The newly introduced methods consisted of several steps utilizing either zero order or ratio spectra without the need for derivatization steps. The developed methods are called area under the curve ("AUC"), modified absorption factor (MAFM) and modified amplitude center (MACM) spectrophotometric methods. Selectivity and validity of the methods were checked by using different synthetic mixtures and by analysis of their combined dosage form where low standard deviation values and good percentage recoveries were obtained. Additionally, methods linearity, accuracy and precision were determined following United States Pharmacopoeia (USP) recommendations. The obtained results were found to agree with the reported ones when they were statistically compared using One Way ANOVA test. These methods are easily applied during drug quality control studies and in laboratories lacking the facilities of chromatographic methods of analysis. Data manipulation steps are very simple, hence these methods can be considered as time and money saving methods comparing to chromatographic methods of analysis.
C1 [Abdelwahab, Nada Sayed] Beni Suef Univ, Pharmaceut Analyt Chem, Fac Pharm, Al Shaheed Shehata Ahmed Hegazy St, Bani Suwayf 62514, Egypt.
   [Mohamed, Mona Ali] Natl Org Drug Control & Res, Pharmaceut Chem Dept, Giza 12654, Egypt.
RP Abdelwahab, NS (reprint author), Beni Suef Univ, Pharmaceut Analyt Chem, Fac Pharm, Al Shaheed Shehata Ahmed Hegazy St, Bani Suwayf 62514, Egypt.
EM nadasayed2003@yahoo.com
CR Abdelaleem EA, 2013, J LIQ CHROMATOGR R T, V36, P1528, DOI 10.1080/10826076.2012.692149
   Abdelaleem EA, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-27
   Abdelaleem EA, 2013, PAK J PHARM SCI, V26, P175
   Abdelrahman MM, 2014, SPECTROCHIM ACTA A, V124, P389, DOI 10.1016/j.saa.2014.01.020
   Abdelrahman MM, 2013, SPECTROCHIM ACTA A, V113, P291, DOI 10.1016/j.saa.2013.04.120
   European Pharmacopoeia, 2002, EUR DIR QUAL MED
   El-Ghobashy M. R., 2008, B FAC PHARM CAIRO, V46, P75
   Farid NF, 2015, SPECTROCHIM ACTA A, V145, P360, DOI 10.1016/j.saa.2015.03.009
   Ghorpade SA, 2010, J CHIL CHEM SOC, V55, P115, DOI 10.4067/S0717-97072010000100027
   Hardman J. G., 1996, PHARM BASIS THERAPEU
   Lotfy HM, 2014, SPECTROCHIM ACTA A, V126, P197, DOI 10.1016/j.saa.2014.02.005
   Lotfy HM, 2013, SPECTROCHIM ACTA A, V113, P107, DOI 10.1016/j.saa.2013.04.064
   Lotfy HM, 2012, SPECTROCHIM ACTA A, V96, P259, DOI 10.1016/j.saa.2012.04.095
   Lotfy H.M., 2013, ANAL CHEM LETT, V3, P208
   Martindale-Extra Pharmacopoeia, 2005, COMPL DRUG REF
   Paramane Sonali, 2006, Indian Journal of Pharmaceutical Sciences, V68, P819
   Patel C.V., 2007, EURASIAN J ANAL CHEM, V2, P159
   Saleh SS, 2014, SPECTROCHIM ACTA A, V132, P239, DOI 10.1016/j.saa.2014.05.004
   Salem H, 2015, SPECTROCHIM ACTA A, V135, P1002, DOI 10.1016/j.saa.2014.07.078
   [Anonymous], 2007, BRIT PHARMACOPOEIA
   [Anonymous], 2012, US PHARM NAT FORM 35
   Youssef RM, 2014, ACTA CHROMATOGR, V26, P67, DOI 10.1556/AChrom.26.2014.1.7
NR 22
TC 0
Z9 0
U1 1
U2 1
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0009-2363
J9 CHEM PHARM BULL
JI Chem. Pharm. Bull.
PD JUN
PY 2017
VL 65
IS 6
BP 558
EP 565
PG 8
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA EW4TI
UT WOS:000402493400006
PM 28566648
OA No
DA 2017-08-17
ER

PT J
AU Helwa, MK
   Caines, PE
AF Helwa, Mohamed K.
   Caines, Peter E.
TI In-Block Controllability of Affine Systems on Polytopes
SO IEEE TRANSACTIONS ON AUTOMATIC CONTROL
LA English
DT Article
DE Controllability; hierarchical control; hybrid systems; invariance
   problems; piecewise affine systems; safety constraints
ID LINEAR-SYSTEMS; HYBRID SYSTEMS; REACH CONTROL; SIMPLICES
AB In this technical note, we introduce the study of the in-block controllability (IBC) of affine systems on polytopes. In particular, we study whether all the states in the interior of a given polytope are mutually accessible through its interior by applying uniformly bounded inputs. The proposed study formalizes controllability under state constraints, and it has strong connections to the study of controllability of piecewise affine hybrid systems. We provide easily checkable necessary conditions for IBC. Then, for an important class of polytopes, simplicial polytopes, we show that these conditions are also sufficient.
C1 [Helwa, Mohamed K.] Univ Toronto, Inst Aerosp Studies, N York, ON M3H 5T6, Canada.
   [Helwa, Mohamed K.] Cairo Univ, Elect Power & Machines Dept, Giza, Egypt.
   [Helwa, Mohamed K.; Caines, Peter E.] McGill Univ, Dept Elect & Comp Engn, Montreal, PQ, Canada.
   [Caines, Peter E.] McGill Univ, Ctr Intelligent Machines, Montreal, PQ, Canada.
RP Helwa, MK (reprint author), Univ Toronto, Inst Aerosp Studies, N York, ON M3H 5T6, Canada.; Helwa, MK (reprint author), Cairo Univ, Elect Power & Machines Dept, Giza, Egypt.
EM mohamed.helwa@robotics.utias.utoronto.ca; peterc@cim.mcgill.ca
CR Barvinok A, 2014, INT MATH RES NOTICES, P4341, DOI 10.1093/imrn/rnt078
   Blanchini F, 1999, AUTOMATICA, V35, P1747, DOI 10.1016/S0005-1098(99)00113-2
   BRAMMER RF, 1972, SIAM J CONTROL, V10, P339, DOI 10.1137/0310026
   Brondsted A., 1983, INTRO CONVEX POLYTOP
   Broucke ME, 2010, SIAM J CONTROL OPTIM, V48, P3482, DOI 10.1137/080735874
   Caines PE, 1998, IEEE T AUTOMAT CONTR, V43, P501, DOI 10.1109/9.664153
   CAINES PE, 1995, SYST CONTROL LETT, V25, P257, DOI 10.1016/0167-6911(94)00090-I
   Caines PE, 2006, LECT NOTES COMPUT SC, V3927, P123
   Camlibel MK, 2008, IEEE T AUTOMAT CONTR, V53, P762, DOI 10.1109/TAC.2008.916660
   CASTELAN EB, 1993, IEEE T AUTOMAT CONTR, V38, P1680, DOI 10.1109/9.262058
   Clarke F. H., 1998, NONSMOOTH ANAL CONTR
   DANSKIN JM, 1966, SIAM J APPL MATH, V14, P641, DOI 10.1137/0114053
   Dorea CET, 1999, EUR J CONTROL, V5, P70
   Filippov A. F., 1988, DIFFERENTIAL EQUATIO
   Girard A, 2007, AUTOMATICA, V43, P1307, DOI 10.1016/j.automatica.2007.01.019
   Habets LCGJM, 2006, IEEE T AUTOMAT CONTR, V51, P938, DOI 10.1109/TAC.2006.876952
   Habets LCGJM, 2004, AUTOMATICA, V40, P21, DOI 10.1016/j.automatica.2003.08.001
   Heemels W. P. M. H., 2007, P 46 IEEE C DEC CONT, P536
   Heemels W. P. M. H., 2008, P 47 IEEE C DEC CONT, P3487
   Helwa M., 2013, THESIS
   Helwa MK, 2015, 2015 54TH IEEE CONFERENCE ON DECISION AND CONTROL (CDC), P276, DOI 10.1109/CDC.2015.7402213
   Helwa MK, 2015, 2015 54TH IEEE CONFERENCE ON DECISION AND CONTROL (CDC), P252, DOI 10.1109/CDC.2015.7402117
   Helwa MK, 2015, AUTOMATICA, V55, P108, DOI 10.1016/j.automatica.2015.02.035
   Helwa MK, 2014, 2014 IEEE 53RD ANNUAL CONFERENCE ON DECISION AND CONTROL (CDC), P3950, DOI 10.1109/CDC.2014.7040003
   Helwa MK, 2014, 2014 IEEE 53RD ANNUAL CONFERENCE ON DECISION AND CONTROL (CDC), P3943, DOI 10.1109/CDC.2014.7040002
   Helwa MK, 2014, 2014 IEEE 53RD ANNUAL CONFERENCE ON DECISION AND CONTROL (CDC), P3936, DOI 10.1109/CDC.2014.7040001
   Helwa MK, 2013, IEEE T AUTOMAT CONTR, V58, P2704, DOI 10.1109/TAC.2013.2256691
   Helwa MK, 2012, IEEE DECIS CONTR P, P4199, DOI 10.1109/CDC.2012.6426521
   Henrion D., 2005, P JOINT IEEE C DEC C, P7581, DOI 10.1109/CDC.2005.1583385
   Hubbard P, 2002, IEEE T AUTOMAT CONTR, V47, P37, DOI 10.1109/9.981721
   Lasdon L. S., 2002, OPTIMIZATION THEORY
   Lee C. W., 1997, HDB DISCRETE COMPUTA, P271
   Moreno JP, 2007, ADV GEOM, V7, P391, DOI 10.1515/ADVGEOM.2007.25
   Rockafella R. T., 1970, CONVEX ANAL
   SONTAG ED, 1984, INT J CONTROL, V39, P181, DOI 10.1080/00207178408933158
   Zamani M, 2012, IEEE T AUTOMAT CONTR, V57, P1804, DOI 10.1109/TAC.2011.2176409
   Zhou T, 2015, AUTOMATICA, V52, P63, DOI 10.1016/j.automatica.2014.10.121
NR 37
TC 0
Z9 0
U1 1
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9286
EI 1558-2523
J9 IEEE T AUTOMAT CONTR
JI IEEE Trans. Autom. Control
PD JUN
PY 2017
VL 62
IS 6
BP 2950
EP 2957
DI 10.1109/TAC.2016.2606363
PG 8
WC Automation & Control Systems; Engineering, Electrical & Electronic
SC Automation & Control Systems; Engineering
GA EW7YG
UT WOS:000402733600028
OA No
DA 2017-08-17
ER

PT J
AU Afia, M
   Alshehri, M
   Alfaifi, M
   Shakor, ABA
AF Afia, Mon
   Alshehri, Mohammed
   Alfaifi, Mohammad
   Shakor, Abo Bakr Abdel
TI Repressive effect of curcumin against 2-amino-3-methylimidazo [4, 5-f]
   quinoline induced hepato- and immunotoxicity in mice
SO INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Apoptosis; Curcuma longa; Cytokines; Heterocyclic aromatic amines;
   Inflammation; IQ mutagenicity; Liver injury; p53; Spice; Tumor
   suppressor protein; Turmeric
ID HETEROCYCLIC AROMATIC-AMINES; CELLS; APOPTOSIS; CANCER; IQ;
   ALPHA-1-ANTITRYPSIN; EXPRESSION; PATHWAYS; LEUKEMIA; ADDUCT
AB The mutagenic heterocyclic amine, 2-amino-3-methylimidazo [4,5-f] quinoline (IQ),produced during cooking of protein rich foods is known to affect liver. Curcumin, a component of turmeric Curcuma longa L., is a safe agent characterized with powerful therapeutic potential. In this study, we explored the possible protective role of curcumin against IQ induced-liver damages on immunological, serological, inflammatory and apoptotic levels. Mice were administered IQ alone or IQ and curcumin together for 1, 15 and 30 days. Our results revealed that IQ exerts time dependent down regulation of p53 and upregulation of bc12 in mice liver, no significant changes were observed in bax and cleaved caspase 3 levels. Curcumin co-administration increased the levels of p53, Bax and cleaved caspase 3 and reduced the level of Bc12 compared with their levels in IQ treated mice. In addition, it was found that curcumin co-administration protects against IQ-induced modulations of some selected serum proteins, leucocytes percentage and cytokines level. Also, the curcumin protected liver cells from IQ-induced inflammation as detected by mRNA level of the inflammatory marker Cc15. We conclude that the dietary curcumin is a powerful repressive natural agent against IQ-induced liver injury.
C1 [Afia, Mon; Shakor, Abo Bakr Abdel] Assiut Univ, Fac Sci, Depaitinent Zool, Lab Mol Cell Biol, Assiut 71516, Egypt.
   [Alshehri, Mohammed; Alfaifi, Mohammad; Shakor, Abo Bakr Abdel] King Khalid Univ, Dept Biol, Fac Sci, Abha, Saudi Arabia.
RP Shakor, ABA (reprint author), Assiut Univ, Fac Sci, Depaitinent Zool, Lab Mol Cell Biol, Assiut 71516, Egypt.; Shakor, ABA (reprint author), King Khalid Univ, Dept Biol, Fac Sci, Abha, Saudi Arabia.
EM eltayeb702002@yahoo.com
FU Assiut University, Assiut, Egypt; King Khalid University, Abha, KSA
FX This work was supported financially by Assiut University, Assiut, Egypt
   for the development of cell and molecular biology research and King
   Khalid University, Abha, KSA for short period projects.
CR ADAMSON RH, 1990, JPN J CANCER RES, V81, P10
   Alrubaie AL, 2015, INDIAN J EXP BIOL, V53, P452
   Bose A, 2015, NUCLEIC ACIDS RES, V43, P8340, DOI 10.1093/nar/gkv750
   Cho JW, 2007, INT J MOL MED, V19, P469
   Coles HE, 1986, VET CLIN PATHOL, P19105
   Ferguson LR, 2012, NUTR CANCER, V64, P218, DOI 10.1080/01635581.2012.638432
   Formanowicz D, 2012, INT UROL NEPHROL, V44, P907, DOI 10.1007/s11255-011-9947-4
   Hirata A, 2007, CANCER SCI, V98, P1164, DOI 10.1111/j.1349-7006.2007.00517.x
   Huang SL, 2015, J AGR FOOD CHEM, V63, P8838, DOI 10.1021/acs.jafc.5b04083
   Kitamura Y, 2006, CANCER SCI, V97, P368, DOI 10.1111/j.1349-7006.2006.00191.x
   Liu YC, 2008, IMMUNOBIOLOGY, V213, P651, DOI 10.1016/j.imbio.2008.02.003
   Mondal G, 2016, GLYCOCONJUGATE J, V33, P209, DOI 10.1007/s10719-016-9658-2
   Mostafavi B, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006180
   Pfau W, 2006, FOOD CHEM TOXICOL, V44, P2086, DOI 10.1016/j.fct.2006.07.011
   Prasad E, 2014, INDIAN J BIOTECHNOL, V13, P324
   Rajan I, 2014, INDIAN J EXP BIOL, V52, P133
   Ryan KM, 2011, EUR J CANCER, V47, P44, DOI 10.1016/j.ejca.2010.10.020
   Saha L, 2016, INDIAN J EXP BIOL, V54, P133
   Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015
   Shakor ABA, 2014, BBA-MOL CELL BIOL L, V1841, P1672, DOI 10.1016/j.bbalip.2014.09.006
   Shishu Singla AK, 2002, INDIAN J EXP BIOL, V40, P1365
   Smerak P, 2006, CZECH J FOOD SCI, V24, P72
   Stavros KM, 2015, CHEM RES TOXICOL, V28, P1455, DOI 10.1021/acs.chemrestox.5b00140
   Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014
   Turesky RJ, 2007, TOXICOL LETT, V168, P219, DOI 10.1016/j.toxlet.2006.10.018
   William BM, 2008, HEMATOLOGY, V13, P333, DOI 10.1179/102453308X343437
   Xie XL, 2012, TOXICOL SCI, V125, P392, DOI 10.1093/toxsci/kfr314
   Yallapu MM, 2013, CURR DRUG METAB, V14, P504
   Yallapu MM, 2012, DRUG DISCOV TODAY, V17, P71, DOI 10.1016/j.drudis.2011.09.009
   Yue X, 2017, J MOL BIOL, V2836, P30163
   Zheng J, 2013, BIOMOL THER, V21, P270, DOI 10.4062/biomolther.2013.030
NR 31
TC 0
Z9 0
U1 1
U2 1
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0019-5189
EI 0975-1009
J9 INDIAN J EXP BIOL
JI Indian J. Exp. Biol.
PD JUN
PY 2017
VL 55
IS 6
BP 365
EP 371
PG 7
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EW9PX
UT WOS:000402852800005
OA No
DA 2017-08-17
ER

PT J
AU Migahed, F
   Abdelrazak, A
   Fawzy, G
AF Migahed, F.
   Abdelrazak, A.
   Fawzy, G.
TI Batch and continuous removal of heavy metals from industrial effluents
   using microbial consortia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Waste water treatment; Biosorption; Microbial consortium; Bioreactor;
   Design of experiment; Microbial immobilization
ID EICOSAPENTAENOIC ACID PRODUCTION; WASTE-WATER; BORON IMPURITY;
   EQUILIBRIUM; BIOSORPTION; ADSORBENTS; ADSORPTION; BIOMASS; COLUMN; IONS
AB Bio-removal of heavy metals, using microbial biomass, increasingly attracting scientific attention due to their significant role in purification of different types of wastewaters making it reusable. Heavy metals were reported to have a significant hazardous effect on human health, and while the conventional methods of removal were found to be insufficient; microbial biosorption was found to be the most suitable alternative. In this work, an immobilized microbial consortium was generated using Statistical Design of Experiment (DOE) as a robust method to screen the efficiency of the microbial isolates in heavy metal removal process. This is the first report of applying Statistical DOE to screen the efficacy of microbial isolates to remove heavy metals instead of screening normal variables. A mixture of bacterial biomass and fungal spores was used both in batch and continuous modes to remove Chromium and Iron ions from industrial effluents. Bakery yeast was applied as a positive control, and all the obtained biosorbent isolates showed more significant efficiency in heavy metal removal. In batch mode, the immobilized biomass was enclosed in a hanged tea bag-like cellulose membrane to facilitate the separation of the biosorbent from the treated solutions, which is one of the main challenges in applying microbial biosorption at large scale. The continuous flow removal was performed using fixed bed mini-bioreactor, and the process was optimized in terms of pH (6) and flow rates (1 ml/min) using Response Surface Methodology. The most potential biosorbent microbes were identified and characterized. The generated microbial consortia and process succeeded in the total removal of Chromium ions and more than half of Iron ions both from standard solutions and industrial effluents.
C1 [Migahed, F.; Abdelrazak, A.; Fawzy, G.] Mansoura Univ, Bot Dept, Fac Sci, Mansoura, Egypt.
   [Abdelrazak, A.] Univ Leeds, Inst Proc Res & Dev, Leeds, W Yorkshire, England.
RP Abdelrazak, A (reprint author), Mansoura Univ, Bot Dept, Fac Sci, Mansoura, Egypt.; Abdelrazak, A (reprint author), Univ Leeds, Inst Proc Res & Dev, Leeds, W Yorkshire, England.
EM A.Abdelrazak@leeds.ac.uk
CR Abd Elrazak A, 2013, J IND MICROBIOL BIOT, V40, P477, DOI 10.1007/s10295-013-1238-x
   Abdel-Satar A.M., 2005, EGYPT J AQUAT RES, V31, P182
   Abdel-Shafy H, 2002, NAVIGATION, V49, P4
   Afifi R, 2016, J LIQ CHROMATOGR R T, V39, P428, DOI 10.1080/10826076.2016.1174712
   Ahalya N., 2003, RES J CHEM ENVIRON, V7, P71
   Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006
   Ali I, 2006, NAT PROTOC, V1, P2661, DOI 10.1038/nprot.2006.370
   Ali I, 2014, SEP PURIF REV, V43, P175, DOI 10.1080/15422119.2012.748671
   Ali I, 2012, J ENVIRON MANAGE, V113, P170, DOI 10.1016/j.jenvman.2012.08.028
   Ali I, 2012, CHEM REV, V112, P5073, DOI 10.1021/cr300133d
   Ali I, 2011, SEP PURIF REV, V40, P25, DOI 10.1080/15422119.2011.542738
   Ali I, 2010, SEP PURIF REV, V39, P95, DOI 10.1080/15422119.2010.527802
   Arica MY, 2004, J HAZARD MATER, V109, P191, DOI 10.1016/j.jhazmat.2004.03.017
   Maah J, 2012, J CHEM, V9, P345, DOI [10.1155/2012/769180, DOI 10.1155/2012/769180]
   Atar N, 2012, CHEM ENG J, V192, P1, DOI 10.1016/j.cej.2012.03.067
   Barnett HL, 1972, ILLUSTRATED GENERA I, P930
   Choi SB, 2006, J HAZARD MATER, V138, P378, DOI 10.1016/j.jhazmat.2006.05.059
   Colak F, 2013, J IND ENG CHEM, V19, P863, DOI 10.1016/j.jiec.2012.11.001
   Cumberlidge N, 2009, MONOGR BIOL, V89, P547
   El Razak AA, 2014, BIOCHEM ENG J, V82, P53, DOI 10.1016/j.bej.2013.10.022
   Engelman R, 1993, POPUL DEV REV, V19, P1
   Faragallah H.M., 2009, EGYPT J ECOLOGY NATU, V1, P106
   Frick C, 1999, P PHYT TECHN SEM MAY, P105
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Ilhan S., 2004, TURKISH ELECT J BIOT, V2, P50
   Malkoc E, 2005, J HAZARD MATER, V127, P120, DOI 10.1016/j.jhazmat.2005.06.030
   Olgun A, 2013, CHEM ENG J, V222, P108, DOI 10.1016/j.cej.2013.02.029
   Olgun A, 2012, J IND ENG CHEM, V18, P1751, DOI 10.1016/j.jiec.2012.03.020
   Parvathi K, 2007, SEP SCI TECHNOL, V42, P625, DOI 10.1080/01496390601070158
   PLACKETT RL, 1946, BIOMETRIKA, V33, P305, DOI 10.2307/2332195
   Rzoska J, 2012, NILE BIOL ANCIENT RI, V29
   Saeed S. M., 2008, P 8 INT S TIL AQ, V2008, P475
   Sawyer C. N., 1978, CHEM ENV ENG
   Vilar VJP, 2007, ADSORPTION, V13, P587, DOI 10.1007/s10450-007-9029-1
   WANG J, 2006, REV BIOTECHNOL ADV, V24, P427, DOI DOI 10.1016/J.BI0TECHADV.2006.03.001
   Webster R, 2008, EUR J SOIL SCI, V59, P1010, DOI [10.1111/j.1365-2389.2008.01052_5.x, DOI 10.1111/J.1365-2389.2008.01052_5.X]
   WIRSEN CO, 1976, ENVIRON SCI TECHNOL, V10, P880, DOI 10.1021/es60120a002
NR 37
TC 0
Z9 0
U1 7
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1735-1472
EI 1735-2630
J9 INT J ENVIRON SCI TE
JI Int. J. Environ. Sci. Technol.
PD JUN
PY 2017
VL 14
IS 6
BP 1169
EP 1180
DI 10.1007/s13762-016-1229-3
PG 12
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EW5JN
UT WOS:000402542000002
OA No
DA 2017-08-17
ER

PT J
AU Ali, AHH
   Ibrahim, MN
AF Ali, A. H. H.
   Ibrahim, M. N.
TI Performance and environmental impact of a turbojet engine fueled by
   blends of biodiesels
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Biodiesel; Combustion; Emission; Gas turbine; JetA-1; Methyl ester;
   Turbojet engine
ID GAS-TURBINE; POLLUTANT EMISSIONS; OIL
AB Depletion of conventional fuels, concerns about environmental pollution and the tightening of exhaust emission legislations are the main reasons for increasing research on alternative fuels produced from agricultural feedstock. In this study, biodiesel fuels produced from cotton and corn vegetable oils are investigated as renewable fuels for a gas turbine engine for aviation. The biodiesel fuels are defined as cotton methyl ester (CTME) and corn methyl ester. The performance characteristics and exhaust emissions of the gas turbine engine are investigated when the engine fueled with three blends of 10%(B10), 20%(B20) and 50%(B50) of biodiesel/JetA-1 by volume. The biodiesel fuels were produced using transesterification process and characterized according to ASTM biodiesel specifications. Chemical and physical properties show a real potential of using biodiesel blends as an alternative for JetA-1. The measured engine performance parameters and exhaust emissions are compared with that of pure JetA-1 over a range of throttle setting. The gas turbine engine used in this study is equipped with pressure, flow, temperature, thrust and speed sensors that connected to data acquisition system and control unit in addition to exhaust gas analyzer. The experimental results show that biodiesel fuels can be used up to blend of 50% with JetA-1 in gas turbine engines with slight enhancement in engine performance and significant improvements in exhaust emissions. The engine static thrust is increased with 2% for B50 at lower and medium engine speeds and decreased with 11% at high engine speed compared to conventional JetA-1 fuel. The thrust-specific fuel consumption for biodiesel blends is lower than that for regular JetA-1 fuel. The gas turbine engine efficiency is increased for biodiesel blends by 14% compared to JetA-1, and this is reported for CTME B50. For oxygen concentration in exhaust gases emissions, the higher the biodiesel blend, the higher the O-2 concentration in the exhaust compared with JetA-1 fuel. The O-2 level increased by 6% for biodiesel blend of B50 compared to JetA-1 fuel. The emissions of CO and HC emissions decreased by 5 and 37%, respectively, compared with conventional JetA-1. Additionally, the biodiesel blends achieve a higher CO2 and NOx emissions with 11 and 27%, respectively, compared to JetA-1. The sulfur dioxide SO2 decreased by 75% compared to the regular JetA-1 fuel.
C1 [Ali, A. H. H.] Assiut Univ, Mech Engn Dept, Fac Engn, Assiut 71516, Egypt.
   [Ibrahim, M. N.] E JUST, Energy Resources Engn Dept, Alexandria 21934, Egypt.
RP Ali, AHH (reprint author), Assiut Univ, Mech Engn Dept, Fac Engn, Assiut 71516, Egypt.
EM ah-hamza@aun.edu.eg
FU Mission Department, Ministry of Higher Education of the Government of
   Egypt
FX The author Mohamed Noureldin Ibrahim would like to acknowledge the
   Mission Department, Ministry of Higher Education of the Government of
   Egypt for the scholarship to study Ph.D. Degree at the Egypt-Japan
   University of Science and Technology, E-JUST.
CR Gires E, 2014, J FUELS
   Asif M, 2007, RENEW SUST ENERG REV, V11, P1388, DOI 10.1016/j.rser.2005.12.004
   Blakey S, 2011, P COMBUST INST, V33, P2863, DOI 10.1016/j.proci.2010.09.011
   Chiang HWD, 2009, INT J TURBO JET ENG, V26, P127
   Chuck CJ, 2014, APPL ENERG, V118, P83, DOI 10.1016/j.apenergy.2013.12.019
   Chum HL, 2001, FUEL PROCESS TECHNOL, V71, P187, DOI 10.1016/S0378-3820(01)00146-1
   Corporan E, 2005, J AIR WASTE MANAGE, V55, P940
   Daggett D., 2006, 25 C INT COUNC AER S
   Daggett DL, 2007, 18 ISABE C ISABE 200
   Demirbas A, 2009, ENERG CONVERS MANAGE, V50, P14, DOI 10.1016/j.enconman.2008.09.001
   do Nascimento MAR, 2011, ADV GAS TURBINE TECH
   Gupta KK, 2010, RENEW SUST ENERG REV, V14, P2946, DOI 10.1016/j.rser.2010.07.025
   Habib Z, 2010, APPL ENERG, V87, P1701, DOI 10.1016/j.apenergy.2009.10.024
   Hashimoto N, 2014, FUEL, V126, P194, DOI 10.1016/j.fuel.2014.02.057
   Ibrahim MN, 2013, THESIS
   Krishna CR, 2007, BNL779272007IR
   Kun-Balog A, 2015, FUEL PROCESS TECHNOL, V134, P352, DOI 10.1016/j.fuproc.2015.02.017
   Lin L, 2011, APPL ENERG, V88, P1020, DOI 10.1016/j.apenergy.2010.09.029
   Maurice LQ, 2001, FUEL, V80, P747, DOI 10.1016/S0016-2361(00)00142-3
   Mendez CJ, 2014, APPL ENERG, V118, P135, DOI 10.1016/j.apenergy.2013.12.011
   Nascimento MAR, 2011, ASME J ENERGY RESOUR, V133
   Nascimento MAR, 2008, ENERGY, V33, P233, DOI 10.1016/j.energy.2007.07.014
   Prussi M, 2012, APPL ENERG, V89, P287, DOI 10.1016/j.apenergy.2011.07.031
   Seljak T, 2014, BIOMASS BIOENERG, V71, P394, DOI 10.1016/j.biombioe.2014.09.016
   Tan EH, 2013, 51 AIAA AER SCI M IN
   Tan EH, 2011, HILLTOP REV, V5, P6
NR 26
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1735-1472
EI 1735-2630
J9 INT J ENVIRON SCI TE
JI Int. J. Environ. Sci. Technol.
PD JUN
PY 2017
VL 14
IS 6
BP 1253
EP 1266
DI 10.1007/s13762-016-1228-4
PG 14
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EW5JN
UT WOS:000402542000010
OA No
DA 2017-08-17
ER

PT J
AU Tarawneh, QY
   El Alfy, M
AF Tarawneh, Q. Y.
   El Alfy, M.
TI Seasonal variation of solar irradiance and sunshine duration in Saudi
   Arabia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Climatology; Meteorological parameters; Saudi Arabia; Solar irradiance;
   Sunshine duration
ID RADIATION; SNOWMELT; CLIMATE; CHINA
AB Saudi Arabia is a huge area with diverse climatic and topographical features. This diversity in climate is augmented by seasonal weather variations. The study discusses solar irradiance and sunshine duration in terms of seasonal weather systems. Sunshine duration and solar irradiance maps show that the East Mediterranean weather systems (such as Cyprus low) in winter affect the majority of the geographical regions in Saudi Arabia. In spring and autumn, Sudan low becomes more active than Cyprus low, especially in the west and central regions. Sunshine duration in April is 47% compared to 50% in January. Sunshine duration in the southwest region is affected by the rainy and wet summer monsoon which reduces sunshine duration to 33% in summer (July), while it is 43% in winter (January). In addition, the study uses the Angstrom equation to estimate solar irradiance. The absolute relative error between estimated and observed solar irradiance ranges between 2 and 10% in the majority of cases, with a few cases exceeding 13%.
C1 [Tarawneh, Q. Y.; El Alfy, M.] King Saud Univ KSA, PSIPW, Prince Sultan Inst Environm Water & Desert Res, Riyadh, Saudi Arabia.
   [El Alfy, M.] Mansoura Univ, Fac Sci, Geol Dept, Mansoura, Egypt.
RP Tarawneh, QY (reprint author), King Saud Univ KSA, PSIPW, Prince Sultan Inst Environm Water & Desert Res, Riyadh, Saudi Arabia.
EM qassemtarawneh@yahoo.com
FU Vice Deanship of Research Chairs at King Saud University
FX The authors wish to express their gratitude to the editor and the
   reviewers for their valuable comments and assistance in revising the
   manuscript. This project was financially supported by the Vice Deanship
   of Research Chairs at King Saud University.
CR A ngstrom A., 1924, Quarterly Journal of the Royal Meteorological Society, V50, P121
   Abdul-Aziz J., 1993, Renewable Energy, V3, P645, DOI 10.1016/0960-1481(93)90071-N
   Aksakal A, 1999, RENEW ENERG, V17, P461, DOI 10.1016/S0960-1481(98)00769-1
   Alkhathlan K, 2015, RENEW SUST ENERG REV, V48, P105, DOI 10.1016/j.rser.2015.03.072
   Almazroui M, 2012, ATMOS RES, V111, P29, DOI 10.1016/j.atmosres.2012.02.013
   Almazroui M, 2011, ATMOS RES, V99, P400, DOI 10.1016/j.atmosres.2010.11.006
   Anslow FS, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000850
   Asheibi A, 2008, POW ENG C 2008 AUPEC, P1
   Gana N.N., 2013, INT J ENG SCI, V2, P58
   Garba AA, 2016, APPL RES J, V2, P19
   Garen DC, 2005, J HYDROL, V315, P126, DOI 10.1016/j.jhydrol.2005.03.026
   Matuszko D, 2012, INT J CLIMATOL, V32, P1527, DOI 10.1002/joc.2370
   MORCRETTE JJ, 1991, J GEOPHYS RES-ATMOS, V96, P9121, DOI 10.1029/89JD01597
   Poudyal KN, 2012, ENERGY POWER ENG, V2012, P415
   Qian Y, 2000, GEOPHYS RES LETT, V27, P3521, DOI 10.1029/2000GL011942
   Sen Z, 2000, SOL ENERGY, V68, P57, DOI 10.1016/S0038-092X(99)00057-2
   Shehadeh N, 1991, CLIMATE JORDAN
   Sirdas S, 2008, HYDROL PROCESS, V22, P1460, DOI 10.1002/hyp.6698
   STONE RJ, 1993, SOL ENERGY, V51, P289, DOI 10.1016/0038-092X(93)90124-7
   Suehrcke H, 2013, SOL ENERGY, V92, P160, DOI 10.1016/j.solener.2013.02.026
   Tarawneh Q, 2003, THEOR APPL CLIMATOL, V74, P123, DOI 10.1007/s00704-002-0705-5
   Tarawneh QY, 2008, ENERG SOURCE PART A, V30, P932, DOI 10.1080/10826070601082682
   Tarawneh QY, 2015, ARAB J GEOSCI, V8, P4147, DOI 10.1007/s12517-014-1468-x
   Tsvieli Y., 2007, ADV GEOSCI, V12, P137, DOI DOI 10.5194/ADGE0-12-137-2007
   Xu Q, 2001, ATMOS ENVIRON, V35, P5029, DOI 10.1016/S1352-2310(01)00315-6
   Zell E, 2015, SOL ENERGY, V119, P422, DOI 10.1016/j.solener.2015.06.031
   Zhang T, 1996, J CLIMATE, V9, P2110, DOI 10.1175/1520-0442(1996)009<2110:IOCOSR>2.0.CO;2
NR 27
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1735-1472
EI 1735-2630
J9 INT J ENVIRON SCI TE
JI Int. J. Environ. Sci. Technol.
PD JUN
PY 2017
VL 14
IS 6
BP 1267
EP 1276
DI 10.1007/s13762-016-1230-x
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EW5JN
UT WOS:000402542000011
OA No
DA 2017-08-17
ER

PT J
AU Kassebaum, N
   Kyu, HH
   Zoeckler, L
   Olsen, H
   Thomas, K
   Pinho, C
   Bhutta, ZA
   Dandona, L
   Ferrari, A
   Ghiwot, TT
   Hay, SI
   Kinfu, Y
   Liang, XF
   Lopez, A
   Malta, DC
   Mokdad, AH
   Naghavi, M
   Patton, GC
   Salomon, J
   Sartorius, B
   Topor-Madry, R
   Vollset, SE
   Werdecker, A
   Whiteford, HA
   Abate, KH
   Abbas, K
   Damtew, SA
   Ahmed, MB
   Akseer, N
   Al-Raddadi, R
   Alemayohu, MA
   Altirkawi, K
   Abajobir, AA
   Amare, AT
   Antonio, CAT
   Amlov, J
   Al Artaman
   Asayesh, H
   Avokpaho, EFGA
   Awasthi, A
   Quintanilla, BPA
   Bacha, U
   Betsu, BD
   Barac, A
   Bamighausen, TW
   Baye, E
   Bedi, N
   Bensenor, IM
   Berhane, A
   Bernabe, E
   Bernal, OA
   Beyene, AS
   Biadgilign, S
   Bikbov, B
   Boyce, CA
   Brazinova, A
   Hailu, GB
   Carter, A
   Castaneda-Orjuela, CA
   Catala-Lopez, F
   Charlson, FJ
   Chitheer, AA
   Choi, JYJ
   Ciobanu, LG
   Crump, J
   Dandona, R
   Dellavalle, RP
   Deribew, A
   Deveber, G
   Dicker, D
   Ding, EL
   Dubey, M
   Endries, AY
   Erskine, HE
   Faraon, EJA
   Faro, A
   Farzadfar, F
   Fernandes, JC
   Fijabi, DO
   Fitzmaurice, C
   Fleming, TD
   Flor, LS
   Foreman, KJ
   Franklin, RC
   Fraser, MS
   Frostad, JJ
   Fullman, N
   Gebregergs, GB
   Gebru, AA
   Geleijnse, JM
   Gibney, KB
   Yihdego, MG
   Ginawi, IAM
   Gishu, MD
   Gizachew, TA
   Glaser, E
   Gold, AL
   Goldberg, E
   Gona, P
   Goto, A
   Gugnani, HC
   Jiang, GH
   Gupta, R
   Tesfay, FH
   Hankey, GJ
   Havmoeller, R
   Hijar, M
   Horino, M
   Hosgood, HD
   Hu, GQ
   Jacobsen, KH
   Jakovljevic, MB
   Jayaraman, SP
   Jha, V
   Jibat, T
   Johnson, CO
   Jonas, J
   Kasaeian, A
   Kawakami, N
   Keiyoro, PN
   Khalil, I
   Khang, YH
   Khubchandani, J
   Ahmad Kiadaliri, AA
   Kieling, C
   Kim, D
   Kissoon, N
   Knibbs, LD
   Koyanagi, A
   Krohn, KJ
   Defo, BK
   Bicer, BK
   Kulikoff, R
   Kumar, A
   Lal, DK
   Lam, HY
   Larson, HJ
   Larsson, A
   Laryea, DO
   Leung, J
   Lim, SS
   Lo, LT
   Lo, WD
   Looker, KJ
   Lotufo, PA
   El Razek, HMA
   Malekzadeh, R
   Shifti, DM
   Mazidi, M
   Meaney, PA
   Meles, KG
   Memiah, P
   Mendoza, W
   Mengistie, MA
   Mengistu, G
   Mensah, GA
   Miller, TR
   Mock, C
   Mohammadi, A
   Mohammed, S
   Monasta, L
   Mueller, U
   Nagata, C
   Naheed, A
   Nguyen, G
   Le Nguyen, Q
   Nsoesie, E
   Oh, IH
   Okoro, A
   Olusanya, JO
   Olusanya, BO
   Ortiz, A
   Paudel, D
   Pereira, DM
   Perico, N
   Petzold, M
   Phillips, MR
   Polanczyk, GV
   Pourmalek, F
   Qorbani, M
   Rafay, A
   Rahimi-Movaghar, V
   Rahman, M
   Rai, RK
   Ram, U
   Rankin, Z
   Remuzzi, G
   Renzaho, AMN
   Roba, HS
   Rojas-Rueda, D
   Ronfani, L
   Sagar, R
   Sanabria, JR
   Mohammed, MSK
   Santos, IS
   Satpathy, M
   Sawhney, M
   Ben Schottker
   Schwebel, DC
   Scott, JG
   Sepanlou, SG
   Shaheen, A
   Shaikh, MA
   She, J
   Shiri, R
   Shiue, I
   Sigfusdottir, ID
   Singh, J
   Silpakit, N
   Smith, A
   Sreeramareddy, C
   Stanaway, JD
   Stein, DJ
   Steiner, C
   Sufiyan, MB
   Swaminathan, S
   Tabares-Seisdedos, R
   Tabb, KM
   Tadese, F
   Tavakkoli, M
   Taye, B
   Teeple, S
   Tegegne, TK
   Shifa, GT
   Terkawi, AS
   Thomas, B
   Thomson, AJ
   Tobe-Gai, R
   Tonelli, M
   Tran, BX
   Troeger, C
   Ukwaja, KN
   Uthman, O
   Vasankari, T
   Venketasubramanian, N
   Vlassov, VV
   Weiderpass, E
   Weintraub, R
   Gebrehiwot, SW
   Westerman, R
   Williams, HC
   Wolfe, CDA
   Woodbrook, R
   Yano, Y
   Yonemoto, N
   Yoon, SJ
   Younis, MZ
   Yu, CH
   Zaki, MES
   Zegeye, EA
   Zuhlke, LJ
   Murray, CJL
   Vos, T
AF Kassebaum, Nicholas
   Hmwe Kyu, Hmwe
   Zoeckler, Leo
   Elizabeth Olsen, Helen
   Thomas, Katie
   Pinho, Christine
   Bhutta, Zulfiqar A.
   Dandona, Lalit
   Ferrari, Alize
   Ghiwot, Tsegaye Tewelde
   Hay, Simon I.
   Kinfu, Yohannes
   Liang, Xiaofeng
   Lopez, Alan
   Carvalho Malta, Deborah
   Mokdad, Ali H.
   Naghavi, Mohsen
   Patton, George C.
   Salomon, Joshua
   Sartorius, Benn
   Topor-Madry, Roman
   Vollset, Stein Emil
   Werdecker, Andrea
   Whiteford, Harvey A.
   Abate, Kalkidan Hasen
   Abbas, Kaja
   Damtew, Solomon Abrha
   Ahmed, Muktar Beshir
   Akseer, Nadia
   Al-Raddadi, Rajaa
   Alemayohu, Mulubirhan Assefa
   Altirkawi, Khalid
   Abajobir, Amanuel Alemu
   Amare, Azmeraw T.
   Antonio, Carl A. T.
   Amlov, Johan
   Al Artaman
   Asayesh, Hamid
   Avokpaho, Euripide Frinel G. Arthur
   Awasthi, Ashish
   Quintanilla, Beatriz Paulina Ayala
   Bacha, Umar
   Betsu, Balem Demtsu
   Barac, Aleksandra
   Bamighausen, Till Winfried
   Baye, Estifanos
   Bedi, Neeraj
   Bensenor, Isabela M.
   Berhane, Adugnaw
   Bernabe, Eduardo
   Alberto Bernal, Oscar
   Beyene, Addisu Shunu
   Biadgilign, Sibhatu
   Bikbov, Boris
   Anne Boyce, Cheryl
   Brazinova, Alexandra
   Hailu, Gessessew Bugssa
   Carter, Austin
   Castaneda-Orjuela, Carlos A.
   Catala-Lopez, Ferran
   Charlson, Fiona J.
   Chitheer, Abdulaal A.
   Choi, Jee-Young Jasmine
   Ciobanu, Liliana G.
   Crump, John
   Dandona, Rakhi
   Dellavalle, Robert P.
   Deribew, Amare
   deveber, Gabrielle
   Dicker, Daniel
   Ding, Eric L.
   Dubey, Manisha
   Endries, Amanuel Yesuf
   Erskine, Holly E.
   Faraon, Emerito Jose Aquino
   Faro, Andre
   Farzadfar, Farshad
   Fernandes, Joao C.
   Obadare Fijabi, Daniel
   Fitzmaurice, Christina
   Fleming, Thomas D.
   Sorio Flor, Luisa
   Foreman, Kyle J.
   Franklin, Richard C.
   Fraser, Maya S.
   Frostad, Joseph J.
   Fullman, Nancy
   Gebregergs, Gebremedhin Berhe
   Gebru, Alemseged Aregay
   Geleijnse, Johanna M.
   Gibney, Katherine B.
   Yihdego, Mahari Gidey
   Ginawi, Ibrahim Abdelmageem Mohamed
   Gishu, Melkamu Dedefo
   Gizachew, Tessema Assefa
   Glaser, Elizabeth
   Gold, Audra L.
   Goldberg, Ellen
   Gona, Philimon
   Goto, Atsushi
   Gugnani, Harish Chander
   Jiang, Guohong
   Gupta, Rajeev
   Tesfay, Fisaha Haile
   Hankey, Graeme J.
   Havmoeller, Rasmus
   Hijar, Martha
   Horino, Masako
   Hosgood, H. Dean
   Hu, Guoqing
   Jacobsen, Kathryn H.
   Jakovljevic, Mihajlo B.
   Jayaraman, Sudha P.
   Jha, Vivekanand
   Jibat, Tariku
   Johnson, Catherine O.
   Jonas, Jost
   Kasaeian, Amir
   Kawakami, Norito
   Keiyoro, Peter N.
   Khalil, Ibrahim
   Khang, Young-Ho
   Khubchandani, Jagdish
   Ahmad Kiadaliri, Aliasghar A.
   Kieling, Christian
   Kim, Daniel
   Kissoon, Niranjan
   Knibbs, Luke D.
   Koyanagi, Ai
   Krohn, Kristopher J.
   Defo, Barthelemy Kuate
   Bicer, Burcu Kucuk
   Kulikoff, Rachel
   Kumar, Anil
   Lal, Dharmesh Kumar
   Lam, Hilton Y.
   Larson, Heidi J.
   Larsson, Anders
   Laryea, Dennis Odai
   Leung, Janni
   Lim, Stephen S.
   Lo, Loon-Tzian
   Lo, Warren D.
   Looker, Katharine J.
   Lotufo, Paulo A.
   El Razek, Hassan Magdy Abd
   Malekzadeh, Reza
   Shifti, Desalegn Markos
   Mazidi, Mohsen
   Meaney, Peter A.
   Meles, Kidanu Gebremariam
   Memiah, Peter
   Mendoza, Walter
   Mengistie, Mubarek Abera
   Mengistu, Gebremichael Welday
   Mensah, George A.
   Miller, Ted R.
   Mock, Charles
   Mohammadi, Alireza
   Mohammed, Shafiu
   Monasta, Lorenzo
   Mueller, Ulrich
   Nagata, Chie
   Naheed, Aliya
   Nguyen, Grant
   Le Nguyen, Quyen
   Nsoesie, Elaine
   Oh, In-Hwan
   Okoro, Anselm
   Olusanya, Jacob Olusegun
   Olusanya, Bolajoko O.
   Ortiz, Alberto
   Paudel, Deepak
   Pereira, David M.
   Perico, Norberto
   Petzold, Max
   Phillips, Michael Robert
   Polanczyk, Guilherme V.
   Pourmalek, Farshad
   Qorbani, Mostafa
   Rafay, Anwar
   Rahimi-Movaghar, Vafa
   Rahman, Mahfuzar
   Rai, Rajesh Kumar
   Ram, Usha
   Rankin, Zane
   Remuzzi, Giuseppe
   Renzaho, Andre M. N.
   Roba, Hirbo Shore
   Rojas-Rueda, David
   Ronfani, Luca
   Sagar, Rajesh
   Sanabria, Juan Ramon
   Mohammed, Muktar Sano Kedir
   Santos, Itamar S.
   Satpathy, Maheswar
   Sawhney, Monika
   Ben Schottker
   Schwebel, David C.
   Scott, James G.
   Sepanlou, Sadaf G.
   Shaheen, Amira
   Shaikh, Masood Ali
   She, June
   Shiri, Rahman
   Shiue, Ivy
   Sigfusdottir, Inga Dora
   Singh, Jasvinder
   Silpakit, Naris
   Smith, Alison
   Sreeramareddy, Chandrashekhar
   Stanaway, Jeffrey D.
   Stein, Dan J.
   Steiner, Caitlyn
   Sufiyan, Muawiyyah Babale
   Swaminathan, Soumya
   Tabares-Seisdedos, Rafael
   Tabb, Karen M.
   Tadese, Fentaw
   Tavakkoli, Mohammad
   Taye, Bineyam
   Teeple, Stephanie
   Tegegne, Teketo Kassaw
   Shifa, Girma Temam
   Terkawi, Abdullah Sulieman
   Thomas, Bernadette
   Thomson, Alan J.
   Tobe-Gai, Ruoyan
   Tonelli, Marcello
   Tran, Bach Xuan
   Troeger, Christopher
   Ukwaja, Kingsley N.
   Uthman, Olalekan
   Vasankari, Tommi
   Venketasubramanian, Narayanaswamy
   Vlassov, Vasiliy Victorovich
   Weiderpass, Elisabete
   Weintraub, Robert
   Gebrehiwot, Solomon Weldemariam
   Westerman, Ronny
   Williams, Hywel C.
   Wolfe, Charles D. A.
   Woodbrook, Rachel
   Yano, Yuichiro
   Yonemoto, Naohiro
   Yoon, Seok-Jun
   Younis, Mustafa Z.
   Yu, Chuanhua
   Zaki, Maysaa El Sayed
   Zegeye, Elias Asfaw
   Zuhlke, Liesl Joanna
   Murray, Christopher J. L.
   Vos, Theo
TI Child and Adolescent Health From 1990 to 2015 Findings From the Global
   Burden of Diseases, Injuries, and Risk Factors 2015 Study
SO JAMA PEDIATRICS
LA English
DT Article
ID TRAUMATIC BRAIN-INJURY; SYSTEMATIC ANALYSIS; DISABILITY WEIGHTS;
   NATIONAL INCIDENCE; LIFE EXPECTANCY; UNITED-STATES; FOLLOW-UP;
   MORTALITY; POPULATION; COUNTRIES
AB IMPORTANCE Comprehensive and timely monitoring of disease burden in all age groups, including children and adolescents, is essential for improving population health.
   OBJECTIVE To quantify and describe levels and trends of mortality and nonfatal health outcomes among children and adolescents from 1990 to 2015 to provide a framework for policy discussion.
   EVIDENCE REVIEW Cause-specific mortality and nonfatal health outcomes were analyzed for 195 countries and territories by age group, sex, and year from 1990 to 2015 using standardized approaches for data processing and statistical modeling, with subsequent analysis of the findings to describe levels and trends across geography and time among children and adolescents 19 years or younger. A composite indicator of income, education, and fertility was developed (Socio-demographic Index [SDI]) for each geographic unit and year, which evaluates the historical association between SDI and health loss.
   FINDINGS Global child and adolescent mortality decreased from 14.18 million (95% uncertainty interval [UI], 14.09 million to 14.28 million) deaths in 1990 to 7.26 million (95% UI, 7.14 million to 7.39 million) deaths in 2015, but progress has been unevenly distributed. Countries with a lower SDI had a larger proportion of mortality burden (75%) in 2015 than was the case in 1990 (61%). Most deaths in 2015 occurred in South Asia and sub-Saharan Africa. Global trends were driven by reductions in mortality owing to infectious, nutritional, and neonatal disorders, which in the aggregate led to a relative increase in the importance of noncommunicable diseases and injuries in explaining global disease burden. The absolute burden of disability in children and adolescents increased 4.3%(95% UI, 3.1%-5.6%) from 1990 to 2015, with much of the increase owing to population growth and improved survival for children and adolescents to older ages. Other than infectious conditions, many top causes of disability are associated with long-term sequelae of conditions present at birth (eg, neonatal disorders, congenital birth defects, and hemoglobinopathies) and complications of a variety of infections and nutritional deficiencies. Anemia, developmental intellectual disability, hearing loss, epilepsy, and vision loss are important contributors to childhood disability that can arise from multiple causes. Maternal and reproductive health remains a key cause of disease burden in adolescent females, especially in lower-SDI countries. In low-SDI countries, mortality is the primary driver of health loss for children and adolescents, whereas disability predominates in higher-SDI locations; the specific pattern of epidemiological transition varies across diseases and injuries.
   CONCLUSIONS AND RELEVANCE Consistent international attention and investment have led to sustained improvements in causes of health loss among children and adolescents in many countries, although progress has been uneven. The persistence of infectious diseases in some countries, coupled with ongoing epidemiologic transition to injuries and noncommunicable diseases, require all countries to carefully evaluate and implement appropriate strategies to maximize the health of their children and adolescents and for the international community to carefully consider which elements of child and adolescent health should be monitored.
C1 [Kassebaum, Nicholas; Hmwe Kyu, Hmwe; Zoeckler, Leo; Elizabeth Olsen, Helen; Thomas, Katie; Pinho, Christine; Dandona, Lalit; Hay, Simon I.; Mokdad, Ali H.; Naghavi, Mohsen; Carter, Austin; Dicker, Daniel; Fitzmaurice, Christina; Fleming, Thomas D.; Foreman, Kyle J.; Fraser, Maya S.; Frostad, Joseph J.; Fullman, Nancy; Gold, Audra L.; Goldberg, Ellen; Johnson, Catherine O.; Khalil, Ibrahim; Krohn, Kristopher J.; Kulikoff, Rachel; Lim, Stephen S.; Nguyen, Grant; Nsoesie, Elaine; Rankin, Zane; Silpakit, Naris; Smith, Alison; Stanaway, Jeffrey D.; Steiner, Caitlyn; Teeple, Stephanie; Thomas, Bernadette; Troeger, Christopher; Woodbrook, Rachel; Murray, Christopher J. L.; Vos, Theo] Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Ste 600, Seattle, WA 98121 USA.
   [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan.
   [Dandona, Lalit] Publ Hlth Fdn India, Gurgaon 122002, India.
   [Ferrari, Alize; Whiteford, Harvey A.; Abajobir, Amanuel Alemu; Charlson, Fiona J.; Knibbs, Luke D.; Larson, Heidi J.; Leung, Janni] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.
   [Ghiwot, Tsegaye Tewelde; Abate, Kalkidan Hasen; Ahmed, Muktar Beshir; Mengistie, Mubarek Abera] Jimma Univ, Jimma, Ethiopia.
   [Hay, Simon I.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England.
   [Kinfu, Yohannes] Univ Canberra, Ctr Res & Action Publ Hlth, Canberra, ACT, Australia.
   [Liang, Xiaofeng] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.
   [Lopez, Alan] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.
   [Carvalho Malta, Deborah] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Patton, George C.] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Salomon, Joshua; Bamighausen, Till Winfried; Ding, Eric L.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [Sartorius, Benn] Univ KwaZulu Natal, South African Med Res Council, Sch Nursing & Publ Hlth, Durban, South Africa.
   [Sartorius, Benn] Univ KwaZulu Natal, Gastrointestinal Canc Res Ctr, Durban, South Africa.
   [Topor-Madry, Roman] Jagiellonian Univ, Med Coll, Fac Hlth Sci, Inst Publ Hlth, Krakow, Poland.
   [Vollset, Stein Emil] Norwegian Inst Publ Hlth, Ctr Dis Burden, Bergen, Norway.
   [Werdecker, Andrea; Mueller, Ulrich; Westerman, Ronny] Fed Inst Populat Res, Wiesbaden, Germany.
   [Abbas, Kaja] Virginia Tech, Dept Populat Hlth, Blacksburg, VA USA.
   [Damtew, Solomon Abrha] Wolaita Soda Univ, Wolaita Soda, Ethiopia.
   [Akseer, Nadia; deveber, Gabrielle] Hosp Sick Children, Ctr Child Hlth, Toronto, ON, Canada.
   [Al-Raddadi, Rajaa] Minist Hlth, Jeddah, Saudi Arabia.
   [Alemayohu, Mulubirhan Assefa; Betsu, Balem Demtsu; Hailu, Gessessew Bugssa; Gebregergs, Gebremedhin Berhe; Gebru, Alemseged Aregay; Tesfay, Fisaha Haile; Meles, Kidanu Gebremariam; Mengistu, Gebremichael Welday; Gebrehiwot, Solomon Weldemariam] Mekelle Univ, Mekelle, Ethiopia.
   [Altirkawi, Khalid] King Saud Univ, Riyadh, Saudi Arabia.
   [Amare, Azmeraw T.; Ciobanu, Liliana G.; Gizachew, Tessema Assefa] Univ Adelaide, Adelaide, SA, Australia.
   [Antonio, Carl A. T.; Faraon, Emerito Jose Aquino] Univ Philippines, Dept Hlth Policy & Adm, Manila, Philippines.
   [Amlov, Johan; Larsson, Anders] Uppsala Univ, Dept Med Serv, Uppsala, Sweden.
   [Amlov, Johan] Dalarna Univ, Uppsala, Sweden.
   [Al Artaman] Univ Manitoba, Winnipeg, MB, Canada.
   [Asayesh, Hamid] Qom Univ Med Sci, Qom, Iran.
   [Avokpaho, Euripide Frinel G. Arthur] Inst Rech Clin Benin, Cotonou, Benin.
   [Awasthi, Ashish] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India.
   [Quintanilla, Beatriz Paulina Ayala] La Trobe Univ, Judith Lumley Ctr Mother Infant & Family Hlth Res, Melbourne, Vic, Australia.
   [Bacha, Umar] Univ Management & Technol, Sch Hlth Sci, Lahore, Pakistan.
   [Barac, Aleksandra] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Baye, Estifanos] Monash Univ, Melbourne, Vic, Australia.
   [Bedi, Neeraj] Coll Publ Hlth & Trop Med, Jazan, Saudi Arabia.
   [Bensenor, Isabela M.; Polanczyk, Guilherme V.; Santos, Itamar S.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Berhane, Adugnaw; Lotufo, Paulo A.] Debre Berhan Univ, Coll Hlth Sci, Debre Berhan, Ethiopia.
   [Bernabe, Eduardo] Kings Coll London, London, England.
   [Alberto Bernal, Oscar; Wolfe, Charles D. A.] Univ Andes, Bogota, Colombia.
   [Beyene, Addisu Shunu; Roba, Hirbo Shore] Haramaya Univ, Dire Dawa, Ethiopia.
   [Biadgilign, Sibhatu; Gishu, Melkamu Dedefo] Independent Publ Hlth Consultants, Addis Ababa, Ethiopia.
   [Bikbov, Boris] VI Shumakov Fed Res Ctr Transplantol & Artificial, Dept Nephrol Issues Transplanted Kidney, Moscow, Russia.
   [Anne Boyce, Cheryl; Mensah, George A.] NIH, Natl Heart Lung & Blood Inst, Bldg 10, Bethesda, MD 20892 USA.
   [Brazinova, Alexandra] Trnava Univ, Dept Publ Hlth, Fac Hlth Sci & SocialWork, Trnava, Slovakia.
   [Castaneda-Orjuela, Carlos A.] Inst Nacl Salud, Bogota, Colombia.
   [Catala-Lopez, Ferran; Tabares-Seisdedos, Rafael] Univ Valencia, Valencia, Spain.
   [Catala-Lopez, Ferran] Hlth Res Inst, Valencia, Spain.
   [Catala-Lopez, Ferran] CIBERSAM, Valencia, Spain.
   [Chitheer, Abdulaal A.] Minist Hlth, Baghdad, Iraq.
   [Choi, Jee-Young Jasmine; Khang, Young-Ho] Seoul Natl Univ, Seoul, South Korea.
   [Crump, John] Univ Otago, Dept Ctr Int Hlth, Dunedin, New Zealand.
   [Dandona, Rakhi; Lal, Dharmesh Kumar] Publ Hlth Fdn India, New Delhi, India.
   [Dellavalle, Robert P.] Univ Colorado, Sch Publ Hlth, Sch Med, Aurora, CO USA.
   [Deribew, Amare] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Dubey, Manisha; Ram, Usha] Int Inst Populat Sci, Mumbai, Maharashtra, India.
   [Endries, Amanuel Yesuf; Shifa, Girma Temam] Arba Minch Univ, Arba Minch, Ethiopia.
   [Erskine, Holly E.] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia.
   [Faro, Andre] Univ Fed Sergipe, Aracaju, Brazil.
   [Farzadfar, Farshad; Kasaeian, Amir; Malekzadeh, Reza; Rahimi-Movaghar, Vafa; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Tehran, Iran.
   [Fernandes, Joao C.] Catholic Univ Portugal, Ctr Biotechnol & Fine Chem, Oporto, Portugal.
   [Obadare Fijabi, Daniel; Glaser, Elizabeth] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA.
   [Sorio Flor, Luisa] Escola Nacl Saude Publica, Sergio Arouca Fiocruz, Rio De Janeiro, Brazil.
   [Franklin, Richard C.] James Cook Univ, Townsville, Qld, Australia.
   [Geleijnse, Johanna M.; Jibat, Tariku] Wageningen Univ, Wageningen, Netherlands.
   [Gibney, Katherine B.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.
   [Yihdego, Mahari Gidey; Jibat, Tariku] Addis Ababa Univ, Addis Ababa, Ethiopia.
   [Yihdego, Mahari Gidey; Mohammed, Muktar Sano Kedir] Mizan Tepi Univ, Dept Publ Hlth, Mizan Teferi, Ethiopia.
   [Ginawi, Ibrahim Abdelmageem Mohamed] Univ Hail, Coll Med, Hail, Saudi Arabia.
   [Gona, Philimon] Univ Massachusetts, Boston, MA USA.
   [Goto, Atsushi] Natl Canc Ctr, Tokyo, Japan.
   [Gugnani, Harish Chander] St James Sch Med, Dept Microbiol, Dept Epidemiol, Quarter, Anguilla.
   [Gugnani, Harish Chander] St James Sch Med, Dept Microbiol, Dept Biostat, Quarter, Anguilla.
   [Jiang, Guohong] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China.
   [Gupta, Rajeev] Eternal Heart Care Ctr & Res Inst, Jaipur, Rajasthan, India.
   [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia.
   [Havmoeller, Rasmus] Karolinska Inst, Stockholm, Sweden.
   [Hijar, Martha] Fdn Entornos, Cuernavaca, Morelos, Mexico.
   [Horino, Masako] Nevada Div Publ & Behav Hlth, Carson, CA USA.
   [Hosgood, H. Dean] Albert Einstein Coll Med, Bronx, NY 10467 USA.
   [Hu, Guoqing] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.
   [Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA.
   [Jakovljevic, Mihajlo B.] Univ Kragujevac, Kragujevac, Serbia.
   [Jayaraman, Sudha P.] Virginia Commonwealth Univ, Med Coll Virginia Campus, Richmond, VA USA.
   [Jha, Vivekanand] George Inst Global Hlth, New Delhi, India.
   [Jha, Vivekanand] Univ Oxford, Oxford, England.
   [Jonas, Jost] Ruprecht Karlas Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany.
   [Kawakami, Norito] Univ Tokyo, Sch Publ Hlth, Tokyo, Japan.
   [Keiyoro, Peter N.] Univ Nairobi, Nairobi, Kenya.
   [Khubchandani, Jagdish] Ball State Univ, Muncie, IN 47306 USA.
   [Ahmad Kiadaliri, Aliasghar A.] Lund Univ, Dept Clin Sci, Lund, Sweden.
   [Kieling, Christian] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Kieling, Christian] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Kim, Daniel] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA.
   [Kissoon, Niranjan; Pourmalek, Farshad] Univ British Columbia, Vancouver, BC, Canada.
   [Koyanagi, Ai] Parc Sanitari Sant Joan Deu, Res & Dev Unit, Barcelona, Spain.
   [Defo, Barthelemy Kuate] Univ Montreal, Montreal, PQ, Canada.
   [Bicer, Burcu Kucuk] Hacettepe Univ, Inst Publ Hlth, Ankara, Turkey.
   [Lam, Hilton Y.] NIH, Inst Hlth Policy & Dev Studies, Manila, Philippines.
   [Larson, Heidi J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Laryea, Dennis Odai] Komfo Anokye Teaching Hosp, Kumasi, Ghana.
   [Lo, Loon-Tzian] UnionHealth Assoc LLC, St Louis, MO USA.
   [Lo, Loon-Tzian] Alton Mental Hlth Ctr, Alton, IL USA.
   [Lo, Warren D.] Ohio State Univ, Dept Neurol, Dept Pediat, Columbus, OH 43210 USA.
   [Looker, Katharine J.] Univ Bristol, Bristol, Avon, England.
   [El Razek, Hassan Magdy Abd; Zaki, Maysaa El Sayed] Mansoura Univ, Fac Med, Mansoura, Egypt.
   [Shifti, Desalegn Markos] MaddaWalabu Univ, Robe, Ethiopia.
   [Mazidi, Mohsen] Chinese Acad Sci, Key State Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China.
   [Meaney, Peter A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Memiah, Peter] Univ West Florida, Pensacola, FL 32514 USA.
   [Mendoza, Walter] United Nations Populat Fund, Lima, Peru.
   [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA.
   [Mock, Charles] Univ Washington, Sch Global Hlth, Sch Med, Seattle, WA 98195 USA.
   [Mohammadi, Alireza; Sufiyan, Muawiyyah Babale] Baqiyatallah Univ Med Sci, Tehran, Iran.
   [Mohammed, Shafiu] Ahmadu Bello Univ, Zaria, Kaduna, Nigeria.
   [Monasta, Lorenzo; Ronfani, Luca] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.
   [Nagata, Chie; Tobe-Gai, Ruoyan] Natl Ctr Child Hlth & Dev, Tokyo, Japan.
   [Naheed, Aliya] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh.
   [Le Nguyen, Quyen] Duy Tan Univ, Inst Global Hlth, Da Nang, Vietnam.
   [Oh, In-Hwan] Kyung Hee Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
   [Okoro, Anselm] Soc Family Hlth, Abuja, Nigeria.
   [Olusanya, Jacob Olusegun] Ctr Healthy Start Initiat, Lagos, Nigeria.
   [Olusanya, Bolajoko O.; Ortiz, Alberto] IIS Fdn Jimenez Diaz UAM, Madrid, Spain.
   [Paudel, Deepak] UK Dept Int Dev, Lalitpur, Nepal.
   [Pereira, David M.] Univ Porto, Oporto, Portugal.
   [Perico, Norberto] Ist Rich Farmacol Mario Negri, Bergamo, Italy.
   [Petzold, Max] Univ Gothenburg, Hlth Metr Unit, Gothenburg, Sweden.
   [Phillips, Michael Robert] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China.
   [Qorbani, Mostafa] Alborz Univ Med Sci, Sch Med, Karaj, Iran.
   [Rafay, Anwar] Contect Int Hlth Consultants, Lahore, Punjab, Pakistan.
   [Rahman, Mahfuzar] Res & Evaluat Div, Bldg Resources Access Communities, Dhaka, Bangladesh.
   [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India.
   [Remuzzi, Giuseppe] Int Soc Nephrol, Brussels, Belgium.
   [Renzaho, Andre M. N.] Western Sydney Univ, Penrith, NSW, Australia.
   [Rojas-Rueda, David] ISGlobal Inst Salud Global Barcelona, Barcelona, Spain.
   [Sagar, Rajesh; Satpathy, Maheswar] India Inst Med Sci, New Delhi, India.
   [Sanabria, Juan Ramon; Sawhney, Monika] Marshall Univ, Huntington, WV USA.
   [Ben Schottker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.
   [Ben Schottker] FOM Univ, Inst Hlth Care & Social Sci, Essen, Germany.
   [Schwebel, David C.; Singh, Jasvinder] Univ Alabama Birmingham, Birmingham, AL USA.
   [Scott, James G.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.
   [Shaheen, Amira] An Najah Univ, Dept Publ Hlth, Nablus, Palestine.
   [Shaikh, Masood Ali] Independent Consultant, Karachi, Pakistan.
   [She, June] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China.
   [Shiri, Rahman] Univ Helsinki, Work Organizat Disabil Program, Finnish Inst Occupat Hlth, Helsinki, Finland.
   [Shiue, Ivy] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England.
   [Sigfusdottir, Inga Dora] Reykjavik Univ, Reykjavik, Iceland.
   [Sreeramareddy, Chandrashekhar] Int Med Univ, Dept Community Med, Kuala Lumpur, Selangor, Malaysia.
   [Stein, Dan J.] Univ Cape Town, Dept Psychiat, Cape Town, South Africa.
   [Swaminathan, Soumya] Indian Council Med Res, Chennai, Tamil Nadu, India.
   [Tabb, Karen M.] Univ Illinois, Champaign, IL 61820 USA.
   [Tadese, Fentaw; Tegegne, Teketo Kassaw] Debre Markos Univ, Debre Markos, Ethiopia.
   [Tavakkoli, Mohammad] New York Med Ctr, Valhalla, NY USA.
   [Taye, Bineyam] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA.
   [Terkawi, Abdullah Sulieman] Univ Virginia, Charlottesville, VA USA.
   [Thomson, Alan J.] Adapt Knowledge Management, Victoria, BC, Canada.
   [Tonelli, Marcello] Univ Calgary, Calgary, AB, Canada.
   [Tran, Bach Xuan] Johns Hopkins Univ, Baltimore, MD USA.
   [Ukwaja, Kingsley N.] Fed Teaching Hosp, Abakaliki, Nigeria.
   [Uthman, Olalekan] Univ Warwick, Coventry, W Midlands, England.
   [Vasankari, Tommi] Inst Hlth Promot Res, Tampere, Finland.
   [Venketasubramanian, Narayanaswamy] Raffles Hosp, Raffles Neurosci Ctr, Singapore, Singapore.
   [Vlassov, Vasiliy Victorovich] Natl Res Univ, Higher Sch Econ, Moscow, Russia.
   [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Weiderpass, Elisabete] Canc Registry Norway, Inst Populat Based Canc Res, Oslo, Norway.
   [Weintraub, Robert] Royal Childrens Hosp, Melbourne, Vic, Australia.
   [Williams, Hywel C.] Univ Nottingham, Nottingham, England.
   [Yano, Yuichiro] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA.
   [Yonemoto, Naohiro] Kyoto Univ, Kyoto, Japan.
   [Yoon, Seok-Jun] Korea Univ, Sch Med, Dept Prevent Med, Seoul, South Korea.
   [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA.
   [Yu, Chuanhua] Wuhan Univ, Wuhan, Peoples R China.
   [Zegeye, Elias Asfaw] Univ KwaZulu Natal, Durban, South Africa.
   [Zuhlke, Liesl Joanna] Red CrossWar Mem Childrens Hosp, Cape Town, South Africa.
RP Kassebaum, N (reprint author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Ste 600, Seattle, WA 98121 USA.
EM nickjk@uw.edu
RI ; Hankey, Graeme /H-4968-2014; Monasta, Lorenzo/B-1388-2012; Patton,
   George/B-5246-2013; Santos, Itamar/K-7055-2012; Satpathy,
   Maheswar/J-3135-2017; Qorbani, Mostafa/M-8171-2017
OI Meaney, Peter/0000-0001-9898-6928; Jacobsen,
   Kathryn/0000-0002-4198-6246; Farzadfar, Farshad/0000-0001-8288-4046;
   Hankey, Graeme /0000-0002-6044-7328; Monasta,
   Lorenzo/0000-0001-7774-548X; Patton, George/0000-0001-5039-8326; Santos,
   Itamar/0000-0003-3212-8466; Hay, Simon/0000-0002-0611-7272; Satpathy,
   Maheswar/0000-0003-3521-4781; Gishu, Melkamu Dedefo/0000-0002-3466-1232;
   Altirkawi, Khalid/0000-0002-7331-4196; Abbas, Kaja/0000-0003-0563-1576;
   Kuate Defo, Barthelemy/0000-0002-6589-0564; Catala-Lopez,
   Ferran/0000-0002-3833-9312
FU GlaxoSmithKline; Merck
FX Dr Larson reported that her research group at the London School of
   Hygiene and Tropical Medicine has received funding from GlaxoSmithKline
   and Merck to convene research symposia, that she has received funding
   from GlaxoSmithKline for advising on issues related to vaccine
   hesitancy, and that she has have served on the Merck Vaccines Strategy
   Advisory Board. No other disclosures were reported.
CR Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607
   Alkema L, 2011, DEMOGRAPHY, V48, P815, DOI 10.1007/s13524-011-0040-5
   Ashley MJ, 2016, TRAUMATIC BRAIN INJU
   Belli PC, 2003, EC BENEFITS INVESTIN
   Bol KA, 2006, PEDIATRICS, V117, P803, DOI 10.1542/peds.2005-1364
   Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092
   Cha ES, 2016, INT J EPIDEMIOL, V45, P470, DOI 10.1093/ije/dyv304
   Chowdhury MM, 2007, BRIT J SURG, V94, P145, DOI 10.1002/bjs.5714
   de Sousa A, 2012, B WORLD HEALTH ORGAN, V90, P183, DOI 10.2471/BLT.11.093989
   Department of Health Social Services and Public Safety, 2010, HLTH CHILD HLTH FUTU
   Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4
   Fajardo-Gutierrez A, 2016, SALUD PUBLICA MEXICO, V58, P162
   Fasfous AF, 2013, J MUSLIM MENT HEALTH, V7, P47
   Fassa A G, 2000, Int J Occup Environ Health, V6, P55
   Field DJ, 2008, BRIT MED J, V336, P1221, DOI 10.1136/bmj.39555.670718.BE
   Flaxman AD, 2014, INT MET FRAM DESCR E
   GBD 2015 SDG Collaborators, 2016, LANCET, V388, P1813
   Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164
   Gupta N, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-16
   Heckman JJ, 2006, SCIENCE, V312, P1900, DOI 10.1126/science.1128898
   Hill K, 2015, LANCET GLOB HEALTH, V3, pE609, DOI 10.1016/S2214-109X(15)00044-3
   Hillner BE, 2000, J CLIN ONCOL, V18, P2327
   Hoofien D, 2001, BRAIN INJURY, V15, P189
   Huicho L, 2010, B WORLD HEALTH ORGAN, V88, P357, DOI 10.2471/BLT.09.070920
   Iaccarino Mary Alexis, 2015, Handb Clin Neurol, V127, P411, DOI 10.1016/B978-0-444-52892-6.00026-X
   Institute for Health Metrics and Evaluation (IHME), 2015, FIN GLOB HLTH 2014 S
   Institute for Health Metrics and Evaluation (IHME), 2013, FIN GLOB HLTH 2012 E
   Italia Y, 2015, J MED SCREEN, V22, P1, DOI 10.1177/0969141314557372
   Jakovljevic M, 2016, HLTH EC POLICY CHALL, P1
   Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001
   Johnson P, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-42
   Kassebaum NJ, 2016, LANCET, V388, P1775
   Kassebaum NJ, 2016, LANCET, V388, P1603
   Kellermann AL, 1998, ANNU REV PUBL HEALTH, V19, P271, DOI 10.1146/annurev.publhealth.19.1.271
   Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103
   Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276
   Linden M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011020.pub2
   Makene CL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0381-3
   McGann PT, 2015, J PEDIATR-US, V167, P1314, DOI 10.1016/j.jpeds.2015.08.068
   Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X
   Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6
   Papile LA, 2012, PEDIATRICS, V130, P587, DOI 10.1542/peds.2012-1999
   Patton GC, 2016, LANCET, V387, P2423, DOI 10.1016/S0140-6736(16)00579-1
   Philip AGS, 2005, PEDIATR RES, V58, P799, DOI 10.1203/01.PDR.0000151693.46655.66
   Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109
   SALOMON JA, 2013, LANCET, V381, P628
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
   Scott JG, 2016, MENTAL NEUROLOGICAL, V4
   Shaw PH, 2015, J PEDIAT HEMATOL ONC, V37, P161, DOI 10.1097/MPH.0000000000000318
   SLOAN JH, 1990, NEW ENGL J MED, V322, P369, DOI 10.1056/NEJM199002083220605
   Smith ER, 2004, NEUROSURGERY, V54, P553, DOI 10.1227/01.NEU.0000108421.69822.67
   Stevens GA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002056
   Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X
   The United Nations, 1989, CONV RIGHTS CHILD, V1577, P3
   UN (United Nations), 2015, MILL DEV GOALS 2015
   Ursin M., 2014, CONTEMP DRUG PROBL, V41, P171, DOI [10.1177/009145091404100203, DOI 10.1177/009145091404100203]
   Vos T, 2016, LANCET, V388, P1545
   Wang HD, 2016, LANCET, V388, P1725
   Wang HD, 2016, LANCET, V388, P1459
   Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X
   World Health Organization, 2013, DEF KEY TERMS
   World Health Organization, GLOB STRAT WOM CHILD
   Wren C, 2001, HEART, V85, P438, DOI 10.1136/heart.85.4.438
   Yuko-Jowi Christine Awuor, 2012, Cardiovasc Diagn Ther, V2, P231, DOI 10.3978/j.issn.2223-3652.2012.07.04
   Zhu JL, 2013, GENET MED, V15, P64, DOI 10.1038/gim.2012.93
   Zuhlke L, 2013, HEART, V99, P1554, DOI 10.1136/heartjnl-2013-303896
NR 67
TC 0
Z9 0
U1 7
U2 7
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD JUN
PY 2017
VL 171
IS 6
BP 573
EP 592
DI 10.1001/jamapediatrics.2017.0250
PG 20
WC Pediatrics
SC Pediatrics
GA EW7SB
UT WOS:000402714300018
OA No
DA 2017-08-17
ER

PT J
AU Elshahat, A
   Lashin, R
AF Elshahat, Ahmed
   Lashin, Riham
TI The Subunit Principle in Scar Face Revision
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Face; revision; scar; subunits; tissue expansion
ID TISSUE EXPANSION; BREAST RECONSTRUCTION; EXPANDER; SILICONE; SKIN
AB Facial scaring is considered one of the most difficult cosmetic problems for any plastic surgeon to solve. The condition is more difficult if the direction of the scar is not parallel to relaxed skin tension lines. Attempts to manage this difficult situation included revisions using geometric designs, Z plasties or W plasties to camouflage the straight line visible scaring. The use of long-lasting resorbable sutures was tried too. Recently, the use of botulinum toxin during revision improved the results. Fractional CO2 lasers, microfat grafts, and platelet-rich plasma were added to the armamentarium. The scar is least visible if placed in the junction between the facial subunits. The aim of this study is to investigate the use of the subunit principle to improve the results of scar revision. Four patients were included in this study. Tissue expansion of the intact part of the subunit allowed shifting the scar to the junction between the affected subunit and the adjacent one. Tissue expansion, delivery of the expanders, and advancement of the flaps were successful in all patients. The fact that this is a 2-stage procedure and sacrifices some of the intact skin from the affected facial subunit, makes this technique reserved to patients with ugly facial scars who are ambitious to improve their appearance.
C1 [Elshahat, Ahmed; Lashin, Riham] Ain Shams Univ, Fac Med, Dept Plast Surg, Cairo, Egypt.
RP Elshahat, A (reprint author), Eldemerdash Hosp, 56 Ramsis St, Cairo 11566, Egypt.
EM elshahat70@hotmail.com
CR Agris J., 1987, AM J COSMET SURG, V4, P301
   Alster T, 2007, DERMATOL SURG, V33, P131, DOI 10.1111/j.1524-4725.2006.33030.x
   ARGENTA LC, 1983, ANN PLAS SURG, V11, P31, DOI 10.1097/00000637-198307000-00005
   ARGENTA LC, 1983, ANN PLAS SURG, V11, P188, DOI 10.1097/00000637-198309000-00003
   Argenta LC, 2006, PLASTIC SURG, P539
   BORGES AF, 1990, CLIN PLAST SURG, V17, P71
   Bradley D T, 2001, Facial Plast Surg, V17, P253, DOI 10.1055/s-2001-18830
   Brenner MJ, 2012, SCAR REVISION SECOND
   BROBMANN GF, 1985, PLAST RECONSTR SURG, V76, P731, DOI 10.1097/00006534-198511000-00013
   BURGET GC, 1985, PLAST RECONSTR SURG, V76, P239, DOI 10.1097/00006534-198508000-00010
   Cassuto Daniel, 2003, J Cosmet Laser Ther, V5, P135, DOI 10.1080/14764170310023227-351
   Clark J M, 2001, Facial Plast Surg, V17, P295, DOI 10.1055/s-2001-18831
   Cohen KI, 2000, CONT SURG S, V2, P2
   de Oliveira GV, 2001, DERMATOL SURG, V27, P721, DOI 10.1046/j.1524-4725.2001.00345.x
   GIBNEY J, 1987, CLIN PLAST SURG, V14, P509
   HARMON CB, 1995, DERMATOL SURG, V21, P503
   HARNICK DB, 1984, LARYNGOSCOPE, V94, P841
   KATZ BE, 1995, CUTIS, V56, P65
   Kelleher J C, 1977, Clin Plast Surg, V4, P247
   LEONARD AG, 1986, BRIT J PLAST SURG, V39, P42, DOI 10.1016/0007-1226(86)90004-4
   MANDERS EK, 1984, PLAST RECONSTR SURG, V74, P493, DOI 10.1097/00006534-198410000-00007
   MENICK FJ, 1987, CLIN PLAST SURG, V14, P723
   Menick FJ, 2007, PLAST RECONSTR SURG, V120, P1208, DOI 10.1097/01.prs.0000254345.98806.47
   MILLARD DR, 1970, PLAST RECONSTR SURG, V45, P616, DOI 10.1097/00006534-197006000-00021
   Mostafapour S P, 2001, Facial Plast Surg, V17, P245, DOI 10.1055/s-2001-18824
   NEUMANN C G, 1957, Plast Reconstr Surg (1946), V19, P124, DOI 10.1097/00006534-195702000-00004
   RADOVAN C, 1982, PLAST RECONSTR SURG, V69, P195, DOI 10.1097/00006534-198202000-00001
   RADOVAN C, 1984, PLAST RECONSTR SURG, V74, P482, DOI 10.1097/00006534-198410000-00005
   SASAKI GH, 1984, PLAST RECONSTR SURG, V74, P59, DOI 10.1097/00006534-198407000-00008
   Thomas JR, 2005, CUMMINGS OTOLARYNGOL, P572
   VERSACI AD, 1987, PLAST RECONSTR SURG, V80, P387, DOI 10.1097/00006534-198709000-00009
   Westine John G, 2005, Facial Plast Surg Clin North Am, V13, P325, DOI 10.1016/j.fsc.2004.12.002
   Wilson AM, 2000, PLAST RECONSTR SURG, V106, P1488, DOI 10.1097/00006534-200012000-00006
   Wilson AM, 2006, PLAST RECONSTR SURG, V117, P1758, DOI 10.1097/01.prs.0000209944.45949.d1
NR 34
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUN
PY 2017
VL 28
IS 4
BP 1027
EP 1029
DI 10.1097/SCS.0000000000003529
PG 3
WC Surgery
SC Surgery
GA EW8EG
UT WOS:000402750600085
PM 28207466
OA No
DA 2017-08-17
ER

PT J
AU El-Anwar, MW
   Sweed, AH
AF El-Anwar, Mohammad Waheed
   Sweed, Ahmed Hassan
TI Simple Percutaneous Transbuccal Approach for Management of Mandibular
   Angular Fracture
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Fracture; internal fixation; mandible; percutaneous
ID ANGLE FRACTURES; FIXATION
AB Objective: To describe a relatively simple, easy, and safe technique for open reduction and internal fixation of the mandibular angle fracture using the combined modified percutaneous and oral approach with no special instrumentation.
   Patients and Methods: This study was carried out on 10 patients who had traumatic mandibular angle fractures. All patients were managed by open reduction and internal fixation. Intraoral exposure and reduction of the fracture was performed through the gingivolabial incision. Then, a modified percutaneous-transbuccal way was utilized for conduction of the microdrill shaft and screw driver to permit screws fixation with perpendicular relations between plate and inserted screws.
   Results: There were no registered soft tissue infections, wound dehiscence, occlusal defects, or facial nerve paresis. The mean surgical duration was 39.7 +/- 11.5 minutes. No patients were recorded to have unsatisfactory external scar and further intervention was not required.
   Conclusion: The described percutaneous approach to mandibular angle fracture can be done effectively and safely using available and operatively fabricated disposable tools.
C1 [El-Anwar, Mohammad Waheed; Sweed, Ahmed Hassan] Zagazig Univ, Fac Med, Otorhinolaryngol Head & Neck Surg Dept, Zagazig 00205523098, Egypt.
RP El-Anwar, MW (reprint author), Zagazig Univ, Fac Med, Otorhinolaryngol Head & Neck Surg Dept, Zagazig 00205523098, Egypt.
EM mwenteg@yahoo.com
CR Ajmal Samira, 2007, J Ayub Med Coll Abbottabad, V19, P51
   Ellis E, 2010, J ORAL MAXIL SURG, V68, P2743, DOI 10.1016/j.joms.2010.05.080
   Gear AJL, 2005, J ORAL MAXIL SURG, V63, P655, DOI 10.1016/j.joms.2004.02.016
   HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L
   Lee JT, 2000, J ORAL MAXIL SURG, V58, P394, DOI 10.1016/S0278-2391(00)90921-2
   Pattar Pradeep, 2014, J Maxillofac Oral Surg, V13, P592, DOI 10.1007/s12663-013-0542-3
   Schierle HP, 1997, J CRANIO MAXILL SURG, V25, P162, DOI 10.1016/S1010-5182(97)80009-1
   Schubert W, 1997, J ORAL MAXIL SURG, V55, P689, DOI 10.1016/S0278-2391(97)90577-2
   Siddiqui A, 2007, BR J ORAL MAXILLOFAC, V45, P233
   Singh V, 2011, AM ACAD OTALARYNGOL, V145, P213
   Sudhakar Goparaju V S, 2015, J Maxillofac Oral Surg, V14, P979, DOI 10.1007/s12663-015-0779-0
   Sugar AW, 2009, INT J ORAL MAX SURG, V38, P241, DOI 10.1016/j.ijom.2008.11.001
   Tams J, 1997, INT J ORAL MAX SURG, V26, P383, DOI 10.1016/S0901-5027(97)80803-X
   Xue Amy S, 2013, Craniomaxillofac Trauma Reconstr, V6, P191, DOI 10.1055/s-0033-1349213
NR 14
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUN
PY 2017
VL 28
IS 4
BP 1035
EP 1037
DI 10.1097/SCS.0000000000003539
PG 3
WC Surgery
SC Surgery
GA EW8EG
UT WOS:000402750600087
PM 28328598
OA No
DA 2017-08-17
ER

PT J
AU El-Anwar, MW
   Ali, AH
   Elnashar, I
   Elfiki, IM
   Ahmed, AF
   Abdulmonaem, G
AF El-Anwar, Mohammad Waheed
   Ali, Atef Hamed
   Elnashar, Ismail
   Elfiki, Inas M.
   Ahmed, Ayman F.
   Abdulmonaem, Ghada
TI Normal Nasopharyngeal Measurement by Computed Tomography in Adult
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Computed tomography; measurements; nasopharynx; nose; sphenoid sinus
ID PHARYNGEAL AIRWAY SPACE
AB Background: This study aims to investigate the detailed computed tomography (CT) measurement of the nasopharynx (NP) in normal adult detecting mean of its dimension and relation of that measurement to that of the sphenoid sinus.
   Methodology/Principal: A normal paranasal CT scan and a straight nasal septum of 128 individuals (256 sphenoid sinuses) were included in the study. Axial images were acquired with multiplanar reformates to obtain delicate details in coronal and sagittal planes for all subjects. Measurement of the width, length, and anteroposterior dimensions of the NP and sphenoid sinuses were taken separately.
   Results: In 128 studied CT of adult subjects, the mean height of the NP was 19.4619 +/- 4.52661 and mean depth was 21.80714 +/- 4.62324 while the mean width was 25.31951 +/- 3.80521. No significant relations between diameters of NP and sphenoid sinuses were found.
   Conclusion: The detailed CT measurement of the NP in normal adult is an easy and reliable measurement. This study put the base of CT measurement of NP for further work to describe changes in such measures in patients with nasal and paranasal sinus anomalies.
C1 [El-Anwar, Mohammad Waheed; Ali, Atef Hamed; Elnashar, Ismail] Zagazig Univ, Otorhinolaryngol Head & Neck Surg Dept, Fac Med, Zagazig 00205523098, Egypt.
   [Elfiki, Inas M.; Ahmed, Ayman F.; Abdulmonaem, Ghada] Zagazig Univ, Radio Diag Dept, Fac Med, Zagazig, Egypt.
RP El-Anwar, MW (reprint author), Zagazig Univ, Otorhinolaryngol Head & Neck Surg Dept, Fac Med, Zagazig 00205523098, Egypt.
EM mwenteg@yahoo.com
CR Appasaheb N, 2012, J DENT MED SCI, V3, P30
   Battagel JM, 2000, EUR J ORTHODONT, V22, P353, DOI 10.1093/ejo/22.4.353
   CEYLAN I, 1995, AM J ORTHOD DENTOFAC, V108, P69, DOI 10.1016/S0889-5406(95)70068-4
   Guijarro-Martinez R, 2011, INT J ORAL MAX SURG, V40, P1227, DOI 10.1016/j.ijom.2011.06.017
   Jat B, 2015, INDIAN J FORENSIC CO, V2, P135
   Karakas S, 2005, ANN SAUDI MED, V25, P41
   Mavropoulos A, 2004, BONE, V35, P191, DOI 10.1016/j.bone.2004.03.020
   Muto T, 2006, INT J ORAL MAX SURG, V35, P132, DOI 10.1016/j.ijom.2005.04.022
   Prado FB, 2012, DENTOMAXILLOFAC RAD, V41, P103, DOI 10.1259/dmfr/22419253
NR 9
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUN
PY 2017
VL 28
IS 4
BP E395
EP E398
DI 10.1097/SCS.0000000000003764
PG 5
WC Surgery
SC Surgery
GA EW8EG
UT WOS:000402750600032
PM 28590397
OA No
DA 2017-08-17
ER

PT J
AU Labib, A
   Elshahat, A
AF Labib, Amir
   Elshahat, Ahmed
TI Supernumerary Nostril: Two Years Follow-Up
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Accessory nostril; congenital nasal malformation and triple nostrils;
   rare; supernumerary nostril
ID OF-THE-LITERATURE; ETIOLOGY; CLEFT; MANAGEMENT; DIAGNOSIS; NEWBORN
AB Supernumerary nostril is a very rare congenital anomaly of the nose. Since the first patient reported by Lindsay in 1906, few number of patients were reported in the literature. Various types had been described with different surgical modalities for correction. It can be isolated or associated with other malformations such as facial cleft, esophageal atresia, and imperforate anus. Most of the patients are unilateral, but it may be bilateral. It may have a communication with a normal nasal cavity or not.
   In this study, the authors present a case of a 1-year-old male with a positive perinatal history of teratogen exposure had isolated supernumerary left nostril with communication to the nasal cavity.
   The authors will discuss different theories related to supernumerary nostril development, differences between published reports, the proposed surgical techniques, and the outcome of their treatment approach.
C1 [Labib, Amir; Elshahat, Ahmed] Ain Shams Univ, Dept Plast Surg, Fac Med, 56 Ramsis St, Cairo 11566, Egypt.
RP Labib, A (reprint author), Ain Shams Univ, Dept Plast Surg, Fac Med, 56 Ramsis St, Cairo 11566, Egypt.
EM Amirlabib2001@gmail.com
OI Labib, Amir/0000-0002-5447-1858
CR Arey LB, 1965, DEV ANATOMY TXB LAB, P336
   BRADLEY PJ, 1982, CLIN OTOLARYNGOL, V7, P87, DOI 10.1111/j.1365-2273.1982.tb01568.x
   deBlecourt RA, 1996, ANN PLAS SURG, V37, P633, DOI 10.1097/00000637-199612000-00011
   Duran A, 2014, ANN MAXILLOFAC SURG, V4, P193
   FARAG MM, 1988, J LARYNGOL OTOL, V102, P1040, DOI 10.1017/S0022215100107212
   Franco D, 2008, J PLAST RECONSTR AES, V61, P442, DOI 10.1016/j.bjps.2006.04.007
   Garg R, 2011, ANN MAXILLOFAC SURG, V1, P169
   HARTIKAINENSORRI AL, 1983, INT J PEDIATR OTORHI, V6, P83
   HUGHES GB, 1980, HEAD NECK SURG, V2, P222, DOI 10.1002/hed.2890020308
   JAZBI B, 1977, OTOLARYNG CLIN N AM, V10, P125
   JEPPESEN F, 1972, ACTA OBSTET GYN SCAN, V51, P5
   Lindsay B., 1906, T PATHOL SOC LOND, V57, P329
   Losee JE, 2004, PLAST RECONSTR SURG, V113, P676, DOI 10.1097/01.PRS.0000101540.32533.EC
   MYER CM, 1983, PEDIATRICS, V72, P766
   NAKAMURA K, 1987, PLAST RECONSTR SURG, V80, P436, DOI 10.1097/00006534-198709000-00018
   Nishimura Y., 1993, CELLS TISSUES ORGANS, V147, P140, DOI 10.1159/000147494
   Numanoglu V, 2007, CLIN DYSMORPHOL, V16, P269, DOI 10.1097/MCD.0b013e3281e668fd
   Orahilly R., 1967, ANAT REC, P380
   Pan XY, 2015, AESTHET PLAST SURG, V39, P574, DOI 10.1007/s00266-015-0501-0
   Rout SK, 2013, J CRANIOFAC SURG, V24, pE13, DOI 10.1097/SCS.0b013e3182668b14
   Sinha R, 2005, ENT-EAR NOSE THROAT, V84, P718
   Tambwekar SR, 1997, PLAST RECONSTR SURG, V100, P682, DOI 10.1097/00006534-199709000-00022
   Umeda T, 1996, BRIT J PLAST SURG, V49, P499, DOI 10.1016/S0007-1226(96)90043-0
   vanKempen AAMW, 1997, CLIN DYSMORPHOL, V6, P147
   Xu Y, 2013, RADIAT ONCOL, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0062397
NR 25
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD JUN
PY 2017
VL 28
IS 4
BP E330
EP E333
DI 10.1097/SCS.0000000000003577
PG 5
WC Surgery
SC Surgery
GA EW8EG
UT WOS:000402750600009
PM 28582959
OA No
DA 2017-08-17
ER

PT J
AU Debeer, D
   Ali, US
   van Rijn, PW
AF Debeer, Dries
   Ali, Usama S.
   van Rijn, Peter W.
TI Evaluating Statistical Targets for Assembling Parallel Mixed-Format Test
   Forms
SO JOURNAL OF EDUCATIONAL MEASUREMENT
LA English
DT Article
ID PARTIAL CREDIT MODEL; ITEM SELECTION; INFORMATION; ALGORITHM
AB Test assembly is the process of selecting items from an item pool to form one or more new test forms. Often new test forms are constructed to be parallel with an existing (or an ideal) test. Within the context of item response theory, the test information function (TIF) or the test characteristic curve (TCC) are commonly used as statistical targets to obtain this parallelism. In a recent study, Ali and van Rijn proposed combining the TIF and TCC as statistical targets, rather than using only a single statistical target. In this article, we propose two new methods using this combined approach, and compare these methods with single statistical targets for the assembly of mixed-format tests. In addition, we introduce new criteria to evaluate the parallelism of multiple forms. The results show that single statistical targets can be problematic, while the combined targets perform better, especially in situations with increasing numbers of polytomous items. Implications of using the combined target are discussed.
C1 [Debeer, Dries] Univ Zurich, Dept Psychol, Res Unit Psychol Methods Evaluat & Stat, Binzmuehlestr 14 PB 27, CH-8050 Zurich, Switzerland.
   [Ali, Usama S.] Educ Testing Serv, 666 Rosedale Rd, Princeton, NJ 08541 USA.
   [Ali, Usama S.] South Valley Univ, Dept Educ Psychol, Qena, Egypt.
   [van Rijn, Peter W.] ETS Global, Strawinskylaan 929, NL-1077 XX Amsterdam, Netherlands.
RP Debeer, D (reprint author), Univ Zurich, Dept Psychol, Res Unit Psychol Methods Evaluat & Stat, Binzmuehlestr 14 PB 27, CH-8050 Zurich, Switzerland.
EM dries.debeer@uzh.ch; uali@ets.org; pvanrijn@etsglobal.org
FU Educational Testing Service
FX This work has been partially funded by the Educational Testing Service.
CR Ali US, 2016, APPL PSYCH MEAS, V40, P163, DOI 10.1177/0146621615613308
   Allen N. L., 1996, TECHNICAL REPORT NAE
   ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814
   Armstrong R, 2005, INTERFACES, V35, P140, DOI 10.1287/inte.1040.0123
   Armstrong RD, 1998, APPL PSYCH MEAS, V22, P237, DOI 10.1177/01466216980223004
   Berkelaar M., 2004, 1P SOLVE OPEN SOURCE
   Birnbaum A., 1968, STAT THEORIES MENTAL, P392
   Chen PH, 2012, EDUC PSYCHOL MEAS, V72, P933, DOI 10.1177/0013164412443688
   Diao Q, 2011, APPL PSYCH MEAS, V35, P398, DOI 10.1177/0146621610392211
   DONOGHUE JR, 1994, J EDUC MEAS, V31, P295, DOI 10.1111/j.1745-3984.1994.tb00448.x
   Donoghue J. R., 2015, RR1505 ED TEST SERV
   Dorans N. J., 1994, TECHNICAL ISSUES REL, P91
   Ercikan K, 1998, J EDUC MEAS, V35, P137, DOI 10.1111/j.1745-3984.1998.tb00531.x
   FICO, 2016, XPRESS OPT REF MAN
   Finkelman M, 2009, J EDUC MEAS, V46, P273
   GNU, 2016, LIN PROGR KIT
   Gurobi Optimization, 2016, GUR OPT REF MAN
   Huitzing HA, 2005, J EDUC MEAS, V42, P223, DOI 10.1111/j.1745-3984.2005.00012.x
   [Anonymous], 2016, IBM ILOG CPLEX OPT S
   Tong Y., 2010, ED MEASUREMENT ISSUE, V29, P8
   LAND AH, 1960, ECONOMETRICA, V28, P497, DOI 10.2307/1910129
   Lord F. M., 1980, APPL ITEM RESPONSE T
   Luecht RM, 1998, APPL PSYCH MEAS, V22, P224, DOI 10.1177/01466216980223003
   MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149, DOI 10.1007/BF02296272
   McDonald RP, 1999, TEST THEORY UNIFIED
   MURAKI E, 1993, APPL PSYCH MEAS, V17, P351, DOI 10.1177/014662169301700403
   MURAKI E, 1992, APPL PSYCH MEAS, V16, P159, DOI 10.1177/014662169201600206
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Rasch G., 1993, PROBABILISTIC MODELS
   Samejima F., 1969, PSYCHOMETRIKA MONO S
   SWANSON L, 1993, APPL PSYCH MEAS, V17, P151, DOI 10.1177/014662169301700205
   THEUNISSEN TJJM, 1985, PSYCHOMETRIKA, V50, P411, DOI 10.1007/BF02296260
   van der Linden WJ, 1998, PSYCHOMETRIKA, V63, P401
   van der Linden WJ, 1998, J EDUC MEAS, V35, P185
   van dersLinden W. J., 2005, LINEAR MODELS OPTIMA
   Veldkamp BP, 2013, APPL PSYCH MEAS, V37, P123, DOI 10.1177/0146621612469825
   Weeks J., 2015, M NAT COUNC MEAS ED
NR 37
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-0655
EI 1745-3984
J9 J EDUC MEAS
JI J. Educ. Meas.
PD SUM
PY 2017
VL 54
IS 2
BP 218
EP 242
DI 10.1111/jedm.12142
PG 25
WC Psychology, Educational; Psychology, Applied; Psychology, Mathematical
SC Psychology
GA EW6OE
UT WOS:000402629200005
OA No
DA 2017-08-17
ER

PT J
AU Tay, KJ
   Polascik, TJ
   Elshafei, A
   Tsivian, E
   Jones, S
AF Tay, Kae Jack
   Polascik, Thomas James
   Elshafei, Ahmed
   Tsivian, Efrat
   Jones, Stephen
TI Propensity Score-Matched Comparison of Partial to Whole-Gland
   Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the
   Cryo On-Line Data Registry Data
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
DE focal therapy; ablation; prostate cancer; mpMRI; prostatectomy;
   radiation
ID TERM-FOLLOW-UP; FOCAL THERAPY; ACTIVE-SURVEILLANCE; OUTCOMES;
   CRYOABLATION; CRYOSURGERY; MEN; STATEMENT; COHORT
AB Objective: To compare the oncologic and functional outcomes of partial vs whole-gland cryotherapy for men with intermediate-risk prostate cancer.
   Subjects/Patients: Men with intermediate-risk prostate cancer treated with primary prostate cryotherapy from 1993 to 2013 were selected from the Cryo On-Line Data Registry for a 1: 1 matched comparison between those undergoing whole-gland and partial prostate cryotherapy (targeted ablation, unilateral/bilateral nerve-sparing ablations). A propensity score was developed based on age, prebiopsy serum prostate-specific antigen, biopsy Gleason score, clinical stage, prostate volume, neoadjuvant androgen deprivation status, year of surgery, and pretreatment potency. Outcomes were biochemical progression-free survival (BPFS) using the American Society for Therapeutic Radiation Oncology (ASTRO) and Phoenix criteria, 12-month continence (strictly pad free), and sexual function (potency sufficient for sexual intercourse). After propensity score matching, BPFS was compared using Kaplan-Meier analysis and functional outcomes using chi-square tests.
   Results: In all, 897 men were identified (731 whole gland and 166 partial). Postmatching, 166 pairs of men were analyzed (mean follow-up 31 months). The 2/5-year BPFS rate was 87.2%/76.4% for whole-gland vs 80.7%/ 70.0% for partial ablation using Phoenix (p = 0.26) and 72.3%/69.6% for whole-gland vs 82.1%/75.0% for partial ablation using ASTRO criteria (p = 0.10). Of 164 pairs, the 12-month continence rate was similar, 94.1% vs 95.1% (p = 0.803). Of 139 pairs, the 12-month rate of effective intercourse was 29.5% for whole-gland and 46.8% for partial ablation (odds ratio 2.1, p = 0.003). The incidence of post-treatment urinary retention was 6.0% and 6.6% (p = 0.88) following whole-gland and partial ablation, respectively, and that of rectourethral fistula was 1.2% and 0% (p = 0.50).
   Conclusion: Partial ablation results in better post-treatment sexual function compared with whole-gland ablation in men with intermediate-risk prostate cancer. We did not observe a difference in early BPFS between the two groups.
C1 [Tay, Kae Jack; Polascik, Thomas James; Tsivian, Efrat] Duke Univ, Duke Canc Inst, Durham, NC USA.
   [Elshafei, Ahmed; Jones, Stephen] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA.
   [Elshafei, Ahmed] Cairo Univ, Sch Med, Giza, Egypt.
RP Tay, KJ (reprint author), Duke Univ, Dept Surg, Div Urol, Box 2804,Yellow Zone Room 1080, Durham, NC 27710 USA.
EM kaejack.tay@gmail.com
FU National Medical Research Council, Singapore
FX Dr. Tay received fellowship funding from the National Medical Research
   Council, Singapore. Dr. Polascik serves on the board of the COLD
   registry and has consulted for Endocare. Dr. Jones is Principal
   Investigator and Board Chairman of the COLD registry and has consulted
   for HealthTronics.
CR American Cancer Society, 2015, CANC FACTS FIG 2015
   American Society for Therapeutic Radiology and Oncology Consensus Panel, 1997, INT J RADIAT ONCOL, V37, P1035
   Arumainayagam N, 2013, RADIOLOGY, V268, P761, DOI 10.1148/radiol.13120641
   Babaian RJ, 2008, J UROLOGY, V180, P1993, DOI 10.1016/j.juro.2008.07.108
   Bahn D, 2012, EUR UROL, V62, P55, DOI 10.1016/j.eururo.2012.03.006
   Barqawi AB, 2014, J UROLOGY, V192, P749, DOI 10.1016/j.juro.2014.03.033
   Bermejo C, 2004, J NATL CANCER I, V96, P1348, DOI 10.1093/jnci/djh282
   Briganti A, 2012, EUR UROL, V61, P480, DOI 10.1016/j.eururo.2011.10.044
   Cespedes RD, 1997, J UROLOGY, V157, P237, DOI 10.1016/S0022-5347(01)65335-7
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Durand M, 2014, BJU INT, V113, P56, DOI 10.1111/bju.12370
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115
   Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192
   Lambert EH, 2007, UROLOGY, V69, P1117, DOI 10.1016/j.urology.2007.02.047
   Leuven E., 2003, PSMATCH2 STATA MODUL
   Lian HB, 2016, INT UROL NEPHROL, V48, P85, DOI 10.1007/s11255-015-1140-8
   Mendez MH, 2015, J ENDOUROL, V29, P1193, DOI 10.1089/end.2014.0881
   Muto S, 2008, JPN J CLIN ONCOL, V38, P192, DOI 10.1093/jjco/hym173
   Onik G, 2008, UROL ONCOL-SEMIN ORI, V26, P500, DOI 10.1016/j.urolonc.2008.03.004
   Perez BA, 2015, UROL ONCOL-SEMIN ORI, V33, P226, DOI 10.1016/j.urolonc.2014.09.018
   Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029
   Rosenkrantz AB, 2012, J UROLOGY, V187, P2032, DOI 10.1016/j.juro.2012.01.074
   Scheltema MJ, 2017, WORLD J UROL, V35, P695, DOI 10.1007/s00345-016-1932-1
   Spiess PE, 2013, WORLD J UROL, V31, P1321, DOI 10.1007/s00345-012-0982-2
   Spiess PE, 2013, BJU INT, V112, pE256, DOI 10.1111/j.1464-410X.2012.11695.x
   Tay K J, 2016, Arch Esp Urol, V69, P317
   Tay KJ, 2015, CURR OPIN UROL, V25, P185, DOI 10.1097/MOU.0000000000000168
   Tosoian JJ, 2015, J CLIN ONCOL, V33, P3379, DOI 10.1200/JCO.2015.62.5764
   Valerio M., 2017, UROL ONCOL, V35, P1, DOI [10.1016/j.urolonc.2016.11.008, DOI 10.1016/J.UROLONC.2016.11.008]
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008
NR 31
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4920
EI 2151-4939
J9 J ENDOUROL
JI J. Endourol.
PD JUN
PY 2017
VL 31
IS 6
BP 564
EP 571
DI 10.1089/end.2016.0830
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA EW7SO
UT WOS:000402716100003
PM 28385075
OA No
DA 2017-08-17
ER

PT J
AU Elhilali, MM
   Badaan, S
   Ibrahim, A
   Andonian, S
AF Elhilali, Mostafa M.
   Badaan, Shadie
   Ibrahim, Ahmed
   Andonian, Sero
TI Use of the Moses Technology to Improve Holmium Laser Lithotripsy
   Outcomes: A Preclinical Study
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
DE Holmium-YAG laser; laser lithotripsy; prospective study; preclinical
   evaluation
ID FRAGMENTATION EFFICIENCY; URETERAL CALCULI
AB Objective: To evaluate in vitro and in vivo effects of Moses technology in Holmium laser and to compare it with the Regular mode in terms of lithotripsy efficiency and laser-tissue interactions.
   Methods: The Lumenis (R) Pulse (TM) P120H holmium laser system together with Moses D/F/L fibers were used to compare the Regular mode with the Moses modes in stone retropulsion by using a high-speed camera, and stone ablation efficiency. In addition, a porcine ureteroscopy model was used to assess stone fragmentation and dusting as well as laser-tissue interaction with the ureteral wall.
   Results: After a laser pulse, in vitro stone displacement experiments showed a significant reduction in retropulsion when using the Moses mode. The stone movement was reduced by 50 times at 0.8 J and 10 Hz (p < 0.01). The pronounced reduction of retropulsion in the Moses mode was clearly observed during fragmentation setting (high energy) and dusting (low energy, high Hz). In addition, stone fragmentation tests showed that the Moses modes resulted in a significantly higher ablation volume when compared with the Regular mode (160% higher; p < 0.001). In vivo assessment also supported the reduction in retropulsion when treating stones in the porcine kidney. Histological analysis of the porcine ureter after direct lasing in the Moses mode suggested less damage than in the Regular mode.
   Conclusions: The Moses technology resulted in more efficient laser lithotripsy, in addition to significantly reduced stone retropulsion, and displayed a margin of safety that may result in a shorter procedural time and safer lithotripsy.
C1 [Elhilali, Mostafa M.; Ibrahim, Ahmed; Andonian, Sero] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Urol, 1001 Blvd Decarie,D05-5327, Montreal, PQ H4A 3J1, Canada.
   [Badaan, Shadie] Rambam Hlth Care Campus, Dept Urol, Haifa, Israel.
   [Ibrahim, Ahmed] Al Azhar Univ, Alhussain Univ Hosp, Dept Urol, Cairo, Egypt.
RP Elhilali, MM (reprint author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Dept Urol, 1001 Blvd Decarie,D05-5327, Montreal, PQ H4A 3J1, Canada.
EM mostafa.elhilali@muhc.mcgill.ca
CR Khoder WY, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-62
   Kronenberg P, 2014, BJU INT, V114, P261, DOI 10.1111/bju.12567
   Lee HJ, 2008, J UROLOGY, V180, P969, DOI 10.1016/j.juro.2008.05.016
   Ordon M, 2015, CUAJ-CAN UROL ASSOC, V9, pE837, DOI 10.5489/cuaj.3483
   Sea J, 2012, J UROLOGY, V187, P914, DOI 10.1016/j.juro.2011.10.147
   Teichmann HO, 2007, WORLD J UROL, V25, P221, DOI 10.1007/s00345-007-0184-5
   Turk C, 2016, EUR UROL, V69, P475, DOI 10.1016/j.eururo.2015.07.041
   Zarrabi Amir, 2011, Ther Adv Urol, V3, P81, DOI 10.1177/1756287211400494
   Zhang JJ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.12.128001
NR 9
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4920
EI 2151-4939
J9 J ENDOUROL
JI J. Endourol.
PD JUN
PY 2017
VL 31
IS 6
BP 598
EP 604
DI 10.1089/end.2017.0050
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA EW7SO
UT WOS:000402716100010
PM 28340540
OA No
DA 2017-08-17
ER

PT J
AU Mohamed, WR
   Metwally, SS
   Ibrahim, HA
   El-Sherief, EA
   Mekhamer, HS
   Moustafa, IMI
   Mabrouk, EM
AF Mohamed, W. R.
   Metwally, S. S.
   Ibrahim, H. A.
   El-Sherief, E. A.
   Mekhamer, H. S.
   Moustafa, Islam M. I.
   Mabrouk, E. M.
TI Impregnation of task-specific ionic liquid into a solid support for
   removal of neodymium and gadolinium ions from aqueous solution
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE Ionic liquid; Silica; Impregnation; Lanthanides; Sorption
ID RARE-EARTH-ELEMENTS; HYDROCHLORIC-ACID SOLUTIONS; WASTE-WATER; DYE
   REMOVAL; ZEOLITE-A; EXTRACTION; SORPTION; SILICA; BATCH; THERMODYNAMICS
AB Impregnation of trihexyl(tetradecyl)phosphonium bis(2,4,4-trimethylpentyl)phosphinate, as an ionic liquid, into silica was carried out for removal of neodymium and gadolinium ions from aqueous solution. Silica and the impregnated silica (Cyphos@silica) were characterized using FT-IR, SEM, XRD and TGA. Comparative sorption behavior of silica and Cyphos@silica for sorption of neodymium and gadolinium ions was investigated. The experimental outcome revealed that the impregnation process enhanced the sorption behavior of silica, from 18 to 67% for neodymium ion and from 20 to 89.45% for gadolinium ion. From the kinetic studies, the sorption could be described well by pseudo-second-order model. Langmuir and Freundlich isotherms were performed to determine the best fit equation for the sorption process; the results indicated that the latter surpasses the former. Comparison of the sorption capacity of Cyphos@silica with other materials reported in the literature shows that the former has a comparatively high sorption capacity. Desorption percent of gadolinium and neodymium ions from Cyphos@silica using 1.0 mol/L of HNO3 was found to be 97.74 and 86.33%, respectively. The desorption studies revealed the reusability of Cyphos@silica for further sorption. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Mohamed, W. R.; Metwally, S. S.; Ibrahim, H. A.; El-Sherief, E. A.; Mekhamer, H. S.] Hot Labs Ctr, Atom Energy Author, Cairo 13759, Egypt.
   [Moustafa, Islam M. I.; Mabrouk, E. M.] Banha Univ, Fac Sci, Chem Dept, Banha, Egypt.
RP Metwally, SS (reprint author), Hot Labs Ctr, Atom Energy Author, Cairo 13759, Egypt.
EM sicosad@hotmail.com
CR Ali OIM, 2011, J HAZARD MATER, V195, P62, DOI 10.1016/j.jhazmat.2011.08.014
   Atta AM, 2016, J IND ENG CHEM, V33, P122, DOI 10.1016/j.jiec.2015.09.028
   Bentouhami E, 2004, CR CHIM, V7, P537, DOI 10.1016/j.crci.2004.01.008
   Castillo J, 2014, HYDROMETALLURGY, V141, P89, DOI 10.1016/j.hydromet.2013.11.001
   Cheng JJ, 2016, J IND ENG CHEM, V36, P206, DOI 10.1016/j.jiec.2016.02.004
   Cholico-Gonzalez D, 2013, J MOL LIQ, V187, P165, DOI 10.1016/j.molliq.2013.06.013
   Cieszynska A, 2012, HYDROMETALLURGY, V113, P79, DOI 10.1016/j.hydromet.2011.12.006
   Dharaskar SA, 2014, FUEL PROCESS TECHNOL, V123, P1, DOI 10.1016/j.fuproc.2014.02.001
   El-Kamash AM, 2008, J HAZARD MATER, V151, P432, DOI 10.1016/j.jhazmat.2007.06.009
   El-Kamash AM, 2005, J HAZARD MATER, V127, P211, DOI 10.1016/j.jhazmat.2005.07.021
   El-Sofany EA, 2008, J HAZARD MATER, V153, P948, DOI 10.1016/j.jhazmat.2007.09.046
   Fraser KJ, 2009, AUST J CHEM, V62, P309, DOI 10.1071/CH08558
   Fryxell GE, 2011, INORG CHEM COMMUN, V14, P971, DOI 10.1016/j.inoche.2011.03.045
   Fuerhacker M, 2012, WATER SCI TECHNOL, V65, P1765, DOI 10.2166/wst.2012.907
   Gharehbaghi M, 2012, CLEAN-SOIL AIR WATER, V40, P290, DOI 10.1002/clen.201100258
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Kim GJ, 2015, PROCESS BIOCHEM, V50, P989, DOI 10.1016/j.procbio.2015.03.009
   Kozak D, 2015, ELECTROCHIM ACTA, V163, P41, DOI 10.1016/j.electacta.2015.02.138
   Liu Y, 2009, IND ENG CHEM RES, V48, P7308, DOI 10.1021/ie900468c
   Metwally SS, 2014, SEP SCI TECHNOL, V49, P2426, DOI 10.1080/01496395.2014.926457
   Metwally SS, 2013, SEP SCI TECHNOL, V48, P1829, DOI 10.1080/01496395.2012.755697
   Metwally S. S., 2013, J ENV CHEM ENG, V1, P252
   Naser AA, 2015, J IND ENG CHEM, V32, P264, DOI 10.1016/j.jiec.2015.08.024
   Navarro R, 2008, REACT FUNCT POLYM, V68, P557, DOI 10.1016/j.reactfunctpolym.2007.10.027
   Ogata T, 2015, HYDROMETALLURGY, V152, P178, DOI 10.1016/j.hydromet.2015.01.005
   Oral R, 2010, CHEMOSPHERE, V81, P194, DOI 10.1016/j.chemosphere.2010.06.057
   Palmieri MC, 2000, PROCESS BIOCHEM, V36, P441, DOI 10.1016/S0032-9592(00)00236-3
   Parsons JG, 2005, TALANTA, V67, P34, DOI 10.1016/j.talanta.2005.02.008
   Ponou J, 2014, J ENV CHEM, V2, P1070, DOI [10.1016/j.jece.2014.04.002, DOI 10.1016/J.JECE.2014.04.002]
   Raouf MWA, 2006, J RADIOANAL NUCL CH, V267, P389, DOI 10.1007/s10967-006-0060-6
   Regel-Rosocka M, 2012, SEP PURIF TECHNOL, V97, P158, DOI 10.1016/j.seppur.2012.01.035
   Shady S. A., 2011, RADIOCHEMISTRY, V53, P396, DOI DOI 10.1134/S1066362211040102
   Tang WM, 2016, J FLUORINE CHEM, V186, P52, DOI 10.1016/j.jfluchem.2016.04.005
   Vekariya RL, 2017, J MOL LIQ, V227, P44, DOI 10.1016/j.molliq.2016.11.123
   Velmurugan P, 2015, J IND ENG CHEM, V29, P298, DOI 10.1016/j.jiec.2015.04.009
   Visser A.E., 2003, ANAL CHIM ACTA, V488, P183
   Yang XY, 2012, T NONFERR METAL SOC, V22, P3126, DOI 10.1016/S1003-6326(12)61764-6
NR 37
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD JUN
PY 2017
VL 236
BP 9
EP 17
DI 10.1016/j.molliq.2017.04.013
PG 9
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EW4AR
UT WOS:000402444900002
OA No
DA 2017-08-17
ER

PT J
AU Atta, AM
   Al-Lohedan, HA
   Ezzat, AO
   Tawfik, AM
   Hashem, AI
AF Atta, Ayman M.
   Al-Lohedan, Hamad A.
   Ezzat, Abdelrhman O.
   Tawfik, Ahmed M.
   Hashem, Ahmed I.
TI Synthesis of zinc oxide nanocomposites using poly (ionic liquids) based
   on quaternary ammonium acrylamidomethyl propane sulfonate for water
   treatment
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE Zinc oxide nano-size; Polymer composite; Water treatment; Poly (ionic
   liquid); Antimicrobial activity
ID HEAVY-METAL REMOVAL; ENVIRONMENTAL APPLICATIONS; OPTICAL-PROPERTIES;
   NANOPARTICLES; FABRICATION; ADSORBENTS; POLLUTANTS; GROWTH
AB Antimicrobial zinc oxide (ZnO) nano-sized materials have been used as environmentally friendly nanocomposites for water treatment applications due to their superior properties. Their particle size growth in water is one of their limitations that affects their preparation as nano-sized ZnO in aqueous medium at room temperature. In the present work, poly(ionic liquid), PIL, based on quaternary ammonium salts of 2-acrylamido-2-methyl propane sulfonic acid homopolymer and its copolymer with N-vinyl pyrrolidone were used as capping agents to control the ZnO shapes and sizes. The surface charges, morphology, particle sizes and chemical structure of ZnO capped with PIL were studied as well as their antimicrobial activity. The prepared ZnO nanomaterial was used to prepare crosslinked 2-acrylamido-2-methyl propane sulfonic acid-co-acrylonitrile nanocomposites to apply as adsorbent for methylene blue dye from water as harmful organic pollutants. The ZnO composites achieved high adsorption removal rate for 3000 mg/L of MB from water during 20 min. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Atta, Ayman M.; Al-Lohedan, Hamad A.; Ezzat, Abdelrhman O.] King Saud Univ, Coll Sci, Chem Dept, Surfactants Res Chair, Riyadh 11451, Saudi Arabia.
   [Atta, Ayman M.] Egyptian Petr Res Inst, Petr Applicat Dept, Cairo 11727, Egypt.
   [Tawfik, Ahmed M.] King Saud Univ, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Hashem, Ahmed I.] Ain Shams Univ, Fac Sci, Chem Dept, Cairo, Egypt.
RP Atta, AM (reprint author), King Saud Univ, Coll Sci, Chem Dept, Surfactants Res Chair, Riyadh 11451, Saudi Arabia.
EM aatta@ksu.edu.sa
FU King Saud University, Vice Deanship of Research Chairs
FX The project was financially supported by King Saud University, Vice
   Deanship of Research Chairs.
CR Abdullah M. M. S., 2016, J MOL LIQ, V219, P54
   Atta AM, 2016, DIG J NANOMATER BIOS, V11, P185
   Atta AM, 2016, J POLYM RES, V23, P1, DOI 10.1007/s10965-016-0963-z
   Atta AM, 2016, J IND ENG CHEM, V33, P122, DOI 10.1016/j.jiec.2015.09.028
   Atta AM, 2011, J DISPER SCI TECHNOL, V32, P1285, DOI 10.1080/01932691.2010.505803
   Atta AM, 2011, J APPL POLYM SCI, V122, P999, DOI 10.1002/app.34245
   Berg JM, 2009, NANOTOXICOLOGY, V3, P276, DOI 10.3109/17435390903276941
   Cao BQ, 2007, J PHYS CHEM C, V111, P2470, DOI 10.1021/jp0666611
   Cao XL, 2008, J PHYS CHEM C, V112, P5267, DOI 10.1021/jp800499r
   Charan KTP, 2014, EUR POLYM J, V60, P114, DOI 10.1016/j.eurpolymj.2014.09.004
   Chong MN, 2010, WATER RES, V44, P2997, DOI 10.1016/j.watres.2010.02.039
   Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875
   Deliyanni EA, 2009, J HAZARD MATER, V172, P550, DOI 10.1016/j.jhazmat.2009.07.130
   Ghoshal T, 2007, CRYST GROWTH DES, V7, P136, DOI 10.1021/cg060289h
   Greenlee LF, 2009, WATER RES, V43, P2317, DOI 10.1016/j.watres.2009.03.010
   Grimm J, 1998, DESALINATION, V115, P285, DOI 10.1016/S0011-9164(98)00047-2
   Hua M, 2012, J HAZARD MATER, V211, P317, DOI 10.1016/j.jhazmat.2011.10.016
   Jing ZH, 2008, ADV MATER, V20, P4547, DOI 10.1002/adma.200800243
   Lee JH, 2005, MATER SCI FORUM, V486-487, P510
   Li L, 2006, CRIT REV ENV SCI TEC, V36, P405, DOI 10.1080/10643380600620387
   Ma XF, 2010, CATAL TODAY, V158, P459, DOI 10.1016/j.cattod.2010.07.013
   Mahamuni S, 1996, NANOSTRUCT MATER, V7, P659, DOI 10.1016/0965-9773(96)00043-8
   Pan BJ, 2009, CHEM ENG J, V151, P19, DOI 10.1016/j.cej.2009.02.036
   Pathania D, 2014, ADV MATER SER, P243
   Pernak J, 2005, CHEM-EUR J, V11, P4441, DOI 10.1002/chem.200500026
   Ren XM, 2011, CHEM ENG J, V170, P395, DOI 10.1016/j.cej.2010.08.045
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   Stefaniuk M, 2016, CHEM ENG J, V287, P618, DOI 10.1016/j.cej.2015.11.046
   Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374
   Umar A, 2006, NANOTECHNOLOGY, V17, P4072, DOI 10.1088/0957-4484/17/16/013
   Upadhyayula VKK, 2009, SCI TOTAL ENVIRON, V408, P1, DOI 10.1016/j.scitotenv.2009.09.027
   U.S. Bureau of Reclamation, 2003, DES WAT PUR TECHN RO
   Xu C, 2006, J PHYS CHEM B, V110, P21741, DOI 10.1021/jp0631681
   Xu PA, 2012, SCI TOTAL ENVIRON, V424, P1, DOI 10.1016/j.scitotenv.2012.02.023
   Yuan JY, 2013, PROG POLYM SCI, V38, P1009, DOI 10.1016/j.progpolymsci.2013.04.002
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
   Zhang WL, 2016, J MOL LIQ, V222, P995, DOI 10.1016/j.molliq.2016.07.144
   Zhao X, 2011, CHEM ENG J, V170, P381, DOI 10.1016/j.cej.2011.02.071
   Zhu HY, 2013, APPL SURF SCI, V285, P865, DOI 10.1016/j.apsusc.2013.09.003
NR 39
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD JUN
PY 2017
VL 236
BP 38
EP 47
DI 10.1016/j.molliq.2017.04.012
PG 10
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EW4AR
UT WOS:000402444900005
OA No
DA 2017-08-17
ER

PT J
AU Shakeel, F
   Salem-Bekhit, MM
   Haq, N
   Siddiqui, NA
AF Shakeel, Faiyaz
   Salem-Bekhit, Mounir M.
   Haq, Nazrul
   Siddiqui, Nasir A.
TI Solubility and thermodynamics of ferulic acid in different neat
   solvents: Measurement, correlation and molecular interactions
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE Activity coefficient; Bioactive compound; Ferulic add; Dissolution
   thermodynamics; Molecular interactions; Solubility
ID SUPERCRITICAL CARBON-DIOXIDE; MAGNESIUM-DL-ASPARTATE; PLUS WATER
   MIXTURES; P-TOLUIC ACID; PHARMACOKINETIC PROPERTIES; PHENOLIC-COMPOUNDS;
   NATURAL SOURCES; DIETARY-INTAKE; 333.15 K; ANTIOXIDANT
AB In the present investigation, the solubility of a bioactive compound ferulic acid (FA) in various neat solvents namely "water, methanol, ethanol, isopropanol (IPA), ethylene glycol (EG), propylene glycol (PG), 1-butanol, 2-butanol, ethyl acetate (EA), dimethyl sulfoxide (DMSO), polyethylene glycol-400 (PEG-400) and Transcutol (R)" was measured, correlated and evaluated for molecular interactions. The solubilities of FA in mole fraction were measured at temperatures "T = 298.2 K to 318.2 K" and pressure "p = 0.1 MPa". The experimental solubilities of FA were correlated with "Van't Hoff and Apelblat models" with root mean square deviation values of <2.0%. The solubilities of FA in mole fraction were recorded maximum in PEG-400 (1.91 x 10(-1)) followed by DMSO (6.47 x 10(-2)), Transcutol (5.92 x 10(-2)), PG (3.59 x 10(-2)), methanol (3.15 x 10(-2)), ethanol (3.08 x 10(-2)), EG (2.71 x 10(-3)), IPA (2.55 x 10(-2)), 2-butanol (2.47 x 10(-2)), 1-butanol (2.38 x 10(-2)), EA (1.98 x 10(-2)) and water (1.36 x 10(-4)) at "T = 318.2 K" and similar trend was also obtained at each temperature level. Generally, FA showed good solubilization potential in each neat solvent except in water. The activity coefficients of FA in each neat solvent were also determined in order to evaluate the molecular interactions between FA and solvent molecules. Higher solute-solvent interactions were seen in "PEG-400, DMSO and Transcutol" based on activity coefficients results. "Apparent thermodynamic analysis" showed an "endothermic and entropy-driven dissolution" of FA in each neat solvent. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Shakeel, Faiyaz; Salem-Bekhit, Mounir M.; Haq, Nazrul] King Saud Univ, Dept Pharmaceut, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
   [Salem-Bekhit, Mounir M.] Al Azhar Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt.
   [Siddiqui, Nasir A.] King Saud Univ, Coll Pharm, Dept Pharmacognosy, POB 2457, Riyadh 11451, Saudi Arabia.
RP Shakeel, F (reprint author), King Saud Univ, Dept Pharmaceut, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
EM faiyazs@fastmail.fm
FU Deanship of Scientific Research at King Saud University [RGP-202]
FX "The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at King Saud University for funding the
   work through the research group project number RGP-202".
CR Almarri F, 2017, J MOL LIQ, V229, P477, DOI 10.1016/j.molliq.2016.12.105
   Anwer MK, 2015, CHINESE J CHEM ENG, V23, P812, DOI 10.1016/j.cjche.2014.03.006
   Anwer MK, 2014, J CHEM ENG DATA, V59, P2065, DOI 10.1021/je500206w
   Apelblat A, 1999, J CHEM THERMODYN, V31, P85, DOI 10.1006/jcht.1998.0424
   Aragon DM, 2009, J SOLUTION CHEM, V38, P1493, DOI 10.1007/s10953-009-9464-6
   Bitencourt RG, 2016, J CHEM THERMODYN, V103, P285, DOI 10.1016/j.jct.2016.08.025
   Cairong Z., 2007, J CHEM IND ENG, V58, P2705
   Castelluccio C, 1996, BIOCHEM J, V316, P691
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   El-Seedi HR, 2012, J AGR FOOD CHEM, V60, P10877, DOI 10.1021/jf301807g
   Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117
   Hildebrand J.H., 1970, REGULAR RELATED SOLU
   Holguin AR, 2012, FLUID PHASE EQUILIBR, V314, P134, DOI 10.1016/j.fluid.2011.11.001
   Kikuzaki H, 2002, J AGR FOOD CHEM, V50, P2161, DOI 10.1021/jf011348w
   KRUG RR, 1976, J PHYS CHEM-US, V80, P2341, DOI 10.1021/j100562a007
   Kumar Naresh, 2014, Biotechnol Rep (Amst), V4, P86, DOI 10.1016/j.btre.2014.09.002
   Manic MS, 2012, J CHEM THERMODYN, V48, P93, DOI 10.1016/j.jct.2011.12.005
   Manrique YJ, 2008, J SOLUTION CHEM, V37, P165, DOI 10.1007/s10953-007-9228-0
   Manzurola E, 2002, J CHEM THERMODYN, V34, P1127, DOI 10.1006/jcht.2002.0975
   Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467
   Mattila P, 2005, J AGR FOOD CHEM, V53, P8290, DOI 10.1021/jf051437z
   Mattila P, 2006, J AGR FOOD CHEM, V54, P7193, DOI 10.1021/jf0615247
   Mota FL, 2008, IND ENG CHEM RES, V47, P5182, DOI 10.1021/ie071452o
   NEAU SH, 1990, PHARMACEUT RES, V7, P1157, DOI 10.1023/A:1015984310068
   Noubigh A, 2007, J CHEM THERMODYN, V39, P297, DOI 10.1016/j.jct.2006.06.014
   Puupponen-Pimia R, 2005, APPL MICROBIOL BIOT, V67, P8, DOI 10.1007/s00253-004-1817-x
   Ruidiaz MA, 2010, FLUID PHASE EQUILIBR, V299, P259, DOI 10.1016/j.fluid.2010.09.027
   Shakeel F, 2017, J MOL LIQ, V230, P511, DOI 10.1016/j.molliq.2017.01.077
   Shakeel F, 2016, J MOL LIQ, V222, P167, DOI 10.1016/j.molliq.2016.07.007
   Shakeel F, 2015, J CHEM ENG DATA, V60, P775, DOI 10.1021/je500893g
   Shakeel F, 2015, FOOD CHEM, V180, P244, DOI 10.1016/j.foodchem.2015.01.102
   Shakeel F, 2015, J CHEM THERMODYN, V82, P156, DOI 10.1016/j.jct.2014.11.008
   Shakeel F, 2014, J MOL LIQ, V195, P255, DOI 10.1016/j.molliq.2014.02.039
   Shakeel F, 2013, J MOL LIQ, V188, P28, DOI 10.1016/j.molliq.2013.09.013
   Sovova H, 2001, J CHEM ENG DATA, V46, P1255, DOI 10.1021/je0101146
   Sun YY, 2005, J CHEM ENG DATA, V50, P1125, DOI 10.1021/je049715y
   Villanueva-Bermejo D., 2016, OPEN CHEM ENG J, V10, P50
   Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039
NR 38
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD JUN
PY 2017
VL 236
BP 144
EP 150
DI 10.1016/j.molliq.2017.04.014
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EW4AR
UT WOS:000402444900017
OA No
DA 2017-08-17
ER

PT J
AU Radwan, AB
   Sliem, MH
   Okonkwo, PC
   Shibl, MF
   Abdullah, AM
AF Radwan, A. Bahgat
   Sliem, Mostafa H.
   Okonkwo, Paul C.
   Shibl, Mohamed F.
   Abdullah, Aboubakr M.
TI Corrosion inhibition of API X120 steel in a highly aggressive medium
   using stearamidopropyl dimethylamine
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE Corrosion; Inhibition; API X120; Impedance spectroscopy; Electrochemical
   polarization; Quantum calculations
ID HYDROCHLORIC-ACID SOLUTION; 1 M HCL; ELECTROCHEMICAL IMPEDANCE
   SPECTROSCOPY; HYDROGEN-INDUCED CRACKING; API-X100 PIPELINE STEEL;
   LOW-CARBON STEEL; MILD-STEEL; MECHANICAL-PROPERTIES; FRIENDLY INHIBITOR;
   EROSION-CORROSION
AB The inhibition efficiency of the stearamidopropyl dimethylamine (SAPDA) surfactant for the corrosion of API X120 steel in a 0.5 M HCI solution at different temperatures was investigated using different electrochemical and microscopy techniques. The kinetics and thermodynamic parameters were discussed. The overall results showed that SAPDA significantly decreased the corrosion rate of API X120 steel with an inhibition efficiency of approximately 99% at an inhibitor concentration of 136 mol L-1. It was revealed that the adsorption of the SAPDA surfactant on the API X120 steel surface followed Langmuir's adsorption isotherm. Polarization studies indicated that SAPDA is chemi/physisorbed on the steel surface. Quantum chemical calculations, using the density functional theory, were applied to better understand the relationship between the inhibitor efficiency and its molecular structure. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Radwan, A. Bahgat; Sliem, Mostafa H.; Okonkwo, Paul C.; Abdullah, Aboubakr M.] Qatar Univ, Ctr Adv Mat, Doha 2713, Qatar.
   [Shibl, Mohamed F.] Qatar Univ, Coll Engn, Gas Proc Ctr, Doha 2713, Qatar.
   [Shibl, Mohamed F.] Cairo Univ, Dept Chem, Fac Sci, Giza 12613, Egypt.
RP Abdullah, AM (reprint author), Qatar Univ, Ctr Adv Mat, Doha 2713, Qatar.; Shibl, MF (reprint author), Qatar Univ, Coll Engn, Gas Proc Ctr, Doha 2713, Qatar.; Shibl, MF (reprint author), Cairo Univ, Dept Chem, Fac Sci, Giza 12613, Egypt.
EM mfshibl@qu.edu.qa; abubakr_2@yahoo.com
FU Center for Advanced Materials; Gas Processing Center at Qatar University
FX The authors gratefully thank the Center for Advanced Materials and the
   Gas Processing Center at Qatar University for their support.
CR Abd El Rehim SS, 2001, MATER CHEM PHYS, V70, P268, DOI 10.1016/S0254-0584(00)00462-4
   Abdallah M, 2016, J MOL LIQ, V223, P1143, DOI 10.1016/j.molliq.2016.09.006
   Ahamad I, 2010, CORROS SCI, V52, P3033, DOI 10.1016/j.corsci.2010.05.022
   Ahamad I, 2010, CORROS SCI, V52, P1472, DOI 10.1016/j.corsci.2010.01.015
   Al-Mansour M, 2009, MATER DESIGN, V30, P4088, DOI 10.1016/j.matdes.2009.05.025
   Amin MA, 2010, CORROS SCI, V52, P140, DOI 10.1016/j.corsci.2009.08.055
   Atta AM, 2011, CORROS SCI, V53, P1680, DOI 10.1016/j.corsci.2011.01.019
   Barker R, 2013, CORROSION, V69, P193, DOI 10.5006/0422
   Beidokhti B, 2009, MAT SCI ENG A-STRUCT, V507, P167, DOI 10.1016/j.msea.2008.11.064
   Bentiss F, 2007, APPL SURF SCI, V253, P3696, DOI 10.1016/j.apsusc.2006.08.001
   Bouammali H, 2015, J IND ENG CHEM, V26, P270, DOI 10.1016/j.jiec.2014.11.039
   Bouklah M, 2006, CORROS SCI, V48, P2831, DOI 10.1016/j.corsci.2005.08.019
   Bousskri A, 2015, J MOL LIQ, V211, P1000, DOI 10.1016/j.molliq.2015.08.038
   Chaitra TK, 2015, J MOL LIQ, V211, P1026, DOI 10.1016/j.molliq.2015.08.031
   Chauhan LR, 2007, CORROS SCI, V49, P1143, DOI 10.1016/j.corsci.2006.08.012
   Choi BW, 2009, MET MATER INT, V15, P373, DOI 10.1007/s12540-009-0373-4
   CHONG DP, 1978, J ELECTRON SPECTROSC, V13, P39, DOI 10.1016/0368-2048(78)85005-1
   El Faydy M, 2016, J MOL LIQ, V219, P396, DOI 10.1016/j.molliq.2016.03.056
   Eliyan FF, 2013, MATER CHEM PHYS, V140, P508, DOI 10.1016/j.matchemphys.2013.03.061
   Eliyan FF, 2012, CORROS SCI, V64, P37, DOI 10.1016/j.corsci.2012.06.032
   Eliyan FF, 2012, CORROS SCI, V58, P181, DOI 10.1016/j.corsci.2012.01.015
   Finsgar M, 2014, CORROS SCI, V86, P17, DOI 10.1016/j.corsci.2014.04.044
   Frisch M.J., 2010, RC GAUSSIAN 09
   Gadala IM, 2014, CORROS SCI, V82, P45, DOI 10.1016/j.corsci.2013.12.020
   Gerengi H, 2012, IND ENG CHEM RES, V51, P780, DOI 10.1021/ie201776q
   Gupta NK, 2016, J MOL LIQ, V215, P47, DOI 10.1016/j.molliq.2015.12.027
   Hamdy A., 2013, EGYPT J PETROLEUM, V22, P17, DOI DOI 10.1016/J.EJPE.2012.06.002
   Haque J, 2017, J MOL LIQ, V225, P848, DOI 10.1016/j.molliq.2016.11.011
   Hernandez-Espejel A, 2010, CORROS SCI, V52, P2258, DOI 10.1016/j.corsci.2010.04.003
   Herran A, 2012, COMPUT CHEM ENG, V37, P248, DOI 10.1016/j.compchemeng.2011.10.003
   Herran A, 2010, COMPUT CHEM ENG, V34, P401, DOI 10.1016/j.compchemeng.2009.11.014
   Igi S, 2011, PROCEDIA ENGINEER, V10, P1451, DOI 10.1016/j.proeng.2011.04.241
   Islam MA, 2013, WEAR, V302, P1592, DOI 10.1016/j.wear.2013.01.041
   Ituen E, 2016, J MOL LIQ, V224, P408, DOI 10.1016/j.molliq.2016.10.024
   Jokar M, 2016, J TAIWAN INST CHEM E, V63, P436, DOI 10.1016/j.jtice.2016.02.027
   KHEDR MGA, 1992, CORROS SCI, V33, P137, DOI 10.1016/0010-938X(92)90023-V
   Koopmans T, 1934, PHYSICA, V1, P104, DOI 10.1016/S0031-8914(34)90011-2
   Laidler K. J., 1963, REACTION KINETICS
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Liao LL, 2016, J COLLOID INTERF SCI, V474, P68, DOI 10.1016/j.jcis.2016.04.015
   Lukovits I, 2001, CORROSION, V57, P3
   MANSFELD F, 1995, J APPL ELECTROCHEM, V25, P187
   Markhali BP, 2013, CORROS SCI, V75, P269, DOI 10.1016/j.corsci.2013.06.010
   Mohtadi-Bonab MA, 2015, INT J HYDROGEN ENERG, V40, P1096, DOI 10.1016/j.ijhydene.2014.11.057
   Morad MS, 2006, CORROS SCI, V48, P3398, DOI 10.1016/j.corsci.2005.12.006
   Mourya P, 2014, CORROS SCI, V85, P352, DOI 10.1016/j.corsci.2014.04.036
   Olalla VC, 2014, MAT SCI ENG A-STRUCT, V604, P46, DOI 10.1016/j.msea.2014.02.066
   PEARSON RG, 1985, J AM CHEM SOC, V107, P6801, DOI 10.1021/ja00310a009
   Quez-Ake J., 2008, INT J ELECTROCHEM SC, P56
   Raghavachari K., 2001, THEORETICAL CHEM ACC, P361
   Rios-Mercado RZ, 2015, APPL ENERG, V147, P536, DOI 10.1016/j.apenergy.2015.03.017
   Sha QY, 2013, MAT SCI ENG A-STRUCT, V585, P214, DOI 10.1016/j.msea.2013.07.055
   Shirinzadeh-Dastgiri M, 2015, ENG FAIL ANAL, V53, P78, DOI 10.1016/j.engfailanal.2015.03.015
   Shukla SK, 2008, CORROS SCI, V50, P2867, DOI 10.1016/j.corsci.2008.07.025
   Singh AK, 2011, MATER CHEM PHYS, V129, P68, DOI 10.1016/j.matchemphys.2011.03.054
   Singh AK, 2009, CORROS SCI, V51, P2752, DOI 10.1016/j.corsci.2009.07.011
   Solomon MM, 2010, CORROS SCI, V52, P1317, DOI 10.1016/j.corsci.2009.11.041
   Tang YM, 2013, CORROS SCI, V74, P271, DOI 10.1016/j.corsci.2013.04.053
   Tawfik SM, 2016, J MOL LIQ, V216, P624, DOI 10.1016/j.molliq.2016.01.066
   Tazouti A, 2016, J MOL LIQ, V221, P815, DOI 10.1016/j.molliq.2016.03.083
   Umoren SA, 2016, J MOL LIQ, V219, P946, DOI 10.1016/j.molliq.2016.03.077
   Valcarce MB, 2009, MATER CHEM PHYS, V115, P313, DOI 10.1016/j.matchemphys.2008.12.007
   Verma CB, 2015, J MOL LIQ, V209, P306, DOI 10.1016/j.molliq.2015.06.013
   Verma C, 2016, J MOL LIQ, V224, P1282, DOI 10.1016/j.molliq.2016.10.117
   Verma C, 2015, J MOL LIQ, V212, P209, DOI 10.1016/j.molliq.2015.09.009
   Vilche JR, 2002, CORROS SCI, V44, P1287, DOI 10.1016/S0010-938X(01)00144-5
   Wang C, 2005, WEAR, V258, P649, DOI 10.1016/j.wear.2004.09.038
   Wang PY, 2015, INT J HYDROGEN ENERG, V40, P11514, DOI 10.1016/j.ijhydene.2015.02.051
   Xu B, 2014, CORROS SCI, V78, P260, DOI 10.1016/j.corsci.2013.10.007
   Zaid B, 2015, J ALLOY COMPD, V629, P188, DOI 10.1016/j.jallcom.2015.01.003
   Zarrok H, 2012, CORROS SCI, V64, P243, DOI 10.1016/j.corsci.2012.07.018
   Zarrouk A, 2016, J MOL LIQ, V222, P239, DOI 10.1016/j.molliq.2016.07.046
   Zhang BR, 2015, CORROS SCI, V94, P6, DOI 10.1016/j.corsci.2014.11.035
   Zhang J, 2015, IND ENG CHEM RES, V54, P5197, DOI 10.1021/ie5044055
   Zhao MC, 2002, MAT SCI ENG A-STRUCT, V335, P14, DOI 10.1016/S0921-5093(01)01904-9
   Zhao TP, 1999, CORROS SCI, V41, P1937, DOI 10.1016/S0010-938X(99)00029-3
   Zheng LF, 2015, CORROSION-US, V71, P692, DOI 10.5006/1524
NR 77
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD JUN
PY 2017
VL 236
BP 220
EP 231
DI 10.1016/j.molliq.2017.03.116
PG 12
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EW4AR
UT WOS:000402444900025
OA No
DA 2017-08-17
ER

PT J
AU Mohammed, GI
   Ahmad, W
   Alwael, H
   Bashammakh, AS
   Saigl, ZM
   El-Shahawi, MS
AF Mohammed, G. I.
   Ahmad, W.
   Alwael, H.
   Bashammakh, A. S.
   Saigl, Z. M.
   El-Shahawi, M. S.
TI Application of pi beta-correction spectrophotometry for determination
   and speciation of bismuth (III) & (V) species in various water samples,
   soil, hair and drug formulations
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE Bismuth(III) & (V); Speciation; Thorin-I; beta-Correction
   spectrophotometry; Structure elucidation; Certified reference material;
   Applications
ID ATOMIC-ABSORPTION-SPECTROMETRY; FLOW-INJECTION EXTRACTION; FLUORESCENCE
   SPECTROMETRY; SELENIUM; SYSTEM; PRECONCENTRATION; COMPLEXES; TELLURIUM;
   ANTIMONY; CHLORIDE
AB A simple strategy has been developed for determination and speciation of bismuth(III) & (V) coupled dual wave beta-correction spectrophotometry. The principle of the study was based on the reaction of bismuth(III) with reagent 1-(o-arsonophenylazo)-2-napthol-3,6-disulphuric acid (Thorin-I) to form a deep red orange colored complex species. The absorbance intensity was recorded at lambda(max) = 540 nm. The method exhibits a wide linear range (0.25-20.0 mu g mL(-1)) and Ringbom's plots in the range 1.6-10.0 mu g mL(-1) for bismuth(III) ions, respectively. The lower limit of detection (LOD) and quantification (LOQ) obtained were 0.045 and 0.15 mu g mL(-1), respectively. Bismuth(V) was determined after reduction to bismuth(III) with Mn2+ in acidic solution. Trace level speciation studies were performed with satisfactorily recovery percentages for bismuth species. The method was applied for analysis of total bismuth in tap water, well water, marine water, hair sample, pharmaceutical formulations (cream) and in certified reference material (IAEA Soil-7). The results were compared successfully in terms of F and t-test with the reference method inductively coupled plasma-mass spectrometry(ICP-OES) and no significant difference was noticed at 95% confidence (P = 0.05). The developed method has a unique advantage to be quantitatively applied to a variety of samples due to rapid response, short analytical time and ability to be detected by naked eye with good reproducibility. The LOD offered has a value lower than that recommended by World Health Organization (WHO) and compared successfully with some reported spectrochemical and electrochemical methods. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Mohammed, G. I.] Umm Al Qura Univ, Fac Appl Sci, Dept Chem, POB 16722, Mecca 27955, Saudi Arabia.
   [Ahmad, W.; Alwael, H.; Bashammakh, A. S.; Saigl, Z. M.; El-Shahawi, M. S.] King Abdulaziz Univ, Dept Chem, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
RP El-Shahawi, MS (reprint author), Damiatta Univ, Dept Chem, Fac Sci, Dumyat, Egypt.
EM malsaeed@kau.edu.sa
CR Abbaspour A, 2005, TALANTA, V65, P692, DOI 10.1016/j.talanta.2004.07.029
   Amin AS, 2015, J TAIBAH UNIV SCI, V9, P490, DOI 10.1016/j.jtusci.2015.01.003
   Barakat SA, 2002, TURK J CHEM, V26, P345
   Belcher R., 1970, QUANTITATIVE INORGAN
   BURNS DT, 1992, FRESEN J ANAL CHEM, V344, P131
   Burns D.T., 1992, CHIM ACTA, V270, P213
   Didi MA, 2011, COLLOID SURFACE A, V375, P169, DOI 10.1016/j.colsurfa.2010.11.082
   Egorysheva AV, 2015, J SOLID STATE CHEM, V225, P97, DOI 10.1016/j.jssc.2014.12.001
   El-Shahawi MS, 2011, CHEM ENG J, V173, P29, DOI 10.1016/j.cej.2011.07.028
   Fathirad F, 2013, ELECTROCHIM ACTA, V103, P206, DOI 10.1016/j.electacta.2013.03.162
   Gadhari NS, 2010, ELECTROCHIM ACTA, V56, P627, DOI 10.1016/j.electacta.2010.09.100
   Gaikwad SH, 2005, INDIAN J CHEM TECHN, V12, P365
   Gumus G, 2005, ANAL CHIM ACTA, V547, P138, DOI 10.1016/j.aca.2005.03.028
   Hamza A, 2010, J HAZARD MATER, V178, P287, DOI 10.1016/j.jhazmat.2010.01.075
   Hamza A, 2010, ANAL CHIM ACTA, V657, P69, DOI 10.1016/j.aca.2009.10.025
   Kilinc E, 2012, SPECTROCHIM ACTA B, V73, P84, DOI 10.1016/j.sab.2012.06.004
   Koper A, 2012, J ELECTROANAL CHEM, V681, P1, DOI 10.1016/j.jelechem.2012.05.020
   Koper A, 2011, J ELECTROANAL CHEM, V663, P67, DOI 10.1016/j.jelechem.2011.09.021
   Lever A.B.P., 1984, INORGANIC ELECT SPEC
   Li YK, 2013, BIOORG MED CHEM LETT, V23, P2288, DOI 10.1016/j.bmcl.2013.02.097
   Liu HM, 2002, ANAL CHIM ACTA, V459, P161, DOI 10.1016/S0003-2670(02)00105-8
   Marczenko Z, 1986, SEPARATION SPECTROPH
   Miller J.C., 2010, STAT ANAL CHEM
   Mohammadi S, 2015, SPECTROCHIM ACTA A, V148, P405, DOI 10.1016/j.saa.2015.03.127
   Nakamoto K., 1971, INFRARED RAMAN SPECT
   Narin I, 1997, FRESEN ENVIRON BULL, V6, P749
   Norisuye K, 2012, ANAL CHIM ACTA, V727, P71, DOI 10.1016/j.aca.2012.03.042
   Rahman L, 2000, TALANTA, V52, P833, DOI 10.1016/S0039-9140(00)00436-7
   Saad EM, 2007, TRANSIT METAL CHEM, V32, P155, DOI 10.1007/s11243-006-0138-6
   Sawyer D.T., 1984, CHEM EXPT INSTRUMENT
   Shia J., 2009, ASIAN J PHARM SCI, V4, P228
   Sivasekar S, 2014, INORG CHIM ACTA, V419, P82, DOI 10.1016/j.ica.2014.04.042
   Sung YH, 2003, ANAL CHIM ACTA, V495, P165, DOI 10.1016/j.aca.2003.07.009
   Taher MA, 2014, J LUMIN, V145, P976, DOI 10.1016/j.jlumin.2013.09.025
   Tokman N, 2005, SPECTROCHIM ACTA B, V60, P291, DOI 10.1016/j.sab.2004.11.001
   Tzanavaras PD, 2004, ANAL CHIM ACTA, V505, P167, DOI 10.1016/S0003-2670(03)00017-5
   Vogel A.I., 1966, QUANTITATIVE INORGAN
   Wen XD, 2014, ANAL METHODS-UK, V6, P8773, DOI 10.1039/c4ay01440e
   Wen XD, 2012, SPECTROCHIM ACTA A, V89, P1, DOI 10.1016/j.saa.2011.12.041
   Wrobel K, 2000, MIKROCHIM ACTA, V135, P87, DOI 10.1007/s006040070022
   Zhang N, 2011, FOOD CHEM, V124, P1185, DOI 10.1016/j.foodchem.2010.07.033
NR 41
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD JUN
PY 2017
VL 236
BP 241
EP 248
DI 10.1016/j.molliq.2017.04.003
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EW4AR
UT WOS:000402444900027
OA No
DA 2017-08-17
ER

PT J
AU Tantawy, AH
   Mohamed, HI
   Khalil, AA
   Hebash, KA
   Basyouni, MZ
AF Tantawy, Ahmed H.
   Mohamed, Hany I.
   Khalil, Ahmed A.
   Hebash, Kaouser A.
   Basyouni, Mahmoud Z.
TI Novel bioactive imidazole-containing polymeric surfactants as
   petroleum-collecting and dispersing agents: Synthesis and surface-active
   properties
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE 1-Vinylimidazole; Lauryl methacrylate; Reactivity ratios; Polymeric
   surfactants; Petroleum-dispersing agents
ID CATIONIC GEMINI SURFACTANTS; QUATERNARY AMMONIUM-SALTS;
   BIOLOGICAL-ACTIVITY; ANTIMICROBIAL ACTIVITY; OLEIC-ACID; BEHAVIOR;
   METHACRYLATE; COMPLEXES; SPACER; OIL
AB Novel series of imidazole-containing polymers and polymeric surfactants have been synthesized via an efficient procedure. It included copolymerization of 1-vinyl-imidazole (VIM) with lauryl methacrylate (LMA) initiated by benzoyl peroxide and the H-1 NMR spectroscopic data was utilized to estimate the monomer reactivity ratio. Conversion of polymers to surfactants was achieved through quaternization of the imidazole nitrogen with dimethyl sulphate. Spectroscopic techniques were used to elucidate the chemical structures of all synthesized compounds. The surface-active properties of polymeric surfactants beside their activities against various microbes were investigated. In addition, petroleum-collecting and dispersing properties of surfactants in diluted and undiluted form in varying waters were evaluated. (C) 2017 Elsevier B.V. All rights reserved,
C1 [Tantawy, Ahmed H.; Mohamed, Hany I.; Khalil, Ahmed A.; Hebash, Kaouser A.; Basyouni, Mahmoud Z.] Benha Univ, Chem Dept, Fac Sci, Banha 13518, Egypt.
   [Tantawy, Ahmed H.] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Man, Wuhan 430070, Peoples R China.
RP Mohamed, HI (reprint author), Benha Univ, Chem Dept, Fac Sci, Banha 13518, Egypt.
EM hany.ibrahim@fsc.bu.edu.eg
CR ABDELLATEEF HM, 2012, CASP J APPL SCI RES, V1, P56
   Abo-Riya M, 2016, J MOL LIQ, V221, P642, DOI 10.1016/j.molliq.2016.05.083
   Aiad I, 2013, J SURFACTANTS DETERG, V16, P927, DOI 10.1007/s11743-013-1491-z
   Aiad I, 2013, J SURFACTANTS DETERG, V16, P243, DOI 10.1007/s11743-012-1402-8
   Al-Sabagh AM, 2003, COLLOID SURFACE A, V216, P9, DOI 10.1016/S0927-7757(02)00493-4
   ALPERT AJ, 1979, J CHROMATOGR, V185, P375, DOI 10.1016/S0021-9673(00)85615-0
   Asadov Z. H., 2013, EGYPTIAN J PETROLEUM, V22, P261
   Asadov Z.H., 2012, CHEM J, V02, P136
   Asadov ZH, 2012, J OLEO SCI, V61, P621, DOI 10.5650/jos.61.621
   BADAWI AM, 1983, CURR SCI INDIA, V52, P1169
   Bass GF, 2015, POLYMER, V72, P301, DOI 10.1016/j.polymer.2015.03.045
   Dierker M, 2010, EUR J LIPID SCI TECH, V112, P122, DOI 10.1002/ejlt.200900126
   Ghumare AK, 2013, J SURFACTANTS DETERG, V16, P85, DOI 10.1007/s11743-012-1406-4
   GOLD DH, 1960, J PHYS CHEM-US, V64, P1461, DOI 10.1021/j100839a026
   Jilde G, 1993, CHROMATOGRAPHIA, V37, P603
   Josson B., 1988, SURFACTANTS POLYM AQ
   Khalil AA, 2013, J POLYM RES, V20, DOI 10.1007/s10965-012-0028-x
   Lirssh J.F., 1964, J AM CHEM SOC, V86, P833
   Liu FS, 2009, J APPL POLYM SCI, V114, P3561, DOI 10.1002/app.30981
   Lu GQ, 2007, REACT FUNCT POLYM, V67, P355, DOI 10.1016/j.reactfunctpolym.2007.01.008
   Massi L, 2003, EUR J MED CHEM, V38, P519, DOI 10.1016/S0223-5234(03)00059-X
   Mazied N.A., 2009, PHYS CHEM, V78, P899
   Nacham O, 2015, COLLOID SURFACE A, V469, P224, DOI 10.1016/j.colsurfa.2015.01.026
   Negm NA, 2014, J IND ENG CHEM, V20, P4463, DOI 10.1016/j.jiec.2014.02.018
   Overberger C.G., 1974, J POLYM SCI S, V45, P39
   Parikh K, 2015, J MOL LIQ, V206, P19, DOI 10.1016/j.molliq.2015.01.055
   Ren CC, 2015, COLLOID SURFACE A, V467, P1, DOI 10.1016/j.colsurfa.2014.11.031
   ROUNDS MA, 1987, J CHROMATOGR, V397, P25, DOI 10.1016/S0021-9673(01)84987-6
   Sayed GH, 2012, J SURFACTANTS DETERG, V15, P735, DOI 10.1007/s11743-012-1375-7
   SHAABAN AF, 1989, ACTA POLYM, V40, P445, DOI 10.1002/actp.1989.010400706
   SHAABAN AF, 1989, J APPL POLYM SCI, V37, P2051, DOI 10.1002/app.1989.070370724
   Shaban SM, 2016, J MOL LIQ, V216, P284, DOI 10.1016/j.molliq.2015.12.111
   Shaban SM, 2015, J MOL LIQ, V207, P256, DOI 10.1016/j.molliq.2015.03.043
   Shehata HA, 2008, J SURFACTANTS DETERG, V11, P139, DOI 10.1007/s11743-008-1064-8
   Sheikh MS, 2013, J SURFACTANTS DETERG, V16, P503, DOI 10.1007/s11743-012-1430-4
   Tantawy AH, 2014, ARAB J SCI ENG, V39, P5437, DOI 10.1007/s13369-014-1144-1
   VILLAR A, 1986, PLANTA MED, P556
   Wang LY, 2014, J SURFACTANTS DETERG, V17, P1099, DOI 10.1007/s11743-014-1614-1
NR 38
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD JUN
PY 2017
VL 236
BP 376
EP 384
DI 10.1016/j.molliq.2017.04.040
PG 9
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EW4AR
UT WOS:000402444900043
OA No
DA 2017-08-17
ER

PT J
AU Hassan, HMA
   Betiha, MA
   Mohamed, SK
   El-Sharkawy, EA
   Ahmed, EA
AF Hassan, Hassan M. A.
   Betiha, Mohamed A.
   Mohamed, Shaimaa K.
   El-Sharkawy, E. A.
   Ahmed, Emad A.
TI Stable and recyclable MIL-101 (Cr)-Ionic liquid based hybrid
   nanomaterials as heterogeneous catalyst
SO JOURNAL OF MOLECULAR LIQUIDS
LA English
DT Article
DE Solid acid catalyst; MIL-101; Ionic liquid; Esterification;
   Friedel-Crafts; Acylation; Acidity
ID METAL-ORGANIC FRAMEWORKS; FRIEDEL-CRAFTS ACYLATION; ACIDIC IONIC
   LIQUIDS; ACETIC-ANHYDRIDE; BIODIESEL PRODUCTION; ESTERIFICATION;
   ANISOLE; EFFICIENT; SILICA; ZEOLITES
AB Bronsted acidic ionic liquid, N-methyl-2-pyrrolidonium methyl sulfonate ([NMP](+) CH3SO3-) immobilized on MIL-101( Cr) was fabricated by simple impregnation method with a good combination of MIL-101(Cr) and IL species. The worthiness of IL/MIL-101 (Cr), as a Bronsted acid catalyst, has been examined for the esterification of acetic acid with amyl alcohol and Friedel-Crafts acylation of anisole. Our findings demonstrated that IL/MIL-101 (Cr) catalyst exhibited distinct catalytic activity with respect to the other catalysts towards the esterification reaction and Friedel-Crafts acylation of anisole. The Bronsted acidic catalysts loaded on MIL-101(Cr) as a new category of porous materials are probably auspicious heterogeneous catalysts for acid-catalyzed to replace the use of traditional homogeneous catalysts. Furthermore, the catalyst can be easily removed from the reactions mixtures and reuse for posterior reactions, more than six times without any considerable decay in catalytic performance. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Hassan, Hassan M. A.; Mohamed, Shaimaa K.; El-Sharkawy, E. A.; Ahmed, Emad A.] Suez Univ, Dept Chem, Fac Sci, Suez, Egypt.
   [Betiha, Mohamed A.] Egyptian Petr Res Inst, Nasr City 11727, Egypt.
RP Hassan, HMA (reprint author), Suez Univ, Dept Chem, Fac Sci, Suez, Egypt.; Betiha, MA (reprint author), Egyptian Petr Res Inst, Nasr City 11727, Egypt.
EM hassan.hassan@suezuniv.edu.eg; mohamed_betiha@hotmail.com
CR Abd El Rahman S.K., 2014, APPL CATAL A-GEN, V487, P110
   Abd El Rahman S.K., 2012, APPL CATAL A-GEN, V411, P77
   Bachiller-Baeza B, 2004, J CATAL, V228, P225, DOI 10.1016/j.jcat.2004.08.010
   Betiha MA, 2016, APPL CATAL B-ENVIRON, V182, P15, DOI 10.1016/j.apcatb.2015.09.010
   Betiha MA, 2012, J MATER CHEM, V22, P17551, DOI [10.1039/c2jm32941, 10.1039/c2jm32941g]
   Britt D, 2010, INORG CHEM, V49, P6387, DOI 10.1021/ic100652x
   Cardoso LAM, 2004, J MOL CATAL A-CHEM, V209, P189, DOI 10.1016/j.molcata.2003.08.022
   Chu WL, 1996, APPL CATAL A-GEN, V145, P125, DOI 10.1016/0926-860X(96)00109-3
   Cohen SM, 2012, CHEM REV, V112, P970, DOI 10.1021/cr200179u
   Du ZY, 2005, J PHYS CHEM B, V109, P19542, DOI 10.1021/jp0529669
   El-Shall MS, 2009, J MATER CHEM, V19, P7625, DOI 10.1039/b912012b
   Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275
   Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b
   Ferreira MC, 2013, IND ENG CHEM RES, V52, P2336, DOI 10.1021/ie300665z
   Goesten MG, 2011, J CATAL, V281, P177, DOI 10.1016/j.jcat.2011.04.015
   Hassan HMA, 2017, APPL SURF SCI, V412, P394, DOI 10.1016/j.apsusc.2017.03.247
   Hassan HMA, 2017, APPL SURF SCI, V402, P99, DOI 10.1016/j.apsusc.2017.01.061
   Hassan MA, 2016, J POROUS MAT, V23, P1339, DOI 10.1007/s10934-016-0193-0
   Hassan SA, 2013, EGYPT J PETROL ELSEV, V22, P179
   Henschel A, 2008, CHEM COMMUN, P4192, DOI 10.1039/b718371b
   Hong DY, 2009, ADV FUNCT MATER, V19, P1537, DOI 10.1002/adfm.200801130
   Ji XF, 2007, CATAL LETT, V117, P171, DOI 10.1007/s10562-007-9131-8
   Juan-Alcaniz J, 2013, CATAL SCI TECHNOL, V3, P2311, DOI 10.1039/c3cy00272a
   Juan-Alcaniz J, 2012, J MATER CHEM, V22, P10102, DOI 10.1039/c2jm15563j
   Juan-Alcaniz J, 2010, J CATAL, V269, P229, DOI 10.1016/j.jcat.2009.11.011
   Kumar A, 2004, J ORG CHEM, V69, P1419, DOI 10.1021/jo035038j
   Leng KY, 2016, CRYST GROWTH DES, V16, P1168, DOI 10.1021/acs.cgd.5b01696
   Mi XL, 2005, J ORG CHEM, V70, P2338, DOI 10.1021/jo048391d
   Olah G. A., 1963, FRIEDEL CRAFTS RELAT, VI-IV
   Otera J., 2010, ESTERIFICATION METHO, P3, DOI DOI 10.1002/9783527627622.CH1
   Padmanabhan A, 2010, CHEM ENG TECHNOL, V33, P998, DOI 10.1002/ceat.200900542
   Rafiee E, 2011, GREEN CHEM, V13, P2116, DOI 10.1039/c1gc15291b
   Rajagopal R, 2003, TETRAHEDRON LETT, V44, P1815, DOI 10.1016/S0040-4039(03)00092-3
   Rao KN, 2006, APPL CATAL A-GEN, V300, P139, DOI 10.1016/j.apcata.2005.10.051
   Roberts I, 1938, J AM CHEM SOC, V60, P2391, DOI 10.1021/ja01277a028
   SANTACESARIA E, 1983, J CATAL, V80, P427, DOI 10.1016/0021-9517(83)90266-X
   Sarin A, 2012, BIODIESEL: PRODUCTION AND PROPERTIES, P1, DOI 10.1039/9781849734721
   Selvin R, 2008, CATAL COMMUN, V10, P169, DOI 10.1016/j.catcom.2008.08.013
   Sharma YC, 2011, BIOFUEL BIOPROD BIOR, V5, P69, DOI 10.1002/bbb.253
   Sheldon R, 2001, CHEM COMMUN, P2399, DOI 10.1039/b107270f
   Skoda-Foldes R, 2014, MOLECULES, V19, P8840, DOI 10.3390/molecules19078840
   Thommes M, 2015, PURE APPL CHEM, V87, P1051, DOI 10.1515/pac-2014-1117
   Vu TA, 2014, RSC ADV, V4, P41185, DOI 10.1039/c4ra06522k
   Wan H, 2015, J MOL CATAL A-CHEM, V398, P127, DOI 10.1016/j.molcata.2014.12.002
   Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5
   Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t
   Wine G, 2006, CATAL COMMUN, V7, P768, DOI 10.1016/j.catcom.2006.03.002
   Wu ZW, 2016, IND ENG CHEM RES, V55, P1833, DOI 10.1021/acs.iecr.5b02906
   Yao QW, 2002, ORG LETT, V4, P2197, DOI 10.1021/ol026172d
   Zang YD, 2013, CATAL SCI TECHNOL, V3, P2044, DOI 10.1039/c3cy00044c
   Zang YD, 2013, REACT KINET MECH CAT, V109, P77, DOI 10.1007/s11144-013-0547-4
   Zerth HM, 2003, ORG LETT, V5, P55, DOI 10.1021/ol0271739
   Zhang HB, 2007, GREEN CHEM, V9, P1208, DOI 10.1039/b705480g
   Zhang YB, 2015, J AM CHEM SOC, V137, P2641, DOI 10.1021/ja512311a
   Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x
   Zhou HC, 2014, CHEM SOC REV, V43, P5415, DOI 10.1039/c4cs90059f
NR 56
TC 1
Z9 1
U1 13
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7322
EI 1873-3166
J9 J MOL LIQ
JI J. Mol. Liq.
PD JUN
PY 2017
VL 236
BP 385
EP 394
DI 10.1016/j.molliq.2017.04.034
PG 10
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EW4AR
UT WOS:000402444900044
OA No
DA 2017-08-17
ER

PT J
AU Shehata, AB
   Mohamed, GG
   Gab-Allah, MA
AF Shehata, A. B.
   Mohamed, G. G.
   Gab-Allah, M. A.
TI Development of Crude Oil Reference Material Certified for the
   Concentrations of Sulfur, Iron, Nickel, Vanadium and Magnesium
SO MAPAN-JOURNAL OF METROLOGY SOCIETY OF INDIA
LA English
DT Article
DE Crude oil; Reference materials; Homogeneity assessment; Stability
   assessment; Certification; Uncertainty estimation
ID ATOMIC-ABSORPTION-SPECTROMETRY; GAMMA-TOCOPHEROL; CERTIFICATION;
   UNCERTAINTY; HOMOGENEITY; STABILITY; METALS; FISH
AB Crude oil quality and uses are largely affected by the presence of sulfur and some other elements. Controlling the risk associated with these elements in crude oil depends on their accurate determination which is crucially governed by the use of certified reference materials (CRMs). This paper describes the development of a natural-matrix reference material for quantification of sulfur, iron, nickel, vanadium and magnesium in crude oil. The crude oil was homogenized and bottled to prepare the candidate material. Homogeneity and stability of the prepared reference material were investigated and characterization of sulfur content was carried out using wavelength-dispersive X-ray fluorescence (WD-XRF) spectrometry and gravimetric methods. Meanwhile, characterization of iron, nickel, vanadium and magnesium content was carried out using atomic absorption spectrometry (AAS) and inductively coupled plasma-optical emission spectrometry (ICP-OES) techniques. Statistical evaluation of the data showed good homogeneity and stability of the candidate reference material. Sufficiently good agreement between methods of characterization was achieved which allowed certification. The certified values and their associated uncertainties were statistically derived using the approach of combining data from two or more independent analytical methods developed by National Institute for Standards and Technology (NIST, Gaithersburg, USA).
C1 [Shehata, A. B.; Gab-Allah, M. A.] Natl Inst Stand, Tersa St,POB 136, Giza 12211, Egypt.
   [Mohamed, G. G.] Cairo Univ, Chem Dept, Fac Sci, Giza 12613, Egypt.
RP Gab-Allah, MA (reprint author), Natl Inst Stand, Tersa St,POB 136, Giza 12211, Egypt.
EM mohamedadly_nis@yahoo.com
CR Adeyemo DJ, 2004, J RADIOANAL NUCL CH, V261, P229, DOI 10.1023/B:JRNC.0000030963.08444.fd
   Aggarwal SG, 2013, MAPAN-J METROL SOC I, V28, P153, DOI 10.1007/s12647-013-0073-x
   Analytic Jena AG, 2010, MICR SAMPL PREP SYST
   ASTM D3177-02, 2007, D317702 ASTM
   ASTM D5863-00a, 2005, D586300A ASTM
   ASTM D4175-09, 2009, D417509 ASTM
   Bureau International des Poids et Mesures (BIPM), 2008, INT VOC METR BAS GEN
   Brandao GP, 2006, ANAL BIOANAL CHEM, V386, P2249, DOI 10.1007/s00216-006-0875-6
   Clancy V, 2004, ANAL BIOANAL CHEM, V378, P1239, DOI 10.1007/s00216-003-2473-1
   Danzer K, 1998, PURE APPL CHEM, V70, P993, DOI 10.1351/pac199870040993
   Dittert IM, 2009, SPECTROCHIM ACTA B, V64, P537, DOI 10.1016/j.sab.2009.02.006
   Ellison S. L. R., 2012, EURACHEM CITAC GUID
   Heilmann J, 2009, J ANAL ATOM SPECTROM, V24, P385, DOI 10.1039/b819879a
   ISO, 2006, 35 ISO
   Jesus A., 2012, SPECTROCHIM ACTA B, V71-72, P86
   Koch M, 2011, ACCREDIT QUAL ASSUR, V16, P429, DOI 10.1007/s00769-011-0783-0
   LINDSEY AS, 1983, ANAL CHEM, V55, P516, DOI 10.1021/ac00254a023
   Linsinger T, 2007, ENERG FUEL, V21, P2240, DOI 10.1021/ef070155t
   Linsinger TPJ, 2001, ACCREDIT QUAL ASSUR, V6, P20, DOI 10.1007/s007690000261
   Linsinger TPJ, 2001, FRESEN J ANAL CHEM, V370, P183, DOI 10.1007/s002160100719
   Matar S., 2001, CHEM PETROCHEMICAL P, P18
   Mello PA, 2012, ANAL CHIM ACTA, V746, P15, DOI 10.1016/j.aca.2012.08.009
   Pereira JSF, 2010, MICROCHEM J, V96, P4, DOI 10.1016/j.microc.2009.12.016
   Pereira JSF, 2009, SPECTROCHIM ACTA B, V64, P554, DOI 10.1016/j.sab.2009.01.011
   Pohl P, 2010, J ANAL ATOM SPECTROM, V25, P704, DOI 10.1039/c000658k
   SCHILLER SB, 1991, SPECTROCHIM ACTA B, V46, P1607, DOI 10.1016/0584-8547(91)80164-X
   Schiller S. B., 1996, NATL I STAND TECHNOL, V260-125
   Sedykh EM, 2011, INORG MATER+, V47, P1539, DOI 10.1134/S0020168511140196
   Shehata AB, 2014, MAPAN-J METROL SOC I, V29, P183, DOI 10.1007/s12647-014-0097-x
   Shehata AB, 2015, J FOOD DRUG ANAL, V23, P82, DOI 10.1016/j.jfda.2014.10.004
   Shehata AB, 2010, ACCREDIT QUAL ASSUR, V15, P563, DOI 10.1007/s00769-010-0678-5
   Souza R. M., 2006, MICROCHEM J, V82, P137
   Speight J. G., 2002, HDB PETROLEUM PRODUC, P40
   Tahoun IF, 2016, MAPAN-J METROL SOC I, V31, P145, DOI 10.1007/s12647-016-0167-3
   Tahoun I. F., 2016, MAPAN-J METROL SOC I, V31, P1
   Ulrich JC, 2013, ACCREDIT QUAL ASSUR, V18, P511, DOI 10.1007/s00769-013-1019-2
   van der Veen AMH, 2001, ACCREDIT QUAL ASSUR, V6, P26, DOI 10.1007/s007690000238
NR 37
TC 0
Z9 0
U1 1
U2 1
PU METROLOGY SOC INDIA
PI NEW DELHI
PA NPL PREMISES, DR K S KRISHNAN MARG, NEW DELHI, 110 012, INDIA
SN 0970-3950
EI 0974-9853
J9 MAPAN-J METROL SOC I
JI MAPAN-J. Metrol. Soc. India
PD JUN
PY 2017
VL 32
IS 2
BP 101
EP 112
DI 10.1007/s12647-017-0205-9
PG 12
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA EW9DX
UT WOS:000402818100003
OA No
DA 2017-08-17
ER

PT J
AU Al-Shomar, SM
   Barakat, MAY
   Mahmoud, SA
AF Al-Shomar, S. M.
   Barakat, Mirham A. Y.
   Mahmoud, S. A.
TI Modified Ultrasonic Technique to Study Gd-Doped ZnO Films
SO MAPAN-JOURNAL OF METROLOGY SOCIETY OF INDIA
LA English
DT Article
DE Ultrasonic transducers; Delay lines; Gd-doped ZnO thin films; Pulse echo
   technique
AB Normal ultrasonic transducers of 0.5, 1, and 2 MHz are modified using delay lines which are made of Quartz. Such modification is to ameliorate the capability of the transducer to investigate Gd-doped ZnO thin films whose thickness is too thin. The normal transducers cannot test materials that have too thin thickness due to the near fields of these transducers. The near field is considered as blind area of the transducer. Therefore, the specimen under test must have thickness bigger than the near field of the used transducer, or instead delay lines can be used. Samples of Gd-doped ZnO thin films are prepared using sol gel technique. The ultrasonic pulse echo method is used at room temperature. Flaws are found in different prepared specimens. Results show that such delay lines are suitable to ameliorate the ultrasonic transducer to test Gd-doped ZnO thin films.
C1 [Al-Shomar, S. M.; Barakat, Mirham A. Y.] Hail Univ, Phys Dept, Fac Sci, Hail, Saudi Arabia.
   [Barakat, Mirham A. Y.] Natl Inst Stand, Ultrason Dept, POB 136,Giza Code 12211,Tersa St, Giza, Egypt.
   [Mahmoud, S. A.] Northern Border Univ, Phys Dept, Fac Sci, Ar Ar, Saudi Arabia.
   [Mahmoud, S. A.] Menia Univ, Phys Dept, Fac Sci, Al Minya, Egypt.
RP Barakat, MAY (reprint author), Hail Univ, Phys Dept, Fac Sci, Hail, Saudi Arabia.; Barakat, MAY (reprint author), Natl Inst Stand, Ultrason Dept, POB 136,Giza Code 12211,Tersa St, Giza, Egypt.
EM mirham75@yahoo.com
CR Barakat M. A., 2011, J PHYS SCI APPL, V1
   Barakat M. A. Y., 2014, INT J ENG TECHNOL, V14
   Baturay S, 2015, J ALLOY COMPD, V645, P29, DOI 10.1016/j.jallcom.2015.04.212
   Ernst R. A. U., 2006, TU112 ECNDT
   Gaafar M. S., 2013, ARCH APPL SCI RES, V5, P158
   Ginzel E. A., 2009, NEAR FIELD FOCUSING
   Haward R. N., 1997, PHYS GLASS POLYM
   Kinsler L. B., 1980, FUNDAMENTALS ACOUSTI
   Krautkramer J., 1990, ULTRASONIC TESTING M
   Mahmoud SA, 2010, ADV COND MATTER PHYS, DOI 10.1155/2010/518209
   Matori KA, 2010, INT J PHYS SCI, V5, P2212
   ROSE JL, 1974, MATER EVAL, V32, P223
   Wang ZH, 2016, ACS APPL MATER INTER, V8, P5466, DOI 10.1021/acsami.6b00339
   [Anonymous], 1995, OPERATION MANUAL SON, V1, P13
NR 14
TC 0
Z9 0
U1 0
U2 0
PU METROLOGY SOC INDIA
PI NEW DELHI
PA NPL PREMISES, DR K S KRISHNAN MARG, NEW DELHI, 110 012, INDIA
SN 0970-3950
EI 0974-9853
J9 MAPAN-J METROL SOC I
JI MAPAN-J. Metrol. Soc. India
PD JUN
PY 2017
VL 32
IS 2
BP 121
EP 126
DI 10.1007/s12647-016-0199-8
PG 6
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA EW9DX
UT WOS:000402818100005
OA No
DA 2017-08-17
ER

PT J
AU Fawzy, MA
AF Fawzy, Mustafa A.
TI Fatty Acid Characterization and Biodiesel Production by the Marine
   Microalga Asteromonas gracilis: Statistical Optimization of Medium for
   Biomass and Lipid Enhancement
SO MARINE BIOTECHNOLOGY
LA English
DT Article
DE Biodiesel; Asteromonas gracilis; Nutrient starvation; Salinity stress;
   Lipid productivity; Response surface methodology
ID RESPONSE-SURFACE METHODOLOGY; CHLORELLA-VULGARIS; SCENEDESMUS-OBLIQUUS;
   NEOCHLORIS-OLEOABUNDANS; NITROGEN STARVATION; LIGHT-INTENSITY; FUEL
   PROPERTIES; CELL-GROWTH; ACCUMULATION; CULTIVATION
AB Lipid production is an important indicator for evaluating microalgal species for biodiesel production. In this study, a new green microalga was isolated from a salt lake in Egypt and identified as Asteromonas gracilis. The main parameters such as biomass productivity, lipid content, and lipid productivity were evaluated in A. gracilis, cultivated in nutrient-starved (nitrogen, phosphorous), and salinity stress as a one-factor-at-a-time method. These parameters in general did not vary significantly from the standard nutrient growth media when these factors were utilized separately. Hence, response surface methodology (RSM) was assessed to study the combinatorial effect of different concentrations of the abovementioned factor conditions and to maximize the biomass productivity, lipid content, and lipid productivity of A. gracilis by determining optimal concentrations. RSM optimized media, including 1.36 M NaCl, 1 g/L nitrogen, and 0.0 g/L phosphorus recorded maximum biomass productivity, lipid content, and lipid productivity (40.6 mg/L/day, 39.3%, and 15.9 mg/L/day, respectively) which agreed well with the predicted values (40.1 mg/L/day, 43.6%, and 14.6 mg/L/day, respectively). Fatty acid profile of A. gracilis was composed of C16:0, C16:1, C18:0, C18:3, C18:2, C18:1, and C20:5, and the properties of fuel were also in agreement with international standards. These results suggest that A. gracilis is a promising feedstock for biodiesel production.
C1 [Fawzy, Mustafa A.] Assiut Univ, Fac Sci, Bot & Microbiol Dept, Assiut 71516, Egypt.
RP Fawzy, MA (reprint author), Assiut Univ, Fac Sci, Bot & Microbiol Dept, Assiut 71516, Egypt.
EM mostafa.mahmoud@science.au.edu.eg
CR Alyabyev AJ, 2007, THERMOCHIM ACTA, V458, P65, DOI 10.1016/j.tca.2007.03.003
   Battah M., 2013, World Applied Sciences Journal, V28, P1536
   Belarbi EH, 2000, ENZYME MICROB TECH, V26, P516, DOI 10.1016/S0141-0229(99)00191-X
   BENAMOTZ A, 1981, PLANT PHYSIOL, V67, P613, DOI 10.1104/pp.67.4.613
   Borowitzka M.A., 1988, MICROALGAL BIOTECHNO, P456
   Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003
   Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001
   DERRINGER G, 1980, J QUAL TECHNOL, V12, P214
   Drevon B, 1964, B TRAV SOC PHARM LYO, V8, P173
   Duong VT, 2012, ENERGIES, V5, P1835, DOI 10.3390/en5061835
   El-Sheekh M, 2013, WORLD J MICROB BIOT, V29, P915, DOI 10.1007/s11274-012-1248-2
   Fan JH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-17
   Feng PZ, 2012, J BIOSCI BIOENG, V114, P405, DOI 10.1016/j.jbiosc.2012.05.007
   Gopinath A, 2009, P I MECH ENG D-J AUT, V223, P565, DOI 10.1243/09544070JAUTO950
   Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7
   Haaland P., 1989, EXPT DESIGN BIOTECHN
   Hoekman SK, 2012, RENEW SUST ENERG REV, V16, P143, DOI 10.1016/j.rser.2011.07.143
   Islam MA, 2013, ENERGIES, V6, P5676, DOI 10.3390/en6115676
   Ramos MJ, 2009, BIORESOURCE TECHNOL, V100, P261, DOI 10.1016/j.biortech.2008.06.039
   Kaewkannetra P, 2012, BIOTECHNOL BIOPROC E, V17, P591, DOI 10.1007/s12257-011-0533-5
   Kalsoom U, 2013, CHROMATOGRAPHIA, V76, P1125, DOI 10.1007/s10337-013-2494-7
   Karpagam R, 2015, BIORESOURCE TECHNOL, V188, P177, DOI 10.1016/j.biortech.2015.01.053
   Kazemi-Beydokhti A, 2015, BRAZ J CHEM ENG, V32, P903, DOI 10.1590/0104-6632.20150324s00003518
   KLOPFENSTEIN WE, 1982, J AM OIL CHEM SOC, V59, P531, DOI 10.1007/BF02636316
   Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef`700639e
   Knothe G, 2009, ENERG ENVIRON SCI, V2, P759, DOI 10.1039/b903941d
   Li X, 2010, BIORESOURCE TECHNOL, V101, P5494, DOI 10.1016/j.biortech.2010.02.016
   Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1
   Lin Q, 2012, BIORESOURCE TECHNOL, V112, P242, DOI 10.1016/j.biortech.2012.02.097
   Liu ZY, 2008, BIORESOURCE TECHNOL, V99, P4717, DOI 10.1016/j.biortech.2007.09.073
   Mandotra SK, 2014, BIORESOURCE TECHNOL, V156, P42, DOI 10.1016/j.biortech.2013.12.127
   Mittal S, 2012, PLANT PHYSIOL BIOCH, V54, P17, DOI 10.1016/j.plaphy.2012.02.003
   Montgomery DC, 2005, DESIGN ANAL EXPT
   Mujtaba G, 2012, BIORESOURCE TECHNOL, V123, P279, DOI 10.1016/j.biortech.2012.07.057
   Murthy MSRC, 2000, BIOPROCESS ENG, V22, P35, DOI 10.1007/PL00009097
   Myers RH, 2002, RESPONSE SURFACE MET
   Nascimento IA, 2013, BIOENERG RES, V6, P1, DOI 10.1007/s12155-012-9222-2
   Ogbonna IO, 2015, AFR J BIOTECHNOL, V14, P1598
   Ordog V, 2016, ALGAL RES, V16, P141, DOI 10.1016/j.algal.2016.03.001
   REED RH, 1985, ARCH MICROBIOL, V143, P290, DOI 10.1007/BF00411252
   RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1
   Sen R, 2004, BIOCHEM ENG J, V21, P141, DOI 10.1016/j.bej.2004.06.006
   Sforza E, 2012, CHEM ENG RES DES, V90, P1151, DOI 10.1016/j.cherd.2011.12.002
   Sharma P, 2009, J HAZARD MATER, V164, P1024, DOI 10.1016/j.jhazmat.2008.08.104
   Weissman JC, 1989, LOOK BACK US DEP ENE, P32
   Shen XF, 2015, APPL ENERG, V158, P348, DOI 10.1016/j.apenergy.2015.08.057
   Sousa C, 2012, BIORESOURCE TECHNOL, V104, P565, DOI 10.1016/j.biortech.2011.10.048
   Vicente G, 2010, ENERG FUEL, V24, P3173, DOI 10.1021/ef9015872
   Vicente G, 2009, BIOCHEM ENG J, V48, P22, DOI 10.1016/j.bej.2009.07.014
   Welter C, 2013, ENVIRON PROG SUSTAIN, V32, P937, DOI 10.1002/ep.11835
   Yang FF, 2014, MAR DRUGS, V12, P1245, DOI 10.3390/md12031245
   Yeesang C, 2011, BIORESOURCE TECHNOL, V102, P3034, DOI 10.1016/j.biortech.2010.10.013
   Yeh KL, 2012, BIORESOURCE TECHNOL, V105, P120, DOI 10.1016/j.biortech.2011.11.103
   Yetilmezsoy K, 2009, J HAZARD MATER, V171, P551, DOI 10.1016/j.jhazmat.2009.06.035
   Yilancioglu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091957
   Zhao GL, 2012, BIORESOURCE TECHNOL, V114, P466, DOI 10.1016/j.biortech.2012.02.129
NR 56
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1436-2228
EI 1436-2236
J9 MAR BIOTECHNOL
JI Mar. Biotechnol.
PD JUN
PY 2017
VL 19
IS 3
BP 219
EP 231
DI 10.1007/s10126-017-9743-y
PG 13
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA EX1EN
UT WOS:000402963500002
PM 28456869
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, A
   Hassan, I
   Hedaya, M
   El-Yazid, TA
   Zu, J
   Wang, ZL
AF Ahmed, Abdelsalam
   Hassan, Islam
   Hedaya, Mohammad
   El-Yazid, Taher Abo
   Zu, Jean
   Wang, Zhong Lin
TI Farms of triboelectric nanogenerators for harvesting wind energy: A
   potential approach towards green energy
SO NANO ENERGY
LA English
DT Article
DE Triboelectrification; Wind energy; Green energy; TENG farm
ID MECHANICAL ENERGY; TURBINE; EFFICIENCY
AB Wind energy plays an important role in new-energy market, and it has the potential to be one of the promising green electric energy sources. Thus, it is very important for scientists and researchers to develop alternative method for harvesting wind energy. Here, we introduce a farm structure consists of triboelectric nanogenerators (TENGs) for large-scale energy harvesting from natural wind. Depending on contact electrification based freestanding mode between two disks with patterns of micro-sized circular sectors, the TENG farm that works with the wind flow converts the low and high wind energy into electricity. Finally, the performance of the TENG and Darrieus turbines is compared both experimentally and theoretically, predicting the unique advantage offered by TENG at low rotation speed. Given the convincing characteristics, such as having little weight, low cost, environmentally friendly, and effortlessly connected, the TENG farm can be an effective way towards large-scale green energy harvesting from the wind.
C1 [Ahmed, Abdelsalam; Hassan, Islam; Zu, Jean; Wang, Zhong Lin] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Ahmed, Abdelsalam] Univ Toronto, Sch Mech & Ind Engn, NanoGenerators & NanoEngn Lab, Toronto, ON M5S 3G8, Canada.
   [Hassan, Islam; Hedaya, Mohammad; El-Yazid, Taher Abo] Ain Shams Univ, Design & Prod Engn Dept, Fac Engn, Cairo 11535, Egypt.
   [Wang, Zhong Lin] Chinese Acad Sci, Beijing Inst Nanoenergy & Nanosyst, Beijing 100083, Peoples R China.
   [Wang, Zhong Lin] Natl Ctr Nanosci & Technol NCNST, Beijing 100083, Peoples R China.
RP Zu, J; Wang, ZL (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM zu@mie.utoronto.ca; zlwang@gatech.edu
FU Hightower Chair foundation; National Key R D Project [2016YFA0202704]
FX This research was supported by the Hightower Chair foundation, and the
   National Key R & D Project from Minister of Science and Technology
   (2016YFA0202704). The support provided for completing this research is
   gratefully acknowledged.
CR Ahmed A., 2016, ENERGY ENV SCI UNPUB
   Ahmed A., 2017, EXTREM MECH LETT, P2352
   Ahmed A., 2016, ADV ENERGY MAT
   Arshad M., 2010, NETWORK ANAL CIRCUIT
   Bae J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5929
   Bhutta MMA, 2012, RENEW SUST ENERG REV, V16, P1926, DOI 10.1016/j.rser.2011.12.004
   Bukala J, 2015, RENEW ENERG, V83, P1166, DOI 10.1016/j.renene.2015.05.047
   Chen SW, 2015, NANO ENERGY, V14, P217, DOI 10.1016/j.nanoen.2014.12.013
   Schwabe P., 2009, WIND LEVELIZED COST
   Dresselhaus MS, 2001, NATURE, V414, P332, DOI 10.1038/35104599
   Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607
   Ishugah TF, 2014, RENEW SUST ENERG REV, V37, P613, DOI 10.1016/j.rser.2014.05.053
   Islam M, 2008, RENEW SUST ENERG REV, V12, P1087, DOI 10.1016/j.rser.2006.10.023
   Jiang T, 2015, ADV FUNCT MATER, V25, P2928, DOI 10.1002/adfm.201500447
   Jin X, 2015, RENEW SUST ENERG REV, V42, P212, DOI 10.1016/j.rser.2014.10.021
   LELE SM, 1991, WORLD DEV, V19, P607, DOI 10.1016/0305-750X(91)90197-P
   LinaWang Z., 2014, FARADAY DISCUSS, V176, P447
   Meyar-Naimi H, 2012, ENERG POLICY, V43, P351, DOI 10.1016/j.enpol.2012.01.012
   Mitcheson PD, 2008, P IEEE, V96, P1457, DOI 10.1109/JPROC.2008.927494
   Mohamed M. H., 2015, Engineering Science and Technology, an International Journal, V18, P1, DOI 10.1016/j.jestch.2014.08.002
   Musgrove P. J., 1987, Solar & Wind Technology, V4, P37, DOI 10.1016/0741-983X(87)90006-3
   Niu SM, 2014, ENERG ENVIRON SCI, V7, P2339, DOI 10.1039/c4ee00498a
   Niu SM, 2013, ADV MATER, V25, P6184, DOI 10.1002/adma.201302808
   Price TJ, 2006, WIND ENG, V30, P225, DOI 10.1260/030952406778606214
   Quan Z., 2016, ADV ENERGY MATER, P6
   Su YJ, 2014, NANO ENERGY, V9, P186, DOI 10.1016/j.nanoen.2014.07.006
   Tummala A, 2016, RENEW SUST ENERG REV, V56, P1351, DOI 10.1016/j.rser.2015.12.027
   Wang SH, 2016, ACS NANO, V10, P5696, DOI 10.1021/acsnano.6b02575
   Wang SH, 2014, ACS NANO, V8, P12004, DOI 10.1021/nn5054365
   Wang SH, 2014, ADV MATER, V26, P2818, DOI 10.1002/adma.201305303
   Wang Z. L., 2017, MAT TODAY
   WILSON RE, 1980, J IND AERODYNAM, V5, P357, DOI 10.1016/0167-6105(80)90042-2
   Xie YN, 2014, ADV MATER, V26, P6599, DOI 10.1002/adma.201402428
   Zhang L, 2016, ADV MATER, V28, P1650, DOI 10.1002/adma.201504462
   Zhao ZF, 2016, ACS NANO, V10, P1780, DOI 10.1021/acsnano.5b07157
   Zheng-Xin Liu, 2015, arXiv
   Zhu G, 2015, NANO ENERGY, V14, P126, DOI 10.1016/j.nanoen.2014.11.050
   Zhu G, 2014, ADV MATER, V26, P3788, DOI 10.1002/adma.201400021
   Zhu HR, 2015, NANO ENERGY, V14, P193, DOI 10.1016/j.nanoen.2014.11.041
   Zi Y., 2016, NAT COMMUN, P7
   Zi YL, 2016, ACS NANO, V10, P4797, DOI 10.1021/acsnano.6b01569
   Zi YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9376
NR 42
TC 0
Z9 0
U1 15
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2211-2855
EI 2211-3282
J9 NANO ENERGY
JI Nano Energy
PD JUN
PY 2017
VL 36
BP 21
EP 29
DI 10.1016/j.nanoen.2017.03.046
PG 9
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EW7OL
UT WOS:000402704000003
OA No
DA 2017-08-17
ER

PT J
AU Abdelrahman, M
   Suzumura, N
   Mitoma, M
   Matsuo, S
   Ikeuchi, T
   Mori, M
   Murakami, K
   Ozaki, Y
   Matsumoto, M
   Uragami, A
   Kanno, A
AF Abdelrahman, Mostafa
   Suzumura, Naoyuki
   Mitoma, Mai
   Matsuo, Satoshi
   Ikeuchi, Takao
   Mori, Mitsutaka
   Murakami, Kyoko
   Ozaki, Yukio
   Matsumoto, Masaru
   Uragami, Atsuko
   Kanno, Akira
TI Comparative de novo transcriptome profiles in Asparagus officinalis and
   A. kiusianus during the early stage of Phomopsis asparagi infection
SO SCIENTIFIC REPORTS
LA English
DT Article
ID STEM BLIGHT; GENE-EXPRESSION; RESISTANCE; GENERATION; GENOTYPES;
   IDENTIFICATION; INOCULATION; PEROXIDASE; GENOMICS; BARLEY
AB Asparagus kiusianus, an important wild relative of cultivated asparagus (A. officinalis), exhibits resistance to stem blight disease caused by Phomopsis asparagi. However, the mechanisms underlying this resistance are not understood and no transcriptomic or genetic resources are available for this species. De novo transcriptome sequencing of A. officinalis and A. kiusianus stems was performed 24 h after inoculation with P. asparagi. In total, 35,259 and 36,321 transcripts were annotated in A. officinalis and A. kiusianus, respectively. 1,027 up-regulated and 752 down-regulated transcripts were differentially expressed in the two Asparagus species. RNA sequencing data were validated using quantitative real-time reverse transcription PCR. Several defense-related genes including peroxidase 4, cationic peroxidase SPC4-like, pathogenesis-related protein-1-like, and jasmonic acid biosynthesis and signaling-related genes including phospholipase D alpha 1, 12-oxophytodienoate reductase and jasmonate-induced protein 23 KD were up-regulated in A. kiusianus relative to A. officinalis. In addition, infected A. kiusianuns exhibited a substantial increase in jasmonic acid and methyl jasmonate relative to A. officinalis. Peroxidase activity was significantly elevated in infected A. kiusianus compared with infected A. officinalis. Our transcriptomic database provides a resource for identifying novel genes and molecular markers-associated with Phomopsis disease resistance and will facilitate breeding and improvement of cultivated asparagus varieties.
C1 [Abdelrahman, Mostafa; Suzumura, Naoyuki; Kanno, Akira] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.
   [Abdelrahman, Mostafa] Aswan Univ, Fac Sci, Bot Dept, Aswan 81528, Egypt.
   [Matsuo, Satoshi] Natl Agr & Food Res Org NARO, Inst Vegetable & Floriculture Sci, 360 Kusawa, Tsu, Mie 5142392, Japan.
   [Ikeuchi, Takao; Mori, Mitsutaka] Kagawa Prefectural Agr Expt Stn, 1534-1 Ayagawa, Kagawa 7612306, Japan.
   [Ozaki, Yukio] Kyushu Univ, Fac Agr, Fukuoka 8112307, Japan.
   [Matsumoto, Masaru] Kyushu Univ, Inst Trop Agr, Fukuoka 8128581, Japan.
   [Uragami, Atsuko] NARO, Inst Vegetable & Floriculture Sci, Tsukuba, Ibaraki 3058519, Japan.
RP Abdelrahman, M; Kanno, A (reprint author), Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.; Abdelrahman, M (reprint author), Aswan Univ, Fac Sci, Bot Dept, Aswan 81528, Egypt.
EM meettoo2000@ige.tohoku.ac.jp; kanno@ige.tohoku.ac.jp
FU Ministry of Agriculture, Forestry and Fisheries (MAFF) (Japan)
FX This work was supported in part by a Grant-in-Aid for Science and
   technology research promotion program for agriculture, forestry,
   fisheries and food industry from the Ministry of Agriculture, Forestry
   and Fisheries (MAFF) (Japan). We would like to thank Pranali S. for some
   bioinformatic analysis.
CR Abdelrahman M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0378-2
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x
   Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140
   Biesgen C, 1999, PLANTA, V208, P155, DOI 10.1007/s004250050545
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Cao FB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-611
   Cardoso DC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-66
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Dasgupta MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094803
   Dhokane D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155851
   Du H. S., 2015, PLANT SCI, V6, P1173, DOI [10.3389/fpls.2015.01173, DOI 10.3389/FPLS.2015.01173]
   Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421
   Elena K, 2006, PLANT PATHOL, V55, P300, DOI 10.1111/j.1365-3059.2005.01265.x
   Figueiredo A, 2015, EUR J PLANT PATHOL, V142, P645, DOI 10.1007/s10658-015-0634-7
   Golubenko Z, 2007, PHYTOPARASITICA, V35, P401, DOI 10.1007/BF02980704
   Govind SR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01593
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Guerreiro A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00565
   Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084
   Ito T, 2011, EUPHYTICA, V182, P285, DOI 10.1007/s10681-011-0508-9
   Iwato M., 2014, Advances in Horticultural Science, V28, P202
   Kanno A, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - VEGETABLES, P23, DOI 10.1007/978-3-642-20450-0_3
   Kim YH, 1996, ENZYME MICROB TECH, V18, P531, DOI 10.1016/0141-0229(95)00168-9
   Kubota S, 2012, THEOR APPL GENET, V124, P345, DOI 10.1007/s00122-011-1709-2
   Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692
   Li HY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-9
   Lu G, 2008, HORTSCIENCE, V43, P811
   Lyons R, 2013, PLANT CELL REP, V32, P815, DOI 10.1007/s00299-013-1400-y
   Madsen DK, 2006, AM J POTATO RES, V83, P349
   Marcellan ON, 1996, CAN J BOT, V74, P1621
   Martin M, 2011, EMBNET J, V1, P10, DOI DOI 10.14806/EJ.17.1.200
   Matic S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2925-6
   Moin M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01284
   Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004
   Nagaraj Satish, 2015, Front Plant Sci, V6, P1192, DOI 10.3389/fpls.2015.01192
   Ohwi J., 1965, FLORA JAPAN, P300
   Roohie R. K., 2015, BIO-TECHNOL, V5, P1089
   Rosskopf EN, 2000, PLANT DIS, V84, P1225, DOI 10.1094/PDIS.2000.84.11.1225
   SCHWEIZER P, 1993, PLANT PHYSIOL, V102, P503
   Sonoda T, 1997, HORTSCIENCE, V32, P1085
   Taggar GK, 2012, PLANT SIGNAL BEHAV, V7, P1321, DOI 10.4161/psb.21435
   Taheri P, 2012, PLANT DIS, V96, P398, DOI 10.1094/PDIS-08-11-0661
   Udayanga D, 2011, FUNGAL DIVERS, V50, P189, DOI 10.1007/s13225-011-0126-9
   Unamba CIN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01074
   Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213
   Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197
NR 49
TC 0
Z9 0
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 1
PY 2017
VL 7
AR 2608
DI 10.1038/s41598-017-02566-7
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW4XT
UT WOS:000402508300019
PM 28572584
OA gold
DA 2017-08-17
ER

PT J
AU Nassr, AA
   Shazly, SAM
   Abdelmagied, AM
   Araujo, E
   Tonni, G
   Kilby, MD
   Ruano, R
AF Nassr, A. A.
   Shazly, S. A. M.
   Abdelmagied, A. M.
   Araujo Junior, E.
   Tonni, G.
   Kilby, M. D.
   Ruano, R.
TI Effectiveness of vesicoamniotic shunt in fetuses with congenital lower
   urinary tract obstruction: an updated systematic review and
   meta-analysis
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE fetal obstructive uropathy; posterior urethral valve; vesicoamniotic
   shunt
ID POSTNATAL RENAL-FUNCTION; FETAL CYSTOSCOPY; UROPATHY; DIAGNOSIS;
   INTERVENTION; THERAPY; QUALITY; MANAGEMENT; MEGACYSTIS; ACCURACY
AB Objective To evaluate the effect on perinatal and postnatal survival of vesicoamniotic shunt (VAS) as treatment for fetal lower urinary tract obstruction (LUTO).
   Methods An electronic search of Ovid MEDLINE, Ovid EMBASE, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews and Scopus using relevant search terms was conducted from inception to June 2015 to identify studies comparing outcomes of VAS vs conservative management for treatment of LUTO. Cohort studies and clinical trials were considered eligible. Single-arm studies and studies that did not report survival were excluded. Sample size and language were not criteria for exclusion. Two reviewers extracted independently data in a standardized form, including study characteristics and results. Primary outcomes were perinatal and postnatal survival. Secondary outcome was postnatal renal function. Data on fetal survival were expressed as odds ratio (OR) and 95% CI.
   Results Of the 423 abstracts retrieved, nine studies were eligible for inclusion. These studies included 112 fetuses treated with VAS and 134 that were managed conservatively. There was heterogeneity in study design. Although the data demonstrated a difference in effect estimates between the study arms in terms of perinatal survival (OR, 2.54 (95% CI, 1.14-5.67)), there was no difference in 6-12-month survival (OR, 1.77 (95% CI, 0.25-12.71)) or 2-year survival (OR, 1.81 (95% CI, 0.09-38.03)). In addition, there was no difference in effect on postnatal renal function between fetuses that underwent intervention and those that did not (OR, 2.09 (95% CI, 0.74-5.94)).
   Conclusions Available data seem to support an advantage for perinatal survival in fetuses treated with VAS compared with conservative management. However, 1-2-year survival and outcome of renal function after VAS procedure remain uncertain. Further studies are necessary to evaluate the effectiveness of fetal intervention for LUTO based on different severity of the disease, due to the very low quality of the studies according to GRADE guidelines. Copyright (C) 2016 ISUOG. Published by John Wiley & Sons Ltd.
C1 [Nassr, A. A.; Shazly, S. A. M.; Abdelmagied, A. M.] Mayo Clin, Coll Med, Dept Obstet & Gynecol, Rochester, MN USA.
   [Nassr, A. A.; Shazly, S. A. M.; Abdelmagied, A. M.] Assiut Univ Hosp, Womens Hlth Hosp, Assiut, Egypt.
   [Nassr, A. A.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   [Nassr, A. A.] Texas Childrens Fetal Ctr, Houston, TX USA.
   [Araujo Junior, E.] Univ Fed Sao Paulo, Paulista Sch Med, Dept Obstet, Sao Paulo, Brazil.
   [Tonni, G.] AUSL Reggio Emilia, Dept Obstet & Gynecol, Prenatal Diagnost Serv, Reggio Emilia, Italy.
   [Kilby, M. D.] Univ Birmingham, Coll Med & Dent Sci, Inst Metab & Syst Res, Ctr Womens & Childrens Hlth, Birmingham, W Midlands, England.
   [Ruano, R.] Mayo Clin, Fetal Diagnost & Therapeut Ctr, Rochester, MN USA.
RP Ruano, R (reprint author), Mayo Clin, Div Maternal Fetal Med, 200 First St SW, Rochester, MN 55905 USA.
EM ruano.rodrigo@mayo.edu
OI Araujo Junior, Edward/0000-0002-6145-2532
CR Anumba DO, 2005, PRENATAL DIAG, V25, P7, DOI 10.1002/pd.1074
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Clark TJ, 2003, OBSTET GYNECOL, V102, P367, DOI 10.1016/S0029-7844(03)00577-5
   CROMBLEHOLME TM, 1990, AM J OBSTET GYNECOL, V162, P1239
   Diwakar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082564
   Freedman AL, 1996, J UROLOGY, V156, P720, DOI 10.1016/S0022-5347(01)65795-1
   GRIGNON A, 1986, RADIOLOGY, V160, P645
   Guyatt GH, 2008, BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE
   Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   JOHNSON MP, 1994, AM J OBSTET GYNECOL, V170, P1770
   Kagan KO, 2010, ULTRASOUND OBST GYN, V36, P10, DOI 10.1002/uog.7646
   Kilby MD, 2014, NAT REV UROL, V11, P412, DOI 10.1038/nrurol.2014.132
   LIPITZ S, 1993, AM J OBSTET GYNECOL, V168, P174
   McLorie G, 2001, J UROLOGY, V166, P1036, DOI 10.1016/S0022-5347(05)65913-7
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   Morris RK, 2007, PRENATAL DIAG, V27, P900, DOI 10.1002/pd.1810
   Morris RK, 2007, ARCH DIS CHILD-FETAL, V92, pF166, DOI 10.1136/adc.2006.099820
   Morris RK, 2015, ULTRASOUND OBST GYN, V46, P424, DOI 10.1002/uog.14808
   Morris RK, 2010, BJOG-INT J OBSTET GY, V117, P382, DOI 10.1111/j.1471-0528.2010.02500.x
   Morris RK, 2009, BJOG-INT J OBSTET GY, V116, P1290, DOI 10.1111/j.1471-0528.2009.02194.x
   Morris RK, 2013, LANCET, V382, P1496, DOI 10.1016/S0140-6736(13)60992-7
   NICOLINI U, 1991, PRENATAL DIAG, V11, P159, DOI 10.1002/pd.1970110305
   Pinette MG, 2003, J CLIN ULTRASOUND, V31, P328, DOI 10.1002/jcu.10179
   Ruano R, 2016, ULTRASOUND OBST GYN, V48, P476, DOI 10.1002/uog.15844
   Ruano R, 2015, ULTRASOUND OBST GYN, V45, P452, DOI 10.1002/uog.14652
   Ruano R, 2011, ULTRASOUND OBST GYN, V37, P696, DOI 10.1002/uog.8963
   Ruano R, 2010, PRENATAL DIAG, V30, P30, DOI 10.1002/pd.2418
   Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287
   Der Simonian R., 1986, CONTROLLED CLIN TRIA, V7, P177, DOI DOI 10.1016/0197-2456(86)90046-2
   Van Mieghem T, 2013, LANCET, V382, P1471, DOI 10.1016/S0140-6736(13)61446-4
   Wells GA, NEWCASTLE OTTAWA SCA
   WILKINS IA, 1987, AM J OBSTET GYNECOL, V157, P694
   Williams O, 2012, NEONATOLOGY, V101, P83, DOI 10.1159/000329445
   [Anonymous], 2014, REV MAN REVMAN COMP
NR 35
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD JUN
PY 2017
VL 49
IS 6
BP 696
EP 703
DI 10.1002/uog.15988
PG 8
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA EW6TA
UT WOS:000402642000005
PM 27270578
OA No
DA 2017-08-17
ER

PT J
AU Hegazy, A
   Ghallab, AO
   Ashour, FH
AF Hegazy, A.
   Ghallab, A. O.
   Ashour, F. H.
TI Integrated gasification combined cycle using Egyptian Maghara coal-rice
   straw feedstock
SO WASTE MANAGEMENT & RESEARCH
LA English
DT Article
DE Integrated gasification combined cycle; biomass; power generation;
   syngas; Maghara coal; rice straw
ID BIOMASS; IGCC; TECHNOLOGY; MODEL
AB Rice straw is an agricultural waste that causes an annoying problem in Egypt if it is not well exploited. This study focuses on using this waste in power generation by co-gasification of Egyptian Maghara coal and rice straw blends using entrained flow gasifier technology. Aspen Plus was used to conduct a parametric study for investigation of the effect of changing the inputs to the gasifier on the produced gas composition. Three different input parameters, influencing the performance of the gasifier, including the percentage of coal to rice straw in the blend, the fraction of added water to the blend, and the mass percentage of oxygen with respect to the mass of the blend fed to the gasifier were analysed. Two alternative power production schemes (with and without carbon capturing) have been investigated. The obtained optimum feed conditions are: 40% coal in the feed blend, 20% water concentration in the feed slurry, and 80% oxygen with respect to the dry feed blend to the gasifier. For (10 0000 kg per hour) of the feed blend, the power generated was 270.1 MW in the case of non-carbon capturing, while in the case of carbon capturing, 263.52 MW was generated. Although it produces less power, applying carbon capturing techniques means handling less flue gas and thus using smaller gas turbines and results in more environmentally friendly emissions.
C1 [Hegazy, A.; Ghallab, A. O.; Ashour, F. H.] Cairo Univ, Dept Chem Engn, Giza, Egypt.
RP Ghallab, AO (reprint author), Cairo Univ, Dept Chem Engn, Fac Engn, Cairo 12316, Egypt.
EM ayatossama@hotmail.com
CR Adeyemi I, 2017, APPL ENERG, V185, P1007, DOI 10.1016/j.apenergy.2016.05.119
   Barrera R., 2014, INT J CHEM ENG, V2014
   Basu P, 2010, BIOMASS GASIFICATION AND PYROLYSIS: PRACTICAL DESIGN AND THEORY, P1
   Bhattacharya A, 2013, BIOMASS BIOENERG, V54, P239, DOI 10.1016/j.biombioe.2013.04.008
   Biagini E, 2009, IND ENG CHEM RES, V48, P9028, DOI 10.1021/ie801804g
   Biomass Gasification Technology Assessment National Renewable Energy Laboratory, 2012, CONS REP
   BP Statistical Review of World Energy, 2015, STAT REP
   Brar JS, 2012, INT J FORESTRY RES, V2012, DOI 10.1155/2012/363058.
   Chang H, 2014, CHINESE J CHEM ENG, V22, P522
   Chen C, 2009, ENERG POLICY, V37, P915, DOI 10.1016/j.enpol.2008.09.093
   Doherty W, 2013, ASPEN PLUS SIMULATIO, P212
   Dudley B, 2015, BP STAT REV WORLD EN
   El Gemayel J, 2014, FUEL, V117, P1288, DOI 10.1016/j.fuel.2013.06.045
   Forbes SM, 2008, WORLD RESOURCES I CA
   Frey H. C., 2001, PROBABILISTIC MODELI
   [Anonymous], 2014, INS SER
   Karg J, 2009, IGCC EXPERIENCE FURT
   Kopyscinski J, 2010, FUEL, V89, P1763, DOI 10.1016/j.fuel.2010.01.027
   Kumar A, 2009, ENERGIES, V2, P556, DOI 10.3390/en20300556
   Mastellone ML, 2012, WASTE MANAGE, V32, P733, DOI 10.1016/j.wasman.2011.09.005
   McDaniel JE, 1998, 6 ANN CLEAN COAL TEC, VII, P31
   Melegy A, 2009, PETROLOGICAL ENV GEO, P44
   Motghare KA, 2016, WASTE MANAGE, V47, P40, DOI 10.1016/j.wasman.2015.07.032
   Ng KS, 2010, CHEM ENG RES DES, V88, P170, DOI 10.1016/j.cherd.2009.08.002
   Obernberger I, 2008, 8 EUR C IND FURN BOI
   Rodrigues I, 2011, INT C COAL SCI TECHN
   Shinada O, 2002, ENERG CONVERS MANAGE, V43, P1221, DOI 10.1016/S0196-8904(02)00009-2
   Stahl R, 2007, FUELS CHEM RICE STRA
   Thattai AT, 2016, APPL ENERG, V168, P381, DOI 10.1016/j.apenergy.2016.01.131
   Van der Drift A, 2004, ECNC04039
   World Energy Resources: Coal World Energy Council, 2013, WORLD EN COUNC SUST
   Worley M., 2012, NRELSR510057085
   Zhou CG, 2016, APPL ENERG, V172, P230, DOI 10.1016/j.apenergy.2016.03.106
NR 33
TC 0
Z9 0
U1 3
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0734-242X
EI 1096-3669
J9 WASTE MANAGE RES
JI Waste Manage. Res.
PD JUN
PY 2017
VL 35
IS 6
BP 656
EP 668
DI 10.1177/0734242X17702728
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA EW6RS
UT WOS:000402638600011
PM 28462684
OA No
DA 2017-08-17
ER

PT J
AU Rashed, ANZ
   Mohamed, AA
   Sharshar, HA
   Tabour, MS
   El-Sherbeny, A
AF Rashed, Ahmed Nabih Zaki
   Mohamed, Abd El-Naser A.
   Sharshar, Hamdy A.
   Tabour, Mohamed Salah
   El-Sherbeny, Ahmed
TI Optical Cross Connect Performance Enhancement in Optical Ring Metro
   Network for Extended Number of Users and Different Bit Rates Employment
SO WIRELESS PERSONAL COMMUNICATIONS
LA English
DT Article
DE Optical cross connect; Metro networks; Bit error rate; Crosstalk;
   Optical add drop multiplexer; Erbium doped fiber amplifier; Mach
   Zehender modulator; Dispersion compensation fiber DCF
AB Optical cross connect (OXC) is important device that play a vital role in switching high speed optical signals and in our case as high speed switch to open the first ring to the second ring to become one ring in case of path failure or during maintenance in any node in this path and also if the failure path get in service it switch the two ring again to become isolated from each other. This paper has presented different enhancement techniques to increase number of users at different bit rates and also increased the transmission distance between nodes. Its main advantages have made it to disaster path in case of any failure cause in any node or path between two optical cross connect OXC. That is no doubt that crosstalk, dispersion and noise are produced when OXC separates incoming optical signals onto different output paths.
C1 [Rashed, Ahmed Nabih Zaki; Mohamed, Abd El-Naser A.; Sharshar, Hamdy A.; Tabour, Mohamed Salah; El-Sherbeny, Ahmed] Menoufia Univ, Elect & Elect Commun Engn Dept, Fac Elect Engn, Menoufia 32951, Egypt.
RP Rashed, ANZ (reprint author), Menoufia Univ, Elect & Elect Commun Engn Dept, Fac Elect Engn, Menoufia 32951, Egypt.
EM ahmed_733@yahoo.com
CR Barua B., 2011, INT J COMPUTER SCI I, V3
   Breed G., 2005, ANAL SIGNALS USING E
   Chaudhary N., 2014, INT J EMERGING TECHN, V4
   El-Bawab TS, 2000, OPT FIBER TECHNOL, V6, P213, DOI 10.1006/ofte.2000.0334
   Mehra R., 2014, INT J COMPUTER APPL
   [Anonymous], OPTISYSTEM TUTORIALS, V2
   [Anonymous], ANAL SIGNALS USING E
   [Anonymous], INT J EMERGING TECHN
   [Anonymous], INT J COMPUTER APPL
NR 9
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0929-6212
EI 1572-834X
J9 WIRELESS PERS COMMUN
JI Wirel. Pers. Commun.
PD JUN
PY 2017
VL 94
IS 3
BP 927
EP 947
DI 10.1007/s11277-016-3658-1
PG 21
WC Telecommunications
SC Telecommunications
GA EV4UM
UT WOS:000401758400037
OA No
DA 2017-08-17
ER

PT J
AU Kasban, H
   El-Bendary, MAMMK
AF Kasban, H.
   El-Bendary, Mohsen A. M. Mohamed Kaseem
TI Performance Improvement of Digital Image Transmission over Mobile WiMAX
   Networks
SO WIRELESS PERSONAL COMMUNICATIONS
LA English
DT Article
DE WiMAX; Image transmission; Fading channels; Coding; Interleaving;
   Modulation
ID CONVOLUTIONAL-CODES; TURBO-CODES; OFDM; ALGORITHM; CHANNELS; SYSTEMS
AB This paper studies the performance of image transmission over WiMAX networks under different fading channels. The objective is determining the optimum technique in every transmission stage that can be used for obtaining the optimum performance of the image transmission process. The results are evaluated in terms of Bit Error Rate, and Peak Signal to Noise Ratio for various values of Signal to Noise Ratio. The first stage is the image segmentation, where the transmitted image is segmented into packets; the tested packet lengths are 1, 2, 4, 8, 16 Kbits. The second stage is the encoding, where the Convolutional Code, Low Density Parity Check, and Turbo codes with different code rates are tested. The third stage is the interleaving, where the block, chaotic interleaver algorithms are tested. The fourth stage is modulation; where Binary Phase Shift Keying (BPSK), Quadrature Phase Shift Keying and Quadrature Amplitude Modulation with different lengths are tested. The results show that, the performance of image transmission over the mobile WiMAX can be improved by applying the optimum technique in each transmission stage. Increasing the packet length, using the Turbo code with 1/2 code rate, chaotic interleaver and BPSK modulation achieves the optimum performance.
C1 [Kasban, H.] Atom Energy Author, Dept Engn, Nucl Res Ctr, Cairo, Egypt.
   [El-Bendary, Mohsen A. M. Mohamed Kaseem] Helwan Univ, Fac Ind Educ, Dept Elect Technol, Cairo, Egypt.
RP Kasban, H (reprint author), Atom Energy Author, Dept Engn, Nucl Res Ctr, Cairo, Egypt.
EM Hany_kasban@yahoo.com; dr_m.kassem@yahoo.com
CR ABOUELFADL AA, 2014, LIFE SCI J, V11, P342
   Abu Ali N, 2009, COMPUT COMMUN, V32, P511, DOI 10.1016/j.comcom.2008.09.015
   Agarwal A., 2013, INT J ELECT COMMUNIC, V6, P41
   Nuaymi L., 2008, P 1 INT C SIM TOOLS
   Benvenuto N, 1998, IEEE T VEH TECHNOL, V47, P919, DOI 10.1109/25.704845
   Berrou C, 1996, IEEE T COMMUN, V44, P1261, DOI 10.1109/26.539767
   Borin JF, 2008, SIMUL MODEL PRACT TH, V16, P817, DOI 10.1016/j.simpat.2008.05.002
   Chan F, 1997, IEEE T COMMUN, V45, P1389, DOI 10.1109/26.649755
   El-Bakary EM, 2013, WIRELESS PERS COMMUN, V69, P979, DOI 10.1007/s11277-012-0622-6
   El-Bendary M. A. M., 2014, INT J INFORM TECHNOL, V16
   GALLAGER RG, 1962, IRE T INFORM THEOR, V8, P21, DOI 10.1109/TIT.1962.1057683
   Hassan ES, 2012, WIRELESS PERS COMMUN, V62, P183, DOI 10.1007/s11277-010-0047-z
   Islam A. Z. M. T., 2012, INT J INFORM SCI TEC, V2, P39
   Karim N. S., 2008, INT C COMP COMM ENG, P849
   Singh K., 2014, INT J TECHNOLOGICAL, V1, P1135
   Kene JD, 2012, PROC TECH, V1, P666, DOI 10.1016/j.protcy.2012.10.080
   Khan Muhammad Nadeem, 2008, Institution of Engineering and Technology Conference on Wireless, Mobile and Multimedia Networks, P117, DOI 10.1049/cp:20080159
   Kunst R, 2011, COMPUT NETW, V55, P3659, DOI 10.1016/j.comnet.2011.04.018
   Lakra M., 2013, INT J ADV RES ELECT, V2, P2869
   Lawal IA, 2014, PROCD SOC BEHV, V129, P441, DOI 10.1016/j.sbspro.2014.03.699
   Mirahmadi M, 2013, IEEE T COMMUN, V61, P4602, DOI 10.1109/TCOMM.2013.102313.130220
   Nandhini A., 2014, INT J INNOVATIVE RES, V2, P3905
   Naqvi A. N., 2012, INT J ADV RES COMPUT, V1, P563
   Nassar SS, 2016, WIRELESS PERS COMMUN, V88, P479, DOI 10.1007/s11277-015-3142-3
   Nguyen VD, 2001, IEEE VTS VEH TECHNOL, P470, DOI 10.1109/VTC.2001.956643
   Rekha S. M., 2013, INT J ENG ADV TECHNO, V2, P8
   Shanthi T., 2014, INT J ENG SCI RES TE, V3, P7045
   Sharon O, 2014, PHYS COMMUN-AMST, V10, P72, DOI 10.1016/j.phycom.2013.12.004
   Shi Y. Q., 2004, IEEE Circuits and Systems Magazine, V4, P29, DOI 10.1109/MCAS.2004.1286985
   Shin KW, 2012, J SEMICOND TECH SCI, V12, P24, DOI 10.5573/JSTS.2012.12.1.24
   Soliman NF, 2014, WIRELESS PERS COMMUN, V79, P2141, DOI 10.1007/s11277-014-1977-7
   Vinoth P., 2013, INT J COMPUT APPL, V73, P18
   WiMAX Forum Network Working Group, 2008, WIMAX FOR
NR 33
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0929-6212
EI 1572-834X
J9 WIRELESS PERS COMMUN
JI Wirel. Pers. Commun.
PD JUN
PY 2017
VL 94
IS 3
BP 1087
EP 1103
DI 10.1007/s11277-016-3671-4
PG 17
WC Telecommunications
SC Telecommunications
GA EV4UM
UT WOS:000401758400046
OA No
DA 2017-08-17
ER

PT J
AU Shalaby, WA
   Saad, W
   Shokair, M
   Dessouky, M
AF Shalaby, Wafaa A.
   Saad, Waleed
   Shokair, Mona
   Dessouky, Moawad
TI Efficient Parameters for Compressed Sensing Recovery Algorithms
SO WIRELESS PERSONAL COMMUNICATIONS
LA English
DT Article
DE Compressive sensing; Sub-Nyquist sampling; Recovery algorithms;
   Denoising
ID ORTHOGONAL MATCHING PURSUIT; L(1) MINIMIZATION; UNDERDETERMINED SYSTEMS;
   LINEAR-EQUATIONS; DICTIONARIES; MATRICES; SIGNALS
AB Compressed sensing CS has been an effective research area which it plays an efficient role in many applications such as cognitive radio, imaging, radar and many other applications. The main part of CS system is to recover an input signal by using minimum number of samples than used by conventional (Nyquist) sampling. In this paper, the minimum number of measurements and the number of sparsity level used to reconstruct the signal with minimum error, computational complexity and time will be optimized. Moreover, different recovery algorithms such as convex optimization, greedy algorithms, iterative hard thresholding and hard thresholding pursuit algorithms are used for optimal recovery of sparse signal from a small number of linear measurements. Furthermore, the effect of using CS as denosing will be investigated. Then comparisons study between CS as denoising and conventional denoising process will be made to reduce the effect of noise on the signal.
C1 [Shalaby, Wafaa A.; Saad, Waleed; Shokair, Mona; Dessouky, Moawad] Menoufia Univ, Elect & Elect Commun Engn Dept, Fac Elect Engn, Menoufia, Egypt.
RP Shalaby, WA (reprint author), Menoufia Univ, Elect & Elect Commun Engn Dept, Fac Elect Engn, Menoufia, Egypt.
EM wafa.ahmed55@el-eng.menofia.edu.eg; waleed.saad@el-eng.menofia.edu.eg;
   mona.sabry@el-eng.menofia.edu.eg; Dr.Moawad@yahoo.com
CR Baraniuk R, 2008, CONSTR APPROX, V28, P253, DOI 10.1007/s00365-007-9003-x
   Blumensath T, 2010, IEEE J-STSP, V4, P298, DOI 10.1109/JSTSP.2010.2042411
   Davies M, 2009, APPL COMPUTATIONAL H, V27, P265
   Boyd S., 2004, CONVEX OPTIMIZATION
   Cai TT, 2009, IEEE T INFORM THEORY, V55, P3388, DOI 10.1109/TIT.2009.2021377
   Candes E., 2005, LI MAGIC RECOVERY SP
   Candes E., 2005, IEEE T INFORM THEORY, P1
   Candes E. J., 2006, P INT C MATH, V3, P1433, DOI DOI 10.4171/022-3/69
   Candes EJ, 2009, ANN STAT, V37, P2145, DOI 10.1214/08-AOS653
   Desai S, 2013, INT J EMERGING TECHN, V3, P18
   DeVore RA, 1996, ADV COMPUT MATH, V5, P173, DOI 10.1007/BF02124742
   DeVore RA, 2007, J COMPLEXITY, V23, P918, DOI 10.1016/j.jco.2007.04.002
   Donoho DL, 2012, IEEE T INFORM THEORY, V58, P1094, DOI 10.1109/TIT.2011.2173241
   Donoho DL, 2006, COMMUN PUR APPL MATH, V59, P797, DOI 10.1002/cpa.20132
   Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582
   Donoho DL, 2003, P NATL ACAD SCI USA, V100, P2197, DOI 10.1073/pnas.0437847100
   Foucart S, 2011, SIAM J NUMER ANAL, V49, P2543, DOI 10.1137/100806278
   Gribonval R, 2003, IEEE T INFORM THEORY, V49, P3320, DOI 10.1109/TIT.2003.820031
   Hayashi K, 2013, IEICE T COMMUN, VE96B, P685, DOI 10.1587/transcom.E96.B.685
   Kutyniok G., 2012, COMPRESSED SENSING T
   MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082
   Mishali M, 2010, IEEE J-STSP, V4, P375, DOI 10.1109/JSTSP.2010.2042414
   Needell D, 2009, APPL COMPUT HARMON A, V26, P301, DOI 10.1016/j.acha.2008.07.002
   Needell D, 2009, FOUND COMPUT MATH, V9, P317, DOI 10.1007/s10208-008-9031-3
   Patil P. B, 2012, P INT C PATT REC INF
   Rockafellar R. T., 1970, CONVEX ANAL
   Rudelson M, 2008, COMMUN PUR APPL MATH, V61, P1025, DOI 10.1002/cpa.20227
   SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969
   Pourmohammad A, 2012, INT J COMPUTER THEOR, V4, P266
   Wan-zheng N., 2011, IEEE INT C SIGN PROC, V1, P14
   WELCH LR, 1974, IEEE T INFORM THEORY, V20, P397, DOI 10.1109/TIT.1974.1055219
NR 31
TC 1
Z9 1
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0929-6212
EI 1572-834X
J9 WIRELESS PERS COMMUN
JI Wirel. Pers. Commun.
PD JUN
PY 2017
VL 94
IS 3
BP 1715
EP 1736
DI 10.1007/s11277-016-3708-8
PG 22
WC Telecommunications
SC Telecommunications
GA EV4UM
UT WOS:000401758400078
OA No
DA 2017-08-17
ER

PT J
AU El-Khamy, SE
   Moussa, KH
   El-Sherif, AA
AF El-Khamy, Said E.
   Moussa, Karim H.
   El-Sherif, Amr A.
TI Performance of Enhanced Massive Multiuser MIMO Systems Using Transmit
   Beamforming and Transmit Antenna Selection Techniques
SO WIRELESS PERSONAL COMMUNICATIONS
LA English
DT Article
DE Massive; Multiuser; MIMO; Beamforming; Antenna selection
ID NEXT-GENERATION WIRELESS
AB In this paper, the performances of massive multiuser multiple input multiple output (MMU MIMO) system with different transmit beamforming (BF) techniques and different suboptimal transmit antenna selection (TAS) algorithms over Rayleigh fading channels are investigated. Three linear transmit BF types are considered, namely, maximum ratio transmission (MRT BF), zero forcing (ZF BF) and minimum mean square error (MMSE BF). Two TAS algorithms are considered, that are pairwise error probability minimization (PM) and the capacity maximization (CM). TAS techniques are used in order to reduce the number of radio frequency (RF) chains, system complexity, and cost. This makes MMU MIMO more applicable in beyond 4G communication systems. The simulation results show that TAS algorithms are capable of decreasing the complexity of the system while maintaining the same performance of the MMU MIMO system, complex TAS techniques are not needed at large number of RF chains, and the performance improvement due to the increase of this number is limited to a certain threshold. It also demonstrated that the MMSE BF and ZF BF bit error rate performance values are better than MRT BF values for both CM and PM TAS algorithms, but it is limited to the large number of users. On the other hand, the MRT BF technique performance is good at small E-b/N-0 values for both PM and CM TAS but it is relatively less affected by increasing the number of users.
C1 [El-Khamy, Said E.; El-Sherif, Amr A.] Alexandria Univ, Dept Elect Engn, Alexandria 21544, Egypt.
   [Moussa, Karim H.] Alexandria Inst Engn & Technol, Alexandria 21311, Egypt.
RP Moussa, KH (reprint author), Alexandria Inst Engn & Technol, Alexandria 21311, Egypt.
EM elkhamy@ieee.org; karim.moussa@aiet.edu.eg; aasherif@alexu.edu.eg
CR Bjornson E, 2014, IEEE SIGNAL PROC MAG, V31, P142, DOI 10.1109/MSP.2014.2312183
   Chiurtu N., 2001, Proceedings. 2001 IEEE International Symposium on Information Theory (IEEE Cat. No.01CH37252), DOI 10.1109/ISIT.2001.935916
   Cho Y. S., 2010, MIMO OFDM WIRELESS C
   Choi RLU, 2004, IEEE T WIREL COMMUN, V3, P1936, DOI 10.1109/TWC.2004.837636
   Dao ND, 2010, IEEE T VEH TECHNOL, V59, P3617, DOI 10.1109/TVT.2010.2052293
   El-khamy S. E., 2015, 32 NAT RAD SCI C NRS, P139
   Foschini G. J., 1998, Wireless Personal Communications, V6, P311, DOI 10.1023/A:1008889222784
   Gao X., 2011, IEEE VEH TECHN C
   Hoydis J, 2013, IEEE J SEL AREA COMM, V31, P160, DOI 10.1109/JSAC.2013.130205
   Jiang M, 2007, P IEEE, V95, P1430, DOI 10.1109/JPROC.2007.898869
   Joham M, 2005, IEEE T SIGNAL PROCES, V53, P2700, DOI 10.1109/TSP.2005.850331
   Ko K, 2012, IEEE T COMMUN, V60, P649, DOI 10.1109/TCOMM.2012.020912.110060
   Larsson EG, 2014, IEEE COMMUN MAG, V52, P186, DOI 10.1109/MCOM.2014.6736761
   Lu L, 2014, IEEE J-STSP, V8, P742, DOI 10.1109/JSTSP.2014.2317671
   Marzetta TL, 2010, IEEE T WIREL COMMUN, V9, P3590, DOI 10.1109/TWC.2010.092810.091092
   Rusek F, 2013, IEEE SIGNAL PROC MAG, V30, P40, DOI 10.1109/MSP.2011.2178495
   Sanayei S, 2004, IEEE COMMUN MAG, V42, P68, DOI 10.1109/MCOM.2004.1341263
   Sklar B., 1993, IEEE COMMUNICATIONS, V35, P90
   Xiang ZZ, 2014, IEEE J SEL AREA COMM, V32, P1180, DOI 10.1109/JSAC.2014.2328144
   Yilmaz A, 2014, IEEE T VEH TECHNOL, V63, P1976, DOI 10.1109/TVT.2013.2267962
   Yoo T, 2006, IEEE J SEL AREA COMM, V24, P528, DOI 10.1109/JSAC.2005.862421
   Zhao L., 2013, 78 IEEE VEH TECHN C, P1
NR 22
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0929-6212
EI 1572-834X
J9 WIRELESS PERS COMMUN
JI Wirel. Pers. Commun.
PD JUN
PY 2017
VL 94
IS 3
BP 1825
EP 1838
DI 10.1007/s11277-016-3713-y
PG 14
WC Telecommunications
SC Telecommunications
GA EV4UM
UT WOS:000401758400083
OA No
DA 2017-08-17
ER

PT J
AU Ajarem, J
   Al Rashedi, G
   Mohany, M
   Allam, A
AF Ajarem, Jamaan
   Al Rashedi, Gawaher
   Mohany, Mohamed
   Allam, Ahmed
TI Neurobehavioral changes in mice offspring exposed to green tea during
   fetal and early postnatal development
SO BEHAVIORAL AND BRAIN FUNCTIONS
LA English
DT Article
DE Green tea; Sensory motor reflexes; Offspring; Anxiety; Mice
ID ACETYLCHOLINESTERASE ACTIVITY; CAMELLIA-SINENSIS; EXTRACT; SERUM;
   CHOLESTEROL; MODEL; RATS; METAANALYSIS; POLYPHENOLS; ABSORPTION
AB Background: Green tea extract (GTE) has various health promoting effects on animals and humans. However, the effects of perinatal exposure to GTE on the behavioral aspects of offspring have not been elucidated thus far. GTE was provided for pregnant female mice at concentrations of either 20 or 50 g/L, beginning the day of conception until the third week after delivery, postnatal day 22 (PD 22). Mice pups were subjected to behavioral testing to assess sensory motor reflexes, locomotion, anxiety, and learning on various postnatal days.
   Results: Perinatal exposure to GTE resulted in a significant reduction in body weight, as well as earlier body hair appearance and opening of the eyes. Sensory motor reflexes exhibited faster responses and significant stimulatory effects in pups exposed to GTE. During the adolescent period, male and female offspring exhibited increased locomotor activity (on PD 22), reduced anxiety and fear (on PD 25), and enhanced memory and learning abilities (on PD 30), all in both GTE treated groups. All blood counts (RBCs, WBCs, Hb, and platelets), and glucose, cholesterol, triglyceride, and low density lipoprotein concentrations were significantly lower in the GTE-treated pups; however, there was no effect on high density lipoprotein levels.
   Conclusion: Our data provide evidence that the high dose of GTE (50 g/L) had higher anxiolytic properties and positive effects on locomotor activities and sensory motor reflexes, as well as learning and memory of the offspring than the low dose of GTE (20 g/L).
C1 [Ajarem, Jamaan; Mohany, Mohamed; Allam, Ahmed] King Saud Univ, Dept Zool, Coll Sci, Fac Sci, POB 2455, Riyadh 11451, Saudi Arabia.
   [Al Rashedi, Gawaher] Hail Univ, Coll Sci, Dept Biol, Hail, Saudi Arabia.
   [Allam, Ahmed] Beni Suef Univ, Dept Zool, Coll Sci, Fac Sci, Bani Suwayf 65211, Egypt.
RP Mohany, M; Allam, A (reprint author), King Saud Univ, Dept Zool, Coll Sci, Fac Sci, POB 2455, Riyadh 11451, Saudi Arabia.; Allam, A (reprint author), Beni Suef Univ, Dept Zool, Coll Sci, Fac Sci, Bani Suwayf 65211, Egypt.
EM mohamedmhnye@yahoo.com; aallam@ksu.edu.sa
FU King Saud University, Deanship of Scientific Research
FX This work was supported by King Saud University, Deanship of Scientific
   Research.
CR Ajarem JS, 1998, SAUDI J BIOL SCI, V5, P78
   Al-Basher G, 2017, INT J PHARMACOL, V13, P109, DOI 10.3923/ijp.2017.109.121
   Allam A, 2017, AFR J TRADIT COMPLEM, V2, P166
   Banji D, 2011, BRAIN RES, V1410, P141, DOI 10.1016/j.brainres.2011.06.063
   BURSTEIN M, 1970, J LIPID RES, V11, P583
   Butt MS, 2015, CRIT REV FOOD SCI, V55, P792, DOI 10.1080/10408398.2012.680205
   DEEG R, 1983, CLIN CHEM, V29, P1798
   Di Lorenzo A, 2016, MOL NUTR FOOD RES, V60, P566, DOI 10.1002/mnfr.201500567
   Dietz C, 2017, CURR PHARM DES
   FOSSATI P, 1982, CLIN CHEM, V28, P2077
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Friedrich M, 2011, INT J OBES LOND, V36, P735
   Garcia ML, 2017, J HYPERTENS, V35, P348, DOI 10.1097/HJH.0000000000001149
   Guo SH, 2007, BIOL PSYCHIAT, V62, P1353, DOI 10.1016/j.biopsych.2007.04.020
   Haque AM, 2006, J NUTR, V136, P1043
   Heese Traci, 2009, AANA J, V77, P445
   Hsu YW, 2011, FOOD CHEM TOXICOL, V49, P2624, DOI 10.1016/j.fct.2011.07.007
   Kaur T, 2008, BRAIN COGNITION, V67, P25, DOI 10.1016/j.bandc.2007.10.003
   Kobayashi Y, 2000, J AGR FOOD CHEM, V48, P5618, DOI 10.1021/jf0006832
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Levites Y, 2003, FASEB J, V17, P952, DOI 10.1096/fj.02-0881-fje
   Lu Jun-Hua, 2006, Zhong Yao Cai, V29, P352
   Maodaa SN, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0090-3
   Matsumoto E, 2016, J DEV ORIG HLTH DIS, V6, P1
   Michna L, 2003, LIFE SCI, V73, P1383, DOI 10.1016/S0024-3205903)00468-5
   Mirza B, 2013, PAK J PHARM SCI, V26, P511
   Momose Y, 2016, INT J FOOD SCI NUTR, V67, P606, DOI 10.1080/09637486.2016.1196655
   Morita O, 2009, FOOD CHEM TOXICOL, V47, P1296, DOI 10.1016/j.fct.2009.03.005
   Ni CX, 2017, NUTR CANCER, V69, P211, DOI 10.1080/01635581.2017.1263754
   Samman S, 2001, AM J CLIN NUTR, V73, P607
   Shin KO, 2007, J NUTR SCI VITAMINOL, V53, P145, DOI 10.3177/jnsv.53.145
   Siest G, 1981, INTERPRETATION EXAME, P206
   Singal A, 2005, J MED FOOD, V8, P47, DOI 10.1089/jmf.2005.8.47
   SMART JL, 1971, BRAIN RES, V33, P303, DOI 10.1016/0006-8993(71)90105-3
   Souza AC, 2015, BRAIN RES, V1595, P10, DOI 10.1016/j.brainres.2014.10.039
   Sugita M, 2016, NUTRITION, V32, P321, DOI 10.1016/j.nut.2015.09.005
   Unno K, 2016, J SPORTS MED PHYS FI, V5, P117
   Velayutham P, 2008, CURR MED CHEM, V15, P1840
   Vignes M, 2006, BRAIN RES, V1110, P102, DOI 10.1016/j.brainres.2006.06.062
   Yang MH, 2001, J NUTR BIOCHEM, V12, P14, DOI 10.1016/S0955-2863(00)00140-6
   Zhang SS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1325-4
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
   ZHONG JX, 2016, AM J OBSTET GYNECOL, V215
NR 43
TC 0
Z9 0
U1 2
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1744-9081
J9 BEHAV BRAIN FUNCT
JI Behav. Brain Funct.
PD JUN 1
PY 2017
VL 13
AR 10
DI 10.1186/s12993-017-0128-1
PG 14
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA EW7BP
UT WOS:000402665000001
PM 28569203
OA gold
DA 2017-08-17
ER

PT J
AU Hasan, HF
   Abdel-Rafei, MK
   Galal, SM
AF Hasan, Hesham Farouk
   Abdel-Rafei, Mohamed Khairy
   Galal, Shereen Mohamed
TI Diosmin attenuates radiation-induced hepatic fibrosis by boosting
   PPAR-gamma expression and hampering miR-17-5p-activated canonical
   Wnt-beta-catenin signaling
SO BIOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE diosmin; gamma-radiation; miR-17-5p; Wnt-beta-catenin; liver fibrosis
ID STELLATE CELL ACTIVATION; INDUCED OXIDATIVE STRESS; NF-KAPPA-B; LIVER
   FIBROSIS; RECEPTOR-GAMMA; SPECTROPHOTOMETRIC METHOD;
   HEPATOCELLULAR-CARCINOMA; IONIZING-RADIATION; THERAPEUTIC TARGET; MICE
AB Background: Liver fibrosis is one of the major complications from upper right quadrant radiotherapy. MicroRNA-17-5p (miR-17-5p) is hypothesized to act as a regulator of hepatic stellate cell (HSCs) activation by activation of the canonical Wnt-beta-catenin pathway. Diosmin (Dios), a citrus bioflavonoid, is known to possess potent antioxidant, anti-inflammatory, and anti-apoptotic properties. Purpose: To explore the molecular mechanisms that underlie radiation-induced liver fibrosis, and to evaluate the possible influence of Dios on the miR-17-5p-Wnt-beta-catenin signaling axis during fibrogenesis provoked by irradiation (IRR) in rats. Also, the effect of Dios on hepatic peroxisome proliferator activated receptor-gamma (PPAR-gamma) expression as a regulator for HSC activation was considered. Methods: We administered 100 mg center dot(kg body mass)(-1)center dot day(-1) (per oral) of Dios were administered to IRR-exposed rats (overall dose of 12 Gy on 6 fractions of 2 Gy each) for 6 successive weeks. Results: Data analysis revealed that Dios treatment mitigated oxidative stress, enhanced antioxidant defenses, alleviated hepatic inflammatory responses, abrogated pro-fibrogenic cytokines, and stimulated PPAR-gamma expression. Dios treatment repressed the miR-17-5p activated Wnt-beta-catenin signaling induced by IRR. Moreover, Dios treatment restored the normal hepatic architecture and reversed pathological alterations induced by IRR. Conclusion: We hypothesize that the stimulation of PPAR-gamma expression and interference with miR-17-5p activated Wnt-beta-catenin signaling mediates the antifibrotic properties of Dios.
C1 [Hasan, Hesham Farouk; Abdel-Rafei, Mohamed Khairy] Natl Ctr Radiat Res & Technol, Radiat Biol Dept, Atom Energy Author, POB 29, Cairo, Egypt.
   [Galal, Shereen Mohamed] Natl Ctr Radiat Res & Technol, Hlth Radiat Res Dept, Atom Energy Author, POB 29, Cairo, Egypt.
RP Hasan, HF (reprint author), Natl Ctr Radiat Res & Technol, Radiat Biol Dept, Atom Energy Author, POB 29, Cairo, Egypt.
EM hes_fa@yahoo.com
CR Abdel-Rafei MKH, 2017, HUM EXP TOXICOL, V36, P62, DOI 10.1177/0960327116637657
   Abraham P, 2002, CLIN CHIM ACTA, V325, P117, DOI 10.1016/S0009-8981(02)00279-6
   AHMED AE, 1991, J BIOCHEM TOXICOL, V6, P115, DOI 10.1002/jbt.2570060205
   Al-Attar Atef M, 2010, Saudi J Biol Sci, V17, P295, DOI 10.1016/j.sjbs.2010.05.007
   Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938
   Arab HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122417
   Banchroft J. D., 1996, THEORY PRACTICE HIST
   Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516
   Binuclara J., 2013, INT J RES PHARM NANO, V2, P283
   Caglar OM, 2012, TURK J BIOCHEM, V37, P437, DOI 10.5505/tjb.2012.49469
   Campo GM, 2008, BRIT J PHARMACOL, V155, P945, DOI 10.1038/bjp.2008.338
   Cheema AK, 2014, J PROTEOME RES, V13, P3065, DOI 10.1021/pr500278t
   Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007
   Cheng W, 2015, MOL MED REP, V11, P2592, DOI 10.3892/mmr.2014.3051
   Chittezhath M, 2006, TUMORI, V92, P163
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Cohen SR, 2013, MED HYPOTHESES, V80, P172, DOI 10.1016/j.mehy.2012.11.022
   Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036
   Cui XZ, 2003, J HEPATOL, V39, P731, DOI 10.1016/S0168-8278(03)00216-2
   Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18
   DOUMAS BT, 1973, CLIN CHEM, V19, P984
   El Shawi O. E., 2015, J BIOSCI MED, V3, P24, DOI [10.4236/jbm.2015.310004, DOI 10.4236/JBM.2015.310004]
   Fan GJ, 2009, ENVIRON TOXICOL PHAR, V28, P350, DOI 10.1016/j.etap.2009.05.013
   Friedman L. S., 1996, HEPATOLOGY TXB LIVER
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683
   Gaur A., 2009, PHARMACOGN RES, V1, P72
   Ge WS, 2014, MOL MED REP, V9, P2145, DOI 10.3892/mmr.2014.2099
   Ghiassi-Nejad Zahra, 2008, Expert Rev Gastroenterol Hepatol, V2, P803, DOI 10.1586/17474124.2.6.803
   Gu LN, 2016, TOXICOL APPL PHARM, V292, P19, DOI 10.1016/j.taap.2015.12.024
   Gurung A, 2009, AM J PATHOL, V174, P248, DOI 10.2353/ajpath.2009.080576
   Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005
   Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242
   Ibrahim N.K., 2013, INT J BIOL LIFE SCI, V9, P7
   Jacob NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057603
   Jain Dilpesh, 2014, J Integr Med, V12, P35, DOI 10.1016/S2095-4964(14)60001-7
   JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4
   Juma'a KM, 2009, AFR J PHARM PHARMACO, V3, P242
   Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085
   Lan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129743
   Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942
   Linard C, 2008, J PHARMACOL EXP THER, V324, P911, DOI 10.1124/jpet.107.129122
   Litvinov Dmitry, 2012, N Am J Med Sci, V4, P523, DOI 10.4103/1947-2714.103310
   Liu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18038
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Lyseng-Williamson KA, 2003, DRUGS, V63, P71, DOI 10.2165/00003495-200363010-00005
   Mansour HH, 2012, ECOTOX ENVIRON SAFE, V80, P14, DOI 10.1016/j.ecoenv.2012.02.003
   Mansour HH, 2014, AM J PHYTOMEDICINE C, V2, P495
   Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1
   Meydan D, 2011, J INT MED RES, V39, P1239
   Mingone CJ, 2003, EXP BIOL MED, V228, P535
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   Moccia KD, 2010, J AM ASSOC LAB ANIM, V49, P323
   Mohammed NA, 2003, J PATHOL, V200, P647, DOI 10.1002/path.1377
   Nakamura W., 1968, COMP CELLULAR SPECIE
   Nan YM, 2009, SCAND J GASTROENTERO, V44, P358, DOI 10.1080/00365520802530861
   Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270
   Omar HA, 2009, MOL PHARMACOL, V76, P957, DOI 10.1124/mol.109.058180
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Pathak R, 2014, ANTIOXID REDOX SIGN, V20, P1436, DOI 10.1089/ars.2012.5025
   Pradeep K, 2008, EUR J PHARMACOL, V587, P273, DOI 10.1016/j.ejphar.2008.03.052
   Queenthy SS, 2013, EUR J PHARMACOL, V718, P213, DOI [10.1016/j.ejphar.2013.08.031, 10.1016/j.ejphar.2013.03.031]
   Ramos AS, 2014, ENVIRON TOXICOL PHAR, V37, P1221, DOI 10.1016/j.etap.2014.04.005
   Rehman MU, 2013, BRIT J NUTR, V110, P699, DOI 10.1017/S0007114512005752
   Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Shan SW, 2013, J CELL SCI, V126, P1517, DOI 10.1242/jcs.122895
   Sinha M, 2012, INDIAN J EXP BIOL, V50, P209
   SZASZ G, 1969, CLIN CHEM, V15, P124
   Tahir M, 2013, TOXICOL LETT, V220, P205, DOI 10.1016/j.toxlet.2013.04.004
   Tanrikulu Y, 2013, BOSNIAN J BASIC MED, V13, P218
   Tietz NW., 1990, CLIN GUIDE LAB TESTS, P566
   Tipoe GL, 2006, HISTOL HISTOPATHOL, V21, P1157, DOI 10.14670/HH-21.1157
   Tiwari B. K., 2014, ISRN PHARM, DOI [10.1155/2014/608590, DOI 10.1155/2014/608590]
   Dung TD, 2012, FOOD CHEM TOXICOL, V50, P1802, DOI 10.1016/j.fct.2012.01.021
   Tu XL, 2014, J PATHOL, V234, P46, DOI 10.1002/path.4373
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Wang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074141
   Wei J, 2013, BIOMED PHARMACOTHER, V67, P387, DOI 10.1016/j.biopha.2013.03.014
   WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186
   Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033
   Xu RN, 2014, CELL MOL IMMUNOL, V11, P224, DOI 10.1038/cmi.2014.2
   Yang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016229
   Yu FJ, 2016, ONCOTARGET, V7, P81, DOI 10.18632/oncotarget.6447
   Zhang F, 2013, CELL MOL LIFE SCI, V70, P259, DOI 10.1007/s00018-012-1046-x
   Zhang XL, 2015, CHEM COMMUN, V51, P11064, DOI 10.1039/c4cc09160d
   Zhang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep09713
NR 91
TC 0
Z9 0
U1 1
U2 1
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0829-8211
EI 1208-6002
J9 BIOCHEM CELL BIOL
JI Biochem. Cell Biol.
PD JUN
PY 2017
VL 95
IS 3
SI SI
BP 400
EP 414
DI 10.1139/bcb-2016-0142
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EW8CV
UT WOS:000402746700009
PM 28177765
OA No
DA 2017-08-17
ER

PT J
AU Mousa, E
   Azam, A
   El-Shabrawy, M
   El-Badawy, SM
AF Mousa, E.
   Azam, A.
   El-Shabrawy, M.
   El-Badawy, S. M.
TI Laboratory characterization of reclaimed asphalt pavement for road
   construction in Egypt
SO CANADIAN JOURNAL OF CIVIL ENGINEERING
LA English
DT Article
DE reclaimed asphalt pavement; resilient modulus; load duration;
   permeability; California Bearing Ratio
ID BASE LAYER; MODULUS
AB This paper presents the engineering characteristics of reclaimed asphalt pavement (RAP), blended with virgin aggregate for unbound base and subbase layers. The proportions of RAP were 0%, 20%, 60%, 80%, and 100% by total mass of the blend. The experimental laboratory testing included index properties such as gradation, modified Proctor compaction, California Bearing Ratio, and hydraulic conductivity. Repeated load resilient modulus testing was conducted on the blends. The impact of load duration on resilient modulus was also investigated. A strong inverse trend was found between resilient modulus and California Bearing Ratio. An accurate model was proposed for the prediction of the resilient modulus as a function of stress state and reclaimed asphalt pavement percentage with coefficient of determination of 0.94. Finally, multilayer elastic analysis of typical pavement sections with the base layer constructed of virgin aggregate and reclaimed asphalt pavement blends showed good performance.
C1 [Mousa, E.; Azam, A.; El-Shabrawy, M.; El-Badawy, S. M.] Mansoura Univ, Publ Works Engn Dept, Fac Engn, Mansoura, Egypt.
RP Azam, A (reprint author), Mansoura Univ, Publ Works Engn Dept, Fac Engn, Mansoura, Egypt.
EM azaam001@mymail.unisa.edu.au
FU 7th Cycle for the fund; HEI Labs Accreditation Project (HLAB)
FX The authors would like to acknowledge the HEI Labs Accreditation Project
   (HLAB), 7th Cycle for the fund used to purchase the UTM-25 at Mansoura
   University H&AE LAB.
CR AASHTO, 1993, AASHTO GUID DES PAV
   [Anonymous], 2012, M14591 AASHTO
   [Anonymous], 2012, T30799 AASHTO
   [Anonymous], 2012, T9699 AASHTO
   [Anonymous], 2008, T28991 AASHTO
   [Anonymous], 2014, T8996 AASHTO
   [Anonymous], 2002, T16497 AASHTO
   [Anonymous], 2015, T9000 AASHTO
   [Anonymous], 2012, T27299 AASHTO
   [Anonymous], 2012, T8591 AASHTO
   [Anonymous], 2003, T19399 AASHTO
   [Anonymous], 2012, T18097 AASHTO
   Abd El-Hakim R, 2016, TRANSPORT RES REC, P21, DOI 10.3141/2578-03
   Alam TB, 2010, INT J PAVEMENT ENG, V11, P123, DOI 10.1080/10298430902731362
   Alotaibi A., 2011, J ENVIRON SCI, V40, P1
   ARA Inc: ERES Consultants Division, 2004, 137A ARA INC NCHRP
   [Anonymous], 2007, D585695 ASTM INT
   Ayan V., 2011, THESIS
   Ayres M., 1997, THESIS
   Azam AM, 2013, J MATER CIVIL ENG, V25, P788, DOI 10.1061/(ASCE)MT.1943-5533.0000634
   Bennert T, 2000, TRANSPORT RES REC, P33
   Bennert T., 2005, FHWANJ2005003 CAIT U
   Dong Q, 2014, J MATER CIVIL ENG, V26, P379, DOI 10.1061/(ASCE)MT.1943-5533.0000820
   DPTI (Department for Transport Energy and Infrastructure), 2011, PAV MAT 215
   [Anonymous], 2008, ECP104 HOUS BUILD NA
   El-Maaty A.E.A., 2015, AM J ENG APPL SCI, V8, P233, DOI [10.3844/ajeassp.2015.233.248, DOI 10.3844/AJEASSP.2015.233.248]
   Garg N., 1996, TRANSPORT RES REC, V1547, P89, DOI DOI 10.3141/1547-13
   Gupta S. C., 2009, 200932 U MINN MINN D
   Hicks R.G., 1971, J TRANSPORTATION RES, V345, P15
   Hicks RG, 1970, THESIS
   Huang Y. H., 2004, PAVEMENT ANAL DESIGN
   Ji R, 2014, SCI WORLD J, DOI 10.1155/2014/372838
   Kamel A.M.E.A., 2007, THESIS
   Khan M.I., 2015, EVALUATION SPEED EFF
   Kim W, 2007, TRANSP RES RECORD, P27, DOI 10.3141/2005-04
   Kolay P. K., 2016, ASCE GEO CHICAGO 201, P677
   MacGregor J.A.C., 1999, TRANSPORT RES REC, V1687, P22, DOI 10.3141/1687-03
   McGarrah E.J., 2007, 7131 WARD U WASH DEP
   Mokwa R.L., 2005, FHWAMT05008811724 MO
   National Cooperative Highway Research Program (NCHRP), 2004, GUID MECH EMP DES NE
   Powell W.D., 1984, 1332 TRRL LR
   Sayed SM, 2011, J MATER CIVIL ENG, V23, P188, DOI 10.1061/(ASCE)MT.1943-5533.0000157
   Sayed S.M., 1993, J MATER CIVIL ENG, V5, P321, DOI [10.1061/(ASCE)0899-1561(1993)5:3(321), DOI 10.1061/(ASCE)0899-1561(1993)5:3(321)]
   Seed H.B., 1965, TE656 U CAL SOIL MEC
   Taha R., 1999, TRANSPORT RES REC, V1652, P264, DOI 10.3141/1652-33
   Thom N. H., 1987, TRANSPORT RES REC, P50
   Trzebiatowski B.D., 2005, GEOTECH TEST J, V28, P1, DOI [10.1520/GTJ12698, DOI 10.1520/GTJ12698]
   Wu M., 2011, THESIS
   Wu MQ, 2012, TRANSPORT RES REC, P65, DOI 10.3141/2267-07
NR 49
TC 0
Z9 0
U1 1
U2 1
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0315-1468
EI 1208-6029
J9 CAN J CIVIL ENG
JI Can. J. Civ. Eng.
PD JUN
PY 2017
VL 44
IS 6
BP 417
EP 425
DI 10.1139/cjce-2016-0435
PG 9
WC Engineering, Civil
SC Engineering
GA EW8DP
UT WOS:000402748800003
OA No
DA 2017-08-17
ER

PT J
AU Fayez, YM
   Nessim, CK
   Michael, AM
   Lotfy, HM
AF Fayez, Yasmin M.
   Nessim, Christine K.
   Michael, Adel M.
   Lotfy, Hayam M.
TI Validated Stability-Indicating Chromatographic Methods for the
   Determination of Chlordiazepoxide and Clidinium Bromide in the Presence
   of its Alkali-Induced Degradation Product: Kinetic Study
SO CHROMATOGRAPHIA
LA English
DT Article
DE RP-HPLC; TLC-densitometric; Chlordiazepoxide; Clidinium bromide;
   Stability-indicating methods; Comparative study; Kinetic study
ID SPECTROPHOTOMETRIC DETERMINATION; DOSAGE FORMS; HYDROCHLORIDE;
   FORMULATIONS
AB Accurate, simple and selective stability-indicating reversed phase HPLC and TLC-densitometric methods with UV detection have been developed and validated for simultaneous determination of chlordiazepoxide (CDZ) and clidinium bromide (CDB) in the presence of its alkali-induced degradation product (DEG). Successful separation of the drugs from the degradation product was achieved. For the RP-HPLC method, the stationary phase was ACE-126-2546 AQ C-18 (250 x 4.6 mm i.d., 5 mu m particle size) column at 25 A degrees C, in an isocratic mode, using mobile phase containing a mixture of 25 mM ammonium acetate (pH 5.4): acetonitrile in the ratio of (20:80, v/v), at the flow rate of 1.0 mL min(-1) and UV detection was performed at 222 nm. The retention times were (4.13 +/- 0.01) and (8.5 +/- 0.01) min for CDZ and CDB, respectively. For the TLC-densitometric method, the separation was performed using a stationary phase of precoated Silica Gel G/UV254 and mobile phase composed of a mixture of ethyl acetate: methanol: ammonia (8:3:1, v/v/v) and scanned at 222 nm. The R (f) values were (0.79 +/- 0.02) and (0.11 +/- 0.01) for CDZ and CDB, respectively. The linearity graphs for CDZ and CDB, respectively, were found to be linear over (0.5-40) mu g mL(-1) and (2-45) mu g mL(-1) with mean percentage recoveries (99.69 +/- 0.836) and (99.28 +/- 1.838) for RP-HPLC method and (1-14) mu g band(-1) and (0.5-10) mu g band(-1) with mean percentage recoveries (100.00 +/- 0.782) and (100.19 +/- 1.010) for TLC-densitometric method. A comparative study of different analytical validation parameters such as accuracy, precision, specificity and robustness were conducted. The obtained results were statistically compared with those of the official and reported methods; using Student's t test, F test and one-way ANOVA, showing no significant difference with high accuracy and good precision. The proposed RP-HPLC method was also used to study the kinetics of the alkaline hydrolysis of clidinium bromide that was found to follow pseudo-first order kinetics. The t (1/2) was 8.5729 min while k (the degradation rate constant) was 0.0808353 min(-1).
C1 [Fayez, Yasmin M.; Lotfy, Hayam M.] Cairo Univ, Dept Analyt Chem, Fac Pharm, Cairo 11562, Egypt.
   [Nessim, Christine K.; Michael, Adel M.] Ahram Canadian Univ, Analyt Chem Dept, Fac Pharm, 6th of October 12566, Egypt.
   [Lotfy, Hayam M.] Future Univ, Fac Pharmaceut Sci & Pharmaceut Ind, Pharmaceut Chem Dept, Cairo, Egypt.
RP Nessim, CK (reprint author), Ahram Canadian Univ, Analyt Chem Dept, Fac Pharm, 6th of October 12566, Egypt.
EM christinekamal29@yahoo.com
CR Actavis Totowa LLC, 2006, CHLORD HYDR CLID BRO
   Ashour S, 2013, J PHARM, V2013, P1
   British Pharmacopoeia, 2013, STAT OFF BE HALF MED, VI
   Brunton LL, 2006, GOODMAN GILMANS PHAR
   El-Sayed GO, 2009, J CHEM PHARM RES, V1, P225
   Florence AT, 1998, PHYS PRINCIPLES PHAR
   ICH Q1A, 1993, P INT C HARM GEN
   JALAL IM, 1987, ANAL LETT, V20, P635
   Khoshayand MR, 2010, DRUG TEST ANAL, V2, P430, DOI 10.1002/dta.162
   Lotfy HM, 2016, SPECTROCHIM ACTA A, V155, P11, DOI 10.1016/j.saa.2015.10.033
   Lotfy HM, 2016, EUR J CHEM, V7, P315
   Martin A, 1983, PHYS PHARM, P359
   Mcevory GK, 1990, AHFS DRUG INFORM, P1256
   Nickerson B, 1997, J PHARMACEUT BIOMED, V15, P965, DOI 10.1016/S0731-7085(96)01922-X
   Patel S, 2009, INDIAN J PHARM SCI, V71, P472, DOI 10.4103/0250-474X.57305
   Pathak A, 2010, J CHROMATOGR SCI, V48, P235
   Rudy BC, 1973, ANAL PROFILES DRUG S, V2, P145
   SUN SR, 1978, J PHARM SCI, V67, P639, DOI 10.1002/jps.2600670517
   Toral MI, 1999, INT J PHARM, V189, P67, DOI 10.1016/S0378-5173(99)00238-0
   United States Pharmacopoeia, 2011, US PHARMACOPOEIA CON
   United States Pharmacopoeia Commission, 2004, US PHARMACOPEFIA NAT, P2280
   WALASH MI, 1988, TALANTA, V35, P895, DOI 10.1016/0039-9140(88)80209-1
   YUEN SM, 1991, J ASSOC OFF ANA CHEM, V74, P461
NR 23
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0009-5893
EI 1612-1112
J9 CHROMATOGRAPHIA
JI Chromatographia
PD JUN
PY 2017
VL 80
IS 6
BP 911
EP 922
DI 10.1007/s10337-017-3301-7
PG 12
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA EW9GI
UT WOS:000402824400009
OA No
DA 2017-08-17
ER

PT J
AU Ezzat, MA
   El-Bary, AA
AF Ezzat, Magdy A.
   El-Bary, Alaa A.
TI Generalized fractional magneto-thermo-viscoelasticity
SO MICROSYSTEM TECHNOLOGIES-MICRO-AND NANOSYSTEMS-INFORMATION STORAGE AND
   PROCESSING SYSTEMS
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Engineering and Technology Innovation
   (ICETI)
CY OCT 31-NOV 04, 2014
CL Kenting, TAIWAN
ID STATE-SPACE APPROACH; 2 RELAXATION-TIMES; THERMOELASTIC PLANE-WAVES;
   FREE-CONVECTION FLOW; BOUNDARY-LAYER-FLOW; HEAT-CONDUCTION LAW;
   POROUS-MEDIUM; RECIPROCITY THEOREMS; VOLUME PROPERTIES; FLUID-FLOW
AB The new model of the equations of the linear theory of magneto-thermo-viscoelasticity with two relaxation times and fractional heat transfer involving fractional relaxation operator is given. The resulting formulation is applied to thermal shock problems for a perfect electrically conducting half-space in the presence of a transverse magnetic field. Laplace transform techniques are used. Some essential theorems on the linear coupled and generalized theories of thermo-viscoelasticity with two relaxation times are established. According to the numerical results and its graphs, conclusion about the new theory has been constructed. The effects of the fractional relaxation operator on viscoelastic material like poly (methyl methacrylate) (Perspex) are discussed.
C1 [Ezzat, Magdy A.] Alexandria Univ, Dept Math, Fac Educ, Alexandria, Egypt.
   [El-Bary, Alaa A.] Arab Acad Sci & Technol, POB 1029, Alexandria, Egypt.
RP Ezzat, MA (reprint author), Alexandria Univ, Dept Math, Fac Educ, Alexandria, Egypt.
EM maezzat2000@yahoo.com; aaelbary@aast.edu
CR Abouhamzeh M, 2015, COMPOS STRUCT, V133, P871, DOI 10.1016/j.compstruct.2015.08.050
   Adolfsson K, 2005, MECH TIME-DEPEND MAT, V9, P15, DOI 10.1007/s11043-005-3442-1
   ATKINSON C, 1995, PROG AEROSP SCI, V31, P1, DOI 10.1016/0376-0421(93)E0001-M
   Berti A, 2015, J MATH ANAL APPL, V421, P1163, DOI 10.1016/j.jmaa.2014.07.049
   BIOT MA, 1955, PHYS REV, V97, P1463, DOI 10.1103/PhysRev.97.1463
   BIOT MA, 1954, J APPL PHYS, V25, P1385, DOI 10.1063/1.1721573
   Caputo M., 1971, Rivista del Nuovo Cimento, V1, P161, DOI 10.1007/BF02820620
   CAPUTO M, 1974, J ACOUST SOC AM, V56, P897, DOI 10.1121/1.1903344
   Chadwick P, 1960, PROGR SOLID MECH, V1, P236
   CHOUDHURI SKR, 1984, INT J ENG SCI, V22, P519, DOI 10.1016/0020-7225(84)90054-5
   El-Karamany AS, 2011, MATH MECH SOLIDS, V16, P334, DOI 10.1177/1081286510397228
   El-Karamany AS, 2011, J THERM STRESSES, V34, P264, DOI 10.1080/01495739.2010.545741
   El-Karamany AS, 2004, J THERM STRESSES, V27, P1187, DOI 10.1080/014957390523598
   El-Karamany AS, 2004, APPL MATH COMPUT, V151, P347, DOI 10.1016/S0096-3003(03)00345-X
   El-Karamany AS, 2004, INT J ENG SCI, V42, P649, DOI 10.1016/j.ijengsci.2003.07.009
   El-Karamany AS, 2002, INT J ENG SCI, V40, P1943, DOI 10.1016/S0020-7225(02)00043-5
   Ezzat M, 1996, ACTA MECH, V119, P147, DOI 10.1007/BF01274245
   Ezzat MA, 2015, J MECH SCI TECHNOL, V29, P4273, DOI 10.1007/s12206-015-0924-1
   Ezzat MA, 2012, MAGNETOHYDRODYNAMICS, V48, P587
   Ezzat MA, 2010, J APPL POLYM SCI, V117, P1934, DOI 10.1002/app.32170
   EZZAT MA, 1994, CAN J PHYS, V72, P311
   Ezzat MA, 1997, J FRANKLIN I, V334B, P685, DOI 10.1016/S0016-0032(96)00095-6
   Ezzat MA, 2006, MAT SCI ENG B-SOLID, V130, P11, DOI 10.1016/j.mseb.2006.01.020
   Ezzat MA, 2002, J THERM STRESSES, V25, P295, DOI 10.1080/014957302317262323
   Ezzat MA, 2002, J THERM STRESSES, V25, P507, DOI 10.1080/01495730290074261
   Ezzat MA, 2002, INT J ENG SCI, V40, P1275, DOI 10.1016/S0020-7225(01)00099-4
   Ezzat MA, 2002, INT J ENG SCI, V40, P1251, DOI 10.1016/S0020-7225(02)00012-5
   Ezzat MA, 2001, INT J ENG SCI, V39, P799, DOI 10.1016/S0020-7225(00)00059-8
   Ezzat MA, 2000, INT J ENG SCI, V38, P107, DOI 10.1016/S0020-7225(99)00013-0
   EZZAT MA, 1995, INT J ENG SCI, V33, P2011, DOI 10.1016/0020-7225(95)00050-8
   Ezzat MA, 1997, Z ANGEW MATH MECH, V77, P197, DOI 10.1002/zamm.19970770307
   Ezzat MA, 1999, CAN J PHYS, V77, P813, DOI 10.1139/cjp-77-10-813
   Ezzat MA, 2015, J ELECTROMAGNET WAVE, V29, P1018, DOI 10.1080/09205071.2015.1027795
   Ezzat MA, 2015, INT J APPL ELECTROM, V47, P95, DOI 10.3233/JAE-130177
   Ezzat MA, 2014, HEAT MASS TRANSFER, V50, P907, DOI 10.1007/s00231-014-1300-x
   Ezzat MA, 2012, HEAT MASS TRANSFER, V48, P71, DOI 10.1007/s00231-011-0830-8
   Ezzat MA, 2011, Z ANGEW MATH PHYS, V62, P937, DOI 10.1007/s00033-011-0126-3
   Ezzat MA, 2011, APPL MATH MODEL, V35, P4965, DOI 10.1016/j.apm.2011.04.004
   Ezzat MA, 2011, CAN J PHYS, V89, P311, DOI 10.1139/P11-022
   Ezzat MA, 2011, EUR J MECH A-SOLID, V30, P491, DOI 10.1016/j.euromechsol.2011.02.004
   Ezzat MA, 2011, INT J THERM SCI, V50, P449, DOI 10.1016/j.ijthermalsci.2010.11.005
   Ezzat MA, 2011, PHYSICA B, V406, P30, DOI 10.1016/j.physb.2010.10.005
   Ezzat MA, 2010, PHYSICA B, V405, P4188, DOI 10.1016/j.physb.2010.07.009
   Ezzat MA, 2010, J POLYM ENG, V30, P1, DOI 10.1515/POLYENG.2010.30.1.1
   Ezzat MA, 2010, INT J ENG SCI, V48, P460, DOI 10.1016/j.ijengsci.2009.11.006
   Ezzat MA, 2008, CAN J PHYS, V86, P1241, DOI 10.1139/P08-069
   Green A. E., 1972, J ELASTICITY, V2, P1, DOI DOI 10.1007/BF00045689
   Gross B., 1953, MATH STRUCTURE THEOR
   Hamza F, 2014, J THERM STRESSES, V37, P1080, DOI 10.1080/01495739.2014.936196
   HONIG G, 1984, J COMPUT APPL MATH, V10, P113, DOI 10.1016/0377-0427(84)90075-X
   Huilgol R., 1997, FLUID MECH VISCOELAS
   Ilioushin A. A., 1970, FUNDAMENTALS MATH TH
   Jumarie G, 2010, COMPUT MATH APPL, V59, P1142, DOI 10.1016/j.camwa.2009.05.015
   Kaliski S, 1959, P VIB PROB, V4, P83
   KNOPOFF L, 1955, J GEOPHYS RES, V60, P441, DOI 10.1029/JZ060i004p00441
   Menon S, 2004, COMPUT STRUCT, V82, P1123, DOI 10.1016/j.compstruc.2004.03.023
   MISRA SC, 1992, COMPUT STRUCT, V43, P951, DOI 10.1016/0045-7949(92)90309-N
   MORLAND LW, 1960, T SOC RHEOL, V4, P233
   NAYFEH AH, 1972, J APPL MECH, V39, P108
   Nowinski J.L., 1978, THEORY THERMOELASTIC
   Othman MIA, 2002, INT J ENG SCI, V40, P1329, DOI 10.1016/S0020-7225(02)00023-X
   PARIA G, 1962, P CAMB PHILOS SOC, V58, P527
   Paria G., 1966, ADV APPL MECH, V10, P73, DOI DOI 10.1016/S0065-2156(08)70394-6
   Pobedria BE, 1984, J DURAB PLAST, V2, P224
   Povstenko YZ, 2005, J THERM STRESSES, V28, P83, DOI 10.1080/014957390523741
   Rajagopal KR, 2007, INT J ENG SCI, V45, P41, DOI 10.1016/j.ijengsci.2006.07.015
   Suhubi E, 1975, CONTEMP PHYS, VII
   Tanner R. I., 1988, ENG RHEOLOGY
   Tschoegl N. W., 1997, Mechanics of Time-Dependent Materials, V1, P3, DOI 10.1023/A:1009748023394
NR 69
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-7076
EI 1432-1858
J9 MICROSYST TECHNOL
JI Microsyst. Technol.
PD JUN
PY 2017
VL 23
IS 6
SI SI
BP 1767
EP 1777
DI 10.1007/s00542-016-2904-5
PG 11
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Materials Science;
   Physics
GA EV3BB
UT WOS:000401630800016
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Satar, AM
   Ali, MH
   Goher, ME
AF Abdel-Satar, Amaal M.
   Ali, Mohamed H.
   Goher, Mohamed E.
TI Distribution and speciation of Fe, Mn, Zn, Cu, Pb and P in surface
   sediments of Lake Mariut, Egypt
SO OCEANOLOGICAL AND HYDROBIOLOGICAL STUDIES
LA English
DT Article
DE heavy metals; chemical speciation; risk assessment; phosphorus;
   sediment; Lake Mariut
ID HEAVY-METALS FRACTIONATION; SEQUENTIAL EXTRACTION; PHOSPHORUS
   SPECIATION; TRACE-ELEMENTS; CHINA; WETLAND; GEOCHEMISTRY; ESTUARY;
   GREECE; SOIL
AB Lake Mariut is suffering from pollution as it receives industrial effluents and a mix of sewage from different drains, often lacking treatment systems. Sequential extraction procedures were applied for the speciation of heavy metals (Fe, Mn, Zn, Cu and Pb) and P in the lake sediment to evaluate their potential bioavailability. Total concentrations of metals had low values compared with the sediment quality guidelines. The chemical speciation data for Mn and Zn indicate a potential pollution level since the non-residual fractions contain up to 77.6 and 64.9% (respectively) of the total metal content. However, Fe, Cu and Pb are mostly linked to the inert fraction. Risk assessment of metals was carried out using the mobility factor, the contamination factor, the risk assessment code and the enrichment factor. All the analytical approaches indicated the accumulation of pollutants exceeding the adsorptive capacity of Lake Mariut sediments. The organic phosphorus fractions dominated in the sediment accounting for 51.4%, while the most abundant form of inorganic phosphorus was Ca-bound phosphorus. The rank order of P fractions was HCl-P > NaOH-P > BD-P > NH4Cl-P > Res-P. The decrease both in the dissolved oxygen level in the lake water and the Fe: P ratio in the lake sediment resulted in the high contribution of the phosphorus fractions to the overlying water.
C1 [Abdel-Satar, Amaal M.; Ali, Mohamed H.; Goher, Mohamed E.] NIOF, Inland Water & Aquaculture Branch, 101 Kasr El Aini St, Cairo, Egypt.
   [Abdel-Satar, Amaal M.] Univ Hail, Dept Chem, Fac Sci, Hail, Saudi Arabia.
RP Abdel-Satar, AM (reprint author), NIOF, Inland Water & Aquaculture Branch, 101 Kasr El Aini St, Cairo, Egypt.; Abdel-Satar, AM (reprint author), Univ Hail, Dept Chem, Fac Sci, Hail, Saudi Arabia.
EM abdelsatarmena11@yahoo.com
CR Abdel-Satar AM, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4592-5
   Abdel-Satar AM, 2010, ENVIRON MONIT ASSESS, V169, P169, DOI 10.1007/s10661-009-1160-x
   Abdel-Satar A. M., 2009, THALASSIA SAL, V32, P3
   Akcay H, 2003, WATER RES, V37, P813, DOI 10.1016/S0043-1354(02)00392-5
   Anshumali, 2007, APPL GEOCHEM, V22, P1860, DOI 10.1016/j.apgeochem.2007.03.050
   Aydin I, 2009, J HAZARD MATER, V168, P664, DOI 10.1016/j.jhazmat.2009.02.095
   Canadian Council of Ministers of the Environment (CCME), 2001, CAN ENV QUAL GUID
   Donia N., 2016, LAKE SCI CLIMATE CHA, DOI [10.5772/63526, DOI 10.5772/63526]
   El-Rayis O., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P145, DOI 10.1007/s11027-005-7836-9
   El-Shabrawy G. M., 2011, RIVER DELTAS TYPES S, P35
   Fytianos K, 2004, ENVIRON INT, V30, P11, DOI 10.1016/S0160-4120(03)00143-0
   Fytianos K, 2005, ENVIRON MONIT ASSESS, V100, P191, DOI 10.1007/s10661-005-4770-y
   Gao XL, 2010, ESTUAR COAST SHELF S, V86, P369, DOI 10.1016/j.ecss.2009.10.012
   Gu JW, 2013, ESTUAR COAST SHELF S, V117, P282, DOI 10.1016/j.ecss.2012.06.012
   Hudson-Edwards KA, 2014, CHEM GEOL, V384, P16, DOI 10.1016/j.chemgeo.2014.06.014
   Huu HH, 2010, VIETNAM GEOL BELG, V13, P37
   Khairy H. M., 2015, INT C ADV AGR BIOL E, P22
   KHALIL MK, 2013, WORLD APPL SCI J, V24, P282, DOI DOI 10.5829/idosi.wasj.2013.24.03.75115
   Kljakovic-Gaspic Z, 2009, ENVIRON GEOL, V58, P751, DOI 10.1007/s00254-008-1549-9
   Kumar R. N., 2012, IJES, V2, DOI [10.6088/ijes.00202030074, DOI 10.6088/IJES.00202030074]
   Lesmes L. E., 1996, TROP COUNTR 2 INT S
   Malecki-Brown LM, 2007, J ENVIRON QUAL, V36, P1904, DOI 10.2134/jeq2007.0159
   Masoud M.S., 2011, EGYPT AFR J ENV SCI, V5, P280
   Moore F, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4117-7
   MURPHY J, 1962, ANAL CHIM ACTA, V26, P31
   Nowrouzi M, 2014, CHEM SPEC BIOAVAILAB, V26, P99, DOI 10.3184/095422914X13951584546986
   OGUNFOWOKAN A. O., 2013, INT J ENV PROT, V3, P6
   Ong M. C., 2013, Oriental Journal of Chemistry, V29, P39, DOI 10.13005/ojc/290106
   Paludan C, 1995, WETLANDS, V15, P365
   Perin GCL, 1985, HEAVY METAL ENV, P454
   PETTERSSON K, 1988, HYDROBIOLOGIA, V170, P91, DOI 10.1007/BF00024900
   Rao CRM, 2008, WATER AIR SOIL POLL, V189, P291, DOI 10.1007/s11270-007-9564-0
   Rauret G, 1998, TALANTA, V46, P449, DOI 10.1016/S0039-9140(97)00406-2
   Ribeiro DC, 2008, CHEMOSPHERE, V70, P1256, DOI 10.1016/j.chemosphere.2007.07.064
   Saad M. A. H., 1980, EUTROPHICATION LAKE
   Saad M. A. H., 2003, DIFF POLL C DUBL
   TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017
   Topcu A, 2008, FRESEN ENVIRON BULL, V17, P164
   TUREKIAN KK, 1961, GEOL SOC AM BULL, V72, P175, DOI 10.1130/0016-7606(1961)72[175:DOTEIS]2.0.CO;2
   Wang LL, 2013, CHINESE GEOGR SCI, V23, P574, DOI 10.1007/s11769-013-0627-4
   Wang SR, 2008, J ENVIRON MANAGE, V88, P845, DOI 10.1016/j.jenvman.2007.04.006
   Yahaya M. I., 2012, J ENV CHEM ECOTOXICO, V4, P212, DOI DOI 10.5897/JECE11.080
   Yuan CG, 2004, ENVIRON INT, V30, P769, DOI 10.1016/j.envint.2004.01.001
   Zhang RY, 2013, J ENVIRON SCI-CHINA, V25, P1124, DOI 10.1016/S1001-0742(12)60163-6
   Zhou QX, 2001, CHEMOSPHERE, V42, P221, DOI 10.1016/S0045-6535(00)00129-6
   Zhu GW, 2006, PEDOSPHERE, V16, P726
NR 46
TC 0
Z9 0
U1 10
U2 10
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1730-413X
EI 1897-3191
J9 OCEANOL HYDROBIOL ST
JI Oceanol. Hydrobiol. Stud.
PD JUN
PY 2017
VL 46
IS 2
BP 154
EP 167
DI 10.1515/ohs-2017-0016
PG 14
WC Marine & Freshwater Biology; Oceanography
SC Marine & Freshwater Biology; Oceanography
GA EW6NU
UT WOS:000402628100003
OA No
DA 2017-08-17
ER

PT J
AU Saleh, NY
   El Fotoh, WMMA
   El-Hawy, MA
AF Saleh, Nagwan Yossery
   El Fotoh, Wafaa Moustafa M. Abo
   El-Hawy, Mahmoud A.
TI Serum Neutrophil Gelatinase-Associated Lipocalin: A Diagnostic Marker in
   Pediatric Sepsis
SO PEDIATRIC CRITICAL CARE MEDICINE
LA English
DT Article
DE C-reactive protein; critically ill; neutrophil gelatinase-associated
   lipocalin; Pediatric Risk of Mortality; Pediatric Index of Mortality 2;
   sepsis
ID ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; RENAL REPLACEMENT THERAPY;
   EMERGENCY-DEPARTMENT; PLASMA NGAL; BIOMARKER; MORTALITY; IMPACT
AB Objectives: Sepsis is a life-threatening condition that arises when the response of the body to infection injures its own tissues and organs. The early prediction of sepsis by current clinical and laboratory methods remains inadequate. Serum neutrophil gelatinase-associated lipocalin level is increased in sepsis irrespective of renal dysfunction. Therefore, we aimed to correlate the serum neutrophil gelatinase-associated lipocalin value determined at admission with clinical progression and severity of disease in critically ill children and to declare its role as a potential diagnostic and prognostic marker for sepsis in critically ill children in the emergency department.
   Design: A prospective cohort study.
   Setting: The study carried out at the PICU of Menoufia University Hospital.
   Patients: We serially enrolled 120 critically ill children admitted to the PICU at 2 fixed days per week in addition to 40 healthy children served as controls.
   Interventions: Clinical examination was performed including calculation of the Pediatric Risk of Mortality and Pediatric Index of Mortality 2. Serum neutrophil gelatinase-associated lipocalin measurement was performed for patients at admission and for the controls. Patients were followed up for 30 days. The discriminatory power of neutrophil gelatinase-associated lipocalin was determined using the receiver-operating characteristic and other predictive likelihood values.
   Measurements and Main Results: Serum neutrophil gelatinase-associated lipocalin level was significantly higher among the total patient cohort and those with sepsis than among the controls (p < 0.001), also in patients with systemic inflammatory response syndrome without sepsis and patients without systemic inflammatory response syndrome (p = 0.04 and <0.001). Furthermore, plasma level of neutrophil gelatinase-associated lipocalin was significantly elevated in nonsurvivors compared with survivors (p < 0. 001). Receiver-operating characteristic curve analysis exhibited an area under the curve of 0.84 for neutrophil gelatinase-associated lipocalin for diagnosis of sepsis, whereas C-reactive protein had an area under the curve of 0.79. Regarding the prognosis, neutrophil gelatinase-associated lipocalin had an area under the curve of 0.74 for prediction of mortality, whereas the area under the curve for Pediatric Risk of Mortality, Pediatric Index of Mortality 2, and C-reactive protein were 0.59, 0.58, and 0.62, respectively.
   Conclusion: Overall, the data support the view that measurement at admission, serum neutrophil gelatinase-associated lipocalin results in substantial added value for early diagnosis and prognostication of sepsis in critically sick children.
C1 [Saleh, Nagwan Yossery; El Fotoh, Wafaa Moustafa M. Abo; El-Hawy, Mahmoud A.] Menoufia Univ Hosp, Dept Pediat, Fac Med, Menoufia Governorate, Egypt.
RP El Fotoh, WMMA (reprint author), Menoufia Univ Hosp, Fac Med, Shibin Al Kawm, Egypt.
EM wafaamoustafa60@yahoo.com
CR Aydogdu M, 2013, DIS MARKERS, V34, P237, DOI 10.3233/DMA-130966
   Bagshaw SM, 2013, J CRIT CARE, V28, P371, DOI 10.1016/j.jcrc.2012.10.007
   BAUD L, 1989, KIDNEY INT, V35, P1111, DOI 10.1038/ki.1989.98
   Bihorac A, 2013, J TRAUMA ACUTE CARE, V74, P1005, DOI 10.1097/TA.0b013e31828586ec
   Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020
   Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896
   Cunningham PN, 2002, J IMMUNOL, V168, P5817
   de Geus HRH, 2013, BIOMARK MED, V7, P415, DOI [10.2217/bmm.13.5, 10.2217/BMM.13.5]
   Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af
   Devarajan P, 2010, BIOMARK MED, V4, P265, DOI [10.2217/bmm.10.12, 10.2217/BMM.10.12]
   Di Nardo M, 2013, BLOOD PURIFICAT, V35, P172, DOI 10.1159/000346629
   Fatemeh G, 2014, J PARAMED SCI, V5, P63
   Hjortrup PB, 2015, ACTA ANAESTH SCAND, V59, P25, DOI 10.1111/aas.12427
   Huang HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059482
   Katagiri D, 2013, J CRIT CARE, V28, P564, DOI 10.1016/j.jcrc.2013.01.009
   Kim H, 2013, CLIN BIOCHEM, V46, P1414, DOI 10.1016/j.clinbiochem.2013.05.069
   Kumpers P, 2010, CRIT CARE, V14, DOI 10.1186/cc8861
   Langenberg C, 2007, INTENS CARE MED, V33, P1614, DOI 10.1007/s00134-007-0734-8
   Martensson J, 2010, INTENS CARE MED, V36, P1333, DOI 10.1007/s00134-010-1887-4
   Mellor A, 2013, DIS MARKERS, P537, DOI 10.1155/2013/601214
   Mike S, 2014, BIOMED RES INT, V2014
   Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X
   Otto GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124429
   Otto GP, 2013, CRIT CARE, V17, DOI 10.1186/cc12540
   POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006
   Ridder WP, 2010, CRIT CARE S1, V14, pP528
   Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882
   Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2
   Strehlow MC, 2006, ANN EMERG MED, V48, P326, DOI 10.1016/j.annemergmed.2006.05.003
   Wan Li, 2003, Curr Opin Crit Care, V9, P496, DOI 10.1097/00075198-200312000-00006
   Wang MM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0634-6
NR 31
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1529-7535
EI 1947-3893
J9 PEDIATR CRIT CARE ME
JI Pediatr. Crit. Care Med.
PD JUN
PY 2017
VL 18
IS 6
BP E245
EP E252
DI 10.1097/PCC.0000000000001186
PG 8
WC Critical Care Medicine; Pediatrics
SC General & Internal Medicine; Pediatrics
GA EW8BS
UT WOS:000402743700002
PM 28445241
OA No
DA 2017-08-17
ER

PT J
AU Salama, FM
   Abd El-Ghani, MM
   El-Tayeh, NA
   Amro, A
   Abdrabbu, HS
AF Salama, Fawzy M.
   Abd El-Ghani, Monier M.
   El-Tayeh, Noha A.
   Amro, Ahmed
   Abdrabbu, Heba S.
TI Correlations between soil variables and weed communities in major crops
   of the desert reclaimed lands in southern Egypt
SO RENDICONTI LINCEI-SCIENZE FISICHE E NATURALI
LA English
DT Article
DE Egypt; Agro diversity; Distribution; Soil factors; CCA; Weed flora
ID NILE DELTA REGION; SAUDI-ARABIA; VEGETATION; FLORA; DIVERSITY;
   PHENOLOGY; ROTATION; AREA
AB The weed flora of the reclaimed desert lands in the eastern and western stretches of Qena Governorate along the Nile Valley was investigated. This study attempted to identify the vegetation groups (communities) prevailing in common winter and summer crops, to recognise the crop-weed relationships, and to assess the role of different soil factors on the distribution and composition of the weed flora in each season. Three major crops were selected: alfa-alfa (winter and summer seasons), wheat (winter season) and millet (summer season). Altogether, 146 studied fields (stands) were monitored, and distributed as follows: 49 in the wheat fields, 38 in alfa-alfa (summer season), 24 in alfa-alfa (winter season), and 35 in millet fields. Frequency (f %) of weed species within the different crop farmlands was used as measure of ecological success. The total number of species varied among the studied crops: the highest was 131 species in alfa-alfa (the perennial crop), followed by 111 species in wheat (the winter crop), and the lowest (29 species) was in millet (the summer crop). The relationships between the recorded species and crops were discussed. TWINSPAN as a classification method and DCA as an ordination methods were used to assess differences in floristic composition in different seasons. The resulted TWINSPAN vegetation groups from winter and summer seasons were clearly separated along the first 2 axes of DCA. Canonical correspondence analysis was used to evaluate the relationships between the examined soil factors and the floristic presence/absence data sets in each season.
C1 [Salama, Fawzy M.; Amro, Ahmed] Assiut Univ, Dept Bot & Microbiol, Fac Sci, Assiut, Egypt.
   [Abd El-Ghani, Monier M.] Cairo Univ, Dept Bot & Microbiol, Fac Sci, Giza 12613, Egypt.
   [El-Tayeh, Noha A.; Abdrabbu, Heba S.] South Valley Univ, Dept Bot, Fac Sci, Qena, Egypt.
RP Salama, FM (reprint author), Assiut Univ, Dept Bot & Microbiol, Fac Sci, Assiut, Egypt.
EM fawzysalama2020@yahoo.com
CR Abd El-Ghani MM, 1998, J ARID ENVIRON, V38, P297, DOI 10.1006/jare.1997.0323
   Abd El-Ghani MM, 2000, GLOBAL ECOL BIOGEOGR, V9, P499, DOI 10.1046/j.1365-2699.2000.00209.x
   Abd El-Ghani M, 2013, TURK J BOT, V37, P464, DOI 10.3906/bot-1205-11
   Abd El-Ghani Monier M., 1998, Fragmenta Floristica et Geobotanica, V43, P257
   Abd El-Ghani Monier M., 2004, Systematics and Geography of Plants, V74, P319
   Abd-El-Ghani M. M., 1990, Egyptian Journal of Botany, V33, P15
   Abd El-Fattah RI, 1986, THESIS
   Abd El-Ghani MM, 1981, THESIS
   Abd El-Ghani MM, 1985, THESIS
   El-Bakry AA, 1992, B FACULTY AGR CAIRO, V43, P1221
   Fawzy AM, 2006, INT J AGRIC BIOL, V8, P249
   Abd El-Ghani MM, 1994, FEDDES REPERT, V105, P387
   Abd El Razik TM, 1972, J GEOL, V16, P235
   Allen MM, 1974, CHEM ANAL ECOLOGICAL, P565
   Andersson TN, 1998, WEED SCI, V46, P30
   Andreasen C, 1992, 9 DAN PLANT PROT C W, p[2178, 49]
   Andreasen C, 2009, AGR ECOSYST ENVIRON, V133, P61, DOI 10.1016/j.agee.2009.05.003
   Baessler C, 2006, AGR ECOSYST ENVIRON, V115, P43, DOI 10.1016/j.agee.2005.12.007
   Bardsley CE, 1965, METHODS SOIL ANALYSI, V9, P1102
   Boulos L., 1995, FLORA EGYPT CHECKLIS
   Boulos L, 1999, FLORA EGYPT, V1-4
   DALE MRT, 1992, CAN J BOT, V70, P1931
   El-Demerdash M. A., 1997, Feddes Repertorium, V108, P219
   El-Amry MI, 1981, THESIS CAIRO U EGYPT
   El-Bakry AA, 1982, THESIS CAIRO U
   ELDEMERDASH MA, 1995, J ARID ENVIRON, V30, P161, DOI 10.1016/S0140-1963(05)80067-9
   El-Fahar RA, 2002, EGYPTIAN J BIOTECHNO, V11, P330
   ELGHAREEB R, 1989, J ARID ENVIRON, V17, P13
   Hosni HA, 1999, TAECKHOLMIA, V19, P127
   Hegazy A. K., 2004, Community Ecology, V5, P163, DOI 10.1556/ComEc.5.2004.2.3
   Henderson P. A., 1999, COMMUNITY ANAL PACKA
   HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870
   Jackson ML, 1967, SOIL CHEM ANAL ADV C
   Kassas M, 1962, B SOC GEOGRAPHIE EGY, V35, P129
   Kenkel NC, 2002, WEED SCI, V50, P281, DOI 10.1614/0043-1745(2002)050[0281:RMAIWS]2.0.CO;2
   Marshall EJR, 2002, AGR ECOSYST ENVIRON, V89, P5, DOI 10.1016/S0167-8809(01)00315-2
   Menalled FD, 2001, ECOL APPL, V11, P1586, DOI 10.1890/1051-0761(2001)011[1586:WAASCR]2.0.CO;2
   MOUSTAFA AA, 1995, J ARID ENVIRON, V30, P385, DOI 10.1006/jare.1995.0033
   Muller-Dombois D, 1974, AIMS METHODS VEGETAT, P335
   Norderhaug A, 1999, SKJOTSELSBOKA KULTUR
   Ryan PJ, 1996, ROLE EUCALYPTUS OTHE
   Said R, 1991, GEOLOGY EGYPT, P487
   Said R, 1981, GEOLOGICAL EVALUATIO
   SALONEN J, 1993, AGR SCI FINLAND, V2, P525
   Shaheen AM, 1987, THESIS
   SHALTOUT K H, 1988, Feddes Repertorium, V99, P153
   SHALTOUT KH, 1993, J VEG SCI, V4, P567, DOI 10.2307/3236085
   SHALTOUT KH, 1991, J VEG SCI, V2, P385, DOI 10.2307/3235931
   SHALTOUT KH, 1994, VEGETATIO, V112, P35, DOI 10.1007/BF00045098
   Shaltout KH, 1997, BIODIVERS CONSERV, V6, P1027, DOI 10.1023/A:1018319714993
   SHALTOUT KH, 1993, FLORA, V187, P329
   Shehata MN, 2000, P 1 INT C BIOL SCI I, V1, P315
   Sher H, 2011, AFR J AGR RES, V6, P901
   Sokal RR, 1981, BIOMETRY FREEMAN
   Soliman AT, 1989, THESIS
   Sparks D. L., 1996, METHODS SOIL ANAL 3
   Stevenson FC, 1997, WEED SCI, V45, P798
   STREIBIG JC, 1979, J APPL ECOL, V16, P577, DOI 10.2307/2402532
   Tackholm V, 1974, STUDENTS FLORA EGYPT
   TERBRAAK CJF, 1986, ECOLOGY, V67, P1167
   ter Braak C.J.F., 1990, UPDATE NOTES CANOCO
   Ter Braak CJF, 1987, CANOCO FORTRAN PROGR
   Walter AM, 2002, WEED RES, V42, P26, DOI 10.1046/j.1365-3180.2002.00259.x
   Woods JT, 1941, SOIL CHEM ANAL, P141
   Zahran MA, 2009, VEGETATION EGYPT
NR 65
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 2037-4631
EI 1720-0776
J9 REND LINCEI-SCI FIS
JI Rend. Lincei.-Sci. Fis. Nat.
PD JUN
PY 2017
VL 28
IS 2
BP 363
EP 378
DI 10.1007/s12210-017-0604-4
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV4XJ
UT WOS:000401766800010
OA No
DA 2017-08-17
ER

PT J
AU Moustafa, AA
   Tindle, R
   Ansari, Z
   Doyle, MJ
   Hewedi, DH
   Eissa, A
AF Moustafa, Ahmed A.
   Tindle, Richard
   Ansari, Zaheda
   Doyle, Margery J.
   Hewedi, Doaa H.
   Eissa, Abeer
TI Mathematics, anxiety, and the brain
SO REVIEWS IN THE NEUROSCIENCES
LA English
DT Article
DE cognition; math anxiety; math education; math learning disability;
   neural studies; parietal cortex; prefrontal cortex; working memory
ID VISUOSPATIAL WORKING-MEMORY; MATH-ANXIETY; EPISODIC BUFFER;
   LEARNING-DISABILITIES; COGNITIVE REFLECTION; PANIC DISORDER; EARLY
   IDENTIFICATION; EXECUTIVE FUNCTIONS; LANGUAGE PRODUCTION;
   GERSTMANNS-SYNDROME
AB Given that achievement in learning mathematics at school correlates with work and social achievements, it is important to understand the cognitive processes underlying abilities to learn mathematics efficiently as well as reasons underlying the occurrence of mathematics anxiety (i.e. feelings of tension and fear upon facing mathematical problems or numbers) among certain individuals. Over the last two decades, many studies have shown that learning mathematical and numerical concepts relies on many cognitive processes, including working memory, spatial skills, and linguistic abilities. In this review, we discuss the relationship between mathematical learning and cognitive processes as well as the neural substrates underlying successful mathematical learning and problem solving. More importantly, we also discuss the relationship between these cognitive processes, mathematics anxiety, and mathematics learning disabilities (dyscalculia). Our review shows that mathematical cognition relies on a complex brain network, and dysfunction to different segments of this network leads to varying manifestations of mathematical learning disabilities.
C1 [Moustafa, Ahmed A.; Tindle, Richard; Ansari, Zaheda] Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW 2751, Australia.
   [Moustafa, Ahmed A.] Western Sydney Univ, Marcs Inst Brain & Behav, Sydney, NSW 2751, Australia.
   [Doyle, Margery J.] L3 Commun Link Simulat & Training, Dayton, OH USA.
   [Hewedi, Doaa H.; Eissa, Abeer] Ain Shams Univ, Inst Psychiat, Psychogeriatr Res Ctr, Fac Med, Cairo 10021, Egypt.
RP Moustafa, AA (reprint author), Western Sydney Univ, Sch Social Sci & Psychol, Sydney, NSW 2751, Australia.; Moustafa, AA (reprint author), Western Sydney Univ, Marcs Inst Brain & Behav, Sydney, NSW 2751, Australia.
EM a.moustafa@westernsydney.edu.au
CR Acheson DJ, 2009, PSYCHOL BULL, V135, P50, DOI 10.1037/a0014411
   Alloway TP, 2010, BRIT J EDUC PSYCHOL, V80, P567, DOI 10.1348/000709910X494566
   American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   Ashcraft MH, 2007, PSYCHON B REV, V14, P243, DOI 10.3758/BF03194059
   Ashcraft MH, 2012, J EXP CHILD PSYCHOL, V111, P246, DOI 10.1016/j.jecp.2011.08.005
   Ashcraft MH, 2002, CURR DIR PSYCHOL SCI, V11, P181, DOI 10.1111/1467-8721.00196
   Ashcraft M. H., 2005, HDB MATH COGNITION, Vxvii
   Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158
   Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201
   Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187
   Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2
   Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851
   Baddeley A. D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1
   Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422
   Barbaresi WJ, 2005, AMBUL PEDIATR, V5, P281, DOI 10.1367/A04-209R.1
   Barrouillet P, 2005, J EXP CHILD PSYCHOL, V91, P183, DOI 10.1016/j.jecp.2005.03.002
   Beilock SL, 2007, J EXP PSYCHOL LEARN, V33, P983, DOI 10.1037/0278-7393.33.6.983
   Berlingeri M, 2008, BEHAV NEUROL, V19, P29
   Bhatarah P, 2009, MEM COGNITION, V37, P689, DOI 10.3758/MC.37.5.689
   Blair K, 2008, AM J PSYCHIAT, V165, P1193, DOI 10.1176/appi.ajp.2008.07071060
   Blatchford P, 1996, RES PAPERS ED, V11, P263
   Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3
   Burgess N, 1999, PSYCHOL REV, V106, P551, DOI 10.1037/0033-295X.106.3.551
   Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536
   Bynner J., 1997, EVIDENCE NATL CHILD
   Carey Emma, 2015, Front Psychol, V6, P1987, DOI 10.3389/fpsyg.2015.01987
   Carota A, 2004, EUR NEUROL, V52, P1, DOI 10.1159/000079251
   Casey BM, 2014, EARLY CHILD RES Q, V29, P636, DOI 10.1016/j.ecresq.2014.07.005
   Chein JM, 2010, J EXP PSYCHOL GEN, V139, P117, DOI 10.1037/a0018200
   Chen ZJ, 2009, Q J EXP PSYCHOL, V62, P1420, DOI 10.1080/17470210802453977
   Coluccia E, 2004, J ENVIRON PSYCHOL, V24, P329, DOI 10.1016/j.jenvp.2004.08.006
   Cowan N, 2003, PSYCHON B REV, V10, P74, DOI 10.3758/BF03196469
   Cragg L, 2014, TRENDS NEUROSCI ED, V3, P63, DOI DOI 10.1016/J.TINE.2013.12.001
   Davidse NJ, 2014, COGN NEUROPSYCHOL, V31, P221, DOI 10.1080/02643294.2013.876980
   de Hevia MD, 2008, NEUROSCI BIOBEHAV R, V32, P1361, DOI 10.1016/j.neubiorev.2008.05.015
   Dehaene S, 2001, MIND LANG, V16, P16, DOI 10.1111/1468-0017.00154
   Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970
   DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0096-3445.122.3.371
   Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6
   Delgado AR, 2004, INTELLIGENCE, V32, P25, DOI 10.1016/S0160-2896(03)00061-8
   Desoete A, 2005, BRIT J EDUC PSYCHOL, V75, P119, DOI 10.1348/000709904x22287
   DeStefano D, 2004, EUR J COGN PSYCHOL, V16, P353, DOI 10.1080/09541440244000328
   Dowker A, 2005, J LEARN DISABIL-US, V38, P324, DOI 10.1177/00222194050380040801
   Dowker A., 2012, CHILD DEV RES, V2012, P1, DOI [10.1155/2012/124939, DOI 10.1155/2012/124939]
   Dowker A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00508
   Evans KC, 2008, DEPRESS ANXIETY, V25, P496, DOI 10.1002/da.20347
   Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336
   Eysenck MW, 2005, COGNITION EMOTION, V19, P1214, DOI 10.1080/02699930500260245
   Faust M. W., 1996, MATH COGNITION, V2, P25, DOI DOI 10.1080/135467996387534
   Fiehler K, 2008, CEREB CORTEX, V18, P243, DOI 10.1093/cercor/bhm071
   Fletcher JM, 2005, J LEARN DISABIL-US, V38, P308, DOI 10.1177/00222194050380040501
   Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732
   Fuller E., 2016, 1 C INT NETW DID RES
   Galli S, 2011, LEARN INDIVID DIFFER, V21, P392, DOI 10.1016/j.lindif.2011.04.005
   Gallistel C. R., 2005, CAMBRIDGE HDB THINKI, P559
   Gathercole S. E., 2008, WORKING MEMORY COGNI, P33
   Geary DC, 2007, DEV NEUROPSYCHOL, V32, P471
   Geary D. C., 2012, J EDUC PSYCHOL, V104, P1477
   Gersten R, 2005, J LEARN DISABIL-US, V38, P293, DOI 10.1177/00222194050380040301
   Gersten R., 2008, REPORT TASK GROUP IN
   GIERL MJ, 1995, J EXP EDUC, V63, P139
   Gresham G, 2007, EARLY CHILD EDUC J, V35, P181, DOI 10.1007/s10643-007-0174-7
   Gross J., 2009, LONG TERM COSTS NUME
   Guay F, 2010, BRIT J EDUC PSYCHOL, V80, P711, DOI 10.1348/000709910X499084
   Guyer AE, 2008, ARCH GEN PSYCHIAT, V65, P1303, DOI 10.1001/archpsyc.65.11.1303
   Haase V. G., 2012, CHILD DEV RES, V2012, P1, DOI DOI 10.1155/2012/982672
   Haist F, 2015, HUM BRAIN MAPP, V36, P804, DOI 10.1002/hbm.22666
   Hale JB, 2003, J PSYCHOEDUC ASSESS, V21, P358, DOI 10.1177/073428290302100404
   Halpern D. F., 2007, SCI SEX GOOD SENSE W
   Hawes Z, 2015, TRENDS NEUROSCI EDUC, V4, P60, DOI 10.1016/j.Line.2015.05.001
   Heaton S. K., 1993, WISCONSIN CARD SORTI
   Holmes J, 2008, EUR J COGN PSYCHOL, V20, P272, DOI 10.1080/09541440701612702
   Holmes J, 2014, EDUC PSYCHOL-UK, V34, P440, DOI 10.1080/01443410.2013.797338
   Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221
   Hyun JS, 2007, PSYCHON B REV, V14, P154, DOI 10.3758/BF03194043
   Kellogg RT, 2007, ACTA PSYCHOL, V124, P382, DOI 10.1016/j.actpsy.2006.02.005
   Kimura D., 2000, J EXP PSYCHOL GEN
   Kolkman ME, 2013, LEARN INDIVID DIFFER, V24, P145, DOI 10.1016/j.lindif.2013.01.004
   Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095
   Laski EV, 2013, LEARN INDIVID DIFFER, V23, P123, DOI 10.1016/j.lindif.2012.08.001
   LeFevre JA, 2010, CHILD DEV, V81, P1753, DOI 10.1111/j.1467-8624.2010.01508.x
   Liberali JM, 2012, J BEHAV DECIS MAKING, V25, P361, DOI 10.1002/bdm.752
   LIGHT JG, 1995, J LEARN DISABIL, V28, P96
   Logie R. H., 1995, VISUO SPATIAL WORKIN, P1
   Logie RH, 2011, CURR DIR PSYCHOL SCI, V20, P240, DOI 10.1177/0963721411415340
   Lopez M. F., 1996, ED TREATMENT CHILDRE, V19, P286
   Lyons IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048076
   Lyons IM, 2012, CEREB CORTEX, V22, P2102, DOI 10.1093/cercor/bhr289
   Mattarella-Micke A, 2011, EMOTION, V11, P1000, DOI 10.1037/a0023224
   Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x
   MCCARTHY G, 1993, P NATL ACAD SCI USA, V90, P4952, DOI 10.1073/pnas.90.11.4952
   McCloskey M., 2007, WHY IS MATH SO HARD, P415
   McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97
   Menon V., 2014, HDB MATH COGNITION
   Mercer N., 2006, LANGUAGE ED, V20, P507, DOI DOI 10.2167/LE678.0
   Meyer ML, 2010, LEARN INDIVID DIFFER, V20, P101, DOI 10.1016/j.lindif.2009.08.004
   Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568
   Morsanyi K, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-31
   Moustafa AA, 2013, BRAIN COGNITION, V82, P137, DOI 10.1016/j.bandc.2013.04.001
   Neath I, 2003, HUMAN MEMORY INTRO R
   Okuyama S, 2015, SCI REP-UK, V5, DOI 10.1038/srep10059
   Osaka M, 2007, COGN AFFECT BEHAV NE, V7, P130, DOI 10.3758/CABN.7.2.130
   Passolunghi MC, 2010, EUR J COGN PSYCHOL, V22, P944, DOI 10.1080/09541440903091127
   Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085
   Pickering SJ, 2001, CORTEX, V37, P457, DOI 10.1016/S0010-9452(08)70587-2
   Pillay SS, 2007, J ANXIETY DISORD, V21, P381, DOI 10.1016/j.janxdis.2006.04.001
   Pnevmatikos D, 2013, J EXP CHILD PSYCHOL, V115, P245, DOI 10.1016/j.jecp.2013.01.010
   Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005
   Quinn JG, 2008, COGN PROCESS, V9, P35, DOI 10.1007/s10339-007-0184-9
   Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005
   Ramirez G, 2013, J COGN DEV, V14, P187, DOI 10.1080/15248372.2012.664593
   Reuhkala M, 2001, ED PSYCHOL, V21, P387, DOI DOI 10.1080/01443410120090786
   RICHARDSON FC, 1972, J COUNS PSYCHOL, V19, P551, DOI 10.1037/h0033456
   Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005
   Rudner M., 2006, COGNITIVE PROCESSING, V7, P183, DOI 10.1007/s10339-006-0141-z
   Rudner M, 2008, COGN PROCESS, V9, P19, DOI 10.1007/s10339-007-0183-x
   Rudner M, 2007, EAR HEARING, V28, P879
   Rudner M, 2007, NEUROPSYCHOLOGIA, V45, P2258, DOI 10.1016/j.neuropsychologia.2007.02.017
   Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010
   Scheepers C, 2014, Q J EXP PSYCHOL, V67, P1643, DOI 10.1080/17470218.2013.873815
   Shalev RS, 2005, DEV MED CHILD NEUROL, V47, P121, DOI 10.1017/S0012162205000216
   Silk KJ, 2014, J HEALTH COMMUN, V19, P838, DOI 10.1080/10810730.2013.837549
   Sokolowski HM, 2016, J NEUROSCI, V36, P1439, DOI 10.1523/JNEUROSCI.4039-15.2016
   Swanson HL, 2001, J EXP CHILD PSYCHOL, V79, P294, DOI 10.1006/jecp.2000.2587
   Swanson HL, 2004, J EDUC PSYCHOL, V96, P471, DOI 10.1037/0022-0663.96.3.471
   SWANSON HL, 1992, SCHOOL PSYCHOL REV, V21, P427
   Takeuchi H, 2010, REV NEUROSCIENCE, V21, P427
   Tillfors M, 2001, AM J PSYCHIAT, V158, P1220, DOI 10.1176/appi.ajp.158.8.1220
   Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1
   Tzuriel D, 2010, CHILD DEV, V81, P1417, DOI 10.1111/j.1467-8624.2010.01482.x
   Vallar G, 2007, CNS SPECTRUMS, V12, P527
   van den Heuvel OA, 2005, ARCH GEN PSYCHIAT, V62, P922, DOI 10.1001/archpsyc.62.8.922
   Verdine BN, 2014, CHILD DEV, V85, P1062, DOI [10.1111/cdev.12165, 10.1111/cdev.12179]
   Wheatley G., 1996, QUICK DRAW DEV SPAT
   White NM, 2009, BEHAV BRAIN RES, V199, P3, DOI 10.1016/j.bbr.2008.12.003
   Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558
   Wilson KM, 2001, J LEARN DISABIL-US, V34, P237, DOI 10.1177/002221940103400304
   Witt Marcus, 2011, Adv Cogn Psychol, V7, P7, DOI 10.2478/v10053-008-0083-3
   Wu SS, 2014, J LEARN DISABIL-US, V47, P503, DOI 10.1177/0022219412473154
   YACKEL E, 1991, J RES MATH EDUC, V22, P390, DOI 10.2307/749187
   Young CB, 2012, PSYCHOL SCI, V23, P492, DOI 10.1177/0956797611429134
   Zhang X, 2014, CHILD DEV, V85, P1091, DOI [10.1111/cdev.12173, 10.1111/cdev.12158]
NR 142
TC 0
Z9 0
U1 4
U2 4
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-1763
EI 1607-8470
J9 REV NEUROSCIENCE
JI Rev. Neurosci.
PD JUN
PY 2017
VL 28
IS 4
BP 417
EP 429
DI 10.1515/revneuro-2016-0065
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA EW6MD
UT WOS:000402623700007
PM 28157694
OA No
DA 2017-08-17
ER

PT J
AU Abdelsalam, DG
   Stanislas, M
AF Abdelsalam, Dahi Ghareab
   Stanislas, Michel
TI Spherical aberration measurement of a microscope objective by use of
   calibrated spherical particles
SO APPLIED OPTICS
LA English
DT Article
ID OPTICS
AB The purpose of this paper is to characterize the spherical aberration of a microscope objective lens by using diffraction light from nanosphere particles. The experimental image of the diffraction spot of a nanosphere is fitted with the Nijboer-Zernike model to estimate the spherical aberration. The method can easily be extended to the measurement of other and higher-order aberrations. Noticeable features of this new measurement technique are real-time measurements, simple structure, and flexibility, which lead it to measure optical aberrations with a good accuracy. (C) 2017 Optical Society of America
C1 [Abdelsalam, Dahi Ghareab] Natl Inst Stand, Engn & Surface Metrol Lab, Tersa Str, El Haram, El Giza, Egypt.
   [Stanislas, Michel] Univ Lille Nord France, Ecole Cent Lille, F-59655 Villeneuve Dascq, France.
RP Abdelsalam, DG (reprint author), Natl Inst Stand, Engn & Surface Metrol Lab, Tersa Str, El Haram, El Giza, Egypt.
EM dahi.abdelsalam@nis.sci.eg
CR Abdelsalam DG, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/8/084006
   Abdelsalam DG, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/8/084007
   Abdelsalam DG, 2011, OPT EXPRESS, V19, P17951, DOI 10.1364/OE.19.017951
   Booth MJ, 2007, PHILOS T R SOC A, V365, P2829, DOI 10.1098/rsta.2007.0013
   Bruckner A, 2011, J MICRO-NANOLITH MEM, V10, DOI 10.1117/1.3659144
   Dirksen P, 2002, P SOC PHOTO-OPT INS, V4691, P1392, DOI 10.1117/12.474523
   Ersoy O. K., 2007, DIFFRACTION FOURIER, P105
   GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0
   GEARY J, 1984, OPT ENG, V23, P52, DOI 10.1117/12.7973252
   GEARY JM, 1986, OPT ENG, V25, P286
   Goodwin PC, 2007, METHOD CELL BIOL, V81, P397, DOI 10.1016/S0091-679X(06)81018-6
   Huang CQ, 2002, REMOTE SENS ENVIRON, V80, P203, DOI 10.1016/S0034-4257(01)00298-X
   Juskaitis R., 2006, HDB BIOL CONFOCAL MI, P239, DOI 10.1007/978-0-387-45524-2_11
   Lentzen M, 2006, MICROSC MICROANAL, V12, P191, DOI 10.1017/S1431927606060326
   Perez J.-P., 1994, OPTIQUE GEOMETRIQUE
   PETERSON P, 1986, OPT ENG, V25, P1232, DOI 10.1117/12.7973987
   Stanislas M, 2013, APPL OPTICS, V52, P4715, DOI 10.1364/AO.52.004715
   Thibault S, 2011, OPT LETT, V36, P4770, DOI 10.1364/OL.36.004770
   Torok P, 1998, OPT COMMUN, V155, P335, DOI 10.1016/S0030-4018(98)00384-8
   Washer F.E., 1962, Journal of Research of the National Bureau of Standards, V66C, P185
   Wilcox M., 1999, MEASURE MTF OTHER PR
   WOLF E, 1951, REP PROG PHYS, V14, P95, DOI 10.1088/0034-4885/14/1/304
NR 22
TC 0
Z9 0
U1 2
U2 2
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1559-128X
EI 2155-3165
J9 APPL OPTICS
JI Appl. Optics
PD JUN 1
PY 2017
VL 56
IS 16
BP 4766
EP 4771
DI 10.1364/AO.56.004766
PG 6
WC Optics
SC Optics
GA EW5XK
UT WOS:000402579600028
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Hafez, SMN
   Rifaai, RA
   Abdelzaher, WY
AF Abdel-Hafez, Sara Mohammed Naguib
   Rifaai, Rehab Ahmed
   Abdelzaher, Walaa Yehia
TI Possible protective effect of royal jelly against cyclophosphamide
   induced prostatic damage in male albino rats; a biochemical,
   histological and immuno-histo-chemical study
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Royal jelly; Cyclophosphamide; Prostatic tissue
ID INDUCED OXIDATIVE STRESS; SMOOTH-MUSCLE-CELLS; ANTIOXIDANT PROPERTIES;
   DNA-DAMAGE; CHOLESTEROL; APOPTOSIS; TOXICITY; ACID; CARDIOMYOPATHY;
   INHIBITION
AB Almost all the chemotherapy treat many cancer types effectively, but it leads to severe side effects. Chemotherapy like cyclophosphamide (CP) not works only on the active cells, such as cancer cells, but also acts on the healthy cells. Royal jelly (RJ) was reported to have a lot of therapeutic effects besides being an anti-oxidant and anti-cancer agent. The purpose of this study was to assess the possible protective role of RJ in ameliorating the toxic effects of CP overdose in the rat prostatic tissue. The rats were separated into 4 groups; control group, RJ group, CP group and RJ with CP group. Prostatic specimens were processed for biochemical, histological and immune-histo-chemical studies. The mean area fractions of eNOS and Bax expression were measured in all groups, and statistical analysis was carried out. The results showed that in CP treated group, there were marked biological changes in the form of significant increase in prostatic malondialdehyde (MDA) and C - reactive protein (CRP). Additionally there was a significant decrease in glutathione peroxidase (GPx) in prostatic tissue if compared with the control group. Furthermore, the histological changes showed marked acinar and stromal prostatic degeneration. Most prostatic acini showed less PAS reaction and more (eNOS and Bax) expression if compared with the control group. Concomitant administration of RJ with CP revealed a noticeable amelioration of these biochemical and histological changes. In conclusion, RJ provided biochemical and histo-pathological improvement in CP induced prostatic tissue toxicity. These findings revealed that this improvement was associated with a decrease in the tissue oxidative damage and apoptosis. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Abdel-Hafez, Sara Mohammed Naguib; Rifaai, Rehab Ahmed] Menia Univ, Fac Med, Dept Histol, Al Minya, Egypt.
   [Abdelzaher, Walaa Yehia] Menia Univ, Fac Med, Dept Pharmacol, Al Minya, Egypt.
RP Abdel-Hafez, SMN (reprint author), Menia Univ, Fac Med, Dept Histol, Al Minya, Egypt.
EM sara_histology@yahoo.com; rehabrifaai@yahoo.com; walaayehia22@yahoo.com
CR Amien A. I., 2015, Journal of Basic and Applied Zoology, V72, P154, DOI 10.1016/j.jobaz.2015.09.006
   Arzi A, 2015, JUNDISHAPUR J NAT PH, V10
   Ayhanci A, 2010, BIOL TRACE ELEM RES, V136, P171, DOI 10.1007/s12011-009-8535-2
   BAKER GL, 1987, AM J MED, V83, P1, DOI 10.1016/0002-9343(87)90490-6
   Bancroft J., 2007, THEORY PRACTICE HIST, p[85, 310]
   Baran D., 2002, ASIAN J ANDROL SEP, V4, P201
   Bayer R., 1990, INT J FERTIL, V5, P70
   Bhatia AL, 2006, J MED FOOD, V9, P261, DOI 10.1089/jmf.2006.9.261
   Bohnenstengel F, 2000, CANCER CHEMOTH PHARM, V45, P63, DOI 10.1007/PL00006745
   Braida D, 2008, BIOL PSYCHIAT, V63, P286, DOI 10.1016/j.biopsych.2007.07.020
   Buege J A, 1978, Methods Enzymol, V52, P302
   Carolina A., 2010, MEDEIROS 3 EXP UROL, V25, P43
   Cavusoglu K, 2009, J MED FOOD, V12, P1286, DOI 10.1089/jmf.2008.0203
   Chen J, 2016, J HUAZHONG U SCI-MED, V36, P806, DOI 10.1007/s11596-016-1666-8
   Christina A., 2008, J BIOL, V7, P11
   Das UB, 2002, ASIAN J ANDROL, V4, P201
   Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9
   Dollery C., 1999, THERAPEUTIC DRUGS
   Drury R., 1980, CARLETON HISTOLOGICA, P279
   Elham G., 2016, INT J REPROD BIOMED, V14, P519
   Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jeb.10724
   Gesquiere L, 1999, FREE RADICAL BIO MED, V27, P134, DOI 10.1016/S0891-5849(99)00055-6
   Ghobadi E., 2016, EXPERT OPIN DRUG MET, V10, P10
   Guo H, 2008, J NUTR SCI VITAMINOL, V54, P191, DOI 10.3177/jnsv.54.191
   Hanaa A.S., 2010, J APPL BIOSCI, V29, P1736
   Hashmi S., 2012, PLOS ONE, V7
   Hassan AA., 2009, IRAQI J VET SCI, V23, P155
   Ibrahim A. A. E., 2014, Journal of Basic and Applied Zoology, V67, P140, DOI 10.1016/j.jobaz.2014.08.006
   Inoue S, 2003, EXP GERONTOL, V38, P965, DOI 10.1016/S0531-5565(03)00165-7
   Jnaneshwari S., 2012, PHARM PHARM, V65, P604
   Karadeniz A, 2011, OXID MED CELL LONGEV, DOI 10.1155/2011/981793
   Keay S, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-17
   Khan TS, 2004, MED ONCOL, V21, P167, DOI 10.1385/MO:21:2:167
   Klinger MB, 2007, AM J PHYSIOL-REG I, V293, pR677, DOI 10.1152/ajpregu.00305.2007
   Lee CK, 1996, BONE MARROW TRANSPL, V18, P573
   Li JF, 2004, EXP BIOL MED, V229, P264
   Links M, 1999, DRUGS, V57, P293, DOI 10.2165/00003495-199957030-00003
   Malekinejad H, 2016, IRAN J BASIC MED SCI, V19, P221
   McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860
   Mohammad S., 2014, BIOMED RES INT, V1, P6
   Mythili Y, 2006, EUR J PHARMACOL, V543, P92, DOI 10.1016/j.ejphar.2006.06.007
   Nagai T, 2004, FOOD CHEM, V84, P181, DOI 10.1016/S0308-8146(03)00198-5
   Napolitano J., 2002, EXPERT REV MOL MED, V9, P1
   Oboh G, 2005, LWT-FOOD SCI TECHNOL, V38, P513, DOI 10.1016/j.lwt.2004.07.007
   Oboh G, 2010, EXP TOXICOL PATHOL, V62, P227, DOI 10.1016/j.etp.2009.03.011
   Oter S, 2004, UROL RES, V32, P185, DOI 10.1007/s00240-003-0398-y
   Oyagbemi AA, 2016, INT J PREVENTIVE MED, V7, DOI 10.4103/2008-7802.177898
   Pajovic B., 2000, AGING MALE, V1, P22
   Metcalfe DD, 2003, J ALLERGY CLIN IMMUN, V111, P486, DOI DOI 10.1067/MAI.2003.120
   Rezvanfar MA, 2008, HUM EXP TOXICOL, V27, P901, DOI 10.1177/0960327108102046
   Roaiah MMF, 2007, ANDROLOGIA, V39, P185, DOI 10.1111/j.1439-0272.2007.00793.x
   Sancho M, 2014, NITRIC OXIDE-BIOL CH, V39, P8, DOI 10.1016/j.niox.2014.04.002
   Santra A, 2000, Indian J Gastroenterol, V19, P21
   Sastry KVH, 2002, ANAL BIOCHEM, V306, P79, DOI 10.1006/abio.2002.5676
   Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279
   Silici S, 2009, UROLOGY, V74, P545, DOI 10.1016/j.urology.2009.05.024
   Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721
   Stankiewicz Anna, 2002, Drug Metabolism and Drug Interactions, V19, P67
   Sundaram R., 2011, ASIAN PAC J TROP BIO, V1, P348
   Tushrendra S., 2011, INT J PHARM LIFE SCI, V2, P1035
   Tyler C.R., 2016, PART FIBRE TOXICOL J, V13
   Ueno M, 2006, BRAIN RES, V1088, P57, DOI 10.1016/j.brainres.2006.03.042
   Venkatesan N, 1998, BIOCHEM PHARMACOL, V56, P895, DOI 10.1016/S0006-2952(98)00221-4
   VITTEK J, 1995, EXPERIENTIA, V51, P927, DOI 10.1007/BF01921742
   Wang H, 2013, CURR MED CHEM, V20, P2899
NR 65
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN
PY 2017
VL 90
BP 15
EP 23
DI 10.1016/j.biopha.2017.03.020
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EW4KS
UT WOS:000402471000003
PM 28340377
OA No
DA 2017-08-17
ER

PT J
AU Rizk, MZ
   Ali, SA
   Hamed, MA
   El-Rigal, NS
   Aly, HF
   Salah, HH
AF Rizk, Maha Z.
   Ali, Sanaa A.
   Hamed, Manal A.
   El-Rigal, Nagy Saba
   Aly, Hanan F.
   Salah, Heba H.
TI Toxicity of titanium dioxide nanoparticles: Effect of dose and time on
   biochemical disturbance, oxidative stress and genotoxicity in mice
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Titanium dioxide nanoparticles; Oxidative stress; Liver function; Liver
   histology; Microsomal aberration
ID LUNG; RAT
AB The toxic impact of titanium dioxide nanoparticles (TiO(2)NPs) on human health is of prime importance owing to their wide uses in many commercial industries. In the present study, the effect of different doses and exposure time durations of TiO(2)NPs (21 nm) inducing oxidative stress, biochemical disturbance, histological alteration and cytogenetic aberration in mice liver and bone marrow was investigated. Different doses of (TiO(2)NPs) ( 50, 250 and 500 mg/kg body weight) were each daily intrapertioneally injected to mice for 7, 14 and 45 days. Aspartate and alanine aminotransferases (AST &ALT), gamma glutamyl transpeptidase (GGT), total protein, total antioxidant capacity (TAC), malondialdehyde (MDA), glutathione (GSH), catalase (CAT) and nitric oxide (NO) levels were measured. The work was extended to evaluate the liver histopathological pattern and the chromosomal aberration in mice spinal cord bone marrow. The results revealed severe TiO(2)NPs toxicity in a dose and time dependent manner with positive correlation (r = 0.98) for most investigated biochemical parameters. The same observation was noticed for the histological analysis. In case of cytogenetic study, chromosomal aberrations were demonstrated after injection of TiO(2)NPs with 500 mg/kg b. wt. for 45 days. In conclusion, the selected biochemical parameters and the liver architectures were influenced with dose and time of TiO(2)NPs toxicity, while the genetic disturbance started at the high dose of exposure and for long duration. Further studies are needed to fulfil the effect of TiO(2)NPs on pharmaceutical and nutritional applications. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Rizk, Maha Z.; Ali, Sanaa A.; Hamed, Manal A.; El-Rigal, Nagy Saba; Aly, Hanan F.] Natl Res Ctr, Therapeut Chem Dept, 33 El Bohouth St, Cairo, Egypt.
   [Salah, Heba H.] Natl Res Ctr, Genet Dept, 33 El Bohouth St, Cairo, Egypt.
   [Salah, Heba H.] Natl Res Ctr, Cytol Dept, 33 El Bohouth St, Cairo, Egypt.
RP Hamed, MA (reprint author), Natl Res Ctr, Therapeut Chem Dept, 33 El Bohouth St, Cairo, Egypt.
EM manal_hamed@yahoo.com
FU Academy of Science and Technology, Cairo, Egypt
FX The authors would like to express their deepest appreciation to the
   Academy of Science and Technology, Cairo, Egypt for financially
   supporting this work through a project entitled: Potential risks to the
   use of titanium dioxide nanoparticles.
CR Attia HF, 2013, AM J PHARM TOXICOL, V8, P141
   Banchroft J. D., 1996, THEORY PRACTICE HIST
   Bheeman D., 2014, ADV TOXICOL, V2014, P1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brown JS, 2002, AM J RESP CRIT CARE, V166, P1240, DOI 10.1164/rccm.00205-399OC
   Buege J A, 1978, Methods Enzymol, V52, P302
   Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414
   El Mahdy M. M., 2014, EXPT TOXICOLOGIC PAT, V67, P21
   Elsaesser A, 2012, ADV DRUG DELIVER REV, V64, P129, DOI 10.1016/j.addr.2011.09.001
   Fu YY, 2014, INT J MOL SCI, V15, P6961, DOI 10.3390/ijms15046961
   Hoet P. H., 2004, J NANOBIOTECHNOL, V2, P12, DOI [10.1186/1477-3155-2-12, DOI 10.1186/1477-3155-2-12]
   IARC, 2006, IARC MON EV CARC RIS, V93
   Jeon J. M., 2013, J ENVIRON BIOL, V34, P283
   Kamruzzaman S.K.M., 2007, BIOMATERIALS, V28, P710
   Kertmen H, 2013, EUR J PHARMACOL, V714, P148, DOI 10.1016/j.ejphar.2013.05.012
   Ma LL, 2010, BIOMATERIALS, V31, P99, DOI 10.1016/j.biomaterials.2009.09.028
   Ma LL, 2009, NANOSCALE RES LETT, V4, P1275, DOI 10.1007/s11671-009-9393-8
   McIntyre Robin A., 2012, Science Progress, V95, P1, DOI 10.3184/003685012X13294715456431
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   MOSHAGE H, 1995, CLIN CHEM, V41, P892
   Nohynek GJ, 2007, CRIT REV TOXICOL, V37, P251, DOI 10.1080/10408440601177780
   Okaya T, 2012, J HEPATO-BIL-PAN SCI, V19, P397, DOI 10.1007/s00534-011-0435-0
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10
   Schilling K, 2010, PHOTOCH PHOTOBIO SCI, V9, P495, DOI 10.1039/b9pp00180h
   Skocaj M, 2011, RADIOL ONCOL, V45, P227, DOI 10.2478/v10019-011-0037-0
   SZASZ G, 1969, CLIN CHEM, V15, P124
   Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001
   Wang JX, 2008, TOXICOLOGY, V254, P82, DOI 10.1016/j.tox.2008.09.014
   YOSIDA TH, 1965, CHROMOSOMA, V16, P658
   Zhou JK, 2006, BIOMATERIALS, V27, P2001, DOI 10.1016/j.biomaterials.2005.10.013
NR 31
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN
PY 2017
VL 90
BP 466
EP 472
DI 10.1016/j.biopha.2017.03.089
PG 7
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EW4KS
UT WOS:000402471000058
PM 28391168
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, H
   Abushouk, AI
   Gabr, M
   Negida, A
   Abdel-Daim, MM
AF Ahmed, Hussien
   Abushouk, Abdelrahman Ibrahim
   Gabr, Mohamed
   Negida, Ahmed
   Abdel-Daim, Mohamed M.
TI Parkinson's disease and pesticides: A meta-analysis of disease
   connection and genetic alterations
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Parkinsonism; Pesticides; Genetic alterations; Meta-analysis
ID ENVIRONMENTAL RISK-FACTORS; ALPHA-SYNUCLEIN; ALDEHYDE DEHYDROGENASE;
   OCCUPATIONAL-EXPOSURE; ORGANOPHOSPHATE EXPOSURE; DOPAMINE TRANSPORTER;
   PARAQUAT EXPOSURE; NERVE-TERMINALS; POPULATION; POLYMORPHISMS
AB Parkinson's disease (PD) is a globally prevalent, multifactorial disorder that occurs due to interactions between genetic and environmental factors. Observational studies have shown a link between exposure to pesticides and the risk of PD. We performed this study to systemically review published case-control studies and estimate quantitatively the association between pesticide exposure and PD. We searched Medline (through PubMed) for eligible case-control studies. The association between pesticide exposure and PD risk or occurrence of certain genetic alterations, related to the pathogenesis of PD was presented as odds ratios (OR) and pooled under the random effects model, using the statistical add-in (MetaXL, version 5.0). The pooled result showed that exposure to pesticides is linked to PD (OR 1.46, 95% CI [1.21, 1.77]), but there was a significant heterogeneity among included studies. Exposure to pesticides increased the risk of alterations in different PD pathogenesis-related genes, such as GST (OR 1.97, 95% CI [1.41, 2.76]), PON-1 (OR 1.32, 95% CI [1.09, 1.6]), MDR1 (OR 2.06, 95% CI [1.58, 2.68]), and SNCA genes (OR 1.28, 95% CI [1.02, 1.37]). There was no statistically significant association between exposure to pesticides and alteration of CYP2D6 (OR 1.19, 95% CI [0.91, 1.54]), SLC6A3 (OR 0.74, 95% CI [0.55, 1]), MnSOD (OR 1.45, 95% CI [0.97, 2.16]), NQO1 (OR 1.35, 95% CI [0.91, 2.01]), and PON-2 genes (OR 0.88, 95% CI [0.53, 1.45]). In conclusion, this meta-analysis provides evidence that pesticide exposure is significantly associated with the risk of PD and alterations in genes involved in PD pathogenesis. However, the underlying mechanism of this association and the effect of the duration of exposure or the type of pesticides should be addressed by future research. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Ahmed, Hussien; Abushouk, Abdelrahman Ibrahim; Gabr, Mohamed; Negida, Ahmed] Med Res Grp Egypt, Cairo, Egypt.
   [Ahmed, Hussien; Gabr, Mohamed; Negida, Ahmed] Zagazig Univ, Fac Med, Zagazig, El Sharkia, Egypt.
   [Abushouk, Abdelrahman Ibrahim] Ain Shams Univ, Fac Med, Cairo, Egypt.
   [Abushouk, Abdelrahman Ibrahim] NovaMed Med Res Assoc, Cairo, Egypt.
   [Abdel-Daim, Mohamed M.] Suez Canal Univ, Fac Vet Med, Pharmacol Dept, Ismailia 41522, Egypt.
   [Abdel-Daim, Mohamed M.] Dr DY Patil Med Coll, Pharmacol Dept, Pune, Maharashtra, India.
RP Abdel-Daim, MM (reprint author), Suez Canal Univ, Fac Vet Med, Pharmacol Dept, Ismailia 41522, Egypt.; Abdel-Daim, MM (reprint author), Dr DY Patil Med Coll, Pharmacol Dept, Pune, Maharashtra, India.
EM abdeldaim.m@vet.suez.edu.eg
OI Ahmed, Hussien/0000-0001-7101-837X
CR Abushouk AI, 2017, BIOMED PHARMACOTHER, V85, P635, DOI 10.1016/j.biopha.2016.11.074
   Abushouk AI, 2016, MED EDUC ONLINE, V21, DOI 10.3402/meo.v21.32476
   Baba M, 1998, AM J PATHOL, V152, P879
   Baldi I, 2003, NEUROEPIDEMIOLOGY, V22, P305, DOI 10.1159/000071194
   Bellou V., 2015, PARKINSONISM RELATED
   Benmoyal-Segal L, 2005, FASEB J, V19, P452, DOI 10.1096/fj.04-2106fje
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   Brighina L, 2008, NEUROLOGY, V70, P1461, DOI 10.1212/01.wnl.0000304049.31377.f2
   Campdelacreu J, 2014, NEUROLOGIA, V29, P541, DOI 10.1016/j.nrl.2012.04.001
   Chan DKY, 1998, J NEUROL NEUROSUR PS, V65, P781, DOI 10.1136/jnnp.65.5.781
   CHATURVEDI S, 1995, CAN J NEUROL SCI, V22, P232
   Checkoway H, 1999, EPIDEMIOLOGY, V10, P327, DOI 10.1097/00001648-199905000-00023
   Chin-Chan M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00124
   Cho AW, 2008, J CLIN NEUROL, V4, P23
   Chou AP, 2008, J BIOL CHEM, V283, P34696, DOI 10.1074/jbc.M802210200
   CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695
   Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006
   Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753
   Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105
   Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215
   Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003
   Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012
   Dutheil F, 2010, ARCH NEUROL-CHICAGO, V67, P739, DOI 10.1001/archneurol.2010.101
   Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x
   Duzcan F, 2003, MOVEMENT DISORD, V18, P799, DOI 10.1002/mds.10440
   Egger M, 1997, BRIT MED J, V315, P629
   Elbaz A, 2004, ANN NEUROL, V55, P430, DOI 10.1002/ana.20051
   Elbaz A, 2009, ANN NEUROL, V66, P494, DOI 10.1002/ana.21717
   Feero WG, 2010, J MED, V363, P166
   Firestone JA, 2010, AM J IND MED, V53, P217, DOI 10.1002/ajim.20788
   Fitzmaurice AG, 2014, NEUROLOGY, V82, P419, DOI 10.1212/WNL.0000000000000083
   Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110
   Fong CS, 2007, CLIN CHIM ACTA, V378, P136, DOI 10.1016/j.cca.2006.11.006
   Fong Chin-Shih, 2005, Acta Neurol Taiwan, V14, P55
   Frigerio R, 2006, MOVEMENT DISORD, V21, P1688, DOI 10.1002/mds.21009
   Furlong M, 2015, ENVIRON INT, V75, P144, DOI 10.1016/j.envint.2014.11.002
   Galanaud JP, 2005, MOVEMENT DISORD, V20, P181, DOI 10.1002/mds.20307
   Gatto NM, 2009, ENVIRON HEALTH PERSP, V117, P1912, DOI 10.1289/ehp.0900852
   Goldman SM, 2012, MOVEMENT DISORD, V27, P1652, DOI 10.1002/mds.25216
   Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040
   Gorell JM, 1998, NEUROLOGY, V50, P1346
   GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125
   Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6
   Hernandez D.G., 2016, J NEUROCHEM, V41, P1
   HERTZMAN C, 1994, MOVEMENT DISORD, V9, P69, DOI 10.1002/mds.870090111
   Hirsch L, 2016, NEUROEPIDEMIOLOGY, V46, P292, DOI 10.1159/000445751
   Hristina VD, 2010, INT J NEUROSCI, V120, P361, DOI 10.3109/00207451003668374
   HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73
   Jia ZQ, 2008, NEUROCHEM RES, V33, P790, DOI 10.1007/s11064-007-9496-5
   Kalinderi K, 2016, ACTA NEUROL SCAND, V134, P314, DOI 10.1111/ane.12563
   Kamel F, 2014, PARKINSONISM RELAT D, V20, P82, DOI 10.1016/j.parkreldis.2013.09.023
   Kanthasamy AG, 2005, NEUROTOXICOLOGY, V26, P701, DOI 10.1016/j.neuro.2004.07.010
   Kelada SNP, 2006, HUM MOL GENET, V15, P3055, DOI 10.1093/hmg/ddl247
   Kiyohara C, 2010, PARKINSONISM RELAT D, V16, P447, DOI 10.1016/j.parkreldis.2010.04.009
   Kiyohara C, 2013, DRUG METAB PHARMACOK, V28, P138, DOI 10.2133/dmpk.DMPK-12-RG-075
   Klingelhoefer L, 2015, NAT REV NEUROL, V11, P625, DOI 10.1038/nrneurol.2015.197
   Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4
   Lee PC, 2013, ENVIRON INT, V56, P42, DOI 10.1016/j.envint.2013.03.004
   Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28
   Liew Z, 2014, ARCH ENVIRON OCCUP H, V69, P241, DOI 10.1080/19338244.2013.778808
   Liou HH, 1997, NEUROLOGY, V48, P1583
   Liu XW, 2013, GENET TEST MOL BIOMA, V17, P826, DOI 10.1089/gtmb.2013.0313
   Louis ED, 2006, NEUROTOXICOLOGY, V27, P579, DOI 10.1016/j.neuro.2006.03.005
   Manthripragada AD, 2010, EPIDEMIOLOGY, V21, P87, DOI 10.1097/EDE.0b013e3181c15ec6
   Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1
   Martin CA, 2016, EXP NEUROL, V275, P232, DOI 10.1016/j.expneurol.2015.09.017
   McCann SJ, 1998, NEUROEPIDEMIOLOGY, V17, P310, DOI 10.1159/000026185
   Menegon A, 1998, LANCET, V352, P1344, DOI 10.1016/S0140-6736(98)03453-9
   Moisan F, 2015, ENVIRON HEALTH PERSP, V123, P1123, DOI 10.1289/ehp.1307970
   Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718
   Muangpaisan Weerasak, 2011, Journal of the Medical Association of Thailand, V94, P749
   Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043
   Narayan S, 2015, ENVIRON RES, V143, P98, DOI 10.1016/j.envres.2015.08.022
   Narayan S, 2013, INT J EPIDEMIOL, V42, P1476, DOI 10.1093/ije/dyt170
   Nuti A, 2004, PARKINSONISM RELAT D, V10, P481, DOI 10.1016/j.parkreldis.2004.01.008
   Paul K.C., 2015, ENV HLTH PERSPECT, V124
   Pereira D, 2010, ACTA MEDICA PORT, V23, P15
   Petersen MS, 2008, NEUROTOXICOLOGY, V29, P584, DOI 10.1016/j.neuro.2008.03.001
   Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945
   Rana AQ, 2015, EXPERT REV NEUROTHER, V15, P549, DOI 10.1586/14737175.2015.1038244
   Richardson JR, 2011, NEUROTOXICOLOGY, V32, P640, DOI 10.1016/j.neuro.2011.04.002
   Richardson JR, 2009, ARCH NEUROL-CHICAGO, V66, P870, DOI 10.1001/archneurol.2009.89
   Ritz BR, 2009, ENVIRON HEALTH PERSP, V117, P964, DOI 10.1289/ehp.0800277
   Romuk E, 2015, POSTEP HIG MED DOSW, V69, P661, DOI 10.5604/17322693.1156935
   Rugbjerg K, 2011, SCAND J WORK ENV HEA, V37, P427, DOI 10.5271/sjweh.3142
   RUHL GR, 2003, MOV DISORD 18, V18, pS71, DOI DOI 10.1002/MDS.10578
   Sanyal J, 2010, CAN J NEUROL SCI, V37, P637
   Scd J.M.W., 2010, ARCH ENVIRON OCCUP H, V60, P37
   Seidler A, 1996, NEUROLOGY, V46, P1275
   SEMCHUK KM, 1992, NEUROLOGY, V42, P1328
   Skeie GO, 2010, MOVEMENT DISORD, V25, P1847, DOI 10.1002/mds.23178
   STERN M, 1991, ARCH NEUROL-CHICAGO, V48, P903
   Stoytcheva M., 2011, PESTICIDES MODERN WO
   Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195
   Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#
   Taylor MC, 2000, J NEURAL TRANSM, V107, P979, DOI 10.1007/s007020070046
   Uversky VN, 2001, FEBS LETT, V500, P105, DOI 10.1016/S0014-5793(01)02597-2
   Van Maele-Fabry G, 2012, ENVIRON INT, V46, P30, DOI 10.1016/j.envint.2012.05.004
   Wang A, 2011, EUR J EPIDEMIOL, V26, P547, DOI 10.1007/s10654-011-9574-5
   WANG FL, 1994, J CLIN EPIDEMIOL, V47, P797, DOI 10.1016/0895-4356(94)90177-5
   Weisskopf MG, 2010, NEUROLOGY, V74, P1055, DOI 10.1212/WNL.0b013e3181d76a93
   Werneck ALD, 1999, ARQ NEURO-PSIQUIAT, V57, P347, DOI 10.1590/S0004-282X1999000300001
   Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122
   Xu SL, 2015, BIOMOLECULES, V5, P1122, DOI 10.3390/biom5021122
   Zorzon M, 2002, ACTA NEUROL SCAND, V105, P77, DOI 10.1034/j.1600-0404.2002.1o040.x
   Zschiedrich K, 2009, J NEUROL, V256, P115, DOI 10.1007/s00415-009-0089-x
NR 108
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN
PY 2017
VL 90
BP 638
EP 649
DI 10.1016/j.biopha.2017.03.100
PG 12
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EW4KS
UT WOS:000402471000077
PM 28412655
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, MM
   Hussein, MMA
AF Ahmed, Mona M.
   Hussein, Mohamed M. A.
TI Neurotoxic effects of silver nanoparticles and the protective role of
   rutin
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Silver nanoparticles; Neurotransmitters; Brain; Rutin
ID OXIDATIVE STRESS; RAT-BRAIN; IN-VITRO; ANTIOXIDANT PROPERTIES;
   PARKINSONS-DISEASE; CELL-DEATH; ACID; GLUTAMATE; EXPOSURE; MODEL
AB The toxicological studies on silver nanoparticles (Ag-NPs) have become a hot topic over the past few decades due to their unique properties on the nanoscale and widespread in many commercial products that launched into the market recently. This study was undertaken to shed light on Ag-NPs toxicity on neurotransmitters with special emphasis on the impact of concurrent administration of rutin with Ag-NPs in the experimental rats. The oral administration of Ag-NPs in rats induced brain oxidative stress, significant alterations in neurotransmitters and amino acids. Furthermore, transcriptional levels of glutamatergic N-methyl-D-aspartate (NMDA) receptors, monoamino oxidases (MAO-A, MAO-B) and metallothionein-III (MT-III) showed a significant elevation in Ag-NPs intoxicated rats. Moreover, histological examinations revealed astrogliosis and demyelination of neurons concomitant with neuronal degeneration and vacuolation. Strikingly, oral administration of rutin counterbalanced the toxic effects triggered by Ag-NPs. Taken together, our findings suggested that oral administration of Ag-NPs induced neurotoxicity in rats and rutin mitigates these effects. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Ahmed, Mona M.] Zagazig Univ, Fac Vet Med, Dept Forens Med & Toxicol, Zagazig 44519, Egypt.
   [Hussein, Mohamed M. A.] Zagazig Univ, Fac Vet Med, Dept Biochem, Zagazig 44519, Egypt.
RP Hussein, MMA (reprint author), Zagazig Univ, Fac Vet Med, Dept Biochem, Zagazig 44519, Egypt.
EM hamza_vet@yahoo.com
FU Faculty of Veterinary Medicine, Zagazig University, Egypt
FX This work was supported by the Faculty of Veterinary Medicine, Zagazig
   University, Egypt. The authors thank Dr. Mohamed Metwally, assistant
   professor of pathology, Faculty of Veterinary Medicine, Zagazig
   University for his support in histopathological examination.
CR ALBIN RL, 1992, NEUROLOGY, V42, P733
   Bernacki J, 2008, PHARMACOL REP, V60, P600
   Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3
   BEUTLER E, 1969, J CLIN INVEST, V48, P1957, DOI 10.1172/JCI106162
   Bishnoi M, 2007, FUND CLIN PHARMACOL, V21, P521, DOI 10.1111/j.1472-8206.2007.00512.x
   Borisova T, 2015, INT J BIOCHEM CELL B, V59, P203, DOI 10.1016/j.biocel.2014.11.016
   Capra JC, 2010, EUR J PHARMACOL, V643, P232, DOI 10.1016/j.ejphar.2010.06.043
   Costa C, 2010, MOL CELL BIOCHEM, V342, P51, DOI 10.1007/s11010-010-0467-9
   Cushen M, 2014, J AGR FOOD CHEM, V62, P1403, DOI 10.1021/jf404038y
   Dziendzikowska K, 2012, J APPL TOXICOL, V32, P920, DOI 10.1002/jat.2758
   El Mahdy MM, 2015, EXP TOXICOL PATHOL, V67, P21, DOI 10.1016/j.etp.2014.09.005
   Entschladen F, 2002, CANCER IMMUNOL IMMUN, V51, P467, DOI 10.1007/s00262-002-0300-8
   Fedorovich SV, 2010, BIOCHEM SOC T, V38, P536, DOI 10.1042/BST0380536
   Hadrup N, 2012, NEUROTOXICOLOGY, V33, P416, DOI 10.1016/j.neuro.2012.04.008
   Hussein MMA, 2015, PESTIC BIOCHEM PHYS, V119, P28, DOI 10.1016/j.pestbp.2015.02.010
   Javed H, 2012, NEUROSCIENCE, V210, P340, DOI 10.1016/j.neuroscience.2012.02.046
   Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026
   Kim YS, 2008, INHAL TOXICOL, V20, P575, DOI 10.1080/08958370701874663 
   Klein S, 2013, BIOCHEM BIOPH RES CO, V434, P217, DOI 10.1016/j.bbrc.2013.03.042
   Koda T, 2008, NUTR RES, V28, P629, DOI 10.1016/j.nutres.2008.06.004
   La Casa C, 2000, J ETHNOPHARMACOL, V71, P45, DOI 10.1016/S0378-8741(99)00174-9
   Lavoie J, 2014, BIOL PSYCHIAT, V75, P479, DOI 10.1016/j.biopsych.2012.11.024
   Lee MH, 2001, J AGR FOOD CHEM, V49, P5551, DOI 10.1021/jf010622j
   Liu Y, 2012, TOXICOL LETT, V209, P227, DOI 10.1016/j.toxlet.2012.01.001
   Liu ZW, 2012, NANOTOXICOLOGY, V6, P414, DOI 10.3109/17435390.2011.583996
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Magalingam KB, 2015, J MOL NEUROSCI, V55, P609, DOI 10.1007/s12031-014-0400-x
   Mandel S, 2003, CNS DRUGS, V17, P729, DOI 10.2165/00023210-200317100-00004
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   MOORE S, 1958, FED PROC, V17, P1107
   Moustafa GG, 2016, BIOMED PHARMACOTHER, V84, P687, DOI 10.1016/j.biopha.2016.09.092
   NAIR V, 1984, LIPIDS, V19, P804, DOI 10.1007/BF02534475
   Nakamura Y, 2000, J HEALTH SCI, V46, P229
   Nakayama M, 2011, MOL VIS, V17, P1784
   NEGRESALVAYRE A, 1991, PHARMACOLOGY, V42, P262, DOI 10.1159/000138807
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Panieri E, 2013, FREE RADICAL BIO MED, V57, P176, DOI 10.1016/j.freeradbiomed.2012.12.024
   Panyala NR, 2008, J APPL BIOMED, V6, P117
   Park SE, 2014, NEUROCHEM RES, V39, P707, DOI 10.1007/s11064-014-1259-5
   Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923
   Rahman MF, 2009, TOXICOL LETT, V187, P15, DOI 10.1016/j.toxlet.2009.01.020
   Ramalingayya GV, 2016, PHARMACOGN MAG, V12, pS63, DOI 10.4103/0973-1296.176104
   Reisman SA, 2009, BIOCHEM PHARMACOL, V77, P1273, DOI 10.1016/j.bcp.2008.12.028
   Safari M., 2016, NANOMED J, V3, P83
   Sanpui P, 2011, ACS APPL MATER INTER, V3, P218, DOI 10.1021/am100840c
   Sharma HS, 2013, AMINO ACIDS, V45, P1055, DOI 10.1007/s00726-013-1584-z
   SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7
   Skalska J, 2015, NEUROTOXICOLOGY, V46, P145, DOI 10.1016/j.neuro.2014.11.002
   Sofic E., 2010, Medicinal Plants, V2, P97
   Vasak M, 2011, J BIOL INORG CHEM, V16, P1067, DOI 10.1007/s00775-011-0799-2
   Waseem TV, 2008, NEUROCHEM RES, V33, P1316, DOI 10.1007/s11064-007-9585-5
   Wilson I., 2008, THEORY PRACTICE HIST, P125
   Win-Shwe TT, 2011, INT J MOL SCI, V12, P6267, DOI 10.3390/ijms12096267
   Xu FL, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-29
   Xu LM, 2015, INT J NANOMED, V10, P6105, DOI 10.2147/IJN.S85265
   Zatta P, 1999, NEUROREPORT, V10, P3645, DOI 10.1097/00001756-199911260-00033
   Zieminska E, 2016, NEUROTOX RES, V29, P325, DOI 10.1007/s12640-015-9583-3
   Zieminska E, 2014, TOXICOLOGY, V315, P38, DOI 10.1016/j.tox.2013.11.008
NR 60
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN
PY 2017
VL 90
BP 731
EP 739
DI 10.1016/j.biopha.2017.04.026
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EW4KS
UT WOS:000402471000089
PM 28419969
OA No
DA 2017-08-17
ER

PT J
AU Hussein, J
   El-Banna, M
   Mahmoud, KF
   Morsy, S
   Latif, YA
   Medhat, D
   Refaat, E
   Farrag, AR
   El-Daly, SM
AF Hussein, Jihan
   El-Banna, Mona
   Mahmoud, Khaled F.
   Morsy, Safaa
   Latif, Yasmin Abdel
   Medhat, Dalia
   Refaat, Eman
   Farrag, Abdel Razik
   El-Daly, Sherien M.
TI The therapeutic effect of nano-encapsulated and nano-emulsion forms of
   carvacrol on experimental liver fibrosis
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Liver fibrosis; Carvacrol; Nano-encapsulation; Nano-emulsion;
   Inflammation; Oxidative stress; Apoptosis
ID MONOCYTE CHEMOATTRACTANT PROTEIN-1; DIFFERENT MACROPHAGE POPULATIONS;
   OXIDATIVE STRESS; INDUCED HEPATOTOXICITY; ANTIMICROBIAL ACTIVITY;
   HEPATIC-FIBROSIS; INJURY; RATS; OIL; INGREDIENTS
AB Objective: The present study aimed to compare the therapeutic efficiency of nano-encapsulated and nano-emulsion carvacrol administration on liver injury in thioacetamide (TAA) treated rats.
   Methods: To fulfill our target, we used sixty male albino rats classified into six groups as follow: control, nano-encapsulated carvacrol, nano-emulsion carvacrol, thioacetamide, treated nano-encapsulated carvacrol and treated nano-emulsion carvacrol groups. Blood samples were collected from all groups and the separated serum was used for analysis of the following biochemical parameters; aspartate aminotransferase (AST), alanine aminotransferase (ALT), S100 B protein, alpha fetoprotein (AFP) and caspase-3. The levels of malondialdehyde (MDA), reduced glutathione (GSH), nitric oxide (NO), monocyte chemoattractant protein-1(MCP-1) and hydroxyproline content were all evaluated in liver tissue homogenate. Histopathological examinations for liver tissues were also performed.
   Results: Thioacetamide induced hepatic damage in rats as revealed by the significant increase in the levels of serum ALT, AST and produced oxidative stress as displayed by the significant elevation in the levels of hepatic MDA and NO concomitant with a significant decrease in GSH. In addition, thioacetamide significantly increased serum S100B protein, alpha fetoprotein and caspase-3 along with hepatic MCP-1 and hydroxyproline; these results were confirmed by the histopathological investigation. In contrast, nano-encapsulated and nano-emulsion carvacrol were able to ameliorate these negative changes in the thioacetamide injected rats. However, the effect of the nano-encapsulated form of carvacrol was more prominent than the nano-emulsion form.
   Conclusion: Nano-encapsulated and nano-emulsion carvacrol can ameliorate thioacetamide induced liver injury. These results could be attributed to the potential anti-inflammatory, antioxidant, and antiapoptotic activities of carvacrol in addition to the effectiveness of the encapsulation technique that can protect carvacrol structure and increase its efficiency and stability. Moreover, nano-encapsulation of carvacrol is more efficient than nano-emulsion. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Hussein, Jihan; El-Banna, Mona; Morsy, Safaa; Latif, Yasmin Abdel; Medhat, Dalia; Refaat, Eman; El-Daly, Sherien M.] Natl Res Ctr, Med Div, Med Biochem Dept, 33 El Buhouth St Dokki, Giza 12622, Egypt.
   [Mahmoud, Khaled F.] NRC, Technol Dept, Giza, Egypt.
   [Farrag, Abdel Razik] Natl Res Ctr, Pathol Dept, Giza, Egypt.
RP El-Daly, SM (reprint author), Natl Res Ctr, Med Div, Med Biochem Dept, 33 El Buhouth St Dokki, Giza 12622, Egypt.
EM sm.el-daly@nrc.sci.eg
OI El-Bana, Mona A./0000-0002-5502-913X; El-Daly,
   Sherien/0000-0003-0049-8606; F. Mahmoud, Khaled/0000-0001-7684-1605
CR Abdollahi M, 2012, J FOOD ENG, V111, P343, DOI 10.1016/j.jfoodeng.2012.02.012
   Aram G, 2009, HEPATOLOGY, V49, P911, DOI 10.1002/hep.22708
   Aristatile B, 2009, FUND CLIN PHARMACOL, V23, P757, DOI 10.1111/j.1472-8206.2009.00721.x
   Augustin MA, 2009, CHEM SOC REV, V38, P902, DOI 10.1039/b801739p
   Bancroft J. B., 2002, THEORY PRACTICE HIST
   Bilia AR, 2014, EVID-BASED COMPL ALT, DOI 10.1155/2014/651593
   Chakraborty J.B., 2012, INT J HEPATOL
   Chen SR, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0036-y
   DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z
   De Bleser PJ, 1999, J BIOL CHEM, V274, P33881, DOI 10.1074/jbc.274.48.33881
   Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027
   El-khayat Z., 2013, INT J PHARM PHARM SC, V5, P196
   Gao F, 1997, PERFUSION-UK, V12, P163, DOI 10.1177/026765919701200303
   Hirai H., 1982, BIOCHEMICAL MARKERS, P23
   Huang QR, 2010, J FOOD SCI, V75, pR50, DOI 10.1111/j.1750-3841.2009.01457.x
   Ide M, 2003, J COMP PATHOL, V128, P41, DOI 10.1053/jcpa.2002.0603
   Jayakumar S, 2012, MOL CELL BIOCHEM, V360, P51, DOI 10.1007/s11010-011-1043-7
   Keawchaoon L, 2011, COLLOID SURFACE B, V84, P163, DOI 10.1016/j.colsurfb.2010.12.031
   Kilic Y, 2016, CYTOTECHNOLOGY, V68, P1243, DOI 10.1007/s10616-015-9885-6
   Kim E, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/290104
   Li XN, 2002, J HEPATOL, V36, P488, DOI 10.1016/S0168-8278(02)00011-9
   Liang R, 2012, J AGR FOOD CHEM, V60, P7548, DOI 10.1021/jf301129k
   Lima MD, 2013, EUR J PHARMACOL, V699, P112, DOI 10.1016/j.ejphar.2012.11.040
   Liu YR, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-145
   Magi G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00165
   Mahmoud K.F., 2014, IJFST, V4, P1
   Maletzki C, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7240
   Mannaa F, 2005, PHARMAZIE, V60, P689
   Moretti M. D. L., 2002, AAPS PHARMSCITECH, V3, P13
   Mori Y, 2009, TOXICOL PATHOL, V37, P463, DOI 10.1177/0192623309335634
   Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001
   MOSHAGE H, 1995, CLIN CHEM, V41, P892
   Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299
   Nafees S, 2013, HUM EXP TOXICOL, V32, P1292, DOI 10.1177/0960327113499047
   Nakano H, 1998, TRANSPLANT P, V30, P3735, DOI 10.1016/S0041-1345(98)01215-9
   NAVARRO MC, 1993, PLANTA MED, V59, P312, DOI 10.1055/s-2006-959688
   Patiyal SN, 2006, PHYSIOL RES, V55, P97
   Pinzani M, 2008, NAT CLIN PRACT GASTR, V5, P95, DOI 10.1038/ncpgasthep1025
   Pustylnyak VO, 2011, BRAIN RES, V1394, P33, DOI 10.1016/j.brainres.2011.04.025
   RAJU SBG, 2012, INT J PHARM SCI, V4, P494
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Rubilar JF, 2013, J FOOD ENG, V115, P466, DOI 10.1016/j.jfoodeng.2012.07.009
   Sakai N, 2006, J LEUKOCYTE BIOL, V79, P555, DOI 10.1189/jlb.0305127
   Salam O.M Abdel, 2013, EUR REV MED PHARMACO, V7, P735
   Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014
   Siegmund SV, 2005, ALCOHOL CLIN EXP RES, V29, p102S, DOI 10.1097/01.alc.0000189275.97419.58
   Soliman E. A., 2013, J ENCAPSULATION ADSO, V3, P48, DOI DOI 10.4236/JEAS.2013.31006
   Subramaniyan J, 2014, MOL CELL BIOCHEM, V395, P65, DOI 10.1007/s11010-014-2112-5
   Terjung N, 2012, FOOD FUNCT, V3, P290, DOI 10.1039/c2fo10198j
   Tolve R, 2016, INT J FOOD SCI NUTR, V67, P888, DOI 10.1080/09637486.2016.1205552
   Ultee A, 2000, J FOOD PROTECT, V63, P620
   Watanabe M, 2001, J SURG RES, V101, P146, DOI 10.1006/jsre.2001.6251
   Yeh CN, 2004, CARCINOGENESIS, V25, P631, DOI 10.1093/carcin/bgh037
   Zamara E, 2007, J HEPATOL, V46, P230, DOI 10.1016/j.jhep.2006.09.007
NR 54
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN
PY 2017
VL 90
BP 880
EP 887
DI 10.1016/j.biopha.2017.04.020
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EW4KS
UT WOS:000402471000105
PM 28437891
OA No
DA 2017-08-17
ER

PT J
AU Abushouk, AI
   Ismail, A
   Salem, AMA
   Afifi, AM
   Abdel-Daim, MM
AF Abushouk, Abdelrahman Ibrahim
   Ismail, Ammar
   Salem, Amr Muhammad Abdo
   Afifi, Ahmed M.
   Abdel-Daim, Mohamed M.
TI Cardioprotective mechanisms of phytochemicals against
   doxorubicin-induced cardiotoxicity
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review
DE Cardioprotection; Doxorubicin; Phytochemicals; Toxicity
ID ADRIAMYCIN-INDUCED CARDIOTOXICITY; INDUCED OXIDATIVE STRESS; INDUCED
   CARDIAC TOXICITY; CONGESTIVE-HEART-FAILURE; BARBADENSIS MILLER GEL; AGED
   GARLIC EXTRACT; TUMOR-BEARING MICE; IN-VITRO; RAT CARDIOMYOCYTES;
   INDUCED APOPTOSIS
AB Doxorubicin (DOX) is an anthracycline antibiotic, which is effectively used in the treatment of different malignancies, such as leukemias and lymphomas. Its most serious side effect is dose-dependent cardiotoxicity, which occurs through inducing oxidative stress apoptosis. Due to the myelosuppressive effect of dexrazoxane, a commonly-used drug to alleviate DOX-induced cardiotoxicity, researchers investigated the potential of phytochemicals for prophylaxis and treatment of this condition. Phytochemicals are plant chemicals that have protective or disease preventive properties. Preclinical trials have shown antioxidant properties for several plant extracts, such as those of Aerva lanata, Aronia melanocarpa, Astragalus polysaccharide, and Bombyx mori plants. Other plant extracts showed an ability to inhibit apoptosis, such as those of Astragalus polysaccharide, Azadirachta indica, Bombyx mori, and Allium stavium plants. Unlike synthetic agents, phytochemicals do not impair the clinical activity of DOX and they are particularly safe for long-term use. In this review, we summarized the results of preclinical trials that investigated the cardioprotective effects of phytochemicals against DOX-induced cardiotoxicity. Future human trials are required to translate these cardioprotective mechanisms into practical clinical implications. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Abushouk, Abdelrahman Ibrahim; Salem, Amr Muhammad Abdo; Afifi, Ahmed M.] Ain Shams Univ, Fac Med, Cairo, Egypt.
   [Abushouk, Abdelrahman Ibrahim; Ismail, Ammar; Salem, Amr Muhammad Abdo] NovaMed Med Res Assoc, Cairo, Egypt.
   [Ismail, Ammar] Al Azhar Univ, Fac Med, Cairo, Egypt.
   [Abdel-Daim, Mohamed M.] Suez Canal Univ, Pharmacol Dept, Fac Vet Med, Ismailia 41522, Egypt.
   [Abdel-Daim, Mohamed M.] Dr DY Patil Med Coll, Pharmacol Dept, Pune, Maharashtra, India.
RP Abdel-Daim, MM (reprint author), Suez Canal Univ, Pharmacol Dept, Fac Vet Med, Ismailia 41522, Egypt.; Abdel-Daim, MM (reprint author), Dr DY Patil Med Coll, Pharmacol Dept, Pune, Maharashtra, India.
EM abdeldaim.m@vet.suez.edu.eg
OI Ismail, Ammar/0000-0001-7024-1537
CR Abdel-Wahab MH, 2003, PHARMACOL RES, V48, P461, DOI 10.1016/S1043-6618(03)00214-7
   AbdelAleem S, 1997, J MOL CELL CARDIOL, V29, P789, DOI 10.1006/jmcc.1996.0323
   Abushouk AI, 2017, BIOMED PHARMACOTHER, V85, P635, DOI 10.1016/j.biopha.2016.11.074
   Adwas AA, 2016, J INFECT CHEMOTHER, V22, P36, DOI 10.1016/j.jiac.2015.10.001
   Agha AM, 2001, J EXP CLIN CANC RES, V20, P39
   Akbas Halide S, 2006, Expert Rev Clin Immunol, V2, P931, DOI 10.1586/1744666X.2.6.931
   Al-Shabanah OA, 1998, J EXP CLIN CANC RES, V17, P193
   Alkreathy H, 2010, FOOD CHEM TOXICOL, V48, P951, DOI 10.1016/j.fct.2010.01.005
   Alkreathy HM, 2012, INTEGR CANCER THER, V11, P364, DOI 10.1177/1534735411426726
   Alpsoy S, 2013, J APPL TOXICOL, V33, P202, DOI 10.1002/jat.1738
   Andreadou I, 2007, J MOL CELL CARDIOL, V42, P549, DOI 10.1016/j.yjmcc.2006.11.016
   Andrieu-Abadie N, 1999, FASEB J, V13, P1501
   Aniss HA, 2014, REDOX REP, V19, P170, DOI 10.1179/1351000214Y.0000000088
   Arafa Hossam M, 2005, J Egypt Natl Canc Inst, V17, P291
   Arafa MH, 2014, J PHYSIOL BIOCHEM, V70, P701, DOI 10.1007/s13105-014-0339-y
   ARCAMONE F, 1969, BIOTECHNOL BIOENG, V11, P1101, DOI 10.1002/bit.260110607
   Arozal W, 2015, DRUG RES, V65, P574, DOI 10.1055/s-0034-1394457
   Ashour OM, 2012, Z NATURFORSCH C, V67, P297, DOI 10.5560/ZNC.2012.67c0297
   Ashour OM, 2011, MED SCI MONITOR, V17, pBR110
   Barman NR, 2013, CHIN J NAT MEDICINES, V11, P38
   Barry E, 2007, EXPERT OPIN PHARMACO, V8, P1039, DOI 10.1517/14656566.8.8.1039
   Bernard Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025302
   Bernstein D, 2005, AM J PHYSIOL-HEART C, V289, pH2441, DOI 10.1152/ajpheart.00005.2005
   Breitbart E, 2001, HUM EXP TOXICOL, V20, P337, DOI 10.1191/096032701680350604
   Cao Y., 2014, OXID MED CELL LONGEV, V2014, DOI [10.1155/2014/674219, DOI 10.1155/2014/674219]
   Carvalho C, 2009, CURR MED CHEM, V16, P3267
   Chahine N, 2014, Z NATURFORSCH C, V69, P459, DOI [10.5560/znc.2014-0124, 10.5560/ZNC.2014-0124]
   Chahine N, 2013, PHARM BIOL, V51, P1564, DOI 10.3109/13880209.2013.802812
   Chang WT, 2011, J CELL BIOCHEM, V112, P2873, DOI 10.1002/jcb.23201
   Chatterjee K, 2008, BIOCHEM BIOPH RES CO, V373, P555, DOI 10.1016/j.bbrc.2008.06.067
   Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166
   Chen B, 2007, CARDIOVASC TOXICOL, V7, P114, DOI 10.1007/s12012-007-0005-5
   Chen CT, 2015, NUTRIENTS, V7, P4938, DOI 10.3390/nu7064938
   Chen R.C., 2015, ALTERN MED ECAM, V2015
   Chennuru A, 2013, BIOMED RES INT, DOI 10.1155/2013/934239
   Chlopcikova A, 2004, PHYTOTHER RES, V18, P107, DOI 10.1002/ptr.1415
   Chlopcikova S, 2004, PHYTOTHER RES, V18, P408, DOI 10.1002/ptr.1461
   Choi EH, 2008, GENES NUTR, V2, P337, DOI 10.1007/s12263-007-0073-y
   Choi HJ, 2008, EXP BIOL MED, V233, P1554, DOI 10.3181/0807-RM-221
   Chularojmontri L, 2005, BIOL PHARM BULL, V28, P1165, DOI 10.1248/bpb.28.1165
   Dai CL, 2007, CANCER CHEMOTH PHARM, V60, P741, DOI 10.1007/s00280-007-0420-0
   Demirkaya E, 2009, CAN J PHYSIOL PHARM, V87, P633, DOI [10.1139/y09-051, 10.1139/Y09-051]
   DOROSHOW JH, 1983, CANCER RES, V43, P460
   Dutta D, 2014, FREE RADICAL BIO MED, V74, P252, DOI 10.1016/j.freeradbiomed.2014.06.011
   El Hassan M. A. I. Abou, 2003, British Journal of Cancer, V89, P357
   El-Bakly WM, 2012, CANCER CHEMOTH PHARM, V70, P833, DOI 10.1007/s00280-012-1975-y
   El-Boghdady NA, 2013, INDIAN J BIOCHEM BIO, V50, P202
   Elberry AA, 2010, FOOD CHEM TOXICOL, V48, P1178, DOI 10.1016/j.fct.2010.02.008
   Fard M. H., 2008, IJP - International Journal of Pharmacology, V4, P466
   Fard MH, 2011, PHARM BIOL, V49, P377, DOI 10.3109/13880209.2010.517758
   Fouad AA, 2013, ENVIRON TOXICOL PHAR, V36, P347, DOI 10.1016/j.etap.2013.04.018
   Fouad AA, 2011, ARCH PHARM RES, V34, P821, DOI 10.1007/s12272-011-0516-2
   Ghibu S, 2012, BIOCHIMIE, V94, P932, DOI 10.1016/j.biochi.2011.02.015
   Gnanapragasam A, 2007, MOL CELL BIOCHEM, V294, P55, DOI 10.1007/s11010-006-9245-0
   Granados-Principal S, 2014, BIOCHEM PHARMACOL, V90, P25, DOI 10.1016/j.bcp.2014.04.001
   Hamza A, 2008, CELL BIOL TOXICOL, V24, P63, DOI 10.1007/s10565-007-9016-z
   Han XZ, 2008, FOOD CHEM TOXICOL, V46, P3140, DOI 10.1016/j.fct.2008.06.086
   Han XZ, 2012, BIOSCI TRENDS, V6, P19, DOI 10.5582/bst.2012.v6.1.19
   Hao EK, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00261
   Hao G, 2015, XENOBIOTICA, V45, P1024, DOI 10.3109/00498254.2015.1034223
   Indu R, 2014, J CANCER RES THER, V10, P62, DOI 10.4103/0973-1482.131370
   Ishibashi Y, 2008, J CARD FAIL, V14, P724, DOI 10.1016/j.cardfail.2008.06.450
   Jagetia GC, 2005, PHYTOTHER RES, V19, P772, DOI 10.1002/ptr.1713
   Janeesh PA, 2014, BIOMED PHARMACOTHER, V68, P989, DOI 10.1016/j.biopha.2014.09.010
   Jiang B, 2008, FOOD CHEM TOXICOL, V46, P1510, DOI 10.1016/j.fct.2007.12.020
   Kaithwas G, 2014, DRUG CHEM TOXICOL, V37, P135, DOI 10.3109/01480545.2013.834350
   Kaithwas G, 2011, INDIAN J EXP BIOL, V49, P260
   Kang YJ, 2006, TOXICOL PATHOL, V34, P58, DOI 10.1080/01926230500419421
   Karimi G, 2005, PHYTOTHER RES, V19, P912, DOI 10.1002/ptr.1746
   Khan G, 2014, ACTA POL PHARM, V71, P861
   Khan M, 2006, J CARDIOVASC PHARM, V47, P9, DOI 10.1097/01.fjc.0000191520.48404.27
   Khan MS, 2014, EXCLI J, V13, P1043
   Khedr NF, 2015, TUMOR BIOL, V36, P9267, DOI 10.1007/s13277-015-3655-0
   Kim DS, 2007, LIFE SCI, V80, P314, DOI 10.1016/j.lfs.2006.09.019
   Kim DS, 2006, EUR J PHARMACOL, V541, P24, DOI 10.1016/j.ejphar.2006.04.045
   Kim SY, 2006, EXP MOL MED, V38, P535
   Kok LDS, 2000, LIFE SCI, V67, P91, DOI 10.1016/S0024-3205(00)00605-6
   Komolafe K., 2013, International Journal of Applied Research in Natural Products, V6, P39
   Koti BC, 2009, INDIAN J EXP BIOL, V47, P41
   Koti BC, 2013, PHARMACOGN MAG, V9, P176, DOI 10.4103/0973-1296.111287
   Koul A, 2014, INDIAN J EXP BIOL, V52, P323
   Kumral Alkin, 2015, Pathophysiology, V22, P117, DOI 10.1016/j.pathophys.2015.04.002
   KURABAYASHI M, 1994, J BIOL CHEM, V269, P6031
   LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2
   Li B, 2015, INT J MOL MED, V36, P53, DOI 10.3892/ijmm.2015.2199
   Li M, 2015, MOLECULES, V20, P15192, DOI 10.3390/molecules200815192
   Li W, 2009, BASIC CLIN PHARMACOL, V104, P192, DOI 10.1111/j.1742-7843.2008.00358.x
   Li WJ, 2010, J AGR FOOD CHEM, V58, P8977, DOI 10.1021/jf101277t
   LIN TJ, 1992, FREE RADICAL BIO MED, V12, P347, DOI 10.1016/0891-5849(92)90083-S
   Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093
   Liu L, 2008, PLANTA MED, V74, P203, DOI 10.1055/s-2008-1034303
   Liu Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010189
   Liu Z, 2009, CHINESE MED J-PEKING, V122, P2652, DOI 10.3760/cma.j.issn.0366-6999.2009.21.024
   Lv XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047351
   Mahesh BU, 2013, ENVIRON TOXICOL PHAR, V36, P840, DOI 10.1016/j.etap.2013.07.016
   Mahsa Zarei, 2013, Der Pharmacia Lettre, V5, P334
   Mandziuk S, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.29754
   Mantawy EM, 2014, EUR J PHARMACOL, V728, P107, DOI 10.1016/j.ejphar.2014.01.065
   Meadowcroft AM, 1998, AM J HEALTH-SYST PH, V55, P1898
   MIMNAUGH EG, 1985, BIOCHEM PHARMACOL, V34, P847, DOI 10.1016/0006-2952(85)90766-X
   Minotti G, 1996, J CLIN INVEST, V98, P650, DOI 10.1172/JCI118836
   Miranda-Vilela AL, 2014, J NUTR BIOCHEM, V25, P1161, DOI 10.1016/j.jnutbio.2014.06.005
   Miranda-Vilela AL, 2011, J NUTR BIOCHEM, V22, P1091, DOI 10.1016/j.jnutbio.2010.09.009
   Mohamad RH, 2009, J MED FOOD, V12, P394, DOI 10.1089/jmf.2007.0715
   Mohan M, 2010, FOOD CHEM TOXICOL, V48, P436, DOI 10.1016/j.fct.2009.10.042
   Mokni M, 2012, CARDIOVASC TOXICOL, V12, P158, DOI 10.1007/s12012-012-9155-1
   Momin Firoz, 2011, PHARMACOLOGYONLINE, V3, P1145
   MONTI E, 1995, ANTICANCER RES, V15, P193
   Moss RW, 2006, INTEGR CANCER THER, V5, P63, DOI 10.1177/1534735405285882
   Mukherjee Sumanta, 2003, BMC Pharmacology, V3, P16, DOI 10.1186/1471-2210-3-16
   Myers C, 1998, SEMIN ONCOL, V25, P10
   Nagai K., 2013, Biomedicine & Preventive Nutrition, V3, P197
   Nagi MN, 2000, PHARMACOL RES, V41, P283, DOI 10.1006/phrs.1999.0585
   Nazmi AS, 2011, TOXICOL MECH METHOD, V21, P41, DOI 10.3109/15376516.2010.529188
   Ojha S., 2016, OXID MED CELL LONGEV, V2016
   Palani S, 2012, TOXICOL ENVIRON CHEM, V94, P1014, DOI 10.1080/02772248.2012.678996
   Panda S, 2009, CARDIOVASC THER, V27, P108, DOI 10.1111/j.1755-5922.2009.00078.x
   Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43
   Patel SS, 2011, REV BRAS FARMACOGN, V21, P704, DOI 10.1590/S0102-695X2011005000090
   Pavlova V., 2014, Bulgarian Journal of Agricultural Science, V20, P188
   Psotova J, 2005, FITOTERAPIA, V76, P556, DOI 10.1016/j.fitote.2005.04.019
   Putri Herwandhani, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P371, DOI 10.1016/S2221-1691(13)60079-9
   Ragavendran Paramasivam, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS212
   Raskovic A, 2011, MOLECULES, V16, P8601, DOI 10.3390/molecules16108601
   Sakthivel K., 2013, Journal of Biological Sciences, V13, P313, DOI 10.3923/jbs.2013.313.322
   Schildknecht S, 2011, J BIOL CHEM, V286, P4991, DOI 10.1074/jbc.M110.169565
   SEIFERT CF, 1994, ANN PHARMACOTHER, V28, P1063
   Shah S.A., 2009, IRANIAN J PHARM THER, V8, P61
   Shah S, 2013, NAT PROD RES, V27, P1502, DOI 10.1080/14786419.2012.724409
   SINGAL PK, 1984, RES COMMUN CHEM PATH, V43, P67
   Singh G, 2008, J ETHNOPHARMACOL, V117, P123, DOI 10.1016/j.jep.2008.01.022
   Singh MK, 2012, INT J DRUG DEV RES, V4, P298
   Singh P, 2015, FREE RADICAL BIO MED, V86, P90, DOI 10.1016/j.freeradbiomed.2015.05.028
   Su SW, 2014, TOXICOL LETT, V224, P257, DOI 10.1016/j.toxlet.2013.10.034
   Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064526
   Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407
   Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x
   Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002
   THAYER WS, 1985, LIFE SCI, V36, P635, DOI 10.1016/0024-3205(85)90167-5
   TONG J, 1991, AM J PHYSIOL, V260, pH909
   Trivedi PP, 2011, CARDIOVASC TOXICOL, V11, P215, DOI 10.1007/s12012-011-9114-2
   Troyano A, 2001, J BIOL CHEM, V276, P47107, DOI 10.1074/jbc.M104516200
   van Acker FAA, 2001, CLIN CANCER RES, V7, P1378
   van Acker FAA, 2000, CLIN CANCER RES, V6, P1337
   vanAcker SABE, 1997, CLIN CANCER RES, V3, P1747
   Viero RM, 1998, RENAL FAILURE, V20, P565, DOI 10.3109/08860229809045148
   VONHOFF DD, 1979, ANN INTERN MED, V91, P710
   Wahiba K.A., 2016, INT J PHARM SCI REV, V36, P1
   Wang BQ, 2002, AM J PHYSIOL-HEART C, V282, pH1685, DOI 10.1152/ajpheart.00266.2001
   Wang SQ, 2013, PHYTOCHEMISTRY, V87, P119, DOI 10.1016/j.phytochem.2012.11.020
   Wang WC, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-138
   Wang XY, 2015, PHYTOMEDICINE, V22, P875, DOI 10.1016/j.phymed.2015.06.010
   Xiao J, 2012, TOXICOLOGY, V292, P53, DOI 10.1016/j.tox.2011.11.018
   Xin YF, 2007, PHYTOTHER RES, V21, P1020, DOI 10.1002/ptr.2186
   Xin YF, 2007, BASIC CLIN PHARMACOL, V101, P421, DOI 10.1111/j.1742-7843.2007.00144.x
   Xin YF, 2011, FOOD CHEM TOXICOL, V49, P259, DOI 10.1016/j.fct.2010.10.028
   Xu HD, 2015, INT J CLIN EXP PATHO, V8, P10816
   Xu M, 2010, TUMORI, V96, P460
   Yi SY, 2008, CHIN J INTEGR TRADIT, V28, P68
   You JS, 2007, PHYTOTHER RES, V21, P1146, DOI 10.1002/ptr.2225
   Zhang Hua, 2012, Drugs R D, V12, P101, DOI 10.2165/11632530-000000000-00000
   Zhang SH, 2009, ACTA PHARMACOL SIN, V30, P1479, DOI 10.1038/aps.2009.144
NR 162
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN
PY 2017
VL 90
BP 935
EP 946
DI 10.1016/j.biopha.2017.04.033
PG 12
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EW4KS
UT WOS:000402471000112
PM 28460429
OA No
DA 2017-08-17
ER

PT J
AU Naga, SM
   Sayed, M
   Elmaghraby, HF
   Khalil, MS
   El-Sayed, MA
AF Naga, Salma M.
   Sayed, M.
   Elmaghraby, H. F.
   Khalil, M. Sh.
   El-Sayed, M. A.
TI Fabrication and properties of cordierite / anorthite composites
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Cordierite; Anorthite; Ceramic composite; Thermal expansion
ID CERAMICS; BEHAVIOR
AB The designed cordierite/anorthite batch compositions were studied to gain the favorable properties of both materials where, cordierite has low thermal expansion coffecient and high strength than anorthite.Low cost starting materials such as sugar beat filter cake and talc carbonate were used in the present study. Examination of the effect of cordierite addition (in the range of 10-25mass-%) on the physical, mechanical, electrical and thermal expansion coefficient properties as well as the phase composition and microstructure for the fabricated cordierite/anorthite composites were carried out. The results reveal that the increase in the cordierite content up to 20 mass-%, improves the sinterability and electrical properties. In addition, it increases the bending strength, hardness and decreases the thermal expansion coffecient. However, further increase in the cordierite content up to 25 mass% has negative influence on the physical, electrical and mechanical properties of the cordierite/anorthite composites.
C1 [Naga, Salma M.; Sayed, M.; Elmaghraby, H. F.] Natl Res Ctr, Ceram Dept, El Bohous Str, Cairo 12622, Egypt.
   [Khalil, M. Sh.; El-Sayed, M. A.] Natl Res Ctr, Inorgan Chem Dept, El Bohous Str, Cairo 12622, Egypt.
RP Naga, SM (reprint author), Natl Res Ctr, Ceram Dept, El Bohous Str, Cairo 12622, Egypt.
EM salmanaga@yahoo.com
OI El-Maghraby, Hesham/0000-0002-5932-3002
CR Boudchicha MR, 2001, J MATER SCI LETT, V20, P215, DOI 10.1023/A:1006782215366
   Camerucci MA, 2001, J EUR CERAM SOC, V21, P1195, DOI 10.1016/S0955-2219(00)00334-4
   El-Maghraby A.A., 2002, ADV SCI TECHNOL, V34, P319
   El-Maghraby H.F., 2013, INT CERAM, V62, P426
   GDULA RA, 1971, AM CERAM SOC BULL, V50, P555
   Gibbs G. H., 1996, MINERAL, V51, P1068
   ISMAIL MGMU, 1992, NIPPON SERAM KYO GAK, V100, P1385
   Kavalci S, 2008, CERAM INT, V34, P1629, DOI 10.1016/j.ceramint.2007.07.007
   Klosek-Wawrzyn E, 2013, PROCEDIA ENGINEER, V57, P572, DOI 10.1016/j.proeng.2013.04.073
   KOBAYASHI Y, 1994, J AM CERAM SOC, V77, P833, DOI 10.1111/j.1151-2916.1994.tb05373.x
   Lin YM, 2012, KEY ENG MATER, V512-515, P590, DOI 10.4028/www.scientific.net/KEM.512-515.590
   Miyake A, 2005, J AM CERAM SOC, V88, P121, DOI 10.1111/j.1551-2916.2004.00016.x
   Naga S.M., 2011, INTERCERAM, P48
   Naga S.M., 2015, INTERCERAM, V64, P34
   Niwa K., 1989, ADV CERAM, V26, P323
   SCHMIDBAUER E, 1993, MINER PETROL, V48, P201, DOI 10.1007/BF01163098
   Tulyaganov DU, 2000, J AM CERAM SOC, V83, P3141
   Yang JF, 2002, J AM CERAM SOC, V85, P1512
   Ismail M.G. M.U., 1994, Patent Number, Patent No. [5,369,067, 5369067]
NR 19
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUN 1
PY 2017
VL 43
IS 8
BP 6024
EP 6028
DI 10.1016/j.ceramint.2017.01.142
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA EV0AT
UT WOS:000401401500028
OA No
DA 2017-08-17
ER

PT J
AU Elkhoshkhany, N
   Syala, E
AF Elkhoshkhany, N.
   Syala, Eslam
TI Kinetic characterization of TeO2-Bi2O3 -V2O5 -Na2O TiO2 glass system
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Kinetic; DSC; Activation energy; Avrami exponent
ID BORO-TELLURITE GLASSES; CRYSTALLIZATION KINETICS; TRANSPORT-PROPERTIES;
   THERMAL-PROPERTIES; ELASTIC-MODULI; TRANSITION; TEMPERATURE; PARAMETERS;
   ENERGY; DSC
AB In continuation of our earlier work on (the mechanical and thermal properties of TeO2-Bi2O3 -V2O5 -Na2O TiO2 glass system), in this study, we have investigated the kinetic parameters of this system as a function of increasing TiO2 mol% by using differential scanning calorimetry (DSC) data under non-isothermal (isochronal) conditions. The thermodynamic fragility (F) and the glass forming tendency (K-g), (T-g/T-m) factors of the present glass have been evaluated to determine the relationship between the change in the structure and the thermal stability of the glass. The activation energies of both glass transition (E-g) and crystallization (E-c) processes have been evaluated by the methods of Kissinger and Ozawa by the data obtained from (DSC) at heating rates (beta) 10, 15, 20 and 25 K/min. The quantitative interpretation of these kinetic parameters has been carried out by coupling with the previous estimated elastic moduli. The kinetic Avrami coefficient (n) was also calculated by several estimation methods to determine and confirm the mechanism of the crystallization process.
C1 [Elkhoshkhany, N.; Syala, Eslam] Alexandria Univ, Inst Grad Studies & Res, Dept Mat Sci, 163 Horreya Ave, Shatby 21526, Egypt.
RP Elkhoshkhany, N (reprint author), Alexandria Univ, Inst Grad Studies & Res, Dept Mat Sci, 163 Horreya Ave, Shatby 21526, Egypt.
EM Elkhoshkhany@alexu.edu.eg
CR Arora A, 2008, J NON-CRYST SOLIDS, V354, P3944, DOI 10.1016/j.jnoncrysol.2008.05.035
   AUGIS JA, 1978, J THERM ANAL, V13, P283, DOI 10.1007/BF01912301
   Bhat MH, 2004, CURR SCI INDIA, V86, P676
   Chen FF, 2014, J NON-CRYST SOLIDS, V404, P32, DOI [10.1016/j.jnoncrysol.2014.07.041, 10.1016/j.jnoncryso1.2014.07.041]
   Durga DK, 2001, J MATER SCI, V36, P5625, DOI 10.1023/A:1012521817440
   Ei-Desoky MM, 2005, J NON-CRYST SOLIDS, V351, P3139, DOI 10.1016/j.jnoncrysol.2005.08.004
   El-Desoky MM, 2007, MAT SCI ENG B-SOLID, V137, P237, DOI 10.1016/j.mseb.2006.11.032
   El-Mallawany R, 2008, J MATER SCI, V43, P5131, DOI 10.1007/s10853-008-2737-4
   El-Mallawany R, 2010, J MATER SCI, V45, P871, DOI 10.1007/s10853-009-4015-5
   Elkhoshkhany N, 2016, CERAM INT, V42, P19218, DOI 10.1016/j.ceramint.2016.09.086
   Elkhoshkhany N, 2014, CERAM INT, V40, P11985, DOI 10.1016/j.ceramint.2014.04.036
   ElMallawany R, 1997, PHYS STATUS SOLIDI A, V163, P377, DOI 10.1002/1521-396X(199710)163:2<377::AID-PSSA377>3.0.CO;2-A
   Fu ZF, 2016, CERAM INT, V42, P6005, DOI 10.1016/j.ceramint.2015.12.153
   Grujic S, 2008, SCI SINTER, V40, P333, DOI 10.2298/SOS0803333G
   Hruby A., 1972, J PHYS B ATOM MOL PH, V22, P1187
   HU WY, 1994, PHYSICA B, V203, P147, DOI 10.1016/0921-4526(94)90288-7
   KISSINGER HE, 1957, ANAL CHEM, V29, P1702
   Kumar MP, 2008, PHYSICA B, V403, P4088, DOI 10.1016/j.physb.2008.08.012
   Lakshminarayana G, 2017, J ALLOY COMPD, V690, P799, DOI 10.1016/j.jallcom.2016.08.180
   LASOCKA M, 1976, MATER SCI ENG, V23, P173, DOI 10.1016/0025-5416(76)90189-0
   MAHADEVAN S, 1986, J NON-CRYST SOLIDS, V88, P11, DOI 10.1016/S0022-3093(86)80084-9
   Mahraz ZAS, 2015, J ALLOY COMPD, V649, P1102, DOI 10.1016/j.jallcom.2015.07.232
   Moharram AH, 2016, CHALCOGENIDE LETT, V13, P435
   Ozawa T., 1965, CHEM SOC JPN, V38, P1881, DOI DOI 10.1246/BCSJ.38.1881
   Rao NN, 2012, CERAM INT, V38, P2551, DOI 10.1016/j.ceramint.2011.11.026
   Rao NN, 2012, J NON-CRYST SOLIDS, V358, P702, DOI 10.1016/j.jnoncrysol.2011.11.019
   Rao PSG, 2016, EMERG MATER RES, V5, P95, DOI 10.1680/jemmr.15.00011
   Rodrigues A.M., 2013, MAT RES
   ROJO JM, 1990, J NON-CRYST SOLIDS, V116, P167, DOI 10.1016/0022-3093(90)90689-J
   Sakka S., 1971, Journal of Non-Crystalline Solids, V6, P145, DOI 10.1016/0022-3093(71)90053-6
   Sayyed MI, 2017, RADIAT PHYS CHEM, V130, P335, DOI 10.1016/j.radphyschem.2016.09.019
   Souri D, 2015, PHYSICA B, V456, P185, DOI 10.1016/j.physb.2014.09.001
   Souri D, 2011, MEASUREMENT, V44, P1904, DOI 10.1016/j.measurement.2011.08.031
   Srinivasu C, 2011, J NON-CRYST SOLIDS, V357, P1051, DOI 10.1016/j.jnoncrysol.2010.10.027
   Subbalakshmi P, 2002, J NON-CRYST SOLIDS, V298, P89, DOI 10.1016/S0022-3093(01)01039-0
   Vaish R, 2007, J CRYST GROWTH, V307, P477, DOI 10.1016/j.jcrysgro.2007.07.009
   YINNON H, 1983, J NON-CRYST SOLIDS, V54, P253, DOI 10.1016/0022-3093(83)90069-8
   Yousef ES, 2013, SOLID STATE SCI, V23, P42, DOI 10.1016/j.solidstatesciences.2013.06.005
NR 38
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD JUN 1
PY 2017
VL 43
IS 8
BP 6156
EP 6162
DI 10.1016/j.ceramint.2017.02.011
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA EV0AT
UT WOS:000401401500046
OA No
DA 2017-08-17
ER

PT J
AU Koehler, K
AF Koehler, Kevin
TI Political militaries in popular uprisings: A comparative perspective on
   the Arab Spring
SO INTERNATIONAL POLITICAL SCIENCE REVIEW
LA English
DT Article
DE Military insubordination; mass uprisings; civil-military relations; Arab
   Spring
ID MIDDLE-EAST; COUPS
AB What determines whether militaries will defect from authoritarian incumbents during regime crises? Variance in military behavior in the Arab Spring has given rise to a debate around this issue. This article highlights weaknesses of the dominant explanation and develops an alternative account of military behavior in endgame scenarios'. If militaries are politicized institutions that play a major role in regulating access to power under authoritarianism, they are more likely to intervene during normal times, but less likely to defect during mass uprisings. I quantitatively test this argument against data on military coups between 1975 and 2000 drawing on a new variable that allows me to explicitly model the impact of major regime crises. I illustrate the emergence of different forms of political-military relations and their consequences in the Arab Spring by drawing on evidence from Syria, Egypt, and Tunisia.
C1 [Koehler, Kevin] Amer Univ Cairo, Polit Sci, New Cairo, Egypt.
RP Koehler, K (reprint author), Amer Univ Cairo, Dept Polit Sci, AUC Ave,POB 74, New Cairo 11835, Egypt.
EM kevin.koehler@aucegypt.edu
FU European Research Council
FX Research for this article has been conducted while I was a Research
   Associate in a research project on the international politics of
   authoritarian rule at King's College London funded by the European
   Research Council. I would like to thank my colleagues there, Oisin
   Tansey and Alex Schmotz, for their support. The data on popular mass
   uprisings are part of a joint project with Holger Albrecht. I thank him
   for sharing his insights and for allowing me to use the data here. I
   also want to specifically thank Theodore McLauchlin for offering help
   far beyond the regular duties of a reviewer. David Pion-Berlin and
   Philippe Schmitter commented on earlier drafts.
CR Abdelaziz Belkhodja, 2013, 14 JANVIER LENQUETE
   Albrecht H, 2015, MEDITERR POLIT, V20, P36, DOI 10.1080/13629395.2014.932537
   Alfred Stepan, 1988, RETHINKING MILITARY
   Ali Hilal, 2006, TATAWWUR AL NIZAM AL
   Barany Z, 2011, J DEMOCR, V22, P24
   Beck T, 2001, WORLD BANK ECON REV, V15, P165, DOI 10.1093/wber/15.1.165
   Belkin Aaron, 2005, SECURITY STUDIES, V14, P140, DOI 10.1080/09636410591002527
   Bellin E, 2012, COMP POLIT, V44, P127
   Nassif Hicham Bou, 2013, MIDDLE E J, V67, P509
   COOPER MN, 1982, INT J MIDDLE E STUD, V14, P203
   David Singer, 1972, PEACE WAR NUMBERS, P19
   Erica Frantz, 2011, POLITICS DICTATORSHI
   Eyal Zisser, 2013, MIDDLE E Q       SPR, P65
   Gaub F, 2013, J STRATEGIC STUD, V36, P221, DOI 10.1080/01402390.2012.742010
   Guillermo O'Donnell, 1986, TRANSITIONS AUTHORIT, V4
   Holger Albrecht, 2014, 2014 ANN M AM POL SC
   Jason Brownlee, 2008, ARAB STUDIES J, V15-16, P36
   Jebnoun N, 2014, J NORTH AFR STUD, V19, P296, DOI 10.1080/13629387.2014.891821
   Joseph Holliday, 2013, SYRIAN ARMY DOCTRINA
   Joshua Stacher, 2012, ADAPTABLE AUTOCRATS
   Kevin Koehler, 2016, COMP POLITI IN PRESS
   King Gary, 2001, POLIT ANAL, V9, P137
   King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316
   Harkness Kristen A, 2014, J CONFLICT RESOLUT, DOI [10.1177/0022002714545332, DOI 10.1177/0022002714545332]
   Louer L, 2013, J STRATEGIC STUD, V36, P245, DOI 10.1080/01402390.2013.790314
   Willis Michael J, 2012, POLITICS POWER MAGHR
   Michel Camau, 2003, SYNDROME AUTORITAIRE
   Mietzner M, 2014, CONTEMP POLIT, V20, P435, DOI 10.1080/13569775.2014.968473
   Svolik Milan W, 2012, POLITICS AUTHORITARI
   Mustafa Bakry, 2011, AL JAYSH WA L THAWRA
   Pachon A, 2014, J STRATEGIC STUD, V37, P508, DOI 10.1080/01402390.2013.847825
   Pion-Berlin D, 2010, COMP POLIT, V42, P395
   Powell J, 2012, J CONFLICT RESOLUT, V56, P1017, DOI 10.1177/0022002712445732
   Powell JM, 2011, J PEACE RES, V48, P249, DOI 10.1177/0022343310397436
   Querine Halon, 2012, PROSPECTS SECURITY S
   Quinlivan JT, 1999, INT SECURITY, V24, P131, DOI 10.1162/016228899560202
   Risa Brooks, 1998, POLITICAL MILITARY R
   Finer Samuel E, 1962, MAN HORSEBACK ROLE M
   Stephen Haber, 2006, OXFORD HDB POLITICAL, P693
   Cook Steven A, 2007, RULING NOT GOVERNING
   Terence Lee, 2015, DEFECT DEFEND MILITA
   Theda Skocpol, 1979, STATES SOCIAL REVOLU
   Yezid Sayigh, 2012, STATE OFFICERS REPUB
   Zoltan Barany, 2012, SOLDIER CHANGING STA
NR 44
TC 1
Z9 1
U1 2
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0192-5121
EI 1460-373X
J9 INT POLIT SCI REV
JI Int. Polit. Sci. Rev.
PD JUN
PY 2017
VL 38
IS 3
BP 363
EP 377
DI 10.1177/0192512116639746
PG 15
WC Political Science
SC Government & Law
GA EW6OZ
UT WOS:000402631400008
OA No
DA 2017-08-17
ER

PT J
AU El-Saied, HMA
   Adullatif, AM
AF El-Saied, Heba M. A.
   Adullatif, Abdussalam M.
TI Value of Intravitreal Gas Injection With Ahmed Valve Implantation in the
   Prevention of Suprachoroidal Hemorrhage in Aphakic, Aniridic, and
   Vitrectomized Glaucomatous Eyes: A Pilot Study
SO JOURNAL OF GLAUCOMA
LA English
DT Article
DE vitrectomized; aphakia; aniridia; Ahmed valve; suprachoroidal hemorrhage
ID FILTRATION PROCEDURES; RISK-FACTORS; SURGERY
AB Purpose: The aim of this study was to assess the value of intravitreal injection of nonexpansile C3F8 12% in the prevention of suprachoroidal hemorrhage (SCH) after Ahmed valve implantation for the treatment of secondary glaucoma in vitrectomized, aphakic, and aniridic eyes following blunt trauma.
   Patients and Methods: This is a case series of 5 patients who presented with traumatic secondary glaucoma in vitrectomized, aphakic, and aniridic eyes. Vitrectomy was performed in all eyes after trauma for the treatment of the vitreous hemorrhage. Ahmed valve implantation with complete filling of the vitreous cavity with nonexpansile C3F8 was carried out 2 +/- 0.2 months after vitrectomy. The outcome measures were evaluating the value of intraoperative filling of the vitreous cavity with gas in preventing SCH after Ahmed valve implantation and the ability of Ahmed valve implantation to control the intraocular pressure (IOP) in vitrectomized, aphakic, and aniridic eyes. All patients were examined up to 6 months.
   Results: Inspite of the multiple risk factors present in our patients in the form of aphakia, vitrectomized eyes, and aniridia, no patient developed postoperative hypotony or SCH during the postoperative period. The gas was absorbed over 2 months and the IOP was maintained during the early postoperative period. Mean postoperative IOP was 15.2 +/- 1.09, 12.2 +/- 1.09, 18.4 +/- 7.12, 15.2 +/- 2.28, and 14.8 +/- 1. 09 mm Hg at 1 day, 1 week, 1 month, 3 months, and 6 months, respectively. The final postoperative best-corrected visual acuity was 0.66 +/- 0.13.
   Conclusions: Complete filling of the vitreous cavity with nonexpansile gas can prevent postoperative SCH after Ahmed valve implantation in the treatment of secondary glaucoma in vitrectomized, aphakic, and aniridic eyes.
C1 [El-Saied, Heba M. A.; Adullatif, Abdussalam M.] Cairo Univ, Kasr Al Ainy Hosp, Dept Ophthalmol, Cairo, Egypt.
RP El-Saied, HMA (reprint author), 5 ElEsraa St, Giza 12411, Egypt.
EM hebamagdy13@yahoo.com
CR Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1
   Chak M, 2003, EYE, V17, P525, DOI 10.1038/sj.eye.6700388
   Chu TG, 1999, SURV OPHTHALMOL, V43, P471, DOI 10.1016/S0039-6257(99)00037-5
   Duncker GIW, 1995, INT OPHTHALMOL, V19, P173
   Eriksson A, 1998, J CATARACT REFR SURG, V24, P793
   The Fluorouracil Filtering Surgery Study Group, 1992, AM J OPHTHALMOL, V113, P501
   GIVENS K, 1987, AM J OPHTHALMOL, V103, P689
   Jeganathan VSE, 2008, BRIT J OPHTHALMOL, V92, P1393, DOI 10.1136/bjo.2008.141689
   Paysse E, 1996, J GLAUCOMA, V5, P170
   PEDERSON JE, 1979, ARCH OPHTHALMOL-CHIC, V97, P536
   Pfingst AO, 1936, SOUTH MED J, V29, P323
   RUDERMAN JM, 1986, ARCH OPHTHALMOL-CHIC, V104, P201
   Sharma T, 1997, OPHTHALMIC SURG LAS, V28, P640
   SPEAKER MG, 1991, OPHTHALMOLOGY, V98, P202
   Tuli SS, 2001, OPHTHALMOLOGY, V108, P1808, DOI 10.1016/S0161-6420(01)00763-1
   WOLTER JR, 1988, OPHTHALMIC SURG LAS, V19, P344
NR 16
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD JUN
PY 2017
VL 26
IS 6
BP E190
EP E193
DI 10.1097/IJG.0000000000000657
PG 4
WC Ophthalmology
SC Ophthalmology
GA EW5CY
UT WOS:000402524000004
PM 28263264
OA No
DA 2017-08-17
ER

PT J
AU Mahmoud, SA
   Bendary, SH
   Atia, H
   Martin, A
AF Mahmoud, Sawsan A.
   Bendary, Samar H.
   Atia, H.
   Martin, A.
TI Effect of Different Electrolytes on the Efficiency of Dye Sensitized
   Solar Cells for Solar Energy Conversion
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Open Circuit Potential; Photosensitizers; Dye Sensitized Solar Cells;
   Fill Factor; Conversion Efficiency
ID INDUCED PHOTOCATALYTIC ACTIVITY; IONIC LIQUID; OPTICAL-PROPERTIES;
   SOLVOTHERMAL PROCESS; PHOTOGALVANIC CELL; TITANIUM NITRIDE;
   CHARGE-TRANSPORT; TIO2 ANATASE; THIN-FILMS; RECOMBINATION
AB Effects of different electrolytes of dye sensitized solar cells (DSSC) on the photovoltaic parameters were studied by electrochemical impedance spectroscopy (EIS). Copper (II) phthalocyanine (CuPc), Copper iodide (CuI) and 1-Methyl-3-propylimidazolium iodide (IL) were used as solid electrolytes. TiO2 semiconductor photoanode was synthesized by sol-gel method using urea as nitrogen source. The prepared TiO2 was characterized by N-2 adsorption-desorption isotherm, X-ray diffraction (XRD), Raman and Fourier Transform Infra-Red (FTIR) spectroscopy, Scanning Electron Microscopy (SEM), High Resolution Transmission electronmicroscopy (HRTEM) and Ultraviolet-Visible absorption spectroscopy. It was observed that open circuit voltage (V-oc), short circuit current density (J(sc)), fill factor (FF) and conversion efficiency (eta) decreases with using p-type semiconductor electrolyte and increases by using IL. Our results confirmed that it is essential to use low-viscosity iodide melts with smaller cations to achieve high-efficiency dye-sensitized solar cells. Electrochemical impedance spectroscopy (EIS) results indicate that the use of 1-Methyl-3-propylimidazolium iodide might passivate the surface recombination sites and increases the electron lifetime in the nanostructured TiO2 film, resulting in the improvement of the cell efficiency. The order of the activity of the electrolytes is IL > CuPc > CuI. The conversion efficiency was found to be 0.15, 0.88, and 1.47% for copper iodide, copper phthalocyanine and 1-Methyl-3-propylimidazolium iodide, respectively.
C1 [Mahmoud, Sawsan A.; Bendary, Samar H.] Egyptian Petr Res Inst, 1 Ahmed El Zomr St,POB 11727, Cairo, Egypt.
   [Atia, H.; Martin, A.] Leibniz Inst Katalyse EV, Albert Einstein Str 29a, D-18059 Rostock, Germany.
RP Mahmoud, SA (reprint author), Egyptian Petr Res Inst, 1 Ahmed El Zomr St,POB 11727, Cairo, Egypt.
CR Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051
   Bellardita M, 2009, PHYS CHEM CHEM PHYS, V11, P4084, DOI 10.1039/b816708g
   BERGER H, 1993, J CRYST GROWTH, V130, P108, DOI 10.1016/0022-0248(93)90842-K
   Bernard M, 2000, THIN SOLID FILMS, V380, P252, DOI 10.1016/S0040-6090(00)01531-5
   Betz D, 2011, COORDIN CHEM REV, V255, P1518, DOI 10.1016/j.ccr.2010.12.004
   Bidikoudi M, 2015, ELECTROCHIM ACTA, V179, P228, DOI 10.1016/j.electacta.2015.02.122
   Bisquert J, 2002, J PHYS CHEM B, V106, P325, DOI 10.1021/jp01194lg
   Burgos M, 1999, THIN SOLID FILMS, V349, P19, DOI 10.1016/S0040-6090(99)00139-X
   CASTELLANO FN, 1994, CHEM MATER, V6, P2123, DOI 10.1021/cm00047a037
   Docampo P, 2013, J PHYS CHEM LETT, V4, P698, DOI 10.1021/jz400084n
   Dong F, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/36/365607
   Elia GA, 2014, NANO LETT, V14, P6572, DOI 10.1021/nl5031985
   Exarhos G. J., 1985, MATER RES SOC S P, V48, P461, DOI 10.1557/PROC-48-461
   Ghicov A, 2006, NANO LETT, V6, P1080, DOI 10.1021/nl0600979
   Goswami N, 2010, PHYSICA E, V42, P1675, DOI 10.1016/j.physe.2010.01.023
   Gyogy E., 2002, APPL SURF SCI, V186, P130
   Hauch A, 2001, ELECTROCHIM ACTA, V46, P3457, DOI 10.1016/S0013-4686(01)00540-0
   HSU LS, 1986, J APPL PHYS, V59, P3475, DOI 10.1063/1.336817
   Irie H, 2003, J PHYS CHEM B, V107, P5483, DOI 10.1021/jp030133h
   Jose A. N, 1999, APPL CATAL A-GEN, V178, P91
   Kang IC, 2008, APPL CATAL B-ENVIRON, V84, P570, DOI 10.1016/j.apcatb.2008.05.017
   Kopidakis N, 2003, J PHYS CHEM B, V107, P11307, DOI 10.1021/jp0304475
   Kraus M, 2010, J APPL PHYS, V107, DOI 10.1063/1.3354086
   Li Q, 2008, ADV MATER, V20, P3717, DOI 10.1002/adma.200800685
   Liu JJ, 2009, J HAZARD MATER, V163, P273, DOI 10.1016/j.jhazmat.2008.06.086
   Liufu S. C., COLLOID INTERFACE SC
   Lv BH, 2015, CHEM ENG J, V270, P372, DOI 10.1016/j.cej.2015.02.010
   Mahmoud SA, 2016, SOL ENERGY, V134, P452, DOI 10.1016/j.solener.2016.05.022
   Mahmoud SA, 2015, INT J ELECTROCHEM SC, V10, P3340
   Mahmoud SA, 2015, SOL ENERG MAT SOL C, V136, P38, DOI 10.1016/j.solmat.2014.12.035
   Mahmoud SA, 2014, ENRGY PROCED, V46, P227, DOI 10.1016/j.egypro.2014.01.177
   Murakami SY, 2007, RES CHEM INTERMEDIAT, V33, P285, DOI 10.1163/156856707779238612
   Mwabora JM, 2004, J PHYS CHEM B, V108, P20193, DOI 10.1021/jp0368987
   OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0
   Pandian S, 2015, J POWER SOURCES, V286, P204, DOI 10.1016/j.jpowsour.2015.03.130
   PORTO SPS, 1967, PHYS REV, V154, P522, DOI 10.1103/PhysRev.154.522
   Rengifo-Herrera JA, 2009, APPL CATAL B-ENVIRON, V88, P398, DOI 10.1016/j.apcatb.2008.10.025
   SAHA NC, 1992, J APPL PHYS, V72, P3072, DOI 10.1063/1.351465
   Sharma GD, 2013, ELECTROCHIM ACTA, V102, P459, DOI 10.1016/j.electacta.2013.04.003
   Sistla YS, 2015, CHEM ENG J, V273, P268, DOI 10.1016/j.cej.2014.09.043
   Teesetsopon P, 2012, INT J ELECTROCHEM SC, V7, P4988
   Wilken S, 2015, J POWER SOURCES, V275, P935, DOI 10.1016/j.jpowsour.2014.11.071
   Wu ZB, 2008, J HAZARD MATER, V157, P57, DOI 10.1016/j.jhazmat.2007.12.079
   Yang KS, 2007, J PHYS CHEM C, V111, P12086, DOI 10.1021/jp067491f
   Yang SH, 2010, B MATER SCI, V33, P209, DOI 10.1007/s12034-010-0032-x
   Yin S, 2006, J EUR CERAM SOC, V26, P2735, DOI 10.1016/j.jeurceramsoc.2005.05.012
   Yin S, 2006, J PHOTOCH PHOTOBIO A, V179, P105, DOI 10.1016/j.jphotochem.2005.08.001
   Yin S, 2005, J MATER CHEM, V15, P674, DOI 10.1039/b413377c
   Yokosuka Y, 2009, RES CHEM INTERMEDIAT, V35, P43, DOI 10.1007/s11164-008-0019-z
   Zhang J, 2015, ELECTROCHIM ACTA, V165, P98, DOI 10.1016/j.electacta.2015.02.244
   Zhang ZP, 2005, J PHYS CHEM B, V109, P21818, DOI 10.1021/jp054305h
   Zhao DB, 2002, CATAL TODAY, V74, P157, DOI 10.1016/S0920-5861(01)00541-7
   Zhao Y, 2007, MATER LETT, V61, P79, DOI 10.1016/j.matlet.2006.04.010
   Zhu K, 2006, J PHYS CHEM B, V110, P25174, DOI 10.1021/jp065284+
NR 54
TC 0
Z9 0
U1 13
U2 13
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2017
VL 17
IS 6
BP 3719
EP 3728
DI 10.1166/jnn.2017.14004
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EW4PR
UT WOS:000402483900010
OA No
DA 2017-08-17
ER

PT J
AU Yousef, A
   El-Halwany, MM
   El-Newehy, MH
   Al-Deyab, SS
   Barakat, NAM
AF Yousef, Ayman
   El-Halwany, M. M.
   El-Newehy, Mohamed H.
   Al-Deyab, Salem S.
   Barakat, Nasser. A. M.
TI Synthesis of Cu-S-Codoped TiO2 Nanoparticles Supported on Carbon
   Nanofibers for Simultaneous Adsorption and Photocatalytic Decomposition
   of Reactive Black 5
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Copper; Sulphur; TiO2 Carbon Nanofibers; Photocatalyst; Adsorption
ID METHANOL AQUEOUS-SOLUTION; AMMONIA BORANE; ELECTROSPUN NANOFIBERS;
   HYDROGEN-PRODUCTION; DOPED TIO2; EFFICIENT
AB Cu-S-codoped TiO2 NPs supported on carbon nanofibers were prepared by the simple electrospinning method followed by calcinations at 800 degrees C in an argon atmosphere. The nanocomposite was characterized by the standard techniques. Results indicated that the Cu-S-codoped TiO2 NPs was covered by the graphite layer. This layer revealed an excellent adsorption behavior. Moreover, this layer has good electrical properties that can enhance electron transfer during the photocatalytic process. The Cu and S can decrease the band gap that suppresses the electron-hole recombination process. It subsequently enhanced the photocatalytic activity. The prepared nanocomposite appeared to have better adsorption and photocatalytic behavior than that of TiO2 CNFs for decolorization of reactive black 5 (RB5). Kinetic study indicated that adsorption and photocatalytic processes are closed to a pseudo first order model.
C1 [Yousef, Ayman] Helwan Univ, Fac Engn Matteria, Math & Phys Engn Dept, Cairo 11718, Egypt.
   [El-Halwany, M. M.] Mansoura Univ, Engn Math & Phys Dept, Fac Engn, Mansoura 35516, Egypt.
   [El-Newehy, Mohamed H.; Al-Deyab, Salem S.] King Saud Univ, Dept Chem, Coll Sci, Petrochem Res Chair, Riyadh 11451, Saudi Arabia.
   [El-Newehy, Mohamed H.] Tanta Univ, Dept Chem, Fac Sci, Tanta 31527, Egypt.
   [Barakat, Nasser. A. M.] Chonbuk Natl Univ, Organ Mat & Fiber Engn Dept, Jeonju 561756, South Korea.
RP Yousef, A (reprint author), Helwan Univ, Fac Engn Matteria, Math & Phys Engn Dept, Cairo 11718, Egypt.; El-Newehy, MH (reprint author), King Saud Univ, Dept Chem, Coll Sci, Petrochem Res Chair, Riyadh 11451, Saudi Arabia.; El-Newehy, MH (reprint author), Tanta Univ, Dept Chem, Fac Sci, Tanta 31527, Egypt.; Barakat, NAM (reprint author), Chonbuk Natl Univ, Organ Mat & Fiber Engn Dept, Jeonju 561756, South Korea.
FU King Saud University, Vice Deanship of Scientific Research Chairs
FX The project was supported by King Saud University, Vice Deanship of
   Scientific Research Chairs.
CR Afeesh R, 2012, COLLOID SURFACE A, V409, P21, DOI 10.1016/j.colsurfa.2012.05.021
   Chien S., 1980, SOIL SCI SOC AM J, V44, P268
   Chong MN, 2010, WATER RES, V44, P2997, DOI 10.1016/j.watres.2010.02.039
   El-Halwany MM, 2010, DESALINATION, V250, P208, DOI 10.1016/j.desal.2008.07.030
   Hamadanian M, 2010, APPL SURF SCI, V256, P1837, DOI 10.1016/j.apsusc.2009.10.016
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Im Y, 2014, POWDER TECHNOL, V267, P103, DOI 10.1016/j.powtec.2014.07.002
   Mu J, 2011, ACS APPL MATER INTER, V4, P424
   Nalbandian MJ, 2015, J HAZARD MATER, V299, P141, DOI 10.1016/j.jhazmat.2015.05.053
   Pant B, 2014, J COLLOID INTERF SCI, V434, P159, DOI 10.1016/j.jcis.2014.07.039
   Pant B, 2014, CATAL COMMUN, V50, P63, DOI 10.1016/j.catcom.2014.03.002
   Pavasupree S, 2015, J ENVIRON SCI-CHINA, V37, P59, DOI 10.1016/j.jes.2015.04.020
   Sundaramurthy J., 2014, BIOFUEL RES J, V1, P44
   Wang QZ, 2013, INT J HYDROGEN ENERG, V38, P10739, DOI 10.1016/j.ijhydene.2013.02.131
   Xu J, 2011, J HAZARD MATER, V196, P426, DOI 10.1016/j.jhazmat.2011.09.010
   Ye M., 2012, J NANOSCI LETT, V2, P1
   Yousef A, 2015, ECS ELECTROCHEM LETT, V4, pF51, DOI 10.1149/2.0091509eel
   Yousef A, 2015, CERAM INT, V41, P6137, DOI 10.1016/j.ceramint.2015.01.058
   Yousef A, 2012, COLLOID SURFACE A, V410, P59, DOI 10.1016/j.colsurfa.2012.06.017
   Zhang P, 2012, J HAZARD MATER, V237, P331, DOI 10.1016/j.jhazmat.2012.08.054
   Zhang P, 2011, NANOSCALE, V3, P2943, DOI 10.1039/c1nr10269a
   Zhang WY, 2015, CATAL COMMUN, V59, P189, DOI 10.1016/j.catcom.2014.10.029
   Zhang XL, 2015, J ENVIRON SCI-CHINA, V33, P97, DOI 10.1016/j.jes.2015.01.014
NR 23
TC 0
Z9 0
U1 7
U2 7
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2017
VL 17
IS 6
BP 3998
EP 4004
DI 10.1166/jnn.2017.13113
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EW4PR
UT WOS:000402483900052
OA No
DA 2017-08-17
ER

PT J
AU Hardwick, JS
   Ptchelkine, D
   El-Sagheer, AH
   Tear, I
   Singleton, D
   Phillips, SEV
   Lane, AN
   Brown, T
AF Hardwick, Jack S.
   Ptchelkine, Denis
   El-Sagheer, Afaf H.
   Tear, Ian
   Singleton, Daniel
   Phillips, Simon E. V.
   Lane, Andrew N.
   Brown, Tom
TI 5-Formylcytosine does not change the global structure of DNA
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID NUCLEIC-ACID STRUCTURES; STEM-CELL DNA; THYMINE DNA; CRYSTAL-STRUCTURES;
   MAMMALIAN DNA; TET PROTEINS; A-DNA; 5-CARBOXYLCYTOSINE; GLYCOSYLASE;
   BASE
AB The mechanism by which the recently identified DNA modification 5-formylcytosine (C-f) is recognized by epigenetic writer and reader proteins is not known. Recently, an unusual DNA structure, F-DNA, has been proposed as the basis for enzyme recognition of clusters of fC. We used NMR and X-ray crystallography to compare several modified DNA duplexes with unmodified analogs and found that in the crystal state the duplexes all belong to the A family, whereas in solution they are all members of the B family. We found that, contrary to previous findings, fC does not significantly affect the structure of DNA, although there are modest local differences at the modification sites. Hence, global conformation changes are unlikely to account for the recognition of this modified base, and our structural data favor a mechanism that operates at base-pair resolution for the recognition of fC by epigenome-modifying enzymes.
C1 [Hardwick, Jack S.; El-Sagheer, Afaf H.; Brown, Tom] Univ Oxford, Chem Res Lab, Dept Chem, Oxford, England.
   [Ptchelkine, Denis; Phillips, Simon E. V.] Rutherford Appleton Lab, Res Complex Harwell, Didcot, Oxon, England.
   [Ptchelkine, Denis] Univ Oxford, Weatherall Inst Mol Med, Oxford, England.
   [El-Sagheer, Afaf H.] Suez Univ, Fac Petr & Min Engn, Dept Sci & Math, Chem Branch, Suez, Egypt.
   [Tear, Ian; Singleton, Daniel] Univ Southampton, Sch Chem, ATDBio, Southampton, Hants, England.
   [Phillips, Simon E. V.] Univ Oxford, Dept Biochem, Oxford, England.
   [Lane, Andrew N.] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40506 USA.
RP Brown, T (reprint author), Univ Oxford, Chem Res Lab, Dept Chem, Oxford, England.; Lane, AN (reprint author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40506 USA.
EM andrew.lane@uky.edu; tom.brown@chem.ox.ac.uk
RI El-Sagheer, Afaf/J-8870-2017
OI El-Sagheer, Afaf/0000-0001-8706-1292; /0000-0001-8922-0250; Brown,
   Tom/0000-0002-6538-3036
FU BBSRC sLoLa grant [BB/J001694/2]; Oxford University/EPSRC; Carmen L.
   Buck endowment; University of Kentucky; NCI Cancer Center Support Grant
   [P30 CA177558]
FX This work was supported by a BBSRC sLoLa grant BB/J001694/2 (Extending
   the boundaries of nucleic acid chemistry), by an Oxford University/EPSRC
   Doctoral Training Partnership award (J.S.H.) and in part by a Carmen L.
   Buck endowment (to A.N.L.). NMR data were recorded at the Center for
   Environmental and Systems Biochemistry, which is supported by the
   University of Kentucky and NCI Cancer Center Support Grant (P30
   CA177558).
CR Bachman M, 2015, NAT CHEM BIOL, V11, P555, DOI 10.1038/nchembio.1848
   Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6
   Conte MR, 1996, J BIOMOL NMR, V7, P190
   DIGABRIELE AD, 1989, P NATL ACAD SCI USA, V86, P1816, DOI 10.1073/pnas.86.6.1816
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721
   Gueron M, 1995, METHOD ENZYMOL, V261, P383
   Gyi JI, 1998, BIOCHEMISTRY-US, V37, P73, DOI 10.1021/bi9719713
   Haran TE, 2009, Q REV BIOPHYS, V42, P41, DOI 10.1017/S0033583509004752
   He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944
   Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020
   Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597
   Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303
   Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   KAWAI G, 1994, NUCLEOS NUCLEOT, V13, P1189, DOI 10.1080/15257779408011889
   Kellinger MW, 2012, NAT STRUCT MOL BIOL, V19, P831, DOI 10.1038/nsmb.2346
   Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026
   LANE AN, 1991, BIOCHEMISTRY-US, V30, P1372, DOI 10.1021/bi00219a030
   Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608
   Lercher L, 2014, CHEM COMMUN, V50, P1794, DOI 10.1039/c3cc48151d
   Liu J, 1999, J BIOL CHEM, V274, P24749, DOI 10.1074/jbc.274.35.24749
   Liu J, 1998, FEBS LETT, V438, P211, DOI 10.1016/S0014-5793(98)01295-2
   Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680
   Maiti A, 2013, J AM CHEM SOC, V135, P15813, DOI 10.1021/ja406444x
   Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314
   NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0
   Ngo TTM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10813
   Pfaffeneder T, 2014, NAT CHEM BIOL, V10, P574, DOI [10.1038/nchembio.1532, 10.1038/NCHEMBIO.1532]
   Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899
   Pidugu LS, 2016, BIOCHEMISTRY-US, V55, P6205, DOI 10.1021/acs.biochem.6b00982
   Raiber EA, 2015, NAT STRUCT MOL BIOL, V22, P44, DOI 10.1038/nsmb.2936
   Raiber EA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r69
   Renciuk D, 2013, NUCLEIC ACIDS RES, V41, P9891, DOI 10.1093/nar/gkt738
   ROONGTA VA, 1990, BIOCHEMISTRY-US, V29, P5245, DOI 10.1021/bi00474a005
   SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   SPINK N, 1995, P NATL ACAD SCI USA, V92, P10767, DOI 10.1073/pnas.92.23.10767
   SPONER J, 1991, J MOL BIOL, V221, P761, DOI 10.1016/0022-2836(91)80172-Q
   Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004
   Su M, 2016, ANGEW CHEM INT EDIT, V55, P11797, DOI 10.1002/anie.201605994
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Szulik MW, 2015, BIOCHEMISTRY-US, V54, P1294, DOI 10.1021/bi501534x
   Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116
   VANWIJK J, 1992, METHOD ENZYMOL, V211, P286
   Wahl MC, 1997, BIOPOLYMERS, V44, P45, DOI 10.1002/(SICI)1097-0282(1997)44:1<45::AID-BIP4>3.0.CO;2-#
   Wang LF, 2015, NATURE, V523, P621, DOI 10.1038/nature14482
   Wang R, 2016, NUCLEIC ACIDS RES, V44, P4968, DOI 10.1093/nar/gkw235
   Weber AR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10806
   Xu Y, 2016, J COMPUT CHEM, V37, P896, DOI 10.1002/jcc.24307
   YOON C, 1988, P NATL ACAD SCI USA, V85, P6332, DOI 10.1073/pnas.85.17.6332
   Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/nchembio.914, 10.1038/NCHEMBIO.914]
   Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358
NR 56
TC 0
Z9 0
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD JUN
PY 2017
VL 24
IS 6
BP 544
EP +
DI 10.1038/nsmb.3411
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA EW8SZ
UT WOS:000402789700012
PM 28504696
OA No
DA 2017-08-17
ER

PT J
AU Nour, EH
   Elsayed, TR
   Springael, D
   Smalla, K
AF Nour, Eman H.
   Elsayed, Tarek R.
   Springael, Dirk
   Smalla, Kornelia
TI Comparable dynamics of linuron catabolic genes and IncP-1 plasmids in
   biopurification systems (BPSs) as a response to linuron spiking
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Total community DNA; 16S rRNAgenes; Degradative genes; PCR
   hybridization; Plasmids
ID 16S RIBOSOMAL-RNA; SP. STRAIN ADP; HERBICIDE LINURON; SOIL;
   MINERALIZATION; DEGRADATION; COMMUNITIES; HYDROLASE; ELEMENTS;
   BIOAUGMENTATION
AB On-farm biopurification systems (BPSs) represent an efficient technology for treating pesticide-contaminated wastewater. Biodegradation by genetically adapted bacteria has been suggested to perform a major contribution to the removal of pesticides in BPSs. Recently, several studies pointed to the role of IncP-1 plasmids in the degradation of pesticides in BPSs but this was never linked with catabolic markers. Therefore, a microcosm experiment was conducted in order to examine whether changes in mobile genetic element (MGE) abundances in response to the application of phenylurea herbicide linuron are linked with changes in catabolic genes. Denaturing gradient gel electrophoresis (DGGE) fingerprints of 16S ribosomal RNA gene fragments amplified from total community (TC)-DNA suggested significant shifts in the bacterial community composition. PCR-Southern blot-based detection of genes involved in linuron hydrolysis (libA and hylA) or degradation of its metabolite 3,4-dichloroaniline (dcaQ (I) , dcaQ (II) , and ccdC) in TC-DNA showed that the abundance of the hylA gene was increased faster and stronger in response to linuron application than that of the libA gene, and that the dcaQ (II) gene was more abundant than the isofunctional gene dcaQ (I) 20 and 60 days after linuron addition. Furthermore, a significant increase in the relative abundance of the IncP-1-specific korB gene in response to linuron was recorded. Our data suggest that different bacterial populations bearing isofunctional genes coding for enzymes degrading linuron seemed to be enriched in BPSs in response to linuron and that IncP-1 plasmids might be involved in their dissemination.
C1 [Nour, Eman H.; Elsayed, Tarek R.; Smalla, Kornelia] Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Epidemiol & Pathogen Diagnost, Messeweg 11-12, D-38104 Braunschweig, Germany.
   [Elsayed, Tarek R.] Cairo Univ, Fac Agr, Giza, Egypt.
   [Springael, Dirk] Katholieke Univ Leuven, Div Soil & Water Management, B-3001 Leuven, Belgium.
RP Smalla, K (reprint author), Julius Kuhn Inst, Fed Res Ctr Cultivated Plants, Inst Epidemiol & Pathogen Diagnost, Messeweg 11-12, D-38104 Braunschweig, Germany.
EM kornelia.smalla@julius-kuehn.de
FU EU [222625]
FX This study was supported by the EU 7th Framework Programme project
   MetaExplore 222625.
CR Bergmark L, 2012, FEMS MICROBIOL LETT, V333, P77, DOI 10.1111/j.1574-6968.2012.02601.x
   Bers K, 2013, APPL ENVIRON MICROB, V79, P5258, DOI 10.1128/AEM.01478-13
   Bers K, 2011, APPL ENVIRON MICROB, V77, P8754, DOI 10.1128/AEM.06162-11
   Binh CTT, 2008, FEMS MICROBIOL ECOL, V66, P25, DOI 10.1111/j.1574-6941.2008.00526.x
   Breugelmans P, 2007, FEMS MICROBIOL ECOL, V62, P374, DOI 10.1111/j.1574-6941.2007.00391.x
   Caux PY, 1998, ENVIRON TOXIC WATER, V13, P1, DOI 10.1002/(SICI)1098-2256(1998)13:1<1::AID-TOX1>3.0.CO;2-B
   de Souza ML, 1998, APPL ENVIRON MICROB, V64, P2323
   De Wilde T, 2007, PEST MANAG SCI, V63, P111, DOI 10.1002/ps.1323
   Dealtry S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv157
   Dealtry S, 2014, APPL ENVIRON MICROB, V80, P4012, DOI 10.1128/AEM.04016-13
   Dealtry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089922
   Dejonghe W, 2003, APPL ENVIRON MICROB, V69, P1532, DOI 10.1128/AEM.69.3.1532-1541.2003
   Dunon V, 2013, FEMS MICROBIOL ECOL, V86, P415, DOI 10.1111/1574-6941.12173
   Gotz A, 1996, APPL ENVIRON MICROB, V62, P2621
   Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177
   Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233
   Heuer H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00002
   Horemans B, 2016, APPL ENVIRON MICROB, V82, P2843, DOI 10.1128/AEM.04018-15
   Jechalke S, 2013, APPL ENVIRON MICROB, V79, P1410, DOI 10.1128/AEM.03728-12
   Khurana JL, 2009, BIOCHEM J, V418, P431, DOI 10.1042/BJ20081488
   Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002
   Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001
   Satsuma K, 2010, PEST MANAG SCI, V66, P847, DOI 10.1002/ps.1951
   Sniegowski K, 2011, FEMS MICROBIOL ECOL, V76, P64, DOI 10.1111/j.1574-6941.2010.01031.x
   Sorensen SR, 2005, APPL ENVIRON MICROB, V71, P4144, DOI 10.1128/AEM.71.7.4144-4148.2005
   Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000
   Top EM, 2003, CURR OPIN BIOTECH, V14, P262, DOI 10.1016/S0958-1669(03)00066-1
   Top EM, 2002, FEMS MICROBIOL ECOL, V42, P199, DOI 10.1111/j.1574-6941.2002.tb01009.x
   Turnbull GA, 2001, APPL ENVIRON MICROB, V67, P2270, DOI 10.1128/AEM.67.5.2270-2275.2001
   Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09
NR 30
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUN
PY 2017
VL 101
IS 11
BP 4815
EP 4825
DI 10.1007/s00253-017-8135-6
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EV8CP
UT WOS:000402008300039
PM 28235988
OA No
DA 2017-08-17
ER

PT J
AU Bergen, PM
   Kruger, DF
   Taylor, AD
   Eid, WE
   Bhan, A
   Jackson, JA
AF Bergen, Paula M.
   Kruger, Davida F.
   Taylor, April D.
   Eid, Wael E.
   Bhan, Arti
   Jackson, Jeffrey A.
TI Translating U-500R Randomized Clinical Trial Evidence to the Practice
   Setting: A Diabetes Educator/Expert Prescriber Team Approach
SO DIABETES EDUCATOR
LA English
DT Article
ID HUMAN REGULAR U-500; INSULIN-RESISTANT PATIENTS; DOSE U-100 INSULIN;
   AMERICAN ASSOCIATION; POSITION STATEMENT; EUROPEAN ASSOCIATION;
   CONSENSUS STATEMENT; MANAGEMENT; ENDOCRINOLOGISTS; THERAPY
AB Purpose The purpose of this article is to provide recommendations to the diabetes educator/expert prescriber team for the use of human regular U-500 insulin (U-500R) in patients with severely insulin-resistant type 2 diabetes, including its initiation and titration, by utilizing dosing charts and teaching materials translated from a recent U-500R clinical trial.
   Conclusions Clinically relevant recommendations and teaching materials for the optimal use and management of U-500R in clinical practice are provided based on the efficacy and safety results of and lessons learned from the U-500R clinical trial by Hood et al, current standards of practice, and the authors' clinical expertise. This trial was the first robustly powered, randomized, titration-to-target trial to compare twice-daily and three-times-daily U-500R dosing regimens. Modifications were made to the initiation and titration dosing algorithms used in this trial to simplify dosing strategies for the clinical setting and align with current glycemic targets recommended by the American Diabetes Association. Leveraging the expertise, resources, and patient interactions of the diabetes educator who can provide diabetes self-management education and support in collaboration with the multidisciplinary diabetes team is strongly recommended to ensure patients treated with U-500R receive the timely and comprehensive care required to safely and effectively use this highly concentrated insulin.
C1 [Bergen, Paula M.; Eid, Wael E.] St Elizabeth Phys Reg Diabet Ctr, 1500 James Simpson Jr Way,Suite 301, Covington, KY 41011 USA.
   [Kruger, Davida F.; Bhan, Arti] Henry Ford Hlth Syst, Detroit, MI USA.
   [Taylor, April D.; Jackson, Jeffrey A.] Lilly USA LLC, Lilly Diabet, Indianapolis, IN USA.
   [Eid, Wael E.] Univ Kentucky, Coll Med, Lexington, KY USA.
   [Eid, Wael E.] Univ South Dakota, Sanford Sch Med, Sioux Falls, SD USA.
   [Eid, Wael E.] Univ Alexandria, Alexandria, Egypt.
RP Bergen, PM (reprint author), St Elizabeth Phys Reg Diabet Ctr, 1500 James Simpson Jr Way,Suite 301, Covington, KY 41011 USA.
EM paula.bergen@stelizabeth.com
FU Lilly USA, LLC, Indianapolis, Indiana; Eli Lilly and Company; Astra
   Zeneca; Novo Nordisk; Helmsley Foundation; Dexcom; Medtronic; Lexicon
FX This work is supported by Lilly USA, LLC, Indianapolis, Indiana. P.M.B.
   and A.B. have no conflicts of interest to report. D.F.K. serves on
   advisory boards for Eli Lilly and Company, Novo Nordisk, Abbott, Sanofi
   Aventis, and Janssen; serves on speakers bureaus for Eli Lilly and
   Company, Boehringer Ingelheim/Eli Lilly and Company Alliance, Janssen,
   Valeritas, Astra Zeneca, Animas, Novo Nordisk, and Dexcom; received
   grants/research support to Henry Ford Health System from Eli Lilly and
   Company, Astra Zeneca, Novo Nordisk, Helmsley Foundation, Dexcom,
   Medtronic, and Lexicon; and is a Dexcom stock owner. W.E.E. serves on
   speakers bureaus for Amgen and Sanofi_Regeneron. A.D.T. and J.A.J. are
   full-time employees of Lilly USA, LLC, and J.A.J. is a minor stockholder
   of Eli Lilly and Company.
CR American Diabetes Association, 2015, DIABETES CARE S1, V38, pS33, DOI [10.2337/dc15-S009, DOI 10.2337/DC15-S009]
   American Diabetes Association, 2016, DIABETES CARE S1, V39, pS52, DOI DOI 10.2337/DC16-S010
   American Diabetes Association, 2017, DIABETES CARE S1, V40, pS48
   American Diabetes Association, 2012, DIABETES CARE S1, V35, pS11, DOI DOI 10.2337/DC12-S011
   American Diabetes Association, 2017, DIABETES CARE S1, V40, pS6
   American Diabetes Association, 2017, DIABETES CARE S1, V40, pS25, DOI DOI 10.2337/DC17-S006
   Bailey TS, 2016, ENDOCR PRACT, V22, P231, DOI 10.4158/EP151124.CS
   Ballani P, 2006, DIABETES CARE, V29, P2504, DOI 10.2337/dc06-1478
   Barnosky A, 2016, POSTGRAD MED, V128, P381, DOI 10.1080/00325481.2016.1159909
   Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES
   Centers for Disease Control and Prevention National Center for Health Statistics, 2014, NUMB CIV NON PERS DI
   Cochran E, 2005, DIABETES CARE, V28, P1240, DOI 10.2337/diacare.28.5.1240
   Cochran EK, 2014, DIABETES EDUCATOR, V40, P153, DOI 10.1177/0145721713508822
   Dailey AM, 2011, CURR DIABETES REP, V11, P77, DOI 10.1007/s11892-010-0167-6
   de la Pena Amparo, 2014, J Diabetes Sci Technol, V8, P821, DOI 10.1177/1932296814532326
   de la Pena A, 2014, DIABETES CARE, V37, P2414, DOI 10.2337/dc14-er08
   Duncan I, 2011, DIABETES EDUCATOR, V37, P638, DOI 10.1177/0145721711416256
   Eby EL, 2015, BMJ OPEN DIABETES RE, V3
   Eby EL, 2014, ENDOCR PRACT, V20, P663, DOI 10.4158/EP13407.OR
   Eby Elizabeth L, 2013, J Med Econ, V16, P529, DOI 10.3111/13696998.2013.772059
   [Anonymous], 2016, HUM U 500R PACK INS
   [Anonymous], 2015, HUM U 100R PACK INS
   Eng C, 2014, LANCET, V384, P2228, DOI 10.1016/S0140-6736(14)61335-0
   Fain J A, 1987, Diabetes Educ, V13, P386, DOI 10.1177/014572178701300406
   Garber AJ, 2016, ENDOCR PRACT, V22, P84, DOI 10.4158/EP151126.CS
   Garber AJ, 2015, ENDOCR PRACT, V21, P438, DOI 10.4158/EP15693.CS
   Heinemann L., 2004, TIME ACTION PROFILES
   Hood RC, 2016, ENDOCR PRACT, V22, P905
   Hood RC, 2015, ENDOCR PRACT, V21, P782, DOI 10.4158/EP15612.OR
   Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0
   Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441
   Jones P, 2013, DIABETES OBES METAB, V15, P882, DOI 10.1111/dom.12094
   Kabul S, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0541-4
   Lamos EM, 2016, THER CLIN RISK MANAG, V12, P389, DOI 10.2147/TCRM.S99855
   Lane W, 2014, DIABETES OBES METAB, V16, P827, DOI 10.1111/dom.12286
   Lane WS, 2009, ENDOCR PRACT, V15, P71
   Lipska Kasia J, 2016, JAMA, V316, P362, DOI 10.1001/jama.2016.2087
   Mari, 2016, ENDOCR PRACT, V22, P646
   Mari A, 2015, ENDOCR PRACT, V21, P1344, DOI 10.4158/EP15898.OR
   Martin AL, 2013, DIABETES EDUCATOR, V39, P436, DOI 10.1177/0145721713486526
   Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545
   Nayyar V, 2010, PRACTICAL DIABETES I, V27, P194, DOI [10.1002/pdi.1480, DOI 10.1002/PDI.1480]
   Neal J Matthew, 2005, Endocr Pract, V11, P305
   Powers MA, 2015, DIABETES EDUCATOR, V41, P417, DOI 10.1177/0145721715588904
   Reutrakul Sirimon, 2012, J Diabetes Sci Technol, V6, P412
   Rizza RA, 2003, DIABETES CARE, V26, P1545, DOI 10.2337/diacare.26.5.1545
   Rosenstock J, 2014, DIABETES CARE, V37, P1815, DOI 10.2337/dc13-3055
   Schechter R, 2015, CURR DIABETES REP, V15, P1
   Segal AR, 2010, AM J HEALTH-SYST PH, V67, P1526, DOI 10.2146/ajhp090554
   WHO, 2016, GLOB REP DIAB
   Wong M, 2015, AM ASS CLIN END AACE
   Wysham C, 2016, ENDOCR PRACT, V22, P653, DOI 10.4158/EP15959.OR
   Ziesmer AE, 2012, ENDOCR PRACT, V18, P34, DOI 10.4158/EP11043.OR
NR 53
TC 0
Z9 0
U1 2
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0145-7217
EI 1554-6063
J9 DIABETES EDUCATOR
JI Diabetes Educ.
PD JUN
PY 2017
VL 43
IS 3
BP 311
EP 323
DI 10.1177/0145721717701579
PG 13
WC Endocrinology & Metabolism; Public, Environmental & Occupational Health
SC Endocrinology & Metabolism; Public, Environmental & Occupational Health
GA EV4SU
UT WOS:000401753100008
PM 28427304
OA No
DA 2017-08-17
ER

PT J
AU Mohamed, AT
AF Mohamed, Ahmed Thabet
TI Theoretical analysis for effects of nanoparticles on dielectric
   characterization of electrical industrial materials
SO ELECTRICAL ENGINEERING
LA English
DT Article
DE Dielectric constant; EPL Model; Nanocomposite; Nanoparticles; Electrical
   materials
ID COMPOSITES; FILMS
AB Dielectric constant is an essential property that is required for a variety of electrical applications. An important challenge is to be able to control on the dielectric characteristics of electrical materials using nanotechnology techniques. Computational simulation programs have the potential to join theory and experimental work as a third powerful research methodology; therefore, this paper studied the enhancing and controlling the dielectric properties of electrical industrial materials (polyethylene, polypropylene acrylonitrile butadiene styrene, polyvinyl chloride, polyimide, polyetherimide, and polyethylene terephthalate) using various nanoparticles based on recent theoretical models for computing the effective response of nanocomposites. In addition, dielectric characterization has been controlled using specified optimal concentrations of nanoparticles.
C1 [Mohamed, Ahmed Thabet] Aswan Univ, Nanotechnol Res Ctr, Fac Energy Engn, Aswan 81528, Egypt.
RP Mohamed, AT (reprint author), Aswan Univ, Nanotechnol Res Ctr, Fac Energy Engn, Aswan 81528, Egypt.
EM athm@aswu.edu.eg
FU Nanotechnology Research Center at Aswan University; Science and
   Technology Development Fund (STDF), Egypt [505]
FX The present work was supported by Nanotechnology Research Center at
   Aswan University established with the aid of the Science and Technology
   Development Fund (STDF), Egypt, Grant No: Project ID 505, 2009-2011.
CR Barber P, 2009, MATERIALS, V2, P1697, DOI 10.3390/ma2041697
   Chatterjee A, 2013, INT J ELEC POWER, V45, P137, DOI 10.1016/j.ijepes.2012.08.044
   Chen H, 2007, CERAM INT, V33, P1369, DOI 10.1016/j.ceramint.2006.05.010
   Choi HW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2354425
   Dang ZM, 2009, ADV MATER, V21, P2077, DOI 10.1002/adma.200803427
   Dang ZM, 2003, ADV MATER, V15, P1625, DOI 10.1002/adma.200304911
   Fan BH, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3691198
   Gouda O, 2014, INT J ELECT ENG INFO, V6, P1
   Kamalapur GD, 2011, INT J ELEC POWER, V33, P594, DOI 10.1016/j.ijepes.2010.12.014
   Kobayashi Y, 2008, J EUR CERAM SOC, V28, P117, DOI 10.1016/j.jeurceramsoc.2007.05.007
   Lombardo N, 2007, COMPOS SCI TECHNOL, V67, P728, DOI 10.1016/j.compscitech.2006.04.009
   Lutz MP, 2005, INT J SOLIDS STRUCT, V42, P429, DOI 10.1016/j.ijsolstr.2004.06.046
   Qi L, 2005, ADV MATER, V17, P1777, DOI 10.1002/adma.200401816
   Sarathi R, 2013, INT J ELEC POWER, V48, P1, DOI 10.1016/j.ijepes.2012.11.017
   Smith RC, 2008, IEEE T DIELECT EL IN, V15, P187, DOI 10.1109/T-DEI.2008.4446750
   Tanaka T, 2005, IEEE T DIELECT EL IN, V12, P914, DOI 10.1109/TDEI.2005.1522186
   Thabet A, 2015, INT J ELECT COMPUT E, V5, P13
   Thabet A, 2015, ADV ELECT ELECT ENG, V13, P182
   Thabet A, 2013, INT J ELECT ENG TECH, V4, P58
   Thabet A, 2010, INT C MAT IMP NEW MI
   Thabet A, 2011, 21 INT C EXH EL DIST, P6
   Thabet A, 2013, INT J ELECT ENG TECH, V4, P1
   Thabet A, 2015, INT J ELECT ENG INF, V7, P1
   Thabet A, 2016, J INT MEAS C IMEKO, V89, P28
   Thabet A., 2015, IJEPES INT J ELECT P, V64, P469
   Vo HT, 2001, MICROELECTRON J, V32, P331, DOI 10.1016/S0026-2692(00)00152-X
   Wei EB, 2004, PHYS LETT A, V328, P395, DOI 10.1016/j.physleta.2004.06.033
   Yu KW, 2002, CONDUCT MAT
   Zak AK, 2011, CERAM INT, V37, P1653, DOI 10.1016/j.ceramint.2011.01.037
NR 29
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-7921
EI 1432-0487
J9 ELECTR ENG
JI Electr. Eng.
PD JUN
PY 2017
VL 99
IS 2
BP 487
EP 493
DI 10.1007/s00202-016-0375-4
PG 7
WC Engineering, Electrical & Electronic
SC Engineering
GA EV3XO
UT WOS:000401692600003
OA No
DA 2017-08-17
ER

PT J
AU Oshaba, AS
   Ali, ES
   Abd Elazim, SM
AF Oshaba, A. S.
   Ali, E. S.
   Abd Elazim, S. M.
TI PI controller design via ABC algorithm for MPPT of PV system supplying
   DC motor-pump load
SO ELECTRICAL ENGINEERING
LA English
DT Article
DE Artificial bee colony; DC series motor-pump system; Photovoltaic system;
   Optimization algorithm; Maximum power point tracking; PI controller
ID POWER POINT TRACKING; PARTICLE SWARM OPTIMIZATION; PHOTOVOLTAIC SYSTEMS
AB Artificial Bee Colony (ABC) algorithm has various features that make it more attractive than other algorithms. Particularly, it is simple, it uses fewer control parameters and its convergence is independent of the initial conditions. In this paper, a new MPPT system has been suggested for photovoltaic (PV)-DC motor-pump system by designing two PI controllers via ABC algorithm. The first one is used to reach MPPT by monitoring the voltage and current of the PV array and adjusting the duty cycle of the DC/DC converter. The second PI controller is designed for speed control of DC series motor by setting the voltage fed to the DC series motor through another DC/DC converter. The suggested design problem of MPPT and speed controller is formulated as an optimization task which is solved by ABC to search for optimal parameters of PI controllers. Simulation results have shown the validity of the developed technique in delivering MPPT to DC series motor-pump system under atmospheric conditions and tracking the reference speed of motor. Moreover, the performance of the ABC algorithm is compared with Genetic Algorithm (GA) for various disturbances to prove its robustness.
C1 [Oshaba, A. S.] Power Elect & Energy Convers, Elect Res Inst, NRC Blg, Giza 12311, Egypt.
   [Ali, E. S.; Abd Elazim, S. M.] Zagazig Univ, Elect Power & Machine Dept, Fac Engn, Zagazig, Egypt.
RP Ali, ES (reprint author), Zagazig Univ, Elect Power & Machine Dept, Fac Engn, Zagazig, Egypt.
EM ehabsalimalisalama@yahoo.com
OI ali, ehab/0000-0002-2759-7965
CR Abd-Elazim SM, 2013, INT J ELEC POWER, V46, P334, DOI 10.1016/j.ijepes.2012.10.047
   Abd-Elazim S.M., 2013, INT J WSEAS T POWER, V8, P74
   Abedinia O, 2011, 10 ENV EL EN INT C E, P100
   Ahin AE, 2012, TECHNICAL REPORT
   AI-Amoudi A., 2000, IEE P-GENER TRANSM D, V147, P310, DOI DOI 10.1049/IP-GTD:20000605
   Ali E. S., 2014, WSEAS Transactions on Power Systems, V9, P428
   Ali ES, 2014, INT J ELEC POWER, V61, P683, DOI 10.1016/j.ijepes.2014.04.007
   Ali ES, 2013, INT ARAB J SCI ENG, V38, P599
   Amrouche B., 2007, REV ENERGIES RENOUVE, V7, P11
   Armstrong S., 2004, 39th International Universities Power Engineering Conference (IEEE Cat. No. 04EX858), P604
   Babar B., 2014, RENEWABLE ENERGY POW, V12, P1
   Baek J, 2010, INT C EL MACH SYST I, P638
   Bahgat ABG, 2005, RENEW ENERG, V30, P1257, DOI 10.1016/j.renene.2004.09.011
   Brambilla A., 1999, 30 ANN IEEE POW EL S, V2, P632, DOI 10.1109/PESC.1999.785575
   Ait Cheikh MS, 2007, J RENEW ENERG, V10, P387
   Erickson R. W., 2001, FUNDAMENTALS POWER E
   Gokmen N, 2013, SOL ENERGY, V98, P322, DOI 10.1016/j.solener.2013.09.025
   Hohm DP, 2000, IEEE PHOT SPEC CONF, P1699, DOI 10.1109/PVSC.2000.916230
   Hua Chihchiang, 1997, IECON C, V2, P827
   Hui J., 2010, COMM COM INF SC, V97, P220, DOI 10.1007/978-3-642-15853-7_28
   Hussein K. H., 1995, P I ELECTR ENG, V142, P59, DOI DOI 10.1049/IP-GTD:19951577
   Ishaque K., 2011, ELSEVIER SOLAR ENERG, V85, P1768
   Ishaque K, 2012, IEEE T POWER ELECTR, V27, P3627, DOI 10.1109/TPEL.2012.2185713
   Ishaque K, 2011, SOL ENERGY, V85, P2349, DOI 10.1016/j.solener.2011.06.025
   JABOORI MG, 1991, IEEE T ENERGY CONVER, V6, P401, DOI 10.1109/60.84313
   Javadi MR, 2011, 7 INT C EL EL ENG 1, P204
   Karaboga D., 2005, TR06 ERC U COMP ENG
   Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x
   Karaboga D, 2014, ARTIF INTELL REV, V42, P21, DOI 10.1007/s10462-012-9328-0
   Liu XJ, 2004, IEEE POWER ELECTRON, P2005, DOI 10.1109/PESC.2004.1355425
   Liu YH, 2013, SOL ENERGY, V89, P42, DOI 10.1016/j.solener.2012.11.017
   Logeswaran T, 2014, ENRGY PROCED, V54, P228, DOI 10.1016/j.egypro.2014.07.266
   Ma LB, 2014, J CENT SOUTH UNIV, V21, P4220, DOI 10.1007/s11771-014-2418-1
   Masters G., 2004, RENEWABLE EFFICIENT
   Mehta R, 2013, PRINCIPLES ELECT MAC
   Mohan N., 2003, POWER ELECT CONVERTE
   Mostofi F, 2013, INT J RENEW ENERGY R, V3, P928
   Nafeh AEA, 1998, ENERG SOURCE, V20, P45, DOI 10.1080/00908319808970042
   Oliva D, 2014, ENERGY, V72, P93, DOI 10.1016/j.energy.2014.05.011
   Oshaba AS, 2015, INT J ELEC POWER, V67, P529, DOI 10.1016/j.ijepes.2014.12.009
   OSHABA AS, 2014, INT J ELECT ENG, V14, P195
   Oshaba AS, 2013, RES J APPL SCI ENG T, V5, P4576
   Oshaba AS, 2013, RES J APPL SCI ENG T, V5, P4594
   Osheba DS, 2011, THESIS
   Oshiro M, 2011, INT J ELEC POWER, V33, P485, DOI 10.1016/j.ijepes.2010.11.002
   Ouada Mehdi, 2013, WSEAS Transactions on Power Systems, V8, P104
   Patel M. R., 2006, WIND SOLAR POWER SYS
   Piegari L, 2010, IET RENEW POWER GEN, V4, P317, DOI 10.1049/iet-rpg.2009.0006
   Pooja B., 2013, INT J ADV RES COMPUT, V3, P238
   Ramaprabha R, 2011, IEEE INT C EL EN SYS, P264
   Sahnoun MA, 2013, ENRGY PROCED, V42, P650, DOI 10.1016/j.egypro.2013.11.067
   Shayanfar HA, 2012, INT J TECHN PHYS PRO, V4, P75
   Swiegers W., 1998, P IEEE INT S IND EL, V1, P40
   Tiacharoen S., 2012, American Journal of Applied Sciences, V9, P1464
   Veerachary M, 2001, IEE P-ELECT POW APPL, V148, P494, DOI 10.1049/ip-epa:20010656
   Yeadon WH, 2001, HDB SMALL ELECT MOTO
   Youesf A., 2012, J ENG SCI ASSIUT U, V40, P1455
   Yu GJ, 2004, SOL ENERGY, V76, P455, DOI 10.1016/j.solener.2003.08.038
   Zhang H., 2011, LNEE ADV COMPUT COMM, V121, P77
   Zhao Yuhong, 2014, TELKOMNIKA INDONESIA, V12, P261
NR 60
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-7921
EI 1432-0487
J9 ELECTR ENG
JI Electr. Eng.
PD JUN
PY 2017
VL 99
IS 2
BP 505
EP 518
DI 10.1007/s00202-016-0371-8
PG 14
WC Engineering, Electrical & Electronic
SC Engineering
GA EV3XO
UT WOS:000401692600005
OA No
DA 2017-08-17
ER

PT J
AU Thabet, A
   Mobarak, Y
AF Thabet, Ahmed
   Mobarak, Youssef
TI The effect of cost-fewer nanoparticles on the electrical properties of
   polyvinyl chloride
SO ELECTRICAL ENGINEERING
LA English
DT Article
DE Polyvinyl chloride; Electric properties; Nanoparticles; Nanocomposites;
   Polymers
ID LOW-DENSITY POLYETHYLENE; DIELECTRIC-PROPERTIES; MORPHOLOGY; BREAKDOWN
AB This paper leads to synthesize new electrical insulating polyvinyl chloride nanocomposites to achieve more cost-effective, energy-effective and hence innovate better environmental materials using nanotechnology techniques. It has been investigated simulations and experimental work for studying the effect of cost-fewer nanoparticles on electric properties (resistance and susceptance) of the new resin system nanocomposites. Cambridge Engineering Selector program was carried out the electrical/mechanical predictable models for the suggested materials. In addition, it has been compared between electrical, thermal and mechanical characterization of new polyvinyl chloride nanocomposites with the same unfilled industrial materials within variant frequencies up to 1 kHz.
C1 [Thabet, Ahmed; Mobarak, Youssef] Aswan Univ, Elect Engn Dept, Fac Energy Engn, Nanotechnol Res Ctr, Sahari 81528, Aswan, Egypt.
   [Mobarak, Youssef] King Abdulaziz Univ, Elect Engn Dept, Fac Engn, Rabigh 21911, Saudi Arabia.
RP Thabet, A (reprint author), Aswan Univ, Elect Engn Dept, Fac Energy Engn, Nanotechnol Res Ctr, Sahari 81528, Aswan, Egypt.
EM athm@aswu.edu.eg; y.a.mobarak@gmail.com
FU Nanotechnology Research Center in Aswan University; Science and
   Technology Development Fund (STDF), Egypt [505]
FX The present work was supported by Nanotechnology Research Center in
   Aswan University; this center is established under supervision of the
   Science and Technology Development Fund (STDF), Egypt, Grant No: Project
   ID 505, 2009-2011.
CR Aman A, 2013, INT J ELEC POWER, V45, P346, DOI 10.1016/j.ijepes.2012.09.004
   Chao Z, 2005, IEEE P INT S EL INS
   Ciuprina F, 2010, IEEE INT C SOL DIEL, P1
   da Silva DA, 2013, INT J ELEC POWER, V53, P488, DOI 10.1016/j.ijepes.2013.05.023
   Dang ZM, 2003, J APPL PHYS, V93, P5543, DOI 10.1063/1.1562740
   Dong X, 2006, IEEE INT C PROP APPL
   Fang P, 2010, IEEE T DIELECT EL IN, V17, P1079, DOI 10.1109/TDEI.2010.5539678
   Gouda O, 2014, INT J ELECT ENG INFO, V6, P1
   Hinata K, 2006, 2006 ANNUAL REPORT CONFERENCE ON ELECTRICAL INSULATION AND DIELECTRIC PHENOMENA, P313, DOI 10.1109/CEIDP.2006.311932
   Hong JI, 2003, APPL PHYS LETT, V82, P1956, DOI 10.1063/1.1563306
   Hosier IL, 2002, IEEE T DIELECT EL IN, V9, P353, DOI 10.1109/TDEI.2002.1007697
   Ishimotol K, 2008, IEEE C EL INS DIEL P, P208
   Kuznetsova IE, 2010, IEEE T ULTRASON FERR, V57, P2099, DOI 10.1109/TUFFC.2010.1658
   McCalley JD, 2014, INT J ELEC POWER, V54, P559, DOI 10.1016/j.ijepes.2013.08.008
   Sarathi R, 2013, INT J ELEC POWER, V48, P1, DOI 10.1016/j.ijepes.2012.11.017
   Shengtao L, 2010, INT WORKSH EM TECHN, P1, DOI 10.1109/CEC.2010.5586414
   Tanaka T, 2004, DIELECTRICS ELECT IN, V11, P763
   Thabet A, 2012, J ENG SCI, V40, P1375
   Thabet A, 2012, INT J ELECT ENG TECH, V3, P353
   Thabet A., 2012, INT J ELECT ENG TECH, V3, P553
   Thabet A, 2015, ADV ELECT ELECT ENG, V13, P182
   Thabet A, 2014, INT J ELECT ENG INFO, V6, P631
   Thabet A, 2010, P INT C HIGH VOLT EN, P568, DOI [10.1109/ICHVE.2010.5640767, DOI 10.1109/ICHVE.2010.5640767]
   Thabet A, 2016, ELECTRON ENG, V1-7, DOI [10.1007/s00202-016-0375-4, DOI 10.1007/S00202-016-0375-4]
   Thabet A, 2013, INT J ELECT ENG TECH, V4, P1
   Thabet A, 2016, J INT MEAS C IMEKO, V89, P28
   Thabet A., 2015, IJEPES INT J ELECT P, V64, P469
   Ulzutuev AN, 2008, INT CONF ADV OPTOEL, P435, DOI 10.1109/CAOL.2008.4671988
   Wang X, 2008, IEEE T DIELECT EL IN, V15, P319, DOI 10.1109/TDEI.2008.4483448
   Yamamoto Y, 2004, IEEE T DIELECT EL IN, V11, P881, DOI 10.1109/TDEI.2004.1349794
   Bassyouni M, 2013, ADV MATER SCI ENG, V2013, P1
   Zhang C, 2003, IEEE T DIELECT EL IN, V10, P435
NR 32
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-7921
EI 1432-0487
J9 ELECTR ENG
JI Electr. Eng.
PD JUN
PY 2017
VL 99
IS 2
BP 625
EP 631
DI 10.1007/s00202-016-0392-3
PG 7
WC Engineering, Electrical & Electronic
SC Engineering
GA EV3XO
UT WOS:000401692600016
OA No
DA 2017-08-17
ER

PT J
AU Dabour, SM
   Allam, SM
   Rashad, EM
AF Dabour, Sherif M.
   Allam, Said M.
   Rashad, Essam M.
TI A carrier-based PWM scheme for maximizing the voltage transfer ratio of
   five-phase to three-phase matrix converter
SO ELECTRICAL ENGINEERING
LA English
DT Article
DE Ac-to-ac converter; Matrix converter; Carrier-based PWM; Five-phase
ID VECTOR-MODULATED 3-PHASE
AB This paper presents a scheme using carrier-based PWM to control the five-to three-phase matrix converter ( MC). This scheme is based on the equivalent indirect converter model, which models the converter as two independent stages to perform rectification and inversion processes. It presents a comprehensive solution for linear modulation (LM) and over-modulation (OM) operations. The OM operating region is classified into three different regions based on the choice of the rectifier and inverter stages switching functions. These regions of operation are rectifier-side OM (RSO), inverter-side OM (ISO) and both sides OM (BSO). With these schemes, maximum voltage transfer ratio (VTR) of this converter reaches 1.05 in the LM and 1.19 in BSO mode. These values are the maximum possible VTR that can be achieved in MC. The proposed technique has been implemented using a laboratory setup. Simulation and measured results showed the validity of the given analysis.
C1 [Dabour, Sherif M.; Allam, Said M.; Rashad, Essam M.] Tanta Univ, Dept Elect Power & Machines Engn, Tanta, Egypt.
RP Dabour, SM (reprint author), Tanta Univ, Dept Elect Power & Machines Engn, Tanta, Egypt.
EM shdabour@yahoo.com; sm_allam@yahoo.com; emrashad@ieee.org
OI Rashad, Essam Eddin/0000-0003-3338-2546
CR Ahmed SK, 2010, INT C EL MACH ICEM R
   Ahmed SM, 2011, IEEE T IND ELECTRON, V58, P3925, DOI 10.1109/TIE.2010.2098373
   Ahmed S.M., 2012, INT J AUTOMATION POW, V1, P186
   Alesina A, 1989, IEEE T POWER ELECTR, V4, P101, DOI 10.1109/63.21879
   Allam SM, 2016, RENEW ENERGY SUSTAIN, V2, P1
   Altun H, 2013, ELECTR ENG, V95, P157, DOI 10.1007/s00202-012-0250-x
   Dabour SM, 2012, IET POWER ELECTRON, V5, P1374, DOI 10.1049/iet-pel.2012.0014
   Dabour SM, 2014, P IET PEMD C MANCH, P1
   Dabour SM, 2015, GCC C EXH GCCCE 2015, p[1, 6], DOI DOI 10.1109/IEEEGCC.2015.7060058
   Dabour SM, 2014, P IEEE 16 INT MIDDL
   Gozde H, 2015, ELECTR ENG, V97, P181, DOI 10.1007/s00202-014-0327-9
   Hassanin NAM, 2007, INT C POW ENG EN EL, P648
   Huber L, 1995, IEEE T IND APPL, V31, P1234, DOI 10.1109/28.475693
   Iqbal A, 2006, 37 IEEE POW EL SPEC, P18
   Masoud MI, 2015, ALEX ENG J, V54, P1091, DOI 10.1016/j.aej.2015.07.004
   Mihret M, 2010, EN CONV C EXP ECCE 2, P1887, DOI DOI 10.1109/ECCE.2010.5618296
   Mohapatra KK, 2005, IEEE POWER ELECTRON, P2410, DOI 10.1109/PESC.2005.1581970
   Ojo O, 2010, IEEE INTERNATIONAL SYMPOSIUM ON INDUSTRIAL ELECTRONICS (ISIE 2010), P2141, DOI 10.1109/ISIE.2010.5637634
   Abu-Rub H, 2013, APPL POW EL C EXP AP, P3246
   Venturini M, 1980, P POWERCON
NR 20
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-7921
EI 1432-0487
J9 ELECTR ENG
JI Electr. Eng.
PD JUN
PY 2017
VL 99
IS 2
BP 737
EP 750
DI 10.1007/s00202-016-0445-7
PG 14
WC Engineering, Electrical & Electronic
SC Engineering
GA EV3XO
UT WOS:000401692600027
OA No
DA 2017-08-17
ER

PT J
AU Zaki, SM
   Denning, DW
AF Zaki, S. M.
   Denning, D. W.
TI Serious fungal infections in Egypt
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT Meeting of the International-Society-for-Human-and-Animal-Mycology
   (ISHAM)
CY MAY 04-08, 2015
CL Melbourne, AUSTRALIA
SP Int Soc Human & Anim Mycol
ID OBSTRUCTIVE PULMONARY-DISEASE; GLOBAL BURDEN; NORTH-AFRICA; MIDDLE-EAST;
   ASPERGILLOSIS; BREATHE; ASTHMA; CAIRO
AB We aimed to estimate the burden of serious fungal infections in Egypt, currently unknown, based on the size of the populations at risk and available epidemiological data. Data were obtained from the World Health Organization (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS), and published reports with clearcut denominators. When no data existed, risk populations were used to estimate frequencies of fungal infections, using previously described methodology. The population of Egypt in 2011 was similar to 82,500,000; 31% children, and 8% women > 60 years of age. Amongst about 21.8 million women aged 15-50 years, recurrent vulvovaginal candidiasis (ae4 episodes/year) is estimated to occur in 1.3 million (3,169/100,000 females). Using a low international average rate of 5/100,000, we estimate 4,127 cases of candidaemia, and 619 patients with intra-abdominal candidiasis. Amongst the survivors of pulmonary tuberculosis (TB) in Egypt in 2012, 319 new cases of chronic pulmonary aspergillosis (CPA) are likely, a prevalence of 1,005 post-TB and a total prevalence estimate of 3,015 CPA patients in all. Asthma is common in Egypt, affecting 9.4% of adults, 5.35 million, and so ABPA and SAFS were estimated in around 162/100,000 and 214/100,000 respectively. Invasive aspergillosis is estimated to affect 495 patients following leukaemia therapy, there are an estimated 37 cases in renal and liver transplant recipients, and an estimated 132 patients develop IA in the context of lung cancer. Amongst 641,000 COPD admissions to hospital each year, 8,337 patients develop IA. The total HIV-infected population is small, with an estimated 6,500 patients, 2,500 not on antiretroviral therapy. Amongst HIV-infected patients, 38 (0.6%) cases of cryptococcal meningitis and 125 (1.9%) cases of Pneumocystis pneumonia are estimated each year. Fungal keratitis is common, with 28-55% (mean 40%) of corneal infections being fungal, an estimated total of 11,550 cases. The present study indicates that 2% of the Egyptian population is affected by fungal infections. The estimates are certainly incomplete, and need further epidemiological and diagnostic studies.
C1 [Zaki, S. M.] Ain Shams Univ, Microbiol Dept, Mycol Unit, Fac Sci, Cairo 11566, Egypt.
   [Denning, D. W.] Univ Manchester, Manchester, Lancs, England.
   [Denning, D. W.] Univ Manchester, Natl Aspergillosis Ctr, Univ Hosp South Manchester, Manchester, Lancs, England.
RP Zaki, SM (reprint author), Ain Shams Univ, Microbiol Dept, Mycol Unit, Fac Sci, Cairo 11566, Egypt.
EM sherifdaha@sci.asu.edu.eg
CR Al-Mobeireek AF, 2001, RESP MED, V95, P341, DOI 10.1053/rmed.2001.1047
   Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2
   Ben Abdella F, 2011, WAO J S
   Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967
   Denning DW, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-14
   Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312
   Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441
   Denning DW, 2016, EMERG INFEC IN PRESS
   Elias Mona L, 2009, J Egypt Public Health Assoc, V84, P169
   Elkholy EM, 2015, EGYPTIAN J IN PRESS
   Global Action Fund for Fungal Infections, 2015, IMPROVING OUTCOMES P
   Guinea J, 2010, CLIN MICROBIOL INFEC, V16, P870, DOI 10.1111/j.1469-0691.2009.03015.x
   Matee MI, 2000, ORAL DIS, V6, P106
   Moharram AM, 2013, J BASIC APPL MYCOL, V4, P21
   Moharram A. M., 1999, P 2 INT C FUNG HOP C, V1, P133
   Montravers P, 2011, CLIN MICROBIOL INFEC, V17, P1061, DOI 10.1111/j.1469-0691.2010.03360.x
   Polatli M, 2012, RESP MED, V106, pS75, DOI 10.1016/S0954-6111(12)70016-1
   Shabrawy RM, 2013, J MICROBIOL INFECT D, V3, P186
   Sinko J, 2015, MYCOSES, V58, P29, DOI 10.1111/myc.12385
   SMITH E, 1990, SCAND J INFECT DIS, V22, P665, DOI 10.3109/00365549009027119
   Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9
   Tageldin MA, 2012, RESP MED, V106, pS25, DOI 10.1016/S0954-6111(12)70012-4
   Taj-Aldeen SJ, 2015, MYCOSES, V58, P51, DOI 10.1111/myc.12386
   UNAIDS, 2013, UNAIDS GLOB REP 2013
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   WHO, 2011, WORLD HLTH STAT
   [Anonymous], 2014, GLOB TUB REP 2014
   Xu H, 2012, CHIN J INTEGR MED, V18, P403, DOI 10.1007/s11655-012-1126-7
   Yan X, 2009, CANCER, V1, P5018
   Zaki SM, 2009, MYCOPATHOLOGIA, V167, P133, DOI 10.1007/s11046-008-9165-5
   Zaki SM, 2014, MED MYCOL, V52, P73, DOI 10.3109/13693786.2013.809629
   Zaki SM, 2015, J BASIC APPL MYCOL, V6, P9
NR 32
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD JUN
PY 2017
VL 36
IS 6
BP 971
EP 974
DI 10.1007/s10096-017-2929-4
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EV8AL
UT WOS:000402002600009
PM 28213689
OA No
DA 2017-08-17
ER

PT J
AU Ali, A
   Wagreich, M
AF Ali, Ahmed
   Wagreich, Michael
TI Geochemistry, environmental and provenance study of the Middle Miocene
   Leitha limestones (Central Paratethys)
SO GEOLOGICA CARPATHICA
LA English
DT Article
DE Central Paratethys; Neogene; Leitha limestones; geochemistry; provenance
ID RARE-EARTH-ELEMENTS; QUANTITATIVE SUBSIDENCE ANALYSIS;
   CARPATHIAN-PANNONIAN REGION; VIENNA BASIN; CARBONATE PLATFORM; STYRIAN
   BASIN; HYDROTHERMAL FLUIDS; WESTERN-AUSTRALIA; MARINE-SEDIMENTS;
   ATLANTIC RIDGE
AB Mineralogical, major, minor, REE and trace element analyses of rock samples were performed on Middle Miocene limestones (Leitha limestones, Badenian) collected from four localities from Austria (Mannersdorf,-Wllersdorf, Kummer and Rosenberg quarries) and the Fertorakos quarry in Hungary. Impure to pure limestones (i.e. limited by Al2O3 contents above or below 0.43 wt. %) were tested to evaluate the applicability of various geochemical proxies and indices in regard to provenance and palaeoenvironmental interpretations. Pure and impure limestones from Mannersdorf and Wllersdorf (southern Vienna Basin) show signs of detrital input (REEs = 27.6 +/- 9.8 ppm, Ce anomaly = 0.95 +/- 0.1 and the presence of quartz, muscovite and clay minerals in impure limestones) and diagenetic influence (low contents of, e.g., Sr = 221 +/- 49 ppm, Na is not detected, Ba = 15.6 +/- 8.8 ppm in pure limestones). Thus, in both limestones the reconstruction of original sedimentary palaeoenvironments by geochemistry is hampered. The Kummer and Fertorokos (Eisenstadt-Sopron Basin) comprise pure limestones (e. g., averages Sr = 571 +/- 139 ppm, Na = 213 +/- 56 ppm, Ba = 21 +/- 4 ppm, REEs = 16 +/- 3 ppm and Ce anomaly = 0.62 +/- 0.05 and composed predominantly of calcite) exhibiting negligible diagenesis. Deposition under a shallow-water, well oxygenated to intermittent dysoxic marine environment can be reconstructed. Pure to impure limestones at Rosenberg-Retznei (Styrian Basin) are affected to some extent by detrital input and-volcano-siliciclastic admixture. The Leitha limestones at Rosenberg have the least diagenetic influence among the-studied localities (i. e. averages Sr = 1271 +/- 261 ppm, Na = 315 +/- 195 ppm, Ba = 32 +/- 15 ppm, REEs = 9.8 +/- 4.2 ppm and-Ce anomaly = 0.77 +/- 0.1 and consist of calcite, minor dolomite and quartz). The siliciclastic sources are characterized by immobile-elemental ratios (i. e. La/Sc and Th/Co) which apply not only for the siliciclastics, but also for marls and impure-limestones. At Mannersdorf the detrital input source varies between intermediate to silicic igneous rocks, while in Kummer and Rosenberg the source is solely silicic igneous rocks. The Chemical Index of Alteration (CIA) is only applicable in the shale-contaminated impure limestones. CIA values of the Leitha limestones from Mannersdorf indicate a gradual-transition from warm to temperate palaeoclimate within the limestone succession of the Badenian.
C1 [Ali, Ahmed] Menia Univ, Geol Dept, Fac Sci, Menia 61519, Egypt.
   [Ali, Ahmed; Wagreich, Michael] Univ Vienna, Dept Geodynam & Sedimentol, Ctr Earth Sci, A-1090 Vienna, Austria.
RP Ali, A (reprint author), Menia Univ, Geol Dept, Fac Sci, Menia 61519, Egypt.; Ali, A (reprint author), Univ Vienna, Dept Geodynam & Sedimentol, Ctr Earth Sci, A-1090 Vienna, Austria.
EM ahmad.ali@mu.edu.eg
FU Egyptian Cultural Affairs & Missions Sector; UNESCO-IUGS IGCP [609];
   Austrian Academy of Sciences
FX We thank the quarry companies, especially Lafarge Zementwerke GmbH
   (former Lafarge- Perlmoser)for making available sampling in the active
   quarry sites, and for hospitality and support for the work. Thanks go to
   the Egyptian Cultural Affairs & Missions Sector for providing a PhD
   scholarship for the first author. Field work was partly financed by
   UNESCO-IUGS IGCP 609 and the Austrian Academy of Sciences. We also thank
   Shahid Iqbal and Wolfgang Knierzinger for assistance during field work,
   Sabine Hruby-Nichtenberger and Maria Meszar for sample preparation and
   lab work.
CR Ali S, 2013, CHEM GEOL, V337, P99, DOI 10.1016/j.chemgeo.2012.12.001
   Anderson PE, 2007, PALAEOGEOGR PALAEOCL, V243, P118, DOI 10.1016/j.palaeo.2006.07.015
   Ando A, 2006, SEDIMENT GEOL, V191, P37, DOI 10.1016/j.sedgeo.2006.01.003
   Arndt S, 2013, EARTH-SCI REV, V123, P53, DOI 10.1016/j.earscirev.2013.02.008
   Azmy K, 2011, CHEM GEOL, V280, P180, DOI 10.1016/j.chemgeo.2010.11.007
   BAKER PA, 1988, GEOCHIM COSMOCHIM AC, V52, P335, DOI 10.1016/0016-7037(88)90088-9
   Balogh K., 1994, JUBILAUMSSCHRIFT 20, P55
   BAU M, 1995, CHEM ERDE-GEOCHEM, V55, P1
   Bau M, 1997, MAR CHEM, V56, P123, DOI 10.1016/S0304-4203(96)00091-6
   BAU M, 1991, CHEM GEOL, V93, P219, DOI 10.1016/0009-2541(91)90115-8
   Bau M, 1999, CHEM GEOL, V155, P77, DOI 10.1016/S0009-2541(98)00142-9
   BAU M, 1992, MINER PETROL, V45, P231, DOI 10.1007/BF01163114
   Bau M, 2010, EARTH PLANET SC LETT, V299, P310, DOI 10.1016/j.epsl.2010.09.011
   Bojar AV, 2004, PALAEOGEOGR PALAEOCL, V203, P95, DOI 10.1016/S0031-0182(03)00662-X
   BOSWELL SM, 1988, MAR CHEM, V25, P197, DOI 10.1016/0304-4203(88)90050-3
   BRAND U, 1980, J SEDIMENT PETROL, V50, P1219
   Calvert SE, 1996, GEOCHIM COSMOCHIM AC, V60, P1577, DOI 10.1016/0016-7037(96)00041-5
   CAMPBELL AC, 1988, NATURE, V335, P514, DOI 10.1038/335514a0
   CHITTLEBOROUGH DJ, 1991, AUST J EARTH SCI, V38, P115, DOI 10.1080/08120099108727959
   Craddock PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5494, DOI 10.1016/j.gca.2010.07.003
   CULLERS R, 1988, LITHOS, V21, P301, DOI 10.1016/0024-4937(88)90035-7
   CULLERS RL, 1988, CHEM GEOL, V70, P335, DOI 10.1016/0009-2541(88)90123-4
   Cullers RL, 2002, CHEM GEOL, V191, P305, DOI 10.1016/S0009-2541(02)00133-X
   Cullers RL, 2000, PRECAMBRIAN RES, V104, P77, DOI 10.1016/S0301-9268(00)00090-5
   Cullers RL, 2000, LITHOS, V51, P181, DOI 10.1016/S0024-4937(99)00063-8
   CULLERS RL, 1994, GEOCHIM COSMOCHIM AC, V58, P4955, DOI 10.1016/0016-7037(94)90224-0
   DEBAAR HJW, 1983, NATURE, V301, P324, DOI 10.1038/301324a0
   DEBAAR HJW, 1985, GEOCHIM COSMOCHIM AC, V49, P1943, DOI 10.1016/0016-7037(85)90089-4
   Dubinin AV, 2004, LITHOL MINER RESOUR+, V39, P289, DOI 10.1023/B:LIMI.0000033816.14825.a2
   Dullo W., 1983, FACIES, V8, P1, DOI 10.1007/BF02536740
   EBNER F, 1995, TECTONOPHYSICS, V242, P133, DOI 10.1016/0040-1951(94)00155-3
   ELDERFIELD H, 1988, PHILOS T R SOC A, V325, P105, DOI 10.1098/rsta.1988.0046
   ELDERFIELD H, 1982, NATURE, V296, P214, DOI 10.1038/296214a0
   Fenninger Alois, 1997, Geologisch-Palaeontologische Mitteilungen, V22, P71
   Garbelli C, 2016, GONDWANA RES, V35, P272, DOI 10.1016/j.gr.2015.05.012
   Haley BA, 2004, GEOCHIM COSMOCHIM AC, V68, P1265, DOI 10.1016/j.gca.2003.09.012
   Handler R, 2006, GEOL CARPATH, V57, P483
   HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156
   Harangi S, 2006, GEOL SOC MEM, V32, P167, DOI 10.1144/GSL.MEM.2006.032.01.10
   HARNOIS L, 1988, SEDIMENT GEOL, V55, P319, DOI 10.1016/0037-0738(88)90137-6
   Harzhauser M, 2010, SPEC PUBL INT ASS SE, V42, P183
   Hedberg H.D., 1976, INT STRATIGRAPHIC GU, P1
   Hinkley T.K., 1987, J GEOPHYS RES, V92, P1943
   Hohenegger J, 2009, INT J EARTH SCI, V98, P915, DOI 10.1007/s00531-007-0287-7
   Hohenegger J, 2014, GEOL CARPATH, V65, P55, DOI 10.2478/geoca-2014-0004
   Hohenegger J, 2012, INT J EARTH SCI, V101, P339, DOI 10.1007/s00531-011-0658-y
   Hongo Y, 2001, GEOCHEM J, V35, P347
   Ivanov D, 2002, PALAEOGEOGR PALAEOCL, V178, P19, DOI 10.1016/S0031-0182(01)00365-0
   Johannesson KH, 2014, MOD APPR SOL EARTH S, V7, P385, DOI 10.1007/978-94-007-7615-9_14
   Kim JH, 2012, CHEM GEOL, V291, P152, DOI 10.1016/j.chemgeo.2011.10.010
   Kocsis L, 2010, GEOCHIM COSMOCHIM AC, V74, P6077, DOI 10.1016/j.gca.2010.08.007
   Kovac M, 2007, GEOL CARPATH, V58, P579
   Kovacova P, 2009, INT J EARTH SCI, V98, P1109, DOI 10.1007/s00531-008-0307-2
   Kroll A., 1988, ERLAUTERUNGEN KARTEN, P16
   KULP JL, 1952, GEOL SOC AM BULL, V63, P701
   LAND LS, 1973, J SEDIMENT PETROL, V43, P614
   Lankreijer A, 1995, TECTONOPHYSICS, V252, P433, DOI 10.1016/0040-1951(95)00099-2
   Laskarev V.N., 1924, RECEUIL TRAVEAUX OFF, P73
   Lee EY, 2017, INT J EARTH SCI, V106, P687, DOI 10.1007/s00531-016-1329-9
   Madhavaraju J, 2010, CRETACEOUS RES, V31, P400, DOI 10.1016/j.cretres.2010.05.006
   MCLENNAN SM, 1983, GEOCHIM COSMOCHIM AC, V47, P1211, DOI 10.1016/0016-7037(83)90063-7
   MCLENNAN SM, 1990, GEOCHIM COSMOCHIM AC, V54, P2015, DOI 10.1016/0016-7037(90)90269-Q
   McLennan S.M., 1993, GEOL SOC AM SPEC PAP, V284, P21, DOI [DOI 10.1130/SPE284-P21, 10.1130/SPE284-p21, rg/10.1130/SPE284-p21]
   MICHARD A, 1983, NATURE, V303, P795, DOI 10.1038/303795a0
   Mielke J.E., 1979, REV RES MODERN PROBL, P13
   MORRISON JO, 1986, GEOSCI CAN, V13, P237
   Morse J.W., 1990, GEOCHEMISTRY SEDIMEN, P1
   NESBITT HW, 1982, NATURE, V299, P715, DOI 10.1038/299715a0
   Neuhuber S, 2016, CHEM GEOL, V420, P280, DOI 10.1016/j.chemgeo.2015.11.023
   Nothdurft LD, 2004, GEOCHIM COSMOCHIM AC, V68, P263, DOI 10.1016/S0016-7037(03)00422-8
   Nozaki Y, 1997, EARTH PLANET SC LETT, V148, P329, DOI 10.1016/S0012-821X(97)00034-4
   Nozaki Y., 2001, ENCY OCEAN SCI, V4, P2354
   OLIVAREZ AM, 1991, CHEM GEOL, V92, P317, DOI 10.1016/0009-2541(91)90076-4
   Papp A., 1978, CHRONOSTRATIGRAPHIE, P1
   PIEPGRAS DJ, 1992, GEOCHIM COSMOCHIM AC, V56, P1851, DOI 10.1016/0016-7037(92)90315-A
   Piller W.E., 1991, EXC GUID 6 INT S FOS, P1
   Piller W.E., 1996, SEDIMENTOLOGENTREFFE, P1
   Piller W.E., 1997, EXCURSION GUIDES, P70
   Piller WE, 2007, STRATIGRAPHY, V4, P151
   PIPER DZ, 1974, CHEM GEOL, V14, P285, DOI 10.1016/0009-2541(74)90066-7
   Reuter M, 2012, PALAEOGEOGR PALAEOCL, V350, P198, DOI 10.1016/j.palaeo.2012.06.032
   Riegl B, 2000, PALAIOS, V15, P399, DOI 10.2307/3515512
   Rohatsch A., 2005, MITTEILUNGEN IAG BOK, P9
   Rosta E., 1993, FOLDTANI KOZLONY, V123, P167
   Royden L. H., 1985, SOC ECON PALEONT MIN, V37, P319
   Salvador A., 1994, INT STRATIGRAPHIC GU, P1
   Schieber J, 2011, J SEDIMENT RES, V81, P447, DOI 10.2110/jsr.2011.41
   Schmid HP, 2001, ANN NATURHIST MUS A, V102, P1
   Schmidt K, 2010, GEOCHIM COSMOCHIM AC, V74, P4058, DOI 10.1016/j.gca.2010.04.007
   Scholle P., 2003, AAPG BULL, V77, P1
   Schreilechner M. G., 2007, AUSTRIAN J EARTH SCI, V100, P164
   Schuster R., 2015, EINHEITEN OSTALPINEN, P10
   Seghedi I, 2011, GONDWANA RES, V20, P655, DOI 10.1016/j.gr.2011.06.009
   Slapansky P., 1999, ABHANDLUNGEN GEOLOGI, V56, P419
   STEININGER F. F., 1999, COUR FORSCH I SENCKE, V209, P1
   Strauss P, 2006, GEOL CARPATH, V57, P185
   Suess E., 1860, VERHANDLUNGEN GEOLOG, V1860, P1
   Taylor SR, 1985, CONTINENTAL CRUST IT, P1
   Tollmann A., 1985, GEOLOGIE OSTERREICH, P1
   Ullmann CV, 2016, GONDWANA RES, V38, P60, DOI 10.1016/j.gr.2015.10.010
   VEIZER J., 1983, REV MINERAL, V11, P265
   Wagreich M, 2002, TERRA NOVA, V14, P163, DOI 10.1046/j.1365-3121.2002.00404.x
   Webb GE, 2009, SEDIMENTOLOGY, V56, P1433, DOI 10.1111/j.1365-3091.2008.01041.x
   Wedepohl K.H., 1978, HDB GEOCHEMISTRY, P1
   Wessely G., 2006, GEOLOGIE OSTERREICHI, P1
   Wessely G., 1983, MITT OSTERR GEOL GES, V76, P27
   Wiedl T, 2014, FACIES, V60, P865, DOI 10.1007/s10347-014-0408-2
   Wiedl T, 2013, PALAEOGEOGR PALAEOCL, V370, P232, DOI 10.1016/j.palaeo.2012.12.015
   Wiedl T, 2012, FACIES, V58, P523, DOI 10.1007/s10347-011-0290-0
   ZHANG J, 1994, GEOPHYS RES LETT, V21, P2677, DOI 10.1029/94GL02404
   Zhao MY, 2014, GEOCHIM COSMOCHIM AC, V141, P508, DOI 10.1016/j.gca.2014.07.001
NR 111
TC 0
Z9 0
U1 2
U2 2
PU SLOVAK ACAD SCIENCES GEOLOGICAL  INST
PI BRATISLAVA
PA DUBRAVSKA CESTA 9, BRATISLAVA, 840 05, SLOVAKIA
SN 1335-0552
EI 1336-8052
J9 GEOL CARPATH
JI Geol. Carpath.
PD JUN
PY 2017
VL 68
IS 3
BP 248
EP 268
DI 10.1515/geoca-2017-0018
PG 21
WC Geosciences, Multidisciplinary
SC Geology
GA EW3DM
UT WOS:000402375100005
OA gold
DA 2017-08-17
ER

PT J
AU Hegazi, AM
   El-Shraiy, AM
   Ghoname, AA
AF Hegazi, Amira M.
   El-Shraiy, Amal M.
   Ghoname, A. A.
TI Mitigation of Salt Stress Negative Effects on Sweet Pepper Using
   Arbuscular Mycorrhizal Fungi (AMF), Bacillus megaterium and
   Brassinosteroids (BRs)
SO GESUNDE PFLANZEN
LA English
DT Article
DE Salt stress; AMF; Bacillus megaterium; Brassinosteroids (BRs);
   Antioxidant enzymes; LRWC; MP
ID PLANT-GROWTH; STOMATAL CONDUCTANCE; SALINITY TOLERANCE; FIELD
   CONDITIONS; WATER RELATIONS; NUTRIENT-UPTAKE; SUBTILIS FZB24;
   SALICYLIC-ACID; L. PLANTS; ALLEVIATION
AB A study was conducted at the experimental farm of Faculty of Agriculture, Ain Shams University, Cairo, Egypt, during two successive summer seasons (2014 and 2015) to investigate the effects of arbuscular mycorrhizal fungi (Glomus irradicans 10% w/w), Bacillus megaterium (10 ml/pot) and brassinosteroids (24-EBL, C28H48O6; 2 A mu M) on growth, nutrient absorption, chlorophyll, proline content, antioxidant enzymes activity and fruit yield of sweet pepper plants (Capsicum annuum L.) cv. Marconi. Plants were grown under three levels of salinity (0, 25 and 50 mM). The obtained results showed that plants grown under non-saline water (0 mM NaCl), with or without treatments, significantly gave the most vigorous vegetative growth and had the highest fruit yield compared with those grown under salt stress conditions. All anti-salinity treatments (Mycorrhiza, Bacillus and Brassinosteroids) improved growth when compared with untreated plants (control). Plants inoculated with mycorrhiza or treated with brassinosteroids showed better vegetative growth and shoot biomass (total fresh and dry weight per plant), chlorophyll a and b concentrations, antioxidant content expressed as total soluble phenols and proline concentrations at all studied salinity levels followed by plants inoculated with Bacillus megaterium compared with control plants which showed severe growth retardant especially under higher salt concentration (50 mM). Carotenoids concentration increased proportionally with the increase of salinity concentration. The maximum leaf relative water content (LRWC) and lowest values of membrane permeability (MP) were significantly observed with mychorhiza inoculated plants and brassinosteroid application respectively, followed by Bacillus inoculated plants. Antioxidant enzyme activity were highest in plants irrigated with moderate saline water (25 mM) than plants under high salinity irrigation water (50 mM) except polyphenol oxidase (PPO) as compared with unstressed plants (0 mM). Mycorrhizal inoculated plants accumulated higher K and lower Na and Cl followed by plants treated with brassinosteroids and then plants inoculated with Bacillus megaterium. Anti-salinity treatments positively enhanced fruit yield of sweet pepper plants under all salinity stress levels and the highest fruit yield were significantly observed with brassinosteroid application followed by mychorhiza inoculated plants and then Bacillus inoculated plants.
C1 [Hegazi, Amira M.] Ain Shams Univ, Agr Bot Dept, Fac Agr, Plant Physiol, Cairo, Egypt.
   [El-Shraiy, Amal M.] Ain Shams Univ, Agr Bot Dept, Fac Agr, Cairo, Egypt.
   [Ghoname, A. A.] Natl Res Ctr, Vegetable Res Dept, Cairo, Egypt.
RP Hegazi, AM (reprint author), Ain Shams Univ, Agr Bot Dept, Fac Agr, Plant Physiol, Cairo, Egypt.
EM amirahegazi@yahoo.com
CR Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873
   Abu-Muriefah S. S., 2015, International Journal of Agriculture and Crop Sciences (IJACS), V8, P94
   Al-Karaki GN, 2006, SCI HORTIC-AMSTERDAM, V109, P1, DOI 10.1016/j.scienta.2006.02.019
   Al-Karaki GN, 2001, MYCORRHIZA, V11, P43, DOI 10.1007/s005720100098
   Alpaslan Mehmet, 1999, Turkish Journal of Biology, V23, P499
   Arora Nitika, 2008, Brazilian Journal of Plant Physiology, V20, P153, DOI 10.1590/S1677-04202008000200007
   Ashraf M, 2004, BIOL FERT SOILS, V40, P157, DOI 10.1007/s00374-004-0766-y
   Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097
   Auge RM, 2008, MYCORRHIZA, V18, P115, DOI 10.1007/s00572-008-0162-9
   Beauchamp C, 1971, Anal Biochem, V44, P276
   Behnamnia M., 2009, General and Applied Plant Physiology, V35, P22
   Bishopp A, 2006, DEVELOPMENT, V133, P1857, DOI 10.1242/dev.02359
   Bochow H, 2001, Z PFLANZENK PFLANZEN, V108, P21
   Bothe H, 2012, SYMBIOSIS, V58, P7, DOI 10.1007/s13199-012-0196-9
   Cardarelli M, 2013, HORTSCIENCE, V48, P568
   Chen ShanNa, 1997, Acta Botanica Yunnanica, V19, P184
   Choe K., 2006, J PLANT PHYSL, V163, P517
   Daei G, 2009, J PLANT PHYSIOL, V166, P617, DOI 10.1016/j.jplph.2008.09.013
   El-Bassiony AM, 2012, GESUNDE PFLANZ, V64, P175, DOI 10.1007/s10343-012-0286-x
   El-Mashad AAA, 2012, PROTOPLASMA, V249, P625, DOI 10.1007/s00709-011-0300-7
   Elhindi KM, 2017, SAUDI J BIOL SCI, V24, P170, DOI 10.1016/j.sjbs.2016.02.010
   Evelin H, 2012, MYCORRHIZA, V22, P203, DOI 10.1007/s00572-011-0392-0
   Evelin H, 2009, ANN BOT-LONDON, V104, P1263, DOI 10.1093/aob/mcp251
   Garg N, 2009, J AGRON CROP SCI, V195, P110, DOI 10.1111/j.1439-037X.2008.00349.x
   Ghoname A.A., 2010, RES J AGR BIOL SCI, V6, P349
   Giri B, 2004, MYCORRHIZA, V14, P307, DOI 10.1007/s00572-003-0274-1
   GRATTAN SR, 1992, AGR ECOSYST ENVIRON, V38, P275, DOI 10.1016/0167-8809(92)90151-Z
   Grieve CM, 2000, J PLANT NUTR, V23, P1217, DOI 10.1080/01904160009382095
   GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0
   Gupta B, 2014, INT J GENOMICS, DOI 10.1155/2014/701596
   HAHLBROCK K, 1975, ARCH BIOCHEM BIOPHYS, V166, P41, DOI 10.1016/0003-9861(75)90362-8
   HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P73, DOI 10.1016/0048-4059(82)90025-X
   Han H.S., 2005, J AGR BIOL SCI, V1, P210
   Hayat S, 2010, ENVIRON EXP BOT, V69, P105, DOI 10.1016/j.envexpbot.2010.03.004
   Hegazi AM, 2015, GESUNDE PFLANZ, V67, P21, DOI 10.1007/s10343-014-0333-x
   Houimli S. M., 2010, EURASIA J BIOSCI, V4, P96
   Houimli SM, 2008, EUR ASIA J BIO SCI, V2, P83
   Huang Z, 2010, AGR SCI CHINA, V9, P1150, DOI 10.1016/S1671-2927(09)60202-9
   Ibrahim AH, 2011, PHYTON-ANN REI BOT A, V51, P261
   Karlidag H, 2011, SCI HORTIC-AMSTERDAM, V130, P133, DOI 10.1016/j.scienta.2011.06.025
   Kaya C, 2003, J PLANT NUTR, V26, P807, DOI 10.1081/PLN-120018566
   Kaya C, 2009, SCI HORTIC-AMSTERDAM, V121, P1, DOI 10.1016/j.scienta.2009.01.001
   Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z
   Abdel Latef AA, 2011, SCI HORTIC, V127
   Lichtenthaler K, 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]
   Maggio A, 2002, PLANT J, V31, P699, DOI 10.1046/j.1365-313X.2002.01389.x
   Mayak S, 2004, PLANT PHYSIOL BIOCH, V42, P565, DOI 10.1016/j.plaphy.2004.05.009
   Montavon P, 2007, ANAL BIOCHEM, V360, P207, DOI 10.1016/j.ab.2006.10.035
   Noel TC, 1996, CAN J MICROBIOL, V42, P279
   OKTAY M, 1995, J FOOD SCI, V60, P494, DOI 10.1111/j.1365-2621.1995.tb09810.x
   Peters W, 1997, J PLANT PHYSIOL, V151, P362
   Rady MM, 2011, SCI HORTIC-AMSTERDAM, V129, P232, DOI 10.1016/j.scienta.2011.03.035
   ROSENDAHL CN, 1991, ENVIRON EXP BOT, V31, P313, DOI 10.1016/0098-8472(91)90055-S
   Ruiz-Lozano JM, 2000, MYCORRHIZA, V10, P137, DOI 10.1007/s005720000075
   Sakr MT, 2015, ZAGAZIG J AGR BOT, V42, P1397
   Saleh SA, 2010, ACTA HORTIC, V852, P311
   Saleh SA, 2005, J APPL BOT FOOD QUAL, V79, P24
   Samira I. M. H., 2012, Journal of Stress Physiology & Biochemistry, V8, P232
   Shahid MA, 2011, AUST J CROP SCI, V5, P500
   Shekoofeh E, 2011, J PLANT PHYSL, V1, P215
   Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7
   Shi Q, 2006, PLANT GROWTH REGUL, V48, P127, DOI 10.1007/s10725-005-5482-6
   Snedecor G. W., 1994, STAT METHODS
   Stevens J, 2006, PLANT GROWTH REGUL, V49, P77, DOI 10.1007/s10725-006-0019-1
   Tian CY, 2004, APPL SOIL ECOL, V26, P143, DOI 10.1016/j.apsoil.2003.10.010
   TROLL W, 1955, J BIOL CHEM, V215, P655
   Wettasinghe M, 1999, FOOD CHEM, V67, P399, DOI 10.1016/S0308-8146(99)00137-5
   Wu QS, 2010, PLANT SOIL ENVIRON, V56, P470
   Xu Cheng-Xiang, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P73
   Yildirim E, 2009, PLANT SOIL ENVIRON, V55, P213
   Zuccarini P, 2007, PLANT SOIL ENVIRON, V53, P283
NR 71
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0367-4223
EI 1439-0345
J9 GESUNDE PFLANZ
JI Gesunde Pflanz.
PD JUN
PY 2017
VL 69
IS 2
BP 91
EP 102
DI 10.1007/s10343-017-0393-9
PG 12
WC Agronomy
SC Agriculture
GA EW3LB
UT WOS:000402395700005
OA No
DA 2017-08-17
ER

PT J
AU Hegazi, AM
   El-Shraiy, AM
   Ghoname, AA
AF Hegazi, Amira M.
   El-Shraiy, Amal M.
   Ghoname, A. A.
TI Mitigation of Salt Stress Negative Effects on Sweet Pepper Using
   Arbuscular Mycorrhizal Fungi (AMF), Bacillus megaterium and
   Brassinosteroids (BRs) (vol 69, pg 91, 2017)
SO GESUNDE PFLANZEN
LA English
DT Correction
C1 [Hegazi, Amira M.; El-Shraiy, Amal M.] Ain Shams Univ, Agr Bot Dept, Fac Agr, Cairo, Egypt.
   [Ghoname, A. A.] Natl Res Ctr, Vegetable Res Dept, Cairo, Egypt.
RP Hegazi, AM (reprint author), Ain Shams Univ, Agr Bot Dept, Fac Agr, Cairo, Egypt.
EM amirahegazi@yahoo.com
CR Riad GS, 2017, GESUNDE PFLANZ, V69, P21, DOI [10.1007/s10343-017-0381-0, 10.1007/s10343-017-0393-9]
NR 1
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0367-4223
EI 1439-0345
J9 GESUNDE PFLANZ
JI Gesunde Pflanz.
PD JUN
PY 2017
VL 69
IS 2
BP 111
EP 111
DI 10.1007/s10343-017-0394-8
PG 1
WC Agronomy
SC Agriculture
GA EW3LB
UT WOS:000402395700007
OA No
DA 2017-08-17
ER

PT J
AU Elmahdy, MF
   Buonamici, P
   Trapani, M
   Valenti, R
   Migliorini, A
   Parodi, G
   Antoniucci, D
AF Elmahdy, Mahmoud Farouk
   Buonamici, Piergiovanni
   Trapani, Maurizio
   Valenti, Renato
   Migliorini, Angela
   Parodi, Guido
   Antoniucci, David
TI Long-Term Primary Patency Rate After Nitinol Self-Expandable Stents
   Implantation in Long, Totally Occluded Femoropopliteal (TASC II C & D)
   Lesions
SO HEART LUNG AND CIRCULATION
LA English
DT Article
DE Femoropopliteal lesions; Nitinol self-expandable stents; Primary patency
   rate
ID SUPERFICIAL FEMORAL-ARTERY; INTER-SOCIETY CONSENSUS; BALLOON
   ANGIOPLASTY; RANDOMIZED-TRIAL; DISEASE; PLACEMENT; BYPASS
AB Background Endovascular therapy for long femoropopliteal lesions using percutaneous transluminal balloon angioplasty or first-generation of peripheral stents has been associated with unacceptable one-year restenosis rates. However, with recent advances in equipment and techniques, a better primary patency rate is expected. This study was conducted to detect the long-term primary patency rate of nitinol self-expandable stents implanted in long, totally occluded femoropopliteal lesions TransAtlantic Inter-Society Census (TASC II type C & D), and determine the predictors of reocclusion or restenosis in the stented segments.
   Methods The demographics, clinical, anatomical, and procedural data of 213 patients with 240 de novo totally occluded femoropopliteal (TASC II type C & D) lesions treated with nitinol self-expandable stents were retrospectively analysed. Of these limbs, 159 (66.2%) presented with intermittent claudication, while 81 (33.8%) presented with critical limb ischaemia. The mean-time of follow-up was 36 +/- 22.6 months, (range: 6.3-106.2 months). Outcomes evaluated were, primary patency rate and predictors of reocclusion or restenosis in the stented segments.
   Results The mean age of the patients was 70.9 +/- 9.3 years, with male gender 66.2%. Mean pre-procedural ABI was 0.45 +/- 0.53. One-hundred-and-seventy-five (73%) lesions were TASC II type C, while 65 (27%) were type D lesions. The mean length of the lesions was 17.9 +/- 11.3 mm. Procedure related complications occurred in 10 (4.1%) limbs. There was no periprocedural mortality. Reocclusion and restenosis were detected during follow-up in 45 and 30 limbs respectively, and all were re-treated by endovascular approach. None of the patients required major amputation. Primary patency rates were 81.4 +/- 1.1%, 77.7 +/- 1.9% and 74.4 +/- 2.8% at 12, 24, and 36 months respectively. Male gender, severe calcification, and TASC II D lesion were independent predictors for reocclusion, while predictors of restenosis were DM, smoking and TASC II D lesions.
   Conclusions Treatment of long, totally occluded femoropopliteal (TASC II C & D) lesions with nitinol self-expandable stents is safe and is associated with highly acceptable long-term primary patency rates.
C1 [Elmahdy, Mahmoud Farouk] Cairo Univ, Kasr Alaini Hosp, Cairo, Egypt.
   [Elmahdy, Mahmoud Farouk; Antoniucci, David] Aswan Heart Ctr, Div Cardiol, Aswan, Egypt.
   [Buonamici, Piergiovanni; Trapani, Maurizio; Valenti, Renato; Migliorini, Angela; Parodi, Guido; Antoniucci, David] Careggi Hosp, Div Cardiol, Florence, Italy.
RP Elmahdy, MF (reprint author), Cairo Univ, Kasr Alaini Hosp, Cairo, Egypt.
EM drmahmoudfarouk@yahoo.com
CR Armstrong EJ, 2014, J ENDOVASC THER, V21, P34, DOI 10.1583/13-4399MR.1
   Aune S, 1998, EUR J VASC ENDOVASC, V16, P509, DOI 10.1016/S1078-5884(98)80242-6
   Becquemin JP, 2003, J VASC SURG, V37, P487, DOI 10.1067/mva.2003.155
   Bosiers M, 2011, J VASC SURG, V54, P1042, DOI 10.1016/j.jvs.2011.03.272
   Bosiers M, 2009, J ENDOVASC THER, V16, P261, DOI 10.1583/08-2676.1
   Chalmers N, 2013, CARDIOVASC INTER RAD, V36, P353, DOI 10.1007/s00270-012-0492-z
   Davaine JM, 2012, EUR J VASC ENDOVASC, V44, P432, DOI 10.1016/j.ejvs.2012.07.015
   Diehm N, 2007, EUR HEART J, V28, P798, DOI 10.1093/eurheartj/ehl545
   Dormandy J A, 2000, J Vasc Surg, V31, pS1
   Dorrucci V, 2004, J CARDIOVASC SURG, V45, P193
   Duda SH, 2005, J VASC INTERV RADIOL, V16, P331, DOI 10.1097/01.RVI.0000151260.74519.CA
   Duda SH, 2006, J ENDOVASC THER, V13, P701, DOI 10.1583/05-1704.1
   Grimm J, 2001, J VASC INTERV RADIOL, V12, P935, DOI 10.1016/S1051-0443(07)61572-3
   Krankenberg H, 2007, CIRCULATION, V116, P285, DOI 10.1161/CIRCULATIONAHA.107.689141
   Laird JR, 2010, CIRC-CARDIOVASC INTE, V3, P267, DOI 10.1161/CIRCINTERVENTIONS.109.903468
   Mewissen MW, 2009, J ENDOVASC THER, V16, P63
   Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037
   Pereira CE, 2006, J VASC SURG, V44, P510, DOI 10.1016/j.jvs.2006.04.054
   Rocha-Singh KJ, 2007, CATHETER CARDIO INTE, V69, P910, DOI 10.1002/ccd.21104
   Sabeti S, 2005, J ENDOVASC THER, V12, P6, DOI 10.1583/04-1359.1
   Scheinert D, 2005, J AM COLL CARDIOL, V45, P312, DOI 10.1016/j.jacc.2004.11.026
   Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1443-9506
EI 1444-2892
J9 HEART LUNG CIRC
JI Heart Lung Circ.
PD JUN
PY 2017
VL 26
IS 6
BP 604
EP 611
DI 10.1016/j.hlc.2016.09.011
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EW4JH
UT WOS:000402467300012
PM 27939742
OA No
DA 2017-08-17
ER

PT J
AU El-Ghammaz, AMS
AF El-Ghammaz, Amro Mohamed Sedky
TI Bacteremia During Early Post-allogeneic Hematopoietic Stem Cell
   Transplantation Period: A Single Center Experience
SO INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
LA English
DT Article
DE Allogeneic hematopoietic stem cell transplantation; Bacteremia; Early
   post-transplant period; Risk factors; Overall survival
ID BLOOD-STREAM INFECTIONS; BONE-MARROW-TRANSPLANTATION; GRAM-NEGATIVE
   BACTEREMIA; RISK-FACTORS; RECIPIENTS; BACTERIAL; EPIDEMIOLOGY;
   MORTALITY; CONTAMINATION; LEVOFLOXACIN
AB Bacteremia is a significant complication of allogeneic hematopoietic stem cell transplantation (HSCT). We aimed to study bacteremia occurring during early post-transplant period at Bone Marrow Transplantation Unit of Ain Shams University regarding its risk factors and impact on survival. Patients performing allogeneic HSCT were followed up for occurrence of bacteremia. Survival status was assessed at 180 days post-transplant. Bacteremia occurred in 53.3 % of patients. On univariate analysis, CD34 +ve cell dose (P = 0.004), duration of neutropenia (P = 0.018), time interval between day of stem cell infusion and day of neutrophil engraftment (P = 0.043) and > 1 apheresis days (P = 0.040) were associated with higher rates of bacteremia. On multivariate analysis, CD34 +ve cell dose (P = 0.002) and apheresis day number (P = 0.038) remained significant. There was significant difference between patients who developed bacteremia and those who did not regarding overall survival (OS) (P = 0.042). Patients developing bacteremia caused by Gram negative bacteria (GNB) had lower OS than Gram positive bacteria (GPB) (P < 0.001). In conclusion, stem cell dose and apheresis day number influence bacteremia risk. Also, Gram negative bacteremia has negative impact on allogeneic transplant recipient survival rates.
C1 [El-Ghammaz, Amro Mohamed Sedky] Ain Shams Univ, Internal Med Dept, Hematol & Bone Marrow Transplantat Unit, Fac Med, Cairo, Egypt.
RP El-Ghammaz, AMS (reprint author), Ain Shams Univ, Internal Med Dept, Hematol & Bone Marrow Transplantat Unit, Fac Med, Cairo, Egypt.
EM amro.sedky@yahoo.com
CR Abe R, 2010, CRIT CARE, V14, DOI 10.1186/cc8898
   Almeida ID, 2012, BRAZ J INFECT DIS, V16, P345, DOI 10.1016/j.bjid.2012.06.012
   Almyroudis NG, 2005, TRANSPL INFECT DIS, V7, P11, DOI 10.1111/j.1399-3062.2005.00088.x
   Bittencourt H, 2002, BLOOD, V99, P2726, DOI 10.1182/blood.V99.8.2726
   Busca A, 2012, TRANSPL INFECT DIS, V14, P40, DOI 10.1111/j.1399-3062.2011.00650.x
   Cappellano P, 2007, NEW MICROBIOL, V30, P89
   Collin BA, 2001, CLIN INFECT DIS, V33, P947, DOI 10.1086/322604
   Crawford J, 2004, CANCER, V100, P228, DOI 10.1002/cncr.11882
   Frere P, 2004, BONE MARROW TRANSPL, V33, P745, DOI 10.1038/sj.bmt.1704414
   Ghazal SS, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-20
   Goncalves TL, 2009, OXID MED CELL LONGEV, V2, P82
   Guthrie KA, 2010, BONE MARROW TRANSPL, V45, P675, DOI 10.1038/bmt.2009.216
   Horwitz ME, 2006, BLOOD REV, V20, P15, DOI 10.1016/j.blre.2005.01.007
   Jugo J, 2002, J HOSP INFECT, V50, P48, DOI 10.1053/jhin.2001.1101
   Kedia S, 2013, J STEM CELL RES TH S, DOI [10.4172/2157-7633.S3-002, DOI 10.4172/2157-7633.S3-002]
   Kwon Jae-Cheol, 2013, Infect Chemother, V45, P51, DOI 10.3947/ic.2013.45.1.51
   Majado MJ, 2007, BONE MARROW TRANSPL, V39, P121, DOI 10.1038/sj.bmt.1705549
   Maschmeyer G, 2011, CURR CLIN ONCOL, P17, DOI 10.1007/978-1-60761-644-3_2
   Mendes ET, 2012, INT J INFECT DIS, V16, pE424, DOI 10.1016/j.ijid.2012.01.015
   Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024
   Ninin E, 2001, CLIN INFECT DIS, V33, P41, DOI 10.1086/320871
   Oliveira AL, 2007, BONE MARROW TRANSPL, V39, P775, DOI 10.1038/sj.bmt.1705677
   Ortega M, 2005, ANN HEMATOL, V84, P40, DOI 10.1007/s00277-004-0909-0
   Poutsiaka DD, 2007, BONE MARROW TRANSPL, V40, P63, DOI 10.1038/sj.bmt.1705690
   Rajasekar R, 2009, BIOL BLOOD MARROW TR, V15, P597, DOI 10.1016/j.bbmt.2009.01.016
   Ramphal R, 2004, CLIN INFECT DIS, V39, pS25, DOI 10.1086/383048
   Rosa RG, 2014, CAN J INFECT DIS MED, V25, pE14
   Sparrelid E, 1998, BONE MARROW TRANSPL, V22, P795, DOI 10.1038/sj.bmt.1701404
   Therriault BL, 2010, MAYO CLIN PROC, V85, P711, DOI 10.4065/mcp.2010.0006
   Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339
   Worth LJ, 2009, BLOOD REV, V23, P113, DOI 10.1016/j.blre.2008.10.003
NR 31
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0971-4502
EI 0974-0449
J9 INDIAN J HEMATOL BLO
JI Indian J. Hematol. Blood Transfus.
PD JUN
PY 2017
VL 33
IS 2
BP 200
EP 206
DI 10.1007/s12288-016-0703-x
PG 7
WC Hematology
SC Hematology
GA EV8ZT
UT WOS:000402074700010
PM 28596651
OA No
DA 2017-08-17
ER

PT J
AU Ragab, M
   Soliman, MG
   Tawfik, A
   Raheem, AA
   El-Tatawy, H
   Farha, MA
   Magdy, M
   Elashry, O
AF Ragab, Maged
   Soliman, Mohamed G.
   Tawfik, Ahmed
   Raheem, Ali Abdel
   El-Tatawy, Hassan
   Farha, Mohamed Abo
   Magdy, Michael
   Elashry, Osama
TI The role of pregabalin in relieving ureteral stent-related symptoms: a
   randomized controlled clinical trial
SO INTERNATIONAL UROLOGY AND NEPHROLOGY
LA English
DT Article
DE Pregabalin; Stent-related symptoms; Ureteral stent symptom
   questionnaire; Management of stent-related symptoms
ID QUALITY-OF-LIFE; OVERACTIVE BLADDER; ALPHA-BLOCKERS; GABAPENTIN;
   THERAPY; METAANALYSIS; TAMSULOSIN; DRUG
AB To investigate the role of pregabalin in relieving USRS in patients with an indwelling double-J (DJ) stents.
   A total of 500 adult patients with a unilateral single ureteral stone who underwent ureteroscopic stone management and required DJ stent insertion were prospectively included in our study. Patients were blindly assigned into four groups A, B, C and D. Those in group A were managed with combination of solifenacin 5-mg tablets and pregabalin 75-mg capsules bid. Patients in group B were managed with solifenacin 5-mg tablets. Those in group C were managed with pregabalin 75-mg capsules bid. Those in group D were control group. All patients were evaluated on day 15 postoperatively for stent-related symptoms using the Arabic translated and validated ureteral stent symptom questionnaire (USSQ).
   The total USSQ score as well as general health index was significantly lower in group A as compared to other groups. In addition, urinary symptom index was significantly improved in both groups A and B as compared to group C and group D. Pain symptom index was significantly improved in both groups A and C as compared to groups B and D. No statistically significant difference was reported regarding sexual index and work performance index among the whole study groups.
   Pregabalin appears to be a well-tolerated, safe and effective drug in reducing most of USRS, especially relief of pain with subsequent improvement of patient's quality of life. Its combination with solifenacin should be considered to manage patients with USRS as it shows a significant improvement in total USSQ score and general health index when compared to each drug alone.
C1 [Ragab, Maged; Soliman, Mohamed G.; Tawfik, Ahmed; Raheem, Ali Abdel; El-Tatawy, Hassan; Farha, Mohamed Abo; Magdy, Michael; Elashry, Osama] Tanta Univ Hosp, Urol Dept, Tanta, Egypt.
RP Soliman, MG (reprint author), Tanta Univ Hosp, Urol Dept, Tanta, Egypt.
EM mohagab2006@yahoo.com
CR Ansari MS, 2013, J PEDIATR UROL, V9, P17, DOI 10.1016/j.jpurol.2011.10.022
   Beddingfield R, 2009, J UROLOGY, V181, P170, DOI 10.1016/j.juro.2008.09.026
   Bockbrader HN, 2010, CLIN PHARMACOKINET, V49, P661, DOI 10.2165/11536200-000000000-00000
   Carbone A, 2006, CLIN NEUROPHARMACOL, V29, P206, DOI 10.1097/01.WNF.0000228174.08885.AB
   Chew BH, 2004, NAT CLIN PRACT UROL, V1, P44, DOI 10.1038/ncpuro0014
   Chew BH, 2004, CURR OPIN UROL, V14, P111, DOI 10.1097/01.mou.0000120257.13439.75
   Damiano R, 2008, J ENDOUROL, V22, P651, DOI 10.1089/end.2007.0257
   Deliveliotis C, 2006, UROLOGY, V67, P35, DOI 10.1016/j.urology.2005.07.038
   EL-Nahas AR, 2016, WORLD J UROL, V34, P963, DOI 10.1007/s00345-015-1704-3
   El-Nahas Ahmed R, 2014, Arab J Urol, V12, P290, DOI 10.1016/j.aju.2014.08.001
   Haleblian G, 2008, J UROLOGY, V179, P424, DOI 10.1016/j.juro.2007.09.026
   Hansen HC, 2000, SOUTHERN MED J, V93, P238
   Hao P, 2008, J ENDOUROL, V22, P65, DOI 10.1089/end.2007.0114
   Ho CH, 2008, J ENDOUROL, V22, P1427, DOI 10.1089/end.2008.0037
   Jeong H, 2004, BJU INT, V93, P1032, DOI 10.1111/j.1464-410X.2004.04776.x
   Joshi HB, 2003, J UROLOGY, V169, P1065, DOI 10.1097/01.ju.0000048980.33855.90
   Joshi HB, 2003, J UROLOGY, V169, P1060, DOI 10.1097/01.ju.0000049198.53425.1d
   Kuyumcuoglu U, 2012, CUAJ-CAN UROL ASSOC, V6, pE234, DOI 10.5489/cuaj.10143
   Lim Kyoung Taek, 2011, Korean J Urol, V52, P485, DOI 10.4111/kju.2011.52.7.485
   Moore RA, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007076.PUB2
   Park SC, 2009, J ENDOUROL, V23, P1913, DOI 10.1089/end.2009.0173
   POLLARD SG, 1988, J UROLOGY, V139, P37
   Shalaby E, 2013, ADV UROL, V2013, DOI [DOI 10.1155/2013/752382, 10.1155/2013/752382]
   Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008
   Tehranchi A, 2013, INT BRAZ J UROL, V39, P832, DOI 10.1590/S1677-5538.IBJU.2013.06.09
   Toth C, 2010, PAIN MED, V11, P456, DOI 10.1111/j.1526-4637.2009.00796.x
   Yakoubi R, 2011, J UROLOGY, V186, P928, DOI 10.1016/j.juro.2011.04.061
   Yoshimura N, 2002, J UROLOGY, V168, P1897, DOI 10.1097/01.ju.0000031061.70559.40
   Zhou L, 2015, J ENDOUROL, V29, P650, DOI 10.1089/end.2014.0715
   ZIMSKIND PD, 1967, J UROLOGY, V97, P840
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-1623
EI 1573-2584
J9 INT UROL NEPHROL
JI Int. Urol. Nephrol.
PD JUN
PY 2017
VL 49
IS 6
BP 961
EP 966
DI 10.1007/s11255-017-1561-7
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA EV8ZZ
UT WOS:000402075400007
PM 28260223
OA No
DA 2017-08-17
ER

PT J
AU Ramadan, MF
AF Ramadan, Mohamed Fawzy
TI Artificial neural networks: a novel tool for detecting GMO (Retraction
   of Vol 6, Pg 13, 2011)
SO JOURNAL FUR VERBRAUCHERSCHUTZ UND LEBENSMITTELSICHERHEIT-JOURNAL OF
   CONSUMER PROTECTION AND FOOD SAFETY
LA English
DT Retraction
C1 [Ramadan, Mohamed Fawzy] Zagazig Univ, Dept Biochem, Fac Agr, Zagazig 44511, Egypt.
   [Ramadan, Mohamed Fawzy] King Saud Univ, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia.
RP Ramadan, MF (reprint author), Zagazig Univ, Dept Biochem, Fac Agr, Zagazig 44511, Egypt.; Ramadan, MF (reprint author), King Saud Univ, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia.
EM hassanienmohamed@yahoo.com
CR Ramadan MF, 2011, J VERBRAUCH LEBENSM, V6, P13, DOI 10.1007/s00003-010-0579-x
NR 1
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1661-5751
EI 1661-5867
J9 J VERBRAUCH LEBENSM
JI J. Verbrauch. Lebensm.
PD JUN
PY 2017
VL 12
IS 2
BP 175
EP 175
DI 10.1007/s00003-017-1099-8
PG 1
WC Food Science & Technology
SC Food Science & Technology
GA EW3LK
UT WOS:000402396900011
OA No
DA 2017-08-17
ER

PT J
AU Moussa, YY
   Tawfik, SH
   Haiba, MM
   Saad, MI
   Hanafi, MY
   Abdelkhalek, TM
   Oriquat, GA
   Kamel, MA
AF Moussa, Y. Y.
   Tawfik, S. H.
   Haiba, M. M.
   Saad, M. I.
   Hanafi, M. Y.
   Abdelkhalek, T. M.
   Oriquat, G. A.
   Kamel, M. A.
TI Disturbed nitric oxide and homocysteine production are involved in the
   increased risk of cardiovascular diseases in the F1 offspring of
   maternal obesity and malnutrition
SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
LA English
DT Article
DE Diabetes; Fetal reprogramming; Malnutrition; Obesity
ID INSULIN-RESISTANCE; BIRTH-WEIGHT; SYNTHASE; CHILDREN; ATHEROSCLEROSIS;
   NONOBESE; HEALTH; IMPACT; INDEX
AB Purpose The present study aimed to evaluate the changes in levels of different independent risk factors for vascular diseases in the rat offspring of maternal obesity and malnutrition as maternal health disturbances are thought to have direct consequences on the offspring health. The effect of postnatal diet on the offspring was also assessed.
   Methods Three groups of female Wistar rats were used (control, obese and malnourished). After the pregnancy and delivery, the offspring were weaned to control diet or highcaloric (HCD) diet and followed up for 30 weeks. Every 5 weeks postnatal, 20 pups (10 males and 10 females) of each subgroup were sacrificed after overnight fasting, the blood sample was obtained, and the rats were dissected out to obtain heart muscle. The following parameters were assessed; lipid profile, NEFA, homocysteine (Hcy), nitric oxide end product (NOx) and myocardial triglyceride content.
   Results Maternal obesity and malnutrition caused significant elevation in the body weight, triglycerides, NEFA, Hcy and NOx in the F1 offspring especially those maintained under HCD. Also, the male offspring showed more prominent changes than female offspring.
   Conclusions Maternal malnutrition and obesity may increase the risk of the development of cardiovascular diseases in the offspring, especially the male ones. Results Maternal obesity and malnutrition caused significant elevation in the body weight, triglycerides, NEFA, Hcy and NOx in the F1 offspring especially those maintained under HCD. Also, the male offspring showed more prominent changes than female offspring. Conclusions Maternal malnutrition and obesity may increase the risk of the development of cardiovascular diseases in the offspring, especially the male ones.
C1 [Moussa, Y. Y.] Alexandria Univ, Fac Sci, Dept Biochem, Alexandria, Egypt.
   [Tawfik, S. H.] Padova Univ, Mol Med Dept, Padua, Italy.
   [Tawfik, S. H.; Haiba, M. M.; Saad, M. I.; Hanafi, M. Y.; Kamel, M. A.] Alexandria Univ, Med Res Inst, Dept Biochem, Alexandria, Egypt.
   [Saad, M. I.] Monash Univ, Ritchie Ctr, Hudson Inst Med Res, Melbourne, Vic, Australia.
   [Abdelkhalek, T. M.] Alexandria Univ, Med Res Inst, Dept Human Genet, Alexandria, Egypt.
   [Oriquat, G. A.] Al Ahliyya Amman Univ, Fac Pharm & Med Sci, Amman, Jordan.
RP Saad, MI (reprint author), Alexandria Univ, Med Res Inst, Dept Biochem, Alexandria, Egypt.; Saad, MI (reprint author), Monash Univ, Ritchie Ctr, Hudson Inst Med Res, Melbourne, Vic, Australia.
EM m.ibrahim1988@hotmail.com
OI Kamel, Maher/0000-0002-6791-9850
CR Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160
   Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005
   Catalano PM, 2009, DIABETES CARE, V32, P1076, DOI 10.2337/dc08-2077
   Domanic N, 2006, ACTA MED OKAYAMA, V60, P35
   Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532
   Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6
   Heydrick SJ, 2004, FREE RADICAL BIO MED, V36, P632, DOI 10.1016/j.freeradbiomed.2003.12.001
   Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060
   Kamel M. A., 2014, International Journal of Biochemistry Research and Review, V4, P440, DOI 10.9734/IJBCRR/2014/10649
   Kanauchi M, 2003, J CLIN ENDOCR METAB, V88, P3444, DOI 10.1210/jc.2002-021641
   Konukoglu D, 2003, CLIN BIOCHEM, V36, P405, DOI 10.1016/S0009-9120(03)00059-6
   Konukoglu D, 2003, J BIOMED LAB SCI, V19, P107
   Kramer MS, 2003, J NUTR, V133, p1592S
   Lebenthal E, 2007, J NUTR, V137, P1073
   Levrand S, 2006, FREE RADICAL BIO MED, V41, P886, DOI 10.1016/j.freeradbiomed.2006.04.034
   Li L, 2011, ARTERIOSCL THROM VAS, V31, P1547, DOI 10.1161/ATVBAHA.111.226456
   Lozano JV, 2008, CURR MED RES OPIN, V24, P659, DOI 10.1185/030079908X273372
   Martin H, 2000, CIRCULATION, V102, P2739
   Obeid R, 2009, FEBS LETT, V583, P1215, DOI 10.1016/j.febslet.2009.03.038
   Ong Ken K, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P30, DOI 10.1097/MED.0b013e328013da6c
   Pepine CJ, 2009, AM J MED, V122, P10, DOI 10.1016/j.amjmed.2009.03.003
   Szostak-Wegierek Dorota, 2004, Ginekol Pol, V75, P692
   Szostak-Wegierek Dorota, 2014, Int J Womens Health, V6, P647, DOI 10.2147/IJWH.S48751
   Tawfik SH, 2015, BIOCHEM RES INT, DOI 10.1155/2015/567945
   Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606
   Willette AA, 2012, NEUROBIOL AGING, V33, P670, DOI 10.1016/j.neurobiolaging.2010.06.003
   Woo CWH, 2003, MOL CELL BIOCHEM, V243, P37, DOI 10.1023/A:1021601512058
   Wu GY, 2004, J NUTR, V134, P2169
   Wu JT, 2008, J BIOMED LAB SCI, V19, P107
   Yu QJ, 2011, CARDIOVASC RES, V89, P516, DOI 10.1093/cvr/cvq349
   Zhang XH, 2000, AM J PHYSIOL-RENAL, V279, pF671
   Zhang ZY, 2014, MATERN CHILD HLTH J, V18, P1423, DOI 10.1007/s10995-013-1382-y
NR 34
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1720-8386
J9 J ENDOCRINOL INVEST
JI J. Endocrinol. Invest.
PD JUN
PY 2017
VL 40
IS 6
BP 611
EP 620
DI 10.1007/s40618-016-0600-z
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EV8ZI
UT WOS:000402073400006
PM 28028785
OA No
DA 2017-08-17
ER

PT J
AU Kamal, N
AF Kamal, Naglaa
TI Alstrom syndrome: A novel mutation in Saudi girl with insulin-resistant
   diabetes (vol 96, e6192, 2017)
SO MEDICINE
LA English
DT Correction
C1 [Kamal, Naglaa] Cairo Univ, Fac Med, Cairo, Egypt.
RP Kamal, N (reprint author), Cairo Univ, Fac Med, Cairo, Egypt.
CR Bakar AA, MEDICINE, V96, pe6192
   Bakar AA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006192
NR 2
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JUN
PY 2017
VL 96
IS 22
AR e7121
DI 10.1097/MD.0000000000007121
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EW5GL
UT WOS:000402533700061
OA gold
DA 2017-08-17
ER

PT J
AU Lowe, DH
   Todd, ADW
   Van den Bossche, R
   Bloembergen, P
   Anhalt, K
   Ballico, M
   Bourson, F
   Briaudeau, S
   Campos, J
   Cox, MG
   del Campo, D
   Dury, MR
   Gavrilov, V
   Grigoryeva, I
   Hernanz, ML
   Jahan, F
   Khlevnoy, B
   Khromchenko, V
   Lu, X
   Machin, G
   Mantilla, JM
   Martin, MJ
   McEvoy, HC
   Rougie, B
   Sadli, M
   Salim, SGR
   Sasajima, N
   Taubert, DR
   van der Ham, E
   Wang, T
   Wei, D
   Whittam, A
   Wilthan, B
   Woods, DJ
   Woodward, JT
   Woolliams, ER
   Yamada, Y
   Yamaguchi, Y
   Yoon, HW
   Yuan, Z
AF Lowe, D. H.
   Todd, A. D. W.
   Van den Bossche, R.
   Bloembergen, P.
   Anhalt, K.
   Ballico, M.
   Bourson, F.
   Briaudeau, S.
   Campos, J.
   Cox, M. G.
   del Campo, D.
   Dury, M. R.
   Gavrilov, V.
   Grigoryeva, I.
   Hernanz, M. L.
   Jahan, F.
   Khlevnoy, B.
   Khromchenko, V.
   Lu, X.
   Machin, G.
   Mantilla, J. M.
   Martin, M. J.
   McEvoy, H. C.
   Rougie, B.
   Sadli, M.
   Salim, S. G. R.
   Sasajima, N.
   Taubert, D. R.
   van der Ham, E.
   Wang, T.
   Wei, D.
   Whittam, A.
   Wilthan, B.
   Woods, D. J.
   Woodward, J. T.
   Woolliams, E. R.
   Yamada, Y.
   Yamaguchi, Y.
   Yoon, H. W.
   Yuan, Z.
TI The equilibrium liquidus temperatures of rhenium-carbon, platinum-carbon
   and cobalt-carbon eutectic alloysc
SO METROLOGIA
LA English
DT Article
DE high-temperature fixed points; thermodynamic temperature; equilibrium
   liquidus; temperature scale
ID CO-C; THERMOMETRY; UNCERTAINTY; IMPURITIES; FURNACE; POINTS
AB The eutectic alloys rhenium-carbon, platinum-carbon and cobalt-carbon have been proposed as reference standards for thermometry, with temperature and uncertainty values specified within the mise en pratique of the definition of the kelvin. These alloys have been investigated in a collaboration of eleven national measurement institutes and laboratories. Published results reported the point-of-inflection in the melting curve with extremely low uncertainties. However, to be considered as standards it is necessary to stipulate what phenomenon a temperature value has been ascribed to; specifically, this should be a thermodynamic state. Therefore, the data have been further evaluated and the equilibrium liquidus temperatures determined based on a consideration of limits and assuming a rectangular probability distribution. The values are: for rhenium-carbon 2747.91 +/- 0.44 K, for platinum-carbon 2011.50 +/- 0.22 K and for cobalt-carbon 1597.48 +/- 0.14 K, with uncertainties at approximately a 95% coverage probability. It is proposed that these values could be used as the basis of thermodynamic temperature measurement at high temperatures (above 1300 K).
C1 [Lowe, D. H.; Cox, M. G.; Dury, M. R.; Machin, G.; McEvoy, H. C.; Whittam, A.; Woolliams, E. R.] Natl Phys Lab, Hampton Rd, Teddington TW11 0LW, Middx, England.
   [Todd, A. D. W.; Woods, D. J.] Natl Res Council Canada NRC, 1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada.
   [Van den Bossche, R.] Univ Surrey, Guildford GU2 7XH, Surrey, England.
   [Bloembergen, P.; Lu, X.; Wang, T.; Wei, D.; Yuan, Z.] Natl Inst Metrol, 18 Bei San Huan Dong Lu, Beijing 100029, Peoples R China.
   [Anhalt, K.; Taubert, D. R.; Wilthan, B.] PTB, Abbestr 2-12, D-10587 Berlin, Germany.
   [Ballico, M.; Jahan, F.; van der Ham, E.] Natl Measurement Inst Australia, Bradfield Rd, West Lindfield, NSW 2070, Australia.
   [Bourson, F.; Briaudeau, S.; Rougie, B.; Sadli, M.; Salim, S. G. R.] Lab Commun Metrol LNE Cnam LNE Cnam, 61 Rue Landy, F-93210 St Denis, Reunion, France.
   [Campos, J.; Hernanz, M. L.] CSIC, Spanish Natl Res Council, Serrano 144, Madrid 28006, Spain.
   [del Campo, D.; Mantilla, J. M.; Martin, M. J.] CEM, C Alfar 2, Tres Cantos 28760, Spain.
   [Gavrilov, V.; Grigoryeva, I.; Khlevnoy, B.] All Russian Res Inst Opt & Phys Measurements VNII, Ozernaya 46, Moscow 119361, Russia.
   [Khromchenko, V.; Woodward, J. T.; Yoon, H. W.] NIST, 100 Bur Dr, Gaithersburg, MD 20899 USA.
   [Salim, S. G. R.] Natl Inst Stand, President Sadat St,BO Box 136, Giza, Egypt.
   [Sasajima, N.; Yamada, Y.; Yamaguchi, Y.] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.
RP Lowe, DH (reprint author), Natl Phys Lab, Hampton Rd, Teddington TW11 0LW, Middx, England.
EM dave.lowe@npl.co.uk
FU European Metrology Research Programme (EMPR); EMRP - EURAMET; EMRP -
   European Union; National Key Technology Support Program [2006BAF06B03];
   National Natural Science Foundation of China [51206151]; Ministry of
   education and Science of the Russian Federation [RFMEF159214X0001]
FX NPL, PTB, LNE_CNAM, CSIC, CEM acknowledge funding from the European
   Metrology Research Programme (EMPR), through which the 'Implementing the
   new kelvin' (InK) project was funded. The EMRP is jointly funded by the
   EMRP participating countries within EURAMET and the European Union.; NIM
   acknowledges the support from the National Key Technology Support
   Program (NO 2006BAF06B03) and the National Natural Science Foundation of
   China (NO 51206151).; VNIIOFI acknowledges funding from the Ministry of
   education and Science of the Russian Federation (identification number
   RFMEF159214X0001).
CR Bloembergen P, 2007, METROLOGIA, V44, P279, DOI 10.1088/0026-1394/44/5/004
   Bloembergen P, 2016, INT J THERMOPHYS, V37, DOI 10.1007/s10765-016-2048-y
   Bloembergen P, 2015, INT J THERMOPHYS, V36, P1859, DOI 10.1007/s10765-015-1892-5
   Bloembergen P, 2011, INT J THERMOPHYS, V32, P2633, DOI 10.1007/s10765-011-1070-3
   da Silva Rodrigo, 2017, Metrologia, V54, P365, DOI 10.1088/1681-7575/aa6ab3
   Dong W, 2017, MEASUREMENT, V106, P88, DOI 10.1016/j.measurement.2017.04.005
   Fellmuth B, 2006, METROLOGIA, V43, P71, DOI 10.1088/0026-1394/43/1/011
   Fischer J, 2003, UNCERTAINTY BUDGETS
   Imbe M, 2016, MEAS SCI TECHNOL, V27, DOI 10.1088/0957-0233/27/12/125020
   Machin G, 2007, INT J THERMOPHYS, V28, P1976, DOI 10.1007/s10765-007-0250-7
   Machin G, 2010, INT J THERMOPHYS, V31, P1779, DOI 10.1007/s10765-010-0834-5
   Milton MJT, 2006, METROLOGIA, V43, pS291, DOI 10.1088/0026-1394/43/4/S17
   Todd ADW, 2014, INT J THERMOPHYS, V35, P1366, DOI 10.1007/s10765-014-1666-5
   Woolliams ER, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0044
   Yamada Y, 1999, METROLOGIA, V36, P207, DOI 10.1088/0026-1394/36/3/6
   Yamada Y, 2015, INT J THERMOPHYS, P36
NR 16
TC 0
Z9 0
U1 2
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0026-1394
EI 1681-7575
J9 METROLOGIA
JI Metrologia
PD JUN
PY 2017
VL 54
IS 3
DI 10.1088/1681-7575/aa6eeb
PG 9
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA EW3CI
UT WOS:000402371900002
OA No
DA 2017-08-17
ER

PT J
AU Khalil, MAF
   Elgaml, A
   El-Mowafy, M
AF Khalil, Mahmoud A. F.
   Elgaml, Abdelaziz
   El-Mowafy, Mohammed
TI Emergence of Multidrug-Resistant New Delhi
   Metallo-beta-Lactamase-1-Producing Klebsiella pneumoniae in Egypt
SO MICROBIAL DRUG RESISTANCE
LA English
DT Article
DE Klebsiella pneumoniae; multidrug resistance; carbapenems; New
   Delhi-metallo-B-lactamase-1; Egypt
ID CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE; ACINETOBACTER-BAUMANNII;
   BETA-LACTAMASE; INDIA; EPIDEMIOLOGY; OUTBREAK; BACTERIA; CLOACAE;
   SPREAD; CLONE
AB Despite expansion of the New Delhi metallo-beta-lactamase-1 (NDM-1) worldwide, the incident of outbreaks regarding Egypt is still uncommon. In this survey, we denounce the emanation of multidrug-resistant NDM-1producing Klebsiella pneumoniae in Egypt. We have reclaimed 46 unrepeatable carbapenem-resistant K. pneumoniae isolates at El-demerdash hospital, Ain Shams University, Cairo, Egypt. All the isolates showed a decreased sensitivity to imipenem and meropenem via the disc diffusion method. Among the isolates, 10 were proven as NDM-1 producers by utilizing the phenotypic methods (modified Hodge test and EDTA synergistic test) and specific PCR detection of NDM-1 encoding gene, bla(NDM-1). The isolates hosting the bla(NDM-1) showed an elevated resistance to several classes of beta-lactam and non beta-lactam antibiotics. All bla(NDM-1)-harboring isolates have showed positivity for one or more other plasmid-mediated bla genes; in addition, the isolates carried class 1 integron. Enterobacterial repetitive intergenic consensus (ERIC)-PCR results revealed that majority of the isolates, including the NDM-1 producers, are unrelated to each other. This highlights the danger of horizontal transfer of plasmids encoding for such carbapenemases, including NDM-1, between the isolates of K. pneumoniae. In summary, this study has confirmed the incidence of bla(NDM-1) together with other bla genes among the K. pneumoniae isolates in Egypt. Control and prevention of infection can be achieved through early detection of resistance genes among bacterial isolates; through limiting the dispersal of these organisms.
C1 [Khalil, Mahmoud A. F.] Misr Univ Sci & Technol, Fac Pharm, Dept Microbiol & Immunol, 6th Of October City, Egypt.
   [Elgaml, Abdelaziz; El-Mowafy, Mohammed] Mansoura Univ, Fac Pharm, Dept Microbiol & Immunol, Mansoura 35516, Egypt.
RP Elgaml, A (reprint author), Mansoura Univ, Fac Pharm, Dept Microbiol & Immunol, Mansoura 35516, Egypt.
EM elgamel3a@mans.edu.eg
CR Abdelaziz MO, 2013, J GLOB ANTIMICROB RE, V1, P213, DOI 10.1016/j.jgar.2013.06.003
   Berrazeg M., 2014, Eurosurveillance, V19, P20809, DOI 10.2807/1560-7917.ES2014.19.20.20809
   Bharadwaj R, 2012, INT J ANTIMICROB AG, V39, P265, DOI 10.1016/j.ijantimicag.2011.09.027
   Bora A, 2012, J CLIN DIAGN RES, V6, P794
   Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431
   Medina-Presentado JC, 2013, INT J INFECT DIS, V17, pE422, DOI 10.1016/j.ijid.2012.12.025
   CLSI. Clinical and laboratory standards institute, 2013, M100S23 CLSI
   Collee JG, 1996, MACKIE MCCARTNEY PRA, P131
   Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498
   Dortet L, 2014, BIOMED RES INT, DOI 10.1155/2014/249856
   Duan HY, 2009, ENVIRON RES, V109, P511, DOI 10.1016/j.envres.2009.02.014
   Elgaml A., 2013, African Journal of Microbiology Research, V7, P2862
   European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014, BREAKP TABL INT MICS
   Fluit AC, 1999, EUR J CLIN MICROBIOL, V18, P761, DOI 10.1007/s100960050398
   Fouad M, 2013, INT J INFECT DIS, V17, pE1252, DOI 10.1016/j.ijid.2013.07.012
   Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001
   Jeon BC, 2005, J CLIN MICROBIOL, V43, P2241, DOI 10.1128/JCM.43.5.2241-2245.2005
   Jin YY, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0119571, 10.1371/journal.pone.0142574]
   Khan AU, 2012, J MED MICROBIOL, V61, P454, DOI 10.1099/jmm.0.039008-0
   Lee CM, 2012, ANTIMICROB AGENTS CH, V56, P5016, DOI 10.1128/AAC.00878-12
   Liu PYF, 1997, DIAGN MICR INFEC DIS, V29, P19, DOI 10.1016/S0732-8893(97)00080-1
   Marra A, 2011, FUTURE MICROBIOL, V6, P137, DOI [10.2217/fmb.10.171, 10.2217/FMB.10.171]
   Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655
   Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10
   Peirano G, 2009, J ANTIMICROB CHEMOTH, V63, P265, DOI 10.1093/jac/dkn484
   Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P598, DOI 10.1128/AAC.05639-11
   Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10
   Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431
   Seema K, 2011, J ANTIMICROB CHEMOTH, V66, P1646, DOI 10.1093/jac/dkr180
   Teo Jeanette, 2012, Western Pac Surveill Response J, V3, P19, DOI 10.5365/WPSAR.2011.2.4.010
   Tsakris A, 2011, J CLIN MICROBIOL, V49, P2804, DOI 10.1128/JCM.00666-11
   Tseng SH, 2011, J MICROBIOL IMMUNOL, V44, P157, DOI 10.1016/j.jmii.2011.03.001
   Venkatachalam I, 2012, EMERG INFECT DIS, V18, P1381, DOI 10.3201/eid1808.110893
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823
   Wang JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121668
   Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026356
   Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11
   Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09
NR 38
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-6294
EI 1931-8448
J9 MICROB DRUG RESIST
JI Microb. Drug Resist.
PD JUN
PY 2017
VL 23
IS 4
BP 480
EP 487
DI 10.1089/mdr.2016.0003
PG 8
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA EW5SW
UT WOS:000402567800011
PM 27575913
OA No
DA 2017-08-17
ER

PT J
AU Mubaraki, MA
   Hafiz, TA
   Al-Quraishy, S
   Dkhil, MA
AF Mubaraki, Murad A.
   Hafiz, Taghreed A.
   Al-Quraishy, Saleh
   Dkhil, Mohamed A.
TI Oxidative stress and genes regulation of cerebral malaria upon Zizyphus
   spina-christi treatment in a murine model
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Zizyphus spina-Christi; Plasmodium berghei; Cerebral malaria; Oxidative
   stress; Apoptosis; Mice
ID ANTIMICROBIAL ACTIVITY; FALCIPARUM-MALARIA; ANTI-EIMERIA; MICE;
   INFECTION; EXTRACTS; CHANNELS; VACCINE; ANKA; ROOT
AB The development and spread of multidrug-resistant strains of malarial parasites have led to an overwhelming increase in the resistance to current antimalarial drugs. The urgent need for alternative antimalarial drugs has directed some of the current studies toward folkloric medicine approaches. Interestingly, the Zizyphus spina Cristi leaf extract (ZLE) has been found to exhibit antiplasmodial activity. This study evaluated the protective effect of ZLE against Plasmodium berghei-induced cerebral tissue injuries in mice. Male C57Bl/6 mice received an injection of P. berghei-infected red blood cells. Mice were divided into three groups (control, infected, and ZLE-treated), and were subjected to histological, biochemical, and molecular analyses.
   Murine malaria infections induced significant weight loss; however, upon ZLE treatment, the weight of mice was markedly restored. Additionally, infected mice showed brain histopathological changes and induction of oxidative damage. Significantly, ZLE treatment restored the levels of oxidative markers and antioxidant enzyme to the normal ranges. The mRNA expression of several genes in the brain of mice including Cacnb4, Adam23, Glrb, Vdac3, and Cabp1 was significantly upregulated during P. berghei infection. In contrast, ZLE markedly reduced the mRNA expression of these genes. To conclude, the results indicate that ZLE could play an important role in reducing the destructive effect of P. berghei-induced cerebral malaria owing to its antiplasmodial and antioxidant activities. (C) 2017 Published by Elsevier Ltd.
C1 [Mubaraki, Murad A.; Hafiz, Taghreed A.] King Saud Univ, Coll Appl Med Sci, Clin Lab Sci Dept, POB 10219, Riyadh 11433, Saudi Arabia.
   [Al-Quraishy, Saleh; Dkhil, Mohamed A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia.
   [Dkhil, Mohamed A.] Helwan Univ, Dept Zool & Entomol, Fac Sci, Qism Helwan, Cairo Governora, Egypt.
RP Mubaraki, MA (reprint author), King Saud Univ, Coll Appl Med Sci, Clin Lab Sci Dept, POB 10219, Riyadh 11433, Saudi Arabia.
EM mmubaraki@ksu.edu.sa
FU Deanship of Scientific Research at King Saud University [RG-198]
FX The authors extend their appreciations to the Deanship of Scientific
   Research at King Saud University for funding their work through the
   research group project No. RG-198.
CR Abdel-Zaher AO, 2005, J ETHNOPHARMACOL, V101, P129, DOI 10.1016/j.jep.2005.04.007
   Adzu B, 2001, FITOTERAPIA, V72, P344, DOI 10.1016/S0367-326X(00)00289-6
   Adzu B, 2007, INT J BIOL CHEM SCI, V1, P281
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Ali-Shtayeh MS, 1998, J ETHNOPHARMACOL, V60, P265, DOI 10.1016/S0378-8741(97)00153-0
   Alzahrani F, 2016, PAK J ZOOL, V48, P409
   Asgarpanah J, 2012, AFR J PHARM PHARMACO, V6, P2332, DOI 10.5897/AJPP12.509
   Basir R, 2012, IRAN J PARASITOL, V7, P62
   Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049
   Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x
   Chalphin Alexander V, 2010, Front Mol Neurosci, V3, P11, DOI 10.3389/fnmol.2010.00011
   Cizkova A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Coban EP, 2010, AFR J MICROBIOL RES, V4, P2318
   Darbandi-Tonkabon R, 2004, J PHARMACOL EXP THER, V308, P502, DOI 10.1124/jpet.103.058123
   Desruisseaux MS, 2008, J INFECT DIS, V197, P1621, DOI 10.1086/587908
   Desruisseaux M. S., 2010, J NEUROPARASITOLOGY, V1
   Dkhil MA, 2015, PARASITOL RES, V114, P1581, DOI 10.1007/s00436-015-4344-z
   Dkhil MA, 2013, SCI WORLD J, DOI 10.1155/2013/439865
   Dkhil MA, 2013, PARASITOL RES, V112, P2639, DOI 10.1007/s00436-013-3430-3
   Dua VK, 2004, J ETHNOPHARMACOL, V95, P247, DOI 10.1016/j.jep.2004.07.008
   ELING W, 1977, Z PARASITENKD, V54, P29, DOI 10.1007/BF00380634
   Ellman G.L., 1959, BIOCH BIOPHYS, V82, P70
   GLOMBITZA KW, 1994, PLANTA MED, V60, P244, DOI 10.1055/s-2006-959468
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Greenwood B, 2009, PARASITE IMMUNOL, V31, P582, DOI 10.1111/j.1365-3024.2009.01140.x
   Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320
   Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717
   Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x
   LEE IS, 1989, J NAT PROD, V52, P337, DOI 10.1021/np50062a020
   Lev E, 2000, J ETHNOPHARMACOL, V72, P191, DOI 10.1016/S0378-8741(00)00230-0
   Livak K. J., METHODS, V25
   Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034
   Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074
   Moorthy V. S., 2009, MALAR J, V8
   O'Meara WP, 2009, PARASITE IMMUNOL, V31, P574, DOI 10.1111/j.1365-3024.2009.01144.x
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Oppenheim R. D., 2014, PLOS PATHOG, P10
   Panseeta P, 2011, PHYTOCHEMISTRY, V72, P909, DOI 10.1016/j.phytochem.2011.03.003
   SENANAYAKE N, 1994, J NEUROL, V241, P456, DOI 10.1007/BF00900965
   Shen XC, 2009, J ETHNOPHARMACOL, V122, P555, DOI 10.1016/j.jep.2009.01.027
   Tsakiris S, 2004, PHARMACOL RES, V49, P475, DOI 10.1016/j.phrs.2003.11.006
   Turner G, 1997, BRAIN PATHOL, V7, P569, DOI 10.1111/j.1750-3639.1997.tb01075.x
   WHO, 2012, WORLD MALARIA REPORT 2012, P1
NR 43
TC 0
Z9 0
U1 1
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD JUN
PY 2017
VL 107
BP 69
EP 74
DI 10.1016/j.micpath.2017.03.017
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EW4UI
UT WOS:000402496000011
PM 28336326
OA No
DA 2017-08-17
ER

PT J
AU Aly, I
   Taher, EE
   EL-Sayed, H
   Mohammed, FA
   ELnain, G
   Hamad, RS
   Bayoumy, EM
AF Aly, Ibrahim
   Taher, Eman E.
   EL-Sayed, Hoda
   Mohammed, Faten A.
   ELnain, Gehan
   Hamad, Rabab S.
   Bayoumy, Elsayed M.
TI Efficacy of soluble glycoprotein fraction from Allium sativum purified
   by size exclusion chromatography on murine Schistosomiasis mansoni
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Schistosoma mansoni; Allium sativum; Soluble glycoprotein fraction;
   Fibrocellular granuloma
ID NIGELLA-SATIVA; MICE; PRAZIQUANTEL; RESISTANCE; ANTIOXIDANT; AGENT
AB In this work, the efficiency of crude MeOH extracts and soluble glycoprotein fraction of Allium sativum purified by size-exclusion chromatography (SEC) on parasitological, histopathological and some biochemical parameters in Schistosoma mansoni infected mice were investigated. Animals were infected by tail immersion with 100 cercariae/each mouse and divided into five groups in addition to the normal control. The results revealed a significant decrease in mean worm burden in all treated mice especially in the group treated with soluble glycoprotein fraction of A. sativum as compared to infected non-treated control with the disappearance of female worms. Administration of the studied extracts revealed remarkable amelioration in the levels of all the measured parameters in S. mansoni infected mice. In addition, treatment of mice with crude A. sativum MeOH extract and soluble glycoprotein fraction of A. sativum decreased significantly the activities of studied enzymes as compared to the infected untreated group. The highest degrees of enhancement in pathological changes was observed in the treated one with soluble glycoprotein fraction of A. sativum compared to the infected group represented by small sized, late fibro-cellular granuloma, the decrease in cellular constituents and degenerative changes in eggs. In conclusion, A. sativum treatment had effective schistosomicidal activities, through reduction of worm burden and tissue eggs, especially when it was given in purified glycoprotein fraction. Moreover, the soluble glycoprotein fraction of A. sativum largely modulates both the size and the number of granulomas. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Aly, Ibrahim; ELnain, Gehan; Hamad, Rabab S.] Theodor Bilharz Res Inst, Parasitol Lab, Giza, Egypt.
   [Taher, Eman E.] Res Inst Ophthalmol, Clin Parasitol Dept, Giza, Egypt.
   [Mohammed, Faten A.] Zagazig Univ, Fac Med, Parasitol Dept, Zagazig, Egypt.
   [ELnain, Gehan] Abu Dhabi Univ, Univ Coll, Nat Sci Math & Sci Program, Abu Dhabi, U Arab Emirates.
   [Hamad, Rabab S.] King Faisal Univ, Biol Sci Dept, Al Hufuf, Saudi Arabia.
   [Bayoumy, Elsayed M.] Natl Res Ctr, Hydrobiol Dept, Giza, Egypt.
   [Bayoumy, Elsayed M.] Univ Dammam, Girls Sci Coll, Biol Dept, Dammam, Saudi Arabia.
RP Bayoumy, EM (reprint author), Natl Res Ctr, Hydrobiol Dept, Giza, Egypt.
EM bayoumy2004@yahoo.com
OI Bayoumy, Elsayed/0000-0002-3106-6745
CR Abu El Ezz Nadia M. T., 2005, Journal of the Egyptian Society of Parasitology, V35, P511
   Ahmad Aftab, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P337, DOI 10.1016/S2221-1691(13)60075-1
   Aly IRB, 2010, MEM I OSWALDO CRUZ, V105, P729, DOI 10.1590/S0074-02762010000600001
   Barth LR, 1997, MEM I OSWALDO CRUZ, V92, P427, DOI 10.1590/S0074-02761997000300022
   BELFIELD A, 1971, ENZYME, V12, P561
   CHEEVER A W, 1968, Bulletin of the World Health Organization, V39, P328
   DUVALL RH, 1967, AM J TROP MED HYG, V16, P483
   El Ridi Rashika A F, 2013, J Adv Res, V4, P467, DOI 10.1016/j.jare.2012.05.002
   El Shenawy NS, 2008, REV I MED TROP, V50, P29, DOI 10.1590/S0036-46652008000100007
   El-Kott A. F., 2011, Research Journal of Parasitology, V6, P151
   El-Sheikh YWA, 2012, NY SCI J, V5, P19
   Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1
   Fallon PG, 2000, J IMMUNOL, V164, P2585
   FALLON PG, 1994, AM J TROP MED HYG, V51, P83
   Ferguson J., 2012, BIOL INFECT DIS LECT, P112
   Foroutan-Rad M., 2017, EVID-BASED COMPL ALT, V22, P141
   GONNERT R, 1977, Z PARASITENKD, V52, P129, DOI 10.1007/BF00389899
   Gryseels B, 2001, TROP MED INT HEALTH, V6, P864, DOI 10.1046/j.1365-3156.2001.00811.x
   Henry R.J., 1964, CLIN CHEM PRINCIPLES, P525
   lqbal Z., 2016, WORLD J PHARM RES, V5, P1959
   Ismail M, 1999, AM J TROP MED HYG, V60, P932
   Kamel E.G., 2006, P 4 INT C BIOL SCI Z, V219
   Kamel ROA, 2015, ASIAN PAC J TROP MED, V8, P974, DOI 10.1016/j.apjtm.2015.11.016
   Kyo E, 2001, J NUTR, V131, p1075S
   Larson MK, 2014, INT J PARASITOL, V44, P343, DOI 10.1016/j.ijpara.2013.11.004
   Liang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020247
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mantawy MM, 2012, EUR REV MED PHARMACO, V16, P69
   Mantawy Mona M., 2002, Journal of the Egyptian Society of Parasitology, V32, P271
   Metwally NS., 2006, EGYPT J HOSP MED, V23, P319
   Nyakaana S, 2013, ACTA TROP, V128, P226, DOI 10.1016/j.actatropica.2012.12.010
   PELLEGRINO J, 1962, AM J TROP MED HYG, V11, P201
   PIPER KP, 1990, PARASITE IMMUNOL, V12, P367, DOI 10.1111/j.1365-3024.1990.tb00975.x
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Riad NH., 2007, J APPL SCI RES, V3, P949
   SALOMI MJ, 1991, NUTR CANCER, V16, P67
   Snedecor G.W., 1981, STAT METHODS
   Szasz G., 1974, CLIN CHEM CLIN BIOCH, V12, P228
   Von Lichtenberg, 1962, AM J PATHOL, V41, P711
   World Health Organisation, 2016, SCHISTOSOMIASIS
   Zhang MH, 2012, J ANAL METHODS CHEM, DOI 10.1155/2012/709656
NR 41
TC 0
Z9 0
U1 1
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD JUN
PY 2017
VL 107
BP 243
EP 248
DI 10.1016/j.micpath.2017.03.039
PG 6
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EW4UI
UT WOS:000402496000036
PM 28373144
OA No
DA 2017-08-17
ER

PT J
AU Hegazy, YY
   Hassanein, W
   Ennker, J
   Keshk, N
   Bauer, S
   Sodian, R
AF Hegazy, Yasser Y.
   Hassanein, Wael
   Ennker, Juergen
   Keshk, Noha
   Bauer, Stefan
   Sodian, Ralf
TI The Use of Bilateral Internal Mammary Artery Grafting in Different
   Degrees of Obesity
SO THORACIC AND CARDIOVASCULAR SURGEON
LA English
DT Article
DE obesity; wound healing; coronary artery bypass grafts surgery; coronary
   artery bypass graft
ID PROPENSITY-MATCHED ANALYSIS; STERNAL WOUND-INFECTION; 30-YEAR FOLLOW-UP;
   THORACIC ARTERY; MYOCARDIAL REVASCULARIZATION; DIABETIC-PATIENTS;
   BYPASS; SINGLE; RISK; MORTALITY
AB Background Obesity is a limiting factor for the use of bilateral internalmammary arteries (BIMAs). Therefore, we assessed the safety of their use in different degrees of obesity.
   Patients and Methods We studied two groups of patients with obesity using propensity matching. The first group received single internal mammary artery and saphenous vein grafts (SIMA group, 526 patients) and the second group received bilateral internalmammary arteries (BIMA group, 526 patients). Patients were classified further according to their bodymass index (BMI) into overweight (BMI = 25-29.9 kg/m(2)), obese (BMI = 30-34.9 kg/m(2)), and severely obese (BMI >= 35 kg/m(2)).
   Results Preoperative data were similar regarding age (62.78 +/- 9.96 vs. 62.98 +/- 9.66 years; p = 0.734), female sex (17.5 vs. 18.6%; p = 0.631), diabetes mellitus (26.3 vs. 27.2%; p = 0.74), EuroSCORE (3.21 +/- 2.23 vs. 3.18 +/- 2.41; p = 0.968), and COPD (16 vs. 16%; p = 1). No significant differences were noticed between the two groups regarding the number of peripheral anastomoses (3.09 +/- 0.84 vs. 3.12 +/- 0.83; p = 0.633), myocardial infarction (1.7 vs. 1.7%; p = 1), reexploration (1.3 vs. 2.1%; p = 0.34), deep sternal wound infection (DSWI) (2.1 vs. 2.9%; p = 0.43), and 30-day mortality (0.8 vs. 1.1%; p = 0.53). Multivariate analysis identified BMI and intensive care unit stay as independent predictors for DSWI. However, postoperative blood loss (694.56 +/- 631.84 vs. 811.67 +/- 688.73 mL; p < 0.001) and the incidence of pneumothorax (1 vs. 2.7%; p = 0.037) were higher in BIMA group.
   Conclusion Patients with obesity can benefit from BIMA grafting. However, postoperative blood loss and the incidence of pneumothorax can be higher using this technique.
C1 [Hegazy, Yasser Y.; Ennker, Juergen; Keshk, Noha; Bauer, Stefan; Sodian, Ralf] Mediclin Heart Inst, Dept Cardiac Surg, Lahr Baden, Germany.
   [Hegazy, Yasser Y.; Hassanein, Wael] Alexandria Univ, Fac Med, Dept Cardiothorac Surg, Alexandria, Egypt.
   [Ennker, Juergen] Univ Witten Herdecke, Fac Hlth, Sch Med, Witten, Germany.
RP Hegazy, YY (reprint author), Mediclin Heart Inst Lahr, Dept Cardiac Surg, Hohbergweg 2, D-77933 Lahr, Germany.
EM yasserhegazy@yahoo.com
CR Benedetto U, 2015, J THORAC CARDIOVASC, V149
   Berreklouw E, 2001, ANN THORAC SURG, V72, P1535, DOI 10.1016/S0003-4975(01)03040-5
   Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2001.120329
   Calafiore AM, 2004, EUR J CARDIO-THORAC, V26, P542, DOI 10.1016/j.ejcts.2004.05.028
   Dai CY, 2013, ANN THORAC SURG, V95, P1938, DOI 10.1016/j.athoracsur.2012.12.038
   DEJESUS RA, 1995, ANN THORAC SURG, V59, P163, DOI 10.1016/0003-4975(94)00722-J
   Dorman MJ, 2012, CIRCULATION, V126, P2935, DOI 10.1161/CIRCULATIONAHA.112.117606
   Gansera B, 2003, Z KARDIOL, V92, P398, DOI 10.1007/s00392-003-0926-3
   Gansera B, 2006, EUR J CARDIO-THORAC, V30, P318, DOI 10.1016/j.ejcts.2006.05.017
   Grau JB, 2012, EUR J CARDIO-THORAC, V41, P770, DOI 10.1093/ejcts/ezr213
   Hassanein W, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-25
   Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e
   Hu X, 2011, ANN THORAC SURG, V92, P48, DOI 10.1016/j.athoracsur.2011.03.067
   Itagaki S, 2013, HEART, V99, P849, DOI 10.1136/heartjnl-2013-303672
   Kieser TM, 2014, J THORAC CARDIOV SUR, V148, P1887, DOI 10.1016/j.jtcvs.2014.02.022
   Kurlansky PA, 2010, ANN THORAC SURG, V90, P101, DOI 10.1016/j.athoracsur.2010.04.006
   LaPar DJ, 2015, ANN THORAC SURG, V100, P8, DOI 10.1016/j.athoracsur.2015.02.088
   Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288
   Pick AW, 1997, ANN THORAC SURG, V64, P599, DOI 10.1016/S0003-4975(97)00620-6
   Ruttmann E, 2011, CIRCULATION, V124, P1321, DOI 10.1161/CIRCULATIONAHA.111.030536
   Sabik JF, 2005, ANN THORAC SURG, V79, P544, DOI 10.1016/j.athoracsur.2004.07.047
   Saito A, 2013, EUR J CARDIO-THORAC, V44, P711, DOI 10.1093/ejcts/ezt157
   Syrakas CA, 2007, THORAC CARDIOV SURG, V55, P491, DOI 10.1055/s-2007-965599
   Tabata M, 2009, CIRCULATION, V120, P935, DOI 10.1161/CIRCULATIONAHA.108.832444
   Terada T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003282
   Toumpoulis Ioannis K, 2007, Interact Cardiovasc Thorac Surg, V6, P787, DOI 10.1510/icvts.2007.164343
   Wee CC, 2008, J AM COLL CARDIOL, V52, P620, DOI 10.1016/j.jacc.2008.05.021
   Weiss Aaron J, 2013, Ann Cardiothorac Surg, V2, P390, DOI 10.3978/j.issn.2225-319X.2013.07.16
   World Health Organization, OB OV
   Windecker S, 2014, EUR HEART J, V35, P2541, DOI 10.1093/eurheartj/ehu278
NR 30
TC 0
Z9 0
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0171-6425
EI 1439-1902
J9 THORAC CARDIOV SURG
JI Thorac. Cardiovasc. Surg.
PD JUN
PY 2017
VL 65
IS 4
BP 278
EP 285
DI 10.1055/s-0037-1598028
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA EW5GM
UT WOS:000402533800005
PM 28110487
OA No
DA 2017-08-17
ER

PT J
AU Abdelhafez, TH
   El Din, NGB
   Tabll, AA
   Mashaly, MM
   Dawood, RM
   Yassin, NA
   El-Awady, MK
AF Abdelhafez, Tawfeek H.
   El Din, Noha G. Bader
   Tabll, Ashraf A.
   Mashaly, Mohammad M.
   Dawood, Reham M.
   Yassin, Nemat A.
   El-Awady, Mostafa K.
TI Mice Antibody Response to Conserved Nonadjuvanted Multiple Antigenic
   Peptides Derived from E1/E2 Regions of Hepatitis C Virus
SO VIRAL IMMUNOLOGY
LA English
DT Article
DE HCV; synthetic peptides; neutralizing antibodies
ID HUMAN MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODIES; ENVELOPE
   GLYCOPROTEIN; SYNTHETIC PEPTIDE; HCV INFECTION; PROTECTIVE IMMUNITY;
   CONTROLLED TRIAL; E2 GLYCOPROTEIN; HEPG2 CELLS; VACCINE
AB Synthetic peptides are one of the hepatitis C virus (HCV)-specific small molecules that have antiviral activity and represent a target for HCV vaccine. This study aims to determine the lowest concentration of adjuvanted and non-adjuvanted (multiple antigenic peptide [MAP]) form of three conserved HCV envelope peptides that can induce murine immunogenic responses and evaluate the neutralization capacities of the generated antibodies (Abs) against HCV in cultured Huh7.5 cells. In this study, three HCV synthetic peptides, E1 peptide (a.a 315-323) and E2 peptides (a.a 412-419 and a.a 516-531) were synthesized. Female Balb/c mice were immunized with different concentration of either adjuvanted linear peptides or nonadjuvanted MAP peptides to determine the lowest dose that generates Ab responses enough to confer viral neutralization in vitro. The humoral responses targeting these peptides in immunized mice sera were measured by enzyme-linked immunosorbent assay ( ELISA). Viral neutralization capacities of the generated mice Abs were assessed using Huh7.5 cells infected with the HCVcc infectious system (J6/JFH-1). The results of this study showed that the MAPs induce higher Ab titers than adjuvanted linear peptides after 4 weeks of immunization (p = 0.003). The viral neutralization experiments showed that the immunized mice sera contain anti E1/E2 Abs that blocked HCVcc (J6/JFH-1) entry into Huh7.5 cells. In conclusion, the three HCV envelope MAP peptides are more immunogenic and produce higher neutralizing Abs than linear peptides; therefore, they can be essential components for HCV vaccine.
C1 [Abdelhafez, Tawfeek H.; El Din, Noha G. Bader; Tabll, Ashraf A.; Dawood, Reham M.; El-Awady, Mostafa K.] Natl Res Ctr, Dept Microbial Biotechnol, Giza 12622, Egypt.
   [Yassin, Nemat A.] Natl Res Ctr, Dept Pharmacol, Giza, Egypt.
   [Mashaly, Mohammad M.] Damietta Univ, Fac Sci, Dept Chem, Dumyat, Egypt.
RP Abdelhafez, TH (reprint author), Natl Res Ctr, Dept Microbial Biotechnol, Giza 12622, Egypt.
EM tawfeek_hussein@yahoo.com
CR BRATTEGAARD K, 1995, AIDS, V9, P656, DOI 10.1097/00002030-199506000-00023
   Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   De Clercq E, 2014, BIOCHEM PHARMACOL, V89, P441, DOI 10.1016/j.bcp.2014.04.005
   Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080
   Drummer HE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00329
   Edwards VC, 2012, J GEN VIROL, V93, P1, DOI 10.1099/vir.0.035956-0
   El Abd YS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-391
   El Awady MK, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-18
   El-Awady MK, 1999, CLIN CHIM ACTA, V283, P1, DOI 10.1016/S0009-8981(99)00007-8
   El-Awady MK, 2006, WORLD J GASTROENTERO, V12, P2530
   El-Awady MK, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-66
   El-Shenawy Reem, 2015, J Immunoassay Immunochem, V36, P63, DOI 10.1080/15321819.2014.896264
   Eren R, 2006, J VIROL, V80, P2654, DOI 10.1128/JVI.80.6.2654-2664.2006
   Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766
   Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394
   FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801
   Firbas C, 2006, VACCINE, V24, P4343, DOI 10.1016/j.vaccine.2006.03.009
   Flint M, 1999, J VIROL, V73, P6235
   HEM S L, 1984, Journal of Parenteral Science and Technology, V38, P2
   Huang XJ, 2013, J VIROL METHODS, V189, P47, DOI 10.1016/j.jviromet.2013.01.003
   Joshi VG, 2013, INDIAN J VIROL, V24, P312, DOI 10.1007/s13337-013-0162-z
   KATO N, 1993, J VIROL, V67, P3923
   Kim P, 2001, J IMMUNOL METHODS, V257, P51, DOI 10.1016/S0022-1759(01)00444-6
   Klade CS, 2008, GASTROENTEROLOGY, V134, P1385, DOI 10.1053/j.gastro.2008.02.058
   Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485
   Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x
   Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8
   Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004
   Law JLM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059776
   Mancini N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008254
   McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014
   Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07
   Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005
   Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0
   Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07
   Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1072/pnas.0607026104
   Piazza M, 1997, ARCH INTERN MED, V157, P1537, DOI 10.1001/archinte.157.14.1537
   Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938
   Pockros Paul J, 2010, Therap Adv Gastroenterol, V3, P191, DOI 10.1177/1756283X10363055
   Poordad F, 2012, J VIRAL HEPATITIS, V19, P449, DOI 10.1111/j.1365-2893.2012.01617.x
   Prince AM, 2005, J INFECT DIS, V192, P1701, DOI 10.1086/496889
   Rollier C, 2004, J VIROL, V78, P187, DOI 10.1128/JVI.78.1.187-196.2004
   ROSA C, 1995, J VIROL METHODS, V55, P219, DOI 10.1016/0166-0934(95)00060-8
   Sadler K, 2002, J BIOTECHNOL, V90, P29
   Saravanan P, 2004, ACTA VIROL, V48, P39
   Sautto GA, 2012, NEW MICROBIOL, V35, P387
   Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529
   Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105
   Shimizu YK, 1996, HEPATOLOGY, V23, P205
   Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819
   Stamataki Z, 2007, VACCINE, V25, P7773, DOI 10.1016/j.vaccine.2007.08.053
   Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015
   Tabll Ashraf, 2013, Human Antibodies, V22, P55, DOI 10.3233/HAB-140271
   Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088
   Verstrepen BE, 2011, J INFECT DIS, V204, P837, DOI 10.1093/infdis/jir423
   Wang Y, 2011, VIRUSES-BASEL, V3, P2127, DOI 10.3390/v3112127
   Weiner AJ, 2001, J VIROL, V75, P7142, DOI 10.1128/JVI.75.15.7142-7148.2001
NR 58
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD JUN
PY 2017
VL 30
IS 5
BP 359
EP 365
DI 10.1089/vim.2016.0123
PG 7
WC Immunology; Virology
SC Immunology; Virology
GA EW5QW
UT WOS:000402562400008
PM 28402196
OA No
DA 2017-08-17
ER

PT J
AU Abd El-Malek, AH
   Al-Qahtani, FS
   Radaydeh, RM
   Zummo, SA
   Alnuweiri, H
AF Abd El-Malek, Ahmed H.
   Al-Qahtani, Fawaz S.
   Radaydeh, Redha M.
   Zummo, Salam A.
   Alnuweiri, Hussein
TI Performance Analysis and Power Allocation for Underlay Cognitive MIMO
   Relaying Networks with Transmit Antenna Selection Under Antenna
   Correlation
SO WIRELESS PERSONAL COMMUNICATIONS
LA English
DT Article
DE Cognitive relay networks; Decode-and-forward; Antenna correlation;
   Outage probability; Power allocation
ID SPECTRUM ACCESS; INTERFERENCE; ENVIRONMENTS; SYSTEMS; OUTAGE
AB In this paper, we examine transmit antenna selection with receiver maximal ratio combining (TAS/MRC), and selection combining (TAS/SC) in underlay multiple-input multiple-output cognitive relay networks with decode-and-forward relaying protocol, considering optimal and suboptimal cases. The considered secondary user (SU) network consists of a source, a relay and a destination each equipped with multiple correlated antennas. On the other hand, the primary network is composed of L primary users (PU) destinations, each of which is equipped with multiple correlated antennas. The SU transmission power is limited to the minimum between the maximum allowable power for transmission and the maximum interference power allowed by the PU network. In the analysis, all the channel coefficients between the PU and SU networks and between the SU nodes are assumed to follow independent and identically distributed (i.i.d.) Rayleigh fading distribution. Hence, new exact closed-form expressions are derived to study the outage performance of the considered CRN system. Moreover, for the high SNR values, simple asymptotic expressions for the outage probability are obtained to get more insights on the characterization of the achievable diversity orders and coding gains. The impact of antenna correlation on the system outage probability is investigated for special correlation cases. To enhance SU network performance, a power allocation optimization problem is formulated to minimize the SU asymptotic outage probability by optimally distributing the SU power budget between the SU source and SU relay under the constraints of total allowable SU transmission power and maximum allowable PU interference limit. The derived analytical formulas herein are supported by numerical and simulation results to clarify the main contributions. The results show that although the antenna correlation harms the system coding gain, the considered system can still achieve a full diversity order. Also, The results show that although the outage performance of optimal case outperforms the suboptimal case, the optimal case is more complicated compared to the suboptimal one. Moreover, the optimal power allocation solutions enhance the system outage performance compared to equal distribution model.
C1 [Abd El-Malek, Ahmed H.; Zummo, Salam A.] King Fahd Univ Petr & Minerals, Dept Elect Engn, Dhahran, Saudi Arabia.
   [Al-Qahtani, Fawaz S.; Alnuweiri, Hussein] Texas A&M Univ Qatar, Elect & Comp Engn Program, Doha, Qatar.
   [Radaydeh, Redha M.] Alfaisal Univ, Dept Elect Engn, Riyadh, Saudi Arabia.
   [Abd El-Malek, Ahmed H.] Pharos Univ Alexandria, Dept Elect Engn, Alexandria, Egypt.
RP Zummo, SA (reprint author), King Fahd Univ Petr & Minerals, Dept Elect Engn, Dhahran, Saudi Arabia.
EM ahmed.abdelmalek@pua.edu.eg; fawaz.al-qahtani@qatar.tamu.edu;
   redha.radaydeh@gmail.com; zummo@kfupm.edu.sa;
   hussein.alnuweiri@qatar.tamu.edu
FU King Fahd University of Petroleum & Minerals (KFUPM) [FT141007]; NPRP
   from the Qatar National Research Fund (a member of Qatar Foundation)
   [8-1545-2-657]
FX This paper was made possible by King Fahd University of Petroleum &
   Minerals (KFUPM) grant no. FT141007 and the NPRP grant No. 8-1545-2-657
   from the Qatar National Research Fund (a member of Qatar Foundation).
   The statements made herein are solely the responsibility of the authors.
CR Akyildiz IF, 2006, COMPUT NETW, V50, P2127, DOI 10.1016/j.comnet.2006.05.001
   Boyd S., 2004, CONVEX OPTIMIZATION
   Duong T. Q., 2013, P IEEE INT C COMM
   Duong TQ, 2012, IEEE COMMUN LETT, V16, P2075, DOI 10.1109/LCOMM.2012.100812.121859
   Ferdinand NS, 2013, IEEE ICC, P5301, DOI 10.1109/ICC.2013.6655429
   Ferdinand NS, 2011, IEEE T WIREL COMMUN, V10, P3002, DOI 10.1109/TWC.2011.072511.101783
   Ghasemi A, 2007, IEEE T WIREL COMMUN, V6, P649, DOI 10.1109/TWC.2007.05447
   Gradshteyn I. S., 2000, TABLE INTEGRALS SERI
   Han Y, 2009, IEEE T WIREL COMMUN, V8, P4945, DOI 10.1109/TWC.2009.081484
   Hu S. Q., 2012, 1 P IEEE INT C COMM, P5608
   Jayasinghe L., 2010, P IEEE 72 VEH TECHN, P1
   Lee J, 2011, IEEE T WIREL COMMUN, V10, P390, DOI 10.1109/TWC.2010.120310.090852
   Lee K, 2011, IEEE T WIREL COMMUN, V10, P3570, DOI 10.1109/TWC.2011.092711.101305
   Li LY, 2011, IEEE T WIREL COMMUN, V10, P33, DOI 10.1109/TWC.2010.101810.100311
   Liu Zhong-Hua, 2011, International Journal of Neuropsychopharmacology, V14, P618, DOI 10.1017/S1461145710000520
   Louie RHY, 2009, IEEE T WIREL COMMUN, V8, P3132, DOI 10.1109/TWC.2009.080807
   Mohammadi A, 2011, IEEE COMMUN MAG, V49, P104, DOI 10.1109/MCOM.2011.6094013
   Pareek U., 2011, P IEEE INT C SIGN PR, P1
   Prakash S, 2011, IEEE T VEH TECHNOL, V60, P2555, DOI 10.1109/TVT.2011.2157184
   Radaydeh RM, 2008, IET COMMUN, V2, P1077, DOI 10.1049/iet-com:20070594
   Radaydeh RM, 2009, IEEE COMMUN LETT, V13, P390, DOI 10.1109/LCOMM.2009.082078
   Sanayei S, 2004, IEEE COMMUNICATIONS, V42
   Xu W, 2012, IEEE COMMUN LETT, V16, P1252, DOI 10.1109/LCOMM.2012.061912.120770
   Yeoh PL, 2014, IEEE T VEH TECHNOL, V63, P3250, DOI 10.1109/TVT.2014.2298387
   Yeoh PL, 2013, IEEE T VEH TECHNOL, V62, P933, DOI 10.1109/TVT.2012.2227862
   Yeoh P. L., 2013, P IEEE VEH TECHN C
   Zafar A., 2012, P IEEE WCNC, P658
   Zarifi K., 2011, P IEEE ICC KYOT JAP, P1
   Zhao Q, 2007, IEEE SIGNAL PROC MAG, V24, P79, DOI 10.1109/MSP.2007.361604
   Zhong CJ, 2011, IEEE T VEH TECHNOL, V60, P2875, DOI 10.1109/TVT.2011.2159256
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0929-6212
EI 1572-834X
J9 WIRELESS PERS COMMUN
JI Wirel. Pers. Commun.
PD JUN
PY 2017
VL 94
IS 4
BP 3057
EP 3089
DI 10.1007/s11277-016-3765-z
PG 33
WC Telecommunications
SC Telecommunications
GA EV8US
UT WOS:000402060300071
OA No
DA 2017-08-17
ER

PT J
AU Tryfonidis, K
   Marreaud, S
   Khaled, H
   De Valk, B
   Vermorken, J
   Welnicka-Jaskiewicz, M
   Aalders, K
   Bartlett, JMS
   Biganzoli, L
   Bogaerts, J
   Cameron, D
AF Tryfonidis, Konstantinos
   Marreaud, S.
   Khaled, H.
   De Valk, B.
   Vermorken, J.
   Welnicka-Jaskiewicz, M.
   Aalders, K.
   Bartlett, J. M. S.
   Biganzoli, L.
   Bogaerts, J.
   Cameron, David
CA EORTC-Breast Canc Grp
TI Cardiac safety, efficacy, and correlation of serial serum
   HER2-extracellular domain shed antigen measurement with the outcome of
   the combined trastuzumab plus CMF in women with HER2-positive metastatic
   breast cancer: results from the EORTC 10995 phase II study
SO BREAST CANCER RESEARCH AND TREATMENT
LA English
DT Article
DE Metastatic breast cancer; HER2-positive; CMF; Trastuzumab; Cardiac
   toxicity; Serum-shed antigen
ID ADJUVANT CHEMOTHERAPY; CLINICAL-TRIALS; CYCLOPHOSPHAMIDE; FLUOROURACIL;
   METHOTREXATE; TOLERABILITY; EXPERIENCE; PERTUZUMAB; HER-2/NEU; DOCETAXEL
AB Cardiotoxicity is a side effect of trastuzumab. We assessed efficacy and cardiac safety of CMF with trastuzumab (CMF+T) in HER2-positive metastatic breast cancer patients (MBC).
   In this phase II study, centrally confirmed, previously treated HER2-positive MBC patients with measurable disease (per RECIST v 1.0) were enrolled. Initially, patients were randomized between 8 CMF cycles alone or combined with trastuzumab during chemotherapy, followed by 3-weekly trastuzumab maintenance till progression. A protocol amendment dropped the CMF arm and thereafter all patients received CMF+T. Translational research for prediction of treatment benefit was performed through serial serum HER2-shed antigen assessments.
   Ninety patients (CMF: 19; CMF+T: 71) were enrolled between 2002 and 2006. Median age was 54 years. 42 patients had prior chemotherapy (33 with anthracyclines) and 41/71 patients who received CMF+T continued trastuzumab monotherapy for a median duration of 40 weeks. Overall response rate was 50% for CMF+T (35/70) and 32% for CMF (6/19). Median duration of response was 10.3 months and 5.4 months, respectively. Median progression-free survival was 9.4 months (95% CI 8.1-11.6) and 4.8 months (95% CI 2.8-7.9), respectively. In the CMF+T arm, 13(18%) patients had an absolute LVEF decline, including 3 patients developing any grade of New York Heart Association cardiac dysfunction. Patients with an increase of 30% over baseline shed antigen had a higher progression risk (95% CI 7.6, 3.9-14.8).
   CMF+T is effective, with an acceptable cardiotoxicity profile. LVEF declines were mostly asymptomatic and occurred irrespective of previous anthracycline exposure. CMF+T can be considered for these patients, if other cytotoxics are contraindicated.
C1 [Tryfonidis, Konstantinos; Marreaud, S.; Aalders, K.; Bogaerts, J.] EORTC Headquarters, Brussels, Belgium.
   [Khaled, H.] Cairo Univ, Dept Med Oncol, Natl Canc Inst, Cairo, Egypt.
   [De Valk, B.] Onze Lieve Vrouw Hosp, Dept Med Oncol, Amsterdam, Netherlands.
   [Vermorken, J.] Antwerp Univ Hosp, Dept Med Oncol, Edegem, Belgium.
   [Welnicka-Jaskiewicz, M.] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland.
   [Bartlett, J. M. S.] Ontario Inst Canc Res, Toronto, ON, Canada.
   [Biganzoli, L.] New Hosp Prato, Dept Med Oncol, Ist Toscano Tumori, Prato, Italy.
   [Bartlett, J. M. S.; Cameron, David] Univ Edinburgh, Western Gen Hosp, Canc Res Ctr, Edinburgh, Midlothian, Scotland.
RP Tryfonidis, K (reprint author), EORTC Headquarters, Brussels, Belgium.; Cameron, D (reprint author), Univ Edinburgh, Western Gen Hosp, Canc Res Ctr, Edinburgh, Midlothian, Scotland.
EM konstantinos.tryfonidis@eortc.be; sandrine.marreaud@eortc.be;
   khussein528@gmail.com; BdeValk@spaarnegasthuis.nl;
   JanB.Vermorken@uza.be; mwelj@gumed.edu.pl; kim.aalders@eortc.be;
   John.Bartlett@oicr.on.ca; laura.biganzoli@uslcentro.toscana.it;
   jan.bogaerts@eortc.be; D.Cameron@ed.ac.uk
FU F. Hoffmann-La Roche Ltd.; National Cancer Institute (Bethesda,
   Maryland, USA) [2U10 CA11488-25, 2U10 CA11488-26, 2U10 CA11488-27, 2U10
   CA11488-28, 2U10 CA11488-29, 2U10 CA11488-30, 2U10 CA11488-31, 2U10
   CA11488-32, 2U10 CA11488-33, 2U10 CA11488-34, 2U10 CA11488-35, 2U10
   CA11488-36];  [2U10 CA11488-37];  [2U10 CA11488-38];  [2U10 CA11488-39];
    [2U10 CA11488-40];  [2U10 CA011488-41]
FX This work was supported by F. Hoffmann-La Roche Ltd. This publication
   was supported by Grants Number 2U10 CA11488-25 through 2U10 CA011488-41
   from the National Cancer Institute (Bethesda, Maryland, USA) and by a
   donation from the EORTC Cancer Research Fund.
CR Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216
   BONADONNA G, 1976, NEW ENGL J MED, V294, P405, DOI 10.1056/NEJM197602192940801
   BONADONNA G, 1995, NEW ENGL J MED, V332, P901, DOI 10.1056/NEJM199504063321401
   Bryant J, 1995, BIOMETRICS, V51, P1372, DOI 10.2307/2533268
   Cardoso F, 2016, ANN ONCOL, DOI 10.1093/annonc/mdw544
   ENGELSMAN E, 1991, EUR J CANCER, V27, P966, DOI 10.1016/0277-5379(91)90259-G
   Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4
   Guarneri V, 2006, J CLIN ONCOL, V24, P4107, DOI 10.1200/JCO.2005-04.9551
   Ha JH, 2014, J BREAST CANCER, V17, P33, DOI 10.4048/jbc.2014.17.1.33
   Jahanzeb Mohammad, 2003, Clin Breast Cancer, V4, P28, DOI 10.3816/CBC.2003.n.009
   Luftner D, 2003, CLIN BIOCHEM, V36, P233, DOI 10.1016/S0009-9120(03)00026-2
   Perez EA, 2004, J CLIN ONCOL, V22, P322, DOI 10.1200/JCO.2004.01.120
   Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306
   Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764
   Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122
   Schwartz MK, 2000, INT J BIOL MARKER, V15, P324
   Seidman A, 2002, J CLIN ONCOL, V20, P1215, DOI 10.1200/JCO.20.5.1215
   Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101
   SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106
   Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513
   TANCINI G, 1983, J CLIN ONCOL, V1, P2
   TANNOCK IF, 1988, J CLIN ONCOL, V6, P1377
   Telli ML, 2007, J CLIN ONCOL, V25, P3525, DOI 10.1200/JCO.2007.11.0106
   von Minckwitz G, 1999, J CLIN ONCOL, V17, P1999
   Zardavas D, 2013, AM SOC CLIN ONCOL ED, V2013, P2, DOI DOI 10.1200/EDB00K_
   Zardavas D, 2017, J CLIN ONCOL, V35, P878, DOI 10.1200/JCO.2015.65.7916
NR 26
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0167-6806
EI 1573-7217
J9 BREAST CANCER RES TR
JI Breast Cancer Res. Treat.
PD JUN
PY 2017
VL 163
IS 3
BP 507
EP 515
DI 10.1007/s10549-017-4203-y
PG 9
WC Oncology
SC Oncology
GA EV0VU
UT WOS:000401465200010
PM 28324265
OA No
DA 2017-08-17
ER

PT J
AU Abd El-Fattah, AI
   Fathy, MM
   Ali, ZY
   El-Garawany, AA
   Mohamed, EK
AF Abd El-Fattah, Abeer I.
   Fathy, Mohamed M.
   Ali, Zeinab Y.
   El-Garawany, Abd El-Rahman A.
   Mohamed, Ehsan K.
TI Enhanced therapeutic benefit of quercetin-loaded phytosome nanoparticles
   in ovariectomized rats
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE Quercetin; Phytosome; Phytoestrogen; Nanoparticles; Ovariectomized rats
ID DENSITY-LIPOPROTEINS; OXIDATIVE STRESS; IN-VITRO; PHYTOESTROGENS; CELLS;
   SERUM; CHOLESTEROL; FORMULATION; RESPONSES; CALCIUM
AB Quercetin, a dietary flavonol phytoestrogen, has many health benefits but it is poorly absorbed when administered orally. To improve its bioavailability, we prepared quercetin-loaded phytosome nano particles (QP) using the thin film hydration method. The prepared nano-formulations were characterized using different techniques. Transmission electron microscopy revealed the homogeneously spherical, well and uniformly dispersed, nano-sized nature of QP. Dynamic light scattering measurements of QP (70 +/- 7.44 nm) also confirmed this. Stability of the formed nanoparticles was established via zeta potential determination. The prepared QP exhibited very high encapsulation efficiency (98.4%). The estrogenic activity of QP, concerning inflammation, oxidative stress, bone, lipid profile, blood glucose level and weight gain, was investigated in ovariectomized rat model using 10 and 50 mg/kg/day oral doses for 4 weeks. Treatment with QP showed significant increase in serum calcium, inorganic phosphorus and glutathione content. Whereas, it significantly decreased serum alkaline phosphatase, acid phosphatase, malondialdehyde level, tumor necrosis factor-alpha and glucose level and improved lipid profile. Consequently, the results obtained confirm the superiority of QP over free quercetin at the same doses as a promising hormone replacement therapy. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Abd El-Fattah, Abeer I.] Al Azhar Univ, Fac Pharm Girls, Biochem Dept, Cairo, Egypt.
   [Fathy, Mohamed M.] Cairo Univ, Fac Sci, Biophys Dept, Giza 12613, Egypt.
   [Ali, Zeinab Y.; El-Garawany, Abd El-Rahman A.; Mohamed, Ehsan K.] Natl Org Drug Control & Res NODCAR, Madkour Stn, 6 Abou Hazem St,Alharm St, Giza 12553, Egypt.
RP Mohamed, EK (reprint author), Natl Org Drug Control & Res NODCAR, Madkour Stn, 6 Abou Hazem St,Alharm St, Giza 12553, Egypt.
EM abeeribrahim75@yahoo.com; mfathy@sci.cu.edu.eg;
   zeinabyousef65@ymail.com; AbdElRahmanElGarawany@hotmail.com;
   drehsankhedre@hotmail.com
OI Ali, Zeinab Yousef/0000-0002-5210-9433
CR Akdemir FNE, 2016, J ENZYM INHIB MED CH, V31, P162, DOI 10.1080/14756366.2016.1193735
   BELFIELD A, 1971, ENZYME, V12, P561
   Benyoucef S, 1996, PATHOL BIOL, V44, P393
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Buege J A, 1978, Methods Enzymol, V52, P302
   Chen FP, 2014, CLIMACTERIC, V17, P682, DOI 10.3109/13697137.2014.937688
   Rodrigues MFC, 2013, CLINICS, V68, P1247, DOI 10.6061/clinics/2013(09)12
   da Silva IF, 2016, J ETHNOPHARMACOL, V192, P123, DOI 10.1016/j.jep.2016.07.011
   Dong YS, 2014, INT J MED SCI, V11, P282, DOI 10.7150/ijms.7634
   EI-Denshary E. S., 2015, SOFT NANOSCI LETT, V5, P36
   Elkomy M. M., 2015, Journal of Basic and Applied Zoology, V72, P81, DOI 10.1016/j.jobaz.2015.04.007
   ELMERZABANI MM, 1977, J CLIN CHEM CLIN BIO, V15, P715
   Federici LM, 2016, PSYCHONEUROENDOCRINO, V65, P127, DOI 10.1016/j.psyneuen.2015.12.011
   FOSSATI P, 1982, CLIN CHEM, V28, P2077
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087
   GINDLER EM, 1972, AM J CLIN PATHOL, V58, P376
   Gomes IBS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00247
   Guazelli CFS, 2013, J NAT PROD, V76, P200, DOI 10.1021/np300670w
   Harris DM, 2005, EXP BIOL MED, V230, P558
   Imessaoudene A, 2016, J NUTR BIOCHEM, V29, P107, DOI 10.1016/j.jnutbio.2015.11.011
   Joshi U. J., 2011, International Journal of Research in Pharmaceutical and Biomedical Sciences, V2, P1756
   Karthivashan G, 2016, INT J NANOMED, V11, P3417, DOI 10.2147/IJN.S112045
   Karuppagounder V, 2016, DRUG DISCOV TODAY, V21, P632, DOI 10.1016/j.drudis.2016.02.011
   Kim Jeong Hyun, 2016, J Matern Fetal Neonatal Med, P1, DOI 10.1080/14767058.2016.1247799
   KIND PRN, 1954, J CLIN PATHOL, V7, P322, DOI 10.1136/jcp.7.4.322
   Li CQ, 2016, GENE, V577, P275, DOI 10.1016/j.gene.2015.12.012
   Liao YR, 2015, LIFE SCI, V137, P89, DOI 10.1016/j.lfs.2015.07.015
   Lima LP, 2006, STEROIDS, V71, P653, DOI 10.1016/j.steroids.2006.03.007
   Long ZC, 2016, GENET MOL RES, V15, DOI 10.4238/gmr15048539
   LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882
   Maiti K., 2005, IRANIAN J PHARM THER, V4, P84
   Minaei A, 2016, MOL BIOL REP, V43, P99, DOI 10.1007/s11033-016-3942-x
   Miodini P, 1999, BRIT J CANCER, V80, P1150, DOI 10.1038/sj.bjc.6690479
   Morrone MDS, 2016, OXID MED CELL LONGEV, DOI 10.1155/2016/5719291
   Nathiya S, 2014, DIG J NANOMATER BIOS, V9, P1603
   Rasaie S., 2014, Pharmaceutical Sciences, V20, P96
   RICHMOND W, 1973, CLIN CHEM, V19, P1350
   Trinder P., 1969, ANNALS CLINICAL BIOC, V6, P24
   Tripathi G, 2015, J MATER CHEM B, V3, P8694, DOI 10.1039/c5tb01574j
   Tunc S, 2012, COLLOID SURFACE A, V398, P37, DOI 10.1016/j.colsurfa.2012.02.006
   WIELAND H, 1983, J LIPID RES, V24, P904
   Yang XF, 2017, J INORG BIOCHEM, V167, P36, DOI 10.1016/j.jinorgbio.2016.11.023
   Yigitaslan S, 2016, ERCIYES MED J, V38, P53, DOI 10.5152/etd.2016.0005
   Zhao LY, 2011, J BIOMED NANOTECHNOL, V7, P358, DOI 10.1166/jbn.2011.1298
NR 46
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD JUN 1
PY 2017
VL 271
BP 30
EP 38
DI 10.1016/j.cbi.2017.04.026
PG 9
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA EW4AL
UT WOS:000402444300005
PM 28460884
OA No
DA 2017-08-17
ER

PT J
AU Whetton, R
   Zhao, YF
   Shaddad, S
   Mouazen, AM
AF Whetton, Rebecca
   Zhao, Yifan
   Shaddad, Sameh
   Mouazen, Abdul M.
TI Nonlinear parametric modelling to study how soil properties affect crop
   yields and NDVI
SO COMPUTERS AND ELECTRONICS IN AGRICULTURE
LA English
DT Review
DE Yield limiting factors; Proximal soil sensing; Nonlinear parametric
   modelling; VNRX
ID NEAR-INFRARED-SPECTROSCOPY; LIFE-CYCLE ASSESSMENT; MANAGEMENT ZONES;
   SYSTEM IDENTIFICATION; ONLINE; GROWTH; SENSOR; REFLECTANCE; DELINEATION;
   SELECTION
AB This paper explores the use of a novel nonlinear parametric modelling technique based on a Volterra Non-linear Regressive with eXogenous inputs (VNRX) method to quantify the individual, interaction and overall contributions of six soil properties on crop yield and normalised difference vegetation index (NDVI). The proposed technique has been applied on high sampling resolution data of soil total nitrogen (TN) in %, total carbon (TC) in %, potassium (K) in cmol kg(-1), pH, phosphorous (P) in mg kg-I and moisture content (MC) in %, collected with an on-line visible and near infrared (VIS-NIR) spectroscopy sensor from a 18 ha field in Bedfordshire, UK over 2013 (wheat) and 2015 (spring barley) cropping seasons. The online soil data were first subjected to a raster analysis to produce a common 5 m by 5 m grid, before they were used as inputs into the VNRX model, whereas crop yield and NDVI represented system outputs. Results revealed that the largest contributions commonly observed for both yield and NDVI were from K, P and TC. The highest sum of the error reduction ratio (SERR) of 48.59% was calculated with the VNRX model for NDVI, which was in line with the highest correlation coefficient (r) of 0.71 found between measured and predicted NDVI. However, on-line measured soil properties led to larger contributions to early measured NDVI than to a late measurement in the growing season. The performance of the VNRX model was better for NDVI than for yield, which was attributed to the exclusion of the influence of crop diseases, appearing at late growing stages. It was recommended to adopt the VNRX method for quantifying the contribution of on-line collected soil properties to crop NDVI and yield. However, it is important for future work to include additional soil properties and to account for other factors affecting crop growth and yield, to improve the performance of the VNRX model. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Whetton, Rebecca; Mouazen, Abdul M.] Cranfield Univ, Cranfield Soil & AgriFood Inst, Cranfield MK43 0AL, Beds, England.
   [Zhao, Yifan] Cranfield Univ, Through Life Engn Serv Inst, Cranfield MK43 0AL, Beds, England.
   [Shaddad, Sameh] Zagazig Univ, Fac Agr, Soil Sci Dept, Zagazig 44511, Egypt.
   [Mouazen, Abdul M.] Univ Ghent, Dept Soil Management, Coupure 653, B-9000 Ghent, Belgium.
RP Mouazen, AM (reprint author), Univ Ghent, Dept Soil Management, Coupure 653, B-9000 Ghent, Belgium.
EM Abdul.Mouazen@UGent.be
FU ICT-AGRI under the European Commission's ERA-NET scheme under the 7th
   Framework Programme; UK Department of Environment, Food and Rural
   Affairs [IF0208]
FX We acknowledge the funding received for FarmFUSE project from the
   ICT-AGRI under the European Commission's ERA-NET scheme under the 7th
   Framework Programme, and the UK Department of Environment, Food and
   Rural Affairs (contract no: IF0208).
CR Adamchuk VI, 1999, T ASAE, V42, P885
   Ashraf M. Y., 1998, J SCI IND RES INDIA, V41, P151
   Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098
   Bigg GR, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2013.0662
   BILLINGS SA, 1989, INT J CONTROL, V49, P2157, DOI 10.1080/00207178908559767
   Boone L, 2016, SCI TOTAL ENVIRON, V553, P551, DOI 10.1016/j.scitotenv.2016.02.089
   Bravo C, 2003, BIOSYST ENG, V84, P137, DOI 10.1016/S1537-5110(02)00269-6
   British Standards Institute (BSI), 2007, SAMPL PREP CHEM PHYS
   British Standard Institute (BSI), 1998, 389 BSI
   British Standard Institute (BSI), 1995, 389 BSI
   CANNELL RQ, 1980, J SCI FOOD AGR, V31, P117, DOI 10.1002/jsfa.2740310203
   Cantelmo C, 2010, IET CONTROL THEORY A, V4, P2693, DOI 10.1049/iet-cta.2009.0581
   Chen S., 1989, CONTROL, V49, P1013
   Christy CD, 2008, COMPUT ELECTRON AGR, V61, P10, DOI 10.1016/j.compag.2007.02.010
   COAKLEY SM, 1988, ANNU REV PHYTOPATHOL, V26, P163
   Dammer KH, 2006, PRECIS AGRIC, V7, P137, DOI 10.1007/s11119-006-9005-x
   Donald CM., 1963, COMPETITION CROP PAS
   EBERHART SA, 1966, CROP SCI, V6, P36
   Frogbrook ZL, 2007, SOIL USE MANAGE, V23, P40, DOI 10.1111/j.1475-2743.2006.00065.x
   Grant CA, 2001, CAN J PLANT SCI, V81, P211
   Khosla R, 2008, PRECIS AGRIC, V9, P85, DOI 10.1007/s11119-008-9057-1
   Kuang B, 2012, ADV AGRON, V114, P155, DOI 10.1016/B978-0-12-394275-3.00003-1
   Mitscherlich E. A., 1909, LANDWIRTSCHAFTLICHE, V38, P537
   Mouazen AM, 2007, SOIL TILL RES, V93, P13, DOI 10.1016/j.still.2006.03.009
   Mouazen AM, 2006, J NEAR INFRARED SPEC, V14, P189
   Mouazen AM, 2014, SOIL TILL RES, V143, P95, DOI 10.1016/j.still.2014.06.003
   Mouazen AM, 2005, SOIL TILL RES, V80, P171, DOI 10.1016/j.still.2004.03.022
   MURPHY J, 1962, ANAL CHIM ACTA, V26, P31
   Nicholls C., 2015, SOILS 5 PH NUTR HGCA
   Olsen S R, 1954, 939 USDA
   Ozanne P. G., 1980, ROLE PHOSPHORUS AGR, P559
   Paveley N., 2012, WHEAT DIS MANAGEMENT
   Ravikumar P., 2013, P INT AC EC ENV SCI, P330
   Renouf MA, 2010, INT J LIFE CYCLE ASS, V15, P927, DOI 10.1007/s11367-010-0226-x
   Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007
   Roy R. N., 2006, PLANT NUTR FOOD SEC
   Sarrigiannis PG, 2014, CLIN NEUROPHYSIOL, V125, P32, DOI 10.1016/j.clinph.2013.06.012
   SCHUBERT S, 1990, PLANT SOIL, V124, P239, DOI 10.1007/BF00009266
   Shaddad S., 2013, PROXIMAL SOIL SENSOR
   Shaddad SM, 2016, PRECIS AGRIC, V17, P200, DOI 10.1007/s11119-015-9417-6
   Shibusawa S., 2001, PRECIS AGRIC, V1, P497
   SOIL SURVEY STAFF, 1999, AGR HDB, V436
   Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7
   Tashev Ivan J., 2009, SOUND CAPTURE PROCES
   Wei HL, 2004, INT J CONTROL, V77, P86, DOI 10.1080/00207170310001639640
   ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x
   Zhao Y, 2012, IEEE T SYST MAN CY B, V42, P1283, DOI 10.1109/TSMCB.2012.2185790
   Zhao YF, 2017, MECH SYST SIGNAL PR, V85, P382, DOI 10.1016/j.ymssp.2016.08.033
   Zhao YF, 2016, COLD REG SCI TECHNOL, V121, P167, DOI 10.1016/j.coldregions.2015.08.006
   Zhao YF, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051919
   Mouazen A. M., 2006, BE Patent, Patent No. [WO/2006/015463, 2006015463]
NR 51
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0168-1699
EI 1872-7107
J9 COMPUT ELECTRON AGR
JI Comput. Electron. Agric.
PD JUN 1
PY 2017
VL 138
BP 127
EP 136
DI 10.1016/j.compag.2017.04.016
PG 10
WC Agriculture, Multidisciplinary; Computer Science, Interdisciplinary
   Applications
SC Agriculture; Computer Science
GA EW2XV
UT WOS:000402360200013
OA No
DA 2017-08-17
ER

PT J
AU Selim, AA
   Erfan, AM
   Hagag, N
   Zanaty, A
   Samir, AH
   Samy, M
   Abdelhalim, A
   Arafa, ASA
   Soliman, MA
   Shaheen, M
   Ibraheem, EM
   Mahrous, I
   Hassan, MK
   Naguib, MM
AF Selim, Abdullah A.
   Erfan, Ahmed M.
   Hagag, Naglaa
   Zanaty, Ali
   Samir, Abdel-Hafez
   Samy, Mohamed
   Abdelhalim, Ahmed
   Arafa, Abdel-Satar A.
   Soliman, Mohamed A.
   Shaheen, Momtaz
   Ibraheem, Essam M.
   Mahrous, Ibrahim
   Hassan, Mohamed K.
   Naguib, Mahmoud M.
TI Highly Pathogenic Avian Influenza Virus (H5N8) Clade 2.3.4.4 Infection
   in Migratory Birds, Egypt
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We isolated highly pathogenic avian influenza virus (H5N8) of clade 2.3.4.4 from the common coot (Fulica atra) in Egypt, documenting its introduction into Africa through migratory birds. This virus has a close genetic relationship with subtype H5N8 viruses circulating in Europe. Enhanced surveillance to detect newly emerging viruses is warranted.
C1 [Selim, Abdullah A.; Erfan, Ahmed M.; Hagag, Naglaa; Zanaty, Ali; Samir, Abdel-Hafez; Samy, Mohamed; Abdelhalim, Ahmed; Arafa, Abdel-Satar A.; Soliman, Mohamed A.; Shaheen, Momtaz; Ibraheem, Essam M.; Hassan, Mohamed K.; Naguib, Mahmoud M.] Anim Hlth Res Inst, Natl Lab Vet Qual Control Poultry Prod, Giza, Egypt.
   [Mahrous, Ibrahim] Gen Org Vet Serv, Giza, Egypt.
   [Naguib, Mahmoud M.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Insel Riems, Germany.
RP Naguib, MM (reprint author), Bundesforsch Inst Tiergesundheit, Friedrich Loeffler Inst, Sudufer 10, D-17493 Greifswald, Germany.
EM Mahmoud.naguib@fli.de
OI Naguib, Mahmoud/0000-0001-6876-8903
CR Alexander DJ, 2009, REV SCI TECH OIE, V28, P19
   Dalby A., COMPLETE ANAL H5 HEM
   European Centre for Disease Prevention and Control, 2016, OUTBR HIGHL PATH AV
   Lee DH, 2017, EMERG INFECT DIS, V23, P358, DOI 10.3201/eid2302.161252
   Lee DH, 2016, EMERG INFECT DIS, V22, P1283, DOI 10.3201/eid2207.160048
   Lee DH, 2015, J VIROL, V89, P6521, DOI 10.1128/JVI.00728-15
   Lee YJ, 2014, EMERG INFECT DIS, V20, P1087, DOI 10.3201/eid2006.140233
   Naguib MM, 2015, INFECT GENET EVOL, V34, P278, DOI 10.1016/j.meegid.2015.06.004
   Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222
   Wu HB, 2014, EMERG INFECT DIS, V20, P1315, DOI 10.3201/eid2008.140339
NR 10
TC 0
Z9 0
U1 6
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2017
VL 23
IS 6
BP 1048
EP 1051
DI 10.3201/eid2306.162056
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EW1OB
UT WOS:000402259100038
PM 28518040
OA gold
DA 2017-08-17
ER

PT J
AU Dounousi, E
   Torino, C
   Pizzini, P
   Cutrupi, S
   Panuccio, V
   D'Arrigo, G
   Abd ElHafeez, S
   Tripepi, G
   Mallamaci, F
   Zoccali, C
AF Dounousi, Evangelia
   Torino, Claudia
   Pizzini, Patrizia
   Cutrupi, Sebastiano
   Panuccio, Vincenzo
   D'Arrigo, Graziella
   Abd ElHafeez, Samar
   Tripepi, Giovanni
   Mallamaci, Francesca
   Zoccali, Carmine
TI Intact FGF23 and -klotho during acute inflammation/sepsis in CKD
   patients
SO EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Letter
C1 [Dounousi, Evangelia] Sch Hlth Sci, Nephrol, Ioannina, Greece.
   [Torino, Claudia; Pizzini, Patrizia; Cutrupi, Sebastiano; D'Arrigo, Graziella; Tripepi, Giovanni; Mallamaci, Francesca; Zoccali, Carmine] CNR IFC, Clin Epidemiol & Physiopathol Renal Dis & Hyperte, Reggio Di Calabria, Italy.
   [Panuccio, Vincenzo; Mallamaci, Francesca] OORR Reggio Calabria, Div Nephrol Dialysis & Transplantat, Reggio Di Calabria, Italy.
   [Abd ElHafeez, Samar] High Inst Publ Hlth, Epidemiol, Alexandria, Egypt.
RP Zoccali, C (reprint author), Nefrol Osped Riuniti, CNR IFC, Clin Epidemiol & Physiopathol Renal Dis & Hyperte, I-89124 Reggio Di Calabria, Italy.
EM carmine.zoccali@tin.it
CR CAMPESE VM, 1982, KIDNEY INT, V21, P371, DOI 10.1038/ki.1982.32
   Dounousi E, 2016, NUTR METAB CARDIOVAS, V26, P80, DOI 10.1016/j.numecd.2015.10.004
   Dounousi E, 2016, EUR J CLIN INVEST, V46, P234, DOI 10.1111/eci.12588
   Grassi G, 2011, CLIN J AM SOC NEPHRO, V6, P2620, DOI 10.2215/CJN.06970711
NR 4
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2972
EI 1365-2362
J9 EUR J CLIN INVEST
JI Eur. J. Clin. Invest.
PD JUN
PY 2017
VL 47
IS 6
BP 470
EP 472
DI 10.1111/eci.12765
PG 3
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EW1VP
UT WOS:000402283900009
PM 28489248
OA No
DA 2017-08-17
ER

PT J
AU Nakano, T
   Xu, X
   Salem, AMH
   Shoulkamy, MI
   Ide, H
AF Nakano, Toshiaki
   Xu, Xu
   Salem, Amir M. H.
   Shoulkamy, Mahmoud I.
   Ide, Hiroshi
TI Radiation-induced DNA-protein cross-links: Mechanisms and biological
   significance
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Ionizing radiation; DNA-protein cross-link; Hypoxic cells; Mechanism of
   formation; Repair; Biological consequences
ID NUCLEOTIDE EXCISION-REPAIR; FIBROSARCOMA HT1080 CELLS; NUCLEOSOME CORE
   PARTICLE; ONE-ELECTRON OXIDATION; CHINESE-HAMSTER CELLS; INTACT
   HUMAN-CELLS; IONIZING-RADIATION; MAMMALIAN-CELLS; CELLULAR-DNA; IN-VIVO
AB Ionizing radiation produces various DNA lesions such as base damage, DNA single-strand breaks (SSBs), DNA double-strand breaks (DSBs), and DNA-protein cross-links (DPCs). Of these, the biological significance of DPCs remains elusive. In this article, we focus on radiation-induced DPCs and review the current understanding of their induction, properties, repair, and biological consequences. When cells are irradiated, the formation of base damage, SSBs, and DSBs are promoted in the presence of oxygen. Conversely, that of DPCs is promoted in the absence of oxygen, suggesting their importance in hypoxic cells, such as those present in tumors. DNA and protein radicals generated by hydroxyl radicals (i.e., indirect effect) are responsible for DPC formation. In addition, DPCs can also be formed from guanine radical cations generated by the direct effect. Actin, histones, and other proteins have been identified as cross-linked proteins. Also, covalent linkages between DNA and protein constituents such as thymine-lysine and guanine-lysine have been identified and their structures are proposed. In irradiated cells and tissues, DPCs are repaired in a biphasic manner, consisting of fast and slow components. The half-time for the fast component is 20 min-2 h and that for the slow component is 2-70 h. Notably, radiation-induced DPCs are repaired more slowly than DSBs. Homologous recombination plays a pivotal role in the repair of radiation-induced DPCs as well as DSBs. Recently, a novel mechanism of DPC repair mediated by a DPC protease was reported, wherein the resulting DNA-peptide cross-links were bypassed by translesion synthesis. The replication and transcription of DPC-bearing reporter plasmids are inhibited in cells, suggesting that DPCs are potentially lethal lesions. However, whether DPCs are mutagenic and induce gross chromosomal alterations remains to be determined.
C1 [Nakano, Toshiaki; Xu, Xu; Salem, Amir M. H.; Shoulkamy, Mahmoud I.; Ide, Hiroshi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.
   [Salem, Amir M. H.] Natl Res Ctr, Div Med Res, Dept Pathol, El Bohouth St, Giza 12311, Egypt.
   [Shoulkamy, Mahmoud I.] Menia Univ, Fac Sci, Dept Zool, Biol Sci Bldg, Al Minya 61519, Egypt.
RP Ide, H (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima 7398526, Japan.
EM ideh@hiroshima-u.ac.jp
FU KAKENHI from the Japan Society for Promotion of Science [26340023,
   16H01642]
FX This work was partly supported by KAKENHI from the Japan Society for
   Promotion of Science (Grant numbers: 26340023 to T.N. and 16H01642 to
   H.I).
CR Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08
   Angelov D, 2003, PHOTOCHEM PHOTOBIOL, V77, P592, DOI 10.1562/0031-8655(2003)077<0592:SSOTNP>2.0.CO;2
   Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200
   BALASUBRAMANIAM U, 1995, BIOCHEMISTRY-US, V34, P12790, DOI 10.1021/bi00039a040
   Ban FQ, 2002, J AM CHEM SOC, V124, P2753, DOI 10.1021/ja011528m
   Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200
   Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003
   Belmadoui N, 2010, ORG BIOMOL CHEM, V8, P3211, DOI 10.1039/c004531d
   Bjorklund CC, 2007, BIOCHEMISTRY-US, V46, P10745, DOI 10.1021/bi700475b
   Blakely EA, 1995, RADIATION RESEARCH 1895-1995, CONGRESS PROCEEDINGS, P136
   BURNS WG, 1981, J CHEM SOC FARAD T 1, V77, P2803, DOI 10.1039/f19817702803
   Cadet J, 2005, RADIAT PHYS CHEM, V72, P293, DOI 10.1016/j.radphyschem.2003.12.059
   CADET J, 1992, J PHOTOCH PHOTOBIO B, V15, P277, DOI 10.1016/1011-1344(92)85135-H
   Cadet J, 2008, ACCOUNTS CHEM RES, V41, P1075, DOI 10.1021/ar700245e
   Cadet J, 2017, FREE RADICAL BIO MED, V107, P2, DOI 10.1016/j.freeradbiomed.2017.03.030
   Cadet J, 2014, ARCH BIOCHEM BIOPHYS, V557, P47, DOI 10.1016/j.abb.2014.05.001
   Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005
   Charlton T.S., ADV DNA REPAIR
   CHIU SM, 1986, INT J RADIAT ONCOL, V12, P1529
   CHIU SM, 1984, INT J RADIAT BIOL, V46, P681, DOI 10.1080/09553008414551921
   Chiu SM, 1998, RADIAT RES, V149, P543, DOI 10.2307/3579900
   Cho SH, 2013, CHEM RES TOXICOL, V26, P1005, DOI 10.1021/tx400145e
   Costa M, 1996, MUTAT RES-GENET TOX, V369, P13, DOI 10.1016/S0165-1218(96)90043-9
   Costa M, 1997, J TOXICOL ENV HEALTH, V50, P433, DOI 10.1080/00984109708984000
   CRESS AE, 1983, RADIAT RES, V95, P610, DOI 10.2307/3576104
   DeMott MS, 2002, J BIOL CHEM, V277, P7637, DOI 10.1074/jbc.C100577200
   DIZDAROGLU M, 1989, BIOCHEMISTRY-US, V28, P3625, DOI 10.1021/bi00434a071
   DIZDAROGLU M, 1989, CANCER RES, V49, P3463
   Dizdaroglu M, 2012, CANCER LETT, V327, P26, DOI 10.1016/j.canlet.2012.01.016
   Duxin JP, 2015, CURR OPIN CELL BIOL, V37, P49, DOI 10.1016/j.ceb.2015.09.002
   Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024
   EGUCHI K, 1987, INT J RADIAT BIOL, V52, P115, DOI 10.1080/09553008714551541
   EWIG RAG, 1977, CANCER RES, V37, P2114
   FORNACE AJ, 1977, BIOCHIM BIOPHYS ACTA, V477, P343, DOI 10.1016/0005-2787(77)90253-2
   FRANKENBERGSCHWAGER M, 1990, RADIAT ENVIRON BIOPH, V29, P273, DOI 10.1007/BF01210408
   Friedberg EC, 2006, DNA REPAIR MUTAGENES
   GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P977, DOI 10.1021/bi00456a020
   Gebicki S, 1999, BIOCHEM J, V338, P629, DOI 10.1042/0264-6021:3380629
   Gervais B, 2006, RADIAT PHYS CHEM, V75, P493, DOI 10.1016/j.radphyschem.2005.09.015
   Gherezghiher TB, 2013, J PROTEOME RES, V12, P2151, DOI 10.1021/pr3011974
   GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021
   Groehler A, 2016, CHEM RES TOXICOL, V29, P190, DOI 10.1021/acs.chemrestox.5b00430
   Horton JK, 2014, MOL CANCER RES, V12, P1128, DOI 10.1158/1541-7786.MCR-13-0502
   Ide H, 2015, ADVANCES IN DNA REPAIR, P43, DOI 10.5772/59683
   Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007
   ILIAKIS G, 1991, BIOESSAYS, V13, P641
   Jenner TJ, 1998, RADIAT RES, V150, P593, DOI 10.2307/3579877
   Kanvah S, 2010, ACCOUNTS CHEM RES, V43, P280, DOI 10.1021/ar900175a
   Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964
   Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038
   Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103
   Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003
   Loeber RL, 2009, CHEM RES TOXICOL, V22, P1151, DOI 10.1021/tx900078y
   Maskey RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6744
   Mattagajasingh SN, 1996, J BIOL CHEM, V271, P33550
   Mattagajasingh SN, 1999, MOL CELL BIOCHEM, V199, P149, DOI 10.1023/A:1006910732307
   McClendon AK, 2007, MUTAT RES-FUND MOL M, V623, P83, DOI 10.1016/j.mrfmmm.2007.06.009
   MEE LK, 1979, INT J RADIAT BIOL, V36, P359, DOI 10.1080/09553007914551141
   MEE LK, 1981, P NATL ACAD SCI-BIOL, V78, P2194, DOI 10.1073/pnas.78.4.2194
   MEYN RE, 1987, RADIAT RES, V109, P419, DOI 10.2307/3577042
   Michaelson-Richie ED, 2011, J PROTEOME RES, V10, P2785, DOI 10.1021/pr200042u
   Michaelson-Richie ED, 2010, J PROTEOME RES, V9, P4356, DOI 10.1021/pr1000835
   Minko I.G., 2008, BIOCHEMISTRY-US, V21, P1983
   Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395
   Mu HB, 2016, MUTAT RES-GEN TOX EN, V797, P21, DOI 10.1016/j.mrgentox.2015.12.001
   MURRAY D, 1988, INT J RADIAT BIOL, V53, P921, DOI 10.1080/09553008814551291
   NACKERDIEN Z, 1991, BIOCHEMISTRY-US, V30, P4873, DOI 10.1021/bi00234a006
   Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029
   Nakano T, 2015, MUTAT RES-FUND MOL M, V771, P45, DOI 10.1016/j.mrfmmm.2014.12.003
   Nakano T, 2013, J BIOL CHEM, V288, P4649, DOI 10.1074/jbc.M112.419358
   Nakano T, 2012, J BIOL CHEM, V287, P6562, DOI 10.1074/jbc.M111.318410
   Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174
   Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2
   Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607
   O'Neill P, 2005, ENVIRON MOL MUTAGEN, V46, P207, DOI 10.1002/em.20143
   OLEINICK N L, 1987, British Journal of Cancer, V55, P135
   OLINSKI R, 1992, ARCH BIOCHEM BIOPHYS, V297, P139, DOI 10.1016/0003-9861(92)90651-C
   Patel AG, 2016, NUCLEIC ACIDS RES, V44, P2816, DOI 10.1093/nar/gkw109
   Perrier S, 2006, J AM CHEM SOC, V128, P5703, DOI 10.1021/ja057656i
   Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020
   Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c
   Prasad R, 2014, NUCLEIC ACIDS RES, V42, P6337, DOI 10.1093/nar/gku288
   Qin Haibo, 2009, J Proteome Res, V8, P1983
   Quinones JL, 2015, P NATL ACAD SCI USA, V112, P8602, DOI 10.1073/pnas.1501101112
   RADFORD IR, 1986, INT J RADIAT BIOL, V49, P621
   RAMAKRISHNAN N, 1987, CANCER RES, V47, P2032
   SANKARANARAYANAN K, 1991, MUTAT RES, V258, P75, DOI 10.1016/0165-1110(91)90029-U
   Sczepanski JT, 2010, P NATL ACAD SCI USA, V107, P22475, DOI 10.1073/pnas.1012860108
   Shoulkamy MI, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks601
   Silerme S, 2014, CHEM RES TOXICOL, V27, P1011, DOI 10.1021/tx500063d
   Smith K.C., 1976, PHOTOCHEM PHOTOBIOL, V2, P187
   STEENKEN S, 1989, CHEM REV, V89, P503, DOI 10.1021/cr00093a003
   Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031
   Stingele J, 2015, NAT REV MOL CELL BIO, V16, P455, DOI 10.1038/nrm4015
   Stingele J, 2015, TRENDS BIOCHEM SCI, V40, P67, DOI 10.1016/j.tibs.2014.10.012
   Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053
   Tretyakova NY, 2015, ACCOUNTS CHEM RES, V48, P1631, DOI 10.1021/acs.accounts.5b00056
   Tretyakova NY, 2013, BIOCHEMISTRY-US, V52, P3171, DOI 10.1021/bi400273m
   Uvaydov Y, 2014, PHYS CHEM CHEM PHYS, V16, P11729, DOI 10.1039/c4cp00675e
   Vaz B, 2016, MOL CELL, V64, P704, DOI 10.1016/j.molcel.2016.09.032
   Von-Sonntag C., 1987, CHEM BASIS RAD BIOL
   WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401
   WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X
   Wickramaratne S, 2016, J BIOL CHEM, V291, P23589, DOI 10.1074/jbc.M116.745257
   Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638
   Woynarowski JM, 2000, MOL PHARMACOL, V58, P920
   Xie MZ, 2016, MUTAT RES-FUND MOL M, V786, P41, DOI 10.1016/j.mrfmmm.2016.02.005
   Xu XY, 2008, J AM CHEM SOC, V130, P703, DOI 10.1021/ja077102a
   Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u
   ZHANG H, 1995, RADIAT RES, V142, P163, DOI 10.2307/3579024
   ZWELLING LA, 1979, CANCER RES, V39, P365
NR 111
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JUN
PY 2017
VL 107
BP 136
EP 145
DI 10.1016/j.freeradbiomed.2016.11.041
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EW5NH
UT WOS:000402552600013
PM 27894771
OA No
DA 2017-08-17
ER

PT J
AU El Saftawy, EA
   Abd El-Aal, A
   Badawi, M
   Attia, SS
   Abdelraouf, A
   Shoeib, EY
   Hassany, M
   Mohsen, A
   Afife, AA
   Gohar, H
   Badr, MS
AF El Saftawy, E. A.
   Abd El-Aal, A.
   Badawi, M.
   Attia, S. S.
   Abdelraouf, A.
   Shoeib, E. Y.
   Hassany, M.
   Mohsen, A.
   Afife, A. A.
   Gohar, H.
   Badr, M. S.
TI One minute, intraoperative assessment of the viability of hydatid cysts
   using a simple reagent strip test
SO HELMINTHOLOGIA
LA English
DT Article
DE Hydatid-viability-strip test
ID ECHINOCOCCUS-GRANULOSUS CESTODA; PROTOSCOLEX FORMATION; METABOLISM;
   ULTRASTRUCTURE; INFECTION; SCOLICES; ORIGIN; FLUID; STAGE
AB The aim of the current work was to evaluate the possibility of using a rapid and simple reagent strip test to investigate the viability of hydatid cysts intraoperatively, via testing certain biochemical parameters. Thirty eight HCF samples were processed and examined by different methods for determining the viability status. Using the reagent strip test in the current study, the highest significant level of glucose was detected in HCF samples with the highest viability % at pH 7.5 and the lowest significant level of glucose was detected in HCF samples with the lowest viability % at pH 8.5, indicating a likely correlation between glucose concentration and the viability of PSs. On the contrary, protein was not detected in HCF containing viable PSs and was found to be higher in HCF containing non-viable PSs, denoting the possible degenerative processes in such PSs. Haemoglobin was found in trace amounts in all of our samples. In addition, the strip test detected bacterial contamination in 8 samples and biliary leakage in 7 samples. Our results suggest that the simple reagent strip test can assist in providing fast, uncomplicated primary data regarding the viability status of the hydatid cysts. Thus, it may aid the surgeons to make informed decisions for further management and appropriate follow up to minimise the risk of post-operative recurrence.
C1 [El Saftawy, E. A.; Abd El-Aal, A.; Attia, S. S.; Shoeib, E. Y.] Cairo Univ, Fac Med, Dept Med Parasitol, Giza, Egypt.
   [Badawi, M.] Natl Res Inst, Dept Pathol, Giza, Egypt.
   [Abdelraouf, A.; Hassany, M.] Natl Hepatol & Trop Med Res Inst, Dept Trop Med, Cairo, Egypt.
   [Mohsen, A.] Natl Res Ctr, Dept Community Med, Cairo, Egypt.
   [Afife, A. A.] Univ Manchester, Manchester, Lancs, England.
   [Gohar, H.] Cairo Univ, Fac Med, Dept Med Microbiol, Cairo, Egypt.
   [Badr, M. S.] Ain Shams Univ, Fac Med, Med Res Ctr, Dept Mol Biol, Cairo, Egypt.
RP Attia, SS (reprint author), Cairo Univ, Fac Med, Dept Med Parasitol, Giza, Egypt.
EM ssattia@kasralainy.edu.eg
CR AGOSIN M, 1963, COMP BIOCHEM PHYSIOL, V8, P245, DOI 10.1016/0010-406X(63)90128-2
   AGOSIN M, 1965, COMP BIOCHEM PHYSIOL, V14, P299, DOI 10.1016/0010-406X(65)90206-9
   Aziz A, 2011, J PROTEOMICS, V74, P1560, DOI 10.1016/j.jprot.2011.02.021
   Garcia MB, 2010, AM J TROP MED HYG, V82, P376, DOI 10.4269/ajtmh.2010.09-0375
   CARBONE G, 1957, Rass Med Sarda, V59, P519
   Chemale G, 2003, PROTEOMICS, V3, P1633, DOI 10.1002/pmic.200300487
   CHEN P. H., 1990, J PARASITOL PARASITI, V8, P181
   Chen YC, 2002, AM J TROP MED HYG, V67, P524
   CMELIK S, 1953, BIOCHEM Z, V324, P104
   DIAZ A, 1995, EXP PARASITOL, V80, P473, DOI 10.1006/expr.1995.1059
   FRAYHA GJ, 1980, INT J PARASITOL, V10, P359, DOI 10.1016/0020-7519(80)90036-3
   Galindo M, 2002, BIOL RES, V35, P365, DOI 10.4067/S0716-97602002000300011
   HUANG Y., 1994, CHINESE J ZOO, V10, P27, DOI [10.1590/0037-8682-0154-2013, DOI 10.1590/0037-8682-0154-2013]
   JEFFS SA, 1988, PARASITOLOGY, V96, P145
   Joshi Deepti, 2013, J Neurosci Rural Pract, V4, P140, DOI 10.4103/0976-3147.112737
   KAGAN IG, 1968, B WORLD HEALTH ORGAN, V39, P13
   Karaoglanoglu M, 2011, TURK J MED SCI, V41, P1001, DOI 10.3906/sag-1010-1240
   Kayaalp C, 2011, CLINICS, V66, P421, DOI 10.1590/S1807-59322011000300010
   KRVAVICA S., 1959, VET ARH ZAGREB, V29, P314
   Lawn SD, 2004, AM J TROP MED HYG, V70, P329
   Li JY, 2013, REV SOC BRAS MED TRO, V46, P605, DOI 10.1590/0037-8682-0154-2013
   Li Z. H., 1985, CHINESE J VET SCI TE, V11, P36, DOI [10.1590/0037-8682-0154-2013, DOI 10.1590/0037-8682-0154-2013]
   MACPHERSON CNL, 1985, INT J PARASITOL, V15, P137, DOI 10.1016/0020-7519(85)90078-5
   Nunnari G, 2012, WORLD J GASTROENTERO, V18, P1448, DOI 10.3748/wjg.v18.i13.1448
   Radfar Mohammad Hossein, 2004, Veterinarski Arhiv, V74, P435
   READ CP, 1967, J PARASITOL, V53, P1023, DOI 10.2307/3276830
   ROGAN MT, 1987, PARASITOLOGY, V94, P359
   Skuhala T, 2014, CROAT MED J, V55, P146, DOI 10.3325/cmj.2014.55.146
   SMITH SA, 1991, PARASITOLOGY, V103, P267
   Soulsby E.J.L., 1982, HELMINTHS ARTHROPODS
   Stankovic Nebojsa, 2005, Vojnosanit Pregl, V62, P175, DOI 10.2298/VSP0503175S
   Tarcoveanu E, 2008, CHIRURGIA-BUCHAREST, V103, P417
   ZHAO W. X., 1987, HUMAN PARASITOLOGY, V514
NR 33
TC 0
Z9 0
U1 1
U2 1
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0440-6605
EI 1336-9083
J9 HELMINTHOLOGIA
JI Helminthologia
PD JUN
PY 2017
VL 54
IS 2
BP 157
EP 164
DI 10.1515/helm-2017-0020
PG 8
WC Parasitology; Zoology
SC Parasitology; Zoology
GA EW4BV
UT WOS:000402447900008
OA gold
DA 2017-08-17
ER

PT J
AU Abd El-Shazly, A
   Ebeid, WM
   Elkitkat, RS
   Deghedy, MR
AF Abd El-Shazly, Amany
   Ebeid, Weam Mohamed
   Elkitkat, Rania Serag
   Deghedy, Marwa Reda
TI ELECTRORETINOGRAPHIC AND VISUAL-EVOKED POTENTIAL CHANGES IN RELATION TO
   CHELATION MODALITY IN CHILDREN WITH THALASSEMIA
SO RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
LA English
DT Article
DE beta thalassemia; deferoxamine retinopathy; electrophysiologic studies;
   oral iron chelators; preclinical maculopathy
ID HYDROXYCHLOROQUINE RETINAL TOXICITY; BETA-THALASSEMIA; MULTIFOCAL
   ELECTRORETINOGRAPHY; DEFEROXAMINE RETINOPATHY; OCULAR TOXICITY; ISCEV
   STANDARD; ALBINO-RAT; DESFERRIOXAMINE; COMPLICATIONS; UPDATE
AB Purpose: To evaluate possible benefits of using electrophysiological investigations for detecting retinal and visual pathway changes and correlating them with chelation modality in children with thalassemia.
   Methods: This study included 60 patients on single oral iron chelator (deferasirox) (Group 1), 60 on deferoxamine chelator (Group 2), and 60 controls (Group 3). Participants underwent full ophthalmologic examination, pattern visual-evoked potential, pattern electroretinogram, and multifocal electroretinogram.
   Results: Fundus showed no abnormalities. Multifocal electroretinogram mean P1 amplitude showed statistically significant differences in all 5 rings, amplitudes being significantly lower in Groups 1 and 2 than Group 3; moreover, significantly lower in Group 2 than Group 1. There was a statistically significant difference between groups regarding P50 wave latency and N35-P50 of pattern electroretinogram amplitude (P < 0.001 and P, 0.001, respectively). However, there were no statistically significant differences between groups regarding N95 wave of pattern electroretinogram and pattern visual-evoked potential waves' amplitude and latency. Multiple regression analyses illustrated that chelator was the most important determinant for multifocal electroretinogram and P50 parameters.
   Conclusion: Preclinical electrophysiologic changes existed in thalassemics, more obvious in those on deferoxamine. Electrophysiologic studies analysis denotes an early toxic macular insult rather than optic nerve affection. Thus, regular follow-up using multifocal electroretinogram and pattern electroretinogram is recommended.
C1 [Abd El-Shazly, Amany; Ebeid, Weam Mohamed; Elkitkat, Rania Serag] Ain Shams Univ, Dept Ophthalmol, Fac Med, Cairo, Egypt.
   [Deghedy, Marwa Reda] Ain Shams Univ, Dept Pediat, Fac Med, Cairo, Egypt.
RP Ebeid, WM (reprint author), Ain Shams Univ, Fac Med, Cairo 11571, Egypt.
EM Weam.ebeid@med.asu.edu.eg
CR Adam MK, 2012, BRIT J OPHTHALMOL, V96, P723, DOI 10.1136/bjophthalmol-2011-300504
   ARDEN GB, 1984, BRIT J OPHTHALMOL, V68, P873, DOI 10.1136/bjo.68.12.873
   Baath JS, 2008, RETINA-J RET VIT DIS, V28, P894, DOI 10.1097/IAE.0b013e3181679f67
   BLOOMFIELD SE, 1978, J PEDIAT OPHTH STRAB, V15, P154
   Borgna-Pignatti C, 1998, ANN NY ACAD SCI, V850, P227, DOI 10.1111/j.1749-6632.1998.tb10479.x
   Cao A, 2010, GENET MED, V12, P61, DOI 10.1097/GIM.0b013e3181cd68ed
   DAVIES SC, 1983, LANCET, V2, P181
   Dennerlein Jasmin-Alma, 1995, Ophthalmologe, V92, P38
   GARTAGANIS S, 1989, AM J OPHTHALMOL, V108, P699
   GEHLBACH PL, 1993, INVEST OPHTH VIS SCI, V34, P2871
   GOOD PA, 1990, OPHTHALMOLOGICA, V201, P32
   Graves GS, 2014, ACTA OPHTHALMOL, V92, pE377, DOI 10.1111/aos.12353
   Haimovici R, 2002, OPHTHALMOLOGY, V109, P164, DOI 10.1016/S0161-6420(01)00947-2
   Hidajat RR, 2004, DOC OPHTHALMOL, V109, P273, DOI 10.1007/s10633-005-1336-9
   Holder GE, 2007, DOC OPHTHALMOL, V114, P111, DOI 10.1007/s10633-007-9053-1
   Kertes PJ, 2004, CAN J OPHTHALMOL, V39, P656
   LAKHANPAL V, 1984, OPHTHALMOLOGY, V91, P443
   Lyons JS, 2007, AM J OPHTHALMOL, V143, P801, DOI 10.1016/j.ajo.2006.12.042
   Lyons JS, 2009, DOC OPHTHALMOL, V118, P29, DOI 10.1007/s10633-008-9130-0
   MARCIANI MG, 1991, HAEMATOLOGICA, V76, P131
   Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4
   OLIVIERI NF, 1986, NEW ENGL J MED, V314, P869, DOI 10.1056/NEJM198604033141402
   Ibrahim MS, 2014, J BASIC APPL SCI RES, V4, P61
   Sen Parveen, 2010, Retin Cases Brief Rep, V4, P224, DOI 10.1097/ICB.0b013e3181bcf374
   Thein SL, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011700
   Wu D, 2001, Zhonghua Yan Ke Za Zhi, V37, P98
   Zafeiriou DI, 2006, BRAIN DEV-JPN, V28, P477, DOI 10.1016/j.braindev.2006.02.005
NR 27
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0275-004X
EI 1539-2864
J9 RETINA-J RET VIT DIS
JI Retin.-J. Retin. Vitr. Dis.
PD JUN
PY 2017
VL 37
IS 6
BP 1168
EP 1175
PG 8
WC Ophthalmology
SC Ophthalmology
GA EW0KL
UT WOS:000402179100036
OA No
DA 2017-08-17
ER

PT J
AU Ghoneim, NH
   Abdel-Moein, KA
   Zaher, HM
AF Ghoneim, Nahed H.
   Abdel-Moein, Khaled A.
   Zaher, Hala M.
TI Molecular Detection of Francisella spp. Among Ticks Attached to Camels
   in Egypt
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE camels; Egypt; Francisella tularensis; ticks
ID TULAREMIA; TULARENSIS; SEROPREVALENCE; ENDOSYMBIONTS; EPIDEMIOLOGY;
   BACTERIA; AGENTS; PCR
AB This study was conducted to investigate the possible role of camels and attached ticks in the epidemiology of Francisella spp. including Francisella tularensis. For this purpose, a total of 319 ticks (248 Hyalomma dromedarii and 71 Amblyomma spp.) as well as 100 blood and 50 fecal samples collected from camels were screened for the presence of Francisella spp. by PCR through amplification of Francisella 16S rRNA gene. Positive samples were then tested for F. tularensis by PCR. In addition, serum samples from 75 camel abattoir workers were examined for the presence of IgG antibodies against F. tularensis using enzyme-linked immunosorbent assay (ELISA). Of the examined ticks, 15 were positive for Francisella spp. with prevalence of 4.7%, all positive results were recorded in Hyalomma dromedarii (6%). Neither blood nor fecal samples from camels yielded Francisella spp. even camels which carried Francisella spp. positive ticks. Moreover, F. tularensis could not be detected among Francisella-positive ticks. Phylogenetic analysis of some Francisella 16S rRNA gene sequences obtained in this study points out that these sequences are closely related to Francisella-like endosymbionts. In contrast, seroprevalence of F. tularensis antibodies among examined abattoir workers was 9.3% with significantly high prevalence among workers frequently exposed to tick bites (20.7%) rather than occasionally exposed workers (2.2%). In conclusion, however, F. tularensis could not be detected in this study; the high seroprevalence among camel abattoir workers especially those frequently exposed to tick bites underlines the possible role of ticks attached to camels in transmission of tularemia to humans.
C1 [Ghoneim, Nahed H.; Abdel-Moein, Khaled A.; Zaher, Hala M.] Cairo Univ, Dept Zoonoses, Fac Vet Med, Cairo 12211, Egypt.
RP Abdel-Moein, KA (reprint author), Cairo Univ, Dept Zoonoses, Fac Vet Med, Cairo 12211, Egypt.
EM khal_105@cu.edu.eg
CR Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005
   Bonnet S, 2013, VECTOR-BORNE ZOONOT, V13, P226, DOI 10.1089/vbz.2011.0933
   Brevik OJ, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-5
   Carvalho CL, 2014, COMP IMMUNOL MICROB, V37, P85, DOI 10.1016/j.cimid.2014.01.002
   Clark DV, 2012, VECTOR-BORNE ZOONOT, V12, P558, DOI 10.1089/vbz.2010.0081
   Dergousoff SJ, 2012, APPL ENVIRON MICROB, V78, P965, DOI 10.1128/AEM.05762-11
   Duzlu O, 2016, VECTOR-BORNE ZOONOT, V16, P26, DOI 10.1089/vbz.2015.1818
   Esmaeili S, 2014, T ROY SOC TROP MED H, V108, P516, DOI 10.1093/trstmh/tru094
   Genchi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133593
   Ivanov IN, 2011, APPL ENVIRON MICROB, V77, P5562, DOI 10.1128/AEM.02934-10
   Jenzora A, 2008, FEMS IMMUNOL MED MIC, V53, P183, DOI 10.1111/j.1574-695X.2008.00408.x
   Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011
   McCoy GW, 1909, J INFECT DIS, V6, P170
   Ozanic M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005208
   Rom WN, 2007, ENV OCCUPATIONAL MED
   Rotz LD, 2002, EMERG INFECT DIS, V8, P225
   Scoles GA, 2004, J MED ENTOMOL, V41, P277, DOI 10.1603/0022-2585-41.3.277
   Sjostedt A, 1997, J CLIN MICROBIOL, V35, P1045
   Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009
   Sreter-Lancz Z, 2009, VECTOR-BORNE ZOONOT, V9, P123, DOI 10.1089/vbz.2008.0010
   Sumrandee C, 2016, TICKS TICK-BORNE DIS, V7, P678, DOI 10.1016/j.ttbdis.2016.02.015
   Szigeti A, 2014, TICKS TICK-BORNE DIS, V5, P818, DOI 10.1016/j.ttbdis.2014.06.002
   Toma L, 2014, VECTOR-BORNE ZOONOT, V14, P199, DOI 10.1089/vbz.2013.1458
   Walker AR, 2003, BIOSCIENCE REPORTS
NR 24
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JUN
PY 2017
VL 17
IS 6
BP 384
EP 387
DI 10.1089/vbz.2016.2100
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EW1IP
UT WOS:000402243800003
PM 28402703
OA No
DA 2017-08-17
ER

PT J
AU Sherief, HH
   Allam, AA
AF Sherief, Hany H.
   Allam, Allam A.
TI Electro-magneto interaction in a two-dimensional generalized
   thermoelastic solid cylinder
SO ACTA MECHANICA
LA English
DT Article
ID LONG ANNULAR CYLINDER; FRACTIONAL ORDER THEORY; HALF-SPACE PROBLEM;
   DIFFUSION INTERACTION
AB In this work, an investigation of electro-magneto interaction of a two-dimensional problem is presented for an infinitely long solid conducting circular cylinder. The problem is considered in the context of generalized electro-magneto-thermoelasticity with one relaxation time. The lateral surface of the solid is traction free and having a known temperature in the presence of a uniform magnetic field in the direction of the axis. The Laplace transform technique is used to obtain the solution in the transform domain. The solution is obtained by a direct approach without the customary use of potential functions. Numerical inversion of the Laplace transform is carried out to obtain the temperature, displacement, stress and induced magnetic field distributions. Numerical results are represented graphically and discussed.
C1 [Sherief, Hany H.] Univ Alexandria, Fac Sci, Dept Math, Alexandria, Egypt.
   [Allam, Allam A.] Arab Acad Sci Technol & Maritime Transport, Coll Engn & Technol, Dept Basic & Appl Sci, POB 1029,Abu Quir Campus, Alexandria, Egypt.
RP Allam, AA (reprint author), Arab Acad Sci Technol & Maritime Transport, Coll Engn & Technol, Dept Basic & Appl Sci, POB 1029,Abu Quir Campus, Alexandria, Egypt.
EM hanysherief@gmail.com; abdoallahallam@yahoo.com
CR Allam AA, 2016, ACTA MECH, V227, P1429, DOI 10.1007/s00707-016-1569-6
   Allam AA, 2016, J THERM STRESSES, V39, P532, DOI 10.1080/01495739.2016.1158608
   Allam AA, 2014, APPL MATH MODEL, V38, P4995, DOI 10.1016/j.apm.2014.03.044
   Allam AA, 2014, ARCH APPL MECH, V84, P953, DOI 10.1007/s00419-014-0841-2
   Asnafi A, 2015, ACTA MECH, V226, P2347, DOI 10.1007/s00707-015-1321-7
   BIOT MA, 1956, J APPL PHYS, V27, P240, DOI 10.1063/1.1722351
   Boley B., 1962, J APPL MECH, V2, P637
   CHESTER M, 1963, PHYS REV, V131, P2013, DOI 10.1103/PhysRev.131.2013
   DHALIWAL RS, 1980, Q APPL MATH, V38, P1
   Duhamel J. H., 1837, J ECOLE POLYTECHNIQU, V15
   Ezzat MA, 2011, J THERM STRESSES, V34, P851, DOI 10.1080/01495739.2011.586274
   Green A. E., 1972, J ELASTICITY, V2, P1, DOI DOI 10.1007/BF00045689
   Hetnarski R., 1961, ARCH MECH STOSOW, V13, P295
   Hetnarski R.B., 1964, Bulletin de l'Academie Polonaise des Sciences, Serie des Sciences Techniques, V12, P49
   HONIG G, 1984, J COMPUT APPL MATH, V10, P113, DOI 10.1016/0377-0427(84)90075-X
   Kaliski S., 1959, P VIBR PROBL, V4, P1
   KNOPOFF L, 1955, J GEOPHYS RES, V60, P441, DOI 10.1029/JZ060i004p00441
   LORD HW, 1967, J MECH PHYS SOLIDS, V15, P299, DOI 10.1016/0022-5096(67)90024-5
   Maxwell J. C., 1867, PHILOS T ROY SOC LON, V157, P49, DOI DOI 10.1098/RSTL.1867.0004
   Neumann F., 1841, VORLESUNGEN THEORIE
   Nowinski J. L., 1978, THEORY THERMOELASTIC, V3
   Paria G., 1966, ADV APPL MECH, V10, P73, DOI DOI 10.1016/S0065-2156(08)70394-6
   PURUSHOTHAMA CM, 1965, MATH P CAMB PHIL SOC, V61, P939, DOI 10.1017/S0305004100039335
   Sherief HH, 2013, APPL MATH MODEL, V37, P762, DOI 10.1016/j.apm.2012.02.056
   Sherief HH, 2010, INT J SOLIDS STRUCT, V47, P269, DOI 10.1016/j.ijsolstr.2009.09.034
   Sherief HH, 2005, J THERM STRESSES, V28, P409, DOI 10.1080/01495730590916641
   SHERIEF HH, 1994, J THERM STRESSES, V17, P213, DOI 10.1080/01495739408946256
   Sherief HH, 1998, J ENG MATH, V34, P387, DOI 10.1023/A:1004376014083
   Sherief H. H., 1980, THESIS
   Tripathi JJ, 2015, ACTA MECH, V226, P3263, DOI 10.1007/s00707-015-1383-6
   Tripathi JJ, 2015, ACTA MECH, V226, P2121, DOI 10.1007/s00707-015-1305-7
   Wang C, 2015, ACTA MECH, V226, P3831, DOI 10.1007/s00707-015-1441-0
   Weiner J., 1957, Q APPL MATH, V15, P102
   WILLSON AJ, 1963, MATH P CAMB PHILOS S, V59, P483, DOI 10.1017/S0305004100037087
NR 34
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0001-5970
EI 1619-6937
J9 ACTA MECH
JI Acta Mech.
PD JUN
PY 2017
VL 228
IS 6
BP 2041
EP 2062
DI 10.1007/s00707-017-1814-7
PG 22
WC Mechanics
SC Mechanics
GA EV6YF
UT WOS:000401920000006
OA No
DA 2017-08-17
ER

PT J
AU Husein, DZ
   Aazam, E
   Battia, M
AF Husein, Dalal Z.
   Aazam, Elham
   Battia, Maram
TI Adsorption of Cadmium(II) onto Watermelon Rind Under Microwave Radiation
   and Application into Surface Water from Jeddah, Saudi Arabia
SO ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING
LA English
DT Article
DE Adsorption; Watermelon; Cadmium removal; Real surface water
ID AQUEOUS-SOLUTIONS; REMOVAL; IONS; BIOSORPTION; SORBENT; MECHANISM;
   WALNUT; COPPER; SHELL; GREEN
AB The present study investigates four adsorbents prepared from watermelon rind as a lignocellulosic material for developing efficient adsorbents for cadmium removal from aqueous solution and environmental real samples. Watermelon rind was microwave-irradiated in , NaOH and deionized water. Adsorption experiments were performed in batch mode to study the effects of physical and chemical treatments on cadmium adsorption properties of the powder. The isotherm analysis revealed that Langmuir model could describe the adsorption data and the maximum adsorption capacities were found to be the highest when the watermelon was irradiated in deionized water. The pseudo-second-order model better fitted the obtained kinetics data, and the adsorption process was spontaneous and exothermic. The results suggested that modified watermelon rind had the potential to become a promising material for in situ cadmium metal-contaminated water treatment.
C1 [Husein, Dalal Z.] Assiut Univ, Chem Dept, Fac Sci, New Valley Branch, POB 72511, Assiut, Egypt.
   [Aazam, Elham; Battia, Maram] King Abdulaziz Univ, Chem Dept, Fac Sci, Female Sect, Jeddah, Saudi Arabia.
RP Husein, DZ (reprint author), Assiut Univ, Chem Dept, Fac Sci, New Valley Branch, POB 72511, Assiut, Egypt.
EM dalal_husein@yahoo.com
CR Abdelkreem M., 2012, EGYPT J ENV RES, V1, P42
   Al-Saadi AA, 2013, J MOL LIQ, V188, P136, DOI 10.1016/j.molliq.2013.09.036
   Alidoust D, 2015, J ENVIRON MANAGE, V150, P103, DOI 10.1016/j.jenvman.2014.10.032
   Benaissa H, 2006, J HAZARD MATER, V132, P189, DOI 10.1016/j.jhazmat.2005.07.085
   Calvete T, 2010, CLEAN-SOIL AIR WATER, V38, P521, DOI 10.1002/clen.201000027
   Chand P, 2014, INT BIODETER BIODEGR, V90, P8, DOI 10.1016/j.ibiod.2013.10.028
   Cheung CW, 2001, WATER RES, V35, P605, DOI 10.1016/S0043-1354(00)00306-7
   Dada A., 2012, J APPL CHEM-USSR, V3, P38, DOI DOI 10.9790/5736-0313845
   Ekmekyapar F, 2006, J HAZARD MATER, V137, P293, DOI 10.1016/j.jhazmat.2006.02.003
   Elamin A., 2013, INT J CHEM ENV TECH, V1, P1
   Esposito A, 2002, CHEM ENG SCI, V57, P307, DOI 10.1016/S0009-2509(01)00399-2
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Guo H, 2015, CARBOHYD POLYM, V115, P177, DOI 10.1016/j.carbpol.2014.08.041
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Husein DZ, 2017, ARAB J SCI ENG, V42, P1399, DOI 10.1007/s13369-016-2250-z
   Husein DZ, 2013, DESALIN WATER TREAT, V51, P6761, DOI 10.1080/19443994.2013.801793
   Husein D. Z., 2015, EJER, V3, P12
   Moreno-Barbosa JJ, 2013, ADSORPTION, V19, P675, DOI 10.1007/s10450-013-9491-x
   Lagergren S., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Lakshmipathy R, 2013, INT J MINER PROCESS, V122, P63, DOI 10.1016/j.minpro.2013.03.002
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Liang S, 2010, J HAZARD MATER, V174, P756, DOI 10.1016/j.jhazmat.2009.09.116
   Lim AP, 2014, BIOCHEM ENG J, V87, P50, DOI 10.1016/j.bej.2014.03.019
   Memon SQ, 2007, J HAZARD MATER, V139, P116, DOI 10.1016/j.jhazmat.2006.06.013
   Nouri L, 2007, J HAZARD MATER, V149, P115, DOI 10.1016/j.jhazmat.2007.03.055
   Obregon-Valencia D., 2015, BIOCH ENG J, V87, P50
   Ofudje E. A., 2013, IJSER, V4, P1629
   Pehlivan E, 2008, J HAZARD MATER, V155, P378, DOI 10.1016/j.jhazmat.2007.11.071
   Marin ABP, 2010, BIOCHEM ENG J, V53, P2, DOI 10.1016/j.bej.2008.12.010
   Perez-Marin AB, 2007, J HAZARD MATER, V139, P122, DOI 10.1016/j.jhazmat.2006.06.008
   Rao MM, 2006, J HAZARD MATER, V129, P123, DOI 10.1016/j.jhazmat.2005.08.018
   Regmi P, 2012, J ENVIRON MANAGE, V109, P61, DOI 10.1016/j.jenvman.2012.04.047
   Temkin M. J., 1940, ACTA PHYSIOCHIM USSR, V12, P217, DOI 10.1016/j.jhazmat.2008.12.093
   Umoren SA, 2013, J MAT ENV SCI, V4, P75
   Weber W.J., 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Zheng LC, 2012, CARBOHYD POLYM, V90, P1008, DOI 10.1016/j.carbpol.2012.06.035
NR 36
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2193-567X
EI 2191-4281
J9 ARAB J SCI ENG
JI Arab. J. Sci. Eng.
PD JUN
PY 2017
VL 42
IS 6
BP 2403
EP 2415
DI 10.1007/s13369-016-2381-2
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV9CG
UT WOS:000402081500022
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Wahab, BF
   Khidre, RE
   Mohamed, HA
   El-Hiti, GA
AF Abdel-Wahab, Bakr F.
   Khidre, Rizk E.
   Mohamed, Hanan A.
   El-Hiti, Gamal A.
TI A Simple Process for the Synthesis of Novel Pyrazolyltriazole and
   Dihydropyrazolylthiazole Derivatives as Antimicrobial Agents
SO ARABIAN JOURNAL FOR SCIENCE AND ENGINEERING
LA English
DT Article
DE Antimicrobial activity; Dihydropyrazolylthiazoles;
   Pyrazole-4-carbaldehydes; Pyrazolyltriazole; Synthesis
ID ONE-POT SYNTHESIS; 3,5-DISUBSTITUTED 1H-PYRAZOLES; BIOLOGICAL-ACTIVITY;
   PYRAZOLES; SUBSTITUTION; LITHIATION; DESIGN
AB Series of novel 1,2-bis((3-(1-aryl-5-methyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene) hydrazines 4 and 2-(5-(3-(1,2,3-triazol-4-yl)pyrazol-4-yl) pyrazol-1-yl)thiazoles 13 were synthesized using simple and convenient procedures, and their structures were established. Treatment of pyrazole-4-carbaldehydes 1 with methyl ketones in alkaline medium gave the corresponding (E)-1-aryl-3-(3-(1-aryl-5-methyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)prop-2-en-1-ones 3 in 82-86% yields. Treatment of 3 with hydrazine hydrate gave 4, in 69-75% yields, rather than the expected 1-aryl-5-methyl-4-(1-aryl-4-(3-phenyl-4,5-dihydro-1H-pyrazol-5-yl)-1H-pyrazol-3-yl)-1H-1,2,3-triazoles. Reactions of 3 with thiosemicarbazide gave the corresponding carbothioamides 9 which in reaction with phenacyl bromides gave the corresponding dihydropyrazolylthiazoles 13 in 82-87% yields. The novel synthesized product exhibits good antimicrobial activities against the tested microorganisms.
C1 [Abdel-Wahab, Bakr F.; Mohamed, Hanan A.] Natl Res Ctr, Appl Organ Chem Dept, Giza 12622, Egypt.
   [Abdel-Wahab, Bakr F.; Mohamed, Hanan A.] Shaqra Univ, Dept Chem, Coll Sci & Humanities, Duwadimi, Saudi Arabia.
   [Khidre, Rizk E.] Natl Res Ctr, Chem Ind Div, Giza 12622, Egypt.
   [Khidre, Rizk E.] Jazan Univ, Fac Sci, Chem Dept, Jazan, Saudi Arabia.
   [El-Hiti, Gamal A.] King Saud Univ, Cornea Res Chair, Dept Optometry, Coll Appl Med Sci, POB 10219, Riyadh 11433, Saudi Arabia.
RP Abdel-Wahab, BF (reprint author), Natl Res Ctr, Appl Organ Chem Dept, Giza 12622, Egypt.; Abdel-Wahab, BF (reprint author), Shaqra Univ, Dept Chem, Coll Sci & Humanities, Duwadimi, Saudi Arabia.; El-Hiti, GA (reprint author), King Saud Univ, Cornea Res Chair, Dept Optometry, Coll Appl Med Sci, POB 10219, Riyadh 11433, Saudi Arabia.
EM balshobia@su.edu.sa; gelhiti@ksu.edu.sa
OI Abdel-Wahab, bakr/0000-0002-4333-7004; E. Khidre,
   Rizk/0000-0002-2317-8683
FU King Saud University, Deanship of Scientific Research, Research Chairs
FX We thank Professor Ghada E. A. Awad, National Research Center, Giza,
   Egypt, for the antimicrobial evaluation. The project was supported by
   King Saud University, Deanship of Scientific Research, Research Chairs.
CR Abdel-Wahab BF, 2012, EUR J MED CHEM, V52, P263, DOI 10.1016/j.ejmech.2012.03.023
   Abdel-Wahab BF, 2011, ARKIVOC, P196
   Abdel-Wahab B. F., 2015, J MOD MED CHEM, V3, P9
   Baashen MA, 2016, HETEROCYCLES, V92, P1931, DOI 10.3987/REV-16-847
   Balouiri M, 2016, J PHARM ANA, V6, P71, DOI 10.1016/j.jpha.2015.11.005
   Bekheit MS, 2016, CHEM HETEROCYCL COM+, V52, P766, DOI 10.1007/s10593-016-1961-0
   Bhat M, 2016, RSC ADV, V6, P59375, DOI 10.1039/c6ra06093e
   Distinto R, 2014, J FLUORINE CHEM, V167, P184, DOI 10.1016/j.jfluchem.2014.07.010
   El-Hiti G.A., 2015, ARKIVOC, VIV, P19
   Gosselin F, 2006, SYNLETT, P3267, DOI 10.1055/s-2006-956487
   Gouda MA, 2016, RES CHEM INTERMEDIAT, V42, P2119, DOI 10.1007/s11164-015-2139-6
   Harigae R, 2014, J ORG CHEM, V79, P2049, DOI 10.1021/jo4027116
   Havrylyuk D, 2016, EUR J MED CHEM, V113, P145, DOI 10.1016/j.ejmech.2016.02.030
   Heller ST, 2006, ORG LETT, V8, P2675, DOI 10.1021/ol060570p
   Kaur K, 2015, MED CHEM RES, V24, P3863, DOI 10.1007/s00044-015-1429-2
   Panda N, 2012, J ORG CHEM, V77, P9401, DOI 10.1021/jo301770k
   Patel H, 2012, LETT DRUG DES DISCOV, V9, P840
   Pokhodylo NT, 2009, RUSS J GEN CHEM+, V79, P309, DOI 10.1134/S1070363209020248
   Reddy CR, 2013, SYNTHESIS-STUTTGART, V45, P830, DOI 10.1055/s-0032-1316856
   Schmitt DC, 2015, ORG LETT, V17, P1405, DOI 10.1021/acs.orglett.5b00266
   Scott A. C., 1989, MACKIE MCCARTNEY PRA, P161
   Smith K, 2014, ARKIVOC, P365
   Smith K, 2014, ARKIVOC, P301
   Smith K, 2011, BEILSTEIN J ORG CHEM, V7, P1219, DOI 10.3762/bjoc.7.142
   Specklin S, 2014, J ORG CHEM, V79, P7772, DOI 10.1021/jo501420r
   Wu LL, 2012, SYNTHESIS-STUTTGART, V44, P1577, DOI 10.1055/s-0031-1290772
   Ye L, 2013, BIOORG MED CHEM LETT, V23, P340, DOI 10.1016/j.bmcl.2012.10.080
   Ye L, 2010, J MED CHEM, V53, P3772, DOI 10.1021/jm100235h
NR 28
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2193-567X
EI 2191-4281
J9 ARAB J SCI ENG
JI Arab. J. Sci. Eng.
PD JUN
PY 2017
VL 42
IS 6
BP 2441
EP 2448
DI 10.1007/s13369-017-2530-2
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV9CG
UT WOS:000402081500026
OA No
DA 2017-08-17
ER

PT J
AU Sadik, NAH
   Metwally, NS
   Shaker, OG
   Soliman, MS
   Mohamed, AA
   Abdelmoaty, MM
AF Sadik, Nermin Abdel-hamid
   Metwally, Nadia Said
   Shaker, Olfat Gamil
   Soliman, Mahmoud Sanad
   Mohamed, Ahmed Abdelaziz
   Abdelmoaty, Mai Mohamed
TI Local renin-angiotensin system regulates the differentiation of
   mesenchymal stem cells into insulin-producing cells through angiotensin
   type 2 receptor
SO BIOCHIMIE
LA English
DT Article
DE Angiotensin type 1 receptor; Angiotensin type 2 receptor;
   Insulin-producing cells; Mesenchymal stem cells; Renin-angiotensin
   system
ID IMPROVED ISLET TRANSPLANTATION; PROGENITOR CELLS; ADIPOSE-TISSUE;
   EXPRESSION; MUSCLE
AB Differentiation of stem cells into insulin-producing cells (IPCs) suitable for therapeutic transplantation offers a desperately needed approach for the diabetic patients. Elucidation of the molecular mechanisms during the differentiation of mesenchymal stem cells (MSCs) into IPCs assists the successful production of IPCs and provides an important insight into the improvement of the role of MSCs as a therapeutic tool for diabetes mellitus (DM). The present study aimed to investigate the role of local renin-angiotensin system (RAS) on MSCs differentiation into IPCs by measuring the expression of local RAS in MSCs during the differentiation into IPCs and assessing the effect of angiotensin type 1 receptor (AT(1)R) blocker and angiotensin type 2 receptor (AT(2)R) blocker on the differentiation process. Our data showed that the differentiation of MSCs into IPCs was associated with an increase in cellular angiotensinogen, angiotensin-converting enzyme (ACE), renin, and AT(2)R expression and undetectable expression of MIR. The net effect was an increase in cellular angiotensin II (Ang II) during the differentiation process. AT(1)R blockade allowed the differentiation of MSCs into IPCs, whereas AT(2)R blockade alone and blockade of both ATIR and AT(2)R inhibited the differentiation of MSCs into IPCs. Our data demonstrated an important role of local RAS in the regulation of MSCs differentiation into IPCs and that Ang II mainly orchestrates this role through AT(2)R activation. (C) 2017 Elsevier B.V. and Societe Francaise de Biochimie et Biologie Moleculaire (SFBBM). All rights reserved.
C1 [Sadik, Nermin Abdel-hamid] Cairo Univ, Fac Pharm, Biochem Dept, Kasr El Einy St, Cairo 11562, Egypt.
   [Metwally, Nadia Said; Soliman, Mahmoud Sanad; Abdelmoaty, Mai Mohamed] Natl Res Ctr, Therapeut Chem Dept, Pharmaceut & Drug Ind Res Div, El Buhouth St, Giza 12622, Egypt.
   [Shaker, Olfat Gamil] Cairo Univ, Fac Med, Med Biochem & Mol Biol Dept, Kasr El Einy St, Cairo, Egypt.
   [Mohamed, Ahmed Abdelaziz] Future Univ, Dept Supplementary Gen Sci, Cairo, Egypt.
   [Abdelmoaty, Mai Mohamed] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA.
RP Abdelmoaty, MM (reprint author), Natl Res Ctr, Therapeut Chem Dept, Pharmaceut & Drug Ind Res Div, El Buhouth St, Giza 12622, Egypt.; Abdelmoaty, MM (reprint author), Univ Nebraska Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE 68198 USA.
EM nerminsadik@yahoo.com; nadiametwally@yahoo.com; olfatshaker@yahoo.com;
   mmsanad2000@yahoo.com; aabdelaziz83@yahoo.com; mm.abdelmoaty@nrc.sci.eg
FU National Research Centre, Egypt [14/2/2]
FX We thank National Research Centre, Egypt for the financial assistance
   (14/2/2).
CR Bosch P, 2000, J ORTHOPAED RES, V18, P933, DOI 10.1002/jor.1100180613
   de Gasparo M, 2000, PHARMACOL REV, V52, P415
   Fan Y, 2015, INT J CLIN EXP PATHO, V8, P2505
   Guo QS, 2012, EXP DIABETES RES, DOI 10.1155/2012/672013
   Iwanami J, 2008, STROKE, V39, P2554, DOI 10.1161/STROKEAHA.107.513275
   Kim YM, 2008, INT J BIOCHEM CELL B, V40, P2482, DOI 10.1016/j.biocel.2008.04.016
   LATIF ZA, 1988, TRANSPLANTATION, V45, P827
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670
   Leung KK, 2014, DEV DYNAM, V243, P415, DOI 10.1002/dvdy.24084
   Liang J, 2012, DIABETES OBES METAB, V14, P842, DOI 10.1111/j.1463-1326.2012.01612.x
   Matsushita K, 2006, HYPERTENSION, V48, P1095, DOI 10.1161/01.HYP.0000248211.82232.a7
   Motawi TMK, 2014, CELL BIOCHEM BIOPHYS, V68, P111, DOI 10.1007/s12013-013-9698-1
   Musina RA, 2006, B EXP BIOL MED+, V141, P147, DOI 10.1007/s10517-006-0115-2
   Narang AS, 2006, PHARMACOL REV, V58, P194, DOI 10.1124/pr.58.2.6
   Numasawa Y, 2011, STEM CELLS, V29, P1405, DOI 10.1002/stem.691
   Ouyang JF, 2014, CHEM-BIOL INTERACT, V208, P1, DOI 10.1016/j.cbi.2013.11.007
   Owen M., 2007, CIBA FDN S
   Rubio D, 2005, CANCER RES, V65, P3035
   Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284
   Strawn WB, 2004, BRIT J HAEMATOL, V126, P120, DOI 10.1111/j.1365-2141.2004.04998.x
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Wang L, 2013, MOL CELL ENDOCRINOL, V381, P261, DOI 10.1016/j.mce.2013.08.008
   Wei F, 2011, EXP CELL RES, V317, P2661, DOI 10.1016/j.yexcr.2011.08.011
   WHO, 2016, GLOB REP DIAB
   Wong RSY, 2011, EXP DIABETES RES, DOI 10.1155/2011/406182
   Wu H, 2011, MOL PHARMACEUT, V8, P1458, DOI 10.1021/mp200135e
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 28
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD JUN
PY 2017
VL 137
BP 132
EP 138
DI 10.1016/j.biochi.2017.03.002
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EW0XO
UT WOS:000402214700015
PM 28288872
OA No
DA 2017-08-17
ER

PT J
AU Abuoghaba, AA
AF Abuoghaba, Ahmed Abdelkareem
TI Impact of spraying incubated eggs submitted to high temperature with
   ascorbic acid on embryonic development, hatchability, and some
   physiological responses of hatched chicks
SO CANADIAN JOURNAL OF ANIMAL SCIENCE
LA English
DT Article
DE incubation temperatures; ascorbic acid; chick quality traits;
   hatchability; embryonic development
ID COTURNIX-JAPONICA EGGS; PULMONARY-HYPERTENSION SYNDROME;
   BROILER-CHICKENS; MICROBIAL ACTIVITY; THERMAL MANIPULATIONS;
   AMBIENT-TEMPERATURE; GROWTH-PERFORMANCE; BREEDER EGGS; TURKEY EGGS;
   HEAT-STRESS
AB Three hundred and sixty Hubbard broiler eggs were divided into two equal groups. In the first group, eggs were incubated at 37.5 degrees C for up to 19 d, while those in the second group were incubated at the same temperature except for 3 d (days 6, 7, and 8) when they were exposed to 40.0 degrees C for 3 h each day. Eggs were equally classified into three ascorbic acid (AA) treatments. The first one was sprayed with distilled water (control), while the second and third treatments were sprayed with same solution but containing 20 and 30 g AA L-1, respectively. The highest embryo weight (EW) per gram and lowest yolk sac weight (YSW) per gram were obtained in the chronic group (P <= 0.05). Embryonic mortalities were significantly (P <= 0.05) increased, while hatchability was significantly decreased in the chronic group compared with the control group. Chick weight (g) and glucose and triiodothyronine (T3) levels were significantly lower (P <= 0.05) in the chronic group compared with the control group. The heterophil-lymphocyte (H/L) ratio was significantly (P <= 0.01) affected by incubation temperature. Body weight (g) and percentages of liver, spleen, and bursa of Fabricius were significantly (P <= 0.05) lower in broilers in the chronic group compared with the control group. Referring to AA treatment, EWs (g) were not affected, whereas YSW per gram, packed cell volume (PCV) (%), red blood cells (RBCs) (10(6)), H/L ratio, and bursa percentage were significantly (P <= 0.05) affected.
C1 [Abuoghaba, Ahmed Abdelkareem] Sohag Univ, Dept Poultry Prod, Fac Agr, Sohag 82524, Egypt.
RP Abuoghaba, AA (reprint author), Sohag Univ, Dept Poultry Prod, Fac Agr, Sohag 82524, Egypt.
EM abuoghaba@yahoo.com
CR Aygun A, 2012, POULTRY SCI, V91, P1018, DOI 10.3382/ps.2011-01944
   Aygun A, 2012, POULTRY SCI, V91, P732, DOI 10.3382/ps.2011-01901
   Aygun A, 2013, POULTRY SCI, V92, P3330, DOI 10.3382/ps.2013-03291
   Badran A. M., 2012, Egyptian Poultry Science Journal, V32, P675
   Caglayan T., 2009, J ANIM SCI, V8, P567, DOI [10.4081/ijas.2009.567, DOI 10.4081/IJAS.2009.567]
   Decuypere E, 2000, WORLD POULTRY SCI J, V56, P367, DOI 10.1079/WPS20000025
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   French NA, 1997, POULTRY SCI, V76, P124
   Ghonim A. I. A., 2009, EGYPTPOULTRY SCI, V29, P1085
   Gomez-de-Travecedo P, 2014, POULTRY SCI, V93, P747, DOI 10.3382/ps.2013-03329
   GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198
   Hill D., 2001, AVIAN POULT BIOL REV, V12, P188
   HUCHZERMEYER FW, 1988, ONDERSTEPOORT J VET, V55, P5
   Hulet R, 2007, POULTRY SCI, V86, P408
   HULET RM, 1987, POULTRY SCI, V66, P428
   Kutlu HR, 2001, ARCH ANIM NUTR, V54, P127
   Leksrisompong N, 2007, POULTRY SCI, V86, P2685, DOI 10.3382/ps.2007-00170
   Lourens A, 2007, POULTRY SCI, V86, P2194
   Lourens A, 2005, POULTRY SCI, V84, P914
   Lourens A., 2000, AVIAN POULT BIOL REV, V11, P299
   Lubritz D. L., 1994, Journal of Applied Poultry Research, V3, P171
   Maatjens CM, 2014, POULTRY SCI, V93, P645, DOI 10.3382/ps.2013-03490
   MAXWELL MH, 1992, COMP HAEMATOL INT, V2, P190, DOI 10.1007/BF00216094
   Meijerhof R., 2009, Proceedings of the 20th Australian Poultry Science Symposium, 2009, Sydney, New South Wales, Australia, 9-11th February 2009, P106
   MOHAMMED KA, 2011, EGYPT POULTRY SCI, V31, P379
   Molenaar R, 2011, POULTRY SCI, V90, P624, DOI 10.3382/ps.2010-00970
   Molenaar R, 2010, BRAZ J POULTRY SCI, V12, P137, DOI 10.1590/S1516-635X2010000300001
   Morita VS, 2009, BRAZ J POULT SCI, V11, P7, DOI 10.1590/S1516-635X2009000100002
   Narinc D, 2016, ANIMAL, V10, P1328, DOI 10.1017/S1751731116000276
   Nichelmann M, 2002, COMP BIOCHEM PHYS A, V131, P751, DOI 10.1016/S1095-6433(02)00013-2
   Nowaczewski S, 2012, FOLIA BIOL-KRAKOW, V60, P93, DOI 10.3409/fb60_1-2.93-97
   ONO H, 1994, ISRAEL J ZOOL, V40, P467
   PALO PE, 1995, POULTRY SCI, V74, P1470
   Pulikanti R, 2012, POULTRY SCI, V91, P55, DOI 10.3382/ps.2011-01759
   RAHN H, 1981, POULTRY SCI, V60, P2536
   RICHARDS SA, 1971, J PHYSIOL-LONDON, V216, P1
   ROBEL EJ, 1993, POULTRY SCI, V72, P1740
   Sahin K, 2002, BIOL TRACE ELEM RES, V89, P53, DOI 10.1385/BTER:89:1:53
   SAS Institute, 2004, SAS STAT US GUID VER
   Schalm O. W., 1975, VET HEMATOLOGY, P140
   Selim S. A., 2012, Emirates Journal of Food and Agriculture, V24, P264
   Sgavioli S, 2015, BRAZ J POULTRY SCI, V17, P181, DOI 10.1590/1516-635x1702181-190
   Shafey TM, 2002, BRIT POULTRY SCI, V43, P135, DOI 10.1080/00071660120109999
   Sozcu A, 2015, POULTRY SCI, V94, P319, DOI 10.3382/ps/peu080
   TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158
   Tullett S. C., 1978, RESP FUNCTION BIRDS, P217
   Walstra I, 2010, POULTRY SCI, V89, P1502, DOI 10.3382/ps.2009-00568
   Wideman RF, 2001, WORLD POULTRY SCI J, V57, P289, DOI 10.1079/WPS20010021
   Willemsen H, 2011, POULTRY SCI, V90, P1302, DOI 10.3382/ps.2011-01390
   Willemsen H, 2010, POULTRY SCI, V89, P2678, DOI 10.3382/ps.2010-00853
   Yalcin S, 2003, POULTRY SCI, V82, P1388
   Yalcin S, 2009, POULTRY SCI, V88, P2006, DOI 10.3382/ps.2008-00505
   Yassein D. M. M., 2014, Egyptian Poultry Science Journal, V34, P715
NR 53
TC 0
Z9 0
U1 1
U2 1
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-3984
EI 1918-1825
J9 CAN J ANIM SCI
JI Can. J. Anim. Sci.
PD JUN
PY 2017
VL 97
IS 2
BP 172
EP 182
DI 10.1139/cjas-2016-0025
PG 11
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA EW2HC
UT WOS:000402316300003
OA No
DA 2017-08-17
ER

PT J
AU Ghaly, PE
   Churchill, CDM
   Abou El-Magd, RM
   Hajkova, Z
   Draber, P
   West, FG
   Tuszynski, JA
AF Ghaly, Peter E.
   Churchill, Cassandra D. M.
   Abou El-Magd, Rabab M.
   Hajkova, Zuzana
   Draber, Pavel
   West, F. G.
   Tuszynski, Jack A.
TI Synthesis and biological evaluation of structurally simplified noscapine
   analogues as microtubule binding agents
SO CANADIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE noscapine; microtubule; tubulin; cytotoxicity; microtubule dynamics;
   docking
ID ANTICANCER AGENTS; INTERFERING AGENTS; PERTURB MITOSIS; CANCER-CELLS;
   DERIVATIVES; POTENT; CHECKPOINT; COLCHICINE; APOPTOSIS; DYNAMICS
AB This paper reports on the results of chemical synthesis and biological assays performed on several new analogues of noscapine. We have successfully synthesized four noscapine analogues called 1a-4a, as well as their four corresponding enantiomers called 1b-4b. The chemical pathway consisted of three steps with yields in excess of 60% in each step. Subsequently, we have performed biological activity assays intended to reveal the mode of action of these compounds on microtubules in buffer and in cancer cell lines. We have assayed fluorescence quenching effects in microtubule polymerization experiments, cytotoxicity evaluation in breast cancer cell lines, as well as microtubule dynamicity assessments, for each of the synthesized compounds. Finally, we performed computational docking simulations to two binding sites on beta-tubulin: (a) the colchicine binding site and (b) the noscapine binding site. Our results indicate that these compounds have relatively low cytotoxicity profile and less pronounced effects on microtubule dynamics compared with noscapine. Our computational results indicate that these compounds bind to both putative binding sites but have higher affinity for the colchicine site.
C1 [Ghaly, Peter E.; Churchill, Cassandra D. M.; West, F. G.] Univ Alberta, Dept Chem, E3-43 Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada.
   [Abou El-Magd, Rabab M.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada.
   [Abou El-Magd, Rabab M.] Genet Engn & Biotechnol Inst, City Sci Res & Technol Applicat, Alexandria 21934, Egypt.
   [Hajkova, Zuzana; Draber, Pavel] Acad Sci Czech Republic, Inst Mol Genet, Lab Biol Cytoskeleton, CZ-14220 Prague 4, Czech Republic.
   [Tuszynski, Jack A.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada.
   [Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada.
RP West, FG (reprint author), Univ Alberta, Dept Chem, E3-43 Gunning Lemieux Chem Ctr, Edmonton, AB T6G 2G2, Canada.
EM frederick.west@ualberta.ca
FU NSERC (Canada); Grant Agency of the Czech Republic [15-22194S]; NSERC;
   Alberta Innovates-Technology Futures; Killam Trust; IODE War Memorial
   Scholarship; University of Alberta
FX This research was partially funded by grants from NSERC (Canada) awarded
   to J.A.T and F.G.W and grant 15-22194S from the Grant Agency of the
   Czech Republic awarded to P.D. C.D. M.C thanks NSERC, Alberta
   Innovates-Technology Futures, the Killam Trust, the IODE War Memorial
   Scholarship, and the University of Alberta for funding.
CR Alisaraie L, 2011, CHEM BIOL DRUG DES, V78, P535, DOI 10.1111/j.1747-0285.2011.01189.x
   Anderson JT, 2005, J MED CHEM, V48, P7096, DOI 10.1021/jm050674q
   Aneja R, 2006, MOL PHARMACOL, V69, P1801, DOI 10.1124/mol.105.021899
   Aneja R, 2007, CANCER CHEMOTH PHARM, V60, P831, DOI 10.1007/s00280-007-0430-y
   Aneja R, 2006, BIOCHEM PHARMACOL, V72, P415, DOI 10.1016/j.bcp.2006.05.004
   Aneja R, 2006, BIOORGAN MED CHEM, V14, P8352, DOI 10.1016/j.bmc.2006.09.012
   Aneja R, 2010, EUR J CANCER, V46, P1668, DOI 10.1016/j.ejca.2010.02.017
   Colello D, 2010, J CELL SCI, V123, P2093, DOI 10.1242/jcs.057505
   DeBono A, 2015, J MED CHEM, V58, P5699, DOI 10.1021/jm501180v
   DeBono AJ, 2014, CHEMMEDCHEM, V9, P399, DOI 10.1002/cmdc.201300395
   Freedman H, 2009, J CHEM INF MODEL, V49, P424, DOI 10.1021/ci8003336
   Frisch M. J., 2009, GAUSSIAN 09 REVISON
   Ghaly PE, 2016, ONCOTARGET, V7, P40518, DOI 10.18632/oncotarget.9642
   Henary M, 2014, BIOCHEM PHARMACOL, V92, P192, DOI 10.1016/j.bcp.2014.07.020
   Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w
   Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z
   Manchukonda NK, 2012, BIOORG MED CHEM LETT, V22, P2983, DOI 10.1016/j.bmcl.2012.02.033
   Manchukonda NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077970
   Mishra RC, 2015, BIOORG MED CHEM LETT, V25, P2133, DOI 10.1016/j.bmcl.2015.03.076
   Mukkavilli R, 2015, EUR J PHARM SCI, V77, P90, DOI 10.1016/j.ejps.2015.05.026
   Naik PK, 2011, J MOL GRAPH MODEL, V29, P947, DOI 10.1016/j.jmgm.2011.03.004
   Percy AJ, 2012, ANAL CHIM ACTA, V721, P7, DOI 10.1016/j.aca.2012.01.037
   Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393
   Rida PCG, 2015, MED RES REV, V35, P1072, DOI 10.1002/med.21357
   Santoshi S, 2015, J COMPUT AID MOL DES, V29, P249, DOI 10.1007/s10822-014-9820-5
   Sulimenko V, 2015, J IMMUNOL, V194, P4099, DOI 10.4049/jimmunol.1402459
   Suri C, 2015, SAR QSAR ENVIRON RES, V26, P507, DOI 10.1080/1062936X.2015.1070200
   THOMA K, 1990, INT J PHARM, V58, P197, DOI 10.1016/0378-5173(90)90195-A
   Vinopal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029919
   Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601
   Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200
   Zhou J, 2003, MOL PHARMACOL, V63, P799, DOI 10.1124/mol.63.4.799
NR 32
TC 0
Z9 0
U1 1
U2 1
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4042
EI 1480-3291
J9 CAN J CHEM
JI Can. J. Chem.
PD JUN
PY 2017
VL 95
IS 6
BP 649
EP 655
DI 10.1139/cjc-2016-0649
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA EW2HG
UT WOS:000402316800003
OA No
DA 2017-08-17
ER

PT J
AU El-Gohary, OA
   Allam, MM
AF El-Gohary, Ola Ahmed
   Allam, Mona Maher
TI Effect of vitamin D on isoprenaline-induced myocardial infarction in
   rats: possible role of peroxisome proliferator-activated receptor-gamma
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE vitamin D; isoprenaline; myocardial infarction; peroxisome proliferator
   activated receptor-gamma; oxidative stress
ID RANDOMIZED CONTROLLED-TRIAL; WISTAR RATS; CARDIOVASCULAR-DISEASE;
   SIGNALING PATHWAY; D SUPPLEMENTATION; OXIDATIVE STRESS; HEART-FAILURE;
   PPAR-GAMMA; ISOPROTERENOL; INJURY
AB Infarct-like lesion induced by isoprenaline is a well-known model to study myocardial infarction (MI). Vitamin D has been shown to have anti-inflammatory and antioxidant effects. Recent studies highlighted cross talk between vitamin D and peroxisome proliferator-activated receptor gamma (PPAR-gamma). The present study was designed to investigate the effect of pretreatment with vitamin D on the isoprenaline-induced infarct-like lesion in rats and the role of PPAR-gamma as a novel mechanism in vitamin-D-mediated cardioprotective effect. Markers chosen to assess cardiac damage included serum level of creatine kinase (CK), lactate dehydrogenase (LDH), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6). Cardiac contents of malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH) were also assessed. Furthermore, ECG monitoring and measurement of injury extension were carried out. Isoprenaline increased the level of cardiac enzymes, as well as inflammatory and oxidative stress biomarkers. In addition, it produced ST-segment elevation. Pretreatment with vitamin D significantly improved previous parameters. The prior treatment with bisphenol A diglycidyl ether (BADGE), a PPAR-gamma antagonist, significantly attenuated the protective effect of vitamin D. In conclusion, vitamin D can be demonstrated as a promising cardioprotective agent in MI and PPAR-gamma significantly contributes toward vitamin-D-mediated protection.
C1 [El-Gohary, Ola Ahmed; Allam, Mona Maher] Benha Univ, Fac Med, Physiol Dept, Banha, Egypt.
RP El-Gohary, OA (reprint author), Benha Univ, Fac Med, Physiol Dept, Banha, Egypt.
EM ola.algohari@fmed.bu.edu.eg
CR Abood AM, 2015, BIOMED RES-INDIA, V26, P755
   Al Mheid I, 2013, EUR HEART J, V34, P3691, DOI 10.1093/eurheartj/eht166
   Arnson Y, 2013, CLIN REV ALLERG IMMU, V45, P236, DOI 10.1007/s12016-013-8356-0
   Basak T, 2015, J PROTEOMICS, V127, P50, DOI 10.1016/j.jprot.2015.04.027
   Bharti S., 2010, MICROSCOPY SCI TECHN, P361
   Brandenburg VM, 2012, ATHEROSCLEROSIS, V225, P253, DOI 10.1016/j.atherosclerosis.2012.08.005
   Chatterjee PK, 2004, CARDIOVASC RES, V61, P630, DOI 10.1016/j.cardiores.2003.10.024
   Creighton D., 2012, B C MED J, V54, P136
   Cusack MR, 2002, J AM COLL CARDIOL, V39, P1917, DOI 10.1016/S0735-1097(02)01899-5
   Dai XJ, 2008, J DERMATOL SCI, V50, P53, DOI 10.1016/j.jdermsci.2007.10.011
   Das S, 2000, CURR SCI INDIA, V78, P486
   Cavalcante IGD, 2015, EXP GERONTOL, V66, P10, DOI 10.1016/j.exger.2015.03.011
   Delerive P, 1999, CIRC RES, V85, P394
   EVANS RG, 1985, CARDIOVASC RES, V19, P132, DOI 10.1093/cvr/19.3.132
   Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5
   Gagnon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109607
   Gao F, 2001, BRIT J PHARMACOL, V132, P869, DOI 10.1038/sj.bjp.0703881
   Goleniewska B, 2014, CARDIOL J, V21, P18, DOI 10.5603/CJ.a2013.0048
   Hlaing SM, 2014, J MOL ENDOCRINOL, V53, P303, DOI 10.1530/JME-14-0168
   Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X
   Kapil A, 2013, J SURG RES, V185, P774, DOI 10.1016/j.jss.2013.07.017
   Kumaran KS, 2010, CELL STRESS CHAPERON, V15, P791, DOI 10.1007/s12192-010-0187-9
   Kurian GA, 2005, J ETHNOPHARMACOL, V97, P457, DOI 10.1016/j.jep.2004.11.028
   Lee JH, 2011, AM J CARDIOL, V107, P1636, DOI 10.1016/j.amjcard.2011.01.048
   Loh HK, 2007, BASIC CLIN PHARMACOL, V100, P233, DOI 10.1111/j.1742-7843.2007.00022.x
   Mancuso P, 2008, J CARDIOVASC PHARM, V51, P559, DOI 10.1097/FJC.0b013e3181761906
   Mohan Mahalaxmi, 2010, J Pharmacol Pharmacother, V1, P32, DOI 10.4103/0976-500X.64533
   Mohanty I, 2004, BASIC CLIN PHARMACOL, V94, P184
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005
   Panda VS, 2009, ALTERN MED REV, V14, P161
   Patel SS, 2011, REV BRAS FARMACOGN, V21, P704, DOI 10.1590/S0102-695X2011005000090
   Peacock WF, 2007, AM J EMERG MED, V25, P353, DOI 10.1016/j.ajem.2006.07.013
   Prince PSM, 2010, EUR J PHARMACOL, V635, P142, DOI 10.1016/j.ejphar.2010.02.019
   Rajadurai M, 2007, TOXICOLOGY, V230, P178, DOI 10.1016/j.tox.2006.11.053
   Rathore N., 2000, Indian Journal of Physiology and Pharmacology, V44, P161
   Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754
   Shab-Bidar S, 2015, EUR J CLIN NUTR, V69, P216, DOI 10.1038/ejcn.2014.240
   Sharma A, 2000, MOL CELL BIOCHEM, V214, P31, DOI 10.1023/A:1007167519596
   Shikalgar T. S., 2010, J PHARM SCI TECHNOL, V2, P298
   Tawfik MK, 2010, EUR REV MED PHARMACO, V14, P499
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Upaganlawar Aman, 2010, J Pharmacol Pharmacother, V1, P24, DOI 10.4103/0976-500X.64532
   Vennila L, 2010, REDOX REP, V15, P36, DOI 10.1179/174329210X12650506623168
   VIVALDI MT, 1985, AM J PATHOL, V121, P522
   Wang L, 2013, EUR J NUTR, V52, P1771, DOI 10.1007/s00394-012-0480-8
   Wang SB, 2009, EUR J PHARMACOL, V615, P125, DOI 10.1016/j.ejphar.2009.04.061
   Witham MD, 2013, ATHEROSCLEROSIS, V230, P293, DOI 10.1016/j.atherosclerosis.2013.08.005
   Zaafan M. A., 2013, Bulletin of the Faculty of Pharmacy, Cairo University, V51, P35, DOI 10.1016/j.bfopcu.2013.03.001
   Zhang J, 2008, TOXICOL PATHOL, V36, P277, DOI 10.1177/0192623307313010
   Zittermann A, 2008, MOL ASPECTS MED, V29, P423, DOI 10.1016/j.mam.2008.04.002
NR 51
TC 0
Z9 0
U1 1
U2 1
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD JUN
PY 2017
VL 95
IS 6
BP 641
EP 646
DI 10.1139/cjpp-2016-0150
PG 6
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA EW2HY
UT WOS:000402318700003
PM 28177670
OA No
DA 2017-08-17
ER

PT J
AU Moustafa, EM
   Thabet, NM
AF Moustafa, Enas Mahmoud
   Thabet, Noura Magdy
TI Beta-sitosterol upregulated paraoxonase-1 via peroxisome
   proliferator-activated receptor-gamma in irradiated rats
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE beta-sitosterol; gamma-radiation; PPAR-gamma; PON-1; MDA
ID FATTY LIVER-DISEASE; SERUM PARAOXONASE; LIPID PROFILE; EXPRESSION;
   MODULATION; MECHANISM
AB This study was designed to evaluate the effect of beta-sitosterol (BS) on the peroxisome proliferator-activated receptor gamma (PPAR-gamma) gene expression role in the activity of paraoxonase (PON-1) enzyme in oxidative stress status of irradiated rats. Animals were exposed to whole body gamma-radiation single dose 6 Gy and received BS dose (40 mg.(kg body mass)(-1).day(-1), orally). In liver tissue, gene expression of PPAR-gamma ligand was determined. Oxidative stress marker (malondialdehyde, MDA) and antioxidant enzyme activities (superoxide dismutase (SOD), catalase (CAT), PON-1, and arylesterase (ARE)) were assayed in serum and liver tissue. Also, serum lipid profile (cholesterol, triglycerides (TG), low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c)) was measured. In irradiated animals that received BS, expression of PPAR-gamma ligand increase significantly associated with increase in PON-1 and ARE enzyme activities. Also, the activities of SOD, CAT enzymes, and HDL-c levels display elevation. By contrast, significant decrease in MDA content, cholesterol, TG, and LDL-c levels were revealed after BS administration. Our findings in this study provide the evidence that BS has radio-protective effect via regulating the gene expression of PPAR-gamma, causing an increase in PON-1 and ARE enzyme activities. This action of BS is due to its free radical scavenging properties, antioxidant effect, lowering of cholesterol, and PPAR-gamma agonist properties.
C1 [Moustafa, Enas Mahmoud; Thabet, Noura Magdy] Atom Energy Author, Radiat Biol Dept, Natl Ctr Radiat Res & Technol, Cairo, Egypt.
RP Thabet, NM (reprint author), Atom Energy Author, Radiat Biol Dept, Natl Ctr Radiat Res & Technol, Cairo, Egypt.
EM noura_magdy@hotmail.com
CR Aksoy H, 2009, J CLIN LAB ANAL, V23, P105, DOI 10.1002/jcla.20298
   Al-Rejaie SS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-136
   Berger Alvin, 2004, Lipids Health Dis, V3, P5, DOI 10.1186/1476-511X-3-5
   Bergmeyer H.U., 1986, METHODS ENZYMATIC AN, V3
   Bin Sayeed MS, 2015, NUTR CANCER, V67, P1214, DOI 10.1080/01635581.2015.1087042
   Bozaykut P, 2014, FREE RADICAL BIO MED, V70, P174, DOI 10.1016/j.freeradbiomed.2014.02.017
   Camps J, 2012, PPAR RES, DOI 10.1155/2012/616371
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   GAN KN, 1991, DRUG METAB DISPOS, V19, P100
   Ganapathy P, 2014, J ACAD IND RES, V3, P209
   Guo Ruijuan, 2015, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V27, P285, DOI 10.3760/cma.j.issn.2095-4352.2015.04.012
   Gupta R, 2011, J DIABETES, V3, P29, DOI 10.1111/j.1753-0407.2010.00107.x
   Houston M, 2012, J CLIN HYPERTENS, V14, P121, DOI 10.1111/j.1751-7176.2011.00576.x
   Huang B, 2015, STEM CELLS INT, DOI 10.1155/2015/359416
   KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130
   Khateeb J, 2012, ARTERIOSCL THROM VAS, V32, P449, DOI 10.1161/ATVBAHA.111.239889
   Lazim N.H.M., 2015, J CHEM PHARM RES, V7, P121
   Linard C, 2008, J PHARMACOL EXP THER, V324, P911, DOI 10.1124/jpet.107.129122
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mackness B, 2002, EUR J CLIN INVEST, V32, P259, DOI 10.1046/j.1365-2362.2002.00977.x
   Nencu I, 2015, FARMACIA, V63, P710
   Ren Ping, 2015, Clin Med Insights Oncol, V9, P43, DOI 10.4137/CMO.s23527
   Romani R, 2009, J LIPID RES, V50, P2036, DOI 10.1194/jlr.M800493-JLR200
   Saeidnia S., 2014, European Journal of Medicinal Plants, V4, P590
   Tarantino G, 2011, J BIOL REG HOMEOS AG, V25, P47
   Tarantino G, 2007, WORLD J GASTROENTERO, V13, P4669
   Trautwein E.A., 2007, CORPS GRAS LIPIDES, V14, P259, DOI [10.1051/ocl.2007.0145, DOI 10.1051/OCL.2007.0145]
   Unal E, 2005, PANCREAS, V31, P84, DOI 10.1097/01.mpa.0000168227.74203.e4
   Virmani A., 2015, INT J CLIN MED, V6, P71
   Yildirim S, 2012, J MED PLANTS RES, V6, P2317, DOI DOI 10.5897/JMPR011.788
   YOSHIOKA T, 1979, AM J OBSTET GYNECOL, V135, P372
NR 31
TC 0
Z9 0
U1 0
U2 0
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD JUN
PY 2017
VL 95
IS 6
BP 661
EP 666
DI 10.1139/cjpp-2016-0397
PG 6
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA EW2HY
UT WOS:000402318700006
PM 28177669
OA No
DA 2017-08-17
ER

PT J
AU Sedky, AA
   El Serafy, OMH
   Hassan, OA
   Abdel-kawy, HS
   Hasanin, AH
   Raafat, MH
AF Sedky, Amina Ahmed
   El Serafy, Osama Mahmoud Hassan
   Hassan, Olfat Ahmed
   Abdel-kawy, Hala Salah
   Hasanin, Amany Helmy
   Raafat, Mona Hussein
TI Trimetazidine potentiates the antiepileptic activity and ameliorates the
   metabolic changes associated with pentylenetetrazole kindling in rats
   treated with valproic acid
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE epilepsy; valproic acid; trimetazidine; pentylenetetrazole
ID OXIDATIVE STRESS; SERUM-CHOLESTEROL; VASCULAR RISK; TOXICITY; EPILEPSY;
   LIVER; MODEL; ATHEROSCLEROSIS; CARBAMAZEPINE; STIMULATION
AB Oxidative stress is implicated in epileptogenesis as well as in the metabolic changes associated with increased risk of atherosclerotic vascular disease in epilepsy. The present work investigated the impact of the antioxidant trimetazidine (TMZ) on the antiepileptic activity of valproic acid (VPA) and on the metabolic and histological changes in hippocampal, aortic, and hepatic tissues associated with epilepsy and (or) VPA. Rats were divided into non-pentylenetetrazole (non-PTZ) group subdivided into control and VPA-treated groups, and PTZ-treated group subdivided into PTZ, PTZ/VPA, PTZ/TMZ, and PTZ/VPA + TMZ groups. VPA treatment in PTZ rats resulted in an antioxidant effect with improvement in oxidative stress, metabolic and histopathological changes induced by PTZ in hippocampus, aortic, and hepatic tissues. TMZ exhibited anticonvulsant activity and potentiated the anticonvulsant effect of VPA. Combination of TMZ with VPA induced a greater reduction in oxidative stress, improvement in the metabolic and histopathological changes compared to VPA treatment. In contrast, VPA administration in non-PTZ-treated rats induced a pro-oxidative effect, associated with metabolic and histopathological changes in aortic and hepatic tissues. These findings suggest that co-administration of TMZ with VPA in epilepsy might antagonize not only the oxidative stress associated with epilepsy but might also counteract a potential pro-oxidative effect of VPA.
C1 [Sedky, Amina Ahmed; El Serafy, Osama Mahmoud Hassan; Hassan, Olfat Ahmed; Abdel-kawy, Hala Salah; Hasanin, Amany Helmy] Ain Shams Univ, Dept Pharmacol, Fac Med, Cairo, Egypt.
   [Raafat, Mona Hussein] Ain Shams Univ, Fac Med, Dept Histol, Cairo, Egypt.
RP Abdel-kawy, HS (reprint author), Ain Shams Univ, Dept Pharmacol, Fac Med, Cairo, Egypt.
EM halaabdelkawy@med.asu.edu.eg
CR Abdel Salam Omar Mohamed E, 2010, Inflammopharmacology, V18, P87, DOI 10.1007/s10787-009-0027-7
   Azam F, 2012, CURR TOP MED CHEM, V12, P994
   Bancroft J. D., 2008, THEORY PRACTICE HIST
   Belcastro V, 2013, EPILEPSY RES, V107, P1, DOI 10.1016/j.eplepsyres.2013.08.016
   Bowes AJ, 2009, AM J PATHOL, V174, P330, DOI 10.2353/ajpath.2009.080385
   BUELKESAM J, 1978, LAB ANIM SCI, V28, P157
   Chuang YC, 2012, EPILEPSIA, V53, P120, DOI 10.1111/j.1528-1167.2011.03316.x
   Dayanithi G, 2007, EUR J PHARMACOL, V574, P8, DOI 10.1016/j.ejphar.2007.07.003
   Dehina L, 2013, N-S ARCH PHARMACOL, V386, P205, DOI 10.1007/s00210-012-0826-z
   Dillioglugil MO, 2010, BRAIN RES BULL, V83, P356, DOI 10.1016/j.brainresbull.2010.09.007
   Elimadi A, 1998, J PHARMACOL EXP THER, V286, P23
   Erdemir A, 2009, BRAIN DEV-JPN, V31, P713, DOI 10.1016/j.braindev.2008.11.001
   Hopps E, 2010, NUTR METAB CARDIOVAS, V20, P72, DOI 10.1016/j.numecd.2009.06.002
   Ishikura H, 1996, J ANAL TOXICOL, V20, P55
   Jafarian I, 2013, TOXICOL MECH METHOD, V23, P617, DOI 10.3109/15376516.2013.821567
   Jain S, 2011, N-S ARCH PHARMACOL, V383, P385, DOI 10.1007/s00210-011-0606-1
   Kiernan MC, 1999, BRAIN, V122, P933, DOI 10.1093/brain/122.5.933
   Knapp AC, 2008, J PHARMACOL EXP THER, V324, P568, DOI 10.1124/jpet.107.131185
   Kudin AP, 2009, EXP NEUROL, V218, P326, DOI 10.1016/j.expneurol.2009.02.014
   Li J., 2010, ZHONGGUO DANGDAI ERK, V12, P479
   LoPinto-Khoury C, 2010, CURR TREAT OPTION NE, V12, P300, DOI 10.1007/s11940-010-0080-y
   Mania M., 2011, GEORGIAN MED NEWS, V199, P48
   Mannaa Fathia, 2011, Pathophysiology, V18, P287, DOI 10.1016/j.pathophys.2011.04.002
   Martinc B, 2012, CURR NEUROPHARMACOL, V10, P328, DOI 10.2174/157015912804143504
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McAlpine CS, 2012, ARTERIOSCL THROM VAS, V32, P82, DOI 10.1161/ATVBAHA.111.237941
   Mehla J, 2010, LIFE SCI, V87, P596, DOI 10.1016/j.lfs.2010.09.006
   Mortazavi F, 2005, EPILEPSY BEHAV, V7, P629, DOI 10.1016/j.yebeh.2005.08.019
   Nikolaos T, 2004, MED SCI MONITOR, V10, pMT50
   Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P964, DOI 10.1002/pds.2186
   Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073
   Onay-Besikci A, 2008, CARDIOVASC THER, V26, P147, DOI 10.1111/j.1527-3466.2008.00043.x
   Park KH, 2010, AM J CARDIOL, V105, P1723, DOI 10.1016/j.amjcard.2010.01.351
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0
   Reeta KH, 2011, PHARMACOL BIOCHEM BE, V99, P399, DOI 10.1016/j.pbb.2011.05.011
   Saleh Dina Ahmed Amin, 2012, Pak J Biol Sci, V15, P68
   Schulpis K, 1998, PEDIATRICS, V101, P861, DOI 10.1542/peds.101.5.861
   Shao L, 2005, BIOL PSYCHIAT, V58, P879, DOI 10.1016/j.biopsych.2005.04-052
   Sicras A, 2008, BIPOLAR DISORD, V10, P607, DOI 10.1111/j.1399-5618.2008.00599.x
   Srivastava AK, 2013, EPILEPSY RES, V104, P26, DOI 10.1016/j.eplepsyres.2012.10.003
   Tong V, 2005, TOXICOL SCI, V86, P436, DOI 10.1093/toxsci/kfi185
   Tong V, 2005, TOXICOL SCI, V86, P427, DOI 10.1093/toxsci/kfi184
   TRINDER P, 1969, J CLIN PATHOL, V22, P246, DOI 10.1136/jcp.22.2.246-b
NR 43
TC 0
Z9 0
U1 2
U2 2
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD JUN
PY 2017
VL 95
IS 6
BP 686
EP 696
DI 10.1139/cjpp-2016-0263
PG 11
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA EW2HY
UT WOS:000402318700010
PM 28177664
OA No
DA 2017-08-17
ER

PT J
AU Rizk, FH
   Ibrahim, MAA
   Abd-Elsalam, MM
   Soliman, NA
   Abd-Elsalam, SM
AF Rizk, Fatma H.
   Ibrahim, Marwa A. A.
   Abd-Elsalam, Marwa M.
   Soliman, Nema A.
   Abd-Elsalam, Sherief M.
TI Gastroprotective effects of montelukast and Nigella sativa oil against
   corticosteroid- induced gastric damage: they are much more than
   antiasthmatic drugs
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE montelukast; Nigella sativa; dexamethasone; gastric damage
ID MUCOSAL DAMAGE; PROSTAGLANDIN E-2; DEXAMETHASONE; RATS; THYMOQUINONE;
   INJURY; ULCER; PROLIFERATION; LEUKOTRIENES; INFLAMMATION
AB Corticosteroids are used to treat a variety of diseases like bronchial asthma. However, long-term corticosteroids have a gastric ulcerogenic potential. Montelukast (MTK) and Nigella sativa oil (NSO) are used in treatment of bronchial asthma. Previous studies showed that MTK and NSO had gastroprotective effects in other models of gastric ulcer. The present study assesses synergistic gastroprotective effects of both drugs in dexamethasone (DXM)-induced gastric damage. Fifty male rats were divided into 5 groups: normal control (I), DXM group (II), MTK + DXM group (III), NSO + DXM group (IV), MTK + NSO + DXM group (V). After 7 days, stomachs were removed for biochemical analysis and histological examinations. Significant increases in malondialdehyde (MDA) level, superoxide dismutase (SOD) activity, myeloperoxidase (MPO) activity, and proliferating cell nuclear antigen (PCNA) positive cells, with significant decreases in mucus secretion were detected in DXM-treated group compared with group I. Meanwhile, significant decreases of MDA level, MPO activity, and PCNA positive cells and significant increases in mucus secretion were detected in treated groups compared with group II. SOD activity significantly decreased in group V compared with group II. We could conclude that administration of either MTK or NSO or both with DXM counteracts DXM-induced gastric lesions.
C1 [Rizk, Fatma H.] Tanta Univ, Dept Physiol, Fac Med, Tanta, Gharbia Governo, Egypt.
   [Ibrahim, Marwa A. A.] Tanta Univ, Dept Histol, Fac Med, Tanta, Gharbia Governo, Egypt.
   [Abd-Elsalam, Marwa M.] Kafr Elsheikh Univ, Dept Histol, Fac Med, Kafr El Shaikh, Kafr El Sheikh, Egypt.
   [Soliman, Nema A.] Tanta Univ, Dept Biochem, Fac Med, Tanta, Gharbia Governo, Egypt.
   [Abd-Elsalam, Sherief M.] Tanta Univ, Dept Trop Med, Fac Med, Tanta, Gharbia Governo, Egypt.
RP Rizk, FH (reprint author), Tanta Univ, Dept Physiol, Fac Med, Tanta, Gharbia Governo, Egypt.
EM Fatma.rezk@med.tanta.edu.eg
CR Abdel-Sater KA, 2009, INT J PHYSL PATH PHA, V1, P143
   Abdelwahab SI, 2013, INT J NANOMED, V8, P2163, DOI 10.2147/IJN.S44108
   Al-Bayati N.J., 2015, INT J CURR MICROBIOL, V4, P80
   Bandyopadhyay U, 1999, MOL CELL BIOCHEM, V202, P31, DOI 10.1023/A:1007018212822
   Bayir Y, 2006, PHYTOMEDICINE, V13, P584, DOI 10.1016/j.phymed.2005.07.002
   But P G, 2003, Izv Akad Nauk Ser Biol, P261
   Cuciureanu Magda, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P750
   Dengiz GO, 2007, J PHARMACOL SCI, V105, P94, DOI 10.1254/jphs.FP0070122
   Ducharme FM, 2002, BRIT MED J, V324, P1545, DOI 10.1136/bmj.324.7353.1545
   El-Maraghy SA, 2015, CHEM-BIOL INTERACT, V229, P26, DOI 10.1016/j.cbi.2015.01.015
   Ewadh M., 2015, ADV LIFE SCI TECHNOL, V28, P7
   Fiorucci S, 2001, DIGEST LIVER DIS, V33, pS35, DOI 10.1016/S1590-8658(01)80157-2
   Gamble M., 2008, THEORY PRACTICE HIST, P121
   Gandhi M. N., 2012, Asian Pacific Journal of Tropical Disease, V2, P215, DOI 10.1016/S2222-1808(12)60049-8
   Kacem R, 2006, YAKUGAKU ZASSHI, V126, P301, DOI 10.1248/yakushi.126.301
   Kanter M, 2006, ARCH TOXICOL, V80, P217, DOI 10.1007/s00204-005-0037-1
   Klein K, 2016, PEDIATR BLOOD CANCER, V63, P1457, DOI 10.1002/pbc.26011
   KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu NZ, 2004, ANN NY ACAD SCI, V1024, P102, DOI 10.1196/annals.1321.008
   Luo JC, 2004, EUR J PHARMACOL, V485, P275, DOI 10.1016/j.ejphar.2003.11.038
   Luo JC, 2007, J PHARMACOL EXP THER, V320, P687, DOI 10.1124/jpet.106.113035
   Magdy MA, 2012, EUR J PHARMACOL, V697, P126, DOI 10.1016/j.ejphar.2012.09.042
   Manjari V, 2000, PROSTAG LEUKOTR ESS, V62, P85, DOI 10.1054/plef.1999.0125
   Mansour MA, 2000, LIFE SCI, V66, P2583, DOI 10.1016/S0024-3205(00)00592-0
   Marsik P, 2005, PLANTA MED, V71, P739, DOI 10.1055/s-2005-871288
   Muthuraman A, 2010, PROSTAG LEUKOTR ESS, V83, P55, DOI 10.1016/j.plefa.2010.01.003
   Ozbakis-Dengiz G, 2013, TURK J GASTROENTEROL, V24, P88, DOI 10.4318/tjg.2013.0711
   Rahayu W. P., 2012, Makara Seri Kesehatan, V16, P51
   Rajkapoor B, 2002, CURR SCI INDIA, V82, P177
   Ramirez V, 2009, AM J PHYSIOL-RENAL, V297, pF932, DOI 10.1152/ajprenal.00252.2009
   Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393
   Romarheim OH, 2011, J NUTR, V141, P124, DOI 10.3945/jn.110.128900
   Salama R.H.M., 2008, ALPE ADRIA MICROBIOL, V6, P1
   Shimizu N, 2000, J GERONTOL A-BIOL, V55, pB489
   Spinozzi F, 2004, CLIN EXP ALLERGY, V34, P1876, DOI 10.1111/j.1365-2222.2004.02119.x
   Suddek G.M., 2014, INT J BASIC CLIN PHA, V3, P255, DOI [10.5455/2319-2003.ijbcp20140401, DOI 10.5455/2319-2003.ijbcp20140401]
   Sullivan GW, 2000, J LEUKOCYTE BIOL, V67, P591
   SUN Y, 1988, CLIN CHEM, V34, P497
   Swamy AHMV, 2011, INDIAN J PHARM SCI, V73, P193
   Tripathi K.D., 2004, ESSENTIALS MED PHARM, P255
   TSUJI S, 1990, J CLIN GASTROENTEROL, V12, pS85, DOI 10.1097/00004836-199001001-00015
   Ukena D, 2008, DTSCH ARZTEBL INT, V105, P385, DOI 10.3238/arztebl.2008.0385
   Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008
NR 44
TC 0
Z9 0
U1 8
U2 8
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD JUN
PY 2017
VL 95
IS 6
BP 714
EP 720
DI 10.1139/cjpp-2016-0374
PG 7
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA EW2HY
UT WOS:000402318700013
PM 28187265
OA No
DA 2017-08-17
ER

PT J
AU Amin, SN
   El-Aidi, AA
   Zickri, MB
   Rashed, LA
   Hassan, SS
AF Amin, Shaimaa Nasr
   El-Aidi, Ahmed Amro
   Zickri, Maha Baligh
   Rashed, Laila Ahmed
   Hassan, Sherif Sabry
TI Hepatoprotective effect of blocking N-methyl-D-aspartate receptors in
   male albino rats exposed to acute and repeated restraint stress
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE acute stress; repeated stress; restraint; liver; memantine
ID FIBRILLARY ACIDIC PROTEIN; ZINC TRANSPORTER ZIP14; PSYCHOLOGICAL STRESS;
   OXIDATIVE STRESS; STELLATE CELLS; LIVER-INJURY; GLUTAMATERGIC
   TRANSMISSION; SUPEROXIDE-DISMUTASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION
AB Stress affects many organs in addition to the brain, including the liver. We assessed the effects on the liver of blocking N-methyl-D-aspartate (NMDA) glutamate receptors with memantine in acute and repeated restraint stress. Forty-two male albino rats were divided into 7 groups; control, acute restraint stress (ARS), ARS + memantine, repeated restraint stress, repeated restraint + memantine, and positive control groups. We measured serum iron, zinc, alanine transferase and aspartame transferase, hepatic malondialdehyde, tumor necrosis factor-alpha (TNF-alpha), glutathione peroxidase, superoxide dismutase, metallothionein content, zinc transporter ZRT/IRT-like protein 14 mRNA expression, and hepcidin expression. We conducted a histopathological evaluation via histological staining and immunostaining for glial fibrillary acidic protein and synaptophysin expression, both of which are markers of hepatic stellate cell (HSC) activation. Both ARS and repeated stress increased markers of hepatic cell injury, oxidative stress, and HSC activation. Blocking NMDA with memantine provided a hepatoprotective effect in acute and repeated restraint stress and decreased hepatic cell injury, oxidative stress, and HSC activation.
C1 [Amin, Shaimaa Nasr] Cairo Univ, Dept Med Physiol, Fac Med, Cairo, Egypt.
   [El-Aidi, Ahmed Amro] Hikma Pharmaceut, Qual Assurance Dept, Cairo, Egypt.
   [Zickri, Maha Baligh] Cairo Univ, Dept Histol, Fac Med, Cairo, Egypt.
   [Rashed, Laila Ahmed] Cairo Univ, Dept Biochem, Fac Med, Cairo, Egypt.
   [Hassan, Sherif Sabry] Cairo Univ, Dept Anat, Fac Med, Cairo, Egypt.
   [Hassan, Sherif Sabry] Calif Univ Sci & Med, Sch Med, Dept Med Educ, Colton, CA USA.
RP Amin, SN (reprint author), Cairo Univ, Dept Med Physiol, Fac Med, Cairo, Egypt.
EM shaimaa599@yahoo.com
CR Adikwu E., 2013, Pharmacology and Pharmacy, V4, P84
   Amin SN, 2015, NEUROMOL MED, V17, P121, DOI 10.1007/s12017-015-8343-0
   Bancroft J. D., 2008, THEORY PRACTICE HIST
   Basuroy S, 2013, AM J PHYSIOL-CELL PH, V304, pC1105, DOI 10.1152/ajpcell.00023.2013
   Batra Jyoti, 2002, Indian J Clin Biochem, V17, P108, DOI 10.1007/BF02867982
   Buijsse B, 2007, EUR J CARDIOV PREV R, V14, P495, DOI 10.1097/HJR.0b013e3280111e41
   Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793
   Chen JB, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-83
   Chien LT, 2001, COMP BIOCHEM PHYS B, V128, P91, DOI 10.1016/S1096-4959(00)00299-2
   Czech B, 2013, INT J CLIN EXP PATHO, V6, P1585
   Dohare P, 2014, FREE RADICAL BIO MED, V77, P168, DOI 10.1016/j.freeradbiomed.2014.08.029
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Emsley R, 2010, STAT METHODS MED RES, V19, P237, DOI 10.1177/0962280209105014
   Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387
   Ferreira Marcelo, 2011, Int Arch Med, V4, P5, DOI 10.1186/1755-7682-4-5
   GARD AL, 1985, J NEUROIMMUNOL, V8, P359, DOI 10.1016/S0165-5728(85)80073-4
   Gorg B, 2013, ARCH BIOCHEM BIOPHYS, V536, P158, DOI 10.1016/j.abb.2013.03.010
   Greenwel P., 1994, BIOL PATHOBIOLOGY, P1367
   Hassan S, 2014, PAK J MED SCI, V30, P1027, DOI 10.12669/pjms.305.5534
   Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011
   JOHNSEN O, 1987, INT J ANDROL, V10, P435, DOI 10.1111/j.1365-2605.1987.tb00216.x
   Kageyama K, 2007, J ENDOCRINOL, V195, P199, DOI 10.1677/JOE-07-0125
   Kiernan J.A., 2001, HISTOLOGICAL HISTOCH, P111
   Knecht K, 1997, NEUROSCI LETT, V229, P201, DOI 10.1016/S0304-3940(97)00444-8
   Krebs NF, 2001, BIOMETALS, V14, P397, DOI 10.1023/A:1012942409274
   Kumar A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-18
   Liu W, 2013, NEUROTOX RES, V24, P320, DOI 10.1007/s12640-013-9386-3
   Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lupp A, 2003, EXP TOXICOL PATHOL, V54, P441, DOI 10.1078/0940-2993-00280
   Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478
   Maskos K, 1998, P NATL ACAD SCI USA, V95, P3408, DOI 10.1073/pnas.95.7.3408
   McGahan MC, 2005, AM J PHYSIOL-CELL PH, V288, pC1117, DOI 10.1152/ajpcell.00444.2004
   Millan M, 2008, DIS MARKERS, V25, P181
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Muqbil I, 2006, CANCER LETT, V240, P213, DOI 10.1016/j.canlet.2005.09.008
   Musazzi L, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00060
   National Research Council, 2011, GUIDE CARE USE LAB A
   Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498
   Ohashi T, 2008, CYTOTECHNOLOGY, V57, P181, DOI 10.1007/s10616-008-9148-x
   PEKAREK RS, 1971, P SOC EXP BIOL MED, V138, P728
   Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138
   Quan MN, 2011, NEUROSCIENCE, V182, P88, DOI 10.1016/j.neuroscience.2011.03.026
   Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178
   Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049
   SELYE H, 1955, SCIENCE, V122, P625, DOI 10.1126/science.122.3171.625
   Stewart RK, 2014, J HEPATOL, V60, P298, DOI 10.1016/j.jhep.2013.09.013
   Storto M, 2000, HEPATOLOGY, V31, P649, DOI 10.1002/hep.510310315
   Tennakoon AH, 2015, EXP TOXICOL PATHOL, V67, P53, DOI 10.1016/j.etp.2014.09.008
   Tian X, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-32
   Tiebosch M.H., 2014, THESIS, P18
   Vasquez B, 2014, INT J CLIN EXP PATHO, V7, P4627
   Wang L, 2015, AMINO ACIDS, V47, P1309, DOI 10.1007/s00726-015-1966-5
   Wei CL, 2008, INT J HEMATOL, V88, P52, DOI 10.1007/s12185-008-0105-4
   Wills ED., 1987, BIOCH TOXICOLOGY PRA, P127
   Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8
   Xu Jie-kun, 2006, Yaoxue Xuebao, V41, P631
   Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263
   Yuen EY, 2011, MOL PSYCHIATR, V16, P156, DOI 10.1038/mp.2010.50
   Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106
   Zelena D, 2005, BRAIN RES, V1031, P185, DOI 10.1016/j.brainres.2004.10.034
   Zhao M, 2008, BIOCHEM BIOPH RES CO, V373, P90, DOI 10.1016/j.bbrc.2008.05.166
   Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248
NR 63
TC 0
Z9 0
U1 1
U2 1
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD JUN
PY 2017
VL 95
IS 6
BP 721
EP 731
DI 10.1139/cjpp-2016-0556
PG 11
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA EW2HY
UT WOS:000402318700014
PM 28317386
OA No
DA 2017-08-17
ER

PT J
AU Hussein, AM
   Abbas, KM
   Abulseoud, OA
   El-Hussainy, EMA
AF Hussein, Abdelaziz M.
   Abbas, Khaled M.
   Abulseoud, Osama A.
   El-Hussainy, El-Hussainy M. A.
TI Effects of ferulic acid on oxidative stress, heat shock protein 70,
   connexin 43, and monoamines in the hippocampus of
   pentylenetetrazole-kindled rats
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE heat shock protein 70; Cx43; ferulic acid; pentylenetetrazole; kindling;
   rats; norepinephrine; serotonin
ID GAP-JUNCTION HEMICHANNELS; TEMPORAL-LOBE EPILEPSY;
   CENTRAL-NERVOUS-SYSTEM; IN-VIVO PROTECTION; INDUCED SEIZURES;
   MITOCHONDRIAL DYSFUNCTION; DOPAMINE RELEASE; BIOGENIC-AMINES;
   ANIMAL-MODELS; ETHYL-ESTER
AB The present study investigated the effects of ferulic acid (FA) on pentylenetetrazole (PTZ)-induced seizures, oxidative stress markers (malondialdehyde (MDA), catalase, and reduced glutathione (GSH)), connexin (Cx) 43, heat shock protein 70 (Hsp 70), and monoamines (serotonin (5-HT) and norepinephrine (NE)) levels in a rat model of PTZ-induced kindling. Sixty Sprague Dawley rats were divided into 5 equal groups: (a) normal group; (b) FA group: normal rats received FA at a dose of 40 mg/kg daily; (c) PTZ group: normal rats received PTZ at a dose of 50 mg/kg i.p. on alternate days for 15 days; (d) FA-before group: treatment was the same as for the PTZ group, except rats received FA; and (e) FA-after group: rats received FA from sixth dose of PTZ. PTZ caused a significant increase in MDA, Cx43, and Hsp70 along with a significant decrease in GSH, 5-HT, and NE levels and CAT activity in the hippocampus (p < 0.05). Pre-and post-treatment with FA caused significant improvement in behavioral parameters, MDA, CAT, GSH, 5-HT, NE, Cx43 expression, and Hsp70 expression in the hippocampal region (p < 0.05). We conclude that FA has neuroprotective effects in PTZ-induced epilepsy, which might be due to attenuation of oxidative stress and Cx43 expression and upregulation of neuroprotective Hsp70 and neurotransmitters (5-HT and NE).
C1 [Hussein, Abdelaziz M.; Abbas, Khaled M.] Mansoura Univ, Fac Med, El Gomhoria St, Mansoura, Egypt.
   [Abulseoud, Osama A.] NIDA, Chem & Drug Metab, Intramural Res Program, NIH,Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.
   [El-Hussainy, El-Hussainy M. A.] Kafrelsheikh Univ, Fac Med, El Gish St, Kafr Al Sheikh, Egypt.
RP Hussein, AM (reprint author), Mansoura Univ, Fac Med, El Gomhoria St, Mansoura, Egypt.
EM zizomenna28@yahoo.com
CR Ammon-Treiber S, 2007, N-S ARCH PHARMACOL, V375, P115, DOI 10.1007/s00210-007-0143-0
   Atack JR, 2000, PHARMACOL BIOCHEM BE, V65, P743, DOI 10.1016/S0091-3057(99)00267-1
   Avoli M, 2004, EPILEPSIA, V45, P882, DOI 10.1111/j.0013-9580.2004.12603.x
   Avoli Massimo, 2007, Epilepsy Curr, V7, P116, DOI 10.1111/j.1535-7511.2007.00194.x
   Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x
   Becker A, 2000, PHARMACOL BIOCHEM BE, V66, P425, DOI 10.1016/S0091-3057(99)00264-6
   Behr C, 2016, REV NEUROL-FRANCE, V172, P27, DOI 10.1016/j.neurol.2015.11.003
   Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008
   Bhowmik M, 2012, BRIT J PHARMACOL, V167, P1398, DOI 10.1111/j.1476-5381.2012.02093.x
   Bidmon HJ, 2004, EPILEPSIA, V45, P1549, DOI 10.1111/j.0013-9580.2004.14904.x
   Bozzi Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00157
   Brigo F, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006967.pub3
   BROWNING RA, 1989, J PHARMACOL EXP THER, V249, P229
   Callado LF, 2000, NEUROREPORT, V11, P173, DOI 10.1097/00001756-200001170-00034
   Chang M, 1996, DEV BIOL, V175, P50, DOI 10.1006/dbio.1996.0094
   Chang SJ, 2010, J BIOENERG BIOMEMBR, V42, P457, DOI 10.1007/s10863-010-9317-4
   Chen JL, 2015, METAB BRAIN DIS, V30, P129, DOI 10.1007/s11011-014-9635-z
   Cheng CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155748
   Chimakurthy Jithendra, 2010, Psychol. Neurosci., V3, P238, DOI 10.3922/j.psns.2010.2.013
   Cho JY, 2005, PROG NEURO-PSYCHOPH, V29, P899, DOI 10.1016/j.pnpbp.2005.04.022
   Chuang Yao-Chung, 2010, Acta Neurol Taiwan, V19, P3
   Ekimova IV, 2010, J NEUROCHEM, V115, P1035, DOI 10.1111/j.1471-4159.2010.06989.x
   Ferrendelli J A, 1986, Adv Neurol, V44, P393
   Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9
   Gaikwad R. V., 2005, Indian Journal of Experimental Biology, V43, P620
   Giblin KA, 2010, NEUROSCIENTIST, V16, P253, DOI 10.1177/1073858409354385
   Giorgi FS, 2004, NEUROSCI BIOBEHAV R, V28, P507, DOI 10.1016/j.neubiorev.2004.06.008
   Gupta YK, 2006, EUR NEUROPSYCHOPHARM, V16, P85, DOI 10.1016/j.euroneuro.2005.07.004
   Gupta YK, 2003, PHARMACOL BIOCHEM BE, V74, P579, DOI 10.1016/S0091-3057(02)01044-4
   Huang H, 2015, INT J CLIN PHARM TH, V53, P828, DOI 10.5414/CP202295
   Joshi G, 2006, NEUROCHEM INT, V48, P318, DOI 10.1016/j.neuint.2005.11.006
   Joshi G, 2005, FREE RADICAL BIO MED, V38, P1023, DOI 10.1016/j.freeadabiomed.2004.12.027
   Jung ME, 1999, J PHARMACOL EXP THER, V291, P576
   Kinjo ER, 2013, EXP NEUROL, V248, P546, DOI 10.1016/j.expneurol.2013.07.022
   KOBAYASHI K, 1977, FOLIA PSYCHIAT NEU J, V31, P483
   Krueger AMR, 1999, MOL BRAIN RES, V71, P265, DOI 10.1016/S0169-328X(99)00198-9
   Kumar VL, 2014, NEUROCHEM RES, V39, P2501, DOI 10.1007/s11064-014-1451-7
   Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7
   Laura MC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0176-5
   LAZAROVA M, 1983, N-S ARCH PHARMACOL, V322, P147, DOI 10.1007/BF00512388
   Lin TY, 2013, J MED FOOD, V16, P112, DOI 10.1089/jmf.2012.2387
   Loscher W, 1997, PROG NEUROBIOL, V53, P239, DOI 10.1016/S0301-0082(97)00035-X
   Machado KC, 2015, CHEM-BIOL INTERACT, V242, P273, DOI 10.1016/j.cbi.2015.10.003
   MCNAMARA JO, 1994, J NEUROSCI, V14, P3413
   Mehla J, 2010, LIFE SCI, V87, P596, DOI 10.1016/j.lfs.2010.09.006
   Moloney TC, 2010, BRAIN RES, V1359, P33, DOI 10.1016/j.brainres.2010.08.040
   Mylvaganam S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00172
   Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009
   Naseer MI, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-20
   Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004
   Pacia SV, 2001, BRAIN RES, V899, P106, DOI 10.1016/S0006-8993(01)02214-4
   Parfenova H, 2012, J CEREBR BLOOD F MET, V32, P1024, DOI 10.1038/jcbfm.2012.13
   Perluigi M, 2006, J NEUROSCI RES, V84, P418, DOI 10.1002/jnr.20879
   Picot MC, 2008, EPILEPSIA, V49, P1230, DOI 10.1111/j.1528-1167.2008.01579.x
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0
   Rajabzadeh A, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-56
   Roy S, 2013, ENDOCRINE, V44, P369, DOI 10.1007/s12020-012-9868-8
   Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014
   Saha Lekha, 2014, J Epilepsy Res, V4, P45
   Samoilova M, 2003, J NEUROCHEM, V86, P687, DOI 10.1046/j.1471-4159.2003.01893.x
   Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811
   Sefil F, 2014, INT J CLIN EXP MED, V7, P2471
   Sharma Monisha, 2005, Indian J Physiol Pharmacol, V49, P395
   Shehata A.M., 2011, B EGYPT SOC PHYSL SC, V31, P135
   Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92
   Statnick MA, 1996, LIFE SCI, V59, P1763, DOI 10.1016/0024-3205(96)00519-X
   [苏曼 Su Man], 2010, [南方医科大学学报, Journal of Southern Medical University], V30, P2738
   Su V, 2014, FEBS LETT, V588, P1212, DOI 10.1016/j.febslet.2014.01.013
   Tchekalarova J, 2015, EPILEPSY BEHAV, V46, P66, DOI 10.1016/j.yebeh.2015.03.021
   Tso MM, 2004, NEUROCHEM INT, V44, P1, DOI 10.1016/S0197-0186(03)00104-9
   VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045
   Verselis VK, 2008, J GEN PHYSIOL, V132, P315, DOI 10.1085/jgp.200810029
   Waggas Abeer M, 2010, Saudi J Biol Sci, V17, P269, DOI 10.1016/j.sjbs.2010.05.003
   Waldbaum S, 2010, J BIOENERG BIOMEMBR, V42, P449, DOI 10.1007/s10863-010-9320-9
   WENGER GR, 1973, NEUROPHARMACOLOGY, V12, P693, DOI 10.1016/0028-3908(73)90122-6
   Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007
   Yu LJ, 2006, EUR NEUROPSYCHOPHARM, V16, P170, DOI 10.1016/j.euroneuro.2005.08.006
   Zhang XA, 1997, EUR J NEUROSCI, V9, P760, DOI 10.1111/j.1460-9568.1997.tb01424.x
   Zhao X.-H., 2012, CHIN J PATHOPHYSIOL, V1, P118
   Zhao Z, 2003, J AGR FOOD CHEM, V51, P5534, DOI 10.1021/jf034455u
   Zhao ZH, 2004, J NUTR, V134, P3083
NR 81
TC 0
Z9 0
U1 1
U2 1
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD JUN
PY 2017
VL 95
IS 6
BP 732
EP 742
DI 10.1139/cjpp-2016-0219
PG 11
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA EW2HY
UT WOS:000402318700015
PM 28177659
OA No
DA 2017-08-17
ER

PT J
AU Araya, DB
   Grolinger, K
   ElYamany, HF
   Capretz, MAM
   Bitsuamlak, G
AF Araya, Daniel B.
   Grolinger, Katarina
   ElYamany, Hany F.
   Capretz, Miriam A. M.
   Bitsuamlak, Girma
TI An ensemble learning framework for anomaly detection in building energy
   consumption
SO ENERGY AND BUILDINGS
LA English
DT Article
DE Anomaly detection; Ensemble learning; Autoencoder; Support vector
   regression; Random forest; Building energy consumption
ID PRINCIPAL COMPONENT ANALYSIS; DIMENSIONALITY REDUCTION; INTRUSION
   DETECTION; OFFICE BUILDINGS; FAULT-DETECTION; ROC CURVE; PREDICTION;
   REGRESSION; NETWORKS
AB During building operation, a significant amount of energy is wasted due to equipment and human related faults. To reduce waste, today's smart buildings monitor energy usage with the aim of identifying abnormal consumption behaviour and notifying the building manager to implement appropriate energy saving procedures. To this end, this research proposes a new pattern-based anomaly classifier, the collective contextual anomaly detection using sliding window (CCAD-SW) framework. The CCAD-SW framework identifies anomalous consumption patterns using overlapping sliding windows. To enhance the anomaly detection capacity of the CCAD-SW, this research also proposes the ensemble anomaly detection (EAD) framework. The EAD is a generic framework that combines several anomaly detection classifiers using majority voting. To ensure diversity of anomaly classifiers, the EAD is implemented by combining pattern-based (e.g., CCAD-SW) and prediction-based anomaly classifiers. The research was evaluated using real-world data provided by Powersmiths, located in Brampton, Ontario, Canada. Results show that the EAD framework improved the sensitivity of the CCAD-SW by 3.6% and reduced false alarm rate by 2.7%. (C) 2017 The Author(s). Published by Elsevier B.V.
C1 [Araya, Daniel B.; Grolinger, Katarina; ElYamany, Hany F.; Capretz, Miriam A. M.] Western Univ, Dept Elect & Comp Engn, London, ON N6A 5B9, Canada.
   [Bitsuamlak, Girma] Western Univ, Dept Civil & Environm Engn, London, ON N6A 5B9, Canada.
   [ElYamany, Hany F.] Suez Canal Univ, Dept Comp Sci, Ismailia, Egypt.
RP Capretz, MAM (reprint author), Western Univ, Dept Elect & Comp Engn, London, ON N6A 5B9, Canada.
EM dberhane@uwo.ca; kgroling@uwo.ca; helyama@uwo.ca; mcapretz@uwo.ca;
   gbitsuam@uwo.ca
FU NSERC CRDat Western University [CRDPJ 453294-13]; Powersmiths
FX This research was supported in part by an NSERC CRDat Western University
   (CRDPJ 453294-13). In addition, the authors would like to acknowledge
   the support provided by Powersmiths.
CR Aburomman AA, 2016, APPL SOFT COMPUT, V38, P360, DOI 10.1016/j.asoc.2015.10.011
   Amozegar M, 2016, NEURAL NETWORKS, V76, P106, DOI 10.1016/j.neunet.2016.01.003
   Araya D. B., 2016, INT JOINT C NEUR NET, P1
   Arjunan P., 2015, P 2 ACM INT C EMB SY, P35
   Bellala G., 2012, 18 ACM SIGKDD INT C, P994
   Bengio Yoshua, 2009, Foundations and Trends in Machine Learning, V2, P1, DOI 10.1561/2200000006
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1023/A:1018054314350
   Cabrera JBD, 2008, INFORM FUSION, V9, P96, DOI 10.1016/j.inffus.2007.03.001
   Capozzoli A, 2015, EXPERT SYST APPL, V42, P4324, DOI 10.1016/j.eswa.2015.01.010
   Chandola V, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1541880.1541882
   Chou JS, 2014, RENEW SUST ENERG REV, V33, P400, DOI 10.1016/j.rser.2014.01.088
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411
   Didaci L., 2002, WORKSH MACH LEARN ME
   Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1
   Dragoicea M, 2013, LECT NOTES BUS INF P, V143, P14
   Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191
   Folino Gianluigi, 2016, Applications of Evolutionary Computation. 19th European Conference, EvoApplications 2016. Proceedings: LNCS 9597, P315, DOI 10.1007/978-3-319-31204-0_21
   Fontugne R, 2013, 2013 ACM/IEEE INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN), P129, DOI 10.1109/IPSN.2013.6917580
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   Grandvalet Y, 2004, MACH LEARN, V55, P251, DOI 10.1023/B:MACH.0000027783.34431.42
   Hajian-Tilaki Karimollah, 2013, Caspian J Intern Med, V4, P627
   Hastie T., 2005, MATH INTELL, V27
   Hayes MA, 2015, J BIG DATA, V2, P1, DOI [10.1186/s40537-014-0011-y, DOI 10.1186/S40537-014-0011-Y]
   Hill DJ, 2010, ENVIRON MODELL SOFTW, V25, P1014, DOI 10.1016/j.envsoft.2009.08.010
   Jain RK, 2014, APPL ENERG, V123, P168, DOI 10.1016/j.apenergy.2014.02.057
   Janetzko H., 2013, COMPUT GRAPH-UK, V38, P1
   Jiang Y., 2014, SIGKDD WORKSH OUTL D, P23
   Jovanovic RZ, 2015, ENERG BUILDINGS, V94, P189, DOI 10.1016/j.enbuild.2015.02.052
   Kumar R, 2011, INDIAN PEDIATR, V48, P277
   Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006
   Kusiak A, 2010, APPL ENERG, V87, P3092, DOI 10.1016/j.apenergy.2010.04.008
   Lam JC, 2008, ENERG BUILDINGS, V40, P828, DOI 10.1016/j.enbuild.2007.06.001
   MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307
   Nguyen Cuong, 2013, J BIOMEDICAL SCI ENG, V6, P551
   Opitz D., 1999, J ARTIFICIAL INTELLI, V11, P169, DOI DOI 10.1613/JAIR.614
   Orsenigo C, 2013, KNOWL-BASED SYST, V47, P14, DOI 10.1016/j.knosys.2013.03.001
   Pefia M., 2016, EXPERT SYST APPL, V56, P242
   Ploennigs J., 2013, 5 ACM WORKSH EMB SYS
   Polikar R, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9326-7_1
   Praus P, 2005, CENT EUR J CHEM, V3, P731, DOI 10.2478/BF02475200
   Pyle D, 1999, DATA PREPARATION DAT
   Sakurada M., 2014, MLSDA 2014 2 WORKSH, P4
   Shoemaker L, 2011, LECT NOTES COMPUT SC, V6713, P6, DOI 10.1007/978-3-642-21557-5_3
   Smola A., 1997, ADV NEURAL INFORM PR, V9, P155
   Torres-Sospedra J, 2011, LECT NOTES COMPUT SC, V7063, P588, DOI 10.1007/978-3-642-24958-7_68
   Tsai FS, 2011, EXPERT SYST APPL, V38, P2766, DOI 10.1016/j.eswa.2010.08.067
   Vapnik V. N., 1982, ESTIMATION DEPENDENC, V40
   Wrinch M., 2012, 2012 IEEE POW EN SOC, P1
   Zhang YL, 2011, SYM REL DIST SYST, P1, DOI [10.1109/SRDS.2011.10, 10.1109/CSAE.2011.5953158]
   Zhao ZR, 2015, LECT NOTES ARTIF INT, V9101, P514, DOI 10.1007/978-3-319-19066-2_50
   Zhou Z. H., 2015, ENCY BIOMETRICS, P411
   Zorita AL, 2016, ENERG BUILDINGS, V110, P377, DOI 10.1016/j.enbuild.2015.11.005
NR 53
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0378-7788
EI 1872-6178
J9 ENERG BUILDINGS
JI Energy Build.
PD JUN 1
PY 2017
VL 144
BP 191
EP 206
DI 10.1016/j.enbuild.2017.02.058
PG 16
WC Construction & Building Technology; Energy & Fuels; Engineering, Civil
SC Construction & Building Technology; Energy & Fuels; Engineering
GA EU9XM
UT WOS:000401393000016
OA No
DA 2017-08-17
ER

PT J
AU El-Sarnagawy, GN
   Hafez, ASAF
AF El-Sarnagawy, Ghada N.
   Hafez, Amal S. A. F.
TI Comparison of different scores as predictors of mechanical ventilation
   in drug overdose patients
SO HUMAN & EXPERIMENTAL TOXICOLOGY
LA English
DT Article
DE acute physiology and chronic health evaluation II score; Glasgow Coma
   Scale; rapid acute physiology score; rapid emergency medicine score;
   prognosis
ID EMERGENCY-DEPARTMENT PATIENTS; GLASGOW COMA SCALE; CRITICALLY-ILL
   PATIENTS; APACHE-II; MEDICINE SCORE; POISONED PATIENT; MORTALITY; NEED;
   RESUSCITATION; SYSTEMS
AB The decision of intubation and mechanical ventilation in poisoned patients with impaired consciousness can be a difficult task. The present study aimed to evaluate the power of Glasgow Coma Scale (GCS), acute physiology and chronic health evaluation (APACHE II), rapid acute physiology score (RAPS) and rapid emergency medicine score (REMS) at admission in predicting the need of intubation and mechanical ventilation in drug overdose patients with disturbed consciousness level (DCL). This prospective observational study was conducted on 104 poisoned patients who were admitted to Tanta Toxicological Unit with a DCL. Four scoring systems (GCS, APACHE II, RAPS and REMS) were recorded for all patients on admission. Discrimination was evaluated using receiver operating characteristics curve and calculating the area under the curve (AUC). Twenty-four cases required mechanical ventilation. The mechanically ventilated patients had significantly lower value of GCS and higher values of APACHE II, REMS and RAPS than other group (p < 0.001). Although the APACHE II score has the best AUC value (0.796) in predicting mechanical ventilation, there was no statistically significant difference between the four scores. GCS > 8 had 100% negative predictive value, while REMS > 8 had 100% positive predictive value.
C1 [El-Sarnagawy, Ghada N.; Hafez, Amal S. A. F.] Tanta Univ, Tanta Fac Med, Dept Forens Med & Clin Toxicol, Tanta 31527, Gharbia, Egypt.
RP Hafez, ASAF (reprint author), Tanta Univ, Tanta Fac Med, Dept Forens Med & Clin Toxicol, Tanta 31527, Gharbia, Egypt.
EM amalsa3ed@yahoo.com
CR Akkose S., 2010, Eastern Mediterranean Health Journal, V16, P101
   Bilgin TE, 2005, TOXICOL IND HEALTH, V21, P141, DOI 10.1191/0748233705th222oa
   Budhathoki S, 2009, Nepal Med Coll J, V11, P170
   Carrillo MJ, 2012, REV MED CHILE, V140, P1297, DOI 10.4067/S0034-98872012001000009
   Cattermole GN, 2009, RESUSCITATION, V80, P1000, DOI 10.1016/j.resuscitation.2009.06.012
   Chan Betty, 1993, Journal of Emergency Medicine, V11, P579, DOI 10.1016/0736-4679(93)90312-U
   Christ A, 2006, INTENS CARE MED, V32, P1423, DOI 10.1007/s00134-006-0277-4
   Dawson B, 2001, BASIC CLIN BIOSTATIC
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Donald C, 2009, EMERG MED J, V26, P510, DOI 10.1136/emj.2008.064998
   Duncan R, 2009, J EMERG MED, V37, P451, DOI 10.1016/j.jemermed.2008.11.026
   Eizadi-Mood N, 2007, HUM EXP TOXICOL, V26, P573, DOI 10.1177/09603271060080076
   GENTLEMAN D, 1993, BRIT MED J, V307, P547
   Grmec S, 2001, CRIT CARE, V5, P19
   Hamad AE, 2000, J INTENSIVE CARE MED, V15, P321, DOI 10.1046/j.1525-1489.2000.00321.x
   Heard K, 2004, HUM EXP TOXICOL, V23, P197, DOI 10.1191/0960327104ht436oa
   Heyman EN, 1996, HEART LUNG, V25, P246, DOI 10.1016/S0147-9563(96)80035-5
   Kelly CA, 2004, ANN EMERG MED, V44, P108, DOI 10.1016/j.annemergmed.2004.03.028
   KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009
   Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3
   Ku HL, 2010, GEN HOSP PSYCHIAT, V32, P310, DOI 10.1016/j.genhosppsych.2009.11.005
   Eizadi Mood N, 2011, CRIT CARE RES PRACT, V2011
   Eizadi Mood N, 2011, INDIAN J ANAESTH, V55, P599
   Olsson T, 2004, J INTERN MED, V255, P579, DOI 10.1111/j.1365-2796.2004.01321.x
   Olsson T, 2004, ACAD EMERG MED, V11, P1008, DOI 10.1197/j.aem.2004.05.027
   Olsson T, 2003, ACAD EMERG MED, V10, P1040, DOI 10.1197/S1069-6563(03)00342-7
   RHEE KJ, 1987, AM J EMERG MED, V5, P278, DOI 10.1016/0735-6757(87)90350-0
   Safavi M, 2007, ARCH IRAN MED, V10, P354
   Soyuncu S., 2011, Erciyes Medical Journal, V33, P29
   Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F
   TEASDALE G, 1974, LANCET, V2, P81
   Teksam O, 2010, EUR J EMERG MED, V17, P192, DOI 10.1097/MEJ.0b013e328320ad48
   Unverir P, 2006, HUM EXP TOXICOL, V25, P605, DOI 10.1177/096032706072470
   Yoshida Y, 2008, J ANESTH, V22, P201, DOI 10.1007/s00540-008-0637-z
NR 34
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0960-3271
EI 1477-0903
J9 HUM EXP TOXICOL
JI Hum. Exp. Toxicol.
PD JUN
PY 2017
VL 36
IS 6
BP 539
EP 546
DI 10.1177/0960327116655389
PG 8
WC Toxicology
SC Toxicology
GA EW0AN
UT WOS:000402150300001
PM 27337981
OA No
DA 2017-08-17
ER

PT J
AU Elmorsy, E
   Attalla, SM
   Fikry, E
   Kocon, A
   Turner, R
   Christie, D
   Warren, A
   Nwidu, LL
   Carter, WG
AF Elmorsy, E.
   Attalla, S. M.
   Fikry, E.
   Kocon, A.
   Turner, R.
   Christie, D.
   Warren, A.
   Nwidu, L. L.
   Carter, W. G.
TI Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics
SO HUMAN & EXPERIMENTAL TOXICOLOGY
LA English
DT Article
DE Anti-TB drugs; drug-induced hepatotoxicity; mitochondrial complex I and
   complex III activity; mitochondrial membrane potential; mitophagy
ID LATENT TUBERCULOSIS INFECTION; COMPLEX-I; INDUCED HEPATOTOXICITY;
   PULMONARY TUBERCULOSIS; MITOCHONDRIAL-FUNCTION; RESPIRATORY-CHAIN;
   LIVER-FAILURE; RISK-FACTORS; PYRAZINAMIDE; TROGLITAZONE
AB Tuberculosis (TB) is an intractable chronic infection. Disease treatment with anti-TB drugs remains challenging due to drug-induced hepatotoxicity. The toxicity of the anti-TB drugs rifampicin (RIF), isoniazid (INH) and pyrazinamide (PZA) either alone or in combination was investigated in HepG2 cells. Assays of intracellular adenosine triphosphate (ATP) levels at 4-, 24- and 48-h post-exposure to gradient concentrations of RIF, INH and PZA were conducted. Drug-induced effects on mitochondrial membrane potential (MMP), mitochondrial complex I and complex III activity, nicotinamide adenine dinucleotide (NAD(+)) levels and cellular lactate production were assessed. Decreased ATP levels were dose-dependent and correlated with drug exposure duration. Approximate 24-h IC(50)s were 0.5 mM, 70 mM and 84 mM for RIF, INH and PZA, respectively. Twenty-four hours post-drug treatment, reductions of MMP (p = 0.0005), mitochondrial complex I and III activities (p = 0.0001 and p = 0.0003, respectively), NAD(+) levels (p = 0.0057) and increased lactate production (p < 0.0001) were observed. Drug combinations used to mimic cumulative drug treatments induced a synergistic inhibition of mitochondrial complex I activity. An assessment of cellular ultrastructure using transmission electron microscopy indicated drug-induced mitophagy. Collectively, our study suggests that hepatotoxicity of commonly employed anti-TB drugs is mediated by their curtailment of mitochondrial function.
C1 [Elmorsy, E.; Attalla, S. M.; Fikry, E.] Mansoura Univ, Dept Forens Med & Clin Toxicol, Mansoura, Egypt.
   [Kocon, A.; Turner, R.; Warren, A.; Carter, W. G.] Univ Nottingham, Sch Med, Nottingham, England.
   [Christie, D.] Univ Nottingham, Sch Life Sci, Nottingham, England.
   [Nwidu, L. L.] Univ Port Harcourt, Fac Pharmaceut Sci, Dept Expt Pharmacol & Toxicol, Port Harcourt, Nigeria.
RP Carter, WG (reprint author), Univ Nottingham, Royal Derby Hosp Ctr, Sch Med, Derby DE22 3DT, England.
EM wayne.carter@nottingham.ac.uk
FU Mansoura University, Egypt; University of Nottingham, UK
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   authors gratefully acknowledge financial support from Mansoura
   University, Egypt, and the University of Nottingham, UK.
CR AW TY, 1989, ANNU REV NUTR, V9, P229
   Bartacek A, 2009, INT J TUBERC LUNG D, V13, P760
   Chang KC, 2008, AM J RESP CRIT CARE, V177, P1391, DOI 10.1164/rccm.200802-355OC
   Devarbhavi Harshad, 2011, Trop Gastroenterol, V32, P167
   Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119
   DURAND F, 1995, HEPATOLOGY, V21, P929, DOI 10.1016/0270-9139(95)90236-8
   Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013
   Eid N, 2016, HISTOL HISTOPATHOL, V31, P1747
   Fountain FF, 2005, CHEST, V128, P116, DOI 10.1378/chest.128.1.116
   Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Jeong I, 2015, J KOREAN MED SCI, V30, P167, DOI 10.3346/jkms.2015.30.2.167
   Lian Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072058
   McElroy PD, 2005, CLIN INFECT DIS, V41, P1125, DOI 10.1086/444463
   Miyazawa S, 2015, INTERNAL MED, V54, P591, DOI 10.2169/internalmedicine.54.3669
   Narayanan PK, 2003, CYTOM PART A, V52A, P28, DOI 10.1002/cyto.a.10011
   Neustadt J, 2008, MOL NUTR FOOD RES, V52, P780, DOI 10.1002/mnfr.200700075
   Resende LSO, 2015, J BRAS PNEUMOL, V41, P77, DOI 10.1590/S1806-37132015000100010
   Ong MMK, 2006, FREE RADICAL BIO MED, V40, P420, DOI 10.1016/j.freeradbiomed.2005.08.038
   Pessayre Dominique, 2003, P55
   Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST
   Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997
   Schaberg T, 1996, EUR RESPIR J, V9, P2026, DOI 10.1183/09031936.96.09102026
   Singh M, 2012, HUM EXP TOXICOL, V31, P788, DOI 10.1177/0960327111433901
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Tasduq SA, 2006, HUM EXP TOXICOL, V25, P111, DOI 10.1191/0960327106ht601oa
   Teleman MD, 2002, INT J TUBERC LUNG D, V6, P699
   Tirmenstein MA, 2002, TOXICOL SCI, V69, P131, DOI 10.1093/toxsci/69.1.131
   Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x
   Valsecchi F, 2010, DEV DISABIL RES REV, V16, P175, DOI 10.1002/ddrr.107
   van Ingen J, 2011, CLIN INFECT DIS, V52, pE194, DOI 10.1093/cid/cir184
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1
   World Health Organization (WHO), TUBERCULOSIS
NR 34
TC 1
Z9 1
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0960-3271
EI 1477-0903
J9 HUM EXP TOXICOL
JI Hum. Exp. Toxicol.
PD JUN
PY 2017
VL 36
IS 6
BP 616
EP 625
DI 10.1177/0960327116660751
PG 10
WC Toxicology
SC Toxicology
GA EW0AN
UT WOS:000402150300009
PM 27461009
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, KE
   Rizk, MR
   Farag, MM
AF Ahmed, Khaled E.
   Rizk, Mohamed R.
   Farag, Mohammed M.
TI Overloaded CDMA Crossbar for Network-On-Chip
SO IEEE TRANSACTIONS ON VERY LARGE SCALE INTEGRATION (VLSI) SYSTEMS
LA English
DT Article
DE Code-division multiple access (CDMA) interconnect; CDMA router;
   network-on-chip (NoC); NoC physical layer; overloaded CDMA crossbar
AB On-chip interconnects are the performance bottleneck in modern system-on-chips. Code-division multiple access (CDMA) has been proposed to implement on-chip crossbars due to its fixed latency, reduced arbitration overhead, and higher bandwidth. In CDMA, medium sharing is enabled in the code space by assigning a limited number of N-chip length orthogonal spreading codes to the processing elements sharing the interconnect. In this paper, we advance overloaded CDMA interconnect (OCI) to enhance the capacity of CDMA network-on-chip (NoC) crossbars by increasing the number of usable spreading codes. Serial and parallel OCI architecture variants are presented to adhere to different area, delay, and power requirements. Compared with the conventional CDMA crossbar, on a Xilinx Artix-7 AC701 FPGA kit, the serial OCI crossbar achieves 100% higher bandwidth, 31% less resource utilization, and 45% power saving, while the parallel OCI crossbar achieves N times higher bandwidth compared with the serial OCI crossbar at the expense of increased area and power consumption. A 65-node OCI-based star NoC is implemented, evaluated, and compared with an equivalent space division multiple access based torus NoC for various synthetic traffic patterns. The evaluation results in terms of the resource utilization and throughput highlight the OCI as a promising technology to implement the physical layer of NoC routers.
C1 [Ahmed, Khaled E.; Rizk, Mohamed R.; Farag, Mohammed M.] Alexandria Univ, Elect Engn Dept, Alexandria 21544, Egypt.
RP Ahmed, KE (reprint author), Alexandria Univ, Elect Engn Dept, Alexandria 21544, Egypt.
EM k.e.elsayed@ieee.org; mohamed.rizk@alexu.edu.eg; mmorsy@alexu.edu.eg
CR Ahmed K. E., 2014, P IET INT C POW EL M, P1
   Ahmed KE, 2015, PROCEEDINGS 2015 IEEE 23RD ANNUAL SYMPOSIUM ON HIGH-PERFORMANCE INTERCONNECTS - HOTI 2015, P78, DOI 10.1109/HOTI.2015.12
   Asanovic K., 2006, TECH REP
   Bell RH, 2001, CONF REC ASILOMAR C, P1246, DOI 10.1109/ACSSC.2001.987690
   Bjerregaard T, 2006, ACM COMPUT SURV, V38, P1, DOI 10.1145/1132952.1132953
   Bogdan P., 2015, P 9 INT S NETW CHIP
   Chen H.H., 2007, NEXT GENERATION CDMA
   Halak B, 2014, MICROELECTRON J, V45, P424, DOI 10.1016/j.mejo.2014.02.002
   Hollis SJ, 2014, IEEE T COMPUT, V63, P570, DOI 10.1109/TC.2012.273
   Hosseini S. A., 2011, EURASIP J WIREL COMM, V1, P1
   Kim D, 2005, IEEE INT SYMP CIRC S, P2369
   Kim Daewook, 2004, CIRC SYST 2004 P 200, V1, P137
   Kim D., 2005, P INT SOC DES C NOV, P32
   Kim J, 2007, IEEE T VLSI SYST, V15, P881, DOI 10.1109/TVLSI.2007.900739
   Kumar S., 2002, P IEEE COMP SOC ANN, P105, DOI DOI 10.1109/ISVLSI.2002.1016885
   Lai B.-C. C., 2004, SIGN SYST COMP 2004, V2, P1868
   Lee HG, 2007, ACM T DES AUTOMAT EL, V12, DOI 10.1145/1255456.1255460
   Lee W, 2009, ISCAS: 2009 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOLS 1-5, P1349, DOI 10.1109/ISCAS.2009.5118014
   Majumder T., 2015, P DES AUT TEST EUR C, P1102
   Mubeen S, 2010, 13TH EUROMICRO CONFERENCE ON DIGITAL SYSTEM DESIGN: ARCHITECTURES, METHODS AND TOOLS, P181, DOI 10.1109/DSD.2010.57
   Nikolic T, 2010, Proceedings 2010 IEEE 13th International Symposium on Design and Diagnostics of Electronic Circuits & Systems (DDECS), P243, DOI 10.1109/DDECS.2010.5491774
   Nikolic T, 2008, INT CONF MICROELECTR, P437, DOI 10.1109/ICMEL.2008.4559315
   Nikolic T, 2009, MICROELECTRON RELIAB, V49, P448, DOI 10.1016/j.microrel.2009.02.002
   Papamichael MK, 2012, FPGA 12: PROCEEDINGS OF THE 2012 ACM-SIGDA INTERNATIONAL SYMPOSIUM ON FIELD PROGRAMMABLE GATE ARRAYS, P37
   Postman J., 2012, ISRN ELECT, V2012, P1
   Qian ZL, 2012, CODES+ISSS'12:PROCEEDINGS OF THE TENTH ACM INTERNATIONAL CONFERENCE ON HARDWARE/SOFTWARE-CODESIGN AND SYSTEM SYNTHESIS, P161
   Wang J, 2016, IEEE T VLSI SYST, V24, P1607, DOI 10.1109/TVLSI.2015.2471077
   Wang X, 2007, IEEE T VLSI SYST, V15, P1091, DOI 10.1109/TVLSI.2007.903914
   Xue Y., 2015, P 9 INT S NETW ON CH
   Xue YK, 2014, 2014 EIGHTH IEEE/ACM INTERNATIONAL SYMPOSIUM ON NETWORKS-ON-CHIP (NOCS), P17, DOI 10.1109/NOCS.2014.7008757
NR 30
TC 0
Z9 0
U1 2
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1063-8210
EI 1557-9999
J9 IEEE T VLSI SYST
JI IEEE Trans. Very Large Scale Integr. (VLSI) Syst.
PD JUN
PY 2017
VL 25
IS 6
BP 1842
EP 1855
DI 10.1109/TVLSI.2017.2664660
PG 14
WC Computer Science, Hardware & Architecture; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA EV9WO
UT WOS:000402137300005
OA No
DA 2017-08-17
ER

PT J
AU Ali, MAS
   Lobos, CM
   Abdelmegid, MAKF
   El-Sayed, AM
AF Ali, Mostafa A. Sayed
   Lobos, Christina Milad
   Abdelmegid, Mohamed Aboel-Kassem F.
   El-Sayed, Ahmed Moustafa
TI The frequency and nature of medication errors in hospitalized patients
   with acute coronary syndrome
SO INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
LA English
DT Article
DE Acute coronary syndrome; Cardiovascular drugs; Coronary care unit;
   Egypt; Medication errors
ID ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION;
   AMERICAN-HEART-ASSOCIATION; PRESCRIBING ERRORS; SCIENTIFIC STATEMENT;
   LEARNING-SYSTEM; PRIMARY-CARE; RISK-FACTORS; PREVALENCE; GUIDELINES
AB Background Cardiovascular medications have been commonly associated with medication errors. Objective The objective of this study was to investigate the incidence and predictors of medication errors in patients with acute coronary syndrome. Setting the coronary care unit of a university teaching hospital. Methods This was a prospective observational study on 150 patients admitted to the coronary care unit between August 2014 and July 2015. Main outcome measure The principal outcome was the number (frequency) of encountered medication errors. Results Of total 5790 prescription items reviewed, 547 (9.4%) potential medication errors were identified of which 523 (9.0%) were prescribing errors and 24 were monitoring errors. The most frequent prescribing errors were dosing errors (231, 42.2%) followed by loading dose omission error (91, 16.6%), omission of essential drugs on 1st day (43, 7.9%), and timing error (40, 7.3%). Errors frequently encountered with drugs such as aspirin, enoxaparin, beta-blockers followed by angiotensin-converting enzyme inhibitors and clopidogrel. Multivariate logistic regression analysis revealed that renal impairment (OR 6.02; 95% CI 1.4-35.4; p = 0.02) and longer duration of hospital stay (OR 4.01; 95% CI 1.5-10.7; p = 0.005) were predictors of the higher incidence of medication errors. Conclusion Prescribing and monitoring errors in coronary care unit are frequent and avoidable, with the majority of errors were ranked to be of mild to moderate severity. Dosing errors, omission of essential drugs and monitoring errors were most common error types encountered. Dosage adjustment based on estimation of the glomerular filtration rate immediately after admission help avoiding dosage-related errors.
C1 [Ali, Mostafa A. Sayed; Lobos, Christina Milad] Assiut Univ, Dept Clin Pharm, Fac Pharm, Assiut 71526, Egypt.
   [Abdelmegid, Mohamed Aboel-Kassem F.] Assiut Univ, Dept Cardiovasc Med, Fac Med, Assiut, Egypt.
   [El-Sayed, Ahmed Moustafa] Assiut Univ, Dept Pharmaceut, Fac Pharm, Assiut, Egypt.
RP Ali, MAS (reprint author), Assiut Univ, Dept Clin Pharm, Fac Pharm, Assiut 71526, Egypt.
EM mostafa.ali3@pharm.au.edu.eg
CR Al Khaja KAJ, 2005, INT J CLIN PHARM TH, V43, P294
   Al Khaja KAJ, 2007, HEALTH POLICY, V81, P350, DOI 10.1016/j.healthpol.2006.07.001
   Al-Dhawailie AA, 2011, SAUDI PHARM J, V19, P193, DOI 10.1016/j.jsps.2011.03.001
   Alexander D, 2008, AM HEART J, V156, P606, DOI 10.1016/j.ahj.2008.05.012
   Alsulami Z, 2013, EUR J CLIN PHARMACOL, V69, P995, DOI 10.1007/s00228-012-1435-y
   Aronson JK, 2009, QJM-INT J MED, V102, P513, DOI 10.1093/qjmed/hcp052
   Ashcroft DM, 2015, DRUG SAFETY, V38, P833, DOI 10.1007/s40264-015-0320-x
   Avery T, 2012, INVESTIGATING PREVAL
   Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897
   Ben-Yehuda A, 2011, DRUG AGING, V28, P491, DOI 10.2165/11590610-000000000-00000
   Bradford WD, 1999, PHARMACOECONOMICS, V15, P257, DOI 10.2165/00019053-199915030-00005
   BRAND DA, 1995, J AM COLL CARDIOL, V26, P1432, DOI 10.1016/0735-1097(95)00362-2
   Brixey J, 2002, P AMIA S AM MED INF
   Chertow GM, 2001, JAMA-J AM MED ASSOC, V286, P2839, DOI 10.1001/jama.286.22.2839
   Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301
   Cousins DH, 2012, BRIT J CLIN PHARMACO, V74, P597, DOI 10.1111/j.1365-2125.2011.04166.x
   Dornan T, 2009, IN DEPTH INVESTIGATI, P1
   Freedman JE, 2002, CIRCULATION, V106, P2623, DOI 10.1161/01.CIR.0000037748.19282.7D
   Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236
   Holloway RG, 2007, NEUROLOGY, V68, P550, DOI 10.1212/01.wnl.0000254992.39919.2e
   Keers RN, 2013, ANN PHARMACOTHER, V47, P237, DOI 10.1345/aph.1R147
   LaPointe NMA, 2007, ARCH INTERN MED, V167, P1539, DOI 10.1001/archinte.167.14.1539
   LaPointe NMA, 2003, ARCH INTERN MED, V163, P1461, DOI 10.1001/archinte.163.12.1461
   Lewis PJ, 2009, DRUG SAFETY, V32, P379, DOI 10.2165/00002018-200932050-00002
   Lisby M, 2010, INT J QUAL HEALTH C, V22, P507, DOI 10.1093/intqhc/mzq059
   Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7
   Mansouri A, 2013, DARU, V21, DOI 10.1186/2008-2231-21-49
   Michaels AD, 2010, CIRCULATION, V121, P1664, DOI 10.1161/CIR.0b013e3181d4b43e
   Overbaugh KJ, 2009, AM J NURS, V109, P42, DOI 10.1097/01.NAJ.0000351508.39509.e2
   ROGERS WJ, 1994, CIRCULATION, V90, P2103
   Sabry N, 2009, AUST J BASIC APPL SC, V3, P995
   Schachter M., 2012, MEDICINE, V40, P394
   Seden K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002036
   Spinler SA, 2013, PHARMACOTHERAPY PRIN, P133
   Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215
   Teich JM, 2000, ARCH INTERN MED, V160, P2741, DOI 10.1001/archinte.160.18.2741
   Williams SD, 2009, INT J QUAL HEALTH C, V21, P316, DOI 10.1093/intqhc/mzp034
NR 37
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2210-7703
EI 2210-7711
J9 INT J CLIN PHARM-NET
JI Int. J. Clin. Phar,.
PD JUN
PY 2017
VL 39
IS 3
BP 542
EP 550
DI 10.1007/s11096-017-0457-z
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EV8RW
UT WOS:000402051500007
PM 28374341
OA No
DA 2017-08-17
ER

PT J
AU Mostafa, EM
AF Mostafa, Engy Mohamed
TI Comparison between corneal elevation maps using different reference
   surfaces with Scheimpflug-Placido topographer
SO INTERNATIONAL OPHTHALMOLOGY
LA English
DT Article
DE Keratoconus; Elevation maps; Spheric reference surface; Aspheric
   reference surface; Aspherotoric reference surface
ID SUBCLINICAL KERATOCONUS; HEIGHT DATA; NORMAL EYES; ORBSCAN-II; ANTERIOR;
   REPEATABILITY; PARAMETERS; PENTACAM; CAMERA; SHAPE
AB The purpose of this study was to compare the anterior and posterior elevation measurements using different reference surfaces (spheric, aspheric, and aspherotoric) with Scheimpflug-Placido topography in simple myopic and keratoconus patients. 600 eyes of 600 patients undergoing screening for keratorefractive surgery (500 simple myopic, 100 keratoconus stage 1 and 2) in Sohag refractive center, Egypt, were examined by Scheimpflug-Placido topography (Sirius, CSO, Italy) for both the anterior and posterior corneal elevation maps using the spheric, aspheric, and aspherotoric reference surfaces. 100 keratoconic eyes showed higher discriminating power using the aspherotoric reference surface in both the anterior and posterior elevation maps. The use of aspherotoric reference surface gives more data for eyes with keratoconus and its use is more informative in screening.
C1 [Mostafa, Engy Mohamed] Sohag Univ, Dept Ophthalmol, Fac Med, Sohag, Egypt.
RP Mostafa, EM (reprint author), Sohag Univ, Dept Ophthalmol, Fac Med, Sohag, Egypt.
EM engymostafa@yahoo.com
CR Belin MW, 2009, CLIN EXP OPHTHALMOL, V37, P14, DOI 10.1111/j.1442-9071.2008.01821.x
   Bessho K, 2006, JPN J OPHTHALMOL, V50, P409, DOI 10.1007/s10384-006-0349-6
   BOGAN SJ, 1990, ARCH OPHTHALMOL-CHIC, V108, P945
   Ciolino JB, 2007, J CATARACT REFR SURG, V33, P1366, DOI 10.1016/j.jcrs.2007.04.016
   de Jong T, 2013, J CATARACT REFR SURG, V39, P1570, DOI 10.1016/j.jcrs.2013.04.032
   de Sanctis U, 2008, OPHTHALMOLOGY, V115, P1534, DOI 10.1016/j.ophtha.2008.02.020
   Fam HB, 2006, J CATARACT REFR SURG, V32, P1281, DOI 10.1016/j.jcrs.2006.02.060
   Kovacs I, 2011, ACTA OPHTHALMOL, V89, pe251, DOI 10.1111/j.1755-3768.2010.02053.x
   Lim L, 2007, AM J OPHTHALMOL, V143, P390, DOI 10.1016/j.ajo.2006.11.030
   Milla M, 2011, J CATARACT REFR SURG, V37, P310, DOI 10.1016/j.jcrs.2010.08.038
   Nilforoushan MR, 2008, J CATARACT REFR SURG, V34, P623, DOI 10.1016/j.jcrs.2007.11.054
   Salouti R, 2009, J CATARACT REFR SURG, V35, P856, DOI 10.1016/j.jcrs.2009.01.008
   Savini G, 2011, J CATARACT REFR SURG, V37, P1809, DOI 10.1016/j.jcrs.2011.04.033
   Schlegel Z, 2008, J CATARACT REFR SURG, V34, P789, DOI [10.1016/j.jcrs.2007.12.036, 10.1016/j.icrs.2007.12.036]
   Sideroudi H, 2014, OPTOMETRY VISION SCI, V91, P676, DOI 10.1097/OPX.0000000000000258
   Smadja D, 2013, J REFRACT SURG, V29, P274, DOI 10.3928/1081597X-20130318-07
   Sonmez B, 2007, AM J OPHTHALMOL, V143, P401, DOI 10.1016/j.ajo.2006.11.044
   Swartz T, 2007, CURR OPIN OPHTHALMOL, V18, P325, DOI 10.1097/ICU.0b013e3281ca7121
   Ucakhan OO, 2011, J CATARACT REFR SURG, V37, P1116, DOI 10.1016/j.jcrs.2010.12.049
NR 19
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-5701
EI 1573-2630
J9 INT OPHTHALMOL
JI Int. Ophthalmol.
PD JUN
PY 2017
VL 37
IS 3
BP 553
EP 558
DI 10.1007/s10792-016-0291-7
PG 6
WC Ophthalmology
SC Ophthalmology
GA EV6XQ
UT WOS:000401918500016
PM 27469194
OA No
DA 2017-08-17
ER

PT J
AU EI-Mokadem, MY
   El-Din, ANMN
   Ramadan, TA
   Rashad, AMA
   Taha, TA
   Samak, MA
AF EI-Mokadem, M. Y.
   El-Din, A. N. M. Nour
   Ramadan, T. A.
   Rashad, A. M. A.
   Taha, T. A.
   Samak, M. A.
TI Manipulation of reproductive seasonality using melatonin implantation in
   Anglo-Nubian does treated with controlled internal drug release and
   equine chorionic gonadotropin during the nonbreeding seasons
SO JOURNAL OF DAIRY SCIENCE
LA English
DT Article
DE melatonin; controlled internal drug release-equine chorionic
   gonadotropin protocol; reproductive seasonality; goat
ID RASA-ARAGONESA EWES; FEMALE MEDITERRANEAN GOATS; EXOGENOUS MELATONIN;
   IN-VITRO; BREEDING-SEASON; CORPUS-LUTEUM; LH-SECRETION; DEVELOPMENTAL
   COMPETENCE; FOLLICULAR-GROWTH; OXYTOCIN RECEPTOR
AB The objective of this study was to compare the efficiency of hormonal treatments on ovarian activity and reproductive performance in anestrous Anglo-Nubian does during the nonbreeding season (February to May). A total of 48 multiparous does were divided into 2 groups (24 lactating does and 24 dry does). In each group, animals were allocated randomly into 2 equal subgroups (12 does each). In the first subgroup, does received a single 18-mg melatonin implant for 42 d followed by a controlled internal drug release (CIDR) device for 19 d in conjunction with 500 IU of equine chorionic gonadotropin (eCG) i.m. on the day of CIDR device removal. The second subgroup received CIDR combined with eCG in parallel with the first subgroup. Melatonin implantation induced a luteotrophic effect, expressed as an increasing number of corpora lutea, increased serum progesterone concentration, and reduced estradiol concentration. Regardless of treatment, dry does showed greater value of progesterone concentration. With the advancement of day of treatment, number of total follicles, small follicles, and medium follicles tended to increase to the greatest values at the day of CIDR device insertion. Furthermore, at day of mating, the numbers of large follicles reached the greatest value, which was associated with the lowest value of the number of corpora lutea. At day of mating, serum progesterone concentration achieved the lowest value, which increased until d 56 of pregnancy. The estradiol:progesterone ratio showed the opposite trend. The detrimental effect of reproductive seasonality, expressed as cessation of estrus behavior and fertile mating during the nonbreeding season, was successfully alleviated by the CIDR-eCG protocol. Furthermore, melatonin implantation in conjunction with the CIDR-eCG protocol enhanced conception rate and fecundity at d 28 of pregnancy and prolificacy at d 56 of pregnancy compared with does that were not implanted. Interestingly, does that failed to conceive did not come to heat again. In conclusion, the beneficial effect of melatonin implantation in conjunction with the CIDR-eCG protocol on the luteotrophic effect was reflected in the increasing number of corpora lutea, increasing progesterone concentration, and decreasing estradiol concentration. Furthermore, conception rate, prolificacy, and fecundity were improved compared with does that were not implanted during the nonbreeding season. Key words: melatonin, controlled internal drug release equine chorionic gonadotropin protocol, reproductive seasonality, goat
C1 [EI-Mokadem, M. Y.; Ramadan, T. A.] Agr Res Ctr, Anim Prod Res Inst, 4 Nadi El Said, Giza 12311, Egypt.
   [El-Din, A. N. M. Nour; Rashad, A. M. A.; Taha, T. A.; Samak, M. A.] Alexandria Univ, Anim Prod Dept, Fac Agr El Shatby, Alexandria 22545, Egypt.
RP Taha, TA (reprint author), Alexandria Univ, Anim Prod Dept, Fac Agr El Shatby, Alexandria 22545, Egypt.
EM tahaataha@yahoo.com
FU Animal Production Department, Faculty of Agriculture (El-Shatby),
   Alexandria University, Alexandria, Egypt
FX This research was funded by Animal Production Department, Faculty of
   Agriculture (El-Shatby), Alexandria University, Alexandria, Egypt. The
   authors thank M. El-Tourky, the former Dean of Faculty of Agriculture
   (El-Shatby), for his valuable support. The authors also thank Ahmed
   Mostafa and Galal Sayed for their technical assistance.
CR Abecia JA, 2006, DOMEST ANIM ENDOCRIN, V31, P52, DOI 10.1016/j.domaniend.2005.09.003
   Abecia JA, 2003, THERIOGENOLOGY, V60, P1345, DOI 10.1016/S0093-691X(03)00168-7
   Abecia JA, 2002, VET RES COMMUN, V26, P151, DOI 10.1023/A:1014099719034
   Abecia JA, 2011, VET CLIN N AM-FOOD A, V27, P67, DOI 10.1016/j.cvfa.2010.10.001
   AOAC, 1984, OFF METH AN
   ATKINSON S, 1988, J ENDOCRINOL, V117, P167, DOI 10.1677/joe.0.1170167
   BARATTA M, 1992, ACTA ENDOCRINOL-COP, V127, P366
   BEARD AP, 1994, J REPROD FERTIL, V100, P469
   Bedos M, 2014, DOMEST ANIM ENDOCRIN, V48, P93, DOI 10.1016/j.domaniend.2014.02.003
   Berlinguer F, 2009, J PINEAL RES, V46, P383, DOI 10.1111/j.1600-079X.2009.00674.x
   Bister JL, 1999, DOMEST ANIM ENDOCRIN, V17, P315, DOI 10.1016/S0739-7240(99)00047-8
   Blaszczyk B, 2004, SMALL RUMINANT RES, V51, P209, DOI 10.1016/S0921-4488(03)00190-1
   Bojanowska E, 1997, BRAIN RES BULL, V42, P457, DOI 10.1016/S0361-9230(96)00372-3
   Boscos CM, 2003, REPROD DOMEST ANIM, V38, P170, DOI 10.1046/j.1439-0531.2003.00407.x
   Buffoni A, 2014, SMALL RUMINANT RES, V120, P121, DOI 10.1016/j.smallrumres.2014.05.003
   CARATY A, 1989, J ENDOCRINOL, V123, P375, DOI 10.1677/joe.0.1230375
   Casao A, 2010, SPAN J AGRIC RES, V8, P35
   Celi I, 2013, ANIM REPROD SCI, V137, P183, DOI 10.1016/j.anireprosci.2013.01.015
   Clark J., 1992, TXB ENDOCRINOLOGY, P35
   Contreras-Villarreal V, 2016, ANIM SCI J, V87, P750, DOI 10.1111/asj.12493
   Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417
   deNicolo G, 2008, ANIM REPROD SCI, V109, P124, DOI 10.1016/j.anireprosci.2007.10.012
   Durotoye LA, 1997, RES VET SCI, V62, P87, DOI 10.1016/S0034-5288(97)90126-0
   FABRENYS C, 1991, J ENDOCRINOL, V130, P367, DOI 10.1677/joe.0.1300367
   FASS, 2010, GUID CAR US AGR AN R
   Fatet A, 2011, ANIM REPROD SCI, V124, P211, DOI 10.1016/j.anireprosci.2010.08.029
   Fonseca JF, 2008, ANIM REPROD SCI, V103, P366, DOI 10.1016/j.anireprosci.2007.05.013
   Fonseca JF, 2005, ANIM REPROD SCI, V85, P117, DOI 10.1016/j.anireprosci.2004.03.005
   Forcada F, 2006, THERIOGENOLOGY, V65, P356, DOI 10.1016/j.theriogenology.2005.05.038
   Forcada F, 2002, AUST J AGR RES, V53, P167, DOI 10.1071/AR00172
   FORCADA F, 1995, THERIOGENOLOGY, V43, P1179, DOI 10.1016/0093-691X(95)00090-U
   Fukui Yutaka, 2001, Journal of Reproduction and Development, V47, P189, DOI 10.1262/jrd.47.189
   GIMENO MF, 1980, ACTA PHYSIOL LAT AM, V30, P38
   GIMENO MF, 1980, EUR J PHARMACOL, V62, P309, DOI 10.1016/0014-2999(80)90098-9
   Gonzalez-Bulnes A, 2010, REPROD DOMEST ANIM, V45, P9, DOI 10.1111/j.1439-0531.2010.01640.x
   Grattan DR, 2002, REPRODUCTION, V123, P497, DOI 10.1530/rep.0.1230497
   Hafez B., 2000, REPROD FARM ANIMALS
   Hashem NM, 2015, THERIOGENOLOGY, V83, P192, DOI 10.1016/j.theriogenology.2014.09.016
   HELMER SD, 1989, J REPROD FERTIL, V87, P89
   Honparkhe M, 2011, INDIAN J ANIM SCI, V81, P340
   Ishwar AK, 1996, SMALL RUMINANT RES, V19, P35, DOI 10.1016/0921-4488(95)00735-0
   JEROME A, 2012, ASIAN PAC J REPROD, V1, P238, DOI DOI 10.1016/S2305-0500(13)60085-8
   KANN G, 1975, NATURE, V257, P63, DOI 10.1038/257063a0
   Kaya S, 2013, SMALL RUMINANT RES, V113, P365, DOI 10.1016/j.smallrumres.2013.03.018
   Khan TH, 2003, ANIM REPROD SCI, V76, P81, DOI 10.1016/S0378-4320(02)00194-X
   Kumar S, 2009, SMALL RUMINANT RES, V82, P152, DOI 10.1016/j.smallrumres.2009.02.005
   LAWSON RAS, 1983, J REPROD FERTIL, V67, P473
   Leyva V, 1998, THERIOGENOLOGY, V50, P377, DOI 10.1016/S0093-691X(98)00147-2
   Mann G. E., 2002, P 22 WORLD BUIATR C, P300
   Mellado J, 2014, VET ZOOTECH-LITH, V66, P40
   Menchaca A, 2007, ANIM REPROD SCI, V102, P76, DOI 10.1016/j.anireprosci.2006.10.001
   Misztal T, 1997, NEUROENDOCRINOLOGY, V66, P360, DOI 10.1159/000127259
   Moakhar HK, 2012, SMALL RUMINANT RES, V102, P63, DOI 10.1016/j.smallrumres.2011.09.017
   Mondal M, 2006, HORM BEHAV, V49, P626, DOI 10.1016/j.yhbeh.2005.12.015
   MORI Y, 1985, Japanese Journal of Animal Reproduction, V31, P9
   NEPHEW KP, 1994, J ANIM SCI, V72, P453
   NOEL B, 1994, THERIOGENOLOGY, V41, P719, DOI 10.1016/0093-691X(94)90181-H
   Noel B, 1999, SMALL RUMINANT RES, V32, P269, DOI 10.1016/S0921-4488(98)00187-4
   NRC, 2007, NUTR REQ SMALL RUM
   Ollier S, 2013, J DAIRY SCI, V96, P335, DOI 10.3168/jds.2012-5955
   Parks J., 2004, HORMONES HYPOTHALAMU
   PLANTE C, 1989, J DAIRY SCI, V72, P1859, DOI 10.3168/jds.S0022-0302(89)79304-8
   PRANDI A, 1987, ANIM REPROD SCI, V13, P291, DOI 10.1016/0378-4320(87)90066-2
   Ramukhithi FV, 2012, J APPL ANIM RES, V40, P292, DOI 10.1080/09712119.2012.685280
   Rowe JD, 2010, J VET PHARMACOL THER, V33, P605, DOI 10.1111/j.1365-2885.2010.01172.x
   Schmitt EJP, 1996, J ANIM SCI, V74, P1915
   SHETH AR, 1978, CURR SCI INDIA, V47, P75
   Souza JMG, 2011, ANIM REPROD SCI, V129, P50, DOI 10.1016/j.anireprosci.2011.09.012
   Spencer TE, 1996, ENDOCRINOLOGY, V137, P1144, DOI 10.1210/en.137.3.1144
   Spencer TE, 2004, REPRODUCTION, V128, P657, DOI 10.1530/rep.1.00398
   Steel R. G. D., 1980, PRINCIPLES PROCEDURE
   Sullivan RR, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-113
   Vazquez MI, 2013, ANIM REPROD SCI, V141, P52, DOI 10.1016/j.anireprosci.2013.07.007
   Vazquez MI, 2010, REPROD DOMEST ANIM, V45, P677, DOI 10.1111/j.1439-0531.2008.01329.x
   Yue CW, 2010, ASIAN AUSTRAL J ANIM, V23, P1291
   Zarazaga LA, 2012, REPROD DOMEST ANIM, V47, P436, DOI 10.1111/j.1439-0531.2011.01899.x
   Zarazaga LA, 2011, ANIMAL, V5, P1414, DOI 10.1017/S1751731111000413
   Zarazaga LA, 2009, THERIOGENOLOGY, V72, P910, DOI 10.1016/j.theriogenology.2009.05.020
   Zarazaga LA, 2012, VET J, V192, P441, DOI 10.1016/j.tvjl.2011.09.012
   Zarazaga LA, 2011, J ENDOCRINOL, V211, P263, DOI 10.1530/JOE-11-0225
   Zuniga O, 2002, ANIM REPROD SCI, V72, P165, DOI 10.1016/S0378-4320(02)00117-3
NR 81
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-0302
EI 1525-3198
J9 J DAIRY SCI
JI J. Dairy Sci.
PD JUN
PY 2017
VL 100
IS 6
BP 5028
EP 5039
DI 10.3168/jds.2016-12240
PG 12
WC Agriculture, Dairy & Animal Science; Food Science & Technology
SC Agriculture; Food Science & Technology
GA EV5DX
UT WOS:000401783800073
OA No
DA 2017-08-17
ER

PT J
AU Alqutaibi, AY
AF Alqutaibi, Ahmed Yaseen
TI CEMENT- AND SCREW-RETAINED IMPLANT-SUPPORTED RESTORATIONS SHOWED
   COMPARABLE MARGINAL BONE LOSS AND IMPLANT SURVIVAL RATE
SO JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE
LA English
DT Editorial Material
AB Evaluation of cement-retained versus screw-retained implant-supported restorations for marginal bone loss: A systematic review and meta-analysis.
C1 [Alqutaibi, Ahmed Yaseen] Ahram Canadian Univ, Fac Oral & Dent Med, Dept Prosthodont, Cairo, Egypt.
   [Alqutaibi, Ahmed Yaseen] IBB Univ, Fac Oral & Dent Med, Dept Prosthodont, Ibb, Yemen.
RP Alqutaibi, AY (reprint author), Ahram Canadian Univ, Fac Oral & Dent Med, Dept Prosthodont, Cairo, Egypt.; Alqutaibi, AY (reprint author), IBB Univ, Fac Oral & Dent Med, Dept Prosthodont, Ibb, Yemen.
EM am01012002@gmail.com
FU Sao Paulo Research Foundation (FAPESP) [2014/02490-8]
FX Sao Paulo Research Foundation (FAPESP), grant 2014/02490-8.
CR AHLQVIST J, 1990, International Journal of Oral and Maxillofacial Implants, V5, P155
   Korsch M, 2015, CLIN IMPLANT DENT R, V17, pE45, DOI 10.1111/cid.12122
   Pennington J, 2012, COMPEND CONTIN ED DE, V72, P74
   Pennington Jeff, 2012, Compend Contin Educ Dent, V33, P268
   Pjetursson BE, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2012.02546.x
   Shadid R, 2012, J ORAL IMPLANTOL, V38, P298, DOI 10.1563/AAID-JOI-D-10-00146
   Taylor TD, 2000, INT J ORAL MAX IMPL, V15, P66
NR 7
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-3382
EI 1532-3390
J9 J EVID-BASED DENT PR
JI J. Evid.-Based Dent. Pract.
PD JUN
PY 2017
VL 17
IS 2
BP 107
EP 109
DI 10.1016/j.jebdp.2017.03.009
PG 3
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EV8HS
UT WOS:000402021900008
PM 28501054
OA No
DA 2017-08-17
ER

PT J
AU Hammad, AH
   Abdelghany, AM
   Okasha, A
   Marzouk, SY
AF Hammad, Ahmed H.
   Abdelghany, A. M.
   Okasha, Aly
   Marzouk, S. Y.
TI The influence of fluorine and nickel ions on the structural,
   spectroscopic, and optical properties of (100-x)
   [15NaF-5CaF(2)-80B(2)O(3)]-xNiO glasses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article
ID ALKALI FLUOROBORATE GLASSES; SODIUM-BORATE GLASSES;
   ELECTRICAL-PROPERTIES; LUMINESCENCE; CERAMICS; ABSORPTION; IRRADIATION;
   CONDUCTION; SYSTEMS; V2O5
AB Borate glasses containing sodium fluoride and calcium fluoride were prepared. Nickel oxide was doped into the host glass in different ratios ranging from 0.05 to 1 wt%. Structural studies were exempted by Fourier transform infrared spectroscopy which suggested that the incorporation of fluorine ions in both BO3 and BO4 structural units tends to modify these units to form B-O-F linkage like BOF2 and BOF3, respectively. The glass structure is strongly affected by the ratio of nickel ions especially the infrared absorption region from 400 to 2000 cm(-1). Nickel ions are favored to exist in octahedral states occupying the vacancies in the borate network. Optical transition is assumed to be direct transition according to the Yakupanoglu and Arslan procedure with acceptable error ratio about 4.5%. The density values are observed to increase linearly as the nickel ions increases.
C1 [Hammad, Ahmed H.] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah, Saudi Arabia.
   [Hammad, Ahmed H.] Natl Res Ctr, Div Phys, Electron Microscope & Thin Films Dept, 33 El Behouth St, Cairo 12622, Egypt.
   [Abdelghany, A. M.; Okasha, Aly] Natl Res Ctr, Div Phys, Dept Spect, 33 El Behouth St, Cairo 12622, Egypt.
   [Marzouk, S. Y.] Arab Acad Sci & Technol, Basic & Appl Sci, Fac Engn, Cairo, Egypt.
RP Hammad, AH (reprint author), King Abdulaziz Univ, Ctr Nanotechnol, Jeddah, Saudi Arabia.; Hammad, AH (reprint author), Natl Res Ctr, Div Phys, Electron Microscope & Thin Films Dept, 33 El Behouth St, Cairo 12622, Egypt.
EM ahosny2005@gmail.com
CR Abdelghany AM, 2015, SPECTROCHIM ACTA A, V137, P39, DOI 10.1016/j.saa.2014.08.012
   Adam JL, 2001, J FLUORINE CHEM, V107, P265, DOI 10.1016/S0022-1139(00)00368-7
   Batchelor C, 2003, APPL PHYS LETT, V82, P4035, DOI 10.1063/1.1581374
   Condrate R.A., 1972, INTRO GLASS SCI, P101
   COOK L, 1982, J AM CERAM SOC, V65, P597, DOI 10.1111/j.1151-2916.1982.tb09936.x
   DAVIS EA, 1970, PHILOS MAG, V22, P903, DOI 10.1080/14786437008221061
   Dejneka MJ, 1998, J NON-CRYST SOLIDS, V239, P149, DOI 10.1016/S0022-3093(98)00731-5
   Nardi RPRD, 2015, OPT MATER, V49, P249, DOI 10.1016/j.optmat.2015.09.008
   Doweidar H, 2012, J MATER SCI, V47, P4028, DOI 10.1007/s10853-012-6256-y
   DOWEIDAR H, 1986, J PHYS D APPL PHYS, V19, P1939, DOI 10.1088/0022-3727/19/10/018
   Duffy JA, 1997, PHYS CHEM GLASSES, V38, P289
   El-Batal HA, 2012, INDIAN J PURE AP PHY, V50, P398
   ElBatal FH, 2016, CERAM INT, V42, P8247, DOI 10.1016/j.ceramint.2016.02.037
   Elkholy MM, 2010, J LUMIN, V130, P1880, DOI 10.1016/j.jlumin.2010.05.002
   FAURE C, 1991, J POWER SOURCES, V35, P279, DOI 10.1016/0378-7753(91)80112-B
   Feng GF, 2008, J ALLOY COMPD, V457, P506, DOI 10.1016/j.jallcom.2007.03.034
   FUNCK E, 1967, BERICH BUNSEN GESELL, V71, P170
   GUTZOW I, 1989, J MATER SCI, V24, P1281, DOI 10.1007/BF02397059
   Kaminskii A., 1996, CRYSTALLINE LASERS P
   KAMITSOS EI, 1988, SOLID STATE IONICS, V28, P783, DOI 10.1016/S0167-2738(88)80146-2
   Kamitsos EI, 2003, PHYS CHEM GLASSES, V44, P79
   Lucas J, 1999, CURR OPIN SOLID ST M, V4, P181, DOI 10.1016/S1359-0286(99)00007-8
   MAYA L, 1977, J AM CERAM SOC, V60, P323, DOI 10.1111/j.1151-2916.1977.tb15552.x
   Moncke D, 2004, OPT MATER, V25, P425, DOI 10.1016/j.optmat.2003.11.001
   Nazabal V, 2003, J NON-CRYST SOLIDS, V326, P359, DOI 10.1016/S0022-3093(03)00435-6
   Poch W., 1967, GLASTECH BER, V30, P261
   Polishchuk SA, 2011, GLASS PHYS CHEM+, V37, P1, DOI 10.1134/S108765961101010X
   Rao PN, 2006, J LUMIN, V117, P53, DOI 10.1016/j.jlumin.2005.04.006
   Rao RB, 2008, MATER CHEM PHYS, V112, P186, DOI 10.1016/j.matchemphys.2008.05.046
   Rayappan IA, 2013, J NON-CRYST SOLIDS, V367, P43, DOI 10.1016/j.jnoncrysol.2013.02.016
   Reshak AH, 2006, J MATER SCI, V41, P1927, DOI 10.1007/s10853-006-4487-5
   Chialanza MR, 2015, J NON-CRYST SOLIDS, V427, P191, DOI 10.1016/j.jnoncrysol.2015.07.045
   Scholze H., 1991, GLASS NATURE STRUCTU
   Shaw R. R., 1969, Journal of Non-Crystalline Solids, V1, P474, DOI 10.1016/0022-3093(69)90009-X
   Shelby JE, 1998, PHYS CHEM GLASSES, V39, P23
   SIGEL GH, 1968, GLASS TECHNOL, V9, P66
   Sindhu S, 2005, PHYSICA B, V365, P65, DOI 10.1016/j.physb.2005.04.037
   Yakuphanoglu F, 2007, PHYSICA B, V393, P304, DOI 10.1016/j.physb.2007.01.017
   Yazici N., 2006, NUCL INSTRUM METH B, V246, P402
NR 39
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
EI 1573-482X
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD JUN
PY 2017
VL 28
IS 12
BP 8662
EP 8668
DI 10.1007/s10854-017-6590-6
PG 7
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA EV5PG
UT WOS:000401819000039
OA No
DA 2017-08-17
ER

PT J
AU Al-Ghamdi, AA
   Al-Turki, Y
   Aal, NA
   Yakuphanoglu, F
   El-Tantawy, F
AF Al-Ghamdi, A. A.
   Al-Turki, Yusuf
   Aal, Nadia Abdel
   Yakuphanoglu, Fahrattin
   El-Tantawy, Farid
TI Microwave-assisted hydrothermal synthesis of monoclinic bismuth trioxide
   nanorods: optical and photocatalytic properties
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article
ID METHYL-ORANGE; MORPHOLOGICAL CONTROL; DEGRADATION; BI2O3; DYE;
   NANOPARTICLES
AB Herein, the successful synthesis of bismuth trioxide (Bi2O3) nanorods via a new microwave-assisted hydrothermal technique is reported. Detailed characterizations for the prepared nanorods employing various analytical techniques were considered for their structural, compositional, morphological, optical and photocatalytic properties. The detailed results confirmed that the prepared nanorods have a well-crystalline structure, growing with a high density and having pure monoclinic crystal structure. The prepared nanorods exhibited good optical properties were confirmedly the room-temperature photoluminescence (PL) spectroscopy. The as-prepared Bi2O3 nanorod structures showed efficient photocatalytic activity for the degradation of methyl orange (MO) dyes under the application of UV light irradiation (365 nm). The pseudo-first order reaction rate constant is 0.007 min(- 1). The fabricated Bi2O3 nanorods are very useful as ultraviolet light activated photocatalyst nanorod materials for decomposing methyl orange and various types of organic dyes.
C1 [Al-Ghamdi, A. A.; El-Tantawy, Farid] King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah, Saudi Arabia.
   [Al-Turki, Yusuf] King Abdulaziz Univ, Dept Elect & Comp Engn, Fac Engn, Jeddah, Saudi Arabia.
   [Aal, Nadia Abdel] Suez Canal Univ, Dept Chem, Fac Sci, Ismailia, Egypt.
   [Yakuphanoglu, Fahrattin] Firat Univ, Dept Phys, Fac Sci, Elazig, Turkey.
   [El-Tantawy, Farid] Suez Canal Univ, Dept Phys, Fac Sci, Ismailia, Egypt.
RP El-Tantawy, F (reprint author), King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah, Saudi Arabia.; El-Tantawy, F (reprint author), Suez Canal Univ, Dept Phys, Fac Sci, Ismailia, Egypt.
EM faridtantawy@yahoo.com
CR Ajmal A, 2014, RSC ADV, V4, P37003, DOI 10.1039/c4ra06658h
   Al-Hazmi F, 2012, SUPERLATTICE MICROST, V52, P200, DOI 10.1016/j.spmi.2012.04.013
   Anandan S, 2010, IND ENG CHEM RES, V49, P9729, DOI 10.1021/ie101361c
   Arabatzis IM, 2003, APPL CATAL B-ENVIRON, V42, P187, DOI 10.1016/S0926-3373(02)00233-3
   Gou XL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495501
   Hassan ME, 2014, MATERIALS, V7, P8024, DOI 10.3390/ma7128024
   Ho CH, 2013, OPT EXPRESS, V21, P11965, DOI 10.1364/OE.21.011965
   Hosseinpour-mashkani SM, 2016, J MATER SCI-MATER EL, V27, P7548, DOI 10.1007/s10854-016-4735-7
   Hosseinpour-Mashkani SM, 2016, J MATER SCI-MATER EL, V27, P5758, DOI 10.1007/s10854-016-4489-2
   Hosseinpour-Mashkani SM, 2016, J ELECTRON MATER, V45, P3612, DOI 10.1007/s11664-016-4532-3
   Hosseinpour-Mashkani S, 2016, J MATER SCI-MATER EL, V27, P3240, DOI 10.1007/s10854-015-4150-5
   Hosseinpour-Mashkani SM, 2016, J MATER SCI-MATER EL, V27, P474, DOI 10.1007/s10854-015-3776-7
   Hosseinpour-Mashkani SM, 2015, J MATER SCI-MATER EL, V26, P6086, DOI 10.1007/s10854-015-3186-x
   Kumar R, 2013, MATER LETT, V97, P100, DOI 10.1016/j.matlet.2013.01.044
   Li S, 2013, J AM CERAM SOC, V96, P3155, DOI 10.1111/jace.12473
   Ling B, 2010, J NANOSCI NANOTECHNO, V10, P8322, DOI 10.1166/jnn.2010.3051
   Liu XW, 2011, NANO RES, V4, P470, DOI 10.1007/s12274-011-0103-3
   Luan XW, 2015, ENVIRON ENG MANAG J, V14, P703
   Park S, 2015, B KOREAN CHEM SOC, V36, P468, DOI 10.1002/bkcs.10076
   Singh A.K., 2013, ADV NANOPARTICLES, V2, P66
   Sobhani-Nasab A, 2016, J MATER SCI-MATER EL, V27, P11946, DOI 10.1007/s10854-016-5341-4
   Wu ZF, 2011, J NANOPART RES, V13, P4575, DOI 10.1007/s11051-011-0417-9
   Zhou L, 2009, CHEM-EUR J, V15, P1776, DOI 10.1002/chem.200801234
NR 23
TC 0
Z9 0
U1 14
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
EI 1573-482X
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD JUN
PY 2017
VL 28
IS 12
BP 8684
EP 8693
DI 10.1007/s10854-017-6593-3
PG 10
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA EV5PG
UT WOS:000401819000042
OA No
DA 2017-08-17
ER

PT J
AU Reben, M
   Yousef, E
   Piasecki, M
   Albassam, AA
   El-Naggar, AM
   Lakshminarayana, G
   Kityk, IV
   Grelowska, I
AF Reben, M.
   Yousef, El. Sayed
   Piasecki, M.
   Albassam, A. A.
   El-Naggar, A. M.
   Lakshminarayana, G.
   Kityk, I. V.
   Grelowska, I.
TI Different modifier oxides effect on the photoluminescence and
   photoinduced piezooptics of Er3+-doped fluorotellurite glasses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article
ID TELLURITE GLASSES; OPTICAL-PROPERTIES; FIBER LASER; ER3+ IONS; EMISSION;
   RAMAN; PHOTONICS; GREEN
AB Novel fluorotellurite glasses with composition 70TeO(2)center dot 5MxOy center dot 10P(2)O(5)center dot 10ZnO center dot 5PbF(2) (mol %) containing 600 ppm Er2O3, where MxOy = (MgO, PbO, Bi2O3, Nb2O5, TiO2, BaO, WO3, SrO, CdO) have been prepared using the conventional melt-quenching method. Studies of the nonlinear optical refractive index and photoinduced piezooptics were carried out. The Mid-Infrared spectroscopy, optical transmission, photoluminescence and photoinduced changes of diagonal piezooptics and nonlinear optics refractive indices coefficient measurements were applied to determine the appropriate glass modifier to achieve the desirable optical properties and high performance. The glasses may be useful for operation by high-intensity laser pulses.
C1 [Reben, M.; Grelowska, I.] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Mickiewicza 30, PL-30059 Krakow, Poland.
   [Yousef, El. Sayed] King Khalid Univ, Dept Phys, Fac Sci, POB 9004, Abha, Saudi Arabia.
   [Piasecki, M.] Jan Dlugosz Univ, Inst Phys, Armii Krajowej 13-15, PL-42200 Czestochowa, Poland.
   [Albassam, A. A.; El-Naggar, A. M.] King Saud Univ, Res Chair Exploitat Renewable Energy Applicat Sau, Dept Phys & Astron, Coll Sci, POB 2455, Riyadh 11451, Saudi Arabia.
   [El-Naggar, A. M.] Ain Shams Univ, Dept Phys, Fac Sci, Cairo 11566, Egypt.
   [Lakshminarayana, G.] Univ Putra Malaysia, Wireless & Photon Networks Res Ctr, Fac Engn, Serdang 43400, Selangor, Malaysia.
   [Kityk, I. V.] Czestochowa Tech Univ, Fac Elect Engn, Armii Krajowej 17, PL-42200 Czestochowa, Poland.
RP Lakshminarayana, G (reprint author), Univ Putra Malaysia, Wireless & Photon Networks Res Ctr, Fac Engn, Serdang 43400, Selangor, Malaysia.
EM glnphysics@gmail.com
RI Piasecki, Michal/J-8302-2015
OI Piasecki, Michal/0000-0003-1040-8811
FU Deanship of Scientific Research, King Saud University through Vice
   Deanship of Scientific Research Chairs
FX The authors are grateful to the Deanship of Scientific Research, King
   Saud University for funding through Vice Deanship of Scientific Research
   Chairs.
CR Benmadani Y, 2013, OPT MATER, V35, P2234, DOI 10.1016/j.optmat.2013.06.014
   Burtan B, 2012, OPT MATER, V34, P2050, DOI 10.1016/j.optmat.2012.03.030
   Damak K, 2014, OPT MATER EXPRESS, V4, P597, DOI 10.1364/OME.4.000597
   Domachuk P, 2008, OPT EXPRESS, V16, P7161, DOI 10.1364/OE.16.007161
   Eggleton BJ, 2011, NAT PHOTONICS, V5, P141, DOI [10.1038/nphoton.2011.309, 10.1038/NPHOTON.2011.309]
   Feng X, 2001, J NON-CRYST SOLIDS, V281, P48, DOI 10.1016/S0022-3093(00)00429-4
   Jlassi I, 2010, OPT MATER, V32, P743, DOI 10.1016/j.optmat.2010.02.006
   Leon-Luis SF, 2011, SENSOR ACTUAT B-CHEM, V158, P208, DOI 10.1016/j.snb.2011.06.005
   Liao GH, 2009, J NON-CRYST SOLIDS, V355, P447, DOI 10.1016/j.jnoncrysol.2009.01.011
   Mori A, 1997, ELECTRON LETT, V33, P863, DOI 10.1049/el:19970585
   Nazabal V, 2003, J NON-CRYST SOLIDS, V326, P359, DOI 10.1016/S0022-3093(03)00435-6
   O'Donnell MD, 2007, J AM CERAM SOC, V90, P1448, DOI 10.1111/j.1551-2916.2007.01574.x
   O'Donnell MD, 2003, J NON-CRYST SOLIDS, V331, P48, DOI 10.1016/j.jnoncrysol.2003.08.081
   Sanghera JS, 2009, IEEE J SEL TOP QUANT, V15, P114, DOI 10.1109/JSTQE.2008.2010245
   Tokita S, 2009, OPT LETT, V34, P3062, DOI 10.1364/OL.34.003062
   Tsang WS, 2002, J APPL PHYS, V91, P1871, DOI 10.1063/1.1429762
   Yousef E, 2013, J ALLOY COMPD, V561, P234, DOI 10.1016/j.jallcom.2013.01.199
   Yue J, 2015, J NON-CRYST SOLIDS, V408, P1, DOI 10.1016/j.jnoncrysol.2014.10.006
   Zhang JJ, 2002, MATER LETT, V55, P77
NR 19
TC 1
Z9 1
U1 7
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
EI 1573-482X
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD JUN
PY 2017
VL 28
IS 12
BP 8969
EP 8975
DI 10.1007/s10854-017-6627-x
PG 7
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA EV5PG
UT WOS:000401819000076
OA No
DA 2017-08-17
ER

PT J
AU Al-Rasheedi, A
   Wageh, S
   Al-Zhrani, E
   Al-Ghamdi, A
AF Al-Rasheedi, Asmaa
   Wageh, S.
   Al-Zhrani, Ebtesam
   Al-Ghamdi, Ahmed
TI Structural and optical properties of CdZnTe quantum dots capped with a
   bifunctional Molecule
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article
ID 3-MERCAPTOPROPIONIC ACID; AQUEOUS SYNTHESIS; NANOPARTICLES; CDTE; RAMAN;
   SIZE; PHOTOLUMINESCENCE; NANOCRYSTALS; EMISSION; DEVICES
AB CdTe and ternary CdZnTe quantum dots capped with 3-mercaptopropionic acid in aqueous medium with different percentages of Zn have been prepared using K2TeO3 as a source of tellurium. The structure and morphology of these quantum dots were characterized by XRD, TEM, EDX, FTIR and Raman spectroscopy. The results revealed that the ternary CdZnTe quantum dots (QDs) have nearly spherical shape with hexagonal structure. Doping with Zn leads to a pronounced change in relative intensity of the X-ray diffraction peaks. The optical properties were investigated by using UV-Vis absorption and photoluminescence measurements. The UV-Vis showed a gradual increase in the optical band gap of ternary alloy compound of CdZnTe QDs plus a continuous shift of photoluminescence emission with increasing of Zn content. The color distribution analysis showed a gradual change in color with Zn percentage for red, green and blue components. The nanoparticle sizes were determined from optical absorption, XRD, Raman and HRTEM measurements indicating that the prepared binary CdTe and ternary CdZnTe capped with MPA are in a strong confinement regime as an indicative of quantum dots structure.
C1 [Al-Rasheedi, Asmaa; Wageh, S.; Al-Zhrani, Ebtesam; Al-Ghamdi, Ahmed] King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 21589, Saudi Arabia.
   [Al-Rasheedi, Asmaa] Univ Jeddah, Fac Sci & Arts, Dept Phys, POB 80200, Khulais 21589, Saudi Arabia.
   [Wageh, S.] Menoufia Univ, Fac Elect Engn, Phys & Engn Math Dept, Menoufia 32952, Egypt.
RP Wageh, S (reprint author), King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 21589, Saudi Arabia.; Wageh, S (reprint author), Menoufia Univ, Fac Elect Engn, Phys & Engn Math Dept, Menoufia 32952, Egypt.
EM wageh1@yahoo.com
CR Adachi S., 2004, HDB PHYS PROPERTIES, V3
   AYDINLI A, 1991, SOLID STATE COMMUN, V80, P465, DOI 10.1016/0038-1098(91)90051-V
   BRENNAN JG, 1990, CHEM MATER, V2, P403, DOI 10.1021/cm00010a017
   Camacho J, 2002, J PHYS-CONDENS MAT, V14, P739, DOI 10.1088/0953-8984/14/4/309
   CAMPBELL IH, 1986, SOLID STATE COMMUN, V58, P739, DOI 10.1016/0038-1098(86)90513-2
   Cao J, 2010, J COLLOID INTERF SCI, V348, P369, DOI 10.1016/j.jcis.2010.05.007
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217
   Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y
   Gilic M, 2013, J ALLOY COMPD, V579, P330, DOI 10.1016/j.jallcom.2013.06.081
   Greytak AB, 2012, CHEM SCI, V3, P2028, DOI 10.1039/c2sc00561a
   He H, 2012, ACS APPL MATER INTER, V4, P6362, DOI 10.1021/am3020108
   Jenkins Ron, 1996, INTRO XRAY POWDER DI
   Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314
   Li WW, 2010, J MATER CHEM, V20, P2133, DOI 10.1039/b921686c
   Liu YF, 2010, J COLLOID INTERF SCI, V351, P1, DOI 10.1016/j.jcis.2010.07.047
   Marcus M. A., 1992, Nanostructured Materials, V1, P323, DOI 10.1016/0965-9773(92)90039-Z
   Najeeb MA, 2016, RSC ADV, V6, P23048, DOI 10.1039/c6ra01052k
   OLEGO DJ, 1985, APPL PHYS LETT, V47, P1172, DOI 10.1063/1.96316
   Pouchert C.J., 1997, ALDRICH LIB FT IR SP
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Silva FO, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-536
   Sobhana SSL, 2011, J NANOPART RES, V13, P1747, DOI 10.1007/s11051-010-9934-1
   TALWAR DN, 1993, PHYS REV B, V48, P17064, DOI 10.1103/PhysRevB.48.17064
   TANAKA A, 1992, J PHYS SOC JPN, V61, P4222, DOI 10.1143/JPSJ.61.4222
   TOBIN SP, 1995, J ELECTRON MATER, V24, P697, DOI 10.1007/BF02657981
   Trallero-Giner C, 1998, PHYS REV B, V57, P4664, DOI 10.1103/PhysRevB.57.4664
   Tripathi SK, 2015, APPL PHYS A-MATER, V118, P1287, DOI 10.1007/s00339-014-8833-1
   Viswanatha R, 2005, PHYS REV B, V72, DOI [10.1103/PhysRevB.72.045333, 10.1103/PhysRevB.045333]
   Wageh S, 2008, PHYSICA E, V40, P2810, DOI 10.1016/j.physe.2007.12.013
   Wageh S, 2007, PHYSICA E, V39, P8, DOI 10.1016/j.physe.2006.12.003
   Wageh S, 2016, J MATER SCI-MATER EL, V27, P10877, DOI 10.1007/s10854-016-5197-7
   Wageh S, 2016, J MATER SCI-MATER EL, V27, P8384, DOI 10.1007/s10854-016-4850-5
   Wageh S, 2014, IEEE J QUANTUM ELECT, V50, P1, DOI 10.1109/JQE.2014.2335819
   Wageh S, 2013, J MATER SCI-MATER EL, V24, P3049, DOI 10.1007/s10854-013-1210-6
   Wageh S, 2013, J SOL-GEL SCI TECHN, V66, P443, DOI 10.1007/s10971-013-3030-9
   Wageh S, 2014, RSC ADV, V4, P24110, DOI 10.1039/c4ra03139c
   Wuister SF, 2003, NANO LETT, V3, P503, DOI 10.1021/nl034054t
   Zheng YG, 2007, ADV MATER, V19, P1475, DOI 10.1002/adma.200601939
NR 39
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
EI 1573-482X
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD JUN
PY 2017
VL 28
IS 12
BP 9114
EP 9125
DI 10.1007/s10854-017-6645-8
PG 12
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA EV5PG
UT WOS:000401819000094
OA No
DA 2017-08-17
ER

PT J
AU Wallace, CL
   Swagerty, D
   Barbagallo, M
   Vellas, B
   Cha, HB
   Holmerova, I
   Dong, BR
   Koopmans, R
   Cruz-Jentoft, AJ
   Robledo, LMG
   Moreno, JC
   Hajjar, R
   Woo, J
   Arai, H
   Okochi, J
   Visvanathan, R
   Abdul-Rahman, SA
   Goel, A
   Moser, A
   Rolland, Y
   Abbatecola, AM
   Russo, M
   Morley, JE
AF Wallace, Cara L.
   Swagerty, Daniel
   Barbagallo, Mario
   Vellas, Bruno
   Cha, Heung Bong
   Holmerova, Iva
   Dong, Birong
   Koopmans, Raymond
   Cruz-Jentoft, Alfonso J.
   Gutierrez Robledo, Luis Miguel
   Cuadros Moreno, Juan
   Hajjar, Ramzi
   Woo, Jean
   Arai, Hidenori
   Okochi, Jiro
   Visvanathan, Renuka
   Abdul-Rahman, Samia A.
   Goel, Ashish
   Moser, Andrea
   Rolland, Yves
   Abbatecola, Angela M.
   Russo, Marcello
   Morley, John E.
TI IAGG/IAGG GARN International Survey of End-of-Life Care in Nursing Homes
SO JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION
LA English
DT Article
DE End-of-life care; nursing home research; hospice; palliative care
ID QUALITY; PEOPLE
AB This article reports the findings of a survey on end-of-life (EOL) care in nursing homes of 18 long-term care experts across 15 countries. The experts were chosen as a convenience-based sample of known experts in each country. The survey was administered in 2016 and included both open-ended responses for defining hospice care, palliative care, and "end of life," and a series of questions related to the following areas-attitudes toward EOL care, current practice and EOL interventions, structure of care, and routine barriers. Overall experts strongly agreed that hospice and palliative care should be available in long-term care facilities and that both are defined by holistic, interdisciplinary approaches using measures of comfort across domains. However, it appears the experts felt that in most countries the reality fell short of what they believed would be ideal care. As a result, experts call for increased training, communication, and access to specialized EOL services within the nursing home. (C) 2017 AMDA The Society for Post-Acute and Long-Term Care Medicine.
C1 [Wallace, Cara L.] St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, St Louis, MO 63103 USA.
   [Swagerty, Daniel] Univ Kansas, Sch Med, Landon Ctr Aging, Kansas City, KS USA.
   [Barbagallo, Mario] Univ Palermo, Dept Internal Med, Clin Sect, Palermo, Italy.
   [Vellas, Bruno; Rolland, Yves] Toulouse Univ Hosp CHU, Gerontopole, Toulouse, France.
   [Cha, Heung Bong] IAGG, Seoul, South Korea.
   [Holmerova, Iva] Charles Univ Prague, Fac Human, Int Relat, Prague, Czech Republic.
   [Dong, Birong] Sichuan Univ, West China Hosp, Ctr Gerontol & Geriatr, West China Med Sch, Chengdu, Sichuan, Peoples R China.
   [Koopmans, Raymond] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands.
   [Koopmans, Raymond] Joachin Anna Ctr Specialized Geriatr Care, Nijmegen, Netherlands.
   [Cruz-Jentoft, Alfonso J.] Hosp Univ Ramon & Cajal, IRYCIS, Serv Geriatr, Madrid, Spain.
   [Gutierrez Robledo, Luis Miguel; Cuadros Moreno, Juan] Inst Nacl Salud Mexico, Inst Nacl Geriatr, Mexico City, DF, Mexico.
   [Hajjar, Ramzi] Amer Univ Beirut, Med Ctr, Geriatr Med & Palliat Care, Beirut, Lebanon.
   [Woo, Jean] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China.
   [Arai, Hidenori] Natl Ctr Geriatr & Gerontol, Obu, Japan.
   [Okochi, Jiro] Tatsumanosato Geriatr Hlth Serv Facil, Daito, Japan.
   [Visvanathan, Renuka] Univ Adelaide, Adelaide Geriatr & Training Res Aged Care GTRAC C, Adelaide, SA, Australia.
   [Visvanathan, Renuka] Queen Elizabeth Hosp, Aged & Extended Care Serv, Adelaide, SA, Australia.
   [Abdul-Rahman, Samia A.] Ain Shams Univ, Fac Med, Geriatr & Gerontol Dept, Egyptian Soc Geriatr & Gerontol, Cairo, Egypt.
   [Goel, Ashish] UCMS & GTB Hosp, Dept Med, Delhi, India.
   [Moser, Andrea] Jewish Home Aged Baycrest, Toronto, ON, Canada.
   [Abbatecola, Angela M.] Azienda Sanitaria Locale ASL Frosinone, Frosinone, Italy.
   [Morley, John E.] St Louis Univ, Sch Med, Div Geriatr Med, St Louis, MO 63103 USA.
RP Morley, JE (reprint author), Div Geriatr Med, 1402 S Grand Blvd,M238, St Louis, MO 63104 USA.
EM morley@slu.edu
RI Woo, Jean/K-2625-2014; Abdul-Rahman, Samia/K-6835-2013
OI Woo, Jean/0000-0001-7593-3081; Abdul-Rahman, Samia/0000-0001-9910-312X
CR Briesacher BA, 2013, JAMA-J AM MED ASSOC, V309, P440, DOI 10.1001/jama.2012.211266
   Broad JB, 2013, INT J PUBLIC HEALTH, V58, P257, DOI 10.1007/s00038-012-0394-5
   DeLellis NO, 2013, HEALTH CARE MANAGE R, V38, P156, DOI 10.1097/HMR.0b013e31824bec38
   Feng ZL, 2009, INT J GERIATR PSYCH, V24, P1110, DOI 10.1002/gps.2232
   Huskamp HA, 2012, MED CARE RES REV, V69, P3, DOI 10.1177/1077558711418518
   Institute of Medicine, 2014, DYING AM IMPR QUAL H
   Livingston G, 2012, INT J GERIATR PSYCH, V27, P643, DOI 10.1002/gps.2772
   Lucas JA, 2014, INT J GERIATR PSYCH, V29, P1049, DOI 10.1002/gps.4098
   Meier DE, 2011, MILBANK Q, V89, P343, DOI 10.1111/j.1468-0009.2011.00632.x
   Morley JE, 2014, J AM MED DIR ASSOC, V15, P309, DOI 10.1016/j.jamda.2014.03.003
   Oliver Debra Parker, 2005, J Am Med Dir Assoc, V6, pS21, DOI 10.1016/j.jamda.2005.03.017
   Stevenson DG, 2009, J PAIN SYMPTOM MANAG, V38, P440, DOI 10.1016/j.jpainsymman.2009.05.006
   Tolson D, 2011, J AM MED DIR ASSOC, V12, P184, DOI 10.1016/j.jamda.2010.12.013
   World Health Organization, 2012, WHO DEF PALL CAR
   World Health Organisation, 2014, 67 WORLD HLTH ASS
   World Health Organization, 2011, GLOBAL HLTH AGING
   Worldwide Hospice Palliative Care Alliance, GEN FACT SHEET 2015
   Wowchuk Suzanne M, 2006, Int J Palliat Nurs, V12, P260
   Wowchuk Suzanne M, 2007, Int J Palliat Nurs, V13, P345
NR 19
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-8610
EI 1538-9375
J9 J AM MED DIR ASSOC
JI J. Am. Med. Dir. Assoc.
PD JUN 1
PY 2017
VL 18
IS 6
BP 465
EP 469
DI 10.1016/j.jamda.2017.04.002
PG 5
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA EW3VK
UT WOS:000402431200003
PM 28549702
OA No
DA 2017-08-17
ER

PT J
AU Arnous, AH
   Ullah, MZ
   Asma, M
   Moshokoa, SP
   Mirzazadeh, M
   Biswas, A
   Belic, M
AF Arnous, Ahmed H.
   Ullah, Malik Zaka
   Asma, Mir
   Moshokoa, Seithuti P.
   Mirzazadeh, Mohammad
   Biswas, Anjan
   Belic, Milivoj
TI Nematicons in liquid crystals by modified simple equation method
SO NONLINEAR DYNAMICS
LA English
DT Article
DE Nematicons; Liquid crystals; Modified simple equation method
ID MULTIPLE-SOLITON-SOLUTIONS; OPTICAL SOLITONS
AB This paper obtains nematicon solutions in liquid crystals by the aid of modified simple equation method. There are four types of nonlinearity studied. They are cubic law, power law, parabolic law and dual-power law. Bright, dark and singular types of these solitons are obtained. The constraints guarantee their existence.
C1 [Arnous, Ahmed H.] Higher Inst Engn, Dept Engn Math & Phys, Cairo, Egypt.
   [Ullah, Malik Zaka; Biswas, Anjan] King Abdulaziz Univ, Dept Math, Operator Theory & Applicat Res Grp, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
   [Asma, Mir] Univ Malaya, Inst Math Sci, Fac Sci, Kuala Lumpur 50601, Malaysia.
   [Moshokoa, Seithuti P.; Biswas, Anjan] Tshwane Univ Technol, Dept Math & Stat, ZA-0008 Pretoria, South Africa.
   [Mirzazadeh, Mohammad] Univ Guilan, Fac Engn & Technol, Dept Engn Sci, East Of Guilan 4489163157, Rudsar Vajargah, Iran.
   [Belic, Milivoj] Texas A&M Univ Qatar, Sci Program, POB 23874, Doha, Qatar.
RP Biswas, A (reprint author), King Abdulaziz Univ, Dept Math, Operator Theory & Applicat Res Grp, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
EM biswas.anjan@gmail.com
RI Ullah, Malik/H-2068-2013
OI Ullah, Malik/0000-0003-2944-0352
FU Department of Mathematics and Statistics at Tshwane University of
   Technology; South African National Foundation [92052 IRF1202210126];
   Qatar National Research Fund (QNRF) [NPRP 6-021-1-005]
FX The fourth author (SPM) would like to thank the research support
   provided by the Department of Mathematics and Statistics at Tshwane
   University of Technology and the support from the South African National
   Foundation under Grant Number 92052 IRF1202210126. The research work of
   seventh author (MB) was supported by Qatar National Research Fund (QNRF)
   under the Grant Number NPRP 6-021-1-005.
CR Arnous A.H., 2015, J COMPUT THEOR NANOS, p[12, 5940]
   Arnous AH, 2017, OPTIK, V130, P996, DOI 10.1016/j.ijleo.2016.11.101
   Arnous AH, 2016, OPTIK, V127, P11450, DOI 10.1016/j.ijleo.2016.09.055
   Arnous AH, 2015, OPTOELECTRON ADV MAT, V9, P1214
   El-Borai MM, 2017, OPTIK, V130, P324, DOI 10.1016/j.ijleo.2016.10.105
   Mirzazadeh M, 2015, NONLINEAR DYNAM, V81, P277, DOI 10.1007/s11071-015-1989-1
   Savescu M., 2015, J COMPUT THEOR NANOS, V12, P4667
   Sciberras LW, 2014, J NONLINEAR OPT PHYS, V23, DOI 10.1142/S0218863514500453
   Vega-Guzman J, 2017, NONLINEAR DYNAM, V87, P427, DOI 10.1007/s11071-016-3052-2
   Wazwaz AM, 2017, NONLINEAR DYNAM, V87, P1685, DOI 10.1007/s11071-016-3144-z
   Wazwaz AM, 2016, NONLINEAR DYNAM, V86, P1455, DOI 10.1007/s11071-016-2971-2
   Wazwaz AM, 2016, NONLINEAR DYNAM, V85, P731, DOI 10.1007/s11071-016-2718-0
   Wazwaz AM, 2016, NONLINEAR DYNAM, V84, P1107, DOI 10.1007/s11071-015-2555-6
   Wazwaz AM, 2016, NONLINEAR DYNAM, V83, P591, DOI 10.1007/s11071-015-2349-x
   Zayed EME, 2012, AIP CONF PROC, V1479, P2044, DOI 10.1063/1.4756591
NR 15
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0924-090X
EI 1573-269X
J9 NONLINEAR DYNAM
JI Nonlinear Dyn.
PD JUN
PY 2017
VL 88
IS 4
BP 2863
EP 2872
DI 10.1007/s11071-017-3416-2
PG 10
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA EW3LZ
UT WOS:000402399500037
OA No
DA 2017-08-17
ER

PT J
AU Wazwaz, AM
   El-Tantawy, SA
AF Wazwaz, Abdul-Majid
   El-Tantawy, S. A.
TI Solving the -dimensional KP-Boussinesq and BKP-Boussinesq equations by
   the simplified Hirota's method
SO NONLINEAR DYNAMICS
LA English
DT Article
DE Generalized KP equation; BKP equation; Boussinesq equation; Simplified
   Hirota's method
ID KADOMTSEV-PETVIASHVILI EQUATION; PARTIAL-DIFFERENTIAL-EQUATIONS; WAVE
   SOLUTIONS; SOLITONS
AB We study two (31)-dimensional generalized equations, namely the Kadomtsev-Petviashvili-Boussinesq equation and the B-type Kadomtsev-Petviashvili-Boussinesq equation. We use the simplified Hirota's method to conduct this study and to find the general phase shift of these equations. We obtain one- and two-soliton solutions, for each equation, with the coefficients of the three spatial variables are left as free parameters. However, we also develop special conditions on the coefficients of the spatial variables guarantee the existence of three-soliton solutions for each of these two equation.
C1 [Wazwaz, Abdul-Majid] St Xavier Univ, Dept Math, Chicago, IL 60655 USA.
   [El-Tantawy, S. A.] Port Said Univ, Dept Phys, Fac Sci, Port Said 42521, Egypt.
RP Wazwaz, AM (reprint author), St Xavier Univ, Dept Math, Chicago, IL 60655 USA.
EM wazwaz@sxu.edu
CR Baldwin D, 2006, J NONLINEAR MATH PHY, V13, P90, DOI 10.2991/jnmp.2006.13.1.8
   Biswas A, 2011, PHYS WAVE PHENOM, V19, P24, DOI 10.3103/S1541308X11010067
   Biswas A, 2011, NONLINEAR DYNAM, V63, P623, DOI 10.1007/s11071-010-9824-1
   Biswas A, 2010, NONLINEAR DYNAM, V59, P423, DOI 10.1007/s11071-009-9548-2
   Biswas A, 2009, NONLINEAR DYNAM, V58, P345, DOI 10.1007/s11071-009-9480-5
   El-Tantawy SA, 2015, PHYS SCRIPTA, V90, DOI 10.1088/0031-8949/90/8/085606
   El-Tantawy SA, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4879815
   Hereman W, 1997, MATH COMPUT SIMULAT, V43, P13, DOI 10.1016/S0378-4754(96)00053-5
   Hirota R., 2004, DIRECT METHOD SOLITO
   Kadomtsev B. B., 1970, Soviet Physics - Doklady, V15, P539
   Leblond H, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063835
   Leblond H, 2013, PHYS REP, V523, P61, DOI 10.1016/j.physrep.2012.10.006
   Ma WX, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/05/055003
   Ma WX, 2012, APPL MATH COMPUT, V218, P11871, DOI 10.1016/j.amc.2012.05.049
   Wazwaz AM, 2015, COMMUN THEOR PHYS, V63, P727, DOI 10.1088/0253-6102/63/6/727
   Wazwaz AM, 2007, APPL MATH COMPUT, V188, P1205, DOI 10.1016/j.amc.2006.10.075
   Wazwaz AM, 2016, NONLINEAR DYNAM, V84, P1107, DOI 10.1007/s11071-015-2555-6
   Wazwaz AM, 2016, NONLINEAR DYNAM, V83, P1529, DOI 10.1007/s11071-015-2427-0
   Wazwaz AM, 2016, NONLINEAR DYNAM, V83, P591, DOI 10.1007/s11071-015-2349-x
   Wazwaz AM, 2012, COMMUN NONLINEAR SCI, V17, P491, DOI 10.1016/j.cnsns.2011.05.025
   Wazwaz AM, 2011, PHYS SCRIPTA, V83, DOI 10.1088/0031-8949/83/03/035003
   Wazwaz AM, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/06/065006
   Wazwaz AM, 2004, APPL MATH COMPUT, V150, P365, DOI 10.1016/S0096-3003(03)00238-8
   Wazwaz AM, 2009, NONLINEAR PHYS SCI, P1, DOI 10.1007/978-3-642-00251-9
NR 24
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0924-090X
EI 1573-269X
J9 NONLINEAR DYNAM
JI Nonlinear Dyn.
PD JUN
PY 2017
VL 88
IS 4
BP 3017
EP 3021
DI 10.1007/s11071-017-3429-x
PG 5
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA EW3LZ
UT WOS:000402399500049
OA No
DA 2017-08-17
ER

PT J
AU Anwar, E
   Hamdy, G
   Taher, E
   Fawzy, E
   Abdulattif, S
   Attia, MH
AF Anwar, Enas
   Hamdy, Gehan
   Taher, Eman
   Fawzy, Esmat
   Abdulattif, Sherif
   Attia, Mohamed H.
TI Burden and Outcome of Vitamin D Deficiency Among Critically Ill
   Patients: A Prospective Study
SO NUTRITION IN CLINICAL PRACTICE
LA English
DT Article
DE vitamin D; mortality; hospital stay period; critically ill patients;
   vitamin D deficiency; critical illness; length of stay; intensive care
   units
ID INTENSIVE-CARE-UNIT; MORTALITY; PEOPLE; COMMON; RISK
AB Background: Vitamin D deficiency is a prevalent condition among critically ill patients. Information about the relationship between vitamin D levels and outcomes in the intensive care unit (ICU) is sparse. Purpose: To evaluate vitamin D status among critically ill patients and its relevance to severity of illness, ICU stay period, and mortality. Methods: This prospective multicenter study was conducted in the ICUs of Fayoum, Cairo, Alazhar, and Ain Shams university hospitals. All patients were subjected to interview questionnaire, laboratory investigation, vitamin D level assessment, and severity of illness evaluation using the Acute Physiologic Assessment and Chronic Health Evaluation II (APACHE II) score. Results: In total, 250 patients were included in the study. The median age was 62 (40-73) years, and most patients were male (52%). The median serum level of vitamin D was 19 (7-40.6). Vitamin D was deficient in 197 patients (78.8%) on admission. While we grouped the ICU patients as vitamin D deficient, insufficient, and sufficient, vitamin D-deficient patients had more severe diseases (mean APACHE II score, 44 +/- 15; P = .014). Prolonged ICU stay was observed among the deficient group but with no significant association. The overall mortality rate was 6.8%; of these, 70.5% were vitamin D-deficient patients. However, logistic regression analysis demonstrated that vitamin D deficiency was not an independent risk factor for mortality. Conclusion: Vitamin D insufficiency is common in critically ill patients (69%); it is associated with more severity of illness, but it is not an independent risk factor for longer ICU stay or mortality.
C1 [Anwar, Enas] Fayoum Univ, Internal Med Dept, Fac Med, Al Fayyum, Egypt.
   [Hamdy, Gehan] Cairo Univ, Internal Med Dept, Fac Med, Cairo, Egypt.
   [Taher, Eman] Cairo Univ, Community Dept, Fac Med, Cairo, Egypt.
   [Fawzy, Esmat] Zagazig Univ, Clin & Chem Pathol Dept, Fac Med, Zagazig, Egypt.
   [Abdulattif, Sherif] Al Azhar Univ, Anesthesia & ICU Dept, Fac Med, Cairo, Egypt.
   [Attia, Mohamed H.] Ain Shams Univ, Internal Med Dept, Fac Med, Cairo, Egypt.
RP Hamdy, G (reprint author), Cairo Univ, Internal Med Dept, Fac Med, 100 Hay Al Ashgar Compound 6th October City, Giza, Egypt.
EM gegehamdy@gmail.com
CR Abuannadi M, 2011, PRIM CARE CARDIOVASC, V4, P59
   Arnosy Y, 2012, Q J MED, V105, P633
   Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730
   Aygencel G, 2013, CRIT CARE RES PRACT, V2013
   Azim Afzal, 2013, J Intensive Care, V1, P14, DOI 10.1186/2052-0492-1-14
   Bjelakovic G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub2
   Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf
   Brock K, 2004, J STEROID BIOCHEM, V89-90, P581, DOI 10.1016/j.jsbmb.2004.03.073
   Cecchi A, 2011, MINERVA ANESTESIOL, V77, P1184
   Danescu LG, 2009, ENDOCRINE, V35, P11, DOI 10.1007/s12020-008-9115-5
   EISMAN JA, 1979, LANCET, V2, P1335
   Fiscella K, 2010, ANN FAM MED, V8, P11, DOI 10.1370/afm.1035
   Garland CF, 2006, INT J EPIDEMIOL, V35, P220, DOI 10.1093/ije/dyi230
   Ginde AA, 2011, ACAD EMERG MED, V18, P550, DOI 10.1111/j.1553-2712.2011.01047.x
   Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174
   Hirani V, 2005, AGE AGEING, V34, P485, DOI 10.1093/ageing/afi153
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Institute of Medicine Food and Nutrition Board, 2010, DIETARY REFERENCE IN
   Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28
   Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033
   Khadilkar VV, 2013, INDIAN J PEDIATR, V80, P215, DOI 10.1007/s12098-012-0877-7
   Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x
   Lee P, 2009, NEW ENGL J MED, V360, P1912, DOI 10.1056/NEJMc0809996
   Long-Xiang SU, 2013, CHIN MED J, V126, P2725
   Lucidarme O, 2010, INTENS CARE MED, V36, P1609, DOI 10.1007/s00134-010-1875-8
   McKinney JD, 2011, J AM MED DIR ASSOC, V12, P208, DOI 10.1016/j.jamda.2010.04.004
   Nair P, 2013, INTENS CARE MED, V39, P267, DOI 10.1007/s00134-012-2713-y
   Nair P, 2012, CRIT CARE RESUSC, V14, P268
   Sambrook PN, 2002, MED J AUSTRALIA, V176, P560
   Theodoratou E, 2014, BMJ-BRIT MED J, V348, P1
   Toner CD, 2010, J AM DIET ASSOC, V110, P1492, DOI 10.1016/j.jada.2010.07.007
   Van den Berghe G, 2003, J CLIN ENDOCR METAB, V88, P4623, DOI 10.1210/jc.2003-030358
   Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585
   Vieth R, 2001, EUR J CLIN NUTR, V55, P1091, DOI 10.1038/sj.ejcn.1601275
   Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204
   Zittermann A, 2009, CURR OPIN CLIN NUTR, V12, P634, DOI 10.1097/MCO.0b013e3283310767
   Zivin JR, 2001, AM J KIDNEY DIS, V37, P689
NR 38
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0884-5336
EI 1941-2452
J9 NUTR CLIN PRACT
JI Nutr. Clin. Pract.
PD JUN
PY 2017
VL 32
IS 3
BP 378
EP 384
DI 10.1177/0884533616671741
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EV8XX
UT WOS:000402069100010
PM 28537519
OA No
DA 2017-08-17
ER

PT J
AU El Saiedi, S
   Behairy, NH
   Kharabish, A
   Esmail, R
   Seliem, ZS
   Shafik, M
   El Mozy, W
AF El Saiedi, Sonia
   Behairy, Noha Hossam
   Kharabish, Ahmed
   Esmail, Reem
   Seliem, Zeinab Salah
   Shafik, Mervat
   El Mozy, Wesam
TI Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy:
   Correlation with LV Function, Echocardiography, and Demographic
   Parameters
SO PEDIATRIC CARDIOLOGY
LA English
DT Article
DE Hypertrophic cardiomyopathy; LV function; Delayed enhancement; Cardiac
   magnetic resonance
ID CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT;
   NONSUSTAINED VENTRICULAR-TACHYCARDIA; PROGNOSTIC-SIGNIFICANCE;
   CLINICAL-SIGNIFICANCE; RISK STRATIFICATION; DIAGNOSIS; ARRHYTHMIAS;
   PREVALENCE; FIBROSIS
AB Our aim was (1) to detect the presence of fibrosis by Cardiac magnetic resonance imaging (CMR) in the pediatric age group. (2) Correlate CMR findings with demographic data, LV function, and other echocardiographic parameters. We studied 40 pediatric patients diagnosed as HCM by echocardiography. All patients were subjected to clinical examination (in which the NYHA classification was determined for each patient), echocardiography, and CMR. CMR was done on a 1.5T Philips Achieva scanner in SSFP with delayed myocardial enhancement (DE-MRI). All demographic and functional parameters as well as pressure gradient across left ventricular outflow tract (LVOT) were correlated with the percentage of myocardial enhancement. We studied 13 female and 27 male patients from 45 days up to 18 years. The mean percentage of DE-MRI was 9.7 +/- 9%. We found significant correlation between the NYHA classification and the pressure gradient across the LVOT (P = < 0.001) as well as the percentage of DE-MRI (P = 0.004). The percentage of DE-MRI showed positive correlation with LV myocardial mass index (P = 0.042). It didn't correlate with any other demographic or LV functional cardiac parameters. A good positive correlation was detected between the percentage of DE-MRI and the severity of pressure gradient across LVOT measured by echocardiography (r = 0.69 and P = < 0.001). We found a significant correlation between the percentage of DE-MRI in children with HCM and the pressure gradient across LVOT, NYHA classification, and LV myocardial mass. This may help in the further management of those patients, planning for follow-up, and prognosis of the disease.
C1 [El Saiedi, Sonia; Behairy, Noha Hossam; Kharabish, Ahmed; Esmail, Reem; Seliem, Zeinab Salah; Shafik, Mervat; El Mozy, Wesam] Cairo Univ, Kasr El Aini Hosp, Giza, Egypt.
RP Behairy, NH (reprint author), Cairo Univ, Kasr El Aini Hosp, Giza, Egypt.
EM myheartclinic@windowslive.com; nohabehairy@gmail.com;
   ahmedkharabish@hotmail.com; esmail_reem@yahoo.com;
   zeinabsalah14@yahoo.com; mervatshafik@gmail.com; wesozy@gmail.com
CR Adabag AS, 2005, J AM COLL CARDIOL, V45, P697, DOI 10.1016/j.jacc.2004.11.043
   Aryana A, 2007, CIRCULATION, V115, P1191, DOI 10.1161/CIRCULATIONAHA.106.672162
   Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5
   Colan SD, 2007, CIRCULATION, V115, P773, DOI 10.1161/CIRCULATIONAHA.106.621185
   The Criteria Committee for the New York Heart Association, 1994, NOM CRIT DIAGN DIS H, P253
   Dimitrow PP, 2008, INT J CARDIOVAS IMAG, V24, P77, DOI 10.1007/s10554-007-9209-9
   Dumont CA, 2007, REV ESP CARDIOL, V60, P15, DOI 10.1157/13097921
   Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7
   Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284
   El-Saiedi SA, 2013, CARDIOL YOUNG, V29, P1
   Gerdts E, 2002, J HYPERTENS, V20, P1223, DOI 10.1097/00004872-200206000-00037
   Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011
   Hansen MW, 2007, AM J ROENTGENOL, V189, P1344, DOI 10.2214/AJR.07.2287
   Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500
   Hudsmith LE, 2008, NAT CLIN PRACT CARD, V5, pS49, DOI 10.1038/ncpcardio1158
   Kwon DH, 2009, J AM COLL CARDIOL, V54, P242, DOI 10.1016/j.jacc.2009.04.026
   Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258
   Maron MS, 2007, AM J CARDIOL, V100, P1293, DOI 10.1016/j.amjcard.2007.05.061
   Maron MS, 2008, CIRC-HEART FAIL, V1, P184, DOI 10.1161/CIRCHEARTFAILURE.108.768119
   Maron MS, 2009, J AM COLL CARDIOL, V54, P220, DOI 10.1016/j.jacc.2009.05.006
   Mavrogeni S, 2013, EUR HEART J-CARD IMG, V14, P518, DOI 10.1093/ehjci/jes302
   Monserrat L, 2003, J AM COLL CARDIOL, V42, P873, DOI 10.1016/S0735-1097(03)00827-1
   Moon JC, 2005, HEART, V91, P1036, DOI 10.1136/hrt.2004.041384
   Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035
   Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X
   Nazarian S, 2008, J AM COLL CARDIOL, V51, P1375, DOI 10.1016/j.jacc.2008.01.010
   Noureldin RA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-17
   O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010
   Rickers C, 2005, CIRCULATION, V112, P855, DOI 10.1161/CIRCULATIONAHA.104.507723
   Rubinshtein R, 2010, CIRC-HEART FAIL, V3, P51, DOI 10.1161/CIRCHEARTFAILURE.109.854026
   Sipola P, 2005, RADIOLOGY, V236, P815, DOI 10.1148/radiol.2363041165
   Teraoka K, 2004, MAGN RESON IMAGING, V22, P155, DOI 10.1016/j.mri.2003.08.009
   Wilson JM, 2002, TEX HEART I J, V29, P176
NR 33
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0172-0643
EI 1432-1971
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD JUN
PY 2017
VL 38
IS 5
BP 1024
EP 1031
DI 10.1007/s00246-017-1612-y
PG 8
WC Cardiac & Cardiovascular Systems; Pediatrics
SC Cardiovascular System & Cardiology; Pediatrics
GA EW3MV
UT WOS:000402402600019
PM 28401251
OA No
DA 2017-08-17
ER

PT J
AU Badr, A
   El-Shazly, HH
   Ahmed, HIS
   Hamouda, M
   El-Khateeb, E
   Sakr, M
AF Badr, Abdelfattah
   El-Shazly, Hanaa H.
   Ahmed, Hanan I. Sayed
   Hamouda, Marwa
   El-Khateeb, Eman
   Sakr, Mahmoud
TI Genetic diversity of Achillea fragrantissima in Egypt inferred from
   phenotypic variations and ISSR markers associated with traits of plant
   size and seed yield
SO PLANT GENETIC RESOURCES-CHARACTERIZATION AND UTILIZATION
LA English
DT Article
DE Achillea fragrantissima; conservation; genetic diversity; ISSR markers
ID DIFFERENT REGIONS; ESSENTIAL OIL; POPULATIONS; JORDAN
AB Substantial variation in phenotypic traits and ISSR fingerprinting was observed among twenty populations of Achillea fragrantissima (Forssk.) Sch. Bip. in Egypt. Such variation was reflected in the clustering of the examined populations into two major groups: one representing populations in the mountainous area of South Sinai and the other comprising populations growing at low elevations in the middle of Sinai and the desert west of the Suez Canal from Suez in the east to Cairo in the west. Five populations in the eastern part of Sinai near Nuwieba and Taba on the Gulf of Aqaba were loosely assigned to the first group. The populations growing at high elevations in South Sinai, under lower temperature and higher humidity, were characterized by a higher number of total and polymorphic ISSR markers compared with other populations. Unique ISSR markers were more often observed in the fingerprinting of seven populations including five populations growing in the high mountains of Saint Catherine in South Sinai and two populations growing at low elevations but at Wadi Hof south-east of Cairo. Interestingly, unique bands were found in the populations that possessed traits associated with larger plant size and seed yield as well as better vigour. These are important criteria for the selection of A. fragrantissima populations for conservation and sustainable commercial use.
C1 [Badr, Abdelfattah] Helwan Univ, Fac Sci, Bot & Microbiol Dept, Cairo 11790, Egypt.
   [El-Shazly, Hanaa H.] Ain Shams Univ, Biol & Geol Sci Dept, Fac Educ, Cairo 11341, Egypt.
   [Ahmed, Hanan I. Sayed; Hamouda, Marwa; El-Khateeb, Eman] Tanta Univ, Bot Dept, Fac Sci, Tanta 31527, Egypt.
   [Sakr, Mahmoud] Natl Res Ctr, Genet Engn & Biotechnol Div, Giza, Egypt.
RP Badr, A (reprint author), Helwan Univ, Fac Sci, Bot & Microbiol Dept, Cairo 11790, Egypt.
EM abdelfattahbadr@yahoo.com
FU Science and Technology Development Fund of Egypt through 'Development of
   reference genetic fingerprints, and biotechnology-based production of
   pharmaceutically bioactive substances of some threatened Egyptian
   medicinal plants' [4218]
FX The authors are grateful to the Science and Technology Development Fund
   of Egypt for supporting this work through funding the Project ID 4218
   'Development of reference genetic fingerprints, and biotechnology-based
   production of pharmaceutically bioactive substances of some threatened
   Egyptian medicinal plants'.
CR Sayed Ahmed HI, 2012, EGYPTIAN J EXPT BIOL, V8, P315
   Atayat A, 1993, MED PLANTS ENCY PHAR
   Ayyad MA, 2003, J ARID ENVIRON, V54, P165, DOI 10.1006/jare.2001.0881
   Badr A, 2014, TAECKHOLMIA, V34, P49
   Badr A, 2014, RECENT PROGR MED PLA, V39, P317
   BAREL S, 1991, J ETHNOPHARMACOL, V33, P187, DOI 10.1016/0378-8741(91)90177-F
   BAREL S, 1989, CURR MICROBIOL, V19, P337, DOI 10.1007/BF01570878
   Batanouny KH, 1999, WILD MED PLANTS EGYP
   BEUSELINCK PR, 1992, FIELD CROP RES, V29, P261, DOI 10.1016/0378-4290(92)90029-9
   Boulos L., 1983, MED PLANTS N AFRICA
   Boulos L, 2002, FLORA EGYPT, V3
   Edwards R, 2004, NEW SCI, V181, P10
   Farnsworth NR, 1991, CONSERVATION MED PLA, P25, DOI 10.1017/CBO9780511753312.005
   Fufa H, 2005, EUPHYTICA, V145, P133, DOI 10.1007/s10681-005-0626-3
   Gharibi S, 2011, J MED PLANTS RES, V5, P2413
   Godwin ID, 1997, ELECTROPHORESIS, V18, P1524, DOI 10.1002/elps.1150180906
   GUREVITCH J, 1992, GENETICS, V130, P385
   Hamrick J. L., 1996, P281
   Kalpana J, 2004, CURR SCI, V87, P159
   Legendre L, 1983, NUMERICAL ECOLOGY
   Morsy A. A., 2007, International Journal of Agriculture and Biology, V9, P11
   Rahimmalek M, 2009, BIOCHEM SYST ECOL, V37, P354, DOI 10.1016/j.bse.2009.06.002
   Rawashdeh I. M., 2011, Jordan Journal of Biological Sciences (JJBS), V4, P21
   Rawashdeh Ibrahim M., 2009, Crop Research (Hisar), V37, P242
   Rohlf FJ, 2005, NTSYSPC NUMERICAL TA
   SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   Seaby R, 2007, COMMUNITY ANAL PACKA
   Sokal R. R., 1958, U KANS SCI B, V28, P1409
   Soltan MM, 2009, J ETHNOPHARMACOL, V126, P102, DOI 10.1016/j.jep.2009.08.001
   Tharachand C., 2012, Research in Plant Biology, V2, P1
   WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967
   YANIV Z, 1987, J ETHNOPHARMACOL, V19, P145, DOI 10.1016/0378-8741(87)90038-9
   ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151
NR 34
TC 0
Z9 0
U1 2
U2 2
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 1479-2621
EI 1479-263X
J9 PLANT GENET RESOUR-C
JI Plant Genet. Resour.-Charact. Util.
PD JUN
PY 2017
VL 15
IS 3
BP 239
EP 247
DI 10.1017/S1479262115000568
PG 9
WC Plant Sciences; Genetics & Heredity
SC Plant Sciences; Genetics & Heredity
GA EW0AK
UT WOS:000402150000005
OA No
DA 2017-08-17
ER

PT J
AU Yakout, SM
AF Yakout, Sobhy M.
TI Physicochemical Characteristics of Biochar Produced from Rice Straw at
   Different Pyrolysis Temperature for Soil Amendment and Removal of
   Organics
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES INDIA SECTION A-PHYSICAL
   SCIENCES
LA English
DT Article
DE Pyrolysis; Biochar; Rice straw; Characterization; Soil amendment
ID ACTIVATED CARBONS; AGRICULTURAL RESIDUES; ADSORPTION PROPERTIES; SLOW
   PYROLYSIS; CORN STOVER; BIO-CHAR; OIL; GASIFICATION; SYSTEMS; WASTE
AB In this paper, rice straw was pyrolyzed at three temperatures (400, 500 and 600 degrees C) to study its influence on biochars properties and its chemical composition as soil amendment. Elemental analysis, surface area, pore size distributions, Fourier transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD) were used in the characterization of resultant biochar. As pyrolysis temperature increased, ash content, yield, acidity, total hydrogen and oxygen contents decreased while total carbon, nitrogen and basicity decreased by the reason of pyrolytic volatilization through pyrolysis. Surface area, total pore, micropore and mesopore volume reach its maximum at pyrolysis temperature of 500 degrees C in biochar-500. Biochars exhibit wide particle size distribution, from narrow micropores (<0.7 nm) to wide mesopores (>2.0 nm). One sharp peaks was obtained at about 1.0-1.5 nm in the case of micropore region and two broad peaks at about 3.0 and 5.0 nm in mesopore region. FTIR spectra exhibited that high pyrolysis temperatures induce condensation reactions, which leads to aromaticity increasing and decreasing of biochar polarity. With increasing of pyrolysis temperature, cellulose loss and minerals contents increased, as showed by XRD analysis. Results recommend that high pyrolysis temperature give biochar with higher carbon sequestration potential characteristics when applied as soil amendment. Rice-based biochars gave high adsorption capacity for various molecular sizes like phenol, iodine and methylene blue. Biochars acidity/alkalinity and hydrophilicity represents one of the most important property that affecting their solution adsorption behavior.
C1 [Yakout, Sobhy M.] King Saud Univ, Coll Sci, Biochem Dept, POB 2455, Riyadh 11451, Saudi Arabia.
   [Yakout, Sobhy M.] Atom Energy Author, Hot Labs Ctr, Cairo 13759, Egypt.
RP Yakout, SM (reprint author), King Saud Univ, Coll Sci, Biochem Dept, POB 2455, Riyadh 11451, Saudi Arabia.; Yakout, SM (reprint author), Atom Energy Author, Hot Labs Ctr, Cairo 13759, Egypt.
EM sobhy.yacoot@gmail.com
FU Deanship of Scientific Research at King Saud University [RGP-184]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at King Saud University for funding of
   this research through the Research Group Project No RGP-184.
CR Abdullah H, 2009, ENERG FUEL, V23, P4174, DOI 10.1021/ef900494t
   Adel AM, 2013, ENV SCI, V8, P315
   Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071
   Al-Wabel MI, 2013, BIORESOURCE TECHNOL, V131, P374, DOI 10.1016/j.biortech.2012.12.165
   Angin D, 2013, BIORESOURCE TECHNOL, V128, P593, DOI 10.1016/j.biortech.2012.10.150
   Aygun A, 2003, MICROPOR MESOPOR MAT, V66, P189, DOI 10.1016/j.micromeso.2003.08.028
   Bansal R.C., 1988, ACTIVE CARBON
   BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0
   Brewer CE, 2009, ENVIRON PROG SUSTAIN, V28, P386, DOI 10.1002/ep.10378
   Calvelo P. R., 2011, ORG GEOCHEM, V42, P1331, DOI DOI 10.1016/J.0RGGE0CHEM.2011.09.002
   Chen BL, 2011, BIORESOURCE TECHNOL, V102, P716, DOI 10.1016/j.biortech.2010.08.067
   Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w
   Cox M, 1999, J CHEM TECHNOL BIOT, V74, P1019, DOI 10.1002/(SICI)1097-4660(199911)74:11<1019::AID-JCTB152>3.3.CO;2-E
   Cuiping L., 2004, BIOMASS BIOENERG, V27, P119, DOI DOI 10.1016/J.BI0MBI0E.2004.01.002
   D4607- 94 A, 1999, D460794 ASTM
   Demirbas A, 2004, J ANAL APPL PYROL, V72, P243, DOI 10.1016/j.jaap.2004.07.003
   Downie A., 2009, BIOCHAR ENV MANAGEME, P13
   Fu P, 2011, BIORESOURCE TECHNOL, V102, P8211, DOI 10.1016/j.biortech.2011.05.083
   Gaskin JW, 2008, T ASABE, V51, P2061
   GERGOVA K, 1994, CARBON, V32, P693, DOI 10.1016/0008-6223(94)90091-4
   Girgis BS, 2002, MATER LETT, V57, P164, DOI 10.1016/S0167-577X(02)00724-3
   Heo HS, 2010, BIORESOURCE TECHNOL, V101, P3672, DOI 10.1016/j.biortech.2009.12.078
   Inyang M, 2010, BIORESOURCE TECHNOL, V101, P8868, DOI 10.1016/j.biortech.2010.06.088
   Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419
   Kun-yu Z., 2008, NONFERROUS MET SOC C, V18, P1285
   Laird DA, 2009, BIOFUEL BIOPROD BIOR, V3, P547, DOI 10.1002/bbb.169
   Lehmann J, 2009, BIOCHAR ENV MANAGEME
   Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022
   Meyer S, 2011, ENVIRON SCI TECHNOL, V45, P9473, DOI 10.1021/es201792c
   MOLINASABIO M, 1985, CARBON, V23, P91, DOI 10.1016/0008-6223(85)90202-7
   MORA GP, 1994, J BIOMED MATER RES, V28, P189, DOI 10.1002/jbm.820280208
   Moreno-Castilla C, 2000, CARBON, V38, P1995, DOI 10.1016/S0008-6223(00)00048-8
   Muradov N, 2012, BIOMASS BIOENERG, V42, P123, DOI 10.1016/j.biombioe.2012.03.003
   Novak J. M., 2009, Annals of Environmental Science, V3, P195
   Peterson SC, 2014, IND CROP PROD, V53, P228, DOI 10.1016/j.indcrop.2013.12.028
   Pradhan BK, 1999, CARBON, V37, P1323, DOI 10.1016/S0008-6223(98)00328-5
   Puziy AM, 2003, CARBON, V41, P1181, DOI 10.1016/S0008-6223(03)00031-9
   Ronsse F, 2013, GCB BIOENERGY, V5, P104, DOI 10.1111/gcbb.12018
   Shackley S, 2012, ENERG POLICY, V42, P49, DOI 10.1016/j.enpol.2011.11.026
   Shah A, 2012, BIORESOURCE TECHNOL, V125, P348, DOI 10.1016/j.biortech.2012.09.061
   Shawabkeh RA, 2004, MICROPOR MESOPOR MAT, V75, P107, DOI 10.1016/j.micromeso.2004.07.020
   Shim JW, 2001, CARBON, V39, P1635, DOI 10.1016/S0008-6223(00)00290-6
   Song WP, 2012, J ANAL APPL PYROL, V94, P138, DOI 10.1016/j.jaap.2011.11.018
   Stuart B., 1996, MODERN INFRARED SPEC
   Thangalazhy-Gopakumar S, 2010, BIORESOURCE TECHNOL, V101, P8389, DOI 10.1016/j.biortech.2010.05.040
   Tsatou P., 2002, J HAZARD MAT B, V91, P187
   Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x
   Wu WX, 2012, BIOMASS BIOENERG, V47, P268, DOI 10.1016/j.biombioe.2012.09.034
   Yakout SM, 2015, ENVIRON ENG MANAG J, V14, P473
   Yang HP, 2004, ENERG FUEL, V18, P1814, DOI 10.1021/ef030193m
   Yenisoy-Karakas S, 2004, CARBON, V42, P477, DOI 10.1016/j.carbon.2003.11.019
   Yun CH, 2001, CARBON, V39, P559, DOI 10.1016/S0008-6223(00)00163-9
   2012, J ANAL APPL PYROL, V96, P24, DOI DOI 10.1016/J.JAAP.2012.02.016
NR 53
TC 0
Z9 0
U1 16
U2 16
PU NATL ACAD SCIENCES INDIA
PI ALLAHABAD
PA 5 LAJPATRAI RD, ALLAHABAD 211002, INDIA
SN 0369-8203
EI 2250-1762
J9 P NATL A SCI INDIA A
JI Proc. Nat. Acad. Sci. India A
PD JUN
PY 2017
VL 87
IS 2
BP 207
EP 214
DI 10.1007/s40010-017-0343-z
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV9EL
UT WOS:000402088100006
OA No
DA 2017-08-17
ER

PT J
AU Abubakar, MY
   Jung, LT
   Zakaria, N
   Younes, A
   Abdel-Aty, AH
AF Abubakar, Mustapha Y.
   Jung, Low Tang
   Zakaria, Nordin
   Younes, Ahmed
   Abdel-Aty, Abdel-Haleem
TI Reversible circuit synthesis by genetic programming using dynamic gate
   libraries
SO QUANTUM INFORMATION PROCESSING
LA English
DT Article
DE Reversible circuits; Gate library; Quantum circuit; Optimization
ID BOOLEAN FUNCTIONS; QUANTUM CIRCUITS; LOGIC SYNTHESIS; ALGORITHM;
   OPTIMIZATION; SIMPLIFICATION; NETWORKS; COST; SET
AB We have defined a new method for automatic construction of reversible logic circuits by using the genetic programming approach. The choice of the gate library is 100% dynamic. The algorithm is capable of accepting all possible combinations of the following gate types: NOT TOFFOLI, NOT PERES, NOT CNOT TOFFOLI, NOT CNOT SWAP FREDKIN, NOT CNOT TOFFOLI SWAP FREDKIN, NOT CNOT PERES, NOT CNOT SWAP FREDKIN PERES, NOT CNOT TOFFOLI PERES and NOT CNOT TOFFOLI SWAP FREDKIN PERES. Our method produced near optimum circuits in some cases when a particular subset of gate types was used in the library. Meanwhile, in some cases, optimal circuits were produced due to the heuristic nature of the algorithm. We compared the outcomes of our method with several existing synthesis methods, and it was shown that our algorithm performed relatively well compared to the previous synthesis methods in terms of the output efficiency of the algorithm and execution time as well.
C1 [Abubakar, Mustapha Y.; Jung, Low Tang; Zakaria, Nordin] Univ Teknol PETRONAS, Comp & Informat Sci Dept, Seri Iskandar 32610, Perak, Malaysia.
   [Abubakar, Mustapha Y.] Kano State Polytech, Dept Comp Sci, Sch Technol, Kano, Nigeria.
   [Younes, Ahmed] Alexandria Univ, Math & Comp Sci, Alexandria, Egypt.
   [Abdel-Aty, Abdel-Haleem] Al Azhar Univ, Dept Phys, Fac Sci, Asyut, Egypt.
RP Abdel-Aty, AH (reprint author), Al Azhar Univ, Dept Phys, Fac Sci, Asyut, Egypt.
EM mygawuna@gmail.com; lowtanjung@petronas.com.my;
   nordinzakaria@petronas.com.my; ayounes2@yahoo.com; halimaty@gmail.com
CR Al-Rabadi A.N., 2012, REVERSIBLE LOGIC SYN
   Amy M, 2014, IEEE T COMPUT AID D, V33, P1476, DOI 10.1109/TCAD.2014.2341953
   Amy M, 2013, IEEE T COMPUT AID D, V32, P818, DOI 10.1109/TCAD.2013.2244643
   Arabzadeh M., 2010, P AS S PAC DES AUT C, P849
   Arabzadeh M, 2013, QUANTUM INF PROCESS, V12, P1677, DOI 10.1007/s11128-012-0482-8
   Athas W. C., 1994, Proceedings. Workshop on Physics and Computation PhysComp '94, P111, DOI 10.1109/PHYCMP.1994.363692
   Bahauddin S. M., 2012, J QUANTUM INFORM SCI, V2, P61
   BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457
   Bautu A, 2007, ROM J PHYS, V52, P697
   De Vos A, 2006, J PHYS A-MATH GEN, V39, P5015, DOI 10.1088/0305-4470/39/18/017
   De Vos A, 2000, LECT NOTES COMPUT SC, V1918, P255
   De Vos A, 1999, PROG QUANT ELECTRON, V23, P1, DOI 10.1016/S0079-6727(99)00002-6
   Dmitri M., 2016, REVERSIBLE LOGIC SYN
   Donald J, 2008, ACM J EMERG TECH COM, V4, DOI 10.1145/1330521.1330523
   Fazel K., 2007, IEEE PAC RIM C COMM, P206
   Fredkin E., 2002, CONSERVATIVE LOGIC
   GAP Groups, 2016, ALG PROGR VERS 4 8 3
   Golubitsky O, 2012, IEEE T COMPUT, V61, P1341, DOI 10.1109/TC.2011.144
   Grobe D., 2007, P 17 ACM GREAT LAK S, P96
   Gupta P, 2006, IEEE T COMPUT AID D, V25, P2317, DOI 10.1109/TCAD.2006.871622
   Hawash M.M., 2013, THESIS
   Hirata Y, 2011, QUANTUM INF COMPUT, V11, P142
   Hung WNN, 2006, IEEE T COMPUT AID D, V25, P1652, DOI 10.1109/TCAD.2005.858352
   Kameyama M., 2011, ARXIV11073383
   Kerntopf P, 2004, DES AUT CON, P834, DOI 10.1145/996566.996789
   Li M, 2010, DES AUT TEST EUROPE, P307
   Lukac M, 2002, 2002 NASA/DOD CONFERENCE ON EVOLABLE HARDWARE, PROCEEDINGS, P177, DOI 10.1109/EH.2002.1029883
   Lukac M., 2002, P 5 INT WORKSH BOOL
   Mamun M., 2014, ARXIV14077098
   Markov K.N.P.I.L., 2008, QUANTUM INF COMPUT, V8
   Maslov D, 2007, IET COMPUT DIGIT TEC, V1, P98, DOI 10.1049/iet-cdt:20060070
   Maslov D, 2005, DES AUT TEST EUROPE, P1208, DOI 10.1109/DATE.2005.249
   Maslov D, 2005, IEEE T VLSI SYST, V13, P765, DOI 10.1109/TVLSI.2005.844284
   Maslov D, 2007, ACM T DES AUTOMAT EL, V12, DOI 10.1145/1278349.1278355
   Maslov D., 2016, REVERSIBLE LOGIC SYN
   Maslov D., 2003, ICCAD, P256, DOI DOI 10.1109/ICCAD.2003.73
   Maslov D, 2008, IEEE T COMPUT AID D, V27, P436, DOI 10.1109/TCAD.2007.911334
   Maslov D, 2011, IEEE T COMPUT AID D, V30, P806, DOI 10.1109/TCAD.2011.2105555
   Miller DM, 2003, DES AUT CON, P318
   Mukhanov OA, 2011, IEEE T APPL SUPERCON, V21, P760, DOI 10.1109/TASC.2010.2096792
   Nagamani AN, 2016, J ELECTRON TEST, V32, P175, DOI 10.1007/s10836-016-5574-4
   Nielsen M. A., 2000, QUANTUM COMPUTATION
   Perkowski M., 2001, P RM 2001 STARKV, P119
   Prasad A. K., 2006, ACM J EMERG TECH COM, V2, P277, DOI 10.1145/1216396.1216399
   RAYNER MR, 1995, J PHYS A-MATH GEN, V28, P5623, DOI 10.1088/0305-4470/28/19/016
   Rubinstein B.I., 2001, EV COMP P 2001 C, V1, P144
   Ruican C, 2009, IEEE C EVOL COMPUTAT, P896, DOI 10.1109/CEC.2009.4983040
   Saeedi M., 2008, P AS S PAC DES AUT C, P83
   Saeedi M., 2010, JETC, V6, P13
   Saeedi M, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431220
   Saeedi M, 2010, MICROELECTRON J, V41, P185, DOI 10.1016/j.mejo.2010.02.002
   Sasamal TN, 2015, PROCEDIA COMPUT SCI, V70, P407, DOI 10.1016/j.procs.2015.10.054
   Sasanian Z, 2012, DES AUT CON, P36
   Shende VV, 2002, IEEE/ACM INTERNATIONAL CONFERENCE ON CAD-02, DIGEST OF TECHNICAL PAPERS, P353, DOI 10.1109/ICCAD.2002.1167558
   Shende VV, 2003, IEEE T COMPUT AID D, V22, P710, DOI 10.1109/TCAD.2003.811448
   Spector L., 2006, AUTOMATIC QUANTUM CO, V7
   Storme L., 1999, J UNIVERS COMPUT SCI, V5, P307
   Szyprowski M., 2011, ARXIV11055831
   Toffoli T, 1980, REVERSIBLE COMPUTING
   Vatan F, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032315
   Wille R., 2008, DESIGN AUTOMATION TE, P1015
   Wille Robert, 2010, ARXIV10044609
   Wille R, 2009, DES AUT CON, P270
   Wille R, 2009, I CONF VLSI DESIGN, P189, DOI 10.1109/VLSI.Design.2009.40
   Williams C.P., 1999, AUTOMATED DESIGN QUA
   Yabuki T., 2000, 2000 GEN EV COMP C, P421
   Yang GW, 2005, ASIA S PACIF DES AUT, P1002
   Ye YB, 1996, IEEE T CIRCUITS-I, V43, P769, DOI 10.1109/81.536746
   Younes A., 2015, APPL MATH INFORM SCI, V9, P2579
   Younes A, 2014, J CIRCUIT SYST COMP, V23, DOI 10.1142/S0218126614500406
   Younes A, 2010, J CIRCUIT SYST COMP, V19, P1423, DOI 10.1142/S0218126610006736
   Zakablukov D., 2015, ARXIV150704309
   Zakablukov D., 2015, ARXIV150406876
   Zakablukov D.V., 2014, PRIKL DISKRETN MAT, V2, P101
NR 74
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1570-0755
EI 1573-1332
J9 QUANTUM INF PROCESS
JI Quantum Inf. Process.
PD JUN
PY 2017
VL 16
IS 6
AR UNSP 160
DI 10.1007/s11128-017-1609-8
PG 24
WC Physics, Multidisciplinary; Physics, Mathematical
SC Physics
GA EV9IA
UT WOS:000402098500019
OA No
DA 2017-08-17
ER

PT J
AU Elbendary, A
   Xue, RZ
   Valdebran, M
   Torres, KMT
   Parikh, K
   Elattar, I
   Kwon, EJ
   Elston, DM
AF Elbendary, Amira
   Xue, Ruzeng
   Valdebran, Manuel
   Torres, Kara Melissa T.
   Parikh, Kruti
   Elattar, Inas
   Kwon, Eun Ji
   Elston, Dirk M.
TI Diagnostic Criteria in Intraepithelial Pagetoid Neoplasms: A
   Histopathologic Study and Evaluation of Select Features in Paget
   Disease, Bowen Disease, and Melanoma In Situ
SO AMERICAN JOURNAL OF DERMATOPATHOLOGY
LA English
DT Article
DE Paget disease; Bowen disease; melanoma in situ; pagetoid
ID EXTRAMAMMARY; MAMMARY
AB Background: Paget disease, Bowen disease, and malignant melanoma in situ are intraepidermal neoplasms, characterized by the presence of pagetoid scatter of atypical cells in the epidermis. This study reviewed the frequency of select histologic criteria to validate their usefulness in the histologic distinction between these entities.
   Methods: One hundred forty-four specimens with the diagnosis of Bowen disease, 144 specimens with Paget disease (mammary and extramammary), and 144 specimens with malignant melanoma in situ were examined microscopically to define frequencies of select histologic criteria present in each disease.
   Results: Comparison between mammary Paget and extramammary Paget disease showed no significant differences in the features studied. Crushing of basal keratinocytes, presence of atypical cells in the corneum, and presence of large cells with amphophilic cytoplasm were significantly noted in Paget disease. Transition between the atypical clear cells and surrounding keratinocytes was absent in all cases of melanoma in situ and in 87 (60.4%) cases of Paget disease, but it was significantly associated with Bowen disease (98.6%). Dyskeratotic cells were significantly associated with Bowen disease cases.
   Conclusion: Our study demonstrated a practical histologic approach to differentiate between intraepidermal pagetoid neoplasms. Careful histologic study of the proposed criteria may reduce reliance on immunohistochemical stains.
C1 [Elbendary, Amira] Cairo Univ, Dept Dermatol, Kasralainy Fac Med, Cairo, Egypt.
   [Xue, Ruzeng; Valdebran, Manuel; Torres, Kara Melissa T.] Ackerman Acad Dermatopathol, New York, NY USA.
   [Xue, Ruzeng] Southern Med Univ, Dermatol Hosp, Guangdong Prov Dermatol Hosp, Guangzhou, Guangdong, Peoples R China.
   [Valdebran, Manuel] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA.
   [Torres, Kara Melissa T.] Jose R Reyes Mem Med Ctr, Dept Dermatol, Manila, Philippines.
   [Parikh, Kruti] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA.
   [Elattar, Inas] Cairo Univ, Biostat, Dept Biostat & Epidemiol, Natl Canc Inst, Cairo, Egypt.
   [Kwon, Eun Ji] Dermpath Diagnost New York, Port Chester, NY USA.
   [Elston, Dirk M.] Med Univ South Carolina, Dept Dermatol & Dermatol Surg, MSC 578 135 Rutledge Ave,11th Floor, Charleston, SC 29425 USA.
RP Elston, DM (reprint author), Med Univ South Carolina, Dept Dermatol & Dermatol Surg, MSC 578 135 Rutledge Ave,11th Floor, Charleston, SC 29425 USA.
EM elstond@musc.edu
CR Bowen JT, 1912, J CUTAN DIS, V30, P241
   Calonje E, 2012, MCKEES PATHOLOGY SKI
   David E, 2008, LEVERS HISTOPATHOLOG
   FITZPATRICK JE, 1991, CLIN DERMATOL, V9, P255, DOI 10.1016/0738-081X(91)90015-D
   GUARNER J, 1989, AM J DERMATOPATH, V11, P313, DOI 10.1097/00000372-198908000-00004
   Kanitakis J, 2007, J EUR ACAD DERMATOL, V21, P581, DOI 10.1111/j.1468-3083.2007.02154.x
   Kim SA, 2011, ANN DERMATOL, V23, pS222, DOI 10.5021/ad.2011.23.S2.S222
   Matsumoto M, 2007, J CUTAN PATHOL, V34, P47, DOI 10.1111/j.1600-0560.2007.00732.x
   Quinn AM, 2004, ARCH PATHOL LAB MED, V128, P84
   Raiten K, 1976, J Dermatol Surg, V2, P24
   Raju RR, 2003, INT J GYNECOL PATHOL, V22, P127, DOI 10.1097/01.PGP.0000055171.04957.F4
   SITAKALIN C, 1985, AM J DERMATOPATH, V7, P335, DOI 10.1097/00000372-198508000-00004
   Weedon D, 2010, WEEDONS SKIN PATHOLO
NR 13
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0193-1091
EI 1533-0311
J9 AM J DERMATOPATH
JI Am. J. Dermatopathol.
PD JUN
PY 2017
VL 39
IS 6
BP 419
EP 427
PG 9
WC Dermatology
SC Dermatology
GA EV5LJ
UT WOS:000401807200003
PM 28525420
OA No
DA 2017-08-17
ER

PT J
AU Ghareb, N
   Elshihawy, HA
   Abdel-Daim, MM
   Helal, MA
AF Ghareb, Nagat
   Elshihawy, Hosam A.
   Abdel-Daim, Mohamed M.
   Helal, Mohamed A.
TI Novel pyrazoles and pyrazolo[1,2-a]pyridazines as selective COX-2
   inhibitors; Ultrasound-assisted synthesis, biological evaluation, and
   DFT calculations
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Pyrazole; Pyrazolo[1,2-a]pyridazine; COX-2; Anti-inflammatory;
   Ultrasound-assisted reactions; DFT calculations
ID CYCLOOXYGENASE-2 INHIBITORS; DERIVATIVES; AGENTS; IDENTIFICATION;
   ACTIVATION; MOLECULES; MECHANISM; ANALOGS; ASPIRIN
AB COX-2 is an inducible enzyme mediating inflammatory responses. Selective targeting of COX-2 is useful for developing anti-inflammatory agents devoid of ulcerogenic activity. Herein, we report the design and synthesis of a series of pyrazoles and pyrazolo[1,2-a]pyridazines with selective COX-2 inhibitory activity and in vivo anti-inflammatory effect. Both series were accessed through acid-catalyzed ultrasound assisted reactions. The most active compounds in this study are two novel molecules, 11 and 16, showing promising selectivity and decent IC50 of 16.2 and 20.1 nM, respectively. These compounds were also docked into the crystal structure of COX-2 enzyme (PDB ID: 3LN1) to understand their mode of binding. Finally, Mulliken charges and electrostatic surface potential were calculated for both compound 11 and celecoxib using DFT method to get insights into the molecular determinants of activity of this compound. These results could lead to the development of novel COX-2 inhibitors with improved selectivity. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Ghareb, Nagat; Elshihawy, Hosam A.] Suez Canal Univ, Fac Pharm, Pharmaceut Organ Chem Dept, Ismailia 41522, Egypt.
   [Abdel-Daim, Mohamed M.] Suez Canal Univ, Fac Vet Med, Pharmacol Dept, Ismailia 41522, Egypt.
   [Helal, Mohamed A.] Suez Canal Univ, Fac Pharm, Med Chem Dept, Ismailia 41522, Egypt.
RP Helal, MA (reprint author), Suez Canal Univ, Fac Pharm, Med Chem Dept, Ismailia 41522, Egypt.
EM mohamed_hilal@pharm.suez.edu.eg
CR Aal EHA, 2002, MONATSH CHEM, V133, P255
   Akama T, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3300127
   Almansa C, 2003, J MED CHEM, V46, P3463, DOI 10.1021/jm030765s
   Arunkumar S, 2009, E-J CHEM, V6, pS123
   Bannwarth B, 1999, PRESSE MED, V28, P1180
   Bekhit AA, 2008, EUR J MED CHEM, V43, P456, DOI 10.1016/j.ejmech.2007.03.030
   Beswick P, 2004, BIOORG MED CHEM LETT, V14, P5445, DOI 10.1016/j.bmcl.2004.07.089
   Black WC, 1999, J MED CHEM, V42, P1274, DOI 10.1021/jm980642l
   Bourass M, 2016, CHEM CENT J, V10, DOI 10.1186/s13065-016-0216-6
   Brubaker L, 2016, INT J SURG, V32, P158, DOI 10.1016/j.ijsu.2016.07.003
   Burdan F, 2009, FOLIA MORPHOL, V68, P59
   COLLIER HOJ, 1971, NATURE, V232, P17, DOI 10.1038/232017a0
   EI Sayed MA., 2011, BIOORGAN MED CHEM, V19, P3416
   Eren G, 2010, BIOORGAN MED CHEM, V18, P6367, DOI 10.1016/j.bmc.2010.07.009
   Fahmy HH, 2001, ARCH PHARM RES, V24, P180, DOI 10.1007/BF02978253
   Fahmy HH, 2001, ARCH PHARM RES, V24, P27, DOI 10.1007/BF02976489
   Fonseca G. C., 2004, J COMPUT CHEM, V25, P189, DOI DOI 10.1002/JCC.10351
   FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4
   Gupta AK, 2008, EUR J MED CHEM, V43, P1297, DOI 10.1016/j.ejmech.2007.06.022
   Helal MA, 2014, BIOORG MED CHEM LETT, V24, P5330, DOI 10.1016/j.bmcl.2014.07.043
   Heravi MM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040441
   Hu WH, 2003, BIOORGAN MED CHEM, V11, P5539, DOI 10.1016/j.bmc.2003.09.008
   Kalgutkar AS, 1998, SCIENCE, V280, P1268, DOI 10.1126/science.280.5367.1268
   Khalil NA, 2014, BIOORGAN MED CHEM, V22, P2080, DOI 10.1016/j.bmc.2014.02.042
   Kozak KR, 2002, BIOORG MED CHEM LETT, V12, P1315, DOI 10.1016/S0960-894X(02)00133-6
   Lazer ES, 1997, J MED CHEM, V40, P980, DOI 10.1021/jm9607010
   Liu Y, 2016, J BIOL CHEM, V291, P948, DOI 10.1074/jbc.M115.668038
   Ma ZM, 2016, INT J BIOL MACROMOL, V93, P1279, DOI 10.1016/j.ijbiomac.2016.09.095
   MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228
   Melais N, 2015, BIOPROC BIOSYST ENG, V38, P1579, DOI 10.1007/s00449-015-1400-0
   Nabid MR, 2010, ULTRASON SONOCHEM, V17, P159, DOI 10.1016/j.ultsonch.2009.06.012
   Needleman P, 1997, J RHEUMATOL, V24, P6
   Norn S, 2009, MEDICINHIST ARBOG, V37, P79
   Ouimet N, 1999, BIOORG MED CHEM LETT, V9, P151, DOI 10.1016/S0960-894X(98)00705-7
   Palomer A, 2002, J MED CHEM, V45, P1402, DOI 10.1021/jm010458r
   Pepper C, 2011, CELL PROLIF
   Sancheti SV, 2017, ULTRASON SONOCHEM, V36, P527, DOI 10.1016/j.ultsonch.2016.08.009
   Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298
   Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2
   Tewari AK, 2014, BIOORG CHEM, V56, P8, DOI 10.1016/j.bioorg.2014.05.004
   Tonk RK, 2012, EUR J MED CHEM, V57, P176, DOI 10.1016/j.ejmech.2012.08.045
   Umukoro Solomon, 2014, Journal of Basic and Clinical Physiology and Pharmacology, V25, P439, DOI 10.1515/jbcpp-2013-0149
   Wang JL, 2010, BIOORG MED CHEM LETT, V20, P7159, DOI 10.1016/j.bmcl.2010.07.054
   Wey SJ, 2007, J MED CHEM, V50, P6367, DOI 10.1021/jm0611861
   Xue DT, 2011, INT ORTHOP, V35, P3, DOI 10.1007/s00264-009-0886-y
   Zaheer Z, 2016, BIOORG MED CHEM LETT, V26, P1696, DOI 10.1016/j.bmcl.2016.02.057
NR 46
TC 1
Z9 1
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD JUN 1
PY 2017
VL 27
IS 11
BP 2377
EP 2383
DI 10.1016/j.bmcl.2017.04.020
PG 7
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA EV8IL
UT WOS:000402023800022
PM 28427813
OA No
DA 2017-08-17
ER

PT J
AU El-Khoulya, ME
   El-Mohsnawy, E
   Fukuzumi, S
AF El-Khoulya, Mohamed E.
   El-Mohsnawy, Eithar
   Fukuzumi, Shunichi
TI Solar energy conversion: From natural to artificial photosynthesis
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY C-PHOTOCHEMISTRY REVIEWS
LA English
DT Review
DE Natural photosynthesis; Artificial photosynthesis; Semi-artificial
   photosynthesis
ID PHOTOINDUCED ELECTRON-TRANSFER; CYANOBACTERIAL PHOTOSYSTEM-I;
   PHOTOCATALYTIC HYDROGEN EVOLUTION; LIGHT-HARVESTING COMPLEX;
   PORPHYRIN-FULLERENE DYAD; CHARGE-SEPARATED STATES; REACTION CENTER
   MIMICRY; MOLECULAR-ORBITAL CALCULATIONS; IMIDAZOLE-APPENDED FULLERENE;
   TRANSITION-METAL-COMPLEXES
AB Solar energy has a great potential as a clean, cheap, renewable and sustainable energy source, but it must be captured and transformed into useful forms of energy as plants do. An especially attractive approach is to store solar energy in the form of chemical bonds as performed in natural photosynthesis. Therefore, there is a challenge in the last decades to construct semi-artificial and artificial photosynthetic systems, which are able to efficiently capture and convert solar energy and then store it in the form of chemical bonds of solar fuels such as hydrogen or hydrogen peroxide, while at the time producing oxygen from water. Here, we review the molecular level details of the natural photosynthesis, particularly the mechanism of light dependent reactions in oxygen evolving organisms, absorption efficiency of solar energy and direct energy production. We then demonstrate the concept and examples of the semi-artificial photosynthesis in vitro. Finally we demonstrate the artificial photosynthesis, which is composed of light harvesting and charge-separation units together with catalytic units of water oxidation and reduction as well as CO2 reduction. The reported photosynthetic molecular and supramolecular systems have been designed and examined in order to mimic functions of the antenna-reaction center of the natural process. The relations between structures and photochemical behaviors of these artificial photosynthetic systems are discussed in relation to the rates and efficiencies of charge-separation and charge-recombination processes by utilizing the laser flash photolysis technique, as well as other complementary techniques. Finally the photocatalytic production of hydrogen peroxide as a more promising solar fuel is discussed in relation with the natural photosynthesis, which also produces hydrogen peroxide in addition to NADPH. (C) 2017 Elsevier B.V. All rights reserved.
C1 [El-Khoulya, Mohamed E.] Kafrelsheikh Univ, Dept Chem, Fac Sci, Kafrelsheikh 33516, Egypt.
   [El-Mohsnawy, Eithar] Kafrelsheikh Univ, Dept Bot, Fac Sci, Kafrelsheikh 33516, Egypt.
   [Fukuzumi, Shunichi] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul 120750, South Korea.
   [Fukuzumi, Shunichi] Meijo Univ, Fac Sci & Engn, Nagoya, Aichi 4688502, Japan.
RP El-Khoulya, ME (reprint author), Kafrelsheikh Univ, Dept Chem, Fac Sci, Kafrelsheikh 33516, Egypt.; Fukuzumi, S (reprint author), Ewha Womans Univ, Dept Chem & Nano Sci, Seoul 120750, South Korea.
EM mohamedelkhouly@yahoo.com; fukuzumi@chem.eng.osaka-u.ac.jp
FU Science and Technology Development Fund (STDF, Egypt) [5537, 12436];
   JSPS KAKENHI [16H02268]
FX This project was supported financially by the Science and Technology
   Development Fund (STDF, Egypt, Grant Nos. 5537 and 12436). S. Fukuzumi
   thanks JSPS KAKENHI (Grant no. 16H02268). S. Fukuzumi and M.E.El-Khouly
   would like to acknowledge Francis D'souza for a long term and fruitful
   collaboration. E.El-Mohsnawy also acknowledges M. Rogner for the
   long-term collaboration.
CR ALLEN JF, 1989, PHOTOSYNTH RES, V22, P157, DOI 10.1007/BF00035446
   Amao Y, 2003, SOL ENERG MAT SOL C, V79, P103, DOI 10.1016/S0927-0248(02)00373-2
   An L, 2015, SCI BULL, V60, P55, DOI 10.1007/s11434-014-0694-7
   Appel J, 1998, J PHOTOCH PHOTOBIO B, V47, P1, DOI 10.1016/S1011-1344(98)00179-1
   Applegate AM, 2016, PHOTOSYNTH RES, V127, P5, DOI 10.1007/s11120-014-0064-y
   Arbeloa FL, 1998, CHEM PHYS, V236, P331, DOI 10.1016/S0301-0104(98)00215-8
   Arbeloa FL, 2003, PHOTOCHEM PHOTOBIOL, V78, P30
   Armaroli N, 2007, ANGEW CHEM INT EDIT, V46, P52, DOI 10.1002/anie.200602373
   Armaroli N, 2016, CHEM-EUR J, V22, P32, DOI 10.1002/chem.201503580
   Asada Y, 2000, BBA-GENE STRUCT EXPR, V1490, P269, DOI 10.1016/S0167-4781(00)00010-5
   Badre S, 2006, J PHOTOCH PHOTOBIO A, V183, P238, DOI 10.1016/j.jphotochem.2006.07.002
   Badura A, 2011, ENERG ENVIRON SCI, V4, P2435, DOI 10.1039/c1ee01126j
   Baltazar CSA, 2011, EUR J INORG CHEM, P948, DOI 10.1002/ejic.201001127
   Balzani V, 1996, CHEM REV, V96, P759, DOI 10.1021/cr941154y
   Balzani V, 2008, CHEMSUSCHEM, V1, P26, DOI 10.1002/cssc.200700087
   BAMWENDA GR, 1995, J PHOTOCH PHOTOBIO A, V89, P177, DOI 10.1016/1010-6030(95)04039-I
   Bandi V, 2013, CHEM COMMUN, V49, P2867, DOI 10.1039/c3cc40471d
   Barber J., 2013, J R T SOC INTERFACE, V10, P98410
   Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n
   Barber J. Q., 2003, REV BIOPHYS, V36, P71, DOI DOI 10.1017/S0033583502003839
   Ben-Shem A, 2004, FEBS LETT, V564, P274, DOI 10.1016/S0014-5793(04)00360-6
   Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200
   Benemann JR, 2000, J APPL PHYCOL, V12, P291, DOI 10.1023/A:1008175112704
   Benniston AC, 2008, MATER TODAY, V11, P26, DOI 10.1016/S1369-7021(08)70250-5
   Berera R, 2009, PHOTOSYNTH RES, V101, P105, DOI 10.1007/s11120-009-9454-y
   Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239
   Biesiadka J, 2004, PHYS CHEM CHEM PHYS, V6, P4733, DOI 10.1039/b406989g
   Blankenship R. E., 2002, MOL MECH PHOTOSYNTHE
   Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104
   Bothe H, 2010, MICROBIOL MOL BIOL R, V74, P529, DOI 10.1128/MMBR.00033-10
   Bouit PA, 2009, ADV MATER, V21, P1151, DOI 10.1002/adma.200801778
   Bullock RM, 2014, CHEM COMMUN, V50, P3125, DOI 10.1039/c3cc46135a
   Busschaert N, 2015, CHEM REV, V115, P8038, DOI 10.1021/acs.chemrev.5b00099
   CHAN SF, 1981, J AM CHEM SOC, V103, P369, DOI 10.1021/ja00392a022
   Chen Y, 2002, CHEM MATER, V14, P5163, DOI 10.1021/cm021257u
   Cheng Y, 2010, LANGMUIR, V26, P2248, DOI 10.1021/la902390d
   Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593
   Chitta R., 2002, THESIS
   Christopher C. M., 2005, PHOTOCHEM PHOTOBIOL, V4, P933
   Ciamician G, 1912, Science, V36, P385, DOI 10.1126/science.36.926.385
   Claessens CG, 2000, TETRAHEDRON LETT, V41, P6361, DOI 10.1016/S0040-4039(00)01056-X
   Claessens CG, 2014, CHEM REV, V114, P2192, DOI 10.1021/cr400088w
   Concepcion JJ, 2012, P NATL ACAD SCI USA, V109, P15560, DOI 10.1073/pnas.1212254109
   Connolly J. S., 1981, PHOTOCHEMICAL CONVER
   Constant P, 2011, APPL ENVIRON MICROB, V77, P6027, DOI 10.1128/AEM.00673-11
   Croce R, 2001, BIOPHYS J, V80, P901
   Cui AJ, 2007, J PHOTOCH PHOTOBIO A, V186, P85, DOI 10.1016/j.jphotochem.2006.07.015
   Cuni A, 2004, PHYS CHEM CHEM PHYS, V6, P4825, DOI 10.1039/b407511k
   D'Souza F, 2005, J PHYS CHEM B, V109, P10107, DOI 10.1021/jp0505911
   D'Souza F, 2004, J AM CHEM SOC, V126, P7898, DOI 10.1021/ja030647u
   D'Souza F, 2005, CHEM COMMUN, P1279, DOI 10.1039/b416736h
   D'Souza F, 2004, J PHYS CHEM B, V108, P11333, DOI 10.1021/jp0485688
   D'Souza F, 2002, J PHYS CHEM A, V106, P12393, DOI 10.1021/jp021926r
   D'Souza F, 2002, J PHYS CHEM A, V106, P3243, DOI 10.1021/jp013165i
   D'Souza F, 2001, J AM CHEM SOC, V123, P5277, DOI 10.1021/ja010356q
   D'Souza F, 2007, J PHYS CHEM A, V111, P8552, DOI 10.1021/jp073121v
   D'Souza F, 2012, J AM CHEM SOC, V134, P654, DOI 10.1021/ja209718g
   D'Souza F, 2012, CHEM SOC REV, V41, P86, DOI 10.1039/c1cs15201g
   D'Souza F, 2011, PHYS CHEM CHEM PHYS, V13, P18168, DOI 10.1039/c1cp90147h
   D'Souza F, 2009, J AM CHEM SOC, V131, P16138, DOI 10.1021/ja9048306
   Datta K, 2004, J PHYS CHEM B, V108, P16100, DOI 10.1021/jp0472515
   Dau H, 2010, CHEMCATCHEM, V2, P724, DOI 10.1002/cctc.201000126
   Dau H, 2009, ACCOUNTS CHEM RES, V42, P1861, DOI 10.1021/ar900225y
   Dayal S, 2006, APPL PHYS B-LASERS O, V84, P309, DOI 10.1007/s00340-006-2293-z
   Deetz MJ, 2000, J AM CHEM SOC, V122, P6201, DOI 10.1021/ja994487r
   DEISENHOFER J, 1989, EMBO J, V8, P2149
   del Rey B, 1998, J AM CHEM SOC, V120, P12808, DOI 10.1021/ja980508q
   delaTorre G, 1997, ADV MATER, V9, P265, DOI 10.1002/adma.19970090320
   Deniz M., 2006, ORG LETT, V8, P2871
   Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238
   Diner B. A., OXYGENIC PHOTOSYNTHE
   Ding YB, 2016, CHEM REV
   Dini D, 2001, EUR J ORG CHEM, P3759
   Disselkamp RS, 2010, INT J HYDROGEN ENERG, V35, P1049, DOI 10.1016/j.ijhydene.2009.11.073
   Drews G., 1991, VARIATIONS AUTOTROPH, P51
   Du PW, 2006, J AM CHEM SOC, V128, P7726, DOI 10.1021/ja0610683
   E-Khouly ME, 2008, J PHYS CHEM B, V112, P3910, DOI 10.1021/jp7108658
   Eberle U, 2012, ENERG ENVIRON SCI, V5, P8780, DOI 10.1039/c2ee22596d
   Eggenspiller A, 2012, J PHYS CHEM A, V116, P3889, DOI 10.1021/jp300415a
   El-Khouly ME, 2005, PHYS CHEM CHEM PHYS, V7, P3163, DOI 10.1039/b507673k
   El-Khouly ME, 2004, J PHOTOCH PHOTOBIO C, V5, P79, DOI 10.1016/j.jphotochemrev.2004.01.003
   El-Khouly ME, 2003, J PORPHYR PHTHALOCYA, V7, P1
   El-Khouly ME, 2003, CHEMPHYSCHEM, V4, P474, DOI 10.1002/cphc.200200540
   El-Khouly ME, 2007, CHEM-EUR J, V13, P2854, DOI 10.1002/chem.200601254
   El-Khouly ME, 2006, J PORPHYR PHTHALOCYA, V10, P1156
   El-Khouly ME, 2015, J PORPHYR PHTHALOCYA, V19, P261, DOI 10.1142/S1088424614501168
   El-Khouly ME, 2014, CHEMPHYSCHEM, V15, P30, DOI 10.1002/cphc.201300715
   El-Khouly ME, 2013, J PORPHYR PHTHALOCYA, V17, P1055, DOI 10.1142/S1088424613501046
   El-Khouly ME, 2012, J PHYS CHEM C, V116, P19709, DOI 10.1021/jp3066103
   El-Khouly ME, 2012, CHEM-EUR J, V18, P5239, DOI 10.1002/chem.201103074
   El-Khouly ME, 2012, CHEMPHYSCHEM, V13, P1191, DOI 10.1002/cphc.201100948
   El-Khouly ME, 2012, PHYS CHEM CHEM PHYS, V14, P3612, DOI 10.1039/c2cp23285e
   El-Khouly ME, 2010, PHYS CHEM CHEM PHYS, V12, P12746, DOI 10.1039/c0cp00612b
   El-Khouly ME, 2010, CHEM-EUR J, V16, P6193, DOI 10.1002/chem.201000045
   El-Khouly ME, 2009, J AM CHEM SOC, V131, P6370, DOI 10.1021/ja901588f
   El-Khouly ME, 2009, J PHYS CHEM C, V113, P15444, DOI 10.1021/jp904310f
   El-Khouly ME, 2009, CHEM-EUR J, V15, P5301, DOI 10.1002/chem.200900165
   El-Mohsnawy E, 2010, BIOCHEMISTRY-US, V49, P4740, DOI 10.1021/bi901807p
   El-Mohsnawy E., 2007, THESIS, P112
   Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1005/tpc.002154
   Ermilov EA, 2006, CHEM PHYS, V328, P428, DOI 10.1016/j.chemphys.2006.07.040
   Esper B, 2006, TRENDS PLANT SCI, V11, P543, DOI 10.1016/j.tplants.2006.09.001
   Farren C, 2002, J ORG CHEM, V67, P9130, DOI 10.1021/jo020340y
   Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087
   Flavin K, 2012, SUPRAMOL CHEM, V24, P23, DOI 10.1080/10610278.2011.622381
   Flavin K, 2011, ACS NANO, V5, P1198, DOI 10.1021/nn102831x
   Fleming GR, 1997, CURR OPIN STRUC BIOL, V7, P738, DOI 10.1016/S0959-440X(97)80086-3
   Frolov L, 2005, ADV MATER, V17, P2434, DOI 10.1002/adma.200500295
   Fromme P, 2003, FEBS LETT, V555, P40, DOI 10.1016/S0014-5793(03)01124-4
   Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Fujita E., 2008, B JPN SOC COORD CHEM, V51, P41, DOI 10.4019/bjscc.51.41
   Fukuzumi S, 2006, B CHEM SOC JPN, V79, P177, DOI 10.1246/bcsj.79.177
   FUKUZUMI S, 1987, J AM CHEM SOC, V109, P305, DOI 10.1021/ja00236a003
   Fukuzumi S, 2004, J AM CHEM SOC, V126, P1600, DOI 10.1021/ja038656q
   Fukuzumi S, 2002, J PHYS CHEM A, V106, P1903, DOI 10.1021/jp011613g
   Fukuzumi S, 2001, J AM CHEM SOC, V123, P2571, DOI 10.1021/ja002052u
   Fukuzumi S, 2008, PHYS CHEM CHEM PHYS, V10, P2283, DOI 10.1039/b801198m
   Fukuzumi S, 2008, J MATER CHEM, V18, P1427, DOI 10.1039/b717958h
   Fukuzumi S, 2008, EUR J INORG CHEM, P1351, DOI 10.1002/ejic.200701369
   Fukuzumi S, 2016, BBA-BIOENERGETICS, V1857, P604, DOI [10.1016/j.bbabio.2015.08.012, 10.1016/j.bbabio2015.08.012]
   Fukuzumi S, 2015, CURR OPIN CHEM BIOL, V25, P18, DOI 10.1016/j.cbpa.2014.12.008
   Fukuzumi S, 2014, ACCOUNTS CHEM RES, V47, P1455, DOI 10.1021/ar400200u
   Fukuzumi S, 2014, AUST J CHEM, V67, P354, DOI 10.1071/CH13436
   Fukuzumi S, 2013, DALTON T, V42, P15846, DOI 10.1039/c3dt51883c
   Fukuzumi S, 2012, ELECTROCHIM ACTA, V82, P493, DOI 10.1016/j.electacta.2012.03.132
   Fukuzumi S, 2011, ENERG ENVIRON SCI, V4, P2754, DOI 10.1039/c1ee01551f
   Fukuzumi S, 2009, DALTON T, P3880, DOI 10.1039/b901191a
   Gahleitner G, 2013, INT J HYDROGEN ENERG, V38, P2039, DOI 10.1016/j.ijhydene.2012.12.010
   Garg V, 2013, J PHYS CHEM B, V117, P11299, DOI 10.1021/jp402265e
   Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005
   Golbeck J. H., 2004, PHOTOSYNTHETIC REACT
   Gonalez-Rodriguez D., 2006, J AM CHEM SOC, V128, P10680
   Gong XM, 2003, J BIOL CHEM, V278, P19141, DOI 10.1074/jbc.M301808200
   Gorman A, 2004, J AM CHEM SOC, V126, P10619, DOI 10.1021/ja047649e
   Gradinaru CC, 2000, J PHYS CHEM B, V104, P9330, DOI 10.1021/jp001752i
   GRATZEL M, 1981, ACCOUNTS CHEM RES, V14, P376
   GREENBAUM E, 1985, SCIENCE, V230, P1373, DOI 10.1126/science.230.4732.1373
   GREENBAUM E, 1988, J PHYS CHEM-US, V92, P4571, DOI 10.1021/j100327a001
   Grossi M, 2012, J ORG CHEM, V77, P9304, DOI 10.1021/jo301972w
   Grotjohann I, 2005, PHOTOSYNTH RES, V85, P51, DOI 10.1007/s11120-005-1440-4
   Guilleme J, 2014, J AM CHEM SOC, V136, P14289, DOI 10.1021/ja508181b
   Guldi D. M., 2002, SYNTHESIS OPTICAL PR
   Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559
   GUST D, 1989, SCIENCE, V244, P35, DOI 10.1126/science.244.4900.35
   Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b
   HAEHNEL W, 1979, BIOELECTROCH BIOENER, V6, P563, DOI 10.1016/0302-4598(79)80025-2
   Hall MJ, 2005, J ORG CHEM, V70, P5571, DOI 10.1021/jo050696k
   Hambourger M, 2009, CHEM SOC REV, V38, P25, DOI 10.1039/b800582f
   Hammarstrom L., 2008, R SOC LONDON SER B, V363, P1283
   Hanack M., 1998, METHODS ORGANIC CH E, VE 94, P717
   Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x
   Harris BJ, 2016, J PHYS CHEM B, V120, P599, DOI 10.1021/acs.jpcb.5b07812
   Hartmann V, 2014, PHYS CHEM CHEM PHYS, V16, P11936, DOI 10.1039/c4cp00380b
   Heinecke D., 2001, ENCY LIFE SCI, P1
   Hill JP, 2010, CHEM COMMUN, V46, P7933, DOI 10.1039/c0cc03167d
   Hoff AJ, 1997, PHYS REP, V287, P1, DOI 10.1016/S0370-1573(97)00004-5
   Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811
   Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103
   Holzwarth AR, 2005, J PHYS CHEM B, V109, P5903, DOI 10.1021/jp046299f
   Honda S, 2010, CHEM COMMUN, V46, P6596, DOI 10.1039/c0cc01787f
   Horner DS, 2002, TRENDS BIOCHEM SCI, V27, P148, DOI 10.1016/S0968-0004(01)02053-9
   Hu GF, 2016, NEW J CHEM, V40, P8032, DOI 10.1039/c6nj01782g
   Huang J, 2015, ACS APPL MATER INTER, V7, P3732, DOI 10.1021/am508476d
   Huynh MHV, 2005, COORDIN CHEM REV, V249, P457, DOI 10.1016/j.ccr.2004.07.005
   Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778
   Imahori H, 2004, ADV FUNCT MATER, V14, P525, DOI 10.1002/adfm.200305172
   Imahori H, 2003, J PHOTOCH PHOTOBIO C, V4, P51, DOI 10.1016/S1389-5567(03)00004-2
   Imahori H, 2001, J AM CHEM SOC, V123, P6617, DOI 10.1021/ja004123v
   Imahori H, 2001, J PHYS CHEM A, V105, P325, DOI 10.1021/jp002158b
   Isaka Y, 2016, RSC ADV, V6, P42041, DOI 10.1039/c6ra06814f
   Isaka Y, 2016, CATAL SCI TECHNOL, V6, P681, DOI 10.1039/c5cy01845e
   Isaka Y, 2015, J MATER CHEM A, V3, P12404, DOI 10.1039/c5ta02446c
   Ishii K, 2007, CHEM PHYS LETT, V436, P94, DOI 10.1016/j.cplett.2007.01.011
   Ishii K, 2012, COORDIN CHEM REV, V256, P1556, DOI 10.1016/j.ccr.2012.03.022
   IZATT RM, 1985, CHEM REV, V85, P271, DOI 10.1021/cr00068a003
   Jiang DL, 2004, J AM CHEM SOC, V126, P12084, DOI 10.1021/ja048912e
   Jiang XJ, 2010, CHEM-EUR J, V16, P4777, DOI 10.1002/chem.200903580
   Jones MR, 2001, CURR BIOL, V11, pR318, DOI 10.1016/S0960-9822(01)00174-9
   Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000
   Joshua S, 2004, PLANT PHYSIOL, V135, P2112, DOI 10.1104/pp.104.046110
   JOU RW, 1991, J AM CHEM SOC, V113, P6685, DOI 10.1021/ja00017a056
   Kalyanasundaram K, 2010, CURR OPIN BIOTECH, V21, P298, DOI 10.1016/j.copbio.2010.03.021
   Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100
   Kang SH, 1999, CHEM COMMUN, P1661, DOI 10.1039/a904254g
   Karapetyan NV, 2004, BIOFIZIKA+, V49, P212
   Karapetyan NV, 1999, FEBS LETT, V460, P395, DOI 10.1016/S0014-5793(99)01352-6
   KAROLIN J, 1994, J AM CHEM SOC, V116, P7801, DOI 10.1021/ja00096a042
   Kato S, 2013, ENERG ENVIRON SCI, V6, P3756, DOI 10.1039/c3ee42815j
   Kc CB, 2016, COORDIN CHEM REV, V322, P104, DOI 10.1016/j.ccr.2016.05.012
   Ke B, 2002, PHOTOSYNTH RES, V73, P207, DOI 10.1023/A:1020455315170
   KE B, 1973, BIOCHIM BIOPHYS ACTA, V301, P1, DOI 10.1016/0304-4173(73)90010-4
   Ke B., 2003, ADV PHOTOSYNTHESIS, V10
   Kern J, 2007, PHOTOSYNTH RES, V92, P389, DOI 10.1007/s11120-007-9173-1
   Khanna N, 2015, INT J MOL SCI, V16, P10537, DOI 10.3390/ijms160510537
   Nguyen K, 2014, BBA-BIOENERGETICS, V1837, P1553, DOI 10.1016/j.bbabio.2013.12.013
   Kim D, 2012, MULTIPORPHYRIN ARRAYS: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1201/b11621
   Kim DH, 2015, ANGEW CHEM INT EDIT, V54, P7028, DOI 10.1002/anie.201500871
   Kim JH, 2008, CHEM LETT, V37, P544, DOI 10.1246/cl.2008.544
   Kipp RA, 1998, J PHYS CHEM A, V102, P5659, DOI 10.1021/jp980383b
   Kirilovsky D., 2014, DISSIPATION PLANTS A, V40
   Klimmek F, 2005, BIOCHEMISTRY-US, V44, P3065, DOI 10.1021/bi047873g
   Kobayashi N, 2002, B CHEM SOC JPN, V75, P1, DOI 10.1246/bcsj.75.1
   Kobayashi N, 2002, J AM CHEM SOC, V124, P8007, DOI 10.1021/ja0123812
   Kobayashi N, 2002, COORDIN CHEM REV, V227, P129, DOI 10.1016/S0010-8545(02)00010-3
   Kobayashi N, 1999, J AM CHEM SOC, V121, P9096, DOI 10.1021/ja983325c
   KOBAYASHI N, 2002, J INORG CHEM, V41, P5350, DOI DOI 10.1021/IC011152D
   Kodis G, 2004, J PHYS CHEM B, V108, P414, DOI 10.1021/jp036139o
   Kodis G, 2002, J PHYS CHEM A, V106, P2036, DOI 10.1021/jp012133s
   Kotani H, 2007, PHYS CHEM CHEM PHYS, V9, P1487, DOI [10.1039/b612794k, 10.1039/b61279k]
   Kotani H, 2006, J PHYS CHEM B, V110, P24047, DOI 10.1021/jp065215v
   Kotani H, 2012, FARADAY DISCUSS, V155, P89, DOI 10.1039/c1fd00084e
   Kothe T, 2013, ANGEW CHEM INT EDIT, V52, P14233, DOI 10.1002/anie.201303671
   Kouril R, 2005, PHOTOCH PHOTOBIO SCI, V4, P1091, DOI 10.1039/b505519a
   KRISHNAN CV, 1985, J AM CHEM SOC, V107, P2005, DOI 10.1021/ja00293a035
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   Kruse O, 2005, PHOTOCH PHOTOBIO SCI, V4, P957, DOI 10.1039/b506923h
   Kubas GJ, 2007, CHEM REV, V107, P4152, DOI 10.1021/cr050197j
   Kuciauskas D, 1996, J PHYS CHEM-US, V100, P15926, DOI 10.1021/jp9612745
   Lai RY, 2003, J PHYS CHEM B, V107, P5036, DOI 10.1021/jp034578h
   LeBlanc G, 2012, ADV MATER, V24, P5959, DOI 10.1002/adma.201202794
   Leblebici SY, 2011, ACS APPL MATER INTER, V3, P4469, DOI 10.1021/am201157d
   Lee SH, 2016, CHEM SCI, V7, P6534, DOI 10.1039/c6sc01076h
   LEHN JM, 1993, SCIENCE, V260, P1762, DOI 10.1126/science.8511582
   LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041
   Lengeler J., 1999, BIOL PROKARYOTES
   Lessard BH, 2015, J MATER CHEM A, V3, P24512, DOI 10.1039/c5ta07173a
   Lewis NS, 2007, MRS BULL, V32, P808, DOI 10.1557/mrs2007.168
   Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014
   Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103
   Li FR, 1998, J AM CHEM SOC, V120, P10001, DOI 10.1021/ja9812047
   LIDDELL PA, 1994, PHOTOCHEM PHOTOBIOL, V60, P537, DOI 10.1111/j.1751-1097.1994.tb05145.x
   Liddell PA, 1997, J AM CHEM SOC, V119, P1400, DOI 10.1021/ja9631054
   LINDBERG K, 1993, PHOTOSYNTH RES, V38, P401, DOI 10.1007/BF00046767
   Liu JY, 2011, CHEM-EUR J, V17, P1605, DOI 10.1002/chem.201002333
   Liu JY, 2011, CHEM-ASIAN J, V6, P174, DOI 10.1002/asia.201000537
   Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373
   Lomoth R, 2006, PHOTOSYNTH RES, V87, P25, DOI 10.1007/s11120-005-9005-0
   Loudet A, 2007, CHEM REV, V107, P4891, DOI 10.1021/cr078381n
   Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814
   Lubitz W, 2008, ENERG ENVIRON SCI, V1, P15, DOI 10.1039/b808792j
   Lubner CE, 2011, P NATL ACAD SCI USA, V108, P20988, DOI 10.1073/pnas.1114660108
   Luo C, 2000, J AM CHEM SOC, V122, P6535, DOI 10.1021/ja993959z
   Macor L, 2009, ENERG ENVIRON SCI, V2, P529, DOI 10.1039/b822954f
   Maeda K., 2008, ENERG ENVIRON SCI, V1, P15
   Maligaspe E, 2009, J PHYS CHEM A, V113, P8478, DOI 10.1021/jp9032194
   MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113
   Martin-Gomis L, 2007, ORG LETT, V9, P3441, DOI 10.1021/ol701444d
   Martin-Gomis L., 2008, J PHYS CHEM A, V112, P10744
   Mase K, 2016, ACS ENERGY LETT, V1, P913, DOI 10.1021/acsenergylett.6b00415
   Mase K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11470
   Mazik M, 2006, ORG LETT, V8, P855, DOI 10.1021/ol052902g
   Mazor Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07433
   McConnell I, 2010, CHEM BIOL, V17, P434, DOI 10.1016/j.chembiol.2010.05.005
   Medina M, 2009, FEBS J, V276, P3942, DOI 10.1111/j.1742-4658.2009.07122.x
   Melis A, 2004, PHOTOSYNTH RES, V82, P277, DOI 10.1007/s11120-004-2050-2
   Melis A, 1996, PHOTOSYNTH RES, V47, P253, DOI 10.1007/BF02184286
   Melis A, 2002, INT J HYDROGEN ENERG, V27, P1217, DOI 10.1016/S0360-3199(02)00110-6
   Mershin A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00234
   Meyer GJ, 2005, INORG CHEM, V44, P6852, DOI 10.1021/ic0505908
   MEYER TJ, 1989, ACCOUNTS CHEM RES, V22, P163, DOI 10.1021/ar00161a001
   Michel K. P., 2003, THESIS U BIELEFELD
   Miller JD, 2007, TOXICOL APPL PHARM, V224, P290, DOI 10.1016/j.taap.2007.01.025
   Miloslavina Y, 2006, BIOCHEMISTRY-US, V45, P2436, DOI 10.1021/bi052248c
   Moser C. C., 2003, ADV PROTEIN CHEM, P71
   MULLINEAUX CW, 1994, BBA-BIOENERGETICS, V1184, P71, DOI 10.1016/0005-2728(94)90155-4
   Mullineaux CW, 1997, NATURE, V390, P421, DOI 10.1038/37157
   Mullins CS, 2008, COORDIN CHEM REV, V252, P416, DOI 10.1016/j.ccr.2007.07.021
   Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p
   Murtagh J, 2009, ORG LETT, V11, P5386, DOI 10.1021/ol902140v
   Nakano S, 2016, CHEM-EUR J, V22, P7706, DOI 10.1002/chem.201600548
   Nalwa HS, 1999, CHEM PHYS, V245, P17, DOI 10.1016/S0301-0104(99)00145-7
   Nantalaksakul A, 2006, PHOTOSYNTH RES, V87, P133, DOI 10.1007/s11120-005-8387-3
   Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525
   Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350
   Nelson N, 2011, BBA-BIOENERGETICS, V1807, P856, DOI 10.1016/j.bbabio.2010.10.011
   Nield J, 2004, EUKARYOT CELL, V3, P1370, DOI 10.1128/EC.3.6.1370-1380.2004
   Nierengarten JF, 2006, CR CHIM, V9, P1022, DOI 10.1016/j.crci.2005.11.005
   Nierengarten JF, 2014, STRUCT BOND, V159, pV
   Nocera DG, 2012, ACCOUNTS CHEM RES, V45, P767, DOI 10.1021/ar2003013
   Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671
   Ocakoglu K, 2014, ADV FUNCT MATER, V24, P7467, DOI 10.1002/adfm.201401399
   OKURA I, 1979, J MOL CATAL, V6, P227, DOI 10.1016/0304-5102(79)85004-X
   OKURA I, 1992, J PHYS CHEM-US, V96, P4466, DOI 10.1021/j100190a063
   OKURA I, 1985, COORDIN CHEM REV, V68, P53, DOI 10.1016/0010-8545(85)80030-8
   Olson JM, 2001, PHOTOSYNTH RES, V68, P95, DOI 10.1023/A:1011807229154
   Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886
   Otsuki J, 2004, CHEM COMMUN, P1290, DOI 10.1039/b403991b
   Palma A, 2009, ORG LETT, V11, P3638, DOI 10.1021/ol901413u
   Panda MK, 2012, COORDIN CHEM REV, V256, P2601, DOI 10.1016/j.ccr.2012.04.041
   Parkin A, 2008, J AM CHEM SOC, V130, P13410, DOI 10.1021/ja803657d
   Parkin A, 2014, METAL IONS LIFE SCI, V14, P99, DOI 10.1007/978-94-017-9269-1_5
   PAVLOPOULOS TG, 1988, APPL OPTICS, V27, P4998, DOI 10.1364/AO.27.004998
   PAVLOPOULOS TG, 1990, APPL OPTICS, V29, P3885, DOI 10.1364/AO.29.003885
   PEDERSEN CJ, 1967, J AM CHEM SOC, V89, P7017, DOI 10.1021/ja01002a035
   PERSAUD L, 1987, J AM CHEM SOC, V109, P7309, DOI 10.1021/ja00258a011
   Polle JEW, 2002, INT J HYDROGEN ENERG, V27, P1257, DOI 10.1016/S0360-3199(02)00116-7
   Popelkova H, 2008, BIOCHEMISTRY-US, V47, P12593, DOI 10.1021/bi801512s
   Popelkova H, 2007, PHOTOSYNTH RES, V93, P111, DOI 10.1007/s11120-006-9121-5
   Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961
   Prodohl A, 2004, BIOHYDROGEN III: RENEWABLE ENERGY SYSTEM BY BIOLOGICAL SOLAR ENERGY CONVERSION, P171, DOI 10.1016/B978-008044356-0/50015-4
   Qin WW, 2005, J PHYS CHEM A, V109, P7371, DOI 10.1021/jp052626n
   Quartarolo AD, 2006, CHEM-EUR J, V12, P6797, DOI 10.1002/chem.200501636
   Rakhimberdieva MG, 2001, BIOCHEMISTRY-US, V40, P15780, DOI 10.1021/bi010009t
   Remy A, 2004, EUR J BIOCHEM, V271, P563, DOI 10.1046/j.1432-1033.2003.03958.x
   Rio Y, 2010, CHEM-EUR J, V16, P1929, DOI 10.1002/chem.200902507
   Rodriguez-Redondo J. L., 2006, CHEM COMMUN, V126, P5
   Roger C, 2006, J AM CHEM SOC, V128, P6542, DOI 10.1021/ja0584469
   Rudolf M, 2016, CHEM SOC REV, V45, P612, DOI 10.1039/c5cs00774g
   Safont-Sempere MM, 2011, CHEM REV, V111, P5784, DOI 10.1021/cr100357h
   Sakai T, 2013, ANGEW CHEM INT EDIT, V52, P12313, DOI 10.1002/anie.201306214
   Santabarbara S, 2005, BBA-BIOENERGETICS, V1708, P283, DOI 10.1016/j.bbabio.2005.05.001
   Sarcina M, 2001, J BIOL CHEM, V276, P46830, DOI 10.1074/jbc.M107111200
   Sastre A, 1996, J AM CHEM SOC, V118, P2746, DOI 10.1021/ja9533050
   Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7
   SCHUHMANN W, 1987, ANGEW CHEM INT EDIT, V26, P241, DOI 10.1002/anie.198702411
   Schuhmann W., 1987, ANGEW CHEM, V99, P264, DOI 10.1002/ange.19870990326
   Schutz K, 2004, PLANTA, V218, P350, DOI 10.1007/s00425-003-1113-5
   Schwarze A, 2010, APPL ENVIRON MICROB, V76, P2641, DOI 10.1128/AEM.02700-09
   Seibert M., 2001, BIOHYDROGEN, P67
   Semenov AY, 2004, BIOFIZIKA+, V49, P227
   Sener MK, 2005, BIOPHYS J, V89, P1630, DOI 10.1529/biophysj.105.066464
   Sener MK, 2004, J CHEM PHYS, V120, P11183, DOI 10.1063/1.1739400
   Service RF, 2005, SCIENCE, V309, P548, DOI 10.1126/science.309.5734.548
   Sessler JL, 2006, MONOGR SUPRAMOL CHEM, P1, DOI 10.1039/9781847552471
   Sessler J. L., 2000, PORPHYRIN HDB, V6
   Setif P, 2001, BBA-BIOENERGETICS, V1507, P161, DOI 10.1016/S0005-2728(01)00205-5
   Shaegh SAM, 2012, ENERG ENVIRON SCI, V5, P8225, DOI 10.1039/c2ee21806b
   Shah M., 1990, HETEROATOM CHEM, V1, P389, DOI DOI 10.1002/HC.520010507
   Shen Z, 2004, CHEM-EUR J, V10, P4853, DOI 10.1002/chem.200400173
   Shi MH, 2016, J MATER CHEM C, V4, P7783, DOI 10.1039/c6tc02750d
   Shi WJ, 2013, CHEM-EUR J, V19, P11332, DOI 10.1002/chem.201300318
   Shiragami T, 2005, J PHOTOCH PHOTOBIO A, V170, P287, DOI 10.1016/j.jphotochem.2004.08.018
   Sibrian-Vazquez M, 2007, BIOCONJUGATE CHEM, V18, P410, DOI 10.1021/bc060297b
   Siegbahn PEM, 1999, J AM CHEM SOC, V121, P117, DOI 10.1021/ja982290d
   Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k
   Small YA, 2011, ENERG ENVIRON SCI, V4, P3008, DOI 10.1039/c1ee01170g
   Smil V., 2006, ENERGY
   Solladie N, 2003, CHEM COMMUN, P2412, DOI 10.1039/b308631c
   STEFFEN MA, 1994, SCIENCE, V264, P810, DOI 10.1126/science.264.5160.810
   Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106
   Subois D., 1992, J PHYS CHEM, V96, P7137
   Sun LC, 2001, CHEM SOC REV, V30, P36, DOI 10.1039/a801490f
   Szczepaniak M, 2009, BIOPHYS J, V96, P621, DOI 10.1016/j.bpj.2008.09.036
   Tachibana Y, 2012, NAT PHOTONICS, V6, P511, DOI 10.1038/nphoton.2012.175
   Takeda A, 2013, SYNTHETIC MET, V177, P48, DOI 10.1016/j.synthmet.2013.06.011
   Tamura H, 2013, ANGEW CHEM INT EDIT, V52, P9656, DOI 10.1002/anie.201305089
   Tanaka T, 2015, CHEM SOC REV, V44, P943, DOI 10.1039/c3cs60443h
   Tannert S, 2007, J PHYS CHEM B, V111, P8053, DOI 10.1021/jp0724222
   Terasaki N, 2006, THIN SOLID FILMS, V499, P153, DOI 10.1016/j.tsf.2005.07.050
   Terasaki N, 2009, LANGMUIR, V25, P11969, DOI 10.1021/la901091e
   Terasaki N, 2009, ANGEW CHEM INT EDIT, V48, P1585, DOI 10.1002/anie.200805748
   Terazono Y, 2011, J AM CHEM SOC, V133, P2916, DOI 10.1021/ja107753f
   Teuber M, 2001, BBA-BIOENERGETICS, V1506, P31, DOI 10.1016/S0005-2728(01)00178-5
   Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103
   Tommos C., 2000, DALTON T, V1458, P199
   Torres T, 2006, ANGEW CHEM INT EDIT, V45, P2834, DOI 10.1002/anie.200504265
   Toshima N, 1999, POLYM J, V31, P1127, DOI 10.1295/polymj.31.1127
   TREIBS A, 1968, LIEBIGS ANN CHEM, V718, P208, DOI 10.1002/jlac.19687180119
   Trelka M, 2011, CHEM COMMUN, V47, P9986, DOI 10.1039/c1cc11658d
   Tsuda A, 2001, SCIENCE, V293, P79, DOI 10.1126/science.1059552
   Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913
   Urbani M, 2014, CHEM REV, V114, P12330, DOI 10.1021/cr5001964
   van Thor JJ, 1998, BOT ACTA, V111, P430
   van Gorkom H. J., 2005, PHOTOSYSTEM, P307
   Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102
   Volbeda A, 2015, METALLOMICS, V7, P710, DOI 10.1039/c4mt00309h
   Wasielewski MR, 2009, ACCOUNTS CHEM RES, V42, P1910, DOI 10.1021/ar9001735
   Wasielewski MR, 2006, J ORG CHEM, V71, P5051, DOI 10.1021/jo060225d
   WASIELEWSKI MR, 1992, CHEM REV, V92, P435, DOI 10.1021/cr00011a005
   Whitmarsh J, 1999, CONCEPTS IN PHOTOBIOLOGY, P11
   Wiechen M, 2012, DALTON T, V41, P21, DOI 10.1039/c1dt11537e
   Wijesinghe CA, 2013, CHEM-EUR J, V19, P9629, DOI 10.1002/chem.201300877
   Wijesinghe CA, 2010, CHEM COMMUN, V46, P3301, DOI 10.1039/c000565g
   Wincencjusz H, 1999, BIOCHEMISTRY-US, V38, P3719, DOI 10.1021/bi982295n
   Xie Y, 2008, J PHYS CHEM C, V112, P10559, DOI 10.1021/jp8028209
   Yacoby I, 2011, P NATL ACAD SCI USA, V108, P9396, DOI 10.1073/pnas.1103659108
   Yamada Y, 2015, ENERG ENVIRON SCI, V8, P1698, DOI 10.1039/c5ee00748h
   Yamada Y, 2014, INORG CHEM, V53, P1272, DOI 10.1021/ic403008d
   Yamada Y, 2011, ENERG ENVIRON SCI, V4, P2822, DOI 10.1039/c1ee01587g
   Yamamoto M, 2016, CHEMPLUSCHEM, V81, P1028, DOI 10.1002/cplu.201600236
   Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010
   YONEMOTO EH, 1992, J AM CHEM SOC, V114, P8081, DOI 10.1021/ja00047a017
   Yuan MJ, 2009, CHEM-ASIAN J, V4, P707, DOI 10.1002/asia.200800391
   Zango G, 2015, CHEM SCI, V6, P5571, DOI 10.1039/c5sc01709b
   Zeng MT, 2002, BBA-BIOENERGETICS, V1556, P254, DOI 10.1016/S0005-2728(02)00370-5
   Zhang M. F., 2008, NATL ACAD SCI US, V105, P14773
   Zhang XX, 2004, J MOL STRUC-THEOCHEM, V673, P103, DOI 10.1016/j.theochem.2003.12.004
   Ziessel R, 2013, J AM CHEM SOC, V135, P11330, DOI 10.1021/ja4049306
   Zinth W, 2005, CHEMPHYSCHEM, V6, P871, DOI 10.1002/cphc.200400458
   Zouni A, 2001, STRUCTURE, V409, P739
   [Anonymous], 2007, SCIENCE, V315, P781
NR 392
TC 1
Z9 1
U1 60
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-5567
EI 1873-2739
J9 J PHOTOCH PHOTOBIO C
JI J. Photochem. Photobiol. C-Photochem. Rev.
PD JUN
PY 2017
VL 31
BP 36
EP 83
DI 10.1016/j.jphotochemrev.2017.02.001
PG 48
WC Chemistry, Physical
SC Chemistry
GA EV9OO
UT WOS:000402115500002
OA No
DA 2017-08-17
ER

PT J
AU Rehman, H
   Aziz, A
   Saggu, S
   VanWert, AL
   Zidan, N
   Saggu, S
AF Rehman, Hasibur
   Aziz, Al Thbiani
   Saggu, Shalini
   VanWert, Adam L.
   Zidan, Nahla
   Saggu, Sundeep
TI Additive toxic effect of deltamethrin and cadmium on hepatic,
   hematological, and immunological parameters in mice
SO TOXICOLOGY AND INDUSTRIAL HEALTH
LA English
DT Article
DE Deltamethrin; cadmium intoxication; hematology; immunosuppression;
   oxidative stress
ID CHEMICAL-MIXTURES; IN-VITRO; EXPOSURE; RATS; INTOXICATION; BLOOD
AB Exposure to natural and man-made environmental toxins concurrently can pose a greater threat to multiple organs. In the present work, we investigated interactions between deltamethrin (DM) and cadmium (Cd), whose mechanisms of action in humans are poorly understood. Albino mice were randomly divided into four groups, each containing six mice: saline as control, DM-treated, cadmium chloride (CdCl2)-treated, and CdCl2 plus DM treated. After 2 weeks of treatment biochemical and hematological effects, total leukocyte count (TLC), differential leukocyte count, humoral-mediated immune responses, and histopathological studies were conducted. Mice exposed to DM and Cd showed a significant increase in aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Also, DM and Cd administration resulted in suppression of humoral immunity, erythrocyte count, hemoglobin, hematocrit, and TLC. Histopathological evidence revealed hepatic damage, supporting the AST and ALT findings. Cd and DM exhibited an additive type of toxicity. It could be concluded that these toxins either target different cellular pathways, or the individual amounts used in this study were not enough to saturate the toxicological target, thus producing additive effects.
C1 [Rehman, Hasibur; Aziz, Al Thbiani; Saggu, Shalini] Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
   [VanWert, Adam L.] Wilkes Univ, Nesbitt Sch Pharm, Dept Pharmaceut Sci, Wilkes Barre, PA 18766 USA.
   [Zidan, Nahla] Univ Tabuk, Dept Home Econ & Nutr, Fac Sci, Tabuk, Saudi Arabia.
   [Zidan, Nahla] Kafrelsheikh Univ, Fac Specif Educ, Dept Home Econ, Kafr El Shaikh, Egypt.
   [Saggu, Sundeep] Indian Inst Technol Delhi, Dept Comp Sci & Engn, New Delhi, India.
RP Rehman, H (reprint author), Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
EM hrehman@ut.edu.sa
FU Deanship of Scientific Research, University of Tabuk, Tabuk, Saudi
   Arabia [S-1435-0078]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was financially supported by the Deanship of Scientific Research,
   University of Tabuk, Tabuk, Saudi Arabia, under the no. S-1435-0078.
CR Abdel-Daim MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072991
   Anand SS, 2006, DRUG METAB DISPOS, V34, P389, DOI 10.1124/dmd.105.007807
   ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF CADM
   Banerjee B D, 2001, Rev Environ Health, V16, P1
   BESSEY OA, 1946, J BIOL CHEM, V164, P321
   Bilal BH, 2003, INT IMMUNOPHARMACOL, V2, P257
   Bin-Hafeez B, 2003, INT IMMUNOPHARMACOL, V3, P257, DOI 10.1016/S1567-5769(02)00292-8
   Chargui I, 2012, BIOMED ENVIRON SCI, V25, P672, DOI 10.3967/0895-3988.2012.06.009
   Chen Z, 2014, ENVIRON MONIT ASSESS, V86, P1039
   CUSHMAN JR, 1983, TOXICOL APPL PHARM, V70, P29, DOI 10.1016/0041-008X(83)90176-X
   DESI I, 1986, ECOTOX ENVIRON SAFE, V12, P220, DOI 10.1016/0147-6513(86)90014-X
   Edwards CD, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-161
   El-Sayed YS, 2007, ENVIRON TOXICOL PHAR, V24, P212, DOI 10.1016/j.etap.2007.05.006
   Fan JL, 2009, CAN J SOIL SCI, V89, P435
   Garcia-Esquinas E, 2014, ENVIRON HEALTH PERSP, V122, P363, DOI 10.1289/ehp.1306587
   Garg S, 2000, THESIS
   Groten JP, 1997, FUND APPL TOXICOL, V36, P15, DOI 10.1006/faat.1996.2281
   Hounkpatin ASY, 2013, AFRICAN J BIOTECHNOL, V12, P3731
   Institoris L, 1999, HUM EXP TOXICOL, V18, P88, DOI 10.1191/096032799678839752
   IPCS, 1990, ENV HLTH CRIT
   Jarup L, 1998, OCCUP ENVIRON MED, V55, P435
   Lee J S, 1980, Am J Ind Med, V1, P307, DOI 10.1002/ajim.4700010308
   Lokke H, 2013, TOXICOLOGY, V313, P73, DOI 10.1016/j.tox.2012.11.009
   Malik G, 2005, INDIAN J ANIM SCI, V75, P668
   MANCA D, 1991, TOXICOLOGY, V67, P303, DOI 10.1016/0300-483X(91)90030-5
   Manna S., 2005, Indian Journal of Pharmacology, V37, P160
   REHMAN H., 2014, J ENTOMOL ZOOL STUD, V2, P60
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   RILEY V, 1960, P SOC EXP BIOL MED, V104, P751
   Rosalki S B, 1975, Adv Clin Chem, V17, P53, DOI 10.1016/S0065-2423(08)60248-6
   Scheuer PJ, 1986, CLIN TEST HISTOPATOL
   SHOPP GM, 1985, J TOXICOL ENV HEALTH, V15, P293
   Simmons JE, 1995, TOXICOLOGY, V105, P111, DOI 10.1016/0300-483X(95)03205-T
   SIMPSON MA, 1978, J IMMUNOL METHODS, V21, P159, DOI 10.1016/0022-1759(78)90232-6
   Singh P, 2007, J HERBAL MED TOXICOL, V1, P67
   VARSHNEYA C, 1992, Indian Journal of Physiology and Pharmacology, V36, P123
   WILTROUT RW, 1978, B ENVIRON CONTAM TOX, V20, P423
   Wu HH, 2011, CHEMOSPHERE, V83, P599, DOI 10.1016/j.chemosphere.2010.12.004
   Zhang XW, 2012, ENVIRON MONIT ASSESS, V184, P2261, DOI 10.1007/s10661-011-2115-6
NR 39
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0748-2337
EI 1477-0393
J9 TOXICOL IND HEALTH
JI Toxicol. Ind. Health
PD JUN
PY 2017
VL 33
IS 6
BP 495
EP 502
DI 10.1177/0748233716684710
PG 8
WC Public, Environmental & Occupational Health; Toxicology
SC Public, Environmental & Occupational Health; Toxicology
GA EW4FN
UT WOS:000402457500004
PM 28071525
OA No
DA 2017-08-17
ER

PT J
AU Chen, HY
   Jin, WB
   Liang, ZY
   Abomohra, A
   Zhou, X
   Tu, RJ
   Han, SF
AF Chen, Hongyi
   Jin, Wenbiao
   Liang, Zhaoyun
   Abomohra, Abd El-Fatah
   Zhou, Xu
   Tu, Renjie
   Han, Songfang
TI Abundance and diversity of ammonia-oxidizing archaea in a biological
   aerated filter process
SO ANNALS OF MICROBIOLOGY
LA English
DT Article
DE Ammonia-oxidizing archaea; Ammonia-oxidizing bacteria; Biological
   aerated filter; Environmental factors
ID WATER TREATMENT-PLANT; DOMESTIC WASTE-WATER; AMOA GENES; TREATMENT
   SYSTEMS; BACTERIA; NITROGEN; SEDIMENTS; POPULATIONS; PERFORMANCE;
   ENRICHMENT
AB Ammonia-oxidizing archaea (AOA) represent an important group of ammonia-oxidizing microorganisms that are able to convert ammonia to nitrite, a function which is crucial for the removal of nitrogen from wastewater. In this study, we investigated the abundance and diversity of AOA in a full-scale wastewater treatment plant (WWTP) which used a biological aerated filter (BAF) as the main processing mode. According to the quantitative PCR results, AOA clearly outnumbered ammonia-oxidizing bacteria (AOB) during the whole process. The abundance of AOA amoA genes in the filter layer of BAF was highest with the value varied from 6.32 x 10(3) to 3.8 x 10(4) copies/ng DNA. The highest abundance of AOB amoA genes was 1.32 x 10(2) copies/ng DNA, recorded in the effluent of the ACTIFLOA (R) settling tank. The ratios of AOA/AOB in the WWTP were maintained at two or three orders of magnitude. Most AOA obtained from the WWTP fell within the Nitrosopumilus cluster. The abundance of AOA and AOB was significantly correlated with ammonium nitrogen concentrations and pH value. The community structure of AOA was significantly influenced by dissolved oxygen concentrations, pH value and chemical oxygen demand.
C1 [Chen, Hongyi; Jin, Wenbiao; Liang, Zhaoyun; Abomohra, Abd El-Fatah; Zhou, Xu; Tu, Renjie; Han, Songfang] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Engn Lab Microalgal Bioenergy, Shenzhen 518055, Peoples R China.
   [Abomohra, Abd El-Fatah] Tanta Univ, Bot Dept, Fac Sci, Tanta 31527, Egypt.
RP Jin, WB; Zhou, X (reprint author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Engn Lab Microalgal Bioenergy, Shenzhen 518055, Peoples R China.
EM jinwb@hit.edu.cn; zhouxu@hit.edu.cn
FU National Natural Science Foundation of China [50978069]
FX This work was supported by the National Natural Science Foundation of
   China (No. 50978069).
CR Bai YH, 2012, FEMS MICROBIOL ECOL, V80, P323, DOI 10.1111/j.1574-6941.2012.01296.x
   Bao T, 2016, SEP PURIF TECHNOL, V167, P154, DOI 10.1016/j.seppur.2016.05.011
   Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79
   CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532
   Chen C, 2017, BIORESOURCE TECHNOL, V232, P417, DOI 10.1016/j.biortech.2017.02.031
   Chen YL, 2013, APPL SOIL ECOL, V68, P36, DOI 10.1016/j.apsoil.2013.03.006
   Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x
   Ferrera I, 2016, BIOTECHNOL ADV, V34, P790, DOI 10.1016/j.biotechadv.2016.04.003
   Gao JF, 2013, BIORESOURCE TECHNOL, V138, P285, DOI 10.1016/j.biortech.2013.03.176
   Gao JF, 2014, APPL MICROBIOL BIOT, V98, P3339, DOI 10.1007/s00253-013-5428-2
   GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344
   Hill T.C.J., 2003, MICROB ECOL, V43, P1
   Hou J, 2013, WATER RES, V47, P2285, DOI 10.1016/j.watres.2013.01.042
   Jin T, 2010, APPL MICROBIOL BIOT, V87, P1167, DOI 10.1007/s00253-010-2595-2
   Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11
   Kayee P, 2011, MICROB ECOL, V62, P776, DOI 10.1007/s00248-011-9893-9
   Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485
   Li YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23747
   Limpiyakorn T, 2013, APPL MICROBIOL BIOT, V97, P1425, DOI 10.1007/s00253-012-4650-7
   Lv ZLWJ, 2013, J ENV SCI CHINA, V25, P1195
   Mumann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI DOI 10.1073/PNAS.1106427108
   NEPA Chinese, 2002, WAT WAST MON METH
   Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06
   Park SJ, 2008, EXTREMOPHILES, V12, P605, DOI 10.1007/s00792-008-0165-7
   Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x
   Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704
   Sakami T, 2012, MICROBES ENVIRON, V27, P61, DOI 10.1264/jsme2.ME11218
   Santoro AE, 2011, ISME J, V5, P1796, DOI 10.1038/ismej.2011.58
   Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x
   Sonthiphand P, 2011, APPL MICROBIOL BIOT, V89, P843, DOI 10.1007/s00253-010-2902-y
   Sun W, 2013, MICROBES ENVIRON, V28, P457, DOI 10.1264/jsme2.ME13066
   Wang Q, 2017, SCI TOTAL ENV
   Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x
   Wu YJ, 2013, J BIOSCI BIOENG, V115, P424, DOI 10.1016/j.jbiosc.2012.11.005
   Yan L, 2016, ECOL ENG, V93, P46, DOI 10.1016/j.ecoleng.2016.05.002
   Yapsakli K, 2011, J ENVIRON MANAGE, V92, P714, DOI 10.1016/j.jenvman.2010.10.017
   Ye L, 2011, BIOTECHNOL BIOENG, V108, P2544, DOI 10.1002/bit.23211
   Yu QS, 2016, BIORESOURCE TECHNOL, V219, P403, DOI 10.1016/j.biortech.2016.07.122
   Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08
   Zhang T, 2009, J APPL MICROBIOL, V107, P970, DOI 10.1111/j.1365-2672.2009.04283.x
   Zhang T, 2011, APPL MICROBIOL BIOT, V91, P1215, DOI 10.1007/s00253-011-3408-y
NR 41
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1590-4261
EI 1869-2044
J9 ANN MICROBIOL
JI Ann. Microbiol.
PD JUN
PY 2017
VL 67
IS 6
BP 405
EP 416
DI 10.1007/s13213-017-1272-4
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA EV9XU
UT WOS:000402141300002
OA No
DA 2017-08-17
ER

PT J
AU Saleh, MA
   Ramadan, MM
   Arram, EO
AF Saleh, Mohammed A.
   Ramadan, Mahmoud M.
   Arram, Eman O.
TI Toll-like receptor-2 Arg753Gln and Arg677Trp polymorphisms and
   susceptibility to pulmonary and peritoneal tuberculosis
SO APMIS
LA English
DT Article
DE Toll-like receptor; polymorphisms; tuberculosis
ID GENE POLYMORPHISMS; PROTEIN; LIPOPEPTIDES; POPULATION; IMMUNITY;
   DISEASE; TLR2
AB Recent evidence suggests that toll-like receptor-2 (TLR2) is important for host defense against Mycobacterium tuberculosis (MTB). TLR2 polymorphisms have shown significant impact on susceptibility or resistance to tuberculosis (TB). This case-control study aims to determine the influence of TLR2 (Arg753Gln and Arg677Trp) polymorphisms on the susceptibility to develop pulmonary or peritoneal TB. Genotyping of TLR2 (Arg753Gln and Arg677Trp) polymorphisms was carried out on 52 patients with pulmonary TB, 44 patients with peritoneal TB, and 50 healthy controls using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). There was a significant association between the GA genotype (heterozygous mutant) of TLR2 Arg753Gln polymorphism and the risk of infection with pulmonary TB (p = 0.003, OR = 4.83) and TB peritonitis (p = 0.003, OR = 6.2). Differences in the genotype frequencies of TLR2 Arg677Trp polymorphisms between patients with pulmonary or peritoneal TB and healthy controls were not detected. GA753 TLR2 polymorphism may play a role in the susceptibility to pulmonary and peritoneal TB infection. Further studies on a large number of ethnically diverse patient cohorts may help to confirm the possible effect of these polymorphisms on the susceptibility to pulmonary and peritoneal TB.
C1 [Saleh, Mohammed A.] Al Azhar Univ, Fac Med, Dept Microbiol & Immunol, New Damietta, Egypt.
   [Ramadan, Mahmoud M.] Mansoura Univ, Fac Med, Dept Cardiol, Mansoura, Egypt.
   [Arram, Eman O.] Mansoura Univ, Fac Med, Dept Thorac Med, Mansoura, Egypt.
RP Saleh, MA (reprint author), Al Azhar Univ, Fac Med, Dept Microbiol & Immunol, New Damietta, Egypt.
EM msaleh_2016@yahoo.com
CR Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12
   Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002
   Ben-Ali M, 2004, CLIN DIAGN LAB IMMUN, V11, P625, DOI 10.1128/CDLI.11.3.625-626.2004
   Biswas Debasis, 2009, BMC Res Notes, V2, P162, DOI 10.1186/1756-0500-2-162
   Branger J, 2004, INT IMMUNOL, V16, P509, DOI 10.1093/intimm/dxh052
   Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955
   Chen YC, 2010, BMC MED GENET, V11, DOI [10.1186/1471-2350-11-17, 10.1186/1471-2350-11-46]
   Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218
   Diagnostic Standards and Classification of Tuberculosis in Adults and Children, 2000, AM J RESP CRIT CARE, V161, P1376
   Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907
   Koneman E, 2006, KONEMANS COLOR ATLAS, P893
   Medzhitov R, 1997, NATURE, V388, P394
   Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315
   Notle FS, 1995, MANUAL CLIN MICROBIO, P400
   Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703
   Ryu YJ, 2006, CLIN VACCINE IMMUNOL, V13, P818, DOI 10.1128/CVI.00025-06
   Saleh MA, 2012, J MED MICROBIOL, V61, P514, DOI 10.1099/jmm.0.035121-0
   Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2
   Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001
   Shahsavar F., 2016, Asian Pacific Journal of Tropical Disease, V6, P354
   Suzuki Y, 2004, CANCER RES, V64, P8754, DOI 10.1158/0008-5472.CAN-04-1691
   Takeda K, 2002, J ENDOTOXIN RES, V8, P459, DOI 10.1179/096805102125001073
   Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990
   Thada S, 2013, SCAND J IMMUNOL, V78, P221, DOI 10.1111/sji.12066
   Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405
   Tsao TC, 2000, CHEST, V122, P1285
   Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459
   Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7
   Wang JR, 2013, NONLINEAR ANAL-HYBRI, V8, P1, DOI 10.1016/j.nahs.2012.08.003
   Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493
   Xue Y, 2010, INT J IMMUNOGENET, V37, P135, DOI 10.1111/j.1744-313X.2009.00892.x
   Yim JJ, 2006, GENES IMMUN, V7, P150, DOI 10.1038/sj.gene.6364274
   Zhang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063357
NR 34
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0903-4641
EI 1600-0463
J9 APMIS
JI APMIS
PD JUN
PY 2017
VL 125
IS 6
BP 558
EP 564
DI 10.1111/apm.12680
PG 7
WC Immunology; Microbiology; Pathology
SC Immunology; Microbiology; Pathology
GA EW1ZO
UT WOS:000402295800006
PM 28332241
OA No
DA 2017-08-17
ER

PT J
AU Saleh, IH
   Abdel-Halim, AA
AF Saleh, I. H.
   Abdel-Halim, A. A.
TI Be-7 in soil, deposited dust and atmospheric air and its using to infer
   soil erosion along Alexandria region, Egypt
SO JOURNAL OF ENVIRONMENTAL RADIOACTIVITY
LA English
DT Article
DE Airborne; Be-7; Deposition velocity; Dust; Scavenging rates; Soil
   erosion
ID BERYLLIUM-7; PB-210; TRACER; PROFILES; AEROSOLS; BEHAVIOR; WATERS;
   PERIOD; RATES; CHINA
AB This study investigated the radioactivity behavior of Be-7 in surface soil, airborne and deposited dust along Alexandria region in Egypt. The results obtained were used to predict scavenging processes of Be-7 from surface soil to infer soil erosion and land vulnerable to accelerated sea-level rise. The areal activity concentrations of Be-7 in surface soil were investigated in 30 undisturbed sites and Be-7 inventories were determined via deposited dust in 10 locations. Results of the former were found to be ranged from 78 Bq/m(2) to 104 Bq/m(2). High levels were observed in western sites associated with high dust deposition rate. On the other hand, low levels were found in the eastern sites, those may be attributed to scavenging processes such as land erosion toward the direction to the sea. The effective removal rates of Be-7 were calculated using the box-model, showing a broad special trend of inventories generally decreasing eastwards. The scavenging rates were ranged between 3.13 yr(-1) in western sites to 5.34 yr(-1) in eastern ones which denote that the east of the city suffers from rapid soil erosion. The airborne Be-7 was monthly monitored along the period from October 2014 to September 2015 through one site located at the mid of the city. The results revealed lower values in winter and autumn than in summer and spring ranged between 6.2 mBq/m(3) and 10.5 mBq/m(3). These levels are comparable with that in other world regions and the seasonal variations are associated with the prevailing climatic conditions in Alexandria region. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Saleh, I. H.] Alexandria Univ, Inst Grad Studies & Res, Dept Environm Studies, POB 832, Alexandria, Egypt.
   [Abdel-Halim, A. A.] Arab Acad Sci Technol & Maritime Transport, Coll Engn & Technol, Dept Basic & Appl Sci, POB 1029, Alexandria, Egypt.
RP Saleh, IH (reprint author), Alexandria Univ, Inst Grad Studies & Res, Dept Environm Studies, POB 832, Alexandria, Egypt.
EM ibshsh@yahoo.com; amoneim@aast.edu
CR Abdel-Halim AA, 2016, J TAIBAH UNIV SCI, V10, P212, DOI 10.1016/j.jtusci.2015.02.016
   Al-Azmi D, 2001, APPL RADIAT ISOTOPES, V55, P413, DOI 10.1016/S0969-8043(01)00077-X
   Baeza A, 1996, J RADIOAN NUCL CH AR, V207, P331, DOI 10.1007/BF02071239
   Blake WH, 1999, APPL RADIAT ISOTOPES, V51, P599, DOI 10.1016/S0969-8043(99)00086-X
   Daish SR, 2005, J ENVIRON RADIOACTIV, V84, P457, DOI 10.1016/j.jenvrad.2005.05.003
   Eisenbud M., 1997, ENV RADIOACTIVITY NA, P134, DOI 10.1016/B978-012235154-9/50010-4
   El-Raey M, 1997, OCEAN COAST MANAGE, V37, P29, DOI 10.1016/S0964-5691(97)00056-2
   El-Raey M, 1999, MITIG ADAPT STRAT GL, V4, P343, DOI 10.1023/A:1009684210570
   El-Raey M., 1995, J COASTAL RES, V14, P190
   HARDY EP, 1973, NATURE, V241, P444, DOI 10.1038/241444a0
   Hernandez-Ceballos MA, 2015, J ENVIRON RADIOACTIV, V141, P62, DOI 10.1016/j.jenvrad.2014.12.003
   Kaste JM, 2002, REV MINERAL GEOCHEM, V50, P271
   LAL D, 1958, J ATMOS TERR PHYS, V12, P306, DOI 10.1016/0021-9169(58)90062-X
   Lazarevie Nataga, 1999, SCI TECH REV, VLIX, P65
   Matisoff G, 2002, J ENVIRON QUAL, V31, P54
   MOORE HE, 1976, J GEOPHYS RES-OC ATM, V81, P1056, DOI 10.1029/JC081i006p01056
   NOZAKI Y, 1978, J GEOPHYS RES-OCEANS, V83, P4047, DOI 10.1029/JC083iC08p04047
   OLSEN CR, 1986, J GEOPHYS RES-OCEANS, V91, P896, DOI 10.1029/JC091iC01p00896
   PAPASTEFANOU C, 1995, J ENVIRON RADIOACTIV, V26, P273, DOI 10.1016/0265-931X(94)00011-K
   Schuller P, 2006, J ENVIRON QUAL, V35, P1756, DOI 10.2134/jeq2005.0410
   Sepulveda A, 2008, J ENVIRON RADIOACTIV, V99, P35, DOI 10.1016/j.jenvrad.2007.06.010
   Steinmann P, 1999, GEOCHIM COSMOCHIM AC, V63, P1621, DOI 10.1016/S0016-7037(99)00021-6
   Tan KY, 2013, J RADIOANAL NUCL CH, V298, P883, DOI 10.1007/s10967-013-2524-9
   UNSCEAR, 2008, SOURC EFF ION RAD, P234
   UNSCEAR, 2000, SOURC EFF ION RAD, P89
   Walling DE, 1999, WATER RESOUR RES, V35, P3865, DOI 10.1029/1999WR900242
   Yoshimori M, 2005, ADV SPACE RES, V36, P922, DOI 10.1016/j.asr.2005.04.093
   Yoshimori M, 2005, ADV SPACE RES, V36, P828, DOI 10.1016/j.asr.2005.04.088
   Zhang FB, 2013, ATMOS ENVIRON, V77, P178, DOI 10.1016/j.atmosenv.2013.05.002
NR 29
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0265-931X
EI 1879-1700
J9 J ENVIRON RADIOACTIV
JI J. Environ. Radioact.
PD JUN
PY 2017
VL 172
BP 24
EP 29
DI 10.1016/j.jenvrad.2017.03.005
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EV6KF
UT WOS:000401877600004
PM 28314187
OA No
DA 2017-08-17
ER

PT J
AU Anis, EA
   Dhar, M
   Legendre, AM
   Wilkes, RP
AF Anis, Eman A.
   Dhar, Madhu
   Legendre, Alfred M.
   Wilkes, Rebecca P.
TI Transduction of hematopoietic stem cells to stimulate RNA interference
   against feline infectious peritonitis
SO JOURNAL OF FELINE MEDICINE AND SURGERY
LA English
DT Article
ID BONE-MARROW; DIFFERENTIATION; CORONAVIRUSES; REPLICATION; RIBOZYME;
   THERAPY
AB Objectives The goals of the study were: (1) to develop and evaluate non-replicating lentivirus vectors coding for feline coronavirus (FCoV)-specific micro (mi)RNA as a potential antiviral therapy for feline infectious peritonitis (FIP); (2) to assess the feasibility of transducing hematopoietic stem cells (HSCs) with ex vivo introduction of the miRNA-expressing lentivirus vector; and (3) to assess the ability of the expressed miRNA to inhibit FCoV replication in HSCs in vitro.
   Methods HSCs were obtained from feline bone marrow and replicated in vitro. Three lentiviruses were constructed, each expressing a different anti-FCoV miRNA. HSCs were stably transduced with the miRNA-expressing lentivirus vector that produced the most effective viral inhibition in a feline cell line. The effectiveness of the transduction and the expression of anti-FCoV miRNA were tested by infecting the HSCs with two different strains of FCoV. The inhibition of coronavirus replication was determined by relative quantification of the inhibition of intracellular viral genomic RNA synthesis using real-time, reverse-transcription PCR. The assessment of virus replication inhibition was determined via titration of extracellular virus using the TCID50 assay.
   Results Inhibition of FCoV was most significant in feline cells expressing miRNA-L2 that targeted the viral leader sequence, 48 h postinfection. miRNA-L2 expression in stably transduced HSCs resulted in 90% and 92% reductions in FIPV WSU 79-1146 genomic RNA synthesis and extracellular virus production, respectively, as well as 74% and 80% reduction in FECV WSU 79-1683 genomic RNA synthesis and extracellular virus production, respectively, as compared with an infected negative control sample producing non-targeting miRNA.
   Conclusions and relevance These preliminary results show that genetic modification of HSCs for constitutive production of anti-coronavirus miRNA will reduce FCoV replication.
C1 [Anis, Eman A.; Wilkes, Rebecca P.] Univ Georgia, Coll Vet Med, Infect Dis Vet Diagnost & Invest Lab, POB 1389,43 Brighton Rd, Tifton, GA 31793 USA.
   [Anis, Eman A.] Univ Sadat, Dept Virol, Fac Vet Med, Sadat City, Egypt.
   [Dhar, Madhu] Univ Tennessee, Coll Vet Med, Large Anim Clin Sci, Knoxville, TN USA.
   [Legendre, Alfred M.] Univ Tennessee, Coll Vet Med, Small Anim Clin Sci, Knoxville, TN USA.
RP Wilkes, RP (reprint author), Univ Georgia, Coll Vet Med, Infect Dis Vet Diagnost & Invest Lab, POB 1389,43 Brighton Rd, Tifton, GA 31793 USA.
EM beckpen@uga.edu
FU San Francisco Foundation Miller Trust/Winn Feline Foundation [MT 13-008]
FX This work was funded by San Francisco Foundation Miller Trust/Winn
   Feline Foundation (grant number MT 13-008).
CR Amado RG, 2004, HUM GENE THER, V15, P251, DOI 10.1089/104303404322886101
   Anis EA, 2014, AM J VET RES, V75, P828, DOI 10.2460/ajvr.75.9.828
   Charrier S, 2011, GENE THER, V18, P479, DOI 10.1038/gt.2010.163
   De Groot-Mijnes JDF, 2005, J VIROL, V79, P1036, DOI 10.1128/JVU.79.2.1036-1044.2005
   Dewerchin HL, 2005, ARCH VIROL, V150, P2483, DOI 10.1007/s00705-005-0598-6
   Gavrilov Kseniya, 2012, Yale Journal of Biology and Medicine, V85, P187
   Gut M, 1999, J VIROL METHODS, V77, P37, DOI 10.1016/S0166-0934(98)00129-3
   Hartmann K, 2005, VET CLIN N AM-SMALL, V35, P39, DOI 10.1016/j.cvsm.2004.10.011
   Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0
   Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932
   Morris KV, 2006, GENE THER, V13, P553, DOI 10.1038/sj.gt.3302688
   Munoz JL, 2012, DIFFERENTIATION, V84, P214, DOI 10.1016/j.diff.2012.07.002
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86
   Takano T, 2007, VET MICROBIOL, V119, P121, DOI 10.1016/j.vetmic.2006.08.033
NR 16
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1098-612X
EI 1532-2750
J9 J FELINE MED SURG
JI J. Feline Med. Surg.
PD JUN
PY 2017
VL 19
IS 6
BP 680
EP 686
DI 10.1177/1098612X16654958
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA EV9VX
UT WOS:000402135500016
PM 27354226
OA No
DA 2017-08-17
ER

PT J
AU Emara, AAM
   Aboudina, MM
   Fahmy, HAH
AF Emara, Ahmed A. M.
   Aboudina, Mohamed M.
   Fahmy, Hossam A. H.
TI Non-volatile low-power crossbar memcapacitor-based memory
SO MICROELECTRONICS JOURNAL
LA English
DT Article
DE Memcapacitor; Memory; Sneak paths
ID SNEAK PATHS
AB This paper proposes the use of a memcapacitor as a new memory cell. This new element may lead to a better memory on many directions: non-volatility, speed, density, and power consumption. To the best of our knowledge, we present the first Verilog-A model for memcapacitors and use it to simulate the memory cell then complete crossbar arrays of various sizes. The reading circuits completely solve the sneak paths problem including the effect of coupling parasitics in the large arrays. Our analysis indicates that memcapacitor memories are non-volatile memories with a density at least equivalent to dynamic RAMS but with lower power consumption.
C1 [Emara, Ahmed A. M.; Aboudina, Mohamed M.; Fahmy, Hossam A. H.] Cairo Univ, Fac Engn, Elect & Elect Commun Engn, Giza 12613, Egypt.
RP Emara, AAM (reprint author), Cairo Univ, Fac Engn, Elect & Elect Commun Engn, Giza 12613, Egypt.
EM a_emara@outlook.com
CR CHUA LO, 1976, P IEEE, V64, P209, DOI 10.1109/PROC.1976.10092
   CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337
   Di Ventra M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/25/255201
   Emara A.A., 2014, CIRCUITS SYST MWSCAS, P499
   Kim KH, 2012, NANO LETT, V12, P389, DOI 10.1021/nl203687n
   Martinez-Rincon J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195430
   Martinez-Rincon J, 2011, IEEE T ELECTRON DEV, V58, P1809, DOI 10.1109/TED.2011.2126022
   Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932
   Ventra M., 2009, P IEEE, V97, P1717, DOI DOI 10.1109/JPR0C.2009.2027660
   Xue C. J., 2011, IEEE ACM CODES ISSS, P325
   Yan ZB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02482
   Zidan MA, 2014, IEEE T NANOTECHNOL, V13, P274, DOI 10.1109/TNANO.2014.2299558
   Zidan MA, 2013, MICROELECTRON J, V44, P176, DOI 10.1016/j.mejo.2012.10.001
NR 13
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0026-2692
EI 1879-2391
J9 MICROELECTRON J
JI Microelectron. J.
PD JUN
PY 2017
VL 64
BP 39
EP 44
DI 10.1016/j.mejo.2017.04.005
PG 6
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA EW0XX
UT WOS:000402215600006
OA No
DA 2017-08-17
ER

PT J
AU Thabet, K
   Chan, HLY
   Petta, S
   Mangia, A
   Berg, T
   Boonstra, A
   Brouwer, WP
   Abate, ML
   Wong, VWS
   Nazmy, M
   Fischer, J
   Liddle, C
   George, J
   Eslam, M
AF Thabet, Khaled
   Chan, Henry Lik Yuen
   Petta, Salvatore
   Mangia, Alessandra
   Berg, Thomas
   Boonstra, Andre
   Brouwer, Willem P.
   Abate, Maria Lorena
   Wong, Vincent Wai-Sun
   Nazmy, Maiiada
   Fischer, Janett
   Liddle, Christopher
   George, Jacob
   Eslam, Mohammed
TI The Membrane-Bound O-Acyltransferase Domain-Containing 7 Variant
   rs641738 Increases Inflammation and Fibrosis in Chronic Hepatitis B
SO HEPATOLOGY
LA English
DT Article
ID FATTY LIVER-DISEASE; GENE-EXPRESSION; LYSOPHOSPHOLIPID ACYLTRANSFERASES;
   RISK-FACTORS; STEATOSIS; INFECTION; APOPTOSIS; GENOTYPE; MBOAT7; CELLS
AB Chronic hepatitis B (CHB) is characterized by hepatic inflammation that promotes progression to cirrhosis and predisposes to the development of hepatocellular carcinoma (HCC). Subtle interindividual genetic variation as well as viral and environmental factors interact to determine disease progression between individuals. Recently, the rs641738 membrane-bound O-acyltransferase domain-containing 7 (MBOAT7) polymorphism was demonstrated to influence histological liver damage in alcoholic liver disease, nonalcoholic fatty liver disease, and hepatitis C, but no data are available for CHB. We evaluated rs641738 influence on disease severity in a cohort of 1,101 patients with CHB. Forty-two patients underwent gene expression analysis to assess the functional consequences of rs641738 on hepatic MBOAT7 expression. The minor allele (T) of rs641738 was associated with greater inflammation (odds ratio [OR], 1.45; 95% confidence interval [CI], 1.06-1.95; P = 0.001) and fibrosis (OR = 1.31; 95% CI, 1.19-1.92; P = 0.01). Risk allele frequency in whites (0.43) was greater than in Chinese (0.24), translating to a larger size effect in the former. The rs641738 (T) allele was associated with lower hepatic MBOAT7 expression (P = 0.008), and the latter was associated with serum liver enzymes and inflammation. Neither patatin-like phospholipase domain-containing protein 3 rs738409 nor transmembrane 6 superfamily member 2 rs58542926 polymorphisms influenced disease severity. Conclusion: In patients with CHB, MBOAT7 rs641738 influences hepatic inflammation and fibrosis stage.
C1 [Thabet, Khaled; Liddle, Christopher; George, Jacob; Eslam, Mohammed] Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia.
   [Thabet, Khaled; Liddle, Christopher; George, Jacob; Eslam, Mohammed] Univ Sydney, Sydney, NSW, Australia.
   [Thabet, Khaled; Nazmy, Maiiada] Menia Univ, Biochem Dept, Fac Pharm, Al Minya, Egypt.
   [Chan, Henry Lik Yuen; Wong, Vincent Wai-Sun] Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Henry Lik Yuen; Wong, Vincent Wai-Sun] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China.
   [Petta, Salvatore] Univ Palermo, Sez Gastroenterol, DiBiMIS, Palermo, Italy.
   [Mangia, Alessandra] Osped Casa Sollievo Sofferenza, Div Hepatol, IRCCS, San Giovanni Rotondo, Italy.
   [Berg, Thomas; Fischer, Janett] Univ Clin Leipzig, Sect Hepatol, Clin Gastroenterol & Rheumatol, Leipzig, Germany.
   [Boonstra, Andre; Brouwer, Willem P.] Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.
   [Abate, Maria Lorena] Univ Turin, Div Gastroenterol & Hepatol, Dept Med Sci, Turin, Italy.
RP George, J (reprint author), Westmead Hosp, Dept Med, Westmead, NSW 2145, Australia.
EM jacob.george@sydney.edu.au
RI Wong, Vincent/K-3864-2014
FU Robert W. Storr Bequest; National Health and Medical Research Council of
   Australia (NHMRC) [1053206, APP1107178, APP1108422]; Egyptian
   government; Virgo consortium; Dutch government [FES0908]
FX M.E. and J.G. are supported by the Robert W. Storr Bequest to the Sydney
   Medical Foundation, University of Sydney; a National Health and Medical
   Research Council of Australia (NHMRC) Program Grant (1053206) and
   Project grants (APP1107178 and APP1108422). K.T. is supported by a
   Scholarship from the Egyptian government. A.B. was supported by the
   Virgo consortium, funded by the Dutch government project number FES0908.
CR Auton A, 2015, NATURE, V526, P68, DOI DOI 10.1038/NATURE15393
   Balboa MA, 2003, J IMMUNOL, V171, P989
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417
   Cohen J, 1988, PERCEPT MOTOR SKILL, V67, P1007
   Di Bisceglie AM, 2017, J VIRAL HEPATITIS, V24, P320, DOI 10.1111/jvh.12643
   Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014
   Eslam M, 2016, HEPATOLOGY, V64, P34, DOI 10.1002/hep.28475
   Eslam M, 2016, J HEPATOL, V64, P390, DOI 10.1016/j.jhep.2015.11.008
   Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422
   Eslam M, 2014, J HEPATOL, V61, P235, DOI 10.1016/j.jhep.2014.03.039
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149
   Ghany MG, 2015, CLIN GASTROENTEROL H, V13, P183, DOI 10.1016/j.cgh.2014.06.028
   Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200
   Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850
   Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078
   Kabir I, 2016, J BIOL CHEM, V291, P7651, DOI 10.1074/jbc.M115.697011
   Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201
   Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190
   Luukkonen PK, 2016, J HEPATOL, V65, P1263, DOI 10.1016/j.jhep.2016.07.045
   Machado MV, 2011, J GASTROEN HEPATOL, V26, P1361, DOI 10.1111/j.1440-1746.2011.06801.x
   Mancina RM, 2016, GASTROENTEROLOGY, V150, P1219, DOI 10.1053/j.gastro.2016.01.032
   Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327
   Minakari M, 2009, EUR J GASTROEN HEPAT, V21, P512, DOI 10.1097/MEG.0b013e328326792e
   Notarnicola M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-10
   Nur U, 2009, EUR J EPIDEMIOL, V24, P589, DOI 10.1007/s10654-009-9384-1
   Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108
   Robichaud PP, 2013, J LIPID RES, V54, P2665, DOI 10.1194/jlr.M037044
   Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002
   Ruis-Gonzalez MD, 2015, J PROTEOMICS, V119, P169, DOI 10.1016/j.jprot.2015.02.003
   Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2
   Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955
   Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142
   Thabet K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12757
   Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8
   Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350
   Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622
   Vanwolleghem T, 2015, HEPATOLOGY, V62, P87, DOI 10.1002/hep.27805
   Vigano M, 2013, HEPATOLOGY, V58, P1245, DOI 10.1002/hep.26445
   Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   Zarini S, 2014, PROSTAG OTH LIPID M, V113, P52, DOI 10.1016/j.prostaglandins.2014.08.003
NR 42
TC 1
Z9 1
U1 8
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUN
PY 2017
VL 65
IS 6
BP 1840
EP 1850
DI 10.1002/hep.29064
PG 11
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA EV2TV
UT WOS:000401608900009
PM 28109005
OA No
DA 2017-08-17
ER

PT J
AU Yumurtaci, A
   Sipahi, H
   Al-Abdallat, A
   Jighly, A
   Baum, M
AF Yumurtaci, Aysen
   Sipahi, Hulya
   Al-Abdallat, Ayed
   Jighly, Abdulqader
   Baum, Michael
TI Construction of new EST-SSRs for Fusarium resistant wheat breeding
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Wheat; EST; Fusarium; Genetic diversity; Resistance; SSRs
ID HEAD BLIGHT RESISTANCE; TRITICUM-AESTIVUM L.; MICROSATELLITE MARKERS;
   WINTER-WHEAT; CROWN ROT; SPRING WHEAT; BREAD WHEAT; QTL; DNA;
   GRAMINEARUM
AB Surveying Fusarium resistance in wheat with easy applicable molecular markers such as simple sequence repeats (SSRs) is a prerequest for molecular breeding. Expressed sequence tags (ESTs) are one of the main sources for development of new SSR candidates. Therefore, 18.292 publicly available wheat ESTs were mined and genotyping of newly developed 55 EST-SSR derived primer pairs produced clear fragments in ten wheat cultivars carrying different levels of Fusarium resistance. Among the proved markers, 23 polymorphic EST-SSRs were obtained and related alleles were mostly found on B and D genome. Based on the fragment profiling and similarity analysis, a 327 bp amplicon, which was a product of contig 1207 (chromosome 5BL), was detected only in Fusarium head blight (FHB) resistant cultivars (CM82036 and Sumai) and the amino acid sequences showed a similarity to pathogen related proteins. Another FHB resistance related EST-SSR, Contig 556 (chromosome 1BL) produced a 151 bp fragment in Sumai and was associated to wax2-like protein. A polymorphic 204 bp fragment, derived from Contig 578 (chromosome 1DL), was generated from root rot (FRR) resistant cultivars (2-49; Altay2000 and Sunco). A total of 98 alleles were displayed with an average of 1.8 alleles per locus and the polymorphic information content (PIC) ranged from 0.11 to 0.78. Dendrogram tree with two main and five sub-groups were displayed the highest genetic relationship between FRR resistant cultivars (2-49 and Altay2000), FRR sensitive cultivars (Seri82 and Scout66) and FHB resistant cultivars (CM82036 and Sumai). Thus, exploitation of these candidate EST-SSRs may help to genotype other wheat sources for Fusarium resistance. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Yumurtaci, Aysen] Univ Marmara, Fac Sci & Letters, Dept Biol, TR-34722 Istanbul, Turkey.
   [Sipahi, Hulya] Univ Sinop, Fac Arts & Sci, Dept Biol, TR-57000 Sinop, Turkey.
   [Al-Abdallat, Ayed; Jighly, Abdulqader] ICARDA, Giza, Egypt.
   [Al-Abdallat, Ayed] Univ Jordan, Fac Agr, Dept Hort & Crop Sci, Amman 11942, Jordan.
   [Baum, Michael] ICARDA, Av Mohamed Belarbi Alaoui,POB 6299, Rabat, Morocco.
RP Yumurtaci, A (reprint author), Univ Marmara, Fac Sci & Letters, Dept Biol, TR-34722 Istanbul, Turkey.
EM yumurtaciay@yahoo.com; hulyasipahi@hotmail.com; a.al-abdallat@cgiar.org;
   m.baum@cgiar.org
FU Scientific Research Projects (BAP), University of Sinop, Turkey
   [FEF-1901.13-02]
FX This study was partially funded by Scientific Research Projects (BAP,
   project number FEF-1901.13-02), University of Sinop, Turkey. We
   gratefully acknowledge Miss. Shireen Qasrawi and Miss. Shiamaa Mahmoud
   for their technical assistance.
CR Anderson JA, 2001, THEOR APPL GENET, V102, P1164, DOI 10.1007/s001220000509
   Anderson J. A., 1998, P 9 INT WHEAT GEN S, V1, P135
   Arslan U., 2002, ULUDAG U AGR FAC J, V16, P69
   Bilgen M, 2004, BIOINFORMATICS, V20, P3379, DOI 10.1093/bioinformatics/bth410
   Bovill WD, 2006, PLANT BREEDING, V125, P538, DOI 10.1111/j.1439-0523.2006.01251.x
   Budak H, 2005, THEOR APPL GENET, V111, P1545, DOI 10.1007/s00122-005-0083-3
   Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6
   Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x
   Burt C, 2015, THEOR APPL GENET, V128, P1725, DOI 10.1007/s00122-015-2542-9
   Castillo A, 2010, ANN APPL BIOL, V156, P347, DOI 10.1111/j.1744-7348.2010.00391.x
   Castillo A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-97
   Chen H., 2005, CHINESE SCI BULL, V20, P2328
   Collard B. C. Y., 2005, PLANT BREEDING, V124, P1
   Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7
   DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409
   Doganay G. D., 2008, BIOCH GENET, V46, P663
   Dong P, 2009, HEREDITAS, V146, P1, DOI 10.1111/j.1601-5223.2009.02098.x
   Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738
   Gosman N, 2010, PLANT PATHOL, V59, P147, DOI 10.1111/j.1365-3059.2009.02202.x
   Guo XW, 2008, PLANT DIS, V92, P756, DOI 10.1094/PDIS-92-5-0756
   Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4
   Haberle J, 2009, THEOR APPL GENET, V119, P325, DOI 10.1007/s00122-009-1041-2
   Hekimhan H., 2013, TABAD, Tarim Bilimleri Arastirma Dergisi, V6, P56
   Hekimhan H., 2011, SELCUK TARIM GIDA BI, V25, P25
   Hilton AJ, 1999, PLANT PATHOL, V48, P202, DOI 10.1046/j.1365-3059.1999.00339.x
   Hollingsworth CR, 2008, PLANT DIS, V92, P1339, DOI 10.1094/PD1S-92-9-l339
   Jayatilake D, 2011, THEOR APPL GENET, V122, P1189, DOI 10.1007/s00122-010-1523-2
   Jennings P, 2004, PLANT PATHOL, V53, P643, DOI 10.1111/j.1365-3059.2004.01061.x
   Jin F, 2013, CROP SCI, V53, P2006, DOI 10.2135/cropsci2012.09.0531
   Joukhadar Reem, 2012, BMC Res Notes, V5, P556, DOI 10.1186/1756-0500-5-556
   Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165
   Lehoczki-Krsjak S, 2010, FOOD ADDIT CONTAM A, V27, P616, DOI 10.1080/19440041003606144
   Li HB, 2010, THEOR APPL GENET, V121, P941, DOI 10.1007/s00122-010-1363-0
   Li L, 2008, PROG NAT SCI, V18, P1485, DOI 10.1016/j.pnsc.2008.05.012
   Lucas SJ, 2012, GENOMICS, V12, P173
   Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x
   Metzgar D, 2000, GENOME RES, V10, P72
   Miedaner T, 2008, J PHYTOPATHOL, V156, P129, DOI 10.1111/j.1439-0434.2007.01394.x
   Mitter V, 2006, PLANT PATHOL, V55, P433, DOI 10.1111/j.1365-3059.2006.01384.x
   Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822
   Nicol J. M., 2006, PHYTOPATHOLOGY, V96
   Paillard S, 2004, THEOR APPL GENET, V109, P323, DOI 10.1007/s00122-004-1628-6
   Roder MS, 1998, GENETICS, V149, P2007
   Rohlf F. J., 1998, APPL BIOSTATISTICS
   Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033
   Steed A, 2005, THEOR APPL GENET, V111, P521, DOI 10.1007/s00122-005-2043-3
   Steiner B, 2009, THEOR APPL GENET, V118, P753, DOI 10.1007/s00122-008-0935-8
   Talas F, 2011, EUR J PLANT PATHOL, V131, P39, DOI 10.1007/s10658-011-9785-3
   Torres AM, 2010, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, SECOND EDITION, P185, DOI 10.1007/978-90-481-2967-6_8
   Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005
   Waldron BL, 1999, CROP SCI, V39, P805
   Ward TJ, 2008, FUNGAL GENET BIOL, V45, P473, DOI 10.1016/j.fgb.2007.10.003
   Wei L., 2008, AGR SCI CHINA, V7, P1029
   WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407
   Zhang XH, 2012, THEOR APPL GENET, V125, P495, DOI 10.1007/s00122-012-1848-0
NR 55
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD JUN
PY 2017
VL 68
BP 22
EP 28
DI 10.1016/j.compbiolchem.2017.02.003
PG 7
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA EV6JN
UT WOS:000401875800004
PM 28231525
OA No
DA 2017-08-17
ER

PT J
AU Kamal, S
   Chowdhury, L
   Khan, MI
   Ashour, AS
   Tavares, JMRS
   Dey, N
AF Kamal, Sarwar
   Chowdhury, Linkon
   Khan, Mohammad Ibrahim
   Ashour, Amira S.
   Tavares, Joao Manuel R. S.
   Dey, Nilanjan
TI Hidden Markov model and Chapman Kolmogrov for protein structures
   prediction from images
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Hidden Markov model; Chapman Kolmogrov equation; Flood fill; Warshall
   algorithm; Tertiary structure
ID SECONDARY-STRUCTURE PREDICTION; SUPPORT VECTOR MACHINES; GENETIC
   ALGORITHM; FOLD RECOGNITION; COMPUTATIONAL DESIGN; SEQUENCE ALIGNMENT;
   SCORING MATRIX; SPECIFICITY; SPACE; PROBABILITIES
AB Protein structure prediction and analysis are more significant for living organs to perfect asses the living organ functionalities. Several protein structure prediction methods use neural network (NN). However, the Hidden Markov model is more interpretable and effective for more biological data analysis compared to the NN. It employs statistical data analysis to enhance the prediction accuracy. The current work proposed a protein prediction approach from protein images based on Hidden Markov Model and Chapman Kolmogrov equation. Initially, a preprocessing stage was applied for protein images' binarization using Otsu technique in order to convert the protein image into binary matrix. Subsequently, two counting algorithms, namely the Flood fill and Warshall are employed to classify the protein structures. Finally, Hidden Markov model and Chapman Kolmogrov equation are applied on the classified structures for predicting the protein structure. The execution time and algorithmic performances are measured to evaluate the primary, secondary and tertiary protein structure prediction. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Kamal, Sarwar] East West Univ, Dhaka, Bangladesh.
   [Chowdhury, Linkon; Khan, Mohammad Ibrahim] Chittagong Univ Engn & Technol, Chittagong, Bangladesh.
   [Ashour, Amira S.] Tanta Univ, Fac Engn, Dept Elect & Elect Commun Engn, Tanta, Egypt.
   [Tavares, Joao Manuel R. S.] Univ Porto, Fac Engn, Dept Engn Mecan, Inst Ciencia & Inovaca Engn Mecan & Engn Ind, Oporto, Portugal.
   [Dey, Nilanjan] Techno India Coll Technol, Dept Informat Technol, Kolkata 740000, W Bengal, India.
RP Kamal, S (reprint author), East West Univ, Dhaka, Bangladesh.
EM sarwar.saubdcoxbazar@gmail.com; linkoncuet@gmail.com;
   muhammad_ikhancuet@yahoo.com; amirasashour@yahoo.com; tavares@fe.up.pt;
   neelanjan.dey@gmail.com
CR ASAI K, 1993, COMPUT APPL BIOSCI, V9, P141
   Aydin Y., 2004, IEEE INT C AC SPEECH
   Aydin Z, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-178
   Benitez C. M. V., 2010, J BRAZILIAN COMPUTER, V16, P69, DOI DOI 10.1007/S13173-010-0002-6
   Bidgood WD, 1997, J AM MED INFORM ASSN, V4, P199
   Bindu H., 2012, INT J ADV SCI TECHNO, V38, P67
   Brender JR, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004494
   Buades A, 2005, PROC CVPR IEEE, P60
   Carnevali P, 2003, J AM CHEM SOC, V125, P14244, DOI 10.1021/ja036647b
   Chetia S., 2012, 3 INT C COMP COMM TE
   Chu W., 2004, INT C MACH LEARN, V161, P168
   Contreras-Moreira B, 2003, PROTEINS, V53, P424, DOI 10.1002/prot.10549
   Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304
   Cui Y, 1998, PROTEINS, V31, P247, DOI 10.1002/(SICI)1097-0134(19980515)31:3<247::AID-PROT2>3.0.CO;2-G
   Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238
   Dandekar T, 1997, PROTEIN ENG, V10, P877, DOI 10.1093/protein/10.8.877
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   Day R.O., 2002, P IEEE DARPA INT C C, P32
   Deerman K.R., 2001, P ACM S APPL COMP MA, V19, P333
   Dehzangi A., 2013, EXPLORING POTENTIAL
   Dehzangi A, 2013, IEEE ACM T COMPUT BI, V10, P564, DOI 10.1109/TCBB.2013.65
   Fromer M, 2010, BIOINFORMATICS, V26, P2266, DOI 10.1093/bioinformatics/btq412
   Goldberg D. E., 1989, GENETIC ALGORITHMS S
   Gonzales R.C., 2007, DIGITAL IMAGE PROCES
   Guo J, 2004, PROTEINS, V54, P738, DOI 10.1002/prot.10634
   He Y, 2015, P NATL ACAD SCI USA, V112, P5029, DOI 10.1073/pnas.1504806112
   Hiner Mark C., 2016, BMC BIOINF, V17
   Hogue M.T., 2009, BIOMEDICAL DATA APPL, P317
   Hogue M.T., 2015, TR20154
   Holland J.H., 2001, ADAPTATION NATURAL A
   Hu HJ, 2004, IEEE T NANOBIOSCI, V3, P265, DOI 10.1109/TNB.2004.837906
   Iqbal S, 2015, J THEOR BIOL, V380, P380, DOI 10.1016/j.jtbi.2015.06.012
   Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Kaiser C.E., 1997, P 8 SIAM C PAR PROC
   Kamal S, 2015, INT J COMPUT SCI NET, V15, P29
   Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005
   Kim H, 2003, PROTEIN ENG, V16, P553, DOI 10.1093/protein/gzg072
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749
   Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427
   Kumar M, 2015, EXCLI J, V14, P1232, DOI 10.17179/excli2015-302
   Sukesh Kumar R., 2007, WORLD ACAD SCI ENG T, V1, P1607
   Lee B, 1996, FASEB J, V10, P119
   Lopes A, 2010, J COMPUT CHEM, V31, P1273, DOI 10.1002/jcc.21414
   lqbal S., 2015, SWARMAND EVOLUT COMP, V24, P50
   Lyons J, 2015, IEEE T NANOBIOSCI, V14, P761, DOI 10.1109/TNB.2015.2457906
   Lyons J, 2014, J THEOR BIOL, V354, P137, DOI 10.1016/j.jtbi.2014.03.033
   Malekpour SA, 2009, MATH BIOSCI, V221, P130, DOI 10.1016/j.mbs.2009.07.004
   Mandal S., 2017, P 2012 INT C INF ENV, P171
   Martin J, 2005, IEEE INTELL SYST, V20, P19, DOI 10.1109/MIS.2005.102
   McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500
   Milan T., 2013, APPL SOFT COMPUT, P687
   Nguyen M.N., 2004, PAC S BIOC PAC S BIO, P346
   Ollikainen N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003313
   Otsu Nobuyuki, 1979, NEW AFR, V9, P62
   Padmavathi G., 2010, INT J COMPUTER SCI I, V7, P35
   Paliwal KK, 2014, IEEE T NANOBIOSCI, V13, P44, DOI 10.1109/TNB.2013.2296050
   Pence WD, 2010, ASTRON ASTROPHYS, V524, DOI 10.1051/0004-6361/201015362
   Peng Z., 2016, BRIEF BIOINFORM, P17
   Pratt WK, 2007, DIGITAL IMAGE PROCES
   Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035
   Przybylski D, 2002, PROTEINS, V46, P197, DOI 10.1002/prot.10029
   Quan Lijun, 2016, BIOINFORMATICS, P1
   Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2000.4336
   Saini H., 2014, J ADV COMPUT INTELL, V8
   Schmidler SC, 2000, J COMPUT BIOL, V7, P233, DOI 10.1089/10665270050081496
   Schulze-Kremer S., 1994, Proceedings of the Twenty-Seventh Hawaii International Conference on System Sciences. Vol.V: Biotechnology Computing (Cat. No.94TH0607-2), P345, DOI 10.1109/HICSS.1994.323562
   Sen D, 2009, IEEE T IMAGE PROCESS, V18, P879, DOI 10.1109/TIP.2009.2012890
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008
   Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100
   Siegel JB, 2015, P NATL ACAD SCI USA, V112, P3704, DOI 10.1073/pnas.1500545112
   Singh T., 2012, NEW LOCAL ADAPTIVE T
   STULTZ CM, 1993, PROTEIN SCI, V2, P305
   Tao WB, 2003, PATTERN RECOGN LETT, V24, P3069, DOI 10.1016/S0167-8655(03)00166-1
   Tomasi C., 1998, 6 INT C COMP VIS, V1998, P839, DOI DOI 10.1109/ICCV.1998.710815
   Tragante-do-O V., 2010, LEARN NONLINEAR MODE, V8, P135
   Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223
   WHITE JV, 1994, MATH BIOSCI, V119, P35, DOI 10.1016/0025-5564(94)90004-3
   Yao XQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-49
   Yaroslaysky L.P., 1986, GRAPHICS IMAGE PROCE, V35, P234
   Zhang XL, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S6
   Zheng Wei-Mou, 2004, J Bioinform Comput Biol, V2, P333, DOI 10.1142/S0219720004000582
NR 84
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD JUN
PY 2017
VL 68
BP 231
EP 244
DI 10.1016/j.compbiolchem.2017.04.003
PG 14
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA EV6JN
UT WOS:000401875800027
OA No
DA 2017-08-17
ER

PT J
AU Elgiddawy, N
   Essam, TM
   El Rouby, WMA
   Raslan, M
   Farghali, AA
AF Elgiddawy, Nada
   Essam, Tamer M.
   El Rouby, Waleed M. A.
   Raslan, Mai
   Farghali, Ahmed A.
TI New approach for enhancing Chlorella vulgaris biomass recovery using
   ZnAl-layered double hydroxide nanosheets
SO JOURNAL OF APPLIED PHYCOLOGY
LA English
DT Article
DE Microalgae; Flocculation; Settleability; LDH nanosheets; Wastewater
ID WASTE-WATER TREATMENT; FLOCCULATION; MICROALGAE; CHITOSAN; ADSORPTION;
   PARTICLES; EXCHANGE; GREEN
AB The lack of cost-effective techniques for harvesting microalgae is a major challenge for microalgal application in wastewater treatment plants as well as large-scale production of microalgae. Here, a novel approach for the recovery of Chlorella vulgaris biomass using zinc aluminum-layered double hydroxide (ZnAl-LDH) nanosheets is introduced. ZnAl-LDHs are a green "eco-friendly" and efficient flocculent with capacity up to 0.521 g g(-1). The adsorption and agglomeration of microalgal cells onto LDH layers were elucidated and confirmed. Different factors affecting flocculation efficiency including LDH concentration, algae concentration, pH, temperature, and time were studied and statistically optimized using the Plackett-Burman design. The best flocculation efficiency (96%) was obtained at the following conditions: pH 6, 35 A degrees C temperature, and microalgae concentration range from 4.8 to 8.7 mg L-1 based on chlorophyll a content, 1 g L-1 LDH dosage and sedimentation time of 1 min. LDH concentrations higher than 1 g L-1 had no positive effect on the efficiency of the flocculation process.
C1 [Elgiddawy, Nada; Raslan, Mai] Beni Suef Univ, Fac Postgrad Studies Adv Sci PSAS, Dept Biotechnol & Life Sci, Bani Suwayf 62511, Egypt.
   [Essam, Tamer M.] Cairo Univ, Fac Pharm, Biotechnol Ctr, Dept Microbiol & Immunol, Cairo, Egypt.
   [El Rouby, Waleed M. A.; Farghali, Ahmed A.] Beni Suef Univ, Fac Postgrad Studies Adv Sci PSAS, Mat Sci & Nanotechnol Dept, Bani Suwayf 62511, Egypt.
RP Elgiddawy, N (reprint author), Beni Suef Univ, Fac Postgrad Studies Adv Sci PSAS, Dept Biotechnol & Life Sci, Bani Suwayf 62511, Egypt.; El Rouby, WMA (reprint author), Beni Suef Univ, Fac Postgrad Studies Adv Sci PSAS, Mat Sci & Nanotechnol Dept, Bani Suwayf 62511, Egypt.
EM nadagiddawy@yahoo.com; waleedmohamedali@psas.bsu.edu.eg
OI Raslan, Mai/0000-0003-3136-6833
FU science and technology development fund (STDF) in Egypt [14970]
FX This work was supported by the science and technology development fund
   (STDF) in Egypt, under the research support grants (RSG) project ID no.
   14970
CR Abdel-Raouf N, 2012, SAUDI J BIOL SCI, V19, DOI 10.1016/j.sjbs.2012.04.005
   Abdolmohammad-Zadeh H, 2015, CHEM ENG COMMUN, V202, P1349, DOI 10.1080/00986445.2014.927357
   Alekseeva T, 2011, J HAZARD MATER, V191, P126, DOI 10.1016/j.jhazmat.2011.04.050
   Ayawei N, 2015, INT J CHEM, V7, P122, DOI [10.5539/ijc.v7n1p122, DOI 10.5539/IJC.V7N1P122]
   Beach ES, 2012, BIORESOURCE TECHNOL, V121, P445, DOI 10.1016/j.biortech.2012.06.012
   Chen L, 2013, BIORESOURCE TECHNOL, V133, P9, DOI 10.1016/j.biortech.2013.01.071
   Choi SJ, 2008, J MATER CHEM, V18, P615, DOI 10.1039/b711208d
   Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015
   Costantino U., 2013, HDB CLAY SCI B, V5, P765
   Craggs R, 2012, J APPL PHYCOL, V24, P329, DOI 10.1007/s10811-012-9810-8
   Divakaran R, 2002, J APPL PHYCOL, V14, P419, DOI 10.1023/A:1022137023257
   El Rakaiby M, 2012, J BIOREMEDIAT BIODEG, DOI [10.4172/2155-6199.S8-001, DOI 10.4172/2155-6199.S8-001]
   Hidouri S, 2016, AFR J BIOTECHNOL, V15, P1520
   Huo SH, 2014, ENERGIES, V7, P6186, DOI 10.3390/en7096186
   Kuang Y, 2010, MATERIALS, V3, P5220, DOI 10.3390/ma3125220
   Liang JJ, 2015, J APPL PHYCOL, V27, P2313, DOI 10.1007/s10811-014-0482-4
   Liu JY, 2013, APPL CLAY SCI, V75-76, P39, DOI 10.1016/j.clay.2013.02.007
   Liu Y, 2016, J APPL PHYCOL, V28, P1623, DOI 10.1007/s10811-015-0735-x
   Mabrouk M., 2012, AFR J APPL MICROB RE, V2, P6
   Mobin S, 2014, 19 AUSTR FLUID MECH, P8
   Morrissey KL, 2015, BIOTECHNOL BIOENG, V112, P74, DOI 10.1002/bit.25340
   Oh JM, 2009, J MATER CHEM, V19, P2553, DOI 10.1039/b819094a
   Oswald W. J., 1988, Micro-algal biotechnology, P305
   Pahl S. L., 2013, ALGAE BIOFUELS ENERG, P165
   Parekh V.J., 2011, INT J PHARM BIOL SCI, V1, P103
   Park DH, 2013, PROG POLYM SCI, V38, P1442, DOI 10.1016/j.progpolymsci.2013.05.007
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Rakesh S, 2014, J APPL PHYCOL, V26, P399, DOI 10.1007/s10811-013-0114-4
   Salak AN, 2010, CHEM PHYS LETT, V495, P73, DOI 10.1016/j.cplett.2010.06.041
   Sansuk S, 2015, GREEN CHEM, V17, P3837, DOI 10.1039/c5gc00713e
   Silion M, 2009, J OPTOELECTRON ADV M, V11, P528
   Sirin S, 2012, J APPL PHYCOL, V24, P1067, DOI 10.1007/s10811-011-9736-6
   Sostaric M, 2009, CHEM BIOCHEM ENG Q, V23, P471
   TENNEY MW, 1969, APPL MICROBIOL, V18, P965
   Theiss FL, 2012, THESIS
   Vandamme D, 2013, TRENDS BIOTECHNOL, V31, P233, DOI 10.1016/j.tibtech.2012.12.005
   Vandamme D, 2012, BIORESOURCE TECHNOL, V105, P114, DOI 10.1016/j.biortech.2011.11.105
   Zhang Y, 2012, COLLOID SURFACE A, V408, P71, DOI 10.1016/j.colsurfa.2012.05.033
NR 38
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-8971
EI 1573-5176
J9 J APPL PHYCOL
JI J. Appl. Phycol.
PD JUN
PY 2017
VL 29
IS 3
BP 1399
EP 1407
DI 10.1007/s10811-017-1050-5
PG 9
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA EV0KU
UT WOS:000401429300027
OA No
DA 2017-08-17
ER

PT J
AU Isber, S
   Barakat, MME
   Al-Sayyed, N
   Noureddine, S
   Awad, R
AF Isber, S.
   Barakat, M. M. E.
   Al-Sayyed, N.
   Noureddine, S.
   Awad, R.
TI Ac Magnetic Susceptibility and EPR Studies of
   (Co0.5Zn0.5Fe2O4)(x)/(Cu0.5Tl0.5)-1223 Composites
SO JOURNAL OF SUPERCONDUCTIVITY AND NOVEL MAGNETISM
LA English
DT Article
DE (Cu center dot Tl)-1223; Ac magnetic susceptibility; EPR; Magnetic
   moment
ID WEAK-LINK BEHAVIOR; SUPERCONDUCTING PROPERTIES; SINGLE-CRYSTALS;
   THIN-FILMS; PHASE
AB Cobalt zinc ferrite nanoparticles (Co0.5Zn0. 5Fe2O4) (x) (similar to 5-8 nm in size) added to Cu0.5Tl0.5Ba2Ca2Cu3O10-delta superconductor samples, 0.00 aexae 0.20 wt. %, were prepared using a singlestep solid-state reaction technique. The temperature dependence of the real (chi (')) and imaginary (chi (aEuro3)) components of the magnetic susceptibility (ACMS) was measured at various ac magnetic field amplitudes (3-16 Oe). The results were analyzed by using Bean critical state model to estimate the critical current density (J (c)) It was found that J (c) increases as x increases up to 0.08 and then it decreases with further increase in x. X- and Q-Band (9.3 and 33. GHz) electron paramagnetic resonance (EPR) spectra were measured in the temperature range from 300 to 10 K.The g values of Cu (2+) monomer were found to correspond to that of rhombic site symmetry with g (xx) = 2.21 +/- 0.02, g (yy) = 2.10 +/- 0.02, and g (zz) = 2.02 +/- 0.02.
C1 [Isber, S.] Amer Univ Beirut, Dept Phys, POB 11-0236, Beirut, Lebanon.
   [Barakat, M. M. E.] Alexandria Univ, Fac Sci, Phys Dept, Alexandria, Egypt.
   [Al-Sayyed, N.; Awad, R.] Beirut Arab Univ, Fac Sci, Phys Dept, Beirut, Lebanon.
   [Noureddine, S.] Lebanese Univ, Fac Sci, Phys Dept, Beirut, Lebanon.
RP Isber, S (reprint author), Amer Univ Beirut, Dept Phys, POB 11-0236, Beirut, Lebanon.
EM si00@aub.edu.lb
CR Abou Aly AI, 2012, J SUPERCOND NOV MAGN, V25, P2281, DOI 10.1007/s10948-012-1621-2
   Awad R, 2008, J ALLOY COMPD, V460, P500, DOI 10.1016/j.jallcom.2007.05.100
   Bahgat AA, 2007, PHYSICA B, V399, P70, DOI 10.1016/j.physb.2007.05.027
   Barakat M. M. E., 2016, J SUPERCOND NO UNPUB
   BEAN CP, 1964, REV MOD PHYS, V36, P31, DOI 10.1103/RevModPhys.36.31
   Chao-Ying L., 2013, PHYSICA B, V412, P22
   Dhage P, 2013, SURF INTERFACE ANAL, V45, P865, DOI 10.1002/sia.5174
   GINGOLD DB, 1990, PHYS REV B, V42, P8220, DOI 10.1103/PhysRevB.42.8220
   Gomory F, 1997, SUPERCOND SCI TECH, V10, P523, DOI 10.1088/0953-2048/10/8/001
   Gratens X, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075207
   HOFFMANN SK, 1992, J MAGN RESON, V98, P1, DOI 10.1016/0022-2364(92)90104-F
   HUTH M, 1991, PHYSICA C, V178, P203, DOI 10.1016/0921-4534(91)90178-2
   Ihara H, 1999, IEEE T APPL SUPERCON, V9, P1551, DOI 10.1109/77.784690
   Ilonca G, 2001, INT J INORG MATER, V3, P763, DOI 10.1016/S1466-6049(01)00049-6
   Khan NA, 1999, PHYSICA C, V320, P39, DOI 10.1016/S0921-4534(99)00294-4
   Khan S, 1998, SOLID STATE COMMUN, V106, P621, DOI 10.1016/S0038-1098(98)00101-X
   Khan S, 1997, PHYSICA C, V281, P143, DOI 10.1016/S0921-4534(97)00328-6
   LOMBARDO LW, 1992, PHYS REV B, V46, P5615, DOI 10.1103/PhysRevB.46.5615
   MISRA SK, 1989, J PHYS-CONDENS MAT, V1, P9499, DOI 10.1088/0953-8984/1/47/018
   Mohammed NH, 2013, J LOW TEMP PHYS, V172, P234, DOI 10.1007/s10909-013-0867-9
   Farach H. A., 1995, SUPERCONDUCTIVITY
   Sahoo LK, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.214501
   Salamati H, 2003, SOLID STATE COMMUN, V125, P407, DOI 10.1016/S0038-1098(02)00809-8
   Sedky A, 2006, SOLID STATE COMMUN, V139, P126, DOI 10.1016/j.ssc.2006.05.017
   Zhang ZH, 2015, LOW TEMP PHYS+, V41, P177, DOI 10.1063/1.4913755
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1939
EI 1557-1947
J9 J SUPERCOND NOV MAGN
JI J. Supercond. Nov. Magn
PD JUN
PY 2017
VL 30
IS 6
BP 1673
EP 1680
DI 10.1007/s10948-016-3677-x
PG 8
WC Physics, Applied; Physics, Condensed Matter
SC Physics
GA EU9GZ
UT WOS:000401348600038
OA No
DA 2017-08-17
ER

PT J
AU El-hady, ES
   Brzdek, J
   Nassar, H
AF El-hady, El-sayed
   Brzdek, Janusz
   Nassar, Hamed
TI On the structure and solutions of functional equations arising from
   queueing models
SO AEQUATIONES MATHEMATICAE
LA English
DT Article
DE Two-place functional equation; Boundary value problem; Two-queue system;
   Probability generating function; PGF; Canonical form
ID PERFORMANCE ANALYSIS; COUPLED PROCESSORS; SERVICE CAPACITY; BUFFERED
   SWITCH; 2 DEMANDS; QUEUES; ARRIVALS; PRIORITY; PARALLEL; NETWORKS
AB It is a survey on functional equations of a certain type, for functions in two complex variables, which often arise in queueing models. They share a common pattern despite their apparently different forms. In particular, they invariably characterize the probability generating function of the bivariate distribution characterizing a two-queue system and their forms depend on the composition of the underlying system. Unfortunately, there is no general methodology of solving them, but rather various ad-hoc techniques depending on the nature of a particular equation; most of the techniques involve advanced complex analysis tools. Also, the known solutions to particular cases of this type of equations are in general of quite involved forms and therefore it is very difficult to apply them practically. So, it is clear that the issues connected with finding useful descriptions of solutions to these equations create a huge area of research with numerous open problems. The aim of this article is to stimulate a methodical study of this area. To this end we provide a survey of the queueing literature with such two-place functional equations. We also present several observations obtained while preparing it. We hope that in this way we will make it easier to take some steps forward on the road towards a (more or less) general solving theory for this interesting class of equations.
C1 [El-hady, El-sayed] Suez Canal Univ, Fac Comp & Informat, Ismailia, Egypt.
   [Brzdek, Janusz] Pedag Univ, Dept Math, Krakow, Poland.
   [Nassar, Hamed] Suez Canal Univ, Fac Comp & Informat, Comp Sci Dept, Ismailia, Egypt.
RP El-hady, ES (reprint author), Suez Canal Univ, Fac Comp & Informat, Ismailia, Egypt.
EM elsayed_elhady@ci.suez.edu.eg; jbrzdek@up.krakow.pl;
   nassar@ci.suez.edu.eg
FU Ministry of Higher Education and Scientific Research, Cairo, Egypt;
   Innsbruck University, Austria [2014/3/MIP - 12]
FX El-sayed El-hady was a joint-scholarship holder. This scholarship was
   fully funded by the the Ministry of Higher Education and Scientific
   Research, Cairo, Egypt during the period January, 2013 till January,
   2015. He was also getting a scholarship number 2014/3/MIP - 12 funded by
   Innsbruck University, Austria.
CR Adan I. J.-B. F., 1994, COMPENSATION APPROAC, V104
   ADAN IJBF, 1993, OR SPEKTRUM, V15, P95, DOI 10.1007/BF01720521
   ADAN IJBF, 1993, ADV APPL PROBAB, V25, P783, DOI 10.2307/1427792
   Adan IJBF, 2001, QUEUEING SYST, V37, P65, DOI 10.1023/A:1011040100856
   Agarwal RP, 2011, INTRODUCTION TO COMPLEX ANALYSIS, P1, DOI 10.1007/978-1-4614-0195-7
   Ahlfors L. V., 1966, INT SERIES PURE APPL, V3
   Blanc J. P. C., 1982, APPL THEORY BOUNDARY, V153
   Boxma O. J., 1988, CWI MONOGRAPHS, V7, P261
   Boxma O. J., 1993, PROBAB ENG INFORM SC, V7, P471
   Bruneel H, 2015, MATH METHOD OPER RES, V82, P285, DOI 10.1007/s00186-015-0515-z
   Bruneel H, 2016, ANN OPER RES, V239, P359, DOI 10.1007/s10479-013-1428-y
   Bruneel H, 2014, TOP, V22, P421, DOI 10.1007/s11750-014-0330-3
   Bruneel H, 2012, EUR J OPER RES, V223, P123, DOI 10.1016/j.ejor.2012.06.031
   Brzdek J, 2016, AEQUATIONES MATH, V90, P671, DOI 10.1007/s00010-016-0421-3
   Cohen J. W., 1988, Queueing Systems Theory and Applications, V3, P97, DOI 10.1007/BF01189045
   Cohen JW, 1998, QUEUEING SYST, V30, P385, DOI 10.1023/A:1019133525165
   Cohen J. W., 1983, MATH STUDIES, V79
   Cooper R. B., 1981, INTRO QUEUEING THEOR, V2
   Dautray R., 2000, INTEGRAL EQUATIONS N, V4
   FAYOLLE G, 1982, ADV APPL PROBAB, V14, P295, DOI 10.2307/1426522
   FAYOLLE G, 1979, Z WAHRSCHEINLICHKEIT, V47, P325, DOI 10.1007/BF00535168
   Fayolle G., 1999, STOCHASTIC MODELLING, V40
   Fayolle G., 1980, ACM SIGMETR PERFORM, V9, P283, DOI 10.1145/1009375.806175
   Fayolle G., 1983, P INT WORKSH COMP PE, P55
   Flajolet P., 2009, ANAL COMBINATORICS
   FLATTO L, 1984, SIAM J APPL MATH, V44, P1041, DOI 10.1137/0144074
   FLATTO L, 1985, SIAM J APPL MATH, V45, P861, DOI 10.1137/0145052
   Forster O., 1981, LECT RIEMANN SURFACE, V81
   Fricker C., 2015, ARXIV150705746
   Gakhov F.D., 1990, BOUNDARY VALUE PROBL
   Greene D. H., 2007, MATH ANAL ALGORITHMS
   Guillemin F, 2014, QUEUEING SYST, V76, P109, DOI 10.1007/s11134-013-9391-5
   Guillemin F., 2013, ARXIV13053536
   Guillemin F, 2014, QUEUEING SYST, V78, P189, DOI 10.1007/s11134-014-9418-6
   Guillemin F, 2013, QUEUEING SYST, V74, P235, DOI 10.1007/s11134-012-9332-8
   Guillemin F, 2011, SIAM J APPL MATH, V71, P1220, DOI 10.1137/100808629
   Guillemin F, 2011, QUEUEING SYST, V67, P1, DOI 10.1007/s11134-010-9197-7
   HENRICI P., 1993, APPL COMPUTATIONAL C, V3
   Houtum V. G.-J., 1995, THESIS
   KINGMAN JF, 1961, ANN MATH STAT, V32, P1314, DOI 10.1214/aoms/1177704869
   Kleinrock L., 1975, QUEUEING SYSTEMS, V1
   Li H, 2011, QUEUEING SYST, V69, P77, DOI 10.1007/s11134-011-9227-0
   Lopatatzidis S, 2016, QUEUEING SYST, V82, P75, DOI 10.1007/s11134-015-9458-6
   Maertens T, 2009, AEU-INT J ELECTRON C, V63, P853, DOI 10.1016/j.aeue.2008.07.004
   Morrison JA, 2007, QUEUEING SYST, V57, P19, DOI 10.1007/s11134-007-9043-8
   Morrison JA, 2010, QUEUEING SYST, V64, P49, DOI 10.1007/s11134-009-9126-9
   Muskhelishvili N. I., 2008, SINGULAR INTEGRAL EQ
   Nada F. A., 2010, AUTOMATIKA, V51, P293
   Nassar H, 2004, J CIRCUIT SYST COMP, V13, P999, DOI 10.1142/S0218126604001842
   Nassar H, 2004, IEICE T COMMUN, VE87B, P1505
   Nassar H, 2003, IEE P-COMMUN, V150, P189, DOI 10.1049/ip-com:20030218
   Nassar H, 2003, AEU-INT J ELECTRON C, V57, P190, DOI 10.1078/1434-8411-54100161
   Nassar H., 2006, WSEAS Transactions on Communications, V5, P1585
   Nassar H, 2002, MATH COMP MODEL DYN, V8, P199, DOI 10.1076/mcmd.8.2.199.8590
   Nassar H., 2016, CONTRIBUTIONS MATH E
   Nassar H., 2006, P 10 WSEAS INT C COM, P425
   Nassar H., 2003, COMMUNICATIONS INFOR, V3, P101
   Ponnusamy S., 2006, COMPLEX VARIABLES AP
   Resing J, 2003, OPER RES LETT, V31, P383, DOI 10.1016/S0167-6377(03)00046-4
   Rogiest W, 2015, ANN OPER RES, V226, P527, DOI 10.1007/s10479-014-1721-4
   SIDI M, 1983, IEEE T COMMUN, V31, P123, DOI 10.1109/TCOM.1983.1095740
   Takagi H., 1991, QUEUEING ANAL FDN PE, V1
   Van Leeuwaarden JSH, 2005, QUEUEING SYST, V51, P29, DOI 10.1007/s11134-005-1683-y
   Vanlerberghe J, 2015, LECT NOTES COMPUT SC, V9272, P96, DOI 10.1007/978-3-319-23267-6_7
   Walraevens Joris, 2013, Analytical and Stochastic Modeling Techniques and Applications. 20th International Conference, ASMTA 2013. Proceedings: LNCS 7984, P443, DOI 10.1007/978-3-642-39408-9_31
   Walraevens J, 2003, COMPUT OPER RES, V30, P1807, DOI 10.1016/S0305-0548(02)00108-9
   Walraevens J., 2004, THESIS
   Wilf H. S., 2013, GENERATINGFUNCTIONOL
   Woodward M. E., 1993, COMMUNICATION COMPUT
   WRIGHT PE, 1992, ADV APPL PROBAB, V24, P986, DOI 10.2307/1427722
NR 70
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0001-9054
EI 1420-8903
J9 AEQUATIONES MATH
JI Aequ. Math.
PD JUN
PY 2017
VL 91
IS 3
BP 445
EP 477
DI 10.1007/s00010-017-0471-1
PG 33
WC Mathematics, Applied; Mathematics
SC Mathematics
GA EV3PC
UT WOS:000401670400004
OA No
DA 2017-08-17
ER

PT J
AU Mahmoud, AAA
   El-Shafei, HI
   Yassin, HM
   Elramely, MA
   Abdelhaq, MM
   El Kady, HW
   Awada, WNF
AF Ahmed Mahmoud, Ahmed Abdelaal
   El-Shafei, Hassan Ismail
   Yassin, Hany Mahmoud
   Elramely, Mohamed Adly
   Abdelhaq, Mohamed Mohamed
   El Kady, Hany Wafiq
   Fahemy Awada, Wael Nabil
TI Comparison Between Retrograde and Antegrade Peripheral Venous
   Cannulation in Intensive Care Unit Patients: Assessment of Thrombus
   Formation
SO ANESTHESIA AND ANALGESIA
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; CLINICALLY INDICATED REPLACEMENT;
   SUPERFICIAL VEIN-THROMBOSIS; CATHETER-RELATED INFECTIONS; INTRAVENOUS
   CATHETERS; SEPTIC THROMBOPHLEBITIS; ROUTINE REPLACEMENT;
   PULMONARY-EMBOLISM; UPPER EXTREMITY; DIAGNOSIS
AB BACKGROUND: Antegrade cannulation of peripheral veins is the usual practice. Blood stasis between a catheter and the wall of the vein or at its tip in addition to catheter-induced phlebitis may initiate a thrombosis. The use of retrograde ventriculojugular shunts against the direction of the blood flow with resultant decrease in the incidence of venous thrombosis encouraged us to compare retrograde versus conventional antegrade peripheral venous cannulation.
   METHODS: Monocentric, nonblinded, prospective observational cohort of 40 intensive care unit patients receiving 2 peripheral venous catheters in upper limbs, 1 inserted in the direction of blood flow (antegrade cannula) and the other inserted in an opposite direction to blood flow (retrograde cannula). Daily ultrasound assessment of the angle between the catheter and the vascular wall was done to detect onset and progression of thrombus formation.
   RESULTS: The study included 40 patients, aged 46.7 +/- 10.132 years. The incidence of thrombus formation was 100% in both techniques. The onset time of thrombus formation between the catheter and the wall of a vein was significantly longer with the retrograde catheters than with the antegrade catheters with median time (interquartile range [range]) 6 days (5-6.75 [4-8]) with 95% confidence interval (CI), 5.58-6.42 vs 3 days (3-4 [2-5]) with 95% CI (2.76-3.24), respectively, with a P value <. 001. The time needed by the recently detected thrombus to reach the catheter tip determined by ultrasound with or without catheter failure was significantly longer in the retrograde catheters than in the antegrade catheter with median time (interquartile range [range]) 9 days (8-9 [7-10]) with 95% CI, 8.76-9.24 vs 4 days (4-5 [3-6]) with 95% CI, 3.76-4.24, respectively, with a P value <. 001.
   CONCLUSIONS: Retrograde cannulation did not decrease the incidence of thrombus formation, but significantly increased the onset time until thrombus formation and prolonged the time needed by the newly formed thrombus to reach the catheter tip compared with conventional antegrade cannulation.
C1 [Ahmed Mahmoud, Ahmed Abdelaal] Beni Suef Univ, Fac Med, Bani Suwayf, Egypt.
   [El-Shafei, Hassan Ismail; Abdelhaq, Mohamed Mohamed; El Kady, Hany Wafiq; Fahemy Awada, Wael Nabil] Cairo Univ, Fa Med, Cairo, Egypt.
   [Yassin, Hany Mahmoud] Fayoum Univ, Fac Med, Al Fayyum, Egypt.
   [Elramely, Mohamed Adly] Cairo Univ, Natl Canc Inst, Cairo, Egypt.
RP Mahmoud, AAA (reprint author), Beni Suef Univ, Fac Med, 7th Dist,39 Mousa Ebn Nousir St, Nasr City 11471, Cairo, Egypt.
EM carnitin7@yahoo.com
FU Beni-Suef University Hospital
FX Beni-Suef University Hospital.
CR Adhikari S, 2013, J EMERG MED, V44, P183, DOI 10.1016/j.jemermed.2011.08.014
   Bauersachs RM, 2013, HAMOSTASEOLOGIE, V33, P232, DOI 10.5482/HAMO-13-04-0027
   Bravery Karen, 2006, Br J Nurs, V15, P1244
   Bregenzer T, 1998, ARCH INTERN MED, V158, P151, DOI 10.1001/archinte.158.2.151
   Cornely OA, 2002, INFECT CONT HOSP EP, V23, P249, DOI 10.1086/502044
   Di Nisio M, 2015, COCHRANE DB SYST REV, V11, DOI 10.1002/14651858.CD011015.pub2.
   El-Shafei IL, 2010, PEDIATR NEUROSURG, V46, P160, DOI 10.1159/000316639
   Gaitini D, 2006, J ULTRAS MED, V25, P1297
   Grune F, 2004, INFECTION, V32, P30, DOI 10.1007/s15010-04-1037-4
   Harigai M, 2012, CLIN IMAG, V36, P496, DOI 10.1016/j.clinimag.2012.01.016
   Hylton VJ, 2002, CIRCULATION, V106, P1874
   Jeanneret C, 2012, HAUTARZT, V63, P609, DOI 10.1007/s00105-012-2367-2
   Johansson ME, 2009, J CLIN NURS, V18, P3366, DOI 10.1111/j.1365-2702.2009.02973.x
   Jose AL, 2013, CLIN KIDNEY J, V6, P8
   Katz SC, 2005, J TRAUMA, V59, P750, DOI 10.1097/01.ta.0000183220.07235.05
   Kooij JDB, 1997, NETH J MED, V50, P238, DOI 10.1016/S0300-2977(97)00020-X
   Lai Kwan Kew, 1998, American Journal of Infection Control, V26, P66, DOI 10.1016/S0196-6553(98)70063-X
   Leung A, 2016, THROMBOSIS, V2016
   Litzendorf ME, 2011, VASC HEALTH RISK MAN, V7, P569, DOI 10.2147/VHRM.S15562
   Maki DG, 2006, MAYO CLIN PROC, V81, P1159
   McCabe WL, 1967, UNIT OPERATIONS CHEM, P47
   Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376
   O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257
   Palese A, J INFUS NURS, V34, P319
   Periard D, 2008, J THROMB HAEMOST, V6, P1281, DOI 10.1111/j.1538-7836.2008.03053.x
   Rickard CM, 2012, LANCET, V380, P1066, DOI 10.1016/S0140-6736(12)61082-4
   Rickard CM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-53
   Schultz Alyce A, 2005, Evid Based Nurs, V8, P8, DOI 10.1136/ebn.8.1.8
   Van Canneyt K, 2008, P I MECH ENG H, V222, P455, DOI 10.1243/09544119JEIM299
   Van Donk P, 2009, INFECT CONT HOSP EP, V30, P915, DOI 10.1086/599776
   Webster J, 2015, COCHRANE DB SYST REV, V8, DOI [10.1002/14651858.CD007798.pub4., DOI 10.1002/14651858.CD007798.PUB4]
   Webster J, 2007, INT J NURS STUD, V44, P664, DOI 10.1016/j.ijnurstu.2006.02.003
   Webster J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007798.pub2
   Webster J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a339
   Wichers IM, 2005, HAEMATOL-HEMATOL J, V90, P672
   Zhang L, 2011, INT J ANTIMICROB AG, V38, P9, DOI 10.1016/j.ijantimicag.2011.01.020
NR 36
TC 0
Z9 0
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0003-2999
J9 ANESTH ANALG
JI Anesth. Analg.
PD JUN
PY 2017
VL 124
IS 6
BP 1839
EP 1845
DI 10.1213/ANE.0000000000001703
PG 7
WC Anesthesiology
SC Anesthesiology
GA EV3XU
UT WOS:000401693200018
OA No
DA 2017-08-17
ER

PT J
AU Zahran, AM
   Eltayeb, AA
   Elsayh, KI
   Saad, K
   Ahmad, FA
   Ibrahim, AIM
AF Zahran, Asmaa M.
   Eltayeb, Azza A.
   Elsayh, Khalid I.
   Saad, Khaled
   Ahmad, Faisal-Alkhateeb
   Ibrahim, Ahmad I. M.
TI Activated and Memory T Lymphocytes in Children with Gaucher Disease
SO ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
LA English
DT Article
DE Activated T lymphocytes; Children; Gaucher disease
ID ENZYME REPLACEMENT THERAPY; CELLS; ABNORMALITIES; MONOCYTES
AB Gaucher disease (GD) is the most prevalent lysosomal storage disorder. Gaucher disease is associated with remarkable alterations in the immune system, and GD patients are more susceptible to infections and are at a higher risk of developing autoimmune disorders and malignancies. In a case-control study, we used three-color flow cytometric immunophenotyping for determination of the frequency of lymphocyte subpopulations and activated T lymphocytes among 18 children with GD1 under enzyme replacement therapy managed in Assiut University Hospitals. We found significant increases in the frequencies of total lymphocytes, CD19(+), CD3(+), CD4(+), and CD8(+) in children with GD1 when compared to healthy control. The frequencies of activated T lymphocytes (CD3(+)HLA-DR+), activated T-helper cells (CD4(+)HLA-DR+), and activated T-suppressor/cytotoxic cells (CD8(+)HLA-DR+) were significantly higher in GD1 as compared to healthy children. Our data show that the increased proportion of activated T lymphocytes in children with GD1 raises the issue of their possible involvement in the pathogenesis of the immune dysfunction seen in these patients. Our data suggested that the activated T lymphocytes could play a role in the clinical course of GD1. The relationship of these cells to immune disorders in GD1 children remains to be determined.
C1 [Zahran, Asmaa M.] Assiut Univ, South Egypt Canc Inst, Dept Clin Pathol, Assiut, Egypt.
   [Eltayeb, Azza A.; Elsayh, Khalid I.; Saad, Khaled; Ahmad, Faisal-Alkhateeb; Ibrahim, Ahmad I. M.] Assiut Univ, Dept Pediat, Fac Med, Assiut 71516, Egypt.
RP Saad, K (reprint author), Assiut Univ, Dept Pediat, Fac Med, Assiut 71516, Egypt.
EM ksaad8@yahoo.com
RI Saad, Khaled/G-9901-2012
OI Saad, Khaled/0000-0002-8473-6116
CR Arikan-Ayyildiz Z, 2011, PEDIATR BLOOD CANCER, V56, P664, DOI 10.1002/pbc.22863
   Balreira A, 2005, BRIT J HAEMATOL, V129, P667, DOI 10.1111/j.1365-2141.2005.05503.x
   Bettman N, 2015, BLOOD CELL MOL DIS, V55, P180, DOI 10.1016/j.bcmd.2014.12.003
   Braudeau C, 2013, BLOOD CELL MOL DIS, V50, P281, DOI 10.1016/j.bcmd.2013.01.001
   BURSTEIN Y, 1987, J CLIN LAB IMMUNOL, V23, P149
   Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4
   de Fost M, 2006, BLOOD CELL MOL DIS, V36, P53, DOI 10.1016/j.bcmd.2005.08.004
   Giraldo P, 2016, BLOOD CELL MOL DIS, V56, P23, DOI 10.1016/j.bcmd.2015.10.001
   Lacerda L, 1999, BLOOD CELL MOL DIS, V25, P130, DOI 10.1006/bcmd.1999.0237
   Matta MC, 2016, HUM IMMUNOL, V77, P196, DOI 10.1016/j.humimm.2015.11.018
   Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107
   Pandey Manoj Kumar, 2013, Critical Reviews in Oncogenesis, V18, P197
   Sanchez R, 2005, J CLIN ONCOL, V23, P4792, DOI 10.1200/JCO.2005.05.141
   Sotiropoulos C, 2015, JIMD REP, V18, P107, DOI 10.1007/8904_2014_357
   Zahran AM, 2016, BLOOD CELL MOL DIS, V57, P91, DOI 10.1016/j.bcmd.2016.01.005
NR 15
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0004-069X
EI 1661-4917
J9 ARCH IMMUNOL THER EX
JI Arch. Immunol. Ther. Exp.
PD JUN
PY 2017
VL 65
IS 3
BP 263
EP 269
DI 10.1007/s00005-016-0421-y
PG 7
WC Immunology
SC Immunology
GA EV2ZS
UT WOS:000401627000007
PM 27638481
OA No
DA 2017-08-17
ER

PT J
AU Hussein, AA
   Hinata, N
   Dibaj, S
   May, PR
   Kozlowski, JD
   Abol-Enein, H
   Abaza, R
   Eun, D
   Khan, MS
   Mohler, JL
   Agarwal, P
   Pohar, K
   Sarle, R
   Boris, R
   Mane, SS
   Hutson, A
   Guru, KA
AF Hussein, Ahmed A.
   Hinata, Nobuyuki
   Dibaj, Shiva
   May, Paul R.
   Kozlowski, Justen D.
   Abol-Enein, Hassan
   Abaza, Ronney
   Eun, Daniel
   Khan, Mohamed S.
   Mohler, James L.
   Agarwal, Piyush
   Pohar, Kamal
   Sarle, Richard
   Boris, Ronald
   Mane, Sridhar S.
   Hutson, Alan
   Guru, Khurshid A.
TI Development, validation and clinical application of Pelvic
   Lymphadenectomy Assessment and Completion Evaluation: intraoperative
   assessment of lymph node dissection after robot-assisted radical
   cystectomy for bladder cancer
SO BJU INTERNATIONAL
LA English
DT Article
DE robot-assisted; radical cystectomy; lymph node dissection; quality;
   lymphadenectomy; #BladderCancer; #blcsm
ID IMPACT; CARCINOMA; SURVIVAL; NUMBER; COUNT
AB Objectives
   To develop a scoring tool, Pelvic Lymphadenectomy Appropriateness and Completion Evaluation (PLACE), to assess the intraoperative completeness and appropriateness of pelvic lymph node dissection (PLND) following robot-assisted radical cystectomy (RARC).
   Patients, Subjects and Methods
   A panel of 11 open and robotic surgeons developed the content and structure of PLACE. The PLND template was divided into three zones. In all, 21 de-identified videos of bilateral robot-assisted PLNDs were assessed by the 11 experts using PLACE to determine inter-rater reliability. Lymph node (LN) clearance was defined as the proportion of cleared LNs from all PLACE zones. We investigated the correlation between LN clearance and LN count. Then, we compared the LN count of 18 prospective PLNDs using PLACE with our retrospective series performed using the extended template (No PLACE).
   Results
   A significant reliability was achieved for all PLACE zones among the 11 raters for the 21 bilateral PLND videos. The median (interquartile range) for LN clearance was 468 (431545). There was a significant positive correlation between LN clearance and LN count (R-2 = 0.70, P < 0.01). The PLACE group yielded similar LN counts when compared to the No PLACE group.
   Conclusions
   Pelvic Lymphadenectomy Appropriateness and Completion Evaluation is a structured intraoperative scoring system that can be used intraoperatively to measure and quantify PLND for quality control and to facilitate training during RARC.
C1 [Hussein, Ahmed A.; Dibaj, Shiva; May, Paul R.; Kozlowski, Justen D.; Mohler, James L.; Mane, Sridhar S.; Hutson, Alan; Guru, Khurshid A.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA.
   [Hussein, Ahmed A.] Cairo Univ, Dept Urol, Cairo, Egypt.
   [Hinata, Nobuyuki] Univ Kobe, Dept Urol, Kobe, Hyogo, Japan.
   [Abol-Enein, Hassan] Mansoura Univ, Dept Urol & Nephrol, Mansoura, Egypt.
   [Abaza, Ronney] OhioHlth Robot Surg, Dublin, OH USA.
   [Eun, Daniel] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
   [Agarwal, Piyush] NCI, Ctr Canc Res, Bethesda, MD 20892 USA.
   [Pohar, Kamal] Ohio State Univ, Columbus, OH 43210 USA.
   [Sarle, Richard] Michigan Inst Urol, Dearborn, MI USA.
   [Boris, Ronald] Indiana Univ, Indianapolis, IN 46204 USA.
   [Khan, Mohamed S.] Guys & St Thomas NHS Fdn Trust, London, England.
   [Khan, Mohamed S.] Kings Coll London, Sch Med, London, England.
RP Guru, KA (reprint author), Roswell Pk Canc Inst, Dept Urol, ATLAS Appl Technol Lab Adv Surg Program, Elm & Carlton St, Buffalo, NY 14263 USA.
EM Khurshid.guru@roswellpark.org
OI Kozlowski, Justen/0000-0003-1250-2799
FU Intuitive Surgical
FX Dr. Abaza has a research grant from Intuitive Surgical.
CR Abboudi H, 2014, BJU INT, V114, P617, DOI 10.1111/bju.12315
   Abol-Enein H, 2004, J UROLOGY, V172, P1818, DOI 10.1097/01.ju.0000140457.83695.a7
   Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625
   Bochner BH, 2004, J UROLOGY, V172, P1286, DOI 10.1097/01.ju.0000137817.56888.d1
   Bochner BH, 2001, J UROLOGY, V166, P2295, DOI 10.1016/S0022-5347(05)65555-3
   Dangle Pankaj P, 2009, Ther Adv Urol, V1, P167, DOI 10.1177/1756287209346832
   Desai MM, 2012, EUR UROL, V61, P350, DOI 10.1016/j.eururo.2011.09.011
   Dhar NB, 2008, J UROLOGY, V179, P873, DOI 10.1016/j.juro.2007.10.076
   Hellenthal NJ, 2011, BJU INT, V107, P642, DOI 10.1111/j.1464-410X.2010.09473.x
   Herr HW, 2001, J UROLOGY, V165, P62, DOI 10.1097/00005392-200101000-00015
   Konety BR, 2003, J UROLOGY, V169, P946, DOI 10.1097/01.0000052721.61645.a3
   Koppie TM, 2006, CANCER, V107, P2368, DOI 10.1002/cncr.22250
   Leissner J, 2000, BJU INT, V85, P817, DOI 10.1046/j.1464-410x.2000.00614.x
   Leissner J, 2004, J UROLOGY, V171, P139, DOI 10.1097/01.ju.0000102302.26806.fb
   Leow JJ, 2014, EUR UROL, V66, P569, DOI 10.1016/j.eururo.2014.01.029
   Marin-Aguilera M, 2008, EUR UROL, V54, P1363, DOI 10.1016/j.eururo.2008.04.059
   Parkash V, 2010, AM J CLIN PATHOL, V134, P42, DOI 10.1309/AJCPO92DZMUCGEUF
   Poulsen AL, 1998, J UROLOGY, V160, P2015, DOI 10.1016/S0022-5347(01)62229-8
   SKINNER DG, 1982, J UROLOGY, V128, P34
   Stein JP, 2003, J UROLOGY, V170, P35, DOI 10.1097/01.ju.0000072422.69286.0e
   Tarin TV, 2012, EUR UROL, V61, P1025, DOI 10.1016/j.eururo.2012.01.049
NR 21
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD JUN
PY 2017
VL 119
IS 6
BP 879
EP 884
DI 10.1111/bju.13748
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA EV5JW
UT WOS:000401802300011
PM 27987527
OA No
DA 2017-08-17
ER

PT J
AU El-Mashad, HM
   Pan, ZL
AF El-Mashad, Hamed M.
   Pan, Zhongli
TI Application of Induction Heating in Food Processing and Cooking
SO FOOD ENGINEERING REVIEWS
LA English
DT Review
DE Induction food processing; Induction cooking; Energy efficiency;
   Alternative processing systems
ID OPTIMAL-DESIGN; APPLIANCES; PYROLYSIS; OIL
AB Induction heating is an electromagnetic heating technology that has several advantages such as high safety, scalability, and high energy efficiency. It has been applied for a long time in metal processing, medical applications, and cooking. However, the application of this technology in food processing industry is still in its early stages. The objectives of this article were to review the basics of induction heating technology and the factors affecting its performance and to assess the application status of this technology in food processing. The research needs and future perspectives of this technology in food processing are also presented. Although several patents on using the induction heating to process food materials are available, there is still a need to generate more scientific data on the design, performance, and energy efficiency of the induction heating technology to be applied in different unit operations, such as drying, pasteurization, sterilization, and roasting, in food processing. It is needed to optimize different design and operational parameters, such as applied current frequency, type of equipment material, equipment size and configuration, and coil configurations. The information on the effect of the induction heating on sensory and nutritional quality of different food materials is lack. Research is also needed to compare the efficiency of the induction heating and other heating technologies, such as infrared, microwave, and ohmic heating, for food processing applications.
C1 [El-Mashad, Hamed M.; Pan, Zhongli] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA.
   [El-Mashad, Hamed M.] Mansoura Univ, Fac Agr, Agr Engn Dept, Mansoura, Egypt.
   [Pan, Zhongli] ARS, Hlth Proc Foods Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.
RP Pan, ZL (reprint author), Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA.; Pan, ZL (reprint author), ARS, Hlth Proc Foods Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.
EM zlpan@ucdavis.edu
CR Acero J, 2005, IEEE T MAGN, V41, P1280, DOI 10.1109/TMAG.2005.844844
   Meka AT, 2014, INT J SOFT COMPUTING, V4, P73
   Atyhanov A, 2013, APPL TECHNOLOGIES IN, V9, P17
   Byun JK, 2000, IEEE T MAGN, V36, P1390, DOI 10.1109/20.877698
   Davies E. J., 1990, CONDUCTION INDUCTION
   Fechter J, 2015, SUGAR IND FERRITIC S
   Frogner K, 2011, P 44 CIRP INT C MAN
   GH Induction Atmospheres, 2016, INN IND HEAT
   Kolleck R, 2009, CIRP ANN-MANUF TECHN, V58, P275, DOI 10.1016/j.cirp.2009.03.090
   Kuzmichev A, 2011, ADV INDUCTION MICROW
   Legendre B, 2011, J THERM ANAL CALORIM, V105, P141, DOI 10.1007/s10973-011-1448-2
   Levacher L, 2009, ECEEE 2009 SUMMER ST, P1092
   Lucia O, 2014, IEEE T IND ELECTRON, V61, P2509, DOI 10.1109/TIE.2013.2281162
   Lucian SG, 2014, INT J APPL INNOVATIO, V3, P423
   Manuel G., 2016, DESIGN INDUCTION HEA
   O'Keefe S, 2003, FOOD ANAL
   Onsemi, 2016, IND COOK EV YOU NEED
   Onsemi, 2014, IND COOK SEM COMP IN
   Pan Z., 2010, INFRARED HEATING FOO
   Pavlov N, 1978, ENG CALCULATIONS IND
   Qiu L, 2015, RUSS ELECT ENG, V86, P106
   Rapoport E. Ya., 2007, OPTIMAL CONTROL INDU
   Risman PO, 2009, DEV PACKAGING PRODUC
   Rudnev V, 2003, HDB INDUCTION HEATIN
   Rudnev VI, 2004, HEAT TREATING PROGR
   Ryszard N, 2011, INDUCTION MICROWAVE, V9, P51000
   Sadler PC, 2011, THESIS
   Sastry SK, 2000, J FOOD SCI S, V65, P42, DOI 10.1111/j.1745-4565.2000.tb00617.x
   Sazak BS, 2007, INT J ELECTRON, V94, P197, DOI 10.1080/00207210601114867
   STUCHLY MA, 1987, J MICROWAVE POWER EE, V22, P63
   Sweeney M, 2014, 2014 ACEEE SUMMER ST
   Tomita H, 2000, SUPERHEATED STEAM GE
   Tsai WT, 2009, BIORESOURCE TECHNOL, V100, P2650, DOI 10.1016/j.biortech.2008.11.023
   Tsai WT, 2006, J ANAL APPL PYROL, V76, P230, DOI 10.1016/j.jaap.2005.11.007
   Vairamohan B, 2011, 2011 ACEEE SUMMER ST
   Velasco S, 2007, PHYS TEACH, V45, P387, DOI 10.1119/1.2768702
   Wenstrup MJ, 2014, INT J FOOD SCI TECH, V49, P2223, DOI 10.1111/ijfs.12568
   Zinn S, 1988, HEAT TREATING
   Zouambia Y, 2017, ARAB J CHEM, V10, P480, DOI 10.1016/j.arabjc.2014.11.011
   Matsushita K, 1986, US patent, Patent No. [4:614,852, 4614852]
   Chavanaz JP, 1997, US Patent, Patent No. [5628,241, 5628241]
   Maupin SL, 2011, Anti-oxidation food preparation device, Patent No. [US8076620 B2, 8076620]
   Tsuchiya T, 1980, US patent, Patent No. [4,265,922, 4265922]
NR 43
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1866-7910
EI 1866-7929
J9 FOOD ENG REV
JI Food Eng. Rev.
PD JUN
PY 2017
VL 9
IS 2
BP 82
EP 90
DI 10.1007/s12393-016-9156-0
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA EV4ZE
UT WOS:000401771500002
OA No
DA 2017-08-17
ER

PT J
AU Elshazly, KM
   Sakr, RY
   Ali, RK
   Salem, MR
AF Elshazly, K. M.
   Sakr, R. Y.
   Ali, R. K.
   Salem, M. R.
TI Effect of gamma-Al2O3/water nanofluid on the thermal performance of
   shell and coil heat exchanger with different coil torsions
SO HEAT AND MASS TRANSFER
LA English
DT Article
ID PRESSURE-DROP; WATER NANOFLUID; FRICTION FACTOR; TUBE; FLOW; FLUX
AB This work investigated experimentally the thermal performance of shell and coil heat exchanger with different coil torsions (lambda) for gamma-Al2O3/water nanofluid flow. Five helically coiled tube (HCT) with 0.0442 <= lambda <= 0.1348 were tested within turbulent flow regime. The average size of gamma-Al2O3 particles is 40 nm and volume concentration (phi) is varied from 0 to 2%. Results showed that reducing coil torsion enhances the heat transfer rate and increases HCT-friction factor (f(c)). Also, it is noticed that HCT average Nusselt number (Nu(t)) and f(c) of nanofluids increase with increasing gamma-Al2O3 volume concentration. The thermal performance index, TPI = (h(t,nf)/h(t,bf))/(Delta P-c,P-nf/Delta P-c,P-bf). increases with increasing nanoparticles concentration, coil torsion, HCT-side inlet temperature and nanofluid flow rate. Over the studied range of HCT-Reynolds number, the average value of TPI is of 1.34 and 2.24 at phi = 0.5% and phi = 2%, respectively. The average value of TPI is of 1.64 at lambda = 0.0442 while its average value at lambda = 0.1348 is of 2.01. One of the main contributions is to provide heat equipments designers with Nu(t) and f(c) correlations for practical configurations shell and coil heat exchangers with a wide range of nanofluid concentration.
C1 [Elshazly, K. M.; Sakr, R. Y.; Ali, R. K.; Salem, M. R.] Benha Univ, Fac Engn Shoubra, Mech Engn Dept, 108 Shoubra St, Cairo 11689, Egypt.
RP Ali, RK (reprint author), Benha Univ, Fac Engn Shoubra, Mech Engn Dept, 108 Shoubra St, Cairo 11689, Egypt.
EM Ragabkhalil1971@gmail.com
CR Bai B, 1999, HEAT TRANSFER ASIAN, V28, P395, DOI 10.1002/(SICI)1523-1496(1999)28:5<395::AID-HTJ5>3.0.CO;2-Y
   Chingulpitak S, 2011, INT COMMUN HEAT MASS, V38, P398, DOI 10.1016/j.icheatmasstransfer.2010.12.014
   Chingulpitak S, 2010, INT COMMUN HEAT MASS, V37, P1305, DOI 10.1016/j.icheatmasstransfer.2010.07.005
   Das S.K., 2007, NANOFLUIDS SCI TECHN
   Genssle A, 2000, INT J THERM SCI, V39, P30, DOI 10.1016/S1290-0729(00)00197-5
   Hashemi SM, 2012, INT COMMUN HEAT MASS, V39, P144, DOI 10.1016/j.icheatmasstransfer.2011.09.002
   Huminic G, 2011, INT J HEAT MASS TRAN, V54, P4280, DOI 10.1016/j.ijheatmasstransfer.2011.05.017
   Hussein AM, 2014, CASE STUD THERM ENG, V2, P50
   Kern DQ, 2000, PROCESS HEAT TRANSFE
   Kline S. J., 1953, MECH ENG, V75, P3
   Koo J, 2005, INT J HEAT MASS TRAN, V48, P2652, DOI 10.1016/j.ijheatmasstransfer.2005.01.029
   Koo J, 2004, J NANOPART RES, V6, P577, DOI 10.1007/s11051-004-3170-5
   Kumar K. P., 2008, INT J NANOSYST, V1, P87
   Kumar PCM, 2013, J MECH SCI TECHNOL, V27, P239, DOI 10.1007/s12206-012-1206-9
   Mukesh Kumar P. C., 2012, J MAT ENV SCI, V3, P766
   KUMAR PCM, 2012, EUR J SCI RES, V82, P161
   Kumar V, 2006, CHEM ENG SCI, V61, P4403, DOI 10.1016/j.ces.2006.01.039
   Li Q, 2002, SCI CHINA SER E, V45, P408
   Manca O, 2010, ADV MECH ENG, DOI 10.1155/2010/380826
   Moraveji MK, 2012, INT COMMUN HEAT MASS, V39, P995, DOI 10.1016/j.icheatmasstransfer.2012.05.003
   Peyghambarzadeh SM, 2011, INT COMMUN HEAT MASS, V38, P1283, DOI 10.1016/j.icheatmasstransfer.2011.07.001
   Peyghambarzadeh SM, 2011, APPL THERM ENG, V31, P1833, DOI 10.1016/j.applthermaleng.2011.02.029
   PRASAD BVSSS, 1989, HEAT RECOV SYST CHP, V9, P249, DOI 10.1016/0890-4332(89)90008-2
   Razi P, 2011, INT COMMUN HEAT MASS, V38, P964, DOI 10.1016/j.icheatmasstransfer.2011.04.010
   Rennie TJ, 2004, NUMERICAL EXPT STUDI
   Rogers G. F. C., 1964, INT J HEAT MASS TRAN, V7, P1207, DOI DOI 10.1016/0017-9310(64)90062-6]
   Salem MR, 2016, J THERM SCI ENG APPL, V8, DOI 10.1115/1.4030732
   Salem MR, 2015, J THERM SCI ENG APPL, V7
   Salem MR, 2015, J THERM SCI ENG APPL, V7
   Sandeep KP, 1999, 2 FLOW COILED TUBES
   SCHMIDT EF, 1967, CHEM-ING-TECH, V39, P781, DOI 10.1002/cite.330391302
   Xin RC, 1997, J HEAT TRANS-T ASME, V119, P467, DOI 10.1115/1.2824120
   Xuan YM, 2000, INT J HEAT MASS TRAN, V43, P3701, DOI 10.1016/S0017-9310(99)00369-5
   Zamzamian A, 2011, EXP THERM FLUID SCI, V35, P495, DOI 10.1016/j.expthermflusci.2010.11.013
   Zhao ZX, 2011, INT COMMUN HEAT MASS, V38, P1189, DOI 10.1016/j.icheatmasstransfer.2011.06.014
NR 35
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-7411
EI 1432-1181
J9 HEAT MASS TRANSFER
JI Heat Mass Transf.
PD JUN
PY 2017
VL 53
IS 6
BP 1893
EP 1903
DI 10.1007/s00231-016-1949-4
PG 11
WC Thermodynamics; Mechanics
SC Thermodynamics; Mechanics
GA EV6BW
UT WOS:000401855700004
OA No
DA 2017-08-17
ER

PT J
AU Nada, SA
   Elfeky, KE
   Attia, AMA
   Alshaer, WG
AF Nada, S. A.
   Elfeky, K. E.
   Attia, Ali M. A.
   Alshaer, W. G.
TI Experimental parametric study of servers cooling management in data
   centers buildings
SO HEAT AND MASS TRANSFER
LA English
DT Article
ID SYSTEMS; MODEL; RACK
AB A parametric study of air flow and cooling management of data centers servers is experimentally conducted for different design conditions. A physical scale model of data center accommodating one rack of four servers was designed and constructed for testing purposes. Front and rear rack and server's temperatures distributions and supply/return heat indices (SHI/RHI) are used to evaluate data center thermal performance. Experiments were conducted to parametrically study the effects of perforated tiles opening ratio, servers power load variation and rack power density. The results showed that (1) perforated tile of 25% opening ratio provides the best results among the other opening ratios, (2) optimum benefit of cold air in servers cooling is obtained at uniformly power loading of servers (3) increasing power density decrease air re-circulation but increase air bypass and servers temperature. The present results are compared with previous experimental and CFD results and fair agreement was found.
C1 [Nada, S. A.; Elfeky, K. E.; Attia, Ali M. A.; Alshaer, W. G.] Benha Univ, Benha Fac Engn, Dept Mech Engn, Banha 13511, Egypt.
RP Nada, SA (reprint author), Benha Univ, Benha Fac Engn, Dept Mech Engn, Banha 13511, Egypt.
EM samehnadar@yahoo.com
OI Attia, Ali/0000-0003-3634-8685
CR Alkharabsheh S, 2014, INTSOC CONF THERMAL, P547, DOI 10.1109/ITHERM.2014.6892329
   Almoli A, 2012, APPL ENERG, V89, P150, DOI 10.1016/j.apenergy.2011.02.003
   Arghode VK, 2013, J HEAT TRANSF, V135
   ASHRAE, 2008, ENV GUID DAT EQ
   Cho J, 2011, ENERG BUILDINGS, V43, P2145, DOI 10.1016/j.enbuild.2011.04.025
   Cho J, 2009, ENERG BUILDINGS, V41, P1107, DOI 10.1016/j.enbuild.2009.05.017
   EPA, 2007, PUBLIC LAW, P109
   Estebe B. D., 2014, APPL ENERG, V134, P45
   Fernando H, 2012, INT CONF INF AUTOMAT, P273, DOI 10.1109/ICIAFS.2012.6419916
   Fulpagare Y, 2015, APPL THERM ENG, V80, P187, DOI 10.1016/j.applthermaleng.2015.01.065
   Fulpagare Y, 2015, RENEW SUST ENERG REV, V43, P981, DOI 10.1016/j.rser.2014.11.056
   Gondipalli S, 2008, P 11 IEEE ITH C 2008
   Ham SW, 2015, APPL ENERG, V138, P258, DOI 10.1016/j.apenergy.2014.10.066
   Ham SW, 2015, ENERG BUILDINGS, V86, P328, DOI 10.1016/j.enbuild.2014.10.058
   Herrlin M, 2006, P INT SOC C THERM PH
   Herrlin MK, 2006, P TEL EN C, P1
   Karlsson JF, 2005, ENERG BUILDINGS, V37, P1075, DOI 10.1016/j.enbuild.2004.12.014
   Khalaj AH, 2015, APPL ENERG, V138, P432, DOI 10.1016/j.apenergy.2014.10.083
   Kumar P, 2011, P IEEE SEMICOND THER, P90, DOI 10.1109/STHERM.2011.5767184
   Nada SA, 2016, J BUILD ENG, V5, P41, DOI 10.1016/j.jobe.2015.11.001
   Nada SA, 2016, ALEX ENG J, V55, P959, DOI 10.1016/j.aej.2016.02.025
   Nada SA, 2016, INT J REFRIG, V63, P87, DOI 10.1016/j.ijrefrig.2015.10.027
   Nada SA, 2016, APPL THERM ENG, V98, P110, DOI 10.1016/j.applthermaleng.2015.12.020
   Nada S.A., 2015, INT J CURR ENG TECHN, V5, P3448
   Nada S. A., 2015, INT J EMERG TRENDS E, V11, P145
   Nakao M., 1991, P INT TEL EN C INTEL, V12, P393
   Patankar SV, 2010, J HEAT TRANS-T ASME, V132, DOI 10.1115/1.4000703
   Premnath R, 2011, THESIS
   Rasmussen N, 2011, 46 SCHN EL DAT CENT
   Sharma RK, 2002, P AIAA2002 3091 AM I
   Shrivastava S, 2005, P IPACK SAN FRANC CA, P329
   [Anonymous], 2011, P ASME INTERPACK POR
   Sorell V, 2005, ASHRAE TRAN, V111, P756
   [Anonymous], 2004, TC 9 9
   Van Gilder J, 2005, P ASME INTERPACK 05
   [Anonymous], 1993, DESIGNERS SPECIFIERS
NR 36
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-7411
EI 1432-1181
J9 HEAT MASS TRANSFER
JI Heat Mass Transf.
PD JUN
PY 2017
VL 53
IS 6
BP 2083
EP 2097
DI 10.1007/s00231-017-1966-y
PG 15
WC Thermodynamics; Mechanics
SC Thermodynamics; Mechanics
GA EV6BW
UT WOS:000401855700020
OA No
DA 2017-08-17
ER

PT J
AU Mansour, MK
   Hassab, MA
AF Mansour, M. Khamis
   Hassab, M. A.
TI Simplified approach of predictions of thermal performance for
   counterflow fully-wet cooling coil
SO HEAT AND MASS TRANSFER
LA English
DT Article
ID TUBE HEAT-EXCHANGERS; MASS-TRANSFER CHARACTERISTICS; MODEL
AB An innovative correlation associating the effectiveness (epsilon) of the fully-wet cooling coil with its number of transfer unit and vice versa is presented in this work. The thermal performance and design of fully-wet cooling coil can be predicted simply through those correlations. The analytical model was constructed on a basis of solving heat and mass transfer equation "enthalpy potential method" simultaneously coupled with the energy equations. The validity of the new correlations was tested by experimental reported in the available literature. A good agreement with deviation less than 10% was found during the comparison between the output results of the new correlations and those obtained from the literature. The main benefits of those new correlations (1) Its simplicity to be implemented through simple calculations of input parameters (2) It provides helpful guidelines for optimization of wet cooling coil performance during its operation coupling with the thermal system at which the coil is integrated.
C1 [Mansour, M. Khamis] Beirut Arab Univ, Dept Mech Engn, Beirut, Lebanon.
   [Mansour, M. Khamis; Hassab, M. A.] Alexandria Univ, Dept Mech Engn, Alexandria, Egypt.
RP Mansour, MK (reprint author), Beirut Arab Univ, Dept Mech Engn, Beirut, Lebanon.; Mansour, MK (reprint author), Alexandria Univ, Dept Mech Engn, Alexandria, Egypt.
EM m.mansour@bau.edu.lb
CR Bandyopadhyay G, 2008, ENERG BUILDINGS, V40, P1816, DOI 10.1016/j.enbuild.2008.04.005
   Bielski S, 2005, INT COMMUN HEAT MASS, V32, P1034, DOI 10.1016/j.icheatmasstransfer.2004.10.031
   Braun J. E., 1989, ASHRAE T, V95, P3270
   Chi J., 1982, INT J REFRIG, V5, P176, DOI 10.1016/0140-7007(82)90099-8
   Elmahdy AH, 1977, ASHRAE T, V83, P103
   Goodman W, 1938, HEAT-PIPING-AIR COND, V10, P697
   Hassab MA, 1988, ASHRAE T, V94, P3192
   Jia X, 1999, INT J REFRIG, V22, P126, DOI 10.1016/S0140-7007(98)00043-7
   Kabashnikov VP, 2002, INT J HEAT MASS TRAN, V45, P2407, DOI 10.1016/S0017-9310(01)00319-2
   Klein H, 2001, INT J HEAT MASS TRAN, V44, P3553, DOI 10.1016/S0017-9310(01)00010-2
   Lee CK, 2014, INT J REFRIG, V43, P167, DOI 10.1016/j.ijrefrig.2014.04.003
   Mansour MK, 2016, DESALINATION, V395, P72, DOI 10.1016/j.desal.2016.05.025
   Mansour MK, 2014, ENERGY, V74, P855, DOI 10.1016/j.energy.2014.07.059
   McQuiston FC, 1975, ASHRAE T 1, V81, P350
   MIRTH DR, 1993, INT J HEAT FLUID FL, V14, P391, DOI 10.1016/0142-727X(93)90013-D
   Oliet C, 2007, INT J REFRIG, V30, P1266, DOI 10.1016/j.ijrefrig.2007.02.005
   Pirompugd W, 2006, INT J HEAT MASS TRAN, V49, P132, DOI 10.1016/j.ijheatmasstransfer.2005.05.043
   Pirompugd W, 2007, INT J HEAT MASS TRAN, V50, P552, DOI 10.1016/j.ijheatmasstransfer.2006.07.017
   Ramachandran PV, 1984, THESIS
   Ren CQ, 2006, INT J HEAT MASS TRAN, V49, P617, DOI 10.1016/j.ijheatmasstransfer.2005.08.019
   Theerakulpisut S, 1998, INT COMMUN HEAT MASS, V25, P127, DOI 10.1016/S0735-1933(97)00144-9
   Threlkeld JL, 1968, THERMAL ENV ENG
   Vardhan A, 1998, INT J REFRIG, V21, P77, DOI 10.1016/S0140-7007(97)00020-0
   Xia LA, 2010, ENERG CONVERS MANAGE, V51, P2079, DOI 10.1016/j.enconman.2010.02.041
   Xia L, 2009, INT J THERM SCI, V48, P2159, DOI 10.1016/j.ijthermalsci.2009.04.002
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0947-7411
EI 1432-1181
J9 HEAT MASS TRANSFER
JI Heat Mass Transf.
PD JUN
PY 2017
VL 53
IS 6
BP 2211
EP 2217
DI 10.1007/s00231-016-1942-y
PG 7
WC Thermodynamics; Mechanics
SC Thermodynamics; Mechanics
GA EV6BW
UT WOS:000401855700029
OA No
DA 2017-08-17
ER

PT J
AU Salaheldin, HI
   Almalki, MHK
   Osman, GEH
AF Salaheldin, Hosam I.
   Almalki, Meshal H. K.
   Osman, Gamal E. H.
TI Green synthesis of silver nanoparticles using bovine skin gelatin and
   its antibacterial effect on clinical bacterial isolates
SO IET NANOBIOTECHNOLOGY
LA English
DT Article
ID BACILLUS-THURINGIENSIS; OPTICAL-PROPERTIES
AB Nanoparticles are being increasingly used in day-to-day life. Therefore, concerns have been raised regarding their interactions with the surrounding environment. This study focused on a simple green method for synthesizing silver nanoparticles (Ag-NPs) in an autoclave at 15 psi (103kPa) and 121 degrees C. An aqueous solution of AgNO3 as a precursor of Ag-NPs and gelatin (type B) reducing and/or stabilizing (capping) agent were used. The effect of various AgNO3 concentrations of certain gelatin concentration and various gelatin concentrations at constant AgNO3 concentration, and autoclaving time, was studied. UV-Vis spectra ascribed that the presence of localized surface plasmon resonance (SPR) of the synthesized Ag-NPs. TEM images and the selected area of electron diffraction confirmed, the formation of Ag-NPs with a diameter of approximately 5 +/- 0.35nm. Furthermore, FT-IR revealed that a gelatin polymer matrix stabilized the synthesized Ag-NPs. The Well diffusion assay was used to test the effect of Ag-NPs on six clinical bacterial isolates, where Gram positive bacteria were more susceptible to Ag-NPs than Gram negative bacteria. Therefore, Ag-NPs capped by gelatin have remarkable potential effect as an antibacterial agent, and they not only have various medical applications but can also be used in biological, pharmaceutical and industrial fields.
C1 [Salaheldin, Hosam I.] Mansoura Univ, Fac Sci, Dept Phys, Mansoura 35516, Egypt.
   [Salaheldin, Hosam I.] Umm Al Qura Univ, Fac Appl Sci, Dept Phys, POB 715, Mecca 21955, Saudi Arabia.
   [Almalki, Meshal H. K.; Osman, Gamal E. H.] Umm Al Qura Univ, Fac Appl Sci, Dept Biol, POB 715, Mecca 21955, Saudi Arabia.
   [Osman, Gamal E. H.] AGERI, Giza 12619, Egypt.
RP Salaheldin, HI (reprint author), Mansoura Univ, Fac Sci, Dept Phys, Mansoura 35516, Egypt.; Salaheldin, HI (reprint author), Umm Al Qura Univ, Fac Appl Sci, Dept Phys, POB 715, Mecca 21955, Saudi Arabia.
EM dr.hosamibrahim@gmail.com
CR Abdul-Hamid A, 2002, FOOD CHEM, V78, P69, DOI 10.1016/S0308-8146(01)00380-6
   Abulreesh HH, 2012, INDIAN J MICROBIOL, V52, P500, DOI 10.1007/s12088-012-0257-z
   Al-Saidi G. S., 2012, International Food Research Journal, V19, P1167
   Alam M. J., 2013, CURR RES MICROBIOL B, V1, P245
   Alothyqic N., 2016, Journal of Microbial and Biochemical Technology, V8, P83
   Assaeedi ASA, 2011, AUST J CROP SCI, V5, P1185
   CREIGHTON JA, 1991, J CHEM SOC FARADAY T, V87, P3881, DOI 10.1039/ft9918703881
   Darroudi M, 2011, INT J MOL SCI, V12, P6346, DOI 10.3390/ijms12096346
   Deepak V, 2011, METAL NANOPARTICLES IN MICROBIOLOGY, P17, DOI 10.1007/978-3-642-18312-6_2
   El-Ghareeb DK, 2012, BIOCONTROL SCI TECHN, V22, P11, DOI 10.1080/09583157.2011.635288
   El-Kheshen A. A., 2012, PHARM CHEM, V4, P53
   Emam M., 2006, J CULTURE COLLECT, V5, P78
   Garidel P., 2006, BIOPROCESS INT, V4, P48
   Gaudreau C, 1997, J ANTIMICROB CHEMOTH, V39, P707, DOI 10.1093/jac/39.6.707
   Raja Mohd Hafidz R. N., 2011, INT FOOD RES J, V18, P813
   Hermanto S, 2013, J FOOD PHARM SCI, V1, P68
   Jeevithan E, 2014, MAR DRUGS, V12, P3852, DOI 10.3390/md12073852
   Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y
   Liu Y, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9756-1
   Mahmoud KH, 2013, SPECTROCHIM ACTA A, V116, P610, DOI 10.1016/j.saa.2013.07.106
   Mendes L. C., 2012, MAT SCI APPL, V3, P580
   Osman G., 2015, J ENV CHEM ENG, V3, P1847
   Natarajan K, 2010, DIG J NANOMATER BIOS, V5, P135
   Petrus E.M., 2011, INT FOOD RES J, V18, P55
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Sanyasi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24929
   Shameli K, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-73
   Shankar SS, 2003, BIOTECHNOL PROGR, V19, P1627, DOI 10.1021/bp034070w
   Sheikh N, 2009, PHYSICA E, V42, P132, DOI 10.1016/j.physe.2009.09.013
   Stepanov A.L., 1997, REV TECH PHYS, V49, P143
   Torres A, 2004, THERMOCHIM ACTA, V415, P107, DOI 10.1016/j.tca.2003.06.005
   Venkatesham M, 2014, APPL NANOSCI, V4, P113, DOI 10.1007/s13204-012-0180-y
   Vigneshwaran N, 2006, CARBOHYD RES, V341, P2012, DOI 10.1016/j.carres.2006.04.042
   Wangoo N, 2008, J COLLOID INTERF SCI, V323, P247, DOI 10.1016/j.jcis.2008.04.043
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
NR 35
TC 0
Z9 0
U1 1
U2 1
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1751-8741
EI 1751-875X
J9 IET NANOBIOTECHNOL
JI IET Nanobiotechnol.
PD JUN
PY 2017
VL 11
IS 4
BP 420
EP 425
DI 10.1049/iet-nbt.2016.0126
PG 6
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA EV6PF
UT WOS:000401890600011
PM 28530191
OA No
DA 2017-08-17
ER

PT J
AU Salaheldin, HI
   Almalki, MHK
   Hezma, AM
   Osman, GEH
AF Salaheldin, Hosam I.
   Almalki, Meshal H. K.
   Hezma, Abd Elhameed. M.
   Osman, Gamal E. H.
TI Facile synthesis of silver nanoparticles mediated by
   polyacrylamide-reduction approach to antibacterial application
SO IET NANOBIOTECHNOLOGY
LA English
DT Article
DE antibacterial activity; silver; nanoparticles; nanomedicine; surface
   plasmon resonance; X-ray chemical analysis; transmission electron
   microscopy; electron diffraction; Fourier transform infrared
   spectroscopy; microorganisms; ultraviolet spectra; visible spectra;
   Ag-NP facile synthesis; PAM-reduction approach; antibacterial
   application; antibiotic resistant super-bugs; food safety; antimicrobial
   agents; antibiotics; antimicrobial substances; Ag salt solution
   concentration; ultraviolet-visible absorption spectra; polyacrylamide;
   transmission electron microscopy; electron diffraction; energy
   dispersive X-ray spectroscopy; TEM images; Fourier transform infrared
   spectroscopy; PAM polymer matrix; diffusion method; Gram positive
   bacteria; Gram negative bacteria; clinical bacterial isolates; Ag
ID ONE-POT SYNTHESIS; ESCHERICHIA-COLI; ACRYLAMIDE; ION; POLYMERIZATION;
   NANOCOMPOSITE; HYDROGELS; NITRATE; CANCER
AB The current time increase in the prevalence of antibiotic resistant 'super-bugs' and the risks associated with food safety have become global issues. Therefore, further research is warranted to identify new and effective antimicrobial substances. Silver nanoparticles (Ag-NPs) were synthesized by autoclaving technique using, different concentrations of Ag salt (AgNO3) solution (1, 5, 10, and 25 mM). Their presence was confirmed by a surface plasmon resonance band at similar to 435 nm using UV-Vis absorption spectra. The morphology of the synthesized Ag-NPs stabilized by polyacrylamide (PAM) was examined by TEM, SAED, and EDS. TEM images revealed that the synthesized Ag-NPs had an average diameter of 2.98 +/- 0.08 nm and SAED and EDS results confirmed the formation of Ag-NPs. In addition, FT-IR spectroscopy revealed that a PAM polymer matrix stabilized the Ag-NPs. The well diffusion method, was used to test, Gram positive and Gram negative bacteria were examined. Also the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were studied against Ag-NPs. The Ag-NPs exhibited strong inhibitory activity, MIC and MBC against the tested clinical bacterial isolates. These results suggest that Ag-NPs stabilized in PAM are highly effective against clinical bacterial isolates can be applied in medical fields.
C1 [Salaheldin, Hosam I.] Mansoura Univ, Fac Sci, Dept Phys, Mansoura 35516, Egypt.
   [Salaheldin, Hosam I.] Umm Al Qura Univ, Fac Appl Sci, Dept Phys, POB 715, Mecca 21955, Saudi Arabia.
   [Almalki, Meshal H. K.; Osman, Gamal E. H.] Umm Al Qura Univ, Fac Appl Sci, Dept Biol, POB 715, Mecca 21955, Saudi Arabia.
   [Hezma, Abd Elhameed. M.] Natl Res Ctr, Phys Div, Spect Dept, Giza 12622, Egypt.
   [Osman, Gamal E. H.] AGERI, Microbial Genet Dept, Giza 12619, Egypt.
RP Salaheldin, HI (reprint author), Mansoura Univ, Fac Sci, Dept Phys, Mansoura 35516, Egypt.; Salaheldin, HI (reprint author), Umm Al Qura Univ, Fac Appl Sci, Dept Phys, POB 715, Mecca 21955, Saudi Arabia.
EM dr.hosamibrahim@gmail.com
CR Abdel-Halim ES, 2011, CARBOHYD POLYM, V85, P692, DOI 10.1016/j.carbpol.2011.03.039
   Abdelrazek EM, 2010, PHYSICA B, V405, P4339, DOI 10.1016/j.physb.2010.07.038
   Ahmed V, 2014, INT J POLYM MATER PO, V63, P471, DOI 10.1080/00914037.2013.854217
   Alothyqic N., 2016, Journal of Microbial and Biochemical Technology, V8, P83
   Andersen FA, 2005, INT J TOXICOL, V24, P21, DOI 10.1080/10915810590953842
   Bai J, 2007, MATER CHEM PHYS, V106, P412, DOI 10.1016/j.matchemphys.2007.06.021
   Bajpai AK, 2009, POLYM COMPOSITE, V30, P1532, DOI 10.1002/pc.20726
   Chalal S, 2012, J POLYM RES, V19, DOI 10.1007/s10965-012-0024-1
   Chamakura K, 2011, COLLOID SURFACE B, V84, P88, DOI 10.1016/j.colsurfb.2010.12.020
   Chen M, 2006, J PHYS CHEM B, V110, P11224, DOI 10.1021/jp061134n
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021
   Chumachenko V, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-164
   Djokovi V., 2011, PHYS CHEM INTERFACES, V8098, P1
   El-Rafie M. H., 2014, INT SCH RES NOT, V1, P1
   Exon J H, 2006, J Toxicol Environ Health B Crit Rev, V9, P397, DOI 10.1080/10937400600681430
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Ghorbaniazar P, 2015, ADV PHARM BULL, V5, P269, DOI 10.15171/apb.2015.037
   Gilbert J, 2008, BIOACTIVE COMPOUNDS
   Gilbert J., 2007, BIOACTIVE COMPOUNDS
   Guozhong C, 2003, NANOSTRUCTURES NANOM
   Guozhong C., 2004, NANOSTRUCTURES NANOM
   Gurunathan S., 2014, NANOSCALE RES LETT, V9, P1
   Hebeish A., 2013, J NANOTECHNOL, V2013, P10
   Hungund B S, 2015, J NANOMEDICINE NANOT, V6, P1
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Jyoti K, 2016, J RADIAT RES APPL SI, V9, P217, DOI 10.1016/j.jrras.2015.10.002
   Kora A. J., 2012, ORG MED CHEM LETT, V2, P1
   Kutsevol N, 2016, MICRO NANO LETT, V11, P256, DOI 10.1049/mnl.2015.0547
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Lara HH, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-30
   Luo HY, 2015, RSC ADV, V5, P13470, DOI 10.1039/c4ra16469e
   Maciollek A, 2014, BEILSTEIN J NANOTECH, V5, P380, DOI 10.3762/bjnano.5.44
   Magalhaes ASG, 2012, QUIM NOVA, V35, P1464, DOI 10.1590/S0100-40422012000700030
   Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Murugan R, 1998, J KOREAN PHYS SOC, V32, P505
   Ozeroglu C, 2007, EXPRESS POLYM LETT, V1, P132, DOI 10.3144/expresspolymlett.2007.22
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Peng S, 2010, P NATL ACAD SCI USA, V107, P14530, DOI 10.1073/pnas.1007524107
   Pennisi M, 2013, INT J ENV RES PUB HE, V10, P3843, DOI 10.3390/ijerph10093843
   Petrus E.M., 2011, INT FOOD RES J, V18, P55
   Prathna TC, 2010, BIOMIMETICS, LEARNING FROM NATURE, P1
   Sen G, 2009, MACROMOL SYMP, V277, P100, DOI 10.1002/masy.200950313
   Shameli K, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-73
   Shameli K, 2010, INT J NANOMED, V5, P875, DOI 10.2147/IJN.S13632
   Shipp A, 2006, CRIT REV TOXICOL, V36, P481, DOI 10.1080/10408440600851377
   Singhal R, 2002, IRAN POLYM J, V11, P143
   Smith Eldon A., 1991, Reviews on Environmental Health, V9, P215
   Song HY, 2006, EUR CELLS MATER, V11, P58
   Sowwan M., 2011, INT J PHYS SCI, V6, P6280
   Srivastava SK, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-70
   Taglietti A, 2012, LANGMUIR, V28, P8140, DOI 10.1021/la3003838
   Torres A, 2004, THERMOCHIM ACTA, V415, P107, DOI 10.1016/j.tca.2003.06.005
   Venkatesham M, 2014, APPL NANOSCI, V4, P113, DOI 10.1007/s13204-012-0180-y
   Virk-Baker MK, 2014, NUTR CANCER, V66, P774, DOI 10.1080/01635581.2014.916323
   Xiong YJ, 2007, J MATER CHEM, V17, P2600, DOI 10.1039/b705253g
   Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005
   Yan F, 1998, J APPL POLYM SCI, V67, P747, DOI 10.1002/(SICI)1097-4628(19980124)67:4<747::AID-APP17>3.0.CO;2-0
NR 60
TC 0
Z9 0
U1 1
U2 1
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1751-8741
EI 1751-875X
J9 IET NANOBIOTECHNOL
JI IET Nanobiotechnol.
PD JUN
PY 2017
VL 11
IS 4
BP 448
EP 453
DI 10.1049/iet-nbt.2016.0135
PG 6
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA EV6PF
UT WOS:000401890600015
PM 28530195
OA No
DA 2017-08-17
ER

PT J
AU Badawi, GA
   Abd El Fattah, MA
   Zaki, HF
   El Sayed, MI
AF Badawi, Ghada A.
   Abd El Fattah, Mai A.
   Zaki, Hala F.
   El Sayed, Moushira I.
TI Sitagliptin and liraglutide reversed nigrostriatal degeneration of
   rodent brain in rotenone-induced Parkinson's disease
SO INFLAMMOPHARMACOLOGY
LA English
DT Article
DE PD; Rotenone; Liraglutide; Sitagliptin; GDNF; TGF-beta 1; IL-1 beta;
   IL-6; Apoptosis
ID GLUCAGON-LIKE PEPTIDE-1; NF-KAPPA-B; ALPHA-LIPOIC ACID;
   DOPAMINERGIC-NEURONS; MOUSE MODEL; RAT-BRAIN; INFLAMMATORY PROCESS;
   RECEPTOR EXPRESSION; OXIDATIVE STRESS; ANIMAL-MODELS
AB The present study investigated the possible relationship between pro-inflammatory cytokines and programmed nigral neuronal death in rotenone model of Parkinson's disease (PD). Sitagliptin and liraglutide efficacy to inhibit the inflammatory-apoptotic degenerative process were investigated, too. The experimental PD were induced in male albino rats by ten subcutaneously injections of rotenone (3 mg/kg/day, s.c). All treatment drugs were administered for 16 days after induction of Parkinson rat's model. Sitagliptin and liraglutide were administered in three different dose levels (10-20-30 mg/kg, p.o), (25-50-100 mu g/kg, s.c), respectively. Cylindrical and catalepsy tests were used to detect the optimum dose response of each drug. Sitagliptin (30 mg/kg/day, p.o) and liraglutide (50 mu g/kg, s.c.) showed statistically significant (p <= 0.05) effect on behavioral activity. Where both doses improved the motor performance significantly in comparison with other doses in both cylindrical and catalepsy tests. Furthermore, they reversed rotenone-induced nigral neuronal loss, associated with marked decrease of pro-inflammatory cytokines: interleukin (IL)-1 beta, IL-6, transforming growth factor (TGF)-beta 1, together with a significant increase of striatal dopamine, nigral glial cell line-derived neurotrophic factor (GDNF), and tyrosine hydroxylase positive (TH+) cells. Moreover, the proapoptotic environment in nigrostriatal tissues was abrogated significantly, as the pro-apoptotic protein Bax decreased along with the anti-apoptotic protein Bcl-2 increased. In conclusion, sitagliptin and liraglutide represent a promising strategy to mitigate the progression of PD by their anti-inflammatory, anti-apoptotic neurotrophic and neurogenic mechanistic activities.
C1 [Badawi, Ghada A.; El Sayed, Moushira I.] Sinai Univ, Fac Pharm & Pharmaceut Ind, Dept Pharmacol & Toxicol, Al Arish, Egypt.
   [Abd El Fattah, Mai A.; Zaki, Hala F.] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.
RP Badawi, GA (reprint author), Sinai Univ, Fac Pharm & Pharmaceut Ind, Dept Pharmacol & Toxicol, Al Arish, Egypt.
EM ghadaali1986@yahoo.com
CR Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087
   Abdin AA, 2011, NEUROSCI RES, V71, P387, DOI 10.1016/j.neures.2011.08.008
   Ahmed HH, 2016, WORLD J STEM CELLS, V8, P106, DOI 10.4252/wjsc.v8.i3.106
   Alam M, 2002, BEHAV BRAIN RES, V136, P317, DOI 10.1016/S0166-4328(02)00180-8
   Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067
   Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004
   Cabou Cendrine, 2011, Rev Diabet Stud, V8, P418, DOI 10.1900/RDS.2011.8.418
   Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016
   Chen YT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-270
   Chera H, 2004, BRAIN RES, V1006, P150, DOI 10.1016/j.brainres.2004.01.065
   Chowen JA, 1999, NEUROPEPTIDES, V33, P212, DOI 10.1054/npep.1999.0757
   Dai Y, 2014, CARDIOVASC DRUG THER, V28, P425, DOI 10.1007/s10557-014-6539-4
   Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018
   Dobrian AD, 2011, ENDOCRINOL METAB, V300, P410
   Drinkut A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.263
   Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004
   Fleming SM, 2004, EXP NEUROL, V187, P418, DOI 10.1016/j.expneurol.2004.01.023
   Gao HM, 2003, J NEUROSCI, V23, P1228
   [高慧亭 Gao Huiting], 2013, [南方医科大学学报, Journal of Southern Medical University], V33, P1661
   GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x
   Gou S, 2014, INT IMMUNOPHARMACOL, V22, P498, DOI 10.1016/j.intimp.2014.07.010
   Hald Andreas, 2007, Subcell Biochem, V42, P249
   Hamilton A, 2011, J NEUROSCI RES, V89, P481, DOI 10.1002/jnr.22565
   Han L, 2016, NEUROREPORT, V27, P23, DOI 10.1097/WNR.0000000000000490
   Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x
   Herrera GM, 2007, MEDLINES, V1, P2
   Hoeglinger GU, 2006, J NEURAL TRANSM-SUPP, P269
   Hoelscher Christian, 2014, Shengli Xuebao, V66, P497
   Hunter K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-33
   Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008
   Kappe C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-276
   Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007
   Kim S, 2009, J ENDOCRINOL, V202, P431, DOI 10.1677/JOE-09-0132
   Lee YS, 2012, DIABETOLOGIA, V55, P2456, DOI 10.1007/s00125-012-2592-3
   Lee YS, 2016, MEDIAT INFLAMM, DOI 10.1155/2016/3094642
   Lee YS, 2014, METABOLISM, V63, P9, DOI 10.1016/j.metabol.2013.09.010
   Lew M, 2007, PHARMACOTHERAPY, V27, p155S, DOI 10.1592/phco.27.12part2.155S
   Liu B, 2006, AAPS J, V8, pE606, DOI 10.1208/aapsj080369
   Liu W, 2015, NEUROSCIENCE, V303, P42, DOI 10.1016/j.neuroscience.2015.06.054
   Liu WJ, 2012, J PHARMACOL EXP THER, V340, P248, DOI 10.1124/jpet.111.186866
   Marques C, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/538737
   McClean PL, 2011, J NEUROSCI, V31, P6587, DOI 10.1523/JNEUROSCI.0529-11.2011
   McGeer EG, 2007, CNS DRUGS, V21, P789, DOI 10.2165/00023210-200721100-00001
   Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5
   Mogi M, 2007, NEUROSCI LETT, V414, P94, DOI 10.1016/j.neulet.2006.12.003
   Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010
   Nagai T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160993
   Nagatsu T, 2002, J NEURAL TRANSM, V109, P731, DOI 10.1007/s007020200061
   Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620
   Nagatsu T., 2000, Journal of Neural Transmission Supplement, V60, P277
   Nassar NN, 2015, NEUROPHARMACOLOGY, V89, P308, DOI 10.1016/j.neuropharm.2014.10.007
   Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200
   Parthsarathy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058784
   Perry Tracy Ann, 2005, Current Alzheimer Research, V2, P377, DOI 10.2174/1567205054367892
   Sawada M, 2006, J NEURAL TRANSM-SUPP, P373
   Schmidt WJ, 2006, J NEURAL TRANSM-SUPP, P273
   Schmidt WJ, 1997, NEUROSCI BIOBEHAV R, V21, P381, DOI 10.1016/S0149-7634(96)00044-9
   Sherer TB, 2003, J NEUROSCI, V23, P10756
   Teema AM, 2016, NEUROPHARMACOLOGY, V107, P432, DOI 10.1016/j.neuropharm.2016.03.034
   Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332
   Tremblay AJ, 2014, METABOLISM, V63, P1141, DOI 10.1016/j.metabol.2014.06.004
   Wang DJ, 2013, DIABETES, V62, P1697, DOI 10.2337/db12-1025
   Wilms H, 2007, CURR PHARM DESIGN, V13, P1925
   Zaitone SA, 2012, PHARMACOL BIOCHEM BE, V100, P347, DOI 10.1016/j.pbb.2011.09.002
   Zhang LH, 2015, CARDIOVASC DRUG THER, V29, P243, DOI 10.1007/s10557-015-6592-7
NR 65
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0925-4692
EI 1568-5608
J9 INFLAMMOPHARMACOLOGY
JI Inflammopharmacology
PD JUN
PY 2017
VL 25
IS 3
BP 369
EP 382
DI 10.1007/s10787-017-0331-6
PG 14
WC Immunology; Pharmacology & Pharmacy; Toxicology
SC Immunology; Pharmacology & Pharmacy; Toxicology
GA EV5PF
UT WOS:000401818900007
PM 28258522
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, WAS
   Kishk, EA
   Farhan, RI
   Khamees, RE
AF Ahmed, Waleed Ali Sayed
   Kishk, Eman Ahmed
   Farhan, Rasha Imam
   Khamees, Rasha Elsayed
TI Female sexual function following different degrees of perineal tears
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Perineal tears; Episiotomy; Female sexual dysfunction; FSFI
ID ANAL-SPHINCTER INJURY; RISK-FACTORS; PROSPECTIVE COHORT; VAGINAL
   DELIVERY; FUNCTION INDEX; WOMEN; DYSPAREUNIA; CHILDBIRTH; PREVALENCE;
   DYSFUNCTION
AB Perineal tears may have a negative impact on female sexual function (FSF). The aim of the study was to assess the effect of different degrees of perineal tears sustained during delivery on subsequent FSF.
   This prospective cohort study assessed women with third- or fourth-degree perineal tears following vaginal delivery (study group) and compared them with women who underwent episiotomy or had minor lacerations (control group). Sexual function of postpartum women meeting inclusion criteria was assessed using the validated Arabic version of the Female Sexual Function Index (FSFI) questionnaire at 6 and 12 months postpartum.
   One hundred and fifty-six women completed the study: 56 and 100 in the study and control groups, respectively. Mean total FSFI scores were significantly different between groups at 6 months postpartum [28.1 +/- 4.1 vs. 18 +/- 2.4 (p < 0.002)]. After 12 months, and despite slight improvement, sexual function was significantly lower in the repaired compared with the control group (21.8 +/- 2.9 vs. 29.2 +/- 4.1). Women in the study group showed significant decreases in the scores of desire, arousal, lubrication, orgasm, satisfaction, and pain domains 12 months postdelivery.
   Higher-degree perineal tears negatively affect FSF up to 1 year after delivery. Evaluation of FSF and appropriate counseling are necessary for women with perineal tears, especially the higher degree tears.
C1 [Ahmed, Waleed Ali Sayed; Kishk, Eman Ahmed; Farhan, Rasha Imam; Khamees, Rasha Elsayed] Suez Canal Univ, Fac Med, Dept Obstet & Gynecol, Round Rd, Ismailia 41111, Egypt.
RP Ahmed, WAS (reprint author), Suez Canal Univ, Fac Med, Dept Obstet & Gynecol, Round Rd, Ismailia 41111, Egypt.
EM waleed.asa@gmail.com
CR Andrews V, 2008, EUR J OBSTET GYN R B, V137, P152, DOI 10.1016/j.ejogrb.2007.06.005
   Anis TH, 2011, J SEX MED, V8, P3370, DOI 10.1111/j.1743-6109.2011.02471.x
   Barrett G, 2000, BRIT J OBSTET GYNAEC, V107, P186, DOI 10.1111/j.1471-0528.2000.tb11689.x
   Buhling KJ, 2006, EUR J OBSTET GYN R B, V124, P42, DOI 10.1016/j.ejogrb.2005.04.008
   Dudding TC, 2008, ANN SURG, V247, P224, DOI 10.1097/SLA.0b013e318142cdf4
   Fleiss J. L, 1981, STAT METHODS RATES P
   Gurol-Urganci I, 2013, BJOG-INT J OBSTET GY, V120, P1516, DOI 10.1111/1471-0528.12363
   Harkin R, 2003, EUR J OBSTET GYN R B, V109, P149, DOI 10.1016/S0301-2115(03)00008-3
   Ibrahim ZM, 2013, ARCH GYNECOL OBSTET, V287, P1173, DOI 10.1007/s00404-012-2677-8
   Kettle C, 2011, BMJ CLIN EVID REV, V2011
   Khajehei M, 2015, J SEX MED, V12, P1415, DOI 10.1111/jsm.12901
   McDonald EA, 2015, BJOG-INT J OBSTET GY, V122, P672, DOI 10.1111/1471-0528.13263
   Nichols CM, 2004, OBSTET GYNECOL, V104, P690, DOI 10.1097/01.AOG.0000139518.46032.e5
   Pollack J, 2004, OBSTET GYNECOL, V104, P1397, DOI 10.1097/01.AOG.0000147597.45349.e8
   Royal College of Obstetricians and Gynecologists, 2015, MAN 3 4 DEGR PER TEA
   Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597
   Signorello LB, 2001, AM J OBSTET GYNECOL, V184, P881, DOI 10.1067/mob.2001.113855
   Sultan AH, 2002, BEST PRACT RES CL OB, V16, P99, DOI 10.1053/beog.2002.0258
   Thompson JF, 2002, BIRTH-ISS PERINAT C, V29, P83, DOI 10.1046/j.1523-536X.2002.00167.x
   World Health Organization, POSTP CAR MOTH NEWB
   Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206
NR 21
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD JUN
PY 2017
VL 28
IS 6
BP 917
EP 921
DI 10.1007/s00192-016-3210-6
PG 5
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA EV5FM
UT WOS:000401787900018
OA No
DA 2017-08-17
ER

PT J
AU Harb, HS
   Rabea, H
   Fathy, M
   Elberry, AA
   Abdelrahim, M
AF Harb, Hadeer S.
   Rabea, Hoda
   Fathy, Maha
   Elberry, Ahmed A.
   Abdelrahim, Mohamed
TI COMBIHALER VS T-PIECE FOR AEROSOL DELIVERY IN SINGLE LIMB NON-INVASIVE
   MECHANICAL VENTILATION
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Harb, Hadeer S.; Rabea, Hoda] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Fathy, Maha] Beni Suef Univ, Fac Med, Resp Dept, Bani Suwayf, Egypt.
   [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6Th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 3
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 006
BP 2
EP 3
PG 2
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600004
OA No
DA 2017-08-17
ER

PT J
AU Hassan, A
   Eldin, RS
   Abdelrahman, MM
   Abdelrahim, M
AF Hassan, Ahmed
   Eldin, Randa Salah
   Abdelrahman, Maha M.
   Abdelrahim, Mohamed
TI IN-VITRO / IN-VIVO COMPARISON OF INHALED SALBUTAMOL DOSE DELIVERED BY
   JET NEBULIZER, VIBRATING MESH NEBULIZER AND METERED DOSE INHALER WITH
   SPACER IN NON-INVASIVE VENTILATION
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Hassan, Ahmed] Beba Gen Hosp, Hosp Pharm Dept, Bani Suwayf, Egypt.
   [Eldin, Randa Salah] Beni Suef Univ, Fac Med, Resp Dept, Bani Suwayf, Egypt.
   [Abdelrahman, Maha M.] Beni Suef Univ, Fac Pharm, Analyt Chem Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6Th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 005
BP 2
EP 2
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600003
OA No
DA 2017-08-17
ER

PT J
AU Madney, YM
   Fathy, M
   Elberry, AA
   Rabea, H
   Abdelrahim, M
AF Madney, Yasmin M.
   Fathy, Maha
   Elberry, Ahmed A.
   Rabea, Hoda
   Abdelrahim, Mohamed
TI NEBULIZERS AND SPACERS FOR AEROSOL DELIVERY THROUGH ADULT NASAL CANNULA
   AT LOW OXYGEN FLOW RATE: AN IN-VITRO STUDY
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Madney, Yasmin M.; Rabea, Hoda] Beni Suef Univ, Clin Pharm Dept, Fac Pharm, Bani Suwayf, Egypt.
   [Fathy, Maha] Beni Suef Univ, Fac Med, Resp Dept, Bani Suwayf, Egypt.
   [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Clin Pharm Dept, Fac Pharm, 6Th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 003
BP 2
EP 2
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600002
OA No
DA 2017-08-17
ER

PT J
AU Saeed, H
   Eldin, AS
   Elberry, AA
   Rabea, H
   Abdelrahim, M
AF Saeed, Haitham
   Eldin, Abeer Salah
   Elberry, Ahmed A.
   Rabea, Hoda
   Abdelrahim, Mohamed
TI EFFECT OF FILL VOLUME ON AEROSOL DELIVERY DURING NON-INVASIVE
   VENTILATION
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Saeed, Haitham; Rabea, Hoda] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Eldin, Abeer Salah] Beni Suef Univ, Fac Med, Resp Dept, Bani Suwayf, Egypt.
   [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6Th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 007
BP 3
EP 3
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600005
OA No
DA 2017-08-17
ER

PT J
AU Sarhan, RM
   Elberry, AA
   Abdelwahab, NS
   Rabea, H
   Abdelrahim, M
AF Sarhan, Rania M.
   Elberry, Ahmed A.
   Abdelwahab, Nada Saed
   Rabea, Hoda
   Abdelrahim, Mohamed
TI THE FEASIBILITY OF USING AEROGEN ULTRA AS ADD ON DEVICE FOR NEBULIZERS
   OTHER THAN AEROGEN SOLO
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Sarhan, Rania M.; Rabea, Hoda] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt.
   [Abdelwahab, Nada Saed] Beni Suef Univ, Fac Med, Analyt Chem Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6Th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 021
BP 3
EP 4
PG 2
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600007
OA No
DA 2017-08-17
ER

PT J
AU Boshra, MS
   Almeldien, AG
   Eldin, RS
   Elberry, AA
   Abdelwahab, NS
   Rabea, H
   Abdelrahim, M
AF Boshra, Mariane S.
   Almeldien, Ahmed G.
   Eldin, Randa Salah
   Elberry, Ahmed A.
   Abdelwahab, Nada Saed
   Rabea, Hoda
   Abdelrahim, Mohamed
TI EFFECT OF INHALATION FLOW, INHALATION VOLUME AND INHALATION DEVICE
   CHANGES ON DRY POWDER INHALER TOTAL EMITTED DOSE
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Boshra, Mariane S.; Rabea, Hoda] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Almeldien, Ahmed G.] Childrens Canc Hosp Cairo, Clin Res Dept, Cairo, Egypt.
   [Eldin, Randa Salah] Beni Suef Univ, Fac Med, Resp Dept, Bani Suwayf, Egypt.
   [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt.
   [Abdelwahab, Nada Saed] Beni Suef Univ, Fac Pharm, Analyt Chem Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6Th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 022
BP 4
EP 4
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600008
OA No
DA 2017-08-17
ER

PT J
AU Moustafa, IOF
   Ali, MRA
   Al Hallag, M
   Rabea, H
   Fink, JB
   Dailey, P
   Abdelrahim, M
AF Moustafa, Islam O. F.
   Ali, Mohamed R. A.
   Al Hallag, Moataz
   Rabea, Hoda
   Fink, James B.
   Dailey, Patricia
   Abdelrahim, Mohamed
TI URINARY LEVEL AS INDEX OF LUNG DEPOSITION AND SYSTEMIC BIOAVALIABILITY
   ASSOCIATED WITH THE USE OF DIFFERENT AEROSOL DEVICE WITH AND WITHOUT
   HUMIDIFICATION IN MECHANICALLY VENTILATED PATIENTS
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Moustafa, Islam O. F.] Saudi German Hosp Sgh, Clin Pharmacist Dept, Cairo, Egypt.
   [Ali, Mohamed R. A.] Beni Suef Univ, Fac Pharm, Pharmacol & Toxicol Dept, Bani Suwayf, Egypt.
   [Al Hallag, Moataz] Cairo Univ, Fac Med, Crit Care Med, Cairo, Egypt.
   [Rabea, Hoda] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Fink, James B.] Georgia State Univ, Div Allied Hlth, Atlanta, GA 30303 USA.
   [Dailey, Patricia] Aerogen Ltd, Med Affairs Clin, Galway, Ireland.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6Th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 024
BP 4
EP 5
PG 2
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600010
OA No
DA 2017-08-17
ER

PT J
AU Saeed, H
   Abdelrahim, M
   Fink, JB
AF Saeed, Haitham
   Abdelrahim, Mohamed
   Fink, James B.
TI THE EFFECT OF HEAT AND HUMIDIFICATION ON COMMONLY NEBULIZED DRUGS
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Saeed, Haitham] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6Th Of October City, Giza Governorat, Egypt.
   [Fink, James B.] Georgia State Univ, Div Allied Hlth, Atlanta, GA 30303 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 023
BP 4
EP 4
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600009
OA No
DA 2017-08-17
ER

PT J
AU Moustafa, IOF
   ElHansy, MHE
   Al Hallag, M
   Fink, JB
   Dailey, P
   Rabea, H
   Abdelrahim, M
AF Moustafa, Islam O. F.
   ElHansy, Muhammad H. E.
   Al Hallag, Moataz
   Fink, James B.
   Dailey, Patricia
   Rabea, Hoda
   Abdelrahim, Mohamed
TI CLINICAL OUTCOMES ASSOCIATED WITH THE USE OF DIFFERENT INHALATION METHOD
   WITH AND WITHOUT HUMIDIFICATION IN ASTHMATIC MECHANICALLY VENTILATED
   PATIENTS
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Moustafa, Islam O. F.] Saudi German Hosp Sgh, Clin Pharmacist Dept, Cairo, Egypt.
   [ElHansy, Muhammad H. E.] Fayoum Univ, Teaching Hosp, Clin Pharm Dept, Fac Med, Faiyum, Egypt.
   [Al Hallag, Moataz] Cairo Univ, Crit Care Med, Crit Care, Fac Med, Giza, Giza Governorat, Egypt.
   [Fink, James B.] Georgia State Univ, Div Allied Hlth, Atlanta, GA 30303 USA.
   [Dailey, Patricia] Aerogen Ltd, Med Sci Liaison, Med Affairs Clin, Galway, Ireland.
   [Rabea, Hoda] Beni Suef Univ, Clin Pharm Dept, Fac Pharm, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Clin Pharm Dept, Fac Pharm, 6th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 025
BP 5
EP 5
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600011
OA No
DA 2017-08-17
ER

PT J
AU ElHansy, MHE
   Emad, M
   Farid, H
   Chrystyn, H
   El-Maraghi, SK
   Al-Kholy, MB
   El Essawy, AFM
   Abdelrahman, MM
   Said, ASA
   Abdelrahim, M
AF ElHansy, Muhammad H. E.
   Emad, Marina
   Farid, Heba
   Chrystyn, Henry
   El-Maraghi, Sameh Kamal
   Al-Kholy, Mohamed Bakry
   El Essawy, Assem Fouad Mohamed
   Abdelrahman, Maha M.
   Said, Amira S. A.
   Abdelrahim, Mohamed
TI NEW IN-VITRO METHODOLOGY WITH THE INTRODUCTION OF PATIENT INHALATION
   PROFILE TO DETERMINE AERODYNAMIC CHARACTERISTICS OF AEROSOL DELIVERY IN
   MECHANICAL VENTILATION
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [ElHansy, Muhammad H. E.; Emad, Marina] Fayoum Univ, Teaching Hosp, Fac Med, Clin Pharm Dept, Faiyum, Egypt.
   [Farid, Heba] Beni Suef Univ, Teaching Hosp, Fac Med, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Chrystyn, Henry] Plymouth Univ, Inhalat Consultancy Ltd, Plymouth, Devon, England.
   [El-Maraghi, Sameh Kamal; Al-Kholy, Mohamed Bakry] Beni Suef Univ, Crit Care Dept, Fac Med, Bani Suwayf, Egypt.
   [El Essawy, Assem Fouad Mohamed] Cairo Univ, Dept Chest Dis, Fac Med, Giza, Giza Governorat, Egypt.
   [Abdelrahman, Maha M.] Beni Suef Univ, Analyt Chem Dept, Fac Pharm, Bani Suwayf, Egypt.
   [Said, Amira S. A.] Beni Suef Univ, Clin Pharm Dept, Fac Pharm, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Clin Pharm Dept, Fac Pharm, 6th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 075
BP 7
EP 7
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600018
OA No
DA 2017-08-17
ER

PT J
AU Saeed, H
   Elberry, AA
   Eldin, AS
   Rabea, H
   Abdelrahim, M
AF Saeed, Haitham
   Elberry, Ahmed A.
   Eldin, Abeer Salah
   Rabea, Hoda
   Abdelrahim, Mohamed
TI EFFECT OF NEBULIZER DESIGN ON AEROSOL DELIVERY DURING NON-INVASIVE
   MECHANICAL VENTILATION: MODELING STUDY OF IN-VITRO DATA
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Saeed, Haitham; Rabea, Hoda] Beni Suef Univ, Clin Pharm Dept, Fac Pharm, Bani Suwayf, Egypt.
   [Elberry, Ahmed A.] Beni Suef Univ, Clin Pharmacol Dept, Fac Med, Bani Suwayf, Egypt.
   [Eldin, Abeer Salah] Beni Suef Univ, Resp Dept, Fac Med, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Clin Pharm Dept, Fac Pharm, 6th Of October City, Giza Governorat, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 074
BP 7
EP 7
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600017
OA No
DA 2017-08-17
ER

PT J
AU Nicola, M
   Roshdy, RRS
   Sayed, O
   Elberry, AA
   Saeed, H
   Abdelrahim, M
AF Nicola, Mina
   Roshdy, Raghda R. S.
   Sayed, Osama
   Elberry, Ahmed A.
   Saeed, Haitham
   Abdelrahim, Mohamed
TI IMPACT OF ADDING TRAINING DEVICE TO FAMILIAR COUNSELING ON INHALATION
   TECHNIQUE IN ASTHMATICS
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Nicola, Mina; Roshdy, Raghda R. S.; Saeed, Haitham] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Sayed, Osama] Beni Suef Univ, Fac Pharm, Pharmecut & Ind Sci Dept, Bani Suwayf, Egypt.
   [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6th Of October City, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 076
BP 17
EP 17
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600054
OA No
DA 2017-08-17
ER

PT J
AU Nicola, M
   Hussein, RRS
   Sayed, O
   Elberry, AA
   Saeed, H
   Abdelrahim, M
AF Nicola, Mina
   Hussein, Raghda R. S.
   Sayed, Osama
   Elberry, Ahmed A.
   Saeed, Haitham
   Abdelrahim, Mohamed
TI INFLUENCE OF USING TRAINING DEVICE ADDED TO THE CONVENTIONAL COUNSELING
   ON INHALATION TECHNIQUE OF DRY POWDER INHALERS IN ASTHMATICS
SO JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY
LA English
DT Meeting Abstract
C1 [Nicola, Mina; Hussein, Raghda R. S.; Saeed, Haitham] Beni Suef Univ, Fac Pharm, Clin Pharm Dept, Bani Suwayf, Egypt.
   [Sayed, Osama] Beni Suef Univ, Fac Pharm, Pharmecut & Ind Sci Dept, Bani Suwayf, Egypt.
   [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt.
   [Abdelrahim, Mohamed] Ahram Canadian Univ, Fac Pharm, Clin Pharm Dept, 6th Of October City, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1941-2711
EI 1941-2703
J9 J AEROSOL MED PULM D
JI J. Aerosol Med. Pulm. Drug Deliv.
PD JUN
PY 2017
VL 30
IS 3
MA 185
BP 18
EP 18
PG 1
WC Respiratory System
SC Respiratory System
GA EU9EU
UT WOS:000401341600057
OA No
DA 2017-08-17
ER

PT J
AU El Sherif, FA
   Mohamed, SAB
   Kamal, SM
AF El Sherif, Fatma Adel
   Mohamed, Sahar Abdel-Baky
   Kamal, Shereen Mamdouh
TI The effect of morphine added to bupivacaine in ultrasound guided
   transversus abdominis plane (TAP) block for postoperative analgesia
   following lower abdominal cancer surgery, a randomized controlled study
SO JOURNAL OF CLINICAL ANESTHESIA
LA English
DT Article
DE Morphine; Bupivacaine; TAP block; Postoperative; Pain; Abdominal surgery
ID INGUINAL-HERNIA REPAIR; AXILLARY PLEXUS BLOCK; INTRAARTICULAR MORPHINE;
   CONTROLLED-TRIAL; BRACHIAL-PLEXUS; DOUBLE-BLIND; PAIN; INFILTRATION;
   MECHANISMS; LIDOCAINE
AB Objectives: Transversus abdominis plane (TAP) block used for management of surgical abdominal pain by injecting local anesthetics into the plane between the internal oblique and transversus abdominis muscles. We aimed to explore the effect of adding morphine to bupivacaine in ultrasound guided TAP-block in patients undergoing lower abdominal cancer surgery.
   Study design: Randomized, double-blind, prospective study. Clinical trial identifier: NCT02566096.
   Setting: Academic medical center.
   Patients: Sixty patients were enrolled in this study after ethical committee approval.
   Interventions: Patients divided into 2 groups (30 each): Bupivacaine group (GB): given ultrasound guided TAP block 20 ml 0.5% bupivacaine diluted in 20 ml saline; Morphine group (GM): given ultrasound guided TAP block with 20 ml 0.5% bupivacaine + 10 mg morphine sulphate diluted in 20 ml saline.
   Measurements: Patients were observed for total morphine consumption, time for first request of rescue analgesia, sedation scores, hemodynamics and side effects for 24 h postoperatively.
   Results: Morphine added to bupivacaine in TAP block compared to bupivacaine alone reduced total morphine consumption (5.33 +/- 128 mg) (10.70 +/- 3.09 mg) respectively (p < 0.001), prolonged the time to first request of analgesia (10.40 +/- 4.96 h) (6.97 +/- 3.26 h) respectively (p < 0.008), with a statistically significant decrease in (VAS-M) in GM compared with GB at 12 h postoperatively (p < 0.002). No significant differences in hemodynamics, respiratory rate, oxygen saturation, sedation score, and side effects except for nausea were observed (p > 0.05).
   Conclusion: Addition of morphine to bupivacaine in TAP block is effective method for pain management in patients undergoing major abdominal cancer surgery without serious side effects. (C) 2017 Elsevier Inc. All rights reserved.
C1 [El Sherif, Fatma Adel; Mohamed, Sahar Abdel-Baky; Kamal, Shereen Mamdouh] Assiut Univ, South Egypt Canc Inst, Assiut, Egypt.
RP El Sherif, FA (reprint author), Assiut Univ, South Egypt Canc Inst, Assiut, Egypt.
EM fatma_anesthesia@aun.edu.eg
CR Abdelaal W, 2015, ENLIVEN, V2
   Aveline C, 2011, BRIT J ANAESTH, V106, P380, DOI 10.1093/bja/aeq363
   Beyaz Serbulent Gokhan, 2012, J Anaesthesiol Clin Pharmacol, V28, P496, DOI 10.4103/0970-9185.101940
   BOURKE DL, 1993, J CLIN ANESTH, V5, P114, DOI 10.1016/0952-8180(93)90137-4
   CAMPBELL JN, 1979, J NEUROPHYSIOL, V42, P1669
   Carney J, 2008, ANESTH ANALG, V107, P2056, DOI 10.1213/ane.0b013e3181871313
   Charlton S, 2010, COCHRANE DB SYST REV, V8
   Einarsson JI, 2004, OBSTET GYNECOL, V104, P1335, DOI 10.1097/01.AOG.0000146283.90934.fd
   Elkousy H, 2013, ORTHOPEDICS, V36, pE1121, DOI 10.3928/01477447-20130821-12
   Elvenes J, 2003, BIOCHEM BIOPH RES CO, V311, P202, DOI 10.1016/j.bbrc.2003.09.191
   FLETCHER D, 1994, REGION ANESTH, V19, P183
   Ghadirian S, 2016, VET ANAESTH ANALG, V43, P109, DOI 10.1111/vaa.12280
   Griffiths JD, 2010, ANESTH ANALG, V111, P797, DOI 10.1213/ANE.0b013e3181e53517
   Gupta A, 2001, ANESTH ANALG, V93, P761, DOI 10.1097/00000539-200109000-00042
   Hamada T, 2016, ANAESTHESIA, V71, P411, DOI 10.1111/anae.13408
   Houghton AK, 1998, ANESTHESIOLOGY, V89, P190, DOI 10.1097/00000542-199807000-00026
   Johns N, 2012, COLORECTAL DIS, V14, pE635, DOI 10.1111/j.1463-1318.2012.03104.x
   Kalso E, 1997, PAIN, V71, P127, DOI 10.1016/S0304-3959(97)03344-7
   KARDASH K, 1995, REGION ANESTH, V20, P311
   Kuppuvelumani P, 1993, Asia Oceania J Obstet Gynaecol, V19, P165
   Likar R, 1999, BRIT J ANAESTH, V83, P241
   McDonnell JG, 2007, ANESTH ANALG, V104, P193, DOI 10.1213/01.ane.0000250223.49963.0f
   Mukhtar K, 2009, BRIT J ANAESTH, V102, P143, DOI 10.1093/bja/aen338
   Murphy DB, 2000, ANESTH ANALG, V90, P1122, DOI 10.1097/00000539-200005000-00023
   Petersen PL, 2013, EUR J ANAESTH, V30, P415, DOI 10.1097/EJA.0b013e32835fc86f
   RACZ H, 1991, ANESTH ANALG, V72, P769
   Rafi AN, 2001, ANAESTHESIA, V56, P1024, DOI 10.1046/j.1365-2044.2001.02279-40.x
   Ribeiro MDC, 2004, J PAIN SYMPTOM MANAG, V27, P434, DOI 10.1016/j.jpainsymman.2003.09.011
   Garcia JBSG, 2010, REV BRAS ANESTESIOL, V60, P1, DOI 10.1590/S0034-70942010000100001
   Saryazdi Hamid, 2015, Adv Biomed Res, V4, P232, DOI 10.4103/2277-9175.167901
   SCHAFER M, 1995, EUR J PHARMACOL, V279, P165, DOI 10.1016/0014-2999(95)00150-J
   Sehgal N, 2011, PAIN PHYSICIAN, V14, P249
   Senel AC, 2014, BIOMED RES INT, DOI 10.1155/2014/686287
   Sharma Priya, 2013, J Nat Sci Biol Med, V4, P177, DOI 10.4103/0976-9668.107286
   Singh Devinder, 2013, J Anaesthesiol Clin Pharmacol, V29, P356, DOI 10.4103/0970-9185.117109
   STEIN C, 1995, NEW ENGL J MED, V332, P1685
   Stein C, 2009, BRAIN RES REV, V60, P90, DOI 10.1016/j.brainresrev.2008.12.017
   Tegeder I, 2003, BRAIN, V126, P1092, DOI 10.1093/brain/awg115
   Ventham NT, 2013, BRIT J SURG, V100, P1280, DOI 10.1002/bjs.9204
   Wai EK, 2010, ANESTH ANALG, V110, P928, DOI 10.1213/ANE.0b013e3181cb3f32
NR 40
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0952-8180
EI 1873-4529
J9 J CLIN ANESTH
JI J. Clin. Anesth.
PD JUN
PY 2017
VL 39
BP 4
EP 9
DI 10.1016/j.jclinane.2017.03.009
PG 6
WC Anesthesiology
SC Anesthesiology
GA EV3UQ
UT WOS:000401685000003
PM 28494906
OA No
DA 2017-08-17
ER

PT J
AU El-Shmaa, NS
   Ezz, HAA
   Younes, A
AF EL-Shmaa, Nagat S.
   Ezz, Hoda Alsaid Ahmed
   Younes, Ahmed
TI The efficacy of Labetalol versus Nitroglycerin for induction of
   controlled hypotension during sinus endoscopic surgery. A prospective,
   double-blind and randomized study
SO JOURNAL OF CLINICAL ANESTHESIA
LA English
DT Article
DE Sinus endoscopic surgery; Controlled hypotension; Labetalol;
   Nitroglycerin
AB Objective: To assess the efficacy of labetalol versus nitroglycerin for induction of controlled hypotension during sinus endoscopic surgery.
   Design: A prospective, double-blind and randomized study.
   Setting: Carried out in operating room in university hospital.
   Patients: 60 patients of both sexes, American Society of Anesthesiologists (ASA) physical status I and II, age range from 20 to 60 years; scheduled for elective sinus endoscopic surgery under general anesthesia (GA).
   Interventions: Patients were divided into two groups (30 each). NTG group received nitroglycerin infusion at a dose of 2-5 pg/kg/min, LAB group received labetalol infusion at a dose of 0.5-2 mg/min.
   Measurements: Surgical condition was assessed by surgeon using average category scale (ACS) of 0-5, a value of 2-3 being ideal. In both groups mean arterial blood pressure (MAP) was gradually reduced till the ideal ACS for assessment of surgical condition, the target of ACS was 2-3 or lower.
   Results: Both studied drugs achieved desired hypotension and improved visualization of surgical field by decreasing bleeding in the surgical site, but ideal surgical conditions were created at mild hypotension (MAP 70-75) in LAB group while same conditions were created at MAP of 65-69 mm Hg in NTG group. Mean heart rate (HR) was significantly higher in NTG group as compared to LAB group. Blood loss decreased significantly in LAB group.
   Conclusion: Both labetalol and NTG are effective and safe drugs for induction of controlled hypotension during sinus endoscopic surgery. While, labetalol was better as it offered optimum operative condition with mild decrease in blood pressure, decreased surgical bleeding and less tachycardia during the surgery. (C) 2017 Elsevier Inc. All rights reserved.
C1 [EL-Shmaa, Nagat S.; Ezz, Hoda Alsaid Ahmed] Tanta Univ, Fac Med, Dept Anesthesia & Surg ICU, Tanta, Egypt.
   [Younes, Ahmed] Tanta Univ, Fac Med, Dept ENT, Tanta, Egypt.
RP El-Shmaa, NS (reprint author), Tanta Univ, Fac Med, Dept Anesthesia & Surg ICU, Tanta, Egypt.
EM ahmed.younes@med.tanta.edu.eg
CR Ankichetty SP, 2011, J ANAESTH CLIN PHARM, V77, P328
   Baker AR, 2010, ACTA ANAESTH SCAND, V54, P795, DOI 10.1111/j.1399-6576.2010.02259.x
   Das A, 2016, SAUDI J ANAESTH, V10, P74, DOI 10.4103/1658-354X.169480
   Degoute CS, 2007, DRUGS, V67, P1053, DOI 10.2165/00003495-200767070-00007
   FROMME GA, 1986, ANESTH ANALG, V65, P683
   Jacobi KE, 2000, J CLIN ANESTH, V12, P202, DOI 10.1016/S0952-8180(00)00145-8
   Kamal HM, 2008, EJCTA, V2, P158
   Nair S, 2004, LARYNGOSCOPE, V114, P1042, DOI 10.1097/00005537-200406000-00016
   Rodrigo C, 1995, Anesth Prog, V42, P41
   Sajedi P, 2016, J RES PHARM PRACT, V5, P264, DOI 10.4103/2279-042X.192463
   SCOTT DB, 1982, BRIT J CLIN PHARMACO, V13, pS133
   Babita Singh B, 2015, KARNATAKA ANAESTH J, V1, P64
   Srivastava U, 2013, INDIAN J OTOLARYNGOL, V65, pS440, DOI 10.1007/s12070-013-0655-5
   STAMMBERGER H, 1986, OTOLARYNG HEAD NECK, V94, P147
   STANKIEWICZ JA, 1989, OTOLARYNG CLIN N AM, V22, P749
   Tirelli G, 2004, Acta Otorhinolaryngol Ital, V24, P137
   Tobias Joseph D, 2002, Paediatr Drugs, V4, P439, DOI 10.2165/00148581-200204070-00003
   Van Aken H, 2000, ANESTHESIA, P1470
   Wu Tao, 2006, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V20, P1126
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0952-8180
EI 1873-4529
J9 J CLIN ANESTH
JI J. Clin. Anesth.
PD JUN
PY 2017
VL 39
BP 154
EP 158
DI 10.1016/j.jclinane.2017.03.003
PG 5
WC Anesthesiology
SC Anesthesiology
GA EV3UQ
UT WOS:000401685000042
PM 28494895
OA No
DA 2017-08-17
ER

PT J
AU Zanaty, OM
   El Metainy, S
   Abdelmaksoud, R
   Demerdash, H
   Aliaa, DA
   El Wafa, HA
AF Zanaty, Ola M.
   El Metainy, Shahira
   Abdelmaksoud, Rania
   Demerdash, Hala
   Aliaa, Doaa Abo
   El Wafa, Heba Abo
TI Occupational stress of anesthesia: Effects on aging
SO JOURNAL OF CLINICAL ANESTHESIA
LA English
DT Article
DE Anesthetists; Occupational stress; Skin aging; Telomere
ID VALIDATED ASSESSMENT SCALES; PSYCHOLOGICAL STRESS; WORKING-CONDITIONS;
   OXIDATIVE STRESS; DNA-DAMAGE; SKIN; ANESTHETISTS; TELOMERASE; BURNOUT;
   SATISFACTION
AB Background: Anesthesiology has been identified as a stressful specialty. Chronic psychological stress may lead to biological aging and skin aging.
   Study objective: The primary outcome was to measure physical health and emotional well-being. Secondary outcomes include skin aging analysis, telomere shortening in anesthetists.
   Design: This is a prospective observational study.
   Settings: University of Alexandria.
   Patients: Study was carried out on 366 ASA I-II physicians 30-50 yr.
   Interventions: Physicians were categorized into two equal groups, Group A (183) were anesthesia physicians and Group B (183) were physicians in less stressful specialties (laboratory specialties). Subgroup analysis was performed comparing 10 years' intervals from (30-40) and from (40-50).
   Measurements: Physical health and emotional well-being were evaluated. All physicians were exposed to validated assessment scales for the upper face and the lower face for skin aging analysis. Blood sampling were drowned from all physicians during their working hours for analysis of telomere length, markers of oxidative stress.
   Results: The two studied groups showed comparable demographic data and years of work. Physical health score and emotional health score showed higher values in Group A than Group B. Upper and lower face aesthetic unit summary score showed higher values in Group A than Group B. Telomere (TTAGGG) repeats for terminal restriction fragments (TRF) of Group A individuals revealed a significant decrease of TRF compared to Group B (p = 0.001*).
   Conclusion: Biological and skin aging is evident in anesthetists who are chronically exposed to occupational stress, with obvious shorter telomere length, higher lower and upper face scores, and free radicals. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Zanaty, Ola M.; El Metainy, Shahira; Aliaa, Doaa Abo] Univ Alexandria, Dept Anesthesia & Surg Intens Care, Fac Med, el Azerita Sq, Alexandria, Egypt.
   [Abdelmaksoud, Rania] Univ Alexandria, Fac Med, Dept Dermatol Venereol & Androl, Alexandria, Egypt.
   [Demerdash, Hala] Pharos Univ, Dept Clin Pathol, Fac Pharm, Alexandria, Egypt.
   [El Wafa, Heba Abo] Univ Alexandria, Fac Med, Dept Neuropsychiat, Alexandria, Egypt.
RP Zanaty, OM (reprint author), Univ Alexandria, Dept Anesthesia & Surg Intens Care, Fac Med, el Azerita Sq, Alexandria, Egypt.
EM ec.secretary@alexmed.edu.eg
CR Ahola K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040186
   Allerhand M, 2011, EUR GERIATR MED, V2, P140, DOI 10.1016/j.eurger.2011.04.009
   Association of Anaesthetists of Great Britain and Ireland, 1997, STRESS AN
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V15, P30
   Chen Ying, 2014, Inflammation & Allergy Drug Targets, V13, P177
   Clergue F, 2010, EUR J ANAESTH, V27, P761, DOI 10.1097/EJA.0b013e32833c1bb3
   Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685
   Coomber S, 2002, BRIT J ANAESTH, V89, P873, DOI 10.1093/bja/aef273
   De Robertis E, 2010, EUR J ANAESTH, V27, P223, DOI 10.1097/EJA.0b013e32832d3d66
   Dunn Jeffrey H, 2013, Dermatol Online J, V19, P18561
   Elpern EH, 2006, CURR OPIN CRIT CARE, V12, P395, DOI 10.1097/01.ccx.0000244116.31624.b3
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013
   Flynn TC, 2012, DERMATOL SURG, V38, P309, DOI 10.1111/j.1524-4725.2011.02248.x
   Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368
   Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296
   Kain ZN, 2002, ANESTH ANALG, V95, P177, DOI 10.1097/00000539-200207000-00031
   Kammeyer A, 2015, AGEING RES REV, V21, P16, DOI 10.1016/j.arr.2015.01.001
   Kiecolt-Glaser JK, 2010, BRAIN BEHAV IMMUN, V24, P529, DOI 10.1016/j.bbi.2010.02.002
   Kinzl JF, 2006, DEUT MED WOCHENSCHR, V131, P2461, DOI 10.1055/s-2006-955030
   Kinzl JF, 2005, BRIT J ANAESTH, V94, P211, DOI 10.1093/bja/aei035
   Lederer W, 2006, ACTA ANAESTH SCAND, V50, P58, DOI 10.1111/j.1399-6576.2005.00867.x
   Lindfors PM, 2006, ANAESTHESIA, V61, P856, DOI 10.1111/j.1365-2044.2006.04749.x
   Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.000023315.38086.bc
   Narins RS, 2012, DERMATOL SURG, V38, P333, DOI 10.1111/j.1524-4725.2011.02247.x
   Nyssen AS, 2003, BRIT J ANAESTH, V90, P333, DOI 10.1093/bja/aeg058
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184
   Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614
   Pizzimenti S, 2006, FREE RADICAL BIO MED, V40, P1578, DOI 10.1016/j.freeradbiomed.2005.12.024
   Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199
   Sonja E, 2011, P NATL ACAD SCI USA, V108, P513
   Vera E, 2012, AGING-US, V4, P379
   Volquind D, 2013, REV BRAS ANESTESIOL, V63, P227, DOI [10.1016/S0034-7094(13)70221-6, 10.1590/S0034-70942013000200013]
   Wolfle U, 2014, SKIN PHARMACOL PHYS, V27, P316, DOI 10.1159/000360092
NR 36
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0952-8180
EI 1873-4529
J9 J CLIN ANESTH
JI J. Clin. Anesth.
PD JUN
PY 2017
VL 39
BP 159
EP 164
DI 10.1016/j.jclinane.2017.03.047
PG 6
WC Anesthesiology
SC Anesthesiology
GA EV3UQ
UT WOS:000401685000043
PM 28494896
OA No
DA 2017-08-17
ER

PT J
AU Hanafy, DM
   Prenzler, PD
   Burrows, GE
   Ryan, D
   Nielsen, S
   El Sawi, SA
   El Alfy, TS
   Abdelrahman, EH
   Obied, HK
AF Hanafy, Doaa M.
   Prenzler, Paul D.
   Burrows, Geoffrey E.
   Ryan, Danielle
   Nielsen, Sharon
   El Sawi, Salma A.
   El Alfy, Taha S.
   Abdelrahman, Enas H.
   Obied, Hassan K.
TI Biophenols of mints: Antioxidant, acetylcholinesterase,
   butyrylcholinesterase and histone deacetylase inhibition activities
   targeting Alzheimer's disease treatment
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Cholinesterase; Lamiaceae; Mentha; Mentha diemenica; Mentha requienii;
   Polyphenol
ID LC-MS ANALYSIS; MEDICINAL-PLANTS; PHENOLIC-COMPOUNDS;
   SALVIA-OFFICINALIS; IN-VITRO; OXIDATIVE STRESS; MENTHA-ARVENSIS;
   EXTRACTS; L.; POLYPHENOLS
AB Alzheimer's disease (AD) is a progressive age-related brain disorder that slowly destroys memory, with no cure for AD currently available. Plants from the Lamiaceae have been used traditionally for improving memory. Nineteen Mentha taxa were screened for in vitro antioxidant and acetyl- (AChE) and butyryl-cholinesterase (BuChE) and histone deacetylase (HDAC) inhibition activities. Total phenolic content was assessed, together with chromatographic determination of the phenolic composition. Two species, Mentha diemenica and M. requienii, were investigated for the first time. Mints showed strong antioxidant and moderate AChE and BuChE inhibition activities. Mint extracts exhibited good HDAC inhibition activity which was strongly correlated to their biophenol content. Apigenin-7-O-beta-D-diglucuronide, chicoric acid and isosakuranetin were tentatively identified as new compounds in Mentha. Our results suggest that mints provide a substantial basis for future research into AD treatment. Furthermore, we highlight that biophenol composition and bioactivity can vary according to several factors within a single taxon. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Hanafy, Doaa M.; Obied, Hassan K.] Charles Sturt Univ, Sch Biomed Sci, Locked Bag 588, Wagga Wagga, NSW 2678, Australia.
   [Hanafy, Doaa M.; El Sawi, Salma A.] Natl Res Ctr, Dept Pharmacognosy, Cairo 12622, Egypt.
   [Prenzler, Paul D.; Burrows, Geoffrey E.; Ryan, Danielle] Charles Sturt Univ, Sch Agr & Wine Sci, Locked Bag 588, Wagga Wagga, NSW 2678, Australia.
   [Nielsen, Sharon] Charles Sturt Univ, Quantitat Consulting Unit, Res Off, Locked Bag 588, Wagga Wagga, NSW 2678, Australia.
   [El Alfy, Taha S.; Abdelrahman, Enas H.] Cairo Univ, Fac Pharm, Dept Pharmacognosy, Kasr El Ainy St, Cairo 11562, Egypt.
RP Prenzler, PD (reprint author), Charles Sturt Univ, Sch Agr & Wine Sci, Locked Bag 588, Wagga Wagga, NSW 2678, Australia.
EM pprenzler@csu.edu.au
FU Cultural Affairs and Missions Sector, Ministry of Higher Education,
   Egypt
FX This work was funded by a grant from the Cultural Affairs and Missions
   Sector, Ministry of Higher Education, Egypt, and was carried out using
   the facilities and laboratories of Charles Sturt University, Wagga
   Wagga, Australia. We thank Prof. Dr. Khaled Hammam, Prof. of Medicinal
   and Aromatic Plants, Horticultural Research Institute, Agricultural
   Research Centre, Cairo, Egypt, for authenticating mint collected from
   Egypt. We thank Michael Loughlin (Charles Sturt University) for his
   technical support.
CR Adsersen A, 2006, J ETHNOPHARMACOL, V104, P418, DOI 10.1016/j.jep.2005.09.032
   AI CB, 1994, PHYTOCHEMISTRY, V37, P907, DOI 10.1016/S0031-9422(00)90382-0
   Akhondzadeh S, 2003, J CLIN PHARM THER, V28, P53, DOI 10.1046/j.1365-2710.2003.00463.x
   Al-Juhaimi F, 2011, PAK J BOT, V43, P2235
   Ambigaipalan P, 2016, J AGR FOOD CHEM, V64, P6584, DOI [10.1021/acs.jafc.6b02950, 10.1021/acsofc.6b02950]
   Antolovich M, 2000, ANALYST, V125, P989, DOI 10.1039/b000080i
   Barros L, 2013, FOOD CHEM, V136, P1, DOI 10.1016/j.foodchem.2012.07.107
   Benedec D, 2013, FARMACIA, V61, P262
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bichra M., 2013, Journal of Microbiology, Biotechnology and Food Sciences, V2, P2320
   Bisma Malik, 2013, Journal of Pharmacy Research, V7, P427
   Brickell C., 1997, AM HORTICULTURAL SOC
   Brito A, 2014, MOLECULES, V19, P17400, DOI 10.3390/molecules191117400
   Butterfield DA, 2002, J NUTR BIOCHEM, V13, P444, DOI 10.1016/S0955-2863(02)00205-X
   da Graca Campos M., 2007, STRUCTURE INFORM HPL
   Capuzzo A., 2014, PLANT BIOSYST, V150, P236
   Conforti F, 2008, FOOD CHEM TOXICOL, V46, P3325, DOI 10.1016/j.fct.2008.08.004
   Dalla V, 1999, TETRAHEDRON, V55, P6923, DOI 10.1016/S0040-4020(99)00321-X
   de Camargo AC, 2016, FOOD CHEM, V212, P395, DOI 10.1016/j.foodchem.2016.05.047
   Dorman HJD, 2003, J AGR FOOD CHEM, V51, P4563, DOI 10.1021/jf034108k
   El-Kashoury E. S. A., 2014, Journal of Medicinal Plants Research, V8, P747
   Fatiha B, 2015, IND CROP PROD, V74, P722, DOI 10.1016/j.indcrop.2015.04.038
   Ferreira F. M., 2014, BIOCHIM BIOPHYS ACTA, pe60
   Ferri C., 2009, WORLD ALZHEIMER REPO, P1
   Fialova S, 2015, NAT PROD COMMUN, V10, P937
   Fraisse D., 2011, Food and Nutrition Sciences, V2, P181, DOI 10.4236/fns.2011.230025
   Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137
   Greig NH, 2002, INT PSYCHOGERIATR, V14, P77, DOI 10.1017/S1041610203008676
   Guarnerio CF, 2012, PLANT CELL REP, V31, P361, DOI 10.1007/s00299-011-1171-2
   Hawryl MA, 2014, J AOAC INT, V97, P1268, DOI 10.5740/jaoacint.SGEHawryl
   Ivanova D, 2005, J ETHNOPHARMACOL, V96, P145, DOI 10.1016/j.jep.2004.08.033
   Jivad Nahid, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P780
   Joshi H., 2014, ALZHEIMERS DEMENT, V10, pP461
   Jung HA, 2012, ARCH PHARM RES, V35, P1021, DOI 10.1007/s12272-012-0610-0
   Kamran M, 2015, IND CROP PROD, V78, P29, DOI 10.1016/j.indcrop.2015.10.031
   Kapp K, 2015, THESIS
   Kendall M, 2009, NUTRITION, V25, P270, DOI 10.1016/j.nut.2008.08.008
   Kim YC, 2010, ARCH PHARM RES, V33, P1611, DOI 10.1007/s12272-010-1011-x
   Korolev IO, 2014, MED STUDENT RES J, V4, P24
   Ksiksi T, 2012, MOLECULES, V17, P12521, DOI 10.3390/molecules171112521
   Lee, 2010, J FUNCTIONAL FOODS, V2, P158
   Lee J, 2013, FRONT CHEM, V1, DOI 10.3389/fchem.2013.00040
   Londonkar Ramesh L, 2009, World J Gastrointest Oncol, V1, P82, DOI 10.4251/wjgo.v1.i1.82
   Lopez V, 2010, PHYTOTHER RES, V24, P869, DOI 10.1002/ptr.3037
   Lu YR, 2001, FOOD CHEM, V75, P197, DOI 10.1016/S0308-8146(01)00198-4
   luvone T., 2006, J PHARMACOL EXP THER, V317, P1143
   Mckay DL, 2006, PHYTOTHER RES, V20, P619, DOI 10.1002/ptr.1936
   Miron TL, 2011, J CHROMATOGR A, V1218, P4918, DOI 10.1016/j.chroma.2010.11.055
   Moldovan RI, 2014, DIG J NANOMATER BIOS, V9, P559
   Obied HK, 2007, FOOD CHEM TOXICOL, V45, P1238, DOI 10.1016/j.fct.2007.01.004
   Obied HK, 2012, ADV MOLEC TOXICOL, V6, P195, DOI 10.1016/B978-0-444-59389-4.00006-9
   Obied H. K., 2013, FUNCTIONAL FOODS HLT, V3, P230
   Oinonen PP, 2006, FITOTERAPIA, V77, P429, DOI 10.1016/j.fitote.2006.05.002
   Olsen HT, 2008, J ETHNOPHARMACOL, V117, P500, DOI 10.1016/j.jep.2008.02.015
   Orhan I, 2008, FOOD CHEM, V108, P663, DOI 10.1016/j.foodchem.2007.11.023
   Pereira DM, 2009, MOLECULES, V14, P2202, DOI 10.3390/molecules14062202
   Prince M., 2015, GLOBAL IMPACT DEMENT, P1
   Qawasmeh A, 2012, J AGR FOOD CHEM, V60, P3381, DOI 10.1021/jf204105k
   Riachi LG, 2015, FOOD CHEM, V176, P72, DOI 10.1016/j.foodchem.2014.12.028
   Rice EC, 1997, TRENDS PLANT SCI, V2, P152
   Senawong T, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-232
   Sharififar F, 2012, FOOD CHEM, V130, P20, DOI 10.1016/j.foodchem.2011.06.034
   Shekarchi M, 2012, PHARMACOGN MAG, V8, P37, DOI 10.4103/0973-1296.93316
   Shen DD, 2011, J FOOD SCI, V76, pC900, DOI 10.1111/j.1750-3841.2011.02281.x
   Sonnen JA, 2008, FREE RADICAL BIO MED, V45, P219, DOI 10.1016/j.freeradbiomed.2008.04.022
   Stagos D, 2012, FOOD CHEM TOXICOL, V50, P4115, DOI 10.1016/j.fct.2012.08.033
   Sulaiman SF, 2011, J FOOD COMPOS ANAL, V24, P506, DOI 10.1016/j.jfca.2011.01.020
   Szwajgier D, 2015, ANN AGR ENV MED, V22, P690, DOI 10.5604/12321966.1185777
   Talie S., 2014, B CHEM TECHNOLOGISTS, V43, P11
   Tang KSC, 2016, FOOD CHEM, V192, P698, DOI 10.1016/j.foodchem.2015.07.032
   Teles S, 2013, IND CROP PROD, V46, P1, DOI 10.1016/j.indcrop.2012.12.009
   TUCKER A. O., 2007, GENUS MENTHA MED ARO, V2007, P3
   Upadhyay RK, 2014, IND CROP PROD, V59, P184, DOI 10.1016/j.indcrop.2014.05.019
   Vallverdu-Queralt A, 2010, RAPID COMMUN MASS SP, V24, P2986, DOI 10.1002/rcm.4731
   Vladimir-Knezevic S, 2014, MOLECULES, V19, P767, DOI 10.3390/molecules19010767
   Xiao JB, 2006, J PHARM ALLIED SCI, V3, P310
   Xu JZ, 2008, J ZHEJIANG UNIV-SC B, V9, P728, DOI 10.1631/jzus.B0820095
   Xu K, 2011, OXID MED CELL LONGEV, DOI 10.1155/2011/143269
   Yao ZG, 2014, CELL MOL NEUROBIOL, V34, P805, DOI 10.1007/s10571-013-0012-y
   Yi WG, 2010, J SCI FOOD AGR, V90, P1063, DOI 10.1002/jsfa.3921
   ZHANG HJ, 1994, PLANTA MED, V60, P70, DOI 10.1055/s-2006-959411
   Zhao GR, 2008, FOOD CHEM TOXICOL, V46, P73, DOI 10.1016/j.fct.2007.06.034
   Zimmermann BF, 2011, J CHROMATOGR B, V879, P2459, DOI 10.1016/j.jchromb.2011.06.038
NR 83
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUN
PY 2017
VL 33
BP 345
EP 362
DI 10.1016/j.jff.2017.03.027
PG 18
WC Food Science & Technology
SC Food Science & Technology
GA EV6LT
UT WOS:000401881600039
OA No
DA 2017-08-17
ER

PT J
AU Mohareb, ASO
   Hassanin, AH
   Candelier, K
   Thevenon, MF
   Candan, Z
AF Mohareb, Ahmed S. O.
   Hassanin, Ahmed H.
   Candelier, K.
   Thevenon, Marie France
   Candan, Zeki
TI Developing Biocomposites Panels from Food Packaging and Textiles Wastes:
   Physical and Biological Performance
SO JOURNAL OF POLYMERS AND THE ENVIRONMENT
LA English
DT Article
DE Food packaging; Textiles waste; Biocomposites; Fungi; Termite
ID COMPOSITES; POLYETHYLENE; ALUMINUM; WOOD
AB The urban solid waste problem has been one of the biggest environmental challenges these days. In this context, developing biocomposites with improved performance by using various sources and wastes has been intensified in the last decades for economic and environmental points of view. In this study, physical behavior, fungal decay and termite attack tests were conducted in laboratory conditions to investigate the performance of composites developed from TetraPak and textile wastes. All the results were compared to standard wood products. The water swelling properties strongly decreased in the manufactured TetraPak composites when compared with the conventional particleboard panels. The fungal decay resistance tests revealed that the stand alone TetraPak based composites were not completely resistant to wood-decaying fungi. A significant amelioration in the decay durability was observed for the manufactured TetraPak composites compared to the standard wood samples. Durability classes were determined according to the criteria given in the European standard (CEN/TS15083-1). Interestingly, the data indicated that the increment of the wool waste proportion in the produced boards lead to a significant enhancement counter the test fungi. The results of termite screening test showed further considerable resistance for whole TetraPak based composites against termites when compared to traditional wood samples. Such panels could be an available alternative without any additives for wood based composite structures and it can be used in a wide range of applications.
C1 [Mohareb, Ahmed S. O.] Alexandria Univ, Fac Agr, Forestry & Wood Technol Dept, Alexandria, Egypt.
   [Hassanin, Ahmed H.] Alexandria Univ, Text Engn Dept, Fac Engn, Alexandria, Egypt.
   [Candelier, K.; Thevenon, Marie France] CIRAD, Wood Preservat Lab, Res Unit BIOWOOEB, TA B 114-16,73 Rue Jean Francois Breton, F-34398 Montpellier 5, France.
   [Candan, Zeki] Istanbul Univ, Dept Forest Prod Engn, Fac Forestry, Istanbul, Turkey.
RP Mohareb, ASO (reprint author), Alexandria Univ, Fac Agr, Forestry & Wood Technol Dept, Alexandria, Egypt.
EM ahmed_mohareb@yahoo.com
FU Scientific and Technological Research Council of Turkey (TUBITAK)
   [21514107-216.01-237755]
FX This work has been partially funded by Scientific and Technological
   Research Council of Turkey (TUBITAK) under Grant Nos.
   21514107-216.01-237755. The authors thank EKOPAN Company and Yunsa wool
   Company of Turkey for providing raw materials.
CR Ashori A, 2008, BIORESOURCE TECHNOL, V99, P4661, DOI 10.1016/j.biortech.2007.09.043
   Ayrilmis N, 2013, COMPOS PART B-ENG, V47, P150, DOI 10.1016/j.compositesb.2012.10.019
   [Anonymous], 2006, 150831 CENTS
   De Vetter L, 2009, INT BIODETER BIODEGR, V63, P130, DOI 10.1016/j.ibiod.2008.08.002
   Ebadi M, 2016, J THERMOPLAST COMPOS, V29, P1601, DOI 10.1177/0892705715618745
   European Committee for Standardization, 1999, 322 NF EN
   European Committee for Standardization, 1999, 317 NF EN
   European Committee for Standardization, 1999, 323 NF EN
   European committee for standardization, 1990, 117 NF EN
   Gu DJ, 2003, INT BIODETER BIODEGR, V52, P69
   Gu DJ, 2007, INT BIODETER BIODEGR, V59, P170
   Khanjanzadeh H., 2012, African Journal of Biotechnology, V11, P8045
   Klyosov AA, 2007, WOOD PLASTIC COMPOSI
   Li X, 2007, J POLYM ENVIRON, V15, P25, DOI 10.1007/s10924-006-0042-3
   Lopes CMA, 2006, J APPL POLYM SCI, V101, P3183, DOI 10.1002/app.23406
   Lykidis Charalampos, 2014, Wood Material Science & Engineering, V9, P202, DOI 10.1080/17480272.2013.875589
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   Mohareb A, 2010, INT BIODETER BIODEGR, V64, P135, DOI 10.1016/j.ibiod.2009.12.004
   Mohareb ASO, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42253
   Pekhtasheva E., 2012, CHEM CHEM TECHNOL, V6, P263
   Reux F, 2012, 5 INNOVATIVE COMPOSI, P26
   Sassoni E, 2014, ENERG BUILDINGS, V77, P219, DOI 10.1016/j.enbuild.2014.03.033
   Segerholm K, 2012, THESIS
   Sen S, 2010, AFR J AGR RES, V5, P159
   Shah UD, 2013, J MATER SCI, V48, P6083
   Terzi E, 2009, INT BIODETER BIODEGR, V63, P806, DOI 10.1016/j.ibiod.2009.01.010
   Yilgor N, 2012, INT C REC REUS IST T
   Yilgor N, 2014, BIORESOURCES, V9, P4784
NR 28
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1566-2543
EI 1572-8900
J9 J POLYM ENVIRON
JI J. Polym. Environ.
PD JUN
PY 2017
VL 25
IS 2
BP 126
EP 135
DI 10.1007/s10924-016-0791-6
PG 10
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA EV5PL
UT WOS:000401819500003
OA No
DA 2017-08-17
ER

PT J
AU Awadallah-F, A
AF Awadallah-F, Ahmed
TI Adsorptive Removal of Malachite Green Chloride and Reactive Red-198 from
   Aqueous Solutions by Using Multiwall Carbon Nanotubes-Graft-Poly
   (2-acrylamido-2-methyl-1-propanesulfonic acid)
SO JOURNAL OF POLYMERS AND THE ENVIRONMENT
LA English
DT Article
DE Multiwall carbon nanotubes; Poly
   (2-acrylamido-2-methyl-1-propanesulfonic acid); Modification; Kinetics
   models; Adsorption isotherms
ID LANGMUIR-FREUNDLICH ISOTHERM; PORE-EXPANDED MCM-41; ACTIVATED CARBON;
   WASTE-WATER; AZO DYES; TITANIUM-DIOXIDE; EFFICIENT REMOVAL;
   METHYLENE-BLUE; CO2 ADSORPTION; RED 198
AB The multiwall carbon nanotubes (MWCNTs) were modified by 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS) via grafting reaction and gamma-rays of Co-60 source was used as initiator. The outcome product was called hydroxyethylated (HOEt-MWCNTs) graft poly(AMPS) and abbreviated as HOEt-MWCNTs-g-PAMPS. The parameters that affected the grafting yield were optimized. The maximum grafting obtained was similar to 20 %. HOEt-MWCNTs-g-PAMPS were characterized by Fourier transform infra red, scanning electron microscopy, high resolution transmission electron microscopy, thermal gravimetric analysis. The adsorptive removals of malachite green chloride (MGC) and reactive red 198 (RR-198) onto HOEt-MWCNTs-g-PAMPS were studied at variable conditions. The adsorption isotherms were analyzed using Langmuir, Redlich-Peterson, Freundlich, Khan and Sips models. The results referred that Sips model is the best fitting to adsorption of MGC and Freundlich model is the best fitting to RR-198 adsorption. The monolayer coverage capacities of HOEt-MWCNTs-g-PAMPS for MGC and RR-198 dyes were found 172 and 323 mg g(-1), respectively. The rate of kinetic adsorption processes of MGC and RR-198 onto HOEt-MWCNTs-g-PAMPS were described by using pseudo-first order, pseudo-second order and intraparticle diffusion models. The pseudo-first order and pseudo-second order models were the best choice among the kinetic models to depict the adsorption behaviors of MGC and RR-198 dyes onto HOEt-MWCNTs-g-PAMPS, respectively. Further, the effect of temperature on the adsorption isotherms was investigated and the thermodynamic parameters were obtained. The results indicated that the adsorption process is spontaneous and endothermic. The values of Delta GA degrees varied in range with the mean values showing a gradual increase from -3.17 to -3.64 kJ mol(-1) for MGC and -3.36 to -3.73 kJ mol(-1) for RR-198. The reusability and regeneration of adsorbent were investigated. The outcome data referred to that the efficiency of adsorbent > 98 %. The outline results declared that there is a good potentiality for the HOEt-MWCNTs-g-PAMPS to be used as an adsorbent for the removal of MGC and RR-198 from aqueous solutions.
C1 [Awadallah-F, Ahmed] Atom Energy Author, Radiat Res Polymer Dept, Natl Ctr Radiat Res & Technol, POB 29, Cairo, Egypt.
RP Awadallah-F, A (reprint author), Atom Energy Author, Radiat Res Polymer Dept, Natl Ctr Radiat Res & Technol, POB 29, Cairo, Egypt.
EM elsheshengy@yahoo.co.uk
CR Al-Jabari M, 2016, ENV TECHNOL INNOV, V6, P27, DOI [10.1016/j.eti.2016.04.005, DOI 10.1016/J.ETI.2016.04.005]
   Ambrosio ST, 2012, MOLECULES, V17, P452, DOI 10.3390/molecules17010452
   Asfaram A, 2017, ULTRASON SONOCHEM, V34, P1, DOI 10.1016/j.ultsonch.2016.05.011
   Awadallah A, 2015, CHINESE J POLYM SCI, V33, P376, DOI 10.1007/s10118-015-1591-5
   Balarak D, 2015, COLLOID INTERFAC SCI, V7, P16, DOI 10.1016/j.colcom.2015.11.004
   Brian CS, 1995, FUNDAMENTALS FOURIER, P1
   Chen SM, 2006, MACROMOLECULES, V39, P330, DOI 10.1021/ma0520500
   CHERNOFF H, 1954, ANN MATH STAT, V25, P579, DOI 10.1214/aoms/1177728726
   Dahri MK, 2014, J ENV CHEM ENG, V2, P1434, DOI DOI 10.1016/J.JECE.2014.07.008
   Dahri MK, 2015, ALEX ENG J, V54, P1253, DOI 10.1016/j.aej.2015.07.005
   Dehghani MH, 2016, J MOL LIQ, V215, P671, DOI 10.1016/j.molliq.2015.12.057
   El Qada EN, 2008, CHEM ENG J, V135, P174, DOI 10.1016/j.cej.2007.02.023
   Gajera HP, 2015, PROCESS SAF ENVIRON, V98, P406, DOI 10.1016/j.psep.2015.10.005
   Gangupomu RH, 2016, J HAZARD MATER, V302, P362, DOI 10.1016/j.jhazmat.2015.09.002
   Gautam RK, 2015, J MOL LIQ, V212, P227, DOI 10.1016/j.molliq.2015.09.006
   Ghaedi M, 2014, J IND ENG CHEM, V20, P1085, DOI 10.1016/j.jiec.2013.06.046
   Ghaneian MT, 2015, RES CHEM INTERMEDIAT, V41, P3223, DOI 10.1007/s11164-013-1427-2
   Gholami M, 2016, J TAIWAN INST CHEM E, V59, P205, DOI 10.1016/j.jtice.2015.07.021
   Guler UA, 2016, PROCESS SAF ENVIRON, V99, P194, DOI 10.1016/j.psep.2015.11.006
   Gulnaz O, 2011, CHEM ENG J, V174, P579, DOI 10.1016/j.cej.2011.09.061
   Gupta VK, 2012, CHEM ENG J, V180, P81, DOI 10.1016/j.cej.2011.11.006
   Gupta VK, 2012, MAT SCI ENG C-MATER, V32, P12, DOI 10.1016/j.msec.2011.08.018
   Gupta VK, 2011, MAT SCI ENG C-MATER, V31, P1062, DOI 10.1016/j.msec.2011.03.006
   Gupta VK, 2011, J HAZARD MATER, V185, P17, DOI 10.1016/j.jhazmat.2010.08.053
   Gupta Vinod Kumar, 2015, Environmental Engineering Research, V20, P1
   Gupta VK, 2013, ADV COLLOID INTERFAC, V193, P24, DOI 10.1016/j.cis.2013.03.003
   Gupta VK, 2012, RSC ADV, V2, P6380, DOI 10.1039/c2ra20340e
   Gupta VK, 1998, WASTE MANAGE, V17, P517
   Haghtalab A, 2012, FUEL PROCESS TECHNOL, V104, P73, DOI 10.1016/j.fuproc.2011.07.005
   Hao GP, 2010, CARBON, V48, P3330, DOI 10.1016/j.carbon.2010.05.011
   Ho YS, 2004, CARBON, V42, P2115, DOI 10.1016/j.carbon.2004.03.019
   Jain AK, 2003, SEP SCI TECHNOL, V38, P463, DOI 10.1081/SS-120016585
   Jeppu GP, 2012, J CONTAM HYDROL, V129, P46, DOI 10.1016/j.jconhyd.2011.12.001
   Kacan E, 2016, J ENVIRON MANAGE, V166, P116, DOI 10.1016/j.jenvman.2015.09.044
   Karimi L, 2014, NEW CARBON MATER, V29, P380, DOI 10.1016/S1872-5805(14)60144-X
   Karthikeyan S, 2012, J MOL LIQ, V173, P153, DOI 10.1016/j.molliq.2012.06.022
   Kono H., 2015, J WATER PROCESS ENG, V7, P83, DOI DOI 10.1016/J.JWPE.2015.05.007
   Kyzas GZ, 2011, CHEM ENG J, V168, P577, DOI 10.1016/j.cej.2011.01.026
   Leng LJ, 2015, FUEL, V155, P77, DOI 10.1016/j.fuel.2015.04.019
   Li HY, 2016, COLLOID SURFACE A, V494, P222, DOI 10.1016/j.colsurfa.2016.01.048
   Liang CZ, 2014, J MEMBRANE SCI, V469, P306, DOI 10.1016/j.memsci.2014.06.057
   Lin KYA, 2016, APPL SURF SCI, V361, P114, DOI 10.1016/j.apsusc.2015.11.108
   Lin KYA, 2015, CHEMOSPHERE, V139, P624, DOI 10.1016/j.chemosphere.2015.01.041
   Loganathan S, 2016, CHEM ENG J, V303, P89, DOI 10.1016/j.cej.2016.05.106
   Loganathan S, 2015, CHEM ENG J, V280, P9, DOI 10.1016/j.cej.2015.05.103
   Lu YJ, 2016, BIOSENS BIOELECTRON, V81, P373, DOI 10.1016/j.bios.2016.03.012
   Mittal A, 2010, J COLLOID INTERF SCI, V342, P518, DOI 10.1016/j.jcis.2009.10.046
   Mittal A, 2009, J COLLOID INTERF SCI, V340, P16, DOI 10.1016/j.jcis.2009.08.019
   Mittal A, 2009, J COLLOID INTERF SCI, V337, P345, DOI 10.1016/j.jcis.2009.05.016
   Mona S, 2011, ECOL ENG, V37, P1589, DOI 10.1016/j.ecoleng.2011.04.005
   Moussavi G, 2009, J HAZARD MATER, V168, P806, DOI 10.1016/j.jhazmat.2009.02.097
   NAYAK PL, 1979, J APPL POLYM SCI, V23, P1345, DOI 10.1002/app.1979.070230507
   Pushpa TB, 2015, ECOTOX ENVIRON SAFE, V118, P177, DOI 10.1016/j.ecoenv.2015.04.033
   Rajabi M, 2016, J IND ENG CHEM, V34, P130, DOI 10.1016/j.jiec.2015.11.001
   Sadegh H, 2015, J MOL LIQ, V206, P151, DOI 10.1016/j.molliq.2015.02.007
   Saleh T, 2012, ENVIRON SCI POLLUT R, V19, P1224, DOI 10.1007/s11356-011-0670-6
   Saleh TA, 2012, J COLLOID INTERF SCI, V371, P101, DOI 10.1016/j.jcis.2011.12.038
   Santos SCR, 2016, J ENVIRON CHEM ENG, V4, P1473, DOI 10.1016/j.jece.2016.02.009
   Shamsizadeh A, 2014, J MOL LIQ, V195, P212, DOI 10.1016/j.molliq.2014.02.035
   Singh S.A., 2015, J ENV CHEM ENG, V3, P2684, DOI DOI 10.1016/J.JECE.2015.09.029
   Tichonovas M, 2013, CHEM ENG J, V229, P9, DOI 10.1016/j.cej.2013.05.095
   Tien C, 2014, SEP PURIF TECHNOL, V136, P303, DOI 10.1016/j.seppur.2014.08.013
   TSUKADA M, 1988, J APPL POLYM SCI, V35, P2133, DOI 10.1002/app.1988.070350813
   Venkat MS, 2002, J HAZARD MATER, V90, P189, DOI 10.1016/S0304-3894(01)00348-X
   Vinu R, 2010, J HAZARD MATER, V176, P765, DOI 10.1016/j.jhazmat.2009.11.101
   Wu CH, 2008, DYES PIGMENTS, V77, P31, DOI 10.1016/j.dyepig.2007.03.003
   Yamjala K, 2016, FOOD CHEM, V192, P813, DOI 10.1016/j.foodchem.2015.07.085
   Yao L, 2016, J HAZARD MATER, V301, P462, DOI 10.1016/j.jhazmat.2015.09.027
   Yu F, 2016, CHEM ENG J, V285, P588, DOI 10.1016/j.cej.2015.10.039
   Zheng H, 2015, J ENVIRON MANAGE, V162, P232, DOI 10.1016/j.jenvman.2015.07.057
   Zhou YM, 2015, INT J BIOL MACROMOL, V74, P271, DOI 10.1016/j.ijbiomac.2014.12.020
NR 71
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1566-2543
EI 1572-8900
J9 J POLYM ENVIRON
JI J. Polym. Environ.
PD JUN
PY 2017
VL 25
IS 2
BP 258
EP 276
DI 10.1007/s10924-016-0804-5
PG 19
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA EV5PL
UT WOS:000401819500016
OA No
DA 2017-08-17
ER

PT J
AU Ghobashy, MM
   Khafaga, MR
AF Ghobashy, Mohamed Mohamady
   Khafaga, Mervat Rabie
TI Chemical Modification of Nano Polyacrylonitrile Prepared by Emulsion
   Polymerization Induced by Gamma Radiation and Their Use for Removal of
   Some Metal Ions
SO JOURNAL OF POLYMERS AND THE ENVIRONMENT
LA English
DT Article
DE Emulsion polymerization; Chemical modification; Nano polyacrylonitrile;
   Gamma radiation; Metal ions removal
ID MINIEMULSION POLYMERIZATION; HEAVY; ADSORPTION; KINETICS; SORPTION
AB Emulsion polymerization of acrylonitrile (AN) was carried out using gamma irradiation at a dose of 20 kGy. Tween 80 (poly oxy ethylene sorbitan monooleate) and (sodium dodecylsulfate) SDS were used as emulsifiers. The chemical modification of nano PAN was carried out to convert the nitrile group into the carboxylic acid group by refluxed nano PAN with sodium hydroxide. The chemical modified nano PAN was characterized by Fourier transform infrared spectroscopy The Transmission electron microscopy has been used to assess the average particle diameter of the chemically modified nano PAN, the results indicates that the diameter of chemically modified nano PAN particle is ranged from 5 to 15 nm. The ability of modified nano PAN attachment with carboxylic acid groups have been applied effectively for adsorption of various metal ions such as (Pb2+, Cu2+ and Cd2+). The capability and efficiency of the modified nano PAN for the removal of Pb2+, Cu2+ and Cd2+ was detected by atomic absorption spectroscopy. A solution containing about 10 mg L-1 of three metal ions of (Pb2+, Cu2+ and Cd2+) was treated with 0.01 g of modified nano PAN at a temperature of 40 degrees C. The metal ion removal capacity of modified nano PAN was found to follow the order: Cd2+ > Cu2+ > Pb2+. The highest removal efficiency of the modified nano PAN was for Cd2+, in which the highest amount of Cd2+ removal was 4.951 mg g(-1) dry of modified nano PAN.
C1 [Ghobashy, Mohamed Mohamady] Atom Energy Author, Radiat Res Polymer Dept, NCRRT, POB 29,Ahmed El Zomor St, Cairo, Egypt.
   [Khafaga, Mervat Rabie] Atom Energy Author, Chem Radiat Dept, NCRRT, POB 29,Ahmed El Zomor St, Cairo, Egypt.
RP Ghobashy, MM (reprint author), Atom Energy Author, Radiat Res Polymer Dept, NCRRT, POB 29,Ahmed El Zomor St, Cairo, Egypt.
EM Mohamed.ghobashy@eaea.org.eg; mervatrabie@yahoo.com
OI Ghobashy, Mohamed/0000-0003-0968-1423
CR Alkan M, 2001, J COLLOID INTERF SCI, V243, P280, DOI 10.1006/jcis.2001.7796
   Azarudeen RS, 2015, J CHEM TECHNOL BIOT, V90, P2170, DOI 10.1002/jctb.4528
   Bekheit MM, 2011, INT J BIOL MACROMOL, V48, P558, DOI 10.1016/j.ijbiomac.2011.01.018
   Chen Y, 2007, EUR POLYM J, V43, P2848, DOI 10.1016/j.eurpolymj.2007.04.013
   FERROGARCIA MA, 1988, CARBON, V26, P363, DOI 10.1016/0008-6223(88)90228-X
   Ho YS, 2000, ADSORPT SCI TECHNOL, V18, P639, DOI 10.1260/0263617001493693
   Ho YS, 1999, RESOUR CONSERV RECY, V25, P171, DOI 10.1016/S0921-3449(98)00053-6
   Hussain K, 2003, J APPL POLYM SCI, V88, P414
   Joseph P, 2012, POLYM DEGRAD STABIL, V97, P2531, DOI 10.1016/j.polymdegradstab.2012.07.014
   Kang MS, 2004, J MEMBRANE SCI, V229, P137, DOI 10.1016/j.memsci.2003.10.021
   Kantipuly G, 1993, TALANTA, V37, P491
   Meunier N, 2003, BIORESOURCE TECHNOL, V90, P255, DOI 10.1016/S0960-8524(03)00129-9
   Nga NK, 2017, J POLYM ENVIRON, V25, P146, DOI 10.1007/s10924-016-0792-5
   Ouyang Q, 2008, POLYM DEGRAD STABIL, V93, P1415, DOI 10.1016/j.polymdegradstab.2008.05.021
   Polikarpov VV, 1974, POLY SCI USSR, V16, P2559, DOI 10.1016/0032-3950(74)90445-6
   Rajvaidya S, 2006, J APPL POLYM SCI, V101, P2581, DOI 10.1002/app.23938
   Rao JP, 2011, PROG POLYM SCI, V36, P887, DOI 10.1016/j.progpolymsci.2011.01.001
   REED BE, 1993, SEP SCI TECHNOL, V28, P2179, DOI 10.1080/01496399308016742
   Soto D, 2016, J POLYM ENVIRON, V24, P343, DOI 10.1007/s10924-016-0780-9
   Tabata Y, 2003, J POLYM SCI POL CHEM, V2, P4077
   Unlu N, 2006, J HAZARD MATER, V136, P272, DOI 10.1016/j.jhazmat.2005.12.013
   Wang SJ, 2007, EUR POLYM J, V43, P178, DOI 10.1016/j.eurpolymj.2006.09.010
NR 22
TC 2
Z9 2
U1 4
U2 4
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1566-2543
EI 1572-8900
J9 J POLYM ENVIRON
JI J. Polym. Environ.
PD JUN
PY 2017
VL 25
IS 2
BP 343
EP 348
DI 10.1007/s10924-016-0805-4
PG 6
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA EV5PL
UT WOS:000401819500024
OA No
DA 2017-08-17
ER

PT J
AU El-Sayed, MM
   Sorour, MH
   Abd El Moneem, N
   Shalaan, H
   El Marsafy, S
AF El-Sayed, Marwa M.
   Sorour, Mohamed H.
   Abd El Moneem, Nabil
   Shalaan, Hayam
   El Marsafy, Sahar
TI Grafting of Acrylamide onto Polysaccharides Blend Using Photo-initiators
SO JOURNAL OF POLYMERS AND THE ENVIRONMENT
LA English
DT Article
DE Polysaccharide; Hydrogel; Photo-initiator; Ultraviolet
ID PHOTOINITIATING SYSTEMS; UV; POLYMERIZATION; MONOMER; SURFACE
AB The present paper comprises of hydrogel synthesis processes using a blend of three natural polysaccharides (PsB) "starch, chitosan and alginate" grafted acrylamide (PsB-g-Am) using ultraviolet (UV) irradiation. The grafting process has been undergo using three different photo-initiators [Dimethoxy-2-phenylacetophenone (DMPA), benzoin methyl ether (BME) and benzophenone (BP)]. Furthermore, different PsB/Am weight ratios have been used. The prepared hydrogel has been characterized using XRD and SEM. Grafting percentage (%G), grafting efficiency (%GE), grafting yield (%GY) also have been compared. Among the three used photo-initiators, DMPA gave the maximum attained values of %G (130 %), %GE (72 %) and %GY (89 %) followed by BME and BP, respectively. Swelling water ratio (SWR) for the grafted hydrogels in distilled water (DW) has been studied. Grafted hydrogel using DMPA photo-initiator gave the maximum SWR of 30 g/g. Am/PsB weight ratio and the used photo-initiator had a direct effect on SWR of the produced hydrogel.
C1 [El-Sayed, Marwa M.; Sorour, Mohamed H.; Shalaan, Hayam] Natl Res Ctr, Chem Engn & Pilot Plant Dept, El Bohouth St,El Tahrir St,POB 12622, Cairo, Egypt.
   [Abd El Moneem, Nabil; El Marsafy, Sahar] Cairo Univ, Dept Chem Engn, Fac Engn, Giza, Egypt.
RP El-Sayed, MM (reprint author), Natl Res Ctr, Chem Engn & Pilot Plant Dept, El Bohouth St,El Tahrir St,POB 12622, Cairo, Egypt.
EM eng_marwa06@yahoo.com
CR Alexander L, 2007, J PHOTOCH PHOTOBIO A, V192, P98
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Cho JD, 2006, J APPL POLYM SCI, V99, P1446, DOI 10.1002/app.22631
   DECKER C, 1987, J COATING TECHNOL, V59, P97
   Farquet P, 1995, J APPL POLYM SCI, V55, P1291
   Gui P, 2008, BIORESOURCE TECHNOL, V99, P444
   Hong KH, 2009, EUR POLYM J, V45, P2443, DOI 10.1016/j.eurpolymj.2009.04.026
   Hsieh MD, 2002, SENSOR ACTUAT B-CHEM, V82, P287, DOI 10.1016/S0925-4005(01)01011-5
   Kato K, 2003, PROG POLYM SCI, V28, P209, DOI 10.1016/S0079-6700(02)00032-1
   Kawai T, 2000, RADIAT PHYS CHEM, V59, P405, DOI 10.1016/S0969-806X(00)00298-X
   Kyta T, 2002, W BIOMATER, V23, P4307
   Lee JS, 2005, FOOD CHEM, V91, P203, DOI [10.1016/j.foodchem.2003.08.032, 10.1016/j.foodchain.2003.08.032]
   Liangliang C, 2011, PROG ORG COAT, V71, P355
   Matyjaszewski k, 2003, HDB RADICAL POLYM, V3
   Mishra M, 1998, HDB RADICAL VINYL PO
   Mubarak A, 2006, CARBOHYD POLYM, V63, P500
   Rong MZ, 2003, TRIBOL INT, V36, P697, DOI 10.1016/S0301-679X(03)00029-X
   Salmi H, 2013, EUR POLYM J, V49, P2275, DOI 10.1016/j.eurpolymj.2013.05.012
   Singh V, 2006, STARCH-STARKE, V58, P536, DOI 10.1002/star.200600520
   Sorour M, 2011, WORLD APPL SCI J, V13, P360
   Sorour M, 2013, STARCH-STARKE, V65, P172, DOI 10.1002/star.201200108
   Telitel S, 2016, CR CHIM, V19, P71, DOI 10.1016/j.crci.2015.06.016
   Uezu K, 1996, AICHE J, V42, P1095, DOI 10.1002/aic.690420420
NR 23
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1566-2543
EI 1572-8900
J9 J POLYM ENVIRON
JI J. Polym. Environ.
PD JUN
PY 2017
VL 25
IS 2
BP 402
EP 407
DI 10.1007/s10924-016-0816-1
PG 6
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA EV5PL
UT WOS:000401819500030
OA No
DA 2017-08-17
ER

PT J
AU Ali, H
   Ismail, N
   Amin, MS
   Mekewi, M
AF Ali, Heba
   Ismail, N.
   Amin, M. S.
   Mekewi, Mohamed
TI Efficient photoelectrodes from anatase TiO2 nanotube arrays decorated
   with particles/rods/3D microflower rutile crystals for
   photoelectrochemical water splitting
SO JOURNAL OF SOLID STATE ELECTROCHEMISTRY
LA English
DT Article
DE TiO2 nanotube arrays; TiCl4 treatment; Mixed phase; XRD;
   Photoelectrochemical water oxidation
ID SENSITIZED SOLAR-CELLS; ENHANCED PHOTOCATALYTIC ACTIVITY; MIXED-PHASE
   TIO2; TICL4 TREATMENT; VISIBLE-LIGHT; TEMPERATURE; MORPHOLOGY; LAYER;
   NANOPARTICLES; PHOTOCURRENT
AB Efficient photoanodes are designed of vertically aligned anatase TiO2 nanotube arrays (anatase TNTAs) decorated with different shaped rutile TiO2 structures (particles, 1D nanorods, 3D microflowers) to improve the photoelectrochemical water oxidation performance of pristine TNTAs. Anatase TNTAs were prepared by anodic oxidation of Ti substrate in NH4F electrolyte, and the rutile percent and shape are controlled by tuning the TiCl4 treatment time (20-120 min). The effects of treatment time on the morphology, crystal structure, band gap, photocurrent, and photoconversion efficiency are characterized by FESEM, HRTEM, XRD, UV-Vis diffuse reflectance spectroscopy, and photoelectrochemical measurements. XRD data confirmed that TiCl4 treatment induced the formation of the rutile phase of TiO2 over anatase TNTAs and the rutile amount in the TNTAs was increased upon increasing the treatment time. Additionally, the band gap of TNTAs was gradually decreased by increasing the rutile percent. The optimum treatment time is 80 min, which produces TiO2 photoanode array that possess the following characteristics: rutile/anatase mixed phase, nanorode/nanotube mixed morphology, 3.09 eV band gap, two times increase in photocurrent, and almost more than twofold enhancement in the photoconversion efficiency relative to pure TNTA.
C1 [Ali, Heba; Ismail, N.] Natl Res Ctr, Phys Chem Dept, Cairo, Egypt.
   [Amin, M. S.] Taibah Univ, Dept Basic Sci & Technol, Community Coll, Medina, Saudi Arabia.
   [Amin, M. S.; Mekewi, Mohamed] Ain Shams Univ, Chem Dept, Fac Sci, Cairo, Egypt.
RP Ali, H (reprint author), Natl Res Ctr, Phys Chem Dept, Cairo, Egypt.
EM heba_future@yahoo.com
FU Science and Technology Development Fund (STDF) in Egypt [3649]
FX The Science and Technology Development Fund (STDF) in Egypt is
   acknowledged for funding this work as part of project ID 3649.
CR Abe R, 2005, CHEM LETT, V34, P1162, DOI 10.1246/cl.2005.1162
   Ali H, 2015, J SOLID STATE ELECTR, V19, P3019, DOI 10.1007/s10008-015-2919-3
   Ali H, 2014, ELECTROCHIM ACTA, V150, P314, DOI 10.1016/j.electacta.2014.10.142
   Ambade SB, 2013, CHEM COMMUN, V49, P2921, DOI 10.1039/c3cc00310h
   Buddee S, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2336-z
   Dobromir M, 2016, SURF COAT TECH, V285, P197, DOI 10.1016/j.surfcoat.2015.11.031
   Eom TS, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JG10
   Gao Q, 2013, J ALLOY COMPD, V579, P322, DOI 10.1016/j.jallcom.2013.06.071
   Hurum DC, 2003, J PHYS CHEM B, V107, P4545, DOI 10.1021/jp0273934
   Jensen H, 2016, J EXPT NANOSCI, V1, P355
   Kim KJ, 2002, CHEM MATER, V14, P1042, DOI 10.1021/cm0106421
   Kubelka P., 1931, Zeitschrift fur Technische Physik, V12, P593
   Kuvarega AT, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0776-x
   Lee BH, 2009, J PHYS CHEM C, V113, P21453, DOI 10.1021/jp907855x
   Lee SW, 2012, J PHYS CHEM C, V116, P21285, DOI 10.1021/jp3079887
   Li QT, 2015, KEY ENG MATER, V633, P39
   Li YK, 2013, ELECTROCHIM ACTA, V107, P313, DOI 10.1016/j.electacta.2013.05.090
   Lin YH, 2012, INT J ELECTROCHEM SC, V7, P9478
   Ma J, 2014, PHYSICA E, V58, P24, DOI 10.1016/j.physe.2013.11.006
   O'Regan BC, 2007, J PHYS CHEM C, V111, P14001, DOI 10.1021/jp073056p
   Park JH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356075
   Park JH, 2012, MOL CRYST LIQ CRYST, V567, P19, DOI 10.1080/15421406.2012.702375
   Park JH, 2011, J POWER SOURCES, V196, P8904, DOI 10.1016/j.jpowsour.2011.06.063
   Peng W, 2011, NANOTECHNOLOGY, V22
   Sakai N, 2013, J PHYS CHEM C, V117, P10949, DOI 10.1021/jp401106u
   Shahi SK, 2016, APPL SURF SCI, V360, P953, DOI 10.1016/j.apsusc.2015.11.092
   Shan GB, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/2/025604
   Shengqiang F, 2006, RARE METALS, V25, P163
   Song MY, 2005, SYNTHETIC MET, V155, P635, DOI 10.1016/j.synthmet.2005.08.018
   SPURR RA, 1957, ANAL CHEM, V29, P760, DOI 10.1021/ac60125a006
   Verma R, 2015, J ALLOY COMPD, V629, P105, DOI 10.1016/j.jallcom.2014.12.218
   Wang D, 2014, ELECTROCHIM ACTA, V130, P290, DOI 10.1016/j.electacta.2014.03.024
   Wang YW, 2007, J PHYS CHEM C, V111, P2709, DOI 10.1021/jp066519k
   Xie KP, 2010, ELECTROCHIM ACTA, V55, P7211, DOI 10.1016/j.electacta.2010.07.030
   Xin XK, 2011, LANGMUIR, V27, P14594, DOI 10.1021/la2034627
   Xu H, 2009, J PHYS CHEM C, V113, P1785, DOI 10.1021/jp8089903
   Yang JS, 2013, ACS APPL MATER INTER, V5, P7425, DOI 10.1021/am401746b
   Yang MJ, 2011, J PHYS CHEM C, V115, P14534, DOI 10.1021/jp2025126
   Yang YN, 2016, ELECTROCHIM ACTA, V196, P348, DOI 10.1016/j.electacta.2016.03.022
   Yao HZ, 2016, J ALLOY COMPD, V680, P206, DOI 10.1016/j.jallcom.2016.04.133
   Yin HB, 2002, J MATER CHEM, V12, P378, DOI 10.1039/b105637a
   Yip CT, 2008, APPL PHYS A-MATER, V92, P589, DOI 10.1007/s00339-008-4624-x
   Yoong LS, 2009, ENERGY, V34, P1652, DOI 10.1016/j.energy.2009.07.024
   Yu H, 2013, CHEM-EUR J, V19, P13569, DOI 10.1002/chem.201300999
   Zhu YF, 2000, J MATER SCI, V35, P4049, DOI 10.1023/A:1004882120249
NR 45
TC 0
Z9 0
U1 9
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1432-8488
EI 1433-0768
J9 J SOLID STATE ELECTR
JI J. Solid State Electrochem.
PD JUN
PY 2017
VL 21
IS 6
BP 1605
EP 1613
DI 10.1007/s10008-017-3523-5
PG 9
WC Electrochemistry
SC Electrochemistry
GA EV4NA
UT WOS:000401736100010
OA No
DA 2017-08-17
ER

PT J
AU Wagdy, A
   Sherif, A
   Sabry, H
   Arafa, R
   Mashaly, I
AF Wagdy, Ayman
   Sherif, Ahmed
   Sabry, Hanan
   Arafa, Rasha
   Mashaly, Islam
TI Daylighting simulation for the configuration of external sun-breakers on
   south oriented windows of hospital patient rooms under a clear desert
   sky
SO SOLAR ENERGY
LA English
DT Article
DE Spatial Daylight Autonomy (sDA); Annual Sunlight Exposure (ASE); Shading
   devices; Tilt angle; Clear sky
AB Provision of a healing environment could help arrive at better healthcare outcomes. Healing environments that enjoy natural daylight have a positive impact on the health and well-being of patients and medical staff. They contribute to the achievement of shorter lengths of stay, reduction of stress and increase of patients and staff satisfaction. Several studies have emphasized the positive role of daylighting as one of the most influential factors for creating successful healing environments in healthcare facilities. This is especially important in patient rooms, which represent the largest component of hospital buildings.
   Provision of adequate daylighting is quiet a challenging task in desert locations which are typically characterized by year-long clear skies. External sun-breakers are typically used in these locations to control solar penetration, thus improving illuminance distribution and decreasing visual discomfort.
   This study aims at defining the main characteristics of the sun-breakers that could be used to control solar access into hospital patient rooms under clear-sky conditions. The study addressed two common patient room designs: inboard bathroom design and outboard bathroom design. The tested rooms had three equidistant sun-breakers that are externally fixed in front of a window facing south in Cairo, Egypt. The focus was on the impact of the sun-breakers' cut off angle and the corresponding tilt angle on year-round illuminance distribution and visual discomfort. The main goal was to ensure adequate daylighting performance without discomfort glare inside these rooms.
   Parametric simulation runs were performed using Grasshopper, Diva-for-Rhino, and SpeedSim-for-DIVA, plug-ins for Rhinoceros modeling software to interface with the simulation engines Radiance and Daysim software.
   The outcomes of this study identified the range of sun-breaker cut off angles and their corresponding tilt angles which produced adequate daylighting performance for the two patient room types at different window to wall ratios. In general, the number of accepted sun-breaker cases increased with higher window to wall ratios for both patient room designs. It was noted that a wider range of accepted tilt angles was identified for the patient rooms having inboard bathrooms. Both the inboard and outboard bathroom designs had the same range of accepted cut off angles. It was observed that efficient daylighting performance was achieved in all tested WWRs for the two patient room layouts with cut off angles between 50 and 54 with the wall. Moreover, horizontal sun-breakers achieved successful results in all tested WWRs for the two patient room layouts. It was also noted that the cut off angles were more influential in providing adequate daylighting performance in comparison with tilt angles. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Wagdy, Ayman; Sherif, Ahmed; Sabry, Hanan; Arafa, Rasha; Mashaly, Islam] Amer Univ Cairo, AUC Ave,POB 74, New Cairo 11835, Egypt.
RP Sherif, A (reprint author), Amer Univ Cairo, AUC Ave,POB 74, New Cairo 11835, Egypt.
EM aymanwagdy@aucegypt.edu; asherif@aucegypt.edu; drhanansabry@gmail.com;
   rashamahmoud@aucegypt.edu; islammashaly@aucegypt.edu
FU American University in Cairo
FX This publication is based on research work supported by a research grant
   from The American University in Cairo.
CR Alzubaidi S., 2013, INT J ENERGY ENG, V3, P287
   Choi JH, 2012, BUILD ENVIRON, V50, P65, DOI 10.1016/j.buildenv.2011.10.010
   Curtin M, 2005, BRUTE FORCE: CRACKING THE DATA ENCRYPTION STANDARD, P1
   Dilani A. P. D., 2008, DESIGN HLTH SCI REV, V1, P47
   Elghazi Y., 2014, DAYLIGHTING DRIVEN D
   Iesna I., 2012, LM8312 IESNA LIGHT M
   Joarder M., 2012, INT SEM ARCH ED PRAC, P436
   Joseph A., 2006, 2 CTR HLTH DES
   Koppen-Geiger, 2006, WORLD MAP KOPP GEIG
   Pechacek C., 2008, P 5 NAT C IBPSA ESIM
   Rutten D., 2014, GRASSHOPPER ALGORITH
   Sherif A., 2014, 2 SAUDI FORUM PLANNI
   Sherif A., 2013, P BUILD SIM C BS 201
   Sherif A., 2015, P BS 2015 14 INT C I, P1383
   Sherif A., 2015, P 12 INT C EN ENV SU
   Sherif A., 2014, P 30 INT C PASS LOW
   Sherif A., 2013, P SUST BUILD C SB 20
   Sherif A., 2014, WORLD HLTH DESIGN, V7, P64
   Sherif A, 2016, SOL ENERGY, V133, P1, DOI 10.1016/j.solener.2016.03.053
   Sherif A, 2015, ENRGY PROCED, V78, P1805, DOI 10.1016/j.egypro.2015.11.315
   Shikder S., 2010, P INT C COMP CIV BUI
   Solemma L, 2014, DIVA RHINO SOFTWARE
   USGBC, 2014, LEED V4 DAYL, V2014
   Wagdy Ayman, 2015, Journal of Building Engineering, V3, P155, DOI 10.1016/j.jobe.2015.07.007
   Wagdy A, 2015, SPEEDSIM FOR DIVA VE
NR 25
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0038-092X
J9 SOL ENERGY
JI Sol. Energy
PD JUN
PY 2017
VL 149
BP 164
EP 175
DI 10.1016/j.solener.2017.04.009
PG 12
WC Energy & Fuels
SC Energy & Fuels
GA EV3WC
UT WOS:000401688800016
OA No
DA 2017-08-17
ER

PT J
AU Kishk, S
   Almofari, NH
   Zaki, FW
AF Kishk, S.
   Almofari, N. H.
   Zaki, F. W.
TI Distributed resource allocation in D2D communication networks with
   energy harvesting relays using stable matching
SO AD HOC NETWORKS
LA English
DT Article
DE Resource allocation; D2D relay assisted; Stable matching
ID TO-DEVICE COMMUNICATION; MULTIUSER OFDM; UNDERLAY; SYSTEMS
AB Fifth Generation (5G) cellular networks are expected to provide high data rates by using emerging technologies such as multi-tier heterogeneous networks, Device to Device (D2D) communication and densification of small base stations. D2D uses direct transmission between two cellular devices to increase the system throughput. Relays are used to reduce the loss in user data rate when the D2D users are far from each other and the relay nodes are used to serve the cellular users when the channel is not good enough. To get good performance from D2D relay assisted network, suitable, robust and low complexity resource allocation algorithm must be used. In this paper, an algorithm for user association, resource blocks allocation and power control when considering the energy harvesting relays in heterogeneous multi-tier network is presented. This paper introduces a centralized solution using time sharing strategy and a distributed low complexity solution using stable matching theory. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Kishk, S.; Almofari, N. H.; Zaki, F. W.] Mansoura Univ, Fac Engn, Elect & Commun Dept, Mansoura, Egypt.
RP Kishk, S (reprint author), Mansoura Univ, Fac Engn, Elect & Commun Dept, Mansoura, Egypt.
EM shkishk@mans.edu.eg; almofaryn@mans.edu.eg; fwzaki@mans.edu.eg
CR Abdelhy Ehab H., 2015, 32 NAT RAD SCINC C, P329
   Abdelnasser A, 2013, IEEE ICC, P6002, DOI 10.1109/ICC.2013.6655560
   Boyd S., 2004, VANDENBERGHE CONVEX
   Doppler K, 2009, IEEE COMMUN MAG, V47, P42, DOI 10.1109/MCOM.2009.5350367
   Fodor G., 2012, COMMUNICATIONS MAGAZ, V50, P170, DOI DOI 10.1109/MC0M.2012.6163598
   GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726
   Gusfield D., 1989, STABLE MARRIAG PREOP
   Hasan M., 2015, 2015 IEEE INT C COMM, P4552
   Hasan M, 2014, IEEE T WIREL COMMUN, V13, P6326, DOI 10.1109/TWC.2014.2330831
   Huang XQ, 2016, IEEE T VEH TECHNOL, V65, P2424, DOI 10.1109/TVT.2015.2424218
   Huang XQ, 2015, IEEE T MOBILE COMPUT, V14, DOI 10.1109/TMC.2015.2388478
   Iwama K, 2008, INTERNATIONAL CONFERENCE ON INFORMATICS EDUCATION AND RESEARCH FOR KNOWLEDGE-CIRCULATING SOCIETY, PROCEEDINGS, P131, DOI 10.1109/ICKS.2008.7
   Iwamura M., 2010, NTT DOCOMO TECH J, V12, P29
   Jangsher S, 2015, IEEE J SEL AREA COMM, V33, P482, DOI 10.1109/JSAC.2015.2391916
   Jorswieck E., 2011, 17 INT C DIG SIGN PR, P1
   Li K, 2014, IEEE T EVOLUT COMPUT, V18, P909, DOI 10.1109/TEVC.2013.2293776
   Shen ZK, 2005, IEEE T WIREL COMMUN, V4, P2726, DOI 10.1109/TWC.2005.858010
   Wong CY, 1999, IEEE J SEL AREA COMM, V17, P1747, DOI 10.1109/49.793310
   Xu C, 2013, IEEE J SEL AREA COMM, V31, P348, DOI 10.1109/JSAC.2013.SUP.0513031
   Zhang HJ, 2014, IEEE T COMMUN, V62, P2366, DOI 10.1109/TCOMM.2014.2328574
   Zhou ZY, 2015, IET COMMUN, V9, P375, DOI 10.1049/iet-com.2014.0337
   Zulhasnine M, 2010, IEEE CONF WIREL MOB, P368, DOI 10.1109/WIMOB.2010.5645039
NR 22
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-8705
EI 1570-8713
J9 AD HOC NETW
JI Ad Hoc Netw.
PD JUN
PY 2017
VL 61
BP 114
EP 123
DI 10.1016/j.adhoc.2017.03.010
PG 10
WC Computer Science, Information Systems; Telecommunications
SC Computer Science; Telecommunications
GA EV5DH
UT WOS:000401782200008
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Aziem, AA
   El-Basatiny, HMY
AF Abdel-Aziem, Amr A.
   El-Basatiny, Heba M. Y.
TI Effectiveness of backward walking training on walking ability in
   children with hemiparetic cerebral palsy: a randomized controlled trial
SO CLINICAL REHABILITATION
LA English
DT Article
DE Cerebral palsy; backward walking; forward walking; gait analysis;
   children
ID CLINICAL-TRIAL; GAIT; MOVEMENTS; SUPPORT; STROKE
AB Objective: To compare the effects of backward walking training and forward walking training on spatiotemporal gait parameters, and gross motor function measures in children with cerebral palsy.
   Design: Randomized controlled clinical trial.
   Setting: Physical therapy clinics.
   Subjects: A total of 30 children with hemiparetic cerebral palsy of both sexes (10 to 14years of age, classified as I or II by gross motor function classification system) participated in this study. They were randomly assigned into two equal groups.
   Interventions: Both groups received a conventional physical therapy program for 12 successive weeks (three sessions per week). The experimental group additionally received (25min) backward walking training. The control group additionally received (25min) forward walking training.
   Outcome measures: Baseline, posttreatment, and follow-up assessment for spatiotemporal gait parameters and gross motor functions were evaluated by using three dimensional gait analysis system and gross motor function measures.
   Results: There was a significant improvement in step length, walking velocity, cadence, stance phase, and swing phase percentage and gross motor function measures (Dimensions D and E) of the experimental group (0.550.16, 0.53 +/- 0.19, 121.73 +/- 2.89, 54.73 +/- 1.67, 44.40 +/- 1.40, 90.20 +/- 6.44, 82.47 +/- 12.82), respectively, than the control group (0.39 +/- 0.13, 0.46 +/- 0.20, 125.80 +/- 2.96, 50.27 +/- 1.62, 49.47 +/- 1.55, 82.47 +/- 7.05, 80.47 +/- 12.61), respectively, (p<0.05). The significant improvement of all measured outcomes of the experimental group was maintained at 1month follow-up assessment (p<0.05).
   Conclusion: In addition to a conventional physical therapy program, backward walking training is more effective than forward walking training on spatiotemporal gait parameters, and gross motor function measures in children with hemiparetic cerebral palsy.
C1 [Abdel-Aziem, Amr A.] Cairo Univ, Fac Phys Therapy, Dept Biomech, 7 Ahmed Elziat St, Giza, Egypt.
   [El-Basatiny, Heba M. Y.] Univ Dammam, Coll Appl Med Sci, Phys Therapy Dept, Dammam, Saudi Arabia.
RP Abdel-Aziem, AA (reprint author), Cairo Univ, Fac Phys Therapy, Dept Biomech, 7 Ahmed Elziat St, Giza, Egypt.
EM amralmaz@yahoo.com
CR Abel MF, 1996, J PEDIATR ORTHOPED, V16, P753
   Adams M. A., 2000, PEDIAT PHYSICAL THER, V12, P114
   Bjornson KF, 1998, PEDIAT PHYSICAL THER, V10, P43
   BOHANNON RW, 1987, PHYS THER, V67, P206
   Chan CCH, 2002, BRAIN INJURY, V16, P873, DOI 10.1080/02699050210131975
   Cherng RJ, 2007, AM J PHYS MED REHAB, V86, P548, DOI 10.1097/PHM.0b013e31806dc302
   CIPRIANI DJ, 1995, J ORTHOP SPORT PHYS, V22, P95
   Grecco LAC, 2013, CLIN REHABIL, V27, P686, DOI 10.1177/0269215513476721
   Davies PM, 1990, RIGHT MIDDLE SELECTI
   DIETZ V, 1992, PHYSIOL REV, V72, P33
   Dietz V, 2002, NAT REV NEUROSCI, V3, P781, DOI 10.1038/nrn939
   Dodd KJ, 2003, DEV MED CHILD NEUROL, V45, P652, DOI 10.1017/S0012162203001221
   El-Basatiny HMY, 2015, CLIN REHABIL, V29, P457, DOI 10.1177/0269215514547654
   FLYNN TW, 1994, MED SCI SPORT EXER, V26, P89
   Godde B, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00139
   Hoogkamer W, 2014, EXERC SPORT SCI REV, V42, P23, DOI 10.1249/JES.0000000000000000
   HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369
   Kim SG, 2013, INT J REHABIL RES, V36, P246, DOI 10.1097/MRR.0b013e32835dd620
   Kramer JF, 1991, PHYSIOTHER CAN, V33, P77
   Kurz MJ, 2012, NEUROIMAGE, V59, P1602, DOI 10.1016/j.neuroimage.2011.08.084
   Meyns P, 2012, RES DEV DISABIL, V33, P1418, DOI 10.1016/j.ridd.2012.03.020
   Russell D, 2002, GROSS MOTOR FUNCTION
   Smania N, 2011, AM J PHYS MED REHAB, V90, P137, DOI 10.1097/PHM.0b013e318201741e
   Van den Broeck C, 2010, EUR J PAEDIATR NEURO, V14, P519, DOI 10.1016/j.ejpn.2010.03.004
   van Deursen RWM, 1998, GAIT POSTURE, V7, P214, DOI 10.1016/S0966-6362(98)00007-1
   Wang X, 2012, NEURAL REGEN RES, V7, P1578, DOI 10.3969/j.issn.1673-5374.2012.20.008
   Willoughby KL, 2009, DISABIL REHABIL, V31, P1971, DOI 10.3109/09638280902874204
   Yang JF, 2006, NEUROSCIENTIST, V12, P379, DOI 10.1177/1073858406292151
   Yang YR, 2005, CLIN REHABIL, V19, P264, DOI 10.1191/0269215505cr860oa
   Zwier JN, 2010, DISABIL REHABIL, V32, P1501, DOI 10.3109/09638288.2010.497017
NR 30
TC 0
Z9 0
U1 3
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0269-2155
EI 1477-0873
J9 CLIN REHABIL
JI Clin. Rehabil.
PD JUN
PY 2017
VL 31
IS 6
BP 790
EP 797
DI 10.1177/0269215516656468
PG 8
WC Rehabilitation
SC Rehabilitation
GA EV4HL
UT WOS:000401719500010
PM 27356944
OA No
DA 2017-08-17
ER

PT J
AU Elaziz, MSA
   Zaky, AG
   El SaebaySarhan, AR
AF Elaziz, Mohamed Samy Abd
   Zaky, Adel Galal
   El SaebaySarhan, Abdel Rahman
TI Stromal lenticule transplantation for management of corneal
   perforations; one year results
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE Corneal perforation; Femto-smile; Lenticule
ID AMNIOTIC MEMBRANE TRANSPLANTATION; FEMTOSECOND LASER; TISSUE ADHESIVE;
   EXTRACTION; KERATOPLASTY; ULCERATION; THICKNESS; KERATITIS; SURGERY;
   GRAFT
AB To study application of stromal lenticules extracted by femtolaser small incision lenticule extraction (SMILE) surgery as a surgical adjuvant to seal corneal perforations.
   Corneal stromal lenticules obtained through SMILE surgery with central thickness 100 mu m or more were fixed over corneal perforation sites using 10-0 nylon interrupted stitches with an overlying single layer of amniotic membrane. Seven patients who had been followed up for a minimum of 12 months were assessed using slit-lamp biomicroscopy, fluorescein stain, tonometry, and best spectacle-corrected visual acuity (BSCVA) measurements. Postoperative complications were recorded throughout the follow up period.
   Corneal perforations had successfully been sealed in all 7 patients; 3 patients (42.9%) exhibited improved postoperative BSCVA. During the follow-up period of one year, no signs of re-perforation or infections were detected in any patient.
   These early findings suggest that the use of corneal stromal lenticules could be a safe and efficient surgical adjuvant for corneal perforation closure with potential clinical application, together with amniotic membrane, as relatively simple and low cost temporary measures to prepare perforated corneas for further definitive procedures.
C1 [Elaziz, Mohamed Samy Abd; Zaky, Adel Galal; El SaebaySarhan, Abdel Rahman] Menoufia Univ, Fac Med, Dept Ophthalmol, Menoufia, Egypt.
RP Elaziz, MSA (reprint author), Menoufia Univ, Fac Med, Dept Ophthalmol, Menoufia, Egypt.
EM MOHAMMED.SAMI66@med.menofia.edu.eg
CR ARENTSEN JJ, 1985, OPHTHALMIC SURG LAS, V16, P29
   Bhandari V, 2016, CORNEA, V35, P408, DOI 10.1097/ICO.0000000000000741
   Chan ES, 2011, CORNEA, V30, P838, DOI 10.1097/ICO.0b013e31820ce80f
   Hanada K, 2001, AM J OPHTHALMOL, V131, P324, DOI 10.1016/S0002-9394(00)00825-4
   HIRST LW, 1982, OPHTHALMOLOGY, V89, P630
   Hjortdal JO, 2012, J REFRACT SURG, V28, P865, DOI 10.3928/1081597X-20121115-01
   Jhanji V, 2011, SURV OPHTHALMOL, V56, P522, DOI 10.1016/j.survophthal.2011.06.003
   KENYON KR, 1982, OPHTHALMOLOGY, V89, P44
   Kobayashi Akira, 2012, Case Rep Ophthalmol, V3, P226, DOI 10.1159/000341094
   Li C, 2012, INT J OPHTHALMOL-CHI, V5, P698, DOI 10.3980/j.issn.2222-3959.2012.06.09
   Lim CHL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083046
   PORTNOY SL, 1989, SURV OPHTHALMOL, V34, P47, DOI 10.1016/0039-6257(89)90129-X
   Pradhan KR, 2013, J REFRACT SURG, V29, P777, DOI 10.3928/1081597X-20131021-07
   Reinstein DZ, 2010, J REFRACT SURG, V26, P107, DOI 10.3928/1081597X-20100121-06
   Rodriguez-Ares MT, 2004, CORNEA, V23, P577, DOI 10.1097/01.ico.0000121709.58571.12
   SAINI JS, 1992, OPHTHALMIC SURG LAS, V23, P399
   Sandinha T, 2006, EYE, V20, P84, DOI 10.1038/sj.eye.6701814
   Setlik DE, 2005, AM J OPHTHALMOL, V140, P920, DOI 10.1016/j.ajo.2005.04.062
   Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033
   Ti SE, 2007, AM J OPHTHALMOL, V143, P755, DOI 10.1016/j.ajo.2007.01.015
   WEISS JL, 1983, OPHTHALMOLOGY, V90, P610
   Wolf EJ, 2007, J CATARACT REFR SURG, V33, P1974, DOI 10.1016/j.jcrs.2007.06.043
   Wu F, 2015, CORNEA, V34, P658, DOI 10.1097/ICO.0000000000000397
NR 23
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD JUN
PY 2017
VL 255
IS 6
BP 1179
EP 1184
DI 10.1007/s00417-017-3645-6
PG 6
WC Ophthalmology
SC Ophthalmology
GA EV0NL
UT WOS:000401437600017
OA No
DA 2017-08-17
ER

PT J
AU Mohamed, A
AF Mohamed, Ali Wagdy
TI An efficient modified differential evolution algorithm for solving
   constrained non-linear integer and mixed-integer global optimization
   problems
SO INTERNATIONAL JOURNAL OF MACHINE LEARNING AND CYBERNETICS
LA English
DT Article
DE Evolutionary computation; Global optimization; Differential evolution;
   Triangular mutation; Mixed-integer non-linear programming (MINLP)
ID PROGRAMMING-PROBLEMS; OUTER-APPROXIMATION; GENETIC ALGORITHM; BOUND
   ALGORITHM; MUTATION; BRANCH; STRATEGIES; FRAMEWORK; SEARCH
AB In this paper, an efficient modified Differential Evolution algorithm, named EMDE, is proposed for solving constrained non-linear integer and mixed-integer global optimization problems. In the proposed algorithm, new triangular mutation rule based on the convex combination vector of the triplet defined by the three randomly chosen vectors and the difference vectors between the best,better and the worst individuals among the three randomly selected vectors is introduced. The proposed novel approach to mutation operator is shown to enhance the global and local search capabilities and to increase the convergence speed of the new algorithm compared with basic DE. EMDE uses Deb's constraint handling technique based on feasibility and the sum of constraints violations without any additional parameters. In order to evaluate and analyze the performance of EMDE, Numerical experiments on a set of 18 test problems with different features, including a comparison with basic DE and four state-of-the-art evolutionary algorithms are executed. Experimental results indicate that in terms of robustness, stability and efficiency, EMDE is significantly better than other five algorithms in solving these test problems. Furthermore, EMDE exhibits good performance in solving two high-dimensional problems, and it finds better solutions than the known ones. Hence, EMDE is superior to the compared algorithms.
C1 [Mohamed, Ali Wagdy] Cairo Univ, Inst Stat Studies & Res, Operat Res Dept, Giza 12613, Egypt.
RP Mohamed, A (reprint author), Cairo Univ, Inst Stat Studies & Res, Operat Res Dept, Giza 12613, Egypt.
EM aliwagdy@gmail.com
CR Abhishek K, 2010, INFORMS J COMPUT, V22, P555, DOI 10.1287/ijoc.1090.0373
   Belotti P, 2013, ACTA NUMER, V22, P1, DOI 10.1017/S0962492913000032
   Bonami P, 2008, DISCRETE OPTIM, V5, P186, DOI 10.1016/j.disopt.2006.10.011
   BORCHERS B, 1994, COMPUT OPER RES, V21, P359, DOI 10.1016/0305-0548(94)90024-8
   Burer S., 2012, SURV OPER RES MANAGE, V17, P97, DOI DOI 10.1016/J.S0RMS.2012.08.001
   Cai JB, 1996, ADV ENG SOFTW, V25, P177, DOI 10.1016/0965-9978(95)00104-2
   Cao YJ, 2000, APPL MATH MODEL, V24, P931, DOI 10.1016/S0307-904X(00)00026-3
   Cardoso MF, 1997, COMPUT CHEM ENG, V21, P1349, DOI 10.1016/S0098-1354(97)00015-X
   Catalao JPS, 2010, ELECTR POW SYST RES, V80, P935, DOI 10.1016/j.epsr.2009.12.015
   Cetinkaya C, 2013, EUR J OPER RES, V230, P539, DOI 10.1016/j.ejor.2013.05.001
   Conley W, 1984, COMPUTER OPTIMIZATIO
   Costa L, 2001, COMPUT CHEM ENG, V25, P257, DOI 10.1016/S0098-1354(00)00653-0
   D'Ambrosio C, 2011, 4OR-Q J OPER RES, V9, P329, DOI 10.1007/s10288-011-0181-9
   Das S, 2011, EVOLUTIONARY COMPUTA, V15, P4
   Deb K, 2000, COMPUT METHOD APPL M, V186, P311, DOI 10.1016/S0045-7825(99)00389-8
   Deep K, 2009, APPL MATH COMPUT, V212, P505, DOI 10.1016/j.amc.2009.02.044
   Dong N, 2014, J APPL MATH, DOI 10.1155/2014/606019
   Dua V, 1998, CHEM ENG RES DES, V76, P408, DOI 10.1205/026387698524839
   DURAN MA, 1986, MATH PROGRAM, V36, P307, DOI 10.1007/BF02592064
   Engelbrecht A. P., 2005, FUNDAMENTALS COMPUTA
   Fan HY, 2003, J GLOBAL OPTIM, V27, P105, DOI 10.1023/A:1024653025686
   Feoktistov V, 2006, SPRINGER SER OPTIM A, V5, pXI
   FLETCHER R, 1994, MATH PROGRAM, V66, P327, DOI 10.1007/BF01581153
   Gao Y, 2011, INF TECHNOL J, V10, P2068
   Garroppo RG, 2013, COMPUT OPER RES, V40, P273, DOI 10.1016/j.cor.2012.06.014
   Geoffrion A. M., 1972, Journal of Optimization Theory and Applications, V10, P237, DOI 10.1007/BF00934810
   Glover F, 2006, COMPUT OPER RES, V33, P2449, DOI 10.1016/j.cor.2005.07.009
   Grossmann IE, 2002, OPTIM ENG, V3
   Grossmann IE, 2002, OPTIM ENG, V4
   Grossmann IE, 2002, OPTIM ENG, V3, P227, DOI 10.1023/A:1021039126272
   GUPTA OK, 1985, MANAGE SCI, V31, P1533, DOI 10.1287/mnsc.31.12.1533
   Hsieh YC, 2015, APPL MATH MODEL, V39, P5759, DOI 10.1016/j.apm.2014.12.019
   Hua ZS, 2006, INFORM SCIENCES, V176, P2869, DOI 10.1016/j.ins.2005.04.009
   Kesen SE, 2010, COMPUT OPER RES, V37, P1148, DOI 10.1016/j.cor.2009.10.006
   Lampinen J, 1999, P MEND 99 5 INT MEND
   Lee S, 2000, COMPUT CHEM ENG, V24, P2125, DOI 10.1016/S0098-1354(00)00581-0
   Li H, 2014, ENG OPTIMIZ, V46, P1238, DOI 10.1080/0305215X.2013.836637
   Li YX, 1996, INFORMATION INTELLIGENCE AND SYSTEMS, VOLS 1-4, P2677, DOI 10.1109/ICSMC.1996.561362
   Liberti L, 2009, STUD COMPUT INTELL, V203, P153
   Lin YC, 2004, COMPUT MATH APPL, V47, P1295, DOI 10.1016/j.camwa.2004.04.014
   Liu P, 2011, COMPUT CHEM ENG, V35, P1359, DOI 10.1016/j.compchemeng.2011.01.014
   Lu HY, 2008, J GLOBAL OPTIM, V41, P427, DOI 10.1007/s10898-007-9255-9
   Maldonado S, 2014, INFORM SCIENCES, V279, P163, DOI 10.1016/j.ins.2014.03.110
   Mallipeddi R, 2011, APPL SOFT COMPUT, V11, P1679, DOI 10.1016/j.asoc.2010.04.024
   Mezura-Montes E, 2005, IEEE T EVOLUT COMPUT, V9, P1, DOI 10.1109/TEVC.2004.836819
   Mohamed AW, 2015, COMPUT IND ENG, V85, P359, DOI 10.1016/j.cie.2015.04.012
   Mohamed AW, 2012, INFORM SCIENCES, V194, P171, DOI 10.1016/j.ins.2012.01.008
   Mohan C, 1999, COMPUT OPTIM APPL, V14, P103, DOI 10.1023/A:1008761113491
   Ng CK, 2005, COMPUT OPTIM APPL, V31, P87, DOI 10.1007/s10589-005-0985-7
   Omran MGH, 2007, IEEE C EVOL COMPUTAT, P2237, DOI 10.1109/CEC.2007.4424749
   Price KV, 2005, DIFFERENTIAL EVOLUTI
   Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706
   QUESADA I, 1992, COMPUT CHEM ENG, V16, P937, DOI 10.1016/0098-1354(92)80028-8
   Rosen SL, 2005, COMPUT OPER RES, V32, P343, DOI 10.1016/S0305-0548(03)00240-5
   SANDGREN E, 1990, J MECH DESIGN, V112, P223, DOI 10.1115/1.2912596
   Schluter M, 2009, COMPUT OPER RES, V36, P2217, DOI 10.1016/j.cor.2008.08.015
   Socha K, 2004, LECT NOTES COMPUT SC, V3172, P25
   Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328
   Storn R., 1995, TR95012 ICSI
   Trespalacios F, 2014, CHEM-ING-TECH, V86, P991, DOI 10.1002/cite.201400037
   Turkkan N., 2003, ANN C CAN SOC CIV EN
   Venkatraman S, 2005, IEEE T EVOLUT COMPUT, V9, P424, DOI 10.1109/TEVC.2005.846817
   Wang Y, 2011, IEEE T EVOLUT COMPUT, V15, P55, DOI 10.1109/TEVC.2010.2087271
   Wasanapradit T, 2011, KOREAN J CHEM ENG, V28, P32, DOI 10.1007/s11814-010-0323-3
   WESTERLUND T, 1995, COMPUT CHEM ENG, V19, pS131, DOI 10.1016/0098-1354(95)00164-W
   Woon SF, 2010, APPL MATH COMPUT, V217, P25, DOI 10.1016/j.amc.2010.05.009
   Xu G, 2009, COMPUT IND ENG, V56, P1205, DOI 10.1016/j.cie.2008.07.012
   Yiqing L., 2007, COMPUT CHEM ENG, V31, P153, DOI 10.1016/j.compchemeng.2006.05.016
   Yokota T, 1996, COMPUT IND ENG, V30, P905, DOI 10.1016/0360-8352(96)00041-1
   Yongjian Y., 2007, J COMPUT APPL MATH, V202, P280, DOI 10.1016/j.cam.2006.02.032
   Yue T., 2014, J CENTRAL S U, V21, P2731
   Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613
NR 72
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1868-8071
EI 1868-808X
J9 INT J MACH LEARN CYB
JI Int. J. Mach. Learn. Cybern.
PD JUN
PY 2017
VL 8
IS 3
BP 989
EP 1007
DI 10.1007/s13042-015-0479-6
PG 19
WC Computer Science, Artificial Intelligence
SC Computer Science
GA EV0PF
UT WOS:000401443500021
OA No
DA 2017-08-17
ER

PT J
AU Liu, YH
   Guo, JW
   Li, L
   Asem, MD
   Zhang, YG
   Mohamad, OA
   Salam, N
   Li, WJ
AF Liu Yonghong
   Guo Jianwei
   Li Li
   Asem, Mipeshwaree D.
   Zhang Yongguang
   Mohamad, Osama A.
   Salam, Nimaichand
   Li Wenjun
TI Endophytic bacteria associated with endangered plant Ferula
   sinkiangensis K. M. Shen in an arid land: diversity and plant
   growth-promoting traits
SO JOURNAL OF ARID LAND
LA English
DT Article
DE endophytic bacteria; Ferula sinkiangensis; endangered species; growth
   promoting
ID SP NOV.; ANTIMICROBIAL ACTIVITY; INDEPENDENT METHODS; GEN. NOV.; ORD.
   NOV; FAM. NOV; ACTINOBACTERIA; RHIZOSPHERE; RICE; IDENTIFICATION
AB Ferula spp. are traditional medicinal plants found in arid land. Large-scale excavation for extracting bioactive compounds from the plants in arid regions of Xinjiang over the last few years has, however, significantly decreased their distributions. Due to the urgent need for preservation of these plant resources, along with the need of searching for alternative source of the useful metabolites, it is important to screen the endophytic microbial resources associated with the plant Ferula sinkiangensis K. M. Shen. In the study, a total of 125 endophytic bacteria belonging to 3 phyla, 13 orders, 23 families, and 29 genera were isolated based on 16S rRNA gene sequencing data. Among the different isolates, three strains isolated from roots were potential novel species of the genera Porphyrobacter, Paracoccus and Amycolatopsis. In this study, 79.4% and 57.1% of the total isolates were capable of producing indole-3-acetic acid (IAA) and siderophore, respectively. And, 40.6% of the strains inhibit the growth of fungal pathogen Alternaria alternata, 17.2% and 20.2% strains were positive for antagonism against Verticillium dahlia 991 and V. dahlia 7, respectively. These results demonstrated that F. sinkiangensis is a rich reservoir of endophytic bacterial resources with potential for production of biologically important functions such as plant growth-promoting factors.
C1 [Liu Yonghong; Guo Jianwei; Li Li; Zhang Yongguang; Mohamad, Osama A.; Li Wenjun] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China.
   [Liu Yonghong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Guo Jianwei] Honghe Univ, Yunnan Higher Educ Inst, Key Lab Crops High Qual & Efficient Cultivat & Se, Mengzi 661100, Peoples R China.
   [Asem, Mipeshwaree D.; Salam, Nimaichand; Li Wenjun] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.
   [Asem, Mipeshwaree D.; Salam, Nimaichand; Li Wenjun] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China.
   [Mohamad, Osama A.] Arish Univ, Inst Post Grad Environm Study, Environm Sci Dept, Arish 45511, Egypt.
RP Li, WJ (reprint author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi 830011, Peoples R China.; Li, WJ (reprint author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.; Li, WJ (reprint author), Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China.
EM liwenjun3@mail.sysu.edu.cn
OI Mohamad, Osama Abdalla/0000-0002-2234-8273
FU National Natural Science Foundation of China [U1403101, 31200008]; China
   Postdoctoral Science Foundation [2016M602566]; State Key Laboratory of
   Biocontrol, Sun Yat-Sen University [SKLBC14F02]; West Light Foundation
   of the Chinese Academy of Sciences; Chinese Academy of Sciences;
   Guangdong Province Higher Vocational Colleges & Schools Pearl River
   Scholar Funded Scheme
FX This work was supported by the National Natural Science Foundation of
   China (U1403101, 31200008), the China Postdoctoral Science Foundation
   (2016M602566), the Visiting Scholar Grant of State Key Laboratory of
   Biocontrol, Sun Yat-Sen University (SKLBC14F02) and the West Light
   Foundation of the Chinese Academy of Sciences. The author LI Wenjun was
   also supported by Hundred Talents Program of the Chinese Academy of
   Sciences and Guangdong Province Higher Vocational Colleges & Schools
   Pearl River Scholar Funded Scheme (2014).
CR Aldesuquy HS, 1998, FOLIA MICROBIOL, V43, P465, DOI 10.1007/BF02820792
   ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386
   Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002
   Asaf S, 2017, J PLANT INTERACT, V12, P31, DOI 10.1080/17429145.2016.1274060
   Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7
   Boukhalfa H, 2002, BIOMETALS, V15, P325, DOI 10.1023/A:1020218608266
   Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753
   Cui Bei-mi, 2008, Xibei Zhiwu Xuebao, V28, P2343
   Pereira GVDM, 2012, MICROB ECOL, V63, P405, DOI 10.1007/s00248-011-9919-3
   Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1
   Feng Y, 2006, J APPL MICROBIOL, V100, P938, DOI 10.1111/j.1365-2672.2006.02843.x
   Giassi V, 2016, MICROBIOL RES, V190, P46, DOI 10.1016/j.micres.2015.12.006
   Gtari M, 2012, ARCH MICROBIOL, V194, P3, DOI 10.1007/s00203-011-0733-6
   Hallmann J, 1998, SOIL BIOL BIOCHEM, V30, P925, DOI 10.1016/S0038-0717(97)00183-1
   Hara Francisco Adilson dos Santos, 2004, Acta Amazonica, V34, P343, DOI 10.1590/S0044-59672004000300002
   He ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep13323
   Jose PA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00242
   Kaplan D, 2013, AM J BOT, V100, P1713, DOI 10.3732/ajb.1200615
   Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0
   Lei ZC, 2014, J GEN APPL MICROBIOL, V60, P101, DOI 10.2323/jgam.60.101
   Liu Y H, 2016, BIO-TECHNOL, V6, P209
   Lodewyckx C, 2002, CRIT REV PLANT SCI, V21, P583, DOI 10.1080/0735-260291044377
   Mano H, 2008, MICROBES ENVIRON, V23, P109, DOI 10.1264/jsme2.23.109
   Marasco R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048479
   Meunchang S, 2006, PLANT SOIL, V280, P171, DOI 10.1007/s11104-005-2949-1
   Nimaichand S, 2016, PLANT GROWTH PROMOTI, P1
   Palaniyandi SA, 2013, APPL MICROBIOL BIOT, V97, P9621, DOI 10.1007/s00253-013-5206-1
   Patten CL, 1996, CAN J MICROBIOL, V42, P207
   Pimenov M. G., 2004, Turkish Journal of Botany, V28, P139
   Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724
   Qin S, 2012, ENV MICROBIOL REP, V4, P522, DOI 10.1111/j.1758-2229.2012.00357.x
   Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09
   Santoyo G, 2016, MICROBIOL RES, V183, P92, DOI 10.1016/j.micres.2015.11.008
   SCHIPPERS B, 1987, ANNU REV PHYTOPATHOL, V25, P339, DOI 10.1146/annurev.py.25.090187.002011
   Sen M, 1965, MICROBIOLOGY, V41, P1
   Sibanda T, 2017, MICROB BIOTECHNOL, V10, P570, DOI 10.1111/1751-7915.12602
   Soussi A, 2016, PLANT SOIL, V405, P357, DOI 10.1007/s11104-015-2650-y
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Triplett EW, 1996, PLANT SOIL, V186, P29, DOI 10.1007/BF00035052
   Verma VC, 2009, MICROB ECOL, V57, P749, DOI 10.1007/s00248-008-9450-3
   Vurukonda SSKP, 2016, MICROBIOL RES, V184, P13, DOI 10.1016/j.micres.2015.12.003
   Wang H., 2015, THESIS
   Wang HF, 2015, ANTON LEEUW INT J G, V107, P835, DOI 10.1007/s10482-014-0376-0
   Wang WF, 2016, MICROBIOL RES, V190, P12, DOI 10.1016/j.micres.2016.05.003
   Wang XR, 2009, PLANT PHYSIOL, V151, P233, DOI 10.1104/pp.109.138891
   WELLER DM, 1988, ANNU REV PHYTOPATHOL, V26, P379, DOI 10.1146/annurev.py.26.090188.002115
   Zhang YG, 2016, INT J SYST EVOL MICR, V66, P530, DOI 10.1099/ijsem.0.000749
   Zhang YG, 2016, INT J SYST EVOL MICR, V66, P283, DOI 10.1099/ijsem.0.000713
NR 48
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1674-6767
EI 2194-7783
J9 J ARID LAND
JI J. Arid Land
PD JUN
PY 2017
VL 9
IS 3
BP 432
EP 445
DI 10.1007/s40333-017-0015-5
PG 14
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EV0PS
UT WOS:000401445300010
OA No
DA 2017-08-17
ER

PT J
AU Yousef, A
   Brooks, RM
   El-Halwany, MM
   Abutaleb, A
   El-Newehy, MH
   Al-Deyab, SS
   Kim, HY
AF Yousef, Ayman
   Brooks, Robert M.
   El-Halwany, M. M.
   Abutaleb, Ahmed
   El-Newehy, Mohamed H.
   Al-Deyab, Salem S.
   Kim, Hak Yong
TI Electrospun CoCr7C3-supported C nanofibers: Effective, durable, and
   chemically stable catalyst for H-2 gas generation from ammonia borane
SO MOLECULAR CATALYSIS
LA English
DT Article
DE Electrospinning; CoCrC/C composite; Nanofibers; Hydrogen generation;
   Ammonia borane
ID CORE-SHELL NANOPARTICLES; HYDROGEN GENERATION; HYDROLYTIC
   DEHYDROGENATION; POROUS CARBON; METHACRYLATE) CRYOGEL; METAL
   NANOPARTICLE; ROOM-TEMPERATURE; FACILE SYNTHESIS; EFFICIENT; GRAPHENE
AB Cobalt-chromium carbide-embedded carbon nanofibers (nanocomposite) were prepared via electro-spinning of a solution containing cobalt acetate tetrahydrate (CoAc), chromium (II) acetate dimer monohydrate (CrAc), and polyvinylpyrrolidone (PVP) followed by carbonization. Carbonization was achieved at a low temperature (850 degrees C, Ar gas, 6h) as the nanocomposite contained metal carbide. The synthesized nanocomposite was analyzed using advanced analytical techniques. The catalytic activity of the nanocomposite in hydrogen liberation through the hydrolysis of aqueous ammonia borane (AB) solution was evaluated and compared to those of cobalt/carbon nanofibers (Co/CNFs) and cobalt nanoparticles (Co NPs). The synthesized nanocomposite showed the highest catalytic activity at 0.2475 mol/min compared to Co/CNFs, 0.174 mol min(-1), and Co NPs, 0.09 mol min(-1). The synthesized nanocomposite also showed high stability; it was reused six times without makeup, reactivation, or regeneration. Kinetic studies showed that the rate of AB hydrolysis is dependent on the catalyst concentration and temperature; the value of turn over frequency (TOF) and the activation energy for the prepared nanocomposite were found to be 25.78 mol(H2) min(-1)(mol(metal)(-1)) and similar to 24.2 kJ mol(-1), respectively. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Yousef, Ayman] Helwan Univ, Dept Math & Phys Engn, Fac Engn Mataria, Cairo 11718, Egypt.
   [Yousef, Ayman; Kim, Hak Yong] Chonbuk Natl Univ, Organ Mat & Fiber Engn Dept, Jeonju 561756, South Korea.
   [Brooks, Robert M.] Temple Univ, Dept Civil & Environm Engn, 1947 N 12th St, Philadelphia, PA 19122 USA.
   [El-Halwany, M. M.] Mansoura Univ, Engn Math & Phys Dept, Fac Engn, Mansoura, Egypt.
   [Abutaleb, Ahmed] Jazan Univ, Chem Engn Dept, Jazan, Saudi Arabia.
   [El-Newehy, Mohamed H.; Al-Deyab, Salem S.] King Saud Univ, Dept Chem, Coll Sci, Petrochem Res Chair, Riyadh 11451, Saudi Arabia.
   [El-Newehy, Mohamed H.] Tanta Univ, Dept Chem, Fac Sci, Tanta 31527, Egypt.
RP Yousef, A (reprint author), Helwan Univ, Dept Math & Phys Engn, Fac Engn Mataria, Cairo 11718, Egypt.; Kim, HY (reprint author), Chonbuk Natl Univ, Organ Mat & Fiber Engn Dept, Jeonju 561756, South Korea.
EM aymanyousef84@gmail.com; khy@jbnu.ac.kr
FU Deanship of Scientific Research, King Saud University
FX The authors are grateful to the Deanship of Scientific Research, King
   Saud University, for funding through Vice Deanship of Scientific
   Research Chairs.
CR Akdim O, 2013, INT J HYDROGEN ENERG, V38, P5627, DOI 10.1016/j.ijhydene.2013.02.110
   Arthur EE, 2014, ENERGY, V76, P822, DOI 10.1016/j.energy.2014.08.080
   Barakat NAM, 2013, INT J HYDROGEN ENERG, V38, P7438, DOI 10.1016/j.ijhydene.2013.04.012
   Barakat NAM, 2013, APPL CATAL A-GEN, V451, P21, DOI 10.1016/j.apcata.2012.10.034
   Bulut A, 2016, APPL CATAL B-ENVIRON, V180, P121, DOI 10.1016/j.apcatb.2015.06.021
   Chen LF, 2012, ACS NANO, V6, P7092, DOI 10.1021/nn302147s
   Dai L, 2015, INT J REFRACT MET H, V51, P153, DOI 10.1016/j.ijrmhm.2015.03.012
   Demirci S, 2014, FUEL PROCESS TECHNOL, V127, P88, DOI 10.1016/j.fuproc.2014.06.013
   Du YS, 2013, NEW J CHEM, V37, P3035, DOI 10.1039/c3nj00552f
   Feng WQ, 2014, INT J HYDROGEN ENERG, V39, P3371, DOI [10.1016/j.ijhydene.2013.12.113, 10.1036/j.ijhydene.2013.12.113]
   Fernandes R, 2015, APPL CATAL A-GEN, V495, P23, DOI 10.1016/j.apcata.2015.01.034
   Guo LT, 2015, ACS CATAL, V5, P388, DOI 10.1021/cs501692n
   Kaplan B., 2013, 18 PLANS SEM
   Kiran V, 2014, RSC ADV, V4, P12057, DOI 10.1039/c3ra46281a
   Krueger A, 2008, CHEM-EUR J, V14, P1382, DOI 10.1002/chem.200700987
   Lee KJ, 2010, CARBON, V48, P4248, DOI 10.1016/j.carbon.2010.07.034
   Li J, 2015, CATAL SCI TECHNOL, V5, P525, DOI 10.1039/c4cy01049c
   Lu ZH, 2014, INT J HYDROGEN ENERG, V39, P13389, DOI 10.1016/j.ijhydene.2014.04.086
   Magnuson M, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/22/225004
   Metin O, 2011, INT J HYDROGEN ENERG, V36, P11528, DOI 10.1016/j.ijhydene.2011.06.057
   Metin O, 2009, ENERG FUEL, V23, P3517, DOI 10.1021/ef900171t
   Nirmala R, 2012, INT J HYDROGEN ENERG, V37, P10036, DOI 10.1016/j.ijhydene.2012.03.164
   Patel N, 2012, INT J HYDROGEN ENERG, V37, P2007, DOI 10.1016/j.ijhydene.2011.06.059
   Patel N, 2015, INT J HYDROGEN ENERG, V40, P1429, DOI 10.1016/j.ijhydene.2014.11.052
   Qie L, 2012, ADV MATER, V24, P2047, DOI 10.1002/adma.201104634
   Qiu FY, 2014, INT J HYDROGEN ENERG, V39, P436, DOI 10.1016/j.ijhydene.2013.10.080
   Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678
   Roy B, 2015, J ALLOY COMPD, V645, pS234, DOI 10.1016/j.jallcom.2015.01.046
   Sahiner N, 2014, INT J HYDROGEN ENERG, V39, P10476, DOI 10.1016/j.ijhydene.2014.04.214
   Sahiner N, 2014, FUEL PROCESS TECHNOL, V125, P148, DOI 10.1016/j.fuproc.2014.03.037
   Sahiner N, 2014, J POWER SOURCES, V246, P55, DOI 10.1016/j.jpowsour.2013.07.043
   Satyapal S, 2007, CATAL TODAY, V120, P246, DOI 10.1016/j.cattod.2006.09.022
   Seven F, 2014, INT J HYDROGEN ENERG, V39, P15455, DOI 10.1016/j.ijhydene.2014.07.093
   Seven F, 2013, INT J HYDROGEN ENERG, V38, P15275, DOI 10.1016/j.ijhydene.2013.09.076
   Shenderova OA, 2002, CRIT REV SOLID STATE, V27, P227, DOI 10.1080/10408430208500497
   Shi RX, 2011, INT J REFRACT MET H, V29, P692, DOI 10.1016/j.ijrmhm.2011.05.003
   Staubitz A, 2010, CHEM REV, V110, P4079, DOI 10.1021/cr100088b
   Sterneland T, 2006, METALL MATER TRANS A, V37A, P3023, DOI 10.1007/s11661-006-0183-y
   Tong DG, 2010, J MATER SCI, V45, P2862, DOI 10.1007/s10853-010-4275-0
   Vamvakaki V, 2006, ANAL CHEM, V78, P5538, DOI 10.1021/ac060551t
   Wang HX, 2015, J ALLOY COMPD, V651, P382, DOI 10.1016/j.jallcom.2015.08.139
   Wang Q, 2016, INT J HYDROGEN ENERG, V41, P8470, DOI 10.1016/j.ijhydene.2016.01.178
   Xu Q, 2006, J POWER SOURCES, V163, P364, DOI 10.1016/j.jpowsour.2006.09.043
   Yan JM, 2012, J MATER CHEM, V22, P10990, DOI 10.1039/c2jm31042b
   Yan JM, 2010, J POWER SOURCES, V195, P1091, DOI 10.1016/j.jpowsour.2009.08.067
   Yang L, 2013, ACS APPL MATER INTER, V5, P8231, DOI 10.1021/am402373p
   Yildiz S, 2014, INT J HYDROGEN ENERG, V39, P14690, DOI 10.1016/j.ijhydene.2014.07.035
   Yousef A., 2014, CERAM INT, V43
   Yousef A, 2015, COLLOID SURFACE A, V470, P194, DOI 10.1016/j.colsurfa.2015.02.004
   Yousef A, 2013, APPL CATAL A-GEN, V467, P98, DOI 10.1016/j.apcata.2013.07.019
   Yousef A, 2012, INT J HYDROGEN ENERG, V37, P17715, DOI 10.1016/j.ijhydene.2012.09.038
   Yousef A, 2012, COLLOID SURFACE A, V410, P59, DOI 10.1016/j.colsurfa.2012.06.017
   Yousef A, 2012, J LUMIN, V132, P1668, DOI 10.1016/j.jlumin.2012.02.031
   Zackrisson J, 1998, INT J REFRACT MET H, V16, P417, DOI 10.1016/S0263-4368(98)00048-1
   Zhang S, 2014, J SOLID STATE ELECTR, V18, P2193, DOI 10.1007/s10008-014-2462-7
   Zhao ZW, 2015, INT J REFRACT MET H, V48, P46, DOI 10.1016/j.ijrmhm.2014.07.026
   Zhao ZW, 2013, INT J REFRACT MET H, V41, P558, DOI 10.1016/j.ijrmhm.2013.07.007
   Zhong J, 2014, MICROPOR MESOPOR MAT, V190, P309, DOI 10.1016/j.micromeso.2014.02.029
NR 58
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2468-8231
J9 MOL CATAL
JI Mol. Catal.
PD JUN
PY 2017
VL 434
BP 32
EP 38
DI 10.1016/j.mcat.2017.02.036
PG 7
WC Chemistry, Physical
SC Chemistry
GA EV3RE
UT WOS:000401676000005
OA No
DA 2017-08-17
ER

PT J
AU Ammar, NR
   Seddiek, IS
AF Ammar, Nader R.
   Seddiek, Ibrahim S.
TI Eco-environmental analysis of ship emission control methods: Case study
   RO-RO cargo vessel
SO OCEAN ENGINEERING
LA English
DT Article
DE Selective catalytic reduction; Seawater scrubbing; LNG; RO-RO cargo
   ship; IMO; Emission reduction
ID LIQUEFIED NATURAL-GAS; MARINE APPLICATIONS; PASSENGER SHIPS; SO2
   EMISSIONS; EXHAUST-GAS; FUEL-CELLS; STRATEGIES; ENGINE; COSTS; OCEAN
AB Air pollution from ships mainly comes from using heavy fuel oils for power generation. Although, these fuels are economical, they produce significant amounts of pollutant emissions. Two methods can be considered to cope with the International Maritime Organization's new emission regulations, either by using diesel fuel or marine gas oil with exhaust gas reduction measures, or by using alternative fuels like Liquefied Natural Gas (LNG). The aim of the current research is to compare between these two methods from environmental and economic points of view. As a case study, medium speed RO-RO cargo vessel operating in the Red Sea area has been investigated. Results show specific environmental benefits of selective catalytic reduction method for reducing NOx emissions by 90% with cost effectiveness of 873.5 $/ton and SOx emissions by 98% with 3115 $/ton in case of using seawater scrubbing. On the other hand, LNG appears the optimum proposed solution from environmental and economic points of view. It reduces NOx, SOx and CO2 emissions by about 77.6%, 92.5% and 14.5% with cost effectiveness of 1486 $/ton, 4084 $/ton and 160.8 $/ton, respectively.
C1 [Ammar, Nader R.] Alexandria Univ, Dept Naval Architecture & Marine Engn, Fac Engn, Alexandria 21544, Egypt.
   [Seddiek, Ibrahim S.] Arab Acad Sci Technol & Maritime Transport, Dept Marine Engn Technol, Alexandria 1029, Egypt.
RP Ammar, NR (reprint author), Alexandria Univ, Dept Naval Architecture & Marine Engn, Fac Engn, Alexandria 21544, Egypt.
EM nader@alexu.edu.eg
CR Aksoyoglu S, 2016, ATMOS CHEM PHYS, V16, P1895, DOI 10.5194/acp-16-1895-2016
   Andreasen A, 2007, ENERG FUEL, V21, P3274, DOI 10.1021/ef700359w
   Azzara A., 2014, FEASIBILITY IMO ANNE
   Banawan AA, 2010, P I MECH ENG M-J ENG, V224, P103, DOI 10.1243/14750902JEME181
   Bellaby P, 2016, INT J HYDROGEN ENERG, V41, P6534, DOI 10.1016/j.ijhydene.2016.03.024
   Bengtsson S, 2011, P I MECH ENG M-J ENG, V225, P97, DOI 10.1177/1475090211402136
   Bortnowska M, 2009, POL MARIT RES, V16, P70, DOI 10.2478/v10012-008-0036-2
   Bunkerworld, 2016, FUEL PRIC
   Burel F, 2013, ENERGY, V57, P412, DOI 10.1016/j.energy.2013.05.002
   Burgard DA, 2016, ATMOS ENVIRON, V136, P54, DOI 10.1016/j.atmosenv.2016.04.014
   Capaldo K, 1999, NATURE, V400, P743
   Carr EW, 2015, ENVIRON SCI TECHNOL, V49, P9584, DOI 10.1021/acs.est.5b02151
   Chanchaona S., 1997, P 2 AS REN EN C PHUK
   CHART, 2016, STOR LIQ NATUR GAS
   Chorowski M., 2015, ADV CRYOG ENG IOP C, P101
   Contini D, 2015, ATMOS ENVIRON, V102, P183, DOI 10.1016/j.atmosenv.2014.11.065
   Corbett JJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003751
   Corbett J.J., 2014, NATURAL GAS WATERBOR
   Doudnikoff M, 2014, INT J SHIP TRANS LOG, V6, P213, DOI 10.1504/IJSTL.2014.059571
   EEA, 2000, EPA420R00002 EEA US
   El Gohary MM, 2015, BRODOGRADNJA, V66, P61
   Endresen O, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007630
   Eyring V, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005619
   Farooqui Z.M., 2013, J ENV PROT, V4, P722
   Feng LY, 2016, ENERGIES, V9, DOI 10.3390/en9040304
   Fuglestvedt J, 2009, ENVIRON SCI TECHNOL, V43, P9057, DOI 10.1021/es901944r
   Hunt E., 1995, MARINE ENG EC COST A
   ICF, 2009, TOWB EMISS RED FEAS
   ICF, 2009, CURR METH PREP MOB S
   INTERTANKO, 2007, USE MDO SHIPS PART H
   Lawrence MG, 1999, NATURE, V402, P167, DOI 10.1038/46013
   Leo TJ, 2010, ENERGY, V35, P1164, DOI 10.1016/j.energy.2009.06.010
   Livanos GA, 2014, ENERG CONVERS MANAGE, V79, P640, DOI 10.1016/j.enconman.2013.12.050
   Mansor M.R.A., 2017, FUEL, V190, P281
   Mikelis N., 2008, WMU J MARIT AFFAIRS, V7, P227, DOI 10.1007/BF03195133
   Molland AF, 2014, INT J MARIT ENG, V156, P175, DOI 10.3940/rina.ijme.2014.a2.289
   Mukherjee U, 2015, INT J HYDROGEN ENERG, V40, P9760, DOI 10.1016/j.ijhydene.2015.05.102
   Nikopoulou Z., 2008, 08107 SECA CHALMB U
   Oikawa K, 2003, ENVIRON PROG, V22, P67, DOI 10.1002/ep.670220118
   Oil & gas, 2016, EG EG OIL GAS WEB PO
   Rolls-Royce, 2012, OV METH SLIP ROLLS R
   Sattler G, 2000, J POWER SOURCES, V86, P61, DOI 10.1016/S0378-7753(99)00414-0
   Seddiek IS, 2016, J MAR SCI TECH-JAPAN, V21, P493, DOI 10.1007/s00773-016-0371-4
   Seddiek IS, 2015, BRODOGRADNJA, V66, P23
   Seddiek IS, 2014, INT J NAV ARCH OCEAN, V6, P737, DOI 10.2478/IJNAOE-2013-0209
   Seddiek IS, 2012, INT J NAV ARCH OCEAN, V4, P460, DOI 10.3744/JNAOE.2012.4.4.460
   SEFIC, 2016, IMO7 T 75 TANK CONT
   SENES, 2004, REV METH US CALC MAR
   Song SK, 2014, ENVIRON SCI POLLUT R, V21, P6612, DOI 10.1007/s11356-014-2569-5
   Srivastava RK, 2001, ENVIRON PROG, V20, P219, DOI 10.1002/ep.670200410
   Sulligoi Giorgio, 2016, IEEE Transactions on Transportation Electrification, V2, P507, DOI 10.1109/TTE.2016.2598078
   Thomson H, 2015, ENERG POLICY, V87, P153, DOI 10.1016/j.enpol.2015.08.027
   Ulpre H, 2014, MAR POLLUT BULL, V88, P292, DOI 10.1016/j.marpolbul.2014.08.027
   Wang CF, 2007, TRANSPORT RES D-TR E, V12, P577, DOI 10.1016/j.trd.2007.08.003
   Wartsila, 2016, SCRUBB SYST DES
   Wartsila, 2014, WARTS GAS FIR ENG WA
   Welaya YMA, 2013, INT J NAV ARCH OCEAN, V5, P529, DOI 10.2478/IJNAOE-2013-0151
   Wik C, 2010, J MAR ENG TECHNOL, P37
   Zbaraza D., 2004, THESIS
NR 59
TC 0
Z9 0
U1 8
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0029-8018
J9 OCEAN ENG
JI Ocean Eng.
PD JUN 1
PY 2017
VL 137
BP 166
EP 173
DI 10.1016/j.oceaneng.2017.03.052
PG 8
WC Engineering, Marine; Engineering, Civil; Engineering, Ocean;
   Oceanography
SC Engineering; Oceanography
GA EV3ST
UT WOS:000401680100016
OA No
DA 2017-08-17
ER

PT J
AU Moussa, TAA
   Al-Zahrani, HS
   Kadasa, NMS
   Ahmed, SA
   de Hoog, GS
   Al-Hatmi, AMS
AF Moussa, Tarek A. A.
   Al-Zahrani, Hassan S.
   Kadasa, Naif M. S.
   Ahmed, Sarah A.
   de Hoog, G. Sybren
   Al-Hatmi, Abdullah M. S.
TI Two new species of the Fusarium fujikuroi species complex isolated from
   the natural environment
SO ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR
   MICROBIOLOGY
LA English
DT Article
DE Fusarium; Saprobe; Morphology; Molecular phylogeny
ID PHYLOGENETIC TREES; GENETIC DIVERSITY; MALDI-TOF; IDENTIFICATION; FUNGI;
   EVOLUTION; INFERENCE; SUPPORT; BANANA; MUSAE
AB Two new species in the Fusarium fujikuroi species complex (FFSC) are introduced. One of these, represented by strain CBS 454.97 was isolated from plant debris (Striga hermonthica) in the Sudan, while the second, represented by strains CBS 119850 and CBS 483.94, which originated from soil in Australia. Molecular analyses were performed including TEF1 spanning 576 bp region, 860 bp region of rPB2, and 500 bp BT2 region. Phylogenetic trees based on these regions showed that the two species are clearly distinct from all known taxa in the F. fujikuroi species complex. Based on phenotypic, physiological characters and molecular data, we introduce Fusarium sudanense and Fusarium terricola as novel species in the complex.
C1 [Moussa, Tarek A. A.; Al-Zahrani, Hassan S.; Kadasa, Naif M. S.] King Abdulaziz Univ, Fac Sci, Biol Sci Dept, Jeddah, Saudi Arabia.
   [Moussa, Tarek A. A.; Kadasa, Naif M. S.; de Hoog, G. Sybren] Univ Jeddah, Fac Sci, Biol Sci Dept, Jeddah, Saudi Arabia.
   [Ahmed, Sarah A.; de Hoog, G. Sybren; Al-Hatmi, Abdullah M. S.] Westerdijk Fungal Biodivers Inst, POB 85167, NL-3508 AD Utrecht, Netherlands.
   [Moussa, Tarek A. A.] Cairo Univ, Fac Sci, Bot & Microbiol Dept, Giza, Egypt.
   [Ahmed, Sarah A.] Univ Khartoum, Fac Med Lab Sci, Dept Med Microbiol, Khartoum, Sudan.
   [de Hoog, G. Sybren; Al-Hatmi, Abdullah M. S.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.
   [Al-Hatmi, Abdullah M. S.] Ibri Hosp, Minist Hlth, Directorate Gen Hlth Serv, Ibri, Oman.
RP Al-Hatmi, AMS (reprint author), Westerdijk Fungal Biodivers Inst, POB 85167, NL-3508 AD Utrecht, Netherlands.
EM abdullaalhatmi@gmail.com
OI Al-Hatmi, Abdullah/0000-0002-5206-2647
FU Deanship of Scientific Research (DSR) at King Abdulaziz University,
   Jeddah [30-130-36-RG]; DSR
FX This project was funded by the Deanship of Scientific Research (DSR) at
   King Abdulaziz University, Jeddah, under Grant No. 30-130-36-RG. The
   authors, therefore, acknowledge with thanks DSR for technical and
   financial support.
CR Al-Hatmi AMS, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.126
   Al-Hatmi AMS, 2016, FUNGAL BIOL-UK, V120, P265, DOI 10.1016/j.funbio.2015.08.001
   Al-Hatmi AMS, 2016, FUNGAL BIOL-UK, V120, P231, DOI 10.1016/j.funbio.2015.08.006
   Al-Hatmi AMS, 2015, FUTURE MICROBIOL, V10, P1939, DOI 10.2217/fmb.15.108
   Al-Hatmi AM, 2016, PLOS PATHOG, V1
   Alves-Santos FM, 1999, APPL ENVIRON MICROB, V65, P3335
   DeNijs M, 1997, J FOOD SAFETY, V17, P161
   Edwards J, 2016, MYCOLOGIA, V108, P981, DOI 10.3852/15-333
   FISHER JD, 1982, PSYCHOL BULL, V91, P27, DOI 10.1037//0033-2909.91.1.27
   Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0
   Herron DA, 2015, STUD MYCOL, P131, DOI 10.1016/j.simyco.2014.12.001
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Karim Nurul Farah Abdul, 2016, Trop Life Sci Res, V27, P1
   Larget B, 1999, MOL BIOL EVOL, V16, P750
   Laurence MH, 2016, FUNGAL DIVERS, V77, P349, DOI 10.1007/s13225-015-0337-6
   Leslie JF, 2006, J FOOD SAFETY, V17, P161
   Nirenberg HI, 1976, MITT BIOL BUNDESANST, V169, P1
   Nirenberg HI, 1998, MYCOLOGIA, V90, P434, DOI 10.2307/3761403
   O'Donnell K, 2007, J CLIN MICROBIOL, V45, P2235, DOI 10.1128/JCM.00533-07
   O'Donnell K, 2016, J CLIN MICROBIOL, V54, P2813, DOI 10.1128/JCM.01607-16
   O'Donnell K, 2015, PHYTOPARASITICA, V43, P583, DOI 10.1007/s12600-015-0484-z
   O'Donnell K, 2013, FUNGAL GENET BIOL, V52, P20, DOI 10.1016/j.fgb.2012.12.004
   O'Donnell K, 2009, FUNGAL GENET BIOL, V46, P936, DOI 10.1016/j.fgb.2009.08.006
   O'Donnell Kerry, 2000, Mycoscience, V41, P61, DOI 10.1007/BF02464387
   Ordonez N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005197
   Park B, 2013, THESIS
   Proctor RH, 2013, MOL MICROBIOL, V90, P290, DOI 10.1111/mmi.12362
   Reeb V, 2004, MOL PHYLOGENET EVOL, V32, P1036, DOI 10.1016/j.ympev.2004.04.012
   Rep M, 2005, MOL PLANT MICROBE IN, V18, P15, DOI 10.1094/MPMI-18-0015
   Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053
   Scauflaire J, 2011, MYCOLOGIA, V103, P586, DOI 10.3852/10-135
   Smith S. N., 2007, Plant Pathology Bulletin, V16, P97
   Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Stielow JB, 2015, PERSOONIA, V35, P242, DOI 10.3767/003158515X689135
   Summerell BA, 2010, FUNGAL DIVERS, V44, P3, DOI 10.1007/s13225-010-0060-2
   Taylor JW, 1999, ANNU REV PHYTOPATHOL, V37, P197, DOI 10.1146/annurev.phyto.37.1.197
   Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228
   Triest D, 2015, MYCOLOGIA, V107, P46, DOI 10.3852/14-174
   Van Hove F, 2011, MYCOLOGIA, V103, P570, DOI 10.3852/10-038
   Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015
   Watanabe M, 2013, MYCOTOXINS, V63, P133
NR 42
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0003-6072
EI 1572-9699
J9 ANTON LEEUW INT J G
JI Antonie Van Leeuwenhoek
PD JUN
PY 2017
VL 110
IS 6
BP 819
EP 832
DI 10.1007/s10482-017-0855-1
PG 14
WC Microbiology
SC Microbiology
GA EV0VM
UT WOS:000401464000010
PM 28303400
OA No
DA 2017-08-17
ER

PT J
AU Ibrahim, AS
   Saleh, H
   El-Shafey, M
   Hussein, KA
   El-Masry, K
   Baban, B
   Sheibani, N
   Wang, MH
   Tawfik, A
   Al-Shabrawey, M
AF Ibrahim, Ahmed S.
   Saleh, Heba
   El-Shafey, Mohamed
   Hussein, Khaled A.
   El-Masry, Khaled
   Baban, Babak
   Sheibani, Nader
   Wang, Mong-Heng
   Tawfik, Amany
   Al-Shabrawey, Mohamed
TI Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in
   monocytes/macrophages, attenuates high glucose-induced retinal
   leukostasis
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article
DE Diabetic retinopathy; 12/15-Lipoxygenase; 12-HETE; 15-HETE; Leukostasis;
   ICAM-1; Eicosanoids; Bioactive lipids; Blood retinal barrier;
   Permeability
ID SMOOTH-MUSCLE-CELLS; INTRACELLULAR ADHESION MOLECULE-1; FACTOR-KAPPA-B;
   DIABETIC-RETINOPATHY; ANGIOTENSIN-II; MICROVASCULAR DYSFUNCTION;
   MONOCYTE ADHESION; DEFICIENT MICE; GROWTH-FACTOR; ATHEROSCLEROSIS
AB Aims: Our previous studies have established a role for 12/15-lipoxygenase (LO) in mediating the inflammatory response in diabetic retinopathy (DR). However, the extent at which the local or systemic induction of 12/15-LO activity involved is unclear. Thus, the current study aimed to characterize the relative contribution of retinal endothelial versus monocytic/macrophagic 12/15-LO to inflammatory responses in DR.
   Materials & methods: We first generated a clustered heat map for circulating bioactive lipid metabolites in the plasma of streptozotocin (STZ)-induced diabetic mice using liquid chromatography coupled with mass-spectrometry (LC-MS) to evaluate changes in circulating 12/15-LO activity. This was followed by comparing the in vitro mouse endothelium-leukocytes interaction between leukocytes isolated from 12/15-LO knockout (KO) versus those isolated from wild type (WT) mice using the myeloperoxidase (MPO) assay. Finally, we examined the effects of knocking down or inhibiting endothelial 12/15-LO on diabetes-induced endothelial cell activation and ICAM-1 expression.
   Results: Analysis of plasma bioactive lipids' heat map revealed that the activity of circulating 12/15-LO was not altered by diabetes as evident by no significant changes in the plasma levels of major metabolites derived from 12/15-lipoxygenation of different PUFAs, including linoleic acid (13-HODE), arachidonic acid (12- and 15HETEs), eicosapentaenoic acid (12- and 15- HEPEs), or docosahexaenoic acid (17-HDoHE). Moreover, leukocytes from 12/15-LO KO mice displayed a similar increase in adhesion to high glucose (HG)-activated endothelial cells as do leukocytes from WT mice. Furthermore, abundant proteins of 12-LO and 15-LO were detected in human retinal endothelial cells (HRECs), while it was undetected (15-LO) or hardly detectable (12-LO) in human monocyte-like U937 cells. Inhibition or knock down of endothelial 12/15-LO in HRECs blocked HG-induced expression of ICAM-1, a well-known identified important molecule for leukocyte adhesion in DR.
   Conclusion: Our data support that endothelial, rather than monocytic/macrophagic, 12/15-LO has a critical role in hyperglycemia-induced ICAM-1 expression, leukocyte adhesion, and subsequent local retinal barrier dysfunction. This may facilitate the development of more precisely targeted treatment strategies for DR.
C1 [Ibrahim, Ahmed S.; Saleh, Heba; El-Shafey, Mohamed; Hussein, Khaled A.; El-Masry, Khaled; Baban, Babak; Tawfik, Amany; Al-Shabrawey, Mohamed] Augusta Univ, Dent Coll Georgia, Dept Oral Biol & Anat, Augusta, GA USA.
   [Ibrahim, Ahmed S.; Saleh, Heba; Tawfik, Amany; Al-Shabrawey, Mohamed] Augusta Univ, MCG, Dept Ophthalmol, Augusta, GA USA.
   [Ibrahim, Ahmed S.; Saleh, Heba; Tawfik, Amany; Al-Shabrawey, Mohamed] Augusta Univ, MCG, Culver Vis Discovery Inst, Augusta, GA USA.
   [Ibrahim, Ahmed S.] Mansoura Univ, Dept Biochem & Clin Biochem, Fac Pharm, Mansoura, Egypt.
   [El-Shafey, Mohamed; El-Masry, Khaled; Al-Shabrawey, Mohamed] Mansoura Univ, Dept Anat, Fac Med, Mansoura, Egypt.
   [Hussein, Khaled A.] Natl Res Ctr, Oral & Dent Res Div, Oral Med & Surg Dept, Boulder, CO USA.
   [Baban, Babak] Augusta Univ, Dept Surg, Sect Plast Surg, Augusta, GA USA.
   [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci & Biomed Engn, Madison, WI USA.
   [Wang, Mong-Heng] Augusta Univ, Dept Physiol, MCG, Augusta, GA USA.
   [El-Masry, Khaled; Tawfik, Amany; Al-Shabrawey, Mohamed] Augusta Univ, Cellular Biol & Anat, MCG, Augusta, GA USA.
RP Al-Shabrawey, M (reprint author), Augusta Univ, Vis Discovery Inst, Dent & Med Coll Georgia, Dept Oral Biol, 1120 15th St, Augusta, GA 30912 USA.; Al-Shabrawey, M (reprint author), Augusta Univ, Vis Discovery Inst, Dent & Med Coll Georgia, Dept Cellular Biol, 1120 15th St, Augusta, GA 30912 USA.; Al-Shabrawey, M (reprint author), Augusta Univ, Vis Discovery Inst, Dent & Med Coll Georgia, Dept Anat & Ophthalmol, 1120 15th St, Augusta, GA 30912 USA.
EM malshabrawey@augusta.edu
FU National Eye Institute (NIH) Grant [5R01EY023315-02]; National Center
   for Research Resources Grant [S10RR027926]; Research to Prevent
   Blindness Foundation; Retina Research Foundation [EY016665, EY022883,
   EPA 83573701]
FX This work has been supported by the National Eye Institute (NIH) Grant
   5R01EY023315-02 (MA). This study was also supported in part by National
   Center for Research Resources Grant S10RR027926 for the lipid analysis
   and by James and Jean Culver Vision Discovery Institute (ASI). The work
   in NS laboratory is supported in part by non-restricted funds from
   Research to Prevent Blindness Foundation, Retina Research Foundation,
   EY016665, EY022883, and EPA 83573701. The authors would like to thank
   Dr. Bhagelu Achyut for his assistance with heat map making software.
CR Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x
   Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008
   Antonipillai I, 1996, J CLIN ENDOCR METAB, V81, P1940, DOI 10.1210/jc.81.5.1940
   Bai Ningyan, 2003, Yan Ke Xue Bao, V19, P176
   Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617
   Belkner J, 1998, J BIOL CHEM, V273, P23225, DOI 10.1074/jbc.273.36.23225
   Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6
   Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3
   Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057
   Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001
   Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff
   Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5
   Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217
   Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564
   Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100
   Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200
   Herbertsson H, 1999, ARCH BIOCHEM BIOPHYS, V367, P33, DOI 10.1006/abbi.1999.1233
   Hirano Y, 2010, INVEST OPHTH VIS SCI, V51, P508, DOI 10.1167/iovs.09-3457
   Hirata F, 2006, EXP EYE RES, V82, P179, DOI 10.1016/j.exer.2005.08.022
   Ibrahim AS, 2015, J LIPID RES, V56, P599, DOI 10.1194/jlr.M056069
   Ibrahim AS, 2015, BBA-MOL CELL BIOL L, V1851, P290, DOI 10.1016/j.bbalip.2014.12.017
   Ibrahim AS, 2011, DIABETES, V60, P1122, DOI 10.2337/db10-1160
   Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje
   Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje
   Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1
   KIM JA, 1995, ARTERIOSCL THROM VAS, V15, P942
   KUHN H, 1994, J LIPID RES, V35, P1749
   LOPEZ S, 1993, BIOCHIM BIOPHYS ACTA, V1170, P17, DOI 10.1016/0005-2760(93)90170-E
   Maddipati K. R., 2014, FASEB J
   MCLEOD DS, 1995, AM J PATHOL, V147, P642
   Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836
   Nagai N, 2007, INVEST OPHTH VIS SCI, V48, P4342, DOI 10.1167/iovs.06-1473
   NATARAJAN R, 1993, P NATL ACAD SCI USA, V90, P4947, DOI 10.1073/pnas.90.11.4947
   Natarajan R, 2002, DIABETOLOGIA, V45, P125, DOI 10.1007/s125-002-8253-x
   Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528
   Nonaka A, 2000, INVEST OPHTH VIS SCI, V41, P2702
   Othman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057254
   Patricia MK, 2001, CIRC RES, V88, P659, DOI 10.1161/hh0701.088838
   Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615
   Rangasamy Sampathkumar, 2012, Middle East Afr J Ophthalmol, V19, P52, DOI 10.4103/0974-9233.92116
   SCHRODER S, 1991, AM J PATHOL, V139, P81
   SETTY BNY, 1986, J CLIN INVEST, V77, P202, DOI 10.1172/JCI112277
   Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029
   Su XJ, 2003, MOL VIS, V9, P171
   TAKAHASHI Y, 1993, EUR J BIOCHEM, V218, P165, DOI 10.1111/j.1432-1033.1993.tb18362.x
   Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5
   Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8
   ZETTER BR, 1981, DIABETES, V30, P24
   Zhang L, 2010, LIFE SCI, V87, P223, DOI 10.1016/j.lfs.2010.06.019
   Zhang XL, 2009, CHINESE MED J-PEKING, V122, P338, DOI 10.3760/cma.j.issn.0366-6999.2009.03.019
NR 50
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 0006-3002
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD JUN
PY 2017
VL 1862
IS 6
BP 636
EP 645
DI 10.1016/j.bbalip.2017.03.010
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA EV2ON
UT WOS:000401595100006
PM 28351645
OA No
DA 2017-08-17
ER

PT J
AU Elazab, HA
   Moussa, S
   Siamaki, AR
   Gupton, BF
   El-Shall, MS
AF Elazab, Hany A.
   Moussa, Sherif
   Siamaki, Ali R.
   Gupton, B. Frank
   El-Shall, M. Samy
TI The Effect of Graphene on Catalytic Performance of Palladium
   Nanoparticles Decorated with Fe3O4, Co3O4, and Ni (OH)(2): Potential
   Efficient Catalysts Used for Suzuki Cross-Coupling
SO CATALYSIS LETTERS
LA English
DT Article
DE Graphene; Cross-Coupling; Magnetite (Fe3O4); Pd nanoparticles; Hydrazine
   hydrate; Microwave heating; Catalysis; Catalyst recycling
ID CO OXIDATION; REUSABLE CATALYST; CARBON-MONOXIDE; LASER SYNTHESIS;
   ZINC-OXIDE; CARBONYLATION; NANOMATERIALS; HECK; ALDEHYDES; EXTRACT
AB In this research, we report a scientific investigation of an efficient method used for the synthesis of highly active Palladium Nanoparticles decorated with Fe3O4, Co3O4, and Ni (OH)(2) Supported on Graphene as Potential Efficient Catalysts for Suzuki Cross-Coupling. Pd/Fe3O4 nanoparticles supported on graphene nanosheets (Pd/Fe3O4/G) showed an excellent catalytic activity for Suzuki coupling reactions and recycled for up to four times without loss of catalytic activity. An efficient magnetic catalyst has been successfully synthesized using a simple, reproducible fast and reliable method using microwave irradiation conditions. The prepared catalysts are magnetic as in case of iron and cobalt oxides which is an advantage in the separation process of catalyst from the reaction medium via applying a strong external magnetic field. The synthesis approach is based on the Microwave (MW)-assisted simultaneous reduction of palladium and ferric nitrates in the presence of graphene oxide (GO) nanosheets using hydrazine hydrate as the reducing agent. The results provide a fundamental understanding of the system variables by comparing the catalytic activity and recyclability of different catalysts with different properties. The most active and recyclable catalyst was Pd-Fe3O4-supported on graphene which offers several added advantages including recyclability of up to seven times, mild reaction conditions, and short reaction times in an environmentally benign solvent system. Furthermore, the magnetic properties imparted by the Fe3O4 component of the catalyst enables the catalyst to be easily isolated and recycled, thus greatly simplifying the ability to purify the reaction products and increasing the economic value of the catalyst. The utility of these magnetic catalysts towards Suzuki cross coupling reaction was also demonstrated. The high activity and recyclability of these catalysts are attributed to a strong catalyst-support interaction where the defect sites in the reduced GO nanosheets act as nucleation centers for anchoring the Pd and Fe3O4 nanoparticles thus minimizing the potential of their agglomeration and the subsequent decrease in the catalytic activity.
C1 [Elazab, Hany A.] British Univ Egypt, Chem Engn Dept, Cairo, Egypt.
   [Moussa, Sherif; El-Shall, M. Samy] Virginia Commonwealth Univ, Dept Chem, Box 2006, Richmond, VA 23284 USA.
   [Elazab, Hany A.; Siamaki, Ali R.; Gupton, B. Frank; El-Shall, M. Samy] Virginia Commonwealth Univ, Dept Chem Engn, Richmond, VA 23284 USA.
RP Elazab, HA (reprint author), British Univ Egypt, Chem Engn Dept, Cairo, Egypt.; Elazab, HA (reprint author), Virginia Commonwealth Univ, Dept Chem Engn, Richmond, VA 23284 USA.
EM Hany.Elazab@bue.edu
FU Virginia Commonwealth University (VCU); National Science Foundation
   (NSF) [OISE-1002970]; British University in Egypt (BUE) through Young
   Investigator Research Award (YIRG)
FX We express our deep gratitude to Virginia Commonwealth University (VCU)
   and to the National Science Foundation (NSF)-(OISE-1002970) for the
   support of this work. We also thank the British University in Egypt
   (BUE) for supporting this work through Young Investigator Research Award
   (YIRG).
CR Atarod M, 2016, J COLLOID INTERF SCI, V465, P249, DOI 10.1016/j.jcis.2015.11.060
   Beckert M, 2015, GREEN CHEM, V17, P1032, DOI 10.1039/c4gc01676a
   Bondioli F, 2008, J AM CERAM SOC, V91, P3746, DOI 10.1111/j.1551-2916.2008.02666.x
   Ceylan S, 2011, CHEM-EUR J, V17, P1884, DOI 10.1002/chem.201002291
   Chen ST, 2012, J PHYS CHEM C, V116, P12969, DOI 10.1021/jp3036204
   El-Shall MS, 2009, J MATER CHEM, V19, P7625, DOI 10.1039/b912012b
   Elazab HA, 2015, APPL CATAL A-GEN, V491, P58, DOI 10.1016/j.apcata.2014.11.033
   Elazab HA, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2477-0
   El-Shall MS, 2009, ABSTRACTS PAPERS AM, V238
   Fouad OA, 2012, NANO, V7, DOI 10.1142/S1793292012500348
   Fukui K, 2012, CHEM ENG J, V211, P1, DOI 10.1016/j.cej.2012.09.032
   Gaikwad AV, 2007, CHEM-EUR J, V13, P6908, DOI 10.1002/chem.200700105
   Glasnov TN, 2009, CHEM-EUR J, V15, P1001, DOI 10.1002/chem.200802200
   Glaspell G, 2008, TOP CATAL, V47, P22, DOI 10.1007/s11244-007-9036-1
   Gniewek A, 2008, J CATAL, V254, P121, DOI 10.1016/j.jcat.2007.12.004
   Gupta A, 2011, J NANOSCI NANOTECHNO, V11, P5028, DOI 10.1166/jnn.2011.4184
   He LH, 2010, J NANOSCI NANOTECHNO, V10, P6348, DOI 10.1166/jnn.2010.2549
   Iglesias-Juez A, 2011, J AM CHEM SOC, V133, P4484, DOI 10.1021/ja110320y
   Ivanova AS, 2010, APPL CATAL B-ENVIRON, V97, P57, DOI 10.1016/j.apcatb.2010.03.024
   Ji Y, 2009, J MOL CATAL A-CHEM, V314, P63, DOI 10.1016/j.molcata.2009.08.018
   Kajitani M, 2006, TETRAHEDRON, V62, P6355, DOI 10.1016/j.tet.2006.04.039
   Kim HY, 2012, J PHYS CHEM LETT, V3, P2194, DOI 10.1021/jz300631f
   Kirschning A, 2012, CHEM LETT, V41, P562, DOI 10.1246/cl.2012.562
   Kumar S, 2015, BIOSENS BIOELECTRON, V70, P498, DOI 10.1016/j.bios.2015.03.062
   Liu B, 2011, J PHYS CHEM C, V115, P15875, DOI 10.1021/jp204976y
   Liu JM, 2009, ORG LETT, V11, P1321, DOI 10.1021/ol9001027
   Malewicz M, 2009, INT SPR SEM ELECT TE, P47
   Moussa S, 2012, ACS CATAL, V2, P145, DOI 10.1021/cs200497e
   Moussa S, 2011, CHEM PHYS LETT, V510, P179, DOI 10.1016/j.cplett.2011.05.026
   Nasrollahzadeh M, 2017, J COLLOID INTERF SCI, V486, P153, DOI 10.1016/j.jcis.2016.09.053
   Nasrollahzadeh M, 2016, J COLLOID INTERF SCI, V464, P147, DOI 10.1016/j.jcis.2015.11.020
   Nasrollahzadeh M, 2014, RSC ADV, V4, P19731, DOI 10.1039/c3ra48003h
   Nasrollahzadeh M, 2014, TETRAHEDRON LETT, V55, P2813, DOI 10.1016/j.tetlet.2014.03.066
   Neri G, 2015, CHEM COMMUN, V51, P4846, DOI 10.1039/c5cc00518c
   Neumann H, 2006, ADV SYNTH CATAL, V348, P1255, DOI 10.1002/adsc.200606044
   Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4442, DOI 10.1002/anie.200500368
   Nishioka M, 2011, NANOSCALE, V3, P2621, DOI 10.1039/c1nr10199d
   Pourmortazavi SM, 2012, APPL SURF SCI, V263, P745, DOI 10.1016/j.apsusc.2012.09.153
   Schatz A, 2010, ADV FUNCT MATER, V20, P4323, DOI 10.1002/adfm.201000959
   Senapati KK, J MOL CATAL, V339, P24
   Shviro M, 2013, RSC ADV, V3, P1380, DOI 10.1039/c2ra22024e
   Sreedhar B, SYNLETT, V8, P1081
   Tsvelikhovsky D, 2009, EUR J ORG CHEM, P98, DOI 10.1002/ejoc.200800852
   Veige AS, 2008, POLYHEDRON, V27, P3177, DOI 10.1016/j.poly.2008.07.019
   Xie XW, 2009, NANOSCALE, V1, P50, DOI 10.1039/b9nr00155g
   Xu MH, 2009, CHINESE PHYS LETT, V26, DOI 10.1088/0256-307X/26/11/116103
   Yan JM, 2009, J POWER SOURCES, V194, P478, DOI 10.1016/j.jpowsour.2009.04.023
   Yang DP, 2009, CURR NANOSCI, V5, P485
   Zedan AF, 2010, J PHYS CHEM C, V114, P19920, DOI 10.1021/jp107297x
NR 49
TC 0
Z9 0
U1 10
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1011-372X
EI 1572-879X
J9 CATAL LETT
JI Catal. Lett.
PD JUN
PY 2017
VL 147
IS 6
BP 1510
EP 1522
DI 10.1007/s10562-017-1990-z
PG 13
WC Chemistry, Physical
SC Chemistry
GA EV0WG
UT WOS:000401466600025
OA No
DA 2017-08-17
ER

PT J
AU Bakr, SA
   Pardo, D
AF Bakr, Shaaban A.
   Pardo, David
TI A multi-domain decomposition-based Fourier finite element method for the
   simulation of 3D marine CSEM measurements
SO COMPUTATIONAL GEOSCIENCES
LA English
DT Article
DE Multi-domain decomposition; Finite element method; Secondary field
   formulation; Fourier series; Marine CSEM
ID BOREHOLE RESISTIVITY MEASUREMENTS; FREQUENCY-DOMAIN; ELECTROMAGNETIC
   INDUCTION; NONORTHOGONAL SYSTEM; SERIES EXPANSION; IDENTIFICATION;
   TRANSFORMS; INVERSION; SOLVERS; FIELDS
AB We introduce a multi-domain decomposition Fourier finite element (MDDFFE) method for the simulation of three-dimensional (3D) marine controlled source electromagnetic measurement (CSEM). The method combines a 2D finite element (FE) method in two spatial dimensions with a hybrid discretization based on a Fourier FE method along the third dimension. The method employs a secondary field formulation rather than the total field formulation. We apply the MDDFFE method to several synthetic marine CSEM examples exhibiting bathymetry and/or multiple 3D subdomains. Numerical results show that the use of the MDDFFE method reduces the problem size by as much as 87 % in terms of the number of unknowns, without any sacrifice in accuracy.
C1 [Bakr, Shaaban A.; Pardo, David] Basque Ctr Appl Math, Mazarredo 14, E-48009 Bilbao, Spain.
   [Bakr, Shaaban A.] Assiut Univ, Dept Math, Assiut 71516, Egypt.
   [Pardo, David] Univ Basque Country, UPV EHU, Bilbao, Spain.
   [Pardo, David] Ikerbasque, Bilbao, Spain.
RP Bakr, SA (reprint author), Basque Ctr Appl Math, Mazarredo 14, E-48009 Bilbao, Spain.; Bakr, SA (reprint author), Assiut Univ, Dept Math, Assiut 71516, Egypt.
EM shaaban.bakr1@gmail.com; dzubiaur@gmail.com
OI bakr, shaaban/0000-0002-9931-9067
FU Basque Government through the BERC program; Spanish Ministry of Economy
   and Competitiveness BCAM Severo Ochoa excellence accreditation
   [SEV-2013-0323]; RISE Horizon European Project GEAGAM [644602]; Spanish
   Ministry of Economy and Competitiveness [MTM2013-40824-P]; Consolidated
   Research Group Grant on "Mathematical Modeling, Simulation, and
   Industrial Applications (M2SI)" [IT649-13]
FX This research is supported by the Basque Government through the BERC
   2014-2017 program and by the Spanish Ministry of Economy and
   Competitiveness BCAM Severo Ochoa excellence accreditation
   SEV-2013-0323. David Pardo was partially funded by the RISE Horizon 2020
   European Project GEAGAM (644602), the Project of the Spanish Ministry of
   Economy and Competitiveness with reference MTM2013-40824-P, and the
   Consolidated Research Group Grant IT649-13 on "Mathematical Modeling,
   Simulation, and Industrial Applications (M2SI)".
CR ANDERSON WL, 1989, GEOPHYSICS, V54, P263, DOI 10.1190/1.1442650
   Ansari S, 2014, GEOPHYSICS, V79, pE149, DOI 10.1190/GEO2013-0172.1
   Bakr S. A., 2012, 2 5D FINITE ELEMENT, V1
   Bakr SA, 2013, J COMPUT PHYS, V255, P456, DOI 10.1016/j.jcp.2013.08.041
   Bakr SA, 2009, GEOPHYSICS, V74, pF107, DOI 10.1190/1.3192910
   BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159
   Berre I, 2011, J COMPUT PHYS, V230, P3915, DOI 10.1016/j.jcp.2011.02.015
   Cai HZ, 2014, COMPUT GEOSCI-UK, V73, P164, DOI 10.1016/j.cageo.2014.09.008
   CHAVE AD, 1983, GEOPHYSICS, V48, P1671, DOI 10.1190/1.1441448
   Chave AD, 2009, GEOPHYS J INT, V179, P1429, DOI [10.1111/J.1365-246X.2009.04367.x, 10.1111/j.1365-246X.2009.04367.x]
   Constable S, 2007, GEOPHYSICS, V72, pWA3, DOI 10.1190/1.2432483
   Constable S, 2010, GEOPHYSICS, V75, pA67, DOI 10.1190/1.3483451
   da Silva NV, 2012, GEOPHYSICS, V77, pE101, DOI [10.1190/geo2010-0398.1, 10.1190/GEO2010-0398.1]
   Eidesmo T., 2002, 1 BREAK, V20, P144, DOI DOI 10.1046/J.1365-2397
   Grayver AV, 2015, GEOPHYSICS, V80, pE277, DOI 10.1190/GEO2015-0013.1
   Grayver AV, 2014, GEOPHYS J INT, V198, P110, DOI 10.1093/gji/ggu119
   Grayver AV, 2014, GEOPHYSICS, V79, pE101, DOI 10.1190/GEO2013-0184.1
   Guptasarma D, 1997, GEOPHYS PROSPECT, V45, P745, DOI 10.1046/j.1365-2478.1997.500292.x
   Hursan G, 2002, RADIO SCI, V37, DOI 10.1029/2001RS002513
   Koldan J, 2014, GEOPHYS J INT, V197, P1442, DOI 10.1093/gji/ggu086
   Loseth LO, 2007, GEOPHYS J INT, V170, P44, DOI 10.1111/j.1365-246X.2007.03390.x
   NEWMAN GA, 1995, GEOPHYS PROSPECT, V43, P1021, DOI 10.1111/j.1365-2478.1995.tb00294.x
   Newman GA, 2014, SURV GEOPHYS, V35, P85, DOI 10.1007/s10712-013-9260-0
   Pardo D, 2008, COMPUT METHOD APPL M, V197, P3836, DOI 10.1016/j.cma.2008.03.007
   Pardo D, 2008, COMPUT METHOD APPL M, V197, P1906, DOI 10.1016/j.cma.2007.12.003
   Pardo D, 2011, COMPUTAT GEOSCI, V15, P53, DOI 10.1007/s10596-010-9195-1
   Puzyrev V, 2016, COMPUT GEOSCI-UK, V89, P79, DOI 10.1016/j.cageo.2016.01.009
   Puzyrev V, 2013, GEOPHYS J INT, V193, P678, DOI 10.1093/gji/ggt027
   Ren ZY, 2014, GEOPHYSICS, V79, pE255, DOI 10.1190/GEO2013-0376.1
   Ren ZY, 2013, GEOPHYS J INT, V194, P700, DOI 10.1093/gji/ggt154
   Schwarzbach C, 2011, GEOPHYS J INT, V187, P63, DOI 10.1111/j.1365-246X.2011.05127.x
   Shewchuk J. R., 1996, LECT NOTES COMPUTER, V1148, P203, DOI DOI 10.1007/BFB0014497
   Tveit S, 2015, GEOPHYS J INT, V201, P1849, DOI 10.1093/gji/ggv114
   Tveit S, 2015, J COMPUT PHYS, V284, P505, DOI 10.1016/j.jcp.2014.12.041
   Um ES, 2010, GEOPHYSICS, V75, pF115, DOI 10.1190/1.3473694
   Ward S. H., 1988, ELECTROMAGNETICS MET, V1
   Weiss CJ, 2013, COMPUT GEOSCI-UK, V58, P40, DOI 10.1016/j.cageo.2013.05.002
NR 37
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1420-0597
EI 1573-1499
J9 COMPUTAT GEOSCI
JI Comput. Geosci.
PD JUN
PY 2017
VL 21
IS 3
BP 345
EP 357
DI 10.1007/s10596-017-9615-6
PG 13
WC Computer Science, Interdisciplinary Applications; Geosciences,
   Multidisciplinary
SC Computer Science; Geology
GA EV0RX
UT WOS:000401453500002
OA No
DA 2017-08-17
ER

PT J
AU Bos, AR
   Sanad, AM
   Elsayed, K
AF Bos, Arthur R.
   Sanad, Ashraf M.
   Elsayed, Khamis
TI Gymnothorax spp. (Muraenidae) as natural predators of the lionfish
   Pterois miles in its native biogeographical range
SO ENVIRONMENTAL BIOLOGY OF FISHES
LA English
DT Article
DE Moray eel; Predation; Pterois; Red Sea; Scorpaenidae
ID MORAY EELS; RED-SEA; WESTERN ATLANTIC; SCORPAENIDAE; INVASION; VOLITANS;
   PACIFIC; DENSITY; REEF
AB Lionfish (Pterois miles) were observed avoiding coral pinnacles inhabited by the moray eels Gymnothorax flavimarginatus and G. javanicus in the northern Red Sea, Egypt. Release of lionfish (Standard Length 93-104 mm) in such coral pinnacles in November 2016 resulted in almost immediate predation by large moray eels (Total Length > 1 m). Predation by moray eels may be the key control mechanism of population growth in the native biogeographical range of Pterois spp. and may indirectly explain the success of the invasive populations. This is the first video-documented record of moray eels feeding on the lionfish P. miles.
C1 [Bos, Arthur R.] Amer Univ Cairo, Dept Biol, POB 74, New Cairo 11835, Egypt.
   [Bos, Arthur R.] Nat Biodivers Ctr, POB 9517, NL-2300 RA Leiden, Netherlands.
   [Sanad, Ashraf M.; Elsayed, Khamis] Dive Pro Acad, POB 94, Sahl Hasheesh, Hurghada, Egypt.
RP Bos, AR (reprint author), Amer Univ Cairo, Dept Biol, POB 74, New Cairo 11835, Egypt.
EM arbos@aucegypt.edu
OI Bos, Arthur/0000-0002-0708-314X
CR Abrams R.W., 1983, Coral Reefs, V1, P185, DOI 10.1007/BF00571196
   ABRAMS RW, 1986, CORAL REEFS, V5, P161, DOI 10.1007/BF00298183
   BERNADSKY G, 1991, COPEIA, P230
   Bruno JF, 2013, PEERJ PREPRINTS
   Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4
   Cote IM, 2013, BIOL CONSERV, V164, P50, DOI 10.1016/j.biocon.2013.04.014
   Cure K, 2012, MAR ECOL PROG SER, V467, P181, DOI 10.3354/meps09942
   Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965
   Donaldson TJ, 2010, P 63 GULF CAR FISH I, V2011, P352
   Fishelson L, 1997, ENVIRON BIOL FISH, V50, P391, DOI 10.1023/A:1007331304122
   Froese R, 2015, FISHBASE
   Gilbert M, 2005, ENVIRON BIOL FISH, V73, P415, DOI 10.1007/s10641-005-2228-2
   Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596
   Hackerott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068259
   Hoeksema BW, 2007, BIOGEOGRAPHY TIME PL, P117, DOI DOI 10.1007/978-1-4020-6374-9_5
   Johnston MW, 2011, MAR POLLUT BULL, V62, P1218, DOI 10.1016/j.marpolbul.2011.03.028
   Jud ZR, 2011, AQUAT BIOL, V13, P21, DOI 10.3354/ab00351
   Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442
   Luiz OJ, 2013, MAR ECOL PROG SER, V485, P1, DOI 10.3354/meps10383
   Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9
   Mctee SA, 2014, MAR ECOL PROG SER, V508, P223, DOI 10.3354/meps10847
   Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8
   Mumby PJ, 2013, PEERJ PREPRINTS, pe45v1
   Naumann MS, 2013, CORAL REEFS, V32, P1111, DOI 10.1007/s00338-013-1079-0
   RANDALL JE, 1995, B MAR SCI, V56, P849
   Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721
   Young RF, 2003, COPEIA, P44
NR 27
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0378-1909
EI 1573-5133
J9 ENVIRON BIOL FISH
JI Environ. Biol. Fishes
PD JUN
PY 2017
VL 100
IS 6
BP 745
EP 748
DI 10.1007/s10641-017-0600-7
PG 4
WC Ecology; Marine & Freshwater Biology
SC Environmental Sciences & Ecology; Marine & Freshwater Biology
GA EV0SK
UT WOS:000401455000010
OA No
DA 2017-08-17
ER

PT J
AU Khalele, BA
AF Khalele, Bacem A.
TI Systematic review of mammary analog secretory carcinoma of salivary
   glands at 7 years after description
SO HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND
   NECK
LA English
DT Review
DE mammary analog; secretory carcinoma; salivary gland cancers; systematic
   review
ID ETV6 GENE REARRANGEMENT; ACINIC CELL-CARCINOMA; PAROTID-GLAND;
   CYTOPATHOLOGIC FEATURES; CYTOLOGICAL FEATURES; DIAGNOSIS; ETV6-NTRK3;
   MASC; IMMUNOHISTOCHEMISTRY; ENTITY
AB Background. Mammary analog secretory carcinoma of the salivary glands (MASC(SG)) is a newly introduced malignant tumor of the salivary glands. For decades, it has been confused with acinic cell carcinoma (ACC) of the salivary glands.
   Methods. All reported cases of MASC(SG) were surveyed from 2010 until January 2017. The collected data was compiled and computationally processed to describe the clinical parameters of MASC(SG). Its epidemiology was also mapped. Moreover, inaccurate data was highlighted.
   Results. Clinically implicating, this article tackles simply the several clinical findings of MASC(SG) so that our contemporary nosology, at 7 years after description, can be updated. The cytogenetic, histologic, and immunohistochemical details are also defined.
   Conclusion. The available data about MASC(SG) is sufficient enough to diagnose it with no need to investigate the ETV6-NTRK3 translocation. Although high-grade malignancy and distant metastases were rarely reported, a rapt attention should be paid both to the nature of this tumor and to the indicated close follow-up of such cases, especially when necrosis, increased mitotic activity, and other classic caveats are conspicuous. (C) 2017 Wiley Periodicals, Inc.
C1 [Khalele, Bacem A.] Minist Hlth Cairo, Cairo, Egypt.
RP Khalele, BA (reprint author), Minist Hlth Cairo, Cairo, Egypt.
EM bacemottoman@gmail.com
CR Abe M, 2015, INT J SURG CASE REP, V9, P8, DOI 10.1016/j.ijscr.2015.02.011
   Aizawa T, 2016, J ORAL MAXILLOFAC SU, V28, P277, DOI 10.1016/j.ajoms.2015.12.009
   Algudkar A, 2012, EUR J SURG ONCOL, V38, P1118
   Bajaj Jaya, 2014, Acta Cytol, V58, P501, DOI 10.1159/000368070
   Balanza R, 2015, INT J SURG CASE REP, V16, P187, DOI 10.1016/j.ijscr.2015.09.031
   Bishop JA, 2013, HUM PATHOL, V44, P1982, DOI 10.1016/j.humpath.2013.03.017
   Bishop JA, 2013, AM J SURG PATHOL, V37, P1053, DOI 10.1097/PAS.0b013e3182841554
   Bishop JA, 2013, CANCER CYTOPATHOL, V121, P228, DOI 10.1002/cncy.21245
   Chiosea SI, 2012, HISTOPATHOLOGY, V61, P387, DOI 10.1111/j.1365-2559.2012.04232.x
   Connor A, 2012, AM J SURG PATHOL, V36, P27, DOI 10.1097/PAS.0b013e318231542a
   Cooper D, 2013, INT J OTOLARYNGOL HE, V2, P174
   Diallo R, 2003, HUM PATHOL, V34, P1299, DOI 10.1016/S0146-8177(03)00423-4
   Din NU, 2016, ANN DIAGN PATHOL, V22, P49, DOI 10.1016/j.anndiagpath.2016.04.003
   Drilon A, 2016, ANN ONCOL, V27, P920, DOI 10.1093/annonc/mdw042
   Fakhoury E, 2016, J CURR SURG, V6, P30
   Fehr A, 2011, AM J SURG PATHOL, V35, P1600, DOI 10.1097/PAS.0b013e31822832c7
   Griffith C, 2011, VIRCHOWS ARCH, V459, P117, DOI 10.1007/s00428-011-1098-6
   Griffith CC, 2013, CANCER CYTOPATHOL, V121, P234, DOI 10.1002/cncy.21249
   Guerin M, 2014, ANN PATHOL, V34, P384, DOI 10.1016/j.annpat.2014.08.004
   Guilmette J, 2016, IS MAMMARY ANALOGUE, V96, p514A
   Helkamaa T, 2015, J ORAL MAXILLOFAC SU, V27, P698, DOI 10.1016/j.ajoms.2015.02.005
   Hernandez-Prera JC, 2016, MACROCYSTIC MAMMARY, V96, p322A
   Higuchi K, 2014, DIAGN CYTOPATHOL, V42, P846, DOI 10.1002/dc.23139
   Hijazi N, 2014, HUM PATHOL CASE REP, V1, P58
   Chi HT, 2012, BIOCHEM BIOPH RES CO, V429, P87, DOI 10.1016/j.bbrc.2012.10.087
   Hsieh MS, 2016, HISTOPATHOLOGY, V68, P641, DOI 10.1111/his.12792
   Hwang MJ, 2014, MED MOL MORPHOL, V47, P57, DOI 10.1007/s00795-013-0051-y
   Inaba T, 2015, CASE REP PATHOL, V2015
   Ishii K, 2015, INT J ORAL MAXILLOF, V44, pe229
   Ito Y, 2015, AM J SURG PATHOL, V39, P602, DOI 10.1097/PAS.0000000000000392
   Joshi P, 2015, INDIAN J PATHOL MICR, V58, P351, DOI 10.4103/0377-4929.162897
   Jung MJ, 2015, DIAGN CYTOPATHOL, V43, P287, DOI 10.1002/dc.23208
   Jung MJ, 2013, KOREAN J PATHOL, V47, P36, DOI 10.4132/KoreanJPathol.2013.47.1.36
   Kawahara A, 2015, CANCER CYTOPATHOL, V123, P603, DOI 10.1002/cncy.21594
   Keisling M, 2014, INT J PEDIATR OTORHI, V9, P163, DOI DOI 10.1016/J.PEDEX.2014.09.003
   Khalele BAEO, 2016, ANN DIAGN PATHOL, V24, P19, DOI 10.1016/j.anndiagpath.2016.07.005
   Khurram SA, 2015, ORAL SURG ORAL MED O, V119, pe107
   Khurram SA, 2016, OR SURG OR MED OR PA, V122, P731, DOI 10.1016/j.oooo.2016.07.008
   Kim HT, 2015, KOREAN J OTORHINOLAR, V58, P563
   Kratochvil FJ, 2012, OR SURG OR MED OR PA, V114, P630, DOI 10.1016/j.oooo.2012.07.480
   Laco J, 2013, PATHOL RES PRACT, V209, P167, DOI 10.1016/j.prp.2012.12.005
   Lei Yu, 2012, Head Neck Pathol, V6, P166, DOI 10.1007/s12105-011-0312-9
   Levine P, 2014, DIAGN CYTOPATHOL, V42, P49, DOI 10.1002/dc.22886
   Luk PP, 2015, PATHOLOGY, V47, P659, DOI 10.1097/PAT.0000000000000322
   Luo WY, 2014, INT J CLIN EXP PATHO, V7, P9008
   Majewska H, 2015, VIRCHOWS ARCH, V466, P245, DOI 10.1007/s00428-014-1701-8
   Mariano FV, 2013, HISTOPATHOLOGY, V63, P558, DOI 10.1111/his.12192
   Overton L, 2013, ORAL ONCOL, V49, pS99, DOI 10.1016/j.oraloncology.2013.03.260
   Oza N, 2016, DIAGN CYTOPATHOL, V44, P519, DOI 10.1002/dc.23459
   Petersson F, 2016, APPL IMMUNOHISTO M M, V24, pE80
   Pinto A, 2014, MODERN PATHOL, V27, P918
   Pisharodi L, 2013, DIAGN CYTOPATHOL, V41, P239, DOI 10.1002/dc.21766
   Projetti F, 2015, J ORAL PATHOL MED, V44, P244, DOI 10.1111/jop.12226
   Quattlebaum SC, 2015, AM J OTOLARYNG, V36, P741, DOI 10.1016/j.amjoto.2015.05.005
   Rastatter JC, 2012, OTOLARYNG HEAD NECK, V146, P514, DOI 10.1177/0194599811419044
   Salat H, 2015, CASE REP OTOLARYNGOL, V2015
   Samulski TD, 2014, CYTOJOURNAL, V11, DOI 10.4103/1742-6413.139726
   Serrano-Arevalo ML, 2015, MED ORAL PATOL ORAL, V20, pE23, DOI 10.4317/medoral.19874
   Sethi R, 2014, LARYNGOSCOPE, V124, P188, DOI 10.1002/lary.24254
   Shah Akeesha A, 2015, Head Neck Pathol, V9, P85, DOI 10.1007/s12105-014-0557-1
   Skalova A, 2013, HEAD NECK PATHOL S1, V7, P30, DOI DOI 10.1007/S12105-013-0455-Y
   Skalova A, 2016, AM J SURG PATHOL, V40, P3, DOI 10.1097/PAS.0000000000000537
   Skalova A, 2014, AM J SURG PATHOL, V38, P23, DOI 10.1097/PAS.0000000000000088
   Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc
   Stevens TM, 2015, MODERN PATHOL, V28, P1084, DOI 10.1038/modpathol.2015.64
   Takeda M, 2015, DIAGN CYTOPATHOL, V43, P131, DOI 10.1002/dc.23146
   Williams Lindsay, 2013, Head Neck Pathol, V7, P316, DOI 10.1007/s12105-013-0443-2
   Wollenberg J, 2013, ORAL SURG ORAL MED O, V116, pe497
   Woo Jennifer, 2014, Head Neck Pathol, V8, P194, DOI 10.1007/s12105-013-0481-9
   Zardawi IM, 2014, PATHOLOGY, V46, P667, DOI 10.1097/PAT.0000000000000179
NR 70
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1043-3074
EI 1097-0347
J9 HEAD NECK-J SCI SPEC
JI Head Neck-J. Sci. Spec. Head Neck
PD JUN
PY 2017
VL 39
IS 6
BP 1243
EP 1248
DI 10.1002/hed.24755
PG 6
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA EU8EC
UT WOS:000401269000025
PM 28370824
OA No
DA 2017-08-17
ER

PT J
AU Kanai, Y
   Almokhtar, M
   Ono, T
   Ohno, Y
   Maehashi, K
   Inoue, K
   Matsumoto, K
AF Kanai, Yasushi
   Almokhtar, Mohamed
   Ono, Takao
   Ohno, Yasuhide
   Maehashi, Kenzo
   Inoue, Kouichi
   Matsumoto, Kazuhiko
TI !Zero-bias conductance anomaly in graphene dots
SO JAPANESE JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID SINGLE-ELECTRON SPIN; QUANTUM DOTS; CARBON NANOTUBES; ROOM-TEMPERATURE;
   QUBIT; TRANSPORT; FIELD
AB We report the Kondo effect in graphene quantum dots. We fabricated graphene quantum dots using CVD graphene. We measured the graphene quantum dots at 20mK in a dilution refrigerator. We detected a zero-bias conductance peak in the Coulomb blockade regime. The zero-bias conductance peak was suppressed under magnetic fields, which indicates the Kondo effect. We evaluated the Kondo temperatures of 4.8K from the zero-bias peak and 3.2K from the tunnel coupling and the charging energy. (C) 2017 The Japan Society of Applied Physics
C1 [Kanai, Yasushi; Ono, Takao; Ohno, Yasuhide; Maehashi, Kenzo; Inoue, Kouichi; Matsumoto, Kazuhiko] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.
   [Almokhtar, Mohamed] Assiut Univ, Phys Dept, Assiut 71516, Egypt.
   [Ohno, Yasuhide] Tokushima Univ, Tokushima 7708501, Japan.
   [Maehashi, Kenzo] Tokyo Univ Agr & Technol, Koganei, Tokyo 1848588, Japan.
RP Kanai, Y (reprint author), Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan.
EM kanai@sanken.osaka-u.ac.jp
RI Maehashi, Kenzo/A-7426-2015
OI Maehashi, Kenzo/0000-0002-9925-8874
FU CREST, Japan Science and Technology (JST) [JPMJCR15F4]; Innovative Areas
   "Molecular Architectonics: Orchestration of Single Molecules for Novel
   Functions" through the Ministry of Education, Culture, Sports, Science
   and Technology of Japan (MEXT) [25110007]; Management Expenses Grant for
   National University Corporations from MEXT; Japan Society for the
   Promotion of Science (JSPS) [15K17679, 15H03551, 15H03986]; Tateishi
   Science and Technology Foundation; Murata Science Foundation; Amada
   Foundation
FX The authors wish to acknowledge the financial support from CREST (No.
   JPMJCR15F4), Japan Science and Technology (JST), from Innovative Areas
   "Molecular Architectonics: Orchestration of Single Molecules for Novel
   Functions" (No. 25110007) through the Ministry of Education, Culture,
   Sports, Science and Technology of Japan (MEXT), from a Management
   Expenses Grant for National University Corporations from MEXT, and from
   Grant-in-Aid for Young Scientists B (No. 15K17679) and for Scientific
   Research B (Nos. 15H03551 and 15H03986) from the Japan Society for the
   Promotion of Science (JSPS), and research grants from Tateishi Science
   and Technology Foundation, Murata Science Foundation and The Amada
   Foundation.
CR Bardarson JH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.226803
   Bischoff D, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/8/083029
   Borzenets IV, 2016, SCI REP-UK, V6, DOI 10.1038/srep23051
   Connolly MR, 2013, NAT NANOTECHNOL, V8, P417, DOI [10.1038/nnano.2013.73, 10.1038/NNANO.2013.73]
   Cronenwett SM, 1998, SCIENCE, V281, P540, DOI 10.1126/science.281.5376.540
   Dlubak B, 2012, NAT PHYS, V8, P557, DOI [10.1038/nphys2331, 10.1038/NPHYS2331]
   Drogeler M, 2014, NANO LETT, V14, P6050, DOI [10.1021/nl501278c, 10.1021/n1501278c]
   Guttinger J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.116801
   Guttinger J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.046810
   Han W, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.167202
   Hofmann A, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.206803
   Jarillo-Herrero P, 2005, NATURE, V434, P484, DOI 10.1038/nature03422
   Kanai Y., 2016, COMPOUND SEMICONDUCT
   Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719
   Kretinin AV, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245316
   Laird EA, 2013, NAT NANOTECHNOL, V8, P565, DOI [10.1038/nnano.2013.140, 10.1038/NNANO.2013.140]
   Medford J, 2013, NAT NANOTECHNOL, V8, P654, DOI [10.1038/nnano.2013.168, 10.1038/NNANO.2013.168]
   Nadj-Perge S, 2010, NATURE, V468, P1084, DOI 10.1038/nature09682
   Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092
   Paaske J, 2006, NAT PHYS, V2, P460, DOI 10.1038/nphys340
   Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955
   Pioro-Ladriere M, 2008, NAT PHYS, V4, P776, DOI 10.1038/nphys1053
   Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663
   Sasaki S, 2000, NATURE, V405, P764, DOI 10.1038/35015509
   Schnez S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3064128
   Stampfer C, 2008, NANO LETT, V8, P2378, DOI 10.1021/nl801225h
   Tan ZB, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.096602
   Todd K, 2009, NANO LETT, V9, P416, DOI 10.1021/nl803291b
   Tombros N, 2007, NATURE, V448, P571, DOI 10.1038/nature06037
   van den Berg JWG, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.066806
   van der Wiel WG, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.126803
NR 31
TC 0
Z9 0
U1 2
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0021-4922
EI 1347-4065
J9 JPN J APPL PHYS
JI Jpn. J. Appl. Phys.
PD JUN
PY 2017
VL 56
IS 6
SU 1
AR 06GE07
DI 10.7567/JJAP.56.06GE07
PG 3
WC Physics, Applied
SC Physics
GA EV1MM
UT WOS:000401510500001
OA No
DA 2017-08-17
ER

PT J
AU Guo, J
   Joo, SH
   Pi, DH
   Zhang, XH
   Zhang, XR
   Abdelaal, M
   Song, YP
   Kim, HS
AF Guo, Jing
   Joo, Soo-Hyun
   Pi, Dong-Hai
   Zhang, Xiaohui
   Zhang, Xiaorong
   Abdelaal, Mohamed
   Song, Yuepeng
   Kim, Hyoung Seop
TI Wear Resistance of the La62Cu12Ni12Al14 Bulk Metallic Glass Under Dry
   Friction Conditions
SO TRIBOLOGY LETTERS
LA English
DT Article
DE Bulk amorphous alloys; Wear; Annealing; Hardness measurement
ID AMORPHOUS-ALLOYS; ABRASIVE WEAR; BEHAVIOR; COMPOSITES; HARDNESS
AB The wear properties of a La62Cu12Ni12Al14 bulk metallic glass (BMG) using sliding wear system under the various normal loads and the annealing conditions have been investigated. Although the La62Cu12Ni12Al14 BMG is brittle during the tensile testing, it exhibits ductile behaviors during the sliding wear process. The SEM and the EDS analyses of the wear tracks and the debris after the sliding wear processes indicate that the wear mechanism is a combination of abrasion, adhesion, and oxidation. It is found that the wear resistance is significantly affected by the normal loads. With the increases in the wear load, the wear loss and the friction coefficient decrease. In addition, it is found that the wear properties are significantly affected by the annealing conditions. Compared with the annealed BMG alloys, the as-cast BMG alloy with a low hardness exhibits good wear resistance, which is attributed to the better ductility during the wear testing.
C1 [Guo, Jing; Kim, Hyoung Seop] Pohang Univ Sci & Technol POSTECH, Dept Mat Sci & Engn, Pohang 790784, South Korea.
   [Guo, Jing; Zhang, Xiaohui; Zhang, Xiaorong; Song, Yuepeng] Shandong Agr Univ, Coll Mech & Elect Engn, Tai An 271018, Shandong, Peoples R China.
   [Guo, Jing; Zhang, Xiaohui; Zhang, Xiaorong; Song, Yuepeng] Shandong Prov Key Lab Hort Machineries & Equipmen, Tai An 271018, Shandong, Peoples R China.
   [Joo, Soo-Hyun] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Pi, Dong-Hai] YUST, Dept Mat Mech & Automat Engn, Yanji 133000, Peoples R China.
   [Abdelaal, Mohamed] Zagazig Univ, Mech Design & Prod Dept, Fac Engn, Zagazig, Egypt.
RP Kim, HS (reprint author), Pohang Univ Sci & Technol POSTECH, Dept Mat Sci & Engn, Pohang 790784, South Korea.
EM hskim@postech.ac.kr
RI Kim, Hyoung Seop/C-2166-2009
OI Kim, Hyoung Seop/0000-0002-3155-583X
FU National Research Foundation of Korea through the Korea-China Young
   Scientist Exchange Program; National Science Foundation of China
   [51301098]; National Research Foundation of Korea (NRF) - Korea
   government (MSIP) [2014R1A2A1A10051322]
FX This study was funded by the National Research Foundation of Korea
   through the Korea-China Young Scientist Exchange Program, the National
   Science Foundation of China (Grant No. 51301098). J. Guo gratefully
   acknowledges B. Zhang of Heifei University and Technology help prepare
   the BMGs. This work was supported by the National Research Foundation of
   Korea (NRF) grant funded by the Korea government (MSIP) (No.
   2014R1A2A1A10051322).
CR Abd El Aal MI, 2014, MATER DESIGN, V53, P373, DOI 10.1016/j.matdes.2013.07.045
   ALPAS AT, 1991, WEAR, V146, P285, DOI 10.1016/0043-1648(91)90069-7
   Bhowmick R, 2006, ACTA MATER, V54, P4221, DOI 10.1016/j.actamat.2006.05.011
   BOSWELL PG, 1979, J MATER SCI, V14, P1505, DOI 10.1007/BF00549329
   CHEN H, 1991, SCRIPTA METALL MATER, V25, P1421, DOI 10.1016/0956-716X(91)90426-2
   Chen XM, 2013, J NON-CRYST SOLIDS, V362, P140, DOI 10.1016/j.jnoncrysol.2012.11.018
   DENG D, 1986, ACTA METALL MATER, V34, P2025, DOI 10.1016/0001-6160(86)90261-0
   Dolezal N., 1985, Rapidly Quenched Metals. Proceedings of the Fifth International Conference, P1767
   Aal MIA El, 2010, MAT SCI ENG A-STRUCT, V527, P3726
   Fu XY, 2001, WEAR, V250, P409, DOI 10.1016/S0043-1648(01)00605-6
   Gloriant T, 2003, J NON-CRYST SOLIDS, V316, P96, DOI 10.1016/S0022-3093(02)01941-5
   Greer AL, 2002, INT MATER REV, V47, P87, DOI 10.1179/095066001225001067
   Greer A.L., 2001, MATER RES SOC S P, V644
   Guo J., 2017, MAT DES UNPUB
   Guo RQ, 2012, INTERMETALLICS, V30, P94, DOI 10.1016/j.intermet.2012.03.026
   Han T., 2003, ACTA MAT, V51, P4551
   Huang YJ, 2014, MATER DESIGN, V58, P284, DOI 10.1016/j.matdes.2014.01.067
   Jeong HG, 2009, J ALLOY COMPD, V483, P283, DOI 10.1016/j.jallcom.2008.08.145
   KIM YH, 1991, MATER T JIM, V32, P331
   KLINGER R, 1983, WEAR, V86, P287, DOI 10.1016/0043-1648(83)90167-9
   Kong J, 2009, TRIBOL LETT, V35, P151, DOI 10.1007/s11249-009-9444-4
   Kumar G, 2011, ADV MATER, V23, P461, DOI 10.1002/adma.201002148
   Li G, 2002, J PHYS-CONDENS MAT, V14, P11077, DOI 10.1088/0953-8984/14/44/428
   Liu Y, 2010, J ALLOY COMPD, V503, P138, DOI 10.1016/j.jallcom.2010.04.217
   Maddala DR, 2010, WEAR, V269, P572, DOI 10.1016/j.wear.2010.06.004
   Mamoru I, 2007, MAT SCI ENG A-STRUCT, V449-451, P149
   Mei L, 2012, MICROELECTRON ENG, V98, P142, DOI 10.1016/j.mee.2012.07.065
   MORETON R, 1985, J MATER SCI LETT, V4, P133, DOI 10.1007/BF00728057
   Wang D, 2009, J ALLOY COMPD, V484, P118, DOI 10.1016/j.jallcom.2009.04.092
   Wang YX, 2010, SCRIPTA MATER, V62, P682, DOI 10.1016/j.scriptamat.2010.01.023
   Whang S.H., 1982, RAPIDLY SOLIDIFIED A, V8, P301
   WONG CJ, 1984, WEAR, V98, P45, DOI 10.1016/0043-1648(84)90216-3
   Zhang Y, 2004, MAT SCI ENG A-STRUCT, V375, P436, DOI 10.1016/j.msea.2003.10.234
   ZUMGAHR KH, 1981, METALL, V35, P988
NR 34
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1023-8883
EI 1573-2711
J9 TRIBOL LETT
JI Tribol. Lett.
PD JUN
PY 2017
VL 65
IS 2
AR 62
DI 10.1007/s11249-017-0844-6
PG 10
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA EV0NG
UT WOS:000401437000032
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Hady, H
   Shouman, B
AF Abdel-Hady, Hesham
   Shouman, Basma
TI Permissive hypercapnia in extremely low-birthweight infants: how far
   should we go?
SO ACTA PAEDIATRICA
LA English
DT Editorial Material
ID RANDOMIZED-TRIAL; PRETERM INFANTS
C1 [Abdel-Hady, Hesham; Shouman, Basma] Mansoura Univ, Childrens Hosp, Pediat Neonatol, Gomhoria St, Mansoura 35516, Egypt.
RP Abdel-Hady, H (reprint author), Mansoura Univ, Childrens Hosp, Pediat Neonatol, Gomhoria St, Mansoura 35516, Egypt.
EM hehady@yahoo.com
CR Ambalavanan N, 2015, ARCH DIS CHILD-FETAL, V100, pF145, DOI 10.1136/archdischild-2014-306802
   Carlo WA, 2002, J PEDIATR-US, V141, P370, DOI 10.1067/mpd.2002.127507
   Fabres J, 2007, PEDIATRICS, V119, P299, DOI 10.1542/peds.2006-2434
   Mariani G, 1999, PEDIATRICS, V104, P1082, DOI 10.1542/peds.104.5.1082
   Miller JD, 2007, CURR OPIN PEDIATR, V19, P142, DOI 10.1097/MOP.0b013e3280895e12
   Rabe H, 2015, LANCET RESP MED, V3, P499, DOI 10.1016/S2213-2600(15)00240-4
   Thome UH, 2006, BIOL NEONATE, V90, P218, DOI 10.1159/000092723
NR 7
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD JUN
PY 2017
VL 106
IS 6
BP 1011
EP 1011
DI 10.1111/apa.13727
PG 1
WC Pediatrics
SC Pediatrics
GA EU4PH
UT WOS:000401011500033
PM 28121055
OA No
DA 2017-08-17
ER

PT J
AU El-Nahass, E
   Moselhy, WA
   Hassan, NEY
AF El-Nahass, El-Shaymaa
   Moselhy, Walaa A.
   Hassan, Nour El-Houda Y.
TI Forensic Image Analyses of Skin and Underlying Muscles as a Tool for
   Postmortem Interval Delimitation Histopathologic Examination
SO AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY
LA English
DT Article
DE histopathology; imageJ; postmortem interval delimitation; skin
ID DEATH; TIME; DEGRADATION; COLLAGEN
AB One of the biggest challenges for forensic pathologists is to diagnose the postmortem interval (PMI) delimitation; therefore, the aim of this study was to use a routine histopathologic examination and quantitative analysis to obtain an accurate diagnosis of PMI. The current study was done by using 24 adult male albino rats divided into 8 groups based on the scarification schedule (0, 8, 16, 24, 32, 40, 48, and 72 hours PMI). Skin specimens were collected and subjected to a routine histopathologic processing. Examination of hematoxylin-eosin-stained sections from the skin, its appendages and underlying muscles were carried out. Morphometric analysis of epidermal nuclear chromatin intensities and area percentages, reticular dermis integrated density, and sebaceous gland nuclei areas and chromatin condensation was done. Progressive histopathologic changes could be detected in epidermis, dermis, hypodermis, underlying muscles including nerve endings, and red blood cells in relation to hours PMI. Significant difference was found in epidermal nuclear chromatin intensities at different-hours PMI (at P < 0.001). The highest intensity was detected 40 hours PMI. Quantitative analysis of measurements of dermal collagen area percentages revealed a high significant difference between 0 hours PMI and 24 to 72 hours PMI (P < 0.001). As the PMI increases, sebaceous gland nuclei and nuclear chromatin condensation showed a dramatic decrease. Significant differences of sebaceous gland nuclei areas between 0 hours and different-hours PMI (P < 0.001) were obtained. A combination between routine histopathologic examination and quantitative and morphometric analysis of the skin could be used to evaluate the time of death in different-hours PMI.
C1 [El-Nahass, El-Shaymaa; Moselhy, Walaa A.; Hassan, Nour El-Houda Y.] Beni Suef Univ, Fac Vet Med, Bani Suwayf 62511, Egypt.
RP El-Nahass, E (reprint author), Beni Suef Univ, Fac Vet Med, Bani Suwayf 62511, Egypt.
EM shima_k81@yahoo.com
CR Allen AC, 2001, 14 BIENN C BIOL MAR
   Bardale R, 2007, MED LEGAL UPDATE, V7, P4
   Bardale RV, 2012, AM J FOREN MED PATH, V33, P357, DOI 10.1097/PAF.0b013e31822c8f21
   Chandrakanth HV, 2013, J FORENSIC LEG MED, V20, P211, DOI 10.1016/j.jflm.2012.09.001
   Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6
   Dokgoz H, 2001, FORENSIC SCI INT, V124, P25, DOI 10.1016/S0379-0738(01)00559-X
   Farid H, 2010, SPIE C MED FOR SEC
   Gomaa MS, 2013, J AM SCI, V9, P535
   Guntheti BK, 2014, J INDIAN ACAD FORENS, V36, P137
   Gurcan M. N., 2009, BIOMEDICAL ENG IEEE, V2, P147, DOI DOI 10.1109/RBME.2009.2034865
   Karikoski Riitta, 2011, Duodecim, V127, P464
   Kovarik C, 2005, AM J FOREN MED PATH, V26, P305, DOI 10.1097/01.paf.0000188087.18273.d2
   Kumar B, 2015, J INDIAN ACAD FORENS, V37, P148
   Kurosumi Masafumi, 2007, Breast Cancer, V14, P342, DOI 10.2325/jbcs.14.342
   Linch CA, 2001, J FORENSIC SCI, V46, P15
   Liu LJ, 2007, J HUAZHONG U SCI-MED, V27, P362, DOI 10.1007/s11596-007-0404-7
   Liu Yang, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P694
   Liu Yang, 2008, Fa Yi Xue Za Zhi, V24, P165
   Lochmuller CM, 2011, AM J FOREN MED PATH, V32, P266, DOI 10.1097/PAF.0b013e3182186f22
   Lochmuller CM, 2007, PRACTICAL FORENSIC M, P149
   McMullen R. L., 2010, International Journal of Cosmetic Science, V32, P143, DOI 10.1111/j.1468-2494.2010.00541.x
   Miot HA, 2010, AN BRAS DERMATOL, V85, P361, DOI 10.1590/S0365-05962010000300010
   Mudaliar K, 2013, J CLIN ANAT PATHOL, V1, P1
   Rao Nageshkumar G., 2007, PRACTICAL FORENSIC M, P113
   Noorlander ML, 2002, J HISTOCHEM CYTOCHEM, V50, P1469
   Pittner S, 2016, INT J LEGAL MED, V130, P1547, DOI 10.1007/s00414-016-1349-9
   Pittner S, 2016, INT J LEGAL MED, V130, P421, DOI 10.1007/s00414-015-1210-6
   Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97
   Sakahira H, 1999, CURR BIOL, V9, P543, DOI 10.1016/S0960-9822(99)80240-1
   Sambrook J, 2001, MOL CLONING LAB MANU
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Smith Andy, 2012, J Forensics Res, V3, P161
   Sukheeja Deepti, 2013, J Lab Physicians, V5, P121, DOI 10.4103/0974-2727.119865
   Sun Z, 2015, SKIN RES TECHNOL, V21, P437, DOI 10.1111/srt.12211
   Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018
   Yamamoto T, 2008, SKIN RES TECHNOL, V14, P26, DOI 10.1111/j.1600-0846.2007.00256.x
   Zaki SM, 2015, J CYTOL HISTOL S, V3, P004
NR 37
TC 0
Z9 0
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0195-7910
EI 1533-404X
J9 AM J FOREN MED PATH
JI Am. J. Forensic Med. Pathol.
PD JUN
PY 2017
VL 38
IS 2
BP 131
EP 138
DI 10.1097/PAF.0000000000000301
PG 8
WC Medicine, Legal; Pathology
SC Legal Medicine; Pathology
GA EU7CR
UT WOS:000401192900010
PM 28263236
OA No
DA 2017-08-17
ER

PT J
AU Blecker, D
   Elashry, MI
   Heimann, M
   Wenisch, S
   Arnhold, S
AF Blecker, D.
   Elashry, M. I.
   Heimann, M.
   Wenisch, S.
   Arnhold, S.
TI New Insights into the Neural Differentiation Potential of Canine Adipose
   Tissue-Derived Mesenchymal Stem Cells
SO ANATOMIA HISTOLOGIA EMBRYOLOGIA
LA English
DT Article
ID MARROW STROMAL CELLS; SPINAL-CORD-INJURY; BONE-MARROW; NEURONAL
   DIFFERENTIATION; NEUROGENIC DIFFERENTIATION; IMMUNOELECTRON MICROSCOPY;
   FUNCTIONAL RECOVERY; PROGENITOR CELLS; VALPROIC ACID; IN-VITRO
AB Adipose tissue-derived stem cells (ASCs) can be obtained from different adipose tissue sources within the body. It is an abundant cell pool, easily accessible, suitable for cultivation and expansion invitro and preparation for therapeutic approaches. Amongst these therapeutic approaches are tissue engineering and nervous system disorders such as spinal cord injuries. For such treatment, ASCs have to be reliably differentiated in to the neuronal direction. Therefore, we investigated the neural differentiation potential of ASCs using protocols with neurogenic inductors such as valproic acid and forskolin, while dog brain tissue served as control. Morphological changes could already be noticed 1h after neuronal induction. Gene expression analysis revealed that the neuronal markers nestin and III-tubulin as well as MAP2 were expressed after induction of neuronal differentiation. Additionally, the expression of the neurotrophic factors NGF, BDNF and GDNF was determined. Some of the neuronal markers and neurotrophic factors were already expressed in undifferentiated cells. Our findings point out that ASCs can reliably be differentiated into the neuronal lineage; therefore, these cells are a suitable cell source for cell transplantation in disorders of the central nervous system. Follow-up studies would show the clinical benefit of these cells after transplantation.
C1 [Blecker, D.; Elashry, M. I.; Heimann, M.; Arnhold, S.] Univ Giessen, Inst Vet Anat Histol & Embryol, Frankfurter Str 98, D-35392 Giessen, Germany.
   [Elashry, M. I.] Univ Mansoura, Anat & Embryol Dept, Fac Vet Med, Mansoura 35516, Egypt.
   [Wenisch, S.] Univ Giessen, Dept Vet Clin Sci, Small Anim Clin, Inst Vet Anat Histol & Embryol, Frankfurter Str 98, D-35392 Giessen, Germany.
RP Arnhold, S (reprint author), Univ Giessen, Inst Vet Anat Histol & Embryol, Frankfurter Str 98, D-35392 Giessen, Germany.
EM Stefan.arnhold@vetmed.uni-giessen.de
CR Arnhold S, 2007, GRAEF ARCH CLIN EXP, V245, P414, DOI 10.1007/s00417-006-0382-7
   Arnhold S, 2006, EUR J CELL BIOL, V85, P551, DOI 10.1016/j.ejcb.2006.01.015
   Arnhold S, 2015, AM J STEM CELLS, V4, P1
   Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911
   Brohlin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045052
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x
   Chung CS, 2013, J VET MED SCI, V75, P879, DOI 10.1292/jvms.12-0470
   DARDICK I, 1976, TISSUE CELL, V8, P561, DOI 10.1016/0040-8166(76)90013-6
   DINSMORE JH, 1991, CELL, V64, P817, DOI 10.1016/0092-8674(91)90510-6
   DIXONSHANIES D, 1975, P SOC EXP BIOL MED, V149, P541
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Edamura K, 2012, J VET MED SCI, V74, P923, DOI 10.1292/jvms.11-0388
   Fanarraga ML, 1999, EUR J NEUROSCI, V11, P517
   Filioli U.M., 2011, MOL REPROD DEV, V78, P361
   Ghoreishian M, 2013, J ORAL MAXIL SURG, V71, P577, DOI 10.1016/j.joms.2012.05.025
   Guercio A, 2012, CELL BIOL INT, V36, P189, DOI 10.1042/CBI20110304
   HIROKAWA N, 1988, J NEUROSCI, V8, P2769
   HOLLENBERG CH, 1968, J CLIN INVEST, V47, P2485, DOI 10.1172/JCI105930
   Jung GA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-66
   Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823
   Kang BJ, 2012, J VET SCI, V13, P299, DOI 10.4142/jvs.2012.13.3.299
   Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205
   Kim BG, 2010, CYTOTHERAPY, V12, P841, DOI 10.3109/14653249.2010.501784
   Kim GA, 2014, THERIOGENOLOGY, V81, P243, DOI 10.1016/j.theriogenology.2013.09.018
   Kurihara Y, 2014, J VET MED SCI, V76, P15, DOI 10.1292/jvms.13-0219
   Lee SH, 2009, NEUROL RES, V31, P996, DOI 10.1179/174313209X385626
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   Lepski G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00155
   Long XX, 2005, STEM CELLS DEV, V14, P65, DOI 10.1089/scd.2005.14.65
   Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148
   Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI 10.1089/tea.2007.0207
   Nicaise C, 2011, NEUROPATH APPL NEURO, V37, P179, DOI 10.1111/j.1365-2990.2010.01124.x
   Ninomiya H, 2015, IN VITRO CELL DEV-AN, V51, P1, DOI 10.1007/s11626-014-9801-y
   Oda Y, 2013, VET RES COMMUN, V37, P133, DOI 10.1007/s11259-013-9555-0
   Ohta M, 2004, J BIOMED MATER RES A, V71A, P661, DOI 10.1002/jbm.a.30194
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Raabe O, 2010, HISTOCHEM CELL BIOL, V134, P545, DOI 10.1007/s00418-010-0760-4
   Reh TA, 2002, NAT NEUROSCI, V5, P392, DOI 10.1038/nn0502-392
   Reich CM, 2012, VET RES COMMUN, V36, P139, DOI 10.1007/s11259-012-9523-0
   Ryu HH, 2009, J VET SCI, V10, P273, DOI 10.4142/jvs.2009.10.4.273
   Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   SHIOMURA Y, 1987, J CELL BIOL, V104, P1575, DOI 10.1083/jcb.104.6.1575
   Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107
   Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764
   Wenisch S, 2006, BONE, V38, P911, DOI 10.1016/j.bone.2005.10.021
   Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C
   Yaghoobi MM, 2006, NEUROSCI LETT, V397, P149, DOI 10.1016/j.neulet.2005.12.009
   Yaghoobi MM, 2008, BRAIN RES, V1203, P26, DOI 10.1016/j.brainres.2008.01.086
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 51
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0340-2096
EI 1439-0264
J9 ANAT HISTOL EMBRYOL
JI Anat. Histol. Embryol.
PD JUN
PY 2017
VL 46
IS 3
BP 304
EP 315
DI 10.1111/ahe.12270
PG 12
WC Anatomy & Morphology; Veterinary Sciences
SC Anatomy & Morphology; Veterinary Sciences
GA EU4CS
UT WOS:000400978000010
PM 28401575
OA No
DA 2017-08-17
ER

PT J
AU Bayomy, NA
   Elbakary, RH
   Ibrahim, MAA
   Abdelaziz, EZ
AF Bayomy, Naglaa A.
   Elbakary, Reda H.
   Ibrahim, Marwa A. A.
   Abdelaziz, Eman Z.
TI Effect of Lycopene and Rosmarinic Acid on Gentamicin Induced Renal
   Cortical Oxidative Stress, Apoptosis, and Autophagy in Adult Male Albino
   Rat
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Article
DE lycopene; rosmarinic acid; gentamicin; nephrotoxicity; Bax; Bcl2; LC3/B;
   antioxidants
ID TUBULAR EPITHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; INDUCED NEPHROTOXICITY;
   INDUCED NEPHROPATHY; CURCUMIN; INFLAMMATION; ANTIOXIDANT; OFFICINALIS;
   INHIBITION; MECHANISMS
AB Gentamicin nephrotoxicity accounts for 10%-15% of all cases of acute renal failure. Several natural antioxidants were found to be effective against drug-induced toxicity. The possible protective effects of lycopene (Lyc) and rosmarinic acid (RA) alone or combined on gentamicin (Gen) induced renal cortical oxidative stress, apoptosis, and autophagy were evaluated. Sixty-three rats were randomly divided into seven groups named: control, group II received RA 50 mg/kg/day, group III received Lyc 4 mg/kg/day, group IV received Gen 100 mg/kg/day, group V (RA + Gen), group VI (Lyc + Gen), and group VII (RA + Lyc + Gen). At the end of the experiment, kidney functions were estimated then the kidneys were sampled for histopathological, immunohistochemistry, and biochemical studies. Administration of rosmarinic acid and lycopene decreased elevated serum creatinine, blood urea nitrogen, renal malondialdehyde and immunoexpression of the proapoptotic protein (Bax), autophagic marker protein (LC3/B), and inducible nitric oxide synthase (iNOS) induced by gentamicin. They increased reduced glutathione, glutathione peroxidase, superoxide dismutase, and immunoexpression of the antiapoptotic protein (Bcl2). They also improved the histopathological changes induced by gentamicin. The combination therapy of rosmarinic acid and lycopene shows better protective effects than the corresponding monotherapy. (C) 2016 Wiley Periodicals, Inc.
C1 [Bayomy, Naglaa A.; Elbakary, Reda H.; Ibrahim, Marwa A. A.] Tanta Univ, Fac Med, Dept Histol, Tanta 31527, Egypt.
   [Abdelaziz, Eman Z.] Suez Canal Univ, Fac Med, Dept Pharmacol, Ismailia, Egypt.
RP Bayomy, NA (reprint author), Tanta Univ, Fac Med, Dept Histol, Tanta 31527, Egypt.
EM naglaa_@hotmail.com
OI Ibrahim, Marwa/0000-0002-8854-8198
CR Alarifi S, 2012, SAUDI J BIOL SCI, V19, P103, DOI 10.1016/j.sjbs.2011.11.002
   Ali BH, 2008, EXP BIOL MED, V233, P891, DOI 10.3181/0711-RM-315
   Ali BH, 2003, FOOD CHEM TOXICOL, V41, P1447, DOI 10.1016/S0278-6915(03)00186-8
   El Saied Azab A, 2014, AM J CLIN EXP MED, V2, P28
   Bae EH, 2011, NEPHROL DIAL TRANSPL, V26, P3866, DOI 10.1093/ndt/gfr386
   Bakirel T, 2008, J ETHNOPHARMACOL, V116, P64, DOI 10.1016/j.jep.2007.10.039
   Balakumar P, 2008, J RENIN-ANGIO-ALDO S, V9, P189, DOI 10.1177/1470320308098343
   Bekheet SHM, 2013, TISSUE CELL, V45, P89, DOI 10.1016/j.tice.2012.09.006
   Brewer MS, 2011, COMPR REV FOOD SCI F, V10, P221, DOI 10.1111/j.1541-4337.2011.00156.x
   Buyuklu M, 2014, EUR REV MED PHARMACO, V18, P461
   Buyuklu M, 2014, HUM EXP TOXICOL, V1, P1
   Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025
   Domitrovic R, 2014, FOOD CHEM TOXICOL, V66, P321, DOI 10.1016/j.fct.2014.02.002
   Erdem A, 2000, NEPHROL DIAL TRANSPL, V15, P1175, DOI 10.1093/ndt/15.8.1175
   Farombi EO, 2006, FOOD CHEM TOXICOL, V44, P1443, DOI 10.1016/j.fct.2006.05.005
   Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304
   Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011
   Gamble M., 2008, THEORY PRACTICE HIST, V2008, P121
   Geleilete TJ, 2002, J NEPHROL, V15, P633
   Genena AK, 2008, CIENCIA TECNOL ALIME, V28, P463, DOI 10.1590/S0101-20612008000200030
   Gopal V, 2013, J INTENS CARE SOC, V14, P244
   Kanchan Gaikwad, 2012, International Journal of Pharmaceutical Sciences and Research (IJPSR), V3, P2451
   Karahan I, 2005, TOXICOLOGY, V215, P198, DOI 10.1016/j.tox.2005.07.007
   Lakshmi BVS, 2009, INDIAN J PHARM SCI, V71, P551, DOI 10.4103/0250-474X.58196
   Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1
   Lee HJ, 2008, TOXICOLOGY, V250, P109, DOI 10.1016/j.tox.2008.06.010
   Lee KE, 2013, BIOCHEM BIOPH RES CO, V434, P527, DOI 10.1016/j.bbrc.2013.03.108
   Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337
   Makina T, 2002, NEPHRON, V92, P898, DOI 10.1159/000065457
   Manikandan R, 2011, EUR J PHARMACOL, V670, P578, DOI 10.1016/j.ejphar.2011.08.037
   Morales AI, 2010, KIDNEY INT, V77, P861, DOI 10.1038/ki.2010.11
   Nagai J, 2006, J CONTROL RELEASE, V112, P43, DOI 10.1016/j.jconrel.2006.01.003
   Nagai Junya, 2004, Drug Metab Pharmacokinet, V19, P159, DOI 10.2133/dmpk.19.159
   Palabiyik SS, 2013, EXP TOXICOL PATHOL, V65, P853, DOI 10.1016/j.etp.2012.12.004
   Reddy VC, 2012, ASIAN J PHARM CLIN R, V5, P36
   Rincon J, 2004, INT J EXP PATHOL, V85, P25, DOI 10.1111/j.0959-9673.2004.0368.x
   Rubinsztein DC, 2009, AUTOPHAGY, V5, P585
   Servais H, 2008, APOPTOSIS, V13, P11, DOI 10.1007/s10495-007-0151-z
   Srinivasan K, 2009, EUR J PHARMACOL, V606, P162
   Su M, 2013, J ONCOL, V2013, DOI [DOI 10.1155/2013/102735, 10.1155/2013/102735]
   Tapiero H, 2004, BIOMED PHARMACOTHER, V58, P100, DOI 10.1016/j.biopha.2003.12.006
   Tavafi M, 2011, TISSUE CELL, V43, P392, DOI 10.1016/j.tice.2011.09.001
   Trachtman H, 2002, PEDIATR NEPHROL, V17, P20
   Venkatachalam K, 2013, EXP TOXICOL PATHOL, V65, P409, DOI 10.1016/j.etp.2011.12.005
   Wiland P, 2003, POL J PHARMACOL, V55, P631
   Yanagida C, 2004, CHEM-BIOL INTERACT, V148, P139, DOI 10.1016/j.cbi.2004.05.005
NR 46
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
EI 1932-8494
J9 ANAT REC
JI Anat. Rec.
PD JUN
PY 2017
VL 300
IS 6
BP 1137
EP 1149
DI 10.1002/ar.23525
PG 13
WC Anatomy & Morphology
SC Anatomy & Morphology
GA EU8FI
UT WOS:000401273000014
PM 27884046
OA No
DA 2017-08-17
ER

PT J
AU Abu Zeid, EH
   Alam, RTM
   Abd El-Hameed, NE
AF Abu Zeid, E. H.
   Alam, R. T. M.
   Abd El-Hameed, N. E.
TI Impact of titanium dioxide on androgen receptors, seminal vesicles and
   thyroid hormones of male rats: possible protective trial with aged
   garlic extract
SO ANDROLOGIA
LA English
DT Article
DE Androgen receptors; immune histochemistry; quantitative real-time PCR;
   seminal vesicles; thyroid hormones; titanium dioxide
ID VASCULAR ENDOTHELIAL-CELLS; TIO2 NANOPARTICLES; ALLIUM-SATIVUM;
   ANTI-ANDROGENS; MOUSE MODEL; TOXICITY; COMPONENT; EXPOSURE; HEALTH;
   INJURY
AB The aim of this study was to evaluate the effect of titanium dioxide (TiO2), a widely produced and consumed pigment in various food products, on the post-natal development of male albino rat seminal vesicle and thyroid hormones, as well as to evaluate the ameliorative effect of aged garlic extract (AGE) on TiO2-induced alterations. Forty male rat pups (3weeks old) were divided into four equal groups. The 1st group received distilled water orally (control group), 2nd group was given 2mlkg(-1) AGE, 3rd group was administered TiO2 (5gkg(-1) BW) day after day for 65days, and the 4th group administered AGE 6hr prior to TiO2 gavage. TiO2-exposed rats showed nonsignificant changes in the serum testosterone, TSH, T-3 and T-4, while serum glucose showed a significant decrease. Androgen receptor (AR) mRNA expression was significantly down-regulated and weak signal of AR immune labelling. Histopathologically, the epithelium cell lining of seminal vesicles showed focal areas of necrosis and fibrous tissue with the prominent fibrous stroma of the atrophied glands. Meanwhile, AGE supplementation ameliorated the deleterious effects of TiO2 intoxication through protecting the tissues from oxidative stress caused by TiO2. In summary, oral administration of TiO2 resulted in abnormal developmental events in male rat seminal vesicle and AGE able to reduce TiO2 toxicity.
C1 [Abu Zeid, E. H.] Zagazig Univ, Dept Forens Med & Toxicol, Fac Vet Med, Zagazig, Sharkia, Egypt.
   [Alam, R. T. M.] Zagazig Univ, Dept Clin Pathol, Fac Vet Med, Zagazig, Sharkia, Egypt.
   [Abd El-Hameed, N. E.] Zagazig Univ, Dept Physiol, Fac Vet Med, Zagazig, Sharkia, Egypt.
RP Alam, RTM (reprint author), Zagazig Univ, Dept Clin Pathol, Fac Vet Med, Zagazig, Sharkia, Egypt.
EM rashaalam@ymail.com
CR Abdel-Daim MM, 2015, CELL J, V17, P379
   Abu El-Magd M, 2014, GENE, V540, P133, DOI 10.1016/j.gene.2014.02.059
   Afaq F, 1998, J APPL TOXICOL, V18, P307, DOI 10.1002/(SICI)1099-1263(1998090)18:5<307::AID-JAT508>3.0.CO;2-K
   AMAGASE H, 1993, CARCINOGENESIS, V14, P1627, DOI 10.1093/carcin/14.8.1627
   Amagase H, 2001, J NUTR, V131, p955S
   Amagase H, 1997, C CLIN NUTR BANFF A
   Amagase H, 1998, INT GARL ITS COMP 4
   Aurthor J. R., 1999, REV BRIT MED B, V55, P658
   Awazu S., 1997, NUTRACEUTICALS DESIG, P131
   Baan R, 2006, LANCET ONCOL, V7, P295, DOI 10.1016/S1470-2045(06)70651-9
   Boffetta P, 2004, CANCER CAUSE CONTROL, V15, P697, DOI 10.1023/B:CACO.0000036188.23970.22
   Borek C, 2001, J NUTR, V131, p1010S
   Bozin B, 2008, FOOD CHEM, V111, P925, DOI 10.1016/j.foodchem.2008.04.071
   BRINKMANN AO, 1995, J STEROID BIOCHEM, V53, P443, DOI 10.1016/0960-0760(95)00090-M
   Bruck R, 2005, LIVER INT, V25, P613, DOI 10.1111/j.1478-3231.2005.01050.x
   CHEN JL, 1988, J OCCUP ENVIRON MED, V30, P937, DOI 10.1097/00043764-198812000-00011
   Cui YL, 2011, J BIOMED MATER RES A, V96A, P221, DOI 10.1002/jbm.a.32976
   Cui YL, 2010, J HAZARD MATER, V183, P874, DOI 10.1016/j.jhazmat.2010.07.109
   Ejaz S, 2003, EXP ONCOL, V25, P93
   El-Magd Mohammed Abu, 2014, Cells Tissues Organs, V199, P278, DOI 10.1159/000369880
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025
   Galal AAA, 2016, ANDROLOGIA, V48, P914, DOI 10.1111/and.12532
   Hayes A. W., 1994, PRINCIPLES METHODS T
   HORIE T, 1992, PLANTA MED, V58, P468, DOI 10.1055/s-2006-961517
   Hussain S, 2011, EUR RESPIR J, V37, P299, DOI 10.1183/09031936.00168509
   Ide N, 1997, J PHARM PHARMACOL, V49, P908
   Jovanovic B, 2015, INTEGR ENVIRON ASSES, V11, P10, DOI 10.1002/ieam.1571
   Kasuga S, 2001, J NUTR, V131, p1080S
   Kodera Y, 2002, J AGR FOOD CHEM, V50, P622, DOI 10.1021/jf0106648
   LEE KP, 1985, TOXICOL APPL PHARM, V79, P179, DOI 10.1016/0041-008X(85)90339-4
   Liu SB, 2012, TOXICOLOGY, V293, P53, DOI 10.1016/j.tox.2011.12.010
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mahdieh Y., 2015, J CHEM PHARM RES, V7, P755
   Mohamed AAR, 2015, ACTA HISTOCHEM, V117, P649, DOI 10.1016/j.acthis.2015.07.002
   Moriguchi T, 1997, CLIN EXP PHARMACOL P, V24, P235, DOI 10.1111/j.1440-1681.1997.tb01813.x
   Nabela I. E., 2010, J AM SCI, V6, P865
   Olmedo DG, 2005, J BIOMED MATER RES A, V73A, P142, DOI 10.1002/jbm.a.30230
   QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271
   SALEM H, 1988, J APPL TOXICOL, V8, P380
   Saravanan G, 2009, J APPL BIOMED, V7, P151
   Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15
   SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741
   Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327
   Suvarna S.K., 2013, BANCROFTS THEORY PRA
   Takabashi O, 2001, ARCH TOXICOL, V75, P42, DOI 10.1007/s002040000204
   Trinder P., 1969, ANNALS CLINICAL BIOC, V6, P24
   Uda N, 2006, J NUTR, V136, p855S
   United States Geological Survey (USGS), 2013, MINERAL COMMODITY SU, V2013, P172
   Wang JX, 2011, CHEMOSPHERE, V83, P461, DOI 10.1016/j.chemosphere.2010.12.069
   Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001
   Wei ZH, 1998, NUTR RES, V18, P61, DOI 10.1016/S0271-5317(97)00200-5
   WILSON JD, 1978, ANNU REV PHYSIOL, V40, P279, DOI 10.1146/annurev.ph.40.030178.001431
   Zhao JS, 2009, J TOXICOL ENV HEAL A, V72, P1141, DOI 10.1080/15287390903091764
NR 53
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-4569
EI 1439-0272
J9 ANDROLOGIA
JI Andrologia
PD JUN
PY 2017
VL 49
IS 5
AR e12651
DI 10.1111/and.12651
PG 8
WC Andrology
SC Endocrinology & Metabolism
GA EU7CC
UT WOS:000401191300003
OA No
DA 2017-08-17
ER

PT J
AU Hussein, TM
   Elneily, D
   Eid, AA
   Abou-ElKhier, H
AF Hussein, T. M.
   Elneily, D.
   Eid, A. A.
   Abou-ElKhier, H.
TI Assessment of antisperm antibodies in a sample of Egyptian patients with
   hepatitis C virus infection
SO ANDROLOGIA
LA English
DT Article
DE antisperm antibodies; HCV; sperm motility
ID HCV INFECTION; SEMEN; SPERM; PARAMETERS; DISEASE; RNA; MANIFESTATIONS;
   INFERTILITY; CONCEPTION; DIAGNOSIS
AB Association of hepatitis C virus (HCV) with autoimmune phenomena and impaired semen parameters has been previously reported. The aim of this study was to investigate the influence of HCV infection on the development of antisperm antibodies (ASAs) in HCV-positive males. The study was conducted on 30 HCV-infected individuals and 30 healthy control subjects. In both patients and control groups, liver enzymes and reproductive hormones were measured; computer-assisted semen analysis (CASA) was performed; HCV-RNA in serum was measured and IgG and IgA ASAs in semen were determined. Free testosterone, sperm concentration, progressive and total motility were significantly lower in HCV patients than in the control group, whereas ASAs of the IgG and IgA classes were significantly higher in HCV patients. However, correlations between viral load and the examined semen parameters and ASAs were nonsignificant. In conclusion, HCV may be responsible for the increased ASAs detected in HCV patients in the present study, possibly providing another plausible explanation for the decreased sperm motility reported in HCV patients. These findings could be of value in fertility management of HCV patients.
C1 [Hussein, T. M.; Eid, A. A.] Alexandria Univ, Dept Dermatol Venereol & Androl, Fac Med, Alexandria, Egypt.
   [Elneily, D.] Alexandria Univ, Dept Clin & Chem Pathol, Fac Med, Alexandria, Egypt.
   [Abou-ElKhier, H.] Alexandria Univ, Dept Trop Med, Fac Med, Alexandria, Egypt.
RP Eid, AA (reprint author), Alexandria Univ, Dept Dermatol Venereol & Androl, Fac Med, Alexandria, Egypt.
EM dramiraeid@yahoo.co.uk
CR Agnello V, 2004, J HEPATOL, V40, P341, DOI 10.1016/j.jhep.2003.10.009
   ALEXANDER NJ, 1984, FERTIL STERIL, V41, P433
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Bourlet T, 2002, J CLIN MICROBIOL, V40, P3252, DOI 10.1128/JCM.40.9.3252-3255.2002
   Chamley LW, 2007, SEMIN IMMUNOPATHOL, V29, P169, DOI 10.1007/s00281-007-0075-2
   CHECK JH, 1991, ARCH ANDROLOGY, V27, P61
   Conca P, 2009, WORLD J GASTROENTERO, V15, P2305, DOI 10.3748/wjg.15.2305
   Coppola MA, 2010, HUM REPROD, V25, P853, DOI 10.1093/humrep/dep413
   Craxi A, 2008, MOL ASPECTS MED, V29, P85, DOI 10.1016/j.mam.2007.09.017
   Durazzo M, 2006, WORLD J GASTROENTERO, V12, P3073
   El-Serafi AT, 2016, ANDROLOGIA, V48, P82, DOI 10.1111/and.12425
   FRIED MW, 1992, GASTROENTEROLOGY, V102, P1306
   Garcia Patricia C., 2007, Reproductive Medicine and Biology, V6, P33, DOI 10.1111/j.1447-0578.2007.00162.x
   Garolla A, 2013, FERTIL STERIL, V99, P125, DOI 10.1016/j.fertnstert.2012.09.006
   Garrido N, 2005, HUM REPROD, V20, P1028, DOI 10.1093/humrep/deh699
   Krapez JA, 1998, HUM REPROD, V13, P3363, DOI 10.1093/humrep/13.12.3363
   LasVignera S., 2012, EUROPEAN J INTERNAL, V23, pe19
   Lehman EM, 2009, J VIRAL HEPATITIS, V16, P650, DOI 10.1111/j.1365-2893.2009.01115.x
   Leruez-Ville M, 2000, LANCET, V356, P42, DOI 10.1016/S0140-6736(00)02435-1
   Levy R, 2002, HUM REPROD, V17, P2650, DOI 10.1093/humrep/17.10.2650
   Lorusso F, 2010, ANDROLOGIA, V42, P121, DOI 10.1111/j.1439-0272.2009.00970.x
   Ludwikowski Grzegorz, 2004, Przegl Lek, V61, P1031
   Mahmoud A, 2000, HUM REPROD, V15, P231, DOI 10.1093/humrep/15.2.231
   Mahmoud AM, 1996, ANDROLOGIA, V28, P191
   MATHUR S, 1984, FERTIL STERIL, V41, P81
   Mazumdar S, 1998, FERTIL STERIL, V70, P799, DOI 10.1016/S0015-0282(98)00302-1
   McMurray RW, 1998, RHEUM DIS CLIN N AM, V24, P353, DOI 10.1016/S0889-857X(05)70013-2
   NAGY ZP, 1995, HUM REPROD, V10, P1775
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Safarinejad MR, 2010, BJU INT, V105, P79, DOI 10.1111/j.1464-410X.2009.08720.x
   Sinclair M, 2012, HEPATOLOGY, V56, P2007, DOI 10.1002/hep.25823
   Walsh T. J., 2009, INFERTILITY MALE, P277, DOI 10.1017/CBO9780511635656.017
   [Anonymous], 2010, WHO LAB MAN EX PROC
   World Health Organization, 1992, WHO LAB MAN EX HUM S
   Zignego AL, 2007, DIGEST LIVER DIS, V39, P2, DOI 10.1016/j.dld.2006.06.008
   Zini A, 2010, J REPROD IMMUNOL, V85, P205, DOI 10.1016/j.jri.2010.03.006
NR 36
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-4569
EI 1439-0272
J9 ANDROLOGIA
JI Andrologia
PD JUN
PY 2017
VL 49
IS 5
AR e12664
DI 10.1111/and.12664
PG 5
WC Andrology
SC Endocrinology & Metabolism
GA EU7CC
UT WOS:000401191300014
OA No
DA 2017-08-17
ER

PT J
AU Brito-Zeron, P
   Acar-Denizli, N
   Zeher, M
   Rasmussen, A
   Seror, R
   Theander, E
   Li, XM
   Baldini, C
   Gottenberg, JE
   Danda, D
   Quartuccio, L
   Priori, R
   Hernandez-Molina, G
   Kruize, AA
   Valim, V
   Kvarnstrom, M
   Sene, D
   Gerli, R
   Praprotnik, S
   Isenberg, D
   Solans, R
   Rischmueller, M
   Kwok, SK
   Nordmark, G
   Suzuki, Y
   Giacomelli, R
   Devauchelle-Pensec, V
   Bombardieri, M
   Hofauer, B
   Bootsma, H
   Brun, JG
   Fraile, G
   Carsons, SE
   Gheita, TA
   Morel, J
   Vollenveider, C
   Atzeni, F
   Retamozo, S
   Horvath, IF
   Sivils, K
   Mandl, T
   Sandhya, P
   De Vita, S
   Sanchez-Guerrero, J
   van der Heijden, E
   Trevisani, VFM
   Wahren-Herlenius, M
   Mariette, X
   Ramos-Casals, M
AF Brito-Zeron, Pilar
   Acar-Denizli, Nihan
   Zeher, Margit
   Rasmussen, Astrid
   Seror, Raphaele
   Theander, Elke
   Li, Xiaomei
   Baldini, Chiara
   Gottenberg, Jacques-Eric
   Danda, Debashish
   Quartuccio, Luca
   Priori, Roberta
   Hernandez-Molina, Gabriela
   Kruize, Aike A.
   Valim, Valeria
   Kvarnstrom, Marika
   Sene, Damien
   Gerli, Roberto
   Praprotnik, Sonja
   Isenberg, David
   Solans, Roser
   Rischmueller, Maureen
   Kwok, Seung-Ki
   Nordmark, Gunnel
   Suzuki, Yasunori
   Giacomelli, Roberto
   Devauchelle-Pensec, Valerie
   Bombardieri, Michele
   Hofauer, Benedikt
   Bootsma, Hendrika
   Brun, Johan G.
   Fraile, Guadalupe
   Carsons, Steven E.
   Gheita, Tamer A.
   Morel, Jacques
   Vollenveider, Cristina
   Atzeni, Fabiola
   Retamozo, Soledad
   Horvath, Ildiko Fanny
   Sivils, Kathy
   Mandl, Thomas
   Sandhya, Pulukool
   De Vita, Salvatore
   Sanchez-Guerrero, Jorge
   van der Heijden, Eefje
   Moca Trevisani, Virginia Fernandes
   Wahren-Herlenius, Marie
   Mariette, Xavier
   Ramos-Casals, Manuel
CA EULAR-SS Task Force Big Data Conso
TI Influence of geolocation and ethnicity on the phenotypic expression of
   primary Sjogren's syndrome at diagnosis in 8310 patients: a
   cross-sectional study from the Big Data Sjogren Project Consortium
SO ANNALS OF THE RHEUMATIC DISEASES
LA English
DT Article
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLASS-II GENES; ALLERGIC DISEASES;
   AUTOIMMUNE; GEOEPIDEMIOLOGY; SUSCEPTIBILITY; CLASSIFICATION; CRITERIA;
   CHINESE
AB Objectives To analyse the influence of geolocation and ethnicity on the clinical presentation of primary Sjgren's syndrome (SjS) at diagnosis.
   Methods The Big Data Sjogren Project Consortium is an international, multicentre registry designed in 2014. By January 2016, 20 centres from five continents were participating. Multivariable logistic regression analyses were performed.
   Results We included 7748 women (93%) and 562 men (7%), with a mean age at diagnosis of primary SjS of 53 years. Ethnicity data were available for 7884 patients (95%): 6174 patients (78%) were white, 1066 patients (14%) were Asian, 393 patients (5%) were Hispanic, 104 patients (1%) were black/African-American and 147 patients (2%) were of other ethnicities. SjS was diagnosed a mean of 7 years earlier in black/African-American compared with white patients; the female-to-male ratio was highest in Asian patients (27: 1) and lowest in black/African-American patients (7: 1); the prevalence of sicca symptoms was lowest in Asian patients; a higher frequency of positive salivary biopsy was found in Hispanic and white patients. A north-south gradient was found with respect to a lower frequency of ocular involvement in northern countries for dry eyes and abnormal ocular tests in Europe (OR 0.46 and 0.44, respectively) and Asia (OR 0.18 and 0.49, respectively) compared with southern countries. Higher frequencies of antinuclear antibodies (ANAs) were reported in northern countries in America (OR=1.48) and Asia (OR=3.80) while, in Europe, northern countries had lowest frequencies of ANAs (OR=0.67) and Ro/La (OR=0.69).
   Conclusions This study provides the first evidence of a strong influence of geolocation and ethnicity on the phenotype of primary SjS at diagnosis.
C1 [Brito-Zeron, Pilar] Hosp CIMA, Dept Med, Autoimmune Dis Unit, Barcelona, Spain.
   [Brito-Zeron, Pilar; Ramos-Casals, Manuel] Univ Barcelona, Hosp Clin, IDIBAPS CELLEX,Sjogren Syndrome Res Grp AGAUR, ICMiD,Dept Autoimmune Dis,Lab Autoimmune Dis Jose, Barcelona, Spain.
   [Acar-Denizli, Nihan] Mimar Sinan Fine Arts Univ, Fac Sci & Letters, Dept Stat, Istanbul, Turkey.
   [Zeher, Margit] Univ Debrecen, Fac Med, Div Clin Immunol, Debrecen, Hungary.
   [Rasmussen, Astrid] Oklahoma Med Res Fdn, Arthritis & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.
   [Seror, Raphaele; Mariette, Xavier] Le Kremlin Bicetre Univ Paris Sud, Hop Univ Paris Sud, Assistance Publ Hop Paris,U1184, Ctr Immunol Viral Infect & Autoimmune Dis,INSERM, Paris, France.
   [Theander, Elke] Lund Univ, Malmo Univ Hosp, Dept Rheumatol, Lund, Sweden.
   [Li, Xiaomei] Anhui Prov Hosp, Dept Rheumatol & Immunol, Hefei, Peoples R China.
   [Baldini, Chiara] Univ Pisa, Rheumatol Unit, Pisa, Italy.
   [Gottenberg, Jacques-Eric] Univ Strasbourg, Strasbourg Univ Hosp, Dept Rheumatol, Strasbourg, France.
   [Danda, Debashish; Sandhya, Pulukool] Christian Med Coll & Hosp, Dept Clin Immunol, Vellore, Tamil Nadu, India.
   [Quartuccio, Luca; De Vita, Salvatore] Univ Hosp Santa Maria Misericordia, Dept Med & Biol Sci, Clin Rheumatol, Udine, Italy.
   [Priori, Roberta] Sapienza Univ Rome, Dept Internal Med & Med Specialties, Rheumatol Clin, Rome, Italy.
   [Hernandez-Molina, Gabriela; Sanchez-Guerrero, Jorge] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Immunol & Rheumatol Dept, Mexico City, DF, Mexico.
   [Kruize, Aike A.; van der Heijden, Eefje] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.
   [Valim, Valeria] Univ Fed Espirito Santo, Dept Med, Vitoria, Brazil.
   [Kvarnstrom, Marika; Wahren-Herlenius, Marie] Karolinska Inst, Dept Med Solna, Unit Expt Rheumatol, Stockholm, Sweden.
   [Kvarnstrom, Marika; Wahren-Herlenius, Marie] Karolinska Univ Hosp, Stockholm, Sweden.
   [Sene, Damien] Univ Paris VII, Assistance Publ Hop Paris, Hop Lariboisiere, Dept Med Interne, Paris, France.
   [Gerli, Roberto] Univ Perugia, Dept Med, Rheumatol Unit, Perugia, Italy.
   [Praprotnik, Sonja] Univ Med Ctr, Dept Rheumatol, Ljubljana, Slovenia.
   [Isenberg, David] UCL, Ctr Rheumatol, Div Med, London, England.
   [Solans, Roser] Hosp Hebron, Dept Internal Med, Barcelona, Spain.
   [Rischmueller, Maureen] Discipline Med Univ Adelaide, Queen Elizabeth Hosp, Dept Rheumatol, Adelaide, SA, Australia.
   [Kwok, Seung-Ki] Cathol Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol, Seoul, South Korea.
   [Nordmark, Gunnel] Uppsala Univ, Dept Med Sci, Rheumatol, Uppsala, Sweden.
   [Suzuki, Yasunori] Kanazawa Univ Hosp, Div Rheumatol, Kanazawa, Ishikawa, Japan.
   [Giacomelli, Roberto] Univ Laquila, Sch Med, Clin Unit Rheumatol, Laquila, Italy.
   [Devauchelle-Pensec, Valerie] Brest Univ Hosp, Rheumatol Dept, Brest, France.
   [Bombardieri, Michele] Queen Mary Univ London, Ctr Expt Med & Rheumatol, London, England.
   [Hofauer, Benedikt] Tech Univ Munich, Otorhinolaryngol Head & Neck Surg, Munich, Germany.
   [Bootsma, Hendrika] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.
   [Brun, Johan G.] Univ Bergen, Dept Clin Sci, Bergen, Norway.
   [Brun, Johan G.] Haukeland Hosp, Dept Rheumatol, Bergen, Norway.
   [Fraile, Guadalupe] Hosp Ramon & Cajal, Dept Internal Med, Madrid, Spain.
   [Carsons, Steven E.] SUNY Stony Brook, Allergy & Immunol Winthrop Univ Hosp, Div Rheumatol, Mineola, NY 11501 USA.
   [Gheita, Tamer A.] Cairo Univ, Kasr Al Ainy Sch Med, Rheumatol Dept, Cairo, Egypt.
   [Morel, Jacques] Teaching Hosp, Dept Rheumatol, Montpellier, France.
   [Morel, Jacques] Univ Montpellier, Montpellier, France.
   [Vollenveider, Cristina] German Hosp, Buenos Aires, DF, Argentina.
   [Atzeni, Fabiola] IRCCS Galeazzi Orthoped Inst, Milan, Italy.
   [Retamozo, Soledad] Inst Univ Biomed Sci Univ Cordoba IUCBC, Hosp Privado Univ Cordoba, Cordoba, Argentina.
   [Moca Trevisani, Virginia Fernandes] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Ramos-Casals, Manuel] Univ Barcelona, Dept Med, Barcelona, Spain.
RP Ramos-Casals, M (reprint author), Hosp Clin Barcelona, Serv Malalties Autoimmunes Sistemi, C Villarroel,170, Barcelona 08036, Spain.
EM mramos@clinic.ub.es
RI SEROR, Raphaele/E-2283-2017; Chamorro, Antonio-J/A-6257-2013
OI SEROR, Raphaele/0000-0002-5523-1856; Chamorro,
   Antonio-J/0000-0002-2345-2873; Wahren-Herlenius,
   Marie/0000-0002-0915-7245
FU Grants Fondo de Investigaciones Sanitarias (MRC) [INT15/00085]; 'Ajut
   per a la Recerca Josep Font' (PBZ, Hospital Clinic-Barcelona)
FX Supported by Grants Fondo de Investigaciones Sanitarias (MRC,
   INT15/00085) and 'Ajut per a la Recerca Josep Font' (PBZ, Hospital
   Clinic-Barcelona 2012).
CR Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Bolstad AI, 2001, J RHEUMATOL, V28, P1554
   Borchers AT, 2010, AUTOIMMUN REV, V9, pA277, DOI 10.1016/j.autrev.2009.12.008
   Brito-Zeron P, 2016, EXPERT REV CLIN IMMU, V12, P137, DOI 10.1586/1744666X.2016.1109449
   Gonzalez LA, 2013, LUPUS, V22, P1214, DOI 10.1177/0961203313502571
   Gonzalez LA, 2014, RHEUM DIS CLIN N AM, V40, P433, DOI 10.1016/j.rdc.2014.04.001
   KANG HI, 1993, J IMMUNOL, V150, P3615
   Kuo CF, 2015, ARTHRITIS RHEUMATOL, V67, P1904, DOI 10.1002/art.39127
   Maldini C, 2014, ARTHRIT CARE RES, V66, P454, DOI 10.1002/acr.22115
   Office of Management and Budget. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity, 1997, FED REGISTER, V62, P58781
   Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x
   Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375
   Ramos-Casals M, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3821
   ROITBERGTAMBUR A, 1993, HUM IMMUNOL, V36, P235, DOI 10.1016/0198-8859(93)90130-S
   Routsias JG, 2010, EUR J CLIN INVEST, V40, P1026, DOI 10.1111/j.1365-2362.2010.02342.x
   Selmi C, 2010, AUTOIMMUN REV, V9, pA247, DOI 10.1016/j.autrev.2010.02.004
   Shapira Y, 2010, NAT REV RHEUMATOL, V6, P468, DOI 10.1038/nrrheum.2010.86
   Shoenfeld Y, 2008, J AUTOIMMUN, V31, P325, DOI 10.1016/j.jaut.2008.08.004
   Sreih AG, 2015, CLIN RHEUMATOL, V34, P943, DOI 10.1007/s10067-014-2617-z
   Uribe AG, 2004, AUTOIMMUN REV, V3, P321, DOI 10.1016/S1568-9972(03)00140-X
   VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309
   Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
   Warren E, 2016, NEW ENGL J MED, V375, P401, DOI 10.1056/NEJMp1607282
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Youinou P, 2010, J AUTOIMMUN, V34, pJ163, DOI 10.1016/j.jaut.2009.12.005
   Zhao Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000667
NR 27
TC 0
Z9 0
U1 2
U2 2
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-4967
EI 1468-2060
J9 ANN RHEUM DIS
JI Ann. Rheum. Dis.
PD JUN
PY 2017
VL 76
IS 6
BP 1042
EP 1050
DI 10.1136/annrheumdis-2016-209952
PG 9
WC Rheumatology
SC Rheumatology
GA EU6IX
UT WOS:000401138800017
PM 27899373
OA No
DA 2017-08-17
ER

PT J
AU Ramiro, S
   Sepriano, A
   Chatzidionysiou, K
   Nam, JL
   Smolen, JS
   van der Heijde, D
   Dougados, M
   van Vollenhoven, R
   Bijlsma, JW
   Burmester, GR
   Scholte-Voshaar, M
   Falzon, L
   Landewe, RBM
AF Ramiro, Sofia
   Sepriano, Alexandre
   Chatzidionysiou, Katerina
   Nam, Jackie L.
   Smolen, Josef S.
   van der Heijde, Desiree
   Dougados, Maxime
   van Vollenhoven, Ronald
   Bijlsma, Johannes W.
   Burmester, Gerd R.
   Scholte-Voshaar, Marieke
   Falzon, Louise
   Landewe, Robert B. M.
TI Safety of synthetic and biological DMARDs: a systematic literature
   review informing the 2016 update of the EULAR recommendations for
   management of rheumatoid arthritis
SO ANNALS OF THE RHEUMATIC DISEASES
LA English
DT Review
ID ANTITUMOR NECROSIS FACTOR; ANTI-TNF THERAPY; MODIFYING ANTIRHEUMATIC
   DRUGS; LONG-TERM SAFETY; INTERSTITIAL LUNG-DISEASE; SOFT-TISSUE
   INFECTIONS; BRITISH SOCIETY; SERIOUS INFECTIONS; FACTOR INHIBITORS;
   HERPES-ZOSTER
AB Objectives To assess the safety of synthetic (s) and biological (b) disease-modifying antirheumatic drugs (DMARDs) for the management of rheumatoid arthritis (RA) to inform the European League Against Rheumatism recommendations for the management of RA.
   Methods Systematic literature review (SLR) of observational studies comparing any DMARD with another intervention for the management of patients with RA. All safety outcomes were included. A comparator group was required for the study to be included. Risk of bias was assessed with the Hayden's tool.
   Results Twenty-six observational studies addressing diverse safety outcomes of therapy with bDMARDs met eligibility criteria (15 on serious infections, 4 on malignancies). Substantial heterogeneity precluded meta-analysis. Together with the evidence from the 2013 SLR, based on 15 studies, 7 at low risk of bias, patients on bDMARDs compared with patients on conventional sDMARDs had a higher risk of serious infections (adjusted HR (aHR) 1.1 to 1.8)-without differences across bDMARDs-a higher risk of tuberculosis (aHR 2.7 to 12.5), but no increased risk of infection by herpes zoster. Patients on bDMARDs did not have an increased risk of malignancies in general, lymphoma or non-melanoma skin cancer, but the risk of melanoma may be slightly increased (aHR 1.5).
   Conclusions These findings confirm the known safety pattern of bDMARDs, including both tumour necrosis factor-a inhibitor (TNFi) and non-TNFi, for the treatment of RA.
C1 [Ramiro, Sofia] Leiden Univ, Med Ctr, Dept Rheumatol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.
   [Sepriano, Alexandre] Univ Nova Lisboa, Nova Med Sch, CEDOC, Lisbon, Portugal.
   [Chatzidionysiou, Katerina] Karolinska Inst, Unit Clin Therapy Res, Inflammatory Dis ClinTRID, Stockholm, Sweden.
   [Nam, Jackie L.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Chapel Allerton Hosp Leeds, Leeds, W Yorkshire, England.
   [Nam, Jackie L.] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England.
   [Nam, Jackie L.] Med Univ Vienna, Div Rheumatol, Dept Med, Vienna, Austria.
   [Smolen, Josef S.] Hietzing Hosp, Dept Med, Vienna, Austria.
   [Dougados, Maxime] Paris Descartes Univ, Cochin Hosp, Dept Rheumatol, INSERM U1153 Clin Epidemiol & Biostat, Paris, France.
   [van Vollenhoven, Ronald] Amsterdam Rheumatol Ctr, Dept Clin Immunol Rheumatol, Amsterdam, Netherlands.
   [Bijlsma, Johannes W.] Univ Med Ctr Utrecht, Dept Rheumatol, Utrecht, Netherlands.
   [Burmester, Gerd R.] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany.
   [Scholte-Voshaar, Marieke] Univ Twente, Dept Psychol Hlth & Technol, Enschede, Netherlands.
   [Scholte-Voshaar, Marieke] EULAR Standing Comm People Arthritis Rheumatism, Rheumatism, Egypt.
   [Falzon, Louise] Columbia Univ, Ctr Behav Cardiovasc Hlth, New York, NY USA.
   [Landewe, Robert B. M.] Zuyderland Med Ctr, Dept Rheumatol, Heerlen, Netherlands.
RP Ramiro, S (reprint author), Leiden Univ, Med Ctr, Dept Rheumatol, Albinusdreef 2,POB 9600, NL-2300 RC Leiden, Netherlands.
EM sofiaramiro@gmail.com
OI Sepriano, Alexandre/0000-0003-1954-0229
CR Aaltonen KJ, 2015, J RHEUMATOL, V42, P372, DOI 10.3899/jrheum.140853
   Amari W, 2011, RHEUMATOLOGY, V50, P1431, DOI 10.1093/rheumatology/ker113
   Askling J, 2009, ANN RHEUM DIS, V68, P648, DOI 10.1136/ard.2007.085852
   Askling J, 2009, ARTHRITIS RHEUM-US, V60, P3180, DOI 10.1002/art.24941
   Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786
   Baddley JW, 2014, ANN RHEUM DIS, V73, P1942, DOI 10.1136/annrheumdis-2013-203407
   Berghen N, 2015, CLIN RHEUMATOL, V34, P1687, DOI 10.1007/s10067-015-3026-7
   Carmona L, 2011, SEMIN ARTHRITIS RHEU, V41, P71, DOI 10.1016/j.semarthrit.2010.08.005
   Chatzidionysiou K, 2017, ANN RHEUM DIS, V76, P1102, DOI 10.1136/annrheumdis-2016-210711
   Chiang YC, 2014, COMPUT METH PROG BIO, V116, P319, DOI 10.1016/j.cmpb.2014.06.008
   Chiu YM, 2014, INT J RHEUM DIS, V17, P9, DOI 10.1111/1756-185X.12539
   Cobo-Ibanez T, 2014, RHEUMATOL INT, V34, P953, DOI 10.1007/s00296-014-2945-y
   Curtis JR, 2014, ARTHRIT CARE RES, V66, P990, DOI 10.1002/acr.22281
   Curtis JR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0835-7
   de Hair M, 2015, ARTHRITIS RHEUMATOL, P67
   del Rincon I, 2014, ARTHRITIS RHEUMATOL, V66, P264, DOI 10.1002/art.38210
   Desai RJ, 2015, ARTHRIT CARE RES, V67, P457, DOI 10.1002/acr.22483
   Dixon WG, 2010, ARTHRIT CARE RES, V62, P755, DOI 10.1002/acr.20129
   Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935
   Dixon WG, 2010, ANN RHEUM DIS, V69, P1596, DOI 10.1136/ard.2009.125526
   Galloway JB, 2013, ANN RHEUM DIS, V72, P229, DOI 10.1136/annrheumdis-2011-201108
   Galloway JB, 2011, RHEUMATOLOGY, V50, P1341, DOI 10.1093/rheumatology/ker146
   Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242
   Garcia-Doval I, 2010, ANN RHEUM DIS, V69, P1751, DOI 10.1136/ard.2009.125658
   Greenberg JD, 2010, ANN RHEUM DIS, V69, P380, DOI 10.1136/ard.2008.089276
   Grijalva CG, 2011, JAMA-J AM MED ASSOC, V306, P2331, DOI 10.1001/jama.2011.1692
   Grijalva CG, 2010, RHEUMATOLOGY, V49, P82, DOI 10.1093/rheumatology/kep325
   Hayden JA, 2006, ANN INTERN MED, V144, P427
   Haynes K, 2013, ARTHRITIS RHEUM-US, V65, P48, DOI 10.1002/art.37740
   Herrinton LJ, 2013, PHARMACOEPIDEM DR S, V22, P394, DOI 10.1002/pds.3409
   Hifinger M, 2017, ANN RHEUM DIS, V76, P126, DOI 10.1136/annrheumdis-2016-209202
   Johnston SS, 2013, SEMIN ARTHRITIS RHEU, V43, P39, DOI 10.1016/j.semarthrit.2012.12.024
   Ke WM, 2013, INT J TUBERC LUNG D, V17, P1590, DOI 10.5588/ijtld.13.0368
   Kearsley-Fleet L, 2015, RHEUMATOLOGY, V54, P1074, DOI 10.1093/rheumatology/keu446
   Kim SC, 2015, AM J MED, V128
   Komano Y, 2011, J RHEUMATOL, V38, P1258, DOI 10.3899/jrheum.101009
   Lampropoulos CE, 2015, CLIN EXP RHEUMATOL, V33, P216
   Lane MA, 2011, MEDICINE, V90, P139, DOI 10.1097/MD.0b013e318211106a
   Listing J, 2015, ANN RHEUM DIS, V74, P415, DOI 10.1136/annrheumdis-2013-204021
   Mariette X, 2010, ANN RHEUM DIS, V69, P400, DOI 10.1136/ard.2009.117762
   McDonald JR, 2009, CLIN INFECT DIS, V48, P1364, DOI 10.1086/598331
   Mercer LK, 2015, ANN RHEUM DIS, V74, P1087, DOI 10.1136/annrheumdis-2013-204851
   Mercer LK, 2012, ANN RHEUM DIS, V71, P869, DOI 10.1136/annrheumdis-2011-200622
   Miranda JV, 2014, REV COLOMB REUMATOL, V21, P27
   Morgan CL, 2014, RHEUMATOLOGY, V53, P186, DOI 10.1093/rheumatology/ket333
   Nam J, 2017, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2016-210711, DOI 10.1136/ANNRHEUMDIS-2016-210711]
   Ogdie A, 2015, ANN RHEUM DIS, V74, P326, DOI 10.1136/annrheumdis-2014-205675
   Pallavicini FB, 2010, AUTOIMMUN REV, V9, P175, DOI 10.1016/j.autrev.2009.07.006
   Pappas DA, 2015, ARTHRIT CARE RES, V67, P1671, DOI 10.1002/acr.22628
   Phillips C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143286
   Raaschou P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1939
   Ramiro S., 2014, ANN RHEUM DIS, V73, P529, DOI DOI 10.1136/ANNRHEUMDIS-2013-204575
   Richter A, 2016, ANN RHEUM DIS, V75, P1667, DOI 10.1136/annrheumdis-2015-207838
   Roubille C, 2015, ANN RHEUM DIS, V74, P480, DOI 10.1136/annrheumdis-2014-206624
   Sackett DL, 1997, EVIDENCE BASED MED P
   Sakai R, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0583-8
   Sakai R, 2012, ARTHRIT CARE RES, V64, P1125, DOI 10.1002/acr.21666
   Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715
   Solomon DH, 2014, SEMIN ARTHRITIS RHEU, V43, P489, DOI 10.1016/j.semarthrit.2013.08.003
   Solomon DH, 2013, ANN RHEUM DIS, V72, P1813, DOI 10.1136/annrheumdis-2012-202136
   Strangfeld A, 2017, ANN RHEUM DIS, V76, P504, DOI 10.1136/annrheumdis-2016-209773
   Strangfeld A, 2011, ANN RHEUM DIS, V70, P1914, DOI 10.1136/ard.2011.151043
   Strangfeld A, 2009, JAMA-J AM MED ASSOC, V301, P737, DOI 10.1001/jama.2009.146
   Strangfeld A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2904
   Tam LS, 2010, CLIN EXP RHEUMATOL, V28, P679
   Tubach F, 2009, ARTHRITIS RHEUM, V60, P1884, DOI 10.1002/art.24632
   Wasson NJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-533
   Winthrop KL, 2016, ANN RHEUM DIS, V75, P1133, DOI 10.1136/annrheumdis-2015-207319
   Winthrop KL, 2013, ANN RHEUM DIS, V72, P37, DOI 10.1136/annrheumdis-2011-200690
   Winthrop KL, 2013, JAMA-J AM MED ASSOC, V309, P887, DOI 10.1001/jama.2013.1099
   Yun HF, 2016, ARTHRITIS RHEUMATOL, V68, P56, DOI 10.1002/art.39399
   Zink A, 2009, ANN RHEUM DIS, V68, P1240, DOI 10.1136/ard.2008.091926
NR 72
TC 4
Z9 4
U1 4
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-4967
EI 1468-2060
J9 ANN RHEUM DIS
JI Ann. Rheum. Dis.
PD JUN
PY 2017
VL 76
IS 6
BP 1093
EP 1101
DI 10.1136/annrheumdis-2016-210708
PG 9
WC Rheumatology
SC Rheumatology
GA EU6IX
UT WOS:000401138800024
PM 28298374
OA No
DA 2017-08-17
ER

PT J
AU Chatzidionysiou, K
   Emamikia, S
   Nam, J
   Ramiro, S
   Smolen, J
   van der Heijde, D
   Dougados, M
   Bijlsma, J
   Burmester, G
   Scholte, M
   van Vollenhoven, R
   Landewe, R
AF Chatzidionysiou, Katerina
   Emamikia, Sharzad
   Nam, Jackie
   Ramiro, Sofia
   Smolen, Josef
   van der Heijde, Desiree
   Dougados, Maxime
   Bijlsma, Johannes
   Burmester, Gerd
   Scholte, Marieke
   van Vollenhoven, Ronald
   Landewe, Robert
TI Efficacy of glucocorticoids, conventional and targeted synthetic
   disease-modifying antirheumatic drugs: a systematic literature review
   informing the 2016 update of The EULAR recommendations for the
   management of rheumatoid arthritis
SO ANNALS OF THE RHEUMATIC DISEASES
LA English
DT Review
ID PATIENT-REPORTED OUTCOMES; NON-INFERIORITY TRIAL; INADEQUATE RESPONSE;
   METHOTREXATE MONOTHERAPY; TOFACITINIB CP-690,550; RANDOMIZED PHASE-3;
   JAPANESE PATIENTS; CARERA TRIAL; TREACH TRIAL; COMBINATION
AB Objectives To perform a systematic literature review (SLR) informing the 2016 update of the recommendations for the management of rheumatoid arthritis (RA).
   Methods An SLR for the period between 2013 and 2016 was undertaken to assess the efficacy of glucocorticoids (GCs), conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and targeted synthetic DMARDs (tsDMARDs) (tofacitinib and baricitinib) in randomised clinical trials.
   Results For GCs, four studies were included in the SLR. Patients without poor prognostic factors experienced benefit when GCs were added to methotrexate (MTX). Lower doses of GCs were similar to higher doses. For csDMARDs, two new studies comparing MTX monotherapy with combination csDMARD were included in the SLR. In the tREACH trial at the end of 12 months no difference between the groups in disease activity, functional ability and radiographic progression was seen, using principles of tight control (treat-to-target). In the CareRA trial, combination therapy with csDMARDs was not superior to MTX monotherapy and monotherapy was better tolerated. For tsDMARDs, tofacitinib and baricitinib were shown to be more effective than placebo (MTX) in different patient populations.
   Conclusions Addition of GCs to csDMARD therapy may be beneficial but the benefits should be balanced against the risk of toxicity. Under tight control conditions MTX monotherapy is not less effective than combination csDMARDs, but better tolerated. Tofacitinib and baricitinib are efficacious in patients with RA, including those with refractory disease.
C1 [Chatzidionysiou, Katerina; Emamikia, Sharzad] Karolinska Inst, Stockholm, Sweden.
   [Nam, Jackie] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England.
   [Ramiro, Sofia] LUMC, Leiden, Netherlands.
   [Smolen, Josef] Med Univ Vienna, Vienna, Austria.
   [van der Heijde, Desiree] Paris Descartes Univ, Paris, France.
   [Dougados, Maxime] Univ Utrecht, Med Ctr, Utrecht, Netherlands.
   [Bijlsma, Johannes] Charite, Berlin, Germany.
   [Burmester, Gerd] Univ Twente, Dept Psychol Hlth & Technol, Enschede, Netherlands.
   [Scholte, Marieke] EULAR Standing Comm People Arthrit Rheumatism, Rheumatism, Egypt.
   [Scholte, Marieke] Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands.
RP Chatzidionysiou, K (reprint author), Karolinska Univ Hosp, Karolinska Inst, Rheumatol Dept, Unit Clin Therapy Res,Inflammatory Dis ClinTRID, S-17176 Stockholm, Sweden.
EM aikaterini.chatzidionysiou@karolinska.se
CR Burmester GR, 2013, LANCET, V381, P451, DOI 10.1016/S0140-6736(12)61424-X
   Burmester GR, 2015, ANN RHEUM DIS, V74, P1037, DOI 10.1136/annrheumdis-2013-204769
   Buttgereit F, 2013, ANN RHEUM DIS, V72, P204, DOI 10.1136/annrheumdis-2011-201067
   Cutolo M, 2013, RHEUMATOLOGY, V52, P1132, DOI 10.1093/rheumatology/kes321
   de Jong PH, 2014, ANN RHEUM DIS, V73, P1331, DOI 10.1136/annrheumdis-2013-204788
   de Jong PH, 2013, ANN RHEUM DIS, V72, P72, DOI 10.1136/annrheumdis-2011-201162
   de Hair M, 2015, ARTHRITIS RHEUMATOL, P67
   den Uyl D, 2014, ANN RHEUM DIS, V73, P1071, DOI 10.1136/annrheumdis-2012-202818
   Dhir V, 2014, CLIN THER, V36, P1005, DOI 10.1016/j.clinthera.2014.05.063
   Dougados M, 2017, ANN RHEUM DIS, V76, P88, DOI 10.1136/annrheumdis-2016-210094
   Emery P, 2015, ARTHRITIS RHEUMATOL, P67
   Fleischmann R, 2015, ARTHRITIS RHEUMATOL, V67, P506
   Gaujoux-Viala C, 2013, ANN RHEUM DIS, V72, P551
   Genovese MC, 2016, NEW ENGL J MED, V374, P1243, DOI 10.1056/NEJMoa1507247
   Hoes JN, 2007, ANN RHEUM DIS, V66, P1560, DOI 10.1136/ard.2007.072157
   Keystone EC, 2015, ANN RHEUM DIS, V74, P333, DOI 10.1136/annrheumdis-2014-206478
   Kremer J, 2013, ANN INTERN MED, V159, P253, DOI 10.7326/0003-4819-159-4-201308200-00006
   Lee EB, 2014, NEW ENGL J MED, V370, P2377, DOI 10.1056/NEJMoa1310476
   Menon Nitin, 2014, J Assoc Physicians India, V62, P673
   Nam J, 2016, ANN RHEUM DIS UNPUB
   Ramiro S, 2016, ANN RHEUM DIS UNPUB
   Ren LM, 2016, INT J RHEUM DIS, V19, P651, DOI 10.1111/1756-185X.12677
   Schoels MM, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2015-208521
   Smolen JS, 2013, ANN RHEUM DIS, V73, P492, DOI [DOI 10.1136/ANNRHEUMDIS-2013-204573, 10.1136/annrheumdis-2013-204573]
   Smolen JS, 2013, ANN RHEUM DIS UNPUB
   Strand V, 2016, RHEUMATOLOGY, V55, P1031, DOI 10.1093/rheumatology/kev442
   Strand V, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0825-9
   Strand V, 2015, ARTHRIT CARE RES, V67, P475, DOI 10.1002/acr.22453
   Tanaka Y, 2016, J RHEUMATOL, V43, P504, DOI 10.3899/jrheum.150613
   Tanaka Y, 2015, MOD RHEUMATOL, V25, P514, DOI 10.3109/14397595.2014.995875
   Taylor PCKE, 2015, ARTHRITIS RHEUMA S10, V67, P2015
   ter Wee MM, 2015, ANN RHEUM DIS, V74, P1233, DOI 10.1136/annrheumdis-2013-205143
   van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816
   Verschueren P, 2015, ANN RHEUM DIS, V74, P27, DOI 10.1136/annrheumdis-2014-205489
   Verschueren P, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0611-8
   Visser K, 2009, ANN RHEUM DIS, V68, P1094, DOI 10.1136/ard.2008.092668
   Wallenstein GV, 2016, CLIN EXP RHEUMATOL, V34, P430
NR 37
TC 4
Z9 4
U1 3
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-4967
EI 1468-2060
J9 ANN RHEUM DIS
JI Ann. Rheum. Dis.
PD JUN
PY 2017
VL 76
IS 6
BP 1102
EP 1107
DI 10.1136/annrheumdis-2016-210711
PG 6
WC Rheumatology
SC Rheumatology
GA EU6IX
UT WOS:000401138800025
PM 28356243
OA No
DA 2017-08-17
ER

PT J
AU Nam, JL
   Takase-Minegishi, K
   Ramiro, S
   Chatzidionysiou, K
   Smolen, JS
   van der Heijde, D
   Bijlsma, JW
   Burmester, GR
   Dougados, M
   Scholte-Voshaar, M
   van Vollenhoven, R
   Landewe, R
AF Nam, Jackie L.
   Takase-Minegishi, Kaoru
   Ramiro, Sofia
   Chatzidionysiou, Katerina
   Smolen, Josef S.
   van der Heijde, Desiree
   Bijlsma, Johannes W.
   Burmester, Gerd R.
   Dougados, Maxime
   Scholte-Voshaar, Marieke
   van Vollenhoven, Ronald
   Landewe, Robert
TI Efficacy of biological disease-modifying antirheumatic drugs: a
   systematic literature review informing the 2016 update of the EULAR
   recommendations for the management of rheumatoid arthritis
SO ANNALS OF THE RHEUMATIC DISEASES
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; FACTOR MONOCLONAL-ANTIBODY; DOUBLE-BLIND;
   INADEQUATE RESPONSE; RADIOGRAPHIC OUTCOMES; SUSTAINED REMISSION;
   PHASE-III; METHOTREXATE; MULTICENTER; THERAPY
AB Objectives To update the evidence for the efficacy of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA) to inform European League Against Rheumatism (EULAR) Task Force treatment recommendations.
   Methods MEDLINE, EMBASE and Cochrane databases were searched for phase III or IV (or phase II, if these studies were lacking) randomised controlled trials (RCTs) published between January 2013 and February 2016. Abstracts from the American College of Rheumatology and EULAR conferences were obtained.
   Results The RCTs confirmed greater efficacy with a bDMARD+conventional synthetic DMARD (csDMARD) versus a csDMARDs alone (level 1A evidence). Using a treat-to-target strategy approach, commencing and escalating csDMARD therapy and adding a bDMARD in cases of non-response, is an effective approach (1B). If a bDMARD had failed, improvements in clinical response were seen on switching to another bDMARD (1A), but no clear advantage was seen for switching to an agent with another mode of action. Maintenance of clinical response in patients in remission or low disease activity was best when continuing rather than stopping a bDMARD, but bDMARD dose reduction or 'spacing' was possible, with a substantial proportion of patients achieving bDMARD-free remission (2B). RCTs have also demonstrated efficacy of several new bDMARDs and biosimilar DMARDs (1B).
   Conclusions This systematic literature review consistently confirmed the previously reported efficacy of bDMARDs in RA and provided additional information on bDMARD switching and dose reduction.
C1 [Nam, Jackie L.; Chatzidionysiou, Katerina; van der Heijde, Desiree; Bijlsma, Johannes W.; Landewe, Robert] Chapel Allerton Hosp, Dept Rheumatol, Second Floor, Leeds LS7 4SA, W Yorkshire, England.
   [Ramiro, Sofia; Dougados, Maxime; Scholte-Voshaar, Marieke; Landewe, Robert] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England.
   [Smolen, Josef S.; Bijlsma, Johannes W.; Dougados, Maxime; Scholte-Voshaar, Marieke] Leeds Teaching Hosp NHS Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England.
   [van der Heijde, Desiree; Burmester, Gerd R.; van Vollenhoven, Ronald] Yokohama City Univ, Ctr Rheumat Dis, Med Ctr, Yokohama, Kanagawa, Japan.
   [Ramiro, Sofia; Chatzidionysiou, Katerina; Smolen, Josef S.; Burmester, Gerd R.; van Vollenhoven, Ronald] Karolinska Inst, Unit Clin Therapy Res, Inflammatory Dis ClinTRID, Stokholm, Sweden.
   [Takase-Minegishi, Kaoru; Ramiro, Sofia; van der Heijde, Desiree; van Vollenhoven, Ronald] Med Univ Vienna, Div Rheumatol, Dept Med, Vienna, Austria.
   [Chatzidionysiou, Katerina; Smolen, Josef S.; Dougados, Maxime; van Vollenhoven, Ronald] Hietzing Hosp, Dept Med, Vienna, Austria.
   [Smolen, Josef S.; Bijlsma, Johannes W.; Scholte-Voshaar, Marieke] Univ Med Ctr Utrecht, Dept Rheumatol, Utrecht, Netherlands.
   [Ramiro, Sofia; Smolen, Josef S.; van der Heijde, Desiree; van Vollenhoven, Ronald] Paris Descartes Univ, Cochin Hosp, Dept Rheumatol, AP HP, Paris, France.
   [Takase-Minegishi, Kaoru; Bijlsma, Johannes W.; Dougados, Maxime] Univ Twente, Dept Psychol Hlth & Technol, Enschede, Netherlands.
   [Ramiro, Sofia; Chatzidionysiou, Katerina; Smolen, Josef S.; Dougados, Maxime] EULAR Standing Comm People Arthrit Rheumatism E, Rheumatism, Egypt.
   [Smolen, Josef S.; van der Heijde, Desiree; Burmester, Gerd R.; Scholte-Voshaar, Marieke] Amsterdam Rheumatol Ctr, Dept Clin Immunol Rheumatol, Amsterdam, Netherlands.
   [Ramiro, Sofia; Smolen, Josef S.; Bijlsma, Johannes W.; Burmester, Gerd R.] Amsterdam Rheumatol Ctr, Dept Rheumatol, Amsterdam, Netherlands.
   [Smolen, Josef S.; Burmester, Gerd R.; Dougados, Maxime; van Vollenhoven, Ronald] Zuyderland Med Ctr, Dept Rheumatol, Heerlen, Netherlands.
RP Nam, JL (reprint author), Chapel Allerton Hosp, Dept Rheumatol, Second Floor, Leeds LS7 4SA, W Yorkshire, England.
EM J.Nam@leeds.ac.uk
FU EULAR
FX The authors thank Liz Dalton, University of Leeds, for her expertise and
   help with the literature search and EULAR for funding this work.
CR Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI 10.1136/ard.2010.138461
   Atsumi T, 2016, ANN RHEUM DIS, V75, P75, DOI 10.1136/annrheumdis-2015-207511
   Bae SC, 2017, ANN RHEUM DIS, V76, P65, DOI 10.1136/annrheumdis-2015-207613
   Behrens F, 2016, ANN RHEUM DIS, V75, P502, DOI 10.1136/annrheumdis-2016-eular.5684
   Bijlsma JWJ, 2016, LANCET, V388, P343, DOI 10.1016/S0140-6736(16)30363-4
   Bingham CO, 2015, ARTHRITIS RHEUMATOL, V67
   Burmester G, 2014, ARTHRITIS RHEUMATOL, V66, pS1231
   Burmester G, 2014, ARTHRITIS RHEUMATOL, V66, pS811
   Burmester GR, 2016, ANN RHEUM DIS, V75, P1081, DOI 10.1136/annrheumdis-2015-207628
   Chatzidionysiou K, 2017, ANN RHEUM DIS, V76, P1102, DOI 10.1136/annrheumdis-2016-210711
   Choe JY, 2017, ANN RHEUM DIS, V76, P58, DOI 10.1136/annrheumdis-2015-207764
   Dougados M, 2004, ANN RHEUM DIS, V63, P1172, DOI 10.1136/ard.2004.023697
   Emery P, 2015, ANN RHEUM DIS, V74, P712, DOI 10.1136/annrheumdis-2015-eular.1499
   Emery P, 2017, ANN RHEUM DIS, V76, P51, DOI 10.1136/annrheumdis-2015-207588
   Emery P, 2015, ANN RHEUM DIS, V74, P19, DOI 10.1136/annrheumdis-2014-206106
   Eremeeva A, 2016, ANN RHEUM DIS, V75, P513, DOI 10.1136/annrheumdis-2016-eular.1715
   Fleischmann R, 2015, ARTHRITIS RHEUMATOL, V67
   Galloway J B, 2015, ANN RHEUM DIS S, V74, P706, DOI 10.1136/annrheumdis-2015-eular.4684
   Genovese MC, 2015, JCR-J CLIN RHEUMATOL, V21, P231, DOI 10.1097/RHU.0000000000000276
   Genovese MC, 2015, ARTHRITIS RHEUMATOL, V67, P1424, DOI 10.1002/art.39093
   Gottenberg JE, 2015, ARTHRITIS RHEUMA S10, V67, P3725
   Huizinga TWJ, 2015, ANN RHEUM DIS, V74, P35, DOI 10.1136/annrheumdis-2014-205752
   Kaneko Y, 2016, ANN RHEUM DIS, V75, P1917, DOI 10.1136/annrheumdis-2015-208426
   Kim J, 2013, J KOREAN MED SCI, V28, P1716, DOI 10.3346/jkms.2013.28.12.1716
   Kivitz A, 2014, ARTHRIT CARE RES, V66, P1653, DOI 10.1002/acr.22384
   Knevel R, 2010, ANN RHEUM DIS, V69, P987, DOI 10.1136/ard.2009.126748
   Manders SHM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0630-5
   Mariette X, 2014, ANN RHEUM DIS, V73, P1508, DOI 10.1136/annrheumdis-2013-203480
   Markusse IM, 2016, ANN INTERN MED, V164, P523, DOI 10.7326/M15-0919
   Matsumoto AK, 2015, ARTHRITIS RHEUMATOL, V67
   Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573
   Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577
   Naredo E, 2015, RHEUMATOLOGY, V54, P1408, DOI 10.1093/rheumatology/kev006
   Ramiro S, 2017, ANN RHEUM DIS, V76, P1093, DOI 10.1136/annrheumdis-2016-210708
   Saleem B, 2010, ANN RHEUM DIS, V69, P1636, DOI 10.1136/ard.2009.117341
   Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201
   Schiff M, 2015, RMD OPEN, V1
   Schoels M, 2012, ANN RHEUM DIS, V71, P1303, DOI 10.1136/annrheumdis-2011-200490
   Schoels MM, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2015-208521
   Scott DL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1046
   Scott IC, 2016, CLIN EXP RHEUMATOL, V34, P88
   Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715
   Smolen JS, 2015, ANN RHEUM DIS, V74, P1567, DOI 10.1136/annrheumdis-2014-207090
   Smolen JS, 2014, ANN RHEUM DIS, V73, P3, DOI 10.1136/annrheumdis-2013-204317
   Takeuchi T, 2015, MOD RHEUMATOL, V25, P817, DOI 10.3109/14397595.2015.1022297
   Takeuchi T, 2014, ANN RHEUM DIS, V73, P536, DOI 10.1136/annrheumdis-2012-202433
   Takeuchi T, 2013, MOD RHEUMATOL, V23, P623, DOI 10.1007/s10165-012-0742-6
   Tanaka Y, 2015, ANN RHEUM DIS, V74, P389, DOI 10.1136/annrheumdis-2013-204016
   Taylor PCKE, 2015, ARTHRITIS RHEUMA S10, V67, P2015
   Thorne C, 2016, ANN RHEUM DIS, V75, P723, DOI 10.1136/annrheumdis-2016-eular.4106
   van der Woude D, 2009, ARTHRITIS RHEUM, V60, P2262, DOI 10.1002/art.24661
   VANHERWAARDEN N, 2015, BMJ-BRIT MED J, V350, P1389, DOI DOI 10.1136/BMJ.H1389
   Weinblatt ME, 2015, ARTHRITIS RHEUMATOL, V67, P2591, DOI 10.1002/art.39249
   Westhovens R, 2015, ANN RHEUM DIS, V74, P564, DOI 10.1136/annrheumdis-2014-206149
   Yamanaka H, 2016, MOD RHEUMATOL, V26, P651, DOI 10.3109/14397595.2015.1123349
   Yoo DH, 2013, ARTHRITIS RHEUM, V65, P3319
   [Anonymous], 2011, COCHRANE HDB SYSTEMA
NR 57
TC 4
Z9 4
U1 3
U2 3
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-4967
EI 1468-2060
J9 ANN RHEUM DIS
JI Ann. Rheum. Dis.
PD JUN
PY 2017
VL 76
IS 6
BP 1108
EP 1113
DI 10.1136/annrheumdis-2016-210713
PG 6
WC Rheumatology
SC Rheumatology
GA EU6IX
UT WOS:000401138800026
PM 28283512
OA No
DA 2017-08-17
ER

PT J
AU Hassaan, MS
   Goda, AS
   Kumar, V
AF Hassaan, M. S.
   Goda, A. M. A. -S.
   Kumar, V.
TI Evaluation of nutritive value of fermented de-oiled physic nut, Jatropha
   curcas, seed meal for Nile tilapia Oreochromis niloticus fingerlings
SO AQUACULTURE NUTRITION
LA English
DT Article
DE Bacillus licheniformis; Bacillus pumilus Jatropha seed meal; growth;
   Oreochromis niloticus; solid-state fermentation
ID SOLID-STATE FERMENTATION; TROUT ONCORHYNCHUS-MYKISS; DIETARY-PROTEIN
   SOURCE; CARPIO L. FINGERLINGS; AMINO-ACID PROFILES; SOYBEAN-MEAL;
   FISH-MEAL; SACCHAROMYCES-CEREVISIAE; CHEMICAL-COMPOSITION; NUTRIENT
   UTILIZATION
AB Jatropha curcas seed meal was fermented with Bacillus licheniformis (LFJSM) and Bacillus pumilus (PFJSM) separately using the solid-state fermentation. After fermentation, the crude protein and the total hydrolysed amino acid contents were increased in LFJSM and PFJSM, while fibre content, phytic acid, trypsin inhibitor and saponins were decreased. An 84-day feeding experiment was designed for the nutritional evaluation of LFJSM and PFJSM in Nile tilapia. Seven isonitrogenous (305.47 g kg(-1) crude protein) and isocaloric (18.21 MJ kg(-1) gross energy) diets were formulated by replacing 0% (control diet), 25% (LFJSM-25), 50% (LFJSM-50), 75% (LFJSM-75) and 25% (PFJSM-25), 50% (PFJSM-50) and 75% (PFJSM-75) of protein from fish meal with LFJSM and PFJSM. The higher weight gain and the best feed conversion ratio were found in fish fed control diet, PFJSM-25 and PFJSM-50, which were insignificantly different. Apparent digestibility coefficient values of dry matter, crude protein, lipid and digestible energy reached a plateau in fish fed PFJSM-25 and PFJSM-50. No significant differences were found in haematocrit, haemoglobin, serum alternative complement pathway components, alanine aminotransferase and aspartate aminotransferase and triglycerides between the control diet, LFJSM-25, LFJSM-50, PFJSM-25 and PFJSM-50 treatment groups. Therefore, these findings suggest that up 50% of fish meal can be replaced by PFJSM in Nile tilapia diets.
C1 [Hassaan, M. S.; Goda, A. M. A. -S.] NIOF, Fish Nutr Res Lab, Cairo, Egypt.
   [Kumar, V.] Kentucky State Univ, Coll Agr Food Sci & Sustainable Syst, Div Aquaculture, Frankfort, KY USA.
RP Hassaan, MS (reprint author), NIOF, Fish Nutr Res Lab, Cairo, Egypt.
EM Mohamed_shaban200065@yahoo.com
CR Abou-Arab A. A., 2010, African Journal of Food Science, V4, P93
   Aderibigbe AO, 1997, ANIM FEED SCI TECH, V67, P223, DOI 10.1016/S0377-8401(96)01136-4
   Cunni P. A., 1995, OFF METH AN AOAC INT, V1, P1298
   APHA, 1998, STAND METH EX WAT WA, P20
   Belewu M. A., 2011, International Journal of Biosciences (IJB), V1, P12
   Belewu M.A., 2010, J YEAST FUNGAL RES, V1, P44
   BRETT JR, 1973, J FISH RES BOARD CAN, V30, P1799
   Buddington RK, 1997, ACTA PHYSIOL SCAND, V161, P67
   Chatzifotis S, 1996, AQUACULTURE, V147, P235, DOI 10.1016/S0044-8486(96)01403-2
   Dajanta K, 2011, FOOD CHEM, V125, P342, DOI 10.1016/j.foodchem.2010.09.002
   Deyab D., 2009, EGYPT J AQUAT BIOL F, V13, P93
   DOUMAS BT, 1981, CLIN CHEM, V27, P1642
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   El-Saidy DMSD, 2011, AQUACULT NUTR, V17, P380, DOI 10.1111/j.1365-2095.2010.00810.x
   El-Saidy DMSD, 2004, AQUAC RES, V35, P859, DOI 10.1111/j.1365-2109.2004.01077.x
   El-Saidy DMSD, 2002, J WORLD AQUACULT SOC, V33, P297, DOI 10.1111/j.1749-7345.2002.tb00506.x
   El-Gamassy, 2008, IMPROVED WASTEWATER
   Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a
   Floreto EAT, 2000, AQUACULTURE, V189, P211, DOI 10.1016/S0044-8486(00)00363-X
   Furukawa A., 1966, NIPPON SUISAN GAKK, V32, P502
   GOMES EF, 1993, AQUACULTURE, V113, P339, DOI 10.1016/0044-8486(93)90404-M
   Hassaan MS, 2015, ANIM FEED SCI TECH, V201, P89, DOI 10.1016/j.anifeedsci.2015.01.007
   He S, 2011, J ANIM SCI, V89, P84, DOI 10.2527/jas.2010-3032
   Heidarieh M, 2013, AQUACULT NUTR, V19, P343, DOI 10.1111/j.1365-2095.2012.00973.x
   Henary R., 1974, CLIN CHEM PRINCIPLES
   HIAI S, 1976, PLANTA MED, V29, P116
   Holker U, 2005, CURR OPIN MICROBIOL, V8, P301, DOI 10.1016/j.mib.2005.04.006
   Hussein EES, 2013, AQUAC RES, V44, P937, DOI 10.1111/j.1365-2109.2012.03100.x
   Jacqueline E. W., 1996, ASSESSING POTENTIAL
   Joshi C, 2011, BIORESOURCE TECHNOL, V102, P4815, DOI 10.1016/j.biortech.2011.01.039
   Kader MA, 2012, AQUAC RES, V43, P1427, DOI 10.1111/j.1365-2109.2011.02945.x
   Kader MA, 2010, AQUACULTURE, V308, P136, DOI 10.1016/j.aquaculture.2010.07.037
   Kaushik SJ, 2004, AQUACULTURE, V230, P391, DOI 10.1016/S0044-8486(03)00422-8
   Kim SS, 2009, ASIAN AUSTRAL J ANIM, V22, P849
   Kumar V, 2011, AQUACULT NUTR, V17, P313, DOI 10.1111/j.1365-2095.2010.00777.x
   Kumar V, 2011, AQUACULT NUTR, V17, P451, DOI 10.1111/j.1365-2095.2010.00825.x
   Kumar V, 2010, FOOD CHEM TOXICOL, V48, P2063, DOI 10.1016/j.fct.2010.05.007
   LIBERALINO AAA, 1988, ARQ BIOL TECNOL, V31, P539
   Lovshin L. L., 2000, CRITERIA SELECTING N
   Makkar HPS, 2008, J SCI FOOD AGR, V88, P1542, DOI 10.1002/jsfa.3248
   Makkar HPS, 1999, ASIAN AUSTRAL J ANIM, V12, P467
   Martinez-Herrera J, 2006, FOOD CHEM, V96, P80, DOI 10.1016/j.foodchem.2005.01.059
   Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3
   PANDEY A, 1992, PROCESS BIOCHEM, V27, P109, DOI 10.1016/0032-9592(92)80017-W
   RACICOT JG, 1975, J FISH BIOL, V7, P825, DOI 10.1111/j.1095-8649.1975.tb04653.x
   Ramachandran S, 2007, BIORESOURCE TECHNOL, V98, P2000, DOI 10.1016/j.biortech.2006.08.002
   REDDY NR, 1994, FOOD RES INT, V27, P281, DOI 10.1016/0963-9969(94)90096-5
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Richter N, 2003, AQUACULTURE, V217, P599, DOI 10.1016/S0044-8486(02)00497-0
   Rock R. C., 1986, TXB CLIN CHEM, P1271
   Saha Sayanti, 2013, Proceedings of the Zoological Society (Calcutta), V66, P41, DOI 10.1007/s12595-012-0051-2
   Sarkar PK, 1997, FOOD CHEM, V59, P69, DOI 10.1016/S0308-8146(96)00118-5
   SAS, 1993, STAT AN SYST PROC GU
   Schneider O, 2004, AQUAC RES, V35, P1370, DOI 10.1111/j.1365-2109.2004.01179.x
   Shamna N, 2015, AQUACULT NUTR, V21, P33, DOI 10.1111/anu.12138
   Shiu YL, 2015, AQUAC RES, V46, P382, DOI 10.1111/are.12186
   SMITH C, 1980, J SCI FOOD AGR, V31, P341, DOI 10.1002/jsfa.2740310403
   Soltan M, 2005, EGYPTAIN J NUTR FEED, V8, P1111
   Svesbodora Z., 1991, UNIFIED METHODS HAEM
   Teng D, 2012, BIOCATAL AGR BIOTECH, V1, P32, DOI DOI 10.1016/J.BCAB.2011.08.005
   Thomas L., 1998, CLIN LAB DIAGNOSTICS, P667
   VAINTRAUB IA, 1988, ANAL BIOCHEM, V175, P227, DOI 10.1016/0003-2697(88)90382-X
   VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583
   Yuan YC, 2010, AQUACULTURE, V306, P238, DOI 10.1016/j.aquaculture.2010.05.017
   Zar J, 1984, BIOSTAT ANAL, V1, P185
   Zhang WJ, 2006, TOXICON, V48, P221, DOI 10.1016/j.toxicon.2006.05.003
   Zhang YX, 2012, AQUACULTURE, V354, P68, DOI 10.1016/j.aquaculture.2012.03.038
   Zhou F, 2011, J WORLD AQUACULT SOC, V42, P184, DOI 10.1111/j.1749-7345.2011.00455.x
NR 68
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1353-5773
EI 1365-2095
J9 AQUACULT NUTR
JI Aquac. Nutr.
PD JUN
PY 2017
VL 23
IS 3
BP 571
EP 584
DI 10.1111/anu.12424
PG 14
WC Fisheries
SC Fisheries
GA EU8BD
UT WOS:000401260900014
OA No
DA 2017-08-17
ER

PT J
AU Ibrahim, KS
   El-Yazbi, AF
   El-Gowelli, HM
   El-Mas, MM
AF Ibrahim, Karim S.
   El-Yazbi, Ahmed F.
   El-Gowelli, Hanan M.
   El-Mas, Mahmoud M.
TI Opposite Modulatory Effects of Selective and Non-Selective
   Cyclooxygenase Inhibition on Cardiovascular and Autonomic Consequences
   of Cyclosporine in Female Rats
SO BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
LA English
DT Article
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HEART-RATE-VARIABILITY;
   PHYSIOLOGICAL REGULATION; RHEUMATOID-ARTHRITIS; INDUCED HYPERTENSION;
   CONSCIOUS RATS; ENDOTHELIN ETA; AORTIC RINGS; CELECOXIB; BAROREFLEX
AB Non-steroidal anti-inflammatory drugs (NSAIDs) and the immunosuppressant drug cyclosporine (CSA) are concurrently administered in arthritis. Here, we investigated whether diclofenac (non-selective inhibitor of cyclooxygenase-1 and 2, COX-1/COX-2), celecoxib (selective COX-2 inhibitor) or SC560 (selective COX-1 inhibitor) interact variably with haemodynamic effects of CSA in conscious female rats. Changes caused by CSA (10 mg/kg i.v.) in blood pressure (BP), heart rate (HR), HR variability (HRV) and myocardial contractility were assessed in the absence and presence of individual NSAIDs (10 mg/kg each). Compared with vehicle values, CSA caused immediate and sustained (i) increases in BP and decreases in pulse pressure index (PPI) and HR, (ii) elevations in left ventricular (LV) contractility (dP/dt(max)) and isovolumic relaxation constant (au) and (iii) increases in the time- and frequency-domain indices of HRV and shifted the cardiac sympathovagal balance towards parasympathetic dominance. CSA hypertension was abolished in rats pre-treated with celecoxib and intensified in the presence of diclofenac or SC560. Alternatively, the CSA-evoked decreases in PPI, increases in HRV indices and cardiac parasympathetic dominance were blunted by celecoxib in contrast to no effect for diclofenac or SC560. Similarly, celecoxib, but not other NSAIDs, eliminated the elevated LV contractility (dP/dt(max)) and isovolumic relaxation constant (au, ), which reflect cardiac systolic and diastolic function, respectively, that accompanied the CSA-induced pressure load. The data underscore the preferential capacity of selective COX-2 inhibition by celecoxib to mitigate CSA hypertension and consequent alterations in cardiac performance and autonomic balance. By contrast, CSA effects are preserved or even exacerbated after COX-1 inhibition.
C1 [Ibrahim, Karim S.; El-Yazbi, Ahmed F.; El-Gowelli, Hanan M.; El-Mas, Mahmoud M.] Alexandria Univ, Dept Pharmacol & Toxicol, Fac Pharm, Alexandria 21521, Egypt.
RP El-Mas, MM (reprint author), Alexandria Univ, Dept Pharmacol & Toxicol, Fac Pharm, Alexandria 21521, Egypt.
EM mahelm@hotmail.com
FU ALEX-REP Grant Fund, Alexandria University [HLTH-13-01]
FX Supported by the ALEX-REP Grant Fund, Alexandria University (Grant
   HLTH-13-01).
CR Agca R, 2016, HEART, V102, P790, DOI 10.1136/heartjnl-2015-307838
   ALTMAN RD, 1992, AM J MED, V93, P396, DOI 10.1016/0002-9343(92)90169-C
   Ash Z, 2012, ANN RHEUM DIS, V71, P319, DOI 10.1136/ard.2011.150995
   Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103
   Camm AJ, 1996, CIRCULATION, V93, P1043
   Cauduro RL, 2005, CLIN TRANSPLANT, V19, P470, DOI 10.1111/j.1399-0012.2005.00357.x
   Cavalcante EGN, 2011, LUPUS, V20, P960, DOI 10.1177/0961203311400113
   Chuang HC, 2013, TOXICOL APPL PHARM, V266, P298, DOI 10.1016/j.taap.2012.11.006
   Coxib and traditional NSAID Trialists' (CNT) Collaboration, 2013, LANCET, V6736, P1
   Cunha NV, 2010, LIFE SCI, V87, P375, DOI 10.1016/j.lfs.2010.07.014
   El-Gowelli HM, 2015, N-S ARCH PHARMACOL, V388, P351, DOI 10.1007/s00210-014-1074-1
   El-Gowelli HM, 2014, TOXICOL APPL PHARM, V275, P88, DOI 10.1016/j.taap.2014.01.008
   El-Mas MA, 2005, LIFE SCI, V76, P901, DOI 10.1016/j.lfs.2004.10.002
   El-Mas MM, 2007, J CARDIOVASC PHARM, V49, P174, DOI 10.1097/FJC.0b013e3180318afb
   El-Mas MM, 2015, TOXICOL APPL PHARM, V284, P1, DOI 10.1016/j.taap.2015.01.018
   El-Mas MM, 2012, EUR J PHARMACOL, V694, P82, DOI 10.1016/j.ejphar.2012.08.021
   El-Mas MM, 2012, TOXICOL APPL PHARM, V258, P410, DOI 10.1016/j.taap.2011.12.011
   El-Mas MM, 2011, LIFE SCI, V88, P187, DOI 10.1016/j.lfs.2010.11.009
   El-Mas MM, 1999, J PHARMACOL EXP THER, V288, P455
   ElMas MM, 1997, ALCOHOL CLIN EXP RES, V21, P19
   ElMas MM, 1997, HYPERTENSION, V30, P288
   Feng GS, 2008, WORLD J GASTROENTERO, V14, P4535, DOI 10.3748/wjg.14.4535
   FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288
   Gardiner SM, 2004, BRIT J PHARMACOL, V141, P634, DOI 10.1038/sj.bjp.0705659
   Goldman RK, 2009, AM J PHYSIOL-REG I, V296, pR1419, DOI 10.1152/ajpregu.91030.2008
   Grzesk G, 2014, BIOMED REP, V2, P412
   Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614
   Hardy G, 2000, J CARDIOVASC PHARM, V36, P693, DOI 10.1097/00005344-200012000-00002
   Harris RC, 2001, AM J PHYSIOL-RENAL, V281, pF1
   Helmy MW, 2015, BRIT J PHARMACOL, V172, P4291, DOI 10.1111/bph.13199
   Huang Chien-Hua, 2011, Resuscitation, V82 Suppl 2, pS41, DOI 10.1016/S0300-9572(11)70150-2
   Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x
   Klein IHHT, 2010, J HYPERTENS, V28, P1928, DOI 10.1097/HJH.0b013e32833c20eb
   Klein T, 2007, CARDIOVASC RES, V75, P390, DOI 10.1016/j.cardiores.2007.02.026
   Kovarik JM, 1997, J CLIN PHARMACOL, V37, P336
   LaPointe MC, 2004, AM J PHYSIOL-HEART C, V286, pH1416, DOI 10.1152/ajpheart.00136.2003
   Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082
   MATSUBARA H, 1995, CIRCULATION, V92, P2318
   Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Nasser SA, 2014, EUR J PHARMACOL, V727, P52, DOI 10.1016/j.ejphar.2014.01.034
   Nishiyama A, 2003, HYPERTENSION, V42, P754, DOI 10.1161/01.HYP.0000085195.38870.44
   Omar AG, 2004, CARDIOVASC DRUG THER, V18, P461, DOI 10.1007/s10557-004-6223-1
   Oriji GK, 1996, PROSTAG LEUKOTR ESS, V55, P309, DOI 10.1016/S0952-3278(96)90036-8
   Peeters P, 2007, ACTA CLIN BELG, V62, P389
   Peng-Lin Y, 2009, MED HYPOTHESES, V72, P729, DOI 10.1016/j.mehy.2008.12.041
   Edward K., 2008, J PHARM SCI, V11, P81, DOI DOI 10.18433/J3T886
   Schertel ER, 1998, THORAC CARDIOV SURG, V46, P248, DOI 10.1055/s-2007-1013081
   Sehgal R, 2005, MEDIAT INFLAMM, P216, DOI 10.1155/MI.2005.216
   Shaltout HA, 2003, J PHARMACOL EXP THER, V305, P966, DOI 10.1124/jpet.102.048447
   Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405
   Straino S, 2007, J CARDIOVASC PHARM, V50, P571
   Sudano I, 2012, CURR HYPERTENS REP, V14, P304, DOI 10.1007/s11906-012-0274-7
   Trelle S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c7086
   Veltman JD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-464
   Yarishkin OV, 2009, KOREAN J PHYSIOL PHA, V13, P437, DOI 10.4196/kjpp.2009.13.6.437
   Yokoyama T, 2002, TRANSPLANT P, V34, P1405, DOI 10.1016/S0041-1345(02)02906-8
   Zhang WG, 2000, AM J HYPERTENS, V13, P999, DOI 10.1016/S0895-7061(00)00288-0
   Zhu CZ, 2015, EUR J PAIN, V19, P1527, DOI 10.1002/ejp.686
NR 59
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-7835
EI 1742-7843
J9 BASIC CLIN PHARMACOL
JI Basic Clin. Pharmacol. Toxicol.
PD JUN
PY 2017
VL 120
IS 6
BP 571
EP 581
DI 10.1111/bcpt.12754
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA EU6LR
UT WOS:000401146000007
PM 28054752
OA No
DA 2017-08-17
ER

PT J
AU Awad, M
   Pialek, L
   Kreji, A
   Laugier, G
   Nedved, O
AF Awad, Mona
   Pialek, Lubomir
   Kreji, Alena
   Laugier, Guillaume
   Nedved, Oldrich
TI Paternity following multiple mating in ladybird Harmonia axyridis
SO BIOCONTROL
LA English
DT Article
DE Coccinellidae; Microsatellites; Fertility; Sperm competition
ID ADALIA-BIPUNCTATA COLEOPTERA; 2-SPOT LADYBIRD; SEXUAL SELECTION;
   INTRASPECIFIC VARIATION; PROPYLEA-DISSECTA; SPERM PRECEDENCE;
   COCCINELLIDAE; BEETLE; FERTILIZATION; POLYMORPHISM
AB We investigated factors which may determine realised paternity following multiple mating in a promiscuous ladybird Harmonia axyridis (Pallas) (Coleoptera: Coccinellidae), namely the mating order and ability of males of different morphs to fertilize females. In experiments using males of two colour morphs, we found that the first male had a reproductive advantage over the second male (sperm precedence P2 = 0.38). Males of the melanic morph spectabilis had a reproductive advantage over males of the semi-melanic morph axyridis (P2 = 0.35). Analysis of paternity using microsatellites applied to young larvae, which avoids possible differential mortality of progeny, confirmed the precedence of the first male and higher paternity rate of colour morphs that are more frequent in the wild. Hatchability of eggs increased from 65% after the first mating to 85% after the second mating delayed by five days. Average duration of mating was 157 min and did not differ between the first and second mating and between the colour morphs of males.
C1 [Awad, Mona; Pialek, Lubomir; Kreji, Alena; Nedved, Oldrich] Univ South Bohemia, Fac Sci, Ceske Budejovice 1760, Czech Republic.
   [Awad, Mona; Kreji, Alena; Nedved, Oldrich] Acad Sci Czech Republic, Inst Entomol, Branisovska 31, Ceske Budejovice, Czech Republic.
   [Awad, Mona] Cairo Univ, Fac Agr, Giza 12613, Egypt.
   [Laugier, Guillaume] INRA CBGP, F-34398 Montpellier 5, France.
   [Laugier, Guillaume] Ctr Estudios Avanzados Zonas Aridas, Raul Bitran 1305, La Serena, Chile.
RP Nedved, O (reprint author), Univ South Bohemia, Fac Sci, Ceske Budejovice 1760, Czech Republic.
EM nedved@prf.jcu.cz
FU Ministry of Agriculture [QH82047]; Academy of Science of the Czech
   Republic [ASRT-16-06]; RVO in Biology Center [60077344]
FX The study was conducted with support from the Ministry of Agriculture,
   grant number QH82047, mobility project ASRT-16-06 funded by the Academy
   of Science of the Czech Republic, and with institutional support RVO:
   60077344 in Biology Center. We are grateful to Tom Fayle and John
   Sloggett for their valuable comments and corrections of the early
   version of the manuscript and an anonymous reviewer for his persistent
   force on the later improvement.
CR Awad Mona, 2015, Acta Societatis Zoologicae Bohemicae, V79, P11
   Awad M, 2015, APPL ENTOMOL ZOOL, V50, P427, DOI 10.1007/s13355-015-0348-5
   Awad M, 2013, BIOCONTROL, V58, P657, DOI 10.1007/s10526-013-9512-4
   BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21
   Birkhead TR, 1998, SPERM COMPETITION SE
   Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191
   Chaudhary DD, 2016, BEHAV PROCESS, V131, P1, DOI 10.1016/j.beproc.2016.07.015
   Darwin C., 1871, DESCENT MAN SELECTIO
   de Jong PW, 1998, BEHAV ECOL, V9, P559, DOI 10.1093/beheco/9.6.559
   DEJONG PW, 1993, HEREDITY, V70, P172, DOI 10.1038/hdy.1993.26
   Dougherty LR, 2016, ANIM BEHAV, V116, P13, DOI 10.1016/j.anbehav.2016.03.003
   Eberhard WG, 1996, FEMALE CONTROL SEXUA
   Garcia-Gonzalez F, 2007, CURR BIOL, V17, P32, DOI 10.1016/j.cub.2006.10.054
   Haddrill PR, 2008, MOL ECOL, V17, P3189, DOI 10.1111/j.1365-294X.2008.03812.x
   Haddrill PR, 2007, EUR J ENTOMOL, V104, P393
   Haelewaters D, 2017, BIOCONTROL, V62, P355, DOI 10.1007/s10526-016-9766-8
   Harvey IF, 2000, P ROY SOC B-BIOL SCI, V267, P2537, DOI 10.1098/rspb.2000.1317
   Hodek I, 2000, EUR J ENTOMOL, V97, P449
   Hodek I., 1973, BIOL COCCINELLIDAE
   Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x
   Kaufmann T, 1996, ANN ENTOMOL SOC AM, V89, P238
   Kenis M, 2017, BIOCONTROL, V62, P341, DOI 10.1007/s10526-016-9764-x
   Loiseau A, 2009, MOL ECOL RESOUR, V9, P934, DOI 10.1111/j.1755-0998.2009.02517.x
   Mishra G, 2014, J ETHOL, V32, P165, DOI 10.1007/s10164-014-0405-5
   Nedved Oldrich, 2012, P54
   Nedvedova T., 2013, IOBC/WPRS Bulletin, V94, P117
   OBATA S, 1991, P207
   Obata S., 1988, P39
   OBATA S, 1987, CAN ENTOMOL, V119, P603
   Okuda T, 2000, INVERTEBR REPROD DEV, V38, P71, DOI 10.1080/07924259.2000.9652438
   Omkar, 2006, Insect Science, V13, P301, DOI 10.1111/j.1744-7917.2006.00098.x
   Omkar, 2012, J ASIA-PAC ENTOMOL, V15, P219, DOI 10.1016/j.aspen.2011.12.002
   OSAWA N, 1992, HEREDITY, V69, P297
   Perry JC, 2009, ANIM BEHAV, V77, P743, DOI 10.1016/j.anbehav.2008.12.013
   R Core Team, 2016, R LANG ENV STAT COMP
   Reznik SY, 2015, EUR J ENTOMOL, V112, P642
   Riddick EW, 2017, BIOCONTROL, V62, P319, DOI 10.1007/s10526-016-9758-8
   Roy HE, 2016, BIOL INVASIONS, V18, P997, DOI 10.1007/s10530-016-1077-6
   Shahid M, 2016, EUR J ENTOMOL, V113, P44, DOI 10.14411/eje.2016.005
   Simmons LW, 2001, J EVOLUTION BIOL, V14, P585, DOI 10.1046/j.1420-9101.2001.00309.x
   Soper D, 2013, STAT CALCULATORS V 3
   StatSoft Inc, 2011, STATISTICA DAT AN SO
   Thomas ML, 2015, AUSTRAL ENTOMOL, V54, P433, DOI 10.1111/aen.12144
   Thornhill R, 1983, EVOLUTION INSECT MAT
   UENO H, 1994, J ETHOL, V12, P169, DOI 10.1007/BF02350061
   Ueno H, 1996, APPL ENTOMOL ZOOL, V31, P621
   Wang S, 2015, B ENTOMOL RES, V105, P245, DOI 10.1017/S0007485315000036
NR 47
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1386-6141
EI 1573-8248
J9 BIOCONTROL
JI Biocontrol
PD JUN
PY 2017
VL 62
IS 3
SI SI
BP 297
EP 307
DI 10.1007/s10526-017-9806-z
PG 11
WC Entomology
SC Entomology
GA EU4HO
UT WOS:000400990600002
OA No
DA 2017-08-17
ER

PT J
AU Mesbah, NM
   Wiegel, J
AF Mesbah, Noha M.
   Wiegel, Juergen
TI A Halophilic, Alkalithermostable, Ionic Liquid-Tolerant Cellulase and
   Its Application in In Situ Saccharification of Rice Straw
SO BIOENERGY RESEARCH
LA English
DT Article
DE Cellulase; Halophilic; Alkalithermophilic; Wadi An Natrun; Ionic liquid
ID LIGNOCELLULOSIC BIOMASS; ENZYMATIC-HYDROLYSIS; ORGANIC-SOLVENTS; STABLE
   CELLULASE; PRETREATMENT; ENZYMES
AB A cellulase, En5H, from halophilic, alkalithermophilic Alkalilimnicola sp. NM-DCM1 was expressed and purified. En5H had maximal hydrolytic activity at 55 A degrees C, pH 8.8, and 2.5 M NaCl. En5H is beta-1,4 linkage-specific, hydrolyzing carboxymethyl cellulose, Avicel, cellobiose, and p-nitrophenyl beta-d-glucopyranoside. En5H was resistant to inhibitors and organic solvents. The half-life of En5H was increased 16-43-fold when incubated in 20% (v/v) of ionic liquids (IL) at 55 A degrees C in the presence of 2.5 M NaCl, and maximal hydrolytic activity of En5H in 10% (v/v) 1-allyl-3-methylimidazolium chloride and 1,3-dimethylimidazolium dimethyl phosphate was 122 and 110%, respectively, as compared with activity in buffer. A cellulase-IL system combining IL pretreatment and enzymatic saccharification was tested. With an enzyme load of 110 U/g rice straw, the conversion of rice straw cellulose and hemicellulose increased by 28% compared with unpretreated rice straw. En5H has potential for use in transformation of lignocellulose to glucose in a single-step process.
C1 [Mesbah, Noha M.] Suez Canal Univ, Dept Biochem, Fac Pharm, Ismailia 41522, Egypt.
   [Wiegel, Juergen] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.
RP Mesbah, NM (reprint author), Suez Canal Univ, Dept Biochem, Fac Pharm, Ismailia 41522, Egypt.
EM noha_mesbah@pharm.suez.edu.eg
OI Mesbah, Noha/0000-0002-8863-968X
FU US-Egypt Science and Technology Joint Fund; Suez Canal University
   (Egypt) [1841]; University of Georgia (USA) [NSF-OISE-1132412]
FX This work was supported in part by the US-Egypt Science and Technology
   Joint Fund in cooperation with the Suez Canal University (Egypt) under
   project number 1841 and the University of Georgia (USA) under project
   number NSF-OISE-1132412.
CR Anish R, 2007, BIOTECHNOL BIOENG, V96, P48, DOI 10.1002/bit.21175
   Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186
   Benhmad I, 2016, BIOPROC BIOSYST ENG, V39, P685, DOI 10.1007/s00449-016-1549-1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365
   Constatinescu D, 2010, PHYS CHEM CHEM PHYS, V12, P1756, DOI 10.1039/b921037g
   Dougherty MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100836
   Farahani SV, 2016, CATAL TODAY, V269, P2, DOI 10.1016/j.cattod.2015.12.022
   Fu DB, 2011, BIORESOURCE TECHNOL, V102, P7008, DOI 10.1016/j.biortech.2011.04.049
   Gaur R, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0129-9
   Gunny AAN, 2014, BIORESOURCE TECHNOL, V155, P177, DOI 10.1016/j.biortech.2013.12.101
   Henrissat B, 1996, P NATL ACAD SCI USA, V93, P5674
   Kamiya N, 2008, BIOTECHNOL LETT, V30, P1037, DOI 10.1007/s10529-008-9638-0
   Kim JS, 2016, BIORESOURCE TECHNOL, V199, P42, DOI 10.1016/j.biortech.2015.08.085
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li Q, 2010, APPL MICROBIOL BIOT, V87, P117, DOI 10.1007/s00253-010-2484-8
   Maki-Arvela P, 2010, IND CROP PROD, V32, P175, DOI 10.1016/j.indcrop.2010.04.005
   Mesbah NM, 2014, INT J BIOL MACROMOL, V70, P222, DOI 10.1016/j.ijbiomac.2014.06.053
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Nordwald EM, 2013, BIOTECHNOL BIOENG, V110, P2352, DOI 10.1002/bit.24910
   Ogino H, 2001, J BIOSCI BIOENG, V91, P109, DOI 10.1263/jbb.91.109
   Oren A, 2010, ENVIRON TECHNOL, V31, P825, DOI 10.1080/09593330903370026
   Orencio-Trejo M, 2016, BIOENERG RES, DOI [10.1007/s12155-12016-19797-12150, DOI 10.1007/S12155-12016-19797-12150]
   Raddadi N, 2013, BIORESOURCE TECHNOL, V150, P121, DOI 10.1016/j.biortech.2013.09.089
   Reddy AP, 2012, J APPL MICROBIOL, V113, P1362, DOI 10.1111/jam.12002
   Shi J, 2013, GREEN CHEM, V15, P2579, DOI 10.1039/c3gc40545a
   Shi RR, 2013, BIORESOURCE TECHNOL, V142, P338, DOI 10.1016/j.biortech.2013.05.037
   Sindhu R, 2016, BIORESOURCE TECHNOL, V199, P76, DOI 10.1016/j.biortech.2015.08.030
   Sluiter A., 2010, NRELTP51042618
   Sun N, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-39
   Sun SN, 2016, BIORESOURCE TECHNOL, V199, P49, DOI 10.1016/j.biortech.2015.08.061
   Trivedi N, 2013, BIORESOURCE TECHNOL, V132, P313, DOI 10.1016/j.biortech.2013.01.040
   Wahlstrom RM, 2015, GREEN CHEM, V17, P694, DOI 10.1039/c4gc01649a
   Wahlstrom R, 2012, RSC ADV, V2, P4472, DOI 10.1039/c2ra01299e
   Wang Y, 2011, BIOTECHNOL BIOENG, V108, P1042, DOI [10.1002/bit.23045, 10.1002/btpr.566]
   Wilson K, 1997, CURRENT PROTOCOLS MO
   Xu JX, 2016, BIOMASS BIOENERG, V93, P180, DOI 10.1016/j.biombioe.2016.07.019
   Xu JX, 2016, BIORESOURCE TECHNOL, V200, P961, DOI 10.1016/j.biortech.2015.10.031
   Xu JX, 2015, CHEM ENG J, V267, P163, DOI 10.1016/j.cej.2014.12.112
   Xu JX, 2014, BIORESOURCE TECHNOL, V157, P166, DOI 10.1016/j.biortech.2014.01.102
   Yin J, 2015, BIOTECHNOL ADV, V33, P1433, DOI 10.1016/j.biotechadv.2014.10.008
   Yu HY, 2015, BIOMASS BIOENERG, V81, P19, DOI 10.1016/j.biombioe.2015.05.020
   Zavrel M, 2009, BIORESOURCE TECHNOL, V100, P2580, DOI 10.1016/j.biortech.2008.11.052
   Zhang T, 2011, GREEN CHEM, V13, P2083, DOI 10.1039/c1gc15193b
NR 44
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1939-1234
EI 1939-1242
J9 BIOENERG RES
JI BioEnergy Res.
PD JUN
PY 2017
VL 10
IS 2
BP 583
EP 591
DI 10.1007/s12155-017-9825-8
PG 9
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA EU2LR
UT WOS:000400861200025
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, HH
   Abd El-Maksoud, MD
   Moneim, AEA
   Aglan, HA
AF Ahmed, Hanaa H.
   Abd El-Maksoud, Mohamed Diaa
   Moneim, Ahmed E. Abdel
   Aglan, Hadeer A.
TI Pre-Clinical Study for the Antidiabetic Potential of Selenium
   Nanoparticles
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE Elemental selenium nanoparticles; Liposome; Diabetes; Oxidative stress;
   Inflammation; Rats
ID INDUCED DIABETIC-RATS; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN;
   OXIDATIVE STRESS; PROINFLAMMATORY CYTOKINES; ANTIOXIDANT STATUS; SODIUM
   SELENITE; NANO-PARTICLES; BLOOD-PRESSURE; NIDDM PATIENTS
AB This research was delineated to explore the efficacy of selenium nanoparticles delivered in liposomes (L-Se) in the mitigation of type-2 diabetes mellitus. Adult female Wistar rats were assigned into four groups: group I, the normal control group in which the rats received normal saline solution orally; group II, the diabetic control group in which the rats were injected intraperitoneally with a single dose of streptozotocin (STZ) for induction of diabetes; group III, the metformin (Met)-treated group in which the diabetic rats were treated orally with Met; and group IV, the L-Se-treated group in which the diabetic rats were treated orally with L-Se. All treatments were delivered for 21 days. Blood and pancreas tissue samples were obtained for biochemical analysis, immunohistochemical examinations, and histopathological investigation. The L-Se-treated group showed significant drop in serum glucose and pancreatic malondialdehyde (MDA), nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), and prostaglandin F2 alpha (PGF2 alpha) levels associated with significant rise in serum insulin and pancreatic glutathione, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) values, in addition to significant improvement in the immunohistochemical indices (insulin and glucagon). Aforementioned results are appreciated by the histopathological findings of pancreatic tissue. In conclusion, our data have brought about compelling evidence favoring the antidiabetic potency of elemental selenium nanoparticles delivered in liposomes through preservation of pancreatic beta cell integrity with consequent increment of insulin secretion and in turn glucose depletion, repression of oxidative stress, potentiation of the antioxidant defense system, and inhibition of pancreatic inflammation.
C1 [Ahmed, Hanaa H.; Aglan, Hadeer A.] Natl Res Ctr, Hormones Dept, 33 El Bohouth St,PO 12622, Giza, Egypt.
   [Abd El-Maksoud, Mohamed Diaa] Natl Res Ctr, Dept Biochem, Giza, Egypt.
   [Moneim, Ahmed E. Abdel] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt.
RP Ahmed, HH (reprint author), Natl Res Ctr, Hormones Dept, 33 El Bohouth St,PO 12622, Giza, Egypt.
EM hanaaomr@yahoo.com
OI Abdel Moneim, Ahmed/0000-0002-2654-2591
CR Abdelaleem RMA, 2016, INDIAN J PHARM EDUC, V50, P170, DOI 10.5530/ijper.50.1.21
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Aguirre F, 1998, FREE RADICAL BIO MED, V24, P580, DOI 10.1016/S0891-5849(97)00293-1
   Al-Quraishy S, 2015, INT J NANOMED, V10, P6741, DOI 10.2147/IJN.S91377
   Andrews M, 2012, REV MED CHILE, V140, P1377, DOI 10.4067/S0034-98872012001100001
   Banchroft J. D., 1996, THEORY PRACTICE HIST
   Beisswenger P, 2003, DIABETES METAB, V29, pS95
   Birben Esra, 2012, World Allergy Organ J, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Campbell SC, 2008, FEBS LETT, V582, P2333, DOI 10.1016/j.febslet.2008.05.038
   Ceriello A, 1997, DIABETES CARE, V20, P194, DOI 10.2337/diacare.20.2.194
   Chakraborty A, 2011, DIABETES RES CLIN PR, V93, P56, DOI 10.1016/j.diabres.2010.11.030
   Cuncio F, 1995, THROMB DIATH HAEMO, V74, P963
   DEFRONZO RA, 1991, J CLIN ENDOCR METAB, V73, P1294
   Dwivedi C, 2011, J NANOTECHNOL, V2011, P1, DOI DOI 10.1155/2011/651971
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Eskander EF, 2000, ARAB J LAB MED, V26, P185
   Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE
   Factor VM, 1998, J BIOL CHEM, V273, P15846, DOI 10.1074/jbc.273.25.15846
   Faure P, 1999, DIABETES, V48, P353, DOI 10.2337/diabetes.48.2.353
   FAZILATI M, 2016, INT J BIOL PHARM ALL, V5, P335
   Gorray K C, 1986, Pancreas, V1, P130, DOI 10.1097/00006676-198603000-00004
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Hassan Z, 2010, MOLECULES, V15, P9008, DOI 10.3390/molecules15129008
   Hassanin KMA, 2013, INT J NANOMED, V8, P1713, DOI 10.2147/IJN.S42736
   Hei YJ, 1998, MOL CELL BIOCHEM, V178, P367, DOI 10.1023/A:1006819906820
   Hull RL, 2005, DIABETES, V54, P2235, DOI 10.2337/diabetes.54.7.2235
   Hyun Bobae, 2013, Immune Netw, V13, P123, DOI 10.4110/in.2013.13.4.123
   Ilahi I, 2012, ISRN PHARM, V2012, DOI 10.5402/2012/478023
   Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75
   Ito M, 2001, ENVIRON TOXICOL PHAR, V9, P71, DOI 10.1016/S1382-6689(00)00064-8
   Jozanov-Stankov Olga, 1998, Journal of Environmental Pathology Toxicology and Oncology, V17, P251
   Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398
   Kanter M, 2004, ANAT REC PART A, V279A, P685, DOI 10.1002/ar.a.20056
   Kato Y, 2010, HORM METAB RES, V42, P632, DOI 10.1055/s-0030-1255033
   Kim J, 2014, J BIOL CHEM, V289, P23246, DOI 10.1074/jbc.M114.577908
   KIM S, 1985, BIOCHIM BIOPHYS ACTA, V812, P793, DOI 10.1016/0005-2736(85)90274-3
   Kohrle J, 2000, BIOL CHEM, V381, P849, DOI 10.1515/BC.2000.107
   Kosegawa I, 1999, CLIN EXP HYPERTENS, V21, P199, DOI 10.3109/10641969909068661
   Liao CD, 2010, FOOD CHEM, V119, P896, DOI 10.1016/j.foodchem.2009.07.056
   Loeschner K, 2014, METALLOMICS, V6, P330, DOI 10.1039/c3mt00309d
   Majithiya JB, 2006, LIFE SCI, V78, P2615, DOI 10.1016/j.lfs.2005.10.020
   Matough Fatmah A, 2012, Sultan Qaboos Univ Med J, V12, P5
   Matsuoka T, 1997, J CLIN INVEST, V99, P144, DOI 10.1172/JCI119126
   Mercuri F, 2000, Diabetes Technol Ther, V2, P589, DOI 10.1089/15209150050502014
   Mohammed ET, 2013, BENI SUEF UNI J BASI, V2, P80, DOI 10.1016/j.bjbas.2013.01.003
   Mohapatra P, 2014, INT J PHARMACOL, V10, P160, DOI 10.3923/ijp.2014.160.167
   Mueller AS, 2006, J NUTR BIOCHEM, V17, P548, DOI 10.1016/j.jnutbio.2005.10.006
   Neri S, 2005, CLIN THER, V27, P1764, DOI 10.1016/j.clinthera.2005.11.006
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Park K, 2012, DIABETES CARE, V35, P1544, DOI 10.2337/dc11-2136
   Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   RODEN M, 1995, HEPATOLOGY, V22, P169, DOI 10.1016/0270-9139(95)90370-4
   Schottker B, 2013, DIABETES CARE, V36, P1703, DOI 10.2337/dc12-1416
   Simmons RA, 2012, BEST PRACT RES CL EN, V26, P701, DOI 10.1016/j.beem.2012.03.012
   SPANGLER RS, 1990, DIABETES CARE, V13, P911, DOI 10.2337/diacare.13.9.911
   Srivastava P, 2014, BIOTECHNOL PROGR, V30, P1480, DOI 10.1002/btpr.1992
   Sternberger L. A., 1979, IMMUNOCYTOCHEMISTRY
   TEMPLE R, 1992, DIABETIC MED, V9, P503
   Tessier D, 1999, METABOLISM, V48, P897, DOI 10.1016/S0026-0495(99)90226-3
   Tong WM, 1998, METABOLISM, V47, P415, DOI 10.1016/S0026-0495(98)90052-X
   TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158
   Usha J, 2011, J CLIN DIAGN RES, V5, P70
   Wang H, 2005, ACTA PHARMACOL SIN, V26, P745, DOI 10.1111/j.1745-7254.2005.00110.x
   Wang JG, 2014, FOOD CHEM TOXICOL, V68, P183, DOI 10.1016/j.fct.2014.03.003
   Wang YX, 2011, CZECH J ANIM SCI, V56, P305
   Wei Michael, 2003, Heart Lung Circ, V12, P44, DOI 10.1046/j.1444-2892.2003.00160.x
   YU B, 1994, BIOCHEM PHARMACOL, V48, P949, DOI 10.1016/0006-2952(94)90365-4
   Zeng JH, 2009, J NUTR BIOCHEM, V20, P530, DOI 10.1016/j.jnutbio.2008.05.012
   Ziegler D, 2004, DIABETES CARE, V27, P2178, DOI 10.2337/diacare.27.9.2178
NR 74
TC 0
Z9 0
U1 9
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
EI 1559-0720
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD JUN
PY 2017
VL 177
IS 2
BP 267
EP 280
DI 10.1007/s12011-016-0876-z
PG 14
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EU1JO
UT WOS:000400775100007
PM 27785741
OA No
DA 2017-08-17
ER

PT J
AU Jung, TW
   Kim, HC
   El-Aty, AMA
   Jeong, JH
AF Jung, Tae Woo
   Kim, Hyung-Chun
   El-Aty, A. M. Abd
   Jeong, Ji Hoon
TI Protectin DX suppresses hepatic gluconeogenesis through
   AMPK-HO-1-mediated inhibition of ER stress
SO CELLULAR SIGNALLING
LA English
DT Article
DE Protectin DX; Gluconeogenesis; Endoplasmic reticulum stress;
   AMP-activated protein kinase; Heme oxygenase 1
ID ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; HEME OXYGENASE-1
   GENE; GLUCOSE-HOMEOSTASIS; INSULIN ACTION; IN-VIVO; EXPRESSION; INJURY;
   LIVER; DEPHOSPHORYLATION
AB Several studies have shown that protectins, which are ca-3 fatty acid-derived proresolution mediators, may improve insulin resistance. Recently, protectin DX (PDX) was documented to attenuate insulin resistance by stimulating IL-6 expression in skeletal muscle, thereby regulating hepatic gluconeogenesis. These findings made us investigate the direct effects of PDX on hepatic glucose metabolism in the context of diabetes. In the current study, we show that PDX regulates hepatic gluconeogenesis in a manner distinct from its indirect glucoregulatory activity via IL-6. We found that PDX stimulated AMP-activated protein kinase (AMPK) phosphorylation, thereby inducing heme oxygenase 1 (HO-1) expression. This induction blocked hepatic gluconeogenesis by suppressing endoplasmic reticulum (ER) stress in hepatocytes under hyperlipidemic conditions. These effects were significantly dampened by silencing AMPK or HO-1 expression with small interfering RNA (siRNA). We also demonstrated that administration of PDX to high fat diet (HFD)-fed mice resulted in increased hepatic AMPK phosphorylation and HO-1 expression, whereas hepatic ER stress was substantially attenuated. Furthermore, PDX treatment suppressed the expression of gluconeogenic genes, thereby decreasing blood glucose levels in HFD-fed mice. In conclusion, our findings suggest that PDX inhibits hepatic gluconeogenesis via AMPK-H0-1-dependent suppression of ER stress. Thus, PDX may be an effective therapeutic target for the treatment of insulin resistance and type 2 diabetes through the regulation of hepatic gluconeogenesis.
C1 [Jung, Tae Woo] Seoul Natl Univ, Res Adm Team, Bundang Hosp, Gyeonggi, South Korea.
   [Kim, Hyung-Chun] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon, South Korea.
   [Jeong, Ji Hoon] Chung Ang Univ, Dept Pharmacol, Coll Med, 221 Heuksuk Dong, Seoul 156756, South Korea.
   [El-Aty, A. M. Abd] Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza 12211, Egypt.
   [El-Aty, A. M. Abd] Konkuk Univ, Dept Vet Pharmacol & Toxicol, Coll Vet Med, Seoul 143701, South Korea.
RP Jeong, JH (reprint author), Chung Ang Univ, Dept Pharmacol, Coll Med, 221 Heuksuk Dong, Seoul 156756, South Korea.
EM jhjeong3@cau.ac.kr
OI Abd El-Aty, A. M./0000-0001-6596-7907
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT and Future Planning
   [2016R1C1B2012674]
FX This study was supported by Basic Science Research Program through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Science, ICT and Future Planning (2016R1C1B2012674).
CR Ben-Ari Z, 2013, APOPTOSIS, V18, P547, DOI 10.1007/s10495-013-0814-x
   BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533
   Chen P, 2009, FEBS LETT, V583, P3478, DOI 10.1016/j.febslet.2009.10.004
   Chen Y., 2016, OXID MED CELL LONGEV, V2016
   Cheng ZY, 2012, NAT MED, V18, P351, DOI 10.1038/nm.2694
   Chung J, 2011, MOL IMMUNOL, V48, P1793, DOI 10.1016/j.molimm.2011.05.014
   Chute C G, 1991, Proc Annu Symp Comput Appl Med Care, P185
   Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010
   Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200
   CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550
   Courtney AE, 2008, AM J KIDNEY DIS, V51, P678, DOI 10.1053/j.ajkd.2007.11.033
   Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637
   Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331
   Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8
   Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200
   Kim H, 2015, AM J PHYSIOL-RENAL, V308, pF226, DOI 10.1152/ajprenal.00495.2014
   Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381
   Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684
   Liu XM, 2007, CARDIOVASC RES, V75, P381, DOI 10.1016/j.cardiores.2007.03.004
   Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010
   Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011
   Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219
   Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9
   Serhan CN, 2006, J IMMUNOL, V176, P1848
   Sikorski EM, 2004, AM J PHYSIOL-RENAL, V286, pF425, DOI 10.1152/ajprenal.00297.2003
   Son Y, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/639541
   Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005
   Viollet B, 2009, FRONT BIOSCI, V14, P3380, DOI 10.2741/4060
   Wang HQ, 2009, BRIT J PHARMACOL, V158, P1405, DOI 10.1111/j.1476-5381.2009.00455.x
   Wang Y, 2011, J BIOL CHEM, V286, P11119, DOI 10.1074/jbc.M110.203323
   White PJ, 2015, METABOLISM, V64, P666, DOI 10.1016/j.metabol.2015.01.017
   White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549
   Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JC126373
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zimmermann K, 2015, FREE RADICAL BIO MED, V88, P417, DOI 10.1016/j.freeradbiomed.2015.03.030
NR 38
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0898-6568
EI 1873-3913
J9 CELL SIGNAL
JI Cell. Signal.
PD JUN
PY 2017
VL 34
BP 133
EP 140
DI 10.1016/j.cellsig.2017.03.013
PG 8
WC Cell Biology
SC Cell Biology
GA EU9VU
UT WOS:000401388600014
PM 28342842
OA No
DA 2017-08-17
ER

PT J
AU Negm, OH
   MacKenzie, B
   Hamed, MR
   Ahmad, OAJ
   Shone, CC
   Humphreys, DP
   Acharya, KR
   Loscher, CE
   Marszalowska, I
   Lynch, M
   Wilcox, MH
   Monaghan, TM
AF Negm, O. H.
   MacKenzie, B.
   Hamed, M. R.
   Ahmad, O. A. J.
   Shone, C. C.
   Humphreys, D. P.
   Acharya, K. Ravi
   Loscher, C. E.
   Marszalowska, I.
   Lynch, M.
   Wilcox, M. H.
   Monaghan, T. M.
TI Protective antibodies against Clostridium difficile are present in
   intravenous immunoglobulin and are retained in humans following its
   administration
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Article
DE antibodies; Clostridium difficile; intravenous immunoglobulin
ID HUMORAL IMMUNE-RESPONSES; TOXIN-A; MONOCLONAL-ANTIBODIES; INFECTION;
   RECURRENCE; DIARRHEA; DISEASE; ASSOCIATION; MORTALITY; SEVERITY
AB The prevalence of serum antibodies against Clostridium difficile (CD) toxins A and B in healthy populations have prompted interest in evaluating the therapeutic activity of intravenous immunoglobulin (IVIg) in individuals experiencing severe or recurrent C. difficile infection (CDI). Despite some promising case reports, a definitive clinical role for IVIg in CDI remains unclear. Contradictory results may be attributed to a lack of consensus regarding optimal dose, timing of administration and patient selection as well as variability in specific antibody content between commercial preparations. The purpose of this study was to investigate retrospectively the efficacy of three commercial preparations of IVIg for treating severe or recurrent CDI. In subsequent mechanistic studies using protein microarray and toxin neutralization assays, all IVIg preparations were analysed for specific binding and neutralizing antibodies (NAb) to CD antigens in vitro and the presence of anti-toxin NAbs in vivo following IVIg infusion. A therapeutic response to IVIg was observed in 41% (10 of 17) of the CDI patients. Significant variability in multi-isotype specific antibodies to a 7-plex panel of CD antigens and toxin neutralization efficacies were observed between IVIg preparations and also in patient sera before and after IVIg administration. These results extend our current understanding of population immunity to CD and support the inclusion of surface layer proteins and binary toxin antigens in CD vaccines. Future strategies could enhance IVIg treatment response rates by using protein microarray to preselect donor plasma/serum with the highest levels of anti-CD antibodies and/or anti-toxin neutralizing capacities prior to fractionation.
C1 [Negm, O. H.; Hamed, M. R.; Ahmad, O. A. J.] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England.
   [Negm, O. H.; Hamed, M. R.] Mansoura Univ, Med Microbiol & Immunol Dept, Fac Med, Mansoura 35516, Egypt.
   [MacKenzie, B.; Humphreys, D. P.] UCB Celltech, Slough SL1 3WE, Berks, England.
   [Shone, C. C.] Publ Hlth England, Salisbury SP4 OJG, Wilts, England.
   [Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.
   [Loscher, C. E.; Marszalowska, I.; Lynch, M.] Dublin City Univ, Immunomodulat Res Grp, Dublin 9, Ireland.
   [Wilcox, M. H.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds LS1 3EX, W Yorkshire, England.
   [Monaghan, T. M.] Univ Nottingham, NIHR Biomed Res Unit Gastrointestinal & Liver Dis, Nottingham NG7 2UH, England.
   [Monaghan, T. M.] Univ Nottingham, Nottingham NG7 2UH, England.
RP Monaghan, TM (reprint author), Univ Nottingham, NIHR Biomed Res Unit Gastrointestinal & Liver Dis, Nottingham NG7 2UH, England.; Monaghan, TM (reprint author), Univ Nottingham, Nottingham NG7 2UH, England.
EM tanya.monaghan@nottingham.ac.uk
FU University of Nottingham Hermes Fellowship; NIHR Nottingham Digestive
   Diseases Biomedical Research Unit
FX We thank Drs V. Weston, E. Drewe, E. McDermott and V. Prashantha for
   providing permissions to access IVIg patients for this study. We also
   gratefully acknowledge the IVIg neurology (F. McGinley and S. White) and
   immunology (R. Weldon) nurse specialists for their help in recruiting
   and acquiring blood samples from patients' pre- and post-IVIg therapy.
   We acknowledge support from Dr Paddy Tighe to use the Post-Genomic
   Technologies Facility ( School of Life Sciences, University of
   Nottingham). Special thanks go to M. Lingaya and Y. Falcone for their
   assistance with sample handling and storage. We also thank Sahar Elkady,
   Gyasi-Antwi Philemon and Dr Abigail Davies for their help in this
   project. We thank Professor Danny Altmann for kindly reviewing the
   manuscript. T. M. M. and O. H. N. were supported by a University of
   Nottingham Hermes Fellowship and the NIHR Nottingham Digestive Diseases
   Biomedical Research Unit. The views expressed are those of the authors
   and not necessarily those of the National Health Service (NHS), the
   National Institute for Health Research or the Department of Health.
CR Abougergi MS, 2011, DIGEST DIS SCI, V56, P19, DOI 10.1007/s10620-010-1411-2
   Alexander BT, 2010, PHARMACOTHERAPY, V30, P554, DOI 10.1592/phco.30.6.554
   BACON AE, 1994, DIAGN MICR INFEC DIS, V18, P205, DOI 10.1016/0732-8893(94)90021-3
   Bauer MP, 2014, CLIN MICROBIOL INFEC, V20, P1323, DOI 10.1111/1469-0691.12769
   Bihl F, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-71
   Boyce N, 2001, TRANSFUS MED REV, V15, P157, DOI 10.1053/tmrv.2001.22618
   Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002
   Cao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064024
   Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12
   Gupta SB, 2016, CLIN INFECT DIS, V63, P730, DOI 10.1093/cid/ciw364
   Irani V, 2015, MOL IMMUNOL, V67, P171, DOI 10.1016/j.molimm.2015.03.255
   Kassam Z, 2016, ALIMENT PHARM THER, V43, P725, DOI 10.1111/apt.13546
   Katchar K, 2007, CLIN GASTROENTEROL H, V5, P707, DOI 10.1016/j.cgh.2007.02.025
   Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604
   Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3
   Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144
   Madan R, 2012, TRENDS MOL MED, V18, P658, DOI 10.1016/j.molmed.2012.09.005
   Martin JSH, 2016, NAT REV GASTRO HEPAT, V13, P206, DOI 10.1038/nrgastro.2016.25
   MATHIESEN T, 1988, Clinical and Experimental Immunology, V72, P211
   Monaghan TM, 2015, INFECT DIS CLIN N AM, V29, P1, DOI 10.1016/j.idc.2014.11.007
   Monaghan TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074452
   Negm OH, 2015, CLIN VACCINE IMMUNOL, V22, P1033, DOI 10.1128/CVI.00190-15
   O'Horo J, 2009, INT J INFECT DIS, V13, P663, DOI 10.1016/j.ijid.2008.11.012
   Salcedo J, 1997, GUT, V41, P366
   Shah Nihar, 2014, J Glob Infect Dis, V6, P82, DOI 10.4103/0974-777X.132053
   Solomon K, 2013, J MED MICROBIOL, V62, P1453, DOI 10.1099/jmm.0.058479-0
   Vedantam Gayatri, 2012, Gut Microbes, V3, P121, DOI 10.4161/gmic.19399
   VISCIDI R, 1983, J INFECT DIS, V148, P93
   WHO, 2014, POS PAP COLL US CONV
   Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265
NR 30
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD JUN
PY 2017
VL 188
IS 3
SI SI
BP 437
EP 443
DI 10.1111/cei.12946
PG 7
WC Immunology
SC Immunology
GA EU4IM
UT WOS:000400993000014
PM 28213939
OA No
DA 2017-08-17
ER

PT J
AU Trojan, K
   Zhu, L
   Aly, M
   Weimer, R
   Bulut, N
   Morath, C
   Opelz, G
   Daniel, V
AF Trojan, K.
   Zhu, L.
   Aly, M.
   Weimer, R.
   Bulut, N.
   Morath, C.
   Opelz, G.
   Daniel, V.
TI Association of peripheral NK cell counts with Helios(+)IFN-gamma(-)
   T-regs in patients with good long-term renal allograft function
SO CLINICAL AND EXPERIMENTAL IMMUNOLOGY
LA English
DT Article
DE CD8(+) lymphocytes; CTLA-4; good long-term renal allograft function;
   glomerular filtration rate; Helios(+)IFN-gamma(-) T-reg; peripheral NK
   cells; serum creatinine; TGF-beta; T-reg subsets
ID NATURAL-KILLER-CELLS; TRANSCRIPTION FACTOR HELIOS; BETA-DEPENDENT
   MANNER; TRANSPLANT RECIPIENTS; IMMUNOSUPPRESSIVE DRUGS;
   ORGAN-TRANSPLANTATION; INTERFERON-GAMMA; REGULATORY-CELLS; TARGET-CELLS;
   BONE-MARROW
AB Little is known about a possible interaction of natural killer (NK) cells with regulatory T cells (T-reg) in long-term stable kidney transplant recipients. Absolute counts of lymphocyte and Treg subsets were studied in whole blood samples of 136 long-term stable renal transplant recipients and 52 healthy controls using eight-colour fluorescence flow cytometry. Patients were 1946 +/- 2201 days (153-10 268 days) post-transplant and showed a serum creatinine of 1.7 +/- 0.7 mg/dl. Renal transplant recipients investigated > 1.5 years post-transplant showed higher total NK cell counts than recipients studied < 1.5 years after transplantation (P = 0.006). High NK cells were associated with high glomerular filtration rate (P = 0.002) and low serum creatinine (P = 0.005). Interestingly, high NK cells were associated with high CD4(+) CD25(+) CD127(-) forkhead box protein 3 (FoxP3 (+)) T-reg that co-express the phenotype Helios(+)interferon (IFN)-gamma(-) and appear to have stable FoxP3 expression and originate from the thymus. Furthermore, high total NK cells were associated with T-reg that co-express the phenotypes interleukin (IL)-10(-) transforming growth factor (TGF)-beta(+) (P = 0.013), CD183(+)CD62L(-) (P = 0.003), CD183(+)CD62(+) (P = 0.001), CD183(-)CD62L(+) (P = 0.002), CD252(-)CD152(+) (P < 0.001), CD28(+) human leucocyte antigen D-related (HLA-DR-) (P = 0.002), CD28(+) HLA-DR+ (P < 0.001), CD95(+)CD178(-) (P < 0.001) and CD279(-)CD152(+) (P < 0.001), suggesting that these activated T-reg home in peripheral tissues and suppress effector cells via TGF-beta and cytotoxic T lymphocyte associated protein 4 (CTLA-4). The higher numbers of NK and T-reg cell counts in patients with long-term good allograft function and the statistical association of these two lymphocyte subsets with each other suggest a direct or indirect (via DC) interaction of these cell subpopulations that contributes to good long-term allograft acceptance. Moreover, we speculate that regulatory NK cells are formed late post- transplant that are able to inhibit graft- reactive effector cells.
C1 [Trojan, K.; Zhu, L.; Aly, M.; Opelz, G.; Daniel, V.] Univ Hosp Heidelberg, Inst Immunol, Transplantat Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.
   [Zhu, L.] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Wuhan, Peoples R China.
   [Aly, M.] Assiut Univ, Dept Internal Med, Nephrol Unit, Assiut, Egypt.
   [Weimer, R.; Bulut, N.] Univ Giessen, Dept Internal Med, Giessen, Germany.
   [Morath, C.] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany.
RP Daniel, V (reprint author), Univ Hosp Heidelberg, Inst Immunol, Transplantat Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany.
EM Volker.Daniel@med.uni-heidelberg.de
CR Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226
   Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010
   Baine I, 2013, J IMMUNOL, V190, P1008, DOI 10.4049/jimmunol.1200792
   Barao I, 2006, P NATL ACAD SCI USA, V103, P5460, DOI 10.1073/pnas.0509249103
   Baron M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105422
   Benichou G, 2011, CURR OPIN ORGAN TRAN, V16, P47, DOI 10.1097/MOT.0b013e32834254cf
   Bergmann C, 2011, EUR J IMMUNOL, V41, P3564, DOI 10.1002/eji.201141532
   Bulmer JN, 2015, ADV EXP MED BIOL, V868, P95, DOI 10.1007/978-3-319-18881-2_5
   Chesneau M, 2015, J AM SOC NEPHROL, V26, P2588, DOI 10.1681/ASN.2014040404
   Daniel V, 2008, TRANSPL INT, V21, P646, DOI 10.1111/j.1432-2277.2008.00662.x
   Daniel V, 2016, HUM IMMUNOL, V77, P146, DOI 10.1016/j.humimm.2015.11.006
   Daniel V, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0111-2
   Daniel V, 2014, INT REV IMMUNOL, V33, P195, DOI 10.3109/08830185.2013.845181
   Daniel V, 2013, HUM IMMUNOL, V74, P151, DOI 10.1016/j.humimm.2012.09.010
   Daniel V, 2011, HUM IMMUNOL, V72, P699, DOI 10.1016/j.humimm.2011.05.020
   Deniz G, 2008, J IMMUNOL, V180, P850
   dos Santos DC, 2016, TRANSPL INT, V29, P443, DOI 10.1111/tri.12726
   Elkord E, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00276
   Elkord E, 2015, ONCOTARGET, V6, P20026
   Gasteiger G, 2013, J EXP MED, V210, P1167, DOI 10.1084/jem.20122462
   Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571
   Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001
   Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511
   Giuliani M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002241
   Gottschalk RA, 2012, J IMMUNOL, V188, P976, DOI 10.4049/jimmunol.1102964
   Grzanka J, 2013, INT IMMUNOPHARMACOL, V16, P343, DOI 10.1016/j.intimp.2013.02.004
   Himmel ME, 2013, J IMMUNOL, V190, P2001, DOI 10.4049/jimmunol.1201379
   Hongo D, 2012, BLOOD, V119, P1581, DOI 10.1182/blood-2011-08-371948
   Jukes JP, 2012, AM J TRANSPLANT, V12, P590, DOI 10.1111/j.1600-6143.2011.03847.x
   Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616
   Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031
   Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731
   McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099
   Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937
   Melsen JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00262
   Mori M, 2016, SEMIN IMMUNOPATHOL, V38, P635, DOI 10.1007/s00281-016-0574-0
   NeudoerfI C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00046
   Newell KA, 2015, AM J TRANSPLANT, V15, P2908, DOI 10.1111/ajt.13480
   Newell KA, 2015, CURR OPIN ORGAN TRAN, V20, P400, DOI 10.1097/MOT.0000000000000207
   Pedroza-Pacheco I, 2013, CELL MOL IMMUNOL, V10, P222, DOI 10.1038/cmi.2013.2
   Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409
   Romagnani C, 2005, EUR J IMMUNOL, V35, P2452, DOI 10.1002/eji.200526069
   Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922
   Saito S, 2007, SEMIN IMMUNOPATHOL, V29, P115, DOI 10.1007/s00281-007-0067-2
   Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785
   Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704
   Seillet C, 2016, CURR TOP MICROBIOL, V395, P37, DOI 10.1007/82_2015_474
   Shigeru S, 2008, J REPROD IMMUNOL, V77, P14, DOI 10.1016/j.jri.2007.04.007
   Sitrin J, 2013, J EXP MED, V210, P1153, DOI 10.1084/jem.20122248
   Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028
   van der Touw W, 2010, AM J TRANSPLANT, V10, P1354, DOI 10.1111/j.1600-6143.2010.03086.x
   Verneris MR, 2013, HEMATOL-AM SOC HEMAT, P335
   Yu JP, 2011, TRANSPL INT, V24, P201, DOI 10.1111/j.1432-2277.2010.01185.x
   Zabransky DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034547
   Zecher D, 2010, J IMMUNOL, V184, P6649, DOI 10.4049/jimmunol.0903729
   Zhang JH, 2016, CELL TISSUE RES, V363, P249, DOI 10.1007/s00441-015-2315-4
   Zhou H, 2010, AUTOIMMUNITY, V43, P299, DOI 10.3109/08916930903405875
NR 57
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0009-9104
EI 1365-2249
J9 CLIN EXP IMMUNOL
JI Clin. Exp. Immunol.
PD JUN
PY 2017
VL 188
IS 3
SI SI
BP 467
EP 479
DI 10.1111/cei.12945
PG 13
WC Immunology
SC Immunology
GA EU4IM
UT WOS:000400993000017
PM 28194759
OA No
DA 2017-08-17
ER

PT J
AU Elsawah, AM
   Qin, H
AF Elsawah, A. M.
   Qin, Hong
TI Optimum mechanism for breaking the confounding effects of mixed-level
   designs
SO COMPUTATIONAL STATISTICS
LA English
DT Article
DE Centered L-2-discrepancy; Foldover plan; Foldover design; Combined
   design; Optimal combined design
ID FRACTIONAL FACTORIAL-DESIGNS; OPTIMAL FOLDOVER PLANS; MIXTURE
   DISCREPANCY
AB Fractional factorial designs (FFD's) are no doubt the most widely used designs in the experimental investigations due to their efficient use of experimental runs to study many factors simultaneously. One consequence of using FFD's is the aliasing of factorial effects. Follow-up experiments may be needed to break the confounding. A simple strategy is to add a foldover of the initial design, the new fraction is called a foldover design. Combining a foldover design with the original design converts a design of resolution r into a combined design of resolution . In this paper, we take the centered -discrepancy as the optimality measure to construct the optimal combined design and take asymmetrical factorials with mixed two and three levels, which are most commonly used in practice, as the original designs. New and efficient analytical expressions based on the row distance of the for combined designs are obtained. Based on these new formulations, we present new and efficient lower bounds of the . Using the new formulations and lower bounds as the benchmarks, we may implement a new algorithm for constructing optimal mixed-level combined designs. By this search heuristic, we may obtain mixed-level combined designs with low discrepancy.
C1 [Elsawah, A. M.; Qin, Hong] Cent China Normal Univ, Fac Math & Stat, Wuhan 430079, Peoples R China.
   [Elsawah, A. M.] Zagazig Univ, Dept Math, Fac Sci, Zagazig 44519, Egypt.
   [Elsawah, A. M.] BNU HKBU United Int Coll, Div Sci & Technol, Zhuhai 519085, Peoples R China.
RP Elsawah, AM (reprint author), Cent China Normal Univ, Fac Math & Stat, Wuhan 430079, Peoples R China.; Elsawah, AM (reprint author), Zagazig Univ, Dept Math, Fac Sci, Zagazig 44519, Egypt.; Elsawah, AM (reprint author), BNU HKBU United Int Coll, Div Sci & Technol, Zhuhai 519085, Peoples R China.
EM a_elsawah85@yahoo.com
FU UIC Research Grant [R201409]; National Natural Science Foundation of
   China [11271147, 11471135, 11471136]
FX The authors greatly appreciate helpful suggestions of the two referees
   and the Associate Editor that greatly improved the paper. Elsawah is
   indebted to Professor Kai-Tai Fang for his help and his kind support.
   This work was partially supported by the UIC Research Grant (R201409)
   and the National Natural Science Foundation of China (Nos. 11271147,
   11471135, 11471136).
CR Elsawah AM, 2017, COMMUN STAT-THEOR M, V46, P1621, DOI 10.1080/03610926.2015.1024862
   Elsawah AM, 2016, J APPL STAT, V43, P2280, DOI 10.1080/02664763.2016.1140727
   Elsawah AM, 2016, J KOREAN STAT SOC, V45, P77, DOI 10.1016/j.jkss.2015.07.004
   Elsawah AM, 2016, ACTA MATH SIN, V32, P286, DOI 10.1007/s10114-016-4749-3
   Elsawah AM, 2015, STAT PROBABIL LETT, V104, P123, DOI 10.1016/j.spl.2015.05.007
   Elsawah AM, 2015, STAT PROBABIL LETT, V103, P116, DOI 10.1016/j.spl.2015.04.020
   Elsawah AM, 2015, J STAT PLAN INFER, V161, P1, DOI 10.1016/j.jspi.2014.12.007
   Elsawah AM, 2015, STAT PROBABIL LETT, V96, P273, DOI 10.1016/j.spl.2014.09.027
   Elsawah AM, 2014, STAT PROBABIL LETT, V93, P65, DOI 10.1016/j.spl.2014.06.008
   Fang KT, 2000, BIOMETRIKA, V87, P193, DOI 10.1093/biomet/87.1.193
   Fang KT, 2003, STAT PROBABIL LETT, V62, P245, DOI 10.1016/S0167-7152(03)00008-7
   Li W, 2003, TECHNOMETRICS, V45, P142, DOI 10.1198/004017003188618779
   Ou ZJ, 2014, COMMUN STAT-THEOR M, V43, P2274, DOI 10.1080/03610926.2013.776082
   Qin H, 2007, STAT PAP, V48, P491, DOI 10.1007/s00362-006-0350-7
   Wang B, 2010, J STAT PLAN INFER, V140, P1497, DOI 10.1016/j.jspi.2009.12.011
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0943-4062
EI 1613-9658
J9 COMPUTATION STAT
JI Comput. Stat.
PD JUN
PY 2017
VL 32
IS 2
BP 781
EP 802
DI 10.1007/s00180-016-0651-9
PG 22
WC Statistics & Probability
SC Mathematics
GA EU2IP
UT WOS:000400852400017
OA No
DA 2017-08-17
ER

PT J
AU Vasylieva, N
   Barnych, B
   Wan, DB
   El-Sheikh, EA
   Nguyen, HM
   Wulff, H
   McMahen, R
   Strynar, M
   Gee, SJ
   Hammock, BD
AF Vasylieva, Natalia
   Barnych, Bogdan
   Wan, Debin
   El-Sheikh, El-Sayed A.
   Nguyen, Hai M.
   Wulff, Heike
   McMahen, Rebecca
   Strynar, Mark
   Gee, Shirley J.
   Hammock, Bruce D.
TI Hydroxy-fipronil is a new urinary biomarker of exposure to fipronil
SO ENVIRONMENT INTERNATIONAL
LA English
DT Article
DE Insecticide; GABA receptor bioassay; Metabolite; LC-MS/MS; Antibody;
   Immunoassay; Screening; Sensor
ID PHENYLPYRAZOLE INSECTICIDE FIPRONIL; TANDEM MASS-SPECTROMETRY;
   SOLID-PHASE EXTRACTION; GAS-CHROMATOGRAPHY; METABOLITES; MECHANISMS;
   PESTICIDES; SULFONE; PLASMA
AB Occupational medical surveillance is highly desirable in manufacturing facilities where exposure to chemicals is significant. The insecticide fipronil is generally considered safe for humans but with increasing use, exposure to fipronil is of concern. Identification of urinarymetabolites of fipronil may allowdevelopment of affordable, cheap and rapid procedures for human exposure evaluation. In this study we developed a fast and easy approach for synthesis of hydroxy-fipronil, a potential urinary metabolite of fipronil. This standard was used to develop a sensitive analytical LC-MS/MS method with a limit of quantification (LOQ) of 0.4 ng/mL. Fipronil sulfone, a known metabolite, and hydroxy-fipronil were quantified in urine samples from rats treated with a fipronil containing diet. Fipronil sulfone concentration centered around 20 ng/mL, while the concentration of hydroxy-fipronil was dose-dependent ranging in 10-10,000 ng/mL and thus being a more sensitive marker of fipronil exposure. A fipronil immunoassay with cross-reactivity to hydroxy-fipronil showed a good correlation in signal intensity with LC-MS data. It was also used to demonstrate the applicability of the method for sample screening in the evaluation of exposure levels. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Vasylieva, Natalia; Barnych, Bogdan; Wan, Debin; Gee, Shirley J.; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Vasylieva, Natalia; Barnych, Bogdan; Wan, Debin; Gee, Shirley J.; Hammock, Bruce D.] Univ Calif Davis, UCD Comprehens Canc Ctr, Davis, CA 95616 USA.
   [El-Sheikh, El-Sayed A.] Zagazig Univ, Dept Plant Protect, Fac Agr, Zagazig, Egypt.
   [Nguyen, Hai M.; Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.
   [McMahen, Rebecca; Strynar, Mark] US EPA, Natl Exposure Res Lab, Res Triangle Pk, NC 27711 USA.
RP Hammock, BD (reprint author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.; Hammock, BD (reprint author), Univ Calif Davis, UCD Comprehens Canc Ctr, Davis, CA 95616 USA.
EM bdhammock@ucdavis.edu
FU National Institute of Environmental Health Sciences, Superfund Research
   Program [P42 ES04699]; National Institute for Occupational Safety and
   Health Western Regional Center for Agricultural Health Science [U50
   OH07550]; National Institute of Neurological Disorders and Stroke [U54
   NS079202]; CounterACT Program, National Institutes of Health Office of
   the Director
FX This work was supported by National Institute of Environmental Health
   Sciences, Superfund Research Program, P42 ES04699 and the National
   Institute for Occupational Safety and Health Western Regional Center for
   Agricultural Health Science U50 OH07550. The research was also supported
   by the CounterACT Program, National Institutes of Health Office of the
   Director, and the National Institute of Neurological Disorders and
   Stroke, grant number U54 NS079202.
CR Banks B. J., 2000, PARASITICIDAL COMPOU
   Bichon E, 2008, J CHROMATOGR A, V1201, P91, DOI 10.1016/j.chroma.2008.06.024
   Cazorla-Reyes R, 2011, TALANTA, V85, P183, DOI 10.1016/j.talanta.2011.03.048
   Clark L., 2010, GRAND ROUNDS SPECIAL, V10, P110
   Cochran RC, 2015, J TOXICOL ENV HEAL A, V78, P1217, DOI 10.1080/15287394.2015.1076363
   Cravedi JP, 2013, CHEMOSPHERE, V93, P2276, DOI 10.1016/j.chemosphere.2013.07.083
   CUBBON RCP, 1968, J CHEM SOC C, P2978, DOI 10.1039/j39680002978
   Das PC, 2006, CHEM-BIOL INTERACT, V164, P200, DOI 10.1016/j.cbi.2006.09.013
   FAO, 2001, JMPR EV FIPR
   Freeborn DL, 2015, TOXICOL APPL PHARM, V282, P184, DOI 10.1016/j.taap.2014.11.011
   Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.RO7-02
   Hainzl D, 1998, CHEM RES TOXICOL, V11, P1529, DOI 10.1021/tx980157t
   Hainzl D, 1996, P NATL ACAD SCI USA, V93, P12764, DOI 10.1073/pnas.93.23.12764
   Hamernik K. L., 1998, TOX JOINT FAO WHO M
   Herin F, 2011, THYROID, V21, P701, DOI 10.1089/thy.2010.0449
   Jackson D., 2009, FIPRONIL TECHNICAL F
   Lacroix MZ, 2010, J CHROMATOGR B, V878, P1934, DOI 10.1016/j.jchromb.2010.05.018
   Li AG, 2006, J ECON ENTOMOL, V99, P914
   McMahen RL, 2015, ENVIRON INT, V78, P16, DOI 10.1016/j.envint.2015.01.016
   Mohamed F, 2004, J TOXICOL-CLIN TOXIC, V42, P955, DOI 10.1081/CLT-200041784
   Ozkaya HM, 2015, CASE REP ENDOCRINOL, DOI 10.1155/2015/684648
   Powles P., 1992, C FIPRONIL 14C M B 4
   Ratra GS, 2001, TOXICOL LETT, V122, P215, DOI 10.1016/S0378-4274(01)00366-6
   Schottner E, 2010, ORG LETT, V12, P784, DOI 10.1021/ol902854t
   Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y
   Vasylieva N, 2015, ENVIRON SCI TECHNOL, V49, P10038, DOI 10.1021/acs.est.5b01005
   Vidau C, 2011, NEUROTOXICOLOGY, V32, P935, DOI 10.1016/j.neuro.2011.04.006
   Vidau C, 2009, TOXICOL IN VITRO, V23, P589, DOI 10.1016/j.tiv.2009.01.017
   Wang GW, 2011, EUR J ORG CHEM, P4429, DOI 10.1002/ejoc.201100374
   Watts M., 2012, PAN AP FACTSHEET SER
   Marrs TC, 2012, ISSUES TOXICOL, P1, DOI 10.1039/9781849733007
NR 31
TC 0
Z9 0
U1 13
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
EI 1873-6750
J9 ENVIRON INT
JI Environ. Int.
PD JUN
PY 2017
VL 103
BP 91
EP 98
DI 10.1016/j.envint.2017.03.012
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EU5XX
UT WOS:000401108800010
PM 28343720
OA No
DA 2017-08-17
ER

PT J
AU Iskander, NM
   El-Hennawi, DM
   Yousef, TF
   El-Tabbakh, MT
   Elnahriry, TA
AF Iskander, Nagi M.
   El-Hennawi, Diaa M.
   Yousef, Tarek F.
   El-Tabbakh, Mohammed T.
   Elnahriry, Tarek A.
TI Evaluation of the effect of cigarette smoking on the olfactory
   neuroepithelium of New Zealand white rabbit, using scanning electron
   microscope
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Article
DE Olfactory neuroepithelium; Smoking effects; Smell disturbances; Scanning
   electron microscope
ID EPITHELIUM; MICE; INHALATION; NASAL; CELLS
AB To detect ultra-structural changes of Rabbit's olfactory neuro-epithelium using scanning electron microscope after exposure to cigarette smoking. Sixty six rabbits (Pathogen free New Zealand white rabbits weighing 1-1.5 kg included in the study were randomly assigned into one of three groups: control group did not expose to cigarette smoking, study group 1 was exposed to cigarette smoking for 3 months and study group 2 was exposed to cigarette smoking 3 months and then stopped for 2 months. Olfactory neuro-epithelium from all rabbits were dissected and examined under Philips XL-30 scanning electron microscope. Changes that were found in the rabbits of study group 1 in comparison to control group were loss of microvilli of sustentacular cells (p = 0.016) and decreases in distribution of specialized cilia of olfactory receptor cells (p = 0.046). Also respiratory metaplasia was detected. These changes were reversible in study group 2. Cigarette smoking causes ultra-structural changes in olfactory neuro-epithelium which may explain why smell was affected in cigarette smokers. Most of these changes were reversible after 45 days of cessation of cigarette smoking to the rabbits.
C1 [Iskander, Nagi M.; El-Hennawi, Diaa M.; Yousef, Tarek F.; El-Tabbakh, Mohammed T.; Elnahriry, Tarek A.] Suez Canal Univ, Teaching Hosp, Dept Otorhinolaryngol, Fac Med, Ismailia, Egypt.
RP El-Tabbakh, MT (reprint author), Suez Canal Univ, Teaching Hosp, Dept Otorhinolaryngol, Fac Med, Ismailia, Egypt.
EM abolobna2@gmail.com
CR Benninger MS, 1999, AM J RHINOL, V13, P435, DOI 10.2500/105065899781329683
   Coggins CRE, 1998, TOXICOL PATHOL, V26, P307
   FRYE RE, 1990, JAMA-J AM MED ASSOC, V263, P1233, DOI 10.1001/jama.263.9.1233
   Katotomichelakis M, 2007, RHINOLOGY, V45, P273
   Mullol J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001256
   Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC
   Pereira ME, 2011, TOXICOL PATHOL, V39, P893, DOI 10.1177/0192623311409594
   Rosli Y, 1999, J ELECTRON MICROSC, V48, P77
   Simmen D, 2006, RHINOLOGY, V44, P98
   Ueha R, 2016, NEUROTOX RES, V30, P213, DOI 10.1007/s12640-016-9617-5
   Ueha R, 2016, AM J PATHOL, V186, P579, DOI 10.1016/j.ajpath.2015.11.009
NR 11
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0937-4477
EI 1434-4726
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD JUN
PY 2017
VL 274
IS 6
BP 2461
EP 2468
DI 10.1007/s00405-017-4475-1
PG 8
WC Otorhinolaryngology
SC Otorhinolaryngology
GA EU1DY
UT WOS:000400754900013
PM 28251320
OA No
DA 2017-08-17
ER

PT J
AU Abdelkawy, KS
   Lack, K
   Elbarbry, F
AF Abdelkawy, Khaled S.
   Lack, Kelsey
   Elbarbry, Fawzy
TI Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors
SO EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
LA English
DT Review
ID NITRIC-OXIDE SYNTHASE; HYDROXY-L-ARGININE; NOR-L-ARGININE; SALVIANOLIC
   ACID-B; HUMAN LIVER-MICROSOMES; FEMALE SEXUAL AROUSAL; APOE-NULL MICE;
   IMPAIRED ENDOTHELIAL FUNCTION; TRANSITION-STATE ANALOG;
   ALPHA-DIFLUOROMETHYLORNITHINE
AB Up-regulation of arginase activity in several chronic disease conditions, including cancer and hypertension, may suggest new targets for treatment. Recently, the number of new arginase inhibitors with promising therapeutic effects for asthma, cancer, hypertension, diabetes mellitus, and erectile dysfunction has shown a remarkable increase. Arginase inhibitors may be chemical substances, such as boron-based amino acid derivatives, alpha-difluoromethylornithine (DMFO), and N omega-hydroxy-nor-l-arginine (nor-NOHA) or, of plant origin such as sauchinone, salvianolic acid B (SAB), piceatannol-3-O-beta-D-glucopyranoside (PG) and obacunone. Despite their promising therapeutic potential, little is known about pharmacokinetics and pharmacodynamics of some of these agents. Several studies were conducted in different animal species and in vitro systems and reported significant differences in pharmacokinetics and pharmacodynamics of arginase inhibitors. Therefore, extra caution should be considered before extrapolating these studies to human. Physicochemical and pharmacokinetic profiles of some effective arginase inhibitors make it challenging to formulate stable and effective formulation. In this article, existing literature on the pharmacokinetics and pharmacodynamics of arginase inhibitors were reviewed and compared together with emphasis on possible drug interactions and solutions to overcome pharmacokinetics challenges and shortage of arginase inhibitors in clinical practice.
C1 [Abdelkawy, Khaled S.] Kafrelsheikh Univ, Fac Pharm, Kafr Al Sheikh, Egypt.
   [Lack, Kelsey; Elbarbry, Fawzy] Pacific Univ, Sch Pharm, 222 SE 8th Ave, Hillsboro, OR 97123 USA.
RP Elbarbry, F (reprint author), Pacific Univ, Sch Pharm, 222 SE 8th Ave, Hillsboro, OR 97123 USA.
EM Fawzy.elbarbry@pacificu.edu
FU Pacific University, Oregon
FX This work was supported in part by the Faculty Development Grant from
   Pacific University, Oregon.
CR AbdulHussain MN, 1996, EUR J PHARMACOL, V305, P155, DOI 10.1016/0014-2999(96)00163-X
   Bachetti T, 2004, J MOL CELL CARDIOL, V37, P515, DOI 10.1016/j.uyjmcc.2004.05.004
   Baggio R, 1999, J PHARMACOL EXP THER, V290, P1409
   Baggio R, 1997, J AM CHEM SOC, V119, P8107, DOI 10.1021/ja971312d
   Bagi Z, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00293
   Bagnost T, 2008, J HYPERTENS, V26, P1110, DOI 10.1097/HJH.0b013e3282fcc357
   Beranova P, 2005, EUR J PHARMACOL, V516, P260, DOI 10.1016/j.ejphar.2005.04.021
   Bivalacqua TJ, 2001, BIOCHEM BIOPH RES CO, V283, P923, DOI 10.1006/bbrc.2001.4874
   Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1340, DOI 10.1152/ajpheart.00121.2005
   BOUCHER JL, 1994, BIOCHEM BIOPH RES CO, V203, P1614, DOI 10.1006/bbrc.1994.2371
   Buga GM, 1998, AM J PHYSIOL-REG I, V275, pR1256
   Busnel O, 2005, BIOORGAN MED CHEM, V13, P2373, DOI 10.1016/j.bmc.2005.01.053
   Cama E, 2003, BIOCHEMISTRY-US, V42, P8445, DOI 10.1021/bi034340j
   Car BD, 2009, BLOOD, V114, P1479
   Carbone PP, 2000, CLIN CANCER RES, V6, P3850
   Carneiro FS, 2008, J SEX MED, V5, P1156, DOI 10.1111/j.1743-6109.2007.00752.x
   Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x
   Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342
   Cho JS, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0112-y
   Choi K, 2014, KOREAN J PHYSIOL PHA, V18, P95, DOI 10.4196/kjpp.2014.18.2.95
   Christianson DW, 2005, ACCOUNTS CHEM RES, V38, P191, DOI 10.1021/ar040183k
   Chu YB, 2016, MOL CELL BIOCHEM, V412, P91, DOI 10.1007/s11010-015-2611-z
   Clement B, 2006, BIOCHEM BIOPH RES CO, V349, P869, DOI 10.1016/j.bbrc.2006.08.123
   Cox JD, 2001, BIOCHEMISTRY-US, V40, P2689, DOI 10.1021/bi002318+
   Cox JD, 1999, NAT STRUCT BIOL, V6, P1043
   Davies KP, 2015, FUTURE SCI OA, V1, P1, DOI [10.4155/fso.15.53, DOI 10.4155/FSO.15.53]
   De A, 2016, EUR J PHARMACOL, V771, P247, DOI 10.1016/j.ejphar.2015.12.008
   Demougeot C, 2005, J HYPERTENS, V23, P971, DOI 10.1097/01.hjh.0000166837.78559.93
   Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x
   Frombaum M, 2011, FREE RADICAL RES, V45, P293, DOI 10.3109/10715762.2010.527337
   Gao DY, 2009, ARCH PHARM RES, V32, P773, DOI 10.1007/s12272-009-1517-2
   Girard-Thernier C, 2015, MINI-REV MED CHEM, V15, P798
   Golebiowski A, 2013, BIOORG MED CHEM LETT, V23, P4837, DOI 10.1016/j.bmcl.2013.06.092
   Golebiowski A, 2013, BIOORG MED CHEM LETT, V23, P2027, DOI 10.1016/j.bmcl.2013.02.024
   Gotoh T, 1996, FEBS LETT, V395, P119, DOI 10.1016/0014-5793(96)01015-0
   GRIFFIN CA, 1987, INVEST NEW DRUG, V5, P177
   Gronros J, 2011, AM J PHYSIOL-HEART C, V300, pH1174, DOI 10.1152/ajpheart.00560.2010
   GUNARATNA PC, 1994, J PHARMACEUT BIOMED, V12, P1249, DOI 10.1016/0731-7085(94)00064-6
   Guo XH, 2009, AM J PHYSIOL-HEART C, V297, pH238, DOI 10.1152/ajpheart.00196.2009
   HAEGELE KD, 1981, CLIN PHARMACOL THER, V30, P210
   Haffner I, 2008, J CELL BIOCHEM, V103, P520, DOI 10.1002/jcb.21422
   Havlinova Z, 2014, GEN PHYSIOL BIOPHYS, V33, P189, DOI 10.4149/gpb_2013078
   Havlinova Z, 2013, XENOBIOTICA, V43, P886, DOI 10.3109/00498254.2013.780672
   HERZFELD A, 1976, BIOCHEM J, V153, P469
   Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200
   Holowatz LA, 2007, J PHYSIOL-LONDON, V581, P863, DOI 10.1113/jphysiol.2007.128959
   Hou Rui, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3641
   Hroch M, 2012, J CHROMATOGR B, V880, P90, DOI 10.1016/j.jchromb.2011.11.022
   Hu H, 2015, BIOCHEM BIOPH RES CO, V464, P840, DOI 10.1016/j.bbrc.2015.07.048
   HU T, 1995, J CHROMATOGR A, V716, P381, DOI 10.1016/0021-9673(95)00604-L
   Huang Bin, 2013, Zhongguo Zhong Yao Za Zhi, V38, P889
   Hubbard SA, 1998, BIOL TRACE ELEM RES, V66, P343, DOI 10.1007/BF02783147
   Huynh NN, 2009, BRIT J PHARMACOL, V156, P84, DOI 10.1111/j.1476-5381.2008.00036.x
   Hwang HM, 2015, J PHARMACOL EXP THER, V355, P57, DOI 10.1124/jpet.115.224592
   Ilies M, 2010, J MED CHEM, V53, P4266, DOI 10.1021/jm100306a
   Ivanenkov Yan A, 2014, Pharm Pat Anal, V3, P65, DOI 10.4155/ppa.13.75
   Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8
   Jeyabalan G, 2008, NITRIC OXIDE-BIOL CH, V19, P29, DOI 10.1016/j.niox.2008.04.002
   Joe Y, 2012, J PHARMACOL EXP THER, V341, P850, DOI 10.1124/jpet.111.190736
   Jung C, 2010, CARDIOVASC RES, V85, P147, DOI 10.1093/cvr/cvp303
   Jung HJ, 2000, PLANTA MED, V66, P74
   KANYO ZF, 1992, J MOL BIOL, V224, P1175, DOI 10.1016/0022-2836(92)90479-4
   Kim DH, 2000, BIOL PHARM BULL, V23, P830
   Kim NN, 2004, J NUTR, V134, p2873S
   Kim NN, 2001, BIOCHEMISTRY-US, V40, P2678, DOI 10.1021/bi002317h
   Kim N. N., 2004, J NUTR, V134, p2873S
   Kim SW, 2013, ARCH PHARM RES, V36, P922, DOI 10.1007/s12272-013-0125-3
   Kim YJ, 2015, BIOL PHARM BULL, V38, P218, DOI 10.1248/bpb.b14-00524
   KINNORY DS, 1955, ARCH BIOCHEM BIOPHYS, V55, P546, DOI 10.1016/0003-9861(55)90432-X
   Kossel A, 1904, H-S Z PHYSIOL CHEM, P321
   Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960
   Krotova K, 2010, MOL CELL BIOCHEM, V343, P211, DOI 10.1007/s11010-010-0515-5
   Lacchini R, 2014, NITRIC OXIDE-BIOL CH, V42, P142, DOI 10.1016/j.niox.2014.09.129
   Lai Xiao-juan, 2010, Yaoxue Xuebao, V45, P1576
   Lewis C, 2008, J VASC SURG, V48, P441, DOI 10.1016/j.jvs.2008.02.030
   Li XX, 2016, DRUG METAB PHARMACOK, V31, P95, DOI 10.1016/j.dmpk.2015.10.005
   Lim CJ, 2012, B KOREAN CHEM SOC, V33, P3079, DOI 10.5012/bkcs.2012.33.9.3079
   Liu Xiang-dan, 2015, Zhongguo Zhong Yao Za Zhi, V40, P2428
   Lv GY, 2011, J ETHNOPHARMACOL, V137, P449, DOI 10.1016/j.jep.2011.05.049
   Maarsingh H, 2011, EUR RESPIR J, V38, P318, DOI 10.1183/09031936.00057710
   MCCANN PP, 1981, MED BIOL, V59, P434
   McCann PPPAE, 1987, INHIBITION POLYAMINE
   Mendez JD, 2002, REPROD TOXICOL, V16, P809, DOI 10.1016/S0890-6238(02)00057-6
   Ming XF, 2004, CIRCULATION, V110, P3708, DOI 10.1161/01.CIR.0000142867.26182.32
   Miyanaka K, 1998, HISTOCHEM J, V30, P741, DOI 10.1023/A:1003468726969
   Morgan ET, 2009, CLIN PHARMACOL THER, V85, P434, DOI 10.1038/clpt.2008.302
   Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547
   Mumenthaler SM, 2008, INT J ONCOL, V32, P357
   Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x
   Numao N, 2007, BJU INT, V99, P1495, DOI 10.1111/j.1464-410X.2007.06860.x
   Olivon VC, 2013, ATHEROSCLEROSIS, V227, P236, DOI 10.1016/j.atherosclerosis.2012.12.014
   Osowska S, 2004, GUT, V53, P1781, DOI 10.1136/gut.2004.042317
   Pokrovskiy MV, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/515047
   Prati C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3860
   Prati C, 2011, ARTHRITIS RHEUM-US, V63, P2309, DOI 10.1002/art.30391
   Qi Q, 2013, CHIN J NAT MEDICINES, V11, P560, DOI [10.1016/S1875-5364(13)60101-6, 10.3724/SP.J.1009.2013.00560]
   Qin CZ, 2015, INT J CLIN EXP MED, V8, P15549
   Qiu FR, 2008, DRUG METAB DISPOS, V36, P1308, DOI 10.1124/dmd.108.021030
   Que LG, 2002, NITRIC OXIDE-BIOL CH, V6, P1, DOI 10.1006/niox.2001.0355
   Quitter F, 2013, CLIN HEMORHEOL MICRO, V54, P75, DOI 10.3233/CH-2012-1617
   REDDY PUM, 1981, EXPERIENTIA, V37, P814, DOI 10.1007/BF01985654
   Reid KM, 2007, AM J PHYSIOL-GASTR L, V292, pG512, DOI 10.1152/ajpgi.00227.2006
   Ren W, 2015, RAPID COMMUN MASS SP, V29, P2045, DOI 10.1002/rcm.7365
   Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028
   SAHEKI T, 1979, J BIOCHEM-TOKYO, V86, P745
   Santhanam L, 2007, CIRC RES, V101, P692, DOI 10.1161/CIRCRESAHA.107.157727
   Sasatomi K, 2008, UROLOGY, V72, P696, DOI 10.1016/j.urology.2007.12.002
   Schade D, 2011, ORG BIOMOL CHEM, V9, P5249, DOI 10.1039/c0ob01117g
   Segal R, 2012, J ANDROL, V33, P1169, DOI 10.2164/jandrol.111.015834
   Selamnia M, 1998, BIOCHEM PHARMACOL, V55, P1241, DOI 10.1016/S0006-2952(97)00572-8
   Shemyakin A, 2012, CIRCULATION, V126, P2943, DOI 10.1161/CIRCULATIONAHA.112.140335
   Shin W, 2013, J GINSENG RES, V37, P64, DOI 10.5142/jgr.2013.37.64
   Singh R, 2000, CANCER RES, V60, P3305
   Steppan J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00278
   Sun Jiang-hao, 2003, Yaoxue Xuebao, V38, P968
   Takahashi N, 2010, AM J PHYSIOL-LUNG C, V299, pL17, DOI 10.1152/ajplung.00216.2009
   Tenu JP, 1999, NITRIC OXIDE-BIOL CH, V3, P427, DOI 10.1006/niox.1999.0255
   TEWS JK, 1986, J NUTR, V116, P1464
   Van Zandt MC, 2013, J MED CHEM, V56, P2568, DOI 10.1021/jm400014c
   Wang L, 2015, MICROVASC RES, V98, P1, DOI 10.1016/j.mvr.2014.11.002
   Wang P, 2013, J CHROMATOGR B, V928, P44, DOI 10.1016/j.jchromb.2013.03.018
   Woo A, 2013, INT J MOL MED, V31, P803, DOI 10.3892/ijmm.2013.1261
   Woo A, 2010, EXP MOL MED, V42, P524, DOI 10.3858/emm.2010.42.7.053
   Wu GY, 1998, BIOCHEM J, V336, P1
   Xie DH, 2007, J SEX MED, V4, P898, DOI 10.1111/j.1743-6109.2007.00518.x
   Xu CL, 2012, BIOMED CHROMATOGR, V26, P1210, DOI 10.1002/bmc.2681
   Xu LY, 2003, IMMUNOLOGY, V110, P141, DOI 10.1046/j.1365-2567.2003.01713.x
   Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje
   Yang ZH, 2006, CURR HYPERTENS REP, V8, P54, DOI 10.1007/s11906-006-0041-8
   Yoon J, 2014, VASC PHARMACOL, V60, P102, DOI 10.1016/j.vph.2014.01.006
   You HN, 2013, KIDNEY INT, V84, P1189, DOI 10.1038/ki.2013.215
   Zhang Cui-ying, 2015, Zhongguo Zhong Yao Za Zhi, V40, P1589
   Zhang JL, 2005, BIOMED CHROMATOGR, V19, P15, DOI 10.1002/bmc.408
   Zhao Jie, 2015, Zhongguo Zhong Yao Za Zhi, V40, P3088
NR 134
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 0378-7966
EI 2107-0180
J9 EUR J DRUG METAB PH
JI Eur. J. Drug Metabol. Pharmacokinet.
PD JUN
PY 2017
VL 42
IS 3
BP 355
EP 370
DI 10.1007/s13318-016-0381-y
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EU4GO
UT WOS:000400988000002
PM 27734327
OA No
DA 2017-08-17
ER

PT J
AU Abdlekawy, KS
   Donia, AM
   Elbarbry, F
AF Abdlekawy, Khaled S.
   Donia, Ahmed M.
   Elbarbry, Fawzy
TI Effects of Grapefruit and Pomegranate Juices on the Pharmacokinetic
   Properties of Dapoxetine and Midazolam in Healthy Subjects
SO EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
LA English
DT Article
ID ANTIOXIDANT ACTIVITY; CYP3A4; INHIBITION; TRANSPORT; RATS
AB Background The package leaflet for dapoxetine, an effective treatment for premature ejaculation, includes a strict warning against coadministration with drugs or herbal remedies that strongly induce or inhibit the activity of Cytochrome P450 (CYP) 3A4 enzyme.
   Objective To assess the effects of multiple daily consumption of grapefruit juice (GFJ) and pomegranate juice (PJ) on the pharmacokinetics of dapoxetine, we conducted an open-label, three-way crossover study in 12 healthy subjects using midazolam as a probe substrate for CYP3A4.
   Methods Participants received a single oral dose of dapoxetine (60 mg) and midazolam (7.5 mg) after pretreatment with 250 ml of either water, undiluted GFJ, or PJ for three consecutive days. All subjects were monitored for adverse effects during the study period.
   Results Compared to pretreatment with water, GFJ increased the area under the plasma concentration-time curve from time zero to infinity (AUC(0-infinity)) and peak plasma concentration (C-max) of dapoxetine by 60 and 80 %, respectively, and prolonged its elimination half-life (t (1/2)) by 43 %. Similar effects of GFJ on the pharmacokinetics of midazolam were observed with a significant increase in AUC(0-infinity) (75 %), C-max (40 %), and t(1/2) (92 %). Slight but not statistically significant changes were observed in the pharmacokinetics of dapoxetine and midazolam after pretreatment with PJ. Time to reach C-max (T-max) did not differ among the three phases.
   Conclusion These results suggest that GFJ increases the extent of absorption and reduces clearance of dapoxetine possibly by inhibition of both intestinal and hepatic CYP3A4, whereas PJ has little effect on dapoxetine pharmacokinetics. Although the impact of GFJ on the pharmacokinetics of dapoxetine was mild, a great caution should be considered when they are concomitantly administered.
C1 [Abdlekawy, Khaled S.] Kafrelsheikh Univ, Fac Pharm, Kafr Al Sheikh, Egypt.
   [Donia, Ahmed M.] Tanta Univ, Fac Pharm, Tanta, Egypt.
   [Elbarbry, Fawzy] Pacific Univ, Sch Pharm, 222 SE 8th Ave, Hillsboro, OR 97123 USA.
RP Elbarbry, F (reprint author), Pacific Univ, Sch Pharm, 222 SE 8th Ave, Hillsboro, OR 97123 USA.
EM Fawzy.elbarbry@pacificu.edu
FU Pacific University; Pacific University School of Pharmacy
FX This work was supported in part by the Faculty Development Grant from
   Pacific University, and Research Incentive Grant from Pacific University
   School of Pharmacy (F.E.).
CR BAILEY DG, 1993, CLIN PHARMACOL THER, V54, P589
   Chenel M, 2008, J PHARMACOKINET PHAR, V35, P635, DOI 10.1007/s10928-008-9104-6
   Chenel M, 2008, J PHARMACOKINET PHAR, V35, P661, DOI 10.1007/s10928-008-9105-5
   Cuciureanu Magdalena, 2010, Rev Med Chir Soc Med Nat Iasi, V114, P885
   Desta Z, 2001, BRIT J CLIN PHARMACO, V52, P399, DOI 10.1046/j.0306-5251.2001.01473.x
   Dresser MJ, 2006, J CLIN PHARMACOL, V46, P1023, DOI 10.1177/0091270006291033
   Foti RS, 2010, DRUG METAB DISPOS, V38, P981, DOI 10.1124/dmd.110.032094
   Gil MI, 2000, J AGR FOOD CHEM, V48, P4581, DOI 10.1021/jf000404a
   Hanley MJ, 2011, EXPERT OPIN DRUG MET, V7, P267, DOI 10.1517/17425255.2011.553189
   Hidaka M, 2005, DRUG METAB DISPOS, V33, P644, DOI 10.1124/dmd.104.002824
   Holmberg MT, 2015, BRIT J CLIN PHARMACO, V80, P139, DOI 10.1111/bcp.12581
   Holmberg MT, 2013, BRIT J CLIN PHARMACO, V75, P1488, DOI 10.1111/bcp.12026
   Hu M, 2013, DRUG METAB PHARMACOK, V28, P104, DOI 10.2133/dmpk.DMPK-12-RG-067
   Hyson DA, 2015, ADV NUTR, V6, P37, DOI 10.3945/an.114.005728
   Langley P, 2000, BRIT MED J, V321, P1153, DOI 10.1136/bmj.321.7269.1153
   Laumann EO, 1999, INT J IMPOT RES, V11, pS60, DOI 10.1038/sj.ijir.3900487
   Lee JW, 2016, AM J MED, V129, P26, DOI 10.1016/j.amjmed.2015.07.036
   McMahon CG, 2011, CLIN MED INSIGHTS RE, V2, P25
   Murphy MM, 2014, FOOD NUTR RES, V58, P1, DOI 10.3402/fnnv58.22179
   Ohno Y, 2007, CLIN PHARMACOKINET, V46, P681, DOI 10.2165/00003088-200746080-00005
   Paine MF, 2008, AM J CLIN NUTR, V87, P863
   Paine MF, 2005, J PHARMACOL EXP THER, V312, P1151, DOI 10.1124/jpet.104.076836
   Singh RP, 2002, J AGR FOOD CHEM, V50, P81, DOI 10.1021/jf010865b
   Strauch K, 2009, FOOD CHEM TOXICOL, V47, P1928, DOI 10.1016/j.fct.2009.05.004
   Voruganti S, 2012, PHYTOTHER RES, V26, P1240, DOI 10.1002/ptr.3704
   Wanwimolruk Sompon, 2009, Drug Metabolism and Drug Interactions, V24, P17, DOI 10.1515/DMDI.2009.24.1.17
   Won CS, 2012, PHARMACOL THERAPEUT, V136, P186, DOI 10.1016/j.pharmthera.2012.08.001
NR 27
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 0378-7966
EI 2107-0180
J9 EUR J DRUG METAB PH
JI Eur. J. Drug Metabol. Pharmacokinet.
PD JUN
PY 2017
VL 42
IS 3
BP 397
EP 405
DI 10.1007/s13318-016-0352-3
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EU4GO
UT WOS:000400988000005
PM 27294349
OA No
DA 2017-08-17
ER

PT J
AU El Kassas, M
   Elbaz, T
   Hafez, E
   Wifi, MN
   Esmat, G
AF El Kassas, Mohamed
   Elbaz, Tamer
   Hafez, Enas
   Wifi, Mohamed Naguib
   Esmat, Gamal
TI Discovery and preclinical development of dasabuvir for the treatment of
   hepatitis C infection
SO EXPERT OPINION ON DRUG DISCOVERY
LA English
DT Review
DE Hepatitis C virus; dasabuvir; preclinical; drug discovery
ID TREATMENT-NAIVE PATIENTS; INTERFERON-FREE THERAPY; GENOTYPE 1 INFECTION;
   POLYMERASE INHIBITOR; VIRUS-INFECTION; PHASE-2 TRIAL; RIBAVIRIN; HCV;
   ABT-450/R-OMBITASVIR; COMBINATION
AB Introduction: Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality. Positively, the introduction of new directly-acting antivirals (DAAs) have led to dramatic improvements in response rates to antiviral therapy. Furthermore, newer generations of DAAs have demonstrated better safety profiles as well as efficacy than older generations. Current treatment recommendations are based on different combinations of DAAs. Current combination therapies rely on agents that target the different steps of viral replication by using different molecules from various DAAs families.
   Areas covered: In this review, the authors summarize data from of one of the recently developed NS5B polymerase inhibitors, dasabuvir, formerly known as ABT-333. Herein, the authors discuss the drug discovery data for dasabuvir including data from preclinical, toxicological resistance studies. The authors also review dasabuvir's clinical efficacy across various clinical challenges, in addition to its limitations in clinical practice.
   Expert opinion: Dasabuvir represents an important medical advance when used as a combination therapy for HCV. Unfortunately, it does present limitations like low genotypic coverage and further research is still required to address some of the lingering issues
C1 [El Kassas, Mohamed] Helwan Univ, Endem Med Dept, Fac Med, Cairo, Egypt.
   [Elbaz, Tamer; Esmat, Gamal] Cairo Univ, Endem Hepatogastroenterol, Fac Med, Cairo, Egypt.
   [Hafez, Enas] New Cairo Viral Hepatitis Treatment Unit, Clin Pharm Unit, Cairo, Egypt.
   [Wifi, Mohamed Naguib] Cairo Univ, Internal Med Dept, Fac Med, Cairo, Egypt.
RP El Kassas, M (reprint author), Helwan Univ, Endem Med Dept, Fac Med, Cairo, Egypt.
EM m_elkassas@yahoo.com
CR Abbott, 2010, STUD ASS SAF TOL PHA
   Abbott, 2010, BIOAV ABT 333 TABL V
   Abbott, 2010, STUD ABT 333 BOTH HL
   Abbott, 2010, STUD HLTH AD SUBJ EV
   AbbVie, 2014, BIOAV ABT 333 GASTR
   AbbVie, 2015, STUD EV CHRON HEP C
   AbbVie, 2015, DAS INV BROCH
   AbbVie, 2014, FOLL UP ASS RES ABT
   Badri PS, 2016, CLIN PHARMACOKINET, V55, P275, DOI 10.1007/s40262-015-0317-8
   Cooke GS, 2013, J VIRAL HEPATITIS, V20, P600, DOI 10.1111/jvh.12123
   Davies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055373
   Eron JJ, 2014, J INT AIDS SOC, V17, P9, DOI 10.7448/IAS.17.4.19500
   European Medicines Agency, EUR PUBL ASS REP EPA
   Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057
   Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722
   Ferenci P, 2014, J HEPATOL, V60, pS527
   Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338
   Ford N, 2012, B WORLD HEALTH ORGAN, V90, P540, DOI 10.2471/BLT.11.097147
   Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227
   Gaultier I, 2011, 21 C AS PAC ASS STUD
   Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912
   Kati W, 2015, ANTIMICROB AGENTS CH, V59, P1510, DOI 10.1128/AAC.04619-14
   Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227
   Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921
   Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107
   Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2
   Lawitz E, 2013, J HEPATOL, V59, P18, DOI 10.1016/j.jhep.2013.02.009
   Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1
   Liu L., 2012, J BIOMED BIOTECHNOL, V2012, DOI [10.1155/2012/251364, DOI 10.1155/2012/251364]
   Maring C, 2009, J HEPATOL, V50, pS347
   Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141
   Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869
   Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809
   Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494
   Rodriguez-Torres M, 2009, HEPATOLOGY, V50, p91A
   Shen JW, 2016, DRUG METAB DISPOS, V44, P1139, DOI 10.1124/dmd.115.067512
   Trivella JP, 2015, EXPERT OPIN PHARMACO, V16, P617, DOI 10.1517/14656566.2015.1012493
   Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561
NR 38
TC 0
Z9 0
U1 7
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1746-0441
EI 1746-045X
J9 EXPERT OPIN DRUG DIS
JI Expert. Opin. Drug Discov.
PD JUN
PY 2017
VL 12
IS 6
BP 635
EP 642
DI 10.1080/17460441.2017.1322955
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EU8FB
UT WOS:000401272000009
PM 28440681
OA No
DA 2017-08-17
ER

PT J
AU Khairy, M
   Zahran, M
   Wassal, A
AF Khairy, Mahmoud
   Zahran, Mohamed
   Wassal, Amr
TI SACAT: Streaming-Aware Conflict-Avoiding Thrashing-Resistant GPGPU Cache
   Management Scheme
SO IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS
LA English
DT Article
DE Cache management; GPGPU
ID ADAPTIVE CACHE; ASSOCIATIVITY; PERFORMANCE; PROCESSORS; ALLOCATION
AB Modern graphical processing units (GPUs) are equipped with general-purpose L1 and L2 caches to reduce the memory bandwidth demand and improve the performance of some irregular general-purpose GPU (GPGPU) applications. However, due to the massive multithreading, GPGPU caches suffer from severe resource contention and low data-sharing which may lead to performance degradation instead. This paper proposes a low-cost streaming-aware conflict-avoiding thrashing-resistant (SACAT) GPGPU cache management scheme that efficiently utilizes the GPGPU cache resources and addresses all the problems associated with GPGPU caches. The proposed scheme employs three orthogonal techniques. First, it dynamically detects and bypasses streaming applications at fine granularity. Second, a dynamic warp throttling via cores sampling (DWT-CS) is proposed to alleviate cache thrashing. DWT-CS runs an exhaustive search over cores to find the best number of warps that achieves the highest performance. Third, it employs pseudo random interleaving cache (PRIC), which is an improved cache indexing function based on polynomial modulus mapping, to mitigate associativity stalls and eliminate conflict misses. Experimental results demonstrate that the proposed scheme achieves a 1.87 x and a 1.5 x performance improvement over the cache-conscious wavefront scheduler (CCWS) and the memory request prioritization buffer (MRPB), respectively.
C1 [Khairy, Mahmoud; Wassal, Amr] Cairo Univ, Dept Comp Engn, Giza 12613, Egypt.
   [Zahran, Mohamed] NYU, Dept Comp Sci, 550 1St Ave, New York, NY 10003 USA.
RP Khairy, M (reprint author), Cairo Univ, Dept Comp Engn, Giza 12613, Egypt.
EM makhairy@eng.cu.edu.eg; mzahran@cs.nyu.edu; wassal@eng.cu.edu.eg
CR Bakhoda A, 2009, INT SYM PERFORM ANAL, P163, DOI 10.1109/ISPASS.2009.4919648
   Che S., 2010, P IEEE INT S WORKL C, P44
   Chen X., 2014, BIOMED RES INT, V2014, P1
   Chen XH, 2014, INT SYMP MICROARCH, P343, DOI 10.1109/MICRO.2014.11
   Danalis A., 2010, P 3 WORKSH GEN PURP, P63, DOI DOI 10.1145/1735688.1735702
   Fung W. W., 2007, DYNAMIC WARP FORMATI
   Gonzalez A., 1997, P 11 INT C SUP, P76, DOI DOI 10.1145/263580.263599
   Grauer-Gray S, 2012, AUTOTUNING HIGH LEVE, V2012, P1, DOI DOI 10.HTTP://DX.D0L0RG/10.1109/INPAR.2012.6339595
   Gwennap L., 2010, SANDY BRIDGE SPANS G, V9, P10
   HARPER DT, 1987, IEEE T COMPUT, V36, P1440
   He BS, 2008, PACT'08: PROCEEDINGS OF THE SEVENTEENTH INTERNATIONAL CONFERENCE ON PARALLEL ARCHITECTURES AND COMPILATION TECHNIQUES, P260, DOI 10.1145/1454115.1454152
   HILL MD, 1989, IEEE T COMPUT, V38, P1612, DOI 10.1109/12.40842
   Jia Wenhao, 2012, P 26 ACM INT C SUP, P15
   Jia WH, 2014, INT S HIGH PERF COMP, P272, DOI 10.1109/HPCA.2014.6835938
   Jog Adwait, 2013, P 18 INT C ARCH SUPP, P395
   Kayiran O, 2013, INT CONFER PARA, P157, DOI 10.1109/PACT.2013.6618813
   Keckler SW, 2011, IEEE MICRO, V31, P7, DOI 10.1109/MM.2011.89
   Kharbutli M, 2004, 10TH INTERNATIONAL SYMPOSIUM ON HIGH PERFORMANCE COMPUTER ARCHITECTURE, PROCEEDINGS, P288, DOI 10.1109/HPCA.2004.10015
   Kirk David, 2010, PROGRAMMING MASSIVEL
   Lee JS, 2013, MULTIMED TOOLS APPL, V67, P31, DOI 10.1007/s11042-012-1011-6
   Lee M, 2014, INT S HIGH PERF COMP, P260, DOI 10.1109/HPCA.2014.6835937
   Li C., 2015, P 29 ACM INT C SUP, P67
   Li D, 2015, INT S HIGH PERF COMP, P89, DOI 10.1109/HPCA.2015.7056024
   Li DD, 2016, IEEE COMPUT ARCHIT L, V15, P25, DOI 10.1109/LCA.2015.2435709
   Mantor M., 2011, AMD FUSION DEV SUMMI
   Meltzer R., 2013, P GPU TECHN C
   Micikevicius P., 2012, P GPU TECHN C
   NVIDIA, 2013, CUDA C C SDK COD SAM
   [Anonymous], 2013, CUDA C PROGR GUID V5
   [Anonymous], 2013, NVIDIAS NEXT GEN CUD
   [Anonymous], 2015, OPENCL SPEC VERS 2 0
   Qureshi MK, 2005, CONF PROC INT SYMP C, P544, DOI 10.1109/ISCA.2005.52
   Rau B. R., 1991, P 18 ANN INT S COMP, P74, DOI DOI 10.1145/115952.115961
   Rogers T. G., 2013, P 46 ANN IEEE ACM IN, P99
   Rogers TG, 2012, INT SYMP MICROARCH, P72, DOI 10.1109/MICRO.2012.16
   Seznec A., 1993, ACM SIGARCH COMPUT A, V21, P169, DOI 10.1145/173682.165152
   Sohi G. S., 1988, 753 U WISC MAD
   Tian Yingying, 2015, P 8 WORKSH GEN PURP, P25
   Topham N, 1997, INT SYMP MICROARCH, P71, DOI 10.1109/MICRO.1997.645799
   Wittenbrink CM, 2011, IEEE MICRO, V31, P50, DOI 10.1109/MM.2011.24
   Zheng Z, 2015, IEEE COMPUT ARCHIT L, V14, P90, DOI 10.1109/LCA.2014.2359882
   [Anonymous], 2012, GPGPU SIM 3 X MANUAL
NR 42
TC 0
Z9 0
U1 0
U2 0
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA
SN 1045-9219
EI 1558-2183
J9 IEEE T PARALL DISTR
JI IEEE Trans. Parallel Distrib. Syst.
PD JUN
PY 2017
VL 28
IS 6
BP 1740
EP 1753
DI 10.1109/TPDS.2016.2627560
PG 14
WC Computer Science, Theory & Methods; Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA EU9MZ
UT WOS:000401365300016
OA No
DA 2017-08-17
ER

PT J
AU El-Soussi, AH
   Asfour, HI
AF El-Soussi, Azza H.
   Asfour, Hayam I.
TI A return to the basics; nurses' practices and knowledge about
   interventional patient hygiene in critical care units
SO INTENSIVE AND CRITICAL CARE NURSING
LA English
DT Article
DE Basic nursing care; Critical care units; Interventional patient hygiene;
   Nurses' knowledge; Nurses' practices
ID ORAL CARE; MODEL
AB Background: The Nursing profession is struggling to return to basic nursing care to maintain patients' safety. "Interventional patient hygiene" (IPH) is a measurement model for reducing the bioburden of both the patient and health care worker, and its components are hand hygiene, oral care, skin care/antisepsis, and catheter site care.
   Objectives: To identify the level of nurses' practice and knowledge about interventional patient hygiene and identify barriers for implementing interventional patient hygiene in critical care units.
   Methodology: A descriptive research design was used and three tools were applied in this study: "The Interventional Patient Hygiene Observational Checklist", "The Interventional Patient Hygiene Knowledge Questionnaire" and "The Barriers for Implementing Interventional Patient Hygiene in Critical Care Units".
   Results: The mean percentage nurses' knowledge score is higher than the mean percentage practice score in all items (hand hygiene (71.28 +/- 25.46, compared with 46.15 +/- 17.87), oral care (100:0 +/- 0.0, compared with 25.32 +/- 24.25), catheter care (75.76 +/- 9.40, compared with 8.97 +/- 24.14) and skin care (47.80 +/- 6.79, compared with 26.28 +/- 16.57). Barriers for implementing hand hygiene are workload (71.79%), insufficient resources (61.53%), and lack of knowledge (10.25%).
   Conclusion: The mean percentage IPH knowledge score is higher than the mean percentage IPH practice score of all IPH items. Barriers for implementing IPH include workload, insufficient resources, and lack of knowledge/training. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [El-Soussi, Azza H.; Asfour, Hayam I.] Alexandria Univ, Fac Nursing, Crit Care & Emergency Nursing, Crit Care & Emergency Nursing Dept, Alexandria, Egypt.
RP Asfour, HI (reprint author), Alexandria Univ, Fac Nursing, Crit Care & Emergency Nursing, Crit Care & Emergency Nursing Dept, Alexandria, Egypt.
EM hayamasfour2002@gmail.com
CR Alsubaie S, 2013, AM J INFECT CONTROL, V41, P131, DOI 10.1016/j.ajic.2012.02.035
   Burns SM, 2013, INTENS CRIT CARE NUR, V29, P247, DOI 10.1016/j.iccn.2013.06.001
   Carr D, 2009, ADV SKIN WOUND CARE, V22, P74, DOI 10.1097/01.ASW.0000345281.97908.24
   Drekonja DM, 2010, AM J INFECT CONTROL, V38, P31, DOI 10.1016/j.ajic.2009.05.005
   Duffin Christian, 2014, Nurs Stand, V28, P10, DOI [10.7748/ns2014.04.28.35.10.s9, 10.7748/ns2014.04.28.34.10.s9, 10.7748/ns2014.04.28.33.10.s8, 10.7748/ns2014.03.28.28.10.s9, 10.7748/ns2014.02.28.26.10.s9, 10.7748/ns.28.51.10.s9]
   Abd Elaziz K., 2008, J COMMUN MED, V26, P50
   Eskander HG, 2013, J ED PRACT, V4, P160
   Feider LL, 2010, AM J CRIT CARE, V19, P175, DOI 10.4037/ajcc2010816
   Guy Heidi, 2013, Br J Nurs, V22, ppassim
   Hinno S, 2012, J CLIN NURS, V21, P1584, DOI 10.1111/j.1365-2702.2011.03956.x
   Juan H., 2011, SAJCC, V27, P42
   Lin YS, 2011, J CLIN NURS, V20, P3204, DOI 10.1111/j.1365-2702.2011.03819.x
   McGuckin M, 2008, AM J INFECT CONTROL, V36, P59, DOI 10.1016/j.ajic.2007.01.010
   Morton P., 2013, CRITICAL CARE NURSIN
   Titsworth WL, 2012, J NEUROSURG, V116, P911, DOI 10.3171/2011.11.JNS11974
   Vollman K, 2005, AACN NEWS, V22, P1
   Vollman K, 2009, AUST CRIT CARE, V22, P152, DOI 10.1016/j.aucc.2009.09.001
   Vollman KM, 2013, INTENS CRIT CARE NUR, V29, P250, DOI 10.1016/j.iccn.2013.04.004
   Watret L., 2012, J COMMUN NURS, V26, P37
   Watson J., 2009, MUNDO SAUDE, V33, P143
   Whitlock J., 2013, WOUNDCARE, pS32
   World Health Organization, 2009, WHO GUID HAND HYG HL
NR 22
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0964-3397
EI 1532-4036
J9 INTENS CRIT CARE NUR
JI Intensive Crit. Care Nurs.
PD JUN
PY 2017
VL 40
BP 11
EP 17
DI 10.1016/j.iccn.2016.10.002
PG 7
WC Nursing
SC Nursing
GA EU9XW
UT WOS:000401394000002
PM 28131655
OA No
DA 2017-08-17
ER

PT J
AU Tashani, OA
   AlAbas, OA
   Kabil, RAM
   Johnson, MI
AF Tashani, Osama A.
   AlAbas, Oras A.
   Kabil, Raafat A. M.
   Johnson, Mark I.
TI Psychometric Properties of an Arabic Pain Anxiety Symptoms Scale-20
   (PASS-20) in Healthy Volunteers and Patients Attending a Physiotherapy
   Clinic
SO INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE
LA English
DT Article
DE Pain; Anxiety; Fear of pain; Psychometric analysis; Libya
ID FEAR-AVOIDANCE; RESPONSES; CONSEQUENCES; SAMPLE
AB The aim of this study was to cross-culturally adapt the PASS-20 questionnaire for use in Libya.
   Participants were 71 patients (42 women) attending the physiotherapy clinic, Ibn Sina Hospital, Sirt, Libya for management of persistent pain and 137 healthy unpaid undergraduate students (52 women) from the University of Sirt, Libya. The English PASS-20 was translated into Arabic. Patients completed the Arabic PASS-20 and the Arabic Pain Rating Scales on two occasions separated by a 14-day interval. Healthy participants completed the Arabic PASS-20 on one occasion.
   The internal consistency (ICC) for pain patient and healthy participant samples yielded a good reliability for the total score, cognitive anxiety, fear of pain, and physiological anxiety. The test-retest reliability of the Arabic PASS-20 score showed high reliability for the total score (ICC = 0.93, p < 0.001), escape/avoidance (ICC = 0.93, p < 0.001), fear of pain (ICC = 0.94, p < 0.001), and physiological anxiety subscales (ICC = 0.96, p < 0.001) and good reliability for the cognitive anxiety (ICC = 0.85, p < 0.001). Inspection of the Promax rotation showed that each factor comprised of five items were consistent with the theoretical constructs of the original PASS-20 subscales.
   The Arabic PASS-20 retained internal consistency and reliability with the original English version and can be used to measure pain anxiety symptoms in both pain and healthy individual samples in Libya.
C1 [Tashani, Osama A.; AlAbas, Oras A.; Johnson, Mark I.] Leeds Beckett Univ, Ctr Pain Res, Leeds, W Yorkshire, England.
   [Tashani, Osama A.; Johnson, Mark I.] Leeds Beckett Univ, MENA Res Grp, Leeds, W Yorkshire, England.
   [AlAbas, Oras A.; Kabil, Raafat A. M.] Sirte Univ, Sirte, Libya.
   [Kabil, Raafat A. M.] Sohag Univ, Sohag, Egypt.
RP Tashani, OA (reprint author), Leeds Beckett Univ, Ctr Pain Res, Leeds, W Yorkshire, England.; Tashani, OA (reprint author), Leeds Beckett Univ, MENA Res Grp, Leeds, W Yorkshire, England.
EM O.tashani@LeedsBeckett.ac.uk
FU Leeds Beckett University
FX This study was funded by Leeds Beckett University.
CR Abrams MP, 2007, J PAIN, V8, P879, DOI 10.1016/j.jpain.2007.06.004
   Bland JM, 1996, BRIT MED J, V313, P106
   Cho SK, 2010, INT J BEHAV MED, V17, P108, DOI 10.1007/s12529-010-9080-2
   Coons MJ, 2004, EUR J PAIN, V8, P511, DOI 10.1016/j.ejpain.2003.11.018
   Costello A, 2005, PRACT ASSESS RES EVA, V10, P10
   Cronbach L. J., 1984, ESSENTIALS PSYCHOL T
   Goffaux P, 2011, PAIN, V152, P2065, DOI 10.1016/j.pain.2011.05.002
   Hasenbring MI, 2010, CLIN J PAIN, V26, P747, DOI 10.1097/AJP.0b013e3181e104f2
   Keogh Edmund, 2006, Cognitive Behaviour Therapy, V35, P198, DOI 10.1080/16506070600898330
   Kreddig N, 2015, INT J BEHAV MED, V22, P197, DOI 10.1007/s12529-014-9426-2
   McCracken Lance M, 2002, Pain Res Manag, V7, P45
   MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P
   McCracken LM, 1996, BEHAV RES THER, V34, P927, DOI 10.1016/S0005-7967(96)00057-5
   McCracken LM, 1998, BEHAV RES THER, V36, P621, DOI 10.1016/S0005-7967(97)10039-0
   Roelofs J, 2004, J BEHAV MED, V27, P167, DOI 10.1023/B:JOBM.0000019850.51400.a6
   Streiner DL, 2014, HLTH MEASUREMENT SCA, P416
   Tabachnick BG, 2001, USING MULTIVARIATE S
   Tashani OA, 2010, GENDER MED, V7, P309, DOI 10.1016/j.genm.2010.07.002
   Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0
   WEISENBERG M, 1975, PSYCHOSOM MED, V37, P123
   Wong WS, 2012, J PAIN SYMPTOM MANAG, V43, P1131, DOI 10.1016/j.jpainsymman.2011.06.021
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1070-5503
EI 1532-7558
J9 INT J BEHAV MED
JI Int. J. Behav. Med.
PD JUN
PY 2017
VL 24
IS 3
BP 457
EP 472
DI 10.1007/s12529-016-9608-1
PG 16
WC Psychology, Clinical
SC Psychology
GA EU1JT
UT WOS:000400775600006
PM 27834043
OA No
DA 2017-08-17
ER

PT J
AU Attia, MA
AF Attia, Mohamed A.
TI On the mechanics of functionally graded nanobeams with the account of
   surface elasticity
SO INTERNATIONAL JOURNAL OF ENGINEERING SCIENCE
LA English
DT Article
DE Nonlocal-couple stress theory; Surface elasticity theory; Eringen's
   nonlocal elasticity; FG nanobeams; Size effect
ID COUPLE STRESS THEORY; NONLINEAR FREE-VIBRATION; SIZE-DEPENDENT BEHAVIOR;
   STRAIN GRADIENT THEORY; MODEL INCORPORATING MICROSTRUCTURE; NONLOCAL
   INTEGRAL MODEL; TIMOSHENKO BEAM THEORY; EULER-BERNOULLI; FG NANOBEAMS;
   BUCKLING ANALYSIS
AB In this paper, size-dependent bending, buckling and free vibration responses of functionally graded (FG) nanobeams are investigated using an integrated nonclassical continuum model. The integrated model accounts for the simultaneous effects of the microstructure local rotation and the surface energy in the framework of the nonlocal elasticity. The proposed nonlocal-couple stress-surface elasticity (NLCSSE) model is formulated by incorporating the Eringen nonlocal elasticity theory, modified couple stress theory and surface elasticity theory into the classical Euler-Bernoulli beam model. It is assumed that the material properties of the bulk and surface of the FG nanobeam change continuously through the thickness according to a power law. The size-dependent equations of motion and corresponding boundary conditions are derived utilizing the Hamilton's principle. The proposed model is validated by comparing the obtained results with available benchmark results. Numerical results are presented to reveal the effects of nonlocal parameter, material length scale parameter, surface energy, gradient index, Poisson ratio, thickness and length to-thickness ratio on the deflection, critical buckling load and natural frequency of a FG simply supported nanobeam. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Attia, Mohamed A.] Zagazig Univ, Mech Design & Prod Engn Dept, Zagazig 44511, Egypt.
RP Attia, MA (reprint author), Zagazig Univ, Mech Design & Prod Engn Dept, Zagazig 44511, Egypt.
EM omarmadly@yahoo.com
CR Aifantis EC, 2011, INT J ENG SCI, V49, P1367, DOI 10.1016/j.ijengsci.2011.03.016
   Akgoz B, 2013, COMPOS STRUCT, V98, P314, DOI 10.1016/j.compstruct.2012.11.020
   Ansari R, 2017, MECCANICA, V52, P283, DOI 10.1007/s11012-016-0396-0
   Ansari R, 2013, COMPOS PART B-ENG, V55, P240, DOI 10.1016/j.compositesb.2013.05.040
   Ansari R, 2011, INT J ENG SCI, V49, P1244, DOI 10.1016/j.ijengsci.2011.01.007
   Arash B, 2012, COMP MATER SCI, V51, P303, DOI 10.1016/j.commatsci.2011.07.040
   Asghari M, 2011, MATER DESIGN, V32, P1435, DOI 10.1016/j.matdes.2010.08.046
   Asghari M, 2010, MATER DESIGN, V31, P2324, DOI 10.1016/j.matdes.2009.12.006
   Attia MA, 2016, INT J MECH MATER DES, P1, DOI [10.1007/s10999-016-9343-4, DOI 10.1007/S10999-016-9343-4]
   Attia MA, 2016, INT J MECH SCI, V105, P126, DOI 10.1016/j.ijmecsci.2015.11.002
   Attia MA, 2015, INT J MECH SCI, V94-95, P36, DOI 10.1016/j.ijmecsci.2015.02.016
   Aydogdu M, 2009, PHYSICA E, V41, P1651, DOI 10.1016/j.physe.2009.05.014
   Birman V, 2014, INT J ENG SCI, V78, P18, DOI 10.1016/j.ijengsci.2014.01.002
   Cuenot S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.165410
   Dingreville R, 2005, J MECH PHYS SOLIDS, V53, P1827, DOI 10.1016/j.jmps.2005.02.012
   Ebrahimi F, 2017, COMPOS STRUCT, V159, P174, DOI 10.1016/j.compstruct.2016.09.058
   Ebrahimi F, 2015, COMPOS PART B-ENG, V78, P272, DOI 10.1016/j.compositesb.2015.03.068
   Ebrahimi F, 2015, COMPOS STRUCT, V128, P363, DOI 10.1016/j.compstruct.2015.03.023
   Eltaher MA, 2016, APPL MATH MODEL, V40, P4109, DOI 10.1016/j.apm.2015.11.026
   Eltaher MA, 2013, COMPOS STRUCT, V99, P193, DOI 10.1016/j.compstruct.2012.11.039
   Eltaher MA, 2013, COMPOS STRUCT, V96, P82, DOI 10.1016/j.compstruct.2012.09.030
   Eltaher MA, 2012, APPL MATH COMPUT, V218, P7406, DOI 10.1016/j.amc.2011.12.090
   Eptaimeros KG, 2016, INT J MECH SCI, V115, P68, DOI 10.1016/j.ijmecsci.2016.06.013
   ERINGEN AC, 1983, J APPL PHYS, V54, P4703, DOI 10.1063/1.332803
   ERINGEN AC, 1972, INT J ENG SCI, V10, P1, DOI 10.1016/0020-7225(72)90070-5
   Eringen A. C., 1999, THEORY MICROPOLAR EL, P101
   Eringen A. C., 2002, NONLOCAL CONTINUUM F
   Eringen A. G., 1965, LINEAR THEORY MICROP
   Fernandez-Saez J, 2016, INT J ENG SCI, V99, P107, DOI 10.1016/j.ijengsci.2015.10.013
   FLECK NA, 1994, ACTA METALL MATER, V42, P475, DOI 10.1016/0956-7151(94)90502-9
   FLECK NA, 1993, J MECH PHYS SOLIDS, V41, P1825, DOI 10.1016/0022-5096(93)90072-N
   Gao XL, 2015, Z ANGEW MATH PHYS, V66, P1871, DOI 10.1007/s00033-014-0455-0
   Gao XL, 2015, ACTA MECH, V226, P457, DOI 10.1007/s00707-014-1189-y
   Gao XL, 2014, Z ANGEW MATH PHYS, V65, P393, DOI 10.1007/s00033-013-0343-z
   Ghadiri M, 2016, MICROSYST TECHNOL, V22, P2853, DOI 10.1007/s00542-015-2662-9
   Ghadiri M, 2016, ACTA ASTRONAUT, V121, P221, DOI 10.1016/j.actaastro.2016.01.003
   GURTIN ME, 1975, ARCH RATION MECH AN, V57, P291
   GURTIN ME, 1978, INT J SOLIDS STRUCT, V14, P431, DOI 10.1016/0020-7683(78)90008-2
   Hosseini-Hashemi S, 2014, APPL MATH MODEL, V38, P3538, DOI 10.1016/j.apm.2013.11.068
   Hosseini-Hashemi S, 2013, COMPOS PART B-ENG, V52, P199, DOI 10.1016/j.compositesb.2013.04.023
   Jha DK, 2013, COMPOS STRUCT, V96, P833, DOI 10.1016/j.compstruct.2012.09.001
   Ke LL, 2011, COMPOS STRUCT, V93, P342, DOI 10.1016/j.compstruct.2010.09.008
   Khodabakhshi P, 2015, INT J ENG SCI, V95, P60, DOI 10.1016/j.ijengsci.2015.06.006
   Khorshidi MA, 2016, INT J MECH SCI, V110, P160, DOI 10.1016/j.ijmecsci.2016.03.006
   Kiani K, 2016, PHYSICA E, V83, P151, DOI 10.1016/j.physe.2016.04.018
   Koiter WT, 1964, P K NED AKAD B PHYS, V67, P17
   Koutsoumaris C., 2016, INT J SOLIDS STRUCT, DOI DOI 10.1016/J.IJS0LSTR.2016.09.007
   Lam DCC, 2003, J MECH PHYS SOLIDS, V51, P1477, DOI 10.1016/S0022-5096(03)00053-X
   Li L, 2016, INT J ENG SCI, V107, P77, DOI 10.1016/j.ijengsci.2016.07.011
   Li L, 2016, INT J ENG SCI, V102, P77, DOI 10.1016/j.ijengsci.2016.02.010
   Li XB, 2017, COMPOS STRUCT, V165, P250, DOI 10.1016/j.compstruct.2017.01.032
   Lim CW, 2015, J MECH PHYS SOLIDS, V78, P298, DOI 10.1016/j.jmps.2015.02.001
   Lim CW, 2010, APPL MATH MECH-ENGL, V31, P37, DOI 10.1007/s10483-010-0105-7
   Lu CF, 2009, COMPOS SCI TECHNOL, V69, P1124, DOI 10.1016/j.compscitech.2009.02.005
   McFarland AW, 2005, J MICROMECH MICROENG, V15, P1060, DOI 10.1088/0960-1317/15/5/024
   Miller RE, 2000, NANOTECHNOLOGY, V11, P139, DOI 10.1088/0957-4484/11/3/301
   Mindlin R.D., 1968, International Journal of Solids and Structures, V4, P109, DOI 10.1016/0020-7683(68)90036-X
   MINDLIN RD, 1964, ARCH RATION MECH AN, V16, P51
   MINDLIN RD, 1963, ARCH RATION MECH AN, V11, P415
   Mindlin RD, 1963, EXP MECH, V3, P1, DOI DOI 10.1007/BF02327219
   Mohammad-Abadi M, 2014, INT J ENG SCI, V74, P1, DOI 10.1016/j.ijengsci.2013.08.010
   Nateghi A, 2012, APPL MATH MODEL, V36, P4971, DOI 10.1016/j.apm.2011.12.035
   Nateghi A, 2013, COMPOS STRUCT, V96, P97, DOI 10.1016/j.compstruct.2012.08.048
   Nazemnezhad R, 2014, COMPOS STRUCT, V110, P192, DOI 10.1016/j.compstruct.2013.12.006
   Nejad MZ, 2016, INT J ENG SCI, V105, P1, DOI 10.1016/j.ijengsci.2016.04.011
   Nejad MZ, 2016, INT J ENG SCI, V103, P1, DOI 10.1016/j.ijengsci.2016.03.001
   Norouzzadeh A, 2017, PHYSICA E, V88, P194, DOI 10.1016/j.physe.2017.01.006
   Ozturk A, 2011, INT J ENG SCI, V49, P1047, DOI 10.1016/j.ijengsci.2011.06.001
   Peddieson J, 2003, INT J ENG SCI, V41, P305, DOI 10.1016/S0020-7225(02)00210-0
   Pisano AA, 2003, INT J SOLIDS STRUCT, V40, P13
   Poole WJ, 1996, SCRIPTA MATER, V34, P559, DOI 10.1016/1359-6462(95)00524-2
   Rahmani O, 2014, INT J ENG SCI, V77, P55, DOI 10.1016/j.ijengsci.2013.12.003
   Reddy JN, 2007, INT J ENG SCI, V45, P288, DOI 10.1016/j.ijengsci.2007.04.004
   Romano G, 2017, COMPOS PART B-ENG, V114, P184, DOI 10.1016/j.compositesb.2017.01.008
   Romano G, 2017, INT J MECH SCI, V121, P151, DOI 10.1016/j.ijmecsci.2016.10.036
   Sahmani S, 2015, COMPOS STRUCT, V121, P377, DOI 10.1016/j.compstruct.2014.11.033
   Sari M, 2017, COMPOS STRUCT, V163, P280, DOI 10.1016/j.compstruct.2016.11.093
   Shafiei N, 2016, APPL PHYS A-MATER, V122, DOI 10.1007/s00339-016-0245-y
   Shafiei N, 2016, INT J ENG SCI, V101, P29, DOI 10.1016/j.ijengsci.2015.12.008
   Sharabiani PA, 2013, COMPOS PART B-ENG, V45, P581, DOI 10.1016/j.compositesb.2012.04.064
   Simek M., 2013, COMPOS STRUCT, V97, P378
   Simsek M, 2013, INT J ENG SCI, V64, P37, DOI 10.1016/j.ijengsci.2012.12.002
   Simsek M, 2016, INT J ENG SCI, V105, P12, DOI 10.1016/j.ijengsci.2016.04.013
   Simsek M, 2012, COMP MATER SCI, V61, P257, DOI 10.1016/j.commatsci.2012.04.001
   Stofken J., 1998, ACTA MAT, V46, P5109
   STREITZ FH, 1994, PHYS REV B, V49, P10699, DOI 10.1103/PhysRevB.49.10699
   Thai HT, 2015, COMPOS STRUCT, V123, P337, DOI 10.1016/j.compstruct.2014.11.065
   Thai HT, 2012, INT J ENG SCI, V52, P56, DOI 10.1016/j.ijengsci.2011.11.011
   Trinh LC, 2016, COMPOS STRUCT, V154, P556, DOI 10.1016/j.compstruct.2016.07.033
   Tuna M, 2016, INT J ENG SCI, V107, P54, DOI 10.1016/j.ijengsci.2016.07.004
   Tuna M, 2016, INT J ENG SCI, V105, P80, DOI 10.1016/j.ijengsci.2016.05.001
   Wang CM, 2006, J PHYS D APPL PHYS, V39, P3904, DOI 10.1088/0022-3727/39/17/029
   Wang Q, 2006, INT J STRUCT STAB DY, V6, P285, DOI 10.1142/S0219455406001964
   Wang YB, 2016, AIP ADV, V6, DOI 10.1063/1.4961695
   Xu XJ, 2017, COMPOS STRUCT, V160, P366, DOI 10.1016/j.compstruct.2016.10.038
   Xu XJ, 2016, COMPOS STRUCT, V145, P43, DOI 10.1016/j.compstruct.2016.02.073
   Yang F, 2002, INT J SOLIDS STRUCT, V39, P2731, DOI 10.1016/S0020-7683(02)00152-X
   Zhang L., 2016, J NANOMECHANICS MICR, DOI [10.1061/(ASCE)NM.2153-5477.0000117, DOI 10.1061/(ASCE)NM.2153-5477.0000117]
   Zhang WC, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/49/495201
NR 99
TC 0
Z9 0
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7225
EI 1879-2197
J9 INT J ENG SCI
JI Int. J. Eng. Sci.
PD JUN
PY 2017
VL 115
BP 73
EP 101
DI 10.1016/j.ijengsci.2017.03.011
PG 29
WC Engineering, Multidisciplinary
SC Engineering
GA EU2RX
UT WOS:000400878400006
OA No
DA 2017-08-17
ER

PT J
AU Capozziello, S
   Saridakis, EN
   Bamba, K
   Sepehri, A
   Rahaman, F
   Ali, AF
   Pincak, R
   Pradhan, A
AF Capozziello, Salvatore
   Saridakis, Emmanuel N.
   Bamba, Kazuharu
   Sepehri, Alireza
   Rahaman, Farook
   Ali, Ahmed Farag
   Pincak, Richard
   Pradhan, Anirudh
TI Cosmic space and Pauli exclusion principle in a system of M0-branes
SO INTERNATIONAL JOURNAL OF GEOMETRIC METHODS IN MODERN PHYSICS
LA English
DT Article
DE Universe's expansion; cosmic space; fermions; M1 and M3-branes
ID MODIFIED GRAVITY THEORIES; BIONIC SYSTEM; DARK ENERGY; EMERGENCE;
   COSMOLOGY; MODELS
AB An emergence of cosmic space has been suggested by Padmanabhan [Emergence and expansion of cosmic space as due to the quest for holographic equipartition, arXiv: hepth/1206.4916] where he proposed that the expansion of the universe originates from a difference between the number of degrees of freedom on a holographic surface and the one in the emerged bulk. Now, a natural question that arises is how this proposal would explain the production of fermions and an emergence of the Pauli exclusion principle during the evolution of the universe? We try to address this issue in a system of M0-branes. In this model, there is a high symmetry and the system is composed of M0-branes to which only scalar fields are attached that represent scalar modes of the graviton. Then, when M0-branes join each other and hence form M1-branes, this symmetry is broken and gauge fields are formed. Therefore, these M1-branes interact with the anti-M1-branes and the force between them leads to a break of a symmetry such as the lower and upper parts of these branes are not the same. In these conditions, gauge fields which are localized on M1-branes and scalars which are attached to them symmetrically, decay to fermions with upper and lower spins which attach to the upper and lower parts of the M1-branes anti-symmetrically. The curvature produced by the coupling of identical spins has the opposite sign of the curvature produced by non-identical spins which lead to an attractive force between anti-parallel spins and a repelling force between parallel spins and hence an emergence of the Pauli exclusion principle. By approaching M1-branes to each other, the difference between curvatures of parallel spins and curvatures of anti-parallel spins increases, which leads to an inequality between the number of degrees of freedom on the surface and the one in the emerged bulk and hence lead to an occurrence of the cosmic expansion. By approaching M1-branes to each other, the square of the energy of the system becomes negative and hence tachyonic states arise. To remove these states, M1-branes compactify, the sign of gravity changes and anti-gravity emerges which leads to the branes moving away from each other. By joining M1-branes, M3-branes are produced which are similar to an initial system that oscillates between compacting and opening branches. Our universe is placed on one of these M3-branes and by changing the difference between the amount of couplings between identical and non-identical spins, it contracts or expands.
C1 [Capozziello, Salvatore] Univ Napoli Federico II, Dipartimento Fis, I-80126 Naples, Italy.
   [Capozziello, Salvatore] INFN, Sez Napoli, Compless Univ Monte St Angelo,Edificio G, I-80126 Naples, Italy.
   [Capozziello, Salvatore] Gran Sasso Sci Inst INFN, Viale F Crispi 7, I-67100 Laquila, Italy.
   [Capozziello, Salvatore] Tomsk State Pedag Univ, Ul Kievskaya 60, Tomsk 634061, Russia.
   [Saridakis, Emmanuel N.] Baylor Univ, CASPER, Phys Dept, Waco, TX 76798 USA.
   [Saridakis, Emmanuel N.] Pontificia Univ Catolica Valparaso, Inst Fis, Casilla 4950, Valparaiso, Chile.
   [Bamba, Kazuharu] Fukushima Univ, Div Human Support Syst, Fukushima 9601296, Japan.
   [Sepehri, Alireza] Shahid Bahonar Univ, Dept Phys, POB 76175, Kerman, Iran.
   [Sepehri, Alireza] RIAAM, POB 55134-441, Maragha, Iran.
   [Rahaman, Farook] Jadavpur Univ, Dept Math, Kolkata 700032, India.
   [Ali, Ahmed Farag] Benha Univ, Dept Phys, Banha 13518, Egypt.
   [Pincak, Richard] Slovak Acad Sci, Inst Expt Phys, Watsonova 47, Kosice 04353, Slovakia.
   [Pincak, Richard] Joint Inst Nucl Res, Bogoliubov Lab Theoret Phys, Dubna 141980, Moscow Region, Russia.
   [Pradhan, Anirudh] GLA Univ, Dept Math, Inst Appl Sci & Humanities, Mathura 281406, Uttar Pradesh, India.
RP Pradhan, A (reprint author), GLA Univ, Dept Math, Inst Appl Sci & Humanities, Mathura 281406, Uttar Pradesh, India.
EM capozziello@na.infn.it; emmanuel_saridakis@baylor.edu;
   bamba@sss.fukushima-u.ac.jp; alireza.sepehri@uk.ac.ir;
   rahaman@associates.iucaa.in; ahmed.ali@fsc.bu.edu.eg; pincak@saske.sk;
   pradhan@associates.iucaa.in
OI Saridakis, Emmanuel/0000-0003-1500-0874
FU Research Institute for Astronomy and Astrophysics of Maragha (RIAAM),
   Iran [1/4165-14]; IUCAA, Pune, India; VEGA Grant [2/0009/16]; JSPS
   [25800136]; Fukushima University
FX The work of A. Sepehri has been supported by Research Institute for
   Astronomy and Astrophysics of Maragha (RIAAM), Iran Under Research
   Project No. 1/4165-14. F. Rahaman and A. Pradhan acknowledge IUCAA,
   Pune, India for awarding Visiting Associateship. The work was partially
   supported by the VEGA Grant No. 2/0009/16. R. Pincak would like to thank
   the TH division in CERN for hospitality. This work was partially
   supported by the JSPS Grant-in-Aid for Young Scientists (B) # 25800136
   and the research funds provided by Fukushima University (K.B.).
CR Ali AF, 2014, PHYS LETT B, V732, P335, DOI 10.1016/j.physletb.2014.04.011
   Bagger J, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.065008
   Bamba K, 2015, SYMMETRY-BASEL, V7, P220, DOI 10.3390/sym7010220
   Bamba K, 2012, ASTROPHYS SPACE SCI, V342, P155, DOI 10.1007/s10509-012-1181-8
   Capozziello S, 2011, PHYS REP, V509, P167, DOI 10.1016/j.physrep.2011.09.003
   Chang-Young E., 2014, J HIGH ENERGY PHYS, V1404, P125
   Chu C.-S., 2009, JHEP, V0904
   Constable NR, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.106009
   Constable N. R., 2001, HIGH ENERGY PHYS, V0106
   Cruz M, 2013, CLASSICAL QUANT GRAV, V30, DOI 10.1088/0264-9381/30/11/115012
   de la Cruz-Dombriz A, 2012, ENTROPY-SWITZ, V14, P1717, DOI 10.3390/e14091717
   de Rham C, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.043503
   de Rham C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.231101
   Eune M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.067303
   Gustavsson A, 2009, NUCL PHYS B, V811, P66, DOI 10.1016/j.nuclphysb.2008.11.014
   Heisenberg L, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.103008
   Ho PM, 2008, J HIGH ENERGY PHYS
   Joyce A, 2015, PHYS REP, V568, P1, DOI 10.1016/j.physrep.2014.12.002
   Kluson J., 2000, J HIGH ENERGY PHYS, V0011
   Koyama K, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/4/046902
   Ling Y, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.043518
   Mukhi S., 2008, JHEP, V0805
   Myers RC, 1999, J HIGH ENERGY PHYS
   Nojiri S, 2007, INT J GEOM METHODS M, V4, P115, DOI 10.1142/S0219887807001928
   Nojiri S, 2011, PHYS REP, V505, P59, DOI 10.1016/j.physrep.2011.04.001
   Padmanabhan T., ARXIV12064916HEPTH
   Sathiapalan B., 2008, J HIGH ENERGY PHYS, V0808
   Sepehri A, 2015, PHYS LETT B, V741, P92, DOI 10.1016/j.physletb.2014.12.030
   Sepehri A, 2016, PHYS LETT A, V380, P2247, DOI 10.1016/j.physleta.2016.05.015
   Sepehri A, 2016, EUR PHYS J C, V76, DOI 10.1140/epjc/s10052-016-4084-y
   Sepehri A, 2015, PHYS LETT B, V748, P328, DOI 10.1016/j.physletb.2015.07.017
   Sepehri A, 2015, PHYS LETT B, V747, P1, DOI 10.1016/j.physletb.2015.05.042
   Sheykhi A, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.061501
   Yang K, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.104013
NR 34
TC 0
Z9 0
U1 1
U2 1
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-8878
EI 1793-6977
J9 INT J GEOM METHODS M
JI Int. J. Geom. Methods Mod. Phys.
PD JUN
PY 2017
VL 14
IS 6
AR 1750095
DI 10.1142/S0219887817500955
PG 32
WC Physics, Mathematical
SC Physics
GA EU2UX
UT WOS:000400886500014
OA No
DA 2017-08-17
ER

PT J
AU Baraka, A
   Sherief, LM
   Kamal, NM
   El Shorbagy, S
AF Baraka, Ahmad
   Sherief, Laila M.
   Kamal, Naglaa M.
   El Shorbagy, Shereen
TI Detection of minimal residual disease in childhood B-acute lymphoblastic
   leukemia by 4-color flowcytometry
SO INTERNATIONAL JOURNAL OF HEMATOLOGY
LA English
DT Article
DE B-lineage acute lymphoblastic leukemia; Minimal residual disease (MRD);
   4-color flow cytometry
ID CHILDREN; MARKERS
AB Monitoring of minimal residual disease (MRD) is currently considered the most powerful predictor of outcome in acute lymphoblastic leukemia (ALL). Achievement of a negative MRD state assessed by multicolor flowcytometry (MFC) is an important predictor of disease-free survival (DFS) and overall survival (OS) in ALL patients. We sought to determine whether panels of antibodies combination are more suitable for detection of MRD in Childhood ALL. Eighty-four (84) patients with ALL (B-lineage subtype) were enrolled in this study. Normal template for B cell precursors was established in 15 control participants using 4-four panels of monoclonal Antibodies (Mo Abs),{CD22, CD45, CD58 and CD97 in combination with CD10, CD19, CD34}. At diagnosis, CD22 exhibited the lowest incidence of expression in only 50% of all patients, while CD45, CD58, and CD97 were expressed in 80.9, 59.5 and 92.8%, respectively. Analysis of MRD was performed for each Mo Abs combination at day 0 and day 14 post-induction of chemotherapy by 4-color (FCM). The incidence of MRD was 61.9, 70.6, 60.0 and 55.1% for CD22, CD45, CD58 and CD97, respectively. In B-ALL patients, (CD10/CD19/CD34/CD45) + (CD10/CD19/CD34/CD97) represented the highest incidence of expression of leukemic cells markers with a significant correlation with blasts count, suggesting that these are more specific for MRD detection. Also FCM is relatively cost effective for detection of MRD in ALL patients and its applicability in routine leukemia lab is valuable. MRD evaluation at the end of the induction therapy (i.e. day 35 or 42 according to the different schedules) is advised. Also, Ig/T cell receptor gene rearrangements and gene fusions analyzed by polymerase chain reaction (PCR) are preferred.
C1 [Baraka, Ahmad] Zagazig Univ, Dept Clin Pathol, Fac Med, Zagazig, Egypt.
   [Sherief, Laila M.] Zagazig Univ, Dept Pediat, Fac Med, Zagazig, Egypt.
   [Kamal, Naglaa M.] Cairo Univ, Dept Pediat, Fac Med, Cairo, Egypt.
   [El Shorbagy, Shereen] Zagazig Univ, Dept Med Oncol, Fac Med, Zagazig, Egypt.
RP Baraka, A (reprint author), Zagazig Univ, Dept Clin Pathol, Fac Med, Zagazig, Egypt.
EM barakalab@yahoo.com
CR Campana D, 2004, ACTA HAEMATOL-BASEL, V112, P8, DOI 10.1159/000077554
   Campana D, 2012, CURR OPIN HEMATOL, V19, P313, DOI 10.1097/MOH.0b013e3283543d5c
   Coustan-Smith E, 2006, BLOOD, V108, P97, DOI 10.1182/blood-2006-01-0066
   Coustan-Smith E, 2011, BLOOD, V117, P6267, DOI 10.1182/blood-2010-12-324004
   Dean F., 2006, EUR J SCI RES, V23, P244
   Fossat C, 2015, CYTOM PART B-CLIN CY, V88, P21, DOI 10.1002/cyto.b.21195
   Gaipa G, 2013, CYTOM PART B-CLIN CY, V84, P359, DOI 10.1002/cyto.b.21101
   Irving J, 2009, HAEMATOLOGICA, V116, P512
   Braham Jmili N, 2010, OPEN LEUKEMIA J, V3, P47
   Karawajew L, 2015, HAEMATOLOGICA, V100, P935, DOI 10.3324/haematol.2014.116707
   McKenna RW, 2004, LEUKEMIA LYMPHOMA, V45, P277, DOI 10.1080/1042819031000151950
   Neale GAM, 2004, LEUKEMIA, V18, P934, DOI 10.1038/sj.leu.2403348
   Oudot C, 2008, J CLIN ONCOL, V26, P1496, DOI 10.1200/JCO.2007.12.2820
   Patkar N, 2012, CYTOM PART B-CLIN CY, V82B, P252, DOI 10.1002/cyto.b.21017
   Mikhail Roshal I, 2010, CYTOM PART B-CLIN CY, V78, P139
   Schrappe Martin, 2012, Hematology Am Soc Hematol Educ Program, V2012, P137, DOI 10.1182/asheducation-2012.1.137
   Smara M, 2013, J EGYPT NATL CANC I, V25, P135
   Sullivan-Chang L, 2013, TARGETING CD22 B CEL
   van Dongen JJM, 2015, BLOOD, V125, P26
   Veltroni M, 2003, HAEMATOLOGICA, V88, P1245
   Victoria C, 2012, BLOOD AM SOC HEMATOL, V120, P1882
   Xia M, 2016, J PEDIAT HEMATOL ONC, V38, P418, DOI 10.1097/MPH.0000000000000624
   Xu Chong, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P717
NR 23
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0925-5710
EI 1865-3774
J9 INT J HEMATOL
JI Int. J. Hematol.
PD JUN
PY 2017
VL 105
IS 6
BP 784
EP 791
DI 10.1007/s12185-017-2206-4
PG 8
WC Hematology
SC Hematology
GA EU8YJ
UT WOS:000401324100011
PM 28324281
OA No
DA 2017-08-17
ER

PT J
AU Habib, AMA
   Zanaty, OM
   Anwer, HF
   Alia, DA
AF Habib, A. M. A.
   Zanaty, O. M.
   Anwer, H. F.
   Alia, D. Abo
TI The effect of paravertebral block on maxillofacial free flap survival
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE paravertebral block; microvascular surgery; free flap; survival
ID MICROCIRCULATORY BLOOD-FLOW; BRACHIAL-PLEXUS BLOCKADE;
   EPIDURAL-ANESTHESIA; TISSUE TRANSFER; SURGERY; RECONSTRUCTION; EXTREMITY
AB The purpose of this study was to investigate whether continuous paravertebral block at levels T1 and T2 with bupivacaine infusion can improve the survival of free flaps in maxillofacial reconstruction. The study was designed as a randomized controlled trial and included 36 adult patients scheduled for maxillofacial free flap reconstruction under general anesthesia. Patients were randomly divided into two groups: patients in group A received continuous paravertebral block at levels Ti and T2, while patients in group B served as controls. Postoperatively, a skin thermometer was used to assess the skin temperature. Perfusion of the flaps was evaluated by analysis of skin color, turgor, and capillary refill. Survival of the free flap was recorded. The surface temperature of the reconstructive flap, skin color score, and capillary refill score were significantly higher in group A patients than in group B patients during follow-up. The total perfusion score was significantly higher in group A than in group B at 16 h and 20 h postoperative (P = 0.041 and P = 0.039, respectively). Re-operation was recorded in three cases in group B (16.7%) (P = 0.031). Continuous paravertebral block at levels Ti and T2 can increase the skin temperature and improve skin color and capillary refilling, which are indices of adequate tissue perfusion and indicate maxillofacial free flap survival.
C1 [Habib, A. M. A.] Univ Alexandria, Fac Dent, Maxillofacial & Plast Surg, 13 Zaki Ragab St,Smouha, Alexandria, Egypt.
   [Zanaty, O. M.; Anwer, H. F.; Alia, D. Abo] Univ Alexandria, Fac Dent, Anaesthesia & Surg Intens Care, Alexandria, Egypt.
RP Habib, AMA (reprint author), Univ Alexandria, Fac Dent, Maxillofacial & Plast Surg, 13 Zaki Ragab St,Smouha, Alexandria, Egypt.
EM seragito2000@yahoo.com
OI Habib, Ahmed Serag ElDin/0000-0003-0741-1788
CR Adams J, 2003, BR J ANAESTH CEPD RE, V3, P33
   Alam NH, 2006, J PLAST RECONSTR AES, V59, P1463, DOI 10.1016/j.bjps.2005.12.021
   Banic A, 1997, PLAST RECONSTR SURG, V100, P945, DOI 10.1097/00006534-199709001-00017
   Ben Aziz M, 2014, RESEARCH, V1, P971
   Buggy DJ, 2004, ANESTHESIOLOGY, V100, P375, DOI 10.1097/00000542-200402000-00029
   Carey JN, 2012, J RECONSTR MICROSURG, V28, P189, DOI 10.1055/s-0031-1301070
   Chelly Jacques E, 2012, Anesthesiol Clin, V30, P75, DOI 10.1016/j.anclin.2011.12.001
   Erni D, 1999, EUR J ANAESTH, V16, P692, DOI 10.1046/j.1365-2346.1999.00565.x
   Hagau N, 2009, MICROSURG, V29, P161, DOI 10.1002/micr.20584
   HIDALGO DA, 1990, PLAST RECONSTR SURG, V86, P492, DOI 10.1097/00006534-199009000-00019
   Kurt E, 2005, ANN PLAS SURG, V54, P24, DOI 10.1097/01.sap.0000139568.57928.86
   Lang RS, 2012, ANESTH ANALG, V115, P678, DOI 10.1213/ANE.0b013e31825da401
   Lumenta DB, 2011, ANESTH ANALG, V113, P199, DOI 10.1213/ANE.0b013e31821893f4
   SCOTT GR, 1993, PLAST RECONSTR SURG, V91, P673, DOI 10.1097/00006534-199304000-00016
   Shemesh D, 2006, ULTRASOUND MED BIOL, V32, P817, DOI 10.1016/j.ultrasmedbio.2006.02.1420
   SIGURDSSON GH, 1995, EUR J ANAESTH, V12, P101
   Su Han-Hsiang, 2005, Chang Gung Med J, V28, P567
   Voscopoulos C, 2012, REG ANESTH PAIN, V105
NR 18
TC 0
Z9 0
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JUN
PY 2017
VL 46
IS 6
BP 706
EP 711
DI 10.1016/j.ijom.2017.01.022
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA EU7KZ
UT WOS:000401215000006
PM 28292551
OA No
DA 2017-08-17
ER

PT J
AU Alqutaibi, AY
   Kaddah, AF
   Farouk, M
AF Alqutaibi, A. Y.
   Kaddah, A. F.
   Farouk, M.
TI Randomized study on the effect of single-implant versus two implant
   retained overdentures on implant loss and muscle activity: a 12-month
   follow-up report
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE dental implants; muscle activity; overdentures; single-implant
   overdenture
ID MAXIMUM BITE FORCE; MANDIBULAR OVERDENTURES; EDENTULOUS PATIENTS;
   SUPPORTED OVERDENTURES; ATTACHMENT SYSTEMS; BONE LOSS; TRIAL;
   SATISFACTION; ADAPTATION; PROSTHESES
AB The objective was to evaluate and compare single-and two-implant retained overdentures for the rehabilitation of the edentulous mandible. Fifty-six edentulous subjects were eligible for inclusion. Using a random sampling system, a single implant or two implants were placed in the mandible. After 3 months, locator attachments were connected to the implants and the denture delivered with the retentive components incorporated in the denture base. Implant failure and muscle activity were evaluated at the 3-, 6-, and 12-month follow-up examinations. The study sample comprised 56 patients (32 male, 24 female), with a mean age of 58.2 years. A total of 84 implants were placed (28 in the single-implant group and 56 in the two-implant group). All patients completed the 12 months of follow-up. No significant differences were found between subjects in the two groups with respect to implant failure. With regard to improvements in muscle activity, the two-implant group showed statistically significant but perhaps not clinically important differences. Single-implant mandibular overdentures may be suggested as an alternative treatment modality for the rehabilitation of edentulous patients who cannot afford the cost of a two-implant overdenture.
C1 [Alqutaibi, A. Y.; Kaddah, A. F.; Farouk, M.] Cairo Univ, Fac Oral & Dent Med, Dept Prosthodont, Cairo, Egypt.
   [Alqutaibi, A. Y.] Ibb Univ, Fac Oral & Dent Med, Dept Prosthodont, Ibb, Yemen.
RP Alqutaibi, AY (reprint author), 10 Ali Sherif, Cairo, Egypt.
EM am01012002@gmail.com
FU Ibb University Research Foundation, Ibb, Yemen
FX Ibb University Research Foundation, Ibb, Yemen.
CR Al-Magaleh WR, 2016, IMPLANT DENT, V25, P199, DOI 10.1097/ID.0000000000000374
   Alqutaibi AY, 2016, J EVID-BASED DENT PR, V16, P44, DOI 10.1016/j.jebdp.2016.01.009
   Alsabeeha N, 2009, CLIN ORAL IMPLAN RES, V20, P356, DOI 10.1111/j.1600-0501.2008.01666.x
   Alsabeeha NHM, 2011, CLIN ORAL IMPLAN RES, V22, P330, DOI 10.1111/j.1600-0501.2010.02004.x
   Attard NJ, 2004, INT J PROSTHODONT, V17, P417
   Bryant SR, 2015, J DENT RES, V94, P36, DOI 10.1177/0022034514554224
   Burns D R, 2000, J Prosthodont, V9, P37, DOI 10.1111/j.1532-849X.2000.00037.x
   Celik G, 2014, J PROSTHODONT, V23, P374, DOI 10.1111/jopr.12129
   Chee W, 2006, BRIT DENT J, V201, P337, DOI 10.1038/sj.bdj.4814041
   Feine J S, 2002, Gerodontology, V19, P3
   Feine JS, 2006, J ORAL REHABIL, V33, P301, DOI 10.1111/j.1365-2842.2006.01614.x
   Fukuda T. Y., 2010, J APPL RES CLIN EXP, V10, P32
   Grover M, 2014, CLIN ORAL IMPLAN RES, V25, P580, DOI 10.1111/clr.12111
   Heckmann SM, 2009, CLIN ORAL IMPLAN RES, V20, P1200, DOI 10.1111/j.1600-0501.2009.01722.x
   Ibrahim S, 2012, BASIC RES J MED CLIN, V1, P25
   Kronstrom M, 2014, CLIN IMPLANT DENT R, V16, P323, DOI 10.1111/cid.12006
   LUNDQUIST LW, 1986, J ORAL REHABIL, V13, P21, DOI 10.1111/j.1365-2842.1986.tb01552.x
   Passia N, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-186
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   Spitzl C, 2011, INT J ORAL MAXILLOF, V27, P155
   Tavakolizadeh S, 2015, J ADV PROSTHODONT, V7, P191, DOI 10.4047/jap.2015.7.3.191
   Thomason JM, 2009, BRIT DENT J, V207, P185, DOI 10.1038/sj.bdj.2009.728
   Ucankale M, 2012, GERODONTOLOGY, V29, P24, DOI 10.1111/j.1741-2358.2010.00389.x
   van Kampen FMC, 2002, J DENT RES, V81, P170
   Wolfart S, 2008, QUINTESSENCE INT, V39, P541
   Yoshida M, 2001, INT J PROSTHODONT, V14, P77
NR 26
TC 0
Z9 0
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
EI 1399-0020
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JUN
PY 2017
VL 46
IS 6
BP 789
EP 797
DI 10.1016/j.ijom.2017.02.001
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA EU7KZ
UT WOS:000401215000016
PM 28237542
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Kareem, AAA
   El-Sheikh, TM
AF Abdel-Kareem, A. A. A.
   El-Sheikh, T. M.
TI Impact of supplementing diets with propolis on productive performance,
   egg quality traits and some haematological variables of laying hens
SO JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION
LA English
DT Article
DE propolis supplementation; laying hens; egg quality traits;
   haematological parameters
ID HEAT-STRESS; CHICKENS; CORTICOSTERONE; LYMPHOCYTE
AB One hundred and twenty eight, 28-weeks-old Lohmann LSL hybrid layers were used in this experiment, which lasted 12weeks to investigate the effect of propolis supplementation on the productive performance, egg quality traits and haematological variables of laying hens. All hens were randomly classified into four equal experimental groups, eight replicates (4birds/each). Hens in group 1 were fed on a commercial diet and considered as control group, while those in groups 2, 3 and 4 were fed on the same commercial diet and supplemented with 250, 500 and 1000mg propolis/kg diet. The obtained results revealed that daily feed consumption/hen increased insignificantly with increasing propolis level than that of the control group. Regarding the means of egg mass and egg production rate, it was observed that the laying hens fed diets containing 250 and 1000mg propolis/kg significantly (p<0.05) produced more and heaver egg in comparison with control group. External egg quality traits have not affected with increasing the level of propolis, while eggshell weight was significantly (p<0.05) increased. The internal egg quality traits except albumen and yolk percentages increased significantly (p<0.05) with increasing propolis level for treated hens as compared to those in the control. Concerning the haematological parameters, the results showed that the levels of total protein and globulin increased significantly with increasing propolis level, while cholesterol and liver enzymes were significantly decreased (p<0.05). Heterophils count of hens in the treated groups significantly decreased, whereas the lymphocyte count significantly increased, resulting in a decreased H/L ratio than that of the control group. Thus, it could be concluded that the supplementation of 250mg propolis/kg diet is highly recommended to improving egg production, blood constituent and haematological parameters of the commercial laying hens.
C1 [Abdel-Kareem, A. A. A.; El-Sheikh, T. M.] Sohag Univ, Fac Agr, Dept Poultry Prod, Sohag, Egypt.
RP Abdel-Kareem, AAA; El-Sheikh, TM (reprint author), Sohag Univ, Fac Agr, Dept Poultry Prod, Sohag, Egypt.
EM abuoghaba@yahoo.com; talatm2@yahoo.com
CR Albokhadaim I., 2015, J ADV VET ANIMAL RES, V2, P56
   AMOROS M, 1994, J NAT PROD, V57, P644, DOI 10.1021/np50107a013
   Bonomi A., 2002, Rivista di Scienza dell'Alimentazione, V31, P15
   Buhatel T., 1983, AGRONOMIC CLUJ NAPOC, V37, P45
   Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2
   CARTER TC, 1975, BRIT POULTRY SCI, V16, P131, DOI 10.1080/00071667508416171
   DAVISON TF, 1983, RES VET SCI, V34, P236
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   Bassuony EL- AA, 2009, REV LATINOAM QUIM, V37, P85
   El-Hanoun A. M., 2007, 4 WORLD POULT C 27 3
   Abou El-Naga M. K., 2014, EGYPTIAN POULTRY SCI, V34, P119
   El-Neney B. A. M., 2014, 7 INT POULTR C P, P58
   Galal A., 2008, International Journal of Poultry Science, V7, P272
   GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198
   GROSS WB, 1985, POULTRY SCI, V64, P2230
   Guclu-Kocaoglu B., 2010, ERE U J HLTH SCI, V19, P94
   Haro A, 2000, J AGR FOOD CHEM, V48, P5715, DOI 10.1021/jf000635h
   Hashem NM, 2013, LIVEST SCI, V157, P520, DOI 10.1016/j.livsci.2013.09.003
   Hegazi A., 2012, BRIT J POULTRY SCI, V1, P25
   James W. A., 1994, J NUTR, V124, P78
   Kamel K. I., 2007, 5 INT C RABB PROD HO, P403
   Khojasteh SS, 2006, INT J POULTRY SCI, V5, P84
   Krell R., 1996, FAO AGR SERVICES B, V124
   Kul S., 2004, International Journal of Poultry Science, V3, P400
   Kwiecien M, 2009, J ELEM, V14, P705
   Mathivanan V, 2013, INDIAN J SCI, V2, P23
   MAXWELL MH, 1993, WORLD POULTRY SCI J, V49, P34, DOI 10.1079/WPS19930004
   Miyataka H, 1997, BIOL PHARM BULL, V20, P496
   MONIRA K. N, 2003, INT J POULT SCI, V2, P261
   Murad JM, 2002, J ETHNOPHARMACOL, V79, P331, DOI 10.1016/S0378-8741(01)00404-4
   Ozkok D, 2013, J ANIM VET ADV, V12, P269
   Peric L., 2009, Biotechnology in Animal Husbandry, V25, P387
   Petruska P., 2012, Journal of Microbiology, Biotechnology and Food Sciences, V1, P593
   Plail R., 2006, Poultry International, V45, P34
   Roodsari M.H., 2004, AGR SCI TECHNO, V18, P57
   SAS User's Guide, 1998, SAS US GUID REL 6 03
   Seven I, 2011, REV MED VET-TOULOUSE, V162, P186
   Seven PT, 2009, ACTA VET BRNO, V78, P75, DOI 10.2754/avb200978010075
   Velikova M, 2000, FITOTERAPIA, V71, P693, DOI 10.1016/S0367-326X(00)00213-6
   Zeng Z., 2004, SCI AGR SINICA, V37, P751
NR 40
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0931-2439
EI 1439-0396
J9 J ANIM PHYSIOL AN N
JI J. Anim. Physiol. Anim. Nutr.
PD JUN
PY 2017
VL 101
IS 3
BP 441
EP 448
DI 10.1111/jpn.12407
PG 8
WC Agriculture, Dairy & Animal Science; Veterinary Sciences
SC Agriculture; Veterinary Sciences
GA EU6RZ
UT WOS:000401162800006
PM 26614568
OA No
DA 2017-08-17
ER

PT J
AU Moussa, RR
   Mahmoud, AHA
AF Moussa, Rania Rushdy
   Mahmoud, Ayman Hassaan Ahmed
TI Energy-scape elements: An approach on integrating landscape elements
   with renewable energy devices
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Energy-scape; Landscape elements; Renewable energy
ID LIFE-CYCLE ASSESSMENT; SMALL HYDROPOWER; SUSTAINABLE DEVELOPMENT;
   ELECTRICITY-GENERATION; CARBON EMISSIONS; TURKEY; BIOMASS; FUTURE;
   POWER; OPPORTUNITIES
AB Today Landscape elements have been recognized as contributors to the physical quality of urban environments. More recently, they are considered as valuable contributors in increasing the property values, creating a place attractiveness, offering job opportunities, giving sense of social belonging, improving the public health, creating sustainable urban environment and improving the overall quality of life. The present research aims to use landscape elements in enhancing the urban environments by integrating these elements with renewable energy devices and creating Energy-scape elements. The research explores the impact of Energy-scape elements upon time, area, money and power produced by conducting two marketing survey cover the properties of landscape elements and renewable energy devices. This paper shows that landscape elements can be integrated with renewable energy devices and create Energy-scape elements, it also identifies Energy-scape elements and present its properties and measure its efficiency by applying it on a case study. A comparison between energy consumption before using Energy-scape elements and after using Energy-scape elements will also be presented. Energy-scape elements will help in reducing the growth of the global environmental problems such as ozone depletion and climate change and will help the 3rd world countries to develop since that the energy is the skeleton of any development. The objective of this research is to help landscape designers to understand the benefits of Energy-scape elements and to identify the type and location of Energy-scape system that can be used in their projects. The outcome is divided into two parts; theoretical outcome and empirical outcome. The theoretical outcome presents a database for the properties of Energy-scape elements that occurs from integrating landscape elements with different renewable energy sources. While, the empirical outcome presents a pilot project using Energy-scape elements and presents comparison between energy consumption before and after using Energy-scape elements. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Moussa, Rania Rushdy] British Univ Egypt, Cairo, Egypt.
   [Mahmoud, Ayman Hassaan Ahmed] Cairo Univ, Fac Engn, Dept Architecture Engn, Giza, Egypt.
RP Moussa, RR (reprint author), British Univ Egypt, Cairo, Egypt.
EM Rania.rushdy@bue.edu.eg; ayman.h.mahmoud@eng.cu.edu.eg
CR Akpinar A, 2013, RENEW ENERG, V51, P206, DOI 10.1016/j.renene.2012.09.049
   Akpmar A., 2011, ENERG SOURCE PART B, V6, P252
   Al-Amin AQ, 2015, ENVIRON SCI POLICY, V50, P24, DOI 10.1016/j.envsci.2015.02.002
   Altinbilek H. D., 2002, International Journal on Hydropower & Dams, V9, P61
   Andrews R., 2015, REV CONCENTRATED SOL
   Atik M, 2015, LAND USE POLICY, V44, P90, DOI 10.1016/j.landusepol.2014.11.019
   Bakis R, 2007, ENERG SOURCE PART B, V2, P259, DOI 10.1080/15567240500402958
   Bakis R, 2005, ENERG EXPLOR EXPLOIT, V23, P495, DOI 10.1260/014459805776986911
   Balaman SY, 2016, J CLEAN PROD, V133, P863, DOI 10.1016/j.jclepro.2016.06.001
   Bauer N, 2015, TECHNOL FORECAST SOC, V90, P243, DOI 10.1016/j.techfore.2013.09.009
   Berkun M, 2010, CAN J CIVIL ENG, V37, P684, DOI 10.1139/L10-003
   Biello D., 2008, SCI AM
   Bilen K, 2008, RENEW SUST ENERG REV, V12, P1529, DOI 10.1016/j.rser.2007.03.003
   Boyle A., 2010, PG E MAKES DEAL SOLA
   Boyle G, 2012, RENEWABLE ENERGY POW, P20
   Butler T., 2012, ENERGY OVERDEVELOPME
   Cambridge Econometrics, 2005, HM REV CUST
   Cantu H.T, 2011, LIFE CYCLE COST ANAL
   Capik M, 2012, RENEW SUST ENERG REV, V16, P6160, DOI 10.1016/j.rser.2012.06.005
   Council of Europe, 2000, EUR LANDWSC CONV
   Dagnall S, 2000, BIORESOURCE TECHNOL, V71, P225, DOI 10.1016/S0960-8524(99)00076-0
   Demirbas A, 2001, ENERG CONVERS MANAGE, V42, P1357, DOI 10.1016/S0196-8904(00)00137-0
   Drive J.S., 2015, ADELAIDE AIRPORT LTD
   Dursun B, 2011, RENEW ENERG, V36, P1227, DOI 10.1016/j.renene.2010.10.001
   Dyck B., 2003, UNFF INT EXP M ROL P
   Erdogdu E, 2011, RENEW SUST ENERG REV, V15, P689, DOI 10.1016/j.rser.2010.09.019
   Federal Ministry of Economics and Labor, 2005, INN NEW EN TECHN 5 E
   Georgi N. J., 2006, Urban Ecosystems, V9, P195, DOI 10.1007/s11252-006-8590-9
   Givoni B, 2003, ENERG BUILDINGS, V35, P77, DOI 10.1016/S0378-7788(02)00082-8
   Grant J., 1997, J CLEAN PROD, V5, P75, DOI [10.1016/S0959-6526(97)00008-5, DOI 10.1016/S0959-6526(97)00008-5]
   Haque M.T., 2004, LANDSCAPE DESIGN ENE
   Hill D, 2014, ASSESSMENT PIEZOELEC
   IEA, 2008, WORLDW TRENDS EN US
   Jahankhani H., 2011, 1 WORLD SUSTAINABILI
   Janet LS., 2010, PROSPECTS RENEWABLE
   Kaygusuz K, 1999, ENERG SOURCE, V21, P275, DOI 10.1080/00908319950014894
   Kost C., 2013, LEVELIZED COST ELECT
   Kracker L., 1997, MIDDLE STATES GEOGR, V30, P19
   Krukanont P, 2004, BIOMASS BIOENERG, V26, P47, DOI 10.1016/S0961-9534(03)00060-6
   Lenzholzer S, 2013, J CLEAN PROD, V61, P89, DOI 10.1016/j.jclepro.2012.12.038
   Mao GZ, 2017, J CLEAN PROD, V142, P2446, DOI 10.1016/j.jclepro.2016.11.031
   Martin J, 2007, LANDSCAPE CHARACTER
   Matek B., 2013, VALUES GEOTHERMAL EN
   Moussa R.R, 2013, ICECESS 2013 INT C E
   Nautiyal H, 2011, RENEW SUST ENERG REV, V15, P2021, DOI 10.1016/j.rser.2011.01.006
   Puglia G, 2013, LIFE CYCLE COST ANAL
   Purohit P, 2009, J CLEAN PROD, V17, P181, DOI 10.1016/j.jclepro.2008.04.004
   Quej VH, 2017, J CLEAN PROD, V141, P75, DOI 10.1016/j.jclepro.2016.09.062
   Rahman T., 2012, DESIGN EFFICIENT ENE
   Saelens B.E., 2006, J PHYS ACTIVITY H S1, V3, P190
   Sharaf OZ, 2015, RENEW SUST ENERG REV, V50, P1500, DOI 10.1016/j.rser.2015.05.036
   Sherer P.M., 2003, REPORT BENEFITS PARK
   Silva R.R., 2012, REVSBAU PIRACICABA, V7, P53
   Singh J, 2015, RENEW SUST ENERG REV, V42, P286, DOI 10.1016/j.rser.2014.10.015
   Southern Electric, 2009, SOL PV TAR
   Spirn A.W., 1998, THEORY LANDSCAPE ARC
   Swaffield S.R., 2005, CULTURED LANDSCAPE D, P3
   Swanwick C., 2002, LANDSCAPE CHARACTER
   Taylor K, 2009, LANDSCAPE RES, V34, P7, DOI 10.1080/01426390802387513
   Tiwari A., 2012, INT J ELECT ELECT CO, V1, P404
   Turner S.C., 2005, DEVON HISTORIC LANDS
   Tyrvainen L, 2005, URBAN FORESTS TREES
   Uzlu E, 2011, RENEW ENERG, V36, P676, DOI 10.1016/j.renene.2010.08.012
   Valles-Planells M, 2014, ECOL SOC, V19, DOI 10.5751/ES-06251-190144
   vandenBroek R, 1996, BIOMASS BIOENERG, V11, P271, DOI 10.1016/0961-9534(96)00033-5
   Zhang XC, 2015, BUILD ENVIRON, V86, P89, DOI 10.1016/j.buildenv.2015.01.003
NR 66
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD JUN
PY 2017
VL 153
IS 1
BP 114
EP 130
DI 10.1016/j.jclepro.2017.03.077
PG 17
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA EU4ZT
UT WOS:000401042100011
OA No
DA 2017-08-17
ER

PT J
AU El-Gilany, AH
   El-shaer, S
   Khashaba, E
   El-dakroory, SA
   Omar, N
AF El-Gilany, A. -H.
   El-shaer, S.
   Khashaba, E.
   El-dakroory, S. A.
   Omar, N.
TI Knowledge, attitude, and practice (KAP) of 'teaching laboratory'
   technicians towards laboratory safety and waste management: a pilot
   interventional study
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Article
DE Laboratory technician; Waste disposal; Laboratory safety; Intervention
   study
AB A quasi-experimental study was performed on 20 technicians working in the Faculty of Medicine, Mansoura University, Egypt. The knowledge, attitude, and practice (KAP) of laboratory technicians was measured before and two months after enrolling them in an intervention programme about laboratory best practice procedures. The programme addressed laboratory safety and medical waste management. The assessment was performed using a validated Arabic self-administered questionnaire. Pre- and post-intervention scores were compared using non-parametric tests. There are significant increases in the scores of KAP after implementation of the training programme. (C) 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
C1 [El-Gilany, A. -H.; El-shaer, S.] Mansoura Univ, Fac Med, Publ Hlth, Mansoura, Egypt.
   [Khashaba, E.] Mansoura Univ, Fac Med, Occupat Med, Mansoura, Egypt.
   [El-dakroory, S. A.] Mansoura Univ, Fac Med, Forens Med & Clin Toxicol, Mansoura, Egypt.
   [Omar, N.] Mansoura Univ, Fac Med, Microbiol, Mansoura, Egypt.
RP El-shaer, S (reprint author), Mansoura Univ, Fac Med, Publ Hlth & Community Med, Gomhoria St, Mansoura 35516, Egypt.
EM shereenelshaer@gmail.com
CR Adogu POU, 2014, ASIAN J SCI TECHNOL, V5, P828
   Bharti Koria, 2012, Healthline, Journal of Indian Association of Preventive and Social Medicine, V3, P63
   Can S, 2015, PROCEDIA SOCIAL BEHA, V174, P3131
   Emmert Elizabeth A B, 2013, J Microbiol Biol Educ, V14, P78, DOI 10.1128/jmbe.v14i1.531
   Goswami H. M., 2011, National Journal of Community Medicine, V2, P470
   Guggari G., 2013, THESIS
   Madhukumar S, 2012, IRAN J BASIC MED SCI, V3, P7
   Mathur Vanesh, 2011, Indian J Community Med, V36, P143, DOI 10.4103/0970-0218.84135
   Occupational Safety and Health Administration, 2011, LAB SAF GUID, P3404
   Zaveri J, 2012, NATL J MED RES, V2, P113
NR 10
TC 0
Z9 0
U1 4
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0195-6701
EI 1532-2939
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD JUN
PY 2017
VL 96
IS 2
BP 192
EP 194
DI 10.1016/j.jhin.2017.02.007
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EU4YS
UT WOS:000401038700019
PM 28268025
OA No
DA 2017-08-17
ER

PT J
AU Al-Biltagi, MA
   Abo-Elezz, AAAE
   Abu-Ela, KT
   Suliman, GA
   Sultan, TGH
AF Al-Biltagi, Mohammed A.
   Abo-Elezz, Ahmed Ahmed Abd ElBasset
   Abu-Ela, Khaled Talaat
   Suliman, Ghada Abudelmomen
   Sultan, Tamer Gomaa Hassan
TI The Prognostic Value of Soluble Intercellular Adhesion Molecule 1 Plasma
   Level in Children With Acute Lung Injury
SO JOURNAL OF INTENSIVE CARE MEDICINE
LA English
DT Article
DE acute lung injury; acute respiratory distress syndrome; C-reactive
   protein; soluble intercellular adhesion molecule 1; sICAM-1; prognosis;
   children
ID RESPIRATORY-DISTRESS-SYNDROME; ARDS; SICAM-1
AB Objective: The objective of this study was to evaluate the prognostic significance of soluble intercellular adhesion molecule 1 (sICAM-1) measurement in plasma for the prediction of outcome of acute lung injury (ALI) in children that may allow early recognition of critical cases.
   Methods: The study was performed as a prospective, controlled cohort study involving 40 children with ALI and 30 healthy children. The plasma level of sICAM-1 was measured at days 1 and 3 of development of ALI for the patient group and measured only once for the control group. C-Reactive protein was measured in both groups on day 1 only.
   Results: There was significant increase in sICAM-1 in the patient group than in the control group (P = .001*). The mortality rate reached 55% in children with ALI. The ceased group had significantly higher plasma sICAM-1 levels both at days 1 and 3 than the survived group (P < .001*), and there was positive correlation between plasma sICAM-1 level and both duration of mechanical ventilation and the death rate, but more significant correlation was observed with plasma sICAM-1 levels at day 3 than day 1.
   Conclusion: Plasma sICAM-1 level served as a good predictor biomarker for both mechanical ventilation duration and the mortality risk in children with ALI.
C1 [Al-Biltagi, Mohammed A.; Abo-Elezz, Ahmed Ahmed Abd ElBasset; Abu-Ela, Khaled Talaat; Sultan, Tamer Gomaa Hassan] Tanta Univ, Dept Pediat, Fac Med, Med Complex,Qism 2, Tanta 11432, Egypt.
   [Suliman, Ghada Abudelmomen] Tanta Univ, Dept Clin Pathol, Fac Med, Tanta, Egypt.
RP Al-Biltagi, MA (reprint author), Tanta Univ, Dept Pediat, Fac Med, Med Complex,Qism 2, Tanta 11432, Egypt.
EM mbelrem@hotmail.com
CR Agouridakis P, 2002, RESPIR RES, V3, DOI 10.1186/rr193
   BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818
   BERRY CC, 1992, JAMA-J AM MED ASSOC, V268, P2513, DOI 10.1001/jama.268.18.2513
   Briassoulis G, 2007, CLIN BIOCHEM, V40, P299, DOI 10.1016/j.clinbiochem.2006.11.015
   Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6
   CAUGHMAN SW, 1992, J INVEST DERMATOL, V98, pS61, DOI 10.1111/1523-1747.ep12462226
   Cepkova M, 2006, CRIT CARE, V10, DOI 10.1186/cc5037
   Cornfield DN, 2013, CURR OPIN PEDIATR, V25, P338, DOI 10.1097/MOP.0b013e328360bbe7
   Flori Heidi R, 2003, Pediatr Crit Care Med, V4, P315, DOI 10.1097/01.PCC.0000074583.27727.8E
   Gando S, 2004, INFLAMMATION, V28, P237, DOI 10.1023/B:IFLA.0000049049.81688.fe
   Han YJ, 2012, J KOREAN MED SCI, V27, P1541, DOI 10.3346/jkms.2012.27.12.1541
   Lai Chou-Cheng, 2004, Journal of Microbiology Immunology and Infection, V37, P153
   McClintock D, 2008, CRIT CARE, V12, DOI 10.1186/cc6846
   Mendez MP, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-12
   Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669
   Reutershan J, 2004, CRIT CARE, V8, P453, DOI 10.1186/cc2881
   Samransamruajkit R, 2005, ASIAN PAC J ALLERGY, V23, P181
   van de Stolpe Avan der Saag PT, 1996, J MOL MED, V74, P13, DOI DOI 10.1007/BF00202069
   Z'graggen BR, 2010, CLIN EXP IMMUNOL, V161, P324, DOI 10.1111/j.1365-2249.2010.04175.x
NR 19
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0885-0666
EI 1525-1489
J9 J INTENSIVE CARE MED
JI J. Intensive Care Med.
PD JUN
PY 2017
VL 32
IS 5
BP 320
EP 325
DI 10.1177/0885066615605071
PG 6
WC Critical Care Medicine
SC General & Internal Medicine
GA EU4NH
UT WOS:000401005800003
PM 26358469
OA No
DA 2017-08-17
ER

PT J
AU Mohammed, NY
   Samak, YAA
AF Mohammed, Nisreen Yacoub
   Samak, Yasser Abdelazim Abdelmawgoud
TI Spoil the Rod and Save the Child: Socioeconomic Predictors of Harsh
   Discipline by Parents, Egyptian Case Study
SO JOURNAL OF INTERPERSONAL VIOLENCE
LA English
DT Article
DE child abusers; child abuse; physical abuse; disclosure of domestic
   violence; domestic violence; predicting domestic violence; cultural
   contexts
ID BEHAVIORS; PUNISHMENT
AB The purpose of this article is to investigate the use of harsh disciplinary methods by parents as corrective techniques for their children, and the resulting behavioral aspects in the affected children. Sociodemographic predictors are tested for estimating the impact of harsh disciplining by parents. A primary survey of a sample of 1,751 children 10 to 12 years of age across 12 provinces of Assiut Governorate in Egypt is considered. The analysis is carried out using exploratory factor analysis and confirmatory factor analysis. Structural equation modeling is used for testing the significance of the seven predictors. The findings show that harsh disciplining is significantly affected by the age, education level, income level, and marital status of parents. Harsh disciplining is evident for different dimensions: beating for discipline, beating while children grow up, beating with a stick can discipline children, and children should not be listened to. Some parents believe that beating will help in correcting the behavior of their children and in instilling desirable attitudes in them. This approach has ill effects, but it can only be corrected by addressing the poor economic conditions and education of the parents.
C1 [Mohammed, Nisreen Yacoub] King Abdulaziz Univ, Psychotherapy, Jeddah, Saudi Arabia.
   [Samak, Yasser Abdelazim Abdelmawgoud] Assiut Univ, Fac Arts, Dept Geog & GIS, Assiut, Egypt.
RP Mohammed, NY (reprint author), King Abdulaziz Univ, Dept Psychol, Fac Arts & Humanities, POB 42803, Jeddah 21551, Saudi Arabia.
EM geopsychologie@gmail.com
RI yacoub, Nisreen/L-7846-2017
FU Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah
   [246/79/D1436]; DSR
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   project was funded by the Deanship of Scientific Research (DSR), King
   Abdulaziz University, Jeddah (Grant No: 246/79/D1436). The authors,
   therefore, acknowledge with thanks DSR technical and financial support.
CR Al-Mahroos FT, 2007, SAUDI MED J, V28, P241
   Brink J., 2014, CHILDREN MUSLIM MIDD, P84
   Cain P. M., 2011, JOINT STATEMENT PHYS
   Chang L, 2003, J FAM PSYCHOL, V17, P598, DOI 10.1037/0893-3200.17.4.598
   Colyar M., 2011, ASSESSMENT SCH AGE C
   Damon W., 2006, HDB CHILD PSYCHOL SO
   Dillen A, 2011, ITQ, V76, P164
   Dwairy M, 2006, J CROSS CULT PSYCHOL, V37, P230, DOI 10.1177/0022022106286922
   Dwairy M., 2006, COUNSELLING PSYCHOTH
   Fernea E.W., 1995, CHILDREN MUSLIM MIDD
   Gershoff ET, 2016, FAM RELAT, V65, P151, DOI 10.1111/fare.12177
   Gershoff ET, 2010, CHILD DEV, V81, P487, DOI 10.1111/j.1467-8624.2009.01409.x
   Gershoff ET, 2002, PSYCHOL BULL, V128, P539, DOI 10.1037//0033-2909.128.4.539
   Global Initiative to End All Corporal Punishment of Children, 2016, CORPORAL PUNISHMENT
   GRUSEC JE, 1994, DEV PSYCHOL, V30, P4, DOI 10.1037//0012-1649.30.1.4
   Hassan A, 2016, PERTANIKA J SOC SCI, V24, P937
   Jameson J. S., 2008, THESIS
   Jansen PW, 2012, FAM RELAT, V61, P253, DOI 10.1111/j.1741-3729.2011.00691.x
   Kline T. J. B., 2005, PSYCHOL TESTING
   Mayes L., 2012, CAMBRIDGE HDB ENV HU
   McKee L, 2007, J FAM VIOLENCE, V22, P187, DOI 10.1007/s10896-007-9070-6
   Mitchell L., 2008, CORPORAL PUNISHMENT
   Montgomery H, 2008, INTRO CHILDHOOD ANTH
   Nix RL, 1999, CHILD DEV, V70, P896, DOI 10.1111/1467-8624.00065
   Runyan DK, 2010, PEDIATRICS, V126, pE701, DOI 10.1542/peds.2008-2374
   Smith A.B., 2005, DISCIPLINE GUIDANCE
   Steinberg L., 2010, DEV INFANCY ADOLESCE
   The United Nations International Children's Emergency Fund, 2010, CHILD DISC PRACT HOM
   UN Children's Fund (UNICEF), 2013, UNICEF ANN REP 2012
   World Health Organization, YOUTH VIOLENCE
   Wilmshurst L., 2012, CLIN ED CHILD PSYCHO
NR 31
TC 0
Z9 0
U1 1
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0886-2605
EI 1552-6518
J9 J INTERPERS VIOLENCE
JI J. Interpers. Violence
PD JUN
PY 2017
VL 32
IS 11
BP 1730
EP 1752
DI 10.1177/0886260517698703
PG 23
WC Criminology & Penology; Family Studies; Psychology, Applied
SC Criminology & Penology; Family Studies; Psychology
GA EU1WW
UT WOS:000400817700008
OA No
DA 2017-08-17
ER

PT J
AU Elsyad, MA
   Shaheen, NH
   Ashmawy, TM
AF Elsyad, M. A.
   Shaheen, N. H.
   Ashmawy, T. M.
TI Long-term clinical and prosthetic outcomes of soft liner and clip
   attachments for bar/implant overdentures: a randomised controlled
   clinical trial
SO JOURNAL OF ORAL REHABILITATION
LA English
DT Article
DE soft liner; clip; attachments; bar; mandibular; implant; overdenture
ID RETAINED MANDIBULAR OVERDENTURES; IMPLANT-SUPPORTED OVERDENTURES;
   RESILIENT LINER; EDENTULOUS PATIENTS; LINING MATERIALS; BOND STRENGTH;
   BAR; SILICONE; SYSTEMS
AB Long-term clinical and prosthetic outcomes of soft liner attachments for bar/implant overdentures were not sufficiently investigated. The aim of this trial was to evaluate clinical and prosthetic outcomes of resilient liner and clip attachments for bar/implant-retained mandibular overdenture after 7 years. Thirty edentulous male participants received two implants in the canine areas of the mandible. Three months later, implants were splinted with a resilient bar. Mandibular overdentures were connected to the bars with either clip (CR group, n = 15) or resilient liner (RR group, n = 15) attachments. Plaque index (PI), gingival index (GI), probing depth (PD), vertical bone loss (VBL), horizontal bone loss (HBLO) and prosthetic complications (PCs) were evaluated at denture delivery (T0), 6 (T-6m), 12 (T1), 24 (T2), 36 (T3), 48 (T4), 60 (T5), 72 (T6) and 84 (T7) months after insertion. PI and GI increased significantly with time for CR and decreased significantly for RR (P < 0001). PD increased at T1 (CR) and T6 m (RR) and then decreased thereafter (P < 005). VBL increased significantly with time in both groups (P < 0005). HBLO increased at T2 (CR) and T1 (RR) and then decreased thereafter. CR recorded significant higher PI, GI, PD, VBLO and HBLO compared to RR at all observation times (P < 0042). The survival rates were 966% and 100% for CR and RR after 7 years. The most common PCs for CR and RR were clip wears and separation of the resilient liner from the denture base, respectively. Within the limitations of this study, resilient liner attachments are recommended for bar/implant-retained mandibular overdentures than clip attachments in terms of peri-implant tissue health and prosthetic complications after 7 years.
C1 [Elsyad, M. A.] Univ Mansoura, Fac Dent, Dept Removable Prosthodont, POB 35516, Mansoura, El Dakahlia, Egypt.
   [Shaheen, N. H.] Misr Univ Sci & Technol, Coll Oral & Dent Surg, Dept Removable Prosthodont, Cairo, Egypt.
   [Ashmawy, T. M.] Cairo Univ, Natl Canc Inst, Dept Maxillofacial Prosthodont, Cairo, Egypt.
RP Elsyad, MA (reprint author), Univ Mansoura, Fac Dent, Dept Removable Prosthodont, POB 35516, Mansoura, El Dakahlia, Egypt.
EM m_syad@mans.edu.eg
OI Elsyad, Moustafa/0000-0001-9514-6931
CR ADRIAN ED, 1992, J PROSTHET DENT, V67, P219, DOI 10.1016/0022-3913(92)90457-L
   Ahuja S, 2011, J PROSTHET DENT, V105, P332, DOI 10.1016/S0022-3913(11)60064-4
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Brunner E, 1999, NICHPARAMETRISCHE AN
   Burns D R, 2000, J Prosthodont, V9, P37, DOI 10.1111/j.1532-849X.2000.00037.x
   Carpentieri Joseph R, 2004, Pract Proced Aesthet Dent, V16, P755
   Demir H, 2011, J ADHES DENT, V13, P579, DOI 10.3290/j.jad.a21851
   El-Hadary A, 2000, J PROSTHET DENT, V83, P356, DOI 10.1016/S0022-3913(00)70140-5
   Elsyad MA, 2014, J ORAL REHABIL, V41, P69, DOI 10.1111/joor.12120
   ELsyad MA, 2017, INT J PROSTHODONT, DOI 10.11607/ijp.5114
   Elsyad MA, 2016, J PROSTHET DENT, V116, P741, DOI 10.1016/j.prosdent.2016.03.005
   ELsyad MA, 2016, J ORAL IMPLANTOL, V42, P442, DOI 10.1563/aaid-joi-D-16-00022
   ELsyad MA, 2012, INT J PROSTHODONT, V25, P148
   Elsyad MA, 2010, CLIN ORAL IMPLAN RES, V21, P473, DOI 10.1111/j.1600-0501.2009.01879.x
   Heckmann SM, 2001, CLIN ORAL IMPLAN RES, V12, P640, DOI 10.1034/j.1600-0501.2001.120613.x
   Jacobs R, 1992, Clin Oral Implants Res, V3, P63, DOI 10.1034/j.1600-0501.1992.030203.x
   Kapur K K, 1988, J Dent Educ, V52, P760
   Kiat-Amnuay S, 1999, J PROSTHET DENT, V81, P568, DOI 10.1016/S0022-3913(99)70211-8
   Kim HY, 2012, J ADV PROSTHODONT, V4, P197, DOI 10.4047/jap.2012.4.4.197
   Kobayashi M, 2014, CLIN ORAL IMPLAN RES, V25, P426, DOI 10.1111/clr.12156
   Kronstrom M, 2010, INT J ORAL MAX IMPL, V25, P181
   Lachmann S, 2007, INT J PROSTHODONT, V20, P37
   Lekholm U, 1985, TISSUE INTEGRATED PR, P199
   Meijer HJA, 2009, CLIN ORAL IMPLAN RES, V20, P722, DOI 10.1111/j.1600-0501.2009.01710.x
   Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x
   Murata H, 1998, J PROSTHET DENT, V80, P714, DOI 10.1016/S0022-3913(98)70060-5
   Naert I, 1998, CLIN ORAL IMPLAN RES, V9, P170, DOI 10.1034/j.1600-0501.1998.090304.x
   Sadowsky SJ, 2001, J PROSTHET DENT, V86, P468, DOI 10.1067/mpr.2001.119921
   Sesma Newton, 2005, Braz Dent J, V16, P129, DOI 10.1590/S0103-64402005000200008
   Stoker G, 2012, CLIN ORAL IMPLAN RES, V23, P925, DOI 10.1111/j.1600-0501.2011.02237.x
   Thomason JM, 2009, BRIT DENT J, V207, P185, DOI 10.1038/sj.bdj.2009.728
   Walton JN, 2002, INT J ORAL MAX IMPL, V17, P391
   Waters MGJ, 1997, J PROSTHET DENT, V77, P306, DOI 10.1016/S0022-3913(97)70188-4
NR 33
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-182X
EI 1365-2842
J9 J ORAL REHABIL
JI J. Oral Rehabil.
PD JUN
PY 2017
VL 44
IS 6
BP 472
EP 480
DI 10.1111/joor.12500
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EU4HJ
UT WOS:000400990100007
PM 28258636
OA No
DA 2017-08-17
ER

PT J
AU Safwat, S
   Ishak, RA
   Hathout, RM
   Mortada, ND
AF Safwat, Sally
   Ishak, Rania A.
   Hathout, Rania M.
   Mortada, Nahed D.
TI Statins anticancer targeted delivery systems: re-purposing an old
   molecule
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Review
DE cancer; nanoparticles; statins; targeted delivery
ID HMG-COA REDUCTASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-ASSOCIATED
   MACROPHAGES; P-GLYCOPROTEIN ACTIVITY; DRUG-DELIVERY; BREAST-CANCER;
   NITRIC-OXIDE; IN-VIVO; MULTIDRUG-RESISTANCE; ANTITUMOR-ACTIVITY
AB ObjectivesExploring the use of statins as anticancer agents and exploiting different drug delivery systems in targeting these molecules to cancerous sites. Literature review was performed to investigate the use of statins in cancer treatment in one hand, and the different pharmaceutical approaches to deliver and target these drugs to their site of action.
   Key findingsStatins were used for decades as antihypercholestrolemic drugs but recently have been proven potential for broad anticancer activities. The incorporation of statins in nanoparticulate drug delivery systems not only augmented the cytotoxicity of statins but also overcame the resistance of cancerous cells against the traditional chemotherapeutic agents. Statins-loaded nanoparticles could be easily tampered to target the cancerous cells and consequently minimal drug amount could be utilized.
   SummaryThis review reconnoitered the different endeavors to incorporate statins in various nanoparticles and summarized the successful effects in targeting cancerous cells and reducing their proliferation without the side effects of commonly used chemotherapeutic agents.
C1 [Safwat, Sally; Ishak, Rania A.; Hathout, Rania M.; Mortada, Nahed D.] Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, African Union Org St, Cairo 11566, Egypt.
   [Hathout, Rania M.] Univ Lancaster, Dept Chem, Lancaster, England.
   [Hathout, Rania M.] Univ Lancaster, Inst Mat Sci, Lancaster, England.
RP Hathout, RM (reprint author), Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, African Union Org St, Cairo 11566, Egypt.
EM r_hathout@yahoo.com
CR Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043
   Aggarwal S, 2011, J BIOMED NANOTECHNOL, V7, P137, DOI 10.1166/jbn.2011.1238
   Alayoubi AY, 2013, EUR J PHARM SCI, V48, P385, DOI 10.1016/j.ejps.2012.12.011
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Allen TM, 2002, NAT REV CANCER, V2, P750, DOI 10.1038/nrc903
   Alupei MC, 2014, ANTI-CANCER DRUG, V25, P393, DOI 10.1097/CAD.0000000000000065
   Alupei MC, 2015, CANCER LETT, V356, P946, DOI 10.1016/j.canlet.2014.11.010
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Badran MM, 2016, J DRUG DELIV SCI TEC, V32, P1, DOI 10.1016/j.jddst.2016.01.004
   Bagwe RP, 2001, CRIT REV THER DRUG, V18, P77
   Banciu M, 2008, J CONTROL RELEASE, V127, P131, DOI 10.1016/j.jconrel.2008.01.008
   Banciu M, 2008, NEOPLASIA, V10, P108, DOI 10.1593/neo.07913
   BANGHAM AD, 1965, J MOL BIOL, V13, P238
   Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104
   Benakanakere Indira, 2014, Exp Hematol Oncol, V3, P24, DOI 10.1186/2162-3619-3-24
   Bendele A, 1998, TOXICOL SCI, V42, P152, DOI 10.1006/toxs.1997.2396
   Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009
   Bertrand N, 2012, J CONTROL RELEASE, V161, P152, DOI 10.1016/j.jconrel.2011.09.098
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Borowski E, 2005, ACTA BIOCHIM POL, V52, P609
   Brennan FR, 2004, MOL BIOTECHNOL, V27, P59, DOI 10.1385/MB:27:1:59
   BROWN GC, 1995, EUR J BIOCHEM, V232, P188, DOI 10.1111/j.1432-1033.1995.tb20798.x
   Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005
   Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
   Cao J, 2013, J BIOMED NANOTECHNOL, V9, P1847, DOI 10.1166/jbn.2013.1686
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   Chan KKW, 2003, CLIN CANCER RES, V9, P10
   Chauhan VP, 2011, ANGEW CHEM INT EDIT, V50, P11417, DOI 10.1002/anie.201104449
   Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338
   Chow S, 2016, LEUKEMIA LYMPHOMA, V57, P797, DOI 10.3109/10428194.2015.1088651
   Coimbra M, 2010, J CONTROL RELEASE, V148, P303, DOI 10.1016/j.jconrel.2010.09.011
   Dalenc F, 2005, BREAST CANCER RES, V7, pR1159, DOI 10.1186/bcr1357
   Deepa N., 2014, WIRES NANOMED NANOBI, V6, P574
   Denoyelle C, 2003, CELL SIGNAL, V15, P327, DOI 10.1016/S0898-6568(02)00124-9
   Dintaman JM, 1999, PHARMACEUT RES, V16, P1550, DOI 10.1023/A:1015000503629
   Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615
   Eckford PDW, 2008, BIOCHEMISTRY-US, V47, P13686, DOI 10.1021/bi801409r
   Fan W, 2012, COLLOID SURFACE B, V95, P258, DOI 10.1016/j.colsurfb.2012.03.006
   Farid MM, 2014, COLLOID SURFACE B, V1, P123
   Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029
   Fischer MJE, 2010, METHODS MOL BIOL, V627, P55, DOI 10.1007/978-1-60761-670-2_3
   Fraga-Silva RA, 2015, CURR PHARM DESIGN, V21, P4000, DOI 10.2174/1381612821666150826095346
   Friedman DR, 2010, LEUKEMIA LYMPHOMA, V51, P2295, DOI 10.3109/10428194.2010.520050
   Gabizon AA, 2001, CLIN CANCER RES, V7, P223
   Gao J, 2010, NANOMEDICINE-UK, V5, P1141, DOI [10.2217/nnm.10.94, 10.2217/NNM.10.94]
   Gayet L, 2005, BIOCHEMISTRY-US, V44, P4499, DOI 10.1021/bi048669w
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010
   Graf H, 2008, DIGESTION, V78, P34, DOI 10.1159/000156702
   Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839
   Gu F, 2008, P NATL ACAD SCI USA, V105, P2586, DOI 10.1073/pnas.0711714105
   Hamidi M, 2011, J PHARM SCI-US, V100, P1702, DOI 10.1002/jps.22395
   Harisa GI, 2016, SAUDI PHARM J, V24, P74, DOI 10.1016/j.jsps.2015.03.024
   Hathout RM, 2012, J CONTROL RELEASE, V161, P62, DOI 10.1016/j.jconrel.2012.04.032
   Heurtault B, 2002, PHARMACEUT RES, V19, P875, DOI 10.1023/A:1016121319668
   Ho EA, 2010, J PHARM SCI-US, V99, P2839, DOI 10.1002/jps.22043
   Hormann K, 2016, J CONTROL RELEASE, V223, P85, DOI 10.1016/j.jconrel.2015.12.016
   Holtzman CW, 2006, PHARMACOTHERAPY, V26, P1601, DOI 10.1592/phco.26.11.1601
   Honore PM, 2017, BLOOD PURIFICAT, V43, P91, DOI 10.1159/000453577
   Huang KC, 2003, J BIOMED SCI, V10, P396, DOI 10.1159/000071159
   Huo SD, 2013, CANCER RES, V73, P319, DOI 10.1158/0008-5472.CAN-12-2071
   Huynh NT, 2009, INT J PHARMACEUT, V379, P201, DOI 10.1016/j.ijpharm.2009.04.026
   Ichihara K, 2002, LANCET, V359, P2195, DOI 10.1016/S0140-6736(02)09098-0
   Ishak RAH, 2015, INT J PHARMACEUT, V485, P249, DOI 10.1016/j.ijpharm.2015.03.019
   Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344
   Jiang LQ, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-66
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Junping Wang, 2003, International Journal of Pharmaceutics (Kidlington), V251, P13, DOI 10.1016/S0378-5173(02)00580-X
   Kamaly N, 2012, CHEM SOC REV, V41, P2971, DOI 10.1039/c2cs15344k
   Kangde Y, 2012, CHITOSAN BASED HYDRO, P154
   Katz MS, 2005, NAT CLIN PRACT ONCOL, V2, P82, DOI 10.1038/ncponc0097
   Kawata S, 2001, BRIT J CANCER, V84, P886, DOI 10.1054/bjoc.2001.1716
   Keawchaoon L, 2011, COLLOID SURFACE B, V84, P163, DOI 10.1016/j.colsurfb.2010.12.031
   Kimura G, 2016, CLIN EXP NEPHROL, V2, P211
   Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632
   Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199
   Kivisto KT, 2007, PHARM RES, V24, P239, DOI 10.1007/s11095-006-9159-2
   Kopecka J, 2011, J CONTROL RELEASE, V149, P196, DOI 10.1016/j.jconrel.2010.10.003
   Koshkaryev A, 2013, ADV DRUG DELIVER REV, V65, P24, DOI 10.1016/j.addr.2012.08.009
   Kostic IT, 2014, COLLOID SURFACE B, V122, P250, DOI 10.1016/j.colsurfb.2014.06.043
   Lacroix M, 2004, ONCOL REP, V12, P701
   Laine AL, 2014, NANOMED-NANOTECHNOL, V10, P1667, DOI 10.1016/j.nano.2014.05.002
   Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063
   Laufs U, 2000, TRENDS CARDIOVAS MED, V10, P143, DOI 10.1016/S1050-1738(00)00044-X
   Lavie Y, 1999, LIPIDS, V34, pS57, DOI 10.1007/BF02562229
   Lawrence MJ, 2000, ADV DRUG DELIVER REV, V45, P89, DOI 10.1016/S0169-409X(00)00103-4
   Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748
   Lieleg O, 2009, BIOPHYS J, V97, P1569, DOI 10.1016/j.bpj.2009.07.009
   Lifeng Q, 2006, BIOORG MED CHEM LETT, V16, P4243
   Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1
   Maheshwari RA, 2015, INDIAN J PHARMACOL, V47, P17, DOI 10.4103/0253-7613.150311
   Mekhail GM, 2012, INT J BIOL MACROMOL, V51, P351, DOI 10.1016/j.ijbiomac.2012.05.026
   Meng H, 2011, ACS NANO, V5, P4131, DOI 10.1021/nn200809t
   Metwally AA, 2015, CHEM ENG RES DES, V104, P453, DOI 10.1016/j.cherd.2015.09.003
   Mills CN, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-104
   Mitra R, 2001, INT J PHARM, V217, P25, DOI 10.1016/S0378-5173(01)00588-9
   Mo HB, 2004, EXP BIOL MED, V229, P567
   Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/nnano.2012.207, 10.1038/NNANO.2012.207]
   MORI A, 1991, FEBS LETT, V284, P263, DOI 10.1016/0014-5793(91)80699-4
   Mukherjee S, 1997, PHYSIOL REV, V77, P759
   Murakami Y, 1997, DRUG DELIV, V4, P23, DOI 10.3109/10717549709033184
   Narang AS, 2007, INT J PHARM, V345, P9, DOI 10.1016/j.ijpharm.2007.08.057
   Nikanjam M, 2007, INT J PHARM, V328, P86, DOI 10.1016/j.ijpharm.2006.07.046
   Noguchi Y, 1998, JPN J CANCER RES, V89, P307
   Nomura T, 1998, J CONTROL RELEASE, V52, P239, DOI 10.1016/S0168-3659(97)00185-5
   Nomura T, 1998, PHARMACEUT RES, V15, P128, DOI 10.1023/A:1011921324952
   Ong FS, 2012, EXPERT REV MOL DIAGN, V12, P593, DOI [10.1586/erm.12.59, 10.1586/ERM.12.59]
   Ouyang CP, 2012, POLYM BULL, V68, P27, DOI 10.1007/s00289-011-0516-x
   Ouyang YM, 2013, J BIOMED NANOTECHNOL, V9, P931, DOI 10.1166/jbn.2013.1605
   Paillard A, 2010, BIOMATERIALS, V31, P7542, DOI 10.1016/j.biomaterials.2010.06.024
   Park IH, 2012, AM J RHINOL ALLERGY, V26, P7, DOI 10.2500/ajra.2012.26.3679
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Park W, 2012, BIOMATERIALS, V33, P8848, DOI 10.1016/j.biomaterials.2012.08.042
   Patel AR, 2011, LWT-FOOD SCI TECHNOL, V44, P1958, DOI 10.1016/j.lwt.2011.04.005
   Pedersen TR, 2000, AM J CARDIOL, V86, P257, DOI 10.1016/S0002-9149(00)00910-3
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Pinheiro VB, 2012, SCIENCE, V336, P341, DOI 10.1126/science.1217622
   Pooja D, 2014, COLLOID SURFACE B, V121, P461, DOI 10.1016/j.colsurfb.2014.06.059
   Prabaharan M, 2015, INT J BIOL MACROMOL, V72, P1313, DOI 10.1016/j.ijbiomac.2014.10.052
   Prabhu RH, 2015, INT J NANOMED, V10, P1001, DOI 10.2147/IJN.S56932
   Qiu LY, 2006, PHARM RES, V23, P1, DOI 10.1007/s11095-005-9046-2
   Ratajczak-Wrona W, 2013, INT J ORAL SCI, V5, P141, DOI 10.1038/ijos.2013.59
   Rieux AD, 2013, ADV DRUG DELIVER REV, V65, P833, DOI 10.1016/j.addr.2013.01.002
   Riganti C, 2006, INT J CANCER, V119, P17, DOI 10.1002/ijc.21832
   Riganti C, 2005, CANCER RES, V65, P516
   Ruggiero A, 2010, P NATL ACAD SCI USA, V107, P12369, DOI 10.1073/pnas.0913667107
   Safwat S, 2017, J LIPOSOME RES, V27, P1, DOI 10.3109/08982104.2015.1137313
   Saha RN, 2010, MOL MEMBR BIOL, V27, P215, DOI 10.3109/09687688.2010.510804
   Schiffelers RM, 2005, NEOPLASIA, V7, P118, DOI 10.1593/neo.04340
   Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0
   Shapiro CL, 2001, NEW ENGL J MED, V344, P1997
   Shen KT, 2009, FOOD CHEM TOXICOL, V47, P1864, DOI 10.1016/j.fct.2009.04.044
   Shi JJ, 2011, ACCOUNTS CHEM RES, V44, P1123, DOI 10.1021/ar200054n
   Simard P, 2010, MOL PHARMACEUT, V7, P1098, DOI 10.1021/mp900261m
   Stefanick JF, 2013, ACS NANO, V7, P2935, DOI 10.1021/nn305663e
   Suarato G, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4944661
   Sultana S, 2013, J DRUG TARGET, V21, P107, DOI 10.3109/1061186X.2012.712130
   Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965
   Taurin S, 2012, J CONTROL RELEASE, V164, P265, DOI 10.1016/j.jconrel.2012.07.013
   Thurnher M, 2013, BBA-MOL CELL BIOL L, V1831, P1009, DOI 10.1016/j.bbalip.2013.03.003
   Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100
   Troost J, 2004, MOL PHARMACOL, V66, P1332, DOI 10.1124/mol.104.002329
   Ungaro R, 2016, AM J GASTROENTEROL, V111, P1416, DOI 10.1038/ajg.2016.233
   Valencia PM, 2011, BIOMATERIALS, V32, P6226, DOI 10.1016/j.biomaterials.2011.04.078
   van de Donk NWCJ, 2006, CURR PHARM DESIGN, V12, P327, DOI 10.2174/138161206775201974
   Vert M, 2009, J MATER SCI-MATER M, V20, P437, DOI 10.1007/s10856-008-3581-4
   Vrignaud S, 2011, BIOMATERIALS, V32, P8593, DOI 10.1016/j.biomaterials.2011.07.057
   Wali VB, 2007, LIPIDS, V42, P1113, DOI 10.1007/s11745-007-3102-0
   Wang KZ, 2009, ACTA RADIOL, V50, P1095, DOI 10.3109/02841850903008800
   Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419
   Weinberg WC, 2005, CANCER METAST REV, V24, P569, DOI 10.1007/s10555-005-6196-y
   Wright RS, 2002, MAYO CLIN PROC, V77, P1085
   Wu YP, 2015, J BIOMED NANOTECHNOL, V11, P1247, DOI 10.1166/jbn.2015.2068
   Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003
   Xiao ZY, 2012, ACS NANO, V6, P3670, DOI 10.1021/nn301869z
   Yang CM, 2013, J BIOMED NANOTECHNOL, V9, P1617, DOI 10.1166/jbn.2013.1646
   Yew NS, 2013, MOL GENET METAB, V109, P339, DOI 10.1016/j.ymgme.2013.05.011
   Yilmaz MI, 2004, BIOL TRACE ELEM RES, V98, P119, DOI 10.1385/BTER:98:2:119
   Yokoi K, 2014, CANCER LETT, V345, P48, DOI 10.1016/j.canlet.2013.11.015
   Yu B, 2010, MOL MEMBR BIOL, V27, P286, DOI 10.3109/09687688.2010.521200
   Yuan JS, 2008, INT J PHARM, V349, P130, DOI 10.1016/j.ijpharm.2007.07.047
   Zhou S.H., 2007, CHINESE J TISSUE ENG, V11, P9688
   Zolnierczyk JD, 2013, ONCOL REP, V29, P2065, DOI 10.3892/or.2013.2301
NR 165
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD JUN
PY 2017
VL 69
IS 6
BP 613
EP 624
DI 10.1111/jphp.12707
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EU1LY
UT WOS:000400782500001
PM 28271498
OA No
DA 2017-08-17
ER

PT J
AU Youssef, FS
   Ashour, ML
   Ebada, SS
   Sobeh, M
   El-Beshbishy, HA
   Singab, AN
   Wink, M
AF Youssef, Fadia S.
   Ashour, Mohamed L.
   Ebada, Sherif S.
   Sobeh, Mansour
   El-Beshbishy, Hesham A.
   Singab, Abdel Nasser
   Wink, Michael
TI Antihyperglycaemic activity of the methanol extract from leaves of
   Eremophila maculata (Scrophulariaceae) in streptozotocin-induced
   diabetic rats
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
DE antihyperglycaemic; Eremophila maculata; molecular modelling;
   Scrophulariaceae; streptozotocin
ID ALPHA-GLUCOSIDASE; GLYCOSIDES; CONSTITUENTS; INHIBITORS; MECHANISM;
   CELLS
AB ObjectivesThis study was designed to evaluate the antihyperglycaemic activity of the methanol leaf extract of Eremophila maculata (EMM) both in vitro and in vivo.
   MethodsThe antihyperglycaemic activity was assessed in vitro using differentiated 3T3-L1 adipocytes, whereas in-vivo effect was evaluated in streptozotocin-induced diabetic rats. Chemical profiling of EMM was done using LC-ESI-MS techniques. Molecular modelling experiments of the identified compounds were performed using C-Docker protocol.
   Key findingsEremophila maculata slightly enhanced cellular glucose uptake and utilization in vitro by 3.92% relative to the untreated control. A stronger in-vivo effect was observed for EMM and its dichloromethane fraction. A pronounced elevation in serum insulin by 88.89 and 66.67%, respectively, accompanied by an apparent decline in fasting blood glucose (FBG) level by 65.60 and 70.37% comparable to streptozotocin-induced diabetic rats was observed. This effect was stronger than that of the reference drug glibenclamide (GLB). Chemical profiling of EMM revealed that leucoseptoside A, verbascoside, syringaresinol-4-O--D-glucopyranoside, pinoresinol-4-O--D-glucopyranoside and pinoresinol-4-O-[6-O-(E)-feruloyl]--D-glucopyranoside are the major compounds. Molecular modelling showed that martynoside, verbascoside and phillygenin exhibited the highest inhibition to human pancreatic -amylase (HPA), maltase glucoamylase (MGAM) and aldose reductase (AR), respectively.
   ConclusionEremophila maculata offers an interesting relatively safer antihyperglycaemic candidate comparable to synthetic analogues.
C1 [Youssef, Fadia S.; Ashour, Mohamed L.; Ebada, Sherif S.; Singab, Abdel Nasser] Ain Shams Univ, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt.
   [Ashour, Mohamed L.; Sobeh, Mansour; Wink, Michael] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [El-Beshbishy, Hesham A.] Fakeeh Coll Med Sceinces, Med Lab Sci Dept, Jeddah, Saudi Arabia.
   [El-Beshbishy, Hesham A.] Al Azhar Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.
RP Wink, M (reprint author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.; Singab, AN (reprint author), Ain Shams Univ, Fac Pharm, African Union Org St, Cairo 11566, Egypt.
EM dean@pharma.asu.edu.eg; wink@uni-heidelberg.de
OI Ashour, Mohamed, Lotfy/0000-0002-9270-6267; Singab, Abdel
   nasser/0000-0001-7445-963X; Wink, Michael/0000-0002-7875-4510
CR Babu PS, 2004, J PHARM PHARMACOL, V56, P1435, DOI 10.1211/0022357044607
   Beattie KD, 2009, PHYTOCHEMICAL STUDIE
   Bonora E, 2008, NUTR METAB CARDIOVAS, V18, P74, DOI 10.1016/j.numecd.2007.05.004
   Chu HB, 2011, Z NATURFORSCH B, V66, P641
   Dastlik K. A., 1992, Fitoterapia, V63, P523
   Eid SY, 2015, EVID-BASED COMPL ALT, DOI 10.1155/2015/868424
   GHISALBERTI EL, 1994, PHYTOCHEMISTRY, V35, P7
   GHISALBERTI EL, 1994, J ETHNOPHARMACOL, V44, P1, DOI 10.1016/0378-8741(94)90092-2
   HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715
   Hsieh TJ, 2012, FOOD CHEM TOXICOL, V50, P779, DOI 10.1016/j.fct.2011.12.023
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kamalakkannan N, 2006, J PHARM PHARMACOL, V58, P1091, DOI 10.1211/jpp.58.8.0010
   Lee Kuo-Hsiung, 2003, Phytochemistry Reviews, V2, P341, DOI 10.1023/B:PHYT.0000045495.59732.58
   Milad R., 2013, World Journal of Pharmaceutical Research, V2, P2711
   MIYASE T, 1982, CHEM PHARM BULL, V30, P2732
   Omar HS, 2011, THESCIENTIFICWORLDJO, V11, P788, DOI 10.1100/tsw.2011.71
   Ouyang MA, 2007, J AGR FOOD CHEM, V55, P6460, DOI 10.1021/jf0709808
   Puranik N, 2010, TURK J MED SCI, V40, P265, DOI 10.3906/sag-0802-40
   Rao M. U., 2010, International Journal of PharmTech Research, V2, P1883
   Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3
   Sarkhail Parisa, 2006, Daru, V14, P115
   Singab AN, 2013, J PHARM PHARMACOL, V65, P1239, DOI 10.1111/jphp.12092
   Singab A.N., 2014, MED AROMAT PLANTS, V3, P151
   Sobeh M, 2016, MED CHEM RES, V25, P2304, DOI 10.1007/s00044-016-1677-9
   Szkudelski T, 2001, PHYSIOL RES, V50, P537
   Tahtah Y, 2016, FITOTERAPIA, V110, P52, DOI 10.1016/j.fitote.2016.02.008
   TOMLINSON DR, 1994, TRENDS PHARMACOL SCI, V15, P293, DOI 10.1016/0165-6147(94)90010-8
   Tundis R, 2010, MINI-REV MED CHEM, V10, P315
   Vats V, 2004, J ETHNOPHARMACOL, V90, P155, DOI 10.1016/j.jep.2003.09.034
   Venkateswarulu M, 2010, DRUG INVENTION TODAY, V2, P25
   Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003
   Wikul A, 2012, BIOORG MED CHEM LETT, V22, P5215, DOI 10.1016/j.bmcl.2012.06.068
   Wu J, 2004, MAGN RESON CHEM, V42, P659, DOI 10.1002/mrc.1393
   Youssef FS, 2016, PHYTOMEDICINE, V23, P1484, DOI 10.1016/j.phymed.2016.08.006
   Youssef FS, 2014, CHEM BIODIVERS, V11, P831, DOI 10.1002/cbdv.201300366
NR 35
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD JUN
PY 2017
VL 69
IS 6
BP 733
EP 742
DI 10.1111/jphp.12690
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EU1LY
UT WOS:000400782500013
PM 28321889
OA No
DA 2017-08-17
ER

PT J
AU Said, S
   Riad, M
   Helmy, M
   Mikhail, S
   Khalil, L
AF Said, S.
   Riad, M.
   Helmy, M.
   Mikhail, S.
   Khalil, L.
TI The effect of ceria modified cryptomelane on the oxidative
   dehydrogenation of cyclohexane
SO JOURNAL OF POROUS MATERIALS
LA English
DT Article
DE Manganese oxide octahedral molecular sieves; CeO2/OMS-2; Heterogeneous
   catalysis; Oxidative dehydrogenation; Cyclohexane
ID SUPERCRITICAL WATER OXIDATION; MANGANESE OXIDES; CATALYTIC-PROPERTIES;
   ADSORPTION; PHENOL; OMS-2
AB Nanostructure cryptomelane has been synthesized in neutral medium using CTAB as a structure directing agent and was modified by impregnation with ceria (2.5, 5 and 7.5 wt%). XRD, FT-IR, TEM and N-2 adsorption techniques were employed to study the characterization of the prepared samples. The catalytic activity of the prepared samples towards the oxidative dehydrogenation of cyclohexane in air was evaluated. The catalytic activity results revealed that the ceria/OMS-2 samples is the most selective catalyst towards benzene formation at all reaction temperature although the selectivity to benzene formation decreases from 99 at 300 A degrees C to 56% with the increase of reaction temperature to 400 A degrees C. The parent OMS-2N catalyst is an active and selective one towards the formation of cyclohexanol (oxidation reaction) which reaches maximum 47% at 375 A degrees C.
C1 [Said, S.; Riad, M.; Helmy, M.; Mikhail, S.] EPRI, Catalysis Dept, Petr Refining Div, Cairo 11727, Egypt.
   [Khalil, L.] Ain Shams Univ, Fac Sci, Dept Chem, Cairo, Egypt.
RP Said, S (reprint author), EPRI, Catalysis Dept, Petr Refining Div, Cairo 11727, Egypt.
EM ssm_epri83@yahoo.com
CR Abecassis-Wolfovich M, 2004, IND ENG CHEM RES, V43, P5089, DOI 10.1021/ie049756n
   Aki S, 1999, IND ENG CHEM RES, V38, P358, DOI 10.1021/ie980485o
   Atribak I, 2010, APPL CATAL B-ENVIRON, V93, P267, DOI 10.1016/j.apcatb.2009.09.038
   Brock SL, 1998, CHEM MATER, V10, P2619, DOI 10.1021/cm980227h
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   Cai J, 2001, CHEM MATER, V13, P2413, DOI 10.1021/cm0014233
   Calvert C, 2008, CHEM MATER, V20, P6382, DOI 10.1021/cm801146m
   Chen L, 2009, J PHYS CHEM C, V113, P21177, DOI [10.1021/jp907109e, 10.1021/jp907109c]
   Ding ZY, 1998, IND ENG CHEM RES, V37, P1707, DOI 10.1021/ie9709345
   DING ZY, 1995, ENVIRON SCI TECHNOL, V29, P2748, DOI 10.1021/es00011a008
   Gac W, 2007, APPL CATAL B-ENVIRON, V75, P107, DOI 10.1016/j.apcatb.2007.04.002
   Hirano M, 2000, J MATER CHEM, V10, P473, DOI 10.1039/a907510k
   Jothiramalingam R, 2005, CATAL COMMUN, V6, P41, DOI 10.1016/j.catcom.2004.10.008
   Julien CM, 2004, SPECTROCHIM ACTA A, V60, P689, DOI 10.1016/S1386-1425(03)00279-8
   Luo J, 2008, J AM CHEM SOC, V130, P3198, DOI 10.1021/ja077706e
   Ho PH, 2015, FUEL PROCESS TECHNOL, V131, P238, DOI 10.1016/j.fuproc.2014.11.019
   Susana M.-M., 2006, J MOL CATAL A-CHEM, V252, P226
   Tian H, 2011, MICROPOR MESOPOR MAT, V138, P118, DOI 10.1016/j.micromeso.2010.09.022
NR 18
TC 0
Z9 0
U1 9
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-2224
EI 1573-4854
J9 J POROUS MAT
JI J. Porous Mat.
PD JUN
PY 2017
VL 24
IS 3
BP 829
EP 836
DI 10.1007/s10934-016-0322-9
PG 8
WC Chemistry, Applied; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA EU2XC
UT WOS:000400892200030
OA No
DA 2017-08-17
ER

PT J
AU Li, WL
   Yan, T
   Abd Elgawad, M
   Qin, H
AF Li Wenlong
   Yan Ting
   Abd Elgawad, Mohamed
   Qin Hong
TI Degree-based moment estimation for ordered networks
SO JOURNAL OF SYSTEMS SCIENCE & COMPLEXITY
LA English
DT Article
DE Asymptotic normality; consistency; moment estimators; increasing number
   of parameters; ordered network
ID PROTEIN-INTERACTION NETWORKS; RANDOM GRAPH MODELS; EXPONENTIAL-FAMILY;
   COMPLEXES; NUMBER
AB The edges between vertices in networks take not only the common binary values, but also the ordered values in some situations (e.g., the measurement of the relationship between people from worst to best in social networks). In this paper, the authors study the asymptotic property of the moment estimator based on the degrees of vertices in ordered networks whose edges are ordered random variables. In particular, the authors establish the uniform consistency and the asymptotic normality of the moment estimator when the number of parameters goes to infinity. Simulations and a real data example are provided to illustrate asymptotic results.
C1 [Li Wenlong; Yan Ting; Abd Elgawad, Mohamed; Qin Hong] Cent China Normal Univ, Dept Stat, Wuhan 430079, Peoples R China.
   [Li Wenlong; Yan Ting; Abd Elgawad, Mohamed; Qin Hong] Cent China Normal Univ, Hubei Key Lab Math Sci, Wuhan 430079, Peoples R China.
   [Abd Elgawad, Mohamed] Benha Univ, Dept Math, Fac Sci, Banha 13518, Egypt.
RP Yan, T (reprint author), Cent China Normal Univ, Dept Stat, Wuhan 430079, Peoples R China.; Yan, T (reprint author), Cent China Normal Univ, Hubei Key Lab Math Sci, Wuhan 430079, Peoples R China.
EM wenlongli@mails.ccnu.edu.cn; tingyanty@mail.ccnu.edu.cn;
   mohamed_salem240@yahoo.com; qinhong@mail.ccnu.edu.cn
FU National Natural Science Foundation of China [11271147, 11471135,
   11401239]; Self-Determined Research Funds of CCNU from the Colleges's
   Basic Research and Operation of MOE [CCNU15A02032, CCNU15ZD011]; Fund
   from KLAS [130026507]
FX Qin's research is partially supported by the National Natural Science
   Foundation of China under Grant Nos. 11271147, 11471135, and Yan's
   research is partially supported by the National Natural Science
   Foundation of China under Grant No. 11401239, and the Self-Determined
   Research Funds of CCNU from the Colleges's Basic Research and Operation
   of MOE (CCNU15A02032, CCNU15ZD011) and a Fund from KLAS (130026507).
CR Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Blitzstein J., 2010, INTERNET MATH, V6, P489, DOI DOI 10.1080/15427951.2010.557277
   Calin O, 2014, MAXIMUM ENTROPY DIST, P165
   Chatterjee S, 2011, ANN APPL PROBAB, V21, P1400, DOI 10.1214/10-AAP728
   Christakis Nicholas A., 2009, CONNECTED SURPRISING
   Fienberg SE, 2012, J COMPUT GRAPH STAT, V21, P825, DOI 10.1080/10618600.2012.738106
   FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017
   Goldenberg A., 2010, FDN TRENDS MACHINE L, V2, P129, DOI DOI 10.1561/2200000005
   Goodman D, 2004, SOCIOL RURALIS, V44, P3, DOI 10.1111/j.1467-9523.2004.00258.x
   Hillar C., 2013, ARXIV13013321
   HOEFFDING W, 1963, J AM STAT ASSOC, V58, P13, DOI 10.2307/2282952
   HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037
   Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869
   Krivitsky PN, 2012, ELECTRON J STAT, V6, P1100, DOI 10.1214/12-EJS696
   Loeve M, 1994, PROBABILITY THEORY, V2
   Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]
   Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179
   Pothoven K, 2013, REAL FUNCTIONAL ANAL
   Sadinle M, 2012, ARXIV12110312
   Schweinberger M, 2011, J AM STAT ASSOC, V106, P1361, DOI 10.1198/jasa.2011.tm10747
   Seyfang G, 2006, J RURAL STUD, V22, P383, DOI 10.1016/j.jrurstud.2006.01.003
   Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x
   von Mering C, 2002, NATURE, V417, P399
   Watts Duncan J., 1999, SMALL WORLDS DYNAMIC
   Williams R, 2015, ORDERED LOGIT MODELS
   WINSHIP C, 1984, AM SOCIOL REV, V49, P512, DOI 10.2307/2095465
   Yan T, 2016, STAT SINICA, V26, P273, DOI 10.5705/ss.2014.180
   Yan T, 2015, J MULTIVARIATE ANAL, V133, P61, DOI 10.1016/j.jmva.2014.08.013
   Yan T, 2013, BIOMETRIKA, V100, P519, DOI 10.1093/biomet/ass084
   Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636
NR 31
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1009-6124
EI 1559-7067
J9 J SYST SCI COMPLEX
JI J. Syst. Sci. Complex.
PD JUN
PY 2017
VL 30
IS 3
BP 721
EP 733
DI 10.1007/s11424-017-5307-5
PG 13
WC Mathematics, Interdisciplinary Applications
SC Mathematics
GA EU5GM
UT WOS:000401059600014
OA No
DA 2017-08-17
ER

PT J
AU Hammam, MAS
   Abdel-Rahim, MA
   Hafiz, MM
   Abu-Sehly, AA
AF Hammam, Mohamed A. S.
   Abdel-Rahim, M. A.
   Hafiz, M. M.
   Abu-Sehly, A. A.
TI New combination of non-isothermal kinetics-revealing methods
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE Thermal analysis; Non-isothermal conditions; Variant activation energy;
   Chalcogenides; Generalized Sestak-Berggren function; New method
ID TE GLASSY SYSTEM; CRYSTALLIZATION KINETICS; ISOCONVERSIONAL METHODS;
   ACTIVATION-ENERGY; THERMAL-ANALYSIS; COMMITTEE RECOMMENDATIONS;
   STRUCTURAL RELAXATION; CHALCOGENIDE GLASSES; THIN-FILMS; SE
AB This work introduces a new method of calculations depending on the essential assumptions of the kinetic methods, with the least amount of approximations to find the apparent kinetic parameters calculated for the crystallization of the Se90Te10 powders with heterogeneous particle sizes and shapes under non-isothermal conditions. The apparent kinetic parameters calculated by the new method are compared with that calculated blindly by applying Malek's method, ignoring its applicability condition of invariant activation energy. The new method is based on the assumption that the kinetic function parameters are independent of the heating rate and time , and the fitting temperature function is assumed to be in the approximated form . The exponents and are calculated isoconversionally, while the constant and the kinetic function parameters are calculated by a curve fitting method using a generalized form of the estak and Berggren function, considering the steadily and logarithmic acceleration and deceleration of the curve. According to the data in this work, the fitting temperature function can be roughly approximated to the form which work in with the physical dimensions of the rate constant. Moreover, the Arrhenian and the non-Arrhenian parameters, which describe the fitting temperature function , are calculated isoconversionally. The deduced parameters work harmonically together to perfectly fit the experimental and the true data.
C1 [Hammam, Mohamed A. S.; Abdel-Rahim, M. A.; Hafiz, M. M.; Abu-Sehly, A. A.] Assiut Univ, Fac Sci, Phys Dept, Assiut 71516, Egypt.
RP Hammam, MAS (reprint author), Assiut Univ, Fac Sci, Phys Dept, Assiut 71516, Egypt.
EM mas_hammam@aun.edu.eg
CR Abdelazim NM, 2014, J NON-CRYST SOLIDS, V387, P79, DOI 10.1016/j.jnoncrysol.2014.01.012
   Adam JL, 2014, WOODH PUB SER ELECT, P1
   Akahira T, 1971, RES REPORT CHIBA I T, V16, P22
   Avramov I, 2014, J THERM ANAL CALORIM, V118, P1715, DOI 10.1007/s10973-014-4144-1
   Barrie PJ, 2012, PHYS CHEM CHEM PHYS, V14, P327, DOI 10.1039/c1cp22667c
   Bartak J, 2015, CRYST GROWTH DES, V15, P4287, DOI 10.1021/acs.cgd.5b00598
   Bartak J, 2014, J APPL PHYS, V115, DOI 10.1063/1.4869547
   Bartak J, 2012, J APPL PHYS, V111, DOI 10.1063/1.4712625
   BINNER JGP, 1995, J MATER SCI, V30, P5389, DOI 10.1007/BF00351548
   Bureau B, 2008, SOLID STATE SCI, V10, P427, DOI 10.1016/j.solidstatesciences.2007.12.017
   Bureau B, 2009, MOLECULES, V14, P4337, DOI 10.3390/molecules14114337
   Calventus Y, 1996, J PHYS-CONDENS MAT, V8, P927, DOI 10.1088/0953-8984/8/8/005
   Calventus Y, 1997, J MATER RES, V12, P1069, DOI 10.1557/JMR.1997.0149
   Chen K, 2009, MACROMOL BIOSCI, V9, P383, DOI 10.1002/mabi.200800214
   Doyle C. D., 1961, J APPL POLYM SCI, V5, P285, DOI DOI 10.1002/APP.1961.070051506
   ELKORASHY A, 1995, THIN SOLID FILMS, V261, P328, DOI 10.1016/S0040-6090(95)06512-1
   ELKORASHY A, 1995, SOLID STATE COMMUN, V95, P335, DOI 10.1016/0038-1098(94)00913-9
   Farjas J, 2011, J THERM ANAL CALORIM, V105, P757, DOI 10.1007/s10973-011-1446-4
   FLYNN JH, 1966, J RES NBS A PHYS CH, VA 70, P487, DOI 10.6028/jres.070A.043
   Friedman H.L., 1964, J POLYM SCI C, V6, P183, DOI DOI 10.1002/P0LC.5070060121
   Ghosh G, 1994, J PHASE EQUILIB, V15, P213, DOI DOI 10.1007/BF02646370
   GORBACHEV VM, 1980, J THERM ANAL, V18, P193, DOI 10.1007/BF01909467
   Greenwood P. E., 1996, GUIDE CHI SQUARED TE, V280
   Holba P., 2012, THERMAL ANAL MICRO N, P99
   Holba P, 2014, RUSSIAN FIZ IN PRESS, V40, P486
   Holba P, 2015, J THERM ANAL CALORIM, V121, P303, DOI 10.1007/s10973-015-4486-3
   Khan ZH, 2011, J EXP NANOSCI, V6, P337, DOI 10.1080/17458080.2010.497946
   KOGA N, 1991, THERMOCHIM ACTA, V182, P201, DOI 10.1016/0040-6031(91)80005-4
   Kostrzepa IM, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/12/125401
   Kushwaha N, 2005, J OPTOELECTRON ADV M, V7, P2293
   Lacaita AL, 2006, SOLID STATE ELECTRON, V50, P24, DOI 10.1016/j.sse.2005.10.046
   LAIDLER KJ, 1984, J CHEM EDUC, V61, P494
   LAKSHMIKUMAR ST, 1982, J MATER SCI, V17, P183, DOI 10.1007/BF00809050
   LANYON HPD, 1966, PHYS STATUS SOLIDI, V17, pK185, DOI 10.1002/pssb.19660170256
   Lyubin V, 2009, PHYS STATUS SOLIDI B, V246, P1758, DOI 10.1002/pssb.200982003
   Malek J, 1995, THERMOCHIM ACTA, V267, P61, DOI 10.1016/0040-6031(95)02466-2
   MALEK J, 1992, THERMOCHIM ACTA, V200, P257, DOI 10.1016/0040-6031(92)85118-F
   Malek J, 2000, THERMOCHIM ACTA, V355, P239, DOI 10.1016/S0040-6031(00)00449-4
   Mehta N, 2006, J SCI IND RES INDIA, V65, P777
   Moharram AH, 2001, THIN SOLID FILMS, V392, P34, DOI 10.1016/S0040-6090(01)00968-3
   Murray P., 1955, BRIT CERAM T, V54, P204
   Orfao JJM, 2007, AICHE J, V53, P2905, DOI 10.1002/aic.11296
   Perejon A, 2011, J PHYS CHEM B, V115, P1780, DOI 10.1021/jp110895z
   Perez-Maqueda LA, 2006, J PHYS CHEM A, V110, P12456, DOI 10.1021/jp064792g
   Raoux S, 2010, CHEM REV, V110, P240, DOI 10.1021/cr900040x
   Serra R, 1998, THERMOCHIM ACTA, V316, P37, DOI 10.1016/S0040-6031(98)00295-0
   Sestak, 2015, J THERM ANAL CALORIM, DOI [10.1007/s10973-015-4998-x, DOI 10.1007/S10973-015-4998-X]
   Sestak J., 2005, SCI HEAT THERMOPHYSI, P276, DOI 10.1016/B978-044451954-2/50010-2
   Sestak J, 1971, THERMOCHIM ACTA, V3, P1, DOI DOI 10.1016/0040-6031(71)85051-7
   Sestak J., 1984, THERMAL ANAL THEIR M, V12, P172
   Sestak J., 2005, SCI HEAT THERMOPHYSI
   Sestak J, 2015, THERMOCHIM ACTA, V611, P26, DOI 10.1016/j.tca.2015.04.026
   Sestak J, 2014, J THERM ANAL CALORIM, V117, P3, DOI 10.1007/s10973-014-3810-7
   Sestak J, 2013, J THERM ANAL CALORIM, V113, P1633, DOI 10.1007/s10973-013-3025-3
   Sewry JD, 2002, THERMOCHIM ACTA, V390, P217, DOI 10.1016/S0040-6031(02)00083-7
   Simon P, 2005, J THERM ANAL CALORIM, V82, P651, DOI 10.1007/s10973-005-0945-6
   Simon P, 2005, J THERM ANAL CALORIM, V79, P703, DOI 10.1007/s10973-005-0599-4
   Simon P, 2004, J THERM ANAL CALORIM, V76, P123, DOI 10.1023/B:JTAN.0000027811.80036.6c
   Starink M., 2003, ACTA, V404, P163
   Svoboda R, 2015, J THERM ANAL CALORIM, V119, P155, DOI 10.1007/s10973-014-4199-z
   Svoboda R, 2014, THIN SOLID FILMS, V571, P121, DOI 10.1016/j.tsf.2014.10.005
   Svoboda R, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4903543
   Svoboda R, 2013, J THERM ANAL CALORIM, V111, P161, DOI 10.1007/s10973-012-2347-x
   Svoboda R, 2011, THERMOCHIM ACTA, V526, P237, DOI 10.1016/j.tca.2011.10.005
   Svoboda R, 2011, J NON-CRYST SOLIDS, V357, P3123, DOI 10.1016/j.jnoncrysol.2011.05.002
   Svoboda R, 2011, J NON-CRYST SOLIDS, V357, P2163, DOI 10.1016/j.jnoncrysol.2011.02.035
   Svoboda R, 2010, J NON-CRYST SOLIDS, V356, P165, DOI 10.1016/j.jnoncrysol.2009.12.002
   Vermeulen PA, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4886185
   Vyazovkin S, 2002, INT J CHEM KINET, V34, P418, DOI 10.1002/kin.10068
   Vyazovkin S, 2006, MACROMOL RAPID COMM, V27, P1515, DOI 10.1002/marc.200600404
   Vyazovkin S, 2011, THERMOCHIM ACTA, V520, P1, DOI 10.1016/j.tca.2011.03.034
   Vyazovkin S, 2008, HBK THERMAL ANAL CAL, V5, P503
   VYAZOVKIN SV, 1987, THERMOCHIM ACTA, V122, P413, DOI 10.1016/0040-6031(87)87059-4
   Wuttig M, 2007, NAT MATER, V6, P1004, DOI 10.1038/nmat2077
   YINNON H, 1983, J NON-CRYST SOLIDS, V54, P253, DOI 10.1016/0022-3093(83)90069-8
   Zakery A, 2003, J NON-CRYST SOLIDS, V330, P1, DOI 10.1016/j.jnoncrysol.2003.08.064
   Zhao G, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/03/035603
   ZSAKO J, 1968, J PHYS CHEM-US, V72, P2406, DOI 10.1021/j100853a022
NR 78
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1588-2926
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUN
PY 2017
VL 128
IS 3
BP 1391
EP 1405
DI 10.1007/s10973-017-6086-x
PG 15
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA EU9HK
UT WOS:000401349800016
OA No
DA 2017-08-17
ER

PT J
AU Saad, FA
   Elghalban, MG
   Al-Fahemi, JH
   Yarkandy, N
   El-Metwaly, NM
   Abou-Melha, KS
   Al-Hazmi, GA
   Saleh, KA
AF Saad, F. A.
   Elghalban, M. G.
   Al-Fahemi, Jabir H.
   Yarkandy, N.
   El-Metwaly, Nashwa M.
   Abou-Melha, K. S.
   Al-Hazmi, G. A.
   Saleh, K. A.
TI Simulative aurintricarboxylic acid molecular docking with antitumor
   activity for its VO(II), Cr(III), Mn(II) and Fe(III) complexes, HF/DFT
   modeling and elaborated EPR studies
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE Schiff base; HF/DFT; Molecular docking; Antitumor and EPR
ID ELECTRONIC-PROPERTIES; DENSITY FUNCTIONALS; VANADIUM COMPLEXES;
   COPPER(II) ION; SPIN-ORBIT; TRANSITION; STEREOCHEMISTRY; MIMICS; SALTS;
   MONO
AB A synthesized aurintricarboxylic acid (ATA) complex was deliberately investigated. Spectral, thermal, theoretical and antitumor studies are accomplished in this study. Elaborated electronic and EPR considerations are introducing parameters support the structural discussion of complexes. Octahedral geometry is proposed for all complexes except VO(II) is a square-pyramidal configuration. Molecular modeling utilizing Gaussian 09 program (HF/DFT) was used to verify the mode of bonding through the optimized geometries as well as essential quantum parameters were calculated using frontier energies (E (HOMO) & E (LUMO)). The soft character of the complexes may expect their excellent biological feature. The molecular docking computational achievement displays distinguished bounds of ATA drug with human colorectal carcinoma and human hepatic carcinoma. However, the interaction with human breast carcinoma receptor is completely absent. This behavior may clarify the antitumor activity of the complexes under investigation. The experimental work was supported with docking for carcinoma receptors used experimentally. VO(II) complex displays distinguished inhibition activity toward human carcinoma used. This is pointed to the other important use for ATA drug complexes exceeding the antibacterial field.
C1 [Saad, F. A.; Elghalban, M. G.; Al-Fahemi, Jabir H.; Yarkandy, N.; El-Metwaly, Nashwa M.] Umm Al Qura Univ, Chem Dept, Coll Appl Sci, Mecca, Saudi Arabia.
   [Elghalban, M. G.; El-Metwaly, Nashwa M.] Mansoura Univ, Chem Dept, Fac Sci, Mansoura, Egypt.
   [Abou-Melha, K. S.; Al-Hazmi, G. A.] King Khalid Univ, Chem Dept, Fac Sci, POB 9004, Abha, Saudi Arabia.
   [Al-Hazmi, G. A.] Taiz Univ, Fac Sci Appl, Chem Dept, POB 82, Taizi, Yemen.
   [Saleh, K. A.] King Khalid Univ, Biol Dept, Fac Sci, POB 9004, Abha, Saudi Arabia.
RP El-Metwaly, NM (reprint author), Umm Al Qura Univ, Chem Dept, Coll Appl Sci, Mecca, Saudi Arabia.; El-Metwaly, NM (reprint author), Mansoura Univ, Chem Dept, Fac Sci, Mansoura, Egypt.
EM n_elmetwaly00@yahoo.com
CR Abragam A., 1970, ELECT PARAMAGNETIC R
   Al- Iede MM, 2015, RECURRENT DIAPHRAGMA
   Ataiw S. H., 2003, EGYPT J CHEM, V46, P685
   CARRANO CJ, 1990, INORG CHEM, V29, P944, DOI 10.1021/ic00330a009
   Chikate RC, 2005, POLYHEDRON, V24, P1689, DOI 10.1016/j.poly.2005.04.037
   Cullity B. D., 1993, ELEMENTS XRAY DIFFRA
   Delol H., 2007, J KERBALA U, V5, P65
   Dennington R II, 2007, GAUSSVIEW VERSION 4
   Dong YH, 2000, J INORG BIOCHEM, V78, P321, DOI 10.1016/S0162-0134(00)00060-X
   Du SZ, 2013, DALTON T, V42, P9699, DOI 10.1039/c3dt50865j
   DUNN TM, 1961, T FARADAY SOC, V57, P1441, DOI 10.1039/tf9615701441
   El-Metwally NM, 2005, SPECTROCHIM ACTA A, V61, P1113, DOI 10.1016/j.saa.2004.06.027
   El-Metwaly NM, 2007, TRANSIT METAL CHEM, V32, P88, DOI 10.1007/s11243-006-0135-9
   Fahem AA, 2012, SPECTROCHIM ACTA A, V88, P10, DOI 10.1016/j.saa.2011.11.037
   Fleming I., 1976, FRONTIER ORBITALS OR
   Frisch M. J., 2010, GAUSSIAN 09
   Gasser G, 2011, J MED CHEM, V54, P3, DOI 10.1021/jm100020w
   Geary WJ, 1971, J COORD CHEM REV, V7, P81, DOI DOI 10.1016/S0010-8545(00)80009-0
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
   HATHAWAY BJ, 1970, COORDIN CHEM REV, V5, P143, DOI 10.1016/S0010-8545(00)80135-6
   HATHAWAY BJ, 1984, STRUCT BOND, V57, P55
   Jorgensen CK, 1962, PROGR INORG CHEM, V4, P73, DOI DOI 10.1002/9780470166055.CH2
   Kadhier A F., 2009, J KERBALA U, V7, P190
   Mabbs F. E., 1992, ELECT PARAMAGNETIC R
   MCGARVEY BR, 1967, J PHYS CHEM-US, V71, P51, DOI 10.1021/j100860a007
   Michal H, 2002, ENDOCRINOLOGY, V143, P837
   Mitic N, 2009, J AM CHEM SOC, V131, P8173, DOI 10.1021/ja900797u
   MONTGOMERY H, 1966, ACTA CRYSTALLOGR, V20, P728, DOI 10.1107/S0365110X66001750
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Nakamoto K, 1968, SPECTROSCOPY STRUCTU
   OWEN J, 1955, PROC R SOC LON SER-A, V227, P183, DOI 10.1098/rspa.1955.0003
   PRICE ER, 1974, J INORG NUCL CHEM, V36, P67, DOI 10.1016/0022-1902(74)80659-7
   Quintal MM, 2006, J PHYS CHEM A, V110, P709, DOI 10.1021/jp054449w
   RAY RK, 1990, INORG CHIM ACTA, V173, P207, DOI 10.1016/S0020-1693(00)80215-7
   Russo MG, 2014, J MOL STRUCT, V1061, P5, DOI 10.1016/j.molstruc.2013.12.073
   Sagdinc S, 2009, J MOL STRUCT, V917, P63, DOI 10.1016/j.molstruc.2008.06.033
   SALAGRAM M, 1986, POLYHEDRON, V5, P1171, DOI 10.1016/S0277-5387(00)81388-1
   Sanderson RT, 1967, INORGANIC CHEM
   Schultz NE, 2005, J PHYS CHEM A, V109, P11127, DOI 10.1021/jp0539223
   Schultz NE, 2005, J PHYS CHEM A, V109, P4388, DOI 10.1021/jp0504468
   Shahrjerdi A, 2015, ULTRASON SONOCHEM, V22, P382, DOI 10.1016/j.ultsonch.2014.06.007
   SKIDMORE AF, 1989, BIOCHEM J, V263, P73
   SOLIS FJ, 1981, MATH OPER RES, V6, P19, DOI 10.1287/moor.6.1.19
   Stoklosa HJ, 1973, J CHEM EDUC, V50, P50
   Suss-Fink G, 2004, INORG CHIM ACTA, V357, P475, DOI 10.1016/j.ica.2003.05.005
   Thompson KH, 1999, CHEM REV, V99, P2561, DOI 10.1021/cr980427c
   Tracey A. S., 1998, ACS S SERIES, V711
   Triller MU, 2002, INORG CHEM, V41, P5544, DOI 10.1021/ic025897a
   Tripathi SK, 2013, J THEOR BIOL, V334, P87, DOI 10.1016/j.jtbi.2013.05.014
   Vogel AI, 1986, TXB QUANTITATIVE INO
   WILLING A, 1988, EUR J BIOCHEM, V170, P603, DOI 10.1111/j.1432-1033.1988.tb13740.x
NR 51
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1588-2926
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUN
PY 2017
VL 128
IS 3
BP 1565
EP 1578
DI 10.1007/s10973-016-6054-x
PG 14
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA EU9HK
UT WOS:000401349800031
OA No
DA 2017-08-17
ER

PT J
AU Ali, OAM
AF Ali, Omyma A. M.
TI Characterization, thermal and fluorescence study of Mn(II) and Pd(II)
   Schiff base complexes
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE Thermal investigation; Catalytic properties; Metal complexes;
   Antibacterial study
ID CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE; METAL-COMPLEXES; SPECTRAL
   CHARACTERIZATION; BIOLOGICAL-ACTIVITIES; ZINC(II) COMPLEXES; CU(II)
   COMPLEXES; ZN(II) COMPLEXES; DNA-BINDING; LIGAND
AB 2-[(pyridin-2-ylmethylidene)amino]-6-aminopyridine (L-1), 2-[(2-furylmethylene)]phenylenediamine (L-2) and their Mn(II) and Pd(II) complexes have been synthesized as potential photoactive materials, and their structures were elucidated using a variety of physicochemical techniques. The molar conductance data reveal that all complexes are nonionic in nature. Theoretical calculations were computed using the density functional theory, where the B3LYP functional was employed. The experimental results and the calculated parameters revealed a square planar and octahedral geometry around Pd(II) and Mn(II), respectively, in which the ligands coordinate to the metal ions as a bidentate manner. The thermal decomposition of the complexes has been studied. The catalytic activity of the complexes toward hydrogen peroxide decomposition reaction was investigated at 35 and 55 A degrees C. In addition, the synthesized ligands, in comparison with their metal complexes, were screened for their antibacterial activity.
C1 [Ali, Omyma A. M.] Ain Shams Univ, Fac Women Arts Sci & Educ, Chem Dept, Cairo, Egypt.
RP Ali, OAM (reprint author), Ain Shams Univ, Fac Women Arts Sci & Educ, Chem Dept, Cairo, Egypt.
EM omaymaahmed92@yahoo.com
CR Abdel-Ghani NT, 2011, J MOL STRUCT, V991, P108, DOI 10.1016/j.molstruc.2011.02.014
   Akbari A, 2012, E-J CHEM, V9, P2114
   Al-Shaalan NH, 2011, MOLECULES, V16, P8629, DOI 10.3390/molecules16108629
   Ali OAM, 2015, SPECTROCHIM ACTA A, V144, P99, DOI 10.1016/j.saa.2015.02.078
   Ali OAM, 2015, SPECTROCHIM ACTA A, V136, P651, DOI 10.1016/j.saa.2014.09.079
   Ali OAM, 2014, J MOL STRUCT, V1074, P713, DOI 10.1016/j.molstruc.2014.05.035
   Ali OAM, 2014, SPECTROCHIM ACTA A, V132, P52, DOI 10.1016/j.saa.2014.03.127
   Bal S, 2015, J THERM ANAL CALORIM, V121, P909, DOI 10.1007/s10973-015-4617-x
   Booysen IN, 2015, POLYHEDRON, V85, P144, DOI 10.1016/j.poly.2014.08.007
   Calu L, 2015, J THERM ANAL CALORIM, V120, P375, DOI 10.1007/s10973-014-3970-5
   Das P, 2016, COORDIN CHEM REV, V311, P1, DOI 10.1016/j.ccr.2015.11.010
   Ejidike IP, 2015, MOLECULES, V20, P9788, DOI 10.3390/molecules20069788
   Elsherbiny AS, 2015, INT J CHEM KINET, V47, P162, DOI 10.1002/kin.20900
   Geeta B, 2010, SPECTROCHIM ACTA A, V77, P911, DOI 10.1016/j.saa.2010.08.004
   Guha A, 2011, INDIAN J CHEM A, V50, P1574
   Gwaram NS, 2012, J APPL PHARM SCI, V2
   Hanif M, 2013, SPECTROCHIM ACTA A, V104, P468, DOI 10.1016/j.saa.2012.11.077
   Hosny NM, 2007, TRANSIT METAL CHEM, V32, P117, DOI 10.1007/s11243-006-0132-z
   Ibrahim WNW, 2012, CRYST STRUCT THEOR A, V1, P25
   Jose J, 2003, J APPL POLYM SCI, V90, P895, DOI 10.1002/app.12421
   Kalinowska M, 2016, J THERM ANAL CALORIM, V126, P141, DOI 10.1007/s10973-016-5362-5
   Kaya I, 2010, SYNTHETIC MET, V160, P911, DOI 10.1016/j.synthmet.2010.01.044
   Khalaji AD, 2015, J THERM ANAL CALORIM, V120, P1529, DOI 10.1007/s10973-015-4534-z
   Komatsuzaki NO, 2011, SOL ENERG MAT SOL C, V95, P310
   Kotov SV, 2003, J MOL CATAL A-CHEM, V195, P83, DOI 10.1016/S1381-1169(02)00578-2
   Koutsouri E, 2013, POLYHEDRON, V52, P234, DOI 10.1016/j.poly.2012.09.041
   Kumari N, 2012, INDIAN J CHEM A, V51, P554
   Manoharan A, 2003, INDIAN J MED RES, V117, P81
   Maxim C, 2008, INORG CHIM ACTA, V361, P3903, DOI 10.1016/j.ica.2008.03.013
   Mohamed GG, 2005, SPECTROCHIM ACTA A, V62, P1140, DOI 10.1016/j.saa.2005.03.031
   Popescu M, 2015, J THERM ANAL CALORIM, V120, P641, DOI 10.1007/s10973-015-4454-y
   Pouralimardan O, 2007, INORG CHIM ACTA, V360, P1599, DOI 10.1016/j.ica.2006.08.056
   Priyarega S, 2011, J CHEM SCI, V123, P319
   Sain S, 2012, POLYHEDRON, V31, P82, DOI 10.1016/j.poly.2011.08.040
   Sen S, 2006, POLYHEDRON, V25, P2737, DOI 10.1016/j.poly.2006.03.031
   Shah RK, 2016, J THERM ANAL CALORIM, V123, P731, DOI 10.1007/s10973-015-4838-z
   Shakir M, 2011, SPECTROCHIM ACTA A, V78, P29, DOI 10.1016/j.saa.2010.02.034
   Sheikhshoaie I, 2014, B CHEM SOC ETHIOPIA, V28, P265, DOI 10.4314/bcse.v28i2.10
   Sherif OE, 2014, SPECTROCHIM ACTA A, V117, P519, DOI 10.1016/j.saa.2013.08.037
   Soliman AA, 2013, DYES PIGMENTS, V99, P1056, DOI 10.1016/j.dyepig.2013.08.007
   Sultan JS, 2015, OPEN J INORG CHEM, V5, P102
   Suresh MS, 2011, E-J CHEM, V8, P1408
   Sutar AK, 2010, CHEM SOC REV, V39, P1724, DOI 10.1039/b912806a
   Taha ZA, 2011, SPECTROCHIM ACTA A, V81, P317, DOI 10.1016/j.saa.2011.06.018
   Tercero JM, 2003, INORG CHIM ACTA, V342, P77, DOI 10.1016/S0020-1693(02)01071-X
   Tyagi M., 2012, OJIC, V2, P41
   Yimer AM, 2015, REV CATAL, V2, P14
   Zayed EM, 2015, J THERM ANAL CALORIM, V120, P893, DOI 10.1007/s10973-014-4061-3
NR 48
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1588-2926
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUN
PY 2017
VL 128
IS 3
BP 1579
EP 1590
DI 10.1007/s10973-016-6055-9
PG 12
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA EU9HK
UT WOS:000401349800032
OA No
DA 2017-08-17
ER

PT J
AU Atyia, HE
   Farid, AS
AF Atyia, H. E.
   Farid, A. S.
TI Investigation and evaluation of the glass stability criteria for
   Se60Ge15X25 (X = Sn, As) compositions
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE DTA; Non-isothermal conditions; Glass stability criteria; Relative
   change parameter
ID FORMING ABILITY CRITERION; BULK METALLIC GLASSES; CHALCOGENIDE GLASSES;
   ALLOYS; TENDENCY
AB Study of the glass stability for amorphous Se60Ge15X25 (X = Sn, As) compositions has been performed by determination and evaluation of the widely used and more recently glass stability (GS) criteria. Calorimetric differential thermal analysis (DTA) measurements have been used under non-isothermal conditions at different heating rates. GS criteria have been determined based on the interrelationship of the estimated characteristic temperatures from DTA curves. All GS criteria are found to be heating rate and composition dependence. Their values and behaviors indicated that the most stable composition against devitrification with As addition. The calculated criteria values based on the onset crystallization temperature T (x) and the maximum (peak) crystallization temperature T (c) exhibit a similar behavior as a function of heating rate and composition, whereas both of them have incompatible values. The relative change parameter of GS criteria as well as their heating rate and composition dependence reflects that the more suitable and sensitive GS criterion, for the studied compositions, is Saad and Poulain(')s criterion K (s) and the less one is Lu and Liu's criterion K (LL) for two studied compositions.
C1 [Atyia, H. E.; Farid, A. S.] Ain Shams Univ, Dept Phys, Fac Educ, Cairo, Egypt.
RP Atyia, HE (reprint author), Ain Shams Univ, Dept Phys, Fac Educ, Cairo, Egypt.
EM hebaelghrip@hotmail.com
CR Abd-Elrahman MI, 2016, J ALLOY COMPD, V675, P1, DOI 10.1016/j.jallcom.2016.03.103
   Abdelazim NM, 2015, MAT SCI SEMICON PROC, V39, P156, DOI 10.1016/j.mssp.2015.05.005
   ABDELRAHIM MA, 1992, J MATER SCI, V27, P1757, DOI 10.1007/BF01107200
   Afifi MA, 2008, VACUUM, V83, P326, DOI 10.1016/j.vacuum.2008.05.034
   Bytchkov A, 2013, PHYS CHEM CHEM PHYS, V15, P8487, DOI 10.1039/c3cp50536g
   Chen QJ, 2006, MAT SCI ENG A-STRUCT, V433, P155, DOI 10.1016/j.msea.2006.06.053
   Du XH, 2007, J APPL PHYS, V101, DOI 10.1063/1.2718286
   Eggleton BJ, 2011, NAT PHOTONICS, V5, P141, DOI [10.1038/nphoton.2011.309, 10.1038/NPHOTON.2011.309]
   Fan GJ, 2007, J NON-CRYST SOLIDS, V353, P102, DOI 10.1016/j.jnoncrysol.2006.08.049
   Goknal AB, 1990, B ALLOY PHASE DIGRAM, V11, P257
   Guo S, 2010, INTERMETALLICS, V18, P2065, DOI 10.1016/j.intermet.2010.06.012
   HRUBY A, 1972, CZECH J PHYS SECT B, VB 22, P1187, DOI 10.1007/BF01690134
   Long ZL, 2009, MAT SCI ENG A-STRUCT, V509, P23, DOI 10.1016/j.msea.2009.01.063
   Lu ZP, 2002, ACTA MATER, V50, P3501, DOI 10.1016/S1359-6454(02)00166-0
   Mahadevan S, 2000, J NON-CRYST SOLIDS, V275, P147, DOI 10.1016/S0022-3093(00)00256-8
   MATUSITA K, 1984, J MATER SCI, V19, P291, DOI 10.1007/BF00553020
   Mehta N, 2006, MATER RES BULL, V41, P1664, DOI 10.1016/j.materresbull.2006.02.024
   Mehta N., 2004, CHALCO LETT, V1, P131
   Nascimento MLF, 2005, J NON-CRYST SOLIDS, V351, P3296, DOI 10.1016/j.jnoncrysol.2005.08.013
   Plotnichenko VG, 2014, OPT MATER EXPRESS, V4, P366, DOI 10.1364/OME.4.000366
   RABINAL MK, 1995, J NON-CRYST SOLIDS, V188, P98, DOI 10.1016/0022-3093(94)00699-7
   Saad M., 1987, MATER SCI FORUM, V19-20, P11, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/MSF.19-20.11
   Sinch K, 2003, B MATER SCI, V26, P543
   SRIVASTAVA SK, 1993, PHYSICA B, V183, P409, DOI 10.1016/0921-4526(93)90133-Q
   Svoboda R, 2015, J NON-CRYST SOLIDS, V413, P39, DOI 10.1016/j.jnoncrysol.2015.01.021
   TANAKA K, 1989, PHYS REV B, V39, P1270, DOI 10.1103/PhysRevB.39.1270
   Tang C, 2010, U ELECT TECHNOL, V30, P488
   THORNBURG DD, 1974, MATER RES BULL, V9, P1481, DOI 10.1016/0025-5408(74)90094-4
   TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405
   WEINBERG MC, 1994, PHYS CHEM GLASSES, V35, P119
   WEINBERG MC, 1994, J NON-CRYST SOLIDS, V167, P81, DOI 10.1016/0022-3093(94)90370-0
   Yuan ZZ, 2008, J ALLOY COMPD, V459, P251, DOI 10.1016/j.jallcom.2007.05.037
   Zhang P, 2009, J NON-CRYST SOLIDS, V355, P2183, DOI 10.1016/j.jnoncrysol.2009.06.001
NR 33
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1588-2926
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUN
PY 2017
VL 128
IS 3
BP 1793
EP 1800
DI 10.1007/s10973-016-6077-3
PG 8
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA EU9HK
UT WOS:000401349800051
OA No
DA 2017-08-17
ER

PT J
AU Khairy, M
   Amin, NH
   Kamal, R
AF Khairy, M.
   Amin, N. H.
   Kamal, R.
TI Optical and kinetics of thermal decomposition of PMMA/ZnO nanocomposites
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE PMMA; Nano-ZnO; Nanocomposites; Thermogravimetric analysis;
   Non-isothermal decomposition kinetics; Kinetic models
ID SITU BULK-POLYMERIZATION; THERMOGRAVIMETRIC DATA; SILICA NANOPARTICLES;
   APPROXIMATE FORMULA; ZNO NANOPARTICLES; DEGRADATION; FILMS; PYROLYSIS;
   SURFACE; MATRIX
AB PMMA/ZnO nanocomposites with different concentrations of nano-ZnO were prepared by in situ polymerization method. The effect of ZnO on the morphology, optical properties and thermal degradation kinetics of PMMA was investigated by means of XRD, TEM, FTIR, TG-DSC, photoluminescence (PL) spectra and UV-visible absorption spectra. The introduction of ZnO into PMMA slightly increases its thermal stability. The PL intensity of PMMA/ZnO nanocomposites increases with increasing the concentration of ZnO in the PMMA. The kinetic parameters were evaluated from TG data by several integral and iso-conversional methods. Based on the iterative iso-conversional calculation procedure, the activation energy values E (it) for the decomposition steps obtained were evaluated. The activation energy values for the thermal degradation of the nanocomposites were higher than that of pure PMMA. The most probable mechanism functions for the degradation of PMMA and its nanocomposite are suggested.
C1 [Khairy, M.] Benha Univ, Chem Dept, Fac Sci, Banha, Egypt.
   [Khairy, M.] Al Imam Muhammad Ibn Saud Islamic Univ, Chem Dept, Coll Sci, Riyadh, Saudi Arabia.
   [Amin, N. H.; Kamal, R.] Ain Shams Univ, Fac Educ, Chem Dept, Cairo 11757, Egypt.
RP Khairy, M (reprint author), Benha Univ, Chem Dept, Fac Sci, Banha, Egypt.; Khairy, M (reprint author), Al Imam Muhammad Ibn Saud Islamic Univ, Chem Dept, Coll Sci, Riyadh, Saudi Arabia.
EM Khairy_m22@yahoo.com
CR Achilias DS, 2010, J THERM ANAL CALORIM, V102, P451, DOI 10.1007/s10973-010-0935-1
   Toledano M., 2014, MAT SCI ENG C, V42, P161
   Chen FX, 2012, J THERM ANAL CALORIM, V109, P1457, DOI 10.1007/s10973-011-1834-9
   Cheng ZC, 2015, J THERM ANAL CALORIM, V119, P1429, DOI 10.1007/s10973-014-4215-3
   COATS AW, 1964, NATURE, V201, P68, DOI 10.1038/201068a0
   Debanath MK, 2013, MATER LETT, V111, P116, DOI 10.1016/j.matlet.2013.08.069
   Du XW, 2006, SEMICOND SCI TECH, V21, P1202, DOI 10.1088/0268-1242/21/8/037
   Ferriol M, 2003, POLYM DEGRAD STABIL, V79, P271, DOI 10.1016/S0141-3910(02)00291-4
   Friedman H.L., 1964, J POLYM SCI C, V6, P183, DOI DOI 10.1002/P0LC.5070060121
   Hongjun L., 2014, OPT MATER EXPRESS, V4, P1762
   KASHIWAGI T, 1986, MACROMOLECULES, V19, P2160, DOI 10.1021/ma00162a010
   Kok MV, 2014, ENERG SOURCE PART A, V36, P173, DOI 10.1080/15567036.2010.532193
   Kok MV, 2013, THERMOCHIM ACTA, V569, P66, DOI 10.1016/j.tca.2013.07.014
   Kulyk B, 2010, J ALLOY COMPD, V502, P24, DOI 10.1016/j.jallcom.2010.04.162
   Liqing L, 2004, J THERM ANAL CALORIM, V78, P283, DOI 10.1023/B:JTAN.0000042175.27569.ee
   Liu YL, 2005, POLYMER, V46, P1851, DOI 10.1016/j.polymer.2005.01.009
   MADHUSUDANAN PM, 1986, THERMOCHIM ACTA, V97, P189, DOI 10.1016/0040-6031(86)87019-8
   Matai I, 2014, COLLOID SURFACE B, V115, P359, DOI 10.1016/j.colsurfb.2013.12.005
   Mendonca ARV, 2015, J THERM ANAL CALORIM, V121, P807, DOI 10.1007/s10973-015-4551-y
   Nie SB, 2015, J THERM ANAL CALORIM, V120, P1183, DOI 10.1007/s10973-015-4393-7
   OZAWA T, 1965, B CHEM SOC JPN, V38, P1881, DOI 10.1246/bcsj.38.1881
   Popescu C, 1996, THERMOCHIM ACTA, V285, P309, DOI 10.1016/0040-6031(96)02916-4
   Razavi RS, 2011, CURR NANOSCI, V7, P807
   Rotaru A, 2010, THERMOCHIM ACTA, V498, P81, DOI 10.1016/j.tca.2009.10.006
   Sadeghi B, 2014, SPECTROCHIM ACTA A, V118, P787, DOI 10.1016/j.saa.2013.09.022
   Saladino ML, 2012, POLYM DEGRAD STABIL, V97, P452, DOI 10.1016/j.polymdegradstab.2011.11.006
   Saladino ML, 2010, LANGMUIR, V26, P13442, DOI 10.1021/la9042809
   SENUM GI, 1977, J THERM ANAL, V11, P445, DOI 10.1007/BF01903696
   Sestak J, 1971, THERMOCHIM ACTA, V3, P1, DOI DOI 10.1016/0040-6031(71)85051-7
   Shobhana E., 2012, INT J MOD ENG RES, V2, P1092
   Tang EJ, 2006, POWDER TECHNOL, V161, P209, DOI 10.1016/j.powtec.2005.10.007
   Tang WJ, 2003, THERMOCHIM ACTA, V408, P39, DOI 10.1016/S0040-6031(03)00310-1
   Valanciene E, 2016, J THERM ANAL CALORIM, V124, P341, DOI 10.1007/s10973-015-5150-7
   Viratyaporn W, 2011, J THERM ANAL CALORIM, V103, P267, DOI 10.1007/s10973-010-1051-y
   Wahab R, 2011, CHEM ENG J, V175, P450, DOI 10.1016/j.cej.2011.09.055
   Wanjun T, 2003, J THERM ANAL CALORIM, V74, P309, DOI 10.1023/A:1026310710529
   Ye QQ, 2016, J THERM ANAL CALORIM, V124, P1471, DOI 10.1007/s10973-016-5314-0
   Zhang SH, 2015, J THERM ANAL CALORIM, V119, P1853, DOI 10.1007/s10973-014-4309-y
   Zhang YW, 2013, OPT MATER, V36, P169, DOI 10.1016/j.optmat.2013.08.021
NR 39
TC 0
Z9 0
U1 18
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1588-2926
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUN
PY 2017
VL 128
IS 3
BP 1811
EP 1824
DI 10.1007/s10973-016-6062-x
PG 14
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA EU9HK
UT WOS:000401349800053
OA No
DA 2017-08-17
ER

PT J
AU Hussein, AA
   Saar, M
   May, PR
   Wijburg, CJ
   Richstone, L
   Wagner, A
   Wilson, T
   Yuh, B
   Redorta, JP
   Dasgupta, P
   Khan, MS
   Menon, M
   Peabody, JO
   Hosseini, A
   Gaboardi, F
   Mottrie, A
   Rha, KH
   Hemal, A
   Stockle, M
   Kelly, J
   Maatman, TJ
   Canda, AE
   Wiklund, P
   Guru, KA
AF Hussein, Ahmed A.
   Saar, Matthias
   May, Paul R.
   Wijburg, Carl J.
   Richstone, Lee
   Wagner, Andrew
   Wilson, Timothy
   Yuh, Bertram
   Redorta, Joan Palou
   Dasgupta, Prokar
   Khan, Mohammad Shamim
   Menon, Mani
   Peabody, James O.
   Hosseini, Abolfazl
   Gaboardi, Franco
   Mottrie, Alexandre
   Rha, Koon-ho
   Hemal, Ashok
   Stockle, Michael
   Kelly, John
   Maatman, Thomas J.
   Canda, Abdullah Erdem
   Wiklund, Peter
   Guru, Khurshid A.
TI Early Oncologic Failure after Robot-Assisted Radical Cystectomy: Results
   from the International Robotic Cystectomy Consortium
SO JOURNAL OF UROLOGY
LA English
DT Article
DE urinary bladder neoplasms; neoplasm recurrence, local; robotic surgical
   procedures; cystectomy; treatment failure
ID TRANSITIONAL-CELL CARCINOMA; PORT SITE METASTASES; BLADDER-CANCER;
   INTRAPERITONEAL CHEMOTHERAPY; UROTHELIAL CARCINOMA; IMPLANTATION;
   RECURRENCE; LYMPHADENECTOMY; LAPAROSCOPY; PATTERNS
AB Purpose: We sought to investigate the prevalence and variables associated with early oncologic failure.
   Materials and Methods: We retrospectively reviewed the IRCC (International Radical Cystectomy Consortium) database of patients who underwent robotassisted radical cystectomy since 2003. The final cohort comprised a total of 1,894 patients from 23 institutions in 11 countries. Early oncologic failure was defined as any disease relapse within 3 months of robot-assisted radical cystectomy. All institutions were surveyed for the pneumoperitoneum pressure used, breach of oncologic surgical principles, and techniques of specimen and lymph node removal. A multivariate model was fit to evaluate predictors of early oncologic failure. The Kaplan-Meier method was applied to depict disease specific and overall survival, and Cox proportional regression analysis was used to evaluate predictors of disease specific and overall survival.
   Results: A total of 305 patients (22%) experienced disease relapse, which was distant in 220 (16%), local recurrence in 154 (11%), peritoneal carcinomatosis in 17 (1%) and port site recurrence in 5 (0.4%). Early oncologic failure developed in 71 patients (5%) at a total of 10 institutions. The incidence of early oncologic failure decreased from 10% in 2006 to 6% in 2015. On multivariate analysis the presence of any complication (OR 2.87, 95% CI 1.38-5.96, p = 0.004), pT3 or greater disease (OR 3.73, 95% CI 2.00-6.97, p < 0.001) and nodal involvement (OR 2.14, 95% CI 1.21-3.80, p = 0.008) was a significant predictor of early oncologic failure. Patients with early oncologic failure demonstrated worse disease specific and overall survival (23% and 13%, respectively) at 1 and 3 years compared to patients who experienced later or no recurrences (log rank p < 0.001).
   Conclusions: The incidence of early oncologic failure following robot-assisted radical cystectomy has decreased with time. Disease related rather than technical related factors have a major role in early oncologic failure after robot-assisted radical cystectomy.
C1 [Hussein, Ahmed A.; May, Paul R.; Guru, Khurshid A.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA.
   [Richstone, Lee] Arthur Smith Inst Urol, New York, NY USA.
   [Hussein, Ahmed A.] Cairo Univ, Cairo, Egypt.
   [Saar, Matthias; Stockle, Michael] Univ Saarland, Homburg, Germany.
   [Wijburg, Carl J.] Rijnstate Hosp, Arnhem, Netherlands.
   [Wagner, Andrew] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   [Wilson, Timothy; Yuh, Bertram] City Hope Natl Med Ctr, Duarte, CA USA.
   [Wilson, Timothy; Yuh, Bertram] Beckman Res Inst, Duarte, CA USA.
   [Redorta, Joan Palou] Fundacio Puigvert, Barcelona, Spain.
   [Dasgupta, Prokar; Khan, Mohammad Shamim] Guys Hosp, London, England.
   [Dasgupta, Prokar; Khan, Mohammad Shamim] Kings Coll London, London Sch Med, London, England.
   [Kelly, John] UCL, Dept Urol, Div Surg & Intervent Sci, London, England.
   [Menon, Mani; Peabody, James O.] Henry Ford Hlth Syst, Detroit, MI USA.
   [Maatman, Thomas J.] Michigan Urol Clin, Grand Rapids, MI USA.
   [Hosseini, Abolfazl; Wiklund, Peter] Karolinska Univ Hosp, Stockholm, Sweden.
   [Gaboardi, Franco] Luigi Sacco Univ Hosp, Milan, Italy.
   [Mottrie, Alexandre] Onze Lieve Vrouw Hosp, Aalast, Belgium.
   [Rha, Koon-ho] Yonsei Univ Hlth Syst, Severance Hosp, Seoul, South Korea.
   [Hemal, Ashok] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA.
   [Canda, Abdullah Erdem] Yildirim Beyazit Univ, Sch Med, Ankara Ataturk Training & Res Hosp, Ankara, Turkey.
RP Guru, KA (reprint author), Roswell Pk Canc Inst, Dept Urol, Appl Technol Lab, Adv Surg Program, Elm & Carlton Sts, Buffalo, NY 14263 USA.
EM Khurshid.guru@roswellpark.org
OI Tan, Wei Shen/0000-0002-6119-4043
FU Vattikuti Foundation Collective Quality Initiative; Roswell Park Cancer
   Institute Alliance Foundation
FX Supported by the Vattikuti Foundation Collective Quality Initiative and
   Roswell Park Cancer Institute Alliance Foundation.
CR Abaza R, 2006, J UROLOGY, V175, P2317, DOI 10.1016/S0022-5347(06)00257-6
   Albisinni S, 2016, J UROLOGY, V195, P1710, DOI 10.1016/j.juro.2016.01.008
   BREUL J, 1992, EUR UROL, V22, P86
   Carmignani CP, 2004, SURG ENDOSC, V18, P1, DOI 10.1007/s00464-003-4538-9
   Chakravarti A, 2000, BJU INT, V85, P1150, DOI 10.1046/j.1464-410x.2000.00684.x
   El-Tabey NA, 2005, UROLOGY, V66, P11101, DOI 10.1016/j.urology.2005.05.048
   Engilbertsson H, 2015, J UROLOGY, V193, P53, DOI 10.1016/j.juro.2014.06.083
   Hewett PJ, 1996, DIS COLON RECTUM, V39, pS62, DOI 10.1007/BF02053808
   Huguet J, 2013, ACTAS UROL ESP, V37, P376, DOI 10.1016/j.acuro.2013.01.005
   Hussein A, 2016, J UROLOGY, V195, pE534
   Hussein AA, 2016, UROLOGY, V97, P124, DOI 10.1016/j.urology.2016.06.063
   Jaaback K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005340.pub4
   Jacobi CA, 1998, BRIT J SURG, V85, P1419
   Kang LY, 2013, J CHIN MED ASSOC, V76, P425, DOI 10.1016/j.jcma.2013.04.004
   Karam JA, 2008, LANCET ONCOL, V9, P317, DOI 10.1016/S1470-2045(08)70087-1
   KAZEMIER G, 1995, BRIT J SURG, V82, P1141, DOI 10.1002/bjs.1800820850
   Kluth LA, 2014, EUR UROL, V66, P913, DOI 10.1016/j.eururo.2013.11.040
   Leow JJ, 2014, EUR UROL, V66, P569, DOI 10.1016/j.eururo.2014.01.029
   Marin-Aguilera M, 2008, EUR UROL, V54, P1363, DOI 10.1016/j.eururo.2008.04.059
   Nguyen DP, 2016, J UROLOGY, V196, P1390, DOI 10.1016/j.juro.2016.05.101
   Nguyen DP, 2015, EUR UROL, V68, P399, DOI 10.1016/j.eururo.2015.02.003
   Ost MC, 2008, J ENDOUROL, V22, P105, DOI 10.1089/end.2007.9858
   Pourmalek F, 2016, EUR UROL, V69, pE35, DOI 10.1016/j.eururo.2015.06.048
   Raza SJ, 2015, EUR UROL, V68, P721, DOI 10.1016/j.eururo.2015.04.021
   Sonpavde G, 2011, J UROLOGY, V185, P456, DOI 10.1016/j.juro.2010.09.110
   STOLLA V, 1994, EUR UROL, V26, P342
   Tarin TV, 2012, EUR UROL, V61, P1025, DOI 10.1016/j.eururo.2012.01.049
   Tsivian A, 2003, J UROLOGY, V169, P1213, DOI 10.1097/01.ju.0000035910.75480.4b
   Via KJ, 2010, CAN J UROL, V17, P5216
   Williams SB, 2015, BJU INT, V116, P172, DOI 10.1111/bju.12952
NR 30
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD JUN
PY 2017
VL 197
IS 6
BP 1427
EP 1436
DI 10.1016/j.juro.2016.12.048
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA EU2YS
UT WOS:000400896400017
PM 27993668
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Kader, MS
   Alam, P
   Alqarni, MH
   Salkini, MA
AF Abdel-Kader, Maged Saad
   Alam, Prawez
   Alqarni, Mohammed Hamed
   Salkini, Mohamad Ayman
TI High-Performance Thin-Layer Chromatographic Method for the Estimation of
   Benzyl Isothiocyanate in Salvadora persica Root Extract and Dental Care
   Herbal Products
SO JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC
LA English
DT Article; Proceedings Paper
CT International Symposium for High-Performance Thin-Layer Chromatography
   (HPTLC)
CY JUL 04-08, 2017
CL Berlin, GERMANY
DE Salvadora persica; Benzyl isothiocyanate; High-performance thin-layer
   chromatography-densitometry; ICH guidelines; Qualitative; Quantitative
AB A novel, simple, and sensitive high-performance thin-layer chromatography (HPTLC) method has been successfully developed and validated for the quantification of benzyl isothiocyanate in Salvadora persica (Miswak or Siwak) extract and some dental care herbal products labeled to contain Siwak extract. A modified HPTLC method was carried out using glass-coated silica gel 60 F-254 plates and mobile phase consisting of n-hexane. ethyl acetate (9: 1) furnished compact spots at R-F 0.61 +/- 0.01. The developed plate was scanned and quantified densitometrically at 191 nm. Linear regression analysis revealed a good linear relationship between peak area and amount of benzyl isothiocyanate in the range of 100-600 ng band(-1) (r(2) = 0.9991). The method was validated in accordance with the International Conference on Harmonization (ICH) guidelines for precision, accuracy, and robustness. The proposed method will be useful to evaluate the therapeutic efficacy of Siwak extracts and dental care herbal formulations containing Siwak.
C1 [Abdel-Kader, Maged Saad; Alam, Prawez; Alqarni, Mohammed Hamed; Salkini, Mohamad Ayman] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Pharmacognosy, POB 173, Al Kharj 11942, Saudi Arabia.
   [Abdel-Kader, Maged Saad] Alexandria Univ, Fac Pharm, Dept Pharmacognosy, Alexandria 21215, Egypt.
RP Abdel-Kader, MS (reprint author), Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Pharmacognosy, POB 173, Al Kharj 11942, Saudi Arabia.; Abdel-Kader, MS (reprint author), Alexandria Univ, Fac Pharm, Dept Pharmacognosy, Alexandria 21215, Egypt.
EM mpharm101@hotmail.com
FU Sheikh Abdullah bin Zaid bin Ghonaim Research Chair of Prophetic
   Medicine, Developing and Manufacturing Natural Products, College of
   Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, KSA
FX This project was supported by Sheikh Abdullah bin Zaid bin Ghonaim
   Research Chair of Prophetic Medicine, Developing and Manufacturing
   Natural Products, College of Pharmacy, Prince Sattam Bin Abdulaziz
   University, Al-Kharj, KSA.
CR Al lafi T, 1995, Int Dent J, V45, P218
   Almas K, 1997, BIOMED LETT, V56, P145
   Almas K, 1999, Indian J Dent Res, V10, P23
   de Castro IM, 2008, QUIM NOVA, V31, P1953, DOI 10.1590/S0100-40422008000800007
   Fuu Sheu, 1996, Journal of Food and Drug Analysis, V4, P327
   Herzallah S, 2012, LWT-FOOD SCI TECHNOL, V47, P293, DOI 10.1016/j.lwt.2012.01.022
   [Anonymous], 1996, HARM TRIPL GUID VAL
   Martoni M.-R., 2013, UPB SCI B B, V75, P63
   Sofrata A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023045
   TANG CS, 1971, PHYTOCHEMISTRY, V10, P117, DOI 10.1016/S0031-9422(00)90258-9
NR 10
TC 0
Z9 0
U1 1
U2 1
PU AKADEMIAI KIADO RT
PI BUDAPEST
PA PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY
SN 0933-4173
EI 1789-0993
J9 JPC-J PLANAR CHROMAT
JI JPC-J. Planar Chromatogr.-Mod. TLC
PD JUN
PY 2017
VL 30
IS 3
BP 211
EP 215
DI 10.1556/1006.2017.30.3.10
PG 5
WC Chemistry, Analytical
SC Chemistry
GA EU6LX
UT WOS:000401146600011
OA No
DA 2017-08-17
ER

PT J
AU Nady, A
   Ahmed, MHM
   Latiff, AA
   Numan, A
   Ooi, CHR
   Harun, SW
AF Nady, A.
   Ahmed, M. H. M.
   Latiff, A. A.
   Numan, A.
   Ooi, C. H. Raymond
   Harun, S. W.
TI Nickel oxide nanoparticles as a saturable absorber for an all-fiber
   passively Q-switched erbium-doped fiber laser
SO LASER PHYSICS
LA English
DT Article
DE fiber lasers; optical absorption; Q-switching
ID THIN-FILMS; ELECTROCHEMICAL PROPERTIES; DEPOSITION; NIO; ABSORPTION;
   GRAPHENE
AB Nickel oxide (NiO) nanoparticles were synthesized by a facile sonochemical method to fabricate saturable absorber (SA) composite film with a modulation depth of 39% and saturation intensity of 0.025 MW cm(-2). By inserting the NiO SA into a laser cavity, a stable Q-switched operation is achieved at 1561.2 nm. The laser has a pump threshold of 25 mW, a pulse repetition rate tunable from 19.57 to 52.18 kHz, a high signal-to-noise ratio of 55 dB and a minimum pulse duration of 5.2 mu s. Such results imply that NiO nanoparticles are a comparable candidate for an SA in passively Q-switched fiber lasers at a low pump intensity. To the best of our knowledge, this is the first demonstration of a fiber laser based on NiO SA.
C1 [Nady, A.; Numan, A.; Ooi, C. H. Raymond] Univ Malaya, Phys Dept, Fac Sci, Kuala Lumpur 50603, Malaysia.
   [Ahmed, M. H. M.; Harun, S. W.] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
   [Latiff, A. A.] Univ Malaya, Photon Res Ctr, Kuala Lumpur 50603, Malaysia.
   [Nady, A.] Beni Suef Univ, Phys Dept, Fac Sci, Bani Suwayf 62511, Egypt.
RP Harun, SW (reprint author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur 50603, Malaysia.
EM swharun@um.edu.my
FU University of Malaya [PG173-2015B]
FX This work is financially supported by University of Malaya under PPP
   Grant Scheme (Grant No: PG173-2015B).
CR Ahmad H, 2016, OPT COMMUN, V381, P72, DOI 10.1016/j.optcom.2016.06.073
   Ahmad H, 2016, IEEE PHOTONICS J, V8, DOI 10.1109/JPHOT.2015.2506169
   Chen Y, 2015, OPT EXPRESS, V23, P12823, DOI 10.1364/OE.23.012823
   Chigane M, 1998, J CHEM SOC FARADAY T, V94, P3665, DOI 10.1039/a806459h
   de Melo RP, 2009, J APPL PHYS, V106, DOI 10.1063/1.3254233
   Du J, 2014, SCI REP, V4
   Duraisamy N, 2016, J COLLOID INTERF SCI, V471, P136, DOI 10.1016/j.jcis.2016.03.013
   Duraisamy N, 2015, MATER LETT, V161, P694, DOI 10.1016/j.matlet.2015.09.059
   Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803
   Kumar A, 2013, SYNTHESIS BIOMEDICAL
   Latiff AA, 2017, J MOD OPTIC, V64, P187, DOI 10.1080/09500340.2016.1220641
   Li HP, 2015, IEEE PHOTONIC TECH L, V27, P69, DOI 10.1109/LPT.2014.2361899
   Liu H, 2014, OPT LETT, V39, P4591, DOI 10.1364/OL.39.004591
   Luo ZQ, 2014, J LIGHTWAVE TECHNOL, V32, P4077, DOI 10.1109/JLT.2014.2362147
   Martinez A, 2013, NAT PHOTONICS, V7, P842, DOI 10.1038/nphoton.2013.304
   MISHO RH, 1988, PHYS STATUS SOLIDI A, V109, pK101, DOI 10.1002/pssa.2211090237
   Nishizawa N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.090101
   Pan L, 2007, IEEE PHOTONIC TECH L, V19, P1979, DOI 10.1109/LPT.2007.909700
   PRAMANIK P, 1990, J ELECTROCHEM SOC, V137, P3869, DOI 10.1149/1.2086316
   Shablaev SI, 2003, PHYS SOLID STATE+, V45, P1742, DOI 10.1134/1.1611243
   Sobon G, 2012, LASER PHYS LETT, V9, P581, DOI 10.7452/lapl.201210038
   Surca A, 1996, J ELECTROANAL CHEM, V408, P83, DOI 10.1016/0022-0728(96)04509-3
   Tian Z, 2015, LASER PHYS LETT, V12, DOI 10.1088/1612-2011/12/6/065104
   Utriainen M, 1998, MAT SCI ENG B-SOLID, V54, P98, DOI 10.1016/S0921-5107(98)00135-4
   VARKEY AJ, 1993, THIN SOLID FILMS, V235, P47, DOI 10.1016/0040-6090(93)90241-G
   Wang J, 2015, NANOSCALE RES LETT, V10, DOI [10.1186/s11671-015-0907-2, 10.1186/s11671-015-1170-2]
   Woodward RI, 2015, OPT EXPRESS, V23, P20051, DOI 10.1364/OE.23.020051
   Xie Y, 1996, J CRYST GROWTH, V167, P656, DOI 10.1016/0022-0248(96)00285-0
   Yamashita S, 2014, OPT FIBER TECHNOL, V20, P702, DOI 10.1016/j.yofte.2014.08.013
   Zhao CJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4767919
NR 30
TC 0
Z9 0
U1 10
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1054-660X
EI 1555-6611
J9 LASER PHYS
JI Laser Phys.
PD JUN
PY 2017
VL 27
IS 6
AR 065105
DI 10.1088/1555-6611/aa6bd7
PG 6
WC Optics; Physics, Applied
SC Optics; Physics
GA EU2ZG
UT WOS:000400897800002
OA No
DA 2017-08-17
ER

PT J
AU Asran, AM
   Emam, A
   E-Fakharani, A
AF Asran, Asran Mohamed
   Emam, Ashraf
   El-Fakharani, Abdelhamid
TI Geology, structure, geochemistry and ASTER-based mapping of
   Neoproterozoic Gebel El-Delihimmi granites, Central Eastern Desert of
   Egypt
SO LITHOS
LA English
DT Article
DE El-Delihimmi; Central Eastern Desert; Deformation; ASTER-SWIR; I-type
   granites
ID SPACEBORNE THERMAL EMISSION; REFLECTION RADIOMETER ASTER; ALLAQI-HEIANI
   SUTURE; BASEMENT ROCKS; NUBIAN SHIELD; LANDSAT TM; OPHIOLITE COMPLEX;
   PLUTONIC ROCKS; ARABIAN SHIELD; DATA PRODUCTS
AB The Gebel El-Delihimmi granite intrusion, located in the Central Eastern Desert of Egypt, cuts the core of a major anticlinal structure of calc-alkaline metavolcanics and ophiolitic melange rocks. The intrusion is microscopically differentiated into granodiorite, monzogranite, syenogranite and alkali-feldspar granite. Decorrelation stretch and band-ratio techniques were applied to Advanced Spaceborne Thermal Emission and Reflection Radiometer data. Processing of ASTER-SWIR bands enabled discrimination of El-Delihimmi granite phases and generation of a detailed lithologic map of the study area. The structural and microfabric data suggest that the El-Delihimmi granite underwent at least two phases of deformations. The first was related to the Najd fault system during which the older granodiorite phase of the intrusion was affected by sinistral ductile shearing. During the second phase, monzogranite and syenogranite in the intrusion were affected by brittle E-W compressional deformation. Geochemical data reported here reveal that the granodiorite phase has K2O/Na2O ratio <1 and represents an evolved calc-alkaline granite. The monzogranite, syenogranite and alkali-feldspar granite phases have K2O/Na2O ratio >1. The granite phases are generally I-type, metaluminous to slightly peraluminous and are interpreted as formed above subducted slabs of oceanic lithosphere rather than in continental collision zones. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Asran, Asran Mohamed] Sohag Univ, Dept Geol, Fac Sci, Sohag, Egypt.
   [Emam, Ashraf; El-Fakharani, Abdelhamid] Aswan Univ, Dept Geol, Fac Sci, Aswan Governorate, Egypt.
   [El-Fakharani, Abdelhamid] King Abdulaziz Univ, Fac Earth Sci, Dept Struct Geol & Remote Sensing, Jeddah, Saudi Arabia.
RP Emam, A (reprint author), Aswan Univ, Dept Geol, Fac Sci, Aswan Governorate, Egypt.
EM ashrafemam99@hotmail.com
CR ABDELRAHMAN AFM, 1987, J GEOL SOC LONDON, V144, P577, DOI 10.1144/gsjgs.144.4.0577
   Aboelkhair H, 2010, J AFR EARTH SCI, V58, P141, DOI 10.1016/j.jafrearsci.2010.01.007
   ABRAMS M, 1995, IEEE T GEOSCI REMOTE, V33, P692, DOI 10.1109/36.387584
   Abrams M, 2000, INT J REMOTE SENS, V21, P847, DOI 10.1080/014311600210326
   Akaad M.K., 1980, KING ABDULAZIZ U JED, V4, P127
   Akaad M.K., 2002, 78 EGSMA, P118
   Akaad M.K., 1979, DELTA J SCI, V3, P107
   Aly M.M., 1983, 66 EG GEOL SURV MIN, P149
   Amer R, 2010, J AFR EARTH SCI, V56, P75, DOI 10.1016/j.jafrearsci.2009.06.004
   Asran A.M., 1991, THESIS
   BENTOR YK, 1985, PRECAMBRIAN RES, V28, P1, DOI 10.1016/0301-9268(85)90074-9
   Chappell B., 1974, PAC GEOL, V8, P173
   Clarke DB, 1981, CAN MINERAL, V19, P3
   Drury S.A., 1993, IMAGE INTERPRETATION
   Drury S. A, 1998, IMAGES EARTH GUIDE R
   El Anwar M.A.M., 1983, THESIS
   El Gaby S., 1994, EGYPT B FS ASSIUT U, V23, P185
   El Gaby S., 1983, 5 INT C BAS TECT CAI, P1
   El Gaby S., 1975, NEUES JB MINERALOGIE, V124, P147
   El Gaby S., 1988, EGYPT B FAC SCI ASSI, V17, P51
   El-Ramly M.F., 1960, BASEMENT COMPLEX CEN, V8, P1
   Emam A, 2016, INT GEOL REV, V58, P525, DOI 10.1080/00206814.2015.1094382
   Gabr S, 2010, ORE GEOL REV, V38, P59, DOI 10.1016/j.oregeorev.2010.05.007
   Gabr SS, 2015, ORE GEOL REV, V71, P1, DOI 10.1016/j.oregeorev.2015.04.021
   Gad S, 2007, GONDWANA RES, V11, P326, DOI 10.1016/j.gr.2006.02.010
   GILLESPIE AR, 1986, REMOTE SENS ENVIRON, V20, P209, DOI 10.1016/0034-4257(86)90044-1
   GREEN TH, 1980, TECTONOPHYSICS, V63, P367, DOI 10.1016/0040-1951(80)90121-3
   Hamimi Z, 1996, EGYPT J GEOL, V40, P423
   Hassan M., 1990, GEOLOGY EGYPT, P201
   Hassan SM, 2015, ARAB J GEOSCI, V8, P4641, DOI 10.1007/s12517-014-1562-0
   Hassan SM, 2015, ARAB J GEOSCI, V8, P6853, DOI 10.1007/s12517-014-1729-8
   Hume W.F., 1935, GEOLOGY EGYPT 2, P301
   HUSSEIN AAA, 1982, J VOLCANOL GEOTH RES, V14, P187, DOI 10.1016/0377-0273(82)90048-8
   Inzana J, 2003, J AFR EARTH SCI, V37, P59, DOI 10.1016/S0899-5362(03)00071-X
   JACKSON NJ, 1984, CONTRIB MINERAL PETR, V87, P205, DOI 10.1007/BF00373054
   JELINEK E, 1993, PRECAMBRIAN RES, V62, P103, DOI 10.1016/0301-9268(93)90096-K
   Jing C, 2014, INT J APPL EARTH OBS, V33, P127, DOI 10.1016/j.jag.2014.04.014
   Kamal El Din G.M., 1993, THESIS, P19
   Kanjanapayont P, 2012, J ASIAN EARTH SCI, V56, P263, DOI 10.1016/j.jseaes.2012.05.029
   Khan SD, 2008, EARTH-SCI REV, V89, P135, DOI 10.1016/j.earscirev.2008.04.004
   Khan SD, 2007, J ASIAN EARTH SCI, V30, P333, DOI 10.1016/j.jseaes.2006.11.001
   Khudeir A.A., 1992, GEOL AR WORLD C CAIR
   Kusky TM, 2002, J AFR EARTH SCI, V35, P107, DOI 10.1016/S0899-5362(02)00029-5
   Liegeois J. P., 1987, GEOL SOC SPEC PUBL, V30, P381, DOI 10.1144/GSL.SP.1987.030.01.18
   Madani A, 2003, EGYPT J REMOTE SENS, V6, P47
   Madani AA, 2011, ARAB J GEOSCI, V4, P45, DOI 10.1007/s12517-009-0059-8
   MANIAR PD, 1989, GEOL SOC AM BULL, V101, P635, DOI 10.1130/0016-7606(1989)101<0635:TDOG>2.3.CO;2
   Mars JC, 2010, REMOTE SENS ENVIRON, V114, P2011, DOI 10.1016/j.rse.2010.04.008
   Mason B., 1982, PRINCIPLES GEOCHEMIS
   Moghazi AM, 2002, MINER PETROL, V75, P41, DOI 10.1007/s007100200014
   Padfield T., 1971, MAJOR ELEMENT ROCK A
   Passchier CW, 2005, MICROTECTONICS
   PEARCE JA, 1984, J PETROL, V25, P956
   Pearce J.A., 1983, CONTINENTAL BASALTS, P230
   Pearce T.H., 1977, GEOLOGICAL SOC LONDO, V134, P14
   PECCERILLO A, 1976, CONTRIB MINERAL PETR, V58, P63, DOI 10.1007/BF00384745
   Pitcher W. S., 1983, MOUNTAIN BUILDING PR, P19
   Pour B.A., 2014, ASTER ALI HYPERION S, P130
   Pour B.A., 2013, INT J IMAGE DATA FUS, V4, P126, DOI DOI 10.1080/19479832.2012.753115
   Qari MHT, 2008, ARAB J SCI ENG, V33, P99
   Qiu F, 2006, J AFR EARTH SCI, V44, P169, DOI 10.1016/j.jafrearsci.2005.10.009
   Rajendran S, 2012, ORE GEOL REV, V44, P121, DOI 10.1016/j.oregeorev.2011.09.010
   Ramadan TM, 2001, PHOTOGRAMM ENG REM S, V67, P491
   RAMSAY CR, 1986, J AFR EARTH SCI, V4, P13, DOI 10.1016/S0899-5362(86)80065-3
   ROGERS JJW, 1990, J GEOL, V98, P291
   Rowan LC, 2005, REMOTE SENS ENVIRON, V99, P105, DOI 10.1016/j.rse.2004.11.021
   Rundnick RL, 2003, TREATISE GEOCHEMISTR, V3, P1
   Sabet A.H., 1961, THESIS
   Sabins FF, 1999, ORE GEOL REV, V14, P157, DOI 10.1016/S0169-1368(99)00007-4
   Sadeghi B, 2013, J AFR EARTH SCI, V85, P103, DOI 10.1016/j.jafrearsci.2013.05.003
   Sadek MF, 2015, ARAB J GEOSCI, V8, P10459, DOI 10.1007/s12517-015-1973-6
   Saunder A.D., 1980, OPHIOLITES, P193
   Stern R. J., 1979, THESIS
   STOESER DB, 1985, GEOL SOC AM BULL, V96, P817, DOI 10.1130/0016-7606(1985)96<817:PMAOTA>2.0.CO;2
   Streckeisen A., 1979, NEUES JB MINER ABH, V16, P169
   SYLVESTER PJ, 1989, J GEOL, V97, P261
   Tangestani MH, 2008, INT J REMOTE SENS, V29, P2833, DOI 10.1080/01431160701422239
   Tangestani MH, 2011, REMOTE SENS ENVIRON, V115, P2243, DOI 10.1016/j.rse.2011.04.023
   THOMPSON RN, 1984, PHILOS T R SOC A, V310, P549, DOI 10.1098/rsta.1984.0008
   Tuttle O.F., 1958, GEOLOGICAL SOC AM ME, V24, P1
   WYLLIE PJ, 1977, J GEOL, V85, P187
   Yamaguchi Y, 1998, IEEE T GEOSCI REMOTE, V36, P1062, DOI 10.1109/36.700991
   Zoheir B, 2014, J AFR EARTH SCI, V99, P150, DOI 10.1016/j.jafrearsci.2013.06.006
   Zoheir B, 2012, J AFR EARTH SCI, V66-67, P22, DOI 10.1016/j.jafrearsci.2012.02.007
NR 84
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0024-4937
EI 1872-6143
J9 LITHOS
JI Lithos
PD JUN
PY 2017
VL 282
BP 358
EP 372
DI 10.1016/j.lithos.2017.03.022
PG 15
WC Geochemistry & Geophysics; Mineralogy
SC Geochemistry & Geophysics; Mineralogy
GA EU9VP
UT WOS:000401388100025
OA No
DA 2017-08-17
ER

PT J
AU Tolba, MM
   Belal, F
AF Tolba, M. M.
   Belal, F.
TI Two liquid chromatographic approaches for the simultaneous determination
   of xipamide and its degradation product (2,6-xylidine) using
   time-programmed fluorescence detection
SO LUMINESCENCE
LA English
DT Article
DE Xipamide; Stability-indicating assay; Human urine; Content uniformity
   testing
ID SODIUM DODECYL-SULFATE; MICELLAR MOBILE-PHASE; HUMAN URINE;
   MASS-SPECTROMETRY; DIRECT-INJECTION; STATIONARY-PHASE; DOPING AGENTS;
   DIURETICS; EFFICIENCY; FORM
AB A study of the performance of reversed-phase chromatography with a programmable multiwavelength fluorimetric technique using either conventional hydro-organic or micellar eluent is established for the determination of xipamide (XIP) in the presence of its degradation product, 2,6-xylidine (XY). In conventional liquid chromatography (CLC), the analyses were carried out on a Promosil ODS 100 angstrom column (250mmx4.6mm i.d., 5m) using a mobile phase consisting of methanol/0.1M phosphate buffer (65: 35, v/v) at pH4.0. For micellar liquid chromatography (MLC), a short Spherisorb column (150mmx4.6mm i.d., 5m) was employed in conjunction with a greener mobile phase (pH5.0) containing 0.1M sodium dodecyl sulfate and 15% n-propanol. CLC proved to be superior to MLC in terms of sensitivity for the determination of the degradation product because it could detect trace amounts down to 10.0ng/ml of XY as a degradation product in XIP. However, MLC represents an eco-friendly approach for the simultaneous determination of XIP and XY. In addition, the opportunity for the direct introduction of biological matrices into the chromatographic system is one of the distinctive benefits of MLC. The proposed methods were applied for the determination of XIP in its tablets, human urine and content uniformity testing. The results of the proposed methods were statistically compared with those obtained using the comparison fluorimetric method, revealing no significant differences in the performance of the methods regarding accuracy and precision.
C1 [Tolba, M. M.; Belal, F.] Univ Mansoura, Dept Analyt Chem, Mansoura, Egypt.
RP Tolba, MM (reprint author), Mansoura Univ, Dept Analyt Chem, Fac Pharm, Mansoura 35516, Egypt.
EM manarmohd@mans.edu.eg
CR Abd El-Hay SS, 2016, ACTA PHARMACEUT, V66, P109, DOI 10.1515/acph-2016-0022
   Alvarez-Coque MCG, 1999, J CHROMATOGR B, V736, P1
   Torres-Lapasio J. R., 2000, CHROMATOGRAPHIA, V52, P185
   ARMSTRONG DW, 1981, ANAL CHEM, V53, P1662, DOI 10.1021/ac00234a026
   ARUNYANART M, 1984, ANAL CHEM, V56, P1557, DOI 10.1021/ac00273a005
   Badoud F, 2010, J CHROMATOGR A, V1217, P4109, DOI 10.1016/j.chroma.2009.11.001
   Belal F, 2014, LUMINESCENCE, V29, P559, DOI 10.1002/bio.2577
   BERTHOD A, 1988, J CHROMATOGR, V449, P349, DOI 10.1016/S0021-9673(00)94400-5
   Berthod A, 1997, J CHROMATOGR A, V780, P191, DOI 10.1016/S0021-9673(97)00195-7
   Berthod A., 2000, MICELLAR LIQUID CHRO
   BONETDOMINGO E, 1994, ANAL CHIM ACTA, V287, P201, DOI 10.1016/0003-2670(93)E0598-2
   Bonet-Domingo E., 1993, QUIM ANAL, V12, P167
   BORGERDING MF, 1988, ANAL CHEM, V60, P2520, DOI 10.1021/ac00173a018
   Deventer K, 2009, J CHROMATOGR A, V1216, P5819, DOI 10.1016/j.chroma.2009.06.003
   DORSEY JG, 1983, ANAL CHEM, V55, P924, DOI 10.1021/ac00257a024
   El-Din MS, 2013, LUMINESCENCE, V28, P332, DOI 10.1002/bio.2386
   El-Shaheny RN, 2015, OPEN CHEM, V13, P877, DOI 10.1515/chem-2015-0101
   El Guindi N. M., 2010, J DRUG RES, V31, P93
   HEMPELMANN FW, 1977, ARZNEIMITTEL-FORSCH, V27-2, P2140
   [Anonymous], 1996, ICH HARM TRIP GUID V
   Kim YJ, 2004, RAPID COMMUN MASS SP, V18, P2505, DOI 10.1002/rcm.1636
   KORD AS, 1992, ANAL CHEM, V64, P1894, DOI 10.1021/ac00041a026
   LEGORBURU MJ, 1993, BIOELECTROCH BIOENER, V32, P57, DOI 10.1016/0302-4598(93)80020-U
   Maher HM, 2012, J PHARMACEUT BIOMED, V61, P78, DOI 10.1016/j.jpba.2011.11.032
   McCormick TJ, 2000, ANAL CHEM, V72, P294, DOI 10.1021/ac9903398
   Miller J. N., 2005, STAT CHEMOMETRICS AN, p[39, 107, 256]
   Moffat A. C., 2004, CLARKS ANAL DRUGS PO, VII
   Noguera-Orti JF, 1999, ANAL CHIM ACTA, V387, P127, DOI 10.1016/S0003-2670(99)00045-8
   Omar MA, 2010, J FLUORESC, V20, P275, DOI 10.1007/s10895-009-0551-2
   Qin Y, 2003, J CHROMATOGR B, V794, P193, DOI 10.1016/S1570-0232(03)00422-7
   Rambla-Alegre M., 2012, CHROMATOGR RES INT, DOI [10.1155/2012/898520, DOI 10.1155/2012/898520]
   Rosado-Maria A, 2000, J CHROMATOGR B, V748, P415, DOI 10.1016/S0378-4347(00)00367-4
   Ruiz-Angel MJ, 2004, J CHROMATOGR A, V1022, P51, DOI 10.1016/j.chroma.2003.09.061
   Sadana G. S., 1986, INDIAN DRUGS, V23, P559
   SOBEL M, 1980, J CHROMATOGR, V183, P124, DOI 10.1016/S0378-4347(00)81410-3
   Sweetman SC, 2011, MARTINDALE COMPLETE
   THOMAS ORT, 1989, BIOTECHNOL APPL BIOC, V11, P318
   Tolba MM, 2014, LUMINESCENCE, V29, P738, DOI 10.1002/bio.2615
   Torres-Cartas S., 1995, ANAL CHIM ACTA, V302, P163
   Wagieh NE, 2010, DRUG TEST ANAL, V2, P113, DOI 10.1002/dta.92
   Walash MI, 2014, J FLUORESC, V24, P363, DOI 10.1007/s10895-013-1301-z
   Walash MI, 2014, LUMINESCENCE, V29, P914, DOI 10.1002/bio.2641
   [Anonymous], 2011, US PHARM 34 NAT FORM
NR 43
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1522-7235
EI 1522-7243
J9 LUMINESCENCE
JI Luminescence
PD JUN
PY 2017
VL 32
IS 4
BP 491
EP 501
DI 10.1002/bio.3203
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EU6KZ
UT WOS:000401144200003
PM 27562288
OA No
DA 2017-08-17
ER

PT J
AU Ibrahim, FA
   Elbrashy, AM
   Nasr, JJM
   El-Dien, MMB
AF Ibrahim, Fawzia A.
   Elbrashy, Amina M.
   Nasr, Jenny Jeehan M.
   El-Dien, Mostafa M. Badr
TI Application of acceptors to the spectrophotometric and
   spectrofluorimetric determination of vincamine and naftidrofuryl oxalate
   in their pharmaceutical preparations
SO LUMINESCENCE
LA English
DT Article
DE naftidrofuryl oxalate (NF); spectrofluorimetric; spectrophotometric;
   tablet; vincamine (VN)
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; VALIDATED HPLC METHOD; ULTRAVIOLET
   DETECTION; DEGRADATION-PRODUCT; ACID APPLICATIONS; PLASMA; FORMULATIONS;
   METABOLITE; TABLETS
AB Three different spectrophotometric and two spectrofluorimetric methods have been developed and validated for the determination of vincamine (VN) and naftidrofuryl oxalate (NF) in tablets. The spectrophotometric methods depend on charge transfer complex formation between each of VN and NF with 7,7,8,8-tetracyano-quinodimethane (TCNQ), 2,6-dichloroquinone-4-chloroimide (DCQ) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) at 843, 580 and 588nm, respectively. The spectrofluorimetric methods are based on the formation of charge transfer complex between each of the two drugs and TCNQ, with measurement of the fluorophore formed at 312/375 and 284/612nm, respectively, or with DDQ at 400/475 and 284/396nm, respectively. In the spectrophotometric measurements, Beer's law was obeyed at concentration ranges of 1.5-16, 10-180 and 12-140g/ml for VN with TCNQ, DCQ, and DDQ, respectively. For NF, the corresponding concentrations were 2-28, 5-75 and 25-150g/ml with TCNQ, DCQ, and DDQ, respectively. In the spectrofluorimetric measurements, the ranges for VN were 0.05-0.9 and 0.3-4g/ml with TCNQ and DDQ, respectively, whereas for NF the ranges were 0.05-0.85 and 0.5-8g/ml with TCNQ and DDQ, respectively. The different experimental parameters affecting the development and stability of the formed color or fluorophore were studied and optimized and the molar ratios of the complexes were calculated. The proposed methods were validated according to ICH guidelines and were successfully applied for the determination of VN and NF in their tablet dosage forms.
C1 [Ibrahim, Fawzia A.; Elbrashy, Amina M.; Nasr, Jenny Jeehan M.; El-Dien, Mostafa M. Badr] Univ Mansoura, Dept Pharmaceut Analyt Chem, Mansoura, Egypt.
RP Nasr, JJM (reprint author), Univ Mansoura, Dept Pharmaceut Analyt Chem, Fac Pharm, Mansoura 35516, Egypt.
EM nasrjj@yahoo.com
CR Abbas Samah S., 2012, Port. Electrochim. Acta, V30, P177, DOI 10.4152/pea.201203177
   Aboutabl E. A., 1998, PHARM ACTA HELV, V73, P193, DOI 10.1016/S0031-6865(98)00022-3
   AMATO A, 1983, J CHROMATOGR, V270, P387, DOI 10.1016/S0021-9673(01)96391-5
   Ayad M., 2013, ASIAN J PHARM CLIN, V6, P92
   Bayer J, 1972, Acta Pharm Hung, V42, P249
   Belal TS, 2009, J FOOD DRUG ANAL, V17, P415
   Beltagi AM, 2008, CHEM PHARM BULL, V56, P1651, DOI 10.1248/cpb.56.1651
   BRODIE RR, 1979, J CHROMATOGR, V164, P534, DOI 10.1016/S0378-4347(00)81559-5
   DALBO L, 1992, J CHROMATOGR-BIOMED, V573, P158, DOI 10.1016/0378-4347(92)80491-8
   Darwish I, 2005, ANN CHIM-ROME, V95, P345, DOI 10.1002/adic.200590039
   El-Saharty YSI, 2008, J AOAC INT, V91, P311
   El-Gindy A., 2006, B FAC PHARM CAIRO, V44, P279
   El-Sayed M. A., 2007, B FAC PHARM CAIRO, V45, P27
   Ganescu I, 2002, ACTA CHIM SLOV, V49, P181
   Ganescu I., 2001, FARM BUCHUREST, V49, P62
   Ibrahim FA, 2015, ANAL METHODS-UK, V7, P5954, DOI 10.1039/c3ay41819g
   International Conference on Harmonization (ICH), 2005, Q2 R1 VAL AN PROC TE
   Iven H, 1977, Arzneimittelforschung, V27, P1248
   MICHOTTE Y, 1985, J CHROMATOGR, V344, P367, DOI 10.1016/S0378-4347(00)82042-3
   Milliken J, 2010, SECRYPT 2010: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SECURITY AND CRYPTOGRAPHY, P37
   Mohamed GG, 2002, J PHARMACEUT BIOMED, V28, P1127, DOI 10.1016/S0731-7085(01)00718-X
   O'Neil M. J., 2013, MERCK INDEX
   PIETTA P, 1981, J CHROMATOGR, V210, P149, DOI 10.1016/S0021-9673(00)91192-0
   Raj G., 2016, ADV INORG CHEM, VII, P369
   Sabry SM, 2013, DRUG TEST ANAL, V5, P500, DOI 10.1002/dta.421
   Sabry Suzy M, 2009, Int J Biomed Sci, V5, P283
   Sabry SM, 2010, J FOOD DRUG ANAL, V18, P447
   Shehata MAM, 2005, J PHARMACEUT BIOMED, V38, P72, DOI 10.1016/j.jpba.2004.11.057
   Skoog D. A., 2007, PRINCIPLES INSTRUMEN, p[385, 399]
   SMYTH MR, 1986, ANALYST, V111, P851, DOI 10.1039/an9861100851
   Sriewoelan S., 1985, J ACTA PHARM INDONES, V10, P46
   Sweetman S. C., 2014, MARTINDALE EXTRA PHA
   Theiaa N. A., 2015, EUR CHEM B, V4, P372
   WAALER PJ, 1992, INT J PHARM, V87, P223, DOI 10.1016/0378-5173(92)90246-X
   Younes K. M., 2014, EUR J CHEM, V5, P272
   [Anonymous], 2009, BRIT PHARMACOPOEIA, V1
NR 36
TC 0
Z9 0
U1 6
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1522-7235
EI 1522-7243
J9 LUMINESCENCE
JI Luminescence
PD JUN
PY 2017
VL 32
IS 4
BP 555
EP 563
DI 10.1002/bio.3221
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EU6KZ
UT WOS:000401144200012
PM 27753197
OA No
DA 2017-08-17
ER

PT J
AU Hammad, A
   Yahia, S
   Laimon, W
   Hamed, SM
   Shouma, A
   Shalaby, NM
   Abdel-Hady, D
   Ghanem, R
   El-Farahaty, RM
   El-Bassiony, SR
   Hammad, EM
AF Hammad, A.
   Yahia, S.
   Laimon, W.
   Hamed, S. M.
   Shouma, A.
   Shalaby, N. M.
   Abdel-Hady, D.
   Ghanem, R.
   El-Farahaty, R. M.
   El-Bassiony, S. R.
   Hammad, E. M.
TI Angiotensin-converting enzyme insertion/deletion gene polymorphism in
   Egyptian children with systemic lupus erythematosus: a possible relation
   to proliferative nephritis
SO LUPUS
LA English
DT Article
DE Systemic lupus erythematosus; ACE I; D gene polymorphism; lupus
   nephritis; Egyptian children
ID ACE GENE; CHINESE POPULATION; REVISED CRITERIA; ASSOCIATION;
   CLASSIFICATION; SUSCEPTIBILITY; METAANALYSIS; NEPHROPATHY; COHORT; SLE
AB Introduction Angiotensin-converting enzyme (ACE) is crucial in the pathogenesis of systemic lupus erythematosus through angiotensin II which regulates vascular tone and endothelial functions.
   Objectives To study the frequency of ACE insertion/deletion (I/D) gene polymorphism in Egyptian children with systemic lupus erythematosus and its possible relation to the renal pathology in cases with lupus nephritis.
   Subjects and methods The frequency of ACE gene insertion/deletion polymorphism genotypes was determined in 78 Egyptian children with systemic lupus erythematosus and compared to a matched group of 140 healthy controls using polymerase chain reaction.
   Results The DD genotype of the ACE gene was higher in systemic lupus erythematosus patients when compared to controls (P<0.0001; odds ratio (OR) 2.4; 95% confidence interval (CI) 1.7-3.3) and the D allele was more frequent than the I allele in systemic lupus erythematosus patients in comparison to controls (P<0.0001; OR=2.2; 95% CI=(1.6-3.1). In the lupus nephritis group, the DD genotype was significantly higher in those with proliferative lupus nephritis when compared to those with non-proliferative lupus nephritis (P=0.02; OR=1.45; 95% CI=1.4-1.6). Also, patients with proliferative lupus nephritis showed a higher frequency of the D allele (P<0.001; OR=1.98; 95% CI=1.3-2.9).
   Conclusion The D allele and DD genotype of the ACE gene appear to be a risk factor for the susceptibility of systemic lupus erythematosus and occurrence of proliferative nephritis in Egyptian children.
C1 [Hammad, A.] Mansoura Univ, Dept Pediat, Pediat Nephrol Unit, Fac Med, Mansoura, Egypt.
   [Yahia, S.; Abdel-Hady, D.] Mansoura Univ, Dept Pediat, Pediat Genet Unit, Fac Med, Mansoura, Egypt.
   [Laimon, W.; Shalaby, N. M.] Mansoura Univ, Dept Pediat, Pediat Endocrinol Unit, Fac Med, Mansoura, Egypt.
   [Hamed, S. M.] Mansoura Univ, Urol & Nephrol Ctr, Mansoura, Egypt.
   [Shouma, A.] Mansoura Univ, Dept Pediat, Fac Med, Mansoura, Egypt.
   [Ghanem, R.] Delta Univ Sci & Technol, Fac Dent & Oral Med, Gamasa, Egypt.
   [El-Farahaty, R. M.] Mansoura Univ, Dept Clin Pathol, Fac Med, Mansoura, Egypt.
   [El-Bassiony, S. R.; Hammad, E. M.] Mansoura Univ, Dept Rheumatol & Rehabil, Fac Med, Mansoura, Egypt.
RP Laimon, W (reprint author), Mansoura Univ, Childrens Hosp, Fac Med, Gomhoria St, Mansoura 35516, Egypt.
EM wafaalaimon@yahoo.com
CR Abbas D, 2012, LUPUS, V21, P103, DOI 10.1177/0961203311418268
   Akai Y, 1999, CLIN NEPHROL, V51, P141
   Al-Awadhi AM, 2007, CLIN EXP RHEUMATOL, V25, P437
   Croca SC, 2011, RHEUMATOLOGY, V50, P1424, DOI 10.1093/rheumatology/ker101
   Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767
   Gong AM, 2012, MOL BIOL REP, V39, P9485, DOI 10.1007/s11033-012-1813-7
   Guan T, 1997, Zhonghua Nei Ke Za Zhi, V36, P461
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Hussain N, 2010, AFR J BIOTECHNOL, V9, P8134
   Kaufman KM, 2001, MOL CELL ENDOCRINOL, V177, P81, DOI 10.1016/S0303-7207(01)00424-5
   Kim CH, 2001, METABOLISM, V50, P473, DOI 10.1053/meta.2001.21022
   Kranzhofer R, 1999, ARTERIOSCL THROM VAS, V19, P1623
   Lee YH, 2013, J RENIN-ANGIO-ALDO S, V14, P248, DOI 10.1177/1470320312459979
   Li X, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-94
   Lonn EM, 2001, CIRCULATION, V103, P919
   MATTEI MG, 1989, CYTOGENET CELL GENET, V51, P1041
   Mohan C, 2015, NAT REV NEPHROL, V11, P329, DOI 10.1038/nrneph.2015.33
   Molad Y, 2000, SEMIN ARTHRITIS RHEU, V30, P132, DOI 10.1053/sarh.2000.8365
   Nagata Michio, 2004, Nihon Jinzo Gakkai Shi, V46, P383
   Pullmann R, 1999, CLIN EXP RHEUMATOL, V17, P593
   Rabbani Malik Anas, 2008, Saudi J Kidney Dis Transpl, V19, P761
   RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a
   Sato H, 1998, LUPUS, V7, P530, DOI 10.1191/096120398678920622
   Settin A, 2009, J RENIN-ANGIO-ALDO S, V10, P96, DOI 10.1177/1470320309105198
   Sprovieri SRS, 2005, LUPUS, V14, P356, DOI 10.1191/0961203305lu2093oa
   TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101
   Tassiulas IO, 1998, CLIN NEPHROL, V50, P8
   Uhm WS, 2002, LUPUS, V11, P227, DOI 10.1191/0961203302lu174oa
   Xu JH, 2007, J RHEUMATOL, V34, P2408
   Zhou TB, 2012, J RHEUMATOL, V39, P686, DOI 10.3899/jrheum.110863
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0961-2033
EI 1477-0962
J9 LUPUS
JI Lupus
PD JUN
PY 2017
VL 26
IS 7
BP 762
EP 767
DI 10.1177/0961203316682096
PG 6
WC Rheumatology
SC Rheumatology
GA EU1IJ
UT WOS:000400770700012
PM 27956582
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Haleem, FM
   Rizk, MS
AF Abdel-Haleem, Fatehy M.
   Rizk, Mahmoud S.
TI Highly selective thiocyanate optochemical sensor based on
   manganese(III)-salophen ionophore
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Optochemical sensors; Anion sensors; Thiocyanate optode;
   Mn(III)-salophen ionophores; pH chromoionophore
ID SPECTROPHOTOMETRIC DETERMINATION; OPTICAL SENSORS; BULK OPTODES; ION;
   SALIVA; ELECTRODES; COMPLEXES; CYANIDE; CARRIER; URINE
AB We report on the development of optochemical sensor based on Mn(III)-salophen ionophore. The sensor was prepared by embedding the ionophore in a plasticized poly (vinyl chloride) impregnated with the chromoionophore ETH7075. Optical response to thiocyanate occurred due to thiocyanate extraction into the polymer via formation of strong complex with the ionophore and simultaneous protonation of the indicator dye yielding the optical response at 545 nm. The developed optochemical sensor exhibited high selectivity for thiocyanate over other anions including the most lipophilic species such as salicylate and perchlorate. For instance, the optical selectivity coefficients, logK(SCN,)(opt)anion, were as follow: ClO4- = 5.8; Sal(-) = -4.0; NO3- -6. Further, the thiocyanate optical selectivity obtained using the present optochemical sensor was greatly enhanced in comparison with that obtained using an anion-exchanger based sensor. Also, the optimized optochemical sensor exhibited micro-molar detection limit with 2 min response time at pH 4.5 using acetate buffer. The reversibility of the optimized sensor was poor due to strong ligation of the thiocyanate to the central Metal ion, log K = 14.1, which can be overcome by soaking the optode in sodium hydroxide followed by soaking in buffer solution. The developed sensor was utilized successfully for the determination of thiocyanate in human saliva and in spiked saliva samples. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Abdel-Haleem, Fatehy M.; Rizk, Mahmoud S.] Cairo Univ, Fac Sci, Chem Dept, Giza, Egypt.
RP Abdel-Haleem, FM (reprint author), Cairo Univ, Fac Sci, Chem Dept, Giza, Egypt.
EM fatehy@sci.cu.edu.eg
FU Cairo University
FX The author thanks Cairo University for the financial support of this
   work.
CR Abbaspour A, 2002, TALANTA, V57, P859, DOI 10.1016/S0039-9140(02)00129-7
   Abdel-Haleem FM, 2016, SENSOR ACTUAT B-CHEM, V233, P257, DOI 10.1016/j.snb.2016.04.088
   Abdel-Haleem F.M., 2016, ELECTROANAL IN PRESS
   Abdel-Haleem F. M., 2015, ELECTROANAL, V27, P1
   Ardakani M. Mazloum, 2002, Analytica Chimica Acta, V462, P25
   Badr IHA, 2001, ANAL LETT, V34, P2019, DOI 10.1081/AL-100106836
   Bakker E, 2006, ANAL CHEM, V78, P3965, DOI 10.1021/ac060637m
   Bakker E, 1997, CHEM REV, V97, P3083, DOI 10.1021/cr940394a
   BROWN PD, 1991, J AGR FOOD CHEM, V39, P1226, DOI 10.1021/jf00007a006
   Buhlmann P, 1998, CHEM REV, V98, P1593, DOI 10.1021/cr970113+
   Dubach JM, 2007, J AM CHEM SOC, V129, P8418, DOI 10.1021/ja072522I
   Ershad S, 2009, ANAL SCI, V25, P665
   Gong BL, 1999, ANAL CHIM ACTA, V394, P171, DOI 10.1016/S0003-2670(99)00295-0
   HUSER M, 1990, HELV CHIM ACTA, V73, P1481, DOI 10.1002/hlca.19900730528
   Khorasani JH, 2002, SENSOR ACTUAT B-CHEM, V87, P448, DOI 10.1016/S0925-4005(02)00294-0
   Lahti M, 1999, J CHEM EDUC, V76, P1281
   LERCHI M, 1992, ANAL CHEM, V64, P1534, DOI 10.1021/ac00038a007
   Navratil T, 2003, CHEM ANAL-WARSAW, V48, P127
   OLEA F, 1992, J ANAL TOXICOL, V16, P258
   Olea Serrano M R, 1988, J Anal Toxicol, V12, P307
   Potter J, 2001, FOOD CHEM TOXICOL, V39, P141, DOI 10.1016/S0278-6915(00)00126-5
   Shortreed MR, 1996, SENSOR ACTUAT B-CHEM, V35, P217, DOI 10.1016/S0925-4005(97)80058-5
   Garcia MS, 2006, SENSORS-BASEL, V6, P1224
   SWEILEH JA, 1989, ANAL CHIM ACTA, V220, P65, DOI 10.1016/S0003-2670(00)80250-0
   Torano JS, 2003, ANALYST, V128, P838, DOI 10.1039/b304051h
   van Staden JF, 2000, ANAL CHIM ACTA, V403, P279, DOI 10.1016/S0003-2670(99)00651-0
   WANG EJ, 1993, ANAL CHIM ACTA, V283, P673, DOI 10.1016/0003-2670(93)85281-N
   Yuan R, 2003, ELECTROCHEM COMMUN, V5, P717, DOI 10.1016/S1388-2481(03)00171-1
NR 28
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2017
VL 75
BP 682
EP 687
DI 10.1016/j.msec.2017.02.096
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA EU0SE
UT WOS:000400720800078
PM 28415515
OA No
DA 2017-08-17
ER

PT J
AU Khashaba, PY
   Ali, HRH
   El-Wekil, MM
AF Khashaba, Pakinaz Y.
   Ali, Hassan Refat H.
   El-Wekil, Mohamed M.
TI Simultaneous voltammetric analysis of anti-ulcer and D-2-antagonist
   agents in binary mixture using redox sensor and their determination in
   human serum
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Pantoprazole sodium; Domperidone; Pencil graphite electrode;
   Poly(eriochrome black T)-synthetic mixtures human serum
ID GLASSY-CARBON ELECTRODE; PHARMACEUTICAL FORMULATIONS; PANTOPRAZOLE;
   DOMPERIDONE; FILMS; NADH
AB Pencil graphite electrode was successfully modified with a thin film of poly (eriochrome black T) and applied for the sensitive and selective voltammetric simultaneous determination of pantoprazole sodium and domperidone in a binary mixture. The preparation and basic electrochemical behavior of poly (eriochrome black T) film on the Pencil graphite electrode were investigated. The modified electrode has exhibited very high electro-catalytic activity towards the cited mixture. The anodic peaks of the both species were well defined with enhanced oxidation peak currents. Under the optimum conditions, the linearity ranges were 0.4-55 x 10(-7) M and 0.1-34 x 10(-7) M for pantoprazole sodium and domperidone, respectively with detection limits of 0.12 x 10(-7) M and 0.04 x 10(-7) M for pantoprazole sodium and domperidone, respectively. The proposed sensor has been successfully applied in the analysis of pantoprazole sodium and domperidone in synthetic binary mixtures and human serum. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Khashaba, Pakinaz Y.; Ali, Hassan Refat H.; El-Wekil, Mohamed M.] Assiut Univ, Dept Pharmaceut Analyt Chem, Fac Pharm, Assiut, Egypt.
   [Khashaba, Pakinaz Y.] Deraya Univ, Fac Pharm, Dept Pharmaceut Analyt Chem, El Minya, Egypt.
RP El-Wekil, MM (reprint author), Assiut Univ, Dept Pharmaceut Analyt Chem, Fac Pharm, Assiut, Egypt.
EM mohamed.mohamoud@ymail.com
CR Bard A. J., 1980, ELECTROCHEMICAL METH
   Barone JA, 1999, ANN PHARMACOTHER, V33, P429, DOI 10.1345/aph.18003
   Battu P. R., 2009, INT J CHEM TECH RES, V2, P275
   BEDIOUI F, 1995, ACCOUNTS CHEM RES, V28, P30, DOI 10.1021/ar00049a005
   Bhavesh H. P., 2008, J AOAC INT, V90, P142
   BROWN AP, 1977, ANAL CHEM, V49, P1589, DOI 10.1021/ac50019a033
   El-Shahawi MS, 2007, ANAL BIOANAL CHEM, V387, P719, DOI 10.1007/s00216-006-0906-3
   El-Kommos M. E., 2013, J PLAN CHROMATOGR MO, V27, P217
   Elsied AMH, 2015, INT J ELECTROCHEM SC, V10, P7147
   Erk N, 2003, ANAL BIOCHEM, V323, P48, DOI 10.1016/j.ab.2003.08.023
   Gosavi S., 2007, JPC-J PLANAR CHROMAT, V19, P302
   Gupta P, 2015, ELECTROCHIM ACTA, V151, P1, DOI 10.1016/j.electacta.2014.11.005
   Kakde R. B., 2009, INT J PHARM RES, V1, P386
   Karyakin AA, 1995, J ELECTROANAL CHEM, V399, P179, DOI 10.1016/0022-0728(95)04300-4
   Khashaba P. Y., 2016, ELECTROANALYSIS
   Kumar KG, 2010, J APPL ELECTROCHEM, V40, P65, DOI 10.1007/s10800-009-9975-2
   Kumar P. R., 2006, E-J CHEM, V3, P142
   Kumar SA, 2008, SENSORS-BASEL, V8, P739, DOI 10.3390/s8020739
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Liu X, 2012, BIOELECTROCHEMISTRY, V86, P38, DOI 10.1016/j.bioelechem.2012.01.008
   Mazloum-Ardakani M, 2008, SENSOR ACTUAT B-CHEM, V132, P52, DOI 10.1016/j.snb.2008.01.012
   Medany S.S., 2012, J ADVERTISING RES, V3, P261
   Nambiar S, 2011, BIOSENS BIOELECTRON, V26, P1825, DOI 10.1016/j.bios.2010.09.046
   Nigovic B, 2013, ELECTROCHIM ACTA, V109, P818, DOI 10.1016/j.electacta.2013.07.173
   Noronha BV, 2014, MAT SCI ENG C-MATER, V43, P517, DOI 10.1016/j.msec.2014.07.060
   Park DH, 1999, APPL ENVIRON MICROB, V65, P2912
   Patrick G. L., 2009, INTRO MED CHEM, V25, P653
   Periasamy AP, 2011, BIOSENS BIOELECTRON, V29, P151, DOI 10.1016/j.bios.2011.08.010
   Podlovchenko BI, 2002, RUSS CHEM REV, V71, P837, DOI DOI 10.1070/RC2002V071N10ABEH000672
   Radi A., 2003, Farmaco (Lausanne), V58, P535, DOI 10.1016/S0014-827X(03)00082-X
   Sun W, 2012, ANAL CHIM ACTA, V751, P59, DOI 10.1016/j.aca.2012.09.006
   Tarek W., 2005, FARMACO, V60, P830
   Thanikachalam S, 2008, CHROMATOGRAPHIA, V67, P41, DOI 10.1365/s10337-007-0452-y
NR 33
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2017
VL 75
BP 733
EP 741
DI 10.1016/j.msec.2017.02.092
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EU0SE
UT WOS:000400720800084
PM 28415523
OA No
DA 2017-08-17
ER

PT J
AU Yarkandi, NH
   El-Ghamry, HA
   Gaber, M
AF Yarkandi, Naeema H.
   El-Ghamry, Hoda A.
   Gaber, Mohamed
TI Synthesis, spectroscopic and DNA binding ability of Co-II, Ni-II, Cu-II
   and Zn-II complexes of Schiff base ligand
   (E)-1-(((1H-benzo[d]imidazol-2-yl) methylimino) methyl) naphthalen-2-ol.
   X-ray crystal structure determination of cobalt (II) complex
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE 2-(Aminomethyl)benzimidazole; Schiff base; DNA binding; Single crystal
ID TRANSITION-METAL-COMPLEXES; PENCIL-GRAPHITE ELECTRODE; NITROGEN-DONOR
   LIGANDS; CU(II) COMPLEXES; COPPER(II) COMPLEXES; ANTITUMOR-ACTIVITY;
   IN-VITRO; BIOLOGICAL-PROPERTIES; CORROSION-INHIBITORS; ANTIOXIDANT
   ACTIVITY
AB A novel Schiff base ligand, (E)-1-(((1H-benzo[d]imidazol-2-yl)methylimino)methyl)naphthalen-2-ol (HL), has been designed and synthesized in addition to its metal chelates [Co(L)2(])center dot I2H(2)O, [Ni(L)Cl center dot(H2O)(2)]center dot 5H(2)O, [Cu(L)CI] and [Zn(L)(CH3COO)]. The structures of the isolated compounds have been confirmed and identified by means of different spectral and physicochemical techniques including CHN analysis, H-1 &(CNMR)-C-13, mass spectral analysis, molar conductivity measurement UV Vis, infrared, magnetic moment in addition to TGA technique. The infrared spectral results ascertained that the ligand acts as monobasic tridentate binding to the metal centers via deprotonated hydroxyl oxygen, azomethine and imidazole nitrogen atoms. The UV Vis, magnetic susceptibility and molar conductivity data implied octahedral geometry for Co(II) & Ni(II) complexes, tetrahedral for Zn(II) complex and square planar for Cu(II) complex. X-ray structural analysis of Co(II) complex 1 has been reported and discussed. Moreover, the type of interaction between the ligand & its complexes towards salmon sperm DNA (SS-DNA) has been examined by the measurement of absorption spectra and viscosity which confirmed that the ligand and its complexes interact with DNA via intercalation interaction as concluded from the values of binding constants (K-b). (C) 2017 Elsevier B.V. All rights reserved.
C1 [Yarkandi, Naeema H.; El-Ghamry, Hoda A.] Umm Al Qura Univ, Chem Dept, Fac Appl Sci, Mecca, Saudi Arabia.
   [El-Ghamry, Hoda A.; Gaber, Mohamed] Tanta Univ, Fac Sci, Chem Dept, Tanta, Egypt.
RP El-Ghamry, HA (reprint author), Umm Al Qura Univ, Chem Dept, Fac Appl Sci, Mecca, Saudi Arabia.
EM helghamrymo@yahoo.com
CR Alaghaz ANMA, 2013, J MOL STRUCT, V1035, P83, DOI 10.1016/j.molstruc.2012.09.032
   Ali OAM, 2014, SPECTROCHIM ACTA A, V132, P52, DOI 10.1016/j.saa.2014.03.127
   ALLEN FH, 1987, J CHEM SOC PERK T 2, pS1, DOI 10.1039/p298700000s1
   Amer S, 2013, J MOL STRUCT, V1049, P326, DOI 10.1016/j.molstruc.2013.06.059
   Behpour M, 2011, CORROS SCI, V53, P3380, DOI 10.1016/j.corsci.2011.06.017
   Behpour M, 2009, CORROS SCI, V51, P1073, DOI 10.1016/j.corsci.2009.02.011
   BIDDLE BN, 1991, APPL ORGANOMET CHEM, V5, P439, DOI 10.1002/aoc.590050512
   Busto N, 2013, INORG CHEM, V52, P9962, DOI 10.1021/ic401197a
   Chandra S, 2007, SPECTROCHIM ACTA A, V66, P1347, DOI 10.1016/j.saa.2006.04.047
   Chaviara AT, 2004, J INORG BIOCHEM, V98, P1271, DOI 10.1016/j.jinorgbio.2004.05.010
   CILLER JA, 1986, J HETEROCYCLIC CHEM, V23, P1583
   Drozdzak R, 2005, COORDIN CHEM REV, V249, P3055, DOI 10.1016/j.ccr.2005.05.003
   Ei-Sherif AA, 2011, SPECTROCHIM ACTA A, V79, P1803, DOI 10.1016/j.saa.2011.05.062
   El-Baradie K, 2014, SPECTROCHIM ACTA A, V121, P180, DOI 10.1016/j.saa.2013.09.070
   El-Baradie KY, 2015, APPL ORGANOMET CHEM, V29, P117, DOI 10.1002/aoc.3255
   El-Sherif AA, 2006, J SOLUTION CHEM, V35, P1287, DOI 10.1007/s10953-006-9062-9
   El-Sonbati AZ, 2016, J MOL LIQ, V215, P711, DOI 10.1016/j.molliq.2015.12.010
   El-Wakiel N, 2011, J MOL STRUCT, V1001, P1, DOI 10.1016/j.molstruc.2011.04.021
   Etaiw SEH, 2011, SPECTROCHIM ACTA A, V79, P1331, DOI 10.1016/j.saa.2011.04.064
   Gaber M, 2015, SPECTROCHIM ACTA A, V137, P919, DOI 10.1016/j.saa.2014.09.015
   Ghosh K, 2011, INORG CHEM COMMUN, V14, P489, DOI 10.1016/j.inoche.2011.01.008
   Hanif M, 2013, SPECTROCHIM ACTA A, V104, P468, DOI 10.1016/j.saa.2012.11.077
   Hirohama T, 2005, J INORG BIOCHEM, V99, P1205, DOI 10.1016/j.jinorgbio.2005.02.020
   HOLMAN TR, 1992, INORG CHEM, V31, P937, DOI 10.1021/ic00032a002
   Huo YP, 2015, J MOL STRUCT, V1083, P144, DOI 10.1016/j.molstruc.2014.11.029
   Issa RM, 2012, CHINESE J CHEM, V30, P547, DOI 10.1002/cjoc.201280004
   Jogi P., 2012, J CHEM PHARM RES, V4, P1389
   Jogi P, 2011, E-J CHEM, V8, P1662
   KABANOS TA, 1992, J CHEM SOC DALTON, P2729, DOI 10.1039/dt9920002729
   Kaim W., 1996, BIOINORGANIC CHEM IN
   Kakanejadifard A, 2014, SPECTROCHIM ACTA A, V132, P700, DOI 10.1016/j.saa.2014.04.181
   Kakanejadifard A, 2013, SPECTROCHIM ACTA A, V114, P404, DOI 10.1016/j.saa.2013.05.027
   Karastogianni S, 2013, J INORG BIOCHEM, V118, P48, DOI 10.1016/j.jinorgbio.2012.09.015
   Khan MI, 2013, INORG CHEM COMMUN, V35, P104, DOI 10.1016/j.inoche.2013.06.014
   Khedr AM, 2012, J COORD CHEM, V65, P1672, DOI 10.1080/00958972.2012.678338
   Kiran T, 2015, INORG CHIM ACTA, V433, P26, DOI 10.1016/j.ica.2015.04.033
   Kizilcikli I, 2004, SYN REACT INORG MET, V34, P653, DOI 10.1081/SIM-120035948
   KRATZ F, 1992, POLYHEDRON, V11, P487, DOI 10.1016/S0277-5387(00)83206-4
   Durmaz B., 1997, DRUG RES, V47, P667
   Kulkarni NV, 2011, J MOL STRUCT, V1006, P580, DOI 10.1016/j.molstruc.2011.10.008
   Kumar DN, 2006, SPECTROCHIM ACTA A, V64, P141, DOI 10.1016/j.saa.2005.07.008
   Kumar R, 2015, SPECTROCHIM ACTA A, V136, P818, DOI 10.1016/j.saa.2014.09.099
   Kumar R, 2014, RSC ADV, V4, P33190, DOI 10.1039/c4ra03651d
   Kustu C, 2007, CORROS SCI, V49, P2800, DOI 10.1016/j.corsci.2007.02.002
   Lalezari JP, 2002, ANTIMICROB AGENTS CH, V46, P2969, DOI 10.1128/AAC.46.9.2969-2976.2002
   Lever A.B.P., 1984, INORGANIC ELECT SPEC
   Li FH, 2006, J INORG BIOCHEM, V100, P36, DOI 10.1016/j.jinorgbio.2005.09.012
   Li GY, 2013, J INORG BIOCHEM, V119, P43, DOI 10.1016/j.jinorgbio.2012.09.019
   Li TR, 2008, EUR J MED CHEM, V43, P1688, DOI 10.1016/j.ejmech.2007.10.006
   Lueckheide M, 2013, POLYHEDRON, V58, P79, DOI 10.1016/j.poly.2012.08.003
   Maurya MR, 2007, J MOL CATAL A-CHEM, V263, P227, DOI 10.1016/j.molcata.2006.08.084
   Mohanraj M, 2016, MAT SCI ENG C-MATER, V69, P1297, DOI 10.1016/j.msec.2016.08.043
   Murray R. K., 1988, HARPERS BIOCH, V2
   MYLONAS S, 1988, J INORG BIOCHEM, V34, P265, DOI 10.1016/0162-0134(88)83004-6
   Nakamoto K., 1986, INFRARED SPECTRA INO
   Patel MN, 2013, SPECTROCHIM ACTA A, V104, P48, DOI 10.1016/j.saa.2012.11.045
   Pathan AH, 2012, POLYHEDRON, V34, P149, DOI 10.1016/j.poly.2011.12.033
   Paulpandiyan R, 2016, J MOL STRUCT, V1125, P374, DOI 10.1016/j.molstruc.2016.07.003
   Pragathi J., 2012, J CHEM PHARM RES, V4, P1389
   PYLE AM, 1989, J AM CHEM SOC, V111, P3051, DOI 10.1021/ja00190a046
   Reddy PR, 2011, J INORG BIOCHEM, V105, P1603, DOI 10.1016/j.jinorgbio.2011.08.022
   Rehman Z., 2009, POLYHEDRON, V28, P3439
   Roy S, 2010, POLYHEDRON, V29, P2787, DOI 10.1016/j.poly.2010.06.028
   Sanchez-Moreno MJ, 2004, INORG CHEM, V43, P1311, DOI 10.1021/ic030175k
   Sherif OE, 2014, SPECTROCHIM ACTA A, V117, P519, DOI 10.1016/j.saa.2013.08.037
   Sierra-Zenteno A., 2002, REV SOC QUIM MEX, V46, P125
   Skalitzky DJ, 2003, J MED CHEM, V46, P210, DOI 10.1021/jm0255769
   Song WJ, 2014, SPECTROCHIM ACTA A, V121, P70, DOI 10.1016/j.saa.2013.09.142
   Srishailam A, 2014, J PHOTOCH PHOTOBIO B, V141, P47, DOI 10.1016/j.jphotobiol.2014.09.003
   Tajik S, 2015, TALANTA, V134, P60, DOI 10.1016/j.talanta.2014.10.063
   Tajik S, 2014, J ELECTROANAL CHEM, V720, P134, DOI [10.1016/j.jelechem.2014.03.039, 10.1016/j.jelchem.2014.03.039]
   Tian J. L., 2007, NAT REV CANCER, V7, P573
   Vinuelas-Zahinos E, 2008, POLYHEDRON, V27, P879, DOI 10.1016/j.poly.2007.11.009
   Vyas KM, 2011, SPECTROCHIM ACTA A, V84, P256, DOI 10.1016/j.saa.2011.09.039
   Wang BD, 2007, J INORG BIOCHEM, V101, P1492, DOI 10.1016/j.jinorgbio.2007.04.007
   WARING MJ, 1965, J MOL BIOL, V13, P269
   Xue F, 2012, J INORG BIOCHEM, V115, P78, DOI 10.1016/j.jinorgbio.2012.05.018
   Yang DD, 2017, J MOL STRUCT, V1128, P493, DOI 10.1016/j.molstruc.2016.08.037
   Zhang HD, 2005, J MOL CATAL A-CHEM, V238, P175, DOI 10.1016/j.molcata.2005.05.024
   Zuber G, 1998, J AM CHEM SOC, V120, P9368, DOI 10.1021/ja981937r
NR 80
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2017
VL 75
BP 1059
EP 1067
DI 10.1016/j.msec.2017.02.171
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA EU0SE
UT WOS:000400720800122
PM 28415390
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Salam, GMH
   Abdel-Hamid, MS
   Mohammad, SA
   Abdel-Ghafar, SF
   Soliman, DR
   EL-Bassyouni, HT
   Effat, L
   Zaki, MS
AF Abdel-Salam, Ghada M. H.
   Abdel-Hamid, Mohamed S.
   Mohammad, Shaimaa A.
   Abdel-Ghafar, Sherif F.
   Soliman, Doaa R.
   EL-Bassyouni, Hala T.
   Effat, Laila
   Zaki, Maha S.
TI Aicardi-GoutiSres syndrome: unusual neuro-radiological manifestations
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE Aicardi-Goutieres syndrome; Unusual; Neuro-radiologic; Dysmorphic
   ventricles; Unilateral cerebellar hypoplasia; Porencephalic cysts;
   RNASEH2B; Chilblains
ID CEREBROSPINAL-FLUID LYMPHOCYTOSIS; GOUTIERES-SYNDROME; BASAL GANGLIA;
   MUTATIONS; RNASEH2C; SAMHD1; CALCIFICATIONS; ENCEPHALOPATHY; INFANCY;
   TREX1
AB Aicardi-GoutiSres syndrome (AGS) is one of the expanding group of inherited congenital infection like syndromes. Here, we describe the detailed clinical and imaging findings of two sibs with AGS. Each shows scattered periventricular intracranial calcifications, severe global delay, seizures, microcephaly and spasticity. Interestingly, chilblains were observed in the two sisters as well as their parents and a paternal uncle. The brain MRI of the older sister showed marked ventricular dilatation as a result of unusual associated porencephalic cysts. Unexpectedly, unilateral cerebellar hypoplasia was also noted. In comparison, her younger sister displayed the classic atrophic changes and white matter loss of AGS. The diagnosis of AGS was confirmed by sequence analysis, which identified a previously reported homozygous RNASEH2B mutation, c.554 T > G (p.V185G). Parents were heterozygous for the same mutation. Further molecular analysis excluded mutations in potentially related manifestations of COL4A1 gene. This is the first report of chilblains associated with heterozygous RNASEH2B mutation. Further, the brain imaging findings appear particularly interesting, which until now has not been reported in any AGS patient. We discuss the possible reasons for this unusual presentation.
C1 [Abdel-Salam, Ghada M. H.; EL-Bassyouni, Hala T.; Zaki, Maha S.] Natl Res Ctr, Human Genet & Genome Res Div, Clin Genet Dept, Cairo, Egypt.
   [Abdel-Hamid, Mohamed S.; Abdel-Ghafar, Sherif F.; Effat, Laila] Natl Res Ctr, Human Genet & Genome Res Div, Med Mol Genet Dept, Cairo, Egypt.
   [Mohammad, Shaimaa A.] Ain Shams Univ, Dept Radiodiag, Fac Med, Cairo, Egypt.
   [Soliman, Doaa R.] Benha Univ, Dept Pediat, Fac Med, Banha, Egypt.
RP Abdel-Salam, GMH (reprint author), Natl Res Ctr, Human Genet & Genome Res Div, Clin Genet Dept, Cairo, Egypt.
EM ghada.abdelsalam@yahoo.com
FU local research project - National Research Centre [P101301]
FX This study was partially funded by a local research project sponsored by
   National Research Centre (Grant number: P101301).
CR Abdel-Salam GMH, 2010, NEUROPEDIATRICS, V41, P18, DOI 10.1055/s-0030-1255059
   AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109
   Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842
   Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887
   La Piana R, 2016, NEUROLOGY, V86, P28, DOI 10.1212/WNL.0000000000002228
   Lanzi Giovanni, 2002, Eur J Paediatr Neurol, V6 Suppl A, pA9, DOI 10.1053/ejpn.2002.0568
   Livingston JH, 2016, NEUROPEDIATRICS, V47, P355, DOI 10.1055/s-0036-1592307
   Livingston JH, 2013, DEV MED CHILD NEUROL, V55, P46, DOI 10.1111/j.1469-8749.2012.04437.x
   Malinger G, 2006, EUR J PAEDIATR NEURO, V10, P93, DOI 10.1016/j.ejpn.2006.02.002
   Olivieri I, 2013, LUPUS, V22, P1064, DOI 10.1177/0961203313498800
   Ostergaard JR, 1999, NEUROPEDIATRICS, V30, P38, DOI 10.1055/s-2007-973455
   Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373
   Rossler L, 2012, PEDIATR RADIOL, V42, P932, DOI 10.1007/s00247-012-2384-4
   TOLMIE JL, 1995, J MED GENET, V32, P881, DOI 10.1136/jmg.32.11.881
   Uggetti C, 2009, AM J NEURORADIOL, V30, P1971, DOI 10.3174/ajnr.A1694
   Vermeulen RJ, 2011, NEUROPEDIATRICS, V42, P1, DOI 10.1055/s-0031-1275343
   Vogt J, 2013, AM J MED GENET A, V161A, P338, DOI 10.1002/ajmg.a.35712
   Xin BZ, 2011, P NATL ACAD SCI USA, V108, P5372, DOI 10.1073/pnas.1014265108
NR 18
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
EI 1573-7365
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD JUN
PY 2017
VL 32
IS 3
BP 679
EP 683
DI 10.1007/s11011-017-9993-4
PG 5
WC Endocrinology & Metabolism; Neurosciences
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA EU1HP
UT WOS:000400767700004
PM 28332073
OA No
DA 2017-08-17
ER

PT J
AU Aoyama, Y
   Sasai, H
   Abdelkreem, E
   Otsuka, H
   Nakama, M
   Kumar, S
   Aroor, S
   Shukla, A
   Fukao, T
AF Aoyama, Yuka
   Sasai, Hideo
   Abdelkreem, Elsayed
   Otsuka, Hiroki
   Nakama, Mina
   Kumar, Sandeep
   Aroor, Shrikiran
   Shukla, Anju
   Fukao, Toshiyuki
TI A novel mutation (c.121-13T > A) in the polypyrimidine tract of the
   splice acceptor site of intron 2 causes exon 3 skipping in mitochondrial
   acetoacetyl-CoA thiolase gene
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE mitochondrial acetoacetyl-CoA thiolase deficiency; T2 deficiency; splice
   acceptor site; polypyrimidine tract; aberrant splicing; exon skipping
ID KETONE-BODY UTILIZATION; COENZYME-A THIOLASE; IN-SILICO TOOLS;
   3-KETOTHIOLASE DEFICIENCY; MISSENSE MUTATIONS; BETA-KETOTHIOLASE;
   MOLECULAR-BASIS; IDENTIFICATION; SUBSTITUTION; EXPRESSION
AB Mitochondrial acetoacetyl-CoA thiolase (T2) (gene symbol: ACAT1) deficiency is an autosomal recessive disorder affecting isoleucine catabolism and ketone body utilization. In this study, mutational analysis of an Indian T2-deficient patient revealed a homozygous mutation (c.121-13T>A) located at the polypyrimidine tract of the splice acceptor site of intron 2, and exon 3 skipping was identified by cDNA analysis using cycloheximide. We made three mutant constructs (c.121-13T > A, T > C, and T > G substitutions) followed by making a wild-type minigene construct that included an ACAT1 segment from exon 2 to 4 for a splicing experiment. The minigene splicing experiment demonstrated that exon 3 skipping was induced not only by c. 121-13T > A mutation, but also by the other two substitutions. It was difficult to predict the effect of these mutations on splicing using in silico tools, as predictions of different tools were inconsistent with each other. The minigene splicing experiment remains the most reliable method to unravel splicing abnormalities.
C1 [Aoyama, Yuka; Sasai, Hideo; Abdelkreem, Elsayed; Otsuka, Hiroki; Fukao, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Pediat, 1-1 Yanagido, Gifu 5011194, Japan.
   [Aoyama, Yuka] Chubu Univ, Dept Biomed Sci, Educ & Training Ctr Med Technol, Kasugai, Aichi 4878501, Japan.
   [Abdelkreem, Elsayed] Sohag Univ, Dept Pediat, Fac Med, Nasser 82524, Sohag, Egypt.
   [Nakama, Mina] Gifu Univ Hosp, Div Clin Genet, Gifu 5011194, Japan.
   [Kumar, Sandeep; Aroor, Shrikiran] Manipal Univ, Kasturba Med Coll, Dept Pediat, Manipal 576104, Karnataka, India.
   [Shukla, Anju] Manipal Univ, Kasturba Med Coll, Dept Med Genet, Manipal 576104, Karnataka, India.
RP Fukao, T (reprint author), Gifu Univ, Grad Sch Med, Dept Pediat, 1-1 Yanagido, Gifu 5011194, Japan.
EM toshi-gif@umin.net
OI Abdelkreem, Elsayed/0000-0002-8976-2989
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [26114708, 24591505, 16K09962, 15K01693]; Health and Labour Science
   Research Grants for Research on Intractable Diseases from the Ministry
   of Health, Labour and Welfare of Japan; Practical Research Project for
   Rare/Intractable Diseases from Japan Agency for Medical Research and
   Development (AMED)
FX The authors thank Ms. Naomi Sakaguchi for her technical assistance. The
   present study was supported in part by a Grant-in-Aid for Scientific
   Research from the Ministry of Education, Culture, Sports, Science and
   Technology of Japan (nos. 26114708, 24591505, 16K09962 and 15K01693),
   Health and Labour Science Research Grants for Research on Intractable
   Diseases from the Ministry of Health, Labour and Welfare of Japan, and
   the Practical Research Project for Rare/Intractable Diseases from Japan
   Agency for Medical Research and Development (AMED).
CR Abdelkreem E, 2016, J INBORN ERRORS META, V4, P1
   Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538
   Ben Rhouma F, 2013, MOL BIOL REP, V40, P4197, DOI 10.1007/s11033-013-2500-z
   DAUM RS, 1971, LANCET, V2, P1289
   Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215
   FUKAO T, 1992, J CLIN INVEST, V89, P474, DOI 10.1172/JCI115608
   Fukao T, 1997, HUM MUTAT, V9, P277, DOI 10.1002/(SICI)1098-1004(1997)9:3<277::AID-HUMU11>3.0.CO;2-#
   FUKAO T, 1990, J CLIN INVEST, V86, P2086, DOI 10.1172/JCI114946
   Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013
   Fukao T, 1998, HUM MUTAT, V12, P245, DOI 10.1002/(SICI)1098-1004(1998)12:4<245::AID-HUMU5>3.0.CO;2-E
   FUKAO T, 1992, BIOCHIM BIOPHYS ACTA, V1139, P184, DOI 10.1016/0925-4439(92)90132-7
   Fukao T, 2001, MOL GENET METAB, V72, P109, DOI 10.1006/mgme.2000.3113
   Fukao T, 2008, MOL GENET METAB, V94, P417, DOI 10.1016/j.ymgme.2008.04.014
   Fukao T, 2014, J INHERIT METAB DIS, V37, P541, DOI 10.1007/s10545-014-9704-9
   Fukao T, 2010, MOL GENET METAB, V100, P339, DOI 10.1016/j.ymgme.2010.03.012
   Hori T, 2015, PEDIATR INT, V57, P41, DOI 10.1111/ped.12585
   Hori T, 2013, HUM MUTAT, V34, P473, DOI 10.1002/humu.22258
   Houdayer C, 2012, HUM MUTAT, V33, P1228, DOI 10.1002/humu.22101
   Jian XQ, 2014, GENET MED, V16, P497, DOI 10.1038/gim.2013.176
   KANO M, 1991, GENE, V109, P285, DOI 10.1016/0378-1119(91)90623-J
   Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701
   Nakamura K, 2001, MOL GENET METAB, V72, P115, DOI 10.1006/mgme.2000.3125
   NIWA H, 1991, GENE, V108, P193
   Nouri N, 2014, GENE, V535, P250, DOI 10.1016/j.gene.2013.11.022
   Ogawa A, 2000, J HUM GENET, V45, P52, DOI 10.1007/s100380050010
   SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155
   Thery JC, 2011, EUR J HUM GENET, V19, P1052, DOI 10.1038/ejhg.2011.100
   Thummler S, 2010, TOHOKU J EXP MED, V220, P27, DOI 10.1620/tjem.220.27
   Vatanavicharn N, 2015, BRAIN DEV-JPN, V37, P698, DOI 10.1016/j.braindev.2014.10.005
   WILLIAMS.DH, 1971, BIOCHEM J, V121, P41
NR 30
TC 0
Z9 0
U1 3
U2 3
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD JUN
PY 2017
VL 15
IS 6
BP 3879
EP 3884
DI 10.3892/mmr.2017.6434
PG 6
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA EU5LA
UT WOS:000401071600060
PM 28393214
OA No
DA 2017-08-17
ER

PT J
AU Moussa, TAA
   Al-Zahrani, HS
   Kadasa, NMS
   Moreno, LF
   van den Ende, AHGG
   de Hoog, GS
   Al-Hatmi, AMS
AF Moussa, Tarek A. A.
   Al-Zahrani, Hassan S.
   Kadasa, Naif M. S.
   Moreno, Leandro F.
   van den Ende, A. H. G. Gerrits
   de Hoog, G. Sybren
   Al-Hatmi, Abdullah M. S.
TI Nomenclatural notes on Nadsoniella and the human opportunist black yeast
   genus Exophiala
SO MYCOSES
LA English
DT Article
DE black yeast; morphology; nomenclature; opportunists; phylogeny; taxon
   sampling
ID AROMATIC-HYDROCARBONS; HERPOTRICHIELLACEAE; CHAETOTHYRIALES; DIVERSITY;
   ANIMALS; DISEASE; CLADE; FUNGI
AB The opportunistic black yeast are particularly known through the genus Exophiala, characterised by annellidic budding cells. However, this phenotype is polyphyletic within the order Chaetothyriales. Seventeen generic names are available in the family Herpotrichiellaceae, one of which is Exophiala. Future taxonomy will be based on molecular phylogeny; each multi-species clade may qualify for one of these names. This paper focuses on the genus Nadsoniella, which is the oldest valid name in the Herpotrichiellaceae. Despite its exophiala-like phenotype, the type species of Nadsoniella clusters in the jeanselmei-clade, competing with the sympodial genus Rhinocladiella. In contrast, Exophiala competes with morphologically pronounced genera Thysanorea and Veronaea. Replacing the current phenotypic system for phylogenetic nomenclature requires highly stable phylogenies, which currently are not available.
C1 [Moussa, Tarek A. A.; Al-Zahrani, Hassan S.; Kadasa, Naif M. S.; de Hoog, G. Sybren] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.
   [Moussa, Tarek A. A.] Univ Jeddah, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.
   [Moussa, Tarek A. A.] Cairo Univ, Dept Bot & Microbiol, Fac Sci, Giza, Egypt.
   [Moreno, Leandro F.; van den Ende, A. H. G. Gerrits; de Hoog, G. Sybren; Al-Hatmi, Abdullah M. S.] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands.
   [Moreno, Leandro F.; de Hoog, G. Sybren; Al-Hatmi, Abdullah M. S.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.
   [Al-Hatmi, Abdullah M. S.] Ibri Hosp, Minist Hlth, Directorate Gen Hlth Serv, Ibri, Oman.
RP de Hoog, GS (reprint author), CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands.
EM s.hoog@cbs.knaw.nl
OI Al-Hatmi, Abdullah/0000-0002-5206-2647
FU Deanship of Scientific Research (DSR) [30-130-36-RG]
FX Deanship of Scientific Research (DSR), Grant/Award Number: 30-130-36-RG.
CR Badali H, 2011, FUNGAL BIOL-UK, V115, P1019, DOI 10.1016/j.funbio.2011.04.005
   Carmichael J W, 1966, Sabouraudia, V5, P120
   Chomnunti P, 2012, FUNGAL DIVERS, V56, P63, DOI 10.1007/s13225-012-0197-2
   Cooke MC, 1871, HDB BRIT FUNGI
   Crous PW, 2007, STUD MYCOL, P185, DOI 10.3114/sim.2007.58.07
   Crous PW, 2011, PERSOONIA, V26, P70, DOI 10.3767/003158511X574532
   de Hoog GS, 2011, PERSOONIA, V27, P46, DOI 10.3767/003158511X614258
   de Hoog GS, 2003, J CLIN MICROBIOL, V41, P4767, DOI 10.1128/JCM.41.10.4767-4778.2003
   De Hoog GS, 1985, FUNGI PATHOGENIC HUM, P327
   de Hoog G. S., 1977, STUD MYCOL, V15, P1
   desTeixeira MM, 2016, STUD MYCOL IN PRESS
   Gumral R, 2014, MICROB ECOL, V68, P699, DOI 10.1007/s00248-014-0459-5
   Haase G, 1999, STUD MYCOL, P80
   Isola D, 2013, MYCOPATHOLOGIA, V175, P369, DOI 10.1007/s11046-013-9635-2
   Issatschenko N, 1914, T MURMANSKOI NAUCHNO, P273
   Kozlova PM, 1981, MIKROBIOLOGIYA, V50, P279
   Lyakh SP, 1970, IZV AKAD NAUK SSSR, V4, P581
   MCGINNIS MR, 1985, SABOURAUDIA, V23, P179
   Melin E, 1934, SVENSKA SKOGSVARDSFO, V32, P397
   MULLER E, 1987, T BRIT MYCOL SOC, V88, P63
   Nepel M, 2016, FUNGAL ECOL, V23, P131, DOI 10.1016/j.funeco.2016.07.007
   PEDERSEN OA, 1989, MYCOL RES, V92, P153
   Prenafeta-Boldu FX, 2006, FEMS MICROBIOL REV, V30, P109, DOI 10.1111/j.1574-6976.2005.00007.x
   Puttemans A., 1904, B SOC MYCOL FR, V20, P152
   REYNOLDS DR, 1982, MYCOTAXON, V14, P189
   Seyedmousavi S, 2013, CLIN MICROBIOL REV, V26, P19, DOI 10.1128/CMR.00065-12
   Seyedmousavi S, 2011, FUNGAL BIOL-UK, V115, P1030, DOI 10.1016/j.funbio.2011.06.004
   Sudhadham M, 2008, STUD MYCOL, P145, DOI 10.3114/sim.2008.61.15
   Untereiner WA, 2011, FUNGAL DIVERS, V49, P225, DOI 10.1007/s13225-011-0097-x
   Voglmayr H, 2011, FUNGAL BIOL-UK, V115, P1077, DOI 10.1016/j.funbio.2010.11.006
   Zeng JS, 2014, FUNGAL DIVERS, V65, P3, DOI 10.1007/s13225-013-0226-9
NR 31
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0933-7407
EI 1439-0507
J9 MYCOSES
JI Mycoses
PD JUN
PY 2017
VL 60
IS 6
BP 358
EP 365
DI 10.1111/myc.12600
PG 8
WC Dermatology; Mycology
SC Dermatology; Mycology
GA EU1MZ
UT WOS:000400785800001
PM 28111800
OA No
DA 2017-08-17
ER

PT J
AU Nimeri, A
   Al Hadad, M
   Khoursheed, M
   Maasher, A
   Al Qahtani, A
   Al Shaban, T
   Fawal, H
   Safadi, B
   Alderazi, A
   Abdalla, E
   Bashir, A
AF Nimeri, Abdelrahman
   Al Hadad, Mohammed
   Khoursheed, Mousa
   Maasher, Ahmed
   Al Qahtani, Aayed
   Al Shaban, Talat
   Fawal, Hayssam
   Safadi, Bassem
   Alderazi, Amer
   Abdalla, Emad
   Bashir, Ahmad
TI The Peri-operative Bariatric Surgery Care in the Middle East Region
SO OBESITY SURGERY
LA English
DT Article
DE Peri-operative; Bariatric surgery practice; Middle East
ID LAPAROSCOPIC-SLEEVE-GASTRECTOMY; LONGITUDINAL ASSESSMENT; HOSPITAL
   VOLUME; WEIGHT-LOSS; GUIDELINES; BYPASS; TRIAL
AB Bariatric surgery is common in the Middle East region. However, regional accreditation bodies and guidelines are lacking. We present the current peri-operative practice of bariatric surgery in the Middle East region.
   Public and private practice in the Middle East region.
   A questionnaire was designed to study trends of peri-operative care in bariatric surgery. It was sent to members of the Pan Arab Society for Metabolic and Bariatric Surgery (PASMBS).
   Ninety-three surgeons (88.6%) responded, 63.4% were in private practice, 68.5% have been in practice for more than 5 years, and 61.1% performed more than 125 cases per year. Laparoscopic sleeve gastrectomy (LSG) was the commonest procedure performed, then laparoscopic Roux-en-Y gastric bypass (LRYGB), one anastomosis gastric bypass/mini gastric bypass (OAGB/MGB), and laparoscopic adjustable gastric banding (LAGB). Pre-operatively as a routine, 65% referred patients for dietitian and (78.3%) for smoking cessation. In contrast as a routine, 22.6% referred patients to a psychologist, 30% screened for obstructive sleep apnea (OSA), and when they did, they did not use a questionnaire. For patients 50 years of age, 22% performed a screening colonoscopy and 33.7% referred patients to a cardiologist. Intra-operatively as a routine, 25.3% placed a drain and 42.2% placed urinary catheters. In contrast, 77.1% performed a leak test (82.7% as a methylene blue leak test). Post-operatively, 79.5% used chemoprophylaxis for venous thromboembolism and 89% required patients to take vitamins. In contrast, 25% prescribed ursodeoxycholic acid.
   The wide variation in the peri-operative care of bariatric surgery in the Middle East region highlights the need for regional guidelines based on international guidelines.
C1 [Nimeri, Abdelrahman; Maasher, Ahmed; Al Shaban, Talat] Sheikh Khalifa Med City, Bariatr & Metab Inst Abu Dhabi, Abu Dhabi, U Arab Emirates.
   [Nimeri, Abdelrahman; Maasher, Ahmed; Al Shaban, Talat] Sheikh Khalifa Med City, Div Gen Thorac & Vasc Surg, Abu Dhabi, U Arab Emirates.
   [Al Hadad, Mohammed] Dr Hadad Hlth Point Hosp, Abu Dhabi, U Arab Emirates.
   [Khoursheed, Mousa] Kuwait Univ, Kuwait, Kuwait.
   [Al Qahtani, Aayed] King Saud Univ, Riyadh, Saudi Arabia.
   [Fawal, Hayssam] Makassed Gen Hosp, Beirut, Lebanon.
   [Safadi, Bassem] Amer Univ Beirut, Med Ctr, Beirut, Lebanon.
   [Alderazi, Amer] Sulaimania Med Complex, Beirut, Lebanon.
   [Abdalla, Emad] Mansoura Univ, Mansoura, Egypt.
   [Bashir, Ahmad] Jordan Hosp, Amman, Jordan.
RP Nimeri, A (reprint author), Sheikh Khalifa Med City, Bariatr & Metab Inst Abu Dhabi, Abu Dhabi, U Arab Emirates.; Nimeri, A (reprint author), Sheikh Khalifa Med City, Div Gen Thorac & Vasc Surg, Abu Dhabi, U Arab Emirates.
EM Nimeri@gmail.com
CR Abd Ellatif ME, 2016, WORLD J GASTROINTEST, V8, P409, DOI 10.4253/wjge.v8.i10.409
   Almazeedi S, 2014, OBES SURG, V24, P397, DOI 10.1007/s11695-013-1092-y
   Aminian A, 2016, ANN SURG, V8
   Angrisani L, 2015, OBES SURG, V25, P1822, DOI 10.1007/s11695-015-1657-z
   Apovian CM, 2009, OBESITY, V17, P871, DOI 10.1038/oby.2008.580
   Bauchowitz AU, 2005, PSYCHOSOM MED, V67, P825, DOI 10.1097/01.psy.0000174173.32271.01
   Bhatti JA, 2016, JAMA SURG, V151, P226, DOI 10.1001/jamasurg.2015.3414
   De Luca M, 2016, OBES SURG, V26, pS422
   de Raaff CA, 2016, SURG ENDOSC
   Finks JF, 2012, ANN SURG, V255, P1100, DOI 10.1097/SLA.0b013e31825659d4
   Flum DR, 2009, NEW ENGL J MED, V361, P445
   Fried M, 2014, OBES SURG, V24, P42, DOI 10.1007/s11695-013-1079-8
   Fruhbeck G, 2015, NAT REV ENDOCRINOL, V11, P465, DOI 10.1038/nrendo.2015.84
   Hadad M, 2014, SURG ENDOSC, V28, P1607
   Kavuturu S, 2012, OBES SURG, V22, P177, DOI 10.1007/s11695-011-0560-5
   Khan A, 2013, J CLIN SLEEP MED, V9, P21, DOI 10.5664/jcsm.2332
   Klautzer Lisa, 2014, Int J Health Policy Manag, V2, P109, DOI 10.15171/ijhpm.2014.33
   Martin AR, 2011, CAN J SURG, V54, P154, DOI 10.1503/cjs.048909
   Mechanick JI, 2013, SURG OBES RELAT DIS, V9, P159, DOI 10.1016/j.soard.2012.12.010
   Medina FJ, 2016, REV MED CHILE, V144, P451, DOI 10.4067/S0034-98872016000400005
   Meyer SB, 2015, AUST HEALTH REV, V39, P63, DOI 10.1071/AH14140
   Miller K, 2003, ANN SURG, V238, P697, DOI 10.1097/01.sla.0000094305.77843.cf
   Milone L, 2005, OBES SURG, V15, P612, DOI 10.1381/0960892053923833
   Morgan DJ, 2016, ANN SURG, V18
   Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24
   Nimeri AA, 2015, CLIN APPL THROMB HEM
   Peterli R, 2013, ANN SURG, V258, P690, DOI 10.1097/SLA.0b013e3182a67426
   Ponce J, 2016, SURG OBES RELAT DIS, V26
   Sharaf RN, 2004, OBES SURG, V14, P313, DOI 10.1381/096089204322917800
   SUGERMAN HJ, 1995, AM J SURG, V169, P91, DOI 10.1016/S0002-9610(99)80115-9
   Varban OA, 2015, SURG OBES RELAT DIS, V11, P343, DOI 10.1016/j.soard.2014.09.030
NR 31
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0960-8923
EI 1708-0428
J9 OBES SURG
JI Obes. Surg.
PD JUN
PY 2017
VL 27
IS 6
BP 1543
EP 1547
DI 10.1007/s11695-016-2503-7
PG 5
WC Surgery
SC Surgery
GA EU5JG
UT WOS:000401066800021
PM 28000089
OA No
DA 2017-08-17
ER

PT J
AU Kotb, A
AF Kotb, Amer
TI Theoretical analysis of soliton NOR gate with semiconductor optical
   amplifier-assisted Mach-Zehnder interferometer
SO OPTICAL AND QUANTUM ELECTRONICS
LA English
DT Article
DE NOR gate; Soliton; Semiconductor optical amplifier; Mach-Zehnder
   interferometer
ID SPONTANEOUS EMISSION; LOGIC NOR; FIBER; SOA
AB The performance of soliton all-optical logic NOR gate with semiconductor optical amplifiers (SOAs)-assisted a Mach-Zehnder interferometer is theoretically analyzed and investigated. The dependence of the output quality factor on the soliton characteristics and SOA parameters is studied. The achieved results confirm that the solitonbased all-optical NOR gate is indeed feasible with the proposed scheme at a data rate of 80 Gb/s with logical correctness and acceptable quality.
C1 [Kotb, Amer] Fayoum Univ, Fac Sci, Dept Phys, Al Fayyum 63514, Egypt.
RP Kotb, A (reprint author), Fayoum Univ, Fac Sci, Dept Phys, Al Fayyum 63514, Egypt.
EM asm05@fayoum.edu.eg
OI Kotb, Amer/0000-0002-3776-822X
CR Agrawal G.P., 2002, APPL NONLINEAR FIBER
   Dimitriadou E, 2012, OPT COMMUN, V285, P1710, DOI 10.1016/j.optcom.2011.11.122
   Dong JJ, 2008, OPT COMMUN, V281, P1710, DOI 10.1016/j.optcom.2007.11.054
   Doran N.J., 1998, P SPIE OPTOELECTRON, V836, P238
   Dutta N.K., 2013, SEMICONDUCTOR OPTICA
   Hamie A, 2002, IEEE PHOTONIC TECH L, V14, P1439, DOI 10.1109/LPT.2002.802426
   ISLAM MN, 1992, OPT QUANT ELECTRON, V24, pS1215, DOI 10.1007/BF00624671
   KIM JY, 2006, LIGHTWAVE TECHNOLOGY, V24, P3392, DOI DOI 10.1109/JLT.2006.880593
   Kotb A, 2011, OPT COMMUN, V284, P5798, DOI 10.1016/j.optcom.2011.08.046
   Kotb A., 2012, ALL OPTICAL LOGIC GA
   Kotb A., 2015, J KOREAN PHYS SOC, V66, P1593
   Kotb A, 2016, OPT ENG, V55, DOI 10.1117/1.OE.55.8.087109
   Kotb A, 2016, OPT QUANT ELECTRON, V48, DOI 10.1007/s11082-016-0600-4
   Kotb A, 2015, BRAZ J PHYS, V45, P288, DOI 10.1007/s13538-015-0312-4
   Kotb A, 2013, OPT QUANT ELECTRON, V45, P1259, DOI 10.1007/s11082-013-9746-5
   Kotb A, 2013, OPT QUANT ELECTRON, V45, P473, DOI 10.1007/s11082-013-9661-9
   LAZARIDIS P, 1995, OPT LETT, V20, P1160, DOI 10.1364/OL.20.001160
   Mollenauer L. E., 2006, SOLITONS OPTICAL FIB
   MOLLENAUER LF, 1986, IEEE J QUANTUM ELECT, V22, P157, DOI 10.1109/JQE.1986.1072858
   Naruse M, 2005, IEEE PHOTONIC TECH L, V17, P1701, DOI 10.1109/LPT.2005.851879
   Patel NS, 1998, APPL OPTICS, V37, P2831, DOI 10.1364/AO.37.002831
   Saxena S., 1996, LIGHTWAVE TECHNOL, V14, P1776
   Singh P, 2014, OPTIK, V125, P4437, DOI 10.1016/j.ijleo.2014.02.032
   Son CW, 2007, JPN J APPL PHYS 1, V46, P232, DOI [10.1143/JJAP.46.232, 10.1143/JJAP.46.2321]
   Sun H., 2007, SPIE P, V6775
   Talli G, 2003, OPT COMMUN, V218, P161, DOI 10.1016/S0030-4018(03)01196-9
   WILLIAMS GR, 1995, OPT LETT, V20, P1671, DOI 10.1364/OL.20.001671
   Xu J, 2006, OPT EXPRESS, V14, P10708, DOI 10.1364/OE.14.010708
   Zhao C, 2005, OPT EXPRESS, V13, P2793, DOI 10.1364/OPEX.13.002793
NR 29
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0306-8919
EI 1572-817X
J9 OPT QUANT ELECTRON
JI Opt. Quantum Electron.
PD JUN
PY 2017
VL 49
IS 5
AR 180
DI 10.1007/s11082-017-1017-4
PG 11
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA EU2DP
UT WOS:000400837200004
OA No
DA 2017-08-17
ER

PT J
AU Shenashen, M
   Derbalah, A
   Hamza, A
   Mohamed, A
   El Safty, S
AF Shenashen, Mohamed
   Derbalah, Aly
   Hamza, Amany
   Mohamed, Ahmed
   El Safty, Sherif
TI Antifungal activity of fabricated mesoporous alumina nanoparticles
   against root rot disease of tomato caused by Fusarium oxysporium
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE control; alumina; root rot; nanoparticles; tomato
ID TOXICITY; SILVER
AB BACKGROUNDThe present work involved the synthesis and characterisation of mesoporous alumina sphere (MAS) nanoparticles to evaluate their biological activity against tomato root rot caused by Fusarium oxysporium, as compared with the recommended fungicide, tolclofos-methyl, under laboratory and greenhouse conditions. The effects of MAS nanoparticles on the growth of tomato plants were also evaluated and compared with those of tolclofos-methyl.
   RESULTSThe physical characteristics and structural features of MAS nanoparticles, such as their large surface-area-to-volume ratio, active surface sites and open channel pores, caused high antifungal efficacy against F. oxysporium. MAS nanoparticles presented an antifungal potential similar to that of tolclofos-methyl and much greater than that of the control under both laboratory and greenhouse conditions. The highest growth parameters were recorded in tomato plants treated with MAS nanoparticles, followed by those treated with tolclofos-methyl.
   CONCLUSIONSOur study demonstrated the possible use of cylindrically cubic MAS nanoparticles as an effective alternative for the control of Fusarium root rot in tomato. (c) 2016 Society of Chemical Industry
C1 [Shenashen, Mohamed; Derbalah, Aly; El Safty, Sherif] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan.
   [Shenashen, Mohamed] EPRI, Petrochem Dept, 1 Ahmed El Zomor St El Zohour Reg, Cairo 11727, Egypt.
   [Derbalah, Aly; Hamza, Amany] Kafr El Shiekh Univ, Pesticides Chem & Toxicol Dept, Fac Agr, Kafr Al Sheikh 33516, Egypt.
   [Mohamed, Ahmed] Agr Res Ctr, Plant Pathol Res Inst, Giza, Egypt.
   [El Safty, Sherif] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan.
RP Derbalah, A (reprint author), Kafr El Shiekh Univ, Pesticides Chem & Toxicol Dept, Fac Agr, Kafr Al Sheikh 33516, Egypt.
EM aliderbalah@yahoo.com
CR Ainsworth GC, 1971, AINSWORTH BISBYS DIC, P663
   Alexopoulos C. J., 1996, INTRO MYCOLOGY
   Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053
   Barik TK, 2008, PARASITOL RES, V103, P253, DOI 10.1007/s00436-008-0975-7
   Brecht M, 2003, ROLE SILICON SUPPRES, P1
   Dhingra O. D., 1995, BASIC PLANT PATHOLOG, P434
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   El-Mohamedy R. S. R., 2014, Tunisian Journal of Plant Protection, V9, P45
   El-Mougy Nehal S., 2009, Journal of Plant Protection Research, V49, P353
   El-Safty SA, 2013, SMALL, V9, P2288, DOI 10.1002/smll.201202407
   El-Safty SA, 2013, COLLOID SURFACE B, V103, P288, DOI 10.1016/j.colsurfb.2012.10.040
   El-Safty SA, 2012, CHEM COMMUN, V48, P6708, DOI 10.1039/c2cc30725a
   El-Safy SA, 2005, ADV MATER, V17, P47, DOI 10.1002/adma.200401317
   El-Mougy N. S., 2013, J ENG INNOVATIVE TEC, V3, P71
   Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005
   Hibar K, 2006, TUNISIAN J PLANT PRO, V1, P19
   Jiang W, 2009, ENVIRON POLLUT, V157, P1619, DOI 10.1016/j.envpol.2008.12.025
   Juhel G, 2011, AQUAT TOXICOL, V105, P328, DOI 10.1016/j.aquatox.2011.06.019
   Ke XB, 2013, SEP PURIF TECHNOL, V120, P239, DOI 10.1016/j.seppur.2013.10.011
   Kern A, 2004, SPRINGER SERIES MAT, V68, P17
   Khalifa EZ, 1987, THESIS MENOUIFYA U E, P148
   Kucharek T, 2000, 1025 U FLOR I FOOD A
   Martinez-Gutierrez F, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI 10.1016/j.nano.2010.02.001
   Paulkumar K, 2014, SCI WORLD J, DOI 10.1155/2014/829894
   Rajan YC, 2015, RSC ADV, V5, P15126, DOI 10.1039/c4ra10445e
   Sadiq IM, 2009, NANOMED-NANOTECHNOL, V5, P282, DOI 10.1016/j.nano.2009.01.002
   Salem HF, 2011, INT J DRUG DELIVERY, V3, P293
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Shenashen MA, 2013, SEP PURIF TECHNOL, V116, P73, DOI 10.1016/j.seppur.2013.05.011
   Shobha G, 2014, INT J PHARM SCI INVE, V3, P28
   VINCENT JM, 1947, NATURE, V159, P850, DOI 10.1038/159850b0
NR 31
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JUN
PY 2017
VL 73
IS 6
BP 1121
EP 1126
DI 10.1002/ps.4420
PG 6
WC Agronomy; Entomology
SC Agriculture; Entomology
GA EU1HN
UT WOS:000400767400009
PM 27558672
OA No
DA 2017-08-17
ER

PT J
AU Heve, WK
   El-Borai, FE
   Carrillo, D
   Duncan, LW
AF Heve, William K.
   El-Borai, Fahiem E.
   Carrillo, Daniel
   Duncan, Larry W.
TI Biological control potential of entomopathogenic nematodes for
   management of Caribbean fruit fly, Anastrepha suspensa Loew
   (Tephritidae)
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE Anastrepha suspensa; entomopathogenic nematodes; resistant pupae;
   susceptible larvae; emerging adults; bioassays; biological control
ID STEINERNEMA-FELTIAE; DIAPREPES-ABBREVIATUS;
   HETERORHABDITIS-BACTERIOPHORA; LABORATORY CONDITIONS; DIPTERA
   TEPHRITIDAE; RHABDITIDA; CURCULIONIDAE; COLEOPTERA; SOIL; INFECTIVITY
AB BACKGROUNDCaribbean fruit fly (Caribfly) is a serious economic insect pest because of development of larvae that hatch from eggs oviposited into fruits by female adults. This study assessed the virulence of twelve entomopathogenic nematode (EPN) isolates to Caribfly in laboratory bioassays as a starting point toward evaluation of management strategies for the fruit-to-soil-dwelling stages of A. suspensa in fields infested by Caribfly.
   RESULTSInoculation of A. suspensa with 1 mL of ca 200 IJs larva(-1) killed Caribfly at either larval or pupal stage. Pupae were more resistant to EPN infections than larvae. Adult emergence from inoculated pupae in soil microcosms was significantly lower than that observed in filter paper assays. Longest or largest steinernematids suppressed emergence of more adult Caribfly from pupae in soils, whereas shorter heterorhabditids were more infectious to Caribfly larvae. The highest mortalities of A. suspensa were caused by exotic nematodes Steinernema feltiae and Heterorhabditis bacteriophora, followed by the native Heterorhabditis indica and the exotic Steinernema carpocapsae.
   CONCLUSIONEntomopathogenic nematodes reduced the development of Caribfly larvae and pupae to adult in our bioassays, suggesting that EPNs have potential for biological control of A. suspensa. Future work will assess management strategies, using the virulent EPNs, in orchards infested by A. suspensa. (c) 2016 Society of Chemical Industry
C1 [Heve, William K.; El-Borai, Fahiem E.; Duncan, Larry W.] Univ Florida, Inst Food & Agr Sci, Ctr Citrus Res & Educ, 700 Expt Stn Rd, Lake Alfred, FL 33850 USA.
   [El-Borai, Fahiem E.] Zagazig Univ, Fac Agr, Plant Protect Dept, Zagazig, Egypt.
   [Carrillo, Daniel] Univ Florida, Inst Food & Agr Sci, Ctr Trop Res & Educ, Homestead, FL 33031 USA.
RP Duncan, LW (reprint author), Univ Florida, Inst Food & Agr Sci, Ctr Citrus Res & Educ, 700 Expt Stn Rd, Lake Alfred, FL 33850 USA.
EM lwduncan@ufl.edu
FU Department of Entomology and Nematology, University of Florida
FX The first author thanks the Department of Entomology and Nematology,
   University of Florida, for awarding him a PhD Research Assistantship
   that paved the way for the study and research opportunities into
   biological control and pest management. We appreciate contributions,
   recommendations and technical support of Vanessa Simoes Dias De Castro
   of the Entomology and Nematology Department, University of Florida, Dr
   Nancy Epsky of USDA in Miami, Florida, Suzanne Frazer of the Florida
   Department of Agriculture and Consumer Services (FDACS) in Gainesville,
   Florida, Prof. Lukasz Stelinski, Josh Q Fluty and Dr Nabil Killiny of
   CREC-UF/IFAS in Lake Alfred, Florida, and all persons whose names we
   could not mention.
CR Baranowski RM, 1987, WASPS STING FLIES, P12
   Bronson CH, 2014, PROCEDURES MANUAL MA, P1
   Burditt Jr AK, 1975, APPL STERILIZATION T, P93
   Campos-Herrera R, 2006, J NEMATOL, V38, P68
   Campos-Herrera R, 2011, ANN APPL BIOL, V158, P55, DOI 10.1111/j.1744-7348.2010.00433.x
   Chaisson KE, 2012, TRENDS PARASITOL, V28, P427, DOI 10.1016/j.pt.2012.07.004
   da Silva Alexandre C., 2010, Nematologia Brasileira, V34, P31
   des Minas RS, 2011, SCI AGRARIA, V12, P115
   Dolinski C, 2016, BIOCONTROL, V61, P325, DOI 10.1007/s10526-015-9695-y
   Duncan LW, 2003, J NEMATOL, V35, P178
   Foelkel E, 2016, CIENC RURAL, V46, P405, DOI 10.1590/0103-8478cr20150370
   Giron-Pablo S., 2012, African Journal of Biotechnology, V11, P16525
   Grewal PS, 2005, NEMATODES AS BIOCONTROL AGENTS, P1, DOI 10.1079/9780851990170.0000
   Hatting J, 2009, J INVERTEBR PATHOL, V102, P120, DOI 10.1016/j.jip.2009.07.003
   Hazir S, 2001, J INVERTEBR PATHOL, V77, P243, DOI 10.1006/jipa.2001.5029
   Hazir S, 2016, J INVERTEBR PATHOL, V135, P53, DOI 10.1016/j.jip.2016.02.004
   HETZ SK, 1994, BIOELECTROCH BIOENER, V33, P165, DOI 10.1016/0302-4598(94)85008-9
   Jabbour R, 2011, BIOL CONTROL, V59, P277, DOI 10.1016/j.biocontrol.2011.07.016
   Kamali S, 2013, BIOCONTROL SCI TECHN, V23, P1307, DOI 10.1080/09583157.2013.835790
   Koppenhofer AM, 2006, J INVERTEBR PATHOL, V92, P11, DOI 10.1016/j.jip.2006.02.003
   Lacey LA, 2012, J NEMATOL, V44, P218
   Laznik Z, 2009, HELMINTHOLOGIA, V46, P135, DOI 10.2478/s11687-009-0026-7
   Laznik Z, 2016, J CHEM ECOL, V42, P314, DOI 10.1007/s10886-016-0686-y
   Laznik Z, 2010, J FOOD AGRIC ENVIRON, V8, P150
   Maketon M, 2011, NEMATROPICA, V41, P52
   Meirelles RN, 2013, FLA ENTOMOL, V96, P412, DOI 10.1653/024.096.0204
   Mekete T, 2005, NEMATROPICA, V35, P31
   Miles C, 2012, PACIF NW EXT PUBLS P, V544, P1
   Minas Ramon dos Santos, 2016, Nematoda, V3, pe02016, DOI 10.4322/nematoda.02016
   Mossler MA, 2012, EDIS PUBLICATION CIR, V1415, P1
   Nguyen KB, 1996, J NEMATOL, V28, P286
   Nguyen KB, 2002, J NEMATOL, V34, P159
   Norwegian Scientific Committee for Food Safety, 2014, RISK ASS BIOL PLANT
   Pena JM, 2015, INFECT IMMUN, V83, P1130, DOI 10.1128/IAI.02740-14
   Perea-Castellanos C, 2015, J ECON ENTOMOL, V108, P1720, DOI 10.1093/jee/tov177
   Poinar GO, 2012, J NEMATOL, V44, P153
   Rohde C., 2012, Revista Brasileira de Ciencias Agrarias (Agraria), V7, P797
   Sarwar M, 2015, INT J ANIM BIOL, V1, P196
   Shahidi NS, 2006, COMMUN AGRIC APPL A, V71A, P689
   Shapiro DI, 2000, J ECON ENTOMOL, V93, P1090
   Shapiro-Ilan DI, 2002, J IND MICROBIOL BIOT, V28, P137, DOI 10.1038/sj/jim/7000230
   SLAMA K, 1992, ARCH INSECT BIOCHEM, V20, P135, DOI 10.1002/arch.940200205
   Stock SP, 2005, NEMATODES AS BIOCONTROL AGENTS, P3, DOI 10.1079/9780851990170.0003
   Tarasco E, 2015, REDIA, V98, P109
   Thompson CR, 2014, FEATURED CREATURES E
   Trdan S, 2006, J PLANT DIS PROTECT, V113, P168
   Turlings TCJ, 2012, PLANT SOIL, V358, P47, DOI 10.1007/s11104-012-1295-3
   Watts JL, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020019
   Weems Jr HV, 2014, FEATURED CREATURES E
NR 49
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JUN
PY 2017
VL 73
IS 6
BP 1220
EP 1228
DI 10.1002/ps.4447
PG 9
WC Agronomy; Entomology
SC Agriculture; Entomology
GA EU1HN
UT WOS:000400767400022
PM 27717178
OA No
DA 2017-08-17
ER

PT J
AU Mohamed, ABA
   Eleuch, H
AF Mohamed, A-B A.
   Eleuch, H.
TI Quantum correlation control for two semiconductor microcavities
   connected by an optical fiber
SO PHYSICA SCRIPTA
LA English
DT Article
DE quantum wells; microcavity damping; quantum correlations
ID SEPARATED CAVITIES; ENTANGLEMENT; ATOMS; GENERATION; STATE
AB We explore the quantum correlations for two coupled quantum wells. Each quantum well is inside a semiconductor microcavity. The two cavities are connected by an optical fiber. The study of quantum correlations, namely the geometric quantum discord, measurement-induced non-locality and negativity, reveals sudden death and sudden birth phenomena. These effects depend not only on the initial states, coupling strengths of the cavity-fiber and cavity-exciton constants, but also on the dissipation rates of the semiconductor microcavities. We show that the coupling constants control the quantum correlations.
C1 [Mohamed, A-B A.] Prince Sattam Bin Abdulaziz Univ, Coll Sci, Al Aflaj, Saudi Arabia.
   [Mohamed, A-B A.] Assiut Univ, Fac Sci, Assiut, Egypt.
   [Eleuch, H.] Texas A&M Univ, Inst Quantum Sci & Engn, College Stn, TX 77843 USA.
   [Eleuch, H.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada.
RP Mohamed, ABA (reprint author), Prince Sattam Bin Abdulaziz Univ, Coll Sci, Al Aflaj, Saudi Arabia.; Mohamed, ABA (reprint author), Assiut Univ, Fac Sci, Assiut, Egypt.
EM abdelbastm@yahoo.com
FU Prince Sattam Bin Abdulaziz University [2016/01/6267]
FX We would like to thank the referees and the associate editor for their
   important remarks which have helped us to improve the manuscript. This
   study was supported by the Deanship of Scientific Research at Prince
   Sattam Bin Abdulaziz University under the Research Project No.
   2016/01/6267.
CR Cho JY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160501
   Cirac JI, 1999, PHYS REV A, V59, P4249, DOI 10.1103/PhysRevA.59.4249
   Clark S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.177901
   CLAUSER JF, 1969, PHYS REV LETT, V23, P880, DOI 10.1103/PhysRevLett.23.880
   Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331
   Dakic B, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.190502
   Eleuch H, 2008, J PHYS B-AT MOL OPT, V41, DOI 10.1088/0953-4075/41/5/055502
   Eleuch H, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.013830
   Eleuch H, 2012, PHYS LETT A, V376, P1970, DOI 10.1016/j.physleta.2012.04.050
   Gadomskii ON, 2004, QUANTUM ELECTRON+, V34, P249, DOI 10.1070/QE2004v034n03ABEH002622
   Giacobino E, 2002, CR PHYS, V3, P41, DOI 10.1016/S1631-0705(02)01302-6
   Henderson MR, 2011, ADV MATER, V23, P2806, DOI 10.1002/adma.201100151
   Hermann-Avigliano C, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.013815
   Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865
   Houdre R, 2000, PHYS REV LETT, V85, P2793, DOI 10.1103/PhysRevLett.85.2793
   Lettner M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.210503
   Liu YC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.213602
   Louisell W., 1973, QUANTUM STAT PROPERT
   Luo SL, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.042303
   Luo SL, 2012, THEOR MATH PHYS+, V171, P870, DOI 10.1007/s11232-012-0082-x
   Luo SL, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.120401
   Luo SL, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.034302
   Maleki Y, 2016, QUANTUM INF PROCESS, V15, P4537, DOI 10.1007/s11128-016-1382-0
   Mancini S, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.032308
   Mirza IM, 2015, PHYS LETT A, V379, P1643, DOI 10.1016/j.physleta.2015.04.035
   Mohamed ABA, 2016, LASER PHYS LETT, V13, DOI 10.1088/1612-2011/13/8/085202
   Mohamed ABA, 2014, J PHYS A-MATH THEOR, V47, DOI 10.1088/1751-8113/47/33/335301
   Muller A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3245311
   Nilsen M.A., 2000, QUANTUM COMPUTATION
   Obada ASF, 2011, SOLID STATE COMMUN, V151, P1824, DOI 10.1016/j.ssc.2011.08.016
   Ollivier H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017901
   Paternostro M, 2003, J MOD OPTIC, V50, P2075, DOI 10.1080/0950034031000102697
   Pellizzari T, 1997, PHYS REV LETT, V79, P5242, DOI 10.1103/PhysRevLett.79.5242
   Sames C, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043601
   Sanjenbam P, 2014, J MYCOL MED, V24, P211, DOI 10.1016/j.mycmed.2014.03.004
   Sete EA, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.013841
   Sete EA, 2012, IEEE J SEL TOP QUANT, V18, P541, DOI 10.1109/JSTQE.2011.2135339
   Su SL, 2015, EUR PHYS J D, V69, DOI 10.1140/epjd/e2015-50901-6
   Tan CM, 2013, NAT NANOTECHNOL, V8, P602, DOI [10.1038/nnano.2013.132, 10.1038/NNANO.2013.132]
   Wang DY, 2015, ANN PHYS-NEW YORK, V360, P228, DOI 10.1016/j.aop.2015.05.015
   Yang RC, 2015, OPT COMMUN, V338, P366, DOI 10.1016/j.optcom.2014.10.069
   Yu T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140404
   Yu T, 2009, SCIENCE, V323, P598, DOI 10.1126/science.1167343
   Zheng B, 2016, QUANTUM INF PROCESS, V15, P2181, DOI 10.1007/s11128-016-1262-7
NR 44
TC 0
Z9 0
U1 1
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD JUN
PY 2017
VL 92
IS 6
AR 065101
DI 10.1088/1402-4896/aa6efb
PG 8
WC Physics, Multidisciplinary
SC Physics
GA EV2VJ
UT WOS:000401614300001
OA No
DA 2017-08-17
ER

PT J
AU Mahros, AM
   Tharwat, MM
   Elrashidi, A
AF Mahros, Amr M.
   Tharwat, Marwa M.
   Elrashidi, Ali
TI Exploring the Impact of Nano-Particles Shape on the Performance of
   Plasmonic Based Fiber Optics Sensors
SO PLASMONICS
LA English
DT Article
DE FDTD; Plasmonics; SPR; FOM; Sensitivity
ID HOLE ARRAYS; GAS SENSOR; SURFACE; TRANSMISSION; FLUORESCENT
AB In this paper, we introduce a plasmonic structure-based fiber optics gas sensor using gold nano-particles on the end face. The proposed optical sensors are designed and evaluated to investigate the influence of the shape of the nano-particles. Evaluation techniques such as wavelength and peak sensitivities, full width at half maximum, and figure of merit are studied. By extension, we numerically study the macroscopic electric and magnetic field distributions and the microscopic polarization and current density in order to interpret the physical mechanism. The optical sensor based on nano-particles of classical spherical shape shows the highest wavelength sensitivity. However, it was motivating that the sensor based on nano-particles of the conical shape offers a better performance. It exhibits resonance wavelength and peak intensity sensitivities of 157 nm/RIU and 44 %/RIU, respectively, which give a higher overall sensitivity. In addition, it offers a narrow stable line width and high figures of merit.
C1 [Mahros, Amr M.] Univ Jeddah, Dept Phys, Jeddah 21432, Saudi Arabia.
   [Mahros, Amr M.; Elrashidi, Ali] Alexandria Univ, Dept Engn Phys, Alexandria 21544, Egypt.
   [Tharwat, Marwa M.] King Abdulaziz Univ, Dept Elect & Comp Engn, Jeddah 21432, Saudi Arabia.
RP Mahros, AM (reprint author), Univ Jeddah, Dept Phys, Jeddah 21432, Saudi Arabia.; Mahros, AM (reprint author), Alexandria Univ, Dept Engn Phys, Alexandria 21544, Egypt.
EM amr.mahros@mena.vt.edu
FU Deanship of Scientific Research (DSR), University of Jeddah, Jeddah
   [142-965-G1436]; DSR
FX This work was supported by the Deanship of Scientific Research (DSR),
   University of Jeddah, Jeddah, under grant no. (142-965-G1436). The
   authors, therefore, gratefully acknowledge the DSR technical and
   financial support.
CR Ashry I., 2014, P 2014 ZON C AM SOC
   Ashry I, 2015, PLASMONICS, V10, P511, DOI 10.1007/s11468-014-9835-8
   Boon-Brett L, 2010, INT J HYDROGEN ENERG, V35, P373, DOI 10.1016/j.ijhydene.2009.10.064
   Buttner WJ, 2011, INT J HYDROGEN ENERG, V36, P2462, DOI 10.1016/j.ijhydene.2010.04.176
   Dang XN, 2013, NANO LETT, V13, P637, DOI 10.1021/nl3043823
   Dore K, 2004, J AM CHEM SOC, V126, P4240, DOI 10.1021/ja038900d
   Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Fine GF, 2010, SENSORS-BASEL, V10, P5469, DOI 10.3390/s100605469
   Fraiwan L., 2011, MIDD E C BIOM ENG SH, P11
   Grande M, 2011, SENSOR ACTUAT B-CHEM, V160, P1056, DOI 10.1016/j.snb.2011.09.025
   Hornyak Gabor L., 2008, INTRO NANOSCIENCE NA, P177
   Jia PP, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4811700
   Kim HN, 2011, CHEM SOC REV, V40, P79, DOI 10.1039/c0cs00058b
   Kim S, 2014, IEEE PHOTONIC TECH L, V26, P1259, DOI 10.1109/LPT.2014.2320907
   Li CY, 2010, POSTHARVEST BIOL TEC, V55, P144, DOI 10.1016/j.postharvbio.2009.11.004
   Lin YB, 2011, BIOMED OPT EXPRESS, V2, P478, DOI 10.1364/BOE.2.000478
   Mahros AM, 2015, J EUR OPT SOC-RAPID, V10, DOI 10.2971/jeos.2015.15023
   Mahros AM, 2015, J NANOMATER, V2015
   McMahon JM, 2007, OPT EXPRESS, V15, P18119, DOI 10.1364/OE.15.018119
   Neethirajan S, 2009, FOOD BIOPROCESS TECH, V2, P115, DOI 10.1007/s11947-008-0154-y
   Pearton SJ, 2010, PROG MATER SCI, V55, P1, DOI 10.1016/j.pmatsci.2009.08.003
   Rakic AD, 1998, APPL OPTICS, V37, P5271, DOI 10.1364/AO.37.005271
   Ramya V, 2012, PROCEDIA ENGINEER, V30, P869, DOI 10.1016/j.proeng.2012.01.939
   Ravi A, 2015, PLASMONICS, V10, P1505, DOI 10.1007/s11468-015-9963-9
   Sanders M, 2014, BIOSENS BIOELECTRON, V61, P95, DOI 10.1016/j.bios.2014.05.009
   Schmitt K, 2007, BIOSENS BIOELECTRON, V22, P2591, DOI 10.1016/j.bios.2006.10.016
   Shukla T, 2011, SENSOR LETT, V9, P533, DOI 10.1166/sl.2011.1508
   Wang ZJ, 2016, NANO ENERGY, V19, P328, DOI 10.1016/j.nanoen.2015.11.032
   Washburn AL, 2009, ANAL CHEM, V81, P9499, DOI 10.1021/ac902006p
   Yoon HJ, 2011, SENSOR ACTUAT B-CHEM, V157, P310, DOI 10.1016/j.snb.2011.03.035
   Zhan ZB, 2015, ACS NANO, V9, P4583, DOI 10.1021/acsnano.5b01226
   Zhang BY, 2010, ENERG FUEL, V24, P2530, DOI 10.1021/ef901446n
   Zhdanov AV, 2010, INTEGR BIOL-UK, V2, P443, DOI 10.1039/c0ib00021c
NR 34
TC 0
Z9 0
U1 8
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1955
EI 1557-1963
J9 PLASMONICS
JI Plasmonics
PD JUN
PY 2017
VL 12
IS 3
BP 563
EP 570
DI 10.1007/s11468-016-0298-y
PG 8
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA EU2XO
UT WOS:000400893400005
OA No
DA 2017-08-17
ER

PT J
AU Fouad, DM
   El-Said, WA
   Ali, MH
   El-Gahami, MA
AF Fouad, Dina M.
   El-Said, Waleed A.
   Ali, Mohamed H.
   El-Gahami, Mohamed A.
TI Silica-Gold Nanocomposite for Removal of Organophosphorous Pesticides
SO PLASMONICS
LA English
DT Article
DE Nanocomposite; Mesoporous silica; Gold NPs; Adsorption; Methacrifos
ID ACTIVATED CARBON; ADSORPTION; NANOPARTICLES; MALATHION; SORPTION;
   MCM-41; 2,4-D; WATER; ACID
AB Mesoporous silica nanoparticles-gold nanoparticles (MSNPs/AuNPs) nanocomposite was prepared using mono-dispersed mesoporous silica as a template for gold nanoparticles without any functional group on the silica surface. The growth of gold layer over the surface of mesoporous silica nanoparticles (MSNPs) was demonstrated via scanning electron microscopies (SEM), Fourier transform infrared (FTIR) spectra, high-resolution transmission electron microscopy (HRTEM), and ultraviolet-visible (UV) adsorption spectrum. The presence of gold on the mesoporous nanoparticles gave an absorption band at 520 nm, also X-ray diffraction (XRD) indicated the crystal structure of gold NPs which has a cubic shape. Raman spectra proofed the high ability of MSNPs/AuNPs nanocomposite for removing methacrifos from water which was also confirmed by using high-performance liquid chromatography (HPLC) at room temperature where the removal rate exceeded 98 %. MSNPs/AuNPs nanocomposite has high capacity as an adsorbent which could be considered as a new eco-friendly strategy for pesticide removal and appears to be the new promising material in water treatment application.
C1 [Fouad, Dina M.; El-Said, Waleed A.; Ali, Mohamed H.; El-Gahami, Mohamed A.] Assiut Univ, Dept Chem, Fac Sci, Assiut 71516, Egypt.
RP Fouad, DM (reprint author), Assiut Univ, Dept Chem, Fac Sci, Assiut 71516, Egypt.
EM dinafouad93@hotmail.com
CR Aksu Z, 2004, SEP PURIF TECHNOL, V35, P223, DOI 10.1016/S1383-5866(03)00144-8
   Bavcon M, 2003, CHEMOSPHERE, V50, P595, DOI 10.1016/S0045-6535(02)00643-4
   Chen SS, 2004, DESALINATION, V160, P103, DOI 10.1016/S0011-9164(04)90000-8
   Chingombe P, 2006, J COLLOID INTERF SCI, V297, P434, DOI 10.1016/j.jcis.2005.10.054
   Colosio C, 2009, NEUROTOXICOLOGY, V30, P1155, DOI 10.1016/j.neuro.2009.09.001
   Sanchez Cortes S, 2001, LANGMUIR, V17, P1157
   Costi R, 2010, ANGEW CHEM INT EDIT, V49, P4878, DOI 10.1002/anie.200906010
   El-Safty SA, 2010, CHEM COMMUN, V46, P3917, DOI 10.1039/c001654c
   El-Said WA, 2016, SENSOR ACTUAT B-CHEM, V228, P401, DOI 10.1016/j.snb.2016.01.041
   El-Sayed MA, 2001, ACCOUNTS CHEM RES, V34, P257, DOI 10.1021/ar960016n
   Fouad DM, 2013, PLASMONICS, V8, P937, DOI 10.1007/s11468-013-9493-2
   Fouad DM, 2015, SPECTROCHIM ACTA A, V140, P392, DOI 10.1016/j.saa.2014.12.097
   Fouad DM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/45/455705
   Gupta VK, 2006, J COLLOID INTERF SCI, V299, P556, DOI 10.1016/j.jcis.2006.02.017
   Jokanovic M, 2009, CURR MED CHEM, V16, P2177
   Kreibig U., 1995, OPTICAL PROPERTIES M
   Liu BH, 2012, ANAL CHEM, V84, P255, DOI 10.1021/ac202452t
   Mangrulkar PA, 2008, J HAZARD MATER, V160, P414, DOI 10.1016/j.jhazmat.2008.03.013
   Ng EP, 2008, MICROPOR MESOPOR MAT, V114, P1, DOI 10.1016/j.micromeso.2007.12.022
   Nyazi K, 2005, CARBON, V43, P2218, DOI 10.1016/j.carbon.2005.03.015
   Pozo O, 2001, CHROMATOGR A, V75, P923
   Sperling RA, 2008, CHEM SOC REV, V9, P37
   Yair S, 2008, CRIT REV BIOTECHNOL, V28, P265, DOI 10.1080/07388550802455742 
   Zhao XS, 2001, COLLOID SURFACE A, V179, P261, DOI 10.1016/S0927-7757(00)00646-4
NR 24
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1955
EI 1557-1963
J9 PLASMONICS
JI Plasmonics
PD JUN
PY 2017
VL 12
IS 3
BP 869
EP 875
DI 10.1007/s11468-016-0338-7
PG 7
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA EU2XO
UT WOS:000400893400043
OA No
DA 2017-08-17
ER

PT J
AU Raafat, AI
   Ali, AE
AF Raafat, Amany Ismael
   Ali, Amr El-Hag
TI pH-controlled drug release of radiation synthesized graphene
   oxide/(acrylic acid-co-sodium alginate) interpenetrating network
SO POLYMER BULLETIN
LA English
DT Article
DE Alginate; Graphene oxide; Swelling characteristics; Drug delivery
   systems; Biocomposites
ID ANTICANCER DRUG; DELIVERY-SYSTEM; MECHANICAL-PROPERTIES; COMPOSITE
   FILMS; OXIDE; HYDROGELS; CARRIERS; NANOCOMPOSITES; NANOPARTICLES;
   NANOSHEETS
AB Hydrogel biocomposites containing a combination of graphene oxide (GO) and natural polymer-based copolymer of sodium alginate (Alg) and acrylic acid (AAc) were prepared by radiation-induced copolymerization and crosslinking. FTIR, XRD, and AFM analyses revealed the successful preparation of single-layered graphene oxide sheets. FTIR and TGA data confirmed the incorporation of GO within the (AAc-co-Alg) copolymer hydrogel. The effect of GO content, as interpenetrating network, on the swelling behavior of (AAc-co-Alg) copolymer hydrogel was investigated. The results of the pH-dependent swelling showed the presence of GO within the prepared hydrogel improve the ability of the GO/(AAc-co-Alg) nanocomposite hydrogel to bypass the acidity of the simulated stomach medium (pH 1) without significant swelling and regulate it for longer period in simulated intestine medium (pH 7). Moreover, the swelling kinetics showed that all the samples under investigation possess Fickian at pH 1 and non-Fickian at pH 7. The evaluation of the prepared GO/(AAc-co-Alg) nanocomposite hydrogel as drug carrier was carried out in either simulated stomach and intestine media using cefadroxil as a model drug. The drug release profile came in a good agreement with swelling results which recommend the GO/(AAc-co-Alg) nanocomposite hydrogel as potential targeted drug delivery system.
C1 [Raafat, Amany Ismael; Ali, Amr El-Hag] Atom Energy Author, Natl Ctr Radiat Res & Technol, Dept Polymer Chem, POB 29, Cairo 11731, Egypt.
RP Raafat, AI (reprint author), Atom Energy Author, Natl Ctr Radiat Res & Technol, Dept Polymer Chem, POB 29, Cairo 11731, Egypt.
EM ismaelraafat_a@hotmail.com
CR Aderibigbe BA, 2015, COLLOID POLYM SCI, V293, P409, DOI 10.1007/s00396-014-3400-z
   Ali AEH, 2006, RADIAT PHYS CHEM, V75, P1041, DOI 10.1016/j.radphyschem.2005.05.022
   Ali AEH, 2009, CARBOHYD POLYM, V78, P725, DOI 10.1016/j.carbpol.2009.06.009
   Ali AEH, 2008, J MACROMOL SCI A, V45, P628, DOI 10.1080/10601320802168751
   Bai H, 2010, CHEM COMMUN, V46, P2376, DOI 10.1039/c000051e
   Cardenas G, 2000, EUR POLYM J, V36, P1091, DOI 10.1016/S0014-3057(99)00187-1
   Chandra S, 2010, MATER SCI ENG B-ADV, V167, P133, DOI 10.1016/j.mseb.2010.01.029
   Choi KS, 2010, LANGMUIR, V26, P12902, DOI 10.1021/la101698j
   Choi SH, 2012, J MACROMOL SCI B, V51, P197, DOI 10.1080/00222348.2011.583193
   Colombo P., 2000, PHARM SCI TECHNOL TO, V3, P198, DOI 10.1016/S1461-5347(00)00269-8
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gupta S, 2015, J ELECTRON MATER, V44, P4492, DOI 10.1007/s11664-015-4016-x
   Han SJ, 2014, J MACROMOL SCI B, V53, P1193, DOI 10.1080/00222348.2013.879804
   Ionita M, 2013, CARBOHYD POLYM, V94, P339, DOI 10.1016/j.carbpol.2013.01.065
   Kim F, 2010, ADV MATER, V22, P1954, DOI 10.1002/adma.200903932
   Kim H, 2010, MACROMOLECULES, V43, P6515, DOI 10.1021/ma100572e
   Lan Z, 2015, J APPL POLYM SCI, V132, DOI [10.1002/app.42648, 10.1002/APP.42648]
   Liao KH, 2011, ACS NANO, V5, P1253, DOI 10.1021/nn1028967
   Luo YL, 2009, MATER CHEM PHYS, V118, P329, DOI 10.1016/j.matchemphys.2009.07.063
   Miao W, 2013, BIOMATERIALS, V34, P9638, DOI 10.1016/j.biomaterials.2013.08.058
   Paredes JI, 2008, LANGMUIR, V24, P10560, DOI 10.1021/la801744a
   Puri P, 2015, J ELECTRON MATER, V44, P4255, DOI 10.1007/s11664-015-4004-1
   Raafat AI, 2010, J APPL POLYM SCI, V118, P2642, DOI 10.1002/app.32601
   Rapoport N, 2015, J CONTROL RELEASE, V206, P153, DOI 10.1016/j.jconrel.2015.03.010
   Reddy KR, 2015, APPL CATAL A-GEN, V489, P1, DOI 10.1016/j.apcata.2014.10.001
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Said AEA, 2005, BIOMATERIALS, V26, P2733, DOI 10.1016/j.biomaterials.2004.07.049
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Si Y, 2008, NANO LETT, V8, P1679, DOI 10.1021/nl080604h
   Sirc J, 2015, PHYSIOL RES, V64, pS51
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Sun ST, 2011, J MATER CHEM, V21, P4095, DOI 10.1039/c1jm10276a
   Sundar S, 2014, POWDER TECHNOL, V266, P321, DOI 10.1016/j.powtec.2014.06.033
   Vadukumpully S, 2011, CARBON, V49, P198, DOI 10.1016/j.carbon.2010.09.004
   Wang J, 2014, COLLOID SURFACE B, V113, P223, DOI 10.1016/j.colsurfb.2013.09.009
   Wegrzyn M, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42793
   Wu R, 2015, RSC ADV, V5, P49182, DOI 10.1039/c5ra02099a
   Xue MY, 2015, INT J PHARMACEUT, V495, P771, DOI 10.1016/j.ijpharm.2015.08.056
   Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k
   Zhang J, 2010, ACTA BIOMATER, V6, P445, DOI 10.1016/j.actbio.2009.07.001
   Zhao X, 2010, MACROMOLECULES, V43, P9411, DOI 10.1021/ma101456y
   Zhou QL, 2015, J POWER SOURCES, V296, P186, DOI 10.1016/j.jpowsour.2015.07.012
NR 44
TC 0
Z9 0
U1 20
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0170-0839
EI 1436-2449
J9 POLYM BULL
JI Polym. Bull.
PD JUN
PY 2017
VL 74
IS 6
BP 2045
EP 2062
DI 10.1007/s00289-016-1818-9
PG 18
WC Polymer Science
SC Polymer Science
GA EU4AD
UT WOS:000400971300007
OA No
DA 2017-08-17
ER

PT J
AU Mousaa, IM
   Radi, H
AF Mousaa, I. M.
   Radi, H.
TI Photosynthesis of anticorrosive protective coatings for steel substrate
   based on acrylated oil containing unsaturated amino acid compounds
SO PROGRESS IN ORGANIC COATINGS
LA English
DT Article
DE Corrosion inhibitors; Coating; Mild steel; Weight loss
ID VOLATILE ORGANIC-COMPOUNDS; MILD-STEEL; CORROSION-INHIBITORS; HCL
   SOLUTION; DERIVATIVES; RESISTANCE
AB Novel environment friendly anticorrosive coating formulations for mild steel substrate based on acrylated oil were prepared by using unsaturated amino acid compounds. In the first, epoxidized soybean oil acrylate (ESOA) was hardened and modified by the different functionality of monomers to be used in anticorrosive coating formulations. In this article, new corrosion inhibitors were synthesized through two steps. In step one; renewable resource based palm oil was epoxidized under a well-established condition to form epoxidized triglyceride ester of palm oil (EPO). FTIR and oxirane content analysis were used to confirm the formation of the epoxidation reaction. In step two, the EPO was reacted chemically with 4-aminobenzoic acid (AB) and 2-aminoacrylic acid (AA) under controlled conditions of an inert atmosphere and high temperature to produce EPO/AB and EPO/AA adducts. The prepared adducts were characterized by FTIR-spectroscopy and oxirane content analysis. The adducts are evaluated as corrosion inhibitors via adding different concentrations of them to the ESOA coating formulations. Then all coating films were subjected to UV irradiation. Degrees of rusting, blistering, failure at scribe, and weight loss values were measured for all UV cured films, in addition to the chemical and mechanical measurements. The obtained experimental results revealed that the cured coating films containing EPO/AB inhibitor displayed higher resistance to corrosion on the mild steel substrate than EPO/AA without any effect on the mechanical and chemical properties of cured films. Also, the optimum concentration of the prepared inhibitors was to be 0.5%. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Mousaa, I. M.; Radi, H.] Atom Energy Author, Natl Ctr Radiat Res & Technol, Radiat Res Div, Radiat Chem Dept, Cairo 29, Egypt.
RP Mousaa, IM (reprint author), Atom Energy Author, Natl Ctr Radiat Res & Technol, Radiat Res Div, Radiat Chem Dept, Cairo 29, Egypt.
EM issa_moss@yahoo.com
CR Abiola O. K., 2002, J CORROS SCI ENG, V21, P117
   AJMAL M, 1994, CORROS SCI, V36, P79, DOI 10.1016/0010-938X(94)90110-4
   BADRAN BM, 1976, J OIL COLOUR CHEM AS, V59, P291
   Badran B. M., 1994, PIGM RESIN TECHNOL, V23, P10
   Bandres M, 2011, CR CHIM, V14, P636, DOI 10.1016/j.crci.2010.07.008
   Bobina M, 2013, CORROS SCI, V69, P389, DOI 10.1016/j.corsci.2012.12.020
   Boruah M, 2012, PROG ORG COAT, V74, P596, DOI 10.1016/j.porgcoat.2012.02.007
   Bouklah M, 2006, CORROS SCI, V48, P2831, DOI 10.1016/j.corsci.2005.08.019
   Eddy N. O., 2009, Port. Electrochim. Acta, V27, P443
   El-Din MRN, 2015, J IND ENG CHEM, V24, P342, DOI 10.1016/j.jiec.2014.10.007
   Gonzalez-Garcia Y, 2007, CORROS SCI, V49, P3514, DOI 10.1016/j.corsci.2007.03.018
   Hussin MH, 2016, MEASUREMENT, V78, P90, DOI 10.1016/j.measurement.2015.10.007
   Kosari A, 2014, CORROS SCI, V78, P138, DOI 10.1016/j.corsci.2013.09.009
   Liu XW, 2009, PROG ORG COAT, V64, P497, DOI 10.1016/j.porgcoat.2008.08.012
   Mohamed HA, 2010, CORROS ENG SCI TECHN, V45, P262, DOI 10.1179/174327809X397839
   Mohamed HA, 2001, J APPL POLYM SCI, V80, P286, DOI 10.1002/1097-4628(20010411)80:2<286::AID-APP1098>3.0.CO;2-5
   Obot IB, 2010, CORROS SCI, V52, P198, DOI 10.1016/j.corsci.2009.09.002
   Pirvu C, 2010, PROG ORG COAT, V68, P274, DOI 10.1016/j.porgcoat.2010.03.014
   Qiana B, 2013, CORROS SCI, V75, P184, DOI 10.1016/j.corsci.2013.06.001
   Ramezanzadeh B, 2011, MATER CHEM PHYS, V130, P1208, DOI 10.1016/j.matchemphys.2011.08.065
   Rengasamy S, 2013, PROG ORG COAT, V76, P78, DOI 10.1016/j.porgcoat.2012.08.012
   Sherif EM, 2010, ELECTROCHIM ACTA, V55, P3657, DOI 10.1016/j.electacta.2010.01.117
   Shihab MS, 2014, J MOL STRUCT, V1076, P658, DOI 10.1016/j.molstruc.2014.08.038
   Tang YM, 2013, CORROS SCI, V74, P271, DOI 10.1016/j.corsci.2013.04.053
   Wang SB, 2007, ENVIRON INT, V33, P694, DOI 10.1016/j.envint.2007.02.011
   Wan Rosli WD, 2003, EUR POLYM J, V39, P593, DOI [10.1016/S0014-3057(02)00241-0, DOI 10.1016/S0014-3057(02)00241-0]
   Xu HP, 2012, PROG ORG COAT, V73, P47, DOI 10.1016/j.porgcoat.2011.08.019
   Yan YG, 2013, CORROS SCI, V73, P123, DOI 10.1016/j.corsci.2013.03.031
   Zafar S, 2008, J APPL POLYM SCI, V107, P215, DOI 10.1002/app.27022
NR 29
TC 1
Z9 1
U1 10
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0300-9440
J9 PROG ORG COAT
JI Prog. Org. Coat.
PD JUN
PY 2017
VL 107
BP 18
EP 28
DI 10.1016/j.porgcoat.2017.03.006
PG 11
WC Chemistry, Applied; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA EU7LS
UT WOS:000401216900004
OA No
DA 2017-08-17
ER

PT J
AU Deyab, MA
   Ouarsal, R
   Al-Sabagh, AM
   Lachkar, M
   El Bali, B
AF Deyab, M. A.
   Ouarsal, Rachid
   Al-Sabagh, A. M.
   Lachkar, Mohammed
   El Bali, B.
TI Enhancement of corrosion protection performance of epoxy coating by
   introducing new hydrogenphosphate compound
SO PROGRESS IN ORGANIC COATINGS
LA English
DT Article
DE Epoxy coating; Corrosion resistance; Hydrogenphosphate; Electrochemical;
   Carbon steel
ID SODIUM-CHLORIDE SOLUTION; CARBON-STEEL; HYDROTHERMAL SYNTHESIS;
   MECHANICAL-PROPERTIES; CATHODIC PROTECTION; MILD-STEEL; NANO-TUBES;
   RESISTANCE; PHOSPHITE; PARTICLES
AB (NH4)(2)[Mg(H2O)(6)](3)(HP0(3))(4) (MgHP) was synthesized by a wet chemistry route and characterized by IR spectroscopy. The influence of MgHP on the anti-corrosion and mechanical properties of epoxy coating were investigated using electrochemical impedance spectroscopy (EIS), nano-indentation and scanning electron microscopy (SEM) techniques as well as the water uptake measurements. The performance of new epoxy coating was investigated for coated carbon steel in 3.5 wt% NaCI solution. Results showed that the incorporation of MgHP particles increased anti-corrosion and mechanical properties of epoxy coating. The epoxy coating performance enhances with increasing concentration of MgHP particles up 1.0%. It was observed that the volume of water uptake by epoxy coating reduced after modification with MgHP particles as compared to neat epoxy coating. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Deyab, M. A.; Al-Sabagh, A. M.] Egyptian Petr Res Inst, POB 11727, Cairo, Egypt.
   [Ouarsal, Rachid; Lachkar, Mohammed; El Bali, B.] Univ Sidi Mohamed Ben Abdellah, Fac Sci, Lab Ingn Mat Organometall & Mol, Unite Associee CNRST URAC 19, BP 1796 Atlas, Fes 30000, Morocco.
RP Deyab, MA (reprint author), Egyptian Petr Res Inst, POB 11727, Cairo, Egypt.
EM hamadadeiab@yahoo.com
CR Abdallah KI, 2006, ACTA CRYSTALLOGR C, V62, pI43, DOI 10.1107/S0108270106008882
   Al-Sabagh AM, 2012, EGYPT J PETROL, V21, P89
   Becker O, 2002, POLYMER, V43, P4365, DOI 10.1016/S0032-3861(02)00269-0
   BONAVIA G, 1995, CHEM MATER, V7, P1995, DOI 10.1021/cm00059a002
   Brouzi K, 2004, J RAMAN SPECTROSC, V35, P41, DOI 10.1002/jrs.1078
   Cheetham AK, 1999, ANGEW CHEM INT EDIT, V38, P3268, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3268::AID-ANIE3268>3.0.CO;2-U
   Deyab MA, 2017, PROG ORG COAT, V105, P286, DOI 10.1016/j.porgcoat.2017.01.008
   Deyab MA, 2017, PROG ORG COAT, V105, P245, DOI 10.1016/j.porgcoat.2016.12.026
   Deyab MA, 2016, J MOL LIQ, V220, P513, DOI 10.1016/j.molliq.2016.04.115
   Deyab MA, 2016, J MOL LIQ, V219, P994, DOI 10.1016/j.molliq.2016.04.027
   Deyab MA, 2016, J MOL LIQ, V216, P699, DOI 10.1016/j.molliq.2016.01.092
   Deyab MA, 2016, J MOL LIQ, V216, P636, DOI 10.1016/j.molliq.2016.01.075
   Deyab MA, 2016, DESALINATION, V384, P60, DOI 10.1016/j.desal.2016.02.001
   Deyab MA, 2015, RSC ADV, V5, P64326, DOI 10.1039/c5ra08119j
   Deyab MA, 2015, PROG ORG COAT, V85, P146, DOI 10.1016/j.porgcoat.2015.04.003
   Deyab MA, 2015, RSC ADV, V5, P48868, DOI 10.1039/c5ra06611e
   Deyab MA, 2014, J POWER SOURCES, V268, P50, DOI 10.1016/j.jpowsour.2014.06.021
   Deyab MA, 2014, MATER CHEM PHYS, V146, P406, DOI 10.1016/j.matchemphys.2014.03.045
   Deyab MA, 2013, J POWER SOURCES, V242, P86, DOI 10.1016/j.jpowsour.2013.05.066
   Deyab MA, 2009, J SOLID STATE ELECTR, V13, P1737, DOI 10.1007/s10008-009-0848-8
   Eltai EO, 2013, PROG ORG COAT, V76, P548, DOI 10.1016/j.porgcoat.2012.11.006
   Feng PY, 2005, ACCOUNTS CHEM RES, V38, P293, DOI 10.1021/ar0401754
   Fernandez S, 2002, CHEM MATER, V14, P2300, DOI 10.1021/cm0112845
   Fernandez S, 2002, ANGEW CHEM INT EDIT, V41, P3683, DOI 10.1002/1521-3773(20021004)41:19<3683::AID-ANIE3683>3.0.CO;2-J
   Fu WS, 2003, J SOLID STATE CHEM, V174, P11, DOI 10.1016/S0022-4596(03)00179-8
   Hare C. H., 1979, FEDERATION SERIES CO
   Harrison WTA, 2001, J CHEM SOC DALTON, P2459, DOI 10.1039/b102007m
   Haruyama S., 1987, ELECTROCHEM SOC P, V87, P197
   Jiang JX, 2010, ANGEW CHEM INT EDIT, V49, P3120, DOI 10.1002/anie.200904016
   Kalendova A, 2009, PROG ORG COAT, V64, P5, DOI 10.1016/j.porgcoat.2008.07.003
   Kreuer KD, 2000, SOLID STATE IONICS, V136, P149, DOI 10.1016/S0167-2738(00)00301-5
   Liang J, 2003, CHEM COMMUN, P882, DOI 10.1039/b212181f
   MARCOS MD, 1993, INORG CHEM, V32, P5044, DOI 10.1021/ic00075a017
   Messouri I, 2005, ACTA CRYSTALLOGR E, V61, pI129, DOI 10.1107/s160053680501723X
   Migahed MA, 2013, EGYPT J PETROL, V22, P149
   Miskovic-Stankovic VB, 1999, PROG ORG COAT, V36, P53, DOI 10.1016/S0300-9440(99)00024-7
   Nakamoto K., 1997, INFRARED RAMAN SPE A
   Natarajan S, 2008, ANGEW CHEM INT EDIT, V47, P4798, DOI 10.1002/anie.200701404
   Ngopoh FAI, 2015, J CHEM CRYSTALLOGR, V45, P369, DOI 10.1007/s10870-015-0603-1
   Norsworthy R., 2009, 4017 NACE INT
   Ouarsal R, 2005, ACTA CRYSTALLOGR E, V61, pI171, DOI 10.1107/S1600536805021720
   Ouarsal R, 2005, ACTA CRYSTALLOGR E, V61, pI168, DOI 10.1107/S1600536805021719
   Ouarsal R, 2003, ACTA CRYSTALLOGR E, V59, pI33, DOI 10.1107/S1600536803002757
   Park JH, 2002, CORROS SCI, V44, P1087, DOI 10.1016/S0010-938X(01)00118-4
   Parnham ER, 2007, ACCOUNTS CHEM RES, V40, P1005, DOI 10.1021/ar700025k
   Peabody A. W., 2001, CONTROL PIPELINE COR
   PHILIP D, 1990, J RAMAN SPECTROSC, V21, P523, DOI 10.1002/jrs.1250210810
   POWELL DR, 1994, ACTA CRYSTALLOGR C, V50, P342, DOI 10.1107/S0108270193008169
   Qian YY, 2015, INT J ELECTROCHEM SC, V10, P10756
   Ranade S, 2016, PROG ORG COAT, V101, P111, DOI 10.1016/j.porgcoat.2016.08.007
   Rashvand M, 2013, PROG ORG COAT, V76, P1413, DOI 10.1016/j.porgcoat.2013.04.013
   Shi SH, 2004, J SOLID STATE CHEM, V177, P3038, DOI [10.1016/j.jssc.2004.05.002, 10.1016/j.jssc.20045.05.002]
   Shi XM, 2009, SURF COAT TECH, V204, P237, DOI 10.1016/j.surfcoat.2009.06.048
   Suay JJ, 2003, PROG ORG COAT, V46, P121, DOI 10.1016/S0300-9440(02)00219-9
   Tracton A. A., 2006, COATINGS MATERIALS S
   Wang Y, 2003, J SOLID STATE CHEM, V170, P303, DOI 10.1016/S0022-4596(02)00090-7
NR 56
TC 0
Z9 0
U1 9
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0300-9440
J9 PROG ORG COAT
JI Prog. Org. Coat.
PD JUN
PY 2017
VL 107
BP 37
EP 42
DI 10.1016/j.porgcoat.2017.03.014
PG 6
WC Chemistry, Applied; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA EU7LS
UT WOS:000401216900006
OA No
DA 2017-08-17
ER

PT J
AU Sharshir, SW
   Elsheikh, AH
   Peng, GL
   Yang, N
   El-Samadony, MOA
   Kabeel, AE
AF Sharshir, S. W.
   Elsheikh, A. H.
   Peng, Guilong
   Yang, Nuo
   El-Samadony, M. O. A.
   Kabeel, A. E.
TI Thermal performance and exergy analysis of solar stills - A review
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review
DE Solar still; Desalination; Thermal performance; Energy balance; Exergy
   balance; Review
ID FLAT-PLATE COLLECTOR; TILTED WICK STILL; GLASS COVER;
   HUMIDIFICATION-DEHUMIDIFICATION; DESALINATION SYSTEM; BASIN TYPE;
   CHARACTERISTIC EQUATION; MASS-TRANSFER; WATER DEPTH; EXPERIMENTAL
   VALIDATION
AB Over recent decades, the global demand for freshwater is increasing rapidly; however, the supply of freshwater is limited. Solar still (SS) is a valuable solar device that is used for converting the brackish and saline water into purified water. Several investigations depicted in literature have been performed, either experimentally or theoretically, on SS to assess its performance under different climatic and operational conditions. Apart from experimental studies, theoretical analysis is beneficial for evaluating the effectiveness of virtually designed SS. The theoretical analysis and simulation modeling of SSs can provide clear understanding on the mechanics, which may give directions on the design setup in experiments. In this review different theoretical approaches which have been used to assess the thermal performance of SS and exergy analysis of such devices are discussed. The reviewed studies indicate that the productivity of the SS depends on different external and internal operating parameters. In addition, the distillate quantity varies according to the design features and the related technical advancements of the SS. Our findings indicate that there are still few more parameters and design aspects to be considered while designing new SS. The objective of,his paper is to highlight design methods so as to allow the researchers to optimize the SS for further development. Recommendations for further research have been also proposed.
C1 [Sharshir, S. W.; Peng, Guilong; Yang, Nuo] Huazhong Univ Sci & Technol, State Key Lab Coal Combust, Wuhan 430074, Peoples R China.
   [Sharshir, S. W.; Peng, Guilong; Yang, Nuo] Huazhong Univ Sci & Technol, Sch Energy & Power Engn, Nano Interface Ctr Energy, Wuhan 430074, Peoples R China.
   [Sharshir, S. W.] Kafrelsheikh Univ, Mech Engn Dept, Fac Engn, Kafrelsheikh, Egypt.
   [Elsheikh, A. H.] Tanta Univ, Prod Engn & Mech Design Dept, Fac Engn, Tanta, Egypt.
   [Elsheikh, A. H.] Huazhong Univ Sci & Technol, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Hubei, Peoples R China.
   [El-Samadony, M. O. A.; Kabeel, A. E.] Tanta Univ, Mech Power Engn Dept, Fac Engn, Tanta, Egypt.
RP Sharshir, SW; Yang, N (reprint author), Huazhong Univ Sci & Technol, State Key Lab Coal Combust, Wuhan 430074, Peoples R China.
EM swellamali@yahoo.com; nuo@hust.edu.cn
FU National Natural Science Foundation of China - China [51576076]
FX N.Y. was sponsored by the National Natural Science Foundation of China -
   China (No. 51576076).
CR Abdallah S, 2008, DESALINATION, V219, P222, DOI 10.1016/j.desal.2007.05.015
   Abdallah S, 2009, DESALINATION, V242, P128, DOI 10.1016/j.desal.2008.03.036
   Abdullah AS, 2013, DESALINATION, V319, P60, DOI 10.1016/j.desal.2013.04.003
   Abu-Hijleh BAK, 2003, ENERG CONVERS MANAGE, V44, P1411, DOI 10.1016/S0196-8904(02)00162-0
   AbuHijleh BAK, 1996, DESALINATION, V107, P235, DOI 10.1016/S0011-9164(96)00165-8
   AbuHijleh BAK, 1997, ENERGY, V22, P43, DOI 10.1016/S0360-5442(96)00088-6
   A1-Hamadani AAF, 2014, DISTRIB GENER ALTEM, V29, P7
   Ahmed S. T., 1988, Solar & Wind Technology, V5, P637, DOI 10.1016/0741-983X(88)90061-6
   Al-Hinai H, 2002, DESALINATION, V150, P75, DOI 10.1016/S0011-9164(02)00931-1
   Al-Hinai H, 2002, ENERG CONVERS MANAGE, V43, P1639, DOI 10.1016/S0196-8904(01)00120-0
   Alaian WM, 2016, DESALINATION, V379, P10, DOI 10.1016/j.desal.2015.10.010
   Alaudeen A, 2014, J KING SAUD U ENG SC, V26, P176
   ALHUSSAINI H, 1994, RENEW ENERG, V5, P532, DOI 10.1016/0960-1481(94)90430-8
   ALHUSSAINI H, 1995, ENERG CONVERS MANAGE, V36, P1047, DOI 10.1016/0196-8904(95)00003-V
   Arunkumar T, 2016, RENEW ENERG, V88, P391, DOI 10.1016/j.renene.2015.11.051
   Arunkumar T, 2012, DESALINATION, V286, P342, DOI 10.1016/j.desal.2011.11.047
   Asbik M, 2016, DESALINATION, V381, P26, DOI 10.1016/j.desal.2015.11.031
   Badran AA, 2005, DESALINATION, V172, P227, DOI 10.1016/j.desal.2004.06.203
   Bait O, 2016, ENERGY, V98, P308, DOI 10.1016/j.energy.2016.01.017
   Bian YanHong, 2016, Desalination, V381, P95, DOI 10.1016/j.desal.2015.11.016
   Castillo-Tellez M, 2015, APPL THERM ENG, V75, P1192, DOI 10.1016/j.applthermaleng.2014.10.032
   Chen ZL, 2013, DESALINATION, V330, P42, DOI 10.1016/j.desal.2013.09.017
   Chong TL, 2014, DESALINATION, V347, P66, DOI 10.1016/j.desal.2014.05.023
   COOPER PI, 1973, SOL ENERGY, V15, P205, DOI 10.1016/0038-092X(73)90085-6
   Dabaghian Z, 2016, DESALINATION, V381, P117, DOI 10.1016/j.desal.2015.12.006
   Dehghan AA, 2015, SOL ENERGY, V115, P277, DOI 10.1016/j.solener.2015.02.038
   Deng RY, 2010, ENERGY, V35, P4368, DOI 10.1016/j.energy.2009.05.025
   Deniz E, 2013, ENVIRON PROG SUSTAIN, V32, P350, DOI 10.1002/ep.11612
   Dev R, 2012, DESALIN WATER TREAT, V41, P204, DOI 10.1080/19443994.2012.664715
   Dev R, 2011, DESALINATION, V267, P261, DOI 10.1016/j.desal.2010.09.037
   Dev R, 2011, DESALINATION, V269, P67, DOI 10.1016/j.desal.2010.10.043
   Dev R, 2010, DESALINATION, V254, P126, DOI 10.1016/j.desal.2009.12.004
   Dev R, 2009, DESALINATION, V245, P246, DOI 10.1016/j.desal.2008.07.011
   Dincer I, 2007, EXERGY: ENERGY, ENVIRONMENT AND SUSTAINABLE DEVELOPMENT, P1
   DiPippo R, 2004, GEOTHERMICS, V33, P565, DOI 10.1016/j.geothermics.2003.10.003
   Dwivedi VK, 2010, DESALINATION, V250, P49, DOI 10.1016/j.desal.2009.06.060
   Edalatpour M, 2015, INT COMMUN HEAT MASS, V66, P63, DOI 10.1016/j.icheatmasstransfer.2015.05.015
   El-Agouz SA, 2014, ENERG CONVERS MANAGE, V86, P186, DOI 10.1016/j.enconman.2014.05.021
   El-Bahi A, 1999, DESALINATION, V123, P79, DOI 10.1016/S0011-9164(99)00061-2
   El-Bialy E, 2014, ENERGY, V68, P117, DOI 10.1016/j.energy.2014.02.095
   El-Maghlany WM, 2015, ALEX ENG J, V54, P823, DOI 10.1016/j.aej.2015.06.010
   El-Samadony Y. A. F., 2016, Desalination, V384, P68, DOI 10.1016/j.desal.2016.01.031
   El-Samadony YAF, 2014, ENERGY, V68, P744, DOI 10.1016/j.energy.2014.01.080
   El-Sebaii AA, 2008, ENERG CONVERS MANAGE, V49, P2839, DOI 10.1016/j.enconman.2008.03.002
   El-Sebaii AA, 2009, DESALINATION, V249, P699, DOI 10.1016/j.desal.2009.02.060
   Estahbanati MRK, 2016, APPL ENERG, V165, P537, DOI 10.1016/j.apenergy.2015.12.047
   FATH HES, 1993, ENERG CONVERS MANAGE, V34, P63, DOI 10.1016/0196-8904(93)90008-X
   GARG HP, 1976, SOL ENERGY, V18, P159, DOI 10.1016/0038-092X(76)90052-9
   Gude VG, 2011, ENERGY, V36, P78, DOI 10.1016/j.energy.2010.11.008
   Hamed MH, 2015, DESALINATION, V358, P9, DOI 10.1016/j.desal.2014.12.005
   Hansen RS, 2015, DESALINATION, V358, P1, DOI 10.1016/j.desal.2014.12.006
   Heidari AA, 2005, DESALINATION, V183, P23, DOI 10.1016/j.desal.2005.02.042
   Hepbasli A, 2008, RENEW SUST ENERG REV, V12, P593, DOI 10.1016/j.rser.2006.10.001
   Incropera F. P., 2002, FUNDAMENTALS HEAT MA
   Janarthanan B, 2006, DESALINATION, V190, P51, DOI 10.1016/j.desal.2005.08.005
   Kabeel A, 2000, MANSOURA U J MEJ FAC, P25
   Kabeel AE, 2014, ENERG CONVERS MANAGE, V86, P268, DOI 10.1016/j.enconman.2014.05.050
   Kabeel AE, 2014, ENERGY, V68, P218, DOI 10.1016/j.energy.2014.02.094
   Kabeel AE, 2012, DESALINATION, V289, P12, DOI 10.1016/j.desal.2011.12.023
   Kabeel A.E., 2013, NAT RESOUR, V4, P286, DOI DOI 10.4236/NR.2013.43036
   Kalidasa M. K., 2010, APPL ENERG, V87, P514
   Kalidasa M. K., 2011, RENEW ENERG, V36, P612
   Kalidasa M.K., 2008, DESALINATION, V220, P687
   Kaushik SC, 2013, ENERG EFFIC, V6, P595, DOI 10.1007/s12053-013-9194-x
   Kianifar A, 2012, ENERGY, V38, P31, DOI 10.1016/j.energy.2011.12.046
   Kumar S, 2014, DESALINATION, V347, P15, DOI 10.1016/j.desal.2014.05.019
   Kumar S, 2011, INT J THERM SCI, V50, P2543, DOI 10.1016/j.ijthermalsci.2011.06.015
   LAWRENCE SA, 1990, ENERG CONVERS MANAGE, V30, P277, DOI 10.1016/0196-8904(90)90010-V
   Madhlopa A, 2009, RENEW ENERG, V34, P1668, DOI 10.1016/j.renene.2008.12.032
   Malaeb L, 2016, SOL ENERGY, V125, P360, DOI 10.1016/j.solener.2015.12.025
   Mahdi JT, 2011, DESALINATION, V267, P233, DOI DOI 10.1016/J.DESA1.2010.09.032
   Manikandan V, 2013, RENEW SUST ENERG REV, V20, P322, DOI 10.1016/j.rser.2012.11.046
   Matrawy KK, 2015, ENERG CONVERS MANAGE, V105, P1261, DOI 10.1016/j.enconman.2015.09.006
   Monowe P, 2011, DESALINATION, V280, P332, DOI 10.1016/j.desal.2011.07.031
   Morad MM, 2015, DESALINATION, V373, P1, DOI 10.1016/j.desal.2015.06.017
   Muftah AF, 2014, RENEW SUST ENERG REV, V32, P430, DOI 10.1016/j.rser.2013.12.052
   Nafey AS, 2001, ENERG CONVERS MANAGE, V42, P1401, DOI 10.1016/S0196-8904(00)00107-2
   Nassar YF, 2007, DESALINATION, V209, P177, DOI 10.1016/j.desal.2007.04.039
   NIJEGORODOV N, 1994, RENEW ENERG, V4, P123, DOI 10.1016/0960-1481(94)90074-4
   Ohshiro K, 1996, DESALINATION, V105, P207, DOI 10.1016/0011-9164(96)00078-1
   OKEKE CE, 1990, ENERGY, V15, P1071, DOI 10.1016/0360-5442(90)90035-Z
   Omara ZM, 2013, DESALINATION, V314, P67, DOI 10.1016/j.desal.2013.01.007
   Ozden E, ENERGY EXERGY EC ANA
   Panchal Hitesh N., 2015, Journal of King Saud University - Engineering Sciences, V27, P170, DOI 10.1016/j.jksues.2013.06.007
   Park SR, 2014, RENEW SUST ENERG REV, V30, P105, DOI 10.1016/j.rser.2013.09.011
   Prakash J., 1986, Solar & Wind Technology, V3, P119, DOI 10.1016/0741-983X(86)90023-8
   Prakash P, 2015, RENEW SUST ENERG REV, V49, P585, DOI 10.1016/j.rser.2015.04.136
   Rahbar N, 2013, ENERGY, V49, P289, DOI 10.1016/j.energy.2012.10.023
   Rajamanickam MR, 2012, ENRGY PROCED, V14, P1701
   Rajaseenivasan T, 2014, DESALINATION, V347, P131, DOI 10.1016/j.desal.2014.05.029
   Rajaseenivasan T., 2015, WATER TREAT, V55, P1786
   RAJVANSHI AK, 1981, SOL ENERGY, V27, P51, DOI 10.1016/0038-092X(81)90020-7
   Ranjan KR, 2013, INT J LOW CARBON TEC
   Rubio E, 2004, RENEW ENERG, V29, P895, DOI 10.1016/j.renene.2003.11.001
   Rubio-Cerda E, 2002, RENEW ENERG, V27, P301, DOI 10.1016/S0960-1481(01)00196-3
   Sahota L, 2016, DESALINATION, V388, P9, DOI 10.1016/j.desal.2016.02.039
   Sakthivel M, 2008, INT J ENERG RES, V32, P68, DOI 10.1002/er.1335
   Sethi AK, 2013, DESALIN WATER TREAT, V51, P7394, DOI 10.1080/19443994.2013.777945
   Shanmugan S, 2012, INT J AMBIENT ENERGY, V33, P142, DOI 10.1080/01430750.2012.686194
   Sharon H, 2015, RENEW SUST ENERG REV, V41, P1080, DOI 10.1016/j.rser.2014.09.002
   Sharshir SW, 2017, APPL THERM ENG, V113, P684, DOI 10.1016/j.applthermaleng.2016.11.085
   Sharshir SW, 2016, APPL THERM ENG, V108, P1268, DOI 10.1016/j.applthermaleng.2016.07.179
   Sharshir SW, 2016, ENERG CONVERS MANAGE, V124, P287, DOI 10.1016/j.enconman.2016.07.028
   Sharshir SW, 2016, APPL THERM ENG, V104, P734, DOI 10.1016/j.applthermaleng.2016.05.120
   Sherwood T. K., 1975, MASS TRANSFER
   SINGH AK, 1993, ENERG CONVERS MANAGE, V34, P697, DOI 10.1016/0196-8904(93)90105-J
   Singh SK, 1996, ENERG CONVERS MANAGE, V37, P247, DOI 10.1016/0196-8904(95)00166-B
   SODHA MS, 1981, SOL ENERGY, V26, P127, DOI 10.1016/0038-092X(81)90075-X
   Somanchi NS, 2015, AQUAT PR, V4, P1477, DOI 10.1016/j.aqpro.2015.02.191
   Somwanshi A, 2014, DESALINATION, V352, P92, DOI 10.1016/j.desal.2014.08.011
   Sotehi O, 2016, DESALINATION, V385, P1, DOI 10.1016/j.desal.2016.01.034
   Srithar K, 2016, RENEW ENERG, V90, P157, DOI 10.1016/j.renene.2015.12.063
   Srivastava PK, 2013, DESALINATION, V311, P198, DOI 10.1016/j.desal.2012.11.035
   Sun FM, 2014, RENEW ENERG, V66, P268, DOI 10.1016/j.renene.2013.12.015
   SZARGUT J, 1980, ENERGY, V5, P709, DOI 10.1016/0360-5442(80)90090-0
   Tanaka H, 2007, SOL ENERGY, V81, P1035, DOI 10.1016/j.solener.2006.11.006
   Tanaka H, 2017, DESALINATION, V402, P19, DOI 10.1016/j.desal.2016.09.031
   Tanaka H, 2016, DESALINATION, V377, P65, DOI 10.1016/j.desal.2015.09.013
   Tanaka H, 2009, DESALINATION, V249, P411, DOI 10.1016/j.desal.2009.06.048
   Tanaka H, 2009, DESALINATION, V249, P130, DOI 10.1016/j.desal.2009.02.057
   Tiris M, 1998, ENERGY CONVERS MANAG, P853
   Tiwari GN, 2009, DESALINATION, V242, P1, DOI 10.1016/j.desal.2008.03.027
   Tiwari GN, 2003, DESALINATION, V154, P171, DOI 10.1016/S0011-9164(03)80018-8
   TIWARI GN, 1985, ENERG CONVERS MANAGE, V25, P315, DOI 10.1016/0196-8904(85)90049-4
   Tiwari GN, 1996, APPL THERM ENG, V16, P189, DOI 10.1016/1359-4311(95)00053-G
   Tiwari GN, 2008, SOLAR DISTILLATION P
   Torchia-Nunez JC, 2008, RENEW ENERG, V33, P608, DOI 10.1016/j.renene.2007.04.001
   Tripathi R, 2005, DESALINATION, V173, P187, DOI 10.1016/j.desal.2004.08.03
   Nations U., 2016, WORLD POP INCR 2 6 B
   Vaithilingam S, 2014, DESALIN WATER TREAT, P1
   Velmurugan V, 2008, ENERGY, V33, P1719, DOI 10.1016/j.energy.2008.07.001
   Velmurugan V, 2008, ENERG CONVERS MANAGE, V49, P2602, DOI 10.1016/j.enconman.2008.05.010
   Velmurugan V, 2007, DESALINATION, V216, P232, DOI 10.1016/j.desal.2006.12.012
   Velmurugan V, 2009, DESALINATION, V249, P902, DOI 10.1016/j.desal.2009.06.070
   Velmurugan V, 2009, DESALINATION, V249, P143, DOI 10.1016/j.desal.2009.06.016
   Velmurugan V, 2009, ENERGY, V34, P1179, DOI 10.1016/j.energy.2009.04.029
   Vinoth K. K., 2008, DESALINATION, V230, P51, DOI DOI 10.1016/J.DESA1.2007.11.015
   Voropoulos K, 2001, DESALINATION, V138, P103, DOI 10.1016/S0011-9164(01)00251-X
   Will B, FORSCHUNG GEBIETE IN, V22, P167
   Xiao G, 2013, APPL ENERG, V103, P642, DOI 10.1016/j.apenergy.2012.10.029
   YADAV YP, 1991, ENERG CONVERS MANAGE, V31, P255, DOI 10.1016/0196-8904(91)90079-X
   Yuan GF, 2011, DESALINATION, V277, P92, DOI 10.1016/j.desal.2011.04.002
   Zhani K, 2011, ENERGY, V36, P3159, DOI 10.1016/j.energy.2011.03.005
   Zhani K, 2010, RENEW ENERG, V35, P2610, DOI 10.1016/j.renene.2010.03.033
   Zoori HA, 2013, DESALINATION, V325, P113, DOI 10.1016/j.desal.2013.07.004
   Zuo L, 2011, DESALINATION, V276, P207, DOI 10.1016/j.desal.2011.03.052
   Zurigat YH, 2004, APPL THERM ENG, V24, P1061, DOI 10.1016/j.applthermaleng.2003.11.010
   [Anonymous], 2008, THERM SCI, V12, P153
NR 148
TC 2
Z9 2
U1 6
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD JUN
PY 2017
VL 73
BP 521
EP 544
DI 10.1016/j.rser.2017.01.156
PG 24
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA EU7HA
UT WOS:000401204700042
OA No
DA 2017-08-17
ER

PT J
AU Shalaby, SM
AF Shalaby, S. M.
TI Reverse osmosis desalination powered by photovoltaic and solar Rankine
   cycle power systems: A review
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review
DE Reverse osmosis; Photovoltaic; Rankine cycle; Water desalination
ID MULTISTAGE FLASH DISTILLATION; WASTE HEAT-RECOVERY; WORKING FLUIDS; RO
   DESALINATION; ECONOMIC-FEASIBILITY; THERMAL PERFORMANCE; WATER
   DESALINATION; PRELIMINARY DESIGN; ENERGY; STILL
AB In this work, reverse osmosis water desalination plants powered by PV and solar RC cycle systems are reviewed in detail. This review focused on the display of different designs and software used to improve productivity of the desalination plants as well as the types of solar collectors used, membrane, heat transfer fluid and working fluid of the Rankine cycle. The specific energy consumption and cost of fresh water production are also of great interest in this work. According to the results presented in this review it is not recommended to use batteries with PV to drive RO desalination plants because of the high capital and replacement cost of batteries. It is also found that when the energy recovery devices are used, the pre-heating of feed water is not required, especially in the case of PV-RO systems. Currently most of working RO plants are driven by PV, whereas solar thermal power systems (usually using PTC with ORC) are still at the stage of theoretical research. Although, the PTC-ORC-RO desalination system is recommended, it has not yet been implemented on a large scale.
C1 [Shalaby, S. M.] USF, Coll Engn, Clean Energy Res Ctr, Tampa, FL USA.
   [Shalaby, S. M.] Tanta Univ, Fac Engn, Engn Phys & Math Dept, Tanta, Egypt.
RP Shalaby, SM (reprint author), Tanta Univ, Fac Engn, Engn Phys & Math Dept, Tanta, Egypt.
EM shalaby1@mail.usf.edu
CR Abdullah AS, 2013, DESALINATION, V319, P60, DOI 10.1016/j.desal.2013.04.003
   Abu-Jabal MS, 2001, DESALINATION, V137, P1, DOI 10.1016/S0011-9164(01)00197-7
   Alaudeen A, 2014, J KING SAUD U ENG SC, V26, P176
   Alghoul MA, 2016, RENEW ENERG, V93, P101, DOI 10.1016/j.renene.2016.02.015
   Ali MT, 2011, RENEW SUST ENERG REV, V15, P4187, DOI 10.1016/j.rser.2011.05.012
   Alsheghri A, 2015, ENRGY PROCED, V75, P319, DOI 10.1016/j.egypro.2015.07.365
   Angelino A, 2000, P 35 INT EN CONV ENG, V2, P1400
   Angelino G, 1998, ENERGY, V23, P449, DOI 10.1016/S0360-5442(98)00009-7
   Angelino G, 1984, P INT VDI SEM ZUR
   Angelino G, 2000, 2000 FUEL CELL SEM P
   [Anonymous], 2004, AMI MEMBR 2 5 SEAW F
   [Anonymous], ASP PLUS VERS 12 1 2
   Ayuthaya RPN, 2013, RENEW ENERG, V54, P227, DOI 10.1016/j.renene.2012.08.004
   Badawi WT, 1983, DESALINATION, V44, P153
   BADR O, 1985, APPL ENERG, V21, P1, DOI 10.1016/0306-2619(85)90072-8
   Bilton AM, 2011, RENEW ENERG, V36, P3246, DOI 10.1016/j.renene.2011.03.040
   Borsukiewicz-Gozdur A, 2007, ENERGY, V32, P344, DOI 10.1016/j.energy.2006.07.012
   Burn S, 2015, DESALINATION, V364, P2, DOI 10.1016/j.desal.2015.01.041
   Caputo R., 1981, SOLAR ENERGY HDB
   Bruno JC, 2008, APPL THERM ENG, V28, P2212, DOI 10.1016/j.applthermaleng.2007.12.022
   Chandrashekara M, 2017, RENEW SUST ENERG REV, V67, P1308, DOI 10.1016/j.rser.2016.08.058
   Cheah SF, 2004, 104 ITN EN SYST INC
   Childs WD, 1999, DESALINATION, V125, P155, DOI 10.1016/S0011-9164(99)00134-4
   Delgado-Torres AM, 2007, DESALINATION, V216, P292, DOI 10.1016/j.desal.2006.12.015
   Delgado-Torres AM, 2007, DESALINATION, V216, P252, DOI 10.1016/j.desal.2006.12.011
   Delgado-Torres AM, 2010, ENERG CONVERS MANAGE, V51, P2913, DOI 10.1016/j.enconman.2010.06.032
   [Anonymous], 2010, FILMTEC TAP WRAPP 25
   [Anonymous], 2006, ROSA REV OSM SYST AN
   [Anonymous], FILMT RO DES SOFTW R
   Duffie J.A., 1980, SOLAR ENG THERMAL PR
   El-Nashar AM, 2001, DESALINATION, V134, P173, DOI 10.1016/S0011-9164(01)00124-2
   El-Sebaii AA, 2015, RENEW SUST ENERG REV, V49, P1198, DOI 10.1016/j.rser.2015.04.161
   El-Sebaii AA, 2005, DESALINATION, V174, P23, DOI 10.1016/j.desal.2004.08.038
   El-Nashar AM, RENEWABLE ENERGY, V14, P263
   ERI -Energy Recovery Inc, PROD CAT
   EVANGELISTA F, 1985, IND ENG CHEM PROC DD, V24, P211, DOI 10.1021/i200028a036
   Farwati MA, 1997, ENERGY, V22, P1, DOI 10.1016/S0360-5442(96)00056-4
   Garcia-Rodriguez L, 1999, DESALINATION, V125, P133, DOI 10.1016/S0011-9164(99)00131-9
   Garcia-Rodriguez L, 1999, DESALINATION, V122, P215, DOI 10.1016/S0011-9164(99)00051-X
   Garcia-Rodriguez L, 2007, DESALINATION, V212, P319, DOI 10.1016/j.desal.2006.10.016
   Gawlik K, 1998, P GEOTH RES COUNC AN
   Geng DH, 2016, DESALINATION, V381, P38, DOI 10.1016/j.desal.2015.11.026
   Helal AM, 2008, DESALINATION, V221, P1, DOI 10.1016/j.desal.2007.01.064
   Herold D, 2001, DESALINATION, V137, P285, DOI 10.1016/S0011-9164(01)00230-2
   Hung TC, 1997, ENERGY, V22, P661, DOI 10.1016/S0360-5442(96)00165-X
   Hung TC, 2001, ENERG CONVERS MANAGE, V42, P539, DOI 10.1016/S0196-8904(00)00081-9
   Ibarra M, 2014, ENRGY PROCED, V49, P2251, DOI 10.1016/j.egypro.2014.03.238
   Jiang JY, 2009, RENEW ENERG, V34, P2798, DOI 10.1016/j.renene.2009.06.002
   Jones MA, 2016, DESALINATION, V387, P35, DOI 10.1016/j.desal.2016.02.035
   Kabeel AE, 2012, DESALINATION, V289, P12, DOI 10.1016/j.desal.2011.12.023
   Kelley LC, 2013, DESALINATION, V314, P10, DOI 10.1016/j.desal.2012.11.036
   Kosmadakis G, 2010, RENEW ENERG, V35, P989, DOI 10.1016/j.renene.2009.10.032
   Kosmadakis G, 2010, DESALINATION, V250, P323, DOI 10.1016/j.desal.2009.09.050
   Kosmadakis G, 2009, DESALINATION, V243, P74, DOI 10.1016/j.desal.2008.04.016
   Kosmadakis G, 2009, DESALIN WATER TREAT, V1, P114
   Kreith F, 1978, PRINCIPALS SOLAR ENG
   Kumarasamy S, 2015, DESALINATION, V375, P89, DOI 10.1016/j.desal.2015.07.029
   Lamei A, 2008, ENERG POLICY, V36, P1748, DOI 10.1016/j.enpol.2007.12.026
   Lemort V, 2009, APPL THERM ENG, V29, P3094, DOI 10.1016/j.applthermaleng.2009.04.013
   Li CN, 2013, RENEW SUST ENERG REV, V19, P136, DOI 10.1016/j.rser.2012.04.059
   Liu BT, 2004, ENERGY, V29, P1207, DOI 10.1016/j.energy.2004.01.004
   Maizza V, 2001, APPL THERM ENG, V21, P381, DOI 10.1016/S1359-4311(00)00044-2
   Manolakos D, 2008, DESALINATION, V221, P37, DOI 10.1016/j.desal.2007.01.066
   Manolakos D, 2007, DESALINATION, V203, P366, DOI 10.1016/j.desal.2006.04.018
   Manolakos D, 2005, DESALINATION, V183, P73, DOI 10.1016/j.desal.2005.02.044
   Manolakos D, 2009, SOL ENERGY, V83, P646, DOI 10.1016/j.solener.2008.10.014
   Moharned ES, 2008, DESALINATION, V221, P17, DOI 10.1016/j.desal.2007.01.065
   Moya E. Zarza, 2003, THESIS
   Nafey AS, 2010, RENEW ENERG, V35, P2571, DOI 10.1016/j.renene.2010.03.034
   Nafey AS, 2007, ENERG CONVERS MANAGE, V48, P528, DOI 10.1016/j.enconman.2006.06.010
   Nguyen VM, 2001, APPL THERM ENG, V21, P169, DOI 10.1016/S1359-4311(00)00052-1
   Omara ZM, 2013, DESALINATION, V314, P67, DOI 10.1016/j.desal.2013.01.007
   Omara ZM, 2011, DESALINATION, V277, P281, DOI 10.1016/j.desal.2011.04.042
   Penate B, 2012, DESALINATION, V284, P86, DOI 10.1016/j.desal.2011.08.040
   Penate B, 2011, DESALINATION, V281, P354, DOI 10.1016/j.desal.2011.08.010
   Price H, 2002, MODULAR POWER PLANT
   Rufuss DDW, 2016, RENEW SUST ENERG REV, V63, P464, DOI 10.1016/j.rser.2016.05.068
   Sagie D, 2001, DESALINATION, V139, P21, DOI 10.1016/S0011-9164(01)00291-0
   Salcedo R, 2012, DESALINATION, V286, P358, DOI 10.1016/j.desal.2011.11.050
   Saleh B, 2007, ENERGY, V32, P1210, DOI 10.1016/j.energy.2006.07.001
   Shalaby SM, 2016, DESALINATION, V398, P247, DOI 10.1016/j.desal.2016.07.042
   Shatat M, 2013, SUSTAIN CITIES SOC, V9, P67, DOI 10.1016/j.scs.2013.03.004
   SHERWOOD TK, 1965, IND ENG CHEM FUND, V4, P113, DOI 10.1021/i160014a001
   Soric A, 2012, DESALINATION, V301, P67, DOI 10.1016/j.desal.2012.06.013
   Sourirajan S, 1979, ULTRAFILTERATION MEM
   Tchanche BF, 2011, RENEW SUST ENERG REV, V15, P3963, DOI 10.1016/j.rser.2011.07.024
   Thomson M, 2003, DESALINATION, V153, P229, DOI 10.1016/S0011-9164(02)01141-4
   Thomson M, 2003, DESALINATION, V153, P1, DOI 10.1016/S0011-9164(03)80004-8
   TIWARI GN, 1989, ENERG CONVERS MANAGE, V29, P259, DOI 10.1016/0196-8904(89)90030-7
   Torres A., 2012, RENEW SUST ENERG REV, V16, P44
   Tzen E, 2003, SOL ENERGY, V75, P375, DOI 10.1016/j.solener.2003.07.010
   Velmurugan V, 2008, ENERGY, V33, P1719, DOI 10.1016/j.energy.2008.07.001
   Velmurugan V, 2008, ENERG CONVERS MANAGE, V49, P2602, DOI 10.1016/j.enconman.2008.05.010
   Velmurugan V, 2009, ENERGY, V34, P1179, DOI 10.1016/j.energy.2009.04.029
   Voros NG, 1998, DESALINATION, V115, P83, DOI 10.1016/S0011-9164(98)00029-0
   Vyas H, 2015, ENERG CONVERS MANAGE, V103, P94, DOI 10.1016/j.enconman.2015.05.076
   Xiong JY, 2013, ENERG CONVERS MANAGE, V73, P176, DOI 10.1016/j.enconman.2013.04.024
   Yamamoto T, 2001, ENERGY, V26, P239, DOI 10.1016/S0360-5442(00)00063-3
   Maydan D., 2011, U.S Patent Application, Patent No. [2011/0011802 A1, 20110011802]
   [Anonymous], 2004, TRANSYS 16 TRANSIENT
NR 100
TC 0
Z9 0
U1 15
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD JUN
PY 2017
VL 73
BP 789
EP 797
DI 10.1016/j.rser.2017.01.170
PG 9
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA EU7HA
UT WOS:000401204700061
OA No
DA 2017-08-17
ER

PT J
AU Zaid, SA
   Kassem, AM
AF Zaid, S. A.
   Kassem, Ahmed M.
TI Review, analysis and improving the utilization factor of a PV-grid
   connected system via HERIC transformerless approach
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review
DE PV-grid connected; Transformerless inverter,HERIC topology; Utilization
   factor
ID PHOTOVOLTAIC SYSTEMS; POWER CONVERTERS; STAND-ALONE; INVERTERS; MODE;
   DESIGN
AB This paper proposed an improved Highly Efficient and Reliable Inverter Concept (HERIC) inverter with photovoltaic (PV)-grid connected power system. However, transformerless inverter based on HERIC topology is considered as one of the most reliable, efficient, and approximately leakage free inverters with the PV-grid connected systems. The main drawback of this inverter is drawing a discontinuous current from the photovoltaic generating unit. Also, continuous photovoltaic current is needed to guarantee the maximum power point tracking (MPPT) operation. Subsequently, the operation of the HERIC inverter at maximum power point tracking condition is not a clear issue. Therefore, the PV utilization factor (K-uf) value falls down to about 50%, which leads to increasing in the cost and size of the photovoltaic generator unit. In this study, derivation of the utilization factor based on the PV-grid connected through HERIC inverter analyses are presented. Also, an improved version of the HERIC inverter is introduced to remove the previous drawbacks. To validate the analysis and idea, digital simulation results are carried out for both the proposed and classical PV-grid via HERIC inverter system. The transient response of the proposed grid current controller, proportion resonance (PR) controller, is tested. The effects of parameters uncertainties on the system performance factors are also studied to validate the robustness of the control approach.
C1 [Zaid, S. A.] Cairo Univ, Dept Elect Power, Fac Engn, Giza, Giza Governorat, Egypt.
   [Kassem, Ahmed M.] Sohag Univ, Dept Elect Engn, Fac Engn, Sohag, Egypt.
RP Kassem, AM (reprint author), Sohag Univ, Dept Elect Engn, Fac Engn, Sohag, Egypt.
EM sherifzaid3@yahoo.com; kassem_ahmed53@hotmail.com
CR Adly M, 2013, INT J ELEC POWER, V51, P243, DOI 10.1016/j.ijepes.2013.02.027
   Agirman I, 2003, IEEE T IND APPL, V39, P519, DOI 10.1109/TIA.2003.808925
   Bsekhoj Kjaer Soren, 2012, IEEE T ENERGY CONVER, V27, P922
   Castilla M, 2008, IEEE T IND ELECTRON, V55, P2724, DOI 10.1109/TIE.2008.920585
   Eugenio Gubi'a, 2007, PROG PHOTOVOLTAICS, V15, P629
   Frede Blaabjerg, 2006, IEEE T IND ELECT, V53
   Gonzalez R, 2007, IEEE T POWER ELECTR, V22, P693, DOI 10.1109/TPEL.2007.892120
   Haeberlin H., 2001, P 17 EUR PHOT SOL EN, P426
   Hu H., 2010, EN CONV C EXP ECCE 2, P3235
   [Anonymous], 1992, IEEE519
   Kassem AM, 2012, INT J ELEC POWER, V43, P90, DOI 10.1016/j.ijepes.2012.04.047
   Kerekes T, 2009, ANAL MODELING TRANSF
   Kjaer SB, 2005, IEEE T IND APPL, V41, P1292, DOI 10.1109/TIA.2005.853371
   Kouro S, 2015, IEEE IND ELECTRON M, V9, P47, DOI 10.1109/MIE.2014.2376976
   Li Q, 2008, IEEE T POWER ELECTR, V23, P1320, DOI 10.1109/TPEL.2008.920883
   Li Wuhua, 2015, IEEE T IND ELECTRON, V41, P1292
   Liu JX, 2017, IEEE T IND ELECTRON, V64, P22, DOI 10.1109/TIE.2016.2610400
   Liu JX, 2016, IEEE T IND ELECTRON, V63, P3261, DOI 10.1109/TIE.2016.2535118
   Liu JX, 2014, CONTROL ENG PRACT, V30, P124, DOI 10.1016/j.conengprac.2013.10.012
   Liu JX, 2014, INT J CONTROL, V87, P1117, DOI 10.1080/00207179.2013.868609
   Lopez O, 2010, IEEE T ENERGY CONVER, V25, P140, DOI 10.1109/TEC.2009.2037810
   Maaspaliza Azri, 2015, ELECTR POW COMPO SYS, V43, P1352
   Mao P, 2014, TELKOMNIKA, V12, P563
   Mohan W. P. R., 2003, POWER ELECT CONVERTE
   Myrzik J. M. A., 2003, P IEEE POW TECH C P
   Ning PQ, 2013, IEEE IND ELECTRON M, V7, P6, DOI 10.1109/MIE.2012.2231729
   Romero-Cadaval E, 2013, IEEE IND ELECTRON M, V7, P6, DOI 10.1109/MIE.2013.2264540
   Teodorescu R, 2004, IEEE T POWER ELECTR, V19, P1323, DOI 10.1109/TPEL.2004.833452
   Teodorescu R, 2006, ELECT POWER APPL IEE, V153, DOI DOI 10.1049/IP-EPA:20060008
   Trends in Phot ovoltaic Applications, 2005, T114 IEAPVPS
   Xiao HF, 2010, IEEE T ELECTROMAGN C, V52, P902, DOI 10.1109/TEMC.2010.2064169
   Xing S, 2014, LECT NOTES ELECT ENG, V238
   Yang Yongheng, 2015, ELECTR POW COMPO SYS, V43, P928
   Zhang L, 2014, IEEE T POWER ELECTR, V29, P1229, DOI 10.1109/TPEL.2013.2260178
   Zhang NY, 2014, ENERGIES, V7, P3934, DOI 10.3390/en7063934
   ZHUANG M, 1993, IEE PROC-D, V140, P216
   Heribert S, 2003, Europe Patent, Patent No. [1 369 985(A2), 1369985]
NR 37
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD JUN
PY 2017
VL 73
BP 1061
EP 1069
DI 10.1016/j.rser.2017.02.025
PG 9
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA EU7HA
UT WOS:000401204700080
OA No
DA 2017-08-17
ER

PT J
AU Abu Eldahab, YE
   Saad, NH
   Zekry, A
AF Abu Eldahab, Yasser E.
   Saad, Naggar H.
   Zekry, Abdalhalim
TI Enhancing the tracking techniques for the global maximum power point
   under partial shading conditions
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review
DE Partial shading; Photovoltaic systems; Maximum power point tracking;
   Global maximum power point; Renewable energy; Genetic Algorithm
ID PHOTOVOLTAIC SYSTEMS; PV SYSTEM; MODULES; ARRAYS; DEGRADATION;
   ALGORITHM; MPPT
AB The partial shading is one of most critical problems facing the Maximum Power Point Tracking (MPPT) techniques for photovoltaic systems. This paper provides a review of challenges and opportunities regarding the problem of partial shading. In addition, it introduces a new technique for tracking the Global Maximum Power Point (GMPP) under different Partial Shading Conditions (PSC). The technique utilizes a two-stage algorithm to accomplish the tracking process efficiently. In the first stage, it applies a Genetic Algorithm (GA) to get the nearest point to the GMPP. In the second stage, it utilizes a new and fast MPPT algorithm to search for the target GMPP starting from the nearest point fetched in step one. In order to evaluate the new technique, a complete microcontroller based prototype is implemented and tested. The experimental results show that the new technique reaches directly to the GMPP in very short time and with limited steady state oscillations. Accordingly, the new technique has a significant improvement in energy extraction efficiency from the photovoltaic array to the load.
C1 [Abu Eldahab, Yasser E.] Arab Contractor Co, Cairo, Egypt.
   [Saad, Naggar H.] Ain Shams Univ, Elect Power & Machines Dept, Fac Engn, Cairo, Egypt.
   [Zekry, Abdalhalim] Ain Shams Univ, Elect & Commun Dept, Fac Engn, Cairo, Egypt.
RP Abu Eldahab, YE (reprint author), Arab Contractor Co, Cairo, Egypt.
CR Abu Eldahab YE, 2016, RENEW SUST ENERG REV, V58, P646, DOI 10.1016/j.rser.2015.12.061
   Abu Eldahab YE, 2014, RENEW SUST ENERG REV, V40, P505, DOI 10.1016/j.rser.2014.07.202
   Ahmed Fathy, 2015, RENEW ENERG, V81, P78
   Ahmed J, 2014, APPL ENERG, V119, P118, DOI 10.1016/j.apenergy.2013.12.062
   Alonso-Garcia MC, 2006, RENEW ENERG, V31, P1986, DOI 10.1016/j.renene.2005.09.030
   Bai A, 2016, RENEW SUST ENERG REV, V60, P1086, DOI 10.1016/j.rser.2016.02.003
   Chandrasekar M, 2015, ENERG BUILDINGS, V86, P692, DOI 10.1016/j.enbuild.2014.10.071
   Chowdhury SR, 2010, SOL ENERG MAT SOL C, V94, P1441, DOI 10.1016/j.solmat.2010.04.011
   de Oliveira Reiter RD, 2012, 10 IEEE IAS INT C
   Derso Sera, 2008, P 2 WSEAS IASME INT
   Deshkar SN, 2015, RENEW SUST ENERG REV, V43, P102, DOI 10.1016/j.rser.2014.10.098
   Diaz-Dorado E, 2014, SOL ENERGY, V103, P96, DOI 10.1016/j.solener.2014.01.037
   Ishaque K, 2013, RENEW SUST ENERG REV, V19, P475, DOI 10.1016/j.rser.2012.11.032
   Ishaque K, 2012, APPL ENERG, V99, P414, DOI 10.1016/j.apenergy.2012.05.026
   Jubaer Ahmed, 2015, RENEW SUST ENERG REV, V47, P933
   Kahoul N, 2014, ENERG CONVERS MANAGE, V82, P320, DOI 10.1016/j.enconman.2014.03.034
   Kamarzaman NA, 2014, RENEW SUST ENERG REV, V37, P585, DOI 10.1016/j.rser.2014.05.045
   Kaplani E, 2012, J ENG SCI TECHNOL RE, V5, P1
   Keyrouz F, 2011, IEEE ELECT POWER ENE
   Nayak B.K., 2012, AEROSPACE ELECT SYST, V1, P1, DOI DOI 10.1109/TAES.2011
   Miyatake M, 2011, IEEE T AEROSP ELECT, V47
   Ndiaye A, 2014, SOL ENERGY, V103, P70, DOI 10.1016/j.solener.2014.02.006
   Phimmasone V, 2010, IEEE ELECT MACHINES, P10
   Piazza MCD, 2010, APPL ENERG, V87, P814, DOI DOI 10.1016/J.APENERGY.2009.09.036
   Poornima Mazumdar, SMART PV MOD DES CON
   Punitha K, 2013, ENERGY, V62, P330, DOI 10.1016/j.energy.2013.08.022
   Rahman MM, 2014, P 3 IET INT C
   Rizzo SA, 2015, APPL ENERG, V145, P124, DOI 10.1016/j.apenergy.2015.01.077
   Sanchez RC, 2013, APPL ENERG, V103, P278
   Tafticht T, 2008, RENEW ENERG, V33, P1508, DOI 10.1016/j.renene.2007.08.015
   Taheri H, 2010, P 2010 IEEE S IND EL, P82
   [Anonymous], 2012, SOL EL PAN INT BANK
NR 32
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD JUN
PY 2017
VL 73
BP 1173
EP 1183
DI 10.1016/j.rser.2017.02.029
PG 11
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA EU7HA
UT WOS:000401204700088
OA No
DA 2017-08-17
ER

PT J
AU Harby, K
AF Harby, K.
TI Hydrocarbons and their mixtures as alternatives to environmental
   unfriendly halogenated refrigerants: An updated overview
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review
DE Alternative refrigerant; Hydrocarbon refrigerants; Natural refrigerants;
   Environmental impact; Energy efficiency; COP
ID DRIVEN ADSORPTION SYSTEM; WINDOW AIR-CONDITIONER; DOMESTIC
   REFRIGERATORS; HEAT-PUMP; WASTE-HEAT; HFC407C/HC290/HC600A MIXTURE;
   PERFORMANCE EVALUATION; REPLACE HFC-134A; PROPANE; OPTIMIZATION
AB Vapor compression refrigeration systems consume high-grade energy and contribute to global warming and ozone layer depletion due to the environmentally unfriendly refrigerants. The use of hydrocarbons offer good drop-in replacements for the existing halogenated refrigerants in terms of environmental impacts and energy consumption. In this study, a review of the previous studies carried out with hydrocarbons as alternative refrigerants in refrigeration, air conditioning and heat pump, and automobile air conditioning systems is presented. An attempt has been made to cover the current status, possibilities, and problems related to the use of hydrocarbons as alternative refrigerants. Hydrocarbon characteristics, allowable refrigerant charge, flammable properties, and safety considerations are also presented. In addition, the study contains also a useful amount of information about the refrigerant properties, environmental impacts, and replacement strategy of conventional refrigerants. Results showed that in spite of highly flammable characteristics, hydrocarbons can offer proper alternatives to the halogenated refrigerants from the standpoint of environment impact, energy efficiency, COP, refrigerant mass, and compressor discharge temperatures. Roadmap on the future work needs in this field is presented. Finally, a summary of previous studies and strategies on pure HC, HC mixtures, and HC/HFC blends used for different applications has been presented and discussed in detail.
C1 [Harby, K.] Menia Univ, Mech Power Engn & Energy Dept, Fac Engn, Al Minya 61519, Egypt.
RP Harby, K (reprint author), Menia Univ, Mech Power Engn & Energy Dept, Fac Engn, Al Minya 61519, Egypt.
EM khaledharby8@yahoo.com
CR AFEAS, PROD SAL ATM REL FLU
   Agarwal SA, 1995, P INT CFC HAL ALT WA, P248
   Aisbett E, 1996, P SEM ENV DEV VIETN, P1
   Akash BA, 2003, ENERG CONVERS MANAGE, V44, P381, DOI 10.1016/S0196-8904(02)00065-1
   Alsaad MA, 1998, APPL THERM ENG, V18, P911, DOI 10.1016/S1359-4311(97)00113-0
   Andrew G., 2004, INT J REFRIG, V27, P621
   ASHRAE, 2001, FUND HDB
   [Anonymous], 2007, 342007 ASHRAE
   Babrauskak V, 2003, IGNITION HDB
   Bandarra EP, 2009, INT J REFRIG, V32, P185, DOI 10.1016/j.ijrefrig.2008.06.013
   Bayrakci HC, 2009, INT J ENERG RES, V33, P1070, DOI 10.1002/er.1538
   Ben AB, 1998, P IIF IIR C COMM B1, P610
   Bhatti M, 1999, ASHRAE T 1, P1186
   BODIO E, 1993, INT J REFRIG, V16, P353, DOI 10.1016/0140-7007(93)90008-V
   Bolaji BO, 2013, RENEW SUST ENERG REV, V18, P49, DOI 10.1016/j.rser.2012.10.008
   [Anonymous], 2000, 378 BS EN
   [Anonymous], 1997, 44341995 BS
   Buzelin LOS, 2005, INT J REFRIG, V28, P165, DOI 10.1016/j.ijrefrig.2004.08.013
   Calm JM, 2001, ENG SYST, V18, P74
   Cavestri RC, 1993, COMPATIBILITY REFRIG
   Chaichana C, 2003, INT J REFRIG, V26, P637, DOI 10.1016/S0140-7007(03)00046-X
   Chang YS, 2000, INT J REFRIG, V23, P232, DOI 10.1016/S0140-7007(99)00042-0
   Cheng S, 2014, APPL THERM ENG, V64, P83, DOI 10.1016/j.applthermaleng.2013.12.022
   Choi DK, 1996, P 2R C APPL NAT REFR, P467
   Colbourne D, 2015, INT J REFRIG, V59, P295, DOI 10.1016/j.ijrefrig.2015.06.026
   Colbourne D, 2002, P 16 INT COMPR ENG C
   Colbourne D, 2000, REFRIGERATION 20 NOV, P1
   Corberan JM, 2008, INT J REFRIG, V31, P716, DOI 10.1016/j.ijrefrig.2007.12.011
   Dalkilic AS, 2010, INT COMMUN HEAT MASS, V37, P1340, DOI 10.1016/j.icheatmasstransfer.2010.07.006
   Dang C, 2012, INT J REFRIG, V35, P1410, DOI 10.1016/j.ijrefrig.2012.03.015
   Daniel D, 2007, REFRIGERATION SELECT
   De Smedt G, 1999, J HAZARD MATER, V70, P105, DOI 10.1016/S0304-3894(99)00163-6
   Devotta S, 2005, INT J REFRIG, V28, P594, DOI 10.1016/j.ijrefrig.2004.09.013
   Devotta S, 1997, P INT C OZ PROT TECH, P194
   DIDION DA, 1990, INT J REFRIG, V13, P163, DOI 10.1016/0140-7007(90)90071-4
   Didion D.A., 1999, INT J APPL THERMODYN, V2, P19
   [Anonymous], 7003 DIN
   Domanski P., 1987, IMPACT REFRIGERANT P
   Dongsoo J, 2000, INT J REFRIG, V23, P517
   Douglas JD, 1996, P INT REFR C PURD 23, P13
   Elefsen F, 2003, FIELD TEST 75 R404A
   Environmental management of refrigeration equipment, 2011, WHO TECHN REP SER S
   Erol A, 2006, THERMODYNAMIC ANAL R, V26, P430
   Fatouh M, 2006, ENERG CONVERS MANAGE, V47, P2644, DOI 10.1016/j.enconman.2005.10.018
   Fatouh M, 2006, APPL THERM ENG, V26, P1593, DOI 10.1016/j.applthermaleng.2005.11.026
   Fine A., 1997, P INT C OZ PROT TECH, P203
   Garland NP, 2005, MATER DESIGN, V26, P578, DOI 10.1016/j.matdes.2004.08.009
   Gerrard A., 2005, ALT COOL TECHN C LON
   Ghazy M, 2016, INT J REFRIG, V70, P196, DOI 10.1016/j.ijrefrig.2016.01.012
   Gibb P, 2003, P 2003 CIBSE ASHRAE
   Granryd E, 2001, INT J REFRIG, V24, P15, DOI 10.1016/S0140-7007(00)00065-7
   Grob DP, 1998, STATUS SAFETY REQUIR
   Halimic E, 2003, APPL THERM ENG, V23, P1441, DOI 10.1016/S1359-4311(03)00081-4
   Hamdy M, 2015, RENEW SUST ENERG REV, V51, P1223, DOI 10.1016/j.rser.2015.07.056
   Hammad MA, 1999, APPL THERM ENG, V19, P1181, DOI 10.1016/S1359-4311(98)00116-1
   Harby K, 2016, RENEW SUST ENERG REV, V58, P347, DOI 10.1016/j.rser.2015.12.313
   He MG, 2005, APPL THERM ENG, V25, P1169, DOI 10.1016/j.applthermaleng.2004.06.003
   Hewitt NJ, 1994, SOME ASPECTS USING H, P10
   International Institute of Refrigeration, 1997, STAND FLAMM REFR 13
   loan S, 2014, INT J REFRIG, V46, P123
   Jabaraj DB, 2007, INT J THERM SCI, V46, P276, DOI 10.1016/j.ijthermalsci.2006.05.004
   Jabaraj DB, 2006, ENERG CONVERS MANAGE, V47, P2578, DOI 10.1016/j.enconman.2005.10.026
   JAMES RW, 1992, INT J REFRIG, V15, P95, DOI 10.1016/0140-7007(92)90033-Q
   Joseph SS, 2004, INT J THERM SCI, V43, P307
   Joseph S, 2003, ECOLIBRIUM J AUST I, V2, P24
   Joseph SS, 2004, ENERG CONVERS MANAG, V45, P1175
   Jung D, 1999, INT J REFRIG, V22, P558, DOI 10.1016/S0140-7007(99)00022-5
   Jung D, 2000, INT J REFRIG, V23, P517, DOI 10.1016/S0140-7007(99)00084-5
   Jung D., 1996, ASHRAE T, V3, P1077
   Jwo CS, 2009, MEASUREMENT, V42, P697, DOI 10.1016/j.measurement.2008.11.006
   Khalid A Joudi, 2014, ENERG CONVERS MANAGE, V86, P496
   Kondo S, 2009, J HAZARD MATER, V171, P613, DOI 10.1016/j.jhazmat.2009.06.042
   Kruse H., 1996, P INT C OZ PROT TECH, P179
   Lee MY, 2008, INT J REFRIG, V31, P734, DOI 10.1016/j.ijrefrig.2007.11.014
   Lee YS, 2002, APPL THERM ENG, V22, P507, DOI 10.1016/S1359-4311(01)00106-5
   Lommers CA, 2003, AIR CONDITIONING REF
   Mahmoud G, 1999, 010874 SAE
   Mani K, 2008, INT J THERM SCI, V47, P1490, DOI 10.1016/j.ijthermalsci.2007.11.008
   Mathur GD., 1996, P INT C OZ PROT TECH, P835
   Mehdi R, 2013, INT J THERM SCI, V74, P86
   Miyara A, 2010, INT J REFRIG, V18, P1
   Mohamed M, 2015, ENERGY, V86, P344
   Mohanraj M, 2013, ENERGY SUSTAIN DEV, V17, P471, DOI 10.1016/j.esd.2013.05.005
   Mohanraj M, 2011, INT J ENERG RES, V35, P647, DOI 10.1002/er.1736
   Mohanraj M, 2009, INT J THERM SCI, V48, P1036, DOI 10.1016/j.ijthermalsci.2008.08.001
   Mohanraj M, 2009, INT J GREENH GAS CON, V3, P108, DOI 10.1016/j.ijggc.2008.07.003
   Palm B, 2008, INT J REFRIG, V31, P552, DOI 10.1016/j.ijrefrig.2007.11.016
   Park KJ, 2007, APPL ENERG, V84, P985, DOI 10.1016/j.apenergy.2007.05.002
   Park KJ, 2007, ENERG BUILDINGS, V39, P675, DOI 10.1016/j.enbuild.2006.10.003
   Park KJ, 2010, J MECH SCI TECHNOL, V24, P879, DOI 10.1007/s12206-010-0205-y
   Park KJ, 2009, APPL ENERG, V86, P2598, DOI 10.1016/j.apenergy.2009.04.009
   Pelletier O., 1998, ISBNKTHREFRR9824SE
   Perry R. H., 1997, PERRYS CHEM ENG HDB
   Proldima GT, 2010, GUIDELINES SAFE USE
   Purkayastha B., 1998, INT J REFRIG, V21, P213
   Raja MH, 2008, INT J AMBIENT ENERGY, V29, P207
   Rasti M, 2012, MEASUREMENT, V45, P1807, DOI 10.1016/j.measurement.2012.04.002
   Ravikumar TS, 2009, ENERG CONVERS MANAGE, V50, P1891, DOI 10.1016/j.enconman.2009.04.027
   RICHARDSON RN, 1995, INT J REFRIG, V18, P58, DOI 10.1016/0140-7007(94)P3712-A
   Shecco, 2012, NAT REFR MARK GROWTH
   Stephen O, 2002, PROTECTING OZONE LAY
   Sudipta P, 2013, INT J EMERG TECHNOL, V3, P400
   Tashtoush B, 2002, APPL THERM ENG, V22, P495, DOI 10.1016/S1359-4311(01)00107-7
   Teng TP, 2012, APPL THERM ENG, V32, P100, DOI 10.1016/j.applthermaleng.2011.08.036
   Thonon B, 2008, INT J REFRIG, V31, P633, DOI 10.1016/j.ijrefrig.2008.02.006
   UNEP, 2003, HDB INT TREAT PROT O
   [Anonymous], 2014, MONTR PROT SUBST DEP
   Urchueguia JF, 2004, ECOBIBRIUM J AIRAH, P23
   Verde M, 2017, APPL THERM ENG, V111, P489, DOI 10.1016/j.applthermaleng.2016.09.099
   Verde M, 2016, ENERGY, V115, P996, DOI 10.1016/j.energy.2016.09.086
   Verde M, 2016, ENERGY, V116, P526, DOI 10.1016/j.energy.2016.09.113
   Wang CC, 2012, RENEW SUST ENERG REV, V16, P5071, DOI 10.1016/j.rser.2012.04.054
   Environmental management of refrigeration equipment, 2011, WHO TECHN REP SER S, V961
   Wongwises S, 2006, ENERG CONVERS MANAGE, V47, P1644, DOI 10.1016/j.enconman.2005.04.013
   Wongwises S, 2005, ENERG CONVERS MANAGE, V46, P85, DOI 10.1016/j.enconman.2004.02.011
   Yu CC, 2014, APPL THERM ENG, V66, P507, DOI 10.1016/j.applthermaleng.2014.02.050
   Yun WJ, 2002, T SAREK, V14, P73
   Zhao Yang, 1999, APPL THERM ENG, V19, P801, DOI 10.1016/S1359-4311(98)00093-3
   Zhou GB, 2010, APPL THERM ENG, V30, P1477, DOI 10.1016/j.applthermaleng.2010.03.009
NR 119
TC 1
Z9 1
U1 11
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD JUN
PY 2017
VL 73
BP 1247
EP 1264
DI 10.1016/j.rser.2017.02.039
PG 18
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA EU7HA
UT WOS:000401204700094
OA No
DA 2017-08-17
ER

PT J
AU El-Badry, DA
   Mohamed, RH
   EL-Metwally, HA
   Abo Al-Naga, TR
AF El-Badry, D. A.
   Mohamed, R. H.
   EL-Metwally, H. A.
   Abo Al-Naga, T. R.
TI The effect of some cryoprotectants on dromedary camel frozen-thawed
   semen
SO REPRODUCTION IN DOMESTIC ANIMALS
LA English
DT Article
DE dromedary camel; glycerol; DMF; DMSO; ethylene glycol; cryoprotectant;
   freezing
ID EGG-YOLK; SPERMATOZOA; CRYOPRESERVATION; GLYCEROL; INTEGRITY; EXTENDERS
AB Contents The cryopreserved camel semen is often associated with poor quality and fertility. This study aimed to improve the dromedary frozen semen quality by comparing the efficiency of four cryoprotectant agents (CPAs) on sperm freezability. Semen samples were collected from seven male Maghrabi camels, diluted with Shotor diluent supplemented with glycerol (Sh-G), dimethyl formamide (DMF, Sh-DF), dimethyl sulfoxide (DMSO, Sh-DS) or ethylene glycol (EG, Sh-EG), all at 6% final concentration, and the samples were subjected to cryopreservation. The results revealed the superiority of Sh-DF over Sh-G and Sh-DS in terms of post-thaw motility (55.83 +/- 2.20 vs. 47.50 +/- 4.33 and 45.00 +/- 2.89%, respectively), sperm membrane (49.00 +/- 0.58, 39.33 +/- 3.33 and 42.67 +/- 1.45%, respectively) and acrosomal integrities (53.00 +/- 0.58, 57.33 +/- 0.88 and 52.33 +/- 1.45%, respectively). Sh-EG group showed the lowest post-thaw motility, plasma membrane and acrosome integrities (12.50 +/- 1.44, 22.67 +/- 1.45 and 30.67 +/- 1.45, respectively). In conclusion, the protocols of dromedary camel semen cryopreservation could be enhanced using 6% DMF as a cryoprotectant agent.
C1 [El-Badry, D. A.] Agr Res Ctr ARC, Artifcial Inseminat & Embryo Transfer Dept, Anim Reprod Res Inst, Giza, Egypt.
   [Mohamed, R. H.] Aswan Univ, Fac Vet Med, Theriogenol Dept, Giza, Egypt.
   [EL-Metwally, H. A.] ARC, Anim Prod Res Inst, Giza, Egypt.
   [Abo Al-Naga, T. R.] Desert Res Ctr, Dept Anim Hlth, Cairo, Egypt.
RP El-Badry, DA (reprint author), Agr Res Ctr ARC, Artifcial Inseminat & Embryo Transfer Dept, Anim Reprod Res Inst, Giza, Egypt.
EM diyabadry@hotmail.com
CR Abd El-Salaam A. M., 2013, EGYPT J BASIC APPL P, V12, P17
   Aller J. F., 2003, Archivos de Zootecnia, V52, P15
   Ariantie O. S., 2013, Jurnal Ilmu Ternak dan Veteriner, V18, P239
   Carretero MI, 2015, ANDROLOGIA, V47, P685, DOI 10.1111/and.12319
   Crichton EG, 2015, THERIOGENOLOGY, V83, P168, DOI 10.1016/j.theriogenology.2014.09.005
   DIDION BA, 1989, GAMETE RES, V22, P51, DOI 10.1002/mrd.1120220106
   ELBADRY DA, 2014, ASSIUT VET MED J, V60, P29
   El-Bahrawy K. A., 2006, INT SCI CAM C 9 11 M
   Fuller B, 2004, LIFE IN THE FROZEN STATE, P505, DOI 10.1201/9780203647073.ch18
   GILMORE JA, 1995, BIOL REPROD, V53, P985, DOI 10.1095/biolreprod53.5.985
   JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219
   Martins-Bessa A, 2006, THERIOGENOLOGY, V66, P2047, DOI 10.1016/j.theriogenology.2006.06.004
   Morton K. M., 2009, Journal of Camelid Science, V2, P15
   Niasari-Naslaji A, 2007, THERIOGENOLOGY, V68, P618, DOI 10.1016/j.theriogenology.2007.04.059
   Santiani A, 2005, ASIAN J ANDROL, V7, P303, DOI 10.1111/j.1745-7262.2005.00021.x
   Ziapour S, 2014, ANIM REPROD SCI, V151, P15, DOI 10.1016/j.anireprosci.2014.09.016
NR 16
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0936-6768
EI 1439-0531
J9 REPROD DOMEST ANIM
JI Reprod. Domest. Anim.
PD JUN
PY 2017
VL 52
IS 3
BP 522
EP 525
DI 10.1111/rda.12934
PG 4
WC Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary
   Sciences
SC Agriculture; Reproductive Biology; Veterinary Sciences
GA EU1WG
UT WOS:000400816100024
PM 28176384
OA No
DA 2017-08-17
ER

PT J
AU Kayid, M
   Izadkhah, S
   Zuo, MJ
AF Kayid, M.
   Izadkhah, S.
   Zuo, Ming J.
TI Some results on the relative ordering of two frailty models
SO STATISTICAL PAPERS
LA English
DT Article
DE Stochastic order; Likelihood ratio order; Aging classes; Hazard rate
ID AGING INTENSITY FUNCTION; RANDOM MINIMA; STOCHASTIC COMPARISONS; LIFE
   DISTRIBUTIONS; MAXIMA
AB In this paper, relative behavior of two frailty models with different frailty variables and a common baseline variable are considered. We show that, under some conditions on frailty variables, the ratio of the hazard rate (mean residual life) functions of two frailty models is increasing. Finally, some applications are examined to validate the obtained results.
C1 [Kayid, M.] King Saud Univ, Coll Sci, Dept Stat & Operat Res, Riyadh, Saudi Arabia.
   [Izadkhah, S.] Higher Educ Complex Bam, Fac Math & Comp, Dept Stat, Kerman, Iran.
   [Zuo, Ming J.] Univ Elect Sci & Technol China, Sch Mechatron Engn, Chengdu 611731, Sichuan, Peoples R China.
   [Kayid, M.] Suez Univ, Fac Sci, Dept Math & Comp Sci, Suez 41522, Egypt.
   [Zuo, Ming J.] Univ Alberta, Dept Mech Engn, Edmonton, AB T6G 1H9, Canada.
RP Kayid, M (reprint author), King Saud Univ, Coll Sci, Dept Stat & Operat Res, Riyadh, Saudi Arabia.; Kayid, M (reprint author), Suez Univ, Fac Sci, Dept Math & Comp Sci, Suez 41522, Egypt.
EM drkayid@ksu.edu.sa; sizadkhah@yahoo.com; mzuo@ualberta.ca
FU Deanship of Scientific Research at King Saud University [RG-1435-036];
   Natural Sciences and Engineering Research Council of Canada (NSERC)
FX The authors are grateful to three anonymous referees for making some
   useful comments on an earlier version of this manuscript. The authors
   would also like to extend their sincere appreciation to the Deanship of
   Scientific Research at King Saud University for funding this Research
   Group (No. RG-1435-036). This work also was supported by the Natural
   Sciences and Engineering Research Council of Canada (NSERC).
CR Aalen OO, 2008, STAT BIOL HEALTH, P1
   Barlow R.E., 1981, STAT THEORY RELIABIL
   Barlow R. E., 1965, MATH THEORY RELIABIL
   Bartoszewicz J, 2001, STAT PROBABIL LETT, V55, P107, DOI 10.1016/S0167-7152(01)00139-0
   Bhattacharjee S, 2013, STAT PROBABIL LETT, V83, P1364, DOI 10.1016/j.spl.2013.01.016
   Block H, 1997, Lifetime Data Anal, V3, P269, DOI 10.1023/A:1009653032333
   Cha JH, 2014, RELIAB ENG SYST SAFE, V123, P99, DOI 10.1016/j.ress.2013.10.008
   Di Crescenzo A, 2000, STAT PROBABIL LETT, V50, P313
   Duchateau L, 2008, STAT BIOL HEALTHSPRI
   Enki DG, 2014, ANN APPL STAT, V8, P430, DOI 10.1214/13-AOAS693
   Finkelstein M, 2006, STAT PROBABIL LETT, V76, P939, DOI 10.1016/j.spl.2005.10.027
   Finkelstein M, 2006, COMMUN STAT-THEOR M, V35, P1943, DOI 10.1080/03610920600762871
   Govindarajulu US, 2011, STAT MED, V30, P2754, DOI 10.1002/sim.4277
   Gupta RC, 2009, J STAT PLAN INFER, V139, P3277, DOI 10.1016/j.jspi.2009.03.003
   Hanagal DD, 2011, MODELING SURVIVAL DA
   Hougaard P., 2000, ANAL MULTIVARIATE SU
   Kalashnikov VV, 1986, PROBABILITY THEORY M, V2
   Karlin S., 1968, TOTAL POSITIVITY
   Lai CD, 2003, MATH COMPUT MODEL, V38, P1339, DOI [10.1016/S0895-7177(03)00347-9, 10.1016/S0895-7-177(03)00347-9]
   Li XH, 2004, NAV RES LOG, V51, P332, DOI 10.1002/nav.10122
   Li XH, 2012, METHODOL COMPUT APPL, V14, P1033, DOI 10.1007/s11009-011-9218-y
   Li XH, 2009, J STAT PLAN INFER, V139, P2624, DOI 10.1016/j.jspi.2008.12.002
   Lim JH, 1998, COMMUN STAT-THEOR M, V27, P965, DOI 10.1080/03610929808832138
   Misra N, 2003, J STAT PLAN INFER, V115, P683, DOI 10.1016/S0378-3758(02)00157-X
   Nanda AK, 2013, PROBAB ENG INFORM SC, V46, P1
   Nanda AK, 2007, STAT PROBABIL LETT, V77, P365, DOI 10.1016/j.spl.2006.08.002
   Nanda AK, 2011, J STAT PLAN INFER, V141, P2108, DOI 10.1016/j.jspi.2010.12.025
   Rezaei M, 2015, COMMUN STAT-THEOR M, V44, P300, DOI 10.1080/03610926.2012.745559
   Righter R, 2009, PROBAB ENG INFORM SC, V23, P563, DOI 10.1017/S0269964809990015
   Rowell G, 1998, PROBAB ENG INFORM SC, V12, P469
   SENGUPTA D, 1994, J APPL PROBAB, V31, P991, DOI 10.2307/3215323
   Shaked M, 1997, J APPL PROBAB, V34, P420, DOI 10.2307/3215381
   Shaked M, 2007, SPRINGER SER STAT, P3
   VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224
   WEI XH, 1992, MICROELECTRON RELIAB, V32, P1319, DOI 10.1016/0026-2714(92)90655-5
   Wienke A, 2010, FRAILTY MODELS SURVI
   Xu M, 2008, J STAT PLAN INFER, V138, P1433, DOI 10.1016/j.jspi.2007.04.029
NR 37
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-5026
EI 1613-9798
J9 STAT PAP
JI Stat. Pap.
PD JUN
PY 2017
VL 58
IS 2
BP 287
EP 301
DI 10.1007/s00362-015-0697-8
PG 15
WC Statistics & Probability
SC Mathematics
GA EV0FP
UT WOS:000401414200001
OA No
DA 2017-08-17
ER

PT J
AU Arnous, AH
   Mahmood, SA
   Younis, M
AF Arnous, A. H.
   Mahmood, S. A.
   Younis, M.
TI Dynamics of optical solitons in dual-core fibers via two integration
   schemes
SO SUPERLATTICES AND MICROSTRUCTURES
LA English
DT Article
DE Optical solitons; Dual-core fibers; Integrability
ID G'/G-EXPANSION; LAW NONLINEARITY; HIROTA EQUATION; DISPERSION; PULSES
AB This article studies the dynamics of optical solitons in dual-core fibers with group velocity mismatch, group velocity dispersion and linear coupling coefficient under Kerr law nonlinearity via two integration schemes, namely, Q-function scheme and trial solution approach. The Q-function scheme extracts dark and singular 1-soliton solutions, along with the corresponding existence restriction. This scheme, however, fails to retrieve bright 1-soliton solution. Moreover, the trial solution approach extracts bright, dark and singular 1-soliton solutions. The constraint conditions, for the existence of the soliton solutions, are also listed. Additionally, a couple of other solutions known as singular periodic solutions, fall out as a by-product of this scheme. The obtained results have potential applications in the study of solitons based optical communication. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Arnous, A. H.] Higher Inst Engn, Dept Engn Math & Phys, El Shorouk, Egypt.
   [Mahmood, S. A.] Univ Punjab, Dept Space Sci, Lahore 54590, Pakistan.
   [Younis, M.] Univ Punjab, Ctr Undergrad Studies, Lahore 54590, Pakistan.
RP Younis, M (reprint author), Univ Punjab, Ctr Undergrad Studies, Lahore 54590, Pakistan.
EM ahmed.h.arnous@gmail.com; amerpakistan@gmail.com; younis.pu@gmail.com
CR Adesanya SO, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15114-5
   Bakodah H. O., 2015, J COMPUT THEOR NANOS, V12, P5846
   Biswas A, 2008, PHYS LETT A, V372, P5941, DOI 10.1016/j.physleta.2008.07.052
   Biswas A, 2014, OPTIK, V125, P4603, DOI 10.1016/j.ijleo.2014.05.035
   Biswas A, 2014, OPTIK, V125, P4215, DOI 10.1016/j.ijleo.2014.03.039
   Biswas A, 2013, J ELECTROMAGNET WAVE, V27, P1976, DOI 10.1080/09205071.2013.832488
   Green PD, 2010, COMMUN NONLINEAR SCI, V15, P3865, DOI 10.1016/j.cnsns.2010.01.018
   Kudryashov NA, 2014, APPL MATH LETT, V32, P53, DOI 10.1016/j.aml.2014.02.009
   Kudryashov NA, 2012, COMMUN NONLINEAR SCI, V17, P2248, DOI 10.1016/j.cnsns.2011.10.016
   Liu CS, 2006, COMMUN THEOR PHYS, V45, P219
   Mirzazadeh M, 2015, NONLINEAR DYNAM, V81, P277, DOI 10.1007/s11071-015-1989-1
   Rizvi STR, 2016, OPTIK, V127, P5328, DOI 10.1016/j.ijleo.2016.03.044
   Sardar A, 2016, J NANOELECTRON OPTOE, V11, P382, DOI 10.1166/jno.2016.1905
   Triki H, 2011, MATH METHOD APPL SCI, V34, P958, DOI 10.1002/mma.1414
   Younis M, 2015, J OPTOELECTRON ADV M, V17, P505
   Younis M., 2014, J ADV PHYS, V3, P258
   Younis M., 2015, J COMPUT THEOR NANOS, V12, P5745
   Younis M, 2016, J NANOELECTRON OPTOE, V11, P276, DOI 10.1166/jno.2016.1904
   Younis M, 2015, OPTIK, V126, P5812, DOI 10.1016/j.ijleo.2015.08.233
   Younis M, 2015, OPTOELECTRON ADV MAT, V9, P1126
   Younis M, 2015, J NANOELECTRON OPTOE, V10, P179, DOI 10.1166/jno.2015.1723
   Zayed EME, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/8/080203
   Zhou Q, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15138-9
   Zhou Q, 2015, LASER PHYS, V25, DOI 10.1088/1054-660X/25/1/015402
   Zhou Q, 2014, OPT APPL, V44, P399, DOI 10.5277/oa140305
   Zhou Q, 2014, OPTOELECTRON ADV MAT, V8, P837
NR 26
TC 2
Z9 2
U1 2
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0749-6036
J9 SUPERLATTICE MICROST
JI Superlattices Microstruct.
PD JUN
PY 2017
VL 106
BP 156
EP 162
DI 10.1016/j.spmi.2017.03.044
PG 7
WC Physics, Condensed Matter
SC Physics
GA EU7JT
UT WOS:000401211800016
OA No
DA 2017-08-17
ER

PT J
AU O'Connor, Z
   Faniriko, M
   Thelander, K
   O'Connor, J
   Thompson, D
   Park, A
AF O'Connor, Zachary
   Faniriko, Marco
   Thelander, Keir
   O'Connor, Jennifer
   Thompson, David
   Park, Adrian
TI Laparoscopy Using Room Air Insufflation in a Rural African Jungle
   Hospital: The Bongolo Hospital Experience, January 2006 to December 2013
SO SURGICAL INNOVATION
LA English
DT Article
DE laparoscopy; room air insufflation; rural surgery
ID CARBON-DIOXIDE; DIAGNOSTIC LAPAROSCOPY; SURGERY; PNEUMOPERITONEUM;
   PERITONEAL; OFFICE; GAS
AB Introduction. Carbon dioxide is the standard insufflation gas for laparoscopy. However, in many areas of the world, bottled carbon dioxide is not available. Laparoscopy offers advantages over open surgery and has been practiced using filtered room air insufflation since 2006 at Bongolo Hospital in Gabon, Africa. Objective. Our primary goal was to evaluate the safety of room air insufflation related to intraoperative and postoperative complications. Our secondary aim was to review the types of cases performed laparoscopically at our institution. Methods. This retrospective review evaluates laparoscopic cases performed at Bongolo Hospital between January 2006 and December 2013. Demographic and perioperative information for patients undergoing laparoscopic procedures was collected. Insufflation was achieved using a standard, oil-free air compressor using filtered air and a standard insufflation regulator. Results. A total of 368 laparoscopic procedures were identified within the time period. The majority of cases were gynecologic (43%). There was a 2% (8/368) complication rate with one perioperative death. The 2 complications related to insufflation were episodes of hypotension responsive to standard corrective measures. No intracorporeal combustion events were observed in any cases in which the use of diathermy and room air insufflation were combined. The other complications and the death were unrelated to the use of insufflation with air. Conclusion. Insufflation complications with room air occurred in our study. However, the complications related to insufflation with room air in our study were no different than those described in the literature using carbon dioxide. As room air is less costly than carbon dioxide and readily available, confirming the safety of room air insufflation in prospective studies is warranted. Room air appears to be safe for establishing and maintaining pneumoperitoneum, making laparoscopic surgery more accessible to patients in low-resource settings.
C1 [O'Connor, Zachary; Faniriko, Marco; Thelander, Keir; O'Connor, Jennifer; Thompson, David] PAACS Bongolo Hosp, BP 49, Lebamba, Ngounie Provinc, Gabon.
   [Thelander, Keir] Loma Linda Univ, Loma Linda, CA 92350 USA.
   [Thompson, David] PAACS Harpur Mem Hosp, Menoufia, Egypt.
   [Park, Adrian] Anne Arundel Hlth Syst, Annapolis, MD USA.
   [Park, Adrian] Johns Hopkins Univ, Baltimore, MD USA.
RP O'Connor, Z (reprint author), PAACS Bongolo Hosp, BP 49, Lebamba, Ngounie Provinc, Gabon.
EM zachandjenoconnor@gmail.com
CR Bergstrom BS, 2010, ACTA OBSTET GYN SCAN, V89, P975, DOI 10.3109/00016349.2010.486435
   Cheng Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009569.pub2
   Chiesa OA, 2009, CAN J VET RES, V73, P42
   Diaz M O, 1980, Int J Gynaecol Obstet, V18, P119
   Ikechebelu J I, 2005, J Obstet Gynaecol, V25, P172
   Ikechebelu JI, 2013, NIGER J CLIN PRACT, V16, P155, DOI 10.4103/1119-3077.110129
   Ikechebelu JI, 2008, NIGER J CLIN PRACT, V11, P127
   Menes T, 2000, SURG ENDOSC-ULTRAS, V14, P1050, DOI 10.1007/s004640000216
   Moehrlen U, 2012, PEDIATR SURG INT, V28, P507, DOI 10.1007/s00383-012-3070-1
   Nzoghe Nguema P, 2001, J GYNECOL OBST BIO R, V30, P462
   Park EY, 2012, YONSEI MED J, V53, P459, DOI 10.3349/ymj.2012.53.3.459
   PENFIELD AJ, 1995, J AM ASSOC GYN LAP, V2, P365, DOI 10.1016/S1074-3804(05)80126-4
   Power NE, 2012, J ENDOUROL, V26, P1639, DOI 10.1089/end.2012.0298
   Richter S, 2013, SURG ENDOSC, V27, P1791, DOI 10.1007/s00464-012-2651-3
   Sezeur A, 2009, J CHIR-PARIS, V146, P98, DOI 10.1016/j.jchir.2009.03.006
   Taylor SP, 2010, CAN J ANESTH, V57, P774, DOI 10.1007/s12630-010-9320-6
   Tekelioglu UY, 2013, EUR REV MED PHARMACO, V17, P895
   Trunzo JA, 2010, SURG ENDOSC, V24, P1727, DOI 10.1007/s00464-009-0839-y
   Tung PHM, 1999, SURG ENDOSC-ULTRAS, V13, P473, DOI 10.1007/s004649901015
   Ure BM, 2002, SURG ENDOSC, V16, P836, DOI 10.1007/s00464-001-9093-7
   von Delius S, 2010, GASTROINTEST ENDOSC, V72, P161, DOI 10.1016/j.gie.2010.01.013
NR 21
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1553-3506
EI 1553-3514
J9 SURG INNOV
JI Surg. Innov.
PD JUN
PY 2017
VL 24
IS 3
BP 264
EP 267
DI 10.1177/1553350617697172
PG 4
WC Surgery
SC Surgery
GA EU6QW
UT WOS:000401159600010
PM 28492353
OA No
DA 2017-08-17
ER

PT J
AU Saadeldin, IM
   Swelum, AAA
   Yacloob, SH
   Alowaimer, AN
AF Saadeldin, Islam M.
   Swelum, Ayman Abdel-Aziz
   Yacloob, Syed Hilal
   Alowaimer, Abdullah Nasser
TI Morphometric assessment of in vitro matured dromedary camel oocytes
   determines the developmental competence after parthenogenetic activation
SO THERIOGENOLOGY
LA English
DT Article
DE Meiosis; In vitro maturation; Oocytes; Embryo; Morphometry; Camel
ID INTRACYTOPLASMIC SPERM INJECTION; POLAR BODY EXTRUSION; ELECTRICAL
   ACTIVATION; NUCLEAR MATURATION; TRANSCRIPTIONAL ACTIVITY; REPRODUCTIVE
   PHYSIOLOGY; CHEMICAL ACTIVATION; MEIOTIC COMPETENCE; EMBRYO DEVELOPMENT;
   IMMATURE OOCYTES
AB The aim of the current study was to improve the selection method of camel oocytes after in vitro maturation by reducing exclusion criteria that were based only on the presence of the first polar body. A combined nuclear and morphometric assessment of camel oocytes after in vitro maturation was included to perform a judgment. The nuclear status of the oocytes, including the presence of the first polar body, meiosis I stage, and lack of nuclear materials, was investigated. The morphometric criteria that comprised the dimensions of each oocyte were as follows: diameter of the whole oocyte, including the zona pellucida (ZPO), zona pellucida thickness (ZPT), ooplasm diameter (OD), the perivitelline space (PVS) area, and PVS diameter. Among the oocytes with different nuclear status, there were no differences in ZPO and ZPT. However, oocytes with no nuclear material showed a significant reduction in OD (110.19 +/- 1.4 mu m) and a significant increase in PVS area (2139 +/- 324.6 mu m(2)) and PVS diameter (13.9 +/- 1.96 mu m) when compared with oocytes in the meiosis I stage (117.41 +/- 2.85 mu m, 1287.4 +/- 123.4 mu m(2), and 8.56 +/- 0.65 mu m, respectively). To simplify the selection, the major difference between meiosis I and degenerated oocytes was the diameter of the PVS, which was greater than the ZPT in degenerated oocytes. Therefore, three groups were morphologically differentiated into oocytes with polar bodies (PB1), meiosis I (MI) oocytes, and degenerated oocytes. MI oocytes were able to extrude the polar body after activation but were not able to develop into blastocysts. In contrast, MI oocytes were able to develop into blastocysts after a biphasic activation protocol in which the oocytes were electrically activated and treated with ionomycin after 2 h. In conclusion, the results obtained by the morphometric assessment allowed us to develop a simple and objective classification system for in vitro matured dromedary camel oocytes, which will lead to accurate oocyte selection for the support of subsequent embryonic development. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Saadeldin, Islam M.; Swelum, Ayman Abdel-Aziz; Yacloob, Syed Hilal; Alowaimer, Abdullah Nasser] King Saud Univ, Coll Food & Agr Sci, Dept Anim Prod, Riyadh 11451, Saudi Arabia.
   [Saadeldin, Islam M.] Zagazig Univ, Fac Vet Med, Dept Physiol, Zagazig 44519, Egypt.
   [Swelum, Ayman Abdel-Aziz] Zagazig Univ, Fac Vet Med, Dept Theriogenol, Zagazig 44519, Egypt.
RP Saadeldin, IM (reprint author), King Saud Univ, Coll Food & Agr Sci, Dept Anim Prod, Riyadh 11451, Saudi Arabia.; Saadeldin, IM (reprint author), Zagazig Univ, Fac Vet Med, Dept Physiol, Zagazig 44519, Egypt.
EM isaadeldin@ksu.edu.sa
OI Saadeldin, Islam/0000-0002-7633-730X
FU Deanship of Scientific Research at King Saud University [RG-1438-018]
FX The authors extended their appreciation to the Deanship of Scientific
   Research at King Saud University for funding this work through the
   research group No (RG-1438-018).
CR Abdoon ASS, 2007, REPROD DOMEST ANIM, V42, P88, DOI 10.1111/j.1439-0531.2006.00737.x
   Arlotto T, 1996, THERIOGENOLOGY, V45, P943, DOI 10.1016/0093-691X(96)00024-6
   Chang HC, 2005, HUM REPROD, V20, P1958, DOI 10.1093/humrep/dei003
   de Wit AAC, 2001, ANIM REPROD SCI, V65, P51, DOI 10.1016/S0378-4320(00)00215-3
   FAIR T, 1995, MOL REPROD DEV, V42, P437, DOI 10.1002/mrd.1080420410
   Fair T, 1996, MOL REPROD DEV, V43, P503
   Fathi M, 2014, THERIOGENOLOGY, V81, P1286, DOI 10.1016/j.theriogenology.2014.02.010
   Gordon I, 2004, REPROD TECHNOLOGIES, P68
   Griffin Jeanine, 2006, J Exp Clin Assist Reprod, V3, P2, DOI 10.1186/1743-1050-3-2
   HAGEN DR, 1991, MOL REPROD DEV, V28, P70, DOI 10.1002/mrd.1080280111
   HAZELEGER NL, 1995, THERIOGENOLOGY, V43, P509, DOI 10.1016/0093-691X(94)00043-T
   Hwang S, 2000, J ASSIST REPROD GEN, V17, P310, DOI 10.1023/A:1009496726343
   Kafi M, 2005, THERIOGENOLOGY, V63, P2458, DOI 10.1016/j.theriogenology.2004.09.059
   Kandil OM, 2015, P REG C CAM MAN PROD
   Khalil W. A., 2014, Asian Journal of Animal and Veterinary Advances, V9, P428
   Khatir H, 2009, ANIM REPROD SCI, V113, P212, DOI 10.1016/j.anireprosci.2008.07.007
   Kitagawa T., 2006, Bulletin of the Faculty of Agriculture, Niigata University, V59, P21
   Koo OJ, 2008, THERIOGENOLOGY, V70, P1111, DOI 10.1016/j.theriogenology.2008.06.031
   Kwon D, 2014, REPROD DOMEST ANIM, V49, P995, DOI 10.1111/rda.12420
   Leal CLV, 1998, ANIM REPROD SCI, V52, P51, DOI 10.1016/S0378-4320(98)00084-0
   Leblanc J, 2011, MOL HUM REPROD, V17, P305, DOI 10.1093/molehr/gar026
   Levi M, 2011, MOL HUM REPROD, V17, P328, DOI 10.1093/molehr/gar025
   Lucas X, 2002, THERIOGENOLOGY, V58, P871, DOI 10.1016/S0093-691X(02)00699-4
   Mesbah F, 2016, REPROD DOMEST ANIM, V51, P916, DOI 10.1111/rda.12758
   Monaco D, 2015, EMIR J FOOD AGR, V27, P328, DOI 10.9755/ejfa.v27i4.19904
   Morgan DO, 2007, PRIMERS BIOL SERIES, P193
   Nazari S, 2011, IRAN J REPROD MED, V9, P209
   Otoi T, 2000, THERIOGENOLOGY, V54, P535, DOI 10.1016/S0093-691X(00)00368-X
   Otoi T, 1997, THERIOGENOLOGY, V48, P769, DOI 10.1016/S0093-691X(97)00300-2
   Peteran A, 2015, ANN ROM SOC CELL BIO, V19, P1
   Romao GS, 2010, FERTIL STERIL, V93, P621, DOI 10.1016/j.fertnstert.2008.12.124
   Sensui N, 1996, DEV GROWTH DIFFER, V38, P341
   Skidmore JA, 2010, SOC REPROD FERTIL, V67, P467
   Skidmore JA, 2011, ANIM REPROD SCI, V124, P148, DOI 10.1016/j.anireprosci.2010.08.023
   Ueno S., 2009, Bulletin of the Faculty of Agriculture, Niigata University, V61, P127
   Valeri C, 2011, J ASSIST REPROD GEN, V28, P545, DOI 10.1007/s10815-011-9555-3
   Versieren K, 2010, REPROD BIOMED ONLINE, V21, P769, DOI 10.1016/j.rbmo.2010.07.001
   Wani NA, 2008, THERIOGENOLOGY, V69, P591, DOI 10.1016/j.theriogenology.2007.11.011
   Wani NA, 2010, REPROD DOMEST ANIM, V45, pE189, DOI 10.1111/j.1439-0531.2009.01547.x
   Wani NA, 2005, THERIOGENOLOGY, V64, P75, DOI 10.1016/j.theriogenology.2004.11.009
   Wells D, 2011, MOL HUM REPROD, V17, P273, DOI 10.1093/molehr/gar028
   Yousaf MR, 2003, REPROD FERT DEVELOP, V15, P223, DOI 10.1071/RD03006
   Zhang J, 1999, FERTIL STERIL, V72, P509, DOI 10.1016/S0015-0282(99)00264-2
   Zhou XM, 2013, J ASSIST REPROD GEN, V30, P1605, DOI 10.1007/s10815-013-0113-z
NR 44
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0093-691X
EI 1879-3231
J9 THERIOGENOLOGY
JI Theriogenology
PD JUN
PY 2017
VL 95
BP 141
EP 148
DI 10.1016/j.theriogenology.2017.03.015
PG 8
WC Reproductive Biology; Veterinary Sciences
SC Reproductive Biology; Veterinary Sciences
GA EU5DM
UT WOS:000401051800020
PM 28460668
OA No
DA 2017-08-17
ER

PT J
AU Al-Kotb, MS
   Al-Waheidi, JZ
   Kotkata, MF
AF Al-Kotb, M. S.
   Al-Waheidi, Jumana Z.
   Kotkata, M. F.
TI Investigation on microstructural and optical properties of
   nano-crystalline CdSe thin films
SO THIN SOLID FILMS
LA English
DT Article
DE Nano-crystalline thin film; Cadmium selenide; Microstructure Optical
   properties; Sellmeier dispersion; Wemple-DiDomenico model
ID SPACED VACUUM SUBLIMATION; LIGHT-EMITTING-DIODES; LINE-PROFILE ANALYSIS;
   X-RAY; QUANTUM DOTS; SEMICONDUCTOR NANOCRYSTALS; DISLOCATION DENSITIES;
   REFRACTIVE-INDEX; STACKING-FAULTS; CONSTANTS
AB In this work, nano-crystalline CdSe thin films were deposited by thermal evaporation technique from CdSe nano-powders on glass substrates. The deposited films were characterized by using optical transmission measurements, and X-ray diffraction (XRD). X-ray line profile analysis revealed that the CdSe films are nano-crystalline and having a wurtzite (hexagonal) structure. These nano-crystalline CdSe films were preferentially oriented along the (002) planewith a c-axis perpendicular to the substrate surface. The crystallite size of these films varied from 16 to 36 nm as measured from X-ray line broadening. The variation of film thickness had a great influence on the microstructural parameters, such as micro-strain, stacking-fault probabilities, and dislocation densities. The obtained results demonstrate that the micro-strain, dislocation density, and stacking fault probabilities decrease by increasing the film thickness. The estimated refractive indices of the films fitted well with Sellmeier dispersion formula over a spectral range, 200 nm and 2500 nm. The effective resonance absorption wavelengths were between 610 and 723 nm. Optical parameters of nano-crystalline CdSe films were investigated extensively, and interpreted in the frame of Wemple-DiDomenico single oscillator model. These parameters provided valuable physical insights, such as the relationship between the ionicity of the CdSe films and microstructural parameters. The studied samples obviously had two distinct regions in Tauc plot, except for that sample CS04, due to the strong influence of strain and dislocations. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Al-Kotb, M. S.; Al-Waheidi, Jumana Z.; Kotkata, M. F.] Ain Shams Univ, Fac Sci, Phys Dept, Semicond Technol Lab, Cairo 11566, Egypt.
RP Al-Kotb, MS (reprint author), Ain Shams Univ, Fac Sci, Phys Dept, Semicond Technol Lab, Cairo 11566, Egypt.
EM msalkotb@aucegypt.edu
OI Al-Kotb, M.S./0000-0002-9047-1791
CR Adachi S., 2009, PROPERTIES SEMICONDU
   Al-Kabbi AS, 2015, THIN SOLID FILMS, V586, P1, DOI 10.1016/j.tsf.2015.04.030
   Al-Kotb MS, 2014, SUPERLATTICE MICROST, V69, P149, DOI 10.1016/j.spmi.2014.02.007
   Al-Kotb MS, 2013, SUPERLATTICE MICROST, V55, P131, DOI 10.1016/j.spmi.2012.11.013
   Aven M., 1967, PHYS CHEM 2 6 COMPOU
   Ballato J, 2003, J OPT SOC AM B, V20, P1838, DOI 10.1364/JOSAB.20.001838
   Balzar D., 2004, PHYS REV B, V70
   Bhattacharyya SR, 2009, THIN SOLID FILMS, V517, P5530, DOI 10.1016/j.tsf.2009.03.168
   Bish D.L., 1989, REV MINERALOGY MINER
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Budai JD, 1997, NATURE, V390, P384, DOI 10.1038/37079
   CAGLIOTI G, 1958, NUCL INSTRUM METHODS, V3, P223, DOI 10.1016/0369-643X(58)90029-X
   Chen Y.-C., 2012, J APPL PHYS, V112
   COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0
   Dai XL, 2014, NATURE, V515, P96, DOI 10.1038/nature13829
   DAWERITZ L, 1974, J CRYST GROWTH, V23, P307, DOI 10.1016/0022-0248(74)90075-X
   DELHEZ R, 1982, FRESEN Z ANAL CHEM, V312, P1, DOI 10.1007/BF00482725
   Engwall AM, 2016, MATER DESIGN, V110, P616, DOI 10.1016/j.matdes.2016.07.089
   FITZGERALD EA, 1989, J VAC SCI TECHNOL B, V7, P782, DOI 10.1116/1.584600
   Ghosh M, 2016, NANO LETT, V16, P5969, DOI 10.1021/acs.nanolett.6b00571
   Gnatenko YP, 2014, J LUMIN, V146, P174, DOI 10.1016/j.jlumin.2013.09.070
   HILL RJ, 1992, J APPL CRYSTALLOGR, V25, P589, DOI 10.1107/S0021889892003649
   Hoffmann W, 2012, THIN SOLID FILMS, V520, P4094, DOI 10.1016/j.tsf.2011.04.146
   Hughes SM, 2013, NANO LETT, V13, P106, DOI 10.1021/nl3036417
   Ivashchenko MM, 2015, VACUUM, V119, P81, DOI 10.1016/j.vacuum.2015.04.036
   Kale RB, 2005, SEMICOND SCI TECH, V20, P1, DOI 10.1088/0268-1242/20/1/001
   Kasap S., 2007, SPRINGER HDB ELECT P
   Kubinyi M, 1996, THIN SOLID FILMS, V286, P164, DOI 10.1016/S0040-6090(96)08737-8
   LEE PA, 1969, J PHYS CHEM SOLIDS, V30, P2719, DOI 10.1016/0022-3697(69)90045-6
   Li JB, 2004, APPL PHYS LETT, V85, P2929, DOI 10.1063/1.1800288
   Lin CC, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4915615
   Liu X, 2004, J APPL PHYS, V95, P7754, DOI 10.1063/1.1739291
   Liu YC, 2006, J CRYST GROWTH, V287, P105, DOI 10.1016/j.jcrysgro.2005.10.052
   LOGOTHETIDIS S, 1986, PHYS REV B, V34, P2458, DOI 10.1103/PhysRevB.34.2458
   LUDEKE R, 1967, PHYS STATUS SOLIDI, V23, P413, DOI 10.1002/pssb.19670230142
   MANIFACIER JC, 1976, J PHYS E SCI INSTRUM, V9, P1002, DOI 10.1088/0022-3735/9/11/032
   NINOMIYA S, 1995, J APPL PHYS, V78, P4681, DOI 10.1063/1.359815
   Pacifici D, 2007, NAT PHOTONICS, V1, P402, DOI 10.1038/nphoton.2007.95
   PAL U, 1993, J APPL PHYS, V74, P6368, DOI 10.1063/1.355161
   Poelman D, 2003, J PHYS D APPL PHYS, V36, P1850, DOI 10.1088/0022-3727/36/15/316
   RAOULT F, 1989, THIN SOLID FILMS, V182, P1, DOI 10.1016/0040-6090(89)90238-1
   RAU H, 1978, J PHYS CHEM SOLIDS, V39, P879, DOI 10.1016/0022-3697(78)90149-X
   Ren ML, 2015, NANO LETT, V15, P7341, DOI 10.1021/acs.nanolett.5b02690
   Robel I, 2006, J AM CHEM SOC, V128, P2385, DOI 10.1021/ja056494n
   Rodriguez-Carvajal J., 2001, NEWSLETTER, V26, P12
   RUSLI, 1995, APPL OPTICS, V34, P7914
   Sarasamak K, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.024104
   Scherrer P., 1918, NACHR GES WISS GOTT, V2, P98
   Scherrer P., 1912, KOLLOIDCHEMIE LEHRBU, P387, DOI [DOI 10.1007/978-3-662-33915-2_7, 10.1007/978-3-662-33915-2_7]
   Sezen H, 2010, J VAC SCI TECHNOL A, V28, P639, DOI 10.1116/1.3289319
   SHAALAN MS, 1990, SOL CELLS, V28, P185, DOI 10.1016/0379-6787(90)90052-7
   Smith AM, 2009, NAT NANOTECHNOL, V4, P56, DOI [10.1038/nnano.2008.360, 10.1038/NNANO.2008.360]
   Stokes AR, 1944, P PHYS SOC, V56, P174, DOI 10.1088/0959-5309/56/3/303
   SWANEPOEL R, 1983, J PHYS E SCI INSTRUM, V16, P1214, DOI 10.1088/0022-3735/16/12/023
   Taylor J, 2001, J CLUST SCI, V12, P571, DOI 10.1023/A:1014246315331
   TEREKHOVA SF, 1985, PHYS STATUS SOLIDI B, V131, P207, DOI 10.1002/pssb.2221310121
   Tiwald T., 2009, NEWSLETTER, V10, P8
   Tropf W.J., 1995, HDB OPTICS DEVICES M
   Ungar T, 2007, J MATER SCI, V 42, P1584, DOI 10.1007/s10853-006-0696-1
   WALTON AK, 1963, P PHYS SOC LOND, V81, P509, DOI 10.1088/0370-1328/81/3/319
   WARREN BE, 1955, ACTA METALL MATER, V3, P473, DOI 10.1016/0001-6160(55)90138-3
   WEMPLE SH, 1971, PHYS REV B, V3, P1338, DOI 10.1103/PhysRevB.3.1338
   WILLIAMSON GK, 1956, PHILOS MAG, V1, P34, DOI 10.1080/14786435608238074
   Yacobi B.G., 2003, SEMICONDUCTOR MAT MO
   Yang JN, 2002, J APPL PHYS, V91, P420, DOI 10.1063/1.1417995
   Zhang G, 2008, IEEE ELECTR DEVICE L, V29, P1302, DOI 10.1109/LED.2008.2005651
NR 66
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD JUN 1
PY 2017
VL 631
BP 219
EP 226
DI 10.1016/j.tsf.2017.04.017
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA EU5OR
UT WOS:000401082400031
OA No
DA 2017-08-17
ER

PT J
AU Saeed, M
   Naveed, M
   Arain, MA
   Arif, M
   El-Hack, MEA
   Alagawany, M
   Siyal, FA
   Soomro, RN
   Sun, C
AF Saeed, M.
   Naveed, M.
   Arain, M. A.
   Arif, M.
   El-Hack, M. E. Abd
   Alagawany, M.
   Siyal, F. A.
   Soomro, R. N.
   Sun, C.
TI Quercetin: Nutritional and beneficial effects in poultry
SO WORLDS POULTRY SCIENCE JOURNAL
LA English
DT Article
DE flavonoids; quercetin; chemical structure; beneficial aspects; health;
   poultry
ID DIETARY SUPPLEMENTATION; OXIDATIVE STABILITY; FOOD SOURCES; FLAVONOIDS;
   BIOAVAILABILITY; ANTIOXIDANTS; RATS; POLYPHENOLS; METABOLISM; MECHANISMS
AB Flavonoids are natural compounds derived from fruits, vegetables and medicinal plants. These compounds have been reported to possess various biological actions including anti-inflammatory, antioxidant, growth promoter, antiviral, hepatoprotective, antibacterial, antiallergic, anticarcinogenic, antithrombotic and immunomodulator activities in various animals and poultry species. Quercetin is found in various foods such as vegetables, tea, fruits, wine apples and onions and is known to exert positive effects on poultry production and health. Since, quercetin enhances the immune system by stimulating lymphocytes, macrophages and IgY antibody production and improving natural killer cell activity, lymphoid organs (spleen, thymus and bursa) weights as well as activating the cytokines profile, its supplementation can lead to a state of immune alertness and a lower incidence of infections and diseases. In addition, it affects the dendritic cells (DCs) that play an important role in adaptive and innate immunity. Quercetin revokes the ability of lipopolysaccharide (LPS)-stimulated dendritic cells to induce specific T cell activation and reduce the cytotoxicity in both in vivo and in vitro studies, suggesting quercetin works as an immunosuppressive agent. As immune function is crucial for poultry productivity and prosperity, this review elucidates the potential nutritional effects and health benefits of quercetin on poultry as a replacer for traditional immune boosters and growth promoters. It includes the antiviral activity of quercetin against influenza A virus, rhinovirus (caused common cold), adenovirus (source of necrotic pancreatitis in broilers) and suggests its role in counteracting heavy metal toxicity. However, further studies on molecular basis are required to understand mode of action, beneficial applications as a natural feed additive, growth promoter and immune enhancer, beside the side effects of this compound in poultry.
C1 [Saeed, M.] Northwest A&F Univ, Coll Anim Sci & Technol, Dept Anim Nutr, Yangling 712100, Shaanxi, Peoples R China.
   [Saeed, M.] Univ Agr Faisalabad, Inst Anim Sci, Faisalabad 38040, Pakistan.
   [Naveed, M.] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Nanjing 211198, Jiangsu, Peoples R China.
   [Naveed, M.] Islamia Univ Bahawalpur, Fac Pharm & Alternat Med, Bahawalpur 63100, Punjab, Pakistan.
   [Arain, M. A.; Soomro, R. N.; Sun, C.] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China.
   [Arain, M. A.] Lasbela Univ Agr Water & Marine Sci Uthal, Fac Vet & Anim Sci, Uthal 3800, Pakistan.
   [Arif, M.] Univ Sargodha, Dept Anim Sci, Coll Agr, Sargodha, Pakistan.
   [El-Hack, M. E. Abd; Alagawany, M.] Zagazig Univ, Dept Poultry, Fac Agr, Zagazig 44511, Egypt.
   [Siyal, F. A.] Sindh Agr Univ Tando Jam, Fac Anim Husb & Vet Sci, Dept Anim Nutr, Tandojam 70060, Pakistan.
RP Sun, C (reprint author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China.; Alagawany, M (reprint author), Zagazig Univ, Dept Poultry, Fac Agr, Zagazig 44511, Egypt.
EM dr.mahmoud.alagwany@gmail.com; sunchao2775@163.com
CR Abaza I. M., 2008, JPN POULT SCI, V7, P872
   Ader P, 2000, FREE RADICAL BIO MED, V28, P1056, DOI 10.1016/S0891-5849(00)00195-7
   ADES T. B, 2009, QUERCETIN AM CANC SO
   Alagawany M, 2016, ANN ANIM SCI, V16, P489, DOI 10.1515/aoas-2015-0079
   Alrawaiq N. S., 2014, INT J PHARMTECH RES, V6, P933
   BENTZ A. B, 2009, J YOUNG INVESTIGATOR, V6, P391
   HOLDEN J. M., 2011, USDA DATABASE FLAVON
   Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249
   Chirumbolo Salvatore, 2010, Inflammation & Allergy Drug Targets, V9, P263
   Choi HJ, 2009, EUR J PHARM SCI, V37, P329, DOI 10.1016/j.ejps.2009.03.002
   Comalada M, 2006, BIOCHEM PHARMACOL, V72, P1010, DOI 10.1016/j.bcp.2006.07.016
   Crespy V, 1999, AM J PHYSIOL-GASTR L, V277, pG120
   Day AJ, 2000, FREE RADICAL BIO MED, V29, P1234, DOI 10.1016/S0891-5849(00)00416-0
   Dhama K, 2015, INT J PHARMACOL, V11, P152, DOI 10.3923/ijp.2015.152.176
   Exon JH, 1998, IMMUNOPHARM IMMUNOT, V20, P173, DOI 10.3109/08923979809034816
   Fellenberg MA, 2006, WORLD POULTRY SCI J, V62, P53, DOI 10.1079/WPS200584
   Ganesan S, 2012, ANTIVIR RES, V94, P258, DOI 10.1016/j.antiviral.2012.03.005
   Goliomytis M, 2014, BRIT POULTRY SCI, V55, P98, DOI 10.1080/00071668.2013.870328
   Hager-Theodorides AL, 2014, ANIM FEED SCI TECH, V198, P224, DOI 10.1016/j.anifeedsci.2014.09.021
   Hodek P, 2002, CHEM-BIOL INTERACT, V139, P1, DOI 10.1016/S0009-2797(01)00285-X
   Huang RY, 2010, J IMMUNOL, V184, P6815, DOI 10.4049/jimmunol.0903991
   Iqbal M, 2002, POULTRY SCI, V81, P252
   Kamboh AA, 2014, POULTRY SCI, V93, P2175, DOI 10.3382/ps.2014-03971
   Kamboh AA, 2013, POULTRY SCI, V92, P454, DOI 10.3382/ps.2012-02584
   Kim AR, 2005, ARCH PHARM RES, V28, P297, DOI 10.1007/BF02977796
   Kim DH, 1999, BIOL PHARM BULL, V22, P749
   Kim Dong Wook, 2015, [Korean Journal of Poultry Science, 한국가금학회지], V42, P33
   Koli R, 2010, J AGR FOOD CHEM, V58, P3927, DOI 10.1021/jf9024823
   Konrad M, 2011, INT J SPORT NUTR EXE, V21, P338
   Korver DR, 2012, ANIM FEED SCI TECH, V173, P54, DOI 10.1016/j.anifeedsci.2011.12.019
   Kumazawa Y, 2006, CURR PHARM DESIGN, V12, P4271, DOI 10.2174/138161206778743565
   Larson AJ, 2012, ADV NUTR, V3, P39, DOI 10.3945/an.111.001271
   Lee CK, 2008, PHYTOTHER RES, V22, P223, DOI 10.1002/ptr.2296
   LEE K. H., 2011, NUTR RES PRACT, V66, P163
   Liu HN, 2014, POULTRY SCI, V93, P347, DOI 10.3382/ps.2013-03225
   Liu H, 2012, MOLECULES, V17, P4281, DOI 10.3390/molecules17044281
   Malesev D, 2007, J SERB CHEM SOC, V72, P921, DOI 10.2298/JSC0710921M
   Manach C, 2004, AM J CLIN NUTR, V79, P727
   Manach C, 1999, FREE RADICAL BIO MED, V27, P1259, DOI 10.1016/S0891-5849(99)00159-8
   Min YD, 2007, INFLAMM RES, V56, P210, DOI 10.1007/s00011-007-6172-9
   Moreira MR, 2007, LIFE SCI, V81, P317, DOI 10.1016/j.lfs.2007.05.016
   Nishimuro H, 2015, NUTRIENTS, V7, P2345, DOI 10.3390/nu7042345
   Orsolic N, 2004, J ETHNOPHARMACOL, V94, P307, DOI 10.1016/j.jep.2004.06.006
   Petrus K, 2011, ANAL BIOANAL CHEM, V400, P2555, DOI 10.1007/s00216-010-4614-7
   Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509
   WILHELMOVA N., 1999, J AGR FOOD CHEM, V47, P2274
   REN-YEONG H., 2010, J IMMUNOL, V184, P6815
   Rupasinghe HPV, 2010, J SCI FOOD AGR, V90, P1172, DOI 10.1002/jsfa.3944
   Sampson L, 2002, J AM DIET ASSOC, V102, P1414, DOI 10.1016/S0002-8223(02)90314-7
   Serafini M, 2010, P NUTR SOC, V69, P273, DOI 10.1017/S002966511000162X
   Smith C., 2003, TEX J AGR NATL RESOU, V16, P24
   Sohaib M, 2016, J FOOD PROCESS PRES, V40, P373, DOI 10.1111/jfpp.12614
   Somerset SM, 2008, NUTR CANCER, V60, P442, DOI 10.1080/01635580802143836
   Tsuji M, 2009, J BONE MINER METAB, V27, P673, DOI 10.1007/s00774-009-0088-0
   Wiczkowski W, 2008, J NUTR, V138, P885
   Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023
   Yu ES, 2008, BIOCHEM PHARMACOL, V76, P70, DOI 10.1016/j.bcp.2008.03.020
   [Anonymous], 2014, USDA DATABASE FLAVON
NR 58
TC 0
Z9 0
U1 7
U2 7
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0043-9339
EI 1743-4777
J9 WORLD POULTRY SCI J
JI Worlds Poult. Sci. J.
PD JUN
PY 2017
VL 73
IS 2
BP 355
EP 364
DI 10.1017/S004393391700023X
PG 10
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA EV0OU
UT WOS:000401441600011
OA No
DA 2017-08-17
ER

PT J
AU Eldean, MAS
   Soliman, AM
AF Eldean, Mohamed A. Sharaf
   Soliman, A. M.
TI A novel study of using oil refinery plants waste gases for thermal
   desalination and electric power generation: Energy, exergy & cost
   evaluations
SO APPLIED ENERGY
LA English
DT Article
DE Oil refinery waste gases; Desalination; Hybrid MSF-MED; Design analyses;
   Organic Rankine Cycle (ORC); Gas Turbine Cycle (GTC)
ID ORGANIC RANKINE-CYCLE; TEMPERATURE FLUE-GAS; HEAT-RECOVERY; PARAMETRIC
   OPTIMIZATION; THERMOECONOMIC ANALYSIS; DIESEL-ENGINE; PERFORMANCE;
   DESIGN; SYSTEM; DRIVEN
AB Thermal desalination plants need large amounts of fuel to desalinate large quantities of seawater. At the same time, burning non-beneficial gases in the oil refineries is considered a huge waste of energy instead of using it. In this paper, a novel study on the possibility of operating the thermal desalination plants by waste gases that emerged from oil refineries rather than burning these gases in the air is performed. Hybrid MSF-MED thermal desalination processes are utilized in this study to produce a total range of 100-40,000 m(3)/day. Three scenarios are performed utilizing the waste gases with MSF-MED. The comparison brings out that using waste gases would save roughly 1136 $/h (UHC-unit hourly costs, $/h) while comparing against the conventional natural gas operation. Moreover; 5 m(3)/h of waste gases would produce an amount of 58-60 MW of electric power combined with a production of 100 m(3)/d of fresh water (gas turbine cycle scenario) and 4.5-5 MW combined with a production of 40,000 m(3)/d in case of organic Rankine cycle operation. Based on energy and exergy balances, the 3rd scenario gives remarkable results. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Eldean, Mohamed A. Sharaf] Suez Univ, Fac Petr & Min Engn, Dept Engn Sci, Suez 43721, Egypt.
   [Soliman, A. M.] Al Jouf Univ, Fac Engn, Dept Mech Engn, Sakaka, Saudi Arabia.
RP Eldean, MAS (reprint author), Suez Univ, Fac Petr & Min Engn, Dept Engn Sci, Suez 43721, Egypt.
EM mohammed.eldeen@suezuniv.edu.eg; ahsoliman69@hotmail.com
OI Sharaf Eldean, Mohamed A/0000-0002-6702-8425
CR Anh Lai Ngoc, 2011, ENERGY, V36, P199
   Braimakis K, 2015, ENERGY, V88, P80, DOI 10.1016/j.energy.2015.03.092
   Calise F, 2014, SOL ENERGY, V103, P595, DOI 10.1016/j.solener.2013.09.031
   Chen QC, 2012, APPL ENERG, V98, P562, DOI 10.1016/j.apenergy.2012.04.035
   Cioccolanti L, 2016, APPL THERM ENG, V100, P646, DOI 10.1016/j.applthermaleng.2016.02.082
   Dastgerdi HR, 2016, DESALINATION, V395, P57, DOI 10.1016/j.desal.2016.05.022
   Elminshawy NAS, 2015, ENERG CONVERS MANAGE, V103, P28, DOI 10.1016/j.enconman.2015.06.035
   Feng L, 2016, PROCEDIA ENGINEER, V146, P593, DOI 10.1016/j.proeng.2016.06.407
   Fernandez FJ, 2011, ENERGY, V36, P5239, DOI 10.1016/j.energy.2011.06.028
   He W, 2016, APPL ENERG, V162, P1251, DOI 10.1016/j.apenergy.2015.03.036
   El-Dessouky Hisham T, 2002, FUNDAMENTAL SALT WAT
   Ihm S, 2016, DESALINATION, V397, P116, DOI 10.1016/j.desal.2016.06.029
   Li CY, 2016, APPL ENERG, V180, P707, DOI 10.1016/j.apenergy.2016.08.007
   Li CY, 2015, ENRGY PROCED, V75, P1590, DOI 10.1016/j.egypro.2015.07.370
   Lu ZS, 2016, APPL ENERG, V174, P224, DOI 10.1016/j.apenergy.2016.04.102
   Mabrouk AA, 2007, DESALINATION, V204, P482, DOI 10.1016/j.desal.2006.02.046
   Mabrouk AA, 2007, DESALINATION, V205, P354, DOI 10.1016/j.desal.2006.02.059
   Maheswari KS, 2015, DESALINATION, V358, P94, DOI 10.1016/j.desal.2014.12.023
   Mohamed A., 2011, THESIS
   Sharaf Eldean Mohamed A, DESALINATION WATER T
   Sharaf Eldean Mohamed A, ASME J SOLAR ENERGY
   Nafey AS, 2010, DESALINATION, V259, P197, DOI 10.1016/j.desal.2010.04.005
   Nafey AS, 2010, RENEW ENERG, V35, P2571, DOI 10.1016/j.renene.2010.03.034
   Sanne Lemmens, 2015, 3 INT SEM ORC POW SY
   Shengjun Z., 2011, APPL ENERG, V88, P2740, DOI DOI 10.1016/LAPENERGV.2011.02.034
   Srinivas T., 2012, International Journal of Energy Technology and Policy, V8, P94, DOI 10.1504/IJETP.2012.046016
   Veera Gnaneswar, 2015, APPL ENERG, V137, P877
   Wade NM, 1999, DESALINATION, V123, P115, DOI 10.1016/S0011-9164(99)00065-X
   Wang DX, 2012, APPL ENERG, V91, P341, DOI 10.1016/j.apenergy.2011.10.003
   Yagli H, 2016, ENERGY, V111, P923, DOI 10.1016/j.energy.2016.05.119
   Zhou NJ, 2013, ENERGY, V55, P216, DOI 10.1016/j.energy.2013.03.047
NR 31
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-2619
EI 1872-9118
J9 APPL ENERG
JI Appl. Energy
PD JUN 1
PY 2017
VL 195
BP 453
EP 477
DI 10.1016/j.apenergy.2017.03.052
PG 25
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA ET4CO
UT WOS:000400227000036
OA No
DA 2017-08-17
ER

PT J
AU Mahmoud, SAM
   El-Rouby, DH
   Abd El-Ghani, SF
   Badawy, OM
AF Mahmoud, Sarah Ahmed Mohamed
   El-Rouby, Dalia Hussein
   Abd El-Ghani, Safa Fathy
   Badawy, Omnia Mohamed
TI Correlation between ploidy status using flow cytometry and nucleolar
   organizer regions in benign and malignant epithelial odontogenic tumors
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE Ameloblastoma; Keratocystic odontogenic tumor; Ameloblastic carcinoma;
   Clear cell odontogenic carcinoma; Flow cytometry; AgNORs
ID SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; LYMPH-NODE;
   DNA-PLOIDY; PATTERN; AGNOR
AB Objective: Differentiation between the aggressive benign odontogenic tumors and their malignant counterparts is controversial and difficult. While flow cytometry (FCM) allowed DNA analysis in neoplasia, argyrophilic organizer regions (AgNORs) number and/or size in a nucleus are correlated with the ribosomal gene activity and therefore with cellular proliferation. The aim of this research was to study the diagnostic accuracy of FCM and AgNORs staining in differentiating between benign and malignant epithelial odontogenic tumors and to correlate between these two interventions.
   Design: Sixteen benign cases 18 cases of ameloblastoma (AB) and 8 cases of keratocystic odontogenic tumor (KCOT)] and 13 malignant epithelial odontogenic tumors [8 cases of ameloblastic carcinoma (ABC) and 5 cases of clear cell odontogenic carcinoma(CCOC)] were included in the current study. For FCM analysis, a single cell suspension from Formalin fixed paraffin-embedded (FFPE) tumors was prepared according to a modified method described by Hedley (1989) and AgNORs staining were performed in accordance to the Ploton protocol (1986). Analysis of AgNORs was performed using both quantitative and qualitative methods.
   Results: The work revealed that all the examined tumors were diploid, except for 40% of CCOC cases. The S-phase fraction (SPF) value, AgNORs count and AgNORs area/cell showed statistically significant difference on comparing benign and malignant groups. A weak positive correlation was observed between SPF and AgNORs count.
   Conclusion: The SPF value was considered to be more sensitive and specific in differentiation between aggressive benign and malignant epithelial odontogenic tumors in comparison to AgNORs counting. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Mahmoud, Sarah Ahmed Mohamed; El-Rouby, Dalia Hussein; Abd El-Ghani, Safa Fathy] Cairo Univ, Fac Oral & Dent Med, Giza 11222, Giza Governorat, Egypt.
   [Badawy, Omnia Mohamed] Cairo Univ, Natl Canc Inst, Giza, Giza Governorat, Egypt.
RP Mahmoud, SAM (reprint author), Cairo Univ, Fac Oral & Dent Med, Giza 11222, Giza Governorat, Egypt.
EM sarah.badawy@dentistry.cu.edu.eg; daliael.rouby@dentistry.cu.edu.eg;
   safa.fathy@dentistry.cu.edu.eg
CR Abd El Wahed S. M., 2014, EDJ, V60, P1455
   BARETTON G, 1995, ORAL SURG ORAL MED O, V79, P68, DOI 10.1016/S1079-2104(05)80077-0
   Bello IO, 2009, ORAL ONCOL, V45, P760, DOI 10.1016/j.oraloncology.2008.11.011
   CROCKER J, 1989, J PATHOL, V158, P185, DOI 10.1002/path.1711580303
   Das SN, 2011, INDIAN J MED RES, V134, P54
   Das SN, 2005, INDIAN J MED RES, V122, P216
   Diana H., 2014, JCDR, V8, P115
   El-Deftar M F, 2012, J Egypt Natl Canc Inst, V24, P7, DOI 10.1016/j.jnci.2011.12.001
   Eminovic-Behrem S, 2000, CROAT MED J, V41, P154
   Giaretti W, 2012, CELL ONCOL, V35, P43, DOI 10.1007/s13402-011-0064-2
   Giaretti W, 2013, CANCER EPIDEM BIOMAR, V22, P1133, DOI 10.1158/1055-9965.EPI-13-0147
   HEDLEY DW, 1989, CYTOMETRY, V10, P229, DOI 10.1002/cyto.990100302
   Jain K., 2012, JOMFP, V16, P354
   [刘进忠 Liu Jinzhong], 2002, [华西口腔医学杂志, West China Journal of Stomatology], V20, P187
   Lorand-Metze I, 2004, CELL ONCOL, V26, P63
   Marx R. E., 2013, ORAL MAXILLOFACIAL P, P613
   Piloni Maria J, 2005, Acta Odontol Latinoam, V18, P37
   PLOTON D, 1986, HISTOCHEM J, V18, P5, DOI 10.1007/BF01676192
   Prasanna M., 2014, JOMFP, V18, P45
   Rubini C., 2002, J DENT RES, V81, P299
   Selvi F, 2012, INT J MED SCI, V9, P262, DOI 10.7150/ijms.4243
   Tabll A., 2011, LIVER BIOPSY
   UENO S, 1989, J ORAL MAXIL SURG, V47, P11, DOI 10.1016/0278-2391(89)90116-X
   van Zyl AW, 2012, HEAD NECK PATHOL, V6, P322, DOI 10.1007/s12105-012-0352-9
   [王恩博 Wang Enbo], 2002, [中华口腔医学杂志, Chinese Journal of Stomatology], V37, P421
NR 25
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
EI 1879-1506
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD JUN
PY 2017
VL 78
BP 94
EP 99
DI 10.1016/j.archoralbio.2017.02.015
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA EU0RM
UT WOS:000400719000013
OA No
DA 2017-08-17
ER

PT J
AU Kim, SW
   Rahman, MM
   Abd El-Aty, AM
   Kabir, MH
   Na, TW
   Choi, JH
   Shin, HC
   Shim, JH
AF Kim, Sung-Woo
   Rahman, Md Musfiqur
   Abd El-Aty, A. M.
   Kabir, Md Humayun
   Na, Tae Woong
   Choi, Jeong-Heui
   Shin, Ho-Chul
   Shim, Jae-Han
TI Simultaneous detection of sulfoxaflor and its metabolites, X11719474 and
   X11721061, in lettuce using a modified QuEChERS extraction method and
   liquid chromatography-tandem mass spectrometry
SO BIOMEDICAL CHROMATOGRAPHY
LA English
DT Article
DE half-life; lettuce; liquid chromatography-tandem mass spectrometry;
   QuEChERS; residues; sulfoxaflor; metabolites
ID CHIRAL NEONICOTINOID SULFOXAFLOR; SOLID-PHASE EXTRACTION; INSECTICIDE
   SULFOXAFLOR; GAS-CHROMATOGRAPHY; DISSIPATION; VEGETABLES; RESIDUES; SOIL
AB An analytical method has been developed to quantify the residual levels of sulfoxaflor and its metabolites (X11719474 and X11721061) in/on cultivated lettuce grown under greenhouse conditions. Samples were extracted and purified using a quick, easy, cheap, effective, rugged, and safe QuEChERS' method (original version) following systematic method optimization and were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Good linearity with coefficient of determination 0.9930 was obtained and the limits of detection (LOD) and quantification (LOQ) were in the ranges of 0.003-0.006 and 0.01-0.02mg/kg, respectively. The recovery rates of both the parent compound and its metabolites (fortified at 10 and 50x the LOQ) estimated from six replicates ranged between 81.9 and 115.5% with a relative standard deviation <12%. The validated method was applied to field-incurred samples (collected over 7days) sprayed once or twice with a water-dispersible granule formulation. Notably, a substantial reduction in rate was observed after 3days and the half-life was short, only 1.5days. The developed method is simple and versatile and can be used for various leafy vegetables.
C1 [Kim, Sung-Woo; Rahman, Md Musfiqur; Kabir, Md Humayun; Choi, Jeong-Heui; Shim, Jae-Han] Chonnam Natl Univ, Coll Agr & Life Sci, Biotechnol Res Inst, Yongbong Ro 77, Gwangju 500757, South Korea.
   [Abd El-Aty, A. M.; Shin, Ho-Chul] Konkuk Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Seoul 143701, South Korea.
   [Abd El-Aty, A. M.] Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza, Egypt.
   [Na, Tae Woong] Jeonnam Bioindustry Fdn, Biocontrol Res Ctr Immyeon, Gokseonggun, Jellanamdo, South Korea.
RP Shim, JH (reprint author), Chonnam Natl Univ, Coll Agr & Life Sci, Biotechnol Res Inst, Yongbong Ro 77, Gwangju 500757, South Korea.; Abd El-Aty, AM (reprint author), Konkuk Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Seoul 143701, South Korea.
EM abdelaty44@hotmail.com; jhshim@chonnam.ac.kr
OI Shim, Jae-Han/0000-0002-5361-2903; Shin, Ho-chul/0000-0001-5500-3901;
   Abd El-Aty, A. M./0000-0001-6596-7907
FU Rural Development Administration
FX Rural Development Administration
CR Anastassiades M, 2003, J AOAC INT, V86, P412
   Chen ZL, 2016, J AGR FOOD CHEM, V64, P2655, DOI 10.1021/acs.jafc.5b05940
   Chen ZL, 2014, ANAL BIOANAL CHEM, V406, P6677, DOI 10.1007/s00216-014-8089-9
   Chen ZL, 2014, CHIRALITY, V26, P114, DOI 10.1002/chir.22278
   Cutler P, 2013, PEST MANAG SCI, V69, P607, DOI 10.1002/ps.3413
   Do J. A., 2013, KOREAN J FOOD SCI TE, V45, P148
   European Commission, 2016, EU PEST DAT
   European Food Safety Authority, 2014, EFSA J, V12, P3692
   Institute of Medicine, 2002, DIET REF INT EN CARB
   Im SJ, 2016, BIOMED CHROMATOGR, V30, P946, DOI 10.1002/bmc.3634
   Jiao WT, 2016, FOOD CHEM, V210, P26, DOI 10.1016/j.foodchem.2016.04.097
   Jovanov P, 2013, TALANTA, V111, P125, DOI 10.1016/j.talanta.2013.02.059
   Kim MJ, 2016, J FOOD COMPOS ANAL, V49, P19, DOI 10.1016/j.jfca.2016.03.004
   Ko AY, 2014, FOOD CHEM, V148, P402, DOI 10.1016/j.foodchem.2013.10.055
   Longhurst C, 2013, PEST MANAG SCI, V69, P809, DOI 10.1002/ps.3439
   Loso MR, 2016, BIOORGAN MED CHEM, V24, P378, DOI 10.1016/j.bmc.2015.11.022
   [MFDS Ministry of Food and Drug Safety], 2015, PEST VET DRUGS INF
   Nugent BM, 2015, PEST MANAG SCI, V71, P928, DOI 10.1002/ps.3865
   SANTE, 2015, SANTE119452015
   Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P1, DOI 10.1016/j.pestbp.2013.05.014
   Tanner G, 2011, J AGR FOOD CHEM, V59, P12271, DOI 10.1021/jf202775m
   Tian CY, 2016, J AGR FOOD CHEM, V64, P2641, DOI 10.1021/acs.jafc.6b00285
   Watson GB, 2011, INSECT BIOCHEM MOLEC, V41, P432, DOI 10.1016/j.ibmb.2011.01.009
   Xu J, 2012, ANAL METHODS-UK, V4, P4019, DOI 10.1039/c2ay25782c
NR 24
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-3879
EI 1099-0801
J9 BIOMED CHROMATOGR
JI Biomed. Chromatogr.
PD JUN
PY 2017
VL 31
IS 6
AR UNSP e3885
DI 10.1002/bmc.3885
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA ET9CX
UT WOS:000400604700001
OA No
DA 2017-08-17
ER

PT J
AU Osman, D
   Ali, O
   Obada, M
   El-Mezayen, H
   El-Said, H
AF Osman, Diaa
   Ali, Omnia
   Obada, Manar
   El-Mezayen, Hatem
   El-Said, Hala
TI Chromatographic determination of some biomarkers of liver cirrhosis and
   hepatocellular carcinoma in Egyptian patients
SO BIOMEDICAL CHROMATOGRAPHY
LA English
DT Article
DE gas chromatography; mass spectrometry; hepatocellular carcinoma; liver
   cirrhosis; metabolomic profile; principle components analysis
ID MASS-SPECTROMETRY; CANCER-CELLS; METABOLOMICS; URINE; PROLIFERATION;
   SPECTROSCOPY; METABOLISM; GC/MS; ACTIVATION; DIAGNOSIS
AB Metabolomics has been shown to be an effective tool for disease diagnosis, biomarker screening and characterization of biological pathways. A total of 140 subjects were included in this study; urine metabolomes of patients with liver cirrhosis (LC, n=40), patients with hepatocellular carcinoma (HCC; n=55) and healthy male subjects (n=45) as a control group were studied. Gas chromatography/mass spectrometry-based urine metabolomics profiles were investigated for all participants. Diagnostic models were constructed with a combination of marker metabolites, using principal components analysis and receiver operator characteristic curves. A total of 57 peaks could be auto-identified of which 13 marker metabolites (glycine, serine, threonine, proline, urea, phosphate, pyrimidine, arabinose, xylitol, hippuric acid, citric acid, xylonic acid and glycerol) were responsible for the separation of HCC group from healthy subjects. Also, eight markers metabolites (glycine, serine, threonine, proline, citric acid, urea, xylitol and arabinose) showed significant differences between the LC group and healthy subjects. No significant difference was detected between HCC and LC groups regarding all these metabolites. Metabolomic profile using GC-MS established an optimized diagnostic model to discriminate between HCC patients and healthy subjects; also it could be useful for diagnosis of LC patients. However, it failed to differentiate between HCC and LC patients.
C1 [Osman, Diaa; Obada, Manar; El-Said, Hala] Menoufia Univ, Natl Liver Inst, Dept Clin Biochem, Al Minufiyah, Egypt.
   [Ali, Omnia; El-Mezayen, Hatem] Helwan Univ, Dept Chem, Fac Sci, Cairo, Egypt.
RP Ali, O (reprint author), Helwan Univ, Dept Chem, Fac Sci, Cairo, Egypt.
EM omniaibrahim95@gmail.com
FU Clinical Biochemistry Department, National Liver Institute, Menoufia
   University
FX The authors would like to acknowledge the financial support kindly
   provided by the Clinical Biochemistry Department, National Liver
   Institute, Menoufia University. We also acknowledge Professor Gaber F.
   Al-Fayoumy (Egyptian Petroleum Research Institute, Cairo, Egypt) for his
   effective help.
CR Beyoglu D, 2013, HEPATOLOGY, V58, P229, DOI 10.1002/hep.26350
   Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232
   Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540
   Chen L, 2010, ANN SURG ONCOL, V17, P2518, DOI 10.1245/s10434-010-1038-8
   Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945
   Diao XX, 2014, DRUG METAB DISPOS, V42, P774, DOI 10.1124/dmd.113.056218
   El-mezayen HA, 2014, TUMOR BIOL, V35, P6501, DOI 10.1007/s13277-014-1858-4
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Evans AA, 2002, CANCER EPIDEM BIOMAR, V11, P369
   Fancy SA, 2006, RAPID COMMUN MASS SP, V20, P2271, DOI 10.1002/rcm.2583
   Fitian AI, 2014, LIVER INT, V34, P1428, DOI 10.1111/liv.12541
   Gao R, 2015, SCI REP-UK, V5, DOI 10.1038/srep18175
   Gou SJ, 2013, CLIN J AM SOC NEPHRO, V8, P1884, DOI 10.2215/CJN.02790313
   Hussain Shahid M, 2002, Magn Reson Imaging Clin N Am, V10, P31, DOI 10.1016/S1064-9689(03)00048-5
   Icard P, 2012, BBA-REV CANCER, V1826, P423, DOI 10.1016/j.bbcan.2012.07.001
   Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595
   Jonsson P, 2004, ANAL CHEM, V76, P1738, DOI 10.1021/ac0352427
   Kassahun Woubet T, 2006, Exp Clin Transplant, V4, P549
   Lorenzi R, 2011, INT J TOXICOL, V30, P253, DOI 10.1177/1091581810395630
   Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042
   Moustafa T, 2012, GASTROENTEROLOGY, V142, P140, DOI 10.1053/j.gastro.2011.09.051
   Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S
   Parikh S, 2007, AM J MED, V120, P194, DOI 10.1016/j.amjmed.2006.11.020
   Ressom HW, 2012, ANAL CHIM ACTA, V743, P90, DOI 10.1016/j.aca.2012.07.013
   Ryder SD, 2003, GUT, V52, pIII1, DOI 10.1136/gut.52.suppl_3.iii1
   Saude EJ, 2007, METABOLOMICS, V3, P19, DOI 10.1007/s11306-006-0042-2
   SCHACHTER D, 1953, J BIOL CHEM, V203, P925
   Shariff MIF, 2011, J PROTEOME RES, V10, P1828, DOI 10.1021/pr101096f
   Singh R, 2006, GLYCOBIOLOGY, V16, P594, DOI 10.1093/glycob/cwj108
   Wang XJ, 2013, HEPATOLOGY, V57, P2072, DOI 10.1002/hep.26130
   Wu H, 2009, J CHROMATOGR B, V877, P3111, DOI 10.1016/j.jchromb.2009.07.039
   Wu H, 2009, ANAL CHIM ACTA, V648, P98, DOI 10.1016/j.aca.2009.06.033
   Xie C, 2013, BRIT J PHARMACOL, V168, P1687, DOI 10.1111/bph.12047
   Yang T., 2014, INTEGRATIVE MED INT, V1, P136
   Yang YX, 2007, J PROTEOME RES, V6, P2605, DOI 10.1021/pr070063h
   Zhang AH, 2012, CLIN CHIM ACTA, V414, P65, DOI 10.1016/j.cca.2012.08.016
NR 36
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-3879
EI 1099-0801
J9 BIOMED CHROMATOGR
JI Biomed. Chromatogr.
PD JUN
PY 2017
VL 31
IS 6
AR UNSP e3893
DI 10.1002/bmc.3893
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA ET9CX
UT WOS:000400604700009
OA No
DA 2017-08-17
ER

PT J
AU Truong, LTB
   Abd El-Aty, AM
   Kim, HJ
   Rahman, MM
   Kim, SW
   Shin, HC
   Shim, JH
AF Truong, Lieu T. B.
   Abd El-Aty, A. M.
   Kim, Hyun Jin
   Rahman, Md. Musfiqur
   Kim, Sung-Woo
   Shin, Ho-Chul
   Shim, Jae-Han
TI Application of a solvent-free solid injection technique coupled with
   GC-MS for discrimination between the secondary metabolites of wild and
   cultivated South Korean medicinal foods
SO BIOMEDICAL CHROMATOGRAPHY
LA English
DT Article
DE cultivated; deodeok (Codonopsis lanceolata); doraji (Platycodon
   grandiflorum); dureup (young fatsia shoot; Aralia elata); solid-free
   solvent injection (SFSI); wild
ID BETA-ELEMENE; VOLATILE; IDENTIFICATION; COMPONENTS; HEALTHY; GC/MS; HPLC
AB Solvent-free solid injection was applied to differentiate between wild and cultivated South Korean medicinal foods, including dureup (Aralia elata), deodeok (Codonopsis lanceolata) and doraji (Platycodon grandiflorus). A number of compounds were identified in wild and cultivated dureup (53 and 46), deodeok (47 and 51) and doraji (43 and 38). Secondary metabolites, including butanal,2-methyl-, -caryophyllene, neoclovene, -humulene, -curcumene, -bisabolene, and phytol, were identified in dureup with significantly (P<0.05) different amounts between both types. In deodeok, squalene and other main components such as acetic acid, methyl ester, furan-methyl-furfural, 2-furan-methanol, and 5-methyl-furfural, were statistically different between the two types. Doraji has significantly different compounds such as furfural, 5-methyl-furfural, 2-methoxy-phenol, 2-methoxy-4-(1-propenyl)-phenol, and 1-(4-hydroxy-3-methoxyphenyl)-2-propanone. Although we failed to confirm the key compounds, a new compound, namely desaspidinol, was synthesized for the first time and its retention index determined under the experimental conditions. This solventless, easy technique can be used as a simple way to discriminate between wild and cultivated types of medicinal plants via identification of volatile markers or specific fingerprints.
C1 [Truong, Lieu T. B.; Rahman, Md. Musfiqur; Kim, Sung-Woo; Shim, Jae-Han] Chonnam Natl Univ, Biotechnol Res Inst, Coll Agr & Life Sci, 300 Yongbong Dong, Gwangju 500757, South Korea.
   [Truong, Lieu T. B.] HCMC Natl Univ, Int Univ, Sch Biotechnol, Dept Food Technol, Ho Chi Minh City, Vietnam.
   [Abd El-Aty, A. M.; Shin, Ho-Chul] Konkuk Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Seoul 143701, South Korea.
   [Abd El-Aty, A. M.] Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza, Egypt.
   [Kim, Hyun Jin] Korea Res Inst Chem Technol, Daejeon, South Korea.
RP Shim, JH (reprint author), Chonnam Natl Univ, Biotechnol Res Inst, Coll Agr & Life Sci, 300 Yongbong Dong, Gwangju 500757, South Korea.; Abd El-Aty, AM (reprint author), Konkuk Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Seoul 143701, South Korea.
EM abdelaty44@hotmail.com; jhshim@chonnam.ac.kr
OI Shin, Ho-chul/0000-0001-5500-3901; Abd El-Aty, A. M./0000-0001-6596-7907
CR Abd El-Aty A M, 2008, Biomed Chromatogr, V22, P556, DOI 10.1002/bmc.969
   Babushok V. I., 2011, J PHYS CHEM REF DATA, V40
   Fargasova A., 2007, ATLAS SEEDS FRUITS C, P441
   Cao XF, 2014, J AGR FOOD CHEM, V62, P12360, DOI 10.1021/jf505074d
   Chung J. H., 1996, KOREAN J AGR CHEM BI, V39, P517
   Dahham SS, 2015, MOLECULES, V20, P11808, DOI 10.3390/molecules200711808
   EURL-SRM, 2013, EU REF LAB PEST REQ
   Gao Y.-X., 2015, CHINESE J NEW DRUGS, V14, P1665
   Hossen MJ, 2016, PHYTOTHER RES, V30, P347, DOI 10.1002/ptr.5553
   Ichikawa M, 2009, J NAT MED-TOKYO, V63, P52, DOI 10.1007/s11418-008-0294-4
   Islam MT, 2015, CHEM-BIOL INTERACT, V240, P60, DOI 10.1016/j.cbi.2015.07.010
   KATO K, 1967, AGR BIOL CHEM TOKYO, V31, P657
   Kelly G S, 1999, Altern Med Rev, V4, P29
   Kim IK, 2007, J PHARMACEUT BIOMED, V45, P487, DOI 10.1016/j.jpba.2007.07.025
   Kim J.-H., 1992, KOREAN J FOOD SCI TE, V24, P171
   Kim Mira, 2005, [THE KOREAN JOURNAL OF PESTICIDE SCIENCE, 농약과학회지], V9, P237
   Kim MR, 2006, J CHROMATOGR A, V1116, P259, DOI 10.1016/j.chroma.2006.03.060
   Kim S.-C., 1994, COLOURED RESOURCES P, V632, P636
   Kim S.-K., 1999, J MED CROP SCI, V7, P58
   Kim S.-M., 1996, APPL BIOL CHEM, V39, P389
   Kim SJ, 2014, ASIAN J CHEM, V26, P777
   Ko AY, 2014, FOOD CHEM, V156, P326, DOI 10.1016/j.foodchem.2014.02.001
   Kovats E, 1965, ADV CHROMATOGR, V1, P229
   Lee J. S., 2010, NEW WOODY PLANT FLOR, P296
   Li Y, 2007, FOOD CONTROL, V18, P364, DOI 10.1016/j.foodcont.2005.11.001
   Lim T. K., 2015, EDIBLE MED NONMEDICA, V9, P874
   Neves P, 2013, GREEN CHEM, V15, P3367, DOI 10.1039/c3gc41908h
   Nguyen VH, 2015, BIOORGAN MED CHEM, V23, P4311, DOI 10.1016/j.bmc.2015.06.027
   Nyakudya Elijah, 2014, Prev Nutr Food Sci, V19, P59, DOI 10.3746/pnf.2014.19.2.059
   Oh Haesook, 2005, [The Korean Society of Community Living Science, 한국지역사회생활과학회지], V16, P15
   Park J.-Y., 1989, J KOREAN AGR CHEM SO, V32, P338
   Saeki T, 1999, PLANTA MED, V65, P428
   Shim JH, 2003, J CHROMATOGR A, V1015, P233, DOI 10.1016/S0021-9673(03)01260-3
   Sikorski Z. E., 1997, CHEM FUNCTIONAL PROP, P213
   Singh SK, 2016, NEW J CHEM, V40, P3677, DOI 10.1039/c5nj02916c
   Tomasini D, 2015, THESIS
   Wanakhachornkrai P., 2003, ANAL NUTR CLIN METHO, V83, P619
   Wang G, 2005, CELL MOL LIFE SCI, V62, P881, DOI 10.1007/s00018-005-5017-3
   Zheng CP, 2014, PAK J MED SCI, V30, P1270, DOI 10.12669/pjms.306.5207
NR 39
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-3879
EI 1099-0801
J9 BIOMED CHROMATOGR
JI Biomed. Chromatogr.
PD JUN
PY 2017
VL 31
IS 6
AR UNSP e3896
DI 10.1002/bmc.3896
PG 16
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA ET9CX
UT WOS:000400604700012
OA No
DA 2017-08-17
ER

PT J
AU Zhang, D
   Park, JA
   Kim, SK
   Cho, SH
   Cho, SM
   Shim, JH
   Kim, JS
   Abd El-Aty, AM
   Shin, HC
AF Zhang, Dan
   Park, Jin-A
   Kim, Seong-Kwan
   Cho, Sang-Hyun
   Cho, Soo-Min
   Shim, Jae-Han
   Kim, Jin-Suk
   Abd El-Aty, A. M.
   Shin, Ho-Chul
TI Simple extraction method for quantification of phenothiazine residues in
   pork muscle using liquid chromatography-triple quadrupole tandem mass
   spectrometry
SO BIOMEDICAL CHROMATOGRAPHY
LA English
DT Article
DE detection; phenothiazine; pork muscle; residue level; tandem mass
   spectrometry
ID SOLID-PHASE EXTRACTION; PORCINE MUSCLE; MILK; TISSUES; DRUGS;
   VALIDATION; RISKS; EGGS
AB In this study, an analytical method was developed for quantification of residues of the anthelmintic drug phenothiazine (PTZ) in pork muscle using liquid chromatography-tandem mass spectrometry. Muscles were extracted using 0.2% formic acid and 10mm ammonium formate in acetonitrile, defatted and purified using n-hexane. The drug was well separated on a Waters XBridge C-18 analytical column using a binary solvent system consisting of 0.2% formic acid and 10mm ammonium formate in ultrapure water (A) and acetonitrile (B). Good linearity was achieved over a six-point concentration range in matrix-matched calibration with determination coefficient =0.9846. Fortified pork muscle having concentrations equivalent to and double the limit of quantification (1ng/g) yielded recovery ranges between 100.82 and 104.03% and relative standard deviations <12%. Samples (n=5) collected from large markets located in Seoul City tested negative for PTZ residue. In conclusion, 0.2% formic acid and ammonium formate in acetonitrile can effectively extract PTZ from pork muscle without solid-phase extraction, a step normally required for cleanup before analysis and the validated method can be used for routine analysis to ensure the quality of animal products.
C1 [Zhang, Dan; Park, Jin-A; Kim, Seong-Kwan; Cho, Sang-Hyun; Cho, Soo-Min; Kim, Jin-Suk; Abd El-Aty, A. M.; Shin, Ho-Chul] Konkuk Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Seoul 143701, South Korea.
   [Shim, Jae-Han] Chonnam Natl Univ, Biotechnol Res Inst, Coll Agr & Life Sci, Gwangju, South Korea.
   [Abd El-Aty, A. M.] Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza, Egypt.
RP Abd El-Aty, AM; Shin, HC (reprint author), Konkuk Univ, Coll Vet Med, Dept Vet Pharmacol & Toxicol, Seoul 143701, South Korea.
EM abdelaty44@hotmail.com; hshin@konkuk.ac.kr
OI Shin, Ho-chul/0000-0001-5500-3901; Abd El-Aty, A. M./0000-0001-6596-7907
FU Ministry of Food and Drug Safety Administration [14162MFDS886]
FX Ministry of Food and Drug Safety Administration in 2015, Grant/Award
   Number: 14162MFDS886
CR Adams H. R., 2001, VET PHARM THERAPEUTI
   Andersen JH, 2008, ANAL CHIM ACTA, V617, P216, DOI 10.1016/j.aca.2008.02.070
   Ballweber LR, 2006, VET CLIN N AM-FOOD A, V22, P451, DOI 10.1016/j.cvfa.2006.03.002
   Baltzell P, 2015, VET PARASITOL, V214, P2, DOI 10.1016/j.vetpar.2015.09.019
   BARSHICK SA, 1994, J AOAC INT, V77, P1428
   BLACKMAN GL, 1980, J ASSOC OFF ANA CHEM, V63, P988
   Cho HJ, 2011, BIOMED CHROMATOGR, V25, P1061, DOI 10.1002/bmc.1579
   Cho SK, 2013, FOOD CHEM, V136, P1414, DOI 10.1016/j.foodchem.2012.09.068
   Codex Alimentarius Commission, 1993, CACGL1641
   Danicke S, 2015, FOOD CHEM TOXICOL, V84, P225, DOI 10.1016/j.fct.2015.08.009
   Gao BL, 2014, ANAL BIOCHEM, V454, P7, DOI 10.1016/j.ab.2014.02.032
   HERD R, 1995, INT J PARASITOL, V25, P875, DOI 10.1016/0020-7519(95)00018-W
   Lumaret JP, 2002, VET RES, V33, P547, DOI 10.1051/vetres:2002038
   McKellar QA, 1997, VET PARASITOL, V72, P413, DOI 10.1016/S0304-4017(97)00108-8
   Ministry of Food and Drug Safety, 2015, MAX RES LIM MRLS VET
   Park JA, 2015, J SEP SCI, V38, P2772, DOI 10.1002/jssc.201500501
   Schrenk D., 2012, SERIES FOOD SCI TECH, V235
   Shi FS, 2016, J ENVIRON SCI HEAL B, V51, P715, DOI 10.1080/03601234.2016.1191919
   Takeda N, 2011, FOOD ADDIT CONTAM A, V28, P1168, DOI 10.1080/19440049.2011.587028
   Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003
   Zhang D, 2016, J CHROMATOGR B, V1012, P8, DOI 10.1016/j.jchromb.2016.01.011
   Zhang D, 2016, FOOD CHEM, V192, P299, DOI 10.1016/j.foodchem.2015.07.014
NR 22
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-3879
EI 1099-0801
J9 BIOMED CHROMATOGR
JI Biomed. Chromatogr.
PD JUN
PY 2017
VL 31
IS 6
AR UNSP e3891
DI 10.1002/bmc.3891
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA ET9CX
UT WOS:000400604700007
OA No
DA 2017-08-17
ER

PT J
AU Ashraf, B
   Ghonim, MR
   Eladl, HM
   Elsisi, H
AF Ashraf, B.
   Ghonim, M. R.
   Eladl, H. M.
   Elsisi, H.
TI Title: Role of Malleus relocation in cholesteatoma surgery: our
   experience in 145 patients
SO CLINICAL OTOLARYNGOLOGY
LA English
DT Letter
ID RESIDUAL CHOLESTEATOMA; RECONSTRUCTION
C1 [Ashraf, B.; Ghonim, M. R.; Eladl, H. M.; Elsisi, H.] Mansoura Univ, Mansoura Fac Med, Dept ORL, Otol & Neurotol Unit, Mansoura, Egypt.
RP Ashraf, B (reprint author), Mansoura Univ, Mansoura Fac Med, Dept ORL, Otol & Neurotol Unit, El Gomhoria St, Mansoura, Egypt.
EM dr_bassem_ashraf@yahoo.com
CR De Vos C, 2007, OTOL NEUROTOL, V28, P61, DOI 10.1097/01.mao.0000231598.33585.8f
   East D., 1997, CHOLESTEATOMA MASTOI, P579
   Gaillardin L, 2012, EUR ANN OTORHINOLARY, V129, P136, DOI 10.1016/j.anorl.2011.01.009
   Ghonim MR, 2016, CLIN OTOLARYNGOL, V41, P176, DOI 10.1111/coa.12461
   Ghonim MR, 2011, J LARYNGOL OTOL, V125, P441, DOI 10.1017/S0022215110002264
   Haginomori SI, 2008, ARCH OTOLARYNGOL, V134, P652, DOI 10.1001/archotol.134.6.652
   KARTUSH JM, 1994, OTOLARYNG CLIN N AM, V27, P689
   Marchioni D, 2010, AM J OTOLARYNG, V31, P453, DOI 10.1016/j.amjoto.2009.08.010
   Uzun C, 2005, J LARYNGOL OTOL, V119, P429
   Vincent R, 2004, OTOL NEUROTOL, V25, P223, DOI 10.1097/00129492-200405000-00004
   [Anonymous], 1995, HEAD NECK SURG, V113, P186
NR 11
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1749-4478
EI 1749-4486
J9 CLIN OTOLARYNGOL
JI Clin. Otolaryngol.
PD JUN
PY 2017
VL 42
IS 3
BP 738
EP 743
DI 10.1111/coa.12658
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA ET0GZ
UT WOS:000399941300036
PM 27086553
OA No
DA 2017-08-17
ER

PT J
AU Abdelsalam, E
   Samer, M
   Attia, YA
   Abdel-Hadi, MA
   Hassan, HE
   Badr, Y
AF Abdelsalam, E.
   Samer, M.
   Attia, Y. A.
   Abdel-Hadi, M. A.
   Hassan, H. E.
   Badr, Y.
TI Effects of Co and Ni nanoparticles on biogas and methane production from
   anaerobic digestion of slurry
SO ENERGY CONVERSION AND MANAGEMENT
LA English
DT Article
DE Nanotechnology; Nanoparticles; Anaerobic digestion; Biogas; Methane
   production; Trace metals; Chemical additives; Manure management; Slurry
   treatment
ID TRACE-ELEMENT ADDITION; ACTIVATED-SLUDGE; GRANULAR SLUDGE; FOOD WASTE;
   HEAVY-METALS; WHEAT-STRAW; MANURE; COBALT; REQUIREMENTS; FERMENTATION
AB Nanoparticles (NPs) were hypothesized to enhance the anaerobic process and to accelerate the slurry digestion, which increases the biogas and methane production. The effects of NPs on biogas and methane production were investigated using a specially designed batch anaerobic system. For this purpose, a series of 2 L biodigesters were manufactured and implemented to study the effects of Cobalt (Co) and Nickel (Ni) nanoparticles with different concentrations on biogas and methane production. The best results of NPs additives were determined based on the statistical analysis (Least Significant Difference using M-Stat) of biogas and methane production, which were 1 mg/L Co NPs and 2 mg/L Ni NPs (p < 0.05). These NPs additives delivered the highest biogas and methane yields in comparison with their other concentrations (0.5, 1, and 2 mg/L), their salts (CoCl2, and NiCl2) and the control. Furthermore, the addition of 1 mg/L Co NPs and 2 mg/L Ni NPs significantly increased the biogas volume (p < 0.05) by 1.64 and 1.74 times the biogas volume produced by the control, respectively. Moreover, the aforementioned additives significantly increased the methane volume (p < 0.05) by 1.86 and 2.01 times the methane volume produced by the control, respectively. The highest specific biogas and methane production were attained with 2 mg/L Ni NPs (p < 0.05), and were 614.5 ml Biogas g(-1) VS and 361.6 ml CH4 g(-1) VS, respectively compared with the control which yielded only 352.6 ml Biogas g(-1) VS and 179.6 ml CH4 g(-1) VS. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Abdelsalam, E.; Attia, Y. A.; Hassan, H. E.; Badr, Y.] Cairo Univ, NILES, Giza 12613, Egypt.
   [Samer, M.] Cairo Univ, Fac Agr, Dept Agr Engn, Giza 12613, Egypt.
   [Abdel-Hadi, M. A.] Suez Canal Univ, Fac Agr, Dept Agr Engn, Ismailia, Egypt.
   [Attia, Y. A.] Univ Santiago Compostela, Fac Chem, Phys Chem Dept, E-15782 Santiago De Compostela, Spain.
   [Attia, Y. A.] Univ Santiago Compostela, Fac Chem, Phys Chem Dept, NANOMAG Lab, E-15782 Santiago De Compostela, Spain.
RP Abdelsalam, E (reprint author), Cairo Univ, NILES, Giza 12613, Egypt.; Samer, M (reprint author), Cairo Univ, Fac Agr, Dept Agr Engn, Giza 12613, Egypt.
EM abdelsalam@niles.edu.eg; msamer@agr.cu.edu.eg
OI Samer, Mohamed/0000-0002-3689-286X
FU Cairo University; National Institute of Laser Enhanced Sciences (NILES)
FX The authors would like to acknowledge Cairo University and the National
   Institute of Laser Enhanced Sciences (NILES) for supporting this
   scientific research.
CR Abdelsalam E., 2015, THESIS
   Altas L, 2009, J HAZARD MATER, V162, P1551, DOI 10.1016/j.jhazmat.2008.06.048
   Amon T, 2007, AGR ECOSYST ENVIRON, V118, P173, DOI 10.1016/j.agee.2006.05.007
   Banks CJ, 2012, BIORESOURCE TECHNOL, V104, P127, DOI 10.1016/j.biortech.2011.10.068
   Bartacek J, 2008, J IND MICROBIOL BIOT, V35, P1465, DOI 10.1007/s10295-008-0448-0
   Bini E, 2010, FEMS MICROBIOL ECOL, V73, P1, DOI 10.1111/j.1574-6941.2010.00876.x
   Bozym M, 2015, RENEW ENERG, V77, P467, DOI 10.1016/j.renene.2014.11.010
   Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057
   Demirel B, 2011, BIOMASS BIOENERG, V35, P992, DOI 10.1016/j.biombioe.2010.12.022
   El-Mashad Hamed M., 2003, Reviews in Environmental Science and Bio/Technology, V2, P53, DOI 10.1023/B:RESB.0000022933.77648.09
   Esen M, 2013, ENERG BUILDINGS, V65, P340, DOI 10.1016/j.enbuild.2013.06.018
   Facchin V, 2013, BIOCHEM ENG J, V70, P71, DOI 10.1016/j.bej.2012.10.004
   Feng XM, 2010, FEMS MICROBIOL ECOL, V74, P226, DOI 10.1111/j.1574-6941.2010.00932.x
   Feng YH, 2014, WATER RES, V52, P242, DOI 10.1016/j.watres.2013.10.072
   Fermoso FG, 2009, SCI TOTAL ENVIRON, V407, P3652, DOI 10.1016/j.scitotenv.2008.10.043
   Gustavsson J, 2013, APPL ENERG, V112, P473, DOI 10.1016/j.apenergy.2013.02.009
   Hendroko R, 2014, ENERGY PROCEDIA, V47, P255
   Holm-Nielsen JB, 2009, BIORESOURCE TECHNOL, V100, P5478, DOI 10.1016/j.biortech.2008.12.046
   Jarvis A, 1997, BIOMASS BIOENERG, V12, P453, DOI 10.1016/S0961-9534(97)00015-9
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Cuetos MJ, 2011, BIOTECHNOL BIOPROC E, V16, P1044, DOI 10.1007/s12257-011-0117-4
   Karlsson A, 2012, J BIOSCI BIOENG, V114, P446, DOI 10.1016/j.jbiosc.2012.05.010
   Kida K, 2001, J BIOSCI BIOENG, V91, P590, DOI 10.1263/jbb.91.590
   Krongthamchat K., 2006, International Journal of Environmental Science and Technology, V3, P103
   Laroui H, 2011, AM J PHYSIOL-GASTR L, V300, pG371, DOI 10.1152/ajpgi.00466.2010
   Liu LL, 2015, ENERG CONVERS MANAGE, V97, P132, DOI 10.1016/j.enconman.2015.03.049
   Lo HM, 2012, BIORESOURCE TECHNOL, V114, P90, DOI 10.1016/j.biortech.2012.03.002
   Ramos-Suarez JL, 2014, ENERG CONVERS MANAGE, V88, P1263, DOI 10.1016/j.enconman.2014.02.064
   Luna-delRisco M, 2011, J HAZARD MATER, V189, P603, DOI 10.1016/j.jhazmat.2011.02.085
   Meissner Y, 2008, J PHARM SCI-US, V97, P2878, DOI 10.1002/jps.21216
   Mu H, 2011, BIORESOURCE TECHNOL, V102, P10305, DOI 10.1016/j.biortech.2011.08.100
   Nassar NN, 2010, J HAZARD MATER, V184, P538, DOI 10.1016/j.jhazmat.2010.08.069
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Ni SQ, 2013, BIORESOURCE TECHNOL, V143, P555, DOI 10.1016/j.biortech.2013.06.041
   OLESZKIEWICZ JA, 1990, BIOL WASTE, V31, P45, DOI 10.1016/0269-7483(90)90043-R
   Parisi C, 2015, NANO TODAY, V10, P124, DOI 10.1016/j.nantod.2014.09.009
   Powell JJ, 2010, J AUTOIMMUN, V34, pJ226, DOI 10.1016/j.jaut.2009.11.006
   Qiang H, 2013, CHEM ENG J, V222, P330, DOI 10.1016/j.cej.2013.02.076
   Qiang H, 2012, BIORESOURCE TECHNOL, V103, P21, DOI 10.1016/j.biortech.2011.09.036
   Ravuri H.K., 2013, INT J ADV CHEM, V1, P31
   Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006
   Samer M, 2010, T ASABE, V53, P1277
   Schattauer A, 2011, BIOSYST ENG, V108, P57, DOI 10.1016/j.biosystemseng.2010.10.010
   Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931
   Tratnyek PG, 2006, NANO TODAY, V1, P44, DOI 10.1016/S1748-0132(06)70048-2
   Uemura S, 2010, INT J ENVIRON RES, V4, P33
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Vintiloiu A, 2013, CHEM ENG J, V223, P436, DOI 10.1016/j.cej.2013.02.104
   Vintiloiu A, 2012, ENG LIFE SCI, V12, P287, DOI 10.1002/elsc.201100159
   Wang L, 2013, WATER RES, V47, P3835, DOI 10.1016/j.watres.2013.04.003
   Wang XJ, 2012, BIORESOURCE TECHNOL, V120, P78, DOI 10.1016/j.biortech.2012.06.058
   Wei SZ, 2014, ENERG CONVERS MANAGE, V88, P40, DOI 10.1016/j.enconman.2014.08.018
   Wu DL, 2011, J HAZARD MATER, V195, P170, DOI 10.1016/j.jhazmat.2011.08.021
   Yadvika, 2004, BIORESOURCE TECHNOL, V95, P1, DOI 10.1016/j.biortech.2004.02.010
   Yin DX, 2014, BIORESOURCE TECHNOL, V166, P373, DOI 10.1016/j.biortech.2014.05.037
   Zandvoort MH, 2006, ENG LIFE SCI, V6, P293, DOI 10.1002/elsc.200620129
   Zandvoort MH, 2006, J CHEM TECHNOL BIOT, V81, P1486, DOI 10.1002/jctb.1559
   Zandvoort MH, 2006, ENZYME MICROB TECH, V39, P337, DOI 10.1016/j.enzmictec.2006.03.034
   Zhang WX, 2003, J NANOPART RES, V5, P323, DOI 10.1023/A:1025520116015
   Zitomer DH, 2008, J ENVIRON ENG-ASCE, V134, P42, DOI 10.1061/(ASCE)0733-9372(2008)134:1(42)
   Zou SZ, 2016, ENERG CONVERS MANAGE, V112, P226, DOI 10.1016/j.enconman.2015.12.087
NR 61
TC 0
Z9 0
U1 25
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0196-8904
EI 1879-2227
J9 ENERG CONVERS MANAGE
JI Energy Conv. Manag.
PD JUN 1
PY 2017
VL 141
SI SI
BP 108
EP 119
DI 10.1016/j.enconman.2016.05.051
PG 12
WC Thermodynamics; Energy & Fuels; Mechanics
SC Thermodynamics; Energy & Fuels; Mechanics
GA ET8FC
UT WOS:000400533400013
OA No
DA 2017-08-17
ER

PT J
AU Takeuchi, S
   Rohren, EM
   Abdel-Wahab, R
   Xiao, LC
   Morris, JS
   Macapinlac, HA
   Hassan, MM
   Kaseb, AO
AF Takeuchi, Satoshi
   Rohren, Eric M.
   Abdel-Wahab, Reham
   Xiao, Lianchun
   Morris, Jeffrey S.
   Macapinlac, Homer A.
   Hassan, Manal M.
   Kaseb, Ahmed O.
TI Refining prognosis in patients with hepatocellular carcinoma through
   incorporation of metabolic imaging biomarkers
SO EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
LA English
DT Article
DE FDG PET/CT; Hepatocellular carcinoma; CLIP scoring system; BCLC staging
   system
ID POSITRON-EMISSION-TOMOGRAPHY; TOTAL LESION GLYCOLYSIS; F-18-FDG PET/CT;
   FDG-PET; SURVIVAL; CANCER; CLASSIFICATION; C-11-ACETATE
AB F-18-fluorodeoxyglucose positron emission tomopraphy/computed tomography (FDGPET/CT) has been proven to be useful for imaging many types of cancer; however, its role is not well defined in hepatocellular carcinoma (HCC). We assessed the prognostic value of metabolic imaging biomarkers as established by baseline pretreatment FDG PET/CT in patients with HCC.
   We retrospectively analyzed the records of patients with HCC who underwent FDG PET/CT before initial treatment from May 2013 through May 2014. Four PET/CT parameters were measured: maximum standardized uptake value (SUVmax), total lesion glycolysis (TLG), metabolic tumor volume (MTV), and tumor-to-normal-liver SUV ratio (TNR). Optimal cut-off values for the PET/CT parameters to stratify patients in terms of overall survival (OS) were determined. Multivariate analysis was performed to determine whether the PET/CT parameters could add to the prognostic value of the Cancer of the Liver Italian Program (CLIP) scoring system and the Barcelona-Clinic Liver Cancer (BCLC) staging system.
   The analysis included 56 patients. Univariate analysis of the association between OS and continuous variables, including the PET/CT parameters SUVmax, TLG, tumor size, total bilirubin level, and alkaline phosphatase level were significant predictors of OS. SUVmax ae 11.7, TLG ae 1,341, MTV ae 230 mL, and TNR ae 4.8 were identified as cut-off values. Multivariate analysis revealed that SUVmax ae 11.7 and TNR ae 4.8 were independent factors predicting a poor prognosis in both the CLIP scoring system and the BCLC staging system, as was TLG in the BCLC staging system.
   Pretreatment FDG PET/CT in patients with HCC can add to the prognostic value of standard clinical measures. Incorporation of imaging biomarkers derived from FDG PET/CT into HCC staging systems should be considered.
C1 [Takeuchi, Satoshi] Hokkaido Univ, Dept Med Oncol, Grad Sch Med, North 15 West 7 Kita Ku, Sapporo, Hokkaido, Japan.
   [Takeuchi, Satoshi; Rohren, Eric M.; Macapinlac, Homer A.] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, 1515 Holcombe Blvd,Unit 1483, Houston, TX 77030 USA.
   [Rohren, Eric M.; Hassan, Manal M.] Baylor Coll Med, Dept Radiol, One Baylor Plaza, Houston, TX 77030 USA.
   [Abdel-Wahab, Reham; Kaseb, Ahmed O.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,Unit 426, Houston, TX 77030 USA.
   [Abdel-Wahab, Reham] Assiut Univ Hosp, Clin Oncol Dept, Assiut, Egypt.
   [Xiao, Lianchun; Morris, Jeffrey S.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, 1515 Holcombe Blvd,Unit 1411, Houston, TX 77030 USA.
   [Kaseb, Ahmed O.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,Unit 1483, Houston, TX 77030 USA.
RP Kaseb, AO (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,Unit 426, Houston, TX 77030 USA.; Kaseb, AO (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,Unit 1483, Houston, TX 77030 USA.
EM akaseb@mdanderson.org
FU MD Anderson Cancer Center James E. Anderson Distinguished Professorship
   in Nuclear Medicine; Society of Nuclear Medicine and Molecular Imaging
   Wagner-Torizuka Fellowship; NIH [CA170035-01, CA106458-01]; NIH/NCI
   [P30CA016672]
FX This work was supported in part by the MD Anderson Cancer Center James
   E. Anderson Distinguished Professorship in Nuclear Medicine (to Dr.
   Macapinlac), the Society of Nuclear Medicine and Molecular Imaging
   2012/2014 Wagner-Torizuka Fellowship (to Dr. Takeuchi), NIH grants
   CA170035-01 (to Dr. Kaseb) and CA106458-01 (to Dr. Hassan), and the
   NIH/NCI under award number P30CA016672.
CR Ahn SG, 2011, J GASTROINTEST SURG, V15, P2044, DOI 10.1007/s11605-011-1660-1
   Beyer T, 2000, J NUCL MED, V41, P1369
   Chen HHW, 2012, RADIOLOGY, V264, P559, DOI 10.1148/radiol.12111148
   Cheung TT, 2013, J NUCL MED, V54, P192, DOI 10.2967/jnumed.112.107516
   Chevret S, 1999, J HEPATOL, V31, P133, DOI 10.1016/S0168-8278(99)80173-1
   Chung HH, 2012, ANN SURG ONCOL, V19, P1966, DOI 10.1245/s10434-011-2153-x
   [Anonymous], 1998, HEPATOLOGY, V28, P751
   Costelloe CM, 2009, J NUCL MED, V50, P340, DOI 10.2967/jnumed.108.058461
   Davison J, 2013, AM J ROENTGENOL, V200, P635, DOI 10.2214/AJR.12.9138
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Hayakawa N, 2014, INT J CLIN ONCOL, V19, P1020, DOI 10.1007/s10147-013-0653-3
   Ho CL, 2003, J NUCL MED, V44, P213
   Jiang L, 2016, CLIN NUCL MED, V41, P1, DOI 10.1097/RLU.0000000000000998
   Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038
   Lee SW, 2010, J GASTROENTEROL, V45, P560, DOI 10.1007/s00535-009-0188-6
   Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384
   Lim R, 2012, J NUCL MED, V53, P1506, DOI 10.2967/jnumed.111.101402
   Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122
   Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   National Comprehensive Cancer Network, 2016, NCCN CLIN PRACT GUID
   Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729
   Pons F, 2005, INT HEPATOPANCREATOB, V7, P35, DOI DOI 10.1080/13651820410024058
   Shibata T, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.6
   Stewart BW, 2014, WORLD CANC REPORT 20
   Talbot JN, 2010, J NUCL MED, V51, P1699, DOI 10.2967/jnumed.110.075507
   TORIZUKA T, 1995, J NUCL MED, V36, P1811
   Trojan J, 1999, AM J GASTROENTEROL, V94, P3314
   Yu J, 2013, SEMIN CANCER BIOL, V23, P483, DOI 10.1016/j.semcancer.2013.07.003
NR 29
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1619-7070
EI 1619-7089
J9 EUR J NUCL MED MOL I
JI Eur. J. Nucl. Med. Mol. Imaging
PD JUN
PY 2017
VL 44
IS 6
BP 969
EP 978
DI 10.1007/s00259-016-3583-2
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA ET0AZ
UT WOS:000399924800008
PM 27942837
OA No
DA 2017-08-17
ER

PT J
AU Saleh, AA
   Sharafaddin, AH
   El Komy, MH
   Ibrahim, YE
   Hamad, YK
   Molan, YY
AF Saleh, Amgad A.
   Sharafaddin, Anwar H.
   El Komy, Mahmoud H.
   Ibrahim, Yasser E.
   Hamad, Younis K.
   Molan, Younis Y.
TI Fusarium species associated with date palm in Saudi Arabia
SO EUROPEAN JOURNAL OF PLANT PATHOLOGY
LA English
DT Article
DE Date palm; Fusarium proliferatum; Fusarium solani; DNA-based data
ID PROLIFERATUM; DISEASE; TRANSMISSION; SAROCLADIUM; ZEARALENONE; COMPLEX;
   WHEAT; SOIL; IRAN
AB Fusarium is one of the most destructive fungal genera whose members cause many diseases on plants, animals, and humans. Moreover, many Fusarium species secrete mycotoxins (e.g. trichothecenes and fumonisins) that are toxic to humans and animals. Fusarium isolates from date palm trees showing disease symptoms, e.g. chlorosis, necrosis and whitening, were collected from seven regions across Saudi Arabia. After single-sporing, the fungal strains were morphologically characterized. To confirm the identity of morphologically characterized Fusarium strains, three nuclear loci, two partial genes of translation elongation factor 1 alpha (tef1 alpha) and beta-tubulin (tub2), and the rDNA-ITS region, were amplified and sequenced. Of the 70 Fusarium strains, 70 % were identified as F. proliferatum that were recovered from six regions across Saudi Arabia. Fusarium solani (13 %), as well as one strain each of the following species: F. brachygibbosum, F. oxysporum, and F. verticillioides were also recovered. In addition, five Fusarium-like strains were recognized as Sarocladium kiliense by DNA-based data. The preliminary in vitro pathogenicity results showed that F. proliferatum had the highest colonization abilities on date palm leaflets, followed by F. solani. Although F. oxysporum f. sp. albedinis is the most serious date palm pathogen, F. proliferatum and F. solani are becoming serious pathogens and efforts should be made to restrict and control them. In addition, the potential toxin risks of strains belonging to F. proliferatum should be evaluated.
C1 [Saleh, Amgad A.; Sharafaddin, Anwar H.; El Komy, Mahmoud H.; Ibrahim, Yasser E.; Hamad, Younis K.; Molan, Younis Y.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, POB 2460, Riyadh 11451, Saudi Arabia.
   [Saleh, Amgad A.] Agr Res Ctr, Agr Genet Engn Res Inst, Giza, Egypt.
   [El Komy, Mahmoud H.; Ibrahim, Yasser E.] Agr Res Ctr, Plant Pathol Inst, Giza, Egypt.
   [Hamad, Younis K.] Alexandria Univ, Plant Pathol Dept, Fac Agr, Alexandria, Egypt.
RP Saleh, AA (reprint author), Agr Res Ctr, Agr Genet Engn Res Inst, Giza, Egypt.
EM asa7976@gmail.com
FU National Plan for Science, Technology and Innovation (MAARIFAH), King
   Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia
   [11-AGR1475-02]
FX This Project was funded by the National Plan for Science, Technology and
   Innovation (MAARIFAH), King Abdulaziz City for Science and Technology,
   Kingdom of Saudi Arabia, Award Number (11-AGR1475-02).
CR Abdalla MY, 2000, PLANT DIS, V84, P321, DOI 10.1094/PDIS.2000.84.3.321
   Al-Abdely HM, 2004, CURR OPIN INFECT DIS, V17, P527, DOI 10.1097/00001432-200412000-00004
   Al-Julaifi MZ, 2001, J FOOD PROTECT, V64, P1603
   Al-Sadi AM, 2012, CROP PROT, V37, P1, DOI 10.1016/j.cropro.2012.02.011
   Al-Sadi AM, 2015, J PHYTOPATHOL, V163, P947, DOI 10.1111/jph.12397
   Alkahtani M., 2011, American Journal of Food Technology, V6, P730, DOI 10.3923/ajft.2011.730.741
   Al-Yasiri N. A., 2010, P 4 INT DAT PALM C M, P505
   Armengol J, 2005, EUR J PLANT PATHOL, V112, P123, DOI 10.1007/s10658-005-2552-6
   Betts M. J., 2003, BIOINFORMATICS GENET, P289, DOI DOI 10.1002/0470867302.CH14
   Bokhary H. A., 2006, SAUDI J BIOL SCI, V17, P327, DOI DOI 10.1016/j.sjbs.2010.06.005
   Cohen Y, 2010, HORTSCIENCE, V45, P887
   Desjardins AE, 2006, FUSARIUM MYCOTOXINS
   Djerbi M., 1982, DATE PALM J, V1, P153
   DOVAL SL, 1976, INDIAN J AGR SCI, V46, P545
   Elliott ML, 2010, PLANT DIS, V94, P31, DOI 10.1094/PDIS-94-1-0031
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Flood J, 2006, PHYTOPATHOLOGY, V96, P660, DOI 10.1094/PHYTO-96-0660
   Gashgari RM, 2010, FOODBORNE PATHOG DIS, V7, P1047, DOI 10.1089/fpd.2009.0506
   Gelderblom WCA, 2008, TOXICOLOGY, V250, P89, DOI 10.1016/j.tox.2008.06.004
   GILLESPIE DR, 1993, ANN APPL BIOL, V123, P539, DOI 10.1111/j.1744-7348.1993.tb04926.x
   Hameed M. A., 2012, African Journal of Biotechnology, V11, P8616
   Hartmann N, 2008, ENVIRON SCI TECHNOL, V42, P5455, DOI 10.1021/es8007326
   Hernandez-Hernandez J, 2010, PHYTOPATHOL MEDITERR, V49, P84
   JARVIS WR, 1993, ANN APPL BIOL, V122, P23, DOI 10.1111/j.1744-7348.1993.tb04010.x
   Khairi MMA, 2010, ACTA HORTIC, V882, P37
   Khudhair M. W., 2014, International Journal of Phytopathology, V3, P67
   KLUMPP LM, 2003, THE JOURNAL OF BIOLO, V278, P39059, DOI DOI 10.1074/JBC.M304250200
   Kvas M, 2009, FUNGAL DIVERS, V34, P1
   Lemmer ER, 2004, CARCINOGENESIS, V25, P1257, DOI 10.1093/carcin/bgh129
   Leslie JF, 2006, FUSARIUM LAB MANUAL
   Maitlo W. A., 2014, Pakistan Journal of Phytopathology, V26, P67
   Mandeel Q, 2005, CRYPTOGAMIE MYCOL, V26, P365
   Mansoori B, 2006, J PHYTOPATHOL, V154, P125, DOI 10.1111/j.1439-0434.2006.01067.x
   Mansoori B, 2012, J AGR SCI TECH-IRAN, V14, P1133
   Marasas WFO, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3435014
   Meldrum RA, 2013, AUSTRALAS PLANT PATH, V42, P543, DOI 10.1007/s13313-013-0214-2
   Munoz A, 2011, PHYTOPATHOLOGY, V101, pS125
   MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321
   Musa MO, 2000, BRIT J HAEMATOL, V108, P544, DOI 10.1046/j.1365-2141.2000.01856.x
   O'Donnell K, 1998, MYCOLOGIA, V90, P465, DOI 10.2307/3761407
   O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044
   O'Donnell Kerry, 2000, Mycoscience, V41, P61, DOI 10.1007/BF02464387
   ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376
   Polizzi G, 2003, PLANT DIS, V87, P1149, DOI 10.1094/PDIS.2003.87.9.1149A
   Prouillac C, 2009, TOXICOLOGY, V263, P100, DOI 10.1016/j.tox.2009.06.023
   Saleh AA, 2015, EUR J PLANT PATHOL, V143, P507, DOI 10.1007/s10658-015-0703-y
   Salgado-Neto G, 2016, CIENC RURAL, V46, P943, DOI 10.1590/0103-8478cr20150471
   Sambrook J., 1989, MOL CLONING LAB MANU
   Seifert KA, 2003, MYCOL RES, V107, P643, DOI 10.1017/S095375620323820X
   Stanghellini ME, 1999, PHYTOPATHOLOGY, V89, P476, DOI 10.1094/PHYTO.1999.89.6.476
   Stepien L, 2011, J APPL GENET, V52, P487, DOI 10.1007/s13353-011-0059-8
   Summerbell RC, 2011, STUD MYCOL, P139, DOI 10.3114/sim.2011.68.06
   Swofford D. L., 2002, PAUP PHYLOGENETIC AN
   White T. J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071
   Yeh YH, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-25
   Zaid A., 2002, DATE PALM CULTIVATIO, P223
NR 56
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0929-1873
EI 1573-8469
J9 EUR J PLANT PATHOL
JI Eur. J. Plant Pathol.
PD JUN
PY 2017
VL 148
IS 2
BP 367
EP 377
DI 10.1007/s10658-016-1095-3
PG 11
WC Agronomy; Plant Sciences; Horticulture
SC Agriculture; Plant Sciences
GA ET8JA
UT WOS:000400544500012
OA No
DA 2017-08-17
ER

PT J
AU Sudha, T
   Bharali, DJ
   Sell, S
   Darwish, NHE
   Davis, PJ
   Mousa, SA
AF Sudha, Thangirala
   Bharali, Dhruba J.
   Sell, Stewart
   Darwish, Noureldien H. E.
   Davis, Paul J.
   Mousa, Shaker A.
TI Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma
   Xenografts
SO HORMONES & CANCER
LA English
DT Article
ID CONVECTION-ENHANCED DELIVERY; ACTIVATED PROTEIN-KINASE; CELL-SURFACE
   RECEPTOR; THYROID-HORMONE; TETRAIODOTHYROACETIC ACID; BRAIN-TUMORS;
   RADIATION-THERAPY; MALIGNANT GLIOMAS; CANCER-PATIENTS; L-THYROXINE
AB Thyroid hormone as L-thyroxine (T-4) stimulates proliferation of glioma cells in vitro and medical induction of hypothyroidism slows clinical growth of glioblastoma multiforme (GBM). The proliferative action of T-4 on glioma cells is initiated nongenomically at a cell surface receptor for thyroid hormone on the extracellular domain of integrin alpha v beta 3. Tetraiodothyroacetic acid (tetrac) is a thyroid hormone derivative that blocks T-4 action at alpha v beta 3 and has anticancer and anti-angiogenic activity. Tetrac has been covalently bonded via a linker to a nanoparticle (Nanotetrac, Nano-diamino-tetrac, NDAT) that increases the potency of tetrac and broadens the anticancer properties of the drug. In the present studies of human GBM xenografts in immunodeficient mice, NDAT administered daily for 10 days subcutaneously as 1 mg tetrac equivalent/kg reduced tumor xenograft weight at animal sacrifice by 50%, compared to untreated control lesions (p < 0.01). Histopathological analysis of tumors revealed a 95% loss of the vascularity of treated tumors compared to controls at 10 days (p < 0.001), without intratumoral hemorrhage. Up to 80% of tumor cells were necrotic in various microscopic fields (p < 0.001 vs. control tumors), an effect attributable to devascularization. There was substantial evidence of apoptosis in other fields (p < 0.001 vs. control tumors). Induction of apoptosis in cancer cells is a well-described quality of NDAT. In summary, systemic NDAT has been shown to be effective by multiple mechanisms in treatment of GBM xenografts.
C1 [Sudha, Thangirala; Bharali, Dhruba J.; Darwish, Noureldien H. E.; Davis, Paul J.; Mousa, Shaker A.] Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, 1 Discovery Dr, Rensselaer, NY 12144 USA.
   [Sell, Stewart] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
   [Darwish, Noureldien H. E.] Mansoura Univ, Dept Clin Pathol, Fac Med, Mansoura, Egypt.
   [Davis, Paul J.] Albany Med Coll, Dept Med, Albany, NY 12208 USA.
   [Davis, Paul J.; Mousa, Shaker A.] NanoPharmaceuticals LLC, Rensselaer, NY 12144 USA.
RP Davis, PJ (reprint author), Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, 1 Discovery Dr, Rensselaer, NY 12144 USA.; Davis, PJ (reprint author), Albany Med Coll, Dept Med, Albany, NY 12208 USA.; Davis, PJ (reprint author), NanoPharmaceuticals LLC, Rensselaer, NY 12144 USA.
EM pdavis.ordwayst@gmail.com
FU NanoPharmaceuticals LLC, Rensselaer, NY
FX The work reported here was supported in part by a grant from
   NanoPharmaceuticals LLC, Rensselaer, NY.
CR Alexander BM, 2013, EXPERT REV ANTICANC, V13, P569, DOI [10.1586/era.13.44, 10.1586/ERA.13.44]
   Bergh JJ, 2005, ENDOCRINOLOGY, V146, P2864, DOI 10.1210/en.2005-0102
   Bharali DJ, 2013, NANOMEDICINE-UK, V8, P1943, DOI 10.2217/nnm.12.200
   Chaichana KL, 2014, WORLD NEUROSURG, V82, pE257, DOI 10.1016/j.wneu.2014.01.019
   Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324
   Davis FB, 2006, CANCER RES, V66, P7270, DOI 10.1158/0008-5472.CAN-05-4365
   Davis FB, 2004, CIRC RES, V94, P1500, DOI 10.1161/01.RES.0000130784.90237.4a
   Davis PJ, 2016, NAT REV ENDOCRINOL, V12, P111, DOI 10.1038/nrendo.2015.205
   Davis PJ, 2016, COMPR PHYSIOL, V6, P353, DOI 10.1002/cphy.c150011
   Davis Paul J, 2014, Front Endocrinol (Lausanne), V5, P240, DOI 10.3389/fendo.2014.00240
   Davis PJ, 2011, ANNU REV PHARMACOL, V51, P99, DOI 10.1146/annurev-pharmtox-010510-100512
   Desai R, 2016, EXPERT OPIN EMERG DR, V21, P133, DOI 10.1080/14728214.2016.1186643
   Drean A, 2016, EXPERT REV NEUROTHER, V16, P1285, DOI 10.1080/14737175.2016.1202761
   Dvorak HF, 2015, CANCER J, V21, P237, DOI 10.1097/PPO.0000000000000124
   Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209
   Fraum TJ, 2011, J NEURO-ONCOL, V105, P281, DOI 10.1007/s11060-011-0579-4
   Hercbergs AA, 2003, ANTICANCER RES, V23, P617
   Hercbergs A, 2015, ONCOLOGIST, V20, P72, DOI 10.1634/theoncologist.2014-0308
   Hercbergs AH, 2011, CELL CYCLE, V10, P352, DOI 10.4161/cc.10.2.14641
   Kalkan Rasime, 2015, Clin Med Insights Oncol, V9, P95, DOI 10.4137/CMO.S30271
   Letarte N, 2013, CANCER CHEMOTH PHARM, V71, P1561, DOI 10.1007/s00280-013-2155-4
   Lieberman NAP, 2016, EXPERT REV ANTICANC, V16, P775, DOI 10.1080/14737140.2016.1192470
   Lin HY, 2008, CARCINOGENESIS, V29, P62, DOI 10.1093/carcin/bgm239
   Lin HY, 2016, STEROIDS, V114, P59, DOI 10.1016/j.steroids.2016.05.006
   Lin HY, 2016, COMPR PHYSIOL, V6, P1221, DOI 10.1002/cphy.c150035
   Lin HY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001073
   Lin HY, 2009, AM J PHYSIOL-CELL PH, V296, pC980, DOI 10.1152/ajpcell.00305.2008
   Mamo A, 2016, CURR ONCOL, V23, pE468, DOI 10.3747/co.23.3108
   Mohme M, 2014, CANCER TREAT REV, V40, P248, DOI 10.1016/j.ctrv.2013.08.008
   Mousa SA, 2014, ANGIOGENESIS, V17, P463, DOI 10.1007/s10456-014-9418-5
   Mousa SA, 2012, LUNG CANCER, V76, P39, DOI 10.1016/j.lungcan.2011.10.003
   Mrugala MM, 2013, DISCOV MED, V15, P221
   Narita Y, 2013, JPN J CLIN ONCOL, V43, P587, DOI 10.1093/jjco/hyt051
   Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319
   Peng L, 2014, TUMOR BIOL, V35, P9419, DOI 10.1007/s13277-014-2189-1
   Peschillo S, 2016, J NEUROINTERV SURG, V8, P1078, DOI 10.1136/neurintsurg-2015-012048
   Rahmathulla G, 2013, ONCOTARGETS THER, V6, P371, DOI 10.2147/OTT.S38628
   Ramirez Yulian P, 2013, Pharmaceuticals (Basel), V6, P1475, DOI 10.3390/ph6121475
   Seystahl K, 2016, CRIT REV ONCOL HEMAT, V99, P389, DOI 10.1016/j.critrevonc.2016.01.018
   Shih A, 2004, ENDOCRINOLOGY, V145, P1708, DOI 10.1210/en.2003-0742
   Thomas AA, 2014, CURR TREAT OPTION ON, V15, P551, DOI 10.1007/s11864-014-0308-2
   Tivnan A, 2013, MOL NEUROBIOL, V48, P757, DOI 10.1007/s12035-013-8464-0
   Venur VA, 2015, CANCER TREAT RES, V163, P103, DOI 10.1007/978-3-319-12048-5_7
   Vogelbaum MA, 2007, NEUROSURGERY, V61, P1031, DOI 10.1227/01.NEU.0000280092.91489.08
   Vogelbaum MA, 2007, J NEURO-ONCOL, V83, P97, DOI 10.1007/s11060-006-9308-9
   Vogelbaum MA, 2015, NEURO-ONCOLOGY, V17, pII3, DOI 10.1093/neuonc/nou354
   Vogelbaum MA, 2012, HAND CLINIC, V104, P355, DOI 10.1016/B978-0-444-52138-5.00023-2
   Von Neubeck C, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150354
   Yalcin M, 2010, J CLIN ENDOCR METAB, V95, P1972, DOI 10.1210/jc.2009-1926
   Yalcin M, 2009, ANTICANCER RES, V29, P3825
   Yalcin M, 2013, HORM CANCER-US, V4, P176, DOI 10.1007/s12672-013-0137-y
   Yalcin M, 2010, THYROID, V20, P281, DOI 10.1089/thy.2009.0249
   Yin AA, 2013, CRIT REV ONCOL HEMAT, V87, P265, DOI 10.1016/j.critrevonc.2013.01.007
NR 53
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1868-8497
EI 1868-8500
J9 HORM CANCER-US
JI Horm. Cancer
PD JUN
PY 2017
VL 8
IS 3
BP 157
EP 165
DI 10.1007/s12672-017-0293-6
PG 9
WC Oncology; Endocrinology & Metabolism
SC Oncology; Endocrinology & Metabolism
GA ET8YI
UT WOS:000400590600003
PM 28396979
OA No
DA 2017-08-17
ER

PT J
AU Eid, MA
   Aly, SM
   Huneif, MA
   Ismail, DK
AF Eid, Mohamed A.
   Aly, Sobhy M.
   Huneif, Mohamed A.
   Ismail, Dina K.
TI Effect of isokinetic training on muscle strength and postural balance in
   children with Down's syndrome
SO INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH
LA English
DT Article
DE balance; Down's syndrome; isokinetic training; muscle strength
ID RANDOMIZED CONTROLLED-TRIAL; BIODEX STABILITY SYSTEM;
   MENTAL-RETARDATION; ADULTS; INDIVIDUALS; PROGRAM; RELIABILITY; FITNESS
AB Children with Down's syndrome (DS) often have greater postural sway and delay in motor development. Muscle weakness and hypotonia, particularly of the lower extremities, are theorized to impair their overall physical health and ability to perform daily activities. Therefore, the aim of this study was to investigate the effects of isokinetic training on muscle strength and postural balance in children with DS. Thirty-one children with DS ranging in age from 9 to 12 years were assigned randomly into two groups. The control group received the conventional physical therapy, whereas the study group received the same therapy as the control group in addition to the isokinetic training 3 days a week for 12 weeks. Measurement of stability indices using the Biodex Stability System as well as peak torque of knee flexors and extensors of both sides using the isokinetic dynamometer was performed before and after 12 weeks of the treatment program. Each group showed significant improvements in postural balance and peak torque of knee flexors and extensors (P < 0.05), with significantly greater improvements observed in the study group compared with the control group (P < 0.05). These outcomes indicated that participation in the isokinetic training program induced greater improvements in muscle strength and postural balance in children with DS. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Eid, Mohamed A.; Aly, Sobhy M.] Najran Univ, Coll Appl Med Sci, Dept Phys Therapy, Najran, Saudi Arabia.
   [Huneif, Mohamed A.] Najran Univ, Coll Med, Dept Pediat, Najran, Saudi Arabia.
   [Eid, Mohamed A.] Cairo Univ, Dept Phys Therapy Disturbances Growth & Dev Child, Cairo, Egypt.
   [Aly, Sobhy M.] Cairo Univ, Fac Phys Therapy, Dept Biomech, Cairo, Egypt.
   [Ismail, Dina K.] Sheikh Zayed Specialized Hosp, Dept Phys Therapy, Giza, Egypt.
RP Eid, MA (reprint author), Najran Univ, Coll Appl Med Sci, Dept Phys Therapy, Najran, Saudi Arabia.; Eid, MA (reprint author), Cairo Univ, Dept Phys Therapy Disturbances Growth & Dev Child, Cairo, Egypt.
EM mohamed.eid27@yahoo.com
FU Deanship of Scientific Research, Najran University, Najran, Saudi Arabia
   [NU/MID/14/59]; Deanship of Scientific Research, Najran University,
   Najran, Saudi Arabia
FX The authors thank the Deanship of Scientific Research, Najran
   University, Najran, Saudi Arabia, for sponsoring this study, project
   number NU/MID/14/59. They would also like to thank all the children and
   their parents for their collaboration in this study.; The authors
   declare that this article is sponsored by the Deanship of Scientific
   Research, Najran University, Najran, Saudi Arabia.
CR Arnold BL, 1998, J ATHL TRAINING, V33, P323
   Aruin AS, 1996, AM J MENT RETARD, V101, P256
   Cachupe W., 2001, MEAS PHYS ED EXERC S, V5, P97, DOI DOI 10.1207/S15327841MPEE0502_
   Ching LH, 2012, RES DEV DISABIL, V33, P2236
   Cowie V, 1970, STUDY EARLY DEV MONG
   DAVIS WE, 1987, J MOTOR BEHAV, V19, P130, DOI 10.1080/00222895.1987.10735404
   Dutta UR, 2012, GENE, V495, P199, DOI 10.1016/j.gene.2011.12.034
   ESSELMAN PC, 1991, ARCH PHYS MED REHAB, V72, P723
   Evetovich TK, 1998, ISOKINET EXERC SCI, V7, P123
   Gupta S, 2011, CLIN REHABIL, V25, P425, DOI 10.1177/0269215510382929
   Heller T, 2004, AM J MENT RETARD, V109, P175, DOI 10.1352/0895-8017(2004)109<175:AAPOOA>2.0.CO;2
   Hill DA, 2003, ARCH INTERN MED, V163, P705, DOI 10.1001/archinte.163.6.705
   Hoppeler H, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00483
   HORVAT M, 1993, PERCEPT MOTOR SKILL, V77, P643
   Jee Yong-Seok, 2015, J Exerc Rehabil, V11, P65, DOI 10.12965/jer.150197
   Jesudason C, 2002, AUST J PHYSIOTHER, V48, P73
   Lewis PB, 2012, CLIN SPORT MED, V31, P255, DOI 10.1016/j.csm.2011.09.009
   ODUNAIYA NA, 2009, NIGERIA PAK J MED SC, V25, P583
   OZMUN JC, 1994, MED SCI SPORT EXER, V26, P510
   PITETTI KH, 1990, ARCH PHYS MED REHAB, V71, P669
   Polastri PF, 2005, ADAPT PHYS ACT Q, V22, P39
   POLETTO PR, 2008, REV BRAS FISIOTER, V12, P331, DOI 10.1590/S1413-35552008000400013
   Rimmer JH, 2004, AM J MENT RETARD, V109, P165, DOI 10.1352/0895-8017(2004)109<165:IIPFIA>2.0.CO;2
   Schmitz R, 1998, J SPORT REHABIL, V7, P95
   Shields N, 2008, ARCH PHYS MED REHAB, V89, P1215, DOI 10.1016/j.apmr.2007.11.056
   SHUMWAYCOOK A, 1985, PHYS THER, V65, P1315
   Stopka CB, 1998, J SPORT REHABIL, V7, P197
   Suman OE, 2001, J APPL PHYSIOL, V91, P1168
   Tsimaras VK, 2004, J STRENGTH COND RES, V18, P343
   Vuillerme N, 2001, ADAPT PHYS ACT Q, V18, P417
   Wang Wai-Yi, 1999, Kaohsiung Journal of Medical Sciences, V15, P226
   Weber R, 1988, CLIN KINESIOL, V42, P13
NR 32
TC 0
Z9 0
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0342-5282
EI 1473-5660
J9 INT J REHABIL RES
JI Int. J. Rehabil. Res.
PD JUN
PY 2017
VL 40
IS 2
BP 127
EP 133
DI 10.1097/MRR.0000000000000218
PG 7
WC Rehabilitation
SC Rehabilitation
GA ET7JH
UT WOS:000400471100005
PM 28146007
OA No
DA 2017-08-17
ER

PT J
AU Farag, MM
   Abd-Allah, WM
   Ahmed, HYA
AF Farag, M. M.
   Abd-Allah, W. M.
   Ahmed, Hanaa Y. A.
TI Study of the dual effect of gamma irradiation and strontium substitution
   on bioactivity, cytotoxicity, and antimicrobial properties of 45S5
   bioglass
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE 45S5 glass; gamma ray; SrO substitution; antimicrobial activity;
   cytotoxicity
ID ANTIBACTERIAL PROPERTIES; PARTICULATE BIOGLASS(R); ULTRASONIC
   TECHNIQUES; STRUCTURAL-PROPERTIES; ABSORPTION-SPECTRA; GLASS STRUCTURE;
   ION RELEASE; CALCIUM; SPECTROSCOPY; BEHAVIOR
AB In this work, we studied simultaneous effect of gamma irradiation and SrO substitution for Na2O on bioactivity, cytotoxicity and antimicrobial properties of 45S5 glass. Gamma irradiation was mainly introduced in this work as an effective sterilizing technique, improvement of bulk properties and surface modification of glass. Where, gamma irradiation is considered a modifier for glass network due to generation of defects resulted from this irradiation. Furthermore, SrO was introduced into the glass structure in place of Na2O in order to reduce a probable toxic effect of Na2O for surrounding tissue by decreasing its percentage. Where, Sr2+ is characterized by its antibacterial properties, as well as, it induces formation of bone tissue and inhibits its resorption. The cell viability was studied for selected samples using Vero cells. As well as, antimicrobial activity was evaluated against Bacillus subtilis, Staphylococcus pneumonia, and Escherichia coli and Pseudomonas aeruginosa bacteria. The results showed that substitution of Na2O by SrO in glass composition decreased the glass dissolution in SBF. However, the glass dissolution increased after irradiation of such glass due to generation of nonbridgingoxygens (NBOs) throughout glass network by gamma irradiation, and this effect was more obvious for Sr-contained glass. On the other hand, two selected Sr-containing glasses (gamma irradiated at 0 and 25 kGy) showed a good ability to stimulate cell proliferation of normal fibroblast cells, as well as, they represented a potential ability to inhibit the growth of or kill bacteria, which is considered an important issue commonly found in a clinical situation. (c) 2017 Wiley Periodicals, Inc.
C1 [Farag, M. M.] Natl Res Ctr, Glass Res Dept, 33 El Bohooth St, Giza 1262, Egypt.
   [Abd-Allah, W. M.] Egyptian Atom Energy Author, Radiat Chem Dept, Natl Ctr Radiat Res & Technol, Cairo, Egypt.
   [Ahmed, Hanaa Y. A.] Al Azhar Univ, Reg Ctr Mycol & Biotechnol, Cairo, Egypt.
RP Farag, MM (reprint author), Natl Res Ctr, Glass Res Dept, 33 El Bohooth St, Giza 1262, Egypt.
EM mmfarag_nrc@yahoo.com
CR Allan I, 2002, CLIN ORAL IMPLAN RES, V13, P53, DOI 10.1034/j.1600-0501.2002.130106.x
   Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   Begum S, 2016, BIOMED MATER, V11, DOI 10.1088/1748-6041/11/1/015006
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   Brown GE, 1995, REV MINERAL, V32, P317
   Cheng YL, 2003, LIFE SCI, V73, P2383, DOI 10.1016/S0024-3205(03)00648-9
   El-Batal FH, 2013, SILICON-NETH, V5, P171, DOI 10.1007/s12633-012-9112-4
   ElBatal FH, 2008, MATER CHEM PHYS, V110, P352, DOI 10.1016/j.matchemphys.2008.02.011
   ElBatal HA, 2003, MATER CHEM PHYS, V80, P599, DOI 10.1016/S0254-0584(03)00082-8
   Farag MM, 2015, DRUG DELIV TRANSL RE, V5, P63, DOI 10.1007/s13346-014-0214-y
   Farah K, 2014, NUCL INSTRUM METH B, V323, P36, DOI 10.1016/j.nimb.2014.01.019
   Fredholm YC, 2012, J R SOC INTERFACE, V9, P880, DOI 10.1098/rsif.2011.0387
   Fredholm YC, 2010, J NON-CRYST SOLIDS, V356, P2546, DOI 10.1016/j.jnoncrysol.2010.06.078
   Friebele EJ, 1991, OPTICAL PROPERTIES G, P205
   Goel A, 2012, ACTA BIOMATER, V8, P361, DOI 10.1016/j.actbio.2011.08.026
   Goel A, 2011, ACTA BIOMATER, V7, P4071, DOI [10.1016/j.actbio.2011.06.047, 10.1016/Lactbio.2011.06.047]
   Guida A, 2003, J MATER SCI LETT, V22, P1401, DOI 10.1023/A:1025794927195
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1992, BIOCERAMICS, V5, P67
   Hu S, 2009, J MATER SCI-MATER M, V20, P281, DOI 10.1007/s10856-008-3564-5
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   Jacobs A, 2007, COLLOID SURFACE B, V59, P35, DOI 10.1016/j.colsurfb.2007.04.008
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Laopaiboon R, 2014, APPL RADIAT ISOTOPES, V89, P42, DOI 10.1016/j.apradiso.2014.02.008
   Laopaiboon R, 2014, ANN NUCL ENERGY, V68, P220, DOI 10.1016/j.anucene.2014.01.026
   Li YF, 2012, BIOCHEM BIOPH RES CO, V418, P725, DOI 10.1016/j.bbrc.2012.01.088
   Lin YG, 2008, J WUHAN UNIV TECHNOL, V23, P475, DOI 10.1007/s11595-006-4475-2
   Lotfibakhshaiesh N, 2010, J NON-CRYST SOLIDS, V356, P2583, DOI 10.1016/j.jnoncrysol.2010.05.017
   Massera J, 2014, J MATER SCI-MATER M, V25, P657, DOI 10.1007/s10856-013-5120-1
   Moncke D, 2006, J NON-CRYST SOLIDS, V352, P2631, DOI 10.1016/j.jnoncrysol.2006.03.034
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   O'Donnell MD, 2008, ACTA BIOMATER, V4, P1455, DOI 10.1016/j.actbio.2008.04.018
   O'Donnell MD, 2010, J MATER CHEM, V20, P8934, DOI 10.1039/c0jm01139h
   O'Donnell MD, 2010, ACTA BIOMATER, V6, P2382, DOI 10.1016/j.actbio.2010.01.006
   Pratten J, 2004, J BIOMATER APPL, V19, P47, DOI 10.1177/0885328204043200
   Ravi ND, 2012, J AM CERAM SOC, V95, P2700, DOI 10.1111/j.1551-2916.2012.05262.x
   Sharma G, 2006, RADIAT PHYS CHEM, V75, P959, DOI 10.1016/j.radphyschem.2006.02.008
   Smania A. Jr., 1999, International Journal of Medicinal Mushrooms, V1, P325
   Wren AW, 2013, J MATER SCI-MATER M, V24, P2255, DOI 10.1007/s10856-013-4974-6
   Yang F, 2010, ENG MED BIOL SOC EMB
NR 42
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2017
VL 105
IS 6
BP 1646
EP 1655
DI 10.1002/jbm.a.36035
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ET5ND
UT WOS:000400329500009
PM 28187505
OA No
DA 2017-08-17
ER

PT J
AU Abd-Elhady, AA
   Sallam, HEDM
AF Abd-Elhady, Amr A.
   Sallam, Hossam El-Din M.
TI Discussion of "Fatigue Behavior of Cracked Steel Plates Strengthened
   with Different CFRP Systems and Configurations" by Hai-Tao Wang, Gang
   Wu, and Jian-Biao Jiang
SO JOURNAL OF COMPOSITES FOR CONSTRUCTION
LA English
DT Editorial Material
C1 [Abd-Elhady, Amr A.] Helwan Univ, Dept Mech Design, Fac Engn, Cairo 11718, Egypt.
   [Sallam, Hossam El-Din M.] Jazan Univ, Dept Civil Engn, Fac Engn, Jazan 706, Saudi Arabia.
   [Sallam, Hossam El-Din M.] Zagazig Univ, Dept Mat Engn, Zagazig 44519, Egypt.
RP Sallam, HEDM (reprint author), Jazan Univ, Dept Civil Engn, Fac Engn, Jazan 706, Saudi Arabia.; Sallam, HEDM (reprint author), Zagazig Univ, Dept Mat Engn, Zagazig 44519, Egypt.
EM aaa_elhady@yahoo.com; hem_sallam@yahoo.com
CR Abd-Elhady AA, 2015, ENG FRACT MECH, V147, P55, DOI 10.1016/j.engfracmech.2015.08.005
   Naga S. R., 1991, 5 INT C MECH DES PRO, P385
   Sallam H. E. M., 1999, FINITE ELEMENT ANAL
   Sallam HEM, 2010, J BRIDGE ENG, V15, P117, DOI 10.1061/(ASCE)BE.1943-5592.72
NR 4
TC 0
Z9 0
U1 1
U2 1
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 1090-0268
EI 1943-5614
J9 J COMPOS CONSTR
JI J. Compos. Constr.
PD JUN
PY 2017
VL 21
IS 3
AR 07016002
DI 10.1061/(ASCE)CC.1943-5614.0000647
PG 1
WC Engineering, Civil; Mechanics; Materials Science, Composites
SC Engineering; Mechanics; Materials Science
GA ET8CC
UT WOS:000400524800013
OA No
DA 2017-08-17
ER

PT J
AU Benmokrane, B
   Robert, M
   Mohamed, HM
   Ali, AH
   Cousin, P
AF Benmokrane, Brahim
   Robert, Mathieu
   Mohamed, Hamdy M.
   Ali, Ahmed H.
   Cousin, Patrice
TI Durability Assessment of Glass FRP Solid and Hollow Bars (Rock Bolts)
   for Application in Ground Control of Jurong Rock Caverns in Singapore
SO JOURNAL OF COMPOSITES FOR CONSTRUCTION
LA English
DT Article
DE Durability; Fiber-reinforced polymer (FRP); Solid and hollow glass
   fiber-reinforced polymer (GFRP) rock bolts; Aging; Saline solution;
   Tensile strength; Jurong rock caverns in Singapore
AB This study was conducted to investigate the durability of two types of vinyl-ester/glass fiber-reinforced polymer (GFRP) rock bolts [solid and hollow (tubular) GFRP bars] that were subsequently used for ground control of the Jurong rock caverns in Singapore. The testing program aimed to assess the long-term durability characteristics of unstressed hollow and solid GFRP rock bolts subjected to a saline solution (simulating the subsea cavern water of the Jurong rock caverns in Singapore) and predicting their long-term tensile strength in such environments. The study simulated rather aggressive conditions by immersing the hollow and solid GFRP bars (rock bolts) in the solution at different elevated temperatures (20, 40, and 50 degrees C) in climate chambers for different exposure times of 1,000, 3,000, and 5,000 h. Arrhenius plots were applied to the test results, extrapolating the project's life to 50 years at a mean annual temperature (MAT) of 32 degrees C. The predicted tensile strength at a MAT of 32 degrees C is 96.8 and 97.3% for a service life of 50 years for solid and hollow GFRP bars, respectively. Based on the obtained results, the tested GFRP rock bolts were recommended as alternatives to stainless-steel rock bolts and successfully used as ground control in the Jurong rock caverns in Singapore. (C) 2016 American Society of Civil Engineers.
C1 [Benmokrane, Brahim] Univ Sherbrooke, Dept Civil Engn, Civil Engn, Sherbrooke, PQ J1K 2R1, Canada.
   [Benmokrane, Brahim] Univ Sherbrooke, Dept Civil Engn, Adv Composite Mat Civil Struct, Sherbrooke, PQ J1K 2R1, Canada.
   [Benmokrane, Brahim] Univ Sherbrooke, Dept Civil Engn, FRP Reinforcement Concrete Struct, Sherbrooke, PQ J1K 2R1, Canada.
   [Robert, Mathieu; Mohamed, Hamdy M.; Ali, Ahmed H.; Cousin, Patrice] Univ Sherbrooke, Dept Civil Engn, Sherbrooke, PQ J1K 2R1, Canada.
   [Mohamed, Hamdy M.] Helwan Univ, Qism Helwan, Cairo Governora, Egypt.
RP Benmokrane, B (reprint author), Univ Sherbrooke, Dept Civil Engn, Civil Engn, Sherbrooke, PQ J1K 2R1, Canada.; Benmokrane, B (reprint author), Univ Sherbrooke, Dept Civil Engn, Adv Composite Mat Civil Struct, Sherbrooke, PQ J1K 2R1, Canada.; Benmokrane, B (reprint author), Univ Sherbrooke, Dept Civil Engn, FRP Reinforcement Concrete Struct, Sherbrooke, PQ J1K 2R1, Canada.
EM Brahim.Benmokrane@usherbrooke.ca; Mathieu.Robert2@USherbrooke.ca;
   Hamdy.Mohamed@usherbrooke.ca; Ahmed.Ali@usherbrooke.ca;
   Patrice.Cousin@USherbrooke.ca
FU National Science and Engineering Research Council (NSERC) of Canada;
   Hyundai Engineering and Construction (Singapore); Firep International AG
   (Switzerland)
FX This research was supported by the National Science and Engineering
   Research Council (NSERC) of Canada, Hyundai Engineering and Construction
   (Singapore), and Firep International AG (Switzerland). The authors thank
   the technical staff at the Department of Civil Engineering, University
   of Sherbrooke (Sherbrooke, Quebec, Canada) for their assistance in
   fabricating and testing the specimens.
CR ACI, 2015, 4401R15 ACI
   ASTM, 2011, D7205 ASTM
   ASTM, 2003, E1131 ASTM
   ASTM, 2005, C150 ASTM
   ASTM, 2012, D7705 ASTM
   Bank LC, 2003, CONSTR BUILD MATER, V17, P405, DOI 10.1016/S0950-0618(03)00041-2
   Benmokrane B., 2016, J COMPOS CONSTR, DOI 10.1061/(ASCE)CC.1943-5614.0000606,04015043
   Benmokrane B., 2012, DURABILITY GLASS FRP
   Robert M, 2010, J COMPOS CONSTR, V14, P368, DOI 10.1061/(ASCE)CC.1943-5614.0000104
   Zhang BR, 2001, J COMPOS CONSTR, V5, P85, DOI 10.1061/(ASCE)1090-0268(2001)5:2(85)
NR 10
TC 0
Z9 0
U1 1
U2 1
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 1090-0268
EI 1943-5614
J9 J COMPOS CONSTR
JI J. Compos. Constr.
PD JUN
PY 2017
VL 21
IS 3
AR 06016002
DI 10.1061/(ASCE)CC.1943-5614.0000775
PG 4
WC Engineering, Civil; Mechanics; Materials Science, Composites
SC Engineering; Mechanics; Materials Science
GA ET8CC
UT WOS:000400524800019
OA No
DA 2017-08-17
ER

PT J
AU Elgabbas, F
   Ahmed, EA
   Benmokrane, B
AF Elgabbas, Fareed
   Ahmed, Ehab A.
   Benmokrane, Brahim
TI Flexural Behavior of Concrete Beams Reinforced with Ribbed Basalt-FRP
   Bars under Static Loads
SO JOURNAL OF COMPOSITES FOR CONSTRUCTION
LA English
DT Article
DE Basalt; Fiber; reinforced polymer (FRP); Ribbed surface; Beams; Service
   load; Deflection; Crack width; Bond-dependent coefficient; Flexure
ID POLYMER; SERVICEABILITY; DEFORMABILITY; DEFLECTIONS; PERFORMANCE;
   CRACKING; MEMBERS
AB Recently, basalt fiber-reinforced polymer (BFRP) reinforcement emerged as a new FRP type. Research is needed, however, to understand the behavior of BFRP bars in concrete members. This paper presents an experimental study aimed at investigating the flexural behavior and serviceability performance of concrete beams reinforced with ribbed BFRP bars. A total of eight concrete beams measuring 3,100 mm in length x 200 mm in width x 300 mm in depth were constructed and tested up to failure. Six beams were reinforced with 8-, 12-, and 16-mm BFRP bars with ribbed surfaces and two reference beams were reinforced with 10M and 15M steel bars. The beam specimens were designed in accordance with Canadian standards, and tested under four-point bending over a clear span of 2,700 mm until failure. The test results are presented and discussed in terms of cracking behavior, deflection, and failure modes. The test results yielded an average bond-dependent coefficient (kb) of 0.83, which is lower than 1.0 recommended by Canadian standards for ribbed FRP bars. Moreover, comparing the test results to the design provisions showed that American Concrete Institute (ACI) Committee 440 Guide underestimated the deflections at service load for the beams reinforced with ribbed BFRP bars, while Canadian standards for design and construction of building structures with FRP yielded reasonable and conservative deflections. (C) 2016 American Society of Civil Engineers.
C1 [Elgabbas, Fareed; Ahmed, Ehab A.] Univ Sherbrooke, Dept Civil Engn, Sherbrooke, PQ J1K 2R1, Canada.
   [Ahmed, Ehab A.] Menoufia Univ, Dept Civil Engn, Menoufia, Egypt.
   [Benmokrane, Brahim] Univ Sherbrooke, Dept Civil Engn, Civil Engn, Sherbrooke, PQ J1K 2R1, Canada.
   [Benmokrane, Brahim] Univ Sherbrooke, Tier Canada Res Chair Adv Composite Mat Civil Str, Sherbrooke, PQ J1K 2R1, Canada.
   [Benmokrane, Brahim] Univ Sherbrooke, NSERC Res Chair Innovat FRP Reinforcement Concret, Sherbrooke, PQ J1K 2R1, Canada.
RP Benmokrane, B (reprint author), Univ Sherbrooke, Dept Civil Engn, Civil Engn, Sherbrooke, PQ J1K 2R1, Canada.; Benmokrane, B (reprint author), Univ Sherbrooke, Tier Canada Res Chair Adv Composite Mat Civil Str, Sherbrooke, PQ J1K 2R1, Canada.; Benmokrane, B (reprint author), Univ Sherbrooke, NSERC Res Chair Innovat FRP Reinforcement Concret, Sherbrooke, PQ J1K 2R1, Canada.
EM Fareed.Elgabbas@USherbrooke.ca; Ehab.Ahmed@USherbrooke.ca;
   Brahim.Benmokrane@USherbrooke.ca
FU Natural Sciences and Engineering Research Council of Canada; Canada
   Research Chair in Advanced Composite Materials for Civil Structures;
   Fonds de la recherche du Quebec-Nature et Technologie-(FRQ-NT)
FX The authors would like to express their special thanks and gratitude to
   the Natural Sciences and Engineering Research Council of Canada, Canada
   Research Chair in Advanced Composite Materials for Civil Structures, the
   Fonds de la recherche du Quebec-Nature et Technologie-(FRQ-NT) for their
   financial support, ASA.TEC (Austria) for providing the BFRP
   reinforcement, and the staff of the structural lab of the Department of
   Civil Engineering at the University of Sherbrooke for their technical
   help.
CR ACI (American Concrete Institute), 2008, 4406M08 ACI
   ACI, 2015, 4401R15 ACI
   [Anonymous], 2006, 4401R06 ACI
   ASTM, 2011, D7205 ASTM
   ASTM, 2014, D7913 ASTM
   ASTM, 2011, D3171 ASTM
   Benmokrane B, 2015, J COMPOS CONSTR, V19, DOI 10.1061/(ASCE)CC.1943-5614.0000564
   Bischoff P. H., 2009, ACI J, V264, P53
   Bischoff PH, 2011, J COMPOS CONSTR, V15, P490, DOI 10.1061/(ASCE)CC.1943-5614.0000195
   Bischoff PH, 2001, CAN J CIVIL ENG, V28, P363, DOI 10.1139/cjce-28-3-363
   Branson D, 1968, ACI J P, V65, P730
   CSA (Canadian Standards Association), 2014, S614 CSA CANCSA
   CSA (Canadian Standards Association), 2002, S80602 CSA CANCSA
   CSA (Canadian Standards Association), 2010, S80710 CSA CANCSA
   CSA (Canadian Standards Association), 2012, S80612 CSA CANCSA
   El-Nemr A, 2013, ACI STRUCT J, V110, P1077
   Elgabbas F, 2015, CONSTR BUILD MATER, V95, P623, DOI 10.1016/j.conbuildmat.2015.07.036
   Gribniak V, 2015, BALT J ROAD BRIDGE E, V10, P201, DOI 10.3846/bjrbe.2015.25
   Gulbrandsen P., 2005, THESIS
   Jaeger L., 1997, P 3 INT S NONM FRP R, P551
   Kassem C, 2011, J COMPOS CONSTR, V15, P682, DOI 10.1061/(ASCE)CC.1943-5614.0000216
   Lapko A, 2015, ARCH CIV MECH ENG, V15, P223, DOI 10.1016/j.acme.2014.03.008
   Lopresto V, 2011, COMPOS PART B-ENG, V42, P717, DOI 10.1016/j.compositesb.2011.01.030
   Mota C., 2006, J COMPOS CONSTR, P183, DOI [10.1061/(ASCE)1090-0268(2006)10:3(183), DOI 10.1061/(ASCE)1090-0268(2006)10:3(183]
   Newhook J, 2002, CAN J CIVIL ENG, V29, P125, DOI 10.1139/L01-085
   Ovitigala T., 2012, THESIS
   Rizkalla S. H., 2013, 6 N CAR STAT U
   Serbescu A., 2015, J COMPOS CONSTR, DOI 10.1061/(ASCE)CC.1943-5614.0000497
   Theriault M., 1998, J COMPOS CONSTR, P7, DOI [10.1061/(ASCE)1090-0268(1998)2:1(7), DOI 10.1061/(ASCE)1090-0268(1998)2:1(7)]
   Tomlinson D, 2015, J COMPOS CONSTR, V19, DOI 10.1061/(ASCE)CC.1943-5614.0000491
   Urbanski M, 2013, PROCEDIA ENGINEER, V57, P1183, DOI 10.1016/j.proeng.2013.04.149
   Vijay PV, 2001, ACI STRUCT J, V98, P834
   Vincent P., 2013, P 3 SPEC C MAT ENG A
   Wei B, 2010, MAT SCI ENG A-STRUCT, V527, P4708, DOI 10.1016/j.msea.2010.04.021
   Wu G, 2015, J COMPOS CONSTR, V19, DOI 10.1061/(ASCE)CC.1943-5614.0000517
   Wu Z., 2012, P 6 INT C FRP COMP C
   Zhang LZ, 2015, MATER STRUCT, V48, P3279, DOI 10.1617/s11527-014-0398-0
NR 37
TC 0
Z9 0
U1 9
U2 9
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 1090-0268
EI 1943-5614
J9 J COMPOS CONSTR
JI J. Compos. Constr.
PD JUN
PY 2017
VL 21
IS 3
AR 04016098
DI 10.1061/(ASCE)CC.1943-5614.0000752
PG 12
WC Engineering, Civil; Mechanics; Materials Science, Composites
SC Engineering; Mechanics; Materials Science
GA ET8CC
UT WOS:000400524800001
OA No
DA 2017-08-17
ER

PT J
AU Namir, M
   Elzahar, K
   Ramadan, MF
   Allaf, K
AF Namir, Mohammad
   Elzahar, Khaled
   Ramadan, Mohamed Fawzy
   Allaf, Karim
TI Cactus pear peel snacks prepared by instant pressure drop texturing:
   Effect of process variables on bioactive compounds and functional
   properties
SO JOURNAL OF FOOD MEASUREMENT AND CHARACTERIZATION
LA English
DT Article
DE Opuntia ficus-indica; Drying; Instant controlled pressure drop; Chemical
   composition; Textural attributes; Bioactive component; By-product
ID OPUNTIA-FICUS-INDICA; EXTRUSION; FRUITS; COLOR; ONION
AB Cactus pear (Opuntia ficus-indica) has a growing interest from both food manufacturers and consumers due to its medicinal and functional traits. Peel is a major waste from cactus pear juice industry accounting for about 38 % of the fruit weight. New concept of snacks preparation has been developed using instant controlled pressure drop (D,tente instantan,e controlee, DIC) techniques that provide a texturing stage between initial and final hot air drying stages. In this study, the application of DIC of cactus pear peel (CPP) was performed to be used as starch-free snacks with functional attributes. DIC resulted in high crispness CPP snacks with improved structural and nutritional attributes as well as high relative expansion ratio (up to 21 times). DIC expanded CPP snacks exhibited cutting force (3.34 N) that was much lower than untreated CPP (19.41 N). It is worth noting that optimized DIC treatment (P = 0.6 MPa for t = 15 s) allowed more availability of phenolic compounds and beta-carotene by 83 and 551 %, respectively. In addition, antioxidant activity was increased up to 53 %. Results showed that steam pressure had significant effect on fat and alcohol insoluble solids (AIS) contents, wherein the correlation coefficients revealed critical relationships between structural and biochemical availabilities. Therefore, DIC could be used as an innovative technology to value this by-product leading to manufacture of crispy CPP snacks with high nutritious quality. There was a significant difference among the DIC treated and untreated CPP in respect to sensory properties, DIC treated CPP at operation conditions of saturated steam pressure = 0.6 MPa and processing time = 15 had the highest acceptability.
C1 [Namir, Mohammad; Elzahar, Khaled] Zagazig Univ, Fac Agr, Dept Food Sci, Zagazig 44519, Egypt.
   [Ramadan, Mohamed Fawzy] Zagazig Univ, Fac Agr, Agr Biochem Dept, Zagazig 44519, Egypt.
   [Allaf, Karim] Univ La Rochelle, UMR CNRS 7356, Lab Engn Sci Environm LaSIE, Ave Michel Crepeau, F-17042 Nantes 01, France.
RP Namir, M (reprint author), Zagazig Univ, Fac Agr, Dept Food Sci, Zagazig 44519, Egypt.
EM M_Namir@zu.edu.eg
OI Fawzy Ramadan Hassanien, Prof. Mohamed/0000-0002-5431-8503
CR Albitar N, 2011, DRY TECHNOL, V29, P993, DOI 10.1080/07373937.2010.507912
   Allaf K., 1988, CR89103 UTC IND SILV
   Allaf T., 2014, FOOD ENG SERIES
   Ankit P., 2009, INNOV FOOD SCI EMERG, V10, P16
   Ankit P., 2009, INNOV FOOD SCI EMERG, V10, P308
   AOAC, 2000, OFF METH AN ASS OFF
   Besombes C, 2010, J CHROMATOGR A, V1217, P6807, DOI 10.1016/j.chroma.2010.08.050
   Bimbenet J., 1992, FOOD DRYING QUALITY, P42
   Bourne M.C., 2002, FOOD TEXTURE VISCOSI
   BUSTOS OE, 1981, AM J ENOL VITICULT, V32, P228
   Chou SK, 2001, TRENDS FOOD SCI TECH, V12, P359, DOI 10.1016/S0924-2244(01)00102-9
   El Kossori RL, 1998, PLANT FOOD HUM NUTR, V52, P263, DOI 10.1023/A:1008000232406
   Epsinosa A., 1973, FRUITS, V28, P285
   Farnworth ER, 2001, FOOD RES INT, V34, P25, DOI 10.1016/S0963-9969(00)00124-1
   Fernandes FAN, 2007, J FOOD ENG, V82, P261, DOI 10.1016/j.jfoodeng.2007.02.032
   Feugang JM, 2006, FRONT BIOSCI, V11, P2574, DOI 10.2741/1992
   FORNI E, 1994, CARBOHYD POLYM, V23, P231, DOI 10.1016/0144-8617(94)90183-X
   Huang WS, 2013, INNOV FOOD SCI EMERG, V18, P74, DOI 10.1016/j.ifset.2013.01.001
   Karel M., 1991, DRYING, V91, P26
   Kobus Z., 2005, ACTA AGROPHYSICA, V6, P125
   Laban S., 1998, THESIS
   Lahsasni S., 2004, PHYS CHEM NEWS, V18, P89
   Louka N, 2004, J FOOD ENG, V65, P233, DOI 10.1016/j.jfoodeng.2004.01.020
   Mounir S, 2011, DRY TECHNOL, V29, P331, DOI 10.1080/07373937.2010.491585
   Mounir S, 2012, DRY TECHNOL, V30, P1508, DOI 10.1080/07373937.2012.693145
   Mounir S, 2011, DAIRY SCI TECHNOL, V91, P441, DOI 10.1007/s13594-011-0023-8
   Moussa-Ayoub TE, 2015, FOOD RES INT, V78, P442, DOI 10.1016/j.foodres.2015.08.019
   Munzuroglu O, 2003, FOOD CHEM, V83, P205, DOI 10.1016/S0308-8146(03)00064-5
   Namir M, 2015, J FOOD MEAS CHARACT, V9, P557, DOI 10.1007/s11694-015-9264-1
   Oliveira MA, 2001, QUIM NOVA, V24, P307, DOI 10.1590/S0100-40422001000300004
   Ramadan MF, 2003, FOOD CHEM, V83, P447, DOI 10.1016/S0308-8146(03)00128-6
   Ratti C, 2001, J FOOD ENG, V49, P311, DOI 10.1016/S0260-8774(00)00228-4
   Rezzoug SA, 2000, CARBOHYD POLYM, V42, P73, DOI 10.1016/S0144-8617(99)00122-8
   Robert P, 2015, LWT-FOOD SCI TECHNOL, V60, P1039, DOI 10.1016/j.lwt.2014.10.038
   Saenz C., 1996, ACTA HORTIC, V438, P135
   SAWAYA WN, 1983, J FOOD TECHNOL, V18, P183
   Siliha H., 1995, HYDR FOOD PROC P INT
   Thibault JF, 1996, PROGR BIOTECHNOL, V14, P425, DOI 10.1016/S0921-0423(96)80273-5
   Van Loey A., 2004, EURO FOOD RES TECHNO, V2, P161
   Vernon S., 1999, METHOD ENZYMOL, V299, P152
   YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007
NR 41
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2193-4126
EI 2193-4134
J9 J FOOD MEAS CHARACT
JI J. Food Meas. Charact.
PD JUN
PY 2017
VL 11
IS 2
BP 388
EP 400
DI 10.1007/s11694-016-9407-z
PG 13
WC Food Science & Technology
SC Food Science & Technology
GA ET6EY
UT WOS:000400385000004
OA No
DA 2017-08-17
ER

PT J
AU Khalafallah, NME
   El-Bakry, SY
   Mohamed, BF
   Bourham, MA
AF Khalafallah, N. M. E.
   El-Bakry, S. Y.
   Mohamed, B. F.
   Bourham, M. A.
TI Computational Investigation of Nonideal Higher Ionization Carbon Plasma
   Under Simulated High Heat Fluxes in Fusion Tokamak Reactors
SO JOURNAL OF FUSION ENERGY
LA English
DT Article
DE Plasma facing materials; Tokamak hard disruptions; High heat flux
   ablation; High ionization carbon ions; High-density nonideal plasma
ID DIII-D TOKAMAK; FACING COMPONENTS; DISRUPTION; GRAPHITE; GUN; ABLATION;
   EROSION; DESIGN; MODEL; ION
AB Plasma-facing materials in future large tokamaks will suffer from ablation due to expected hard disruptions, which affects the reactor interior lining tiles and the divertor modules. Ablation and surface evaporation due to the intense heat flux from disruption is associated with ionization of the evolved particulates. Generated ions at such plasma conditions may allow for higher ionization states such that the plasma at the boundary can be composed of electrons, ions (first, second and third ionization) and excited atoms. The boundary layer is dense and tends to be weakly nonideal. The NC State University electrothermal plasma code ETFLOW used to simulate the high heat flux conditions in which the carbon liner tested for simulated heat fluxes for transient discharge period of 100 mu s, with FWHM of similar to 50 mu s, to provide a wide range for obtaining reasonable good fits for the scaling laws. Transient events with similar to 10 MJ/m(2) energy deposition over short transient of 50-100 mu s would produce heat fluxes of 100-200 GW/m(2). The heat flux range in this simulation is up to 288 GW/m(2) to explore the generation of carbon plasma up to the third ionization C+++. The generation of such heat fluxes in the electrothermal plasma source requires discharge currents of up to 250 kA over a 100 mu s pulse length with similar to 50 mu s FWHM. The number density of the third ionization is six orders of magnitude less than the first ionization at the lowest heat flux and two orders of magnitude less at the highest heat flux. Plasma temperature varies from 31,600 K (2.722 eV) to 47,500 K (4.092 eV) at the lowest and highest heat fluxes, respectively. The plasma temperature and number density indicate typical high-density weakly nonideal plasma. The evolution of such high-density plasma particles into the reactor vacuum chamber will spread into the vessel and nucleate on the other interior components. The lifetime of the PFCs will shorten if the number of hard disruptions at such extreme heat fluxes would be increasing, resulting in major deterioration of the armor tiles.
C1 [Khalafallah, N. M. E.; El-Bakry, S. Y.] Ain Shams Univ, Phys Dept, Fac Sci, Cairo, Egypt.
   [Mohamed, B. F.] Atom Energy Author, Plasma Phys Dept, Nucl Res Ctr, Cairo, Egypt.
   [Bourham, M. A.] North Carolina State Univ, Dept Nucl Engn, Raleigh, NC 27695 USA.
RP Bourham, MA (reprint author), North Carolina State Univ, Dept Nucl Engn, Raleigh, NC 27695 USA.
EM nmkhalaf@ncsu.edu; elbakry_salah@yahoo.com; mohamedbahf@yahoo.co.uk;
   bourham@ncsu.edu
CR Abd Al-Halim MA, 2014, J FUSION ENERG, V33, P258, DOI 10.1007/s10894-014-9664-y
   AlMousa N, 2016, J FUSION ENERG, V35, P786, DOI 10.1007/s10894-016-0106-x
   Almousa NM, 2016, IEEE T PLASMA SCI, V44, P1642, DOI 10.1109/TPS.2016.2566445
   Arnoux J., 2009, NUCL FUSION, V49
   Barabash V, 1999, PHYS SCRIPTA, VT81, P74, DOI 10.1238/Physica.Topical.081a00074
   Buzhinskij OI, 2005, PLASMA DEVICES OPER, V13, P193, DOI 10.1080/10519990500159897
   Dale GE, 1998, FUSION TECHNOL, V34, P901
   Echols JR, 2014, J FUSION ENERG, V33, P60, DOI 10.1007/s10894-013-9639-4
   Edamitsu T, 2006, VACUUM, V80, P1223, DOI 10.1016/j.vacuum.2006.01.055
   Gebhart T. E., P 2013 IEEE 25 S FUS, P1, DOI [10.1109/SOFE.2013.6635502, DOI 10.1109/SOFE.2013.6635502]
   GILLIGAN J, 1993, J FUSION ENERG, V12, P311, DOI 10.1007/BF01079675
   Gonzalez PPV, 2015, IEEE T PLASMA SCI, V43, P3645, DOI 10.1109/TPS.2015.2474835
   Hassanein A, 1996, FUSION TECHNOL, V30, P713
   HASSANEIN A, 1995, J NUCL MATER, V220, P244, DOI 10.1016/0022-3115(94)00421-8
   Kirschner A, 2000, NUCL FUSION, V40, P989, DOI 10.1088/0029-5515/40/5/311
   Linke JM, 2004, FUSION SCI TECHNOL, V46, P142
   Luxon JL, 2002, NUCL FUSION, V42, P614, DOI 10.1088/0029-5515/42/5/313
   MIYAHARA A, 1988, J NUCL MATER, V155, P49, DOI 10.1016/0022-3115(88)90226-7
   Nakamura K., 1993, P 15 IEEE NPSS S FUS, V2, P830
   Pekker L, 2009, J PROPUL POWER, V25, P958, DOI 10.2514/1.41076
   Penzhorn RD, 2001, J NUCL MATER, V288, P170, DOI 10.1016/S0022-3115(00)00705-4
   Pitts RA, 2011, J NUCL MATER, V415, pS957, DOI 10.1016/j.jnucmat.2011.01.114
   Porwitzky AJ, 2009, IEEE T MAGN, V45, P412, DOI 10.1109/TMAG.2008.2008688
   ROCKETT PD, 1995, J NUCL MATER, V220, P785, DOI 10.1016/0022-3115(94)00585-0
   Rubel M, 2003, J NUCL MATER, V313, P321, DOI 10.1016/S0022-3115(02)01350-8
   Sauthoff N, 1995, SOFE '95 - 16TH IEEE/NPSS SYMPOSIUM ON FUSION ENGINEERING, VOLS 1 AND 2, P130, DOI 10.1109/FUSION.1995.534189
   Seki M., 1986, Journal of Fusion Energy, V5, P181, DOI 10.1007/BF01050612
   Sharpe JP, 2001, J NUCL MATER, V290, P1128, DOI 10.1016/S0022-3115(00)00550-X
   Sharpe J. P., 1997, P 17 IEEE NPSS S FUS, V1, P153
   VIETZKE E, 1995, J NUCL MATER, V220, P249, DOI 10.1016/0022-3115(94)00422-6
   Whyte DG, 2001, NUCL FUSION, V41, P1243, DOI 10.1088/0029-5515/41/9/313
   Winfrey AL, 2012, IEEE T PLASMA SCI, V40, P843, DOI 10.1109/TPS.2011.2179985
   Zaghloul MR, 2009, IEEE T PLASMA SCI, V37, P1626, DOI 10.1109/TPS.2009.2024423
   Zaghloul MR, 1999, PHYS LETT A, V262, P86, DOI 10.1016/S0375-9601(99)00560-5
NR 34
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0164-0313
EI 1572-9591
J9 J FUSION ENERG
JI J. Fusion Energy
PD JUN
PY 2017
VL 36
IS 2-3
BP 100
EP 111
DI 10.1007/s10894-017-0128-z
PG 12
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA ET7TK
UT WOS:000400501200008
OA No
DA 2017-08-17
ER

PT J
AU El-Chimi, MS
   Awad, HA
   El-Gammasy, TM
   El-Farghali, OG
   Sallam, MT
   Shinkar, DM
AF El-Chimi, Mohamed S.
   Awad, Hisham A.
   El-Gammasy, Tarek M.
   El-Farghali, Ola G.
   Sallam, Mohamed T.
   Shinkar, Dina M.
TI Sustained versus intermittent lung inflation for resuscitation of
   preterm infants: a randomized controlled trial
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE BPD; delivery room; respiratory outcome; T-piece resuscitator
ID RESPIRATORY-DISTRESS-SYNDROME; EMERGENCY CARDIOVASCULAR CARE; T-PIECE
   RESUSCITATOR; NEONATAL RESUSCITATION; DELIVERY ROOM;
   CARDIOPULMONARY-RESUSCITATION; BIRTH; VENTILATION; RECRUITMENT; DEVICES
AB Aim: To evaluate efficacy and safety of delivery room (DR) sustained lung inflation (SLI) in resuscitation of preterm neonates.
   Methods: Randomized Controlled Trial including 112 preterm infants randomized to either SLI (n = 57) using T-piece resuscitator [maximum three inflations with maximum pressure of 30 cmH(2)O for 15 s followed by continuous positive airway pressure (CPAP) of 5-7 cmH(2)O] or conventional bag/mask inflation (CBMI) (n = 55) using traditional self-inflating bag (maximum pressure of 40 cmH(2)O at a rate of 40-60 per min). Failure was defined as the need for DR or first 72 h intubation. Cord and 2-h post-resuscitation blood samples were collected to measure interleukin (IL)-1 beta and tumor necrosis factor-a levels before and after intervention.
   Results: SLI was associated with significantly higher success rate compared to CBMI [75.4 versus 54.5%; p = 0.017], lower need for DR intubation [5.3% versus 23.6%; (X-2 = 7.7; p = 0.005)], higher 5-min-Apgar score (median 8 versus 7; p = 0.018), shorter duration on nasal-CPAP (p = 0.017), and non-significantly different air leak (7% versus 11%; p = 0.3) and bronchopulmonary dysplasia rates among survivors (2% versus 11%; p = 0.09). Post-resuscitation IL-1 beta plasma levels increased significantly in CBMI (p = 0.009) and not in SLI group.
   Conclusion: Delivery room SLI is more effective than intermittent bag and mask inflation for improving short-term respiratory outcome in preterm infants, without significant adverse effects.
C1 [El-Chimi, Mohamed S.; Awad, Hisham A.; El-Gammasy, Tarek M.; El-Farghali, Ola G.; Shinkar, Dina M.] Ain Shams Univ, Childrens Hosp, Neonatol Div, Dept Pediat, Cairo, Egypt.
   [Sallam, Mohamed T.] Ain Shams Univ, Dept Clin Pathol, Cairo, Egypt.
RP El-Farghali, OG (reprint author), Ain Shams Univ, Pediat, 19 Ahmed Kamal St,Hegaz Sq, Cairo 11351, Egypt.
EM olag.badr@med.asu.edu.eg
CR Aly H, 2012, BRAIN DEV-JPN, V34, P201, DOI 10.1016/j.braindev.2011.04.006
   Bjorklund LJ, 2001, ACTA ANAESTH SCAND, V45, P986, DOI 10.1034/j.1399-6576.2001.450811.x
   Bohrer B, 2010, J PEDIATR-US, V156, P16, DOI 10.1016/j.jpeds.2009.07.027
   Carlo WA, 2014, PEDIATRICS, V133, P171, DOI 10.1542/peds.2013-3442
   Dani C, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-67
   Dawson JA, 2011, J PAEDIATR CHILD H, V47, P698, DOI 10.1111/j.1440-1754.2011.02036.x
   Foglia EE, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0601-9
   Grasso C, 2015, EARLY HUM DEV, V91, P71, DOI 10.1016/j.earlhumdev.2014.12.002
   Harling AE, 2005, ARCH DIS CHILD-FETAL, V90, pF406, DOI 10.1136/adc.2004.059303
   Hawkes CP, 2012, RESUSCITATION, V83, P797, DOI 10.1016/j.resuscitation.2011.12.020
   Jayaram A, 2013, RESP CARE, V58, P1233, DOI 10.4187/respcare.02109
   Keszler M, 2015, CURR OPIN PEDIATR, V27, P145, DOI 10.1097/MOP.0000000000000204
   Klingenberg C, 2012, ARCH DIS CHILD-FETAL, V7
   Klingenberg C, 2011, NEONATOLOGY, V100, P78, DOI 10.1159/000322983
   Koksal N, 2012, EUR CYTOKINE NETW, V23, P29, DOI 10.1684/ecn.2012.0304
   Krause MF, 2001, PEDIATR RES, V50, P34, DOI 10.1203/00006450-200107000-00009
   Lindner W, 2005, ACTA PAEDIATR, V94, P303, DOI 10.1080/08035250410023647
   Lindner W, 1999, PEDIATRICS, V103, P961, DOI 10.1542/peds.103.5.961
   Lista G, 2015, PEDIATRICS, V135, pE457, DOI 10.1542/peds.2014-1692
   Lista G, 2011, NEONATOLOGY, V99, P45, DOI 10.1159/000298312
   Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788
   O'Donnell CPF, 2015, COCHRANE DB SYST REV, V7
   Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127
   Schmolzer GM, 2015, ARCH DIS CHILD-FETAL, V100, pF361, DOI 10.1136/archdischild-2014-306836
   Szyld E, 2014, J PEDIATR-US, V165, P234, DOI 10.1016/j.jpeds.2014.02.035
   Pas ABT, 2007, PEDIATRICS, V120, P322, DOI 10.1542/peds.2007-0114
   te Pas AB, 2009, PEDIATR RES, V66, P295, DOI 10.1203/PDR.0b013e3181b1bca4
   te Pas AB, 2006, CURR PEDIAT REV, V2, P187, DOI 10.2174/157339606778019693
   van Vonderen JJ, 2014, J PEDIATR-US, V165, P903, DOI 10.1016/j.jpeds.2014.06.007
   Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19
   Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267
NR 31
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD JUN
PY 2017
VL 30
IS 11
BP 1273
EP 1278
DI 10.1080/14767058.2016.1210598
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ET6DV
UT WOS:000400381900004
PM 27384245
OA No
DA 2017-08-17
ER

PT J
AU Midan, DA
   El Fotoh, WMMA
   El Shalakany, AH
AF Midan, Dina A.
   El Fotoh, Wafaa Moustafa M. Abo
   El Shalakany, Abeer H.
TI The potential role of incorporating real-time PCR and DNA sequencing for
   amplification and detection of 16S rRNA gene signatures in neonatal
   sepsis
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Neonates; sepsis; blood culture; 16S rRNA; real time PCR; sequencing
ID CLINICAL MICROBIOLOGY; BACTERIAL; IDENTIFICATION; BACTEREMIA; DIAGNOSIS;
   TOOL
AB Objectives: This study aimed to explore whether 16S rRNA gene amplification by real time PCR and sequencing could serve as genetic-based methods in rapid and accurate diagnosis of neonatal sepsis.Patients and methods: This case control study was conducted on 40 neonates suffering from sepsis like manifestations recruited from the neonatal intensive care unit of Menoufia university hospital over a period of 6 months. Their blood samples were used for paired analysis of bacterial growth using BACTEC 9050 instrument and real time PCR assay with subsequent DNA sequencing for bacterial species identification.Results: The detection rate of culture proven sepsis was 70%. By using real time 16S r RNA PCR amplification method, the detection of bacteria was improved to 80%. Real time PCR revealed sensitivity, specificity, positive predictive value and negative predictive value of [100%, 66.7%, 87.5% and 100%] respectively. Compared to culture, the 16S rRNA real time PCR demonstrated a high negative value for ruling out neonatal sepsis. There was significant statistical difference between the PCR positive and negative cases as regards the hematological sepsis score. The results demonstrated the ability of DNA sequencing to recognize 4 pathogens which were negative by blood culture. The time consumed to detect sepsis using blood culture was up to 5 days while it took up to 16h only by PCR and sequencing methods.Conclusion: 16S rRNA gene amplification by real time PCR and sequence analysis could be served as ideal and reliable genetic-based methods to diagnose and rule out sepsis with provision of additional data that cannot be obtained by routine laboratory tests with a shorter turnaround time than those with culture-based protocols.
C1 [Midan, Dina A.; El Fotoh, Wafaa Moustafa M. Abo] Menoufia Univ, Dept Pediat, Fac Med, Menoufia, Egypt.
   [El Shalakany, Abeer H.] Menoufia Univ, Dept Clin Pathol, Fac Med, Menoufia, Egypt.
RP Midan, DA (reprint author), Menoufia Univ Hosp, Dept Pediat, Fac Med, Menoufia, Egypt.
EM dinamidan@yahoo.com
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Andrade SS, 2008, SHOCK, V30, P41, DOI [10.1097/SHK.0b013e3181819f6c, 10.1097/SHK.0b013e3181919f6c]
   Badrawi N, 2005, THESIS
   Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308
   Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552
   Bosshard PP, 2003, J CLIN MICROBIOL, V41, P4134, DOI 10.1128/JCM.41.9.4134-4140.2003
   Buttery JP, 2002, ARCH DIS CHILD, V87, pF25, DOI 10.1136/fn.87.1.F25
   Chacko B, 2005, INDIAN J PEDIATR, V72, P23
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Edwards KJ, 2012, J MED MICROBIOL, V61, P645, DOI 10.1099/jmm.0.041764-0
   El-Badawy A, 2003, THESIS
   El-Hawary IM, 2011, EVIDENCE BASED WOMEN, V1, P64
   Fahey JO, 2008, J MIDWIFERY WOM HEAL, V53, P227, DOI 10.1016/j.jmwh.2008.01.001
   Fayed SM, 2009, EGYPT J MED MICROBIO, V18, P21
   Fujimori M, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-53
   Haque KN, 2004, INFECT CONT HOSP EP, V25, P759, DOI 10.1086/502473
   Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0
   Jordan JA, 2005, J MOL DIAGN, V7, P105, DOI 10.1016/S1525-1578(10)60015-3
   Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.638-680.2004
   Kilani R A, 2000, J Med Liban, V48, P77
   Ladhani S, 2004, ARCH DIS CHILD, V89, P568, DOI 10.1136/adc.2003.026781
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   MCCABE KM, 1995, PEDIATRICS, V95, P165
   Ohlin A, 2008, ACTA PAEDIATR, V97, P1376, DOI 10.1111/j.1651-2227.2008.00924.x
   Rodwell RL, 1993, J PEDIAT, V112, P761
   Sankar MJ, 2008, INDIAN J PEDIATR, V75, P261, DOI 10.1007/s12098-008-0056-z
   Scott M, 2005, PEDIATR INFECT DIS J, V87, P613
   Shaw C K, 2007, Kathmandu Univ Med J (KUMJ), V5, P153
   Sullivan DJ, 2002, AM SOC MICROBIOL, V28, P427
   Tollner U, 1988, EUR J PEDIATR, V138, P331
   Ucar B, 2008, MEDIAT INFLAMM, DOI 10.1155/2008/737141
   [吴亦栋 WU Yidong], 2007, [中华儿科杂志, Chinese Journal of Pediatrics], V45, P446
NR 32
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD JUN
PY 2017
VL 30
IS 12
BP 1476
EP 1483
DI 10.1080/14767058.2016.1219994
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ET6FU
UT WOS:000400387400020
PM 27484181
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, MR
   Aref, NK
   Ahmed, WAS
   Arain, FR
AF Ahmed, Magdy R.
   Aref, Nisreen K.
   Ahmed, Waleed A. Sayed
   Arain, Farzana R.
TI Chlorhexidine vaginal wipes prior to elective cesarean section: does it
   reduce infectious morbidity? A randomized trial
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Cesarean section; infectious morbidity; chlorhexidine
ID POVIDONE-IODINE; ANTISEPTIC SOLUTION; ENDOMETRITIS; MORTALITY; DELIVERY;
   RISK
AB Objective: To evaluate the efficacy of preoperative vaginal cleansing using chlorhexidine 0.25% antiseptic wipes on rates of postcesarean section (CS) infectious morbidities (endometritis, febrile morbidity and wound infection).Methods: This prospective randomized trial was conducted among 218 pregnant women scheduled for term elective CS. Patients were equally divided into two groups by simple randomization. After spinal anesthesia and catheterization under aseptic technique, the study group had preoperative vaginal cleansing using chlorhexidine 0.25% antiseptic wipes for about 1min, while the control group did not. All cases received the prophylactic antibiotics and the usual abdominal scrub. All participants received the routine postoperative care without other interventions. Adverse postcesarean infectious morbidities such as endometritis, febrile morbidity and wound infection were observed at the time of hospital discharge and weekly for 6 weeks postpartum.Results: Both groups were matched regarding the baseline patients' characteristics (age, gestational age, BMI, operative time and postoperative hospital stay). Overall, post-CS infectious morbidity were significantly reduced from 24.4% in the control group to 8.8% in the intervention group; p value<0.05. Marked reduction was seen in the incidence of endometritis (13.2% in the control group versus 2.9% in the intervention group; p value<0.05). However, fever and wound infection showed no significant difference between both groups.Conclusion: Cleansing the birth canal with chlorhexidine 0.25% wipes prior to elective CS appears to be effective in reducing rates of post-CS infectious morbidity mainly endometritis.
C1 [Ahmed, Magdy R.; Ahmed, Waleed A. Sayed] Suez Canal Univ, Dept Obstet & Gynecol, Ismailia, Egypt.
   [Ahmed, Magdy R.; Aref, Nisreen K.; Arain, Farzana R.] Taif Univ, Dept Obstet & Gynecol, At Taif, Saudi Arabia.
RP Ahmed, MR (reprint author), Suez Canal Univ, Dept Obstet & Gynecol, Fac Med, Round Rd, Ismailia 41111, Egypt.; Ahmed, MR (reprint author), Taif Univ, Dept Obstet & Gynecol, Coll Med, At Taif, Saudi Arabia.
EM dr_magdygyn@yahoo.com
CR Asghania M, 2011, J OBSTET GYNAECOL, V31, P400, DOI 10.3109/01443615.2011.568644
   Bagratee JS, 2001, BRIT J OBSTET GYNAEC, V108, P143, DOI 10.1111/j.1471-0528.2001.00042.x
   Bakr AF, 2005, J WOMENS HEALTH, V14, P496, DOI 10.1089/jwh.2005.14.496
   EMILSON CG, 1977, SCAND J DENT RES, V85, P255
   Fleiss J. L, 1981, STAT METHODS RATES P
   French LM, 2004, COCHRANE DB SYST REV, V2
   FROST L, 1989, J HOSP INFECT, V13, P143, DOI 10.1016/0195-6701(89)90020-0
   Goldenberg RL, 2006, OBSTET GYNECOL, V107, P1139, DOI 10.1097/01.AOG.0000215000.65665.dd
   Guzman MA, 2002, PRIMARY CARE UPDATE, V9, P206, DOI 10.1016/S1068-607X(02)00119-1
   Haas DM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.005
   Haas DM, 2014, COCHRANE DB SYST REV, V12
   HAERI AD, 1976, S AFR MED J, V50, P1984
   Lumbiganon P, 2004, COCHRANE DB SYST REV, V4
   Memon S, 2011, J PAK MED ASSOC, V61, P1179
   MTIMAVALYE L, 1995, NEW ENGL J MED, V332, P890
   Reid VC, 2001, OBSTET GYNECOL, V97, P147, DOI 10.1016/S0029-7844(00)01087-5
   Starr RV, 2005, OBSTET GYNECOL, V105, P1024, DOI 10.1097/01.AOG.0000164032.16599.7e
   Taha TE, 1997, BRIT MED J, V315, P216
   VORHERR H, 1984, J INFECTION, V8, P195, DOI 10.1016/S0163-4453(84)93811-8
   Wilson CM, 2004, JAIDS-J ACQ IMM DEF, V35, P138, DOI 10.1097/00126334-200402010-00006
   Yildirim G, 2012, J MATERN-FETAL NEO M, V25, P2316, DOI 10.3109/14767058.2012.693994
   Yokoe DS, 2001, EMERG INFECT DIS, V7, P837
NR 22
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD JUN
PY 2017
VL 30
IS 12
BP 1484
EP 1487
DI 10.1080/14767058.2016.1219996
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ET6FU
UT WOS:000400387400021
PM 27583685
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, WAS
   Habash, YH
   Hamdy, MA
   Ghoneim, HM
AF Ahmed, Waleed Ali Sayed
   Habash, Yasser Hasan
   Hamdy, Mostafa Ahmed
   Ghoneim, Hanan Mohamed
TI Rupture of the pregnant uterus - a 20-year review
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Rupture uterus; scarred and unscarred uterus; maternal outcome; foetal
   outcome; fertility
ID UTERINE RUPTURE; CESAREAN DELIVERY; CONSEQUENCES; WOMEN
AB Objectives: To examine the incidence, causative factors, maternal and foetal outcomes and subsequent fertility in cases of uterine rupture in scarred and unscarred uteri.Methods: A 20 years' retrospective review was carried out where relevant data were collected from the medical records. Outcome measures included labour characteristics, operative procedures, maternal and perinatal outcome in addition to subsequent fertility.Results: Forty-nine cases of complete uterine rupture were identified. Women in the unscarred group were older, had higher parity and heavier babies (p values < 0.05). Alternatively, the scarred group cases were associated with more silent rupture discovered at time of surgery, recession of the presenting part and more visceral involvement in particularly the urinary bladder. Admission to NICU and birth asphyxia were more frequent in the scarred group while stillbirth and early neonatal death were more common in the unscarred one. Twenty-four out of 49 cases had repair with no bilateral tubal ligation and out of these, 13 patients subsequently conceived and had 22 babies.Conclusion: Physicians should be vigilant to the risk factors and clinical presentations of uterine rupture during pregnancy. Cautious attempts to repair the ruptured uterus should be tried for patients' wellbeing and to help maintain fertility.
C1 [Ahmed, Waleed Ali Sayed; Hamdy, Mostafa Ahmed; Ghoneim, Hanan Mohamed] Suez Canal Univ, Dept Obstet Gynecol, Ismailia, Egypt.
   [Habash, Yasser Hasan] Suez Canal Univ, Dept Obstet Gynecol, Ismailia, Egypt.
   [Habash, Yasser Hasan] Secur Forces Hosp, Obstet Gynecol, Riyadh, Saudi Arabia.
RP Ahmed, WAS (reprint author), Suez Canal Univ, Dept Obstet Gynecol, Ismailia, Egypt.
EM waleed.asa@gmail.com
CR Al Qahtani NH, 2011, ARCH GYNECOL OBSTET, V284, P1123, DOI 10.1007/s00404-010-1831-4
   Al Sakka M, 1998, INT J GYNECOL OBSTET, V63, P105, DOI 10.1016/S0020-7292(98)00124-6
   Date Shilpa, 2014, J Obstet Gynaecol India, V64, P362, DOI 10.1007/s13224-012-0277-y
   Datta S, 2016, J OBSTET GYNAECOL, V36, P549, DOI 10.3109/01443615.2015.1072808
   Guise JM, 2004, BRIT MED J, V329, P19, DOI 10.1136/bmj.329.7456.19
   Igwegbe Anthony Osita, 2013, Niger Med J, V54, P415, DOI 10.4103/0300-1652.126300
   LEUNG AS, 1993, AM J OBSTET GYNECOL, V169, P945
   Macones GA, 2006, AM J OBSTET GYNECOL, V195, P1148, DOI 10.1016/j.ajog.2006.06.042
   Miller DA, 1997, OBSTET GYNECOL, V89, P671, DOI 10.1016/S0029-7844(97)00073-2
   Murphy DJ, 2006, CURR OPIN OBSTET GYN, V18, P135, DOI 10.1097/01.gco.0000192989.45589.57
   Nagao Y, 2016, INT MED CASE REP J, V9, P1, DOI 10.2147/IMCRJ.S94363
   Okada Y, 2016, J MED ULTRASON, V43, P133, DOI 10.1007/s10396-015-0665-x
   Soltan MH, 1996, INT J GYNECOL OBSTET, V52, P37, DOI 10.1016/0020-7292(95)02560-X
   Vachon-Marceau C, 2016, AM J PERINAT, V33, P577, DOI 10.1055/s-0035-1570382
   Vandenberghe G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010415
   Walsh CA, 2007, OBSTET GYNECOL SURV, V62, P327, DOI 10.1097/01.ogx.0000261643.11301.56
   Zwart JJ, 2009, BJOG-INT J OBSTET GY, V116, P1069, DOI 10.1111/j.1471-0528.2009.02136.x
NR 17
TC 0
Z9 0
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD JUN
PY 2017
VL 30
IS 12
BP 1488
EP 1493
DI 10.1080/14767058.2016.1219997
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ET6FU
UT WOS:000400387400022
OA No
DA 2017-08-17
ER

PT J
AU Mohareb, R
   Abbas, NS
   Mohamed, AA
AF Mohareb, Rafat M.
   Abbas, Nermeen S.
   Mohamed, Abeer A.
TI Synthesis of tetrahydropyrazolo-quinazoline and
   tetrahydropyrazolo-pyrimidocarbazole derivatives as potential
   anti-prostate cancer agents and Pim-1 kinase inhibitors
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE Cyclohexan-1; 3-dione; Quinoline; Pyrazole; Anti-proliferative activity
ID MEK MAPKK INHIBITORS; QUINOLINE DERIVATIVES;
   6,7-DISUBSTITUTED-4-PHENOXYQUINOLINE DERIVATIVES; FRIEDLANDER SYNTHESIS;
   BIOLOGICAL EVALUATION; MOIETY; DISCOVERY; BEARING; DESIGN; PYRAN
AB The multi-component reactions of arylhydrazopyrazoles 2, aromatic aldehydes 3 and cylohexane-1,3-dione gave pyrazoloquinazolinones 5. In addition, compounds 5 reacted with elemental sulfur and either of malononitrile or ethyl cyanoacetate to give the thiophene derivatives 7, respectively. Compounds 5 were used to synthesis the 5,6,11,12-tetrahydro-3H-pyrazolo[1',5':1,2]pyrimido[5,4-a]carbazol-2-ol derivatives 9 through their reaction with phenylhydrazine. Similarly, the reaction of the pyrazole derivatives 2, with 3 and dimedone (10) gave the quinoline derivatives 11. The newly synthesized products were evaluated against c-Met kinase, PC-3 prostate cancer cell lines and six typical cancer cell lines (A549, H460, HT-29, MKN-45, U87MG, and SMMC-7721). The most promising compounds were 5b, 5c, 5e-i, 7e, 7p, 7q, 7r, and 11i were further investigated against tyrosin kinase (c-Kit, Flt-3, VEGFR-2, EGFR, and PDGFR). Some compounds were selected to examine their Pim-1 kinase inhibition activity where compounds 5h and 7u showed high inhibitions.
C1 [Mohareb, Rafat M.] Cairo Univ, Dept Chem, Fac Sci, Giza, Egypt.
   [Abbas, Nermeen S.] Helwan Univ, Dept Chem, Fac Sci, Cairo, Egypt.
   [Abbas, Nermeen S.] Taibah Univ, Dept Chem, Fac Sci, Medina, Saudi Arabia.
   [Mohamed, Abeer A.] Natl Org Res Control Biol, Giza, Egypt.
RP Mohareb, R (reprint author), Cairo Univ, Dept Chem, Fac Sci, Giza, Egypt.
EM raafat_mohareb@yahoo.com
FU Alexander von Humboldt Foundation in Bonn, Germany
FX RMM would like to thank the Alexander von Humboldt Foundation in Bonn,
   Germany for affording him regular fellowships in Germany for finance and
   completing his research work.
CR Bandini M, 2009, ANGEW CHEM INT EDIT, V48, P9608, DOI 10.1002/anie.200901843
   Berger D, 2003, BIOORG MED CHEM LETT, V13, P3031, DOI 10.1016/S0960-894X(03)00640-1
   Berger DM, 2008, BIOORGAN MED CHEM, V16, P9202, DOI 10.1016/j.bmc.2008.09.009
   Charpentier P, 1998, TETRAHEDRON LETT, V39, P4013, DOI 10.1016/S0040-4039(98)00677-7
   CHENG CC, 1982, ORG REACTIONS, V28, P37
   Cui SL, 2008, J AM CHEM SOC, V130, P13526, DOI 10.1021/ja805706r
   Elnagdi EM, 1989, COLL CZACH CHEM COMM, V54, P1082
   Fischer E, 1884, BER DTSCH CHEM GES, V17, P559, DOI 10.1002/cber.188401701155
   Fleming FF, 2010, J MED CHEM, V53, P7902, DOI 10.1021/jm100762r
   Franklin EC, 1944, CHEM REV, V35, P77
   Jones G., 1977, CHEM HETEROCYCL COMP, V32, P93, DOI 10.1002/9780470187029.ch2
   Li K, 2016, BIOORGAN MED CHEM, V24, P1889, DOI 10.1016/j.bmc.2016.03.016
   Li S, 2013, BIOORGAN MED CHEM, V21, P2843, DOI 10.1016/j.bmc.2013.04.013
   Liao WK, 2014, EUR J MED CHEM, V87, P508, DOI 10.1016/j.ejmech.2014.09.095
   Liu J, 2016, EUR J MED CHEM, V123, P431, DOI 10.1016/j.ejmech.2016.07.059
   MANSKE RHF, 1953, ORG REACTIONS, V7, P59
   Mohareb RM, 2014, STEROIDS, V84, P46, DOI 10.1016/j.steroids.2014.03.012
   Mohareba RM, 2015, CHEM PHARM BULL, V63, P678, DOI 10.1248/cpb.c15-00115
   Muscia GC, 2006, TETRAHEDRON LETT, V47, P8811, DOI 10.1016/j.tetlet.2006.10.073
   Okten S, 2015, TETRAHEDRON LETT, V56, P5337, DOI 10.1016/j.tetlet.2015.07.092
   Park IK, 2009, ORG LETT, V11, P5454, DOI 10.1021/ol902250x
   Pauvert M, 2005, TETRAHEDRON LETT, V46, P2983, DOI 10.1016/j.tetlet.2005.03.034
   Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063
   Srivastava SK, 2000, J MED CHEM, V43, P2275, DOI 10.1021/jm990438d
   Tang QD, 2016, BIOORG MED CHEM LETT, V26, P1680, DOI 10.1016/j.bmcl.2016.02.059
   Tang QD, 2014, BIOORGAN MED CHEM, V22, P1236, DOI 10.1016/j.bmc.2014.01.014
   Tang QD, 2013, EUR J MED CHEM, V69, P77, DOI 10.1016/j.ejmech.2013.08.019
   Zhang N, 2001, BIOORG MED CHEM LETT, V11, P1407, DOI 10.1016/S0960-894X(01)00238-4
   Zhang N, 2000, BIOORG MED CHEM LETT, V10, P2825, DOI 10.1016/S0960-894X(00)00580-1
   Zhou SG, 2014, BIOORGAN MED CHEM, V22, P6438, DOI 10.1016/j.bmc.2014.09.037
   Wissner A, 1999, US Patent, Patent No. [1999-6002008, 19996002008]
   Martine S, 2006, US patent, Patent No. 183909
NR 32
TC 0
Z9 0
U1 9
U2 9
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD JUN
PY 2017
VL 26
IS 6
BP 1073
EP 1088
DI 10.1007/s00044-017-1811-3
PG 16
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA ET5YB
UT WOS:000400365900001
OA No
DA 2017-08-17
ER

PT J
AU El-Sayed, AM
   Ibrahim, SM
   Soltan, MK
   Abo-Kul, ME
AF El-Sayed, Ahmed M.
   Ibrahim, Samy M.
   Soltan, Mostafa K.
   Abo-Kul, Mansour E.
TI Synthesis and antimicrobial activity of newly synthesized
   4-substituted-pyrazolo[3,4-d]pyrimidine derivatives
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE Pyrazolo[3,4-d]pyrimidine; 1,3,4-oxadiazole; Hydrazones; Antimicrobial;
   Microplate assay
ID AGENTS; ANTIBACTERIAL; HYDRAZONES; ANTICANCER; LEADS
AB The purpose of this study was to explore the possibility of synthesizing pyrazolo[3,4-d]pyrimidine derivatives that have antimicrobial activities. A novel series of 4-substituted-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives including hydrazones (4a-i and 5), pyrazoles (6a, b) and (8), and oxadiazole-2-thiol (7), has been synthesized. Compounds 4g, 4b, 4h, 4d, 6a, 7, 8 have shown that some of the synthesized compounds have a moderate to outstanding antimicrobial activity against Gram Positive bacteria: Streptococcus pneumonia and Bacillis subtilis, gram negative bacteria: Pseudomonas aeruginosa and Escherichia coli, and fungi: Aspergillus fumigatus and Candida albicans strains. Interestingly, compound (7) "5-{[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]methyl}-1,3,4-oxadiazole-2-thiol" exhibited superior antimicrobial activity compared to ampicillin and gentamicin suggesting that it can be used as a lead compound for further investigations.
C1 [El-Sayed, Ahmed M.; Ibrahim, Samy M.; Soltan, Mostafa K.; Abo-Kul, Mansour E.] Zagazig Univ, Dept Med Chem, Fac Pharm, Zagazig 44519, Egypt.
   [Soltan, Mostafa K.] Oman Assistant Pharm Inst, Muscat, Oman.
   [Abo-Kul, Mansour E.] Tabuk Univ, Dept Pharmaceut Chem, Fac Pharm, Tabuk, Saudi Arabia.
RP El-Sayed, AM (reprint author), Zagazig Univ, Dept Med Chem, Fac Pharm, Zagazig 44519, Egypt.
EM Ahmed_el_sayed87@yahoo.com
CR Bakavoli M, 2010, EUR J MED CHEM, V45, P647, DOI 10.1016/j.ejmech.2009.10.051
   Bondock S, 2008, EUR J MED CHEM, V43, P2122, DOI 10.1016/j.ejmech.2007.12.009
   Centers for Disease Control and Prevention, 1993, MMWR-MORBID MORTAL W, V42, P3
   Devarakonda M, 2013, MED CHEM RES, V22, P1090, DOI 10.1007/s00044-012-0084-0
   Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017
   Geddes A, 2008, INT J ANTIMICROB AG, V32, P373, DOI 10.1016/j.ijantimicag.2008.06.001
   Ghorab MM, 2010, EUR J MED CHEM, V45, P171, DOI 10.1016/j.ejmech.2009.09.039
   Gupta S, 2008, EUR J MED CHEM, V43, P771, DOI 10.1016/j.ejmech.2007.06.002
   MKAEl Hamid, 2012, EUR J MED CHEM, V57, P323
   HARDEN FA, 1991, J MED CHEM, V34, P2892, DOI 10.1021/jm00113a031
   Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017
   Kasula M, 2013, CHEMMEDCHEM, V8, P1673, DOI 10.1002/cmdc.201300277
   Kaya E.G., 2009, ANKEM DERG, V23, P110
   Khobragade CN, 2010, EUR J MED CHEM, V45, P1635, DOI 10.1016/j.ejmech.2009.12.040
   KRAKOFF IH, 1966, CANCER, V19, P1489, DOI 10.1002/1097-0142(196611)19:11<1489::AID-CNCR2820191105>3.0.CO;2-F
   Kucukguzel SG, 2003, EUR J MED CHEM, V38, P1005, DOI 10.1016/j.ejmech.2003.08.004
   Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098
   MAKINO H, 1988, AGENTS ACTIONS, V25, P385, DOI 10.1007/BF01965047
   Othman AA, 2014, ARAB J CHEM, DOI [10.1016/j.arabjc.2014.09.003, DOI 10.1016/J.ARABJC.2014.09.003]
   Pieczonka AM, 2013, EUR J MED CHEM, V64, P389, DOI 10.1016/j.ejmech.2013.04.023
   Ranganath D, 2012, MED CHEM RES, V21, P2458, DOI 10.1007/s00044-011-9769-z
   Rashad AE, 2009, EUR J MED CHEM, V44, P3285, DOI 10.1016/j.ejmech.2009.02.012
   Shah RC, 2014, PEDIAT INFECT DIS, V6, P49
   Siddiqui AB, 2014, BIOORG MED CHEM LETT, V24, P1493, DOI 10.1016/j.bmcl.2014.02.012
   Song YoungGoo, 2012, Infection and Chemotherapy, V44, P263, DOI 10.3947/ic.2012.44.4.263
   Sugimoto O, 1999, TETRAHEDRON LETT, V40, P7477, DOI 10.1016/S0040-4039(99)01316-7
   Trivedi A, 2008, ARCH PHARM, V341, P435, DOI 10.1002/ardp.200800027
   Wang HQ, 2004, PHOSPHORUS SULFUR, V179, P2039, DOI 10.1080/10426500490474897
   World Health Organization, 2014, ANT RES GLOB REP SUR, P257
   Yewale SB, 2012, BIOORG MED CHEM LETT, V22, P6616, DOI 10.1016/j.bmcl.2012.08.119
NR 30
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD JUN
PY 2017
VL 26
IS 6
BP 1107
EP 1116
DI 10.1007/s00044-017-1814-0
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA ET5YB
UT WOS:000400365900004
OA No
DA 2017-08-17
ER

PT J
AU Mohamed, NM
   Makboul, A
   Farag, SF
   Tarawneh, AH
   Khan, SI
   Brooks, TA
   Wang, YH
   Ross, SA
AF Mohamed, Nesma M.
   Makboul, A.
   Farag, Salwa F.
   Tarawneh, Amer H.
   Khan, Shabana I.
   Brooks, Tracy A.
   Wang, Yan-Hong
   Ross, Samir A.
TI Iridoid and phenylpropanoid glycosides from the roots of Lantana
   montevidensis
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE Lantana; Iridoids; Phenylpropanoids; Anti-inflammatory; Anticancer;
   Reactive oxidative stress
ID NF-KAPPA-B; CHEMICAL-COMPOSITION; VERBENACEAE; LEAVES; ANTIPROTOZOAL;
   CONSTITUENTS; INFLAMMATION; ANTIOXIDANT; CANCER; BRIQ.
AB A new iridoid glycoside; 6-O-beta-D-xylopyranoside-shanzhiside methyl ester (1) along with six known compounds; shanzhiside methyl ester (2), lamalbid (3), geniposidic acid (4), theveside (5), verbascoside (6) and arenarioside (7) were isolated from the roots of Lantana montevidensis. The structures of the compounds were determined through 1D and 2D NMR spectroscopic data analysis, HRESIMS, electronic circular dichorism and UPLC-UV/MS method. The total extract, chloroformic (F1) and aqueous (F2) fractions together with the isolated compounds were tested for their antimicrobial, antiprotozoal, antiplasmodial, anti-inflammatory, monoamine oxidase inhibition and cell viability activities in addition to free radical scavenging activity using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. The phenylpropanoid compounds (6 and 7) resulted in a potent antioxidant activity. Total methanolic extract together with the aqueous fraction (F2) showed decrease in reactive oxidative stress with 57 and 66%, respectively, while the chloroformic fraction (F1), together with the total methanolic extract, showed a decrease in iNOS with IC50 values 5 and 30 mu g/mL, respectively. Compounds 1, 2, 3, 6, and 7 showed inhibition in the reactive oxidative stress with values 50, 60, 57, 63, and 52%, respectively. Both F1 and F2 fractions demonstrated measurable inhibition of MCF-7 breast cancer cell growth, with IC50 value 0.3 mg/mL. Compounds 2 and 7 showed mild monoamine oxidase inhibition. None of the tested compounds showed antimicrobial, antiplasmodial or antiprotozoal activity.
C1 [Mohamed, Nesma M.; Khan, Shabana I.; Wang, Yan-Hong; Ross, Samir A.] Univ Mississippi, Natl Ctr Nat Prod Res, Pharmaceut Sci Res Inst, Sch Pharm, Oxford, MS 38677 USA.
   [Mohamed, Nesma M.; Makboul, A.; Farag, Salwa F.] Assiut Univ, Dept Pharmacognosy, Fac Pharm, Assiut 71526, Egypt.
   [Tarawneh, Amer H.; Khan, Shabana I.; Brooks, Tracy A.; Ross, Samir A.] Univ Mississippi, Dept Biomol Sci, Sch Pharm, Oxford, MS 38677 USA.
   [Tarawneh, Amer H.] Tafila Tech Univ, Dept Chem, POB 179, Tafila, Jordan.
RP Ross, SA (reprint author), Univ Mississippi, Natl Ctr Nat Prod Res, Pharmaceut Sci Res Inst, Sch Pharm, Oxford, MS 38677 USA.
EM sross@olemiss.edu
FU Egyptian Government; National Center for Natural Products Research, The
   University of Mississippi, School of Pharmacy, Mississippi, USA
FX The authors are grateful to the Egyptian Government and the National
   Center for Natural Products Research, The University of Mississippi,
   School of Pharmacy, Mississippi, USA for their financial support. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the aforementioned
   institutions. We are also thankful to Dr. Baharthi Avula for providing
   the HRESIMS, Dr. Babu L. Tekwani and Dr. Narayan D. Chaurasiya for
   carrying out the MAOI assay and to Dr. Melissa Jacob for performing the
   antimicrobial assay.
CR Akdemir ZS, 2004, TURK J CHEM, V28, P227
   ANDARY C, 1985, J NAT PROD, V48, P778, DOI 10.1021/np50041a010
   Barreto Fs, 2010, J Young Pharm, V2, P42, DOI 10.4103/0975-1483.62211
   Bharate SB, 2007, BIOORGAN MED CHEM, V15, P87, DOI 10.1016/j.bmc.2006.10.006
   Breitmaier E, 1990, CARBON 13 NMR SPECTR, P318
   Bruhn T, 2014, SPECDIS VERSION 1 62
   Core LE, 1955, PLANT TAXONOMY, P402
   Datta SC, 1970, HDB SYSTEMATIC BOT, P310
   Dinda B, 2007, CHEM PHARM BULL, V55, P689, DOI 10.1248/cpb.55.689
   FORD CW, 1980, AUST J CHEM, V33, P509
   Frisch M. J., 2010, GAUSSIAN 09
   Guvenalp Z, 2006, TURK J CHEM, V30, P515
   Ko JSK, 2013, CURR PHARM DESIGN, V19, P48, DOI 10.2174/13816128130109
   Kobayashi S, 1986, IRIDOID GLYCOSIDES L
   Lawrence GHM, 1951, TAXONOMY VASCULAR PL, P686
   Ma GY, 2007, CANCER CHEMOTH PHARM, V60, P35, DOI 10.1007/s00280-006-0344-0
   Makboul A. M., 2013, J NAT PHARM, V1, P13
   Makboul M. A., 2014, Pharmacognosy Journal, V6, P27, DOI 10.5530/pj.2014.6.6
   Makboul MA, 2013, NAT PROD RES, V27, P2046, DOI 10.1080/14786419.2013.824443
   MAKLER MT, 1993, AM J TROP MED HYG, V48, P205
   Mohamed NM, 2016, PHYTOCHEM LETT, V15, P30, DOI 10.1016/j.phytol.2015.11.008
   Montanari RM, 2011, QUIM NOVA, V34, P1550, DOI 10.1590/S0100-40422011000900013
   Munir Ahmad Abid, 1996, Journal of the Adelaide Botanic Gardens, V17, P1
   Nagao T, 2002, BIOL PHARM BULL, V25, P875, DOI 10.1248/bpb.25.875
   Padmanabhan P., 2012, International Journal of Pharmaceutical Sciences and Drug Research, V4, P143
   Qureshi MN, 2010, REC NAT PROD, V4, P124
   Samoylenko V, 2010, J ETHNOPHARMACOL, V127, P357, DOI 10.1016/j.jep.2009.10.030
   [Anonymous], 2012, MACR 9 9
   Sousa EO, 2011, REC NAT PROD, V5, P60
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   Wang YH, 2012, PLANTA MED, V78, P834, DOI 10.1055/s-0031-1298432
   Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166
   Yue HL, 2013, J CHROMATOGR B, V936, P57, DOI 10.1016/j.jchromb.2013.08.007
   Zaki MA, 2013, J NAT PROD, V76, P679, DOI 10.1021/np300893n
   Zhao JP, 2014, J NAT PROD, V77, P509, DOI 10.1021/np400780n
NR 35
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD JUN
PY 2017
VL 26
IS 6
BP 1117
EP 1126
DI 10.1007/s00044-017-1817-x
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA ET5YB
UT WOS:000400365900005
OA No
DA 2017-08-17
ER

PT J
AU Ahmed, NS
   Badahdah, KO
   Qassar, HM
AF Ahmed, N. S.
   Badahdah, K. O.
   Qassar, H. M.
TI Novel quinoline bearing sulfonamide derivatives and their cytotoxic
   activity against MCF7 cell line
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE Enaminones; 5,6,7,8-Tetrahydroquinolin; Sulphanilamid; Ultrasonic
   irradiation; CA inhibitors
ID CARBONIC-ANHYDRASE INHIBITORS; ANTICONVULSANT ACTIVITY; ANTIFUNGAL
   ACTIVITY; ANTITUMOR AGENTS; ENAMINONES; DESIGN; ANTIBACTERIAL;
   ANTICANCER; MOIETY; C-2
AB The present work reports the synthesis of novel 5-Oxo-5,6,7,8-tetrahydroquinoline and 2,5-dioxo-5,6,7,8-tetrahydroquinoline derivatives containing enaminone system and bearing a sulfonamide moiety. The newly synthesized compounds were designed in compliance with the general pharmacophoric requirements for carbonic anhydrase inhibiting anticancer drugs, as this may play a role in their anticancer activity. Twelve of the newly synthesized compounds were evaluated for their in vitro anticancer activity against human breast cancer cell line (MCF7). Compounds 5c, 7, 10, and 12c showed IC50 values (0.048, 0.040, 0.041, 0.044 mu M, respectively) comparable to that of the reference drug doxorubicin (IC50 = 0.04 mu M). On the other hand, compounds 12a, 12d, and 16b exhibited better activity than doxorubicin with an IC50 values (0.025, 0.036, 0.015 mu M, respectively).
C1 [Ahmed, N. S.; Badahdah, K. O.; Qassar, H. M.] King Abdulaziz Univ, Dept Chem, Fac Sci, Jeddah, Saudi Arabia.
   [Ahmed, N. S.] Natl Res Ctr, Dept Med Chem, Cairo, Egypt.
RP Ahmed, NS (reprint author), King Abdulaziz Univ, Dept Chem, Fac Sci, Jeddah, Saudi Arabia.; Ahmed, NS (reprint author), Natl Res Ctr, Dept Med Chem, Cairo, Egypt.
EM nesreen69eg@yahoo.com
CR Abbas EMH, 2010, MONATSH CHEM, V141, P661, DOI 10.1007/s00706-010-0312-6
   Ahmed N, 2010, BIOORGAN MED CHEM, V18, P2872, DOI 10.1016/j.bmc.2010.03.015
   Al-Said MS, 2011, EUR J MED CHEM, V46, P201, DOI 10.1016/j.ejmech.2010.11.002
   Alqasoumi SI, 2010, EUR J MED CHEM, V45, P1849, DOI 10.1016/j.ejmech.2010.01.022
   Alqasoumi SI, 2010, EUR J MED CHEM, V45, P738, DOI 10.1016/j.ejmech.2009.11.021
   Alqasoumi SI, 2009, BIOORG MED CHEM LETT, V19, P6939, DOI 10.1016/j.bmcl.2009.10.065
   Carta A, 2011, BIOORGAN MED CHEM, V19, P7070, DOI 10.1016/j.bmc.2011.10.009
   Garcia GC, 2012, SAR QSAR ENVIRON RES, V23, P751, DOI 10.1080/1062936X.2012.719543
   Creaven BS, 2010, INORG CHIM ACTA, V363, P4048, DOI 10.1016/j.ica.2010.08.009
   Daniel L, 2007, ORGANIC CHEM DRUG SY, P167
   Edafiogho IO, 2009, EUR J MED CHEM, V44, P967, DOI 10.1016/j.ejmech.2008.07.005
   Eddington ND, 2002, EUR J MED CHEM, V37, P635, DOI 10.1016/S0223-5234(02)01377-6
   Eddington ND, 2000, CURR MED CHEM, V7, P417
   El-Hashim A, 2010, EUR J PHARMACOL, V632, P73, DOI 10.1016/j.ejphar.2009.12.004
   El-Hashim AZ, 2011, LIFE SCI, V89, P378, DOI 10.1016/j.lfs.2011.07.007
   El-Sabbagh OI, 2010, EUR J MED CHEM, V45, P5390, DOI 10.1016/j.ejmech.2010.08.064
   El-Sabbagh OI, 2009, EUR J MED CHEM, V44, P3680, DOI 10.1016/j.ejmech.2009.04.001
   Gao MZ, 2010, BIOORGAN MED CHEM, V18, P2099, DOI 10.1016/j.bmc.2010.02.011
   Garudachari B, 2012, EUR J MED CHEM, V54, P900, DOI 10.1016/j.ejmech.2012.05.027
   Ghodsi R, 2010, BIOORGAN MED CHEM, V18, P1029, DOI 10.1016/j.bmc.2009.12.060
   Ghorab MM, 2009, DRUG RES, V57, P795
   Ghorab MM, 2010, EUR J MED CHEM, V45, P3677, DOI 10.1016/j.ejmech.2010.05.014
   Guo RH, 2011, BIOORGAN MED CHEM, V19, P1400, DOI 10.1016/j.bmc.2011.01.006
   Jackson PL, 2012, EUR J MED CHEM, V51, P42, DOI 10.1016/j.ejmech.2012.02.003
   Jayagobi M, 2011, EUR J MED CHEM, V46, P2075, DOI 10.1016/j.ejmech.2011.02.060
   Korrichi L, 2009, EUROPEAN J BIOL SCI, V1, P32
   Kouznetsov VV, 2012, BIOORGAN MED CHEM, V20, P6506, DOI 10.1016/j.bmc.2012.08.036
   Kumar KS, 2012, BIOORGAN MED CHEM, V20, P2199, DOI 10.1016/j.bmc.2012.02.027
   Lu CM, 2010, BIOORGAN MED CHEM, V18, P1948, DOI 10.1016/j.bmc.2010.01.033
   Makawana JA, 2012, CHINESE CHEM LETT, V23, P427, DOI 10.1016/j.cclet.2012.01.017
   Michael JP, 1999, PURE APPL CHEM, V71, P979, DOI 10.1351/pac199971060979
   Perin N, 2011, BIOORGAN MED CHEM, V19, P6329, DOI 10.1016/j.bmc.2011.09.002
   Pretorius SI, 2013, BIOORGAN MED CHEM, V21, P269, DOI 10.1016/j.bmc.2012.10.019
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   Supuran CT, 2003, MED RES REV, V23, P146, DOI 10.1002/med.10025
   Thiry A, 2006, J MED CHEM, V49, P2743, DOI 10.1021/jm0600287
   Vandurm P, 2009, BIOORG MED CHEM LETT, V19, P4806, DOI 10.1016/j.bmcl.2009.06.044
   Wang L, 2012, BIOORGAN MED CHEM, V20, P4820, DOI 10.1016/j.bmc.2012.05.054
   Wu YR, 2011, BIOORGAN MED CHEM, V19, P3361, DOI 10.1016/j.bmc.2011.04.039
NR 39
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD JUN
PY 2017
VL 26
IS 6
BP 1201
EP 1212
DI 10.1007/s00044-017-1850-9
PG 12
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA ET5YB
UT WOS:000400365900013
OA No
DA 2017-08-17
ER

PT J
AU Lamie, PF
   Philoppes, JN
AF Lamie, Phoebe F.
   Philoppes, John N.
TI Design and synthesis of three series of novel antitumor-azo derivatives
SO MEDICINAL CHEMISTRY RESEARCH
LA English
DT Article
DE Benzimidazole; Benzoxazole; Benzothiazole derivatives; Antitumor
ID CANCER CELL-LINES; BIOLOGICAL-ACTIVITY; IN-VITRO; ANTIMICROBIAL
   ACTIVITY; ANTICANCER ACTIVITY; X-RAY; BENZOTHIAZOLE; POTENT;
   4-THIAZOLIDINONES; INHIBITORS
AB Three new series of thiazoles, quinolones, and thiazolidinones merged with benzimidazole, benzoxazole, and benzothiazole nuclei were synthesized. The compounds were subjected to Infrared, H-1 nuclear magnetic resonance, C-13 nuclear magnetic resonance, mass spectrometry, and elemental analyses. Cytotoxic activity of compounds were evaluated against breast (MCF-7) and colon (HCT-116) cell lines. Seven of the compounds had IC50 values between 0.0112 and 0.0198 A mu M and are hence more potent than the reference drug doxorubicin (IC50 = 0.0084 and 0.0088 A mu M against MCF-7 and HCT-116, respectively).
C1 [Lamie, Phoebe F.; Philoppes, John N.] Beni Suef Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Bani Suwayf 62514, Egypt.
RP Lamie, PF (reprint author), Beni Suef Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Bani Suwayf 62514, Egypt.
EM feby.farag@yahoo.com
CR Abd Ell-All AS, 2015, ARCH PHARM CHEM LIFE, V348, P1
   Abdelgawad MA, 2013, J CHEM PHARM RES, V5, P318
   Alang G, 2010, INT J PHARM BIOL ARC, V1, P56
   Amnekar N, 2010, DIG J NANO BIO, V5, P177
   AsIm Z, 2004, ARCH PHARM RES, V27, P1081
   Bhuva HA, 2010, J MOL GRAPH MODEL, V29, P32, DOI 10.1016/j.jmgm.2010.04.003
   Caleta I, 2009, J MED CHEM, V52, P1744, DOI 10.1021/jm801566q
   Doma A, 2014, PHARMACOPHORE, V5, P331
   Franchini C, 2009, ARCH PHARM, V342, P605, DOI 10.1002/ardp.200900092
   Gabr MT, 2014, EXCLI J, V13, P573
   Gajdos P, 2009, MOLECULES, V14, P5382, DOI 10.3390/molecules14125382
   Gulcan HO, 2003, TURK J CHEM, V27, P467
   GULLICK WJ, 1991, BRIT MED BULL, V47, P87
   Gupta A, 2010, J CHEM PHARM RES, V2, P244
   Havrylyuk D, 2010, EUR J MED CHEM, V45, P5012, DOI 10.1016/j.ejmech.2010.08.008
   HIBI S, 1994, J MED CHEM, V37, P3062, DOI 10.1021/jm00045a011
   Hoi S, 2006, BIOORGAN MED CHEM, V14, P1229
   Jin LH, 2006, BIOORG MED CHEM LETT, V16, P1537, DOI 10.1016/j.bmcl.2005.12.041
   Kamal A, 2010, BIOORGAN MED CHEM, V18, P4747, DOI 10.1016/j.bmc.2010.05.007
   Kandeel MM, 2013, J CHEM PHARM RES, V5, P16
   Kaur H, 2010, DIG J NANOMATER BIOS, V5, P67
   Khattab M, 2013, RES CHEM INTERMEDIAT, V39, P2917, DOI 10.1007/s11164-012-0843-z
   Kohli P, 2007, J CHIN CHEM SOC-TAIP, V54, P1003
   Kricker A, 2012, CANCER CAUSE CONTROL, V23, P89, DOI 10.1007/s10552-011-9858-9
   Lipunova GN, 2000, PHARM CHEM J, V34, P19, DOI 10.1007/BF02524552
   Micael C, 2005, J MED CHEM, V48, P3141
   Mortimer CG, 2006, J MED CHEM, V49, P179, DOI 10.1021/jm050942k
   Mosula L, 2009, FARMACIA, V57, P321
   Nitta A, 2008, BIOORG MED CHEM LETT, V18, P5435, DOI 10.1016/j.bmcl.2008.09.042
   Pardasani RT, 1998, PHOSPHORUS SULFUR, V142, P221, DOI 10.1080/10426509808029676
   Pareek D, 2014, INT J PHARM PHARM SC, V6, P438
   Patel N. B., 2010, Journal of Sciences-Islamic Republic of Iran, V21, P121
   Prabhu PP, 2015, J SAUDI CHEM SOC, V19, P181, DOI 10.1016/j.jscs.2012.02.001
   Racane L, 2010, BIOORGAN MED CHEM, V18, P1038, DOI 10.1016/j.bmc.2009.12.054
   Ramurthy S, 2011, BIOORG MED CHEM LETT, V21, P3286, DOI 10.1016/j.bmcl.2011.04.023
   Rana A, 2008, EUR J MED CHEM, V43, P1114, DOI 10.1016/j.ejmech.2007.07.008
   Sathe B. S., 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P510
   Seetaramswamy S, 2013, INT J CURR PHARM RES, V5, P63
   Shi DF, 1996, J MED CHEM, V39, P3375, DOI 10.1021/jm9600959
   Siddiqui N, 2007, BIOORG MED CHEM LETT, V17, P4178, DOI 10.1016/j.bmcl.2007.05.048
   Siddiqui N, 2009, ACTA PHARMACEUT, V59, P441, DOI 10.2478/v10007-009-0031-x
   SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107
   Surya KD, 2009, BIOORGAN MED CHEM, V17, P2712
   Temiz O, 1998, FARMACO, V53, P337, DOI 10.1016/S0014-827X(98)00030-5
   Tzanopoulou S, 2010, J MED CHEM, V53, P4633, DOI 10.1021/jm1001293
   Venkatesh P., 2009, INT J CHEM TECH RES, V1, P1354
   Wee XK, 2009, BIOORGAN MED CHEM, V17, P7562, DOI 10.1016/j.bmc.2009.09.008
   Weng JR, 2009, CARCINOGENESIS, V30, P1702, DOI 10.1093/carcin/bgp202
   Aurrecoechea N, 2010, Pub. N0.: US, Patent No. [2010/0081653, 20100081653]
NR 49
TC 0
Z9 0
U1 7
U2 7
PU SPRINGER BIRKHAUSER
PI NEW YORK
PA 233 SPRING STREET, 6TH FLOOR, NEW YORK, NY 10013 USA
SN 1054-2523
EI 1554-8120
J9 MED CHEM RES
JI Med. Chem. Res.
PD JUN
PY 2017
VL 26
IS 6
BP 1228
EP 1240
DI 10.1007/s00044-017-1839-4
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA ET5YB
UT WOS:000400365900015
OA No
DA 2017-08-17
ER

PT J
AU Kiamehr, S
   Ahmed, H
   Viswanathan, N
   Seetharaman, S
AF Kiamehr, Saeed
   Ahmed, Hesham
   Viswanathan, Nurni
   Seetharaman, Seshadri
TI Changes in Effective Thermal Conductivity During the Carbothermic
   Reduction of Magnetite Using Graphite
SO METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND
   MATERIALS PROCESSING SCIENCE
LA English
DT Article
ID POROUS-MEDIA; HEMATITE; CARBON
AB Knowledge of the effective thermal diffusivity changes of systems undergoing reactions where heat transfer plays an important role in the reaction kinetics is essential for process understanding and control. Carbothermic reduction process of magnetite containing composites is a typical example of such systems. The reduction process in this case is highly endothermic and hence, the overall rate of the reaction is greatly influenced by the heat transfer through composite compact. Using Laser-Flash method, the change of effective thermal diffusivity of magnetite-graphite composite pellet was monitored in the dynamic mode over a pre-defined thermal cycle (heating at the rate of 7 K/min to 1423 K (1150 A degrees C), holding the sample for 270 minutes at this temperature and then cooling it down to the room temperature at the same rate as heating). These measurements were supplemented by Thermogravimetric Analysis under comparable experimental conditions as well as quenching tests of the samples in order to combine the impact of various factors such as sample dilatations and changes in apparent density on the progress of the reaction. The present results show that monitoring thermal diffusivity changes during the course of reduction would be a very useful tool in a total understanding of the underlying physicochemical phenomena. At the end, effort is made to estimate the apparent thermal conductivity values based on the measured thermal diffusivity and dilatations.
C1 [Kiamehr, Saeed; Seetharaman, Seshadri] Royal Inst Technol KTH, S-10044 Stockholm, Sweden.
   [Ahmed, Hesham; Viswanathan, Nurni] Lulea Tech Univ, S-97187 Lulea, Sweden.
   [Ahmed, Hesham] Cent Met Res & Dev Inst, POB 87, Cairo, Egypt.
   [Viswanathan, Nurni; Seetharaman, Seshadri] Indian Inst Technol, Bombay 400076, Maharashtra, India.
RP Ahmed, H (reprint author), Lulea Tech Univ, S-97187 Lulea, Sweden.; Ahmed, H (reprint author), Cent Met Res & Dev Inst, POB 87, Cairo, Egypt.
EM Hesham.ahmed@ltu.se
FU Centre of Advanced Mining & Metallurgy (CAMM), Lulea, Sweden
FX The partial financial support from the Centre of Advanced Mining &
   Metallurgy (CAMM), Lulea, Sweden is greatly acknowledged.
CR Abas RA, 2007, INT J THERMOPHYS, V28, P109, DOI 10.1007/s10765-007-0163-5
   Abas R.A., 2006, EXPT STUDIES THERMAL
   Ahmed HM, 2014, STEEL RES INT, V85, P293, DOI 10.1002/srin.201300072
   Ahmed HM, 2010, METALL MATER TRANS B, V41, P161, DOI 10.1007/s11663-009-9302-7
   Ahmed HM, 2015, ISIJ INT, V55, P2082, DOI 10.2355/isijinternational.ISIJINT-2015-182
   AKIYAMA T, 1992, ISIJ INT, V32, P829, DOI 10.2355/isijinternational.32.829
   CHAURASIA PB, 1974, J APPL CHEM BIOTECHN, V24, P437, DOI 10.1002/jctb.5020240803
   Hayashi M, 2003, Z METALLKD, V94, P1179
   Liu GS, 2004, THERMOCHIM ACTA, V410, P133, DOI 10.1016/S0040-6031(03)00398-8
   LOEB AL, 1954, J AM CERAM SOC, V37, P96
   LUIKOV AV, 1968, INT J HEAT MASS TRAN, V11, P117, DOI 10.1016/0017-9310(68)90144-0
   Marcussen L., 1985, MATH MODELS EFFECTIV, P585
   RAO YK, 1974, CHEM ENG SCI, V29, P1435, DOI 10.1016/0009-2509(74)80168-5
   Russell HW, 1935, J AM CERAM SOC, V18, P1, DOI 10.1111/j.1151-2916.1935.tb19340.x
   SRINIVASAN NS, 1977, METALL TRANS B, V8, P175, DOI 10.1007/BF02656367
   Szelagowski H., 1998, POWDER TECHNOLOGY PR
   Touloukian Y.S., 1976, THERMOPHYSICAL PROPE, V6S
   Vander Voort G. F., 2004, METALLOGRAPHY MICROS, V9, P44073
   WOODSIDE W, 1961, J APPL PHYS, V32, P1688, DOI 10.1063/1.1728419
NR 19
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1073-5615
EI 1543-1916
J9 METALL MATER TRANS B
JI Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.
PD JUN
PY 2017
VL 48
IS 3
BP 1502
EP 1513
DI 10.1007/s11663-017-0944-6
PG 12
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA ET6FF
UT WOS:000400385900010
OA No
DA 2017-08-17
ER

PT J
AU Sorial, ME
   El Sayed, NSE
AF Sorial, Mirna Ezzat
   El Sayed, Nesrine Salah El Dine
TI Protective effect of valproic acid in streptozotocin-induced sporadic
   Alzheimer's disease mouse model: possible involvement of the cholinergic
   system
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article
DE Intracerebroventricular; Streptozotocin; Valproic acid; Cholinergic
   system; Alzheimer's disease
ID OBJECT RECOGNITION MEMORY; INSULIN-DEGRADING ENZYME; AMYLOID
   BETA-PROTEIN; TAIL SUSPENSION TEST; LONG-TERM-MEMORY;
   INTRACEREBROVENTRICULAR-STREPTOZOTOCIN; OXIDATIVE STRESS; BEHAVIORAL
   DEFICITS; COGNITIVE IMPAIRMENT; SYNAPTIC PLASTICITY
AB Sporadic Alzheimer's disease (SAD) is a slowly progressive neurological disorder that is the most common form of dementia. Cholinergic system dysfunction and amyloid beta formation are the two main underlying pathological mechanisms for the disease development. In recent studies, insulin receptor desensitization and disturbances in the downstream effects of insulin receptor signaling were observed in the brains of Alzheimer's patients. Currently, intracereberoventricular (ICV) injection of streptozotocin (STZ) is found to induce behavioral, neurochemical, and structural alterations in animals resembling those found in SAD patients. Valproic acid (VPA), a histone deacetylase inhibitor (HDACi), was recently shown to regulate the transcription of several genes in both in vivo and in vitro models of Alzheimer's disease. The aim of the current study is to investigate the potential effect of different doses of valproic acid, in an ICV-STZ-induced animal model of SAD. Streptozotocin-injected mice showed cognitive and spatial memory dysfunction in the Y-maze, object recognition test, and Morris water maze (MWM) neurobehavioral tests. The mice also exhibited a decrease in acetylcholine (ACh) and neprilysin (NEP) levels accompanied by an increase in acetylcholinesterase (AChE) activity. For the first time to our knowledge, our findings have shown that VPA is capable of restoring ACh levels in ICV-STZ-injected mice, as well as normalizing both NEP levels and AChE activity. Via this mechanism, an enhancement of cognitive functions is observed. Thus, VPA is suggested to be a promising therapeutic approach against SAD.
C1 [Sorial, Mirna Ezzat; El Sayed, Nesrine Salah El Dine] German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmacol & Toxicol, New Cairo City 11835, Egypt.
   [El Sayed, Nesrine Salah El Dine] Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Giza 12613, Egypt.
RP El Sayed, NSE (reprint author), German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmacol & Toxicol, New Cairo City 11835, Egypt.; El Sayed, NSE (reprint author), Cairo Univ, Dept Pharmacol & Toxicol, Fac Pharm, Giza 12613, Egypt.
EM nesrine_salah2002@yahoo.com
CR Agrawal R, 2009, NEUROPHARMACOLOGY, V56, P779, DOI 10.1016/j.neuropharm.2009.01.005
   Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z
   Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222
   Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029
   Bernardi A, 2012, INT J NANOMED, V7, P4927, DOI 10.2147/IJN.S35333
   Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7
   BLOKLAND A, 1994, PHARMACOL BIOCHEM BE, V47, P833, DOI 10.1016/0091-3057(94)90284-4
   Blokland A, 2004, BEHAV BRAIN RES, V154, P71, DOI 10.1016/i.bbr.2004.01.022
   Botton PH, 2010, BEHAV BRAIN RES, V214, P254, DOI 10.1016/j.bbr.2010.05.034
   Broadbent Nicola J, 2010, Learn Mem, V17, P5, DOI 10.1101/lm.1650110
   Castillo-Carranza DL, 2015, J NEUROSCI, V35, P4857, DOI 10.1523/JNEUROSCI.4989-14.2015
   Chang P, 2014, NEUROBIOL DIS, V62, P296, DOI 10.1016/j.nbd.2013.10.017
   Chen YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051432
   Chesneau V, 2000, BIOCHEM J, V351, P509, DOI 10.1042/0264-6021:3510509
   Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107
   Cunha MP, 2015, PURINERG SIGNAL, V11, P215, DOI 10.1007/s11302-015-9446-7
   Cunha MP, 2013, PROG NEURO-PSYCHOPH, V44, P39, DOI 10.1016/j.pnpbp.2013.01.014
   D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4
   Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028
   de la Monte SM, 2009, BMB REP, V42, P475
   Deshmukh R, 2009, EUR J PHARMACOL, V620, P49, DOI 10.1016/j.ejphar.2009.08.027
   Dhull DK, 2012, J MOL NEUROSCI, V46, P223, DOI 10.1007/s12031-011-9583-6
   Dunning CJ, 2016, ACS CHEM NEUROSCI, V7, P161, DOI 10.1021/acschemneuro.5b00262
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X
   Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036
   Farr SA, 2016, J ALZHEIMERS DIS, V54, P1339, DOI 10.3233/JAD-160416
   Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772
   Fisk L, 2007, NEUROCHEM RES, V32, P1741, DOI 10.1007/s11064-007-9349-2
   Frumberg DB, 2007, BRAIN RES, V1144, P209, DOI 10.1016/j.brainres.2007.01.134
   Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003
   GILBERSTADT ML, 1984, ANAL BIOCHEM, V138, P78, DOI 10.1016/0003-2697(84)90772-3
   Goulart BK, 2010, NEUROSCIENCE, V167, P969, DOI 10.1016/j.neuroscience.2010.03.032
   Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008
   Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925
   Gupta R, 2012, PHARMACOL BIOCHEM BE, V102, P184, DOI 10.1016/j.pbb.2012.03.028
   Haettig J, 2011, LEARN MEMORY, V18, P71, DOI 10.1101/lm.1986911
   Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005
   Harada H, 2000, NEUROSCI LETT, V284, P163, DOI 10.1016/S0304-3940(00)01013-2
   Hidaka N, 2011, ACTA MED OKAYAMA, V65, P269
   Hoyer S, 2002, J NEURAL TRANSM, V109, P991, DOI 10.1007/s007020200082
   HOYER S, 1989, J NEURAL TRANSM, V75, P227, DOI 10.1007/BF01258634
   Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009
   ISRAEL M, 1982, J NEUROCHEM, V39, P248, DOI 10.1111/j.1471-4159.1982.tb04727.x
   Jessberger S, 2007, J NEUROSCI, V27, P5967, DOI 10.1523/JNEUROSCI.0110-07.2007
   Jolivalt CG, 2010, EXP NEUROL, V223, P422, DOI 10.1016/j.expneurol.2009.11.005
   Kamei D, 2004, J BIOL CHEM, V279, P33684, DOI 10.1074/jbc.M400199200
   Khalili Mohsen, 2010, Iran Biomed J, V14, P59
   Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197
   Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002
   Lai JS, 2006, EUR J PHARMACOL, V539, P18, DOI 10.1016/j.ejphar.2006.03.076
   Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199
   Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037
   Liu P, 2014, PSYCHOPHARMACOLOGY, V231, P345, DOI 10.1007/s00213-013-3240-4
   Loscher W, 2002, CNS DRUGS, V16, P669
   [陆剑平 Lu Jianping], 2012, [中华神经科杂志, Chinese Journal of Neurology], V45, P102
   Luszczki JJ, 2005, NEUROPSYCHOPHARMACOL, V30, P958, DOI 10.1038/sj.npp.1300602
   McGeer PL, 1996, NEUROLOGY, V47, P425
   Mehan S., 2011, INT J PHARMA PROFESS, V2
   Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95
   Mumby DG, 2002, BEHAV BRAIN RES, V132, P215, DOI 10.1016/S0166-4328(01)00444-2
   Nalivaeva NN, 2012, J MOL NEUROSCI, V46, P569, DOI 10.1007/s12031-011-9644-x
   Narenjkar J, 2012, J BASIC CLIN PATHOPH, V1, P46
   NITSCH R, 1991, NEUROSCI LETT, V128, P199, DOI 10.1016/0304-3940(91)90260-Z
   Okamura N, 2011, NEUROPSYCHOPHARMACOL, V36, P744, DOI 10.1038/npp.2010.207
   Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310
   Paola V., 2011, OBJECT RECOGNITION
   Pelleymounter MA, 2000, J PHARMACOL EXP THER, V293, P799
   Pelleymounter MA, 2002, J PHARMACOL EXP THER, V302, P145, DOI 10.1124/jpet.302.1.145
   Pinton S, 2013, J ALZHEIMERS DIS, V33, P133, DOI 10.3233/JAD-2012-121150
   Prickaerts J, 2000, J NEURAL TRANSM, V107, P745, DOI 10.1007/s007020070056
   Qin W, 2006, MOL PSYCHIATR, V11, P172, DOI 10.1038/sj.mp.4001773
   Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588
   Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730
   ROGERS J, 1993, NEUROLOGY, V43, P1609
   Salkovic-Petrisic M, 2007, J NEURAL TRANSM-SUPP, P217
   Sarkisyan G, 2009, BEHAV BRAIN RES, V202, P26, DOI 10.1016/j.bbr.2009.03.011
   Sberna G, 1997, J NEUROCHEM, V69, P1177
   Sharma M, 2001, LIFE SCI, V68, P1021, DOI 10.1016/S0024-3205(00)01005-5
   Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200
   Shoham S, 2007, NEUROPHARMACOLOGY, V52, P836, DOI 10.1016/j.neuropharm.2006.10.005
   Singh B, 2013, J RENIN-ANGIO-ALDO S, V14, P124, DOI 10.1177/1470320312459977
   Sodhi RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070487
   Sonkusare S, 2005, LIFE SCI, V77, P1, DOI 10.1016/j.lfs.2004.10.036
   Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106
   Szkudelski T, 2001, PHYSIOL RES, V50, P537
   Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034
   Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999
   Van Obberghen E, 2001, EUR J CLIN INVEST, V31, P966, DOI 10.1046/j.1365-2362.2001.00896.x
   VAVRA J. J., 1959, ANTIBIOT ANN, V7, P230
   Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007
   Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404
   Wang JF, 2004, J NEUROCHEM, V88, P1477, DOI 10.1046/j.1471-4159.2003.02276.x
   Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x
   Wang X, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-46
   Warnock GI, 2007, STUDY CENTRAL CORTIC
   Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309
   Yildirim E, 2003, NEUROSCI LETT, V345, P141, DOI 10.1016/S0304-3940(03)00490-7
NR 98
TC 0
Z9 0
U1 12
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD JUN
PY 2017
VL 390
IS 6
BP 581
EP 593
DI 10.1007/s00210-017-1357-4
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ET8KM
UT WOS:000400548300003
PM 28188358
OA No
DA 2017-08-17
ER

PT J
AU Zakaria, EM
   El-Maraghy, NN
   Ahmed, F
   Ali, AA
   El-Bassossy, HM
AF Zakaria, Esraa M.
   El-Maraghy, Nabila N.
   Ahmed, F.
   Ali, Abdelmonim A.
   El-Bassossy, Hany M.
TI PARP inhibition ameliorates nephropathy in an animal model of type 2
   diabetes: focus on oxidative stress, inflammation, and fibrosis
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article
DE PARP; Type 2 diabetes; Nephropathy; 4-aminobenzamide
ID POLY(ADP-RIBOSE) POLYMERASE; MOLECULAR-MECHANISMS; RENAL HYPERTROPHY;
   CELL-DEATH; TGF-BETA; EXPRESSION; MICE; GENE; RATS; COMPLICATIONS
AB Poly(ADP-ribose) polymerase (PARP) enzyme contributes to nephropathy, a serious diabetic complication which may lead to end-stage renal disease. The study aims to investigate the effect of PARP over-activation on kidney functions in a type 2 diabetic rat model. The study also tests the therapeutic use of PARP inhibitors in diabetic nephropathy. Type 2 diabetes was induced in adult male rats by high-fructose/high-fat diet and low streptozotocin dose. Then, the PARP inhibitor 4-aminobenzamide (4-AB) was administered daily for 10 weeks. At the end, urine samples were collected to measure urine creatinine, albumin, and total proteins. PARP activity, superoxide dismutase (SOD) activity, and nitrite content were measured in kidney tissue homogenate. Glucose, fructosamine, insulin, and tumor necrosis factor-alpha (TNF-alpha) were measured in serum. Furthermore, histological studies, collagen deposition, and immunofluorescence of nuclear factor kappa B (NF kappa B) and transforming growth factor beta1 (TGF-beta 1) were carried out. PARP enzyme activity was significantly higher in the diabetic group and was significantly reduced by 4-AB administration. Diabetic animals had clear nephropathy indicated by proteinuria and increased albumin excretion rate (AER) which were significantly decreased by PARP inhibition. In addition, PARP inhibition increased creatinine clearance in diabetic animals and reduced renal TGF-beta 1 and glomerular fibrosis. Moreover, PARP inhibition alleviated the elevated serum TNF-alpha level, renal NF kappa B, nitrite, and the decrease in SOD activity in diabetic animals. However, PARP inhibition did not significantly affect neither hyperglycemia nor insulin sensitivity. PARP enzyme inhibition alleviates diabetic nephropathy through decreasing inflammation, oxidative stress, and renal fibrosis.
C1 [Zakaria, Esraa M.; Ahmed, F.; El-Bassossy, Hany M.] Zagazig Univ, Fac Pharm, Dept Pharmacol, POB 44519, Zagazig, Egypt.
   [El-Maraghy, Nabila N.] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmacol, Cairo, Egypt.
   [Ali, Abdelmonim A.] Zagazig Univ, Dept Pathol, Fac Vet Med, Zagazig, Egypt.
   [El-Bassossy, Hany M.] King Abdulaziz Univ, Dept Pharmacol, Fac Pharm, Jeddah, Saudi Arabia.
RP Zakaria, EM (reprint author), Zagazig Univ, Fac Pharm, Dept Pharmacol, POB 44519, Zagazig, Egypt.
EM emzakaria@zu.edu.eg; callnabila@hotmail.com; af53nab@yahoo.com;
   abdelmoneim.ahmedali@yahoo.com; helbassossy@kau.edu.sa
FU Egyptian Ministry for Higher Education Funding Agency; Science and
   Technology Development (STDF) [1024]
FX This work was funded by a research fund from the Egyptian Ministry for
   Higher Education Funding Agency; Science and Technology Development
   (STDF, www.stdf.org.eg), Fund ID 1024.
CR Afsar B, 2012, DIABETIC MED, V29, P1043, DOI 10.1111/j.1464-5491.2012.03593.x
   Arora MK, 2013, VASC PHARMACOL, V58, P259, DOI 10.1016/j.vph.2013.01.001
   Beneke S, 2008, EXP GERONTOL, V43, P605, DOI 10.1016/j.exger.2008.04.008
   BENHUR E, 1985, CANCER RES, V45, P2123
   Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535
   Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008
   Cutroneo KR, 2007, WOUND REPAIR REGEN, V15, pS54, DOI 10.1111/j.1524-475X.2007.00226.x
   DAI S, 1995, J PHARMACOL TOXICOL, V33, P101, DOI 10.1016/1056-8719(94)00063-A
   Drel VR, 2011, INT J MOL MED, V28, P629, DOI 10.3892/ijmm.2011.709
   Drel VR, 2009, ENDOCRINOLOGY, V150, P5273, DOI 10.1210/en.2009-0628
   Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894
   Eijkelkamp WBA, 2007, J AM SOC NEPHROL, V18, P1540, DOI 10.1681/ASN.200605445
   El-Bassossy HM, 2015, TRANSL RES, V165, P621, DOI 10.1016/j.trsl.2014.11.008
   El-Bassossy HM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0445-9
   Gauldie J, 2007, BIOCHEM SOC T, V35, P661
   Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200
   Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399
   Heilig Charles W., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010490
   Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7
   Hirata K, 1998, DIABETOLOGIA, V41, P185, DOI 10.1007/s001250050888
   Khan TA, 2003, J AM COLL SURGEONS, V197, P270, DOI 10.1016/S1072-7515(03)00538-6
   Khanra R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0364-1
   McCluskey James D, 2011, Int J Crit Illn Inj Sci, V1, P97, DOI 10.4103/2229-5151.84788
   Minchenko AG, 2003, FASEB J, V17, P1514, DOI 10.1096/fj.03-0013fje
   Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034
   Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008
   Ray SD, 2001, FREE RADICAL BIO MED, V31, P277, DOI 10.1016/S0891-5849(01)00562-7
   Reusch JEB, 2003, J CLIN INVEST, V112, P986, DOI 10.1172/JCI200319902
   Shevalye H, 2010, BBA-MOL BASIS DIS, V1802, P1020, DOI 10.1016/j.bbadis.2010.07.004
   Shevalye H, 2010, BIOCHEM PHARMACOL, V79, P1007, DOI 10.1016/j.bcp.2009.11.018
   Srinivasan K, 2007, INDIAN J MED RES, V125, P451
   Sun SF, 2015, CLIN EXP PHARMACOL P, V42, P662, DOI 10.1111/1440-1681.12402
   Szabo C, 2006, DIABETES, V55, P3004, DOI 10.2337/db06-0147
   Szabo C, 2006, TRENDS PHARMACOL SCI, V27, P626, DOI 10.1016/j.tips.2006.10.003
   Tas Hekimoglu A, 2014, Eur Rev Med Pharmacol Sci, V18, P34
   Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200
   Thiemermann C, 1997, P NATL ACAD SCI USA, V94, P679, DOI 10.1073/pnas.94.2.679
   Werth S, 2015, INTERNIST, V56, P513, DOI 10.1007/s00108-014-3629-0
   Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x
   Xu BY, 2008, DIABETES-METAB RES, V24, P404, DOI 10.1002/dmrr.842
   Ye DZ, 2006, DIABETES, V55, P742, DOI 10.2337/diabetes.55.03.06.db05-0653
   Yuan F, 2014, MOL MED REP, V9, P2293, DOI 10.3892/mmr.2014.2133
   Zhu YQ, 2007, SEMIN NEPHROL, V27, P153, DOI 10.1016/j.semnephrol.2007.01.008
NR 45
TC 0
Z9 0
U1 7
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD JUN
PY 2017
VL 390
IS 6
BP 621
EP 631
DI 10.1007/s00210-017-1360-9
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ET8KM
UT WOS:000400548300006
PM 28224182
OA No
DA 2017-08-17
ER

PT J
AU Elfar, EI
   Ellwood, BB
   Wang, WH
   Bell, GL
AF Elfar, Emad I.
   Ellwood, Brooks B.
   Wang, Wei-Hsung
   Bell, Gorden L., Jr.
TI Sea level and climatic-induced facies variations in the Middle Cambrian
   House Range Embayment, western Laurentia
SO PALAEOGEOGRAPHY PALAEOCLIMATOLOGY PALAEOECOLOGY
LA English
DT Article
DE Middle Cambrian; Drumian GSSP; Paleoclimatic facies variations; Sea
   level fluctuations; House Range Embayment; Wheeler Formation
ID MAGNETIC-SUSCEPTIBILITY; CARBONATE PLATFORM; DRUM-MOUNTAINS;
   GREAT-BASIN; STRATOTYPE-SECTION; WHEELER FORMATION; NORTH-AMERICA; POINT
   GSSP; UTAH; USA
AB The Middle Cambrian House Range Embayment (HRE) represents a deep-water incursion into an extensive carbonate platform along the passive margin of western Laurentia. The distribution and source of HRE mixed siliciclastic-carbonate sediments are poorly understood because many key elements were missed during past field observations or coarse correlation. This study describes the HRE complex lithological variations, and improves current understanding concerning the global climatic and sea level fluctuations that drove these variations. Magnetic susceptibility (chi), gamma radiation (GR) and carbonate content (CaCO3%) are used to construct high-resolution correlation among three overlapping Middle Cambrian marine sedimentary sections: 1) the Drumian Global boundary Stratotype Section and Point (GSSP) in the Drum Mountains, western Utah, 2) the Marjum Pass section in the House Range, western Utah, and 3) the Packrat section Great Basin National Park in the Snake Range, eastern Nevada. Middle Cambrian HRE lithological variations followed broad fades patterns. Carbonate sediments dominated the HRE edges and decreased inward, while shale, dominated the HRE trough and decreased outward. The carbonate/detrital ratio varied along the area between the HRE Edge and trough due to; 1) sea level fluctuations, (2) the depositional setting at each section, and 3) the allocyclic, climatic variations that acted on the carbonate platform of western Laurentia. Sea level and climatic fluctuations drove temporal fades variations that are well correlated among the three sections, while the depositional setting for each section drove spatial facies variations that account for carbonate and detrital sediment sources and their trajectories into the HRE. The GSSP is a shallow trough section; Marjum Pass is a lower slope section of the northern HRE ramp; and the Packrat is a lower slope section situated along the southern HRE ramp. Sea level and climatic cycles during the Middle Cambrian Drumian Stage, induced long-term and short-term facies variations, respectively, that were superimposed on each other. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Elfar, Emad I.; Ellwood, Brooks B.] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA.
   [Elfar, Emad I.] Tanta Univ, Dept Geol, Tanta 31527, Egypt.
   [Wang, Wei-Hsung] Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA.
   [Bell, Gorden L., Jr.] Great Basin Natl Pk, Baker, NV 89311 USA.
RP Elfar, EI (reprint author), Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA.
EM eelfar1@lsu.edu
FU Egyptian Ministry of Higher Education [GM-0934]; Robey Clark endowment
   [LSU-RC-BG002649]
FX This work was funded by a grant to Emad Elfar from the Egyptian Ministry
   of Higher Education (GM-0934), and, in part, from the Robey Clark
   endowment to Louisiana State University (LSU-RC-BG002649). The authors
   would like to thank Loren Babcock, Suzanne Ellwood, Eman Eldakkak,
   Jennifer Kenyon, and Minhee Chou for their kind assistance during the
   fieldwork, and Amber Ellwood for her help during sample preparation and
   measurement. Appreciation is also extended to Dr. Samuel Bentley, Dr.
   Sophie Warny for reviewing a draft of this manuscript, and to the
   reviewers for their constructive comments.
CR Ahlberg P, 2009, LETHAIA, V42, P2, DOI 10.1111/j.1502-3931.2008.00127.x
   AITKEN J D, 1978, Bulletin of Canadian Petroleum Geology, V26, P515
   Aitken J.D., 1997, B GEOL SURV CAN, V398, P322
   Babcock LE, 2004, GEOBIOS-LYON, V37, P149, DOI 10.1016/j.geobios.2003.03.007
   Babcock LE, 2007, EPISODES, V30, P85
   Babek O, 2007, FACIES, V53, P293, DOI 10.1007/s10347-006-0095-8
   Brady M.J., 1979, W CENTRAL UTAH GEO 1, V26, P1
   Brasier MD, 1998, CAN J EARTH SCI, V35, P353, DOI 10.1139/e97-122
   Brett CE, 2009, PALAEOGEOGR PALAEOCL, V277, P9, DOI 10.1016/j.palaeo.2009.02.010
   DALRYMPLE RW, 1985, GEOLOGY, V13, P607, DOI 10.1130/0091-7613(1985)13<607:EAATDO>2.0.CO;2
   Dickinson W.R., 1981, GEOTECTONIC DEV CALI, P1
   Drewes H., 1957, Bulletin of the American Association of Petroleum Geologists, V41, P104
   Elfar E.I, 2016, THESIS
   Ellwood BB, 2000, GEOLOGY, V28, P1135, DOI 10.1130/0091-7613(2000)28<1135:MEACMA>2.0.CO;2
   Ellwood BB, 1999, AAPG BULL, V83, P1119
   Ellwood BB, 2008, PALAEOGEOGR PALAEOCL, V261, P270, DOI 10.1016/j.palaeo.2008.01.022
   Ellwood BB, 2006, MAR GEOL, V230, P237, DOI 10.1016/j.margeo.2006.05.008
   Ellwood BB, 2013, PALAEOGEOGR PALAEOCL, V378, P75, DOI 10.1016/j.palaeo.2013.02.018
   Elrick M, 2002, SEDIMENTOLOGY, V49, P1021, DOI 10.1046/j.1365-3091.2002.00488.x
   Gaines RR, 2005, PALAEOGEOGR PALAEOCL, V220, P193, DOI 10.1016/j.palaeo.2004.07.034
   Gould KM, 2014, MAR PETROL GEOL, V57, P445, DOI 10.1016/j.marpetgeo.2014.06.008
   Halgedahl SL, 2009, PALAEOGEOGR PALAEOCL, V277, P34, DOI 10.1016/j.palaeo.2009.02.011
   HINTZE LF, 1975, GEOL SOC AM BULL, V86, P881, DOI 10.1130/0016-7606(1975)86<881:MCSOTH>2.0.CO;2
   Hintze L.F, 1988, SPECIAL PUBLICATION, V7
   Hong J, 2016, SEDIMENT GEOL, V341, P58, DOI 10.1016/j.sedgeo.2016.04.012
   Howley R.A, 2010, THESIS
   Howley RA, 2006, PALAEOWORLD, V15, P360, DOI DOI 10.1016/J.PALWOR.2006.10.010
   Howley RA, 2010, PALAEOGEOGR PALAEOCL, V296, P138, DOI 10.1016/j.palaeo.2010.07.001
   JONES GA, 1983, J SEDIMENT PETROL, V53, P655
   Jongsun H., 2016, ACTA GEOL SINICA, V90, P783
   KARLIN R, 1983, NATURE, V303, P327, DOI 10.1038/303327a0
   KARLIN R, 1985, J GEOPHYS RES-SOLID, V90, P373, DOI 10.1029/JB090iB12p10373
   Langenburg E.S., 2003, THESIS
   Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068
   Maruyama S, 2014, GONDWANA RES, V25, P910, DOI 10.1016/j.gr.2013.03.012
   Nagata T., 1961, ROCK MAGNETISM
   Osleger DA, 1996, SEDIMENTOLOGY, V43, P197, DOI 10.1046/j.1365-3091.1996.d01-13.x
   Palmer A.R., 1965, 493 US GEOL SURV
   Palmer A.R., 1971, CAMBRIAN NEW WORLD, P1
   Peng S. C., 2008, CONCISE GEOLOGIC TIM, P37, DOI DOI 10.1017/S0016756808004913
   REES MN, 1986, GEOL SOC AM BULL, V97, P1054, DOI 10.1130/0016-7606(1986)97<1054:AFTTAC>2.0.CO;2
   Rees M.N., 1984, THESIS
   ROBISON RA, 1982, J PALEONTOL, V56, P132
   Robison R.A., 1999, BASE PTYCHAGNOSTUS A, P15
   Rogers J.C., 1984, HOUSE RANGE UTAH GEO, V31, P97
   Santosh M, 2014, GONDWANA RES, V25, P945, DOI 10.1016/j.gr.2013.03.013
   Scotese C. R., 2001, ATLAS EARTH HIST, V1
   Scotese C.R., 1990, GEOL SOC MEM, V12, P75
   Simicek D, 2012, SEDIMENT GEOL, V261, P50, DOI 10.1016/j.sedgeo.2012.03.003
   Speed R.C., 1982, AAPG BULL, V34, P457
   SWARTZENDRUBER LJ, 1991, J MAGN MAGN MATER, V100, P573, DOI 10.1016/0304-8853(91)90841-W
   Tarling DH, 1993, MAGNETIC ANISOTROPY
   Xiao S., 2012, AGU FALL M, P8
   Young GM, 2015, GEOSCI FRONT, V6, P523, DOI 10.1016/j.gsf.2014.09.001
   Zhu MY, 2004, GEOBIOS-LYON, V37, P287, DOI 10.1016/j.geobios.2003.06.001
NR 55
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0031-0182
EI 1872-616X
J9 PALAEOGEOGR PALAEOCL
JI Paleogeogr. Paleoclimatol. Paleoecol.
PD JUN 1
PY 2017
VL 475
BP 125
EP 139
DI 10.1016/j.palaeo.2017.03.024
PG 15
WC Geography, Physical; Geosciences, Multidisciplinary; Paleontology
SC Physical Geography; Geology; Paleontology
GA ET8EU
UT WOS:000400532500011
OA No
DA 2017-08-17
ER

PT J
AU Badawy, SM
   Thompson, AA
   Lai, JS
   Penedo, FJ
   Rychlik, K
   Liem, RI
AF Badawy, Sherif M.
   Thompson, Alexis A.
   Lai, Jin-Shei
   Penedo, Frank J.
   Rychlik, Karen
   Liem, Robert I.
TI Health-related quality of life and adherence to hydroxyurea in
   adolescents and young adults with sickle cell disease
SO PEDIATRIC BLOOD & CANCER
LA English
DT Article
DE adherence; adolescents; compliance; health-related quality of life;
   hydroxyurea; patient-reported outcomes; patient-reported outcomes
   measurement information system; PROMIS (R); sickle cell anemia; sickle
   cell disease; young adults
ID RANDOMIZED CONTROLLED-TRIAL; PATIENT-REPORTED OUTCOMES; ITEM RESPONSE
   THEORY; MEDICATION ADHERENCE; PSYCHOMETRIC PROPERTIES; PEDIATRIC
   MEASURES; BABY HUG; CHILDREN; FATIGUE; SCALES
AB Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD.
   Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12-22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS (R)) computerized adaptive testing and (c) Modified Morisky Adherence Scale 8-items ((c) MMAS-8).
   Results: Participants (59% male, 91% Black) had median age of 13.5 (range 12-18) years. Ninety-one percent completed PROMIS (R) measures electronically in the clinic, meeting our feasibility criterion of >= 85% completion rate. (c) MMAS-8 scores positively correlated with fetal hemoglobin (HbF) (r(s) = 0.34, P = 0.04) and mean corpuscular volume (MCV) (r(s) = 0.42, P = 0.01) and inversely correlated with fatigue (r(s) = -0.45, P = 0.01), depression (r(s) = -0.3, P = 0.08), and social isolation (r(s) = -0.78, P = 0.02). Low (c) MMAS-8 scores, indicating poor adherence, were associated with worse fatigue (P = 0.001) and trended toward significance for pain (P = 0.07) and depression (P = 0.06). Homozygous hemoglobin S disease patients with low HbF (< 16%) had worse social isolation (P = 0.04) and those with low MCV (< 102 fl) reported worse fatigue (P = 0.001), pain (P = 0.01), mobility (P = 0.01), and social isolation (P = 0.04).
   Conclusions: HRQOL assessment in the SCD clinic is feasible. SCD patients with low hydroxyurea adherence and/or low HbF or MCV levels had worse HRQOL scores, particularly fatigue. Future prospective studies examining the relationship between HRQOL and hydroxyurea adherence are warranted.
C1 [Badawy, Sherif M.; Thompson, Alexis A.; Lai, Jin-Shei; Rychlik, Karen; Liem, Robert I.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Badawy, Sherif M.; Thompson, Alexis A.; Liem, Robert I.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, 225 E Chicago Ave,Box 30, Chicago, IL 60611 USA.
   [Badawy, Sherif M.] Zagazig Univ, Fac Med, Dept Pediat, Div Hematol & Oncol, Zagazig, Egypt.
   [Lai, Jin-Shei; Penedo, Frank J.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Rychlik, Karen] Northwestern Univ, Stanley Mantle Childrens Res Inst, Ann & Robert H Lurie Childrens Hosp, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Badawy, SM (reprint author), Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, 225 E Chicago Ave,Box 30, Chicago, IL 60611 USA.
EM sbadawy@luriechildrens.org
CR Ameringer S, 2014, J PEDIATR ONCOL NURS, V31, P6, DOI 10.1177/1043454213514632
   Amr Mostafa Abdel-Monhem, 2011, Pan Afr Med J, V8, P10
   Anderson LM, 2015, J PEDIAT HEMATOL ONC, V37, P584, DOI 10.1097/MPH.0000000000000431
   Badawy SM, 2016, PEDIATR BLOOD CANCER, V63, P848, DOI 10.1002/pbc.25905
   Ballas SK, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-59
   Berry DL, 2011, J CLIN ONCOL, V29, P1029, DOI 10.1200/JCO.2010.30.3909
   Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011
   Dale JC, 2011, J PEDIATR HEALTH CAR, V25, P208, DOI 10.1016/j.pedhc.2009.12.006
   Dampier C, 2016, PEDIATR BLOOD CANCER, V63, P1031, DOI 10.1002/pbc.25944
   Dampier C, 2016, PEDIATR BLOOD CANCER, V63, P1038, DOI 10.1002/pbc.25931
   Dampier C, 2010, PEDIATR BLOOD CANCER, V55, P485, DOI 10.1002/pbc.22497
   Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027
   DeWalt DA, 2015, QUAL LIFE RES, V24, P2195, DOI 10.1007/s11136-015-0953-3
   Dobrozsi S, 2015, HEMATOL-AM SOC HEMAT, P501
   Dobrozsi SK, 2015, 57 AM SOC HEM ANN M
   Engelen V, 2011, PEDIATR BLOOD CANCER, V56, P646, DOI 10.1002/pbc.22795
   Engelen V, 2012, PEDIATR BLOOD CANCER, V58, P766, DOI 10.1002/pbc.23158
   Glasgow RE, 2012, HEALTH AFFAIR, V31, P497, DOI 10.1377/hlthaff.2010.1295
   Irwin DE, 2010, QUAL LIFE RES, V19, P585, DOI 10.1007/s11136-010-9618-4
   Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59
   Lai JS, 2013, QUAL LIFE RES, V22, P2417, DOI 10.1007/s11136-013-0357-1
   Lai JS, 2011, J PEDIATR PSYCHOL, V36, P766, DOI 10.1093/jpepsy/jsr005
   Modi AC, 2009, CHILD HEALTH CARE, V38, P107, DOI 10.1080/02739610902813245
   Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x
   Myrvik MP, 2014, CLIN PRACTICE PEDTR, V2, P39, DOI DOI 10.1037/CPP0000052
   National Heart Lung and Blood Institute, 2012, WHAT IS SICKL CELL A
   NIH-PROMIS, 2016, PROM COMP AD TEST CA
   Oyeku SO, 2013, PEDIATR BLOOD CANCER, V60, P653, DOI 10.1002/pbc.24381
   Palermo TM, 2002, J BEHAV MED, V25, P269, DOI 10.1023/A:1015332828213
   Panepinto JA, 2005, BRIT J HAEMATOL, V130, P437, DOI 10.1111/j.1365-2141.2005.05622.x
   Panepinto JA, 2008, J PEDIAT HEMATOL ONC, V30, P666, DOI 10.1097/MPH.0b013e31817e4a44
   Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776
   Panepinto JA, 2012, PEDIATR BLOOD CANCER, V59, P377, DOI 10.1002/pbc.24176
   Patel NG, 2010, PEDIATR BLOOD CANCER, V55, P554, DOI 10.1002/pbc.22605
   Quinn H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0160-x
   Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X
   Strouse JJ, 2008, PEDIATRICS, V122, P1332, DOI 10.1542/peds.2008-0441
   Thissen D, 2016, QUAL LIFE RES, V25, P13, DOI 10.1007/s11136-015-1058-8
   Thornburg CD, 2012, BLOOD, V120, P4304, DOI 10.1182/blood-2012-03-419879
   Thornburg CD, 2011, J PEDIAT HEMATOL ONC, V33, P251, DOI 10.1097/MPH.0b013e3182114c54
   Thornburg CD, 2010, J PEDIATR-US, V156, P415, DOI 10.1016/j.jpeds.2009.09.044
   Varni JW, 2014, QUAL LIFE RES, V23, P1233, DOI 10.1007/s11136-013-0544-0
   Velikova G, 2004, J CLIN ONCOL, V22, P714, DOI 10.1200/JCO.2004.06.078
   Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325
   Walsh KE, 2014, PEDIATRICS, V134, P1175, DOI 10.1542/peds.2014-0177
   Wang WC, 2013, PEDIATRICS, V132, P677, DOI 10.1542/peds.2013-0333
   Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3
   Wolfe J, 2014, J CLIN ONCOL, V32, P1119, DOI 10.1200/JCO.2013.51.5981
   Yost KJ, 2011, J CLIN EPIDEMIOL, V64, P507, DOI 10.1016/j.jclinepi.2010.11.018
NR 49
TC 3
Z9 3
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD JUN
PY 2017
VL 64
IS 6
AR UNSP e26369
DI 10.1002/pbc.26369
PG 8
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA ET9GW
UT WOS:000400616500029
OA No
DA 2017-08-17
ER

PT J
AU Mahrous, AA
   Abdelmaaboud, AK
AF Mahrous, Abeer A.
   Abdelmaaboud, Abdelhamid K.
TI Antecedents of participation in online brand communities and their
   purchasing behavior consequences
SO SERVICE BUSINESS
LA English
DT Article
DE Online communities; Purchase decisions; Customer participation; Facebook
   brand communities; Egyptian telecommunication industry
ID VIRTUAL COMMUNITIES; CUSTOMER PARTICIPATION; CONSUMER PARTICIPATION;
   GENDER-DIFFERENCES; SOCIAL-INFLUENCE; TRUST; SOCIABILITY; PERSPECTIVE;
   COMMITMENT; USABILITY
AB This study intends to fill some gaps in knowledge about online communities and their influence on consumers' purchase decisions. A review of the extant literature on online brand communities reveals that most prior studies have focused on identifying the factors associated with joining and participating in online communities. However, limited studies examine the implications of participation in online brand communities in terms of consumer behaviors, such as brand liking and intention to purchase the brand. In addition, these few studies have either focused on the influence of operational elements of the online community on purchase intention or on the influence of community members' characteristics regarding purchase intention. Therefore, this study aims to provide an integrated framework for operational and user characteristics' antecedents associated with consumers' participation in online brand communities and their effect on purchase decisions. Structural equation modeling was used to test the conceptual model. Data were collected via a survey of the Facebook pages of 282 members of Egyptian telecommunication companies. The findings provide insights into how these antecedents should be managed to enhance participation in virtual telecommunication communities.
C1 [Mahrous, Abeer A.; Abdelmaaboud, Abdelhamid K.] Cairo Univ, Fac Commerce, POB 12613, Giza, Egypt.
RP Mahrous, AA (reprint author), Cairo Univ, Fac Commerce, POB 12613, Giza, Egypt.
EM abeer.mahrous@foc.cu.edu.eg
CR Adjei MT, 2010, J ACAD MARKET SCI, V38, P634, DOI 10.1007/s11747-009-0178-5
   Algesheimer R, 2005, J MARKETING, V69, P19, DOI 10.1509/jmkg.69.3.19.66363
   Leal GPA, 2014, J BUS RES, V67, P882, DOI 10.1016/j.jbusres.2013.07.007
   Bagozzi RP, 2006, INT J RES MARK, V23, P45, DOI 10.1016/j.ijresmar.2006.01.005
   Bagozzi R. P, 2002, J INTERACT MARK, V16, P2, DOI DOI 10.1002/DIR.10006
   Bazarvoice, 2014, GET POW TRUST
   Berger SC, 2009, INT J BANK MARK, V27, P446, DOI [10.1108/02652320910988320, DOI 10.1108/02652320910988320]
   Bone SA, 2015, J SERV RES-US, V18, P23, DOI 10.1177/1094670514537710
   Brengman M, 2012, MANAG RES REV, V35, P791, DOI 10.1108/01409171211256569
   Chan KW, 2010, J BUS RES, V63, P1033, DOI 10.1016/j.jbusres.2008.08.009
   Chiu CM, 2010, ELECTRON COMMER R A, V9, P148, DOI 10.1016/j.elerap.2009.04.003
   Chung J. Y., 2008, Information Technology and Tourism, V10, P267, DOI 10.3727/109830508788403123
   Dholakia UM, 2004, INT J RES MARK, V21, P241, DOI 10.1016/j.ijresmar.2003.12.004
   El Araby, 2015, MARK RES 2015 ART SC
   Elsharnouby TH, 2015, J RES INTERACT MARK, V9, P313, DOI 10.1108/JRIM-06-2014-0038
   Field A., 2013, DISCOVERING STAT USI
   Gallagher SE, 2013, COMPUT HUM BEHAV, V29, P1028, DOI 10.1016/j.chb.2012.09.011
   Grace-Farfaglia P., 2006, Electronic Commerce Research, V6, P75, DOI 10.1007/s10660-006-5989-6
   Gummerus J, 2012, MANAG RES REV, V35, P857, DOI 10.1108/01409171211256578
   Guo Y. Q., 2004, THESIS
   Hair J. F., 2010, MULTIVARIATE DATA AN
   Hargittai E, 2015, INFORM COMMUN SOC, V18, P424, DOI 10.1080/1369118X.2014.957711
   Ho CW, 2014, EUROMED J BUS, V9, P252, DOI 10.1108/EMJB-12-2013-0057
   Hofstede G., 2010, GEERT HOFSTEDE
   Huang LT, 2012, PACIFIC ASIA J ASS I, V4
   Kang J, 2014, INT J HOSP MANAG, V36, P145, DOI 10.1016/j.ijhm.2013.08.015
   Kim HS, 2008, INT J RETAIL DISTRIB, V36, P812, DOI 10.1108/09590550810901008
   Kim SH, 2009, SERV BUS, V3, P149, DOI 10.1007/s11628-008-0059-x
   Koivisto J, 2014, COMPUT HUM BEHAV, V35, P179, DOI 10.1016/j.chb.2014.03.007
   Komiak S. X., 2004, Information Technology & Management, V5, P181, DOI 10.1023/B:ITEM.0000008081.55563.d4
   Komiak SYX, 2006, MIS QUART, V30, P941
   Koufaris M, 2002, INFORM SYST RES, V13, P205, DOI 10.1287/isre.13.2.205.83
   Kozinets RV, 2010, J MARKETING, V74, P71
   Ku ECS, 2011, INTERNET RES, V21, P282, DOI 10.1108/10662241111139318
   Kumar RS, 2013, MARK INTELL PLAN, V31, P141, DOI 10.1108/02634501311312044
   Kumar V, 2013, J SERV MANAGE, V24, P330, DOI 10.1108/09564231311327021
   Kunkel E, 2013, 15 SOCIAL MEDIA STAT
   Lian JW, 2014, COMPUT HUM BEHAV, V37, P133, DOI 10.1016/j.chb.2014.04.028
   Liao SL, 2012, ONLINE INFORM REV, V36, P442, DOI 10.1108/14684521211241440
   Litt E, 2013, NEW MEDIA SOC, V15, P612, DOI 10.1177/1461444813475424
   Mahrous Abeer A., 2011, International Journal of Electronic Marketing and Retailing, V4, P248, DOI 10.1504/IJEMR.2011.045610
   Mahrous AA, 2015, INT J TECNOL MARK
   Malinen S, 2015, COMPUT HUM BEHAV, V46, P228, DOI 10.1016/j.chb.2015.01.004
   MCIT, 2014, INF COMM TECHN IND B
   McKnight DH, 2002, INFORM SYST RES, V13, P334, DOI 10.1287/isre.13.3.334.81
   MORGAN RM, 1994, J MARKETING, V58, P20, DOI 10.2307/1252308
   Nambisan P, 2016, HEALTH EXPECT, V19, P87, DOI 10.1111/hex.12332
   Nielsen, 2015, AFR NAV RET DISTR LA
   Nielson, 2013, INT US EG WIR NEED
   Nunnally J., 1978, PSYCHOMETRIC METHODS
   Nusair K, 2013, TOURISM MANAGE, V35, P13, DOI 10.1016/j.tourman.2012.05.005
   Park H, 2012, J CONSUM MARK, V29, P400, DOI 10.1108/07363761211259214
   Phang CW, 2009, J ASSOC INF SYST, V10, P721
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879
   Porter CE, 2004, J COMPUT-MEDIAT COMM, V10, P00, DOI [10.1111/j.1083-6101.2004.tb00228.x, DOI 10.1111/J.1083-6101.2004.TB00228.X]
   Porter CE, 2012, J MARKET THEORY PRAC, V20, P39, DOI 10.2753/MTP1069-6679200103
   Preece J, 2001, BEHAV INFORM TECHNOL, V20, P347, DOI 10.1080/01449290110084683
   Rheingold H., 1993, VIRTUAL COMMUNITY HO
   Shen K, 2014, PACIS 2014 P
   Socialbakers, 2014, EG FAC STAT
   Spagnoletti P., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P4082, DOI 10.1109/HICSS.2012.54
   Spaulding TJ, 2010, ELECTRON COMMER R A, V9, P38, DOI 10.1016/j.elerap.2009.07.004
   Sun N, 2014, COMPUT HUM BEHAV, V38, P110, DOI 10.1016/j.chb.2014.05.022
   Teichmann K, 2015, PSYCHOL MARKET, V32, P341, DOI 10.1002/mar.20783
   van der Heijden H, 2003, INFORM MANAGE-AMSTER, V40, P541, DOI 10.1016/S0378-7206(02)00079-4
   Wang Y. C., 2004, Journal of Travel Research, V42, P261, DOI 10.1177/0047287503258824
   Wang YC, 2004, TOURISM MANAGE, V25, P709, DOI 10.1016/j.tourman.2003.09.011
   Wiertz C, 2007, ORGAN STUD, V28, P347, DOI 10.1177/0170840607076003
   Wirtz J, 2013, J SERV MANAGE, V24, P223, DOI 10.1108/09564231311326978
   Wohn D, 2012, P 2012 ACM C HUM FAC, P2905
   Xu A, 2012, P CSCW 2012, P295
   Zaglia ME, 2013, J BUS RES, V66, P216, DOI 10.1016/j.jbusres.2012.07.015
   Zhang KZK, 2015, COMPUT HUM BEHAV, V44, P357, DOI 10.1016/j.chb.2014.11.068
NR 73
TC 0
Z9 0
U1 9
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1862-8516
EI 1862-8508
J9 SERV BUS
JI Serv. Bus.
PD JUN
PY 2017
VL 11
IS 2
BP 229
EP 251
DI 10.1007/s11628-016-0306-5
PG 23
WC Business; Management
SC Business & Economics
GA ET8PT
UT WOS:000400562800001
OA No
DA 2017-08-17
ER

PT J
AU Najeeb, MA
   Ahmad, Z
   Shakoor, RA
   Mohamed, AMA
   Kahraman, R
AF Najeeb, Mansoor Ani
   Ahmad, Zubair
   Shakoor, R. A.
   Mohamed, A. M. A.
   Kahraman, Ramazan
TI A novel classification of prostate specific antigen (PSA) biosensors
   based on transducing elements
SO TALANTA
LA English
DT Article
DE Prostate cancer; Biosensor; PSA
ID SURFACE-PLASMON RESONANCE; REFERENCE RANGES; CANCER; SERUM; MEN;
   SENSORS; IMMUNOASSAY; POPULATION; STRATEGIES; PEPTIDE
AB During the last few decades, there has been a tremendous rise in the number of research studies dedicated towards the development of diagnostic tools based on bio-sensing technology for the early detection of various diseases like cardiovascular diseases (CVD), many types of cancer, diabetes mellitus (DM) and many infectious diseases. Many breakthroughs have been developed in the areas of improving specificity, selectivity and repeatability of the biosensor devices. Innovations in the interdisciplinary areas like biotechnology, genetics, organic electronics and nanotechnology also had a great positive impact on the growth of bio-sensing technology. As a product of these improvements, fast and consistent sensing policies have been productively created for precise and ultrasensitive biomarker-based disease diagnostics. Prostate-specific antigen (PSA) is widely considered as an important biomarker used for diagnosing prostate cancer. There have been many publications based on various biosensors used for PSA detection, but a limited review was available for the classification of these biosensors used for the detection of PSA. This review highlights the various biosensors used for PSA detection and proposes a novel classification for PSA biosensors based on the transducer type used. We also highlight the advantages, disadvantages and limitations of each technique used for PSA biosensing which will make this article a complete reference tool for the future researches in PSA biosensing.
C1 [Najeeb, Mansoor Ani; Ahmad, Zubair; Shakoor, R. A.] Qatar Univ, Ctr Adv Mat, Doha 2713, Qatar.
   [Mohamed, A. M. A.] Suez Univ, Fac Petr & Min Engn, Dept Met & Mat Engn, Suez 43721, Egypt.
   [Kahraman, Ramazan] Qatar Univ, Coll Engn, Dept Chem Engn, Doha 2713, Qatar.
RP Najeeb, MA; Shakoor, RA (reprint author), Qatar Univ, Ctr Adv Mat, Doha 2713, Qatar.
EM animansoor@qu.edu.qa; shakoor@qu.edu.qa
RI Najeeb, Mansoor Ani/C-6585-2014
OI Najeeb, Mansoor Ani/0000-0002-8258-0613; Mohamed, Adel
   Mohamed/0000-0002-7505-6274
CR Ambrosi A, 2010, ANAL CHEM, V82, P1151, DOI 10.1021/ac902492c
   Arya S.K., 2012, BIOSENSORS J, V1, DOI DOI 10.4303/BJ/H110601
   Banica F.-G., 2012, CHEM SENSORS BIOSENS
   Bhushan B, 2007, MICROELECTRON ENG, V84, P387, DOI 10.1016/j.mee.2006.10.059
   Blum LJ, 2006, NATO SCI SER II-MATH, V224, P157
   Brawer MK, 1999, CA-CANCER J CLIN, V49, P264, DOI 10.3322/canjclin.49.5.264
   CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702
   Catalona W.J., 2014, ASIAN J UROL, V1, P12
   Ceylan Koydemir H, 2011, BIOSENS BIOELECTRON, V29, P1, DOI 10.1016/j.bios.2011.07.071
   DeLuna F., 2017, P SOC PHOTO-OPT INS, V2017
   Escamilla-Gomez V, 2009, BIOSENS BIOELECTRON, V24, P2678, DOI 10.1016/j.bios.2009.01.043
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Ghindilis AL, 1998, BIOSENS BIOELECTRON, V13, P113, DOI 10.1016/S0956-5663(97)00031-6
   Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093
   Grieshaber Dorothee, 2008, SENSORS, V8
   Grubisha DS, 2003, ANAL CHEM, V75, P5936, DOI 10.1021/ac034356f
   He Y, 2015, ACS APPL MATER INTER, V7, P13360, DOI 10.1021/acsami.5b01827
   Healy DA, 2007, TRENDS BIOTECHNOL, V25, P125, DOI 10.1016/j.tibtech.2007.01.004
   Homola J, 2003, ANAL BIOANAL CHEM, V377, P528, DOI 10.1007/s00216-003-2101-0
   Huang L, 2005, BIOSENS BIOELECTRON, V21, P483, DOI 10.1016/j.bios.2004.11.016
   Inan H., 2017, CHEM SOC REV
   Jang HD, 2015, BIOSENS BIOELECTRON, V63, P546, DOI 10.1016/j.bios.2014.08.008
   Kamal BA, 2003, SAUDI MED J, V24, P665
   Kehinde EO, 2005, BJU INT, V96, P308, DOI 10.1111/j.1464-410X.2005.05620.x
   Kim YH, 2009, SENSOR ACTUAT B-CHEM, V139, P471, DOI 10.1016/j.snb.2009.03.013
   Kong RM, 2015, ANAL BIOANAL CHEM, V407, P369, DOI 10.1007/s00216-014-8267-9
   KOST GJ, 1995, AM J CLIN PATHOL, V104, pS111
   KURIYAMA M, 1980, Cancer Research, V40, P4658
   Lee SE, 2000, UROLOGY, V56, P1007, DOI 10.1016/S0090-4295(00)00837-2
   Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351
   Lind K, 2005, J IMMUNOL METHODS, V304, P107, DOI 10.1016/j.jim.2005.06.015
   Liu J, 2013, CHEM COMMUN, V49, P6602, DOI 10.1039/c3cc43532f
   Liu ZY, 2009, ASIAN J ANDROL, V11, P100, DOI 10.1038/aja.2008.17
   Luboldt H.-J., 2007, EAU EBU UPDATE SERIE, V5, P38, DOI DOI 10.1016/J.EEUS.2006.10.003
   Maehashi K, 2004, APPL PHYS LETT, V85, P858, DOI 10.1063/1.1778471
   Maehashi K., 2006, P 64 DEV RES C, P181
   Malati T, 2004, Indian J Clin Biochem, V19, P132, DOI 10.1007/BF02872408
   Muezzinoglu Talha, 2005, International Urology and Nephrology, V37, P299, DOI 10.1007/s11255-004-7976-y
   Mungroo Nawfal Adam, 2014, Biosensors (Basel), V4, P472, DOI 10.3390/bios4040472
   Neves-Petersen MT, 2013, BIOSENSORS AND CANCER, P378
   OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860
   Pan LH, 2017, BIOSENS BIOELECTRON, V89, P598, DOI 10.1016/j.bios.2016.01.077
   PAPSIDERO LD, 1980, CANCER RES, V40, P2428
   Presnova G., 2016, BIOSENS BIOELECTRON
   Qi HL, 2014, ANAL CHEM, V86, P1372, DOI 10.1021/ac402991r
   Rebelo MSCR, 2014, ELECTROCHIM ACTA, V132, P142, DOI 10.1016/j.electacta.2014.03.108
   Rocchitta G, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060780
   Rusling JF, 2010, ANALYST, V135, P2496, DOI 10.1039/c0an00204f
   Sana A.K., 2017, P SOC PHOTO-OPT INS
   Saw S, 2000, PATHOLOGY, V32, P245
   Shin KS, 2016, BIOSENS BIOELECTRON, V85, P16, DOI 10.1016/j.bios.2016.04.086
   Soukka T, 2003, CLIN CHIM ACTA, V328, P45, DOI 10.1016/S0009-8981(02)00376-5
   Su L, 2013, BIOSENS BIOELECTRON, V46, P155, DOI 10.1016/j.bios.2013.01.074
   Suaifan GARY, 2013, ANALYST, V138, P3735, DOI 10.1039/c3an36881e
   Tainaka K, 2010, SENSORS-BASEL, V10, P1355, DOI 10.3390/s100201355
   Turner A.W., 1987, BIOSENSORS FUNDAMENT, P770
   Uludag Y, 2012, ANAL CHEM, V84, P5898, DOI 10.1021/ac300278p
   Waggoner PS, 2007, LAB CHIP, V7, P1238, DOI 10.1039/b707401h
   Wang Y, 2009, ANAL CHEM, V81, P9625, DOI 10.1021/ac901662e
   Wolfbeis OS, 2005, J MATER CHEM, V15, P2657, DOI 10.1039/b501536g
   Wu CC, 2012, INT J ELECTROCHEM SC, V7, P4432
   Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856
   Wu Z, 2016, BIOSENS BIOELECTRON, V85, P657, DOI 10.1016/j.bios.2016.05.074
   Yu JH, 2011, BIOSENS BIOELECTRON, V26, P3284, DOI 10.1016/j.bios.2010.12.044
   Zhang S., ANAL CHEM
   Zhao XY, 2013, SENSORS-BASEL, V13, P14570, DOI 10.3390/s131114570
   Zheng W., 2016, METHODS ENHANCE STAB
NR 67
TC 0
Z9 0
U1 8
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD JUN 1
PY 2017
VL 168
BP 52
EP 61
DI 10.1016/j.talanta.2017.03.022
PG 10
WC Chemistry, Analytical
SC Chemistry
GA EU0RT
UT WOS:000400719700007
PM 28391865
OA No
DA 2017-08-17
ER

PT J
AU Tolba, MF
   El-Serafi, AT
   Omar, HA
AF Tolba, Mai F.
   El-Serafi, Ahmed T.
   Omar, Hany A.
TI Caffeic acid phenethyl ester protects against glucocorticoid-induced
   osteoporosis in vivo: Impact on oxidative stress and RANKL/OPG signals
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Dexamethasone; Caffeic acid phenethyl ester; Osteoporosis; GSH; SOD;
   Apoptosis
ID NF-KAPPA-B; PEROXIDE-INDUCED DYSFUNCTION; OSTEOBLASTIC MC3T3-E1 CELLS;
   NECROSIS-FACTOR-ALPHA; OSTEOCLAST DIFFERENTIATION; BONE-FORMATION;
   RECEPTOR SUPERFAMILY; ANTIOXIDANT; EXPRESSION; DEXAMETHASONE
AB Glucocorticoid-induced osteoporosis (GIO) is one of the most common causes of secondary osteoporosis. Given that glucocorticoids are considered as a main component of the treatment protocols for a variety of inflammation and immune-mediated diseases besides its use as adjuvant to several chemotherapeutic agents, it is crucial to find ways to overcome this critical adverse effect. Caffeic acid phenethyl ester (CAPE), which is a natural compound derived from honeybee propolis displayed promising antiosteoporotic effects against mechanical bone injury in various studies. The current work aimed at investigating the potential protective effect of CAPE against GIO in vivo with emphasis on the modulation of oxidative status and receptor activator of NF-kB ligand (RANKL)/osteoprotegrin (OPG) signaling. The results showed that CAPE opposed dexamethasone (DEX)-mediated alterations in bone histology and tartarate-resistant acid phosphatase (TRAP) activity. In addition, CAPE restored oxidative balance, Runt-related transcription factor 2 (RunX2) expression and reduced caspase-3 activity in femur tissues. Co-administration of CAPE with DEX normalized RANKL/OPG ratio and Akt activation indicating a reduction in DEX-osteoclastogenesis. In conclusion, concurrent treatment of CAPE with DEX exhibited promising effects in the protection against DEX-induced osteoporosis through opposing osteoclastogenesis and protecting osteoblasts. The potent antioxidant activity of CAPE is, at least in part, involved in its anti-apoptotic effects and modulation of RunX2 and RANKL/OPG signals. The use of CAPE-enriched propolis formulas is strongly recommended for patients on chronic glucocorticoid therapy to help in the attenuation of GIO. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Tolba, Mai F.] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo 11566, Egypt.
   [Tolba, Mai F.] Chapman Univ, Irvine, CA 92618 USA.
   [El-Serafi, Ahmed T.; Omar, Hany A.] Univ Sharjah, Sharjah Inst Med Res, Sharjah 27272, U Arab Emirates.
   [El-Serafi, Ahmed T.] Suez Canal Univ, Fac Med, Dept Med Biochem, Ismailia, Egypt.
   [Omar, Hany A.] Beni Suef Univ, Fac Pharm, Dept Pharmacol, Bani Suwayf 62514, Egypt.
RP Omar, HA (reprint author), Univ Sharjah, Sharjah Inst Med Res, Sharjah 27272, U Arab Emirates.; Omar, HA (reprint author), Univ Sharjah, Coll Pharm, Sharjah 27272, U Arab Emirates.
EM hanyomar@sharjah.ac.ae
OI Omar, Hany/0000-0002-4670-8149
FU Fulbright Scholarship
FX MFT is supported by a Fulbright Scholarship FY2015/2016. The authors are
   thankful to Dr. Kawkab A. Ahmed, Professor of Pathology, Faculty of
   Veterinary Medicine, Cairo University, Egypt for her kind help in the
   histopathology and immunohistochemistry.
CR Ahmed HH, 2012, EUR REV MED PHARMACO, V16, P1446
   Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481
   Altindag O, 2008, RHEUMATOL INT, V28, P317, DOI 10.1007/s00296-007-0452-0
   AntrasFerry J, 1997, FEBS LETT, V403, P100, DOI 10.1016/S0014-5793(97)00033-1
   Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200
   Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073
   Banchroft J. D., 1996, THEORY PRACTICE HIST
   Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522
   Boulanger J, 2014, CURR ONCOL, V21, pE630, DOI 10.3747/co.21.1966
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Briot K, 2015, RMD OPEN, V1, P1, DOI DOI 10.1136/RMD0PEN-2014-000014
   Brzovic-Saric V, 2015, MOL VIS, V21, P649
   Camm EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021142
   Chen YJ, 2009, J FOOD SCI, V74, pH162, DOI 10.1111/j.1750-3841.2009.01199.x
   Choi EM, 2009, TOXICOL IN VITRO, V23, P862, DOI 10.1016/j.tiv.2009.05.005
   Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Erdem M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-8
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   FLOHE L, 1984, METHOD ENZYMOL, V105, P93
   Lucinda LMF, 2013, PHYTOTHER RES, V27, P515, DOI 10.1002/ptr.4747
   Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006
   Giguere V, 1990, Genet Eng (N Y), V12, P183
   Gocer H, 2011, INT J FOOD SCI NUTR, V62, P821, DOI 10.3109/09637486.2011.585963
   Gunay A, 2014, DRUG DES DEV THER, V8, P2069, DOI 10.2147/DDDT.S67623
   Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexer.2004.07.035
   Ha J, 2009, INT IMMUNOPHARMACOL, V9, P774, DOI 10.1016/j.intimp.2009.03.001
   Harding G, 2006, CYTOKINE, V36, P57, DOI 10.1016/j.cyto.2006.10.012
   Hartmann K, 2016, PHYSIOL REV, V96, P409, DOI 10.1152/physrev.00011.2015
   Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/endo.140.10.7034
   HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0
   Hurson CJ, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-12
   Ibrahim WH, 2013, FREE RADICAL BIO MED, V65, P143, DOI 10.1016/j.freeradbiomed.2013.06.026
   Jiang L, 2014, AM J CHINESE MED, V42, P679, DOI 10.1142/S0192415X1450044X
   Kanzaki H, 2013, J BIOL CHEM, V288, P23009, DOI 10.1074/jbc.M113.478545
   Kaur B, 2014, APPL MICROBIOL BIOT, V98, P8539, DOI 10.1007/s00253-014-5950-x
   Kazancioglu Hakki Oguz, 2015, Drug Des Devel Ther, V9, P6483, DOI 10.2147/DDDT.S97797
   Kazancioglu HO, 2015, ACTA ODONTOL SCAND, V73, P21, DOI 10.3109/00016357.2014.942876
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Kondo T, 2008, J CELL BIOCHEM, V103, P335, DOI 10.1002/jcb.21414
   Kong YY, 1999, NATURE, V397, P315
   Koriem K.M., 2014, J TOXICOL, V2014, DOI DOI 10.1155/2014/583494]
   Koromila T, 2014, J CELL BIOCHEM, V115, P27, DOI 10.1002/jcb.24646
   Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662
   Lin H, 2015, BIOCHEM BIOPH RES CO, V460, P422, DOI 10.1016/j.bbrc.2015.03.049
   Liu Q, 2017, J AGR FOOD CHEM, V65, P338, DOI 10.1021/acs.jafc.6b04873
   Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9
   Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024
   Martin T John, 2013, World J Orthop, V4, P186, DOI 10.5312/wjo.v4.i4.186
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   Nguyen GC, 2016, GASTROENTEROLOGY, V150, P242, DOI 10.1053/j.gastro.2015.11.008
   Nieves JW, 2013, OSTEOPOROSIS INT, V24, P771, DOI 10.1007/s00198-012-2214-4
   Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007
   Ozgocmen S, 2007, ARCH MED RES, V38, P196, DOI 10.1016/j.arcmed.2006.09.010
   Pereira RC, 2002, BONE, V30, P685, DOI 10.1016/S8756-3282(02)00687-7
   Phan H, 2015, EXPERT REV RESP MED, V9, P391, DOI 10.1586/17476348.2015.1068692
   Rahman I, 1999, J BIOL CHEM, V274, P5088, DOI 10.1074/jbc.274.8.5088
   Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005
   Sendur OF, 2009, JOINT BONE SPINE, V76, P514, DOI 10.1016/j.jbspin.2009.02.005
   Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480
   Sivagurunathan S, 2005, J BONE MINER RES, V20, P390, DOI 10.1359/JBMR.041233
   Tolba MF, 2016, CRIT REV FOOD SCI, V56, P2183, DOI 10.1080/10408398.2013.821967
   Tolba MF, 2013, IUBMB LIFE, V65, P699, DOI 10.1002/iub.1189
   Ucan MC, 2013, J INT MED RES, V41, P1648, DOI 10.1177/0300060513490613
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Wang T, 2008, CAN J PHYSIOL PHARM, V86, P279, DOI 10.1139/y08-029
   Wang XY, 2010, EUR J PHARMACOL, V635, P16, DOI 10.1016/j.ejphar.2010.02.034
   Wang Y, 2013, PHYTOMEDICINE, V20, P787, DOI 10.1016/j.phymed.2013.03.005
   Wangping D., 2014, CHIN MED J, V127, P3932
   Yan XT, 2014, FOOD CHEM, V156, P408, DOI 10.1016/j.foodchem.2014.01.078
   Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324
   Yongtao Zhang, 2014, Endocrine, V47, P598, DOI 10.1007/s12020-014-0196-z
   Zhang JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057251
   Zhang JK, 2012, EUR J PHARMACOL, V689, P31, DOI 10.1016/j.ejphar.2012.05.045
   Zhang XN, 2016, CHEM-BIOL INTERACT, V256, P188, DOI 10.1016/j.cbi.2016.07.003
   Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024
NR 76
TC 0
Z9 0
U1 8
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD JUN 1
PY 2017
VL 324
BP 26
EP 35
DI 10.1016/j.taap.2017.03.021
PG 10
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA ET6QL
UT WOS:000400416500003
PM 28363435
OA No
DA 2017-08-17
ER

PT J
AU ElMasry, I
   Elshiekh, H
   Abdlenabi, A
   Saad, A
   Arafa, A
   Fasina, FO
   Lubroth, J
   Jobre, YM
AF ElMasry, I.
   Elshiekh, H.
   Abdlenabi, A.
   Saad, A.
   Arafa, A.
   Fasina, F. O.
   Lubroth, J.
   Jobre, Y. M.
TI Avian Influenza H5N1 Surveillance and its Dynamics in Poultry in Live
   Bird Markets, Egypt
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE Egypt; H5N1 HPAI; live bird markets; prevalence; surveillance
ID WILD BIRDS; VIRUS H5N1; TEMPERATURE; SURVIVAL; IMPACT
AB H5N1, a highly pathogenic avian influenza (H5N1 HPAI), is an endemic disease that is significant for public health in Egypt. Live bird markets (LBMs) are widespread in Egypt and play an important role in HPAI disease dynamics. The aim of the study was to evaluate the H5N1 HPAI prevalence in representative LBMs from 2009 to 2014, assess the effects of other variables and evaluate past outbreaks and human cases. It was found that ducks and geese are high-risk species and that the prevalence of H5N1 HPAI was higher immediately after the political crises of 2011. The end of a calendar year (June to December) was a high-risk period for positive samples, and the risk in urban LBMs was twice the risk in rural LBMs. Winter and political unrest was associated with higher H5N1 HPAI prevalence. Both human and poultry populations will continue to rise in Egypt, so continued poultry outbreaks are likely to be linked to more human cases. LBMs will continue to play a role in the dynamics of poultry disease in Egypt, and there is a need to reorganize markets in terms of biosecurity and traceability. It may also be beneficial to reduce inter-governorate inter-regional movements associated with poultry trade through promotion of regional trade or in the alternative provide sanitary features along the poultry market chain to reduce the speed of H5N1 HPAI infections. Policy formulation, design and enforcement must be pro-poor, and consideration of the sociocultural and economic realities in Egypt is important. The LBMs provide ideal platforms to carry out sound surveillance plans and mitigate zoonotic risks of H5N1 HPAI to humans.
C1 [ElMasry, I.; Saad, A.; Arafa, A.; Jobre, Y. M.] Food & Agr Org United Nations FAO, Emergency Ctr Transboundary Anim Dis ECTAD, Giza, Egypt.
   [Elshiekh, H.; Abdlenabi, A.] Minist Agr & Land Reclamat, Gen Org Vet Serv, Giza, Egypt.
   [Fasina, F. O.] Univ Pretoria, Dept Prod Anim Studies, Fac Vet Sci, Pretoria, South Africa.
   [Lubroth, J.] Food & Agr Org FAO, Rome, Italy.
RP ElMasry, I (reprint author), FAO, ECTAD, Giza, Egypt.; Fasina, FO (reprint author), Univ Pretoria, Dept Prod Anim Studies, ZA-0110 Onderstepoort, South Africa.
EM ihab.elmasry@fao.org; daydupe2003@yahoo.co.uk
FU United States Agency for International Development (USAID)
   [AID-263-IO-11-00001, OSRO/EGY/101/USA]; USAID; Support for Smallholder
   Poultry Development Personal Development Grant; Food and Agriculture
   Organization of the United Nations (FAO); International Fund for
   Agricultural Development (IFAD) [GCP/INT/197/IFA]
FX This work was supported by the United States Agency for International
   Development (USAID) [grant number AID-263-IO-11-00001, Mod.#3] in the
   framework of OSRO/EGY/101/USA, through projects jointly implemented by
   the FAO, General Organization for Veterinary Services and NLQP. The
   authors express their sincere gratitude to USAID for its continued
   support in addressing the endemic HPAI situation in Egypt. FOF was
   supported by a Support for Smallholder Poultry Development Personal
   Development Grant (Associate Poultry Adviser) facilitated by
   International Network for Family Poultry Development (INFPD), the Food
   and Agriculture Organization of the United Nations (FAO) and the
   International Fund for Agricultural Development (IFAD) grant number
   GCP/INT/197/IFA.
CR Abdelwhab EM, 2010, AVIAN DIS, V54, P911
   Ahmed SSU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024324
   Ali A. M., 2013, 11 FAO AN PROD HLTH
   Aly F. A., 2012, World Applied Sciences Journal, V17, P1009
   Arafa AS, 2015, EUROSURVEILLANCE, V20, P2
   Bakamanume B. B., 1998, E AFR GEOGR REV, V20, P58
   Central Agency for Public Mobilization and Statistics (CAPMAS), 2006, FIN RES POP HOUS CEN
   Cardona C, 2009, POULTRY SCI, V88, P856, DOI 10.3382/ps.2008-00338
   Choi JG, 2013, VIRUSES-BASEL, V5, P1153, DOI 10.3390/v5041153
   Chumpolbanchorn Kamlang, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P102
   European Centre for Disease Prevention and Control (ECDC), 2015, RAP RISK ASS HUM INF
   El-Zoghby EF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-203
   Elnagar A., 2007, CASE STUDY EGYPTIAN
   Emergency Prevention System Global Animal Disease Information System (EMPRES i), 2014, GLOB AN DIS INF SYST
   Food and Agriculture Organisation of the United Nations (FAO), 2013, 5 REP GLOB PROGR PRE
   Food and Agriculture Organisation of the United Nations (FAO), 2007, INT IMPR BIOS SMALL
   Food and Agriculture Organisation of the United Nations (FAO), 2007, GLOB STRAT PROGR CON
   Food and Agriculture Organisation of the United Nations (FAO), 2004, FAO REC PREV CONTR E
   Food and Agriculture Organisation of the United Nations (FAO), 2015, GLOB LIV PROD HLTH A
   Food and Agriculture Organisation of the United Nations (FAO), 2011, 171 FAO UN AN PROD H
   Fasina FO, 2016, ZOONOSES PUBLIC HLTH, V63, P20, DOI 10.1111/zph.12200
   Fasina FO, 2012, PREV VET MED, V103, P178, DOI 10.1016/j.prevetmed.2011.09.016
   Fournie G, 2011, J R SOC INTERFACE, V8, P1079, DOI 10.1098/rsif.2010.0510
   Geerlings E., 2007, HIGHLY PATHOGENIC AV
   Hosny F., 2007, IMPACT HIGHLY PATHOG
   Ibrahim A. A., 2007, MARKET IMPACTS UNPUB
   Ibrahim M, 2013, VET MICROBIOL, V167, P651, DOI 10.1016/j.vetmic.2013.09.022
   Kandeel A, 2010, EMERG INFECT DIS, V16, P1101, DOI 10.3201/eid1607.091695
   Kayali G, 2014, EMERG INFECT DIS, V20, P542, DOI 10.3201/eid2004.131295
   Kherallah M., 2012, AVICENNA J MED, V2, P51
   Kirunda H, 2015, ZOONOSES PUBLIC HLTH, V62, P334, DOI 10.1111/zph.12151
   Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151
   Ministry of Agriculture and Land Reclamation (MoALR), 2010, INT NAT PLAN AV HUM
   World Organisation for Animal Health (OIE), 2008, 7 OIE
   Paek MR, 2010, POULTRY SCI, V89, P1647, DOI 10.3382/ps.2010-00800
   Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X
   [Anonymous], 2015, AV INFL HUM 97 EG H5
   Rabinowitz PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043851
   Rivas AL, 2010, EPIDEMIOL INFECT, V138, P192, DOI 10.1017/S0950268809990495
   Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0
   Samaan G, 2011, PREV VET MED, V100, P71, DOI 10.1016/j.prevetmed.2011.03.003
   Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38
   Shakal MA, 2013, POULT FISH WILDL SCI, V2, P111
   Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002
   Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9
   WHO Global Influenza Programme, 2015, CUM NUMB CONF HUM CA
   World Health Organization Regional Office for Eastern Mediterranean (WHO-EMRO), 2015, EG UPS H5N1 HUM POUL
   World Bank, 2015, WORLD DEV IND
   Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014
NR 49
TC 3
Z9 3
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD JUN
PY 2017
VL 64
IS 3
BP 805
EP 814
DI 10.1111/tbed.12440
PG 10
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA ET3EW
UT WOS:000400161300015
PM 26608470
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Aziz, M
   Azab, N
   Lasheen, H
   Naguib, N
   Reda, R
AF Abdel-Aziz, Mosaad
   Azab, Noha
   Lasheen, Hisham
   Naguib, Nader
   Reda, Ramez
TI Swallowing disorders among patients with diffuse idiopathic skeletal
   hyperostosis
SO ACTA OTO-LARYNGOLOGICA
LA English
DT Article
DE Dysphagia; swallowing difficulty; cervical osteophytes; DISH; spinal
   ligament
ID FIBEROPTIC ENDOSCOPIC EVALUATION; ASSESSMENT-TOOL EAT-10; EXTRASPINAL
   MANIFESTATIONS; CERVICAL-SPINE; DYSPHAGIA; DISH; OSTEOPHYTES;
   OBSTRUCTION
AB Conclusion: Diffuse idiopathic skeletal hyperostosis (DISH) is a cause of swallowing disorders in elderly, and otolaryngologists should be aware of the disease on dealing with old patients complaining of dysphagia. The condition may be treated conservatively in most patients; however, surgical reduction of cervical osteophytes may be needed in severe cases.
   Objective: Large cervical osteophytes may cause dysphagia; they compress the pharynx leading to mechanical impairment of swallowing. DISH is characterized by ossification of the anterior longitudinal spinal ligament with formation of osteophytes. The aim was to investigate swallowing disorders among patients with DISH.
   Method: The study included 139 patients with DISH. Their swallowing was evaluated using the eating assessment tool (EAT-10), and patients with swallowing disorders were subjected to fiber-optic endoscopic evaluation of swallowing (FEES), they received conservative treatment for 6 months. Patients were assessed again after treatment using the same measures that were employed before treatment.
   Results: Twenty-three patients (16.5%) demonstrated swallowing disorder, and FEES showed residues of food in the pharynx after swallow in all of them. Significant overall improvement after conservative treatment was achieved, with two patients resuming their normal regular diet. However, one patient demonstrated no improvement, and he needed surgical reduction of his large cervical osteophytes.
C1 [Abdel-Aziz, Mosaad; Lasheen, Hisham] Cairo Univ, Dept Otolaryngol, Giza, Giza Governorat, Egypt.
   [Azab, Noha] Cairo Univ, Dept Rheumatol & Rehabil, Giza, Giza Governorat, Egypt.
   [Naguib, Nader; Reda, Ramez] Beni Suef Univ, Dept Otolaryngol, Bani Sweif, Beni Suef Gover, Egypt.
RP Abdel-Aziz, M (reprint author), 2 El Salam St, Cairo, Egypt.
EM mosabeez@yahoo.com
CR Abdel-Aziz M, 2014, EUR ARCH OTO-RHINO-L, V271, P1785, DOI 10.1007/s00405-013-2827-z
   Aydin E, 2006, ACTA OTO-LARYNGOL, V126, P775, DOI 10.1080/00016480500504192
   Belafsky PC, 2008, ANN OTO RHINOL LARYN, V117, P919
   Carlson ML, 2011, DYSPHAGIA, V26, P34, DOI 10.1007/s00455-009-9264-6
   Castellano DM, 2006, LARYNGOSCOPE, V116, P341, DOI 10.1097/01.mlg.0000197936.48414.fa
   Cheney DM, 2015, ANN OTO RHINOL LARYN, V124, P351, DOI 10.1177/0003489414558107
   FORESTIER J, 1950, ANN RHEUM DIS, V9, P321, DOI 10.1136/ard.9.4.321
   Fuerderer S, 2004, J BONE JOINT SURG BR, V86B, P837, DOI 10.1302/0301-620X.86B6.14933
   Giuffra V, 2010, EUR SPINE J, V19, pS103, DOI 10.1007/s00586-009-1125-3
   Hiss SG, 2003, LARYNGOSCOPE, V113, P1386, DOI 10.1097/00005537-200308000-00023
   JULKUNEN H, 1975, SCAND J RHEUMATOL, V4, P23
   Langmore SE, 2009, OTOLARYNG CLIN N AM, V42, P87, DOI 10.1016/j.otc.2008.09.005
   Lavin JM, 2013, OTOLARYNG CLIN N AM, V46, P447, DOI 10.1016/j.otc.2013.02.009
   Mader R, 2008, J RHEUMATOL, V35, P377
   Mader R, 2009, RHEUMATOLOGY, V48, P1478, DOI 10.1093/rheumatology/kep308
   Nacci A, 2008, ACTA OTORHINOLARYNGO, V28, P206
   Nimmons G, 2010, LARYNGOSCOPE, V120, P23, DOI 10.1002/lary.20681
   Ohki M., 2012, CASE REP OTOLARYNGOL, V2012
   RESNICK D, 1975, RADIOLOGY, V115, P513
   RotesQuerol J, 1996, BRIT J RHEUMATOL, V35, P1193
   Solaroglu I, 2008, TURK NEUROSURG, V18, P409
NR 21
TC 0
Z9 0
U1 6
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0001-6489
EI 1651-2251
J9 ACTA OTO-LARYNGOL
JI Acta Oto-Laryngol.
PD JUN
PY 2017
VL 137
IS 6
BP 623
EP 626
DI 10.1080/00016489.2016.1272136
PG 4
WC Otorhinolaryngology
SC Otorhinolaryngology
GA ET3KX
UT WOS:000400178600010
PM 28084872
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Gaber, R
   Abdel-Ghaffar, F
   Shazly, MA
   Morsy, K
   Al Quraishy, S
   Mohamed, S
   Mehlhorn, H
AF Abdel-Gaber, Rewaida
   Abdel-Ghaffar, Fathy
   Shazly, Mohamed Abdallah
   Morsy, Kareem
   Al Quraishy, Saleh
   Mohamed, Sanna
   Mehlhorn, Heinz
TI Morphological re-description of Electrotaenia malapteruri (Cestoda:
   Proteocephalidae) and Dujardinnascaris malapteruri (Nematoda:
   Heterocheilidae) infecting the Electric catfish Malapterurus electricus
   and heavy metal accumulation in host and parasites in relation to water
   and sediment analysis in Lake Manzala, North Delta, Egypt
SO ACTA PARASITOLOGICA
LA English
DT Article
DE Electrotaenia spp.; Dujardinnascaris spp.; Malapterurus electricus;
   morphological studies; heavy metals accumulation; biological indicators
ID ANGUILLA-ANGUILLA; DIFFERENT TISSUES; ELEMENTS; BAY; BREAM; FISH; LEAD;
   SEA
AB Parasites are one of the most serious limiting factors in aquaculture. The Electric catfish Malapterurus electricus was subjected to study the prevalence and mean intensity of parasitic infections throughout the whole year of 2015. Heavy metals accumulation in host fish and parasites were determined in relation to water quality and sediments of two different sites of Lake Manzala (Manzala and Bahr El-Baqar), Egypt. A total of 100 specimens of Electric catfish were collected and examined for the presence of helminth parasites. Two parasite species were recovered and morphologically identified. These were cestoda Electrotaenia malapteruri and nematode Dujardinnascaris malapteruri. Heavy metal analysis in water and sediments showed that measured heavy metals in Bahr El-Baqar were found in risky levels higher than permissible limits and Manzala site. Sediments were found to contain a higher level of metals than water samples. Heavy metals accumulation in recovered parasites and their host were also determined and showed significantly higher concentrations in parasites compared to their host tissues. According to bioconcentration factors, E. malapteruri showed that highest accumulation rate for all recorded elements up to 302. Essential elements like Cu and Fe were found in significantly higher concentrations in D. malapteruri, whereas E. malapteruri accumulated elements Cd, Pb, Ni, Mn, Zn and Ca to a significantly higher degree. Accordingly, the ratios (C-[D. malapteruri]/C-[E. malapteruri]) for most essential elements were higher than 0.5. Therefore, fish cestodes can be regarded as useful bio-indicators more than nematodes when evaluating the environmental pollution of aquatic ecosystems by heavy metals.
C1 [Abdel-Gaber, Rewaida; Abdel-Ghaffar, Fathy; Shazly, Mohamed Abdallah; Morsy, Kareem; Mohamed, Sanna] Cairo Univ, Fac Sci, Dept Zool, Cairo, Egypt.
   [Al Quraishy, Saleh] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia.
   [Mehlhorn, Heinz] Dusseldorf Univ, Parasitol Inst, Dusseldorf, Germany.
RP Abdel-Gaber, R (reprint author), Cairo Univ, Fac Sci, Dept Zool, Cairo, Egypt.
EM rewaida@sci.cu.edu.eg
FU Deanship of Scientific Research at King Saud University [PRG-1436-02]
FX The authors are thankful to the Faculty of Science, Cairo University,
   Cairo, Egypt, for providing all the facilities to complete this work. In
   addition, the authors extend their appreciations to the Deanship of
   Scientific Research at King Saud University for funding the work through
   the international research group project PRG-1436-02.
CR Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P513, DOI 10.1007/s00436-014-4213-1
   Abdel-Ghaffar F, 2014, PARASITOL RES, V113, P3457, DOI 10.1007/s00436-014-4016-4
   Abdel-Baky T.E., 1998, J EGYPT GER SOC ZOOL, V26, P25
   Abdel-Gaber R, 2016, J HELMINTHOL, V8, P1
   Akhtar Y., 2008, FEEDING HABITS NEMAT, P268
   Ali HR, 2014, MAR POLLUT BULL, V85, P287, DOI 10.1016/j.marpolbul.2014.05.049
   Ali M., 2005, J AQUAT RES, V31, P261
   Badawy Mohamed I., 1997, International Journal of Environmental Health Research, V7, P161
   Barus V, 2007, PARASITOL RES, V100, P929, DOI 10.1007/s00436-006-0384-8
   Baylis H. A., 1923, Parasitology Cambridge, V15, P1
   Baylis H. A., 1947, Annals & Magazine of Natural History Series 11, V14, P123
   Bilqees Fatima Mujib, 2004, Proceedings of Parasitology, V38, P63
   Bleeker P., 1858, VERHANDELINGEN KONIN, V4
   Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227
   Coetzee L, 2002, WATER SA, V28, P433
   Courtney-Hogue C, 2016, PARASITOLOGY, V143, P794, DOI 10.1017/S003118201600038X
   de Chambrier A, 2004, SYST PARASITOL, V57, P97, DOI 10.1023/B:SYPA.0000013859.16345.24
   Demirezen D, 2006, MEAT SCI, V74, P255, DOI 10.1016/j.meatsci.2006.03.012
   Dick T. A., 1995, FISH DIS DISORDERS, V1, P391
   Dural M, 2011, ENVIRON MONIT ASSESS, V174, P147, DOI 10.1007/s10661-010-1445-0
   Eissa JAM, 2010, J AGR VET SCI, V3, P21
   El-Seify M.A., 1997, EGYPTIAN J AQUATIC B, V1, P431
   Fritsch G., 1886, SITZUNGSBERICHTE AKA, V6, P99
   Gedoeist L., 1916, REV ZOOL AFRIC S, P1
   Gmelin J.F., 1789, FISHES, V1, P3
   HAFSTEINSSON H, 1987, J FOOD PROTECT, V50, P70
   Hoffman G.L., 1970, PARASITE N AM FRESH, P480
   Ibrahim A.M., 1999, Journal of the Egyptian German Society of Zoology, V29, P43
   Innes W.T., 1966, EXOTIC AQUARIUM FISH
   Khaleghzadeh-Ahangar H, 2011, PARASITOLOGY, V138, P1400, DOI 10.1017/S0031182011000977
   Khalil L.F., 1997, CHECKLIST HELMINTH P, P185
   Khallaf Elsayed A., 1998, Journal of the Egyptian German Society of Zoology, V26, P39
   Klimpel S, 2011, PARASITOL RES, V108, P1047, DOI 10.1007/s00436-010-2168-4
   La Rue G.R., 1911, ZOOL ANZ, V38, P473
   Mazhar R, 2014, PARASITOL RES, V113, P3737, DOI 10.1007/s00436-014-4039-x
   Nachev M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-21
   Nybelin O., 1942, BIHANG TILL GOTEBO B, V1, P1
   Page A.L., 1982, AM SOC AGRONOMY, P8
   Palikova M, 2003, ACTA VET BRNO, V72, P289, DOI 10.2754/avb200372020289
   POURANG N, 1995, ENVIRON MONIT ASSESS, V35, P207, DOI 10.1007/BF00547632
   Pradit S, 2016, B ENVIRON CONTAM TOX, V96, P472, DOI 10.1007/s00128-015-1717-z
   RADWAN S, 1990, SCI TOTAL ENVIRON, V96, P121, DOI 10.1016/0048-9697(90)90012-J
   Railliet A., 1905, Compte Rendu de la Societe de Biologie Paris, V58
   Rego A.A., 1994, P257
   Schludermann C, 2003, PARASITOLOGY, V126, pS61, DOI 10.1017/S0031182003003743
   Shakweer L.M., 1998, Journal of the Egyptian German Society of Zoology, V25, P125
   SPRENT JFA, 1990, SYST PARASITOL, V16, P149, DOI 10.1007/BF00009613
   Sures B, 1999, ENVIRON TOXICOL CHEM, V18, P2574, DOI 10.1897/1551-5028(1999)018<2574:COEITZ>2.3.CO;2
   Tenora F, 2000, HELMINTHOLOGIA, V37, P15
   Torres J, 2015, J AGR FOOD CHEM, V63, P9349, DOI 10.1021/acs.jafc.5b03886
   UNEP/FAO/IOC/IAEA, 1984, REVIEW, V2, P19
   USEPA, 1986, 4401586001 USEPA
   Vidal-Martinez VM, 2010, TRENDS PARASITOL, V26, P44, DOI 10.1016/j.pt.2009.11.001
   WHO-IPCS-Environmental Health, 1987, INT PROGR CHEM SAF
   Woo P.T.K., 1995, FISH DIS DISORDERS
   Yamaguti S., 1961, SYSTEMA HELIMINTHU 1
   Yamaguti S., 1961, SYSTEMA HELMINTHUM 2, VIII
   YAMAGUTI SATY, 1941, JAP JOUR ZOOL, V9, P343
   Yilmaz AB, 2005, TURK J VET ANIM SCI, V29, P257
NR 59
TC 0
Z9 0
U1 7
U2 7
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1230-2821
EI 1896-1851
J9 ACTA PARASITOL
JI Acta Parasitolog.
PD JUN
PY 2017
VL 62
IS 2
BP 319
EP 335
DI 10.1515/ap-2017-0040
PG 17
WC Parasitology
SC Parasitology
GA ES8QA
UT WOS:000399820700010
PM 28426422
OA No
DA 2017-08-17
ER

PT J
AU Abdelaal, MMO
   Brennan, GP
   Hanna, REB
   Abdel-Aziz, A
   Fairweather, I
AF Abdelaal, Mohamed M. O.
   Brennan, Gerard P.
   Hanna, Robert E. B.
   Abdel-Aziz, Ahmed
   Fairweather, Ian
TI Disruption of egg production by triclabendazole-resistant Fasciola
   hepatica following treatment with a commercial preparation of myrrh
   (Mirazid)
SO ACTA PARASITOLOGICA
LA English
DT Article
DE Fasciola hepatica; liver fluke; Mirazid; in vitro; transmission electron
   microscopy; histology; vitellaria; ovary; uterus; Mehlis' gland; egg
   production
ID TREATMENT IN-VIVO; LIVER FLUKE; VITELLINE CELLS; ELECTRON-MICROSCOPE;
   REPRODUCTIVE-SYSTEM; COMMIPHORA MOLMOL; NATURAL-PRODUCTS; COMPOUND
   ALPHA; SCENTED MYRRH; VOLATILE OIL
AB An in vitro study has been carried out to monitor changes to the female reproductive system in adult triclabendazole (TCBZ)resistant Fasciola hepatica following treatment with a commercial preparation of myrrh ("Mirazid"). Flukes were immersed for 6 h and 24 h in myrrh extract at a concentration of 200 mu g/ml, then processed for histological and transmission electron microscope (TEM) examination of the uterus, Mehlis' gland, ovary and vitellaria. Egg production had become abnormal at 6 h post-treatment (pt), with the uterine lumen being filled with free vitelline cells and masses of shell protein material; few eggs were present. At 24 h pt, no eggs were present. Distinct changes to the ovary and Mehlis' gland were only observed after 24 h incubation in Mirazid. The ovary contained numbers of apoptotic oogonia and oocytes. In the Mehlis' gland, the S1 cells were disorganised and the processes from them were vacuolated, although the disruption was not significant. More severe changes were observed in the vitelline cells and follicles. After 6 h incubation in Mirazid, although the gross organisation of the vitelline follicles appeared to be normal, nuclear changes indicative of the early stages of apoptosis were observed in the stem cells and shell protein production by the mature cells had decreased. At 24 h pt, a distinct shift in cell population was evident, with the follicles containing mainly mature cells and spaces were present between the cells. The shell globule clusters in the mature cells were disorganised. In more severely-affected follicles, cells were seen to be breaking down, with karyolytic nuclei and disintegrating cytoplasm. Overall, the results have shown that exposure to Mirazid treatment had a severe impact on egg production by TCBZ-resistant flukes, an effect that was mediated by disruption of the vitelline cells and of the mechanism co-ordinating egg formation in the ootype.
C1 [Abdelaal, Mohamed M. O.; Abdel-Aziz, Ahmed] Al Azhar Univ, Fac Sci, Dept Zool, Cairo, Egypt.
   [Abdelaal, Mohamed M. O.; Brennan, Gerard P.; Fairweather, Ian] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Parasite Therapeut Res Grp, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
   [Hanna, Robert E. B.] AFBI, Vet Sci Div, Belfast BT4 3SD, Antrim, North Ireland.
RP Fairweather, I (reprint author), Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Parasite Therapeut Res Grp, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM i.fairweather@qub.ac.uk
FU Egyptian Government
FX Mohamed Abdelaal was a Visiting Research Associate at The Queen's
   University of Belfast. He was in receipt of an Egyptian Government
   Scholarship under the Channel Scheme.
CR Abdelaal M.M.O., 2016, J HELMINATHOLOGY, V91, P1, DOI [10.1017/S0022149X16000705, DOI 10.1017/S0022149X16000705]
   Abdul-Ghani RA, 2009, PARASITOL INT, V58, P210, DOI 10.1016/j.parint.2009.04.006
   Abo-Madyan Ahmed A., 2004, Journal of the Egyptian Society of Parasitology, V34, P423
   Abo-Madyan Ahmed A., 2004, Journal of the Egyptian Society of Parasitology, V34, P807
   Andersson M, 1997, PLANTA MED, V63, P251, DOI 10.1055/s-2006-957665
   Ashrafi K, 2014, TRAVEL MED INFECT DI, V12, P636, DOI 10.1016/j.tmaid.2014.09.006
   Badria F, 2001, PHARM BIOL, V39, P127, DOI 10.1076/phbi.39.2.127.6253
   Basyoni MMA, 2013, KOREAN J PARASITOL, V51, P297, DOI 10.3347/kjp.2013.51.3.297
   Bjorkman N., 1964, Z ZELLFORSCHUNG MIKR
   Botros S, 2004, AM J TROP MED HYG, V71, P206
   Botros S., 2005, J TROPICAL MED HOUSE
   Botros SS, 2009, ANN TROP MED PARASIT, V103, P605, DOI 10.1179/000349809X12459740922453
   Chin YW, 2006, AAPS J, V8, pE239
   CLAESON P, 1991, PLANTA MED, V57, P352, DOI 10.1055/s-2006-960116
   Colhoun LM, 1998, PARASITOLOGY, V116, P555, DOI 10.1017/S0031182098002662
   Cragg GM, 2014, J NAT PROD, V77, P703, DOI 10.1021/np5000796
   Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008
   DAWES B, 1966, NATURE, V209, P424, DOI 10.1038/209424a0
   Dawes B., 1967, HELMINTHOLOGIA, V8, P97
   Dawes B, 1966, HELMINTHOLOGIA
   Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026
   EL Ashry ESH, 2003, PHARMAZIE, V58, P163
   El-Malky MA, 2013, PARASITOL RES, V112, P373, DOI 10.1007/s00436-012-3145-x
   FAIRWEATHER I, 1988, INT J PARASITOL, V18, P1061, DOI 10.1016/0020-7519(88)90076-8
   Fairweather I, 2012, VET PARASITOL, V183, P249, DOI 10.1016/j.vetpar.2011.07.023
   Fairweather I, 2011, VET PARASITOL, V176, P1, DOI 10.1016/j.vetpar.2010.12.011
   Fairweather I, 1999, FASCIOLOSIS, P47
   Fathy Fouad M., 2011, Journal of the Egyptian Society of Parasitology, V41, P155
   GRESSON RAR, 1964, Q J MICROSC SCI, V105, P213
   Halferty L, 2009, VET PARASITOL, V159, P126, DOI 10.1016/j.vetpar.2008.10.007
   Hamed MA, 2005, MEM I OSWALDO CRUZ, V100, P771, DOI 10.1590/S0074-02762005000700017
   Hammond JA, 1997, VET RES COMMUN, V21, P213, DOI 10.1023/A:1005884429253
   Hanna REB, 2008, VET PARASITOL, V157, P222, DOI 10.1016/j.vetpar.2008.07.022
   Hanna REB, 2006, VET PARASITOL, V142, P78, DOI 10.1016/j.vetpar.2006.06.025d
   Hanna REB, 2015, VET PARASITOL, V207, P34, DOI 10.1016/j.vetpar.2014.11.016
   Hanna REB, 2013, VET PARASITOL, V191, P240, DOI 10.1016/j.vetpar.2012.09.014
   Hanna REB, 2012, VET PARASITOL, V184, P341, DOI 10.1016/j.vetpar.2011.08.023
   Hanna REB, 2010, VET PARASITOL, V168, P240, DOI 10.1016/j.vetpar.2009.11.014
   Hanna R, 2015, PATHOGENS, V4, P431, DOI 10.3390/pathogens4030431
   HAPPICH FA, 1969, AUST VET J, V45, P329, DOI 10.1111/j.1751-0813.1969.tb05012.x
   Haridy Fouad M, 2003, J Egypt Soc Parasitol, V33, P917
   Haridy Fouad M., 2006, Journal of the Egyptian Society of Parasitology, V36, P259
   Haridy Fouad M., 2004, Journal of the Egyptian Society of Parasitology, V34, P775
   Hassan Mohsen, 2003, J Egypt Soc Parasitol, V33, P999
   IRWIN SWB, 1972, EXP PARASITOL, V31, P321, DOI 10.1016/0014-4894(72)90093-8
   IRWIN SWB, 1970, EXP PARASITOL, V28, P399, DOI 10.1016/0014-4894(70)90108-6
   Kayser O, 2003, PARASITOL RES, V90, pS55, DOI 10.1007/s00436-002-0768-3
   Keiser J, 2005, EMERG INFECT DIS, V11, P1507
   Massoud A, 2001, AM J TROP MED HYG, V65, P96
   Massoud A. M., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P875, DOI 10.1016/S2221-1691(12)60246-9
   Massoud Ahmad Mohamed, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P501, DOI 10.1016/S2221-1691(13)60104-5
   Massoud Ahmed M A, 2004, J Egypt Soc Parasitol, V34, P1051
   McConville M, 2012, VET PARASITOL, V187, P183, DOI 10.1016/j.vetpar.2011.12.028
   Ndjonka D, 2013, INT J MOL SCI, V14, P3395, DOI 10.3390/ijms14023395
   Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s
   O'Neill JF, 2015, VET PARASITOL, V211, P182, DOI 10.1016/j.vetpar.2015.05.027
   Ramzy F, 2010, PHARM BIOL, V48, P775, DOI 10.3109/13880200903074635
   Robinson MW, 2001, PARASITOLOGY, V123, P509, DOI 10.1017/S0031182001008630
   Sheir Z, 2001, AM J TROP MED HYG, V65, P700
   Shen T, 2012, J ETHNOPHARMACOL, V142, P319, DOI 10.1016/j.jep.2012.05.025
   SKUCE PJ, 1988, EXP PARASITOL, V65, P20, DOI 10.1016/0014-4894(88)90103-8
   SKUCE PJ, 1990, PARASITOL RES, V76, P241, DOI 10.1007/BF00930821
   Soliman Othman E., 2004, Journal of the Egyptian Society of Parasitology, V34, P941
   STAMMERS BM, 1976, RES VET SCI, V20, P174
   STAMMERS BM, 1975, Z PARASITENKD, V46, P153, DOI 10.1007/BF00389956
   Stitt AW, 1996, PARASITOL RES, V82, P333, DOI 10.1007/s004360050122
   Tagboto S., 2001, ADV PARASIT, V50, P198
   Thorsell W., 1965, EXPT PARASITOLOGY, V54, P352
   THREADGOLD LT, 1970, Z PARASITENK, V35, P16
   Toner E, 2008, PARASITOLOGY, V135, P1189, DOI 10.1017/S0031182008004630
   Toner E, 2011, VET PARASITOL, V177, P79, DOI 10.1016/j.vetpar.2010.11.032
   Vissiennon C, 2015, PLANTA MED, V81, P116, DOI 10.1055/s-0034-1383391
NR 72
TC 0
Z9 0
U1 2
U2 2
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1230-2821
EI 1896-1851
J9 ACTA PARASITOL
JI Acta Parasitolog.
PD JUN
PY 2017
VL 62
IS 2
BP 336
EP 347
DI 10.1515/ap-2017-0041
PG 12
WC Parasitology
SC Parasitology
GA ES8QA
UT WOS:000399820700011
PM 28426420
OA No
DA 2017-08-17
ER

PT J
AU Abdel-Gaber, R
   Abdel-Ghaffar, F
   Kamel, R
   Maher, S
   El Deeb, N
   Al Quraishy, S
   Mehlhorn, H
AF Abdel-Gaber, Rewaida
   Abdel-Ghaffar, Fathy
   Kamel, Reem
   Maher, Sherein
   El Deeb, Nashwa
   Al Quraishy, Saleh
   Mehlhorn, Heinz
TI Morphological description of Cosmocerca sp (Nematoda: Cosmocerdidae)
   from the Mascarene grass frog Ptychadena cf. mascareniensis (Amphibia:
   Ptychadenidae). A light and scanning electron microscopic studies
SO ACTA PARASITOLOGICA
LA English
DT Article
DE Amphibians; Ptychadena cf. mascareniensis; Cosmocercids; morphological
   description
ID PAPUA-NEW-GUINEA; AQUATIC EUTROPHICATION; TREMATODE INFECTION; LAND-USE;
   HELMINTHS; AMPHIBIANS; PARASITES; ANURA; MICROHYLIDAE; GEKKONIDAE
AB The Mascarene grass frog Ptychadena cf. mascareniensis is a species of frog with a vast area of distribution in Africa. A total of 300 frog specimens were collected from different localities at El-Giza province, Egypt; then dissected and examined for the presence of parasitic infection. Only eighty six (28.66%) specimens were found to be naturally infected with nematode parasite. Seasonally, the prevalence of infection was reached its maximum value of 74.66% during summer and minimum values of 26.66% (20/75), 13.33% (10/75) during spring and autumn, respectively; while no records were observed during winter season. The morphology of the recovered parasite was studied by using light and scanning electron microscopy. The adult worm characterized by anterior extremity with small mouth opening being surrounded by three lips provided with four sub-median cephalic papillae and one pair of lateral amphids. Body measurements showed that male worms were smaller than females measuring 1.22-2.43 (2.21 +/- 0.1) mm in length and 0.21-0.34 (0.29 +/- 0.01) mm in width. Females measured 1.9-3.7 (2.8 +/- 0.1) mm in length and 0.24-0.42 (0.38 +/- 0.01) mm in width. Comparing the present parasite with other species of the same genus described previously, several similarities were observed. However, peculiar new characteristics such as the arrangement of plectanes and somatic papillae, the presence of gubernaculum, the position of nerve ring, excretory pore, and vulval opening make it reasonable belongs to the family Cosmocercidae and identified as Cosmocerca sp. In addition, the present study was the first report for occurrence of cosmocercid species from the Mascarene grass frog in Egypt.
C1 [Abdel-Gaber, Rewaida; Abdel-Ghaffar, Fathy] Cairo Univ, Dept Zool, Fac Sci, Cairo, Egypt.
   [Kamel, Reem; Maher, Sherein; El Deeb, Nashwa] Ain Shams Univ, Fac Women Arts Sci & Educ, Zool Dept, Heliopolis, Egypt.
   [El Deeb, Nashwa] Taibah Univ, Fac Sci Yanbu, Biol Dept, Medina, Saudi Arabia.
   [Al Quraishy, Saleh] King Saud Univ, Dept Zool, Coll Sci, Riyadh, Saudi Arabia.
   [Mehlhorn, Heinz] Dusseldorf Univ, Parasitol Inst, Dusseldorf, Germany.
RP Abdel-Gaber, R (reprint author), Cairo Univ, Dept Zool, Fac Sci, Cairo, Egypt.
EM rewaida@sci.cu.edu.eg
FU Deanship of Scientific Research at King Saud University [PRG-1436-02]
FX The authors are thankful to the Faculty of Science, Cairo University,
   Cairo, Egypt, for providing all the facilities to complete this work.
   Also, authors extend their appreciation to The Deanship of Scientific
   Research at King Saud University for funding the work through the
   international research group project PRG-1436-02.
CR Abdel-Ghaffar F., 2016, EGYPTIAN PARASITOLOG, V116, P133, DOI 10.1007/s00436-016-5269-x
   Aisien SO, 2004, AFR ZOOL, V39, P133
   Assemian N.E, 2016, INT J INFORM RES REV, V3, P1717
   Baker M.R., 1987, OCCASIONAL PAPERS BI, V11
   Boquimpani-Freitas L, 2001, J HELMINTHOL, V75, P233
   Bursey CR, 2015, ACTA PARASITOL, V60, P675, DOI 10.1515/ap-2015-0096
   Bursey CR, 2013, ACTA PARASITOL, V58, P26, DOI 10.2478/s11686-013-0101-6
   Bursey CR, 2001, COMP PARASITOL, V68, P21
   Bursey CR, 2005, J PARASITOL, V91, P882, DOI 10.1645/GE-3450.1
   Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227
   Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6
   Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x
   Diesing K., 1861, SITZUNGSBERICHTE MN, V42, P595
   Duellman W E, 1986, BIOL AMPHIBIANS
   Dumeril A.M.C., 1841, ERPETOLOGIE GEN HIST, V8
   DURETTE-DESSET M-C, 1974, Annales de Parasitologie Humaine et Comparee, V49, P567
   Gonzalez CE, 2008, REV BIOL TROP, V56, P2147
   Frost D. R., 2007, AMPHIBIAN SPECIES WO
   GASSMANN M, 1975, Annales de Parasitologie Humaine et Comparee, V50, P559
   Goldberg SR, 2007, COMP PARASITOL, V74, P327, DOI 10.1654/4268.1
   Gonzalez C. E., 2009, NEOTROPICAL HELMINTH, V6, P9
   Gray MJ, 2007, HERPETOL CONSERV BIO, V2, P23
   Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650
   Hoff G., 1984, DIS AMPHIBIANS REPTI
   Johnson PTJ, 2007, P NATL ACAD SCI USA, V104, P15781, DOI 10.1073/pnas.0707763104
   Johnson PTJ, 2004, ECOL LETT, V7, P521, DOI 10.1111/j.1461-0248.2004.00610.x
   Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802
   Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899
   Kirin Diana, 2002, Experimental Pathology and Parasitology, V5, P13
   Kung C. C., 1945, SINENSIA, V16, P78
   MARTINEZ SA, 1989, P HELM SOC WASH, V56, P97
   McAllister CT, 2004, COMP PARASITOL, V71, P61, DOI 10.1654/4076
   Mohammad Mohammad K., 2010, Egyptian Academic Journal of Biological Sciences B Zoology, V2, P17
   MORAVEC F, 1987, FOLIA PARASIT, V34, P255
   MORAVEC F, 1985, Parasitologia Hungarica, V18, P63
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Railliet A., 1916, RECUEIL MED VET, V92, P426
   Rizvi AN, 2011, ACTA PARASITOL, V56, P202, DOI 10.2478/s11686-011-0028-8
   Saad Atef I., 2009, World Journal of Zoology, V4, P29
   SESSIONS SK, 1990, J EXP ZOOL, V254, P38, DOI 10.1002/jez.1402540107
   Sou SK, 2015, ACTA PARASITOL, V60, P261, DOI 10.1515/ap-2015-0037
   Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538
   Tkach VV, 2006, J PARASITOL, V92, P631, DOI 10.1645/GE-625R.1
   TRAVASSOS L., 1925, SCI MED, V3, P673
   Yildirimhan HS, 2006, COMP PARASITOL, V73, P237, DOI 10.1654/4191.1
NR 45
TC 0
Z9 0
U1 2
U2 2
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1230-2821
EI 1896-1851
J9 ACTA PARASITOL
JI Acta Parasitolog.
PD JUN
PY 2017
VL 62
IS 2
BP 449
EP 458
DI 10.1515/ap-2017-0052
PG 10
WC Parasitology
SC Parasitology
GA ES8QA
UT WOS:000399820700022
PM 28426400
OA No
DA 2017-08-17
ER

PT J
AU Abumandour, MMA
   El-Bakary, NER
AF Abumandour, Mohamed M. A.
   El-Bakary, Neveen E. R.
TI Morphological features of the tongue and laryngeal entrance in two
   predatory birds with similar feeding preferences: common kestrel (Falco
   tinnunculus) and Hume's tawny owl (Strix butleri)
SO ANATOMICAL SCIENCE INTERNATIONAL
LA English
DT Article
DE Anatomy; Scanning electron microscopy; Tongue; Common kestrel; Hume's
   tawny owl
ID EMU DROMAIUS-NOVAEHOLLANDIAE; COTURNIX-COTURNIX-JAPONICA; BAT
   ROUSETTUS-AEGYPTIACUS; FINE-STRUCTURE; FUNCTIONAL-MORPHOLOGY;
   HALCYON-SMYRNENSIS; LINGUAL PAPILLAE; SALIVARY-GLANDS; CAMELUS TONGUE;
   LIGHT
AB The aim of this investigation was to describe the morphological characters of the tongue of two predatory birds with similar feeding preferences, i.e. the common kestrel and Hume's tawny owl. Descriptive information on the lingual morphology of these two birds, particularly Hume's tawny owl, is incomplete. We found that the lingual apex of the owl has an oval, concave, shovel-like form with a bifid lingual tip, while that of the kestrel has the shape of a horny tip-like spoon with a central process in addition to there being several filiform-like papillae on the dorsal surface of the apex and body. In the owl, the dorsal surface of the apex and body is subdivided into four U-shaped regions: lingual tip, two lateral regions and a median region. The two lateral regions are characterized by the presence of papillae and several openings of lingual glands, while the median region carries filiform-like papillae. In both birds, the papillary crest is located between the body and root. In the kestrel, there is an additional row of papillae rostral to crest, while in the owl there is a rostral lateral extension of papillae on the lateral lingual surface so the distribution pattern has a W-shape. In the kestrel, the posterior part of lingual body has several openings of glands, while the root lacks glands completely, although it has many taste buds. In the owl, the lingual root is folded and has a large number of gland openings. In the kestrel caudally to the glottis, there are two paramedian transverse rows of pharyngeal papillae with a pair of median huge papillae, while in the owl, there is only one transverse row of papillae. The dorsal and ventral lingual surfaces of both birds are lined with non-keratinized stratified squamous epithelium.
C1 [Abumandour, Mohamed M. A.] Alexandria Univ, Dept Anat & Embryol, Fac Vet Med, Edfina 22785, Behera, Egypt.
   [El-Bakary, Neveen E. R.] Damietta Univ, Dept Zool, Fac Sci, Dumyat, Egypt.
RP Abumandour, MMA (reprint author), Alexandria Univ, Dept Anat & Embryol, Fac Vet Med, Edfina 22785, Behera, Egypt.
EM m.abumandour@yahoo.com
CR Abou-Zaid DF, 2008, EGYPT J EXP BIOL ZOO, V4, P65
   Abumandour MMA, 2014, J LIFE SCI RES, V1, P80
   Abumandour MMA, 2014, INT J MORPHOL, V32, P1407, DOI 10.4067/S0717-95022014000400045
   Abumandour M, 2013, VET RES COMMUN, V37, P229, DOI 10.1007/s11259-013-9567-9
   Al-Zahaby SA, 2014, J BASIC APPL ZOOL, V67, P91
   Baumel J, 1993, HDB AVIAN ANATOMY NO
   Capacchietti M, 2009, HISTOL HISTOPATHOL, V24, P1087, DOI 10.14670/HH-24.1087
   Crole MR, 2009, ONDERSTEPOORT J VET, V76, P335
   Crole MR, 2009, ONDERSTEPOORT J VET, V76, P347
   Crole MR, 2010, ANAT HISTOL EMBRYOL, V39, P355, DOI 10.1111/j.1439-0264.2010.01002.x
   Crole MR, 2010, ANAT HISTOL EMBRYOL, V39, P207, DOI 10.1111/j.1439-0264.2010.00998.x
   Dehkordi RAF, 2010, SLOV VET RES, V47, P139
   Del Hoyo J, 2004, HDB BIRDS WORLD
   El-Bakary Neveen E.R., 2012, Global Veterinaria, V9, P192
   El-Bakary Neveen E.R., 2011, Journal of American Science, V7, P394
   El-Beltagy Abd El-Fattah B.M., 2013, Egyptian Academic Journal of Biological Sciences D Histology & Histochemistry, V4, P1
   Emura S, 2008, ANAT HISTOL EMBRYOL, V37, P475, DOI 10.1111/j.1439-0264.2008.00871.x
   Emura S., 2009, MED BIOL, V153, P423
   Emura S, 2001, MAMMALIAN SCI, V41, P187
   Emura Shoichi, 2012, Okajimas Folia Anatomica Japonica, V89, P57
   Emura Shoichi, 2011, Okajimas Folia Anatomica Japonica, V88, P17
   Emura Shoichi, 2009, Okajimas Folia Anatomica Japonica, V86, P31
   Emura Shoichi, 2008, Acta Anatomica Nipponica, V83, P77
   Emura Shoichi, 2009, Okajimas Folia Anatomica Japonica, V86, P1
   Emura Shoichi, 2008, Okajimas Folia Anatomica Japonica, V85, P11, DOI 10.2535/ofaj.85.11
   Erdogan S, 2012, BRIT POULTRY SCI, V53, P307, DOI 10.1080/00071668.2012.700507
   Erdogan S, 2015, ACTA ZOOL-STOCKHOLM, V96, P264, DOI 10.1111/azo.12075
   Erdogan S, 2014, ANN ANAT, V196, P75, DOI 10.1016/j.aanat.2013.09.005
   Erdogan S, 2012, MICROSC RES TECHNIQ, V75, P1245, DOI 10.1002/jemt.22057
   Erdogan S, 2012, MICROSC RES TECHNIQ, V75, P379, DOI 10.1002/jemt.21067
   Guimaraes JP, 2009, ZOOL SCI, V26, P153, DOI 10.2108/zsj.26.153
   Gussekloo SWS, 2005, J EXP BIOL, V208, P3395, DOI 10.1242/jeb.01769
   Iwasaki S, 1997, ANAT REC, V247, P149, DOI 10.1002/(SICI)1097-0185(199702)247:2<149::AID-AR1>3.0.CO;2-T
   IWASAKI S, 1992, J MORPHOL, V212, P13, DOI 10.1002/jmor.1052120103
   Iwasaki S, 2002, J ANAT, V201, P1, DOI 10.1046/j.1469-7580.2002.00073.x
   IWASAKI S-I, 1986, Acta Anatomica Nipponica, V61, P83
   Jackowiak H, 2006, ZOOL SCI, V23, P161, DOI 10.2108/zsj.23.161
   Jackowiak H, 2005, ANN ANAT, V187, P251, DOI 10.1016/j.aanat.2004.11.003
   Jackowiak H., 2014, ACTA ZOOLOGICA, V96, P436
   Jackowiak H, 2008, ZOOL SCI, V25, P188, DOI 10.2108/zsj.25.188
   Jackowiak H, 2011, ANAT REC, V294, P1574, DOI 10.1002/ar.21447
   Jackowiak H, 2010, ZOOL SCI, V27, P589, DOI 10.2108/zsj.27.589
   King A. S., 1984, BIRDS THEIR STRUCTUR
   Kobayashi K, 1998, ARCH HISTOL CYTOL, V61, P37, DOI 10.1679/aohc.61.37
   Liman N, 2001, ANAT HISTOL EMBRYOL, V30, P367, DOI 10.1046/j.1439-0264.2001.00353.x
   Onuk B, 2013, ACTA ZOOL-STOCKHOLM, V96, P60
   Parchami A., 2011, Middle East Journal of Scientific Research, V7, P81
   Parchami A., 2010, World Journal of Zoology, V5, P257
   Parchami A., 2010, World Applied Sciences Journal, V10, P1185
   Rico-Guevara A, 2011, P NATL ACAD SCI USA, V108, P9356, DOI 10.1073/pnas.1016944108
   Samar M. E., 1995, MAR ORNITHOL, V23, P154
   Santos TC, 2011, ZOOL SCI, V28, P41, DOI 10.2108/zsj.28.41
   Shindo Junji, 2006, Okajimas Folia Anatomica Japonica, V82, P127, DOI 10.2535/ofaj.82.127
   Suvarna S.K., 2013, BANCROFTS THEORY PRA
   Tomlinson CAB, 2000, FEEDING FORM FUNCTIO, P359
   Tutuncu S, 2012, KAFKAS UNIV VET FAK, V18, P623
   Ziswiler V, 1972, AVIAN BIOL, P344
NR 57
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1447-6959
EI 1447-073X
J9 ANAT SCI INT
JI Anat. Sci. Int.
PD JUN
PY 2017
VL 92
IS 3
BP 352
EP 363
DI 10.1007/s12565-016-0339-9
PG 12
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA ES9MK
UT WOS:000399882900007
PM 27084364
OA No
DA 2017-08-17
ER

PT J
AU Lyu, S
   Arends, D
   Nassar, MK
   Brockmann, GA
AF Lyu, S.
   Arends, D.
   Nassar, M. K.
   Brockmann, G. A.
TI Fine mapping of a distal chromosome 4 QTL affecting growth and muscle
   mass in a chicken advanced intercross line
SO ANIMAL GENETICS
LA English
DT Article
DE association analysis; body composition; bone mass; New Hampshire; single
   nucleotide polymorphism; White Leghorn
ID MEAT QUALITY TRAITS; DNA-SEQUENCING DATA; EGG-PRODUCTION; NEW-HAMPSHIRE;
   BODY-WEIGHT; LOCI; ASSOCIATION; GENERATION; CD38; POLYMORPHISMS
AB In our previous research, QTL analysis in an F-2 cross between the inbred New Hampshire (NHI) and White Leghorn (WL77) lines revealed a growth QTL in the distal part of chromosome 4. To physically reduce the chromosomal interval and the number of potential candidate genes, we performed fine mapping using individuals of generations F-10, F-11 and F-12 in an advanced intercross line that had been established from the initial F-2 mapping population. Using nine single nucleotide polymorphism (SNP) markers within the QTL region for an association analysis with several growth traits from hatch to 20weeks and body composition traits at 20weeks, we could reduce the confidence interval from 26.9 to 3.4Mb. Within the fine mapped region, markers rs14490774, rs314961352 and rs318175270 were in full linkage disequilibrium (D=1.0) and showed the strongest effect on growth and muscle mass (LOD4.00). This reduced region contains 30 genes, compared to 292 genes in the original region. Chicken 60K and 600K SNP chips combined with DNA sequencing of the parental lines were used to call mutations in the reduced region. In the narrowed-down region, 489 sequence variants were detected between NHI and WL77. The most deleterious variants are a missense variant in ADGRA3 (SIFT=0.02) and a frameshift deletion in the functional unknown gene ENSGALG00000014401 in NHI chicken. In addition, five synonymous variants were discovered in genes PPARGC1A, ADGRA3, PACRGL, SLIT2 and FAM184B. In our study, the confidence interval and the number of potential genes could be reduced 8- and 10- fold respectively. Further research will focus on functional effects of mutant genes.
C1 [Lyu, S.; Arends, D.; Nassar, M. K.; Brockmann, G. A.] Humboldt Univ, Albrecht Daniel Thaer Inst Agr & Hort Sci, Invalidenstr 42, D-10115 Berlin, Germany.
   [Nassar, M. K.] Cairo Univ, Dept Anim Prod, Fac Agr, El Gamma Str 6, Giza 12613, Egypt.
RP Brockmann, GA (reprint author), Humboldt Univ, Albrecht Daniel Thaer Inst Agr & Hort Sci, Invalidenstr 42, D-10115 Berlin, Germany.
EM gudrun.brockmann@agrar.hu-berlin.de
FU German Federal Ministry of Education and Research [FKZ 0315528E]; China
   Scholarship Council [201408410049]
FX The genotyping results by Affymetrix Axiom (R) Genome-Wide Chicken
   Genotyping Array were provided by the SYNBREED project, which was
   supported by the German Federal Ministry of Education and Research (FKZ
   0315528E). Shijie Lyu thanks the China Scholarship Council (No.
   201408410049) for fellowship support. We acknowledge Annett Kannegiesser
   of the Experimental Animal Facility at Humboldt-Universitat zu Berlin
   for assistance in data collection.
CR Al-Mamun HA, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0142-4
   Bates D, 2015, J STAT SOFTW, V67, P1
   Besnier F, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-3
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Drummond FJ, 2006, J BONE MINER METAB, V24, P28, DOI 10.1007/s00774-005-0642-3
   Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476
   Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1
   Felicio AM, 2013, GENET MOL RES, V12, P208, DOI 10.4238/2013.January.24.13
   Gandolfi G, 2011, MEAT SCI, V89, P478, DOI 10.1016/j.meatsci.2011.05.015
   Gonzales NM, 2014, MAMM GENOME, V25, P271, DOI 10.1007/s00335-014-9523-1
   Goraga Z, 2010, ARCH TIERZUCHT, V53, P337
   Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872
   Hoppman N, 2010, BONE, V47, P272, DOI 10.1016/j.bone.2010.04.607
   Howell GR, 2007, GENETICS, V175, P699, DOI 10.1534/genetics.106.065177
   Ishihara K., 2014, MESSENGER, V1, P5
   Karim Baktiar O, 2014, Front Oncol, V4, P323, DOI 10.3389/fonc.2014.00323
   Kreuzer S, 2013, VET MICROBIOL, V162, P293, DOI 10.1016/j.vetmic.2012.07.049
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061172
   Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007
   Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330
   Mehta K, 1996, FASEB J, V10, P1408
   Nassar MK, 2015, ANIM GENET, V46, P441, DOI 10.1111/age.12298
   Nassar MK, 2012, ANIM GENET, V43, P739, DOI 10.1111/j.1365-2052.2012.02344.x
   Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x
   Schmitt AO, 2009, MAMM GENOME, V20, P321, DOI 10.1007/s00335-009-9185-6
   Shi YY, 2005, CELL RES, V15, P97
   Sun L, 2003, FASEB J, V17, P369, DOI 10.1096/fj.02-0205com
NR 31
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-9146
EI 1365-2052
J9 ANIM GENET
JI Anim. Genet.
PD JUN
PY 2017
VL 48
IS 3
BP 295
EP 302
DI 10.1111/age.12532
PG 8
WC Agriculture, Dairy & Animal Science; Genetics & Heredity
SC Agriculture; Genetics & Heredity
GA ET0LE
UT WOS:000399953100005
PM 28124378
OA No
DA 2017-08-17
ER

PT J
AU Mahmoud, MR
   Rashad, GM
   Metwally, E
   Saad, EA
   Elewa, AM
AF Mahmoud, Mamdoh R.
   Rashad, Ghada M.
   Metwally, Essam
   Saad, Ebtissam A.
   Elewa, Ahmed M.
TI Adsorptive removal of Cs-134(+), Co-60(2+) and Eu-152+154(3+)
   radionuclides from aqueous solutions using sepiolite: Single and
   multi-component systems
SO APPLIED CLAY SCIENCE
LA English
DT Article
DE Radionuclide; Sepiolite; Adsorption; Removal; Clay
ID SORPTION; EQUILIBRIUM; EU(III); MONTMORILLONITE; THERMODYNAMICS;
   IMMOBILIZATION; URANIUM(VI); BENTONITE; COMPOSITE; KINETICS
AB Single and multi-component adsorptive removal of Cs-134(+), Co-60(2+) and Eu-152+154(3+) from aqueous solutions onto sepiolite are studied in the present study. Removal of these radionuclides in single systems is found to be strongly dependent on the initial pH on the solution. Removals > 99% (for(60)Co(2+) and 152+154EU3+) and of about 82% (for Cs-134(+)).are achieved at initial pH values higher than 4 and 5, respectively. The kinetic data and the equilibrium isotherms are modeled by two kinetic models, the pseudo-first-order and the pseudo-second-order, and two isotherm models, Langmuir and Freundlich, respectively. The effect of various coexisting cations, Na+, Ca2+ and Al3+, at different concentrations on the adsorption processes of the concerned radionuclides in single systems was evaluated. Desorption studies of radionuclide-loaded sepiolite are studied using different concentrations of organic, EDTA and HA (strong complexing agents for radionuclides), and inorganic, HCI, NaCI, CaCl2, Mg(NO3)(2) and AlCl3, desorbing agents. Adsorption mechanisms of radionuclides onto sepiolite are deeply discussed. Multi-component adsorptive removal of Cs-134(+), Co-60(2+) and Eu-152+154(3+) onto sepiolite as a function of adsorbent weight and time was also studied. The influence of the solution pH on co-removal efficiency of radionuclides was investigated in presence of EDTA. Furthermore, the present investigation evaluated the removal efficiency of radionuclides, in multi-systems, in presence of different concentrations either of NaCI or CaCl2. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Mahmoud, Mamdoh R.; Rashad, Ghada M.; Metwally, Essam; Elewa, Ahmed M.] Atom Energy Author, Nucl Chem Dept, Hot Labs Ctr, POB 13759, Cairo, Egypt.
   [Saad, Ebtissam A.] Ain Shams Univ, Fac Sci, Chem Dept, Cairo, Egypt.
RP Mahmoud, MR (reprint author), Atom Energy Author, Nucl Chem Dept, Hot Labs Ctr, POB 13759, Cairo, Egypt.
EM mamdohrefaat@yahoo.com
CR Bergaya F, 2006, DEV CLAY SCI, V1, P1
   Cobas M, 2014, ECOL ENG, V70, P287, DOI 10.1016/j.ecoleng.2014.06.014
   Dolatyari L, 2016, J TAIWAN INST CHEM E, V60, P174, DOI 10.1016/j.jtice.2015.11.004
   Duman O, 2015, MICROPOR MESOPOR MAT, V210, P176, DOI 10.1016/j.micromeso.2015.02.040
   El Afifi EM, 2016, J ENVIRON RADIOACTIV, V151, P156, DOI 10.1016/j.jenvrad.2015.10.001
   Elzinga EJ, 1999, J COLLOID INTERF SCI, V213, P506, DOI 10.1006/jcis.1999.6161
   Essington M.E., 2004, SOIL WATER CHEM INTE
   Fan QH, 2009, ENVIRON SCI TECHNOL, V43, P5776, DOI 10.1021/es901241f
   Fu RB, 2015, CHEMOSPHERE, V138, P726, DOI 10.1016/j.chemosphere.2015.07.051
   GILES CH, 1960, J CHEM SOC, P3973, DOI 10.1039/jr9600003973
   Hayes K.F., 1996, PHYS CHEM MINER, P147
   Hongxia Z., 2016, APPL CLAY SCI, V127-128, P35
   Huang JY, 2015, J MOL LIQ, V209, P706, DOI 10.1016/j.molliq.2015.05.047
   Kara A, 2016, J ENVIRON CHEM ENG, V4, P1642, DOI 10.1016/j.jece.2016.02.028
   Katz L.E., 2001, SSSA SPEC PUBL, V56
   Metwally SS, 2016, APPL CLAY SCI, V126, P33, DOI 10.1016/j.clay.2016.02.021
   Reinoso-Maset E, 2016, J ENVIRON RADIOACTIV, V157, P136, DOI 10.1016/j.jenvrad.2016.03.014
   Reinoso-Maset E, 2012, ENVIRON POLLUT, V162, P399, DOI 10.1016/j.envpol.2011.11.038
   Santos SCR, 2016, J ENVIRON CHEM ENG, V4, P1473, DOI 10.1016/j.jece.2016.02.009
   Soliman MA, 2015, RADIOCHIM ACTA, V103, P643, DOI 10.1515/ract-2015-2390
   Sparks D.L., 2003, ENV SOIL CHEM
   Sun YB, 2014, GEOCHIM COSMOCHIM AC, V140, P621, DOI 10.1016/j.gca.2014.06.001
   Towle SN, 1997, J COLLOID INTERF SCI, V187, P62, DOI 10.1006/jcis.1996.4539
   Uzal N, 2011, J COLLOID INTERF SCI, V362, P615, DOI 10.1016/j.jcis.2011.06.072
   Wypych F., 2004, CLAY SURFACES FUNDAM, V1, P1, DOI 10.1016/S1573-4285(04)80036-X
   Yu SM, 2016, J TAIWAN INST CHEM E, V59, P221, DOI 10.1016/j.jtice.2015.07.025
   Yu SJ, 2015, J MOL LIQ, V203, P39, DOI 10.1016/j.molliq.2014.12.041
   Zhu YH, 2014, PROG NUCL ENERG, V71, P172, DOI 10.1016/j.pnucene.2013.12.005
   Zhu YK, 2016, J MOL LIQ, V218, P565, DOI 10.1016/j.molliq.2016.01.100
   Zong PF, 2015, J MOL LIQ, V209, P358, DOI 10.1016/j.molliq.2015.05.052
NR 30
TC 0
Z9 0
U1 14
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-1317
EI 1872-9053
J9 APPL CLAY SCI
JI Appl. Clay Sci.
PD JUN
PY 2017
VL 141
BP 72
EP 80
DI 10.1016/j.clay.2016.12.021
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy
SC Chemistry; Materials Science; Mineralogy
GA ES8ZT
UT WOS:000399846400008
OA No
DA 2017-08-17
ER

PT J
AU Omran, EE
AF Omran, El-Sayed Ewis
TI Early sensing of peanut leaf spot using spectroscopy and thermal imaging
SO ARCHIVES OF AGRONOMY AND SOIL SCIENCE
LA English
DT Article
DE Arachis hypogaea; leaf spot; Hyperion image; thermal camera;
   spectroscopy; early detection
ID PRECISION AGRICULTURE; HYPERION DATA; PLANT; EXTRACTION; DISEASES
AB Early and late leaf spot are the most devastating, important fungal foliar diseases affecting peanut. The economic loss caused by peanut diseases justifies the necessity to develop more reliable detection methods. Point and image spectroscopy and thermal imaging were used in this study for the early detection of peanut leaf spot. The spectral reflectance factors differ significantly according to the health condition. The leaves of the healthy peanut showed a decreasing reflection in 1015nm, whereas the heavily diseased leaves showed an increasing reflection. At the thermal infrared range, affected plants show a higher temperature than healthy ones. A presymptomatic decrease in leaf temperature using thermal imagery was found about 1.3 degrees C lower than the healthy leaves. However, the diseased plant's temperature was 2.2 degrees C higher than that of the healthy one. The temperature difference allowed the discrimination between the infected and healthy leaves before the appearance of visible necrosis on leaves. Two simple indices, early leaf spot index (ELSI) and late leaf spot index (LLSI), were developed to allow early prediction of the peanut disease severity. The disease severity estimation using ELSI and LLSI has an overall accuracy of 78% and 89%, respectively. This demonstrates the efficiency of the proposed indices to estimate the peanut disease.
C1 [Omran, El-Sayed Ewis] Suez Canal Univ, Fac Agr, Dept Soil & Water, Ismailia, Egypt.
RP Omran, EE (reprint author), Suez Canal Univ, Fac Agr, Dept Soil & Water, Ismailia, Egypt.
EM e.omran@scuegypt.edu.eg
CR AQUINO VM, 1992, PHYTOPATHOLOGY, V82, P546, DOI 10.1094/Phyto-82-546
   Berk A, 2005, P SOC PHOTO-OPT INS, V5655, P88, DOI 10.1117/12.578758
   Bruce LM, 2006, GISCI REMOTE SENS, V43, P67, DOI 10.2747/1548-1603.43.1.67
   Butler DR, 2000, EXP AGR, V36, P469, DOI 10.1017/S0014479700001046
   Chen B., 2008, COMPUTER COMPUTING T, V2, P1169
   Choi YH, 2004, PLANT PHYSIOL, V135, P2398, DOI 10.1104/pp.104.041012
   EBTP, 2015, EUR BIOF TECHN PLATF
   Fahlgren N, 2015, CURR OPIN PLANT BIOL, V24, P93, DOI 10.1016/j.pbi.2015.02.006
   Falcone J. A., 2005, GEOCARTO INT, V20, P3, DOI DOI 10.1080/10106040508542358
   Goggin FL, 2015, CURR OPIN INSECT SCI, V9, P69, DOI 10.1016/j.cois.2015.03.002
   Hahn F., 2009, ALGORITHMS, V2, P301, DOI DOI 10.3390/A2010301
   JACKSON RD, 1986, ANNU REV PHYTOPATHOL, V24, P265, DOI 10.1146/annurev.py.24.090186.001405
   KRUSE FA, 1993, REMOTE SENS ENVIRON, V44, P145, DOI 10.1016/0034-4257(93)90013-N
   Li LT, 2016, IND CROP PROD, V91, P194, DOI 10.1016/j.indcrop.2016.07.008
   Lins EC, 2009, PRECIS AGRIC, V10, P319, DOI 10.1007/s11119-009-9124-2
   Lucas JA, 1998, PLANT PATHOLOGY PLAN
   MacLeod A, 2004, CROP PROT, V23, P601, DOI 10.1016/j.cropro.2003.11.010
   Mahlein AK, 2016, PLANT DIS, V100, P241, DOI 10.1094/PDIS-03-15-0340-FE
   Mutka AM, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00734
   NILSSON HE, 1995, CAN J PLANT PATHOL, V17, P154
   Omran ESE, 2016, EURASIAN SOIL SCI
   Omran ESE, 2015, EGYPT J SOIL SCI, V55
   Pu RL, 2003, IEEE T GEOSCI REMOTE, V41, P916, DOI 10.1109/TGRS.2003.813555
   Purcell DE, 2009, APPL SPECTROSC, V63, P450, DOI 10.1366/000370209787944370
   Qin JW, 2009, J FOOD ENG, V93, P183, DOI 10.1016/j.jfoodeng.2009.01.014
   Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007
   Schlerf M, 2011, HYPERSPECTRAL DATA A, P79
   Shafri Helmi Zulhaidi Mohd, 2009, American Journal of Applied Sciences, V6, P1031
   Stafford JV, 2000, J AGR ENG RES, V76, P267, DOI 10.1006/jaer.2000.0577
   Thenkabail PS, 2004, REMOTE SENS ENVIRON, V91, P354, DOI 10.1016/j.rse.2004.03.013
   Thenkabail PS, 1999, CEO RES PUBLICATION, VI, P47
   Wahabzada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116902
   Walsh SJ, 2008, REMOTE SENS ENVIRON, V112, P1927, DOI 10.1016/j.rse.2007.06.028
   Xu HR, 2006, PROC SPIE, V6381, DOI 10.1117/12.685534
   Yao X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096352
NR 35
TC 1
Z9 1
U1 13
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0365-0340
EI 1476-3567
J9 ARCH AGRON SOIL SCI
JI Arch. Agron. Soil Sci.
PD JUN
PY 2017
VL 63
IS 7
BP 883
EP 896
DI 10.1080/03650340.2016.1247952
PG 14
WC Agronomy; Soil Science
SC Agriculture
GA ES8HR
UT WOS:000399797600001
OA No
DA 2017-08-17
ER

PT J
AU Abdallah, MA
   Zaky, AH
   Covaci, A
AF Abdallah, Mohamed Abou-Elwafa
   Zaky, Amen Hamdy
   Covaci, Adrian
TI Levels and profiles of organohalogenated contaminants in human blood
   from Egypt
SO CHEMOSPHERE
LA English
DT Article
DE Organohalogen contaminants; OCPs; PBDEs; PCBs; Egyptian blood;
   Colorectal cancer
ID PERSISTENT ORGANIC POLLUTANTS; POLYBROMINATED DIPHENYL ETHERS; MEASURES
   SURVEY CHMS; ORGANOCHLORINE PESTICIDES; SERUM CONCENTRATIONS;
   COLORECTAL-CANCER; FLAME RETARDANTS; POLYCHLORINATED-BIPHENYLS;
   EPIDEMIOLOGIC EVIDENCE; EXTERNAL EXPOSURE
AB Concentrations of polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and some organochlorine pesticides (OCPs) were determined in serum of Egyptian colorectal cancer patients (n = 35) and compared to a healthy control group (n = 32). p,p'-DDE (the major metabolite of DDT) was the most frequently detected contaminant with the highest concentration (median = 131 ng/g lw) in all studied serum samples. BDE-209 was the least frequently detected contaminant with a median concentration <0.3 ng/g lw. The contamination profile in patients and controls was almost identical with p,p'-DDE showing the highest median contribution (77%) and oxychlordane the lowest (1%). The low p,p'-DDT/p,p'-DDE ratio (3.7%) in serum implies bioaccumulation and past exposure to DDT (c.f. recent and ongoing intake). Statistical analysis revealed no significant differences (P>0.05) between the levels of target contaminants in serum of patients and the control group. Gender, age and body mass index (BMI) were investigated as potential factors influencing serum contaminant levels. MDDT, hexachlorobenzene and pentachlorophenol concentrations showed significant positive associations with age and/or BMI of the participants. Comparison with other countries revealed concentrations of PBDEs and PCBs in Egyptian serum among the lowest reported worldwide. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Abdallah, Mohamed Abou-Elwafa] Univ Birmingham, Sch Geog Earth & Environm Sci, Div Environm Hlth & Risk Management, Birmingham B15 2TT, W Midlands, England.
   [Abdallah, Mohamed Abou-Elwafa] Assiut Univ, Dept Analyt Chem, Fac Pharm, Assiut 71526, Egypt.
   [Zaky, Amen Hamdy] Assiut Univ, South Egypt Canc Inst, Med Oncol Dept, Assiut, Egypt.
   [Covaci, Adrian] Univ Antwerp, Toxicol Ctr, Univ Pl 1, B-2610 Antwerp, Belgium.
RP Abdallah, MA (reprint author), Univ Birmingham, Sch Geog Earth & Environm Sci, Div Environm Hlth & Risk Management, Birmingham B15 2TT, W Midlands, England.
EM mae_abdallah@yahoo.co.uk
OI Covaci, Adrian/0000-0003-0527-1136
FU European Union Seventh Framework Programme within the INTERFLAME grant
   [295138]
FX The contribution of AC has received funding from the European Union
   Seventh Framework Programme [FP7/2007-2013] within the INTERFLAME grant
   agreement no. 295138. The authors gratefully acknowledge Wesam M.
   El-Koussi; Sally A. El Zohny and Aml I. Mekawy for their help during
   sample preparation and analysis.
CR Abdallah MA, 2015, ISS ENVIRON SCI TECH, P150
   Abdallah MAE, 2015, ENVIRON INT, V74, P13, DOI 10.1016/j.envint.2014.09.012
   Abdallah MA, 2014, ENVIRON INT, V63, P130, DOI 10.1016/j.envint.2013.11.009
   Abdel-Rahman SZ, 2000, CANCER LETT, V159, P79, DOI 10.1016/S0304-3835(00)00537-1
   AHLBORG UG, 1995, CRIT REV TOXICOL, V25, P463, DOI 10.3109/10408449509017924
   Ahmed MT, 2006, NATO SCI S SS IV EAR, V69, P25
   Ahmed MT, 2002, J HAZARD MATER, V89, P41, DOI 10.1016/S0304-3894(01)00283-7
   Ali N, 2016, ENVIRON POLLUT, V213, P206, DOI 10.1016/j.envpol.2016.01.087
   Ali N, 2013, SCI TOTAL ENVIRON, V461, P655, DOI 10.1016/j.scitotenv.2013.05.044
   Arrebola JP, 2015, SCI TOTAL ENVIRON, V520, P106, DOI 10.1016/j.scitotenv.2015.03.045
   Arrebola JP, 2014, ENVIRON POLLUT, V195, P9, DOI 10.1016/j.envpol.2014.08.003
   Aylward LL, 2014, ENVIRON INT, V68, P127, DOI 10.1016/j.envint.2014.03.026
   Bi XH, 2007, ENVIRON SCI TECHNOL, V41, P5647, DOI 10.1021/es070346a
   Bjermo H, 2013, ENVIRON INT, V51, P88, DOI 10.1016/j.envint.2012.10.010
   Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7
   Dey S, 2011, CANCER EPIDEMIOL, V35, P254, DOI 10.1016/j.canep.2010.09.010
   Dirtu AC, 2010, ENVIRON SCI TECHNOL, V44, P2876, DOI 10.1021/es902149b
   El-Shahawy A., 2013, ENV SECURITY ASSESSM, P209
   Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005
   Fujii Y, 2014, ENVIRON POLLUT, V185, P228, DOI 10.1016/j.envpol.2013.11.002
   Gado A, 2014, ALEXANDRIA J MED, V50, P197
   Gascon M, 2013, ENVIRON INT, V52, P51, DOI 10.1016/j.envint.2012.11.005
   Hassan Y, 2015, SCI TOTAL ENVIRON, V505, P47, DOI 10.1016/j.scitotenv.2014.09.080
   Howsam M, 2004, ENVIRON HEALTH PERSP, V112, P1460, DOI 10.1289/ehp.7143
   Ibarluzea J, 2011, CHEMOSPHERE, V82, P114, DOI 10.1016/j.chemosphere.2010.09.051
   Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7
   Kuo CC, 2013, CURR DIABETES REP, V13, P831, DOI 10.1007/s11892-013-0432-6
   Law RJ, 2014, ENVIRON INT, V65, P147, DOI 10.1016/j.envint.2014.01.006
   Mahfouz EM, 2014, CENT EUR J PUBL HEAL, V22, P215
   Mamun M., 2007, ORGANOHALOGEN COMP, V69, P2026
   Mansour SA, 2008, REV ENVIRON CONTAM T, V196, P1, DOI 10.1007/978-0-387-78444-1_1
   Meeker JD, 2007, ENVIRON RES, V104, P296, DOI 10.1016/j.envres.2007.11.007
   Meijer L, 2008, ENVIRON SCI TECHNOL, V42, P3428, DOI 10.1021/es702446p
   Moysich KB, 2002, AM J IND MED, V41, P102, DOI 10.1002/ajim.10043
   PHILLIPS DL, 1989, ARCH ENVIRON CON TOX, V18, P495
   Pi N, 2016, CHEMOSPHERE, V144, P1505, DOI 10.1016/j.chemosphere.2015.10.020
   Rawn DFK, 2014, ENVIRON INT, V63, P26, DOI 10.1016/j.envint.2013.10.012
   Rawn DFK, 2012, ENVIRON INT, V47, P48, DOI 10.1016/j.envint.2012.05.008
   Rylander C, 2012, ENVIRON INT, V43, P13, DOI 10.1016/j.envint.2012.02.008
   Saoudi A, 2014, SCI TOTAL ENVIRON, V472, P1089, DOI 10.1016/j.scitotenv.2013.11.044
   Soliman AS, 1997, ARCH ENVIRON HEALTH, V52, P409
   Thomas GO, 2006, ENVIRON POLLUT, V141, P30, DOI 10.1016/j.envpol.2005.08.027
   Trudel D, 2011, ENVIRON SCI TECHNOL, V45, P2391, DOI 10.1021/es1035046
   UNEP, 2009, UN ENV PROGR PERS OR
   Veruttipong D, 2012, WORLD J GASTROENTERO, V18, P3997, DOI 10.3748/wjg.v18.i30.3997
   Whitehead TP, 2015, ENVIRON RES, V136, P57, DOI 10.1016/j.envres.2014.10.009
   Xu W, 2013, ANAL CHIM ACTA, V790, P1, DOI 10.1016/j.aca.2013.04.026
   Zheng WW, 2011, ENVIRON SCI TECHNOL, V45, P4668, DOI 10.1021/es1043563
NR 48
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD JUN
PY 2017
VL 176
BP 266
EP 272
DI 10.1016/j.chemosphere.2017.02.139
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA ES9AW
UT WOS:000399849300031
OA No
DA 2017-08-17
ER

PT J
AU El-Din, HKS
   Eisa, AS
   Aziz, BHA
   Ibrahim, A
AF El-Din, Hamdy K. Shehab
   Eisa, Ahmed S.
   Aziz, Baligh H. Abdel
   Ibrahim, Ahmed
TI Mechanical performance of high strength concrete made from high volume
   of Metakaolin and hybrid fibers
SO CONSTRUCTION AND BUILDING MATERIALS
LA English
DT Article
DE Hybrid fiber; Metakaolin; Compressive strength; Split tensile strength;
   Bond strength
ID POLYPROPYLENE
AB Among all construction materials, concrete made with Portland cement is one of the most used material all over the world. Reinforced concrete with short fibers distributed randomly was found to improve strength characteristics of cementitious matrices by controlling the initiation and/or spread of cracks. In this study, mechanical properties of high strength concrete with hybrid fibers were investigated. The properties included compressive strength, split tensile strength and bond strength of 21 mixtures containing hybrid fibers and Metakaolin. Combination of fibers, often called hybridization, refers to a composite of two or more types of fibers rationally combined in a matrix in order to produce a mixture that develops benefits from each fiber and shows a very good behavior. This study investigated the combination of different fiber proportions of steel and polypropylene in the presence of Metakaolin for a 60 MPa grade concrete at a total fiber volume fractions of 0.25% and 0.50%. It is concluded that the optimum percentage of cement replacement by MK is 15% either with the hybrid fiber fraction of 0.25% or 0.50%. The addition of different percentages of hybrid fibers to the concrete mixtures was effective for gaining strength at all testing ages. An increase in compressive strength of (13.62%, 24.17%, and 27.51%) for fiber content of 0.25% and (20.57%, 38.07%, 43.34%) for fiber content of 0.50% was observed at 28 days, respectively. A correlation between the compressive strength, split tensile strength, and bond strength were developed. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [El-Din, Hamdy K. Shehab; Eisa, Ahmed S.; Ibrahim, Ahmed] Zagazig Univ, Struct Engn Dept, Fac Engn, Zagazig, Egypt.
   [Aziz, Baligh H. Abdel] Zagazig Univ, Fac Engn, Zagazig, Egypt.
   [Ibrahim, Ahmed] Univ Idaho, Dept Civil Engn, Moscow, ID 83844 USA.
RP Ibrahim, A (reprint author), Univ Idaho, Dept Civil Engn, Moscow, ID 83844 USA.
EM aibrahim@uidaho.edu
CR [Anonymous], 2014, 318 ACI COMM
   Al Menhosh Adel, 2016, J ENG, V2016
   ASTM, 2016, C192C192M16A ASTM
   [Anonymous], 2011, C90015 ASTM
   ASTM, 2010, STAND TEST METH COMP
   [Anonymous], 2011, C49611 ASTM
   BAYASI Z, 1993, ACI MATER J, V90, P605
   Bentur A, 1990, FIBER REINFORCED CEM
   Brooks G., 1986, USE STEEL FIBER REIN, P67
   Dhinakaran G, 2017, CONSTR BUILD MATER, V134, P727, DOI 10.1016/j.conbuildmat.2016.12.201
   Hannant D. J., 1987, FIBER CEMENTS FIBER
   Kim DJ, 2008, CEMENT CONCRETE COMP, V30, P917, DOI 10.1016/j.cemconcomp.2008.08.002
   KUCHARSKA L, 2002, P INT S BRNO U TECHN, P376
   MOBASHER B, 1991, INT J FRACTURE, V50, P199, DOI 10.1007/BF00032157
   MOBASHER B, 1990, AM CONCR I SP, V124, P137
   Rajarajeshwari V., 2013, INT J RES ENG TECHNO, P244
   SOROUSHIAN P, 1992, ACI MATER J, V89, P535
   Zenisek Michal, 2017, Key Engineering Materials, V722, P311, DOI 10.4028/www.scientific.net/KEM.722.311
NR 19
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0950-0618
EI 1879-0526
J9 CONSTR BUILD MATER
JI Constr. Build. Mater.
PD JUN 1
PY 2017
VL 140
BP 203
EP 209
DI 10.1016/j.conbuildmat.2017.02.118
PG 7
WC Construction & Building Technology; Engineering, Civil; Materials
   Science, Multidisciplinary
SC Construction & Building Technology; Engineering; Materials Science
GA ER4EP
UT WOS:000398752200022
OA No
DA 2017-08-17
ER

PT J
AU Abdelhady, AA
   Mohamed, RSA
AF Abdelhady, Ahmed Awad
   Mohamed, Ramadan S. A.
TI Paucispecific macroinvertebrate communities in the Upper Cretaceous of
   El Hassana Dome (Abu Roash, Egypt): Environmental controls vs adaptive
   strategies
SO CRETACEOUS RESEARCH
LA English
DT Article
DE Environmental control; Facies associations; Biotope reconstruction; Late
   Mesozoic; North Africa
ID MAGHARA NORTH SINAI; WESTERN DESERT; SEQUENCE STRATIGRAPHY; CARBONATE
   PLATFORM; FACIES DEVELOPMENT; SEA; BIVALVIA; SUCCESSION; EVOLUTION;
   TAPHONOMY
AB Based on rock and fossil data from the Upper Cretaceous of the El Hassana Dome (Abu Roash, Egypt), factors controlling facies architecture and the nature of biotopes are highlighted. The succession formed on a non-rimmed shelf, the architecture of which varied from an inner to an outer shelf setting upsection. Macrobenthic biotopes are reconstructed and their palaeoecological significance assessed using a novel ternary plot. Based on diversity and community structure (770 specimens assigned to 28 bivalve and gastropod taxa), four paucispecific associations are identified. These are: 1. the 'Cucullaea' Assemblage, a low-energy, soft-substrate, oligotrophic outer shelf environment with reduced terrigenous input dominated by infaunal bivalves and hexactinellid sponges; 2. the 'Plicatula' Assemblage, a low energy, restricted inner shelf lagoonal setting with soupy substrates and dysoxia below the sediment water interface dominated by plicatulid and ostreid bivalves, 3. the 'Durania' Assemblage, a high-energy, high-temperature, shoal environment dominated by elevator rudists with minor numbers of echinoids, corals and bryozoans, which together form several biostromes. and 4. The 'Trochactaeon' Assemblage, which share the same characteristics of the Durania' Assemblage. The paucispecific nature of these biotopes is indicative of different stress factors. Consequently, the predominant taxa exhibit different degrees.of adaptive strategies. In addition to global sea level, local tectonics have significantly affected facies distribution and biotope structure. The shallower facies during the early Turonian and the dysoxia spanning the Coniacian-Santonian were linked to synsedimentary tectonics, which formed many barriers and led to circulation restrictions. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Abdelhady, Ahmed Awad; Mohamed, Ramadan S. A.] Menia Univ, Fac Sci, Geol Dept, Al Minya 61519, Egypt.
RP Abdelhady, AA (reprint author), Menia Univ, Fac Sci, Geol Dept, Al Minya 61519, Egypt.
EM alhady2003@mu.edu.eg
OI Abdelhady, Ahmed/0000-0003-4438-8572
FU Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)
   GmbH/Centre for International Migration and Development (CIM), Germany
   [41704]
FX For providing items of literature and fruitful discussions, we are
   grateful to Drs Gamal El Qot (Benha University) and Ahmed El Sabbagh
   (Alexandria University). We acknowledge the reviewers and the editor
   Prof. Dr. John Jagt, for the critical and careful review and for the
   numerous useful comments and suggestions. This work was supported by the
   Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)
   GmbH/Centre for International Migration and Development (CIM), Germany
   (grant number 41704).
CR Abdel-Gawad GI, 2011, J AFR EARTH SCI, V59, P359, DOI 10.1016/j.jafrearsci.2011.01.008
   Abdel-Gawad G.I., 2001, EGYPTIAN J GEOLOGY, V45/1B, P495
   Abdel-Gawad G.I., 2001, EGYPTIAN J PALEONTOL, V1, P299
   Abdelhady A.A., 2010, MORPHOMETRICS NONMOR, P157
   Abdelhady A. A., 2014, THESIS
   Abdelhady AA, 2016, J AFR EARTH SCI, V115, P191, DOI 10.1016/j.jafrearsci.2015.12.001
   Abdelhady AA, 2015, J PALAEOGEOG-ENGLISH, V4, P305, DOI 10.1016/j.jop.2015.08.008
   Abdelhady AA, 2015, PALAEOGEOGR PALAEOCL, V417, P261, DOI 10.1016/j.palaeo.2014.10.042
   Abdelhady AA, 2014, J AFR EARTH SCI, V97, P173, DOI 10.1016/j.jafrearsci.2014.04.019
   Abdelhady Ahmed Awad, 2008, P103, DOI 10.1007/978-3-540-75916-4_9
   Aberhan M, 2006, PALEOBIOLOGY, V32, P259, DOI 10.1666/05028.1
   Abu Khadrah A.M., 2005, 4 INT C GEOL AFR AS, V2, P639
   Aly M.F., 2005, EGYPT J PALEONTOL, V5, P253
   Ayoub-Hanna W.S., 2011, THESIS
   Ayyad M.H., 1996, EGYPTIAN GEN PETROLE
   Badawy H.S., 2015, RUDIST CORALLINE SPO
   BARTHEL D, 1992, OPHELIA, V36, P111
   Bice KL, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000848
   BURCHETTE TP, 1992, SEDIMENT GEOL, V79, P3, DOI 10.1016/0037-0738(92)90003-A
   Carannante G, 1999, FACIES, V40, P1, DOI 10.1007/BF02537467
   CARTER RM, 1972, J PALEONTOL, V46, P325
   De Castro Piero, 1996, Geologica Romana, V32, P69
   Di Stefano P, 2000, FACIES, V42, P133
   Dunham RJ, 1962, CLASSIFICATION CARBO, V1, P108
   EI-Sabbagh A.M., 2003, EGYPTIAN J PALEONTOL, V3, P243
   El-Hedeny MM, 2007, NEUES JAHRB GEOL P-A, V244, P79, DOI 10.1127/0077-7749/2007/0244-0079
   El-Shazly S, 2011, B GEOSCI, V86, P209, DOI 10.3140/bull.geosci.1151
   Faris M. I., 1948, Bulletin of the Faculty of Science Fouad I University, VNo. 27, P221
   Flugel E., 2004, MICROFACIES CARBONAT
   Fursich FT, 2012, PALAEOGEOGR PALAEOCL, V358, P1, DOI 10.1016/j.palaeo.2012.07.006
   Ghorab M.A., 1961, 3 AR PETR C AL EG
   GILI E, 1995, PALAEOGEOGR PALAEOCL, V118, P245, DOI 10.1016/0031-0182(95)00006-X
   GILINSKY NL, 1994, PALEOBIOLOGY, V20, P245
   Gradinaru Eugen, 1994, Jahrbuch der Geologischen Bundesanstalt, V137, P43
   Gradinaru M, 2016, CRETACEOUS RES, V66, P11, DOI 10.1016/j.cretres.2016.04.012
   Hamza E.H., 1993, NEUES JB GEOLOGIE PA, V2, P75
   Hataba H., 1990, P EG GEN PETR COOP E, P1
   Hofmann R, 2013, ACTA PALAEONTOL POL, V58, P149, DOI 10.4202/app.2011.0060
   Huber BT, 2002, GEOLOGY, V30, P123, DOI 10.1130/0091-7613(2002)030<0123:DSPROE>2.0.CO;2
   Jordan N, 2015, LETHAIA, V48, P540, DOI 10.1111/let.12126
   JUX ULRICH, 1954, NEUES JAHRB GEOL U PALAONTOL ABHANDL, V100, P159
   KHALEK MLA, 1989, J AFR EARTH SCI, V9, P435
   Kollmann HA, 2014, GEODIVERSITAS, V36, P349, DOI 10.5252/g2014n3a2
   KORA M, 1995, FACIES, V32, P223, DOI 10.1007/BF02536871
   Lazo DG, 2004, PALAIOS, V19, P451, DOI 10.1669/0883-1351(2004)019<0451:BTTTEO>2.0.CO;2
   Leinfelder R., 1999, GLOBAL REGIONAL CONT, V2, P227
   Luning S, 1998, CRETACEOUS RES, V19, P153, DOI 10.1006/cres.1997.0104
   Mansour A. S. M., 2004, GEOLOGIA CROATICA, V57, P55
   Martini R, 2007, FACIES, V53, P389, DOI 10.1007/s10347-007-0115-3
   Moro A, 2016, FACIES, V62, DOI 10.1007/s10347-016-0471-y
   Moustafa A.R., 1990, GEOLOGY EGYPT, P381
   Moustafa A.R., 1988, EARTH SCI SERIES, V2, P1
   Norton P., 1967, INTERNAL REPORT
   Ozer S, 2015, J AFR EARTH SCI, V107, P119, DOI 10.1016/j.jafrearsci.2015.03.013
   Poulsen CJ, 2003, GEOLOGY, V31, P115, DOI 10.1130/0091-7613(2003)031<0115:DTROTA>2.0.CO;2
   Robaszynski F., 1984, Revue de Micropaleontologie, V26, P145
   Saber SG, 2009, GEOARABIA, V14, P113
   SAID R., 1990, GEOLOGY EGYPT
   Sanders D, 1997, FACIES, V36, P69, DOI 10.1007/BF02536878
   SCHLAGER W., 1989, SOC EC PALEONTOLOGIS, V44, P15
   Scotese C. R., 2001, PALEOMAP PROJECT, V1, P52
   Sedek MS, 2013, ARAB J GEOSCI, V6, P2261, DOI 10.1007/s12517-011-0511-4
   SEILACHER A, 1984, PALAEONTOLOGY, V27, P207
   Skelton Peter W., 1997, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V92, P225
   Sorensen AM, 2012, CRETACEOUS RES, V33, P21, DOI 10.1016/j.cretres.2011.07.004
   Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6
   Strougo A., 1986, NEUES JB GEOLOGIE PA, V173, P253
   THAYER CW, 1979, SCIENCE, V203, P458, DOI 10.1126/science.203.4379.458
   Waite R, 2008, PALAIOS, V23, P548, DOI 10.2110/palo.2007.p07-048r
   WIECZOREK J, 1979, Acta Palaeontologica Polonica, V24, P299
   Wilmsen M, 2010, FACIES, V56, P59, DOI 10.1007/s10347-009-0190-8
   Wilson JL, 1975, CARBONATE FACIES GEO
   Wilson PA, 2002, GEOLOGY, V30, P607, DOI 10.1130/0091-7613(2002)030<0607:TTCGHU>2.0.CO;2
   Wray DS, 2006, P GEOLOGIST ASSOC, V117, P145
   Zakhera MS, 2010, TURK J EARTH SCI, V19, P745, DOI 10.3906/yer-0902-12
   Zakhera MS, 2002, NEUES JAHRB GEOL P-M, P257
   Zuschin M, 2002, PALAIOS, V17, P602, DOI 10.1669/0883-1351(2002)017<0602:PRFSBA>2.0.CO;2
   Zuschin M, 2009, PALAIOS, V24, P211, DOI 10.2110/palo.2008.p08-062r
NR 78
TC 0
Z9 0
U1 3
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6671
EI 1095-998X
J9 CRETACEOUS RES
JI Cretac. Res.
PD JUN
PY 2017
VL 74
BP 120
EP 136
DI 10.1016/j.cretres.2017.02.014
PG 17
WC Geology; Paleontology
SC Geology; Paleontology
GA ET3YF
UT WOS:000400215200010
OA No
DA 2017-08-17
ER

PT J
AU Elashmawy, M
AF Elashmawy, Mohamed
TI An experimental investigation of a parabolic concentrator solar tracking
   system integrated with a tubular solar still
SO DESALINATION
LA English
DT Article
DE Desalination; Parabolic concentrator; Solar still; PCST-TSS
ID WATER PRODUCTION; PERFORMANCE ANALYSIS; DESALTING SYSTEM; HEAT;
   PRODUCTIVITY; DESIGN; AIR; PCM; PARAMETERS; COLLECTOR
AB This study describes the performance of three different experiments under the climatic conditions of Hail city (27.5(omicron)N, 41.7(omicron)E) in Saudi Arabia by using a tubular solar still (TSS) with a rectangular trough filled with a black cloth and saturated by raw water in the first experiment; a TSS with a half cylindrical trough without clothing in the second experiment, while in the third experiment TSS of the second experiment was integrated with a parabolic concentrator-solar tracking system (PCST-TSS). Results show a high potential of using PCST-TSS compared to conventional TSS. The obtained yields were 0.28, 0.214 and 1.66 L/day for 0.059 m(2) TSS area (4.71, 3.6 and 3.53 L/m(2)day) for the three experiments with daily efficiencies of 36.5%, 30.5% and 28.5% respectively. The PCST-TSS yield was increased by 676% with 45.5% cost reduction per liter (CPL). This promising technique is suitable for house roofs and small communities located in remote areas. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Elashmawy, Mohamed] Univ Hail, Engn Coll, Mech Engn Dept, Hail 2440, Saudi Arabia.
   [Elashmawy, Mohamed] Suez Univ, Fac Petr & Min Engn, Engn Sci Dept, Suez 43721, Egypt.
RP Elashmawy, M (reprint author), Univ Hail, Engn Coll, Mech Engn Dept, Hail 2440, Saudi Arabia.; Elashmawy, M (reprint author), Suez Univ, Fac Petr & Min Engn, Engn Sci Dept, Suez 43721, Egypt.
EM ma.elashmawy@uoh.edu.sa
FU Deanship of Scientific Research, University of Hail, Saudi Arabia
   [0150282]
FX This study is funded by Deanship of Scientific Research, University of
   Hail, Saudi Arabia (no. 0150282, 2015).
CR Ahsan A., 2010, J HYDROSCIENCE HYDRA, V28, P31
   Ahsan A., 2008, J HYDROSCIENCE HYDRA, V26, P15
   Ahsan A, 2013, DESALINATION, V311, P173, DOI 10.1016/j.desal.2012.11.023
   Ahsan A, 2012, DESALINATION, V292, P105, DOI 10.1016/j.desal.2012.02.013
   Ahsan A, 2010, DESALINATION, V260, P172, DOI 10.1016/j.desal.2010.04.044
   Ahsan A, 2010, SOL ENERGY, V84, P1147, DOI 10.1016/j.solener.2010.03.019
   Arunkumar T, 2016, RENEW ENERG, V88, P391, DOI 10.1016/j.renene.2015.11.051
   Arunkumar T, 2016, DESALINATION, V379, P24, DOI 10.1016/j.desal.2015.10.007
   Arunkumar T, 2013, APPL ENERG, V103, P109, DOI 10.1016/j.apenergy.2012.09.014
   Arunkumar T., 2013, J ENV HLTH SCI ENG, V10, P31, DOI DOI 10.1186/1735-2746-10-31
   Arunkumar T., 2012, EXPT STUDY VARIOUS S
   Asbik M, 2016, DESALINATION, V381, P26, DOI 10.1016/j.desal.2015.11.031
   Badran A. A., 1995, International Journal of Solar Energy, V17, P51, DOI 10.1080/01425919508914288
   Badran AA, 2001, DESALINATION, V133, P167, DOI 10.1016/S0011-9164(01)00095-9
   Boukar M, 2007, DESALINATION, V203, P444, DOI 10.1016/j.desal.2006.02.026
   Chaibi MT, 2007, NATO SCI PEACE SECUR, P19, DOI 10.1007/978-1-4020-5508-9_2
   Chang ZH, 2015, DESALINATION, V375, P10, DOI 10.1016/j.desal.2015.07.020
   Dev R, 2011, DESALINATION, V269, P67, DOI 10.1016/j.desal.2010.10.043
   Dev R, 2010, DESALINATION, V254, P126, DOI 10.1016/j.desal.2009.12.004
   Djebedjian B, 2000, DESALINATION, V128, P139, DOI 10.1016/S0011-9164(00)00029-1
   El-Sebaii AA, 2009, APPL ENERG, V86, P1187, DOI 10.1016/j.apenergy.2008.10.014
   Elimelech M., 2006, AQUA, V55, P3
   Esfahani JA, 2011, DESALINATION, V269, P198, DOI 10.1016/j.desal.2010.10.062
   Ettouney H, 2007, NATO SCI PEACE SECUR, P1, DOI 10.1007/978-1-4020-5508-9_1
   Fath HES, 2005, DESALINATION, V171, P267, DOI 10.1016/j.desal.2004.05.007
   Feilizadeh M, 2010, DESALINATION, V262, P166, DOI 10.1016/j.desal.2010.06.005
   Gowtham M., INT J CHEM ENG APPL, V2
   Islam K., 2007, DOBOKU GAKKAI RONB B, V63, P108, DOI 10.2208/jscejb.63.108
   Kabeel AE, 2007, RENEW ENERG, V32, P157, DOI 10.1016/j.renene.2006.01.015
   Kabeel AE, 2016, DESALINATION, V383, P22, DOI 10.1016/j.desal.2016.01.006
   Karuppusamy S, 2012, THERM SCI, V16, P573, DOI 10.2298/TSCI090806079S
   Khalifa AJN, 2011, ENERG CONVERS MANAGE, V52, P431, DOI 10.1016/j.enconman.2010.07.018
   Kumar M, 2015, DESALINATION, V367, P216, DOI 10.1016/j.desal.2015.04.009
   Kumar S, 2010, DESALINATION, V250, P214, DOI 10.1016/j.desal.2008.06.030
   Mahdi JT, 2011, DESALINATION, V267, P233, DOI DOI 10.1016/J.DESA1.2010.09.032
   Matthews S., 2009, DESALINATION MIDDLE, V5
   Nafey AS, 2000, ENERG CONVERS MANAGE, V41, P1797, DOI 10.1016/S0196-8904(99)00188-0
   Nebbia Giorgio, 1957, S SAL WAT CONV WASH, P175
   Omri A, 2007, DESALINATION, V206, P373, DOI 10.1016/j.desal.2006.03.574
   Rahbar N, 2015, SOL ENERGY, V113, P313, DOI 10.1016/j.solener.2014.12.032
   Rodriguez L.G., 2007, ASSESSMENT MOST PROM, P355
   Rufuss DDW, 2016, RENEW SUST ENERG REV, V63, P464, DOI 10.1016/j.rser.2016.05.068
   Samee MA, 2007, RENEW SUST ENERG REV, V11, P543, DOI 10.1016/j.rser.2005.03.003
   Shalaby SM, 2016, DESALINATION, V398, P247, DOI 10.1016/j.desal.2016.07.042
   Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599
   Sharshir SW, 2016, APPL THERM ENG, V100, P267, DOI 10.1016/j.applthermaleng.2015.11.041
   Tanaka H, 2005, DESALINATION, V177, P291, DOI 10.1016/j.desal.2004.12.012
   Tanaka H, 2005, DESALINATION, V171, P243, DOI 10.1016/j.desal.2004.04.006
   Tanaka H, 2004, DESALINATION, V160, P195, DOI 10.1016/S0011-9164(04)90009-4
   Tanaka H, 2011, DESALINATION, V273, P405, DOI 10.1016/j.desal.2011.01.073
   TIWARI GN, 1988, DESALINATION, V69, P309, DOI 10.1016/0011-9164(88)80032-8
   Tleimat B. W., 1965, SOLAR ENERGY C PHOEN, V10, P61
   Tripathi R, 2006, SOL ENERGY, V80, P956, DOI 10.1016/j.solener.2005.08.002
   William GE, 2015, ENERGY, V90, P1707, DOI 10.1016/j.energy.2015.06.125
   Xie G, 2016, APPL ENERG, V179, P972, DOI 10.1016/j.apenergy.2016.07.057
   Yohannes T., 2003, P 24 CANCAM SASK SAS
   Zeroual M, 2011, ENRGY PROCED, V6, P736, DOI 10.1016/j.egypro.2011.05.083
   Zheng HF, 2013, DESALINATION, V311, P62, DOI 10.1016/j.desal.2012.11.021
NR 58
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
EI 1873-4464
J9 DESALINATION
JI Desalination
PD JUN 1
PY 2017
VL 411
BP 1
EP 8
DI 10.1016/j.desal.2017.02.003
PG 8
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA ES9AA
UT WOS:000399847100001
OA No
DA 2017-08-17
ER

PT J
AU Kamal, AM
   El-Sayed, TA
   Farghaly, SH
   El-Butch, AMA
AF Kamal, A. M.
   El-Sayed, T. A.
   Farghaly, S. H.
   El-Butch, A. M. A.
TI Failure pressure of composite membrane housing for SWRO desalination
   plants
SO DESALINATION
LA English
DT Article
DE Desalination; SWRO membrane housing; Failure pressure; Analytical
   solution and FEM; Composite vessel
ID REVERSE-OSMOSIS MEMBRANES; FINITE-ELEMENT-ANALYSIS; VESSELS; DESIGN;
   SYSTEMS
AB In this work, the failure pressure of composite membrane housing used in seawater reverse osmosis (SWRO) desalination plants has been determined using both analytical solution and finite element modeling (FEM) at two types of loading conditions namely; internal pressure neglecting the side thrust and internal pressure with associated side thrust. An experimental study of a membrane housing vessel has been presented in case of internal pressure neglecting the side thrust to verify the theoretical results. Plate samples of unidirectional E-glass/polyester material have been fabricated using hand lay-up method and tested to determine the physical and the mechanical properties. Pipe samples made of the same material with asymmetric angle ply laminate lay-up [+/- 66]10 have been fabricated using filament winding technique and tested to determine the failure pressure by hydrostatic pressure test. Experimental results showed that the failure pressure is less than that of the analytical solution with error of about 6%, while the error of maximum hoop strain is about 11%. FEM results showed that the failure pressure and the maximum hoop strain are slightly larger than that of analytical solution with error less than 1% in case of internal pressure neglecting the side thrust. While in case of internal pressure with associated side thrust, the error of failure pressure and maximum hoop and axial strains is about 3%. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Kamal, A. M.; El-Sayed, T. A.; Farghaly, S. H.; El-Butch, A. M. A.] Helwan Univ, Fac Engn, Dept Mech Design, POB 11718, Cairo, Egypt.
RP Kamal, AM; El-Sayed, TA (reprint author), Helwan Univ, Fac Engn, Dept Mech Design, POB 11718, Cairo, Egypt.
EM amkamalg72@yahoo.com; Tamer_Alsayed@m-eng.helwan.edu.eg;
   Mdm_faceng_Mat@yahoo.com; elbutch@aucegypt.edu
CR Adams D. F., 1967, J COMPOS MATER, V1, P4
   [Anonymous], 2001, HANDBOOK, V21
   Avlonitis SA, 2010, DESALIN WATER TREAT, V13, P74, DOI 10.5004/dwt.2010.1052
   Boiler A., 2010, SUBCOMMITTEE FIBER R
   Cai BP, 2011, COMPOS STRUCT, V93, P2844, DOI 10.1016/j.compstruct.2011.05.020
   William D. W. D. C., 2007, MAT SCI ENG INTRO
   Chou HY, 2013, COMPOS STRUCT, V104, P144, DOI 10.1016/j.compstruct.2013.04.003
   Cohen D., 2001, COMPOSITES B, V32, P413, DOI 10.1016/S1359-8368(01)00009-9
   Daniel I. M., 1994, ENG MECH COMPOSITE M
   Deutschman A. D., 1975, THEORY PRACTICE
   Hocine A, 2009, INT J PRES VES PIP, V86, P649, DOI 10.1016/j.ijpvp.2009.06.002
   Hodgkinson JM, 2000, WOODHEAD PUBLISHING
   Hwang TK, 2012, COMPOS PART A-APPL S, V43, P1467, DOI 10.1016/j.compositesa.2012.04.005
   Jones R. M., 1975, MECH COMPOSITE MAT
   Kamal AM, 2016, DESALINATION, V397, P126, DOI 10.1016/j.desal.2016.06.015
   Kim SJ, 2015, DESALINATION, V370, P44, DOI 10.1016/j.desal.2015.05.013
   Kim YM, 2009, DESALINATION, V238, P312, DOI 10.1016/j.desal.2008.10.004
   Kishizawa N, 2015, DESALINATION, V368, P81, DOI 10.1016/j.desal.2015.01.045
   Kucera J., 2011, REVERSE OSMOSIS IND
   Lekhnitskii S. G., 1963, THEORY ELASTICITY AN
   LIFSHITZ JM, 1995, COMPOS STRUCT, V32, P313, DOI 10.1016/0263-8223(95)00089-5
   Liu PF, 2014, COMPOS PART B-ENG, V56, P54, DOI 10.1016/j.compositesb.2013.08.017
   Liu PF, 2010, MATER DESIGN, V31, P3825, DOI 10.1016/j.matdes.2010.03.031
   Lu YY, 2012, DESALINATION, V307, P42, DOI 10.1016/j.desal.2012.08.025
   Musthak M., 2016, INT J COMPOS MAT, V6, P79
   Pinfold MK, 1995, THESIS
   Quinn J.A., 1999, COMPOSITES DESIGN MA
   ROY AK, 1988, J PRESS VESS-T ASME, V110, P255
   Shachaf N, 2008, DESALINATION, V221, P202, DOI 10.1016/j.desal.2007.02.053
   Williams M. E., 2003, BRIEF REV REVERSE OS
   Xie YJ, 1996, COMPOS SCI TECHNOL, V56, P1349, DOI 10.1016/S0266-3538(96)00079-6
   Xing JZ, 2015, COMPOS STRUCT, V131, P868, DOI 10.1016/j.compstruct.2015.05.036
   Xu P, 2009, MATER DESIGN, V30, P2295, DOI 10.1016/j.matdes.2009.03.006
   Yao X., TEST, V24
NR 34
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
EI 1873-4464
J9 DESALINATION
JI Desalination
PD JUN 1
PY 2017
VL 411
BP 45
EP 58
DI 10.1016/j.desal.2017.02.002
PG 14
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA ES9AA
UT WOS:000399847100006
OA No
DA 2017-08-17
ER

PT J
AU Gerdes, JH
   Huang, CT
   Sharaf, MA
AF Gerdes, John H., Jr.
   Huang, Chin-Tser
   Sharaf, Mohamed A.
TI Incorporating biometrics into veiled certificates: preventing
   unauthorized use of anonymous certificates
SO ELECTRONIC COMMERCE RESEARCH
LA English
DT Article
DE Design Science; Anonymity; Biometric authentication; Biometric
   encryption; Digital certificate; Fuzzy authentication; Error correcting
   code; Veiled authentication; Veiled certificate; X509
ID SYSTEMS
AB A leading cause of Identity Theft is that attackers get access to the victim's personal credentials. We are warned to protect our personal identifiers but we need to share our credentials with various organizations in order to obtain services from them. As a result the safety of our credentials is dependent on both the ability and diligence of the various organizations with which we interact. However, recent data breach incidents are clear proof that existing approaches are insufficient to protect the privacy of our credentials. Using a Design Science methodology, we propose a new technology, veiled certificates, which includes features that prevent fraudulent use of user's credentials and provides a degree of user anonymity. We also incorporate biometric authentication so that service providers know that they are dealing with the owner of the credentials. Results of a bench scale test that demonstrates the feasibility of the approach are reviewed. We also suggest four major applications which could take advantage of these certificates.
C1 [Gerdes, John H., Jr.] Univ South Carolina, Dept Integrated Informat Technol, Columbia, SC 29208 USA.
   [Huang, Chin-Tser] Univ South Carolina, Dept Comp Sci & Engn, Columbia, SC USA.
   [Sharaf, Mohamed A.] Al Azhar Univ, Comp Sci & Engn, Cairo, Egypt.
RP Gerdes, JH (reprint author), Univ South Carolina, Dept Integrated Informat Technol, Columbia, SC 29208 USA.
EM jgerdes@sc.edu; huangct@cse.sc.edu
CR Adler A, 2005, LECT NOTES COMPUT SC, V3546, P1100
   Atallah MJ, 2005, LECT NOTES COMPUT SC, V3570, P357
   Bhargav-Spantzel A, 2007, J COMPUT SECUR, V15, P529, DOI 10.3233/JCS-2007-15503
   Bissessar D, 2014, ANN CONF PRIV SECUR, P75, DOI 10.1109/PST.2014.6890926
   Blanton M., 2009, LNCS, V5927
   Bouncy Castle, 2011, BOUNCY CASTL CRYPT A
   Boyen X., 2004, 11 ACM C COMP COMM S, P82
   Brands S. A., 2000, RETHINKING PUBLIC KE
   Bringer J., 2009, P 6 INT S IM SIGN PR
   Bringer J, 2008, SCI COMPUT PROGRAM, V74, P43, DOI 10.1016/j.scico.2008.09.016
   Buhan I. R., 2008, CONTR LEAK BIOM INF
   Burnett A., 2007, INT J NETWORK SECURI, V5, P317
   Cavoukian A., 2009, BIOMETRICS FUNDAMENT, V26, P655
   Chang Ee-Chien, 2006, P 2006 ACM S INF COM, P182, DOI 10.1145/1128817.1128845
   Chowdhry A., 2014, FORBES
   Deswarte Y., 2010, T DATA PRIVACY, V3, P253
   Dike-Anyiam B., 2006, J INFORM WARFARE, V5, P33
   Dodis Y, 2004, ADV CRYPTOLOGY EUROC, P523, DOI DOI 10.1007/978-3-540-24676-331
   Dodis Y, 2008, SIAM J COMPUT, V38, P97, DOI 10.1137/060651380
   Du W., 2001, NSPW 2001, P13
   Fierrez J, 2007, PATTERN RECOGN, V40, P1389, DOI 10.1016/j.patcog.2006.10.014
   Fisher R., 1948, STAT TABLES BIOL AGR, P26
   [Anonymous], 2006, FVC2006 4 INT FING V
   Gerdes JH, 2009, COMPUT SECUR, V28, P248, DOI 10.1016/j.cose.2008.12.005
   Hao F, 2006, IEEE T COMPUT, V55, P1081, DOI 10.1109/TC.2006.138
   Hardekoph B., 2015, FORBES
   Harmon K., 2008, IMPLEMENTATION SYNDR
   Harrell E., 2012, VICTIMS IDENTITY THE
   Hevner AR, 2004, MIS QUART, V28, P75
   Hong L, 1998, IEEE T PATTERN ANAL, V20, P777, DOI 10.1109/34.709565
   ISO 2009, 2009, 154081 ISOIEC IS
   ITRC, 2015, ID THEFT RES CTR BRE
   ITU (International Telecommunications Union), 2014, X 509 INF TECHN OP S
   Jain AK, 2000, IEEE T IMAGE PROCESS, V9, P846, DOI 10.1109/83.841531
   Jain AK, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/579416
   Ji LP, 2007, IEEE T SYST MAN CY B, V37, P1407, DOI 10.1109/TSMCB.2007.903369
   Kholmatov A., 2008, P SEC FOR STEG WAT M, P6819
   Knuth D. E., 1969, SEMINUMERICAL ALGORI, V2, P139
   Liu EY, 2010, J NETW COMPUT APPL, V33, P221, DOI 10.1016/j.jnca.2009.12.002
   Mathews A. W., 2015, WALL STREET J
   Nandakumar K, 2007, LECT NOTES COMPUT SC, V4642, P927
   Paquin C, 2011, U PROVE CRYPTOGRAPHI
   Paquin Christian, 2011, U PROVE TECHNOLOGY O
   Peterson H., 2014, BUSINESS INSIDER
   Pfitzmann A., 2001, DESIGNING PRIVACY EN, V2009, P1, DOI 10.1007/3-540-44702-4_1
   Pfitzmann A., 2010, TERMINOLOGY TALKING
   Ponemon Institute, 2014, IS YOUR CO READ BIG
   SCHEIRER WJ, 2007, BIOM CONS C BALT SEP
   Shoup V., 2009, NTL LIB DOING NUMBER
   Stallings William, 2006, CRYPTOGRAPHY NETWORK
   Stoianov A, 2009, IEEE TIC-STH 09: 2009 IEEE TORONTO INTERNATIONAL CONFERENCE: SCIENCE AND TECHNOLOGY FOR HUMANITY, P34, DOI 10.1109/TIC-STH.2009.5444478
   Taherdoost H., 2011, INT J SECURITY, V5, P74
   Vijayan J., 2014, COMPUTERWORLD BANKS
   Westervelt R., 2009, SEARCHSECURITY COM
   Yang D., 2012, 8 INT C COMP INT SEC, P452
NR 55
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-5753
EI 1572-9362
J9 ELECTRON COMMER RES
JI Electron. Commer. Res.
PD JUN
PY 2017
VL 17
IS 2
BP 289
EP 316
DI 10.1007/s10660-016-9222-y
PG 28
WC Business; Management
SC Business & Economics
GA ET3RF
UT WOS:000400196500005
OA No
DA 2017-08-17
ER

PT J
AU Hamoda, A
   Hossain, KMA
   Sennah, K
   Shoukry, M
   Mahmoud, Z
AF Hamoda, A.
   Hossain, K. M. A.
   Sennah, K.
   Shoukry, M.
   Mahmoud, Z.
TI Behaviour of composite high performance concrete slab on steel I-beams
   subjected to static hogging moment
SO ENGINEERING STRUCTURES
LA English
DT Article
DE Composite girder; Hogging moment; Engineered cementitious composite;
   Ultrahigh performance fiber reinforced; concrete; Closure strip
ID FIBER-REINFORCED CONCRETE
AB This paper investigates the behavior of composite girders made of high performance concrete (HPC) slab connected to steel I-beam through stud shear connectors subjected to hogging moment. Such girders are widely used in bridge construction. However, reinforcing steel bars in the negative moment region contribute significantly to the moment resistance and is found to be ineffective due to cracking of ordinary concrete. This research proposes the use HPCs containing fibers (with better crack resisting and strain hardening characteristics) in the deck slab to enhance both cracking and yield load carrying capacity of such girders at the negative moment region. Four composite girder specimens made of different types of concrete and having variable slab continuity were tested to failure under monotonic loading simulating negative moment. Three types of concrete were employed in the first three girder specimens, namely: Normal Concrete (NC), Steel Fiber-Reinforced Concrete (SFRC) and engineered cementitious composite (ECC). The fourth girder specimen was constructed using two SFRC end slabs connected together with an Ultra-High Performance Fiber-Reinforced Concrete (UHPFRC) closure strip located at the maximum negative moment mid span region. This specimen represents the case of full width-full depth deck slabs resting over steel girders with transverse joints filled with UHPFRC used to accelerate bridge construction. The SFRC and ECC composite girders showed better performance in terms of cracking characteristics (multi-cracking and smaller crack width), higher pre-cracking linear stiffness, higher cracking load, higher concrete strain development during cracking and higher strength compared to their NC counterparts. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Hamoda, A.; Hossain, K. M. A.; Sennah, K.] Ryerson Univ, Dept Civil Engn, Toronto, ON, Canada.
   [Hamoda, A.] Kafrelsheikh Univ, Dept Civil Engn, Fac Engn, Kafrelsheikh, Egypt.
   [Shoukry, M.; Mahmoud, Z.] Univ Alexandria, Dept Struct Engn, Fac Engn, Alexandria, Egypt.
RP Hossain, KMA (reprint author), Ryerson Univ, Dept Civil Engn, Toronto, ON, Canada.
EM ahossain@ryerson.ca
FU Egyptian ministry of higher education; Ryerson University
FX The authors acknowledge the financial support of the Egyptian ministry
   of higher education for this research. This work was carried out at the
   structural Laboratory of Ryerson University, Toronto, Canada. The
   authors also acknowledge the contributions of technical staff members at
   Ryerson University for providing a great assistance and helpful
   comments.
CR AASHTO, 2007, AASHTO LRFD BRIDG DE
   Ahmed T, 2016, CONSTR BUILD MATER, V112, P980
   Ataei A, 2016, ENG STRUCT, V114, P1, DOI 10.1016/j.engstruct.2015.10.041
   Ban HY, 2013, ENG STRUCT, V56, P1130, DOI 10.1016/j.engstruct.2013.06.040
   Dancygier AN, 2016, ENG STRUCT, V111, P411, DOI 10.1016/j.engstruct.2015.11.046
   Ehsan A, 2015, CONSTR BUILD MATER, V78, P303
   Gholamhoseini A, 2016, ENG STRUCT, V114, P171, DOI 10.1016/j.engstruct.2016.02.010
   Graybeal B, 2010, PB2011101995 NTIS
   Graybeal BA, 2015, MATER STRUCT, V48, P1831, DOI 10.1617/s11527-014-0277-8
   Hamidreza S, 2014, CONSTR BUILD MATER, V73, P289
   Hassan AMT, 2012, CONSTR BUILD MATER, V37, P874, DOI 10.1016/j.conbuildmat.2012.04.030
   Henderson IEJ, 2015, ENG STRUCT, V103, P298, DOI 10.1016/j.engstruct.2015.08.035
   Hosinieh MM, 2015, ENG STRUCT, V99, P388, DOI 10.1016/j.engstruct.2015.05.009
   Hossain K. M. A., 2015, SUSTAINABLE BRIDGE S, P247
   Hossain KMA, 2014, STRUCTURAL FAULTS R
   Hossain KMA, 2012, CAN CIVIL ENG, V29, P12
   Kim YY, 2004, ACI STRUCT J, V101, P792
   Kinda H, 2016, COMPOS B, V86, P214
   Lee JK, 2015, ACI STRUCT J, V112, P451, DOI 10.14359/51687657
   Lepech MD, 2009, MATER STRUCT, V42, P1185, DOI 10.1617/s11527-009-9544-5
   Lin W, 2004, J CONSTR STEEL RES, V101, P175
   Lin W., 2013, J STRUCT ENG, V140
   Lin WW, 2014, J CONSTR STEEL RES, V101, P175, DOI 10.1016/j.jcsr.2014.05.008
   Lin ZF, 2016, ENG STRUCT, V117, P130, DOI 10.1016/j.engstruct.2016.03.014
   Luo JW, 2016, ACI STRUCT J, V113, P75
   Makita T, 2015, ENG STRUCT, V90, P61, DOI 10.1016/j.engstruct.2015.01.049
   Mosallam AS, 2014, COMPOS B, V30, P311
   Pela L, 2012, COMPOS PART B-ENG, V43, P2471, DOI 10.1016/j.compositesb.2011.08.038
   Ruano G, 2015, ENG STRUCT, V86, P168, DOI 10.1016/j.engstruct.2014.12.030
   Saleem MA, 2011, ACI STRUCT J, V108, P601
   Su Q, 2014, J BRIDGE ENG, V20
   Sun QL, 2014, J CONSTR STEEL RES, V100, P1, DOI 10.1016/j.jcsr.2014.04.017
   Tosun-Felekoglu K, 2014, COMPOS B, V31, P536
   Udaipurwala A, 2015, J BRIDGE ENG, V20, DOI 10.1061/(ASCE)BE.1943-5592.0000757
   Vahid A, 2015, CONSTR BUILD MATER, V94, P73
   Vasdravellis G, 2012, J CONSTR STEEL RES, V79, P34, DOI [10.1016/j.jcsr.2012.07.012, 10.1016/j.jcsr2012.07.012]
   Vasdravellis G, 2012, J CONSTR STEEL RES, V68, P20, DOI 10.1016/j.jcsr.2011.06.017
   Wang W, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1016/J.GR.2014.02.002
   Yap SP, 2015, ENG STRUCT, V101, P24, DOI 10.1016/j.engstruct.2015.07.007
   Yoo DY, 2015, ENG STRUCT, V102, P409, DOI 10.1016/j.engstruct.2015.08.029
   Yoo SW, 2016, ENG STRUCT, V118, P1, DOI 10.1016/j.engstruct.2016.03.052
   Yoshitake I, 2016, CONSTR BUILD MATER, V111, P22, DOI 10.1016/j.conbuildmat.2016.02.048
   Zhang P, 2013, COMPOS PART B-ENG, V45, P1587, DOI 10.1016/j.compositesb.2012.10.006
   Zhou J, 2012, CEMENT CONCRETE COMP, V34, P342, DOI 10.1016/j.cemconcomp.2011.11.019
   Zhu P, 2012, J BRIDGE ENG, V17, P191, DOI 10.1061/(ASCE)BE.1943-5592.0000257
NR 45
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-0296
EI 1873-7323
J9 ENG STRUCT
JI Eng. Struct.
PD JUN 1
PY 2017
VL 140
BP 51
EP 65
DI 10.1016/j.engstruct.2017.02.030
PG 15
WC Engineering, Civil
SC Engineering
GA ET1MM
UT WOS:000400033500005
OA No
DA 2017-08-17
ER

PT J
AU Khalil, AEH
   Etman, E
   Atta, A
   Essam, M
AF Khalil, Abd El-Hakim
   Etman, Emad
   Atta, Ahmed
   Essam, Mohamed
TI Behavior of RC beams strengthened with strain hardening cementitious
   composites (SHCC) subjected to monotonic and repeated loads
SO ENGINEERING STRUCTURES
LA English
DT Article
DE RC beams; Strengthening; UHP-SHCC; Ductility; Repeated load; Dissipated
   energy; Stiffness degradation
ID PERFORMANCE
AB Ultra High Performance Strain Hardening Cementitious Composites (UHP-SHCC) is a newly developed construction material, has large advantages on large strain capacity as well as high compressive and tensile strength, which is useful for strengthening or repair concrete members. However, some important obstacles need to be studied, such as the strain localization occurs in the UHP-SHCC strengthening layer around the substrate concrete cracks, which severely limits the ductility of the strengthened beam subjected to monotonic and repeated loads. In the present study, ten specimens were tested experimentally, which divided into two major groups, each group contains five specimens, one as a control and four strengthened with constant UHP-SHCC layer thickness having variable reinforcement ratios embedded in the middle of the strengthening layer. Two types of loading were applied; Monotonic loading for the first group and short time repeated loading for the second group. The recorded tests showed that use additional reinforcement embedded in the strengthening layer for beams strengthened with UHP-SHCC become sufficient at certain limit to eliminate the observed early strain localization and to gain adequate ductility under both monotonic and repeated loading. Another important conclusion is the strengthening of RC structures using an unreinforced UHP-SHCC layer may lead to a brittle failure especially in case of repeated loading. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Khalil, Abd El-Hakim; Etman, Emad; Atta, Ahmed; Essam, Mohamed] Tanta Univ, Fac Engn, Tanta, Egypt.
RP Atta, A (reprint author), Tanta Univ, Fac Engn, Tanta, Egypt.
EM Drahmedatta2003@yahoo.com
CR Abdelsamine S, 2010, ENG STRUCT, V32, P297
   [Anonymous], 2014, 318M14 ACI
   Amino T, 2015, STEEL CORROSION PROT, P1703
   Daniel L, 2002, ACI STRUCT J, V99, P248
   Hussein H., 2012, J CEMENT CONCR COMPO, p[34, 1061]
   JCI-DFRCC Committee, 2003, J ADV CONCR TECHNOL, V1, P335
   Kamal A, 2008, CEMENT CONCRETE COMP, V30, P863, DOI 10.1016/j.cemconcomp.2008.08.003
   Kunieda M., CONCR SOL INT C, P399
   Kunieda M, 2010, P FRAMCOS 7 JEJ KOR, P1557
   Kunieda M, 2012, J ADV CONCR TECHNOL, V10, P313, DOI 10.3151/jact.10.313
   Li VC, 1998, J MATER CIVIL ENG, V10, P66, DOI 10.1061/(ASCE)0899-1561(1998)10:2(66)
   Li V. C., 2003, J ADV CONCR TECHNOL, V1, P215, DOI DOI 10.3151/JACT.1.215
   Li V.C., 1998, FRACTURE MECH CONCRE, P1715
   Li VC, 1998, FIBER REINFORCED CON, P64
   Li VC, 1993, J STRUCT MECH EARTHQ, V10, P37
   Naaman AE, HIGH PERFORMANCE FIB, P95
   Shannag MJ, 2005, CONSTR BUILD MATER, V19, P500, DOI 10.1016/j.conbuildmat.2005.01.007
   Verderame GM, 2008, ENG STRUCT, V30, P2289, DOI 10.1016/j.engstruct.2008.01.024
NR 18
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-0296
EI 1873-7323
J9 ENG STRUCT
JI Eng. Struct.
PD JUN 1
PY 2017
VL 140
BP 151
EP 163
DI 10.1016/j.engstruct.2017.02.049
PG 13
WC Engineering, Civil
SC Engineering
GA ET1MM
UT WOS:000400033500013
OA No
DA 2017-08-17
ER

PT J
AU Heesakkers, J
   Farag, F
   Bauer, RM
   Sandhu, J
   De Ridder, D
   Stenzl, A
AF Heesakkers, John
   Farag, Fawzy
   Bauer, Ricarda M.
   Sandhu, Jaspreet
   De Ridder, Dirk
   Stenzl, Arnulf
TI Pathophysiology and Contributing Factors in Postprostatectomy
   Incontinence: A Review
SO EUROPEAN UROLOGY
LA English
DT Review
DE Urinary sphincter; Prostatectomy; Urinary incontinence; Pathophysiology;
   Fibrosis; Innervation
ID RADICAL RETROPUBIC PROSTATECTOMY; URINARY CONTINENCE RECOVERY; BLADDER
   NECK PRESERVATION; MALE URETHRAL SPHINCTER; NERVE-SPARING TECHNIQUE;
   TERM-FOLLOW-UP; 3-DIMENSIONAL RECONSTRUCTION; FUNCTIONAL OUTCOMES; SLING
   SUSPENSION; LAPAROSCOPIC PROSTATECTOMY
AB Context: The incidence and awareness of postprostatectomy incontinence (PPI) has increased during the past few years, probably because of an increase in prostate cancer surgery. Many theories have been postulated to explain the pathophysiology of PPI.
   Objective: The current review scrutinizes various pathophysiologic mechanisms underlying the occurrence of PPI.
   Evidence acquisition: A search was conducted on PubMed and EMBASE for publications on PPI. The primary search returned 2518 publications. Animal and basic research studies, letters, publications on prostatectomy for benign reasons, pathology of prostatic carcinoma, radiotherapy and hormone therapy of prostatic carcinoma, and review articles were all used as criteria for exclusion from the study. A total of 128 publications were selected for final analysis.
   Evidence synthesis: Neuromuscular anatomic elements and pelvic support are known to influence PPI as evidenced by multiple publications. A number of non-anatomic and surgical elements have been postulated as contributing factors to PPI. Biological factors and preoperative parameters include: functional bladder changes, age, body mass index (BMI), preexisting lower urinary tract symptoms (LUTS), prostate size, and oncologic factors. Multiple studies reported the impact of specific anatomic/surgical factors, including fibrosis, shorter membranous urethral length (MUL), anastomotic stricture, damage to the neurovascular bundle, and extensive dissection, all of which have a negative impact on the continence status of patients following radical prostatectomy (RP). Investigation of the impact of techniques to spare the bladder neck and additional procedures to reconstruct the posterior or anterior support structures (eg, the Rocco stitch) on continence status is ongoing.
   Conclusions: Anatomic support and pelvic innervation appear to be important factors in the etiology of PPI. Biological/preoperative factors including greater age at time of surgery, preexisting LUTS, high BMI, shorter MUL, and functional bladder changes have a negative impact on continence after RP. Extensive dissection during surgery, damage to the neurovascular bundle, and postoperative fibrosis also have a substantial negative impact on the continence status of men undergoing RP. Sparing of the bladder neck and anterior fixation of the bladder-urethra anastomosis are associated with better continence rates. There is still debate about whether posterior pelvic reconstruction leads to better postoperative continence rates.
   Patient summary: Radical prostatectomy is an oncologic procedure and thus requires removal of the entire prostate gland and seminal vesicles, ideally with negative surgical margins. This sometimes results in urinary incontinence. The factors contributing to urinary incontinence are explained in this article. (C) 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.
C1 [Heesakkers, John] Radboud Univ Nijmegen, Dept Urol, Med Ctr, Nijmegen, Netherlands.
   [Farag, Fawzy] Sohag Univ Hosp, Dept Urol, Sohag, Egypt.
   [Bauer, Ricarda M.] Ludwig Maximilians Univ Munchen, Dept Urol, Munich, Germany.
   [Sandhu, Jaspreet] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA.
   [De Ridder, Dirk] Univ Hosp KU, Dept Urol, Leuven, Belgium.
   [Stenzl, Arnulf] Univ Hosp Tubingen, Dept Urol, Tubingen, Germany.
RP Farag, F (reprint author), Sohag Univ Hosp, Dept Urol, Sohag, Egypt.
EM fawzy.farag@radboudumc.nl
FU EU
FX This manuscript is part of COST Action BM1209 ReST funded by the EU. The
   sponsor played no direct role in the study.
CR Akita K, 2003, SURG RADIOL ANAT, V25, P387, DOI 10.1007/s00276-003-0151-9
   Bauer RM, 2009, EUR UROL, V56, P928, DOI 10.1016/j.eururo.2009.07.028
   Boczko J, 2007, J ENDOUROL, V21, P184, DOI 10.1089/end.2006.0163
   Borin JF, 2007, UROLOGY, V70, P173, DOI 10.1016/j.urology.2007.03.050
   Burkhard FC, 2006, J UROLOGY, V176, P189, DOI 10.1016/S0022-5347(06)00574-X
   Burnett AL, 1998, J UROLOGY, V160, P1301, DOI 10.1016/S0022-5347(01)62521-7
   Cambio AJ, 2006, EUR UROL, V50, P903, DOI 10.1016/j.eururo.2006.08.009
   CATALONA WJ, 1993, J UROLOGY, V150, P905
   Chade DC, 2012, EUR UROL, V61, P961, DOI 10.1016/j.eururo.2012.01.022
   Costello AJ, 2004, BJU INT, V94, P1071, DOI 10.1111/j.1464-410X.2004.05106.x
   De Ridder D, 2011, EUR UROL SUPPL, V10, P383, DOI 10.1016/j.eursup.2011.04.001
   DELANCEY JOL, 1994, AM J OBSTET GYNECOL, V170, P1713
   Dubbelman Y, 2012, NEUROUROL URODYNAM, V31, P637, DOI 10.1002/nau.21199
   ELDER JS, 1984, J UROLOGY, V132, P55
   Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045
   GOSLING JA, 1975, BRIT J UROL, V47, P549, DOI 10.1111/j.1464-410X.1975.tb06260.x
   GOSLING JA, 1981, BRIT J UROL, V53, P35, DOI 10.1111/j.1464-410X.1981.tb03125.x
   Gozzi C, 2008, EUR UROL, V54, P257, DOI 10.1016/j.eururo.2008.03.098
   Catarin MVG, 2008, J UROLOGY, V180, P2527, DOI 10.1016/j.juro.2008.08.020
   Hakimi AA, 2011, J ENDOUROL, V25, P1025, DOI 10.1089/end.2010.0692
   Hoyland Kimberley, 2014, Rev Urol, V16, P181
   Hsu EI, 2003, UROLOGY, V61, P601, DOI 10.1016/S0090-4295(02)02422-6
   Hurtes X, 2012, BJU INT, V110, P875, DOI 10.1111/j.1464-410X.2011.10849.x
   Kadono Y, 2016, NEUROUROL URODYNAM, V35, P1034, DOI 10.1002/nau.22877
   Karakiewicz PI, 2004, EUR UROL, V46, P188, DOI 10.1016/j.eururo.2004.04.020
   Karam I, 2005, J ANAT, V206, P395, DOI 10.1111/j.1469-7580.2005.00402.x
   Karam I, 2005, EUR UROL, V48, P858, DOI 10.1016/j.eururo.2005.03.016
   Kaye DR, 2013, UROLOGY, V82, P1348, DOI 10.1016/j.urology.2013.06.067
   Kim IY, 2010, YONSEI MED J, V51, P427, DOI 10.3349/ymj.2010.51.3.427
   KIRSCHNERHERMANNS R, 1993, BRIT J UROL, V72, P715, DOI 10.1111/j.1464-410X.1993.tb16254.x
   Konety BR, 2007, J UROLOGY, V177, P1423, DOI 10.1016/j.juro.2006.11.089
   Koraitim MM, 2008, J UROLOGY, V179, P1683, DOI 10.1016/j.juro.2008.01.010
   Lee H, 2015, KOREAN J UROL, V56, P803, DOI 10.4111/kju.2015.56.12.803
   Lepor H, 2004, J UROLOGY, V171, P1212, DOI 10.1097/01.ju.0000110631.81774.9c
   Loughlin KR, 2010, J UROLOGY, V183, P871, DOI 10.1016/j.juro.2009.11.011
   Marien TP, 2008, BJU INT, V102, P1581, DOI 10.1111/j.1464-410X.2008.07921.x
   Matsushita K, 2015, BJU INT, V116, P577, DOI 10.1111/bju.13087
   Montorsi F, 2005, EUR UROL, V48, P938, DOI 10.1016/j.eururo.2005.09.004
   Murphy DG, 2013, EUR UROL, V63, P445, DOI 10.1016/j.eururo.2012.08.031
   Myers RP, 2002, UROLOGY, V59, P472, DOI 10.1016/S0090-4295(02)01500-5
   Nelson CP, 2003, J UROLOGY, V169, P2225, DOI 10.1097/01.ju.0000058213.15524.90
   Nguyen L, 2008, J UROLOGY, V179, P1907, DOI 10.1016/j.juro.2008.01.036
   Nguyen MM, 2008, BJU INT, V101, P1135, DOI 10.1111/j.1464-410X.2007.07425.x
   Novara G, 2010, J UROLOGY, V184, P1028, DOI 10.1016/j.juro.2010.04.069
   Ozdemir MB, 2007, PROSTATE CANCER P D, V10, P77, DOI 10.1038/sj.pcan.4500917
   Palisaar JR, 2009, BJU INT, V104, P611, DOI 10.1111/j.1464-410X.2009.08474.x
   Paparel P, 2009, EUR UROL, V55, P629, DOI 10.1016/j.eururo.2008.08.057
   Park JM, 1997, BRIT J UROL, V80, P940, DOI 10.1046/j.1464-410X.1997.00488.x
   Pettus JA, 2009, J UROLOGY, V182, P949, DOI 10.1016/j.juro.2009.05.029
   Rehder P, 2007, EUR UROL, V52, P860, DOI 10.1016/j.eururo.2007.01.110
   Rehder P, 2012, EUR UROL, V62, P140, DOI 10.1016/j.eururo.2012.02.038
   Rehder Peter, 2009, Archivos Espanoles de Urologia, V62, P860
   RICHARDSON AC, 1993, CLIN OBSTET GYNECOL, V36, P976, DOI 10.1097/00003081-199312000-00022
   Rocco F, 2007, EUR UROL, V52, P376, DOI 10.1016/j.eururo.2007.01.109
   Rodriguez E, 2006, UROLOGY, V67, P785, DOI 10.1016/j.urology.2005.10.006
   Sacco E, 2006, BJU INT, V97, P1234, DOI 10.1111/j.1464-410X.2006.06185.x
   Schlomm T, 2011, EUR UROL, V60, P320, DOI 10.1016/j.eururo.2011.02.040
   Selli C, 2004, SCAND J UROL NEPHROL, V38, P32, DOI 10.1080/00365590310017280
   Soljanik I, 2014, WORLD J UROL, V32, P1375, DOI 10.1007/s00345-014-1241-5
   Song C, 2010, BJU INT, V106, P681, DOI 10.1111/j.1464-410X.2009.09189.x
   Srivastava A, 2013, EUR UROL, V63, P438, DOI 10.1016/j.eururo.2012.07.009
   STEINER MS, 1994, UROLOGY, V44, P530, DOI 10.1016/S0090-4295(94)80052-9
   Stolzenburg JU, 2010, UROL INT, V85, P135, DOI 10.1159/000314842
   Stolzenburg JU, 2006, EUR UROL, V49, P103, DOI 10.1016/j.eururo.2005.10.002
   Strasser H, 2004, UROLOGE A, V43, P128, DOI 10.1007/s00120-003-0500-7
   Suskind AM, 2014, NEUROUROL URODYNAM, V33, P312, DOI 10.1002/nau.22408
   Takenaka A, 2005, UROLOGY, V65, P136, DOI 10.1016/j.urology.2004.08.028
   Tan GY, 2009, UROLOGY, V74, P492, DOI 10.1016/j.urology.2009.02.005
   Tan GY, 2009, EXPERT REV MED DEVIC, V6, P431, DOI [10.1586/erd.09.19, 10.1586/ERD.09.19]
   TANAGHO EA, 1982, UROLOGY, V20, P415, DOI 10.1016/0090-4295(82)90468-X
   Tuygun C, 2006, UROLOGY, V68, P1308, DOI 10.1016/j.urology.2006.08.1080
   van Randenborgh H, 2004, PROSTATE CANCER P D, V7, P253, DOI 10.1038/sj.pcan.4500726
   Wei JT, 2000, J UROLOGY, V164, P744, DOI 10.1016/S0022-5347(05)67294-1
   Wiltz AL, 2009, UROLOGY, V73, P316, DOI 10.1016/j.urology.2008.08.493
   Wolin KY, 2010, J UROLOGY, V183, P629, DOI 10.1016/j.juro.2009.09.082
   Yucel S, 2004, J UROLOGY, V172, P1973, DOI 10.1097/01.ju.0000142131.37693.05
   Zhang C, 2010, DIS COLON RECTUM, V53, P1315, DOI 10.1007/DCR.0b013e3181e74525
NR 77
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0302-2838
EI 1873-7560
J9 EUR UROL
JI Eur. Urol.
PD JUN
PY 2017
VL 71
IS 6
BP 936
EP 944
DI 10.1016/j.eururo.2016.09.031
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA ET1SX
UT WOS:000400050300027
PM 27720536
OA No
DA 2017-08-17
ER

PT J
AU Amagai, Y
   Gowayed, S
   Martinek, P
   Watanabe, N
AF Amagai, Y.
   Gowayed, S.
   Martinek, P.
   Watanabe, N.
TI The third glume phenotype is associated with rachilla branching in the
   spikes of tetraploid wheat (Triticum L.)
SO GENETIC RESOURCES AND CROP EVOLUTION
LA English
DT Article
DE False-true ramification; Rachilla branching; Ramification; Tetraploid
   wheat; Third glume; Triticum L.
ID SUPERNUMERARY SPIKELETS; INHERITANCE; GENES
AB We investigated the new inflorescence architectural character "three glumes" and a new status of ramification in tetraploid wheat. Using 9 tetraploid accessions with "turgidum type of branching", the segregation of branched spike and the third glume indicated the complete linkage of genes for both phenotypes. The rachilla were elongated and bore florets at basal nodes while bearing spikelets at the apical nodes in T. durum Desf. TRI 9644 and T. turgidum L. PI 67339. The phenotype was different from "sham-ramification" in Triticum jakubzineri Udacz. et Schachm., with florets at basal and apical nodes of elongated spikelet rachilla. We confirmed a new status of ramification, "false-true ramification". It was considered that the "false-true ramification" was determined by the shr2 gene in the long arm of chromosome 2A because the ramification of PI 67339 and TRI 9644 was supposed to be allelic. The segregation of "sham-ramification" and the third glume also indicated the complete linkage of genes for both phenotypes. Thus we concluded that the presence of third glume phenotype is associated with rachis and rachilla branching in the spikes of tetraploid wheat. The present study confirmed the existence of three distinct types of spike ramification, whose classification is not entirely unified: (a) "true ramification"-"branched spike"-"genuine branching"-"turgidum type of branching", (b) "false ramification"-"pseudo-branched spike"-"sham ramification"-"vavilovii type of branching" and (c) "false-true ramification".
C1 [Amagai, Y.; Watanabe, N.] Ibaraki Univ, Coll Agr, 3-21-1 Chuo, Inashiki, Ibaraki 3000393, Japan.
   [Amagai, Y.] Tokyo Univ Agr & Technol, United Grad Sch Agr Sci, 3-5-8 Saiwai, Fuchu, Tokyo 1808509, Japan.
   [Gowayed, S.] Univ Jeddah, Dept Biol, Fac Sci, Jeddah 21589, Saudi Arabia.
   [Gowayed, S.] Suez Canal Univ, Dept Bot, Fac Agr, Ismailia 41522, Egypt.
   [Martinek, P.] Agrotest Fyto Ltd, Havlickova 2787, Kromeriz 76701, Czech Republic.
   [Watanabe, N.] Little Nursery, 6-18-12 Shin Machi, Toride, Ibaraki 3020024, Japan.
RP Watanabe, N (reprint author), Ibaraki Univ, Coll Agr, 3-21-1 Chuo, Inashiki, Ibaraki 3000393, Japan.
EM watnb@tulip.sannet.ne.jp
FU Ministry of Agriculture of the Czech Republic [QJ1510206, RO0211]
FX NW thanks the Leibniz Institute of Plant Genetics and Crop Plant
   Research (IPK), Gatersleben, Germany, the Germplasm Unit, John Innes
   Centre, Norwich, UK, the National Small Grain Collection, Aberdeen,
   Idaho, USA, Dr. N.P. Goncharov, Institute of Cytology and Genetics, SB
   RAS, Novosibirsk, Russia and the late Prof. P.A. Gandilyan, Armenian
   Agricultural Academy, Yerevan, Armenia for providing us the seed of
   accessions for these experiments. We thank Dr. D.L. Klindworth,
   USDA-ARS, Northern Crop Science Laboratory, Fargo, for helpful comments
   on the manuscript. PM thanks for projects QJ1510206 and RO0211 of the
   Ministry of Agriculture of the Czech Republic.
CR Amagai Y, 2014, GENET RESOUR CROP EV, V61, P491, DOI 10.1007/s10722-013-0052-7
   Dobrovolskaya O, 2015, PLANT PHYSIOL, V167, P189, DOI 10.1104/pp.114.250043
   Gowayed S, 2009, THESIS U KASSEL WITZ, P1
   Hammer K, 2011, GENET RESOUR CROP EV, V58, P3, DOI 10.1007/s10722-010-9590-4
   KLINDWORTH DL, 1990, GENOME, V33, P509
   KLINDWORTH DL, 1990, GENOME, V33, P515
   Klindworth DL, 1997, J HERED, V88, P229
   PENNELL AL, 1983, EUPHYTICA, V32, P767, DOI 10.1007/BF00042157
   Poursarebani N, 2015, GENETICS, V201, P155, DOI 10.1534/genetics.115.176628
   Udachin RA, 1977, VESTN S KH NAUKI MOS, V2, P41
   Udachin RA, 1976, T PRIKL BOT GENET, V56, P147
   Wang ZM, 2001, PHOTOSYNTHETICA, V39, P239, DOI 10.1023/A:1013743523029
NR 12
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-9864
EI 1573-5109
J9 GENET RESOUR CROP EV
JI Genet. Resour. Crop Evol.
PD JUN
PY 2017
VL 64
IS 5
BP 835
EP 842
DI 10.1007/s10722-017-0503-7
PG 8
WC Agronomy; Plant Sciences
SC Agriculture; Plant Sciences
GA ET2JP
UT WOS:000400098000001
OA No
DA 2017-08-17
ER

PT J
AU Youssef, HM
   Mascher, M
   Ayoub, MA
   Stein, N
   Kilian, B
   Schnurbusch, T
AF Youssef, Helmy M.
   Mascher, Martin
   Ayoub, Mohammad A.
   Stein, Nils
   Kilian, Benjamin
   Schnurbusch, Thorsten
TI Natural diversity of inflorescence architecture traces cryptic
   domestication genes in barley (Hordeum vulgare L.)
SO GENETIC RESOURCES AND CROP EVOLUTION
LA English
DT Article
DE Barley domestication; Hordeum vulgare; Int-c; Intermedium barleys;
   Spikelet fertility; Vrs1
ID GENOME ASSOCIATION; SPIKELET FERTILITY; WHEAT; GENETICS; LOCUS; TOOL
AB Many-grained mutants occurring spontaneously among their less well-endowed field mates may have appeared to early farmers as fortunate twists of fate foreboding wealth and abundance. In domesticated barley, the number of kernel rows in spike can be tripled by recessive mutant alleles at the Six-rowed spike 1 (vrs1) locus that abolish the suppression of lateral spikelet fertility. In another barley row-type, so called intermedium-spike (int), lateral floret size is often intermediate between six-and two-rowed types. Phenotypic and sequence analyses of our intermedium-spike collection revealed that other genes can increase the size of florets and even stimulate occasional grain setting in lateral spikelets. Here, we show that a complete six-rowed phenotype occurs in a diverse panel of intermedium-spike barley carrying wildtype Vrs1 in the presence of the Int-c.a allele of the intermedium spike-c (int-c) gene, previously considered only as a modifier of lateral spikelet fertility. Int-c.a-type alleles had arisen before domestication and are associated with the enlargement of lateral florets in wild barley, suggesting that natural selection/evolution acts towards reduced lateral floret size. Since Int-c.a cannot overcome the suppression of lateral florets in the genomic background of wild barleys, we infer the existence of other gene loci, at which novel alleles or allelic combinations were selected for after domestication, to increase grain number of barley independently of Vrs1.
C1 [Youssef, Helmy M.; Mascher, Martin; Ayoub, Mohammad A.; Stein, Nils; Kilian, Benjamin; Schnurbusch, Thorsten] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Corrensstr 3, D-06466 Seeland, Germany.
   [Youssef, Helmy M.; Ayoub, Mohammad A.] Cairo Univ, Fac Agr, Giza 12613, Egypt.
   [Kilian, Benjamin] Global Crop Divers Trust, Bonn, Germany.
RP Youssef, HM; Schnurbusch, T (reprint author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Corrensstr 3, D-06466 Seeland, Germany.
EM Youssef@ipk-gatersleben.de; thor@ipk-gatersleben.de
OI Mascher, Martin/0000-0001-6373-6013; Ayoub, Mohammad/0000-0001-9371-3277
FU HEISENBERG Program of the German Research Foundation (DFG) [SCHN
   768/8-1, SCHN 768/9-1]
FX The authors gratefully acknowledge the careful maintenance and supply of
   the intermedium-spike barley accessions from the Federal ex situ
   Genebank of Germany. We are grateful to Michael Grau for supporting the
   phenotypic characterization of the intermedium-spike collection. We
   thank Hend Ibrahim, S. Konig and I. Walde for excellent technical
   assistance. We kindly acknowledge Robbie Waugh (James Hutton Institute,
   Dundee, Scotland) and Gary Muehlbauer (University of Minnesota, St.
   Paul, USA) for providing pre-publication access to exome sequence data.
   We thank Heike Ernst for photography work, Karin Lipfert for help with
   figures and Frank Blattner for helpful discussions and the provision of
   DNA material of Hordeum species. This work was supported by Grants from
   the HEISENBERG Program of the German Research Foundation (DFG), Grant
   No. SCHN 768/8-1 and SCHN 768/9-1 to TS and IPK core funding to MM.
CR Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373
   Bates D., 2014, J STAT SOFTWAR UNPUB, DOI DOI 10.18637/JSS.V067.I01
   BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289
   Boden SA, 2015, NAT PLANTS, V1, P1, DOI [10.1038/nplants.2014.16, 10.1038/NPLANTS.2014.16]
   Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534
   Brassac J, 2015, SYST BIOL, V64, P792, DOI 10.1093/sysbio/syv035
   Dobrovolskaya O, 2015, PLANT PHYSIOL, V167, P189, DOI 10.1104/pp.114.250043
   Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.1313/1-92559-287-7:141
   Forster BP, 2007, ANN BOT-LONDON, V100, P725, DOI 10.1093/aob/mcm183
   HAMMER K, 1984, Kulturpflanze, V32, P11
   HARLAN JR, 1973, EVOLUTION, V27, P311, DOI 10.1111/j.1558-5646.1973.tb00676.x
   Harlan JR, 1968, USDA AGR HDB, V338, P9
   International Barley Genome Sequencing Consortium, 2012, NATURE, V491, P711, DOI DOI 10.1038/NATURE11543
   Kirby EM, 1984, CEREAL DEV GUIDE CER, P1
   Komatsuda T, 2002, THEOR APPL GENET, V105, P85, DOI 10.1007/s00122-001-0858-0
   Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104
   Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444
   LUNDQVIST U., 1997, BARLEY GENET NEWSL, V26, P22
   Mansfeld R, 1950, THEOR APPL GENET, V20, P8
   Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294
   Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139
   Poursarebani N, 2015, GENETICS, V201, P155, DOI 10.1534/genetics.115.176628
   Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745
   Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103
   Russell J, 2016, NAT GENET, V48, P1024, DOI 10.1038/ng.3612
   Sakuma S, 2013, NEW PHYTOL, V197, P939, DOI 10.1111/nph.12068
   VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980
   Wilkins AS, 2014, GENETICS, V197, P795, DOI 10.1534/genetics.114.165423
   Youssef HM, 2017, NAT GENET, V49, P157, DOI 10.1038/ng.3717
   Youssef HM, 2014, THEOR APPL GENET, V127, P1123, DOI 10.1007/s00122-014-2284-0
NR 32
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-9864
EI 1573-5109
J9 GENET RESOUR CROP EV
JI Genet. Resour. Crop Evol.
PD JUN
PY 2017
VL 64
IS 5
BP 843
EP 853
DI 10.1007/s10722-017-0504-6
PG 11
WC Agronomy; Plant Sciences
SC Agriculture; Plant Sciences
GA ET2JP
UT WOS:000400098000002
OA No
DA 2017-08-17
ER

PT J
AU Rakha, M
   Bouba, N
   Ramasamy, S
   Regnard, JL
   Hanson, P
AF Rakha, Mohamed
   Bouba, Ndeye
   Ramasamy, Srinivasan
   Regnard, Jean-Luc
   Hanson, Peter
TI Evaluation of wild tomato accessions (Solanum spp.) for resistance to
   two-spotted spider mite (Tetranychus urticae Koch) based on trichome
   type and acylsugar content
SO GENETIC RESOURCES AND CROP EVOLUTION
LA English
DT Article
DE Insect resistance; Solanum cheesmaniae; S. galapagense; S.
   pimpinellifolium; Trichomes
ID HOST-PLANT RESISTANCE; LYCOPERSICON-PENNELLII; BEMISIA-TABACI;
   FRANKLINIELLA-OCCIDENTALIS; GLANDULAR TRICHOMES; HIRSUTUM; ARGENTIFOLII;
   OVIPOSITION; POPULATIONS; MECHANISMS
AB Tomato wild relatives are important sources of resistance to many pests of cultivated tomato [Solanum lycopersicum L. (syn. Lycopersicon esculentum Mill.)]. Eleven wild tomato accessions previously identified at AVRDC-The World Vegetable Center as resistant to Bemisia tabaci were evaluated for resistance to the two-spotted spider mite [Tetranychus urticae (Koch.)] based on egg numbers using the leaf disc and Tanglefoot no-choice bioassays, and damage scores in choice bioassays. Highest resistance based on choice and no-choice bioassays was identified in AVRDC S. galapagense accessions VI057400, VI045262, VI037869 and VI037239, and S. cheesmaniae accession VI037240, all of which are new sources of T. urticae resistance. In addition, S. pimpinellifolium accession VI030462 exhibited resistance only in the no-choice bioassay based on egg numbers. Resistance to T. urticae based on the number of eggs from the no-choice bioassays was positively correlated with density of type IV glandular trichomes and negatively correlated with densities of type V trichomes. All resistant accessions accumulated high levels of total acylsugars, which were positively associated with type IV trichomes. There was a significant negative relationship between acylsugar content and T. urticae egg numbers from the no-choice bioassays. There was high correlation between the results from the leaf disc test and the Tanglefoot no-choice bioassay. These findings support the possible presence of broad-based insect and mite resistance in accessions closely related to cultivated tomato.
C1 [Rakha, Mohamed; Ramasamy, Srinivasan; Hanson, Peter] World Vegetable Ctr, POB 42, Tainan 74199, Taiwan.
   [Rakha, Mohamed] Kafrelsheikh Univ, Fac Agr, Dept Hort, Kafr Al Sheikh 33516, Egypt.
   [Bouba, Ndeye; Regnard, Jean-Luc] Montpellier SupAgro, UMR AGAP 1334, TA-A-108-03,Ave Agropolis, F-34398 Montpellier 5, France.
RP Rakha, M (reprint author), World Vegetable Ctr, POB 42, Tainan 74199, Taiwan.; Rakha, M (reprint author), Kafrelsheikh Univ, Fac Agr, Dept Hort, Kafr Al Sheikh 33516, Egypt.
EM mohamed.rakha@worldveg.org
FU AVRDC Innovations Fund
FX We thank Grace Hsu for acylsugar analysis, Su Fu-cheng for rearing
   spider mites, and Maureen Mecozzi for editing the manuscript. Financial
   support from the AVRDC Innovations Fund is gratefully acknowledged. Core
   funding to support AVRDC activities worldwide is provided by the
   Republic of China (ROC), UK Department for International Development
   (UK/DFID), United States Agency for International Development (USAID),
   Germany, Thailand, Philippines, Korea, and Japan.
CR Antonious GF, 2006, J ENVIRON SCI HEAL B, V41, P43, DOI 10.1080/03601230500234893
   Antonious GF, 2001, J ENVIRON SCI HEAL B, V36, P835, DOI 10.1081/PFC-100107416
   Ben-Israel I, 2009, PLANT PHYSIOL, V151, P1952, DOI 10.1104/pp.109.146415
   Bleeker PM, 2012, P NATL ACAD SCI USA, V109, P20124, DOI 10.1073/pnas.1208756109
   BUTTER NS, 1989, PHYTOPARASITICA, V17, P251, DOI 10.1007/BF02980754
   CHANNARAYAPPA, 1992, CAN J BOT, V70, P2184
   de Azevedo SM, 2003, EUPHYTICA, V134, P347, DOI 10.1023/B:EUPH.0000005007.14924.d2
   Oriani MAD, 2011, SCI AGR, V68, P147, DOI 10.1590/S0103-90162011000200003
   de Resende JTV, 2006, SCI AGR, V63, P20, DOI 10.1590/S0103-90162006000100004
   Dermauw W, 2012, INSECT BIOCHEM MOLEC, V42, P455, DOI 10.1016/j.ibmb.2012.03.002
   DIMOCK MB, 1983, ENTOMOL EXP APPL, V33, P263
   EAST DA, 1992, CROP PROT, V11, P39, DOI 10.1016/0261-2194(92)90077-I
   Fernandez-Munoz R, 2000, EUPHYTICA, V111, P169, DOI 10.1023/A:1003893432676
   Firdaus S, 2012, EUPHYTICA, V187, P31, DOI 10.1007/s10681-012-0704-2
   Frelichowski JE, 2001, J ECON ENTOMOL, V94, P1249, DOI 10.1603/0022-0493-94.5.1249
   Ghidiu GM, 2006, FLA ENTOMOL, V89, P279, DOI 10.1653/0015-4040(2006)89[279:GDTTFC]2.0.CO;2
   Gimenez-Ferrer R. M., 1993, HortScience, V28, P841
   GOFFREDA JC, 1989, J CHEM ECOL, V15, P2135, DOI 10.1007/BF01207444
   GOOD DE, 1988, HORTSCIENCE, V23, P891
   Gurr GM, 2001, ANN APPL BIOL, V138, P221, DOI 10.1111/j.1744-7348.2001.tb00106.x
   HAWTHORNE DJ, 1992, ENTOMOL EXP APPL, V65, P65
   Kang JH, 2010, J EXP BOT, V61, P1053, DOI 10.1093/jxb/erp370
   Khajehali J, 2011, PEST MANAG SCI, V67, P1424, DOI 10.1002/ps.2191
   Leckie BM, 2012, MOL BREEDING, V30, P1621, DOI 10.1007/s11032-012-9746-3
   LIEDL BE, 1995, J ECON ENTOMOL, V88, P742
   Lucatti AF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-175
   Lucini T, 2015, ARTHROPOD-PLANT INTE, V9, P45, DOI 10.1007/s11829-014-9347-7
   LUCKWILL L. C., 1943, The genus Lycopersicon. An historical, biological, and taxonomic survey of the wild and cultivated tomatoes.
   Maharijaya A, 2011, EUPHYTICA, V177, P401, DOI 10.1007/s10681-010-0277-x
   Maluf WR, 2007, PESQUI AGROPECU BRAS, V42, P1227, DOI 10.1590/S0100-204X2007000900003
   Maluf WR, 2001, EUPHYTICA, V121, P73, DOI 10.1023/A:1012067505361
   Muigai SG, 2002, PHYTOPARASITICA, V30, P347, DOI 10.1007/BF02979682
   Onyambus GK, 2011, EXP APPL ACAROL, V54, P385, DOI 10.1007/s10493-011-9446-4
   Park YL, 2002, J ECON ENTOMOL, V95, P952, DOI 10.1603/0022-0493-95.5.952
   Peralta I. E., 2008, SYST BOT MONOGR, V84, P1, DOI DOI 10.2307/25027972
   Perdikis D., 2008, EUROPEAN J PLANT SCI, V2, P125
   Puentes A, 2013, ENTOMOL EXP APPL, V149, P166, DOI 10.1111/eea.12120
   Rakha M, 2015, GENET RESOUR CROP EV, DOI [10.1007/s10722-015-0347-v, DOI 10.1007/S10722-015-0347-V]
   Rick CM, 1971, FLORA GALAPAGOS ISLA, P468
   RODRIGUEZ AE, 1993, J ECON ENTOMOL, V86, P34
   Saeidi Z., 2006, Journal of Biological Sciences, V6, P847
   Saeidi Z, 2007, EUPHYTICA, V154, P231, DOI 10.1007/s10681-006-9291-4
   SANCES FV, 1981, ENVIRON ENTOMOL, V10, P442
   Setter TL, 2001, CROP SCI, V41, P1530
   Sharma HC, 2009, ARTHROPOD-PLANT INTE, V3, P151, DOI 10.1007/s11829-009-9068-5
   Sibanda T, 2000, CROP PROT, V19, P807, DOI 10.1016/S0261-2194(00)00108-3
   Simmons AT, 2005, AGR FOREST ENTOMOL, V7, P265, DOI 10.1111/j.1461-9555.2005.00271.x
   SNYDER JC, 1984, J AM SOC HORTIC SCI, V109, P837
   Tomczyk A, 1985, SPIDER MITES THEIR B, P312
   Van Leeuwen T, 2004, EXP APPL ACAROL, V32, P249, DOI 10.1023/B:APPA.0000023240.01937.6d
   VANHAREN RJF, 1987, EXP APPL ACAROL, V3, P115
NR 51
TC 0
Z9 0
U1 20
U2 20
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-9864
EI 1573-5109
J9 GENET RESOUR CROP EV
JI Genet. Resour. Crop Evol.
PD JUN
PY 2017
VL 64
IS 5
BP 1011
EP 1022
DI 10.1007/s10722-016-0421-0
PG 12
WC Agronomy; Plant Sciences
SC Agriculture; Plant Sciences
GA ET2JP
UT WOS:000400098000014
OA No
DA 2017-08-17
ER

PT J
AU Badawi, MA
   Negm, NA
   Abou Kana, MTH
   Hefni, HH
   Moneem, MMA
AF Badawi, M. A.
   Negm, N. A.
   Abou Kana, M. T. H.
   Hefni, H. H.
   Moneem, M. M. Abdel
TI Adsorption of aluminum and lead from wastewater by chitosan-tannic acid
   modified biopolymers: Isotherms, kinetics, thermodynamics and process
   mechanism
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Tannic acid; Metal removal; Adsorption isotherm; Kinetic
   models; pH
ID MODIFIED MAGNETIC CHITOSAN; HEAVY-METAL IONS; AQUEOUS-SOLUTIONS;
   COPPER(II) IONS; CARBON NANOTUBES; CROSS-LINKING; REMOVAL; EQUILIBRIUM;
   CU(II); CHITIN
AB Chitosan was reacted by tannic acid to obtain three modified chitosan biopolymer. Their chemical structures were characterized by FTIR and elemental analysis. The prepared biopolymers were used to adsorb Al(III) and Pb(II) metal ions from industrial wastewater. The factors affecting the adsorption process were biosorbent amount, initial concentration of metal ion and pH of the medium. The adsorption efficiency increased considerably with the increase of the biosorbent amount and pH of the medium. The adsorption process of biosorbent on different metal ions was fitted by Freundlich adsorption model. The adsorption kinetics was followed Pseudo-second-order kinetic model. The adsorption process occurred according to diffusion mechanism which was confirmed by the interparticle diffusion model. The modified biopolymers were efficient biosorbents for removal of Pb(II) and Al(III) metal ions from the medium. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Badawi, M. A.; Moneem, M. M. Abdel] Cairo Univ, Fac Sci, Dept Chem, Giza, Egypt.
   [Negm, N. A.; Hefni, H. H.] Egyptian Petr Res Inst, Petrochem Dept, Cairo, Egypt.
   [Abou Kana, M. T. H.] Cairo Univ, Natl Inst Laser Enhanced Sci, Giza, Egypt.
RP Negm, NA (reprint author), Egyptian Petr Res Inst, Petrochem Dept, Cairo, Egypt.
EM nabelnegm@hotmail.com
CR Aelenei N, 2009, J MATER SCI-MATER M, V20, P1095, DOI 10.1007/s10856-008-3675-z
   Ahmad M, 2016, INT J BIOL MACROMOL, V92, P910, DOI 10.1016/j.ijbiomac.2016.07.075
   Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1
   Aman T, 2008, COLLOID SURFACE B, V63, P116, DOI 10.1016/j.colsurfb.2007.11.013
   Banat IM, 1995, ACTA BIOTECHNOL, V15, P251, DOI 10.1002/abio.370150302
   Chen BY, 2007, J HAZARD MATER, V149, P508, DOI 10.1016/j.jhazmat.2007.04.022
   Coelho TC, 2007, REACT FUNCT POLYM, V67, P468, DOI 10.1016/j.reactfunctpolym.2007.02.009
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   Dai BY, 2012, J HAZARD MATER, V219, P103, DOI 10.1016/j.jhazmat.2012.03.065
   Debbaudt AL, 2004, CARBOHYD POLYM, V56, P321, DOI 10.1016/j.carbpol.2004.02.009
   El-Gendi A., 2014, EGYPT J PETROL, V23, P169
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Gode F, 2005, FUEL PROCESS TECHNOL, V86, P875, DOI 10.1016/j.fuproc.2004.10.006
   Gok O, 2008, COLLOID SURFACE A, V317, P174, DOI 10.1016/j.colsurfa.2007.10.009
   Hasan M, 2008, CHEM ENG J, V136, P164, DOI 10.1016/j.cej.2007.03.038
   Hussain M.H.M., 2009, ADV CHITIN SCI, VXI, P493
   Jang A, 2005, ENVIRON POLLUT, V133, P117, DOI 10.1016/j.envpol.2004.05.020
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Kannamba B, 2010, J HAZARD MATER, V175, P939, DOI 10.1016/j.jhazmat.2009.10.098
   Karamac M, 2009, INT J MOL SCI, V10, P5485, DOI 10.3390/ijms10125485
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   Li M, 2014, APPL SURF SCI, V314, P1063, DOI 10.1016/j.apsusc.2014.06.038
   Li N, 2005, SEP PURIF TECHNOL, V42, P237, DOI 10.1016/j.seppur.2004.08.002
   Li Q, 2011, DESALINATION, V266, P188, DOI 10.1016/j.desal.2010.08.025
   Li YH, 2010, J HAZARD MATER, V177, P876, DOI 10.1016/j.jhazmat.2009.12.114
   Li YH, 2005, WATER RES, V39, P605, DOI 10.1016/j.watres.2004.11.004
   Mansoorian HJ, 2014, SEP PURIF TECHNOL, V135, P165, DOI 10.1016/j.seppur.2014.08.012
   Mariamne D., 2003, MACROMOL S, V197, P277
   Martel B, 2001, J POLYM SCI POL CHEM, V39, P169, DOI 10.1002/1099-0518(20010101)39:1<169::AID-POLA190>3.0.CO;2-G
   Martinez L, 2007, EUR J PHARM BIOPHARM, V67, P339, DOI 10.1016/j.ejpb.2007.02.012
   Mcafee BJ, 2001, SEPAR SCI TECHNOL, V36, P3207, DOI 10.1081/SS-100107768
   Monteiro OAC, 1999, J COLLOID INTERF SCI, V212, P212, DOI 10.1006/jcis.1998.6063
   Morisada S, 2011, IND ENG CHEM RES, V50, P1875, DOI 10.1021/ie102193a
   Motawie A.M., 2014, EGYPT J PETROL, V23, P221
   Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002
   Osifo PO, 2008, BIORESOURCE TECHNOL, V99, P7377, DOI 10.1016/j.biortech.2008.01.053
   Ozcan A, 2006, COLLOID SURFACE A, V277, P90, DOI 10.1016/j.colsurfa.2005.11.017
   Ozcan A, 2005, J HAZARD MATER, V124, P200, DOI 10.1016/j.hazmat.2005.05.007
   Paulino AT, 2007, J HAZARD MATER, V147, P139, DOI 10.1016/j.jhazmat.2006.12.059
   Pradhan S, 2005, J HAZARD MATER, V125, P201, DOI 10.1016/j.jhazmat.2005.05.029
   Ren YM, 2008, J HAZARD MATER, V158, P14, DOI 10.1016/j.jhazmat.2008.01.044
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rossouw D.T., 1979, J APPL POLYM SCI, V24, P1571
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Septhum C, 2007, J HAZARD MATER, V148, P185, DOI 10.1016/j.jhazmat.2007.02.024
   Shalaby N.H., 2016, EGYPT J PET IN PRESS
   Srivastava NK, 2008, J HAZARD MATER, V151, P1, DOI 10.1016/j.jhazmat.2007.09.101
   Steenkamp GC, 2002, J MEMBRANE SCI, V197, P147, DOI 10.1016/S0376-7388(01)00608-1
   Sun SL, 2006, SEP PURIF TECHNOL, V51, P409, DOI 10.1016/j.seppur.2006.03.004
   Unlu N, 2006, J HAZARD MATER, V136, P272, DOI 10.1016/j.jhazmat.2005.12.013
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Vieira RS, 2005, ADSORPTION, V11, P731, DOI 10.1007/s10450-005-6015-3
   Vijaya Y, 2008, CARBOHYD POLYM, V72, P261, DOI 10.1016/j.carbpol.2007.08.010
   Wan Ngah W. S., 2008, Chemical Engineering Journal, V143, P62, DOI 10.1016/j.cej.2007.12.006
   Wang YH, 2003, J HAZARD MATER, V102, P291, DOI 10.1016/S0304-3894(03)00218-8
   WanNgah W.S., 2005, BIORESOURCE TECHNOLO, V96, P443
   Ngah W. Wan, 2002, REACT FUNCT POLYM, V50, P181, DOI DOI 10.1016/S1381-5148(01)00113-4
   Wasay SA, 1998, ENVIRON TECHNOL, V19, P369, DOI 10.1080/09593331908616692
   Zhao F, 2007, J HAZARD MATER, V147, P67, DOI 10.1016/j.jhazmat.2006.12.045
   Zhou LM, 2009, J HAZARD MATER, V161, P995, DOI 10.1016/j.jhazmat.2008.04.078
   Zhu YH, 2012, J HAZARD MATER, V221, P155, DOI 10.1016/j.jhazmat.2012.04.026
NR 62
TC 0
Z9 0
U1 54
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN
PY 2017
VL 99
BP 465
EP 476
DI 10.1016/j.ijbiomac.2017.03.003
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA ET1MS
UT WOS:000400034100053
PM 28267611
OA No
DA 2017-08-17
ER

PT J
AU Alsaggaf, MS
   Moussa, SH
   Tayel, AA
AF Alsaggaf, Mohammed S.
   Moussa, Shaaban H.
   Tayel, Ahmed A.
TI Application of fungal chitosan incorporated with pomegranate peel
   extract as edible coating for microbiological, chemical and sensorial
   quality enhancement of Nile tilapia fillets
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Antimicrobial; Biopolymer; Natural; Preservation; Shelf life;
   Oreochromis niloticus
ID OREOCHROMIS-NILOTICUS; PROXIMATE COMPOSITION; FROZEN STORAGE; SILVER
   CARP; SHELF-LIFE; FISH; ANTIOXIDANT; COMPOSITE; PRODUCTS; SAUSAGES
AB Fish are generous sources for providing man with his essential nutritional requirements, but the extreme susceptibility to quality deterioration hinders their optimal usage and storage. Natural derivatives are always the perfect alternatives for food preservation. The application of fungal chitosan (Ch), from Aspergillus niger, and pomegranate peel extract (PPE), in coating films for Nile tilapia (Oreochromis niloticus) fillets preservation and maintaining their microbiological, chemical and sensorial quality during cooled storage at 4 degrees C for 30 days, was investigated. Fish fillet were coated with Ch (2%) and combined Ch + PPE, at PPE percentages of 0.5, 1.0, 1.5 and 2.0%. Fillets coating resulted in sharp decrease of the entire microbial counts during storage; the increased concentrations from PPE strengthened coating film antimicrobial activity. Additionally, fillets coating could retard the chemical spoilage parameters increasing, i.e. nitrogen volatile base (TVB-N), peroxide value (PV) and reactive substances of thiobarbituric acid (TBARS), during storage period. The sensory evaluation indicated higher preferences for the odor, texture, color and overall quality of coated samples. Fish fillets coating with Ch and Ch + PPE could be recommended for shelf life extension and maintaining the microbiological, chemical and sensorial quality through the application of safe preservatives from natural origins. (C) 2017 Elsevier. B.V. All rights reserved.
C1 [Alsaggaf, Mohammed S.; Moussa, Shaaban H.] Shaqra Univ, Coll Sci & Humanitarian Studies, Qwaieah 11971, Saudi Arabia.
   [Moussa, Shaaban H.] Univ Sadat City, Genet Engn & Biotechnol Res Inst, Sadat, Egypt.
   [Tayel, Ahmed A.] Kafrelsheikh Univ, Fac Aquat & Fisheries Sci, El Geish St, Kafrelsheikh City 33516, Egypt.
RP Tayel, AA (reprint author), Kafrelsheikh Univ, Fac Aquat & Fisheries Sci, El Geish St, Kafrelsheikh City 33516, Egypt.
EM tayel_ahmad@yahoo.com
OI Moussa, Shaaban/0000-0002-3067-1265
CR AOAC, 1990, OFFICIAL METHODS ANA
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   British Standards Institution, 2152712008 ISO BSI
   British Standards Institution, 1664922001 ISO BSI
   British Standards Institution, 657922012 ISOTS BSI
   [Anonymous], 688811999 ISO BSI
   British Standards Institution, 48332003 ISO BSI
   British Standards Institution, 174102001 ISO BSI
   British Standards Institution, 2152822004 ISO BSI
   British Standards Institution, 48322006 ISO BSI
   Connell J.J., 1990, CONTROL FISH QUALITY
   Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564
   Egan H., 1997, PEARSONS CHEM ANAL F
   Emire SA, 2010, J FOOD PROCESS PRES, V34, P743, DOI 10.1111/j.1745-4549.2009.00392.x
   Fan WJ, 2008, FOOD CHEM, V108, P148, DOI 10.1016/j.foodchem.2007.10.057
   Fan WJ, 2009, FOOD CHEM, V115, P66, DOI 10.1016/j.foodchem.2008.11.060
   Garduno-Lugo M, 2003, AQUAC RES, V34, P1023, DOI 10.1046/j.1365-2109.2003.00904.x
   Georgantelis D, 2007, MEAT SCI, V76, P172, DOI 10.1016/j.meatsci.2006.10.026
   Gimenez B, 2002, J SCI FOOD AGR, V82, P1154, DOI 10.1002/jsfa.1136
   Jeon YJ, 2002, J AGR FOOD CHEM, V50, P5167, DOI 10.1021/jf011693l
   Kamil JYVA, 2002, FOOD CHEM, V79, P69, DOI 10.1016/S0308-8146(02)00180-2
   Lopez-Caballero ME, 2005, FOOD HYDROCOLLOID, V19, P303, DOI 10.1016/j.foodhyd.2004.06.006
   MALLE P, 1989, J FOOD PROTECT, V52, P419
   Moussa SH, 2013, J FOOD SCI, V78, pM1589, DOI 10.1111/1750-3841.12247
   Moussa SH, 2013, INT J BIOL MACROMOL, V54, P204, DOI 10.1016/j.ijbiomac.2012.12.029
   Negi PS, 2003, J FOOD SCI, V68, P1473, DOI 10.1111/j.1365-2621.2003.tb09669.x
   Ojagh SM, 2010, FOOD CHEM, V120, P193, DOI 10.1016/j.foodchem.2009.10.006
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Ramirez JA, 2011, FOOD HYDROCOLLOID, V25, P1842, DOI 10.1016/j.foodhyd.2011.05.009
   Sallam KI, 2007, FOOD CONTROL, V18, P566, DOI 10.1016/j.foodcont.2006.02.002
   Sathivel S, 2007, J FOOD ENG, V83, P366, DOI 10.1016/j.jfoodeng.2007.03.009
   Seeram N.P., 2006, POMEGRANATES ANCIENT
   Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5
   Tayel AA, 2009, J PLANT DIS PROTECT, V116, P252
   Tayel AA, 2016, INT J BIOL MACROMOL, V93, P41, DOI 10.1016/j.ijbiomac.2016.08.061
   Tayel AA, 2016, J SCI FOOD AGR, V96, P1306, DOI 10.1002/jsfa.7223
   Tayel AA, 2014, INT J BIOL MACROMOL, V69, P471, DOI 10.1016/j.ijbiomac.2014.05.072
   Tayel AA, 2012, FOODBORNE PATHOG DIS, V9, P755, DOI 10.1089/fpd.2012.1203
   Tayel AA, 2010, INT J BIOL MACROMOL, V47, P10, DOI 10.1016/j.ijbiomac.2010.04.005
   Tsai GJ, 2002, FISHERIES SCI, V68, P170, DOI 10.1046/j.1444-2906.2002.00404.x
NR 40
TC 0
Z9 0
U1 28
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN
PY 2017
VL 99
BP 499
EP 505
DI 10.1016/j.ijbiomac.2017.03.017
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA ET1MS
UT WOS:000400034100057
PM 28274866
OA No
DA 2017-08-17
ER

PT J
AU Gecchele, LV
   Bremner-Harrison, S
   Gilbert, F
   Soultan, A
   Davison, A
   Durrant, KL
AF Gecchele, Lisa V.
   Bremner-Harrison, Samantha
   Gilbert, Francis
   Soultan, Alaaeldin
   Davison, Angus
   Durrant, Kate L.
TI A pilot study to survey the carnivore community in the hyper-arid
   environment of South Sinai mountains
SO JOURNAL OF ARID ENVIRONMENTS
LA English
DT Article
DE Carnivores; Conservation; Pilot study; Non-invasive methods; Scat
   collection; Camera trapping; Arabian wolf; Striped hyena; Red fox
ID ESTIMATING SITE OCCUPANCY; DETECTION PROBABILITY PARAMETERS; WOLVES
   CANIS-LUPUS; SAUDI-ARABIA; HYENA-HYENA; ISRAEL; FECES; HYBRIDIZATION;
   CONSERVATION; BEHAVIOR
AB Carnivores are one of the taxa most affected by habitat fragmentation and human persecution; as a result, most carnivore species are declining; for this reason monitoring changes in carnivore population is paramount to plan effective conservation programs. Despite being one of the most threatened habitat, arid environment are often neglected and the carnivore species living in this environment are generally poorly studied.
   We conducted a pilot study to survey the carnivore guild in the St Katherine Protectorate, the largest Egyptian national park and a hotspot for biodiversity and conservation in an arid environments. Three species were detected using both camera trapping and morphological identification of scats: Red fox, Striped hyena and Arabian wolf, while through genetic analysis we were able to confirm the presence of Blandford fox as well. Arabian wolf appeared to be the most elusive and rarer species and should be a conservation priority.
   We also provide guidelines for a monitoring program: we estimated that a survey period of 8-10 weeks would be enough to detect foxes and hyenas with a 95% probability, but it would take at least 26 weeks to detect the presence of wolves. This is the first comprehensive carnivore survey in South Sinai and provides an important baseline for future studies in this unique hyper-arid environment at the conjunction between the African and Eurasian continents. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Gecchele, Lisa V.; Gilbert, Francis; Davison, Angus; Durrant, Kate L.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.
   [Bremner-Harrison, Samantha] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Nottingham NG25 0QF, England.
   [Soultan, Alaaeldin] EEAA, Nat Conservat Sect, St Katherine Protectorate, Protectorate Management Unit, Cairo, Egypt.
   [Gecchele, Lisa V.] Ashworth Labs, Inst Evolutionary Biol, Charlotte Auerbach Rd, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Soultan, Alaaeldin] Max Plank Inst Ornithol, Dept Migrat & Immunoecol, Obstberg 1, D-78315 Radolfzell am Bodensee, Germany.
   [Soultan, Alaaeldin] Univ Konstanz, Dept Biol, D-78464 Constance, Germany.
RP Gecchele, LV (reprint author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.; Gecchele, LV (reprint author), Ashworth Labs, Inst Evolutionary Biol, Charlotte Auerbach Rd, Edinburgh EH9 3FL, Midlothian, Scotland.
EM lisa.gecchele@ed.ac.uk
CR Al-Johany AMH, 2007, J ARID ENVIRON, V68, P20, DOI 10.1016/j.jaridenv.2006.04.002
   Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012
   Barja I, 2004, NATURWISSENSCHAFTEN, V91, P489, DOI 10.1007/s00114-004-0557-1
   Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x
   Borkowski J, 2011, ANN ZOOL FENN, V48, P108
   Boulinier T, 1998, ECOLOGY, V79, P1018, DOI 10.1890/0012-9658(1998)079[1018:ESRTIO]2.0.CO;2
   Boyko AR, 2009, P NATL ACAD SCI USA, V106, P13903, DOI 10.1073/pnas.0902129106
   Bozarth CA, 2010, CONSERV GENET RESOUR, V2, P173, DOI 10.1007/s12686-010-9215-4
   Bray TC, 2014, MAMM BIOL, V79, P409, DOI 10.1016/j.mambio.2014.06.005
   Campbell Lori A., 2008, P223
   Dalerum F, 2009, BIOL LETTERS, V5, P35, DOI 10.1098/rsbl.2008.0520
   Davison A, 2002, J ZOOL, V257, P141, DOI 10.1017/S0952836902000730
   EEAA SEAM Programme, 2003, S SIN DEM POP PROJ
   El Alqamy H., 2002, 1 INT EG C PROT AR S
   Garrote G, 2012, EUR J WILDLIFE RES, V58, P881, DOI 10.1007/s10344-012-0658-7
   Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740
   Gese EM, 2001, CONSERV BIOL SER, V5, P372
   Ginsberg JR, 2001, CONSERV BIOL SER, V5, P498
   Gompper ME, 2006, WILDLIFE SOC B, V34, P1142, DOI 10.2193/0091-7648(2006)34[1142:ACONTT]2.0.CO;2
   Grainger J., 2008, PROTECTED LANDS CAPE, V2
   Guenther R., 2010, EGYPT J BIOL, V7, P55
   Hailer F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003333
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Harrison D.L, 1991, MAMMALS ARABIA
   Hefner R, 1999, J MAMMAL, V80, P611, DOI 10.2307/1383305
   Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465
   Iacolina L, 2010, MAMM BIOL, V75, P341, DOI 10.1016/j.mambio.2010.02.004
   Kays Roland W., 2008, P110
   Leite JV, 2015, ORG DIVERS EVOL, V15, P731, DOI 10.1007/s13127-015-0232-8
   Long R.A., 2006, DEV PREDICTIVE OCCUR
   Long Robert A., 2008, P8
   Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x
   Macdonald D.W., 1980, Symposia of the Zoological Society of London, P107
   MACDONALD DW, 1978, ISRAEL J ZOOL, V27, P189
   Mack R.N., 2000, B ECOL SOC AM, V86, P249
   MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.2307/3072056
   Minta SC, 1999, CARNIVORES IN ECOSYSTEMS: THE YELLOWSTONE EXPERIENCE, P323
   Naves J, 2003, CONSERV BIOL, V17, P1276, DOI 10.1046/j.1523-1739.2003.02144.x
   O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2
   Oliveira M.L.D., 2012, ZOOLOGIA-CURITIBA, V29, P183, DOI DOI 10.1590/S1984-46702012000200012
   Osborn D.J., 1980, CONT LAND MAMMALS EG
   Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514
   Prugh LR, 2005, MOL ECOL, V14, P1585, DOI 10.1111/j.1365-294X.2005.02533.x
   ROY MS, 1994, MOL BIOL EVOL, V11, P553
   SCHIPPER J, 2007, SMALL CARNIVORE CONS, V36, P38
   Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES
   Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8
   Wagner AP, 2008, ANIM BEHAV, V75, P1131, DOI 10.1016/j.anbehav.2007.08.025
   Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2
NR 49
TC 0
Z9 0
U1 9
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0140-1963
EI 1095-922X
J9 J ARID ENVIRON
JI J. Arid. Environ.
PD JUN
PY 2017
VL 141
BP 16
EP 24
DI 10.1016/j.jaridenv.2017.01.009
PG 9
WC Ecology; Environmental Sciences
SC Environmental Sciences & Ecology
GA ET3SZ
UT WOS:000400201100003
OA No
DA 2017-08-17
ER

PT J
AU Mohieldin, A
   Eldali, A
   Aljubran, A
AF Mohieldin, Ahmed
   Eldali, Abdulmoneim
   Aljubran, Ali
TI Knowledge, Perception, and Attitudes of Cancer Patients Towards Cancer
   and Cancer Care: Local Perspective from Saudi Arabia
SO JOURNAL OF CANCER EDUCATION
LA English
DT Article
DE Attitude; Cancer patients; Saudi; Attitude towards care
ID DECISION-MAKING; DISCLOSURE; BELIEFS
AB Understanding the attitudes of cancer patients towards different cancer-related issues is very important for the health care provider in order to deliver an optimal care. This survey was designed to collect data about the initial patient's perception and reaction to the diagnosis of cancer, the patient's preference regarding the disclosure of diagnosis, and prevalence and pattern of complementary and alternative medicine (CAM) use. Between January and December 2011, of 234 cancer patients, 42.2 % believed that eye of evil/envy was the cause of their cancers. In 18.3 % of cases, relatives refused to inform the patient about the diagnosis. Participants liked to be the first to be informed, either with relatives at the same time (44.21 %) or alone (33.48 %). Only 7.7 % of participants liked to totally leave decisions to their doctors and/or relatives. There were 53.4 % tried CAM before starting treatment, and 46.7 % continued using CAM during treatment and most of them used more than one type of CAM. Treatment with the Holy Qur'an or Ruqia was widely reported by the study population (92 %). Our survey confirmed that the patient's preference is towards disclosure while the public attitude is, relatively, still against full disclosure. This situation poses a special challenge to the physicians in Kingdom of Saudi Arabia (KSA) when it comes to discussing the disease and treatment. Educational efforts are required to emphasize the curative role of conventional treatment, especially surgery, in many cases. Such efforts should also address the wrong beliefs and misconceptions regarding CAM.
C1 [Mohieldin, Ahmed] Zagazig Univ, Coll Med, Med Oncol, Zagazig, Egypt.
   [Mohieldin, Ahmed; Aljubran, Ali] King Faisal Specialist Hosp & Res Ctr, Med Oncol, Oncol Ctr, POB 3354,MBC 64, Riyadh 11211, Saudi Arabia.
   [Eldali, Abdulmoneim] King Faisal Specialist Hosp & Res Ctr, Biostat & Epidemiol Dept, POB 3354,MBC 64, Riyadh 11211, Saudi Arabia.
   [Aljubran, Ali] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
RP Aljubran, A (reprint author), King Faisal Specialist Hosp & Res Ctr, Med Oncol, Oncol Ctr, POB 3354,MBC 64, Riyadh 11211, Saudi Arabia.; Aljubran, A (reprint author), Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
EM ahmmohamed@kfshrc.edu.sa; adalee@kfshrc.edu.sa; ajubran@kfshrc.edu.sa
FU King Faisal Specialist Hospital and Research Center (KFSHRC), Riyadh
FX This study is sponsored locally by the King Faisal Specialist Hospital
   and Research Center (KFSH&RC), Riyadh. We greatly appreciate our data
   collectors "Haddad A., Almarhoon F., Almassaad S., Al-Qesiyeh A., and
   ElMakawi B." and our statistician "Ravichandran K." for their generous
   help during the conduction of this study.
CR Al-Amri A M, 2009, East Mediterr Health J, V15, P19
   Al-Faris EA, 2008, ANN SAUDI MED, V28, P4
   Aljubran AH, 2010, ANN SAUDI MED, V30, P141, DOI 10.4103/0256-4947.60520
   BEDIKIAN AY, 1985, K F SPEC HOSP MED J, V5, P17
   Eagly A. H., 1998, HDB SOCIAL PSYCHOL, V1, P269
   Hallenbeck J, 2007, J CLIN ONCOL, V25, P5030, DOI 10.1200/JCO.2007.11.8802
   Kumar S, 2010, ASIAN PAC J CANCER P, V11, P251
   Lord K, 2012, CLIN ONCOL-UK, V24, P4, DOI 10.1016/j.clon.2011.05.008
   Mobeireek AF, 2008, J MED ETHICS, V34, P225, DOI 10.1136/jme.2006.019638
   Mobeireek AF, 1996, J MED ETHICS, V22, P282, DOI 10.1136/jme.22.5.282
NR 10
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-8195
EI 1543-0154
J9 J CANCER EDUC
JI J. Cancer Educ.
PD JUN
PY 2017
VL 32
IS 2
BP 314
EP 319
DI 10.1007/s13187-015-0973-2
PG 6
WC Oncology; Education, Scientific Disciplines; Public, Environmental &
   Occupational Health
SC Oncology; Education & Educational Research; Public, Environmental &
   Occupational Health
GA ET3HE
UT WOS:000400167700019
PM 26803820
OA No
DA 2017-08-17
ER

PT J
AU Tawfik, MY
AF Tawfik, Mirella Youssef
TI The Impact of Health Education Intervention for Prevention and Early
   Detection of Type 2 Diabetes in Women with Gestational Diabetes
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Gestational diabetes; Health belief model; Type 2 diabetes mellitus;
   Gestational weight gain; Postpartum weight retention
ID RANDOMIZED CONTROLLED-TRIAL; WEIGHT-GAIN; GLUCOSE-TOLERANCE;
   SELF-EFFICACY; MELLITUS; PREGNANCY; RISK; HISTORY; METAANALYSIS;
   FEASIBILITY
AB This study aims to investigate the impact of a health belief model (HBM)-based educational intervention on knowledge, beliefs, self-reported practices, gestational and postpartum weight in women with gestational diabetes mellitus (GDM). Subjects and Methods: A cluster randomized controlled trial was performed, with randomization at the level of Primary Health Care centers in three Egyptian cities. Eligible women with GDM were enrolled at 24 weeks pregnancy. The intervention group (n = 103) received health education intervention based on the HBM construct. Control subjects (n = 98) received the usual care. The outcomes measured were: women's knowledge, beliefs, self-reported practices, gestational weight gain (GWG), and postpartum weight retention. Patients were investigated at baseline, at end of pregnancy, and at 6 weeks postpartum. Results: After the intervention, percentages of women who had high knowledge and beliefs scores had significantly increased from less than 50 % to more than 70 % in the intervention group (p < 0.001). More women in the intervention group reported practicing exclusive breast feeding (85.4 %) and screening for T2DM (43.7 %) at 6 weeks postpartum compared to the control group (63.3 and 19.4 % respectively) (p < 0.001). More women with excessive body mass index in the intervention group (65 %) compared to the control group (11.6 %) were meeting recommended GWG (p < 0.001), and postpartum weight (37.7, and 20.3 % respectively) (p < 0.01). Conclusion: This intervention significantly improved knowledge, beliefs, self-reported practices, and gestational and postpartum weight in patients with GDM. Further research is needed for investigating the effectiveness of applying early, multi-phase, and longer intervention.
C1 [Tawfik, Mirella Youssef] Suez Canal Univ, Dept Community Med, Fac Med, Ismailia 41522, Egypt.
RP Tawfik, MY (reprint author), Suez Canal Univ, Dept Community Med, Fac Med, Ismailia 41522, Egypt.
EM mirellatawfik@hotmail.com
CR American Diabetes association, 2015, DIABETES CARE S1, V38, pS8, DOI DOI 10.2337/DC15-S005
   Amason JS, 2016, JOGNN-J OBST GYN NEO, V45, P515, DOI 10.1016/j.jogn.2016.04.003
   Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038
   Bayat Fatemeh, 2013, J Diabetes Metab Disord, V12, P45, DOI 10.1186/2251-6581-12-45
   Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5
   Chasan-Taber L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-100
   Ferrara A, 2011, DIABETES CARE, V34, P1519, DOI 10.2337/dc10-2221
   Glanz K, 2002, HLTH BEHAV HLTH ED T, P45
   Harrison CL, 2013, OBESITY, V21, P904, DOI 10.1002/oby.20163
   Hochbaum G., 1952, HLTH BELIEF MODEL
   International Diabetes Federation, 2009, GLOB GUID PREGN DIAB
   Jones EJ, 2012, JOGNN-J OBST GYN NEO, V41, P246, DOI 10.1111/j.1552-6909.2012.01339.x
   Jones EJ, 2009, JOGNN-J OBST GYN NEO, V38, P516, DOI 10.1111/j.1552-6909.2009.01051.x
   Kaiser B, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-133
   Karamanos B, 2014, EUR J CLIN NUTR, V68, P8, DOI 10.1038/ejcn.2013.177
   Koh D, 2010, J SCI MED SPORT, V13, P42, DOI 10.1016/j.jsams.2008.10.003
   Mamun AA, 2010, AM J CLIN NUTR, V91, P1336, DOI 10.3945/ajcn.2009.28950
   McIntyre H. D., 2012, INT J ENDOCRINOL, V2012, DOI [10.1155/2012/892019, DOI 10.1155/2012/892019]
   Morrison MK, 2010, DIABETIC MED, V27, P882, DOI 10.1111/j.1464-5491.2010.03032.x
   Morrison MK, 2014, WOMEN BIRTH, V27, P52, DOI 10.1016/j.wombi.2013.10.001
   National Diabetes Education Program, 2014, PROGR NAT I HLTH CTR
   Nejad L. M., 2005, E J APPL PSYCHOL SOC, V1, P63, DOI DOI 10.7790/EJAP.V1I1.10
   Nicklas JM, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-23
   Oteng-Ntim E, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-47
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1
   Shyam S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-68
   Tang JW, 2015, MATERN CHILD HLTH J, V19, P1526, DOI 10.1007/s10995-014-1657-y
   World Health Organization, 2000, WHO TECHNICAL REPORT, V984
   Yang Y, 2016, J OBSTET GYNAECOL RE, V42, P511, DOI 10.1111/jog.12934
NR 30
TC 1
Z9 1
U1 10
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD JUN
PY 2017
VL 42
IS 3
BP 500
EP 510
DI 10.1007/s10900-016-0282-7
PG 11
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA ET5XA
UT WOS:000400362100011
PM 27743337
OA No
DA 2017-08-17
ER

PT J
AU Ali, S
   Singh, B
   Sharma, S
AF Ali, Salim
   Singh, Baljit
   Sharma, Savita
TI Development of high-quality weaning food based on maize and chickpea by
   twin-screw extrusion process for low-income populations
SO JOURNAL OF FOOD PROCESS ENGINEERING
LA English
DT Article
DE chickpea; extrusion; maize; response surface methodology (RSM); weaning
   foods
ID PHYSICOCHEMICAL PROPERTIES; STARCH GELATINIZATION; ANTIOXIDANT ACTIVITY;
   FEED MOISTURE; FLOUR BLEND; RICE FLOUR; COOKING; TEMPERATURE; BARLEY;
   DIGESTIBILITY
AB This study was carried out to produce high-quality weaning food from locally available and low cost raw materials. Extrudates of maize (Zea mays) and chickpea (Cicer arietinum) were processed by twin-screw extruder. Experiments were designed using central composite rotatable design (CCRD) with three-independent variables [feed moisture (14-18%), screw speed (400-550 rpm), barrel temperature (125-175 degrees C)] and five-dependent variables [specific mechanical energy (SME), bulk density (BD), water absorption index (WAI), water solubility index (WSI), degree of gelatinization (DG)]. Increase in feed moisture reduced SME, WSI, and DG and increased BD and WAI. Increase in screw speed and barrel temperature decreased BD and WAI and increased WSI and DG of the extrudates. Optimum extrusion conditions were 14.13% feed moisture, 534 rpm screw speed, and 167 degrees C barrel temperature. The ratio of ingredients in the optimized weaning mix was 40% maize-chickpea extrudates, 35% skim milk powder, and 25% sugar (w/w). The nutrient content was in agreement with the standards described by PFA (prevention of food adulteration act and rules, India, 2004) with high protein and starch digestibility.
   Practical applicationsDevelopment of weaning foods from locally available and low cost raw materials is a constant challenge for developing countries. Weaning foods are generally produced by traditional techniques like milling, roasting, drying, and germination. In the present scenario of convenience and newer products, we explored the possibility of using twin-screw extruder for preparation of weaning foods from maize and chickpea. Effects of feed moisture, barrel temperature, and screw speed on the quality parameters of extrudates were studied. Extrudates produced at lower feed moisture, higher screw speed, and higher barrel temperature showed good physicochemical properties and higher protein and starch digestibility.
C1 [Ali, Salim; Singh, Baljit; Sharma, Savita] Punjab Agr Univ, Dept Food Sci & Technol, Ludhiana 141004, Punjab, India.
   [Ali, Salim] Alexandria Univ, Fac Agr Saba Basha, Dept Food Sci, Alexandria 21531, Egypt.
RP Ali, S (reprint author), Punjab Agr Univ, Dept Food Sci & Technol, Ludhiana 141004, Punjab, India.
EM salim_2007@yahoo.com
CR AKESON WR, 1964, J NUTR, V83, P257
   Ali S, 2016, INT J FOOD SCI TECH, V51, P2301, DOI 10.1111/ijfs.13186
   Altan A, 2009, J FOOD SCI, V74, pE77, DOI 10.1111/j.1750-3841.2009.01051.x
   Altan A, 2008, J FOOD ENG, V84, P231, DOI 10.1016/j.jfoodeng.2007.05.014
   ANDERSON RA, 1969, CEREAL SCI TODAY, V14, P4
   AOAC, 2006, OFFICIAL METHODS ANA
   Asma MA, 2006, FOOD NUTR BULL, V27, P26
   Balasubramanian S, 2014, J FOOD SCI TECH MYS, V51, P682, DOI 10.1007/s13197-011-0579-6
   BHATTACHARYA M, 1987, J FOOD SCI, V52, P764, DOI 10.1111/j.1365-2621.1987.tb06722.x
   Bukusuba J, 2008, INT J FOOD SCI TECH, V43, P1424, DOI 10.1111/j.1365-2621.2007.01670.x
   Carvalho CWP, 2010, J FOOD ENG, V98, P103, DOI 10.1016/j.jfoodeng.2009.12.015
   DES, 2015, DIR EC STAT MIN AGR
   Ding QB, 2005, J FOOD ENG, V66, P283, DOI 10.1016/j.jfoodeng.2004.03.019
   Dogan H, 2003, FOOD SCI TECHNOL INT, V9, P101, DOI [10.1177/1082013203009002006, 10.1177/108201303033940]
   Ghumman A, 2016, LWT-FOOD SCI TECHNOL, V70, P349, DOI 10.1016/j.lwt.2016.02.032
   GOMEZ MH, 1983, J FOOD SCI, V48, P378, DOI 10.1111/j.1365-2621.1983.tb10747.x
   Guha M, 1997, J FOOD ENG, V32, P251, DOI 10.1016/S0260-8774(97)00028-9
   Gulati P, 2016, INT J FOOD SCI TECH, V51, P114, DOI 10.1111/ijfs.12974
   Hagenimana A, 2006, J CEREAL SCI, V43, P38, DOI 10.1016/j.jcs.2005.09.003
   Hoan N. van, 2010, Journal of Food Process Engineering, V33, P519
   HOLM J, 1988, AM J CLIN NUTR, V47, P1010
   Imtiaz H., 2011, African Journal of Food Science, V5, P897
   Joshi SMR, 2014, J FOOD PROCESS PRES, V38, P655, DOI 10.1111/jfpp.12015
   Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797
   Kraugerud OF, 2011, J WORLD AQUACULT SOC, V42, P914, DOI 10.1111/j.1749-7345.2011.00522.x
   Kraus S, 2014, J FOOD PROCESS ENG, V37, P220, DOI 10.1111/jfpe.12077
   Lin S, 1997, FOOD SCI TECHNOL-LEB, V30, P754
   Lopez-Martinez LX, 2009, LWT-FOOD SCI TECHNOL, V42, P1187, DOI 10.1016/j.lwt.2008.10.010
   Mouquet C, 2003, FOOD CHEM, V82, P249, DOI 10.1016/S0308-8146(02)00545-9
   Onwulata CI, 2002, J FOOD PROCESS PRES, V26, P179, DOI 10.1111/j.1745-4549.2002.tb00479.x
   PFA, 2004, PREV FOOD AD ACT RUL
   Ruiz-Ruiz J, 2008, LWT-FOOD SCI TECHNOL, V41, P1799, DOI 10.1016/j.lwt.2008.01.005
   Sajilata G., 2002, Food and Nutrition Bulletin, V23, P208
   Satter M. A., 2013, African Journal of Food Science, V7, P238
   Singh B, 2015, J FOOD PROCESS PRES, V39, P270, DOI 10.1111/jfpp.12230
   Singh RKR, 2014, J FOOD SCI TECH MYS, V51, P1827, DOI 10.1007/s13197-012-0725-9
   Singh S, 2007, INT J FOOD SCI TECH, V42, P916, DOI 10.1111/j.1365-2621.2006.01309.x
   Suksomboon A, 2011, INT J FOOD SCI TECH, V46, P201, DOI 10.1111/j.1365-2621.2010.02471.x
   Temba MC, 2016, INT J FOOD SCI TECH, V51, P543, DOI 10.1111/ijfs.13035
   Ullah I., 2010, PAK J NUTR, V9, P1113, DOI DOI 10.3923/PJN.2010.1113.1117
   Zhuang HN, 2010, J FOOD PROCESS PRES, V34, P1080, DOI 10.1111/j.1745-4549.2009.00439.x
NR 41
TC 0
Z9 0
U1 10
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-8876
EI 1745-4530
J9 J FOOD PROCESS ENG
JI J. Food Process Eng.
PD JUN
PY 2017
VL 40
IS 3
AR UNSP e12500
DI 10.1111/jfpe.12500
PG 10
WC Engineering, Chemical; Food Science & Technology
SC Engineering; Food Science & Technology
GA ET3CA
UT WOS:000400153500072
OA No
DA 2017-08-17
ER

PT J
AU EI-Sekelly, W
   Dobry, R
   Abdoun, T
   Steidl, JH
AF EI-Sekelly, W.
   Dobry, R.
   Abdoun, T.
   Steidl, J. H.
TI Two Case Histories Demonstrating the Effect of Past Earthquakes on
   Liquefaction Resistance of Silty Sand
SO JOURNAL OF GEOTECHNICAL AND GEOENVIRONMENTAL ENGINEERING
LA English
DT Article
ID SOUTHERN CALIFORNIA; IMPERIAL-VALLEY; DEFORMATION; DYNAMICS; SWARM;
   FAULT
AB The paper compares two liquefaction case histories in California: (1) the response of the Wildlife site in the Imperial Valley to the 2010 El-Mayor Cucapah earthquake (M-w = 7.2, a(max) = 0.15 g); and (2) the response of the Treasure Island Fire Station (F.S.) site in the San Francisco Bay area to the 1989 Loma Prieta earthquake (M-w = 6.9, a(max) = 0.16 g). Both histories involve silty sand critical layers with nonplastic fines contents, FC = 24-27%, similar normalized shear wave velocities, V-s1 = 145-155 m/s, low cone penetration test (CPT) cone penetration resistances, and groundwater tables at essentially the same depth. The corresponding data points plot almost on top of each other on the shear wave velocity field liquefaction charts, which predict liquefaction at both sites. While Treasure Island F.S. did liquefy during the shaking, Wildlife did not and was far from liquefaction as indicated by piezometers at the site. This paper constitutes an attempt to understand the reason for these very different pore pressure responses through a detailed analysis of similarities and differences between the two histories. It is concluded that preshaking by previous earthquakes is the most probable explanation of the higher liquefaction resistance exhibited by the Wildlife site and other sites in the Imperial Valley. While the Wildlife critical layer was subjected to about 60-70 earthquakes capable of generating significant excess pore pressures between its estimated 1907 deposition and the 2010 earthquake, the Treasure Island F.S. layer was subjected to only about two earthquakes capable of doing so between deposition in the 1930's and the 1989 earthquake. This difference is due to the very high seismic activity in the last 100-plus years in the Imperial Valley compared with a seismically quiet San Francisco Bay Area after the 1906 earthquake. The significance of the prior seismic history is corroborated by recent results from centrifuge and large-scale experiments. These results as well as the methodology developed in the paper may be helpful when analyzing the observed high liquefaction resistance of sandy sites located in other seismic regions. (C) 2017 American Society of Civil Engineers.
C1 [EI-Sekelly, W.] Mansoura Univ, Mansoura 35516, Dakahlia Govern, Egypt.
   [Dobry, R.; Abdoun, T.] Rensselaer Polytech Inst, Dept Civil & Environm Engn, 110 8th St,JEC 4049, Troy, NY 12180 USA.
   [Steidl, J. H.] UC Santa Barbara, Earth Res Inst, 6710 Ellison Hatt, Santa Barbara, CA 93106 USA.
RP EI-Sekelly, W (reprint author), Mansoura Univ, Mansoura 35516, Dakahlia Govern, Egypt.
EM waleed.elsekelly@gmail.com
FU George E. Brown, Jr. Network for Earthquake Engineering Simulation
   program [CMS-0217421, CMMI-0927178]
FX The authors want to acknowledge the California Department of Fish and
   Wildlife that provides access to the monitoring site at the Wildlife
   Liquefaction Array. The NEES@UCSB field site facility received support
   from the George E. Brown, Jr. Network for Earthquake Engineering
   Simulation program through CMS-0217421 and CMMI-0927178. The California
   Geological Surveys' Strong Motion Instrumentation Program (CSMIP)
   provided the ground motion observations for the Treasure Island site,
   and the U.S. Geological Survey National Strong Motion Instrumentation
   project (NSMP) provided the 1987 ground motion and pore pressure
   observations from the Wildlife Site. The authors also want to thank
   Professor R. Andrus for useful discussions about the effects of geologic
   age, preshaking and liquefaction, Dr. T. Holzer for his help in
   clarifying the types of soil deposition at the Wildlife and Treasure
   Island sites, and Professor S. Thevanayagam for his contribution to the
   experimental results included in Fig. 9.
CR Abdoun T, 2013, J GEOTECH GEOENVIRON, V139, P1215, DOI 10.1061/(ASCE)GT.1943-5606.0000821
   Anderson D. G., 1978, ASTM STP
   Andrus RD, 2000, J GEOTECH GEOENVIRON, V126, P1015, DOI 10.1061/(ASCE)1090-0241(2000)126:11(1015)
   Andrus R. D., 2003, GUIDELINES EVALUATIN
   Arango I, 2000, SOIL DYN EARTHQ ENG, V20, P17, DOI 10.1016/S0267-7261(00)00034-8
   Arango I., 1996, REP ON RES
   ASCE, 2010, ASCE, V7
   ATC, 2005, APPL TECHN COUNC
   Baldi G., 1981, P GED SESS CON PEN T
   Bennett M. J., 1984, 84252 US GEOL SURV
   Bierschwale J, 1984, GR8415 U TEX CIV ENG
   Bommer JJ, 2003, B EARTHQ ENG, V1, P171, DOI 10.1023/A:1026323123154
   Bonilla M. G., 1960, 6015 US GEOL SURV ME
   Boulanger R. W., 2014, UCDCGM1401 U CAL CTR
   Brady A. G., 1989, 9787 US GEOL SURV
   CESMD, 2016, CTR ENG STRONG MOT D
   Cetin KO, 2004, J GEOTECH GEOENVIRON, V130, P1314, DOI 10.1061/(ASCE)1090-0241(2004)130:12(1314)
   Cox B. R., 2006, THESIS
   Cox BR, 2013, EARTHQ SPECTRA, V29, pS55, DOI 10.1193/1.4000110
   Darendeli M. B., 2001, THESIS
   de Alba P., 1994, 1551A US GEOL SURV P
   Dobry R., 1981, P ASCE NAT CONV SIT
   Dobry R, 1982, NBS BUILD SCI SER, V138
   Dobry R., 2015, LARGE SCALE TESTING
   Dobry R, 2000, EARTHQ SPECTRA, V16, P41, DOI [10.1193/1.1586082, DOI 10.1193/1.1586082]
   [Anonymous], 2015, J GEOTECH GEOENVIRON, DOI DOI 10.1061/(ASCE)GT.1943-5606
   Dobry R, 2010, P 5 INT C REC ADV GE
   Dobry R., 1992, CASE STUDIES LIQUEFA, V2
   Dobry R, 2015, SOIL DYN EARTHQ ENG, V68, P40, DOI [10.1016/j.soildyn.2014.09.011, 10.1016/j.solidyn.2014.09.011]
   EERI (Earthquake Engineering Research Institute), 1990, LOM PRIET EARTHQ REC
   El-Sekelly W, 2016, J GEOTECH GEOENVIRON, V142, DOI 10.1061/(ASCE)GT.1943-5606.0001430
   El-Sekelly W, 2016, J GEOTECH GEOENVIRON, V142, DOI 10.1061/(ASCE)GT.1943-5606.0001444
   El-Sekelly W. E., 2014, THESIS
   Faris J., 2000, NATL GEOTECHNICAL EX
   Felzer K. R., 2008, 20071437H US GEOL SU
   Field E. H., 2013, 20131165 US GEOL SUR
   FINN WDL, 1981, P INT C REC ADV GEOT
   Finn W D, 1970, J SOIL MECHANICS F D, VSM6, P1917
   Fuhriman M. D., 1993, THESIS
   Gonzalez-Ortega A, 2014, J GEOPHYS RES-SOL EA, V119, P1482, DOI 10.1002/2013JB010193
   Hauksson E, 2013, SEISMOL RES LETT, V84, P177, DOI 10.1785/0220120169
   Hayati H, 2008, J GEOTECH GEOENVIRON, V134, P815, DOI 10.1061/(ASCE)1090-0241(2008)134:6(815)
   Hayati H, 2009, J GEOTECH GEOENVIRON, V135, P1683, DOI 10.1061/(ASCE)GT.1943-5606.0000118
   Heidari T, 2012, J GEOTECH GEOENVIRON, V138, P1196, DOI 10.1061/(ASCE)GT.1943-5606.0000686
   Holzer TL, 2007, B SEISMOL SOC AM, V97, P961, DOI 10.1785/0120060156
   HOLZER TL, 1989, SCIENCE, V244, P56, DOI 10.1126/science.244.4900.56
   Hutton K, 2010, B SEISMOL SOC AM, V100, P423, DOI 10.1785/0120090130
   Idriss IM, 1990, P H BOLT SEED MEM S
   Idriss IM, 2008, MONOGRAPH MNO, V12
   Ishihara K, 1985, P 11 INT C SOIL MECH
   Ishihara K., 1981, P INT C REC ADV GEOT
   Ishihara K, 2011, P INT C GEOT SUST DE
   JOHNSON CE, 1976, B SEISMOL SOC AM, V66, P1133
   Johnson C. E., 1982, 1254 US GEOL SURV US
   Kayen R, 2013, J GEOTECH GEOENVIRON, V139, P407, DOI 10.1061/(ASCE)GT.1943-5606.0000743
   Kokusho T., 1982, SOILS FOUND, V22, P1, DOI DOI 10.3208/SANDF1972.22.4_1
   Liao Y, 2013, EARTHQ SPECTRA, V29, P177, DOI 10.1193/1.4000101
   Liu N, 2006, J GEOTECH GEOENVIRON, V132, P1091, DOI 10.1061/(ASCE)1090-0241(2006)132:8(1091)
   MITCHELL JK, 1984, J GEOTECH ENG-ASCE, V110, P1559
   NRC, 1985, LIQ SOILS EARTHQ
   OLSEN KB, 1995, SCIENCE, V270, P1628, DOI 10.1126/science.270.5242.1628
   Pass D. G., 1994, THESIS
   Petersen MD, 2008, 20081128 US GEOL SUR
   Porcella R. L., 1987, 87672 US GEOL SURV
   Power M. S., 1998, 1551B US GEOL SURV
   Press F., 1978, EARTH
   Pyke R, 2003, J GEOTECH GEOENVIRON, V129, P283, DOI 10.1061/(ASCE)1090-0241(2003)129:3(283)
   Rockwell TK, 2013, B SEISMOL SOC AM, V103, P629, DOI 10.1785/0120120192
   Salgado R, 1998, J GEOTECH GEOENVIRON, V124, P878, DOI 10.1061/(ASCE)1090-0241(1998)124:9(878)
   Salgado R, 1997, J GEOTECH GEOENVIRON, V123, P726, DOI 10.1061/(ASCE)1090-0241(1997)123:8(726)
   SCHMERTMANN JH, 1991, J GEOTECH ENG-ASCE, V117, P1288, DOI 10.1061/(ASCE)0733-9410(1991)117:9(1288)
   SEED HB, 1979, J GEOTECH ENG-ASCE, V105, P201
   SEED HB, 1977, J GEOTECH ENG-ASCE, V103, P757
   Seed H. B., 1971, J SOIL MECHANICS FOU, V107, P1249
   Seed H. B., 1970, 7010 EERC U CAL EART
   Steidl J. H., 2014, P 10 NAT C EARTHQ EN
   Steidl J. M., 2010, P 5 INT C REC ADV GE
   Thevanayagam S, 2009, GEOTECH TEST J, V32, P438
   Vucetic M., 1986, THESIS
   Wildlife liquefaction array, 2016, NEES AT UCSB
   Yasuda S, 1988, SOILS FOUND, V28, P61
   Youd T. Leslie, 2013, Journal of Geotechnical and Geoenvironmental Engineering, V139, P1998, DOI 10.1061/(ASCE)GT.1943-5606.0000668
   YOUD TL, 1977, J GEOTECH ENG-ASCE, V103, P918
   Youd TL, 2003, J GEOTECH GEOENVIRON, V129, P284, DOI 10.1061/(ASCE)1090-0241(2003)129:3(284)
   Youd TL, 2001, J GEOTECH GEOENVIRON, V127, P817, DOI 10.1061/(ASCE)1090-0241(2001)127:10(817)
   Youd T. L., 1984, 84680 US GEOL SURV
   Youd T. L., 1978, 993 GEOL SURV PROF U
   Youd T. L., 2007, P INT C EARTHQ GEOT
   Youd T. L., 1975, J GEOTECH ENG DIV, V101, P217
   ZEGHAL M, 1994, J GEOTECH ENG-ASCE, V120, P996, DOI 10.1061/(ASCE)0733-9410(1994)120:6(996)
NR 90
TC 0
Z9 0
U1 0
U2 0
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 1090-0241
EI 1943-5606
J9 J GEOTECH GEOENVIRON
JI J. Geotech. Geoenviron. Eng.
PD JUN
PY 2017
VL 143
IS 6
AR 04017009
DI 10.1061/(ASCE)GT.1943-5606.0001654
PG 18
WC Engineering, Geological; Geosciences, Multidisciplinary
SC Engineering; Geology
GA ES6JO
UT WOS:000399653700007
OA No
DA 2017-08-17
ER

PT J
AU Hameed, MFO
   Hussain, FFK
   Obayya, SSA
AF Hameed, Mohamed Farhat O.
   Hussain, Firas Faeq K.
   Obayya, Salah S. A.
TI Ultracompact Polarization Rotator Based on Liquid Crystal Channel on
   Silicon
SO JOURNAL OF LIGHTWAVE TECHNOLOGY
LA English
DT Article
DE Channeled; integrated optics devices; liquid crystals;
   polarization-selective devices; waveguides
ID PLASMONIC WAVE-GUIDE; REFRACTIVE-INDEXES; SYMMETRY-BREAKING;
   SPLITTER-ROTATOR; RING RESONATORS; PASS POLARIZER; COMPACT; FIBER;
   CONVERTER; PLATFORM
AB A novel highly tunable polarization rotator (PR) based on channel waveguide on silicon is introduced and analyzed. The proposed SiO2/Si channel is infiltrated with nematic liquid crystal (NLC) material of type E7. The design parameters of the NLC channel PR have been studied to obtain an efficient polarization conversion with an ultrashort device length. Additionally, a tolerance analysis of the structure geometrical parameters, temperature, and operating wavelength is reported in detail. The modal analysis of the NLC PR is carried out using full-vectorial finite-difference method (FVFDM). Further, the propagation characteristics through the suggested design are obtained using full-vectorial finite-difference beam propagation method (FVFD-BPM). The numerical results reveal that the reported PR of compact device length of 4.02 mu m can achieve nearly 100% polarization conversion ratio with insertion loss of 2.19 dB and good crosstalk of -21.73 dB at a wavelength of 1.55 mu m. Further, the crosstalk would be better than -20 dB within the wavelength range of 1.55 +/- 0.04 mu m. Moreover, the polarization conversion ratio can be controlled by applying an external electric field. To the best of the authors' knowledge, it is the first time to introduce ultracompact highly tunable PR based on a channel on silicon platform with simple design and broadband operation.
C1 [Hameed, Mohamed Farhat O.; Obayya, Salah S. A.] Zewail City Sci & Technol, Ctr Photon & Smart Mat, Giza 12588, Egypt.
   [Hameed, Mohamed Farhat O.] Mansoura Univ, Fac Engn, Math & Engn Phys Dept, Mansoura 35516, Egypt.
   [Hussain, Firas Faeq K.] Al Muthana Univ, Phys Dept, Fac Sci, Muthana, Iraq.
   [Obayya, Salah S. A.] Mansoura Univ, Fac Engn, Elect & Commun Engn, Mansoura 35516, Egypt.
RP Obayya, SSA (reprint author), Zewail City Sci & Technol, Ctr Photon & Smart Mat, Giza 12588, Egypt.
EM mfarahat@zewailcity.edu.eg; firas.f@mu.edu.iq; sobayya@zewailcity.edu.eg
OI Hameed, Mohamed/0000-0001-5677-7685
CR Abdelwahab M., 2016, P IEEE ACES INT C WI
   d'Alessandro A., 2006, IEEE J QUANTUM ELECT, V42, P1084
   Alonso-Ramos C, 2012, OPT LETT, V37, P335, DOI 10.1364/OL.37.000335
   Azzam SIH, 2014, IEEE PHOTONIC TECH L, V26, P1633, DOI 10.1109/LPT.2014.2329416
   Barh A., 2000, J LIGHTW TECHNOL, V31, P3687
   Barwicz T, 2007, NAT PHOTONICS, V1, P57, DOI 10.1038/nphoton.2006.41
   Beccherelli R, 2005, MOL CRYST LIQ CRYST, V429, P227, DOI 10.1080/15421400590930971
   Bogaerts W, 2007, OPT EXPRESS, V15, P1567, DOI 10.1364/OE.15.001567
   Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594
   Chang KW, 2016, SCI REP-UK, V6, DOI 10.1038/srep19609
   Chee J, 2012, OPT EXPRESS, V20, P25345, DOI 10.1364/OE.20.025345
   Chen CH, 2005, OPT EXPRESS, V13, P5347, DOI 10.1364/OPEX.13.005347
   Chigrinov V. G., 2007, P SOC PHOTO-OPT INS, V6781
   Dai DX, 2016, OPT LETT, V41, P2346, DOI 10.1364/OL.41.002346
   Dai DX, 2013, LASER PHOTONICS REV, V7, P303, DOI 10.1002/lpor.201200023
   Dai DX, 2012, LIGHT-SCI APPL, V1, DOI 10.1038/lsa.2012.1
   Dai DX, 2011, OPT EXPRESS, V19, P10940, DOI 10.1364/OE.19.010940
   Dai DX, 2010, OPT EXPRESS, V18, P27404, DOI 10.1364/OE.18.027404
   Dhawan A, 2011, OPT EXPRESS, V19, P787, DOI 10.1364/OE.19.000787
   Fallahkhair AB, 2008, J LIGHTWAVE TECHNOL, V26, P1423, DOI 10.1109/JLT.2008.923643
   Fukuda H, 2008, OPT EXPRESS, V16, P2628, DOI 10.1364/OE.16.002628
   GREEN M, 1989, APPL OPTICS, V28, P5202, DOI 10.1364/AO.28.005202
   Haakestad MW, 2005, IEEE PHOTONIC TECH L, V17, P819, DOI 10.1109/LPT.2004.842793
   Hameed M. F. O., 2011, J LIGHTW TECHNOL, V29, P737
   Hameed MFO, 2016, J NANOPHOTONICS, V10, DOI 10.1117/1.JNP.10.046016
   Hameed MFO, 2017, OPT ENG, V56, DOI 10.1117/1.OE.56.1.017107
   Hameed MFO, 2014, OPT LETT, V39, P1077, DOI 10.1364/OL.39.001077
   Hameed MFO, 2013, IEEE PHOTONIC TECH L, V25, P1578, DOI 10.1109/LPT.2013.2270564
   Hameed MFO, 2013, J LIGHTWAVE TECHNOL, V31, P81, DOI 10.1109/JLT.2012.2228631
   Hameed MFO, 2012, J LIGHTWAVE TECHNOL, V30, P283, DOI 10.1109/JLT.2011.2180891
   Hameed MFO, 2010, J LIGHTWAVE TECHNOL, V28, P806, DOI 10.1109/JLT.2010.2040581
   Hameed MFO, 2010, IEEE PHOTONIC TECH L, V22, P188, DOI 10.1109/LPT.2009.2037514
   Hattasan N., 2012, IEEE PHOTONIC TECH L, V24, P724
   Heikal AM, 2013, J LIGHTWAVE TECHNOL, V31, P2184, DOI 10.1109/JLT.2013.2264826
   HU C, 1974, J OPT SOC AM, V64, P1424, DOI 10.1364/JOSA.64.001424
   Huang W. P., 1993, J LIGHTWAVE TECHNOL, V29, P2639
   Huang Y, 2013, OPT EXPRESS, V21, P12790, DOI 10.1364/OE.21.012790
   Hussain FFK, 2014, IEEE J QUANTUM ELECT, V50, DOI 10.1109/JQE.2014.2320700
   Keyvaninia S., 2012, P IEEE GROUP 4 PHOT, P222
   LI HH, 1980, J PHYS CHEM REF DATA, V9, P561
   Li J, 2005, J APPL PHYS, V97, DOI 10.1063/1.1877815
   Li J, 2005, J DISP TECHNOL, V1, P51, DOI 10.1109/JDT.2005.853357
   Lin SY, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3579243
   Liu L, 2011, OPT EXPRESS, V19, P12646, DOI 10.1364/OE.19.012646
   Maune B, 2003, APPL PHYS LETT, V83, P4689, DOI 10.1063/1.1630370
   Morand A, 2006, OPT EXPRESS, V14, P12814, DOI 10.1364/OE.14.012814
   Ren GB, 2008, OPT COMMUN, V281, P1598, DOI 10.1016/j.optcom.2007.11.084
   Schroder H, 2003, ELEC COMP C, P1053, DOI 10.1109/ECTC.2003.1216420
   Socci L, 2015, OPT EXPRESS, V23, P19261, DOI 10.1364/OE.23.019261
   Somasiri N, 2002, J LIGHTWAVE TECHNOL, V20, P751, DOI 10.1109/50.996600
   Tolmachev VA, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430626
   Vermeulen D, 2012, IEEE PHOTONIC TECH L, V24, P482, DOI 10.1109/LPT.2011.2181944
   Wakabayashi Y, 2013, J LIGHTWAVE TECHNOL, V31, DOI 10.1109/JLT.2013.2253445
   Wang ZC, 2008, J OPT SOC AM B, V25, P747, DOI 10.1364/JOSAB.25.000747
   Wei L, 2009, IEEE PHOTONIC TECH L, V21, P1633, DOI 10.1109/LPT.2009.2028156
   Wolinski TR, 2007, MEAS SCI TECHNOL, V18, P3061, DOI 10.1088/0957-0233/18/10/S03
   Xu Y, 2009, OPT EXPRESS, V17, P7837, DOI 10.1364/OE.17.007837
NR 57
TC 0
Z9 0
U1 14
U2 14
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0733-8724
EI 1558-2213
J9 J LIGHTWAVE TECHNOL
JI J. Lightwave Technol.
PD JUN 1
PY 2017
VL 35
IS 11
BP 2190
EP 2199
DI 10.1109/JLT.2017.2686780
PG 10
WC Engineering, Electrical & Electronic; Optics; Telecommunications
SC Engineering; Optics; Telecommunications
GA ET0XE
UT WOS:000399987600017
OA No
DA 2017-08-17
ER

PT J
AU Salama, E
   Soliman, HA
   Youssef, GM
   Hamad, S
AF Salama, E.
   Soliman, H. A.
   Youssef, G. M.
   Hamad, Sara
TI Thermoluminescence properties of borosilicate glass doped with ZnO
SO JOURNAL OF LUMINESCENCE
LA English
DT Article
DE Thermoluminescence; Borosilicate; Zinc; Glass; Ionizing radiation
ID POTASSIUM BORATE GLASS; PHYSICAL-PROPERTIES; GAMMA-RADIATION; SYSTEM;
   SPECTROSCOPIES; XFE(2)O(3); SPECTRA; RAMAN; CAF2; CUO
AB Thermoluminescence (TL) properties of new synthetic borosilicate glass (SiO2-H3BO3-Na2CO3) doped with various concentrations of ZnO are studied. The glasses were prepared by the melt quenching method and irradiated with gamma doses in the range of 0.5-500 Gy. Some properties such as, dose response, minimum detectable dose, reproducibility of the response, thermal and optical fading and IR absorption were studied. Optimum glass composition with a good linear TL gamma dose response over a wide dose range, as well as low fading and excellent reproducibility is obtained. These appealing features indicated that; this new synthetic TL glass material is useful in many radiation detection applications. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Salama, E.; Youssef, G. M.; Hamad, Sara] Ain Shams Univ, Fac Sci, Phys Dept, Cairo, Egypt.
   [Soliman, H. A.] Natl Inst Stand, Ionizing Radiat Metrol Lab, Giza, Egypt.
   [Salama, E.] British Univ Egypt BUE, Fac Engn, Basic Sci Dept, Cairo, Egypt.
RP Salama, E (reprint author), Ain Shams Univ, Fac Sci, Phys Dept, Cairo, Egypt.
EM e_elsayed@sci.asu.edu.eg
CR Aboud H, 2012, INT J PHYS SCI, V7, P922
   Aboud H., 2012, INT J PHYS SCI, V7, P226
   Aboud H, 2014, APPL RADIAT ISOTOPES, V90, P35, DOI 10.1016/j.apradiso.2014.01.012
   Alajerami YSM, 2013, J PHYS CHEM SOLIDS, V74, P1816, DOI 10.1016/j.jpcs.2013.07.013
   Alajerami YSM, 2013, RADIAT PROT DOSIM, V155, P1, DOI 10.1093/rpd/ncs310
   Alajerami YSM, 2012, PHYSICA B, V407, P2390, DOI 10.1016/j.physb.2012.03.029
   Ardelean I, 2000, MOD PHYS LETT B, V14, P653, DOI 10.1142/S0217984900000847
   Ardelean I, 2004, MATER LETT, V58, P3499, DOI 10.1016/j.matlet.2004.06.062
   Ardelean I, 2002, MOD PHYS LETT B, V16, P539, DOI 10.1142/S0217984902003968
   Ayta WEF, 2010, J LUMIN, V130, P1032, DOI 10.1016/j.jlumin.2010.01.020
   Chen R, 2011, RADIAT MEAS, V46, P1380, DOI 10.1016/j.radmeas.2011.01.022
   DELNERY SM, 1994, PHYS REV B, V49, P3760, DOI 10.1103/PhysRevB.49.3760
   DOWEIDAR H, 1991, J PHYS D APPL PHYS, V24, P2222, DOI 10.1088/0022-3727/24/12/015
   El-Egili K, 2003, PHYSICA B, V339, P237, DOI 10.1016/j.physb.2003.07.005
   ElEgili K, 1996, J PHYS-CONDENS MAT, V8, P8959, DOI 10.1088/0953-8984/8/46/003
   Elkholy MM, 2010, J LUMIN, V130, P1880, DOI 10.1016/j.jlumin.2010.05.002
   Hashim S, 2014, APPL RADIAT ISOTOPES, V91, P126, DOI 10.1016/j.apradiso.2014.05.023
   JOHNSON PD, 1950, J CHEM PHYS, V18, P1477, DOI 10.1063/1.1747517
   JOHNSON PD, 1950, J CHEM PHYS, V18, P323, DOI 10.1063/1.1747625
   Kadono K, 2009, NUCL INSTRUM METH B, V267, P2411, DOI 10.1016/j.nimb.2009.04.014
   KAMITSOS EI, 1987, J PHYS CHEM-US, V91, P1073, DOI 10.1021/j100289a014
   Kloss T, 2000, GLASS TECHNOL, V41, P177
   Krause S, 2014, J LUMIN, V151, P29, DOI 10.1016/j.jlumin.2014.01.067
   Lucacel RC, 2006, J OPTOELECTRON ADV M, V8, P1124
   Mostefa R, 2016, OPTIK, V127, P368, DOI 10.1016/j.ijleo.2015.10.061
   Pontuschka WM, 2001, GLASS PHYS CHEM+, V27, P37, DOI 10.1023/A:1009507803955
   Rojas SS, 2006, J NON-CRYST SOLIDS, V352, P3608, DOI 10.1016/j.jnoncrysol.2006.02.128
   Saidu A, 2015, J RADIOANAL NUCL CH, V304, P627, DOI 10.1007/s10967-014-3846-y
   Teixeira MI, 2008, RADIAT MEAS, V43, P480, DOI 10.1016/j.radmeas.2007.11.029
   YAWALE SP, 1995, INDIAN J PURE AP PHY, V33, P34
NR 30
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2313
EI 1872-7883
J9 J LUMIN
JI J. Lumines.
PD JUN
PY 2017
VL 186
BP 164
EP 169
DI 10.1016/j.jlumin.2017.02.008
PG 6
WC Optics
SC Optics
GA ES9EE
UT WOS:000399858100026
OA No
DA 2017-08-17
ER

PT J
AU Abuelezz, SA
   Hendawy, N
   Magdy, Y
AF Abuelezz, Sally A.
   Hendawy, Nevien
   Magdy, Yosra
TI Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via
   Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing
   Depressive Like Behavior in Rats
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Article
DE Depression; Chronic unpredictable mild stress; Co-enzyme Q10;
   Indoleamine2,3-dioxygenase; Kynurenine; Serotonin
ID TRYPTOPHAN-KYNURENINE METABOLISM; UNPREDICTABLE MILD STRESS;
   INFLAMMATORY CYTOKINES; MAJOR DEPRESSION; DOWN-REGULATION; TNF-ALPHA;
   BRAIN; MODEL; METAANALYSIS; HIPPOCAMPUS
AB Depression is a major health problem in which oxidative stress and inflammation are inextricably connected in its pathophysiology. Coenzyme Q10 (CoQ10) is an important anti-oxidant compound with anti-inflammatory and neuro-protective properties. This study was designed to investigate the hypothesis that CoQ10 by its anti-oxidant and anti-inflammatory potentials can alleviate depressive- like behavior by restoring the balance of the tryptophan catabolites kynurenine/serotonin toward the serotonin pathway by down-regulation of hippocampal indoleamine 2,3-dioxygenase 1 (IDO-1). Depressive-like behavior was induced by chronic unpredictable mild stress (CUMS) protocol including food or water deprivation, cage tilting, reversed light cycle etc. Male Wistar rats were randomly divided into five groups; Control, CUMS, CUMS and CoQ10 (50,100 and 200 mg/kg/day i.p. respectively) groups. CoQ10 effects on different behavioral and biochemical tests were analyzed. CoQ10 showed significant antidepressant efficacy, as evidenced by significantly decreased stress induced changes to forced swimming challenge and open field test, as well as attenuating raised corticosterone level and adrenal glands weight. The anti-oxidant effect of CoQ10 was exhibited by its ability to significantly reduce hippocampal elevated malondialdehyde and 4-hydroxynonenal levels and elevate the reduced glutathione and catalase levels. CoQ10 significantly reduced different pro-inflammatory cytokines levels including interleukin (IL)-1 beta, IL-2, IL-6 and tumor necrosis factor-alpha. It suppressed hippocampal IDO-1 and subsequent production of kynurenine and enhanced the hippocampal contents of tryptophan and serotonin. Immunohistochemical analysis revealed that CoQ10 was able to attenuate the elevated microglial CD68 and elevate the astrocyte glial fibrillary acidic protein compared to CUMS group. CoQ10 exhibited antidepressant-like effects on rats exposed to CUMS. This could be attributed to its ability to reduce IDO-1 leading to shift the balance of the Kynurenine/ serotonin toward the serotonin pathway.
C1 [Abuelezz, Sally A.; Hendawy, Nevien; Magdy, Yosra] Ain Shams Univ, Dept Pharmacol, Fac Med, Cairo, Egypt.
RP Abuelezz, SA (reprint author), Ain Shams Univ, Dept Pharmacol, Fac Med, Cairo, Egypt.
EM sallyabuelezz@yahoo.com; nevienhendawy@hotmail.com; y_yosra@hotmail.com
CR Abdollahzad H, 2015, ARCH MED RES, V46, P527, DOI 10.1016/j.arcmed.2015.08.006
   Aboul-Fotouh S, 2013, BEHAV PHARMACOL, V24, P552, DOI 10.1097/FBP.0b013e3283654029
   Aboul-Fotouh S, 2013, PHARMACOL BIOCHEM BE, V104, P105, DOI 10.1016/j.pbb.2012.12.027
   Alcocer-Gomez E, 2014, J CLIN PSYCHOPHARM, V34, P277, DOI 10.1097/JCP.0000000000000097
   Ambade A., 2012, INT J HEPATOL, V2012, DOI DOI 10.1155/2012/853175
   Anderson G, 2014, CURR PHARM DESIGN, V20, P3812
   Beal MF, 2002, FREE RADICAL RES, V36, P455, DOI 10.1080/10715760290021315
   Bellac CL, 2006, NEUROBIOL DIS, V24, P395, DOI 10.1016/j.nbd.2006.07.014
   BRITT SG, 1992, J RECEPTOR RES, V12, P181, DOI 10.3109/10799899209074791
   Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.01
   Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968
   Corona AW, 2013, BRAIN BEHAV IMMUN, V31, P134, DOI 10.1016/j.bbi.2012.08.008
   Corona AW, 2012, J NEUROIMMUNE PHARM, V7, P7, DOI 10.1007/s11481-011-9313-4
   Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982
   Dahl J, 2014, PSYCHONEUROENDOCRINO, V45, P77, DOI 10.1016/j.psyneuen.2014.03.019
   Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297
   Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033
   Forester BP, 2012, J GERIATR PSYCH NEUR, V25, P43, DOI 10.1177/0891988712436688
   Harrison NA, 2008, BIOL PSYCHIAT, V63, p2S, DOI 10.1016/j.biopsych.2007.12.007
   Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Jindal A, 2013, PHARMACOL BIOCHEM BE, V105, P63, DOI 10.1016/j.pbb.2013.01.020
   Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884
   Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005
   Lesser Glenn J, 2013, J Support Oncol, V11, P31
   Li LF, 2013, EUR J PHARMACOL, V711, P42, DOI 10.1016/j.ejphar.2013.04.008
   Liu B, 2015, NEUROSCIENCE, V294, P193, DOI 10.1016/j.neuroscience.2015.02.053
   Liu Y, 2012, J AFFECT DISORDERS, V139, P230, DOI 10.1016/j.jad.2011.08.003
   Liu Y, 2013, PHARMACOL BIOCHEM BE, V104, P27, DOI 10.1016/j.pbb.2012.12.024
   Ma M, 2014, CLIN PSYCHOPHARM NEU, V12, P31, DOI 10.9758/cpn.2014.12.1.31
   Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004
   Maes M, 2009, NEUROENDOCRINOL LETT, V30, P462
   MEFFORD IN, 1981, J NEUROSCI METH, V3, P207, DOI 10.1016/0165-0270(81)90056-X
   Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006
   Mohamed Bassim Msa, 2013, Neuropsychiatr Dis Treat, V9, P697, DOI 10.2147/NDT.S41020
   Moretti M, 2012, J PSYCHIATR RES, V46, P331, DOI 10.1016/j.jpsychires.2011.11.009
   Morris G, 2013, MOL NEUROBIOL, V48, P883, DOI 10.1007/s12035-013-8477-8
   Muller MB, 2001, EUR J NEUROSCI, V14, P1603, DOI 10.1046/j.0953-816x.2001.01784.x
   Oxenkrug GF, 2007, ANN NY ACAD SCI, V1122, P35, DOI 10.1196/annals.1403.003
   Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x
   PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327
   Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006
   Rezin GT, 2008, NEUROCHEM INT, V53, P395, DOI 10.1016/j.neuint.2008.09.012
   Scapagnini G, 2012, CNS DRUGS, V26, P477, DOI 10.2165/11633190-000000000-00000
   Schmelzer C, 2008, BIO FACT, V1-4, P179
   Schwarzer E, 2015, OXID MED CELL LONGEV, DOI 10.1155/2015/638416
   Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001
   Tarry-Adkins JL, 2016, AM J CLIN NUTR, V103, P579, DOI 10.3945/ajcn.115.119834
   Tonissaar M, 2008, PROG NEURO-PSYCHOPH, V32, P164, DOI 10.1016/j.pnpbp.2007.08.001
   Tynan RJ, 2013, ACTA NEUROPATHOL, V126, P75, DOI 10.1007/s00401-013-1102-0
   Vavakova M, 2015, OXID MED CELL LONGEV, DOI 10.1155/2015/898393
   Wang N, 2015, UPSALA J MED SCI, V120, P241, DOI 10.3109/03009734.2015.1060281
   Wang Y, 2011, PROG NEURO-PSYCHOPH, V35, P1831, DOI 10.1016/j.pnpbp.2011.07.004
   World Health Organization, 2015, DEPRESSION
   Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097
   Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456
   Wohleb ES, 2016, NAT REV NEUROSCI, V17, P497, DOI 10.1038/nrn.2016.69
   Xu Y, 2014, CURR NEUROPHARMACOL, V12, P108, DOI 10.2174/1570159X11666131120231448
   Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001
   Zhu XX, 2015, J ETHNOPHARMACOL, V160, P86, DOI 10.1016/j.jep.2014.11.031
NR 60
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD JUN
PY 2017
VL 12
IS 2
BP 277
EP 291
DI 10.1007/s11481-016-9712-7
PG 15
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA ET2DA
UT WOS:000400077600007
PM 27730347
OA No
DA 2017-08-17
ER

PT J
AU Gamal, AY
   Al-Berry, NN
   Hassan, AA
   Rashed, LA
   Iacono, VJ
AF Gamal, A. Y.
   Al-Berry, N. N.
   Hassan, A. A.
   Rashed, L. A.
   Iacono, V. J.
TI In vitro evaluation of the human gingival fibroblast/gingival
   mesenchymal stem cell dynamics through perforated guided tissue
   membranes: cell migration, proliferation and membrane stiffness assay
SO JOURNAL OF PERIODONTAL RESEARCH
LA English
DT Article
DE guided tissue membrane; guided tissue regeneration; periodontal pockets;
   periodontal regeneration
ID BARRIER MEMBRANES; REGENERATION; CULTURE; EXPRESSION; DEFECTS; GROWTH
AB BackgroundMigration of gingival fibroblasts/gingival mesenchymal stem cells through macro-perforated barrier membranes may allow them to participate positively in periodontal regeneration. The optimal guided tissue membrane perforation diameter that could favor maximum cell migration into the defect area and at the same time act as an occlusive barrier for gingival epithelium and its associated gingival extracellular matrix component is not yet identified.
   Material and MethodsCultured human gingival fibroblasts/gingival mesenchymal stem cells were placed in the upper chambers of 12-well collagen-coated polytetrafluoroethylene transwells, which were manually perforated with 0.2, 0.4 and 0.7 mm sized pores. The lower chambers of the transwells received blood clot as an attraction medium. The number of cells that have migrated to the lower chambers was calculated. Proliferation of these cells was evaluated using MTT assay. Scanning electron microscopy images were obtained for the lower surfaces of the transwell membranes. Perforated bovine collagen membranes (Tutopatch((R))) were subjected to mechanical testing to determine the tensile strength and modulus of elasticity.
   ResultsGroup 3 (0.7 mm) showed significantly higher values for cell migration and proliferation. All groups showed a small degree of extracellular matrix migration through membrane perforations. Scanning electron microscopy evaluation revealed variable numbers of cells in fibrin matrices located mainly around the pore edges. There were non-significant differences between groups regarding mechanical properties.
   ConclusionsThe present study demonstrated that macro-membrane perforations of 0.2, 0.4 and 0.7 mm are suitable pore diameters that could maintain membrane stiffness and allow for cellular migration. However, these membrane perforation diameters did not allow for total gingival connective tissue isolation.
C1 [Gamal, A. Y.; Al-Berry, N. N.; Hassan, A. A.] Ain Shams Univ, Dept Periodontol, Fac Dent, Cairo, Egypt.
   [Rashed, L. A.] Cairo Univ, Fac Med, Cairo, Egypt.
   [Iacono, V. J.] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA.
RP Iacono, VJ (reprint author), SUNY Stony Brook, Sch Dent Med, Dept Periodontol, Stony Brook, NY 11794 USA.
EM Vincent.Iacono@stonybrook.edu
CR Buurma B, 1999, EUR J ORAL SCI, V107, P282, DOI 10.1046/j.0909-8836.1999.eos107408.x
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Diegelmann RF, 2004, FRONT BIOSCI, V9, P283, DOI 10.2741/1184
   Fawzy El-Sayed K, 2012, J CLIN PERIODONTOL, V39, P1
   Enoch S., 2007, SURGERY, V26, P31
   Gamal AY, 2016, J PERIODONTAL RES, V51, P407, DOI 10.1111/jre.12321
   Gamal AY, 2013, J PERIODONTOL, V84, P905, DOI 10.1902/jop.2012.120301
   Gamal AY, 2014, J INT ACAD PERIODONT, V16, P1
   Gronthos S, 2011, METHODS MOL BIOL, V698, P107, DOI 10.1007/978-1-60761-999-4_9
   Gutta R, 2009, J ORAL MAXIL SURG, V67, P1218, DOI 10.1016/j.joms.2008.11.022
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   IRWIN CR, 1994, J CELL SCI, V107, P1333
   Ivanovski S, 2001, J PERIODONTAL RES, V36, P131, DOI 10.1034/j.1600-0765.2001.360301.x
   Kuo SM, 2009, J APPL POLYM SCI, V112, P3127, DOI 10.1002/app.29664
   MACHTEI EE, 1994, J PERIODONTOL, V65, P154
   McCabe JF, 2008, APPL DENT MAT, P6
   Mitrano TI, 2010, J PERIODONTOL, V81, P917, DOI 10.1902/jop.2010.090566
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Tomar GB, 2010, BIOCHEM BIOPH RES CO, V393, P377, DOI 10.1016/j.bbrc.2010.01.126
   vansMeerloo J, 2011, CANC CELL CULTURE ME, V791, P237
   Wikesjo U M, 1995, J Calif Dent Assoc, V23, P30
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
NR 23
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3484
EI 1600-0765
J9 J PERIODONTAL RES
JI J. Periodont. Res.
PD JUN
PY 2017
VL 52
IS 3
BP 628
EP 635
DI 10.1111/jre.12431
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA ET0MC
UT WOS:000399955500036
PM 28177132
OA No
DA 2017-08-17
ER

PT J
AU Yakout, SM
   El-Sayed, AM
AF Yakout, S. M.
   El-Sayed, A. M.
TI Influence of single and binary transition metal dopants (Mn, Fe, or Co)
   on the structure, optical, and magnetic properties of SnO2 nanoparticles
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Sol-gel synthesis; SnO2 nanoparticles; (Mn, Fe, or Co) dopants;
   Ferromagnetism; Spintronics
ID DOPED SNO2; FERROMAGNETISM; NANOSTRUCTURES; SEMICONDUCTOR
AB Nanoparticles samples of pure SnO2, Sn0.99Mn0.01O2, Sn0.98Mn0.02O2, Sn0.98Mn0.01Fe0.01O2, Sn0.96Mn0.02Fe0.02O2, Sn0.98Mn0.01Co0.01O2 and Sn0.96Mn0.02Co0.02O2 were synthesized by sol-gel method. X-ray diffraction analysis and Fourier transform infrared spectra of all prepared samples confirmed the formation of single phase SnO2 with tetragonal rutile structure. The average crystallite sizes of the prepared samples were estimated to be in the range of 7-12 nm. Energy-dispersive X-ray spectroscopy analysis of Sn0.98Mn0.02O2, Sn0.96Mn0.02Fe0.02O2, and Sn0.96Mn0.02Co0.02O2 samples evidently proved the existence of Mn, Fe, Co, Sn, and O elements only without any impurity, indicating the high purity of the prepared samples. Transmission electron microscopy images showed the formation of ultra-fine spherical nanoparticles in all samples with average particles sizes of 8.5-15 nm. From the UV-Vis absorption spectra results, the band gap energy value of the pure SnO2 nanoparticles was estimated to be 3.90 eV and it varied with dopant type and its concentration. Room temperature magnetic hysteresis loops of all samples exhibited ferromagnetic behavior. Clear enhancement in the room temperature ferromagnetism was achieved in pure SnO2 nanoparticles after doping with Mn and codoping with (Mn, Fe) or (Mn, Co) dopants. The maximum value of the saturation magnetization was found in Sn0.96Mn0.02Fe0.02O sample, while Sn0.96Mn0.02Co0.02O sample displayed the higher values of coercivity and retentivity.
C1 [Yakout, S. M.; El-Sayed, A. M.] NRC, Dept Inorgan Chem, El Behooth St, Giza 12311, Egypt.
RP Yakout, SM (reprint author), NRC, Dept Inorgan Chem, El Behooth St, Giza 12311, Egypt.
EM s_mabrok2002@yahoo.com
CR Ali A, 2015, J MAGN MAGN MATER, V391, P161, DOI 10.1016/j.jmmm.2015.04.106
   Averous M, 1991, SEMIMAGNETIC SEMICON, DOI [10.1007/978-1-4615-3776-2, DOI 10.1007/978-1-4615-3776-2]
   Chambers SA, 2006, MATER TODAY, V9, P28, DOI 10.1016/S1369-7021(06)71692-3
   Chambers S.A., 2002, MATER TODAY, V5, P34, DOI 10.1016/S1369-7021(02)05423-8
   Cunha TR, 2013, J SUPERCOND NOV MAGN, V26, P2299, DOI 10.1007/s10948-012-1479-3
   Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019
   Dietl T, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/16/165204
   Ghanaatshoar M, 2013, J SUPERCOND NOV MAGN, V26, P995, DOI 10.1007/s10948-012-1942-1
   Gnanam S, 2010, J SOL-GEL SCI TECHN, V56, P128, DOI 10.1007/s10971-010-2285-7
   Gupta A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2712018
   Gupta KM, 2016, ADV SEMICONDUCTING M, DOI 10.1007/978-3-319-19758-6
   Hong NH, 2016, MAGNETIC OXIDE SEMIC, P563, DOI [10.1007/978-94-007-6892-5, DOI 10.1007/978-94-007-6892-5]
   Joshi Vinod Kumar, 2016, Engineering Science and Technology, an International Journal, V19, P1503, DOI 10.1016/j.jestch.2016.05.002
   Khan GG, 2012, J SOLID STATE CHEM, V186, P278, DOI 10.1016/j.jssc.2011.11.038
   Khan R, 2016, J MATER SCI-MATER EL, V27, P10532, DOI 10.1007/s10854-016-5144-7
   Luan HX, 2014, RSC ADV, V4, P9602, DOI 10.1039/c3ra46325g
   Manikandan D, 2016, SUPERLATTICE MICROST, V89, P7, DOI 10.1016/j.spmi.2015.10.045
   Mehraj S, 2015, PHYSICA E, V65, P84, DOI 10.1016/j.physe.2014.08.016
   Hong NH, 2012, J MAGN MAGN MATER, V324, P3013, DOI 10.1016/j.jmmm.2012.04.047
   Okabayashi J, 2012, J APPL PHYS, V112, DOI 10.1063/1.4754454
   Pal U, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0969-3
   Qian X, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/5/057503
   Shaalan NM, 2016, PROG NAT SCI-MATER, V26, P145, DOI 10.1016/j.pnsc.2016.03.002
   Sharma A, 2011, NANOMATER NANOTECHNO, V1, P29
   Sharma PK, 2009, J MAGN MAGN MATER, V321, P4001, DOI 10.1016/j.jmmm.2009.07.066
   Singh C, 2009, MATER LETT, V63, P1921, DOI 10.1016/j.matlet.2009.06.002
   Singh RPP, 2016, J SUPERCOND NOV MAGN, V29, P819, DOI 10.1007/s10948-015-3349-2
   Subramanyam K., 2014, IJITEE, V4, P27
   Sundaresan A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161306
   Sundaresan A, 2009, NANO TODAY, V4, P96, DOI 10.1016/j.nantod.2008.10.002
   Wang J, 2015, J MATER ENG PERFORM, V24, P3426, DOI 10.1007/s11665-015-1637-4
   Wang N, 2015, J MATER SCI-MATER EL, V26, P7751, DOI 10.1007/s10854-015-3420-6
   Xu YB, 2006, J MAGN MAGN MATER, V304, P69, DOI 10.1016/j.jmmm.2006.02.004
   Yakout SM, 2016, J SUPERCOND NOV MAGN, V29, P2961, DOI 10.1007/s10948-016-3641-9
   Yu-Feng T., 2013, CHINESE PHYS B, V22, DOI DOI 10.1088/1674-1056/22/8/088505
   Zarhri Z, 2016, J MAGN MAGN MATER, V406, P212, DOI 10.1016/j.jmmm.2016.01.029
NR 36
TC 0
Z9 0
U1 8
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
EI 1573-4846
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD JUN
PY 2017
VL 82
IS 3
BP 760
EP 771
DI 10.1007/s10971-017-4368-1
PG 12
WC Materials Science, Ceramics
SC Materials Science
GA ES9PU
UT WOS:000399892500016
OA No
DA 2017-08-17
ER

PT J
AU Aly, AA
   Brase, S
AF Aly, Ashraf A.
   Braese, Stefan
TI Oxidation-reduction and heterocyclization of the reactions of
   alkanedithiols with pi-deficient compounds
SO JOURNAL OF SULFUR CHEMISTRY
LA English
DT Article
DE 1,2(3)-Aliphatic dithiols; pi-deficient compounds; oxidation-reduction;
   heterocycles; mechanism
ID DERIVATIVES; NAPHTHOQUINONE; DISULFIDE; QUINONES
AB The reaction of 1,2-ethanedithiol and 1,3-propanedithiol with pi-deficient compounds afforded various oxidation-reduction and cyclized products under mild conditions. Heterocycles containing one sulfur atom (e.g. analogues of seriniquinone) were also obtained. The structures of the products were elucidated by NMR, IR, mass spectral data, and elemental analyses. The mechanisms were also discussed.
C1 [Aly, Ashraf A.] Menia Univ, Fac Sci, Dept Chem, El Minia 61519, Egypt.
   [Braese, Stefan] Karlsruhe Inst Technol, Inst Organ Chem, Karlsruhe, Germany.
RP Aly, AA (reprint author), Menia Univ, Fac Sci, Dept Chem, El Minia 61519, Egypt.
EM ashrafaly63@yahoo.com
RI Braese, Stefan/B-9057-2008
OI Braese, Stefan/0000-0003-4845-3191
FU DFG [BR 1750]
FX We thank the DFG (BR 1750) for its financial support for the stay of
   Professor Aly at the Karlsruhe Institute of Technology, Institute of
   Organic Chemistry, Germany.
CR Aly AA, 2016, J SULFUR CHEM, V37, P141, DOI 10.1080/17415993.2015.1102911
   Beuzer P, 2016, ORG BIOMOL CHEM, V14, P8241, DOI 10.1039/c6ob01418f
   Chen H, 2012, MAR DRUGS, V10, P2715, DOI 10.3390/md10122715
   Chen H, 2012, MAR DRUGS, V10, P932, DOI 10.3390/md10040932
   Desogere P, 2013, EUR J ORG CHEM, P1538, DOI 10.1002/ejoc.201201337
   El Malah T, 2016, J SULFUR CHEM, V37, P222, DOI 10.1080/17415993.2015.1122011
   GREENE TW, 1991, PROTECTIVE GROUPS OR
   JENSEN KA, 1968, ACTA CHEM SCAND, V22, P1107, DOI 10.3891/acta.chem.scand.22-1107
   Kapanda CN, 2009, J MED CHEM, V52, P7310, DOI 10.1021/jm901323s
   KATRITZKY AR, 1988, J HETEROCYCLIC CHEM, V25, P901
   KATRITZKY AR, 1989, J HETEROCYCLIC CHEM, V26, P885
   Khabibullina GR, 2014, TETRAHEDRON, V70, P3502, DOI 10.1016/j.tet.2014.03.053
   Lindenschmidt C, 2016, EUR J MED CHEM, V110, P280, DOI 10.1016/j.ejmech.2016.01.040
   Ma T, 2016, ANGEW CHEM INT EDIT, V55, P6428, DOI 10.1002/anie.201601119
   Mohamed NK, 1996, J PRAK CHEM-CHEM ZTG, V338, P745, DOI 10.1002/prac.199633801145
   OSAKA H, 1994, B CHEM SOC JPN, V67, P918, DOI 10.1246/bcsj.67.918
   PROSTENIK M, 1952, J ORG CHEM, V17, P379, DOI 10.1021/jo01137a008
   Rckentscher K, 1969, J ARCH PHARM, V302, P53, DOI [10.1002/ardp.19693020108, DOI 10.1002/ARDP.19693020108]
   Stasevych MV, 2005, HETEROATOM CHEM, V16, P205, DOI 10.1002/hc.20112
   Taylor R. W., 2012, SUPRAMOL CHEM, V1, P67
   Trzoss L, 2014, P NATL ACAD SCI USA, V111, P14687, DOI 10.1073/pnas.1410932111
   WATSON WH, 1993, TETRAHEDRON, V49, P3035, DOI 10.1016/S0040-4020(01)89885-9
   Zentz F., 2005, Farmaco (Lausanne), V60, P944, DOI 10.1016/j.farmac.2005.06.015
   Zia Z., 2009, NEUROTOXICOLOGY, V30, P1
NR 24
TC 0
Z9 0
U1 3
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1741-5993
EI 1741-6000
J9 J SULFUR CHEM
JI J. Sulfur Chem.
PD JUN
PY 2017
VL 38
IS 3
BP 291
EP 302
DI 10.1080/17415993.2017.1278762
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA ET4JX
UT WOS:000400247300006
OA No
DA 2017-08-17
ER

PT J
AU El-Gaby, MSA
   Ammar, YA
   Ali, GAME
   Helal, MHM
   Salem, MA
   Ghorab, MM
AF El-Gaby, Mohamed S. A.
   Ammar, Yousry A.
   Ali, Gameel A. M. El-Hag
   Helal, Mohamed H. M.
   Salem, Mohamed A.
   Ghorab, Mostafa M.
TI Chemistry of 2-cyanomethylene-4-thiazolidinone
SO JOURNAL OF SULFUR CHEMISTRY
LA English
DT Article
DE 4-Thiazolidinone; thiazolo[3,2-a]pyridine; pyrano[2,3-d]-thiazole;
   [1,2,3]triazine; [1,8]naphthyridine
ID HETEROCYCLIC SYNTHESIS; ACTIVATED NITRILES; ANTIMICROBIAL ACTIVITY;
   BIOLOGICAL-ACTIVITIES; FACILE SYNTHESIS; DERIVATIVES; THIAZOLOPYRIDINES;
   UTILITY; PYRIDINE; MOIETY
AB This article is a brief review about the synthesis and chemistry of 2-cyanomethylene-4-thiazolidinone 1. The most significant applications of 4-thiazolidinone 1 in heterocyclic synthesis are due to its two reactive methylenes. The endo-cyclic methylene protons are activated by the neighboring carbonyl moiety and the exo-cyclic methylene protons by the adjacent cyano group. Different types of reactions, such as alkylation, coupling, and Knoevenagel condensation, as well as cyclization reactions are illustrated for the synthesis of different classes of biologically important heterocyclic skeletons from this novel precursor.
C1 [El-Gaby, Mohamed S. A.] Al Azhar Univ Assiut, Dept Chem, Fac Sci, Assiut 71524, Egypt.
   [Ammar, Yousry A.; Ali, Gameel A. M. El-Hag; Helal, Mohamed H. M.; Salem, Mohamed A.] Al Azhar Univ, Dept Chem, Fac Sci, Cairo, Egypt.
   [Ghorab, Mostafa M.] King Saud Univ, Dept Pharmacognosy, Coll Pharm, Riyadh, Saudi Arabia.
   [Ghorab, Mostafa M.] Atom Energy Author, Dept Drug Radiat Res, Natl Ctr Radiat Res & Technol, Cairo, Egypt.
RP El-Gaby, MSA (reprint author), Al Azhar Univ Assiut, Dept Chem, Fac Sci, Assiut 71524, Egypt.
EM m_elgaby@hotmail.com
CR Abd El Latif FM, 2003, J HETEROCYCLIC CHEM, V40, P57
   ABDELLATIF FF, 1993, PHOSPHORUS SULFUR, V78, P251, DOI 10.1080/10426509308032440
   Abdelrazek FM, 2006, ARCH PHARM, V339, P305, DOI 10.1002/ardp.200500259
   Al-Thebeiti MS, 2000, FARMACO, V55, P109, DOI 10.1016/S0014-827X(99)00130-5
   El-Hag Ali GAM, 2008, PHOSPHORUS SULFUR, V183, P3023
   Ali GAME, 2002, ACTA CHIM SLOV, V49, P365
   Allam YA, 2001, J CHEM RES-S, P346
   Azab Mohamed E., 2003, Acta Pharmaceutica (Zagreb), V53, P213
   Boominathan M, 2014, J HETEROCYCLIC CHEM, V51, P244, DOI 10.1002/jhet.1650
   CEDER O, 1973, ACTA CHEM SCAND, V27, P1923, DOI 10.3891/acta.chem.scand.27-1923
   El-Emary TI, 2005, PHOSPHORUS SULFUR, V180, P19, DOI 10.1080/10426500490494778
   El-Gaby MSA, 2003, PHOSPHORUS SULFUR, V178, P1681, DOI 10.1080/10426500390200729
   El-Maghraby AA, 2002, PHOSPHORUS SULFUR, V177, P293, DOI 10.1080/10426500210240
   El-Rady EA, 2002, J HETEROCYCLIC CHEM, V39, P1109
   ELAGAMEY AGA, 1987, ARCH PHARM, V320, P246, DOI 10.1002/ardp.19873200311
   ELGEMEIE GEH, 1983, Z NATURFORSCH B, V38, P781
   ELMOGHAYAR MRH, 1984, J HETEROCYCLIC CHEM, V21, P1885
   ELMOGHAYAR MRH, 1981, SYNTHESIS-STUTTGART, P635
   ELNAGDI MH, 1979, J HETEROCYCLIC CHEM, V16, P1541
   Elnagdi MH, 1989, PHOSPHORUS SULFUR, V9, P109
   ELSAKKA IA, 1994, ARCH PHARM, V327, P133, DOI 10.1002/ardp.19943270303
   Hafiz ISA, 1998, J CHEM RES-S, P690
   Hussein AM, 2014, J APP PHARM, V6, P296
   Hussein EM, 2012, HETEROCYCL LETT, V2, P19
   IBRAHIM MKA, 1990, PHOSPHORUS SULFUR, V47, P61
   ISIDOR JL, 1973, J ORG CHEM, V38, P3615, DOI 10.1021/jo00960a039
   Jain AK, 2012, BIOORGAN MED CHEM, V20, P3378, DOI 10.1016/j.bmc.2012.03.069
   KAMBE S, 1981, SYNTHESIS-STUTTGART, P531
   Kapoor G, 2016, J CHEM PHARM RES, V8, P151
   KHALIFA FA, 1983, HETEROCYCLES, V20, P1021
   Lamphon RQ, 2004, PHOSPHORUS SULFUR, V179, P1279, DOI 10.1080/10426500490468092
   Mahmoud MR, 2007, PHOSPHORUS SULFUR, V182, P2507, DOI 10.1080/10426500701506465
   Mahmoud MR, 1998, PHOSPHORUS SULFUR, V139, P97, DOI 10.1080/10426509808035681
   Mashrai A., 2016, MED CHEM, V6, P280
   Mortikov VY, 2014, RUSS CHEM B+, V63, P443
   OSMAN SAM, 1986, MONATSH CHEM, V117, P105
   Ottana R, 2005, BIOORGAN MED CHEM, V13, P4243, DOI 10.1016/j.bmc.2005.04.058
   Pemawat G, 2011, INDIAN J CHEM B, V50, P1173
   SADEK KU, 1984, Z NATURFORSCH B, V39, P824
   Salem MAI, 2004, PHOSPHORUS SULFUR, V179, P61, DOI 10.1080/10426500490257041
   SATZINGER G, 1978, LIEBIGS ANN CHEM, P473
   SATZINGER G, 1963, LIEBIGS ANN CHEM, V665, P150
   SHAMS HZ, 1989, B SOC CHIM FR, P119
   Shmeiss NAMM, 2000, MOLECULES, V5, P1101, DOI 10.3390/51001101
   Tripathi AC, 2014, EUR J MED CHEM, V72, P52, DOI 10.1016/j.ejmech.2013.11.017
   Tverdokhlebov AV, 2003, SYNTHESIS-STUTTGART, P2632, DOI 10.1055/s-2003-42451
   Wardakhan WW, 2011, HETEROCYCL COMMUN, V17, P155, DOI 10.1515/HC.2011.033
   Zaky OS, 2012, MOLECULES, V17, P5924, DOI 10.3390/molecules17055924
   Satzinger G, 1965, Patent No. [US 3,193,558 (Cl. 260-306.7), 3193558]
   Satzinger G, 1963, US Appl., Patent No. [Ger. 1,150,985 (Cl. C071d), 1150985]
NR 50
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1741-5993
EI 1741-6000
J9 J SULFUR CHEM
JI J. Sulfur Chem.
PD JUN
PY 2017
VL 38
IS 3
BP 314
EP 345
DI 10.1080/17415993.2016.1263304
PG 32
WC Chemistry, Multidisciplinary
SC Chemistry
GA ET4JX
UT WOS:000400247300008
OA No
DA 2017-08-17
ER

PT J
AU Amer, BA
   Abdel-Aziz, MH
   El-Ashtoukhy, ESZ
   Amin, NK
AF Amer, B. A.
   Abdel-Aziz, M. H.
   El-Ashtoukhy, E. -S. Z.
   Amin, N. K.
TI Extraction of heavy metals from aqueous solutions in a modified rotating
   disc extractor
SO JOURNAL OF WATER REUSE AND DESALINATION
LA English
DT Article
DE extraction; heavy metals; modified disc; naphthenic acid; solvent
   extraction; wastewater
ID MASS-TRANSFER BEHAVIOR; SYSTEMS
AB Extraction of Cu+2 from dilute aqueous solutions as a case study by liquid cation exchanger in a modified rotating disc extractor was studied. The liquid cation exchanger consisted of naphthenic acid dissolved in an inert carrier kerosene. Variables studied were: initial concentration of Cu+2 , disc rotational speed, concentration of naphthenic acid, flow rates of continuous and dispersed phase, degree of roughness, and number of rotating discs. The rate of extraction increased with increasing rotational speed, concentration of naphthenic acid, flow rate of dispersed phase, degree of roughness and number of discs to a certain number, while increasing Cu+2 concentration and flow rate of continuous phase decreased the rate of extraction. All variables were correlated by the dimensionless mass transfer equation. Possible practical applications of the present data in treating aqueous waste from different sources such as petrochemical industries, electroplating, and hydrometallurgical processes was highlighted.
C1 [Amer, B. A.; Abdel-Aziz, M. H.; El-Ashtoukhy, E. -S. Z.; Amin, N. K.] Alexandria Univ, Chem Engn Dept, Fac Engn, Alexandria, Egypt.
   [Abdel-Aziz, M. H.] King Abdulaziz Univ, Fac Engn, Chem & Mat Engn Dept, Rabigh 21911, Saudi Arabia.
RP Amer, BA (reprint author), Alexandria Univ, Chem Engn Dept, Fac Engn, Alexandria, Egypt.
EM bassem.amer1981@gmail.com
RI Abdel-Aziz, Mohamed/I-6801-2013
OI Abdel-Aziz, Mohamed/0000-0002-3075-4968
CR Abdel-Aziz MH, 2013, HYDROMETALLURGY, V137, P126, DOI 10.1016/j.hydromet.2013.06.003
   Barakat MA, 2011, ARAB J CHEM, V4, P361, DOI 10.1016/j.arabjc.2010.07.019
   Behzad F, 2015, INT J TECHNOL, V6, P31, DOI 10.14716/ijtech.v6i1.779
   BOURNE JR, 1991, CHEM ENG J BIOCH ENG, V47, P155, DOI 10.1016/0300-9467(91)85021-M
   CALDERBANK PH, 1961, CHEM ENG SCI, V16, P39, DOI 10.1016/0009-2509(61)87005-X
   Csefalvay E, 2009, DESALINATION, V240, P132, DOI 10.1016/j.desal.2007.11.070
   Fadali O. A., 2004, J BASIC SCI ENG, V12, P233
   Feng D, 2000, MINER ENG, V13, P623, DOI 10.1016/S0892-6875(00)00045-5
   Findlay A., 1965, PRACTICAL PHYS CHEM
   Fletcher A. W., 1961, T I MIN METALL, V73, P765
   Fletcher A. W., 1964, T I MIN METALL, V737, P765
   Flett D. S., 1974, HYDROMETALLURGY, V1, P207
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Glasser D., 1976, MINER SCI ENG, V8, P23
   Incropera F. P., 1990, FUNDAMENTALS HEAT MA
   Li YH, 2010, J HAZARD MATER, V177, P876, DOI 10.1016/j.jhazmat.2009.12.114
   Magwa N. P., 2012, INT J NON FERROUS ME, V1, P49
   Mao ZS, 2004, CHEM ENG SCI, V59, P1815, DOI 10.1016/j.ces.2004.01.035
   Murugesan T, 2004, J CHEM ENG JPN, V37, P1293, DOI 10.1252/jcej.37.1293
   Petrov S, 2004, DESALINATION, V162, P201, DOI 10.1016/S0011-9164(04)00043-8
   Philip S., 1997, HDB SEPARATION TECHN
   Preez A. C., 1992, SOLVENT EXTR ION EXC, V10, P207, DOI 10.1080/07366299208918101
   PRESTON JS, 1985, HYDROMETALLURGY, V14, P171, DOI 10.1016/0304-386X(85)90032-5
   SAITO K, 1990, ANAL CHIM ACTA, V237, P245, DOI 10.1016/S0003-2670(00)83925-2
   Sarubbo LA, 2005, BRAZ J CHEM ENG, V22, P489, DOI 10.1590/S0104-66322005000300016
   Sedahmed GH, 2000, CHEM ENG J, V76, P247, DOI 10.1016/S1385-8947(99)00172-2
   Shahalam AM, 2002, DESALINATION, V150, P235, DOI 10.1016/S0011-9164(02)00979-7
   Shehata AS, 2011, BULG CHEM COMMUN, V43, P427
   Sherwood T. K., 1975, MASS TRANSFER
   Soldenhoff K. H., 1987, SOLVENT EXTR ION EXC, V237, P245
   Torab-Mostaedi M, 2008, BRAZ J CHEM ENG, V25, P473, DOI 10.1590/S0104-66322008000300005
   VILLERMAUX E, 1991, EUR J MECH B-FLUID, V10, P427
   Wang Y. D., 2000, CHEM ENG J, V80, P392
   Welty JR, 2008, FUNDAMENTALS MOMENTU
NR 34
TC 0
Z9 0
U1 6
U2 6
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 2220-1319
J9 J WATER REUSE DESAL
JI J. Water Reuse Desalin.
PD JUN
PY 2017
VL 7
IS 2
BP 187
EP 196
DI 10.2166/wrd.2016.178
PG 10
WC Engineering, Environmental; Water Resources
SC Engineering; Water Resources
GA ET2XS
UT WOS:000400139700008
OA No
DA 2017-08-17
ER

PT J
AU Adly, AR
   El Sehiemy, RA
   Abdelaziz, AY
AF Adly, Ahmed R.
   El Sehiemy, Ragab A.
   Abdelaziz, Almoataz Y.
TI A novel single end measuring system based fast identification scheme for
   transmission line faults
SO MEASUREMENT
LA English
DT Article
DE Power transmission lines; Discrete wavelet transform; Karen-Bell
   transformation; Fast fault identification
ID WAVELET SINGULAR ENTROPY; NEURAL-NETWORK APPROACH; FUZZY-LOGIC;
   CLASSIFICATION; PROTECTION; POWER; LOCATION; TRANSFORM; ALGORITHM; PHASE
AB This paper proposes a novel single end measuring system for fast fault identification in transmission lines (TL). The proposed scheme combines the merits of Discrete Wavelet Transform (DWT) and Karen Bell Transformation (KBT) for the fault analysis process. The proposed scheme is independent on threshold value. The proposed algorithm tested on a 350 km, 500 kV transmission line for different fault types using ATP/EMTP simulation package. Critical issues like a variation in fault location, fault resistance, fault inception angle and different source capacities are validated using the proposed scheme. The scheme extracts distinctive fault features over 1/16 of a cycle data windows with sampling frequency 6.4 kHz. The proposed scheme detects and classifies the fault using only 8 samples from power cycle and the average of fault detection time is 1.25 ms. The obtained results indicate that the developed scheme is fast, reliable, robust compared to the previous works in the literature. (c) 2017 Elsevier Ltd. All rights reserved.
C1 [Adly, Ahmed R.] Nucl Res Ctr, Atom Energy Author, Cairo, Egypt.
   [El Sehiemy, Ragab A.] Kafrelsheikh Univ, Dept Elect Engn, Fac Engn, Kafrelsheikh, Egypt.
   [Abdelaziz, Almoataz Y.] Shams Univ, Elect Power & Machines Dept, Fac Engn, Cairo, Egypt.
RP Adly, AR (reprint author), ETRR 2, Atom Energy Author, Cairo, Egypt.
EM ahmed.adly@eaea.org.eg; elsehiemy@eng.kfs.edu.eg;
   almoatazabdelaziz@hotmail.com
CR Abdelaziz A. Y., 2013, INT J INTELL SYST AP, V3, P23
   Adly AR, 2017, ELECTR POW SYST RES, V144, P197, DOI 10.1016/j.epsr.2016.12.011
   Adly AR, 2016, ELECTR POW SYST RES, V137, P175, DOI 10.1016/j.epsr.2016.03.038
   Adly A.R., 2015, P 17 INT MIDDL E POW
   Adly A.R., 2016, IET GENER T DISTR, V10
   Adly A.R., 2015, REC TRENDS EN SYST C, P89
   Adly A.R., 2016, 1 INT C 1 C NEW TREN, P1
   Al-Kababjie M.F., 2012, RENEWABLE ENERGIES V, P237
   Biswal B, 2014, IET GENER TRANSM DIS, V8, P353, DOI 10.1049/iet-gtd.2013.0171
   Biswarup Das, 2005, IEEE T POWER DELIVER, V20, P609
   Chen KJ, 2016, HIGH VOLT, V1, P25, DOI 10.1049/hve.2016.0005
   Cheng JJ, 2012, TOP CURR CHEM, V310, P1, DOI 10.1007/128_2011_173
   CHRISTOPOULOS C, 1988, IEE PROC-C, V135, P63
   CROSSLEY PA, 1983, IEEE T POWER AP SYST, V102, P2971, DOI 10.1109/TPAS.1983.318102
   CRUSCA F, 2003, IASTED INT SYST CONT, P183
   DALSTEIN T, 1995, IEEE T POWER DELIVER, V10, P1002, DOI 10.1109/61.400828
   Das D., 2006, IEEE POW IND C NEW D
   Dasgupta A, 2012, ELECTR POW COMPO SYS, V40, P1676, DOI 10.1080/15325008.2012.716495
   Dehghani M, 2016, INT J ELEC POWER, V78, P455, DOI 10.1016/j.ijepes.2015.11.048
   Eldin E.S., 1988, IEEE T POWER DELIVER, V3, P894
   Gomez MJ, 2016, ALGORITHMS, V9, DOI 10.3390/a9010019
   Gopakumar P, 2015, ELECTR POW COMPO SYS, V43, P695, DOI 10.1080/15325008.2014.995839
   Guillen D, 2015, IET GENER TRANSM DIS, V9, P2294, DOI 10.1049/iet-gtd.2014.1064
   Hasabe R. P., 2014, International Journal of Smart Grid and Clean Energy, V3, P283
   Hasheminejad S, 2016, IET GENER TRANSM DIS, V10, P1067, DOI 10.1049/iet-gtd.2015.0947
   He ZY, 2014, INT J ELEC POWER, V61, P429, DOI 10.1016/j.ijepes.2014.03.027
   He ZY, 2010, IEEE T POWER DELIVER, V25, P2156, DOI 10.1109/TPWRD.2010.2042624
   Hu Yuanchao, 2011, IEEE INT C SIGN PROC, P1
   Huang S., 2009, IEEE INT S PAR DISTR, P1, DOI DOI 10.1109/IPDPS.2009.5160980
   Jafarian P, 2010, IEEE T POWER DELIVER, V25, P588, DOI 10.1109/TPWRD.2009.2037819
   Jiang Joe-Air, 2003, POWER DELIVERY IEEE, V18, P34
   Kale V. S., 2011, INT J COMPUTER ELECT, V3, P421, DOI DOI 10.7763/IJCEE.2011.V3.354
   Lee JW, 2015, J ELECTR ENG TECHNOL, V10, P729, DOI 10.5370/JEET.2015.10.3.729
   Liu ZG, 2014, IEEE T NEUR NET LEAR, V25, P2043, DOI 10.1109/TNNLS.2014.2303086
   Lopes FV, 2015, IEEE T POWER DELIVER, V30, P1067, DOI 10.1109/TPWRD.2014.2380774
   Misiti M., 2010, WAVELETS TOOLBOX USE
   Morales J.A., 2014, ELECT POWER ENERGY S, V58, P19
   Moravej Z, 2010, ELECTR POW COMPO SYS, V38, P182, DOI 10.1080/15325000903273387
   Nayak PK, 2013, IEEE T POWER DELIVER, V28, P714, DOI 10.1109/TPWRD.2012.2231886
   Oleskovicz M, 2001, IEE CONF PUBL, P335, DOI 10.1049/cp:20010168
   Parikh U.B., 2010, ELECT POWER ENERGY S, V32, P629
   Perera N, 2008, ELECTR POW SYST RES, V78, P1568, DOI 10.1016/j.epsr.2008.01.018
   Perez FE, 2012, IET GENER TRANSM DIS, V6, P593, DOI 10.1049/iet-gtd.2011.0592
   Perez FE, 2011, GENERATION TRANSMISS, V5, P694
   Prasad CD, 2015, PROC TECH, V21, P132, DOI 10.1016/j.protcy.2015.10.020
   Roya N., 2015, ELECTR POW COMPO SYS, V43, P461
   Sampath B., 2012, ENG RES APPL, V2, P931
   Shaik AG, 2015, INT J ELEC POWER, V64, P35, DOI 10.1016/j.ijepes.2014.06.065
   Silva K.M., 2006, TRANSMISSION DISTRIB
   Nguyen T., 1996, WAVELETS FILTER BANK
   Styvaktakis E., 2002, IEEE POW ENG SOC SUM, P824, DOI 10.1109/PESS.2002.1043446
   Sudha G, 2007, IET-UK International Conference on Information and Communication Technology in Electrical Sciences (ICTES 2007), P398, DOI 10.1049/ic:20070645
   Thirumala K, 2015, IEEE T POWER DELIVER, V30, P445, DOI 10.1109/TPWRD.2014.2355296
   Valsan SP, 2009, IEEE T IND ELECTRON, V56, P1793, DOI 10.1109/TIE.2008.2011055
   Wang HS, 1998, IEEE T POWER DELIVER, V13, P1093, DOI 10.1109/61.714467
   Xianzhong Chen, 2009, Proceedings of the 2009 9th International Conference on Electronic Measurement & Instruments (ICEMI 2009), P1, DOI 10.1109/ICEMI.2009.5274795
   Xin-zhou D., 1999, AUTOMATION ELECT POW
   Yadav A., 2014, INT C POW SIGN CONTR, P1
   Yadav A., 2014, ADV ARTIFICIAL NEURA
   Youssef OAS, 2004, IEEE T POWER DELIVER, V19, P582, DOI 10.1109/TPWRD.2004.826386
   Zarbita S, 2015, INT J ELEC POWER, V73, P568, DOI 10.1016/j.ijepes.2015.05.047
   Zin AAM, 2015, NEUROCOMPUTING, V168, P983, DOI 10.1016/j.neucom.2015.05.026
NR 62
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0263-2241
EI 1873-412X
J9 MEASUREMENT
JI Measurement
PD JUN
PY 2017
VL 103
BP 263
EP 274
DI 10.1016/j.measurement.2017.02.041
PG 12
WC Engineering, Multidisciplinary; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA ET1MK
UT WOS:000400033300027
OA No
DA 2017-08-17
ER

PT J
AU Ali, H
   Shebl, M
   Alqarni, AS
   Owayss, AA
   Ansari, MJ
AF Ali, Hussain
   Shebl, Mohamed
   Alqarni, Abdulaziz S.
   Owayss, Ayman A.
   Ansari, Mohammad Javed
TI Nesting biology of two species of the large carpenter bees Xylocopa
   pubescens and Xylocopa fenestrata (Hymenoptera: Apidae) in north-western
   Pakistan
SO ORIENTAL INSECTS
LA English
DT Article
DE Large carpenter bees; pollinator; Poplar; Sesbania; foraging;
   North-western Pakistan
ID BEHAVIOR; ECOLOGY; ANTHOPHORIDAE
AB The large carpenter bees are very promising pollinators for many agriculture crops. The nesting biology and some foraging activities of these large carpenter bees are documented from the north-western Pakistan, most extent of its natural distribution, as these species are potentially important pollinators of cucurbit crops and some agriculture crops in the region. Nests of the large carpenter bees, Xylocopa pubescens Spinola, 1838 and Xylocopa fenestrata Fabricius, 1798, around the Ismaila village, Swabi, Khyber Pakhtunkhwa Province, Pakistan, were observed and sampled from June to August 2012 and 2013. Nest details were recorded and foraging times on various floral species were documented, with bees preferentially nesting in dead wooden stems of Poplar (Populus deltoides) and Sesbania (Sesbania bispinosa). The dissection of nests was carried out and both nest architecture and nesting biology of the species were described. The importance of such studies on wild bees in Pakistan is important for the melittologists, as it will help in conservation of wild bees. The study is also useful in using large carpenter bees for pollination purpose.
C1 [Ali, Hussain; Alqarni, Abdulaziz S.; Owayss, Ayman A.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Riyadh, Saudi Arabia.
   [Shebl, Mohamed] Suez Canal Univ, Dept Plant Protect, Fac Agr, Ismailia, Egypt.
   [Ansari, Mohammad Javed] King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Bee Res Chair, Riyadh, Saudi Arabia.
RP Ansari, MJ (reprint author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Protect, Bee Res Chair, Riyadh, Saudi Arabia.
EM mjavedansari@gmail.com
RI ANSARI, MOHAMMAD/E-9303-2014
OI ANSARI, MOHAMMAD/0000-0002-8718-3078
FU Deanship of Scientific Research at the King Saud University [RGP-189]
FX This work was supported by the Deanship of Scientific Research at the
   King Saud University through the research group project No. RGP-189.
CR Ahmed RA, 1976, NZ ENTOMOL, V6, P191
   Ali H, 2016, FLA ENTOMOL, V99, P89
   Ascher JS, 2010, BEE FAUNA POLLINATIO, P51
   Borollosy ELFN, 1973, B SOC ENTOMOLOGIQUE, V56, P399
   Burgett Michael, 2005, ScienceAsia, V31, P65, DOI 10.2306/scienceasia1513-1874.2005.31.065
   Engel MS, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.244.3979
   Engel MS, 2011, SYST ENTOMOL, V36, P2, DOI 10.1111/j.1365-3113.2010.00544.x
   GERLING D, 1989, ANNU REV ENTOMOL, V34, P163, DOI 10.1146/annurev.en.34.010189.001115
   GERLING D, 1981, J KANSAS ENTOMOL SOC, V54, P209
   Gonzalez VH, 2013, SYST ENTOMOL, V38, P645, DOI 10.1111/syen.12029
   Guershon Moshe, 2012, Israel Journal of Entomology, V41-42, P145
   Hongjamrassilp W, 2014, J HYMENOPT RES, V41, P75, DOI 10.3897/JHR.41.7869
   HURD PAUL D., 1960, ANN ENT SOC AMER, V53, P809
   Hussain A., 2012, African Journal of Biotechnology, V11, P7263
   Iwata K., 1938, T NAT HIST SOC FORMO, V28, P205
   Junqueira CN, 2012, ANN ENTOMOL SOC AM, V105, P884, DOI 10.1603/AN12061
   KAPIL R. P., 1968, Journal of Research - Punjab Agricultural University, V5, P406
   Keasar Tamar, 2010, Psyche (Cambridge), V2010, P1, DOI 10.1155/2010/927463
   MAA TC, 1970, PAC INSECTS, V12, P723
   MAETA Y, 1985, J KANSAS ENTOMOL SOC, V58, P36
   Michener CD, 2007, BEES WORLD
   Minckley RL., 1998, NATURAL HIST MUSEUM, V9, P1
   MORDECHAI Y B, 1978, Israel Journal of Entomology, V12, P107
   Rahman A, 2011, INDIAN J AGR SCI, V81, P780
   Raju AJS, 2006, CURR SCI INDIA, V90, P1210
   Sadeh A, 2007, APIDOLOGIE, V38, P508, DOI 10.1051/apido:2007036
   SIHAG RC, 1993, J APICULT RES, V32, P102
   SIHAG RC, 1993, J APICULT RES, V32, P109
   Silveira Fernando A., 2002, Lundiana, V3, P57
   Terzo M, 2011, ATLAS EUROPEAN BEES
   Vicidomini S, 1998, ANN MUSEO CIVICO ROV, V12, P85
NR 31
TC 0
Z9 0
U1 7
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0030-5316
EI 2157-8745
J9 ORIENT INSECTS
JI Orient. Insects
PD JUN
PY 2017
VL 51
IS 2
BP 185
EP 196
DI 10.1080/00305316.2016.1272500
PG 12
WC Entomology
SC Entomology
GA ET4MP
UT WOS:000400256200010
OA No
DA 2017-08-17
ER

PT J
AU Ijaz, H
   Qureshi, J
   Danish, Z
   Zaman, M
   Abdel-Daim, M
   Bashir, I
AF Ijaz, Hira
   Qureshi, Junaid
   Danish, Zeeshan
   Zaman, Muhammad
   Abdel-Daim, Mohamed
   Bashir, Irfan
TI Design and Evaluation of Bilayer Matrix Tablet of Metoprolol Tartrate
   and Lisinopril Maleate
SO ADVANCES IN POLYMER TECHNOLOGY
LA English
DT Article
DE Differential Scanning Calorimetry; Drug Delivery System; Matrix;
   Lisinopril Maleate; Metoprolol Tartrate
ID FLOATING TABLET; RELEASE; FORMULATION
AB The objective of study was to design bilayer matrix tablet of metoprolol tartrate and lisinopril maleate. The direct compression method was used for preparation of both layers. Precompression and postcompression parameters were evaluated. USP Type II dissolution apparatus was used for the in vitro drug release study using 0.1 N HCl for immediate release of lisinopril maleate layer for 2 h and phosphate buffer at pH 6.8 for 10 h for metoprolol tartrate sustained layer. In vitro data were fitted into various kinetic models. Precompression parameters showed good flow properties of powder blend. Postcompression parameters were within compendia range. L7 (2% SSG and 3% CC-Na) was selected for formulation of immediate release layer that showed 91.6% drug release after 10 min, and for sustained release formulation, M4 (9% pectin, 9% acacia, and 20% Eudragit L100) showed 92.5% drug release for 10 h. Most formulations of sustained layer followed Higuchi drug release kinetics. Bilayer matrix tablet of metoprolol tartrate and lisinopril maleate can be formulated for the treatment of postmyocardial infarction. (C) 2015 Wiley Periodicals, Inc.
C1 [Ijaz, Hira; Qureshi, Junaid] Govt Coll Univ Faisalabad, Coll Pharm, Faisalabad, Pakistan.
   [Danish, Zeeshan] Univ Punjab, Univ Coll Pharm, Lahore, Pakistan.
   [Zaman, Muhammad] Univ Lahore, Fac Pharm, Lahore, Pakistan.
   [Abdel-Daim, Mohamed] Suez Canal Univ, Fac Vet Med, Pharmacol Dept, Ismailia, Egypt.
   [Bashir, Irfan] Univ Cent Punjab, Fac Pharm, Lahore, Pakistan.
RP Ijaz, H (reprint author), Govt Coll Univ Faisalabad, Coll Pharm, Faisalabad, Pakistan.
EM pharmacisthira@gmail.com
RI Abdel-Daim, Mohamed /B-2545-2013
OI Abdel-Daim, Mohamed /0000-0002-4341-2713
CR Abd-Elbary A, 2011, AAPS PHARMSCITECH, V12, P485, DOI 10.1208/s12249-011-9608-z
   Abdelbary A, 2010, AAPS PHARMSCITECH, V11, P1058, DOI 10.1208/s12249-010-9468-y
   Abdelkader H, 2008, AAPS PHARMSCITECH, V9, P675, DOI 10.1208/s12249-008-9094-0
   Abebe A, 2014, INT J PHARMACEUT, V461, P549, DOI 10.1016/j.ijpharm.2013.12.028
   Akseli I, 2010, AAPS PHARMSCITECH, V11, P90, DOI 10.1208/s12249-009-9352-9
   Ansel, 1999, PHARM DOSAGE FORMS D, V227
   Gannu R, 2009, AAPS PHARMSCITECH, V10, P505, DOI 10.1208/s12249-009-9230-5
   Gohel MC, 2009, AAPS PHARMSCITECH, V10, P62, DOI 10.1208/s12249-008-9174-1
   Kottala N, 2012, AAPS PHARMSCITECH, V13, P1190, DOI 10.1208/s12249-012-9846-8
   MESHALI MM, 1993, INT J PHARM, V89, P177, DOI 10.1016/0378-5173(93)90241-7
   Patel V., 2000, AAPS PHARMSCITECH, V8, pE203
   Patra Chinam Niranjan, 2007, Acta Pharmaceutica (Zagreb), V57, P479, DOI 10.2478/v10007-007-0038-0
   Ranade AN, 2012, AAPS PHARMSCITECH, V13, P1518, DOI 10.1208/s12249-012-9882-4
   Siahi R., 2005, AAPS PHARMSCITECH, V6, pE626
   Sorrenti M, 2013, J PHARM SCI-US, V102, P3596, DOI 10.1002/jps.23660
   Sungthongjeen S, 2004, AAPS PHARMSCITECH, V5, DOI 10.1007/BF02830577
   TAKEUCHI H, 1989, DRUG DEV IND PHARM, V15, P1999, DOI 10.3109/03639048909052515
NR 17
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-6679
EI 1098-2329
J9 ADV POLYM TECH
JI Adv. Polym. Technol.
PD SUM
PY 2017
VL 36
IS 2
BP 152
EP 159
DI 10.1002/adv.21582
PG 8
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA ES5PV
UT WOS:000399594800003
OA No
DA 2017-08-17
ER

PT J
AU Abu-Saied, MA
   Wycisk, R
   Abbassy, MM
   Abd El-Naim, G
   El-Demerdash, F
   Youssef, ME
   Bassuony, H
   Pintauro, PN
AF Abu-Saied, M. A.
   Wycisk, Ryszard
   Abbassy, Moustafa M.
   Abd El-Naim, G.
   El-Demerdash, F.
   Youssef, M. E.
   Bassuony, H.
   Pintauro, Peter N.
TI Sulfated chitosan/PVA absorbent membrane for removal of copper and
   nickel ions from aqueous solutions-Fabrication and sorption studies
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Polyvinyl alcohol; Absorbent; Membrane; Heavy metal ions
ID FUEL-CELL APPLICATIONS; HEAVY-METAL IONS; CADMIUM CARCINOGENESIS;
   EXCHANGE MEMBRANES; WASTE-WATER; ACID; BIOSORPTION; ADSORPTION;
   SEPARATION; ADSORBENT
AB Novel absorbents for the removal of Cu2+ and Ni2+ ions from aqueous solutions were prepared from solution cast sulfated chitosan/polyvinyl alcohol membranes (SCS/PVA) and their properties were investigated. FTIR, SEM, XRD and TGA analyses were used to determine membrane structure. The effect of environmental parameters on absorption was studied, including pH, contact time, temperature and the initial concentration of Ni2+ and Cu2+ ions. Freundlich and Langmuir absorption isotherms were fitted to experimental data and a pseudo-second order rate equation was employed to model the kinetics of uptake for several copper and nickel ion concentrations. The results indicate that the affinity of an SCS/PVA membrane for Cu2+ ions was higher than that for Ni2+ ions. The study demonstrated that the SCS/PVA system can be utilized as highly efficient sorbents, to extract Ni2+ and Cu2+ from aqueous feed solutions. (C) 2016 Published by Elsevier Ltd.
C1 [Abu-Saied, M. A.; Abd El-Naim, G.] CSRTA, ATNMRI, Polymer Mat Res Dept, Alexandria 21934, Egypt.
   [Wycisk, Ryszard; Pintauro, Peter N.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Abbassy, Moustafa M.; El-Demerdash, F.; Bassuony, H.] Alexandria Univ, Inst Grad Studies & Res, Dept Environm Studies, Alexandria, Egypt.
   [Youssef, M. E.] City Sci Res & Technol Applicat SRTA City, Informat Res Inst IRI, Comp Based Engn Applicat Dept, Alexandria 21934, Egypt.
RP Abu-Saied, MA (reprint author), CSRTA, ATNMRI, Polymer Mat Res Dept, Alexandria 21934, Egypt.; Abbassy, MM (reprint author), Alexandria Univ, Inst Grad Studies & Res, Dept Environm Studies, Alexandria, Egypt.
EM mouhamedabdelrehem@yahoo.com; abbassymms@yahoo.com
OI Abd El-Naim, Gamal/0000-0003-4059-4520
CR Abdelgawad AM, 2017, INT J BIOL MACROMOL, V94, P96, DOI 10.1016/j.ijbiomac.2016.07.061
   Abu-Saied MA, 2013, J POLYM RES, V20, DOI 10.1007/s10965-013-0187-4
   Abu-Saied MA, 2012, J APPL POLYM SCI, V123, P3710, DOI 10.1002/app.35048
   Al-Saad KA, 2012, ARAB J NUCL SCI APPL, V45, P335
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   BO J, 1992, J APPL POLYM SCI, V46, P783, DOI 10.1002/app.1992.070460505
   Boroglu MS, 2011, EXPRESS POLYM LETT, V5, P470, DOI 10.3144/expresspolymlett.2011.45
   Crini G., 2015, ARABIAN J C IN PRESS
   Dave P. N., 2014, J NANOTECHNOLOGY, V2014, DOI DOI 10.1155/2014/398569
   Eldin MSM, 2011, INT J ELECTROCHEM SC, V6, P5417
   Eldin MSM, 2011, J APPL POLYM SCI, V119, P120, DOI 10.1002/app.32613
   ESPINOZA E, 2012, RES J RECENT SCI, V1, P1
   Hallaji H, 2015, J TAIWAN INST CHEM E, V46, P109, DOI 10.1016/j.jtice.2014.09.007
   He JS, 2014, BIORESOURCE TECHNOL, V160, P67, DOI 10.1016/j.biortech.2014.01.068
   Hebeish A, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40170
   Jaafar J, 2007, MAT SCI ENG A-STRUCT, V460, P475, DOI 10.1016/j.msea.2007.02.095
   Jaros K., 2005, ENVIRON PROT ENG, V31, P3
   Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011
   Kim NH, 2015, CHEM ENG J, V272, P119, DOI 10.1016/j.cej.2015.03.026
   Lacerda VG, 2009, J POWER SOURCES, V193, P908, DOI 10.1016/j.jpowsour.2009.05.004
   Lu Y, 2014, REACT FUNCT POLYM, V82, P98, DOI 10.1016/j.reactfunctpolym.2014.06.004
   Mousavi HZ, 2010, J SERB CHEM SOC, V75, P845, DOI 10.2298/JSC090410044M
   Ozen R, 2015, MATH BIOSCI, V265, P40, DOI 10.1016/j.mbs.2015.04.007
   Paipitak K, 2011, PROCEDIA ENGINEER, V8, P101, DOI 10.1016/j.proeng.2011.03.019
   Parida UK, 2011, J BIOMATER NANOBIOTE, V2, P414, DOI [10.4236/jbnb.2011.24051, DOI 10.4236/JBNB.2011.24051]
   Rad LR, 2014, CHEM ENG J, V256, P119, DOI 10.1016/j.cej.2014.06.066
   Rosi M, 2014, INT J ELECTROCHEM SC, V9, P4251
   Sahin M, 2011, J INORG ORGANOMET P, V21, P69, DOI 10.1007/s10904-010-9421-2
   Schmuhl R, 2001, WATER SA, V27, P1
   Shi R, 2008, CARBOHYD POLYM, V74, P763, DOI 10.1016/j.carbpol.2008.04.045
   Unlu N, 2006, J HAZARD MATER, V136, P272, DOI 10.1016/j.jhazmat.2005.12.013
   Waalkes MP, 2003, MUTAT RES-FUND MOL M, V533, P107, DOI 10.1016/j.mrfmmm.2003.07.011
   Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X
   Wang JL, 2014, BIORESOURCE TECHNOL, V160, P129, DOI 10.1016/j.biortech.2013.12.110
   Wu CH, 2002, CHEMOSPHERE, V47, P283, DOI 10.1016/S0045-6535(01)00217-X
   Wu L, 2008, J MEMBRANE SCI, V322, P286, DOI 10.1016/j.memsci.2008.06.020
   Xiong Y, 2008, J MEMBRANE SCI, V311, P319, DOI 10.1016/j.memsci.2007.12.029
   Yee Rebecca S L, 2013, Membranes (Basel), V3, P182, DOI 10.3390/membranes3030182
   Zaidi SMJ, 2003, ARAB J SCI ENG, V28, P183
   Zhang C., 2010, INT J CHEM, V2, P113
   Zhu J, 2014, ACS APPL MATER INTER, V6, P925, DOI 10.1021/am4042965
NR 41
TC 0
Z9 0
U1 42
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 1
PY 2017
VL 165
BP 149
EP 158
DI 10.1016/j.carbpol.2016.12.039
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA ES1BC
UT WOS:000399261900017
PM 28363535
OA No
DA 2017-08-17
ER

PT J
AU Emam, HE
   Ahmed, HB
   Bechtold, T
AF Emam, Hossam E.
   Ahmed, Hanan B.
   Bechtold, Thomas
TI In-situ deposition of Cu2O micro-needles for biologically active
   textiles and their release properties
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Cu2O; Cellulose; Viscose; Release; Antimicrobial; Durability
ID ANISOTROPIC SILVER NANOPARTICLES; COTTON FABRICS; COPPER NANOPARTICLES;
   CELLULOSE FIBERS; ANTIBACTERIAL PROPERTIES; INTRAUTERINE-DEVICES; AG
   NANOPARTICLES; MORPHOLOGY; IONS; NANOSILVER
AB Metal/metal oxide containing fibres are gradually increasing in textile industrialization recently, owing to their high potential for application as antimicrobial textiles. In this study, the reducing properties of cellulose were applied to synthesize cuprous oxide in-situ. The direct formation of Cu2O on viscose fabrics was achieved via quite simple technique in two subsequent steps: alkalization and sorption. Cu contents in fabrics before and after rinsing ranged between 45.2-86.4 mmol/kg and 18.1-67.7 mmol/kg, respectively. Uniform micro-needles of Cu2O were obtained with regular size and dimensions of 1.60 +/- 0.20 mu m in length and 0.13 +/- 0.03 mu m in width. Release of Cu1+/2+ ions from selected samples was studied in water, physiological fluid and artificial sweat. Copper containing fabrics exhibited a percent of 96.8-97.8% and 85.5-89.0% for reduction in microbial viability, which was tested for S. aureus (as gram positive bacteria), E. coli (as gram-negative bacteria) and C. albicans and A. niger (as fungal species), respectively after 24h contact time. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Emam, Hossam E.] Natl Res Ctr, Text Res Div, Pretreatment & Finishing Cellulos Fibers, El Buhouth St, Cairo 12622, Egypt.
   [Ahmed, Hanan B.] Helwan Univ, Fac Sci, Chem Dept, Cairo 11795, Egypt.
   [Bechtold, Thomas] Univ Innsbruck, Res Inst Text Chem & Text Phys, Hoechsterstr 73, A-6850 Dornbirn, Austria.
RP Emam, HE (reprint author), Natl Res Ctr, Text Res Div, Pretreatment & Finishing Cellulos Fibers, El Buhouth St, Cairo 12622, Egypt.
EM hossamelemam@yahoo.com
CR Aarestrup FM, 2004, VET MICROBIOL, V100, P83, DOI 10.1016/j.vetmic.2004.01.013
   AATCC, 2010, AATCC TECHNICAL MANU, V85, P401
   AATCC, 2010, TM 100 2004 ANT FIN, V85, P141
   AATCC, 2010, AATCC TECHNICAL MANU, V85, P374
   Abdelhameed RM, 2016, RSC ADV, V6, P42324, DOI 10.1039/c6ra04719j
   Abramov OV, 2009, SURF COAT TECH, V204, P718, DOI 10.1016/j.surfcoat.2009.09.030
   Ahmed HB, 2016, RSC ADV, V6, P73974, DOI 10.1039/c6ra16794b
   Ahmed HB, 2016, INT J BIOL MACROMOL, V91, P208, DOI 10.1016/j.ijbiomac.2016.05.060
   Ahmed HB, 2016, FIBER POLYM, V17, P418, DOI 10.1007/s12221-016-5814-3
   Angelova Ts, 2014, J BIOTECHNOL BIOTECH, V28, P747
   ASTM D., 1972, ANN BOOK ASTM STAND
   Azam A, 2012, INT J NANOMED, V7, P6003, DOI 10.2147/IJN.S35347
   Barkhordari S, 2014, J POLYM RES, V21, DOI 10.1007/s10965-014-0454-z
   Barua S, 2013, RSC ADV, V3, P14997, DOI 10.1039/c3ra42209g
   Bechtold T, 2013, CARBOHYD POLYM, V93, P316, DOI 10.1016/j.carbpol.2012.01.064
   Bilian X, 2002, BEST PRACT RES CL OB, V16, P155, DOI 10.1053/beog.2002.0267
   Block SS, 2001, DISINFECTION STERILI
   Borkow G, 2004, FASEB J, V18, P1728, DOI 10.1096/fj.04-2029fje
   Borkow G, 2009, CURR CHEM BIOL, V3, P272, DOI DOI 10.2174/187231309789054887
   Cardenas G, 2009, POLYM BULL, V62, P511, DOI 10.1007/s00289-008-0031-x
   Chattopadhyay DP, 2010, J ENG FIBER FABR, V5, P1
   Chen SY, 2009, J HAZARD MATER, V161, P1355, DOI 10.1016/j.jhazmat.2008.04.098
   Cioffi N, 2005, CHEM MATER, V17, P5255, DOI 10.1021/cm0505244
   COONEY TE, 1995, INFECT CONT HOSP EP, V16, P444
   Diaz-Visurraga J, 2012, INT J NANOMED, V7, P3597, DOI 10.2147/IJN.S32648
   El-Rafie M., 2014, INT SCHOLARLY RES NO
   Emam HE, 2016, INT J BIOL MACROMOL, V84, P308, DOI 10.1016/j.ijbiomac.2015.12.042
   Emam HE, 2015, APPL SURF SCI, V357, P1878, DOI 10.1016/j.apsusc.2015.09.095
   Emam HE, 2016, CARBOHYD POLYM, V135, P300, DOI 10.1016/j.carbpol.2015.08.095
   Emam HE, 2015, FIBER POLYM, V16, P1676, DOI 10.1007/s12221-015-5197-x
   Emam HE, 2015, INT J BIOL MACROMOL, V78, P249, DOI 10.1016/j.ijbiomac.2015.04.018
   Emam HE, 2015, INT J BIOL MACROMOL, V75, P106, DOI 10.1016/j.ijbiomac.2014.12.050
   Emam HE, 2014, CELLULOSE, V21, P4219, DOI 10.1007/s10570-014-0438-5
   Emam HE, 2014, SURF COAT TECH, V254, P344, DOI 10.1016/j.surfcoat.2014.06.036
   Emam HE, 2014, CARBOHYD POLYM, V110, P148, DOI 10.1016/j.carbpol.2014.03.082
   Emam HE, 2012, CARBOHYD POLYM, V90, P1345, DOI 10.1016/j.carbpol.2012.07.003
   Gasana E, 2006, SURF COAT TECH, V201, P3547, DOI 10.1016/j.surfcoat.2006.08.128
   Gawande MB, 2016, CHEM REV, V116, P3722, DOI 10.1021/acs.chemrev.5b00482
   Grace M, 2009, J ENG FIBER FABR, V4, P24
   Gulrajani ML, 2010, WOODHEAD PUBL TEXT, P167
   Guo RH, 2012, J TEXT I, V103, P1267, DOI 10.1080/00405000.2012.675683
   Han EG, 2001, SYNTHETIC MET, V123, P469, DOI 10.1016/S0379-6779(01)00332-0
   Hebeish AA, 2010, CARBOHYD POLYM, V82, P933, DOI 10.1016/j.carbpol.2010.06.020
   Heliopoulos NS, 2013, SURF COAT TECH, V235, P24, DOI 10.1016/j.surfcoat.2013.07.009
   Hostynek Jurij J, 2004, Dermatol Ther, V17, P328, DOI 10.1111/j.1396-0296.2004.04035.x
   Huang LY, 2009, CHEMOSPHERE, V76, P1056, DOI 10.1016/j.chemosphere.2009.04.030
   Hubacher D, 2001, NEW ENGL J MED, V345, P561, DOI 10.1056/NEJMoa010438
   IRIS, 2007, ENV PROT AG INT RISK
   Jia BQ, 2014, J MATER CHEM C, V2, P524, DOI 10.1039/c3tc31865f
   Karnick C., 1994, PHARMACOPOEIAL STAND, V1
   Kavkler K, 2012, TEKSTILEC, V55
   Kotelnikova N, 2007, MACROMOL SYMP, V254, P74, DOI 10.1002/masy.200750811
   Kraltiova D., 2014, J COORD CHEM, V67, P1493
   Kramar A, 2013, SURF COAT TECH, V234, P92, DOI 10.1016/j.surfcoat.2013.03.030
   Kulthong K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-8
   Kumar VV, 2016, RSC ADV, V6, P85083, DOI 10.1039/c6ra16553b
   larikov D., 2012, CLIN INFECT DIS, V55, P1474
   Lu YX, 2012, APPL SURF SCI, V258, P4782, DOI 10.1016/j.apsusc.2012.01.093
   Mallick S, 2012, ACS APPL MATER INTER, V4, P1313, DOI 10.1021/am201586w
   Mary G, 2009, J APPL POLYM SCI, V113, P757, DOI 10.1002/app.29890
   Perelshtein I, 2009, SURF COAT TECH, V204, P54, DOI 10.1016/j.surfcoat.2009.06.028
   Pivec T, 2014, TEXT RES J, V84, P96, DOI 10.1177/0040517513483855
   Pivec T, 2012, MATER TEHNOL, V46, P75
   Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007
   Reza Mohamad, 2016, Trop Med Health, V44, P11, DOI 10.1186/s41182-016-0007-8
   Rodio RT, 1999, CARBOHYD RES, V315, P319
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Schwarz A, 2012, TEXT RES J, V82, P1587, DOI 10.1177/0040517511431291
   Shim IW, 2002, B KOR CHEM SOC, V23, P563
   Tang B, 2013, IND ENG CHEM RES, V52, P4556, DOI 10.1021/ie3033872
   Tang B, 2012, IND ENG CHEM RES, V51, P12807, DOI 10.1021/ie3015704
   Turalija M, 2015, J MATER CHEM B, V3, P5886, DOI 10.1039/c5tb01049g
   Vainio U, 2007, EUR PHYS J D, V42, P93, DOI 10.1140/epjd/e2007-00015-y
   Wei QF, 2008, J IND TEXT, V37, P275, DOI 10.1177/1528083707083794
   Wu J, 2014, CARBOHYD POLYM, V102, P762, DOI 10.1016/j.carbpol.2013.10.093
   Zahran MK, 2014, CARBOHYD POLYM, V111, P971, DOI 10.1016/j.carbpol.2014.05.028
   Zahran MK, 2014, CARBOHYD POLYM, V111, P10, DOI 10.1016/j.carbpol.2014.03.029
NR 77
TC 0
Z9 0
U1 28
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 1
PY 2017
VL 165
BP 255
EP 265
DI 10.1016/j.carbpol:2017.02.044
PG 11
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA ES1BC
UT WOS:000399261900029
PM 28363548
OA No
DA 2017-08-17
ER

PT J
AU Hassabo, AG
   Mohamed, AL
AF Hassabo, Ahmed G.
   Mohamed, Amina L.
TI Enhancement the thermo-regulating property of cellulosic fabric using
   encapsulated paraffins in modified pectin
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Phase change material; Cellulosic fabric; Pectin; Solvent free process;
   Thermal regulating property
ID PHASE-CHANGE MATERIALS; ENERGY STORAGE; MICROENCAPSULATED PCM;
   FUNCTIONALIZATION; TEXTILES; SYSTEM; STARCH
AB Synthesis of smart hosting materials from solvent free modified pectin with fatty acid (have different molecular weight) have been occurred and characterised. Modified pectin with phase change material (PCM) have been prepared and applied to textile material. Smart composite matrix based on modified pectin was produce thermo-regulating characteristics which play the main role to control body temperature for various daily wear. The microcapsules (pectin/PCM) and treated fabric were characterized using SEM, DSC and FT-IR. The results confirmed the synthesis of modified pectin using solvent free method, and also confirmed its reaction with cotton surface. DSC result confirmed that, the treated fabrics have a thermo-regulating property. (C) 2017 Published by Elsevier Ltd.
C1 [Hassabo, Ahmed G.; Mohamed, Amina L.] Natl Res Ctr, Textile Res Div, Pretreatment & Finishing Cellulos Fibres Dept, Scopus Affiliat ID 60014618,33 El Behouth St, Giza, Egypt.
RP Hassabo, AG (reprint author), Natl Res Ctr, Textile Res Div, Pretreatment & Finishing Cellulos Fibres Dept, Scopus Affiliat ID 60014618,33 El Behouth St, Giza, Egypt.
EM aga.hassabo@yahoo.com
FU National Research Centere (NRC) [60014618]; EI-behouth St., Dokki, Giza,
   Egypt [P.O. 12622]
FX The author greatefully acknoeledges National Research Centere (NRC),
   (Scopus affliation ID 60014618), EI-behouth St. (former EI-Tahrir),
   Dokki, P.O. 12622, Giza, Egypt, for financial support and for facilities
   project ID: P100304.
CR Aburto J, 2005, STARCH-STARKE, V57, P145, DOI 10.1002/star.200400380
   Aburto J, 1999, STARCH-STARKE, V51, P302, DOI 10.1002/(SICI)1521-379X(199909)51:8/9<302::AID-STAR302>3.0.CO;2-E
   Beginn U, 2003, MACROMOL MATER ENG, V288, P245, DOI 10.1002/mame.200390021
   Chaudhari V. N., 2013, INT J ENG RES TECHNO, V2
   Chen CZ, 2008, MATER LETT, V62, P3515, DOI 10.1016/j.matlet.2008.03.034
   Doerr D. F., 1997, HEAT STRESS ASSESSME, P2
   Hassabo A.G., 2015, ICAIJ, V10, P59
   Hassabo A. G., 2011, SYNTHESIS DEPOSITION, P154
   Hassabo AG, 2014, CARBOHYD POLYM, V101, P912, DOI 10.1016/j.carbpol.2013.10.006
   Hawlader MNA, 2003, APPL ENERG, V74, P195, DOI 10.1016/S0306-2619(02)00146-0
   Hebeish A., 2016, PHARM CHEM, V8, P259
   Ibrahim N. A., 2017, CHEM PAPERS, P1
   Kaygusuz K, 2008, ENERG SOURCE PART A, V30, P1050, DOI 10.1080/15567030701258212
   Kenisarin M, 2007, RENEW SUST ENERG REV, V11, P1913, DOI 10.1016/j.rser.2006.05.005
   Khudhair AM, 2004, ENERG CONVERS MANAGE, V45, P263, DOI 10.1016/S0196-8904(03)00131-6
   Krishnan S, 2005, CARBOHYD POLYM, V62, P309, DOI 10.1016/j.carbpol.2005.03.020
   Kubota M, 2007, J CHEM ENG JPN, V40, P80, DOI 10.1252/jcej.40.80
   Liu X, 2006, SOL ENERGY, V80, P1561, DOI 10.1016/j.solener.2005.12.008
   Mohamed A. L., 2016, J APPL PHARM SCI
   Mohamed A. L, 2015, FLAME RETARDANTS, P247, DOI DOI 10.1007/978-3-319-03467-6_10
   Mohamed A. L., 2016, J APPL PHARM SCI, V6, P13
   Mohamed AL, 2017, INT J BIOL MACROMOL, V95, P429, DOI 10.1016/j.ijbiomac.2016.10.082
   Mohamed AL, 2016, MICROSYST TECHNOL, V22, P979, DOI 10.1007/s00542-015-2776-0
   Mondal S, 2008, APPL THERM ENG, V28, P1536, DOI 10.1016/j.applthermaleng.2007.08.009
   Mottinger B., 1999, 4512 ASEN U COL
   Nada A. A., 2016, Journal of Applied Pharmaceutical Science, V6, P142
   Nada A. A., 2015, Journal of Applied Pharmaceutical Science, V5, P13
   Onofrei E., 2010, B I POLITEHNIC DIN L, V2, P99
   Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3
   Rolin C., 2002, PECTINS THEIR MANIPU, P222
   Saihi D, 2005, REACT FUNCT POLYM, V64, P127, DOI 10.1016/j.reactfuncetpolym.2005.05.004
   Sarier N, 2007, THERMOCHIM ACTA, V452, P149, DOI 10.1016/j.tca.2006.08.002
   Shim H, 2001, TEXT RES J, V71, P495
   Sun G, 2002, INT J PHARM, V242, P307, DOI 10.1016/S0378-5173(02)00193-X
   Thibault J.-F., 2003, ADV PECTIN PECTINASE, P91
   Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350
   Vincken J. P., 2003, ADV PECTIN PECTINASE, P47
   Wang J. P., 2006, LANGMUIR, P10845
   Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148
   Yamagishi Y, 1996, PROC IECEC, P2077, DOI 10.1109/IECEC.1996.553442
   Yamagishi Y, 1999, AICHE J, V45, P696, DOI 10.1002/aic.690450405
   Zalba B, 2003, APPL THERM ENG, V23, P251, DOI 10.1016/S1359-4311(02)00192-8
   Zhang YP, 2007, BUILD ENVIRON, V42, P2197, DOI 10.1016/j.buildenv.2006.07.023
NR 43
TC 0
Z9 0
U1 18
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 1
PY 2017
VL 165
BP 421
EP 428
DI 10.1016/j.carbpol.2017.02.074
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA ES1BC
UT WOS:000399261900047
PM 28363568
OA No
DA 2017-08-17
ER

PT J
AU El-Sayed, MM
   Hussein, AK
   Sarhan, HA
   Mansour, HF
AF El-Sayed, Marwa M.
   Hussein, Amal K.
   Sarhan, Hatem A.
   Mansour, Heba F.
TI Flurbiprofen-loaded niosomes-in-gel system improves the ocular
   bioavailability of flurbiprofen in the aqueous humor
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE Niosomes; carbopol; carrageenan; pharmacokinetic parameters;
   anti-inflammatory; flurbiprofen
ID DRUG-DELIVERY; VITRO; FORMULATION; IRRITATION; VESICLES; CORNEA; NSAIDS;
   MODEL
AB The present work aimed to prolong the contact time of flurbiprofen (FBP) in the ocular tissue to improve the drug anti-inflammatory activity. Different niosome systems were fabricated adopting thin-film hydration technique and using the nonionic surfactant Span 60. The morphology of the prepared niosomes was characterized by scanning electron microscopy (SEM). Physical characterization by differential scanning calorimetry, X-ray powder diffraction and Fourier transform infrared spectroscopy were conducted for the optimized formula (F5) that was selected on the basis of percent entrapment efficiency, vesicular size and total lipid content. F5 was formulated as 1% w/w Carpobol 934 gel. Pharmacokinetic parameters of FBP were investigated following ocular administration of F5-loaded gel system, F5 niosome dispersion or the corresponding FBP ocular drops to albino rabbits dispersion. Anti-inflamatory effect of F5-loaded carbopol gel was investigated by histopathological examination of the corneal tissue before and after the treatment of inflamed rabbit eye with the system. Results showed that cholesterol content, surfactant type. and total lipid contents had an apparent impact on the vesicle size of the formulated niosomes. Physical characterization revealed reduced drug crystallinity and incidence of interaction with other niosome contents. F5-loaded gel showed higher C-max, area under the curve (AUC(0-12)), and thus higher ocular bioavailability than those of the corresponding FBP ocular solution. F5-loaded gel showed a promising rapid anti-inflammatory effect in the inflamed rabbit eye. These findings will eradicate the necessity for frequent ocular drug instillation and thus, improve patient compliance.
C1 [El-Sayed, Marwa M.; Hussein, Amal K.; Sarhan, Hatem A.; Mansour, Heba F.] Menia Univ, Fac Pharm, Dept Pharmaceut, Al Minya, Egypt.
RP Mansour, HF (reprint author), Menia Univ, Fac Pharm, Dept Pharmaceut, Al Minya, Egypt.
EM drhf2000@hotmail.com
CR Abdelbary G, 2008, AAPS PHARMSCITECH, V9, P740, DOI 10.1208/s12249-008-9105-1
   Abdelkader H, 2010, PHARMAZIE, V65, P811, DOI 10.1691/ph.2010.0138
   Abdelkader H, 2015, PHARM DEV TECHNOL, V20, P410, DOI 10.3109/10837450.2013.871034
   Abou El Ela A., 2014, SAUDI PHARM J, V22, P555
   Abu Hashim II, 2014, BIOL PHARM BULL, V37, P541
   Aggarwal D, 2005, INT J PHARM, V290, P155, DOI 10.1016/j.ijpharm.2004.10.026
   Aggarwal D, 2004, J PHARM PHARMACOL, V56, P1509, DOI 10.1211/0022357044896
   Ahuja M, 2008, AAPS J, V10, P229, DOI 10.1208/s12248-008-9024-9
   Quinteros DA, 2014, J PHARM SCI-US, V103, P3859, DOI 10.1002/jps.24153
   Araujo J, 2009, NANOMED-NANOTECHNOL, V5, P394, DOI 10.1016/j.nano.2009.02.003
   AZMIN MN, 1985, J PHARM PHARMACOL, V37, P237
   Bandara BMK, 2004, CURR EYE RES, V29, P245, DOI 10.1080/02713680490516729
   Brown R M, 1996, Insight, V21, P13, DOI 10.1016/S1060-135X(96)90025-1
   Chandran S, 2008, ANAL LETT, V41, P1318, DOI 10.1080/00032710802119137
   DIESTELHORST M, 1991, INT OPHTHALMOL, V15, P69, DOI 10.1007/BF01046423
   Gannu P. K., 2011, ACTA PHARMACOL SIN, V1, P208
   Gonzalez-Mira E, 2012, J PHARM SCI-US, V101, P707, DOI 10.1002/jps.22784
   Han S, 2010, ACTA PHARMACOL SIN, V31, P990, DOI 10.1038/aps.2010.98
   Kaur IP, 2004, INT J PHARM, V269, P1, DOI 10.1016/j.ijpharm.2003.09.016
   Khalil RM, 2016, J LIPOSOME RES, V30, P1
   Kumbhar D, 2013, AAPS PHARMSCITECH, V14, P1072, DOI 10.1208/s12249-013-9986-5
   KUMBHAT S, 1990, ANAL LETT, V23, P627
   LANG JC, 1995, ADV DRUG DELIVER REV, V16, P39, DOI 10.1016/0169-409X(95)00012-V
   Li Q, 2014, EUR J PHARM SCI, V62, P115, DOI 10.1016/j.ejps.2014.05.020
   Makeshwar KB, 2013, ASIAN J PHARM, V3, P16
   Mohawed OAM, 2014, INT J PHARM PHARM SC, V6, P567
   Mokhtar M, 2008, INT J PHARM, V361, P104, DOI 10.1016/j.ijpharm.2008.05.031
   Muzzalupo R, 2011, EUR J PHARM BIOPHARM, V79, P28, DOI 10.1016/j.ejpb.2011.01.020
   Yacasi GRR, 2016, INT J NANOMED, V11, P4093, DOI 10.2147/IJN.S105606
   TALSMA H, 1994, J PHARM SCI, V83, P276, DOI 10.1002/jps.2600830303
   Uchegbu IF, 1998, INT J PHARM, V172, P33, DOI 10.1016/S0378-5173(98)00169-0
   van Sorge AA, 1999, PHARM WORLD SCI, V21, P91, DOI 10.1023/A:1008609513880
   Zhang WS, 2004, J CONTROL RELEASE, V99, P241, DOI 10.1016/j.jconrel.2004.07.001
NR 33
TC 0
Z9 0
U1 9
U2 9
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0363-9045
EI 1520-5762
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PD JUN
PY 2017
VL 43
IS 6
BP 902
EP 910
DI 10.1080/03639045.2016.1272120
PG 9
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ES3XP
UT WOS:000399463600003
PM 27977311
OA No
DA 2017-08-17
ER

PT J
AU Messih, HAA
   Ishak, RAH
   Geneidi, AS
   Mansour, S
AF Messih, Hanaa A. Abdel
   Ishak, Rania A. H.
   Geneidi, Ahmed S.
   Mansour, Samar
TI Nanoethosomes for transdermal delivery of tropisetron HCl:
   multi-factorial predictive modeling, characterization, and ex vivo skin
   permeation
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE Ethosomes; tropisetron; lecithin; response surface methodology; egg
   yolk; soybean; prediction; optimization
ID PHASE-TRANSITION TEMPERATURES; DRUG-DELIVERY; IN-VITRO; ANTIINFLAMMATORY
   ACTIVITY; VESICULAR CARRIERS; LIPOSOMES; ETHOSOMES; STABILITY;
   PHOSPHATIDYLCHOLINES; UNSATURATION
AB Objective: The aim of the present work is to exclusively optimize and model the effect of phospholipid type either egg phosphatidylcholine (EPC) or soybean phosphatidylcholine (SPC), together with other formulation variables, on the development of nano-ethosomal systems for transdermal delivery of a water-soluble antiemetic drug. Tropisetron HCl (TRO) is available as hard gelatin capsules and IV injections. The transdermal delivery of TRO is considered as a novel alternative route supposing to improve BAV as well as patient convenience.
   Methods: TRO-loaded ethanolic vesicular systems were prepared by hot technique. The effect of formulation variables were optimized through a response surface methodology using 3x2(2)-level full factorial design. The concentrations of both PC (A) and ethanol (B) and PC type (C) were the factors, while entrapment efficiency (Y-1), vesicle size (Y-2), polydispersity index (Y-3), and zeta potential (Y-4) were the responses. The drug permeation across rat skin from selected formulae was studied. Particle morphology, drug-excipient interactions, and vesicle stability were also investigated.
   Results: The results proved the critical role of all formulation variables on ethosomal characteristics. The suggested models for all responses showed good predictability. Only the concentration of phospholipid, irrespective to PC type, had a significant effect on the transdermal flux (p<0.01). The ethosomal vesicles were unilamellar with a nearly spherical shape. EPC-based ethosomes proved good stability.
   Conclusion: The study suggests the applicability of statistical modeling as a promising tool for prediction of ethosomal characteristics. The ethanolic vesicles were considered as novel potential nanocarriers for accentuated transdermal TRO delivery.
C1 [Messih, Hanaa A. Abdel; Ishak, Rania A. H.; Geneidi, Ahmed S.; Mansour, Samar] Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt.
   [Mansour, Samar] German Univ Cairo, Fac Pharm & Biotechnol, Dept Pharmaceut Technol, Cairo, Egypt.
RP Ishak, RAH (reprint author), Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt.
EM raniaaziz77@yahoo.com
CR Ahad A, 2014, INT J BIOL MACROMOL, V67, P99, DOI 10.1016/j.ijbiomac.2014.03.011
   Ahmed TA, 2016, INT J PHARMACEUT, V500, P245, DOI 10.1016/j.ijpharm.2016.01.017
   Ahmed TA, 2015, J LIPOSOME RES, V25, P1, DOI 10.3109/08982104.2014.950276
   Balaguru S, 2014, ASIAN J CHEM, V26, P3736
   Barupal AK, 2010, INDIAN J PHARM SCI, V72, P582, DOI 10.4103/0250-474X.78524
   Bhana R, 2013, INT J PHARM PHARM SC, V5, P35
   Caddeo C, 2013, INT J PHARMACEUT, V443, P128, DOI 10.1016/j.ijpharm.2012.12.041
   Chourasia Manish K, 2011, Results Pharma Sci, V1, P60, DOI 10.1016/j.rinphs.2011.10.002
   David S R N, 2013, INT J DRUG DELIV, V5, P28
   Dayan N, 2000, BIOMATERIALS, V21, P1879, DOI 10.1016/S0142-9612(00)00063-6
   Dubey V, 2010, NANOMED-NANOTECHNOL, V6, P590, DOI 10.1016/j.nano.2010.01.002
   Fang YP, 2008, INT J PHARM, V356, P144, DOI 10.1016/j.ijpharm.2008.01.020
   Ghanbarzadeh S, 2013, BIOMED RES INT, DOI 10.1155/2013/616810
   Giram PS, 2015, WJPPS, V3, P288
   Gralla RJ, 1997, EUR J CANCER, V33, pS63, DOI 10.1016/S0959-8049(97)00147-0
   HAGER AA, 1993, SPECTROCHIM ACTA A, V49, P1999
   Hashad RA, 2016, INT J BIOL MACROMOL, V91, P630, DOI 10.1016/j.ijbiomac.2016.06.014
   Jain S, 2007, AAPS PHARMSCITECH, V8
   Jordan K, 2005, EUR J CANCER, V41, P199, DOI 10.1016/j.ejca.2004.09.026
   KEOUGH KMW, 1987, BIOCHIM BIOPHYS ACTA, V902, P1, DOI 10.1016/0005-2736(87)90129-5
   Lecithin Wendel A., 2014, KIRK OTHMER ENCY CHE, P1
   Li J, 2015, ASIAN J PHARM SCI, V10, P81, DOI 10.1016/j.ajps.2014.09.004
   Manosroi A, 2004, INT J PHARM, V270, P279, DOI 10.1016/j.ijpharm.2003.10.031
   MARSH D, 1992, BIOPHYS J, V61, P1036
   Nii T, 2005, INT J PHARM, V298, P198, DOI 10.1016/j.ijpharm.2005.04.029
   Paolino D, 2005, J CONTROL RELEASE, V106, P99, DOI 10.1016/j.jconrel.2005.04.007
   Prasanthi D, 2012, INT CURR PHARM J, V1, P370
   Pratima NA, 2012, INT J RES PHARM SCI, V2, P1
   SCHREIER H, 1994, J CONTROL RELEASE, V30, P1, DOI 10.1016/0168-3659(94)90039-6
   Shen LN, 2014, INT J PHARMACEUT, V460, P280, DOI 10.1016/j.ijpharm.2013.11.017
   Song CK, 2012, COLLOID SURFACE B, V92, P299, DOI 10.1016/j.colsurfb.2011.12.004
   Teo YY, 2011, B KOREAN CHEM SOC, V32, P59, DOI 10.5012/bkcs.2011.32.1.59
   Touitou E, 2000, J CONTROL RELEASE, V65, P403, DOI 10.1016/S0168-3659(99)00222-9
   Touitou E, 2001, BIOMATERIALS, V22, P3053, DOI 10.1016/S0142-9612(01)00052-7
   Verma DD, 2003, INT J PHARM, V258, P141, DOI 10.1016/S0378-5173(03)00183-2
   Wendel A., 2014, JCBPSC, P1
   Xiong Y, 2009, J PHARMACEUT BIOMED, V49, P646, DOI 10.1016/j.jpba.2008.12.023
   Yu L, 2007, J CHROMATOGR B, V846, P20, DOI 10.1016/j.jchromb.2006.08.023
   Zhou HF, 2010, NANOSCALE RES LETT, V5, P224, DOI 10.1007/s11671-009-9469-5
NR 39
TC 0
Z9 0
U1 6
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0363-9045
EI 1520-5762
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PD JUN
PY 2017
VL 43
IS 6
BP 958
EP 971
DI 10.1080/03639045.2017.1287717
PG 14
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ES3XP
UT WOS:000399463600010
OA No
DA 2017-08-17
ER

PT J
AU Fiaschi, S
   Tessitore, S
   Boni, R
   Di Martire, D
   Achilli, V
   Borgstrom, S
   Ibrahim, A
   Floris, M
   Meisina, C
   Ramondini, M
   Calcaterra, D
AF Fiaschi, Simone
   Tessitore, Serena
   Boni, Roberta
   Di Martire, Diego
   Achilli, Vladimiro
   Borgstrom, Sven
   Ibrahim, Ahmed
   Floris, Mario
   Meisina, Claudia
   Ramondini, Massimo
   Calcaterra, Domenico
TI From ERS-1/2 to Sentinel-1: two decades of subsidence monitored through
   A-DInSAR techniques in the Ravenna area (Italy)
SO GISCIENCE & REMOTE SENSING
LA English
DT Article
DE InSAR; Sentinel-1; subsidence; Ravenna; time series
ID DIFFERENTIAL SAR INTERFEROMETRY; RADAR INTERFEROMETRY; LAND SUBSIDENCE;
   PERMANENT SCATTERERS; TIME-SERIES; SE SPAIN; DEFORMATION; LEVEL;
   INTERFEROGRAMS; SIMULATION
AB Land subsidence due to underground resources exploitation is a well-known problem that affects many cities in the world, especially the ones located along the coastal areas where the combined effect of subsidence and sea level rise increases the flooding risk. In this study, 25years of land subsidence affecting the Municipality of Ravenna (Italy) are monitored using Advanced Differential Interferometric Synthetic Aperture Radar (A-DInSAR) techniques. In particular, the exploitation of the new Sentinel-1A SAR data allowed us to extend the monitoring period till 2016, giving a better understanding of the temporal evolution of the phenomenon in the area. Two statistical approaches are applied to fully exploit the informative potential of the A-DInSAR results in a fast and systematic way. Thanks to the applied analyses, we described the behavior of the subsidence during the monitored period along with the relationship between the occurrence of the displacement and its main driving factors.
C1 [Fiaschi, Simone; Floris, Mario] Univ Padua, Dept Geosci, Via G Gradenigo 6, I-35131 Padua, Italy.
   [Tessitore, Serena; Di Martire, Diego; Ibrahim, Ahmed; Calcaterra, Domenico] Federico II Univ Naples, Dept Earth Environm & Resources Sci, Largo San Marcellino 10, I-80138 Naples, Italy.
   [Boni, Roberta; Meisina, Claudia] Univ Pavia, Dept Earth & Environm Sci, Via Ferrata 1, I-27100 Pavia, Italy.
   [Achilli, Vladimiro] Univ Padua, Dept Civil Environm & Architectural Engn, Via Marzolo 9, I-35131 Padua, Italy.
   [Borgstrom, Sven] Osserv Vesuviano, INGV, Via Diocleziano 328, I-80124 Naples, Italy.
   [Ibrahim, Ahmed] South Valley Univ, Geol Dept, Fac Sci, Qena 83523, Egypt.
   [Ramondini, Massimo] Federico II Univ Naples, Dept Civil Architectural & Environm Engn, Via Claudio 21, I-80125 Naples, Italy.
RP Fiaschi, S (reprint author), Univ Padua, Dept Geosci, Via G Gradenigo 6, I-35131 Padua, Italy.
EM simone.fiaschi@phd.unipd.it
OI Fiaschi, Simone/0000-0001-6544-9755
FU European Space Agency (ESA) [C1P.14280]
FX ERS-1/2 and ENVISAT images are provided by the European Space Agency
   (ESA) through the project C1P.14280. The TerraSAR-X images are provided
   by the German Space Agency (DLR) through the proposals GEO2478 and
   GEO3016. The Sentinel-1A and Sentinel-2 images are freely available from
   the ESA's Sentinel DataHub (https://scihub.copernicus.eu). Authors would
   like to thank Prof. J.J. Mallorqui (Remote Sensing Laboratory of the
   Universitat Politecnica de Catalunya of Barcelona) for providing the
   SUBSOFT processor software. Authors would like to thank also the three
   anonymous reviewers for their careful reading of this manuscript and
   their insightful comments and suggestions.
CR Amorosi A, 1999, SEDIMENTOLOGY, V46, P99
   ARPA (Regional Agency for the Environmental Protection) Emilia-Romagna and Regione Emilia-Romagna, 2010, TECHNICAL REPORT
   Berardino P, 2002, IEEE T GEOSCI REMOTE, V40, P2375, DOI 10.1109/TGRS.2002.803792
   Berti M, 2013, NAT HAZARD EARTH SYS, V13, P1945, DOI 10.5194/nhess-13-1945-2013
   Bertoni W., 1995, P 5 INT S LAND SUBS, P234
   Blanco P, 2006, INT GEOSCI REMOTE SE, P1898, DOI 10.1109/IGARSS.2006.490
   Boni R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8080686
   Carbognin L, 2002, MAR ECOL-P S Z N I, V23, P38, DOI 10.1111/j.1439-0485.2002.tb00006.x
   Carminati E, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000481
   Cascini L, 2010, ENG GEOL, V112, P29, DOI 10.1016/j.enggeo.2010.01.003
   Chaussard E, 2014, J GEOPHYS RES-SOL EA, V119, P6572, DOI 10.1002/2014JB011266
   Chini M, 2015, INT J APPL EARTH OBS, V39, P65, DOI 10.1016/j.jag.2015.02.008
   Costantini M, 1998, IEEE T GEOSCI REMOTE, V36, P813, DOI 10.1109/36.673674
   Costantini M., 1999, P INT GEOSC REM SENS, V1, P267, DOI DOI 10.1109/IGARSS.1999.773467
   Di Martire D, 2016, SCI TOTAL ENVIRON, V550, P556, DOI 10.1016/j.scitotenv.2016.01.102
   European Environment Agency Technical Report, 2007, TECHNICAL REPORT
   ENI (National Hydrocarbons Authority) S. p. A-AGIP and ARPA Emilia-Romagna, 2003, TECHNICAL REPORT
   Ferretti A, 2001, IEEE T GEOSCI REMOTE, V39, P8, DOI 10.1109/36.898661
   Ferretti A, 2000, IEEE T GEOSCI REMOTE, V38, P2202, DOI 10.1109/36.868878
   Fisher R. A., 1942, DESIGN EXPT
   GABRIEL AK, 1989, J GEOPHYS RES-SOLID, V94, P9183, DOI 10.1029/JB094iB07p09183
   GAMBOLATI G, 1991, WATER RESOUR RES, V27, P2899, DOI 10.1029/91WR01567
   Gambolati G, 1999, WATER RESOUR RES, V35, P163, DOI 10.1029/1998WR900031
   Gambolati G, 1998, WATER SCI TECHNOL, V28, P103
   Ghielmi M, 2010, REND LINCEI-SCI FIS, V21, P131, DOI 10.1007/s12210-010-0101-5
   Goldstein RM, 1998, GEOPHYS RES LETT, V25, P4035, DOI 10.1029/1998GL900033
   Herrera G, 2009, ISPRS J PHOTOGRAMM, V64, P501, DOI 10.1016/j.isprsjprs.2008.09.008
   Iglesias R, 2014, IEEE T GEOSCI REMOTE, V52, P3788, DOI 10.1109/TGRS.2013.2276023
   Lanari R, 2004, IEEE T GEOSCI REMOTE, V42, P1377, DOI 10.1109/TGRS.2004.828196
   MASSONNET D, 1995, NATURE, V375, P567, DOI 10.1038/375567a0
   MASSONNET D, 1993, NATURE, V364, P138, DOI 10.1038/364138a0
   Meisina C, 2008, SENSORS-BASEL, V8, P7469, DOI 10.3390/s8117469
   Meyer FJ, 2015, ISPRS J PHOTOGRAMM, V100, P106, DOI 10.1016/j.isprsjprs.2014.05.009
   Mora O, 2003, IEEE T GEOSCI REMOTE, V41, P2243, DOI 10.1109/TGRS.2003.814657
   Notti D, 2015, PURE APPL GEOPHYS, V172, P3081, DOI 10.1007/s00024-015-1071-4
   Snedecor G. W., 1967, STAT METHODS
   Soergel U, 2010, REMOTE SENS DIGIT IM, V15, P1, DOI 10.1007/978-90-481-3751-0
   Teatini P, 2005, ENVIRON GEOL, V47, P831, DOI 10.1007/s00254-004-1215-9
   Tessitore S, 2016, HYDROGEOL J, V24, P727, DOI 10.1007/s10040-015-1349-8
   Tomas R, 2005, REMOTE SENS ENVIRON, V98, P269, DOI 10.1016/j.rse.2005.08.003
   Tomas R, 2014, ENVIRON EARTH SCI, V71, P163, DOI 10.1007/s12665-013-2422-z
NR 41
TC 0
Z9 0
U1 15
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1548-1603
EI 1943-7226
J9 GISCI REMOTE SENS
JI GISci. Remote Sens.
PD JUN
PY 2017
VL 54
IS 3
BP 305
EP 328
DI 10.1080/15481603.2016.1269404
PG 24
WC Geography, Physical; Remote Sensing
SC Physical Geography; Remote Sensing
GA ES4CD
UT WOS:000399475800003
OA No
DA 2017-08-17
ER

PT J
AU El Kamash, W
   Han, J
AF El Kamash, Walid
   Han, Jie
TI Numerical Analysis of Existing Foundations Underpinned by Micropiles
SO INTERNATIONAL JOURNAL OF GEOMECHANICS
LA English
DT Article
DE Underpinning; Micropile; Load transfer; Skin friction; Tip resistance;
   Piled raft
ID BEHAVIOR
AB Micropiles of small diameter have been used in practice to increase load capacities of existing foundations on soft soil, which may resist additional loads from the vertical expansion of structures. Load transfer from the existing foundation to the micropiles is an important mechanism to consider when designing an existing foundation underpinned by micropiles. However, this mechanism has not been well investigated or understood. This paper presents a numerical study on an existing foundation underpinned by micropiles using three-dimensional (3D) finite-difference software. Verification of the numerical model was first achieved by comparing the results of the numerical model to those obtained from the full-scale loading test. In this verification, the numerical model was used to simulate an existing footing initially constructed on a natural soil to support a structure and later subjected to additional loads under two different conditions. Under the first condition, micropiles were installed without connection with the existing foundation. The existing foundation was subjected to initial loads, and then the micropiles were connected to the existing foundation for additional loads. Under the second condition, the foundation was first subjected to initial loads. Micropiles were installed and then connected to the foundation for additional loads. These two conditions were investigated further in a parametric study to understand the behavior of micropiles in the underpinned foundation under additional loading, including the load transfer between the existing foundation and the micropiles. This parametric study revealed that the installation sequence of micropiles had obvious effects on the vertical displacement of the footing, the percent load on the micropile, and the skin friction along the micropile. This study also revealed that the initial pressure ratio for underpinning and the length of micropiles had more effects on the behavior of the existing foundation underpinned by micropiles than the modulus of micropiles.
C1 [El Kamash, Walid] Suez Canal Univ, Dept Civil Engn, Fac Engn, Ismailia 41522, Egypt.
   [El Kamash, Walid] Univ Kansas, Lawrence, KS 66045 USA.
   [Han, Jie] Univ Kansas, Dept Civil Environm & Architectural Engn, Lawrence, KS 66045 USA.
RP Han, J (reprint author), Univ Kansas, Dept Civil Environm & Architectural Engn, Lawrence, KS 66045 USA.
EM waleed_el_kamash@hotmail.com; jiehan@ku.edu
RI Han, Jie/C-7500-2011
CR Armour T., 2000, MICROPILE DESIGN CON
   Bruce D.A, 1988, GROUND ENG, V21, P20
   Bruce D.A., 1989, GROUND ENG, V22, P35
   Esmaeili M, 2013, INT J GEOMECH, V13, P729, DOI 10.1061/(ASCE)GM.1943-5622.0000280
   FLAC3D 3.0 [Computer software], FLAC3D 3 0
   Gorski K., 2013, J STUD GEOTECH MECH, V35, P47, DOI [10.2478/sgem-2013-0036, DOI 10.2478/SGEM-2013-0036]
   Gutierrez A., 2004, REP GEOTECHNICAL INV, V42
   Han J, 2006, CAN GEOTECH J, V43, P19, DOI 10.1139/T05-089
   Han J, 2006, CAN GEOTECH J, V43, P30, DOI 10.1139/T05-087
   Han J., 2015, PRINCIPLES PRACTICE
   Itasca, 2005, FLAC3D 3 0 US GUID
   Liew S., 2003, DESIGN CONSTRUCTION
   Lizzi F., 1980, J IND COSTRUZIONI, V110, P25
   Makarchian M, 1996, J GEOTECH ENG-ASCE, V122, P745, DOI 10.1061/(ASCE)0733-9410(1996)122:9(745)
   Pearlman S. L., 2001, P OH RIV VALL SOILS
   PLAXIS 3D, PLAXIS 3D
   Shu S, 2011, INT J GEOMECH, V11, P370, DOI 10.1061/(ASCE)GM.1943-5622.0000095
   Thorburn S., 1985, UNDERPINNING
   Tomosawa F., 1990, ANN M ARCH I JAP, P497
   USACE (U. S. Army Corps of Engineers), 1990, ENG MAN
   Ye S. L., 1994, SOIL IMPROVEMENT UND
   Ye S. L., 1993, RES REPS TONGJI U
NR 22
TC 0
Z9 0
U1 6
U2 6
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 1532-3641
EI 1943-5622
J9 INT J GEOMECH
JI Int. J. Geomech.
PD JUN
PY 2017
VL 17
IS 6
AR 04016126
DI 10.1061/(ASCE)GM.1943-5622.0000833
PG 16
WC Engineering, Geological
SC Engineering
GA ES3JK
UT WOS:000399425700016
OA No
DA 2017-08-17
ER

PT J
AU Abdelmalak, R
   Briaud, JL
AF Abdelmalak, Remon
   Briaud, Jean-Louis
TI Performance of Stiffened Slab-on-Grade Foundation on Shrink-Swell Soils:
   Case Study of the Ellison Office Building, College Station, Texas
SO JOURNAL OF PERFORMANCE OF CONSTRUCTED FACILITIES
LA English
DT Article
DE Shrink-swell soils; Swelling clays; Soil suction; Active moisture
   variation zone; Vegetation; Unsaturated soils; Foundation performance;
   Stiffened slab-on-grade; Global heave; Weather
AB Stiffened slabs-on-grade are one of the most efficient and inexpensive foundation solutions for lightweight structures on shrinks-well soils. The Ellison Office Building (EOB) is a 1-story steel-framed building founded on a clay formation of high shrink-swell potential. The foundation system of the EOB is composed of a rectangular stiffened slab-on-grade with approximate dimensions of 18.3 by 38.1 m. The slab thickness is 0.1 m, and the depth of all stiffening beams is 1.05 m. Beam spacing distances, center to center, are 3.05 and 3.81 m in the short and long directions, respectively. Exploration of subsurface soil conditions at the EOB site took place to determine soil index properties as well as unsaturated moisture diffusion and volume change characteristics for unsaturated soils. Monitoring the movements of both the slab-on-grade and the 4.5 m soil underneath continued for 2 years after foundation construction, since September 2004. Investigating the EOB foundation performance in light of the soil-structure interaction characteristics of the foundation showed two main distinct slab movement patterns: continuous global heave and localized fluctuating slab edge heave and drop movements. (C) 2016 American Society of Civil Engineers.
C1 [Abdelmalak, Remon] Menia Univ, Fac Engn, Dept Civil Engn, El Minia 11432, Egypt.
   [Briaud, Jean-Louis] Texas A&M Univ, Zachry Dept Civil Engn, College Stn, TX 77843 USA.
RP Abdelmalak, R (reprint author), Menia Univ, Fac Engn, Dept Civil Engn, El Minia 11432, Egypt.
EM remonisaac@gmail.com; briaud@tamu.edu
FU Spencer J. Buchanan Professorship at Texas AM University
FX This research was sponsored by the Spencer J. Buchanan Professorship at
   Texas A&M University. Several students have contributed to this paper,
   including Xiong Zhang and Ken Yun Ree. The authors would like to
   acknowledge Mr. Charles A. Ellison's (founder of the Ellison Firm)
   gracious help and permission to freely access his facility and monitor
   the foundation performance during the entire course of the
   investigation.
CR Abdelmalak R., 2007, THESIS
   ASTM, 2015, D1587 ASTM
   [Anonymous], 2010, D221610 ASTM
   ASTM, 2016, D2166 ASTM
   ASTM, 2014, D114014 ASTM
   ASTM, 2014, D85414 ASTM
   [Anonymous], 2010, D431810E1 ASTM
   Briaud JL, 2003, J GEOTECH GEOENVIRON, V129, P590, DOI 10.1061/(ASCE)1090-0241(2003)129:7(590)
   Durkee D. B., 2000, THESIS
   Hamilton J. J., 1965, P INT RES ENG C EXPA, P183
   Hamilton J. J., 1963, CAN GEOTECH J, V1, P27, DOI 10.1139/t63-004
   Hamilton J. J., 1969, CANADIAN GEOTECHNICA, V6, P65, DOI 10.1139/t69-008
   Masia MJ, 2004, J GEOTECH GEOENVIRON, V130, P572, DOI 10.1061/(ASCE)1090-0241(2004)130:6(572)
   Mitchell P. W., 1979, 1 SMITH ASS PTY LTD
   National Weather Service, 2016, COLL STAT TEMP PREC
   Post-Tensioning Institute, 2004, PHOENIX
   Post-Tensioning Institute, 1996, PHOENIX
   Tien S., 2004, CASE STUDIES RESIDEN
NR 18
TC 1
Z9 1
U1 6
U2 6
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 0887-3828
EI 1943-5509
J9 J PERFORM CONSTR FAC
JI J. Perform. Constr. Facil.
PD JUN
PY 2017
VL 31
IS 3
AR D4016008
DI 10.1061/(ASCE)CF.1943-5509.0000978
PG 9
WC Construction & Building Technology; Engineering, Civil
SC Construction & Building Technology; Engineering
GA ES6JX
UT WOS:000399654700013
OA No
DA 2017-08-17
ER

PT J
AU Metwally, SS
   Ghaly, M
   El-Sherief, EA
AF Metwally, S. S.
   Ghaly, M.
   El-Sherief, E. A.
TI Physicochemical properties of synthetic nano-birnessite and its enhanced
   scavenging of Co2+ and Sr2+ ions from aqueous solutions
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Nano-birnessite; Sorption; Kinetic models; Cobalt; Strontium
ID MANGANESE OXIDE; ACTIVATED CARBON; REMOVAL; ADSORPTION; STRONTIUM;
   SORPTION; EXCHANGE; COBALT; CO-60; RADIONUCLIDES
AB Nano-birnessite was prepared, characterized and used for removal of cobalt and strontium ions from aqueous solutions. Scanning electron microscope and atomic force microscope images indicated that the particles of the prepared material are presented in the nano-scale form, the grain size was found in a range of 58-95 nm. Specific surface area of the prepared nano-birnessite was determined and found to be 200.54 m(2)/g. The Capacities of nano-birnessite for cobalt and strontium are 2.97 and 3.04 meq/g, respectively. The kinetic studies indicated that the sorption of the two ions obeys pseudo-second-order model and controlled by an intra-particle diffusion mechanism. The diffusivity of Co2+ and Sr2+ ions onto nano-birnessite was determined and indicated that the sorption is chemisorption process. Hence, nanobirnessite material is an efficient sorbent and can be used to decrease the influx of pollutants, such as; Co2+ and Sr2+ ions to the environment or their removal from contaminated media. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Metwally, S. S.; Ghaly, M.; El-Sherief, E. A.] Atom Energy Author, Hot Labs Ctr, Cairo 13759, Egypt.
RP Metwally, SS (reprint author), Atom Energy Author, Hot Labs Ctr, Cairo 13759, Egypt.
EM sicosad@hotmail.com
CR Aronson B.J., 1999, J CHEM MAT, V1, P949
   Ching S, 1997, INORG CHEM, V36, P883, DOI 10.1021/ic961088d
   Dai RA, 2009, CHEMOSPHERE, V76, P536, DOI 10.1016/j.chemosphere.2009.03.009
   El-Kamash AM, 2008, J HAZARD MATER, V151, P432, DOI 10.1016/j.jhazmat.2007.06.009
   El-Kamash AM, 2007, J HAZARD MATER, V141, P719, DOI 10.1016/j.jhazmat.2006.07.041
   El-Naggar IM, 2007, J HAZARD MATER, V149, P686, DOI 10.1016/j.jhazmat.2007.04.029
   EL-Naggar MR, 2011, ISOTOPE RAD RES, V43, P1649
   Eren E, 2011, DESALINATION, V279, P75, DOI 10.1016/j.desal.2011.05.058
   Feng XH, 2007, ENVIRON POLLUT, V147, P366, DOI 10.1016/j.envpol.2006.05.028
   Fonseca B, 2009, CHEM ENG J, V152, P212, DOI 10.1016/j.cej.2009.04.045
   Ghaly M, 2016, CHEM ENG J, V284, P1373, DOI 10.1016/j.cej.2015.09.025
   Goff P.L., 1993, J SOLID STATE ION, V61, P309
   GOLDEN DC, 1986, CLAY CLAY MINER, V34, P511, DOI 10.1346/CCMN.1986.0340503
   Guan W, 2011, CHEM ENG J, V167, P215, DOI 10.1016/j.cej.2010.12.025
   Gurboga GE, 2005, J HAZARD MATER, V120, P135, DOI 10.1016/j.jhazmat.2004.12.037
   Hamed MM, 2016, J ENVIRON RADIOACTIV, V164, P113, DOI 10.1016/j.jenvrad.2016.07.005
   Hamed MM, 2016, CHEM ECOL, V32, P68, DOI 10.1080/02757540.2015.1112379
   Hamed MM, 2014, RADIOCHIM ACTA, V102, P1017, DOI 10.1515/ract-2013-2200
   Han RP, 2006, J HAZARD MATER, V137, P384, DOI 10.1016/j.jhazmat.2006.02.021
   Inan S, 2010, SEPAR SCI TECHNOL, V45, P269, DOI 10.1080/01496390903409666
   Inan S, 2013, SEP SCI TECHNOL, V48, P1364, DOI 10.1080/01496395.2012.732980
   Jasquelin P., 2015, CHEM GEOL, V396, P196
   Kang LP, 2007, SPECTROCHIM ACTA A, V67, P864, DOI 10.1016/j.saa.2006.09.001
   Lee S, 2011, J HAZARD MATER, V186, P2117, DOI 10.1016/j.jhazmat.2010.12.126
   Metwally SS, 2016, APPL CLAY SCI, V126, P33, DOI 10.1016/j.clay.2016.02.021
   Metwally SS, 2014, SEP SCI TECHNOL, V49, P2426, DOI 10.1080/01496395.2014.926457
   Metwally SS, 2014, J RADIOANAL NUCL CH, V302, P441, DOI 10.1007/s10967-014-3185-z
   Metwally SS, 2013, SEP SCI TECHNOL, V48, P1829, DOI 10.1080/01496395.2012.755697
   Metwally SS, 2011, SEP SCI TECHNOL, V46, P1808, DOI 10.1080/01496395.2011.572328
   Metwally S. S., 2014, ARAB J NUCL SCI APPL, V47, P94
   Moghaddam HK, 2015, J IND ENG CHEM, V21, P221, DOI 10.1016/j.jiec.2014.02.028
   Mohan D, 2007, J HAZARD MATER, V142, P1, DOI 10.1016/j.jhazmat.2007.01.006
   Naser AA, 2015, J IND ENG CHEM, V32, P264, DOI 10.1016/j.jiec.2015.08.024
   POST JE, 1990, AM MINERAL, V75, P477
   Prieto O, 2003, THERMOCHIM ACTA, V401, P95, DOI 10.1016/S0040-6031(02)00503-8
   Sasaki K, 2014, APPL CLAY SCI, V101, P23, DOI 10.1016/j.clay.2014.06.028
   WALKER GM, 1999, J WATER RES, V33, P1895
   Wang SS, 2015, BIORESOURCE TECHNOL, V181, P13, DOI 10.1016/j.biortech.2015.01.044
   Xiaoyan Y., 2005, J COLLOID INTERF SCI, V287, P25
   Yin H, 2015, J HAZARD MATER, V288, P80, DOI 10.1016/j.jhazmat.2015.01.068
   Yin H, 2011, J HAZARD MATER, V196, P318, DOI 10.1016/j.jhazmat.2011.09.027
   Yuan L, 2013, CHEM ENG J, V215, P432, DOI 10.1016/j.cej.2012.11.016
   Zhang L, 2016, CHEM ENG J, V285, P679, DOI 10.1016/j.cej.2015.10.013
   Zhu G, 2012, MATER RES BULL, V47, P3533, DOI 10.1016/j.materresbull.2012.06.065
NR 44
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JUN 1
PY 2017
VL 193
BP 63
EP 72
DI 10.1016/j.matchemphys.2017.02.006
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA ES0ZT
UT WOS:000399258400009
OA No
DA 2017-08-17
ER

PT J
AU Aly, KA
   Khalil, NM
   Algamal, Y
   Saleem, QMA
AF Aly, Kamal A.
   Khalil, N. M.
   Algamal, Yousif
   Saleem, Qaid M. A.
TI Estimation of lattice strain for zirconia nano-particles based on
   Williamson-Hall analysis
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Nanomaterials; Zirconia synthesis; XRD; SEM
ID SOL-GEL METHOD; X-RAY-DIFFRACTION; THIN-FILMS; ANNEALING TEMPERATURE;
   POWDER DIFFRACTION; CELL PARAMETERS; PHASE; ZRO2; CERAMICS; SIZE
AB Nanoparticles of Zirconia were prepared (ZrO2) by the neutralization of zirconium oxychloride octahydrate (ZrOCl2-8H(2)O) (2M) and ammonia solution (2M) at pH 8. The ZrO2 crystalline state was revealed by X-ray diffraction (XRD). The analysis of Scanning electron microscopy (SEM) and Transmission Electron microscope (TEM) images reveals that the as-synthesized ZrO2 particles at firing temperature of 800 degrees C are uniform and of range of 30 nm. Increasing of the temperature up to 1100 degrees C leads to the increase in particle size and alters the powders shape due to agglomeration arose from zirconia calcination as well as the increase in particle size. The X-ray peak broadening analysis (XRDBA) was used in the estimation of the crystalline size. Williamson-Hall (W-H) analysis was applied successfully to determine the energy density, stress, and the strain values via uniform deformation model (UDM), uniform deformation stress model (UDSM) and uniform deformation energy density model (UDEDM). The mean of the strain root square was calculated. The different strain values obtained from these models predicting the zirconia isotropic behavior. In addition to that, the W-H analysis results were discussed in terms of that obtained by Scherrer's relationship, SEM and TEM images. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Aly, Kamal A.] Univ Jeddah, Fac Sci & Arts Khullais, Phys Dept, Jeddah, Saudi Arabia.
   [Aly, Kamal A.] Al Azhar Univ, Fac Sci, Phys Dept, Assiut Branch, Assiut, Egypt.
   [Khalil, N. M.; Algamal, Yousif; Saleem, Qaid M. A.] Univ Jeddah, Fac Sci & Arts Khullais, Chem Dept, Jeddah, Saudi Arabia.
   [Khalil, N. M.] Natl Res Ctr, Refractories Ceram & Bldg Mat Dept, Cairo 12311, Egypt.
   [Saleem, Qaid M. A.] Aden Univ, Shabwa, Yemen.
RP Aly, KA (reprint author), Univ Jeddah, Fac Sci & Arts Khullais, Phys Dept, Jeddah, Saudi Arabia.
EM kamalaly2001@gmail.com
CR Adachi S., 2004, HDB PHYS PROPERTIES
   Ayeshamariam A., 2011, INT J CHEM ANAL SCI, V2, P54
   Bagheri-Mohagheghi MM, 2008, PHYSICA B, V403, P2431, DOI 10.1016/j.physb.2008.01.004
   Barret CS, 1980, STRUCTURE METALS
   Bensouyad H, 2010, THIN SOLID FILMS, V519, P96, DOI 10.1016/j.tsf.2010.07.062
   Betz U, 1999, NANOSTRUCT MATER, V12, P689, DOI 10.1016/S0965-9773(99)00218-4
   Biju V, 2008, J MATER SCI, V43, P1175, DOI 10.1007/s10853-007-2300-8
   Bish D. L., 2011, EMU NOTES MINERALOGY, P35
   Bish D. L., 1988, OCCURRENCE PROPERTIE, P565
   Bokhimi X, 1998, J SOLID STATE CHEM, V135, P28, DOI 10.1006/jssc.1997.7586
   Cullity B. D., 2001, ELEMENTS XRAY DIFFRA
   El-Khair H. M., 2002, CHINESE PHYS LETT, V19, P967
   HILL RJ, 1987, J APPL CRYSTALLOGR, V20, P467, DOI 10.1107/S0021889887086199
   Joy K, 2012, J ALLOY COMPD, V512, P149, DOI 10.1016/j.jallcom.2011.09.051
   Karagedov GR, 2011, SCI SINTER, V43, P239, DOI 10.2298/SOS1103239K
   Kurzweg H, 1998, BIOMATERIALS, V19, P1507, DOI 10.1016/S0142-9612(98)00067-2
   MITSUDA T, 1986, CEMENT CONCRETE RES, V16, P105, DOI 10.1016/0008-8846(86)90074-8
   Mosa J, 2011, ELECTROCHIM ACTA, V56, P7155, DOI 10.1016/j.electacta.2011.05.074
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7
   Rosenberg Y, 2000, J PHYS-CONDENS MAT, V12, P8081, DOI 10.1088/0953-8984/12/37/307
   Seetawan U, 2011, SOLID STATE SCI, V13, P1599, DOI 10.1016/j.solidstatesciences.2011.06.007
   Senthilkumar V, 2010, PHIL MAG LETT, V90, P337, DOI 10.1080/09500831003662529
   Siddiqui MRH, 2012, MATER RES-IBERO-AM J, V15, P986, DOI [10.1590/S1516-14392012005000128, 10.1590/S1516-14392012000600023]
   Snyder R. L., 1999, EDS IUCR MONOGRAPHS, V10
   Soo MT, 2012, APPL SURF SCI, V258, P5250, DOI 10.1016/j.apsusc.2012.02.008
   Sun LD, 2000, J LUMIN, V87-9, P538, DOI 10.1016/S0022-2313(99)00283-5
   Suryanarayana C., 1998, XRAY DIFFRACTION PRA
   TORAYA H, 1990, J APPL CRYSTALLOGR, V23, P485, DOI 10.1107/S002188989000704X
   TORAYA H, 1989, J AM CERAM SOC, V72, P662, DOI 10.1111/j.1151-2916.1989.tb06191.x
   Wang J, 2014, INT J PLASTICITY, V61, P17, DOI 10.1016/j.ijplas.2014.05.005
   Wang JA, 2001, CATAL TODAY, V68, P21, DOI 10.1016/S0920-5861(01)00319-4
   WINTERER M, 1995, NANOSTRUCT MATER, V5, P679, DOI 10.1016/0965-9773(95)00277-L
   Young RA., 1981, ADV XRAY ANAL, P1
   Young R. W., 1993, IUCR MONOGRAPH CRYST
   Zhang HM, 2006, SOLID STATE COMMUN, V139, P87, DOI 10.1016/j.ssc.2006.05.026
   Zhu WZ, 1998, CERAM INT, V24, P35, DOI 10.1016/S0272-8842(96)00074-0
NR 37
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JUN 1
PY 2017
VL 193
BP 182
EP 188
DI 10.1016/j.matchemphys.2017.01.059
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA ES0ZT
UT WOS:000399258400022
OA No
DA 2017-08-17
ER

PT J
AU El-Say, KM
   Ahmed, OAA
   Aljaeid, BM
   Zidan, AS
AF El-Say, Khalid M.
   Ahmed, Osama A. A.
   Aljaeid, Bader M.
   Zidan, Ahmed S.
TI Matrix-type transdermal films to enhance simvastatin ex vivo skin
   permeability
SO PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
LA English
DT Article
DE Diffusion; Eudragit; experimental design; ex vivo permeation; solvent
   casting
ID DRUG-DELIVERY SYSTEMS; MECHANICAL-PROPERTIES; POLYMERS; RELEASE; PATCHES
AB This study aimed at employing Plackett-Burman design in screening formulation variables that affect quality of matrix-type simvastatin (SMV) transdermal film. To achieve this goal, 12 formulations were prepared by casting method. The investigated variables were Eudragit RL percentage, polymer mixture percentage, plasticizer type, plasticizer percentage, enhancer type, enhancer percentage and dichloromethane fraction in organic phase. The films were evaluated for physicochemical properties and ex vivo SMV permeation. SMV initial, delayed flux, diffusivity and permeability coefficient were calculated on the delayed flux phase with constraint to minimize the initial flux and approaching steady-state flux. The obtained results revealed flat films with homogeneous distribution of SMV within the films. Thickness values changed from 65 to 180 m by changing the factors' combinations. Most of the permeation profiles showed sustained release feature with fast permeation phase followed by slow phase. Analysis of variance (ANOVA) showed significant effects (p<0.05) of the investigated variables on the responses with Prob>F values of 0.0147, 0.0814, 0.0063 and 0.0142 for the initial and delayed fluxes, permeability coefficients and diffusivities, respectively. The findings of screening study showed the importance of the significant variables to be scaled up for full optimization study as a promising alternative drug delivery system.
C1 [El-Say, Khalid M.; Ahmed, Osama A. A.; Aljaeid, Bader M.; Zidan, Ahmed S.] King Abdulaziz Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, POB 80260, Jeddah 21589, Saudi Arabia.
   [El-Say, Khalid M.] Al Azhar Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Cairo, Egypt.
   [Ahmed, Osama A. A.] Menia Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Al Minya, Egypt.
   [Zidan, Ahmed S.] Zagazig Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Zagazig, Egypt.
RP Zidan, AS (reprint author), King Abdulaziz Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, POB 80260, Jeddah 21589, Saudi Arabia.
EM aszidan@kau.edu.sa
RI El-Say, Khalid/I-7339-2012; Ahmed, Osama/H-9787-2012
OI Ahmed, Osama/0000-0002-3204-381X
CR Ahmed TA, 2014, LIFE SCI, V110, P35, DOI 10.1016/j.lfs.2014.06.019
   Ammar HO, 2011, INT J PHARMACEUT, V405, P142, DOI 10.1016/j.ijpharm.2010.11.003
   BODMEIER R, 1994, PHARMACEUT RES, V11, P882, DOI 10.1023/A:1018942127524
   Chen YC, 2012, J PHARM SCI-US, V101, P3811, DOI 10.1002/jps.23279
   Dixit RP, 2010, INDIAN J PHARM SCI, V72, P204, DOI 10.4103/0250-474X.65028
   El Shafie AH, 2012, J WATER CLIM CHANGE, V3, P125, DOI 10.2166/wcc.2012.017
   El-Say KM, 2015, PHARM DEV TECHNOL, V20, P919, DOI 10.3109/10837450.2014.938859
   Hung SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100321
   Jayaprakash S, 2010, PAK J PHARM SCI, V23, P279
   Jun SW, 2007, EUR J PHARM BIOPHARM, V66, P413, DOI 10.1016/j.ejpb.2006.11.013
   Kim KS, 2011, COMPUT CHEM ENG, V35, P1152, DOI 10.1016/j.compchemeng.2011.01.006
   LANGER R, 1983, J MACROMOL SCI R M C, VC23, P61
   LIN SY, 1995, J CONTROL RELEASE, V33, P375, DOI 10.1016/0168-3659(94)00109-8
   Mali S, 2005, CARBOHYD POLYM, V60, P283, DOI 10.1016/j.carbpol.2005.01.003
   Martindale W, 1999, MARTINDALE COMPLETE
   Mukherjee B, 2005, EUR J PHARM BIOPHARM, V59, P475, DOI 10.1016/j.ejpb.2004.09.009
   Murtaza G, 2012, ACTA POL PHARM, V69, P581
   Naseera K, 2012, INT J CURR PHARM RES, V4, P79
   OUANO AC, 1980, POLYM ENG SCI, V20, P160, DOI 10.1002/pen.760200208
   Pichayakorn W, 2013, PHARM DEV TECHNOL, V18, P1111, DOI 10.3109/10837450.2012.705297
   PLACKETT RL, 1946, BIOMETRIKA, V33, P305, DOI 10.2307/2332195
   Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304
   Rowe RG, 2009, HDB PHARM EXCIPIENTS
   Rujivipat S, 2012, EUR J PHARM BIOPHARM, V81, P223, DOI 10.1016/j.ejpb.2012.01.003
   Shinde A.J., 2008, ASIAN J PHARM, V2, P265
   Siepmann J, 1998, J PHARM SCI, V87, P827, DOI 10.1021/js980006a
   Singh B, 2005, CRIT REV THER DRUG, V22, P27, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i1.20
   World Health Organization, 2013, WHO MOD LIST ESS MED
NR 28
TC 0
Z9 0
U1 4
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1083-7450
EI 1097-9867
J9 PHARM DEV TECHNOL
JI Pharm. Dev. Technol.
PD JUN
PY 2017
VL 22
IS 4
BP 492
EP 499
DI 10.3109/10837450.2015.1102279
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ES4JO
UT WOS:000399500700006
PM 26512747
OA No
DA 2017-08-17
ER

PT J
AU Fadel, M
   Samy, N
   Nasr, M
   Alyoussef, AA
AF Fadel, Maha
   Samy, Nevien
   Nasr, Maha
   Alyoussef, Abdullah A.
TI Topical colloidal indocyanine green-mediated photodynamic therapy for
   treatment of basal cell carcinoma
SO PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
LA English
DT Article
DE Laser; skin; transfersomes
ID METHYL AMINOLEVULINATE; DRUG-DELIVERY; SKIN-CANCER; CARRIERS;
   PENETRATION; FORMULATION; VESICLES
AB Indocyanine green (ICG) is a near-IR fluorescent dye with a great potential for application as photosensitizer in topical photodynamic therapy (PDT) of skin diseases. Despite its merits, its use has been hampered by its high degradation rate. Therefore, in the current article, ICG was encapsulated in a vesicular colloidal nanocarrier (transfersomes), with the aim of enhancing its therapeutic efficacy. Transfersomes were characterized for their entrapment efficiency, particle size, zeta potential, morphology, in vitro release and histopathological effect on mice skin. A pilot clinical study was conducted to test its therapeutic potential for PDT of basal cell carcinoma (BCC). Transfersomal ICG displayed particle size (approximate to 125nm) and a negative zeta potential (approximate to-31mV). Transfersomes were also able to sustain the release of ICG >2h. Upon incorporation of transfersomal ICG in gel form, it was found to maintain the normal histology of mice skin post-irradiation with diode laser 820nm. Moreover, ICG transfersomal PDT achieved 80% clearance rate for BCC patients with minimal pain reported during treatment. The previous findings suggest that transfersomal nanoencapsulated ICG is a promising treatment modality for BCC.
C1 [Fadel, Maha] Cairo Univ, Natl Inst Laser Enhanced Sci, Dept Med Applicat Lasers, Pharmaceut Technol Unit, Cairo, Egypt.
   [Samy, Nevien] Cairo Univ, Photobiol & Photosensitizat Lab, Cairo, Egypt.
   [Nasr, Maha] Ain Shams Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Monazamet El Wehda El Afrikia St, Cairo, Egypt.
   [Alyoussef, Abdullah A.] Tabuk Univ, Dermatol Dept, Tabuk, Saudi Arabia.
RP Nasr, M (reprint author), Ain Shams Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Monazamet El Wehda El Afrikia St, Cairo, Egypt.
EM maha2929@gmail.com
CR Atwood SX, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013581
   Bseiso EA, 2015, INDIAN J DERMATOL VE, V81, P457, DOI 10.4103/0378-6323.162328
   Bsieso EA, 2015, NANOMEDICINE-UK, V10, P2017, DOI [10.2217/nnm.15.49, 10.2217/NNM.15.49]
   Cevc G, 2004, ADV DRUG DELIVER REV, V56, P675, DOI 10.1016/j.addr.2003.10.028
   Cevc G, 2001, BBA-BIOMEMBRANES, V1514, P191, DOI 10.1016/S0005-2736(01)00369-8
   Chatterjee DK, 2008, ADV DRUG DELIVER REV, V60, P1627, DOI 10.1016/j.addr.2008.08.003
   Duangjit S, 2013, AAPS PHARMSCITECH, V14, P133, DOI 10.1208/s12249-012-9904-2
   El Zaafarany GM, 2010, INT J PHARMACEUT, V397, P164, DOI 10.1016/j.ijpharm.2010.06.034
   Ericson Marica B, 2008, Ther Clin Risk Manag, V4, P1
   Fadel M, 2011, INT J RES PHARM SCI, V2, P537
   Fadel M, 2015, EJPBS, V2, P20
   Kassab K, 2013, LASER MED SCI, V28, P1353, DOI 10.1007/s10103-012-1256-3
   Lei W., 2013, ASIAN J PHARM SCI, V8, P336
   Li Q, 2011, PHOTOMED LASER SURG, V29, P501, DOI 10.1089/pho.2010.2924
   Li WT, 2013, HDB BIOPHOTONICS, P321
   Romero EL, 2013, INT J NANOMED, V8, P3171, DOI 10.2147/IJN.S33048
   Mahmood S, 2014, INT J NANOMED, V9, P4331, DOI 10.2147/IJN.S65408
   Nasr M, 2008, J MICROENCAPSUL, V25, P499, DOI 10.1080/02652040802055411 
   Tate LP, 2002, P SOC PHOTO-OPT INS, V4609, P247, DOI 10.1117/12.431788
   Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x
   VYAS A, 2012, TRENDS APPL SCI RES, V7, P620, DOI DOI 10.3923/tasr.2012.620.635
   Wiegell SR, 2006, BRIT J DERMATOL, V154, P969, DOI 10.1111/j.1365-2133.2005.07107.x
   Zhao BZ, 2010, EXPERT REV ANTICANC, V10, P1797, DOI [10.1586/era.10.154, 10.1586/ERA.10.154]
NR 23
TC 0
Z9 0
U1 18
U2 18
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1083-7450
EI 1097-9867
J9 PHARM DEV TECHNOL
JI Pharm. Dev. Technol.
PD JUN
PY 2017
VL 22
IS 4
BP 545
EP 550
DI 10.3109/10837450.2016.1146294
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ES4JO
UT WOS:000399500700011
PM 26895257
OA No
DA 2017-08-17
ER

PT J
AU Elsawah, AM
AF Elsawah, A. M.
TI A closer look at de-aliasing effects using an efficient foldover
   technique
SO STATISTICS
LA English
DT Article
DE Uniformity criteria; foldover technique; combined design; complementary
   combined design; optimal combined design; 62K05; 62K15
ID FRACTIONAL FACTORIAL-DESIGNS; LEE DISCREPANCY; MIXTURE DISCREPANCY;
   LEVEL FACTORIALS; L-2-DISCREPANCY; PLANS
AB Foldover techniques are used to reduce the confounding when some important effects (usually lower order effects) cannot be estimated independently. This article develops an efficient foldover mechanism for symmetric or asymmetric designs, whether regular or nonregular. In this paper, we take the uniformity criteria (UC) as the optimality measures to construct the optimal combined designs (initial design plus its corresponding foldover design) which have better capability of estimating lower order effects. The relationship between any initial design and its combined design is studied. A comparison study between the combined designs via different UC is provided. Equivalence between any combined design and its complementary combined design is investigated, which is a very useful constraint that reduce the search space. Using our results as benchmarks, we can implement a powerful algorithm for constructing optimal combined designs. Our work covers as well as gives results better than recent works of about 20 articles in the last few years as special cases. So this article is a good reference for constructing effective designs.
C1 [Elsawah, A. M.] Zagazig Univ, Dept Math, Fac Sci, Zagazig, Egypt.
   [Elsawah, A. M.] Cent China Normal Univ, Fac Math & Stat, Wuhan, Peoples R China.
   [Elsawah, A. M.] Hong Kong Baptist Univ, Beijing Normal Univ, United Int Coll, Zhuhai, Peoples R China.
RP Elsawah, AM (reprint author), Zagazig Univ, Dept Math, Fac Sci, Zagazig, Egypt.; Elsawah, AM (reprint author), Cent China Normal Univ, Fac Math & Stat, Wuhan, Peoples R China.; Elsawah, AM (reprint author), Hong Kong Baptist Univ, Beijing Normal Univ, United Int Coll, Zhuhai, Peoples R China.
EM amelsawah@uic.edu.hk
FU UIC Grant [R201409]; Zhuhai Premier Discipline Grant; National Natural
   Science Foundation of China [11271147, 11471135, 11471136]
FX This work was partially supported by the UIC Grant (R201409), the Zhuhai
   Premier Discipline Grant and the National Natural Science Foundation of
   China (Nos. 11271147, 11471135, 11471136).
CR Chatterjee K, 2012, STAT PROBABIL LETT, V82, P1367, DOI 10.1016/j.spl.2012.03.011
   Chatterjee K, 2012, SCI CHINA MATH, V55, P663, DOI 10.1007/s11425-012-4366-2
   Cheong KTW, 2012, AM J PLANT SCI, V3, P1390, DOI [10.4236/ajps.2012.310168, DOI 10.4236/AJPS.2012.310168]
   Elsawah AM, 2016, J KOREAN STAT SOC, V45, P77, DOI 10.1016/j.jkss.2015.07.004
   Elsawah AM, 2016, ACTA MATH SIN, V32, P286, DOI 10.1007/s10114-016-4749-3
   Elsawah AM, 2015, STAT PROBABIL LETT, V104, P123, DOI 10.1016/j.spl.2015.05.007
   Elsawah AM, 2015, STAT PROBABIL LETT, V103, P116, DOI 10.1016/j.spl.2015.04.020
   Elsawah AM, 2015, J STAT PLAN INFER, V161, P1, DOI 10.1016/j.jspi.2014.12.007
   Elsawah AM, 2015, STAT PROBABIL LETT, V96, P273, DOI 10.1016/j.spl.2014.09.027
   Elsawah AM, 2014, STAT PROBABIL LETT, V93, P65, DOI 10.1016/j.spl.2014.06.008
   Elsawah AM, 2016, COMPUT STAT
   Elsawah AM, 2016, COMMUN STAT THEORY M
   Elsawah AM, 2016, J APP STAT
   Elsawah AM, 2016, J KOREAN STAT SOC
   Fang KT, 2006, MATH COMPUT, V75, P859, DOI 10.1090/S0025-5718-05-01806-5
   Fang KT, 2000, BIOMETRIKA, V87, P193, DOI 10.1093/biomet/87.1.193
   Fang KT, 2003, STAT PROBABIL LETT, V62, P245, DOI 10.1016/S0167-7152(03)00008-7
   Fang KT, 2002, MONTE CARLO QUASIMON
   Hickernell FJ, 1998, MATH COMPUT, V67, P299, DOI 10.1090/S0025-5718-98-00894-1
   Hickernell FJ, 1998, LECT NOTES STAT, V138, P109
   Ke X, 2015, J COMPLEXITY
   Lei Yi Ju, 2012, Acta Mathematica Sinica. English Series, V28, P793
   [雷轶菊 Lei Yiju], 2010, [数学物理学报. A辑, Acta Mathematica Scientia], V30, P1555
   Li PF, 2005, METRIKA, V61, P127, DOI 10.1007/s001840400327
   Li W, 2003, TECHNOMETRICS, V45, P142, DOI 10.1198/004017003188618779
   Montgomery DC, 1996, QUAL TECHNOL, V28, P446
   Ou ZJ, 2015, SCI CHINA MATH, V58, P1537, DOI 10.1007/s11425-014-4936-6
   Ou ZJ, 2014, COMMUN STAT-THEOR M, V43, P2274, DOI 10.1080/03610926.2013.776082
   Ou ZJ, 2011, METRIKA, V74, P109, DOI 10.1007/s00184-009-0292-x
   Wang B, 2010, J STAT PLAN INFER, V140, P1497, DOI 10.1016/j.jspi.2009.12.011
   Zhang QH, 2015, STAT PROBABIL LETT, V96, P133, DOI 10.1016/j.spl.2014.08.023
   Zhou YD, 2008, STAT PROBABIL LETT, V78, P1933, DOI 10.1016/j.spl.2008.01.062
   Zhou YD, 2013, J COMPLEXITY, V29, P283, DOI 10.1016/j.jco.2012.11.006
   Zou N, 2009, STAT PROBABIL LETT, V79, P496, DOI 10.1016/j.spl.2008.09.022
NR 34
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0233-1888
EI 1029-4910
J9 STATISTICS-ABINGDON
JI Statistics
PD JUN
PY 2017
VL 51
IS 3
BP 532
EP 557
DI 10.1080/02331888.2016.1240682
PG 26
WC Statistics & Probability
SC Mathematics
GA ES4EE
UT WOS:000399481400003
OA No
DA 2017-08-17
ER

PT J
AU Abd Elgawad, MA
   Barakat, HM
   Qin, H
   Yan, T
AF Abd Elgawad, M. A.
   Barakat, H. M.
   Qin, Hong
   Yan, Ting
TI Limit theory of bivariate dual generalized order statistics with random
   index
SO STATISTICS
LA English
DT Article
DE Weak convergence; sample of random size; bivariate dual generalized
   order statistics; Primary: 62E20; Secondary: 62E15; 62G30
ID RANDOM-VARIABLES; RANDOM NUMBER; EXTREMES
AB The class of limit distribution functions of bivariate extreme, intermediate and central dual generalized order statistics from independent and identically distributed random variables with random sample size is fully characterized. Two cases are considered. The first case is when the random sample size is assumed to be independent of all basic random variables. The second case is when the interrelation of the random size and the basic random variables is not restricted.
C1 [Abd Elgawad, M. A.; Qin, Hong; Yan, Ting] Cent China Normal Univ, Sch Math & Stat, Wuhan 430079, Peoples R China.
   [Abd Elgawad, M. A.] Benha Univ, Dept Math, Fac Sci, Banha, Egypt.
   [Barakat, H. M.] Zagazig Univ, Dept Math, Fac Sci, Zagazig, Egypt.
RP Abd Elgawad, MA (reprint author), Cent China Normal Univ, Sch Math & Stat, Wuhan 430079, Peoples R China.
EM mohamed_salem240@yahoo.com
CR Barakat HM, 2014, ALEA-LAT AM J PROBAB, V11, P331
   BARAKAT HM, 1990, J STAT PLAN INFER, V26, P353, DOI 10.1016/0378-3758(90)90137-J
   Barakat HM, 1997, J STAT PLAN INFER, V61, P203, DOI 10.1016/S0378-3758(96)00157-7
   Barakat HM, 2015, J PROBAB MATH STAT, V35, P267
   Barakat HM, 2004, B MALAYS MATH SCI SO, V27, P169
   Barakat HM, 1996, B MALAYSIAN MATH SOC, V19, P39
   Barakat HM, 1989, 14 INT C STAT COMP D, P107
   Burkschat M., 2003, METRON, V61, P13
   Chibisov D. M., 1964, THEOR PROBAB APPL, V9, P142, DOI DOI 10.1137/1109021
   Dziubdziela W, 1972, APPL MATH, V13, P199
   Feller W., 1979, INTRO PROBABILITY TH, V2
   GALAMBOS J, 1973, J APPL PROBAB, V10, P122, DOI 10.2307/3212500
   Galambos J., 1987, ASYMPTOTIC THEORY EX
   GNEDENKO BV, 1982, DOKL AKAD NAUK SSSR+, V267, P1039
   Gnedenko BV, 1982, SERDIKA BOLGARSKA MA, V8, P229
   Kamps U., 1995, CONCEPT GEN ORDER ST
   Lebedev N. N., 1965, SPECIAL FUNCTIONS TH
   BarndorffNielsen O., 1964, ACTA MATH AKAD SCI H, V15, P399, DOI [10.1007/BF01897148, DOI 10.1007/BF01897148]
   Smirnov NV, 1952, T AM MATH SOC, V11, P82
NR 19
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0233-1888
EI 1029-4910
J9 STATISTICS-ABINGDON
JI Statistics
PD JUN
PY 2017
VL 51
IS 3
BP 572
EP 590
DI 10.1080/02331888.2016.1265965
PG 19
WC Statistics & Probability
SC Mathematics
GA ES4EE
UT WOS:000399481400005
OA No
DA 2017-08-17
ER

PT J
AU Elkhadragy, MF
   Moneim, AEA
AF Elkhadragy, Manal F.
   Moneim, Ahmed E. Abdel
TI Protective effect of Fragaria ananassa methanolic extract on cadmium
   chloride (CdCl2)-induced hepatotoxicity in rats
SO TOXICOLOGY MECHANISMS AND METHODS
LA English
DT Article
DE Fragaria ananassa; cadmium chloride; oxidative stress; apoptosis; liver
ID OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; INDUCED APOPTOSIS; TOXICITY;
   MICE; ANTIOXIDANT; CYTOTOXICITY; INVOLVEMENT; KIDNEYS; PATHWAY
AB This study investigated the protective effect of Fragaria ananassa methanolic extract on cadmium chloride (CdCl2)-induced hepatotoxicity in rats. CdCl2 was intraperitoneally injected at a dose of 6.5mg/kg of body weight for 5 d with or without methanol extract of Fragaria ananassa (250mg/kg). The hepatic cadmium concentration, lipid peroxidation, nitric oxide, glutathione (GSH) content, and antioxidant enzyme activities, including superoxide dismutase, catalase (CAT), GSH peroxidase, and GSH reductase, were estimated. CdCl2 injection induced a significant elevation in cadmium concentration, lipid peroxidation, and nitric oxide and caused a significant depletion in GSH content compared to controls, along with a remarkable decrease in antioxidant enzymes. Oxidative stress induction and cadmium accumulation in the liver were successfully ameliorated by F. ananassa (strawberry) pre-administration. In addition, the pre-administration of strawberry decreased the elevated gene expression of the pro-apoptotic Bax gene as well as the protein expression of caspases-3 in the liver of CdCl2-injected rats. In addition, the reduced gene expression of anti-apoptotic Bcl-2 was increased. Our results show an increase in the expression of tumor necrosis factor in the liver of rats treated with cadmium. In sum, our results suggested that F. ananassa successfully prevented deleterious effects on liver function by reinforcing the antioxidant defense system, inhibiting oxidative stress and reducing apoptosis.
C1 [Elkhadragy, Manal F.] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia.
   [Elkhadragy, Manal F.; Moneim, Ahmed E. Abdel] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt.
RP Elkhadragy, MF; Moneim, AEA (reprint author), Helwan Univ, Dept Zool & Entomol, Cairo, Egypt.
EM manalelkhadragy@yahoo.com; aest1977@hotmail.com
FU Research Center of the Center for Female Scientific and Medical
   Colleges, King Saud University
FX This research project was supported by a grant from the "Research Center
   of the Center for Female Scientific and Medical Colleges, Deanship of
   Scientific Research, King Saud University".
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Afolabi OK, 2012, EXCLI J, V11, P677
   ARROYO VS, 2012, DRUG METAB TOXICOL, V5, P1
   BELFIELD A, 1971, ENZYME, V12, P561
   Ben PL, 2015, NEUROCHEM RES, V40, P1661, DOI 10.1007/s11064-015-1648-4
   Chang KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054374
   De Vega L, 2002, RENAL FAILURE, V24, P421, DOI 10.1081/JDI-120006769
   DECKER T, 1989, J LEUKOCYTE BIOL, V45, P139
   Dkhil MA, 2014, FOOD CHEM TOXICOL, V74, P98, DOI 10.1016/j.fct.2014.09.013
   El-Habit OH, 2014, BIOL TRACE ELEM RES, V159, P364, DOI 10.1007/s12011-014-0016-6
   El-Refaiy AI, 2013, SAUDI J BIOL SCI, V20, P265, DOI 10.1016/j.sjbs.2013.02.004
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Giampieri F, 2014, FOOD FUNCT, V5, P1939, DOI [10.1039/c4fo00048j, 10.1039/C4FO00048J]
   Giampieri F, 2012, J AGR FOOD CHEM, V60, P2322, DOI 10.1021/jf205065x
   Giampieri F, 2012, NUTRITION, V28, P9, DOI 10.1016/j.nut.2011.08.009
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Hamed SS, 2016, FRONT PHYSIOL, V7, DOI [10.3389/fphys.2016.00325, 10.33989/fphys.2016.00325]
   Haouem S, 2013, J TOXICOL PATHOL, V26, P359, DOI 10.1293/tox.2013-0025
   Hwang DF, 2001, TOXICOLOGY, V167, P173, DOI 10.1016/S0300-483X(01)00472-3
   Ibrahim DS, 2015, INT J EXP PATHOL, V96, P87, DOI 10.1111/iep.12116
   Kumar S., 2013, SCI WORLD J, V2013, P16, DOI DOI 10.1155/2013/162750
   Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI 10.1089/ARS.2009.2695
   Moneim AEA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158965
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Olszowski T, 2012, ACTA BIOCHIM POL, V59, P475
   Packer L, 1993, N Y ACAD SCI, V691, P48
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pari L, 2005, ENVIRON TOXICOL PHAR, V20, P493, DOI 10.1016/j.etap.2005.05.009
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56
   Schmidt M, 1975, Fortschr Med, V93, P1461
   Skrovankova S, 2015, INT J MOL SCI, V16, P24673, DOI 10.3390/ijms161024673
   Stosic J, 2010, BIOMED ENVIRON SCI, V23, P293, DOI 10.1016/S0895-3988(10)60066-9
   Tandon SK, 2001, FOOD CHEM TOXICOL, V39, P571, DOI 10.1016/S0278-6915(00)00167-8
   Thijssen S, 2007, TOXICOLOGY, V236, P29, DOI 10.1016/j.tox.2007.03.022
   USGS, 2008, MINERAL COMMODITY SU
   Van De V., 2013, FOODS, V2, P120
   Wang J, 2015, RSC ADV, V5, P31798, DOI 10.1039/c5ra03210e
   Yazihan N, 2011, ANADOLU KARDIYOL DER, V11, P479, DOI 10.5152/akd.2011.130
   Zhai QX, 2013, APPL ENVIRON MICROB, V79, P1508, DOI 10.1128/AEM.03417-12
NR 40
TC 2
Z9 2
U1 7
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1537-6516
EI 1537-6524
J9 TOXICOL MECH METHOD
JI Toxicol. Mech. Methods
PD JUN
PY 2017
VL 27
IS 5
BP 335
EP 345
DI 10.1080/15376516.2017.1285973
PG 11
WC Toxicology
SC Toxicology
GA ES4VC
UT WOS:000399532500002
PM 28110594
OA No
DA 2017-08-17
ER

PT J
AU Hamed, SM
   Zinta, G
   Klock, G
   Asard, H
   Selim, S
   AbdElgawad, H
AF Hamed, Seham M.
   Zinta, Gaurav
   Kloeck, Gerd
   Asard, Han
   Selim, Samy
   AbdElgawad, Hamada
TI Zinc-induced differential oxidative stress and antioxidant responses in
   Chlorella sorokiniana and Scenedesmus acuminatus
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Green microalgae; Zinc; Oxidative stress; Antioxidants; Zinc
   detoxification
ID LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; GREEN-ALGA; GROWTH; TOLERANCE;
   VULGARIS; REMOVAL; MODULATION; SENESCENCE; CATALASE
AB Algae are frequently exposed to toxic metals, and zinc (Zn) is one of the major toxicants present. We exposed two green microalgae, Chlorella sorokiniana and Scenedesmus acuminatus, to sub-lethal concentrations (1.0 and 0.6 mM) of Zn for seven days. Algal responses were analysed at the level of growth, oxidative stress, and antioxidants. Growth parameters such as cell culture yield and pigment content were less affected by Zn in C. sorokiniana, despite the fact that this alga accumulated more zinc than S. acuminous. Also, C. sorokiniana, but not S. acuminatus, was able to acclimatize during long-term exposure to toxic concentrations of the test metals (specific growth rate (mu) was 0.041/day and total chlorophyll was 14.6 mg/mL). Although, Zn induced oxidative stress in both species, C. sorokiniana experienced less stress than S. acuminatus. This could be explained by a higher accumulation of antioxidants in C. sorokiniana, where flavonoids, polyphenols, tocopherols, glutathione (GSH) and ascorbate (ASC) content increased. Moreover, antioxidant enzymes glutathione S transferase (GST), glutathione reductase (GR), superoxide dismutase (SOD), peroxidase (PDX) and ascorbate peroxidase (APX), showed increased activities in C. sorokiniana. In addition to, and probably also underlying, the higher Zn tolerance in C. sorokiniana, this alga also showed higher Zn biosorption capacity. Use of C. sorokiniana as a bioremediator, could be considered.
C1 [Hamed, Seham M.] Soils Water & Environm Res Inst, Agr Res Ctr, Dept Soil Microbiol, Giza, Egypt.
   [Zinta, Gaurav; Asard, Han; AbdElgawad, Hamada] Univ Antwerp, Dept Biol, Integrated Mol Plant Physiol Res, Antwerp, Belgium.
   [Zinta, Gaurav] Univ Antwerp, Ctr Excellence PLECO Plant & Vegetat Ecol, Dept Biol, Antwerp, Belgium.
   [Kloeck, Gerd] Univ Appl Sci, Hsch Bremen, Bremen, Germany.
   [Selim, Samy] Aljouf Univ, Coll Appl Med Sci, Dept Clin Lab Sci, POB 41522, Sakaka, Saudi Arabia.
   [Selim, Samy] Suez Canal Univ, Fac Sci, Microbiol & Bot Dept, POB 41522, Ismailia, Egypt.
   [AbdElgawad, Hamada] Univ Beni Suef, Fac Sci, Dept Bot & Microbiol, Bani Suwayf 62511, Egypt.
   [Zinta, Gaurav] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.
RP Hamed, SM (reprint author), Soils Water & Environm Res Inst, Agr Res Ctr, Dept Soil Microbiol, Giza, Egypt.; AbdElgawad, H (reprint author), Univ Antwerp, Dept Biol, Integrated Mol Plant Physiol Res, Antwerp, Belgium.
EM seham_moussa939@yahoo.com; hamada.abdelgawad@uantwerpen.be
FU Research Council of the University of Antwerp [GOA-BOF-UA2007]; Flemish
   Science Foundation as Concerted Research project (FWO) [GOD0514N];
   Deanship of Scientific Research (DSR); Aljouf University, Aljouf, KSA;
   Methusalem Funding to the Centre of Excellence PLECO, University of
   Antwerp
FX Authors acknowledge the support of the Research Council of the
   University of Antwerp as concerted research project (GOA-BOF-UA2007),
   and Flemish Science Foundation as Concerted Research project (FWO,
   GOD0514N). Dr. Samy also acknowledge Deanship of Scientific Research
   (DSR), Aljouf University, Aljouf, KSA, for technical and financial
   support. GZ acknowledges support from Methusalem Funding to the Centre
   of Excellence PLECO, University of Antwerp.
CR AbdElgawad H., 2015, NEW PHYTOL
   AbdElgawad H, 2015, PLANT SCI, V231, P1, DOI 10.1016/j.plantsci.2014.11.001
   Akhtar N, 2008, J ENVIRON SCI-CHINA, V20, P231, DOI 10.1016/S1001-0742(08)60036-4
   Arroyo T. H., 2011, BIOMOSS BIOENERG, V35, P2245
   Bacsi I, 2015, INT J ENVIRON SCI TE, V12, P2455, DOI 10.1007/s13762-014-0647-3
   Benzie I. F., 1999, METHOD ENZYMOL, V299, P15
   Chang CC, 2002, J FOOD DRUG ANAL, V10, P178
   Choudhary M, 2007, ECOTOX ENVIRON SAFE, V66, P204, DOI 10.1016/j.ecoenv.2006.02.002
   De Filippis L. F., 1994, ALGAE WATER POLLUTIO, P31
   DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93
   Dietz KJ, 1999, HEAVY METAL STRESS P, P73
   Dinesh K. S., 2014, INT J FISH AQUAC, V6, P1
   Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016
   Guillard R.R, 1973, HDB PHYCOLOGICAL MET, V1, P289
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Halliwell B, 1999, FREE RADICAL BIO MED, P936
   Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524
   JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N
   KUMAR KB, 1982, INDIAN J EXP BIOL, V20, P412
   Li M, 2006, CHEMOSPHERE, V62, P565, DOI 10.1016/j.chemosphere.2005.06.029
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MacKinney G, 1941, J BIOL CHEM, V140, P315
   Murshed R, 2008, ANAL BIOCHEM, V383, P320, DOI 10.1016/j.ab.2008.07.020
   Murugan K, 2007, INDIAN J EXP BIOL, V45, P980
   Nishikawa K, 2001, BIOSCI BIOTECH BIOCH, V65, P2650, DOI 10.1271/bbb.65.2650
   Nowicka B, 2016, ECOTOX ENVIRON SAFE, V130, P133, DOI 10.1016/j.ecoenv.2016.04.010
   Okamoto OK, 2001, ARCH ENVIRON CON TOX, V40, P18
   Omar HH, 2002, BIOL PLANTARUM, V45, P261, DOI 10.1023/A:1015157009150
   Ouyang HL, 2012, CHINESE SCI BULL, V57, P3363, DOI 10.1007/s11434-012-5366-x
   Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x
   Pise NM, 2013, ACTA BOT CROAT, V72, P197, DOI 10.2478/v10184-012-0024-6
   Potters G, 2004, PLANT PHYSIOL, V134, P1479, DOI 10.1104/pp.103.033548
   Sabatini SE, 2009, ECOTOX ENVIRON SAFE, V72, P1200, DOI 10.1016/j.ecoenv.2009.01.003
   Shilip G., 2014, INT J PHARM PHARM SC, V7, P9
   Soto P, 2011, LAT AM J AQUAT RES, V39, P280, DOI 10.3856/vol39-issue2-fulltext-9
   Suman TY, 2015, ECOTOX ENVIRON SAFE, V113, P23, DOI 10.1016/j.ecoenv.2014.11.015
   Travieso L, 1999, B ENVIRON CONTAM TOX, V62, P144
   Tripathi BN, 2006, CHEMOSPHERE, V62, P538, DOI 10.1016/j.chemosphere.2005.06.031
   Venrick E. L., 1978, PHYTOPLANKTON MANUAL, P67
   Wang TC, 1995, BIOREMED SER, V3, P65
   Weckx JEJ, 1997, PLANT PHYSIOL BIOCH, V35, P405
   Zhang Q, 2006, J APPL PHYCOL, V18, P445, DOI 10.1007/s10811-006-9048-4
   Novak Z, 2014, B ENVIRON CONTAM TOX, V93, P676, DOI 10.1007/s00128-014-1374-7
   Zouari M, 2016, ECOTOX ENVIRON SAFE, V128, P195, DOI 10.1016/j.ecoenv.2016.02.024
   NAGALAKSHMI N, 2001, Patent No. 160291
NR 45
TC 0
Z9 0
U1 22
U2 22
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD JUN
PY 2017
VL 140
BP 256
EP 263
DI 10.1016/j.ecoenv.2017.02.055
PG 8
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA ER4HN
UT WOS:000398759800035
PM 28273625
OA No
DA 2017-08-17
ER

PT J
AU Obaida, M
   Galdun, L
   Ryba, T
   Komanicky, V
   Saksl, K
   Durisin, M
   Kovac, J
   Haskova, V
   Szabo, P
   Vargova, Z
   Varga, R
AF Obaida, M.
   Galdun, L.
   Ryba, T.
   Komanicky, V.
   Saksl, K.
   Durisin, M.
   Kovac, J.
   Haskova, V.
   Szabo, P.
   Vargova, Z.
   Varga, R.
TI Spin polarization in Cu2MnSn Heusler alloy produced by melt-spinning
SO INTERMETALLICS
LA English
DT Article
DE Heusler alloys; Spin polarization; Rapid quenching
ID MAGNETIC-PROPERTIES; TRANSPORT-PROPERTIES; HALF-METALLICITY;
   POINT-CONTACT; MN; METAL; GE; SN
AB We report on magnetism, transport and spin polarization characteristics of the melt-spun Cu2MnSn alloy prepared by the rapid quenching technique. The as-cast ribbons showed a relatively well ordered chemical composition (Cu = 50.4%, Mn = 27.1%, Sn = 22.5%). The structural characterization by using X-ray diffraction shows L2(1)/B2 crystalline structure with the lattice parameter alpha = 6.196 angstrom. The magnetic and transport measurements show a metallic behavior with the Curie temperature of 530 K and reveal anisotropic character with the easy magnetization plane parallel with respect to the ribbon plane. As-cast Cu2MnSn ribbons show the spin polarization measured by using Andreev reflection technique within the range 68-75%. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Obaida, M.] Natl Res Ctr, Dept Solid State Phys, 33 El Bohouth St Former El Tahrir St, Giza 12622, Egypt.
   [Obaida, M.; Galdun, L.; Ryba, T.; Komanicky, V.; Haskova, V.; Varga, R.] Safarik Univ, Fac Sci, Inst Phys, Pk Angelinum, Kosice 04154, Slovakia.
   [Saksl, K.; Durisin, M.] IMR SAS, Watsonova 47, Kosice 04001, Slovakia.
   [Kovac, J.; Haskova, V.; Szabo, P.] IEF SAS, Watsonova 47, Kosice 04001, Slovakia.
   [Vargova, Z.] Safarik Univ, Fac Sci, Inst Chem, Pk Angelinum 9, Kosice, Slovakia.
RP Varga, R (reprint author), Safarik Univ, Fac Sci, Inst Phys, Pk Angelinum, Kosice 04154, Slovakia.
EM rastislav.varga@upjs.sk
RI Varga, Rastislav/D-1601-2017
FU Slovak Academic Information Agency (SAIA) under National Scholarship
   program; NanoCEXmat Project [ITMS 26220120019]; Extrem1 project [ITMS
   26220120005]; COST action [MP1201]; U.S. Steel Kosice; Slovak Grant
   Agency VEGA [1/0164/16]; VEGA [2/0149/16, 1/0409/15]; Slovak Grant
   Agency APVV [APVV-0027-11, APVV-0605-14, APVV-0036-11]
FX M. Obaida would like to acknowledge the grant from Slovak Academic
   Information Agency (SAIA) under National Scholarship program. This work
   was supported partially by the NanoCEXmat Project under Grant ITMS
   26220120019, Extrem1 project under Grant ITMS 26220120005 and the COST
   action MP1201 aswell as by the U.S. Steel Kosice. Also part of the
   project was supported by Slovak Grant Agency VEGA under Grants
   1/0164/16, VEGA 2/0149/16 and VEGA 1/0409/15 and Slovak Grant Agency
   APVV under Grants APVV-0027-11, APVV-0605-14 and APVV-0036-11.
CR Ahmadian F, 2013, J ALLOY COMPD, V576, P279, DOI 10.1016/j.jallcom.2013.04.159
   Bainsla L, 2016, CURR APPL PHYS, V16, P68, DOI 10.1016/j.cap.2015.09.015
   Bombor D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.066601
   Buschow K.H.J., 2013, HDB MAGNETIC MAT
   CHEKIN VV, 1967, SOV PHYS JETP-USSR, V24, P472
   COLES BR, 1949, PROC R SOC LON SER-A, V196, P125, DOI 10.1098/rspa.1949.0019
   DEGROOT RA, 1983, PHYS REV LETT, V50, P2024, DOI 10.1103/PhysRevLett.50.2024
   DUBIEL SM, 1980, PHYS REV B, V21, P1735, DOI 10.1103/PhysRevB.21.1735
   DUNLAP RA, 1983, SOLID STATE COMMUN, V45, P67, DOI 10.1016/0038-1098(83)90342-3
   ENDO K, 1964, J PHYS SOC JPN, V19, P1494
   FENANDER NG, 1968, J PHYS CHEM SOLIDS, V29, P1973, DOI 10.1016/0022-3697(68)90047-4
   Feng Y, 2015, J MAGN MAGN MATER, V387, P118, DOI 10.1016/j.jmmm.2015.04.002
   Galanakis I, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.174429
   Graf T, 2011, PROG SOLID STATE CH, V39, P1, DOI 10.1016/j.progsolidstchem.2011.02.001
   Heusler F., 1903, Verhandlungen der Deutschen Physikalischen Gesellschaft, V5
   Hirohata A, 2006, CURR OPIN SOLID ST M, V10, P93, DOI 10.1016/j.cossms.2006.11.006
   Ji Y, 2001, PHYS REV LETT, V86, P5585, DOI 10.1103/PhysRevLett.86.5585
   Kandpal HC, 2007, J PHYS D APPL PHYS, V40, P1507, DOI 10.1088/0022-3727/40/6/S01
   Kant CH, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.212403
   KUBLER J, 1983, PHYS REV B, V28, P1745, DOI 10.1103/PhysRevB.28.1745
   Liu GD, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014424
   Mori H, 2012, THIN SOLID FILMS, V520, P4979, DOI 10.1016/j.tsf.2012.03.045
   Mukhopadhyay S, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2979687
   Nazmunnahar M, 2015, J MAGN MAGN MATER, V386, P98, DOI 10.1016/j.jmmm.2015.03.066
   Obaida M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.184416
   PLECENIK A, 1994, PHYS REV B, V49, P10016, DOI 10.1103/PhysRevB.49.10016
   Prathiba G, 2011, J MAGN MAGN MATER, V323, P22, DOI 10.1016/j.jmmm.2010.08.005
   Sasioglu E, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064417
   Segnan R., 1971, J PHYS COLLOQ, V32, pC1, DOI 10.1051/jphyscol:19711278
   Sharma V, 2010, J MAGN MAGN MATER, V322, P2922, DOI 10.1016/j.jmmm.2010.05.006
   Slater JC, 1930, PHYS REV, V36, P0057, DOI 10.1103/PhysRev.36.57
   Soulen RJ, 1998, SCIENCE, V282, P85, DOI 10.1126/science.282.5386.85
   Strijkers GJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.104510
   TAYLOR RC, 1982, SOLID STATE COMMUN, V41, P503, DOI 10.1016/0038-1098(82)90535-X
   TENHOVER M, 1980, J MAGN MAGN MATER, V20, P158, DOI 10.1016/0304-8853(80)90453-9
   UHL E, 1981, J MAGN MAGN MATER, V25, P221, DOI 10.1016/0304-8853(81)90123-2
   Wang L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.144402
   WEBSTER PJ, 1969, CONTEMP PHYS, V10, P559, DOI 10.1080/00107516908204800
   Williams J.M., 1971, J PHYS-PARIS, V32, pC1, DOI 10.1051/jphyscol:19711277
   YOSIDA K, 1957, PHYS REV, V106, P893, DOI 10.1103/PhysRev.106.893
   ZENER C, 1951, PHYS REV, V81, P440, DOI 10.1103/PhysRev.81.440
NR 41
TC 0
Z9 0
U1 16
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-9795
EI 1879-0216
J9 INTERMETALLICS
JI Intermetallics
PD JUN
PY 2017
VL 85
BP 139
EP 143
DI 10.1016/j.intermet.2017.02.014
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA ES2TQ
UT WOS:000399381200018
OA No
DA 2017-08-17
ER

PT J
AU Al Rez, MF
   Binobaid, A
   Alghosen, A
   Mirza, EH
   Alam, J
   Fouad, H
   Hashem, M
   Alsalman, H
   Almalak, HM
   Mahmood, A
   Moussa, I
   Al-Jassir, FF
AF Al Rez, Mohammed Fayez
   Binobaid, Abdullah
   Alghosen, Abdulmajeed
   Mirza, Eraj Humayun
   Alam, Javed
   Fouad, H.
   Hashem, Mohamed
   Alsalman, Hussain
   Almalak, Hassan Mohammed
   Mahmood, Amer
   Moussa, Ihab
   Al-Jassir, Fawzi F.
TI Tubular Poly(epsilon-caprolactone)/Chitosan Nanofibrous Scaffold
   Prepared by Electrospinning for Vascular Tissue Engineering Applications
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE PCL/CS Tubular Scaffold; Nanofibrous Scaffold; Electrospinning; Vascular
   Tissue Engineering; HUVEC; Cell Culture
ID POLYCAPROLACTONE/CHITOSAN; BIODEGRADABILITY; BLENDS; CELLS
AB Over the years, cardiovascular diseases have been a real life-threatening condition that causes mortality to a lot of people around the globe. The immediate need for a proper treatment encouraged scientists to develop vascular grafts to be used as a solution. However, these vascular grafts tend to show some drawbacks which led the scientists to introduce the field of vascular tissue engineering to overcome the problem. In this study, we emphasized the use of tubular nanofibrous scaffold that is a blend of the synthetic polyester Poly(epsilon-caprolactone) (PCL) and the natural polysaccharide Chitosan (CS). PCL/CS scaffold was fabricated by electrospinning technique. Several tests were performed to evaluate physical, mechanical and morphological properties of PCL/CS scaffolds such as Tensile Test, Atomic Force Microscope (AFM), Scanning Electron Microscope (SEM), and Fourier Transform Infrared Spectroscopy (FTIR). Furthermore, Differential Scanning Calorimetric (DSC) and Thermogravimetric Analysis (TGA) were also performed. We investigated whether this scaffold would be able to support cell attachment and proliferation and become part of a blood vessel. This was done by seeding and culturing Human Umbilical Vein Endothelial Cells (HUVEC) onto the scaffold under feasible conditions. We demonstrated that PCL/CS scaffold does support HUVEC cell attachment, growth and long term proliferation. Given the results of these tests and the biocompatibility of the PCL/CS tubular nanofibrous scaffolds, we found that the blended PCL/CS scaffold has promising properties to be used as a replacement in the blood vessel applications.
C1 [Al Rez, Mohammed Fayez; Binobaid, Abdullah; Alghosen, Abdulmajeed; Mirza, Eraj Humayun; Fouad, H.] King Saud Univ, Biomed Technol Dept, Coll Appl Med Sci, Riyadh 11466, Saudi Arabia.
   [Al Rez, Mohammed Fayez; Binobaid, Abdullah; Alghosen, Abdulmajeed; Mirza, Eraj Humayun; Fouad, H.] King Saud Univ, King Abdullah Inst Nanotechnol, POB 2455, Riyadh 11451, Saudi Arabia.
   [Alam, Javed] Helwan Univ, Biomed Engn Dept, Fac Engn, POB 11792, Helwan, Egypt.
   [Fouad, H.] King Saud Univ, Dent Hlth Dept, Coll Appl Med Sci, Riyadh 11437, Saudi Arabia.
   [Hashem, Mohamed] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11437, Saudi Arabia.
   [Alsalman, Hussain; Almalak, Hassan Mohammed; Mahmood, Amer] King Khalid Univ Hosp, Riyadh 11437, Saudi Arabia.
   [Moussa, Ihab] King Saud Univ, Sch Dent, Riyadh 11437, Saudi Arabia.
   [Al-Jassir, Fawzi F.] King Saud Univ, Coll Med, FRCSC, Riyadh 11461, Saudi Arabia.
   [Al-Jassir, Fawzi F.] King Saud Univ, Orthoped Surg Res Chair, Riyadh 11461, Saudi Arabia.
RP Al Rez, MF (reprint author), King Saud Univ, King Abdullah Inst Nanotechnol, POB 2455, Riyadh 11451, Saudi Arabia.
FU King Saud University, Vice Deanship of Research Chairs
FX The paper was financially supported by King Saud University, Vice
   Deanship of Research Chairs.
CR Al Rez MF, 2015, SCI ADV MATER, V7, P2427, DOI 10.1166/sam.2015.2422
   Athira K., 2014, J POLYM BIOPOLYM PHY, V2, P62
   Bai MY, 2013, MAT SCI ENG C-MATER, V33, P224, DOI 10.1016/j.msec.2012.08.034
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043
   Cardoso G. B., 2014, BIOMATTER, V4, DOI DOI 10.4161/BIOM.29508
   Chen HL, 2011, INT J NANOMED, V6, P453, DOI 10.2147/IJN.S17057
   Cooper A, 2011, CARBOHYD POLYM, V85, P149, DOI 10.1016/j.carbpol.2011.02.008
   Du FY, 2012, BIOMATERIALS, V33, P762, DOI 10.1016/j.biomaterials.2011.10.037
   Ghorbani FM, 2015, CARBOHYD POLYM, V118, P133, DOI 10.1016/j.carbpol.2014.10.071
   Gupta Kailash Chandra, 2014, Biomater Res, V18, P5, DOI 10.1186/2055-7124-18-5
   Hasan M.M., 2014, INT J TEXT SCI, V3, P39
   Hild M, 2015, AUTEX RES J, V15, P54, DOI [10.2478/aut-2015-0016, 10.1515/aut-2015-0016]
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Malheiro VN, 2010, ACTA BIOMATER, V6, P418, DOI 10.1016/j.actbio.2009.07.012
   Mirza EH, 2015, DIG J NANOMATER BIOS, V10, P415
   Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073
   Roozbahani F, 2015, J NANOMATER, DOI 10.1155/2015/747420
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Sasmazel HT, 2011, INT J BIOL MACROMOL, V49, P838, DOI 10.1016/j.ijbiomac.2011.07.022
   Shalumon KT, 2011, INT J BIOL MACROMOL, V48, P571, DOI 10.1016/j.ijbiomac.2011.01.020
   Shalumon KT, 2010, CARBOHYD POLYM, V80, P413, DOI 10.1016/j.carbpol.2009.11.039
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   Van der Schueren L, 2013, CARBOHYD POLYM, V91, P284, DOI 10.1016/j.carbpol.2012.08.003
   Wan Y, 2008, POLYM DEGRAD STABIL, V93, P1736, DOI 10.1016/j.polymdegradstab.2008.08.001
   Wan Y, 2009, J MATER SCI-MATER M, V20, P719, DOI 10.1007/s10856-008-3622-z
   Wei SY, 2013, HIGH PERFORM POLYM, V25, P25, DOI 10.1177/0954008312454152
   Wu CS, 2005, POLYMER, V46, P147, DOI 10.1016/j.polymer.2004.11.013
   Wu H, 2008, MATER LETT, V62, P2733, DOI 10.1016/j.matlet.2008.01.029
NR 30
TC 0
Z9 0
U1 32
U2 32
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD JUN
PY 2017
VL 7
IS 6
BP 427
EP 436
DI 10.1166/jbt.2017.1593
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA ER6QE
UT WOS:000398930300001
OA No
DA 2017-08-17
ER

PT J
AU Khalil, RM
   Abdelbary, GA
   Basha, M
   Awad, GEA
   El-Hashemy, HA
AF Khalil, Rawia M.
   Abdelbary, Ghada A.
   Basha, Mona
   Awad, Ghada E. A.
   El-Hashemy, Hadeer A.
TI Design and evaluation of proniosomes as a carrier for ocular delivery of
   lomefloxacin HCl
SO JOURNAL OF LIPOSOME RESEARCH
LA English
DT Article
DE Conjunctivitis; lomefloxacin HCl; microbiological evaluation; ocular
   delivery; proniosomes
ID DRUG-DELIVERY; VESICLES NIOSOMES; LIPID EMULSION; SYSTEM; FORMULATION;
   PERMEATION; RESISTANCE; LIPOSOMES; OPTIMIZATION; SURFACTANTS
AB The current investigation aims to develop and evaluate novel ocular proniosomal gels of lomefloxacin HCl (LXN); in order to improve its ocular bioavailability for the management of bacterial conjunctivitis. Proniosomes were prepared using different types of nonionic surfactants solely and as mixtures with Span 60. The formed gels were characterized for entrapment efficiency, vesicle size, and in vitro drug release. Only Span 60 was able to form stable LXN-proniosomal gel when used individually while the other surfactants formed gels only in combination with Span 60 at different ratios. The optimum proniosomal gel; P-LXN 7 (Span 60:Tween 60, 9:1) appeared as spherical shaped vesicles having high entrapment efficiency (>80%), appropriate vesicle size (187 nm) as well as controlled drug release over 12 h. Differential scanning calorimetry confirmed the amorphous nature of LXN within the vesicles. Stability study did not show any significant changes in entrapment efficiency or vesicle size after storage for 3 months at 4 degrees C. P-LXN 7 was found to be safe and suitable for ocular delivery as proven by the irritancy test. The antibacterial activity of P-LXN 7 evaluated using the susceptibility test and topical therapy of induced ocular conjunctivitis confirmed the enhanced antibacterial therapeutic efficacy of the LXN-proniosomal gel compared to the commercially available LXN eye drops.
C1 [Khalil, Rawia M.; Basha, Mona; El-Hashemy, Hadeer A.] Natl Res Ctr, Dept Pharmaceut Technol, Cairo, Egypt.
   [Abdelbary, Ghada A.] Cairo Univ, Dept Pharmaceut, Fac Pharm, Cairo, Egypt.
   [Awad, Ghada E. A.] Natl Res Ctr, Chem Nat & Microbial Prod Dept, Cairo, Egypt.
RP Khalil, RM (reprint author), Natl Res Ctr, Dept Pharmaceut Technol, Cairo, Egypt.
EM rawia_khalil@yahoo.com
OI awad, ghada/0000-0002-8973-091X
FU Egyptian National Research Centre, Cairo, Egypt
FX The authors report no declarations of interest. The authors would like
   to thank Egyptian National Research Centre, Cairo, Egypt, for financial
   support.
CR Abd-Elbary A, 2008, INT J PHARMACEUT, V357, P189, DOI 10.1016/j.ijpharm.2008.01.056
   Abdallah M, 2013, IJPSR, V4, P1757
   Abdel-Mottaleb MMA, 2011, DRUG DEV IND PHARM, V37, P178, DOI 10.3109/03639045.2010.502534
   Abdelbary GA, 2014, J LIPOSOME RES, V24, P1
   Abdelbary G, 2008, AAPS PHARMSCITECH, V9, P740, DOI 10.1208/s12249-008-9105-1
   Aboelwafa AA, 2010, AAPS PHARMSCITECH, V11, P1591, DOI 10.1208/s12249-010-9539-0
   Aldred KJ, 2014, BIOCHEMISTRY-US, V53, P1565, DOI 10.1021/bi5000564
   Ali Y, 2006, ADV DRUG DELIVER REV, V58, P1258, DOI 10.1016/j.addr.2006.07.022
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Ammar HO, 2011, INT J PHARMACEUT, V405, P142, DOI 10.1016/j.ijpharm.2010.11.003
   Attia SM, 2008, MUTAGENESIS, V23, P515, DOI 10.1093/mutage/gen045
   Beberok A, 2013, PHARMACOL REP, V65, P689
   Bibi S, 2011, INT J PHARMACEUT, V417, P138, DOI 10.1016/j.ijpharm.2010.12.021
   Comstock Timothy L, 2010, Clin Ophthalmol, V4, P215
   Deshpande JM, 2012, JPSBR, V2, P238
   Dhangar RK, 2014, J DRUG DELIV THERAP, V4, P182
   Di Colo G, 2002, EUR J PHARM BIOPHARM, V54, P193, DOI 10.1016/S0939-6411(02)00086-3
   Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537
   Ei-Laithy HM, 2011, EUR J PHARM BIOPHARM, V77, P43, DOI 10.1016/j.ejpb.2010.10.011
   Fang JY, 2001, INT J PHARM, V215, P91, DOI 10.1016/S0378-5173(00)00669-4
   Gao Y, 2013, BIOMED RES INT, DOI 10.1155/2013/136590
   GREGORIADIS G, 1993, DRUGS, V45, P15, DOI 10.2165/00003495-199345010-00003
   Gupta A, 2007, MOL PHARM, V4, P596, DOI 10.1021/mp0700110
   Gupta M, 2011, ARTIF CELL BLOOD SUB, V39, P376, DOI 10.3109/10731199.2011.611476
   Hao YM, 2002, INT J PHARM, V244, P73, DOI 10.1016/S0378-5173(02)00301-0
   He W, 2013, INT J PHARMACEUT, V458, P305, DOI 10.1016/j.ijpharm.2013.10.033
   Hu CJ, 2000, INT J PHARM, V206, P109, DOI 10.1016/S0378-5173(00)00513-5
   Junyaprasert VB, 2008, AAPS PHARMSCITECH, V9, P851, DOI 10.1208/s12249-008-9121-1
   Katara R, 2013, COLLOID SURFACE B, V103, P455, DOI 10.1016/j.colsurfb.2012.10.056
   Kaur IP, 2004, INT J PHARM, V269, P1, DOI 10.1016/j.ijpharm.2003.09.016
   KHAN KA, 1975, J PHARM PHARMACOL, V27, P48
   Knudsen KB, 2015, NANOMED-NANOTECHNOL, V11, P467, DOI 10.1016/j.nano.2014.08.004
   Krustev SZ, 2014, DRUG DEV IND PHARM, V40, P1459, DOI 10.3109/03639045.2013.828225
   Kumar K, 2012, PHARMAZIE, V67, P852, DOI 10.1691/ph.2012.1164
   Kumar R, 2014, COLLOID SURFACE B, V117, P82, DOI 10.1016/j.colsurfb.2014.02.007
   Lallemand F, 2012, J DRUG DELIV, V2012, DOI DOI 10.1155/2012/604204
   Lavergne A, 2011, J COLLOID INTERF SCI, V360, P645, DOI 10.1016/j.jcis.2011.04.110
   Li Q, 2014, EUR J PHARM SCI, V62, P115, DOI 10.1016/j.ejps.2014.05.020
   Liu SY, 2012, MACROMOL BIOSCI, V12, P608, DOI 10.1002/mabi.201100419
   Manosroi A, 2010, INT J PHARMACEUT, V392, P304, DOI 10.1016/j.ijpharm.2010.03.064
   Mohawed OAM, 2014, INT J PHARM PHARM SC, V6, P567
   Muzzalupo R, 2011, EUR J PHARM BIOPHARM, V79, P28, DOI 10.1016/j.ejpb.2011.01.020
   Nanjwade VK, 2012, INT J DRUG DEV RES, V4, P227
   Perini G, 1996, Boll Chim Farm, V135, P145
   PERRETT S, 1991, J PHARM PHARMACOL, V43, P154
   Ramkanth S, 2014, PAK J PHARM SCI, V27, P115
   Ruckmani K, 2010, AAPS PHARMSCITECH, V11, P1119, DOI 10.1208/s12249-010-9480-2
   Sato H., 1996, J JPN OPHTHALMOL SOC, V100, P513
   Sattar Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084045
   Tamilvanan S, 2004, EUR J PHARM BIOPHARM, V58, P357, DOI 10.1016/j.ejpb.2004.03.033
   Tang JL, 2013, BIOMACROMOLECULES, V14, P424, DOI 10.1021/bm301661w
   Thakur R, 2009, J DRUG TARGET, V17, P442, DOI 10.1080/10611860902963039
   UCHEGBU IF, 1995, ADV COLLOID INTERFAC, V58, P1, DOI 10.1016/0001-8686(95)00242-I
   Uchegbu IF, 1998, INT J PHARM, V172, P33, DOI 10.1016/S0378-5173(98)00169-0
   Ustundag-Okur N, 2014, EUR J PHARM SCI, V63, P204, DOI 10.1016/j.ejps.2014.07.013
   Varshosaz J, 2005, DRUG DELIV, V12, P75, DOI 10.1080/10717540490446044
   Yasam VR, 2014, DRUG DELIV, V21, P243, DOI 10.3109/10717544.2013.841783
   Yasin MN, 2012, PAK J PHARM SCI, V25, P117
   Ying L, 2013, INT J PHARMACEUT, V453, P329, DOI 10.1016/j.ijpharm.2013.06.024
   YOSHIOKA T, 1994, INT J PHARM, V105, P1, DOI 10.1016/0378-5173(94)90228-3
   Zakaria MY, 2013, THESIS
   Zarbin MA, 2013, CURR OPIN PHARMACOL, V13, P134, DOI 10.1016/j.coph.2012.10.003
NR 62
TC 0
Z9 0
U1 6
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0898-2104
EI 1532-2394
J9 J LIPOSOME RES
JI J. Liposome Res.
PD JUN
PY 2017
VL 27
IS 2
BP 118
EP 129
DI 10.3109/08982104.2016.1167737
PG 12
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA ER5UG
UT WOS:000398868200005
PM 27079800
OA No
DA 2017-08-17
ER

PT J
AU Abdullah, AM
   Ali, HA
   Haikal, AY
AF Abdullah, Aref M.
   Ali, Hesham A.
   Haikal, Amira Y.
TI Reliable and efficient hierarchical organization model for computational
   grid
SO JOURNAL OF PARALLEL AND DISTRIBUTED COMPUTING
LA English
DT Article
DE Computational grid; Fault tolerance; Grid scheduling; Load balancing;
   Distributed system
ID LARGE-SCALE; SYSTEMS
AB Although the hierarchical model appears to be an effective solution to organize the resource managements in grid systems which have more stringent demand for both scalability and efficiency, it has some limitations which need to be addressed. For example, the master/manager resources in different levels represent single points of failure and they may be sources of bottleneck and communication overhead especially if they are not efficiently selected. Moreover, the dynamic and fault-prone nature of grids cannot be treated by static structures while the manual construction and repairing are also prohibitive due to the highly caused overhead which often represents a significant obstruction to an efficient resource utilization (especially for those with intermittent availabilities). The main objective of this paper is to first introduce a self-repairing n-try dynamic hierarchical grid model for scheduling and load balancing in which each master resource will be replicated on one of its children resources. Second, an efficient methodology to elect masters-replicas resources is proposed. In this methodology, the masters-replicas are selected based on both resource reliability (in terms of MTBF) and resource proximity from the other nodes in specified groups (in terms of communication latency). Validation of the proposed methodology based on the proposed model is done via simulation. Experimental results show that the proposed model has a great impact on the overall performance. Compared to other approaches, the simulations show that our approach decrements the average completion time (ACT) by 18.9%-25%, increases the tree stability ratio (TSR) up to 26.2%-27.1%, and minimizes the total communication overhead (TCO) by 4.4%-18.7% in the range of system parameter values examined. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Abdullah, Aref M.] Taiz Univ, Comp & Informat Syst Ctr, Taizi, Yemen.
   [Ali, Hesham A.; Haikal, Amira Y.] Mansoura Univ, Fac Engn, Mansoura, Egypt.
RP Abdullah, AM (reprint author), Taiz Univ, Comp & Informat Syst Ctr, Taizi, Yemen.
EM eng.aref77@gmail.com; h_arafat_ali@mans.edu.egp; amirayh@gmail.com
CR Abdullah T, 2013, INT CON ADV INFO NET, P682, DOI 10.1109/AINA.2013.144
   Abdullah T, 2008, SASOW 2008: SECOND IEEE INTERNATIONAL CONFERENCE ON SELF-ADAPTIVE AND SELF-ORGANIZING SYSTEMS WORKSHOPS, PROCEEDINGS, P202, DOI 10.1109/SASOW.2008.21
   Anglano C., 2005, LECT NOTES COMPUTER, P630
   Balasangameshwara J, 2013, IEEE T COMPUT, V62, P990, DOI 10.1109/TC.2012.44
   Banerjee S, 2002, GLOB TELECOMM CONF, P2205
   Bouguerra M.S., 2011, 11 IEEE ACM INT S CL, P305
   Brandic Ivona, 2011, IT-Information Technology, V53, P173, DOI 10.1524/itit.2011.0640
   Celaya J, 2013, FUTURE GENER COMP SY, V29, P1097, DOI 10.1016/j.future.2012.12.009
   Czajkowski I.F.K., 2001, 10 IEEE INT S HIGH P, P1
   Dagnew A.T., 2012, THESIS
   De Falco I, 2010, FUTURE GENER COMP SY, V26, P857, DOI 10.1016/j.future.2010.02.009
   Ei-zoghdy S.F., 2012, INT C MULT COMP SYST, P617
   El-Zoghdy SF, 2012, IJCNIS, V4, P1
   Foster I., 2008, GRID COMP ENV WORKSH, V1, P1, DOI DOI 10.1109/GCE.2008.4738445
   Gorde N.B., 2008, PAR PROC WORKSH 2008, P53
   Hashemi S.M., 2012, ARPN J SYSTEMS SOFTW, V2, P188
   Hwang S., 2003, P 12 IEEE INT S HIGH, P126
   Javadi B, 2013, J PARALLEL DISTR COM, V73, P1208, DOI 10.1016/j.jpdc.2013.04.002
   Javadi B, 2011, IEEE T PARALL DISTR, V22, P1896, DOI 10.1109/TPDS.2011.50
   losup A., 2007, 8 IEEE ACM INT C GRI, P26
   Madhav R.S.G., 2015, INT J RECENT INNOV T, V3, P5058
   Memoria M., 2013, INT J ADV RES COMPUT, V2, P56
   Nandagopal M., 2010, INT J COMPUTER SCI N, V10, P177
   Patel DK, 2016, ENG COMPUT-GERMANY, V32, P173, DOI 10.1007/s00366-015-0409-y
   Patel DK, 2015, ENG COMPUT-GERMANY, V31, P825, DOI 10.1007/s00366-014-0391-9
   Rebbah M., 2011, WORLD APPL PROGRAM J, V1, P309
   Righi R.d.R., 2009, THESIS
   Schroeder B, 2010, IEEE T DEPEND SECURE, V7, P337, DOI 10.1109/TDSC.2009.4
   Snchez J.M., 2010, THESIS
   Stearley J., 2005, P LIN CLUST I C, P15
   Suresh P, 2013, MATH PROBL ENG, DOI 10.1155/2013/439362
   Touzene A, 2011, INT J COMPUT SCI ISS, V8, P213
   Vaquero LM, 2009, ACM SIGCOMM COMP COM, V39, P50, DOI 10.1145/1496091.1496100
   Wolski R, 1999, FUTURE GENER COMP SY, V15, P757, DOI 10.1016/S0167-739X(99)00025-4
   Xu Q., 2005, P IEEE ACM INT WORKS, V2005, P227
   Yang W., 2006, P IEEE INT C CLUST C
   Zhang J., 2010, THESIS
   Zhang Y, 2009, CCGRID: 2009 9TH IEEE INTERNATIONAL SYMPOSIUM ON CLUSTER COMPUTING AND THE GRID, P244, DOI 10.1109/CCGRID.2009.59
   Zhu Y., 2013, TECH REP, P1
NR 39
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0743-7315
EI 1096-0848
J9 J PARALLEL DISTR COM
JI J. Parallel Distrib. Comput.
PD JUN
PY 2017
VL 104
BP 191
EP 205
DI 10.1016/j.jpdc.2017.01.027
PG 15
WC Computer Science, Theory & Methods
SC Computer Science
GA ER4IU
UT WOS:000398763100016
OA No
DA 2017-08-17
ER

PT J
AU Zhang, W
   Ma, MY
   Zhang, XA
   Zhang, ZY
   Saleh, SM
   Wang, XD
AF Zhang, Wei
   Ma, Minyan
   Zhang, Xiao-ai
   Zhang, Ze-yu
   Saleh, Sayed M.
   Wang, Xu-dong
TI Fluorescent proteins as efficient tools for evaluating the surface
   PEGylation of silica nanoparticles
SO METHODS AND APPLICATIONS IN FLUORESCENCE
LA English
DT Article
DE silica nanoparticle; surface PEGylation; protein adsorption; silane;
   methoxypoly(ethylene glycol)
ID ANTICANCER DRUG-DELIVERY; ONE-POT SYNTHESIS; IN-VIVO; W/O MICROEMULSION;
   QUANTUM DOTS; CELLS; ADSORPTION; PARTICLES; CORONA; LUMINESCENT
AB Surface PEGylation is essential for preventing non-specific binding of biomolecules when silica nanoparticles are utilized for. in vivo applications. Methods for installing poly(ethylene glycol) on a. silica surface have been widely explored but varies from study. to study. Because there is a lack of a. satisfactory method for evaluating the properties of silica surface. after PEGylation, the prepared nanoparticles are not fully characterized before use. In some cases, even non-PEGylated silica nanoparticles were produced, which is unfortunately not recognized by the. end-user. In this work, a. fluorescent protein was employed, which acts as a sensitive material for. evaluating the surface protein adsorption properties of silica nanoparticles. Eleven different methods were systematically investigated for their reaction efficiency towards surface PEGylation. Results showed that both reaction conditions (including pH, catalyst) and surface functional groups of parent silica nanoparticles play critical roles in producing fully PEGylated silica nanoparticles. Great care needs to be taken in choosing the. proper coupling chemistry for surface PEGylation. The data and method shown here will guarantee high-quality PEGylated silica nanoparticles to be produced and guide their applications in biology, chemistry, industry and medicine.
C1 [Zhang, Wei; Ma, Minyan; Zhang, Xiao-ai; Zhang, Ze-yu; Wang, Xu-dong] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China.
   [Saleh, Sayed M.] Suez Univ, Fac Petr & Min Engn, Chem Branch, Dept Sci & Math, Suez 43721, Egypt.
RP Wang, XD (reprint author), Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China.
EM wangxudong@fudan.edu.cn
RI Wang, Xu-dong/G-3213-2010
OI Wang, Xu-dong/0000-0002-3402-7995; Saleh, Dr Sayed/0000-0002-2677-0439
FU Recruitment Program of Global Experts (1000 Talent program) in China;
   Program for Professor of Special Appointment (Eastern Scholar) at
   Shanghai Institutions of Higher Learning [TP2014004]
FX This work was financially supported by the Recruitment Program of Global
   Experts (1000 Talent program) in China, and the Program for Professor of
   Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher
   Learning (No. TP2014004), which are greatly acknowledged. Both founders
   had no role in the. study design, data collection and analysis, decision
   to publish, or preparation of the manuscript.
CR ARKLES B, 1992, J ADHES SCI TECHNOL, V6, P193, DOI 10.1163/156856192X00133
   Asaro F, 2010, LANGMUIR, V26, P12917, DOI 10.1021/la101737x
   Bae SW, 2012, CHEM COMMUN, V48, P2270, DOI 10.1039/c2cc16306c
   Bentzen EL, 2005, BIOCONJUGATE CHEM, V16, P1488, DOI 10.1021/bc0502006
   Bisker G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10241
   Bisker G, 2012, PLASMONICS, V7, P609, DOI 10.1007/s11468-012-9349-1
   Bjorkegren SMS, 2015, J COLLOID INTERF SCI, V452, P215, DOI 10.1016/j.jcis.2015.04.043
   Burns A, 2006, CHEM SOC REV, V35, P1028, DOI 10.1039/b600562b
   Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050
   Genovese D, 2013, ANGEW CHEM INT EDIT, V52, P5965, DOI 10.1002/anie.201301155
   He QJ, 2010, BIOMATERIALS, V31, P1085, DOI 10.1016/j.biomaterials.2009.10.046
   He XX, 2011, NANOSCALE, V3, P2936, DOI 10.1039/c0nr00913j
   He XX, 2010, LANGMUIR, V26, P15155, DOI [10.1021/la1019636, 10.1021/1a1019636]
   He XX, 2008, ANAL CHEM, V80, P9597, DOI 10.1021/ac801882g
   Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1
   Iverson NM, 2013, NAT NANOTECHNOL, V8, P873, DOI [10.1038/nnano.2013.222, 10.1038/NNANO.2013.222]
   Korzeniowska B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/44/442002
   Li CX, 2013, BIOMATER SCI-UK, V1, P213, DOI 10.1039/c2bm00087c
   Li ZY, 2014, ACS APPL MATER INTER, V6, P14568, DOI 10.1021/am503846p
   Lim CY, 2014, LANGMUIR, V30, P12868, DOI 10.1021/la503439g
   Lin WS, 2013, J NANOMATER, DOI 10.1155/2013/237439
   Liu D, 2014, ACS APPL MATER INTER, V6, P2131, DOI 10.1021/am405219u
   Liu S, 2007, J BIOMED MATER RES A, V80A, P752, DOI 10.1002/jbm.a.31026
   Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   Ma K, 2015, CHEM MATER, V27, P4119, DOI 10.1021/acs.chemmater.5b01222
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Mortensen NP, 2013, NANOSCALE, V5, P6372, DOI 10.1039/c3nr33280b
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Park JW, 2011, CHEM COMMUN, V47, P4860, DOI 10.1039/c1cc00038a
   Petrizza L, 2016, RSC ADV, V6
   Schlipf DM, 2013, ACS APPL MATER INTER, V5, P10111, DOI 10.1021/am402754h
   Shahabi S, 2015, ACS APPL MATER INTER, V7, P13821, DOI 10.1021/acsami.5b01900
   Tissandier C, 2012, LANGMUIR, V28, P209, DOI 10.1021/la203580q
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   Valenti G, 2016, J AM CHEM SOC, V138, P15935, DOI 10.1021/jacs.6b08239
   van Vlerken LE, 2007, PHARM RES, V24, P1405, DOI 10.1007/s11095-007-9284-6
   Wang KM, 2013, ACCOUNTS CHEM RES, V46, P1367, DOI 10.1021/ar3001525
   Wang L, 2006, ANAL CHEM, V78, P646, DOI 10.1021/ac0693619
   Wang L. F., 2008, WATER SAV IRRIG, V2008, P1, DOI DOI 10.1038/NATURE07065
   Wu CF, 2013, ANGEW CHEM INT EDIT, V52, P3086, DOI 10.1002/anie.201205133
   Wu Y, 2013, DALTON T, V42, P9852, DOI 10.1039/c3dt50658d
   Xu SP, 2011, ACS APPL MATER INTER, V3, P1865, DOI 10.1021/am200052a
   YAMAUCHI H, 1989, COLLOID SURFACE, V37, P71, DOI 10.1016/0166-6622(89)80107-6
   Yoon TJ, 2006, SMALL, V2, P209, DOI 10.1002/smll.200500360
   Zanarini S, 2009, J AM CHEM SOC, V131, P14208, DOI 10.1021/ja906666e
   Zhang Q, 2014, ADV FUNCT MATER, V24, P2450, DOI 10.1002/adfm.201302988
NR 47
TC 0
Z9 0
U1 16
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2050-6120
J9 METHODS APPL FLUORES
JI Methods Appl. Fluoresc.
PD JUN 1
PY 2017
VL 5
IS 2
AR 024003
DI 10.1088/2050-6120/aa64e5
PG 9
WC Chemistry, Analytical; Chemistry, Physical
SC Chemistry
GA ER9MO
UT WOS:000399150700001
OA No
DA 2017-08-17
ER

PT J
AU Abd Elmoneim, A
AF Abd Elmoneim, Abeer
TI Quality of Life among Survivors of Childhood Cancer in a Developing
   Country: a Single Center Study in South Egypt
SO PEDIATRIC BLOOD & CANCER
LA English
DT Meeting Abstract
C1 [Abd Elmoneim, Abeer] Sohag Univ, Sohag, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD JUN
PY 2017
VL 64
SU 1
MA 727
BP S60
EP S60
PG 1
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA ER1RR
UT WOS:000398571100260
OA No
DA 2017-08-17
ER

PT J
AU Eissa, S
   Madney, Y
   Elanany, M
   Romeih, M
   Halaby, L
AF Eissa, Shaimaa
   Madney, Youssef
   Elanany, Mervat
   Romeih, Marwa
   Halaby, Lama
TI Clinical Characteristics and Outcome of Rhino-Cerebral Fungal Infection
   in Children with Hematologic Malignancies
SO PEDIATRIC BLOOD & CANCER
LA English
DT Meeting Abstract
C1 [Eissa, Shaimaa; Madney, Youssef; Elanany, Mervat; Romeih, Marwa; Halaby, Lama] Childrens Canc Hosp Egypt CCHE 57357, Cairo, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD JUN
PY 2017
VL 64
SU 1
MA 305
BP S31
EP S32
PG 2
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA ER1RR
UT WOS:000398571100135
OA No
DA 2017-08-17
ER

PT J
AU Elgammal, A
   Elborai, Y
   Fawzy, M
   Salama, A
   Elattar, I
   Selim, M
   Shalaby, L
AF Elgammal, Ahmed
   Elborai, Yasser
   Fawzy, Mohamed
   Salama, Asmaa
   Elattar, Inas
   Selim, Mustafa
   Shalaby, Lobna
TI Impact of Initial Presentation and Risk Factors on the Outcome of
   Refractory/Relapsed Pediatric Hodgkin Lymphoma in a Developing Country
SO PEDIATRIC BLOOD & CANCER
LA English
DT Meeting Abstract
C1 [Elgammal, Ahmed; Elborai, Yasser; Fawzy, Mohamed; Salama, Asmaa; Elattar, Inas; Selim, Mustafa; Shalaby, Lobna] Natl Canc Inst, Cairo, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD JUN
PY 2017
VL 64
SU 1
MA 318
BP S34
EP S35
PG 2
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA ER1RR
UT WOS:000398571100148
OA No
DA 2017-08-17
ER

PT J
AU Mahmoud, MMH
   Shaheen, I
   Samir, A
   Enein, AA
   Elbeshlawy, A
   Ali, Z
   Samie, HA
AF Mahmoud, Mona Mohamed Hamdy
   Shaheen, Iman
   Samir, Ahmed
   Enein, Azza Aboul
   Elbeshlawy, Amal
   Ali, Zeinab
   Samie, Hala Abdel
TI Peripheral Expression of Hepcidin Gene in Egyptian beta-Thalassemia
   Major
SO PEDIATRIC BLOOD & CANCER
LA English
DT Meeting Abstract
C1 [Mahmoud, Mona Mohamed Hamdy; Shaheen, Iman; Samir, Ahmed; Enein, Azza Aboul; Elbeshlawy, Amal; Ali, Zeinab; Samie, Hala Abdel] Cairo Univ Hosp, Cairo, Egypt.
NR 0
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD JUN
PY 2017
VL 64
SU 1
MA 103
BP S18
EP S18
PG 1
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA ER1RR
UT WOS:000398571100075
OA No
DA 2017-08-17
ER

PT J
AU Mohamed, M
   Mahmoud, H
   Badr, A
   Raouf, A
   Shalan, O
   Sakr, M
   Rahman, ARA
AF Mohamed, Mona
   Mahmoud, Hamdy
   Badr, Ahmed
   Raouf, Ahmed
   Shalan, Osama
   Sakr, Moustafa
   Rahman, Abdel Rahman Abdel
TI Association of Methyltetrahydrofolate Reductase A1298C and C677T
   Polymorphism with Vaso-Occlusive Crisis in Sickle Cell Disease
SO PEDIATRIC BLOOD & CANCER
LA English
DT Meeting Abstract
C1 [Mohamed, Mona; Mahmoud, Hamdy; Badr, Ahmed; Raouf, Ahmed; Shalan, Osama; Sakr, Moustafa; Rahman, Abdel Rahman Abdel] Cairo Univ, Children Hosp, Cairo, Egypt.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD JUN
PY 2017
VL 64
SU 1
MA 157
BP S24
EP S24
PG 1
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA ER1RR
UT WOS:000398571100102
OA No
DA 2017-08-17
ER

PT J
AU Shahat, A
   Trupp, S
AF Shahat, Ahmed
   Trupp, Sabine
TI Sensitive, selective, and rapid method for optical recognition of
   ultra-traces level of Hg(II), Ag(I), Au(III), and Pd(II) in electronic
   wastes
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Colorimetric determination; Recovery; Palladium; Gold; Silver;
   Electronic wastes
ID PRINTED-CIRCUIT BOARDS; TOXIC METAL-IONS;
   ATOMIC-ABSORPTION-SPECTROMETRY; POINT EXTRACTION PRECONCENTRATION;
   PLATINUM-GROUP METALS; ONLINE PRECONCENTRATION; BIOLOGICAL SAMPLES;
   MESOPOROUS SILICA; COLORIMETRIC DETERMINATION; ENVIRONMENTAL-SAMPLES
AB In the present work, a solid chemical sensor using mesoporous silica nanospheres as scaffold, was applied for preconcentration and spectrophotometric determination of the Hg(II), Ag(I), Au(III), and Pd(II) in electronic wastes. Digital Image-Based Colorimetric Analysis was also used for determination of the concentrations of the metal ions as a fast and low-cost colorimetric detections for quantitative chemical analysis. At the optimum conditions, the analytical characteristics of the two methods (e.g., limit of detection and linear range) were evaluated. Linearity was obeyed.in the range of 0.5-10 ng m1(-1) of Au(III) with a linear correlation coefficient of 0.999. The new sensor displayed high sensitivity for very low concentrations of the detectable metals analytes up to 10(-10) mol L-1 in solution. Results showed evidence that Thiomichler's Ketone (TMK) sensor will attract worldwide attention as a promising technological means of recovering and recycling silver, gold and palladium. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Shahat, Ahmed] Suez Univ, Fac Sci, Dept Chem, Suez, Egypt.
   [Trupp, Sabine] Fraunhofer Res Inst Microsyst & Solid State Techn, Workgroup Sensor Mat, Jose Engert Str 13, D-93053 Regensburg, Germany.
RP Shahat, A (reprint author), Suez Univ, Fac Sci, Dept Chem, Suez, Egypt.
EM ashahat@aucegypt.edu
OI Shahat ahmed, ahmed/0000-0001-9198-9712
FU DAAD
FX My thanks are due to the German Academic Exchange Service (DAAD) for
   providing me an opportunity to do a significant part of my research in
   Germany. I consider the award of DAAD scholarship a great achievement in
   life.
CR Argekar AA, 1995, TALANTA, V42, P1937, DOI 10.1016/0039-9140(95)01666-X
   Awual MR, 2015, CHEM ENG J, V265, P210, DOI 10.1016/j.cej.2014.12.052
   Awual MR, 2014, SENSOR ACTUAT B-CHEM, V203, P854, DOI 10.1016/j.snb.2014.07.063
   Barefoot RR, 1999, TALANTA, V49, P1, DOI 10.1016/S0039-9140(98)00347-6
   Birloaga I, 2013, WASTE MANAGE, V33, P935, DOI 10.1016/j.wasman.2013.01.003
   Chang CL, 1997, LANGMUIR, V13, P3295, DOI 10.1021/la961062z
   Chen JG, 2009, TALANTA, V77, P1381, DOI 10.1016/j.talanta.2008.09.021
   Chen YL, 2009, CHEM COMMUN, P5177, DOI 10.1039/b903859k
   CHENG KL, 1966, MICROCHEM J, V10, P158, DOI 10.1016/0026-265X(66)90203-7
   Christian G.D., 2003, ANAL CHEM
   da-Silva C.B., 2010, J COLLOID INTERF SCI, V345, P234
   de Wuilloud JCA, 2002, SPECTROCHIM ACTA B, V57, P365, DOI 10.1016/S0584-8547(01)00393-7
   Donia AM, 2005, SEP PURIF TECHNOL, V42, P111, DOI 10.1016/j.seppur.2004.06.009
   Du X, 2010, LANGMUIR, V26, P10057, DOI 10.1021/la100196j
   El-Safty SA, 2013, SMALL, V9, P2288, DOI 10.1002/smll.201202407
   El-Safty SA, 2013, SENSOR ACTUAT B-CHEM, V183, P58, DOI 10.1016/j.snb.2013.03.041
   El-Safty SA, 2013, SENSOR ACTUAT B-CHEM, V176, P1015, DOI 10.1016/j.snb.2012.09.040
   El-Safty SA, 2012, SENSOR ACTUAT B-CHEM, V166, P253, DOI 10.1016/j.snb.2012.02.055
   Elci L, 2003, ANAL SCI, V19, P1621, DOI 10.2116/analsci.19.1621
   El-Safty S.A., 2015, JOVE-J VIS EXP, V106, P1
   Elshehy EA, 2014, SENSOR ACTUAT B-CHEM, V203, P363, DOI 10.1016/j.snb.2014.06.055
   GEHAUF B, 1950, ANAL CHEM, V22, P498, DOI 10.1021/ac60039a038
   Gu FN, 2012, MICROPOR MESOPOR MAT, V151, P142, DOI 10.1016/j.micromeso.2011.11.001
   Guo XH, 2010, LANGMUIR, V26, P702, DOI 10.1021/la9023647
   Gur'eva RF, 2002, J ANAL CHEM+, V57, P980, DOI 10.1023/A:1020917221896
   Hageluken C, 2012, PLATIN MET REV, V56, P29, DOI 10.1595/147106712X611733
   Han WS, 2009, CHEM SOC REV, V38, P1904, DOI 10.1039/b818893a
   HINDS MW, 1993, SPECTROCHIM ACTA B, V48, P435, DOI 10.1016/0584-8547(93)80048-Y
   Hosoba M, 2009, ANAL CHIM ACTA, V639, P51, DOI 10.1016/j.aca.2009.02.050
   Huang K, 2009, J HAZARD MATER, V164, P399, DOI 10.1016/j.jhazmat.2008.08.051
   Jung JH, 2011, CHEM SOC REV, V40, P4464, DOI 10.1039/c1cs15051k
   Khairy M, 2013, NANOSCALE, V5, P7920, DOI 10.1039/c3nr02403b
   Khalil MMH, 2016, SENSOR ACTUAT B-CHEM, V233, P272, DOI 10.1016/j.snb.2016.04.079
   Kompany-Zareh M, 2002, ANAL CHIM ACTA, V471, P97, DOI 10.1016/S0003-2670(02)00871-1
   Krishna MVB, 2009, TALANTA, V79, P1454, DOI 10.1016/j.talanta.2009.06.008
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Limbeck A, 2003, J ANAL ATOM SPECTROM, V18, P161, DOI 10.1039/b211292b
   Liu JW, 2004, J AM CHEM SOC, V126, P12298, DOI 10.1021/ja046628h
   Liu P, 2000, ANALYST, V125, P147, DOI 10.1039/a906074j
   Medved' J, 2004, ANAL BIOANAL CHEM, V379, P60, DOI 10.1007/s00216-004-2538-9
   Navarro R, 2012, CHEM ENG J, V185, P226, DOI 10.1016/j.cej.2012.01.090
   Oh CJ, 2003, J AIR WASTE MANAGE, V53, P897
   Park YJ, 2009, J HAZARD MATER, V164, P1152, DOI 10.1016/j.jhazmat.2008.09.043
   Pyrzynska K, 2005, SPECTROCHIM ACTA B, V60, P1316, DOI 10.1016/j.sab.2005.06.010
   Ramesh A, 2008, BIORESOURCE TECHNOL, V99, P3801, DOI 10.1016/j.biortech.2007.07.008
   Rampazzo E, 2005, J MATER CHEM, V15, P2687, DOI 10.1039/b502052b
   Rao CRM, 2000, TRAC-TREND ANAL CHEM, V19, P565, DOI 10.1016/S0165-9936(00)00031-5
   Ros-Lis JV, 2008, CHEM-EUR J, V14, P8267, DOI 10.1002/chem.200800632
   Shabazi Z, 2008, J ANAL CHEM+, V63, P446, DOI 10.1134/S1061934808050079
   Shah R, 1996, ANALYST, V121, P807, DOI 10.1039/an9962100807
   Shahat A, 2015, SENSOR ACTUAT B-CHEM, V221, P1027, DOI 10.1016/j.snb.2015.07.032
   Shahat A, 2015, CHEM ENG J, V273, P286, DOI 10.1016/j.cej.2015.03.073
   Shahat A, 2013, ANAL CHIM ACTA, V793, P90, DOI 10.1016/j.aca.2013.07.012
   Shenashen MA, 2013, SEP PURIF TECHNOL, V116, P73, DOI 10.1016/j.seppur.2013.05.011
   Shenashen MA, 2013, J HAZARD MATER, V260, P833, DOI 10.1016/j.jhazmat.2013.06.025
   Shenashen MA, 2015, EUR J INORG CHEM, P179, DOI 10.1002/ejic.201402756
   Tokalioglu S, 2004, ANAL CHIM ACTA, V511, P255, DOI 10.1016/j.aca.2004.02.015
   Torres E, 2005, LANGMUIR, V21, P7951, DOI 10.1021/la046852k
   Wanyika H, 2011, AFR J PHARM PHARMACO, V5, P2402, DOI 10.5897/AJPP11.592
   Zhang JC, 2010, SOLID STATE SCI, V12, P267, DOI 10.1016/j.solidstatesciences.2009.11.005
   Zhang SM, 2002, ANAL CHIM ACTA, V452, P223, DOI 10.1016/S0003-2670(01)01476-3
   ZHANG XS, 1994, CHROMATOGRAPHIA, V39, P693, DOI 10.1007/BF02274585
NR 62
TC 0
Z9 0
U1 20
U2 20
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JUN
PY 2017
VL 245
BP 789
EP 802
DI 10.1016/j.snb.2017.02.008
PG 14
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA ER4HW
UT WOS:000398760700093
OA No
DA 2017-08-17
ER

PT J
AU Oun, AA
   Rhim, JW
AF Oun, Ahmed A.
   Rhim, Jong-Whan
TI Carrageenan-based hydrogels and films: Effect of ZnO and CuO
   nanoparticles on the physical, mechanical, and antimicrobial properties
SO FOOD HYDROCOLLOIDS
LA English
DT Article
DE Carrageenan hydrogel; ZnO nanoparticles; CuO nanoparticles;
   Nanocomposite film; Antibacterial activity; UV-barrier
ID NANOCOMPOSITE FILMS; KAPPA-CARRAGEENAN; COMPOSITE FILMS; ANTIBACTERIAL
   PROPERTIES; CELLULOSE NANOCRYSTALS; SILVER NANOPARTICLES; REDUCING
   AGENTS; DRUG-DELIVERY; COPPER-SALTS; GELATION
AB Carrageenan-based functional hydrogels and dry films were prepared by blending with metallic nano particles such as zinc oxide (ZnO), copper oxide (CuO) NPs, and their combination. Addition of KCI as a cross-linking agent increased the gel strength of carrageenan-based hydrogels. The neat carrageenan hydrogels were transparent, but they became translucent when the metallic nanoparticles were incorporated. Dried hydrogel films were flexible and free-standing. Transmission of UV light of the carrageenan-based films decreased remarkably when metallic NPs were incorporated. The swelling ratio (SR) of carrageenan films with or without cross-linker were 2980% and 2665%, respectively, however, it increased up to 3535% when ZnONPs were incorporated. The carrageenan-based hydrogel films with metallic nanoparticles exhibited strong antibacterial activity against food-bourne pathogenic bacteria, Escherichia coil, and Listeria monocytogenes. The ZnONPs incorporated hydrogel films exhibited higher mechanical, UV-screening, water holding, thermal stability, and antimicrobial properties than the CuONPs incorporated ones. The nanocomposite hydrogels or films have a high potential for the application in the biomedical, cosmetic, and active food packaging areas. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Oun, Ahmed A.] Mokpo Natl Univ, Dept Food Engn, 61 Dorimri, Muangun 534729, Jeonnam, South Korea.
   [Oun, Ahmed A.] Mokpo Natl Univ, Bionanocomposite Res Inst, 61 Dorimri, Muangun 534729, Jeonnam, South Korea.
   [Oun, Ahmed A.] Agr Res Ctr, Food Technol Res Inst, Food Engn & Packaging Dept, Giza, Egypt.
   [Rhim, Jong-Whan] Dept Food Sci & Human Nutr, 26 Kyungheedae Ro, Seoul 120701, South Korea.
RP Rhim, JW (reprint author), Dept Food Sci & Human Nutr, 26 Kyungheedae Ro, Seoul 120701, South Korea.
EM jwrhim@mokpo.ac.kr
OI Rhim, Jong-Whan/0000-0003-1787-5391
FU Business for Cooperative R&D between Industry, Academy, and Research
   Institute - Korea Small and Medium Business Administration [C0297411]
FX This work (Grants No. C0297411) was supported by Business for
   Cooperative R&D between Industry, Academy, and Research Institute funded
   by the Korea Small and Medium Business Administration in 2015.
CR Anitha S, 2012, CARBOHYD POLYM, V87, P1065, DOI 10.1016/j.carbpol.2011.08.030
   Applerot G, 2009, APPL SURF SCI, V256, pS3, DOI 10.1016/j.apsusc.2009.04.198
   Arfat YA, 2014, FOOD HYDROCOLLOID, V41, P265, DOI 10.1016/j.foodhyd.2014.04.023
   Azizi S, 2014, INT J MOL SCI, V15, P11040, DOI 10.3390/ijms150611040
   Beigmohammadi F, 2016, LWT-FOOD SCI TECHNOL, V65, P106, DOI 10.1016/j.lwt.2015.07.059
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Borkow G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011295
   Borkow G, 2010, WOUND REPAIR REGEN, V18, P266, DOI 10.1111/j.1524-475X.2010.00573.x
   Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023
   Daniel-da-Silva AL, 2012, CARBOHYD POLYM, V87, P328, DOI 10.1016/j.carbpol.2011.07.051
   Distantina S., 2013, ENG J, V17, P57, DOI DOI 10.4186/EJ.2013.17.3.57
   Emamifar A, 2010, INNOV FOOD SCI EMERG, V11, P742, DOI 10.1016/j.ifset.2010.06.003
   Farris S, 2009, TRENDS FOOD SCI TECH, V20, P316, DOI 10.1016/j.tifs.2009.04.003
   Hezaveh H, 2012, CARBOHYD POLYM, V89, P138, DOI 10.1016/j.carbpol.2012.02.062
   Kanmani P, 2014, CARBOHYD POLYM, V106, P190, DOI 10.1016/j.carbpol.2014.02.007
   Li WL, 2011, ADV MATER RES-SWITZ, V152-153, P489, DOI 10.4028/www.scientific.net/AMR.152-153.489
   Lin K-S, 2012, J NANOMATER, V2012, P1
   Liu JJ, 2015, CARBOHYD POLYM, V121, P27, DOI 10.1016/j.carbpol.2014.11.063
   Lizundia E, 2016, CARBOHYD POLYM, V136, P250, DOI 10.1016/j.carbpol.2015.09.041
   Mandavinia G.R., 2012, J POLYM RES, V19, P9947
   Mangione MR, 2005, BIOPHYS CHEM, V113, P129, DOI 10.1016/j.bpc.2004.08.005
   Mateescu Anca, 2012, Membranes (Basel), V2, P40, DOI 10.3390/membranes2010040
   Mohandas Annapoorna, 2015, Int J Nanomedicine, V10 Suppl 1, P53, DOI 10.2147/IJN.S79981
   Nguyen BT, 2014, CARBOHYD POLYM, V112, P10, DOI 10.1016/j.carbpol.2014.05.048
   Orsuwan A, 2016, FOOD HYDROCOLLOID, V60, P476, DOI 10.1016/j.foodhyd.2016.04.017
   Oun AA, 2016, CARBOHYD POLYM, V150, P187, DOI 10.1016/j.carbpol.2016.05.020
   Oun AA, 2015, CARBOHYD POLYM, V134, P20, DOI 10.1016/j.carbpol.2015.07.053
   Oun AA, 2015, CARBOHYD POLYM, V127, P101, DOI 10.1016/j.carbpol.2015.03.073
   Paisoonsin S, 2013, APPL SURF SCI, V273, P824, DOI 10.1016/j.apsusc.2013.03.026
   Pascalau V, 2012, J ALLOY COMPD, V536, pS418, DOI 10.1016/j.jallcom.2011.12.026
   Espitia PJP, 2013, CARBOHYD POLYM, V94, P199, DOI 10.1016/j.carbpol.2013.01.003
   Prabhu Y. T., 2015, J SAUDI CHEM SOC
   Rhein-Knudsen N, 2015, MAR DRUGS, V13, P3340, DOI 10.3390/md13063340
   Rhim JW, 2014, APPL CLAY SCI, V97-98, P174, DOI 10.1016/j.clay.2014.05.025
   Rhim JW, 2013, CARBOHYD POLYM, V96, P71, DOI 10.1016/j.carbpol.2013.03.083
   Rhim JW, 2011, J FOOD ENG, V104, P484, DOI 10.1016/j.jfoodeng.2010.08.010
   Roy N, 2012, CARBOHYD POLYM, V89, P346, DOI 10.1016/j.carbpol.2012.03.008
   Salgueiro AM, 2013, CARBOHYD POLYM, V91, P100, DOI 10.1016/j.carbpol.2012.08.004
   Santo VE, 2009, BIOMACROMOLECULES, V10, P1392, DOI 10.1021/bm8014973
   Serpone N, 2007, INORG CHIM ACTA, V360, P794, DOI 10.1016/j.ica.2005.12.057
   Shankar S, 2016, LWT-FOOD SCI TECHNOL, V72, P149, DOI 10.1016/j.lwt.2016.04.054
   Shankar S, 2015, FOOD HYDROCOLLOID, V45, P264, DOI 10.1016/j.foodhyd.2014.12.001
   Shankar S, 2014, CARBOHYD POLYM, V114, P484, DOI 10.1016/j.carbpol.2014.08.036
   Shankar S, 2014, MATER LETT, V132, P307, DOI 10.1016/j.matlet.2014.06.014
   Varghese JS, 2014, COLLOID SURFACE B, V113, P346, DOI 10.1016/j.colsurfb.2013.08.049
   Yu JG, 2009, BIORESOURCE TECHNOL, V100, P2832, DOI 10.1016/j.biortech.2008.12.045
NR 46
TC 0
Z9 0
U1 44
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-005X
EI 1873-7137
J9 FOOD HYDROCOLLOID
JI Food Hydrocolloids
PD JUN
PY 2017
VL 67
BP 45
EP 53
DI 10.1016/j.foodhyd.2016.12.040
PG 9
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA EP4RX
UT WOS:000397368700005
OA No
DA 2017-08-17
ER

PT J
AU Chen, H
   Zuo, QS
   Wang, YJ
   Ahmed, MF
   Jin, K
   Song, JZ
   Zhang, YN
   Li, BC
AF Chen, Hao
   Zuo, Qisheng
   Wang, Yinjie
   Ahmed, Mahmoud F.
   Jin, Kai
   Song, Jiuzhou
   Zhang, Yani
   Li, Bichun
TI Regulation of Hedgehog Signaling in Chicken Embryonic Stem Cells
   Differentiation Into Male Germ Cells (Gallus)
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE HEDGEHOG SIGNALING PATHWAY; ESCs; PGCs; SSCs; RNA-seq
ID SONIC HEDGEHOG; SPECIFICATION; DERIVATION; OOCYTES; MICE
AB The study aims to analyze the key signaling pathways in regulating the process of embryonic stem cells (ESCs) differentiation into spermatogonial stem cells (SSCs). Based on RNA Sequencing result, we further explored the specific regulating mechanisms of Hedgehog (HH) signaling in this process. HH signaling was found to be a crucial signaling pathway participating in the differentiation process of ESCs to SSCs. In Retinoic acid (RA) induced in vitro differentiation assay, the expression of two germ cell marker genes, integrin 6, and integrin 1, was observed to significantly increase, while it decreased dramatically when IHH was knocked down. Fluorescence activated cell sorting analysis showed that the proportion of integrin 6(+) and integrin 1(+) cells in the RA group was significantly higher than that in the RA+siRNA- Indian Hedgehog (IHH) group. In in vivo situations, siRNA-IHH could stably express in fertilized chicken embryos and significantly down-regulate the IHH expression. With real-time quantitative PCR and western blot, we identified that integrin 6 and integrin 1 expression was significantly suppressed along with IHH inhibition in vivo. We concluded that Hedgehog signaling pathway positively regulates the differentiation of ESCs to male germ cells through signal transduction by IHH. J. Cell. Biochem. 118: 1379-1386, 2017. (C) 2016 Wiley Periodicals, Inc.
C1 [Chen, Hao] Soochow Univ, Dept Orthopaed, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China.
   [Zuo, Qisheng; Wang, Yinjie; Jin, Kai; Zhang, Yani; Li, Bichun] Yangzhou Univ, Key Lab Anim Breeding Reprod & Mol Design Jiangsu, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China.
   [Ahmed, Mahmoud F.] Suez Canal Univ, Coll Vet Med, Ismailia 41522, Egypt.
   [Song, Jiuzhou] Univ Maryland, Anim & Avian Sci, College Pk, MD 20741 USA.
RP Li, BC (reprint author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China.
EM yubcli@yzu.edu.cn
FU National Natural Science Foundation of China [31272429, 31301959,
   31472087]; Specialized Research Fund for the Doctoral Program of Higher
   Education [20123250120009]; China Postdoctoral Science Foundation
   [2012M511326, 2014T70550]; Priority Academic Program Development of
   Jiangsu Higher Education Institutions
FX Grant sponsor: National Natural Science Foundation of China; Grant
   numbers: 31272429, 31301959, 31472087; Grant sponsor: Specialized
   Research Fund for the Doctoral Program of Higher Education; Grant
   number: 20123250120009; Grant sponsor: China Postdoctoral Science
   Foundation funded project; Grant numbers: 2012M511326, 2014T70550; Grant
   sponsor: Priority Academic Program Development of Jiangsu Higher
   Education Institutions.
CR Aflatoonian B, 2009, HUM REPROD, V24, P3150, DOI 10.1093/humrep/dep334
   Calder EL, 2015, J NEUROSCI, V35, P11462, DOI 10.1523/JNEUROSCI.3046-14.2015
   Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0
   Choudhry Zia, 2014, Ann Neurosci, V21, P28, DOI 10.5214/ans.0972.7531.210109
   Deshpande G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003720
   El A, 2006, NAT IMMUNOL, V7, P418
   Gr VDB, 2007, PHYSIOL REV, V87, P1343
   Huang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071213
   Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Kang DH, 2009, J GASTROENTEROL, V44, P372, DOI 10.1007/s00535-009-0006-1
   Kerkis A, 2007, CLONING STEM CELLS, V9, P535, DOI 10.1089/clo.2007.0031
   Kobune M, 2008, STEM CELLS, V26, P534, DOI 10.1634/stemcells.2007-0741
   Kondo T, 2005, P NATL ACAD SCI USA, V102, P4789, DOI 10.1073/pnas.0408239102
   Li Feixue, 2003, J CELL BIOL, V25, P206
   Wang Li, 2011, CHINA TISSUE ENG RES, V15, P5091
   Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063
   Liu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010382
   Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606
   Rojas-Rios P, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001298
   Siyu S, 2008, CHINESE J VET SCI, V28, P102
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Xinsheng W, 2008, CHINA POULT, V30, P30
   Xinyan T, 2008, J AGR BIOTECHNOL, V14, P174
   Yamago G, 2001, ARCH DERMATOL RES, V293, P435, DOI 10.1007/s004030100252
   Zhang XJ, 2012, ACTA HISTOCHEM, V114, P429, DOI 10.1016/j.acthis.2011.08.003
   Zhang ZT, 2015, J BIOL CHEM, V290, P13605, DOI 10.1074/jbc.M114.601401
   Zou Lin, 2009, Jiepou Xuebao, V40, P211, DOI 10.3969/j.issn.0529-1356.2009.02.008
NR 28
TC 0
Z9 0
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD JUN
PY 2017
VL 118
IS 6
BP 1379
EP 1386
DI 10.1002/jcb.25796
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA ER1EM
UT WOS:000398532500010
PM 27862257
OA No
DA 2017-08-17
ER

PT J
AU Moussa-Ayoub, TE
   Jager, H
   Knorr, D
   El-Samahy, SK
   Kroh, LW
   Rohn, S
AF Moussa-Ayoub, Tamer E.
   Jaeger, Henry
   Knorr, Dietrich
   El-Samahy, Salah K.
   Kroh, Lothar W.
   Rohn, Sascha
TI Impact of pulsed electric fields, high hydrostatic pressure, and thermal
   pasteurization on selected characteristics of Opuntia dillenii cactus
   juice
SO LWT-FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Opuntia dillenii juice; Pulsed electric fields; High hydrostatic
   pressure; Pasteurization
ID ORANGE JUICE; ANTIOXIDANT CAPACITY; VITAMIN-C; BIOACTIVE COMPOUNDS;
   FLAVONOL INTAKE; FICUS-INDICA; FRUITS; COLORANTS; BEVERAGE; QUALITY
AB Besides its bioactivity, Opuntia dillenii cactus juice exhibits desirable physicochemical properties. In the present study, impact of innovative pasteurization techniques - pulsed electric fields (PEF) and high hydrostatic pressure (HHP) - on the microbial inactivation, selected physicochemical properties and rheological characteristics, ascorbic acid, flavonols, betacyanins, and the antioxidant activity was evaluated in comparison to the non-pasteurized fresh juice. Results showed that PEF and HHP, as well as thermal pasteurization (TP), reduced the microbial populations found in juice from 10(3) to less than 10 cfu/mL. The non-Newtonian pseudoplastic flow behaviour of juice was maintained by all three methods. PEF and HHP resulted in a better retention of ascorbic acid, while TP reduced 22% of the ascorbic acid content. In contrast, TP caused a slight transformation of isorhamnetin glycosides. PEF and HHP maintained antioxidant activity of juice comparatively better than TP. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Moussa-Ayoub, Tamer E.; Kroh, Lothar W.] Tech Univ Berlin, Inst Food Technol & Food Chem, Dept Food Chem & Anal, Gustav Meyer Allee 25, D-13355 Berlin, Germany.
   [Jaeger, Henry] Univ Nat Resources & Life Sci BOKU Vienna, Inst Food Technol, Muthgasse 18, A-1190 Vienna, Austria.
   [Knorr, Dietrich] Tech Univ Berlin, Inst Food Technol & Food Chem, Dept Food Biotechnol & Food Proc Engn, Koenigin Luise Str 22, D-14195 Berlin, Germany.
   [Moussa-Ayoub, Tamer E.; El-Samahy, Salah K.] Suez Canal Univ, Fac Agr, Dept Food Technol, Ismailia 41522, Egypt.
   [Rohn, Sascha] Univ Hamburg, Hamburg Sch Food Sci, Inst Food Chem, Grindelallee 117, D-20146 Hamburg, Germany.
RP Rohn, S (reprint author), Univ Hamburg, Hamburg Sch Food Sci, Inst Food Chem, Grindelallee 117, D-20146 Hamburg, Germany.
EM rohn@chemie.uni-hamburg.de
FU Egyptian Ministry of Higher Education & Scientific Research
FX This work was partially financed and supported by the Egyptian Ministry
   of Higher Education & Scientific Research. Grateful acknowledgments and
   thanks go out to Prof. Dr. Bernhard Senge and Dr. Reinhard Blochwitz,
   Technische Universitat Berlin, Department of Food Rheology for helping
   with the rheological characterization.
CR Bao M, 2006, EUR J PHARMACOL, V547, P22, DOI 10.1016/j.ejphar.2006.07.021
   Barba FJ, 2015, FOOD RES INT, V77, P773, DOI 10.1016/j.foodres.2015.09.015
   Barba FJ, 2012, COMPR REV FOOD SCI F, V11, P307, DOI 10.1111/j.1541-4337.2012.00185.x
   Barba FJ, 2010, J AGR FOOD CHEM, V58, P10070, DOI 10.1021/jf1019483
   Bohm H, 2008, J PROF ASSOC CACTUS, V10, P148
   Boubaker J, 2011, CELL PROLIFERAT, V44, P453, DOI 10.1111/j.1365-2184.2011.00772.x
   Castellar MR, 2012, PLANT FOOD HUM NUTR, V67, P337, DOI 10.1007/s11130-012-0316-y
   Castro S. M., 2005, EMERGING TECHNOLOGIE, P65
   Medina EMD, 2007, FOOD CHEM, V103, P38, DOI 10.1016/j.foodchem.2006.06.064
   EI-Samahy S. K., 2007, J PROFESSIONAL ASS C, V9, P148
   El-Samahy SK, 2006, J PROF ASSOC CACTUS, V8, P39
   Elez-Martinez P, 2007, FOOD CHEM, V102, P201, DOI 10.1016/j.foodchem.2006.04.048
   Herbach KM, 2006, J FOOD SCI, V71, pR41, DOI 10.1111/j.1750-3841.2006.00022.x
   Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624
   Jager H., 2009, INNOV FOOD SCI EMERG, V10, P470
   Kanzler C, 2014, J AGR FOOD CHEM, V62, P2837, DOI 10.1021/jf404322r
   Knorr D, 2011, ANNU REV FOOD SCI T, V2, P203, DOI 10.1146/annurev.food.102308.124129
   Koubaa M, 2016, INNOV FOOD SCI EMERG, V37, P336, DOI 10.1016/j.ifset.2016.04.015
   Loginova KV, 2011, J FOOD ENG, V106, P127, DOI 10.1016/j.jfoodeng.2011.04.019
   Low J. F., 1999, J ETHNOPHARMACOL, V67, P213
   Min S, 2003, J FOOD SCI, V68, P1265, DOI 10.1111/j.1365-2621.2003.tb09637.x
   Moussa-Ayoub TE, 2016, FOOD CHEM, V210, P249, DOI 10.1016/j.foodchem.2016.04.115
   Moussa-Ayoub TE, 2014, FOOD RES INT, V64, P864, DOI 10.1016/j.foodres.2014.08.021
   Moussa-Ayoub TE, 2011, FOOD RES INT, V44, P2169, DOI 10.1016/j.foodres.2011.02.014
   Nothlings U, 2008, AM J CLIN NUTR, V88, P1653, DOI 10.3945/ajcn.2008.26398
   Odriozola-Serrano I, 2008, EUR FOOD RES TECHNOL, V228, P239, DOI 10.1007/s00217-008-0928-5
   Patras A, 2009, INNOV FOOD SCI EMERG, V10, P308, DOI 10.1016/j.ifset.2008.12.004
   Patterson MF, 2005, J APPL MICROBIOL, V98, P1400, DOI 10.1111/j.1365-2672.2005.02564.x
   Rufian-Henares JA, 2007, FOOD RES INT, V40, P995, DOI 10.1016/j.foodres.2007.05.002
   Sanchez-Moreno C, 2005, J AGR FOOD CHEM, V53, P4403, DOI 10.1021/jf048839b
   Smuda M, 2013, ANGEW CHEM INT EDIT, V52, P4887, DOI 10.1002/anie.201300399
   Toepfl S, 2006, FOOD REV INT, V22, P405, DOI 10.1080/87559120600865164
   Yeom HW, 2000, J FOOD SCI, V65, P1359, DOI 10.1111/j.1365-2621.2000.tb10612.x
   Yilmaz Y, 2005, FOOD CHEM, V93, P273, DOI 10.1016/j.foodchem.2004.09.043
   Zhang NJ, 2011, EXP TOXICOL PATHOL, V63, P33, DOI 10.1016/j.etp.2009.09.005
   Zou H, 2016, FOOD BIOPROCESS TECH, V9, P217, DOI 10.1007/s11947-015-1606-9
   Zulueta A, 2013, FOOD BIOPROCESS TECH, V6, P2018, DOI 10.1007/s11947-012-0858-x
NR 37
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0023-6438
EI 1096-1127
J9 LWT-FOOD SCI TECHNOL
JI LWT-Food Sci. Technol.
PD JUN
PY 2017
VL 79
BP 534
EP 542
DI 10.1016/j.lwt.2016.10.061
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA EM9AL
UT WOS:000395603100066
OA No
DA 2017-08-17
ER

PT J
AU Allam, MGM
   Darwish, AMG
   Ayad, EHE
   Shokery, ES
   Darwish, SM
AF Allam, Marwa G. M.
   Darwish, Amira M. G.
   Ayad, Eman H. E.
   Shokery, Enaam S.
   Darwish, Saeid M.
TI Lactococcus species for conventional Karish cheese conservation
SO LWT-FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Karish; Lactococcus spp; EPS; Isolation; Rheology
ID DAIRY-PRODUCTS; RAW-MILK
AB Karish cheese is one of the most popular, oldest cheese varieties in Egypt and Arab countries. As a low fat cheese; it is a promising food in particularly for old people and whom suffering from obesity related diseases. The objective of this work was to isolate, identify and select Lactococcus lactic acid bacteria (LAB) from traditional Karish cheese to conserve and enhance the characteristics of conventional Karish cheese made of pasteurized milk to meet the new regulations for dairy production. Two Lactococcus strains were selected out of 11 Lactococcus LAB isolates from 15 Karish cheese samples, phenotypically and technologically characterized then identified using genotypic 16S rRNA approach. The two unique strains; L. lactis subsp cremoris (KM746) and the exopolysaccharide (EPS) producing strain L lactis subsp lactis (KM721) were applied as single starter cultures in comparison with commercial starter culture used in Karish cheese making. Selected LAB showed decent growth throughout processing and storage at 4 degrees C for 10 days preventing growth of coliform and staphylococci. Chemical composition of tested cheese samples was similar to the conventional Karish cheese, whilst rheological and sensorial properties were enhanced which encourage recommending these strains as starter cultures conserving and enhancing this type of traditional cheese. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Allam, Marwa G. M.; Darwish, Amira M. G.; Ayad, Eman H. E.; Darwish, Saeid M.] Univ Alexandria, Dept Food Sci, Fac Agr, 22 Tag El Roasaa St, Alexandria 21527, Egypt.
   [Darwish, Amira M. G.] Arid Lands Cultivat Res Inst, Dept Food Technol, SRTA City, Alexandria 21934, Egypt.
   [Shokery, Enaam S.] Univ Alexandria, Dairy Sci & Technol Dept, Fac Agr, Alexandria 21526, Egypt.
RP Darwish, AMG (reprint author), City Sci Res & Technol Applicat SRTA City, Dept Food Technol, Arid Lands Cultivat Res Inst, Alexandria 21934, Egypt.
EM amiragdarwish@yahoo.com
OI Darwish, Amira/0000-0003-3586-1575
FU Alexandria Research Enhancement Program (ALXREP); Alexandria University,
   Egypt
FX This work was financially supported by Alexandria Research Enhancement
   Program (ALXREP), Alexandria University, Egypt, project code (MILAB).
CR Abou-Donia S. A., 2008, ALEX J FD SCI TECHNO, V5, P51
   AOAC, 1990, OFFICIAL METHODS ANA, V1
   Ayad EHE, 2004, FOOD MICROBIOL, V21, P715, DOI 10.1016/j.fm.2004.02.009
   Ayad EHE, 2002, INT DAIRY J, V12, P145, DOI 10.1016/S0958-6946(01)00133-9
   Ayad E. H. E., 2001, THESIS
   BOURNE MC, 1978, FOOD TECHNOL-CHICAGO, V32, P62
   Breidt F., 1996, J RAPID METH AUT MIC, V4, P219, DOI 10.1111/j.1745-4581.1996.tb00125.x
   BSI, 1955, 696 BSI, P696
   Bunkoed O., 2014, 26 ANN M THAI SOC BI
   Cdc and Health Canada, 2012, JOINT FDA H IN PRESS, P9
   de la Plaza M, 2006, LETT APPL MICROBIOL, V43, P637, DOI 10.1111/j.1472-765X.2006.02012.x
   DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x
   Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623
   El Soda M., 2003, EMIR J AGR SCI, V15, P51
   Egyptian Standards, 2005, 100842005 EG STAND
   Fahmi A. H., 1960, J AGR SCI CAIRO U, V13, P1
   Felicio TL, 2016, FOOD CHEM, V196, P628, DOI 10.1016/j.foodchem.2015.09.102
   Gaze LV, 2015, J DAIRY SCI, V98, P1443, DOI 10.3168/jds.2014-8470
   Hamad M. N. F., 2015, International Journal of Food Science and Nutrition Engineering, V5, P130
   Harun-ur-Rashid M., 2007, Pakistan Journal of Nutrition, V6, P647
   Hassaine O., 2008, Emirates Journal of Food and Agriculture, V20, P46
   Ibrahim E. M., 1990, Assiut Journal of Agricultural Sciences, V21, P205
   Jesus ALT, 2016, FOOD RES INT, V81, P180, DOI 10.1016/j.foodres.2015.12.030
   Knoshaug EP, 2000, J DAIRY SCI, V83, P633
   Kongo J. M., 2013, LACTIC ACID BACTERIA, P3
   Ling E. R., 1945, TXB DAIRY CHEM
   MacFaddin J. F., 1976, BIOCH TESTS IDENTIFI, P643
   Maniatis T, 1982, MOL CLONING LAB MANU
   Marth E. H., 1978, STANDARD METHODS EXA
   Mostefaoui A., 2014, African Journal of Microbiology Research, V8, P2208
   Patel A., 2013, ADV DAIRY RES, V1, P1, DOI DOI 10.4172/2329-888X.1000107
   Prasad Patil, 2015, Asian Journal of Dairy and Food Research, V34, P280
   THIBOUTOT H, 1995, MILCHWISSENSCHAFT, V50, P448
   Todaro A, 2013, FOOD SCI TECHNOLOGY, V1, P1
   Wouters JTM, 2002, INT DAIRY J, V12, P91, DOI 10.1016/S0958-6946(01)00151-0
   Zycka-Krzesinska J, 2015, INT J FOOD MICROBIOL, V211, P134, DOI 10.1016/j.ijfoodmicro.2015.07.009
NR 36
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0023-6438
EI 1096-1127
J9 LWT-FOOD SCI TECHNOL
JI LWT-Food Sci. Technol.
PD JUN
PY 2017
VL 79
BP 625
EP 631
DI 10.1016/j.lwt.2016.11.032
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA EM9AL
UT WOS:000395603100077
OA No
DA 2017-08-17
ER

PT J
AU Ibrahim, AA
   Abdalla, MA
   Budimir, D
AF Ibrahim, Ahmed A.
   Abdalla, Mahmoud A.
   Budimir, Djuradj
TI COUPLED CRLH TRANSMISSION LINES FOR COMPACT AND HIGH SELECTIVE BANDPASS
   FILTERS
SO MICROWAVE AND OPTICAL TECHNOLOGY LETTERS
LA English
DT Article
DE bandpass filters; coupled-line coupler; CRLH TL
ID DESIGN; RESONATOR; SINGLE
AB A compact size and high selective bandpass filter is presented in this paper. The filter is designed to serve at 3.5 GHz with two transmission zeros at 3.35 GHz and 3.85 GHz. The filter is designed as two gap capacitor coupled to two coupled composite right-left handed transmission lines. The coupled lines were designed to demonstrate a zeroth order phase at 3.5 GHz. Also, the transmission zeros were achieved as a consequence of the electrical/magnetic couplings between the two coupled transmission lines. The employed cell, filter design equations are emphasized. The filter S-parameters were extracted based on the circuit model, full wave simulation, and experimental measurements. A good agreement between modeled, simulated, and measured results is achieved. The measured center frequency of the bandpass filter is 3.55 GHz and 100 MHz bandwidth which is suitable for WiMAX applications. Also, the filter has low measured insertion loss which does not exceed 1 dB within passband. Finally, the filter has advantages of compactness (size is 20 x 18 mm 2) which is only 50% compared to conventional non- selective one-stage coupled line filter. (C) 2017 Wiley Periodicals, Inc.
C1 [Ibrahim, Ahmed A.] Menia Univ, Fac Engn, Al Minya, Egypt.
   [Ibrahim, Ahmed A.] Univ Magdeburg, Inst Micro & Sensor Syst, Magdeburg, Germany.
   [Abdalla, Mahmoud A.] MTC Coll Cairo, Dept Elect Engn, Cairo, Egypt.
   [Budimir, Djuradj] Univ Westminster, Wireless Commun Res Grp, London, England.
RP Ibrahim, AA (reprint author), Menia Univ, Fac Engn, Al Minya, Egypt.; Ibrahim, AA (reprint author), Univ Magdeburg, Inst Micro & Sensor Syst, Magdeburg, Germany.
EM ahmedabdel_monem@mu.edu.eg
OI Abdalla, Mahmoud/0000-0001-6759-7268
CR Abdalla MA, 2009, IET MICROW ANTENNA P, V3, P695, DOI 10.1049/iet-map.2008.0142
   Abdalla MA, 2016, IET MICROW ANTENNA P, V10, P406, DOI 10.1049/iet-map.2015.0515
   Boutejdar A, 2016, MICROW OPT TECHN LET, V58, P947, DOI 10.1002/mop.29705
   Caloz C, 2006, ELECTROMAGNETIC METAMATERIALS: TRANSMISSION LINE THEORY AND MICROWAVE APPLICATIONS: THE ENGINEERING APPROACH, P1
   Chen CY, 2006, IEEE MICROW WIREL CO, V16, P246, DOI 10.1109/LMWC.2006.873584
   Eleftheriades GV, 2005, NEGATIVE-REFRACTION METAMATERIALS: FUNDAMENTAL PRINCIPLES AND APPLICATIONS, P1, DOI 10.1002/0471744751
   Fouad MA, 2014, IET MICROW ANTENNA P, V8, P1097, DOI 10.1049/iet-map.2013.0698
   Hong JS, 2000, IEEE T MICROW THEORY, V48, P1098, DOI 10.1109/22.848492
   Hong J.-S., 2011, MICROSTRIP FILTERS R
   Karimian S., 2012, IEEE MICROW WIREL CO, V22, P421
   Liao CK, 2005, IEEE T MICROW THEORY, V53, P2302, DOI 10.1109/TMTT.2005.850442
   Lim T, 2014, IET MICROW ANTENNA P, V8, P1192, DOI 10.1049/iet-map.2014.0085
   Lin SC, 2014, IEEE T MICROW THEORY, V62, P2911, DOI 10.1109/TMTT.2014.2361340
   Nguyen H.V., 2007, IEEE T MICROW THEORY, V55, P1029, DOI DOI 10.1109/TMTT.2007.895646
   Tsai CM, 2002, IEEE T MICROW THEORY, V50, P2362, DOI 10.1109/TMTT.2002.803421
   Wang HA, 2010, IEEE MICROW WIREL CO, V20, P372, DOI 10.1109/LMWC.2010.2049426
   Wen H., 2012, P INT WORKSH MICR MI, P1
   Yeo KSK, 2001, IEEE T MICROW THEORY, V49, P321, DOI 10.1109/22.903092
NR 18
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0895-2477
EI 1098-2760
J9 MICROW OPT TECHN LET
JI Microw. Opt. Technol. Lett.
PD JUN
PY 2017
VL 59
IS 6
BP 1248
EP 1251
DI 10.1002/mop.30518
PG 5
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA EQ2LJ
UT WOS:000397900300005
OA No
DA 2017-08-17
ER

PT J
AU El-Nashar, YI
AF El-Nashar, Y. I.
TI Response of snapdragon (Antirrhinum majus L.) to blended water
   irrigation and arbuscular mycorrhizal fungi inoculation: uptake of
   minerals and leaf water relations
SO PHOTOSYNTHETICA
LA English
DT Article
DE blending water; leaf water relations; mineral composition; mycorrhizal
   fungi; salt water
ID SALT STRESS; DROUGHT STRESS; PLANT-RESPONSES; MAIZE PLANTS; GROWTH;
   GLOMUS; TOMATO; ALLEVIATION; TOLERANCE; SALINITY
AB A greenhouse study was performed in order to investigate the effects of three arbuscular mycorrhizal fungi (AMF) species on vegetative growth, water relations, and mineral composition parameters of snapdragon (Antirrhinum majus cv. Bells white) under irrigation from different water sources. Five irrigation treatments included using purely desalinized (fresh) water (DW), as a control, three different blends of DW with saline ground water from a well with increasing salinity, and one with 100% of saline well water. Inoculation with AMF enhanced growth rates and a relative water content of snapdragon plants grown under well-water irrigation. AMF also improved the leaf water potential and increased water-use efficiency of the plants. Shoot and root dry masses were higher in the AMF-treated plants than those in AMF-free plants. In both shoots and roots, concentrations of total P, Ca2+, N, Mg2+, and K+ were higher in the AMF-treated plants compared with AMF-free plants under salt-stress conditions. Shoot Cl- and Na+ concentrations were lower in the AMF-treated plants than those in the AMF-free plants grown under well-water irrigation. Snapdragon plants exhibited a high degree of dependency on AMF; it improved plant growth rates and leaf water relations, particularly, with increasing salinity of irrigation water.
C1 [El-Nashar, Y. I.] King Saud Univ, Plant Prod Dept, Coll Food & Agr Sci, POB 2460, Riyadh 11451, Saudi Arabia.
   [El-Nashar, Y. I.] ARC, Inst Hort Res, Al Montaza Garden, Ornamental Plants & Landscape Gardening Res Dept, Giza, Egypt.
RP El-Nashar, YI (reprint author), King Saud Univ, Plant Prod Dept, Coll Food & Agr Sci, POB 2460, Riyadh 11451, Saudi Arabia.; El-Nashar, YI (reprint author), ARC, Inst Hort Res, Al Montaza Garden, Ornamental Plants & Landscape Gardening Res Dept, Giza, Egypt.
EM yelnashar@ksu.edu.sa
FU College of Food and Agricultural Research Center, King Saud University,
   Saudi Arabia; Deanship of Scientific Research, King Saud University,
   Saudi Arabia
FX Authors wish to thank to College of Food and Agricultural Research
   Center and Deanship of Scientific Research, King Saud University, Saudi
   Arabia for supporting this work.
CR Aditya Kumar, 2012, Advances in Bio Research, V3, P78
   Al-Karaki GN, 2006, SCI HORTIC-AMSTERDAM, V109, P1, DOI 10.1016/j.scienta.2006.02.019
   Al-Karaki GN, 2001, MYCORRHIZA, V11, P43, DOI 10.1007/s005720100098
   Al-Karaki GN, 2000, MYCORRHIZA, V10, P51, DOI 10.1007/s005720000055
   Al-Karaki GN, 1998, J PLANT NUTR, V21, P263, DOI 10.1080/01904169809365401
   Al-Khaliel AS, 2010, PLANT SOIL ENVIRON, V56, P318
   AlKaraki GN, 1997, J PLANT NUTR, V20, P1635
   Allen SE, 1989, CHEM ANAL ECOLOGICAL, P368
   Amer A. F., 1999, Egyptian Journal of Soil Science, V39, P111
   Aroca R, 2008, MICROB ECOL, V56, P704, DOI 10.1007/s00248-008-9390-y
   Auge RM, 2004, CAN J SOIL SCI, V84, P373
   Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097
   BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060
   Bhoopander Giri, 1999, Annals of Agricultural Research, V20, P109
   Borde M, 2011, CROP PROT, V30, P265, DOI 10.1016/j.cropro.2010.12.010
   Bulir P, 2009, HORTIC SCI, V36, P154
   Campanelli A., 2012, Journal of Agricultural Science and Technology A, V2, P1071
   Campanelli A, 2013, SYMBIOSIS, V59, P65, DOI 10.1007/s13199-012-0191-1
   Cantrell IC, 2001, PLANT SOIL, V233, P269, DOI 10.1023/A:1010564013601
   Carter CT, 2008, HORTSCIENCE, V43, P710
   Cekic FO, 2012, TURK J BOT, V36, P63, DOI 10.3906/bot-1008-32
   Chapman HD, 1961, METHODS ANAL SOILS P, P184
   Colla G, 2008, BIOL FERT SOILS, V44, P501, DOI 10.1007/s00374-007-0232-8
   Crespo R.J., 2015, THESIS, P92
   DeHayr R., 2004, NATL RES SCI, V55, P55
   El-Nashar YI, 2014, ACTA HORTIC, V1034, P379
   Evelin H, 2012, MYCORRHIZA, V22, P203, DOI 10.1007/s00572-011-0392-0
   Evelin H, 2009, ANN BOT-LONDON, V104, P1263, DOI 10.1093/aob/mcp251
   Giri B, 2004, MYCORRHIZA, V14, P307, DOI 10.1007/s00572-003-0274-1
   Giri B, 2003, BIOL FERT SOILS, V38, P170, DOI 10.1007/s00374-003-0636-z
   Giri B, 2007, MICROB ECOL, V54, P753, DOI 10.1007/s00248-007-9239-9
   Gutierrez-Boem FH, 1999, PLANT SOIL, V207, P87
   Hatimi A, 1999, PLANT SOIL, V216, P93, DOI 10.1023/A:1004745707277
   Kaya C, 2003, J PLANT NUTR, V26, P807, DOI 10.1081/PLN-120018566
   Kaya C, 2002, SCI HORTIC-AMSTERDAM, V93, P53, DOI 10.1016/S0304-4238(01)00310-7
   Kaya C, 2007, ENVIRON EXP BOT, V60, P397, DOI 10.1016/j.envexpbot.2006.12.008
   Kaya C, 2009, SCI HORTIC-AMSTERDAM, V121, P1, DOI 10.1016/j.scienta.2009.01.001
   Khan H. R., 1992, International Journal of Tropical Agriculture, V10, P147
   Kramer P. J., 1995, WATER RELATIONS PLAN, P495
   Lovelli S, 2007, AGR WATER MANAGE, V92, P73, DOI 10.1016/j.agwat.2007.05.005
   Mohiuddin ASM, 1997, RUSS J ECOL+, V28, P298
   Morte A, 2000, MYCORRHIZA, V10, P115, DOI 10.1007/s005720000066
   MUNNS R, 1993, PLANT CELL ENVIRON, V16, P15, DOI 10.1111/j.1365-3040.1993.tb00840.x
   NELSEN CE, 1982, J AM SOC HORTIC SCI, V107, P271
   NELSON DW, 1973, AGRON J, V65, P109
   Noufal E.H.A., 2000, ANN AGR SCI, V38, P1329
   Porcel R, 2004, J EXP BOT, V55, P1743, DOI 10.1093/jxb/erh188
   Ragab R, 2005, AGR WATER MANAGE, V78, P67, DOI 10.1016/j.agwat.2005.04.022
   Rahmaty R, 2011, TURK J BIOL, V35, P51, DOI 10.3906/biy-0811-3
   ROSENDAHL CN, 1991, ENVIRON EXP BOT, V31, P313, DOI 10.1016/0098-8472(91)90055-S
   Ruiz-Lozano JM, 2003, MYCORRHIZA, V13, P309, DOI 10.1007/s00572-003-0237-6
   RUIZLOZANO JM, 1995, APPL ENVIRON MICROB, V61, P456
   RuizLozano JM, 1995, PHYSIOL PLANTARUM, V95, P472, DOI 10.1111/j.1399-3054.1995.tb00865.x
   RuizLozano JM, 1996, PHYSIOL PLANTARUM, V98, P767, DOI 10.1034/j.1399-3054.1996.980413.x
   SAS Institute Inc, 2008, SAS STAT 9 2 US GUID
   SENTENAC H, 1985, PLANT PHYSIOL, V77, P136, DOI 10.1104/pp.77.1.136
   Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7
   Shokri S., 2009, Journal of Agronomy, V8, P79
   Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1
   Steel R.G., 1980, PRINCIPLES PROCEDURE, P232
   Subramanian KS, 1997, MYCORRHIZA, V7, P25, DOI 10.1007/s005720050159
   Vanaja M, 2011, PLANT SOIL ENVIRON, V57, P207
   Wu QS, 2010, SCI HORTIC-AMSTERDAM, V125, P289, DOI 10.1016/j.scienta.2010.04.001
   Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024
   Zhu XC, 2012, PLANT SOIL ENVIRON, V58, P186
NR 65
TC 0
Z9 0
U1 29
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-3604
EI 1573-9058
J9 PHOTOSYNTHETICA
JI Photosynthetica
PD JUN
PY 2017
VL 55
IS 2
BP 201
EP 209
DI 10.1007/s11099-016-0650-7
PG 9
WC Plant Sciences
SC Plant Sciences
GA EQ9WN
UT WOS:000398437100001
OA No
DA 2017-08-17
ER

PT J
AU Hassan, RYA
   El-Attar, RO
   Hassan, HNA
   Ahmed, MA
   Khaled, E
AF Hassan, Rabeay Y. A.
   El-Attar, Rehab O.
   Hassan, Hassan N. A.
   Ahmed, Mona A.
   Khaled, Elmorsy
TI Carbon nanotube-based electrochemical biosensors for determination of
   Candida albicans's quorum sensing molecule
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Candida albicans; Quorum sensing molecule; Electrochemical biosensors;
   Carbon nanotubes; Crown ethers
ID SACCHAROMYCES-CEREVISIAE; BIOFILM FORMATION; ALCOHOLS; TYROSOL; HUMANS
AB Candida albicans produces various quorum sensing molecules (QSMs) which are involved in biological processes, e.g. morphological changes or biofilm formation. Thus, a sensitive and selective electrochemical assay was developed for determination of tryptophol as one of the most important QSMs. Preparation, characterization, and testing the electrocatalytic activity of prepared sensors with various sensing elements and nanomaterials were investigated. In addition, the effects of supporting electrolytes, pH of buffer solutions, scan rate, and possible interferences on the response of tryptophol's sensor were studied. Eventually, improving the sensitivity and selectivity were achieved using a combination of 12-crwon-4-ether and MWCNTs (10% w/w for each). With the developed electrochemical sensor, the linear response was observed from 10 p.g/ml to 110 mu g/ml with the detection limit of 1 mu g/ml and regression coefficient of 0.998. Consequently, the method was successfully applied for the detection of tryptophol in the fungal culture. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Hassan, Rabeay Y. A.; El-Attar, Rehab O.; Hassan, Hassan N. A.; Khaled, Elmorsy] Natl Res Ctr, Appl Organ Chem Dept, Microanal Lab, El Bohouth St, Giza 12622, Egypt.
   [Ahmed, Mona A.] Ain Shams Univ, Dept Chem, Fac Women Arts Sci & Educ, Cairo, Egypt.
RP Hassan, RYA (reprint author), Natl Res Ctr, Appl Organ Chem Dept, Microanal Lab, El Bohouth St, Giza 12622, Egypt.
EM rabeayy@gmail.com
OI Hassan, Rabeay/0000-0002-1867-9643
FU National Research Centre (NRC, Cairo) [1014002]
FX The authors acknowledge the financial support received from National
   Research Centre (NRC, Cairo) for funding the research project (code:
   1014002). Great thanks to Dr. Mona Eissawy for offering Candida albicans
   cultures from the department of Chemistry of Natural and Microbial
   Products, Pharmaceutical industry division. We are very grateful for the
   group leader of Biological Systems Analysis (Prof. Dr. Ursula
   Bilitewski, Helmholtz Centre for Infection Research, HZI, Braunschweig,
   Germany) for presenting the electrochemical station (Gamry
   Potentiostat/Galvanostat/ZRAG750).
CR Alem MAS, 2006, EUKARYOT CELL, V5, P1770, DOI 10.1128/EC.00219-06
   Avbelj M, 2015, J AGR FOOD CHEM, V63, P8544, DOI 10.1021/acs.jafc.5b03400
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101
   Deveau A, 2011, METHODS MOL BIOL, V692, P219, DOI 10.1007/978-1-60761-971-0_16
   Dickinson JR, 2003, J BIOL CHEM, V278, P8028, DOI 10.1074/jbc.M211914200
   Ghosh S, 2008, APPL ENVIRON MICROB, V74, P7211, DOI 10.1128/AEM.01614-08
   Gozalbo Daniel, 2004, Current Drug Targets - Infectious Disorders, V4, P117, DOI 10.2174/1568005043341046
   Han TL, 2011, FUNGAL GENET BIOL, V48, P747, DOI 10.1016/j.fgb.2011.04.002
   Hargarten JC, 2015, INFECT IMMUN, V83, P3857, DOI 10.1128/IAI.00886-15
   Hassan RYA, 2014, SENSOR ACTUAT B-CHEM, V203, P848, DOI 10.1016/j.snb.2014.07.059
   Hassan RYA, 2013, BIOSENS BIOELECTRON, V49, P192, DOI 10.1016/j.bios.2013.05.015
   Hassan RYA, 2011, ANAL BIOCHEM, V419, P26, DOI 10.1016/j.ab.2011.07.025
   Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211
   LINGAPPA BT, 1969, SCIENCE, V163, P192, DOI 10.1126/science.163.3863.192
   Lu Y, 2014, P NATL ACAD SCI USA, V111, P1975, DOI 10.1073/pnas.1318690111
   Mavor A. L., 2005, CURR DRUG TARGETS, V6, P863
   McFarlane W. D., 1964, J I BREWING, V70, P497
   Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06
   Sedki M, 2016, INT J BIOL MACROMOL, V93, P543, DOI 10.1016/j.ijbiomac.2016.09.016
   Shchepin R, 2003, CHEM BIOL, V10, P743, DOI 10.1016/S1074-5521(03)00158-3
   van Burik JAH, 2001, ANNU REV MICROBIOL, V55, P743, DOI 10.1146/annurev.micro.55.1.743
   Wilson AD, 2015, METABOLITES, V5, P140, DOI 10.3390/metabo5010140
NR 23
TC 1
Z9 1
U1 15
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JUN
PY 2017
VL 244
BP 565
EP 570
DI 10.1016/j.snb.2017.01.028
PG 6
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA EN4FL
UT WOS:000395963300064
OA No
DA 2017-08-17
ER

PT J
AU Khaled, E
   Khalil, MM
   el Aziz, GMA
AF Khaled, Elmorsy
   Khalil, M. M.
   el Aziz, G. M. Abed
TI Calixarene/carbon nanotubes based screen printed sensors for
   potentiometric determination of gentamicin sulphate in pharmaceutical
   preparations and spiked surface water samples
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Gentamicin sulphate (GNS); Disposable potentiometric sensor; Calixarene;
   Carbon nanotubes; Surface water samples; Pharmaceutical analysis
ID ION-SELECTIVE ELECTRODES; CARBON NANOTUBES; MEMBRANE ELECTRODES;
   BIOLOGICAL-FLUIDS; CROWN-ETHERS; DERIVATIVES; CYCLODEXTRIN; RECEPTORS;
   BROMIDE
AB Sensitive disposable sensors have been introduced for potentiometric determination of gentamicin sulphate (GNS) based on multi-walled carbon nanotubes-polyvinyl chloride (MWNTs-PVC) composite in presence of calixarene as a molecular recognition element. The proposed sensors showed remarkable selectivity and sensitivity in the GNS concentration range from 10(-7) to 10(-2) mol L-1 with Nernstian slope 30.5 +/- 0.4 mV decade(-1) and detection limit of 7.5 x 10(-8) mol L-1. Modification with carbon nano tubes improved the sensors performance was through promotion of the electron-transfer processes and enhancing the stability of potential reading, response time, and shelf lifetime of sensors. The proposed method has been applied for the potentiometric assay of GNS in different dosage forms and spiked surface water samples with average recoveries agreeable with the reported official method. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Khaled, Elmorsy] Natl Res Ctr, Appl Organ Chem Dept, Microanal Lab, El Bohouth St,Dokki, Giza 12622, Egypt.
   [Khalil, M. M.; el Aziz, G. M. Abed] Beni Suef Univ, Fac Sci, Dept Chem, Bani Suwayf, Egypt.
RP Khaled, E (reprint author), Natl Res Ctr, Appl Organ Chem Dept, Microanal Lab, El Bohouth St,Dokki, Giza 12622, Egypt.
EM elmorsykhaled@yahoo.com
CR Angnes L., 2014, ENV ANAL ELECTROCHEM, V2
   Bakker E, 1999, ELECTROANAL, V11, P915, DOI 10.1002/(SICI)1521-4109(199909)11:13<915::AID-ELAN915>3.0.CO;2-J
   BAUMANN EW, 1968, ANAL CHIM ACTA, V42, P127, DOI 10.1016/S0003-2670(01)80277-4
   BOBACKA J, 1995, ANAL CHEM, V67, P3819, DOI 10.1021/ac00116a034
   BUCK RP, 1994, PURE APPL CHEM, V66, P2527, DOI 10.1351/pac199466122527
   Chen CH, 2014, J FORMOS MED ASSOC, V113, P72, DOI 10.1016/j.jfma.2013.10.002
   Chuong M. C., 2013, INT J PHARM ANAL, V4, P25
   Cosofret V., 1992, PHARM APPL MEMBRANE
   Couto RAS, 2016, TALANTA, V146, P801, DOI 10.1016/j.talanta.2015.06.011
   Danet A., 1998, J FLOW INJECTION ANA, V15, P168
   [Anonymous], 2009, BRIT PHARM, V2, P8374
   El-Kosasy AM, 2011, TALANTA, V85, P913, DOI 10.1016/j.talanta.2011.04.071
   Faridbod F, 2008, SENSORS-BASEL, V8, P1645, DOI 10.3390/s8031645
   Finkel R., 2017, LIPPINCOTT LLUSTRATE, p[411, 374]
   Ganjali MR, 2006, SENSORS-BASEL, V6, P1018, DOI 10.3390/s6081018
   Gonzalez LS, 1998, AM FAM PHYSICIAN, V58, P1811
   Gutsche CD, 2008, MONOGR SUPRAMOL CHEM, P1, DOI 10.1039/9781847558190-FP001
   Hassouna MEM, 2015, INT J ELECTROCHEM SC, V10, P162
   Ji XB, 2010, ELECTROANAL, V22, P7, DOI 10.1002/elan.200900493
   Joseph A, 2010, J PHARMACEUT BIOMED, V51, P521, DOI 10.1016/j.jpba.2009.09.002
   Kaale E, 2000, J CHROMATOGR A, V895, P67, DOI 10.1016/S0021-9673(00)00412-X
   Khaled E, 2014, TALANTA, V119, P467, DOI 10.1016/j.talanta.2013.11.001
   Khaled E, 2010, DRUG TEST ANAL, V2, P424, DOI 10.1002/dta.159
   Khalil MM, 2016, MAT SCI ENG C-MATER, V59, P838, DOI 10.1016/j.msec.2015.10.095
   Khalil M. M., 2016, ELECTROANALYSIS, DOI http://dx.doi.org/10.1002/elan.201600444
   Khalil M. M., 2014, INT J ADV RES, V2, P426
   Kulapina EG, 2005, J ANAL CHEM+, V60, P523, DOI 10.1007/s10809-005-0133-7
   Kurzatkowska K, 2015, SENSOR ACTUAT B-CHEM, V218, P111, DOI 10.1016/j.snb.2015.04.110
   Li M, 2012, ANAL CHIM ACTA, V734, P31, DOI 10.1016/j.aca.2012.05.018
   Lo PK, 2008, SENSORS-BASEL, V8, P5313, DOI 10.3390/s8095313
   Macartney D. H., 2008, J AM CHEM SOC, V130, P10032, DOI 10.1021/ja804385t
   McMahon G, 2003, ARKIVOC, P23
   Merkoci A, 2005, TRAC-TREND ANAL CHEM, V24, P826, DOI 10.1016/j.trac.2005.03.019
   Mohamed HM, 2016, TRAC-TREND ANAL CHEM, V82, P1, DOI 10.1016/j.trac.2016.02.010
   Morf W. E., 1981, PRINCIPLES ION SELEC
   Omar M.A., 2013, J APPL PHARM SCI, V3, P151
   PEDERSEN CJ, 1988, SCIENCE, V241, P536, DOI 10.1126/science.241.4865.536
   Schmitt-Kopplin P., 2008, CAPILLARY ELECTROPHO
   Shahgaldian P, 2006, SENSORS-BASEL, V6, P593, DOI 10.3390/s6060593
   Spitalsky Z, 2010, PROG POLYM SCI, V35, P357, DOI 10.1016/j.progpolymsci.2009.09.003
   Stefan RI, 1997, CRIT REV ANAL CHEM, V27, P307, DOI 10.1080/10408349708050589
   Trojanowicz M, 2003, ELECTROANAL, V15, P347, DOI 10.1002/elan.200390041
   Umezawa K., 1990, CRC HDB ION SELECTIV
   Umezawa Y, 2000, PURE APPL CHEM, V72, P1851, DOI 10.1351/pac200072101851
   VYTRAS K, 1985, ION SEL ELECTRODE R, V7, P77
   Vytras K., 1995, ENCY PHARM TECHNOLOG
   Weber E., 1995, SUPRAMOLECULAR CHEM
   WEINSTEIN MJ, 1963, J MED CHEM, V6, P463, DOI 10.1021/jm00340a034
   Weinstein M. J., 1963, ANTIMICROB AGENTS CH, V1, P1
   Yu Q, 2010, ELECTROANAL, V22, P1012, DOI 10.1002/elan.200900482
   Zareh MM, 2007, J AOAC INT, V90, P147
   Zen JM, 2003, ELECTROANAL, V15, P1073, DOI 10.1002/elan.200390130
NR 52
TC 0
Z9 0
U1 17
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JUN
PY 2017
VL 244
BP 876
EP 884
DI 10.1016/j.snb.2017.01.033
PG 9
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA EN4FL
UT WOS:000395963300102
OA No
DA 2017-08-17
ER

PT J
AU Abd El-Halim, AA
AF Abd El-Halim, A. A.
TI Image processing technique to assess the use of sugarcane pith to
   mitigate clayey soil cracks: Laboratory experiment
SO SOIL & TILLAGE RESEARCH
LA English
DT Article
DE Shrinkage; Water holding capacity; Soil cracking behavior; Sugarcane
   pith
ID SANDY SOIL; DESICCATION; BAGASSE; SURFACE; FIBER; STRENGTH;
   QUANTIFICATION; POLYACRYLAMIDE; BEHAVIOR; FIELD
AB Rapid transport of water and solutes through desiccation soil cracks can lead to crop water and nutrient stress. The challenge of irrigation management of cracking soils is to take advantage of the rapid water intake rate of a dry, cracked soil, while keeping plant water stress at a minimum. Therefore, mitigation not suppression of desiccation cracks is imperative and considered our objective of this study. A laboratory experiment was carried out to investigate the effects of sugarcane pith additive on mitigating desiccation cracks, the volumetric shrinkage strain, the total porosity, and water retention at field capacity of clay soils. The clay soil was treated with the sugarcane pith at dosages of 1, 2, 3, 4 and 5% on dry weight basis. Various experimental methods were used to determine the variations in volumetric shrinkage, total porosity and water retention at field capacity. The characteristics of crack patterns were studied using an image processing technique. Compared with the untreated soil, the results showed that the sugarcane pith can increase the total porosity and water content at field capacity, while reducing volumetric shrinkage strain, and consequently, mitigating the development of desiccation cracks. Therefore, results suggested that the modification of clayey soil by the addition of the sugarcane pith by rates up to 2% on dry weight basis can be a viable and innovative method to mitigate the development of desiccation cracks. In addition, this application will enhance recycling efforts by converting sugarcane pith waste into usable amendment to mitigate cracks in clayey soil. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Abd El-Halim, A. A.] Tanta Univ, Fac Agr, Dept Soil & Water, Tanta 31527, Egypt.
RP Abd El-Halim, AA (reprint author), Tanta Univ, Fac Agr, Dept Soil & Water, Tanta 31527, Egypt.
EM halim.ismail@agr.tanta.edu.eg
CR Abd El Halim AA, 2014, J SOIL SCI PLANT NUT, V14, P483
   Abd El-Halim AA, 2015, INT AGROPHYS, V29, P101, DOI 10.1515/intag-2015-0008
   Abd-Allah A. M. A., 2009, JKAU EARTH SCI, V20, P141
   Abdi MR, 2008, INT J CIV ENG, V6, P284
   ABUHEJLEH AN, 1995, J GEOTECH ENG-ASCE, V121, P493, DOI 10.1061/(ASCE)0733-9410(1995)121:6(493)
   Aguilar Torres M. A., 2004, Spanish Journal of Agricultural Research, V2, P473
   Ali Z.A., 2003, GEZIRA J AGR SCI, V1, P1
   Asher C., 2002, ACIAR AUSTR CTR INT, V83
   [Anonymous], 2007, ANN BOOK ASTM STAND
   Atique A., 2011, 2 INT C ENV SCI TECH, V6, P66
   Azam W. R., 2014, INT J GEOMAT, V7, P927
   Bhogal A, 2009, EUR J SOIL SCI, V60, P276, DOI 10.1111/j.1365-2389.2008.01105.x
   Carroll D. A., 2014, USING AGR BYPRODUCTS
   Cifuentes R, 2013, SUGAR TECH, V15, P406, DOI 10.1007/s12355-013-0217-x
   Deb T, 2014, INT J RES ENG TECHNO, V3, P507
   Estefan G., 2013, METHODS SOIL P LANT
   Haluschak P., 2006, LAB METHODS ANAL CAN, P12
   Hasibul M.H., 2013, INT J ENG RES ONLINE, V1, P35
   Hughes J. C., 2001, South African Journal of Plant and Soil, V18, P128
   Inbar A, 2015, GEODERMA, V239, P107, DOI 10.1016/j.geoderma.2014.09.026
   Intharasombat N, 2007, J INFRASTRUCT SYST, V13, P287, DOI 10.1061/(ASCE)1076-0342(2007)13:4(287)
   Jianhua R., 2015, CHINESE GEOGR SCI, V25, P591
   Kishne AS, 2010, GEODERMA, V157, P109, DOI 10.1016/j.geoderma.2010.03.020
   Kodikara J., 2002, AUST GEOMECH, V7, P25
   Krishna Rani, 2012, Journal of Chemical and Pharmaceutical Research, V4, P1505
   Kumar A, 2006, CONSTR BUILD MATER, V20, P1063, DOI 10.1016/j.conbuildmat.2005.02.027
   Lee SC, 2008, MATER LETT, V62, P2253, DOI 10.1016/j.matlet.2007.11.097
   Lehrsch GA, 2012, GEODERMA, V189, P199, DOI 10.1016/j.geoderma.2012.06.015
   Li JH, 2011, ENG GEOL, V123, P347, DOI 10.1016/j.enggeo.2011.09.015
   Li X, 2014, APPL SOIL ECOL, V73, P58, DOI 10.1016/j.apsoil.2013.08.005
   Liu C, 2013, COMPUT GEOSCI-UK, V57, P77, DOI 10.1016/j.cageo.2013.04.008
   Lois-Correa J.A, 2012, Ing. invest. y tecnol., V13, P417
   Mamedov AI, 2010, SOIL SCI SOC AM J, V74, P1720, DOI 10.2136/sssaj2009.0279
   Maulood Y.I., 2015, ZANCO J PURE APPL SC, V27, P31
   Miller CJ, 1998, J AM WATER RESOUR AS, V34, P677, DOI 10.1111/j.1752-1688.1998.tb00964.x
   MITCHELL AR, 1993, SOIL SCI SOC AM J, V57, P490
   MORRIS PH, 1992, CAN GEOTECH J, V29, P263
   Nahlawi H, 2006, GEOTECH GEOL ENG, V24, P1641, DOI 10.1007/s10706-005-4894-4
   Novak V, 1999, AGR FOREST METEOROL, V98-9, P501, DOI 10.1016/S0168-1923(99)00119-7
   Pandey A, 2000, BIORESOURCE TECHNOL, V74, P69, DOI 10.1016/S0960-8524(99)00142-X
   Pruangka S., 2012, INT J ENV RURAL DEV, V3, P181
   Puppala AJ, 2000, TRANSPORT RES REC, P134
   Puppala J.A.J. Anand, 2006, 045731 TEX DEP TRANS
   Rainey TJ, 2012, APPITA J, V65, P178
   RingroseVoase AJ, 1996, GEODERMA, V71, P245, DOI 10.1016/0016-7061(96)00008-0
   Rolz C, 2010, SUGAR TECH, V12, P15
   Romkens MJM, 2006, AGR WATER MANAGE, V86, P196, DOI 10.1016/j.agwat.2006.07.012
   Samariha A, 2011, BIORESOURCES, V6, P3313
   Sojka RE, 2007, ADV AGRON, V92, P75, DOI 10.1016/S0065-2113(04)92002-0
   Taha O.M., 2014, INT J SCI TECHNOL RE, V3, P47
   Tang CS, 2011, GEODERMA, V166, P111, DOI 10.1016/j.geoderma.2011.07.018
   Tang CS, 2011, APPL CLAY SCI, V52, P69, DOI 10.1016/j.clay.2011.01.032
   Tang CS, 2010, ENG GEOL, V114, P261, DOI 10.1016/j.enggeo.2010.05.003
   Tang CS, 2008, ENG GEOL, V101, P204, DOI 10.1016/j.enggeo.2008.05.005
   [唐朝生 Tang Chaosheng], 2012, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V34, P2181
   Tariful M.I., 1999, PERTANIKA J TROP AGR, V22, P25
   TESTER CF, 1990, SOIL SCI SOC AM J, V54, P827
   Vogel HJ, 2005, GEODERMA, V125, P203, DOI 10.1016/j.geoderma.2004.07.009
   Wirawan R., 2010, IOP C SER MAT SCI EN, V11
   Wu K., 2014, INT C MECH CIV ENG I, P112
   Xing Y, 2010, CHINA PULP PAP, V17, P28
   Yan A, 2002, CEMENT CONCRETE RES, V32, P1371, DOI 10.1016/S0008-8846(02)00788-3
   Yesiller N, 2000, ENG GEOL, V57, P105, DOI 10.1016/S0013-7952(00)00022-3
NR 63
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-1987
EI 1879-3444
J9 SOIL TILL RES
JI Soil Tillage Res.
PD JUN
PY 2017
VL 169
BP 138
EP 145
DI 10.1016/j.sti11.2017.02.007
PG 8
WC Soil Science
SC Agriculture
GA EP9JR
UT WOS:000397690400015
OA No
DA 2017-08-17
ER

PT J
AU Selim, MS
   Shenashen, MA
   El-Safty, SA
   Higazy, SA
   Selim, MM
   Isago, H
   Elmarakbi, A
AF Selim, M. S.
   Shenashen, M. A.
   El-Safty, Sherif A.
   Higazy, S. A.
   Selim, M. M.
   Isago, H.
   Elmarakbi, A.
TI Recent progress in marine foul-release polymeric nanocomposite coatings
SO PROGRESS IN MATERIALS SCIENCE
LA English
DT Review
DE Foul-release (FR); Nanocoatings Polymeric nanocomposite; Inorganic
   nanofillers; Environment
ID METAL-OXIDE NANOPARTICLES; SELF-ASSEMBLED MONOLAYERS; TOUGH
   HYPERBRANCHED EPOXY; FILM COMPOSITE MEMBRANES; LOW SURFACE-ENERGY;
   GREEN-ALGA ULVA; GRAPHENE OXIDE; ANTIFOULING COATINGS; CARBON NANOTUBES;
   SUPERHYDROPHOBIC SURFACES
AB Progress in materials science is associated with the development of nanomaterials in terms of energy-saving, environmentally friendly, and low-cost methods. Since the use of tributyltin compounds in antifouling coatings was banned in 2003, the search for ecofriendly alternatives has been promoted. Foul-release (FR) nanocoatings have been extensively investigated because of their non-stick, ecological, and economic advantages. Such nanocomposite systems are dynamic non-stick surfaces that deter any fouling attachment through physical anti-adhesion terminology. Instead of biocidal solutions, several functional FR nanocomposite coatings have been developed to counter biofouling and biocorrosion with ecological and ecofriendly effects. Selected inorganic nanofillers have been incorporated because of their enhanced interaction at the filler-polymer interface for nanocomposites. Metallic nanoparticles and their oxides have also been widely explored because of their unique morphological characteristics and size-dependent, self-cleaning properties. In modeling a novel series of FR nanocoatings, two modes of prevention are combined: chemical inertness and physical microfouling repulsion for maritime navigation applications. Long-term durability and self-cleaning performance are among the advantages of developing effective, stable, and ecofriendly modeling alternatives. This review provides a holistic overview of nano-FR research achievements and describes recent advancements in non-stick marine nanocoatings for ship hulls. This review highlights the key issues of nanocomposite structures and their features in improving the biological activity and surface self-cleaning performance of ship hulls. This review may also open new horizons toward futuristic developments in FR nanocomposites for maritime navigations. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Selim, M. S.; Shenashen, M. A.; El-Safty, Sherif A.; Isago, H.] Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
   [Selim, M. S.; Shenashen, M. A.; Higazy, S. A.] EPRI, Petr Applicat Dept, Nasr City 11727, Cairo, Egypt.
   [El-Safty, Sherif A.] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.
   [Selim, M. M.] Prince Sattam Bin Abdulaziz Univ, Al Aflaj Coll Sci & Human Studies, Dept Math, Al Aflaj 71011912, Saudi Arabia.
   [Elmarakbi, A.] Univ Sunderland, Fac Engn & Adv & Mfg, Automot Composites Grp, Sunderland SR6 0DD, England.
RP El-Safty, SA (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.; El-Safty, SA (reprint author), Natl Inst Mat Sci, Res Ctr Strateg Mat, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
EM sherif.elsafty@nims.go.jp
OI elmarakbi, ahmed/0000-0002-7479-3870
CR Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x
   Al-Juhni AA, 2006, PROG ORG COAT, V56, P135, DOI 10.1016/j.porgcoat.2006.02.009
   Al-Juhni AA, 2006, THESIS
   Almeida E, 2007, PROG ORG COAT, V59, P2, DOI 10.1016/j.porgcoat.2007.01.017
   Anandan S, 2013, ACS APPL MATER INTER, V5, P207, DOI 10.1021/am302557z
   Anderson C, 2003, J MAR DESIGN OPERA B, V4, P11
   Anderson C.D, 1995, TIN VS TIN FREE ANTI, P1
   Anderson CD, SCI ANT 2
   Atlar M, 2013, BIOFOULING, V29, P39, DOI 10.1080/08927014.2012.745856
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   Baier RE, 2006, J MATER SCI-MATER M, V17, P1057, DOI 10.1007/s10856-006-0444-8
   Baker TJ, 2014, ENVIRON POLLUT, V186, P257, DOI 10.1016/j.envpol.2013.11.014
   Barua S, 2014, RSC ADV, V4, P47797, DOI 10.1039/c4ra07802k
   Barua S, 2013, CHEM ENG SCI, V95, P138, DOI 10.1016/j.ces.2013.03.026
   Basu BJ, 2013, SURF INNOV, V1, P40, DOI 10.1680/si.12.00013
   Beigbeder A, 2008, BIOFOULING, V24, P291, DOI 10.1080/08927010802162885
   Bennett SM, 2010, BIOFOULING, V26, P235, DOI 10.1080/08927010903469676
   Berglin M, 2003, J COLLOID INTERF SCI, V257, P383, DOI 10.1016/S0021-9797(02)00037-1
   Berglin M, 2001, FLUORINATED SURFACES, P96
   Bernbom N, 2011, APPL ENVIRON MICROB, V77, P8557, DOI 10.1128/AEM.06038-11
   Bharathidasan T, 2015, ACS APPL MATER INTER, V7, P18450, DOI 10.1021/acsami.5b04609
   Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003
   Blanck H, 2009, MAR POLLUT BULL, V58, P230, DOI 10.1016/j.marpolbul.2008.09.021
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   Bodkhe RB, 2015, PROG ORG COAT, V78, P369, DOI 10.1016/j.porgcoat.2014.07.011
   Brady RF, 2001, PROG ORG COAT, V43, P188, DOI 10.1016/S0300-9440(01)00180-1
   Brady RF, 2000, BIOFOULING, V15, P73, DOI 10.1080/08927010009386299
   Brady RF, 1999, PROG ORG COAT, V35, P31, DOI 10.1016/S0300-9440(99)00005-3
   Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h
   Brook MA, 2000, SILICON ORGANIC ORGA, P29, DOI 10.1016/B978-008043428-5/50021-7
   Buskens P, 2013, J COAT TECHNOL RES, V10, P29, DOI 10.1007/s11998-012-9456-0
   Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251
   CALLOW M, 1990, CHEM IND-LONDON, P123
   Cao S, 2011, CHINESE SCI BULL, V56, P598, DOI 10.1007/s11434-010-4158-4
   Carl C, 2012, BIOFOULING, V28, P1077, DOI 10.1080/08927014.2012.728588
   Carteaua D., 2014, ELSVIER PROGR ORGANI, V77, P485
   Chakradhar RPS, 2011, APPL SURF SCI, V257, P8569, DOI 10.1016/j.apsusc.2011.05.016
   Chambers LD, 2014, PROG ORG COAT, V77, P473, DOI 10.1016/j.porgcoat.2013.11.013
   Champ MA, 2000, SCI TOTAL ENVIRON, V258, P21, DOI 10.1016/S0048-9697(00)00506-4
   Champ MA, 1996, ORGANOTIN ENV FATE E
   Chang CH, 2012, CARBON, V50, P5044, DOI 10.1016/j.carbon.2012.06.043
   Chang CW, 2010, SOFT MATTER, V6, P5157, DOI 10.1039/c0sm00067a
   Chapman J, 2012, ADV ENG MATER, V14, pB175, DOI 10.1002/adem.201180037
   Chen SH, 2002, NANO LETT, V2, P1003, DOI 10.1021/nl025674h
   Cheyne I., 2010, BIOFOULING, P306
   Chung JS, 2012, J COLLOID INTERF SCI, V366, P64, DOI 10.1016/j.jcis.2011.09.080
   Ciriminna R, 2015, ACS SUSTAIN CHEM ENG, V3, P559, DOI 10.1021/sc500845n
   Clarson JS, 1993, SILOXANE POLYM
   Compere C, 2001, BIOFOULING, V17, P129
   Converse A., 2012, MADE CAPE COD EPAINT
   COOKSEY KE, 1995, AQUAT MICROB ECOL, V9, P87, DOI 10.3354/ame009087
   Cooper SP, 2011, BIOFOULING, V27, P881, DOI 10.1080/08927014.2011.611305
   Corbett JJ, 2011, ENERGY GHG EMISSIONS
   Dafforn KA, 2011, MAR POLLUT BULL, V62, P453, DOI 10.1016/j.marpolbul.2011.01.012
   Dahl B, 1996, MAR POLLUT BULL, V32, P342, DOI 10.1016/0025-326X(96)84828-4
   Dahlback B, 2010, COAST MAR SCI, V34, P212
   Dalton HM, 2000, BIOFOULING, V15, P83, DOI 10.1080/08927010009386300
   Dang ZM, 2012, PROG MATER SCI, V57, P660, DOI 10.1016/j.pmatsci.2011.08.001
   Dash S, 2009, J IND MICROBIOL BIOT, V36, P1047, DOI 10.1007/s10295-009-0588-x
   De B, 2013, J MATER CHEM A, V1, P348, DOI 10.1039/c2ta00011c
   Deka H, 2010, POLYM DEGRAD STABIL, V95, P1509, DOI 10.1016/j.polymdegradstab.2010.06.017
   Deng JN, 2008, J APPL POLYM SCI, V108, P2023, DOI 10.1002/app.27625
   Derbalah A, 2015, NANOSTRUCT NANOOBJEC, V3, P17
   Derbalah A, 2015, CHEMPLUSCHEM, V80, P1119, DOI 10.1002/cplu.201500098
   Detty MR, 2014, ACCOUNTS CHEM RES, V47, P678, DOI 10.1021/ar400240n
   Ekin A, 2007, J COAT TECHNOL RES, V4, P435, DOI 10.1007/s11998-007-9039-7
   El-Safty SA, 2012, EUR J INORG CHEM, P5439, DOI 10.1002/ejic.201200629
   Eliasson J, 2003, LLOYDS LIST EVENT C
   Elsaid AM, 2013, ENV FRIENDLY POLYURE, V80, P230
   Epstein AK, 2012, P NATL ACAD SCI USA, V109, P13182, DOI 10.1073/pnas.1201973109
   Fang J, 2010, POLYMER, V51, P2636, DOI 10.1016/j.polymer.2010.04.024
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Feng LZ, 2011, NANOSCALE, V3, P1252, DOI 10.1039/c0nr00680g
   Ferrari AC, 2015, NANOSCALE, V7, P4598, DOI 10.1039/c4nr01600a
   FOWKES FM, 1978, IND ENG CHEM PROD RD, V17, P3, DOI 10.1021/i360065a002
   FOX HW, 1950, J COLL SCI IMP U TOK, V5, P514, DOI 10.1016/0095-8522(50)90044-4
   Ganbavle VV, 2011, SURF COAT TECH, V205, P5338, DOI 10.1016/j.surfcoat.2011.05.055
   Gaya UI, 2008, J PHOTOCH PHOTOBIO C, V9, P1, DOI 10.1016/j.jphotochemrev.2007.12.003
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Gittens JE, 2013, BIOTECHNOL ADV, V31, P1738, DOI 10.1016/j.biotechadv.2013.09.002
   Glavan AC, 2014, ADV FUNCT MATER, V24, P60, DOI 10.1002/adfm.201300780
   GOOD RJ, 1958, J PHYS CHEM-US, V62, P1418, DOI 10.1021/j150569a016
   Grumping R, 1999, APPL ENVIRON MICROB, V65, P2276
   Gudipati CS, 2005, LANGMUIR, V21, P3044, DOI 10.1021/la048015o
   Gupta A, 2015, PROG MATER SCI, V73, P44, DOI 10.1016/j.pmatsci.2015.02.002
   Hanemann T, 2010, MATERIALS, V3, P3468, DOI 10.3390/ma3063468
   He HY, 2015, MAT SCI SEMICON PROC, V31, P200, DOI 10.1016/j.mssp.2014.11.029
   Higaki Y, 2016, POLYM J, V48, P325, DOI 10.1038/pj.2015.137
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Hintzsche W, 2014, CHALLENGES MODERN AN
   Nguyen H, 2011, J PHYS CHEM C, V115, P8466, DOI 10.1021/jp1116189
   Holm ER, 2003, BIOFOULING, V19, P297, DOI 10.1080/0892701031000137512
   Howell C, 2014, ACS APPL MATER INTER, V6, P13299, DOI 10.1021/am503150y
   Hrenovic J, 2012, CHEMOSPHERE, V88, P1103, DOI 10.1016/j.chemosphere.2012.05.023
   Hu R, 2013, LANGMUIR, V29, P3773, DOI 10.1021/la304708b
   Huang GT, 2014, THESIS
   Huang X, 2009, J MATER SCI, V44, P4522, DOI 10.1007/s10853-009-3660-z
   Hussain F, 2006, J COMPOS MATER, V40, P1511, DOI 10.1177/0021998306067321
   ICS&ISF, 2009, OV INT SHIPP IND
   Imbesi PM, 2012, ACS NANO, V6, P1503, DOI 10.1021/nn204431m
   IMO, 2001, INT CONV CONTR HARM
   IMO, 2008, INT CONV CONTR HARMF
   International Paint & Printing Ink Council, 2009, GLOB PAINT COAT IND
   Irani F, 2013, PROG ORG COAT, V76, P375, DOI 10.1016/j.porgcoat.2012.10.023
   Jeon IY, 2010, MATERIALS, V3, P3654, DOI 10.3390/ma3063654
   Jeong CJ, 2015, POLYM ENG SCI, V55, P2111, DOI 10.1002/pen.24052
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Jiang W, 2015, RSC ADV, V5, P24064, DOI 10.1039/c4ra15774e
   Jiang XC, 2004, J MATER CHEM, V14, P695, DOI 10.1039/b313938g
   Jo HB, 2014, MICROELECTRON ENG, V116, P51, DOI 10.1016/j.mee.2013.10.009
   Johnston E, 1999, MACROMOLECULES, V32, P8173, DOI 10.1021/ma990628y
   Kang D, 2012, ACS NANO, V6, P7763, DOI 10.1021/nn3017316
   Kango S, 2013, PROG POLYM SCI, V38, P1232, DOI 10.1016/j.progpolymsci.2013.02.003
   Karger-Kocsis J, 2015, PROG MATER SCI, V73, P1, DOI 10.1016/j.pmatsci.2015.02.003
   Karger-Kocsis J, 2015, PROG POLYM SCI, V37, P1
   Kavanagh CJ, 2003, BIOFOULING, V19, P381, DOI 10.1080/08927010310001623296
   Khairy M, 2014, SENSOR ACTUAT B-CHEM, V193, P644, DOI 10.1016/j.snb.2013.11.113
   Khairy M, 2014, CHEM COMMUN, V50, P1356, DOI 10.1039/c3cc48155g
   Kholmanov IN, 2012, ACS NANO, V6, P5157, DOI 10.1021/nn300852f
   Khorasani MT, 2005, APPL SURF SCI, V242, P339, DOI 10.1016/j.apsusc.2004.08.035
   Kiil S, 2001, IND ENG CHEM RES, V40, P3906, DOI 10.1021/ie010242n
   Kiil S, 2002, CHEM ENG RES DES, V80, P45, DOI 10.1205/026387602753393358
   Kiil S, 2007, COMPUT-AIDED CHEM EN, V23, P181, DOI 10.1016/S1570-7946(07)80010-1
   Kim BY, 2009, ADV FUNCT MATER, V19, P3796, DOI 10.1002/adfm.200901024
   Kim Jeong-Yi, 2010, THESIS
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003
   Kohl JG, 1999, PROG ORG COAT, V36, P15, DOI 10.1016/S0300-9440(98)00074-5
   Korkut E, 2012, OCEAN ENG, V41, P1, DOI 10.1016/j.oceaneng.2011.12.012
   Kostina NY, 2013, J MATER CHEM B, V1, P5644, DOI 10.1039/c3tb20704h
   Kotal M, 2015, PROG POLYM SCI, V51, P127, DOI 10.1016/j.progpolymsci.2015.10.001
   Kotrikla A, 2009, J ENVIRON MANAGE, V90, pS77, DOI 10.1016/j.jenvman.2008.07.017
   Kratochvil MJ, 2016, ACS INFECT DIS, V2, P509, DOI 10.1021/acsinfecdis.6b00065
   Krishnamoorthy K, 2014, CARBON, V72, P328, DOI 10.1016/j.carbon.2014.02.013
   Krishnan S, 2008, J MATER CHEM, V18, P3405, DOI 10.1039/b801491d
   Krishnan S, 2006, LANGMUIR, V22, P5075, DOI 10.1021/la052978l
   Kuchibhatla SVNT, 2007, PROG MATER SCI, V52, P699, DOI 10.1016/j.pmatsci.2006.08.001
   Latthe SS, 2009, APPL SURF SCI, V256, P217, DOI 10.1016/j.apsusc.2009.07.113
   Lejars M, 2013, POLYM CHEM-UK, V4, P3282, DOI 10.1039/c3py00196b
   Lejars M, 2012, CHEM REV, V112, P4347, DOI 10.1021/cr200350v
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Li XH, 2006, APPL SURF SCI, V252, P7856, DOI 10.1016/j.apsusc.2005.09.068
   Li Y, 2012, LANGMUIR, V28, P12509, DOI 10.1021/la3022563
   Lin JY, 2011, NANOSCALE, V3, P1258, DOI 10.1039/c0nr00812e
   Lindholdt A., 2015, THESIS
   Liu KS, 2014, CHEM REV, V114, P10044, DOI 10.1021/cr4006796
   Liu KS, 2013, PROG MATER SCI, V58, P503, DOI 10.1016/j.pmatsci.2012.11.001
   Lowe S, 2015, POLYM CHEM-UK, V6, P198, DOI 10.1039/c4py01356e
   Lundberg P, 2012, ACS APPL MATER INTER, V2, P903
   Lung KY, 2015, ADV COLLOID INTERFAC, V226, P166
   Lunn I., 1974, ANTIFOULING BRIEF IN
   Lvov Y, 2013, PROG POLYM SCI, V38, P1690, DOI 10.1016/j.progpolymsci.2013.05.009
   Ma ML, 2006, CURR OPIN COLLOID IN, V11, P193, DOI 10.1016/j.cocis.2006.06.002
   MacCallum N, 2015, ACS BIOMATER SCI ENG, V1, P43, DOI 10.1021/ab5000578
   Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4
   Majumdar P, 2007, J COAT TECHNOL RES, V4, P131, DOI 10.1007/s11998-007-9015-2
   Mallakpour S, 2015, PROG POLYM SCI, V51, P74, DOI 10.1016/j.progpolymsci.2015.07.004
   Manna U, 2016, ADV FUNCT MATER, V26, P3599, DOI 10.1002/adfm.201505522
   Manna U, 2015, ADV MATER, V27, P3007, DOI 10.1002/adma.201500893
   Marabotti I, 2009, BIOFOULING, V25, P481, DOI 10.1080/08927010902913187
   Marechal JP, 2009, INT J MOL SCI, V10, P4623, DOI 10.3390/ijms10114623
   Martinelli E, 2011, BIOFOULING, V27, P529, DOI 10.1080/08927014.2011.584972
   Matranga V, 2012, MAR ENVIRON RES, V76, P32, DOI 10.1016/j.marenvres.2012.01.006
   Meng JQ, 2014, J MEMBRANE SCI, V461, P123, DOI 10.1016/j.memsci.2014.03.017
   Merian T, 2012, J AGR FOOD CHEM, V60, P2943, DOI 10.1021/jf204741p
   Mielczarski JA, 2010, LANGMUIR, V26, P2871, DOI 10.1021/la902912h
   Millett J, 1997, FAST 97 C, V1
   Milne A, 1976, INT PAINT, V1, P590
   Milne A, 1977, INT PAINT, V1, P465
   Misdan N, 2016, DESALINATION, V380, P105, DOI 10.1016/j.desal.2015.06.001
   Mohr S, 2009, ENVIRON SCI TECHNOL, V43, P6838, DOI 10.1021/es900595u
   Momen G, 2011, REV ADV MATER SCI, V27, P1
   Momen G, 2011, APPL SURF SCI, V257, P6489, DOI 10.1016/j.apsusc.2011.02.049
   Monteleone FV, 2012, RSC ADV, V2, P9543
   Moore E, 2014, BIOMACROMOLECULES, V15, P2735, DOI 10.1021/bm500601z
   Mumm F, 2009, ACS NANO, V3, P2647, DOI 10.1021/nn900607p
   Munafo P, 2015, CONSTR BUILD MATER, V84, P201, DOI 10.1016/j.conbuildmat.2015.02.083
   Munir S, 2016, MATER DESIGN, V92, P64, DOI 10.1016/j.matdes.2015.12.022
   Murosaki T, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/6/064706
   Nakajima A, 2001, MONATSH CHEM, V132, P31, DOI 10.1007/s007060170142
   Hoa ND, 2011, CHEM-EUR J, V17, P12896, DOI 10.1002/chem.201101122
   Nishimura R, 2016, J AM CHEM SOC, V138, P10299, DOI 10.1021/jacs.6b05562
   Noorbakhsh A, 2016, MICROCHEM J, V129, P310, DOI 10.1016/j.microc.2016.06.009
   Nurioglu AG, 2015, J MATER CHEM B, V3, P6547, DOI 10.1039/c5tb00232j
   Okoro HK, 2011, ASIAN J CHEM, V23, P473
   Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o
   Owens GJ, 2016, PROG MATER SCI, V77, P1, DOI 10.1016/j.pmatsci.2015.12.001
   Pelaz B, 2015, ACS NANO, V9, P6996, DOI 10.1021/acsnano.5b01326
   Prasai D, 2012, ACS NANO, V6, P1102, DOI 10.1021/nn203507y
   Quere D, 2005, REP PROG PHYS, V68, P2495, DOI 10.1088/0034-4885/68/11/R01
   Quigg A, 2013, ACS SUSTAIN CHEM ENG, V1, P686, DOI 10.1021/sc400103x
   Rafiee J, 2010, ADV MATER, V22, P2151, DOI 10.1002/adma.200903696
   Rahaman MS, 2014, J MATER CHEM B, V2, P1724, DOI 10.1039/c3tb21681k
   Rath SK, 2010, APPL SURF SCI, V256, P2440, DOI 10.1016/j.apsusc.2009.10.084
   Rittschof D, 2001, MARINE CHEM ECOLOGY, V17, P543
   Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p
   Roy N, 2010, POLYMER, V51, P5172, DOI 10.1016/j.polymer.2010.08.064
   Sankar GG, 2015, INT BIODETER BIODEGR, V104, P307, DOI 10.1016/j.ibiod.2015.05.022
   SANTAREN J, 1990, CLAY CLAY MINER, V38, P63, DOI 10.1346/CCMN.1990.0380109
   Acevedo MS, 2013, INT BIODETER BIODEGR, V83, P97, DOI 10.1016/j.ibiod.2013.05.002
   Sapozhnikova Y, 2013, MAR POLLUT BULL, V69, P189, DOI 10.1016/j.marpolbul.2013.01.039
   Sarkar B, 2015, PROG POLYM SCI, V40, P33, DOI 10.1016/j.progpolymsci.2014.10.009
   Sarkar S, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-011-0715-2
   Satarkar NS, 2010, SOFT MATTER, V6, P2364, DOI 10.1039/b925218p
   Scardino AJ, 2009, BIOFOULING, V25, P757, DOI 10.1080/08927010903165936
   Schilp S, 2009, LANGMUIR, V25, P10077, DOI 10.1021/la901038g
   Schmidt D., 2000, CURR OPIN SOLID ST M, V6, P205
   Schneider J, 2014, CHEM REV, V114, P9919, DOI 10.1021/cr5001892
   Schultz MP, 2011, BIOFOULING, V27, P87, DOI 10.1080/08927014.2010.542809
   Schultz MP, 2007, BIOFOULING, V23, P331, DOI 10.1080/08927010701461974
   Sdiri A, 2016, APPL CLAY SCI, V126, P89, DOI 10.1016/j.clay.2016.03.003
   Selim Mohamed S, 2016, Data Brief, V8, P1357, DOI 10.1016/j.dib.2016.08.010
   Selim MS, 2016, MATER DESIGN, V101, P218, DOI 10.1016/j.matdes.2016.03.124
   Selim MS, 2015, RSC ADV, V5, P63175, DOI 10.1039/c5ra07400b
   Selim MS, 2015, RSC ADV, V5, P19933, DOI 10.1039/c5ra01597a
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Shenashen MA, 2014, PART PART SYST CHAR, V31, P293, DOI 10.1002/ppsc.201300181
   Shiu JY, 2004, CHEM MATER, V16, P561, DOI 10.1021/cm034696h
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Siegers C, 2004, CHEM-EUR J, V10, P2831, DOI 10.1002/chem.200306073
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   Singh A, 2005, LANGMUIR, V21, P11604, DOI 10.1021/la052110v
   Sjollema SB, 2014, ENVIRON POLLUT, V187, P106, DOI 10.1016/j.envpol.2013.12.019
   Srinivasan M, 2007, ENVIRON MANAGE, V39, P423, DOI 10.1007/s00267-005-0030-8
   Statz A, 2006, BIOFOULING, V22, P391, DOI 10.1080/08927010601004890
   Steele A, 2009, NANO LETT, V9, P501, DOI 10.1021/nl8037272
   Stein J, 2003, BIOFOULING, V19, P87, DOI 10.1080/0892701031000095221
   Stein J, 2003, BIOFOULING, V19, P71, DOI 10.1080/0892701031000089525
   Strathmann RR, 1979, BW BARUCH LIB MARINE, V9
   Su JW, 2014, NANOSCALE, V6, P5181, DOI 10.1039/c4nr00534a
   Suman TY, 2015, ECOTOX ENVIRON SAFE, V113, P23, DOI 10.1016/j.ecoenv.2014.11.015
   Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c
   Sunny S, 2014, ADV FUNCT MATER, V24, P6658, DOI 10.1002/adfm.201401289
   Suriyanarayanan S, 2013, J COLLOID INTERF SCI, V396, P307, DOI 10.1016/j.jcis.2012.12.076
   Taguet A, 2014, PROG POLYM SCI, V39, P1526, DOI 10.1016/j.progpolymsci.2014.04.002
   Tang Q, 2013, PROG MATER SCI, V58, P1244, DOI 10.1016/j.pmatsci.2013.04.003
   Tang XF, 2010, COLLOID SURFACE A, V360, P99, DOI 10.1016/j.colsurfa.2010.02.011
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Tavares MTS, 2014, SURF COAT TECH, V239, P16, DOI 10.1016/j.surfcoat.2013.11.009
   Thomas KV, 2010, BIOFOULING, V26, P73, DOI 10.1080/08927010903216564
   Thunemann AF, 2001, J MATER CHEM, V11, P381, DOI 10.1039/b004405i
   Tian J, 2014, CHEM SOC REV, V43, P6920, DOI 10.1039/c4cs00180j
   Townsin RL, 2009, WOODHEAD PUBL MATER, P693, DOI 10.1533/9781845696313.4.693
   Townsin RL, 2003, BIOFOULING, V19, P9, DOI 10.1080/0892701031000088535
   Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   van Hullebusch Eric D., 2003, Reviews in Environmental Science and Bio/Technology, V2, P9, DOI 10.1023/B:RESB.0000022995.48330.55
   Vashist SK, 2015, CARBON, V84, P519, DOI 10.1016/j.carbon.2014.12.052
   Voronkov MG, 1978, THE SILOXANE BOND, P1
   Wan F, 2012, ACS APPL MATER INTER, V4, P4557, DOI 10.1021/am300912w
   Wang JJ, 2016, MAT SCI ENG C-MATER, V61, P376, DOI 10.1016/j.msec.2015.12.023
   Wang WY, 2015, RSC ADV, V5, P84746, DOI 10.1039/c5ra16077d
   Wei Q, 2014, COLLOID SURFACE B, V122, P684, DOI 10.1016/j.colsurfb.2014.08.001
   Wen XF, 2012, SOFT MATER, V10, P435, DOI 10.1080/1539445X.2010.528118
   Whalan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04072
   Woods Hole Oceanographic Institution (WHOI), 1952, MAR FOUL ITS PREV
   Williams D., 2010, CHALLENGES DEV ANTIF
   Wouters M, 2010, PROG ORG COAT, V68, P4, DOI 10.1016/j.porgcoat.2009.10.005
   Wu SH., 1982, POLYM INTERFACE ADHE
   Wynne KJ, 2000, BIOFOULING, V16, P277
   Xu LB, 2005, ANGEW CHEM INT EDIT, V44, P6009, DOI 10.1002/anie.200500868
   Xu QW, 2005, ENVIRON SCI POLLUT R, V12, P278, DOI 10.1065/espr2005.04.244
   Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292
   Xue LL, 2014, J COLLOID INTERF SCI, V421, P178, DOI 10.1016/j.jcis.2013.12.063
   Yabu H, 2005, CHEM MATER, V17, P5231, DOI 10.1021/cm051281i
   Yan XL, 2015, RSC ADV, V5, P39384, DOI 10.1039/c5ra02904j
   Yang WJ, 2014, PROG POLYM SCI, V39, P1017, DOI 10.1016/j.progpolymsci.2014.02.002
   Yao L, 2014, PROG MATER SCI, V61, P94, DOI 10.1016/j.pmatsci.2013.12.003
   Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001
   Yebra DM, 2011, NACE INT, V50, P4
   Yilgor E, 2014, PROG POLYM SCI, V39, P1165, DOI 10.1016/j.progpolymsci.2013.11.003
   YILGOR I, 1985, ACS SYM SER, V282, P161
   YILGOR I, 1988, ADV POLYM SCI, V86, P1
   Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Yu HL, 2015, MATER DESIGN, V87, P198, DOI 10.1016/j.matdes.2015.08.025
   Yuan JY, 2010, POLYMER, V51, P4015, DOI 10.1016/j.polymer.2010.06.064
   Zhang JL, 2006, LANGMUIR, V22, P2946, DOI 10.1021/la053428q
   Zhang JL, 2004, MACROMOL RAPID COMM, V25, P1105, DOI 10.1002/marc.200400065
   Zhang N, 2013, J CATAL, V299, P210, DOI 10.1016/j.jcat.2012.11.021
   Zhang N, 2012, J PHYS CHEM C, V116, P18023, DOI 10.1021/jp303503c
   Zhang P, 2011, J MATER CHEM, V21, P17746, DOI 10.1039/c1jm12965a
   Zhang W, 2010, LANGMUIR, V26, P5848, DOI 10.1021/la903770s
   Zhang Z, 2009, LANGMUIR, V25, P13516, DOI 10.1021/la901957k
   Zhou CM, 2014, J MEMBRANE SCI, V471, P381, DOI 10.1016/j.memsci.2014.08.033
   Zhu J, 2015, RSC ADV, V5, P53653, DOI 10.1039/c5ra05571g
   Zisman WA, 1964, ADV CHEM SER, V43, P1
   O'Leary CW, 2004, Patent No. [EP1484700, 1484700]
NR 288
TC 1
Z9 1
U1 164
U2 164
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6425
EI 1873-2208
J9 PROG MATER SCI
JI Prog. Mater. Sci.
PD JUN
PY 2017
VL 87
BP 1
EP 32
DI 10.1016/j.pmatsci.2017.02.001
PG 32
WC Materials Science, Multidisciplinary
SC Materials Science
GA ER3DN
UT WOS:000398676100001
OA No
DA 2017-08-17
ER

PT J
AU Kabeel, AE
   Abdelgaied, M
   El-Said, EMS
AF Kabeel, A. E.
   Abdelgaied, Mohamed
   El-Said, Emad M. S.
TI Study of a solar-driven membrane distillation system: Evaporative
   cooling effect on performance enhancement
SO RENEWABLE ENERGY
LA English
DT Article
DE Membrane distillation; Evaporative cooling; Direct contact membrane
ID DESALINATION PROCESS
AB This paper presents an experimental investigation of a solar thermal driven membrane distillation-based desalination system (SDMD). The system consists of direct contact membrane unit and evacuated tube solar water heater assisted by evaporative water cooler. This study was carried out on a pilot system installed at the University of Tanta, Tanta, Egypt. The laboratory work has been carried out in an actual thermal environment in June 2016. The novelty of the system is the performance enhancement of an integrated desalination system assisted with evaporative cooler. The system efficiency is affected by increasing of water mass flow rate more than the increasing of air mass flow rate and reaches about 49.01%. The thermal performance of the system is measured by the gained output ratio (GOR) with daytime. The GOR of the system reaches 0.49. Also cooling water flow rate influences water extraction, however productivity decreases with increasing of cooling water temperature. Maximum productivity was 33.55 L/day. The pressure drop and pumping power across membrane were calculated. The pressure drop in cases of feed water flow rate 10 L/min is 158.89 N/m(2) and 0.0263 Watt pumping power. While in cases of feed water flow rate 15 L/min the pressure drop is about 336.61 N/m(2) and about 0.0828 Watt pumping power. The use of the cooling unit significantly increased the system productivity, almost 1.25 of that without the cooling unit. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Kabeel, A. E.; Abdelgaied, Mohamed] Tanta Univ, Dept Power Mech Engn, Fac Engn, Tanta, Egypt.
   [El-Said, Emad M. S.] Fayoum Univ, Dept Mech Engn, Fac Engn, Al Fayyum, Egypt.
RP El-Said, EMS (reprint author), Fayoum Univ, Dept Mech Engn, Fac Engn, Al Fayyum, Egypt.
EM emad_mech@hotmail.com
CR Andrjesdottir O, 2013, INT J HEAT MASS TRAN, V66, P855, DOI 10.1016/j.ijheatmasstransfer.2013.07.051
   ASHRAE, 2008, ASHRAE HDB HVAC SYST
   Chafidz A, 2016, J CLEAN PROD, V133, P631, DOI 10.1016/j.jclepro.2016.05.127
   Chafidz A, 2014, DESALINATION, V345, P36, DOI 10.1016/j.desal.2014.04.017
   Chang H, 2012, DESALINATION, V286, P400, DOI 10.1016/j.desal.2011.11.057
   Duan ZY, 2016, BUILD ENVIRON, V104, P47, DOI 10.1016/j.buildenv.2016.04.029
   Duong HC, 2015, DESALINATION, V374, P1, DOI 10.1016/j.desal.2015.07.009
   Elzahaby AM, 2016, ENERG CONVERS MANAGE, V110, P397, DOI 10.1016/j.enconman.2015.12.046
   Ho CD, 2016, DESALINATION, V378, P108, DOI 10.1016/j.desal.2015.10.003
   Ho CD, 2013, J MEMBRANE SCI, V433, P160, DOI 10.1016/j.memsci.2012.12.044
   Holman J. P., 1978, EXPT METHODS ENG
   Hou SB, 2005, DESALINATION, V183, P143, DOI 10.1016/j.desal.2005.02.047
   Jacimovic N., 2015, FACULTY MECH ENG BEL, V43, P35
   Khalifa D.U., 2014, J ENG RES APPL, V4, P124
   Qtaishat MR, 2013, DESALINATION, V308, P186, DOI 10.1016/j.desal.2012.01.021
   Rostamani R., 2013, J NOV APPL SCI, V2, P1072
NR 16
TC 0
Z9 0
U1 21
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-1481
J9 RENEW ENERG
JI Renew. Energy
PD JUN
PY 2017
VL 106
BP 192
EP 200
PG 9
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA EM3KB
UT WOS:000395212500020
OA No
DA 2017-08-17
ER

PT J
AU Awad, ASA
   Ahmed, MH
   El-Fouly, THM
   Salama, MMA
AF Awad, Ahmed S. A.
   Ahmed, Mohamed Hassan
   El-Fouly, Tarek H. M.
   Salama, Magdy M. A.
TI The impact of wind farm location and control strategy on wind generation
   penetration and market prices
SO RENEWABLE ENERGY
LA English
DT Article
DE Wind energy; Stochastic optimization; Mathematical program with
   equilibrium; constraints; General algebraic modeling system; Electricity
   market
ID PROBABILISTIC LOAD FLOW; ELECTRICITY MARKET; DISTRIBUTED GENERATION;
   DISTRIBUTION-SYSTEMS; ALLOCATION
AB Wind energy has become one of the most cost-effective renewable sources nowadays. However, the stochastic nature associated with wind-energy production represents a great challenge for power-system operations. Therefore, probabilistic techniques are necessary to evaluate the performance of power systems with substantial amounts of wind generation. This paper presents a probabilistic based bi-level optimization approach for evaluating the impact of wind farm location and control strategy on the penetration level of wind farms and electricity market prices. The bi-level optimization model is formulated as mathematical program with equilibrium constraints (MPEC) and solved by means of the NLPEC solver in the General Algebraic Modeling System (GAMS) environment. Several cases studies are presented in this paper to determine to the optimal wind generation penetration and market prices with different locations and control strategies for wind farms. Moreover, some scenarios are discussed in regards to the practical allocation of wind farms. Crown Copyright (C) 2017 Published by Elsevier Ltd. All rights reserved.
C1 [Awad, Ahmed S. A.] Ain Shams Univ, Fac Engn, Elect Power & Machines Dept, Cairo, Egypt.
   [Ahmed, Mohamed Hassan; Salama, Magdy M. A.] Univ Waterloo, Elect & Comp Engn Dept, Waterloo, ON N2L 3G1, Canada.
   [El-Fouly, Tarek H. M.] Khalifa Univ Sci Technol & Res, Dept Elect & Comp Engn, Abu Dhabi, U Arab Emirates.
   [Awad, Ahmed S. A.] Nat Resources Canada, CanmetENERGY, 1615 Lionel Boulet Blvd, Varennes, PQ J3X 1S6, Canada.
RP Awad, ASA (reprint author), Ain Shams Univ, Fac Engn, Elect Power & Machines Dept, Cairo, Egypt.; Awad, ASA (reprint author), Nat Resources Canada, CanmetENERGY, 1615 Lionel Boulet Blvd, Varennes, PQ J3X 1S6, Canada.
EM a.samir@eng.asu.edu.eg; m2sadek@uwaterloo.ca;
   tarek.elfouly@kustar.ac.ae; msalama@uwaterloo.ca
CR Ahmedou M. O., 2011, POW EN SOC GEN M 201, P1
   Ahmed MH, 2013, IEEE T POWER SYST, V28, P1540, DOI 10.1109/TPWRS.2012.2226611
   ALSAC O, 1974, IEEE T POWER AP SYST, VPA93, P745, DOI 10.1109/TPAS.1974.293972
   Arefifar S.A., 2012, IEEE T SMART GRID, P1
   Atwa YM, 2011, IET RENEW POWER GEN, V5, P79, DOI 10.1049/iet-rpg.2009.0011
   Awad A.S.A., 2014, IEEE 27 CAN C EL COM
   Barker P. P., 2000, P IEEE POW ENG SOC S, P1645
   BORKOWSKA B, 1974, IEEE T POWER AP SYST, VPA93, P752, DOI 10.1109/TPAS.1974.293973
   Chompoo-inwai C, 2005, IEEE T IND APPL, V41, P163, DOI 10.1109/TIA.2004.841032
   Chowdhury AA, 1999, IEEE T IND APPL, V35, P305, DOI 10.1109/28.753621
   Costa PM, 2004, IEEE T POWER SYST, V19, P384, DOI 10.1109/TPWRS.2003.820698
   Association E. W. E., 2003, WIND FORC 12
   El-Fouly THM, 2008, IET RENEW POWER GEN, V2, P162, DOI 10.1049/iet-rpg:20070082
   El-Khattam W., 2002, P POW SYST 2002 C IM, P13
   Energy G., 2005, REP PHASE, V2
   Fabbri A, 2005, IEEE T POWER SYST, V20, P1440, DOI 10.1109/TPWRS.2005.852148
   Gabriel S.A., 2013, COMPLEMENTARITY MODE
   HATZIARGYRIOU ND, 1993, IEEE T POWER SYST, V8, P159, DOI 10.1109/59.221262
   Hatziargyriou ND, 2005, INT J ELEC POWER, V27, P656, DOI 10.1016/j.ijepes.2005.08.007
   Karaki SH, 1999, IEEE T ENERGY CONVER, V14, P217, DOI 10.1109/60.766986
   Liew S., 2002, GENER TRANSM DISTRIB, P256
   Makarov Y.V., 2008, POWER SYST IEEE T, V23, P811
   Mutale J., 2000, GENER TRANSM DISTRIB, P7
   Smith JC, 2004, WIND POWER IMPACTS E
   Zeineldin HH, 2006, IEE P-GENER TRANSM D, V153, P147, DOI 10.1049/ip-gtd:20045117
NR 25
TC 0
Z9 0
U1 17
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-1481
J9 RENEW ENERG
JI Renew. Energy
PD JUN
PY 2017
VL 106
BP 354
EP 364
DI 10.1016/j.renene.2016.12.066
PG 11
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA EM3KB
UT WOS:000395212500035
OA No
DA 2017-08-17
ER

PT J
AU Adam, GP
   Abdelsalam, I
   John, EF
   Burt, GM
   Holliday, D
   Finney, SJ
AF Adam, Grain Philip
   Abdelsalam, Ibrahim
   John, Edward Fletcher
   Burt, Graeme M.
   Holliday, Derrick
   Finney, Stephen Jon
TI New Efficient Submodule for a Modular Multilevel Converter in
   Multiterminal HVDC Networks
SO IEEE TRANSACTIONS ON POWER ELECTRONICS
LA English
DT Article
DE Flying capacitor (FC) cell; half- and full-bridge modular multilevel
   converter; mixed-cell commutation cells; voltage-source converter
   high-voltage direct-current (VSC-HVDC) transmission systems
ID TRANSMISSION-SYSTEMS; CELLS; CAPACITOR; MODELS; FAMILY
AB In high-voltage applications, the magnitude of total semiconductor losses (on-state and switching) determines the viability of modular-type multilevel converters. Therefore, this paper presents a new cell arrangement that aims to lower total semiconductor loss of the modular multilevel converter (MMC) to less than that of the half-bridge modular multilevel converter (HB-MMC). Additional attributes of the proposed cell are: it eliminates the protective thyristors used in conventional half-bridge cells that deviate part of the dc-fault current away from the antiparallel diode of the main switch when the converter is blocked during a dc short-circuit fault, and it can facilitate continued operation of the MMC during cell failures without the need for a mechanical bypass switch. Thus, the MMC that uses the proposed cell retains all advantages of the HB-MMC such as full modularity of the power circuit and internal faultmanagement. The claimed attributes of the proposed cell are verified using illustrative simulations and reduced scale experimentations. Additionally, this paper provides brief and critical discussions that highlight the attributes and limitations of popular MMC control methods and different MMC cells structures proposed in the literature, considering the power electronic system perspective.
C1 [Adam, Grain Philip; Abdelsalam, Ibrahim; Burt, Graeme M.; Holliday, Derrick; Finney, Stephen Jon] Univ Strathclyde, Glasgow G1 1XQ, Lanark, Scotland.
   [Abdelsalam, Ibrahim] Arab Acad Sci & Technol & Maritime Transport, Cairo 1029, Egypt.
   [John, Edward Fletcher] Univ New South Wales, Sydney, NSW 2052, Australia.
RP Adam, GP (reprint author), Univ Strathclyde, Glasgow G1 1XQ, Lanark, Scotland.
EM grain.adam@eee.strath.ac.uk; ibrahim.abdallah@strath.ac.uk;
   john.fletcher@unsw.ed.au; graeme.burt@strath.ac.uk;
   derrick.holliday@strath.ac.uk; stephen.finney@strath.ac.uk
FU Australian Research Council [DP150102368]; SUPERGEN Hubnet project
   [EP/I013636/1]
FX This work was supported by the Australian Research Council under
   Discovery Projects funding scheme through Project DP150102368, and in
   part by the SUPERGEN Hubnet project under Grant EP/I013636/1.
   Recommended for publication by Associate Editor B. Singh.
CR Adam GP, 2015, INT CONF RENEW ENERG, P1432, DOI 10.1109/ICRERA.2015.7418644
   Adam GP, 2014, PROC IEEE INT SYMP, P1390, DOI 10.1109/ISIE.2014.6864817
   Adam GP, 2014, IEEE J EM SEL TOP P, V2, P1089, DOI 10.1109/JESTPE.2014.2315833
   Adam GP, 2016, IET GENER TRANSM DIS, V10, P496, DOI 10.1049/iet-gtd.2015.0894
   Adam GP, 2015, IEEE T POWER DELIVER, V30, P2468, DOI 10.1109/TPWRD.2015.2394387
   Adam GP, 2013, IEEE T POWER SYST, V28, P335, DOI 10.1109/TPWRS.2012.2199337
   Akagi H, 2011, IEEE T POWER ELECTR, V26, P3119, DOI 10.1109/TPEL.2011.2143431
   Bergna G, 2013, IEEE T IND ELECTRON, V60, P2360, DOI 10.1109/TIE.2012.2225397
   Bucher M. K., 2014, PES GEN M C EXP 2014, P1
   Chen C, 2015, IET POWER ELECTRON, V8, P1996, DOI 10.1049/iet-pel.2014.0513
   Dargahi V, 2015, IEEE T POWER ELECTR, V30, P138, DOI 10.1109/TPEL.2014.2304964
   Debnath S, 2015, IEEE T POWER ELECTR, V30, P37, DOI 10.1109/TPEL.2014.2309937
   Espinoza B. M., 2015, P 10 INT C EC VEH RE, P1
   Glinka M, 2005, IEEE T IND ELECTRON, V52, P662, DOI 10.1109/TIE.2005.843973
   Gowaid IA, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P3099, DOI 10.1109/ICIT.2015.7125556
   Hagiwara M, 2012, IEEE T IND APPL, V48, P720, DOI 10.1109/TIA.2011.2182330
   Hagiwara M, 2011, IEEE T POWER ELECTR, V26, P1649, DOI 10.1109/TPEL.2010.2089065
   Jaafar A., 2014, P 16 EUR C POW EL AP, P1
   Jonsson T., 2013, CIGR CAN CAL CAN
   KOLAR JW, 1991, IEEE T IND APPL, V27, P1063, DOI 10.1109/28.108456
   Kolb J, 2015, IEEE T POWER ELECTR, V30, P349, DOI 10.1109/TPEL.2014.2299894
   Lu SZ, 2015, INT C ELECTR MACH SY, P553, DOI 10.1109/ICEMS.2015.7385096
   Merlin M., 2010, P 9 IET INT C AC DC, P1
   Nami A, 2015, IEEE T POWER ELECTR, V30, P18, DOI 10.1109/TPEL.2014.2327641
   Oates C., 2014, P 16 EUR C POW EL AP, P1
   Oates C., 2011, POW EL APPL EPE 2011, P1
   Oates C, 2015, IEEE J EM SEL TOP P, V3, P505, DOI 10.1109/JESTPE.2014.2348611
   Ota JIY, 2015, IEEE T IND APPL, V51, P279, DOI 10.1109/TIA.2014.2326079
   Peralta J, 2012, IEEE T POWER DELIVER, V27, P1501, DOI 10.1109/TPWRD.2012.2188911
   Perez MA, 2015, IEEE T POWER ELECTR, V30, P4, DOI 10.1109/TPEL.2014.2310127
   Sekiguchi K, 2014, IEEE T IND APPL, V50, P2648, DOI 10.1109/TIA.2013.2290867
   Sleiman M, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2514, DOI 10.1109/ICIT.2015.7125468
   Thitichaiworakorn N, 2014, IEEE T IND APPL, V50, P509, DOI 10.1109/TIA.2013.2269896
   Tu QR, 2011, IEEE T POWER DELIVER, V26, P2009, DOI 10.1109/TPWRD.2011.2115258
   Vatani M, 2015, IEEE T POWER DELIVER, V30, P2179, DOI 10.1109/TPWRD.2015.2412151
   Zeng R, 2015, POWER ELECT IEEE T, V30, P1137
   Armschat C., 2012, U.S. Patent, Patent No. [US 20 120 120 691 A1, 20120120691]
NR 37
TC 0
Z9 0
U1 9
U2 9
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0885-8993
EI 1941-0107
J9 IEEE T POWER ELECTR
JI IEEE Trans. Power Electron.
PD JUN
PY 2017
VL 32
IS 6
BP 4258
EP 4278
DI 10.1109/TPEL.2016.2603180
PG 21
WC Engineering, Electrical & Electronic
SC Engineering
GA EN1AF
UT WOS:000395741900013
OA No
DA 2017-08-17
ER

PT J
AU Abouelregal, AE
AF Abouelregal, Ahmed. E.
TI Fibre-Reinforced Generalized Anisotropic Thick Plate with Initial Stress
   under the Influence of Fractional Thermoelasticity Theory
SO ADVANCES IN APPLIED MATHEMATICS AND MECHANICS
LA English
DT Article
DE Fiber-reinforced; anisotropy; fractional thermoelasticity initial
   stress; thick plate
ID FREE-SURFACE; ENERGY-DISSIPATION; ELASTIC-WAVES; PLANE-WAVES;
   HALF-SPACE; SV MOTION; REFLECTION; MEDIA
AB In the present work concentrated on the two-dimensional problem of generalized thermoelasticity for a fiber-reinforced anisotropic thick plate under initial stress. Using generalized thermoelasticity theory with fractional order heat conduction, the problem has been solved by a normal mode analysis. The effect of hydrostatic initial stresses and fractional order parameter is shown graphically on the distributions of the temperature, displacement and thermal stress components. It is found from the graphs that the initial stress and the fractional parameter significantly influences the varieties of field amounts.
C1 [Abouelregal, Ahmed. E.] Mansoura Univ, Fac Sci, Dept Math, POB 35516, Mansoura, Egypt.
   [Abouelregal, Ahmed. E.] Aljouf Univ, Coll Arts & Sci, Dept Math, Al Qurayat, Saudi Arabia.
RP Abouelregal, AE (reprint author), Mansoura Univ, Fac Sci, Dept Math, POB 35516, Mansoura, Egypt.; Abouelregal, AE (reprint author), Aljouf Univ, Coll Arts & Sci, Dept Math, Al Qurayat, Saudi Arabia.
EM ahabogal@gmail.com
CR Abbas IA, 2011, INT J THERMOPHYS, V32, P1098, DOI 10.1007/s10765-011-0959-1
   ABOUELREGAL, 2013, CHINA PHYS B, V22
   Abouelregal AE, 2014, ADV APPL MATH MECH, V6, P783, DOI 10.4208/aamm.2013.m206
   Abouelregal AE, 2011, J THERM STRESSES, V34, P1139, DOI 10.1080/01495739.2011.606018
   Ailawalia P., 2011, ENGINEERING, V3, P622
   Ailawalia P., 2009, MECH MECH ENG, V13, P5
   BELFIELD AJ, 1983, J MECH PHYS SOLIDS, V31, P25, DOI 10.1016/0022-5096(83)90018-2
   Biot M. A., 1965, MECH INCREMENTAL DEF
   CHATTOPADHYAY A, 1982, J ACOUST SOC AM, V72, P255, DOI 10.1121/1.387987
   Cheng JC, 2000, APPL PHYS B-LASERS O, V70, P57, DOI 10.1007/s003400050008
   DEY S, 1985, INDIAN J PURE AP MAT, V16, P1051
   GREEN AE, 1993, J ELASTICITY, V31, P189, DOI 10.1007/BF00044969
   Green A. E., 1972, J ELASTICITY, V2, P1, DOI DOI 10.1007/BF00045689
   Hashin Z., 1964, J APPL MECH        E, V31, P223
   Kumar R., 2009, MULTIDISPLINE MODELI, V5, P283
   Kumar R., 2010, INT J SOLID MECH, V2, P91
   LORD HW, 1967, J MECH PHYS SOLIDS, V15, P299, DOI 10.1016/0022-5096(67)90024-5
   Miller KS, 1993, INTRO FRACTIONAL CAL
   Montanaro A, 1999, J ACOUST SOC AM, V106, P1586, DOI 10.1121/1.427154
   Nowacki W., 1986, THERMOELASTICITY
   Nowacki W., 1975, DYNAMIC PROBLEMS THE
   Oldham K. B., 1974, FRACTIONAL CALCULUS
   Othman MIA, 2007, INT J SOLIDS STRUCT, V44, P5651, DOI 10.1016/j.ijsolstr.2007.01.022
   Podlubny I., 1999, FRACTIONAL DIFFERENT
   Povstenko YZ, 2005, J THERM STRESSES, V28, P83, DOI 10.1080/014957390523741
   Samko S. G., 1993, FRACTIONAL INTEGRALS
   Sengupta PR, 2001, SADHANA-ACAD P ENG S, V26, P363, DOI 10.1007/BF02703405
   Sherief HH, 2010, INT J SOLIDS STRUCT, V47, P269, DOI 10.1016/j.ijsolstr.2009.09.034
   SIDHU RS, 1983, J ACOUST SOC AM, V74, P1640, DOI 10.1121/1.390130
   Singh B, 2004, SADHANA-ACAD P ENG S, V29, P249, DOI 10.1007/BF02703774
   Singh B, 2007, INT J MECH SOLIDS, V2, P39
   SINGH B, 2006, J APPL MATH COMPUT, V177, P170, DOI DOI 10.1016/J.AMC.2005.10.045
   SINGH B, 2008, J APPL MATH COMP, V198, P494, DOI DOI 10.1016/J.AMC.2007.08.072
   Singh B, 2007, ARCH APPL MECH, V77, P253, DOI 10.1007/s00419-006-0094-9
   VERMA PDS, 1983, MECH MATER, V2, P353, DOI 10.1016/0167-6636(83)90026-1
   Youssef HM, 2010, J HEAT TRANS-T ASME, V132, DOI 10.1115/1.4000705
NR 36
TC 0
Z9 0
U1 7
U2 7
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 2070-0733
EI 2075-1354
J9 ADV APPL MATH MECH
JI Adv. Appl. Math. Mech.
PD JUN
PY 2017
VL 9
IS 3
BP 722
EP 741
DI 10.4208/aamm.2015.m60
PG 20
WC Mathematics, Applied; Mechanics
SC Mathematics; Mechanics
GA EK1GY
UT WOS:000393675000011
OA No
DA 2017-08-17
ER

PT J
AU Shehata, AM
   Elaiw, AM
   Elnahary, EK
AF Shehata, A. M.
   Elaiw, A. M.
   Elnahary, E. Kh.
TI Effect of antibodies and latently infected cells on HIV dynamics with
   differential drug efficacy in cocirculating target cells
SO JOURNAL OF COMPUTATIONAL ANALYSIS AND APPLICATIONS
LA English
DT Article
DE Virus infection; Global stability; Latently infected cells;
   cocirculating target cells; Lyapunov function
ID LOGISTIC HEPATOCYTE GROWTH; B-VIRUS INFECTION; CD4(+) T-CELLS; GLOBAL
   STABILITY; MATHEMATICAL-ANALYSIS; HUMORAL IMMUNITY; IN-VIVO; MODEL;
   THERAPY
AB In this paper, we investigate the qualitative behaviors of three viral infection models with two types of cocirculating target cells. The models take into account both antibodies and latently infected cells. The incidence rate is represented by bilinear, saturation and general function. For the first two models, we have derived two threshold parameters, R-0 and R-1 which completely determined the global properties of the models. Lyapunov functions are constructed and LaSalle's invariance principle is applied to prove the global asymptotic stability of all equilibria of the models. For the third model, we have established a set of conditions on the general incidence rate function which are sufficient for the global stability of the equilibria of the model. Theoretical results have been checked by numerical simulations.
C1 [Shehata, A. M.] Univ Pretoria, Dept Elect Elect & Comp Engn, Pretoria, South Africa.
   [Shehata, A. M.] Al Azhar Univ, Fac Sci, Dept Math, Assiut, Egypt.
   [Elaiw, A. M.] King Abdulaziz Univ, Fac Sci, Dept Math, POB 80203, Jeddah 21589, Saudi Arabia.
   [Elnahary, E. Kh.] Sohag Univ, Fac Sci, Dept Math, Sohag, Egypt.
RP Shehata, AM (reprint author), Univ Pretoria, Dept Elect Elect & Comp Engn, Pretoria, South Africa.; Shehata, AM (reprint author), Al Azhar Univ, Fac Sci, Dept Math, Assiut, Egypt.
EM ah_moukh81@yahoo.com; a_m_elaiw@yahoo.com; e_elnahary@yahoo.com
RI Faculty of, Sciences, KAU/E-7305-2017
FU Deanship of Scientific Research (DSR), King Abdulaziz University,
   Jeddah; DSR
FX This article was funded by the Deanship of Scientific Research (DSR),
   King Abdulaziz University, Jeddah. The authors, therefore, acknowledge
   with thanks DSR technical and financial support.
CR Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266
   DEANS JA, 1983, ANNU REV MICROBIOL, V37, P25, DOI 10.1146/annurev.mi.37.100183.000325
   Dominik W., 2000, INT IMMUNOL, V12, P467
   Eikenberry S, 2009, MATH BIOSCI ENG, V6, P283, DOI 10.3934/mbe.2009.6.283
   Elaiw AM, 2016, MATH METHOD APPL SCI, V39, P4, DOI 10.1002/mma.3453
   Elaiw AM, 2015, NONLINEAR ANAL-REAL, V26, P161, DOI 10.1016/j.nonrwa.2015.05.007
   ELAIW A. M., 2015, Journal of the Korean Society for Industrial and Applied Mathematics, V19, P137, DOI 10.12941/jksiam.2015.19.137
   Elaiw AM, 2015, APPL MATH COMPUT, V265, P1067, DOI 10.1016/j.amc.2015.06.011
   Elaiw AM, 2013, MATH METHOD APPL SCI, V36, P383, DOI 10.1002/mma.2596
   Elaiw A, 2012, J KOREAN MATH SOC, V49, P779, DOI 10.4134/JKMS.2012.49.4.779
   Elaiw A. M., 2012, DISCRETE DYN NAT SOC, V20
   Gourley Stephen A., 2008, Journal of Biological Dynamics, V2, P140, DOI 10.1080/17513750701769873
   Hale J. K., 1993, INTRO FUNCTIONAL DIF
   Li JQ, 2011, MATH COMPUT MODEL, V54, P704, DOI 10.1016/j.mcm.2011.03.013
   Li MY, 2012, NONLINEAR ANAL-REAL, V13, P1080, DOI 10.1016/j.nonrwa.2011.02.026
   Murase A, 2005, J MATH BIOL, V51, P247, DOI 10.1007/s00285-005-0321-y
   Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103
   Nowak M. A., 2000, VIRUS DYNAMICS MATH
   Obaid MA, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/650371
   Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107
   Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0
   Qesmi R, 2010, MATH BIOSCI, V224, P118, DOI 10.1016/j.mbs.2010.01.002
   Tanvi P. G., 2014, J MATH BIOL, V69, P1773
   Wang LC, 2006, MATH BIOSCI, V200, P44, DOI 10.1016/j.mbs.2005.12.026
   Wang S., 2012, J APPL MATH, V36, P1313, DOI DOI 10.1016/J.APM.2011.07.086
   Wang TL, 2013, MATH COMPUT SIMULAT, V89, P13, DOI 10.1016/j.matcom.2013.03.004
   Zhao YQ, 2013, B MATH BIOL, V75, P649, DOI 10.1007/s11538-013-9824-7
NR 27
TC 0
Z9 0
U1 17
U2 17
PU EUDOXUS PRESS, LLC
PI CORDOVA
PA 1424 BEAVER TRAIL DRIVE, CORDOVA, TN 38016 USA
SN 1521-1398
EI 1572-9206
J9 J COMPUT ANAL APPL
JI J. Comput. Anal. Appl.
PD JUN 1
PY 2017
VL 22
IS 6
BP 1074
EP 1093
PG 20
WC Computer Science, Theory & Methods; Mathematics, Applied
SC Computer Science; Mathematics
GA EJ0OH
UT WOS:000392908700008
OA No
DA 2017-08-17
ER

PT J
AU Soliman, W
AF Soliman, Wafaa
TI Pseudo line tension in pressurized liquid-phase laser ablation
SO OPTICS AND LASER TECHNOLOGY
LA English
DT Article
DE Pressurized liquid-phase laser ablation; Pseudo line tension; Occupation
   of cavitation bubble with nanoparticles; Adiabatic constant
ID DROP SIZE DEPENDENCE; CONTACT ANGLES; INTERFACIAL-TENSION; 3-PHASE LINE;
   SURFACE; PARTICLES; SYSTEMS
AB In pressurized liquid-phase laser ablation, the ratio between the pseudo line tension and the artificial surface tension (sigma/S) is evaluated for the first time. It is treated as an adjusting parameter in the solution of Rayleigh-Plesset model to obtain the best fitting with the experimental observations of the dynamics of the cavitation bubble. It is found that sigma/S satisfies the relationship sigma/S alpha P-0((-1/3k)), where k is the adiabatic constant. The occupation of the cavitation bubble with nanoparticles, that observed experimentally, deviates the normal magnitudes of sigma/S to anomalous values. At water pressure P-0=0.1 MPa, sigma and S are estimated as 1.9x10(-3)N and 4.2 N/m respectively.
C1 [Soliman, Wafaa] Cairo Univ, Natl Inst Laser Enhanced Sci, El Gama St, Giza 12613, Egypt.
RP Soliman, W (reprint author), Cairo Univ, Natl Inst Laser Enhanced Sci, El Gama St, Giza 12613, Egypt.
EM wafaamas@niles.edu.eg
CR Amirfazli A, 2004, ADV COLLOID INTERFAC, V110, P121, DOI 10.1016/j.cis.2004.05.001
   Amirfazli A, 1998, COLLOID SURFACE A, V142, P183, DOI 10.1016/S0927-7757(98)00265-9
   Aveyard R, 1996, J CHEM SOC FARADAY T, V92, P85, DOI 10.1039/ft9969200085
   Brennen C. E., 1995, CAVITATION BUBBLE DY
   Checco A., 2003, PHYS REV LETT, V91, P18610
   Drelich J, 1996, LANGMUIR, V12, P1913, DOI 10.1021/la9509763
   Drelich J, 1996, COLLOID SURFACE A, V116, P43, DOI 10.1016/0927-7757(96)03651-5
   DUNCAN D, 1995, J COLLOID INTERF SCI, V169, P256, DOI 10.1006/jcis.1995.1032
   Hienola AI, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2565769
   LI D, 1991, J COLLOID INTERF SCI, V142, P224, DOI 10.1016/0021-9797(91)90049-E
   Li DQ, 1996, COLLOID SURFACE A, V116, P1, DOI 10.1016/0927-7757(96)03582-0
   LIN FYH, 1993, J COLLOID INTERF SCI, V159, P86, DOI 10.1006/jcis.1993.1300
   Povarnitsyn ME, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.235414
   Povarnitsyn ME, 2013, PHYS CHEM CHEM PHYS, V15, P3108, DOI 10.1039/c2cp42650a
   Preuss M, 1998, J COLLOID INTERF SCI, V208, P468, DOI 10.1006/jcis.1998.5833
   Sasaki K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.046501
   Soliman W, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.116202
   Soliman W, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.035201
   Stride E, 2009, APPL ACOUST, V70, P1352, DOI 10.1016/j.apacoust.2008.10.003
   VINKE H, 1991, CHEM ENG SCI, V46, P2497, DOI 10.1016/0009-2509(91)80043-X
   Weijs JH, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3546008
NR 21
TC 0
Z9 0
U1 19
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0030-3992
EI 1879-2545
J9 OPT LASER TECHNOL
JI Opt. Laser Technol.
PD JUN 1
PY 2017
VL 91
BP 40
EP 45
DI 10.1016/j.optlastec.2016.12.009
PG 6
WC Optics; Physics, Applied
SC Optics; Physics
GA EJ5ID
UT WOS:000393250100008
OA No
DA 2017-08-17
ER

PT J
AU Ezzat, A
   Ammar, A
   Szabo, Z
   Nyeki, J
   Holb, IJ
AF Ezzat, Ahmed
   Ammar, Amin
   Szabo, Zoltan
   Nyeki, Jozsef
   Holb, Imre J.
TI Postharvest Treatments with Methyl Jasmonate and Salicylic Acid for
   Maintaining Physico-Chemical Characteristics and Sensory Quality
   Properties of Apricot Fruit during Cold Storage and Shelf-Life
SO POLISH JOURNAL OF FOOD AND NUTRITION SCIENCES
LA English
DT Article
DE apricot; methyl jasmonate; salicylic acid; postharvest quality; fruit
   quality estimation
ID REDUCES CHILLING INJURY; PEACH FRUIT
AB The aim of this study was to investigate the effect of methyl jasmonate and salicylic acid on 12 quality parameters of apricot fruit in treatments of cold storage (1 degrees C for 7, 14 and 21 days) and shelf-life (4 and 8 days at 25 degrees C after a 21-day cold storage treatment). Fruit quality parameters included 6 physico-chemical characteristics (weight loss, fruit firmness, total soluble solids, acidity, total soluble solids/acidity ratio and juice pH) and 6 sensory properties (skin and flesh colour, texture, taste, visual appearance and overall acceptability). Among physico-chemical characteristics, applications of 0.2 mmol/L methyl jasmonate and 2 mmol/L salicylic acid significantly reduced fruit weight loss, fruit softening and juice pH and maintained soluble solid content and acidity over the whole storage period. Among sensory properties, all parameters were generally increased by methyl jasmonate and salicylic acid treatments compared to water-treated control and the water-treated fruits showed the lowest scores below the acceptability limit except for skin colour. In conclusion, our results suggest using methyl jasmonate and/or salicylic acid to enhance and prolong the storability of apricot fruits during both cold storage and shelf-life period.
C1 [Ezzat, Ahmed; Szabo, Zoltan; Nyeki, Jozsef; Holb, Imre J.] Univ Debrecen, Inst Hort, POB 36, H-4015 Debrecen, Hungary.
   [Ezzat, Ahmed] Kafrelsheikh Univ, Fac Agr, Dept Hort, Kafr Al Sheikh, Egypt.
   [Ammar, Amin] Kafrelsheikh Univ, Fac Agr, Dept Food Sci & Technol, Kafr Al Sheikh, Egypt.
   [Holb, Imre J.] Hungarian Acad Sci, Inst Plant Protect, Agr Res Ctr, Budapest, Hungary.
RP Holb, IJ (reprint author), Univ Debrecen, Inst Hort, POB 36, H-4015 Debrecen, Hungary.; Holb, IJ (reprint author), Hungarian Acad Sci, Inst Plant Protect, Agr Res Ctr, Budapest, Hungary.
EM holbimre@gmail.com
FU grant of the Hungarian Research Science Found [K108333]
FX This study was supported by a grant of the Hungarian Research Science
   Found K108333.
CR Aghdam M. S., 2011, Journal of Agricultural Science (Toronto), V3, P149
   Gonzalez Aguilar G. A., 2003, POSTHARVEST BIOL TEC, V28, P361
   Asghari M, 2010, TRENDS FOOD SCI TECH, V21, P502, DOI 10.1016/j.tifs.2010.07.009
   Ayala-Zavala JF, 2005, EUR FOOD RES TECHNOL, V221, P731, DOI 10.1007/s00217-005-0069-z
   Colaric M, 2005, J SCI FOOD AGR, V85, P2611, DOI 10.1002/jsfa.2316
   Crisosto C. H., 1995, Postharvest News and Information, V6, p17N
   Fan XT, 1998, J AM SOC HORTIC SCI, V123, P421
   FISHMAN ML, 1993, J AM SOC HORTIC SCI, V118, P343
   Gonzalez-Aguilar GA, 2000, J AGR FOOD CHEM, V48, P515, DOI 10.1021/jf9902806
   Hegedus A, 2011, BIOL RES, V44, P339, DOI [/S0716-97602011000400004, 10.4067/S0716-97602011000400004]
   HUBBARD NL, 1991, PHYSIOL PLANTARUM, V82, P191, DOI 10.1034/j.1399-3054.1991.820208.x
   Infante R, 2008, J HORTIC SCI BIOTECH, V83, P828
   Jin P, 2014, FOOD BIOPROCESS TECH, V7, P2259, DOI 10.1007/s11947-013-1232-3
   Jin P, 2009, J SCI FOOD AGR, V89, P1690, DOI 10.1002/jsfa.3642
   Li L.P., 1999, FOOD SCI, V7, P61
   Meng XH, 2009, FOOD CHEM, V114, P1028, DOI 10.1016/j.foodchem.2008.09.109
   Muftuoglu F, 2012, FOOD BIOPROCESS TECH, V5, P1601, DOI 10.1007/s11947-010-0482-6
   Obenland D, 2009, POSTHARVEST BIOL TEC, V52, P156, DOI 10.1016/j.postharvbio.2009.01.005
   RASKIN I, 1992, ANNU REV PLANT PHYS, V43, P439, DOI 10.1146/annurev.pp.43.060192.002255
   Satraj A., 2013, J BIOL FOOD SCI RES, V2, P66
   Sayyari M, 2011, POSTHARVEST BIOL TEC, V60, P136, DOI 10.1016/j.postharvbio.2010.12.012
   Shafiee M, 2010, SCI HORTIC-AMSTERDAM, V124, P40, DOI 10.1016/j.scienta.2009.12.004
   Srivastava MK, 2000, PLANT SCI, V158, P87, DOI 10.1016/S0168-9452(00)00304-6
   Stanley J, 2010, ACTA HORTIC, V880, P525
   Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679
   Valero D, 2011, J AGR FOOD CHEM, V59, P5483, DOI 10.1021/jf200873j
   Wang LJ, 2006, POSTHARVEST BIOL TEC, V41, P244, DOI 10.1016/j.postharvbio.2006.04.010
   Watkins CB, 2005, ENVIRONMENTALLY FRIENDLY TECHNOLOGIES FOR AGRICULTURAL PRODUCE QUALITY, P447
   Yao HJ, 2005, POSTHARVEST BIOL TEC, V35, P253, DOI 10.1016/j.postharvbio.2004.09.001
   Zheng Y, 2004, ACTA HORTIC, V632, P317
NR 30
TC 0
Z9 0
U1 85
U2 155
PU DE GRUYTER OPEN LTD
PI WARSAW
PA BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND
SN 1230-0322
EI 2083-6007
J9 POL J FOOD NUTR SCI
JI Pol. J. food Nutr. Sci.
PD JUN
PY 2017
VL 67
IS 2
BP 159
EP 166
DI 10.1515/pjfns-2016-0013
PG 8
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA ED9RR
UT WOS:000389210900009
OA gold
DA 2017-08-17
ER

PT J
AU Al-Shamary, DS
   Al-Alshaikh, MA
   Kheder, NA
   Mabkhot, YN
   Badshah, SL
AF Al-Shamary, Danah S.
   Al-Alshaikh, Monirah A.
   Kheder, Nabila Abdelshafy
   Mabkhot, Yahia Nasser
   Badshah, Syed Lal
TI !Molecular docking and biological evaluation of some
   thioxoquinazolin-4(3H)-one derivatives as anticancer, antioxidant and
   anticonvulsant agents
SO CHEMISTRY CENTRAL JOURNAL
LA English
DT Article
DE Thioxoquinazolin-4(3H)-one; Anticancer activity; Antioxidant activity;
   Anticonvulsant activity; Molecular docking
ID ANTITUMOR-ACTIVITY EVALUATION; QUINAZOLINE DERIVATIVES; ANTIINFLAMMATORY
   EVALUATION; CNS DEPRESSANT; INHIBITORS; DESIGN; POTENT;
   QUINAZOLIN-4(3H)-ONES; CYTOTOXICITY; EXTRACTS
AB Background: The quinazoline are an important class of medicinal compounds that possess a number of biological activities like anticancer, anticonvulsant and antioxidant etc.
   Results: We evaluated the previously synthesized quinazoline derivatives 1-3 for their anticancer activities against three cancer cell lines (HepG2, MCF-7, and HCT-116). Among the tested compounds, quinazolines 1 and 3 were found to be more potent than the standard drug Vinblastine against HepG2 and MCF-7 cell lines. All the tested compounds had less antioxidant activity and did not exhibit any anticonvulsant activity. Also, molecular docking studies were performed to get an insight into the binding modes of the compounds with human cyclin-dependent kinase 2, butyrylcholinesterase enzyme, human gamma-aminobutyric acid receptor. These compounds showed better docking properties with the CDK2 as compared to the other two enzymes.
   Conclusions: The overall study showed that thioxoquinazolines are suitable antitumor agents and they should be explored for other biological activities. Modification in the available lot of quinazoline and synthesis of its novel derivatives is essential to explore the potential of this class of compounds. The increase in the threat and with the emergence of drug resistance, it is important to explore and develop more efficacious drugs.
C1 [Al-Shamary, Danah S.; Al-Alshaikh, Monirah A.] King Saud Univ, Women Students Med Studies & Sci Sect, Dept Chem, Coll Sci, POB 22452, Riyadh 11495, Saudi Arabia.
   [Kheder, Nabila Abdelshafy] Cairo Univ, Fac Sci, Dept Chem, Giza 12613, Egypt.
   [Kheder, Nabila Abdelshafy] King Khalid Univ, Dept Pharmaceut Chem, Fac Pharm, Abha 61441, Saudi Arabia.
   [Mabkhot, Yahia Nasser] King Saud Univ, Dept Chem, Coll Sci, POB 2455, Riyadh 11451, Saudi Arabia.
   [Badshah, Syed Lal] Univ Peshawar, Dept Chem, Islamia Coll, Peshawar 25120, Pakistan.
RP Mabkhot, YN (reprint author), King Saud Univ, Dept Chem, Coll Sci, POB 2455, Riyadh 11451, Saudi Arabia.; Badshah, SL (reprint author), Univ Peshawar, Dept Chem, Islamia Coll, Peshawar 25120, Pakistan.
EM yahia@ksu.edu.sa; shahbiochemist@gmail.com
RI Mabkhot, Yahia/E-9301-2017
OI Mabkhot, Yahia/0000-0002-9762-0323; BADSHAH, SYED
   LAL/0000-0002-0229-1425
FU Deanship of Scientific Research at king Saud University [PRG-1437-29]
FX The authors extend their sincere appreciation to the Deanship of
   Scientific Research at king Saud University for its funding this
   Prolific Research group (PRG-1437-29). Also, the authors are thankful to
   Ahmed Abdelshafy Khedr Chemistry department-faculty of science-Cairo
   University for the molecular docking.
CR Agarwal KC, 2009, BIOORG MED CHEM LETT, V19, P5474, DOI 10.1016/j.bmcl.2009.07.081
   Al-Amiery AA, 2014, MED CHEM RES, V23, P236, DOI 10.1007/s00044-013-0625-1
   Al-Shamary DS, 2013, ASIAN J CHEM, V25, P6569
   Alafeefy AM, 2010, EUR J MED CHEM, V45, P4947, DOI 10.1016/j.ejmech.2010.07.067
   Alagarsamy V, 2007, BIOORGAN MED CHEM, V15, P235, DOI 10.1016/j.bmc.2006.09.065
   AL-ALshaikh M, 2013, RES J CHEM ENVIRON
   Al-deeb AO, 2008, APPL SCI, V5, P94
   Asif M, 2014, INT J MED CHEM, V2014, P1, DOI [10.1155/2014/395637, DOI 10.1155/2014/395637]
   Balakumar C, 2010, EUR J MED CHEM, V45, P4904, DOI 10.1016/j.ejmech.2010.07.063
   Bhandar SV, 2008, PHARMACOLOGYONLINE, V2, P604
   Boyapati S, 2010, ARCH PHARM, V343, P570, DOI 10.1002/ardp.201000065
   Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
   Gawad NMA, 2010, EUR J MED CHEM, V45, P6058, DOI 10.1016/j.ejmech.2010.10.008
   Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o
   Gibson AE, 2002, J MED CHEM, V45, P3381, DOI 10.1021/jm020056z
   Giri RS, 2009, EUR J MED CHEM, V44, P2184, DOI 10.1016/j.ejmech.2008.10.031
   Hay RJ, 2000, ANIMAL CELL CULTURE, P78
   He JB, 2012, EUR J MED CHEM, V54, P925, DOI 10.1016/j.ejmech.2012.06.003
   Hei YY, 2016, BIOORG MED CHEM LETT, V26, P4408, DOI 10.1016/j.bmcl.2016.08.015
   Hemalatha K, 2011, INT J PHARM PHARM SC, V3, P6
   Hussein MA, 2013, MED CHEM RES, V22, P4641, DOI 10.1007/s00044-013-0468-9
   Ismail RSM, 2016, FUTURE J PHARM SCI, V2, P9, DOI [10.1016/j.fjps.2016.02.001, DOI 10.1016/J.FJPS.2016.02.001]
   Jatav V, 2008, EUR J MED CHEM, V43, P1945, DOI 10.1016/j.ejmech.2007.12.003
   Jatav V, 2008, EUR J MED CHEM, V43, P135, DOI 10.1016/j.ejmech.2007.02.004
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Kabri Y, 2010, EUR J MED CHEM, V45, P616, DOI 10.1016/j.ejmech.2009.11.005
   Kashaw SK, 2009, EUR J MED CHEM, V44, P4335, DOI 10.1016/j.ejmech.2009.05.008
   Kim YH, 2008, BIOORG MED CHEM LETT, V18, P6279, DOI 10.1016/j.bmcl.2008.09.108
   KRALL RL, 1978, EPILEPSIA, V19, P409, DOI 10.1111/j.1528-1157.1978.tb04507.x
   Krishnan SK, 2011, EUR REV MED PHARMACO, V15, P673
   Kumar A, 2003, BIOORGAN MED CHEM, V11, P5293, DOI 10.1016/S0968-0896(03)00501-7
   Kumar KS, 2010, EUR J MED CHEM, V45, P5474, DOI 10.1016/j.ejmech.2010.07.058
   Kunes J, 2000, FARMACO, V55, P725, DOI 10.1016/S0014-827X(00)00100-2
   Lan P, 2010, BIOORG MED CHEM LETT, V20, P6764, DOI 10.1016/j.bmcl.2010.08.131
   Li HQ, 2012, BIOORGAN MED CHEM, V20, P317, DOI 10.1016/j.bmc.2011.10.085
   Li Z, 2016, ONCOTARGET, V7, P34266, DOI 10.18632/oncotarget.9088
   Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019
   Marvania B, 2011, BIOORGAN MED CHEM, V19, P1987, DOI 10.1016/j.bmc.2011.01.055
   Mosaad SM, 2005, INT J PHARMACEUT, V1, P261
   Qin XM, 2016, BIOORG MED CHEM LETT, V26, P1571, DOI 10.1016/j.bmcl.2016.02.009
   Raffa D, 2004, EUR J MED CHEM, V39, P299, DOI 10.1016/j.ejmech.2003.12.009
   Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002
   Sasmal S, 2012, BIOORG MED CHEM LETT, V22, P3163, DOI 10.1016/j.bmcl.2012.03.049
   Selvam TP, 2010, RES BIOTECHNOL, V1, P38
   Tabor E, 2001, DIGEST LIVER DIS, V33, P115, DOI 10.1016/S1590-8658(01)80062-1
   Tarozzi A, 2016, EUR J MED CHEM, V117, P283, DOI 10.1016/j.ejmech.2016.04.002
   Taylor P, 2011, MOL SIMULAT, V37, P824, DOI [10.1080/08927022.2011.563302, DOI 10.1080/08927022.2011.563302]
   Vadivelan S, 2007, J CHEM INF MODEL, V47, P1526, DOI 10.1021/ci7000742
   Vasconcelos SMM, 2007, J ETHNOPHARMACOL, V110, P271, DOI 10.1016/j.jep.2006.09.023
   Wang SD, 2004, J MED CHEM, V47, P1662, DOI 10.1021/jm0309957
   WERBEL LM, 1987, J MED CHEM, V30, P2151, DOI 10.1021/jm00394a038
   Wilson AP, 2000, ANIMAL CELL CULTURE, P175
   Xu GF, 2007, BIOORGAN MED CHEM, V15, P3768, DOI 10.1016/j.bmc.2007.03.037
   Ye CW, 2010, PESTIC BIOCHEM PHYS, V97, P194, DOI 10.1016/j.pestbp.2010.02.001
   YEN GC, 1994, J AGR FOOD CHEM, V42, P629, DOI 10.1021/jf00039a005
   You JH, 2008, ARKIVOC, P1
   Zhang Y, 2016, BIOORG MED CHEM LETT, V26, P4666, DOI 10.1016/j.bmcl.2016.08.060
NR 57
TC 0
Z9 0
U1 4
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-153X
J9 CHEM CENT J
JI Chem. Cent. J.
PD MAY 31
PY 2017
VL 11
AR 48
DI 10.1186/s13065-017-0272-6
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA EW4ER
UT WOS:000402455300001
OA gold
DA 2017-08-17
ER

PT J
AU Lin, A
   Ibrahim, AA
   Arab, P
   El-Kaderi, HM
   El-Shall, MS
AF Lin, Andrew
   Ibrahim, Amr Awad
   Arab, Pezhman
   El-Kaderi, Hani M.
   El-Shall, M. Samy
TI Palladium Nanoparticles Supported on Ce-Metal-Organic Framework for
   Efficient CO Oxidation and Low-Temperature CO2 Capture
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE palladium nanoparticles; cerium MOF; CO oxidation; CO2 uptake;
   heterogeneous catalysis; Pd catalyst supported on Ce-MOF
ID POROUS COORDINATION POLYMERS; CERIA NANOPARTICLES; CATALYTIC-ACTIVITY;
   HYDROGEN STORAGE; ROOM-TEMPERATURE; CARBON; SITES; PD; PHOTOCATALYSIS;
   NANOCATALYSIS
AB In this article, we report the lowest-temperature CO oxidation catalyst supported onmetal-organic frameworks (MOFs). We have developed a facile, general, and effective approach based on microwave irradiation for the incorporation of Pd nanoparticle catalyst within Ce-MOF. The resulting Pd/ Ce-MOF material is a unique catalyst that is capable of CO oxidation at modest temperatures and also of efficient uptake of the product CO2 gas at low temperatures. The observed catalytic activity of this material toward CO oxidation is significantly higher than those of other reported metal nanoparticles supported on MOFs. The high, activity of the Pd/Ce-MOF catalyst is due to the presence of. Ce(III) and Ce(IV) ions within the metal-organic framework support. The Pd nanoparticles supported on the Ce-MOF store oxygen in the form of a thin palladium oxide layer at the particle-support interface, in addition to the oxygen stored on the Ce(III)/Ce(IV) centers, Oxygen from these reservoirs can be released during CO oxidation at 373 K. At lower temperatures (273 K), the Pd/Ce-MOF has a significant CO2 uptake of 3.5 mmol/g.
C1 [Lin, Andrew; Ibrahim, Amr Awad; Arab, Pezhman; El-Kaderi, Hani M.; El-Shall, M. Samy] Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23284 USA.
   [Ibrahim, Amr Awad] Mansoura Univ, Dept Chem, Fac Sci, Mansoura, Egypt.
RP El-Shall, MS (reprint author), Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23284 USA.
EM mselshal@vcu.edu
FU National Science Foundation [CHE-1463989, IIA-1445489]; Center for
   Rational Catalysis Synthesis (CeRCas) - National Science Foundation at
   the University of South Carolina; Virginia Commonwealth University
FX We thank the National Science Foundation (CHE-1463989 and IIA-1445489)
   for support of this work. This work was also partially supported by the
   Center for Rational Catalysis Synthesis (CeRCas) supported by the
   National Science Foundation at the University of South Carolina and
   Virginia Commonwealth University.
CR Adhikari AK, 2016, CHEM ENG J, V284, P1348, DOI 10.1016/j.cej.2015.09.086
   Almasi M, 2015, CATAL TODAY, V243, P184, DOI 10.1016/j.cattod.2014.07.028
   Cheon YE, 2009, ANGEW CHEM INT EDIT, V48, P2899, DOI 10.1002/anie.200805494
   Choi KM, 2015, J AM CHEM SOC, V137, P7810, DOI 10.1021/jacs.5b03540
   Corma A, 2010, CHEM REV, V110, P4606, DOI 10.1021/cr9003924
   Dhakshinamoorthy A, 2013, CATAL SCI TECHNOL, V3, P2509, DOI 10.1039/c3cy00350g
   El-Shall MS, 2009, J MATER CHEM, V19, P7625, DOI 10.1039/b912012b
   Fateeva A, 2012, ANGEW CHEM INT EDIT, V51, P7440, DOI 10.1002/anie.201202471
   Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444
   Glaspell G, 2008, TOP CATAL, V47, P22, DOI 10.1007/s11244-007-9036-1
   Glaspell G, 2006, J PHYS CHEM B, V110, P21387, DOI 10.1021/jp0651034
   Green F., 1998, IEH ASSESSMENT INDOO
   Guo ZY, 2014, ACS CATAL, V4, P1340, DOI 10.1021/cs400982n
   He L, 2015, RSC ADV, V5, P10707, DOI 10.1039/c4ra10260f
   Hermes S, 2005, ANGEW CHEM INT EDIT, V44, P6237, DOI 10.1002/anie.200462515
   Ibrahim AA, 2017, CHEMCATCHEM, V9, P469, DOI 10.1002/cctc.201600956
   IGARASHI H, 1995, J ELECTROANAL CHEM, V391, P119, DOI 10.1016/0022-0728(95)03914-3
   Jhung SH, 2007, ADV MATER, V19, P121, DOI 10.1002/adma.200601604
   Jiang HL, 2009, J AM CHEM SOC, V131, P11302, DOI 10.1021/ja9047653
   Kar S, 2009, J PHYS CHEM C, V113, P4862, DOI 10.1021/jp811275k
   Kaur P, 2011, ACS CATAL, V1, P819, DOI 10.1021/cs200131g
   Khan NA, 2010, EUR J INORG CHEM, P4975, DOI 10.1002/ejic.201000541
   Kim T, 2015, POLYHEDRON, V90, P18, DOI 10.1016/j.poly.2015.01.031
   Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610
   Li SL, 2013, ENERG ENVIRON SCI, V6, P1656, DOI 10.1039/c3ee40507a
   Lin A., GOLD PLATINUM UNPUB
   Liu B, 2015, J PHYS CHEM C, V119, P12923, DOI 10.1021/acs.jpcc.5b00267
   Mai HL, 2011, APPL SURF SCI, V257, P7551, DOI 10.1016/j.apsusc.2011.03.124
   Mishra AK, 2012, CHEM ENG J, V187, P10, DOI 10.1016/j.cej.2011.01.024
   Moon SY, 2010, ANGEW CHEM INT EDIT, V49, P9504, DOI 10.1002/anie.201002609
   Morozan A, 2012, ENERG ENVIRON SCI, V5, P9269, DOI 10.1039/c2ee22989g
   O'Keeffe M, 2012, CHEM REV, V112, P675, DOI 10.1021/cr200205j
   Perles J, 2005, CHEM MATER, V17, P5837, DOI 10.1021/cm051362e
   Qian L., 2014, ACTA PHYS-CHIM SIN, V30, P129
   Rao KN, 2010, CATAL COMMUN, V11, P863, DOI 10.1016/j.catcom.2010.03.009
   Sabo M, 2007, J MATER CHEM, V17, P3827, DOI 10.1039/b706432b
   Sutradhar N, 2011, J PHYS CHEM C, V115, P7628, DOI 10.1021/jp200645q
   Wang C, 2011, J AM CHEM SOC, V133, P13445, DOI 10.1021/ja203564w
   Yang YL, 2006, CATAL COMMUN, V7, P281, DOI 10.1016/j.catcom.2005.11.014
   Ye JY, 2011, CHEM COMMUN, V47, P2167, DOI 10.1039/c0cc04944a
   Zamaro JM, 2012, CHEM ENG J, V195, P180, DOI 10.1016/j.cej.2012.04.091
   Zhang F, 2004, SURF SCI, V563, P74, DOI 10.1016/j.susc.2004.05.138
   Zhao Y, 2013, CATAL COMMUN, V38, P74, DOI 10.1016/j.catcom.2013.04.019
   Zou RQ, 2006, ANGEW CHEM INT EDIT, V45, P2542, DOI 10.1002/anie.200503923
   Zou RQ, 2007, J AM CHEM SOC, V129, P8402, DOI 10.1021/ja071662s
NR 45
TC 0
Z9 0
U1 33
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 31
PY 2017
VL 9
IS 21
BP 17961
EP 17968
DI 10.1021/acsami.7b03555
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EW7LN
UT WOS:000402691600033
PM 28485981
OA No
DA 2017-08-17
ER

PT J
AU Ayoub, BM
   Mowaka, S
   Elzanfaly, ES
   Ashoush, N
   Elmazar, MM
   Mousa, SA
AF Ayoub, Bassam M.
   Mowaka, Shereen
   Elzanfaly, Eman S.
   Ashoush, Nermeen
   Elmazar, Mohamed M.
   Mousa, Shaker A.
TI Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian
   Volunteers Using LC-MS/MS and Comparison with Other Ethnic Populations
SO SCIENTIFIC REPORTS
LA English
DT Article
ID COTRANSPORTER 2 INHIBITOR; TYPE-2 DIABETES-MELLITUS; SGLT2 INHIBITOR;
   RAT PLASMA; JAPANESE PATIENTS; RENAL IMPAIRMENT; UHPLC-MS/MS;
   PHARMACODYNAMICS; TOLERABILITY; SAFETY
AB The present study considered the pharmacokinetic evaluation of empagliflozin after administration to Egyptian volunteers, and the results were compared with other ethnic populations. The FDA recognizes that standard methods of defining racial subgroups are necessary to compare results across pharmacokinetic studies and to assess potential subgroup differences. The design of the study was as an open labeled, randomized, one treatment, one period, single dose pharmacokinetic study. The main pharmacokinetic parameters estimated were C-max, T-max, t(1/2), elimination rate constant, AUC(0-t) and AUC(0-inf). The insignificant difference in pharmacokinetic parameters between Egyptians and white German subjects suggests that no dose adjustment should be considered with administration of 25 mg empagliflozin to Egyptian population. A new LC-MS/MS method was developed and validated, allowing sensitive estimation of empagliflozin (25-600 ng mL(-1)) in human plasma using dapagliflozin as an internal standard (IS). The method was applied successfully on the underlying pharmacokinetic study with enhanced sample preparation that involved liquid-liquid extraction. Multiple Reaction Monitoring (MRM) of the transition pairs of m/z 449.01 to 371.21 for empagliflozin and m/z 407.00 to 328.81 for dapagliflozin (IS) was employed utilizing negative mode Electro Spray Ionization (ESI). The validated LC-MS/MS method is suitable for further toxicodynamic and bioequivalence studies.
C1 [Ayoub, Bassam M.; Mowaka, Shereen] British Univ Egypt, Pharmaceut Chem Dept, Fac Pharm, Cairo, Egypt.
   [Ayoub, Bassam M.; Mowaka, Shereen; Ashoush, Nermeen; Elmazar, Mohamed M.] British Univ Egypt, Ctr Drug Res & Dev, Fac Pharm, Cairo, Egypt.
   [Mowaka, Shereen] Helwan Univ, Analyt Chem Dept, Fac Pharm, Cairo, Egypt.
   [Elzanfaly, Eman S.] Cairo Univ, Analyt Chem Dept, Fac Pharm, Kasr El Aini St, Cairo, Egypt.
   [Elzanfaly, Eman S.] Cairo Univ, Ctr Appl Res & Adv Studies, Fac Pharm, Kasr El Aini St, Cairo, Egypt.
   [Ashoush, Nermeen] British Univ Egypt, Clin Pharm & Pharm Practice Dept, Fac Pharm, Cairo, Egypt.
   [Elmazar, Mohamed M.] British Univ Egypt, Pharmacol Dept, Fac Pharm, Cairo, Egypt.
   [Mousa, Shaker A.] Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, Rensselaer, NY USA.
RP Ayoub, BM (reprint author), British Univ Egypt, Pharmaceut Chem Dept, Fac Pharm, Cairo, Egypt.; Ayoub, BM (reprint author), British Univ Egypt, Ctr Drug Res & Dev, Fac Pharm, Cairo, Egypt.
EM bassam.ayoub@bue.edu.eg
OI Ayoub, Bassam/0000-0002-3265-1567
FU British University in Egypt, under Young Investigator Research Grant
   Program (YIRG) [YIRG-2016-01]
FX This research was kindly supported and funded by The British University
   in Egypt, under Young Investigator Research Grant Program (YIRG), grant
   number YIRG-2016-01 on 1 October 2016, granted to Dr. Bassam Mahfouz
   Ayoub, the principal investigator of the research project. We declare
   that this work was done by the authors named in this article and all
   liabilities pertaining to claims relating to the content of this article
   will be borne by the authors.
CR Alolga RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep12961
   Aubry AF, 2010, BIOANALYSIS, V2, P2001, DOI [10.4155/bio.10.139, 10.4155/BIO.10.139]
   Baron KT, 2016, DIABETES THER, V7, P455, DOI 10.1007/s13300-016-0174-y
   Brand T, 2012, ADV THER, V29, P889, DOI 10.1007/s12325-012-0055-3
   Fornasaro S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22815
   Friedrich C, 2013, CLIN THER, V35, pA33, DOI 10.1016/j.clinthera.2012.12.002
   Gao Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25659
   Hansen HH, 2014, J PHARMACOL EXP THER, V350, P657, DOI 10.1124/jpet.114.213454
   Heise T, 2013, DIABETES OBES METAB, V15, P613, DOI 10.1111/dom.12073
   Heise T, 2015, CLIN THER, V37, P793, DOI 10.1016/j.clinthera.2014.12.018
   Heise T, 2013, DIABETES THER, V4, P331, DOI 10.1007/s13300-013-0030-2
   International Conference on Harmonisation, 1998, FED REG, V63, P31790
   Iqbal M, 2015, TALANTA, V132, P29, DOI 10.1016/j.talanta.2014.08.041
   Kanada S, 2013, J DIABETES INVEST, V4, P613, DOI 10.1111/jdi.12110
   Kobuchi S, 2017, BIOANALYSIS, V9, P163, DOI 10.4155/bio-2016-0188
   Kobuchi S, 2016, BIOMED CHROMATOGR, V30, P1549, DOI 10.1002/bmc.3720
   Kobuchi S, 2016, J CHROMATOGR B, V1027, P227, DOI 10.1016/j.jchromb.2016.05.053
   Kobuchi S, 2015, J CHROMATOGR B, V1000, P22, DOI 10.1016/j.jchromb.2015.07.013
   Kudgus RA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05669
   Macha S, 2014, DIABETES OBES METAB, V16, P215, DOI 10.1111/dom.12182
   Macha S, 2014, DIABETES OBES METAB, V16, P118, DOI 10.1111/dom.12183
   Macha S, 2015, CLIN THER, V37, P1789, DOI 10.1016/j.clinthera.2015.06.003
   Macha S, 2015, CLIN THER, V37, P1503, DOI 10.1016/j.clinthera.2015.05.002
   Macha S, 2014, CLIN THER, V36, P280, DOI 10.1016/j.clinthera.2014.01.003
   Nair S, 2010, J CLIN ENDOCR METAB, V95, P34, DOI 10.1210/jc.2009-0473
   Riggs MM, 2013, J CLIN PHARMACOL, V53, P1028, DOI 10.1002/jcph.147
   Sarashina A, 2014, CLIN THER, V36, P1606, DOI 10.1016/j.clinthera.2014.08.001
   Sarashina A, 2013, DRUG METAB PHARMACOK, V28, P213, DOI 10.2133/dmpk.DMPK-12-RG-082
   Scheen AJ, 2014, CLIN PHARMACOKINET, V53, P213, DOI 10.1007/s40262-013-0126-x
   Seman L, 2013, CLIN PHARM DRUG DEV, V2, P152, DOI 10.1002/cpdd.16
   Takanaka A., 2001, JPN J CLIN PHARM THE, V32, P217
   Tomlinson B, 2017, EXPERT OPIN DRUG MET, V13, P211, DOI 10.1080/17425255.2017.1258401
   US Food and Drug Administration, GUID IND BIOAN METH
   Xue YJ, 2004, J PHARMACEUT BIOMED, V34, P369, DOI 10.1016/S0731-7085(03)00520-X
   Yang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35460
   Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141
   Zhao X, 2015, CLIN THER, V37, P1493, DOI 10.1016/j.clinthera.2015.05.001
   Zhong YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31364
NR 38
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 31
PY 2017
VL 7
AR 2583
DI 10.1038/s41598-017-02895-7
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW5BE
UT WOS:000402519400047
PM 28566743
OA gold
DA 2017-08-17
ER

PT J
AU Sarhan, MA
   Abdel-Hakeem, MS
   Mason, AL
   Tyrrell, DL
   Houghton, M
AF Sarhan, Mohammed A.
   Abdel-Hakeem, Mohamed S.
   Mason, Andrew L.
   Tyrrell, D. Lorne
   Houghton, Michael
TI Glycogen synthase kinase 3 beta inhibitors prevent hepatitis C virus
   release/assembly through perturbation of lipid metabolism
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN HEPATOMA-CELLS; RNA REPLICATION; PROTEIN; PHOSPHORYLATION;
   INFECTION; MICE; AUTOPHAGY; ALPHA; GSK-3; STEP
AB Direct acting antivirals against hepatitis C virus (HCV) have markedly improved cure rates in the past few years. However, they are expensive, with only few targeting host cell factors, and affecting virus assembly and release. Huh7.5 cells infected with a JFH-1 clone of HCV were treated with two different glycogen synthase kinase (GSK3)-beta inhibitors; AR-A014418 and lithium chloride. Intra-and extracellular HCV virions and specific infectivity was determined using real-time RT-PCR and TCID50, and changes in lipid production were identified by enzyme-linked immunoassay and mass spectrometry analyses. Similarly, effect on two HCV replicon cells were identified by the luciferase activity. Although there was limited effect on virus replication in Huh7.5 cells and replicons, Huh7.5 cells treated with GSK3 beta inhibitors produced significantly less viral particles in comparison to untreated cells. In addition, the treated cells synthesized significantly lower amounts of ApoB and trapped the ApoE lipoproteins in the cells. In conclusion, our study suggests that GSK3 beta plays a pivotal role in HCV virion assembly and release mediated in part through inhibition of apolipoprotein synthesis.
C1 [Sarhan, Mohammed A.; Abdel-Hakeem, Mohamed S.; Mason, Andrew L.; Tyrrell, D. Lorne; Houghton, Michael] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
   [Sarhan, Mohammed A.; Abdel-Hakeem, Mohamed S.; Tyrrell, D. Lorne; Houghton, Michael] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.
   [Sarhan, Mohammed A.] Menoufia Univ, Natl Liver Inst, Dept Microbiol & Immunol, Menoufia, Egypt.
   [Sarhan, Mohammed A.; Mason, Andrew L.] Univ Alberta, Dept Med, Edmonton, AB, Canada.
   [Abdel-Hakeem, Mohamed S.] Cairo Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt.
RP Sarhan, MA (reprint author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Sarhan, MA (reprint author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.; Sarhan, MA (reprint author), Menoufia Univ, Natl Liver Inst, Dept Microbiol & Immunol, Menoufia, Egypt.; Sarhan, MA (reprint author), Univ Alberta, Dept Med, Edmonton, AB, Canada.
EM msarhan@ualberta.ca
FU Canadian Excellence Research Chair; Canadian Institutes of Health
   Research (CIHR); Alberta Innovates Health Solutions; National Canadian
   Research Training Program for HCV (NCRTP-HepC)
FX The authors would like to thank Dr. Ralf Bartenschlager for supplying
   the HCV replicon Huh7 cells for control experiments, Dr. Takaji Wakita
   for Huh7.5 cells, as well as Drs. Rodney S. Russell and Richard Leonard
   for providing technical support. We also thank Mr. Shaw Chin, Justin
   Fields and Darren Hockman for technical support. This work was supported
   by the Canadian Excellence Research Chair operating grant awarded to
   Michael Houghton and Mohammed Sarhan (MS) fellowship awards. MS received
   fellowships from the Canadian Institutes of Health Research (CIHR), the
   Alberta Innovates Health Solutions, and the National Canadian Research
   Training Program for HCV (NCRTP-HepC).
CR Aizawa Y, 2015, WORLD J GASTROENTERO, V21, P10299, DOI 10.3748/wjg.v21.i36.10299
   Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016
   Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200
   Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08
   Chang YS, 2011, J CELL BIOCHEM, V112, P881, DOI 10.1002/jcb.22996
   Cheverud JM, 2011, OBESITY, V19, P160, DOI 10.1038/oby.2010.141
   Cottarel J, 2016, J GEN VIROL, V97, P69, DOI 10.1099/jgv.0.000331
   Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835
   Gonzalez O, 2009, HEPATOLOGY, V50, P1756, DOI 10.1002/hep.23232
   Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042
   Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13
   Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870
   Jammart B, 2013, J VIROL, V87, P5065, DOI 10.1128/JVI.01405-12
   Jones DM, 2011, J VIROL, V85, P12351, DOI 10.1128/JVI.05313-11
   Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2
   Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001
   Lee JY, 2014, J VIROL, V88, P12422, DOI 10.1128/JVI.01660-14
   Li TY, 2013, PHYSIOLOGY, V28, P423, DOI 10.1152/physiol.00023.2013
   McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184
   Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008
   Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001
   Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112
   Reed KE, 1997, J VIROL, V71, P7187
   Ren F, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.56
   Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105
   Sarhan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062159
   Sarhan MA, 2012, J GEN VIROL, V93, P2399, DOI 10.1099/vir.0.045393-0
   Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471
   SIMONETTI RG, 1992, ANN INTERN MED, V116, P97
   Steenbergen RH, 2013, HEPATOLOGY, V58, P1907, DOI 10.1002/hep.26566
   Steenbergen RHG, 2010, AM J PHYSIOL-GASTR L, V299, pG844, DOI 10.1152/ajpgi.00200.2010
   Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010
   Triyatni M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001333
   Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002
NR 34
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 31
PY 2017
VL 7
AR 2495
DI 10.1038/s41598-017-02648-6
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EW5AP
UT WOS:000402517900001
PM 28566716
OA gold
DA 2017-08-17
ER

PT J
AU Zakaria, Y
   Ivanek, L
   Glesk, I
AF Zakaria, Yahia
   Ivanek, Lubomir
   Glesk, Ivan
TI Propagation Measurements and Estimation of Channel Propagation Models in
   Urban Environment
SO KSII TRANSACTIONS ON INTERNET AND INFORMATION SYSTEMS
LA English
DT Article
DE Propagation; Urban; Weissberger's Model; COST 231 Walfish-Ikegami (W-I)
   Model
AB Wireless communication is a telecommunication technology, which enables wireless transmission between the portable devices to provide wireless access in all types of environments. In this research, the measurements and various empirical models are analysed and compared in order to find out a suitable propagation model to provide guidelines for cell planning of wireless communication systems. The measured data was taken in urban region with low vegetation and some trees at 900 MHz frequency band. Path loss models are useful planning tools, which permit the designers of cellular communication to obtain optimal levels for the base station deployment and meeting the expected service level requirements. Outcomes show that these empirical models tend to overestimate the propagation loss. As one of the key outputs, it was observed that the calculations of Weissberger model fit with the measured data in urban environment.
C1 [Zakaria, Yahia; Ivanek, Lubomir] VSB Tech Univ Ostrava, Dept Elect Engn, Fac Elect Engn & Comp Sci, 17 Listopadu 15, Ostrava 70833, Czech Republic.
   [Zakaria, Yahia] NRC, Engn Res Div, PO 12622, Cairo, Egypt.
   [Glesk, Ivan] Univ Strathclyde, Dept Elect & Elect Engn, 204 George St, Glasgow G1 1XW, Lanark, Scotland.
RP Zakaria, Y (reprint author), VSB Tech Univ Ostrava, Dept Elect Engn, Fac Elect Engn & Comp Sci, 17 Listopadu 15, Ostrava 70833, Czech Republic.; Zakaria, Y (reprint author), NRC, Engn Res Div, PO 12622, Cairo, Egypt.
EM yahia.salem.st@vsb.cz; lubomir.ivanek@vsb.cz; ivan.glesk@strath.ac.uk
OI Salem, Yahia Ahmed Zakaria/0000-0002-0524-1802
FU  [SP 2016/143]
FX This research is supported by the project SP 2016/143, "Research of
   antenna systems; effectiveness and diagnostics of electric drives with
   harmonic power; reliability of the supply of electric traction; issue
   data anomalies".
CR Alam Md, 2014, INT J ADV SCI TECHNO, V62, P1
   Bi Q, 2001, IEEE COMMUN MAG, V39, P110, DOI 10.1109/35.894384
   Chu MJ, 2000, IEEE T VEH TECHNOL, V49, P202, DOI 10.1109/25.820712
   Cox, 1984, BELL LABS TECH J, V673, P921
   Greenstein L. J, 1999, IEEE J SELECTED AREA, V17, P1205
   Hashemi H., 1993, IEEE J SEL AREA COMM, P1788
   HONCHARENKO W, 1994, IEEE T ANTENN PROPAG, V42, P232, DOI 10.1109/8.277217
   Isabona J, 2013, ADV PHYS THEORIES AP, V21, P54
   Jadhav A.N., 2014, INT J ADV RES COMPUT, V3
   JuanLlacer L, 1997, ELECTRON LETT, V33, P92, DOI 10.1049/el:19970058
   Keenan J.M., 1990, ER TELEROM TECHNOL J, V8, P19
   Laitinen E., 2012, P 9 WORKSH POS NAV C
   Linnartz J. P., 1993, NARROWBAND LAND MOBI
   Maksymyuk T., 2015, SMART COMPUTING REV, V5, P346
   Maksymyuk T., 2015, SMART COMPUTING REV, V5, P89, DOI DOI 10.6029/SMARTCR.2015.02.002
   Maksymyuk T, 2016, P IEEE 2 INT SCI PRA, P69
   Obot A, 2011, NIGERIAN J TECHNOLOG, V30, P50
   Oeting J., 1983, IEEE COMMUN MAG  NOV, P10
   Rappaport T.S., 1996, WIRELESS COMMUNICATI
   Rizk K, 1993, LAMPPOST PANEL SCATT, P158
   Samimi M. K, 2015, P 2015 IEEE INT C CO
   Saunders R.S, 2002, INGENIA R ACAD ENG I, V12, P36
   SEIDEL SY, 1992, IEEE T ANTENN PROPAG, V40, P207, DOI 10.1109/8.127405
   Seybold JS, 2005, INTRODUCTION TO RF PROPAGATION, P1, DOI 10.1002/0471743690
   Sidhu S., 2012, INT J ELECT ENG, V4, P43
   Sun S, 2016, P 2016 IEEE 83 VEH T
NR 26
TC 0
Z9 0
U1 4
U2 4
PU KSII-KOR SOC INTERNET INFORMATION
PI GANGNAM-GU
PA KOR SCI & TECHNOL CTR, 409 ON 4TH FLR, MAIN BLDG, 635-4 YEOKSAM 1-DONG,
   GANGNAM-GU, SEOUL 00000, SOUTH KOREA
SN 1976-7277
J9 KSII T INTERNET INF
JI KSII Trans. Internet Inf. Syst.
PD MAY 31
PY 2017
VL 11
IS 5
BP 2453
EP 2467
DI 10.3837/tiis.2017.05.008
PG 15
WC Computer Science, Information Systems; Telecommunications
SC Computer Science; Telecommunications
GA EW4SU
UT WOS:000402492000008
OA No
DA 2017-08-17
ER

PT J
AU El Refaeey, AEA
   Abdelfattah, H
   Mosbah, A
   Gamal, AM
   Fayla, E
   Refaie, W
   Zaied, A
   Barakat, RI
   Seleem, AK
   Maher, M
AF El Refaeey, Abd Elaziz A.
   Abdelfattah, Hosam
   Mosbah, Alaa
   Gamal, Anas M.
   Fayla, Emad
   Refaie, Waleed
   Zaied, Abdelhady
   Barakat, Rafik I.
   Seleem, Amal K.
   Maher, Mohammed
TI Is early intervention using Mansoura-VV uterine compression sutures an
   effective procedure in the management of primary atonic postpartum
   hemorrhage? : a prospective study
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Atonic postpartum hemorrhage; Uterine compression sutures
ID B-LYNCH SUTURE
AB Background: Postpartum hemorrhage is the leading cause of maternal death, uterine atony accounts for 75-90% of primary postpartum hemorrhage. The efficacy of the Uterine compression suture in the treatment of atonic postpartum hemorrhage is time-tested and can be said to be almost established. The aim of this study was to assess the role of the Mansoura-VV uterine compression suture as an early intervention in the management of primary atonic postpartum hemorrhage.
   Methods: This prospective observational study included 108 women with primary atonic PPH over a period of 44 months. Uterine atony was diagnosed when the uterus was soft and failed to respond to ordinary ecbolics. Early intervention by Mansoura-VV uterine compression sutures was carried out within 15 min of the second dose of ecobolics and before progressing to any further surgical procedure.
   Results: Following the Mansoura-VV uterine compression sutures, uterine bleeding was controlled in all except one patient (107/108 cases; 99.07%) who required additional bilateral uterine vessels ligation. Another case (0.93%) was subjected to re-laparotomy due to intraperitoneal hemorrhage. Packed RBC transfusion was needed in 10 cases (9.25%). Admission to ICU was needed in 9 cases (8.33%) because of associated medical conditions. One week following the procedure, 1 case (0.93%) was diagnosed with haematometra.
   Conclusion: Early intervention in cases of primary atonic PPH using the Mansoura-VV uterine compression sutures is an easy, rapid and effective method in controlling PPH in low resource settings.
C1 [El Refaeey, Abd Elaziz A.; Abdelfattah, Hosam; Mosbah, Alaa; Gamal, Anas M.; Fayla, Emad; Refaie, Waleed; Zaied, Abdelhady; Barakat, Rafik I.] Mansoura Univ, Dept Obstet & Gynecol, Mansoura 35511, Egypt.
   [Seleem, Amal K.] Mansoura Univ, Dept Med Biochem, Mansoura, Egypt.
   [Maher, Mohammed] Mansoura Univ, Dept Anesthesia, Mansoura, Egypt.
RP El Refaeey, AEA (reprint author), Mansoura Univ, Dept Obstet & Gynecol, Mansoura 35511, Egypt.
EM refaeeysat@yahoo.com
CR AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015
   BLynch C, 1997, BRIT J OBSTET GYNAEC, V104, P372, DOI 10.1111/j.1471-0528.1997.tb11471.x
   Cunningham FG, 2005, WILLIAMS OBSTET, P823
   Devine PC, 2009, SEMIN PERINATOL, V33, P76, DOI 10.1053/j.semperi.2008.12.004
   Dob DP, 2006, INT J OBSTET ANESTH, V15, P137, DOI 10.1016/j.ijoa.2005.07.005
   El-Refaeey AA, 2014, J OBSTET GYNAECOL RE, V40, P387, DOI 10.1111/jog.12166
   Grotegut CA, 2004, J REPROD MED, V49, P849
   Hayman RG, 2002, OBSTET GYNECOL, V99, P502, DOI 10.1016/S0029-7844(01)01643-X
   KANE TT, 1992, STUD FAMILY PLANN, V23, P45, DOI 10.2307/1966827
   Kayem G, 2011, OBSTET GYNECOL, V117, P14, DOI 10.1097/AOG.0b013e318202c596
   Koh E, 2009, SINGAP MED J, V50, P693
   Matsubara S, 2014, J OBSTET GYNAECOL RE, V40, P1165, DOI 10.1111/jog.12338
   Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P378, DOI 10.1111/aogs.12077
   Prendiville W, 1998, EFFECTIVE CARE PREGN, P1145
   Prendville WJP, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]
   Vachhani M, 2006, INTERNET J GYNECOL O, V7
NR 16
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD MAY 31
PY 2017
VL 17
AR 160
DI 10.1186/s12884-017-1349-x
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW5QT
UT WOS:000402562100002
PM 28569213
OA gold
DA 2017-08-17
ER

PT J
AU Whaley, AK
   Ebrahim, W
   El-Neketi, M
   Ancheeva, EU
   Ozkaya, FC
   Pryakhina, NI
   Sipkina, NU
   Luzhanin, VG
   Liu, Z
   Proksch, P
AF Whaley, Andrei K.
   Ebrahim, Weaam
   El-Neketi, Mona
   Ancheeva, Elena U.
   Ozkaya, Ferhat Can
   Pryakhina, Nina I.
   Sipkina, Nadezhda U.
   Luzhanin, Vladimir G.
   Liu, Zhen
   Proksch, Peter
TI New acetylated flavone C-glycosides from Iris lactea
SO TETRAHEDRON LETTERS
LA English
DT Article
DE Flavone C-glycosides; Rotamers; Iris lactea
ID GLYCOSYLFLAVONES; LEAVES
AB Chemical investigation of the aerial parts of Iris lactea afforded three new flavone C-glycosides including 4'''-O-acetyl-embinin (1), 2''',4"'-O-diacetyl-embinin (2) and 6 '',4"'-O-diacetyl-embinin (3) along with the known analogue embinin (4). Their structures were elucidated by 1D and 2D NMR spectroscopic analysis as well as by HRESIMS data. The sugars were characterized following acid hydrolysis of the respective glycosides and TLC analysis compared to known standards. Duplicated signals can be observed in the NMR spectra, indicating the presence of rotamers caused by rotational hindrance around the glycosyl-flavone C-C linkage. All isolated compounds were tested for their antimicrobial and cytotoxic activities but found to be inactive. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Whaley, Andrei K.; Ebrahim, Weaam; Ancheeva, Elena U.; Ozkaya, Ferhat Can; Liu, Zhen; Proksch, Peter] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Univ Str 1, D-40225 Dusseldorf, Germany.
   [Whaley, Andrei K.; Ancheeva, Elena U.; Pryakhina, Nina I.; Sipkina, Nadezhda U.; Luzhanin, Vladimir G.] St Petersburg State Chem Pharmaceut Acad, St Prof Popova 14, St Petersburg 197376, Russia.
   [Ebrahim, Weaam; El-Neketi, Mona] Mansoura Univ, Fac Pharm, Dept Pharmacognosy, Mansoura 35516, Egypt.
RP Liu, Z; Proksch, P (reprint author), Heinrich Heine Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Univ Str 1, D-40225 Dusseldorf, Germany.
EM zhenfeizi0@sina.com; proksch@uni-duesseldorf.de
FU Manchot Foundation
FX P.P. wants to thank the Manchot Foundation for support.
CR HILSENBECK RA, 1983, PHYTOCHEMISTRY, V22, P2215, DOI 10.1016/S0031-9422(00)80150-8
   KAWASE A, 1968, AGR BIOL CHEM TOKYO, V32, P537
   Ma Y., 2012, ACTA PHARMACOL SIN, V2, P598
   Mizuno T, 2013, PLANT PHYSIOL BIOCH, V72, P116, DOI 10.1016/j.plaphy.2013.06.028
   Muharini R, 2014, PHYTOCHEM LETT, V9, P26, DOI 10.1016/j.phytol.2014.04.005
   Pryakhina NI, 1984, CHEM NAT COMPD, V20, P554, DOI 10.1007/BF00580064
   Rayyan S, 2010, J AGR FOOD CHEM, V58, P7211, DOI 10.1021/jf100848c
   Reynaud J, 2005, NAT PROD REP, V22, P504, DOI 10.1039/b416248j
   Shen WJ, 2008, CHINESE CHEM LETT, V19, P821, DOI 10.1016/j.cclet.2008.04.031
   Wang H, 2010, MINI-REV MED CHEM, V10, P643
NR 10
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4039
J9 TETRAHEDRON LETT
JI Tetrahedron Lett.
PD MAY 31
PY 2017
VL 58
IS 22
BP 2171
EP 2173
DI 10.1016/j.tetlet.2017.04.080
PG 3
WC Chemistry, Organic
SC Chemistry
GA EV6KB
UT WOS:000401877200021
OA No
DA 2017-08-17
ER

PT J
AU Mego, M
   Gao, H
   Cohen, EN
   Anfossi, S
   Giordano, A
   Tin, S
   Fouad, TM
   De Giorgi, U
   Giuliano, M
   Woodward, WA
   Alvarez, RH
   Valero, V
   Ueno, NT
   Hortobagyi, GN
   Cristofanilli, M
   Reuben, JM
AF Mego, Michal
   Gao, Hui
   Cohen, Evan N.
   Anfossi, Simone
   Giordano, Antonio
   Tin, Sanda
   Fouad, Tamer M.
   De Giorgi, Ugo
   Giuliano, Mario
   Woodward, Wendy A.
   Alvarez, Ricardo H.
   Valero, Vicente
   Ueno, Naoto T.
   Hortobagyi, Gabriel N.
   Cristofanilli, Massimo
   Reuben, James M.
TI Circulating tumor cells (CTCs) are associated with abnormalities in
   peripheral blood dendritic cells in patients with inflammatory breast
   cancer
SO ONCOTARGET
LA English
DT Article
DE circulating tumors cells; innate immunity; adaptive immunity; dendritic
   cells; inflammatory breast cancer
ID INFILTRATING LYMPHOCYTES; SUPPRESSOR-CELLS; SOLID TUMORS; SURVIVAL;
   METASTASIS; RECEPTOR; PROGRESSION; INTERFERON; DISEASE; STIMULATION
AB CTCs are involved in tumor dissemination and are an independent prognostic factor in primary and metastatic breast cancer patients. Dendritic cells (DCs) are the most efficient antigen presenting cells and are comprised of plasmacytoid-(pDC) and myeloid-(mDC) derived DC subsets. This study aimed to correlate CTC counts with the peripheral blood DC immunophenotypes and functions of inflammatory breast cancer (IBC) patients. This study included 65 IBC patients. Peripheral blood (PB) was obtained from patients prior to starting a new line of chemotherapy for CTCs enumeration by CellSearch (R) and DC phenotype and function by flow cytometry; the characteristics of DCs were then correlated with CTC counts and clinical outcome. Twenty-one (32.3%) patients with CTCs >= 5 had a significantly inferior overall survival (OS) compared to patients with <5 CTCs (p=0.045). In addition, patients with >= 5 CTCs had a lower percentage of mDCs capable of producing TNF-alpha before or after activation through the toll-like receptor (TLR), as well as a lower percentage of mDCs producing IL-12 after TLR-activation. There was a positive correlation between CTCs counts and expression of the activation (CCR7) and costimulatory (CD86) receptors on TLR-activated mDCs and pDCs, respectively. Moreover, presence of high percentage of mDC capable to produce increased levels of TNF-alpha was independently associated with inferior OS (p = 0.0006). An increase in the percentage of mDC producing TNF-alpha might induce a pro-inflammatory environment that could play a role in determining the poor clinical outcome in IBC patients and could add further prognostic value to CTCs.
C1 [Mego, Michal; Gao, Hui; Cohen, Evan N.; Anfossi, Simone; Giordano, Antonio; Tin, Sanda; De Giorgi, Ugo; Giuliano, Mario; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.
   [Fouad, Tamer M.; Alvarez, Ricardo H.; Valero, Vicente; Ueno, Naoto T.; Hortobagyi, Gabriel N.; Cristofanilli, Massimo] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA.
   [Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.
   [Woodward, Wendy A.; Alvarez, Ricardo H.; Valero, Vicente; Ueno, Naoto T.; Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept MD Anderson Morgan Welch Inflammatory Brest, Houston, TX 77030 USA.
   [Mego, Michal] Comenius Univ, Sch Med, Natl Canc Inst, Dept Med Oncol, Bratislava, Slovakia.
   [Fouad, Tamer M.] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt.
   [De Giorgi, Ugo] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Med Oncol, Meldola, FC, Italy.
   [Giuliano, Mario] Univ Federico II, Dept Clin Med & Surg, Naples, Italy.
   [Cristofanilli, Massimo] Northwestern Univ, Div Hematol Oncol, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Giordano, Antonio] Med Univ South Carolina, Dept Med, Charleston, SC USA.
RP Reuben, JM (reprint author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA.; Reuben, JM (reprint author), Univ Texas MD Anderson Canc Ctr, Dept MD Anderson Morgan Welch Inflammatory Brest, Houston, TX 77030 USA.
EM jreuben@mdanderson.org
OI Fouad, Tamer/0000-0002-4168-5275
FU State of Texas Rare and Aggressive Breast Cancer Research Program; UICC
   American Cancer Society International Fellowship for Beginning
   Investigators Award [ACS/08/006]; Slovak Grant Agency [VEGA 1/0044/15];
   National Cancer Institute, National Institutes of Health [CA138239-02]
FX This work was supported by a grant from the State of Texas Rare and
   Aggressive Breast Cancer Research Program, which supports The University
   of Texas MD Anderson Morgan Welch Inflammatory Breast Cancer Research
   Program and Clinic; a UICC American Cancer Society International
   Fellowship for Beginning Investigators Award [ACS/08/006 to M.M.]; a
   grant from the Slovak Grant Agency [VEGA 1/0044/15 to M.M.]; and a grant
   from the National Cancer Institute, National Institutes of Health
   [CA138239-02 to M.C., W.A.W., and J.M.R.].
CR Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378
   Anderson WF, 2005, BREAST DIS, V22, P9
   Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Beury DW, 2014, J LEUKOCYTE BIOL, V96, P1109, DOI 10.1189/jlb.3A0414-210R
   Bidard FC, 2010, ANN ONCOL, V21, P729, DOI 10.1093/annonc/mdp391
   Butchi NB, 2008, J IMMUNOL, V180, P7604
   Cohen EN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132710
   Cristofanilli M, 2003, ONCOLOGIST, V8, P141, DOI 10.1634/theoncologist.8-2-141
   Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766
   Cristofanilli M, 2007, CANCER, V110, P1436, DOI 10.1002/cncr.22927
   Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345
   Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158
   Filipazzi P, 2012, CANCER IMMUNOL IMMUN, V61, P255, DOI 10.1007/s00262-011-1161-9
   Fouad TM, 2015, BREAST CANCER RES TR, V152, P407, DOI 10.1007/s10549-015-3436-x
   Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159
   Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460
   Green TL, 2014, EXP MOL PATHOL, V97, P44, DOI 10.1016/j.yexmp.2014.05.003
   Green TL, 2013, EXP MOL PATHOL, V95, P174, DOI 10.1016/j.yexmp.2013.06.013
   Greene FL, 2002, AJCC CANC STAGING HD
   Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428
   Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/dji172
   Ida JA, 2006, J IMMUNOL METHODS, V310, P86, DOI 10.1016/j.jim.2005.12.008
   Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023
   Lang JE, 2009, BREAST CANCER RES TR, V113, P501, DOI 10.1007/s10549-008-9951-2
   Lee BN, 2006, CANCER, V107, P999, DOI 10.1002/cncr.22092
   Lehner M, 2007, J IMMUNOTHER, V30, P312, DOI 10.1097/01.cji.0000211345.11707.46
   Li ZY, 2012, INT J CANCER, V131, P2584, DOI 10.1002/ijc.27572
   Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633
   Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112
   Loi S, 2013, J CLIN ONCOL, V31, P860, DOI 10.1200/JCO.2011.41.0902
   Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7
   Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0
   Masuda H, 2014, ANN ONCOL, V25, P384, DOI 10.1093/annonc/mdt525
   Matta BM, 2010, EUR J IMMUNOL, V40, P2667, DOI 10.1002/eji.201040839
   Mego M, 2016, J Cancer, V7, P1095, DOI 10.7150/jca.13098
   Mego M, 2009, ANN ONCOL, V20, P1824, DOI 10.1093/annonc/mdp207
   Mego M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0507-6
   Mego M, 2012, INT J CANCER, V130, P808, DOI 10.1002/ijc.26037
   Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171
   Naing A, 2011, J CANCER, V2, P81, DOI 10.7150/jca.2.81
   Oh JZ, 2011, BLOOD, V118, P3028, DOI 10.1182/blood-2011-04-348839
   Rack B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju066
   Riol-Blanco L, 2005, J IMMUNOL, V174, P4070
   Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082
   Salio M, 2007, P NATL ACAD SCI USA, V104, P20490, DOI 10.1073/pnas.0710145104
   Singletary SE, 2003, SURG CLIN N AM, V83, P803, DOI 10.1016/S0039-6109(03)00034-3
   Sisirak V, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22338
   Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468
   Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021
   Treilleux I, 2004, CLIN CANCER RES, V10, P7466, DOI 10.1158/1078-0432.CCR-04-0684
   Ueno NT, 1997, CANCER CHEMOTH PHARM, V40, P321, DOI 10.1007/s002800050664
   Walshe Janice M, 2005, Breast Dis, V22, P35
   Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522
   Zhan M, 2004, HISTOL HISTOPATHOL, V19, P973, DOI 10.14670/HH-19.973
NR 57
TC 0
Z9 0
U1 0
U2 0
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD MAY 30
PY 2017
VL 8
IS 22
BP 35656
EP 35668
DI 10.18632/oncotarget.10290
PG 13
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EX4UI
UT WOS:000403230000020
PM 27374101
OA No
DA 2017-08-17
ER

PT J
AU Amer, SM
   Kadi, AA
   Darwish, HW
   Attwa, MW
AF Amer, Sawsan M.
   Kadi, Adnan A.
   Darwish, Hany W.
   Attwa, Mohamed W.
TI Liquid chromatography tandem mass spectrometry method for the
   quantification of vandetanib in human plasma and rat liver microsomes
   matrices: metabolic stability investigation
SO CHEMISTRY CENTRAL JOURNAL
LA English
DT Article
DE Vandetanib; Quantification; Tandem mass spectrometry; Human plasma; Rat
   liver microsomes; Metabolic stability
ID CANCER
AB Vandetanib (VNT) is a new oral tyrosine kinase inhibitor that acts mainly by inhibiting vascular endothelial growth factor receptor (VEGFR). Fast, specific, sensitive and validated LC-MS/MS was established for the determination of VNT in two various matrices including rat liver microsomes (RLMs) and human plasma. This method was applied in metabolic stability investigation of VNT. Resolution of two analytes was performed using C18 column and isocratic mobile phase composed of binary system of 10 mM ammonium formate (pH 4.1) and acetonitrile in a ratio of 1:1. The flow rate was set at 0.25 mL/min and total run time was 4 min with injection volume of 5 mu L. Ions were generated by ESI source and analyzed by multiple reaction monitoring mode (basis for quantification) in the Agilent 6410 QqQ analyzer. The linearity of the established method ranged from 5 to 500 ng/mL (r(2) >= 0.9996) in human plasma and RLMs. LOQ and LOD were 2.48 and 7.52 ng/mL, and 2.14 and 6.49 in human plasma and RLMs matrices. The intra-day and inter-day precision and accuracy were 0.66-2.66% and 95.05-99.17% in human plasma matrix-while in RLMs matrix, ranged from 0.97 to 3.08% and 95.8 to 100.09%, respectively. In vitro half-life was 39.85 min and intrinsic clearance was 3.92 +/- 0.28 mL/min/kg.
C1 [Amer, Sawsan M.; Darwish, Hany W.; Attwa, Mohamed W.] Cairo Univ, Analyt Chem Dept, Fac Pharm, Kasr El Aini St, Cairo 11562, Egypt.
   [Kadi, Adnan A.; Darwish, Hany W.; Attwa, Mohamed W.] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
RP Attwa, MW (reprint author), Cairo Univ, Analyt Chem Dept, Fac Pharm, Kasr El Aini St, Cairo 11562, Egypt.; Attwa, MW (reprint author), King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia.
EM mzeidan@ksu.edu.sa
FU Deanship of Scientific Research at the King Saud University [RGP-322]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at the King Saud University for funding
   this work through the Research Group Project No. RGP-322.
CR Bai F, 2011, J CHROMATOGR B, V879, P2561, DOI 10.1016/j.jchromb.2011.07.012
   Baranczewski P, 2006, PHARMACOL REP, V58, P453
   Barinaga M, 1997, SCIENCE, V278, P1036, DOI 10.1126/science.278.5340.1036
   Caldwell G, 2014, OPTIMIZATION DRUG DI
   Darwish HW, 2016, TROP J PHARM RES, V15, P2219, DOI 10.4314/tjpr.v15i10.21
   Fda AP, 2000, FED REGISTER, V65, P52776
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010
   Kadi AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164967
   Li F, 2014, J NUCL MED, V55, P1525, DOI 10.2967/jnumed.114.138925
   Lin HJ, 2014, J CANCER RES THER, V10, P84, DOI 10.4103/0973-1482.131393
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martin P, 2012, CLIN THER, V34, P221, DOI 10.1016/j.clinthera.2011.11.011
   Natoli C, 2010, CURR CANCER DRUG TAR, V10, P462
   Thornton K, 2012, CLIN CANCER RES, V18, P3722, DOI 10.1158/1078-0432.CCR-12-0411
   VONJAGOW R, 1965, N-S ARCH EX PATH PH, V251, P73
NR 15
TC 0
Z9 0
U1 3
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-153X
J9 CHEM CENT J
JI Chem. Cent. J.
PD MAY 30
PY 2017
VL 11
AR 45
DI 10.1186/s13065-017-0274-4
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA EW4EP
UT WOS:000402455100001
OA gold
DA 2017-08-17
ER

PT J
AU Lee, ZMP
   Poret-Peterson, AT
   Siefert, JL
   Kaul, D
   Moustafa, A
   Allen, AE
   Dupont, CL
   Eguiarte, LE
   Souza, V
   Elser, JJ
AF Lee, Zarraz M. -P.
   Poret-Peterson, Amisha T.
   Siefert, Janet L.
   Kaul, Drishti
   Moustafa, Ahmed
   Allen, Andrew E.
   Dupont, Chris L.
   Eguiarte, Luis E.
   Souza, Valeria
   Elser, James J.
TI Nutrient Stoichiometry Shapes Microbial Community Structure in an
   Evaporitic Shallow Pond
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE stoichiometry; community structure; beta diversity; bacteria; algae;
   rRNA gene copy number; growth rate hypothesis
ID OPERON COPY NUMBER; FRESH-WATER BACTERIA; PHOSPHORUS ENRICHMENT; CUATRO
   CIENEGAS; GRAZING SNAILS; DIVERSITY; BACTERIOPLANKTON; AVAILABILITY;
   ECOLOGY; GENES
AB Nutrient availability and ratios can play an important role in shaping microbial communities of freshwater ecosystems. The Cuatro Cienegas Basin (CCB) in Mexico is a desert oasis where, perhaps paradoxically, high microbial diversity coincides with extreme oligotrophy. To better understand the effects of nutrients on microbial communities in CCB, a mesocosm experiment was implemented in a stoichiometrically imbalanced pond, Lagunita, which has an average TN:TP ratio of 122 (atomic). The experiment had four treatments, each with five spatial replicates - unamended controls and three fertilization treatments with different nitrogen: phosphorus (N:P) regimes (P only, N:P = 16 and N:P = 75 by atoms). In the water column, quantitative PCR of the 16S rRNA gene indicated that P enrichment alone favored proliferation of bacterial taxa with high rRNA gene copy number, consistent with a previously hypothesized but untested connection between rRNA gene copy number and P requirement. Bacterial and microbial eukaryotic community structure was investigated by pyrosequencing of 16S and 18S rRNA genes from the planktonic and surficial sediment samples. Nutrient enrichment shifted the composition of the planktonic community in a treatment-specific manner and promoted the growth of previously rare bacterial taxa at the expense of the more abundant, potentially endemic, taxa. The eukaryotic community was highly enriched with phototrophic populations in the fertilized treatment. The sediment microbial community exhibited high beta diversity among replicates within treatments, which obscured any changes due to fertilization. Overall, these results showed that nutrient stoichiometry can be an important factor in shaping microbial community structure.
C1 [Lee, Zarraz M. -P.; Elser, James J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.
   [Poret-Peterson, Amisha T.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA.
   [Siefert, Janet L.] Rice Univ, Dept Stat, Houston, TX 77251 USA.
   [Kaul, Drishti; Allen, Andrew E.; Dupont, Chris L.] J Craig Venter Inst, La Jolla, CA USA.
   [Moustafa, Ahmed] Amer Univ Cairo, Dept Biol, New Cairo, Egypt.
   [Moustafa, Ahmed] Amer Univ Cairo, Dept Biol, Biotechnol Grad Program, New Cairo, Egypt.
   [Allen, Andrew E.] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.
   [Eguiarte, Luis E.; Souza, Valeria] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.
   [Elser, James J.] Univ Montana, Flathead Lake Biol Stn, Polson, MT 59860 USA.
RP Elser, JJ (reprint author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.; Elser, JJ (reprint author), Univ Montana, Flathead Lake Biol Stn, Polson, MT 59860 USA.
EM j.elser@asu.edu
RI Elser, James/A-7082-2008
OI Elser, James/0000-0002-1460-2155
FU NSF [DEB-0950175, 1536546]; NASA [NAI5-0018]; NAI [NNH05ZDA001C,
   NNH12ZDA002C, NNA08CN87A, NNA13AA93A]
FX This study was conducted with financial support from NSF (DEB-0950175)
   and NASA (NAI5-0018) grants awarded to JE, WWF-FCS to VS, and NSF
   (1536546) and NAI (NNH05ZDA001C, NNH12ZDA002C, NNA08CN87A, NNA13AA93A)
   to JS.
CR Alcaraz L. D., 2011, EARTH ENV SCI
   Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04158
   Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010
   Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Carbonero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085105
   Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09
   Chan LK, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00159
   Corman JR, 2016, GEOBIOLOGY, V14, P176, DOI 10.1111/gbi.12168
   Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x
   Dupont CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089549
   Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x
   Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x
   Elser JJ, 2006, ECOL LETT, V9, P292, DOI 10.1111/j.1461-0248.2005.00873.x
   Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x
   Elser JJ, 2005, FRESHWATER BIOL, V50, P1826, DOI 10.1111/j.1365-2427.2005.01453.x
   Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x
   Elser J. J., 2003, INT J ASTROBIOL, V2, P185, DOI [10.1017/S1473550403001563, DOI 10.1017/S1473550403001563]
   Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118
   Ghai R, 2012, ENV MICROBIOL REP, V4, P29, DOI 10.1111/j.1758-2229.2011.00274.x
   Grosskopf T, 2016, ISME J, V10, P2725, DOI 10.1038/ismej.2016.49
   Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0
   Hall EK, 2011, ECOSYSTEMS, V14, P261, DOI 10.1007/s10021-010-9408-4
   Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7
   Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219
   Hewson I, 2003, MICROBIAL ECOL, V46, P322, DOI 10.1007/s00248-002-1067-3
   Hillebrand H, 2014, BASIC APPL ECOL, V15, P465, DOI 10.1016/j.baae.2014.06.003
   Horner-Devine MC, 2003, ECOL LETT, V6, P613
   Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x
   Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000
   Klausmeier CA, 2007, J THEOR BIOL, V246, P278, DOI 10.1016/j.jtbi.2006.12.032
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808
   Koblizek M, 2015, FEMS MICROBIOL REV, V39, P854, DOI 10.1093/femsre/fuv032
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054
   Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106
   Lee ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123949
   Leflaive J, 2008, FEMS MICROBIOL ECOL, V66, P379, DOI 10.1111/j.1574-6941.2008.00593.x
   Logue JB, 2012, ISME J, V6, P1127, DOI 10.1038/ismej.2011.184
   Long RA, 2001, APPL ENVIRON MICROB, V67, P4975, DOI 10.1128/AEM.67.11.4975-4983.2001
   Makino W, 2004, AQUAT MICROB ECOL, V34, P33, DOI 10.3354/ame034033
   Nelson CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018320
   Nemergut DR, 2016, ISME J, V10, P1147, DOI 10.1038/ismej.2015.191
   Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10
   Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/nmeth.2658, 10.1038/NMETH.2658]
   Peura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038552
   Ponce-Soto GY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00246
   Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252
   Purdy KJ, 2005, METHOD ENZYMOL, V397, P271, DOI 10.1016/S0076-6879(05)97016-X
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roller BRK, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.160, 10.1038/NMICROBIOL.2016.160]
   Schauer M, 2005, APPL ENVIRON MICROB, V71, P5900, DOI 10.1128/AEM.71.10.5900-5907.2005
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Shade A, 2008, ENVIRON MICROBIOL, V10, P1057, DOI 10.1111/j.1462-2920.2007.01527.x
   SKARSTAD K, 1986, EMBO J, V5, P1711
   Soininen J, 2014, HYDROBIOLOGIA, V740, P137, DOI 10.1007/s10750-014-1949-7
   Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103
   Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917
   Souza V, 2012, ASTROBIOLOGY, V12, P641, DOI 10.1089/ast.2011.0675
   Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201
   Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698
   Valdivia-Anistro Jorge A, 2015, Front Microbiol, V6, P1486, DOI 10.3389/fmicb.2015.01486
   Van Horn DJ, 2011, AQUAT MICROB ECOL, V64, P149, DOI 10.3354/ame01515
   Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808
   Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Zhang R, 2013, FEMS MICROBIOL ECOL, V86, P277, DOI 10.1111/1574-6941.12160
NR 67
TC 0
Z9 0
U1 9
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 30
PY 2017
VL 8
AR 949
DI 10.3389/fmicb.2017.00949
PG 15
WC Microbiology
SC Microbiology
GA EW1JB
UT WOS:000402245000001
PM 28611750
OA gold
DA 2017-08-17
ER

PT J
AU Guswanto, A
   Allamanda, P
   Mariamah, ES
   Munkjargal, T
   Tuvshintulga, B
   Takemae, H
   Sivakumar, T
   AbouLaila, M
   Terkawi, MA
   Ichikawa-Seki, M
   Nishikawa, Y
   Yokoyama, N
   Igarashi, I
AF Guswanto, Azirwan
   Allamanda, Puttik
   Mariamah, Euis Siti
   Munkjargal, Tserendorf
   Tuvshintulga, Bumduuren
   Takemae, Hitoshi
   Sivakumar, Thillaiampalam
   AbouLaila, Mahmoud
   Terkawi, Mohamad Alaa
   Ichikawa-Seki, Madoka
   Nishikawa, Yoshifumi
   Yokoyama, Naoaki
   Igarashi, Ikuo
TI Evaluation of immunochromatographic test (ICT) strips for the
   serological detection of Babesia bovis and Babesia bigemina infection in
   cattle from Western Java, Indonesia
SO VETERINARY PARASITOLOGY
LA English
DT Article
DE Bovine babesiosis; ELISA; Immunochromatographic test strips; Western
   Java
ID SIMULTANEOUS SERODIAGNOSIS; GOLD NANOPARTICLE; WATER-BUFFALOS; ASSAY
AB Three types of immunochromatographic test (ICT) strips were prepared for the detection of an antibody response against spherical body protein 4 (SBP-4) of Babesia bovis (bovICT), C-terminal-truncated rhoptry-associated protein 1 (rRAP1/CT17) of B. bigemina (bigICT), and the combination of both proteins (dual-ICT). The evaluation of their performance was conducted using a confirmed positive and negative serum panel for B. bovis and B. bigemina. Together with ELISA, the ICT strips were applied to determine the seroprevalence of bovine babesiosis in Western Java, Indonesia. Among 991 serum samples, 28.4%, 25.3%, and 24.5% of cattle were detected to be seropositive to B. bovis infection using ELISA, bovICT, and dual-ICT, respectively. B. bigemina seropositive was detected in 27.1%, 24.2%, and 22.8% of samples using ELISA, bigICT, and dual-ICT, respectively. The comparison of ICT strips and ELISA results using field serum samples showed good agreement with Kappa values > 0.7 between all methods The application of ICT strips is preferable in the field situations where rapid diagnosis is required. Furthermore, the data showed the current seroprevalence of bovine babesiosis in Western Java, Indonesia, and efficient control strategies are needed to reduce economic losses due to the disease.
C1 [Guswanto, Azirwan; Munkjargal, Tserendorf; Tuvshintulga, Bumduuren; Takemae, Hitoshi; Sivakumar, Thillaiampalam; Nishikawa, Yoshifumi; Yokoyama, Naoaki; Igarashi, Ikuo] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Nishi 2-13 Inada Cho, Obihiro, Hokkaido 0808555, Japan.
   [Guswanto, Azirwan; Allamanda, Puttik; Mariamah, Euis Siti] Balai Veteriner Subang DIC Subang, Jl Terusan Garuda 33-11 Blok Werasari Dangdeur, Subang 41212, Indonesia.
   [Munkjargal, Tserendorf] Inst Vet Med, Zaisan 17042, Ulaanbaatar, Mongol Peo Rep.
   [Ichikawa-Seki, Madoka] Iwate Univ, Fac Agr, Lab Vet Parasitol, 3-18-8 Ueda, Morioka, Iwate 0208550, Japan.
   [AbouLaila, Mahmoud] Univ Sadat City, Fac Vet Med, Dept Parasitol, Sadat City 32511, Minoufiya, Egypt.
   [Terkawi, Mohamad Alaa] Hokkaido Univ, Sch Med, Dept Orthoped Surg, Frontier Res Ctr Adv Mat & Life Sci,Kita Ku, Kita 21,Nishi 11, Sapporo, Hokkaido 0010021, Japan.
RP Igarashi, I (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Nishi 2-13 Inada Cho, Obihiro, Hokkaido 0808555, Japan.
EM igarcpmi@obihiro.ac.jp
OI AbouLaila, Mahmoud/0000-0003-1535-3696
FU MEXT KAKENHI [16402768, 26304037]; Indonesian Endowment Fund for
   Education (LPDP)
FX The authors would like to thank farmers, Dinas Peternakan of regencies
   and cities in Western Java, Indonesia; and special thanks to the staff
   of Balai Veteriner Subang for their assistance in collecting samples.
   This work was supported by a Grant-in-Aid for Scientific Research (A)
   and (B) from MEXT KAKENHI (Grant Numbers 16402768 and 26304037). Azirwan
   Guswanto is supported by Indonesian Endowment Fund for Education (LPDP).
CR Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190
   Boonchit S, 2002, J CLIN MICROBIOL, V40, P3771, DOI 10.1128/JCM.40.10.3771-3775.2002
   Burns C, 2006, TALANTA, V69, P873, DOI 10.1016/j.talanta.2005.11.038
   Fleiss JL, 2003, STAT METHODS RATES P
   Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000
   Huang XH, 2006, CLIN VACCINE IMMUNOL, V13, P553, DOI 10.1128/CVI.13.5.553-555.2006
   Ibrahim HM, 2013, VET PARASITOL, V198, P187, DOI 10.1016/j.vetpar.2013.08.028
   Kim CM, 2008, AM J TROP MED HYG, V78, P117
   Li Y, 2014, TROP BIOMED, V31, P406
   Moon J, 2012, MATERIALS, V5, P634, DOI 10.3390/ma5040634
   Sergeant E.S., 2016, AUSVET ANIM HEAL SER
   Terkawi MA, 2013, CLIN VACCINE IMMUNOL, V20, P596, DOI 10.1128/CVI.00747-12
   Terkawi MA, 2011, CLIN VACCINE IMMUNOL, V18, P337, DOI 10.1128/CVI.00388-10
   Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008
NR 14
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4017
EI 1873-2550
J9 VET PARASITOL
JI Vet. Parasitol.
PD MAY 30
PY 2017
VL 239
BP 76
EP 79
DI 10.1016/j.vetpar.2017.04.010
PG 4
WC Parasitology; Veterinary Sciences
SC Parasitology; Veterinary Sciences
GA EW2RX
UT WOS:000402344800013
PM 28413078
OA No
DA 2017-08-17
ER

PT J
AU Hasan, M
   Hofstetter, R
   Fassauer, GM
   Link, A
   Siegmund, W
   Oswald, S
AF Hasan, Mahmoud
   Hofstetter, Robert
   Fassauer, Georg M.
   Link, Andreas
   Siegmund, Werner
   Oswald, Stefan
TI Quantitative chiral and achiral determination of ketamine and its
   metabolites by LC-MS/MS in human serum, urine and fecal samples
SO JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
LA English
DT Article
DE Ketamine; Norketamine; Dehydronorketamine; Hydroxynorketamine; LC-MS/MS;
   Chiral
ID CHROMATOGRAPHY-MASS SPECTROMETRY; RECEIVING HOSPICE CARE; REGIONAL PAIN
   SYNDROME; LIQUID-CHROMATOGRAPHY; ORAL KETAMINE; HUMAN PLASMA;
   CAPILLARY-ELECTROPHORESIS; NORKETAMINE ENANTIOMERS; MAJOR METABOLITES;
   EQUINE PLASMA
AB Ketamine (KET) is a widely used anesthetic drug which is metabolized by CYP450 enzymes to norketamine (n-KET), dehydronorketamine (DHNK), hydroxynorketamine (HNK) and hydroxyketamine (HK). Ketamine is a chiral compound and S-ketamine is known to be the more potent enantiomer. Here, we present the development and validation of three LC-MS/MS assays; the first for the quantification of racemic KET, n-KET and DHNK in human serum, urine and feces; the second for the separation and quantification of the S- and R-enantiomers of KET, n-KET and DHNK, and the third for separation and quantification of 2S,6S-hydroxynorketamine (2S,6S-HNK) and 2R,6R-hydroxynorketamine (2R,6R-HNK) in serum and urine with the ability to separate and detect 10 additional hydroxylated norketamine metabolites of racemic ketamine. Sample preparation was done by liquid-liquid extraction using methyl tert-butyl ether. For achiral determination of KET and its metabolites, an isocratic elution with ammonium acetate (pH 3.8; 5 mM) and acetonitrile on a C18 column was performed. For the separation of S- and R-enantiomers of MET, n-KET and DHNK, a gradient elution was applied using a mobile phase of ammonium acetate (pH 7.5; 10mM) and isopropanol on the CHIRAL-AGP (R) column. The enantioselective separation of the HNK metabolites was done on the chiral column Lux (R)-Amylose-2 with a gradient method using ammonium acetate (pH 9; 5 mM) and a mixture of isopropanol and acetonitrile (4:1). The mass spectrometric detection monitored for each analyte 2-3 mass/charge transitions. D4-ketamine and D4-n-KET were used as internal standards. The assays were successfully validated according to current bioanalytical guidelines and applied to a pilot study in one healthy volunteer. Compared to previously published methods, our assays have superior analytical features such as a lower amount of required matrix, faster sample preparation, shorter analytical run time and higher sensitivity (LLOQ up to 0.1 ng/ml). Moreover, our assay enables for the first time the enantioselective determination of 2R,6R- and 2S,6S-HNK which were shown to be responsible for the promising antidepressant effects of ketamine. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Hasan, Mahmoud; Siegmund, Werner; Oswald, Stefan] Univ Med Greifswald, Ctr Drug Absorpt & Transport C DAT, Dept Clin Pharmacol, Felix Hausdorff Str 3, D-17489 Greifswald, Germany.
   [Hofstetter, Robert; Fassauer, Georg M.; Link, Andreas] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Greifswald, Germany.
   [Hasan, Mahmoud] Future Univ Egypt, Dept Pharmaceut Chem, End 90th Rd, Cairo, Egypt.
RP Oswald, S (reprint author), Univ Med Greifswald, Ctr Drug Absorpt & Transport C DAT, Dept Clin Pharmacol, Felix Hausdorff Str 3, D-17489 Greifswald, Germany.
EM stefan.oswald@uni-greifswald.de
OI Link, Andreas/0000-0003-1262-6636
FU German Federal Ministry for Education and Research [03IPT612X];
   institutional grant of Develco Pharma Schweiz AG, Pratteln, Switzerland;
   Future University in Egypt (Hasan Azazy scholarship)
FX The analytic part was supported by the grant 03IPT612X (Inno-Profile) of
   the German Federal Ministry for Education and Research.; The clinical
   study has been sponsored by an institutional grant of Develco Pharma
   Schweiz AG, Pratteln, Switzerland.; Mahmoud Hasan was sponsored by
   Future University in Egypt (Hasan Azazy scholarship).
CR ADAMS JD, 1981, BIOMED MASS SPECTROM, V8, P527, DOI 10.1002/bms.1200081103
   Alkondon P., 2016, NATURE, V533, P481
   Blonk MI, 2010, EUR J PAIN, V14, P466, DOI 10.1016/j.ejpain.2009.09.005
   CHANG T, 1972, ANESTHESIOLOGY, V36, P401, DOI 10.1097/00000542-197204000-00016
   DAVISSON JN, 1978, J CHROMATOGR, V146, P344, DOI 10.1016/S0378-4347(00)81901-5
   DELATOUR P, 1991, J VET PHARMACOL THER, V14, P209, DOI 10.1111/j.1365-2885.1991.tb00825.x
   European Medicines Agency (EMA) and Committee for Medicinal Products for Human Use (CHMP), 2013, GUID BIOAN METH VAL
   Food and Drug Administration (FDA), 2013, GUID IND BIOAN METH
   GEISSLINGER G, 1991, J CHROMATOGR-BIOMED, V568, P165, DOI 10.1016/0378-4347(91)80350-L
   GEISSLINGER G, 1993, BRIT J ANAESTH, V70, P666, DOI 10.1093/bja/70.6.666
   Goldberg ME, 2011, CHIRALITY, V23, P138, DOI 10.1002/chir.20890
   HARTVIG P, 1995, CLIN PHARMACOL THER, V58, P165, DOI 10.1016/0009-9236(95)90194-9
   Irwin SA, 2013, J PALLIAT MED, V16, P958, DOI 10.1089/jpm.2012.0617
   Irwin SA, 2010, J PALLIAT MED, V13, P903, DOI 10.1089/jpm.2010.9808
   KLEPSTAD P, 1990, EUR J PHARMACOL, V187, P513, DOI 10.1016/0014-2999(90)90379-K
   Legrand T, 2008, J PHARMACEUT BIOMED, V48, P171, DOI 10.1016/j.jpba.2008.05.008
   Lian KQ, 2012, J CHROMATOGR A, V1264, P104, DOI 10.1016/j.chroma.2012.09.058
   Marchetti F, 2015, EUR J PAIN, V19, P984, DOI 10.1002/ejp.624
   MARIETTA MP, 1977, J PHARMACOL EXP THER, V202, P157
   Moaddel R, 2010, TALANTA, V82, P1892, DOI 10.1016/j.talanta.2010.08.005
   OYE I, 1992, J PHARMACOL EXP THER, V260, P1209
   REICH DL, 1989, CAN J ANAESTH, V36, P186
   Rosas MER, 2003, J CHROMATOGR B, V794, P99, DOI 10.1016/S1570-0232(03)00420-3
   Schmitz A, 2009, ELECTROPHORESIS, V30, P2912, DOI 10.1002/elps.200900221
   Singh NS, 2014, EXPERT REV NEUROTHER, V14, P1239, DOI 10.1586/14737175.2014.971760
   Svensson JO, 1996, J CHROMATOGR B, V678, P373, DOI 10.1016/0378-4347(95)00545-5
   Theurillat R, 2005, ELECTROPHORESIS, V26, P3942, DOI 10.1002/elps.20050059
   Theurillat R, 2007, ELECTROPHORESIS, V28, P2748, DOI 10.1002/elps.200600820
   Theurillat R, 2014, ELECTROPHORESIS, V35, P2863, DOI 10.1002/elps.201400093
   Turfus SC, 2009, DRUG METAB DISPOS, V37, P1769, DOI 10.1124/dmd.108.026328
   Wang KC, 2005, FORENSIC SCI INT, V147, P81, DOI 10.1016/j.forsciint.2004.03.031
   WHITE PF, 1985, BRIT J ANAESTH, V57, P197, DOI 10.1093/bja/57.2.197
   WIEBER J, 1975, ANAESTHESIST, V24, P260
   Williams ML, 2004, DRUG METAB DISPOS, V32, P786, DOI 10.1124/dmd.32.8.786
   Yanagihara Y, 2000, J CHROMATOGR B, V746, P227, DOI 10.1016/S0378-4347(00)00331-5
   Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998
   Zhao XC, 2012, BRIT J CLIN PHARMACO, V74, P304, DOI 10.1111/j.1365-2125.2012.04198.x
NR 37
TC 0
Z9 0
U1 15
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0731-7085
EI 1873-264X
J9 J PHARMACEUT BIOMED
JI J. Pharm. Biomed. Anal.
PD MAY 30
PY 2017
VL 139
BP 87
EP 97
DI 10.1016/j.jpba.2017.02.035
PG 11
WC Chemistry, Analytical; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA ES9GY
UT WOS:000399865900010
PM 28279931
OA No
DA 2017-08-17
ER

PT J
AU Sirunyan, AM
   Tumasyan, A
   Adam, W
   Asilar, E
   Bergauer, T
   Brandstetter, J
   Brondolin, E
   Dragicevic, M
   Ero, J
   Flechl, M
   Friedl, M
   Fruhwirth, R
   Ghete, VM
   Hartl, C
   Hormann, N
   Hrubec, J
   Jeitler, M
   Konig, A
   Kratschmer, I
   Liko, D
   Matsushita, T
   Mikulec, I
   Rabady, D
   Rad, N
   Rahbaran, B
   Rohringer, H
   Schieck, J
   Strauss, J
   Waltenberger, W
   Wulz, CE
   Dvornikov, O
   Makarenko, V
   Mossolov, V
   Gonzalez, JS
   Zykunov, V
   Shumeiko, N
   Alderweireldt, S
   De Wolf, EA
   Janssen, X
   Lauwers, J
   Van de Klundert, M
   Van Haevermaet, H
   Van Mechelen, P
   Van Remortel, N
   Van Spilbeeck, A
   Abu Zeid, S
   Blekman, F
   D'Hondt, J
   Daci, N
   De Bruyn, I
   Deroover, K
   Lowette, S
   Moortgat, S
   Moreels, L
   Olbrechts, A
   Python, Q
   Skovpen, K
   Tavernier, S
   Van Doninck, W
   Van Mulders, P
   Van Parijs, I
   Brun, H
   Clerbaux, B
   De Lentdecker, G
   Delannoy, H
   Fasanella, G
   Favart, L
   Goldouzian, R
   Grebenyuk, A
   Karapostoli, G
   Lenzi, T
   Leonard, A
   Luetic, J
   Maerschalk, T
   Marinov, A
   Randle-Conde, A
   Seva, T
   Vander Velde, C
   Vanlaer, P
   Vannerom, D
   Yonamine, R
   Zenoni, F
   Zhang, F
   Cimmino, A
   Cornelis, T
   Dobur, D
   Fagot, A
   Gul, M
   Khvastunov, I
   Poyraz, D
   Salva, S
   Schofbeck, R
   Tytgat, M
   Van Driessche, W
   Yazgan, E
   Zaganidis, N
   Bakhshiansohi, H
   Beluffi, C
   Bondu, O
   Brochet, S
   Bruno, G
   Caudron, A
   De Visscher, S
   Delaere, C
   Delcourt, M
   Francois, B
   Giammanco, A
   Jafari, A
   Komm, M
   Krintiras, G
   Lemaitre, V
   Magitteri, A
   Mertens, A
   Musich, M
   Piotrzkowski, K
   Quertenmont, L
   Selvaggi, M
   Marono, MV
   Wertz, S
   Beliy, N
   Alda, WL
   Alves, FL
   Alves, GA
   Brito, L
   Hensel, C
   Moraes, A
   Pol, ME
   Teles, PR
   Das Chagas, EBB
   Carvalho, W
   Chinellato, J
   Custodio, A
   Da Costa, EM
   Da Silveira, GG
   Damiao, DD
   Martins, CD
   De Souza, SF
   Guativa, LMH
   Malbouisson, H
   Figueiredo, DM
   Herrera, CM
   Mundim, L
   Nogima, H
   Da Silva, WLP
   Santoro, A
   Sznajder, A
   Manganote, EJT
   De Araujo, FTD
   Pereira, AV
   Ahuja, S
   Bernardes, CA
   Dogra, S
   Tomei, TRFP
   Gregores, EM
   Mercadante, PG
   Moon, CS
   Novaes, SF
   Padula, SS
   Abad, DR
   Vargas, JCR
   Aleksandrov, A
   Hadjiiska, R
   Iaydjiev, P
   Rodozov, M
   Stoykova, S
   Sultanov, G
   Vutova, M
   Dimitrov, A
   Glushkov, I
   Litov, L
   Pavlov, B
   Petkov, P
   Fang, W
   Ahmad, M
   Bian, JG
   Chen, GM
   Chen, HS
   Chen, M
   Chen, Y
   Cheng, T
   Jiang, CH
   Leggat, D
   Liu, Z
   Romeo, F
   Ruan, M
   Shaheen, SM
   Spiezia, A
   Tao, J
   Wang, C
   Wang, Z
   Zhang, H
   Zhao, J
   Ban, Y
   Chen, G
   Li, Q
   Liu, S
   Mao, Y
   Qian, SJ
   Wang, D
   Xu, Z
   Avila, C
   Cabrera, A
   Sierra, LFC
   Florez, C
   Gomez, JP
   Hernandez, CFG
   Alvarez, JDR
   Sanabria, JC
   Godinovic, N
   Lelas, D
   Puljak, I
   Cipriano, PMR
   Sculac, T
   Antunovic, Z
   Kovac, M
   Brigljevic, V
   Ferencek, D
   Kadija, K
   Mesic, B
   Susa, T
   Attikis, A
   Mavromanolakis, G
   Mousa, J
   Nicolaou, C
   Ptochos, F
   Razis, PA
   Rykaczewski, H
   Tsiakkouri, D
   Finger, M
   Finger, M
   Jarrin, EC
   El-Khateeb, E
   Elgammal, S
   Mohamed, A
   Kadastik, M
   Perrini, L
   Raidal, M
   Tiko, A
   Veelken, C
   Eerola, P
   Pekkanen, J
   Voutilainen, M
   Harkonen, J
   Jarvinen, T
   Karimaki, V
   Kinnunen, R
   Lampen, T
   Lassila-Perini, K
   Lehti, S
   Linden, T
   Luukka, P
   Tuominiemi, J
   Tuovinen, E
   Wendland, L
   Talvitie, J
   Tuuva, T
   Besancon, M
   Couderc, F
   Dejardin, M
   Denegri, D
   Fabbro, B
   Faure, JL
   Favaro, C
   Ferri, F
   Ganjour, S
   Ghosh, S
   Givernaud, A
   Gras, P
   de Monchenault, GH
   Jarry, P
   Kucher, I
   Locci, E
   Machet, M
   Malcles, J
   Rander, J
   Rosowsky, A
   Titov, M
   Abdulsalam, A
   Antropov, I
   Baffioni, S
   Beaudette, F
   Busson, P
   Cadamuro, L
   Chapon, E
   Charlot, C
   Davignon, O
   de Cassagnac, RG
   Jo, M
   Lisniak, S
   Mine, P
   Nguyen, M
   Ochando, C
   Ortona, G
   Paganini, P
   Pigard, P
   Regnard, S
   Salerno, R
   Sirois, Y
   Leiton, AGS
   Strebler, T
   Yilmaz, Y
   Zabi, A
   Zghiche, A
   Agram, JL
   Andrea, J
   Aubin, A
   Bloch, D
   Brom, JM
   Buttignol, M
   Chabert, EC
   Chanon, N
   Collard, C
   Conte, E
   Coubez, X
   Fontaine, JC
   Gele, D
   Goerlach, U
   Le Bihan, AC
   Van Hove, P
   Gadrat, S
   Beauceron, S
   Bernet, C
   Boudoul, G
   Montoya, CAC
   Chierici, R
   Contardo, D
   Courbon, B
   Depasse, P
   El Mamouni, H
   Fay, J
   Gascon, S
   Gouzevitch, M
   Grenier, G
   Ille, B
   Lagarde, F
   Laktineh, IB
   Lethuillier, M
   Mirabito, L
   Pequegnot, AL
   Perries, S
   Popov, A
   Sabes, D
   Sordini, V
   Donckt, MV
   Verdier, P
   Viret, S
   Khvedelidze, A
   Tsamalaidze, Z
   Autermann, C
   Beranek, S
   Feld, L
   Kiesel, MK
   Klein, K
   Lipinski, M
   Preuten, M
   Schomakers, C
   Schulz, J
   Verlage, T
   Albert, A
   Brodski, M
   Dietz-Laursonn, E
   Duchardt, D
   Endres, M
   Erdmann, M
   Erdweg, S
   Esch, T
   Fischer, R
   Guth, A
   Hamer, M
   Hebbeker, T
   Heidemann, C
   Hoepfner, K
   Knutzen, S
   Merschmeyer, M
   Meyer, A
   Millet, P
   Mukherjee, S
   Olschewski, M
   Padeken, K
   Pook, T
   Radziej, M
   Reithler, H
   Rieger, M
   Scheuch, F
   Sonnenschein, L
   Teyssier, D
   Thuer, S
   Cherepanov, V
   Flugge, G
   Kargoll, B
   Kress, T
   Kuensken, A
   Lingemann, J
   Muller, T
   Nehrkorn, A
   Nowack, A
   Pistone, C
   Pooth, O
   Stahl, A
   Martin, MA
   Arndt, T
   Asawatangtrakuldee, C
   Beernaert, K
   Behnke, O
   Behrens, U
   Bin Anuar, AA
   Borras, K
   Campbell, A
   Connor, P
   Contreras-Campana, C
   Costanza, F
   Pardos, CD
   Dolinska, G
   Eckerlin, G
   Eckstein, D
   Eichhorn, T
   Eren, E
   Gallo, E
   Garcia, JG
   Geiser, A
   Gizhko, A
   Luyando, JMG
   Grohsjean, A
   Gunnellini, P
   Harb, A
   Hauk, J
   Hempel, M
   Jung, H
   Kalogeropoulos, A
   Karacheban, O
   Kasemann, M
   Keaveney, J
   Kleinwort, C
   Korol, I
   Krucker, D
   Lange, W
   Lelek, A
   Lenz, T
   Leonard, J
   Lipka, K
   Lobanov, A
   Lohmann, W
   Mankel, R
   Melzer-Pellmann, IA
   Meyer, AB
   Mittag, G
   Mnich, J
   Mussgiller, A
   Pitzl, D
   Placakyte, R
   Raspereza, A
   Roland, B
   Sahin, MO
   Saxena, P
   Schoerner-Sadenius, T
   Spannagel, S
   Stefaniuk, N
   Van Onsem, GP
   Walsh, R
   Wissing, C
   Blobel, V
   Vignali, MC
   Draeger, AR
   Dreyer, T
   Garutti, E
   Gonzalez, D
   Haller, J
   Hoffmann, M
   Junkes, A
   Klanner, R
   Kogler, R
   Kovalchuk, N
   Lapsien, T
   Marchesini, I
   Marconi, D
   Meyer, M
   Niedziela, M
   Nowatschin, D
   Pantaleo, F
   Peiffer, T
   Perieanu, A
   Scharf, C
   Schleper, P
   Schmidt, A
   Schumann, S
   Schwandt, J
   Stadie, H
   Steinbruck, G
   Stober, FM
   Stover, M
   Tholen, H
   Troendle, D
   Usai, E
   Vanelderen, L
   Vanhoefer, A
   Vormwald, B
   Akbiyik, M
   Barth, C
   Baur, S
   Baus, C
   Berger, J
   Butz, E
   Caspart, R
   Chwalek, T
   Colombo, F
   De Boer, W
   Dierlamm, A
   Fink, S
   Freund, B
   Friese, R
   Giffels, M
   Gilbert, A
   Goldenzweig, P
   Haitz, D
   Hartmann, F
   Heindl, SM
   Husemann, U
   Katkov, I
   Kudella, S
   Mildner, H
   Mozer, MU
   Muller, T
   Plagge, M
   Quast, G
   Rabbertz, K
   Rocker, S
   Roscher, F
   Schroder, M
   Shvetsov, I
   Sieber, G
   Simonis, HJ
   Ulrich, R
   Wayand, S
   Weber, M
   Weiler, T
   Williamson, S
   Wohrmann, C
   Wolf, R
   Anagnostou, G
   Daskalakis, G
   Geralis, T
   Giakoumopoulou, VA
   Kyriakis, A
   Loukas, D
   Topsis-Giotis, I
   Kesisoglou, S
   Panagiotou, A
   Saoulidou, N
   Tziaferi, E
   Evangelou, I
   Flouris, G
   Foudas, C
   Kokkas, P
   Loukas, N
   Manthos, N
   Papadopoulos, I
   Paradas, E
   Filipovic, N
   Pasztor, G
   Bencze, G
   Hajdu, C
   Horvath, D
   Sikler, F
   Veszpremi, V
   Vesztergombi, G
   Zsigmond, AJ
   Beni, N
   Czellar, S
   Karancsi, J
   Makovec, A
   Molnar, J
   Szillasi, Z
   Bartok, M
   Raics, P
   Trocsanyi, ZL
   Ujvari, B
   Komaragiri, JR
   Bahinipati, S
   Bhowmik, S
   Choudhury, S
   Mal, P
   Mandal, K
   Nayak, A
   Sahoo, DK
   Sahoo, N
   Swain, SK
   Bansal, S
   Beri, SB
   Bhatnagar, V
   Chawla, R
   Bhawandeep, U
   Kalsi, AK
   Kaur, A
   Kaur, M
   Kumar, R
   Kumari, P
   Mehta, A
   Mittal, M
   Singh, JB
   Walia, G
   Kumar, A
   Bhardwaj, A
   Choudhary, BC
   Garg, RB
   Keshri, S
   Malhotra, S
   Naimuddin, M
   Ranjan, K
   Sharma, R
   Sharma, V
   Bhattacharya, R
   Bhattacharya, S
   Chatterjee, K
   Dey, S
   Dutt, S
   Dutta, S
   Ghosh, S
   Majumdar, N
   Modak, A
   Mondal, K
   Mukhopadhyay, S
   Nandan, S
   Purohit, A
   Roy, A
   Roy, D
   Chowdhury, SR
   Sarkar, S
   Sharan, M
   Thakur, S
   Behera, PK
   Chudasama, R
   Dutta, D
   Jha, V
   Kumar, V
   Mohanty, AK
   Netrakanti, PK
   Pant, LM
   Shukla, P
   Topkar, A
   Aziz, T
   Dugad, S
   Kole, G
   Mahakud, B
   Mitra, S
   Mohanty, GB
   Parida, B
   Sur, N
   Sutar, B
   Banerjee, S
   Dewanjee, RK
   Ganguly, S
   Guchait, M
   Jain, S
   Kumar, S
   Maity, M
   Majumder, G
   Mazumdar, K
   Sarkar, T
   Wickramage, N
   Chauhan, S
   Dube, S
   Hegde, V
   Kapoor, A
   Kothekar, K
   Pandey, S
   Rane, A
   Sharma, S
   Chenarani, S
   Tadavani, EE
   Etesami, SM
   Khakzad, M
   Najafabadi, MM
   Naseri, M
   Mehdiabadi, SP
   Hosseinabadi, FR
   Safarzadeh, B
   Zeinali, M
   Felcini, M
   Grunewald, M
   Abbrescia, M
   Calabria, C
   Caputo, C
   Colaleo, A
   Creanza, D
   Cristella, L
   De Filippis, N
   De Palma, M
   Fiore, L
   Iaselli, G
   Maggi, G
   Maggi, M
   Miniello, G
   My, S
   Nuzzo, S
   Pompili, A
   Abbiendi, G
   Battilana, C
   Bonacorsi, D
   Braibant-Giacomelli, S
   Brigliadori, L
   Campanini, R
   Capiluppi, P
   Castro, A
   Cavallo, FR
   Chhibra, SS
   Codispoti, G
   Cuffiani, M
   Dallavalle, GM
   Fabbri, F
   Fanfani, A
   Fasanella, D
   Giacomelli, P
   Grandi, C
   Guiducci, L
   Marcellini, S
   Masetti, G
   Montanari, A
   Navarria, FL
   Perrotta, A
   Rossi, AM
   Rovelli, T
   Siroli, GP
   Tosi, N
   Albergo, S
   Costa, S
   Di Mattia, A
   Giordano, F
   Potenza, R
   Tricomi, A
   Tuve, C
   Barbagli, G
   Ciulli, V
   Civinini, C
   D'Alessandro, R
   Focardi, E
   Lenzi, P
   Meschini, M
   Paoletti, S
   Russo, L
   Sguazzoni, G
   Strom, D
   Viliani, L
   Benussi, L
   Bianco, S
   Fabbri, F
   Piccolo, D
   Primavera, F
   Calvelli, V
   Ferro, F
   Monge, MR
   Robutti, E
   Tosi, S
   Brianza, L
   Brivio, F
   Ciriolo, V
   Dinardo, ME
   Fiorendi, S
   Gennai, S
   Ghezzi, A
   Govoni, P
   Malberti, M
   Malvezzi, S
   Manzoni, RA
   Menasce, D
   Moroni, L
   Paganoni, M
   Pedrini, D
   Pigazzini, S
   Ragazzi, S
   de Fatis, TT
   Buontempo, S
   Cavallo, N
   De Nardo, G
   Di Guida, S
   Esposito, M
   Fabozzi, F
   Fienga, F
   Iorio, AOM
   Lanza, G
   Lista, L
   Meola, S
   Paolucci, P
   Sciacca, C
   Thyssen, F
   Azzi, P
   Bacchetta, N
   Benato, L
   Bisello, D
   Boletti, A
   Carlin, R
   De Oliveira, ACA
   Checchia, P
   Dall'Osso, M
   Manzano, PD
   Dorigo, T
   Dosselli, U
   Gasparini, F
   Gasparini, U
   Gozzelino, A
   Lacaprara, S
   Margoni, M
   Meneguzzo, AT
   Pazzini, J
   Pozzobon, N
   Ronchese, P
   Simonetto, F
   Torassa, E
   Zanetti, M
   Zotto, P
   Zumerle, G
   Braghieri, A
   Fallavollita, F
   Magnani, A
   Montagna, P
   Ratti, SP
   Re, V
   Riccardi, C
   Salvini, P
   Vai, I
   Vitulo, P
   Solestizi, LA
   Bilei, GM
   Ciangottini, D
   Fano, L
   Lariccia, P
   Leonardi, R
   Mantovani, G
   Menichelli, M
   Saha, A
   Santocchia, A
   Androsov, K
   Azzurri, P
   Bagliesi, G
   Bernardini, J
   Boccali, T
   Castaldi, R
   Ciocci, MA
   Dell'Orso, R
   Donato, S
   Fedi, G
   Giassi, A
   Grippo, MT
   Ligabue, F
   Lomtadze, T
   Martini, L
   Messineo, A
   Palla, F
   Rizzi, A
   Savoy-Navarro, A
   Spagnolo, P
   Tenchini, R
   Tonelli, G
   Venturi, A
   Verdini, PG
   Cipriani, M
   Barone, L
   Cavallari, F
   Cipriani, M
   Del Re, D
   Diemoz, M
   Gelli, S
   Longo, E
   Margaroli, F
   Marzocchi, B
   Meridiani, P
   Organtini, G
   Paramatti, R
   Preiato, F
   Rahatlou, S
   Rovelli, C
   Santanastasio, F
   Amapane, N
   Arcidiacono, R
   Argiro, S
   Arneodo, M
   Bartosik, N
   Bellan, R
   Biino, C
   Cartiglia, N
   Cenna, F
   Costa, M
   Covarelli, R
   Degano, A
   Demaria, N
   Finco, L
   Kiani, B
   Mariotti, C
   Maselli, S
   Migliore, E
   Monaco, V
   Monteil, E
   Monteno, M
   Obertino, MM
   Pacher, L
   Pastrone, N
   Pelliccioni, M
   Angioni, GLP
   Ravera, F
   Romero, A
   Ruspa, M
   Sacchi, R
   Shchelina, K
   Sola, V
   Solano, A
   Staiano, A
   Traczyk, P
   Belforte, S
   Casarsa, M
   Cossutti, F
   Della Ricca, G
   Zanetti, A
   Kim, DH
   Kim, GN
   Kim, MS
   Lee, S
   Lee, SW
   Oh, YD
   Sekmen, S
   Son, DC
   Yang, YC
   Lee, A
   Kim, H
   Cifuentes, JAB
   Kim, TJ
   Cho, S
   Choi, S
   Go, Y
   Gyun, D
   Ha, S
   Hong, B
   Jo, Y
   Kim, Y
   Lee, K
   Lee, KS
   Lee, S
   Lim, J
   Park, SK
   Roh, Y
   Almond, J
   Kim, J
   Lee, H
   Oh, SB
   Radburn-Smith, BC
   Seo, SH
   Yang, UK
   Yoo, HD
   Yu, GB
   Choi, M
   Kim, H
   Kim, JH
   Lee, JSH
   Park, IC
   Ryu, G
   Ryu, MS
   Choi, Y
   Goh, J
   Hwang, C
   Lee, J
   Yu, I
   Dudenas, V
   Juodagalvis, A
   Vaitkus, J
   Ahmed, I
   Ibrahim, ZA
   Ali, MABM
   Idris, FM
   Abdullah, WATW
   Yusli, MN
   Zolkapli, Z
   Castilla-Valdez, H
   De la Cruz-Burelo, E
   Heredia-De la Cruz, I
   Hernandez-Almada, A
   Lopez-Fernandez, R
   Villalba, RM
   Guisao, JM
   Sanchez-Hernandez, A
   Moreno, SC
   Barrera, CO
   Valencia, FV
   Carpinteyro, S
   Pedraza, I
   Ibarguen, HAS
   Estrada, CU
   Pineda, AM
   Krofcheck, D
   Butler, PH
   Ahmad, A
   Ahmad, M
   Hassan, Q
   Hoorani, HR
   Khan, WA
   Saddique, A
   Shah, MA
   Shoaib, M
   Waqas, M
   Bialkowska, H
   Bluj, M
   Boimska, B
   Frueboes, T
   Gorski, M
   Kazana, M
   Nawrocki, K
   Romanowska-Rybinska, K
   Szleper, M
   Zalewski, P
   Bunkowski, K
   Byszuk, A
   Doroba, K
   Kalinowski, A
   Konecki, M
   Krolikowski, J
   Misiura, M
   Olszewski, M
   Walczak, M
   Bargassa, P
   Silva, CBDE
   Calpas, B
   Di Francesco, A
   Faccioli, P
   Parracho, PGF
   Gallinaro, M
   Hollar, J
   Leonardo, N
   Iglesias, LL
   Nemallapudi, MV
   Antunes, JR
   Seixas, J
   Toldaiev, O
   Vadruccio, D
   Varela, J
   Afanasiev, S
   Bunin, P
   Gavrilenko, M
   Golutvin, I
   Gorbunov, I
   Kamenev, A
   Karjavin, V
   Lanev, A
   Malakhov, A
   Matveev, V
   Palichik, V
   Perelygin, V
   Shmatov, S
   Shulha, S
   Skatchkov, N
   Smirnov, V
   Voytishin, N
   Zarubin, A
   Chtchipounov, L
   Golovtsov, V
   Ivanov, Y
   Kim, V
   Kuznetsova, E
   Murzin, V
   Oreshkin, V
   Sulimov, V
   Vorobyev, A
   Andreev, Y
   Dermenev, A
   Gninenko, S
   Golubev, N
   Karneyeu, A
   Kirsanov, M
   Krasnikov, N
   Pashenkov, A
   Tlisov, D
   Toropin, A
   Epshteyn, V
   Gavrilov, V
   Lychkovskaya, N
   Popov, V
   Pozdnyakov, I
   Safronov, G
   Spiridonov, A
   Toms, M
   Vlasov, E
   Zhokin, A
   Aushev, T
   Bylinkin, A
   Danilov, M
   Popova, E
   Rusinov, V
   Andreev, V
   Azarkin, M
   Dremin, I
   Kirakosyan, M
   Leonidov, A
   Terkulov, A
   Baskakov, A
   Belyaev, A
   Boos, E
   Bunichev, V
   Dubinin, M
   Dudko, L
   Klyukhin, V
   Kodolova, O
   Korneeva, N
   Lokhtin, I
   Miagkov, I
   Obraztsov, S
   Perfilov, M
   Savrin, V
   Volkov, P
   Blinov, V
   Skovpen, Y
   Shtol, D
   Azhgirey, I
   Bayshev, I
   Bitioukov, S
   Elumakhov, D
   Kachanov, V
   Kalinin, A
   Konstantinov, D
   Krychkine, V
   Petrov, V
   Ryutin, R
   Sobol, A
   Troshin, S
   Tyurin, N
   Uzunian, A
   Volkov, A
   Adzic, P
   Cirkovic, P
   Devetak, D
   Dordevic, M
   Milosevic, J
   Rekovic, V
   Maestre, JA
   Luna, MB
   Calvo, E
   Cerrada, M
   Llatas, MC
   Colino, N
   De la Cruz, B
   Peris, AD
   Del Valle, AE
   Bedoya, CF
   Ramos, JPF
   Flix, J
   Fouz, MC
   Garcia-Abia, P
   Lopez, OG
   Lopez, SG
   Hernandez, JM
   Josa, MI
   De Martino, EN
   Yzquierdo, APC
   Pelayo, JP
   Olmeda, AQ
   Redondo, I
   Romero, L
   Soares, MS
   de Troconiz, JF
   Missiroli, M
   Moran, D
   Cuevas, J
   Menendez, JF
   Caballero, IG
   Fernandez, JRG
   Cortezon, EP
   Cruz, SS
   Andres, IS
   Vischia, P
   Garcia, JMV
   Cabrillo, IJ
   Calderon, A
   Curras, E
   Fernandez, M
   Garcia-Ferrero, J
   Gomez, G
   Virto, AL
   Marco, J
   Rivero, CM
   Matorras, F
   Gomez, JP
   Rodrigo, T
   Ruiz-Jimeno, A
   Scodellaro, L
   Trevisani, N
   Vila, I
   Cortabitarte, RV
   Abbaneo, D
   Auffray, E
   Auzinger, G
   Baillon, P
   Ball, AH
   Barney, D
   Bloch, P
   Bocci, A
   Botta, C
   Camporesi, T
   Castello, R
   Cepeda, M
   Cerminara, G
   Chen, Y
   d'Enterria, D
   Dabrowski, A
   Daponte, V
   David, A
   De Gruttola, M
   De Roeck, A
   Di Marco, E
   Dobson, M
   Dorney, B
   du Pree, T
   Duggan, D
   Dunser, M
   Dupont, N
   Elliott-Peisert, A
   Everaerts, P
   Fartoukh, S
   Franzoni, G
   Fulcher, J
   Funk, W
   Gigi, D
   Gill, K
   Girone, M
   Glege, F
   Gulhan, D
   Gundacker, S
   Guthoff, M
   Harris, P
   Hegeman, J
   Innocente, V
   Janot, P
   Kieseler, J
   Kirschenmann, H
   Knunz, V
   Kornmayer, A
   Kortelainen, MJ
   Kousouris, K
   Krammer, M
   Lange, C
   Lecoq, P
   Lourenco, C
   Lucchini, MT
   Malgeri, L
   Mannelli, M
   Martelli, A
   Meijers, F
   Merlin, JA
   Mersi, S
   Meschi, E
   Milenovic, P
   Moortgat, F
   Morovic, S
   Mulders, M
   Neugebauer, H
   Orfanelli, S
   Orsini, L
   Pape, L
   Perez, E
   Peruzzi, M
   Petrilli, A
   Petrucciani, G
   Pfeiffer, A
   Pierini, M
   Racz, A
   Reis, T
   Rolandi, G
   Rovere, M
   Sakulin, H
   Sauvan, JB
   Schafer, C
   Schwick, C
   Seidel, M
   Sharma, A
   Silva, P
   Sphicas, P
   Steggemann, J
   Stoye, M
   Takahashi, Y
   Tosi, M
   Treille, D
   Triossi, A
   Tsirou, A
   Veckalns, V
   Veres, GI
   Verweij, M
   Wardle, N
   Wohri, HK
   Zagozdzinska, A
   Zeuner, WD
   Bertl, W
   Deiters, K
   Erdmann, W
   Horisberger, R
   Ingram, Q
   Kaestli, HC
   Kotlinski, D
   Langenegger, U
   Rohe, T
   Wiederkehr, SA
   Bachmair, F
   Bani, L
   Bianchini, L
   Casal, B
   Dissertori, G
   Dittmar, M
   Donega, M
   Grab, C
   Heidegger, C
   Hits, D
   Hoss, J
   Kasieczka, G
   Lustermann, W
   Mangano, B
   Marionneau, M
   del Arbol, PMR
   Masciovecchio, M
   Meinhard, MT
   Meister, D
   Micheli, F
   Musella, P
   Nessi-Tedaldi, F
   Pandolfi, F
   Pata, J
   Pauss, F
   Perrin, G
   Perrozzi, L
   Quittnat, M
   Rossini, M
   Schonenberger, M
   Starodumov, A
   Tavolaro, VR
   Theofilatos, K
   Wallny, R
   Aarrestad, TK
   Amsler, C
   Caminada, L
   Canelli, MF
   De Cosa, A
   Galloni, C
   Hinzmann, A
   Hreus, T
   Kilminster, B
   Ngadiuba, J
   Pinna, D
   Rauco, G
   Robmann, P
   Salerno, D
   Seitz, C
   Yang, Y
   Zucchetta, A
   Candelise, V
   Doan, TH
   Jain, S
   Khurana, R
   Konyushikhin, M
   Kuo, CM
   Lin, W
   Pozdnyakov, A
   Yu, SS
   Kumar, A
   Chang, P
   Chang, YH
   Chao, Y
   Chen, KF
   Chen, PH
   Fiori, F
   Hou, WS
   Hsiung, Y
   Liu, YF
   Lu, RS
   Moya, MM
   Paganis, E
   Psallidas, A
   Tsai, JF
   Asavapibhop, B
   Singh, G
   Srimanobhas, N
   Suwonjandee, N
   Adiguzel, A
   Damarseckin, S
   Demiroglu, ZS
   Dozen, C
   Eskut, E
   Girgis, S
   Gokbulut, G
   Guler, Y
   Hos, I
   Kangal, EE
   Kara, O
   Topaksu, AK
   Kiminsu, U
   Oglakci, M
   Onengut, G
   Ozdemir, K
   Ozturk, S
   Polatoz, A
   Tali, B
   Turkcapar, S
   Zorbakir, IS
   Zorbilmez, C
   Bilin, B
   Bilmis, S
   Isildak, B
   Karapinar, G
   Yalvac, M
   Zeyrek, M
   Gulmez, E
   Kaya, M
   Kaya, O
   Yetkin, EA
   Yetkin, T
   Cakir, A
   Cankocak, K
   Sen, S
   Grynyov, B
   Levchuk, L
   Sorokin, P
   Aggleton, R
   Ball, F
   Beck, L
   Brooke, JJ
   Burns, D
   Clement, E
   Cussans, D
   Flacher, H
   Goldstein, J
   Grimes, M
   Heath, GP
   Heath, HF
   Jacob, J
   Kreczko, L
   Lucas, C
   Newbold, DM
   Paramesvaran, S
   Poll, A
   Sakuma, T
   El Nasr-Storey, SS
   Smith, D
   Smith, VJ
   Bell, KW
   Belyaev, A
   Brew, C
   Brown, RM
   Calligaris, L
   Cieri, D
   Cockerill, DJA
   Coughlan, JA
   Harder, K
   Harper, S
   Olaiya, E
   Petyt, D
   Shepherd-Themistocleous, CH
   Thea, A
   Tomalin, IR
   Williams, T
   Baber, M
   Bainbridge, R
   Buchmuller, O
   Bundock, A
   Burton, D
   Casasso, S
   Citron, M
   Colling, D
   Corpe, L
   Dauncey, P
   Davies, G
   De Wit, A
   Della Negra, M
   Di Maria, R
   Dunne, P
   Elwood, A
   Futyan, D
   Haddad, Y
   Hall, G
   Iles, G
   James, T
   Lane, R
   Laner, C
   Lucas, R
   Lyons, L
   Magnan, AM
   Malik, S
   Mastrolorenzo, L
   Nash, J
   Nikitenko, A
   Pela, J
   Penning, B
   Pesaresi, M
   Raymond, DM
   Richards, A
   Rose, A
   Scott, E
   Seez, C
   Summers, S
   Tapper, A
   Uchida, K
   Acosta, MV
   Virdee, T
   Wright, J
   Zenz, SC
   Cole, JE
   Hobson, PR
   Khan, A
   Kyberd, P
   Reid, ID
   Symonds, P
   Teodorescu, L
   Turner, M
   Borzou, A
   Call, K
   Dittmann, J
   Hatakeyama, K
   Liu, H
   Pastika, N
   Bartek, R
   Dominguez, A
   Buccilli, A
   Cooper, SI
   Henderson, C
   Rumerio, P
   West, C
   Arcaro, D
   Avetisyan, A
   Bose, T
   Gastler, D
   Rankin, D
   Richardson, C
   Rohlf, J
   Sulak, L
   Zou, D
   Benelli, G
   Cutts, D
   Garabedian, A
   Hakala, J
   Heintz, U
   Hogan, JM
   Jesus, O
   Kwok, KHM
   Laird, E
   Landsberg, G
   Mao, Z
   Narain, M
   Piperov, S
   Sagir, S
   Spencer, E
   Syarif, R
   Breedon, R
   Burns, D
   Sanchez, MCDL
   Chauhan, S
   Chertok, M
   Conway, J
   Conway, R
   Cox, PT
   Erbacher, R
   Flores, C
   Funk, G
   Gardner, M
   Ko, W
   Lander, R
   Mclean, C
   Mulhearn, M
   Pellett, D
   Pilot, J
   Shalhout, S
   Shi, M
   Smith, J
   Squires, M
   Stolp, D
   Tos, K
   Tripathi, M
   Bachtis, M
   Bravo, C
   Cousins, R
   Dasgupta, A
   Florent, A
   Hauser, J
   Ignatenko, M
   Mccoll, N
   Saltzberg, D
   Schnaible, C
   Valuev, V
   Weber, M
   Bouvier, E
   Burt, K
   Clare, R
   Ellison, J
   Gary, JW
   Shirazi, SMAG
   Hanson, G
   Heilman, J
   Jandir, P
   Kennedy, E
   Lacroix, F
   Long, OR
   Negrete, MO
   Paneva, MI
   Shrinivas, A
   Si, W
   Wei, H
   Wimpenny, S
   Yates, BR
   Branson, JG
   Cerati, GB
   Cittolin, S
   Derdzinski, M
   Gerosa, R
   Holzner, A
   Klein, D
   Krutelyov, V
   Letts, J
   Macneill, I
   Olivito, D
   Padhi, S
   Pieri, M
   Sani, M
   Sharma, V
   Simon, S
   Tadel, M
   Vartak, A
   Wasserbaech, S
   Welke, C
   Wood, J
   Wuhwein, F
   Yagil, A
   Della Porta, GZ
   Amin, N
   Bhandari, R
   Bradmiller-Feld, J
   Campagnari, C
   Dishaw, A
   Dutta, V
   Sevilla, MF
   George, C
   Golf, F
   Gouskos, L
   Gran, J
   Heller, R
   Incandela, J
   Mullin, SD
   Ovcharova, A
   Qu, H
   Richman, J
   Stuart, D
   Suarez, I
   Yoo, J
   Anderson, D
   Bendavid, J
   Bornheim, A
   Bunn, J
   Duarte, J
   Lawhorn, JM
   Mott, A
   Newman, HB
   Pena, C
   Spiropulu, M
   Vlimant, JR
   Xie, S
   Zhu, RY
   Andrews, MB
   Ferguson, T
   Paulini, M
   Russ, J
   Sun, M
   Vogel, H
   Vorobiev, I
   Weinberg, M
   Cumalat, JP
   Ford, WT
   Jensen, F
   Johnson, A
   Krohn, M
   Leontsinis, S
   Mulholland, T
   Stenson, K
   Wagner, SR
   Alexander, J
   Chaves, J
   Chu, J
   Dittmer, S
   Mcdermott, K
   Mirman, N
   Kaufman, GN
   Patterson, JR
   Rinkevicius, A
   Ryd, A
   Skinnari, L
   Soffi, L
   Tan, SM
   Tao, Z
   Thom, J
   Tucker, J
   Wittich, P
   Zientek, M
   Winn, D
   Abdullin, S
   Albrow, M
   Apollinari, G
   Apresyan, A
   Banerjee, S
   Bauerdick, LAT
   Beretvas, A
   Berryhill, J
   Bhat, PC
   Bolla, G
   Burkett, K
   Butler, JN
   Cheung, HWK
   Chlebana, F
   Cihangir, S
   Cremonesi, M
   Elvira, VD
   Fisk, I
   Freeman, J
   Gottschalk, E
   Gray, L
   Green, D
   Grunendahl, S
   Gutsche, O
   Hare, D
   Harris, RM
   Hasegawa, S
   Hirschauer, J
   Hu, Z
   Jayatilaka, B
   Jindariani, S
   Johnson, M
   Joshi, U
   Klima, B
   Kreis, B
   Lammel, S
   Linacre, J
   Lincoln, D
   Lipton, R
   Liu, M
   Liu, T
   De Sa, RL
   Lykken, J
   Maeshima, K
   Magini, N
   Marraffino, JM
   Maruyama, S
   Mason, D
   McBride, P
   Merkel, P
   Mrenna, S
   Nahn, S
   O'Dell, V
   Pedro, K
   Prokofyev, O
   Rakness, G
   Ristori, L
   Sexton-Kennedy, E
   Soha, A
   Spalding, WJ
   Spiegel, L
   Stoynev, S
   Strait, J
   Strobbe, N
   Taylor, L
   Tkaczyk, S
   Tran, NV
   Uplegger, L
   Vaandering, EW
   Vernieri, C
   Verzocchi, M
   Vidal, R
   Wang, M
   Weber, HA
   Whitbeck, A
   Wu, Y
   Acosta, D
   Avery, P
   Bortignon, P
   Bourilkov, D
   Brinkerhoff, A
   Carnes, A
   Carver, M
   Curry, D
   Das, S
   Field, RD
   Furic, IK
   Konigsberg, J
   Korytov, A
   Low, JF
   Ma, P
   Matchev, K
   Mei, H
   Mitselmakher, G
   Rank, D
   Shchutska, L
   Sperka, D
   Thomas, L
   Wang, J
   Wang, S
   Yelton, J
   Linn, S
   Markowitz, P
   Martinez, G
   Rodriguez, JL
   Ackert, A
   Adams, T
   Askew, A
   Bein, S
   Hagopian, S
   Hagopian, V
   Johnson, KF
   Kolberg, T
   Prosper, H
   Santra, A
   Yohay, R
   Baarmand, MM
   Bhopatkar, V
   Colafranceschi, S
   Hohlmann, M
   Noonan, D
   Roy, T
   Yumiceva, F
   Adams, MR
   Apanasevich, L
   Berry, D
   Betts, RR
   Bucinskaite, I
   Cavanaugh, R
   Evdokimov, O
   Gauthier, L
   Gerber, CE
   Hofman, DJ
   Jung, K
   Gonzalez, IDS
   Varelas, N
   Wang, H
   Wu, Z
   Zakaria, M
   Zhang, J
   Bilki, B
   Clarida, W
   Dilsiz, K
   Durgut, S
   Gandrajula, RP
   Haytmyradov, M
   Khristenko, V
   Merlo, JP
   Mermerkaya, H
   Mestvirishvili, A
   Moeller, A
   Nachtman, J
   Ogul, H
   Onel, Y
   Ozok, F
   Penzo, A
   Snyder, C
   Tiras, E
   Wetzel, J
   Yi, K
   Blumenfeld, B
   Cocoros, A
   Eminizer, N
   Fehling, D
   Feng, L
   Gritsan, AV
   Maksimovic, P
   Roskes, J
   Sarica, U
   Swartz, M
   Xiao, M
   You, C
   Al-bataineh, A
   Baringer, P
   Bean, A
   Boren, S
   Bowen, J
   Castle, J
   Forthomme, L
   Kenny, RP
   Khalil, S
   Kropivnitskaya, A
   Majumder, D
   Mcbrayer, W
   Murray, M
   Sanders, S
   Stringer, R
   Takaki, JDT
   Wang, Q
   Ivanov, A
   Kaadze, K
   Maravin, Y
   Mohammadi, A
   Saini, LK
   Skhirtladze, N
   Toda, S
   Rebassoo, F
   Wright, D
   Anelli, C
   Baden, A
   Baron, O
   Belloni, A
   Calvert, B
   Eno, SC
   Ferraioli, C
   Gomez, JA
   Hadley, NJ
   Jabeen, S
   Jeng, GY
   Kellogg, RG
   Kunkle, J
   Mignerey, AC
   Ricci-Tam, F
   Shin, YH
   Skuja, A
   Tonjes, MB
   Tonwar, SC
   Abercrombie, D
   Allen, B
   Apyan, A
   Azzolini, V
   Barbieri, R
   Baty, A
   Bi, R
   Bierwagen, K
   Brandt, S
   Busza, W
   Cali, IA
   D'Alfonso, M
   Demiragli, Z
   Ceballos, GG
   Goncharov, M
   Hsu, D
   Iiyama, Y
   Innocenti, GM
   Klute, M
   Kovalskyi, D
   Krajczar, K
   Lai, YS
   Levin, YJ
   Levin, A
   Luckey, PD
   Maier, B
   Marini, AC
   Mcginn, C
   Mironov, C
   Narayanan, S
   Niu, X
   Paus, C
   Roland, C
   Roland, G
   Salfeld-Nebgen, J
   Stephans, GSF
   Tatar, K
   Velicanu, D
   Wang, J
   Wang, TW
   Wyslouch, B
   Benvenuti, AC
   Chatterjee, RM
   Evans, A
   Hansen, P
   Kalafut, S
   Kao, SC
   Kubota, Y
   Lesko, Z
   Mans, J
   Nourbakhsh, S
   Ruckstuhl, N
   Rusack, R
   Tambe, N
   Turkewitz, J
   Acosta, JG
   Oliveros, S
   Avdeeva, E
   Bloom, K
   Claes, DR
   Fangmeier, C
   Suarez, RG
   Kamalieddin, R
   Kravchenko, I
   Rodrigues, AM
   Monroy, J
   Siado, JE
   Snow, GR
   Stieger, B
   Alyari, M
   Dolen, J
   Godshalk, A
   Harrington, C
   Iashvili, I
   Kaisen, J
   Nguyen, D
   Parker, A
   Rappoccio, S
   Roozbahani, B
   Alverson, G
   Barberis, E
   Hortiangtham, A
   Massironi, A
   Morse, DM
   Nash, D
   Orimoto, T
   De Lima, RT
   Trocino, D
   Wang, RJ
   Wood, D
   Bhattacharya, S
   Charaf, O
   Hahn, KA
   Kumar, A
   Mucia, N
   Odell, N
   Pollack, B
   Schmitt, MH
   Sung, K
   Trovato, M
   Velasco, M
   Dev, N
   Hildreth, M
   Anampa, KH
   Jessop, C
   Karmgard, DJ
   Kellams, N
   Lannon, K
   Marinelli, N
   Meng, F
   Mueller, C
   Musienko, Y
   Planer, M
   Reinsvold, A
   Ruchti, R
   Rupprecht, N
   Smith, G
   Taroni, S
   Wayne, M
   Wolf, M
   Woodard, A
   Alimena, J
   Antonelli, L
   Bylsma, B
   Durkin, LS
   Flowers, S
   Francis, B
   Hart, A
   Hill, C
   Hughes, R
   Ji, W
   Liu, B
   Luo, W
   Puigh, D
   Winer, BL
   Wulsin, HW
   Cooperstein, S
   Driga, O
   Elmer, P
   Hardenbrook, J
   Hebda, P
   Lange, D
   Luo, J
   Marlow, D
   Medvedeva, T
   Mei, K
   Ojalvo, I
   Olsen, J
   Palmer, C
   Piroue, P
   Stickland, D
   Svyatkovskiy, A
   Tully, C
   Malik, S
   Barker, A
   Barnes, VE
   Folgueras, S
   Gutay, L
   Jha, MK
   Jones, M
   Jung, AW
   Khatiwada, A
   Miller, DH
   Neumeister, N
   Schulte, JF
   Shi, X
   Sun, J
   Wang, F
   Xie, W
   Parashar, N
   Stupak, J
   Adair, A
   Akgun, B
   Chen, Z
   Ecklund, KM
   Geurts, FJM
   Guilbaud, M
   Li, W
   Michlin, B
   Northup, M
   Padley, BP
   Roberts, J
   Rorie, J
   Tu, Z
   Zabel, J
   Betchart, B
   Bodek, A
   de Barbaro, P
   Demina, R
   Duh, YT
   Ferbel, T
   Galanti, M
   Garcia-Bellido, A
   Han, J
   Hindrichs, O
   Khukhunaishvili, A
   Lo, KH
   Tan, P
   Verzetti, M
   Agapitos, A
   Chou, JP
   Gershtein, Y
   Espinosa, TAG
   Halkiadakis, E
   Heindl, M
   Hughes, E
   Kaplan, S
   Elayavalli, RK
   Kyriacou, S
   Lath, A
   Nash, K
   Osherson, M
   Saka, H
   Salur, S
   Schnetzer, S
   Sheffield, D
   Somalwar, S
   Stone, R
   Thomas, S
   Thomassen, P
   Walker, M
   Delannoy, AG
   Foerster, M
   Heideman, J
   Riley, G
   Rose, K
   Spanier, S
   Thapa, K
   Bouhali, O
   Celik, A
   Dalchenko, M
   De Mattia, M
   Delgado, A
   Dildick, S
   Eusebi, R
   Gilmore, J
   Huang, T
   Juska, E
   Kamon, T
   Mueller, R
   Pakhotin, Y
   Patel, R
   Perloff, A
   Pernie, L
   Rathjens, D
   Safonov, A
   Tatarinov, A
   Ulmer, KA
   Akchurin, N
   Cowden, C
   Damgov, J
   De Guio, F
   Dragoiu, C
   Dudero, PR
   Faulkner, J
   Gurpinar, E
   Kunori, S
   Lamichhane, K
   Lee, SW
   Libeiro, T
   Peltola, T
   Undleeb, S
   Volobouev, I
   Wang, Z
   Greene, S
   Gurrola, A
   Janjam, R
   Johns, W
   Maguire, C
   Melo, A
   Ni, H
   Sheldon, P
   Tuo, S
   Velkovska, J
   Xu, Q
   Arenton, MW
   Barria, P
   Cox, B
   Goodell, J
   Hirosky, R
   Ledovskoy, A
   Li, H
   Neu, C
   Sinthuprasith, T
   Sun, X
   Wang, Y
   Wolfe, E
   Xia, F
   Clarke, C
   Harr, R
   Karchin, PE
   Sturdy, J
   Belknap, DA
   Buchanan, J
   Caillol, C
   Dasu, S
   Dodd, L
   Duric, S
   Gomber, B
   Grothe, M
   Herndon, M
   Herve, A
   Klabbers, P
   Lanaro, A
   Levine, A
   Long, K
   Loveless, R
   Perry, T
   Pierro, GA
   Polese, G
   Ruggles, T
   Savin, A
   Smith, N
   Smith, WH
   Taylor, D
   Woods, N
AF Sirunyan, A. M.
   Tumasyan, A.
   Adam, W.
   Asilar, E.
   Bergauer, T.
   Brandstetter, J.
   Brondolin, E.
   Dragicevic, M.
   Eroe, J.
   Flechl, M.
   Friedl, M.
   Fruehwirth, R.
   Ghete, V. M.
   Hartl, C.
   Hoermann, N.
   Hrubec, J.
   Jeitler, M.
   Koenig, A.
   Kraetschmer, I.
   Liko, D.
   Matsushita, T.
   Mikulec, I.
   Rabady, D.
   Rad, N.
   Rahbaran, B.
   Rohringer, H.
   Schieck, J.
   Strauss, J.
   Waltenberger, W.
   Wulz, C. -E.
   Dvornikov, O.
   Makarenko, V.
   Mossolov, V.
   Gonzalez, J. Suarez
   Zykunov, V.
   Shumeiko, N.
   Alderweireldt, S.
   De Wolf, E. A.
   Janssen, X.
   Lauwers, J.
   Van de Klundert, M.
   Van Haevermaet, H.
   Van Mechelen, P.
   Van Remortel, N.
   Van Spilbeeck, A.
   Abu Zeid, S.
   Blekman, F.
   D'Hondt, J.
   Daci, N.
   De Bruyn, I.
   Deroover, K.
   Lowette, S.
   Moortgat, S.
   Moreels, L.
   Olbrechts, A.
   Python, Q.
   Skovpen, K.
   Tavernier, S.
   Van Doninck, W.
   Van Mulders, P.
   Van Parijs, I.
   Brun, H.
   Clerbaux, B.
   De Lentdecker, G.
   Delannoy, H.
   Fasanella, G.
   Favart, L.
   Goldouzian, R.
   Grebenyuk, A.
   Karapostoli, G.
   Lenzi, T.
   Leonard, A.
   Luetic, J.
   Maerschalk, T.
   Marinov, A.
   Randle-Conde, A.
   Seva, T.
   Vander Velde, C.
   Vanlaer, P.
   Vannerom, D.
   Yonamine, R.
   Zenoni, F.
   Zhang, F.
   Cimmino, A.
   Cornelis, T.
   Dobur, D.
   Fagot, A.
   Gul, M.
   Khvastunov, I.
   Poyraz, D.
   Salva, S.
   Schofbeck, R.
   Tytgat, M.
   Van Driessche, W.
   Yazgan, E.
   Zaganidis, N.
   Bakhshiansohi, H.
   Beluffi, C.
   Bondu, O.
   Brochet, S.
   Bruno, G.
   Caudron, A.
   De Visscher, S.
   Delaere, C.
   Delcourt, M.
   Francois, B.
   Giammanco, A.
   Jafari, A.
   Komm, M.
   Krintiras, G.
   Lemaitre, V.
   Magitteri, A.
   Mertens, A.
   Musich, M.
   Piotrzkowski, K.
   Quertenmont, L.
   Selvaggi, M.
   Marono, M. Vidal
   Wertz, S.
   Beliy, N.
   Alda Junior, W. L.
   Alves, F. L.
   Alves, G. A.
   Brito, L.
   Hensel, C.
   Moraes, A.
   Pol, M. E.
   Rebello Teles, P.
   Belchior Batista Das Chagas, E.
   Carvalho, W.
   Chinellato, J.
   Custodio, A.
   Da Costa, E. M.
   Da Silveira, G. G.
   De Jesus Damiao, D.
   De Oliveira Martins, C.
   Fonseca De Souza, S.
   Huertas Guativa, L. M.
   Malbouisson, H.
   Matos Figueiredo, D.
   Mora Herrera, C.
   Mundim, L.
   Nogima, H.
   Prado Da Silva, W. L.
   Santoro, A.
   Sznajder, A.
   Tonelli Manganote, E. J.
   Torres Da Silva De Araujo, F.
   Vilela Pereira, A.
   Ahuja, S.
   Bernardes, C. A.
   Dogra, S.
   Fernandez Perez Tomei, T. R.
   Gregores, E. M.
   Mercadante, P. G.
   Moon, C. S.
   Novaes, S. F.
   Padula, Sandra S.
   Romero Abad, D.
   Ruiz Vargas, J. C.
   Aleksandrov, A.
   Hadjiiska, R.
   Iaydjiev, P.
   Rodozov, M.
   Stoykova, S.
   Sultanov, G.
   Vutova, M.
   Dimitrov, A.
   Glushkov, I.
   Litov, L.
   Pavlov, B.
   Petkov, P.
   Fang, W.
   Ahmad, M.
   Bian, J. G.
   Chen, G. M.
   Chen, H. S.
   Chen, M.
   Chen, Y.
   Cheng, T.
   Jiang, C. H.
   Leggat, D.
   Liu, Z.
   Romeo, F.
   Ruan, M.
   Shaheen, S. M.
   Spiezia, A.
   Tao, J.
   Wang, C.
   Wang, Z.
   Zhang, H.
   Zhao, J.
   Ban, Y.
   Chen, G.
   Li, Q.
   Liu, S.
   Mao, Y.
   Qian, S. J.
   Wang, D.
   Xu, Z.
   Avila, C.
   Cabrera, A.
   Chaparro Sierra, L. F.
   Florez, C.
   Gomez, J. P.
   Gonzalez Hernandez, C. F.
   Ruiz Alvarez, J. D.
   Sanabria, J. C.
   Godinovic, N.
   Lelas, D.
   Puljak, I.
   Cipriano, P. M. Ribeiro
   Sculac, T.
   Antunovic, Z.
   Kovac, M.
   Brigljevic, V.
   Ferencek, D.
   Kadija, K.
   Mesic, B.
   Susa, T.
   Attikis, A.
   Mavromanolakis, G.
   Mousa, J.
   Nicolaou, C.
   Ptochos, F.
   Razis, P. A.
   Rykaczewski, H.
   Tsiakkouri, D.
   Finger, M.
   Finger, M., Jr.
   Carrera Jarrin, E.
   El-khateeb, E.
   Elgammal, S.
   Mohamed, A.
   Kadastik, M.
   Perrini, L.
   Raidal, M.
   Tiko, A.
   Veelken, C.
   Eerola, P.
   Pekkanen, J.
   Voutilainen, M.
   Harkonen, J.
   Jarvinen, T.
   Karimaki, V.
   Kinnunen, R.
   Lampen, T.
   Lassila-Perini, K.
   Lehti, S.
   Linden, T.
   Luukka, P.
   Tuominiemi, J.
   Tuovinen, E.
   Wendland, L.
   Talvitie, J.
   Tuuva, T.
   Besancon, M.
   Couderc, F.
   Dejardin, M.
   Denegri, D.
   Fabbro, B.
   Faure, J. L.
   Favaro, C.
   Ferri, F.
   Ganjour, S.
   Ghosh, S.
   Givernaud, A.
   Gras, P.
   de Monchenault, G. Hamel
   Jarry, P.
   Kucher, I.
   Locci, E.
   Machet, M.
   Malcles, J.
   Rander, J.
   Rosowsky, A.
   Titov, M.
   Abdulsalam, A.
   Antropov, I.
   Baffioni, S.
   Beaudette, F.
   Busson, P.
   Cadamuro, L.
   Chapon, E.
   Charlot, C.
   Davignon, O.
   de Cassagnac, R. Granier
   Jo, M.
   Lisniak, S.
   Mine, P.
   Nguyen, M.
   Ochando, C.
   Ortona, G.
   Paganini, P.
   Pigard, P.
   Regnard, S.
   Salerno, R.
   Sirois, Y.
   Leiton, A. G. Stahl
   Strebler, T.
   Yilmaz, Y.
   Zabi, A.
   Zghiche, A.
   Agram, J. -L.
   Andrea, J.
   Aubin, A.
   Bloch, D.
   Brom, J. -M.
   Buttignol, M.
   Chabert, E. C.
   Chanon, N.
   Collard, C.
   Conte, E.
   Coubez, X.
   Fontaine, J. -C.
   Gele, D.
   Goerlach, U.
   Le Bihan, A. -C.
   Van Hove, P.
   Gadrat, S.
   Beauceron, S.
   Bernet, C.
   Boudoul, G.
   Montoya, C. A. Carrillo
   Chierici, R.
   Contardo, D.
   Courbon, B.
   Depasse, P.
   El Mamouni, H.
   Fay, J.
   Gascon, S.
   Gouzevitch, M.
   Grenier, G.
   Ille, B.
   Lagarde, F.
   Laktineh, I. B.
   Lethuillier, M.
   Mirabito, L.
   Pequegnot, A. L.
   Perries, S.
   Popov, A.
   Sabes, D.
   Sordini, V.
   Donckt, M. Vander
   Verdier, P.
   Viret, S.
   Khvedelidze, A.
   Tsamalaidze, Z.
   Autermann, C.
   Beranek, S.
   Feld, L.
   Kiesel, M. K.
   Klein, K.
   Lipinski, M.
   Preuten, M.
   Schomakers, C.
   Schulz, J.
   Verlage, T.
   Albert, A.
   Brodski, M.
   Dietz-Laursonn, E.
   Duchardt, D.
   Endres, M.
   Erdmann, M.
   Erdweg, S.
   Esch, T.
   Fischer, R.
   Gueth, A.
   Hamer, M.
   Hebbeker, T.
   Heidemann, C.
   Hoepfner, K.
   Knutzen, S.
   Merschmeyer, M.
   Meyer, A.
   Millet, P.
   Mukherjee, S.
   Olschewski, M.
   Padeken, K.
   Pook, T.
   Radziej, M.
   Reithler, H.
   Rieger, M.
   Scheuch, F.
   Sonnenschein, L.
   Teyssier, D.
   Thueer, S.
   Cherepanov, V.
   Fluegge, G.
   Kargoll, B.
   Kress, T.
   Kuensken, A.
   Lingemann, J.
   Mueller, T.
   Nehrkorn, A.
   Nowack, A.
   Pistone, C.
   Pooth, O.
   Stahl, A.
   Martin, M. Aldaya
   Arndt, T.
   Asawatangtrakuldee, C.
   Beernaert, K.
   Behnke, O.
   Behrens, U.
   Bin Anuar, A. A.
   Borras, K.
   Campbell, A.
   Connor, P.
   Contreras-Campana, C.
   Costanza, F.
   Pardos, C. Diez
   Dolinska, G.
   Eckerlin, G.
   Eckstein, D.
   Eichhorn, T.
   Eren, E.
   Gallo, E.
   Garcia, J. Garay
   Geiser, A.
   Gizhko, A.
   Luyando, J. M. Grados
   Grohsjean, A.
   Gunnellini, P.
   Harb, A.
   Hauk, J.
   Hempel, M.
   Jung, H.
   Kalogeropoulos, A.
   Karacheban, O.
   Kasemann, M.
   Keaveney, J.
   Kleinwort, C.
   Korol, I.
   Kruecker, D.
   Lange, W.
   Lelek, A.
   Lenz, T.
   Leonard, J.
   Lipka, K.
   Lobanov, A.
   Lohmann, W.
   Mankel, R.
   Melzer-Pellmann, I. -A.
   Meyer, A. B.
   Mittag, G.
   Mnich, J.
   Mussgiller, A.
   Pitzl, D.
   Placakyte, R.
   Raspereza, A.
   Roland, B.
   Sahin, M. Oe.
   Saxena, P.
   Schoerner-Sadenius, T.
   Spannagel, S.
   Stefaniuk, N.
   Van Onsem, G. P.
   Walsh, R.
   Wissing, C.
   Blobel, V.
   Vignali, M. Centis
   Draeger, A. R.
   Dreyer, T.
   Garutti, E.
   Gonzalez, D.
   Haller, J.
   Hoffmann, M.
   Junkes, A.
   Klanner, R.
   Kogler, R.
   Kovalchuk, N.
   Lapsien, T.
   Marchesini, I.
   Marconi, D.
   Meyer, M.
   Niedziela, M.
   Nowatschin, D.
   Pantaleo, F.
   Peiffer, T.
   Perieanu, A.
   Scharf, C.
   Schleper, P.
   Schmidt, A.
   Schumann, S.
   Schwandt, J.
   Stadie, H.
   Steinbrueck, G.
   Stober, F. M.
   Stoever, M.
   Tholen, H.
   Troendle, D.
   Usai, E.
   Vanelderen, L.
   Vanhoefer, A.
   Vormwald, B.
   Akbiyik, M.
   Barth, C.
   Baur, S.
   Baus, C.
   Berger, J.
   Butz, E.
   Caspart, R.
   Chwalek, T.
   Colombo, F.
   De Boer, W.
   Dierlamm, A.
   Fink, S.
   Freund, B.
   Friese, R.
   Giffels, M.
   Gilbert, A.
   Goldenzweig, P.
   Haitz, D.
   Hartmann, F.
   Heindl, S. M.
   Husemann, U.
   Katkov, I.
   Kudella, S.
   Mildner, H.
   Mozer, M. U.
   Mueller, Th.
   Plagge, M.
   Quast, G.
   Rabbertz, K.
   Roecker, S.
   Roscher, F.
   Schroeder, M.
   Shvetsov, I.
   Sieber, G.
   Simonis, H. J.
   Ulrich, R.
   Wayand, S.
   Weber, M.
   Weiler, T.
   Williamson, S.
   Woehrmann, C.
   Wolf, R.
   Anagnostou, G.
   Daskalakis, G.
   Geralis, T.
   Giakoumopoulou, V. A.
   Kyriakis, A.
   Loukas, D.
   Topsis-Giotis, I.
   Kesisoglou, S.
   Panagiotou, A.
   Saoulidou, N.
   Tziaferi, E.
   Evangelou, I.
   Flouris, G.
   Foudas, C.
   Kokkas, P.
   Loukas, N.
   Manthos, N.
   Papadopoulos, I.
   Paradas, E.
   Filipovic, N.
   Pasztor, G.
   Bencze, G.
   Hajdu, C.
   Horvath, D.
   Sikler, F.
   Veszpremi, V.
   Vesztergombi, G.
   Zsigmond, A. J.
   Beni, N.
   Czellar, S.
   Karancsi, J.
   Makovec, A.
   Molnar, J.
   Szillasi, Z.
   Bartok, M.
   Raics, P.
   Trocsanyi, Z. L.
   Ujvari, B.
   Komaragiri, J. R.
   Bahinipati, S.
   Bhowmik, S.
   Choudhury, S.
   Mal, P.
   Mandal, K.
   Nayak, A.
   Sahoo, D. K.
   Sahoo, N.
   Swain, S. K.
   Bansal, S.
   Beri, S. B.
   Bhatnagar, V.
   Chawla, R.
   Bhawandeep, U.
   Kalsi, A. K.
   Kaur, A.
   Kaur, M.
   Kumar, R.
   Kumari, P.
   Mehta, A.
   Mittal, M.
   Singh, J. B.
   Walia, G.
   Kumar, Ashok
   Bhardwaj, A.
   Choudhary, B. C.
   Garg, R. B.
   Keshri, S.
   Malhotra, S.
   Naimuddin, M.
   Ranjan, K.
   Sharma, R.
   Sharma, V.
   Bhattacharya, R.
   Bhattacharya, S.
   Chatterjee, K.
   Dey, S.
   Dutt, S.
   Dutta, S.
   Ghosh, S.
   Majumdar, N.
   Modak, A.
   Mondal, K.
   Mukhopadhyay, S.
   Nandan, S.
   Purohit, A.
   Roy, A.
   Roy, D.
   Chowdhury, S. Roy
   Sarkar, S.
   Sharan, M.
   Thakur, S.
   Behera, P. K.
   Chudasama, R.
   Dutta, D.
   Jha, V.
   Kumar, V.
   Mohanty, A. K.
   Netrakanti, P. K.
   Pant, L. M.
   Shukla, P.
   Topkar, A.
   Aziz, T.
   Dugad, S.
   Kole, G.
   Mahakud, B.
   Mitra, S.
   Mohanty, G. B.
   Parida, B.
   Sur, N.
   Sutar, B.
   Banerjee, S.
   Dewanjee, R. K.
   Ganguly, S.
   Guchait, M.
   Jain, Sa.
   Kumar, S.
   Maity, M.
   Majumder, G.
   Mazumdar, K.
   Sarkar, T.
   Wickramage, N.
   Chauhan, S.
   Dube, S.
   Hegde, V.
   Kapoor, A.
   Kothekar, K.
   Pandey, S.
   Rane, A.
   Sharma, S.
   Chenarani, S.
   Tadavani, E. Eskandari
   Etesami, S. M.
   Khakzad, M.
   Najafabadi, M. Mohammadi
   Naseri, M.
   Mehdiabadi, S. Paktinat
   Hosseinabadi, F. Rezaei
   Safarzadeh, B.
   Zeinali, M.
   Felcini, M.
   Grunewald, M.
   Abbrescia, M.
   Calabria, C.
   Caputo, C.
   Colaleo, A.
   Creanza, D.
   Cristella, L.
   De Filippis, N.
   De Palma, M.
   Fiore, L.
   Iaselli, G.
   Maggi, G.
   Maggi, M.
   Miniello, G.
   My, S.
   Nuzzo, S.
   Pompili, A.
   Abbiendi, G.
   Battilana, C.
   Bonacorsi, D.
   Braibant-Giacomelli, S.
   Brigliadori, L.
   Campanini, R.
   Capiluppi, P.
   Castro, A.
   Cavallo, F. R.
   Chhibra, S. S.
   Codispoti, G.
   Cuffiani, M.
   Dallavalle, G. M.
   Fabbri, F.
   Fanfani, A.
   Fasanella, D.
   Giacomelli, P.
   Grandi, C.
   Guiducci, L.
   Marcellini, S.
   Masetti, G.
   Montanari, A.
   Navarria, F. L.
   Perrotta, A.
   Rossi, A. M.
   Rovelli, T.
   Siroli, G. P.
   Tosi, N.
   Albergo, S.
   Costa, S.
   Di Mattia, A.
   Giordano, F.
   Potenza, R.
   Tricomi, A.
   Tuve, C.
   Barbagli, G.
   Ciulli, V.
   Civinini, C.
   D'Alessandro, R.
   Focardi, E.
   Lenzi, P.
   Meschini, M.
   Paoletti, S.
   Russo, L.
   Sguazzoni, G.
   Strom, D.
   Viliani, L.
   Benussi, L.
   Bianco, S.
   Fabbri, F.
   Piccolo, D.
   Primavera, F.
   Calvelli, V.
   Ferro, F.
   Monge, M. R.
   Robutti, E.
   Tosi, S.
   Brianza, L.
   Brivio, F.
   Ciriolo, V.
   Dinardo, M. E.
   Fiorendi, S.
   Gennai, S.
   Ghezzi, A.
   Govoni, P.
   Malberti, M.
   Malvezzi, S.
   Manzoni, R. A.
   Menasce, D.
   Moroni, L.
   Paganoni, M.
   Pedrini, D.
   Pigazzini, S.
   Ragazzi, S.
   de Fatis, T. Tabarelli
   Buontempo, S.
   Cavallo, N.
   De Nardo, G.
   Di Guida, S.
   Esposito, M.
   Fabozzi, F.
   Fienga, F.
   Iorio, A. O. M.
   Lanza, G.
   Lista, L.
   Meola, S.
   Paolucci, P.
   Sciacca, C.
   Thyssen, F.
   Azzi, P.
   Bacchetta, N.
   Benato, L.
   Bisello, D.
   Boletti, A.
   Carlin, R.
   De Oliveira, A. Carvalho Antunes
   Checchia, P.
   Dall'Osso, M.
   Manzano, P. De Castro
   Dorigo, T.
   Dosselli, U.
   Gasparini, F.
   Gasparini, U.
   Gozzelino, A.
   Lacaprara, S.
   Margoni, M.
   Meneguzzo, A. T.
   Pazzini, J.
   Pozzobon, N.
   Ronchese, P.
   Simonetto, F.
   Torassa, E.
   Zanetti, M.
   Zotto, P.
   Zumerle, G.
   Braghieri, A.
   Fallavollita, F.
   Magnani, A.
   Montagna, P.
   Ratti, S. P.
   Re, V.
   Riccardi, C.
   Salvini, P.
   Vai, I.
   Vitulo, P.
   Solestizi, L. Alunni
   Bilei, G. M.
   Ciangottini, D.
   Fano, L.
   Lariccia, P.
   Leonardi, R.
   Mantovani, G.
   Menichelli, M.
   Saha, A.
   Santocchia, A.
   Androsov, K.
   Azzurri, P.
   Bagliesi, G.
   Bernardini, J.
   Boccali, T.
   Castaldi, R.
   Ciocci, M. A.
   Dell'Orso, R.
   Donato, S.
   Fedi, G.
   Giassi, A.
   Grippo, M. T.
   Ligabue, F.
   Lomtadze, T.
   Martini, L.
   Messineo, A.
   Palla, F.
   Rizzi, A.
   Savoy-Navarro, A.
   Spagnolo, P.
   Tenchini, R.
   Tonelli, G.
   Venturi, A.
   Verdini, P. G.
   Cipriani, M.
   Barone, L.
   Cavallari, F.
   Cipriani, M.
   Del Re, D.
   Diemoz, M.
   Gelli, S.
   Longo, E.
   Margaroli, F.
   Marzocchi, B.
   Meridiani, P.
   Organtini, G.
   Paramatti, R.
   Preiato, F.
   Rahatlou, S.
   Rovelli, C.
   Santanastasio, F.
   Amapane, N.
   Arcidiacono, R.
   Argiro, S.
   Arneodo, M.
   Bartosik, N.
   Bellan, R.
   Biino, C.
   Cartiglia, N.
   Cenna, F.
   Costa, M.
   Covarelli, R.
   Degano, A.
   Demaria, N.
   Finco, L.
   Kiani, B.
   Mariotti, C.
   Maselli, S.
   Migliore, E.
   Monaco, V.
   Monteil, E.
   Monteno, M.
   Obertino, M. M.
   Pacher, L.
   Pastrone, N.
   Pelliccioni, M.
   Angioni, G. L. Pinna
   Ravera, F.
   Romero, A.
   Ruspa, M.
   Sacchi, R.
   Shchelina, K.
   Sola, V.
   Solano, A.
   Staiano, A.
   Traczyk, P.
   Belforte, S.
   Casarsa, M.
   Cossutti, F.
   Della Ricca, G.
   Zanetti, A.
   Kim, D. H.
   Kim, G. N.
   Kim, M. S.
   Lee, S.
   Lee, S. W.
   Oh, Y. D.
   Sekmen, S.
   Son, D. C.
   Yang, Y. C.
   Lee, A.
   Kim, H.
   Cifuentes, J. A. Brochero
   Kim, T. J.
   Cho, S.
   Choi, S.
   Go, Y.
   Gyun, D.
   Ha, S.
   Hong, B.
   Jo, Y.
   Kim, Y.
   Lee, K.
   Lee, K. S.
   Lee, S.
   Lim, J.
   Park, S. K.
   Roh, Y.
   Almond, J.
   Kim, J.
   Lee, H.
   Oh, S. B.
   Radburn-Smith, B. C.
   Seo, S. H.
   Yang, U. K.
   Yoo, H. D.
   Yu, G. B.
   Choi, M.
   Kim, H.
   Kim, J. H.
   Lee, J. S. H.
   Park, I. C.
   Ryu, G.
   Ryu, M. S.
   Choi, Y.
   Goh, J.
   Hwang, C.
   Lee, J.
   Yu, I.
   Dudenas, V.
   Juodagalvis, A.
   Vaitkus, J.
   Ahmed, I.
   Ibrahim, Z. A.
   Ali, M. A. B. Md
   Idris, F. Mohamad
   Abdullah, W. A. T. Wan
   Yusli, M. N.
   Zolkapli, Z.
   Castilla-Valdez, H.
   De la Cruz-Burelo, E.
   Heredia-De la Cruz, I.
   Hernandez-Almada, A.
   Lopez-Fernandez, R.
   Magana Villalba, R.
   Mejia Guisao, J.
   Sanchez-Hernandez, A.
   Carrillo Moreno, S.
   Oropeza Barrera, C.
   Vazquez Valencia, F.
   Carpinteyro, S.
   Pedraza, I.
   Salazar Ibarguen, H. A.
   Uribe Estrada, C.
   Morelos Pineda, A.
   Krofcheck, D.
   Butler, P. H.
   Ahmad, A.
   Ahmad, M.
   Hassan, Q.
   Hoorani, H. R.
   Khan, W. A.
   Saddique, A.
   Shah, M. A.
   Shoaib, M.
   Waqas, M.
   Bialkowska, H.
   Bluj, M.
   Boimska, B.
   Frueboes, T.
   Gorski, M.
   Kazana, M.
   Nawrocki, K.
   Romanowska-Rybinska, K.
   Szleper, M.
   Zalewski, P.
   Bunkowski, K.
   Byszuk, A.
   Doroba, K.
   Kalinowski, A.
   Konecki, M.
   Krolikowski, J.
   Misiura, M.
   Olszewski, M.
   Walczak, M.
   Bargassa, P.
   Silva, C. Beirao Da Cruz E.
   Calpas, B.
   Di Francesco, A.
   Faccioli, P.
   Ferreira Parracho, P. G.
   Gallinaro, M.
   Hollar, J.
   Leonardo, N.
   Lloret Iglesias, L.
   Nemallapudi, M. V.
   Rodrigues Antunes, J.
   Seixas, J.
   Toldaiev, O.
   Vadruccio, D.
   Varela, J.
   Afanasiev, S.
   Bunin, P.
   Gavrilenko, M.
   Golutvin, I.
   Gorbunov, I.
   Kamenev, A.
   Karjavin, V.
   Lanev, A.
   Malakhov, A.
   Matveev, V.
   Palichik, V.
   Perelygin, V.
   Shmatov, S.
   Shulha, S.
   Skatchkov, N.
   Smirnov, V.
   Voytishin, N.
   Zarubin, A.
   Chtchipounov, L.
   Golovtsov, V.
   Ivanov, Y.
   Kim, V.
   Kuznetsova, E.
   Murzin, V.
   Oreshkin, V.
   Sulimov, V.
   Vorobyev, A.
   Andreev, Yu.
   Dermenev, A.
   Gninenko, S.
   Golubev, N.
   Karneyeu, A.
   Kirsanov, M.
   Krasnikov, N.
   Pashenkov, A.
   Tlisov, D.
   Toropin, A.
   Epshteyn, V.
   Gavrilov, V.
   Lychkovskaya, N.
   Popov, V.
   Pozdnyakov, I.
   Safronov, G.
   Spiridonov, A.
   Toms, M.
   Vlasov, E.
   Zhokin, A.
   Aushev, T.
   Bylinkin, A.
   Danilov, M.
   Popova, E.
   Rusinov, V.
   Andreev, V.
   Azarkin, M.
   Dremin, I.
   Kirakosyan, M.
   Leonidov, A.
   Terkulov, A.
   Baskakov, A.
   Belyaev, A.
   Boos, E.
   Bunichev, V.
   Dubinin, M.
   Dudko, L.
   Klyukhin, V.
   Kodolova, O.
   Korneeva, N.
   Lokhtin, I.
   Miagkov, I.
   Obraztsov, S.
   Perfilov, M.
   Savrin, V.
   Volkov, P.
   Blinov, V.
   Skovpen, Y.
   Shtol, D.
   Azhgirey, I.
   Bayshev, I.
   Bitioukov, S.
   Elumakhov, D.
   Kachanov, V.
   Kalinin, A.
   Konstantinov, D.
   Krychkine, V.
   Petrov, V.
   Ryutin, R.
   Sobol, A.
   Troshin, S.
   Tyurin, N.
   Uzunian, A.
   Volkov, A.
   Adzic, P.
   Cirkovic, P.
   Devetak, D.
   Dordevic, M.
   Milosevic, J.
   Rekovic, V.
   Alcaraz Maestre, J.
   Barrio Luna, M.
   Calvo, E.
   Cerrada, M.
   Chamizo Llatas, M.
   Colino, N.
   De la Cruz, B.
   Delgado Peris, A.
   Escalante Del Valle, A.
   Fernandez Bedoya, C.
   Fernandez Ramos, J. P.
   Flix, J.
   Fouz, M. C.
   Garcia-Abia, P.
   Gonzalez Lopez, O.
   Goy Lopez, S.
   Hernandez, J. M.
   Josa, M. I.
   Navarro De Martino, E.
   Perez-Calero Yzquierdo, A.
   Puerta Pelayo, J.
   Quintario Olmeda, A.
   Redondo, I.
   Romero, L.
   Soares, M. S.
   de Troconiz, J. F.
   Missiroli, M.
   Moran, D.
   Cuevas, J.
   Fernandez Menendez, J.
   Gonzalez Caballero, I.
   Gonzalez Fernandez, J. R.
   Palencia Cortezon, E.
   Sanchez Cruz, S.
   Suarez Andres, I.
   Vischia, P.
   Vizan Garcia, J. M.
   Cabrillo, I. J.
   Calderon, A.
   Curras, E.
   Fernandez, M.
   Garcia-Ferrero, J.
   Gomez, G.
   Lopez Virto, A.
   Marco, J.
   Martinez Rivero, C.
   Matorras, F.
   Piedra Gomez, J.
   Rodrigo, T.
   Ruiz-Jimeno, A.
   Scodellaro, L.
   Trevisani, N.
   Vila, I.
   Vilar Cortabitarte, R.
   Abbaneo, D.
   Auffray, E.
   Auzinger, G.
   Baillon, P.
   Ball, A. H.
   Barney, D.
   Bloch, P.
   Bocci, A.
   Botta, C.
   Camporesi, T.
   Castello, R.
   Cepeda, M.
   Cerminara, G.
   Chen, Y.
   d'Enterria, D.
   Dabrowski, A.
   Daponte, V.
   David, A.
   De Gruttola, M.
   De Roeck, A.
   Di Marco, E.
   Dobson, M.
   Dorney, B.
   du Pree, T.
   Duggan, D.
   Dunser, M.
   Dupont, N.
   Elliott-Peisert, A.
   Everaerts, P.
   Fartoukh, S.
   Franzoni, G.
   Fulcher, J.
   Funk, W.
   Gigi, D.
   Gill, K.
   Girone, M.
   Glege, F.
   Gulhan, D.
   Gundacker, S.
   Guthoff, M.
   Harris, P.
   Hegeman, J.
   Innocente, V.
   Janot, P.
   Kieseler, J.
   Kirschenmann, H.
   Knunz, V.
   Kornmayer, A.
   Kortelainen, M. J.
   Kousouris, K.
   Krammer, M.
   Lange, C.
   Lecoq, P.
   Lourenco, C.
   Lucchini, M. T.
   Malgeri, L.
   Mannelli, M.
   Martelli, A.
   Meijers, F.
   Merlin, J. A.
   Mersi, S.
   Meschi, E.
   Milenovic, P.
   Moortgat, F.
   Morovic, S.
   Mulders, M.
   Neugebauer, H.
   Orfanelli, S.
   Orsini, L.
   Pape, L.
   Perez, E.
   Peruzzi, M.
   Petrilli, A.
   Petrucciani, G.
   Pfeiffer, A.
   Pierini, M.
   Racz, A.
   Reis, T.
   Rolandi, G.
   Rovere, M.
   Sakulin, H.
   Sauvan, J. B.
   Schafer, C.
   Schwick, C.
   Seidel, M.
   Sharma, A.
   Silva, P.
   Sphicas, P.
   Steggemann, J.
   Stoye, M.
   Takahashi, Y.
   Tosi, M.
   Treille, D.
   Triossi, A.
   Tsirou, A.
   Veckalns, V.
   Veres, G. I.
   Verweij, M.
   Wardle, N.
   Wohri, H. K.
   Zagozdzinska, A.
   Zeuner, W. D.
   Bertl, W.
   Deiters, K.
   Erdmann, W.
   Horisberger, R.
   Ingram, Q.
   Kaestli, H. C.
   Kotlinski, D.
   Langenegger, U.
   Rohe, T.
   Wiederkehr, S. A.
   Bachmair, F.
   Bani, L.
   Bianchini, L.
   Casal, B.
   Dissertori, G.
   Dittmar, M.
   Donega, M.
   Grab, C.
   Heidegger, C.
   Hits, D.
   Hoss, J.
   Kasieczka, G.
   Lustermann, W.
   Mangano, B.
   Marionneau, M.
   del Arbol, P. Martinez Ruiz
   Masciovecchio, M.
   Meinhard, M. T.
   Meister, D.
   Micheli, F.
   Musella, P.
   Nessi-Tedaldi, F.
   Pandolfi, F.
   Pata, J.
   Pauss, F.
   Perrin, G.
   Perrozzi, L.
   Quittnat, M.
   Rossini, M.
   Schonenberger, M.
   Starodumov, A.
   Tavolaro, V. R.
   Theofilatos, K.
   Wallny, R.
   Aarrestad, T. K.
   Amsler, C.
   Caminada, L.
   Canelli, M. F.
   De Cosa, A.
   Galloni, C.
   Hinzmann, A.
   Hreus, T.
   Kilminster, B.
   Ngadiuba, J.
   Pinna, D.
   Rauco, G.
   Robmann, P.
   Salerno, D.
   Seitz, C.
   Yang, Y.
   Zucchetta, A.
   Candelise, V.
   Doan, T. H.
   Jain, Sh.
   Khurana, R.
   Konyushikhin, M.
   Kuo, C. M.
   Lin, W.
   Pozdnyakov, A.
   Yu, S. S.
   Kumar, Arun
   Chang, P.
   Chang, Y. H.
   Chao, Y.
   Chen, K. F.
   Chen, P. H.
   Fiori, F.
   Hou, W. -S.
   Hsiung, Y.
   Liu, Y. F.
   Lu, R. -S.
   Moya, M. Minano
   Paganis, E.
   Psallidas, A.
   Tsai, J. F.
   Asavapibhop, B.
   Singh, G.
   Srimanobhas, N.
   Suwonjandee, N.
   Adiguzel, A.
   Damarseckin, S.
   Demiroglu, Z. S.
   Dozen, C.
   Eskut, E.
   Girgis, S.
   Gokbulut, G.
   Guler, Y.
   Hos, I.
   Kangal, E. E.
   Kara, O.
   Topaksu, A. Kayis
   Kiminsu, U.
   Oglakci, M.
   Onengut, G.
   Ozdemir, K.
   Ozturk, S.
   Polatoz, A.
   Tali, B.
   Turkcapar, S.
   Zorbakir, I. S.
   Zorbilmez, C.
   Bilin, B.
   Bilmis, S.
   Isildak, B.
   Karapinar, G.
   Yalvac, M.
   Zeyrek, M.
   Gulmez, E.
   Kaya, M.
   Kaya, O.
   Yetkin, E. A.
   Yetkin, T.
   Cakir, A.
   Cankocak, K.
   Sen, S.
   Grynyov, B.
   Levchuk, L.
   Sorokin, P.
   Aggleton, R.
   Ball, F.
   Beck, L.
   Brooke, J. J.
   Burns, D.
   Clement, E.
   Cussans, D.
   Flacher, H.
   Goldstein, J.
   Grimes, M.
   Heath, G. P.
   Heath, H. F.
   Jacob, J.
   Kreczko, L.
   Lucas, C.
   Newbold, D. M.
   Paramesvaran, S.
   Poll, A.
   Sakuma, T.
   El Nasr-Storey, S. Seif
   Smith, D.
   Smith, V. J.
   Bell, K. W.
   Belyaev, A.
   Brew, C.
   Brown, R. M.
   Calligaris, L.
   Cieri, D.
   Cockerill, D. J. A.
   Coughlan, J. A.
   Harder, K.
   Harper, S.
   Olaiya, E.
   Petyt, D.
   Shepherd-Themistocleous, C. H.
   Thea, A.
   Tomalin, I. R.
   Williams, T.
   Baber, M.
   Bainbridge, R.
   Buchmuller, O.
   Bundock, A.
   Burton, D.
   Casasso, S.
   Citron, M.
   Colling, D.
   Corpe, L.
   Dauncey, P.
   Davies, G.
   De Wit, A.
   Della Negra, M.
   Di Maria, R.
   Dunne, P.
   Elwood, A.
   Futyan, D.
   Haddad, Y.
   Hall, G.
   Iles, G.
   James, T.
   Lane, R.
   Laner, C.
   Lucas, R.
   Lyons, L.
   Magnan, A. -M.
   Malik, S.
   Mastrolorenzo, L.
   Nash, J.
   Nikitenko, A.
   Pela, J.
   Penning, B.
   Pesaresi, M.
   Raymond, D. M.
   Richards, A.
   Rose, A.
   Scott, E.
   Seez, C.
   Summers, S.
   Tapper, A.
   Uchida, K.
   Acosta, M. Vazquez
   Virdee, T.
   Wright, J.
   Zenz, S. C.
   Cole, J. E.
   Hobson, P. R.
   Khan, A.
   Kyberd, P.
   Reid, I. D.
   Symonds, P.
   Teodorescu, L.
   Turner, M.
   Borzou, A.
   Call, K.
   Dittmann, J.
   Hatakeyama, K.
   Liu, H.
   Pastika, N.
   Bartek, R.
   Dominguez, A.
   Buccilli, A.
   Cooper, S. I.
   Henderson, C.
   Rumerio, P.
   West, C.
   Arcaro, D.
   Avetisyan, A.
   Bose, T.
   Gastler, D.
   Rankin, D.
   Richardson, C.
   Rohlf, J.
   Sulak, L.
   Zou, D.
   Benelli, G.
   Cutts, D.
   Garabedian, A.
   Hakala, J.
   Heintz, U.
   Hogan, J. M.
   Jesus, O.
   Kwok, K. H. M.
   Laird, E.
   Landsberg, G.
   Mao, Z.
   Narain, M.
   Piperov, S.
   Sagir, S.
   Spencer, E.
   Syarif, R.
   Breedon, R.
   Burns, D.
   Sanchez, M. Calderon De la Barca
   Chauhan, S.
   Chertok, M.
   Conway, J.
   Conway, R.
   Cox, P. T.
   Erbacher, R.
   Flores, C.
   Funk, G.
   Gardner, M.
   Ko, W.
   Lander, R.
   Mclean, C.
   Mulhearn, M.
   Pellett, D.
   Pilot, J.
   Shalhout, S.
   Shi, M.
   Smith, J.
   Squires, M.
   Stolp, D.
   Tos, K.
   Tripathi, M.
   Bachtis, M.
   Bravo, C.
   Cousins, R.
   Dasgupta, A.
   Florent, A.
   Hauser, J.
   Ignatenko, M.
   Mccoll, N.
   Saltzberg, D.
   Schnaible, C.
   Valuev, V.
   Weber, M.
   Bouvier, E.
   Burt, K.
   Clare, R.
   Ellison, J.
   Gary, J. W.
   Shirazi, S. M. A. Ghiasi
   Hanson, G.
   Heilman, J.
   Jandir, P.
   Kennedy, E.
   Lacroix, F.
   Long, O. R.
   Negrete, M. Olmedo
   Paneva, M. I.
   Shrinivas, A.
   Si, W.
   Wei, H.
   Wimpenny, S.
   Yates, B. R.
   Branson, J. G.
   Cerati, G. B.
   Cittolin, S.
   Derdzinski, M.
   Gerosa, R.
   Holzner, A.
   Klein, D.
   Krutelyov, V.
   Letts, J.
   Macneill, I.
   Olivito, D.
   Padhi, S.
   Pieri, M.
   Sani, M.
   Sharma, V.
   Simon, S.
   Tadel, M.
   Vartak, A.
   Wasserbaech, S.
   Welke, C.
   Wood, J.
   Wuthwein, F.
   Yagil, A.
   Della Porta, G. Zevi
   Amin, N.
   Bhandari, R.
   Bradmiller-Feld, J.
   Campagnari, C.
   Dishaw, A.
   Dutta, V.
   Sevilla, M. Franco
   George, C.
   Golf, F.
   Gouskos, L.
   Gran, J.
   Heller, R.
   Incandela, J.
   Mullin, S. D.
   Ovcharova, A.
   Qu, H.
   Richman, J.
   Stuart, D.
   Suarez, I.
   Yoo, J.
   Anderson, D.
   Bendavid, J.
   Bornheim, A.
   Bunn, J.
   Duarte, J.
   Lawhorn, J. M.
   Mott, A.
   Newman, H. B.
   Pena, C.
   Spiropulu, M.
   Vlimant, J. R.
   Xie, S.
   Zhu, R. Y.
   Andrews, M. B.
   Ferguson, T.
   Paulini, M.
   Russ, J.
   Sun, M.
   Vogel, H.
   Vorobiev, I.
   Weinberg, M.
   Cumalat, J. P.
   Ford, W. T.
   Jensen, F.
   Johnson, A.
   Krohn, M.
   Leontsinis, S.
   Mulholland, T.
   Stenson, K.
   Wagner, S. R.
   Alexander, J.
   Chaves, J.
   Chu, J.
   Dittmer, S.
   Mcdermott, K.
   Mirman, N.
   Kaufman, G. Nicolas
   Patterson, J. R.
   Rinkevicius, A.
   Ryd, A.
   Skinnari, L.
   Soffi, L.
   Tan, S. M.
   Tao, Z.
   Thom, J.
   Tucker, J.
   Wittich, P.
   Zientek, M.
   Winn, D.
   Abdullin, S.
   Albrow, M.
   Apollinari, G.
   Apresyan, A.
   Banerjee, S.
   Bauerdick, L. A. T.
   Beretvas, A.
   Berryhill, J.
   Bhat, P. C.
   Bolla, G.
   Burkett, K.
   Butler, J. N.
   Cheung, H. W. K.
   Chlebana, F.
   Cihangir, S.
   Cremonesi, M.
   Elvira, V. D.
   Fisk, I.
   Freeman, J.
   Gottschalk, E.
   Gray, L.
   Green, D.
   Grunendahl, S.
   Gutsche, O.
   Hare, D.
   Harris, R. M.
   Hasegawa, S.
   Hirschauer, J.
   Hu, Z.
   Jayatilaka, B.
   Jindariani, S.
   Johnson, M.
   Joshi, U.
   Klima, B.
   Kreis, B.
   Lammel, S.
   Linacre, J.
   Lincoln, D.
   Lipton, R.
   Liu, M.
   Liu, T.
   De Sa, R. Lopes
   Lykken, J.
   Maeshima, K.
   Magini, N.
   Marraffino, J. M.
   Maruyama, S.
   Mason, D.
   McBride, P.
   Merkel, P.
   Mrenna, S.
   Nahn, S.
   O'Dell, V.
   Pedro, K.
   Prokofyev, O.
   Rakness, G.
   Ristori, L.
   Sexton-Kennedy, E.
   Soha, A.
   Spalding, W. J.
   Spiegel, L.
   Stoynev, S.
   Strait, J.
   Strobbe, N.
   Taylor, L.
   Tkaczyk, S.
   Tran, N. V.
   Uplegger, L.
   Vaandering, E. W.
   Vernieri, C.
   Verzocchi, M.
   Vidal, R.
   Wang, M.
   Weber, H. A.
   Whitbeck, A.
   Wu, Y.
   Acosta, D.
   Avery, P.
   Bortignon, P.
   Bourilkov, D.
   Brinkerhoff, A.
   Carnes, A.
   Carver, M.
   Curry, D.
   Das, S.
   Field, R. D.
   Furic, I. K.
   Konigsberg, J.
   Korytov, A.
   Low, J. F.
   Ma, P.
   Matchev, K.
   Mei, H.
   Mitselmakher, G.
   Rank, D.
   Shchutska, L.
   Sperka, D.
   Thomas, L.
   Wang, J.
   Wang, S.
   Yelton, J.
   Linn, S.
   Markowitz, P.
   Martinez, G.
   Rodriguez, J. L.
   Ackert, A.
   Adams, T.
   Askew, A.
   Bein, S.
   Hagopian, S.
   Hagopian, V.
   Johnson, K. F.
   Kolberg, T.
   Prosper, H.
   Santra, A.
   Yohay, R.
   Baarmand, M. M.
   Bhopatkar, V.
   Colafranceschi, S.
   Hohlmann, M.
   Noonan, D.
   Roy, T.
   Yumiceva, F.
   Adams, M. R.
   Apanasevich, L.
   Berry, D.
   Betts, R. R.
   Bucinskaite, I.
   Cavanaugh, R.
   Evdokimov, O.
   Gauthier, L.
   Gerber, C. E.
   Hofman, D. J.
   Jung, K.
   Gonzalez, I. D. Sandoval
   Varelas, N.
   Wang, H.
   Wu, Z.
   Zakaria, M.
   Zhang, J.
   Bilki, B.
   Clarida, W.
   Dilsiz, K.
   Durgut, S.
   Gandrajula, R. P.
   Haytmyradov, M.
   Khristenko, V.
   Merlo, J. -P.
   Mermerkaya, H.
   Mestvirishvili, A.
   Moeller, A.
   Nachtman, J.
   Ogul, H.
   Onel, Y.
   Ozok, F.
   Penzo, A.
   Snyder, C.
   Tiras, E.
   Wetzel, J.
   Yi, K.
   Blumenfeld, B.
   Cocoros, A.
   Eminizer, N.
   Fehling, D.
   Feng, L.
   Gritsan, A. V.
   Maksimovic, P.
   Roskes, J.
   Sarica, U.
   Swartz, M.
   Xiao, M.
   You, C.
   Al-bataineh, A.
   Baringer, P.
   Bean, A.
   Boren, S.
   Bowen, J.
   Castle, J.
   Forthomme, L.
   Kenny, R. P., III
   Khalil, S.
   Kropivnitskaya, A.
   Majumder, D.
   Mcbrayer, W.
   Murray, M.
   Sanders, S.
   Stringer, R.
   Takaki, J. D. Tapia
   Wang, Q.
   Ivanov, A.
   Kaadze, K.
   Maravin, Y.
   Mohammadi, A.
   Saini, L. K.
   Skhirtladze, N.
   Toda, S.
   Rebassoo, F.
   Wright, D.
   Anelli, C.
   Baden, A.
   Baron, O.
   Belloni, A.
   Calvert, B.
   Eno, S. C.
   Ferraioli, C.
   Gomez, J. A.
   Hadley, N. J.
   Jabeen, S.
   Jeng, G. Y.
   Kellogg, R. G.
   Kunkle, J.
   Mignerey, A. C.
   Ricci-Tam, F.
   Shin, Y. H.
   Skuja, A.
   Tonjes, M. B.
   Tonwar, S. C.
   Abercrombie, D.
   Allen, B.
   Apyan, A.
   Azzolini, V.
   Barbieri, R.
   Baty, A.
   Bi, R.
   Bierwagen, K.
   Brandt, S.
   Busza, W.
   Cali, I. A.
   D'Alfonso, M.
   Demiragli, Z.
   Ceballos, G. Gomez
   Goncharov, M.
   Hsu, D.
   Iiyama, Y.
   Innocenti, G. M.
   Klute, M.
   Kovalskyi, D.
   Krajczar, K.
   Lai, Y. S.
   Lee, Y. -J.
   Levin, A.
   Luckey, P. D.
   Maier, B.
   Marini, A. C.
   Mcginn, C.
   Mironov, C.
   Narayanan, S.
   Niu, X.
   Paus, C.
   Roland, C.
   Roland, G.
   Salfeld-Nebgen, J.
   Stephans, G. S. F.
   Tatar, K.
   Velicanu, D.
   Wang, J.
   Wang, T. W.
   Wyslouch, B.
   Benvenuti, A. C.
   Chatterjee, R. M.
   Evans, A.
   Hansen, P.
   Kalafut, S.
   Kao, S. C.
   Kubota, Y.
   Lesko, Z.
   Mans, J.
   Nourbakhsh, S.
   Ruckstuhl, N.
   Rusack, R.
   Tambe, N.
   Turkewitz, J.
   Acosta, J. G.
   Oliveros, S.
   Avdeeva, E.
   Bloom, K.
   Claes, D. R.
   Fangmeier, C.
   Suarez, R. Gonzalez
   Kamalieddin, R.
   Kravchenko, I.
   Rodrigues, A. Malta
   Monroy, J.
   Siado, J. E.
   Snow, G. R.
   Stieger, B.
   Alyari, M.
   Dolen, J.
   Godshalk, A.
   Harrington, C.
   Iashvili, I.
   Kaisen, J.
   Nguyen, D.
   Parker, A.
   Rappoccio, S.
   Roozbahani, B.
   Alverson, G.
   Barberis, E.
   Hortiangtham, A.
   Massironi, A.
   Morse, D. M.
   Nash, D.
   Orimoto, T.
   De Lima, R. Teixeira
   Trocino, D.
   Wang, R. -J.
   Wood, D.
   Bhattacharya, S.
   Charaf, O.
   Hahn, K. A.
   Kumar, A.
   Mucia, N.
   Odell, N.
   Pollack, B.
   Schmitt, M. H.
   Sung, K.
   Trovato, M.
   Velasco, M.
   Dev, N.
   Hildreth, M.
   Anampa, K. Hurtado
   Jessop, C.
   Karmgard, D. J.
   Kellams, N.
   Lannon, K.
   Marinelli, N.
   Meng, F.
   Mueller, C.
   Musienko, Y.
   Planer, M.
   Reinsvold, A.
   Ruchti, R.
   Rupprecht, N.
   Smith, G.
   Taroni, S.
   Wayne, M.
   Wolf, M.
   Woodard, A.
   Alimena, J.
   Antonelli, L.
   Bylsma, B.
   Durkin, L. S.
   Flowers, S.
   Francis, B.
   Hart, A.
   Hill, C.
   Hughes, R.
   Ji, W.
   Liu, B.
   Luo, W.
   Puigh, D.
   Winer, B. L.
   Wulsin, H. W.
   Cooperstein, S.
   Driga, O.
   Elmer, P.
   Hardenbrook, J.
   Hebda, P.
   Lange, D.
   Luo, J.
   Marlow, D.
   Medvedeva, T.
   Mei, K.
   Ojalvo, I.
   Olsen, J.
   Palmer, C.
   Piroue, P.
   Stickland, D.
   Svyatkovskiy, A.
   Tully, C.
   Malik, S.
   Barker, A.
   Barnes, V. E.
   Folgueras, S.
   Gutay, L.
   Jha, M. K.
   Jones, M.
   Jung, A. W.
   Khatiwada, A.
   Miller, D. H.
   Neumeister, N.
   Schulte, J. F.
   Shi, X.
   Sun, J.
   Wang, F.
   Xie, W.
   Parashar, N.
   Stupak, J.
   Adair, A.
   Akgun, B.
   Chen, Z.
   Ecklund, K. M.
   Geurts, F. J. M.
   Guilbaud, M.
   Li, W.
   Michlin, B.
   Northup, M.
   Padley, B. P.
   Roberts, J.
   Rorie, J.
   Tu, Z.
   Zabel, J.
   Betchart, B.
   Bodek, A.
   de Barbaro, P.
   Demina, R.
   Duh, Y. T.
   Ferbel, T.
   Galanti, M.
   Garcia-Bellido, A.
   Han, J.
   Hindrichs, O.
   Khukhunaishvili, A.
   Lo, K. H.
   Tan, P.
   Verzetti, M.
   Agapitos, A.
   Chou, J. P.
   Gershtein, Y.
   Espinosa, T. A. Gomez
   Halkiadakis, E.
   Heindl, M.
   Hughes, E.
   Kaplan, S.
   Elayavalli, R. Kunnawalkam
   Kyriacou, S.
   Lath, A.
   Nash, K.
   Osherson, M.
   Saka, H.
   Salur, S.
   Schnetzer, S.
   Sheffield, D.
   Somalwar, S.
   Stone, R.
   Thomas, S.
   Thomassen, P.
   Walker, M.
   Delannoy, A. G.
   Foerster, M.
   Heideman, J.
   Riley, G.
   Rose, K.
   Spanier, S.
   Thapa, K.
   Bouhali, O.
   Celik, A.
   Dalchenko, M.
   De Mattia, M.
   Delgado, A.
   Dildick, S.
   Eusebi, R.
   Gilmore, J.
   Huang, T.
   Juska, E.
   Kamon, T.
   Mueller, R.
   Pakhotin, Y.
   Patel, R.
   Perloff, A.
   Pernie, L.
   Rathjens, D.
   Safonov, A.
   Tatarinov, A.
   Ulmer, K. A.
   Akchurin, N.
   Cowden, C.
   Damgov, J.
   De Guio, F.
   Dragoiu, C.
   Dudero, P. R.
   Faulkner, J.
   Gurpinar, E.
   Kunori, S.
   Lamichhane, K.
   Lee, S. W.
   Libeiro, T.
   Peltola, T.
   Undleeb, S.
   Volobouev, I.
   Wang, Z.
   Greene, S.
   Gurrola, A.
   Janjam, R.
   Johns, W.
   Maguire, C.
   Melo, A.
   Ni, H.
   Sheldon, P.
   Tuo, S.
   Velkovska, J.
   Xu, Q.
   Arenton, M. W.
   Barria, P.
   Cox, B.
   Goodell, J.
   Hirosky, R.
   Ledovskoy, A.
   Li, H.
   Neu, C.
   Sinthuprasith, T.
   Sun, X.
   Wang, Y.
   Wolfe, E.
   Xia, F.
   Clarke, C.
   Harr, R.
   Karchin, P. E.
   Sturdy, J.
   Belknap, D. A.
   Buchanan, J.
   Caillol, C.
   Dasu, S.
   Dodd, L.
   Duric, S.
   Gomber, B.
   Grothe, M.
   Herndon, M.
   Herve, A.
   Klabbers, P.
   Lanaro, A.
   Levine, A.
   Long, K.
   Loveless, R.
   Perry, T.
   Pierro, G. A.
   Polese, G.
   Ruggles, T.
   Savin, A.
   Smith, N.
   Smith, W. H.
   Taylor, D.
   Woods, N.
CA CMS Collaboration
TI Measurement of the top quark mass using single top quark events in
   proton-proton collisions at root s=8 TeV
SO EUROPEAN PHYSICAL JOURNAL C
LA English
DT Article
AB A measurement of the top quark mass is reported in events containing a single top quark produced via the electroweak t channel. The analysis is performed using data from proton-proton collisions collected with the CMS detector at the LHC at a centre-of-mass energy of 8 TeV, corresponding to an integrated luminosity of 19.7 fb(-1). Top quark candidates are reconstructed from their decay to a W boson and a b quark, with the W boson decaying leptonically to a muon and a neutrino. The final state signature and kinematic properties of single top quark events in the t channel are used to enhance the purity of the sample, suppressing the contribution from top quark pair production. A fit to the invariant mass distribution of reconstructed top quark candidates yields a value of the top quark mass of 172.95 +/- 0.77 (stat)(-0.93)(+0.97) (syst) GeV. This result is in agreement with the current world average, and represents the first measurement of the top quark mass in event topologies not dominated by top quark pair production, therefore contributing to future averages with partially uncorrelated systematic uncertainties and a largely uncorrelated statistical uncertainty.
C1 [CMS Collaboration] CERN, CH-1211 Geneva 23, Switzerland.
   [Sirunyan, A. M.; Tumasyan, A.] Yerevan Phys Inst, Yerevan, Armenia.
   [Adam, W.; Asilar, E.; Bergauer, T.; Brandstetter, J.; Brondolin, E.; Dragicevic, M.; Eroe, J.; Flechl, M.; Friedl, M.; Fruehwirth, R.; Ghete, V. M.; Hartl, C.; Hoermann, N.; Hrubec, J.; Jeitler, M.; Koenig, A.; Kraetschmer, I.; Liko, D.; Matsushita, T.; Mikulec, I.; Rabady, D.; Rad, N.; Rahbaran, B.; Rohringer, H.; Schieck, J.; Strauss, J.; Waltenberger, W.; Wulz, C. -E.] Inst Hochenergiephys, Vienna, Austria.
   [Dvornikov, O.; Makarenko, V.; Mossolov, V.; Gonzalez, J. Suarez; Zykunov, V.] Inst Nucl Problems, Minsk, Byelarus.
   [Shumeiko, N.] Natl Ctr Particle & High Energy Phys, Minsk, Byelarus.
   [Alderweireldt, S.; De Wolf, E. A.; Janssen, X.; Lauwers, J.; Van de Klundert, M.; Van Haevermaet, H.; Van Mechelen, P.; Van Remortel, N.; Van Spilbeeck, A.] Univ Antwerp, Antwerp, Belgium.
   [Abu Zeid, S.; Blekman, F.; D'Hondt, J.; Daci, N.; De Bruyn, I.; Deroover, K.; Lowette, S.; Moortgat, S.; Moreels, L.; Olbrechts, A.; Python, Q.; Skovpen, K.; Tavernier, S.; Van Doninck, W.; Van Mulders, P.; Van Parijs, I.] Vrije Univ Brussel, Brussels, Belgium.
   [Brun, H.; Clerbaux, B.; De Lentdecker, G.; Delannoy, H.; Fasanella, G.; Favart, L.; Goldouzian, R.; Grebenyuk, A.; Karapostoli, G.; Lenzi, T.; Leonard, A.; Luetic, J.; Maerschalk, T.; Marinov, A.; Randle-Conde, A.; Seva, T.; Vander Velde, C.; Vanlaer, P.; Vannerom, D.; Yonamine, R.; Zenoni, F.; Zhang, F.; Fang, W.] Univ Libre Bruxelles, Brussels, Belgium.
   [Cimmino, A.; Cornelis, T.; Dobur, D.; Fagot, A.; Gul, M.; Khvastunov, I.; Poyraz, D.; Salva, S.; Schofbeck, R.; Tytgat, M.; Van Driessche, W.; Yazgan, E.; Zaganidis, N.] Univ Ghent, Ghent, Belgium.
   [Bakhshiansohi, H.; Beluffi, C.; Bondu, O.; Brochet, S.; Bruno, G.; Caudron, A.; De Visscher, S.; Delaere, C.; Delcourt, M.; Francois, B.; Giammanco, A.; Jafari, A.; Komm, M.; Krintiras, G.; Lemaitre, V.; Magitteri, A.; Mertens, A.; Musich, M.; Piotrzkowski, K.; Quertenmont, L.; Selvaggi, M.; Marono, M. Vidal; Wertz, S.] Catholic Univ Louvain, Louvain La Neuve, Belgium.
   [Beliy, N.] Univ Mons, Mons, Belgium.
   [Alda Junior, W. L.; Alves, F. L.; Alves, G. A.; Brito, L.; Hensel, C.; Moraes, A.; Pol, M. E.; Rebello Teles, P.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil.
   [Belchior Batista Das Chagas, E.; Carvalho, W.; Chinellato, J.; Custodio, A.; Da Costa, E. M.; Da Silveira, G. G.; De Jesus Damiao, D.; De Oliveira Martins, C.; Fonseca De Souza, S.; Huertas Guativa, L. M.; Malbouisson, H.; Matos Figueiredo, D.; Mora Herrera, C.; Mundim, L.; Nogima, H.; Prado Da Silva, W. L.; Santoro, A.; Sznajder, A.; Tonelli Manganote, E. J.; Torres Da Silva De Araujo, F.; Vilela Pereira, A.] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Ahuja, S.; Bernardes, C. A.; Dogra, S.; Fernandez Perez Tomei, T. R.; Moon, C. S.; Novaes, S. F.; Padula, Sandra S.; Ruiz Vargas, J. C.] Univ Estadual Paulista, Sao Paulo, Brazil.
   [Gregores, E. M.; Mercadante, P. G.; Romero Abad, D.] Univ Fed ABC, Sao Paulo, Brazil.
   [Aleksandrov, A.; Hadjiiska, R.; Iaydjiev, P.; Rodozov, M.; Stoykova, S.; Sultanov, G.; Vutova, M.] Inst Nucl Energy Res, Sofia, Bulgaria.
   [Glushkov, I.; Litov, L.; Pavlov, B.; Petkov, P.] Univ Sofia, Sofia, Bulgaria.
   [Fang, W.] Beihang Univ, Beijing, Peoples R China.
   [Ahmad, M.; Bian, J. G.; Chen, G. M.; Chen, H. S.; Chen, M.; Chen, Y.; Cheng, T.; Jiang, C. H.; Leggat, D.; Liu, Z.; Romeo, F.; Ruan, M.; Shaheen, S. M.; Spiezia, A.; Tao, J.; Wang, C.; Wang, Z.; Zhang, H.; Zhao, J.] Inst High Energy Phys, Beijing, Peoples R China.
   [Zhang, F.; Ban, Y.; Chen, G.; Li, Q.; Liu, S.; Mao, Y.; Qian, S. J.; Wang, D.; Xu, Z.] Peking Univ, State Key Lab Nucl Phys & Technol, Beijing, Peoples R China.
   [Avila, C.; Cabrera, A.; Chaparro Sierra, L. F.; Florez, C.; Gomez, J. P.; Gonzalez Hernandez, C. F.; Ruiz Alvarez, J. D.; Sanabria, J. C.] Univ Los Andes, Bogota, Colombia.
   [Godinovic, N.; Lelas, D.; Puljak, I.; Cipriano, P. M. Ribeiro; Sculac, T.] Univ Split, Fac Elect Engn Mech Engn & Naval Architecture, Split, Croatia.
   [Antunovic, Z.; Kovac, M.] Univ Split, Fac Sci, Split, Croatia.
   [Brigljevic, V.; Ferencek, D.; Kadija, K.; Mesic, B.; Susa, T.] Inst Rudjer Boskov, Zagreb, Croatia.
   [Attikis, A.; Mavromanolakis, G.; Mousa, J.; Nicolaou, C.; Ptochos, F.; Razis, P. A.; Rykaczewski, H.; Tsiakkouri, D.] Univ Cyprus, Nicosia, Cyprus.
   [Finger, M.; Finger, M., Jr.] Charles Univ Prague, Prague, Czech Republic.
   [Carrera Jarrin, E.] Univ San Francisco Quito, Quito, Ecuador.
   [El-khateeb, E.; Elgammal, S.; Mohamed, A.] Egyptian Network High Energy Phys, Acad Sci Res & Technol Arab Republ Egypt, Cairo, Egypt.
   [Kadastik, M.; Perrini, L.; Raidal, M.; Tiko, A.; Veelken, C.] NICPB, Tallinn, Estonia.
   [Eerola, P.; Pekkanen, J.; Voutilainen, M.] Univ Helsinki, Dept Phys, Helsinki, Finland.
   [Voutilainen, M.; Harkonen, J.; Jarvinen, T.; Karimaki, V.; Kinnunen, R.; Lampen, T.; Lassila-Perini, K.; Lehti, S.; Linden, T.; Luukka, P.; Tuominiemi, J.; Tuovinen, E.; Wendland, L.] Helsinki Inst Phys, Helsinki, Finland.
   [Talvitie, J.; Tuuva, T.] Lappeenranta Univ Technol, Lappeenranta, Finland.
   [Besancon, M.; Couderc, F.; Dejardin, M.; Denegri, D.; Fabbro, B.; Faure, J. L.; Favaro, C.; Ferri, F.; Ganjour, S.; Ghosh, S.; Givernaud, A.; Gras, P.; de Monchenault, G. Hamel; Jarry, P.; Kucher, I.; Locci, E.; Machet, M.; Malcles, J.; Rander, J.; Rosowsky, A.; Titov, M.] Univ Paris Saclay, CEA, IRFU, Gif Sur Yvette, France.
   [Abdulsalam, A.; Antropov, I.; Baffioni, S.; Beaudette, F.; Busson, P.; Cadamuro, L.; Chapon, E.; Charlot, C.; Davignon, O.; de Cassagnac, R. Granier; Jo, M.; Lisniak, S.; Mine, P.; Nguyen, M.; Ochando, C.; Ortona, G.; Paganini, P.; Pigard, P.; Regnard, S.; Salerno, R.; Sirois, Y.; Leiton, A. G. Stahl; Strebler, T.; Yilmaz, Y.; Zabi, A.; Zghiche, A.] IN2P3 CNRS, Ecole Polytech, Lab Leprince Ringuet, Palaiseau, France.
   [Beluffi, C.; Agram, J. -L.; Andrea, J.; Aubin, A.; Bloch, D.; Brom, J. -M.; Buttignol, M.; Chabert, E. C.; Chanon, N.; Collard, C.; Conte, E.; Coubez, X.; Fontaine, J. -C.; Gele, D.; Goerlach, U.; Le Bihan, A. -C.; Van Hove, P.] Univ Strasbourg, CNRS IN2P3, IPHC, Strasbourg, France.
   [Gadrat, S.] CNRS IN2P3, Ctr Calcul, Inst Natl Phys Nucl & Phys Particules, Villeurbanne, France.
   [Beauceron, S.; Bernet, C.; Boudoul, G.; Montoya, C. A. Carrillo; Chierici, R.; Contardo, D.; Courbon, B.; Depasse, P.; El Mamouni, H.; Fay, J.; Gascon, S.; Gouzevitch, M.; Grenier, G.; Ille, B.; Lagarde, F.; Laktineh, I. B.; Lethuillier, M.; Mirabito, L.; Pequegnot, A. L.; Perries, S.; Popov, A.; Sabes, D.; Sordini, V.; Donckt, M. Vander; Verdier, P.; Viret, S.] Univ Claude Bernard Lyon 1, CNRS IN2P3, Inst Phys Nucl Lyon, Villeurbanne, France.
   [Khvedelidze, A.] Georgian Tech Univ, Tbilisi, Rep of Georgia.
   [Tsamalaidze, Z.] Tbilisi State Univ, Tbilisi, Rep of Georgia.
   [Autermann, C.; Beranek, S.; Feld, L.; Kiesel, M. K.; Klein, K.; Lipinski, M.; Preuten, M.; Schomakers, C.; Schulz, J.; Verlage, T.] Rhein Westfal TH Aachen, Phys Inst 1, Aachen, Germany.
   [Albert, A.; Brodski, M.; Dietz-Laursonn, E.; Duchardt, D.; Endres, M.; Erdmann, M.; Erdweg, S.; Esch, T.; Fischer, R.; Gueth, A.; Hamer, M.; Hebbeker, T.; Heidemann, C.; Hoepfner, K.; Knutzen, S.; Merschmeyer, M.; Meyer, A.; Millet, P.; Mukherjee, S.; Olschewski, M.; Padeken, K.; Pook, T.; Radziej, M.; Reithler, H.; Rieger, M.; Scheuch, F.; Sonnenschein, L.; Teyssier, D.; Thueer, S.; Borras, K.] Rhein Westfal TH Aachen, Phys Inst A 3, Aachen, Germany.
   [Cherepanov, V.; Fluegge, G.; Kargoll, B.; Kress, T.; Kuensken, A.; Lingemann, J.; Mueller, T.; Nehrkorn, A.; Nowack, A.; Pistone, C.; Pooth, O.; Stahl, A.] Rhein Westfal TH Aachen, Phys Inst B 3, Aachen, Germany.
   [Chen, G. M.; Chen, Y.; Martin, M. Aldaya; Arndt, T.; Asawatangtrakuldee, C.; Beernaert, K.; Behnke, O.; Behrens, U.; Bin Anuar, A. A.; Borras, K.; Campbell, A.; Connor, P.; Contreras-Campana, C.; Costanza, F.; Pardos, C. Diez; Dolinska, G.; Eckerlin, G.; Eckstein, D.; Eichhorn, T.; Eren, E.; Gallo, E.; Garcia, J. Garay; Geiser, A.; Gizhko, A.; Luyando, J. M. Grados; Grohsjean, A.; Gunnellini, P.; Harb, A.; Hauk, J.; Hempel, M.; Jung, H.; Kalogeropoulos, A.; Karacheban, O.; Kasemann, M.; Keaveney, J.; Kleinwort, C.; Korol, I.; Kruecker, D.; Lange, W.; Lelek, A.; Lenz, T.; Leonard, J.; Lipka, K.; Lobanov, A.; Lohmann, W.; Mankel, R.; Melzer-Pellmann, I. -A.; Meyer, A. B.; Mittag, G.; Mnich, J.; Mussgiller, A.; Pitzl, D.; Placakyte, R.; Raspereza, A.; Roland, B.; Sahin, M. Oe.; Saxena, P.; Schoerner-Sadenius, T.; Spannagel, S.; Stefaniuk, N.; Van Onsem, G. P.; Walsh, R.; Wissing, C.] DESY, Hamburg, Germany.
   [Gallo, E.; Roland, B.; Blobel, V.; Vignali, M. Centis; Draeger, A. R.; Dreyer, T.; Garutti, E.; Gonzalez, D.; Haller, J.; Hoffmann, M.; Junkes, A.; Klanner, R.; Kogler, R.; Kovalchuk, N.; Lapsien, T.; Marchesini, I.; Marconi, D.; Meyer, M.; Niedziela, M.; Nowatschin, D.; Pantaleo, F.; Peiffer, T.; Perieanu, A.; Scharf, C.; Schleper, P.; Schmidt, A.; Schumann, S.; Schwandt, J.; Stadie, H.; Steinbrueck, G.; Stober, F. M.; Stoever, M.; Tholen, H.; Troendle, D.; Usai, E.; Vanelderen, L.; Vanhoefer, A.; Vormwald, B.] Univ Hamburg, Hamburg, Germany.
   [Roland, B.; Akbiyik, M.; Barth, C.; Baur, S.; Baus, C.; Berger, J.; Butz, E.; Caspart, R.; Chwalek, T.; Colombo, F.; De Boer, W.; Dierlamm, A.; Fink, S.; Freund, B.; Friese, R.; Giffels, M.; Gilbert, A.; Goldenzweig, P.; Haitz, D.; Hartmann, F.; Heindl, S. M.; Husemann, U.; Katkov, I.; Kudella, S.; Mildner, H.; Mozer, M. U.; Mueller, Th.; Plagge, M.; Quast, G.; Rabbertz, K.; Roecker, S.; Roscher, F.; Schroeder, M.; Shvetsov, I.; Sieber, G.; Simonis, H. J.; Ulrich, R.; Wayand, S.; Weber, M.; Weiler, T.; Williamson, S.; Woehrmann, C.; Wolf, R.] Inst Expt Kernphys, Karlsruhe, Germany.
   [Anagnostou, G.; Daskalakis, G.; Geralis, T.; Giakoumopoulou, V. A.; Kyriakis, A.; Loukas, D.; Topsis-Giotis, I.] NCSR Demokritos, INPP, Aghia Paraskevi, Greece.
   [Kesisoglou, S.; Panagiotou, A.; Saoulidou, N.; Tziaferi, E.; Sphicas, P.] Univ Athens, Athens, Greece.
   [Evangelou, I.; Flouris, G.; Foudas, C.; Kokkas, P.; Loukas, N.; Manthos, N.; Papadopoulos, I.; Paradas, E.] Univ Ioannina, Ioannina, Greece.
   [Filipovic, N.; Pasztor, G.; Vesztergombi, G.; Bartok, M.; Veres, G. I.] Eotvos Lorand Univ, MTA ELTE Lendulet CMS Particle & Nucl Phys Grp, Budapest, Hungary.
   [Bencze, G.; Hajdu, C.; Horvath, D.; Sikler, F.; Veszpremi, V.; Vesztergombi, G.; Zsigmond, A. J.] Wigner Res Ctr Phys, Budapest, Hungary.
   [Horvath, D.; Beni, N.; Czellar, S.; Karancsi, J.; Makovec, A.; Molnar, J.; Szillasi, Z.] Inst Nucl Res ATOMKI, Debrecen, Hungary.
   [Karancsi, J.; Bartok, M.; Raics, P.; Trocsanyi, Z. L.; Ujvari, B.] Univ Debrecen, Inst Phys, Debrecen, Hungary.
   [Komaragiri, J. R.] Indian Inst Sci IISc, Bangalore, Karnataka, India.
   [Bahinipati, S.; Bhowmik, S.; Choudhury, S.; Mal, P.; Mandal, K.; Nayak, A.; Sahoo, D. K.; Sahoo, N.; Swain, S. K.] Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India.
   [Bansal, S.; Beri, S. B.; Bhatnagar, V.; Chawla, R.; Bhawandeep, U.; Kalsi, A. K.; Kaur, A.; Kaur, M.; Kumar, R.; Kumari, P.; Mehta, A.; Mittal, M.; Singh, J. B.; Walia, G.] Panjab Univ, Chandigarh, India.
   [Kumar, Ashok; Bhardwaj, A.; Choudhary, B. C.; Garg, R. B.; Keshri, S.; Malhotra, S.; Naimuddin, M.; Ranjan, K.; Sharma, R.; Sharma, V.] Univ Delhi, Delhi, India.
   [Bhattacharya, R.; Bhattacharya, S.; Chatterjee, K.; Dey, S.; Dutt, S.; Dutta, S.; Ghosh, S.; Majumdar, N.; Modak, A.; Mondal, K.; Mukhopadhyay, S.; Nandan, S.; Purohit, A.; Roy, A.; Roy, D.; Chowdhury, S. Roy; Sarkar, S.; Sharan, M.; Thakur, S.] Saha Inst Nucl Phys, Kolkata, India.
   [Behera, P. K.] Indian Inst Technol Madras, Madras, Tamil Nadu, India.
   [Chudasama, R.; Dutta, D.; Jha, V.; Kumar, V.; Mohanty, A. K.; Netrakanti, P. K.; Pant, L. M.; Shukla, P.; Topkar, A.] Bhabha Atom Res Ctr, Mumbai, Maharashtra, India.
   [Aziz, T.; Dugad, S.; Kole, G.; Mahakud, B.; Mitra, S.; Mohanty, G. B.; Parida, B.; Sur, N.; Sutar, B.] Tata Inst Fundamental Res A, Mumbai, Maharashtra, India.
   [Banerjee, S.; Dewanjee, R. K.; Ganguly, S.; Guchait, M.; Jain, Sa.; Kumar, S.; Maity, M.; Majumder, G.; Mazumdar, K.; Sarkar, T.; Wickramage, N.] Tata Inst Fundamental Res B, Mumbai, Maharashtra, India.
   [Chauhan, S.; Dube, S.; Hegde, V.; Kapoor, A.; Kothekar, K.; Pandey, S.; Rane, A.; Sharma, S.] IISER, Pune, Maharashtra, India.
   [Chenarani, S.; Tadavani, E. Eskandari; Etesami, S. M.; Khakzad, M.; Najafabadi, M. Mohammadi; Naseri, M.; Mehdiabadi, S. Paktinat; Hosseinabadi, F. Rezaei; Safarzadeh, B.; Zeinali, M.] Inst Res Fundamental Sci IPM, Tehran, Iran.
   [Felcini, M.; Grunewald, M.] Univ Coll Dublin, Dublin, Ireland.
   [Abbrescia, M.; Calabria, C.; Caputo, C.; Colaleo, A.; Creanza, D.; Cristella, L.; De Filippis, N.; De Palma, M.; Fiore, L.; Iaselli, G.; Maggi, G.; Maggi, M.; Miniello, G.; My, S.; Nuzzo, S.; Pompili, A.] INFN, Sez Bari, Bari, Italy.
   [Abbrescia, M.; Calabria, C.; Caputo, C.; De Palma, M.; Miniello, G.; My, S.; Nuzzo, S.; Pompili, A.] Univ Bari, Bari, Italy.
   [Creanza, D.; Cristella, L.; De Filippis, N.; Iaselli, G.; Maggi, G.] Politecn Bar, Bari, Italy.
   [Abbiendi, G.; Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Campanini, R.; Capiluppi, P.; Castro, A.; Cavallo, F. R.; Chhibra, S. S.; Codispoti, G.; Cuffiani, M.; Dallavalle, G. M.; Fabbri, F.; Fanfani, A.; Fasanella, D.; Giacomelli, P.; Grandi, C.; Guiducci, L.; Marcellini, S.; Masetti, G.; Montanari, A.; Navarria, F. L.; Perrotta, A.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Tosi, N.] INFN, Sez Bologna, Bologna, Italy.
   [Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Campanini, R.; Capiluppi, P.; Castro, A.; Chhibra, S. S.; Codispoti, G.; Cuffiani, M.; Fanfani, A.; Fasanella, D.; Guiducci, L.; Navarria, F. L.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Tosi, N.] Univ Bologna, Bologna, Italy.
   [Albergo, S.; Costa, S.; Di Mattia, A.; Giordano, F.; Potenza, R.; Tricomi, A.; Tuve, C.] INFN, Sez Catania, Catania, Italy.
   [Albergo, S.; Costa, S.; Giordano, F.; Potenza, R.; Tricomi, A.; Tuve, C.] Univ Catania, Catania, Italy.
   [Barbagli, G.; Ciulli, V.; Civinini, C.; D'Alessandro, R.; Focardi, E.; Lenzi, P.; Meschini, M.; Paoletti, S.; Russo, L.; Sguazzoni, G.; Strom, D.; Viliani, L.] INFN, Sez Firenze, Florence, Italy.
   [Ciulli, V.; D'Alessandro, R.; Focardi, E.; Lenzi, P.; Viliani, L.] Univ Florence, Florence, Italy.
   [Benussi, L.; Bianco, S.; Fabbri, F.; Piccolo, D.; Primavera, F.] INFN, Lab Nazl Frascati, Frascati, Italy.
   [Calvelli, V.; Ferro, F.; Monge, M. R.; Robutti, E.; Tosi, S.] INFN, Sez Genova, Genoa, Italy.
   [Calvelli, V.; Monge, M. R.; Tosi, S.] Univ Genoa, Genoa, Italy.
   [Brianza, L.; Brivio, F.; Dinardo, M. E.; Fiorendi, S.; Gennai, S.; Ghezzi, A.; Govoni, P.; Malberti, M.; Malvezzi, S.; Manzoni, R. A.; Menasce, D.; Moroni, L.; Paganoni, M.; Pedrini, D.; Pigazzini, S.; Ragazzi, S.; de Fatis, T. Tabarelli] INFN, Sez Milano Bicocca, Milan, Italy.
   [Brianza, L.; Brivio, F.; Dinardo, M. E.; Fiorendi, S.; Ghezzi, A.; Govoni, P.; Malberti, M.; Manzoni, R. A.; Paganoni, M.; Pigazzini, S.; Ragazzi, S.; de Fatis, T. Tabarelli] Univ Milano Bicocca, Milan, Italy.
   [Buontempo, S.; Cavallo, N.; Di Guida, S.; Esposito, M.; Fabozzi, F.; Fienga, F.; Iorio, A. O. M.; Lanza, G.; Lista, L.; Meola, S.; Paolucci, P.; Sciacca, C.; Thyssen, F.] INFN, Sez Napoli, Rome, Italy.
   [Esposito, M.; Fienga, F.; Iorio, A. O. M.; Meola, S.; Sciacca, C.] Univ Napoli Federico II, Naples, Italy.
   [Cavallo, N.; Fabozzi, F.] Univ Basilicata, Potenza, Italy.
   [Di Guida, S.] Univ G Marconi, Rome, Italy.
   [Azzi, P.; Bacchetta, N.; Benato, L.; Bisello, D.; Boletti, A.; Carlin, R.; De Oliveira, A. Carvalho Antunes; Checchia, P.; Dall'Osso, M.; Manzano, P. De Castro; Dorigo, T.; Dosselli, U.; Gasparini, F.; Gasparini, U.; Gozzelino, A.; Lacaprara, S.; Margoni, M.; Meneguzzo, A. T.; Pazzini, J.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Torassa, E.; Zanetti, M.; Zotto, P.; Zumerle, G.] INFN, Sez Padova, Trento, Italy.
   [Benato, L.; Bisello, D.; Boletti, A.; Carlin, R.; De Oliveira, A. Carvalho Antunes; Dall'Osso, M.; Gasparini, F.; Gasparini, U.; Margoni, M.; Meneguzzo, A. T.; Pazzini, J.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Zanetti, M.; Zotto, P.; Zumerle, G.] Univ Padua, Padua, Italy.
   Univ Trento, Trento, Italy.
   [Braghieri, A.; Fallavollita, F.; Magnani, A.; Montagna, P.; Ratti, S. P.; Re, V.; Riccardi, C.; Salvini, P.; Vai, I.; Vitulo, P.] INFN, Sez Pavia, Pavia, Italy.
   [Fallavollita, F.; Magnani, A.; Montagna, P.; Ratti, S. P.; Riccardi, C.; Vai, I.; Vitulo, P.] Univ Pavia, Pavia, Italy.
   [Solestizi, L. Alunni; Bilei, G. M.; Ciangottini, D.; Fano, L.; Lariccia, P.; Leonardi, R.; Mantovani, G.; Menichelli, M.; Saha, A.; Santocchia, A.] INFN, Sez Perugia, Perugia, Italy.
   [Solestizi, L. Alunni; Ciangottini, D.; Fano, L.; Lariccia, P.; Leonardi, R.; Mantovani, G.; Santocchia, A.] Univ Perugia, Perugia, Italy.
   [Androsov, K.; Azzurri, P.; Bagliesi, G.; Bernardini, J.; Boccali, T.; Castaldi, R.; Ciocci, M. A.; Dell'Orso, R.; Donato, S.; Giassi, A.; Grippo, M. T.; Ligabue, F.; Lomtadze, T.; Martini, L.; Messineo, A.; Palla, F.; Rizzi, A.; Savoy-Navarro, A.; Spagnolo, P.; Tenchini, R.; Tonelli, G.; Venturi, A.; Verdini, P. G.] INFN, Sez Pisa, Pisa, Italy.
   [Martini, L.; Messineo, A.; Rizzi, A.; Tonelli, G.; Cipriani, M.] Univ Pisa, Pisa, Italy.
   [Donato, S.; Ligabue, F.] Scuola Normale Super Pisa, Pisa, Italy.
   [Barone, L.; Cavallari, F.; Cipriani, M.; Del Re, D.; Diemoz, M.; Gelli, S.; Longo, E.; Margaroli, F.; Marzocchi, B.; Meridiani, P.; Organtini, G.; Paramatti, R.; Preiato, F.; Rahatlou, S.; Rovelli, C.; Santanastasio, F.; Di Marco, E.] INFN, Sez Roma, Rome, Italy.
   [Barone, L.; Del Re, D.; Gelli, S.; Longo, E.; Margaroli, F.; Marzocchi, B.; Organtini, G.; Preiato, F.; Rahatlou, S.; Santanastasio, F.; Di Marco, E.] Univ Roma, Rome, Italy.
   [Amapane, N.; Arcidiacono, R.; Argiro, S.; Arneodo, M.; Bartosik, N.; Bellan, R.; Biino, C.; Cartiglia, N.; Cenna, F.; Costa, M.; Covarelli, R.; Degano, A.; Demaria, N.; Finco, L.; Kiani, B.; Mariotti, C.; Maselli, S.; Migliore, E.; Monaco, V.; Monteil, E.; Monteno, M.; Obertino, M. M.; Pacher, L.; Pastrone, N.; Pelliccioni, M.; Angioni, G. L. Pinna; Ravera, F.; Romero, A.; Ruspa, M.; Sacchi, R.; Shchelina, K.; Sola, V.; Solano, A.; Staiano, A.; Traczyk, P.] INFN, Sez Torino, Turin, Italy.
   [Amapane, N.; Argiro, S.; Bellan, R.; Cenna, F.; Costa, M.; Covarelli, R.; Degano, A.; Finco, L.; Kiani, B.; Migliore, E.; Monaco, V.; Monteil, E.; Obertino, M. M.; Pacher, L.; Angioni, G. L. Pinna; Ravera, F.; Romero, A.; Sacchi, R.; Shchelina, K.; Solano, A.; Traczyk, P.] Univ Torino, Turin, Italy.
   [Arcidiacono, R.; Arneodo, M.; Ruspa, M.] Univ Piemonte Orientale, Novara, Italy.
   [Belforte, S.; Casarsa, M.; Cossutti, F.; Della Ricca, G.; Zanetti, A.] INFN, Sez Trieste, Trieste, Italy.
   [Della Ricca, G.] Univ Trieste, Trieste, Italy.
   [Kim, D. H.; Kim, G. N.; Kim, M. S.; Lee, S.; Lee, S. W.; Oh, Y. D.; Sekmen, S.; Son, D. C.; Yang, Y. C.; Kamon, T.] Kyungpook Natl Univ, Daegu, South Korea.
   [Lee, A.] Chonbuk Natl Univ, Jeonju, South Korea.
   [Kim, H.] Chonnam Natl Univ, Inst Universe & Elementary Particles, Kwangju, South Korea.
   [Cifuentes, J. A. Brochero; Kim, T. J.] Hanyang Univ, Seoul, South Korea.
   [Cho, S.; Choi, S.; Go, Y.; Gyun, D.; Ha, S.; Hong, B.; Jo, Y.; Kim, Y.; Lee, K.; Lee, K. S.; Lee, S.; Lim, J.; Park, S. K.; Roh, Y.] Korea Univ, Seoul, South Korea.
   [Almond, J.; Kim, J.; Lee, H.; Oh, S. B.; Radburn-Smith, B. C.; Seo, S. H.; Yang, U. K.; Yoo, H. D.; Yu, G. B.] Seoul Natl Univ, Seoul, South Korea.
   [Choi, M.; Kim, H.; Kim, J. H.; Lee, J. S. H.; Park, I. C.; Ryu, G.; Ryu, M. S.] Univ Seoul, Seoul, South Korea.
   [Choi, Y.; Goh, J.; Hwang, C.; Lee, J.; Yu, I.] Sungkyunkwan Univ, Suwon, South Korea.
   [Dudenas, V.; Juodagalvis, A.; Vaitkus, J.] Vilnius Univ, Vilnius, Lithuania.
   [Ahmed, I.; Ibrahim, Z. A.; Ali, M. A. B. Md; Idris, F. Mohamad; Abdullah, W. A. T. Wan; Yusli, M. N.; Zolkapli, Z.] Univ Malaya, Natl Ctr Particle Phys, Kuala Lumpur, Malaysia.
   [Castilla-Valdez, H.; De la Cruz-Burelo, E.; Heredia-De la Cruz, I.; Hernandez-Almada, A.; Lopez-Fernandez, R.; Magana Villalba, R.; Mejia Guisao, J.; Sanchez-Hernandez, A.] IPN, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico.
   [Carrillo Moreno, S.; Oropeza Barrera, C.; Vazquez Valencia, F.] Univ Iberoamer, Mexico City, DF, Mexico.
   [Carpinteyro, S.; Pedraza, I.; Salazar Ibarguen, H. A.; Uribe Estrada, C.] Benemerita Univ Autonoma Puebla, Puebla, Mexico.
   [Morelos Pineda, A.] Univ Autonoma San Luis Potosi, San Luis Potosi+, Mexico.
   [Krofcheck, D.] Univ Auckland, Auckland, New Zealand.
   [Butler, P. H.] Univ Canterbury, Christchurch, New Zealand.
   [Ahmad, A.; Ahmad, M.; Hassan, Q.; Hoorani, H. R.; Khan, W. A.; Saddique, A.; Shah, M. A.; Shoaib, M.; Waqas, M.] Quaid I Azam Univ, Natl Ctr Phys, Islamabad, Pakistan.
   [Bialkowska, H.; Bluj, M.; Boimska, B.; Frueboes, T.; Gorski, M.; Kazana, M.; Nawrocki, K.; Romanowska-Rybinska, K.; Szleper, M.; Zalewski, P.] Natl Ctr Nucl Res, Otwock, Poland.
   [Bunkowski, K.; Byszuk, A.; Doroba, K.; Kalinowski, A.; Konecki, M.; Krolikowski, J.; Misiura, M.; Olszewski, M.; Walczak, M.] Univ Warsaw, Inst Expt Phys, Fac Phys, Warsaw, Poland.
   [Bargassa, P.; Silva, C. Beirao Da Cruz E.; Calpas, B.; Di Francesco, A.; Faccioli, P.; Ferreira Parracho, P. G.; Gallinaro, M.; Hollar, J.; Leonardo, N.; Lloret Iglesias, L.; Nemallapudi, M. V.; Rodrigues Antunes, J.; Seixas, J.; Toldaiev, O.; Vadruccio, D.; Varela, J.] Lab Instrumentacao & Fis Expt Particulas, Lisbon, Portugal.
   [Finger, M.; Finger, M., Jr.; Khvedelidze, A.; Tsamalaidze, Z.; Afanasiev, S.; Bunin, P.; Gavrilenko, M.; Golutvin, I.; Gorbunov, I.; Kamenev, A.; Karjavin, V.; Lanev, A.; Malakhov, A.; Matveev, V.; Palichik, V.; Perelygin, V.; Shmatov, S.; Shulha, S.; Skatchkov, N.; Smirnov, V.; Voytishin, N.; Zarubin, A.] Joint Inst Nucl Res, Dubna, Russia.
   [Chtchipounov, L.; Golovtsov, V.; Ivanov, Y.; Kim, V.; Kuznetsova, E.; Murzin, V.; Oreshkin, V.; Sulimov, V.; Vorobyev, A.] Petersburg Nucl Phys Inst, St Petersburg, Russia.
   [Matveev, V.; Andreev, Yu.; Dermenev, A.; Gninenko, S.; Golubev, N.; Karneyeu, A.; Kirsanov, M.; Krasnikov, N.; Pashenkov, A.; Tlisov, D.; Toropin, A.; Musienko, Y.] Inst Nucl Res, Moscow, Russia.
   [Epshteyn, V.; Gavrilov, V.; Lychkovskaya, N.; Popov, V.; Pozdnyakov, I.; Safronov, G.; Spiridonov, A.; Toms, M.; Vlasov, E.; Zhokin, A.; Starodumov, A.; Nikitenko, A.] Inst Theoret & Expt Phys, Moscow, Russia.
   [Aushev, T.; Bylinkin, A.] Moscow Inst Phys & Technol, Moscow, Russia.
   [Matveev, V.; Bylinkin, A.; Danilov, M.; Popova, E.; Rusinov, V.; Azarkin, M.; Dremin, I.; Leonidov, A.] Natl Res Nucl Univ, Moscow Engn Phys Inst MEPhI, Moscow, Russia.
   [Danilov, M.; Andreev, V.; Azarkin, M.; Dremin, I.; Kirakosyan, M.; Leonidov, A.; Terkulov, A.] PN Lebedev Phys Inst, Moscow, Russia.
   [Popov, A.; Katkov, I.; Baskakov, A.; Belyaev, A.; Boos, E.; Bunichev, V.; Dubinin, M.; Dudko, L.; Klyukhin, V.; Kodolova, O.; Korneeva, N.; Lokhtin, I.; Miagkov, I.; Obraztsov, S.; Perfilov, M.; Savrin, V.; Volkov, P.] Lomonosov Moscow State Univ, Skobeltsyn Inst Nucl Phys, Moscow, Russia.
   [Blinov, V.; Skovpen, Y.; Shtol, D.] NSU, Novosibirsk, Russia.
   [Azhgirey, I.; Bayshev, I.; Bitioukov, S.; Elumakhov, D.; Kachanov, V.; Kalinin, A.; Konstantinov, D.; Krychkine, V.; Petrov, V.; Ryutin, R.; Sobol, A.; Troshin, S.; Tyurin, N.; Uzunian, A.; Volkov, A.] Inst High Energy Phys, State Res Ctr Russian Federat, Protvino, Russia.
   [Adzic, P.; Cirkovic, P.; Devetak, D.; Dordevic, M.; Milosevic, J.; Rekovic, V.; Milenovic, P.] Univ Belgrade, Fac Phys, Belgrade, Serbia.
   [Adzic, P.; Cirkovic, P.; Devetak, D.; Dordevic, M.; Milosevic, J.; Rekovic, V.; Milenovic, P.] Vinca Inst Nucl Sci, Belgrade, Serbia.
   [Alcaraz Maestre, J.; Barrio Luna, M.; Calvo, E.; Cerrada, M.; Chamizo Llatas, M.; Colino, N.; De la Cruz, B.; Delgado Peris, A.; Escalante Del Valle, A.; Fernandez Bedoya, C.; Fernandez Ramos, J. P.; Flix, J.; Fouz, M. C.; Garcia-Abia, P.; Gonzalez Lopez, O.; Goy Lopez, S.; Hernandez, J. M.; Josa, M. I.; Navarro De Martino, E.; Perez-Calero Yzquierdo, A.; Puerta Pelayo, J.; Quintario Olmeda, A.; Redondo, I.; Romero, L.; Soares, M. S.] Ctr Invest Energet Medioambientales & Tecnol CIEM, Madrid, Spain.
   [de Troconiz, J. F.; Missiroli, M.; Moran, D.] Univ Autonoma Madrid, Madrid, Spain.
   [Cuevas, J.; Fernandez Menendez, J.; Gonzalez Caballero, I.; Gonzalez Fernandez, J. R.; Palencia Cortezon, E.; Sanchez Cruz, S.; Suarez Andres, I.; Vischia, P.; Vizan Garcia, J. M.] Univ Oviedo, Oviedo, Spain.
   [Cabrillo, I. J.; Calderon, A.; Curras, E.; Fernandez, M.; Garcia-Ferrero, J.; Gomez, G.; Lopez Virto, A.; Marco, J.; Martinez Rivero, C.; Matorras, F.; Piedra Gomez, J.; Rodrigo, T.; Ruiz-Jimeno, A.; Scodellaro, L.; Trevisani, N.; Vila, I.; Vilar Cortabitarte, R.] Univ Cantabria, CSIC, IFCA, Santander, Spain.
   [Stahl, A.; Pantaleo, F.; Hartmann, F.; Mohanty, A. K.; Tosi, N.; Viliani, L.; Primavera, F.; Brianza, L.; Fiorendi, S.; Di Guida, S.; Meola, S.; Paolucci, P.; Azzi, P.; Azzurri, P.; Del Re, D.; Arcidiacono, R.; Abbaneo, D.; Auffray, E.; Auzinger, G.; Baillon, P.; Ball, A. H.; Barney, D.; Bloch, P.; Bocci, A.; Botta, C.; Camporesi, T.; Castello, R.; Cepeda, M.; Cerminara, G.; d'Enterria, D.; Dabrowski, A.; Daponte, V.; David, A.; De Gruttola, M.; De Roeck, A.; Di Marco, E.; Dobson, M.; Dorney, B.; du Pree, T.; Duggan, D.; Dunser, M.; Dupont, N.; Elliott-Peisert, A.; Everaerts, P.; Fartoukh, S.; Franzoni, G.; Fulcher, J.; Gigi, D.; Gill, K.; Girone, M.; Glege, F.; Gulhan, D.; Gundacker, S.; Guthoff, M.; Harris, P.; Hegeman, J.; Janot, P.; Kieseler, J.; Kirschenmann, H.; Kornmayer, A.; Kortelainen, M. J.; Kousouris, K.; Krammer, M.; Lange, C.; Lecoq, P.; Lourenco, C.; Lucchini, M. T.; Malgeri, L.; Mannelli, M.; Martelli, A.; Meijers, F.; Merlin, J. A.; Mersi, S.; Meschi, E.; Milenovic, P.; Moortgat, F.; Morovic, S.; Mulders, M.; Neugebauer, H.; Orfanelli, S.; Orsini, L.; Pape, L.; Perez, E.; Peruzzi, M.; Petrilli, A.; Petrucciani, G.; Pfeiffer, A.; Pierini, M.; Racz, A.; Reis, T.; Rolandi, G.; Rovere, M.; Sakulin, H.; Sauvan, J. B.; Schafer, C.; Schwick, C.; Seidel, M.; Sharma, A.; Silva, P.; Sphicas, P.; Steggemann, J.; Stoye, M.; Tosi, M.; Treille, D.; Triossi, A.; Tsirou, A.; Veres, G. I.; Verweij, M.; Wardle, N.; Wohri, H. K.; Zagozdzinska, A.] CERN, European Org Nucl Res, Geneva, Switzerland.
   [Bertl, W.; Deiters, K.; Erdmann, W.; Horisberger, R.; Ingram, Q.; Kaestli, H. C.; Kotlinski, D.; Langenegger, U.; Rohe, T.; Wiederkehr, S. A.] Paul Scherrer Inst, Villigen, Switzerland.
   [Bachmair, F.; Bani, L.; Bianchini, L.; Casal, B.; Dissertori, G.; Dittmar, M.; Donega, M.; Grab, C.; Heidegger, C.; Hits, D.; Hoss, J.; Kasieczka, G.; Lustermann, W.; Mangano, B.; Marionneau, M.; del Arbol, P. Martinez Ruiz; Masciovecchio, M.; Meinhard, M. T.; Meister, D.; Micheli, F.; Musella, P.; Nessi-Tedaldi, F.; Pandolfi, F.; Pata, J.; Pauss, F.; Perrin, G.; Perrozzi, L.; Quittnat, M.; Rossini, M.; Schonenberger, M.; Starodumov, A.; Tavolaro, V. R.; Theofilatos, K.; Wallny, R.] Swiss Fed Inst Technol, Inst Particle Phys, Zurich, Switzerland.
   [Aarrestad, T. K.; Amsler, C.; Caminada, L.; Canelli, M. F.; De Cosa, A.; Galloni, C.; Hinzmann, A.; Hreus, T.; Kilminster, B.; Ngadiuba, J.; Pinna, D.; Rauco, G.; Robmann, P.; Salerno, D.; Seitz, C.; Yang, Y.; Zucchetta, A.] Univ Zurich, Zurich, Switzerland.
   [Candelise, V.; Doan, T. H.; Jain, Sh.; Khurana, R.; Konyushikhin, M.; Kuo, C. M.; Lin, W.; Pozdnyakov, A.; Yu, S. S.] Natl Cent Univ, Chungli, Taiwan.
   [Kumar, Arun; Chang, P.; Chang, Y. H.; Chao, Y.; Chen, K. F.; Chen, P. H.; Fiori, F.; Hou, W. -S.; Hsiung, Y.; Liu, Y. F.; Lu, R. -S.; Moya, M. Minano; Paganis, E.; Psallidas, A.; Tsai, J. F.] NTU, Taipei, Taiwan.
   [Asavapibhop, B.; Singh, G.; Srimanobhas, N.; Suwonjandee, N.] Chulalongkorn Univ, Fac Sci, Dept Phys, Bangkok, Thailand.
   [Adiguzel, A.; Damarseckin, S.; Demiroglu, Z. S.; Dozen, C.; Eskut, E.; Girgis, S.; Gokbulut, G.; Guler, Y.; Hos, I.; Kangal, E. E.; Kara, O.; Topaksu, A. Kayis; Kiminsu, U.; Oglakci, M.; Onengut, G.; Ozdemir, K.; Ozturk, S.; Polatoz, A.; Tali, B.; Turkcapar, S.; Zorbakir, I. S.; Zorbilmez, C.] Cukurova Univ, Phys Dept Sci & Art Fac, Adana, Turkey.
   [Bilin, B.; Bilmis, S.; Isildak, B.; Karapinar, G.; Yalvac, M.; Zeyrek, M.] Middle East Tech Univ, Phys Dept, Ankara, Turkey.
   [Gulmez, E.; Kaya, M.; Kaya, O.; Yetkin, E. A.; Yetkin, T.] Bogazici Univ, Istanbul, Turkey.
   [Cakir, A.; Cankocak, K.; Sen, S.] Istanbul Tech Univ, Istanbul, Turkey.
   [Grynyov, B.] Inst Scintillat Mat Natl Acad Sci Ukraine, Kharkov, Ukraine.
   [Levchuk, L.; Sorokin, P.] Kharkov Inst Phys & Technol, Natl Sci Ctr, Kharkov, Ukraine.
   [Aggleton, R.; Ball, F.; Beck, L.; Brooke, J. J.; Burns, D.; Clement, E.; Cussans, D.; Flacher, H.; Goldstein, J.; Grimes, M.; Heath, G. P.; Heath, H. F.; Jacob, J.; Kreczko, L.; Lucas, C.; Newbold, D. M.; Paramesvaran, S.; Poll, A.; Sakuma, T.; El Nasr-Storey, S. Seif; Smith, D.; Smith, V. J.] Univ Bristol, Bristol, Avon, England.
   [Kreczko, L.; Newbold, D. M.; Bell, K. W.; Belyaev, A.; Brew, C.; Brown, R. M.; Calligaris, L.; Cieri, D.; Cockerill, D. J. A.; Coughlan, J. A.; Harder, K.; Harper, S.; Olaiya, E.; Petyt, D.; Shepherd-Themistocleous, C. H.; Thea, A.; Tomalin, I. R.; Williams, T.; Lucas, R.] Rutherford Appleton Lab, Didcot, Oxon, England.
   [Kreczko, L.; Cockerill, D. J. A.; Baber, M.; Bainbridge, R.; Buchmuller, O.; Bundock, A.; Burton, D.; Casasso, S.; Citron, M.; Colling, D.; Corpe, L.; Dauncey, P.; Davies, G.; De Wit, A.; Della Negra, M.; Di Maria, R.; Dunne, P.; Elwood, A.; Futyan, D.; Haddad, Y.; Hall, G.; Iles, G.; James, T.; Lane, R.; Laner, C.; Lucas, R.; Lyons, L.; Magnan, A. -M.; Malik, S.; Mastrolorenzo, L.; Nash, J.; Nikitenko, A.; Pela, J.; Penning, B.; Pesaresi, M.; Raymond, D. M.; Richards, A.; Rose, A.; Scott, E.; Seez, C.; Summers, S.; Tapper, A.; Uchida, K.; Acosta, M. Vazquez; Virdee, T.; Wright, J.; Zenz, S. C.] Imperial Coll, London, England.
   [Kreczko, L.; Cockerill, D. J. A.; Cole, J. E.; Hobson, P. R.; Khan, A.; Kyberd, P.; Reid, I. D.; Symonds, P.; Teodorescu, L.; Turner, M.] Brunel Univ, Uxbridge, Middx, England.
   [Kreczko, L.; Cockerill, D. J. A.; Borzou, A.; Call, K.; Dittmann, J.; Hatakeyama, K.; Liu, H.; Pastika, N.] Baylor Univ, Waco, TX 76798 USA.
   [Kreczko, L.; Cockerill, D. J. A.; Bartek, R.; Dominguez, A.] Catholic Univ Amer, Washington, DC USA.
   [Kreczko, L.; Cockerill, D. J. A.; Buccilli, A.; Cooper, S. I.; Henderson, C.; Rumerio, P.; West, C.] Univ Alabama, Tuscaloosa, AL USA.
   [Kreczko, L.; Cockerill, D. J. A.; Arcaro, D.; Avetisyan, A.; Bose, T.; Gastler, D.; Rankin, D.; Richardson, C.; Rohlf, J.; Sulak, L.; Zou, D.] Boston Univ, Boston, MA 02215 USA.
   [Kreczko, L.; Cockerill, D. J. A.; Benelli, G.; Cutts, D.; Garabedian, A.; Hakala, J.; Heintz, U.; Hogan, J. M.; Jesus, O.; Kwok, K. H. M.; Laird, E.; Landsberg, G.; Mao, Z.; Narain, M.; Piperov, S.; Sagir, S.; Spencer, E.; Syarif, R.] Brown Univ, Providence, RI 02912 USA.
   [Kreczko, L.; Cockerill, D. J. A.; Breedon, R.; Burns, D.; Sanchez, M. Calderon De la Barca; Chauhan, S.; Chertok, M.; Conway, J.; Conway, R.; Cox, P. T.; Erbacher, R.; Flores, C.; Funk, G.; Gardner, M.; Ko, W.; Lander, R.; Mclean, C.; Mulhearn, M.; Pellett, D.; Pilot, J.; Shalhout, S.; Shi, M.; Smith, J.; Squires, M.; Stolp, D.; Tos, K.; Tripathi, M.] Univ Calif Davis, Davis, CA 95616 USA.
   [Kreczko, L.; Cockerill, D. J. A.; Bachtis, M.; Bravo, C.; Cousins, R.; Dasgupta, A.; Florent, A.; Hauser, J.; Ignatenko, M.; Mccoll, N.; Saltzberg, D.; Schnaible, C.; Valuev, V.; Weber, M.] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Kreczko, L.; Cockerill, D. J. A.; Bouvier, E.; Burt, K.; Clare, R.; Ellison, J.; Gary, J. W.; Shirazi, S. M. A. Ghiasi; Hanson, G.; Heilman, J.; Jandir, P.; Kennedy, E.; Lacroix, F.; Long, O. R.; Negrete, M. Olmedo; Paneva, M. I.; Shrinivas, A.; Si, W.; Wei, H.; Wimpenny, S.; Yates, B. R.] Univ Calif Riverside, Riverside, CA 92521 USA.
   [Branson, J. G.; Cerati, G. B.; Cittolin, S.; Derdzinski, M.; Gerosa, R.; Holzner, A.; Klein, D.; Krutelyov, V.; Letts, J.; Macneill, I.; Olivito, D.; Padhi, S.; Pieri, M.; Sani, M.; Sharma, V.; Simon, S.; Tadel, M.; Vartak, A.; Wasserbaech, S.; Welke, C.; Wood, J.; Wuthwein, F.; Yagil, A.; Della Porta, G. Zevi] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Amin, N.; Bhandari, R.; Bradmiller-Feld, J.; Campagnari, C.; Dishaw, A.; Dutta, V.; Sevilla, M. Franco; George, C.; Golf, F.; Gouskos, L.; Gran, J.; Heller, R.; Incandela, J.; Mullin, S. D.; Ovcharova, A.; Qu, H.; Richman, J.; Stuart, D.; Suarez, I.; Yoo, J.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.
   [Dubinin, M.; Anderson, D.; Bendavid, J.; Bornheim, A.; Bunn, J.; Duarte, J.; Lawhorn, J. M.; Mott, A.; Newman, H. B.; Pena, C.; Spiropulu, M.; Vlimant, J. R.; Xie, S.; Zhu, R. Y.] CALTECH, Pasadena, CA 91125 USA.
   [Andrews, M. B.; Ferguson, T.; Paulini, M.; Russ, J.; Sun, M.; Vogel, H.; Vorobiev, I.; Weinberg, M.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.
   [Cumalat, J. P.; Ford, W. T.; Jensen, F.; Johnson, A.; Krohn, M.; Leontsinis, S.; Mulholland, T.; Stenson, K.; Wagner, S. R.] Univ Colorado Boulder, Boulder, CO USA.
   [Alexander, J.; Chaves, J.; Chu, J.; Dittmer, S.; Mcdermott, K.; Mirman, N.; Kaufman, G. Nicolas; Rinkevicius, A.; Ryd, A.; Skinnari, L.; Soffi, L.; Tan, S. M.; Tao, Z.; Thom, J.; Tucker, J.; Wittich, P.; Zientek, M.] Cornell Univ, Ithaca, NY USA.
   [Winn, D.] Fairfield Univ, Fairfield, CT 06430 USA.
   [Abdullin, S.; Albrow, M.; Apollinari, G.; Apresyan, A.; Banerjee, S.; Bauerdick, L. A. T.; Beretvas, A.; Berryhill, J.; Bhat, P. C.; Bolla, G.; Burkett, K.; Butler, J. N.; Cheung, H. W. K.; Chlebana, F.; Cihangir, S.; Cremonesi, M.; Elvira, V. D.; Fisk, I.; Freeman, J.; Gottschalk, E.; Gray, L.; Green, D.; Grunendahl, S.; Gutsche, O.; Hare, D.; Harris, R. M.; Hasegawa, S.; Hirschauer, J.; Hu, Z.; Jayatilaka, B.; Jindariani, S.; Johnson, M.; Joshi, U.; Klima, B.; Kreis, B.; Lammel, S.; Linacre, J.; Lincoln, D.; Lipton, R.; Liu, M.; Liu, T.; De Sa, R. Lopes; Lykken, J.; Maeshima, K.; Magini, N.; Marraffino, J. M.; Maruyama, S.; Mason, D.; McBride, P.; Merkel, P.; Mrenna, S.; Nahn, S.; O'Dell, V.; Pedro, K.; Prokofyev, O.; Rakness, G.; Ristori, L.; Sexton-Kennedy, E.; Soha, A.; Spalding, W. J.; Spiegel, L.; Stoynev, S.; Strait, J.; Strobbe, N.; Taylor, L.; Tkaczyk, S.; Tran, N. V.; Uplegger, L.; Vaandering, E. W.; Vernieri, C.; Verzocchi, M.; Vidal, R.; Wang, M.; Weber, H. A.; Whitbeck, A.; Wu, Y.] Fermilab Natl Accelerator Lab, POB 500, Batavia, IL 60510 USA.
   [Kuznetsova, E.; Acosta, D.; Avery, P.; Bortignon, P.; Bourilkov, D.; Brinkerhoff, A.; Carnes, A.; Carver, M.; Curry, D.; Das, S.; Field, R. D.; Furic, I. K.; Konigsberg, J.; Korytov, A.; Low, J. F.; Ma, P.; Matchev, K.; Mei, H.; Mitselmakher, G.; Rank, D.; Shchutska, L.; Sperka, D.; Thomas, L.; Wang, J.; Wang, S.; Yelton, J.] Univ Florida, Gainesville, FL USA.
   [Linn, S.; Markowitz, P.; Martinez, G.; Rodriguez, J. L.] Florida Int Univ, Miami, FL 33199 USA.
   [Ackert, A.; Adams, T.; Askew, A.; Bein, S.; Hagopian, S.; Hagopian, V.; Johnson, K. F.; Kolberg, T.; Prosper, H.; Santra, A.; Yohay, R.] Florida State Univ, Tallahassee, FL 32306 USA.
   [Baarmand, M. M.; Bhopatkar, V.; Colafranceschi, S.; Hohlmann, M.; Noonan, D.; Roy, T.; Yumiceva, F.] Florida Inst Technol, Melbourne, FL 32901 USA.
   [Adams, M. R.; Apanasevich, L.; Berry, D.; Betts, R. R.; Bucinskaite, I.; Cavanaugh, R.; Evdokimov, O.; Gauthier, L.; Gerber, C. E.; Hofman, D. J.; Jung, K.; Gonzalez, I. D. Sandoval; Varelas, N.; Wang, H.; Wu, Z.; Zakaria, M.; Zhang, J.] UIC, Chicago, IL USA.
   [Kreczko, L.; Cockerill, D. J. A.; Bilki, B.; Clarida, W.; Dilsiz, K.; Durgut, S.; Gandrajula, R. P.; Haytmyradov, M.; Khristenko, V.; Merlo, J. -P.; Mermerkaya, H.; Mestvirishvili, A.; Moeller, A.; Nachtman, J.; Ogul, H.; Onel, Y.; Ozok, F.; Penzo, A.; Snyder, C.; Tiras, E.; Wetzel, J.; Yi, K.] Univ Iowa, Iowa City, IA USA.
   [Kreczko, L.; Cockerill, D. J. A.; Blumenfeld, B.; Cocoros, A.; Eminizer, N.; Fehling, D.; Feng, L.; Gritsan, A. V.; Maksimovic, P.; Roskes, J.; Sarica, U.; Swartz, M.; Xiao, M.; You, C.] Johns Hopkins Univ, Baltimore, MD USA.
   [Kreczko, L.; Cockerill, D. J. A.; Al-bataineh, A.; Baringer, P.; Bean, A.; Boren, S.; Bowen, J.; Castle, J.; Forthomme, L.; Kenny, R. P., III; Khalil, S.; Kropivnitskaya, A.; Majumder, D.; Mcbrayer, W.; Murray, M.; Sanders, S.; Stringer, R.; Takaki, J. D. Tapia; Wang, Q.] Univ Kansas, Lawrence, KS 66045 USA.
   [Kreczko, L.; Cockerill, D. J. A.; Ivanov, A.; Kaadze, K.; Maravin, Y.; Mohammadi, A.; Saini, L. K.; Skhirtladze, N.; Toda, S.] Kansas State Univ, Manhattan, KS 66506 USA.
   [Rebassoo, F.; Wright, D.] Lawrence Livermore Natl Lab, Livermore, CA USA.
   [Anelli, C.; Baden, A.; Baron, O.; Belloni, A.; Calvert, B.; Eno, S. C.; Ferraioli, C.; Gomez, J. A.; Hadley, N. J.; Jabeen, S.; Jeng, G. Y.; Kellogg, R. G.; Kunkle, J.; Mignerey, A. C.; Ricci-Tam, F.; Shin, Y. H.; Skuja, A.; Tonjes, M. B.; Tonwar, S. C.] Univ Maryland, College Pk, MD 20742 USA.
   [Abercrombie, D.; Allen, B.; Apyan, A.; Azzolini, V.; Barbieri, R.; Baty, A.; Bi, R.; Bierwagen, K.; Brandt, S.; Busza, W.; Cali, I. A.; D'Alfonso, M.; Demiragli, Z.; Ceballos, G. Gomez; Goncharov, M.; Hsu, D.; Iiyama, Y.; Innocenti, G. M.; Klute, M.; Kovalskyi, D.; Krajczar, K.; Lai, Y. S.; Lee, Y. -J.; Levin, A.; Luckey, P. D.; Maier, B.; Marini, A. C.; Mcginn, C.; Mironov, C.; Narayanan, S.; Niu, X.; Paus, C.; Roland, C.; Roland, G.; Salfeld-Nebgen, J.; Stephans, G. S. F.; Tatar, K.; Velicanu, D.; Wang, J.; Wang, T. W.; Wyslouch, B.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Benvenuti, A. C.; Chatterjee, R. M.; Evans, A.; Hansen, P.; Kalafut, S.; Kao, S. C.; Kubota, Y.; Lesko, Z.; Mans, J.; Nourbakhsh, S.; Ruckstuhl, N.; Rusack, R.; Tambe, N.; Turkewitz, J.] Univ Minnesota, Minneapolis, MN USA.
   [Acosta, J. G.; Oliveros, S.] Univ Mississippi, Oxford, MS USA.
   [Avdeeva, E.; Bloom, K.; Claes, D. R.; Fangmeier, C.; Suarez, R. Gonzalez; Kamalieddin, R.; Kravchenko, I.; Rodrigues, A. Malta; Monroy, J.; Siado, J. E.; Snow, G. R.; Stieger, B.] Univ Nebraska Lincoln, Lincoln, NE USA.
   [Alyari, M.; Dolen, J.; Godshalk, A.; Harrington, C.; Iashvili, I.; Kaisen, J.; Nguyen, D.; Parker, A.; Rappoccio, S.; Roozbahani, B.] SUNY Buffalo, Buffalo, NY USA.
   [Alverson, G.; Barberis, E.; Hortiangtham, A.; Massironi, A.; Morse, D. M.; Nash, D.; Orimoto, T.; De Lima, R. Teixeira; Trocino, D.; Wang, R. -J.; Wood, D.] Northeastern Univ, Boston, MA 02115 USA.
   [Bhattacharya, S.; Charaf, O.; Hahn, K. A.; Kumar, A.; Mucia, N.; Odell, N.; Pollack, B.; Schmitt, M. H.; Sung, K.; Trovato, M.; Velasco, M.] Northwestern Univ, Evanston, IL USA.
   [Dev, N.; Hildreth, M.; Anampa, K. Hurtado; Jessop, C.; Karmgard, D. J.; Kellams, N.; Lannon, K.; Marinelli, N.; Meng, F.; Mueller, C.; Musienko, Y.; Planer, M.; Reinsvold, A.; Ruchti, R.; Rupprecht, N.; Smith, G.; Taroni, S.; Wayne, M.; Wolf, M.; Woodard, A.] Univ Notre Dame, Notre Dame, IN 46556 USA.
   [Abdulsalam, A.; Alimena, J.; Antonelli, L.; Bylsma, B.; Durkin, L. S.; Flowers, S.; Francis, B.; Hart, A.; Hill, C.; Hughes, R.; Ji, W.; Liu, B.; Luo, W.; Puigh, D.; Winer, B. L.; Wulsin, H. W.] Ohio State Univ, Columbus, OH 43210 USA.
   [Abdulsalam, A.; Cooperstein, S.; Driga, O.; Elmer, P.; Hardenbrook, J.; Hebda, P.; Lange, D.; Luo, J.; Marlow, D.; Medvedeva, T.; Mei, K.; Ojalvo, I.; Olsen, J.; Palmer, C.; Piroue, P.; Stickland, D.; Svyatkovskiy, A.; Tully, C.] Princeton Univ, Princeton, NJ 08544 USA.
   [Malik, S.] Univ Puerto Rico, Mayaguez, PR USA.
   [Savoy-Navarro, A.; Barker, A.; Barnes, V. E.; Folgueras, S.; Gutay, L.; Jha, M. K.; Jones, M.; Jung, A. W.; Khatiwada, A.; Miller, D. H.; Neumeister, N.; Schulte, J. F.; Shi, X.; Sun, J.; Wang, F.; Xie, W.] Purdue Univ, W Lafayette, IN 47907 USA.
   [Parashar, N.; Stupak, J.] Purdue Univ Northwest, Hammond, LA USA.
   [Adair, A.; Akgun, B.; Chen, Z.; Ecklund, K. M.; Geurts, F. J. M.; Guilbaud, M.; Li, W.; Michlin, B.; Northup, M.; Padley, B. P.; Roberts, J.; Rorie, J.; Tu, Z.; Zabel, J.] Rice Univ, Houston, TX USA.
   [Betchart, B.; Bodek, A.; de Barbaro, P.; Demina, R.; Duh, Y. T.; Ferbel, T.; Galanti, M.; Garcia-Bellido, A.; Han, J.; Hindrichs, O.; Khukhunaishvili, A.; Lo, K. H.; Tan, P.; Verzetti, M.] Univ Rochester, Rochester, NY 14627 USA.
   [Agapitos, A.; Chou, J. P.; Gershtein, Y.; Espinosa, T. A. Gomez; Halkiadakis, E.; Heindl, M.; Hughes, E.; Kaplan, S.; Elayavalli, R. Kunnawalkam; Kyriacou, S.; Lath, A.; Nash, K.; Osherson, M.; Saka, H.; Salur, S.; Schnetzer, S.; Sheffield, D.; Somalwar, S.; Stone, R.; Thomas, S.; Thomassen, P.; Walker, M.] Rutgers State Univ, Piscataway, NJ USA.
   [Delannoy, A. G.; Foerster, M.; Heideman, J.; Riley, G.; Rose, K.; Spanier, S.; Thapa, K.] Univ Tennessee, Knoxville, TN USA.
   [Bouhali, O.; Celik, A.; Dalchenko, M.; De Mattia, M.; Delgado, A.; Dildick, S.; Eusebi, R.; Gilmore, J.; Huang, T.; Juska, E.; Kamon, T.; Mueller, R.; Pakhotin, Y.; Patel, R.; Perloff, A.; Pernie, L.; Rathjens, D.; Safonov, A.; Tatarinov, A.; Ulmer, K. A.] Texas A&M Univ, College Stn, TX USA.
   [Akchurin, N.; Cowden, C.; Damgov, J.; De Guio, F.; Dragoiu, C.; Dudero, P. R.; Faulkner, J.; Gurpinar, E.; Kunori, S.; Lamichhane, K.; Lee, S. W.; Libeiro, T.; Peltola, T.; Undleeb, S.; Volobouev, I.; Wang, Z.] Texas Tech Univ, Lubbock, TX 79409 USA.
   [Greene, S.; Gurrola, A.; Janjam, R.; Johns, W.; Maguire, C.; Melo, A.; Ni, H.; Sheldon, P.; Tuo, S.; Velkovska, J.; Xu, Q.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Arenton, M. W.; Barria, P.; Cox, B.; Goodell, J.; Hirosky, R.; Ledovskoy, A.; Li, H.; Neu, C.; Sinthuprasith, T.; Sun, X.; Wang, Y.; Wolfe, E.; Xia, F.] Univ Virginia, Charlottesville, VA USA.
   [Clarke, C.; Harr, R.; Karchin, P. E.; Sturdy, J.] Wayne State Univ, Detroit, MI USA.
   [Belknap, D. A.; Buchanan, J.; Caillol, C.; Dasu, S.; Dodd, L.; Duric, S.; Gomber, B.; Grothe, M.; Herndon, M.; Herve, A.; Klabbers, P.; Lanaro, A.; Levine, A.; Long, K.; Loveless, R.; Perry, T.; Pierro, G. A.; Polese, G.; Ruggles, T.; Savin, A.; Smith, N.; Smith, W. H.; Taylor, D.; Woods, N.] Univ Wisconsin Madison, Madison, WI USA.
   [Fruehwirth, R.; Jeitler, M.; Schieck, J.; Wulz, C. -E.; Krammer, M.] Vienna Univ Technol, Vienna, Austria.
   [Chinellato, J.] Univ Estadual Campinas, Campinas, Brazil.
   [Da Silveira, G. G.; Tonelli Manganote, E. J.] Univ Fed Pelotas, Pelotas, Brazil.
   [El-khateeb, E.] Ain Shams Univ, Cairo, Egypt.
   [Elgammal, S.] British Univ Egypt, Cairo, Egypt.
   [Mohamed, A.] Zewail City Sci & Technol, Zewail, Egypt.
   [Agram, J. -L.; Conte, E.; Fontaine, J. -C.] Univ Haute Alsace, Mulhouse, France.
   [Hempel, M.; Karacheban, O.] Brandenburg Tech Univ Cottbus, Cottbus, Germany.
   [Bahinipati, S.; Sahoo, D. K.] Indian Inst Technol Bhubaneswar, Bhubaneswar, Orissa, India.
   [Bhowmik, S.; Maity, M.; Sarkar, T.] Univ Visva Bharati, Santini Ketan, W Bengal, India.
   [Choudhury, S.] Indian Inst Sci Educ & Res, Bhopal, India.
   [Nayak, A.] Inst Phys, Bhubaneswar, Orissa, India.
   [Wickramage, N.] Univ Ruhuna, Matara, Sri Lanka.
   [Chenarani, S.; Etesami, S. M.] Isfahan Univ Technol, Esfahan, Iran.
   [Mehdiabadi, S. Paktinat] Yazd Univ, Yazd, Iran.
   [Safarzadeh, B.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
   [Russo, L.; Androsov, K.; Ciocci, M. A.; Grippo, M. T.] Univ Siena, Siena, Italy.
   [Ali, M. A. B. Md] Int Islamic Univ Malaysia, Kuala Lumpur, Malaysia.
   [Idris, F. Mohamad] Agensi Nuklear Malaysia, MOSTI, Kajang, Malaysia.
   [Heredia-De la Cruz, I.] Consejo Nacl Invest Cient & Tecn, Mexico City, DF, Mexico.
   [Byszuk, A.; Zagozdzinska, A.] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland.
   [Kim, V.] St Petersburg State Polytech Univ, St Petersburg, Russia.
   [Blinov, V.; Skovpen, Y.; Shtol, D.] Budker Inst Nucl Phys, Novosibirsk, Russia.
   [Rolandi, G.] Scuola Normale & Sez INFN, Pisa, Italy.
   [Veckalns, V.] Riga Tech Univ, Riga, Latvia.
   [Amsler, C.] Albert Einstein Ctr Fundamental Phys, Bern, Switzerland.
   [Hos, I.] Istanbul Aydin Univ, Istanbul, Turkey.
   [Kangal, E. E.] Mersin Univ, Mersin, Turkey.
   [Ozdemir, K.] Piri Reis Univ, Istanbul, Turkey.
   [Ozturk, S.] Gaziosmanpasa Univ, Tokat, Turkey.
   [Tali, B.] Adiyaman Univ, Adiyaman, Turkey.
   [Isildak, B.] Ozyegin Univ, Istanbul, Turkey.
   [Karapinar, G.] Izmir Inst Technol, Izmir, Turkey.
   [Kaya, M.] Marmara Univ, Istanbul, Turkey.
   [Kaya, O.] Kafkas Univ, Kars, Turkey.
   [Yetkin, E. A.] Istanbul Bilgi Univ, Istanbul, Turkey.
   [Yetkin, T.] Yildiz Tech Univ, Istanbul, Turkey.
   [Sen, S.] Hacettepe Univ, Ankara, Turkey.
   [Belyaev, A.] Univ Southampton, Sch Phys & Astron, Southampton, Hants, England.
   [Acosta, M. Vazquez] Inst Astrofis Canarias, San Cristobal la Laguna, Spain.
   [Wasserbaech, S.] Utah Valley Univ, Orem, UT USA.
   [Bilki, B.] Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.
   [Mermerkaya, H.] Erzincan Univ, Erzincan, Turkey.
   [Ozok, F.] Mimar Sinan Univ, Istanbul, Turkey.
   [Bouhali, O.] Texas A&M Univ Qatar, Doha, Qatar.
RP Sirunyan, AM (reprint author), Yerevan Phys Inst, Yerevan, Armenia.
RI Scodellaro, Luca/K-9091-2014; Folgueras, Santiago/G-4902-2016;
   Perez-Calero Yzquierdo, Antonio/F-2235-2013; Matorras,
   Francisco/I-4983-2015; Raidal, Martti/F-4436-2012; Della Ricca,
   Giuseppe/B-6826-2013; Manganote, Edmilson/K-8251-2013; Lokhtin,
   Igor/D-7004-2012; Triossi, Andrea/K-2813-2017; Garcia Abia,
   Pablo/K-3595-2017; Paganis, Stathes/J-8413-2017; Konecki,
   Marcin/G-4164-2015; Calvo Alamillo, Enrique/L-1203-2014; Calderon,
   Alicia/K-3658-2014; Puerta Pelayo, Jesus/L-1632-2014; Josa,
   Isabel/K-5184-2014
OI Scodellaro, Luca/0000-0002-4974-8330; Folgueras,
   Santiago/0000-0001-7191-1125; Perez-Calero Yzquierdo,
   Antonio/0000-0003-3036-7965; Matorras, Francisco/0000-0003-4295-5668;
   Raidal, Martti/0000-0001-7040-9491; Della Ricca,
   Giuseppe/0000-0003-2831-6982; Triossi, Andrea/0000-0001-5140-9154;
   Garcia Abia, Pablo/0000-0001-8809-8927; Paganis,
   Stathes/0000-0002-1950-8993; Konecki, Marcin/0000-0001-9482-4841; Calvo
   Alamillo, Enrique/0000-0002-1100-2963; Calderon,
   Alicia/0000-0002-7205-2040; 
FU BMWFW (Austria); FWF (Austria); FNRS (Belgium); FWO (Belgium); CNPq
   (Brazil); CAPES (Brazil); FAPERJ (Brazil); FAPESP (Brazil); MES
   (Bulgaria); CERN; CAS (China); MoST (China); NSFC (China); COLCIENCIAS
   (Colombia); MSES (Croatia); CSF (Croatia); RPF (Cyprus); SENESCYT
   (Ecuador); MoER (Estonia); ERC IUT (Estonia); ERDF (Estonia); Academy of
   Finland (Finland); MEC (Finland); HIP (Finland); CEA (France);
   CNRS/IN2P3 (France); BMBF (Germany); DFG (Germany); HGF (Germany); GSRT
   (Greece); OTKA (Hungary); NIH (Hungary); DAE (India); DST (India); IPM
   (Iran); SFI (Ireland); INFN (Italy); MSIP (Republic of Korea); NRF
   (Republic of Korea); LAS (Lithuania); MOE (Malaysia); UM (Malaysia);
   BUAP (Mexico); CINVESTAV (Mexico); CONACYT (Mexico); LNS (Mexico); SEP
   (Mexico); UASLP-FAI (Mexico); MBIE (New Zealand); PAEC (Pakistan); MSHE
   (Poland); NSC (Poland); FCT (Portugal); JINR (Dubna); MON (Russia);
   RosAtom (Russia); RAS (Russia); RFBR (Russia); RAEP (Russia); MESTD
   (Serbia); SEIDI (Spain); CPAN (Spain); PCTI (Spain); FEDER (Spain);
   Swiss Funding Agencies (Switzerland); MST (Taipei); ThEPCenter
   (Thailand); IPST (Thailand); STAR (Thailand); NSTDA (Thailand); TUBITAK
   (Turkey); TAEK (Turkey); NASU (Ukraine); SFFR (Ukraine); STFC (United
   Kingdom); DOE (USA); NSF (USA); Marie-Curie programme (European Union);
   European Research Council (European Union); EPLANET (European Union);
   Leventis Foundation; A. P. Sloan Foundation; Alexander von Humboldt
   Foundation; Belgian Federal Science Policy Office; Fonds pour la
   Formation a la Recherche dans l'Industrie et dans I'Agriculture
   (FRIA-Belgium); Agentschap voor Innovatie door Wetenschap en Technologie
   (IWT-Belgium); Ministry of Education, Youth and Sports (MEYS) of the
   Czech Republic; Council of Science and Industrial Research, India;
   HOMING PLUS programme of the Foundation for Polish Science; Regional
   Development Fund (Poland); Mobility Plus programme of the Ministry of
   Science and Higher Education (Poland); National Science Center (Poland)
   [2014/14/M/ST2/00428, 2014/13/B/ST2/02543, 201.4/15/B/ST2/03998,
   2015/1.9/B/ST2/02861, 2012/07/E/ST2/01406]; National Priorities Research
   Program by Qatar National Research Fund; Programa Clarin-COFUND del
   Principado de Asturias; European Union (Poland); Thalis program -
   EU-ESF; Aristeia program - EU-ESF; Greek NSRF; Rachadapisek Sompot Fund
   for Postdoctoral Fellowship (Thailand); Chulalongkorn University
   (Thailand); Chulalongkorn Academic into Its 2nd Century Project
   Advancement Project (Thailand); Welch Foundation [C-1845]
FX We congratulate our colleagues in the CERN accelerator departments for
   the excellent performance of the LHC and thank the technical and
   administrative staffs at CERN and at other CMS institutes for their
   contributions to the success of the CMS effort. In addition, we
   gratefully acknowledge the computing centres and personnel of the
   Worldwide LHC Computing Grid for delivering so effectively the computing
   infrastructure essential to our analyses. Finally, we acknowledge the
   enduring support for the construction and operation of the LHC and the
   CMS detector provided by the following funding agencies: BMWFW and FWF
   (Austria); FNRS and FWO (Belgium); CNPq, CAPES, FAPERJ, and FAPESP
   (Brazil); MES (Bulgaria); CERN; CAS, MoST, and NSFC (China); COLCIENCIAS
   (Colombia); MSES and CSF (Croatia); RPF (Cyprus); SENESCYT (Ecuador);
   MoER, ERC IUT, and ERDF (Estonia); Academy of Finland, MEC, and HIP
   (Finland); CEA and CNRS/IN2P3 (France); BMBF, DFG, and HGF (Germany);
   GSRT (Greece); OTKA and NIH (Hungary); DAE and DST (India); IPM (Iran);
   SFI (Ireland); INFN (Italy); MSIP and NRF (Republic of Korea); LAS
   (Lithuania); MOE and UM (Malaysia); BUAP, CINVESTAV, CONACYT, LNS, SEP,
   and UASLP-FAI (Mexico); MBIE (New Zealand); PAEC (Pakistan); MSHE and
   NSC (Poland); FCT (Portugal); JINR (Dubna); MON, RosAtom, RAS, RFBR and
   RAEP (Russia); MESTD (Serbia); SEIDI, CPAN, PCTI and FEDER (Spain);
   Swiss Funding Agencies (Switzerland); MST (Taipei); ThEPCenter, IPST,
   STAR, and NSTDA (Thailand); TUBITAK and TAEK (Turkey); NASU and SFFR
   (Ukraine); STFC (United Kingdom); DOE and NSF (USA). Individuals have
   received support from the Marie-Curie programme and the European
   Research Council and EPLANET (European Union); the Leventis Foundation;
   the A. P. Sloan Foundation; the Alexander von Humboldt Foundation; the
   Belgian Federal Science Policy Office; the Fonds pour la Formation a la
   Recherche dans l'Industrie et dans I'Agriculture (FRIA-Belgium); the
   Agentschap voor Innovatie door Wetenschap en Technologie (IWT-Belgium);
   the Ministry of Education, Youth and Sports (MEYS) of the Czech
   Republic; the Council of Science and Industrial Research, India; the
   HOMING PLUS programme of the Foundation for Polish Science, cofinanced
   from European Union, Regional Development Fund, the Mobility Plus
   programme of the Ministry of Science and Higher Education, the National
   Science Center (Poland), contracts Harmonia 2014/14/M/ST2/00428, Opus
   2014/13/B/ST2/02543, 201.4/15/B/ST2/03998, and 2015/1.9/B/ST2/02861,
   Sonata-bis 2012/07/E/ST2/01406; the National Priorities Research Program
   by Qatar National Research Fund; the Programa Clarin-COFUND del
   Principado de Asturias; the Thalis and Aristeia programmes cofinanced by
   EU-ESF and the Greek NSRF; the Rachadapisek Sompot Fund for Postdoctoral
   Fellowship, Chulalongkorn University and the Chulalongkorn Academic into
   Its 2nd Century Project Advancement Project (Thailand); and the Welch
   Foundation, contract C-1845. This work is dedicated to the memory of
   Maurizio Lo Vetere (1965-2015), our fellow colleague at the University
   of Genoa and INFN, Italy. Maurizio's main contributions to this paper
   include the set up of the event selection to suppress tt events and the
   signal extraction method.
CR Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8
   Alekhin S., 2011, ARXIV11010536
   Aliev M, 2011, COMPUT PHYS COMMUN, V182, P1034, DOI 10.1016/j.cpc.2010.12.040
   Alioli S, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2010)043
   Alwall J, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2014)079
   Argyropoulos S, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP11(2014)043
   ATLASCollaboration, 2011, ATLPHYSPUB2011008
   A T L A S collaboration, 2014, PHYS REV D, V90
   Ball RD, 2013, NUCL PHYS B, V867, P244, DOI 10.1016/j.nuclphysb.2012.10.003
   Bauer J., 2010, THESIS, P98
   BELLE Collaboration, 2000, NUCL INSTRUM METH A, V441, P401, DOI [10.1016/S0168-9002(99)00992-4, DOI 10.1016/S0168-9002(99)00992-4]
   Boos E, 2004, NUCL INSTRUM METH A, V534, P250, DOI 10.1016/j.nima.2004.07.096
   Botje M., 2011, ARXIV11010538
   Cacciari M, 2008, J HIGH ENERGY PHYS
   Cacciari M, 2008, PHYS LETT B, V659, P119, DOI 10.1016/j.physletb.2007.09.077
   Campbell JM, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/10/042
   CDF and D0 Collaboration, 2014, PHYS REV D, V89, DOI DOI 10.1103/PHYSREVD.89.072001
   CMS and ATLAS Coll aboration, 2015, CMSPASJME15001
   CMS Collaboration, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.072004
   CMS Collaboration, 2013, JINST, V8
   CMS Collaboration, 2011, JHEP, V04
   CMS Collaboration, 2010, CMSPASPFT10002
   CMS Collaboration, 2013, JHEP, V04, DOI 10.1007/JHEP04(2013)072
   CMS Collaboration, 2014, JHEP, V06
   CMS Collaboration, 2009, CMSPASPFT09001 CERN
   CMS Collaboration, 2011, JINST, V6, DOI DOI 10.1088/1748-0221/6/11/P11002
   CMS collaboration, 2008, JINST, V3, DOI DOI 10.1088/1748-0221/3/08/S08004
   Corcella G, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/01/010
   Czakon M, 2014, COMPUT PHYS COMMUN, V185, P2930, DOI 10.1016/j.cpc.2014.06.021
   DELPHI Collaboration, 2011, EUR PHYS J C, V71, P1557, DOI [10.1140/epjc/s10052-011-1557-x, DOI 10.1140/EPJC/S10052-011-1557-X]
   Frederix R, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2012)130
   Gao J, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.033009
   Heister A, 2001, PHYS LETT B, V512, P30, DOI 10.1016/S0370-2693(01)00690-6
   Juste A, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3119-5
   Kant P, 2015, COMPUT PHYS COMMUN, V191, P74, DOI 10.1016/j.cpc.2015.02.001
   Kidonakis N., 2012, 20 INT WORKSH DEEP I, P831, DOI [10.3204/DESY-PROC-2012-02/251, DOI 10.3204/DESY-PR0C-2012-02/251]
   Lai HL, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.074024
   Maltoni F, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2013)095
   Martin AD, 2009, EUR PHYS J C, V64, P653, DOI 10.1140/epjc/s10052-009-1164-2
   Martin AD, 2009, EUR PHYS J C, V63, P189, DOI 10.1140/epjc/s10052-009-1072-5
   Nadolsky PM, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.013004
   Oreglia M., 1980, THESIS
   Patrignani C, 2016, CHINESE PHYS C, V40, DOI 10.1088/1674-1137/40/10/100001
   Sjostrand T, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/05/026
   Skands PZ, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.074018
   [Anonymous], 2014, ATLASCONF2014008 CDF
NR 46
TC 0
Z9 0
U1 16
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1434-6044
EI 1434-6052
J9 EUR PHYS J C
JI Eur. Phys. J. C
PD MAY 29
PY 2017
VL 77
IS 5
AR 354
DI 10.1140/epjc/s10052-017-4912-8
PG 25
WC Physics, Particles & Fields
SC Physics
GA EW0TL
UT WOS:000402204000001
OA gold
DA 2017-08-17
ER

PT J
AU Mahmoud, MO
   Aboud, HM
   Hassan, AH
   Ali, AA
   Johnston, TP
AF Mahmoud, Mohamed O.
   Aboud, Heba M.
   Hassan, Amira H.
   Ali, Adel A.
   Johnston, Thomas P.
TI Transdermal delivery of atorvastatin calcium from novel nanovesicular
   systems using polyethylene glycol fatty acid esters: Ameliorated effect
   without liver toxicity in poloxamer 407-induced hyperlipidemic rats
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Atorvastatin calcium; Nanotransfersomes; Transdermal delivery;
   Hyperlipidemia; Liver toxicity; Oxidative stress
ID LASER-SCANNING MICROSCOPY; IN-VIVO EVALUATION; DRUG-DELIVERY; OXIDATIVE
   STRESS; ULTRADEFORMABLE LIPOSOMES; DEPENDENT PATHWAYS; EDGE ACTIVATORS;
   NITRIC-OXIDE; SKIN; CARRIERS
AB Context: Atorvastatin calcium (ATV), a cholesterol-lowering agent, suffers from poor systemic availability (14%) after oral administration in addition to other side effects on the gastrointestinal tract, liver and muscle. Objective: The goal of the present investigation was to improve ATV bioavailability and overcome complications attendant with peroral administration by developing a new nanovesicular system encapsulating ATV for its delivery via the transdermal route.
   Methods: The vesicular systems were prepared by incorporating different polyethylene glycol fatty acid esters such as Labrasol, Cremophor EL, Gelucire 44/ 14 and Tween 80 as edge activators (EAs) in the lipid bilayer. The effect of the phosphatidylcholine (PC): EA molar ratio on the physicochemical properties of the vesicles was investigated. The pharmacokinetic studies of the optimized formulation were evaluated in rats. The optimized formulation was tested in poloxamer 407-induced hyperlipidemic rats. The plasma lipid profile, activity of liver enzymes, and oxidative stress parameters were measured using commercially available kits.
   Results: The results revealed high ATV entrapment efficiency (EE%) ranging from 55.62 to 83.91%. The formulations that contained Labrasol showed the highest EE%. The mean diameter of the vesicles was in the range of 186-583 nm. T8 containing Gelucire 44/ 14 as an EA in the molar ratio of 15: 1 (PC: EA) gave the smallest size and exhibited the best permeation parameters across the skin. The pharmacokinetic studies revealed that about three times statistically significant (p < 0.05) improvement in bioavailability, after transdermal administration of nanotransfersomal ATV gel compared to oral ATV suspension. The transdermal vesicular system exhibited a significant decrease in plasma total cholesterol, triglycerides and LDL cholesterol comparable to oral ATV. Additionally, it lowered the malondialdehyde levels in plasma and abolished the increase in liver enzyme activity.
   Conclusion: The results obtained suggest that the proposed transdermal vesicular system can serve as a promising alternative means for delivery of ATV.
C1 [Mahmoud, Mohamed O.] Beni Suef Univ, Fac Pharm, Dept Biochem, Bani Suwayf, Egypt.
   [Aboud, Heba M.; Hassan, Amira H.; Ali, Adel A.] Beni Suef Univ, Fac Pharm, Dept Pharmaceut, Bani Suwayf, Egypt.
   [Johnston, Thomas P.] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Hlth Sci Bldg Rm 4243,2464 Charlotte St, Kansas City, MO 64108 USA.
RP Johnston, TP (reprint author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Hlth Sci Bldg Rm 4243,2464 Charlotte St, Kansas City, MO 64108 USA.
EM johnstont@umkc.edu
CR Aboud HM, 2016, AAPS PHARMSCITECH, V17, P1353, DOI 10.1208/s12249-015-0440-8
   Aboud HM, 2016, DRUG DELIV, V23, P2471, DOI 10.3109/10717544.2015.1013587
   Ahad A, 2012, NANOMED-NANOTECHNOL, V8, P237, DOI 10.1016/j.nano.2011.06.004
   Al Shuwaili AH, 2016, EUR J PHARM BIOPHARM, V102, P101, DOI 10.1016/j.ejpb.2016.02.013
   Ali MFM, 2015, DRUG DES DEV THER, V9, P2431, DOI [10.2147/DDDT.S81236, 10.2147/DDDT.581236]
   Jimenez-Santos MA, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-22
   Ashtikar M., 2016, J CONTROL RELEASE
   Athyros VG, 2010, EXPERT OPIN DRUG SAF, V9, P667, DOI 10.1517/14740338.2010.495385
   AUNGST BJ, 1988, J PHARMACOL EXP THER, V244, P23
   Badr-Eldin SM, 2016, DRUG DES DEV THER, V10, P1323, DOI 10.2147/DDDT.S103122
   Bancroft JD, 2008, THEORY PRACTICE HIST, P121
   Bandivadekar M, 2013, DRUG DEV IND PHARM, V39, P696, DOI 10.3109/03639045.2012.687745
   BANGHAM AD, 1965, J MOL BIOL, V13, P238
   Basalious EB, 2010, INT J PHARMACEUT, V391, P203, DOI 10.1016/j.ijpharm.2010.03.008
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0
   Bragagni M, 2012, DRUG DELIV, V19, P354, DOI 10.3109/10717544.2012.724472
   Burger C., 2016, CURR DRUG DELIV, V13
   Cevc G, 1996, ADV DRUG DELIVER REV, V18, P349, DOI 10.1016/0169-409X(95)00091-K
   Cevc G, 2004, BBA-BIOMEMBRANES, V1663, P61, DOI 10.1016/j.bbamem.2004.01.006
   Cevc G, 2003, CLIN PHARMACOKINET, V42, P461, DOI 10.2165/00003088-200342050-00004
   Clarke AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151587
   Dora CP, 2010, ACTA POL PHARM, V67, P283
   Duangjit S., 2011, J DRUG DELIV, V2011, DOI DOI 10.1155/2011/418316
   El Zaafarany GM, 2010, INT J PHARMACEUT, V397, P164, DOI 10.1016/j.ijpharm.2010.06.034
   Fang JY, 2001, INT J PHARM, V215, P91, DOI 10.1016/S0378-5173(00)00669-4
   Gohel M, 2000, AAPS PHARMSCITECH, V1, P43, DOI DOI 10.1208/PT010431
   Gupta PN, 2005, J PHARM PHARMACOL, V57, P295, DOI 10.1211/0022357055515
   Hiruta Y, 2006, J CONTROL RELEASE, V113, P146, DOI 10.1016/j.jconrel.2006.04.016
   Hsiao S. H., 2016, J CLIN PHARM THER, P1
   Jain S, 2003, DRUG DEV IND PHARM, V29, P1013, DOI 10.1081/DDC-120025458
   Jain S., 2016, J PHARM SCI
   Johnston TP, 2004, J CARDIOVASC PHARM, V43, P595, DOI 10.1097/00005344-200404000-00016
   Johnston TP, 2001, INT J PHARM, V229, P75, DOI 10.1016/S0378-5173(01)00834-1
   Kamel R, 2013, J LIPOSOME RES, V23, P28, DOI 10.3109/08982104.2012.727422
   Khan MA, 2015, DRUG DELIV, V22, P795, DOI 10.3109/10717544.2014.902146
   Korolenko Tatyana A, 2013, Interdiscip Toxicol, V6, P18, DOI 10.2478/intox-2013-0004
   Lau YY, 2006, DRUG METAB DISPOS, V34, P1175, DOI 10.1124/dmd.105.009076
   Lee EH, 2005, BIOMATERIALS, V26, P205, DOI 10.1016/j.biomaterials.2004.02.020
   Lemieux I, 2001, ARCH INTERN MED, V161, P2685, DOI 10.1001/archinte.161.22.2685
   Lennernas H, 2003, CLIN PHARMACOKINET, V42, P1141, DOI 10.2165/00003088-200342130-00005
   Li HX, 2016, DRUG SAFETY, V39, P409, DOI 10.1007/s40264-016-0394-0
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748
   Manconi M, 2003, INT J PHARM, V260, P261, DOI 10.1016/S0378-5173(03)00268-0
   Manconi M, 2009, COLLOID SURFACE A, V342, P53, DOI 10.1016/j.colsurfa.2009.04.006
   Martinez-Hervas S, 2016, EUR J CLIN INVEST, V46, P636, DOI 10.1111/eci.12642
   Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   Nasr M, 2008, J MICROENCAPSUL, V25, P499, DOI 10.1080/02652040802055411 
   Otunola GA, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-5
   Pal S, 2015, FOOD CHEM TOXICOL, V83, P36, DOI 10.1016/j.fct.2015.05.016
   Pal S, 2015, BIOCHIMIE, V112, P20, DOI 10.1016/j.biochi.2015.02.016
   Perrillo R. P., 2010, BAYL U MED CENT P, V23, P113
   Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504
   Salama HA, 2012, J LIPOSOME RES, V22, P336, DOI 10.3109/08982104.2012.700460
   Shazly G. A., 2012, DRUG DEVELOP RES, P1
   Shen HR, 2006, J PHARM PHARMACOL, V58, P1183, DOI 10.1211/jpp.58.9.0004
   Srivastava R. C., 2005, APPL SURFACE ACTIVIT
   Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x
   Stokes KY, 2002, FREE RADICAL BIO MED, V33, P1026, DOI 10.1016/S0891-5849(02)01015-8
   Subongkot T, 2013, INT J PHARMACEUT, V441, P151, DOI 10.1016/j.ijpharm.2012.12.003
   Sueishi Y, 2011, FOOD CHEM, V129, P866, DOI 10.1016/j.foodchem.2011.05.036
   Sun JK, 2010, DRUG DELIV, V17, P164, DOI 10.3109/10717541003667764
   Tiwari A, 2006, EXPERT OPIN DRUG SAF, V5, P651, DOI 10.1517/14740338.5.5.651
   van den Bergh BAI, 2001, INT J PHARM, V217, P13, DOI 10.1016/S0378-5173(01)00576-2
   Verma DD, 2003, EUR J PHARM BIOPHARM, V55, P271, DOI 10.1016/S0939-6411(03)00021-3
   Vogt A, 2016, J CONTROL RELEASE, V242, P3, DOI 10.1016/j.jconrel.2016.07.027
   Wang Y., 2016, DRUG DELIV, P1
   Warisnoicharoen W, 2000, AAPS PHARMSCI, V2
   Wat E, 2016, J ETHNOPHARMACOL, V178, P104, DOI 10.1016/j.jep.2015.12.004
   Yeom DW, 2015, INT J NANOMED, V10, P3865, DOI 10.2147/IJN.S83520
   Yonezawa Y, 2001, CHEM PHARM BULL, V49, P1448, DOI 10.1248/cpb.49.1448
   Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003
   Zarghi A, 2005, ARZNEIMITTEL-FORSCH, V55, P451
   Zhou XJ, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0324-1
   Zylberberg C, 2016, DRUG DELIV, V23, P3319, DOI 10.1080/10717544.2016.1177136
NR 76
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY 28
PY 2017
VL 254
BP 10
EP 22
DI 10.1016/j.jconrel.2017.03.039
PG 13
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA EX2LB
UT WOS:000403056700002
PM 28344015
OA No
DA 2017-08-17
ER

PT J
AU Mashal, M
   Attia, N
   Puras, G
   Martinez-Navarrete, G
   Fernandez, E
   Pedraz, JL
AF Mashal, Mohamed
   Attia, Noha
   Puras, Gustavo
   Martinez-Navarrete, Gema
   Fernandez, Eduardo
   Luis Pedraz, Jose
TI Retinal gene delivery enhancement by lycopene incorporation into
   cationic niosomes based on DOTMA and polysorbate 60
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Niosomes; Lycopene; Gene therapy; Retina; Non-viral vectors;
   Nanotechnology
ID DRUG-DELIVERY; TRANSFECTION EFFICIENCY; CELL-DEATH; IN-VIVO; THERAPY;
   LIPOSOMES; FORMULATION; MECHANISMS; COMPLEXES; VECTORS
AB The present study aimed to evaluate the incorporation of the natural lipid lycopene into niosome formulations based on cationic lipid DOTMA and polysorbate 60 non-ionic surfactant to analyze the potential application of this novel formulation to deliver genetic material into the rat retina. Both niosomes with and without lycopene were prepared by the reverse phase evaporation method and physicochemically characterized in terms of size, zeta potential, polydispersity index and capacity to condense, release and protect the DNA against enzymatic digestion. In vitro experiments were performed in ARPE-19 cells after complexion of niosomes with pCMS-EGFP plasmid at appropriate cationic lipid/DNA ratios. At 18/1 mass ratio, nioplexes containing lycopene had nanometric size, positive zeta potential, low polydispersity and were able to condense, release and protect DNA. Percentage of transfected cell was around 35% without compromising cell viability. The internalization pathways studies revealed a preference to caveolae mediated endocytosis and macropinocytosis, which could circumvent lysosomal degradation. Both subretinal and intravitreal administrations to the rat retina showed that nioplexes were able to transfect efficiently the outer segments of the retina, which offer reasonable hope for the treatment of many inherited retinal diseases by a safe non-viral vector formulation after the less invasive intravitreal administration.
C1 [Mashal, Mohamed; Attia, Noha; Puras, Gustavo; Luis Pedraz, Jose] Univ Basque Country UPV EHU, Sch Pharm, NanoBioCel Grp, Lab Pharmaceut, Paseo Univ 7, Vitoria 01006, Spain.
   [Attia, Noha] Univ Alexandria, Fac Med, Histol & Cell Biol Dept, Alexandria, Egypt.
   [Puras, Gustavo; Martinez-Navarrete, Gema; Fernandez, Eduardo; Luis Pedraz, Jose] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Vitoria, Spain.
   [Martinez-Navarrete, Gema; Fernandez, Eduardo] Miguel Hernandez Univ, Neuroprothesis & Neuroengn Res Grp, Elche, Spain.
RP Pedraz, JL (reprint author), Univ Basque Country, Fac Pharm, Lab Pharm & Pharmaceut Technol, Vitoria 01006, Spain.
EM joseluis.pedraz@ehu.eus
FU University of the Basque Country UPV/EHU [UFI 11/32]; Research Chair in
   Retinosis Pigmentosas "Bidons Egara"; Spanish Ministry of Education
   [CTQ2010-20541, CTQ2010-14897]; Basque Government (Department of
   Education, University and Research) [BFI-2011-2226]; 
   [MAT2012-39290-C02-01];  [MAT2015- 69967-C3-1-R];  [SAF2013-42347-R]; 
   [IPT-2012-0574-300000]
FX This project was partially supported by the University of the Basque
   Country UPV/EHU (UFI 11/32), by the Research Chair in Retinosis
   Pigmentosas "Bidons Egara", the Spanish Ministry of Education (Grant
   Nos. CTQ2010-20541, CTQ2010-14897), the Basque Government (Department of
   Education, University and Research, predoctoral BFI-2011-2226 grant),
   and by Spanish Grant Nos. MAT2012-39290-C02-01, MAT2015- 69967-C3-1-R,
   SAF2013-42347-R, and IPT-2012-0574-300000. Technical and human support
   provided by SGIker (UPV/EHU) is gratefully acknowledged. The authors
   also wish to thank the intellectual and technical assistance from the
   ICTS "NANBIOSIS", more specifically by the Drug Formulation Unit (U10)
   of the CIBER in Bioengineering, Biomaterials, and Nanomedicine
   (CIBER-BBN) at the University of Basque Country (UPV/ EHU).
CR Abdelbary G, 2008, AAPS PHARMSCITECH, V9, P740, DOI 10.1208/s12249-008-9105-1
   Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002
   Aramaki K, 2015, LANGMUIR, V31, P10664, DOI 10.1021/acs.langmuir.5b02454
   Balazs D. A., 2010, J DRUG DELIV, V2011
   Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008
   Berns K. I., 2013, THE PARVOVIRUSES
   Bernstein PS, 2001, EXP EYE RES, V72, P215, DOI 10.1006/exer.2000.0954
   Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280
   del Pozo-Rodriguez A, 2007, INT J PHARM, V339, P261, DOI 10.1016/j.ijpharm.2007.02.015
   Dukhin AS, 2006, J ELECTROANAL CHEM, V588, P44, DOI 10.1016/j.jelechem.2005.12.001
   El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54
   Ferrari A, 2003, MOL THER, V8, P284, DOI 10.1016/S1525-0016(03)00122-9
   Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698
   Issa PC, 2012, CLIN EXP OPHTHALMOL, V40, P39, DOI 10.1111/j.1442-9071.2011.02649.x
   Kachi S, 2005, GENE THER, V12, P843, DOI 10.1038/sj.gt.3302475
   Kazi Karim Masud, 2010, J Adv Pharm Technol Res, V1, P374, DOI 10.4103/0110-5558.76435
   Koirala A, 2013, BIOMATERIALS, V34, P7158, DOI 10.1016/j.biomaterials.2013.06.002
   Krishnamoorthy Gunasekaran, 2013, Interdiscip Toxicol, V6, P83, DOI 10.2478/intox-2013-0015
   Kuznetsova AV, 2014, J OPHTHALMOL, DOI 10.1155/2014/801787
   Liu A, 2006, MOL CANCER THER, V5, P2879, DOI 10.1158/1535-7163.MCT-06-0373
   Liu F, 1996, PHARMACEUT RES, V13, P1642, DOI 10.1023/A:1016480421204
   Marianecci C, 2014, ADV COLLOID INTERFAC, V205, P187, DOI 10.1016/j.cis.2013.11.018
   Martens TF, 2015, J CONTROL RELEASE, V202, P83, DOI 10.1016/j.jconrel.2015.01.030
   Meyer O, 1998, J BIOL CHEM, V273, P15621, DOI 10.1074/jbc.273.25.15621
   Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036
   Ojeda E, 2015, ORG BIOMOL CHEM, V13, P1068, DOI 10.1039/c4ob02087a
   Ojeda E, 2016, INT J PHARMACEUT, V503, P115, DOI 10.1016/j.ijpharm.2016.02.043
   Oliveira AV, 2016, MAT SCI ENG C-MATER, V58, P264, DOI 10.1016/j.msec.2015.08.047
   Palozza Paola, 2011, Cancers (Basel), V3, P2333, DOI 10.3390/cancers3022333
   Puras G, 2015, MOL PHARMACEUT, V12, P3658, DOI 10.1021/acs.molpharmaceut.5b00422
   Puras G, 2014, J CONTROL RELEASE, V174, P27, DOI 10.1016/j.jconrel.2013.11.004
   Rajera R, 2011, BIOL PHARM BULL, V34, P945
   Ramamoorth Murali, 2015, J Clin Diagn Res, V9, pGE01, DOI 10.7860/JCDR/2015/10443.5394
   Ramezani M, 2009, COLLOID SURFACE B, V72, P1, DOI 10.1016/j.colsurfb.2009.03.018
   Rhein LD, 2007, SURFACTANT SCI SER, V135, P1
   Sakurai F, 2000, J CONTROL RELEASE, V66, P255, DOI 10.1016/S0168-3659(99)00280-1
   Sharoni Y, 2004, ARCH BIOCHEM BIOPHYS, V430, P89, DOI 10.1016/j.abb.2004.03.009
   Shinde V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.325
   Smith JG, 1998, PHARMACEUT RES, V15, P1356, DOI 10.1023/A:1011937218418
   Song YK, 1998, BBA-BIOMEMBRANES, V1372, P141, DOI 10.1016/S0005-2736(98)00054-6
   Stein-Streilein J, 2013, INT REV IMMUNOL, V32, P42, DOI 10.3109/08830185.2012.740535
   Sung WS, 2007, J MICROBIOL BIOTECHN, V17, P1797
   SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194
   Szunerits S., 2015, INTRO PLASMONICS ADV
   Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024
   Whitmore SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-21
   Xia SQ, 2015, COLLOID SURFACE B, V128, P172, DOI 10.1016/j.colsurfb.2015.02.004
   Xiang S., 2013, CELLULAR UPTAKE MECH
   Xiang SN, 2012, J CONTROL RELEASE, V158, P371, DOI 10.1016/j.jconrel.2011.09.093
   Zheng QX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044855
   Zinchuk V., 2008, CURR PROTOC CELL S39, V4
   Zinchuk V., 2008, CURR PROTOC CELL S39, V4
NR 52
TC 0
Z9 0
U1 11
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY 28
PY 2017
VL 254
BP 55
EP 64
DI 10.1016/j.jconrel.2017.03.386
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA EX2LB
UT WOS:000403056700006
PM 28347807
OA No
DA 2017-08-17
ER

PT J
AU Gaber, M
   Medhat, W
   Hany, M
   Saher, N
   Fang, JY
   Elzoghby, A
AF Gaber, Mohamed
   Medhat, Waseem
   Hany, Mark
   Saher, Nourhan
   Fang, Jia-You
   Elzoghby, Ahmed
TI Protein-lipid nanohybrids as emerging platforms for drug and gene
   delivery: Challenges and outcomes
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Protein nanoparticles; Lipid nanoparticles; Liposomes; Nanohybrids; Drug
   delivery; Gene delivery
ID HUMAN SERUM-ALBUMIN; TRANSFERRIN-CONJUGATED LIPOSOMES; LIPOPROTEIN-LIKE
   NANOPARTICLES; LINKED CASEIN NANOPARTICLES; OLEIC ACID NANOPARTICLES;
   IN-VIVO PHARMACOKINETICS; GREATLY LOWERED TOXICITY; FIBROIN-COATED
   LIPOSOMES; BLOOD-BRAIN-BARRIER; BREAST-CANCER CELLS
AB Nanoparticulate drug delivery systems have been long used to deliver a vast range of drugs and bioactives owing to their ability to demonstrate novel physical, chemical, and/or biological properties. An exponential growth has spurred in research and development of these nanocarriers which led to the evolution of a great number of diverse nanosystems including liposomes, nanoemulsions, solid lipid nanoparticles (SLNs), micelles, dendrimers, polymeric nanoparticles (NPs), metallic NPs, and carbon nanotubes. Among them, lipid-based nanocarriers have made the largest progress whether commercially or under development. Despite this progress, these lipid-based nanocarriers suffer from several limitations that led to the development of many protein-coated lipid nanocarriers. To less extent, protein-based nanocarriers suffer from limitations that led to the fabrication of some lipid bilayer enveloping protein nanocarriers. This review discusses in-depth some limitations associated with the lipid-based or protein-based nanocarriers and the fruitful outcomes brought by protein-lipid hybridization. Also discussed are the various hybridization techniques utilized to formulate these protein-lipid nanohybrids and the mechanisms involved in the drug loading process.
C1 [Gaber, Mohamed; Medhat, Waseem; Hany, Mark; Saher, Nourhan; Elzoghby, Ahmed] Univ Alexandria, Fac Pharm, CNRL, Alexandria 21521, Egypt.
   [Fang, Jia-You] Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Taoyuan 333, Taiwan.
   [Fang, Jia-You] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Kweishan, Taiwan.
   [Fang, Jia-You] Chang Gung Univ Sci & Technol, Res Ctr Chinese Herbal Med, Kweishan, Taiwan.
   [Fang, Jia-You] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan 333, Taiwan.
   [Elzoghby, Ahmed] Univ Alexandria, Fac Pharm, Dept Ind Pharm, Alexandria 21521, Egypt.
RP Elzoghby, A (reprint author), Univ Alexandria, Fac Pharm, CNRL, Alexandria 21521, Egypt.; Fang, JY (reprint author), Chang Gung Univ, Grad Inst Nat Prod, Pharmaceut Lab, Taoyuan 333, Taiwan.
EM fajy@mail.cgu.edu.tw; ahmed_elzoghby@alexu.edu.eg
CR Abhinav A., 2011, CURR NANOSCI, V7, P71
   Afzal SM, 2016, DRUG DELIV, V23, P1355, DOI 10.3109/10717544.2015.1030715
   Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Alqahtani MS, 2017, MOL PHARMACEUT, V14, P757, DOI 10.1021/acs.molpharmaceut.6b01017
   Cagdas M., 2014, LIPOSOMES POTENTIAL
   Cardoso ALC, 2008, J CONTROL RELEASE, V132, P113, DOI 10.1016/j.jconrel.2008.08.014
   Chang Q, 2016, DRUG DELIV, V23, P3629, DOI 10.1080/10717544.2016.1214989
   Cheema SK, 2007, INT J PHARMACEUT, V341, P221, DOI 10.1016/j.ijpharm.2007.03.043
   Chen CH, 2015, J DRUG TARGET, V23, P311, DOI 10.3109/1061186X.2014.994182
   Chen HL, 2011, EUR J PHARM SCI, V44, P164, DOI 10.1016/j.ejps.2011.07.007
   Chen HL, 2010, EUR J PHARM SCI, V40, P94, DOI 10.1016/j.ejps.2010.03.007
   Chen JH, 2016, JOINT 2016 INTERNATIONAL CONFERENCE ON SOCIAL SCIENCE AND ENVIRONMENTAL SCIENCE (SSES 2016) AND INTERNATIONAL CONFERENCE ON FOOD SCIENCE AND ENGINEERING (ICFSE 2016), P1
   Chen J, 2015, INT J PHARMACEUT, V490, P219, DOI 10.1016/j.ijpharm.2015.05.047
   Chen SQ, 2016, RSC ADV, V6, P15220, DOI 10.1039/c5ra25129j
   Chen ZL, 2016, NANOMED-NANOTECHNOL, V12, P421, DOI 10.1016/j.nano.2015.10.021
   Chiu SJ, 2006, J CONTROL RELEASE, V112, P199, DOI 10.1016/j.jconrel.2006.02.011
   Chuacharoen T, 2016, COLLOID SURFACE A, V503, P11, DOI 10.1016/j.colsurfa.2016.04.038
   Cinci M, 2015, TARGET ONCOL, V10, P405, DOI 10.1007/s11523-014-0345-6
   De Ilarduya CT, 2006, J DRUG TARGET, V14, P527, DOI 10.1080/10611860600825282
   De Luca MA, 2015, PHARM, V479, P129
   Ding H, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/5/055101
   Dong YX, 2015, EUR J PHARM BIOPHARM, V91, P82, DOI 10.1016/j.ejpb.2015.01.018
   Elgindy N., 2012, J NANOMED NANOTECHNO, V2011
   Elgindy N, 2011, DRUG DEV IND PHARM, V37, P446, DOI 10.3109/03639045.2010.522190
   Elgindy N, 2011, DRUG DEV IND PHARM, V37, P754, DOI 10.3109/03639045.2010.539232
   Elzoghby AO, 2016, CURR PHARM DESIGN, V22, P3305, DOI 10.2174/1381612822666160204120829
   Elzoghby AO, 2015, INT J PHARMACEUT, V491, P113, DOI 10.1016/j.ijpharm.2015.06.015
   Elzoghby Ahmed O, 2015, Adv Protein Chem Struct Biol, V98, P169, DOI 10.1016/bs.apcsb.2014.12.002
   Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019
   Elzoghby AO, 2013, EUR J PHARM BIOPHARM, V85, P444, DOI 10.1016/j.ejpb.2013.07.003
   Elzoghby AO, 2013, PHARM RES-DORDR, V30, P2654, DOI 10.1007/s11095-013-1091-7
   Elzoghby AO, 2013, EUR J PHARM BIOPHARM, V84, P487, DOI 10.1016/j.ejpb.2013.01.005
   Elzoghby AO, 2013, INT J NANOMED, V8, P1721, DOI 10.2147/IJN.S40674
   Elzoghby AO, 2013, PHARM RES-DORDR, V30, P512, DOI 10.1007/s11095-012-0897-z
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Elzoghby AO, 2012, J CONTROL RELEASE, V157, P168, DOI 10.1016/j.jconrel.2011.07.031
   Elzoghby A. O., 2016, J CONTROL RELEASE
   Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013
   Faneca H, 2008, J CONTROL RELEASE, V126, P175, DOI 10.1016/j.jconrel.2007.12.005
   Faneca H, 2007, BBA-BIOMEMBRANES, V1768, P1093, DOI 10.1016/j.bbamem.2006.12.017
   Faneca H, 2004, J GENE MED, V6, P681, DOI 10.1002/jgm.550
   Fang B, 2014, BBA-MOL CELL BIOL L, V1841, P535, DOI 10.1016/j.bbalip.2013.12.008
   Floury J., 2000, Innovative Food Science & Emerging Technologies, V1, P127, DOI 10.1016/S1466-8564(00)00012-6
   Freag MS, 2016, NANOMEDICINE-UK, V11, P2975, DOI 10.2217/nnm-2016-0236
   Freag MS, 2013, INT J NANOMED, V8, P2385, DOI 10.2147/IJN.S45231
   Frenzel M, 2015, FOOD CHEM, V173, P1090, DOI 10.1016/j.foodchem.2014.10.076
   Furumoto K, 2007, INT J PHARMACEUT, V329, P110, DOI 10.1016/j.ijpharm.2006.08.026
   Gaberc-Porekar V, 2008, CURR OPIN DRUG DISC, V11, P242
   Gao HL, 2013, NANOMEDICINE-UK, V8, P1429, DOI [10.2217/nnm.12.180, 10.2217/NNM.12.180]
   Gao JQ, 2013, BIOMATERIALS, V34, P5628, DOI 10.1016/j.biomaterials.2013.03.097
   Gaspar MM, 2012, J AEROSOL MED PULM D, V25, P310, DOI 10.1089/jamp.2011.0928
   Gobin AS, 2006, INT J NANOMED, V1, P81, DOI 10.2147/nano.2006.1.1.81
   Guan PP, 2015, INT J PHARMACEUT, V478, P655, DOI 10.1016/j.ijpharm.2014.12.016
   Han SY, 2013, COLLOID SURFACE B, V102, P833, DOI 10.1016/j.colsurfb.2012.09.010
   Han YQ, 2014, INT J NANOMED, V9, P4107, DOI 10.2147/IJN.S67770
   He W, 2015, INT J PHARMACEUT, V478, P762, DOI 10.1016/j.ijpharm.2014.12.039
   He XY, 2015, INT J PHARMACEUT, V487, P250, DOI 10.1016/j.ijpharm.2015.04.047
   Heidel JD, 2011, PHARM RES-DORDR, V28, P187, DOI 10.1007/s11095-010-0178-7
   Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P127, DOI 10.1016/B978-0-12-382239-0.00002-9
   Hermanson G. T., 2013, HETEROBIFUNCTIONAL C, P299
   Howard MD, 2008, J BIOMED NANOTECHNOL, V4, P133, DOI 10.1166/jbn.2008.021
   Huang FYJ, 2013, INT J MOL SCI, V14, P2862, DOI 10.3390/ijms14022862
   Hurtado-Lopez P, 2006, J PHARM PHARMACOL, V58, P769, DOI 10.1211/jpp.58.6.0007
   Jain S, 2012, MOL PHARMACEUT, V9, P2542, DOI 10.1021/mp300320d
   Jiang HR, 2010, J DAIRY SCI, V93, P3931, DOI 10.3168/jds.2010-3071
   Jung SH, 2010, COLLOID SURFACE B, V76, P434, DOI 10.1016/j.colsurfb.2009.12.002
   Kamps JAAM, 1996, BBA-BIOMEMBRANES, V1278, P183, DOI 10.1016/0005-2736(95)00218-9
   Kamps JAAM, 1997, P NATL ACAD SCI USA, V94, P11681, DOI 10.1073/pnas.94.21.11681
   Kandadi P, 2012, NANOMED-NANOTECHNOL, V8, P1162, DOI 10.1016/j.nano.2011.12.006
   Kaspersen JD, 2014, CHEMBIOCHEM, V15, P2693, DOI 10.1002/cbic.201402407
   Khatik R, 2014, EXPERT OPIN DRUG DEL, V11, P633, DOI 10.1517/17425247.2014.889678
   Kuo YC, 2016, INT J PHARMACEUT, V499, P10, DOI 10.1016/j.ijpharm.2015.12.054
   Kuo YC, 2014, J PHARM SCI-US, V103, P2484, DOI 10.1002/jps.24081
   Kwon TK, 2011, J IND ENG CHEM, V17, P10, DOI 10.1016/j.jiec.2010.10.001
   Lee SJ, 2011, J AGR FOOD CHEM, V59, P415, DOI 10.1021/jf103511v
   Leto I, 2016, CHEMMEDCHEM, V11, P1745, DOI 10.1002/cmdc.201500586
   Li H, 2016, MOL PHARMACEUT, V13, P2555, DOI 10.1021/acs.molpharmaceut.6b00363
   Li YJ, 2017, NANOMED-NANOTECHNOL, V13, P371, DOI 10.1016/j.nano.2016.09.014
   Linkov I, 2008, NANOMED-NANOTECHNOL, V4, P167, DOI 10.1016/j.nano.2008.01.001
   Loureiro A, 2015, NANOMED-NANOTECHNOL, V11, P1077, DOI 10.1016/j.nano.2015.02.022
   Loureiro A, 2015, RSC ADV, V5, P4976, DOI 10.1039/c4ra13802c
   Lv Q, 2013, INT J PHARMACEUT, V444, P1, DOI 10.1016/j.ijpharm.2013.01.025
   Manjunath K, 2005, METHOD FIND EXP CLIN, V27, P127, DOI 10.1358/mf.2005.27.2.876286
   Mehnert W, 2001, ADV DRUG DELIVER REV, V47, P165, DOI 10.1016/S0169-409X(01)00105-3
   Meng FF, 2015, COLLOID SURFACE B, V134, P88, DOI 10.1016/j.colsurfb.2015.06.025
   Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X
   Mulik RS, 2010, INT J PHARMACEUT, V398, P190, DOI 10.1016/j.ijpharm.2010.07.021
   Muller R H, 2000, J PHARM BIOPHARMACEU, V50, P161
   Nakase M, 2005, MOL CANCER THER, V4, P625, DOI 10.1158/1535-7163.MCT-04-0196
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Neves SS, 2006, BBA-BIOMEMBRANES, V1758, P1703, DOI 10.1016/j.bbamem.2006.08.021
   Nielsen SB, 2010, J MOL BIOL, V398, P351, DOI 10.1016/j.jmb.2010.03.012
   Pan XG, 2008, INT J PHARM, V358, P263, DOI 10.1016/j.ijpharm.2008.02.020
   Pandey V, 2015, DRUG DELIV, V22, P199, DOI 10.3109/10717544.2013.877100
   Park C, 2015, EUR J PHARM BIOPHARM, V89, P365, DOI 10.1016/j.ejpb.2014.12.002
   Pawar S, 2015, ADV PHARM BULL, V5, P537, DOI 10.15171/apb.2015.073
   Pedersen JN, 2015, BIOCHEMISTRY-US, V54, P4815, DOI 10.1021/acs.biochem.5b00547
   Peng Q, 2014, ACS APPL MATER INTER, V6, P13730, DOI 10.1021/am503179a
   Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230
   Tran PHL, 2014, J BIOMED NANOTECHNOL, V10, P154, DOI 10.1166/jbn.2014.1660
   Tran PHL, 2013, INT J PHARMACEUT, V455, P235, DOI 10.1016/j.ijpharm.2013.07.025
   Tran PHL, 2013, J BIOMED NANOTECHNOL, V9, P1416, DOI 10.1166/jbn.2013.1621
   Piao LZ, 2013, NANOMED-NANOTECHNOL, V9, P122, DOI 10.1016/j.nano.2012.03.008
   Pooja D, 2016, MOL PHARMACEUT, V13, P3903, DOI 10.1021/acs.molpharmaceut.6b00691
   Puri A, 2009, CRIT REV THER DRUG, V26, P523
   Qian K, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S83731
   Qin L, 2014, ONCOL LETT, V8, P2000, DOI 10.3892/ol.2014.2449
   Reddy JS, 2006, J DRUG TARGET, V14, P13, DOI 10.1080/10611860600613241
   Ruttala HB, 2015, COLLOID SURFACE B, V128, P419, DOI 10.1016/j.colsurfb.2015.02.040
   Ruttala HB, 2015, PHARM RES-DORDR, V32, P1002, DOI 10.1007/s11095-014-1512-2
   Sakaguchi N, 2006, INT J PHARMACEUT, V325, P186, DOI 10.1016/j.ijpharm.2006.06.015
   Sarkar D, 2013, J PHOTOCH PHOTOBIO A, V252, P194, DOI 10.1016/j.jphotochem.2012.11.010
   Shao Zhenyu, 2015, Int J Nanomedicine, V10, P1223, DOI 10.2147/IJN.S77837
   Shilpi S, 2015, PROG BIOMATER, V4, P55, DOI 10.1007/s40204-015-0037-z
   Simoes S, 2000, BBA-BIOMEMBRANES, V1463, P459, DOI 10.1016/S0005-2736(99)00238-2
   Singh I, 2016, J DRUG TARGET, V24, P212, DOI 10.3109/1061186X.2015.1068320
   Singh M, 2006, INT J PHARM, V321, P124, DOI 10.1016/j.ijpharm.2006.05.005
   Singhal A., 1994, GENE THERAPEUTICS ME, P118
   Sonali, 2016, DRUG DELIV, V23, P1261, DOI 10.3109/10717544.2016.1162878
   Soni V, 2005, J DRUG TARGET, V13, P245, DOI 10.1080/10611860500107401
   Sriraman SK, 2016, EUR J PHARM BIOPHARM, V105, P40, DOI 10.1016/j.ejpb.2016.05.023
   Sriraman SK, 2015, J CONTROL RELEASE, V220, P160, DOI 10.1016/j.jconrel.2015.10.037
   Svanborg C, 2003, ADV CANCER RES, V88, P1
   Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103
   Tang B, 2015, ASIAN J PHARM SCI, V10, P363, DOI 10.1016/j.ajps.2015.04.004
   Tang B, 2014, INT J PHARMACEUT, V475, P416, DOI 10.1016/j.ijpharm.2014.09.011
   Thole M, 2002, J DRUG TARGET, V10, P337, DOI 10.1080/10611860290031840
   Troncoso E, 2012, J COLLOID INTERF SCI, V382, P110, DOI 10.1016/j.jcis.2012.05.054
   van der Meel R, 2013, ADV DRUG DELIVER REV, V65, P1284, DOI 10.1016/j.addr.2013.08.012
   Voinea M, 2002, VASC PHARMACOL, V39, P13, DOI 10.1016/S1537-1891(02)00165-9
   Vuarchey C., 2011, NANOTECHNOL DEV, V1, P2
   Wang W, 2012, INT J NANOMED, V7, P2513, DOI 10.2147/IJN.S31915
   Watanabe M, 2008, J CONTROL RELEASE, V127, P231, DOI 10.1016/j.jconrel.2008.02.005
   Weecharangsan W, 2012, DRUG DELIV, V19, P292, DOI 10.3109/10717544.2012.714810
   Weecharangsan W, 2009, MOL PHARMACEUT, V6, P1848, DOI 10.1021/mp900150g
   Weeke-Klimp AH, 2007, J DRUG TARGET, V15, P585, DOI 10.1080/10611860701502889
   Wei MY, 2012, EUR J PHARM SCI, V46, P131, DOI 10.1016/j.ejps.2012.02.007
   Xu SL, 2011, INT J PHARMACEUT, V404, P205, DOI 10.1016/j.ijpharm.2010.10.053
   Xu Y, 2010, J CONTROL RELEASE, V146, P299, DOI 10.1016/j.jconrel.2010.05.022
   Yang XJ, 2009, MOL PHARMACEUT, V6, P221, DOI 10.1021/mp800149s
   Yang ZG, 2014, NANOSCALE, V6, P9742, DOI 10.1039/c4nr01510j
   Yi J, 2014, J AGR FOOD CHEM, V62, P1096, DOI 10.1021/jf404073c
   Yokoe JI, 2008, INT J PHARMACEUT, V353, P28, DOI 10.1016/j.ijphartn.2007.11.008
   Yuan M Q, 2014, Drug Res (Stuttg), V64, P195, DOI 10.1055/s-0033-1355335
   Zhang L, 2014, ACTA PHARMACOL SIN, V35, P846, DOI 10.1038/aps.2014.26
   Zhao CY, 2014, COLLOID SURFACE B, V123, P787, DOI 10.1016/j.colsurfb.2014.10.024
   Zhao YZ, 2014, NANOMED-NANOTECHNOL, V10, P755, DOI 10.1016/j.nano.2013.10.009
   Zheng CY, 2015, INT J CLIN EXP MED, V8, P1658
   Zheng Y, 2010, INT J PHARMACEUT, V390, P234, DOI 10.1016/j.ijpharm.2010.02.008
   Zhong ZR, 2007, PHARMAZIE, V62, P522, DOI 10.1691/ph.2007.7.6248
   Zhou J, 2013, MOL PHARMACEUT, V10, P3832, DOI 10.1021/mp400303w
   Zhuo HQ, 2013, CLIN CANCER RES, V19, P4206, DOI 10.1158/1078-0432.CCR-12-3451
NR 153
TC 2
Z9 2
U1 9
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY 28
PY 2017
VL 254
BP 75
EP 91
DI 10.1016/j.jconrel.2017.03.392
PG 17
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA EX2LB
UT WOS:000403056700008
PM 28365294
OA No
DA 2017-08-17
ER

PT J
AU Kipnusu, WK
   Elsayed, M
   Krause-Rehberg, R
   Kremer, F
AF Kipnusu, Wycliffe K.
   Elsayed, Mohamed
   Krause-Rehberg, Reinhard
   Kremer, Friedrich
TI Glassy dynamics of polymethylphenylsiloxane in one- and two-dimensional
   nanometric confinement-A comparison
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article
ID NANOPOROUS GLASSES; MOLECULAR-DYNAMICS; NEUTRON-SCATTERING; BONDED
   LIQUIDS; TRANSITION; POLYMERS; SPECTROSCOPY; RELAXATION; FILMS
AB Glassy dynamics of polymethylphenylsiloxane (PMPS) is studied by broadband dielectric spectroscopy in one-dimensional (1D) and two-dimensional (2D) nanometric confinement; the former is realized in thin polymer layers having thicknesses down to 5 nm, and the latter in unidirectional (thickness 50 mu m) nanopores with diameters varying between 4 and 8 nm. Based on the dielectric measurements carried out in a broad spectral range at widely varying temperatures, glassy dynamics is analyzed in detail in 1D and in 2D confinements with the following results: (i) the segmental dynamics (dynamic glass transition) of PMPS in 1D confinement down to thicknesses of 5 nm is identical to the bulk in the mean relaxation rate and the width of the relaxation time distribution function; (ii) additionally a well separated surface induced relaxation is observed, being assigned to adsorption and desorption processes of polymer segments with the solid interface; (iii) in 2D confinement with native inner pore walls, the segmental dynamics shows a confinement effect, i. e., the smaller the pores are, the faster the segmental dynamics; on silanization, this dependence on the pore diameter vanishes, but the mean relaxation rate is still faster than in 1D confinement; (iv) in a 2D confinement, a pronounced surface induced relaxation process is found, the strength of which increases with the decreasing pore diameter; it can be fully removed by silanization of the inner pore walls; (v) the surface induced relaxation depends on its spectral position only negligibly on the pore diameter; (vi) comparing 1D and 2D confinements, the segmental dynamics in the latter is by about two orders of magnitude faster. All these findings can be comprehended by considering the density of the polymer; in 1D it is assumed to be the same as in the bulk, hence the dynamic glass transition is not altered; in 2D it is reduced due to a frustration of packaging resulting in a higher free volume, as proven by ortho-positronium annihilation lifetime spectroscopy. Published by AIP Publishing.
C1 [Kipnusu, Wycliffe K.; Kremer, Friedrich] Univ Leipzig, Inst Expt Phys 1, D-04103 Leipzig, Germany.
   [Elsayed, Mohamed; Krause-Rehberg, Reinhard] Martin Luther Univ Halle Wittenberg, Dept Phys, D-06099 Halle, Germany.
   [Elsayed, Mohamed] Menia Univ, Dept Phys, Fac Sci, Al Minya 61519, Egypt.
RP Kipnusu, WK (reprint author), Univ Leipzig, Inst Expt Phys 1, D-04103 Leipzig, Germany.
EM kipnusu@physik.uni-leipzig.de
OI Kiprop Kipnusu, Wycliffe/0000-0003-0643-7716
FU project Polymers under multiple constraints: restricted and controlled
   molecular order and mobility [SFB/TRR 102]
FX Financial support by SFB/TRR 102 within the project Polymers under
   multiple constraints: restricted and controlled molecular order and
   mobility is gratefully acknowledged.
CR Adrjanowicz K, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.265702
   Arndt M, 1996, PHYS REV E, V54, P5377, DOI 10.1103/PhysRevE.54.5377
   Bras AR, 2011, J PHYS CHEM C, V115, P4616, DOI 10.1021/jp107631m
   Carini G, 1997, J CHEM PHYS, V107, P2292, DOI 10.1063/1.474605
   Crupi V, 2002, J PHYS CHEM B, V106, P10884, DOI 10.1021/jp020503m
   Ediger MD, 2014, MACROMOLECULES, V47, P471, DOI 10.1021/ma4017696
   ELDRUP M, 1981, CHEM PHYS, V63, P51, DOI 10.1016/0301-0104(81)80307-2
   Elsayed M, 2015, ACTA MATER, V83, P473, DOI 10.1016/j.actamat.2014.10.021
   Farrer RA, 2003, ACCOUNTS CHEM RES, V36, P605, DOI 10.1021/ar0200302
   Frick B, 2005, J NON-CRYST SOLIDS, V351, P2657, DOI 10.1016/j.jnoncrysol.2005.03.061
   Kansy J, 1996, NUCL INSTRUM METH A, V374, P235, DOI 10.1016/0168-9002(96)00075-7
   Kipnusu WK, 2015, J PHYS CHEM LETT, V6, P3708, DOI 10.1021/acs.jpclett.5b01533
   Kipnusu WK, 2012, Z PHYS CHEM, V226, P797, DOI 10.1524/zpch.2012.0287
   Kremer F., 2003, BROADBAND DIELECTRIC
   Kremer F., 2014, ADV DIELECTRICS
   Kremer F, 2015, J NON-CRYST SOLIDS, V407, P277, DOI 10.1016/j.jnoncrysol.2014.08.016
   Loughnane BJ, 2000, J PHYS CHEM B, V104, P5421, DOI 10.1021/jp000323h
   Mirzaeifard S, 2016, SOFT MATTER, V12, P1783, DOI 10.1039/c5sm02556g
   Patkowski A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021501
   Richert R, 2003, J PHYS CHEM B, V107, P895, DOI 10.1021/jp022039r
   Schonhals A, 2007, EUR PHYS J-SPEC TOP, V141, P255, DOI 10.1141/epjst/e2007-00043-9
   Schonhals A, 2005, J NON-CRYST SOLIDS, V351, P2668, DOI 10.1016/j.jnoncrysol.2005.03.062
   Schonhals A, 2004, COLLOID POLYM SCI, V282, P882, DOI 10.1007/s00396-004-1106-3
   Schonhals A, 2003, J PHYS-CONDENS MAT, V15, pS1139, DOI 10.1088/0953-8984/15/11/334
   Serghei A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2839021
   Tarnacka M, 2016, PHYS CHEM CHEM PHYS, V18, P23709, DOI 10.1039/c6cp03923e
   Tress M, 2013, SCIENCE, V341, P1371, DOI 10.1126/science.1238950
NR 27
TC 1
Z9 1
U1 6
U2 6
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-9606
EI 1089-7690
J9 J CHEM PHYS
JI J. Chem. Phys.
PD MAY 28
PY 2017
VL 146
IS 20
AR 203302
DI 10.1063/1.4974767
PG 6
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA EV5CA
UT WOS:000401778900004
PM 28571386
OA No
DA 2017-08-17
ER

PT J
AU Shakur, H
   Roberts, I
   Fawole, B
   Chaudhri, R
   El-Sheikh, M
   Akintan, A
   Qureshi, Z
   Kidanto, H
   Vwalika, B
   Abdulkadir, A
   Etuk, S
   Noor, S
   Asonganyi, E
   Alfirevic, Z
   Beaumont, D
   Ronsmans, C
   Arulkumaran, S
   Grant, A
   Afsana, K
   Gulmezoglu, M
   Hunt, B
   Olayemi, O
   Roberts, I
   Chalmers, I
   Lumbiganon, P
   Piaggio, G
   Brady, T
   Shakur, H
   Roberts, I
   Alfirevic, Z
   Elbourne, D
   Gulmezoglu, M
   Ronsmans, C
   Balogun, E
   Pepple, T
   Prowse, D
   Quashi, N
   Barneston, L
   Barrow, C
   Beaumont, D
   Cook, L
   Frimley, L
   Gilbert, D
   Gilliam, C
   Jackson, R
   Kawahara, T
   Miah, H
   Kostrov, S
   Ramos, M
   Roberts, I
   Shakur, H
   Edwards, P
   Godec, T
   Huque, S
   Fawole, B
   Okunade, O
   Adetayo, O
   Chaudhri, R
   Kayani, A
   Javaid, K
   Fawole, B
   Chaudhri, R
   Biryabarema, C
   Qureshi, Z
   Tchounzou, R
   El-Sheikh, M
   Kidanto, H
   Regmi, M
   Vwalika, B
   Dallaku, K
   Sahani, M
   Akhter, S
   Abdulkadir, A
   Meda, N
   Dah, AK
   Akintan, A
   Odekunle, O
   Monehin, O
   Ojo, A
   Akinbinu, G
   Offiah, I
   Etuk, S
   Akpan, U
   Udofia, U
   Okon, U
   Omoronyia, E
   James, O
   Olayemi, O
   Bello, N
   Adeyemi, B
   Aimakhu, C
   Akinsanya, O
   Adeleye, B
   Adeyemi, O
   Oluwatosin, K
   Aboyeji, A
   Adeniran, A
   Adewale, A
   Olaomo, N
   Omo-Aghoja, L
   Okpako, E
   Oyeye, L
   Alu, F
   Ogudu, J
   Ladan, E
   Habib, I
   Okusanya, B
   Onafowokan, O
   Isah, D
   Aye, A
   Okogbo, F
   Aigere, E
   Ogbiti, M
   Onile, T
   Salau, O
   Amode, Y
   Shoretire, K
   Owodunni, A
   Ologunde, K
   Ayinde, A
   Alao, M
   Awonuga, O
   Awolaja, B
   Adegbola, O
   Habeebu-Adeyemi, F
   Okunowo, A
   Idris, H
   Okike, O
   Madueke, N
   Mutihir, J
   Joseph, N
   Adebudo, B
   Fasanu, A
   Akintunde, O
   Abidoye, O
   Opreh, O
   Udonwa, S
   Dibia, G
   Bazuaye, S
   Ifemeje, A
   Umoiyoho, A
   Inyang-Etoh, E
   Yusuf, S
   Olayinka, K
   Adeyemi, B
   Ajenifuja, O
   Ibrahim, U
   Adamu, YB
   Akinola, O
   Adekola-Oni, G
   Kua, P
   Iheagwam, R
   Idrisa, A
   Geidam, A
   Jogo, A
   Agulebe, J
   Ikechebelu, J
   Udegbunam, O
   Awoleke, J
   Adelekan, O
   Sulayman, H
   Ameh, N
   Onaolapo, N
   Adelodun, A
   Golit, W
   Audu, D
   Adeniji, A
   Oyelade, F
   Dattijo, L
   Henry, P
   Adeyemi, B
   Loto, O
   Umeora, O
   Onwe, A
   Nzeribe, E
   Okorochukwu, B
   Adeniyi, A
   Gbejegbe, E
   Ikpen, A
   Nwosu, I
   Sambo, A
   Ladipo, O
   Abubakar, S
   Okike, ON
   Nduka, EC
   Ezenkwele, EP
   Onwusulu, D
   Irinyenikan, TA
   Singh, S
   Bariweni, A
   Galadanci, H
   Achara, P
   Gana, M
   Chaudhri, R
   Jabeen, K
   Mobeen, A
   Mufti, S
   Zafar, M
   Noor, S
   Ahmad, B
   Munawar, M
   Gul, J
   Usman, N
   Shaheen, F
   Tariq, M
   Sadiq, N
   Batool, R
   Ali, HS
   Jaffer, M
   Baloch, A
   Mukhtiar, N
   Ashraf, T
   Asmat, R
   Khudaidad, S
   Taj, G
   Qazi, R
   Dars, S
   Sardar, F
   Ashfaq, S
   Majeed, S
   Jabeen, S
   Karim, R
   Burki, F
   Bukhari, SR
   Gul, F
   Jabeen, M
   Sherin, A
   Ain, Q
   Rao, S
   Shaheen, U
   Manzoor, S
   Masood, S
   Rizvi, S
   Ali, A
   Sajid, A
   Iftikhar, A
   Batool, S
   Dar, L
   Sohail, S
   Rasul, S
   Humayun, S
   Sultana, R
   Manzoor, S
   Mazhar, S
   Batool, A
   Nazir, A
   Tasnim, N
   Masood, H
   Khero, R
   Surhio, N
   Aleem, S
   Israr, N
   Javed, S
   Bashir, L
   Iqbal, S
   Aleem, F
   Sohail, R
   Iqbal, S
   Dojki, S
   Bano, A
   Saba, N
   Hafeez, M
   Akram, N
   Israr, N
   Shaheen, R
   Hashmi, H
   Arshad, S
   Hussain, R
   Khan, S
   Shaheen, N
   Khalil, S
   Sachdev, P
   Arain, G
   Zarreen, A
   Saeed, S
   Hanif, S
   Tariq, N
   Jamil, M
   Chaudhry, S
   Rajani, H
   Wasim, T
   Aslam, S
   Mustafa, N
   Quddusi, H
   Karim, S
   Sultana, S
   Harim, M
   Chohan, M
   Salman, N
   Waqar, F
   Sadia, S
   Kahloon, L
   Manzoor, S
   Amin, S
   Akram, U
   Ikram, A
   Kausar, S
   Batool, T
   Kyani, BNT
   Biryabarema, C
   Bulime, R
   Akello, R
   Lwasa, BN
   Ayikoru, J
   Namulwasira, C
   Komagum, P
   Rebecca, I
   Annet, N
   Nuulu, N
   Nionzima, E
   Bwotya, R
   Nankya, M
   Babirye, S
   Ngonzi, J
   Sanchez, C
   Innocent, N
   Anitah, K
   Jackson, A
   Ndagire, E
   Drametu, D
   Meregurwa, G
   Banya, F
   Atim, R
   Martyrs, U
   Byaruhanga, E
   Iman, H
   Oyiengo, V
   Waigi, P
   Wangui, R
   Nassir, F
   Soita, M
   Msengeti, R
   Zubier, Z
   Mabeya, H
   Wanjala, A
   Mwangi, H
   Liyayi, B
   Muthoka, E
   Osoti, A
   Otara, A
   Ongwae, V
   Qureshi, Z
   Wanjohi, V
   Musila, B
   Wekesa, K
   Bosire, AN
   Asonganyi, E
   Ntem, A
   Njoache, A
   Ashu, A
   Simo, A
   Tchounzou, R
   Keka, D
   Bruno, K
   Ndouoya, A
   Saadio, M
   Tchana, M
   Gwan, O
   Assomo, P
   Mutsu, V
   Eric, N
   Foumane, P
   Nsem, P
   Fouedjio, J
   Fouelifack, Y
   Tebeu, PM
   Nabag, W
   Desougi, R
   Mustafa, H
   Eltaib, H
   Umbeli, T
   Elfadl, K
   Ibrahim, M
   Mohammed, A
   Ali, A
   Abdelrahiem, S
   Musa, M
   Bushra, M
   Babiker, O
   Abdullahi, H
   Ahmed, M
   Rayis, D
   Abdelgabar, SA
   Alfirevic, Z
   Houghton, G
   Sharpe, A
   Thornton, J
   Grace, N
   Smith, C
   Hinshaw, K
   Edmundson, D
   Ayuk, P
   Bates, A
   Bugg, G
   Wilkins, J
   Tower, C
   Allibone, A
   Kidanto, H
   Kazumari, A
   Danford, A
   Ngarina, M
   Abeid, M
   Mayumba, K
   Zacharia, M
   Mtove, G
   Madame, L
   Massinde, A
   Mwambe, B
   Ganyaka, SK
   Regmi, M
   Gupta, S
   Bhatt, R
   Agrawal, A
   Pradhan, P
   Dhakal, N
   Yadav, P
   Karki, G
   Shrestha, BR
   Vwalika, B
   Lubeya, M
   Mumba, J
   Silwimba, W
   Hansingo, I
   Bopili, N
   Makukula, Z
   Kawimbe, A
   Lubeya, MK
   Mtambo, W
   Ng'ambi, M
   Dallaku, K
   Cenameri, S
   Tasha, I
   Kruja, A
   Brahimaj, B
   Kaza, L
   Sahani, M
   Tshombe, D
   Buligho, E
   Paluku-Hamuli, R
   Kacha, C
   Faida, K
   Musau, B
   Kalyana, H
   Simisi, P
   Mulyumba, S
   Jason, NK
   Lubamba, JR
   Missumba, W
   Islam, F
   Begum, N
   Akhter, S
   Chowdhury, F
   Begum, R
   Basher, F
   Nargis, N
   Abu Kholdun,
   Jesmin, S
   Paul, S
   Segni, H
   Ayana, G
   Haleke, W
   Abdulkadir, A
   Hussien, H
   Geremew, F
   Bambara, M
   Some, A
   Ly, A
   Pabakba, R
   Fletcher, H
   Samuels, L
   Opare-Addo, H
   Larsen-Reindorf, R
   Nyarko-Jectey, K
   Mola, G
   Wai, M
   El Rahman, M
   Basta, W
   Khamis, H
   Escobar, MF
   Vallecilla, L
   Faye, GE
AF Shakur, Haleema
   Roberts, Ian
   Fawole, Bukola
   Chaudhri, Rizwana
   El-Sheikh, Mohamed
   Akintan, Adesina
   Qureshi, Zahida
   Kidanto, Hussein
   Vwalika, Bellington
   Abdulkadir, Abdulfetah
   Etuk, Saturday
   Noor, Shehla
   Asonganyi, Etienne
   Alfirevic, Zarko
   Beaumont, Danielle
   Ronsmans, Carine
   Arulkumaran, Sabaratnam
   Grant, Adrian
   Afsana, Kaosar
   Gulmezoglu, Metin
   Hunt, Beverley
   Olayemi, Oladapo
   Roberts, Ian
   Chalmers, Iain
   Lumbiganon, Pisake
   Piaggio, Gilda
   Brady, Tony
   Shakur, Haleema
   Roberts, Ian
   Alfirevic, Zarko
   Elbourne, Diana
   Gulmezoglu, Metin
   Ronsmans, Carine
   Balogun, Eni
   Pepple, Tracey
   Prowse, Danielle
   Quashi, Nigel
   Barneston, Lin
   Barrow, Collette
   Beaumont, Danielle
   Cook, Lisa
   Frimley, Lauren
   Gilbert, Daniel
   Gilliam, Catherine
   Jackson, Rob
   Kawahara, Taemi
   Miah, Hakim
   Kostrov, Sergey
   Ramos, Maria
   Roberts, Ian
   Shakur, Haleema
   Edwards, Phil
   Godec, Tom
   Huque, Sumaya
   Fawole, Bukola
   Okunade, Olujide
   Adetayo, Olusade
   Chaudhri, Rizwana
   Kayani, Aasia
   Javaid, Kiran
   Fawole, Bukola
   Chaudhri, Rizwana
   Biryabarema, Chrstine
   Qureshi, Zahida
   Tchounzou, Robert
   El-Sheikh, Mohamed
   Kidanto, Hussein
   Regmi, Mohan
   Vwalika, Bellington
   Dallaku, Kastriot
   Sahani, Mateus
   Akhter, Sayeba
   Abdulkadir, Abdulfetah
   Meda, Nicolas
   Dah, Anthony Kwame
   Akintan, Adesina
   Odekunle, Olufemi
   Monehin, Oluwabusola
   Ojo, Austin
   Akinbinu, Grace
   Offiah, Ifeoma
   Etuk, Saturday
   Akpan, Ubong
   Udofia, Uduak
   Okon, Useneno
   Omoronyia, Ezukwa
   James, Okpe
   Olayemi, Oladapo
   Bello, Nike
   Adeyemi, Blessed
   Aimakhu, Chris
   Akinsanya, Olufemi
   Adeleye, Bamidele
   Adeyemi, Oluwaseun
   Oluwatosin, Kayode
   Aboyeji, Abiodun
   Adeniran, Abiodun
   Adewale, Adebayo
   Olaomo, Noah
   Omo-Aghoja, Lawrence
   Okpako, Emmanuel
   Oyeye, Lucky
   Alu, Francis
   Ogudu, John
   Ladan, Ezekiel
   Habib, Ibrahim
   Okusanya, Babasola
   Onafowokan, Olatunde
   Isah, David
   Aye, Abalaka
   Okogbo, Felix
   Aigere, Egbaname
   Ogbiti, Mark
   Onile, Temitope
   Salau, Olaide
   Amode, Yinka
   Shoretire, Kamil
   Owodunni, Adebola
   Ologunde, Kehinde
   Ayinde, Akintunde
   Alao, Moses
   Awonuga, Olalekan
   Awolaja, Babatunde
   Adegbola, Omololu
   Habeebu-Adeyemi, Fatimah
   Okunowo, Adeyemi
   Idris, Hadiza
   Okike, Ola
   Madueke, Nneka
   Mutihir, Josiah
   Joseph, Nankat
   Adebudo, Babatunde
   Fasanu, Adeniyi
   Akintunde, Olugbenga
   Abidoye, Olufemi
   Opreh, Owigho
   Udonwa, Sophia
   Dibia, Gladys
   Bazuaye, Simeon
   Ifemeje, Arafat
   Umoiyoho, Aniefiok
   Inyang-Etoh, Emmanuel
   Yusuf, Sununu
   Olayinka, Kayode
   Adeyemi, Babalola
   Ajenifuja, Olusegun
   Ibrahim, Umar
   Adamu, Yusuf Baffah
   Akinola, Oluwarotimi
   Adekola-Oni, Grace
   Kua, Paul
   Iheagwam, Roseline
   Idrisa, Audu
   Geidam, Ado
   Jogo, Andrea
   Agulebe, Joseph
   Ikechebelu, Joseph
   Udegbunam, Onyebuchi
   Awoleke, Jacob
   Adelekan, Oluseyi
   Sulayman, Hajaratu
   Ameh, Nkeiruka
   Onaolapo, Nurudeen
   Adelodun, Affiss
   Golit, William
   Audu, Dachollom
   Adeniji, Adetunji
   Oyelade, Folasade
   Dattijo, Lamaran
   Henry, Palmer
   Adeyemi, Babalola
   Loto, Olabisi
   Umeora, Odidika
   Onwe, Abraham
   Nzeribe, Emily
   Okorochukwu, Bartthy
   Adeniyi, Augustine
   Gbejegbe, Emmanuel
   Ikpen, Akpojaro
   Nwosu, Ikemefuna
   Sambo, Abdulrasaq
   Ladipo, Olubunmi
   Abubakar, Sola
   Okike, Ola Nene
   Nduka, Enyinnaya Chikwendu
   Ezenkwele, Eziamaka Pauline
   Onwusulu, Daniel
   Irinyenikan, Theresa Azonima
   Singh, Swati
   Bariweni, Amaitari
   Galadanci, Hadiza
   Achara, Peter
   Gana, Mohammed
   Chaudhri, Rizwana
   Jabeen, Kiran
   Mobeen, Ayesha
   Mufti, Sadaf
   Zafar, Maliha
   Noor, Shehla
   Ahmad, Basharat
   Munawar, Maimoona
   Gul, Jeharat
   Usman, Naseema
   Shaheen, Fehmida
   Tariq, Mariam
   Sadiq, Nadia
   Batool, Rabia
   Ali, Habiba Sharaf
   Jaffer, Manahil
   Baloch, Asma
   Mukhtiar, Noonari
   Ashraf, Tasneem
   Asmat, Raheela
   Khudaidad, Salma
   Taj, Ghazala
   Qazi, Roshan
   Dars, Saira
   Sardar, Faryal
   Ashfaq, Sanobar
   Majeed, Saeeda
   Jabeen, Sadaqat
   Karim, Rukhsana
   Burki, Farzana
   Bukhari, Syeda Rabia
   Gul, Fouzia
   Jabeen, Musarrat
   Sherin, Akhtar
   Ain, Qurratul
   Rao, Shahid
   Shaheen, Uzma
   Manzoor, Samina
   Masood, Shabeen
   Rizvi, Shabana
   Ali, Anita
   Sajid, Abida
   Iftikhar, Aisha
   Batool, Shazia
   Dar, Lubna
   Sohail, Shahenzad
   Rasul, Shazia
   Humayun, Shamsa
   Sultana, Rashida
   Manzoor, Sofia
   Mazhar, Syeda
   Batool, Afshan
   Nazir, Asia
   Tasnim, Nasira
   Masood, Hajira
   Khero, Razia
   Surhio, Neelam
   Aleem, Samana
   Israr, Naila
   Javed, Saba
   Bashir, Lubna
   Iqbal, Samina
   Aleem, Faiza
   Sohail, Rubina
   Iqbal, Saima
   Dojki, Samina
   Bano, Alia
   Saba, Naseem
   Hafeez, Maimoona
   Akram, Nishat
   Israr, Naila
   Shaheen, Riffat
   Hashmi, Haleema
   Arshad, Sharmeen
   Hussain, Rubina
   Khan, Sadia
   Shaheen, Nighat
   Khalil, Safia
   Sachdev, Pushpa
   Arain, Gulfareen
   Zarreen, Amtullah
   Saeed, Sara
   Hanif, Shamayela
   Tariq, Nabia
   Jamil, Mahwish
   Chaudhry, Shama
   Rajani, Hina
   Wasim, Tayyiba
   Aslam, Summera
   Mustafa, Nilofar
   Quddusi, Huma
   Karim, Sajila
   Sultana, Shazia
   Harim, Misbah
   Chohan, Mohd
   Salman, Nabila
   Waqar, Fareesa
   Sadia, Shamsunnisa
   Kahloon, Lubna
   Manzoor, Shehla
   Amin, Samar
   Akram, Umbreen
   Ikram, Ambreen
   Kausar, Samina
   Batool, Tahira
   Kyani, Brigadier Naila Tahir
   Biryabarema, Christine
   Bulime, Ruth
   Akello, Regina
   Lwasa, Bernadette Nakawooya
   Ayikoru, Joselyn
   Namulwasira, Christine
   Komagum, Patrick
   Rebecca, Isabirye
   Annet, Nayiga
   Nuulu, Nakirigya
   Nionzima, Elizabeth
   Bwotya, Rose
   Nankya, Margret
   Babirye, Sarah
   Ngonzi, Joseph
   Sanchez, Cesar
   Innocent, Nkonwa
   Anitah, Kusasira
   Jackson, Ayiko
   Ndagire, Elizabeth
   Drametu, Dominic
   Meregurwa, Grace
   Banya, Francis
   Atim, Rita
   Martyrs, Uganda
   Byaruhanga, Emmanuel
   Iman, Hussein
   Oyiengo, Vincent
   Waigi, Peninah
   Wangui, Rose
   Nassir, Faiza
   Soita, Musimbi
   Msengeti, Rophina
   Zubier, Zeinab
   Mabeya, Hillary
   Wanjala, Antony
   Mwangi, Henry
   Liyayi, Brian
   Muthoka, Evelyn
   Osoti, Alfred
   Otara, Amos
   Ongwae, Veronicah
   Qureshi, Zahida
   Wanjohi, Victor
   Musila, Bonface
   Wekesa, Kubasu
   Bosire, Alex Nyakundi
   Asonganyi, Etienne
   Ntem, Alice
   Njoache, Angeline
   Ashu, Alice
   Simo, Andre
   Tchounzou, Robert
   Keka, Dorothy
   Bruno, Kenfack
   Ndouoya, Amadou
   Saadio, Martin
   Tchana, Mesack
   Gwan, Odel
   Assomo, Pauline
   Mutsu, Venantius
   Eric, Nji
   Foumane, Pascal
   Nsem, Philemon
   Fouedjio, Jeanne
   Fouelifack, Ymele
   Tebeu, Pierre Marie
   Nabag, Wisal
   Desougi, Riham
   Mustafa, Hadia
   Eltaib, Huida
   Umbeli, Taha
   Elfadl, Khalid
   Ibrahim, Murwan
   Mohammed, Abdalla
   Ali, Awadia
   Abdelrahiem, Somia
   Musa, Mohammed
   Bushra, Mahdi
   Babiker, Omer
   Abdullahi, Hala
   Ahmed, Mohamed
   Rayis, Duria
   Abdelgabar, Saeed Abdelrahman
   Alfirevic, Zarko
   Houghton, Gillian
   Sharpe, Andrew
   Thornton, Jim
   Grace, Nick
   Smith, Carys
   Hinshaw, Kim
   Edmundson, Dawn
   Ayuk, Paul
   Bates, Alison
   Bugg, George
   Wilkins, Joanne
   Tower, Clare
   Allibone, Alysha
   Kidanto, Hussein
   Kazumari, Ahmad
   Danford, Anna
   Ngarina, Matilda
   Abeid, Muzdalifat
   Mayumba, Khadija
   Zacharia, Magreth
   Mtove, George
   Madame, Leonard
   Massinde, Anthony
   Mwambe, Berno
   Ganyaka, Sebastian Kitengile
   Regmi, Mohan
   Gupta, Shyam
   Bhatt, Rabindra
   Agrawal, Ajay
   Pradhan, Pramila
   Dhakal, Nikita
   Yadav, Punita
   Karki, Gyanendra
   Shrestha, Bhola Ram
   Vwalika, Bellington
   Lubeya, Mwansa
   Mumba, Jane
   Silwimba, Willies
   Hansingo, Isaiah
   Bopili, Noojiri
   Makukula, Ziche
   Kawimbe, Alexander
   Lubeya, Mwansa Ketty
   Mtambo, Willard
   Ng'ambi, Mathew
   Dallaku, Kastriot
   Cenameri, Saimir
   Tasha, Ilir
   Kruja, Aferdita
   Brahimaj, Besnik
   Kaza, Leon
   Sahani, Mateus
   Tshombe, Desire
   Buligho, Elizabeth
   Paluku-Hamuli, Roger
   Kacha, Charles
   Faida, Kato
   Musau, Badibanga
   Kalyana, Herman
   Simisi, Phanny
   Mulyumba, Serge
   Jason, Nzanzu Kikuhe
   Lubamba, Jean Robert
   Missumba, Willis
   Islam, Ferdousi
   Begum, Nazneen
   Akhter, Sayeba
   Chowdhury, Ferdousi
   Begum, Rokeya
   Basher, Farjana
   Nargis, Nazlima
   Abu Kholdun
   Jesmin, Shahela
   Paul, Shrodha
   Segni, Hailemariam
   Ayana, Getachew
   Haleke, William
   Abdulkadir, Abdulfetah
   Hussien, Hassen
   Geremew, Fikre
   Bambara, Moussa
   Some, Adolphe
   Ly, Amadou
   Pabakba, Roamba
   Fletcher, Horace
   Samuels, Leslie
   Opare-Addo, Henry
   Larsen-Reindorf, Roderick
   Nyarko-Jectey, Kwadwo
   Mola, Glen
   Wai, Malts
   El Rahman, Magdy
   Basta, Wafaa
   Khamis, Hussein
   Escobar, Maria Fernanda
   Vallecilla, Liliana
   Faye, Gabriel Essetchi
CA WOMAN Trial Collaborators
   WOMAN Trial Collaborators
   Steering Comm
   Protocol Comm
   Trial Coordinating Team
   Nigeria Coordinating Team
   Pakistan Coordinating Team
   Natl Coordinators
TI Effect of early tranexamic acid administration on mortality,
   hysterectomy, and other morbidities in women with post-partum
   haemorrhage (WOMAN): an international, randomised, double-blind,
   placebo-controlled trial
SO LANCET
LA English
DT Article
ID MATERNAL MORTALITY; DEATH; METAANALYSIS; HOSPITALS; PROTOCOL
AB Background Post-partum haemorrhage is the leading cause of maternal death worldwide. Early administration of tranexamic acid reduces deaths due to bleeding in trauma patients. We aimed to assess the effects of early administration of tranexamic acid on death, hysterectomy, and other relevant outcomes in women with post-partum haemorrhage.
   Methods In this randomised, double-blind, placebo-controlled trial, we recruited women aged 16 years and older with a clinical diagnosis of post-partum haemorrhage after a vaginal birth or caesarean section from 193 hospitals in 21 countries. We randomly assigned women to receive either 1 g intravenous tranexamic acid or matching placebo in addition to usual care. If bleeding continued after 30 min, or stopped and restarted within 24 h of the first dose, a second dose of 1 g of tranexamic acid or placebo could be given. Patients were assigned by selection of a numbered treatment pack from a box containing eight numbered packs that were identical apart from the pack number. Participants, care givers, and those assessing outcomes were masked to allocation. We originally planned to enrol 15 000 women with a composite primary endpoint of death from all-causes or hysterectomy within 42 days of giving birth. However, during the trial it became apparent that the decision to conduct a hysterectomy was often made at the same time as randomisation. Although tranexamic acid could influence the risk of death in these cases, it could not affect the risk of hysterectomy. We therefore increased the sample size from 15 000 to 20 000 women in order to estimate the effect of tranexamic acid on the risk of death from post-partum haemorrhage. All analyses were done on an intention-to-treat basis. This trial is registered with ISRCTN76912190 (Dec 8, 2008); ClinicalTrials.gov, number NCT00872469; and PACTR201007000192283.
   Findings Between March, 2010, and April, 2016, 20 060 women were enrolled and randomly assigned to receive tranexamic acid (n=10 051) or placebo (n=10 009), of whom 10 036 and 9985, respectively, were included in the analysis. Death due to bleeding was significantly reduced in women given tranexamic acid (155 [1.5%] of 10 036 patients vs 191 [1.9%] of 9985 in the placebo group, risk ratio [RR] 0.81, 95% CI 0.65-1.00; p=0.045), especially in women given treatment within 3 h of giving birth (89 [1.2%] in the tranexamic acid group vs 127 [1.7%] in the placebo group, RR 0.69, 95% CI 0.52-0.91; p=0.008). All other causes of death did not differ significantly by group. Hysterectomy was not reduced with tranexamic acid (358 [3.6%] patients in the tranexamic acid group vs 351 [3.5%] in the placebo group, RR 1.02, 95% CI 0.88-1.07; p=0.84). The composite primary endpoint of death from all causes or hysterectomy was not reduced with tranexamic acid (534 [5.3%] deaths or hysterectomies in the tranexamic acid group vs 546 [5.5%] in the placebo group, RR 0.97, 95% CI 0.87-1.09; p=0.65). Adverse events (including thromboembolic events) did not differ significantly in the tranexamic acid versus placebo group.
   Interpretation Tranexamic acid reduces death due to bleeding in women with post-partum haemorrhage with no adverse effects. When used as a treatment for postpartum haemorrhage, tranexamic acid should be given as soon as possible after bleeding onset.
   Funding London School of Hygiene & Tropical Medicine, Pfizer, UK Department of Health, Wellcome Trust, and Bill & Melinda Gates Foundation. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.
C1 [Akintan, Adesina; Odekunle, Olufemi; Monehin, Oluwabusola; Ojo, Austin; Akinbinu, Grace; Offiah, Ifeoma; Akintunde, Olugbenga] Mother & Child Hosp, Akure, Nigeria.
   [Etuk, Saturday; Akpan, Ubong; Udofia, Uduak; Okon, Useneno; Omoronyia, Ezukwa; James, Okpe] Univ Calabar, Teaching Hosp, Ibadan, Nigeria.
   [Olayemi, Oladapo; Bello, Nike; Adeyemi, Blessed; Aimakhu, Chris] Univ Coll Hosp, Ibadan, Nigeria.
   [Akinsanya, Olufemi; Adeleye, Bamidele; Adeyemi, Oluwaseun; Oluwatosin, Kayode] Fed Med Ctr Owo, Owo, Nigeria.
   [Aboyeji, Abiodun; Adeniran, Abiodun; Adewale, Adebayo; Olaomo, Noah] Univ Ilorin, Teaching Hosp, Ilorin, Nigeria.
   [Omo-Aghoja, Lawrence; Okpako, Emmanuel; Oyeye, Lucky] Delta State Univ, Teaching Hosp, Cleveland, MS 38733 USA.
   [Alu, Francis; Ogudu, John; Ladan, Ezekiel] Maitama Dist Hosp, Abuja, Nigeria.
   [Habib, Ibrahim; Okusanya, Babasola] Fed Med Ctr Katsina, Katsina, Nigeria.
   [Onafowokan, Olatunde; Isah, David; Aye, Abalaka] Univ Abuja, Teaching Hosp, Abuja, Nigeria.
   [Okogbo, Felix; Aigere, Egbaname; Ogbiti, Mark] Irrua Specialist Teaching Hosp, Irrua, Nigeria.
   [Onile, Temitope; Salau, Olaide; Amode, Yinka] Fed Med Ctr Lokoja, Lokoja, Nigeria.
   [Shoretire, Kamil; Owodunni, Adebola; Ologunde, Kehinde] Fed Med Ctr Gusau, Gusau, Nigeria.
   [Ayinde, Akintunde] Adeoyo Matern Hosp, Ibadan, Nigeria.
   [Alao, Moses; Awonuga, Olalekan; Awolaja, Babatunde] Fed Med Ctr Abeokuta, Abeokuta, Nigeria.
   [Adegbola, Omololu; Habeebu-Adeyemi, Fatimah; Okunowo, Adeyemi] Univ Lagos, Teaching Hosp, Lagos, Nigeria.
   [Idris, Hadiza; Okike, Ola; Madueke, Nneka] Nyanya Gen Hosp, Abuja, Nigeria.
   [Mutihir, Josiah; Joseph, Nankat; Adebudo, Babatunde] Univ Jos, Teaching Hosp, Jos, Nigeria.
   [Fasanu, Adeniyi; Akintunde, Olugbenga; Abidoye, Olufemi] Ladoke Akintola Univ Technol, Teaching Hosp Osogbo Site, Ogbomosho, Nigeria.
   [Opreh, Owigho; Udonwa, Sophia; Dibia, Gladys] Seventh Day Adventist Hosp, Bangalore, Karnataka, India.
   [Bazuaye, Simeon; Ifemeje, Arafat] Lagos Isl Matern Hosp, Lagos, Nigeria.
   [Umoiyoho, Aniefiok; Inyang-Etoh, Emmanuel] Univ Uyo, Teaching Hosp, Uyo, Nigeria.
   [Yusuf, Sununu; Olayinka, Kayode] Fed Med Ctr Birnin Kebbi, Birnin Kebbi, Nigeria.
   [Adeyemi, Babalola; Ajenifuja, Olusegun] Obafemi Awolowo Univ, Teaching Hosp, Ife, Nigeria.
   [Ibrahim, Umar; Adamu, Yusuf Baffah] Fed Med Ctr Azare, Bauchi, Nigeria.
   [Akinola, Oluwarotimi; Adekola-Oni, Grace] Lagos State Univ, Teaching Hosp, Lagos, Nigeria.
   [Kua, Paul; Iheagwam, Roseline] Braithwaite Mem Specialist Hosp, Port Harcourt, Nigeria.
   [Idrisa, Audu; Geidam, Ado] Univ Maiduguri, Teaching Hosp, Borno, Nigeria.
   [Jogo, Andrea; Agulebe, Joseph] Fed Med Ctr Makurdi, Borno, Nigeria.
   [Ikechebelu, Joseph; Udegbunam, Onyebuchi] Nnamdi Azikiwe Univ, Teaching Hosp, Awka, Nigeria.
   [Awoleke, Jacob; Adelekan, Oluseyi] Ekiti State Univ, Teaching Hosp, Ekiti, Nigeria.
   [Sulayman, Hajaratu; Ameh, Nkeiruka] Ahmadu Bello Univ, Teaching Hosp, Zaria, Nigeria.
   [Onaolapo, Nurudeen; Adelodun, Affiss] Ajeromi Gen Hosp, Lagos, Nigeria.
   [Golit, William; Audu, Dachollom] Plateau State Specialist Hosp, Jos, Nigeria.
   [Adeniji, Adetunji; Oyelade, Folasade; Abubakar, Sola] Technol Teaching Hosp, Ladoke Akintola Univ, Ogbomoso Site, Jos, Nigeria.
   [Dattijo, Lamaran; Henry, Palmer] Abubakar Tafawa Balewa Univ, Teaching Hosp, Bauchi, Nigeria.
   [Adeyemi, Babalola; Loto, Olabisi] Wesley Guild Hosp OAUTH, Oyo, Nigeria.
   [Umeora, Odidika; Onwe, Abraham] Fed Teaching Hosp Abakaliki, Abakaliki, Nigeria.
   [Nzeribe, Emily; Okorochukwu, Bartthy] Fed Med Ctr Owerri, Owerri, Nigeria.
   [Adeniyi, Augustine] Fed Med Ctr Ido Ekiti, Ido Ekiti, Nigeria.
   [Gbejegbe, Emmanuel; Ikpen, Akpojaro] Kogi State Specialist Hosp, Lokoja, Nigeria.
   [Nwosu, Ikemefuna; Sambo, Abdulrasaq] Fed Med Ctr Bida, Bida, Nigeria.
   [Ladipo, Olubunmi; Abubakar, Sola] Natl Hosp Abuja, Abuja, Nigeria.
   [Okike, Ola Nene] Karshi Gen Hosp, Karshi, Nigeria.
   [Nduka, Enyinnaya Chikwendu] Fed Med Ctr Umuahia, Umuahia, Nigeria.
   [Ezenkwele, Eziamaka Pauline] Univ Nigeria, Teaching Hosp, Nsukka, Nigeria.
   [Onwusulu, Daniel] Fed Med Ctr Asaba, Asaba, Nigeria.
   [Irinyenikan, Theresa Azonima] State Specialist Hosp Akure, Akure, Nigeria.
   [Singh, Swati] Usmanu Danfodiyo Univ, Teaching Hosp, Sokoto, Nigeria.
   [Bariweni, Amaitari] Fed Med Ctr Yenagoa, Yenagoa, Nigeria.
   [Galadanci, Hadiza] Aminu Kano Teaching Hosp, Aminu, Nigeria.
   [Achara, Peter] Fed Med Ctr Keffi, Keffi, Nigeria.
   Gwarimpa Gen Hosp, Gwarimpa, Nigeria.
   [Gana, Mohammed] Gen Hosp Minna, Minna, Nigeria.
   [Chaudhri, Rizwana; Jabeen, Kiran; Mobeen, Ayesha; Mufti, Sadaf; Zafar, Maliha; Shaheen, Fehmida; Tariq, Mariam; Sadiq, Nadia; Batool, Rabia] Holy Family Hosp, Gyn & Obs Unit, Rawalpindi, Pakistan.
   [Ahmad, Basharat; Munawar, Maimoona; Gul, Jeharat; Usman, Naseema; Manzoor, Shehla] Ayub Teaching Hosp, Rawalpindi, Pakistan.
   [Ali, Habiba Sharaf; Jaffer, Manahil; Baloch, Asma; Mukhtiar, Noonari] Ziauddin Univ, Kemari Campus, Karachi, Pakistan.
   [Ashraf, Tasneem; Asmat, Raheela; Khudaidad, Salma; Taj, Ghazala] Bolan Med Complex Hosp Unit II, Balochisthan, Pakistan.
   [Qazi, Roshan; Dars, Saira; Sardar, Faryal; Ashfaq, Sanobar] Liaquat Univ, Hosp LUMHS, Gynae Unit 1, Jamshoro, Pakistan.
   [Majeed, Saeeda] Rehman Med Inst Private Ltd, Peshawar, Pakistan.
   [Jabeen, Sadaqat; Karim, Rukhsana; Burki, Farzana; Bukhari, Syeda Rabia] Lady Reading Hosp, Peshawar, Pakistan.
   [Gul, Fouzia; Jabeen, Musarrat; Sherin, Akhtar; Ain, Qurratul] Liaquat Mem Women & Children Hosp Kohat, Kohat, Pakistan.
   [Rao, Shahid; Shaheen, Uzma; Manzoor, Samina] Nishtar Hosp Unit III, Multan, Pakistan.
   [Masood, Shabeen; Rizvi, Shabana; Ali, Anita] Fatima Bai Hosp, Karachi, Pakistan.
   [Sajid, Abida; Iftikhar, Aisha; Batool, Shazia] Lady Aitchison Hosp, Lahore, Pakistan.
   [Dar, Lubna; Sohail, Shahenzad; Rasul, Shazia] Shalamar Hosp, Lahore, Pakistan.
   [Humayun, Shamsa; Sultana, Rashida; Manzoor, Sofia] Sir Ganga Ram Hosp Lahore, Lahore, Pakistan.
   [Tasnim, Nasira] MCH Ctr PIMS, Obs & Gynae Unit 2, Islamabad, Pakistan.
   [Masood, Hajira] Nishtar Hosp Unit I, Multan, Pakistan.
   [Khero, Razia; Surhio, Neelam; Aleem, Samana] Peoples Univ Med & Hlth Sci, Nawabshah, Pakistan.
   [Israr, Naila; Javed, Saba; Bashir, Lubna] Fed Govt Serv Hosp FGSH Unit III, Islamabad, Pakistan.
   [Iqbal, Samina; Aleem, Faiza] Sobhraj Matern Hosp KMC, Karachi, Pakistan.
   [Sohail, Rubina; Iqbal, Saima] Serv Hosp Lahore Unit II, Lahore, Pakistan.
   [Dojki, Samina; Bano, Alia] Patel Hosp, Karachi, Pakistan.
   [Saba, Naseem] Dera Ismail Khan Dist Teaching Hosp, Islamabad, Pakistan.
   [Hafeez, Maimoona; Akram, Nishat] Sharif Med & Dent City, Lahore, Pakistan.
   [Israr, Naila; Shaheen, Riffat] Fed Govt Poly Clin FGPC, Hosp Unit 1, Islamabad, Pakistan.
   [Hashmi, Haleema; Arshad, Sharmeen] Liaquat Natl Hosp, Islamabad, Pakistan.
   [Hussain, Rubina; Khan, Sadia] Ziauddin Univ Hosp, Clifton Campus, Karachi, Pakistan.
   [Shaheen, Nighat; Khalil, Safia] CGH Cantonment Gen Hosp, Rawalpindi, Pakistan.
   [Sachdev, Pushpa; Arain, Gulfareen] Isra Univ Hosp, Sindh, Pakistan.
   [Zarreen, Amtullah; Saeed, Sara] Jinnah Hosp Lahore, Lahore, Pakistan.
   [Hanif, Shamayela] Fatima Mem Hosp, Lahore, Pakistan.
   [Tariq, Nabia; Jamil, Mahwish] Shifa Int Hosp, Islamabad, Pakistan.
   [Chaudhry, Shama; Rajani, Hina] Ziauddin Univ Hosp, Nazimabad Campus, Karachi, Pakistan.
   [Wasim, Tayyiba; Aslam, Summera] Serv Hosp, Lahore Unit 3, Lahore, Pakistan.
   [Mustafa, Nilofar] Combined Mil Hosp CMH, Lahore, Pakistan.
   [Quddusi, Huma; Karim, Sajila] Nishtar Hosp Unit II, Multan, Pakistan.
   [Sultana, Shazia; Harim, Misbah] Ziauddin Univ Hosp, North Nazimabad Campus, Karachi, Pakistan.
   [Chohan, Mohd] Lady Willingdon Hosp, OBGYN Unit 2, Karachi, Pakistan.
   [Salman, Nabila] Nescom Hosp, Islamabad, Pakistan.
   [Waqar, Fareesa; Sadia, Shamsunnisa] Pakistan Railway Hosp, Multan, Pakistan.
   [Kahloon, Lubna; Manzoor, Shehla] DHQ Hosp Rawalpindi, Rawalpindi, Pakistan.
   [Amin, Samar] Zainab Panjwani Mem Hosp, Karachi, Pakistan.
   [Akram, Umbreen] Combined Mil Hosp CMH Kharian, Lahore, Pakistan.
   [Ikram, Ambreen] Mian Mohammad Trust Hosp, Faisalabad, Pakistan.
   [Kausar, Samina] Punjab Med Coll, Faisalabad, Pakistan.
   [Batool, Tahira] Gen Hosp, Kahota Res Lab KRL, Rawalpindi, Pakistan.
   [Kyani, Brigadier Naila Tahir] Mil Hosp MH Rawalpindi, Rawalpindi, Pakistan.
   [Biryabarema, Christine; Bulime, Ruth; Akello, Regina; Lwasa, Bernadette Nakawooya; Ayikoru, Joselyn; Namulwasira, Christine] Mulago Hosp, Kampala, Uganda.
   [Komagum, Patrick; Rebecca, Isabirye; Annet, Nayiga; Nuulu, Nakirigya] Mubende Reg Referral Hosp, Mubende, Uganda.
   [Nionzima, Elizabeth; Bwotya, Rose; Nankya, Margret; Babirye, Sarah] St Francis Hosp Buluba, Kampala, Uganda.
   [Ngonzi, Joseph; Sanchez, Cesar; Innocent, Nkonwa; Anitah, Kusasira] Mbarara Hosp, Mbarara, Uganda.
   [Jackson, Ayiko; Ndagire, Elizabeth] Entebbe Gen Hosp, Entebbe, Uganda.
   [Drametu, Dominic] Adjumani Hosp, Adjumani, Uganda.
   [Meregurwa, Grace] Angal St Luke Hosp, Angal, Uganda.
   [Banya, Francis; Atim, Rita] Church Uganda Kisiizi Hosp, Kisiizi, Uganda.
   [Byaruhanga, Emmanuel] Ibanda Hosp, Martyrs, Uganda.
   Nyakibale Hosp, Rukungiri, Uganda.
   [Iman, Hussein; Oyiengo, Vincent; Waigi, Peninah; Wangui, Rose] Garissa Prov Gen Hosp, Garissa, Kenya.
   [Nassir, Faiza; Soita, Musimbi; Msengeti, Rophina; Zubier, Zeinab] Coast Prov Gen Hosp, Mombasa, Kenya.
   [Mabeya, Hillary; Wanjala, Antony; Mwangi, Henry] Moi Teaching & Referral Hosp, Eldoret, Kenya.
   [Liyayi, Brian; Muthoka, Evelyn; Osoti, Alfred] AIC Kijabe Hosp, Kijabe, Kenya.
   [Otara, Amos; Ongwae, Veronicah] Nakuru Prov Gen Hosp, Nakuru, Kenya.
   [Qureshi, Zahida; Wanjohi, Victor] Univ Nairobi, Kenyatta Natl Hosp, Nairobi, Kenya.
   [Musila, Bonface] Mwingi Dist Hosp, Mwingi, Kenya.
   [Wekesa, Kubasu] Bungoma Dist Hosp, Bungoma, Kenya.
   [Bosire, Alex Nyakundi] Nairobi Hosp, Nairobi, Kenya.
   [Ntem, Alice; Njoache, Angeline; Ashu, Alice] Kumba Dist Referral Hosp, Kumba, Cameroon.
   [Tchounzou, Robert; Simo, Andre; Keka, Dorothy] Reg Hosp Limbe, Limbe, Cameroon.
   [Bruno, Kenfack; Ndouoya, Amadou; Saadio, Martin] Dschang Dist Hosp, Dschang, Cameroon.
   [Tchana, Mesack; Gwan, Odel; Assomo, Pauline] Hop Laquintinie Douala, Douala, Cameroon.
   [Mutsu, Venantius; Eric, Nji] St Theresas Catholic Hosp, Kumbo, Cameroon.
   [Foumane, Pascal; Nsem, Philemon] Yaounde Gynaecoobstet & Paediat Hosp, Yaounde, Cameroon.
   [Fouedjio, Jeanne; Fouelifack, Ymele] Yaounde Cent Hosp, Yaounde, Cameroon.
   [Tebeu, Pierre Marie] Ctr Hosp & Univ Yaounde, Yaounde, Cameroon.
   Saa Dist Hosp, Yaounde, Cameroon.
   Banyo Dist Hosp, Banyo, Cameroon.
   [Nabag, Wisal; Desougi, Riham; Mustafa, Hadia; Eltaib, Huida] Khartoum North Teaching Hosp, Khartoum, Sudan.
   [Umbeli, Taha; Elfadl, Khalid; Ibrahim, Murwan] Omdurman Matern Hosp, Omdurman, Sudan.
   [Mohammed, Abdalla; Ali, Awadia] Kassala New Hosp Al Saudi, Al Saudi, Sudan.
   [Abdelrahiem, Somia; Musa, Mohammed] Wad Medani Teaching Hosp Obstet & Gynaecol, Wad Madani, Sudan.
   El Obeid Teaching Hosp, Al Ubayyid, Sudan.
   [Bushra, Mahdi; Babiker, Omer] Kosti Hosp, Kosti, Sudan.
   [Abdullahi, Hala; Ahmed, Mohamed] Soba Univ Hosp, Soba, Sudan.
   [Eltaib, Huida] Gadarif Obstet & Gynaecol Hosp, Gadarif, Sudan.
   [Rayis, Duria] Khartoum Teaching Hosp, Khartoum, Sudan.
   [Abdelgabar, Saeed Abdelrahman] Elmek Nimir Univ Hosp, Elmek Nimir, Sudan.
   [Alfirevic, Zarko; Houghton, Gillian; Sharpe, Andrew] Liverpool Womens Hosp, Liverpool Womens NHS Fdn Trust, Liverpool, Merseyside, England.
   [Thornton, Jim; Grace, Nick; Smith, Carys] Nottingham Univ Hosp Trust, City Hosp Nottingham, Nottingham, England.
   [Hinshaw, Kim; Edmundson, Dawn] Sunderland Royal Hosp, City Hosp Sunderland NHS Trust, Sunderland, Tyne & Wear, England.
   [Ayuk, Paul; Bates, Alison] Newcastle Upon Tyne Hosp NHS Trust, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England.
   [Bugg, George; Wilkins, Joanne] Nottingham Univ Hosp Trust, Queens Med Ctr, Nottingham, England.
   [Tower, Clare; Allibone, Alysha] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester, Lancs, England.
   St Thomas Hosp, Guys & St Thomas NHS Fdn Trust, Manchester, Lancs, England.
   [Kidanto, Hussein; Kazumari, Ahmad; Danford, Anna; Ngarina, Matilda] Muhimbili Natl Hosp, Muhimbili, Tanzania.
   [Abeid, Muzdalifat; Mayumba, Khadija; Zacharia, Magreth] Temeke Municipal Hosp, Temeke, Tanzania.
   [Mtove, George; Madame, Leonard] Hospitali Teule Muheza Designated Dist Hosp, Muheza, Tanzania.
   [Massinde, Anthony; Mwambe, Berno] Bugando Med Ctr, Bugando, Tanzania.
   Sekou Toure Reg Hosp, Mwanza, Tanzania.
   [Ganyaka, Sebastian Kitengile] Mwananyamala Municipal Hosp, Mwanza, Tanzania.
   [Regmi, Mohan; Gupta, Shyam; Bhatt, Rabindra; Agrawal, Ajay] BP Koirala Inst Hlth Sci, Dharan, Nepal.
   [Pradhan, Pramila; Dhakal, Nikita; Yadav, Punita] Nepal Med Coll Teaching Hosp, Dharan, Nepal.
   [Karki, Gyanendra] Birat Hosp & Res Ctr, Biratnagar, Nepal.
   [Shrestha, Bhola Ram] Mid Western Reg Hosp, Birendranagar, Nepal.
   [Vwalika, Bellington; Lubeya, Mwansa; Mumba, Jane; Silwimba, Willies] Univ Teaching Hosp Lusaka, Lusaka, Zambia.
   [Hansingo, Isaiah; Bopili, Noojiri] Livingstone Gen Hosp, Livingstone, Zambia.
   [Makukula, Ziche] St Francis Hosp Katete, Katete, Zambia.
   [Kawimbe, Alexander] Kabwe Gen Hosp, Kabwe, Zambia.
   [Lubeya, Mwansa Ketty] Kafue Dist Hosp, Kafue, Zambia.
   [Mtambo, Willard] St Pauls Mission Hosp, Nchelenge, Zambia.
   [Ng'ambi, Mathew] Chipata Gen Hosp, Chipata, Zambia.
   [Dallaku, Kastriot; Cenameri, Saimir; Tasha, Ilir; Kruja, Aferdita] Obstet Gynaecol Univ Hosp K Gliozheni, Shkoder, Albania.
   [Brahimaj, Besnik] Reg Hosp Fier, Fier, Albania.
   Reg Hosp Elbasan, Elbasan, Albania.
   [Kaza, Leon] Lezha Reg Hosp, Lezha, Albania.
   [Sahani, Mateus; Tshombe, Desire; Buligho, Elizabeth] Hope Med Ctr, Likouala, DEM REP CONGO.
   [Paluku-Hamuli, Roger; Kacha, Charles] Ctr Med ADEBECO, Adebeco, DEM REP CONGO.
   [Faida, Kato] CSR Carmel, Goma, DEM REP CONGO.
   [Musau, Badibanga] Ctr Sante Reference Albert Barthel, Badibanga Musau, DEM REP CONGO.
   [Kalyana, Herman] Ctr Med VUHE, Kinshasa, DEM REP CONGO.
   [Simisi, Phanny] Virunga Gen Hosp, Goma, DEM REP CONGO.
   [Mulyumba, Serge] GESOM, Goma, DEM REP CONGO.
   [Jason, Nzanzu Kikuhe] Ctr Sante Reference Kahembe, Kahembe, DEM REP CONGO.
   [Lubamba, Jean Robert] Ctr Hosp Notre Dame Afrique, Goma, DEM REP CONGO.
   [Missumba, Willis] Prov Hosp Goma, Goma, DEM REP CONGO.
   [Islam, Ferdousi; Begum, Nazneen] Dhaka Med Coll Hosp, Dhaka, Bangladesh.
   [Akhter, Sayeba; Chowdhury, Ferdousi] Ad din Womens Med Coll & Hosp, Ad Din, Bangladesh.
   [Begum, Rokeya; Basher, Farjana] Chittagong Med Coll Hosp, Chittagong, Bangladesh.
   [Nargis, Nazlima; Abu Kholdun] Ibn Sina Med Coll Hosp, Dhaka, Bangladesh.
   [Jesmin, Shahela; Paul, Shrodha] Rajshahi Med Coll Hosp, Dhaka, Bangladesh.
   [Segni, Hailemariam; Ayana, Getachew; Haleke, William] Jimma Univ Hosp, Dhaka, Bangladesh.
   [Abdulkadir, Abdulfetah; Hussien, Hassen; Geremew, Fikre] St Pauls Hosp, Millennium Med Coll, Dhaka, Bangladesh.
   [Bambara, Moussa; Some, Adolphe; Ly, Amadou] Ctr Hosp Univ Souro Sanou, Souro Sanou, Burkina Faso.
   [Pabakba, Roamba] Ctr Hosp Reg Dedougou, Dedougou, Burkina Faso.
   [Fletcher, Horace; Samuels, Leslie] Univ Hosp West Indies, Kingston, Jamaica.
   [Opare-Addo, Henry; Larsen-Reindorf, Roderick] Komfo Anokye Teaching Hosp, Kumasi, Ghana.
   [Nyarko-Jectey, Kwadwo] Ashanti Mampong Municipal Hosp, Mampong, Ghana.
   [Wai, Malts] Port Moresby Gen Hosp, Port Moresby, Papua N Guinea.
   [El Rahman, Magdy; Basta, Wafaa; Khamis, Hussein] Mataria Teaching Hosp, Cairo, Egypt.
   [Escobar, Maria Fernanda; Vallecilla, Liliana] Fdn Valle Lili, Cali, Colombia.
   [Faye, Gabriel Essetchi] Hop Gen Abobo Nord, Abobo, Cote Ivoire.
RP Akintan, A (reprint author), London Sch Hyg & Trop Med, Clin Trials Unit, London, England.
OI GUL, FOUZIA/0000-0001-6187-8384; Sherin, Akhtar/0000-0003-1173-9671
FU London School of Hygiene & Tropical Medicine; Pfizer; UK Department of
   Health; Wellcome Trust; Bill & Melinda Gates Foundation
FX London School of Hygiene & Tropical Medicine, Pfizer, UK Department of
   Health, Wellcome Trust, and Bill & Melinda Gates Foundation.
CR Carroli G, 2008, BEST PRACT RES CL OB, V22, P999, DOI 10.1016/j.bpobgyn.2008.08.004
   Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885
   Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87
   Ducloy-Bouthors AS, 2016, BRIT J ANAESTH, V116, P641, DOI 10.1093/bja/aew021
   Electronic Medicines Compendium, SUMM PROD CHAR TRAN
   Ker K, 2013, BRIT J SURG, V100, P1271, DOI 10.1002/bjs.9193
   Ker K, 2012, BMJ-BRIT MED J, V344, pe3054, DOI DOI 10.1136/BMJ.E3054
   KRUITHOF EKO, 1987, BLOOD, V69, P460
   Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424
   Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450
   Prieto-Merino D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6782
   Roberts I, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-450
   Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X
   Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S01406736(06)69380-X
   Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Shah N, 2009, JCPSP-J COLL PHYSICI, V19, P95, DOI 02.2009/JCPSP.9598
   Shakur H, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1332-2
   Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5
   Shakur H, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-40
   Tort J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0669-y
   World Health Organization, 2012, TRENDS MAT MORT 1990
   World Health Organization (WHO), 2012, WHO REC PREV TREATM
   Wu XW, 2016, AM J PHYSIOL-REG I, V310, pR323, DOI 10.1152/ajpregu.00401.2015
   [Anonymous], 1996, INT COUNCIL HARMONIS, V6
NR 25
TC 1
Z9 1
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 27
PY 2017
VL 389
IS 10084
BP 2105
EP 2116
DI 10.1016/S0140-6736(17)30638-4
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA EV7QE
UT WOS:000401973300029
OA No
DA 2017-08-17
ER

PT J
AU Adamczyk, L
   Adkins, JK
   Agakishiev, G
   Aggarwal, MM
   Ahammed, Z
   Ajitanand, NN
   Alekseev, I
   Anderson, DM
   Aoyama, R
   Aparin, A
   Arkhipkin, D
   Aschenauer, EC
   Ashraf, MU
   Attri, A
   Averichev, GS
   Bai, X
   Bairathi, V
   Behera, A
   Bellwied, R
   Bhasin, A
   Bhati, AK
   Bhattarai, P
   Bielcik, J
   Bielcikova, J
   Bland, LC
   Bordyuzhin, IG
   Bouchet, J
   Brandenburg, JD
   Brandin, AV
   Brown, D
   Bunzarov, I
   Butterworth, J
   Caines, H
   Sanchez, MCDB
   Campbell, JM
   Cebra, D
   Chakaberia, I
   Chaloupka, P
   Chang, Z
   Chankova-Bunzarova, N
   Chatterjee, A
   Chattopadhyay, S
   Chen, X
   Chen, JH
   Chen, X
   Cheng, J
   Cherney, M
   Christie, W
   Contin, G
   Crawford, HJ
   Das, S
   De Silva, LC
   Debbe, RR
   Dedovich, TG
   Deng, J
   Derevschikov, AA
   Didenko, L
   Dilks, C
   Dong, X
   Drachenberg, JL
   Draper, JE
   Dunkelberger, LE
   Dunlop, JC
   Efimov, LG
   Elsey, N
   Engelage, J
   Eppley, G
   Esha, R
   Esumi, S
   Evdokimov, O
   Ewigleben, J
   Eyser, O
   Fatemi, R
   Fazio, S
   Federic, P
   Federicova, P
   Fedorisin, J
   Feng, Z
   Filip, P
   Finch, E
   Fisyak, Y
   Flores, CE
   Fulek, L
   Gagliardi, CA
   Garand, D
   Geurts, F
   Gibson, A
   Girard, M
   Greiner, L
   Grosnick, D
   Gunarathne, DS
   Guo, Y
   Gupta, A
   Gupta, S
   Guryn, W
   Hamad, AI
   Hamed, A
   Harlenderova, A
   Harris, JW
   He, L
   Heppelmann, S
   Heppelmann, S
   Hirsch, A
   Hoffmann, GW
   Horvat, S
   Huang, T
   Huang, B
   Huang, X
   Huang, HZ
   Humanic, TJ
   Huo, P
   Igo, G
   Jacobs, WW
   Jentsch, A
   Jia, J
   Jiang, K
   Jowzaee, S
   Judd, EG
   Kabana, S
   Kalinkin, D
   Kang, K
   Kauder, K
   Ke, HW
   Keane, D
   Kechechyan, A
   Khan, Z
   Kikola, DP
   Kisel, I
   Kisiel, A
   Kochenda, L
   Kocmanek, M
   Kollegger, T
   Kosarzewski, LK
   Kraishan, AF
   Kravtsov, P
   Krueger, K
   Kulathunga, N
   Kumar, L
   Kvapil, J
   Kwasizur, JH
   Lacey, R
   Landgraf, JM
   Landry, KD
   Lauret, J
   Lebedev, A
   Lednicky, R
   Lee, JH
   Li, X
   Li, C
   Li, W
   Li, Y
   Lidrych, J
   Lin, T
   Lisa, MA
   Liu, H
   Liu, P
   Liu, Y
   Liu, F
   Ljubicic, T
   Llope, WJ
   Lomnitz, M
   Longacre, RS
   Luo, S
   Luo, X
   Ma, GL
   Ma, L
   Ma, YG
   Ma, R
   Magdy, N
   Majka, R
   Mallick, D
   Margetis, S
   Markert, C
   Matis, HS
   Meehan, K
   Mei, JC
   Miller, ZW
   Minaev, NG
   Mioduszewski, S
   Mishra, D
   Mizuno, S
   Mohanty, B
   Mondal, MM
   Morozov, DA
   Mustafa, MK
   Nasim, M
   Nayak, TK
   Nelson, JM
   Nie, M
   Nigmatkulov, G
   Niida, T
   Nogach, LV
   Nonaka, T
   Nurushev, SB
   Odyniec, G
   Ogawa, A
   Oh, K
   Okorokov, VA
   Olvitt, D
   Page, BS
   Pak, R
   Pandit, Y
   Panebratsev, Y
   Pawlik, B
   Pei, H
   Perkins, C
   Pile, P
   Pluta, J
   Poniatowska, K
   Porter, J
   Posik, M
   Poskanzer, AM
   Pruthi, NK
   Przybycien, M
   Putschke, J
   Qiu, H
   Quintero, A
   Ramachandran, S
   Ray, RL
   Reed, R
   Rehbein, MJ
   Ritter, HG
   Roberts, JB
   Rogachevskiy, OV
   Romero, JL
   Roth, JD
   Ruan, L
   Rusnak, J
   Rusnakova, O
   Sahoo, NR
   Sahu, PK
   Salur, S
   Sandweiss, J
   Saur, M
   Schambach, J
   Schmah, AM
   Schmidke, WB
   Schmitz, N
   Schweid, BR
   Seger, J
   Sergeeva, M
   Seyboth, P
   Shah, N
   Shahaliev, E
   Shanmuganathan, PV
   Shao, M
   Sharma, A
   Sharma, MK
   Shen, WQ
   Shi, Z
   Shi, SS
   Shou, QY
   Sichtermann, EP
   Sikora, R
   Simko, M
   Singha, S
   Skoby, MJ
   Smirnov, N
   Smirnov, D
   Solyst, W
   Song, L
   Sorensen, P
   Spinka, HM
   Srivastava, B
   Stanislaus, TDS
   Strikhanov, M
   Stringfellow, B
   Sugiura, T
   Sumbera, M
   Summa, B
   Sun, Y
   Sun, XM
   Sun, X
   Surrow, B
   Svirida, DN
   Szelezniak, MA
   Tang, AH
   Tang, Z
   Taranenko, A
   Tarnowsky, T
   Tawfik, A
   Thader, J
   Thomas, JH
   Timmins, AR
   Tlusty, D
   Todoroki, T
   Tokarev, M
   Trentalange, S
   Tribble, RE
   Tribedy, P
   Tripathy, SK
   Trzeciak, BA
   Tsai, OD
   Ullrich, T
   Underwood, DG
   Upsal, I
   Van Buren, G
   van Nieuwenhuizen, G
   Vasiliev, AN
   Videbkaek, F
   Vokal, S
   Voloshin, SA
   Vossen, A
   Wang, G
   Wang, Y
   Wang, F
   Wang, Y
   Webb, JC
   Webb, G
   Wen, L
   Westfall, GD
   Wieman, H
   Wissink, SW
   Witt, R
   Wu, Y
   Xiao, ZG
   Xie, W
   Xie, G
   Xu, J
   Xu, N
   Xu, QH
   Xu, YF
   Xu, Z
   Yang, Y
   Yang, Q
   Yang, C
   Yang, S
   Ye, Z
   Ye, Z
   Yi, L
   Yip, K
   Yoo, IK
   Yu, N
   Zbroszczyk, H
   Zha, W
   Zhang, Z
   Zhang, XP
   Zhang, JB
   Zhang, S
   Zhang, J
   Zhang, Y
   Zhang, J
   Zhang, S
   Zhao, J
   Zhong, C
   Zhou, L
   Zhou, C
   Zhu, X
   Zhu, Z
   Zyzak, M
AF Adamczyk, L.
   Adkins, J. K.
   Agakishiev, G.
   Aggarwal, M. M.
   Ahammed, Z.
   Ajitanand, N. N.
   Alekseev, I.
   Anderson, D. M.
   Aoyama, R.
   Aparin, A.
   Arkhipkin, D.
   Aschenauer, E. C.
   Ashraf, M. U.
   Attri, A.
   Averichev, G. S.
   Bai, X.
   Bairathi, V.
   Behera, A.
   Bellwied, R.
   Bhasin, A.
   Bhati, A. K.
   Bhattarai, P.
   Bielcik, J.
   Bielcikova, J.
   Bland, L. C.
   Bordyuzhin, I. G.
   Bouchet, J.
   Brandenburg, J. D.
   Brandin, A. V.
   Brown, D.
   Bunzarov, I.
   Butterworth, J.
   Caines, H.
   Sanchez, M. Calderon de la Barca
   Campbell, J. M.
   Cebra, D.
   Chakaberia, I.
   Chaloupka, P.
   Chang, Z.
   Chankova-Bunzarova, N.
   Chatterjee, A.
   Chattopadhyay, S.
   Chen, X.
   Chen, J. H.
   Chen, X.
   Cheng, J.
   Cherney, M.
   Christie, W.
   Contin, G.
   Crawford, H. J.
   Das, S.
   De Silva, L. C.
   Debbe, R. R.
   Dedovich, T. G.
   Deng, J.
   Derevschikov, A. A.
   Didenko, L.
   Dilks, C.
   Dong, X.
   Drachenberg, J. L.
   Draper, J. E.
   Dunkelberger, L. E.
   Dunlop, J. C.
   Efimov, L. G.
   Elsey, N.
   Engelage, J.
   Eppley, G.
   Esha, R.
   Esumi, S.
   Evdokimov, O.
   Ewigleben, J.
   Eyser, O.
   Fatemi, R.
   Fazio, S.
   Federic, P.
   Federicova, P.
   Fedorisin, J.
   Feng, Z.
   Filip, P.
   Finch, E.
   Fisyak, Y.
   Flores, C. E.
   Fulek, L.
   Gagliardi, C. A.
   Garand, D.
   Geurts, F.
   Gibson, A.
   Girard, M.
   Greiner, L.
   Grosnick, D.
   Gunarathne, D. S.
   Guo, Y.
   Gupta, A.
   Gupta, S.
   Guryn, W.
   Hamad, A. I.
   Hamed, A.
   Harlenderova, A.
   Harris, J. W.
   He, L.
   Heppelmann, S.
   Heppelmann, S.
   Hirsch, A.
   Hoffmann, G. W.
   Horvat, S.
   Huang, T.
   Huang, B.
   Huang, X.
   Huang, H. Z.
   Humanic, T. J.
   Huo, P.
   Igo, G.
   Jacobs, W. W.
   Jentsch, A.
   Jia, J.
   Jiang, K.
   Jowzaee, S.
   Judd, E. G.
   Kabana, S.
   Kalinkin, D.
   Kang, K.
   Kauder, K.
   Ke, H. W.
   Keane, D.
   Kechechyan, A.
   Khan, Z.
   Kikola, D. P.
   Kisel, I.
   Kisiel, A.
   Kochenda, L.
   Kocmanek, M.
   Kollegger, T.
   Kosarzewski, L. K.
   Kraishan, A. F.
   Kravtsov, P.
   Krueger, K.
   Kulathunga, N.
   Kumar, L.
   Kvapil, J.
   Kwasizur, J. H.
   Lacey, R.
   Landgraf, J. M.
   Landry, K. D.
   Lauret, J.
   Lebedev, A.
   Lednicky, R.
   Lee, J. H.
   Li, X.
   Li, C.
   Li, W.
   Li, Y.
   Lidrych, J.
   Lin, T.
   Lisa, M. A.
   Liu, H.
   Liu, P.
   Liu, Y.
   Liu, F.
   Ljubicic, T.
   Llope, W. J.
   Lomnitz, M.
   Longacre, R. S.
   Luo, S.
   Luo, X.
   Ma, G. L.
   Ma, L.
   Ma, Y. G.
   Ma, R.
   Magdy, N.
   Majka, R.
   Mallick, D.
   Margetis, S.
   Markert, C.
   Matis, H. S.
   Meehan, K.
   Mei, J. C.
   Miller, Z. W.
   Minaev, N. G.
   Mioduszewski, S.
   Mishra, D.
   Mizuno, S.
   Mohanty, B.
   Mondal, M. M.
   Morozov, D. A.
   Mustafa, M. K.
   Nasim, Md.
   Nayak, T. K.
   Nelson, J. M.
   Nie, M.
   Nigmatkulov, G.
   Niida, T.
   Nogach, L. V.
   Nonaka, T.
   Nurushev, S. B.
   Odyniec, G.
   Ogawa, A.
   Oh, K.
   Okorokov, V. A.
   Olvitt, D., Jr.
   Page, B. S.
   Pak, R.
   Pandit, Y.
   Panebratsev, Y.
   Pawlik, B.
   Pei, H.
   Perkins, C.
   Pile, P.
   Pluta, J.
   Poniatowska, K.
   Porter, J.
   Posik, M.
   Poskanzer, A. M.
   Pruthi, N. K.
   Przybycien, M.
   Putschke, J.
   Qiu, H.
   Quintero, A.
   Ramachandran, S.
   Ray, R. L.
   Reed, R.
   Rehbein, M. J.
   Ritter, H. G.
   Roberts, J. B.
   Rogachevskiy, O. V.
   Romero, J. L.
   Roth, J. D.
   Ruan, L.
   Rusnak, J.
   Rusnakova, O.
   Sahoo, N. R.
   Sahu, P. K.
   Salur, S.
   Sandweiss, J.
   Saur, M.
   Schambach, J.
   Schmah, A. M.
   Schmidke, W. B.
   Schmitz, N.
   Schweid, B. R.
   Seger, J.
   Sergeeva, M.
   Seyboth, P.
   Shah, N.
   Shahaliev, E.
   Shanmuganathan, P. V.
   Shao, M.
   Sharma, A.
   Sharma, M. K.
   Shen, W. Q.
   Shi, Z.
   Shi, S. S.
   Shou, Q. Y.
   Sichtermann, E. P.
   Sikora, R.
   Simko, M.
   Singha, S.
   Skoby, M. J.
   Smirnov, N.
   Smirnov, D.
   Solyst, W.
   Song, L.
   Sorensen, P.
   Spinka, H. M.
   Srivastava, B.
   Stanislaus, T. D. S.
   Strikhanov, M.
   Stringfellow, B.
   Sugiura, T.
   Sumbera, M.
   Summa, B.
   Sun, Y.
   Sun, X. M.
   Sun, X.
   Surrow, B.
   Svirida, D. N.
   Szelezniak, M. A.
   Tang, A. H.
   Tang, Z.
   Taranenko, A.
   Tarnowsky, T.
   Tawfik, A.
   Thader, J.
   Thomas, J. H.
   Timmins, A. R.
   Tlusty, D.
   Todoroki, T.
   Tokarev, M.
   Trentalange, S.
   Tribble, R. E.
   Tribedy, P.
   Tripathy, S. K.
   Trzeciak, B. A.
   Tsai, O. D.
   Ullrich, T.
   Underwood, D. G.
   Upsal, I.
   Van Buren, G.
   van Nieuwenhuizen, G.
   Vasiliev, A. N.
   Videbkaek, F.
   Vokal, S.
   Voloshin, S. A.
   Vossen, A.
   Wang, G.
   Wang, Y.
   Wang, F.
   Wang, Y.
   Webb, J. C.
   Webb, G.
   Wen, L.
   Westfall, G. D.
   Wieman, H.
   Wissink, S. W.
   Witt, R.
   Wu, Y.
   Xiao, Z. G.
   Xie, W.
   Xie, G.
   Xu, J.
   Xu, N.
   Xu, Q. H.
   Xu, Y. F.
   Xu, Z.
   Yang, Y.
   Yang, Q.
   Yang, C.
   Yang, S.
   Ye, Z.
   Ye, Z.
   Yi, L.
   Yip, K.
   Yoo, I. -K.
   Yu, N.
   Zbroszczyk, H.
   Zha, W.
   Zhang, Z.
   Zhang, X. P.
   Zhang, J. B.
   Zhang, S.
   Zhang, J.
   Zhang, Y.
   Zhang, J.
   Zhang, S.
   Zhao, J.
   Zhong, C.
   Zhou, L.
   Zhou, C.
   Zhu, X.
   Zhu, Z.
   Zyzak, M.
CA STAR Collaboration
TI Measurement of D-0 Azimuthal Anisotropy at Midrapidity in Au plus Au
   Collisions at root S-NN=200 GeV
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID NUCLEUS-NUCLEUS COLLISIONS; HEAVY-ION COLLISIONS; TRANSPORT MODEL; PB
   COLLISIONS; FLAVOR; STAR; COLLABORATION; FLOW; LHC
AB We report the first measurement of the elliptic anisotropy (v(2)) of the charm meson D-0 at midrapidity (broken vertical bar y broken vertical bar < 1) in Au + Au collisions at root S-NN = 200 GeV. The measurement was conducted by the STAR experiment at RHIC utilizing a new high- resolution silicon tracker. The measured D-0 v(2) in 0%-80% centrality Au + Au collisions can be described by a viscous hydrodynamic calculation for a transverse momentum (p(T)) of less than 4 GeV/c. The D-0 v(2) as a function of transverse kinetic energy (m(T) - m(0), where m(T) = root p(T)(2) + m(0)(2) p) is consistent with that of light mesons in 10%- 40% centrality Au + Au collisions. These results suggest that charm quarks have achieved local thermal equilibrium with the medium created in such collisions. Several theoretical models, with the temperature-dependent, dimensionless charm spatial diffusion coefficient (2 pi TDs) in the range of similar to 2-12, are able to simultaneously reproduce our D-0 v(2) result and our previously published results for the D-0 nuclear modification factor.
C1 [Adamczyk, L.; Aparin, A.; Attri, A.; Behera, A.; Bhasin, A.; Fulek, L.; Przybycien, M.; Sikora, R.] AGH Univ Sci & Technol, FPACS, PL-30059 Krakow, Poland.
   [Krueger, K.; Spinka, H. M.; Underwood, D. G.] Argonne Natl Lab, Argonne, IL 60439 USA.
   [Aschenauer, E. C.; Bland, L. C.; Chakaberia, I.; Christie, W.; Debbe, R. R.; Didenko, L.; Dunlop, J. C.; Eyser, O.; Fazio, S.; Fisyak, Y.; Guryn, W.; Jia, J.; Ke, H. W.; Landgraf, J. M.; Lauret, J.; Lebedev, A.; Lee, J. H.; Ljubicic, T.; Longacre, R. S.; Ma, R.; Markert, C.; Ogawa, A.; Page, B. S.; Pak, R.; Pile, P.; Ruan, L.; Schmidke, W. B.; Smirnov, D.; Sorensen, P.; Tang, A. H.; Todoroki, T.; Tribedy, P.; Ullrich, T.; Van Buren, G.; van Nieuwenhuizen, G.; Videbkaek, F.; Webb, J. C.; Webb, G.; Xu, Z.; Yang, S.; Yip, K.] Brookhaven Natl Lab, Upton, NY 11973 USA.
   [Crawford, H. J.; Engelage, J.; Judd, E. G.; Nelson, J. M.; Perkins, C.] Univ Calif Berkeley, Berkeley, CA 94720 USA.
   [Sanchez, M. Calderon de la Barca; Cebra, D.; Draper, J. E.; Flores, C. E.; Heppelmann, S.; Meehan, K.; Romero, J. L.] Univ Calif Davis, Davis, CA 95616 USA.
   [Dunkelberger, L. E.; Esha, R.; Huang, H. Z.; Igo, G.; Landry, K. D.; Nasim, Md.; Sergeeva, M.; Trentalange, S.; Tsai, O. D.; Wang, G.; Wen, L.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA.
   [Bai, X.; Das, S.; Feng, Z.; Liu, F.; Luo, X.; Pei, H.; Shi, S. S.; Sun, X.; Wang, Y.; Xu, J.; Yu, N.; Zhang, J. B.] Cent China Normal Univ, Wuhan, Hubei 430079, Peoples R China.
   [Evdokimov, O.; Huang, B.; Khan, Z.; Luo, S.; Miller, Z. W.; Pandit, Y.] Univ Illinois, Chicago, IL 60607 USA.
   [Cherney, M.; De Silva, L. C.; Rehbein, M. J.; Roth, J. D.; Seger, J.] Creighton Univ, Omaha, NE 68178 USA.
   [Bielcik, J.; Chaloupka, P.; Federicova, P.; Harlenderova, A.; Kvapil, J.; Lidrych, J.; Rusnakova, O.; Trzeciak, B. A.] Czech Tech Univ, FNSPE, Prague 11519, Czech Republic.
   [Bielcikova, J.; Federic, P.; Kocmanek, M.; Rusnak, J.; Saur, M.; Simko, M.; Sumbera, M.] Nucl Phys Inst AS CR, Prague 25068, Czech Republic.
   [Kisiel, A.; Kollegger, T.; Zyzak, M.] FIAS, D-60438 Frankfurt, Germany.
   [Mondal, M. M.; Sahu, P. K.; Tripathy, S. K.] Inst Phys, Bhubaneswar 751005, Orissa, India.
   [Jacobs, W. W.; Kalinkin, D.; Kwasizur, J. H.; Lin, T.; Liu, H.; Skoby, M. J.; Solyst, W.; Vossen, A.; Wissink, S. W.] Indiana Univ, Bloomington, IN 47408 USA.
   [Alekseev, I.; Bordyuzhin, I. G.; Svirida, D. N.] Alikhanov Inst Theoret & Expt Phys, Moscow 117218, Russia.
   [Bhasin, A.; Gupta, A.; Gupta, S.; Sharma, A.; Sharma, M. K.] Univ Jammu, Jammu 180001, India.
   [Agakishiev, G.; Aparin, A.; Attri, A.; Averichev, G. S.; Bunzarov, I.; Chankova-Bunzarova, N.; Dedovich, T. G.; Efimov, L. G.; Fedorisin, J.; Filip, P.; Kechechyan, A.; Lednicky, R.; Panebratsev, Y.; Rogachevskiy, O. V.; Shahaliev, E.; Tokarev, M.; Vokal, S.] Joint Inst Nucl Res, Dubna 141980, Russia.
   [Bouchet, J.; Guo, Y.; Hamad, A. I.; Kabana, S.; Keane, D.; Margetis, S.; Singha, S.; Wu, Y.] Kent State Univ, Kent, OH 44242 USA.
   [Adkins, J. K.; Fatemi, R.; Ramachandran, S.] Univ Kentucky, Lexington, KY 40506 USA.
   [Drachenberg, J. L.] Lamar Univ, Phys Dept, Beaumont, TX 77710 USA.
   [Chen, X.; Zhang, J.] Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Peoples R China.
   [Contin, G.; Dong, X.; Greiner, L.; Lomnitz, M.; Matis, H. S.; Mizuno, S.; Mustafa, M. K.; Odyniec, G.; Porter, J.; Poskanzer, A. M.; Ritter, H. G.; Salur, S.; Schmah, A. M.; Shi, Z.; Sichtermann, E. P.; Szelezniak, M. A.; Thader, J.; Thomas, J. H.; Wieman, H.; Xu, N.; Zhang, J.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
   [Brown, D.; Ewigleben, J.; Reed, R.; Shanmuganathan, P. V.] Lehigh Univ, Bethlehem, PA 18015 USA.
   [Schmitz, N.; Seyboth, P.] Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany.
   [Tarnowsky, T.; Westfall, G. D.] Michigan State Univ, E Lansing, MI 48824 USA.
   [Alekseev, I.; Brandin, A. V.; Kochenda, L.; Kravtsov, P.; Nigmatkulov, G.; Okorokov, V. A.; Strikhanov, M.; Taranenko, A.] Nat Res Nucl Univ MEPhI, Moscow 115409, Russia.
   [Bairathi, V.; Mallick, D.; Mishra, D.; Mohanty, B.] Nat Inst Sci Educ & Res, HBNI, Jatni 752050, India.
   [Huang, T.; Yang, Y.] Natl Cheng Kung Univ, Tainan 70101, Taiwan.
   [Campbell, J. M.; Humanic, T. J.; Lisa, M. A.; Upsal, I.] Ohio State Univ, Columbus, OH 43210 USA.
   [Pawlik, B.] Inst Nucl Phys PAN, PL-31342 Krakow, Poland.
   [Aggarwal, M. M.; Attri, A.; Bhati, A. K.; Kumar, L.; Pruthi, N. K.] Panjab Univ, Chandigarh 160014, India.
   [Dilks, C.; Heppelmann, S.; Summa, B.] Penn State Univ, University Pk, PA 16802 USA.
   [Derevschikov, A. A.; Minaev, N. G.; Morozov, D. A.; Nogach, L. V.; Nurushev, S. B.; Vasiliev, A. N.] Inst High Energy Phys, Protvino 142281, Russia.
   [Garand, D.; He, L.; Hirsch, A.; Qiu, H.; Srivastava, B.; Stringfellow, B.; Wang, F.; Xie, W.; Zhao, J.] Purdue Univ, W Lafayette, IN 47907 USA.
   [Oh, K.; Yoo, I. -K.] Pusan Natl Univ, Pusan 46241, South Korea.
   [Brandenburg, J. D.; Butterworth, J.; Eppley, G.; Geurts, F.; Roberts, J. B.; Tlusty, D.] Rice Univ, Houston, TX 77251 USA.
   [Chen, X.; Jiang, K.; Li, X.; Li, C.; Shao, M.; Sun, Y.; Tang, Z.; Xie, G.; Yang, Q.; Zha, W.; Zhang, S.; Zhang, Y.; Zhou, L.] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China.
   [Deng, J.; Mei, J. C.; Xu, Q. H.; Yang, C.; Zhu, Z.] Shandong Univ, Jinan 250100, Shandong, Peoples R China.
   [Chen, J. H.; Li, W.; Ma, G. L.; Ma, L.; Ma, Y. G.; Nie, M.; Shah, N.; Shen, W. Q.; Shou, Q. Y.; Xu, Y. F.; Zhang, Z.; Zhang, S.; Zhong, C.; Zhou, C.] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China.
   [Ajitanand, N. N.; Behera, A.; Huo, P.; Jia, J.; Lacey, R.; Liu, P.; Magdy, N.; Schweid, B. R.] SUNY Stony Brook, Stony Brook, NY 11794 USA.
   [Gunarathne, D. S.; Kraishan, A. F.; Olvitt, D., Jr.; Posik, M.; Quintero, A.; Surrow, B.] Temple Univ, Philadelphia, PA 19122 USA.
   [Anderson, D. M.; Chang, Z.; Gagliardi, C. A.; Hamed, A.; Liu, Y.; Mioduszewski, S.; Sahoo, N. R.; Tribble, R. E.] Texas A&M Univ, College Stn, TX USA.
   [Bhattarai, P.; Hoffmann, G. W.; Jentsch, A.; Markert, C.; Ray, R. L.; Schambach, J.] Univ Texas Austin, Austin, TX 78712 USA.
   [Bellwied, R.; Kulathunga, N.; Song, L.; Timmins, A. R.] Univ Houston, Houston, TX 77204 USA.
   [Ashraf, M. U.; Cheng, J.; Huang, X.; Kang, K.; Li, Y.; Wang, Y.; Xiao, Z. G.; Zhang, X. P.; Zhu, X.] Tsinghua Univ, Beijing 100084, Peoples R China.
   [Aoyama, R.; Esumi, S.; Nonaka, T.; Sugiura, T.] Univ Tsukuba, Tsukuba, Ibaraki, Japan.
   [Finch, E.] Southern Connecticut State Univ, New Haven, CT 06515 USA.
   [Witt, R.] US Naval Acad, Annapolis, MD 21402 USA.
   [Gibson, A.; Grosnick, D.; Stanislaus, T. D. S.] Valparaiso Univ, Valparaiso, IN 46383 USA.
   [Ahammed, Z.; Chatterjee, A.; Chattopadhyay, S.; Nayak, T. K.] Variable Energy Cyclotron Ctr, Kolkata 700064, India.
   [Girard, M.; Kikola, D. P.; Kisiel, A.; Kosarzewski, L. K.; Pluta, J.; Poniatowska, K.; Zbroszczyk, H.] Warsaw Univ Technol, PL-00661 Warsaw, Poland.
   [Elsey, N.; Jowzaee, S.; Kauder, K.; Llope, W. J.; Niida, T.; Putschke, J.; Voloshin, S. A.] Wayne State Univ, Detroit, MI 48201 USA.
   [Tawfik, A.] World Lab Cosmol & Particle Phys WLCAPP, Cairo 11571, Egypt.
   [Caines, H.; Harris, J. W.; Horvat, S.; Majka, R.; Sandweiss, J.; Smirnov, N.; Yi, L.] Yale Univ, New Haven, CT 06520 USA.
RP Adamczyk, L (reprint author), AGH Univ Sci & Technol, FPACS, PL-30059 Krakow, Poland.
RI Kisel, Ivan/H-7077-2017
OI Kisel, Ivan/0000-0002-4808-419X
FU Office of Nuclear Physics within U.S. DOE Office of Science; U.S.
   National Science Foundation; Ministry of Education and Science of the
   Russian Federation; National Natural Science Foundation of China;
   Chinese Academy of Science; Ministry of Science and Technology of China
   (973 Programme) [2014CB845400]; Chinese Ministry of Education; National
   Research Foundation of Korea; GA of the Czech Republic; MSMT of the
   Czech Republic; Department of Atomic Energy of the Government of India;
   National Science Centre of Poland; National Research Foundation;
   Ministry of Science, Education and Sports of the Republic of Croatia;
   German Bundesministerium fur Bildung, Wissenschaft, Forschung and
   Technologie (BMBF); Helmholtz Association; RHIC Operations Group; RCF at
   BNL; NERSC Center at LBNL; Open Science Grid consortium; RosAtom of
   Russia; Department of Science and Technology of the Government of India
FX We thank the RHIC Operations Group and RCF at BNL, the NERSC Center at
   LBNL, and the Open Science Grid consortium for providing resources and
   support. This work was supported in part by the Office of Nuclear
   Physics within the U.S. DOE Office of Science, the U.S. National Science
   Foundation, the Ministry of Education and Science of the Russian
   Federation, National Natural Science Foundation of China, Chinese
   Academy of Science, the Ministry of Science and Technology of China (973
   Programme No. 2014CB845400) and the Chinese Ministry of Education, the
   National Research Foundation of Korea, GA and MSMT of the Czech
   Republic, Department of Atomic Energy and Department of Science and
   Technology of the Government of India; the National Science Centre of
   Poland, National Research Foundation, the Ministry of Science, Education
   and Sports of the Republic of Croatia, RosAtom of Russia and German
   Bundesministerium fur Bildung, Wissenschaft, Forschung and Technologie
   (BMBF), and the Helmholtz Association.
CR Abelev B, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.034904
   Abelev B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.102301
   Abelev B, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2012)112
   Abelev BI, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.034909
   Abelev BI, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.054901
   Adam J, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2016)081
   Adamczyk L, 2017, PHYS REV C, V95, DOI 10.1103/PhysRevC.95.034907
   Adamczyk L, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.062301
   Adamczyk L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.142301
   Adamczyk L, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.072013
   Adams J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.252301
   Adams J, 2005, NUCL PHYS A, V757, P102, DOI 10.1016/j.nuclphysa.2005.03.085
   Adare A, 2016, PHYS REV C, V93, DOI 10.1103/PhysRevC.93.034904
   Adare A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.172301
   Adcox K, 2005, NUCL PHYS A, V757, P184, DOI 10.1016/j.nuclphysa.2005.03.086
   Afanasiev S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.052301
   Aggarwal MM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.202301
   Alberico WM, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1666-6
   Anderson M, 2003, NUCL INSTRUM METH A, V499, P659, DOI 10.1016/S0168-9002(02)01964-2
   Andronic A, 2016, EUR PHYS J C, V76, DOI 10.1140/epjc/s10052-015-3819-5
   Banerjee D, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.014510
   Beraudo A, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3336-6
   Berrehrah H, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.051901
   Bilandzic A, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.044913
   Borghini N, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.054906
   Cacciari M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.122001
   Cao S., COMMUNICATION
   Cao SS, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.014909
   Cao SS, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.024907
   Ding HT, 2015, INT J MOD PHYS E, V24, DOI 10.1142/S0218301315300076
   Esha R, 2017, J PHYS G NUCL PARTIC, V44, DOI 10.1088/1361-6471/aa5f02
   Gale C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.012302
   He M., COMMUNICATION
   He M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.112301
   He M, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.014903
   Hocker A., 2007, P SCI ACAT2007, VACAT2007
   Llope W, 2004, NUCL INSTRUM METH A, V522, P252, DOI 10.1016/j.nima.2003.11.414
   Llope WJ, 2012, NUCL INSTRUM METH A, V661, pS110, DOI 10.1016/j.nima.2010.07.086
   Masui H, 2016, NUCL INSTRUM METH A, V833, P181, DOI 10.1016/j.nima.2016.07.037
   Molnar D, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.092301
   Moore GD, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.064904
   Muller B, 2012, ANNU REV NUCL PART S, V62, P361, DOI 10.1146/annurev-nucl-102711-094910
   Nahrgang M., COMMUNICATION
   Nahrgang M, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.014904
   Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001
   Ozvenchuk V, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.054909
   Pang L. G., COMMUNICATION
   Pang LG, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.074027
   Pang LG, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.024911
   Poskanzer AM, 1998, PHYS REV C, V58, P1671, DOI 10.1103/PhysRevC.58.1671
   Qiu H, 2014, NUCL PHYS A, V931, P1141, DOI 10.1016/j.nuclphysa.2014.08.056
   Sharma R, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.054902
   Song T, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.014910
   Uphoff J, 2014, NUCL PHYS A, V932, P247, DOI 10.1016/j.nuclphysa.2014.07.024
   Uphoff J, 2012, PHYS LETT B, V717, P430, DOI 10.1016/j.physletb.2012.09.069
   WANG XN, 1992, PHYS REV LETT, V68, P1480, DOI 10.1103/PhysRevLett.68.1480
NR 56
TC 0
Z9 0
U1 6
U2 6
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
EI 1079-7114
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD MAY 26
PY 2017
VL 118
IS 21
AR 212301
DI 10.1103/PhysRevLett.118.212301
PG 7
WC Physics, Multidisciplinary
SC Physics
GA EV8TV
UT WOS:000402057800005
OA No
DA 2017-08-17
ER

PT J
AU EL Hadad, S
   Al-Hamdan, H
   Linjawi, S
AF EL Hadad, Sahar
   Al-Hamdan, Hesa
   Linjawi, Sabah
TI Partial sequencing analysis of the NS5B region confirmed the
   predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi
   Arabia
SO PLOS ONE
LA English
DT Article
ID BLOOD-DONORS; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; GENETIC GROUPS;
   HCV GENOTYPES; RISK-FACTORS; EPIDEMIOLOGY; SUBTYPES; FRANCE;
   CLASSIFICATION
AB Chronic hepatitis C virus (HCV) infection and its progression are major health problems that many countries including Saudi Arabia are facing. Determination of HCV genotypes and subgenotypes is critical for epidemiological and clinical analysis and aids in the determination of the ideal treatment strategy that needs to be followed and the expected therapy response. Although HCV infection has been identified as the second most predominant type of hepatitis in Saudi Arabia, little is known about the molecular epidemiology and genetic variability of HCV circulating in the Jeddah province of Saudi Arabia. The aim of this study was to determine the dominance of various HCV genotypes and subgenotypes circulating in Jeddah using partial sequencing of the NS5B region. To the best of our knowledge, this is the first study of its kind in Saudi Arabia. To characterize HCV genotypes and subgenotypes, serum samples from 56 patients with chronic HCV infection were collected and subjected to partial NS5B gene amplification and sequence analysis. Phylogenetic analysis of the NS5B partial sequences revealed that HCV/1 was the predominant genotype (73%), followed by HCV/4 (24.49%) and HCV/3 (2.04%). Moreover, pairwise analysis also confirmed these results based on the average specific nucleotide distance identity: +/- 0.112, +/- 0.112, and +/- 0.179 for HCV/1, HCV/4, and HCV/3, respectively, without any interference between genotypes. Notably, the phylogenetic tree of the HCV/1 subgenotypes revealed that all the isolates (100%) from the present study belonged to the HCV/1a subgenotype. Our findings also revealed similarities in the nucleotide sequences between HCV circulating in Saudi Arabia and those circulating in countries such as Morocco, Egypt, Canada, India, Pakistan, and France. These results indicated that determination of HCV genotypes and subgenotypes based on partial sequence analysis of the NS5B region is accurate and reliable for HCV subtype determination.
C1 [EL Hadad, Sahar; Al-Hamdan, Hesa; Linjawi, Sabah] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.
   [EL Hadad, Sahar] VACSERA, Res Ctr Genet Engn & Bioinformat, Cairo, Egypt.
RP EL Hadad, S (reprint author), King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.; EL Hadad, S (reprint author), VACSERA, Res Ctr Genet Engn & Bioinformat, Cairo, Egypt.
EM Saharelhadad@hotmail.com
FU King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia,
   research grant [0028-12]
FX This work was supported by King Abdulaziz City for Science and
   Technology, Riyadh, Saudi Arabia, research grant (Project No.0028-12).;
   The authors are grateful to the King Abdulaziz city for science and
   technology (KACST), Jeddah, KSA, for their technical and financial
   support as well as to Dr. Nezar Redhwan for providing us the laboratory
   for practical studies.
CR Abdo AA, 2012, SAUDI J GASTROENTERO, V18, P349, DOI 10.4103/1319-3767.103425
   Akbar HO, 2012, HEPATITIS MONTHLY, DOI 10.5812/hepatmon.6178
   Al-Tawfiq JA, 2008, MED SCI MONITOR, V14, pCR52
   Al-Ahdal NM, 1997, ANN SAUDI MED, V17, P201
   AlFaleh FZ, 1995, J VIRAL HEPATITIS, V2, P293, DOI 10.1111/j.1365-2893.1995.tb00044.x
   Ali S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-193
   Aljarbou AN, 2012, ANTIVIRALS ANTIRETRO, V4, P075
   Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436
   ALTER MJ, 1993, GUT, V34, pS17, DOI 10.1136/gut.34.2_Suppl.S17
   Ashfaq Usman Ali, 2011, Genet Vaccines Ther, V9, P7, DOI 10.1186/1479-0556-9-7
   Baclig Michael O, 2010, Int J Mol Epidemiol Genet, V1, P236
   Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005
   Bdour S, 2002, J MED MICROBIOL, V51, P700
   Boriskin YS, 1999, MICROBIOLOGICA, V22, P173
   BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262
   Cantaloube JF, 2006, J CLIN MICROBIOL, V44, P2051, DOI 10.1128/JCM.02463-05
   Cantaloube JF, 2005, J CLIN MICROBIOL, V43, P3624, DOI 10.1128/JCM.43.8.3624-3629.2005
   Cantaloube JF, 2003, J GEN VIROL, V84, P441, DOI 10.1099/vir.0.18642-0
   Chao DT, 2011, ALIMENT PHARM THER, V34, P286, DOI 10.1111/j.1365-2036.2011.04714.x
   Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002
   DARWISH MA, 1993, AM J TROP MED HYG, V49, P440
   Das BR, 2002, THE INDIAN JOURNAL O, V45, P323
   El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807
   EL Hadad S, 2016, SAUDI J BIOL SCI, DOI [10.1016/j.sjbs.2016.03.003, DOI 10.1016/J.SJBS.2016.03.003]
   ElHadad S. R., 2013, African Journal of Microbiology Research, V7, P814
   Fakeeh M, 1999, AM J TROP MED HYG, V61, P889
   Fakhr AE, 2013, HEPAT MON, V13, P1
   Fauquent CM, 2005, VIRUS TAXONOMY VIIIT
   Foote BS, 2011, ANN PHARMACOTHER, V45, P1085, DOI 10.1345/aph.1P744
   Germer JJ, 2003, J CLIN MICROBIOL, V41, P4855, DOI 10.1128/JCM.41.10.4855-4857.2003
   Gul A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1488-0
   HIBBS RG, 1993, J INFECT DIS, V168, P789
   Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127
   Kao JH, 2003, GASTROENTEROLOGY, V124, P327, DOI 10.1053/gast.2003.50053
   Karkar Ayman, 2007, Hemodial Int, V11, P354, DOI 10.1111/j.1542-4758.2007.00192.x
   Khodabandehloo M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.22915
   Knip DM, 2007, FIELDS VIROLOGY
   Lavanchy D., 2010, CLIN MICROBIOL INFEC, V17, P107
   Liu CJ, 2002, J MED VIROL, V68, P50, DOI 10.1002/jmv.10169
   Lloyd AR, 2006, IMMUNOLOGY AND CELL, V85, P24
   Lu L, 2014, J VIROL, V88, P7120, DOI 10.1128/JVI.00414-14
   Madani TA, 2009, T ROY SOC TROP MED H, V103, P132, DOI 10.1016/j.trstmh.2008.08.001
   Garcia-Montalvo BM, 2008, ANN HEPATOL, V7, P345
   Martial J, 2004, J CLIN MICROBIOL, V42, P784, DOI 10.1128/JCM.42.2.784-791.2004
   McElhinney LM, 2011, J GEN VIROL, V92, P2171, DOI 10.1099/vir.0.032748-0
   MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493
   Memish ZA, 2010, INT J INFECT DIS, V14, pE115, DOI 10.1016/j.ijid.2009.03.027
   Miyakawa Y, 2001, J GASTROEN HEPATOL, V16, P711, DOI 10.1046/j.1440-1746.2001.02543.x
   Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645
   Morice Y, 2001, J GEN VIROL, V82, P1001
   Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06
   Ohba K, 1996, FEBS LETT, V378, P232, DOI 10.1016/0014-5793(95)01441-1
   Osaba AO, 2002, SAUDI MED J, V23, P7
   Osoba AO, 2000, ANN SAUDI MED, V20, P394
   Pockros J., 2010, THERAP ADV GASTROENT, V3, P191
   Poustchi H, 2010, Middle East J Dig Dis, V2, P31
   Qiu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122082
   Rahman El-Zayadi A, 2001, HEPATOL RES, V19, P170, DOI 10.1016/S1386-6346(00)00105-4
   Ramia S, 2006, INT J INFECT DIS, V10, P272, DOI 10.1016/j.ijid.2005.07.008
   Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479
   Sandres-Saune K, 2003, J VIROL METHODS, V109, P187, DOI 10.1016/S0166-0934(03)00070-3
   Shobokshi OA, 2003, SAUDI MED J, V24, pS87
   Shobokshi OA, 1999, J MED VIROL, V58, P44, DOI 10.1002/(SICI)1096-9071(199905)58:1<44::AID-JMV6>3.0.CO;2-U
   Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819
   SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564
   STUYVER L, 1994, P NATL ACAD SCI USA, V91, P10134, DOI 10.1073/pnas.91.21.10134
   STUYVER L, 1995, VIRUS RES, V38, P137, DOI 10.1016/0168-1702(95)00052-R
   Stuyver L, 1996, J CLIN MICROBIOL, V34, P2259
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tokita H, 1996, J GEN VIROL, V77, P293, DOI 10.1099/0022-1317-77-2-293
   Tokita H, 1998, J GEN VIROL, V79, P1847
   White PA, 2000, J CLIN MICROBIOL, V38, P477
   WHO, 2009, THE GROWING THREATS
   YOTSUYANAGI H, 1995, CANCER, V76, P1352, DOI 10.1002/1097-0142(19951015)76:8<1352::AID-CNCR2820760809>3.0.CO;2-M
   Zhou S, 2017, J VIRAL HEPATITIS, DOI [10.1111/jvh.12677.1016/j.trstmh.2008.08.001, DOI 10.1111/JVH.12677.1016/J.TRSTMH.2008.08.001]
NR 75
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 26
PY 2017
VL 12
IS 5
AR e0178225
DI 10.1371/journal.pone.0178225
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV8VT
UT WOS:000402063000030
PM 28552946
OA gold
DA 2017-08-17
ER

PT J
AU Senbel, AM
   Abd Elmoneim, HM
   Sharabi, FM
   El-Din, MMM
AF Senbel, Amira M.
   Abd Elmoneim, Heba M.
   Sharabi, Fouad M.
   El-Din, Mahmoud M. Mohy
TI Neuronal Voltage Gated Potassium Channels May Modulate Nitric Oxide
   Synthesis in Corpus Cavernosum
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE nitric oxide; pottasium channels; erection; corpus cavernosum; voltage;
   gated pottasium channels; 4-amino pyridine
ID SMOOTH-MUSCLE-CELLS; K-ATP-CHANNEL; ERECTILE DYSFUNCTION; PHYSIOLOGICAL
   ROLES; MOLECULAR TARGETS; PENILE ARTERIES; CA CHANNEL; RABBIT; CURRENTS;
   RELAXATION
AB Potassiumchannels (K(+)Ch) in corpus cavernosumplay an important role in the regulation of erection. Nitric oxide (NO) acts through opening of K(+)Ch leading to hyperpolarization and relaxation.
   Aim : This study aims to update knowledge about the role of voltage-gated K(+)Ch (K-V) channels in erectile machinery and investigate their role in the control of NO action &/or synthesis in the corpus cavernosum.
   Methods : Tension studies using isolated rabbit corpus cavernosum (CC) strips and rat anococcygeus muscle were conducted. Results are expressed as mean +/- SEM.
   Results : Electric field stimulation (EFS, 2-16 Hz) evoked frequency-dependent relaxations of the PE (phenylephrine)-precontracted CC strips. At 2 Hz, EFS-induced relaxation amounted to 73.17 +/- 2.55% in presence 4-AP (10(-3) M) compared to 41.98 +/- 1.45% as control. None of the other selective K(+)Ch blockers tested inhibited EFS-induced relaxation. 4-AP (10(-3)M) significantly attenuated ACh-induced relaxation of rabbit CC where dose-response curve was clearly shifted upward, and attenuated SNP-induced relaxation, for example, to 49.28 +/- 4.52% compared to 65.53 +/- 3.01% as control at 10(-6) M SNP. The potentiatory effect of 4-AP on EFS was abolished or reversed in presence of N-G-nitro-L-arginine (L-NNA, non-selective nitric oxide synthase inhibitor, 10(-5)M, and 2 x 10(-4)M). Same results were observed in rat anococcygeus muscle which is a part of the erectile machinery in rats.
   Conclusion : This study provides evidence for the presence of prejunctional voltage-gated K(+)Ch in CC, the blockade of which may increase the neuronal synthesis of NO.
C1 [Senbel, Amira M.; Abd Elmoneim, Heba M.; Sharabi, Fouad M.; El-Din, Mahmoud M. Mohy] Univ Alexandria, Fac Pharm, Dept Pharmacol & Toxicol, Alexandria, Egypt.
RP Senbel, AM (reprint author), Univ Alexandria, Fac Pharm, Dept Pharmacol & Toxicol, Alexandria, Egypt.
EM senbelamira@alexpharmacy.edu.eg
FU Faculty of Pharmacy, Alexandria University, Egypt
FX This work was funded by the Faculty of Pharmacy, Alexandria University,
   Egypt.
CR Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515
   Andre E, 2003, J CARDIOVASC PHARM, V41, P300, DOI 10.1097/00005344-200302000-00020
   Archer SL, 2002, VASC PHARMACOL, V38, P61, DOI 10.1016/S1537-1891(02)00127-1
   Bowery NG, 2006, BRIT J PHARMACOL, V147, pS109, DOI 10.1038/sj.bjp.0706443
   CHRIST GJ, 1993, J ANDROL, V14, P319
   Christ GJ, 2002, J ANDROL, V23, pS10
   Christ GJ, 2000, INT J IMPOT RES, V12, pS15, DOI 10.1038/sj.ijir.3900573
   Costa G, 2001, N-S ARCH PHARMACOL, V364, P516, DOI 10.1007/s002100100480
   Dalaklioglu S, 2014, PHARMACOGN MAG, V10, P47, DOI 10.4103/0973-1296.126658
   Dalaklioglu-Tasatargil S, 2013, PHARMACOLOGY, V91, P243, DOI 10.1159/000348574
   DEMAN JG, 1993, BRIT J PHARMACOL, V110, P559
   FAN SF, 1995, J UROLOGY, V153, P818, DOI 10.1016/S0022-5347(01)67729-2
   Fiorim J, 2012, TOXICOL APPL PHARM, V262, P22, DOI 10.1016/j.taap.2012.04.015
   GILLESPI.JS, 1972, BRIT J PHARMACOL, V45, P404
   Gopalakrishnan M, 2004, EXPERT OPIN THER TAR, V8, P437, DOI 10.1517/14728222.8.5.437
   Gratzke C, 2010, J SEX MED, V7, P445, DOI 10.1111/j.1743-6109.2009.01624.x
   Han DH, 2012, BJU INT, V109, P1404, DOI 10.1111/j.1464-410X.2011.10567.x
   Hannigan KI, 2016, AM J PHYSIOL-CELL PH, V310, pC284, DOI 10.1152/ajpcell.00273.2015
   Hernandez M, 2008, BRIT J PHARMACOL, V153, P1251, DOI 10.1038/sj.bjp.0707669
   HOLMQUIST F, 1990, J UROLOGY, V144, P146
   Humphries ESA, 2015, J BIOMOL SCREEN, V20, P1055, DOI 10.1177/1087057115601677
   Insuk SO, 2003, INT J IMPOT RES, V15, P258, DOI 10.1038/sj.ijir.3901013
   Lily Jan B. A. Y., 2016, VOLTAGE GATED POTASS
   Jepps TA, 2016, BRIT J PHARMACOL, V173, P1478, DOI 10.1111/bph.13444
   Kamouchi M, 1999, GEN PHYSIOL BIOPHYS, V18, P199
   Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65
   Ko EA, 2010, PROG BIOPHYS MOL BIO, V103, P95, DOI 10.1016/j.pbiomolbio.2009.10.001
   Krishnan AV, 2013, MULT SCLER J, V19, P385, DOI 10.1177/1352458512463769
   LAI WS, 1985, J NEUROCHEM, V44, P1936, DOI 10.1111/j.1471-4159.1985.tb07190.x
   Lee SW, 1999, INT J IMPOT RES, V11, P179, DOI 10.1038/sj.ijir.3900398
   Lee SW, 2000, DRUGS TODAY, V36, P147
   Li GY, 2016, NEUROREPORT, V27, P50, DOI 10.1097/WNR.0000000000000499
   Lin CS, 2005, J SEX MED, V2, P478, DOI 10.1111/j.1743-6109.2005.00080.x
   Luca CC, 2013, PARKINSONISM RELAT D, V19, P777, DOI 10.1016/j.parkreldis.2013.04.024
   Malysz J, 2002, J ANDROL, V23, P899
   Malysz J, 2001, J UROLOGY, V166, P1167, DOI 10.1016/S0022-5347(05)65940-X
   Moon DG, 1999, BJU INT, V83, P837
   Musicki B, 2009, J ANDROL, V30, P352, DOI 10.2164/jandrol.108.006999
   Oliveira PWC, 2014, CLIN SCI, V127, P265, DOI 10.1042/CS20130553
   Prieto D, 2008, INT J IMPOT RES, V20, P17, DOI 10.1038/sj.ijir.3901581
   Satake N, 1997, GEN PHARMACOL, V28, P453, DOI 10.1016/S0306-3623(96)00238-8
   Schnee ME, 1998, J PHARMACOL EXP THER, V286, P709
   Stott JB, 2014, DRUG DISCOV TODAY, V19, P413, DOI 10.1016/j.drudis.2013.12.003
   TIBBS GR, 1989, J NEUROCHEM, V52, P201, DOI 10.1111/j.1471-4159.1989.tb10917.x
   Triggle CR, 2012, CAN J PHYSIOL PHARM, V90, P713, DOI [10.1139/y2012-073, 10.1139/Y2012-073]
   Dias FMV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106345
   Wang HZ, 2000, INT J IMPOT RES, V12, P9, DOI 10.1038/sj.ijir.3900444
   Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823
   Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983
   Zygmunt PKE, 1996, N-S ARCH PHARMACOL, V354, P336
NR 50
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD MAY 26
PY 2017
VL 8
AR 297
DI 10.3389/fphar.2017.00297
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EW1PX
UT WOS:000402265300001
PM 28603495
OA gold
DA 2017-08-17
ER

PT J
AU Li, W
   Katin-Grazzini, L
   Gu, XB
   Wang, XJ
   El-Tanbouly, R
   Yer, H
   Thammina, C
   Inguagiato, J
   Guillard, K
   McAvoy, RJ
   Wegrzyn, J
   Gu, TT
   Li, Y
AF Li, Wei
   Katin-Grazzini, Lorenzo
   Gu, Xianbin
   Wang, Xiaojing
   El-Tanbouly, Rania
   Yer, Huseyin
   Thammina, Chandra
   Inguagiato, John
   Guillard, Karl
   McAvoy, Richard J.
   Wegrzyn, Jill
   Gu, Tingting
   Li, Yi
TI Transcriptome Analysis Reveals Differential Gene Expression and a
   Possible Role of Gibberellins in a Shade-Tolerant Mutant of Perennial
   Ryegrass
SO FRONTIERS IN PLANT SCIENCE
LA English
DT Article
DE shadow-1; transcriptome analysis; differentially expressed genes;
   dwarfism; gibberellins; shade tolerance
ID PHYTOCHROME-INTERACTING FACTORS; TALL FESCUE; LIGHT; GROWTH;
   ARABIDOPSIS; AVOIDANCE; RESPONSES; ELONGATION; PERFORMANCE; METABOLISM
AB The molecular basis behind shade tolerance in plants is not fully understood. Previously, we have shown that a connection may exist between shade tolerance and dwarfism, however, the mechanism connecting these phenotypes is not well understood. In order to clarify this connection, we analyzed the transcriptome of a previously identified shade-tolerant mutant of perennial ryegrass (Lolium perenne L.) called shadow-1. shadow-1 mutant plants are dwarf, and are significantly tolerant to shade in a number of environments compared to wild-type controls. In this study, we treated shadow-1 and wild-type plants with 95% shade for 2 weeks and compared the transcriptomes of these shade-treated individuals with both genotypes exposed to full light. We identified 2,200 differentially expressed genes (DEGs) (1,096 up-regulated and 1,104 down-regulated) in shadow-1 mutants, compared to wild type, following exposure to shade stress. Of these DEGs, 329 were unique to shadow-1 plants kept under shade and were not found in any other comparisons that we made. We found 2,245 DEGs (1,153 up-regulated and 1,092 down-regulated) in shadow-1 plants, compared to wild-type, under light, with 485 DEGs unique to shadow-1 plants under light. We examined the expression of gibberellin (GA) biosynthesis genes and found that they were down-regulated in shadow-1 plants compared to wild type, notably gibberellin 20 oxidase (GA20ox), which was down-regulated to 3.3% (96.7% reduction) of the wild-type expression level under shade conditions. One GA response gene, lipid transfer protein 3 (LTP3), was also down-regulated to 41.5% in shadow-1 plants under shade conditions when compared to the expression level in the wild type. These data provide valuable insight into a role that GA plays in dwarfism and shade tolerance, as exemplified by shadow-1 plants, and could serve as a guide for plant breeders interested in developing new cultivars with either of these traits.
C1 [Li, Wei; Katin-Grazzini, Lorenzo; Gu, Xianbin; El-Tanbouly, Rania; Yer, Huseyin; Thammina, Chandra; Inguagiato, John; Guillard, Karl; McAvoy, Richard J.; Li, Yi] Univ Connecticut, Dept Plant Sci & Landscape Architecture, Storrs, CT 06269 USA.
   [Gu, Xianbin; Wang, Xiaojing; Gu, Tingting; Li, Yi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.
   [Gu, Xianbin; Wang, Xiaojing; Gu, Tingting; Li, Yi] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.
   [El-Tanbouly, Rania] Alexandria Univ, Dept Floriculture Ornamental Hort & Landscape Gar, Fac Agr, Alexandria, Egypt.
   [Wegrzyn, Jill] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA.
RP Li, Y (reprint author), Univ Connecticut, Dept Plant Sci & Landscape Architecture, Storrs, CT 06269 USA.; Gu, TT; Li, Y (reprint author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.; Gu, TT; Li, Y (reprint author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.
EM gutingting@njau.edu.cn; yi.li@uconn.edu
FU Storrs Agricultural Experiment Station
FX This project is financially supported by the Storrs Agricultural
   Experiment Station to YL.
CR Alabadi D, 2008, PLANT J, V53, P324, DOI 10.1111/j.1365-313X.2007.03346.x
   Byrne SL, 2015, PLANT J, V84, P816, DOI 10.1111/tpj.13037
   Chen JM, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.3
   Chen S, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.59
   Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938
   Conesa A., 2008, INT J PLANT GENOMICS, V2008, DOI DOI 10.1155/2008/619832
   de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520
   Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448
   Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165
   Gardner DS, 2002, HORTTECHNOLOGY, V12, P465
   Grinberg NF, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00133
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8
   Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245
   Jiang YW, 2004, CROP SCI, V44, P587
   Jiang YW, 2001, HORTSCIENCE, V36, P682
   Kebrom TH, 2006, PLANT PHYSIOL, V140, P1109, DOI 10.1104/pp.105.074856
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kovi MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep28702
   Kozuka T, 2005, PLANT CELL PHYSIOL, V46, P213, DOI 10.1093/pcp/pci016
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Li W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01495
   Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x
   Monna L, 2002, DNA RES, V9, P11, DOI 10.1093/dnares/9.1.11
   Nozue K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004953
   Page ER, 2010, WEED RES, V50, P281, DOI 10.1111/j.1365-3180.2010.00781.x
   Park E, 2012, PLANT J, V72, P537, DOI 10.1111/j.1365-313X.2012.05114.x
   Petersen K, 2004, J PLANT PHYSIOL, V161, P439, DOI 10.1078/0176-1617-01212
   Pons TL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00012
   Procko C, 2014, PLANT PHYSIOL, V165, P1285, DOI 10.1104/pp.114.241844
   Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541
   Sasidharan R, 2010, PLANT PHYSIOL, V154, P978, DOI 10.1104/pp.110.162057
   Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106
   Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028
   Steel RGD, 1997, PRINCIPLES PROCEDURE
   Sun Tai-Ping, 2008, Arabidopsis Book, V6, pe0103, DOI 10.1199/tab.0103
   Tan ZG, 2003, HORTSCIENCE, V38, P113
   Tegg RS, 2004, AUST J EXP AGR, V44, P353, DOI 10.1071/EA02159
   Whipple CJ, 2011, P NATL ACAD SCI USA, V108, pE506, DOI 10.1073/pnas.1102819108
   WILKINS PW, 1991, EUPHYTICA, V52, P201, DOI 10.1007/BF00029397
   Xu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep30258
   Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804
NR 42
TC 0
Z9 0
U1 7
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-462X
J9 FRONT PLANT SCI
JI Front. Plant Sci.
PD MAY 26
PY 2017
VL 8
AR 868
DI 10.3389/fpls.2017.00868
PG 12
WC Plant Sciences
SC Plant Sciences
GA EV8ME
UT WOS:000402034000001
PM 28603533
OA gold
DA 2017-08-17
ER

PT J
AU Said, O
AF Said, Omar
TI Analysis, design and simulation of Internet of Things routing algorithm
   based on ant colony optimization
SO INTERNATIONAL JOURNAL OF COMMUNICATION SYSTEMS
LA English
DT Article
DE IoT; ant colony optimization; routing algorithms; internetworking
ID WIRELESS SENSOR NETWORKS; ENERGY
AB In this paper, a routing algorithm to optimize the selection of the best path for the transmitted data within the Internet of Things (IoT) system is proposed. The algorithm controls the use of ant colony ideas in the IoT system to obtain the best routing benefit. It divides the IoT environment into categorized areas depending on network types. Then, it applies the most suitable ant colony algorithm to the concerned network within each area. Furthermore, the algorithm considers routing problem in intersected areas that may arise in case of IoT system. Finally, Network Simulator 2 is used to evaluate the proposed algorithm performance. Simulation results demonstrate the effectiveness of the proposed routing algorithm in terms of end-to-end delay, packet loss ratio, bandwidth consumption, throughput, overhead of control bits, and energy consumption ratio. Copyright (C) 2016 John Wiley & Sons, Ltd.
C1 [Said, Omar] Menoufia Univ, Math & Comp Sci Dept, Coll Sci, Menoufia 32511, Egypt.
RP Said, O (reprint author), Menoufia Univ, Math & Comp Sci Dept, Coll Sci, Menoufia 32511, Egypt.
EM dr_osaid@yahoo.com
CR Al-Fuqaha A, 2015, IEEE COMMUN SURV TUT, V17, P2347, DOI 10.1109/COMST.2015.2444095
   Al-Karaki JN, 2004, IEEE WIREL COMMUN, V11, P6, DOI 10.1109/MWC.2004.1368893
   Alvi A, 2015, P IEEE 10 INT C INT, P1
   ALZURBA H, 2011, INT J APPL GRAPH THE, V3, P15
   Anusha K, 2015, 2015 INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND COMMUNICATION ENGINEERING SYSTEMS (SPACES), P407, DOI 10.1109/SPACES.2015.7058295
   Bains Vamika, 2012, INT J ELECT COMPUTER, V01, P2516
   Baker C, 2009, P IEEE INT C INT SYS, P1
   Mota RPB, 2013, 2013 IEEE 15TH INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS & 2013 IEEE INTERNATIONAL CONFERENCE ON EMBEDDED AND UBIQUITOUS COMPUTING (HPCC_EUC), P2263, DOI 10.1109/HPCC.and.EUC.2013.325
   Camilo T, 2006, LECT NOTES COMPUT SC, V4150, P49
   Caro G. D., 1998, P 10 IASTED INT C PA, P541
   Chen Z., 2012, P NAT C INF TECHN CO, P709
   Chen Z., 2012, J COMPUTERS, V7, P96
   Cheng C, 2014, PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON SOFT COMPUTING IN INFORMATION COMMUNICATION TECHNOLOGY, P131
   Clausen T, 2011, P IEEE WIMOB 11, P365
   Dayong Y, 2015, J SENSORS, V15, P10026
   Di Caro G., IDSIA2403
   Feng X, 2016, INT J COMMUN SYST, V29, P535, DOI 10.1002/dac.2891
   Heinzelman W, 2000, P 33 IEEE INT C SYST, V7, P1
   Hua- Mei X, 2015, P 2 INT C INF SCI CO, P447
   Lewis A, 2009, STUD COMPUT INTELL, V210, P189
   Lindsey S, 2002, AEROSP CONF PROC, P1125
   Liu W, 2011, P INT C COMP SCI NET, P1072
   Lu Y., 2013, INT J SMART HOME, V7, P365
   Lu Y, 2013, P 2 INT C COMP APPL, V17, P223
   Luigi A., 2010, COMPUTER NETWORKS, V54, P2787
   Machado K, 2013, SENSORS-BASEL, V13, P1942, DOI 10.3390/s130201942
   Misra S, 2012, P IEEE WIR COMM NETW, P815
   Okdem S, 2009, SENSORS-BASEL, V9, P909, DOI 10.3390/s90200909
   Oteafy A, 2012, P IEEE GLOB COMM C G, P214
   Quan L, 2014, P INT C ADV TECHN CO, P424
   Said O., 2013, INT J COMPUTER NETWO, V5, P1
   Shi L, 2015, INT J COMMUN SYST, V28, P1789, DOI 10.1002/dac.2785
   Steenbrink L., ROUTING INTERNET THI
   Sun YJ, 2016, INT J COMMUN SYST, V29, P210, DOI 10.1002/dac.2814
   Tao F., 2016, J IND INFORM INTEGRA, V1, P26, DOI DOI 10.1016/J.JII.2016.03.001
   Wei XF, 2014, 2014 11TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA), P3008, DOI 10.1109/WCICA.2014.7053208
   Yicong T, 2010, P INT C COMP INT SOF, P1
   Zhang B, 2013, INT C CLOUD COMP BIG, P432, DOI 10.1109/CLOUDCOM-ASIA.2013.28
   Zhang Z., 2013, THESIS
   Zhong J, 2012, P GEN EV COMP C GECC, P119
   Zhou Z, 2015, IEEE SENSORS J, VPP
NR 41
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1074-5351
EI 1099-1131
J9 INT J COMMUN SYST
JI Int. J. Commun. Syst.
PD MAY 25
PY 2017
VL 30
IS 8
AR e3174
DI 10.1002/dac.3174
PG 20
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA FB2IE
UT WOS:000405966700003
OA No
DA 2017-08-17
ER

PT J
AU Shaaban, S
AF Shaaban, S.
TI Design and optimization of a novel flowmeter for liquid hydrogen
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article
DE Hydrogen; Flowmeter; Loss coefficient; Discharge coefficient; CFD
ID WET GAS-FLOW; PERFORATED PLATES; VENTURI-METER; SLOTTED ORIFICE;
   CAVITATION; PERFORMANCE; SIMULATION; SYSTEM; ERROR
AB The wide spreading hydrogen energy requires accurate flow measurement. Constriction type flowmeters could be a favorable candidate for liquid hydrogen. However, their permanent pressure losses and installation length could significantly increase the manufacturing, installation, metering, maintenance, and replacement cost. The high permanent pressure losses may also cause cavitation. The present research introduces a novel constriction type flowmeter with an optimized flow profile. Numerical simulation, as well as multidimensional and multi-objective optimization, was utilized in order to minimize the flowmeter's loss coefficient and the required installation length. The applied optimization technique results in significant improvements of the flowmeter design and performance. The proposed flowmeter is shorter than the standard Venturi nozzle by 67.2% and its loss coefficient is lower by up to 10.6%. It measures the flow rate of liquid hydrogen with up to 25.5% higher discharge coefficient and 83.7% lower loss coefficient compared to a corresponding perforated plate flowmeter. Cavitation was not detected inside the proposed flowmeter up to a Reynolds number of 2.2 x 10(6). The present investigation shows that the proposed flowmeter is very promising for liquid hydrogen measurement. (C) 2017 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Shaaban, S.] AASTMT, Coll Engn & Technol, Mech Engn Dept, Cairo Campus, Cairo, Egypt.
RP Shaaban, S (reprint author), AASTMT, Coll Engn & Technol, Mech Engn Dept, Cairo Campus, Cairo, Egypt.
EM Sameh.Shaaban@aast.edu
CR Ball M, 2009, INT J HYDROGEN ENERG, V34, P615, DOI 10.1016/j.ijhydene.2008.11.014
   Beck SBM, 2002, FLOW MEAS INSTRUM, V12, P379, DOI 10.1016/S0955-5986(01)00034-6
   Chen Q, 2014, INT J HYDROGEN ENERG, V39, P6104, DOI 10.1016/j.ijhydene.2014.01.137
   Doblhoff-Dier K, 2011, FLOW MEAS INSTRUM, V22, P97, DOI 10.1016/j.flowmeasinst.2010.12.001
   Dunn S, 2002, INT J HYDROGEN ENERG, V27, P235, DOI 10.1016/S0360-3199(01)00131-8
   Filho J.A.B., 2015, NUCL ENG DES, V284, P74
   FISCHER R, 1995, INT J MULTIPHAS FLOW, V21, P817, DOI 10.1016/0301-9322(94)00090-7
   Fossa M, 2006, INT COMMUN HEAT MASS, V33, P698, DOI 10.1016/j.icheatmasstransfer.2006.02.009
   Frolov SM, 2013, INT J HYDROGEN ENERG, V38, P4177, DOI 10.1016/j.ijhydene.2013.01.075
   Furuichi N, 2015, FLOW MEAS INSTRUM, V46, P103, DOI 10.1016/j.flowmeasinst.2015.10.007
   Gajan P, 2015, FLOW MEAS INSTRUM, V44, P126, DOI 10.1016/j.flowmeasinst.2014.12.004
   Gajan P, 2013, FLOW MEAS INSTRUM, V33, P160, DOI 10.1016/j.flowmeasinst.2013.05.004
   Gan GH, 1997, EXP THERM FLUID SCI, V14, P160, DOI 10.1016/S0894-1777(96)00041-6
   Geng YF, 2006, FLOW MEAS INSTRUM, V17, P123, DOI 10.1016/j.flowmeasinst.2005.08.004
   Gronych T, 2012, VACUUM, P1
   He DH, 2014, MEASUREMENT, V58, P61, DOI 10.1016/j.measurement.2014.08.014
   He DH, 2012, FLOW MEAS INSTRUM, V28, P1, DOI 10.1016/j.flowmeasinst.2012.07.008
   Huang B, 2014, INT J HYDROGEN ENERG, V39, P1698, DOI 10.1016/j.ijhydene.2013.11.025
   Huang SF, 2010, 18 INT C NUCL ENG IC
   Huang SF, 2011, 19 INT C NUCL ENG IC
   Huang SF, 2013, EXP THERM FLUID SCI, V46, P74, DOI 10.1016/j.expthermflusci.2012.11.022
   [Anonymous], 516732003 ISO
   Ji CZ, 2014, AEROSP SCI TECHNOL, V39, P40, DOI 10.1016/j.ast.2014.08.010
   Jin T, 2017, INT J HYDROGEN ENERG, V42, P3890, DOI 10.1016/j.ijhydene.2016.09.072
   KOLODZIE PA, 1957, AICHE J, V3, P305, DOI 10.1002/aic.690030304
   Kumar P, 2011, FLOW MEAS INSTRUM, V22, P33, DOI 10.1016/j.flowmeasinst.2010.12.002
   Lide F., 2007, J PETROL SCI ENG, V57, P247, DOI 10.1016/j.petrol.2006.10.010
   Liu R, 2007, J FLUID ENG-T ASME, V129, P1164, DOI 10.1115/1.2754314
   Long XP, 2017, INT J HEAT MASS TRAN, V109, P879, DOI 10.1016/j.ijheatmasstransfer.2017.02.063
   [马太义 Ma Taiyi], 2010, [核动力工程, Nuclear Power Engineering], V31, P126
   Malavasi S, 2015, FLOW MEAS INSTRUM, V41, P129, DOI 10.1016/j.flowmeasinst.2014.11.002
   Malavasi S, 2012, FLOW MEAS INSTRUM, V28, P57, DOI 10.1016/j.flowmeasinst.2012.07.006
   Manshoor B, 2011, FLOW MEAS INSTRUM, V22, P208, DOI 10.1016/j.flowmeasinst.2011.02.003
   Morioka T, 2014, FLOW MEAS INSTRUM, V39, P19, DOI 10.1016/j.flowmeasinst.2014.05.019
   MORRISON GL, 1995, FLOW MEAS INSTRUM, V6, P207, DOI 10.1016/0955-5986(95)00009-B
   MORRISON GL, 1994, FLOW MEAS INSTRUM, V5, P71, DOI 10.1016/0955-5986(94)90039-6
   Morrison GL, 2001, FLOW MEAS INSTRUM, V12, P175, DOI 10.1016/S0955-5986(01)00018-8
   MORRISON GL, 1994, AICHE J, V40, P1757, DOI 10.1002/aic.690401015
   Ouazzane AK, 1999, I CHEM ENG T ICHEM A, V77
   Peters F, 2002, FLOW MEAS INSTRUM, V12, P361
   Shaaban S, 2015, FLOW MEAS INSTRUM, V46, P44, DOI 10.1016/j.flowmeasinst.2015.08.012
   Shaaban S., CHEM ENG RES DES, V92, P1005
   Sparrow EM, 2009, INT J HEAT MASS TRAN, V52, P3079, DOI 10.1016/j.ijheatmasstransfer.2009.02.010
   Steven RN, 2011, FLOW MEAS INSTRUM, V22, P81
   Tzimas E, 2007, INT J HYDROGEN ENERG, V32, P1369, DOI 10.1016/j.ijhydene.2006.10.017
   Wang WW, 2015, CHINESE J CHEM ENG, V23, P1447, DOI 10.1016/j.cjche.2015.05.008
   Weber LJ, 2000, 411 U IOW IOW I HYDR
   Weissenbrunner A, 2016, FLOW MEAS INSTRUM, V52, P25, DOI 10.1016/j.flowmeasinst.2016.07.011
   Yan LT, 2015, CRYOGENICS, V67, P45, DOI 10.1016/j.cryogenics.2014.12.003
   Yuxing L., 2009, FLOW MEAS INSTRUM, V20, P168
   Zhao TY, 2011, J MECH SCI TECHNOL, V25, P2237, DOI 10.1007/s12206-011-0706-3
   Zhu JK, 2016, INT J HYDROGEN ENERG, V41, P614, DOI 10.1016/j.ijhydene.2015.10.042
NR 52
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD MAY 25
PY 2017
VL 42
IS 21
BP 14621
EP 14632
DI 10.1016/j.ijhydene.2017.04.221
PG 12
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA EX8QF
UT WOS:000403514600026
OA No
DA 2017-08-17
ER

PT J
AU El-Khatib, KM
   Hameed, RMA
   Amin, RS
   Fetohi, AE
AF El-Khatib, K. M.
   Hameed, R. M. Abdel
   Amin, R. S.
   Fetohi, Amani E.
TI Core-shell structured Cu@Pt nanoparticles as effective electrocatalyst
   for ethanol oxidation in alkaline medium
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article
DE Nanomaterials; Core-shell structure; Alcohol oxidation; Cu@Pt/C;
   Electrochemical measurements
ID OXYGEN REDUCTION REACTION; ENHANCED CATALYTIC-ACTIVITY; METHANOL
   FUEL-CELLS; FORMIC-ACID; ELECTROCHEMICAL SYNTHESIS; COPPER
   NANOPARTICLES; EXCHANGE MEMBRANE; CARBON NANOTUBES; HIGHLY EFFICIENT;
   FACILE SYNTHESIS
AB Core-shell nanoparticles of Cu@Pt/C electrocatalysts were synthesized using various Pt:Cu atomic ratios with NaBH4 as a reducing agent. The crystal structure and surface morphology were studied using X-ray diffraction (XRD) and transmission electron micro-scopy (TEM). The incorporation of copper in Cu@Pt/C electrocatalysts was found to shift all Pt diffraction planes in the negative direction with expanding the crystal lattice dimensions. The electrocatalytic activity of various Cu@Pt/C electrocatalysts was investigated using cyclic voltammetry, chronoamperometry and electrochemical impedance spectroscopy. Cu@Pt/C electrocatalysts containing Pt:Cu atomic ratios of 1:0.5 and 1:2 showed an enhanced electrochemical performance for ethanol oxidation when related to Pt/C.(C) 2017 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [El-Khatib, K. M.; Amin, R. S.; Fetohi, Amani E.] Natl Res Ctr, Chem Engn Dept, Giza, Egypt.
   [Hameed, R. M. Abdel] Cairo Univ, Chem Dept, Fac Sci, Giza, Egypt.
RP Hameed, RMA (reprint author), Cairo Univ, Chem Dept, Fac Sci, Giza, Egypt.
EM randa311eg@yahoo.com
CR Ammam M, 2013, J POWER SOURCES, V222, P79, DOI 10.1016/j.jpowsour.2012.07.143
   Antolini E, 2009, J POWER SOURCES, V193, P555, DOI 10.1016/j.jpowsour.2009.04.039
   Ataee-Esfahani H, 2012, CHEM-ASIAN J, V7, P876, DOI 10.1002/asia.201200053
   Awasthi R, 2012, INT J HYDROGEN ENERG, V37, P2103, DOI 10.1016/j.ijhydene.2011.10.092
   Bard A. J., 2001, ELECTROCHEMICAL METH
   Cai JD, 2014, J POWER SOURCES, V270, P257, DOI 10.1016/j.jpowsour.2014.07.131
   Calvo F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.121406
   Cao JY, 2015, J POWER SOURCES, V277, P155, DOI 10.1016/j.jpowsour.2014.12.017
   Chen DH, 2015, ELECTROCHIM ACTA, V177, P86, DOI 10.1016/j.electacta.2015.03.066
   Chen DH, 2014, INT J HYDROGEN ENERG, V39, P16053, DOI 10.1016/j.ijhydene.2013.12.075
   Chen W, 2007, LANGMUIR, V23, P11303, DOI 10.1021/la7016648
   Chen YX, 2003, J AM CHEM SOC, V125, P3680, DOI 10.1021/ja029044t
   Cherevko S, 2011, ELECTROCHIM ACTA, V56, P5771, DOI 10.1016/j.electacta.2011.04.052
   Chu YH, 2010, INT J HYDROGEN ENERG, V35, P11261, DOI 10.1016/j.ijhydene.2010.07.062
   da Silva SG, 2014, INT J HYDROGEN ENERG, V39, P10121, DOI 10.1016/j.ijhydene.2014.04.169
   Demirci UB, 2007, J POWER SOURCES, V169, P239, DOI 10.1016/j.jpowsour.2007.03.050
   Ding KQ, 2014, INT J HYDROGEN ENERG, V39, P17622, DOI 10.1016/j.ijhydene.2014.08.150
   Doner A, 2012, J POWER SOURCES, V205, P71, DOI 10.1016/j.jpowsour.2012.01.020
   Fan Y, 2015, J POWER SOURCES, V296, P282, DOI 10.1016/j.jpowsour.2015.07.078
   Fashedemi OO, 2014, ELECTROCHIM ACTA, V128, P279, DOI 10.1016/j.electacta.2013.10.194
   Fleischm M., 1972, J CHEM SOC P2, V2, P1396, DOI DOI 10.1039/P29720001396
   FRIED I, 1971, J ELECTROANAL CHEM, V29, P429, DOI 10.1016/S0022-0728(71)80105-5
   Fu XZ, 2009, CATAL COMMUN, V10, P1893, DOI 10.1016/j.catcom.2009.06.020
   Gao HL, 2011, J POWER SOURCES, V196, P6138, DOI 10.1016/j.jpowsour.2011.03.031
   Gao HC, 2011, ACS APPL MATER INTER, V3, P3049, DOI 10.1021/am200563f
   Gharibi H, 2016, ELECTROCHIM ACTA, V190, P1100, DOI 10.1016/j.electacta.2015.12.208
   Godoi DRM, 2016, J POWER SOURCES, V311, P81, DOI 10.1016/j.jpowsour.2016.02.011
   Guillen-Villafuerte O, 2012, INT J HYDROGEN ENERG, V37, P7171, DOI 10.1016/j.ijhydene.2011.11.117
   Datta J, 2005, J POWER SOURCES, V145, P124
   Haldorai Y, 2016, ELECTROCHIM ACTA, V220, P465, DOI 10.1016/j.electacta.2016.10.130
   Heli H, 2009, BIOSENS BIOELECTRON, V24, P2328, DOI 10.1016/j.bios.2008.10.036
   Heli H, 2009, ANAL BIOCHEM, V388, P81, DOI 10.1016/j.ab.2009.02.021
   Hu YM, 2016, INT J HYDROGEN ENERG, V41, P11359, DOI 10.1016/j.ijhydene.2016.04.133
   Huang YY, 2016, J POWER SOURCES, V304, P74, DOI 10.1016/j.jpowsour.2015.11.038
   Huang YY, 2013, INT J HYDROGEN ENERG, V38, P3250, DOI 10.1016/j.ijhydene.2012.12.091
   Huang YY, 2013, APPL CATAL B-ENVIRON, V129, P549, DOI 10.1016/j.apcatb.2012.09.049
   Kakaei K, 2016, INT J HYDROGEN ENERG, V41, P3861, DOI 10.1016/j.ijhydene.2016.01.013
   Karim-Nezhad G, 2010, ELECTROCHIM ACTA, V55, P3414, DOI 10.1016/j.electacta.2010.01.057
   Kim J, 2009, J POWER SOURCES, V189, P999, DOI 10.1016/j.jpowsour.2008.12.108
   Lee JY, 2017, J ALLOY COMPD, V691, P26, DOI 10.1016/j.jallcom.2016.08.221
   Lee JM, 2012, APPL CATAL B-ENVIRON, V111, P200, DOI 10.1016/j.apcatb.2011.09.036
   Lee YW, 2010, J PHYS CHEM C, V114, P7689, DOI 10.1021/jp9119588
   Li CL, 2013, ANGEW CHEM INT EDIT, V52, P8050, DOI 10.1002/anie.201303035
   Li GL, 2013, INT J HYDROGEN ENERG, V38, P12767, DOI 10.1016/j.ijhydene.2013.07.076
   Li XL, 2016, CATAL COMMUN, V83, P70, DOI 10.1016/j.catcom.2016.05.012
   Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377
   Lin LL, 2017, J POWER SOURCES, V345, P182, DOI 10.1016/j.jpowsour.2017.02.001
   Lin R, 2013, J POWER SOURCES, V223, P190, DOI 10.1016/j.jpowsour.2012.09.073
   Lin WF, 1997, J ELECTROCHEM SOC, V144, P1917, DOI 10.1149/1.1837721
   Liu BC, 2016, ELECTROCHIM ACTA, V213, P771, DOI 10.1016/j.electacta.2016.07.098
   Liu HP, 2007, ELECTROCHEM COMMUN, V9, P2334, DOI 10.1016/j.elecom.2007.06.036
   Liu Q, 2016, J POWER SOURCES, V302, P394, DOI 10.1016/j.jpowsour.2015.10.079
   Liu YT, 2013, J POWER SOURCES, V243, P622, DOI 10.1016/j.jpowsour.2013.06.029
   Liu ZL, 2007, J APPL ELECTROCHEM, V37, P505, DOI 10.1007/s10800-006-9282-0
   Mahapatra SS, 2011, INT J HYDROGEN ENERG, V36, P14873, DOI 10.1016/j.ijhydene.2010.11.085
   Mahendiran C, 2011, MATER CHEM PHYS, V128, P341, DOI 10.1016/j.matchemphys.2011.02.067
   Mahmoud MA, 2012, LANGMUIR, V28, P4051, DOI 10.1021/la203982h
   Mamuru SA, 2010, J MATER CHEM, V20, P10705, DOI 10.1039/c0jm02210a
   Mao H, 2013, ELECTROCHIM ACTA, V107, P419, DOI 10.1016/j.electacta.2013.06.012
   Marioli J.M., 1992, J ELECTROCHIM ACTA, V37, P1187, DOI DOI 10.1016/0013-4686(92)85055-P
   MARITAN A, 1990, ELECTROCHIM ACTA, V35, P141, DOI 10.1016/0013-4686(90)85051-N
   Maxakato NW, 2010, ELECTROANAL, V22, P519, DOI 10.1002/elan.200900397
   Melnick RE, 2001, J PHYS CHEM B, V105, P1012, DOI 10.1021/jp0030847
   MEYERSTEIN D, 1972, J ELECTROANAL CHEM, V40, P377, DOI 10.1016/S0022-0728(72)80382-6
   Mukherjee P, 2015, INT J HYDROGEN ENERG, V40, P13357, DOI 10.1016/j.ijhydene.2015.07.154
   Paixao TRLC, 2002, ANAL CHIM ACTA, V472, P123, DOI 10.1016/S0003-2670(02)00942-X
   Pech-Rodriguez WJ, 2017, APPL CATAL B-ENVIRON, V203, P654, DOI 10.1016/j.apcatb.2016.10.058
   Poochai C, 2016, ELECTROCHIM ACTA, V222, P1243, DOI 10.1016/j.electacta.2016.11.098
   Poochai C, 2017, APPL SURF SCI, V396, P1793, DOI 10.1016/j.apsusc.2016.11.212
   Ren YB, 2015, INT J HYDROGEN ENERG, V40, P2621, DOI 10.1016/j.ijhydene.2014.12.005
   Rezaei B, 2016, ELECTROCHIM ACTA, V203, P41, DOI 10.1016/j.electacta.2016.04.024
   Rizo R, 2017, J CATAL, V348, P22, DOI 10.1016/j.jcat.2017.02.007
   Rizo R, 2017, APPL CATAL B-ENVIRON, V200, P246, DOI 10.1016/j.apcatb.2016.07.011
   Rong LQ, 2007, TALANTA, V72, P819, DOI 10.1016/j.talanta.2006.12.037
   Rostami H, 2015, INT J HYDROGEN ENERG, V40, P9444, DOI 10.1016/j.ijhydene.2015.05.154
   Sanchez-Padilla NM, 2013, INT J HYDROGEN ENERG, V38, P12681, DOI 10.1016/j.ijhydene.2012.11.026
   Schmidt TJ, 2000, LANGMUIR, V16, P8159, DOI 10.1021/la000339z
   Sedighi M, 2017, INT J HYDROGEN ENERG, V42, P4998, DOI 10.1016/j.ijhydene.2016.12.014
   Seger B, 2009, J PHYS CHEM C, V113, P7990, DOI 10.1021/jp900360k
   Sieben JM, 2014, INT J HYDROGEN ENERG, V39, P11547, DOI 10.1016/j.ijhydene.2014.05.123
   Tamasauskaite-Tamasiunaite L, 2012, J POWER SOURCES, V208, P242, DOI 10.1016/j.jpowsour.2012.02.079
   Thiagarajan V, 2017, INT J HYDROGEN ENERG, V42, P9795, DOI 10.1016/j.ijhydene.2017.01.017
   Torto N, 1999, J ELECTROANAL CHEM, V464, P252, DOI 10.1016/S0022-0728(99)00041-8
   Tsiakaras PE, 2007, J POWER SOURCES, V171, P107, DOI 10.1016/j.jpowsour.2007.02.005
   Tusi MM, 2011, ELECTROCHEM COMMUN, V13, P143, DOI 10.1016/j.elecom.2010.11.035
   Wang GX, 2010, J ALLOY COMPD, V503, pL1, DOI 10.1016/j.jallcom.2010.04.236
   Wang HJ, 2012, CHEM MATER, V24, P1591, DOI 10.1021/cm300054b
   Wang H, 2011, INT J HYDROGEN ENERG, V36, P839, DOI 10.1016/j.ijhydene.2010.09.033
   Wang J, 2008, ANAL CHEM, V80, P997, DOI 10.1021/ac701790z
   Wang L, 2010, CHEM-ASIAN J, V5, P2493, DOI 10.1002/asia.201000496
   Wang M, 2015, ELECTROCHIM ACTA, V178, P259, DOI 10.1016/j.electacta.2015.07.157
   Wen ZL, 2010, ELECTROCHIM ACTA, V56, P139, DOI 10.1016/j.electacta.2010.09.032
   Wieckowski A, 1999, INTERFACIAL ELECTROC, P950
   Xie J, 2016, NANO ENERGY, V21, P247, DOI 10.1016/j.nanoen.2016.01.013
   Xie YH, 2017, J ENERGY CHEM, V26, P193, DOI 10.1016/j.jechem.2016.11.014
   Xiong Y, 2009, J POWER SOURCES, V186, P328, DOI 10.1016/j.jpowsour.2008.10.070
   Yang Y, 2016, ELECTROCHIM ACTA, V222, P1094, DOI 10.1016/j.electacta.2016.11.080
   Zhang CL, 2014, INT J HYDROGEN ENERG, V39, P8246, DOI 10.1016/j.ijhydene.2014.03.193
   Zhang H, 2011, ELECTROCHIM ACTA, V56, P7064, DOI 10.1016/j.electacta.2011.05.118
   Zhang J, 2016, J POWER SOURCES, V324, P199, DOI 10.1016/j.jpowsour.2016.05.083
   Zhang LJ, 2006, APPL SURF SCI, V252, P2191, DOI 10.1016/j.apsusc.2005.03.221
   Zhou WJ, 2003, APPL CATAL B-ENVIRON, V46, P273, DOI 10.1016/S0926-3373(03)00218-2
NR 102
TC 0
Z9 0
U1 7
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD MAY 25
PY 2017
VL 42
IS 21
BP 14680
EP 14696
DI 10.1016/j.ijhydene.2017.04.118
PG 17
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA EX8QF
UT WOS:000403514600032
OA No
DA 2017-08-17
ER

PT J
AU Al-Abyad, M
   Mohamed, GY
   Ditroi, F
   Takacs, S
   Tarkanyi, F
AF Al-Abyad, M.
   Mohamed, Gehan Y.
   Ditroi, F.
   Takacs, S.
   Tarkanyi, F.
TI Experimental study and nuclear model calculations of He-3-induced
   nuclear reactions on zinc
SO EUROPEAN PHYSICAL JOURNAL A
LA English
DT Article
ID EXCITATION-FUNCTIONS; CADMIUM
AB Excitation functions of He-3-induced nuclear reactions on natural zinc were measured using the standard stacked-foil technique and high-resolution gamma-ray spectrometry. From their threshold energies up to 27MeV, the cross-sections for Zn-nat(He-3, xn)Ge-69, Zn-nat(He-3, xnp)Ga-66,Ga-67,Ga-68, and Zn-nat(He-3, x)Zn-62,Zn-65 reactions were measured. The nuclear model codes TALYS-1.6, EMPIRE-3.2 and ALICE-IPPE were used to describe the formation of these products. The present data were compared with the theoretical results and with the available experimental data. Integral yields for some important radioisotopes were determined.
C1 [Al-Abyad, M.; Mohamed, Gehan Y.] Atom Energy Author, Nucl Res Ctr, Phys Dept, Cyclotron Facil, Cairo 13759, Egypt.
   [Ditroi, F.; Takacs, S.; Tarkanyi, F.] Hungarian Acad Sci ATOMKI, Inst Nucl Res, H-4026 Debrecen, Hungary.
RP Al-Abyad, M (reprint author), Atom Energy Author, Nucl Res Ctr, Phys Dept, Cyclotron Facil, Cairo 13759, Egypt.
EM alabyad_m@yahoo.com
CR Al-Abyad M, 2014, APPL RADIAT ISOTOPES, V94, P191, DOI 10.1016/j.apradiso.2014.08.002
   Al-Abyad M, 2010, APPL RADIAT ISOTOPES, V68, P2393, DOI 10.1016/j.apradiso.2010.06.013
   Al-Saleh FS, 2007, APPL RADIAT ISOTOPES, V65, P1101, DOI 10.1016/j.apradiso.2007.05.004
   Al-Abyad M., 2013, ARAB J NUCL SCI APPL, V46, P134
   Ali BM, 2015, NUCL INSTRUM METH B, V362, P93, DOI 10.1016/j.nimb.2015.08.095
   Ali BM, 2014, NUCL INSTRUM METH B, V321, P30, DOI 10.1016/j.nimb.2013.12.022
   BLANN M, 1975, ANNU REV NUCL PART S, V25, P123, DOI 10.1146/annurev.ns.25.120175.001011
   Breeman WAP, 2011, SEMIN NUCL MED, V41, P314, DOI 10.1053/j.semnuclmed.2011.02.001
   Capote R, 2009, NUCL DATA SHEETS, V110, P3107, DOI 10.1016/j.nds.2009.10.004
   Chakravarty R, 2014, ADV MATER, V26, P5119, DOI 10.1002/adma.201401372
   CRISLER DF, 1972, PHYS REV C, V5, P419, DOI 10.1103/PhysRevC.5.419
   Dityuk A. I., 1998, INDCCCP410
   Ekstrom L. P., 2000, BERKELEY LAB ISOTOPE
   Herman M., INDCNDS0603BNL101378
   Hermanne A, 2010, NUCL INSTRUM METH B, V268, P1376, DOI 10.1016/j.nimb.2010.01.022
   HOFFER P, 1980, J NUCL MED, V21, P394
   ISO/IEC/OIML/BIPM, 1995, GUID EXPR UNC MEAS
   Koning AJ, 2005, AIP CONF PROC, V769, P422
   Mirzadeh S, 1996, J RADIOAN NUCL CH AR, V202, P7, DOI 10.1007/BF02037941
   NAGAME Y, 1989, RADIOCHIM ACTA, V46, P5
   Otuka N, 2015, RADIOCHIM ACTA, V103, P1, DOI 10.1515/ract-2013-2234
   Rowshanfarzad P, 2005, NUKLEONIKA, V50, P97
   SZEKELY G, 1985, COMPUT PHYS COMMUN, V34, P313, DOI 10.1016/0010-4655(85)90008-6
   Tarkanyi F, 2006, NUCL INSTRUM METH B, V245, P379, DOI 10.1016/j.nimb.2005.12.004
   Tarkanyi F, 2010, APPL RADIAT ISOTOPES, V68, P250, DOI 10.1016/j.apradiso.2009.10.043
   Tarkanyi F., 2001, 1211 IAEA TECDOC, P123
   Ziegler J. F., SRIM 2013 CODE
NR 27
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1434-6001
EI 1434-601X
J9 EUR PHYS J A
JI Eur. Phys. J. A
PD MAY 25
PY 2017
VL 53
IS 5
AR 107
DI 10.1140/epja/i2017-12296-3
PG 7
WC Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA EV9WK
UT WOS:000402136900001
OA No
DA 2017-08-17
ER

PT J
AU Shahien, M
   Suzuki, M
AF Shahien, Mohammed
   Suzuki, Masato
TI Low power consumption suspension plasma spray system for ceramic coating
   deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Meeting on Thermal Spraying (RIPT)
CY DEC 09-11, 2015
CL Lumoges, FRANCE
DE Low power; Suspension plasma spray; Ceramic coating; Axial injection;
   Twin cathode gun; Only Ar plasma gas
ID POWDERS
AB Suspension plasma spraying (SPS) is a modification of conventional plasma spray techniques that has been developed to overcome the challenge of using nano-sized particles in plasma spray processes. The novel feature of using nano-sized particles in the form of a suspension makes the SPS process promising for several applications and for improving the performance of plasma spray coatings.
   The focus of this study is to develop a new SPS system that consumed low power and gas to deposit ceramic coatings. Several ceramic coatings, such as titanium dioxide (TiO2), aluminum oxide (Al2O3), yttrium oxide (Y2O3), and yttria-stabilized zirconia (8YSZ), were successfully fabricated using only Ar as the plasma gas at a low power of 27 kW with the new SPS system. The new system is characterized by lower power and gas consumption (only Ar as plasma gas) and axial injection. It is a unique SPS system based on a twin-cathode-type plasma spray gun. The gun has three plasma torches, the main one is called a P-torch (anode) and the two sub-torches are called N-torches (cathodes). The main plasma torch has a reversed polarity (with a cathode nozzle and an anode electrode). The two sub-torches have normal polarity (with an anode nozzle and a-cathode electrode). During operation, electric power is supplied between the anode of the P-torch and the two cathodes of the N-torches, so that the so called hairpin-shape of the plasma jet can be maintained. The system requires only argon as the plasma gas (without using any other gases). The voltage (enthalpy of the plasma jet) with Ar is high enough (150 V) for melting ceramic powders, which results in a gas consumption SPS system compared to the other available SPS systems. Furthermore, the electrode of the main torch (P-torch) is a hollowed anode, so that axial feeding of spraying materials could be carried out in this system, which is the best method for spraying. In this configuration, the particles are injected into the center of the plasma jet along the axis of its flow. Therefore, the feedstock suspension would be fully entrapped and melted within the plasma before deposition on the substrate surface. (C) 2016 Published by Elsevier B.V.
C1 [Shahien, Mohammed; Suzuki, Masato] Natl Inst Adv Ind Sci & Technol, Adv Coating Technol Res Ctr, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.
   [Shahien, Mohammed] Cent Met Res & Dev Inst, Adv Mat Dept, Cairo, Egypt.
RP Shahien, M (reprint author), Natl Inst Adv Ind Sci & Technol, Adv Coating Technol Res Ctr, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.
EM mo.shahien@aist.go.jp
FU Japan Society for the Promotion of Science (JSPS) [26.03917]
FX This research was supported by the grants-in-aid (26.03917) for JSPS
   fellows of Japan Society for the Promotion of Science (JSPS).
CR Allen AJ, 2001, SURF COAT TECH, V146, P544, DOI 10.1016/S0257-8972(01)01433-5
   Boulos M. I., 1994, THERMAL PLASMAS FUND
   Chen DY, 2008, SURF COAT TECH, V202, P6113, DOI 10.1016/j.surfcoat.2008.07.017
   Fauchais P, 2008, SURF COAT TECH, V202, P4309, DOI 10.1016/j.surfcoat.2008.04.003
   Fauchais P, 2004, J PHYS D APPL PHYS, V37, pR86, DOI 10.1088/0022-3727/37/9/R02
   Fauchais P, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/19/194011
   Fauchais P, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/9/093001
   Fauchais P, 2001, J THERM SPRAY TECHN, V10, P44, DOI 10.1361/105996301770349510
   Karthikeyan J, 1997, NANOSTRUCT MATER, V8, P61, DOI 10.1016/S0965-9773(97)00066-4
   Kassner H, 2008, J THERM SPRAY TECHN, V17, P115, DOI 10.1007/s11666-007-9144-2
   Killinger A, 2011, J THERM SPRAY TECHN, V20, P677, DOI 10.1007/s11666-011-9639-8
   KOLMAN B, 1994, MIKROCHIM ACTA, V114, P335, DOI 10.1007/BF01244560
   MCPHERSON R, 1989, SURF COAT TECH, V39, P173, DOI 10.1016/0257-8972(89)90052-2
   Oberste Berghaus J, 2008, J THERM SPRAY TECHN, V17, P700, DOI 10.1007/s11666-008-9249-2
   Oberste-Berghaus J., 2006, J THERM SPRAY TECHN, V15, P676
   Pawlowski L, 2009, SURF COAT TECH, V203, P2807, DOI 10.1016/j.surfcoat.2009.03.005
   Tikkanen J, 1997, SURF COAT TECH, V90, P210, DOI 10.1016/S0257-8972(96)03153-2
   Vardelle M, 2001, J THERM SPRAY TECHN, V10, P267, DOI 10.1361/105996301770349367
NR 18
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD MAY 25
PY 2017
VL 318
BP 11
EP 17
DI 10.1016/j.surfcoat.2016.07.040
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA EW2WG
UT WOS:000402356100003
OA No
DA 2017-08-17
ER

PT J
AU Mohamed, EH
   Lotfy, HM
   Hegazy, MA
   Mowaka, S
AF Mohamed, Ekram H.
   Lotfy, Hayam M.
   Hegazy, Maha A.
   Mowaka, Shereen
TI Different applications of isosbestic points, normalized spectra and dual
   wavelength as powerful tools for resolution of multicomponent mixtures
   with severely overlapping spectra
SO CHEMISTRY CENTRAL JOURNAL
LA English
DT Article
DE Derivative transformation; Advanced ratio difference; Induced ratio
   difference normalized spectra; Isosbestic point; Dual wave length
ID 2 TERNARY MIXTURES; SPECTROPHOTOMETRIC METHODS; BINARY-MIXTURE;
   DROTAVERINE HYDROCHLORIDE; LIQUID-CHROMATOGRAPHY; PARACETAMOL; CAFFEINE;
   4-AMINOPHENOL; VALIDATION; RATIO
AB Background: Analysis of complex mixture containing three or more components represented a challenge for analysts. New smart spectrophotometric methods have been recently evolved with no limitation. A study of different novel and smart spectrophotometric techniques for resolution of severely overlapping spectra were presented in this work utilizing isosbestic points present in different absorption spectra, normalized spectra as a divisor and dual wavelengths. A quaternary mixture of drotaverine (DRO), caffeine (CAF), paracetamol (PCT) and para-aminophenol (PAP) was taken as an example for application of the proposed techniques without any separation steps. The adopted techniques adopted of successive and progressive steps manipulating zero /or ratio /or derivative spectra. The proposed techniques includes eight novel and simple methods namely direct spectrophotometry after applying derivative transformation (DT) via multiplying by a decoding spectrum, spectrum subtraction (SS), advanced absorbance subtraction (AAS), advanced amplitude modulation (AAM), simultaneous derivative ratio - (S1DD), advanced ratio difference (ARD), induced ratio difference (IRD) and finally double divisor-ratio difference-dual wavelength (DD- RDDW) methods.
   Results: The proposed methods were assessed by analyzing synthetic mixtures of the studied drugs. They were also successfully applied to commercial pharmaceutical formulations without interference from other dosage form additives. The methods were validated according to the ICH guidelines, accuracy, precision, repeatability, were found to be within the acceptable limits.
   Conclusion: The proposed procedures are accurate, simple and reproducible and yet economic. They are also sensitive and selective and could be used for routine analysis of complex most of the binary, ternary and quaternary mixtures and even more complex mixtures.
C1 [Mohamed, Ekram H.; Mowaka, Shereen] British Univ Egypt, Fac Pharm, Pharmaceut Analyt Chem Dept, El Sherouk City 11837, Egypt.
   [Hegazy, Maha A.] Cairo Univ, Fac Pharm, Pharmaceut Analyt Chem Dept, Kasr El Aini St, Cairo 11562, Egypt.
   [Lotfy, Hayam M.] Future Univ, Fac Pharmaceut Sci & Pharmaceut Ind, Pharmaceut Chem Dept, Cairo 12311, Egypt.
   [Mowaka, Shereen] Helwan Univ, Fac Pharm, Pharmaceut Analyt Chem Dept, Cairo 11795, Egypt.
RP Mohamed, EH (reprint author), British Univ Egypt, Fac Pharm, Pharmaceut Analyt Chem Dept, El Sherouk City 11837, Egypt.
EM Ekram.hany@bue.edu.eg
CR Belal FF, 2015, SEP SCI TECHNOL, V50, P592, DOI 10.1080/01496395.2014.957317
   Budavari S, 2003, MERCK INDEX
   Dejaegher B, 2008, TALANTA, V75, P258, DOI 10.1016/j.talanta.2007.11.029
   Dinc E, 1999, TALANTA, V48, P1145, DOI 10.1016/S0039-9140(98)00337-3
   El-Gindy A, 2010, J AOAC INT, V93, P536
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Gilman AC, 2001, GOODMAN GILMANS PHAR
   Hegazy MA, 2015, SPECTROCHIM ACTA A, V140, P600, DOI 10.1016/j.saa.2014.12.098
   Hegazy M. A., 2014, J PHARM ANAL, V4, P132
   [Anonymous], 2003, BRIT PHARMACOPOEIA, V11
   International conference on harmonization (ICH), 1997, Q2B VAL AN P METH, V62
   Issa YM, 2012, J LIQ CHROMATOGR R T, V35, P2148, DOI 10.1080/10826076.2011.629387
   Jain J., 2010, INT J PHARM PHARM SC, V2, P76
   Lamie NT, 2015, SPECTROCHIM ACTA A, V150, P142, DOI 10.1016/j.saa.2015.05.048
   Lotfy HM, 2015, SPECTROCHIM ACTA A, V148, P328, DOI 10.1016/j.saa.2015.04.004
   Lotfy HM, 2015, SPECTROCHIM ACTA A, V140, P495, DOI 10.1016/j.saa.2014.12.096
   Lotfy HM, 2015, SPECTROCHIM ACTA A, V136, P1786, DOI 10.1016/j.saa.2014.10.084
   Lotfy HM, 2013, SPECTROCHIM ACTA A, V113, P107, DOI 10.1016/j.saa.2013.04.064
   Lotfy H.M., 2013, ANAL CHEM LETT, V3, P208
   Metwally FH, 2007, J AOAC INT, V90, P391
   Nemeth T, 2008, J PHARMACEUT BIOMED, V47, P746, DOI 10.1016/j.jpba.2008.03.003
   SALINAS F, 1990, TALANTA, V37, P347, DOI 10.1016/0039-9140(90)80065-N
   Shafer SH, 1998, BIOCHEM PHARMACOL, V56, P1229, DOI 10.1016/S0006-2952(98)00260-3
   Sweetman S. C., 2009, MARTINDALE COMPLETE
NR 24
TC 0
Z9 0
U1 2
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-153X
J9 CHEM CENT J
JI Chem. Cent. J.
PD MAY 25
PY 2017
VL 11
AR 8
DI 10.1186/s13065-017-0270-8
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA EW4EL
UT WOS:000402454700001
OA gold
DA 2017-08-17
ER

PT J
AU ALrefai, AA
   Alsalamony, AM
   Fatani, SH
   Kamel, HFM
AF ALrefai, Abeer A.
   Alsalamony, Alsayed M.
   Fatani, Sameer H.
   Kamel, Hala F. M.
TI Effect of variable antidiabetic treatments strategy on oxidative stress
   markers in obese patients with T2DM
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE T2DM; Oxidative stress; OHA and insulin
ID DIABETES-MELLITUS; TYPE-2; METFORMIN; COMPLICATIONS; DISEASE; DAMAGE
AB Aim: To evaluate the effect of different anti-diabetic treatment strategy on oxidative stress markers in patients with type 2 diabetes mellitus (T2DM).
   Subject and methods: A total of 93 patients with T2DM treated with metformin (G1 = 25), OHA (G2 = 22), OA and insulin (G3 = 26) and insulin alone (G4 = 20). In all patients, lipid profile and glycemic indices were assessed using routine laboratory tests. MDA and Oxidized LDL were assessed using commercially available ELISA kits. Laboratory tests were performed at baseline and at a control visit after 24 weeks of treatment.
   Results: A significant decrease in the levels of MDA with improvement of glycemic control was observed in the group receiving OHA in combination with insulin therapy. A similar decrease of oxLDL was observed in all diabetic subgroups with borderline significance in those receiving metformin alone. The remaining clinical and biochemical parameters were not changed during follow-up in any of the involved groups.
   Conclusion: A combination therapy with insulin was more effective in glycemic control and MDA reduction in T2DM. Whereas, a significant oxLDLc reduction was observed in T2DM irrespective of categories of antidiabetic treatment or glycemic control.
C1 [ALrefai, Abeer A.] Menoufia Univ, Med Biochem Dept, Fac Med, Shibin Al Kawm, Egypt.
   [Alsalamony, Alsayed M.] Mansoura Univ, Dept Internal Med, Diabet & Endocrinol Unit, Mansoura, Egypt.
   [Fatani, Sameer H.] Umm Al Qura Univ UQU, Fac Med, Biochem Dept, Mecca, Saudi Arabia.
   [Kamel, Hala F. M.] ASU, Fac Med, Med Biochem Dept, Cairo, Egypt.
RP ALrefai, AA (reprint author), Menoufia Univ, Med Biochem Dept, Fac Med, Shibin Al Kawm, Egypt.
EM drabeer1975@hotmail.com
FU KCAST
FX Sharing with a major project funded by KCAST
CR Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   American Diabetes Association, 2015, CLIN DIABETES, V33, P97, DOI DOI 10.2337/DIACLIN.33.2.97
   Aouacheri O, 2015, CAN J DIABETES, V39, P44, DOI 10.1016/j.jcjd.2014.03.002
   Burchardt P, 2013, POL ARCH MED WEWN, V123, P526
   Burchardt P, 2012, KARDIOL POL, V70, P618
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Fan AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085337
   Forsberg E, 2015, J DIABETES COMPLICAT, V29, P1152, DOI 10.1016/j.jdiacomp.2015.08.006
   Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
   Grindel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162082
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75
   Kang HM, 2012, J KOREAN MED SCI, V27, P518, DOI 10.3346/jkms.2012.27.5.518
   Matough Fatmah A, 2012, Sultan Qaboos Univ Med J, V12, P5
   Megson Ian L, 2015, J Diabetes Sci Technol, V9, P573, DOI 10.1177/1932296815570359
   Monnier L, 2011, DIABETES-METAB RES, V27, P348, DOI 10.1002/dmrr.1174
   Moon JS, 2016, J DIABETES COMPLICAT, V09
   Njajou OT, 2009, DIABETES-METAB RES, V25, P733, DOI 10.1002/dmrr.1011
   Odegaard AO, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0369-6
   Pazdro R, 2010, MECH AGEING DEV, V131, P276, DOI 10.1016/j.mad.2010.03.005
   Petrie JR, 2017, DIABETES OBES METAB, V19, P509, DOI 10.1111/dom.12840
   Reddy VS, 2015, EYE, V29, P1585, DOI 10.1038/eye.2015.177
   Schupp N, 2008, ATHEROSCLEROSIS, V199, P278, DOI 10.1016/j.atherosclerosis.2007.11.016
   Silvares RR, 2016, INT J EXP PATHOL, V97, P266, DOI 10.1111/iep.12184
   Tangvarasittichai S, 2016, INDIAN J CLIN BIOCHE, V31, P68, DOI 10.1007/s12291-015-0514-0
   Verges B, 2005, DIABETES METAB, V31, P429, DOI 10.1016/S1262-3636(07)70213-6
   Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x
   Yan ML, 2011, CARDIOVASC DRUG THER, V25, P451, DOI 10.1007/s10557-011-6342-4
   Zhang XX, 2015, J DIABETES INVEST, V6, P708, DOI 10.1111/jdi.12352
NR 29
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD MAY 25
PY 2017
VL 9
AR 27
DI 10.1186/s13098-017-0220-6
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EW0AA
UT WOS:000402148900001
PM 28546831
OA gold
DA 2017-08-17
ER

PT J
AU Khaleel, SA
   Alzokaky, AA
   Raslan, NA
   Alwakeel, AI
   Abd el-Aziz, HG
   Abd-Allah, AR
AF Khaleel, Sahar A.
   Alzokaky, Amany A.
   Raslan, Nahed A.
   Alwakeel, Asmaa I.
   Abd el-Aziz, Heba G.
   Abd-Allah, Adel R.
TI Lansoprazole halts contrast induced nephropathy through activation of
   Nrf2 pathway in rats
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE Contrast induced nephropathy; Lansoprazole; Nrf2; Oxidative stress
ID TRANSCRIPTION FACTOR NRF2; ACUTE KIDNEY INJURY; RADIOCONTRAST-INDUCED
   NEPHROPATHY; OXIDATIVE STRESS; REACTIVE OXYGEN; ANTIOXIDANT RESPONSE;
   NRF2-DEFICIENT MICE; HEME OXYGENASE-1; PREVENTION; TRANSFERASE
AB Contrast-induced nephropathy (CIN) is an important cause of acute kidney injury characterized by significant mortality and morbidity. To date, there is no successful protective regimen for CIN especially in poor kidney function patients. Lansoprazole has been shown to exert antioxidant action through induction of nuclear factor-erythroid 2-related factor 2 (Nrf2) pathway. The aim of the present study is to investigate the potential of lansoprazole to activate Nrf2 pathway in the kidney and consequently to protect against oxidative stress induced by iodinated contrast media. Lansoprazole, at a dose of 100 mg/ kg, showed a significant induction of Nrf2 mRNA after 3 h. Administration of contrast media induced significant increase in serum creatinine and blood urea nitrogen, histological deterioration, and reduction in total antioxidant capacity. Moreover, it instigated the defensive Nrf2 gene expression and immunoreactivity. In addition, there were overexpression of HO-1, caspase 3, p53 and IL6 genes and downregulation of Bcl2 gene. Pre-treatment with lansoprazole (100 mg/kg) ameliorated the nephrotoxicity parameters and oxidative stress, improved histological lesions, and hijacked apoptotic and inflammatory markers that were provoked by contrast media. In conclusion, lansoprazole attenuates experimental CIN which might be due to activation of Nrf2 antioxidant defence pathway. These findings highlight the potential benefit of incorporating lansoprazole in the protective regimen against CIN especially for susceptible patients. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Khaleel, Sahar A.; Alzokaky, Amany A.; Raslan, Nahed A.; Alwakeel, Asmaa I.] Al Azhar Univ, Fac Pharm Girls, Pharmacol & Toxicol Dept, Cairo, Egypt.
   [Abd el-Aziz, Heba G.] Al Azhar Univ Girls, Fac Pharm, Biochem Dept, Cairo, Egypt.
   [Abd-Allah, Adel R.] Al Azhar Univ, Fac Pharm Boys, Pharmacol & Toxicol Dept, Cairo, Egypt.
RP Khaleel, SA (reprint author), Al Azhar Univ, Fac Pharm Girls, Pharmacol & Toxicol Dept, Cairo, Egypt.
EM sa7ar_22@yahoo.com
CR AGMON Y, 1994, J CLIN INVEST, V94, P1069, DOI 10.1172/JCI117421
   Agnihotri Navneet, 2007, Indian J Gastroenterol, V26, P118
   Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344
   Aleksunes LM, 2010, J PHARMACOL EXP THER, V335, P2, DOI 10.1124/jpet.110.170084
   Bancroft J. D., 1996, THEORY PRACTICE HIST
   Bartorelli AL, 2008, J INTERV CARDIOL, V21, P74, DOI 10.1111/j.1540-8183.2007.00318.x
   Chalikias G, 2016, CARDIOVASC DRUG THER, V30, P515, DOI 10.1007/s10557-016-6683-0
   Chen J, 2009, TOXICOL APPL PHARM, V241, P81, DOI 10.1016/j.taap.2009.07.038
   Chung S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-2
   Finn WF, 2006, NEPHROL DIAL TRANSPL, V21, pi2, DOI DOI 10.1093/NDT/GFL213
   Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x
   Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8
   Honicker T, 2016, NEPHROL NURS J, V43, P109
   Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023
   Itoh Y, 2005, J PHARMACOL SCI, V97, P473, DOI 10.1254/jphs.CRJ05002X
   Jiang T, 2010, DIABETES, V59, P850, DOI 10.2337/db09-1342
   Kedrah AE, 2012, KIDNEY BLOOD PRESS R, V35, P425, DOI 10.1159/000336104
   KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315
   Koracevic D, 2001, J CLIN PATHOL, V54, P356, DOI 10.1136/jcp.54.5.356
   Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002
   Lee JY, 2007, MOL PHARMACOL, V72, P1082, DOI 10.1124/mol.107.038174
   Li GY, 2011, ENVIRON TOXICOL, V26, P187, DOI 10.1002/tox.20542
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maity P, 2008, J BIOL CHEM, V283, P14391, DOI 10.1074/jbc.M800414200
   Miyata T, 2011, AM J PHYSIOL-CELL PH, V300, pC226, DOI 10.1152/ajpcell.00430.2010
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Mutter FE, 2015, BIOCHEM SOC T, V43, P657, DOI 10.1042/BST20150044
   Narasimhan M, 2011, MOL PHARMACOL, V80, P988, DOI 10.1124/mol.111.073262
   PIMENTAL RA, 1993, MOL CELL BIOL, V13, P4365
   Pollock DM, 1997, RENAL FAILURE, V19, P753, DOI 10.3109/08860229709037215
   Rai K, 2011, J CLIN BIOCHEM NUTR, V49, P25, DOI 10.3164/jcbn.10-133
   Rang K. W., 2003, JNCI-J NATL CANCER I, V95, P53
   Rokushima M, 2008, CHEM RES TOXICOL, V21, P1186, DOI 10.1021/tx800008e
   Sahu BD, 2014, MOL CELL BIOCHEM, V394, P163, DOI 10.1007/s11010-014-2092-5
   Saito H, 2013, BIOCHEM PHARMACOL, V85, P865, DOI 10.1016/j.bcp.2013.01.006
   Satoh H, 2013, CURR PHARM DESIGN, V19, P67
   Sendeski MM, 2011, CLIN EXP PHARMACOL P, V38, P292, DOI 10.1111/j.1440-1681.2011.05503.x
   Shelton LM, 2013, KIDNEY INT, V84, P1090, DOI 10.1038/ki.2013.248
   Sherratt P. J., 2002, ENZYME SYSTEMS METAB, P319
   Shukla GS, 2000, CELL BIOL TOXICOL, V16, P347, DOI 10.1023/A:1007696610186
   Sitar G, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.37331
   Spargias K, 2004, CIRCULATION, V110, P2837, DOI 10.1161/01.CIR.0000146396.19081.73
   Stedman CAM, 2000, ALIMENT PHARM THERAP, V14, P963, DOI 10.1046/j.1365-2036.2000.00788.x
   Subramanian Sujha, 2007, J Med Econ, V10, P119, DOI 10.3111/200710119134
   Takagi T, 2009, J PHARMACOL EXP THER, V331, P255, DOI 10.1124/jpet.109.152702
   Takagi T, 2009, J CLIN BIOCHEM NUTR, V45, P9, DOI 10.3164/jcbnSR09-28
   Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304
   Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1127/JCI25790
   Wang Z, 2014, KIDNEY INT, V86, P338, DOI 10.1038/ki.2014.65
   Wu YW, 2016, ANN ACAD MED SINGAP, V45, P157
   Yamashita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097419
   Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x
   Yoh K, 2008, GENES CELLS, V13, P1159, DOI 10.1111/j.1365-2443.2008.01234.x
   Zager RA, 2003, KIDNEY INT, V64, P128, DOI 10.1046/j.1523-1755.2003.00059.x
   Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058
NR 57
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD MAY 25
PY 2017
VL 270
BP 33
EP 40
DI 10.1016/j.cbi.2017.04.010
PG 8
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA EV6OR
UT WOS:000401889200005
PM 28412091
OA No
DA 2017-08-17
ER

PT J
AU Mahmoud, AM
   Zaki, AR
   Hassan, ME
   Mostafa-Hedeab, G
AF Mahmoud, Ayman M.
   Zaki, Amr R.
   Hassan, Manal E.
   Mostafa-Hedeab, Gomaa
TI Commiphora molmol resin attenuates
   diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis by
   modulating oxidative stress, inflammation, angiogenesis and
   Nrf2/ARE/HO-1 signaling
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE Myrrh; Carcinogenesis; Nrf2; Oxidative stress; Inflammation
ID CYCLOPHOSPHAMIDE-INDUCED HEPATOTOXICITY; ENDOTHELIAL GROWTH-FACTOR;
   HEPATOCELLULAR-CARCINOMA; UP-REGULATION; PPAR-GAMMA;
   N-NITROSODIETHYLAMINE; ANTIOXIDANT ACTIVITY; CELL-PROLIFERATION;
   LIVER-CANCER; HEPATITIS-B
AB The objective of the current study was to investigate the possible chemopreventive activity of Commiphora molmol resin (myrrh) extract using a rat model of diethylnitrosamine (DEN)/phenobarbital (PB)induced early stage hepatocarcinogenesis. Here, we pointed to the modulatory effect of myrrh on oxidative stress, angiogenesis, inflammation and nuclear factor (erythroid-derived 2)-like 2 (Nrf2). Hepatocarcinogenesis was induced in Wistar rats using DEN for initiation and PB as a promoting agent. The rats received 125 or 250 mg/kg C molmol resin extract throughout the experiment. Both doses of myrrh improved liver function marker enzymes and prevented oval cells proliferation and the distortion of hepatic architecture. The pro-inflammatory cytokine interleukin-6, tumor markers, angiogenesis markers, lipid peroxidation and nitric oxide (NO) were significantly increased in DEN/PB-induced rats. In addition, the antioxidant defenses showed marked reduction in the liver of DEN/PB-induced rats. Oral administration of C molmol extract to DEN/PB-induced rats significantly decreased circulating markers of inflammation, tumor proliferation and angiogenesis, and liver lipid peroxidation and NO. In addition, C molmol markedly ameliorated the antioxidant defenses and up-regulated Nrf2 and hemeoxygenase (HO)-1 in the liver of DEN/PB-induced rats. In conclusion, these results provide evidence that C. molmol resin has a potent chemopreventive activity, possibly by up-regulating the Nrf2/HO-1 signaling and attenuation of inflammation, angiogenesis and oxidative stress. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Mahmoud, Ayman M.] Beni Suef Univ, Fac Sci, Zool Dept, Physiol Div, Bani Suwayf 62514, Egypt.
   [Zaki, Amr R.] Beni Suef Univ, Fac Med, Dept Forens Med & Clin Toxicol, Bani Suwayf, Egypt.
   [Hassan, Manal E.] Beni Sueif Univ, Fac Med, Dept Med Biochem & Mol Biol, Bani Suwayf, Egypt.
   [Mostafa-Hedeab, Gomaa] Beni Suef Univ, Fac Med, Dept Pharmacol, Bani Suwayf, Egypt.
RP Mahmoud, AM (reprint author), Beni Suef Univ, Fac Sci, Zool Dept, Physiol Div, Bani Suwayf 62514, Egypt.
EM ayman.mahmoud@science.bsu.edu.eg
CR Abd El-Twab SM, 2016, RENAL FAILURE, V38, P1516, DOI 10.1080/0886022X.2016.1216722
   Abdel-Daim MM, 2015, CAN J PHYSIOL PHARM, V93, P45, DOI 10.1139/cjpp-2014-0336
   Abdo W, 2015, ONCOL LETT, V10, P716, DOI 10.3892/01.2015.3313
   Al-Rejaie S. S., 2012, Journal of Medical Sciences (Pakistan), V12, P1, DOI 10.3923/jms.2012.1.9
   Ashry KM, 2010, FOOD CHEM TOXICOL, V48, P236, DOI 10.1016/j.fct.2009.10.006
   Aydin E, 2013, BIOLOGIA, V68, P1004, DOI 10.2478/s11756-013-0230-2
   Bacanli M, 2015, FOOD CHEM TOXICOL, V81, P160, DOI 10.1016/j.fct.2015.04.015
   Banakar MC, 2004, WORLD J GASTROENTERO, V10, P1268
   Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094
   Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Blum HE, 2005, WORLD J GASTROENTERO, V11, P7391
   Boyanapalli SSS, 2014, CHEM RES TOXICOL, V27, P2036, DOI 10.1021/tx500234h
   Budhu A, 2006, J LEUKOCYTE BIOL, V80, P1197, DOI 10.1189/jlb.0506297
   Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0084575]
   Chevallier A., 1986, ENCY MED PLANTS, P84
   Davis Gary L, 2008, Proc (Bayl Univ Med Cent), V21, P266
   Dhar DK, 2002, ANTICANCER RES, V22, P379
   El-Shahat M, 2012, ACTA HISTOCHEM, V114, P421, DOI 10.1016/j.acthis.2011.08.002
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Fatani AJ, 2016, EXP THER MED, V12, P730, DOI 10.3892/etm.2016.3398
   Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6
   Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S095500674(03)00002-4
   Hanus Lumir O., 2005, Biomedical Papers (Olomouc), V149, P3
   Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043
   Hu B, 2016, MOLECULES, V21, DOI 10.3390/molecules21020142
   Imai K, 2007, ONCOL REP, V17, P55
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Kamel EM, 2016, FOOD FUNCT, V7, P2094, DOI [10.1039/c6fo00194g, 10.1039/C6FO00194G]
   Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006
   Lee Y, 1998, CLIN CANCER RES, V4, P1711
   Li XM, 1998, J EXP CLIN CANC RES, V17, P13
   Li Y, 2011, EVID-BASED COMPL ALT, DOI 10.1093/ecam/neq044
   LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mahmoud A. M., 2017, BIOCHIM BIOPHYS ACTA, V1981, P3311
   Mahmoud AM, 2017, BIOMED PHARMACOTHER, V86, P297, DOI 10.1016/j.biopha.2016.12.047
   Mahmoud AM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0491-1
   Mahmoud AM, 2014, CAN J PHYSIOL PHARM, V92, P717, DOI 10.1139/cjpp-2014-0204
   Mannervik B, 1981, Methods Enzymol, V77, P231
   Mansour MA, 2014, J BIOCHEM MOL TOXIC, V28, P400, DOI 10.1002/jbt.21577
   Mansour MA, 2011, LIFE SCI, V89, P188, DOI 10.1016/j.lfs.2011.06.002
   Marklund S, 1974, Eur J Biochem, V47, P469
   Marra M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-171
   Mas VR, 2007, TRANSPLANTATION, V84, P1262, DOI 10.1097/01.tp.0000287596.91520.1a
   Matkovics B, 1998, LABORATORIUMI DIAGNO, V15, P248
   Mittal G, 2006, PHARMACOL REP, V58, P413
   Nagababu E, 2010, METHODS MOL BIOL, V610, P165, DOI 10.1007/978-1-60327-029-8_10
   Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071
   Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720
   Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007
   Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485
   Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5
   Park YN, 2000, ARCH PATHOL LAB MED, V124, P1061
   Poon RTP, 2001, AM J SURG, V182, P298, DOI 10.1016/S0002-9610(01)00708-5
   Preuss HG, 1998, J AM COLL NUTR, V17, P116
   Qin SY, 2015, INFLAMM RES, V64, P537, DOI 10.1007/s00011-015-0834-9
   Rahman MM, 2008, PHYTOTHER RES, V22, P1356, DOI 10.1002/ptr.2501
   Roberto D, 2010, BASIC CLIN PHARMACOL, V106, P38, DOI 10.1111/j.1742-7843.2009.00467.x
   Sahin K, 2014, NUTR CANCER, V66, P590, DOI 10.1080/01635581.2014.894092
   Salama A., 2014, Pharmacologia, V5, P135
   Saleh DA, 2010, T ROY SOC TROP MED H, V104, P357, DOI 10.1016/j.trstmh.2010.01.009
   Schumann G, 2003, CLIN CHIM ACTA, V327, P69, DOI 10.1016/S0009-8981(02)00341-8
   Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006
   Shalaby Mostafa Abbas, 2014, J Intercult Ethnopharmacol, V3, P56, DOI 10.5455/jice.20140130015014
   Su SL, 2009, PLANTA MED, V75, P351, DOI 10.1055/s-0028-1112214
   Su SL, 2012, J ETHNOPHARMACOL, V139, P649, DOI 10.1016/j.jep.2011.12.013
   Tipton DA, 2003, TOXICOL IN VITRO, V17, P301, DOI 10.1016/S0887-2333(03)00018-3
   Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006
   Tudek B, 2010, AM J TRANSL RES, V2, P254
   Valgimigli M, 2002, FREE RADICAL RES, V36, P939, DOI 10.1080/107156021000006653
   Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9
   Wenger C., 1984, CLIN CHEM, P1094
   Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x
   Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281
   Yao Deng-Fu, 2005, Hepatobiliary Pancreat Dis Int, V4, P220
   Zhou J, 2000, J CANCER RES CLIN, V126, P57, DOI 10.1007/s004320050009
   Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30
NR 81
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD MAY 25
PY 2017
VL 270
BP 41
EP 50
DI 10.1016/j.cbi.2017.04.012
PG 10
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA EV6OR
UT WOS:000401889200006
PM 28414157
OA No
DA 2017-08-17
ER

PT J
AU Mahmoud, AM
   Hussein, OE
   Hozayen, WG
   Abd el-Twab, SM
AF Mahmoud, Ayman M.
   Hussein, Omnia E.
   Hozayen, Walaa G.
   Abd el-Twab, Sanaa M.
TI Methotrexate hepatotoxicity is associated with oxidative stress, and
   down-regulation of PPAR gamma and Nrf2: Protective effect of 18
   beta-Glycyrrhetinic acid
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE Glycyrrhetinic acid; Oxidative stress; Inflammation; PPAR; Nrf2;
   Methotrexate
ID CYCLOPHOSPHAMIDE-INDUCED HEPATOTOXICITY; INDUCED LIVER-INJURY; ACTIVATED
   RECEPTOR-GAMMA; GLYCYRRHIZIC ACID; UP-REGULATION; LIPID-PEROXIDATION;
   ANTIOXIDANT STATUS; HEPATIC-INJURY; RATS; MICE
AB 18 beta-glycyrrhetinic acid (18 beta-GA) is a bioactive component of licorice with promising hepatoprotective activity. However, its protective mechanism on methotrexate (MTX) hepatotoxicity in not well defined. We investigated the hepatoprotective effect of 18 beta-GA, pointing to the role of peroxisome proliferator activated receptor gamma (PPAR gamma) and the redox-sensitive nuclear factor erythroid 2-related factor 2 (Nrf2). Wistar rats were orally administered 18 beta-GA (50 and 100 mg/kg) 7 days either before or after MTX injection. MTX induced significant increase in circulating liver function marker enzymes and bilirubin with concomitant declined albumin levels. Serum pro-inflammatory cytokines, and liver malondialdehyde and nitric oxide were significantly increased in MTX-induced rats. Treatment with 18 beta-GA significantly reduced serum enzymes of liver function, bilirubin and pro-inflammatory cytokines. 18 beta-GA attenuated MTX-induced oxidative stress and restored the antioxidant defenses. In addition, 18 beta-GA improved liver histological structure and decreased the expression of Bax whereas increased Bcl-2 expression. MTX-induced rats showed significant down-regulation of Nrf2, hemoxygenase-1 and PPAR gamma, an effect that was markedly reversed by 18 beta-GA supplemented either before or after MTX. In conclusion, 18 beta-GA protected against MTX-induced liver injury, possibly by activating Nrf2 and PPAR gamma, and subsequent attenuation of inflammation, oxidative stress and apoptosis. Therefore, 18 beta-GA can provide protection against MIX-induced hepatotoxicity. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Mahmoud, Ayman M.; Hussein, Omnia E.; Abd el-Twab, Sanaa M.] Beni Suef Univ, Fac Sci, Dept Zool, Physiol Div, Salah Salim St, Bani Suwayf 62514, Egypt.
   [Hozayen, Walaa G.] Beni Suef Univ, Fac Sci, Chem Dept, Biochem Div, Bani Suwayf, Egypt.
   [Hozayen, Walaa G.] Beni Suef Univ, Fac Postgrad Studies Adv Sci PSAS, Biotechnol & Life Sci Dept, Bani Suwayf, Egypt.
RP Mahmoud, AM (reprint author), Beni Suef Univ, Fac Sci, Dept Zool, Physiol Div, Salah Salim St, Bani Suwayf 62514, Egypt.
EM ayman.mahmoud@science.bsu.edu.eg
CR Abdel-Raheem IT, 2014, N-S ARCH PHARMACOL, V387, P341, DOI 10.1007/s00210-013-0949-x
   Abdella EM, 2016, PHARM BIOL, V54, P2496, DOI 10.3109/13880209.2016.1160938
   Ali N, 2014, MOL CELL BIOCHEM, V385, P215, DOI 10.1007/s11010-013-1830-4
   Alqahtani S, 2016, OXID MED CELL LONGEV, DOI 10.1155/2016/4016209
   Ayad MW, 2014, EUR J HAEMATOL, V93, P63, DOI 10.1111/ejh.12302
   Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955
   Bartsch H, 2000, TOXICOLOGY, V153, P105, DOI 10.1016/S0300-483X(00)00307-3
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Cao DH, 2016, BIOMED RES INT, DOI 10.1155/2016/4943793
   Chen SR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053662, 10.1371/journal.pone.0084575]
   Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC
   Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08
   Circu ML, 2011, FREE RADICAL RES, V45, P1245, DOI 10.3109/10715762.2011.611509
   Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049
   Duman DG, 2013, BRIT J NUTR, V110, P493, DOI 10.1017/S000711451200517X
   EI-Sheikh A. A., 2015, MEDIAT INFLAMM, V2015
   El-Sheikh AAK, 2014, PPAR RES, DOI 10.1155/2014/626319
   El-Twab S. M. Abd, 2016, REN FAIL, V8, P1
   Erdogan E, 2015, ACTA CIR BRAS, V30, P778, DOI 10.1590/S0102-865020150110000009
   FEAGAN BG, 1995, NEW ENGL J MED, V332, P292, DOI 10.1056/NEJM199502023320503
   Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S095500674(03)00002-4
   Fu YM, 2008, MOL PHARMACOL, V73, P399, DOI 10.1124/mol.107.039818
   Germoush MO, 2014, J CANCER RES CLIN, V140, P1103, DOI 10.1007/s00432-014-1665-8
   Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020
   Hasan S., 2014, HUM EXP TOXICOL
   Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x
   Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074
   Kalaiarasi P, 2009, EUR J PHARMACOL, V606, P269, DOI 10.1016/j.ejphar.2008.12.057
   Kamel EM, 2016, FOOD FUNCT, V7, P2094, DOI [10.1039/c6fo00194g, 10.1039/C6FO00194G]
   Kang L., 2014, CURR OPIN COMPLEMENT, V1, P34
   Kao TC, 2009, J AGR FOOD CHEM, V57, P754, DOI 10.1021/jf802864k
   Khan ZA, 2012, EXPERT OPIN DRUG DEL, V9, P151, DOI 10.1517/17425247.2012.642362
   Kolli VK, 2014, HUM EXP TOXICOL, V33, P1051, DOI 10.1177/0960327113515503
   Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005
   Li M, 2004, WORLD J GASTROENTERO, V10, P1775
   Livak K. J., METHODS, P25
   Lobo ED, 2003, J PHARM SCI, V92, P1654, DOI 10.1002/jps.10431
   Ma T., 2016, SCI REP, V5, P25396
   Mahmoud AM, 2017, BIOMED PHARMACOTHER, V86, P297, DOI 10.1016/j.biopha.2016.12.047
   Mahmoud AM, 2017, BBA-GEN SUBJECTS, V1861, P3311, DOI 10.1016/j.bbagen.2016.08.013
   Mahmoud AM, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0491-1
   Mahmoud AM, 2015, PHYTOTHER RES, V29, P737, DOI 10.1002/ptr.5310
   Mahmoud AM, 2014, CAN J PHYSIOL PHARM, V92, P717, DOI 10.1139/cjpp-2014-0204
   Mahmoud AM, 2014, EXCLI J, V13, P98
   Mannervik B, 1981, Methods Enzymol, V77, P231
   Marklund S, 1974, Eur J Biochem, V47, P469
   MARTINEK RG, 1966, CLIN CHIM ACTA, V13, P161
   Matata BM, 2002, J BIOL CHEM, V277, P2330, DOI 10.1074/jbc.M106393200
   Matkovics B, 1998, LABORATORIUMI DIAGNO, V15, P248
   McKim SE, 2003, GASTROENTEROLOGY, V125, P1834, DOI 10.1053/S0016-5085(03)01511-7
   Messarah M, 2010, EXP TOXICOL PATHOL, V62, P301, DOI 10.1016/j.etp.2009.04.009
   Moghadam AR, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0773-6
   Mukherjee S, 2013, J NUTR BIOCHEM, V24, P2040, DOI 10.1016/j.jnutbio.2013.07.005
   Naik SR, 2007, LIVER INT, V27, P393, DOI 10.1111/j.1478-3231.2007.01463.x
   Okuno Y, 2008, BIOCHEM BIOPH RES CO, V366, P698, DOI 10.1016/j.bbrc.2007.12.001
   PERSIJN JP, 1976, J CLIN CHEM CLIN BIO, V14, P421
   Pesce A., 1984, CLIN CHEM, P1124
   Peyrou M., 2012, PPAR RES, V2012
   Polyakov NE, 2006, FREE RADICAL BIO MED, V40, P1804, DOI 10.1016/j.freeradbiomed.2006.01.015
   Preuss HG, 1998, J AM COLL NUTR, V17, P116
   Rang M. I., 2004, P NATL ACAD SCI USA, V101, P2046
   Rosenberg P, 2007, J HEPATOL, V46, P1111, DOI 10.1016/j.jhep.2007.01.024
   Russmann S, 2009, CURR MED CHEM, V16, P3041
   Sakthiswary R, 2014, LUPUS, V23, P225, DOI 10.1177/0961203313519159
   Schumann G, 2003, CLIN CHIM ACTA, V327, P69, DOI 10.1016/S0009-8981(02)00341-8
   Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200
   Shin S. M., 2013, OXIDATIVE MED CELL L, V2013
   Siow RCM, 1999, CARDIOVASC RES, V41, P385, DOI 10.1016/S0008-6363(98)00278-8
   Triantafyllou K, 2010, BEST PRACT RES CL GA, V24, P203, DOI 10.1016/j.bpg.2010.02.004
   Vandewalle B, 2008, BIOCHEM BIOPH RES CO, V366, P1096, DOI 10.1016/j.bbrc.2007.12.088
   Was H, 2010, CURR DRUG TARGETS, V11, P1551
   WEBSTER D, 1974, CLIN CHIM ACTA, V53, P109, DOI 10.1016/0009-8981(74)90358-1
   Wenger C., 1984, CLIN CHEM, P1094
   Wu CH, 2015, J AGR FOOD CHEM, V63, P1200, DOI 10.1021/jf505471a
   Wu Y. J., 1991, ZHONG GUO YAO LI XUE, V7, P46
   Yang L, 2010, INFLAMM RES, V59, P1061, DOI 10.1007/s00011-010-0226-0
   Yu Y, 2002, BBA-MOL CELL BIOL L, V1581, P89
   Yu Yiben, 2014, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V30, P793
   ZELLER JM, 1984, INFLAMMATION, V8, P231, DOI 10.1007/BF00916413
   Zhu H, 2014, PHARMACOGENOMICS, V15, P551, DOI [10.2217/pgs.14.25, 10.2217/PGS.14.25]
NR 81
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD MAY 25
PY 2017
VL 270
BP 59
EP 72
DI 10.1016/j.cbi.2017.04.009
PG 14
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA EV6OR
UT WOS:000401889200008
PM 28414158
OA No
DA 2017-08-17
ER

PT J
AU Kabeel, AE
   Abdelgaied, M
AF Kabeel, A. E.
   Abdelgaied, Mohamed
TI Performance enhancement of modified solar still using multi-groups of
   two coaxial pipes in basin
SO APPLIED THERMAL ENGINEERING
LA English
DT Article
DE Solar desalination; Modified solar still; Two coaxial pipes;
   Productivity; Efficiency; Cost analysis
ID EVACUATED TUBE COLLECTOR; EXPERIMENTAL VALIDATION; FRESH-WATER; SINGLE;
   SYSTEM; DISTILLATION; PRODUCTIVITY; MODE; DESALINATION; CONCENTRATOR
AB The new configuration of modified solar still with multi-groups of two coaxial pipes in basin have been experimentally investigated. The effects of the thickness of annular space between two coaxial pipes are investigated. Four types of the new configuration of modified stills (Types A, B, C and D) with different annular space between two coaxial pipes were studied. A comparison between the four types of modified still with multi-groups of two coaxial pipes in basin and the conventional still are investigated. The results of the experimental study show that, the modified solar still with multi-groups of two coaxial pipes in basin enhanced the distillate water productivity by 97.8%, 77.4%, 63.6% and 52.7% for Types A, B, C and D, respectively as compared to the conventional solar still. In the modified solar still for increase the thickness of annular space between two coaxial pipes from 5 to 14.5 mm, the daily efficiency decreases from 67.6% to 53.46%. The percentage increases in the daily efficiency for the modified solar still with multi-groups of two coaxial pipes in basin (Types A, B, C and D) are approximately 90.8%, 75.7%, 62.6%, and 52%, respectively as compared to the conventional solar still. The calculated cost of one liter of distillate water productivity reaches 0.02 $, 0.021 $, 0.023 $, 0.024 $ and 0.021 $ for modified stills (Types A, B, C and D) and conventional still, respectively. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Kabeel, A. E.; Abdelgaied, Mohamed] Tanta Univ, Fac Engn, Mech Power Engn Dept, Tanta, Egypt.
RP Kabeel, AE (reprint author), Tanta Univ, Fac Engn, Mech Power Engn Dept, Tanta, Egypt.
EM kabeel6@hotmail.com
CR Abdallah S, 2008, DESALINATION, V220, P669, DOI 10.1016/j.desal.2007.02.047
   Abdenacer PK, 2007, DESALINATION, V209, P298, DOI 10.1016/j.desal.2007.04.043
   ALHUSSAINI H, 1995, ENERG CONVERS MANAGE, V36, P1047, DOI 10.1016/0196-8904(95)00003-V
   ALI HM, 1991, ENERG CONVERS MANAGE, V32, P67, DOI 10.1016/0196-8904(91)90144-8
   Bacha B., 2007, DESALINATION, V206, P341
   Barford N.C., 1990, EXPT MEASUREMENTS PR
   Bassam A/K A. H., 2003, ENERG CONVERS MANAGE, V44, P1411
   Castillo-Tellez M, 2015, APPL THERM ENG, V75, P1192, DOI 10.1016/j.applthermaleng.2014.10.032
   Dev R, 2012, DESALIN WATER TREAT, V41, P204, DOI 10.1080/19443994.2012.664715
   El-Sebaii AA, 2017, APPL THERM ENG, V110, P787, DOI 10.1016/j.applthermaleng.2016.08.215
   El-Dessouky H. T., 2002, FUNDAMENTALS SALT WA
   Fath HES, 2003, DESALINATION, V159, P69, DOI 10.1016/S0011-9164(03)90046-4
   Feilizadeh M, 2015, APPL ENERG, V152, P39, DOI 10.1016/j.apenergy.2015.04.084
   Hiroshi T., 2009, DESALINATION, V249, P130
   Kabeel AE, 2017, SOL ENERGY, V144, P71, DOI 10.1016/j.solener.2017.01.007
   Kabeel AE, 2016, DESALINATION, V383, P22, DOI 10.1016/j.desal.2016.01.006
   Kabeel AE, 2016, DESALINATION, V379, P102, DOI 10.1016/j.desal.2015.11.007
   Kumar S, 1996, ENERG CONVERS MANAGE, V37, P629, DOI 10.1016/0196-8904(95)00177-8
   Kumar S, 2014, DESALINATION, V347, P15, DOI 10.1016/j.desal.2014.05.019
   LAWRENCE SA, 1990, ENERG CONVERS MANAGE, V30, P205, DOI 10.1016/0196-8904(90)90001-F
   Nishikawa H, 1998, APPL THERM ENG, V18, P1067, DOI 10.1016/S1359-4311(98)00020-9
   Omara ZM, 2014, ENERG CONVERS MANAGE, V78, P876, DOI 10.1016/j.enconman.2013.07.092
   Rubio E, 2000, APPL THERM ENG, V20, P1105, DOI 10.1016/S1359-4311(99)00085-X
   Sampathkumar K, 2010, RENEW SUST ENERG REV, V14, P1503, DOI 10.1016/j.rser.2010.01.023
   Sharshir SW, 2016, APPL THERM ENG, V104, P734, DOI 10.1016/j.applthermaleng.2016.05.120
   Singh DB, 2016, SOL ENERGY, V130, P207, DOI 10.1016/j.solener.2016.02.024
   Singh G, 2012, DESALIN WATER TREAT, V45, P182, DOI 10.5004/dwt.2012.3258
   Singh G, 2011, DESALINATION, V277, P399, DOI 10.1016/j.desal.2011.04.064
   Singh RV, 2013, DESALINATION, V318, P25, DOI 10.1016/j.desal.2013.03.012
   Tabrizi FF, 2010, DESALINATION, V253, P195, DOI 10.1016/j.desal.2009.10.003
   Tiwari GN, 2009, DESALINATION, V242, P1, DOI 10.1016/j.desal.2008.03.027
   Velmurugan V, 2008, ENERGY, V33, P1719, DOI 10.1016/j.energy.2008.07.001
   Velmurugan V, 2008, ENERG CONVERS MANAGE, V49, P2602, DOI 10.1016/j.enconman.2008.05.010
   Velmurugan V, 2009, ENERGY, V34, P1179, DOI 10.1016/j.energy.2009.04.029
   Vinoth K. K., 2008, DESALINATION, V230, P51, DOI DOI 10.1016/J.DESA1.2007.11.015
   Voropoulos K, 2003, SOL ENERGY, V75, P199, DOI 10.1016/j.solener.2003.08.001
NR 36
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-4311
J9 APPL THERM ENG
JI Appl. Therm. Eng.
PD MAY 25
PY 2017
VL 118
BP 23
EP 32
DI 10.1016/j.applthermaleng.2017.02.090
PG 10
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA EU2SN
UT WOS:000400880200003
OA No
DA 2017-08-17
ER

PT J
AU Nada, SA
   Said, MA
AF Nada, S. A.
   Said, M. A.
TI Effect of CRAC units layout on thermal management of data center
SO APPLIED THERMAL ENGINEERING
LA English
DT Article
DE Data centers; CFD investigations; Thermal management; Layout
   arrangements of CRAC units
ID BUILDINGS
AB Comprehensive numerical studies of thermal management of data centers were presented by several investigators for different geometric and operating conditions of data centers. In the present work, a technical note regarding the effect of the computer room air conditioning (CRAC) units layout arrangements is presented. Two arrangements of CRAC units layouts are investigated; namely locating CRACs units in line with the racks row and locating the CRACs units perpendicular to the rack row. Temperature distributions, air flow characteristics particularly air recirculation and bypass and thermal management in data centers are evaluated in terms of the measureable overall performance parameters: supply/return heat indices (SHI/RHI) and return temperature indices (RTI). The results showed that locating CRAC units perpendicular to the racks row has the following effects: (i) enhances the uniformity of the air flow from the perforated tiles along the rack row, (ii) reduces the hot air recirculation at the ends racks of the row and the cold air bypass at the middle rack of the row and (iii) enhances the data center performance parameters RTI, SHI and RHI. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Nada, S. A.; Said, M. A.] Benha Univ, Benha Fac Engn, Dept Mech Engn, PO 13511, Banha, Egypt.
RP Nada, SA (reprint author), Benha Univ, Benha Fac Engn, Dept Mech Engn, PO 13511, Banha, Egypt.
EM samehnadar@yahoo.com
CR Abdelmaksoud W., 2012, THESIS
   Abdelmaksoud W.A., 2012, ITHERM
   Bhopte S, 2006, J ELECTRON PACKAGING, V128, P380, DOI 10.1115/1.2356866
   Breen TJ, 2012, J ELECTRON PACKAGING, V134, DOI 10.1115/1.4007744
   Cho Jinkyun, 2009, MEASUREMENTS PREDICT
   Fernando H., 2012, CAN DATA CTR HEAT FL
   Herrlin Magnus K., 2005, ASHRAE T 2
   Ibrahim Mahmoud, 2012, DYNAMIC THERMAL MANA
   Kang S., 2000, ITHERM
   Karki KC, 2003, HVAC&R RES, V9, P153, DOI 10.1080/10789669.2003.10391062
   Karki Kailash C., 2003, P IPACK03 PAC RIM AS
   Karki Kailash C., 2005, AIRFLOW DISTRIBUTION
   Kim Sang, 2009, EFFECTIVENESS SPECIA
   Koomey JG, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034008
   Nada SA, 2016, APPL THERM ENG, V109, P466, DOI 10.1016/j.applthermaleng.2016.08.097
   Nada SA, 2016, J BUILD ENG, V5, P41, DOI 10.1016/j.jobe.2015.11.001
   Nada SA, 2016, ALEX ENG J, V55, P959, DOI 10.1016/j.aej.2016.02.025
   Nada SA, 2016, INT J REFRIG, V63, P87, DOI 10.1016/j.ijrefrig.2015.10.027
   Nada SA, 2016, APPL THERM ENG, V98, P110, DOI 10.1016/j.applthermaleng.2015.12.020
   Nada S.A., 2017, HEAT MASS TRANSFER
   Nada S.A., 2015, INT J CURR ENG TECHN, V5
   Nada S. A., 2015, INT J EMERG TRENDS E, V11, P145
   Schmidt R, 2004, J ELECTRON PACKAGING, V126, P510, DOI 10.1115/1.1827266
   Schmidt R., 2001, ADV ELECT PACKAGING, V2, P905
   Schmidt Roger R., 2005, P IPACK2005
   Sharma Ratnesh K., 2002, DIMENSIONLESS PARAME
   [Anonymous], 2008, EN LOG RED DAT CTR E
NR 27
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-4311
J9 APPL THERM ENG
JI Appl. Therm. Eng.
PD MAY 25
PY 2017
VL 118
BP 339
EP 344
DI 10.1016/j.applthermaleng.2017.03.003
PG 6
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA EU2SN
UT WOS:000400880200031
OA No
DA 2017-08-17
ER

PT J
AU Fatouh, M
   Abou-Ziyan, H
   Mahmoud, O
   El-Raheim, DA
AF Fatouh, M.
   Abou-Ziyan, H.
   Mahmoud, O.
   El-Raheim, D. Abd
TI Experimental analysis of hybrid and conventional air conditioning
   systems working in hot-humid climate
SO APPLIED THERMAL ENGINEERING
LA English
DT Article
DE Hybrid air conditioners; Desiccant cooling; Thin-multilayer desiccant;
   Activated alumina; Cycle duration; Mixing ratio
ID DESICCANT COOLING SYSTEM; ACTIVATED ALUMINA; PERFORMANCE; TECHNOLOGIES;
   WHEEL; BED
AB This paper reports the experimental performance characteristics of a hybrid air conditioning system consists of a conventional (vapor compression) system integrated with thin-multilayer activated alumina bed with single, double and triple-layers. The performance characteristics of both systems are investigated under hot very humid climate with fresh air mixing ratio from 40 to 100% that is replicated at various process air temperature (28-36 degrees C) and relative humidity (50-80%). The performance characteristics of hybrid and conventional evaporators and systems are compared under different conditions. Also, effect of desiccant cycle duration on hybrid system performance is investigated. The obtained results revealed that thin-multilayer alumina bed has substantial effect on hybrid system characteristics. Using the right desiccant layers, hybrid systems achieve better characteristics (smaller evaporator size system and compressor power with higher COP) than conventional system for all the mixing ratios. In the case of pure fresh air, the degree of superheat, pressure ratio and compressor power are lower than those for conventional system by 14.5, 2.0 and 2.7% with higher COP of hybrid system by 12.4%. Short cycle duration has higher sensible heat factor and lower evaporator size while long cycle duration has lower compressor power and higher COP. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Fatouh, M.; Abou-Ziyan, H.; Mahmoud, O.; El-Raheim, D. Abd] Helwan Univ, Mech Power Engn Dept, Fac Engn, Cairo, Egypt.
   [Abou-Ziyan, H.] PAAET, Mech Power Engn Dept, Fac Technol Studies, Kuwait, Kuwait.
RP Abou-Ziyan, H (reprint author), Helwan Univ, Mech Power Engn Dept, Fac Engn, Cairo, Egypt.
EM hosnyaz@hotmail.com
CR Abou-Ziyan H, 2017, APPL ENERG, V190, P29, DOI 10.1016/j.apenergy.2016.12.106
   Al-Alili A, 2012, APPL ENERG, V93, P138, DOI 10.1016/j.apenergy.2011.05.010
   Al-Alili A, 2014, INT J REFRIG, V39, P4, DOI 10.1016/j.ijrefrig.2013.11.028
   Angrisani G, 2015, APPL ENERG, V138, P533, DOI 10.1016/j.apenergy.2014.10.065
   ASHRAE, 2013, ASHRAE HDB FUND IP S
   Beccali M, 2012, RENEW ENERG, V44, P40, DOI 10.1016/j.renene.2011.12.021
   Daou K, 2006, RENEW SUST ENERG REV, V10, P55, DOI 10.1016/j.rser.2004.09.010
   Davanagere BS, 1999, INT J ENERG RES, V23, P7, DOI 10.1002/(SICI)1099-114X(199901)23:1<7::AID-ER439>3.3.CO;2-L
   Deng J, 2011, PROG ENERG COMBUST, V37, P172, DOI 10.1016/j.pecs.2010.05.003
   DUPONT M, 1994, SOL ENERGY, V52, P509, DOI 10.1016/0038-092X(94)90658-0
   EES, 2016, ENG EQ SOLV MICR WIN
   Eicker U, 2010, APPL ENERG, V87, P3735, DOI 10.1016/j.apenergy.2010.06.022
   Elsayed SS, 2006, INT J REFRIG, V29, P219, DOI 10.1016/j.ijrefrig.2005.05.014
   Elzahzby AM, 2014, ENERG CONVERS MANAGE, V78, P882, DOI 10.1016/j.enconman.2013.06.060
   Enteria N, 2011, APPL THERM ENG, V31, P243, DOI 10.1016/j.applthermaleng.2010.09.004
   Enteria N, 2010, APPL ENERG, V87, P478, DOI 10.1016/j.apenergy.2009.08.026
   Fatouh M, 2009, ENERG CONVERS MANAGE, V50, P2670, DOI 10.1016/j.enconman.2009.06.020
   Ghali K, 2008, ENERG CONVERS MANAGE, V49, P3387, DOI 10.1016/j.enconman.2008.04.014
   Henning HM, 2007, APPL THERM ENG, V27, P1734, DOI 10.1016/j.applthermaleng.2006.07.021
   Hurdogan E, 2013, ENERG CONVERS MANAGE, V69, P9, DOI 10.1016/j.enconman.2013.01.009
   Jia CX, 2007, INT J REFRIG, V30, P345, DOI 10.1016/j.ijrefrig.2006.04.001
   Jia CX, 2006, APPL THERM ENG, V26, P2393, DOI 10.1016/j.applthermaleng.2006.02.016
   Kabeel AE, 2009, RENEW ENERG, V34, P255, DOI 10.1016/j.renene.2008.04.011
   La D, 2010, RENEW SUST ENERG REV, V14, P130, DOI 10.1016/j.rser.2009.07.016
   La D, 2011, SOL ENERGY, V85, P2997, DOI 10.1016/j.solener.2011.08.039
   Lee D, 2015, INT J REFRIG, V53, P115, DOI 10.1016/j.ijrefrig.2015.01.013
   Mazzei P, 2005, APPL THERM ENG, V25, P677, DOI 10.1016/j.applthermaleng.2004.07.014
   MOFFAT RJ, 1988, EXP THERM FLUID SCI, V1, P3, DOI 10.1016/0894-1777(88)90043-X
   O'Kelly M, 2015, ENERG BUILDINGS, V86, P45, DOI 10.1016/j.enbuild.2014.09.068
   Parmar H, 2010, INT J ENG SCI TECHNO, V2, P5504
   Sarbu I, 2013, ENERG BUILDINGS, V67, P286, DOI 10.1016/j.enbuild.2013.08.022
   Subramanyam N, 2004, APPL THERM ENG, V24, P2777, DOI 10.1016/j.applthermaleng.2004.04.008
   Thrower M., 2012, ENERGY BUILD IND, V35
   Zouaoui A, 2016, RENEW SUST ENERG REV, V54, P889, DOI 10.1016/j.rser.2015.10.055
NR 34
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-4311
J9 APPL THERM ENG
JI Appl. Therm. Eng.
PD MAY 25
PY 2017
VL 118
BP 570
EP 584
DI 10.1016/j.applthermaleng.2017.03.019
PG 15
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA EU2SN
UT WOS:000400880200054
OA No
DA 2017-08-17
ER

PT J
AU Ebada, SS
   Talaat, AN
   Labib, RM
   Mandi, A
   Kurtan, T
   Muller, WEG
   Singab, A
   Proksch, P
AF Ebada, Sherif S.
   Talaat, Aya N.
   Labib, Rola M.
   Mandi, Attila
   Kurtan, Tibor
   Mueller, Werner E. G.
   Singab, AbdelNasser
   Proksch, Peter
TI Cytotoxic labdane diterpenes and bisflavonoid atropisomers from leaves
   of Araucaria bidwillii
SO TETRAHEDRON
LA English
DT Article
DE Araucaria bidwillii; Labdane diterpene; Antibacterial; Cytotoxicity;
   TDDFT-ECD
ID ABSOLUTE-CONFIGURATION; SPECTROSCOPY; DERIVATIVES; ASSIGNMENT; DIMERS;
   SHIFTS
AB Chemical investigation of a methanolic extract of leaves from Araucaria bidwillii (Araucariaceae) from Egypt afforded four new labdane diterpenoidal metabolites (1-4) together with one known diterpene, 7-oxocallitrisic acid (5), two triterpenoidal metabolites, 2-O-acetyl-11-keto-boswellic acid (6) and beta-sitosterol-3-O-glucopyranoside (7), phloretic acid (8), and two methylated bisflavonoids, agathisflavone-4',7,7"-trimethyl ether (9) and cupressuflavone-4',7,7"-trimethyl ether (10). The new metabolites 1-4 were unambiguously identified by applying extensive 1D and 2D NMR spectroscopic studies as well as HRESIMS. The relative and absolute configurations of 1-4 were determined using ROESY and the modified Mosher's method, respectively. All isolated compounds were assessed for their antimicrobial, antitubercular and cytotoxic activities. Among the tested compounds, the new labdane diterpenes 1-4 revealed significant cytotoxic activity against mouse lymphoma L5178Y cell line with IC50 values ranging from 1.4 to 12.9 mu M, respectively. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Ebada, Sherif S.; Proksch, Peter] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Univ Str 1, D-40225 Dusseldorf, Germany.
   [Ebada, Sherif S.; Talaat, Aya N.; Labib, Rola M.; Singab, AbdelNasser] Ain Shams Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11566, Egypt.
   [Mandi, Attila; Kurtan, Tibor] Univ Debrecen, Dept Organ Chem, POB 400, H-4002 Debrecen, Hungary.
   [Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem, Univ Med, Duesbergweg 6, D-55128 Mainz, Germany.
RP Proksch, P (reprint author), Heinrich Heine Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Univ Str 1, D-40225 Dusseldorf, Germany.; Ebada, SS (reprint author), Ain Shams Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11566, Egypt.
EM sherif_elsayed@pharma.asu.edu.eg; proksch@uni-duesseldorf.de
OI Singab, Abdel nasser/0000-0001-7445-963X
FU Manchot Foundation; EU; European Regional Development Fund
   [GINOP-2.3.2-15-2016-00008]
FX P.P. wants to thank Manchot Foundation for support. The research of the
   Hungarian authors was supported by the EU and co-financed by the
   European Regional Development Fund under the project
   GINOP-2.3.2-15-2016-00008. We thank the Governmental
   Information-Technology Development Agency (KIFU) for CPU time.
CR Ashour M, 2006, J NAT PROD, V69, P1547, DOI 10.1021/np060172v
   Aslam MS, 2013, TROP J PHARM RES, V12, P651, DOI 10.4314/tjpr.v12i4.31
   Bara R, 2013, J MED CHEM, V56, P3257, DOI 10.1021/jm301816a
   Belsner K, 2003, MAGN RESON CHEM, V41, P115, DOI 10.1002/mrc.1138
   Bringmann G, 2005, ANGEW CHEM INT EDIT, V44, P5384, DOI 10.1002/anie.200462661
   CAPUTO R, 1974, PHYTOCHEMISTRY, V13, P475, DOI 10.1016/S0031-9422(00)91236-6
   CAPUTO R, 1976, PHYTOCHEMISTRY, V15, P1401, DOI 10.1016/S0031-9422(00)97126-7
   Chen J, 2011, PLANTA MED, V77, P485, DOI 10.1055/s-0030-1250570
   Covington CL, 2016, J NAT PROD, V79, P2530, DOI 10.1021/acs.jnatprod.6b00395
   Csuk R, 2015, EUR J MED CHEM, V100, P98, DOI 10.1016/j.ejmech.2015.06.003
   DALE JA, 1973, J AM CHEM SOC, V95, P512, DOI 10.1021/ja00783a034
   Dimas K, 1998, PLANTA MED, V64, P208, DOI 10.1055/s-2006-957410
   Ebrahim W, 2016, J NAT PROD, V79, P914, DOI 10.1021/acs.jnatprod.5b00975
   Ebrahim W, 2012, EUR J ORG CHEM, P3476, DOI 10.1002/ejoc.201200245
   Frisch M. J., 2010, GAUSSIAN 09
   Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495
   Inatomi Y, 2005, TETRAHEDRON LETT, V46, P6533, DOI 10.1016/j.tetlet.2005.07.091
   Jung MI, 1998, BIOORG MED CHEM LETT, V8, P3295, DOI 10.1016/S0960-894X(98)00603-9
   LEE CK, 1994, PHYTOCHEMISTRY, V35, P983
   Lin TC, 1999, PHYTOCHEMISTRY, V51, P793, DOI 10.1016/S0031-9422(99)00074-6
   Maldonado E, 2015, J NAT PROD, V78, P202, DOI 10.1021/np500688c
   Mandi A, 2015, J NAT PROD, V78, P2051, DOI 10.1021/acs.jnatprod.5b00369
   NOMA M, 1982, PHYTOCHEMISTRY, V21, P395, DOI 10.1016/S0031-9422(00)95274-9
   OFMAN DJ, 1995, PHYTOCHEMISTRY, V38, P1223, DOI 10.1016/0031-9422(94)00783-P
   Ola ARB, 2014, TETRAHEDRON LETT, V55, P1020, DOI 10.1016/j.tetlet.2013.12.070
   Pescitelli G, 2016, CHIRALITY, V28, P466, DOI 10.1002/chir.22600
   RAHMAN W, 1968, TETRAHEDRON LETT, P675
   Ronsberg D, 2013, J ORG CHEM, V78, P12409, DOI 10.1021/jo402066b
   SANFELICIANO A, 1988, PHYTOCHEMISTRY, V27, P2241
   SEO S, 1978, J AM CHEM SOC, V100, P3331, DOI 10.1021/ja00479a014
   Stephens PJ, 2010, CHIRALITY, V22, P229, DOI 10.1002/chir.20733
   Su BN, 2002, J NAT PROD, V65, P1278, DOI 10.1021/np0202475
   Sun P, 2013, J ORG CHEM, V78, P7030, DOI 10.1021/jo400861j
   Tanagornmeatar K, 2014, ANTICANCER RES, V34, P6573
   Tanaka R, 2000, CANCER LETT, V161, P165, DOI 10.1016/S0304-3835(00)00584-X
   Wu GW, 2015, J NAT PROD, V78, P2691, DOI 10.1021/acs.jnatprod.5b00636
   Zhang P, 2015, RSC ADV, V5, P39870, DOI 10.1039/c5ra02203g
   [Anonymous], 2012, MACROMODEL
NR 38
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4020
J9 TETRAHEDRON
JI Tetrahedron
PD MAY 25
PY 2017
VL 73
IS 21
BP 3048
EP 3055
DI 10.1016/j.tet.2017.04.015
PG 8
WC Chemistry, Organic
SC Chemistry
GA EU9XP
UT WOS:000401393300009
OA No
DA 2017-08-17
ER

PT J
AU El-Bana, MS
   El Radaf, IM
   Fouad, S
   Sakr, GB
AF El-Bana, M. S.
   El Radaf, I. M.
   Fouad, S.
   Sakr, G. B.
TI Structural and optoelectrical properties of nanostructured LiNiO2 thin
   films grown by spray pyrolysis technique
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE LiNiO2; Thin films; Optical parameters; Dielectric constants;
   Optoelectrical properties
ID CDSE QUANTUM DOTS; ELECTROCHEMICAL PROPERTIES; HYDROTHERMAL METHOD;
   OPTICAL-PARAMETERS; DIRECT FABRICATION; REFRACTIVE-INDEX; GLASSY SYSTEM;
   LIOH SOLUTION; ABSORPTION; ELECTRODES
AB LiNiO2 thin films of different thicknesses (200-354 nm) have been synthesized using conventional pyrolysis technique. Systematic investigations of the structure, morphology, optical, and optoelectrical properties have been made using X-ray diffraction (XRD), energy dispersive X-ray (EDX) spectroscopy, High-resolution scanning electron microscopy (HR-SEM), and spectrophotometric analysis. XRD patterns of the as-synthesized LiNiO2 films have revealed the polycrystalline nature of films under study with the rhombohedral crystal structure. HR-SEM micrographs have shown an evolution in films morphology from a rugged to a smooth surface with the increase in the film thickness. The change in morphology has been interpreted to the orientation and/or crystalline phase. Remarkable changes in the crystalline and surface properties of the films have been noticed with increasing film thickness. The optical constants of the studied films have been extracted from both transmittance and reflectance spectra. The films band gap was found to decrease with the increase of film thickness. The dispersion of the refractive index has been analyzed in the view of Wemple-DiDomenico model which enable the determination of linear and nonlinear optical parameters. Among the investigated films, the 354 nm film demonstrated the highest nonlinear optical parameters. This finding could shed lights of the possibility of using LiNiO2 in nonlinear devices. In addition, the real and imaginary parts of the dielectric constants have been utilized to determine various optoelectrical parameters such as the dissipation factor tan delta, relaxation time tau, the optical carrier concentration N-opt, optical mobility mu(opt), optical resistivity rho(opt), plasma frequency omega(p), and damping frequency omega(d). Good correlations have been established between the optical and optoelectrical parameters of the investigated films. (C) 2017 Elsevier B. V. All rights reserved.
C1 [El-Bana, M. S.; Fouad, S.; Sakr, G. B.] Ain Shams Univ, Fac Educ, Dept Phys, Nanosci & Semicond Labs, Cairo, Egypt.
   [El Radaf, I. M.] Natl Res Ctr, Electron Microscope & Thin Films Dept, Cairo, Egypt.
RP El-Bana, MS (reprint author), Ain Shams Univ, Fac Educ, Dept Phys, Nanosci & Semicond Labs, Cairo, Egypt.
EM mohammed.el-bana@bath.edu
OI El Bana, Mohammed/0000-0003-2500-7463
CR Ahmad MM, 2015, RSC ADV, V5, P25824, DOI 10.1039/c4ra15972a
   Aly KA, 2013, J ALLOY COMPD, V561, P284, DOI 10.1016/j.jallcom.2013.01.197
   El-Bana MS, 2017, J ALLOY COMPD, V695, P1532, DOI 10.1016/j.jallcom.2016.10.295
   El-Bana MS, 2016, J ALLOY COMPD, V686, P115, DOI 10.1016/j.jallcom.2016.05.196
   El-Nahass MM, 2014, SYNTHETIC MET, V195, P110, DOI 10.1016/j.synthmet.2014.05.013
   El-Sayed SM, 2001, VACUUM, V62, P353, DOI 10.1016/S0042-207X(01)00352-9
   Fouad SS, 2013, PHYSICA B, V415, P82, DOI 10.1016/j.physb.2013.01.014
   Fouad SS, 2006, J MATER SCI-MATER EL, V17, P193, DOI 10.1007/s10854-006-6760-4
   Fragnaud P, 1995, IONICS, V1, P183, DOI 10.1007/BF02388679
   Gedi S, 2015, OPT MATER, V42, P468, DOI 10.1016/j.optmat.2015.01.043
   GORDILLO G, 1994, IEEE PHOT SPEC CONF, P307, DOI 10.1109/WCPEC.1994.519869
   Han KS, 2002, SOLID STATE IONICS, V151, P11, DOI 10.1016/S0167-2738(02)00598-2
   Han KS, 2002, J AM CERAM SOC, V85, P2444, DOI 10.1111/j.1151-2916.2002.tb00478.x
   Hassanien AS, 2016, J ALLOY COMPD, V671, P566, DOI 10.1016/j.jallcom.2016.02.126
   Holzwarth U, 2011, NAT NANOTECHNOL, V6, P534, DOI 10.1038/nnano.2011.145
   Huang J, 2008, THIN SOLID FILMS, V516, P3314, DOI 10.1016/j.tsf.2007.09.039
   Kalyani P, 2005, SCI TECHNOL ADV MAT, V6, P689, DOI 10.1016/j.stam.2005.06.001
   Kim CJ, 2008, J ALLOY COMPD, V449, P335, DOI 10.1016/j.jallcom.2005.12.128
   Lai X, 2009, J ALLOY COMPD, V487, pL30, DOI 10.1016/j.jallcom.2009.08.060
   Lalitha S, 2004, SOL ENERG MAT SOL C, V82, P187, DOI 10.1016/j.solmat.2004.01.017
   Herrera LJM, 2014, J APPL PHYS, V116, DOI 10.1063/1.4904349
   Michalak F, 1999, ELECTROCHIM ACTA, V44, P3085, DOI 10.1016/S0013-4686(99)00024-9
   Park YJ, 2002, J ELECTROCHEM SOC, V149, pA597, DOI 10.1149/1.1466860
   Saadeddin I, 2007, APPL SURF SCI, V253, P5240, DOI 10.1016/j.apsusc.2006.11.049
   Sharma P, 2007, J PHYS D APPL PHYS, V40, P2115, DOI 10.1088/0022-3727/40/7/038
   Sharma P, 2016, J ALLOY COMPD, V667, P204, DOI 10.1016/j.jallcom.2016.01.179
   Shen Q, 2004, JPN J APPL PHYS 1, V43, P2946, DOI 10.1143/JJAP.43.2946
   Shen Q, 2008, THIN SOLID FILMS, V516, P5927, DOI 10.1016/j.tsf.2007.10.070
   Skordeva E. R., 1999, DISPERSION ENERGIES
   Song MY, 2002, J POWER SOURCES, V111, P97, DOI 10.1016/S0378-7753(02)00263-X
   Tanaka K, 2011, AMORPHOUS CHALCOGENIDE SEMICONDUCTORS AND RELATED MATERIALS, P1, DOI 10.1007/978-1-4419-9510-0
   Tang SB, 2008, J ALLOY COMPD, V449, P300, DOI 10.1016/j.jallcom.2005.12.131
   TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224
   Ticha H, 2002, J OPTOELECTRON ADV M, V4, P381
   WEMPLE SH, 1971, PHYS REV B, V3, P1338, DOI 10.1103/PhysRevB.3.1338
   WEMPLE SH, 1973, PHYS REV B, V7, P3767, DOI 10.1103/PhysRevB.7.3767
   WILLIAMSON GK, 1956, PHILOS MAG, V1, P34, DOI 10.1080/14786435608238074
   Yoshimura M, 1998, SOLID STATE IONICS, V106, P39, DOI 10.1016/S0167-2738(97)00406-2
   Zheng XB, 2016, ELECTROCHIM ACTA, V191, P832, DOI 10.1016/j.electacta.2016.01.142
NR 39
TC 0
Z9 0
U1 15
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD MAY 25
PY 2017
VL 705
BP 333
EP 339
DI 10.1016/j.jallcom.2017.02.106
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA EQ3TC
UT WOS:000397994700044
OA No
DA 2017-08-17
ER

PT J
AU Saad, M
   Stambouli, W
   Mohamed, SA
   Elhouichet, H
AF Saad, Moufida
   Stambouli, Wissal
   Mohamed, Shaimaa A.
   Elhouichet, Habib
TI Ag nanoparticles induced luminescence enhancement of Eu3+ doped
   phosphate glasses
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Phosphate glasses; Ag nanoparticles; Judd Offelt analysis;
   Photoluminescence; Energy transfer
ID ZINC-TELLURITE GLASS; RARE-EARTH IONS; SPECTROSCOPIC PROPERTIES; SILVER
   NANOPARTICLES; OPTICAL-PROPERTIES; HEAT-TREATMENT; FLUOROPHOSPHATE
   GLASSES; BORATE GLASSES; ABSORPTION; EMISSION
AB Sodium phosphate glasses co-doped with Eu3+/Ag NPs were prepared by the melt quenching method. A thermal annealing process is proposed to control the aggregation and growth of Ag NPs. The amorphous nature is confirmed by the x-ray diffraction patterns for all the glasses. TEM picture analyses revealed the presence of silver nanoparticles of almost spherical shape and various sizes inside the glass matrix depending on the annealing time. The absorption spectra revealed seven absorption peaks of Eu(3+)ions in addition to the surface Plasmon resonance (SPR) band of Ag NPs centered at 400 nm. The luminescence properties of Eu3+ doped phosphate glass containing silver nanoparticles (NPs) are investigated. The observed enhancement of the photoluminescence and the PL lifetime relative to D-5(0)-> F-7(2) transitions are explained not only by the energy transfer ions, but NPs to Eu3+ ions but also by the enhancement of local field effect LFE induced by SPR of silver NPs. Based on the emission spectra, Judd Offelt (JO) parameters (Omega(2) and Omega(4)), spontaneous emission probabilities, the radiative lifetime, luminescence branching factors, the quantum yield of luminescence and the stimulated cross-section emissions for D-5(0)-> F-7(2) transition are calculated. The fluorescence quantum efficiencies are found to be enhanced with the increase of heat treatment until it attains 85% for the sample PAZE20. The results indicated that the heat-treated glass for 20 h has a good prospect as a gain medium applied for 615 nm broadband and high-gain europium-doped fiber amplifiers. (C) 2016 Published by Elsevier B. V.
C1 [Saad, Moufida; Stambouli, Wissal; Elhouichet, Habib] Ctr Natl Rech Sci Mat, Lab Mat Mineraux & Leurs Applicat, Technopole Borj Cedria,BP 95, Hammam Lif 2050, Tunisia.
   [Elhouichet, Habib] Univ Tunis El Manar, Fac Sci Tunis, Dept Phys, Tunis 2092, Tunisia.
   [Mohamed, Shaimaa A.] Zewail City Sci & Technol, Ctr Photon & Smart Mat CPMS, Giza 12588, Egypt.
RP Stambouli, W (reprint author), Ctr Natl Rech Sci Mat, Lab Mat Mineraux & Leurs Applicat, Technopole Borj Cedria,BP 95, Hammam Lif 2050, Tunisia.
EM stambouliwissal@gmail.com
CR Amjad J., 2013, CHINESE PHYS LETT, V30
   Amjad RJ, 2014, J LUMIN, V154, P316, DOI 10.1016/j.jlumin.2014.05.009
   Amjad RJ, 2013, OPT EXPRESS, V21, P14282, DOI 10.1364/OE.21.014282
   Ashur Z., 2013, MATER LETT, V112, P136
   Ashur Zahra, 2016, J LUMIN, V180, P1
   Awang Asmahani, 2014, Advanced Materials Research, V895, P254, DOI 10.4028/www.scientific.net/AMR.895.254
   Babu P, 2000, PHYSICA B, V279, P262, DOI 10.1016/S0921-4526(99)00876-5
   Babu SS, 2007, J LUMIN, V126, P109, DOI 10.1016/j.jlumin.2006.05.010
   Bouhelier A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.267405
   CAPOBIANCO JA, 1990, PHYS REV B, V42, P5936, DOI 10.1103/PhysRevB.42.5936
   Dai SX, 2005, SPECTROCHIM ACTA A, V62, P431, DOI 10.1016/j.saa.2005.01.011
   DAVIS EA, 1970, PHILOS MAG, V22, P903, DOI 10.1080/14786437008221061
   de Assumpcao TAA, 2012, J ALLOY COMPD, V536, pS504, DOI 10.1016/j.jallcom.2011.12.078
   Dimitrov V, 1996, J APPL PHYS, V79, P1741, DOI 10.1063/1.360963
   Dousti MR, 2014, J MOL STRUCT, V1065, P39, DOI 10.1016/j.molstruc.2014.02.032
   Dousti MR, 2013, J MOL STRUCT, V1035, P6, DOI 10.1016/j.molstruc.2012.09.023
   Dousti MR, 2012, J NON-CRYST SOLIDS, V358, P2939, DOI 10.1016/j.jnoncrysol.2012.06.024
   Fares H, 2016, RSC ADV, V6, P31136, DOI 10.1039/c6ra02095j
   Fares H, 2015, J APPL PHYS, V117, DOI 10.1063/1.4921436
   Fares H, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896363
   Halimah MK, 2010, MATER SCI-POLAND, V28, P173
   Hu YB, 2014, J LUMIN, V145, P512, DOI 10.1016/j.jlumin.2013.08.022
   Jiao Q, 2014, MATER RES BULL, V51, P315, DOI 10.1016/j.materresbull.2013.12.044
   Jimenez JA, 2017, J ALLOY COMPD, V691, P44, DOI 10.1016/j.jallcom.2016.08.231
   Jlassi I, 2015, J ALLOY COMPD, V645, P125, DOI 10.1016/j.jallcom.2015.05.025
   Jlassi I, 2011, J MATER SCI, V46, P806, DOI 10.1007/s10853-010-4820-x
   Kalpana T, 2015, J NON-CRYST SOLIDS, V419, P75, DOI 10.1016/j.jnoncrysol.2015.03.033
   Karunakaran RT, 2009, SOLID STATE SCI, V11, P1882, DOI 10.1016/j.solidstatesciences.2009.08.001
   Kassab LRP, 2010, J APPL PHYS, V107, DOI 10.1063/1.3431347
   Kaur G, 2011, J NON-CRYST SOLIDS, V357, P858, DOI 10.1016/j.jnoncrysol.2010.11.103
   Kesavulu CR, 2013, MATER CHEM PHYS, V141, P903, DOI 10.1016/j.matchemphys.2013.06.021
   Kumar A, 2002, SPECTROCHIM ACTA A, V58, P2115, DOI 10.1016/S1386-1425(01)00684-9
   Kumar MVV, 2011, J SOLID STATE CHEM, V184, P2145, DOI 10.1016/j.jssc.2011.06.007
   Maheshvaran K, 2012, J LUMIN, V132, P2259, DOI 10.1016/j.jlumin.2012.04.022
   Mattarelli M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125102
   MCDOUGALL J, 1994, PHYS CHEM GLASSES, V35, P258
   Meza-Rocha AN, 2016, OPT MATER, V58, P183, DOI 10.1016/j.optmat.2016.05.043
   Meza-Rocha AN, 2016, OPT MATER, V51, P128, DOI 10.1016/j.optmat.2015.11.032
   Qi JN, 2013, OPT MATER, V35, P2502, DOI 10.1016/j.optmat.2013.07.009
   Rajesh D, 2017, J ALLOY COMPD, V695, P607, DOI 10.1016/j.jallcom.2016.11.058
   Dousti MR, 2016, OPT MATER, V60, P331, DOI 10.1016/j.optmat.2016.08.005
   Sdiri N, 2014, J NON-CRYST SOLIDS, V389, P38, DOI 10.1016/j.jnoncrysol.2014.01.031
   Sdiri N, 2012, J MOL STRUCT, V1010, P85, DOI 10.1016/j.molstruc.2011.11.036
   Soltani I, 2016, J ALLOY COMPD, V686, P556, DOI 10.1016/j.jallcom.2016.06.027
   Soltys M, 2015, OPT MATER, V40, P91, DOI 10.1016/j.optmat.2014.11.052
   Stambouli W, 2013, J LUMIN, V138, P201, DOI 10.1016/j.jlumin.2013.01.019
   Stambouli W, 2012, J LUMIN, V132, P205, DOI 10.1016/j.jlumin.2011.08.018
   Tian Y, 2014, APPL SURF SCI, V313, P504, DOI 10.1016/j.apsusc.2014.06.013
   Tian Y, 2014, J ALLOY COMPD, V590, P61, DOI 10.1016/j.jallcom.2013.12.098
   Tian Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3551584
   Upender G, 2010, J ALLOY COMPD, V504, P468, DOI 10.1016/j.jallcom.2010.06.006
   Vijayakumar R, 2016, J ALLOY COMPD, V665, P294, DOI 10.1016/j.jallcom.2016.01.049
   Wang L, 2016, CERAM INT, V42, P13648, DOI 10.1016/j.ceramint.2016.05.160
   Wang YL, 2009, MATER CHEM PHYS, V113, P407, DOI 10.1016/j.matchemphys.2008.07.117
   Ye S, 2016, J ALLOY COMPD, V685, P891, DOI 10.1016/j.jallcom.2016.06.226
NR 55
TC 1
Z9 1
U1 39
U2 39
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD MAY 25
PY 2017
VL 705
BP 550
EP 558
DI 10.1016/j.jallcom.2016.12.410
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA EQ3TC
UT WOS:000397994700072
OA No
DA 2017-08-17
ER

PT J
AU Issa, SAM
   Hamdalla, TA
   Darwish, AAA
AF Issa, Shams A. M.
   Hamdalla, Taymour A.
   Darwish, A. A. A.
TI Effect of ErCl3 in gamma and neutron parameters for different
   concentration of ErCl3-SiO2 (EDFA) for the signal protection from
   nuclear radiation (vol 698, pg 234, 2017)
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Correction
C1 [Issa, Shams A. M.; Hamdalla, Taymour A.; Darwish, A. A. A.] Univ Tabuk, Dept Phys, Fac Sci, Tabuk, Saudi Arabia.
   [Issa, Shams A. M.] Al Azhar Univ, Dept Phys, Fac Sci, Assiut, Egypt.
   [Hamdalla, Taymour A.] Univ Alexandria, Dept Phys, Fac Sci, Alexandria, Egypt.
   [Darwish, A. A. A.] Sanaa Univ, Fac Educ Al Mahweet, Dept Phys, Al Mahwit, Yemen.
RP Issa, SAM (reprint author), Univ Tabuk, Dept Phys, Fac Sci, Tabuk, Saudi Arabia.
EM shams_issa@yahoo.com
RI Issa, Shams/M-6825-2017
OI Issa, Shams/0000-0002-9166-7497
CR Issa SAM, 2017, J ALLOY COMPD, V698, P234, DOI 10.1016/j.jallcom.2016.12.176
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD MAY 25
PY 2017
VL 705
BP 853
EP 853
DI 10.1016/j.jallcom.2017.02.145
PG 1
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA EQ3TC
UT WOS:000397994700111
OA No
DA 2017-08-17
ER

PT J
AU Qiao, X
   El-Shahat, M
   Ullah, B
   Bao, ZB
   Xing, HB
   Xiao, L
   Ren, QL
   Zhang, ZG
AF Qiao, Xiang
   El-Shahat, Mahmoud
   Ullah, Bakhtar
   Bao, Zongbi
   Xing, Huabin
   Xiao, Li
   Ren, Qilong
   Zhang, Zhiguo
TI Cyclopentadiene-based Bronsted acid as a new generation of
   organocatalyst for transfer hydrogenation of 2-substituted quinoline
   derivatives
SO TETRAHEDRON LETTERS
LA English
DT Article
DE Cyclopentadiene-based Bronsted acid; Hantzsch ester; Organocatalysis;
   Quinoline derivatives; Transfer hydrogenation
ID IRIDIUM-CATALYZED HYDROGENATION; HANTZSCH ESTERS; ASYMMETRIC
   HYDROGENATION; HETEROAROMATIC-COMPOUNDS; RECENT PROGRESS; CHEMISTRY;
   DONORS
AB A simple and readily available cyclopentadiene-based Bronsted acid was employed to catalyze the transfer hydrogenation of 2-substituted quinolines using Hantzsch ester as the hydrogen source. This conceptually new designed organocatalyst demonstrates remarkably high efficiency for this transformation and a variety of substituted 1,2,3,4-tetrahydroquinoline derivatives were afforded in excellent yields under mild reaction conditions. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Qiao, Xiang; El-Shahat, Mahmoud; Ullah, Bakhtar; Bao, Zongbi; Xing, Huabin; Ren, Qilong; Zhang, Zhiguo] Zhejiang Univ, Coll Chem & Biol Engn, Key Lab Biomass Chem Engn, Minist Educ, Zheda Rd 38, Hangzhou 310027, Zhejiang, Peoples R China.
   [El-Shahat, Mahmoud] Natl Res Ctr, Chem Ind Res Div, Photochem Dept, 33 EL Bohouth St, Giza 12622, Egypt.
   [Xiao, Li] Huzhou Univ, Coll Life Sci, Xueshi Rd 1, Huzhou 313000, Peoples R China.
RP Zhang, ZG (reprint author), Zhejiang Univ, Coll Chem & Biol Engn, Key Lab Biomass Chem Engn, Minist Educ, Zheda Rd 38, Hangzhou 310027, Zhejiang, Peoples R China.
EM zhiguo.zhang@zju.edu.cn
FU MOST [2016YFA0202900]; National Natural Science Foundation of China
   [21376212, 21436010]; Foundation of Zhejiang Educational Committee
   [Y201224067]; Natural Science Foundation of Zhejiang Province, China
   [LY13B060001]
FX We are grateful for financial support from the MOST (2016YFA0202900),
   the National Natural Science Foundation of China (21376212, 21436010),
   the Foundation of Zhejiang Educational Committee (Y201224067) and the
   Natural Science Foundation of Zhejiang Province, China (LY13B060001).
CR Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j
   Akiyama T, 2015, CHEM REV, V115, P9277, DOI 10.1021/acs.chemrev.5b00041
   Bartoszewicz A, 2013, CHEM-EUR J, V19, P7274, DOI 10.1002/chem.201202836
   BRUCE MI, 1982, J CHEM SOC DALTON, P2209, DOI 10.1039/dt9820002209
   Chakraborty S, 2014, J AM CHEM SOC, V136, P8564, DOI 10.1021/ja504523b
   Chen F, 2015, J AM CHEM SOC, V137, P11718, DOI 10.1021/jacs.5b06496
   Chenault H K, 1988, Biotechnol Genet Eng Rev, V6, P221
   Connon SJ, 2007, ORG BIOMOL CHEM, V5, P3407, DOI 10.1039/b711499k
   Dobereiner GE, 2011, J AM CHEM SOC, V133, P7547, DOI 10.1021/ja2014983
   Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r
   Frey P. A., 2007, ENZYMATIC REACTION M
   Gheewala CD, 2016, SCIENCE, V351, P961, DOI 10.1126/science.aad0591
   Goff EL, 1964, J ORG CHEM, V29, P423, DOI 10.1021/jo01025a043
   Guo QS, 2008, ANGEW CHEM INT EDIT, V47, P759, DOI 10.1002/anie.200703925
   Katritzky AR, 1996, TETRAHEDRON, V52, P15031, DOI 10.1016/S0040-4020(96)00911-8
   Kelch AS, 2013, BEILSTEIN J ORG CHEM, V9, P1705, DOI 10.3762/bjoc.9.195
   Lu S-M, 2006, ANGEW CHEM, V118, P2318, DOI 10.1002/ange.200503073
   MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367
   Munro AW, 2013, ENCY BIOPHYSICS, P601
   Ojao X, 2014, RSC ADV, V4, P42566
   Ouellet SG, 2007, ACCOUNTS CHEM RES, V40, P1327, DOI 10.1021/ar7001864
   Parmar D, 2014, CHEM REV, V114, P9047, DOI 10.1021/cr5001496
   Ren D, 2012, J AM CHEM SOC, V134, P17592, DOI 10.1021/ja3066978
   Rueping M, 2008, ADV SYNTH CATAL, V350, P1001, DOI 10.1002/adsc.200800020
   Rueping M, 2006, ANGEW CHEM INT EDIT, V45, P3683, DOI 10.1002/anie.200600191
   Rueping M, 2006, SYNLETT, P1071, DOI 10.1055/s-2006-939706
   Rueping M, 2011, GREEN CHEM, V13, P1084, DOI 10.1039/c1gc15027h
   Rueping M, 2010, CHEM SCI, V1, P473, DOI 10.1039/c0sc00206b
   Rueping M, 2010, SYNLETT, P852, DOI 10.1055/s-0029-1219528
   Rueping M, 2010, ADV SYNTH CATAL, V352, P281, DOI 10.1002/adsc.200900746
   SCHMIDT P, 1972, ANGEW CHEM INT EDIT, V11, P513, DOI 10.1002/anie.197205131
   Sridharan V, 2011, CHEM REV, V111, P7157, DOI 10.1021/cr100307m
   Terada M, 2010, SYNTHESIS-STUTTGART, P1929, DOI 10.1055/s-0029-1218801
   Wang D, 2015, CHEM REV, V115, P6621, DOI 10.1021/acs.chemrev.5b00203
   Wang DS, 2012, CHEM REV, V112, P2557, DOI 10.1021/cr200328h
   Wang TL, 2011, J AM CHEM SOC, V133, P9878, DOI 10.1021/ja2023042
   Wang WB, 2003, J AM CHEM SOC, V125, P10536, DOI 10.1021/ja0353762
   Weckbecker A, 2010, ADV BIOCHEM ENG BIOT, V120, P195, DOI 10.1007/10_2009_55
   Wen JL, 2016, CHEM SCI, V7, P3047, DOI 10.1039/c5sc04712a
   You SL, 2007, CHEM-ASIAN J, V2, P820, DOI 10.1002/asia.200700081
   Zheng C, 2012, CHEM SOC REV, V41, P2498, DOI 10.1039/c1cs15268h
   Zhou H, 2008, ANGEW CHEM, V120, P8592, DOI 10.1002/ange.200802237
   Zhou YG, 2007, ACCOUNTS CHEM RES, V40, P1357, DOI 10.1021/ar700094b
   Ziegler M., 2013, ENCY BIOPHYSICS, P1710
NR 44
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4039
J9 TETRAHEDRON LETT
JI Tetrahedron Lett.
PD MAY 24
PY 2017
VL 58
IS 21
BP 2050
EP 2053
DI 10.1016/j.tetlet.2017.04.038
PG 4
WC Chemistry, Organic
SC Chemistry
GA EV3RS
UT WOS:000401677400010
OA No
DA 2017-08-17
ER

PT J
AU Ismail, MF
   El-Mahrouk, AF
   Hamouda, TH
   Radwan, H
   Haneef, A
   Jamjoom, AA
AF Ismail, Mohamed F.
   El-Mahrouk, Ahmed F.
   Hamouda, Tamer H.
   Radwan, Hanan
   Haneef, Ali
   Jamjoom, Ahmed A.
TI Factors influencing postoperative atrial fibrillation in patients
   undergoing on-pump coronary artery bypass grafting, single center
   experience
SO JOURNAL OF CARDIOTHORACIC SURGERY
LA English
DT Article
DE CABG; Atrial fibrillation; Predictors; Postoperative outcome
ID AORTIC-VALVE-REPLACEMENT; CARDIAC-SURGERY; SUPRAVENTRICULAR
   TACHYARRHYTHMIAS; INDEPENDENT RISK; STENOSIS; AGE; ACTIVATION;
   PREVENTION; PREDICTION; OPERATIONS
AB Background: The reported incidence of AF after CABG surgery varies from 20 to 40%, with the arrhythmia usually occurring between second and fourth postoperative days. Postoperative AF after CABG was associated with greater in-hospital mortality and worse survival at long-term follow-up. Therefore, intensive attention has focused on the prevention of AF in high-risk patients. Many perioperative factors have been suggested to increase the incidence of postoperative AF after conventional CABG. In this study we are trying to examine some of these risk factors as predictors for Post-operative AF in our patients. In this study, our aim was to identify the perioperative predictors of AF in our patients who underwent Coronary Artery Bypass Grafting.
   Methods: Our Patients were divided into two groups; Group A included patients who did not develop PO AF (168 patients) and Group B patients who developed PO AF (84 patients). Perioperative Data, including gender, age, demographic variables and postoperative morbidity and mortality were extracted from the medical records.
   Results: This retrospective cohort study was conducted on 252 consecutive adult patients underwent CABG, in King Faisal Specialist Hospital and Research Center in Jeddah, Saudi Arabia. The mean age for patients with PO AF was 65 years (P =.0001). Eight-three patients (49.4%) were diabetics in group A and 56 patients (66.7%) in group B (P =.0001). Patients who developed POAF had a lower ejection fraction (44.8 +/- 5.7%) (P =.0001), diastolic dysfunction (P =.0001), Larger Left atrial volume (P =.0001). Bleeding requiring re-opening for exploration and Postoperative shock were identified as significant predictors for POAF. Multivariate logistic regression (odds ratio, +/- 95% CI, P value) was performed to identify the effect of age, preoperative heart rate, ejection fraction, postoperative bleeding, Shock, ventilator time, Sensitivity was 89.5%, specificity was 94.6%, positive predictive value was 89.5%, and negative predictive value was 94.6%.
   Conclusion: In our study, advanced age, enlarged LA volume, low ejection fraction, combined surgeries and prolonged ventilation time were found to be predictors of atrial fibrillations after coronary artery bypass grafting.
C1 [Ismail, Mohamed F.] Mansoura Univ, Cardiothorac Surg Dept, Fac Med, Mansoura, Egypt.
   [El-Mahrouk, Ahmed F.] Tanta Univ, Fac Med, Cardiothorac Surg Dept, Tanta, Egypt.
   [Hamouda, Tamer H.] Benha Univ, Fac Med, Cardiothorac Surg Dept, Banha, Egypt.
   [Radwan, Hanan] Zagazig Univ, Fac Med, Cardiol Dept, Zagazig, Egypt.
   [Ismail, Mohamed F.; El-Mahrouk, Ahmed F.; Hamouda, Tamer H.; Haneef, Ali; Jamjoom, Ahmed A.] King Faisal Specialist Hosp & Res Ctr, Jeddah, Saudi Arabia.
RP El-Mahrouk, AF (reprint author), Tanta Univ, Fac Med, Cardiothorac Surg Dept, Tanta, Egypt.; El-Mahrouk, AF (reprint author), King Faisal Specialist Hosp & Res Ctr, Jeddah, Saudi Arabia.
EM ael-mahrouk@kfshrc.edu.sa
CR Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011
   Amar D, 2002, ANESTHESIOLOGY, V96, P352, DOI 10.1097/00000542-200202000-00021
   Aranki SF, 1996, CIRCULATION, V94, P390
   Auer J, 2004, AM HEART J, V147, P636, DOI 10.1016/j.ahj.2003.10.041
   Auer J, 2004, JAMA-J AM MED ASSOC, V292, P41, DOI 10.1001/jama.292.1.41-b
   Babaev AA, 2000, AM J CARDIOL, V86, P692, DOI 10.1016/S0002-9149(00)01056-0
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840
   COX JL, 1993, ANN THORAC SURG, V56, P405
   CRESWELL LL, 1993, ANN THORAC SURG, V56, P539
   Echahidi N, 2007, CIRCULATION S, V116
   Filardo G, 2009, CIRC-CARDIOVASC QUAL, V2, P164, DOI 10.1161/CIRCOUTCOMES.108.816843
   GOLDMAN L, 1978, CHEST, V73, P450, DOI 10.1378/chest.73.4.450
   Hogue CW, 2000, ANESTHESIOLOGY, V92, P1286, DOI 10.1097/00000542-200005000-00016
   Jais P, 2000, J CARDIOVASC ELECTR, V11, P623, DOI 10.1111/j.1540-8167.2000.tb00023.x
   Kalman JM, 1995, ANN THORAC SURG, V60, P1709, DOI 10.1016/0003-4975(95)00718-0
   KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703
   Levy F, 2012, ARCH CARDIOVASC DIS, V105, P499, DOI 10.1016/j.acvd.2012.06.002
   Maisel WH, 2001, ANN INTERN MED, V135, P1061
   Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720
   MENDES LA, 1995, J AM COLL CARDIOL, V25, P198, DOI 10.1016/0735-1097(94)00329-O
   Moulton MJ, 1996, J THORAC CARDIOV SUR, V111, P1037, DOI 10.1016/S0022-5223(96)70380-X
   Movahed MR, 2005, INT J CARDIOL, V105, P315, DOI 10.1016/j.ijcard.2005.02.050
   Orlowska-Baranowska E, 2003, J HEART VALVE DIS, V12, P136
   Osranek M, 2006, J AM COLL CARDIOL, V48, P779, DOI 10.1016/j.jacc.2006.03.054
   Pathak RK, 2015, CAN J CARDIOL, V31, DOI 10.1016/j.cjca.2014.10.027
   Patti G, 2006, CIRCULATION, V114, P1455, DOI 10.1161/CIRCULATIONAHA.106.621763
   Rosenberg MA, 2012, EUR HEART J, V33, P904, DOI 10.1093/eurheartj/ehr378
   Steinberg JS, 2004, J AM COLL CARDIOL, V43, P1001, DOI 10.1016/j.jacc.2003.12.033
   WHITE HD, 1984, CIRCULATION, V70, P479
NR 29
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1749-8090
J9 J CARDIOTHORAC SURG
JI J. Cardiothorac. Surg.
PD MAY 23
PY 2017
VL 12
AR 40
DI 10.1186/s13019-017-0609-1
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EV8EJ
UT WOS:000402013000002
PM 28535775
OA gold
DA 2017-08-17
ER

PT J
AU Zibara, K
   El Zein, N
   Sabra, M
   Hneino, M
   Harati, H
   Mohamed, W
   Kobeissy, FH
   Kassem, N
AF Zibara, Kazem
   El Zein, Nabil
   Sabra, Mirna
   Hneino, Mohammad
   Harati, Hayat
   Mohamed, Wael
   Kobeissy, Firas H.
   Kassem, Nouhad
TI Thyroxine (T-4) Transfer from Blood to Cerebrospinal Fluid in Sheep
   Isolated Perfused Choroid Plexus: Role of Multidrug
   Resistance-Associated Proteins and Organic Anion Transporting
   Polypeptides
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE transport; thyroid hormone; blood-cerebrospinal fluid barrier;
   blood-brain barrier; efflux; uptake
ID THYROID-HORMONE TRANSPORTERS; CARRIER-MEDIATED TRANSPORT; BRAIN-BARRIER;
   P-GLYCOPROTEIN; RAT-BRAIN; PRIMARY CULTURE; LEAD-EXPOSURE; CELLS;
   TRANSTHYRETIN; SYSTEM
AB Thyroxine (T-4) enters the brain either directly across the blood-brain barrier (BBB) or indirectly via the choroid plexus (CP), which forms the blood-cerebrospinal fluid barrier (B-CSF-B). In this study, using isolated perfused CP of the sheep by single-circulation paired tracer and steady-state techniques, T4 transport mechanisms from blood into lateral ventricle CP has been characterized as the first step in the transfer across the B-CSF-B. After removal of sheep brain, the CPs were perfused with I-125-T-4 and C-14-mannitol. Unlabeled T-4 was applied during single tracer technique to assess the mode of maximum uptake (U-max) and the net uptake (U-net) on the blood side of the CP. On the other hand, in order to characterize T-4 protein transporters, steady-state extraction of I-125-T-4 was measured in presence of different inhibitors such as probenecid, verapamil, BCH, or indomethacin. Increasing the concentration of unlabeled-T-4 resulted in a significant reduction in U-max%, which was reflected by a complete inhibition of T-4 uptake into CP. In fact, the obtained U-net% decreased as the concentration of unlabeled-T-4 increased. The addition of probenecid caused a significant inhibition of T-4 transport, in comparison to control, reflecting the presence of a carrier mediated process at the basolateral side of the CP and the involvement of multidrug resistance-associated proteins (MRPs: MRP1 and MRP4) and organic anion transporting polypeptides (Oatp1, Oatp2, and Oatp14). Moreover, verapamil, the P-glycoprotein (P-gp) substrate, resulted in similar to 34% decrease in the net extraction of T-4, indicating that MDR1 contributes to T-4 entry into CSF. Finally, inhibition in the net extraction of T-4 caused by BCH or indomethacin suggests, respectively, a role for amino acid "L" system and MRP1/Oatp1 in mediating T-4 transfer. The presence of a carrier-mediated transport mechanism for cellular uptake on the basolateral membrane of the CP, mainly P-gp and Oatp2, would account for the efficient T-4 transport from blood to CSF. The current study highlights a carrier-mediated transport mechanism for T4 movement from blood to brain at the basolateral side of B-CSF-B/CP, as an alternative route to BBB.
C1 [Zibara, Kazem; El Zein, Nabil; Sabra, Mirna; Hneino, Mohammad; Kassem, Nouhad] Lebanese Univ, ER045, PRASE, Beirut, Lebanon.
   [Zibara, Kazem; El Zein, Nabil] Lebanese Univ, Biol Dept, Fac Sci, Beirut, Lebanon.
   [Sabra, Mirna; Harati, Hayat; Kassem, Nouhad] Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Beirut, Lebanon.
   [Hneino, Mohammad] Lebanese Univ, Fac Publ Hlth, Med Lab Dept, Beirut, Lebanon.
   [Mohamed, Wael] Int Islamic Univ Malaysia, Kulliyyah Med, Basic Med Sci Dept, Kuantan, Pahang, Malaysia.
   [Mohamed, Wael] Menoufia Med Sch, Neurosci Unit, Cairo, Egypt.
   [Kobeissy, Firas H.] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon.
RP Zibara, K; Kassem, N (reprint author), Lebanese Univ, ER045, PRASE, Beirut, Lebanon.; Zibara, K (reprint author), Lebanese Univ, Biol Dept, Fac Sci, Beirut, Lebanon.; Kassem, N (reprint author), Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Beirut, Lebanon.; Kobeissy, FH (reprint author), Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon.
EM kzibara@ul.edu.lb; firasko@gmail.com; nouhad.kassem@hotmail.com
CR Abe T, 2002, TRENDS ENDOCRIN MET, V13, P215, DOI 10.1016/S1043-2760(02)00599-4
   Abe T, 1998, J BIOL CHEM, V273, P22395, DOI 10.1074/jbc.273.35.22395
   Ahmed OM, 2008, INT J DEV NEUROSCI, V26, P147, DOI 10.1016/j.ijdevneu.2007.09.011
   Asaba H, 2000, J NEUROCHEM, V75, P1907, DOI 10.1046/j.1471-4159.2000.0751907.x
   Begley DJ, 2004, BLOOD SPINAL CORD BR, P83, DOI 10.1016/B978-012639011-7/50013-9
   BERNAL J, 1992, ACTA MED AUST, V19, P32
   BESLIN A, 1995, ENDOCRINOLOGY, V136, P5385, DOI 10.1210/en.136.12.5385
   BLONDEAU JP, 1988, J BIOL CHEM, V263, P2685
   CENTANNI M, 1987, J CLIN INVEST, V80, P1068, DOI 10.1172/JCI113162
   CHANTOUX F, 1995, J NEUROCHEM, V65, P2549
   Dallas S, 2006, PHARMACOL REV, V58, P140, DOI 10.1124/pr.58.2.3
   Davson H, 1993, INTRO BLOOD BRAIN BA
   de Groot DJA, 2007, BRIT J CANCER, V97, P1077, DOI 10.1038/sj.bjc.6604010
   DEANE R, 1985, J PHYSIOL-LONDON, V362, P245
   DICKSON PW, 1987, J BIOL CHEM, V262, P13907
   DRATMAN MB, 1987, J COMP NEUROL, V260, P392, DOI 10.1002/cne.902600306
   DUSSAULT JH, 1987, ANNU REV PHYSIOL, V49, P321
   FRANCON J, 1989, J NEUROCHEM, V53, P1456, DOI 10.1111/j.1471-4159.1989.tb08538.x
   Gao B, 2001, MICROSC RES TECHNIQ, V52, P60, DOI 10.1002/1097-0029(20010101)52:1<60::AID-JEMT8>3.3.CO;2-3
   Gao P, 1999, J HISTOCHEM CYTOCHEM, V47, P1255
   HAGEN GA, 1974, ENDOCRINOLOGY, V95, P1398
   Hokari M, 1994, SOC NEUROSCI, V20, P518
   INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431
   Kassem NA, 2011, THEM M PHYS SOC EP M
   Kassem NA, 2007, BRAIN RES, V1181, P44, DOI 10.1016/j.brainres.2007.08.052
   Kassem NA, 2006, AM J PHYSIOL-REG I, V291, pR1310, DOI 10.1152/ajpregu.00789.2005
   Keep R F, 1990, Brain Res Dev Brain Res, V56, P47
   KIRKEGAARD C, 1991, ACTA ENDOCRINOL-COP, V124, P166
   Konig S, 2002, CELL MOL NEUROBIOL, V22, P517, DOI 10.1023/A:1021828218454
   KRENNING E, 1981, BIOCHIM BIOPHYS ACTA, V676, P314, DOI 10.1016/0304-4165(81)90165-3
   Kusuhara H, 2003, PHARMACEUT RES, V20, P720, DOI 10.1023/A:1023473216759
   Kusuhara H, 1999, J BIOL CHEM, V274, P13675, DOI 10.1074/jbc.274.19.13675
   LAKSHMANAN M, 1990, ENDOCRINOLOGY, V126, P3245
   Lautier D, 1996, BIOCHEM PHARMACOL, V52, P967, DOI 10.1016/0006-2952(96)00450-9
   Mitchell AM, 2005, J ENDOCRINOL, V185, P93, DOI 10.1677/joe.1.06096
   Morte B, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00082
   Nishino JI, 1999, J PHARMACOL EXP THER, V290, P289
   Ohtsuki S, 2004, J NEUROCHEM, V90, P743, DOI 10.1111/j.1471-4159.2004.02549.x
   OSTY J, 1988, ENDOCRINOLOGY, V123, P2303
   PARDRIDGE WM, 1979, ENDOCRINOLOGY, V105, P605
   PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94
   PRESTON JE, 1992, BRAIN RES, V592, P84, DOI 10.1016/0006-8993(92)91661-W
   PRESTON JE, 1990, BRAIN RES, V525, P275, DOI 10.1016/0006-8993(90)90874-B
   Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900
   Ribeiro RCJ, 1996, J BIOL CHEM, V271, P17147
   Richardson SJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00066
   Ritchie JWA, 2003, MOL ENDOCRINOL, V17, P653, DOI 10.1210/me.2002-0179
   Roberts LM, 2008, NEUROSCIENCE, V155, P423, DOI 10.1016/j.neuroscience.2008.06.015
   Sanchez-Covarrubias L, 2014, CURR PHARM DESIGN, V20, P1422
   SCHREIBER G, 1990, AM J PHYSIOL, V258, pR338
   Sugiyama D, 2003, J BIOL CHEM, V278, P43489, DOI 10.1074/jbc.M306933200
   Sun J, 2004, MED SCI MONITOR, V10, pRA5
   Suzuki T, 2008, CEREBELLUM, V7, P75, DOI 10.1007/s12311-008-0029-9
   Tohyama K, 2004, ENDOCRINOLOGY, V145, P4384, DOI 10.1210/en.2004-0058
   Tsuji A, 1997, ADV DRUG DELIVER REV, V25, P287, DOI 10.1016/S0169-409X(97)00504-8
   Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095
   Zheng W, 1999, TOXICOL APPL PHARM, V155, P24, DOI 10.1006/taap.1998.8611
   Zheng W, 2003, J TOXICOL ENV HEAL A, V66, P435, DOI 10.1080/15287390390156137
   Zheng W, 2001, TOXICOL SCI, V61, P107, DOI 10.1093/toxsci/61.1.107
   Zibara Kazem, 2015, Front Cell Dev Biol, V3, P60, DOI 10.3389/fcell.2015.00060
NR 60
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD MAY 23
PY 2017
VL 8
AR 214
DI 10.3389/fneur.2017.00214
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EV7GP
UT WOS:000401944200001
PM 28588548
OA gold
DA 2017-08-17
ER

PT J
AU Abuohashish, HM
   Ahmed, MM
   Sabry, D
   Khattab, MM
   Al-Rejaie, SS
AF Abuohashish, Hatem M.
   Ahmed, Mohammed M.
   Sabry, Dina
   Khattab, Mahmoud M.
   Al-Rejaie, Salim S.
TI Angiotensin (1-7) ameliorates the structural and biochemical alterations
   of ovariectomy-induced osteoporosis in rats via activation of ACE-2/Mas
   receptor axis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BONE-MINERAL DENSITY; CONVERTING ENZYME-INHIBITOR; RESISTANT
   ACID-PHOSPHATASE; BREAST-CANCER; CROSS-TALK; MICE; SYSTEM; CELLS; DIET;
   TISSUE
AB The local and systemic renin angiotensin system (RAS) influences the skeletal system micro-structure and metabolism. Studies suggested angiotensin 1-7 (Ang(1-7)) as the beneficial RAS molecule via Mas receptor activation. This study examines the function of Ang(1-7) in bone micro-architecture and metabolism in an ovariectomized (OVX) rodent model of osteoporosis. OVX rats showed structural and bone metabolic degeneration in parallel with suppressed expressions of the angiotensin converting enzyme-2 (ACE-2)/Ang(1-7)/Mas components. The infusion of Ang(1-7) markedly alleviated the altered bone metabolism and significantly enhanced both trabecular (metaphyseal) and cortical (metaphyseal-diaphyseal) morphometry. Urinary and bones minerals were also improved in OVX rats by Ang(1-7). The infusion of the heptapeptide enhanced ACE-2/Mas receptor expressions, while downregulated AngII, ACE, and AngII type-1 receptor (AT1R) in OVX animals. Moreover, Ang(1-7) markedly improved osteoprotegerin (OPG) and lowered receptor activator NF-kappa B ligand (RANKL) expressions. The defensive properties of Ang(1-7) on bone metabolism, structure and minerals were considerably eradicated after blockage of Mas receptor with A-779. Ang(1-7)-induced up-regulated ACE-2/Ang(1-7)/Mas cascade and OPG expressions were abolished and the expressions of ACE/AngII/AT1R and RANKL were provoked by A-779. These findings shows for the first time the novel valuable therapeutic role of Ang(1-7) on bone health and metabolism through the ACE-2/Mas cascade.
C1 [Abuohashish, Hatem M.; Ahmed, Mohammed M.; Al-Rejaie, Salim S.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia.
   [Abuohashish, Hatem M.] Univ Dammam, Coll Dent, Dept Biomed Dent Sci, Dammam, Saudi Arabia.
   [Sabry, Dina] Cairo Univ, Fac Med, Dept Med Biochem & Mol Biol, Cairo, Egypt.
   [Khattab, Mahmoud M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.
RP Abuohashish, HM (reprint author), King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia.; Abuohashish, HM (reprint author), Univ Dammam, Coll Dent, Dept Biomed Dent Sci, Dammam, Saudi Arabia.
EM hatem.abuohashish@yahoo.com
FU King Saud University [RGP-VPP-179]
FX The authors extend their appreciation to the Deanship of Scientific
   Research at King Saud University for funding the work through the
   research group project No. RGP-VPP-179.
CR Abuohashish HM, 2015, ACTA PHARMACOL SIN, V36, P209, DOI 10.1038/aps.2014.111
   Asaba Y, 2009, J BONE MINER RES, V24, P241, DOI [10.1359/jbmr.081006, 10.1359/JBMR.081006]
   Brown NM, 2010, CARCINOGENESIS, V31, P886, DOI 10.1093/carcin/bgq025
   Choi MJ, 2009, NUTR RES PRACT, V3, P108, DOI 10.4162/nrp.2009.3.2.108
   de Macedo SM, 2015, PROTEIN PEPTIDE LETT, V22, P332
   Deal C, 2009, NAT CLIN PRACT RHEUM, V5, P20, DOI 10.1038/ncprheum0977
   Diao TY, 2014, J BONE MINER METAB, V32, P261, DOI 10.1007/s00774-013-0500-7
   Donmez BO, 2012, PHARMACOL REP, V64, P878
   Ehnes DD, 2015, DIFFERENTIATION, V89, P97, DOI 10.1016/j.diff.2015.02.001
   Ferretti M, 2010, J ANAT, V217, P48, DOI 10.1111/j.1469-7580.2010.01242.x
   Gao Q, 2008, AM J PHYSIOL-ENDOC M, V294, pE817, DOI 10.1152/ajpendo.00733.2007
   Ghosh M, 2014, ENDOCRINE, V46, P397, DOI 10.1007/s12020-014-0167-4
   Gu SS, 2012, NEPHROLOGY, V17, P767, DOI 10.1111/j.1440-1797.2012.01656.x
   Gu SS, 2012, BIOSCI BIOTECH BIOCH, V76, P1367, DOI 10.1271/bbb.120123
   Hagiwara H, 1998, J ENDOCRINOL, V156, P543, DOI 10.1677/joe.0.1560543
   Hatton R, 1997, J ENDOCRINOL, V152, P5, DOI 10.1677/joe.0.1520005
   Hertrampf T, 2009, TOXICOL LETT, V184, P198, DOI 10.1016/j.toxlet.2008.11.006
   Hiruma Y, 1997, BIOCHEM BIOPH RES CO, V230, P176, DOI 10.1006/bbrc.1996.5914
   Hou MF, 2003, ANN CLIN LAB SCI, V33, P55
   Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200
   Jagtap Vanita R, 2011, Indian J Clin Biochem, V26, P70, DOI 10.1007/s12291-010-0074-2
   Kang KY, 2013, J KOREAN MED SCI, V28, P1139, DOI 10.3346/jkms.2013.28.8.1139
   Krishnan B, 2013, PROSTATE, V73, P71, DOI 10.1002/pros.22542
   Lee HB, 2008, VET MED-CZECH, V53, P214
   Liu YY, 2011, J BONE MINER METAB, V29, P149, DOI 10.1007/s00774-010-0209-9
   Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200
   Lynn H, 2006, BONE, V38, P584, DOI 10.1016/j.bone.2005.09.011
   Ma L, 2010, BONE, V47, P5, DOI 10.1016/j.bone.2010.03.016
   Nian H, 2009, PHYTOMEDICINE, V16, P320, DOI 10.1016/j.phymed.2008.12.006
   Nie WC, 2009, MOL IMMUNOL, V46, P355, DOI 10.1016/j.molimm.2008.10.022
   Andrade JMO, 2014, PEPTIDES, V55, P158, DOI 10.1016/j.peptides.2014.03.006
   Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461
   Prasad M, 2014, VASC HEALTH RISK MAN, V10, P533, DOI 10.2147/VHRM.S63580
   Rajkumar D. S., 2013, J OSTEOPOROS, V2013, DOI [10.1155/2013/325693, DOI 10.1155/2013/325693]
   Rejnmark L, 2006, J HYPERTENS, V24, P581, DOI 10.1097/01.hjh.0000203845.26690.cb
   Rodrigues-Machado MG, 2013, BRIT J PHARMACOL, V170, P835, DOI 10.1111/bph.12318
   Ross PD, 1998, J BONE MINER RES, V13, P297, DOI 10.1359/jbmr.1998.13.2.297
   Santos RAS, 2007, CURR OPIN NEPHROL HY, V16, P122, DOI 10.1097/MNH.0b013e328031f362
   Sapir-Koren R., 2011, BONEKEY, V8, P286, DOI DOI 10.1138/20110516
   Sarac F, 2007, BIOTECHNOL BIOTEC EQ, V21, P194
   Schurman SJ, 2004, PEDIATR NEPHROL, V19, P33, DOI 10.1007/s00467-003-1361-4
   Serizawa K, 2016, J ENDOCRINOL, V228, P75, DOI 10.1530/JOE-15-0332
   Shahnazari M, 2009, J NUTR, V139, P1308, DOI 10.3945/jn.108.101071
   Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954
   Santos SHS, 2013, PEPTIDES, V46, P47, DOI 10.1016/j.peptides.2013.05.010
   THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L
   Vasikaran SD, 2008, CRIT REV CL LAB SCI, V45, P221, DOI 10.1080/10408360801949442 
   Vaz-Silva J, 2012, J MOL HISTOL, V43, P597, DOI 10.1007/s10735-012-9427-x
   Wiemer G, 2002, HYPERTENSION, V40, P847, DOI 10.1161/01.HYP.0000037979.53963.8F
   Yongtao Zhang, 2014, Endocrine, V47, P598, DOI 10.1007/s12020-014-0196-z
   Zhang K, 2015, KIDNEY INT, V87, P359, DOI 10.1038/ki.2014.274
   Zhang YT, 2014, MOL MED REP, V9, P1128, DOI 10.3892/mmr.2014.1978
   Zhao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033228
NR 53
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 23
PY 2017
VL 7
AR 2293
DI 10.1038/s41598-017-02570-x
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV5ZD
UT WOS:000401847800039
PM 28536469
OA gold
DA 2017-08-17
ER

PT J
AU Matboli, M
   Eissa, S
   Ibrahim, D
   Hegazy, MGA
   Imam, SS
   Habib, EK
AF Matboli, Marwa
   Eissa, Sanaa
   Ibrahim, Doaa
   Hegazy, Marwa G. A.
   Imam, Shalabia S.
   Habib, Eman K.
TI Caffeic Acid Attenuates Diabetic Kidney Disease via Modulation of
   Autophagy in a High-Fat Diet/Streptozotocin-Induced Diabetic Rat
SO SCIENTIFIC REPORTS
LA English
DT Article
ID OXIDATIVE STRESS; PHENETHYL ESTER; NEPHROPATHY; STREPTOZOTOCIN;
   PROGRESSION; PROTECTS; CANCER; CELLS; DIET; DEGENERATION
AB The aim of this study is to evaluate the anti-diabetic nephropathy effect of Caffeic acid and to prove our hypothesis for its mechanism of action that it may occur by reactivation of autophagy pathway via suppression of autophagy regulatory miRNAs. In vivo, high-fat diet and streptozotocin-induced (HFD-STZ) diabetic rats were treated with Caffeic acid once per day for 12 weeks before and after development of diabetic nephropathy. Blood and urine biochemical parameters, autophagy transcripts and their epigenetic regulators together with renal tissue morphology were investigated. In diabetic rats, Caffeic acid intake, caused improvement in albumin excretion, blood glucose, reduced renal mesangial matrix extension with increased vacuolation and reappearance of autophagosomes. Meanwhile, it resulted in autophagy genes up-regulation [RB 1-inducible coiled coil protein (RB1CC1), Microtubule-associated proteins 1A/1B light chain 3(MAP1LC3B), Autophagy related gene (ATG-12),] with simultaneous reduction in their epigenetic regulators; miRNA-133b, - 342 and 30a, respectively. These above mentioned effects were more significant in the diabetic nephropathy Caffeic treated rats than in the prophylactic group. Based on our results we postulated that caffeic acid modulates autophagy pathway through inhibition of autophagy regulatory miRNAs, that could explain its curative properties against diabetic kidney disease.
C1 [Matboli, Marwa; Eissa, Sanaa] Ain Shams Univ, Fac Med, Med Biochem & Mol Biol Dept, POB 11381, Cairo, Egypt.
   [Ibrahim, Doaa] Ain Shams Univ, Fac Med, Pharmacol Dept, POB 11381, Cairo, Egypt.
   [Hegazy, Marwa G. A.] Ain Shams Univ, Fac Sci, Biochem Dept, POB 11381, Cairo, Egypt.
   [Imam, Shalabia S.] Natl Desert Res Ctr, Phytochem Dept, Cairo, Egypt.
   [Habib, Eman K.] Ain Shams Univ, Fac Sci, Anat & Embryol Dept, POB 11381, Cairo, Egypt.
RP Matboli, M; Eissa, S (reprint author), Ain Shams Univ, Fac Med, Med Biochem & Mol Biol Dept, POB 11381, Cairo, Egypt.
EM habiba20062001@yahoo.com; Dr_sanaa_eissa@yahoo.com
FU Egyptian Science and Technology Development Fund [RSTDG 12597]
FX This work was supported by the Egyptian Science and Technology
   Development Fund, RSTDG 12597.
CR Ahmed ABA, 2010, PHYTOMEDICINE, V17, P1033, DOI 10.1016/j.phymed.2010.03.019
   Boominathan, VITAMIN BASED THERAP
   Chang CC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-47
   Dhungyal B., 2014, SMU MED J, V1, P2
   Eissa S, 2016, BIOMED PHARMACOTHER, V83, P92, DOI 10.1016/j.biopha.2016.06.018
   Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546
   Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003
   Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Graham ML, 2011, COMPARATIVE MED, V61, P356
   Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492
   Huang DW, 2012, J FUNCT FOODS, V4, P358, DOI 10.1016/j.jff.2012.01.005
   Huang Y, 2010, J PRACTICAL MED, V26, P2299
   Jayanthi R, 2010, Indian J Clin Biochem, V25, P371, DOI 10.1007/s12291-010-0052-8
   Jegga AG, 2011, AUTOPHAGY, V7, P477, DOI 10.4161/auto.7.5.14811
   Khan S, 2016, GENES DIS, V3, P211, DOI 10.1016/j.gendis.2016.04.003
   Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705
   Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386
   Kume S, 2012, DIABETES, V61, P23, DOI 10.2337/db11-0555
   Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629
   Liu B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.422
   Liu XX, 2014, DIABETES METAB, V40, P363, DOI 10.1016/j.diabet.2014.05.004
   Liu Z, 2013, J ETHNOPHARMACOL, V145, P233, DOI 10.1016/j.jep.2012.10.058
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mamal E., 2012, J CYTOL HISTOL, V3, P155
   Nasri Hamid, 2013, J Renal Inj Prev, V2, P31, DOI 10.12861/jrip.2013.11
   Oktem F, 2005, MOL CELL BIOCHEM, V277, P109, DOI 10.1007/s11010-005-5426-5
   Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214
   Robertson KA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002364
   Satirapoj B, 2013, ADV EXP MED BIOL, V771, P107
   Taniguchi K, 2016, ONCOTARGET, V7, P18940, DOI 10.18632/oncotarget.8005
   Tikoo K, 2007, FEBS LETT, V581, P1071, DOI 10.1016/j.febslet.2007.02.006
   Vijayakurup V, 2014, MOL BIOL REP, V41, P85, DOI 10.1007/s11033-013-2840-8
   Wang ZQ, 2011, J NUTR BIOCHEM, V22, P71, DOI 10.1016/j.jnutbio.2009.11.015
   Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006
   Weng, 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2012/984780, DOI 10.1155/2012/984780]
   Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080
   Yao JY, 2015, AUTOPHAGY, V11, P939, DOI 10.1080/15548627.2015.1041699
   Yu SH, 2011, PLANTA MED, V77, P907, DOI 10.1055/s-0030-1250682
   Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65
   Yu Y, 2012, AUTOPHAGY, V8, P853, DOI 10.4161/auto.20053
   Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045
   Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279
   Zhou Yun-Feng, 2012, Sheng Li Ke Xue Jin Zhan, V43, P351
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
NR 45
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 23
PY 2017
VL 7
AR 2263
DI 10.1038/s41598-017-02320-z
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV5ZD
UT WOS:000401847800009
PM 28536471
OA gold
DA 2017-08-17
ER

PT J
AU Sayed, S
   Schimmer, C
   Shade, I
   Leyh, R
   Aleksic, I
AF Sayed, Sameh
   Schimmer, Christoph
   Shade, Ina
   Leyh, Rainer
   Aleksic, Ivan
TI Combined pulmonary and left ventricular support with veno-pulmonary ECMO
   and impella 5.0 for cardiogenic shock after coronary surgery
SO JOURNAL OF CARDIOTHORACIC SURGERY
LA English
DT Article
DE Cardiogenic shock; Extra corporeal membrane oxygenator; Impella 5.0
ID INTRAAORTIC BALLOON PUMP
AB Background: Mechanical circulatory support is a common practice nowadays in the management of patients after cardiogenic shock due to myocardial infarction. The single or combined use of one or more devices for mechanical support depends not only on the advantage or disadvantage of these devices but also on the timing of use of these devices before the development of multi organ failure. In our case we used more than one tool for mechanical circulatory support during the prolonged and complicated course of our patient with postcardiotomy cardiogenic shock after coronary artery bypass surgery.
   Case Presentation: We describe the combined use of Impella 5.0 and veno- pulmonary extra corporeal membrane oxygenation (VP-ECMO) for biventricular failure in a 52 years-old man. He presented with cardiogenic shock after inferior wall ST-elevation myocardial infarction. After emergency coronary artery bypass surgery and failure to wean from extracorporeal circulation we employed V-P ECMO and consecutively Impella 5.0 to manage the primarily failing right and secondarily failing left ventricles.
   He remained hemodynamically stable on both Impella 5.0 and VP- ECMO until Heart Mate II left ventricular assist device implantation on the 14th postoperative day. Right sided support was weaned on 66th postoperative day. The patient remained in the intensive care unit for 77 days. During his prolonged stay, he underwent renal replacement therapy and tracheostomy with complete recovery. Six months later, he was successfully heart transplanted and has completed three and half years of unremarkable follow up.
   Conclusions: The combined use of V-P ECMO and Impella 5.0 is effective in the management of postcardiotomy biventricular failure as a bridge for further mechanical support or heart transplantation.
C1 [Sayed, Sameh; Schimmer, Christoph; Shade, Ina; Leyh, Rainer; Aleksic, Ivan] Univ Wurzburg, Zentrum Operat Med, Dept Cardiothorac Surg, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany.
   [Sayed, Sameh] Assiut Univ, Dept Cardiothorac Surg, Assiut, Egypt.
RP Sayed, S (reprint author), Univ Wurzburg, Zentrum Operat Med, Dept Cardiothorac Surg, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany.; Sayed, S (reprint author), Assiut Univ, Dept Cardiothorac Surg, Assiut, Egypt.
EM samsayed06@gmail.com
CR Babev A, 2005, JAMA-J AM MED ASSOC, V294, P448
   Beurtheret S, 2012, ASAIO J, V58, P291, DOI 10.1097/MAT.0b013e31824c38ef
   Garatti A, 2005, J HEART LUNG TRANSPL, V24, P481, DOI 10.1016/j.healun.2004.02.002
   Kawashima D, 2011, ASAIO J, V57, P169, DOI 10.1097/MAT.0b013e31820e121c
   O'Neill WW, 2012, CIRCULATION, V126, P1717, DOI 10.1161/CIRCULATIONAHA.112.098194
   Ramnarine IR, 2005, EUR J CARDIO-THORAC, V27, P887, DOI 10.1016/j.ejcts.2005.02.001
   Sylvin EA, 2010, J CARDIAC SURG, V25, P442, DOI 10.1111/j.1540-8191.2010.01045.x
   Westaby S, 2012, NAT REV CARDIOL, V9, P195, DOI 10.1038/nrcardio.2011.205
NR 8
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1749-8090
J9 J CARDIOTHORAC SURG
JI J. Cardiothorac. Surg.
PD MAY 22
PY 2017
VL 12
AR 38
DI 10.1186/s13019-017-0594-4
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EV8EH
UT WOS:000402012800001
PM 28532425
OA gold
DA 2017-08-17
ER

PT J
AU El-Ansary, A
   Al-Salem, HS
   Asma, A
   Al-Dbass, A
AF El-Ansary, Afaf
   Al-Salem, Huda S.
   Asma, Alqahtani
   Al-Dbass, Abeer
TI Glutamate excitotoxicity induced by orally administered propionic acid,
   a short chain fatty acid can be ameliorated by bee pollen
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
DE Propionic acid; Bee pollen; Glutamate excitotoxicity; Glutamine; GABA
ID AUTISM SPECTRUM DISORDERS; INDUCED NEUROTOXICITY; TRANSPORTERS; BRAIN;
   RATS; NEUROTRANSMITTERS; PATHOPHYSIOLOGY; VITAMIN-B12; PERSPECTIVE;
   METABOLISM
AB Background: Rodent models may guide investigations towards identifying either environmental neuro-toxicants or drugs with neuro-therapeutic effects. This work aims to study the therapeutic effects of bee pollen on brain glutamate excitotoxicity and the impaired glutamine-glutamate-gamma amino butyric acid (GABA) circuit induced by propionic acid (PPA), a short chain fatty acid, in rat pups.
   Methods: Twenty-four young male Western Albino rats 3-4 weeks of age, and 45-60 g body weight were enrolled in the present study. They were grouped into four equal groups: Group 1, the control received phosphate buffered saline at the same time of PPA adminstration; Group 2, received 750 mg/kg body weight divided into 3 equal daily doses and served as acute neurotoxic dose of PPA; Group 3, received 750 mg/kg body weight divided in 10 equal doses of 75 mg/kg body weight/day, and served as the sub-acute group; and Group 4, the therapeutic group, was treated with bee pollen (50 mg/kg body weight) for 30 days after acute PPA intoxication. GABA, glutamate and glutamine were measured in the brain homogenates of the four groups.
   Results: The results showed that PPA caused multiple signs of excitotoxicity, as measured by the elevation of glutamate and the glutamate/glutamine ratio and the decrease of GABA, glutamine and the GABA/glutamate ratio. Bee pollen was effective in counteracting the neurotoxic effects of PPA to a certain extent.
   Conclusion: In conclusion, bee pollen demonstrates ameliorating effects on glutamate excitotoxicity and the impaired glutamine-glutamate-GABA circuit as two etiological mechanisms in PPA-induced neurotoxicity.
C1 [El-Ansary, Afaf; Asma, Alqahtani] King Saud Univ, Cent Lab, Female Ctr Med Studies, Riyadh, Saudi Arabia.
   [El-Ansary, Afaf; Asma, Alqahtani] King Saud Univ, Sci Sect, Riyadh, Saudi Arabia.
   [Al-Salem, Huda S.] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh, Saudi Arabia.
   [El-Ansary, Afaf] Autism Res & Treatment Ctr, Riyadh, Saudi Arabia.
   [El-Ansary, Afaf] King Saud Univ, Shaik AL Amodi Autism Res Chair, Riyadh, Saudi Arabia.
   [Al-Dbass, Abeer] King Saud Univ, Dept Biochem, Sci Coll, Riyadh, Saudi Arabia.
   [El-Ansary, Afaf] Natl Res Ctr, Med Chem Dept, Cairo, Egypt.
RP El-Ansary, A (reprint author), King Saud Univ, Cent Lab, Female Ctr Med Studies, Riyadh, Saudi Arabia.; El-Ansary, A (reprint author), King Saud Univ, Sci Sect, Riyadh, Saudi Arabia.; El-Ansary, A (reprint author), Autism Res & Treatment Ctr, Riyadh, Saudi Arabia.
EM afafkelansary@gmail.com
FU research center, Center for Female Scientific and Medical Colleges at
   King Saud University, Saudi Arabia
FX This work was funded by the research center, Center for Female
   Scientific and Medical Colleges at King Saud University, Saudi Arabia.
CR Abu Shmais GA, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-4
   Al-Farsi YM, 2013, NUTRITION, V29, P537, DOI 10.1016/j.nut.2012.09.014
   Al-Ghamdi M, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-34
   Al-Salem HS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1099-8
   Almeida-Muradian LB, 2005, J FOOD COMPOS ANAL, V18, P105, DOI 10.1016/j.jfca.2003.10.008
   Di Marco B, 2016, CNS NEUROL DISORD-DR, V15, P448, DOI 10.2174/1871527315666160321105039
   Du L, 2017, PSYCHIAT RES, V253, P28, DOI 10.1016/j.psychres.2017.03.003
   El-Ansary Afaf, 2016, Data Brief, V7, P111, DOI 10.1016/j.dib.2016.02.025
   El-Ansary A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0189-0
   El-Ansary A, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-32
   El-Ansary AK, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-74
   Eraslan G, 2009, ECOTOX ENVIRON SAFE, P931
   Flores-Mendez M, 2016, NEUROCHEM INT, V98, P46, DOI 10.1016/j.neuint.2016.04.004
   Fluegge K, 2017, INT J DEV NEUROSCI, V57, P21, DOI 10.1016/j.ijdevneu.2016.12.007
   Franco JL, 2010, ENVIRON TOXICOL PHAR, V30, P272, DOI 10.1016/j.etap.2010.07.003
   Gaetz W, 2014, NEUROIMAGE, V86, P1, DOI 10.1016/j.neuroimage.2013.05.068
   Ghanizadeh A, 2011, NEUROCHEM RES, V36, P922, DOI 10.1007/s11064-010-0381-2
   Gumpricht E, 2014, NUTRITION, V30, P733, DOI 10.1016/j.nut.2013.11.001
   Han SM, 2007, J ETHNOPHARMACOL, V111, P176, DOI 10.1016/j.jep.2006.11.008
   Kedzia B., 2012, POSTEPY FITOTERAPII, V1, P48
   Khalil SR, 2015, NEUROTOXICOLOGY, V49, P121, DOI 10.1016/j.neuro.2015.05.011
   Kim SR, 2002, FREE RADICAL BIO MED, V32, P596, DOI 10.1016/S0891-5849(02)00751-7
   Komosinska-Vassev K, 2015, COMPLEMENT ALTEMAT M
   LEVY DI, 1990, NEUROSCI LETT, V110, P291, DOI 10.1016/0304-3940(90)90862-4
   MacFabe DF, 2007, BEHAV BRAIN RES, V176, P149, DOI 10.1016/j.bbr.2006.07.025
   Franklin A.E., 2008, AM J BIOCH BIOTECHNO, V4, P146, DOI DOI 10.3844/AJBBSP.2008.146.166
   Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918
   Nicholls DG, 1999, BIOCHEM SOC SYMP, V66, P55
   Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3
   Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5
   Rosa SG, 2016, PHYSIOL BEHAV, V155, P1, DOI 10.1016/j.physbeh.2015.11.038
   Rueda CB, 2016, BBA-BIOENERGETICS, V1857, P1158, DOI 10.1016/j.bbabio.2016.04.003
   Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272
   Tanaka Kohichi, 2009, Japanese Journal of Neuropsychopharmacology, V29, P161
   Tapiero H, 2002, WORLD J GASTROENTERO, V56, P446
   Thomas RH, 2010, J NEUROCHEM, V113, P515, DOI 10.1111/j.1471-4159.2010.06614.x
   Tu WJ, 2012, J CLIN BIOCHEM NUTR, V51, P248, DOI 10.3164/jcbn.12-45
   Wei JJ, 2015, J ETHNOPHARMACOL, V166, P333, DOI 10.1016/j.jep.2015.03.038
   Xue XF, 2012, FOOD CHEM, V133, P573, DOI 10.1016/j.foodchem.2011.12.085
   Yang YF, 2016, J FUNCT FOODS, V27, P140, DOI 10.1016/j.jff.2016.08.056
   Zeidan-Chulia F, 2014, NEUROSCI BIOBEHAV R, V38, P160, DOI 10.1016/j.neubiorev.2013.11.008
NR 41
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1476-511X
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD MAY 22
PY 2017
VL 16
AR 96
DI 10.1186/s12944-017-0485-7
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA EV3YC
UT WOS:000401694000001
PM 28532421
OA gold
DA 2017-08-17
ER

PT J
AU Eissa, HF
   Hassanien, SE
   Ramadan, AM
   El-Shamy, MM
   Saleh, OM
   Shokry, AM
   Abdelsattar, M
   Morsy, YB
   El-Maghraby, MA
   Alameldin, HF
   Hassan, SM
   Osman, GH
   Mahfouz, HT
   El-Karim, GAG
   Madkour, MA
   Bahieldin, A
AF Eissa, Hala F.
   Hassanien, Sameh E.
   Ramadan, Ahmed M.
   El-Shamy, Moustafa M.
   Saleh, Osama M.
   Shokry, Ahmed M.
   Abdelsattar, Mohamed
   Morsy, Yasser B.
   El-Maghraby, Maher A.
   Alameldin, Hussien F.
   Hassan, Sabah M.
   Osman, Gamal H.
   Mahfouz, Hesham T.
   El-Karim, Gharib A. Gad
   Madkour, Magdy A.
   Bahieldin, Ahmed
TI Developing transgenic wheat to encounter rusts and powdery mildew by
   overexpressing barley chi26 gene for fungal resistance
SO PLANT METHODS
LA English
DT Article
DE Transgenesis; Southern; qPCR; Chitinase activity; qRT-PCR; Substantial
   equivalence
ID PATHOGENESIS-RELATED PROTEINS; RICE CHITINASE GENE; CLASS-II CHITINASE;
   ENHANCED RESISTANCE; CONSTITUTIVE EXPRESSION; BETA-1,3-GLUCANASE GENES;
   FUSARIUM-GRAMINEARUM; ENDOCHITINASE GENE; BREAD WHEAT; PLANTS
AB Background: The main aim of this study was to improve fungal resistance in bread wheat via transgenesis. Transgenic wheat plants harboring barley chitinase (chi26) gene, driven by maize ubi promoter, were obtained using biolistic bombardment, whereas the herbicide resistance gene, bar, driven by the CaMV 35S promoter was used as a selectable marker.
   Results: Molecular analysis confirmed the integration, copy number, and the level of expression of the chi26 gene in four independent transgenic events. Chitinase enzyme activity was detected using a standard enzymatic assay. The expression levels of chi26 gene in the different transgenic lines, compared to their respective controls, were determined using qRT-PCR. The transgene was silenced in some transgenic families across generations. Gene silencing in the present study seemed to be random and irreversible. The homozygous transgenic plants of T4, T5, T6, T8, and T9 generations were tested in the field for five growing seasons to evaluate their resistance against rusts and powdery mildew. The results indicated high chitinase activity at T0 and high transgene expression levels in few transgenic families. This resulted in high resistance against wheat rusts and powdery mildew under field conditions. It was indicated by proximate and chemical analyses that one of the transgenic families and the non-transgenic line were substantially equivalent.
   Conclusion: Transgenic wheat with barley chi26 was found to be resistant even after five generations under artificial fungal infection conditions. One transgenic line was proved to be substantially equivalent as compared to the nontransgenic control.
C1 [Eissa, Hala F.; Hassanien, Sameh E.; Ramadan, Ahmed M.; Shokry, Ahmed M.; Abdelsattar, Mohamed; Morsy, Yasser B.; Alameldin, Hussien F.; Osman, Gamal H.; El-Karim, Gharib A. Gad] Agr Res Ctr, Agr Genet Engn Res Inst, Giza 12619, Egypt.
   [Eissa, Hala F.] MUST, Fac Biotechnol, Post Box 77, 6th October City, Egypt.
   [Ramadan, Ahmed M.; Hassan, Sabah M.; Bahieldin, Ahmed] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, POB 80141, Jeddah 21589, Saudi Arabia.
   [El-Shamy, Moustafa M.] Agr Res Ctr, Plant Pathol Res Inst, Giza 12619, Egypt.
   [Saleh, Osama M.] Natl Ctr Radiat Res & Technol, Cairo 11781, Egypt.
   [Saleh, Osama M.] Taif Univ, Fac Appl Med Sci, Dept Biotechnol, Turrabah 21995, Saudi Arabia.
   [El-Maghraby, Maher A.] Agr Res Ctr, Field Crops Res Inst, Giza 12619, Egypt.
   [Alameldin, Hussien F.] Michigan State Univ, Plant Soil & Microbial Sci Dept, E Lansing, MI 48824 USA.
   [Hassan, Sabah M.; Bahieldin, Ahmed] Ain Shams Univ, Dept Genet, Fac Agr, Cairo 11566, Egypt.
   [Osman, Gamal H.] Umm Al Qura Univ, Fac Sci Appl, Dept Biol, Mecca 21955, Saudi Arabia.
   [Mahfouz, Hesham T.] Agr Res Ctr, Dept Pomol, Inst Hort Res, Giza 12619, Egypt.
   [Madkour, Magdy A.] Ain Shams Univ, Arid Lands Agr Res Inst, Fac Agr, POB 68, Cairo 11241, Egypt.
RP Eissa, HF; Osman, GH (reprint author), Agr Res Ctr, Agr Genet Engn Res Inst, Giza 12619, Egypt.; Bahieldin, A (reprint author), King Abdulaziz Univ, Dept Biol Sci, Fac Sci, POB 80141, Jeddah 21589, Saudi Arabia.; Osman, GH (reprint author), Umm Al Qura Univ, Fac Sci Appl, Dept Biol, Mecca 21955, Saudi Arabia.
EM halaeissa@yahoo.com; gamalhosman@yahoo.com; bahieldin55@gmail.com
RI Ramadan, Ahmed/I-8241-2012
OI Ramadan, Ahmed/0000-0002-2502-9921
FU Science and Technology Development Fund (STDF), Ministry for Scientific
   Research, Egypt [265]
FX This project was funded by the Science and Technology Development Fund
   (STDF), Ministry for Scientific Research, Egypt, under Grant No. (265).
CR Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0
   Anand A, 2003, PLANT BIOTECHNOL J, V1, P241, DOI 10.1046/j.1467-7652.2003.00023.x
   Anand A, 2003, J EXP BOT, V54, P1101, DOI 10.1093/jxb/erg110
   Avila-Adame C, 2003, PLANT DIS, V87, P1426, DOI 10.1094/PDIS.2003.87.12.1426
   Ayliffe M, 2014, METHODS MOL BIOL, V1127, P159, DOI 10.1007/978-1-62703-986-4_13
   Belderok B, 2000, PLANT FOOD HUM NUTR, V55, P1, DOI 10.1023/A:1008199314267
   Bezirganoglu I, 2013, PLANT CELL TISS ORG, V112, P227, DOI 10.1007/s11240-012-0227-5
   Bliffeld M, 1999, THEOR APPL GENET, V98, P1079, DOI 10.1007/s001220051170
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Chen WP, 1998, THEOR APPL GENET, V97, P1296, DOI 10.1007/s001220051022
   Chhikara S, 2012, PLANT CELL TISS ORG, V108, P83, DOI 10.1007/s11240-011-0015-7
   Choi DS, 2012, PLANT CELL, V24, P1675, DOI 10.1105/tpc.112.095869
   Colditz F, 2007, PLANTA, V226, P57, DOI 10.1007/s00425-006-0466-y
   Datta K, 2001, PLANT SCI, V160, P405, DOI 10.1016/S0168-9452(00)00413-1
   Demeke T, 1999, THEOR APPL GENET, V99, P947, DOI 10.1007/s001220051401
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   Emani C, 2003, PLANT BIOTECHNOL J, V1, P321, DOI 10.1046/j.1467-7652.2003.00029.x
   Girhepuje PV, 2011, PLANT CELL TISS ORG, V105, P243, DOI 10.1007/s11240-010-9859-5
   Hassanein SE, 2009, EGYPT J GENET CYTOL, V38, P207
   Howarth JR, 2005, ANN APPL BIOL, V146, P311, DOI 10.1111/j.1744-7348.2005.040121.x
   HSU SC, 1975, APPL MICROBIOL, V29, P422
   Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083
   Ignacimuthu S, 2012, J BIOSCIENCES, V37, P135, DOI 10.1007/s12038-011-9178-y
   Iqbal MM, 2012, MOL BIOTECHNOL, V50, P129, DOI 10.1007/s12033-011-9426-2
   Jackson SA, 2001, THEOR APPL GENET, V103, P56, DOI 10.1007/s001220100608
   Kaur Jagdeep, 2011, Fungal Biology Reviews, V25, P128, DOI 10.1016/j.fbr.2011.07.004
   Kohli A, 1998, P NATL ACAD SCI USA, V95, P7203, DOI 10.1073/pnas.95.12.7203
   Kovacs G, 2013, TRANSGENIC RES, V22, P117, DOI 10.1007/s11248-012-9631-1
   LEAH R, 1991, J BIOL CHEM, V266, P1564
   LEATH S, 1990, PLANT DIS, V74, P747, DOI 10.1094/PD-74-0747
   LINTHORST HJM, 1991, CRIT REV PLANT SCI, V10, P123, DOI 10.1080/07352689109382309
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936
   Melander M, 2006, PLANT CELL REP, V25, P942, DOI 10.1007/s00299-006-0153-2
   Meyer P, 1996, ANNU REV PLANT PHYS, V47, P23, DOI 10.1146/annurev.arplant.47.1.23
   Muthukrishnan S, 2001, PLANT CELL TISS ORG, V64, P93, DOI 10.1023/A:1010763506802
   Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248
   Nookaraju A, 2012, PLANT CELL TISS ORG, V111, P15, DOI 10.1007/s11240-012-0166-1
   Oerke EC, 1997, EUR J PLANT PATHOL, V103, P203, DOI 10.1023/A:1008602111248
   Oldach KH, 2001, MOL PLANT MICROBE IN, V14, P832, DOI 10.1094/MPMI.2001.14.7.832
   PETERSON RF, 1948, CAN J RES C, V26, P496
   Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177
   Rasper VF, 2000, HDB CEREAL SCI TECHN, P505
   REISSIG JL, 1955, J BIOL CHEM, V217, P959
   Roelfs AP., 1978, PUBL US AGR RES SERV, V1363, P1
   Rooke L, 2003, EUPHYTICA, V129, P301, DOI 10.1023/A:1022296017801
   Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093
   Saito S, 2011, J PLANT BIOCHEM BIOT, V20, P47, DOI 10.1007/s13562-010-0025-2
   Salomon S, 1998, EMBO J, V17, P6086, DOI 10.1093/emboj/17.20.6086
   Sambrook J., 1989, MOL CLONING LAB MANU
   SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0
   Shin SY, 2008, J EXP BOT, V59, P2371, DOI 10.1093/jxb/ern103
   Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2
   Takahashi W, 2005, PLANT CELL REP, V23, P811, DOI 10.1007/s00299-004-0900-1
   Tang JH, 2004, CROP SCI, V44, P732
   TERVET IW, 1951, PHYTOPATHOLOGY, V41, P282
   Todorovska E, 2009, BIOTECHNOL BIOTEC EQ, V23, P1417, DOI 10.2478/V10133-009-0006-6
   Venneria E, 2008, J AGR FOOD CHEM, V56, P9206, DOI 10.1021/jf8010992
NR 58
TC 0
Z9 0
U1 2
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-4811
J9 PLANT METHODS
JI Plant Methods
PD MAY 22
PY 2017
VL 13
AR 41
DI 10.1186/s13007-017-0191-5
PG 13
WC Biochemical Research Methods; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA EV3YU
UT WOS:000401695800001
PM 28539970
OA gold
DA 2017-08-17
ER

PT J
AU Abdel-Rahman, WM
   Al-Khayyal, NA
   Nair, VA
   Aravind, SR
   Saber-Ayad, M
AF Abdel-Rahman, Wael M.
   Al-Khayyal, Noura A.
   Nair, Vidhya A.
   Aravind, S. R.
   Saber-Ayad, Maha
TI Role of AXL in invasion and drug resistance of colon and breast cancer
   cells and its association with p53 alterations
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE AXL; Breast cancer; Chemotherapy; Colon cancer; Invasion
ID RECEPTOR TYROSINE KINASES; HUMAN COLORECTAL-CANCER; ANTITUMOR-ACTIVITY;
   SOLID CANCER; EXPRESSION; CARCINOMA; METASTASIS; ACTIVATION; INHIBITION;
   PREDICTS
AB AIM
   To characterize AXL receptor tyrosine kinase (AXL) expression in relationship to tumor protein P53 (TP53 gene, p53 protein) and its role in tumor invasion and response to therapy.
   METHODS
   We used 14 cell lines, including 3 isogenic pairs carrying mutant/knockout p53, to gain insight into the relationship between AXL and TP53. These included HCT116, HCT116. p53 mutant, RKO, and RKO. p53(-/-) lines (all from colon cancers) as well as breast cancer cell lines MCF7 and 1001 (MCF7-p53 mutant clone). HeLa cell line was used as a positive control for epithelial to mesenchymal transition (EMT). AXL expression was determined by Western blotting using rabbit monoclonal antibody clone C89E7. AXL siRNA silencing was performed and followed by collagen invasion assay. Cell viability analysis using the sulforhodamine B assay and the invasion assay were performed after exposure to chemotherapeutic agents (doxorubicin for breast cancer cells; 5FU or irinotecan for colon cancer cells).
   RESULTS
   We showed that the introduction of p53 mutations or knockout increased expression levels of AXL in isogenic cells compared to the matching p53 wild-type parental cells. Overall, we found a trend for correlation between the potential EMT candidate AXL, p53 alterations, and EMT markers in colorectal and breast cancers. The expression of AXL in RKO cells, a rare colon cancer cell line with inactive Wnt signaling, suggests that the AXL oncogene might provide an alternative genetic pathway for colorectal carcinogenesis in the absence of Wnt signaling activation and TP53 mutation. AXL silencing in the TP53 mutant isogenic cell lines 1001, HCT116. p53 mutant and RKO. P53(-/-) was > 95% efficient and the silenced cells were less invasive compared to the parental TP53 wild-type cells. AXL silencing showed a subtle trend to restore colon cancer cell sensitivity to 5FU or irinotecan. Importantly, AXL expressing cells developed more invasive potential after exposure to chemotherapy compared to the AXL-silenced cells.
   CONCLUSION
   AXL is influenced by p53 status and could cause the emergence of aggressive clones after exposure to chemotherapy. These findings could have applications in cancer management.
C1 [Abdel-Rahman, Wael M.] Univ Sharjah, Coll Hlth Sci, Dept Med Lab Sci, Sharjah 27272, U Arab Emirates.
   [Abdel-Rahman, Wael M.; Al-Khayyal, Noura A.; Saber-Ayad, Maha] Univ Sharjah, Sharjah Inst Med Res, Univ City Rd, Sharjah 27272, U Arab Emirates.
   [Al-Khayyal, Noura A.] Univ Sharjah, Coll Med, Sharjah 27272, U Arab Emirates.
   [Nair, Vidhya A.; Aravind, S. R.] Univ Sharjah, Sharjah Inst Med Res, Environm & Canc Res Grp, Sharjah 27272, U Arab Emirates.
   [Saber-Ayad, Maha] Univ Sharjah, Coll Med, Dept Basic Med Sci, Sharjah, U Arab Emirates.
   [Saber-Ayad, Maha] Cairo Univ, Cairo 11523, Egypt.
RP Abdel-Rahman, WM (reprint author), Univ Sharjah, Sharjah Inst Med Res, Univ City Rd, Sharjah 27272, U Arab Emirates.; Abdel-Rahman, WM (reprint author), Univ Sharjah, Coll Hlth Sci, Univ City Rd, Sharjah 27272, U Arab Emirates.
EM whassan@sharjah.ac.ae
FU Terry Fox Foundation for Cancer Research
FX Supported by Terry Fox Foundation for Cancer Research.
CR Abdel-Rahman WM, 2016, GASTROENT RES PRACT, DOI 10.1155/2016/6089658
   Abdel-Rahman WM, 2005, ONCOGENE, V24, P1542, DOI 10.1038/sj.onc.1208387
   Boysen J, 2014, LEUKEMIA, V28, P451, DOI 10.1038/leu.2013.298
   Brand TM, 2015, CLIN CANCER RES, V21, P2601, DOI 10.1158/1078-0432.CCR-14-2648
   Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871
   Diarra-Mehrpour M, 2004, CANCER RES, V64, P719, DOI 10.1158/0008-5472.CAN-03-1735
   Dunne PD, 2014, CLIN CANCER RES, V20, P164, DOI 10.1158/1078-0432.CCR-13-1354
   El Bezawy R, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0387-6
   El-Awady RA, 2011, TOXICOL APPL PHARM, V255, P271, DOI 10.1016/j.taap.2011.06.019
   Ferlay J. S. I., 2013, GLOBOCAN 2012 V1 0 C
   Fritz HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135991
   GIOANNI J, 1990, BRIT J CANCER, V62, P8, DOI 10.1038/bjc.1990.219
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Hattori S, 2016, ANN SURG ONCOL, V23, P663, DOI 10.1245/s10434-015-4848-x
   Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027
   Kasikara C, 2017, MOL CANC RES, DOI 10.1158/1541-7786.MCR-16-0350
   Kirane A, 2015, CANCER RES, V75, P3699, DOI 10.1158/0008-5472.CAN-14-2887-T
   Kralj M, 2003, CANCER GENE THER, V10, P457, DOI 10.1038/sj.cgt.7700588
   Lee HJ, 2014, CARCINOGENESIS, V35, P769, DOI 10.1093/carcin/bgt372
   Li R, 2015, TUMOR BIOL, V36, P7277, DOI 10.1007/s13277-015-3445-8
   Li XX, 2014, INT J CLIN EXP PATHO, V7, P2729
   Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X
   LIU E, 1988, P NATL ACAD SCI USA, V85, P1952, DOI 10.1073/pnas.85.6.1952
   Martinelli E, 2015, ONCOTARGET, V6, P23281, DOI 10.18632/oncotarget.3962
   Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13
   Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326
   Nieminen TT, 2012, CANCER EPIDEM BIOMAR, V21, P202, DOI 10.1158/1055-9965.EPI-11-0662
   Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976
   Tsou SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116747
   Vaughan Catherine A, 2012, Genes Cancer, V3, P491, DOI 10.1177/1947601912462719
   Veruttipong D, 2012, WORLD J GASTROENTERO, V18, P3997, DOI 10.3748/wjg.v18.i30.3997
   Wang C, 2016, THERANOSTICS, V6, P1205, DOI 10.7150/thno.15083
   Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972
   Wang Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.186
   Wu XL, 2014, ONCOTARGET, V5, P9546
   Yuli C, 2007, ONCOGENE, V26, P6031, DOI 10.1038/sj.onc.1210420
   Zhang SD, 2016, ONCOL LETT, V11, P1223, DOI 10.3892/ol.2015.3999
NR 37
TC 0
Z9 0
U1 3
U2 3
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD MAY 21
PY 2017
VL 23
IS 19
BP 3440
EP 3448
DI 10.3748/wjg.v23.i19.3440
PG 9
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA EV6QY
UT WOS:000401897100007
PM 28596680
OA No
DA 2017-08-17
ER

PT J
AU Shalaby, M
   Broderick, AE
   Chang, P
   Pfrommer, C
   Lamberts, A
   Puchwein, E
AF Shalaby, Mohamad
   Broderick, Avery E.
   Chang, Philip
   Pfrommer, Christoph
   Lamberts, Astrid
   Puchwein, Ewald
TI SHARP: A Spatially Higher-order, Relativistic Particle-in-cell Code
SO ASTROPHYSICAL JOURNAL
LA English
DT Article
DE instabilities; methods: numerical; plasmas; relativistic processes
ID CHARGE CONSERVATION; COLLISIONLESS SHOCKS; PLASMA SIMULATION; ENERGY;
   ACCELERATION; INSTABILITIES; EQUATIONS; SCHEME; FIELD; MESH
AB Numerical heating in particle-in-cell (PIC) codes currently precludes the accurate simulation of cold, relativistic plasma over long periods, severely limiting their applications in astrophysical environments. We present a spatially higher-order accurate relativistic PIC algorithm in one spatial dimension, which conserves charge and momentum exactly. We utilize the smoothness implied by the usage of higher-order interpolation functions to achieve a spatially higher-order accurate algorithm (up to the fifth order). We validate our algorithm against several test problems-thermal stability of stationary plasma, stability of linear plasma waves, and two-stream instability in the relativistic and non-relativistic regimes. Comparing our simulations to exact solutions of the dispersion relations, we demonstrate that SHARP can quantitatively reproduce important kinetic features of the linear regime. Our simulations have a superior ability to control energy non-conservation and avoid numerical heating in comparison to common second-order schemes. We provide a natural definition for convergence of a general PIC algorithm: the complement of physical modes captured by the simulation, i.e., those that lie above the Poisson noise, must grow commensurately with the resolution. This implies that it is necessary to simultaneously increase the number of particles per cell and decrease the cell size. We demonstrate that traditional ways for testing for convergence fail, leading to plateauing of the energy error. This new PIC code enables us to faithfully study the long-term evolution of plasma problems that require absolute control of the energy and momentum conservation.
C1 [Shalaby, Mohamad; Broderick, Avery E.] Univ Waterloo, Dept Phys & Astron, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
   [Shalaby, Mohamad; Broderick, Avery E.] Perimeter Inst Theoret Phys, 31 Caroline St North, Waterloo, ON N2L 2Y5, Canada.
   [Shalaby, Mohamad] Cairo Univ, Fac Sci, Dept Phys, Giza 12613, Egypt.
   [Chang, Philip] Univ Wisconsin Milwaukee, Dept Phys, 1900 E Kenwood Blvd, Milwaukee, WI 53211 USA.
   [Pfrommer, Christoph] Leibniz Inst Astrophys Potsdam AIP, Sternwarte 16, D-14482 Potsdam, Germany.
   [Pfrommer, Christoph] Heidelberg Inst Theoret Studies, Schloss Wolfsbrunnenweg 35, D-69118 Heidelberg, Germany.
   [Lamberts, Astrid] CALTECH, Theoret Astrophys, Pasadena, CA 91125 USA.
   [Puchwein, Ewald] Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.
   [Puchwein, Ewald] Univ Cambridge, Kavli Inst Cosmol, Madingley Rd, Cambridge CB3 0HA, England.
RP Shalaby, M (reprint author), Univ Waterloo, Dept Phys & Astron, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.; Shalaby, M (reprint author), Perimeter Inst Theoret Phys, 31 Caroline St North, Waterloo, ON N2L 2Y5, Canada.; Shalaby, M (reprint author), Cairo Univ, Fac Sci, Dept Phys, Giza 12613, Egypt.
EM mshalaby@live.ca
FU Perimeter Institute for Theoretical Physics; Natural Sciences and
   Engineering Research Council of Canada; Government of Canada through
   Industry Canada; Province of Ontario through the Ministry of Research
   and Innovation; NASA ATP program through NASA grant [NNX13AH43G]; NSF
   [AST-1255469, 1411920, 1455342]; European Research Council through
   ERC-CoG grant [CRAGSMAN-646955]; Klaus Tschira Foundation; Kavli
   Foundation; Alfred P. Sloan Research Fellowship; NASA ATP Grant
   [NNX14AH35G]
FX We would like to thank Anatoly Spitkovsky for providing access to
   TRISTAN-MP, substantial guidance in its use, and a number of
   constructive comments on the manuscript. M.S. and A.E.B. receive
   financial support from the Perimeter Institute for Theoretical Physics
   and the Natural Sciences and Engineering Research Council of Canada
   through a Discovery Grant. Research at Perimeter Institute is supported
   by the Government of Canada through Industry Canada and by the Province
   of Ontario through the Ministry of Research and Innovation. P.C.
   gratefully acknowledges support from the NASA ATP program through NASA
   grant NNX13AH43G, and the NSF through grant AST-1255469. C.P. gratefully
   acknowledges support by the European Research Council through ERC-CoG
   grant CRAGSMAN-646955 and by the Klaus Tschira Foundation. E.P.
   gratefully acknowledges support by the Kavli Foundation. Support for
   A.L. was provided by an Alfred P. Sloan Research Fellowship, NASA ATP
   Grant NNX14AH35G, and NSF Collaborative Research Grant # 1411920 and
   CAREER grant # 1455342.
CR Ardaneh K, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/1/57
   Besse N, 2003, J COMPUT PHYS, V191, P341, DOI 10.1016/S0021-9991(03)00318-8
   BIRDSALL CK, 1980, J COMPUT PHYS, V36, P1, DOI 10.1016/0021-9991(80)90171-0
   Birdsall C K, 1991, PLASMA PHYS VIA COMP
   Boyd T.J.M., 2003, PHYS PLASMAS
   Brackbill J., 1985, MULTIPLE TIME SCALES, V3
   Brackbill JU, 2016, J COMPUT PHYS, V317, P405, DOI 10.1016/j.jcp.2016.04.050
   Brambilla M, 1998, KINETIC THEORY PLASM
   Broderick AE, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/22
   BUNEMAN O, 1959, PHYS REV, V115, P503, DOI 10.1103/PhysRev.115.503
   Buneman O., 1993, PLASMA PHYS CONTROLL, P285
   Chen G, 2011, J COMPUT PHYS, V230, P7018, DOI 10.1016/j.jcp.2011.05.031
   COURANT R, 1967, IBM J RES DEV, V11, P215
   DAWSON J, 1962, PHYS FLUIDS, V5, P445, DOI 10.1063/1.1706638
   EASTWOOD JW, 1991, COMPUT PHYS COMMUN, V64, P252, DOI 10.1016/0010-4655(91)90036-K
   Esirkepov TZ, 2001, COMPUT PHYS COMMUN, V135, P144, DOI 10.1016/S0010-4655(00)00228-9
   Haugbolle T, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4811384
   Hockney R W., 1988, COMPUTER SIMULATION
   LANGDON AB, 1973, J COMPUT PHYS, V12, P247, DOI 10.1016/S0021-9991(73)80014-2
   Lapenta G., 2016, ARXIV160206326
   Lapenta G, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3602216
   Lewis H. r., 1970, Journal of Computational Physics, V6, P136, DOI 10.1016/0021-9991(70)90012-4
   Lipatov A. S., 2002, HYBRID MULTISCALE SI
   Lyutikov M., 2016, ARXIV160305731
   Markidis S, 2011, J COMPUT PHYS, V230, P7037, DOI 10.1016/j.jcp.2011.05.033
   McKinstrie CJ, 1999, PHYS PLASMAS, V6, P463, DOI 10.1063/1.873212
   Miller K. A., 1999, BAAS, V31, P1510
   Park J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.085003
   Philippov AA, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/1/L19
   Riquelme MA, 2009, ASTROPHYS J, V694, P626, DOI 10.1088/0004-637X/694/1/626
   Rossmanith JA, 2011, J COMPUT PHYS, V230, P6203, DOI 10.1016/j.jcp.2011.04.018
   Sironi L, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/49
   Spitkovsky A, 2005, AIP CONF PROC, V801, P345
   Spitkovsky A, 2008, ASTROPHYS J LETT, V682, pL5, DOI 10.1086/590248
   Umeda T, 2003, COMPUT PHYS COMMUN, V156, P73, DOI 10.1016/S0010-4655(03)00437-5
   VILLASENOR J, 1992, COMPUT PHYS COMMUN, V69, P306, DOI 10.1016/0010-4655(92)90169-Y
   Zhu QR, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/6
NR 37
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0004-637X
EI 1538-4357
J9 ASTROPHYS J
JI Astrophys. J.
PD MAY 20
PY 2017
VL 841
IS 1
AR 52
DI 10.3847/1538-4357/aa6d13
PG 26
WC Astronomy & Astrophysics
SC Astronomy & Astrophysics
GA EW2EY
UT WOS:000402310500038
OA No
DA 2017-08-17
ER

PT J
AU Asim, M
   Al-Thani, H
   El-Menyar, A
AF Asim, Mohammad
   Al-Thani, Hassan
   El-Menyar, Ayman
TI Recurrent Deep Vein Thrombosis After the First Venous Thromboembolism
   Event: A Single-Institution Experience
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Pulmonary Embolism; Recurrence; Risk Factors; Venous Thrombosis
ID POPULATION-BASED-COHORT; PULMONARY-EMBOLISM; RISK-ASSESSMENT;
   LOWER-EXTREMITY; EPIDEMIOLOGY; METAANALYSIS; PREDICTORS; MORTALITY;
   DISEASE; MODEL
AB Background: We investigated the frequency, clinical presentation, risk factors, and outcome after the first deep vein thrombosis (DVT) event.
   Material/Methods: A retrospective study was conducted for patients with DVT between 2008 and 2012 with a 1-year follow-up. Patients were divided into 2 groups: single vs. recurrent DVT (RDVT).
   Results: Of the 6420 patients screened for DVT, 662 (10.3%) had DVT. RDVT constituted 22% of cases. A single event was more frequent in left lower limb DVT (p=0.01), while RDVT cases had more bilateral DVT (p=0.01). Recurrent pulmonary embolism (PE) and comorbidities were significantly higher in the RDVT group (P<0.05). Protein C, protein S, and anti-thrombin III deficiency were higher in patients with RDVT (P< 0.05). Post-thrombotic syndrome was significantly higher among RDVT cases (p=0.01). In addition, obesity, abnormal coagulation, and prior history of PE and bilateral DVT were found to be independent predictors of RDVT. The PE rate was greater with RDVT than those with single events (22% vs. 9%, p=0.001); however, during follow-up and after adjustment for age and sex, this effect was statistically insignificant (adjusted HR 1.23, 95% CI 0.43-3.57, p=0.68). The age-and sex-adjusted mortality rate was higher in patients with single events with a HR 2.3; 95% CI 1.18-4.54 (p=0.01); however, this effect disappeared after adjusting for the duration of warfarin therapy (p=0.22).
   Conclusions: Patients with RDVT are common and have characteristic features that required more attention and further evaluation. These findings should help identifying high-risk patients and set effective preventive measures for RDVT that may revise the duration of warfarin therapy.
C1 [Asim, Mohammad; El-Menyar, Ayman] Hamad Gen Hosp, Dept Surg, Clin Res, Trauma Surg Sect, Doha, Qatar.
   [Al-Thani, Hassan] Hamad Gen Hosp, Dept Vasc Surg, Doha, Qatar.
   [El-Menyar, Ayman] Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar.
   [El-Menyar, Ayman] Ahmed Maher Teaching Hosp, Internal Med, Cardiol Unit, Cairo, Egypt.
RP El-Menyar, A (reprint author), Hamad Gen Hosp, Dept Surg, Clin Res, Trauma Surg Sect, Doha, Qatar.; El-Menyar, A (reprint author), Weill Cornell Med Coll, Dept Clin Med, Doha, Qatar.; El-Menyar, A (reprint author), Ahmed Maher Teaching Hosp, Internal Med, Cardiol Unit, Cairo, Egypt.
EM aymanco65@yahoo.com
CR Agnelli G, 2013, HEMATOL-AM SOC HEMAT, P471
   Al Sayegh F, 2009, CLIN APPL THROMB-HEM, V15, P289, DOI 10.1177/1076029608315168
   Algahtani F, 2013, SAUDI PHARM J, V21, P165, DOI 10.1016/j.jsps.2012.05.008
   Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6
   Brouwer JLP, 2009, THROMB HAEMOSTASIS, V101, P93, DOI 10.1160/TH08-06-0364
   Cannegieter SC, 2013, J THROMB HAEMOST, V11, P161, DOI 10.1111/jth.12263
   Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008
   Chen SY, 2013, J MANAGE CARE PHARM, V19, P291
   Douketis J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d813
   Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214
   Ensor J, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20120
   Fahrni J, 2015, VASC HEALTH RISK MAN, V11, P451, DOI 10.2147/VHRM.S83718
   Galanaud JP, 2014, J THROMB HAEMOST, V12, P436, DOI 10.1111/jth.12512
   Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769
   Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761
   Heit JA, 2008, ARTERIOSCL THROM VAS, V28, P370, DOI 10.1161/ATVBAHA.108.162545
   Heit JA, 2011, BLOOD, V118, P4992, DOI 10.1182/blood-2011-05-357343
   Huang W, 2016, J THROMB THROMBOLYS, V41, P525, DOI 10.1007/s11239-015-1301-8
   Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658
   Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301
   Khaladkar SM, 2014, MED J DY PATIL U, V7, P612
   Kreidy R, 2014, INT J VAS MED
   Kyrle PA, 2010, LANCET, V376, P2032, DOI 10.1016/S0140-6736(10)60962-2
   Labropoulos N, 2008, J VASC SURG, V48, P407, DOI 10.1016/j.jvs.2008.03.016
   Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1
   Mi YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004495
   Montagnana M, 2010, J THROMB THROMBOLYS, V29, P489, DOI 10.1007/s11239-009-0365-8
   Ouriel K, 2000, J VASC SURG, V31, P895, DOI 10.1067/mva.2000.105956
   Palareti G, 2012, SCIENTIFICA
   Piazza G, 2012, AM J MED, V125, P709, DOI 10.1016/j.amjmed.2011.12.004
   Qi XS, 2015, INTERN EMERG MED, V10, P205, DOI 10.1007/s11739-014-1163-7
   Ren W, 2014, MED SCI MONITOR, V20
   Ribeiro DD, 2012, BRAZ J MED BIOL RES, V45, P1, DOI [10.1590/S0100-879X2011007500166, 10.1590/S0100-879X2012000100001]
   Riddle DL, 2004, PHYS THER, V84, P729
   Streiff MB, 2016, J THROMB THROMBOLYS, V41, P32, DOI 10.1007/s11239-015-1317-0
   Swiatkiewicz Andrzej, 2002, Med Sci Monit, V8, pCR263
   Tan M, 2011, BRIT J HAEMATOL, V153, P168, DOI 10.1111/j.1365-2141.2011.08578.x
   Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121
   Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170
   Young L, 2006, J THROMB HAEMOST, V4, P1919, DOI 10.1111/j.1538-7836.2006.02120.x
   Zhang XT, 2016, MED SCI MONITOR, V22, P969
NR 41
TC 0
Z9 0
U1 2
U2 2
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD MAY 20
PY 2017
VL 23
BP 2391
EP 2399
DI 10.12659/MSM.901924
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EV5UN
UT WOS:000401833200002
PM 28527240
OA No
DA 2017-08-17
ER

PT J
AU Marzouk, M
   Abdelkader, EM
   Al-Gahtani, K
AF Marzouk, Mohamed
   Abdelkader, Eslam Mohammed
   Al-Gahtani, Khalid
TI Building information modeling-based model for calculating direct and
   indirect emissions in construction projects
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Construction projects; Construction emissions; Building information
   modeling; Direct emission; Indirect emissions; Project life cycle phases
ID GREENHOUSE-GAS EMISSIONS; LIFE-CYCLE; CO2 EMISSIONS; RESIDENTIAL
   BUILDINGS; CONCRETE
AB The construction industry is considered as one of the most dynamic sectors that have upstream and downstream economic links and has been growing rapidly in the last few decades. On the other hand, it is considered as one of the main sources of greenhouse gases where construction projects represent a huge portion of sources producing carbon dioxide gases (CO2). Furthermore, greenhouse gases (GHG) are one of construction emissions that should be investigated to calculate the overall emissions. Therefore, estimating construction emissions is very important in order to keep emissions at an acceptable level. This paper presents a building information modeling (BIM)-based model that enables the estimation of six types of emissions including: greenhouse gases, sulfur dioxide, particular matter, eutrophication particles, ozone depleting particles and smog. As such, the total direct and indirect emissions can be calculated where these emissions are produced from construction activities during the overall project life cycle phases which are: manufacturing phase, transportation phase, construction phase, operation phase, maintenance phase, and deconstruction/demolition phase. The methods of calculating direct and indirect emissions are extensively described in the paper. A case study is presented to illustrate the use of the proposed BIM -based model. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Marzouk, Mohamed; Abdelkader, Eslam Mohammed] Cairo Univ, Fac Engn, Struct Engn Dept, Giza, Egypt.
   [Al-Gahtani, Khalid] King Saud Univ, Coll Engn, Civil Engn Dept, Riyadh, Saudi Arabia.
RP Marzouk, M (reprint author), Cairo Univ, Fac Engn, Struct Engn Dept, Giza, Egypt.
EM mm_marzouk@yahoo.com; eslam_ahmed1990@hotmail.com; kgahtani@ksu.edu.sa
FU National Plan for Science, Technology, and Innovation (MAARIFAH), King
   Abdul-Aziz City for Science and Technology, Kingdom of Saudi Arabia
   [11-BUI2090-02]
FX This project was funded by the National Plan for Science, Technology,
   and Innovation (MAARIFAH), King Abdul-Aziz City for Science and
   Technology, Kingdom of Saudi Arabia, Award Number (11-BUI2090-02).
CR Acquaye AA, 2010, BUILD ENVIRON, V45, P784, DOI 10.1016/j.buildenv.2009.08.022
   Athena Sustainable Materials Institute, 2016, IMP EST BUILD
   Audenaert A, 2012, ENERG BUILDINGS, V47, P68, DOI 10.1016/j.enbuild.2011.11.028
   Autodesk, 2015, AUT REV
   Aye L, 2012, ENERG BUILDINGS, V47, P159, DOI 10.1016/j.enbuild.2011.11.049
   Azhar S., 2008, 1 INT C CONSTR DEV C, P435
   Center for Climate and Energy Solutions, 2015, OUTC UN CLIM CHANG C
   Department of Energy and Climate Change 2014, 2013, UK GREENH GAS EM PRO
   EPA, 2016, OZ POLL
   EPA, 2002, GREENH GAS GLOB WARM
   EPA, 2016, OV GREENH GAS
   EPA, 2016, PART MATT HLTH
   EPA, 2016, PART MATT
   EPA, 2016, UND GLOB WARM POT
   EPA, 2016, BAS OZ LAYER SCI
   Flower DJM, 2007, INT J LIFE CYCLE ASS, V12, P282, DOI 10.1065/lca2007.05.327
   Heinonen J, 2011, SUSTAINABILITY-BASEL, V3, P1170, DOI 10.3390/su3081170
   IEA EBC, 2014, EV EMB EN CO2EQ BUIL
   Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 ASS
   Jalaei F., 2014, ITCON, V19, P494, DOI DOI 10.1061/9780784413517.015
   Jeong YS, 2012, ENERG BUILDINGS, V49, P437, DOI 10.1016/j.enbuild.2012.02.041
   Krigsvoll Guri, 2010, Sustainability, V2, P3777, DOI 10.3390/su2123777
   Kumar J. V., 2009, J ENG SCI TECHNOLOGY, V2, P165
   Larsen HN, 2013, J CLEAN PROD, V48, P39, DOI 10.1016/j.jclepro.2011.10.007
   Liu W, 2014, J CLEAN PROD, V66, P384, DOI 10.1016/j.jclepro.2013.11.010
   Mao C, 2013, ENERG BUILDINGS, V66, P165, DOI 10.1016/j.enbuild.2013.07.033
   Marzouk M, 2008, CONSTR MANAG ECON, V26, P1113, DOI 10.1080/01446190802400779
   Mattinen MK, 2014, J CLEAN PROD, V81, P70, DOI 10.1016/j.jclepro.2014.05.054
   Memarzadeh M., 2012, CONSTR RES C W LAF I, P1330
   Motawa I, 2013, PROCD SOC BEHV, V74, P419, DOI 10.1016/j.sbspro.2013.03.015
   Nielsen C. V., 2008, P NRMCA 2008 CONCR T, P1
   Ordonez J, 2011, BUILD ENVIRON, V46, P2161, DOI 10.1016/j.buildenv.2011.04.030
   Pacheco-Torres R, 2014, SUSTAIN CITIES SOC, V12, P63, DOI 10.1016/j.scs.2014.01.003
   Park J. H., 2012, INT J CIV ENV ENG, V6, P260
   PBL Netherlands Environmental Assessment Agency, 2013, TRENDS GLOB CO2 EM 2
   Ragheb Ashraf, 2010, CRADLE GRAVE CASE ST
   Rani B, 2011, J ADV SCI RES, V2, P28
   Seo S, 2001, J CONSTR ENG M ASCE, V127, P414, DOI 10.1061/(ASCE)0733-9364(2001)127:5(414)
   Silvestre JD, 2014, J CLEAN PROD, V66, P37, DOI 10.1016/j.jclepro.2013.10.028
   Stern N., 2006, STERN REV EC CLIMATE
   Tang P, 2013, J CLEAN PROD, V54, P78, DOI 10.1016/j.jclepro.2013.03.046
   United Nations Environment Programme, 2009, BUILD CLIM CHANG SUM
   Valipour M, 2014, J CLEAN PROD, V65, P418, DOI 10.1016/j.jclepro.2013.07.055
   Viguier LL, 2003, ENERG POLICY, V31, P459, DOI 10.1016/S0301-4215(02)00075-7
   World Business Council for Sustainable Development (WBCSD), 2004, GREENH GAS PROT CORP
   Wu Z., 2015, J CLEAN PROD
   Yan H, 2010, BUILD ENVIRON, V45, P949, DOI 10.1016/j.buildenv.2009.09.014
   Zhang XL, 2013, RENEW SUST ENERG REV, V17, P160, DOI 10.1016/j.rser.2012.09.024
NR 48
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD MAY 20
PY 2017
VL 152
BP 351
EP 363
DI 10.1016/j.jclepro.2017.03.138
PG 13
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA EU9SK
UT WOS:000401379700032
OA No
DA 2017-08-17
ER

PT J
AU Dieleman, J
   Campbell, M
   Chapin, A
   Eldrenkamp, E
   Fan, VY
   Haakenstad, A
   Kates, J
   Liu, YY
   Matyasz, T
   Micah, A
   Reynolds, A
   Sadat, N
   Schneider, MT
   Sorensen, R
   Evans, T
   Evans, D
   Kurowski, C
   Tandon, A
   Abbas, KM
   Abera, SF
   Kiadaliri, AA
   Ahmed, KY
   Ahmed, MB
   Alam, K
   Alizadeh-Navaei, R
   Alkerwi, A
   Amini, E
   Ammar, W
   Amrock, SM
   Antonio, CAT
   Atey, TM
   Avila-Burgos, L
   Awasthi, A
   Barac, A
   Bernal, OA
   Beyene, AS
   Beyene, TJ
   Birungi, C
   Bizuayehu, HM
   Breitborde, NJK
   Cahuana-Hurtado, L
   Castro, RE
   Catala-Lopez, F
   Dalal, K
   Dandona, L
   Dandona, R
   de Jager, P
   Dharmaratne, SD
   Dubey, M
   Sa Farinha, CSES
   Faro, A
   Feigl, AB
   Fischer, F
   Fitchett, JRA
   Foigt, N
   Giref, AZ
   Gupta, R
   Hamidi, S
   Harb, HL
   Hay, SI
   Hendrie, D
   Horino, M
   Jurisson, M
   Jakovljevic, MB
   Javanbakht, M
   John, D
   Jonas, JB
   Karimi, SM
   Khang, YH
   Khubchandani, J
   Kim, YJ
   Kinge, JM
   Krohn, KJ
   Kumar, GA
   Abd El Razek, HM
   Abd El Razek, MM
   Majeed, A
   Malekzadeh, R
   Masiye, F
   Meier, T
   Meretoja, A
   Miller, TR
   Mirrakhimov, EM
   Mohammed, S
   Nangia, V
   Olgiati, S
   Osman, AS
   Owolabi, MO
   Patel, T
   Caicedo, AJP
   Pereira, DM
   Perelman, J
   Polinder, S
   Rafay, A
   Rahimi-Movaghar, V
   Rai, RK
   Ram, U
   Ranabhat, CL
   Roba, HS
   Salama, J
   Savic, M
   Sepanlou, SG
   Shrime, MG
   Talongwa, RT
   Te Ao, BJ
   Tediosi, F
   Tesema, AG
   Thomson, AJ
   Tobe-Gai, R
   Topor-Madry, R
   Undurraga, EA
   Vasankari, T
   Violante, FS
   Werdecker, A
   Wijeratne, T
   Xu, G
   Yonemoto, N
   Younis, MZ
   Yu, CH
   Zaidi, Z
   Zaki, ME
   Murray, CJL
AF Dieleman, Joseph
   Campbell, Madeline
   Chapin, Abigail
   Eldrenkamp, Erika
   Fan, Victoria Y.
   Haakenstad, Annie
   Kates, Jennifer
   Liu, Yingying
   Matyasz, Taylor
   Micah, Angela
   Reynolds, Alex
   Sadat, Nafis
   Schneider, Matthew T.
   Sorensen, Reed
   Evans, Tim
   Evans, David
   Kurowski, Christoph
   Tandon, Ajay
   Abbas, Kaja M.
   Abera, Semaw Ferede
   Kiadaliri, Aliasghar Ahmad
   Ahmed, Kedir Yimam
   Ahmed, Muktar Beshir
   Alam, Khurshid
   Alizadeh-Navaei, Reza
   Alkerwi, Ala'a
   Amini, Erfan
   Ammar, Walid
   Amrock, Stephen Marc
   Antonio, Carl Abelardo T.
   Atey, Tesfay Mehari
   Avila-Burgos, Leticia
   Awasthi, Ashish
   Barac, Aleksandra
   Alberto Bernal, Oscar
   Beyene, Addisu Shunu
   Beyene, Tariku Jibat
   Birungi, Charles
   Bizuayehu, Habtamu Mellie
   Breitborde, Nicholas J. K.
   Cahuana-Hurtado, Lucero
   Estanislao Castro, Ruben
   Catala-Lopez, Ferran
   Dalal, Koustuv
   Dandona, Lalit
   Dandona, Rakhi
   de Jager, Pieter
   Dharmaratne, Samath D.
   Dubey, Manisha
   Farinha, Carla Sofia e Sa
   Faro, Andre
   Feigl, Andrea B.
   Fischer, Florian
   Fitchett, Joseph Robert Anderson
   Foigt, Nataliya
   Giref, Ababi Zergaw
   Gupta, Rahul
   Hamidi, Samer
   Harb, Hilda L.
   Hay, Simon I.
   Hendrie, Delia
   Horino, Masako
   Jurisson, Mikk
   Jakovljevic, Mihajlo B.
   Javanbakht, Mehdi
   John, Denny
   Jonas, Jost B.
   Karimi, Seyed M.
   Khang, Young-Ho
   Khubchandani, Jagdish
   Kim, Yun Jin
   Kinge, Jonas M.
   Krohn, Kristopher J.
   Kumar, G. Anil
   Abd El Razek, Hassan Magdy
   Abd El Razek, Mohammed Magdy
   Majeed, Azeem
   Malekzadeh, Reza
   Masiye, Felix
   Meier, Toni
   Meretoja, Atte
   Miller, Ted R.
   Mirrakhimov, Erkin M.
   Mohammed, Shafiu
   Nangia, Vinay
   Olgiati, Stefano
   Osman, Abdalla Sidahmed
   Owolabi, Mayowa O.
   Patel, Tejas
   Paternina Caicedo, Angel J.
   Pereira, David M.
   Perelman, Julian
   Polinder, Suzanne
   Rafay, Anwar
   Rahimi-Movaghar, Vafa
   Rai, Rajesh Kumar
   Ram, Usha
   Ranabhat, Chhabi Lal
   Roba, Hirbo Shore
   Salama, Joseph
   Savic, Miloje
   Sepanlou, Sadaf G.
   Shrime, Mark G.
   Talongwa, Roberto Tchio
   Te Ao, Braden J.
   Tediosi, Fabrizio
   Tesema, Azeb Gebresilassie
   Thomson, Alan J.
   Tobe-Gai, Ruoyan
   Topor-Madry, Roman
   Undurraga, Eduardo A.
   Vasankari, Tommi
   Violante, Francesco S.
   Werdecker, Andrea
   Wijeratne, Tissa
   Xu, Gelin
   Yonemoto, Naohiro
   Younis, Mustafa Z.
   Yu, Chuanhua
   Zaidi, Zoubida
   Zaki, Maysaa El Sayed
   Murray, Christopher J. L.
CA Global Burden Dis Hlth Financing
TI Evolution and patterns of global health financing 1995-2014: development
   assistance for health, and government, prepaid private, and
   out-of-pocket health spending in 184 countries
SO LANCET
LA English
DT Article
ID SYSTEMATIC ANALYSIS; LIFE EXPECTANCY; PLASMODIUM-FALCIPARUM; CARE;
   EXPENDITURE; PAYMENTS; AFRICA; BURDEN; TRANSITION; INSURANCE
AB Background An adequate amount of prepaid resources for health is important to ensure access to health services and for the pursuit of universal health coverage. Previous studies on global health financing have described the relationship between economic development and health financing. In this study, we further explore global health financing trends and examine how the sources of funds used, types of services purchased, and development assistance for health disbursed change with economic development. We also identify countries that deviate from the trends.
   Methods We estimated national health spending by type of care and by source, including development assistance for health, based on a diverse set of data including programme reports, budget data, national estimates, and 964 National Health Accounts. These data represent health spending for 184 countries from 1995 through 2014. We converted these data into a common inflation-adjusted and purchasing power-adjusted currency, and used non-linear regression methods to model the relationship between health financing, time, and economic development.
   Findings Between 1995 and 2014, economic development was positively associated with total health spending and a shift away from a reliance on development assistance and out-of-pocket (OOP) towards government spending. The largest absolute increase in spending was in high-income countries, which increased to purchasing power-adjusted $5221 per capita based on an annual growth rate of 3.0%. The largest health spending growth rates were in upper-middle-income (5.9) and lower-middle-income groups (5.0), which both increased spending at more than 5% per year, and spent $914 and $267 per capita in 2014, respectively. Spending in low-income countries grew nearly as fast, at 4.6%, and health spending increased from $51 to $120 per capita. In 2014, 59.2% of all health spending was financed by the government, although in low-income and lower-middle-income countries, 29.1% and 58.0% of spending was OOP spending and 35.7% and 3.0% of spending was development assistance. Recent growth in development assistance for health has been tepid; between 2010 and 2016, it grew annually at 1.8%, and reached US$37.6 billion in 2016. Nonetheless, there is a great deal of variation revolving around these averages. 29 countries spend at least 50% more than expected per capita, based on their level of economic development alone, whereas 11 countries spend less than 50% their expected amount.
   Interpretation Health spending remains disparate, with low-income and lower-middle-income countries increasing spending in absolute terms the least, and relying heavily on OOP spending and development assistance. Moreover, tremendous variation shows that neither time nor economic development guarantee adequate prepaid health resources, which are vital for the pursuit of universal health coverage.
C1 [Dieleman, Joseph; Campbell, Madeline; Chapin, Abigail; Eldrenkamp, Erika; Haakenstad, Annie; Liu, Yingying; Matyasz, Taylor; Micah, Angela; Reynolds, Alex; Sadat, Nafis; Schneider, Matthew T.; Sorensen, Reed; Dandona, Lalit; Dandona, Rakhi; Giref, Ababi Zergaw; Hay, Simon I.; Krohn, Kristopher J.; Salama, Joseph; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Fan, Victoria Y.] Univ Hawaii Manoa, Honolulu, HI 96822 USA.
   [Fan, Victoria Y.] Harvard Univ, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA.
   [Feigl, Andrea B.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
   [Fitchett, Joseph Robert Anderson] Harvard Univ, Boston, MA 02115 USA.
   [Fan, Victoria Y.] Ctr Global Dev, Washington, DC USA.
   [Kates, Jennifer] Kaiser Family Fdn, Washington, DC USA.
   [Evans, Tim; Evans, David; Kurowski, Christoph; Tandon, Ajay] World Bank, 1818 H St NW, Washington, DC 20433 USA.
   [Abbas, Kaja M.] Virginia Tech, Blacksburg, VA USA.
   [Abera, Semaw Ferede] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.
   [Atey, Tesfay Mehari; Tesema, Azeb Gebresilassie] Mekelle Univ, Mekelle, Ethiopia.
   [Abera, Semaw Ferede] Univ Hohenheim, Food Secur, Stuttgart, Germany.
   [Abera, Semaw Ferede] Univ Hohenheim, Inst Biol Chem & Nutr, Stuttgart, Germany.
   [Kiadaliri, Aliasghar Ahmad] Lund Univ, Clin Epidemiol Unit, Dept Clin Sci Lund, Orthoped, Lund, Sweden.
   [Ahmed, Kedir Yimam] Debre Markos Univ, Debre Markos, Ethiopia.
   [Ahmed, Muktar Beshir] Jimma Univ, Dept Epidemiol ICT & E Learning Coordinator, Coll Hlth Sci, Jimma, Ethiopia.
   [Alam, Khurshid] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Alam, Khurshid] Univ Melbourne, Melbourne, Vic, Australia.
   [Alam, Khurshid] Univ Sydney, Sydney, NSW, Australia.
   [Alizadeh-Navaei, Reza] Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Sari, Iran.
   [Alkerwi, Ala'a] LIH, Strassen, Luxembourg.
   [Amini, Erfan] Univ Tehran Med Sci, Urooncol Res Ctr, Tehran, Iran.
   [Amini, Erfan] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Tehran, Iran.
   [Malekzadeh, Reza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.
   [Ammar, Walid; Harb, Hilda L.] Minist Publ Hlth, Beirut, Lebanon.
   [Amrock, Stephen Marc] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Antonio, Carl Abelardo T.] Univ Philippines Manila, Coll Publ Hlth, Dept Hlth Policy & Adm, Manila, Philippines.
   [Avila-Burgos, Leticia; Cahuana-Hurtado, Lucero] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Awasthi, Ashish] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India.
   [Barac, Aleksandra] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Alberto Bernal, Oscar] Univ Andes, Bogota, Colombia.
   [Beyene, Addisu Shunu; Roba, Hirbo Shore] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.
   [Beyene, Tariku Jibat; Giref, Ababi Zergaw] Addis Ababa Univ, Addis, Ethiopia.
   [Beyene, Tariku Jibat] Wageningen Univ, Wageningen, Netherlands.
   [Birungi, Charles] UCL, London, England.
   [Bizuayehu, Habtamu Mellie] Debre Markos Univ, Debre Markos Town, Ethiopia.
   [Breitborde, Nicholas J. K.] Ohio State Univ, Columbus, OH 43210 USA.
   [Estanislao Castro, Ruben] Univ Diego Port, Santiago, Chile.
   [Catala-Lopez, Ferran] Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain.
   [Catala-Lopez, Ferran] CIBERSAM, Valencia, Spain.
   [Catala-Lopez, Ferran] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.
   [Dalal, Koustuv] Orebro Univ, Sch Hlth & Med Sci, Ctr Injury Prevent & Safety Promot, Orebro, Sweden.
   [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil] Publ Hlth Fdn India, New Delhi, India.
   [de Jager, Pieter] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
   [de Jager, Pieter] Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Johannesburg, South Africa.
   [Dharmaratne, Samath D.] Univ Peradeniya, Dept Community Med, Fac Med, Peradeniya, Sri Lanka.
   [Dubey, Manisha; Ram, Usha] Int Inst Populat Sci, Mumbai, Maharashtra, India.
   [Farinha, Carla Sofia e Sa] DGS Directorate Gen Hlth, Lisbon, Portugal.
   [Faro, Andre] Univ Fed Sergipe, Aracaju, Brazil.
   [Fischer, Florian] Bielefeld Univ, Sch Publ Hlth, Bielefeld, Germany.
   [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine.
   [Gupta, Rahul] West Virginia Bur Publ Hlth, Charleston, WV USA.
   [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, United, U Arab Emirates.
   [Hay, Simon I.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England.
   [Hendrie, Delia] Curtin Univ, Ctr Populat Hlth Res, Bentley, WA, Australia.
   [Horino, Masako] Nevada Div Publ & Behav Hlth, Dept Hlth & Human Serv, Carson City, NV USA.
   [Jakovljevic, Mihajlo B.] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia.
   [Javanbakht, Mehdi] Univ Aberdeen, Aberdeen, Scotland.
   [John, Denny] Int Ctr Res Women, New Delhi, India.
   [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.
   [Jurisson, Mikk] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia.
   [Karimi, Seyed M.] Univ Washington Tacoma, Tacoma, WA USA.
   [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea.
   [Khubchandani, Jagdish] Ball State Univ, Muncie, IN 47306 USA.
   [Kim, Yun Jin] Southern Univ Coll, Skudai, Malaysia.
   [Kinge, Jonas M.] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Abd El Razek, Hassan Magdy] Mansoura Fac Med, Mansoura, Egypt.
   [Abd El Razek, Mohammed Magdy] Aswan Univ Hosp, Aswan Fac Med, Aswan, Egypt.
   [Majeed, Azeem] Imperial Coll London, London, England.
   [Masiye, Felix] Univ Zambia, Lusaka, Zambia.
   [Meier, Toni] Martin Luther Univ Halle Wittenberg, Halle, Saale, Germany.
   [Meretoja, Atte] Univ Melbourne, Dept Med, Footscray, Vic, Australia.
   [Wijeratne, Tissa] Univ Melbourne, Footscray, Vic, Australia.
   [Meretoja, Atte] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
   [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA.
   [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth, Perth, WA, Australia.
   [Mirrakhimov, Erkin M.] Kyrgyz State Med Acad, Bishkek, Kyrgyzstan.
   [Mirrakhimov, Erkin M.] Natl Ctr Cardiol & Internal Dis, Bishkek, Kyrgyzstan.
   [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria.
   [Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India.
   [Olgiati, Stefano] State Univ Bergamo, Bergamo, Italy.
   [Osman, Abdalla Sidahmed] Publ Hlth Inst Sudan, Khartoum, Sudan.
   [Owolabi, Mayowa O.] Blossom Specialist Med Ctr, Ibadan, Nigeria.
   [Patel, Tejas] Mt Sinai Hlth Syst, New York, NY USA.
   [Paternina Caicedo, Angel J.] Univ Cartagena, Cartagena, Colombia.
   [Paternina Caicedo, Angel J.] Univ Pittsburgh, Publ Hlth Dynam Lab, Pittsburgh, PA USA.
   [Pereira, David M.] Univ Porto, Fac Farm, Dept QuAm, REQUIMTE LAQV,Lab Farmacognosia, Oporto, Portugal.
   [Perelman, Julian] Natl Sch Publ Hlth, Lisbon, Portugal.
   [Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   [Rafay, Anwar] Contech Int Hlth Consultants, Lahore, Pakistan.
   [Rafay, Anwar] Contech Sch Publ Hlth, Lahore, Pakistan.
   [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India.
   [Ranabhat, Chhabi Lal] Yonsei Univ, Inst Poverty Alleviat & Int Dev, Wonju, South Korea.
   [Ranabhat, Chhabi Lal] Yonsei Univ, Wonju Coll Med, Wonju, South Korea.
   [Talongwa, Roberto Tchio] MINSANTE, Minist Hlth, Yaounde, Cameroon.
   [Te Ao, Braden J.] Auckland Univ Technol, Auckland, New Zealand.
   [Tediosi, Fabrizio] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Thomson, Alan J.] Adapt Knowledge Management, Victoria, BC, Canada.
   [Tobe-Gai, Ruoyan] Natl Ctr Child Hlth & Dev, Tokyo, Japan.
   [Topor-Madry, Roman] Jagiellonian Univ Med Coll, Fac Hlth Sci, Inst Publ Hlth, Krakow, Poland.
   [Topor-Madry, Roman] Wroclaw Med Univ, Fac Hlth Sci, Wroclaw, Poland.
   [Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA.
   [Vasankari, Tommi] UKK Inst Hlth Promot Res, Tampere, Finland.
   [Violante, Francesco S.] Univ Bologna, Bologna, Italy.
   [Werdecker, Andrea] Fed Inst Populat Res, Competence Ctr Mortal Follow Up German Natl Cohor, Wiesbaden, Germany.
   [Wijeratne, Tissa] Western Hlth, Footscray, Vic, Australia.
   [Xu, Gelin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.
   [Yonemoto, Naohiro] Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan.
   [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA.
   [Yu, Chuanhua] Wuhan Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Wuhan, Peoples R China.
   [Zaidi, Zoubida] Univ Hosp, Setif, Algeria.
   [Zaki, Maysaa El Sayed] Mansoura Univ, Fac Med, Mansoura, Egypt.
RP Dieleman, J (reprint author), 2301 Fifth Ave,Suite 600, Seattle, WA 98121 USA.
EM dieleman@uw.edu
RI Pereira, David/M-9286-2013; John, Denny/J-7815-2017; Perelman,
   Julian/B-4350-2013
OI Pereira, David/0000-0003-0384-7592; John, Denny/0000-0002-4486-632X;
   Perelman, Julian/0000-0001-6634-9000; Awasthi,
   Ashish/0000-0002-9308-9782; Abbas, Kaja/0000-0003-0563-1576;
   Catala-Lopez, Ferran/0000-0002-3833-9312; Wijeratne,
   Tissa/0000-0002-1701-7111; Hay, Simon/0000-0002-0611-7272
FU Bill AMP; Melinda Gates Foundation
FX The Bill & Melinda Gates Foundation.
CR Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bill & Melinda Gates Foundation, 2002, B GAT BON CALL LEAD
   Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413
   Bui AL, 2015, B WORLD HEALTH ORGAN, V93, P566, DOI 10.2471/BLT.14.145235
   Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F
   Center for American Progress, 2012, CUTT HLTH CAR COSTS
   The Center for Global Health and Diplomacy, INCR DOM HLTH FUND A
   Chernick Michael R., 2011, BOOTSTRAP METHODS GU
   Damme WV, 2004, TROP MED INT HEALTH, V9, P273, DOI DOI 10.1046/J.1365-3156.2003.01194.X
   Deaton A, 2014, TRYING UNDERSTAND PP
   Dercon S, 2015, MISSING MIDDLE IS TH
   Dieleman JL, 2015, JAMA
   Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885
   Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4
   Dieleman JL, 2014, HEALTH ECON, V23, P129, DOI 10.1002/hec.3016
   Dieleman JL, 2013, J DEV STUD, V49, P1755, DOI 10.1080/00220388.2013.844921
   Emanuel E, 2012, NEW ENGL J MED, V367, P949, DOI 10.1056/NEJMsb1205901
   The Equitable Access Initiative Expert Panel and Technical Working Group, 2016, EQ ACC IN REP
   Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X
   Fan VY, 2014, SOC SCI MED, V105, P112, DOI 10.1016/j.socscimed.2014.01.014
   Feenstra RC, 2015, AM ECON REV, V105, P3150, DOI 10.1257/aer.20130954
   Fisher ES, 2003, ANN INTERN MED, V138, P288
   Galbraith AA, 2005, HEALTH SERV RES, V40, P1722, DOI 10.1111/j.1475-6773.2005.00421.x
   Gething PW, 2016, NEW ENGL J MED, V375, P2435, DOI 10.1056/NEJMoa1606701
   Gotsadze G, 2005, HEALTH POLICY PLANN, V20, P232, DOI 10.1093/heapol/czi029
   Gottret P., 2006, HLTH FINANCING REVIS
   Herman B, 2016, MOD HEALTHC
   Honaker J, 2011, J STAT SOFTW, V45, P1
   Institute for Health Metrics and Evaluation, 2012, FIN GLOB HLTH 2012 E
   James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12
   Jann B, 2009, PSPLINE STATA MODULE
   Kassebaum NJ, 2016, LANCET, V388, P1603
   Kharas H, 2014, FINANCING POST 2015
   Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4
   Muriithi FK, 2015, CLIMATE, V3, P135, DOI 10.3390/cli3010135
   Musgrove P, 2002, B WORLD HEALTH ORGAN, V80, P134
   National Commission on Fiscal Responsibility and Reform, 2010, MON TRUTH REP NAT CO
   OECD, 2000, SYST HLTH ACC VERS 1
   OECD, 2017, TACKL WAST SPEND HLT
   OECD EUROSTAT WHO, 2011, SYST HLTH ACC, DOI [10.1787/9789264116016-en, DOI 10.1787/9789264116016-EN]
   Ottersen T, 2017, HEALTH ECON POLICY L, V12, P223, DOI 10.1017/S1744133116000475
   Pannarunothai S, 1997, SOC SCI MED, V44, P1781, DOI 10.1016/S0277-9536(96)00287-0
   Piette JD, 2004, MED CARE, V42, P102, DOI 10.1097/01.mlr.0000108742.26446.17
   Piette JD, 2004, DIABETES CARE, V27, P384, DOI 10.2337/diacare.27.2.384
   Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3
   Savedoff W., 2012, TRANSITIONS HLTH FIN
   Savedoff WD, 2007, HEALTH AFFAIR, V26, P962, DOI 10.1377/hlthaff.26.4.962
   Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6
   Schieber G, 1999, HEALTH AFFAIR, V18, P193, DOI 10.1377/hlthaff.18.3.193
   Sorenson Corinna, 2013, Clinicoecon Outcomes Res, V5, P223, DOI 10.2147/CEOR.S39634
   Sumner A, 2010, GLOBAL POVERTY NEW E
   United Nations Population Fund, 2007, PRIM MIN TANZ CALLS
   van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3
   Wang HD, 2016, LANCET, V388, P1459
   WHO, 2010, WOR HEALT REP, P1
   WHO, 2002, LONG TERM CAR DEV CO
   WHO, 2015, IND COD BOOK NAT HLT
   WHO, NAT HLTH ACC DAT 199
   World Bank, WORLD BANK COUNTR LE
   Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972
   Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4
NR 61
TC 1
Z9 1
U1 8
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 20
PY 2017
VL 389
IS 10083
BP 1981
EP 2004
DI 10.1016/S0140-6736(17)30874-7
PG 24
WC Medicine, General & Internal
SC General & Internal Medicine
GA EV1OH
UT WOS:000401515300023
PM 28433256
OA No
DA 2017-08-17
ER

PT J
AU Dieleman, JL
   Campbell, M
   Chapin, A
   Eldrenkamp, E
   Fan, VY
   Haakenstad, A
   Kates, J
   Li, ZY
   Matyasz, T
   Micah, A
   Reynolds, A
   Sadat, N
   Schneider, MT
   Sorensen, R
   Abbas, KM
   Abera, SF
   Kiadaliri, AA
   Ahmed, MB
   Alam, K
   Alizadeh-Navaei, R
   Alkerwi, A
   Amini, E
   Ammar, W
   Antonio, CAT
   Atey, TM
   Avila-Burgos, L
   Awasthi, A
   Barac, A
   Berheto, TM
   Beyene, AS
   Beyene, TJ
   Birungi, C
   Bizuayehu, HM
   Breitborde, NJK
   Cahuana-Hurtado, L
   Castro, RE
   Catala-Lopez, F
   Dalal, K
   Dandona, L
   Dandona, R
   Dharmaratne, SD
   Dubey, M
   Faro, A
   Feigl, AB
   Fischer, F
   Fitchett, JRA
   Foigt, N
   Giref, AZ
   Gupta, R
   Hamidi, S
   Harb, HL
   Hay, SI
   Hendrie, D
   Horino, M
   Jurisson, M
   Jakovljevic, MB
   Javanbakht, M
   John, D
   Jonas, JB
   Karimi, SM
   Khang, YH
   Khubchandani, J
   Kim, YJ
   Kinge, JM
   Krohn, KJ
   Kumar, GA
   Leung, R
   Abd El Razek, HM
   Abd El Razek, MM
   Majeed, A
   Malekzadeh, R
   Malta, DC
   Meretoja, A
   Miller, TR
   Mirrakhimov, EM
   Mohammed, S
   Molla, G
   Nangia, V
   Olgiati, S
   Owolabi, MO
   Patel, T
   Caicedo, AJP
   Pereira, DM
   Perelman, J
   Polinder, S
   Rafay, A
   Rahimi-Movaghar, V
   Rai, RK
   Ram, U
   Ranabhat, CL
   Roba, HS
   Savic, M
   Sepanlou, SG
   Te Ao, BJ
   Tesema, AG
   Thomson, AJ
   Tobe-Gai, R
   Topor-Madry, R
   Undurraga, EA
   Vargas, V
   Vasankari, T
   Violante, FS
   Wijeratne, T
   Xu, GL
   Yonemoto, N
   Younis, MZ
   Yu, CH
   Zaidi, Z
   Zaki, ME
   Murray, CJL
AF Dieleman, Joseph L.
   Campbell, Madeline
   Chapin, Abigail
   Eldrenkamp, Erika
   Fan, Victoria Y.
   Haakenstad, Annie
   Kates, Jennifer
   Li, Zhiyin
   Matyasz, Taylor
   Micah, Angela
   Reynolds, Alex
   Sadat, Nafis
   Schneider, Matthew T.
   Sorensen, Reed
   Abbas, Kaja M.
   Abera, Semaw Ferede
   Kiadaliri, Aliasghar Ahmad
   Ahmed, Muktar Beshir
   Alam, Khurshid
   Alizadeh-Navaei, Reza
   Alkerwi, Ala'a
   Amini, Erfan
   Ammar, Walid
   Antonio, Carl Abelardo T.
   Atey, Tesfay Mehari
   Avila-Burgos, Leticia
   Awasthi, Ashish
   Barac, Aleksandra
   Berheto, Tezera Moshago
   Beyene, Addisu Shunu
   Beyene, Tariku Jibat
   Birungi, Charles
   Bizuayehu, Habtamu Mellie
   Breitborde, Nicholas J. K.
   Cahuana-Hurtado, Lucero
   Estanislao Castro, Ruben
   Catala-Lopez, Ferran
   Dalal, Koustuv
   Dandona, Lalit
   Dandona, Rakhi
   Dharmaratne, Samath D.
   Dubey, Manisha
   Faro, Ande
   Feigl, Andrea B.
   Fischer, Florian
   Fitchett, Joseph R. Anderson
   Foigt, Nataliya
   Giref, Ababi Zergaw
   Gupta, Rahul
   Hamidi, Samer
   Harb, Hilda L.
   Hay, Simon I.
   Hendrie, Delia
   Horino, Masako
   Jurisson, Mikk
   Jakovljevic, Mihajlo B.
   Javanbakht, Mehdi
   John, Denny
   Jonas, Jost B.
   Karimi, Seyed M.
   Khang, Young-Ho
   Khubchandani, Jagdish
   Kim, Yun Jin
   Kinge, Jonas M.
   Krohn, Kristopher J.
   Kumar, G. Anil
   Leung, Ricky
   Abd El Razek, Hassan Magdy
   Abd El Razek, Mohammed Magdy
   Majeed, Azeem
   Malekzadeh, Reza
   Malta, Deborah Carvalho
   Meretoja, Atte
   Miller, Ted R.
   Mirrakhimov, Erkin M.
   Mohammed, Shafiu
   Molla, Gedefaw
   Nangia, Vinay
   Olgiati, Stefano
   Owolabi, Mayowa O.
   Patel, Tejas
   Caicedo, Angel J. Paternina
   Pereira, David M.
   Perelman, Julian
   Polinder, Suzanne
   Rafay, Anwar
   Rahimi-Movaghar, Vafa
   Rai, Rajesh Kumar
   Ram, Usha
   Ranabhat, Chhabi Lal
   Roba, Hirbo Shore
   Savic, Miloje
   Sepanlou, Sadaf G.
   Te Ao, Braden J.
   Tesema, Azeb Gebresilassie
   Thomson, Alan J.
   Tobe-Gai, Ruoyan
   Topor-Madry, Roman
   Undurraga, Eduardo A.
   Vargas, Veronica
   Vasankari, Tommi
   Violante, Francesco S.
   Wijeratne, Tissa
   Xu, Gelin
   Yonemoto, Naohiro
   Younis, Mustafa Z.
   Yu, Chuanhua
   Zaidi, Zoubida
   Zaki, Maysaa El Sayed
   Murray, Christopher J. L.
CA Global Burden Dis Hlth Financing
TI Future and potential spending on health 2015-40: development assistance
   for health, and government, prepaid private, and out-of-pocket health
   spending in 184 countries
SO LANCET
LA English
DT Article
ID MEDICAL-CARE; PAYMENTS; DEMAND; INCOME; INSURANCE; POVERTY; CHOICE
AB Background The amount of resources, particularly prepaid resources, available for health can affect access to health care and health outcomes. Although health spending tends to increase with economic development, tremendous variation exists among health financing systems. Estimates of future spending can be beneficial for policy makers and planners, and can identify financing gaps. In this study, we estimate future gross domestic product (GDP), all-sector government spending, and health spending disaggregated by source, and we compare expected future spending to potential future spending.
   Methods We extracted GDP, government spending in 184 countries from 1980-2015, and health spend data from 1995-2014. We used a series of ensemble models to estimate future GDP, all-sector government spending, development assistance for health, and government, out-of-pocket, and prepaid private health spending through 2040. We used frontier analyses to identify patterns exhibited by the countries that dedicate the most funding to health, and used these frontiers to estimate potential health spending for each low-income or middle-income country. All estimates are inflation and purchasing power adjusted.
   Findings We estimated that global spending on health will increase from US$9.21 trillion in 2014 to $24.24 trillion (uncertainty interval [UI] 20.47-29.72) in 2040. We expect per capita health spending to increase fastest in upper-middle-income countries, at 5.3% (UI 4.1-6.8) per year. This growth is driven by continued growth in GDP, government spending, and government health spending. Lower-middle income countries are expected to grow at 4.2% (3.8-4.9). High-income countries are expected to grow at 2.1% (UI 1.8-2.4) and low-income countries are expected to grow at 1.8% (1.0-2.8). Despite this growth, health spending per capita in low-income countries is expected to remain low, at $154 (UI 133-181) per capita in 2030 and $195 (157-258) per capita in 2040. Increases in national health spending to reach the level of the countries who spend the most on health, relative to their level of economic development, would mean $321 (157-258) per capita was available for health in 2040 in low-income countries.
   Interpretation Health spending is associated with economic development but past trends and relationships suggest that spending will remain variable, and low in some low-resource settings. Policy change could lead to increased health spending, although for the poorest countries external support might remain essential.
C1 [Dieleman, Joseph L.; Campbell, Madeline; Chapin, Abigail; Eldrenkamp, Erika; Haakenstad, Annie; Li, Zhiyin; Matyasz, Taylor; Micah, Angela; Reynolds, Alex; Sadat, Nafis; Schneider, Matthew T.; Sorensen, Reed; Dandona, Lalit; Dandona, Rakhi; Hay, Simon I.; Krohn, Kristopher J.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Fan, Victoria Y.] Univ Hawaii Manoa, Honolulu, HI 96822 USA.
   [Fan, Victoria Y.] Harvard Univ, TH Chan Sch Publ Hlth, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA.
   [Feigl, Andrea B.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
   [Fan, Victoria Y.; Feigl, Andrea B.; Fitchett, Joseph R. Anderson] Harvard Univ, Boston, MA 02115 USA.
   [Fan, Victoria Y.] Ctr Global Dev, Washington, DC USA.
   [Kates, Jennifer] Kaiser Family Fdn, Washington, DC USA.
   [Abbas, Kaja M.] Virginia Tech, Blacksburg, VA USA.
   [Abera, Semaw Ferede] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia.
   [Atey, Tesfay Mehari; Tesema, Azeb Gebresilassie] Mekelle Univ, Mekelle, Ethiopia.
   [Abera, Semaw Ferede] Univ Hohenheim, Food Secur & Inst Biol Chem & Nutr, Stuttgart, Germany.
   [Kiadaliri, Aliasghar Ahmad] Lund Univ, Clin Epidemiol Unit, Dept Clin Sci Lund, Orthoped, Lund, Sweden.
   [Ahmed, Muktar Beshir] Jimma Univ, Dept Epidemiol ICT & E Learning Coordinator, Coll Hlth Sci, Jimma, Ethiopia.
   [Alam, Khurshid] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Alam, Khurshid] Univ Sydney, Sydney, NSW, Australia.
   [Alizadeh-Navaei, Reza] Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Sari, Iran.
   [Alkerwi, Ala'a] Luxembourg Inst Hlth, Strassen, Luxembourg.
   [Amini, Erfan] Univ Tehran Med Sci, Urooncol Res Ctr, Tehran, Iran.
   [Amini, Erfan] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Res Inst, Tehran, Iran.
   [Malekzadeh, Reza; Sepanlou, Sadaf G.] Univ Tehran Med Sci, Digest Dis Res Inst, Tehran, Iran.
   [Rahimi-Movaghar, Vafa] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran.
   [Ammar, Walid] Minist Publ Hlth, Beirut, Lebanon.
   [Antonio, Carl Abelardo T.] Univ Philippines Manila, Dept Hlth Policy & Adm, Manila, Philippines.
   [Avila-Burgos, Leticia; Cahuana-Hurtado, Lucero] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Awasthi, Ashish] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India.
   [Barac, Aleksandra] Univ Belgrade, Fac Med, Belgrade, Serbia.
   [Berheto, Tezera Moshago] Wolaita Sodo Univ, Coll Hlth Sci, Sch Publ Hlth, Wolaita Sodo, Ethiopia.
   [Beyene, Addisu Shunu; Roba, Hirbo Shore] Haramaya Univ, Coll Hlth & Med Sci, Harar, Ethiopia.
   [Beyene, Tariku Jibat; Giref, Ababi Zergaw] Addis Ababa Univ, Addis Ababa, Ethiopia.
   [Beyene, Tariku Jibat] Wageningen Univ, Wageningen, Netherlands.
   [Birungi, Charles] UCL, London, England.
   [Bizuayehu, Habtamu Mellie] Debre Markos Univ, Debre Markos, Ethiopia.
   [Breitborde, Nicholas J. K.] Ohio State Univ, Columbus, OH 43210 USA.
   [Estanislao Castro, Ruben] Univ Diego Port, Santiago, Chile.
   [Catala-Lopez, Ferran] Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain.
   [Catala-Lopez, Ferran] CIBERSAM, Valencia, Spain.
   [Catala-Lopez, Ferran] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.
   [Dalal, Koustuv] Orebro Univ, Sch Hlth & Med Sci, Ctr Injury Prevent & Safety Promot, Orebro, Sweden.
   [Dandona, Lalit; Dandona, Rakhi; Kumar, G. Anil] Publ Hlth Fdn India, New Delhi, India.
   [Dharmaratne, Samath D.] Univ Peradeniya, Fac Med, Dept Community Med, Peradeniya, Sri Lanka.
   [Dubey, Manisha; Ram, Usha] Int Inst Populat Sci, Mumbai, Maharashtra, India.
   [Faro, Ande] Univ Fed Sergipe, Aracaju, Brazil.
   [Fischer, Florian] Bielefeld Univ, Sch Publ Hlth, Bielefeld, Germany.
   [Foigt, Nataliya] Acad Med Sci, Inst Gerontol, Kiev, Ukraine.
   [Gupta, Rahul] West Virginia Bur Publ Hlth, Charleston, WV USA.
   [Hamidi, Samer] Hamdan Bin Mohammed Smart Univ, Dubai, U Arab Emirates.
   [Hay, Simon I.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford Big Data Inst, Oxford, England.
   [Hendrie, Delia] Curtin Univ, Ctr Populat Hlth Res, Bentley, WA, Australia.
   [Horino, Masako] Nevada Div Publ & Behav Hlth, Dept Hlth & Human Serv, Carson City, NV USA.
   [Jurisson, Mikk] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia.
   [Jakovljevic, Mihajlo B.] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia.
   [Javanbakht, Mehdi] Univ Aberdeen, Aberdeen, Scotland.
   [John, Denny] Int Ctr Res Women, New Delhi, India.
   [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.
   [Karimi, Seyed M.] Univ Washington Tacoma, Tacoma, WA USA.
   [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea.
   [Khubchandani, Jagdish] Ball State Univ, Muncie, IN USA.
   [Kim, Yun Jin] Southern Univ Coll, Skudai, Malaysia.
   [Kinge, Jonas M.; Savic, Miloje] Norwegian Inst Publ Hlth, Oslo, Norway.
   [Leung, Ricky] SUNY Albany, Rensselaer, NY USA.
   [Abd El Razek, Hassan Magdy] Mansoura Fac Med, Mansoura, Egypt.
   [Abd El Razek, Mohammed Magdy] Aswan Univ Hosp, Aswan Fac Med, Aswan, Egypt.
   [Majeed, Azeem] Imperial Coll London, London, England.
   [Malta, Deborah Carvalho] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Meretoja, Atte] Univ Melbourne, Dept Med, Melbourne, Vic, Australia.
   [Meretoja, Atte] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland.
   [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA.
   [Miller, Ted R.] Curtin Univ, Ctr Populat Hlth, Perth, WA, Australia.
   [Mirrakhimov, Erkin M.] Kyrgyz State Med Acad, Bishkek, Kyrgyzstan.
   [Mirrakhimov, Erkin M.] Natl Ctr Cardiol & Internal Dis, Bishkek, Kyrgyzstan.
   [Mohammed, Shafiu] Ahmadu Bello Univ, Hlth Syst & Policy Res Unit, Zaria, Nigeria.
   [Mohammed, Shafiu] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Molla, Gedefaw] Fed Minist Hlth, Addis Ababa, Ethiopia.
   [Nangia, Vinay] Suraj Eye Inst, Nagpur, Maharashtra, India.
   [Olgiati, Stefano] State Univ Bergamo, Bergamo, Italy.
   [Owolabi, Mayowa O.] Dept Med, Ibadan, Nigeria.
   [Owolabi, Mayowa O.] Blossom Specialist Med Ctr, Ibadan, Nigeria.
   [Patel, Tejas] Mt Sinai Hlth Syst, New York, NY USA.
   [Caicedo, Angel J. Paternina] Univ Cartagena, Cartagena, Colombia.
   [Caicedo, Angel J. Paternina] Univ Pittsburgh, Publ Hlth Dynam Lab, Pittsburgh, PA USA.
   [Pereira, David M.] Univ Porto, Fac Farm, Dept Quim, REQUIMTE LAQV,Lab Farmacognosia, Oporto, Portugal.
   [Perelman, Julian] Natl Sch Publ Hlth, Lisbon, Portugal.
   [Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.
   [Rafay, Anwar] Contech Int Hlth Consultants, Lahore, Pakistan.
   [Rai, Rajesh Kumar] Soc Hlth & Demog Surveillance, Suri, India.
   [Ranabhat, Chhabi Lal] Yonsei Univ, Inst Poverty Alleviat & Int Dev, Wonju Coll Med, Seoul, South Korea.
   [Te Ao, Braden J.] Auckland Univ Technol, Auckland, New Zealand.
   [Thomson, Alan J.] Adapt Knowledge Management, Victoria, BC, Canada.
   [Tobe-Gai, Ruoyan] Natl Ctr Child Hlth & Dev, Tokyo, Japan.
   [Topor-Madry, Roman] Jagiellonian Univ, Med Coll, Fac Hlth Sci, Inst Publ Hlth, Krakow, Poland.
   [Topor-Madry, Roman] Wroclaw Med Univ, Fac Hlth Sci, Wroclaw, Poland.
   [Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA.
   [Vargas, Veronica] Univ Alberto Hurtado, Santiago, Chile.
   [Vasankari, Tommi] UKK Inst Hlth Promot Res, Tampere, Finland.
   [Violante, Francesco S.] Univ Bologna, Bologna, Italy.
   [Wijeratne, Tissa] Western Hlth, Footscray, Vic, Australia.
   [Xu, Gelin] Nanjing Univ, Sch Med, Dept Neurol, Jinling Hosp, Nanjing, Jiangsu, Peoples R China.
   [Yonemoto, Naohiro] Kyoto Univ, Dept Biostat, Sch Publ Hlth, Kyoto, Japan.
   [Younis, Mustafa Z.] Jackson State Univ, Jackson, MS USA.
   [Yu, Chuanhua] Wuhan Univ, Global Hlth Inst, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan, Peoples R China.
   [Zaidi, Zoubida] Univ Hosp, Setif, Algeria.
   [Zaki, Maysaa El Sayed] Mansoura Univ, Fac Med, Mansoura, Egypt.
RP Dieleman, JL (reprint author), 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.
EM dieleman@uw.edu
RI Pereira, David/M-9286-2013; John, Denny/J-7815-2017; Perelman,
   Julian/B-4350-2013
OI Pereira, David/0000-0003-0384-7592; John, Denny/0000-0002-4486-632X;
   Perelman, Julian/0000-0001-6634-9000; Awasthi,
   Ashish/0000-0002-9308-9782; Abbas, Kaja/0000-0003-0563-1576;
   Catala-Lopez, Ferran/0000-0002-3833-9312; Wijeratne,
   Tissa/0000-0002-1701-7111; Hay, Simon/0000-0002-0611-7272
FU Bill AMP; Melinda Gates Foundation
FX Bill & Melinda Gates Foundation.
CR Alleyne GAO, 2002, HLTH EC GROWTH POVER
   Belay T, ASSESSING FISCAL SPA
   Damme WV, 2004, TROP MED INT HEALTH, V9, P273, DOI DOI 10.1046/J.1365-3156.2003.01194.X
   Dieleman JL, 2016, LANCET
   Dieleman JL, 2017, LANCET
   Dieleman JL, 2016, LANCET, V387, P2536, DOI 10.1016/S0140-6736(16)30168-4
   Durairaj V, 2010, FISCAL SPACE HLTH RE
   Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X
   Fan VY, 2014, SOC SCI MED, V105, P112, DOI 10.1016/j.socscimed.2014.01.014
   Feenstra RC, 2015, AM ECON REV, V105, P3150, DOI 10.1257/aer.20130954
   Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1
   Galbraith AA, 2005, HEALTH SERV RES, V40, P1722, DOI 10.1111/j.1475-6773.2005.00421.x
   Global Health Data Exchange, FIN GLOB HLTH 1995 2
   Gotsadze G, 2005, HEALTH POLICY PLANN, V20, P232, DOI 10.1093/heapol/czi029
   Gupta Indrani, 2013, J Health Care Finance, V39, P68
   Hoeting JA, 1999, STAT SCI, V14, P382
   Honaker J, 2011, J STAT SOFTW, V45, P1
   Ichoku HE, 2013, AFR J HLTH EC, V2, P52
   International Monetary Fund, 2016, WORLD EC OUTLOOK DAT
   Jakovljevic M., 2016, HEALTH ECON, DOI [10.1002/hec.3406, DOI 10.1002/HEC.3406]
   Jakovljevic M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00021
   James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12
   Krishnamurti TN, 2000, J CLIMATE, V13, P4196, DOI 10.1175/1520-0442(2000)013<4196:MEFFWA>2.0.CO;2
   MANNING WG, 1987, AM ECON REV, V77, P251
   McIntyre D, 2014, FISCAL SPACE DOMESTI
   Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2
   MWABU G, 1993, J HUM RESOUR, V28, P838, DOI 10.2307/146295
   Piette JD, 2004, DIABETES CARE, V27, P384, DOI 10.2337/diacare.27.2.384
   Remme M, 2016, SOC SCI MED, V169, P66, DOI 10.1016/j.socscimed.2016.09.027
   Sahn DE, 2003, OXFORD B ECON STAT, V65, P241, DOI 10.1111/1468-0084.t01-2-00046
   SCHWARTZ JB, 1988, WORLD BANK ECON REV, V2, P49, DOI 10.1093/wber/2.1.49
   UN Transforming Our World, TRANSF OUR WORLD 203
   UN Department of Economic and Social Affairs. Financing for development office, 2015, DFDFD
   United Nations Statistics Division, NAT ACCOUNTS
   van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3
   Vargas V, 2016, FISCAL SPACE HLTH BA
   Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972
   Yip WC, 1998, HEALTH POLICY PLANN, V13, P311, DOI 10.1093/heapol/13.3.311
NR 38
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 20
PY 2017
VL 389
IS 10083
BP 2005
EP 2030
DI 10.1016/S0140-6736(17)30873-5
PG 26
WC Medicine, General & Internal
SC General & Internal Medicine
GA EV1OH
UT WOS:000401515300024
PM 28433260
OA No
DA 2017-08-17
ER

PT J
AU Ghorab, MM
   El-Gaby, MSA
   Soliman, AM
   Alsaid, MS
   Abdel-Aziz, MM
   Elaasser, MM
AF Ghorab, Mostafa M.
   El-Gaby, Mohamed S. A.
   Soliman, Aiten M.
   Alsaid, Mansour S.
   Abdel-Aziz, Marwa M.
   Elaasser, Mahmoud M.
TI Synthesis, docking study and biological evaluation of some new thiourea
   derivatives bearing benzenesulfonamide moiety
SO CHEMISTRY CENTRAL JOURNAL
LA English
DT Article
DE Thiourea; Sulfonamides; Structure-activity relationship;
   Antimycobacterial
ID MYCOBACTERIUM-TUBERCULOSIS; IN-VITRO; ANTIMYCOBACTERIAL ACTIVITY;
   ANTITUBERCULOSIS AGENTS; ANTICANCER AGENTS; DESIGN; DRUGS; ANALOGS
AB Background: A series of novel N-(2, 6-dimethoxypyrimidin-4-yl)-4-(3-(aryl) thioureido) benzenesulfonamides 3a-t was synthesized by the addition of N-(2,6-dimethoxypyrimidin-4-yl)-4-isothiocyanatobenzenesulfonamide 2 to the appropriate aromatic amine. The structures of the synthesized compounds were inspired from the second line antituberculosis pro-drugs.
   Results: Most of the new compounds were screened for their activity against Mycobacterium tuberculosis. The results of the antimycobacterial assay showed that compound 3i exerted the highest activity (MIC = 3.13 mu g/mL), followed by compound 3s (MIC = 6.25 mu g/mL).
   Conclusion: The structure-activity relationship (SAR) analysis revealed that the introduction of the benzo[1,3] dioxol moiety in 3i and the 4-morpholinyl-4-phenyl moiety in 3s has proven to give the most potent compounds in this study. Docking of the promising compounds inside the active site of M. tuberculosis enoyl reductase InhA was performed in order to emphasize the results. The compounds showed a similar orientation to that of GSK 625 inside the active site of 5JFO and bind to Met 98 in a way similar to that of the co-crystallized ligand.
C1 [Ghorab, Mostafa M.; Alsaid, Mansour S.] King Saud Univ, Coll Pharm, Dept Pharmacognosy, POB 2457, Riyadh 11451, Saudi Arabia.
   [Ghorab, Mostafa M.; Soliman, Aiten M.] Atom Energy Author, Dept Drug Radiat Res, Natl Ctr Radiat Res & Technol, Cairo 113701, Egypt.
   [El-Gaby, Mohamed S. A.] Al Azhar Univ, Dept Chem, Fac Sci, Assiut 71524, Egypt.
   [Abdel-Aziz, Marwa M.; Elaasser, Mahmoud M.] Al Azhar Univ, Reg Ctr Mycol & Biotechnol, Cairo, Egypt.
RP Ghorab, MM (reprint author), King Saud Univ, Coll Pharm, Dept Pharmacognosy, POB 2457, Riyadh 11451, Saudi Arabia.; Ghorab, MM (reprint author), Atom Energy Author, Dept Drug Radiat Res, Natl Ctr Radiat Res & Technol, Cairo 113701, Egypt.
EM mmsghorab@yahoo.com
FU Deanship of Scientific Research at King Saud University [RGP-302]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at King Saud University for its funding
   of this research through the Research Group Project no. RGP-302.
CR Ahmed E.M., 2011, CHEM SIN, V2, P197
   Bhowruth V, 2006, BIOORG MED CHEM LETT, V16, P4743, DOI 10.1016/j.bmcl.2006.06.095
   Burger A, 1990, COMPREHENSIVE MED CH
   Chollet A, 2015, EUR J MED CHEM, V101, P218, DOI 10.1016/j.ejmech.2015.06.035
   Christensen H, 1999, MOL MICROBIOL, V31, P1561, DOI 10.1046/j.1365-2958.1999.01304.x
   Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004
   Dobrikov GM, 2013, EUR J MED CHEM, V63, P468, DOI 10.1016/j.ejmech.2013.02.034
   El-Gaby MSA, 2009, PHOSPHORUS SULFUR, V184, P2645, DOI 10.1080/10426500802561096
   El-Gaby MSA, 2002, J CHIN CHEM SOC-TAIP, V49, P407
   El Ella DAA, 2012, MED CHEM RES, V21, P2395
   Eswaran S, 2010, BIOORG MED CHEM LETT, V20, P1040, DOI 10.1016/j.bmcl.2009.12.045
   Gemma S, 2009, BIOORGAN MED CHEM, V17, P6063, DOI 10.1016/j.bmc.2009.06.051
   Ghorab MM, 2016, EUR J MED CHEM, V124, P299, DOI 10.1016/j.ejmech.2016.08.060
   Ghorab MM, 2016, EUR J MED CHEM, V117, P8, DOI 10.1016/j.ejmech.2016.04.009
   Kucukguzel I, 2001, MED CHEM LETT, V11, P1703
   Kucukguzel I, 2008, EUR J MED CHEM, V43, P381, DOI 10.1016/j.ejmech.2007.04.010
   Maccari R, 2005, BIOORG MED CHEM LETT, V15, P2509, DOI 10.1016/j.bmcl.2005.03.065
   Martinez-Hoyos M, 2016, EBIOMEDICINE, V8, P291, DOI 10.1016/j.ebiom.2016.05.006
   Milosavljevic MM, 2016, J SERB CHEM SOC, V81, P219, DOI 10.2298/JSC150831087M
   Mitnick CD, 2009, EXPERT OPIN PHARMACO, V10, P381, DOI [10.1517/14656560802694564 , 10.1517/14656560802694564]
   Rodrigues MO, 2013, BIOORGAN MED CHEM, V21, P6910, DOI 10.1016/j.bmc.2013.09.034
   Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628
   Sharma S, 1989, SULFUR REPORTS, V8, P327
   Shaw JW, 2015, TOP HETEROCYCL CHEM, V50, P1
   Shiradkar M, 2007, EUR J MED CHEM, V42, P807, DOI 10.1016/j.ejmech.2006.12.001
   Shutalev AD, 1999, P ECSOC 3 3 INT EL C, P1
   Sriram D, 2006, BIOORG MED CHEM LETT, V16, P876, DOI 10.1016/j.bmcl.2005.11.004
   Sriram D, 2007, J ANTIMICROB CHEMOTH, V59, P1194, DOI 10.1093/jac/dkm085
   Stark H, 1996, J MED CHEM, V39, P1157, DOI 10.1021/jm9507688
   Tatar E, 2016, BIOL PHARM BULL, V39, P502, DOI 10.1248/bpb.b15-00698
   Van Poecke S, 2011, BIOORGAN MED CHEM, V19, P7603, DOI 10.1016/j.bmc.2011.10.021
   Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346
   Vistoli G, 2008, DRUG DISCOV TODAY, V13, P285, DOI 10.1016/j.drudis.2007.11.007
   WHO, 2015, GLOB TUB REP 2015
   Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001
NR 35
TC 0
Z9 0
U1 3
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-153X
J9 CHEM CENT J
JI Chem. Cent. J.
PD MAY 19
PY 2017
VL 11
AR 42
DI 10.1186/s13065-017-0271-7
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA EW3ZN
UT WOS:000402441900002
OA gold
DA 2017-08-17
ER

PT J
AU Zaghloul, EM
   Gissberg, O
   Moreno, PMD
   Siggens, L
   Hallbrink, M
   Jorgensen, AS
   Ekwall, K
   Zain, R
   Wengel, J
   Lundin, KE
   Smith, CIE
AF Zaghloul, Eman M.
   Gissberg, Olof
   Moreno, Pedro M. D.
   Siggens, Lee
   Hallbrink, Mattias
   Jorgensen, Anna S.
   Ekwall, Karl
   Zain, Rula
   Wengel, Jesper
   Lundin, Karin E.
   Smith, C. I. Edvard
TI CTG repeat-targeting oligonucleotides for down-regulating Huntingtin
   expression
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID ALLELE-SELECTIVE INHIBITION; LOCKED NUCLEIC-ACIDS; CELL-PENETRATING
   PEPTIDE; EXPANDED CAG REPEATS; MUTANT HUNTINGTIN; ANTISENSE
   OLIGONUCLEOTIDES; DISEASE GENE; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; SOLID
   FORMULATION; RNA INTERFERENCE
AB Huntington's disease (HD) is a fatal, neurodegenerative disorder in which patients suffer from mobility, psychological and cognitive impairments. Existing therapeutics are only symptomatic and do not significantly alter the disease progression or increase life expectancy. HD is caused by expansion of the CAG trinucleotide repeat region in exon 1 of the Huntingtin gene (HTT), leading to the formation of mutant HTT transcripts (muHTT). The toxic gain-of-function of muHTT protein is a major cause of the disease. In addition, it has been suggested that the muHTT transcript contributes to the toxicity. Thus, reduction of both muHTT mRNA and protein levels would ideally be the most useful therapeutic option. We herein present a novel strategy for HD treatment using oligonucleotides (ONs) directly targeting the HTT trinucleotide repeat DNA. A partial, but significant and potentially long-term, HTT knock-down of both mRNA and protein was successfully achieved. Diminished phosphorylation of HTT gene-associated RNA-polymerase II is demonstrated, suggestive of reduced transcription downstream the ON-targeted repeat. Different backbone chemistries were found to have a strong impact on the ON efficiency. We also successfully use different delivery vehicles as well as naked uptake of the ONs, demonstrating versatility and possibly providing insights for in vivo applications.
C1 [Zaghloul, Eman M.; Gissberg, Olof; Moreno, Pedro M. D.; Lundin, Karin E.; Smith, C. I. Edvard] Karolinska Inst, Clin Res Ctr, Dept Lab Med, SE-14186 Stockholm, Sweden.
   [Zaghloul, Eman M.] Alexandria Univ, Fac Pharm, Dept Pharmaceut, El Khartoum Sq, Alexandria 21521, Egypt.
   [Moreno, Pedro M. D.] Univ Porto, Inst Engn Biomed, P-4200135 Oporto, Portugal.
   [Moreno, Pedro M. D.] Univ Porto, Inst Invest & Inovacao Saude, P-4200135 Oporto, Portugal.
   [Siggens, Lee; Ekwall, Karl] Karolinska Inst, Dept Biosci & Nutr, SE-14186 Huddinge, Sweden.
   [Hallbrink, Mattias] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden.
   [Jorgensen, Anna S.; Wengel, Jesper] Univ Southern Denmark, Nucle Acid Ctr, Dept Phys & Chem, DK-5230 Odense, Denmark.
   [Zain, Rula] Karolinska Univ Hosp, Ctr Rare Dis, Dept Clin Genet, SE-17176 Stockholm, Sweden.
RP Zaghloul, EM; Smith, CIE (reprint author), Karolinska Inst, Clin Res Ctr, Dept Lab Med, SE-14186 Stockholm, Sweden.; Zaghloul, EM (reprint author), Alexandria Univ, Fac Pharm, Dept Pharmaceut, El Khartoum Sq, Alexandria 21521, Egypt.
EM eman.zaghloul@ki.se; edvard.smith@ki.se
OI Wengel, Jesper/0000-0001-9835-1009
FU Swedish Medical Research Council; CHDI Foundation, USA; EU Marie
   Sklodowska-Curie [MMBio] [ITN 71613]; Hjarnfonden (The Brain Foundation,
   Stockholm); Tore Nilsson stiftelser, Stockholm; Swedish Cancer
   Foundation
FX Swedish Medical Research Council (to C.I.E.S., K.E.); CHDI Foundation,
   USA (to C.I.E.S.); EU Marie Sklodowska-Curie [ITN 71613, MMBio] (to
   C.I.E.S.); Hjarnfonden (The Brain Foundation, Stockholm) and (for the
   project consumables) Tore Nilsson stiftelser, Stockholm (both to
   E.M.Z.); Swedish Cancer Foundation (to C.I.E.S., K.E.). Funding for open
   access charge: Swedish Medical Research Council.
CR AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483
   Aronin N, 2012, NEW ENGL J MED, V367, P1753, DOI 10.1056/NEJMcibr1209595
   Banez-Coronel M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002481
   Beane RL, 2007, BIOCHEMISTRY-US, V46, P7572, DOI 10.1021/bi700227g
   Bestas B, 2014, J CLIN INVEST, V124, P4067, DOI 10.1172/JCI76175
   Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17
   Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201
   Chung DW, 2011, HUM MOL GENET, V20, P3467, DOI 10.1093/hmg/ddr263
   de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Duzdevich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017119
   Evers MM, 2014, NUCLEIC ACID THER, V24, P4, DOI 10.1089/nat.2013.0452
   Ezzat K, 2012, J CONTROL RELEASE, V162, P1, DOI 10.1016/j.jconrel.2012.06.006
   Ezzat K, 2011, NUCLEIC ACIDS RES, V39, P5284, DOI 10.1093/nar/gkr072
   Fiszer A, 2013, NUCLEIC ACIDS RES, V41, P10426, DOI 10.1093/nar/gkt825
   Fiszer A, 2013, J MOL MED, V91, P683, DOI 10.1007/s00109-013-1016-2
   Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156
   Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k
   Galka-Marciniak P, 2012, BIOL CHEM, V393, P1299, DOI 10.1515/hsz-2012-0218
   Garriga-Canut M, 2012, P NATL ACAD SCI USA, V109, pE3136, DOI 10.1073/pnas.1206506109
   Ge R, 2008, J GENE MED, V10, P101, DOI 10.1002/jgm.1124
   Ge RB, 2007, FASEB J, V21, P1902, DOI 10.1096/fj.06-7225com
   GIOVANNANGELI C, 1992, P NATL ACAD SCI USA, V89, P8631, DOI 10.1073/pnas.89.18.8631
   Godinho BMDC, 2015, DRUG DISCOV TODAY, V20, P50, DOI 10.1016/j.drudis.2014.09.011
   Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333
   HANVEY JC, 1990, NUCLEIC ACIDS RES, V18, P157, DOI 10.1093/nar/18.1.157
   Harper SQ, 2009, ARCH NEUROL-CHICAGO, V66, P933, DOI 10.1001/archneurol.2009.180
   Hu JX, 2014, NUCLEIC ACID THER, V24, P199, DOI 10.1089/nat.2013.0476
   Hu JX, 2010, CHEM BIOL, V17, P1183, DOI 10.1016/j.chembiol.2010.10.013
   Hu JX, 2009, NAT BIOTECHNOL, V27, P478, DOI 10.1038/nbt.1539
   Johannsen MW, 2011, ORG BIOMOL CHEM, V9, P243, DOI 10.1039/c0ob00532k
   Kay C, 2014, CLIN GENET, V86, P29, DOI 10.1111/cge.12385
   Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700
   Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009
   Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127
   Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031
   Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911
   Leavitt B., 2016, NEUROLOGY, V86
   Lee JM, 2012, AM J HUM GENET, V90, P434, DOI 10.1016/j.ajhg.2012.01.005
   Liang XH, 2015, NUCLEIC ACIDS RES, V43, P2927, DOI 10.1093/nar/gkv143
   Liang XH, 2014, NUCLEIC ACIDS RES, V42, P7819, DOI 10.1093/nar/gku484
   Ling JQ, 2011, BBA-GENE REGUL MECH, V1809, P24, DOI 10.1016/j.bbagrm.2010.11.004
   Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220
   Lundin KE, 2015, HUM GENE THER, V26, P475, DOI 10.1089/hum.2015.070
   Lundin KE, 2013, ADV GENET, V82, P47, DOI 10.1016/B978-0-12-407676-1.00002-0
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Madsen AS, 2012, J ORG CHEM, V77, P10718, DOI 10.1021/jo302036h
   McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219
   Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977
   Moreno PMD, 2013, NUCLEIC ACIDS RES, V41, P3257, DOI 10.1093/nar/gkt007
   Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608
   Omi K, 2005, BIOCHEM BIOPH RES CO, V338, P1229, DOI 10.1016/j.bbrc.2005.10.061
   Ostergaard ME, 2015, NUCLEIC ACID THER, V25, P266, DOI 10.1089/nat.2015.0547
   Persichetti F, 1996, NEUROBIOL DIS, V3, P183, DOI 10.1006/nbdi.1996.0018
   Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006
   Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075
   Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006
   Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3
   Rubinsztein David C, 2003, Expert Rev Mol Med, V5, P1
   Rue L, 2016, J CLIN INVEST, V126, P4319, DOI 10.1172/JCI83185
   Simon P, 2008, BIOCHIMIE, V90, P1109, DOI 10.1016/j.biochi.2008.04.004
   Simpson SA, 2007, BRAIN RES BULL, V72, P179, DOI 10.1016/j.brainresbull.2006.10.022
   Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c
   Skotte NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107434
   Snowden JS, 2002, J CLIN EXP NEUROPSYC, V24, P133, DOI 10.1076/jcen.24.2.133.998
   Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200
   Soifer HS, 2012, METHODS MOL BIOL, V815, P333, DOI 10.1007/978-1-61779-424-7_25
   Southwell AL, 2014, MOL THER, V22, P2093, DOI 10.1038/mt.2014.153
   Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841
   Sun X, 2014, HUM MOL GENET, V23, P6302, DOI 10.1093/hmg/ddu349
   Torres Adrian G, 2011, Artif DNA PNA XNA, V2, P71
   van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116
   Verhaart IEC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.1
   WEIDNER DA, 1995, FEBS LETT, V366, P146, DOI 10.1016/0014-5793(95)00517-D
   Wengel J, 2001, NUCLEOS NUCLEOT NUCL, V20, P389, DOI 10.1081/NCN-100002312
   Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002
   Zaghloul EM, 2011, NUCLEIC ACIDS RES, V39, P1142, DOI 10.1093/nar/gkq835
   ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155
NR 78
TC 0
Z9 0
U1 4
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD MAY 19
PY 2017
VL 45
IS 9
BP 5153
EP 5169
DI 10.1093/nar/gkx111
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EV8WE
UT WOS:000402064200022
PM 28334749
OA gold
DA 2017-08-17
ER

PT J
AU Sirunyan, AM
   Tumasyan, A
   Adam, W
   Asilar, E
   Bergauer, T
   Brandstetter, J
   Brondolin, E
   Dragicevic, M
   Ero, J
   Flechl, M
   Friedl, M
   Fruhwirth, R
   Ghete, VM
   Hartl, C
   Hormann, N
   Hrubec, J
   Jeitler, M
   Konig, A
   Kratschmer, I
   Liko, D
   Matsushita, T
   Mikulec, I
   Rabady, D
   Rad, N
   Rahbaran, B
   Rohringer, H
   Schieck, J
   Strauss, J
   Waltenberger, W
   Wulz, CE
   Chekhovsky, V
   Dvornikov, O
   Dydyshka, Y
   Emeliantchik, I
   Litomin, A
   Makarenko, V
   Mossolov, V
   Stefanovitch, R
   Gonzalez, JS
   Zykunov, V
   Shumeiko, N
   Alderweireldt, S
   De Wolf, EA
   Janssen, X
   Lauwers, J
   de Klundert, MV
   Van Haevermaet, H
   Van Mechelen, P
   Van Remortel, N
   Van Spilbeeck, A
   Abu Zeid, S
   Blekman, E
   D'Hondt, J
   Daci, N
   De Bruyn, I
   Deroover, K
   Lowette, S
   Moortgat, S
   Moreels, L
   Olbrechts, A
   Python, Q
   Skovpen, K
   Tavernier, S
   Van Doninck, W
   Van Mulders, P
   Van Parijs, I
   Brun, H
   Clerbaux, B
   De Lentdecker, G
   Delannoy, H
   Fasanella, G
   Favart, L
   Goldouzian, R
   Grebenyuk, A
   Karapostoli, G
   Lenzi, T
   Leonard, A
   Luetic, J
   Maerschalk, T
   Marinov, A
   Randle-Conde, A
   Seva, T
   Velde, CV
   Vanlaer, P
   Vannerom, D
   Yonamine, R
   Zenoni, F
   Zhang, F
   Cimmino, A
   Cornelis, T
   Dobur, D
   Fagot, A
   Gul, M
   Khvastunov, I
   Poyraz, D
   Salva, S
   Schofbeck, R
   Tytgat, M
   Van Driessche, W
   Yazgan, E
   Zaganidis, N
   Bakhshiansohi, H
   Beluffi, C
   Bondu, O
   Brochet, S
   Bruno, G
   Caudron, A
   De Visscher, S
   Delaere, C
   Delcourt, M
   Francois, B
   Giammanco, A
   Jafari, A
   Komm, M
   Krintiras, G
   Lemaitre, V
   Magitteri, A
   Mertens, A
   Musich, M
   Piotrzkowski, K
   Quertenmont, L
   Selvaggi, M
   Marono, MV
   Wertz, S
   Beliy, N
   Alda, WL
   Alves, FL
   Alves, GA
   Brito, L
   Hensel, C
   Moraes, A
   Pol, ME
   Teles, PR
   Das Chagas, EB
   Carvalho, W
   Chinellato, J
   Custodio, A
   Costa, EMD
   Da Silveira, GG
   Damiao, DD
   Martins, CD
   De Souza, SF
   Guativa, LMH
   Malbouisson, H
   Figueiredo, DM
   Herrera, CM
   Mundim, L
   Nogima, H
   Da Silva, WLP
   Santoro, A
   Sznajder, A
   Manganote, EJT
   Pereira, AV
   Ahuja, S
   Bernardes, CA
   Dogra, S
   Tomei, TRFP
   Gregores, EM
   Mercadante, PG
   Moon, CS
   Novaes, SF
   Padula, SS
   Abad, DR
   Vargas, JCR
   Aleksandrov, A
   Hadjiiska, R
   Iaydjiev, P
   Rodozov, M
   Stoykova, S
   Sultanov, G
   Vutova, M
   Dimitrov, A
   Glushkov, I
   Litov, L
   Pavlov, B
   Petkov, P
   Fang, W
   Ahmad, M
   Bian, JG
   Chen, GM
   Chen, HS
   Chen, M
   Chen, Y
   Cheng, T
   Jiang, CH
   Leggat, D
   Liu, Z
   Romeo, F
   Ruan, M
   Shaheen, SM
   Spiezia, A
   Tao, J
   Wang, C
   Wang, Z
   Zhang, H
   Zhao, J
   Ban, Y
   Chen, G
   Li, Q
   Liu, S
   Mao, Y
   Qian, SJ
   Wang, D
   Xu, Z
   Avila, C
   Cabrera, A
   Sierra, LFC
   Florez, C
   Gomez, JP
   Hernandez, CFG
   Alvarez, JDR
   Sanabria, JC
   Godinovic, N
   Lelas, D
   Puljak, I
   Cipriano, PMR
   Sculac, T
   Antunovic, Z
   Kovac, M
   Brigljevic, V
   Ferencek, D
   Kadija, K
   Mesic, B
   Susa, T
   Attikis, A
   Mavromanolakis, G
   Mousa, J
   Nicolaou, C
   Ptochos, F
   Razis, PA
   Rykaczewski, H
   Tsiakkouri, D
   Finger, M
   Finger, M
   Jarrin, EC
   Assran, Y
   Elkafrawy, T
   Mahrous, A
   Kadastik, M
   Perrini, L
   Raidal, M
   Tiko, A
   Veelken, C
   Eerola, P
   Pekkanen, J
   Voutilainen, M
   Harkonen, J
   Jarvinen, T
   Karimaki, V
   Kinnunen, R
   Lampen, T
   Lassila-Perini, K
   Lehti, S
   Linden, T
   Luukka, P
   Tuominiemi, J
   Tuovinen, E
   Wendland, L
   Talvitie, J
   Tuuva, T
   Besancon, M
   Couderc, F
   Dejardin, M
   Denegri, D
   Fabbro, B
   Faure, JL
   Favaro, C
   Ferri, F
   Ganjour, S
   Ghosh, S
   Givernaud, A
   Gras, P
   de Monchenault, GH
   Jarry, P
   Kucher, I
   Locci, E
   Machet, M
   Malcies, J
   Rander, J
   Rosowsky, A
   Titov, M
   Abdulsalam, A
   Antropov, I
   Baffioni, S
   Beaudette, F
   Busson, P
   Cadamuro, L
   Chapon, E
   Chariot, C
   Davignon, O
   de Cassagnac, RG
   Jo, M
   Lisniak, S
   Mine, P
   Nguyen, M
   Ochando, C
   Ortona, G
   Paganini, P
   Pigard, P
   Regnard, S
   Salerno, R
   Sirois, Y
   Strebler, T
   Yilmaz, Y
   Zabi, A
   Zghiche, A
   Agram, JL
   Andrea, J
   Aubin, A
   Bloch, D
   Brom, JM
   Buttignol, M
   Chabert, EC
   Chanon, N
   Collard, C
   Conte, E
   Coubez, X
   Fontaine, JC
   Gele, D
   Goerlach, U
   Jansova, M
   Le Bihan, AC
   Van Hove, P
   Gadrat, S
   Beauceron, S
   Bernet, C
   Boudoul, G
   Montoya, CAC
   Chierici, R
   Contardo, D
   Courbon, B
   Depasse, P
   El Mamouni, H
   Fan, J
   Fay, J
   Gascon, S
   Gouzevitch, M
   Grenier, G
   Ille, B
   Lagarde, F
   Laktineh, IB
   Lethuillier, M
   Mirabito, L
   Pequegnot, AL
   Perries, S
   Popov, A
   Sabes, D
   Sordini, V
   Donckt, MV
   Verdier, P
   Viret, S
   Khvedelidze, A
   Tsamalaidze, Z
   Autermann, C
   Beranek, S
   Feld, L
   Kiesel, MK
   Klein, K
   Lipinski, M
   Preuten, M
   Schomakers, C
   Schulz, J
   Verlage, T
   Zhukov, V
   Albert, A
   Brodski, M
   Dietz-Laursonn, E
   Duchardt, D
   Endres, M
   Erdmann, M
   Erdweg, S
   Esch, T
   Fischer, R
   Guth, A
   Hamer, M
   Hebbeker, T
   Heidemann, C
   Hoepfner, K
   Knutzen, S
   Merschmeyer, M
   Meyer, A
   Millet, P
   Mukherjee, S
   Olschewski, M
   Padeken, K
   Pook, T
   Radziej, M
   Reithler, H
   Rieger, M
   Scheuch, F
   Sonnenschein, L
   Teyssier, D
   Thuer, S
   Cherepanov, V
   Flugge, G
   Kargoll, B
   Kress, T
   Kunsken, A
   Lingemann, J
   Muller, T
   Nehrkorn, A
   Nowack, A
   Pistone, C
   Pooth, O
   Stahl, A
   Martin, MA
   Arndt, T
   Asawatangtrakuldee, C
   Beernaert, K
   Behnke, O
   Behrens, U
   Bin Anuar, AA
   Borras, K
   Campbell, A
   Connor, P
   Contreras-Campana, C
   Costanza, F
   Pardos, CD
   Dolinska, G
   Eckerlin, G
   Eckstein, D
   Eichhorn, T
   Eren, E
   Gallo, E
   Garcia, JG
   Geiser, A
   Gizhko, A
   Luyando, JMG
   Grohsjean, A
   Gunnellini, P
   Harb, A
   Hauk, J
   Hempel, M
   Jung, H
   Kalogeropoulos, A
   Karacheban, O
   Kasemann, M
   Keaveney, J
   Kleinwort, C
   Korol, I
   Krucker, D
   Lange, W
   Lelek, A
   Leonard, J
   Lipka, K
   Lobanov, A
   Lohmann, W
   Mankel, R
   Melzer-Pellmann, IA
   Meyer, AB
   Mittag, G
   Mnich, J
   Mussgiller, A
   Ntomari, E
   Pitzl, D
   Placakyte, R
   Raspereza, A
   Roland, B
   Sahin, MO
   Saxena, P
   Schoerner-Sadenius, T
   Seitz, C
   Spannagel, S
   Stefaniuk, N
   Van Onsem, GP
   Walsh, R
   Wissing, C
   Blobel, V
   Vignali, MC
   Draeger, AR
   Dreyer, T
   Garutti, E
   Gonzalez, D
   Haller, J
   Hoffmann, M
   Junkes, A
   Klanner, R
   Kogler, R
   Kovalchuk, N
   Lapsien, T
   Lenz, T
   Marchesini, I
   Marconi, D
   Meyer, M
   Niedziela, M
   Nowatschin, D
   Pantaleo, F
   Peiffer, T
   Perieanu, A
   Poehlsen, J
   Sander, C
   Scharf, C
   Schleper, P
   Schmidt, A
   Schumann, S
   Schwandt, J
   Stadie, H
   Steinbruck, G
   Stober, FM
   Stover, M
   Tholen, H
   Troendle, D
   Usai, E
   Vanelderen, L
   Vanhoefer, A
   Vormwald, B
   Akbiyik, M
   Barth, C
   Baur, S
   Baus, C
   Berger, J
   Butz, F
   Caspart, R
   Chwalek, T
   Colombo, F
   De Boer, W
   Dierlamm, A
   Fink, S
   Freund, B
   Friese, R
   Giffels, M
   Gilbert, A
   Goldenzweig, P
   Haitz, D
   Hartmann, F
   Heindl, SM
   Husemann, U
   Katkov, I
   Kudella, S
   Mildner, H
   Mozer, MU
   Muller, T
   Plagge, M
   Quast, G
   Rabbertz, K
   Rocker, S
   Roscher, F
   Schroder, M
   Shvetsov, I
   Sieber, G
   Simonis, HJ
   Ulrich, R
   Wayand, S
   Weber, M
   Weiler, T
   Williamson, S
   Wohrmann, C
   Wolf, R
   Anagnostou, G
   Daskalakis, G
   Geralis, T
   Giakournopoulou, VA
   Kyriakis, A
   Loukas, D
   Topsis-Giotis, I
   Kesisoglou, S
   Panagiotou, A
   Saoulidou, N
   Tziaferi, E
   Evangelou, I
   Flouris, G
   Foudas, C
   Kokkas, P
   Loukas, N
   Manthos, N
   Papadopoulos, I
   Paradas, E
   Filipovic, N
   Bencze, G
   Hajdu, C
   Horvath, D
   Sikler, F
   Veszpremi, V
   Vesztergombi, G
   Zsigmond, AJ
   Beni, N
   Czellar, S
   Karancsi, J
   Makovec, A
   Molnar, J
   Szillasi, Z
   Bartok, M
   Raics, P
   Trocsanyi, ZL
   Ujvari, B
   Bahinipati, S
   Choudhury, S
   Mal, P
   Mandal, K
   Nayak, A
   Sahoo, DK
   Sahoo, N
   Swain, SK
   Bansal, S
   Beri, SB
   Bhatnagar, V
   Chawla, R
   Bhawandeep, U
   Kalsi, AK
   Kaur, A
   Kaur, M
   Kumar, R
   Kumari, P
   Mehta, A
   Mittal, M
   Singh, JB
   Walia, G
   Kumar, A
   Bhardwaj, A
   Choudhary, BC
   Garg, RB
   Keshri, S
   Malhotra, S
   Naimuddin, M
   Nishu, N
   Ranjan, K
   Sharma, R
   Sharma, V
   Bhattacharya, R
   Bhattacharya, S
   Chatterjee, K
   Dey, S
   Dutt, S
   Dutta, S
   Ghosh, S
   Majumdar, N
   Modak, A
   Mondal, K
   Mukhopadhyay, S
   Nandan, S
   Purohit, A
   Roy, A
   Roy, D
   Chowdhury, SR
   Sarkar, S
   Sharan, M
   Thakur, S
   Behera, PK
   Chudasama, R
   Dutta, D
   Jha, V
   Kumar, V
   Mohanty, AK
   Netrakanti, PK
   Pant, LM
   Shukla, P
   Topkar, A
   Aziz, T
   Dugad, S
   Kole, G
   Mahakud, B
   Mitra, S
   Mohanty, GB
   Parida, B
   Sur, N
   Sutar, B
   Banerjee, S
   Bhowmik, S
   Dewanjee, RK
   Ganguly, S
   Guchait, M
   Jain, S
   Kumar, S
   Maity, M
   Majumder, G
   Mazumdar, K
   Sarkar, T
   Wickramage, N
   Chauhan, S
   Dube, S
   Hegde, V
   Kapoor, A
   Kothekar, K
   Pandey, S
   Rane, A
   Sharma, S
   Chenarani, S
   Tadavani, EE
   Etesami, SM
   Khakzad, M
   Najafabadi, MM
   Naseri, M
   Mehdiabadi, SP
   Hosseinabadi, FR
   Safarzadeh, B
   Zeinali, M
   Felcini, M
   Grunewald, M
   Abbrescia, M
   Calabria, C
   Caputo, C
   Colaleo, A
   Creanza, D
   Cristella, L
   De Filippis, N
   De Palma, M
   Fiore, L
   Iaselli, G
   Maggi, G
   Maggi, M
   Miniello, G
   My, S
   Nuzzo, S
   Pompili, A
   Pugliese, G
   Radogna, R
   Ranieri, A
   Selvaggi, G
   Sharma, A
   Silvestris, L
   Venditti, R
   Verwilligen, P
   Abbiendi, G
   Battilana, C
   Bonacorsi, D
   Braibant-Giacomelli, S
   Brigliadori, L
   Campanini, R
   Capiluppi, P
   Castro, A
   Cavallo, FR
   Chhibra, SS
   Codispoti, G
   Cuffiani, M
   Dallavalle, GM
   Fabbri, F
   Fanfani, A
   Fasanella, D
   Giacomelli, P
   Grandi, C
   Guiducci, L
   Marcellini, S
   Masetti, G
   Montanari, A
   Navarria, FL
   Perrotta, A
   Rossi, AM
   Rovelli, T
   Siroli, GP
   Tosi, N
   Albergo, S
   Costa, S
   Di Mattia, A
   Giordano, F
   Potenza, R
   Tricomi, A
   Tuve, C
   Barbagli, G
   Ciulli, V
   Civinini, C
   D'Alessandro, R
   Focardi, E
   Lenzi, P
   Meschini, M
   Paoletti, S
   Russo, L
   Sguazzoni, G
   Strom, D
   Viliani, L
   Benussi, L
   Bianco, S
   Fabbri, E
   Piccolo, D
   Primavera, F
   Calvelli, V
   Ferro, F
   Monge, MR
   Robutti, E
   Tosi, S
   Brianza, L
   Brivio, F
   Ciriolo, V
   Dinardo, ME
   Fiorendi, S
   Gennai, S
   Ghezzi, A
   Govoni, P
   Malberti, M
   Malvezzi, S
   Manzoni, RA
   Menasce, D
   Moroni, L
   Paganoni, M
   Pedrini, D
   Pigazzini, S
   Ragazzi, S
   de Fatis, TT
   Buontempo, S
   Cavallo, N
   De Nardo, G
   Di Guida, S
   Esposito, M
   Fabozzi, F
   Fienga, F
   Iorio, AOM
   Lanza, G
   Lista, L
   Meola, S
   Paolucci, P
   Sciacca, C
   Thyssen, F
   Azzi, P
   Bacchetta, N
   Bellato, M
   Benato, L
   Biasotto, M
   Bisello, D
   Boletti, A
   Checchia, P
   Dall'Osso, M
   Manzano, PDC
   Dosselli, U
   Gasparini, F
   Gasparini, U
   Gozzelino, A
   Lacaprara, S
   Margoni, M
   Meneguzzo, AT
   Pazzini, J
   Pozzobon, N
   Ronchese, P
   Simonetto, F
   Torassa, E
   Ventura, S
   Zanetti, M
   Zotto, P
   Zumerle, G
   Braghieri, A
   Fallavollita, F
   Magnani, A
   Montagna, P
   Ratti, SP
   Re, V
   Riccardi, C
   Salvini, P
   Vai, I
   Vitulo, P
   Solestizi, LA
   Bilei, GM
   Ciangottini, D
   Fano, L
   Lariccia, P
   Leonardi, R
   Mantovani, G
   Menichelli, M
   Saha, A
   Santocchia, A
   Androsov, K
   Azzurri, P
   Bagliesi, G
   Bernardini, J
   Boccali, T
   Castaldi, R
   Ciocci, MA
   Dell'Orso, R
   Donato, S
   Fedi, G
   Giassi, A
   Grippo, MT
   Ligabue, F
   Lomtadze, T
   Martini, L
   Messineo, A
   Palla, F
   Rizzi, A
   Savoy-Navarro, A
   Spagnolo, P
   Tenchini, R
   Tonelli, G
   Venturi, A
   Verdini, PG
   Barone, L
   Cavallari, F
   Cipriani, M
   Del Re, D
   Diemoz, M
   Gelli, S
   Longo, E
   Margaroli, F
   Marzocchi, B
   Meridiani, P
   Organtini, G
   Paramatti, R
   Preiato, F
   Rahatlou, S
   Rovelli, C
   Santanastasio, F
   Amapane, N
   Arcidiacono, R
   Argiro, S
   Arneodo, M
   Bartosik, N
   Bellan, R
   Biino, C
   Cartiglia, N
   Cenna, F
   Costa, M
   Covarelli, R
   Degano, A
   Demaria, N
   Finco, L
   Kiani, B
   Mariotti, C
   Maselli, S
   Migliore, E
   Monaco, V
   Monteil, E
   Monteno, M
   Obertino, MM
   Pacher, L
   Pastrone, N
   Pelliccioni, M
   Angioni, GLP
   Ravera, F
   Romero, A
   Ruspa, M
   Sacchi, R
   Shchelina, K
   Sola, V
   Solano, A
   Staiano, A
   Traczyk, P
   Belforte, S
   Casarsa, M
   Cossutti, F
   Della Ricca, G
   Zanetti, A
   Kim, DH
   Kim, GN
   Kim, MS
   Lee, S
   Lee, SW
   Oh, YD
   Sekmen, S
   Son, DC
   Yang, YC
   Lee, A
   Kim, H
   Cifuentes, JAB
   Kim, TJ
   Cho, S
   Choi, S
   Go, Y
   Gyun, D
   Ha, S
   Hong, B
   Jo, Y
   Kim, Y
   Lee, K
   Lee, KS
   Lee, S
   Lim, J
   Park, SK
   Roh, Y
   Almond, J
   Kim, J
   Lee, H
   Oh, SB
   Radburn-Smith, BC
   Seo, SH
   Yang, UK
   Yoo, HD
   Yu, GB
   Choi, M
   Kim, H
   Kim, JH
   Lee, JSH
   Park, IC
   Ryu, G
   Ryu, MS
   Choi, Y
   Goh, J
   Hwang, C
   Lee, J
   Yu, I
   Dudenas, V
   Juodagalvis, A
   Vaitkus, J
   Ahmed, I
   Ibrahim, ZA
   Komaragiri, JR
   Ali, MABM
   Idris, FM
   Abdullah, WATW
   Yusli, MN
   Zolkapli, Z
   Castilla-Valdez, H
   De la Cruz-Burelo, E
   Heredia-De La Cruz, I
   Hernandez-Almada, A
   Lopez-Fernandez, R
   Villalba, RM
   Guisao, JM
   Sanchez-Hernandez, A
   Moreno, SC
   Barrera, CO
   Valencia, FV
   Carpinteyro, S
   Pedraza, I
   Ibarguen, HAS
   Estrada, CU
   Pineda, AM
   Krofcheck, D
   Butler, PH
   Ahmad, A
   Ahmad, M
   Hassan, Q
   Hoorani, HR
   Khan, WA
   Saddique, A
   Shah, MA
   Shoaib, M
   Waqas, M
   Bialkowska, H
   Bluj, M
   Boimska, B
   Frueboes, T
   Gorski, M
   Kazana, M
   Nawrocki, K
   Romanowska-Rybinska, K
   Szleper, M
   Zalewski, P
   Bunkowski, K
   Byszuk, A
   Doroba, K
   Kalinowski, A
   Konecki, M
   Krolikowski, J
   Misiura, M
   Olszewski, M
   Walczak, M
   Bargassa, P
   Silva, CBDE
   Calpas, B
   Di Francesco, A
   Faccioli, P
   Parracho, PGF
   Gallinaro, M
   Hollar, J
   Leonardo, N
   Iglesias, LL
   Nemallapudi, MV
   Antunes, JR
   Seixas, J
   Toldaiev, O
   Vadruccio, D
   Varela, J
   Vischia, P
   Alexakhin, V
   Bunin, P
   Gavrilenko, M
   Golutvin, I
   Gorbunov, I
   Kamenev, A
   Karjavin, V
   Lanev, A
   Malakhov, A
   Matveev, V
   Palichik, V
   Perelygin, V
   Savina, M
   Shmatov, S
   Skatchkov, N
   Smirnov, V
   Voytishin, N
   Zarubin, A
   Chtchipounov, L
   Golovtsov, V
   Ivanov, Y
   Kim, V
   Kuznetsova, E
   Murzin, V
   Oreshkin, V
   Sulimov, V
   Vorobyev, A
   Andreev, Y
   Dermenev, A
   Gninenko, S
   Golubev, N
   Karneyeu, A
   Kirsanov, M
   Krasnikov, N
   Pashenkov, A
   Tlisov, D
   Toropin, A
   Epshteyn, V
   Gavrilov, V
   Lychkovskaya, N
   Popov, V
   Pozdnyakov, I
   Safronov, G
   Spiridonov, A
   Toms, M
   Vlasov, E
   Zhokin, A
   Bylinkin, A
   Markin, O
   Popova, E
   Zhemchugov, E
   Andreev, V
   Azarkin, M
   Dremin, I
   Kirakosyan, M
   Leonidov, A
   Terkulov, A
   Baskakov, A
   Belyaev, A
   Boos, E
   Bunichev, V
   Dubinin, M
   Dudko, L
   Ershov, A
   Gribushin, A
   Klyukhin, V
   Kodolova, O
   Loklitin, I
   Miagkov, I
   Obraztsov, S
   Petrushanko, S
   Savrin, V
   Blinov, V
   Skovpen, Y
   Shtol, D
   Azhgirey, I
   Bayshev, I
   Bitioukov, S
   Elumakhov, D
   Kachanov, V
   Kalinin, A
   Konstantinov, D
   Krychkine, V
   Petrov, V
   Ryutin, R
   Sobol, A
   Troshin, S
   Tyurin, N
   Uzunian, A
   Volkov, A
   Adzic, P
   Cirkovic, P
   Devetak, D
   Dordevic, M
   Milosevic, J
   Rekovic, V
   Maestre, JA
   Luna, MB
   Calvo, E
   Cerrada, M
   Llatas, MC
   Colino, N
   De la Cruz, B
   Peris, AD
   Del Valle, AE
   Bedoya, CF
   Ramos, JPF
   Flix, J
   Fouz, MC
   Garcia-Abia, P
   Lopez, OG
   Lopez, SG
   Hernandez, JM
   Josa, MI
   De Martino, EN
   Yzquierdo, APC
   Pelayo, JP
   Olmeda, AQ
   Redondo, I
   Romero, L
   Soares, MS
   de Troconiz, JF
   Missiroli, M
   Moran, D
   Cuevas, J
   Menendez, JF
   Caballero, IG
   Fernandez, JRG
   Cortezon, EP
   Cruz, SS
   Andres, IS
   Garcia, JMV
   Cabrillo, IJ
   Calderon, A
   Curras, E
   Fernandez, M
   Garcia-Ferrero, J
   Gomez, G
   Virto, AL
   Marco, J
   Rivero, CM
   Matorras, F
   Gomez, JP
   Rodrigo, T
   Ruiz-Jimeno, A
   Scodellaro, L
   Trevisani, N
   Vila, I
   Cortabitarte, RV
   Abbaneo, D
   Auffray, E
   Auzinger, G
   Bachtis, M
   Baillon, P
   Ball, AH
   Barney, D
   Bloch, P
   Bocci, A
   Botta, C
   Camporesi, T
   Castello, R
   Cepeda, M
   Cerminara, G
   Chen, Y
   d'Enterria, D
   Dabrowski, A
   Daponte, V
   David, A
   De Gruttola, M
   De Roeck, A
   Di Marco, E
   Dobson, M
   Dorney, B
   du Pree, T
   Duggan, D
   Dunser, M
   Dupont, N
   Elliott-Peisert, A
   Everaerts, P
   Fartoukh, S
   Franzoni, G
   Fulcher, J
   Funk, W
   Gigi, D
   Gill, K
   Girone, M
   Glege, F
   Gulhan, D
   Gundacker, S
   Guthoff, M
   Harris, P
   Hegeman, J
   Innocente, V
   Janot, P
   Kieseler, J
   Kirschenmann, H
   Knunz, V
   Kornmayer, A
   Kortelainen, MJ
   Kousouris, K
   Krammer, M
   Lange, C
   Lecoq, P
   Lourenco, C
   Lucchini, MT
   Malgeri, L
   Mannelli, M
   Martelli, A
   Meijers, F
   Merlin, JA
   Mersi, S
   Meschi, E
   Milenovic, P
   Moortgat, F
   Morovic, S
   Mulders, M
   Neugebauer, H
   Orfanelli, S
   Orsini, L
   Pape, L
   Perez, E
   Peruzzi, M
   Petrilli, A
   Petrucciani, G
   Pfeiffer, A
   Pierini, M
   Racz, A
   Reis, T
   Rolandi, G
   Rovere, M
   Sakulin, H
   Sauvan, JB
   Schafer, C
   Schwick, C
   Seidel, M
   Sharma, A
   Silva, P
   Sphicas, P
   Steggemann, J
   Stoye, M
   Takahashi, Y
   Tosi, M
   Treille, D
   Triossi, A
   Tsirou, A
   Veckalns, V
   Veres, GI
   Verweij, M
   Wardle, N
   Wohri, HK
   Zagozdzinska, A
   Zeuner, WD
   Bertl, W
   Deiters, K
   Erdmann, W
   Horisberger, R
   Ingram, Q
   Kaestli, HC
   Kotlinski, D
   Langenegger, U
   Rohe, T
   Bachmair, F
   Bani, L
   Bianchini, L
   Casal, B
   Dissertori, G
   Dittmar, M
   Donega, M
   Grab, C
   Heidegger, C
   Hits, D
   Hoss, J
   Kasieczka, G
   Lustermann, W
   Mangano, B
   Marionneau, M
   del Arbol, PMR
   Masciovecchio, M
   Meinhard, MT
   Meister, D
   Michell, F
   Musella, P
   Nessi-Tedaldi, F
   Pandolfi, F
   Pata, J
   Pauss, F
   Perrin, G
   Perrozzi, L
   Quittnat, M
   Rossini, M
   Schonenberger, M
   Starodumov, A
   Tavolaro, VR
   Theofilatos, K
   Wallny, R
   Aarrestad, TK
   Amsler, C
   Caminada, L
   Canelli, MF
   De Cosa, A
   Galloni, C
   Hinzmann, A
   Hreus, T
   Kilminster, B
   Ngadiuba, J
   Pinna, D
   Rauco, G
   Robmann, P
   Salerno, D
   Yang, Y
   Zucchetta, A
   Candelise, V
   Doan, TH
   Jain, S
   Khurana, R
   Konyushikhin, M
   Kuo, CM
   Lin, W
   Lu, YJ
   Pozdnyakov, A
   Yu, SS
   Kumar, A
   Chang, P
   Chang, YH
   Chao, Y
   Chen, KF
   Chen, PH
   Fiori, F
   Hou, WS
   Hsiung, Y
   Liu, YF
   Lu, RS
   Moya, MM
   Paganis, E
   Psallidas, A
   Tsai, JF
   Asavapibhop, B
   Singh, G
   Srimanobhas, N
   Suwonjandee, N
   Adiguzel, A
   Bakirei, MN
   Cerci, S
   Damarseckin, S
   Demiroglu, ZS
   Dozen, C
   Dumanoglu, I
   Girgis, S
   Gokbulut, G
   Guler, Y
   Hos, I
   Kangal, EE
   Kara, O
   Topaksu, AK
   Kiminsu, U
   Oglakci, M
   Onengut, G
   Ozdemir, K
   Tali, B
   Turkcapar, S
   Zorbakir, IS
   Zorbilmez, C
   Bilin, B
   Bilmis, S
   Isildak, B
   Karapinar, G
   Yalvac, M
   Zeyrek, M
   Gulmez, E
   Kaya, M
   Kaya, O
   Yetkin, EA
   Yetkin, T
   Cakir, A
   Cankocak, K
   Sen, S
   Grynyov, B
   Levchuk, L
   Sorokin, P
   Aggleton, R
   Ball, F
   Beck, L
   Brooke, JJ
   Burns, D
   Clement, E
   Cussans, D
   Flacher, H
   Goldstein, J
   Grimes, M
   Heath, GP
   Heath, HF
   Jacob, J
   Kreczko, L
   Lucas, C
   Newbold, DM
   Paramesvaran, S
   Poll, A
   Sakuma, T
   El Nasr-Storey, SS
   Smith, D
   Smith, VJ
   Bell, KW
   Belyaev, A
   Brew, C
   Brown, RM
   Calligaris, L
   Cieri, D
   Cockerill, DJA
   Coughlan, JA
   Harder, K
   Harper, S
   Olaiya, E
   Petyt, D
   Shepherd-Themistocleous, CH
   Thea, A
   Tomalin, IR
   Williams, T
   Baber, M
   Bainbridge, R
   Buchmuller, O
   Bundock, A
   Burton, D
   Casasso, S
   Citron, M
   Colling, D
   Corpe, L
   Dauncey, P
   Davies, G
   De Wit, A
   Della Negra, M
   Di Maria, R
   Dunne, P
   Elwood, A
   Futyan, D
   Haddad, Y
   Hall, G
   Iles, G
   James, T
   Lane, R
   Laner, C
   Lucas, R
   Lyons, L
   Magnan, AM
   Malik, S
   Mastrolorenzo, L
   Nash, J
   Nikitenko, A
   Pela, J
   Penning, B
   Pesaresi, M
   Raymond, DM
   Richards, A
   Rose, A
   Seez, C
   Summers, S
   Tapper, A
   Uchida, K
   Acosta, MV
   Virdee, T
   Wright, J
   Zenz, SC
   Cole, JE
   Hobson, PR
   Khan, A
   Kyberd, P
   Reid, ID
   Symonds, P
   Teodorescu, L
   Turner, M
   Borzou, A
   Call, K
   Dittmann, J
   Hatakeyama, K
   Liu, H
   Pastika, N
   Bartek, R
   Dominguez, A
   Cooper, SI
   Henderson, C
   Rumerio, P
   West, C
   Arcaro, D
   Avetisyan, A
   Bose, T
   Gastler, D
   Rankin, D
   Richardson, C
   Rohlf, J
   Sulak, L
   Zou, D
   Benelli, G
   Cutts, D
   Garabedian, A
   Hakala, J
   Heintz, U
   Hogan, JM
   Jesus, O
   Kwok, KHM
   Laird, E
   Landsberg, G
   Mao, Z
   Narain, M
   Piperov, S
   Sagir, S
   Spencer, E
   Syarif, R
   Breedon, R
   Burns, D
   Sanchez, MCDLB
   Chauhan, S
   Chertok, M
   Conway, J
   Conway, R
   Cox, PT
   Erbacher, R
   Flores, C
   Funk, G
   Gardner, M
   Ko, W
   Lander, R
   Mclean, C
   Mulhearn, M
   Pellett, D
   Pilot, J
   Shalhout, S
   Shi, M
   Smith, J
   Squires, M
   Stolp, D
   Tos, K
   Tripathi, M
   Bravo, C
   Cousins, R
   Dasgupta, A
   Florent, A
   Hauser, J
   Ignatenko, M
   Mccoll, N
   Saltzberg, D
   Schnaible, C
   Valuev, V
   Weber, M
   Bouvier, E
   Burt, K
   Clare, R
   Ellison, J
   Gary, JW
   Shiraz, SMAG
   Hanson, G
   Heilman, J
   Jandir, P
   Kennedy, E
   Lacroix, F
   Long, OR
   Negrete, MO
   Paneva, MI
   Shrinivas, A
   Si, W
   Wei, H
   Wimpenny, S
   Yates, BR
   Branson, JG
   Cerati, GB
   Cittolin, S
   Derdzinski, M
   Gerosa, R
   Holzner, A
   Klein, D
   Kruteiyov, V
   Letts, J
   Macneill, L
   Olivito, D
   Padhi, S
   Pieri, M
   Sani, M
   Sharma, V
   Simon, S
   Tadel, M
   Vartak, A
   Wasserbaech, S
   Welke, C
   Wood, J
   Wurthwein, F
   Yagil, A
   Della Porta, GZ
   Amin, N
   Bhandari, R
   Bradtniller-Feld, J
   Campagnari, C
   Dishaw, A
   Dutta, V
   Sevilla, MF
   George, C
   Golf, F
   Gouskos, L
   Gran, J
   Heller, R
   Incandela, J
   Mullin, SD
   Ovcharova, A
   Qu, H
   Richman, J
   Stuart, D
   Suarez, I
   Yoo, J
   Anderson, D
   Bendavid, J
   Bornheim, A
   Bunn, J
   Duarte, J
   Lawhorn, JM
   Mott, A
   Newman, HB
   Pena, C
   Spiropulu, M
   Vlimant, JR
   Xie, S
   Zhu, RY
   Andrews, MB
   Ferguson, T
   Paulini, M
   Russ, J
   Sun, M
   Vogel, H
   Vorobiev, I
   Weinberg, M
   Cumalat, JP
   Ford, WT
   Jensen, F
   Johnson, A
   Krohn, M
   Mulholland, T
   Stenson, K
   Wagner, SR
   Alexander, J
   Chaves, J
   Chu, J
   Dittmer, S
   Mcdermott, K
   Mirman, N
   Kaufman, GN
   Patterson, JR
   Rinkevicius, A
   Ryd, A
   Skinnari, L
   Soffi, L
   Tan, SM
   Tao, Z
   Thom, J
   Tucker, J
   Wittich, P
   Zientek, M
   Winn, D
   Abdullin, S
   Albrow, M
   Apollinari, G
   Apresyan, A
   Banerjee, S
   Bauerdick, LAT
   Beretvas, A
   Berryhill, J
   Bhat, PC
   Bolla, G
   Burkett, K
   Butler, JN
   Cheung, HWK
   Chlebana, F
   Cihangir, S
   Cremonesi, M
   Elvira, VD
   Fisk, I
   Freeman, J
   Gottschalk, E
   Gray, L
   Green, D
   Grunendahl, S
   Gutsche, O
   Hare, D
   Harris, RM
   Hasegawa, S
   Hirschauer, J
   Hu, Z
   Jayatilaka, B
   Jindariani, S
   Johnson, M
   Joshi, U
   Klima, B
   Kreis, B
   Lammel, S
   Linacre, J
   Lincoln, D
   Lipton, R
   Liu, M
   Liu, T
   De Sa, RL
   Lykken, J
   Maeshima, K
   Magini, N
   Marraffino, JM
   Maruyama, S
   Mason, D
   McBride, P
   Merkel, P
   Mrenna, S
   Nahn, S
   O'Dell, V
   Pedro, K
   Prokofyev, O
   Rakness, G
   Ristori, L
   Sexton-Kennedy, F
   Soha, A
   Spalding, WJ
   Spiegel, L
   Stoynev, S
   Strait, J
   Strobbe, N
   Taylor, L
   Tkaczyk, S
   Tran, NV
   Uplegger, L
   Vaandering, EW
   Vernieri, C
   Verzocchi, M
   Vidal, R
   Wang, M
   Weber, HA
   Whitbeck, A
   Wu, Y
   Acosta, D
   Avery, P
   Bortignon, P
   Bourilkov, D
   Brinkerhoff, A
   Carnes, A
   Carver, M
   Curry, D
   Das, S
   Field, RD
   Furic, IK
   Konigsberg, J
   Korytov, A
   Low, JF
   Ma, P
   Matchev, K
   Mei, H
   Mitselmakher, G
   Rank, D
   Shchutska, L
   Sperka, D
   Thomas, L
   Wang, J
   Wang, S
   Yelton, J
   Linn, S
   Markowitz, P
   Martinez, G
   Rodriguez, JL
   Ackert, A
   Adams, T
   Askew, A
   Bein, S
   Hagopian, S
   Hagopian, V
   Johnson, KF
   Prosper, H
   Santra, A
   Yohay, R
   Baarmand, MM
   Bhopatkar, V
   Colafranceschi, S
   Hohlmann, M
   Noonan, D
   Roy, T
   Yumiceva, F
   Adams, MR
   Apanasevich, L
   Berry, D
   Betts, RR
   Bucinskaite, I
   Cavanaugh, R
   Evdokimov, O
   Gauthier, L
   Gerber, CE
   Hofman, DJ
   Jung, K
   Gonzalez, IDS
   Varelas, N
   Wang, H
   Wu, Z
   Zakaria, M
   Zhang, J
   Bilki, B
   Clarida, W
   Dilsiz, K
   Durgut, S
   Gandrajula, RP
   Haytmyradov, M
   Khristenko, V
   Merlo, JP
   Mermerkaya, H
   Mestvirishvili, A
   Moeller, A
   Nachtman, J
   Ogul, H
   Onel, Y
   Ozok, F
   Penzo, A
   Snyder, C
   Tiras, E
   Wetzel, J
   Yi, K
   Anderson, I
   Blumenfeld, B
   Cocoros, A
   Eminizer, N
   Fehling, D
   Feng, L
   Gritsan, AV
   Maksimovic, P
   Osherson, M
   Roskes, J
   Sarica, U
   Swartz, M
   Xiao, M
   Xin, Y
   You, C
   Al-Bataineh, A
   Baringer, P
   Bean, A
   Boren, S
   Bowen, J
   Castle, J
   Forthomme, L
   Kenny, RP
   Khalil, S
   Kropivnitskaya, A
   Majumder, D
   Mcbrayer, W
   Murray, M
   Sanders, S
   Stringer, R
   Takaki, JDT
   Wang, Q
   Ivanov, A
   Kaadze, K
   Maravin, Y
   Mohammadi, A
   Saini, LK
   Skhirtladze, N
   Toda, S
   Rebassoo, F
   Wright, D
   Anelli, C
   Baden, A
   Baron, O
   Belloni, A
   Calvert, B
   Eno, SC
   Ferraioli, C
   Gomez, JA
   Hadley, NJ
   Jabeen, S
   Kellogg, RG
   Kolberg, T
   Kunkle, J
   Lu, Y
   Mignerey, AC
   Ricci-Tam, F
   Shin, YH
   Skuja, A
   Tonjes, MB
   Tonwar, SC
   Abercrombie, D
   Allen, B
   Apyan, A
   Azzolini, V
   Barbieri, R
   Baty, A
   Bi, R
   Bierwagen, K
   Brandt, S
   Busza, W
   Cali, IA
   D'Alfonso, M
   Demiragli, Z
   Di Matteo, L
   Ceballos, GG
   Goncharov, M
   Hsu, D
   Iiyama, Y
   Innocenti, GM
   Klute, M
   Kovalskyi, D
   Krajczar, K
   Lai, YS
   Lee, YJ
   Levin, A
   Luckey, PD
   Maier, B
   Marini, AC
   Mcginn, C
   Mironov, C
   Narayanan, S
   Niu, X
   Paus, C
   Roland, C
   Roland, G
   Salfeld-Nebgen, J
   Stephans, GSF
   Tatar, K
   Varma, M
   Velicanu, D
   Veverka, J
   Wang, J
   Wang, TW
   Wyslouch, B
   Yang, M
   Benvenuti, AC
   Chatterjee, RM
   Evans, A
   Hansen, P
   Kalafut, S
   Kao, SC
   Kubota, Y
   Lesko, Z
   Mans, J
   Nourbakhsh, S
   Ruckstuhl, N
   Rusack, R
   Tambe, N
   Turkewitz, J
   Acosta, JG
   Oliveros, S
   Avdeeva, E
   Bloom, K
   Claes, DR
   Fangmeier, C
   Suarez, RG
   Kamalieddin, R
   Kravchenko, I
   Rodrigues, AM
   Meier, F
   Monroy, J
   Siado, JE
   Snow, GR
   Stieger, B
   Alyari, M
   Dolen, J
   Godshalk, A
   Harrington, C
   Iashvili, I
   Kaisen, J
   Kharchilava, A
   Parker, A
   Rappoccio, S
   Roozbahani, B
   Alverson, G
   Barberis, E
   Hortiangtham, A
   Massironi, A
   Morse, DM
   Nash, D
   Orimoto, T
   De Lima, RT
   Trocino, D
   Wang, RJ
   Wood, D
   Bhattacharya, S
   Charaf, O
   Hahn, KA
   Kumar, A
   Mucia, N
   Odell, N
   Pollack, B
   Schmitt, MH
   Sung, K
   Trovato, M
   Velasco, M
   Dev, N
   Hildreth, M
   Anampa, KH
   Jessop, C
   Karmgard, DJ
   Kellams, N
   Lannon, K
   Marinelli, N
   Meng, F
   Mueller, C
   Musienko, Y
   Planer, M
   Reinsvold, A
   Ruchti, R
   Smith, G
   Taroni, S
   Wayne, M
   Wolf, M
   Woodard, A
   Alimena, J
   Antonelli, L
   Bylsma, B
   Durkin, LS
   Flowers, S
   Francis, B
   Hart, A
   Hill, C
   Hughes, R
   Ji, W
   Liu, B
   Luo, W
   Puigh, D
   Winer, BL
   Wulsin, HW
   Cooperstein, S
   Driga, O
   Elmer, P
   Hardenbrook, J
   Hebda, P
   Lange, D
   Luo, J
   Marlow, D
   Medvedeva, T
   Mei, K
   Olsen, J
   Palmer, C
   Piroue, P
   Stickland, D
   Svyatkovskiy, A
   Tully, C
   Malik, S
   Barker, A
   Barnes, VE
   Folgueras, S
   Gutay, L
   Jha, MK
   Jones, M
   Jung, AW
   Khatiwada, A
   Miller, DH
   Neumeister, N
   Schulte, JF
   Shi, X
   Sun, J
   Wang, F
   Xie, W
   Parashar, N
   Stupak, J
   Adair, A
   Akgun, B
   Chen, Z
   Ecklund, KM
   Geurts, FJM
   Guilbaud, M
   Li, W
   Michlin, B
   Northup, M
   Padley, BP
   Roberts, J
   Rorie, J
   Tu, Z
   Zabel, J
   Betchart, B
   Bodek, A
   de Barbaro, P
   Demina, R
   Duh, YT
   Ferbel, T
   Galanti, M
   Garcia-Bellido, A
   Han, J
   Hindrichs, O
   Khukhunaishvili, A
   Lo, KH
   Tan, P
   Verzetti, M
   Agapitos, A
   Chou, JP
   Gershtein, Y
   Espinosa, TAG
   Halkiadakis, E
   Heindl, M
   Hughes, E
   Kaplan, S
   Elayavalli, RK
   Kyriacou, S
   Lath, A
   Nash, K
   Saka, H
   Salur, S
   Schnetzer, S
   Sheffield, D
   Somalwar, S
   Stone, R
   Thomas, S
   Thomassen, P
   Walker, M
   Delannoy, AG
   Foerster, M
   Heideman, J
   Riley, G
   Rose, K
   Spanier, S
   Thapa, K
   Bouhali, O
   Celik, A
   Dalchenko, M
   De Mattia, M
   Delgado, A
   Dildick, S
   Eusebi, R
   Gilmore, J
   Huang, T
   Juska, E
   Kamon, T
   Mueller, R
   Pakhotin, Y
   Patel, R
   Perloff, A
   Pernie, L
   Rathjens, D
   Safonov, A
   Tatarinov, A
   Ulmer, KA
   Akchurin, N
   Cowden, C
   Damgov, J
   De Guio, F
   Dragoiu, C
   Dudero, PR
   Faulkner, J
   Gurpinar, E
   Kunori, S
   Lamichhane, K
   Lee, SW
   Libeiro, T
   Peltola, T
   Undleeb, S
   Volobouev, I
   Wang, Z
   Greene, S
   Gurrola, A
   Janjam, R
   Johns, W
   Maguire, C
   Melo, A
   Ni, H
   Sheldon, P
   Tuo, S
   Velkovska, J
   Xu, Q
   Arenton, MW
   Barria, P
   Cox, B
   Goodell, J
   Hirosky, R
   Ledovskoy, A
   Li, H
   Neu, C
   Sinthuprasith, T
   Sun, X
   Wang, Y
   Wolfe, E
   Xia, F
   Clarke, C
   Harr, R
   Karchin, PE
   Sturdy, J
   Belknap, DA
   Buchanan, J
   Caillol, C
   Dasu, S
   Dodd, L
   Duric, S
   Gomber, B
   Grothe, M
   Herndon, M
   Herve, A
   Klabbers, P
   Lanaro, A
   Levine, A
   Long, K
   Loveless, R
   Ojalvo, I
   Perry, T
   Pierro, GA
   Polese, G
   Ruggles, T
   Savin, A
   Smith, N
   Smith, WH
   Taylor, D
   Woods, N
AF Sirunyan, A. M.
   Tumasyan, A.
   Adam, W.
   Asilar, E.
   Bergauer, T.
   Brandstetter, J.
   Brondolin, E.
   Dragicevic, M.
   Eroe, J.
   Flechl, M.
   Friedl, M.
   Fruehwirth, R.
   Ghete, V. M.
   Hartl, C.
   Hoermann, N.
   Hrubec, J.
   Jeitler, M.
   Koenig, A.
   Kraetschmer, I.
   Liko, D.
   Matsushita, T.
   Mikulec, I.
   Rabady, D.
   Rad, N.
   Rahbaran, B.
   Rohringer, H.
   Schieck, J.
   Strauss, J.
   Waltenberger, W.
   Wulz, C. -E.
   Chekhovsky, V.
   Dvornikov, O.
   Dydyshka, Y.
   Emeliantchik, I.
   Litomin, A.
   Makarenko, V.
   Mossolov, V.
   Stefanovitch, R.
   Gonzalez, J. Suarez
   Zykunov, V.
   Shumeiko, N.
   Alderweireldt, S.
   De Wolf, E. A.
   Janssen, X.
   Lauwers, J.
   de Klundert, M. Van
   Van Haevermaet, H.
   Van Mechelen, P.
   Van Remortel, N.
   Van Spilbeeck, A.
   Abu Zeid, S.
   Blekman, E.
   D'Hondt, J.
   Daci, N.
   De Bruyn, I.
   Deroover, K.
   Lowette, S.
   Moortgat, S.
   Moreels, L.
   Olbrechts, A.
   Python, Q.
   Skovpen, K.
   Tavernier, S.
   Van Doninck, W.
   Van Mulders, P.
   Van Parijs, I.
   Brun, H.
   Clerbaux, B.
   De Lentdecker, G.
   Delannoy, H.
   Fasanella, G.
   Favart, L.
   Goldouzian, R.
   Grebenyuk, A.
   Karapostoli, G.
   Lenzi, T.
   Leonard, A.
   Luetic, J.
   Maerschalk, T.
   Marinov, A.
   Randle-Conde, A.
   Seva, T.
   Velde, C. Vander
   Vanlaer, P.
   Vannerom, D.
   Yonamine, R.
   Zenoni, F.
   Zhang, F.
   Cimmino, A.
   Cornelis, T.
   Dobur, D.
   Fagot, A.
   Gul, M.
   Khvastunov, I.
   Poyraz, D.
   Salva, S.
   Schofbeck, R.
   Tytgat, M.
   Van Driessche, W.
   Yazgan, E.
   Zaganidis, N.
   Bakhshiansohi, H.
   Beluffi, C.
   Bondu, O.
   Brochet, S.
   Bruno, G.
   Caudron, A.
   De Visscher, S.
   Delaere, C.
   Delcourt, M.
   Francois, B.
   Giammanco, A.
   Jafari, A.
   Komm, M.
   Krintiras, G.
   Lemaitre, V.
   Magitteri, A.
   Mertens, A.
   Musich, M.
   Piotrzkowski, K.
   Quertenmont, L.
   Selvaggi, M.
   Marono, M. Vidal
   Wertz, S.
   Beliy, N.
   Alda Junior, W. L.
   Alves, F. L.
   Alves, G. A.
   Brito, L.
   Hensel, C.
   Moraes, A.
   Pol, M. E.
   Rebell Teles, P.
   Belchior Batista Das Chagas, E.
   Carvalho, W.
   Chinellato, J.
   Custodio, A.
   Costa, E. M. Da.
   Da Silveira, G. G.
   De Jesus Damiao, D.
   De Oliveira Martins, C.
   Fonseca De Souza, S.
   Huertas Guativa, L. M.
   Malbouisson, H.
   Matos Figueiredo, D.
   Mora Herrera, C.
   Mundim, L.
   Nogima, H.
   Prado Da Silva, W. L.
   Santoro, A.
   Sznajder, A.
   Tonelli Manganote, E. J.
   Vilela Pereira, A.
   Ahuja, S.
   Bernardes, C. A.
   Dogra, S.
   Fernandez Perez Tomei, T. R.
   Gregores, E. M.
   Mercadante, P. G.
   Moon, C. S.
   Novaes, S. F.
   Padula, Sandra S.
   Romero Abad, D.
   Ruiz Vargas, J. C.
   Aleksandrov, A.
   Hadjiiska, R.
   Iaydjiev, P.
   Rodozov, M.
   Stoykova, S.
   Sultanov, G.
   Vutova, M.
   Dimitrov, A.
   Glushkov, I.
   Litov, L.
   Pavlov, B.
   Petkov, P.
   Fang, W.
   Ahmad, M.
   Bian, J. G.
   Chen, G. M.
   Chen, H. S.
   Chen, M.
   Chen, Y.
   Cheng, T.
   Jiang, C. H.
   Leggat, D.
   Liu, Z.
   Romeo, F.
   Ruan, M.
   Shaheen, S. M.
   Spiezia, A.
   Tao, J.
   Wang, C.
   Wang, Z.
   Zhang, H.
   Zhao, J.
   Ban, Y.
   Chen, G.
   Li, Q.
   Liu, S.
   Mao, Y.
   Qian, S. J.
   Wang, D.
   Xu, Z.
   Avila, C.
   Cabrera, A.
   Sierra, L. F. Chaparro
   Florez, C.
   Gomez, J. P.
   Hernandez, C. F. Gonzalez
   Alvarez, J. D. Ruiz
   Sanabria, J. C.
   Godinovic, N.
   Lelas, D.
   Puljak, I.
   Cipriano, P. M. Ribeiro
   Sculac, T.
   Antunovic, Z.
   Kovac, M.
   Brigljevic, V.
   Ferencek, D.
   Kadija, K.
   Mesic, B.
   Susa, T.
   Attikis, A.
   Mavromanolakis, G.
   Mousa, J.
   Nicolaou, C.
   Ptochos, F.
   Razis, P. A.
   Rykaczewski, H.
   Tsiakkouri, D.
   Finger, M.
   Finger, M., Jr.
   Carrera Jarrin, E.
   Assran, Y.
   Elkafrawy, T.
   Mahrous, A.
   Kadastik, M.
   Perrini, L.
   Raidal, M.
   Tiko, A.
   Veelken, C.
   Eerola, P.
   Pekkanen, J.
   Voutilainen, M.
   Harkonen, J.
   Jarvinen, T.
   Karimaki, V.
   Kinnunen, R.
   Lampen, T.
   Lassila-Perini, K.
   Lehti, S.
   Linden, T.
   Luukka, P.
   Tuominiemi, J.
   Tuovinen, E.
   Wendland, L.
   Talvitie, J.
   Tuuva, T.
   Besancon, M.
   Couderc, F.
   Dejardin, M.
   Denegri, D.
   Fabbro, B.
   Faure, J. L.
   Favaro, C.
   Ferri, F.
   Ganjour, S.
   Ghosh, S.
   Givernaud, A.
   Gras, P.
   de Monchenault, G. Hamel
   Jarry, P.
   Kucher, I.
   Locci, E.
   Machet, M.
   Malcies, J.
   Rander, J.
   Rosowsky, A.
   Titov, M.
   Abdulsalam, A.
   Antropov, I.
   Baffioni, S.
   Beaudette, F.
   Busson, P.
   Cadamuro, L.
   Chapon, E.
   Chariot, C.
   Davignon, O.
   de Cassagnac, R. Granier
   Jo, M.
   Lisniak, S.
   Mine, P.
   Nguyen, M.
   Ochando, C.
   Ortona, G.
   Paganini, P.
   Pigard, P.
   Regnard, S.
   Salerno, R.
   Sirois, Y.
   Strebler, T.
   Yilmaz, Y.
   Zabi, A.
   Zghiche, A.
   Agram, J. -L.
   Andrea, J.
   Aubin, A.
   Bloch, D.
   Brom, J. -M.
   Buttignol, M.
   Chabert, E. C.
   Chanon, N.
   Collard, C.
   Conte, E.
   Coubez, X.
   Fontaine, J. -C.
   Gele, D.
   Goerlach, U.
   Jansova, M.
   Le Bihan, A. -C.
   Van Hove, P.
   Gadrat, S.
   Beauceron, S.
   Bernet, C.
   Boudoul, G.
   Montoya, C. A. Carrillo
   Chierici, R.
   Contardo, D.
   Courbon, B.
   Depasse, P.
   El Mamouni, H.
   Fan, J.
   Fay, J.
   Gascon, S.
   Gouzevitch, M.
   Grenier, G.
   Ille, B.
   Lagarde, F.
   Laktineh, I. B.
   Lethuillier, M.
   Mirabito, L.
   Pequegnot, A. L.
   Perries, S.
   Popov, A.
   Sabes, D.
   Sordini, V.
   Donckt, M. Vander
   Verdier, P.
   Viret, S.
   Khvedelidze, A.
   Tsamalaidze, Z.
   Autermann, C.
   Beranek, S.
   Feld, L.
   Kiesel, M. K.
   Klein, K.
   Lipinski, M.
   Preuten, M.
   Schomakers, C.
   Schulz, J.
   Verlage, T.
   Zhukov, V.
   Albert, A.
   Brodski, M.
   Dietz-Laursonn, E.
   Duchardt, D.
   Endres, M.
   Erdmann, M.
   Erdweg, S.
   Esch, T.
   Fischer, R.
   Gueth, A.
   Hamer, M.
   Hebbeker, T.
   Heidemann, C.
   Hoepfner, K.
   Knutzen, S.
   Merschmeyer, M.
   Meyer, A.
   Millet, P.
   Mukherjee, S.
   Olschewski, M.
   Padeken, K.
   Pook, T.
   Radziej, M.
   Reithler, H.
   Rieger, M.
   Scheuch, F.
   Sonnenschein, L.
   Teyssier, D.
   Thueer, S.
   Cherepanov, V.
   Fluegge, G.
   Kargoll, B.
   Kress, T.
   Kuensken, A.
   Lingemann, J.
   Mueller, T.
   Nehrkorn, A.
   Nowack, A.
   Pistone, C.
   Pooth, O.
   Stahl, A.
   Martin, M. Aldaya
   Arndt, T.
   Asawatangtrakuldee, C.
   Beernaert, K.
   Behnke, O.
   Behrens, U.
   Bin Anuar, A. A.
   Borras, K.
   Campbell, A.
   Connor, P.
   Contreras-Campana, C.
   Costanza, F.
   Pardos, C. Diez
   Dolinska, G.
   Eckerlin, G.
   Eckstein, D.
   Eichhorn, T.
   Eren, E.
   Gallo, E.
   Garcia, J. Garay
   Geiser, A.
   Gizhko, A.
   Luyando, J. M. Grados
   Grohsjean, A.
   Gunnellini, P.
   Harb, A.
   Hauk, J.
   Hempel, M.
   Jung, H.
   Kalogeropoulos, A.
   Karacheban, O.
   Kasemann, M.
   Keaveney, J.
   Kleinwort, C.
   Korol, I.
   Kruecker, D.
   Lange, W.
   Lelek, A.
   Leonard, J.
   Lipka, K.
   Lobanov, A.
   Lohmann, W.
   Mankel, R.
   Melzer-Pellmann, I. -A.
   Meyer, A. B.
   Mittag, G.
   Mnich, J.
   Mussgiller, A.
   Ntomari, E.
   Pitzl, D.
   Placakyte, R.
   Raspereza, A.
   Roland, B.
   Sahin, M. Oe.
   Saxena, P.
   Schoerner-Sadenius, T.
   Seitz, C.
   Spannagel, S.
   Stefaniuk, N.
   Van Onsem, G. P.
   Walsh, R.
   Wissing, C.
   Blobel, V.
   Vignali, M. Centis
   Draeger, A. R.
   Dreyer, T.
   Garutti, E.
   Gonzalez, D.
   Haller, J.
   Hoffmann, M.
   Junkes, A.
   Klanner, R.
   Kogler, R.
   Kovalchuk, N.
   Lapsien, T.
   Lenz, T.
   Marchesini, I.
   Marconi, D.
   Meyer, M.
   Niedziela, M.
   Nowatschin, D.
   Pantaleo, F.
   Peiffer, T.
   Perieanu, A.
   Poehlsen, J.
   Sander, C.
   Scharf, C.
   Schleper, P.
   Schmidt, A.
   Schumann, S.
   Schwandt, J.
   Stadie, H.
   Steinbrueck, G.
   Stober, F. M.
   Stoever, M.
   Tholen, H.
   Troendle, D.
   Usai, E.
   Vanelderen, L.
   Vanhoefer, A.
   Vormwald, B.
   Akbiyik, M.
   Barth, C.
   Baur, S.
   Baus, C.
   Berger, J.
   Butz, F.
   Caspart, R.
   Chwalek, T.
   Colombo, F.
   De Boer, W.
   Dierlamm, A.
   Fink, S.
   Freund, B.
   Friese, R.
   Giffels, M.
   Gilbert, A.
   Goldenzweig, P.
   Haitz, D.
   Hartmann, F.
   Heindl, S. M.
   Husemann, U.
   Katkov, I.
   Kudella, S.
   Mildner, H.
   Mozer, M. U.
   Mueller, Th.
   Plagge, M.
   Quast, G.
   Rabbertz, K.
   Roecker, S.
   Roscher, F.
   Schroeder, M.
   Shvetsov, I.
   Sieber, G.
   Simonis, H. J.
   Ulrich, R.
   Wayand, S.
   Weber, M.
   Weiler, T.
   Williamson, S.
   Woehrmann, C.
   Wolf, R.
   Anagnostou, G.
   Daskalakis, G.
   Geralis, T.
   Giakournopoulou, V. A.
   Kyriakis, A.
   Loukas, D.
   Topsis-Giotis, I.
   Kesisoglou, S.
   Panagiotou, A.
   Saoulidou, N.
   Tziaferi, E.
   Evangelou, I.
   Flouris, G.
   Foudas, C.
   Kokkas, P.
   Loukas, N.
   Manthos, N.
   Papadopoulos, I.
   Paradas, E.
   Filipovic, N.
   Bencze, G.
   Hajdu, C.
   Horvath, D.
   Sikler, F.
   Veszpremi, V.
   Vesztergombi, G.
   Zsigmond, A. J.
   Beni, N.
   Czellar, S.
   Karancsi, J.
   Makovec, A.
   Molnar, J.
   Szillasi, Z.
   Bartok, M.
   Raics, P.
   Trocsanyi, Z. L.
   Ujvari, B.
   Bahinipati, S.
   Choudhury, S.
   Mal, P.
   Mandal, K.
   Nayak, A.
   Sahoo, D. K.
   Sahoo, N.
   Swain, S. K.
   Bansal, S.
   Beri, S. B.
   Bhatnagar, V.
   Chawla, R.
   Bhawandeep, U.
   Kalsi, A. K.
   Kaur, A.
   Kaur, M.
   Kumar, R.
   Kumari, P.
   Mehta, A.
   Mittal, M.
   Singh, J. B.
   Walia, G.
   Kumar, Ashok
   Bhardwaj, A.
   Choudhary, B. C.
   Garg, R. B.
   Keshri, S.
   Malhotra, S.
   Naimuddin, M.
   Nishu, N.
   Ranjan, K.
   Sharma, R.
   Sharma, V.
   Bhattacharya, R.
   Bhattacharya, S.
   Chatterjee, K.
   Dey, S.
   Dutt, S.
   Dutta, S.
   Ghosh, S.
   Majumdar, N.
   Modak, A.
   Mondal, K.
   Mukhopadhyay, S.
   Nandan, S.
   Purohit, A.
   Roy, A.
   Roy, D.
   Chowdhury, S. Roy
   Sarkar, S.
   Sharan, M.
   Thakur, S.
   Behera, P. K.
   Chudasama, R.
   Dutta, D.
   Jha, V.
   Kumar, V.
   Mohanty, A. K.
   Netrakanti, P. K.
   Pant, L. M.
   Shukla, P.
   Topkar, A.
   Aziz, T.
   Dugad, S.
   Kole, G.
   Mahakud, B.
   Mitra, S.
   Mohanty, G. B.
   Parida, B.
   Sur, N.
   Sutar, B.
   Banerjee, S.
   Bhowmik, S.
   Dewanjee, R. K.
   Ganguly, S.
   Guchait, M.
   Jain, Sa.
   Kumar, S.
   Maity, M.
   Majumder, G.
   Mazumdar, K.
   Sarkar, T.
   Wickramage, N.
   Chauhan, S.
   Dube, S.
   Hegde, V.
   Kapoor, A.
   Kothekar, K.
   Pandey, S.
   Rane, A.
   Sharma, S.
   Chenarani, S.
   Tadavani, E. Eskandari
   Etesami, S. M.
   Khakzad, M.
   Najafabadi, M. Mohammadi
   Naseri, M.
   Mehdiabadi, S. Paktinat
   Hosseinabadi, F. Rezaei
   Safarzadeh, B.
   Zeinali, M.
   Felcini, M.
   Grunewald, M.
   Abbrescia, M.
   Calabria, C.
   Caputo, C.
   Colaleo, A.
   Creanza, D.
   Cristella, L.
   De Filippis, N.
   De Palma, M.
   Fiore, L.
   Iaselli, G.
   Maggi, G.
   Maggi, M.
   Miniello, G.
   My, S.
   Nuzzo, S.
   Pompili, A.
   Pugliese, G.
   Radogna, R.
   Ranieri, A.
   Selvaggi, G.
   Sharma, A.
   Silvestris, L.
   Venditti, R.
   Verwilligen, P.
   Abbiendi, G.
   Battilana, C.
   Bonacorsi, D.
   Braibant-Giacomelli, S.
   Brigliadori, L.
   Campanini, R.
   Capiluppi, P.
   Castro, A.
   Cavallo, F. R.
   Chhibra, S. S.
   Codispoti, G.
   Cuffiani, M.
   Dallavalle, G. M.
   Fabbri, F.
   Fanfani, A.
   Fasanella, D.
   Giacomelli, P.
   Grandi, C.
   Guiducci, L.
   Marcellini, S.
   Masetti, G.
   Montanari, A.
   Navarria, F. L.
   Perrotta, A.
   Rossi, A. M.
   Rovelli, T.
   Siroli, G. P.
   Tosi, N.
   Albergo, S.
   Costa, S.
   Di Mattia, A.
   Giordano, F.
   Potenza, R.
   Tricomi, A.
   Tuve, C.
   Barbagli, G.
   Ciulli, V.
   Civinini, C.
   D'Alessandro, R.
   Focardi, E.
   Lenzi, P.
   Meschini, M.
   Paoletti, S.
   Russo, L.
   Sguazzoni, G.
   Strom, D.
   Viliani, L.
   Benussi, L.
   Bianco, S.
   Fabbri, E.
   Piccolo, D.
   Primavera, F.
   Calvelli, V.
   Ferro, F.
   Monge, M. R.
   Robutti, E.
   Tosi, S.
   Brianza, L.
   Brivio, F.
   Ciriolo, V.
   Dinardo, M. E.
   Fiorendi, S.
   Gennai, S.
   Ghezzi, A.
   Govoni, P.
   Malberti, M.
   Malvezzi, S.
   Manzoni, R. A.
   Menasce, D.
   Moroni, L.
   Paganoni, M.
   Pedrini, D.
   Pigazzini, S.
   Ragazzi, S.
   de Fatis, T. Tabarelli
   Buontempo, S.
   Cavallo, N.
   De Nardo, G.
   Di Guida, S.
   Esposito, M.
   Fabozzi, F.
   Fienga, F.
   Iorio, A. O. M.
   Lanza, G.
   Lista, L.
   Meola, S.
   Paolucci, P.
   Sciacca, C.
   Thyssen, F.
   Azzi, P.
   Bacchetta, N.
   Bellato, M.
   Benato, L.
   Biasotto, M.
   Bisello, D.
   Boletti, A.
   Checchia, P.
   Dall'Osso, M.
   Manzano, P. De Castro
   Dosselli, U.
   Gasparini, F.
   Gasparini, U.
   Gozzelino, A.
   Lacaprara, S.
   Margoni, M.
   Meneguzzo, A. T.
   Pazzini, J.
   Pozzobon, N.
   Ronchese, P.
   Simonetto, F.
   Torassa, E.
   Ventura, S.
   Zanetti, M.
   Zotto, P.
   Zumerle, G.
   Braghieri, A.
   Fallavollita, F.
   Magnani, A.
   Montagna, P.
   Ratti, S. P.
   Re, V.
   Riccardi, C.
   Salvini, P.
   Vai, I.
   Vitulo, P.
   Solestizi, L. Alunni
   Bilei, G. M.
   Ciangottini, D.
   Fano, L.
   Lariccia, P.
   Leonardi, R.
   Mantovani, G.
   Menichelli, M.
   Saha, A.
   Santocchia, A.
   Androsov, K.
   Azzurri, P.
   Bagliesi, G.
   Bernardini, J.
   Boccali, T.
   Castaldi, R.
   Ciocci, M. A.
   Dell'Orso, R.
   Donato, S.
   Fedi, G.
   Giassi, A.
   Grippo, M. T.
   Ligabue, F.
   Lomtadze, T.
   Martini, L.
   Messineo, A.
   Palla, F.
   Rizzi, A.
   Savoy-Navarro, A.
   Spagnolo, P.
   Tenchini, R.
   Tonelli, G.
   Venturi, A.
   Verdini, P. G.
   Barone, L.
   Cavallari, F.
   Cipriani, M.
   Del Re, D.
   Diemoz, M.
   Gelli, S.
   Longo, E.
   Margaroli, F.
   Marzocchi, B.
   Meridiani, P.
   Organtini, G.
   Paramatti, R.
   Preiato, F.
   Rahatlou, S.
   Rovelli, C.
   Santanastasio, F.
   Amapane, N.
   Arcidiacono, R.
   Argiro, S.
   Arneodo, M.
   Bartosik, N.
   Bellan, R.
   Biino, C.
   Cartiglia, N.
   Cenna, F.
   Costa, M.
   Covarelli, R.
   Degano, A.
   Demaria, N.
   Finco, L.
   Kiani, B.
   Mariotti, C.
   Maselli, S.
   Migliore, E.
   Monaco, V.
   Monteil, E.
   Monteno, M.
   Obertino, M. M.
   Pacher, L.
   Pastrone, N.
   Pelliccioni, M.
   Angioni, G. L. Pinna
   Ravera, F.
   Romero, A.
   Ruspa, M.
   Sacchi, R.
   Shchelina, K.
   Sola, V.
   Solano, A.
   Staiano, A.
   Traczyk, P.
   Belforte, S.
   Casarsa, M.
   Cossutti, F.
   Della Ricca, G.
   Zanetti, A.
   Kim, D. H.
   Kim, G. N.
   Kim, M. S.
   Lee, S.
   Lee, S. W.
   Oh, Y. D.
   Sekmen, S.
   Son, D. C.
   Yang, Y. C.
   Lee, A.
   Kim, H.
   Cifuentes, J. A. Brochero
   Kim, T. J.
   Cho, S.
   Choi, S.
   Go, Y.
   Gyun, D.
   Ha, S.
   Hong, B.
   Jo, Y.
   Kim, Y.
   Lee, K.
   Lee, K. S.
   Lee, S.
   Lim, J.
   Park, S. K.
   Roh, Y.
   Almond, J.
   Kim, J.
   Lee, H.
   Oh, S. B.
   Radburn-Smith, B. C.
   Seo, S. H.
   Yang, U. K.
   Yoo, H. D.
   Yu, G. B.
   Choi, M.
   Kim, H.
   Kim, J. H.
   Lee, J. S. H.
   Park, I. C.
   Ryu, G.
   Ryu, M. S.
   Choi, Y.
   Goh, J.
   Hwang, C.
   Lee, J.
   Yu, I.
   Dudenas, V.
   Juodagalvis, A.
   Vaitkus, J.
   Ahmed, I.
   Ibrahim, Z. A.
   Komaragiri, J. R.
   Ali, M. A. B. Md
   Idris, F. Mohamad
   Abdullah, W. A. T. Wan
   Yusli, M. N.
   Zolkapli, Z.
   Castilla-Valdez, H.
   De la Cruz-Burelo, E.
   Heredia-De la Cruz, I.
   Hernandez-Almada, A.
   Lopez-Fernandez, R.
   Magana Villalba, R.
   Mejia Guisao, J.
   Sanchez-Hernandez, A.
   Carrillo Moreno, S.
   Oropeza Barrera, C.
   Vazquez Valencia, F.
   Carpinteyro, S.
   Pedraza, I.
   Salazar Ibarguen, H. A.
   Uribe Estrada, C.
   Morelos Pineda, A.
   Krofcheck, D.
   Butler, P. H.
   Ahmad, A.
   Ahmad, M.
   Hassan, Q.
   Hoorani, H. R.
   Khan, W. A.
   Saddique, A.
   Shah, M. A.
   Shoaib, M.
   Waqas, M.
   Bialkowska, H.
   Bluj, M.
   Boimska, B.
   Frueboes, T.
   Gorski, M.
   Kazana, M.
   Nawrocki, K.
   Romanowska-Rybinska, K.
   Szleper, M.
   Zalewski, P.
   Bunkowski, K.
   Byszuk, A.
   Doroba, K.
   Kalinowski, A.
   Konecki, M.
   Krolikowski, J.
   Misiura, M.
   Olszewski, M.
   Walczak, M.
   Bargassa, P.
   Silva, C. Beirdo Da Cruz E.
   Calpas, B.
   Di Francesco, A.
   Faccioli, P.
   Parracho, P. G. Ferreira
   Gallinaro, M.
   Hollar, J.
   Leonardo, N.
   Iglesias, L. Lloret
   Nemallapudi, M. V.
   Antunes, J. Rodrigues
   Seixas, J.
   Toldaiev, O.
   Vadruccio, D.
   Varela, J.
   Vischia, P.
   Alexakhin, V.
   Bunin, P.
   Gavrilenko, M.
   Golutvin, I.
   Gorbunov, I.
   Kamenev, A.
   Karjavin, V.
   Lanev, A.
   Malakhov, A.
   Matveev, V.
   Palichik, V.
   Perelygin, V.
   Savina, M.
   Shmatov, S.
   Skatchkov, N.
   Smirnov, V.
   Voytishin, N.
   Zarubin, A.
   Chtchipounov, L.
   Golovtsov, V.
   Ivanov, Y.
   Kim, V.
   Kuznetsova, E.
   Murzin, V.
   Oreshkin, V.
   Sulimov, V.
   Vorobyev, A.
   Andreev, Yu.
   Dermenev, A.
   Gninenko, S.
   Golubev, N.
   Karneyeu, A.
   Kirsanov, M.
   Krasnikov, N.
   Pashenkov, A.
   Tlisov, D.
   Toropin, A.
   Epshteyn, V.
   Gavrilov, V.
   Lychkovskaya, N.
   Popov, V.
   Pozdnyakov, I.
   Safronov, G.
   Spiridonov, A.
   Toms, M.
   Vlasov, E.
   Zhokin, A.
   Bylinkin, A.
   Markin, O.
   Popova, E.
   Zhemchugov, E.
   Andreev, V.
   Azarkin, M.
   Dremin, I.
   Kirakosyan, M.
   Leonidov, A.
   Terkulov, A.
   Baskakov, A.
   Belyaev, A.
   Boos, E.
   Bunichev, V.
   Dubinin, M.
   Dudko, L.
   Ershov, A.
   Gribushin, A.
   Klyukhin, V.
   Kodolova, O.
   Loklitin, I.
   Miagkov, I.
   Obraztsov, S.
   Petrushanko, S.
   Savrin, V.
   Blinov, V.
   Skovpen, Y.
   Shtol, D.
   Azhgirey, I.
   Bayshev, I.
   Bitioukov, S.
   Elumakhov, D.
   Kachanov, V.
   Kalinin, A.
   Konstantinov, D.
   Krychkine, V.
   Petrov, V.
   Ryutin, R.
   Sobol, A.
   Troshin, S.
   Tyurin, N.
   Uzunian, A.
   Volkov, A.
   Adzic, P.
   Cirkovic, P.
   Devetak, D.
   Dordevic, M.
   Milosevic, J.
   Rekovic, V.
   Alcaraz Maestre, J.
   Barrio Luna, M.
   Calvo, E.
   Cerrada, M.
   Chamizo Llatas, M.
   Colino, N.
   De la Cruz, B.
   Delgado Peris, A.
   Escalante Del Valle, A.
   Fernandez Bedoya, C.
   Fernandez Ramos, J. P.
   Flix, J.
   Fouz, M. C.
   Garcia-Abia, P.
   Gonzalez Lopez, O.
   Goy Lopez, S.
   Hernandez, J. M.
   Josa, M. I.
   Navarro De Martino, E.
   Perez-Calero Yzquierdo, A.
   Puerta Pelayo, J.
   Quintario Olmeda, A.
   Redondo, I.
   Romero, L.
   Soares, M. S.
   de Troconiz, J. F.
   Missiroli, M.
   Moran, D.
   Cuevas, J.
   Fernandez Menendez, J.
   Gonzalez Caballero, I.
   Gonzalez Fernandez, J. R.
   Palencia Cortezon, E.
   Sanchez Cruz, S.
   Suarez Andres, I.
   Vizan Garcia, J. M.
   Cabrillo, I. J.
   Calderon, A.
   Curras, E.
   Fernandez, M.
   Garcia-Ferrero, J.
   Gomez, G.
   Lopez Virto, A.
   Marco, J.
   Martinez Rivero, C.
   Matorras, F.
   Piedra Gomez, J.
   Rodrigo, T.
   Ruiz-Jimeno, A.
   Scodellaro, L.
   Trevisani, N.
   Vila, I.
   Vilar Cortabitarte, R.
   Abbaneo, D.
   Auffray, E.
   Auzinger, G.
   Bachtis, M.
   Baillon, P.
   Ball, A. H.
   Barney, D.
   Bloch, P.
   Bocci, A.
   Botta, C.
   Camporesi, T.
   Castello, R.
   Cepeda, M.
   Cerminara, G.
   Chen, Y.
   d'Enterria, D.
   Dabrowski, A.
   Daponte, V.
   David, A.
   De Gruttola, M.
   De Roeck, A.
   Di Marco, E.
   Dobson, M.
   Dorney, B.
   du Pree, T.
   Duggan, D.
   Duenser, M.
   Dupont, N.
   Elliott-Peisert, A.
   Everaerts, P.
   Fartoukh, S.
   Franzoni, G.
   Fulcher, J.
   Funk, W.
   Gigi, D.
   Gill, K.
   Girone, M.
   Glege, F.
   Gulhan, D.
   Gundacker, S.
   Guthoff, M.
   Harris, P.
   Hegeman, J.
   Innocente, V.
   Janot, P.
   Kieseler, J.
   Kirschenmann, H.
   Knuenz, V.
   Kornmayer, A.
   Kortelainen, M. J.
   Kousouris, K.
   Krammer, M.
   Lange, C.
   Lecoq, P.
   Lourenco, C.
   Lucchini, M. T.
   Malgeri, L.
   Mannelli, M.
   Martelli, A.
   Meijers, F.
   Merlin, J. A.
   Mersi, S.
   Meschi, E.
   Milenovic, P.
   Moortgat, F.
   Morovic, S.
   Mulders, M.
   Neugebauer, H.
   Orfanelli, S.
   Orsini, L.
   Pape, L.
   Perez, E.
   Peruzzi, M.
   Petrilli, A.
   Petrucciani, G.
   Pfeiffer, A.
   Pierini, M.
   Racz, A.
   Reis, T.
   Rolandi, G.
   Rovere, M.
   Sakulin, H.
   Sauvan, J. B.
   Schaefer, C.
   Schwick, C.
   Seidel, M.
   Sharma, A.
   Silva, P.
   Sphicas, P.
   Steggemann, J.
   Stoye, M.
   Takahashi, Y.
   Tosi, M.
   Treille, D.
   Triossi, A.
   Tsirou, A.
   Veckalns, V.
   Veres, G. I.
   Verweij, M.
   Wardle, N.
   Woehri, H. K.
   Zagozdzinska, A.
   Zeuner, W. D.
   Bertl, W.
   Deiters, K.
   Erdmann, W.
   Horisberger, R.
   Ingram, Q.
   Kaestli, H. C.
   Kotlinski, D.
   Langenegger, U.
   Rohe, T.
   Bachmair, F.
   Baeni, L.
   Bianchini, L.
   Casal, B.
   Dissertori, G.
   Dittmar, M.
   Donega, M.
   Grab, C.
   Heidegger, C.
   Hits, D.
   Hoss, J.
   Kasieczka, G.
   Lustermann, W.
   Mangano, B.
   Marionneau, M.
   del Arbol, P. Martinez Ruiz
   Masciovecchio, M.
   Meinhard, M. T.
   Meister, D.
   Michell, F.
   Musella, P.
   Nessi-Tedaldi, F.
   Pandolfi, F.
   Pata, J.
   Pauss, F.
   Perrin, G.
   Perrozzi, L.
   Quittnat, M.
   Rossini, M.
   Schoenenberger, M.
   Starodumov, A.
   Tavolaro, V. R.
   Theofilatos, K.
   Wallny, R.
   Aarrestad, T. K.
   Amsler, C.
   Caminada, L.
   Canelli, M. F.
   De Cosa, A.
   Galloni, C.
   Hinzmann, A.
   Hreus, T.
   Kilminster, B.
   Ngadiuba, J.
   Pinna, D.
   Rauco, G.
   Robmann, P.
   Salerno, D.
   Yang, Y.
   Zucchetta, A.
   Candelise, V.
   Doan, T. H.
   Jain, Sh.
   Khurana, R.
   Konyushikhin, M.
   Kuo, C. M.
   Lin, W.
   Lu, Y. J.
   Pozdnyakov, A.
   Yu, S. S.
   Kumar, Arun
   Chang, P.
   Chang, Y. H.
   Chao, Y.
   Chen, K. F.
   Chen, P. H.
   Fiori, F.
   Hou, W. -S.
   Hsiung, Y.
   Liu, Y. F.
   Lu, R. -S.
   Moya, M. Minano
   Paganis, E.
   Psallidas, A.
   Tsai, J. F.
   Asavapibhop, B.
   Singh, G.
   Srimanobhas, N.
   Suwonjandee, N.
   Adiguzel, A.
   Bakirei, M. N.
   Cerci, S.
   Damarseckin, S.
   Demiroglu, Z. S.
   Dozen, C.
   Dumanoglu, I.
   Girgis, S.
   Gokbulut, G.
   Guler, Y.
   Hos, I.
   Kangal, E. E.
   Kara, O.
   Topaksu, A. Kayis
   Kiminsu, U.
   Oglakci, M.
   Onengut, G.
   Ozdemir, K.
   Tali, B.
   Turkcapar, S.
   Zorbakir, I. S.
   Zorbilmez, C.
   Bilin, B.
   Bilmis, S.
   Isildak, B.
   Karapinar, G.
   Yalvac, M.
   Zeyrek, M.
   Gulmez, E.
   Kaya, M.
   Kaya, O.
   Yetkin, E. A.
   Yetkin, T.
   Cakir, A.
   Cankocak, K.
   Sen, S.
   Grynyov, B.
   Levchuk, L.
   Sorokin, P.
   Aggleton, R.
   Ball, F.
   Beck, L.
   Brooke, J. J.
   Burns, D.
   Clement, E.
   Cussans, D.
   Flacher, H.
   Goldstein, J.
   Grimes, M.
   Heath, G. P.
   Heath, H. F.
   Jacob, J.
   Kreczko, L.
   Lucas, C.
   Newbold, D. M.
   Paramesvaran, S.
   Poll, A.
   Sakuma, T.
   El Nasr-Storey, S. Self
   Smith, D.
   Smith, V. J.
   Bell, K. W.
   Belyaev, A.
   Brew, C.
   Brown, R. M.
   Calligaris, L.
   Cieri, D.
   Cockerill, D. J. A.
   Coughlan, J. A.
   Harder, K.
   Harper, S.
   Olaiya, E.
   Petyt, D.
   Shepherd-Themistocleous, C. H.
   Thea, A.
   Tomalin, I. R.
   Williams, T.
   Baber, M.
   Bainbridge, R.
   Buchmuller, O.
   Bundock, A.
   Burton, D.
   Casasso, S.
   Citron, M.
   Colling, D.
   Corpe, L.
   Dauncey, P.
   Davies, G.
   De Wit, A.
   Della Negra, M.
   Di Maria, R.
   Dunne, P.
   Elwood, A.
   Futyan, D.
   Haddad, Y.
   Hall, G.
   Iles, G.
   James, T.
   Lane, R.
   Laner, C.
   Lucas, R.
   Lyons, L.
   Magnan, A. -M.
   Malik, S.
   Mastrolorenzo, L.
   Nash, J.
   Nikitenko, A.
   Pela, J.
   Penning, B.
   Pesaresi, M.
   Raymond, D. M.
   Richards, A.
   Rose, A.
   Seez, C.
   Summers, S.
   Tapper, A.
   Uchida, K.
   Acosta, M. Vazquez
   Virdee, T.
   Wright, J.
   Zenz, S. C.
   Cole, J. E.
   Hobson, P. R.
   Khan, A.
   Kyberd, P.
   Reid, I. D.
   Symonds, P.
   Teodorescu, L.
   Turner, M.
   Borzou, A.
   Call, K.
   Dittmann, J.
   Hatakeyama, K.
   Liu, H.
   Pastika, N.
   Bartek, R.
   Dominguez, A.
   Cooper, S. I.
   Henderson, C.
   Rumerio, P.
   West, C.
   Arcaro, D.
   Avetisyan, A.
   Bose, T.
   Gastler, D.
   Rankin, D.
   Richardson, C.
   Rohlf, J.
   Sulak, L.
   Zou, D.
   Benelli, G.
   Cutts, D.
   Garabedian, A.
   Hakala, J.
   Heintz, U.
   Hogan, J. M.
   Jesus, O.
   Kwok, K. H. M.
   Laird, E.
   Landsberg, G.
   Mao, Z.
   Narain, M.
   Piperov, S.
   Sagir, S.
   Spencer, E.
   Syarif, R.
   Breedon, R.
   Burns, D.
   Sanchez, M. Calderon De la Barca
   Chauhan, S.
   Chertok, M.
   Conway, J.
   Conway, R.
   Cox, P. T.
   Erbacher, R.
   Flores, C.
   Funk, G.
   Gardner, M.
   Ko, W.
   Lander, R.
   Mclean, C.
   Mulhearn, M.
   Pellett, D.
   Pilot, J.
   Shalhout, S.
   Shi, M.
   Smith, J.
   Squires, M.
   Stolp, D.
   Tos, K.
   Tripathi, M.
   Bravo, C.
   Cousins, R.
   Dasgupta, A.
   Florent, A.
   Hauser, J.
   Ignatenko, M.
   Mccoll, N.
   Saltzberg, D.
   Schnaible, C.
   Valuev, V.
   Weber, M.
   Bouvier, E.
   Burt, K.
   Clare, R.
   Ellison, J.
   Gary, J. W.
   Shiraz, S. M. A. Ghiasi
   Hanson, G.
   Heilman, J.
   Jandir, P.
   Kennedy, E.
   Lacroix, F.
   Long, O. R.
   Negrete, M. Olmedo
   Paneva, M. I.
   Shrinivas, A.
   Si, W.
   Wei, H.
   Wimpenny, S.
   Yates, B. R.
   Branson, J. G.
   Cerati, G. B.
   Cittolin, S.
   Derdzinski, M.
   Gerosa, R.
   Holzner, A.
   Klein, D.
   Kruteiyov, V.
   Letts, J.
   Macneill, L.
   Olivito, D.
   Padhi, S.
   Pieri, M.
   Sani, M.
   Sharma, V.
   Simon, S.
   Tadel, M.
   Vartak, A.
   Wasserbaech, S.
   Welke, C.
   Wood, J.
   Wurthwein, F.
   Yagil, A.
   Della Porta, G. Zevi
   Amin, N.
   Bhandari, R.
   Bradtniller-Feld, J.
   Campagnari, C.
   Dishaw, A.
   Dutta, V.
   Sevilla, M. Franco
   George, C.
   Golf, F.
   Gouskos, L.
   Gran, J.
   Heller, R.
   Incandela, J.
   Mullin, S. D.
   Ovcharova, A.
   Qu, H.
   Richman, J.
   Stuart, D.
   Suarez, I.
   Yoo, J.
   Anderson, D.
   Bendavid, J.
   Bornheim, A.
   Bunn, J.
   Duarte, J.
   Lawhorn, J. M.
   Mott, A.
   Newman, H. B.
   Pena, C.
   Spiropulu, M.
   Vlimant, J. R.
   Xie, S.
   Zhu, R. Y.
   Andrews, M. B.
   Ferguson, T.
   Paulini, M.
   Russ, J.
   Sun, M.
   Vogel, H.
   Vorobiev, I.
   Weinberg, M.
   Cumalat, J. P.
   Ford, W. T.
   Jensen, F.
   Johnson, A.
   Krohn, M.
   Mulholland, T.
   Stenson, K.
   Wagner, S. R.
   Alexander, J.
   Chaves, J.
   Chu, J.
   Dittmer, S.
   Mcdermott, K.
   Mirman, N.
   Kaufman, G. Nicolas
   Patterson, J. R.
   Rinkevicius, A.
   Ryd, A.
   Skinnari, L.
   Soffi, L.
   Tan, S. M.
   Tao, Z.
   Thom, J.
   Tucker, J.
   Wittich, P.
   Zientek, M.
   Winn, D.
   Abdullin, S.
   Albrow, M.
   Apollinari, G.
   Apresyan, A.
   Banerjee, S.
   Bauerdick, L. A. T.
   Beretvas, A.
   Berryhill, J.
   Bhat, P. C.
   Bolla, G.
   Burkett, K.
   Butler, J. N.
   Cheung, H. W. K.
   Chlebana, F.
   Cihangir, S.
   Cremonesi, M.
   Elvira, V. D.
   Fisk, I.
   Freeman, J.
   Gottschalk, E.
   Gray, L.
   Green, D.
   Grunendahl, S.
   Gutsche, O.
   Hare, D.
   Harris, R. M.
   Hasegawa, S.
   Hirschauer, J.
   Hu, Z.
   Jayatilaka, B.
   Jindariani, S.
   Johnson, M.
   Joshi, U.
   Klima, B.
   Kreis, B.
   Lammel, S.
   Linacre, J.
   Lincoln, D.
   Lipton, R.
   Liu, M.
   Liu, T.
   De Sa, R. Lopes
   Lykken, J.
   Maeshima, K.
   Magini, N.
   Marraffino, J. M.
   Maruyama, S.
   Mason, D.
   McBride, P.
   Merkel, P.
   Mrenna, S.
   Nahn, S.
   O'Dell, V.
   Pedro, K.
   Prokofyev, O.
   Rakness, G.
   Ristori, L.
   Sexton-Kennedy, F.
   Soha, A.
   Spalding, W. J.
   Spiegel, L.
   Stoynev, S.
   Strait, J.
   Strobbe, N.
   Taylor, L.
   Tkaczyk, S.
   Tran, N. V.
   Uplegger, L.
   Vaandering, E. W.
   Vernieri, C.
   Verzocchi, M.
   Vidal, R.
   Wang, M.
   Weber, H. A.
   Whitbeck, A.
   Wu, Y.
   Acosta, D.
   Avery, P.
   Bortignon, P.
   Bourilkov, D.
   Brinkerhoff, A.
   Carnes, A.
   Carver, M.
   Curry, D.
   Das, S.
   Field, R. D.
   Furic, I. K.
   Konigsberg, J.
   Korytov, A.
   Low, J. F.
   Ma, P.
   Matchev, K.
   Mei, H.
   Mitselmakher, G.
   Rank, D.
   Shchutska, L.
   Sperka, D.
   Thomas, L.
   Wang, J.
   Wang, S.
   Yelton, J.
   Linn, S.
   Markowitz, P.
   Martinez, G.
   Rodriguez, J. L.
   Ackert, A.
   Adams, T.
   Askew, A.
   Bein, S.
   Hagopian, S.
   Hagopian, V.
   Johnson, K. F.
   Prosper, H.
   Santra, A.
   Yohay, R.
   Baarmand, M. M.
   Bhopatkar, V.
   Colafranceschi, S.
   Hohlmann, M.
   Noonan, D.
   Roy, T.
   Yumiceva, F.
   Adams, M. R.
   Apanasevich, L.
   Berry, D.
   Betts, R. R.
   Bucinskaite, I.
   Cavanaugh, R.
   Evdokimov, O.
   Gauthier, L.
   Gerber, C. E.
   Hofman, D. J.
   Jung, K.
   Gonzalez, I. D. Sandoval
   Varelas, N.
   Wang, H.
   Wu, Z.
   Zakaria, M.
   Zhang, J.
   Bilki, B.
   Clarida, W.
   Dilsiz, K.
   Durgut, S.
   Gandrajula, R. P.
   Haytmyradov, M.
   Khristenko, V.
   Merlo, J. -P.
   Mermerkaya, H.
   Mestvirishvili, A.
   Moeller, A.
   Nachtman, J.
   Ogul, H.
   Onel, Y.
   Ozok, F.
   Penzo, A.
   Snyder, C.
   Tiras, E.
   Wetzel, J.
   Yi, K.
   Anderson, I.
   Blumenfeld, B.
   Cocoros, A.
   Eminizer, N.
   Fehling, D.
   Feng, L.
   Gritsan, A. V.
   Maksimovic, P.
   Osherson, M.
   Roskes, J.
   Sarica, U.
   Swartz, M.
   Xiao, M.
   Xin, Y.
   You, C.
   Al-bataineh, A.
   Baringer, P.
   Bean, A.
   Boren, S.
   Bowen, J.
   Castle, J.
   Forthomme, L.
   Kenny, R. P., III
   Khalil, S.
   Kropivnitskaya, A.
   Majumder, D.
   Mcbrayer, W.
   Murray, M.
   Sanders, S.
   Stringer, R.
   Takaki, J. D. Tapia
   Wang, Q.
   Ivanov, A.
   Kaadze, K.
   Maravin, Y.
   Mohammadi, A.
   Saini, L. K.
   Skhirtladze, N.
   Toda, S.
   Rebassoo, F.
   Wright, D.
   Anelli, C.
   Baden, A.
   Baron, O.
   Belloni, A.
   Calvert, B.
   Eno, S. C.
   Ferraioli, C.
   Gomez, J. A.
   Hadley, N. J.
   Jabeen, S.
   Kellogg, R. G.
   Kolberg, T.
   Kunkle, J.
   Lu, Y.
   Mignerey, A. C.
   Ricci-Tam, F.
   Shin, Y. H.
   Skuja, A.
   Tonjes, M. B.
   Tonwar, S. C.
   Abercrombie, D.
   Allen, B.
   Apyan, A.
   Azzolini, V.
   Barbieri, R.
   Baty, A.
   Bi, R.
   Bierwagen, K.
   Brandt, S.
   Busza, W.
   Cali, I. A.
   D'Alfonso, M.
   Demiragli, Z.
   Di Matteo, L.
   Ceballos, G. Gomez
   Goncharov, M.
   Hsu, D.
   Iiyama, Y.
   Innocenti, G. M.
   Klute, M.
   Kovalskyi, D.
   Krajczar, K.
   Lai, Y. S.
   Lee, Y. -J.
   Levin, A.
   Luckey, P. D.
   Maier, B.
   Marini, A. C.
   Mcginn, C.
   Mironov, C.
   Narayanan, S.
   Niu, X.
   Paus, C.
   Roland, C.
   Roland, G.
   Salfeld-Nebgen, J.
   Stephans, G. S. F.
   Tatar, K.
   Varma, M.
   Velicanu, D.
   Veverka, J.
   Wang, J.
   Wang, T. W.
   Wyslouch, B.
   Yang, M.
   Benvenuti, A. C.
   Chatterjee, R. M.
   Evans, A.
   Hansen, P.
   Kalafut, S.
   Kao, S. C.
   Kubota, Y.
   Lesko, Z.
   Mans, J.
   Nourbakhsh, S.
   Ruckstuhl, N.
   Rusack, R.
   Tambe, N.
   Turkewitz, J.
   Acosta, J. G.
   Oliveros, S.
   Avdeeva, E.
   Bloom, K.
   Claes, D. R.
   Fangmeier, C.
   Suarez, R. Gonzalez
   Kamalieddin, R.
   Kravchenko, I.
   Rodrigues, A. Malta
   Meier, F.
   Monroy, J.
   Siado, J. E.
   Snow, G. R.
   Stieger, B.
   Alyari, M.
   Dolen, J.
   Godshalk, A.
   Harrington, C.
   Iashvili, I.
   Kaisen, J.
   Kharchilava, A.
   Parker, A.
   Rappoccio, S.
   Roozbahani, B.
   Alverson, G.
   Barberis, E.
   Hortiangtham, A.
   Massironi, A.
   Morse, D. M.
   Nash, D.
   Orimoto, T.
   De Lima, R. Teixeira
   Trocino, D.
   Wang, R. -J.
   Wood, D.
   Bhattacharya, S.
   Charaf, O.
   Hahn, K. A.
   Kumar, A.
   Mucia, N.
   Odell, N.
   Pollack, B.
   Schmitt, M. H.
   Sung, K.
   Trovato, M.
   Velasco, M.
   Dev, N.
   Hildreth, M.
   Anampa, K. Hurtado
   Jessop, C.
   Karmgard, D. J.
   Kellams, N.
   Lannon, K.
   Marinelli, N.
   Meng, F.
   Mueller, C.
   Musienko, Y.
   Planer, M.
   Reinsvold, A.
   Ruchti, R.
   Smith, G.
   Taroni, S.
   Wayne, M.
   Wolf, M.
   Woodard, A.
   Alimena, J.
   Antonelli, L.
   Bylsma, B.
   Durkin, L. S.
   Flowers, S.
   Francis, B.
   Hart, A.
   Hill, C.
   Hughes, R.
   Ji, W.
   Liu, B.
   Luo, W.
   Puigh, D.
   Winer, B. L.
   Wulsin, H. W.
   Cooperstein, S.
   Driga, O.
   Elmer, P.
   Hardenbrook, J.
   Hebda, P.
   Lange, D.
   Luo, J.
   Marlow, D.
   Medvedeva, T.
   Mei, K.
   Olsen, J.
   Palmer, C.
   Piroue, P.
   Stickland, D.
   Svyatkovskiy, A.
   Tully, C.
   Malik, S.
   Barker, A.
   Barnes, V. E.
   Folgueras, S.
   Gutay, L.
   Jha, M. K.
   Jones, M.
   Jung, A. W.
   Khatiwada, A.
   Miller, D. H.
   Neumeister, N.
   Schulte, J. F.
   Shi, X.
   Sun, J.
   Wang, F.
   Xie, W.
   Parashar, N.
   Stupak, J.
   Adair, A.
   Akgun, B.
   Chen, Z.
   Ecklund, K. M.
   Geurts, F. J. M.
   Guilbaud, M.
   Li, W.
   Michlin, B.
   Northup, M.
   Padley, B. P.
   Roberts, J.
   Rorie, J.
   Tu, Z.
   Zabel, J.
   Betchart, B.
   Bodek, A.
   de Barbaro, P.
   Demina, R.
   Duh, Y. T.
   Ferbel, T.
   Galanti, M.
   Garcia-Bellido, A.
   Han, J.
   Hindrichs, O.
   Khukhunaishvili, A.
   Lo, K. H.
   Tan, P.
   Verzetti, M.
   Agapitos, A.
   Chou, J. P.
   Gershtein, Y.
   Espinosa, T. A. Gomez
   Halkiadakis, E.
   Heindl, M.
   Hughes, E.
   Kaplan, S.
   Elayavalli, R. Kunnawalkam
   Kyriacou, S.
   Lath, A.
   Nash, K.
   Saka, H.
   Salur, S.
   Schnetzer, S.
   Sheffield, D.
   Somalwar, S.
   Stone, R.
   Thomas, S.
   Thomassen, P.
   Walker, M.
   Delannoy, A. G.
   Foerster, M.
   Heideman, J.
   Riley, G.
   Rose, K.
   Spanier, S.
   Thapa, K.
   Bouhali, O.
   Celik, A.
   Dalchenko, M.
   De Mattia, M.
   Delgado, A.
   Dildick, S.
   Eusebi, R.
   Gilmore, J.
   Huang, T.
   Juska, E.
   Kamon, T.
   Mueller, R.
   Pakhotin, Y.
   Patel, R.
   Perloff, A.
   Pernie, L.
   Rathjens, D.
   Safonov, A.
   Tatarinov, A.
   Ulmer, K. A.
   Akchurin, N.
   Cowden, C.
   Damgov, J.
   De Guio, F.
   Dragoiu, C.
   Dudero, P. R.
   Faulkner, J.
   Gurpinar, E.
   Kunori, S.
   Lamichhane, K.
   Lee, S. W.
   Libeiro, T.
   Peltola, T.
   Undleeb, S.
   Volobouev, I.
   Wang, Z.
   Greene, S.
   Gurrola, A.
   Janjam, R.
   Johns, W.
   Maguire, C.
   Melo, A.
   Ni, H.
   Sheldon, P.
   Tuo, S.
   Velkovska, J.
   Xu, Q.
   Arenton, M. W.
   Barria, P.
   Cox, B.
   Goodell, J.
   Hirosky, R.
   Ledovskoy, A.
   Li, H.
   Neu, C.
   Sinthuprasith, T.
   Sun, X.
   Wang, Y.
   Wolfe, E.
   Xia, F.
   Clarke, C.
   Harr, R.
   Karchin, P. E.
   Sturdy, J.
   Belknap, D. A.
   Buchanan, J.
   Caillol, C.
   Dasu, S.
   Dodd, L.
   Duric, S.
   Gomber, B.
   Grothe, M.
   Herndon, M.
   Herve, A.
   Klabbers, P.
   Lanaro, A.
   Levine, A.
   Long, K.
   Loveless, R.
   Ojalvo, I.
   Perry, T.
   Pierro, G. A.
   Polese, G.
   Ruggles, T.
   Savin, A.
   Smith, N.
   Smith, W. H.
   Taylor, D.
   Woods, N.
CA CMS Collaboration
TI Searches for pair production of third-generation squarks in root s=13
   TeV pp collisions
SO EUROPEAN PHYSICAL JOURNAL C
LA English
DT Article
ID SUPERSYMMETRY
AB Searches are presented for direct production of top or bottom squark pairs in proton-proton collisions at the CERN LHC. Two searches, based on complementary techniques, are performed in all-jet final states that are characterized by a significant imbalance in transverse momentum. An additional search requires the presence of a charged lepton isolated from other activity in the event. The data were collected in 2015 at a centre-of-mass energy of 13 TeV with the CMS detector and correspond to an integrated luminosity of 2.3 fb(-1). No statistically significant excess of events is found beyond the expected contribution from standard model processes. Exclusion limits are set in the context of simplified models of top or bottom squark pair production. Models with top and bottom squark masses up to 830 and 890 GeV, respectively, are probed for light neutralinos. For models with top squark masses of 675 GeV, neutralino masses up to 260 GeV are excluded at 95% confidence level.
C1 [Sirunyan, A. M.; Tumasyan, A.] Yerevan Phys Inst, Yerevan, Armenia.
   [Adam, W.; Asilar, E.; Bergauer, T.; Brandstetter, J.; Brondolin, E.; Dragicevic, M.; Eroe, J.; Flechl, M.; Fruehwirth, R.; Ghete, V. M.; Hartl, C.; Hoermann, N.; Hrubec, J.; Jeitler, M.; Koenig, A.; Kraetschmer, I.; Liko, D.; Matsushita, T.; Mikulec, I.; Rabady, D.; Rad, N.; Rahbaran, B.; Rohringer, H.; Schieck, J.; Strauss, J.; Waltenberger, W.; Wulz, C. -E.] Inst Hochenergiephys, Vienna, Austria.
   [Chekhovsky, V.; Dvornikov, O.; Dydyshka, Y.; Emeliantchik, I.; Litomin, A.; Makarenko, V.; Mossolov, V.; Stefanovitch, R.; Gonzalez, J. Suarez; Zykunov, V.] Inst Nucl Problems, Minsk, Byelarus.
   [Shumeiko, N.] Natl Ctr Particle & High Energy Phys, Minsk, Byelarus.
   [Alderweireldt, S.; De Wolf, E. A.; Janssen, X.; Lauwers, J.; de Klundert, M. Van; Van Haevermaet, H.; Van Mechelen, P.; Van Remortel, N.; Van Spilbeeck, A.] Univ Antwerp, Antwerp, Belgium.
   [Abu Zeid, S.; Blekman, E.; D'Hondt, J.; Daci, N.; De Bruyn, I.; Deroover, K.; Lowette, S.; Moortgat, S.; Moreels, L.; Olbrechts, A.; Python, Q.; Skovpen, K.; Tavernier, S.; Van Doninck, W.; Van Mulders, P.; Van Parijs, I.] Vrije Univ Brussel, Brussels, Belgium.
   [Brun, H.; Clerbaux, B.; De Lentdecker, G.; Delannoy, H.; Fasanella, G.; Favart, L.; Goldouzian, R.; Grebenyuk, A.; Karapostoli, G.; Lenzi, T.; Leonard, A.; Luetic, J.; Maerschalk, T.; Marinov, A.; Randle-Conde, A.; Seva, T.; Velde, C. Vander; Vanlaer, P.; Vannerom, D.; Yonamine, R.; Zenoni, F.; Zhang, F.; Fang, W.] Univ Libre Bruxelles, Brussels, Belgium.
   [Cimmino, A.; Cornelis, T.; Dobur, D.; Fagot, A.; Gul, M.; Khvastunov, I.; Poyraz, D.; Salva, S.; Schofbeck, R.; Tytgat, M.; Van Driessche, W.; Yazgan, E.; Zaganidis, N.] Univ Ghent, Ghent, Belgium.
   [Bakhshiansohi, H.; Beluffi, C.; Bondu, O.; Brochet, S.; Bruno, G.; Caudron, A.; De Visscher, S.; Delaere, C.; Delcourt, M.; Francois, B.; Giammanco, A.; Jafari, A.; Komm, M.; Krintiras, G.; Lemaitre, V.; Magitteri, A.; Mertens, A.; Musich, M.; Piotrzkowski, K.; Quertenmont, L.; Selvaggi, M.; Marono, M. Vidal; Wertz, S.] Catholic Univ Louvain, Louvain Ia Neuve, Belgium.
   [Beliy, N.] Univ Mons, Mons, Belgium.
   [Alda Junior, W. L.; Alves, F. L.; Alves, G. A.; Brito, L.; Hensel, C.; Moraes, A.; Pol, M. E.; Rebell Teles, P.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil.
   [Belchior Batista Das Chagas, E.; Carvalho, W.; Chinellato, J.; Custodio, A.; Costa, E. M. Da.; Da Silveira, G. G.; De Jesus Damiao, D.; De Oliveira Martins, C.; Fonseca De Souza, S.; Huertas Guativa, L. M.; Malbouisson, H.; Matos Figueiredo, D.; Mora Herrera, C.; Mundim, L.; Nogima, H.; Prado Da Silva, W. L.; Santoro, A.; Tonelli Manganote, E. J.; Vilela Pereira, A.] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil.
   [Ahuja, S.; Bernardes, C. A.; Dogra, S.; Fernandez Perez Tomei, T. R.; Gregores, E. M.; Mercadante, P. G.; Moon, C. S.; Novaes, S. F.; Padula, Sandra S.; Romero Abad, D.; Ruiz Vargas, J. C.] Univ Estadual Paulista, Sao Paulo, Brazil.
   [Ahuja, S.; Bernardes, C. A.; Dogra, S.; Fernandez Perez Tomei, T. R.; Gregores, E. M.; Mercadante, P. G.; Moon, C. S.; Novaes, S. F.; Padula, Sandra S.; Romero Abad, D.; Ruiz Vargas, J. C.] Univ Fed ABC, Sao Paulo, Brazil.
   [Aleksandrov, A.; Hadjiiska, R.; Iaydjiev, P.; Rodozov, M.; Stoykova, S.; Sultanov, G.; Vutova, M.] Inst Nucl Energy Res, Sofia, Bulgaria.
   [Dimitrov, A.; Glushkov, I.; Litov, L.; Pavlov, B.; Petkov, P.] Univ Sofia, Sofia, Bulgaria.
   [Fang, W.] Beihang Univ, Beijing, Peoples R China.
   [Ahmad, M.; Bian, J. G.; Chen, G. M.; Chen, H. S.; Chen, M.; Chen, Y.; Cheng, T.; Jiang, C. H.; Leggat, D.; Liu, Z.; Romeo, F.; Ruan, M.; Shaheen, S. M.; Spiezia, A.; Tao, J.; Wang, C.; Wang, Z.; Zhang, H.; Zhao, J.] Inst High Energy Phys, Beijing, Peoples R China.
   [Zhang, F.; Ban, Y.; Chen, G.; Li, Q.; Liu, S.; Mao, Y.; Qian, S. J.; Wang, D.; Xu, Z.] Peking Univ, State Key Lab Nucl Phys & Technol, Beijing, Peoples R China.
   [Avila, C.; Cabrera, A.; Sierra, L. F. Chaparro; Florez, C.; Gomez, J. P.; Hernandez, C. F. Gonzalez; Alvarez, J. D. Ruiz; Sanabria, J. C.] Univ Los Andes, Bogota, Colombia.
   [Godinovic, N.; Lelas, D.; Puljak, I.; Cipriano, P. M. Ribeiro; Sculac, T.] Univ Split, Fac Elect Engn Mech Engn & Naval Architecture, Split, Croatia.
   [Antunovic, Z.; Kovac, M.] Univ Split, Fac Sci, Split, Croatia.
   [Brigljevic, V.; Ferencek, D.; Kadija, K.; Mesic, B.; Susa, T.] Inst Rudjer Boskov, Zagreb, Croatia.
   [Attikis, A.; Mavromanolakis, G.; Mousa, J.; Nicolaou, C.; Ptochos, F.; Razis, P. A.; Rykaczewski, H.; Tsiakkouri, D.] Univ Cyprus, Nicosia, Cyprus.
   [Finger, M.; Finger, M., Jr.] Charles Univ Prague, Prague, Czech Republic.
   [Carrera Jarrin, E.] Univ San Francisco Quito, Quito, Ecuador.
   [Assran, Y.; Elkafrawy, T.; Mahrous, A.] Acad Sci Res & Technol Arab Republ Egypt, Egyptian Network High Energy Phys, Cairo, Egypt.
   [Kadastik, M.; Perrini, L.; Raidal, M.; Tiko, A.; Veelken, C.] NICPB, Tallinn, Estonia.
   [Eerola, P.; Pekkanen, J.; Voutilainen, M.] Univ Helsinki, Dept Phys, Helsinki, Finland.
   [Harkonen, J.; Jarvinen, T.; Karimaki, V.; Kinnunen, R.; Lampen, T.; Lassila-Perini, K.; Lehti, S.; Linden, T.; Luukka, P.; Tuominiemi, J.; Tuovinen, E.; Wendland, L.] Helsinki Inst Phys, Helsinki, Finland.
   [Talvitie, J.; Tuuva, T.] Lappeenranta Univ Technol, Lappeenranta, Finland.
   [Besancon, M.; Couderc, F.; Dejardin, M.; Denegri, D.; Fabbro, B.; Faure, J. L.; Favaro, C.; Ferri, F.; Ganjour, S.; Ghosh, S.; Givernaud, A.; Gras, P.; de Monchenault, G. Hamel; Jarry, P.; Kucher, I.; Locci, E.; Machet, M.; Malcies, J.; Rander, J.; Rosowsky, A.; Titov, M.] Univ Paris Saclay, CEA, IRFU, Gif Sur Yvette, France.
   [Abdulsalam, A.; Antropov, I.; Baffioni, S.; Beaudette, F.; Busson, P.; Cadamuro, L.; Chapon, E.; Chariot, C.; Davignon, O.; de Cassagnac, R. Granier; Lisniak, S.; Mine, P.; Nguyen, M.; Ochando, C.; Ortona, G.; Paganini, P.; Pigard, P.; Regnard, S.; Salerno, R.; Sirois, Y.; Strebler, T.; Yilmaz, Y.; Zabi, A.; Zghiche, A.] Ecole Polytech, IN2P3 CNRS, Lab Leprince Ringuet, Palaiseau, France.
   [Beluffi, C.; Agram, J. -L.; Andrea, J.; Aubin, A.; Bloch, D.; Brom, J. -M.; Buttignol, M.; Chabert, E. C.; Chanon, N.; Collard, C.; Conte, E.; Coubez, X.; Fontaine, J. -C.; Gele, D.; Goerlach, U.; Jansova, M.; Le Bihan, A. -C.; Van Hove, P.] Univ Strasbourg, CNRS IN2P3, IPHC, Strasbourg, France.
   [Gadrat, S.] CNRS, IN2P3, Ctr Calcul Inst Natl Phys Nucl & Phys Particlues, Villeurbanne, France.
   [Beauceron, S.; Bernet, C.; Boudoul, G.; Montoya, C. A. Carrillo; Chierici, R.; Contardo, D.; Courbon, B.; Depasse, P.; El Mamouni, H.; Fan, J.; Fay, J.; Gascon, S.; Gouzevitch, M.; Grenier, G.; Ille, B.; Lagarde, F.; Laktineh, I. B.; Lethuillier, M.; Mirabito, L.; Pequegnot, A. L.; Perries, S.; Popov, A.; Sabes, D.; Sordini, V.; Donckt, M. Vander; Verdier, P.; Viret, S.] Univ Claude Bernard Lyon 1, CNRS, IN2P3, Inst Phys Nucl Lyon, Villeurbanne, France.
   [Khvedelidze, A.] Georgian Tech Univ, Tbilisi, Rep of Georgia.
   [Popov, A.; Tsamalaidze, Z.; Katkov, I.] Tbilisi State Univ, Tbilisi, Rep of Georgia.
   [Autermann, C.; Beranek, S.; Feld, L.; Kiesel, M. K.; Klein, K.; Lipinski, M.; Preuten, M.; Schomakers, C.; Schulz, J.; Verlage, T.; Zhukov, V.] Rhein Westfal TH Aachen, Phys Inst 1, Aachen, Germany.
   [Albert, A.; Brodski, M.; Dietz-Laursonn, E.; Duchardt, D.; Endres, M.; Erdmann, M.; Erdweg, S.; Esch, T.; Fischer, R.; Gueth, A.; Hamer, M.; Hebbeker, T.; Heidemann, C.; Hoepfner, K.; Knutzen, S.; Merschmeyer, M.; Meyer, A.; Millet, P.; Mukherjee, S.; Olschewski, M.; Padeken, K.; Pook, T.; Radziej, M.; Reithler, H.; Rieger, M.; Scheuch, F.; Sonnenschein, L.; Teyssier, D.; Thueer, S.; Borras, K.] Rhein Westfal TH Aachen, Phys Inst A 3, Aachen, Germany.
   [Cherepanov, V.; Fluegge, G.; Kargoll, B.; Kress, T.; Kuensken, A.; Lingemann, J.; Mueller, T.; Nehrkorn, A.; Nowack, A.; Pistone, C.; Pooth, O.; Stahl, A.] Rhein Westfal TH Aachen, Phys Inst B 3, Aachen, Germany.
   [Chen, Y.; Martin, M. Aldaya; Arndt, T.; Asawatangtrakuldee, C.; Beernaert, K.; Behnke, O.; Behrens, U.; Bin Anuar, A. A.; Borras, K.; Campbell, A.; Connor, P.; Contreras-Campana, C.; Costanza, F.; Pardos, C. Diez; Dolinska, G.; Eckerlin, G.; Eckstein, D.; Eichhorn, T.; Eren, E.; Gallo, E.; Garcia, J. Garay; Geiser, A.; Gizhko, A.; Luyando, J. M. Grados; Grohsjean, A.; Gunnellini, P.; Harb, A.; Hauk, J.; Hempel, M.; Jung, H.; Kalogeropoulos, A.; Karacheban, O.; Kasemann, M.; Keaveney, J.; Kleinwort, C.; Korol, I.; Kruecker, D.; Lange, W.; Lelek, A.; Leonard, J.; Lipka, K.; Lobanov, A.; Lohmann, W.; Mankel, R.; Melzer-Pellmann, I. -A.; Meyer, A. B.; Mittag, G.; Mnich, J.; Mussgiller, A.; Ntomari, E.; Pitzl, D.; Placakyte, R.; Raspereza, A.; Roland, B.; Sahin, M. Oe.; Saxena, P.; Schoerner-Sadenius, T.; Seitz, C.; Spannagel, S.; Stefaniuk, N.; Van Onsem, G. P.; Walsh, R.; Wissing, C.] DESY, Hamburg, Germany.
   [Gallo, E.; Blobel, V.; Vignali, M. Centis; Draeger, A. R.; Dreyer, T.; Garutti, E.; Gonzalez, D.; Haller, J.; Hoffmann, M.; Junkes, A.; Klanner, R.; Kogler, R.; Kovalchuk, N.; Lapsien, T.; Lenz, T.; Marchesini, I.; Marconi, D.; Meyer, M.; Niedziela, M.; Nowatschin, D.; Pantaleo, F.; Peiffer, T.; Perieanu, A.; Poehlsen, J.; Sander, C.; Scharf, C.; Schleper, P.; Schmidt, A.; Schumann, S.; Schwandt, J.; Stadie, H.; Steinbrueck, G.; Stober, F. M.; Stoever, M.; Tholen, H.; Troendle, D.; Usai, E.; Vanelderen, L.; Vanhoefer, A.; Vormwald, B.] Univ Hamburg, Hamburg, Germany.
   [Akbiyik, M.; Barth, C.; Baur, S.; Baus, C.; Berger, J.; Butz, F.; Caspart, R.; Chwalek, T.; Colombo, F.; De Boer, W.; Dierlamm, A.; Fink, S.; Freund, B.; Friese, R.; Giffels, M.; Gilbert, A.; Goldenzweig, P.; Haitz, D.; Hartmann, F.; Heindl, S. M.; Husemann, U.; Katkov, I.; Kudella, S.; Mildner, H.; Mozer, M. U.; Mueller, Th.; Plagge, M.; Quast, G.; Rabbertz, K.; Roecker, S.; Roscher, F.; Schroeder, M.; Shvetsov, I.; Sieber, G.; Simonis, H. J.; Ulrich, R.; Wayand, S.; Weber, M.; Weiler, T.; Williamson, S.; Woehrmann, C.; Wolf, R.] Inst Expt Kernphys, Karlsruhe, Germany.
   [Anagnostou, G.; Daskalakis, G.; Geralis, T.; Giakournopoulou, V. A.; Kyriakis, A.; Loukas, D.; Topsis-Giotis, I.] NCSR Demokritos, INPP, Aghia Paraskevi, Greece.
   [Kesisoglou, S.; Panagiotou, A.; Saoulidou, N.; Tziaferi, E.] Univ Athens, Athens, Greece.
   [Evangelou, I.; Flouris, G.; Foudas, C.; Kokkas, P.; Loukas, N.; Manthos, N.; Papadopoulos, I.; Paradas, E.] Univ Ioannina, Ioannina, Greece.
   [Filipovic, N.; Vesztergombi, G.; Bartok, M.; Veres, G. I.] Eotvos Lorand Univ, MTA ELTE Lendulet CMS Particle & Nucl Phys Grp, Budapest, Hungary.
   [Bencze, G.; Hajdu, C.; Horvath, D.; Sikler, F.; Veszpremi, V.; Vesztergombi, G.; Zsigmond, A. J.] Wigner Res Ctr Phys, Budapest, Hungary.
   [Horvath, D.; Beni, N.; Czellar, S.; Karancsi, J.; Makovec, A.; Molnar, J.; Szillasi, Z.] Inst Nucl Res ATOMKI, Debrecen, Hungary.
   [Karancsi, J.; Bartok, M.; Raics, P.; Trocsanyi, Z. L.; Ujvari, B.] Univ Debrecen, Inst Phys, Debrecen, Hungary.
   [Bahinipati, S.; Choudhury, S.; Mal, P.; Mandal, K.; Nayak, A.; Sahoo, D. K.; Sahoo, N.; Swain, S. K.] Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India.
   [Bansal, S.; Beri, S. B.; Bhatnagar, V.; Chawla, R.; Bhawandeep, U.; Kalsi, A. K.; Kaur, A.; Kaur, M.; Kumar, R.; Kumari, P.; Mehta, A.; Mittal, M.; Singh, J. B.; Walia, G.] Panjab Univ, Chandigarh, India.
   [Kumar, Ashok; Bhardwaj, A.; Choudhary, B. C.; Garg, R. B.; Keshri, S.; Malhotra, S.; Naimuddin, M.; Nishu, N.; Ranjan, K.; Sharma, R.; Sharma, V.] Univ Delhi, Delhi, India.
   [Ghosh, S.; Bhattacharya, R.; Bhattacharya, S.; Chatterjee, K.; Dey, S.; Dutt, S.; Dutta, S.; Majumdar, N.; Modak, A.; Mondal, K.; Mukhopadhyay, S.; Nandan, S.; Purohit, A.; Roy, A.; Roy, D.; Chowdhury, S. Roy; Sarkar, S.; Sharan, M.; Thakur, S.] Saha Inst Nucl Phys, Kolkata, India.
   [Behera, P. K.] Indian Inst Technol, Madras, Tamil Nadu, India.
   [Chudasama, R.; Dutta, D.; Jha, V.; Kumar, V.; Mohanty, A. K.; Netrakanti, P. K.; Pant, L. M.; Shukla, P.; Topkar, A.] Bhabha Atom Res Ctr, Bombay, Maharashtra, India.
   [Aziz, T.; Dugad, S.; Kole, G.; Mahakud, B.; Mitra, S.; Mohanty, G. B.; Parida, B.; Sur, N.; Sutar, B.] Tata Inst Fundamental Res A, Bombay, Maharashtra, India.
   [Banerjee, S.; Bhowmik, S.; Dewanjee, R. K.; Ganguly, S.; Guchait, M.; Jain, Sa.; Kumar, S.; Maity, M.; Majumder, G.; Mazumdar, K.; Sarkar, T.; Wickramage, N.] Tata Inst Fundamental Res B, Bombay, Maharashtra, India.
   [Chauhan, S.; Dube, S.; Hegde, V.; Kapoor, A.; Kothekar, K.; Pandey, S.; Rane, A.; Sharma, S.] IISER, Pune, Maharashtra, India.
   [Chenarani, S.; Tadavani, E. Eskandari; Etesami, S. M.; Khakzad, M.; Najafabadi, M. Mohammadi; Naseri, M.; Mehdiabadi, S. Paktinat; Hosseinabadi, F. Rezaei; Safarzadeh, B.; Zeinali, M.] Inst Res Fundamental Sci IPM, Tehran, Iran.
   [Felcini, M.; Grunewald, M.] Univ Coll Dublin, Dublin, Ireland.
   [Abbrescia, M.; Calabria, C.; Caputo, C.; Colaleo, A.; Creanza, D.; Cristella, L.; De Filippis, N.; De Palma, M.; Fiore, L.; Iaselli, G.; Maggi, G.; Maggi, M.; Miniello, G.; My, S.; Nuzzo, S.; Pompili, A.; Pugliese, G.; Radogna, R.; Ranieri, A.; Selvaggi, G.; Sharma, A.; Silvestris, L.; Venditti, R.; Verwilligen, P.] Ist Nazl Fis Nucl, Sez Bari, Bari, Italy.
   [Abbrescia, M.; Calabria, C.; Caputo, C.; Cristella, L.; De Palma, M.; Miniello, G.; My, S.; Pompili, A.; Radogna, R.; Selvaggi, G.; Venditti, R.; Verwilligen, P.] Univ Bari, Bari, Italy.
   [Creanza, D.; De Filippis, N.; Iaselli, G.; Maggi, G.; Pugliese, G.] Politec Bari, Bari, Italy.
   [Abbiendi, G.; Battilana, C.; Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Campanini, R.; Capiluppi, P.; Castro, A.; Cavallo, F. R.; Chhibra, S. S.; Codispoti, G.; Cuffiani, M.; Dallavalle, G. M.; Fabbri, F.; Fanfani, A.; Fasanella, D.; Giacomelli, P.; Grandi, C.; Guiducci, L.; Marcellini, S.; Masetti, G.; Montanari, A.; Navarria, F. L.; Perrotta, A.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Tosi, N.] Ist Nazl Fis Nucl, Sez Bologna, Bologna, Italy.
   [Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Campanini, R.; Capiluppi, P.; Castro, A.; Chhibra, S. S.; Codispoti, G.; Cuffiani, M.; Fanfani, A.; Fasanella, D.; Guiducci, L.; Navarria, F. L.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Tosi, N.] Univ Bologna, Bologna, Italy.
   [Albergo, S.; Costa, S.; Di Mattia, A.; Giordano, F.; Potenza, R.; Tricomi, A.; Tuve, C.] Ist Nazl Fis Nucl, Sez Catania, Catania, Italy.
   [Albergo, S.; Costa, S.; Di Mattia, A.; Giordano, F.; Potenza, R.; Tricomi, A.; Tuve, C.] Univ Catania, Catania, Italy.
   [Barbagli, G.; Ciulli, V.; Civinini, C.; D'Alessandro, R.; Focardi, E.; Lenzi, P.; Meschini, M.; Paoletti, S.; Russo, L.; Sguazzoni, G.; Strom, D.; Viliani, L.] Ist Nazl Fis Nucl, Sez Firenze, Florence, Italy.
   [Ciulli, V.; D'Alessandro, R.; Focardi, E.; Lenzi, P.; Viliani, L.] Univ Florence, Florence, Italy.
   [Fabbri, F.; Benussi, L.; Bianco, S.; Piccolo, D.; Primavera, F.] Ist Nazl Fis Nucl, Lab Nazl Frascati, Frascati, Italy.
   [Calvelli, V.; Ferro, F.; Monge, M. R.; Robutti, E.; Tosi, S.] Ist Nazl Fis Nucl, Sez Genova, Genoa, Italy.
   [Calvelli, V.; Monge, M. R.; Tosi, S.] Univ Genoa, Genoa, Italy.
   [Brianza, L.; Brivio, F.; Dinardo, M. E.; Fiorendi, S.; Gennai, S.; Ghezzi, A.; Govoni, P.; Malberti, M.; Malvezzi, S.; Manzoni, R. A.; Menasce, D.; Moroni, L.; Paganoni, M.; Pedrini, D.; Pigazzini, S.; Ragazzi, S.; de Fatis, T. Tabarelli] Ist Nazl Fis Nucl, Sez Milano Bicocca, Milan, Italy.
   [Paganini, P.; Brianza, L.; Brivio, F.; Dinardo, M. E.; Fiorendi, S.; Ghezzi, A.; Govoni, P.; Malberti, M.; Manzoni, R. A.; Pigazzini, S.; Ragazzi, S.; de Fatis, T. Tabarelli] Univ Milan, Milan, Italy.
   [Buontempo, S.; Cavallo, N.; Di Guida, S.; Esposito, M.; Fabozzi, F.; Fienga, F.; Iorio, A. O. M.; Lanza, G.; Lista, L.; Meola, S.; Paolucci, P.; Sciacca, C.; Thyssen, F.] Ist Nazl Fis Nucl, Sez Napoli, Naples, Italy.
   [Esposito, M.; Fienga, F.; Iorio, A. O. M.; Sciacca, C.] Univ Napoli Federico II, Naples, Italy.
   [Cavallo, N.; Fabozzi, F.] Univ Basilicata, Potenza, Italy.
   [Di Guida, S.; Meola, S.] Univ G Marconi, Rome, Italy.
   [Azzi, P.; Bacchetta, N.; Bellato, M.; Benato, L.; Biasotto, M.; Bisello, D.; Boletti, A.; Checchia, P.; Dall'Osso, M.; Manzano, P. De Castro; Dosselli, U.; Gasparini, F.; Gasparini, U.; Gozzelino, A.; Lacaprara, S.; Margoni, M.; Meneguzzo, A. T.; Pazzini, J.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Torassa, E.; Ventura, S.; Zanetti, M.; Zotto, P.; Zumerle, G.] Ist Nazl Fis Nucl, Sez Padova, Padua, Italy.
   [Benato, L.; Bisello, D.; Boletti, A.; Dall'Osso, M.; Gasparini, F.; Gasparini, U.; Margoni, M.; Meneguzzo, A. T.; Pazzini, J.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Zanetti, M.; Zotto, P.; Zumerle, G.] Univ Padua, Padua, Italy.
   Univ Trento, Trento, Italy.
   [Braghieri, A.; Fallavollita, F.; Magnani, A.; Montagna, P.; Ratti, S. P.; Re, V.; Riccardi, C.; Salvini, P.; Vai, I.; Vitulo, P.] Ist Nazl Fis Nucl, Sez Pavia, Pavia, Italy.
   [Fallavollita, F.; Magnani, A.; Montagna, P.; Ratti, S. P.; Riccardi, C.; Vai, I.; Vitulo, P.] Univ Pavia, Pavia, Italy.
   [Solestizi, L. Alunni; Bilei, G. M.; Ciangottini, D.; Fano, L.; Lariccia, P.; Leonardi, R.; Mantovani, G.; Menichelli, M.; Saha, A.; Santocchia, A.] Ist Nazl Fis Nucl, Sez Perugia, Perugia, Italy.
   [Solestizi, L. Alunni; Ciangottini, D.; Fano, L.; Lariccia, P.; Leonardi, R.; Mantovani, G.; Santocchia, A.] Univ Perugia, Perugia, Italy.
   [Androsov, K.; Azzurri, P.; Bagliesi, G.; Bernardini, J.; Boccali, T.; Castaldi, R.; Ciocci, M. A.; Dell'Orso, R.; Donato, S.; Fedi, G.; Giassi, A.; Grippo, M. T.; Ligabue, F.; Lomtadze, T.; Martini, L.; Messineo, A.; Palla, F.; Rizzi, A.; Savoy-Navarro, A.; Spagnolo, P.; Tenchini, R.; Tonelli, G.; Venturi, A.; Verdini, P. G.] Ist Nazl Fis Nucl, Sez Pisa, Pisa, Italy.
   [Martini, L.; Messineo, A.; Rizzi, A.; Tonelli, G.] Univ Pisa, Pisa, Italy.
   [Donato, S.; Ligabue, F.; Rolandi, G.] Scuola Normale Super Pisa, Pisa, Italy.
   [Barone, L.; Cavallari, F.; Cipriani, M.; Del Re, D.; Diemoz, M.; Gelli, S.; Longo, E.; Margaroli, F.; Marzocchi, B.; Meridiani, P.; Organtini, G.; Paramatti, R.; Preiato, F.; Rahatlou, S.; Rovelli, C.; Santanastasio, F.; Di Marco, E.] Ist Nazl Fis Nucl, Sez Roma, Rome, Italy.
   [Barone, L.; Cipriani, M.; Del Re, D.; Gelli, S.; Longo, E.; Margaroli, F.; Marzocchi, B.; Organtini, G.; Preiato, F.; Rahatlou, S.; Santanastasio, F.] Univ Rome, Rome, Italy.
   [Amapane, N.; Arcidiacono, R.; Argiro, S.; Arneodo, M.; Bartosik, N.; Bellan, R.; Biino, C.; Cartiglia, N.; Cenna, F.; Costa, M.; Covarelli, R.; Degano, A.; Demaria, N.; Finco, L.; Kiani, B.; Mariotti, C.; Maselli, S.; Migliore, E.; Monaco, V.; Monteil, E.; Monteno, M.; Obertino, M. M.; Pacher, L.; Pastrone, N.; Pelliccioni, M.; Angioni, G. L. Pinna; Ravera, F.; Romero, A.; Ruspa, M.; Sacchi, R.; Shchelina, K.; Sola, V.; Solano, A.; Staiano, A.; Traczyk, P.] Ist Nazl Fis Nucl, Sez Torino, Turin, Italy.
   [Amapane, N.; Argiro, S.; Bellan, R.; Cenna, F.; Costa, M.; Covarelli, R.; Degano, A.; Finco, L.; Kiani, B.; Migliore, E.; Monaco, V.; Monteil, E.; Obertino, M. M.; Pacher, L.; Angioni, G. L. Pinna; Ravera, F.; Romero, A.; Sacchi, R.; Shchelina, K.; Solano, A.; Traczyk, P.] Univ Turin, Turin, Italy.
   [Arcidiacono, R.; Arneodo, M.; Ruspa, M.] Univ Piemonte Orientale, Novara, Italy.
   [Belforte, S.; Casarsa, M.; Cossutti, F.; Della Ricca, G.; Zanetti, A.] Ist Nazl Fis Nucl, Sez Trieste, Trieste, Italy.
   [Della Ricca, G.] Univ Trieste, Trieste, Italy.
   [Kim, D. H.; Kim, G. N.; Kim, M. S.; Lee, S.; Lee, S. W.; Oh, Y. D.; Sekmen, S.; Son, D. C.; Yang, Y. C.] Kyungpook Natl Univ, Taegu, South Korea.
   [Lee, A.] Chonbuk Natl Univ, Chonju, South Korea.
   [Kim, H.] Chonnam Natl Univ, Inst Univ & Elementary Particles, Kwangju, South Korea.
   [Cifuentes, J. A. Brochero; Kim, T. J.] Hanyang Univ, Seoul, South Korea.
   [Lee, S.; Cho, S.; Choi, S.; Go, Y.; Gyun, D.; Ha, S.; Hong, B.; Jo, Y.; Kim, Y.; Lee, K.; Lee, K. S.; Lim, J.; Park, S. K.; Roh, Y.] Korea Univ, Seoul, South Korea.
   [Almond, J.; Kim, J.; Lee, H.; Oh, S. B.; Radburn-Smith, B. C.; Seo, S. H.; Yang, U. K.; Yoo, H. D.; Yu, G. B.] Seoul Natl Univ, Seoul, South Korea.
   [Kim, H.; Choi, M.; Kim, J. H.; Lee, J. S. H.; Park, I. C.; Ryu, G.; Ryu, M. S.] Univ Seoul, Seoul, South Korea.
   [Choi, Y.; Goh, J.; Hwang, C.; Lee, J.; Yu, I.] Sungkyunkwan Univ, Suwon, South Korea.
   [Dudenas, V.; Juodagalvis, A.; Vaitkus, J.] Vilnius Univ, Vilnius, Lithuania.
   [Ahmed, I.; Ibrahim, Z. A.; Komaragiri, J. R.; Ali, M. A. B. Md; Idris, F. Mohamad; Abdullah, W. A. T. Wan; Yusli, M. N.; Zolkapli, Z.] Univ Malaya, Natl Ctr Particle Phys, Kuala Lumpur, Malaysia.
   [Castilla-Valdez, H.; De la Cruz-Burelo, E.; Heredia-De la Cruz, I.; Hernandez-Almada, A.; Lopez-Fernandez, R.; Magana Villalba, R.; Mejia Guisao, J.; Sanchez-Hernandez, A.] IPN, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico.
   [Carrillo Moreno, S.; Oropeza Barrera, C.; Vazquez Valencia, F.] Univ Iberoamer, Mexico City, DF, Mexico.
   [Carpinteyro, S.; Pedraza, I.; Salazar Ibarguen, H. A.; Uribe Estrada, C.] Benemerita Univ Autonoma Puebla, Puebla, Mexico.
   [Morelos Pineda, A.] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico.
   [Krofcheck, D.] Univ Auckland, Auckland, New Zealand.
   [Butler, P. H.] Univ Canterbury, Christchurch, New Zealand.
   [Ahmad, M.; Ahmad, A.; Hassan, Q.; Hoorani, H. R.; Khan, W. A.; Saddique, A.; Shah, M. A.; Shoaib, M.; Waqas, M.] Quaid I Azam Univ, Natl Ctr Phys, Islamabad, Pakistan.
   [Bialkowska, H.; Bluj, M.; Boimska, B.; Frueboes, T.; Gorski, M.; Kazana, M.; Nawrocki, K.; Romanowska-Rybinska, K.; Szleper, M.; Zalewski, P.] Natl Ctr Nucl Res, Otwock, Poland.
   [Bunkowski, K.; Byszuk, A.; Doroba, K.; Kalinowski, A.; Konecki, M.; Krolikowski, J.; Misiura, M.; Olszewski, M.; Walczak, M.] Univ Warsaw, Fac Phys, Inst Expt Phys, Warsaw, Poland.
   [Bargassa, P.; Silva, C. Beirdo Da Cruz E.; Calpas, B.; Di Francesco, A.; Faccioli, P.; Parracho, P. G. Ferreira; Gallinaro, M.; Hollar, J.; Leonardo, N.; Iglesias, L. Lloret; Nemallapudi, M. V.; Antunes, J. Rodrigues; Seixas, J.; Toldaiev, O.; Vadruccio, D.; Varela, J.; Vischia, P.] Lab Instrumentacao & Fis Expt Particulas, Lisbon, Portugal.
   [Finger, M.; Finger, M., Jr.; Khvedelidze, A.; Tsamalaidze, Z.; Alexakhin, V.; Bunin, P.; Gavrilenko, M.; Golutvin, I.; Gorbunov, I.; Kamenev, A.; Karjavin, V.; Lanev, A.; Malakhov, A.; Matveev, V.; Palichik, V.; Perelygin, V.; Savina, M.; Shmatov, S.; Skatchkov, N.; Smirnov, V.; Voytishin, N.; Zarubin, A.] Joint Inst Nucl Res, Dubna, Russia.
   [Chtchipounov, L.; Golovtsov, V.; Ivanov, Y.; Kim, V.; Kuznetsova, E.; Murzin, V.; Oreshkin, V.; Sulimov, V.; Vorobyev, A.] Petersburg Nucl Phys Inst, St Petersburg, Russia.
   [Andreev, Yu.; Dermenev, A.; Gninenko, S.; Golubev, N.; Karneyeu, A.; Kirsanov, M.; Krasnikov, N.; Pashenkov, A.; Tlisov, D.; Toropin, A.] Inst Nucl Res, Moscow, Russia.
   [Epshteyn, V.; Gavrilov, V.; Lychkovskaya, N.; Popov, V.; Pozdnyakov, I.; Safronov, G.; Spiridonov, A.; Toms, M.; Vlasov, E.; Zhokin, A.; Starodumov, A.] Inst Theoret & Expt Phys, Moscow, Russia.
   [Bylinkin, A.] Moscow Inst Phys & Technol, Moscow, Russia.
   [Bylinkin, A.; Markin, O.; Popova, E.; Zhemchugov, E.; Azarkin, M.; Dremin, I.; Leonidov, A.] Natl Res Nucl Univ, Moscow Engn Phys Inst MEPhI, Moscow, Russia.
   [Andreev, V.; Azarkin, M.; Dremin, I.; Kirakosyan, M.; Leonidov, A.; Terkulov, A.] PN Lebedev Phys Inst, Moscow, Russia.
   [Agram, J. -L.; Conte, E.; Fontaine, J. -C.; Baskakov, A.; Belyaev, A.; Boos, E.; Bunichev, V.; Dubinin, M.; Dudko, L.; Ershov, A.; Gribushin, A.; Klyukhin, V.; Kodolova, O.; Loklitin, I.; Miagkov, I.; Obraztsov, S.; Petrushanko, S.; Savrin, V.] Lomonosov Moscow State Univ, Skobeltsyn Inst Nucl Phys, Moscow, Russia.
   [Blinov, V.; Skovpen, Y.; Shtol, D.] NSU, Novosibirsk, Russia.
   [Azhgirey, I.; Bayshev, I.; Bitioukov, S.; Elumakhov, D.; Kachanov, V.; Kalinin, A.; Konstantinov, D.; Krychkine, V.; Petrov, V.; Ryutin, R.; Sobol, A.; Troshin, S.; Tyurin, N.; Uzunian, A.; Volkov, A.] State Res Ctr Russian Federat, Inst High Energy Phys, Protvino, Russia.
   [Adzic, P.; Cirkovic, P.; Devetak, D.; Dordevic, M.; Milosevic, J.; Rekovic, V.; Milenovic, P.] Univ Belgrade, Fac Phys, Belgrade, Serbia.
   [Adzic, P.; Cirkovic, P.; Devetak, D.; Dordevic, M.; Milosevic, J.; Rekovic, V.; Milenovic, P.] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade, Serbia.
   [Alcaraz Maestre, J.; Barrio Luna, M.; Calvo, E.; Cerrada, M.; Chamizo Llatas, M.; Colino, N.; De la Cruz, B.; Delgado Peris, A.; Escalante Del Valle, A.; Fernandez Bedoya, C.; Fernandez Ramos, J. P.; Flix, J.; Fouz, M. C.; Garcia-Abia, P.; Gonzalez Lopez, O.; Goy Lopez, S.; Hernandez, J. M.; Josa, M. I.; Navarro De Martino, E.; Perez-Calero Yzquierdo, A.; Puerta Pelayo, J.; Quintario Olmeda, A.; Redondo, I.; Romero, L.; Soares, M. S.] CIEMAT, Madrid, Spain.
   [de Troconiz, J. F.; Missiroli, M.; Moran, D.] Univ Autonoma Madrid, Madrid, Spain.
   [Cuevas, J.; Fernandez Menendez, J.; Gonzalez Caballero, I.; Gonzalez Fernandez, J. R.; Palencia Cortezon, E.; Sanchez Cruz, S.; Suarez Andres, I.; Vizan Garcia, J. M.] Univ Oviedo, Oviedo, Spain.
   [Cabrillo, I. J.; Calderon, A.; Curras, E.; Fernandez, M.; Garcia-Ferrero, J.; Gomez, G.; Lopez Virto, A.; Marco, J.; Martinez Rivero, C.; Matorras, F.; Piedra Gomez, J.; Rodrigo, T.; Ruiz-Jimeno, A.; Scodellaro, L.; Trevisani, N.; Vila, I.; Vilar Cortabitarte, R.] Univ Cantabria, CSIC, Inst Fis Cantabria IFCA, Santander, Spain.
   [Chen, Y.; Stahl, A.; Pantaleo, F.; Hartmann, F.; Mohanty, A. K.; Sharma, A.; Silvestris, L.; Tosi, N.; Viliani, L.; Primavera, F.; Brianza, L.; Fiorendi, S.; Di Guida, S.; Meola, S.; Paolucci, P.; Azzi, P.; Azzurri, P.; Del Re, D.; Arcidiacono, R.; Abbaneo, D.; Auffray, E.; Auzinger, G.; Bachtis, M.; Baillon, P.; Ball, A. H.; Barney, D.; Bloch, P.; Bocci, A.; Botta, C.; Camporesi, T.; Castello, R.; Cepeda, M.; Cerminara, G.; d'Enterria, D.; Dabrowski, A.; Daponte, V.; David, A.; De Gruttola, M.; De Roeck, A.; Di Marco, E.; Dobson, M.; Dorney, B.; du Pree, T.; Duggan, D.; Duenser, M.; Dupont, N.; Elliott-Peisert, A.; Everaerts, P.; Fartoukh, S.; Franzoni, G.; Fulcher, J.; Funk, W.; Gigi, D.; Gill, K.; Girone, M.; Glege, F.; Gulhan, D.; Gundacker, S.; Guthoff, M.; Harris, P.; Hegeman, J.; Innocente, V.; Janot, P.; Kieseler, J.; Kirschenmann, H.; Knuenz, V.; Kornmayer, A.; Kortelainen, M. J.; Kousouris, K.; Krammer, M.; Lange, C.; Lecoq, P.; Lourenco, C.; Lucchini, M. T.; Malgeri, L.; Mannelli, M.; Martelli, A.; Meijers, F.; Merlin, J. A.; Mersi, S.; Meschi, E.; Milenovic, P.; Moortgat, F.; Morovic, S.; Mulders, M.; Neugebauer, H.; Orfanelli, S.; Orsini, L.; Pape, L.; Perez, E.; Peruzzi, M.; Petrilli, A.; Petrucciani, G.; Pfeiffer, A.; Pierini, M.; Racz, A.; Reis, T.; Rolandi, G.; Rovere, M.; Sakulin, H.; Sauvan, J. B.; Schaefer, C.; Schwick, C.; Seidel, M.; Silva, P.; Sphicas, P.; Steggemann, J.; Stoye, M.; Takahashi, Y.; Tosi, M.; Treille, D.; Triossi, A.; Tsirou, A.; Veckalns, V.; Veres, G. I.; Verweij, M.; Wardle, N.; Woehri, H. K.; Zagozdzinska, A.; Zeuner, W. D.; Virdee, T.] CERN, European Org Nucl Res, Geneva, Switzerland.
   [Bertl, W.; Deiters, K.; Erdmann, W.; Horisberger, R.; Ingram, Q.; Kaestli, H. C.; Kotlinski, D.; Langenegger, U.; Rohe, T.] Paul Scherrer Inst, Villigen, Switzerland.
   [Bachmair, F.; Baeni, L.; Bianchini, L.; Casal, B.; Dissertori, G.; Dittmar, M.; Donega, M.; Grab, C.; Heidegger, C.; Hits, D.; Hoss, J.; Kasieczka, G.; Lustermann, W.; Mangano, B.; Marionneau, M.; del Arbol, P. Martinez Ruiz; Masciovecchio, M.; Meinhard, M. T.; Meister, D.; Michell, F.; Musella, P.; Nessi-Tedaldi, F.; Pandolfi, F.; Pata, J.; Pauss, F.; Perrin, G.; Perrozzi, L.; Quittnat, M.; Rossini, M.; Schoenenberger, M.; Starodumov, A.; Tavolaro, V. R.; Theofilatos, K.; Wallny, R.] ETH, Inst Particle Phys, Zurich, Switzerland.
   [Aarrestad, T. K.; Amsler, C.; Caminada, L.; Canelli, M. F.; De Cosa, A.; Galloni, C.; Hinzmann, A.; Hreus, T.; Kilminster, B.; Ngadiuba, J.; Pinna, D.; Rauco, G.; Robmann, P.; Salerno, D.; Yang, Y.; Zucchetta, A.] Univ Zurich, Zurich, Switzerland.
   [Candelise, V.; Doan, T. H.; Jain, Sh.; Khurana, R.; Konyushikhin, M.; Kuo, C. M.; Lin, W.; Lu, Y. J.; Pozdnyakov, A.; Yu, S. S.] Natl Cent Univ, Chungli, Taiwan.
   [Kumar, Arun; Chang, P.; Chang, Y. H.; Chao, Y.; Chen, K. F.; Chen, P. H.; Fiori, F.; Hou, W. -S.; Hsiung, Y.; Liu, Y. F.; Lu, R. -S.; Moya, M. Minano; Paganis, E.; Psallidas, A.; Tsai, J. F.] NTU, Taipei, Taiwan.
   [Asavapibhop, B.; Singh, G.; Srimanobhas, N.; Suwonjandee, N.] Chulalongkorn Univ, Fac Sci, Dept Phys, Bangkok, Thailand.
   [Adiguzel, A.; Bakirei, M. N.; Cerci, S.; Damarseckin, S.; Demiroglu, Z. S.; Dozen, C.; Dumanoglu, I.; Girgis, S.; Gokbulut, G.; Guler, Y.; Hos, I.; Kangal, E. E.; Kara, O.; Topaksu, A. Kayis; Kiminsu, U.; Oglakci, M.; Onengut, G.; Ozdemir, K.; Tali, B.; Turkcapar, S.; Zorbakir, I. S.; Zorbilmez, C.] Cukurova Univ, Phys Dept, Sci & Art Fac, Adana, Turkey.
   [Bilin, B.; Bilmis, S.; Isildak, B.; Karapinar, G.; Yalvac, M.; Zeyrek, M.] Middle East Tech Univ, Phys Dept, Ankara, Turkey.
   [Gulmez, E.; Kaya, M.; Kaya, O.; Yetkin, E. A.; Yetkin, T.] Bogazici Univ, Istanbul, Turkey.
   [Hos, I.; Cakir, A.; Cankocak, K.; Sen, S.] Istanbul Tech Univ, Istanbul, Turkey.
   [Grynyov, B.] Natl Acad Sci Ukraine, Inst Scintillat Mat, Kharkov, Ukraine.
   [Levchuk, L.; Sorokin, P.] Kharkov Inst Phys & Technol, Natl Sci Ctr, Kharkov, Ukraine.
   [Aggleton, R.; Ball, F.; Beck, L.; Brooke, J. J.; Burns, D.; Clement, E.; Cussans, D.; Flacher, H.; Goldstein, J.; Grimes, M.; Heath, G. P.; Heath, H. F.; Jacob, J.; Kreczko, L.; Lucas, C.; Newbold, D. M.; Paramesvaran, S.; Poll, A.; Sakuma, T.; El Nasr-Storey, S. Self; Smith, D.; Smith, V. J.] Univ Bristol, Bristol, Avon, England.
   [Belyaev, A.; Newbold, D. M.; Bell, K. W.; Brew, C.; Brown, R. M.; Calligaris, L.; Cieri, D.; Cockerill, D. J. A.; Coughlan, J. A.; Harder, K.; Harper, S.; Olaiya, E.; Petyt, D.; Shepherd-Themistocleous, C. H.; Thea, A.; Tomalin, I. R.; Williams, T.; Lucas, R.] Rutherford Appleton Lab, Didcot, Oxon, England.
   [Baber, M.; Bainbridge, R.; Buchmuller, O.; Bundock, A.; Burton, D.; Casasso, S.; Citron, M.; Colling, D.; Corpe, L.; Dauncey, P.; Davies, G.; De Wit, A.; Della Negra, M.; Di Maria, R.; Dunne, P.; Elwood, A.; Futyan, D.; Haddad, Y.; Hall, G.; Iles, G.; James, T.; Lane, R.; Laner, C.; Lucas, R.; Lyons, L.; Magnan, A. -M.; Malik, S.; Mastrolorenzo, L.; Nash, J.; Nikitenko, A.; Pela, J.; Penning, B.; Pesaresi, M.; Raymond, D. M.; Richards, A.; Rose, A.; Seez, C.; Summers, S.; Tapper, A.; Uchida, K.; Acosta, M. Vazquez; Virdee, T.; Wright, J.; Zenz, S. C.] Imperial Coll, London, England.
   [Cole, J. E.; Hobson, P. R.; Khan, A.; Kyberd, P.; Reid, I. D.; Symonds, P.; Teodorescu, L.; Turner, M.] Brunel Univ, Uxbridge, Middx, England.
   [Borzou, A.; Call, K.; Dittmann, J.; Hatakeyama, K.; Liu, H.; Pastika, N.] Baylor Univ, Waco, TX 76798 USA.
   [Bartek, R.; Dominguez, A.] Catholic Univ Amer, Washington, DC 20064 USA.
   [Cooper, S. I.; Henderson, C.; Rumerio, P.; West, C.] Univ Alabama, Tuscaloosa, AL USA.
   [Arcaro, D.; Avetisyan, A.; Bose, T.; Gastler, D.; Rankin, D.; Richardson, C.; Rohlf, J.; Sulak, L.; Zou, D.] Boston Univ, Boston, MA 02215 USA.
   [Benelli, G.; Cutts, D.; Garabedian, A.; Hakala, J.; Heintz, U.; Hogan, J. M.; Jesus, O.; Kwok, K. H. M.; Laird, E.; Landsberg, G.; Mao, Z.; Narain, M.; Piperov, S.; Sagir, S.; Spencer, E.; Syarif, R.] Brown Univ, Providence, RI 02912 USA.
   [Chauhan, S.; Burns, D.; Breedon, R.; Sanchez, M. Calderon De la Barca; Chertok, M.; Conway, J.; Conway, R.; Cox, P. T.; Erbacher, R.; Flores, C.; Funk, G.; Gardner, M.; Ko, W.; Lander, R.; Mclean, C.; Mulhearn, M.; Pellett, D.; Pilot, J.; Shalhout, S.; Shi, M.; Smith, J.; Squires, M.; Stolp, D.; Tos, K.; Tripathi, M.] Univ Calif Davis, Davis, CA 95616 USA.
   [Weber, M.; Bravo, C.; Cousins, R.; Dasgupta, A.; Florent, A.; Hauser, J.; Ignatenko, M.; Mccoll, N.; Saltzberg, D.; Schnaible, C.; Valuev, V.] Univ Calif Los Angeles, Los Angeles, CA USA.
   [Bouvier, E.; Burt, K.; Clare, R.; Ellison, J.; Gary, J. W.; Shiraz, S. M. A. Ghiasi; Hanson, G.; Heilman, J.; Jandir, P.; Kennedy, E.; Lacroix, F.; Long, O. R.; Negrete, M. Olmedo; Paneva, M. I.; Shrinivas, A.; Si, W.; Wei, H.; Wimpenny, S.; Yates, B. R.] Univ Calif Riverside, Riverside, CA 92521 USA.
   [Sharma, V.; Branson, J. G.; Cerati, G. B.; Cittolin, S.; Derdzinski, M.; Gerosa, R.; Holzner, A.; Klein, D.; Kruteiyov, V.; Letts, J.; Macneill, L.; Olivito, D.; Padhi, S.; Pieri, M.; Sani, M.; Simon, S.; Tadel, M.; Vartak, A.; Wasserbaech, S.; Welke, C.; Wood, J.; Wurthwein, F.; Yagil, A.; Della Porta, G. Zevi] Univ Calif San Diego, San Diego, CA 92103 USA.
   [Amin, N.; Bhandari, R.; Bradtniller-Feld, J.; Campagnari, C.; Dishaw, A.; Dutta, V.; Sevilla, M. Franco; George, C.; Golf, F.; Gouskos, L.; Gran, J.; Heller, R.; Incandela, J.; Mullin, S. D.; Ovcharova, A.; Qu, H.; Richman, J.; Stuart, D.; Suarez, I.; Yoo, J.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.
   [Dubinin, M.; Anderson, D.; Bendavid, J.; Bornheim, A.; Bunn, J.; Duarte, J.; Lawhorn, J. M.; Mott, A.; Newman, H. B.; Pena, C.; Spiropulu, M.; Vlimant, J. R.; Xie, S.; Zhu, R. Y.] CALTECH, Pasadena, CA 91125 USA.
   [Andrews, M. B.; Ferguson, T.; Paulini, M.; Russ, J.; Sun, M.; Vogel, H.; Vorobiev, I.; Weinberg, M.] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.
   [Cumalat, J. P.; Ford, W. T.; Jensen, F.; Johnson, A.; Krohn, M.; Mulholland, T.; Stenson, K.; Wagner, S. R.] Univ Colorado, Boulder, CO 80309 USA.
   [Zeinali, M.; Alexander, J.; Chaves, J.; Chu, J.; Dittmer, S.; Mcdermott, K.; Mirman, N.; Kaufman, G. Nicolas; Patterson, J. R.; Rinkevicius, A.; Ryd, A.; Skinnari, L.; Soffi, L.; Tan, S. M.; Tao, Z.; Thom, J.; Tucker, J.; Wittich, P.] Cornell Univ, Ithaca, NY USA.
   [Winn, D.] Fairfield Univ, Fairfield, CT 06430 USA.
   [Banerjee, S.; Abdullin, S.; Albrow, M.; Apollinari, G.; Apresyan, A.; Bauerdick, L. A. T.; Beretvas, A.; Berryhill, J.; Bhat, P. C.; Bolla, G.; Burkett, K.; Butler, J. N.; Cheung, H. W. K.; Chlebana, F.; Cihangir, S.; Cremonesi, M.; Elvira, V. D.; Fisk, I.; Freeman, J.; Gottschalk, E.; Gray, L.; Green, D.; Grunendahl, S.; Gutsche, O.; Hare, D.; Harris, R. M.; Hasegawa, S.; Hirschauer, J.; Hu, Z.; Jayatilaka, B.; Jindariani, S.; Johnson, M.; Joshi, U.; Klima, B.; Kreis, B.; Lammel, S.; Linacre, J.; Lincoln, D.; Lipton, R.; Liu, M.; Liu, T.; De Sa, R. Lopes; Lykken, J.; Maeshima, K.; Magini, N.; Marraffino, J. M.; Maruyama, S.; Mason, D.; McBride, P.; Merkel, P.; Mrenna, S.; Nahn, S.; O'Dell, V.; Pedro, K.; Prokofyev, O.; Rakness, G.; Ristori, L.; Sexton-Kennedy, F.; Soha, A.; Spalding, W. J.; Spiegel, L.; Stoynev, S.; Strait, J.; Strobbe, N.; Taylor, L.; Tkaczyk, S.; Tran, N. V.; Uplegger, L.; Vaandering, E. W.; Vernieri, C.; Verzocchi, M.; Vidal, R.; Wang, M.; Weber, H. A.; Whitbeck, A.; Wu, Y.] Fermilab Natl Accelerator Lab, POB 500, Batavia, IL 60510 USA.
   [Kuznetsova, E.; Acosta, D.; Avery, P.; Bortignon, P.; Bourilkov, D.; Brinkerhoff, A.; Carnes, A.; Carver, M.; Curry, D.; Das, S.; Field, R. D.; Furic, I. K.; Konigsberg, J.; Korytov, A.; Low, J. F.; Ma, P.; Matchev, K.; Mei, H.; Mitselmakher, G.; Rank, D.; Shchutska, L.; Sperka, D.; Thomas, L.; Wang, J.; Wang, S.; Yelton, J.] Univ Florida, Gainesville, FL USA.
   [Linn, S.; Markowitz, P.; Martinez, G.; Rodriguez, J. L.] Florida Int Univ, Miami, FL 33199 USA.
   [Ackert, A.; Adams, T.; Askew, A.; Bein, S.; Hagopian, S.; Hagopian, V.; Johnson, K. F.; Prosper, H.; Santra, A.; Yohay, R.] Florida State Univ, Tallahassee, FL 32306 USA.
   [Baarmand, M. M.; Bhopatkar, V.; Colafranceschi, S.; Hohlmann, M.; Noonan, D.; Roy, T.; Yumiceva, F.] Florida Inst Technol, Melbourne, FL 32901 USA.
   [Adams, M. R.; Apanasevich, L.; Berry, D.; Betts, R. R.; Bucinskaite, I.; Cavanaugh, R.; Evdokimov, O.; Gauthier, L.; Gerber, C. E.; Hofman, D. J.; Jung, K.; Gonzalez, I. D. Sandoval; Varelas, N.; Wang, H.; Wu, Z.; Zakaria, M.; Zhang, J.] UIC, Chicago, IL USA.
   [Bilki, B.; Clarida, W.; Dilsiz, K.; Durgut, S.; Gandrajula, R. P.; Haytmyradov, M.; Khristenko, V.; Merlo, J. -P.; Mermerkaya, H.; Mestvirishvili, A.; Moeller, A.; Nachtman, J.; Ogul, H.; Onel, Y.; Ozok, F.; Penzo, A.; Snyder, C.; Tiras, E.; Wetzel, J.; Yi, K.] Univ Iowa, Iowa City, IA USA.
   [Anderson, I.; Blumenfeld, B.; Cocoros, A.; Eminizer, N.; Fehling, D.; Feng, L.; Gritsan, A. V.; Maksimovic, P.; Osherson, M.; Roskes, J.; Sarica, U.; Swartz, M.; Xiao, M.; Xin, Y.; You, C.] Johns Hopkins Univ, Baltimore, MD USA.
   [Al-bataineh, A.; Baringer, P.; Bean, A.; Boren, S.; Bowen, J.; Castle, J.; Forthomme, L.; Kenny, R. P., III; Khalil, S.; Kropivnitskaya, A.; Majumder, D.; Mcbrayer, W.; Murray, M.; Sanders, S.; Stringer, R.; Takaki, J. D. Tapia; Wang, Q.] Univ Kansas, Lawrence, KS 66045 USA.
   [Ivanov, A.; Kaadze, K.; Maravin, Y.; Mohammadi, A.; Saini, L. K.; Skhirtladze, N.; Toda, S.] Kansas State Univ, Manhattan, KS 66506 USA.
   [Rebassoo, F.; Wright, D.] Lawrence Livermore Natl Lab, Livermore, CA USA.
   [Anelli, C.; Baden, A.; Baron, O.; Belloni, A.; Calvert, B.; Eno, S. C.; Ferraioli, C.; Gomez, J. A.; Hadley, N. J.; Jabeen, S.; Kellogg, R. G.; Kolberg, T.; Kunkle, J.; Lu, Y.; Mignerey, A. C.; Ricci-Tam, F.; Shin, Y. H.; Skuja, A.; Tonjes, M. B.; Tonwar, S. C.] Univ Maryland, College Pk, MD 20742 USA.
   [Wang, J.; Abercrombie, D.; Allen, B.; Apyan, A.; Azzolini, V.; Barbieri, R.; Baty, A.; Bi, R.; Bierwagen, K.; Brandt, S.; Busza, W.; Cali, I. A.; D'Alfonso, M.; Demiragli, Z.; Di Matteo, L.; Ceballos, G. Gomez; Goncharov, M.; Hsu, D.; Iiyama, Y.; Innocenti, G. M.; Klute, M.; Kovalskyi, D.; Krajczar, K.; Lai, Y. S.; Lee, Y. -J.; Levin, A.; Luckey, P. D.; Maier, B.; Marini, A. C.; Mcginn, C.; Mironov, C.; Narayanan, S.; Niu, X.; Paus, C.; Roland, C.; Roland, G.; Salfeld-Nebgen, J.; Stephans, G. S. F.; Tatar, K.; Varma, M.; Velicanu, D.; Veverka, J.; Wang, T. W.; Wyslouch, B.; Yang, M.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Benvenuti, A. C.; Chatterjee, R. M.; Evans, A.; Hansen, P.; Kalafut, S.; Kao, S. C.; Kubota, Y.; Lesko, Z.; Mans, J.; Nourbakhsh, S.; Ruckstuhl, N.; Rusack, R.; Tambe, N.; Turkewitz, J.] Univ Minnesota, Minneapolis, MN USA.
   [Acosta, J. G.; Oliveros, S.] Univ Mississippi, University, MS 38677 USA.
   [Avdeeva, E.; Bloom, K.; Claes, D. R.; Fangmeier, C.; Suarez, R. Gonzalez; Kamalieddin, R.; Kravchenko, I.; Rodrigues, A. Malta; Meier, F.; Monroy, J.; Siado, J. E.; Snow, G. R.; Stieger, B.] Univ Nebraska, Lincoln, NE USA.
   [Alyari, M.; Dolen, J.; Godshalk, A.; Harrington, C.; Iashvili, I.; Kaisen, J.; Kharchilava, A.; Parker, A.; Rappoccio, S.; Roozbahani, B.] SUNY Buffalo, Buffalo, NY USA.
   [Alverson, G.; Barberis, E.; Hortiangtham, A.; Massironi, A.; Morse, D. M.; Nash, D.; Orimoto, T.; De Lima, R. Teixeira; Trocino, D.; Wang, R. -J.; Wood, D.] Northeastern Univ, Boston, MA 02115 USA.
   [Bhattacharya, S.; Charaf, O.; Hahn, K. A.; Kumar, A.; Mucia, N.; Odell, N.; Pollack, B.; Schmitt, M. H.; Sung, K.; Trovato, M.; Velasco, M.] Northwestern Univ, Evanston, IL USA.
   [Dev, N.; Hildreth, M.; Anampa, K. Hurtado; Jessop, C.; Karmgard, D. J.; Kellams, N.; Lannon, K.; Marinelli, N.; Meng, F.; Mueller, C.; Musienko, Y.; Planer, M.; Reinsvold, A.; Ruchti, R.; Smith, G.; Taroni, S.; Wayne, M.; Wolf, M.; Woodard, A.] Univ Notre Dame, Notre Dame, IN 46556 USA.
   [Alimena, J.; Antonelli, L.; Bylsma, B.; Durkin, L. S.; Flowers, S.; Francis, B.; Hart, A.; Hill, C.; Hughes, R.; Ji, W.; Liu, B.; Luo, W.; Puigh, D.; Winer, B. L.; Wulsin, H. W.] Ohio State Univ, Columbus, OH 43210 USA.
   [Cooperstein, S.; Driga, O.; Elmer, P.; Hardenbrook, J.; Hebda, P.; Lange, D.; Luo, J.; Marlow, D.; Medvedeva, T.; Mei, K.; Olsen, J.; Palmer, C.; Piroue, P.; Stickland, D.; Svyatkovskiy, A.; Tully, C.] Princeton Univ, Princeton, NJ 08544 USA.
   [Malik, S.] Univ Puerto Rico, Mayaguez, PR USA.
   [Savoy-Navarro, A.; Barker, A.; Barnes, V. E.; Folgueras, S.; Gutay, L.; Jha, M. K.; Jones, M.; Jung, A. W.; Khatiwada, A.; Miller, D. H.; Neumeister, N.; Schulte, J. F.; Shi, X.; Sun, J.; Wang, F.; Xie, W.] Purdue Univ, W Lafayette, IN USA.
   [Parashar, N.; Stupak, J.] Purdue Univ Calumet, Hammond, LA USA.
   [Adair, A.; Akgun, B.; Chen, Z.; Ecklund, K. M.; Geurts, F. J. M.; Guilbaud, M.; Li, W.; Michlin, B.; Northup, M.; Padley, B. P.; Roberts, J.; Rorie, J.; Tu, Z.; Zabel, J.] Rice Univ, Houston, TX USA.
   [Betchart, B.; Bodek, A.; de Barbaro, P.; Demina, R.; Duh, Y. T.; Ferbel, T.; Galanti, M.; Garcia-Bellido, A.; Han, J.; Hindrichs, O.; Khukhunaishvili, A.; Lo, K. H.; Tan, P.; Verzetti, M.] Univ Rochester, Rochester, NY 14627 USA.
   [Agapitos, A.; Chou, J. P.; Gershtein, Y.; Espinosa, T. A. Gomez; Halkiadakis, E.; Heindl, M.; Hughes, E.; Kaplan, S.; Elayavalli, R. Kunnawalkam; Kyriacou, S.; Lath, A.; Nash, K.; Saka, H.; Salur, S.; Schnetzer, S.; Sheffield, D.; Somalwar, S.; Stone, R.; Thomas, S.; Thomassen, P.; Walker, M.] Rutgers State Univ, Piscataway, NJ USA.
   [Delannoy, A. G.; Foerster, M.; Heideman, J.; Riley, G.; Rose, K.; Spanier, S.; Thapa, K.] Univ Tennessee, Knoxville, TN USA.
   [Bouhali, O.; Celik, A.; Dalchenko, M.; De Mattia, M.; Delgado, A.; Dildick, S.; Eusebi, R.; Gilmore, J.; Huang, T.; Juska, E.; Kamon, T.; Mueller, R.; Pakhotin, Y.; Patel, R.; Perloff, A.; Pernie, L.; Rathjens, D.; Safonov, A.; Tatarinov, A.; Ulmer, K. A.] Texas A&M Univ, College Stn, TX USA.
   [Wang, Z.; Lee, S. W.; Akchurin, N.; Cowden, C.; Damgov, J.; De Guio, F.; Dragoiu, C.; Dudero, P. R.; Faulkner, J.; Gurpinar, E.; Kunori, S.; Lamichhane, K.; Libeiro, T.; Peltola, T.; Undleeb, S.; Volobouev, I.] Texas Tech Univ, Lubbock, TX 79409 USA.
   [Greene, S.; Gurrola, A.; Janjam, R.; Johns, W.; Maguire, C.; Melo, A.; Ni, H.; Sheldon, P.; Tuo, S.; Velkovska, J.; Xu, Q.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Barrio Luna, M.; Arenton, M. W.; Cox, B.; Goodell, J.; Hirosky, R.; Ledovskoy, A.; Li, H.; Neu, C.; Sinthuprasith, T.; Sun, X.; Wang, Y.; Wolfe, E.; Xia, F.] Univ Virginia, Charlottesville, VA USA.
   [Clarke, C.; Harr, R.; Karchin, P. E.; Sturdy, J.] Wayne State Univ, Detroit, MI USA.
   [Belknap, D. A.; Buchanan, J.; Caillol, C.; Dasu, S.; Dodd, L.; Duric, S.; Gomber, B.; Grothe, M.; Herndon, M.; Herve, A.; Klabbers, P.; Lanaro, A.; Levine, A.; Long, K.; Loveless, R.; Ojalvo, I.; Perry, T.; Pierro, G. A.; Polese, G.; Ruggles, T.; Savin, A.; Smith, N.; Smith, W. H.; Taylor, D.; Woods, N.] Univ Wisconsin, Madison, WI USA.
   [Fruehwirth, R.; Jeitler, M.; Schieck, J.; Wulz, C. -E.; Krammer, M.] Vienna Univ Technol, Vienna, Austria.
   [Chinellato, J.; Tonelli Manganote, E. J.] Univ Estadual Campinas, Campinas, Brazil.
   [Da Silveira, G. G.] Univ Fed Pelotas, Pelotas, Brazil.
   [Assran, Y.] Ain Shams Univ, Cairo, Egypt.
   [Assran, Y.] British Univ Egypt, Cairo, Egypt.
   [Elkafrawy, T.] Zewail City Sci & Technol, Zewail, Egypt.
   [Mahrous, A.] Univ Haute Alsace, Mulhouse, France.
   [Hempel, M.; Karacheban, O.; Lohmann, W.] Brandenburg Tech Univ Cottbus, Cottbus, Germany.
   [Bahinipati, S.; Sahoo, D. K.] Indian Inst Sci Educ & Res Bhopal, Bhopal, India.
   [Bhowmik, S.; Maity, M.; Sarkar, T.] Inst Phys, Bhubaneswar, Orissa, India.
   [Choudhury, S.] Visva Bharati Univ, Santini Ketan, W Bengal, India.
   [Nayak, A.] Univ Ruhuna, Matara, Sri Lanka.
   [Wickramage, N.] Isfahan Univ Technol, Esfahan, Iran.
   [Chenarani, S.; Etesami, S. M.] Yazd Univ, Yazd, Iran.
   [Mehdiabadi, S. Paktinat] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
   [Safarzadeh, B.] Univ Siena, Siena, Italy.
   [Ciocci, M. A.; Grippo, M. T.] Lab Nazl Legnaro, Ist Nazl Fis Nucl, Legnaro, Italy.
   [Ali, M. A. B. Md] Int Islamic Univ Malaysia, Kuala Lumpur, Malaysia.
   [Idris, F. Mohamad] MOSTI, Malaysian Nucl Agcy, Kajang, Malaysia.
   [Heredia-De la Cruz, I.] Consejo Nacl Ciencia & Technol, Mexico City, DF, Mexico.
   [Byszuk, A.; Zagozdzinska, A.] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland.
   [Matveev, V.; Musienko, Y.] Inst Nucl Res, Moscow, Russia.
   [Kim, V.] St Petersburg State Polytech Univ, St Petersburg, Russia.
   [Blinov, V.; Skovpen, Y.; Shtol, D.] Budker Inst Nucl Phys, Novosibirsk, Russia.
   [Sphicas, P.] Natl & Kapodistrian Univ, Athens, Greece.
   [Veckalns, V.] Riga Tech Univ, Riga, Latvia.
   [Amsler, C.] Albert Einstein Ctr Fundamental Phys, Bern, Switzerland.
   [Bakirei, M. N.] Gaziosmanpasa Univ, Tokat, Turkey.
   [Cerci, S.; Tali, B.] Adiyaman Univ, Adiyaman, Turkey.
   [Kangal, E. E.] Mersin Univ, Mersin, Turkey.
   [Onengut, G.] Cag Univ, Mersin, Turkey.
   [Ozdemir, K.] Piri Reis Univ, Istanbul, Turkey.
   [Isildak, B.] Ozyegin Univ, Istanbul, Turkey.
   [Karapinar, G.] Izmir Inst Technol, Izmir, Turkey.
   [Kaya, M.] Marmara Univ, Istanbul, Turkey.
   [Kaya, O.] Kafkas Univ, Kars, Turkey.
   [Yetkin, E. A.] Istanbul Bilgi Univ, Istanbul, Turkey.
   [Yetkin, T.] Yildiz Tech Univ, Istanbul, Turkey.
   [Sen, S.] Hacettepe Univ, Ankara, Turkey.
   [Belyaev, A.] Univ Southampton, Sch Phys & Astron, Southampton, Hants, England.
   [Acosta, M. Vazquez] Inst Astrofis Canarias, San Cristobal la Laguna, Spain.
   [Wasserbaech, S.] Utah Valley Univ, Orem, UT USA.
   [Bilki, B.] Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.
   [Mermerkaya, H.] Erzincan Univ, Erzincan, Turkey.
   [Ozok, F.] Mimar Sinan Univ, Istanbul, Turkey.
   [Bouhali, O.] Texas A&M Univ, Doha, Qatar.
   [Kamon, T.] Kyungpook Natl Univ, Taegu, South Korea.
RP Sirunyan, AM (reprint author), Yerevan Phys Inst, Yerevan, Armenia.; Sirunyan, AM (reprint author), Utah Valley Univ, Orem, UT USA.
RI Calderon, Alicia/K-3658-2014; Puerta Pelayo, Jesus/L-1632-2014; Josa,
   Isabel/K-5184-2014; Della Ricca, Giuseppe/B-6826-2013; Manganote,
   Edmilson/K-8251-2013; Triossi, Andrea/K-2813-2017; Garcia Abia,
   Pablo/K-3595-2017; Paganis, Stathes/J-8413-2017; Konecki,
   Marcin/G-4164-2015; Calvo Alamillo, Enrique/L-1203-2014; Scodellaro,
   Luca/K-9091-2014; Folgueras, Santiago/G-4902-2016; Perez-Calero
   Yzquierdo, Antonio/F-2235-2013; Matorras, Francisco/I-4983-2015; Raidal,
   Martti/F-4436-2012
OI Calderon, Alicia/0000-0002-7205-2040; Della Ricca,
   Giuseppe/0000-0003-2831-6982; Triossi, Andrea/0000-0001-5140-9154;
   Garcia Abia, Pablo/0000-0001-8809-8927; Paganis,
   Stathes/0000-0002-1950-8993; Konecki, Marcin/0000-0001-9482-4841; Calvo
   Alamillo, Enrique/0000-0002-1100-2963; Scodellaro,
   Luca/0000-0002-4974-8330; Folgueras, Santiago/0000-0001-7191-1125;
   Perez-Calero Yzquierdo, Antonio/0000-0003-3036-7965; Matorras,
   Francisco/0000-0003-4295-5668; Raidal, Martti/0000-0001-7040-9491
FU Austrian Federal Ministry of Science, Research and Economy; Austrian
   Science Fund; Belgian Fonds de la Recherche Scientifique; Fonds voor
   Wetenschappelijk Onderzoek; Brazilian Funding Agency (CNPq); Brazilian
   Funding Agency (CAPES); Brazilian Funding Agency (FAPERJ); Brazilian
   Funding Agency (FAPESP); Bulgarian Ministry of Education and Science;
   CERN; Chinese Academy of Sciences, Ministry of Science and Technology;
   National Natural Science Foundation of China; Colombian Funding Agency
   (COLCIENCIAS); Croatian Ministry of Science, Education and Sport;
   Croatian Science Foundation; Research Promotion Foundation, Cyprus;
   Secretariat for Higher Education, Science, Technology and Innovation,
   Ecuador; Ministry of Education and Research, Estonia; Estonian Research
   Council, Estonia [IUT23-4, IUT23-6]; European Regional Development Fund,
   Estonia; Academy of Finland; Finnish Ministry of Education and Culture;
   Helsinki Institute of Physics; Institut National de Physique Nucleaire
   et de Physique des Particules/CNRS, France; Commissariat a l'Engergie
   Atomique et aux Energies Alternatives/CEA, France; Bundesministerium fur
   Bildung und Forschung, Germany; Deutsche Forschungsgemeinschaft,
   Germany; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany;
   General Secretariat for Research and Technology, Greece; National
   Scientific Research Foundation, Hungary; National Innovation Office,
   Hungary; Department of Atomic Energy, India; Department of Science and
   Technology, India; Institute for Studies in Theoretical Physics and
   Mathematics, Iran; Science Foundation, Ireland; Istituto Nazionale di
   Fisica Nucleare, Italy; Ministry of Science, ICT and Future Planning,
   Republic of Korea; National Research Foundation (NRF), Republic of
   Korea; Lithuanian Academy of Sciences; Ministry of Education,
   (Malaysia); University of Malaya (Malaysia); Mexican Funding Agency
   (BUAP); Mexican Funding Agency (CINVESTAV); Mexican Funding Agency
   (CONACYT); Mexican Funding Agency (LNS); Mexican Funding Agency (SEP);
   Mexican Funding Agency (UASLP-FAI); Ministry of Business, Innovation and
   Employment, New Zealand; Pakistan Atomic Energy Commission; Ministry of
   Science and Higher Education, Poland; National Science Centre, Poland;
   Fundacao para a Ciencia e a Tecnologia, Portugal; JINR, Dubna; Ministry
   of Education and Science of the Russian Federation (M.H.U.); Federal
   Agency of Atomic Energy of the Russian Federation, Russian Academy of
   Sciences (M.H.U.); Russian Foundation for Basic Research (M.H.U.);
   Russian Competitiveness Program of NRNU MEPhI (M.H.U.); Ministry of
   Education, Science and Technological Development of Serbia; Secretaria
   de Estado de Investigacion, Desarrollo e Innovacion and Programa
   Consolider-Ingenio, Spain; Swiss Funding Agency (ETH Board); Swiss
   Funding Agency (ETH Zurich); Swiss Funding Agency (PSI); Swiss Funding
   Agency (SNF); Swiss Funding Agency (UniZH); Swiss Funding Agency (Canton
   Zurich); Swiss Funding Agency (SER); Ministry of Science and Technology,
   Taipei; Thailand Center of Excellence in Physics; Institute for the
   Promotion of Teaching Science and Technology of Thailand; Special Task
   Force for Activating Research; National Science and Technology
   Development Agency of Thailand; Scientific and Technical Research
   Council of Turkey; Turkish Atomic Energy Authority; National Academy of
   Sciences of Ukraine, Ukraine; State Fund for Fundamental Researches,
   Ukraine; Science and Technology Facilities Council, UK; US Department of
   Energy; US National Science Foundation; Marie-Curie programme; European
   Research Council (European Union); EPLANET(European Union); Leventis
   Foundation; A. P. Sloan Foundation; Alexander von Humboldt Foundation;
   Belgian Federal Science Policy Office; Fonds pour la Formation a la
   Recherche dans l'Industrie et dans l'Agriculture (FRIA-Belgium);
   Agentschap voor Innovatie door Wetenschap en Technologie (IWT-Belgium);
   Ministry of Education, Youth and Sports (MEYS) of the Czech Republic;
   Council of Science and Industrial Research, India; HOMING PLUS programme
   of the Foundation for Polish Science; European Union, Regional
   Development Fund; Mobility Plus programme of the Ministry of Science and
   Higher Education; National Science Center (Poland) [Harmonia
   2014/14/M/ST2/00428, Opus 2014/13/B/ST2/02543, 2014/15/B/ST2/03998,
   2015/19/B/ST2/02861, Sonata-bis 2012/07/E/ST2/01406]; Thalis programme -
   EU-ESF; Thalis programme - Greek NSRF; Aristeia programme - EU-ESF;
   Aristeia programme - Greek NSRF; National Priorities Research Program by
   Qatar National Research Fund; Programa Clarin-COFUND del Principado de
   Asturias; Rachadapisek Sompot Fund for Post-doctoral Fellowship,
   Chulalongkorn University (Thailand); Chulalongkorn Academic into Its 2nd
   Century Project Advancement Project (Thailand); Welch Foundation
   [C-1845]
FX We congratulate our colleagues in the CERN accelerator departments for
   the excellent performance of the LHC and thank the technical and
   administrative staffs at CERN and at other CMS institutes for their
   contributions to the success of the CMS effort. In addition, we
   gratefully acknowledge the computing centres and personnel of the
   Worldwide LHC Computing Grid for delivering so effectively the computing
   infrastructure essential to our analyses. Finally, we acknowledge the
   enduring support for the construction and operation of the LHC and the
   CMS detector provided by the following funding agencies: the Austrian
   Federal Ministry of Science, Research and Economy and the Austrian
   Science Fund; the Belgian Fonds de la Recherche Scientifique, and Fonds
   voor Wetenschappelijk Onderzoek; the Brazilian Funding Agencies (CNPq,
   CAPES, FAPERJ, and FAPESP); the Bulgarian Ministry of Education and
   Science; CERN; the Chinese Academy of Sciences, Ministry of Science and
   Technology, and National Natural Science Foundation of China; the
   Colombian Funding Agency (COLCIENCIAS); the Croatian Ministry of
   Science, Education and Sport, and the Croatian Science Foundation; the
   Research Promotion Foundation, Cyprus; the Secretariat for Higher
   Education, Science, Technology and Innovation, Ecuador; the Ministry of
   Education and Research, Estonian Research Council via IUT23-4 and
   IUT23-6 and European Regional Development Fund, Estonia; the Academy of
   Finland, Finnish Ministry of Education and Culture, and Helsinki
   Institute of Physics; the Institut National de Physique Nucleaire et de
   Physique des Particules/CNRS, and Commissariat a l'Engergie Atomique et
   aux Energies Alternatives/CEA, France; the Bundesministerium fur Bildung
   und Forschung, Deutsche Forschungsgemeinschaft, and
   Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; the General
   Secretariat for Research and Technology, Greece; the National Scientific
   Research Foundation, and National Innovation Office, Hungary; the
   Department of Atomic Energy and the Department of Science and
   Technology, India; the Institute for Studies in Theoretical Physics and
   Mathematics, Iran; the Science Foundation, Ireland; the Istituto
   Nazionale di Fisica Nucleare, Italy; the Ministry of Science, ICT and
   Future Planning, and National Research Foundation (NRF), Republic of
   Korea; the Lithuanian Academy of Sciences; the Ministry of Education,
   and University of Malaya (Malaysia); the Mexican Funding Agencies (BUAP,
   CINVESTAV, CONACYT, LNS, SEP, and UASLP-FAI); the Ministry of Business,
   Innovation and Employment, New Zealand; the Pakistan Atomic Energy
   Commission; the Ministry of Science and Higher Education and the
   National Science Centre, Poland; the Fundacao para a Ciencia e a
   Tecnologia, Portugal; JINR, Dubna; the Ministry of Education and Science
   of the Russian Federation, the Federal Agency of Atomic Energy of the
   Russian Federation, Russian Academy of Sciences, the Russian Foundation
   for Basic Research and the Russian Competitiveness Program of NRNU MEPhI
   (M.H.U.; ); the Ministry of Education, Science and Technological
   Development of Serbia; the Secretaria de Estado de Investigacion,
   Desarrollo e Innovacion and Programa Consolider-Ingenio 2010, Spain; the
   Swiss Funding Agencies (ETH Board, ETH Zurich, PSI, SNF, UniZH, Canton
   Zurich, and SER); the Ministry of Science and Technology, Taipei; the
   Thailand Center of Excellence in Physics, the Institute for the
   Promotion of Teaching Science and Technology of Thailand, Special Task
   Force for Activating Research and the National Science and Technology
   Development Agency of Thailand; the Scientific and Technical Research
   Council of Turkey, and Turkish Atomic Energy Authority; the National
   Academy of Sciences of Ukraine, and State Fund for Fundamental
   Researches, Ukraine; the Science and Technology Facilities Council, UK;
   the US Department of Energy, and the US National Science Foundation.
   Individuals have received support from the Marie-Curie programme and the
   European Research Council and EPLANET(European Union); the Leventis
   Foundation; the A. P. Sloan Foundation; the Alexander von Humboldt
   Foundation; the Belgian Federal Science Policy Office; the Fonds pour la
   Formation a la Recherche dans l'Industrie et dans l'Agriculture
   (FRIA-Belgium); the Agentschap voor Innovatie door Wetenschap en
   Technologie (IWT-Belgium); the Ministry of Education, Youth and Sports
   (MEYS) of the Czech Republic; the Council of Science and Industrial
   Research, India; the HOMING PLUS programme of the Foundation for Polish
   Science, cofinanced from European Union, Regional Development Fund, the
   Mobility Plus programme of the Ministry of Science and Higher Education,
   the National Science Center (Poland), contracts Harmonia
   2014/14/M/ST2/00428, Opus 2014/13/B/ST2/02543, 2014/15/B/ST2/03998, and
   2015/19/B/ST2/02861, Sonata-bis 2012/07/E/ST2/01406; the Thalis and
   Aristeia programmes cofinanced by EU-ESF and the Greek NSRF; the
   National Priorities Research Program by Qatar National Research Fund;
   the Programa Clarin-COFUND del Principado de Asturias; the Rachadapisek
   Sompot Fund for Post-doctoral Fellowship, Chulalongkorn University and
   the Chulalongkorn Academic into Its 2nd Century Project Advancement
   Project (Thailand); and the Welch Foundation, contract C-1845.
CR Aad G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.211803
   Aad G, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.211802
   Abdullin S, 2011, J PHYS CONF SER, V331, DOI 10.1088/1742-6596/331/3/032049
   Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8
   Alioli S, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2010)043
   Alves D, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/10/105005
   Alwall J, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2014)079
   Alwall J, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.075020
   Alwall J, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.015005
   ATLAS and CMS Collaborations LHC Higgs Combination Group, 2011, ATLPHYSPUB201111 CMS
   ATLAS Collaboration, 2016, PHYS REV D, V94
   ATLAS Collaboration, 2015, EUR PHYS J C, V75, P510
   ATLAS collaboration, 2015, PHYS REV LETT, V114, DOI DOI 10.1103/PHYSREVLETT.114.142001
   ATLAS Collaboration, 2012, JHEP, V11, DOI [10.1007/JHEP11(2012)094, DOI 10.1007/JHEP11(2012)094]
   ATLAS Collaboration, 2014, JHEP, V06, P124, DOI DOI 10.1007/JHEP06(2014)124
   ATLAS Collaboration, 2014, JHEP, V09, DOI DOI 10.1007/JHEP09(2014)015
   ATLAS Collaboration, 2014, PHYS REV D, V90
   ATLAS Collaboration, 2013, JHEP, V10, P189, DOI DOI 10.1007/JHEP10(2013)189
   Bai Y, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2012)110
   Balazs C, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.015007
   Boehm C, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.035012
   Borschensky C, 2014, EUR PHYS J C, V74, DOI 10.1140/epjc/s10052-014-3174-y
   Cacciari M, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/04/068
   Cacciari M, 2008, J HIGH ENERGY PHYS
   Cacciari M, 2006, PHYS LETT B, V641, P57, DOI 10.1016/j.physletb.2006.08.037
   Cacciari M, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-1896-2
   Catani S, 2003, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2003/07/028
   CDE Collaboration, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.251801
   CDF Collaboration, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.092001
   CMS Collaboration, 2016, CMS PHYS AN SUMM CMS
   CMS Collaboration, 2016, JHEP, V08
   C M S collaboration, 2016, JHEP, V01, DOI DOI 10.1007/JHEP01(2016)096
   CMS Collaboration, 2016, EUR PHYS J C, V76, P460, DOI DOI 10.1140/EPJC/S10052-016-4292-5
   CMS Collaboration, 2015, PHYS REV D, V91, DOI DOI 10.1103/PHYSREVD.91.052018
   CMS Collaboration, 2010, CMS PHYS AN SUMM CMS
   CMS Collaboration, 2009, CMSPASPFT09001
   CMS Collaboration, 2012, JINST, V7
   CMS collaboration, 2015, JINST, V10, DOI DOI 10.1088/1748-0221/10/08/P08010
   CMS Collaboration, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.012003
   CMS Collaboration, 2013, EUR PHYS J C, V73, P2677, DOI DOI 10.1140/EPJC/S10052-013-2677-2
   CMS Collaboration, 2015, JHEP, V06, P116, DOI DOI 10.1007/JIIEP06(2015)116
   CMS Collaboration, 2013, JINST, V8
   CMS Collaboration, 2014, CMS PHYS SUMM CMS PA
   CMS Collaboration, 2014, JHEP, V06, P120, DOI 10.1007/JHEP06(2014)120
   CMS Collaboration, 2016, PHYS REV D UNPUN
   CMS Collaboration, 2013, PHYS REV D, V88, DOI DOI 10.1103/PHYSREVD.88.052017
   CMS collaboration, 2013, EUR PHYS J C, V73, P2568, DOI DOI 10.1140/EPJC/S10052-013-2568-6
   CMS Collaboration, 2014, CMS PHYS AN SUMM CMS
   CMS collaboration, 2015, JINST, V10, DOI DOI 10.1088/1748-0221/10/06/P06005
   CMS Collaboration, 2017, EUR PHYS J C, V77, P294, DOI [10.1140/epjc/s10052-017-4787-8, DOI 10.1140/EPIC/S10052-017-4787-8]
   CMS Collaboration, 2016, JHEP, V10, DOI DOI 10.1007/JHEP10(2016)006
   CMS collaboration, 2016, J INSTRUM, V11
   CMS collaboration, 2008, JINST, V3, DOI DOI 10.1088/1748-0221/3/08/S08004
   Cowan G, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1554-0
   D0 Collaboration, 2004, PHYS LETT B, V581, P147, DOI 10.1016/j.physletb.2003.12.001
   D0 Collaboration, 2008, PHYS LETT B, V659, P500, DOI [10.1016/j.physletb.2007.11.086, DOI 10.1016/J.PHYSLETB.2007.11.086]
   D0 Collaboration, 2012, PHYS LETT B, V710, P578, DOI [10.1016/j.physletb.2012.03.028, DOI 10.1016/J.PHYSLETB.2012.03.028]
   Dasgupta M, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2013)029
   DIMOPOULOS S, 1981, NUCL PHYS B, V193, P150, DOI 10.1016/0550-3213(81)90522-8
   DIMOPOULOS S, 1981, NUCL PHYS B, V192, P353, DOI 10.1016/0550-3213(81)90430-2
   DINE M, 1981, NUCL PHYS B, V189, P575, DOI 10.1016/0550-3213(81)90582-4
   Dokshitzer Y. L., 1997, JHEP, V08, P001, DOI DOI 10.1088/1126-6708/1997/08/001
   FARRAR GR, 1978, PHYS LETT B, V76, P575, DOI 10.1016/0370-2693(78)90858-4
   Frixione S, 2007, J HIGH ENERGY PHYS
   Graesser ML, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.121802
   Jungman G, 1996, PHYS REP, V267, P195, DOI 10.1016/0370-1573(95)00058-5
   Junk T, 1999, NUCL INSTRUM METH A, V434, P435, DOI 10.1016/S0168-9002(99)00498-2
   Kaplan DE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.142001
   KAUL RK, 1982, NUCL PHYS B, V199, P36, DOI 10.1016/0550-3213(82)90565-X
   Khachatryan V, 2015, PHYS LETT B, V741, P12, DOI 10.1016/j.physletb.2014.12.003
   LHC SUSY Cross Section Working Group, 2015, SUSY CROSS SECT TWIK
   Nason P, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/11/040
   NNPDF Collaboration, 2015, JHEP, V04, DOI [10.1007/JHEP04(2015)040, DOI 10.1007/JHEP04(2015)040]
   Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001
   Polesello G, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2010)030
   Re E, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1547-z
   Read AL, 2002, J PHYS G NUCL PARTIC, V28, P2693, DOI 10.1088/0954-3899/28/10/313
   Sjostrand T, 2015, COMPUT PHYS COMMUN, V191, P159, DOI 10.1016/j.cpc.2015.01.024
   t Hooft G., 1980, NATO ADV STUDY I S B, V59, P135
   Tovey DR, 2008, J HIGH ENERGY PHYS
   WESS J, 1974, NUCL PHYS B, VB 70, P39, DOI 10.1016/0550-3213(74)90355-1
   WITTEN E, 1981, NUCL PHYS B, V188, P513, DOI 10.1016/0550-3213(81)90006-7
   Wobisch M., 1998, ARXIVHEPPH9907280
NR 83
TC 0
Z9 0
U1 9
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1434-6044
EI 1434-6052
J9 EUR PHYS J C
JI Eur. Phys. J. C
PD MAY 18
PY 2017
VL 77
IS 5
AR 327
DI 10.1140/epjc/s10052-017-4853-2
PG 39
WC Physics, Particles & Fields
SC Physics
GA EV6RM
UT WOS:000401899600010
OA gold
DA 2017-08-17
ER

PT J
AU Booth, J
   Alexandra-Crivac, CN
   Rickaby, KA
   Nneoyiegbe, AF
   Umeobika, U
   McEwan, AR
   Trembleau, L
   Jaspars, M
   Houssen, WE
   Shalashilin, DV
AF Booth, Jonathan
   Alexandra-Crivac, Christina-Nicoleta
   Rickaby, Kirstie A.
   Nneoyiegbe, Ada F.
   Umeobika, Ugochukwu
   McEwan, Andrew R.
   Trembleau, Laurent
   Jaspars, Marcel
   Houssen, Wael E.
   Shalashilin, Dmitrii V.
TI A Blind Test of Computational Technique for Predicting the Likelihood of
   Peptide Sequences to Cyclize
SO JOURNAL OF PHYSICAL CHEMISTRY LETTERS
LA English
DT Article
ID BOXED MOLECULAR-DYNAMICS; DRUG DISCOVERY; MONTE-CARLO; MACROCYCLIZATION;
   PROTEINS; MECHANISM
AB An in silico computational technique for predicting peptide sequences that can be cyclized by cyanobactin macrocyclases, e.g., PatG(mac), is reported. We demonstrate that the propensity for PatG(mac)-mediated cyclization correlates strongly with the free energy of the socalled pre-cyclization conformation (PCC), which is a fold where the cyclizing sequence C and N termini are in close proximity. This conclusion is driven by comparison of the predictions of boxed molecular dynamics (BXD) with experimental data, which have achieved an accuracy of 84%. A true blind test rather than training of the model is reported here as the in silico tool was developed before any experimental data was given, and no parameters of computations were adjusted to fit the data. The success of the blind test provides fundamental understanding of the molecular mechanism of cyclization by cyanobactin macrocyclases, suggesting that formation of PCC is the rate -determining step. PCC formation might also play a part in other processes of cyclic peptides production and on the practical side the suggested tool might become useful for finding cyclizable peptide sequences in general.
C1 [Booth, Jonathan; Shalashilin, Dmitrii V.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England.
   [Alexandra-Crivac, Christina-Nicoleta; Rickaby, Kirstie A.; Nneoyiegbe, Ada F.; Umeobika, Ugochukwu; McEwan, Andrew R.; Trembleau, Laurent; Jaspars, Marcel; Houssen, Wael E.] Univ Aberdeen, Dept Chem, Marine Biodiscovery Ctr, Aberdeen AB24 3UE, Scotland.
   [Alexandra-Crivac, Christina-Nicoleta; McEwan, Andrew R.; Houssen, Wael E.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.
   [Houssen, Wael E.] Mansoura Univ, Pharmacognosy Dept, Fac Pharm, Mansoura 35516, Egypt.
   [Booth, Jonathan] Croda Int Plc, Cowick Hall, Goole DN14 9AA, East Yorks, England.
RP Shalashilin, DV (reprint author), Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England.; Jaspars, M; Houssen, WE (reprint author), Univ Aberdeen, Dept Chem, Marine Biodiscovery Ctr, Aberdeen AB24 3UE, Scotland.; Houssen, WE (reprint author), Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.; Houssen, WE (reprint author), Mansoura Univ, Pharmacognosy Dept, Fac Pharm, Mansoura 35516, Egypt.
EM m.jaspars@abdn.ac.uk; w.houssen@abdn.ac.uk; d.shalashilin@leeds.ac.uk
FU EPSRC [EP/J019240/1, EP/J001481/1]; European Research Council [ERC
   339367]; Tertiary Education Trust Fund (TETFUND), Nigeria; AstraZeneca
FX J.J.B. acknowledges his EPSRC support from Grants EP/J019240/1 and
   EP/J001481/1. The work done at the University of Aberdeen was funded by
   the European Research Council (ERC 339367 (NCB-TNT)). A.F.N. and U.U.
   acknowledge the support from the Tertiary Education Trust Fund
   (TETFUND), Nigeria. K.A.R. was supported by the AstraZeneca studentship.
   We would like to acknowledge David Glowacki for his useful comments and
   help.
CR Besser D, 2000, J PEPT RES, V56, P337, DOI 10.1034/j.1399-3011.2000.00735.x
   Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146
   Booth J, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0384
   Booth JJ, 2016, J PHYS CHEM B, V120, P700, DOI 10.1021/acs.jpcb.5b11519
   Bras NF, 2016, CHEM-EUR J, V22, P13089, DOI 10.1002/chem.201601670
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   CAVELIERFRONTIN F, 1992, J AM CHEM SOC, V114, P8885, DOI 10.1021/ja00049a021
   Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84
   Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590
   Giordanetto F, 2014, J MED CHEM, V57, P278, DOI 10.1021/jm400887j
   Glas A, 2014, ANGEW CHEM INT EDIT, V53, P2489, DOI 10.1002/anie.201310082
   Glowacki DR, 2011, J CHEM THEORY COMPUT, V7, P1244, DOI 10.1021/ct200011e
   Glowacki DR, 2009, J PHYS CHEM B, V113, P16603, DOI 10.1021/jp9074898
   Houssen WE, 2014, ANGEW CHEM INT EDIT, V53, P14171, DOI 10.1002/anie.201408082
   Kaestner J., 2011, WILEY INTERDISCIP RE, V1, P932, DOI 10.1002/wcms.66
   Koehnke J, 2015, NAT CHEM BIOL, V11, P558, DOI 10.1038/nchembio.1841
   Koehnke J, 2012, NAT STRUCT MOL BIOL, V19, P767, DOI 10.1038/nsmb.2340
   Kotz J., 2012, SCIBX, DOI [DOI 10.1038/SCIBX.2012.1176, 10.1038/scibx.2012.1176]
   Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N
   Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351
   Mallinson J, 2012, FUTURE MED CHEM, V4, P1409, DOI [10.4155/fmc.12.93, 10.4155/FMC.12.93]
   McIntosh JA, 2010, J AM CHEM SOC, V132, P15499, DOI 10.1021/ja1067806
   O'Connor M, 2016, FARADAY DISCUSS, V195, P395, DOI 10.1039/c6fd00138f
   Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681
   Shalashilin DV, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4759088
   Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409
   Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   TORRIE GM, 1977, J CHEM PHYS, V66, P1402, DOI 10.1063/1.434125
   White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062
   Wu ZM, 2011, CHEM COMMUN, V47, P9218, DOI 10.1039/c1cc13322e
   Yongye AB, 2009, J COMPUT AID MOL DES, V23, P677, DOI 10.1007/s10822-009-9295-y
NR 32
TC 0
Z9 0
U1 3
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-7185
J9 J PHYS CHEM LETT
JI J. Phys. Chem. Lett.
PD MAY 18
PY 2017
VL 8
IS 10
BP 2310
EP 2315
DI 10.1021/acs.jpclett.7b00848
PG 6
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Atomic, Molecular & Chemical
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EV8JM
UT WOS:000402026500036
PM 28475844
OA No
DA 2017-08-17
ER

PT J
AU Akl, MG
   Fawzy, E
   Deif, M
   Farouk, A
   Elshorbagy, AK
AF Akl, May G.
   Fawzy, Eman
   Deif, Maha
   Farouk, Ayman
   Elshorbagy, Amany K.
TI Perturbed adipose tissue hydrogen peroxide metabolism in centrally obese
   men: Association with insulin resistance
SO PLOS ONE
LA English
DT Article
ID TO-HEIGHT RATIO; HIGH-FAT DIET; OXIDATIVE STRESS; ANTIOXIDANT ENZYMES;
   GLUTATHIONE-PEROXIDASE; WAIST CIRCUMFERENCE; GLYCEMIC CONTROL;
   GLUCOSE-UPTAKE; CATALASE; WOMEN
AB Objective
   Although adipose tissue hydrogen peroxide (H2O2) and its metabolizing enzymes have been linked to obesity and insulin resistance in animal studies, this relation remains to be evaluated in humans.
   Methods
   Non-diabetic men (N = 43, median age, 49 (37, 54 y)) undergoing abdominal surgeries were studied. Participants were classified by body mass index (BMI) into normal-weight (N = 19), or overweight/ obese (Ow/Ob; BMI >= 25; N = 24). Centrally obese men were identified by waist-height ratio >= 0.5. H2O2 and activities of superoxide dismutase, catalase and glutathione peroxidase enzymes were assayed in subcutaneous fat samples, and visceral fat (available from N = 33), and their associations with anthropometric parameters, fasting serum lipids, and the homeostasis model of insulin resistance (HOMA-IR) were tested using correlations and multivariate linear regression.
   Results
   H2O2 concentrations and catalase activity were increased in visceral fat from Ow/Ob men, compared to normal-weight subjects (+ 32%, P = 0.038 and + 51%, P = 0.043 respectively). Centrally obese subjects had > 2-fold higher superoxide dismutase activity (P = 0.005), 46% higher H2O2 (P = 0.028), and 89% higher catalase activity (P = 0.009) in visceral fat, compared to lean subjects. Central obesity did not alter these markers in subcutaneous fat, apart from a 50% increase in catalase, and did not affect glutathione peroxidase in either fat depot. H2O2 in visceral fat positively correlated with insulin resistance (r = 0.40, P = 0.032). Catalase activity in visceral fat was an independent determinant of HOMA-IR, explaining similar to 18% of the variance (ss = 0.42, P = 0.016), after adjustment for age and BMI.
   Conclusion
   These findings suggest that adipose tissue catalase shows compensatory up-regulation in response to obesity-induced H2O2 accumulation, and that perturbed H2O2 metabolism in visceral fat is linked to insulin resistance in obese humans.
C1 [Akl, May G.; Fawzy, Eman; Deif, Maha; Elshorbagy, Amany K.] Univ Alexandria, Fac Med, Dept Physiol, Alexandria, Egypt.
   [Farouk, Ayman] Univ Alexandria, Med Res Inst, Dept Clin & Expt Surg, Alexandria, Egypt.
RP Elshorbagy, AK (reprint author), Univ Alexandria, Fac Med, Dept Physiol, Alexandria, Egypt.
EM amany.elshorbagy@alexmed.edu.eg
FU Egyptian Science and Technology Development Fund [6009]; Egyptian
   Science and Technology Development Fund (STDF) [6009]
FX The study received funding from the Egyptian Science and Technology
   Development Fund (grant no. 6009, to AE). The funder had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; We are grateful to Prof Doaa Ghareeb for
   valuable discussions around the study, and to Ms Hanaa Soliman for
   expert assistance with the biochemical assays. The study has received
   funding from the Egyptian Science and Technology Development Fund (STDF;
   Grant 6009 to AE).
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Amirkhizi F, 2014, OBES RES CLIN PRACT, V8, pE26, DOI 10.1016/j.orcp.2012.07.004
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   Asayama K, 2001, FREE RADICAL RES, V34, P337, DOI 10.1080/10715760100300291
   Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x
   Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159
   Bednarek-Tupikowska G, 2006, CLIN ENDOCRINOL, V64, P463, DOI 10.1111/j.1365-2265.2006.02494.x
   Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Bouwman FG, 2014, OBESITY, V22, P819, DOI 10.1002/oby.20359
   Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003
   CIARALDI TP, 1982, J CELL PHYSIOL, V110, P323, DOI 10.1002/jcp.1041100318
   de Haan JB, 2006, J LIPID RES, V47, P1157, DOI 10.1194/jlr.M500377-JLR200
   Ding HW, 2016, BIOCHEM BIOPH RES CO, V478, P798, DOI 10.1016/j.bbrc.2016.08.028
   Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708
   Fernandez-Real JM, 2010, OBESITY, V18, P482, DOI 10.1038/oby.2009.266
   Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI200421625]
   Goldstein BJ, 2005, DIABETES, V54, P311
   Goth L, 2000, LANCET, V356, P1820, DOI 10.1016/S0140-6736(00)03238-4
   Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2
   Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006
   Kesavulu MM, 2000, DIABETES METAB, V26, P387
   Khoury M, 2013, J AM COLL CARDIOL, V62, P742, DOI 10.1016/j.jacc.2013.01.026
   Kikumoto Y, 2010, BBA-MOL BASIS DIS, V1802, P240, DOI 10.1016/j.bbadis.2009.10.009
   Kojima T, 2010, APOPTOSIS, V15, P83, DOI 10.1007/s10495-009-0415-x
   Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701
   Lee JM, 2006, DIABETES CARE, V29, P2427, DOI 10.2337/dc06-0709
   Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014
   Lijnen HR, 2012, THROMB RES, V129, P74, DOI 10.1016/j.thromres.2011.05.023
   Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009
   Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404
   Margis R, 2008, FEBS J, V275, P3959, DOI 10.1111/j.1742-4658.2008.06542.x
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mueller S, 1997, BLOOD, V90, P4973
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Park YS, 2016, MEDIAT INFLAMM, V2016
   Parker L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00411
   PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3
   Rindler PM, 2013, J BIOL CHEM, V288, P1979, DOI 10.1074/jbc.M112.412890
   Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562
   Ruperez AI, 2013, ANTIOXID REDOX SIGN, V19, P1970, DOI 10.1089/ars.2013.5386
   Saiki R, 2007, J PHARMACOL SCI, V105, P157, DOI 10.1254/jphs.FP0070619
   Serviddio G, 2002, J CLIN ENDOCR METAB, V87, P2843, DOI 10.1210/jc.87.6.2843
   Shin MJ, 2006, CLIN CHIM ACTA, V365, P200, DOI 10.1016/j.cca.2005.08.019
   Sozmen B, 1999, CLIN BIOCHEM, V32, P423, DOI 10.1016/S0009-9120(99)00034-X
   Sozmen EY, 2001, ARCH MED RES, V32, P283, DOI 10.1016/S0188-4409(01)00285-5
   Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542
   Wakabayashi I, 2013, METAB SYNDR RELAT D, V11, P189, DOI 10.1089/met.2012.0131
NR 52
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 18
PY 2017
VL 12
IS 5
AR e0177268
DI 10.1371/journal.pone.0177268
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV3PV
UT WOS:000401672400033
PM 28545081
OA gold
DA 2017-08-17
ER

PT J
AU Mohamed, S
   Schafle, TR
   Uchiyama, N
AF Mohamed, Shuaiby
   Schaefle, Tobias Rainer
   Uchiyama, Naoki
TI Robust control of a redundant wheeled drive system for energy saving and
   fail safe motion
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article
DE Sliding mode control; wheeled mobile robot; robust control; energy
   saving control; redundant drive system
ID ADAPTIVE TRACKING CONTROL; DYNAMIC SURFACE CONTROL; MOBILE ROBOTS;
   MULTIAGENT SYSTEMS
AB This article presents sliding mode-based robust tracking control for a redundant wheeled drive system, which is designed for energy saving and fail safe motion. Wheeled mobile robots are widely used in different applications such as a wheelchair and an automated guided vehicle because of their loading capability, low mechanical complexity, and simple engineering design. In addition, using wheeled mobile robots is an effective way to enhance the quality of life for elderly and disabled people to promote their independence and to extend their activities. Wheeled mobile robots are generally operated using embedded batteries, which determine the operating time. Therefore, saving energy motion is a significant requirement to extend the operation time. The dynamics of a redundant wheeled drive system is described. Distribution control and sliding mode control for wheeled mobile robots are proposed, and its stability is guaranteed based on the Lyapunov stability theory. Finally, the robustness and effectiveness of the proposed method are demonstrated experimentally, providing superior results to conventional state feedback control and robust tracking in the real environment with less energy.
C1 [Mohamed, Shuaiby; Uchiyama, Naoki] Toyohashi Univ Technol, Dept Mech Engn, 1-1 Hibariga Oka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
   [Mohamed, Shuaiby] Assiut Univ, Dept Mech Engn, Fac Engn, Assiut, Egypt.
   [Schaefle, Tobias Rainer] Univ Stuttgart, Stuttgart, Germany.
RP Mohamed, S; Uchiyama, N (reprint author), Toyohashi Univ Technol, Dept Mech Engn, 1-1 Hibariga Oka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
EM shuaib_eng@yahoo.com; uchiyama@tut.jp
CR Aguilar LE, 1997, P 1997 IEEE RSJ INT, V3, P1389, DOI 10.1109/IROS.1997.656541
   Barili A, 1995, P IEEE INT S IND EL, V2, P674, DOI 10.1109/ISIE.1995.497266
   Chan RPM, 2013, ANNU REV CONTROL, V37, P89, DOI 10.1016/j.arcontrol.2013.03.004
   Chen CLP, 2016, IEEE T CYBERNETICS, V46, P1591, DOI 10.1109/TCYB.2015.2452217
   Chen CLP, 2014, IEEE T CYBERNETICS, V44, P583, DOI 10.1109/TCYB.2013.2262935
   Dogru S, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON AUTONOMOUS ROBOT SYSTEMS AND COMPETITIONS (ICARSC), P118, DOI 10.1109/ICARSC.2015.23
   Filipescu A, 2008, IFAC P, V41, P4393
   Fukao T, 2000, IEEE T ROBOTIC AUTOM, V16, P609, DOI 10.1109/70.880812
   Hamel T, 1996, INT J SYST SCI, V27, P695, DOI 10.1080/00207729608929269
   Horiuchi M, 2014, INT J IND ERGONOM, V44, P442, DOI 10.1016/j.ergon.2013.11.014
   Jorge A, 1994, P 1994 IEEE INT C SY, P1938
   Kato T, 2013, P 2013 SICE ANN C NA, P2004
   Mei Y., 2005, P 12 INT C ADV ROB I, P492
   Mei Y, 2004, P IEEE INT C ROB AUT, V5, P4344
   Mei YG, 2006, IEEE T ROBOT, V22, P507, DOI 10.1109/TRO.2006.875494
   Mohamed S, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016676074
   Mohamed S, 2015, 2015 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION (SII), P116, DOI 10.1109/SII.2015.7404964
   Pan YP, 2016, IEEE T AUTOMAT CONTR, V61, P2603, DOI 10.1109/TAC.2015.2495232
   Pan YP, 2015, AUTOMATICA, V57, P29, DOI 10.1016/j.automatica.2015.03.033
   Satoh Y, 2007, EURASIP J IMAGE VIDE, V2007
   Shim H.-S., 1995, P IEEE INT C ROB AUT, V2, P1694
   Slotine JJE, 1991, APPL NONLINEAR CONTR, V199
   SUN T, 2011, INT J ROBUST NONLIN, V23, P123
   Sun TR, 2011, NEUROCOMPUTING, V74, P2886, DOI 10.1016/j.neucom.2011.03.046
   Tzafestas SG, 2013, INTRO MOBILE ROBOT C
   Ueno Y, 2010, P IEEE INT C ROB AUT, P3763
   Wang TY, 2005, IFAC P, V38, P475
   Wen GX, 2015, IET CONTROL THEORY A, V9, P1927, DOI 10.1049/iet-cta.2014.1319
   Xin LJ, 2016, ROBOT AUTON SYST, V78, P36, DOI 10.1016/j.robot.2016.01.002
   Xu B., 2016, IEEE T SYST MAN CYB, P1, DOI DOI 10.1109/TSMC.2016.2558098
   Xu B, 2017, IEEE T SYST MAN CY-S, V47, P161, DOI 10.1109/TSMC.2016.2558098
   Xu B, 2014, IEEE T CYBERNETICS, V44, P2626, DOI 10.1109/TCYB.2014.2311824
   Yang HJ, 2016, ADV ROBOTICS, V30, P68, DOI 10.1080/01691864.2015.1085900
   Yang JM, 1999, IEEE T ROBOTIC AUTOM, V15, P578, DOI 10.1109/70.768190
   Zhang C, 2014, MATH PROBL ENG, V2014
NR 35
TC 0
Z9 0
U1 3
U2 3
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD MAY 18
PY 2017
VL 9
IS 5
AR 1687814017702343
DI 10.1177/1687814017702343
PG 16
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA EV4VD
UT WOS:000401760400001
OA gold
DA 2017-08-17
ER

PT J
AU Sharkawy, A
   Fernandes, IP
   Barreiro, MF
   Rodrigues, AE
   Shoeib, T
AF Sharkawy, Asma
   Fernandes, I. P.
   Barreiro, M. F.
   Rodrigues, Alirio E.
   Shoeib, Tamer
TI Aroma-Loaded Microcapsules with Antibacterial Activity for Eco-Friendly
   Textile Application: Synthesis, Characterization, Release, and Green
   Grafting
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID SPHERICAL MULTINUCLEAR MICROCAPSULES; COMPLEX COACERVATION; COTTON
   FABRICS; MICROENCAPSULATION; OIL; CHITOSAN; FORMALDEHYDE; GELATIN; ACID;
   ENCAPSULATION
AB Fragrant and antimicrobial properties were conferred to cotton fabrics following microencapsulation using green materials. Limonene and vanillin microcapsules were produced by complex coacervation using chitosan/gum Arabic as shell materials and tannic acid as hardening agent. The effect of two emulsifiers; Span 85 and polyglycerol polyricinoleate (PGPR), on the encapsulation efficiency (EE%), microcapsule's size and morphology, and cumulative release profiles was studied. The mean diameter of the produced microcapsules ranged between 10.4 and 39.0 pm, whereas EE% was found to be between 90.4% and 100%. The use of Span 85 resulted in mononuclear morphology while PGPR gave rise to polynuclear structures, regardless of the core material (vanillin or limonene). The obtained microcapsules demonstrated a sustained release pattern; namely the total cumulative release of the active agents after 7 days at 37 +/- 1 degrees C was 75%, 52% and 19.4% for the polynuclear limonene microcapsules, the mononuclear limonene microcapsules and the polynuclear vanillin microcapsules, respectively. Grafting of the produced microcapsules onto cotton fabrics through an esterification reaction using citric acid as a nontoxic cross-linker followed by thermofixation and curing, was confirmed by SEM and FTIR spectroscopy. Standard antibacterial assays conducted on both microcapsules alone and impregnated onto the fabrics indicated a sustained antibacterial activity.
C1 [Sharkawy, Asma; Shoeib, Tamer] Amer Univ Cairo, Dept Chem, New Cairo 11835, Egypt.
   [Fernandes, I. P.; Barreiro, M. F.] Polytech Inst Braganca, Associate Lab LSRE LCM, LSRE, Campus Santa Apolonia, P-5300253 Braganca, Portugal.
   [Rodrigues, Alirio E.] Univ Porto, Fac Engn, Dept Chem Engn, Lab Separat & React Engn, P-4200465 Oporto, Portugal.
   [Shoeib, Tamer] Loughborough Univ Technol, Dept Chem, Ctr Analyt Sci, Loughborough LE11 3TU, Leics, England.
RP Shoeib, T (reprint author), Amer Univ Cairo, Dept Chem, New Cairo 11835, Egypt.; Rodrigues, AE (reprint author), Univ Porto, Fac Engn, Dept Chem Engn, Lab Separat & React Engn, P-4200465 Oporto, Portugal.; Shoeib, T (reprint author), Loughborough Univ Technol, Dept Chem, Ctr Analyt Sci, Loughborough LE11 3TU, Leics, England.
EM arodrig@fe.up.pt; T.Shoeib@aucegypt.edu
OI Barreiro, Filomena/0000-0002-6844-333X
FU American University in Cairo; Associated Laboratory LSRE-LCM - FEDER
   funds through COMPETE2020 [POCI-01-0145-FEDER-006984]; Programa
   Operacional Competitividade e Internacionalizacao (POCI); national funds
   through Fundacao para a Ciencia e a Tecnologia (FCT) in Portugal
   [NORTE-01-0145-FEDER-000006]; NORTE 2020, under PT2020 through ERDF
FX This work was funded by a graduate student research grant provided by
   the American University in Cairo. This work was also in part financed by
   Project POCI-01-0145-FEDER-006984, Associated Laboratory LSRE-LCM funded
   by FEDER funds through COMPETE2020, Programa Operacional Competitividade
   e Internacionalizacao (POCI) and by national funds through Fundacao para
   a Ciencia e a Tecnologia (FCT) in Portugal, NORTE-01-0145-FEDER-000006,
   funded by NORTE 2020, under PT2020 through ERDF. The authors thank
   Professor Dr. Joaquim Faria in the Department of Chemical Engineering at
   the University of Porto for his much appreciated help in conducting the
   FTIR analysis, and Catarina Moreira for her much appreciated technical
   help.
CR Alonso D, 2009, CARBOHYD POLYM, V77, P536, DOI 10.1016/j.carbpol.2009.01.027
   American Society for Testing and Materials, 2001, E214901 ASTM
   Aracil MAB, 2016, J TEXT I, V107, P300, DOI 10.1080/00405000.2015.1029808
   Babu KM, 2015, J TEXT I, V106, P706, DOI 10.1080/00405000.2014.936670
   BASCH H, 1968, APPL MICROBIOL, V16, P1953
   Butstraen C, 2014, CARBOHYD POLYM, V99, P608, DOI 10.1016/j.carbpol.2013.09.006
   Chen MJ, 2016, RSC ADV, V6, P13032, DOI 10.1039/c5ra26052c
   Cogliano VJ, 2005, ENVIRON HEALTH PERSP, V113, P1205, DOI 10.1289/ehp.7542
   Comunian TA, 2013, FOOD RES INT, V52, P373, DOI 10.1016/j.foodres.2013.03.028
   Dalmolin LF, 2016, MAT SCI ENG C-MATER, V62, P1, DOI 10.1016/j.msec.2016.01.031
   Dong ZJ, 2007, J MICROENCAPSUL, V24, P634, DOI 10.1080/02652040701500632
   Dong ZH, 2008, COLLOID SURFACE B, V63, P41, DOI 10.1016/j.colsurfb.2007.11.007
   Dong ZJ, 2011, J FOOD ENG, V104, P455, DOI 10.1016/j.jfoodeng.2011.01.011
   Fan F, 2015, CELLULOSE, V22, P1427, DOI 10.1007/s10570-015-0567-5
   Fernandes IP, 2013, CARBOHYD POLYM, V98, P1229, DOI 10.1016/j.carbpol.2013.07.030
   Flambard X, 2005, POLYM DEGRAD STABIL, V88, P98, DOI 10.1016/j.polymdegradstab.2004.02.024
   Gouin S, 2004, TRENDS FOOD SCI TECH, V15, P330, DOI 10.1016/j.tifs.2003.10.005
   Hebeish A, 2011, CARBOHYD POLYM, V86, P1684, DOI 10.1016/j.carbpol.2011.06.086
   Hebeish A, 2011, CARBOHYD POLYM, V86, P936, DOI 10.1016/j.carbpol.2011.05.048
   Holme I, 2007, COLOR TECHNOL, V123, P59, DOI 10.1111/j.1478-4408.2007.00064.x
   Jegat C, 2000, POLYM BULL, V44, P345, DOI 10.1007/s002890050612
   Kunduru KR, 2015, BIOMACROMOLECULES, V16, P2572, DOI 10.1021/acs.biomac.5b00923
   Lakkis J. M., 2007, ENCAPSULATION CONTRO
   Li L, 2013, TEXT RES J, V83, P1236, DOI 10.1177/0040517512467059
   Liu JY, 2013, COLLOID SURFACE B, V109, P103, DOI 10.1016/j.colsurfb.2013.03.040
   Ma ZH, 2009, COLLOID SURFACE B, V69, P85, DOI 10.1016/j.colsurfb.2008.11.005
   Borreguero AM, 2013, TEXT RES J, V83, P1754, DOI 10.1177/0040517513481872
   Martinez-Camacho AP, 2010, CARBOHYD POLYM, V82, P305, DOI 10.1016/j.carbpol.2010.04.069
   Martins I. M., 2012, THESIS
   Specos MMM, 2010, T ROY SOC TROP MED H, V104, P653, DOI 10.1016/j.trstmh.2010.06.004
   Miro Specos M. M. M., 2010, J IND TEXT, V40, P13
   Monllor P, 2010, TEXT RES J, V80, P631, DOI 10.1177/0040517509346444
   Moreira ACG, 2016, CAN J CHEM ENG, V94, P469, DOI 10.1002/cjce.22411
   Nazzaro F, 2012, CURR OPIN BIOTECH, V23, P182, DOI 10.1016/j.copbio.2011.10.001
   Nelson G, 2002, INT J PHARM, V242, P55, DOI 10.1016/S0378-5173(02)00141-2
   Oliveira BF, 2005, BRAZ J CHEM ENG, V22, P353, DOI 10.1590/S0104-66322005000300004
   Pakzad H, 2013, IJE T B, V26, P807
   Panisello C, 2013, IND ENG CHEM RES, V52, P9995, DOI 10.1021/ie3036096
   Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972
   Rabiskova M, 1998, J MICROENCAPSUL, V15, P747, DOI 10.3109/02652049809008257
   Rodrigues SN, 2009, CHEM ENG J, V149, P463, DOI 10.1016/j.cej.2009.02.021
   Rodrigues S. N., 2010, THESIS
   Rodrigues SN, 2008, IND ENG CHEM RES, V47, P4142, DOI 10.1021/ie800090c
   Salaun F, 2012, CHEM ENG J, V213, P78, DOI 10.1016/j.cej.2012.09.062
   Salaun F, 2011, POLYM DEGRAD STABIL, V96, P131, DOI 10.1016/j.polymdegradstab.2010.10.009
   Salaun F, 2010, THERMOCHIM ACTA, V506, P82, DOI 10.1016/j.tca.2010.04.020
   Sanchez-Silva L, 2012, J APPL POLYM SCI, V124, P4809, DOI 10.1002/app.35546
   Shahid-ul-Islam, 2013, IND ENG CHEM RES, V52, P5245, DOI 10.1021/ie303627x
   Smith WC, 2010, WOODHEAD PUBL TEXT, P3, DOI 10.1533/9781845697785.1.3
   Son K, 2014, CHEM ENG J, V239, P284, DOI 10.1016/j.cej.2013.11.034
   Su JF, 2006, J APPL POLYM SCI, V101, P1522, DOI 10.1002/app.23151
   Sundrarajan M., 2013, ADV CHEM LETT, V1, P40
   Wilson R, 1998, FOOD CHEM TOXICOL, V36, P711, DOI 10.1016/S0278-6915(98)00057-X
   Xiao ZB, 2015, COLLOID POLYM SCI, V293, P1339, DOI 10.1007/s00396-015-3515-x
   Xiao ZB, 2014, J SCI FOOD AGR, V94, P1482, DOI 10.1002/jsfa.6491
   Xiao ZB, 2014, FLAVOUR FRAG J, V29, P166, DOI 10.1002/ffj.3192
   Xing FB, 2004, J APPL POLYM SCI, V91, P2669, DOI 10.1002/app.13449
   Yang ZM, 2014, FOOD CHEM, V145, P272, DOI 10.1016/j.foodchem.2013.08.074
   Yang ZJ, 2014, FLAVOUR FRAG J, V29, P114, DOI 10.1002/ffj.3186
   Zhang L, 2008, COLLOID SURFACE A, V320, P111, DOI 10.1016/j.colsurfa.2008.01.035
   Zhang L, 2010, J SCI FOOD AGR, V90, P2462, DOI 10.1002/jsfa.4107
NR 61
TC 0
Z9 0
U1 9
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD MAY 17
PY 2017
VL 56
IS 19
BP 5516
EP 5526
DI 10.1021/acs.iecr.7b00741
PG 11
WC Engineering, Chemical
SC Engineering
GA EV5DC
UT WOS:000401781700005
OA No
DA 2017-08-17
ER

PT J
AU Al-Qurashi, AD
   Awad, MA
   Mohamed, SA
   Elsayed, MI
AF Al-Qurashi, Adel D.
   Awad, Mohamed A.
   Mohamed, Saleh A.
   Elsayed, Mohamed I.
TI Postharvest chitosan, trans-resveratrol and glycine betaine dipping
   affect quality, antioxidant compounds, free radical scavenging capacity
   and enzymes activities of `Sukkari' bananas during shelf life
SO SCIENTIA HORTICULTURAE
LA English
DT Article
DE Banana; Chitosan; Antioxidants; Resveratrol; Glycine betaine; Enzymes
ID PHYSIOLOGICAL-RESPONSES; FRUIT; STORAGE; STRESS; RESISTANCE;
   CHLOROPLASTS; VEGETABLES; SALINITY; LETTUCE; PLANTS
AB Effects of chitosan (0.5 and 1%), trans-resveratrol (1.6 x 10(-5) M, 1.6 x 10(-4) M and 1.6 x 10(-3)M) and glycine betaine (GB) (10, 15 and 20 mM) dipping on quality and biochemical changes of `SukkarF bananas were studied during ripening at shelf life (SL) conditions for 13 days. Weight loss increased during shelf life but was not affected by treatments. Peel color index increased during SL and was lower at both resveratrol and GB treatments than control. Membrane stability index (MSI) of peel decreased during SL and was higher, especially after 6 days, at resveratrol and GB treatments than control. Firmness decreased during SL and was higher, especially after 6 days, at resveratrol and low and moderate rates of GB than control. TSS increased during SL and was lower at all treatments than control. Acidity concentration decreased during SL and was higher, especially after 6 days, at low rate of chitosan, resveratrol and high rate of GB than control. pH increased during SL and was higher at low rate of GB and lower at low and moderate rates of resveratrol than control. Vitamin C concentration decreased during SL but was not affected by treatments. Total phenols concentration decreased during SL and was higher at GB and moderate rate of resveratrol than control. Total flavonoids concentration decreased during SL and was lower at resveratrol and low and high rates of GB than control. FRSC (DPPH IC50) increased during SL and was lower at GB and low and moderate rates of resveratrol than other treatments, especially after 6 days. The relations of such biochemical changes with alpha-amylase, xylanase, polygalacturonase, peroxidase and polyphenoloxidase activities were discussed. In conclusion, both postharvest trans-resveratrol and GB treatments retained quality of 'Sukkari' bananas during SL and being suggested as natural alternatives to synthetic chemicals. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Al-Qurashi, Adel D.; Awad, Mohamed A.; Elsayed, Mohamed I.] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, POB 80208, Jeddah, Saudi Arabia.
   [Awad, Mohamed A.] Mansoura Univ, Pomol Dept, Fac Agr, Mansoura, Egypt.
   [Mohamed, Saleh A.] King Abdulaziz Univ, Dept Biochem, Fac Sci, POB 80208, Jeddah, Saudi Arabia.
   [Mohamed, Saleh A.] Natl Res Ctr, Mol Biol Dept, Cairo, Egypt.
RP Awad, MA (reprint author), King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, POB 80208, Jeddah, Saudi Arabia.
EM mawad@mans.edu.eg
FU Deanship of Scientific Research (DSR) at King Abdulaziz University,
   Jeddah [G-53-1551437]; DSR
FX This project was funded by the Deanship of Scientific Research (DSR) at
   King Abdulaziz University, Jeddah, under grant G-53-1551437. The
   authors, therefore, acknowledge with thanks DSR for technical and
   financial support. Also, we would like to thank Nageeb Al-Masoudi,
   M.Sc., and Nour Gamal, B.Sc. at the Arid land Agriculture Department,
   Faculty of Meteorology, Environment and Arid land Agriculture, King
   Abdulaziz University, for their indispensable technical support.
CR Adrian M, 1997, J CHEM ECOL, V23, P1689, DOI 10.1023/B:JOEC.0000006444.79951.75
   Ao CW, 2008, FOOD CONTROL, V19, P940, DOI 10.1016/j.foodcont.2007.09.007
   Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006
   Awad MA, 2015, SCI HORTIC-AMSTERDAM, V197, P350, DOI 10.1016/j.scienta.2015.09.065
   Ayranci E, 2003, FOOD CHEM, V80, P423, DOI 10.1016/S0308-8146(02)00485-5
   Bhande SD, 2008, J FOOD ENG, V87, P116, DOI 10.1016/j.jfoodeng.2007.11.019
   Campos-Vargas R, 2002, PHYSIOL PLANTARUM, V114, P73, DOI 10.1034/j.1399-3054.2002.1140111.x
   Cano MP, 1997, FOOD CHEM, V59, P411, DOI 10.1016/S0308-8146(96)00285-3
   Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15
   Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x
   Cherukuri K., 2007, THESIS, P96
   Ciz M, 2010, FOOD CONTROL, V21, P518, DOI 10.1016/j.foodcont.2009.07.017
   Dani C, 2012, GENET MOL RES, V11, P3154, DOI 10.4238/2012.September.3.4
   Duan X. W., 2007, FRESH PRODUCE, V1, P140
   Fernando H. R. P., 2014, International Food Research Journal, V21, P749
   Fu-gui W., 2013, FOOD SCI, V34, P313
   GENARD H, 1991, PLANT PHYSIOL BIOCH, V29, P421
   Gillcin I., 2010, INNOV FOOD SCI EMERG, V11, P210
   Gong DQ, 2013, J HORTIC SCI BIOTECH, V88, P243
   Gonzalez U. A., 2003, J AGR FOOD CHEM, V51, P82, DOI 10.1021/jf020663v
   Hailu M., 2013, African Journal of Biotechnology, V12, P635
   HOFF JE, 1977, J FOOD SCI, V42, P1566, DOI 10.1111/j.1365-2621.1977.tb08427.x
   Hossain M.A., 2014, BIOMED RES INT, V2014, P1
   Hurme EU, 1999, J FOOD PROTECT, V62, P363
   Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2
   Jiang YM, 2002, POSTHARVEST BIOL TEC, V26, P241, DOI 10.1016/S0925-5214(02)00047-9
   Jimenez JB, 2005, J AGR FOOD CHEM, V53, P1526, DOI 10.1021/jf048426a
   Jinasena D., 2011, INT C AS AGR AN IPCB, V13, P56
   Kondo S, 2005, POSTHARVEST BIOL TEC, V36, P309, DOI 10.1016/j.postharvbio.2005.02.003
   Liu J, 2007, POSTHARVEST BIOL TEC, V44, P300, DOI 10.1016/j.postharvbio.2006.12.019
   MACHEIX JJ, 1990, FRUIT PHENOLICS
   Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707
   Maqbool M, 2011, J AGR FOOD CHEM, V59, P5474, DOI 10.1021/jf200623m
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   MIRANDA MV, 1995, APPL BIOCHEM BIOTECH, V53, P147, DOI 10.1007/BF02788604
   Nawaz K, 2010, J AGRON CROP SCI, V196, P28, DOI 10.1111/j.1439-037X.2009.00385.x
   Ou BX, 2002, J AGR FOOD CHEM, V50, P3122, DOI 10.1021/jf0116606
   Pereira A, 2015, J ETHNOPHARMACOL, V160, P149, DOI 10.1016/j.jep.2014.11.008
   Ranganna S., 1979, MANUAL ANAL FRUIT VE, P634
   ROBINSON SP, 1986, AUST J PLANT PHYSIOL, V13, P659
   Romanazzi G, 2013, POSTHARVEST BIOL TEC, V75, P24, DOI 10.1016/j.postharvbio.2012.07.007
   Sairam RK, 1997, J AGRON CROP SCI, V178, P171, DOI 10.1111/j.1439-037X.1997.tb00486.x
   Suseno N, 2014, PROCEDIA CHEM, V9, P113, DOI 10.1016/j.proche.2014.05.014
   Wang YS, 2014, SCI HORTIC-AMSTERDAM, V168, P132, DOI 10.1016/j.scienta.2014.01.022
   Yang WJ, 2003, CROP SCI, V43, P162
   Zhang MM, 2016, J AGR FOOD CHEM, V64, P7921, DOI 10.1021/acs.jafc.6b03592
NR 46
TC 0
Z9 0
U1 20
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4238
EI 1879-1018
J9 SCI HORTIC-AMSTERDAM
JI Sci. Hortic.
PD MAY 17
PY 2017
VL 219
BP 173
EP 181
DI 10.1016/j.scienta.2017.02.046
PG 9
WC Horticulture
SC Agriculture
GA ES1AW
UT WOS:000399261300021
OA No
DA 2017-08-17
ER

PT J
AU Asker, D
   Weiss, J
   McClements, DJ
AF Asker, D.
   Weiss, J.
   McClements, D. J.
TI Analysis of the Interactions of a Cationic Surfactant (Lauric Arginate)
   with an Anionic Biopolymer (Pectin): Isothermal Titration Calorimetry,
   Light Scattering, and Microelectrophoresis (vol 25, pg 116, 2009)
SO LANGMUIR
LA English
DT Correction
C1 [Asker, D.; Weiss, J.; McClements, D. J.] Univ Massachusetts, Dept Food Sci, Amherst, MA 01003 USA.
   [Asker, D.] Alexandria Univ, Fac Agr, Food Sci & Technol Dept, Alexandria, Egypt.
RP McClements, DJ (reprint author), Univ Massachusetts, Dept Food Sci, Amherst, MA 01003 USA.
CR Asker D, 2009, LANGMUIR, V25, P116, DOI 10.1021/la803038w
NR 1
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 16
PY 2017
VL 33
IS 19
BP 4878
EP 4878
DI 10.1021/acs.langmuir.7b00272
PG 1
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA EV3QT
UT WOS:000401674900032
PM 28471178
OA No
DA 2017-08-17
ER

PT J
AU Aboulela, M
   Tanaka, Y
   Nishimura, K
   Mano, S
   Nishimura, M
   Ishiguro, S
   Kimura, T
   Nakagawa, T
AF Aboulela, Mostafa
   Tanaka, Yuji
   Nishimura, Kohji
   Mano, Shoji
   Nishimura, Mikio
   Ishiguro, Sumie
   Kimura, Tetsuya
   Nakagawa, Tsuyoshi
TI Development of an R4 dual-site (R4DS) gateway cloning system enabling
   the efficient simultaneous cloning of two desired sets of promoters and
   open reading frames in a binary vector for plant research
SO PLOS ONE
LA English
DT Article
ID MATRIX ATTACHMENT REGIONS; RED FLUORESCENT PROTEIN;
   ARABIDOPSIS-THALIANA; TRANSGENE EXPRESSION; STOMATAL DEVELOPMENT;
   RESISTANCE GENE; DNA CLONING; TRANSFORMATION; RECOMBINATION; MARKER
AB Vast numbers of proteins work cooperatively to exert their functions in various cells. In order to understand the functions and molecular mechanisms of these proteins in plants, analyses of transgenic plants that concomitantly express two protein-coding genes are often required. We developed a novel Gateway cloning technology-compatible binary vector system, the R4 dual-site (R4DS) Gateway cloning system, which enables the easy and efficient cloning of two desired sets of promoters and open reading frames (ORFs) into a binary vector using promoter and ORF entry clones. In this system, C-terminal fusions with 17 kinds of tags including visible reporters and epitope tags are available for each ORF, and selection by four kinds of resistance markers is possible. We verified that the R4DS Gateway cloning system functioned well in Arabidopsis thaliana by observing the expression and localization patterns of fluorescent proteins fused with organelle-targeting signals and driven by stomatal-lineage specific promoters. We also confirmed that the two cloning sites in the R4DS Gateway cloning system were equivalent and independently regulated. The results obtained indicate that the R4DS Gateway cloning system facilitates detailed comparisons of the expression patterns of two promoters as well as co-localization and interaction analyses of two proteins in specific cells in plants.
C1 [Aboulela, Mostafa; Tanaka, Yuji; Nishimura, Kohji; Nakagawa, Tsuyoshi] Shimane Univ, Interdisciplinary Ctr Sci Res, Org Res, Dept Mol & Funct Genom, Matsue, Shimane, Japan.
   [Aboulela, Mostafa; Nishimura, Kohji; Nakagawa, Tsuyoshi] Tottori Univ, United Grad Sch Agr Sci, Bioresources Sci, Tottori, Japan.
   [Aboulela, Mostafa] Assiut Univ, Fac Sci, Dept Bot & Microbiol, Assiut, Egypt.
   [Mano, Shoji] Natl Inst Basic Biol, Dept Evolutionary Biol & Biodivers, Okazaki, Aichi, Japan.
   [Mano, Shoji] SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan.
   [Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan.
   [Ishiguro, Sumie] Nagoya Univ, Grad Sch Bioagr Sci, Dept Biol Mech & Funct, Nagoya, Aichi, Japan.
   [Kimura, Tetsuya] Mie Univ, Grad Sch Bioresources, Dept Life Sci, Tsu, Mie, Japan.
   [Nishimura, Mikio] Natl Inst Basic Biol, Res Enhancement Strategy Off, Okazaki, Aichi, Japan.
RP Nakagawa, T (reprint author), Shimane Univ, Interdisciplinary Ctr Sci Res, Org Res, Dept Mol & Funct Genom, Matsue, Shimane, Japan.; Nakagawa, T (reprint author), Tottori Univ, United Grad Sch Agr Sci, Bioresources Sci, Tottori, Japan.
EM tnakagaw@life.shimane-u.ac.jp
RI Ishiguro, Sumie/I-6903-2014
FU KAKENHI Grant from Japan Society for the Promotion of Science (JSPS)
   [JP26440157, JP15K07109]; Japan Agency for Medical Research and
   Development, AMED
FX This work was supported by KAKENHI Grant from Japan Society for the
   Promotion of Science (JSPS) [Grant-in-Aid for Scientific Research (C)
   No. JP26440157 to SM and No. JP15K07109 to TN] and Research Program on
   Hepatitis from Japan Agency for Medical Research and Development, AMED,
   to MN. URL for Kakenhi:
   http://www.jsps.go.jp/english/e-grants/index.html; URL for AMED:
   http://www.amed.go.jp/en/. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Benhamed M, 2008, PLANT J, V56, P493, DOI 10.1111/j.1365-313X.2008.03606.x
   Berger D, 2000, GENE DEV, V14, P1119
   Bergmann DC, 2007, ANNU REV PLANT BIOL, V58, P163, DOI 10.1146/annurev.arplant.58.032806.104023
   Buntru M, 2013, TRANSGENIC RES, V22, P153, DOI 10.1007/s11248-012-9640-0
   Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699
   Cheng ZQ, 2001, MOL BREEDING, V7, P317, DOI 10.1023/A:1011655214556
   Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204
   Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9
   Chubet RG, 1996, BIOTECHNIQUES, V20, P136
   Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x
   Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104
   Fernandez AI, 2009, PLANT PHYSIOL, V151, P1729, DOI 10.1104/pp.109.147546
   Ghareeb H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00246
   Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176
   GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z
   HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672
   Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x
   Han KH, 1997, TRANSGENIC RES, V6, P415, DOI 10.1023/A:1018439518649
   Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000
   He Z, 2016, J GENET GENOMICS, V43, P207
   Hecker A, 2015, PLANT PHYSIOL, V168, P776, DOI 10.1104/pp.15.00533
   Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331
   Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259
   JEFFERSON RA, 1987, EMBO J, V6, P3901
   Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989
   Karimi M, 2007, PLANT PHYSIOL, V145, P1183, DOI 10.1104/pp.107.110411
   Kawakami S., 1997, PLANT BIOTECHNOL, V14, P127
   Kim S, 2010, TRANSGENIC RES, V19, P489, DOI 10.1007/s11248-009-9330-8
   Kimura T, 2013, BIOSCI BIOTECH BIOCH, V77, P430, DOI 10.1271/bbb.120877
   Li MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100948
   MLYNAROVA L, 1994, PLANT CELL, V6, P417
   Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.706781
   Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216
   Nakagawa T, 2009, PLANT BIOTECHNOL, V26, P275, DOI 10.5511/plantbiotechnology.26.275
   Nakamura S, 2010, BIOSCI BIOTECH BIOCH, V74, P1315, DOI 10.1271/bbb.100184
   NISHIMURA M, 1986, PLANT PHYSIOL, V81, P313, DOI 10.1104/pp.81.1.313
   Petersen K, 2002, PLANT MOL BIOL, V49, P45, DOI 10.1023/A:1014464127973
   Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531
   Pillitteri LJ, 2008, PLANT CELL PHYSIOL, V49, P934, DOI 10.1093/pcp/pcn067
   Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467
   Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451
   Pruneda-Paz JL, 2014, CELL REP, V8, P621, DOI 10.1016/j.celrep.2014.06.033
   Ren F, 2010, J PLANT PHYSIOL, V167, P1412, DOI 10.1016/j.jplph.2010.03.021
   Sakamoto W, 1996, PLANT PHYSIOL, V112, P1736
   Sambrook J, 2001, MOL CLONING LAB MANU
   Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001
   Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083
   Sherf B. A., 1994, PROMEGA NOTES, V49, P14
   Siligato R, 2016, PLANT PHYSIOL, V170, P627, DOI 10.1104/pp.15.01246
   Singh T, 2009, PLANT J, V60, P488, DOI 10.1111/j.1365-313X.2009.03970.x
   Spiker S, 1996, PLANT PHYSIOL, V110, P15
   Steever A. B., 1998, YEAST, V14, P943
   Sun QX, 2013, PLANT MOL BIOL, V83, P391, DOI 10.1007/s11103-013-0096-2
   Tachiki K, 2009, J BIOSCI BIOENG, V108, P11, DOI 10.1016/j.jbiosc.2009.02.010
   Tanaka Y, 2011, BIOSCI BIOTECH BIOCH, V75, P804, DOI 10.1271/bbb.110063
   Verma D, 2005, PLANT SCI, V169, P704, DOI 10.1016/j.plantsci.2005.05.021
   von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016
   Xie MT, 2001, NAT BIOTECHNOL, V19, P677, DOI 10.1038/90296
   Yano D, 2003, P NATL ACAD SCI USA, V100, P8589, DOI 10.1073/pnas.1430749100
NR 59
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 16
PY 2017
VL 12
IS 5
AR e0177889
DI 10.1371/journal.pone.0177889
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EV1DC
UT WOS:000401485500080
PM 28520787
OA gold
DA 2017-08-17
ER

EF